{"0c03c75f0496cafe4a6bf1f620b26f6d5137f725": [["GENERAL CONSIDERATIONSFrom a contemporary perspective, the liver is a marvel of biology.", [["liver", "ANATOMY", 59, 64], ["liver", "ORGAN", 59, 64], ["liver", "ANATOMY", 59, 64]]], ["It is the guardian of homeostasis, the epicenter of the body's metabolic capability, a massive filter detoxifying the portal blood releasing cleansed blood to the systemic circulation, and a lymphoid organ protecting against infection.", [["body", "ANATOMY", 56, 60], ["portal blood", "ANATOMY", 118, 130], ["blood", "ANATOMY", 150, 155], ["lymphoid organ", "ANATOMY", 191, 205], ["infection", "DISEASE", 225, 234], ["body", "ORGANISM_SUBDIVISION", 56, 60], ["blood", "ORGANISM_SUBSTANCE", 125, 130], ["blood", "ORGANISM_SUBSTANCE", 150, 155], ["lymphoid organ", "TISSUE", 191, 205], ["a massive filter", "TREATMENT", 85, 101], ["a lymphoid organ", "TREATMENT", 189, 205], ["infection", "PROBLEM", 225, 234], ["metabolic capability", "OBSERVATION", 63, 83], ["massive filter", "OBSERVATION", 87, 101], ["portal", "ANATOMY", 118, 124], ["systemic circulation", "ANATOMY", 163, 183], ["lymphoid organ", "OBSERVATION", 191, 205], ["infection", "OBSERVATION", 225, 234]]], ["However high our regard for the liver, it is dwarfed by the perspective of ancient civilizations that regarded the liver as the seat of life and window to the future.", [["liver", "ANATOMY", 32, 37], ["liver", "ANATOMY", 115, 120], ["liver", "ORGAN", 32, 37], ["liver", "ORGAN", 115, 120], ["ancient civilizations", "TREATMENT", 75, 96], ["liver", "ANATOMY", 32, 37], ["liver", "ANATOMY", 115, 120]]], ["In ancient Mesopotamia and Babylonia, the liver was used to divine the future using a technique termed hepatoscopy.", [["liver", "ANATOMY", 42, 47], ["liver", "ORGAN", 42, 47], ["Babylonia", "TREATMENT", 27, 36], ["a technique termed hepatoscopy", "TREATMENT", 84, 114], ["liver", "ANATOMY", 42, 47]]], ["This interest is captured in a Biblical quote from Ezekiel 21 : 21, \"For the king of Babylon stands at the parting of the way, at the head of the two ways, to use divination; he shakes the arrows, he consults the household idols, he looks at the liver.\"", [["liver", "ANATOMY", 246, 251], ["head", "ORGANISM_SUBDIVISION", 134, 138], ["liver", "ORGAN", 246, 251], ["divination", "TREATMENT", 163, 173], ["liver", "ANATOMY", 246, 251]]], ["Hepatoscopy was continued by the Greeks, Etruscans, and the Romans.", [["Hepatoscopy", "TREATMENT", 0, 11]]], ["Liver injury or neoplasia foretells a poor future for many pharmaceuticals in development.GENERAL CONSIDERATIONSThe liver plays a central role in processing dietary carbohydrates, lipids, amino acids, and vitamins; in the synthesis and turnover of most plasma proteins; and in the detoxification and biliary excretion of endogenous wastes and xenobiotic compounds.", [["Liver", "ANATOMY", 0, 5], ["neoplasia", "ANATOMY", 16, 25], ["liver", "ANATOMY", 116, 121], ["plasma", "ANATOMY", 253, 259], ["biliary", "ANATOMY", 300, 307], ["Liver injury", "DISEASE", 0, 12], ["neoplasia", "DISEASE", 16, 25], ["amino acids", "CHEMICAL", 188, 199], ["vitamins", "CHEMICAL", 205, 213], ["carbohydrates", "CHEMICAL", 165, 178], ["amino acids", "CHEMICAL", 188, 199], ["vitamins", "CHEMICAL", 205, 213], ["Liver", "ORGAN", 0, 5], ["neoplasia", "CANCER", 16, 25], ["liver", "ORGAN", 116, 121], ["lipids", "SIMPLE_CHEMICAL", 180, 186], ["amino acids", "AMINO_ACID", 188, 199], ["vitamins", "SIMPLE_CHEMICAL", 205, 213], ["plasma", "ORGANISM_SUBSTANCE", 253, 259], ["biliary", "MULTI-TISSUE_STRUCTURE", 300, 307], ["plasma proteins", "PROTEIN", 253, 268], ["Liver injury", "PROBLEM", 0, 12], ["neoplasia foretells", "PROBLEM", 16, 35], ["many pharmaceuticals", "TREATMENT", 54, 74], ["processing dietary carbohydrates", "TREATMENT", 146, 178], ["lipids", "TREATMENT", 180, 186], ["amino acids", "TREATMENT", 188, 199], ["vitamins", "TREATMENT", 205, 213], ["most plasma proteins", "PROBLEM", 248, 268], ["the detoxification", "TREATMENT", 277, 295], ["endogenous wastes", "TREATMENT", 321, 338], ["xenobiotic compounds", "TREATMENT", 343, 363], ["injury", "OBSERVATION", 6, 12], ["neoplasia", "OBSERVATION", 16, 25], ["pharmaceuticals", "OBSERVATION", 59, 74], ["liver", "ANATOMY", 116, 121], ["biliary", "ANATOMY", 300, 307], ["endogenous wastes", "OBSERVATION", 321, 338], ["xenobiotic compounds", "OBSERVATION", 343, 363]]], ["The liver also functions as an important organ of the innate immune system, integrated into the complex system of defense against foreign macromolecules.", [["liver", "ANATOMY", 4, 9], ["organ", "ANATOMY", 41, 46], ["immune system", "ANATOMY", 61, 74], ["liver", "ORGAN", 4, 9], ["organ", "ORGAN", 41, 46], ["innate", "ANATOMICAL_SYSTEM", 54, 60], ["immune system", "ANATOMICAL_SYSTEM", 61, 74], ["foreign macromolecules", "PROBLEM", 130, 152], ["liver", "ANATOMY", 4, 9], ["foreign macromolecules", "OBSERVATION", 130, 152]]], ["As such, hepatic disorders have far-reaching consequences, given the dependence of other organs on the metabolic function of the liver.Origin, structure, and functionThe embryonic origin of the liver is an out-pouching of the embryonic endoderm forming the duodenum termed the hepatic diverticulum or the liver bud.", [["hepatic", "ANATOMY", 9, 16], ["organs", "ANATOMY", 89, 95], ["liver", "ANATOMY", 129, 134], ["embryonic", "ANATOMY", 170, 179], ["liver", "ANATOMY", 194, 199], ["embryonic endoderm", "ANATOMY", 226, 244], ["duodenum", "ANATOMY", 257, 265], ["hepatic diverticulum", "ANATOMY", 277, 297], ["liver bud", "ANATOMY", 305, 314], ["hepatic disorders", "DISEASE", 9, 26], ["hepatic", "ORGAN", 9, 16], ["organs", "ORGAN", 89, 95], ["liver", "ORGAN", 129, 134], ["embryonic", "DEVELOPING_ANATOMICAL_STRUCTURE", 170, 179], ["liver", "ORGAN", 194, 199], ["embryonic endoderm", "TISSUE", 226, 244], ["duodenum", "ORGAN", 257, 265], ["hepatic diverticulum", "MULTI-TISSUE_STRUCTURE", 277, 297], ["liver bud", "MULTI-TISSUE_STRUCTURE", 305, 314], ["hepatic disorders", "PROBLEM", 9, 26], ["the embryonic endoderm", "PROBLEM", 222, 244], ["the hepatic diverticulum", "PROBLEM", 273, 297], ["hepatic", "ANATOMY", 9, 16], ["disorders", "OBSERVATION", 17, 26], ["metabolic function", "OBSERVATION", 103, 121], ["liver", "ANATOMY", 129, 134], ["structure", "OBSERVATION_MODIFIER", 143, 152], ["embryonic", "OBSERVATION_MODIFIER", 170, 179], ["origin", "ANATOMY_MODIFIER", 180, 186], ["liver", "ANATOMY", 194, 199], ["embryonic endoderm", "OBSERVATION", 226, 244], ["duodenum", "ANATOMY", 257, 265], ["hepatic", "ANATOMY", 277, 284], ["diverticulum", "OBSERVATION", 285, 297], ["liver", "ANATOMY", 305, 310], ["bud", "ANATOMY_MODIFIER", 311, 314]]], ["Primitive epithelial cells of the hepatic diverticulum extend into the adjacent mesenchymal stroma of the septum transversum, a sheet of cells that incompletely separates the pericardial and peritoneal cavity and that will develop into the connective tissue of the liver.", [["epithelial cells", "ANATOMY", 10, 26], ["hepatic diverticulum", "ANATOMY", 34, 54], ["mesenchymal stroma", "ANATOMY", 80, 98], ["septum transversum", "ANATOMY", 106, 124], ["cells", "ANATOMY", 137, 142], ["pericardial", "ANATOMY", 175, 186], ["peritoneal cavity", "ANATOMY", 191, 208], ["connective tissue", "ANATOMY", 240, 257], ["liver", "ANATOMY", 265, 270], ["epithelial cells", "CELL", 10, 26], ["hepatic diverticulum", "PATHOLOGICAL_FORMATION", 34, 54], ["mesenchymal stroma", "TISSUE", 80, 98], ["septum transversum", "TISSUE", 106, 124], ["cells", "CELL", 137, 142], ["pericardial", "ORGAN", 175, 186], ["peritoneal cavity", "MULTI-TISSUE_STRUCTURE", 191, 208], ["connective tissue", "TISSUE", 240, 257], ["liver", "ORGAN", 265, 270], ["Primitive epithelial cells", "CELL_TYPE", 0, 26], ["Primitive epithelial cells of the hepatic diverticulum", "PROBLEM", 0, 54], ["a sheet of cells", "TREATMENT", 126, 142], ["epithelial cells", "OBSERVATION", 10, 26], ["hepatic", "ANATOMY", 34, 41], ["diverticulum", "OBSERVATION", 42, 54], ["mesenchymal stroma", "OBSERVATION", 80, 98], ["septum transversum", "ANATOMY", 106, 124], ["pericardial", "ANATOMY", 175, 186], ["peritoneal cavity", "ANATOMY", 191, 208], ["connective tissue", "ANATOMY_MODIFIER", 240, 257], ["liver", "ANATOMY", 265, 270]]], ["The primitive epithelial cells are arranged in close approximation with the vessels that form the vitelline venous plexus, a complex of vessels that drain the yolk sac.", [["epithelial cells", "ANATOMY", 14, 30], ["vessels", "ANATOMY", 76, 83], ["vitelline venous plexus", "ANATOMY", 98, 121], ["vessels", "ANATOMY", 136, 143], ["yolk sac", "ANATOMY", 159, 167], ["epithelial cells", "CELL", 14, 30], ["vessels", "MULTI-TISSUE_STRUCTURE", 76, 83], ["vitelline venous plexus", "MULTI-TISSUE_STRUCTURE", 98, 121], ["vessels", "MULTI-TISSUE_STRUCTURE", 136, 143], ["yolk sac", "ORGAN", 159, 167], ["primitive epithelial cells", "CELL_TYPE", 4, 30], ["the vitelline venous plexus", "PROBLEM", 94, 121], ["primitive epithelial cells", "OBSERVATION", 4, 30], ["vessels", "ANATOMY", 76, 83], ["vitelline", "ANATOMY_MODIFIER", 98, 107], ["venous plexus", "ANATOMY", 108, 121], ["complex", "OBSERVATION_MODIFIER", 125, 132], ["vessels", "ANATOMY", 136, 143], ["drain", "OBSERVATION", 149, 154], ["yolk", "OBSERVATION_MODIFIER", 159, 163], ["sac", "OBSERVATION_MODIFIER", 164, 167]]], ["Thus the essential sinusoidal arrangement of the liver is established very early in development.", [["liver", "ANATOMY", 49, 54], ["liver", "ORGAN", 49, 54], ["essential", "OBSERVATION_MODIFIER", 9, 18], ["sinusoidal arrangement", "OBSERVATION", 19, 41], ["liver", "ANATOMY", 49, 54]]], ["The gallbladder and the cystic duct arise from the caudal part of the hepatic diverticulum.Origin, structure, and functionThe hepatic diverticulum is also the origin of the biliary epithelium.", [["gallbladder", "ANATOMY", 4, 15], ["cystic duct", "ANATOMY", 24, 35], ["caudal part", "ANATOMY", 51, 62], ["hepatic diverticulum", "ANATOMY", 70, 90], ["hepatic diverticulum", "ANATOMY", 126, 146], ["biliary epithelium", "ANATOMY", 173, 191], ["hepatic diverticulum", "DISEASE", 70, 90], ["hepatic diverticulum", "DISEASE", 126, 146], ["gallbladder", "ORGAN", 4, 15], ["cystic duct", "MULTI-TISSUE_STRUCTURE", 24, 35], ["caudal part", "MULTI-TISSUE_STRUCTURE", 51, 62], ["hepatic diverticulum", "MULTI-TISSUE_STRUCTURE", 70, 90], ["hepatic diverticulum", "PATHOLOGICAL_FORMATION", 126, 146], ["biliary epithelium", "TISSUE", 173, 191], ["The hepatic diverticulum", "PROBLEM", 122, 146], ["gallbladder", "ANATOMY", 4, 15], ["cystic duct", "ANATOMY", 24, 35], ["caudal", "ANATOMY_MODIFIER", 51, 57], ["hepatic", "ANATOMY", 70, 77], ["diverticulum", "OBSERVATION", 78, 90], ["structure", "OBSERVATION_MODIFIER", 99, 108], ["hepatic", "ANATOMY", 126, 133], ["diverticulum", "OBSERVATION", 134, 146], ["origin", "ANATOMY_MODIFIER", 159, 165], ["biliary epithelium", "ANATOMY", 173, 191]]], ["Development of the biliary tree begins at the hilus and spreads outward to reach the subcapsular zone over time.", [["biliary tree", "ANATOMY", 19, 31], ["hilus", "ANATOMY", 46, 51], ["subcapsular zone", "ANATOMY", 85, 101], ["biliary tree", "MULTI-TISSUE_STRUCTURE", 19, 31], ["hilus", "MULTI-TISSUE_STRUCTURE", 46, 51], ["subcapsular zone", "MULTI-TISSUE_STRUCTURE", 85, 101], ["the biliary tree", "PROBLEM", 15, 31], ["biliary", "ANATOMY", 19, 26], ["tree", "ANATOMY_MODIFIER", 27, 31], ["hilus", "ANATOMY", 46, 51], ["outward", "OBSERVATION_MODIFIER", 64, 71], ["subcapsular", "ANATOMY_MODIFIER", 85, 96], ["zone", "ANATOMY_MODIFIER", 97, 101]]], ["Intrahepatic bile ducts develop from the ductal plate, a structure that is composed initially of a single row of hepatoblasts that surround the portal vein branches and ensheath the mesenchyme of the primitive portal tract.", [["Intrahepatic bile ducts", "ANATOMY", 0, 23], ["ductal plate", "ANATOMY", 41, 53], ["hepatoblasts", "ANATOMY", 113, 125], ["portal vein", "ANATOMY", 144, 155], ["mesenchyme", "ANATOMY", 182, 192], ["primitive portal tract", "ANATOMY", 200, 222], ["Intrahepatic bile ducts", "DISEASE", 0, 23], ["Intrahepatic bile ducts", "MULTI-TISSUE_STRUCTURE", 0, 23], ["ductal plate", "TISSUE", 41, 53], ["hepatoblasts", "CANCER", 113, 125], ["portal vein branches", "MULTI-TISSUE_STRUCTURE", 144, 164], ["mesenchyme", "TISSUE", 182, 192], ["primitive portal tract", "ORGANISM_SUBDIVISION", 200, 222], ["Intrahepatic bile ducts", "PROBLEM", 0, 23], ["a single row of hepatoblasts", "PROBLEM", 97, 125], ["bile ducts", "ANATOMY", 13, 23], ["ductal plate", "ANATOMY", 41, 53], ["hepatoblasts", "OBSERVATION", 113, 125], ["portal vein", "ANATOMY", 144, 155], ["branches", "ANATOMY_MODIFIER", 156, 164], ["mesenchyme", "ANATOMY_MODIFIER", 182, 192], ["primitive", "ANATOMY_MODIFIER", 200, 209], ["portal tract", "ANATOMY", 210, 222]]], ["The development of the hepatoblasts adjacent to the portal tract mesenchyme is altered by interactions with the mesenchyme.", [["hepatoblasts", "ANATOMY", 23, 35], ["portal tract mesenchyme", "ANATOMY", 52, 75], ["mesenchyme", "ANATOMY", 112, 122], ["hepatoblasts", "CANCER", 23, 35], ["portal tract mesenchyme", "MULTI-TISSUE_STRUCTURE", 52, 75], ["mesenchyme", "TISSUE", 112, 122], ["the hepatoblasts", "PROBLEM", 19, 35], ["hepatoblasts", "OBSERVATION", 23, 35], ["portal tract", "ANATOMY", 52, 64], ["mesenchyme", "ANATOMY_MODIFIER", 65, 75], ["altered", "OBSERVATION", 79, 86]]], ["Initially, these cells form the ductal plate, a single row of cells surrounding the portal tract.", [["cells", "ANATOMY", 17, 22], ["ductal plate", "ANATOMY", 32, 44], ["cells", "ANATOMY", 62, 67], ["portal tract", "ANATOMY", 84, 96], ["cells", "CELL", 17, 22], ["ductal plate", "CANCER", 32, 44], ["cells", "CELL", 62, 67], ["portal tract", "MULTI-TISSUE_STRUCTURE", 84, 96], ["ductal plate", "ANATOMY", 32, 44], ["cells", "OBSERVATION", 62, 67], ["portal tract", "ANATOMY", 84, 96]]], ["The cells of the ductal plate can be identified by expression of cytokeratin 7, differentiating them from the hepatoblasts ( Fig. 2-1) .", [["cells", "ANATOMY", 4, 9], ["ductal plate", "ANATOMY", 17, 29], ["hepatoblasts", "ANATOMY", 110, 122], ["cells", "CELL", 4, 9], ["ductal plate", "CANCER", 17, 29], ["cytokeratin 7", "GENE_OR_GENE_PRODUCT", 65, 78], ["hepatoblasts", "CELL", 110, 122], ["cytokeratin 7", "PROTEIN", 65, 78], ["hepatoblasts", "CELL_TYPE", 110, 122], ["cytokeratin", "TEST", 65, 76], ["ductal plate", "ANATOMY", 17, 29], ["hepatoblasts", "ANATOMY", 110, 122]]], ["A second discontinuous outer layer of cells forms subsequently, and the 2-cell-thick regions remodel into tubules.", [["outer layer", "ANATOMY", 23, 34], ["cells", "ANATOMY", 38, 43], ["cell", "ANATOMY", 74, 78], ["tubules", "ANATOMY", 106, 113], ["cells", "CELL", 38, 43], ["tubules", "TISSUE", 106, 113], ["A second discontinuous outer layer of cells", "PROBLEM", 0, 43], ["second", "OBSERVATION_MODIFIER", 2, 8], ["discontinuous", "OBSERVATION_MODIFIER", 9, 22], ["outer", "OBSERVATION_MODIFIER", 23, 28], ["layer", "OBSERVATION_MODIFIER", 29, 34], ["cells", "OBSERVATION", 38, 43], ["tubules", "ANATOMY_MODIFIER", 106, 113]]], ["Most undergo apoptosis, but 1 or 2 ducts become incorporated in the developing portal tract.", [["ducts", "ANATOMY", 35, 40], ["portal tract", "ANATOMY", 79, 91], ["ducts", "MULTI-TISSUE_STRUCTURE", 35, 40], ["portal tract", "MULTI-TISSUE_STRUCTURE", 79, 91], ["apoptosis", "PROBLEM", 13, 22], ["apoptosis", "OBSERVATION", 13, 22], ["ducts", "ANATOMY", 35, 40], ["incorporated", "OBSERVATION", 48, 60], ["portal tract", "ANATOMY", 79, 91]]], ["At about the time the bile ducts are forming, the hepatic artery branches appear in the developing portal tract.", [["bile ducts", "ANATOMY", 22, 32], ["hepatic artery branches", "ANATOMY", 50, 73], ["portal tract", "ANATOMY", 99, 111], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 22, 32], ["hepatic artery", "MULTI-TISSUE_STRUCTURE", 50, 64], ["portal tract", "MULTI-TISSUE_STRUCTURE", 99, 111], ["bile ducts", "ANATOMY", 22, 32], ["hepatic artery", "ANATOMY", 50, 64], ["branches", "ANATOMY_MODIFIER", 65, 73], ["portal tract", "ANATOMY", 99, 111]]], ["Nerves and lymphatics eventually invest the portal tracts as well, completing the mature portal tract.", [["Nerves", "ANATOMY", 0, 6], ["lymphatics", "ANATOMY", 11, 21], ["portal tracts", "ANATOMY", 44, 57], ["portal tract", "ANATOMY", 89, 101], ["Nerves", "MULTI-TISSUE_STRUCTURE", 0, 6], ["lymphatics", "MULTI-TISSUE_STRUCTURE", 11, 21], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 44, 57], ["portal tract", "MULTI-TISSUE_STRUCTURE", 89, 101], ["lymphatics", "ANATOMY", 11, 21], ["portal tracts", "ANATOMY", 44, 57], ["mature", "OBSERVATION", 82, 88], ["portal tract", "ANATOMY", 89, 101]]], ["The wave of development from the hilus to the subcapsular region is imperfect, as the veins, arteries, and bile ducts reach their terminal ends separately.", [["hilus", "ANATOMY", 33, 38], ["subcapsular region", "ANATOMY", 46, 64], ["veins", "ANATOMY", 86, 91], ["arteries", "ANATOMY", 93, 101], ["bile ducts", "ANATOMY", 107, 117], ["hilus", "MULTI-TISSUE_STRUCTURE", 33, 38], ["subcapsular region", "MULTI-TISSUE_STRUCTURE", 46, 64], ["veins", "MULTI-TISSUE_STRUCTURE", 86, 91], ["arteries", "MULTI-TISSUE_STRUCTURE", 93, 101], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 107, 117], ["wave", "OBSERVATION_MODIFIER", 4, 8], ["hilus", "ANATOMY", 33, 38], ["subcapsular", "ANATOMY_MODIFIER", 46, 57], ["region", "ANATOMY_MODIFIER", 58, 64], ["imperfect", "OBSERVATION", 68, 77], ["veins", "ANATOMY", 86, 91], ["arteries", "ANATOMY", 93, 101], ["bile ducts", "ANATOMY", 107, 117], ["terminal", "OBSERVATION_MODIFIER", 130, 138]]], ["Consequently, in human liver, up to 30% of subcapsular portal tracts are \"dyads\" containing only bile duct and artery profiles.", [["liver", "ANATOMY", 23, 28], ["subcapsular portal tracts", "ANATOMY", 43, 68], ["bile duct", "ANATOMY", 97, 106], ["artery", "ANATOMY", 111, 117], ["human", "ORGANISM", 17, 22], ["liver", "ORGAN", 23, 28], ["subcapsular portal tracts", "MULTI-TISSUE_STRUCTURE", 43, 68], ["bile duct", "MULTI-TISSUE_STRUCTURE", 97, 106], ["artery", "MULTI-TISSUE_STRUCTURE", 111, 117], ["human", "SPECIES", 17, 22], ["human", "SPECIES", 17, 22], ["human", "ANATOMY_MODIFIER", 17, 22], ["liver", "ANATOMY", 23, 28], ["subcapsular", "ANATOMY_MODIFIER", 43, 54], ["portal tracts", "ANATOMY", 55, 68], ["bile duct", "ANATOMY", 97, 106], ["artery", "ANATOMY", 111, 117]]], ["Sinusoidal lining cells other than the endothelium likely arise in the bone marrow and populate the liver via a hematogenous route.", [["Sinusoidal lining cells", "ANATOMY", 0, 23], ["endothelium", "ANATOMY", 39, 50], ["bone marrow", "ANATOMY", 71, 82], ["liver", "ANATOMY", 100, 105], ["Sinusoidal lining cells", "CELL", 0, 23], ["endothelium", "TISSUE", 39, 50], ["bone marrow", "MULTI-TISSUE_STRUCTURE", 71, 82], ["liver", "ORGAN", 100, 105], ["Sinusoidal lining cells", "CELL_TYPE", 0, 23], ["Sinusoidal lining cells", "PROBLEM", 0, 23], ["a hematogenous route", "TREATMENT", 110, 130], ["lining cells", "OBSERVATION", 11, 23], ["endothelium", "OBSERVATION", 39, 50], ["bone", "ANATOMY", 71, 75], ["marrow", "OBSERVATION", 76, 82], ["liver", "ANATOMY", 100, 105], ["hematogenous", "OBSERVATION", 112, 124]]], ["The liver is the largest internal organ in the body.", [["liver", "ANATOMY", 4, 9], ["organ", "ANATOMY", 34, 39], ["body", "ANATOMY", 47, 51], ["liver", "ORGAN", 4, 9], ["organ", "ORGAN", 34, 39], ["body", "ORGANISM_SUBDIVISION", 47, 51], ["liver", "ANATOMY", 4, 9], ["largest", "OBSERVATION_MODIFIER", 17, 24], ["internal", "ANATOMY_MODIFIER", 25, 33], ["organ", "OBSERVATION", 34, 39], ["body", "ANATOMY_MODIFIER", 47, 51]]], ["In adult carnivores, the liver constitutes ~3% of body weight.", [["liver", "ANATOMY", 25, 30], ["body", "ANATOMY", 50, 54], ["liver", "ORGAN", 25, 30], ["body", "ORGANISM_SUBDIVISION", 50, 54], ["body weight", "TEST", 50, 61], ["adult", "OBSERVATION_MODIFIER", 3, 8], ["carnivores", "OBSERVATION", 9, 19], ["liver", "ANATOMY", 25, 30], ["~3", "OBSERVATION_MODIFIER", 43, 45]]], ["In adult omnivores, it is ~2% of body weight and ~1% of body weight in adult herbivores.", [["body", "ANATOMY", 33, 37], ["body", "ANATOMY", 56, 60], ["body", "ORGANISM_SUBDIVISION", 33, 37], ["body", "ORGANISM_SUBDIVISION", 56, 60], ["body weight", "TEST", 33, 44], ["herbivores", "OBSERVATION", 77, 87]]], ["In neonates of all species, the liver is a larger percentage of body weight than in the adult.", [["liver", "ANATOMY", 32, 37], ["body", "ANATOMY", 64, 68], ["neonates", "ORGANISM", 3, 11], ["liver", "ORGAN", 32, 37], ["body", "ORGANISM_SUBDIVISION", 64, 68], ["all", "OBSERVATION_MODIFIER", 15, 18], ["species", "OBSERVATION", 19, 26], ["liver", "ANATOMY", 32, 37], ["larger", "OBSERVATION_MODIFIER", 43, 49], ["percentage", "OBSERVATION_MODIFIER", 50, 60], ["body weight", "ANATOMY_MODIFIER", 64, 75]]], ["The liver has a smooth capsular surface, and the parenchyma consists of friable red-brown tissue that is divided into lobes.", [["liver", "ANATOMY", 4, 9], ["capsular surface", "ANATOMY", 23, 39], ["parenchyma", "ANATOMY", 49, 59], ["brown tissue", "ANATOMY", 84, 96], ["lobes", "ANATOMY", 118, 123], ["liver", "ORGAN", 4, 9], ["smooth capsular surface", "CELLULAR_COMPONENT", 16, 39], ["parenchyma", "TISSUE", 49, 59], ["red-brown tissue", "TISSUE", 80, 96], ["lobes", "ORGAN", 118, 123], ["friable red-brown tissue", "PROBLEM", 72, 96], ["liver", "ANATOMY", 4, 9], ["smooth", "OBSERVATION_MODIFIER", 16, 22], ["capsular", "OBSERVATION_MODIFIER", 23, 31], ["surface", "OBSERVATION_MODIFIER", 32, 39], ["parenchyma", "ANATOMY", 49, 59], ["friable", "OBSERVATION_MODIFIER", 72, 79], ["red-", "OBSERVATION_MODIFIER", 80, 84], ["brown tissue", "OBSERVATION", 84, 96], ["lobes", "ANATOMY_MODIFIER", 118, 123]]], ["The number and shape of the liver lobes of the major domestic mammals vary among species.", [["liver lobes", "ANATOMY", 28, 39], ["liver lobes", "MULTI-TISSUE_STRUCTURE", 28, 39], ["number", "OBSERVATION_MODIFIER", 4, 10], ["shape", "OBSERVATION_MODIFIER", 15, 20], ["liver", "ANATOMY", 28, 33], ["lobes", "ANATOMY_MODIFIER", 34, 39], ["major", "OBSERVATION_MODIFIER", 47, 52], ["domestic mammals", "OBSERVATION", 53, 69], ["species", "OBSERVATION_MODIFIER", 81, 88]]], ["In monogastric animals, the liver abuts the diaphragm and occupies the central area of the cranial abdomen.", [["liver", "ANATOMY", 28, 33], ["diaphragm", "ANATOMY", 44, 53], ["central area", "ANATOMY", 71, 83], ["cranial abdomen", "ANATOMY", 91, 106], ["liver", "ORGAN", 28, 33], ["diaphragm", "ORGAN", 44, 53], ["central area", "IMMATERIAL_ANATOMICAL_ENTITY", 71, 83], ["cranial abdomen", "ORGAN", 91, 106], ["liver", "ANATOMY", 28, 33], ["diaphragm", "ANATOMY", 44, 53], ["central", "ANATOMY_MODIFIER", 71, 78], ["area", "ANATOMY_MODIFIER", 79, 83], ["cranial", "ANATOMY_MODIFIER", 91, 98], ["abdomen", "ANATOMY", 99, 106]]], ["In ruminants, and to a lesser extent in horses, the liver is displaced to the right side of the cranial abdominal cavity.", [["liver", "ANATOMY", 52, 57], ["cranial abdominal cavity", "ANATOMY", 96, 120], ["horses", "ORGANISM", 40, 46], ["liver", "ORGAN", 52, 57], ["cranial abdominal cavity", "MULTI-TISSUE_STRUCTURE", 96, 120], ["ruminants", "OBSERVATION_MODIFIER", 3, 12], ["lesser", "OBSERVATION_MODIFIER", 23, 29], ["extent", "OBSERVATION_MODIFIER", 30, 36], ["horses", "OBSERVATION", 40, 46], ["liver", "ANATOMY", 52, 57], ["displaced", "OBSERVATION", 61, 70], ["right", "ANATOMY_MODIFIER", 78, 83], ["cranial", "ANATOMY_MODIFIER", 96, 103], ["abdominal cavity", "ANATOMY", 104, 120]]], ["A series of ligaments maintains the liver in its position.", [["ligaments", "ANATOMY", 12, 21], ["liver", "ANATOMY", 36, 41], ["ligaments", "TISSUE", 12, 21], ["liver", "ORGAN", 36, 41], ["ligaments", "ANATOMY", 12, 21], ["liver", "ANATOMY", 36, 41], ["position", "OBSERVATION_MODIFIER", 49, 57]]], ["The coronary ligament attaches the liver to the diaphragm near the esophagus.", [["coronary ligament", "ANATOMY", 4, 21], ["liver", "ANATOMY", 35, 40], ["diaphragm", "ANATOMY", 48, 57], ["esophagus", "ANATOMY", 67, 76], ["coronary ligament", "MULTI-TISSUE_STRUCTURE", 4, 21], ["liver", "ORGAN", 35, 40], ["diaphragm", "ORGAN", 48, 57], ["esophagus", "ORGAN", 67, 76], ["coronary ligament", "ANATOMY", 4, 21], ["liver", "ANATOMY", 35, 40], ["diaphragm", "ANATOMY", 48, 57], ["esophagus", "ANATOMY", 67, 76]]], ["The falciform ligament attaches the midline of the liver to the ventral midline of the abdomen.", [["falciform ligament", "ANATOMY", 4, 22], ["midline", "ANATOMY", 36, 43], ["liver", "ANATOMY", 51, 56], ["ventral midline", "ANATOMY", 64, 79], ["abdomen", "ANATOMY", 87, 94], ["falciform ligament", "TISSUE", 4, 22], ["midline", "ORGAN", 36, 43], ["liver", "ORGAN", 51, 56], ["ventral midline", "MULTI-TISSUE_STRUCTURE", 64, 79], ["abdomen", "ORGAN", 87, 94], ["falciform ligament", "ANATOMY", 4, 22], ["midline", "ANATOMY_MODIFIER", 36, 43], ["liver", "ANATOMY", 51, 56], ["ventral", "ANATOMY_MODIFIER", 64, 71], ["midline", "ANATOMY_MODIFIER", 72, 79], ["abdomen", "ANATOMY", 87, 94]]], ["The round ligament, a remnant of the umbilical vein, is embedded within the falciform ligament.Origin, structure, and functionThe liver receives ~25% of the cardiac output, but is also supplied by the portal vein.", [["round ligament", "ANATOMY", 4, 18], ["umbilical vein", "ANATOMY", 37, 51], ["falciform ligament", "ANATOMY", 76, 94], ["liver", "ANATOMY", 130, 135], ["cardiac", "ANATOMY", 157, 164], ["portal vein", "ANATOMY", 201, 212], ["ligament", "TISSUE", 10, 18], ["umbilical vein", "MULTI-TISSUE_STRUCTURE", 37, 51], ["falciform ligament", "TISSUE", 76, 94], ["liver", "ORGAN", 130, 135], ["cardiac", "ORGAN", 157, 164], ["portal vein", "MULTI-TISSUE_STRUCTURE", 201, 212], ["the cardiac output", "TEST", 153, 171], ["round", "OBSERVATION_MODIFIER", 4, 9], ["ligament", "ANATOMY", 10, 18], ["remnant", "OBSERVATION", 22, 29], ["umbilical vein", "ANATOMY", 37, 51], ["falciform ligament", "ANATOMY", 76, 94], ["structure", "OBSERVATION_MODIFIER", 103, 112], ["liver", "ANATOMY", 130, 135], ["25%", "OBSERVATION_MODIFIER", 146, 149], ["cardiac", "ANATOMY", 157, 164], ["output", "OBSERVATION", 165, 171], ["portal vein", "ANATOMY", 201, 212]]], ["The valveless portal vein drains the digestive tract, forestomachs, glandular stomach, and intestines, as well as the spleen and pancreas.", [["valveless portal vein", "ANATOMY", 4, 25], ["digestive tract", "ANATOMY", 37, 52], ["forestomachs", "ANATOMY", 54, 66], ["glandular stomach", "ANATOMY", 68, 85], ["intestines", "ANATOMY", 91, 101], ["spleen", "ANATOMY", 118, 124], ["pancreas", "ANATOMY", 129, 137], ["valveless portal vein", "MULTI-TISSUE_STRUCTURE", 4, 25], ["digestive tract", "ORGAN", 37, 52], ["forestomachs", "CANCER", 54, 66], ["glandular stomach", "ORGAN", 68, 85], ["intestines", "ORGAN", 91, 101], ["spleen", "ORGAN", 118, 124], ["pancreas", "ORGAN", 129, 137], ["valveless", "ANATOMY_MODIFIER", 4, 13], ["portal vein", "ANATOMY", 14, 25], ["drains", "OBSERVATION", 26, 32], ["digestive tract", "ANATOMY", 37, 52], ["glandular", "ANATOMY_MODIFIER", 68, 77], ["stomach", "ANATOMY", 78, 85], ["intestines", "ANATOMY", 91, 101], ["spleen", "ANATOMY", 118, 124], ["pancreas", "ANATOMY", 129, 137]]], ["Portal vein flow provides 70-80% of the total afferent hepatic blood flow and ~50% of the oxygen supply.", [["Portal vein", "ANATOMY", 0, 11], ["afferent hepatic blood", "ANATOMY", 46, 68], ["oxygen", "CHEMICAL", 90, 96], ["oxygen", "CHEMICAL", 90, 96], ["Portal vein", "MULTI-TISSUE_STRUCTURE", 0, 11], ["hepatic", "MULTI-TISSUE_STRUCTURE", 55, 62], ["blood", "ORGANISM_SUBSTANCE", 63, 68], ["oxygen", "SIMPLE_CHEMICAL", 90, 96], ["Portal vein flow", "TEST", 0, 16], ["the oxygen supply", "TREATMENT", 86, 103], ["vein", "ANATOMY", 7, 11], ["flow", "OBSERVATION", 12, 16], ["total", "ANATOMY_MODIFIER", 40, 45], ["afferent", "ANATOMY_MODIFIER", 46, 54], ["hepatic", "ANATOMY", 55, 62], ["blood flow", "OBSERVATION", 63, 73], ["oxygen supply", "OBSERVATION", 90, 103]]], ["The hepatic artery provides the remainder of hepatic blood flow.", [["hepatic artery", "ANATOMY", 4, 18], ["hepatic blood", "ANATOMY", 45, 58], ["hepatic artery", "MULTI-TISSUE_STRUCTURE", 4, 18], ["hepatic", "MULTI-TISSUE_STRUCTURE", 45, 52], ["blood", "ORGANISM_SUBSTANCE", 53, 58], ["hepatic artery", "ANATOMY", 4, 18], ["hepatic", "ANATOMY", 45, 52], ["blood flow", "OBSERVATION", 53, 63]]], ["Portal blood flow is not regulated, but hepatic arterial flow is regulated, primarily by adenosine, and responds to changes in portal flow.", [["Portal blood", "ANATOMY", 0, 12], ["hepatic arterial", "ANATOMY", 40, 56], ["portal", "ANATOMY", 127, 133], ["adenosine", "CHEMICAL", 89, 98], ["adenosine", "CHEMICAL", 89, 98], ["blood", "ORGANISM_SUBSTANCE", 7, 12], ["hepatic arterial", "MULTI-TISSUE_STRUCTURE", 40, 56], ["adenosine", "SIMPLE_CHEMICAL", 89, 98], ["portal", "MULTI-TISSUE_STRUCTURE", 127, 133], ["Portal blood flow", "TEST", 0, 17], ["hepatic arterial flow", "TEST", 40, 61], ["adenosine", "TREATMENT", 89, 98], ["portal flow", "TEST", 127, 138], ["blood", "ANATOMY", 7, 12], ["flow", "OBSERVATION", 13, 17], ["hepatic", "ANATOMY", 40, 47], ["arterial", "ANATOMY_MODIFIER", 48, 56], ["flow", "OBSERVATION", 57, 61], ["portal", "ANATOMY", 127, 133], ["flow", "OBSERVATION", 134, 138]]], ["When portal blood flow is reduced, less adenosine is washed out of the hepatic circulation, and this increased concentration drives hepatic arterial dilation, creating a hepatic arterial buffer effect whereby a consistent hepatic blood flow is maintained.", [["portal blood", "ANATOMY", 5, 17], ["hepatic", "ANATOMY", 71, 78], ["hepatic arterial", "ANATOMY", 132, 148], ["hepatic arterial", "ANATOMY", 170, 186], ["hepatic blood", "ANATOMY", 222, 235], ["adenosine", "CHEMICAL", 40, 49], ["adenosine", "CHEMICAL", 40, 49], ["portal", "MULTI-TISSUE_STRUCTURE", 5, 11], ["blood", "ORGANISM_SUBSTANCE", 12, 17], ["adenosine", "SIMPLE_CHEMICAL", 40, 49], ["hepatic", "ORGAN", 71, 78], ["hepatic arterial", "MULTI-TISSUE_STRUCTURE", 132, 148], ["hepatic arterial", "MULTI-TISSUE_STRUCTURE", 170, 186], ["hepatic", "MULTI-TISSUE_STRUCTURE", 222, 229], ["blood", "ORGANISM_SUBSTANCE", 230, 235], ["portal blood flow", "TEST", 5, 22], ["hepatic arterial dilation", "PROBLEM", 132, 157], ["a hepatic arterial buffer effect", "TREATMENT", 168, 200], ["portal", "ANATOMY", 5, 11], ["flow", "OBSERVATION", 18, 22], ["reduced", "OBSERVATION_MODIFIER", 26, 33], ["hepatic", "ANATOMY", 71, 78], ["circulation", "ANATOMY_MODIFIER", 79, 90], ["increased", "OBSERVATION_MODIFIER", 101, 110], ["concentration", "OBSERVATION", 111, 124], ["hepatic", "ANATOMY_MODIFIER", 132, 139], ["arterial", "ANATOMY", 140, 148], ["dilation", "OBSERVATION", 149, 157], ["hepatic", "ANATOMY", 170, 177], ["arterial", "ANATOMY_MODIFIER", 178, 186], ["buffer effect", "OBSERVATION", 187, 200], ["hepatic", "ANATOMY", 222, 229], ["blood flow", "OBSERVATION", 230, 240]]], ["Portal blood flow is important for the rapid clearance of nutrients, xenobiotics, microorganisms, and potentially immunogenic materials that enter the circulation from the gastrointestinal tract.", [["Portal blood", "ANATOMY", 0, 12], ["gastrointestinal tract", "ANATOMY", 172, 194], ["blood", "ORGANISM_SUBSTANCE", 7, 12], ["gastrointestinal tract", "ORGANISM_SUBDIVISION", 172, 194], ["Portal blood flow", "TEST", 0, 17], ["the rapid clearance of nutrients", "TREATMENT", 35, 67], ["xenobiotics", "TREATMENT", 69, 80], ["microorganisms", "PROBLEM", 82, 96], ["potentially immunogenic materials", "PROBLEM", 102, 135], ["blood", "ANATOMY", 7, 12], ["flow", "OBSERVATION", 13, 17], ["gastrointestinal tract", "ANATOMY", 172, 194]]], ["Hepatic arterioles disperse into a peribiliary capillary plexus, a perivenous plexus surrounding the portal vein, or join terminal hepatic arterioles before entering the sinusoids, lowering pressure and preventing reversal of portal venous inflow.", [["Hepatic arterioles", "ANATOMY", 0, 18], ["peribiliary capillary plexus", "ANATOMY", 35, 63], ["perivenous plexus", "ANATOMY", 67, 84], ["portal vein", "ANATOMY", 101, 112], ["hepatic arterioles", "ANATOMY", 131, 149], ["sinusoids", "ANATOMY", 170, 179], ["portal venous", "ANATOMY", 226, 239], ["Hepatic arterioles", "MULTI-TISSUE_STRUCTURE", 0, 18], ["peribiliary capillary plexus", "TISSUE", 35, 63], ["perivenous plexus", "TISSUE", 67, 84], ["portal vein", "MULTI-TISSUE_STRUCTURE", 101, 112], ["hepatic arterioles", "MULTI-TISSUE_STRUCTURE", 131, 149], ["sinusoids", "TISSUE", 170, 179], ["portal venous", "MULTI-TISSUE_STRUCTURE", 226, 239], ["lowering pressure", "TREATMENT", 181, 198], ["portal venous inflow", "TREATMENT", 226, 246], ["arterioles", "ANATOMY_MODIFIER", 8, 18], ["peribiliary", "ANATOMY_MODIFIER", 35, 46], ["capillary plexus", "ANATOMY", 47, 63], ["perivenous", "ANATOMY_MODIFIER", 67, 77], ["plexus", "ANATOMY_MODIFIER", 78, 84], ["portal vein", "ANATOMY", 101, 112], ["terminal", "ANATOMY_MODIFIER", 122, 130], ["hepatic", "ANATOMY", 131, 138], ["arterioles", "ANATOMY_MODIFIER", 139, 149], ["sinusoids", "ANATOMY", 170, 179], ["lowering", "OBSERVATION_MODIFIER", 181, 189], ["pressure", "OBSERVATION_MODIFIER", 190, 198], ["portal venous", "ANATOMY", 226, 239], ["inflow", "ANATOMY_MODIFIER", 240, 246]]], ["Portal and arterial blood eventually mix in the low-pressure hepatic sinusoids.", [["Portal", "ANATOMY", 0, 6], ["arterial blood", "ANATOMY", 11, 25], ["hepatic sinusoids", "ANATOMY", 61, 78], ["Portal", "MULTI-TISSUE_STRUCTURE", 0, 6], ["arterial", "ORGANISM_SUBSTANCE", 11, 19], ["blood", "ORGANISM_SUBSTANCE", 20, 25], ["hepatic sinusoids", "MULTI-TISSUE_STRUCTURE", 61, 78], ["Portal and arterial blood", "TEST", 0, 25], ["arterial", "ANATOMY", 11, 19], ["mix", "OBSERVATION_MODIFIER", 37, 40], ["low-pressure", "OBSERVATION_MODIFIER", 48, 60], ["hepatic", "ANATOMY", 61, 68], ["sinusoids", "ANATOMY_MODIFIER", 69, 78]]], ["Both terminal portal venules and hepatic arterioles flow into the sinusoids, but flow is closely regulated by a series of inlet sphincters formed by endothelial cells for the venules and smooth muscle for the arterioles.", [["terminal portal venules", "ANATOMY", 5, 28], ["hepatic arterioles", "ANATOMY", 33, 51], ["sinusoids", "ANATOMY", 66, 75], ["inlet sphincters", "ANATOMY", 122, 138], ["endothelial cells", "ANATOMY", 149, 166], ["venules", "ANATOMY", 175, 182], ["smooth muscle", "ANATOMY", 187, 200], ["arterioles", "ANATOMY", 209, 219], ["portal venules", "MULTI-TISSUE_STRUCTURE", 14, 28], ["hepatic arterioles", "MULTI-TISSUE_STRUCTURE", 33, 51], ["sinusoids", "TISSUE", 66, 75], ["endothelial cells", "CELL", 149, 166], ["venules", "TISSUE", 175, 182], ["smooth muscle", "TISSUE", 187, 200], ["arterioles", "MULTI-TISSUE_STRUCTURE", 209, 219], ["endothelial cells", "CELL_TYPE", 149, 166], ["a series of inlet sphincters", "TREATMENT", 110, 138], ["terminal", "ANATOMY_MODIFIER", 5, 13], ["portal venules", "ANATOMY", 14, 28], ["hepatic", "ANATOMY", 33, 40], ["arterioles", "ANATOMY_MODIFIER", 41, 51], ["flow", "OBSERVATION", 52, 56], ["sinusoids", "OBSERVATION_MODIFIER", 66, 75], ["flow", "OBSERVATION", 81, 85], ["endothelial cells", "OBSERVATION", 149, 166], ["venules", "ANATOMY", 175, 182], ["smooth muscle", "OBSERVATION", 187, 200], ["arterioles", "ANATOMY", 209, 219]]], ["Thus, at any particular time, sinusoidal blood could be entirely venous, mixed arterial and venous, or arterial.", [["sinusoidal blood", "ANATOMY", 30, 46], ["venous", "ANATOMY", 65, 71], ["arterial", "ANATOMY", 79, 87], ["venous", "ANATOMY", 92, 98], ["arterial", "ANATOMY", 103, 111], ["blood", "ORGANISM_SUBSTANCE", 41, 46], ["venous", "MULTI-TISSUE_STRUCTURE", 65, 71], ["arterial", "MULTI-TISSUE_STRUCTURE", 79, 87], ["venous", "MULTI-TISSUE_STRUCTURE", 92, 98], ["arterial", "MULTI-TISSUE_STRUCTURE", 103, 111], ["sinusoidal blood", "TEST", 30, 46], ["venous", "OBSERVATION", 65, 71], ["mixed", "OBSERVATION", 73, 78], ["venous", "ANATOMY", 92, 98], ["arterial", "ANATOMY", 103, 111]]], ["This blood flow pattern may account for the interlobular and intralobular heterogeneity of lesions following various toxicities.", [["blood", "ANATOMY", 5, 10], ["interlobular", "ANATOMY", 44, 56], ["intralobular", "ANATOMY", 61, 73], ["lesions", "ANATOMY", 91, 98], ["toxicities", "DISEASE", 117, 127], ["blood", "ORGANISM_SUBSTANCE", 5, 10], ["interlobular", "MULTI-TISSUE_STRUCTURE", 44, 56], ["intralobular", "IMMATERIAL_ANATOMICAL_ENTITY", 61, 73], ["lesions", "PATHOLOGICAL_FORMATION", 91, 98], ["This blood flow pattern", "TEST", 0, 23], ["the interlobular and intralobular heterogeneity of lesions", "PROBLEM", 40, 98], ["various toxicities", "PROBLEM", 109, 127], ["flow pattern", "OBSERVATION", 11, 23], ["may account for", "UNCERTAINTY", 24, 39], ["interlobular", "ANATOMY_MODIFIER", 44, 56], ["intralobular", "ANATOMY_MODIFIER", 61, 73], ["heterogeneity", "OBSERVATION", 74, 87], ["lesions", "OBSERVATION", 91, 98]]], ["Blood leaves the liver via the hepatic vein, which is very short, and enters the caudal vena cava.Origin, structure, and functionHepatic sinusoids have an average diameter of 10 \u00b5m, but can expand up to 30 \u00b5m.", [["Blood", "ANATOMY", 0, 5], ["liver", "ANATOMY", 17, 22], ["hepatic vein", "ANATOMY", 31, 43], ["caudal vena cava", "ANATOMY", 81, 97], ["Hepatic sinusoids", "ANATOMY", 129, 146], ["Blood", "ORGANISM_SUBSTANCE", 0, 5], ["liver", "ORGAN", 17, 22], ["hepatic vein", "MULTI-TISSUE_STRUCTURE", 31, 43], ["caudal vena cava", "MULTI-TISSUE_STRUCTURE", 81, 97], ["Hepatic sinusoids", "MULTI-TISSUE_STRUCTURE", 129, 146], ["leaves", "OBSERVATION", 6, 12], ["liver", "ANATOMY", 17, 22], ["hepatic vein", "ANATOMY", 31, 43], ["very", "OBSERVATION_MODIFIER", 54, 58], ["short", "OBSERVATION_MODIFIER", 59, 64], ["caudal vena cava", "ANATOMY", 81, 97], ["structure", "OBSERVATION", 106, 115], ["Hepatic", "ANATOMY", 129, 136], ["sinusoids", "ANATOMY_MODIFIER", 137, 146], ["average", "OBSERVATION_MODIFIER", 155, 162], ["diameter", "OBSERVATION_MODIFIER", 163, 171], ["10 \u00b5m", "OBSERVATION_MODIFIER", 175, 180], ["30 \u00b5m", "OBSERVATION_MODIFIER", 203, 208]]], ["The periportal sinusoids are more tortuous than those in the centrilobular region.", [["periportal sinusoids", "ANATOMY", 4, 24], ["centrilobular region", "ANATOMY", 61, 81], ["periportal sinusoids", "MULTI-TISSUE_STRUCTURE", 4, 24], ["periportal sinusoids", "ANATOMY", 4, 24], ["more", "OBSERVATION_MODIFIER", 29, 33], ["tortuous", "OBSERVATION", 34, 42], ["centrilobular", "ANATOMY_MODIFIER", 61, 74], ["region", "ANATOMY_MODIFIER", 75, 81]]], ["Hepatic sinusoids are lined by specialized endothelial cells.", [["Hepatic sinusoids", "ANATOMY", 0, 17], ["endothelial cells", "ANATOMY", 43, 60], ["Hepatic sinusoids", "MULTI-TISSUE_STRUCTURE", 0, 17], ["endothelial cells", "CELL", 43, 60], ["endothelial cells", "CELL_TYPE", 43, 60], ["Hepatic sinusoids", "PROBLEM", 0, 17], ["sinusoids", "OBSERVATION", 8, 17], ["endothelial cells", "OBSERVATION", 43, 60]]], ["Hepatic sinusoids differ from vascular structures elsewhere in that they lack a typical basement membrane, and are supported by a specialized, discontinuous or loose extracellular matrix (ECM).", [["Hepatic sinusoids", "ANATOMY", 0, 17], ["vascular structures", "ANATOMY", 30, 49], ["basement membrane", "ANATOMY", 88, 105], ["extracellular matrix", "ANATOMY", 166, 186], ["ECM", "ANATOMY", 188, 191], ["Hepatic sinusoids", "MULTI-TISSUE_STRUCTURE", 0, 17], ["vascular structures", "MULTI-TISSUE_STRUCTURE", 30, 49], ["basement membrane", "CELLULAR_COMPONENT", 88, 105], ["extracellular matrix", "CELLULAR_COMPONENT", 166, 186], ["ECM", "CELLULAR_COMPONENT", 188, 191], ["Hepatic sinusoids", "PROBLEM", 0, 17], ["a specialized, discontinuous or loose extracellular matrix", "PROBLEM", 128, 186], ["sinusoids", "OBSERVATION", 8, 17], ["vascular", "ANATOMY", 30, 38], ["typical", "OBSERVATION_MODIFIER", 80, 87], ["basement", "OBSERVATION_MODIFIER", 88, 96], ["membrane", "OBSERVATION_MODIFIER", 97, 105], ["specialized", "OBSERVATION_MODIFIER", 130, 141], ["discontinuous", "OBSERVATION_MODIFIER", 143, 156], ["loose", "OBSERVATION_MODIFIER", 160, 165], ["extracellular matrix", "OBSERVATION_MODIFIER", 166, 186]]], ["Hepatic sinusoidal endothelial cells are fenestrated, and these 100-nm diameter sieve-like pores control fluid, solute, and particulate interchange between blood and the perisinusoidal space, regulated by the action of the cellular cytoskeleton.", [["Hepatic sinusoidal endothelial cells", "ANATOMY", 0, 36], ["fluid", "ANATOMY", 105, 110], ["blood", "ANATOMY", 156, 161], ["perisinusoidal space", "ANATOMY", 170, 190], ["cellular cytoskeleton", "ANATOMY", 223, 244], ["Hepatic sinusoidal endothelial cells", "CELL", 0, 36], ["blood", "ORGANISM_SUBSTANCE", 156, 161], ["cellular cytoskeleton", "CELLULAR_COMPONENT", 223, 244], ["Hepatic sinusoidal endothelial cells", "CELL_TYPE", 0, 36], ["Hepatic sinusoidal endothelial cells", "PROBLEM", 0, 36], ["nm diameter sieve", "TEST", 68, 85], ["particulate interchange between blood and the perisinusoidal space", "PROBLEM", 124, 190], ["sinusoidal", "ANATOMY_MODIFIER", 8, 18], ["endothelial cells", "OBSERVATION", 19, 36], ["fenestrated", "OBSERVATION_MODIFIER", 41, 52], ["100-nm diameter", "OBSERVATION_MODIFIER", 64, 79], ["sieve", "OBSERVATION_MODIFIER", 80, 85], ["pores", "OBSERVATION_MODIFIER", 91, 96], ["control", "OBSERVATION_MODIFIER", 97, 104], ["fluid", "OBSERVATION", 105, 110], ["solute", "OBSERVATION_MODIFIER", 112, 118], ["particulate interchange", "OBSERVATION", 124, 147], ["blood", "ANATOMY", 156, 161], ["perisinusoidal space", "ANATOMY", 170, 190], ["cellular cytoskeleton", "OBSERVATION", 223, 244]]], ["Sinusoidal endothelial cells are actively pinocytotic and internalize and degrade various endogenous glycoproteins, glycosaminoglycans, and immune complexes.", [["Sinusoidal endothelial cells", "ANATOMY", 0, 28], ["endothelial cells", "CELL", 11, 28], ["glycosaminoglycans", "GENE_OR_GENE_PRODUCT", 116, 134], ["Sinusoidal endothelial cells", "CELL_TYPE", 0, 28], ["endogenous glycoproteins", "PROTEIN", 90, 114], ["immune complexes", "PROTEIN", 140, 156], ["Sinusoidal endothelial cells", "PROBLEM", 0, 28], ["actively pinocytotic", "PROBLEM", 33, 53], ["glycosaminoglycans", "TREATMENT", 116, 134], ["immune complexes", "TREATMENT", 140, 156], ["endothelial cells", "OBSERVATION", 11, 28], ["pinocytotic", "OBSERVATION_MODIFIER", 42, 53], ["endogenous glycoproteins", "OBSERVATION", 90, 114]]], ["Kupffer substances that are metabolically activated by cytochromes P450.", [["cytochromes P450", "GENE_OR_GENE_PRODUCT", 55, 71], ["cytochromes P450", "PROTEIN", 55, 71]]], ["By comparison, hepatocytes in periportal hepatocytes are more susceptible to direct-acting toxicants, such as ingested metal salts, given their proximity to the vascular inflow.", [["hepatocytes", "ANATOMY", 15, 26], ["periportal hepatocytes", "ANATOMY", 30, 52], ["vascular", "ANATOMY", 161, 169], ["hepatocytes", "CELL", 15, 26], ["periportal hepatocytes", "CELL", 30, 52], ["metal salts", "SIMPLE_CHEMICAL", 119, 130], ["vascular inflow", "MULTI-TISSUE_STRUCTURE", 161, 176], ["hepatocytes", "CELL_TYPE", 15, 26], ["periportal hepatocytes", "CELL_TYPE", 30, 52], ["direct-acting toxicants", "PROBLEM", 77, 100], ["ingested metal salts", "TREATMENT", 110, 130], ["hepatocytes", "ANATOMY", 15, 26], ["periportal", "ANATOMY_MODIFIER", 30, 40], ["hepatocytes", "ANATOMY", 41, 52], ["vascular", "ANATOMY", 161, 169], ["inflow", "ANATOMY_MODIFIER", 170, 176]]], ["Under the influences of various inducers, the patterns of enzyme expression can extend beyond the resting limits.", [["enzyme", "PROTEIN", 58, 64], ["various inducers", "TREATMENT", 24, 40], ["enzyme expression", "PROBLEM", 58, 75], ["resting limits", "OBSERVATION", 98, 112]]], ["Lobular variation is not restricted to parenchymal cells, but is also apparent in the structure and function of sinusoidal endothelial cells, Kupffer cells, perisinusoidal stellate cells, and the composition of the matrix in the space of Disse.Origin, structure, and functionThe portal tract, or portal triad, is a well-defined structure containing at least one small arterial branch, a portal vein branch, and a bile duct, surrounded by connective tissue composed primarily of type I collagen ( Fig. 2-2) .", [["Lobular", "ANATOMY", 0, 7], ["parenchymal cells", "ANATOMY", 39, 56], ["sinusoidal endothelial cells", "ANATOMY", 112, 140], ["Kupffer cells", "ANATOMY", 142, 155], ["perisinusoidal stellate cells", "ANATOMY", 157, 186], ["matrix", "ANATOMY", 215, 221], ["portal tract", "ANATOMY", 279, 291], ["portal triad", "ANATOMY", 296, 308], ["arterial branch", "ANATOMY", 368, 383], ["portal vein branch", "ANATOMY", 387, 405], ["bile duct", "ANATOMY", 413, 422], ["connective tissue", "ANATOMY", 438, 455], ["parenchymal cells", "CELL", 39, 56], ["sinusoidal endothelial cells", "CELL", 112, 140], ["Kupffer cells", "CELL", 142, 155], ["perisinusoidal stellate cells", "CELL", 157, 186], ["matrix", "CELLULAR_COMPONENT", 215, 221], ["portal tract", "MULTI-TISSUE_STRUCTURE", 279, 291], ["arterial branch", "MULTI-TISSUE_STRUCTURE", 368, 383], ["portal vein", "MULTI-TISSUE_STRUCTURE", 387, 398], ["bile duct", "MULTI-TISSUE_STRUCTURE", 413, 422], ["connective tissue", "TISSUE", 438, 455], ["type I collagen", "GENE_OR_GENE_PRODUCT", 478, 493], ["parenchymal cells", "CELL_TYPE", 39, 56], ["sinusoidal endothelial cells", "CELL_TYPE", 112, 140], ["Kupffer cells", "CELL_TYPE", 142, 155], ["perisinusoidal stellate cells", "CELL_TYPE", 157, 186], ["type I collagen", "PROTEIN", 478, 493], ["Lobular variation", "PROBLEM", 0, 17], ["sinusoidal endothelial cells", "PROBLEM", 112, 140], ["perisinusoidal stellate cells", "PROBLEM", 157, 186], ["a well-defined structure", "PROBLEM", 313, 337], ["a bile duct", "PROBLEM", 411, 422], ["connective tissue", "PROBLEM", 438, 455], ["type I collagen ( Fig.", "TREATMENT", 478, 500], ["not restricted", "UNCERTAINTY", 21, 35], ["parenchymal cells", "OBSERVATION", 39, 56], ["sinusoidal endothelial cells", "OBSERVATION", 112, 140], ["Kupffer cells", "OBSERVATION", 142, 155], ["perisinusoidal", "OBSERVATION_MODIFIER", 157, 171], ["stellate cells", "OBSERVATION", 172, 186], ["composition", "OBSERVATION_MODIFIER", 196, 207], ["matrix", "OBSERVATION_MODIFIER", 215, 221], ["space", "ANATOMY_MODIFIER", 229, 234], ["Disse", "ANATOMY_MODIFIER", 238, 243], ["structure", "OBSERVATION_MODIFIER", 252, 261], ["portal tract", "ANATOMY", 279, 291], ["portal triad", "ANATOMY", 296, 308], ["well-defined", "OBSERVATION_MODIFIER", 315, 327], ["structure", "OBSERVATION", 328, 337], ["small", "OBSERVATION_MODIFIER", 362, 367], ["arterial", "ANATOMY_MODIFIER", 368, 376], ["branch", "ANATOMY_MODIFIER", 377, 383], ["portal vein", "ANATOMY", 387, 398], ["branch", "ANATOMY_MODIFIER", 399, 405], ["bile duct", "ANATOMY", 413, 422], ["connective tissue", "OBSERVATION", 438, 455]]], ["Because of the pattern of progressive branching of the portal tract system, individual tracts exhibit a range of sizes and shapes, from round to triangular or branching.", [["portal tract system", "ANATOMY", 55, 74], ["portal tract", "ORGANISM_SUBDIVISION", 55, 67], ["system", "ANATOMICAL_SYSTEM", 68, 74], ["progressive branching of the portal tract system", "PROBLEM", 26, 74], ["individual tracts", "PROBLEM", 76, 93], ["progressive", "OBSERVATION_MODIFIER", 26, 37], ["branching", "OBSERVATION", 38, 47], ["portal tract", "ANATOMY", 55, 67], ["range", "OBSERVATION_MODIFIER", 104, 109], ["sizes", "OBSERVATION_MODIFIER", 113, 118], ["shapes", "OBSERVATION_MODIFIER", 123, 129], ["round", "OBSERVATION_MODIFIER", 136, 141], ["triangular", "OBSERVATION_MODIFIER", 145, 155], ["branching", "OBSERVATION_MODIFIER", 159, 168]]], ["In larger portal tracts, lymphatic channels and autonomic nerve fibers may be seen.", [["portal tracts", "ANATOMY", 10, 23], ["lymphatic", "ANATOMY", 25, 34], ["autonomic nerve fibers", "ANATOMY", 48, 70], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 10, 23], ["lymphatic", "MULTI-TISSUE_STRUCTURE", 25, 34], ["nerve fibers", "MULTI-TISSUE_STRUCTURE", 58, 70], ["autonomic nerve fibers", "PROBLEM", 48, 70], ["larger", "OBSERVATION_MODIFIER", 3, 9], ["portal tracts", "ANATOMY", 10, 23], ["lymphatic channels", "OBSERVATION", 25, 43], ["autonomic nerve fibers", "OBSERVATION", 48, 70], ["may be seen", "UNCERTAINTY", 71, 82]]], ["The bile duct system is a branching outflow that ultimately enters the proximal duodenum.", [["bile duct system", "ANATOMY", 4, 20], ["proximal duodenum", "ANATOMY", 71, 88], ["bile duct", "MULTI-TISSUE_STRUCTURE", 4, 13], ["duodenum", "ORGAN", 80, 88], ["bile duct", "ANATOMY", 4, 13], ["branching", "OBSERVATION_MODIFIER", 26, 35], ["outflow", "OBSERVATION", 36, 43], ["proximal", "ANATOMY_MODIFIER", 71, 79], ["duodenum", "ANATOMY", 80, 88]]], ["Most species, with the exception of the horse and rat, have a bile storage diverticulum (gallbladder).", [["bile storage diverticulum", "ANATOMY", 62, 87], ["gallbladder", "ANATOMY", 89, 100], ["bile storage diverticulum", "DISEASE", 62, 87], ["horse", "ORGANISM", 40, 45], ["rat", "ORGANISM", 50, 53], ["bile storage diverticulum", "PATHOLOGICAL_FORMATION", 62, 87], ["gallbladder", "ORGAN", 89, 100], ["horse", "SPECIES", 40, 45], ["rat", "SPECIES", 50, 53], ["rat", "SPECIES", 50, 53], ["Most species", "PROBLEM", 0, 12], ["a bile storage diverticulum", "PROBLEM", 60, 87], ["bile", "ANATOMY", 62, 66], ["diverticulum", "OBSERVATION", 75, 87], ["gallbladder", "ANATOMY", 89, 100]]], ["Cats occasionally have divided or bipartite gallbladders.", [["gallbladders", "ANATOMY", 44, 56], ["gallbladders", "ORGAN", 44, 56], ["bipartite", "OBSERVATION", 34, 43], ["gallbladders", "ANATOMY", 44, 56]]], ["The bile duct joins the pancreatic duct before entry into the duodenum in some species and has a separate entry in others.", [["bile duct", "ANATOMY", 4, 13], ["pancreatic duct", "ANATOMY", 24, 39], ["duodenum", "ANATOMY", 62, 70], ["bile duct", "MULTI-TISSUE_STRUCTURE", 4, 13], ["pancreatic duct", "MULTI-TISSUE_STRUCTURE", 24, 39], ["duodenum", "ORGAN", 62, 70], ["bile duct", "ANATOMY", 4, 13], ["pancreatic duct", "ANATOMY", 24, 39], ["duodenum", "ANATOMY", 62, 70], ["some species", "OBSERVATION", 74, 86], ["separate", "OBSERVATION_MODIFIER", 97, 105], ["entry", "OBSERVATION_MODIFIER", 106, 111]]], ["Intrahepatic bile ducts range in size from the larger septal or trabecular ducts (internal diameter of >100 \u00b5m in humans) to the smaller interlobular ducts, and tend to be adjacent to a hepatic artery branch of approximately the same size.", [["Intrahepatic bile ducts", "ANATOMY", 0, 23], ["septal", "ANATOMY", 54, 60], ["trabecular ducts", "ANATOMY", 64, 80], ["interlobular ducts", "ANATOMY", 137, 155], ["hepatic artery", "ANATOMY", 186, 200], ["Intrahepatic bile ducts", "MULTI-TISSUE_STRUCTURE", 0, 23], ["septal", "MULTI-TISSUE_STRUCTURE", 54, 60], ["trabecular ducts", "MULTI-TISSUE_STRUCTURE", 64, 80], ["humans", "ORGANISM", 114, 120], ["interlobular ducts", "MULTI-TISSUE_STRUCTURE", 137, 155], ["hepatic artery", "MULTI-TISSUE_STRUCTURE", 186, 200], ["humans", "SPECIES", 114, 120], ["humans", "SPECIES", 114, 120], ["bile ducts", "ANATOMY", 13, 23], ["size", "OBSERVATION_MODIFIER", 33, 37], ["larger", "OBSERVATION_MODIFIER", 47, 53], ["septal", "ANATOMY_MODIFIER", 54, 60], ["trabecular", "ANATOMY_MODIFIER", 64, 74], ["ducts", "ANATOMY_MODIFIER", 75, 80], ["internal", "OBSERVATION_MODIFIER", 82, 90], ["diameter", "OBSERVATION_MODIFIER", 91, 99], ["smaller", "OBSERVATION_MODIFIER", 129, 136], ["interlobular", "ANATOMY_MODIFIER", 137, 149], ["ducts", "ANATOMY", 150, 155], ["hepatic artery", "ANATOMY", 186, 200], ["branch", "ANATOMY_MODIFIER", 201, 207], ["approximately", "OBSERVATION_MODIFIER", 211, 224], ["same", "OBSERVATION_MODIFIER", 229, 233], ["size", "OBSERVATION_MODIFIER", 234, 238]]], ["Bile ducts are lined by cuboidal to low columnar bile duct epithelial cells, subtended by a periodic acid-Schiff (PAS)-positive basement membrane.", [["Bile ducts", "ANATOMY", 0, 10], ["bile duct epithelial cells", "ANATOMY", 49, 75], ["basement membrane", "ANATOMY", 128, 145], ["acid-Schiff", "CHEMICAL", 101, 112], ["Bile ducts", "MULTI-TISSUE_STRUCTURE", 0, 10], ["columnar bile duct epithelial cells", "CELL", 40, 75], ["PAS", "SIMPLE_CHEMICAL", 114, 117], ["basement membrane", "CELLULAR_COMPONENT", 128, 145], ["columnar bile duct epithelial cells", "CELL_TYPE", 40, 75], ["Bile ducts", "PROBLEM", 0, 10], ["cuboidal to low columnar bile duct epithelial cells", "PROBLEM", 24, 75], ["a periodic acid-Schiff (PAS)-positive basement membrane", "PROBLEM", 90, 145], ["ducts", "ANATOMY", 5, 10], ["cuboidal", "OBSERVATION_MODIFIER", 24, 32], ["low", "ANATOMY_MODIFIER", 36, 39], ["columnar", "ANATOMY_MODIFIER", 40, 48], ["bile duct", "ANATOMY", 49, 58], ["epithelial cells", "OBSERVATION", 59, 75], ["periodic", "OBSERVATION_MODIFIER", 92, 100], ["acid-Schiff", "OBSERVATION", 101, 112], ["basement membrane", "OBSERVATION_MODIFIER", 128, 145]]], ["Bile ductules are smaller yet (lumen size of <20 \u00b5m) and are located at the periphery of portal tracts.Cells of the liverHepatocytes (referred to as parenchymal cells) constitute ~70-80% of the liver mass.", [["Bile ductules", "ANATOMY", 0, 13], ["lumen", "ANATOMY", 31, 36], ["portal tracts", "ANATOMY", 89, 102], ["Cells", "ANATOMY", 103, 108], ["liverHepatocytes", "ANATOMY", 116, 132], ["parenchymal cells", "ANATOMY", 149, 166], ["liver mass", "ANATOMY", 194, 204], ["Bile ductules", "MULTI-TISSUE_STRUCTURE", 0, 13], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 31, 36], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 89, 102], ["Cells", "CELL", 103, 108], ["liverHepatocytes", "CELL", 116, 132], ["parenchymal cells", "CELL", 149, 166], ["liver", "ORGAN", 194, 199], ["parenchymal cells", "CELL_TYPE", 149, 166], ["parenchymal cells", "TEST", 149, 166], ["the liver mass", "PROBLEM", 190, 204], ["ductules", "ANATOMY_MODIFIER", 5, 13], ["smaller", "OBSERVATION_MODIFIER", 18, 25], ["lumen", "OBSERVATION_MODIFIER", 31, 36], ["size", "OBSERVATION_MODIFIER", 37, 41], ["<20 \u00b5m", "OBSERVATION_MODIFIER", 45, 51], ["periphery", "ANATOMY_MODIFIER", 76, 85], ["portal tracts", "ANATOMY", 89, 102], ["liver", "ANATOMY", 116, 121], ["liver", "ANATOMY", 194, 199], ["mass", "OBSERVATION", 200, 204]]], ["However, >50% of liver DNA is found in smaller nonparenchymal cells (bile duct epithelium, hepatic stellate cells, sinusoidal endothelium, Kupffer cells) and itinerant cells (such as leukocytes).", [["liver", "ANATOMY", 17, 22], ["nonparenchymal cells", "ANATOMY", 47, 67], ["bile duct epithelium", "ANATOMY", 69, 89], ["hepatic stellate cells", "ANATOMY", 91, 113], ["sinusoidal endothelium", "ANATOMY", 115, 137], ["Kupffer cells", "ANATOMY", 139, 152], ["cells", "ANATOMY", 168, 173], ["leukocytes", "ANATOMY", 183, 193], ["liver", "ORGAN", 17, 22], ["DNA", "CELLULAR_COMPONENT", 23, 26], ["nonparenchymal cells", "CELL", 47, 67], ["bile duct epithelium", "TISSUE", 69, 89], ["hepatic stellate cells", "CELL", 91, 113], ["sinusoidal endothelium", "CELL", 115, 137], ["Kupffer cells", "CELL", 139, 152], ["itinerant cells", "CELL", 158, 173], ["leukocytes", "CELL", 183, 193], ["liver DNA", "DNA", 17, 26], ["nonparenchymal cells", "CELL_TYPE", 47, 67], ["bile duct epithelium", "CELL_TYPE", 69, 89], ["hepatic stellate cells", "CELL_TYPE", 91, 113], ["Kupffer cells", "CELL_TYPE", 139, 152], ["itinerant cells", "CELL_TYPE", 158, 173], ["leukocytes", "CELL_TYPE", 183, 193], ["liver DNA", "TEST", 17, 26], ["smaller nonparenchymal cells (bile duct epithelium, hepatic stellate cells", "PROBLEM", 39, 113], ["itinerant cells", "PROBLEM", 158, 173], ["leukocytes", "TEST", 183, 193], ["liver", "ANATOMY", 17, 22], ["DNA", "OBSERVATION", 23, 26], ["smaller", "OBSERVATION_MODIFIER", 39, 46], ["nonparenchymal cells", "OBSERVATION", 47, 67], ["bile duct", "ANATOMY", 69, 78], ["epithelium", "ANATOMY_MODIFIER", 79, 89], ["hepatic", "ANATOMY", 91, 98], ["stellate cells", "OBSERVATION", 99, 113], ["sinusoidal endothelium", "OBSERVATION", 115, 137], ["Kupffer cells", "OBSERVATION", 139, 152], ["itinerant cells", "OBSERVATION", 158, 173]]], ["The hepatocyte is a polygonal epithelial cell, ~30-40 \u00b5m in diameter, arranged in single-cell-thick anastomosing plates, separated by hepatic sinusoids.", [["hepatocyte", "ANATOMY", 4, 14], ["polygonal epithelial cell", "ANATOMY", 20, 45], ["cell", "ANATOMY", 89, 93], ["hepatic sinusoids", "ANATOMY", 134, 151], ["hepatocyte", "CELL", 4, 14], ["polygonal epithelial cell", "CELL", 20, 45], ["cell", "CELL", 89, 93], ["hepatic sinusoids", "MULTI-TISSUE_STRUCTURE", 134, 151], ["polygonal epithelial cell", "CELL_TYPE", 20, 45], ["a polygonal epithelial cell", "PROBLEM", 18, 45], ["single-cell-thick anastomosing plates", "TREATMENT", 82, 119], ["hepatocyte", "ANATOMY", 4, 14], ["polygonal", "OBSERVATION_MODIFIER", 20, 29], ["epithelial cell", "OBSERVATION", 30, 45], ["30-40 \u00b5m", "OBSERVATION_MODIFIER", 48, 56], ["diameter", "OBSERVATION_MODIFIER", 60, 68], ["single-cell", "OBSERVATION_MODIFIER", 82, 93], ["anastomosing plates", "OBSERVATION", 100, 119], ["hepatic", "ANATOMY", 134, 141], ["sinusoids", "ANATOMY_MODIFIER", 142, 151]]], ["Each hepatocyte is therefore exposed to sinusoidal blood on 2 sides.", [["hepatocyte", "ANATOMY", 5, 15], ["sinusoidal blood", "ANATOMY", 40, 56], ["hepatocyte", "CELL", 5, 15], ["blood", "ORGANISM_SUBSTANCE", 51, 56], ["sinusoidal blood on 2 sides", "PROBLEM", 40, 67], ["hepatocyte", "ANATOMY", 5, 15], ["sinusoidal blood", "OBSERVATION", 40, 56]]], ["A discontinuous line of hepatocytes, termed major blood vessels and also extend along the sinusoids.", [["hepatocytes", "ANATOMY", 24, 35], ["blood vessels", "ANATOMY", 50, 63], ["sinusoids", "ANATOMY", 90, 99], ["hepatocytes", "CELL", 24, 35], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 50, 63], ["sinusoids", "TISSUE", 90, 99], ["hepatocytes", "CELL_TYPE", 24, 35], ["A discontinuous line of hepatocytes", "TREATMENT", 0, 35], ["discontinuous line", "OBSERVATION", 2, 20], ["hepatocytes", "ANATOMY", 24, 35], ["major", "OBSERVATION_MODIFIER", 44, 49], ["blood vessels", "OBSERVATION", 50, 63], ["sinusoids", "ANATOMY", 90, 99]]], ["These may modulate function of hepatocytes, endothelial cells, and hepatic stellate cells.Cells of the liverThe vasculature of the liver parenchyma defines its functional microanatomy, but debate continues as to what best represents the hepatic structural-functional unit.", [["hepatocytes", "ANATOMY", 31, 42], ["endothelial cells", "ANATOMY", 44, 61], ["hepatic stellate cells", "ANATOMY", 67, 89], ["Cells", "ANATOMY", 90, 95], ["liver", "ANATOMY", 103, 108], ["vasculature", "ANATOMY", 112, 123], ["liver parenchyma", "ANATOMY", 131, 147], ["hepatic", "ANATOMY", 237, 244], ["hepatocytes", "CELL", 31, 42], ["endothelial cells", "CELL", 44, 61], ["hepatic stellate cells", "CELL", 67, 89], ["Cells", "CELL", 90, 95], ["liver", "ORGAN", 103, 108], ["vasculature", "MULTI-TISSUE_STRUCTURE", 112, 123], ["liver parenchyma", "MULTI-TISSUE_STRUCTURE", 131, 147], ["hepatic", "ORGAN", 237, 244], ["hepatocytes", "CELL_TYPE", 31, 42], ["endothelial cells", "CELL_TYPE", 44, 61], ["hepatic stellate cells", "CELL_TYPE", 67, 89], ["hepatocytes", "ANATOMY", 31, 42], ["endothelial cells", "OBSERVATION", 44, 61], ["hepatic", "ANATOMY", 67, 74], ["stellate cells", "OBSERVATION", 75, 89], ["liver", "ANATOMY", 103, 108], ["vasculature", "ANATOMY", 112, 123], ["liver", "ANATOMY", 131, 136], ["parenchyma", "ANATOMY_MODIFIER", 137, 147], ["functional microanatomy", "OBSERVATION", 160, 183], ["hepatic", "ANATOMY", 237, 244], ["functional unit", "OBSERVATION", 256, 271]]], ["Mammalian hepatocytes are organized in plate-like monolayer arrays among the sinusoids and in 3 dimensions; plates, sinusoids, and tracts anastomose in a complex pattern.", [["hepatocytes", "ANATOMY", 10, 21], ["monolayer", "ANATOMY", 50, 59], ["sinusoids", "ANATOMY", 77, 86], ["sinusoids", "ANATOMY", 116, 125], ["hepatocytes", "CELL", 10, 21], ["sinusoids", "TISSUE", 77, 86], ["sinusoids", "TISSUE", 116, 125], ["Mammalian hepatocytes", "CELL_TYPE", 0, 21], ["Mammalian hepatocytes", "PROBLEM", 0, 21], ["hepatocytes", "ANATOMY", 10, 21], ["plate", "OBSERVATION_MODIFIER", 39, 44], ["monolayer arrays", "OBSERVATION", 50, 66], ["sinusoids", "OBSERVATION_MODIFIER", 77, 86], ["3 dimensions", "OBSERVATION_MODIFIER", 94, 106], ["plates", "ANATOMY_MODIFIER", 108, 114], ["sinusoids", "ANATOMY", 116, 125], ["tracts", "ANATOMY_MODIFIER", 131, 137], ["complex", "OBSERVATION_MODIFIER", 154, 161], ["pattern", "OBSERVATION_MODIFIER", 162, 169]]], ["These include the well-known lobular and acinar patterns (discussed later) and several others.", [["lobular", "ANATOMY", 29, 36], ["acinar", "ANATOMY", 41, 47], ["lobular", "CANCER", 29, 36], ["acinar", "MULTI-TISSUE_STRUCTURE", 41, 47], ["lobular", "OBSERVATION", 29, 36], ["acinar patterns", "OBSERVATION", 41, 56]]], ["Matsumoto's primary lobule is based on detailed reconstructions of human liver sections, and considers the penetrating venule extending from the portal tract as a \"vascular septum\" and the origin of the primary lobule's blood flow as it is a starting place for the radially arranged sinusoids flowing to the terminal hepatic vein.", [["primary lobule", "ANATOMY", 12, 26], ["liver sections", "ANATOMY", 73, 87], ["venule", "ANATOMY", 119, 125], ["portal tract", "ANATOMY", 145, 157], ["vascular septum", "ANATOMY", 164, 179], ["primary lobule", "ANATOMY", 203, 217], ["blood", "ANATOMY", 220, 225], ["sinusoids", "ANATOMY", 283, 292], ["terminal hepatic vein", "ANATOMY", 308, 329], ["primary lobule", "CANCER", 12, 26], ["human", "ORGANISM", 67, 72], ["liver sections", "MULTI-TISSUE_STRUCTURE", 73, 87], ["venule", "TISSUE", 119, 125], ["portal tract", "ORGANISM_SUBDIVISION", 145, 157], ["vascular septum", "MULTI-TISSUE_STRUCTURE", 164, 179], ["lobule", "CANCER", 211, 217], ["blood", "ORGANISM_SUBSTANCE", 220, 225], ["sinusoids", "TISSUE", 283, 292], ["hepatic vein", "MULTI-TISSUE_STRUCTURE", 317, 329], ["human", "SPECIES", 67, 72], ["human", "SPECIES", 67, 72], ["human liver sections", "TEST", 67, 87], ["the penetrating venule", "PROBLEM", 103, 125], ["primary lobule", "OBSERVATION", 12, 26], ["liver", "ANATOMY", 73, 78], ["penetrating venule", "OBSERVATION", 107, 125], ["portal tract", "ANATOMY", 145, 157], ["vascular septum", "ANATOMY", 164, 179], ["origin", "ANATOMY_MODIFIER", 189, 195], ["primary", "OBSERVATION_MODIFIER", 203, 210], ["lobule", "OBSERVATION_MODIFIER", 211, 217], ["blood flow", "OBSERVATION", 220, 230], ["sinusoids", "OBSERVATION", 283, 292], ["terminal", "ANATOMY_MODIFIER", 308, 316], ["hepatic vein", "ANATOMY", 317, 329]]], ["In this model, there is a series of branches formed by the portal vein.", [["portal vein", "ANATOMY", 59, 70], ["portal vein", "MULTI-TISSUE_STRUCTURE", 59, 70], ["branches", "OBSERVATION_MODIFIER", 36, 44], ["portal vein", "ANATOMY", 59, 70]]], ["The first branches provide a conducting portal flow, and the next level of branches drain directly into the sinusoids forming the distributing portal flow.", [["portal", "ANATOMY", 40, 46], ["sinusoids", "ANATOMY", 108, 117], ["portal", "ANATOMY", 143, 149], ["portal", "MULTI-TISSUE_STRUCTURE", 40, 46], ["sinusoids", "TISSUE", 108, 117], ["portal", "MULTI-TISSUE_STRUCTURE", 143, 149], ["branches drain", "TREATMENT", 75, 89], ["branches", "ANATOMY_MODIFIER", 10, 18], ["portal flow", "OBSERVATION", 40, 51], ["branches", "OBSERVATION_MODIFIER", 75, 83], ["drain", "OBSERVATION", 84, 89], ["sinusoids", "ANATOMY_MODIFIER", 108, 117], ["distributing", "OBSERVATION_MODIFIER", 130, 142], ["portal flow", "OBSERVATION", 143, 154]]], ["The choleohepaton, related to the concept of the nephron, is composed of an isosceles triangle of hepatocytes with its apex in contact with the terminal hepatic venule and drained by a single bile ductule/canal of Hering at the base of the triangle.", [["nephron", "ANATOMY", 49, 56], ["hepatocytes", "ANATOMY", 98, 109], ["hepatic venule", "ANATOMY", 153, 167], ["bile ductule", "ANATOMY", 192, 204], ["canal", "ANATOMY", 205, 210], ["choleohepaton", "DISEASE", 4, 17], ["nephron", "MULTI-TISSUE_STRUCTURE", 49, 56], ["hepatocytes", "CELL", 98, 109], ["hepatic venule", "MULTI-TISSUE_STRUCTURE", 153, 167], ["bile ductule", "MULTI-TISSUE_STRUCTURE", 192, 204], ["canal", "ORGAN", 205, 210], ["hepatocytes", "CELL_TYPE", 98, 109], ["The choleohepaton", "TREATMENT", 0, 17], ["an isosceles triangle of hepatocytes", "PROBLEM", 73, 109], ["nephron", "ANATOMY", 49, 56], ["isosceles", "OBSERVATION", 76, 85], ["hepatocytes", "ANATOMY", 98, 109], ["apex", "ANATOMY_MODIFIER", 119, 123], ["terminal", "ANATOMY_MODIFIER", 144, 152], ["hepatic", "ANATOMY", 153, 160], ["venule", "ANATOMY_MODIFIER", 161, 167], ["drained", "OBSERVATION", 172, 179], ["bile", "ANATOMY", 192, 196], ["ductule", "OBSERVATION", 197, 204], ["canal", "ANATOMY_MODIFIER", 205, 210], ["base", "ANATOMY_MODIFIER", 228, 232], ["triangle", "ANATOMY_MODIFIER", 240, 248]]], ["More detail is available in the cited references.Cells of the liverArrangements of hepatocytes in the most commonly used nomenclature systems are referred to as either acini or lobules.Cells of the liver\u2022 The classic hepatic lobule is a 6-sided anatomic arrangement of hepatocytes centered on the terminal hepatic venule, also termed the \"central vein\" in this context.", [["Cells", "ANATOMY", 49, 54], ["liver", "ANATOMY", 62, 67], ["hepatocytes", "ANATOMY", 83, 94], ["acini", "ANATOMY", 168, 173], ["lobules", "ANATOMY", 177, 184], ["Cells", "ANATOMY", 185, 190], ["liver", "ANATOMY", 198, 203], ["hepatic lobule", "ANATOMY", 217, 231], ["hepatocytes", "ANATOMY", 269, 280], ["hepatic venule", "ANATOMY", 306, 320], ["central vein", "ANATOMY", 339, 351], ["Cells", "CELL", 49, 54], ["liver", "ORGAN", 62, 67], ["hepatocytes", "CELL", 83, 94], ["acini", "MULTI-TISSUE_STRUCTURE", 168, 173], ["lobules", "MULTI-TISSUE_STRUCTURE", 177, 184], ["Cells", "CELL", 185, 190], ["liver", "ORGAN", 198, 203], ["hepatic lobule", "MULTI-TISSUE_STRUCTURE", 217, 231], ["hepatocytes", "CELL", 269, 280], ["hepatic venule", "MULTI-TISSUE_STRUCTURE", 306, 320], ["central vein", "MULTI-TISSUE_STRUCTURE", 339, 351], ["hepatocytes", "CELL_TYPE", 83, 94], ["hepatocytes", "CELL_TYPE", 269, 280], ["a 6-sided anatomic arrangement of hepatocytes", "PROBLEM", 235, 280], ["liver", "ANATOMY", 62, 67], ["hepatocytes", "ANATOMY", 83, 94], ["liver", "ANATOMY", 198, 203], ["classic", "ANATOMY_MODIFIER", 209, 216], ["hepatic", "ANATOMY", 217, 224], ["lobule", "ANATOMY_MODIFIER", 225, 231], ["6-sided", "OBSERVATION_MODIFIER", 237, 244], ["anatomic", "OBSERVATION", 245, 253], ["hepatocytes", "OBSERVATION", 269, 280], ["terminal", "ANATOMY_MODIFIER", 297, 305], ["hepatic", "ANATOMY", 306, 313], ["venule", "ANATOMY_MODIFIER", 314, 320], ["central", "ANATOMY_MODIFIER", 339, 346], ["vein", "ANATOMY", 347, 351]]], ["Peripherally, lobules are outlined by fibrovascular septa extending from the portal tracts.", [["lobules", "ANATOMY", 14, 21], ["fibrovascular septa", "ANATOMY", 38, 57], ["portal tracts", "ANATOMY", 77, 90], ["lobules", "MULTI-TISSUE_STRUCTURE", 14, 21], ["fibrovascular septa", "TISSUE", 38, 57], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 77, 90], ["fibrovascular septa", "PROBLEM", 38, 57], ["lobules", "OBSERVATION", 14, 21], ["fibrovascular septa", "OBSERVATION", 38, 57], ["portal tracts", "ANATOMY", 77, 90]]], ["In the pig liver, septa form obvious lobular perimeters, but in most mammalian species, the lobules are less pronounced because connective tissue is more restricted to portal tracts.", [["liver", "ANATOMY", 11, 16], ["septa", "ANATOMY", 18, 23], ["lobular perimeters", "ANATOMY", 37, 55], ["lobules", "ANATOMY", 92, 99], ["connective tissue", "ANATOMY", 128, 145], ["portal tracts", "ANATOMY", 168, 181], ["pig", "ORGANISM", 7, 10], ["liver", "ORGAN", 11, 16], ["septa", "TISSUE", 18, 23], ["lobular perimeters", "PATHOLOGICAL_FORMATION", 37, 55], ["lobules", "MULTI-TISSUE_STRUCTURE", 92, 99], ["connective tissue", "TISSUE", 128, 145], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 168, 181], ["pig", "SPECIES", 7, 10], ["pig", "SPECIES", 7, 10], ["lobular perimeters", "PROBLEM", 37, 55], ["connective tissue", "PROBLEM", 128, 145], ["pig", "ANATOMY_MODIFIER", 7, 10], ["liver", "ANATOMY", 11, 16], ["septa", "ANATOMY_MODIFIER", 18, 23], ["obvious", "OBSERVATION_MODIFIER", 29, 36], ["lobular", "OBSERVATION_MODIFIER", 37, 44], ["perimeters", "OBSERVATION_MODIFIER", 45, 55], ["most", "OBSERVATION_MODIFIER", 64, 68], ["mammalian species", "OBSERVATION", 69, 86], ["lobules", "ANATOMY", 92, 99], ["less pronounced", "OBSERVATION_MODIFIER", 104, 119], ["connective tissue", "OBSERVATION", 128, 145], ["portal tracts", "ANATOMY", 168, 181]]], ["The terms periportal and centrilobular are mainly used for pathologic conditions that are centered on the hepatocytes surrounding the portal tracts or the central veins of the classic lobule. \u2022 The hepatic acinus of Rappaport is a functional diamondshaped subunit divided into zones in relation to blood supply:Cells of the liver\u2022 Zone 1 hepatocytes are arranged around an axis formed by the portal tract and the distributing vascular branches that leave the portal tract and are closest to the oxygenand nutrient-rich arterial and portal inflow. \u2022 Zone 2 is the transitional midzone. \u2022 Zone 3 (periacinar) hepatocytes form the apex of the diamond-shaped acinus, are nearest the outflow (terminal hepatic venule), and are exposed to reduced oxygen and nutrients.", [["periportal", "ANATOMY", 10, 20], ["centrilobular", "ANATOMY", 25, 38], ["hepatocytes", "ANATOMY", 106, 117], ["portal tracts", "ANATOMY", 134, 147], ["central veins", "ANATOMY", 155, 168], ["lobule", "ANATOMY", 184, 190], ["hepatic acinus", "ANATOMY", 198, 212], ["blood", "ANATOMY", 298, 303], ["Cells", "ANATOMY", 311, 316], ["liver", "ANATOMY", 324, 329], ["hepatocytes", "ANATOMY", 338, 349], ["portal tract", "ANATOMY", 392, 404], ["vascular branches", "ANATOMY", 426, 443], ["portal tract", "ANATOMY", 459, 471], ["arterial", "ANATOMY", 519, 527], ["portal", "ANATOMY", 532, 538], ["midzone", "ANATOMY", 576, 583], ["periacinar) hepatocytes", "ANATOMY", 595, 618], ["acinus", "ANATOMY", 655, 661], ["hepatic venule", "ANATOMY", 697, 711], ["oxygen", "CHEMICAL", 741, 747], ["oxygen", "CHEMICAL", 741, 747], ["periportal", "MULTI-TISSUE_STRUCTURE", 10, 20], ["centrilobular", "MULTI-TISSUE_STRUCTURE", 25, 38], ["hepatocytes", "CELL", 106, 117], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 134, 147], ["central veins", "MULTI-TISSUE_STRUCTURE", 155, 168], ["lobule", "MULTI-TISSUE_STRUCTURE", 184, 190], ["hepatic acinus", "MULTI-TISSUE_STRUCTURE", 198, 212], ["blood", "ORGANISM_SUBSTANCE", 298, 303], ["Cells", "CELL", 311, 316], ["liver", "ORGAN", 324, 329], ["hepatocytes", "CELL", 338, 349], ["portal tract", "MULTI-TISSUE_STRUCTURE", 392, 404], ["vascular branches", "MULTI-TISSUE_STRUCTURE", 426, 443], ["portal tract", "MULTI-TISSUE_STRUCTURE", 459, 471], ["arterial", "MULTI-TISSUE_STRUCTURE", 519, 527], ["portal inflow", "MULTI-TISSUE_STRUCTURE", 532, 545], ["midzone", "CELLULAR_COMPONENT", 576, 583], ["periacinar) hepatocytes", "CELL", 595, 618], ["acinus", "MULTI-TISSUE_STRUCTURE", 655, 661], ["hepatic venule", "MULTI-TISSUE_STRUCTURE", 697, 711], ["oxygen", "SIMPLE_CHEMICAL", 741, 747], ["hepatocytes", "CELL_TYPE", 106, 117], ["diamondshaped subunit", "PROTEIN", 242, 263], ["Zone 3 (periacinar) hepatocytes", "CELL_TYPE", 587, 618], ["pathologic conditions", "PROBLEM", 59, 80], ["a functional diamondshaped subunit", "TREATMENT", 229, 263], ["Zone 1 hepatocytes", "TREATMENT", 331, 349], ["shaped acinus", "PROBLEM", 648, 661], ["periportal", "ANATOMY", 10, 20], ["centrilobular", "ANATOMY_MODIFIER", 25, 38], ["hepatocytes", "ANATOMY", 106, 117], ["portal tracts", "ANATOMY", 134, 147], ["central", "ANATOMY_MODIFIER", 155, 162], ["veins", "ANATOMY", 163, 168], ["classic lobule", "OBSERVATION", 176, 190], ["hepatic", "ANATOMY", 198, 205], ["acinus", "ANATOMY_MODIFIER", 206, 212], ["zones", "ANATOMY_MODIFIER", 277, 282], ["blood supply", "OBSERVATION", 298, 310], ["liver", "ANATOMY", 324, 329], ["hepatocytes", "ANATOMY", 338, 349], ["portal tract", "ANATOMY", 392, 404], ["distributing", "ANATOMY_MODIFIER", 413, 425], ["vascular", "ANATOMY", 426, 434], ["branches", "ANATOMY_MODIFIER", 435, 443], ["portal tract", "ANATOMY", 459, 471], ["arterial", "ANATOMY_MODIFIER", 519, 527], ["portal inflow", "ANATOMY", 532, 545], ["transitional midzone", "OBSERVATION", 563, 583], ["hepatocytes", "ANATOMY", 607, 618], ["apex", "ANATOMY_MODIFIER", 628, 632], ["diamond", "OBSERVATION_MODIFIER", 640, 647], ["shaped", "OBSERVATION_MODIFIER", 648, 654], ["acinus", "OBSERVATION", 655, 661], ["outflow", "ANATOMY_MODIFIER", 679, 686], ["terminal", "ANATOMY_MODIFIER", 688, 696], ["hepatic", "ANATOMY", 697, 704], ["venule", "ANATOMY_MODIFIER", 705, 711], ["reduced", "OBSERVATION_MODIFIER", 733, 740], ["oxygen", "OBSERVATION_MODIFIER", 741, 747]]], ["The functional activity of hepatocytes is heterogeneous, and virtually all liver functions have a zonal gradient.", [["hepatocytes", "ANATOMY", 27, 38], ["liver", "ANATOMY", 75, 80], ["hepatocytes", "CELL", 27, 38], ["liver", "ORGAN", 75, 80], ["hepatocytes", "CELL_TYPE", 27, 38], ["functional activity", "OBSERVATION", 4, 23], ["hepatocytes", "ANATOMY", 27, 38], ["heterogeneous", "OBSERVATION_MODIFIER", 42, 55], ["liver", "ANATOMY", 75, 80], ["zonal gradient", "OBSERVATION", 98, 112]]], ["Periportal hepatocytes, exposed to the blood with the highest concentration of oxygen, insulin, glucagon, and amino acids, are the principal site of gluconeogenesis, protein synthesis, aerobic metabolism, urea cycle, and lipid and cholesterol metabolism.", [["Periportal hepatocytes", "ANATOMY", 0, 22], ["blood", "ANATOMY", 39, 44], ["oxygen", "CHEMICAL", 79, 85], ["glucagon", "CHEMICAL", 96, 104], ["amino acids", "CHEMICAL", 110, 121], ["urea", "CHEMICAL", 205, 209], ["cholesterol", "CHEMICAL", 231, 242], ["oxygen", "CHEMICAL", 79, 85], ["amino acids", "CHEMICAL", 110, 121], ["urea", "CHEMICAL", 205, 209], ["cholesterol", "CHEMICAL", 231, 242], ["Periportal hepatocytes", "CELL", 0, 22], ["blood", "ORGANISM_SUBSTANCE", 39, 44], ["oxygen", "SIMPLE_CHEMICAL", 79, 85], ["insulin", "GENE_OR_GENE_PRODUCT", 87, 94], ["glucagon", "GENE_OR_GENE_PRODUCT", 96, 104], ["amino acids", "AMINO_ACID", 110, 121], ["urea", "SIMPLE_CHEMICAL", 205, 209], ["lipid", "SIMPLE_CHEMICAL", 221, 226], ["cholesterol", "SIMPLE_CHEMICAL", 231, 242], ["Periportal hepatocytes", "CELL_TYPE", 0, 22], ["insulin", "PROTEIN", 87, 94], ["Periportal hepatocytes", "PROBLEM", 0, 22], ["the blood", "TEST", 35, 44], ["oxygen", "TREATMENT", 79, 85], ["insulin", "TREATMENT", 87, 94], ["glucagon", "TREATMENT", 96, 104], ["amino acids", "TEST", 110, 121], ["protein synthesis", "TEST", 166, 183], ["aerobic metabolism", "TEST", 185, 203], ["urea cycle", "TEST", 205, 215], ["lipid and cholesterol metabolism", "TREATMENT", 221, 253], ["hepatocytes", "ANATOMY", 11, 22], ["highest", "OBSERVATION_MODIFIER", 54, 61], ["concentration", "OBSERVATION_MODIFIER", 62, 75], ["oxygen", "OBSERVATION_MODIFIER", 79, 85], ["cholesterol metabolism", "OBSERVATION", 231, 253]]], ["In the centrilobular region, glycolysis, lipogenesis, and the major biotransformation functions are more active, including the expression of most cytochromes P450, glucuronyl transferases, glutathione S-transferases, and other biotransformation/ detoxification enzymes.", [["centrilobular region", "ANATOMY", 7, 27], ["glutathione", "CHEMICAL", 189, 200], ["glucuronyl", "CHEMICAL", 164, 174], ["glutathione", "CHEMICAL", 189, 200], ["S", "CHEMICAL", 201, 202], ["cytochromes P450", "GENE_OR_GENE_PRODUCT", 146, 162], ["glucuronyl transferases", "GENE_OR_GENE_PRODUCT", 164, 187], ["glutathione S-transferases", "GENE_OR_GENE_PRODUCT", 189, 215], ["cytochromes P450", "PROTEIN", 146, 162], ["glucuronyl transferases", "PROTEIN", 164, 187], ["glutathione S-transferases", "PROTEIN", 189, 215], ["detoxification enzymes", "PROTEIN", 246, 268], ["lipogenesis", "PROBLEM", 41, 52], ["most cytochromes P450", "TEST", 141, 162], ["glucuronyl transferases", "TEST", 164, 187], ["glutathione S-transferases", "TEST", 189, 215], ["detoxification enzymes", "TEST", 246, 268], ["centrilobular", "ANATOMY_MODIFIER", 7, 20], ["glycolysis", "OBSERVATION_MODIFIER", 29, 39], ["lipogenesis", "OBSERVATION_MODIFIER", 41, 52], ["major", "OBSERVATION_MODIFIER", 62, 67], ["biotransformation functions", "OBSERVATION", 68, 95]]], ["Centrilobular hepatocytes are therefore more susceptible to hypoxic injury as well as injury by toxic hormones, growth factors, immunoglobulin A, and other endocytotic or signaling ligands are found at the sinusoidal pole.", [["Centrilobular hepatocytes", "ANATOMY", 0, 25], ["sinusoidal pole", "ANATOMY", 206, 221], ["hypoxic injury", "DISEASE", 60, 74], ["Centrilobular hepatocytes", "CELL", 0, 25], ["immunoglobulin A", "GENE_OR_GENE_PRODUCT", 128, 144], ["sinusoidal pole", "MULTI-TISSUE_STRUCTURE", 206, 221], ["Centrilobular hepatocytes", "CELL_TYPE", 0, 25], ["growth factors", "PROTEIN", 112, 126], ["immunoglobulin A", "PROTEIN", 128, 144], ["Centrilobular hepatocytes", "PROBLEM", 0, 25], ["hypoxic injury", "PROBLEM", 60, 74], ["injury", "PROBLEM", 86, 92], ["toxic hormones", "PROBLEM", 96, 110], ["growth factors", "PROBLEM", 112, 126], ["immunoglobulin A", "TEST", 128, 144], ["signaling ligands", "PROBLEM", 171, 188], ["hepatocytes", "ANATOMY", 14, 25], ["hypoxic", "OBSERVATION_MODIFIER", 60, 67], ["injury", "OBSERVATION", 68, 74], ["toxic", "OBSERVATION_MODIFIER", 96, 101], ["signaling ligands", "OBSERVATION", 171, 188], ["sinusoidal", "ANATOMY_MODIFIER", 206, 216], ["pole", "ANATOMY_MODIFIER", 217, 221]]], ["In addition, transmembrane proteins involved in plasma exchange of small ionic substances with the sinusoidal plasma, and transmembrane proteins responsible for matrix recognition, are concentrated on the sinusoidal surface.", [["transmembrane", "ANATOMY", 13, 26], ["plasma", "ANATOMY", 48, 54], ["sinusoidal plasma", "ANATOMY", 99, 116], ["transmembrane", "ANATOMY", 122, 135], ["matrix", "ANATOMY", 161, 167], ["sinusoidal surface", "ANATOMY", 205, 223], ["plasma", "ORGANISM_SUBSTANCE", 48, 54], ["plasma", "ORGANISM_SUBSTANCE", 110, 116], ["transmembrane", "CELLULAR_COMPONENT", 122, 135], ["matrix", "CELLULAR_COMPONENT", 161, 167], ["sinusoidal surface", "CELLULAR_COMPONENT", 205, 223], ["transmembrane proteins", "PROTEIN", 13, 35], ["transmembrane proteins", "PROTEIN", 122, 144], ["transmembrane proteins", "TEST", 13, 35], ["plasma exchange", "TEST", 48, 63], ["small ionic substances", "TREATMENT", 67, 89], ["the sinusoidal plasma", "TEST", 95, 116], ["transmembrane proteins", "PROBLEM", 122, 144], ["matrix recognition", "PROBLEM", 161, 179], ["small ionic substances", "OBSERVATION", 67, 89], ["sinusoidal plasma", "OBSERVATION", 99, 116], ["concentrated", "OBSERVATION_MODIFIER", 185, 197], ["sinusoidal", "OBSERVATION_MODIFIER", 205, 215], ["surface", "OBSERVATION_MODIFIER", 216, 223]]], ["The lateral domain extends from the sinusoidal surface to the edge of the canaliculus.", [["lateral domain", "ANATOMY", 4, 18], ["sinusoidal surface", "ANATOMY", 36, 54], ["canaliculus", "ANATOMY", 74, 85], ["sinusoidal surface", "CELLULAR_COMPONENT", 36, 54], ["canaliculus", "MULTI-TISSUE_STRUCTURE", 74, 85], ["lateral domain", "PROTEIN", 4, 18], ["The lateral domain", "PROBLEM", 0, 18], ["lateral", "OBSERVATION_MODIFIER", 4, 11], ["sinusoidal", "OBSERVATION_MODIFIER", 36, 46], ["surface", "OBSERVATION_MODIFIER", 47, 54], ["edge", "ANATOMY_MODIFIER", 62, 66], ["canaliculus", "ANATOMY", 74, 85]]], ["This portion of the cell membrane is specialized for adhesion via junctional complexes, including desmosomes, tight junctions, and intermediate junctions, as well as for intercellular communication via gap junctions.", [["cell membrane", "ANATOMY", 20, 33], ["junctional complexes", "ANATOMY", 66, 86], ["desmosomes", "ANATOMY", 98, 108], ["tight junctions", "ANATOMY", 110, 125], ["intermediate junctions", "ANATOMY", 131, 153], ["intercellular", "ANATOMY", 170, 183], ["gap junctions", "ANATOMY", 202, 215], ["cell membrane", "CELLULAR_COMPONENT", 20, 33], ["junctional complexes", "CELLULAR_COMPONENT", 66, 86], ["desmosomes", "CELLULAR_COMPONENT", 98, 108], ["tight junctions", "CELLULAR_COMPONENT", 110, 125], ["intermediate junctions", "CELLULAR_COMPONENT", 131, 153], ["gap junctions", "CELLULAR_COMPONENT", 202, 215], ["junctional complexes", "PROTEIN", 66, 86], ["adhesion via junctional complexes", "PROBLEM", 53, 86], ["cell membrane", "OBSERVATION", 20, 33], ["junctional complexes", "OBSERVATION", 66, 86], ["tight junctions", "OBSERVATION", 110, 125], ["intermediate junctions", "OBSERVATION", 131, 153], ["gap junctions", "OBSERVATION", 202, 215]]], ["The canalicular domain is the beginning of the bile drainage system of the liver.", [["canalicular", "ANATOMY", 4, 15], ["bile drainage system", "ANATOMY", 47, 67], ["liver", "ANATOMY", 75, 80], ["canalicular", "MULTI-TISSUE_STRUCTURE", 4, 15], ["bile", "MULTI-TISSUE_STRUCTURE", 47, 51], ["liver", "ORGAN", 75, 80], ["canalicular", "ANATOMY_MODIFIER", 4, 15], ["bile", "ANATOMY", 47, 51], ["drainage", "OBSERVATION", 52, 60], ["liver", "ANATOMY", 75, 80]]], ["The canaliculus is an intercellular space between 2 adjacent hepatocytes, isolated by junctional complexes.", [["canaliculus", "ANATOMY", 4, 15], ["intercellular space", "ANATOMY", 22, 41], ["hepatocytes", "ANATOMY", 61, 72], ["junctional complexes", "ANATOMY", 86, 106], ["canaliculus", "MULTI-TISSUE_STRUCTURE", 4, 15], ["intercellular space", "CELLULAR_COMPONENT", 22, 41], ["hepatocytes", "CELL", 61, 72], ["junctional complexes", "CELLULAR_COMPONENT", 86, 106], ["hepatocytes", "CELL_TYPE", 61, 72], ["junctional complexes", "PROTEIN", 86, 106], ["an intercellular space between 2 adjacent hepatocytes", "PROBLEM", 19, 72], ["canaliculus", "ANATOMY_MODIFIER", 4, 15], ["intercellular space", "OBSERVATION", 22, 41], ["hepatocytes", "ANATOMY", 61, 72], ["junctional complexes", "OBSERVATION", 86, 106]]], ["The canalicular surface is covered with an irregular array of microvilli.", [["canalicular surface", "ANATOMY", 4, 23], ["microvilli", "ANATOMY", 62, 72], ["canalicular surface", "MULTI-TISSUE_STRUCTURE", 4, 23], ["microvilli", "CELLULAR_COMPONENT", 62, 72], ["canalicular", "ANATOMY_MODIFIER", 4, 15], ["surface", "OBSERVATION_MODIFIER", 16, 23], ["irregular", "OBSERVATION_MODIFIER", 43, 52], ["array", "OBSERVATION_MODIFIER", 53, 58], ["microvilli", "OBSERVATION_MODIFIER", 62, 72]]], ["Canalicular diameter increases as it approaches the periportal region, enlarging from ~0.5-2.5 \u00b5m.", [["Canalicular", "ANATOMY", 0, 11], ["periportal region", "ANATOMY", 52, 69], ["Canalicular diameter", "PROBLEM", 0, 20], ["diameter", "OBSERVATION_MODIFIER", 12, 20], ["periportal", "ANATOMY_MODIFIER", 52, 62], ["region", "ANATOMY_MODIFIER", 63, 69], ["enlarging", "OBSERVATION_MODIFIER", 71, 80], ["~0.5-2.5 \u00b5m", "OBSERVATION_MODIFIER", 86, 97]]], ["Bile is propelled along the canaliculi by a web of contractile microfilaments.", [["Bile", "ANATOMY", 0, 4], ["canaliculi", "ANATOMY", 28, 38], ["contractile microfilaments", "ANATOMY", 51, 77], ["Bile", "MULTI-TISSUE_STRUCTURE", 0, 4], ["canaliculi", "MULTI-TISSUE_STRUCTURE", 28, 38], ["contractile microfilaments", "CELLULAR_COMPONENT", 51, 77], ["canaliculi", "ANATOMY_MODIFIER", 28, 38], ["contractile microfilaments", "OBSERVATION", 51, 77]]], ["This specialized membrane contains various adenosine triphosphate (ATP)-dependent carriers that export many products, including leukotrienes, bile salts, xenobiotics, and their metabolites into the bile.", [["membrane", "ANATOMY", 17, 25], ["bile", "ANATOMY", 198, 202], ["adenosine triphosphate", "CHEMICAL", 43, 65], ["ATP", "CHEMICAL", 67, 70], ["leukotrienes", "CHEMICAL", 128, 140], ["bile salts", "CHEMICAL", 142, 152], ["xenobiotics", "CHEMICAL", 154, 165], ["adenosine triphosphate", "CHEMICAL", 43, 65], ["ATP", "CHEMICAL", 67, 70], ["bile salts", "CHEMICAL", 142, 152], ["membrane", "CELLULAR_COMPONENT", 17, 25], ["adenosine triphosphate", "SIMPLE_CHEMICAL", 43, 65], ["ATP", "SIMPLE_CHEMICAL", 67, 70], ["leukotrienes", "SIMPLE_CHEMICAL", 128, 140], ["bile salts", "SIMPLE_CHEMICAL", 142, 152], ["xenobiotics", "SIMPLE_CHEMICAL", 154, 165], ["bile", "MULTI-TISSUE_STRUCTURE", 198, 202], ["various adenosine triphosphate (ATP)", "TREATMENT", 35, 71], ["dependent carriers", "PROBLEM", 72, 90], ["leukotrienes, bile salts", "TEST", 128, 152], ["xenobiotics", "TREATMENT", 154, 165], ["various adenosine triphosphate", "OBSERVATION", 35, 65], ["bile", "ANATOMY", 142, 146], ["bile", "ANATOMY", 198, 202]]], ["The canal of Hering is partly lined by biliary epithelium and partly by hepatocytes and connects the bile canaliculus to the cholangioles and eventually the interlobular bile ducts.Cells of the liverCholangiocytes (biliary epithelium) account for ~3-5% of the liver cell population.", [["canal", "ANATOMY", 4, 9], ["biliary epithelium", "ANATOMY", 39, 57], ["hepatocytes", "ANATOMY", 72, 83], ["bile canaliculus", "ANATOMY", 101, 117], ["cholangioles", "ANATOMY", 125, 137], ["interlobular bile ducts", "ANATOMY", 157, 180], ["Cells", "ANATOMY", 181, 186], ["liverCholangiocytes", "ANATOMY", 194, 213], ["biliary epithelium", "ANATOMY", 215, 233], ["liver cell", "ANATOMY", 260, 270], ["canal", "MULTI-TISSUE_STRUCTURE", 4, 9], ["biliary epithelium", "TISSUE", 39, 57], ["hepatocytes", "CELL", 72, 83], ["bile canaliculus", "MULTI-TISSUE_STRUCTURE", 101, 117], ["cholangioles", "CANCER", 125, 137], ["interlobular bile ducts", "MULTI-TISSUE_STRUCTURE", 157, 180], ["Cells", "CELL", 181, 186], ["liverCholangiocytes", "MULTI-TISSUE_STRUCTURE", 194, 213], ["biliary epithelium", "TISSUE", 215, 233], ["liver cell population", "CELL", 260, 281], ["hepatocytes", "CELL_TYPE", 72, 83], ["canal", "ANATOMY_MODIFIER", 4, 9], ["biliary epithelium", "ANATOMY", 39, 57], ["hepatocytes", "OBSERVATION", 72, 83], ["bile canaliculus", "ANATOMY", 101, 117], ["interlobular", "ANATOMY_MODIFIER", 157, 169], ["bile ducts", "ANATOMY", 170, 180], ["liver", "ANATOMY", 194, 199], ["Cholangiocytes", "OBSERVATION", 199, 213], ["biliary epithelium", "ANATOMY", 215, 233], ["liver", "ANATOMY", 260, 265], ["cell population", "OBSERVATION", 266, 281]]], ["Although derived from common embryologic progenitor cells, cholangiocytes differ from hepatocytes in both phenotype and function.", [["embryologic progenitor cells", "ANATOMY", 29, 57], ["cholangiocytes", "ANATOMY", 59, 73], ["hepatocytes", "ANATOMY", 86, 97], ["embryologic progenitor cells", "CELL", 29, 57], ["cholangiocytes", "CELL", 59, 73], ["hepatocytes", "CELL", 86, 97], ["common embryologic progenitor cells", "CELL_TYPE", 22, 57], ["cholangiocytes", "CELL_TYPE", 59, 73], ["hepatocytes", "CELL_TYPE", 86, 97], ["cholangiocytes", "PROBLEM", 59, 73], ["progenitor cells", "OBSERVATION", 41, 57], ["hepatocytes", "ANATOMY", 86, 97], ["both phenotype", "OBSERVATION", 101, 115]]], ["They contain a strongly developed network of intermediate filaments, including cytokeratins 7 and 19.", [["filaments", "ANATOMY", 58, 67], ["intermediate filaments", "CELLULAR_COMPONENT", 45, 67], ["cytokeratins 7", "GENE_OR_GENE_PRODUCT", 79, 93], ["cytokeratins 7 and 19", "PROTEIN", 79, 100], ["cytokeratins", "TEST", 79, 91], ["intermediate filaments", "OBSERVATION", 45, 67]]], ["They also express marked heterogeneity along the anatomic course of the biliary system.", [["biliary system", "ANATOMY", 72, 86], ["biliary system", "MULTI-TISSUE_STRUCTURE", 72, 86], ["marked heterogeneity", "PROBLEM", 18, 38], ["marked", "OBSERVATION_MODIFIER", 18, 24], ["heterogeneity", "OBSERVATION", 25, 38], ["anatomic", "ANATOMY_MODIFIER", 49, 57], ["biliary system", "ANATOMY", 72, 86]]], ["Functionally, bile duct epithelial cells actively modify the composition of bile.", [["bile duct epithelial cells", "ANATOMY", 14, 40], ["bile", "ANATOMY", 76, 80], ["bile duct epithelial cells", "CELL", 14, 40], ["bile", "MULTI-TISSUE_STRUCTURE", 76, 80], ["bile duct epithelial cells", "CELL_TYPE", 14, 40], ["Functionally, bile duct epithelial cells", "PROBLEM", 0, 40], ["bile duct", "ANATOMY", 14, 23], ["epithelial cells", "OBSERVATION", 24, 40], ["bile", "ANATOMY", 76, 80]]], ["Secretion is primarily under the control of secretin and somatostatin.", [["somatostatin", "CHEMICAL", 57, 69], ["secretin", "GENE_OR_GENE_PRODUCT", 44, 52], ["somatostatin", "GENE_OR_GENE_PRODUCT", 57, 69], ["secretin", "TREATMENT", 44, 52], ["somatostatin", "TREATMENT", 57, 69]]], ["Secretin released from the duodenum triggers secretion of bicarbonate-rich fluids that buffer acids released from the stomach.", [["duodenum", "ANATOMY", 27, 35], ["stomach", "ANATOMY", 118, 125], ["Secretin", "CHEMICAL", 0, 8], ["bicarbonate", "CHEMICAL", 58, 69], ["Secretin", "CHEMICAL", 0, 8], ["bicarbonate", "CHEMICAL", 58, 69], ["Secretin", "GENE_OR_GENE_PRODUCT", 0, 8], ["duodenum", "ORGAN", 27, 35], ["bicarbonate", "SIMPLE_CHEMICAL", 58, 69], ["stomach", "ORGAN", 118, 125], ["Secretin", "PROTEIN", 0, 8], ["Secretin", "TREATMENT", 0, 8], ["bicarbonate-rich fluids", "TREATMENT", 58, 81], ["buffer acids", "TREATMENT", 87, 99], ["duodenum", "ANATOMY", 27, 35], ["stomach", "ANATOMY", 118, 125]]], ["Cholangiocytes secrete immunoglobulin A (IgA) and IgM, but not IgG.", [["Cholangiocytes", "ANATOMY", 0, 14], ["Cholangiocytes", "CELL", 0, 14], ["immunoglobulin A", "GENE_OR_GENE_PRODUCT", 23, 39], ["IgA", "GENE_OR_GENE_PRODUCT", 41, 44], ["IgM", "GENE_OR_GENE_PRODUCT", 50, 53], ["IgG", "GENE_OR_GENE_PRODUCT", 63, 66], ["Cholangiocytes", "CELL_TYPE", 0, 14], ["immunoglobulin A", "PROTEIN", 23, 39], ["IgA", "PROTEIN", 41, 44], ["IgM", "PROTEIN", 50, 53], ["IgG", "PROTEIN", 63, 66], ["Cholangiocytes secrete immunoglobulin A (IgA", "TEST", 0, 44], ["IgM", "TEST", 50, 53], ["IgG", "TEST", 63, 66], ["immunoglobulin", "OBSERVATION", 23, 37]]], ["Absorption involves the sodium-dependent glucose transporter and aquaporins responsible for glucose and water uptake, as in the renal proximal tubule.", [["renal proximal tubule", "ANATOMY", 128, 149], ["sodium", "CHEMICAL", 24, 30], ["glucose", "CHEMICAL", 41, 48], ["glucose", "CHEMICAL", 92, 99], ["sodium", "CHEMICAL", 24, 30], ["glucose", "CHEMICAL", 41, 48], ["glucose", "CHEMICAL", 92, 99], ["sodium", "SIMPLE_CHEMICAL", 24, 30], ["glucose", "SIMPLE_CHEMICAL", 41, 48], ["aquaporins", "GENE_OR_GENE_PRODUCT", 65, 75], ["glucose", "SIMPLE_CHEMICAL", 92, 99], ["water", "SIMPLE_CHEMICAL", 104, 109], ["renal proximal tubule", "MULTI-TISSUE_STRUCTURE", 128, 149], ["sodium-dependent glucose transporter", "PROTEIN", 24, 60], ["aquaporins", "PROTEIN", 65, 75], ["the sodium", "TEST", 20, 30], ["dependent glucose transporter", "TREATMENT", 31, 60], ["aquaporins", "TREATMENT", 65, 75], ["glucose and water uptake", "TEST", 92, 116], ["renal", "ANATOMY", 128, 133], ["proximal", "ANATOMY_MODIFIER", 134, 142], ["tubule", "ANATOMY", 143, 149]]], ["They express \u03b3-glutamyltranspeptidase, which removes glutamic acid from glutathione conjugates.Cells of the liverHepatic progenitor cells (HPCs), formerly known as oval cells in rodents, reside in the region of the canal of Hering.", [["Cells", "ANATOMY", 95, 100], ["liverHepatic progenitor cells", "ANATOMY", 108, 137], ["HPCs", "ANATOMY", 139, 143], ["oval cells", "ANATOMY", 164, 174], ["canal", "ANATOMY", 215, 220], ["glutamic acid", "CHEMICAL", 53, 66], ["glutathione", "CHEMICAL", 72, 83], ["glutamic acid", "CHEMICAL", 53, 66], ["glutathione", "CHEMICAL", 72, 83], ["\u03b3-glutamyltranspeptidase", "GENE_OR_GENE_PRODUCT", 13, 37], ["glutamic acid", "SIMPLE_CHEMICAL", 53, 66], ["glutathione conjugates", "SIMPLE_CHEMICAL", 72, 94], ["Cells", "CELL", 95, 100], ["liverHepatic progenitor cells", "CELL", 108, 137], ["HPCs", "CELL", 139, 143], ["oval cells", "CELL", 164, 174], ["\u03b3-glutamyltranspeptidase", "PROTEIN", 13, 37], ["liverHepatic progenitor cells", "CELL_TYPE", 108, 137], ["HPCs", "CELL_TYPE", 139, 143], ["oval cells", "CELL_TYPE", 164, 174], ["glutamic acid from glutathione conjugates", "TREATMENT", 53, 94], ["oval cells in rodents", "PROBLEM", 164, 185], ["liverHepatic", "ANATOMY", 108, 120], ["progenitor cells", "OBSERVATION", 121, 137], ["oval cells", "OBSERVATION", 164, 174], ["rodents", "OBSERVATION_MODIFIER", 178, 185], ["region", "ANATOMY_MODIFIER", 201, 207], ["canal", "ANATOMY_MODIFIER", 215, 220]]], ["These cells are bipotential and can mature into either biliary epithelium or hepatocytes.", [["cells", "ANATOMY", 6, 11], ["biliary epithelium", "ANATOMY", 55, 73], ["hepatocytes", "ANATOMY", 77, 88], ["cells", "CELL", 6, 11], ["biliary epithelium", "TISSUE", 55, 73], ["hepatocytes", "CELL", 77, 88], ["hepatocytes", "CELL_TYPE", 77, 88], ["biliary epithelium", "ANATOMY", 55, 73], ["hepatocytes", "ANATOMY", 77, 88]]], ["They can proliferate and form a type of ductular reaction.", [["ductular", "ANATOMY", 40, 48], ["ductular", "MULTI-TISSUE_STRUCTURE", 40, 48], ["ductular reaction", "PROBLEM", 40, 57]]], ["In cases of massive hepatic necrosis in which the animal survives for a few days after the initial injury, HPCs can proliferate dramatically, forming cords or small caliber ducts lined by cuboidal basophilic cells with abundant mitochondria.", [["hepatic", "ANATOMY", 20, 27], ["HPCs", "ANATOMY", 107, 111], ["cords", "ANATOMY", 150, 155], ["ducts", "ANATOMY", 173, 178], ["cuboidal basophilic cells", "ANATOMY", 188, 213], ["mitochondria", "ANATOMY", 228, 240], ["hepatic necrosis", "DISEASE", 20, 36], ["hepatic", "PATHOLOGICAL_FORMATION", 20, 27], ["HPCs", "CELL", 107, 111], ["cords", "TISSUE", 150, 155], ["ducts", "MULTI-TISSUE_STRUCTURE", 173, 178], ["cuboidal basophilic cells", "CELL", 188, 213], ["mitochondria", "CELLULAR_COMPONENT", 228, 240], ["HPCs", "CELL_TYPE", 107, 111], ["cuboidal basophilic cells", "CELL_TYPE", 188, 213], ["massive hepatic necrosis", "PROBLEM", 12, 36], ["the initial injury", "PROBLEM", 87, 105], ["small caliber ducts", "PROBLEM", 159, 178], ["cuboidal basophilic cells", "PROBLEM", 188, 213], ["abundant mitochondria", "PROBLEM", 219, 240], ["massive", "OBSERVATION_MODIFIER", 12, 19], ["hepatic", "ANATOMY", 20, 27], ["necrosis", "OBSERVATION", 28, 36], ["injury", "OBSERVATION", 99, 105], ["small", "OBSERVATION_MODIFIER", 159, 164], ["caliber", "OBSERVATION_MODIFIER", 165, 172], ["ducts", "ANATOMY", 173, 178], ["cuboidal basophilic cells", "OBSERVATION", 188, 213], ["abundant mitochondria", "OBSERVATION", 219, 240]]], ["These cells can mature and replace lost hepatocytes and bile ducts.", [["cells", "ANATOMY", 6, 11], ["hepatocytes", "ANATOMY", 40, 51], ["bile ducts", "ANATOMY", 56, 66], ["cells", "CELL", 6, 11], ["hepatocytes", "CELL", 40, 51], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 56, 66], ["hepatocytes", "CELL_TYPE", 40, 51], ["bile ducts", "ANATOMY", 56, 66]]], ["HPCs in humans and rats contain both markers of hepatocyte phenotype (i.e., albumin) and biliary phenotype (i.e., cytokeratin 7).", [["HPCs", "ANATOMY", 0, 4], ["hepatocyte", "ANATOMY", 48, 58], ["biliary", "ANATOMY", 89, 96], ["HPCs", "CELL", 0, 4], ["humans", "ORGANISM", 8, 14], ["rats", "ORGANISM", 19, 23], ["hepatocyte", "CELL", 48, 58], ["albumin", "GENE_OR_GENE_PRODUCT", 76, 83], ["biliary", "ORGAN", 89, 96], ["cytokeratin 7", "GENE_OR_GENE_PRODUCT", 114, 127], ["HPCs", "CELL_TYPE", 0, 4], ["albumin", "PROTEIN", 76, 83], ["cytokeratin 7", "PROTEIN", 114, 127], ["humans", "SPECIES", 8, 14], ["rats", "SPECIES", 19, 23], ["humans", "SPECIES", 8, 14], ["hepatocyte phenotype", "TEST", 48, 68], ["albumin", "TEST", 76, 83], ["biliary phenotype", "PROBLEM", 89, 106], ["cytokeratin", "TEST", 114, 125], ["hepatocyte", "ANATOMY", 48, 58], ["biliary", "ANATOMY", 89, 96]]], ["Similar markers have been described in dogs and cats as well.", [["dogs", "ORGANISM", 39, 43], ["cats", "ORGANISM", 48, 52], ["dogs", "SPECIES", 39, 43], ["cats", "SPECIES", 48, 52]]], ["Bone marrowderived pluripotential stem cells also appear to have the ability to differentiate into hepatocytes.", [["Bone", "ANATOMY", 0, 4], ["pluripotential stem cells", "ANATOMY", 19, 44], ["hepatocytes", "ANATOMY", 99, 110], ["pluripotential stem cells", "CELL", 19, 44], ["hepatocytes", "CELL", 99, 110], ["Bone marrowderived pluripotential stem cells", "CELL_LINE", 0, 44], ["hepatocytes", "CELL_TYPE", 99, 110], ["Bone marrowderived pluripotential stem cells", "PROBLEM", 0, 44], ["pluripotential stem cells", "OBSERVATION", 19, 44], ["hepatocytes", "ANATOMY", 99, 110]]], ["Other types of ductular reaction are discussed in the section on Responses of the liver to injury.Cells of the liverHepatic endothelial cells are specialized, perforated by numerous fenestrations, ~175 nm in diameter, and often the limiting plate, is found at the interface with the collagenous ECM of the portal tract.", [["ductular", "ANATOMY", 15, 23], ["liver", "ANATOMY", 82, 87], ["Cells", "ANATOMY", 98, 103], ["liverHepatic endothelial cells", "ANATOMY", 111, 141], ["fenestrations", "ANATOMY", 182, 195], ["collagenous ECM", "ANATOMY", 283, 298], ["portal tract", "ANATOMY", 306, 318], ["ductular", "MULTI-TISSUE_STRUCTURE", 15, 23], ["liver", "ORGAN", 82, 87], ["Cells", "CELL", 98, 103], ["liverHepatic endothelial cells", "CELL", 111, 141], ["collagenous ECM", "CELLULAR_COMPONENT", 283, 298], ["portal tract", "MULTI-TISSUE_STRUCTURE", 306, 318], ["liverHepatic endothelial cells", "CELL_TYPE", 111, 141], ["ductular reaction", "PROBLEM", 15, 32], ["injury", "PROBLEM", 91, 97], ["the liverHepatic endothelial cells", "PROBLEM", 107, 141], ["numerous fenestrations", "PROBLEM", 173, 195], ["ductular reaction", "OBSERVATION", 15, 32], ["liver", "ANATOMY", 82, 87], ["injury", "OBSERVATION", 91, 97], ["liverHepatic endothelial cells", "OBSERVATION", 111, 141], ["perforated", "OBSERVATION_MODIFIER", 159, 169], ["numerous", "OBSERVATION_MODIFIER", 173, 181], ["fenestrations", "OBSERVATION_MODIFIER", 182, 195], ["175 nm", "OBSERVATION_MODIFIER", 198, 204], ["diameter", "OBSERVATION_MODIFIER", 208, 216], ["limiting", "OBSERVATION_MODIFIER", 232, 240], ["plate", "OBSERVATION_MODIFIER", 241, 246], ["collagenous", "OBSERVATION", 283, 294], ["ECM", "ANATOMY_MODIFIER", 295, 298], ["portal tract", "ANATOMY", 306, 318]]], ["Normal hepatocytes have abundant eosinophilic cytoplasm, and most have a single, round, centrally placed nucleus with finely dispersed chromatin and at least one nucleolus.", [["hepatocytes", "ANATOMY", 7, 18], ["eosinophilic cytoplasm", "ANATOMY", 33, 55], ["nucleus", "ANATOMY", 105, 112], ["chromatin", "ANATOMY", 135, 144], ["nucleolus", "ANATOMY", 162, 171], ["hepatocytes", "CELL", 7, 18], ["eosinophilic cytoplasm", "ORGANISM_SUBSTANCE", 33, 55], ["nucleus", "CELLULAR_COMPONENT", 105, 112], ["chromatin", "CELLULAR_COMPONENT", 135, 144], ["nucleolus", "CELLULAR_COMPONENT", 162, 171], ["Normal hepatocytes", "CELL_TYPE", 0, 18], ["chromatin", "DNA", 135, 144], ["abundant eosinophilic cytoplasm", "PROBLEM", 24, 55], ["a single, round, centrally placed nucleus", "PROBLEM", 71, 112], ["hepatocytes", "ANATOMY", 7, 18], ["abundant", "OBSERVATION_MODIFIER", 24, 32], ["eosinophilic cytoplasm", "OBSERVATION", 33, 55], ["single", "OBSERVATION_MODIFIER", 73, 79], ["round", "OBSERVATION_MODIFIER", 81, 86], ["nucleus", "ANATOMY_MODIFIER", 105, 112], ["finely", "OBSERVATION_MODIFIER", 118, 124], ["dispersed chromatin", "OBSERVATION", 125, 144], ["nucleolus", "OBSERVATION", 162, 171]]], ["Some binucleate hepatocytes are present normally in mammals and can become more numerous in response to various stimuli and injuries that induce or affect regeneration.Cells of the liverHepatocytes are metabolically highly active cells, containing an array of organelles, including smooth and rough endoplasmic reticulum, mitochondria, lysosomes, peroxisomes, Golgi complexes, and transport vesicles.", [["binucleate hepatocytes", "ANATOMY", 5, 27], ["Cells", "ANATOMY", 168, 173], ["liverHepatocytes", "ANATOMY", 181, 197], ["cells", "ANATOMY", 230, 235], ["organelles", "ANATOMY", 260, 270], ["endoplasmic reticulum", "ANATOMY", 299, 320], ["mitochondria", "ANATOMY", 322, 334], ["lysosomes", "ANATOMY", 336, 345], ["peroxisomes", "ANATOMY", 347, 358], ["Golgi complexes", "ANATOMY", 360, 375], ["transport vesicles", "ANATOMY", 381, 399], ["injuries", "DISEASE", 124, 132], ["binucleate hepatocytes", "CELL", 5, 27], ["Cells", "CELL", 168, 173], ["liverHepatocytes", "CELL", 181, 197], ["cells", "CELL", 230, 235], ["organelles", "CELLULAR_COMPONENT", 260, 270], ["endoplasmic reticulum", "CELLULAR_COMPONENT", 299, 320], ["mitochondria", "CELLULAR_COMPONENT", 322, 334], ["lysosomes", "CELLULAR_COMPONENT", 336, 345], ["peroxisomes", "CELLULAR_COMPONENT", 347, 358], ["Golgi", "CELLULAR_COMPONENT", 360, 365], ["transport vesicles", "CELLULAR_COMPONENT", 381, 399], ["binucleate hepatocytes", "CELL_TYPE", 5, 27], ["Golgi complexes", "PROTEIN", 360, 375], ["Some binucleate hepatocytes", "PROBLEM", 0, 27], ["various stimuli", "TEST", 104, 119], ["injuries", "PROBLEM", 124, 132], ["affect regeneration", "PROBLEM", 148, 167], ["metabolically highly active cells", "PROBLEM", 202, 235], ["smooth and rough endoplasmic reticulum", "PROBLEM", 282, 320], ["binucleate hepatocytes", "OBSERVATION", 5, 27], ["more", "OBSERVATION_MODIFIER", 75, 79], ["numerous", "OBSERVATION_MODIFIER", 80, 88], ["various stimuli", "OBSERVATION", 104, 119], ["liver", "ANATOMY", 181, 186], ["Hepatocytes", "ANATOMY", 186, 197], ["active cells", "OBSERVATION", 223, 235], ["smooth", "OBSERVATION_MODIFIER", 282, 288], ["rough", "OBSERVATION_MODIFIER", 293, 298], ["endoplasmic reticulum", "OBSERVATION", 299, 320], ["Golgi complexes", "OBSERVATION", 360, 375], ["transport vesicles", "OBSERVATION", 381, 399]]], ["These organelles support a variety of hepatocellular functions, including the synthesis and secretion of plasma proteins, coagulation factors, and acute-phase proteins.", [["organelles", "ANATOMY", 6, 16], ["hepatocellular", "ANATOMY", 38, 52], ["plasma", "ANATOMY", 105, 111], ["organelles", "CELLULAR_COMPONENT", 6, 16], ["hepatocellular", "CANCER", 38, 52], ["plasma", "ORGANISM_SUBSTANCE", 105, 111], ["coagulation factors", "GENE_OR_GENE_PRODUCT", 122, 141], ["plasma proteins", "PROTEIN", 105, 120], ["coagulation factors", "PROTEIN", 122, 141], ["acute-phase proteins", "PROTEIN", 147, 167], ["hepatocellular functions", "PROBLEM", 38, 62], ["the synthesis and secretion of plasma proteins", "TEST", 74, 120], ["coagulation factors", "TEST", 122, 141], ["acute-phase proteins", "PROBLEM", 147, 167], ["hepatocellular", "ANATOMY", 38, 52]]], ["Hepatocytes store nutrients in times of adequate energy and release glucose when needed.", [["Hepatocytes", "ANATOMY", 0, 11], ["glucose", "CHEMICAL", 68, 75], ["glucose", "CHEMICAL", 68, 75], ["Hepatocytes", "CELL", 0, 11], ["glucose", "SIMPLE_CHEMICAL", 68, 75], ["release glucose", "TEST", 60, 75]]], ["They are key modulators of lipid metabolism, and they synthesize and secrete lipoproteins.", [["lipid", "SIMPLE_CHEMICAL", 27, 32], ["lipoproteins", "PROTEIN", 77, 89]]], ["In addition, they are the only cells capable of bile acid synthesis, and they can absorb and secrete them into bile.", [["cells", "ANATOMY", 31, 36], ["bile", "ANATOMY", 111, 115], ["bile acid", "CHEMICAL", 48, 57], ["cells", "CELL", 31, 36], ["bile acid", "SIMPLE_CHEMICAL", 48, 57], ["bile", "MULTI-TISSUE_STRUCTURE", 111, 115], ["bile acid synthesis", "PROBLEM", 48, 67], ["bile", "ANATOMY", 48, 52], ["bile", "ANATOMY", 111, 115]]], ["Finally, hepatocytes detoxify the large majority of xenobiotics and secrete them into the bile.", [["hepatocytes", "ANATOMY", 9, 20], ["bile", "ANATOMY", 90, 94], ["hepatocytes", "CELL", 9, 20], ["bile", "MULTI-TISSUE_STRUCTURE", 90, 94], ["hepatocytes", "CELL_TYPE", 9, 20], ["hepatocytes detoxify", "TREATMENT", 9, 29], ["xenobiotics", "TREATMENT", 52, 63], ["hepatocytes", "ANATOMY", 9, 20], ["large", "OBSERVATION_MODIFIER", 34, 39], ["bile", "ANATOMY", 90, 94]]], ["Because of this central role in metabolism, the liver is subjected to a variety of nutritionally based insults as well as toxin-related damage.", [["liver", "ANATOMY", 48, 53], ["liver", "ORGAN", 48, 53], ["toxin", "PROTEIN", 122, 127], ["nutritionally based insults", "PROBLEM", 83, 110], ["toxin-related damage", "PROBLEM", 122, 142], ["central", "ANATOMY_MODIFIER", 16, 23], ["liver", "ANATOMY", 48, 53]]], ["A greater proportion of the genome is expressed in the normal liver than has been observed in any other tissue, an indication that brief surveys of liver functions are necessarily oversimplified.", [["liver", "ANATOMY", 62, 67], ["tissue", "ANATOMY", 104, 110], ["liver", "ANATOMY", 148, 153], ["genome", "CELLULAR_COMPONENT", 28, 34], ["liver", "ORGAN", 62, 67], ["tissue", "TISSUE", 104, 110], ["liver", "ORGAN", 148, 153], ["greater", "OBSERVATION_MODIFIER", 2, 9], ["proportion", "OBSERVATION_MODIFIER", 10, 20], ["genome", "OBSERVATION", 28, 34], ["normal", "OBSERVATION", 55, 61], ["liver", "ANATOMY", 62, 67], ["liver", "ANATOMY", 148, 153]]], ["However, those constituents that are most abundant have most influence on the microscopic appearance of the liver.", [["liver", "ANATOMY", 108, 113], ["liver", "ORGAN", 108, 113], ["microscopic", "OBSERVATION", 78, 89], ["liver", "ANATOMY", 108, 113]]], ["The normal hepatocyte contains abundant glycogen, which varies depending on food intake, and which can be demonstrated by PAS staining, as well as variable amounts of stored triglycerides and various proteins, such as ferritin, an iron-binding protein.", [["hepatocyte", "ANATOMY", 11, 21], ["glycogen", "CHEMICAL", 40, 48], ["triglycerides", "CHEMICAL", 174, 187], ["hepatocyte", "CELL", 11, 21], ["glycogen", "SIMPLE_CHEMICAL", 40, 48], ["PAS", "SIMPLE_CHEMICAL", 122, 125], ["triglycerides", "SIMPLE_CHEMICAL", 174, 187], ["ferritin", "GENE_OR_GENE_PRODUCT", 218, 226], ["ferritin", "PROTEIN", 218, 226], ["iron-binding protein", "PROTEIN", 231, 251], ["PAS staining", "TEST", 122, 134], ["stored triglycerides", "TEST", 167, 187], ["various proteins", "PROBLEM", 192, 208], ["ferritin", "TEST", 218, 226], ["an iron-binding protein", "TEST", 228, 251], ["normal", "OBSERVATION", 4, 10], ["hepatocyte", "ANATOMY", 11, 21], ["abundant", "OBSERVATION_MODIFIER", 31, 39], ["glycogen", "OBSERVATION_MODIFIER", 40, 48], ["iron-binding protein", "OBSERVATION", 231, 251]]], ["The cytoplasm of the centrilobular hepatocytes may also contain uniform, golden-brown granules of lipofuscin, particularly in older cats.", [["cytoplasm", "ANATOMY", 4, 13], ["centrilobular hepatocytes", "ANATOMY", 21, 46], ["granules", "ANATOMY", 86, 94], ["lipofuscin", "ANATOMY", 98, 108], ["cytoplasm", "ORGANISM_SUBSTANCE", 4, 13], ["centrilobular hepatocytes", "CELL", 21, 46], ["granules", "ORGANISM_SUBSTANCE", 86, 94], ["lipofuscin", "SIMPLE_CHEMICAL", 98, 108], ["cats", "ORGANISM", 132, 136], ["centrilobular hepatocytes", "CELL_TYPE", 21, 46], ["cats", "SPECIES", 132, 136], ["golden-brown granules of lipofuscin", "PROBLEM", 73, 108], ["cytoplasm", "OBSERVATION", 4, 13], ["centrilobular", "ANATOMY_MODIFIER", 21, 34], ["hepatocytes", "ANATOMY", 35, 46], ["may also contain", "UNCERTAINTY", 47, 63], ["uniform", "OBSERVATION_MODIFIER", 64, 71], ["golden", "OBSERVATION_MODIFIER", 73, 79], ["brown granules", "OBSERVATION", 80, 94], ["of lipofuscin", "OBSERVATION", 95, 108]]], ["This so-called \"wear-and-tear\" pigment becomes more prominent with age, and progressively accumulates in midzonal and periportal hepatocytes.", [["midzonal", "ANATOMY", 105, 113], ["periportal hepatocytes", "ANATOMY", 118, 140], ["midzonal", "CELL", 105, 113], ["periportal hepatocytes", "CELL", 118, 140], ["midzonal and periportal hepatocytes", "CELL_TYPE", 105, 140], ["tear\" pigment", "PROBLEM", 25, 38], ["more prominent", "OBSERVATION_MODIFIER", 47, 61], ["midzonal", "ANATOMY_MODIFIER", 105, 113], ["periportal", "ANATOMY_MODIFIER", 118, 128], ["hepatocytes", "ANATOMY", 129, 140]]], ["Hepatocytes have a cytoskeleton composed of microtubules, microfilaments, and intermediate filaments.", [["Hepatocytes", "ANATOMY", 0, 11], ["cytoskeleton", "ANATOMY", 19, 31], ["microtubules", "ANATOMY", 44, 56], ["microfilaments", "ANATOMY", 58, 72], ["filaments", "ANATOMY", 91, 100], ["Hepatocytes", "CELL", 0, 11], ["cytoskeleton", "CELLULAR_COMPONENT", 19, 31], ["microtubules", "CELLULAR_COMPONENT", 44, 56], ["microfilaments", "CELLULAR_COMPONENT", 58, 72], ["intermediate filaments", "CELLULAR_COMPONENT", 78, 100], ["Hepatocytes", "CELL_TYPE", 0, 11], ["microtubules", "PROTEIN", 44, 56], ["intermediate filaments", "OBSERVATION", 78, 100]]], ["Microtubules are found throughout the cytoplasm, and are involved in the movement of secreted proteins into the extracellular perisinusoidal space; accordingly, microtubule inhibitors such as colchicine and Vinca alkaloids may reduce hepatic protein secretion.", [["Microtubules", "ANATOMY", 0, 12], ["cytoplasm", "ANATOMY", 38, 47], ["extracellular perisinusoidal space", "ANATOMY", 112, 146], ["microtubule", "ANATOMY", 161, 172], ["hepatic", "ANATOMY", 234, 241], ["colchicine", "CHEMICAL", 192, 202], ["Vinca alkaloids", "CHEMICAL", 207, 222], ["colchicine", "CHEMICAL", 192, 202], ["Vinca alkaloids", "CHEMICAL", 207, 222], ["Microtubules", "CELLULAR_COMPONENT", 0, 12], ["cytoplasm", "ORGANISM_SUBSTANCE", 38, 47], ["extracellular perisinusoidal space", "CELLULAR_COMPONENT", 112, 146], ["microtubule", "CELLULAR_COMPONENT", 161, 172], ["colchicine", "SIMPLE_CHEMICAL", 192, 202], ["Vinca alkaloids", "SIMPLE_CHEMICAL", 207, 222], ["hepatic", "ORGAN", 234, 241], ["secreted proteins", "PROTEIN", 85, 102], ["microtubule inhibitors", "TREATMENT", 161, 183], ["colchicine", "TREATMENT", 192, 202], ["Vinca alkaloids", "TREATMENT", 207, 222], ["hepatic protein secretion", "PROBLEM", 234, 259], ["cytoplasm", "OBSERVATION", 38, 47], ["extracellular", "ANATOMY_MODIFIER", 112, 125], ["perisinusoidal space", "ANATOMY", 126, 146], ["hepatic", "ANATOMY", 234, 241], ["protein secretion", "OBSERVATION", 242, 259]]], ["Microfilaments, composed of actin and myosin, are concentrated around the bile canaliculus, where they are involved in canalicular peristalsis and bile secretion; microfilament inhibitors result in cholestasis.", [["bile canaliculus", "ANATOMY", 74, 90], ["canalicular", "ANATOMY", 119, 130], ["bile", "ANATOMY", 147, 151], ["microfilament", "ANATOMY", 163, 176], ["cholestasis", "DISEASE", 198, 209], ["actin", "GENE_OR_GENE_PRODUCT", 28, 33], ["myosin", "GENE_OR_GENE_PRODUCT", 38, 44], ["bile canaliculus", "MULTI-TISSUE_STRUCTURE", 74, 90], ["canalicular", "MULTI-TISSUE_STRUCTURE", 119, 130], ["bile", "MULTI-TISSUE_STRUCTURE", 147, 151], ["actin", "PROTEIN", 28, 33], ["myosin", "PROTEIN", 38, 44], ["Microfilaments", "TREATMENT", 0, 14], ["actin and myosin", "TREATMENT", 28, 44], ["canalicular peristalsis", "PROBLEM", 119, 142], ["bile secretion", "PROBLEM", 147, 161], ["microfilament inhibitors", "TREATMENT", 163, 187], ["cholestasis", "PROBLEM", 198, 209], ["bile canaliculus", "ANATOMY", 74, 90], ["canalicular peristalsis", "ANATOMY", 119, 142], ["bile", "ANATOMY", 147, 151], ["cholestasis", "OBSERVATION", 198, 209]]], ["Intermediate filaments (predominantly cytokeratins 8 and 18) form an irregular meshwork extending from the plasma membrane to the perinuclear zone, and are responsible for spatial organization of the hepatocyte.Cells of the liverThere are 3 morphologically and functionally distinct surfaces of the hepatocyte plasma membrane.", [["filaments", "ANATOMY", 13, 22], ["meshwork", "ANATOMY", 79, 87], ["plasma membrane", "ANATOMY", 107, 122], ["perinuclear zone", "ANATOMY", 130, 146], ["hepatocyte", "ANATOMY", 200, 210], ["Cells", "ANATOMY", 211, 216], ["liver", "ANATOMY", 224, 229], ["hepatocyte plasma membrane", "ANATOMY", 299, 325], ["cytokeratins 8", "GENE_OR_GENE_PRODUCT", 38, 52], ["meshwork", "TISSUE", 79, 87], ["plasma membrane", "CELLULAR_COMPONENT", 107, 122], ["perinuclear zone", "CELLULAR_COMPONENT", 130, 146], ["hepatocyte", "CELL", 200, 210], ["Cells", "CELL", 211, 216], ["liver", "ORGAN", 224, 229], ["hepatocyte", "CELLULAR_COMPONENT", 299, 309], ["plasma membrane", "CELLULAR_COMPONENT", 310, 325], ["cytokeratins 8 and 18", "PROTEIN", 38, 59], ["cytokeratins", "TEST", 38, 50], ["an irregular meshwork", "PROBLEM", 66, 87], ["spatial organization of the hepatocyte", "PROBLEM", 172, 210], ["irregular", "OBSERVATION_MODIFIER", 69, 78], ["meshwork", "OBSERVATION", 79, 87], ["plasma membrane", "OBSERVATION", 107, 122], ["perinuclear", "ANATOMY_MODIFIER", 130, 141], ["zone", "ANATOMY_MODIFIER", 142, 146], ["responsible for", "UNCERTAINTY", 156, 171], ["spatial organization", "OBSERVATION", 172, 192], ["hepatocyte", "ANATOMY", 200, 210], ["liver", "ANATOMY", 224, 229], ["3 morphologically", "OBSERVATION_MODIFIER", 239, 256], ["functionally", "OBSERVATION_MODIFIER", 261, 273], ["distinct", "OBSERVATION_MODIFIER", 274, 282], ["surfaces", "OBSERVATION_MODIFIER", 283, 291], ["hepatocyte", "ANATOMY", 299, 309], ["plasma membrane", "OBSERVATION", 310, 325]]], ["The sinusoidal domain faces the space of Disse and has numerous irregular microvilli, increasing hepatocyte surface area by ~6-fold (considerably less that that seen in enterocytes).", [["microvilli", "ANATOMY", 74, 84], ["hepatocyte surface area", "ANATOMY", 97, 120], ["enterocytes", "ANATOMY", 169, 180], ["irregular microvilli", "CELLULAR_COMPONENT", 64, 84], ["hepatocyte surface area", "CELLULAR_COMPONENT", 97, 120], ["enterocytes", "CELL", 169, 180], ["Disse", "PROTEIN", 41, 46], ["enterocytes", "CELL_TYPE", 169, 180], ["numerous irregular microvilli", "PROBLEM", 55, 84], ["increasing hepatocyte surface area", "PROBLEM", 86, 120], ["sinusoidal domain", "OBSERVATION", 4, 21], ["space", "OBSERVATION_MODIFIER", 32, 37], ["Disse", "OBSERVATION", 41, 46], ["numerous", "OBSERVATION_MODIFIER", 55, 63], ["irregular", "OBSERVATION_MODIFIER", 64, 73], ["microvilli", "OBSERVATION_MODIFIER", 74, 84], ["increasing", "OBSERVATION_MODIFIER", 86, 96], ["hepatocyte", "OBSERVATION_MODIFIER", 97, 107], ["surface", "OBSERVATION_MODIFIER", 108, 115], ["area", "OBSERVATION_MODIFIER", 116, 120], ["~6-fold", "OBSERVATION_MODIFIER", 124, 131], ["enterocytes", "ANATOMY", 169, 180]]], ["This specialized membrane is modified to facilitate an exchange of substances with the blood.", [["membrane", "ANATOMY", 17, 25], ["blood", "ANATOMY", 87, 92], ["membrane", "CELLULAR_COMPONENT", 17, 25], ["blood", "ORGANISM_SUBSTANCE", 87, 92], ["an exchange of substances", "TREATMENT", 52, 77], ["the blood", "TEST", 83, 92]]], ["There are ultrastructurally evident pits between the villi, some of which represent secretory vacuoles in the process of exocytosis, sending various products into the plasma, and others are clatharin-coated pits involved in selective receptor-mediated endocytosis.", [["pits", "ANATOMY", 36, 40], ["villi", "ANATOMY", 53, 58], ["secretory vacuoles", "ANATOMY", 84, 102], ["plasma", "ANATOMY", 167, 173], ["clatharin", "CHEMICAL", 190, 199], ["villi", "MULTI-TISSUE_STRUCTURE", 53, 58], ["secretory vacuoles", "CELLULAR_COMPONENT", 84, 102], ["plasma", "ORGANISM_SUBSTANCE", 167, 173], ["clatharin", "GENE_OR_GENE_PRODUCT", 190, 199], ["ultrastructurally evident pits between the villi", "PROBLEM", 10, 58], ["secretory vacuoles", "PROBLEM", 84, 102], ["exocytosis", "PROBLEM", 121, 131], ["the plasma", "TEST", 163, 173], ["coated pits", "PROBLEM", 200, 211], ["selective receptor-mediated endocytosis", "TREATMENT", 224, 263], ["ultrastructurally", "OBSERVATION_MODIFIER", 10, 27], ["pits", "OBSERVATION_MODIFIER", 36, 40], ["villi", "ANATOMY", 53, 58], ["secretory vacuoles", "OBSERVATION", 84, 102], ["exocytosis", "OBSERVATION", 121, 131], ["plasma", "ANATOMY", 167, 173], ["coated pits", "OBSERVATION", 200, 211], ["selective", "OBSERVATION_MODIFIER", 224, 233], ["endocytosis", "OBSERVATION", 252, 263]]], ["Numerous membrane receptors for glycoproteins, asialoglycoproteins, peptides, in proinflammatory and anti-inflammatory signaling as there are distinct differences in the signaling repertoire of different Kupffer cells.", [["membrane", "ANATOMY", 9, 17], ["Kupffer cells", "ANATOMY", 204, 217], ["membrane", "CELLULAR_COMPONENT", 9, 17], ["asialoglycoproteins", "GENE_OR_GENE_PRODUCT", 47, 66], ["Kupffer cells", "CELL", 204, 217], ["membrane receptors", "PROTEIN", 9, 27], ["glycoproteins", "PROTEIN", 32, 45], ["asialoglycoproteins", "PROTEIN", 47, 66], ["Kupffer cells", "CELL_TYPE", 204, 217], ["Numerous membrane receptors", "PROBLEM", 0, 27], ["glycoproteins", "PROBLEM", 32, 45], ["asialoglycoproteins", "TREATMENT", 47, 66], ["peptides", "PROBLEM", 68, 76], ["proinflammatory and anti-inflammatory signaling", "PROBLEM", 81, 128], ["membrane receptors", "OBSERVATION", 9, 27], ["proinflammatory", "OBSERVATION_MODIFIER", 81, 96], ["anti-inflammatory signaling", "OBSERVATION", 101, 128], ["distinct", "OBSERVATION_MODIFIER", 142, 150], ["differences", "OBSERVATION_MODIFIER", 151, 162], ["Kupffer cells", "OBSERVATION", 204, 217]]], ["Some Kupffer cells are more likely to secrete IL-10, which can suppress macrophage activation and cytokine secretion.", [["Kupffer cells", "ANATOMY", 5, 18], ["macrophage", "ANATOMY", 72, 82], ["Kupffer cells", "CELL", 5, 18], ["IL-10", "GENE_OR_GENE_PRODUCT", 46, 51], ["macrophage", "CELL", 72, 82], ["Kupffer cells", "CELL_TYPE", 5, 18], ["IL-10", "PROTEIN", 46, 51], ["cytokine", "PROTEIN", 98, 106], ["Some Kupffer cells", "PROBLEM", 0, 18], ["cytokine secretion", "PROBLEM", 98, 116], ["Kupffer cells", "OBSERVATION", 5, 18], ["more likely", "UNCERTAINTY", 23, 34], ["cytokine secretion", "OBSERVATION", 98, 116]]], ["Cytokine responses of Kupffer cells are believed to be important in regulating the extent of adaptive immune response or tolerance to potentially antigenic macromolecules that can reach the liver through the portal blood.", [["Kupffer cells", "ANATOMY", 22, 35], ["liver", "ANATOMY", 190, 195], ["portal blood", "ANATOMY", 208, 220], ["Kupffer cells", "CELL", 22, 35], ["liver", "ORGAN", 190, 195], ["portal", "MULTI-TISSUE_STRUCTURE", 208, 214], ["blood", "ORGANISM_SUBSTANCE", 215, 220], ["Cytokine", "PROTEIN", 0, 8], ["Kupffer cells", "CELL_TYPE", 22, 35], ["Kupffer cells", "TREATMENT", 22, 35], ["potentially antigenic macromolecules", "PROBLEM", 134, 170], ["Kupffer cells", "OBSERVATION", 22, 35], ["believed to be", "UNCERTAINTY", 40, 54], ["liver", "ANATOMY", 190, 195], ["portal blood", "ANATOMY", 208, 220]]], ["The liver contains large numbers of lymphocytes, comprising ~5% of the entire cell population of the liver, with an organ-specific lymphocyte distribution characterized by the enrichment of elements of the innate immune system, including natural killer T lymphocytes (NKT cells), natural killer (NK cells), and innate lymphocytes, in addition to the Kupffer cells previously mentioned.", [["liver", "ANATOMY", 4, 9], ["lymphocytes", "ANATOMY", 36, 47], ["cell", "ANATOMY", 78, 82], ["liver", "ANATOMY", 101, 106], ["organ", "ANATOMY", 116, 121], ["lymphocyte", "ANATOMY", 131, 141], ["immune system", "ANATOMY", 213, 226], ["natural killer T lymphocytes", "ANATOMY", 238, 266], ["NKT cells", "ANATOMY", 268, 277], ["natural killer", "ANATOMY", 280, 294], ["NK cells", "ANATOMY", 296, 304], ["lymphocytes", "ANATOMY", 318, 329], ["Kupffer cells", "ANATOMY", 350, 363], ["liver", "ORGAN", 4, 9], ["lymphocytes", "CELL", 36, 47], ["cell", "CELL", 78, 82], ["liver", "ORGAN", 101, 106], ["organ", "ORGAN", 116, 121], ["lymphocyte", "CELL", 131, 141], ["natural killer T lymphocytes", "CELL", 238, 266], ["NKT cells", "CELL", 268, 277], ["natural killer", "CELL", 280, 294], ["NK cells", "CELL", 296, 304], ["innate lymphocytes", "CELL", 311, 329], ["Kupffer cells", "CELL", 350, 363], ["lymphocytes", "CELL_TYPE", 36, 47], ["natural killer T lymphocytes", "CELL_TYPE", 238, 266], ["NKT cells", "CELL_TYPE", 268, 277], ["natural killer", "CELL_TYPE", 280, 294], ["NK cells", "CELL_TYPE", 296, 304], ["innate lymphocytes", "CELL_TYPE", 311, 329], ["Kupffer cells", "CELL_TYPE", 350, 363], ["large numbers of lymphocytes", "PROBLEM", 19, 47], ["an organ-specific lymphocyte distribution", "PROBLEM", 113, 154], ["NKT cells", "TEST", 268, 277], ["innate lymphocytes", "TEST", 311, 329], ["the Kupffer cells", "TREATMENT", 346, 363], ["liver", "ANATOMY", 4, 9], ["large", "OBSERVATION_MODIFIER", 19, 24], ["numbers", "OBSERVATION_MODIFIER", 25, 32], ["lymphocytes", "OBSERVATION", 36, 47], ["~5%", "OBSERVATION_MODIFIER", 60, 63], ["entire", "OBSERVATION_MODIFIER", 71, 77], ["cell population", "OBSERVATION", 78, 93], ["liver", "ANATOMY", 101, 106], ["organ", "ANATOMY", 116, 121], ["specific lymphocyte distribution", "OBSERVATION", 122, 154], ["enrichment", "OBSERVATION_MODIFIER", 176, 186], ["innate immune system", "OBSERVATION", 206, 226], ["natural killer T lymphocytes", "OBSERVATION", 238, 266], ["NKT cells", "OBSERVATION", 268, 277], ["natural killer", "OBSERVATION", 280, 294], ["NK cells", "OBSERVATION", 296, 304], ["innate lymphocytes", "OBSERVATION", 311, 329], ["Kupffer cells", "OBSERVATION", 350, 363]]], ["Elements of the acquired immune system, CD8+ T cells, are also increased when compared with peripheral blood.", [["immune system", "ANATOMY", 25, 38], ["CD8+ T cells", "ANATOMY", 40, 52], ["peripheral blood", "ANATOMY", 92, 108], ["CD8", "GENE_OR_GENE_PRODUCT", 40, 43], ["peripheral blood", "ORGANISM_SUBSTANCE", 92, 108], ["CD8+ T cells", "CELL_TYPE", 40, 52], ["the acquired immune system", "TEST", 12, 38], ["peripheral blood", "TEST", 92, 108], ["increased", "OBSERVATION_MODIFIER", 63, 72], ["peripheral", "ANATOMY_MODIFIER", 92, 102], ["blood", "ANATOMY", 103, 108]]], ["The majority of intrahepatic lymphocytes are involved in innate immune responses rather than acquired immunity.", [["intrahepatic lymphocytes", "ANATOMY", 16, 40], ["intrahepatic lymphocytes", "CELL", 16, 40], ["intrahepatic lymphocytes", "CELL_TYPE", 16, 40], ["intrahepatic lymphocytes", "PROBLEM", 16, 40], ["majority", "OBSERVATION_MODIFIER", 4, 12], ["intrahepatic", "ANATOMY", 16, 28], ["lymphocytes", "OBSERVATION", 29, 40]]], ["Hepatic NK cells constitute ~40% of hepatic lymphocytes and are distinct phenotypically and functionally from blood NK cells.", [["Hepatic NK cells", "ANATOMY", 0, 16], ["hepatic lymphocytes", "ANATOMY", 36, 55], ["blood NK cells", "ANATOMY", 110, 124], ["Hepatic NK cells", "CELL", 0, 16], ["hepatic lymphocytes", "CELL", 36, 55], ["blood NK cells", "CELL", 110, 124], ["Hepatic NK cells", "CELL_TYPE", 0, 16], ["hepatic lymphocytes", "CELL_TYPE", 36, 55], ["blood NK cells", "CELL_TYPE", 110, 124], ["Hepatic NK cells", "TEST", 0, 16], ["hepatic lymphocytes", "TEST", 36, 55], ["distinct phenotypically", "PROBLEM", 64, 87], ["NK cells", "OBSERVATION", 8, 16], ["40%", "OBSERVATION_MODIFIER", 29, 32], ["hepatic", "ANATOMY", 36, 43], ["lymphocytes", "OBSERVATION", 44, 55], ["blood NK cells", "OBSERVATION", 110, 124]]], ["Hepatic NKT cells reside in the space of Disse, are considered large granular lymphocytes, and were previously referred to as pit cells.", [["Hepatic NKT cells", "ANATOMY", 0, 17], ["granular lymphocytes", "ANATOMY", 69, 89], ["pit cells", "ANATOMY", 126, 135], ["Hepatic NKT cells", "CELL", 0, 17], ["Disse", "GENE_OR_GENE_PRODUCT", 41, 46], ["granular lymphocytes", "CELL", 69, 89], ["pit cells", "CELL", 126, 135], ["Hepatic NKT cells", "CELL_TYPE", 0, 17], ["granular lymphocytes", "CELL_TYPE", 69, 89], ["pit cells", "CELL_TYPE", 126, 135], ["Hepatic NKT cells", "TEST", 0, 17], ["large granular lymphocytes", "PROBLEM", 63, 89], ["NKT cells", "OBSERVATION", 8, 17], ["space", "ANATOMY_MODIFIER", 32, 37], ["Disse", "OBSERVATION", 41, 46], ["large", "OBSERVATION_MODIFIER", 63, 68], ["granular lymphocytes", "OBSERVATION", 69, 89]]], ["Intrahepatic NK cells have important functions in defense against foreign antigens released from the gut, viral infections, metastatic tumors, hepatocellular carcinoma, and modulation of hepatic fibrosis.", [["Intrahepatic NK cells", "ANATOMY", 0, 21], ["gut", "ANATOMY", 101, 104], ["metastatic tumors", "ANATOMY", 124, 141], ["hepatocellular carcinoma", "ANATOMY", 143, 167], ["hepatic", "ANATOMY", 187, 194], ["viral infections", "DISEASE", 106, 122], ["tumors", "DISEASE", 135, 141], ["hepatocellular carcinoma", "DISEASE", 143, 167], ["hepatic fibrosis", "DISEASE", 187, 203], ["Intrahepatic NK cells", "CELL", 0, 21], ["gut", "ORGANISM_SUBDIVISION", 101, 104], ["metastatic tumors", "CANCER", 124, 141], ["hepatocellular carcinoma", "CANCER", 143, 167], ["hepatic", "ORGAN", 187, 194], ["Intrahepatic NK cells", "CELL_TYPE", 0, 21], ["foreign antigens", "PROTEIN", 66, 82], ["Intrahepatic NK cells", "PROBLEM", 0, 21], ["foreign antigens", "PROBLEM", 66, 82], ["viral infections", "PROBLEM", 106, 122], ["metastatic tumors", "PROBLEM", 124, 141], ["hepatocellular carcinoma", "PROBLEM", 143, 167], ["hepatic fibrosis", "PROBLEM", 187, 203], ["NK cells", "OBSERVATION", 13, 21], ["gut", "ANATOMY", 101, 104], ["viral", "OBSERVATION_MODIFIER", 106, 111], ["infections", "OBSERVATION", 112, 122], ["metastatic", "OBSERVATION_MODIFIER", 124, 134], ["tumors", "OBSERVATION", 135, 141], ["hepatocellular carcinoma", "OBSERVATION", 143, 167], ["hepatic", "ANATOMY", 187, 194], ["fibrosis", "OBSERVATION", 195, 203]]], ["The liver also contains the largest population of \u03b3\u03b4 T cells in the body.", [["liver", "ANATOMY", 4, 9], ["\u03b3\u03b4 T cells", "ANATOMY", 50, 60], ["body", "ANATOMY", 68, 72], ["liver", "ORGAN", 4, 9], ["\u03b3\u03b4 T cells", "CELL", 50, 60], ["body", "ORGANISM_SUBDIVISION", 68, 72], ["\u03b3\u03b4 T cells", "CELL_TYPE", 50, 60], ["\u03b3\u03b4 T cells in the body", "PROBLEM", 50, 72], ["liver", "ANATOMY", 4, 9], ["largest", "OBSERVATION_MODIFIER", 28, 35], ["population", "OBSERVATION_MODIFIER", 36, 46], ["\u03b3\u03b4 T cells", "OBSERVATION", 50, 60], ["body", "ANATOMY_MODIFIER", 68, 72]]], ["Although the precise function of these diverse lymphocyte types is not currently understood, their large number alone suggests that they must be involved in immunologic homeostasis and respond to immunologic challenges, indicating that the liver can be considered a lymphoid organ.Cells of the liverHepatic dendritic cells play an important role in the induction and regulation of immune responses.", [["lymphocyte", "ANATOMY", 47, 57], ["liver", "ANATOMY", 240, 245], ["lymphoid organ", "ANATOMY", 266, 280], ["Cells", "ANATOMY", 281, 286], ["liverHepatic dendritic cells", "ANATOMY", 294, 322], ["lymphocyte", "CELL", 47, 57], ["liver", "ORGAN", 240, 245], ["lymphoid organ", "TISSUE", 266, 280], ["Cells", "CELL", 281, 286], ["liverHepatic dendritic cells", "CELL", 294, 322], ["lymphocyte types", "CELL_TYPE", 47, 63], ["liverHepatic dendritic cells", "CELL_TYPE", 294, 322], ["immunologic homeostasis", "PROBLEM", 157, 180], ["immunologic challenges", "TEST", 196, 218], ["a lymphoid organ", "PROBLEM", 264, 280], ["the liverHepatic dendritic cells", "TREATMENT", 290, 322], ["the induction", "TREATMENT", 349, 362], ["diverse lymphocyte types", "OBSERVATION", 39, 63], ["large", "OBSERVATION_MODIFIER", 99, 104], ["liver", "ANATOMY", 240, 245], ["lymphoid organ", "OBSERVATION", 266, 280], ["liverHepatic dendritic cells", "OBSERVATION", 294, 322]]], ["These antigenpresenting cells have only recently been studied in the liver.", [["antigenpresenting cells", "ANATOMY", 6, 29], ["liver", "ANATOMY", 69, 74], ["antigenpresenting cells", "CELL", 6, 29], ["liver", "ORGAN", 69, 74], ["antigenpresenting cells", "CELL_TYPE", 6, 29], ["liver", "ANATOMY", 69, 74]]], ["There are several other antigen-presenting cells in the liver, including the sinusoidal endothelial cells and Kupffer cells.", [["cells", "ANATOMY", 43, 48], ["liver", "ANATOMY", 56, 61], ["sinusoidal endothelial cells", "ANATOMY", 77, 105], ["Kupffer cells", "ANATOMY", 110, 123], ["cells", "CELL", 43, 48], ["liver", "ORGAN", 56, 61], ["sinusoidal endothelial cells", "CELL", 77, 105], ["Kupffer cells", "CELL", 110, 123], ["antigen-presenting cells", "CELL_TYPE", 24, 48], ["sinusoidal endothelial cells", "CELL_TYPE", 77, 105], ["Kupffer cells", "CELL_TYPE", 110, 123], ["presenting cells in the liver", "PROBLEM", 32, 61], ["presenting cells", "OBSERVATION", 32, 48], ["liver", "ANATOMY", 56, 61], ["sinusoidal endothelial cells", "OBSERVATION", 77, 105], ["Kupffer cells", "OBSERVATION", 110, 123]]], ["Unlike cells that reside within the sinusoid, hepatic dendritic cells are found within the portal tract.", [["cells", "ANATOMY", 7, 12], ["sinusoid", "ANATOMY", 36, 44], ["hepatic dendritic cells", "ANATOMY", 46, 69], ["portal tract", "ANATOMY", 91, 103], ["cells", "CELL", 7, 12], ["sinusoid", "CELL", 36, 44], ["hepatic dendritic cells", "CELL", 46, 69], ["portal tract", "MULTI-TISSUE_STRUCTURE", 91, 103], ["hepatic dendritic cells", "CELL_TYPE", 46, 69], ["Unlike cells", "PROBLEM", 0, 12], ["cells", "OBSERVATION", 7, 12], ["sinusoid", "ANATOMY", 36, 44], ["hepatic", "ANATOMY", 46, 53], ["dendritic cells", "OBSERVATION", 54, 69], ["portal tract", "ANATOMY", 91, 103]]], ["Hepatic dendritic cells are considered to be functionally immature compared to the dendritic cells of the spleen and bone marrow, and they may be involved in immune tolerance in the liver.Cells of the liverHepatic stellate cells (HSC), originally described by Boll and von Kupffer in the 1870s, were neglected until the 1950s, when they were described in detail by Ito.", [["Hepatic dendritic cells", "ANATOMY", 0, 23], ["dendritic cells", "ANATOMY", 83, 98], ["spleen", "ANATOMY", 106, 112], ["bone marrow", "ANATOMY", 117, 128], ["liver", "ANATOMY", 182, 187], ["Cells", "ANATOMY", 188, 193], ["liverHepatic stellate cells", "ANATOMY", 201, 228], ["HSC", "ANATOMY", 230, 233], ["Hepatic dendritic cells", "CELL", 0, 23], ["dendritic cells", "CELL", 83, 98], ["spleen", "ORGAN", 106, 112], ["bone marrow", "MULTI-TISSUE_STRUCTURE", 117, 128], ["liver", "ORGAN", 182, 187], ["Cells", "CELL", 188, 193], ["liverHepatic stellate cells", "CELL", 201, 228], ["HSC", "CELL", 230, 233], ["Hepatic dendritic cells", "CELL_TYPE", 0, 23], ["dendritic cells", "CELL_TYPE", 83, 98], ["liverHepatic stellate cells", "CELL_TYPE", 201, 228], ["HSC", "CELL_TYPE", 230, 233], ["Hepatic dendritic cells", "PROBLEM", 0, 23], ["functionally immature", "PROBLEM", 45, 66], ["immune tolerance in the liver", "PROBLEM", 158, 187], ["von Kupffer", "TEST", 269, 280], ["dendritic cells", "OBSERVATION", 8, 23], ["considered to be", "UNCERTAINTY", 28, 44], ["dendritic cells", "OBSERVATION", 83, 98], ["spleen", "ANATOMY", 106, 112], ["bone marrow", "ANATOMY", 117, 128], ["immune tolerance", "OBSERVATION", 158, 174], ["liver", "ANATOMY", 182, 187], ["liverHepatic", "ANATOMY_MODIFIER", 201, 213], ["stellate cells", "OBSERVATION", 214, 228], ["HSC", "ANATOMY", 230, 233]]], ["They have also been known as lipocytes, Ito cells, or fat-storing cells.", [["lipocytes", "ANATOMY", 29, 38], ["cells", "ANATOMY", 44, 49], ["fat-storing cells", "ANATOMY", 54, 71], ["lipocytes", "CELL", 29, 38], ["cells", "CELL", 44, 49], ["fat", "TISSUE", 54, 57], ["cells", "CELL", 66, 71], ["lipocytes, Ito cells", "CELL_TYPE", 29, 49], ["fat-storing cells", "CELL_TYPE", 54, 71], ["lipocytes", "ANATOMY", 29, 38]]], ["HSC reside in the space of Disse, but there are other populations of similar cells with the ability to produce ECM and to transform into a myofibroblast phenotype within the connective tissue of the portal tract and centrilobular veins.", [["HSC", "ANATOMY", 0, 3], ["cells", "ANATOMY", 77, 82], ["ECM", "ANATOMY", 111, 114], ["myofibroblast", "ANATOMY", 139, 152], ["connective tissue", "ANATOMY", 174, 191], ["portal tract", "ANATOMY", 199, 211], ["centrilobular veins", "ANATOMY", 216, 235], ["HSC", "CELL", 0, 3], ["cells", "CELL", 77, 82], ["ECM", "CELLULAR_COMPONENT", 111, 114], ["myofibroblast", "CELL", 139, 152], ["connective tissue", "TISSUE", 174, 191], ["portal tract", "MULTI-TISSUE_STRUCTURE", 199, 211], ["centrilobular veins", "MULTI-TISSUE_STRUCTURE", 216, 235], ["HSC", "CELL_TYPE", 0, 3], ["ECM", "PROTEIN", 111, 114], ["similar cells", "PROBLEM", 69, 82], ["a myofibroblast phenotype", "PROBLEM", 137, 162], ["space", "ANATOMY_MODIFIER", 18, 23], ["Disse", "OBSERVATION", 27, 32], ["populations", "OBSERVATION_MODIFIER", 54, 65], ["similar cells", "OBSERVATION", 69, 82], ["myofibroblast phenotype", "OBSERVATION", 139, 162], ["connective tissue", "ANATOMY_MODIFIER", 174, 191], ["portal tract", "ANATOMY", 199, 211], ["centrilobular", "ANATOMY_MODIFIER", 216, 229], ["veins", "ANATOMY", 230, 235]]], ["There are 4 key functions of HSC: (1) storage and homeostasis of retinoids, including vitamin A; (2) maintenance and remodeling of the sinusoidal ECM in health and disease; (3) production of growth factors, such as hepatocyte growth factor and various cytokines; and (4) regulation of sinusoidal diameter by contraction of cellular processes.", [["HSC", "ANATOMY", 29, 32], ["sinusoidal ECM", "ANATOMY", 135, 149], ["sinusoidal", "ANATOMY", 285, 295], ["cellular", "ANATOMY", 323, 331], ["retinoids", "CHEMICAL", 65, 74], ["vitamin A", "CHEMICAL", 86, 95], ["retinoids", "CHEMICAL", 65, 74], ["vitamin A", "CHEMICAL", 86, 95], ["HSC", "CELL", 29, 32], ["retinoids", "SIMPLE_CHEMICAL", 65, 74], ["vitamin A", "SIMPLE_CHEMICAL", 86, 95], ["sinusoidal ECM", "CELLULAR_COMPONENT", 135, 149], ["hepatocyte growth factor", "GENE_OR_GENE_PRODUCT", 215, 239], ["sinusoidal", "MULTI-TISSUE_STRUCTURE", 285, 295], ["cellular", "CELL", 323, 331], ["HSC", "CELL_TYPE", 29, 32], ["growth factors", "PROTEIN", 191, 205], ["hepatocyte growth factor", "PROTEIN", 215, 239], ["cytokines", "PROTEIN", 252, 261], ["homeostasis of retinoids", "TREATMENT", 50, 74], ["vitamin A", "TREATMENT", 86, 95], ["disease", "PROBLEM", 164, 171], ["growth factors", "PROBLEM", 191, 205], ["hepatocyte growth factor", "PROBLEM", 215, 239], ["various cytokines", "PROBLEM", 244, 261], ["sinusoidal diameter", "PROBLEM", 285, 304], ["contraction of cellular processes", "PROBLEM", 308, 341], ["sinusoidal ECM", "OBSERVATION", 135, 149], ["hepatocyte", "ANATOMY", 215, 225], ["sinusoidal diameter", "OBSERVATION", 285, 304], ["cellular processes", "OBSERVATION", 323, 341]]], ["This may be in response to adrenergic stimulation, as all HSC are in contact with autonomic nerve fibers.", [["HSC", "ANATOMY", 58, 61], ["autonomic nerve fibers", "ANATOMY", 82, 104], ["HSC", "CELL", 58, 61], ["nerve fibers", "MULTI-TISSUE_STRUCTURE", 92, 104], ["HSC", "CELL_TYPE", 58, 61], ["adrenergic stimulation", "TREATMENT", 27, 49], ["autonomic nerve fibers", "PROBLEM", 82, 104], ["may be", "UNCERTAINTY", 5, 11], ["adrenergic stimulation", "OBSERVATION", 27, 49], ["autonomic nerve", "ANATOMY", 82, 97]]], ["HSC can become greatly distended with lipid in carnivores on some diets.Cells of the liverActivation of HSC has been extensively studied because of their importance in hepatic fibrosis.", [["HSC", "ANATOMY", 0, 3], ["Cells", "ANATOMY", 72, 77], ["HSC", "ANATOMY", 104, 107], ["hepatic", "ANATOMY", 168, 175], ["fibrosis", "DISEASE", 176, 184], ["HSC", "CELL", 0, 3], ["lipid", "SIMPLE_CHEMICAL", 38, 43], ["Cells", "CELL", 72, 77], ["HSC", "CELL", 104, 107], ["hepatic", "ORGAN", 168, 175], ["HSC", "CELL_TYPE", 0, 3], ["HSC", "CELL_TYPE", 104, 107], ["greatly distended", "PROBLEM", 15, 32], ["the liverActivation of HSC", "TREATMENT", 81, 107], ["hepatic fibrosis", "PROBLEM", 168, 184], ["greatly", "OBSERVATION_MODIFIER", 15, 22], ["distended", "OBSERVATION", 23, 32], ["lipid", "OBSERVATION_MODIFIER", 38, 43], ["HSC", "ANATOMY", 104, 107], ["hepatic", "ANATOMY", 168, 175], ["fibrosis", "OBSERVATION", 176, 184]]], ["In the transition from quiescence to activation, HSC lose their characteristic lipid droplets, possibly catabolizing the lipid to support their clustered together forming sieve plates.", [["HSC", "ANATOMY", 49, 52], ["lipid droplets", "ANATOMY", 79, 93], ["HSC", "CELL", 49, 52], ["lipid droplets", "CELLULAR_COMPONENT", 79, 93], ["HSC", "CELL_TYPE", 49, 52], ["catabolizing the lipid", "TREATMENT", 104, 126], ["lipid droplets", "OBSERVATION", 79, 93], ["sieve plates", "OBSERVATION", 171, 183]]], ["Larger, but less frequent, fenestrations are more common at the periportal end of the sinusoid, but opening size is dynamic, responding to endogenous mediators and toxins.", [["periportal end", "ANATOMY", 64, 78], ["sinusoid", "ANATOMY", 86, 94], ["sinusoid", "TISSUE", 86, 94], ["endogenous mediators", "PROTEIN", 139, 159], ["toxins", "PROBLEM", 164, 170], ["less", "OBSERVATION_MODIFIER", 12, 16], ["frequent", "OBSERVATION_MODIFIER", 17, 25], ["fenestrations", "OBSERVATION", 27, 40], ["more common", "OBSERVATION_MODIFIER", 45, 56], ["periportal", "ANATOMY_MODIFIER", 64, 74], ["sinusoid", "ANATOMY", 86, 94], ["opening", "OBSERVATION_MODIFIER", 100, 107], ["size", "OBSERVATION_MODIFIER", 108, 112], ["dynamic", "OBSERVATION_MODIFIER", 116, 123]]], ["The endothelial cells rest on a very thin and discontinuous ECM.", [["endothelial cells", "ANATOMY", 4, 21], ["ECM", "ANATOMY", 60, 63], ["endothelial cells", "CELL", 4, 21], ["ECM", "CELLULAR_COMPONENT", 60, 63], ["endothelial cells", "CELL_TYPE", 4, 21], ["The endothelial cells", "TEST", 0, 21], ["endothelial cells", "OBSERVATION", 4, 21]]], ["The fenestrations allow direct contact between the sinusoidal lumen and the space of Disse.", [["sinusoidal lumen", "ANATOMY", 51, 67], ["sinusoidal lumen", "MULTI-TISSUE_STRUCTURE", 51, 67], ["The fenestrations", "TREATMENT", 0, 17], ["fenestrations", "OBSERVATION", 4, 17], ["sinusoidal lumen", "OBSERVATION", 51, 67], ["space", "ANATOMY_MODIFIER", 76, 81], ["Disse", "OBSERVATION", 85, 90]]], ["Only larger particles, such as chylomicrons, and cells are excluded.", [["chylomicrons", "ANATOMY", 31, 43], ["cells", "ANATOMY", 49, 54], ["chylomicrons", "MULTI-TISSUE_STRUCTURE", 31, 43], ["cells", "CELL", 49, 54], ["larger particles", "PROBLEM", 5, 21], ["larger", "OBSERVATION_MODIFIER", 5, 11], ["particles", "OBSERVATION", 12, 21], ["chylomicrons", "ANATOMY", 31, 43]]], ["Sinusoidal endothelial cells differ from normal vascular endothelium in several additional ways, including the absence of factor VIII-related antigen (except in inflammatory conditions) and high endocytic activity.", [["Sinusoidal endothelial cells", "ANATOMY", 0, 28], ["vascular endothelium", "ANATOMY", 48, 68], ["Sinusoidal endothelial cells", "CELL", 0, 28], ["vascular endothelium", "TISSUE", 48, 68], ["factor VIII-related antigen", "GENE_OR_GENE_PRODUCT", 122, 149], ["Sinusoidal endothelial cells", "CELL_TYPE", 0, 28], ["factor VIII", "PROTEIN", 122, 133], ["Sinusoidal endothelial cells", "PROBLEM", 0, 28], ["factor VIII", "PROBLEM", 122, 133], ["related antigen", "PROBLEM", 134, 149], ["inflammatory conditions", "PROBLEM", 161, 184], ["high endocytic activity", "PROBLEM", 190, 213], ["endothelial cells", "OBSERVATION", 11, 28], ["normal", "OBSERVATION", 41, 47], ["vascular endothelium", "ANATOMY", 48, 68], ["inflammatory", "OBSERVATION_MODIFIER", 161, 173], ["high endocytic activity", "OBSERVATION", 190, 213]]], ["Endocytosis of immune complexes and some proteoglycans are major functions.", [["proteoglycans", "GENE_OR_GENE_PRODUCT", 41, 54], ["immune complexes", "PROTEIN", 15, 31], ["Endocytosis of immune complexes", "PROBLEM", 0, 31], ["some proteoglycans", "PROBLEM", 36, 54], ["immune complexes", "OBSERVATION", 15, 31], ["some", "OBSERVATION_MODIFIER", 36, 40], ["proteoglycans", "OBSERVATION", 41, 54]]], ["They also synthesize molecules that affect vascular tone such as nitric oxide, endothelins, and prostaglandins.Cells of the liverKupffer cells are specialized macrophages located in sinusoidal lumens, mainly at branch points.", [["vascular", "ANATOMY", 43, 51], ["Cells", "ANATOMY", 111, 116], ["liverKupffer cells", "ANATOMY", 124, 142], ["macrophages", "ANATOMY", 159, 170], ["sinusoidal lumens", "ANATOMY", 182, 199], ["nitric oxide", "CHEMICAL", 65, 77], ["prostaglandins", "CHEMICAL", 96, 110], ["nitric oxide", "CHEMICAL", 65, 77], ["prostaglandins", "CHEMICAL", 96, 110], ["vascular", "MULTI-TISSUE_STRUCTURE", 43, 51], ["nitric oxide", "SIMPLE_CHEMICAL", 65, 77], ["endothelins", "GENE_OR_GENE_PRODUCT", 79, 90], ["prostaglandins", "SIMPLE_CHEMICAL", 96, 110], ["Cells", "CELL", 111, 116], ["liverKupffer cells", "CELL", 124, 142], ["macrophages", "CELL", 159, 170], ["sinusoidal lumens", "MULTI-TISSUE_STRUCTURE", 182, 199], ["liverKupffer cells", "CELL_LINE", 124, 142], ["macrophages", "CELL_TYPE", 159, 170], ["nitric oxide", "TREATMENT", 65, 77], ["endothelins", "TREATMENT", 79, 90], ["prostaglandins", "TREATMENT", 96, 110], ["molecules", "OBSERVATION", 21, 30], ["vascular", "ANATOMY", 43, 51], ["liverKupffer cells", "OBSERVATION", 124, 142], ["macrophages", "OBSERVATION", 159, 170], ["sinusoidal lumens", "OBSERVATION", 182, 199], ["branch", "ANATOMY_MODIFIER", 211, 217]]], ["Once thought to be \"fixed,\" it is now known that they can migrate along the sinusoid and into areas of tissue injury (Fig. 2-3) .", [["sinusoid", "ANATOMY", 76, 84], ["tissue", "ANATOMY", 103, 109], ["sinusoid", "TISSUE", 76, 84], ["tissue", "TISSUE", 103, 109], ["tissue injury", "PROBLEM", 103, 116], ["thought to be", "UNCERTAINTY", 5, 18], ["sinusoid", "ANATOMY", 76, 84], ["tissue", "ANATOMY", 103, 109], ["injury", "OBSERVATION", 110, 116]]], ["Kupffer cells may have a dual origin as they are derived, at least in part, from blood-borne monocytes, but they are also capable of local proliferation, particularly in inflammation.", [["Kupffer cells", "ANATOMY", 0, 13], ["blood", "ANATOMY", 81, 86], ["monocytes", "ANATOMY", 93, 102], ["inflammation", "DISEASE", 170, 182], ["Kupffer cells", "CELL", 0, 13], ["blood", "ORGANISM_SUBSTANCE", 81, 86], ["monocytes", "CELL", 93, 102], ["Kupffer cells", "CELL_TYPE", 0, 13], ["blood-borne monocytes", "CELL_TYPE", 81, 102], ["Kupffer cells", "TREATMENT", 0, 13], ["local proliferation", "PROBLEM", 133, 152], ["inflammation", "PROBLEM", 170, 182], ["borne monocytes", "ANATOMY", 87, 102], ["local", "OBSERVATION_MODIFIER", 133, 138], ["proliferation", "OBSERVATION", 139, 152], ["inflammation", "OBSERVATION", 170, 182]]], ["They are not efficient antigen presenters, but they are proficient phagocytes of apoptotic and necrotic cells, particulates, and microorganisms; consequently, the liver is a major \"filtering organ\" for the body.", [["phagocytes", "ANATOMY", 67, 77], ["necrotic cells", "ANATOMY", 95, 109], ["particulates", "ANATOMY", 111, 123], ["liver", "ANATOMY", 163, 168], ["organ", "ANATOMY", 191, 196], ["body", "ANATOMY", 206, 210], ["necrotic", "DISEASE", 95, 103], ["phagocytes", "CELL", 67, 77], ["apoptotic", "CELL", 81, 90], ["necrotic cells", "CELL", 95, 109], ["liver", "ORGAN", 163, 168], ["organ", "ORGAN", 191, 196], ["body", "ORGANISM_SUBDIVISION", 206, 210], ["phagocytes", "CELL_TYPE", 67, 77], ["apoptotic and necrotic cells", "CELL_TYPE", 81, 109], ["apoptotic and necrotic cells", "PROBLEM", 81, 109], ["microorganisms", "PROBLEM", 129, 143], ["apoptotic", "OBSERVATION_MODIFIER", 81, 90], ["necrotic cells", "OBSERVATION", 95, 109], ["liver", "ANATOMY", 163, 168], ["body", "ANATOMY", 206, 210]]], ["There are species differences in the efficiency of this process.", [["species differences", "PROBLEM", 10, 29], ["species", "OBSERVATION_MODIFIER", 10, 17], ["differences", "OBSERVATION_MODIFIER", 18, 29]]], ["Clearance of particulates, and endotoxin in particular, is accomplished more effectively by Kupffer cells in dogs, humans, and laboratory rodents than in ruminants, horse, pig, cats, and whales, species that have a significant population of intravascular macrophages in the pulmonary vasculature.", [["Kupffer cells", "ANATOMY", 92, 105], ["intravascular macrophages", "ANATOMY", 241, 266], ["pulmonary vasculature", "ANATOMY", 274, 295], ["endotoxin", "CHEMICAL", 31, 40], ["endotoxin", "SIMPLE_CHEMICAL", 31, 40], ["Kupffer cells", "CELL", 92, 105], ["dogs", "ORGANISM", 109, 113], ["humans", "ORGANISM", 115, 121], ["horse", "ORGANISM_SUBDIVISION", 165, 170], ["pig", "ORGANISM", 172, 175], ["cats", "ORGANISM", 177, 181], ["intravascular macrophages", "CELL", 241, 266], ["pulmonary vasculature", "MULTI-TISSUE_STRUCTURE", 274, 295], ["endotoxin", "PROTEIN", 31, 40], ["Kupffer cells", "CELL_TYPE", 92, 105], ["intravascular macrophages", "CELL_TYPE", 241, 266], ["dogs", "SPECIES", 109, 113], ["humans", "SPECIES", 115, 121], ["horse", "SPECIES", 165, 170], ["pig", "SPECIES", 172, 175], ["cats", "SPECIES", 177, 181], ["humans", "SPECIES", 115, 121], ["ruminants", "SPECIES", 154, 163], ["horse", "SPECIES", 165, 170], ["pig", "SPECIES", 172, 175], ["endotoxin", "TREATMENT", 31, 40], ["intravascular macrophages in the pulmonary vasculature", "PROBLEM", 241, 295], ["particulates", "OBSERVATION_MODIFIER", 13, 25], ["significant", "OBSERVATION_MODIFIER", 215, 226], ["population", "OBSERVATION", 227, 237], ["intravascular macrophages", "OBSERVATION", 241, 266], ["pulmonary vasculature", "ANATOMY", 274, 295]]], ["Kupffer cells can phagocytose a variety of gut-derived materials; bacteria, various biologically active bacterial components, including lipopolysaccharides, lipoteichoic acids, and peptidoglycans, without stimulating inflammation.", [["Kupffer cells", "ANATOMY", 0, 13], ["gut", "ANATOMY", 43, 46], ["lipoteichoic acids", "CHEMICAL", 157, 175], ["inflammation", "DISEASE", 217, 229], ["Kupffer cells", "CELL", 0, 13], ["gut", "ORGANISM_SUBDIVISION", 43, 46], ["lipopolysaccharides", "SIMPLE_CHEMICAL", 136, 155], ["lipoteichoic acids", "SIMPLE_CHEMICAL", 157, 175], ["peptidoglycans", "SIMPLE_CHEMICAL", 181, 195], ["Kupffer cells", "CELL_TYPE", 0, 13], ["bacteria", "PROBLEM", 66, 74], ["various biologically active bacterial components", "PROBLEM", 76, 124], ["lipopolysaccharides", "PROBLEM", 136, 155], ["lipoteichoic acids", "TEST", 157, 175], ["peptidoglycans", "PROBLEM", 181, 195], ["stimulating inflammation", "PROBLEM", 205, 229], ["active", "OBSERVATION_MODIFIER", 97, 103], ["bacterial components", "OBSERVATION", 104, 124], ["lipoteichoic acids", "OBSERVATION", 157, 175], ["without", "UNCERTAINTY", 197, 204], ["stimulating", "OBSERVATION_MODIFIER", 205, 216], ["inflammation", "OBSERVATION", 217, 229]]], ["Activated Kupffer cells can secrete tumor necrosis factor-\u03b1 and other cytokines, and nitric oxide; these contribute to peripheral vasodilation and hypotension in systemic inflammatory response syndromes initiated by bacterial components.", [["Kupffer cells", "ANATOMY", 10, 23], ["tumor", "DISEASE", 36, 41], ["nitric oxide", "CHEMICAL", 85, 97], ["hypotension", "DISEASE", 147, 158], ["nitric oxide", "CHEMICAL", 85, 97], ["Kupffer cells", "CELL", 10, 23], ["tumor necrosis factor-\u03b1", "GENE_OR_GENE_PRODUCT", 36, 59], ["nitric oxide", "SIMPLE_CHEMICAL", 85, 97], ["peripheral", "TISSUE", 119, 129], ["Kupffer cells", "CELL_TYPE", 10, 23], ["tumor necrosis factor-\u03b1", "PROTEIN", 36, 59], ["cytokines", "PROTEIN", 70, 79], ["Activated Kupffer cells", "TREATMENT", 0, 23], ["secrete tumor necrosis factor", "PROBLEM", 28, 57], ["other cytokines", "TREATMENT", 64, 79], ["nitric oxide", "TREATMENT", 85, 97], ["peripheral vasodilation", "PROBLEM", 119, 142], ["hypotension", "PROBLEM", 147, 158], ["systemic inflammatory response syndromes", "PROBLEM", 162, 202], ["bacterial components", "PROBLEM", 216, 236], ["peripheral", "ANATOMY_MODIFIER", 119, 129], ["vasodilation", "OBSERVATION", 130, 142], ["hypotension", "OBSERVATION", 147, 158], ["systemic", "OBSERVATION_MODIFIER", 162, 170], ["inflammatory response syndromes", "OBSERVATION", 171, 202], ["bacterial components", "OBSERVATION", 216, 236]]], ["Other secreted cytokines, such as interleukin-1 (IL-1) and IL-6, mediate the acute-phase response and some aspects of the immune and liver regenerative responses.", [["liver", "ANATOMY", 133, 138], ["interleukin-1", "GENE_OR_GENE_PRODUCT", 34, 47], ["IL-1", "GENE_OR_GENE_PRODUCT", 49, 53], ["IL-6", "GENE_OR_GENE_PRODUCT", 59, 63], ["liver", "ORGAN", 133, 138], ["cytokines", "PROTEIN", 15, 24], ["interleukin-1 (IL-1", "PROTEIN", 34, 53], ["IL-6", "PROTEIN", 59, 63], ["Other secreted cytokines", "TEST", 0, 24], ["interleukin", "TEST", 34, 45], ["IL", "TEST", 59, 61], ["cytokines", "OBSERVATION", 15, 24], ["acute", "OBSERVATION_MODIFIER", 77, 82], ["liver", "ANATOMY", 133, 138]]], ["However, there can be a balance activation.", [["balance activation", "OBSERVATION", 24, 42]]], ["They then develop a myofibroblast phenotype characterized by the expression \u03b1-smooth muscle actin.", [["myofibroblast", "ANATOMY", 20, 33], ["\u03b1-smooth muscle", "ANATOMY", 76, 91], ["myofibroblast", "CELL", 20, 33], ["\u03b1-smooth muscle actin", "GENE_OR_GENE_PRODUCT", 76, 97], ["\u03b1-smooth muscle actin", "PROTEIN", 76, 97], ["a myofibroblast phenotype", "PROBLEM", 18, 43], ["myofibroblast phenotype", "OBSERVATION", 20, 43]]], ["Proinflammatory cytokines released primarily by Kupffer cells, such as transforming growth factor-\u03b2 released in response to tissue injury, stimulate HSC to increase the deposition of ECM, including collagen type I, III, and IV, and laminin.", [["Kupffer cells", "ANATOMY", 48, 61], ["tissue", "ANATOMY", 124, 130], ["HSC", "ANATOMY", 149, 152], ["ECM", "ANATOMY", 183, 186], ["Kupffer cells", "CELL", 48, 61], ["transforming growth factor-\u03b2", "GENE_OR_GENE_PRODUCT", 71, 99], ["tissue", "TISSUE", 124, 130], ["HSC", "CELL", 149, 152], ["ECM", "CELLULAR_COMPONENT", 183, 186], ["collagen type I", "GENE_OR_GENE_PRODUCT", 198, 213], ["III", "GENE_OR_GENE_PRODUCT", 215, 218], ["IV", "GENE_OR_GENE_PRODUCT", 224, 226], ["laminin", "GENE_OR_GENE_PRODUCT", 232, 239], ["Proinflammatory cytokines", "PROTEIN", 0, 25], ["Kupffer cells", "CELL_TYPE", 48, 61], ["transforming growth factor-\u03b2", "PROTEIN", 71, 99], ["HSC", "CELL_TYPE", 149, 152], ["ECM", "PROTEIN", 183, 186], ["collagen type I, III, and IV", "PROTEIN", 198, 226], ["laminin", "PROTEIN", 232, 239], ["Proinflammatory cytokines", "PROBLEM", 0, 25], ["transforming growth factor", "PROBLEM", 71, 97], ["tissue injury", "PROBLEM", 124, 137], ["the deposition of ECM", "PROBLEM", 165, 186], ["IV", "TREATMENT", 224, 226], ["Kupffer cells", "OBSERVATION", 48, 61], ["injury", "OBSERVATION", 131, 137]]], ["This new ECM transforms the sinusoid to a less permeable capillary, lined by a basement membrane-like layer and without fenestrations in the sinusoidal endothelium, reducing transfer of macromolecules between hepatocytes and the blood.", [["ECM", "ANATOMY", 9, 12], ["sinusoid", "ANATOMY", 28, 36], ["capillary", "ANATOMY", 57, 66], ["basement membrane", "ANATOMY", 79, 96], ["sinusoidal endothelium", "ANATOMY", 141, 163], ["hepatocytes", "ANATOMY", 209, 220], ["blood", "ANATOMY", 229, 234], ["ECM", "CELLULAR_COMPONENT", 9, 12], ["sinusoid", "TISSUE", 28, 36], ["capillary", "TISSUE", 57, 66], ["basement membrane", "CELLULAR_COMPONENT", 79, 96], ["sinusoidal endothelium", "TISSUE", 141, 163], ["hepatocytes", "CELL", 209, 220], ["blood", "ORGANISM_SUBSTANCE", 229, 234], ["ECM", "PROTEIN", 9, 12], ["hepatocytes", "CELL_TYPE", 209, 220], ["a less permeable capillary", "PROBLEM", 40, 66], ["a basement membrane", "TEST", 77, 96], ["fenestrations in the sinusoidal endothelium", "PROBLEM", 120, 163], ["the blood", "TEST", 225, 234], ["sinusoid", "OBSERVATION_MODIFIER", 28, 36], ["less permeable", "OBSERVATION_MODIFIER", 42, 56], ["capillary", "ANATOMY_MODIFIER", 57, 66], ["layer", "OBSERVATION_MODIFIER", 102, 107], ["without", "UNCERTAINTY", 112, 119], ["fenestrations", "OBSERVATION", 120, 133], ["sinusoidal endothelium", "ANATOMY", 141, 163], ["hepatocytes", "ANATOMY", 209, 220], ["blood", "ANATOMY", 229, 234]]], ["The acquired contractility of the HSC during fibrogenesis is increased because of an increase in the contractile stimulus of endothelin-1 and a reduction in vasodilation driven by diminished nitric oxide generation.", [["HSC", "ANATOMY", 34, 37], ["fibrogenesis", "DISEASE", 45, 57], ["nitric oxide", "CHEMICAL", 191, 203], ["nitric oxide", "CHEMICAL", 191, 203], ["HSC", "CELL", 34, 37], ["endothelin-1", "GENE_OR_GENE_PRODUCT", 125, 137], ["nitric oxide", "SIMPLE_CHEMICAL", 191, 203], ["HSC", "CELL_TYPE", 34, 37], ["fibrogenesis", "PROBLEM", 45, 57], ["an increase", "PROBLEM", 82, 93], ["a reduction in vasodilation", "TREATMENT", 142, 169], ["diminished nitric oxide generation", "TREATMENT", 180, 214], ["contractility", "OBSERVATION", 13, 26], ["HSC", "ANATOMY", 34, 37], ["fibrogenesis", "OBSERVATION", 45, 57], ["increased", "OBSERVATION_MODIFIER", 61, 70], ["increase", "OBSERVATION_MODIFIER", 85, 93], ["contractile stimulus", "OBSERVATION", 101, 121], ["reduction", "OBSERVATION_MODIFIER", 144, 153], ["vasodilation", "OBSERVATION", 157, 169], ["diminished", "OBSERVATION_MODIFIER", 180, 190], ["nitric oxide generation", "OBSERVATION", 191, 214]]], ["In severe chronic injury leading to cirrhosis, the increased expression of contractile proteins within activated stellate cells can further restrict sinusoidal blood flow as a primary effect, rather than a consequence of nodule formation and fibrosis.", [["stellate cells", "ANATOMY", 113, 127], ["sinusoidal blood", "ANATOMY", 149, 165], ["nodule", "ANATOMY", 221, 227], ["chronic injury", "DISEASE", 10, 24], ["cirrhosis", "DISEASE", 36, 45], ["fibrosis", "DISEASE", 242, 250], ["stellate cells", "CELL", 113, 127], ["sinusoidal", "MULTI-TISSUE_STRUCTURE", 149, 159], ["blood", "ORGANISM_SUBSTANCE", 160, 165], ["nodule", "PATHOLOGICAL_FORMATION", 221, 227], ["contractile proteins", "PROTEIN", 75, 95], ["activated stellate cells", "CELL_TYPE", 103, 127], ["severe chronic injury", "PROBLEM", 3, 24], ["cirrhosis", "PROBLEM", 36, 45], ["contractile proteins within activated stellate cells", "PROBLEM", 75, 127], ["sinusoidal blood flow", "TEST", 149, 170], ["nodule formation", "PROBLEM", 221, 237], ["fibrosis", "PROBLEM", 242, 250], ["severe", "OBSERVATION_MODIFIER", 3, 9], ["chronic", "OBSERVATION_MODIFIER", 10, 17], ["injury", "OBSERVATION", 18, 24], ["cirrhosis", "OBSERVATION", 36, 45], ["increased", "OBSERVATION_MODIFIER", 51, 60], ["contractile proteins", "OBSERVATION", 75, 95], ["stellate cells", "OBSERVATION", 113, 127], ["sinusoidal blood flow", "OBSERVATION", 149, 170], ["nodule", "OBSERVATION", 221, 227], ["fibrosis", "OBSERVATION", 242, 250]]], ["Peribiliary fibrosis arises from activation of the circumferential fibroblasts of the bile ducts that undergo a phenotypic transformation similar to that of the HSC along the sinusoids.", [["circumferential fibroblasts", "ANATOMY", 51, 78], ["bile ducts", "ANATOMY", 86, 96], ["HSC", "ANATOMY", 161, 164], ["sinusoids", "ANATOMY", 175, 184], ["fibrosis", "DISEASE", 12, 20], ["fibroblasts", "CELL", 67, 78], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 86, 96], ["HSC", "CELL", 161, 164], ["sinusoids", "TISSUE", 175, 184], ["circumferential fibroblasts", "CELL_TYPE", 51, 78], ["HSC", "CELL_TYPE", 161, 164], ["Peribiliary fibrosis", "PROBLEM", 0, 20], ["the circumferential fibroblasts of the bile ducts", "PROBLEM", 47, 96], ["a phenotypic transformation", "PROBLEM", 110, 137], ["fibrosis", "OBSERVATION", 12, 20], ["circumferential", "OBSERVATION_MODIFIER", 51, 66], ["fibroblasts", "OBSERVATION", 67, 78], ["bile ducts", "ANATOMY", 86, 96], ["phenotypic transformation", "OBSERVATION", 112, 137], ["HSC", "ANATOMY", 161, 164], ["sinusoids", "ANATOMY", 175, 184]]], ["Fibrosis of the portal tracts and the central vein connective tissue develops from activation of myofibroblasts resident in these areas as well.", [["portal tracts", "ANATOMY", 16, 29], ["central vein connective tissue", "ANATOMY", 38, 68], ["myofibroblasts", "ANATOMY", 97, 111], ["Fibrosis of the portal tracts", "DISEASE", 0, 29], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 16, 29], ["central vein connective tissue", "TISSUE", 38, 68], ["myofibroblasts", "CELL", 97, 111], ["myofibroblasts", "CELL_TYPE", 97, 111], ["Fibrosis of the portal tracts", "PROBLEM", 0, 29], ["the central vein connective tissue", "PROBLEM", 34, 68], ["portal tracts", "ANATOMY", 16, 29], ["central", "ANATOMY_MODIFIER", 38, 45], ["vein", "ANATOMY", 46, 50], ["connective tissue", "OBSERVATION", 51, 68], ["myofibroblasts", "OBSERVATION", 97, 111]]], ["It is also possible that epithelial-mesenchymal transition of hepatocytes, biliary epithelial cells, or HSC can contribute to hepatic fibrosis during chronic injury.Cells of the liverMast cells are abundant in the liver, particularly in dogs.", [["epithelial", "ANATOMY", 25, 35], ["mesenchymal", "ANATOMY", 36, 47], ["hepatocytes", "ANATOMY", 62, 73], ["biliary epithelial cells", "ANATOMY", 75, 99], ["HSC", "ANATOMY", 104, 107], ["hepatic", "ANATOMY", 126, 133], ["Cells", "ANATOMY", 165, 170], ["liverMast cells", "ANATOMY", 178, 193], ["liver", "ANATOMY", 214, 219], ["fibrosis", "DISEASE", 134, 142], ["chronic injury", "DISEASE", 150, 164], ["epithelial", "CELL", 25, 35], ["mesenchymal", "CELL", 36, 47], ["hepatocytes", "CELL", 62, 73], ["biliary epithelial cells", "CELL", 75, 99], ["HSC", "CELL", 104, 107], ["hepatic", "ORGAN", 126, 133], ["Cells", "CELL", 165, 170], ["liverMast cells", "CELL", 178, 193], ["liver", "ORGAN", 214, 219], ["dogs", "ORGANISM", 237, 241], ["hepatocytes", "CELL_TYPE", 62, 73], ["biliary epithelial cells", "CELL_TYPE", 75, 99], ["HSC", "CELL_TYPE", 104, 107], ["liverMast cells", "CELL_TYPE", 178, 193], ["dogs", "SPECIES", 237, 241], ["epithelial-mesenchymal transition of hepatocytes", "PROBLEM", 25, 73], ["biliary epithelial cells", "PROBLEM", 75, 99], ["HSC", "PROBLEM", 104, 107], ["hepatic fibrosis", "PROBLEM", 126, 142], ["chronic injury", "PROBLEM", 150, 164], ["is also possible", "UNCERTAINTY", 3, 19], ["epithelial", "ANATOMY_MODIFIER", 25, 35], ["mesenchymal transition", "OBSERVATION", 36, 58], ["hepatocytes", "ANATOMY", 62, 73], ["biliary", "ANATOMY", 75, 82], ["epithelial cells", "OBSERVATION", 83, 99], ["hepatic", "ANATOMY", 126, 133], ["fibrosis", "OBSERVATION", 134, 142], ["chronic", "OBSERVATION_MODIFIER", 150, 157], ["injury", "OBSERVATION", 158, 164], ["liver", "ANATOMY", 178, 183], ["Mast cells", "OBSERVATION", 183, 193], ["abundant", "OBSERVATION_MODIFIER", 198, 206], ["liver", "ANATOMY", 214, 219]]], ["They typically occupy a perivenous location, where they may influence vascular tone and respond to various potentially injurious substances or organisms.", [["perivenous", "ANATOMY", 24, 34], ["vascular", "ANATOMY", 70, 78], ["vascular", "MULTI-TISSUE_STRUCTURE", 70, 78], ["various potentially injurious substances", "PROBLEM", 99, 139], ["organisms", "PROBLEM", 143, 152], ["perivenous location", "OBSERVATION", 24, 43], ["vascular", "ANATOMY", 70, 78]]], ["Degranulation of mast cells in the liver leads to contraction of the spiral smooth muscle, restricting blood outflow from the canine liver.", [["mast cells", "ANATOMY", 17, 27], ["liver", "ANATOMY", 35, 40], ["spiral smooth muscle", "ANATOMY", 69, 89], ["blood", "ANATOMY", 103, 108], ["liver", "ANATOMY", 133, 138], ["mast cells", "CELL", 17, 27], ["liver", "ORGAN", 35, 40], ["spiral smooth muscle", "TISSUE", 69, 89], ["blood outflow", "MULTI-TISSUE_STRUCTURE", 103, 116], ["canine", "ORGANISM", 126, 132], ["liver", "ORGAN", 133, 138], ["mast cells", "CELL_TYPE", 17, 27], ["canine", "SPECIES", 126, 132], ["Degranulation of mast cells in the liver", "PROBLEM", 0, 40], ["mast cells", "OBSERVATION", 17, 27], ["liver", "ANATOMY", 35, 40], ["contraction", "OBSERVATION", 50, 61], ["spiral", "ANATOMY_MODIFIER", 69, 75], ["smooth muscle", "ANATOMY", 76, 89], ["blood outflow", "OBSERVATION", 103, 116], ["canine", "ANATOMY_MODIFIER", 126, 132], ["liver", "ANATOMY", 133, 138]]], ["This is a feature of shock in dogs.Cells of the liverHematopoiesis in the fetal life of mammals occurs mainly in the perisinusoidal compartment of the liver sinusoids.", [["Cells", "ANATOMY", 35, 40], ["liver", "ANATOMY", 48, 53], ["fetal", "ANATOMY", 74, 79], ["perisinusoidal compartment", "ANATOMY", 117, 143], ["liver sinusoids", "ANATOMY", 151, 166], ["shock", "DISEASE", 21, 26], ["dogs", "ORGANISM", 30, 34], ["Cells", "CELL", 35, 40], ["liver", "ORGAN", 48, 53], ["fetal", "ANATOMICAL_SYSTEM", 74, 79], ["perisinusoidal compartment", "MULTI-TISSUE_STRUCTURE", 117, 143], ["liver sinusoids", "MULTI-TISSUE_STRUCTURE", 151, 166], ["dogs", "SPECIES", 30, 34], ["shock in dogs", "PROBLEM", 21, 34], ["the liverHematopoiesis", "PROBLEM", 44, 66], ["shock", "OBSERVATION", 21, 26], ["liver", "ANATOMY", 48, 53], ["Hematopoiesis", "OBSERVATION", 53, 66], ["perisinusoidal", "ANATOMY_MODIFIER", 117, 131], ["liver", "ANATOMY", 151, 156], ["sinusoids", "ANATOMY_MODIFIER", 157, 166]]], ["Postnatally, hepatic hematopoiesis declines but can return as extramedullary hematopoiesis in conditions of increased demand .", [["hepatic", "ANATOMY", 13, 20], ["hepatic", "ORGAN", 13, 20], ["hepatic hematopoiesis", "PROBLEM", 13, 34], ["extramedullary hematopoiesis", "PROBLEM", 62, 90], ["increased demand", "PROBLEM", 108, 124], ["hepatic", "ANATOMY", 13, 20], ["hematopoiesis", "OBSERVATION", 21, 34], ["extramedullary hematopoiesis", "OBSERVATION", 62, 90], ["increased", "OBSERVATION_MODIFIER", 108, 117], ["demand", "OBSERVATION_MODIFIER", 118, 124]]], ["Because the liver is an early site of hematopoiesis, the environmental conditions and cells, including resident populations of appropriate stromal cells and, possibly hematopoietic stem cells, remain supportive for the initiation or reactivation of a stem cell niche.", [["liver", "ANATOMY", 12, 17], ["cells", "ANATOMY", 86, 91], ["stromal cells", "ANATOMY", 139, 152], ["hematopoietic stem cells", "ANATOMY", 167, 191], ["stem cell niche", "ANATOMY", 251, 266], ["liver", "ORGAN", 12, 17], ["cells", "CELL", 86, 91], ["stromal cells", "CELL", 139, 152], ["hematopoietic stem cells", "CELL", 167, 191], ["stem cell", "CELL", 251, 260], ["stromal cells", "CELL_TYPE", 139, 152], ["hematopoietic stem cells", "CELL_TYPE", 167, 191], ["stem cell niche", "CELL_TYPE", 251, 266], ["hematopoiesis", "PROBLEM", 38, 51], ["the environmental conditions and cells", "PROBLEM", 53, 91], ["appropriate stromal cells", "PROBLEM", 127, 152], ["hematopoietic stem cells", "PROBLEM", 167, 191], ["a stem cell niche", "TREATMENT", 249, 266], ["liver", "ANATOMY", 12, 17], ["early", "OBSERVATION_MODIFIER", 24, 29], ["hematopoiesis", "OBSERVATION", 38, 51], ["stromal cells", "OBSERVATION", 139, 152], ["possibly", "UNCERTAINTY", 158, 166], ["hematopoietic stem cells", "OBSERVATION", 167, 191], ["stem cell niche", "OBSERVATION", 251, 266]]], ["The degree of hepatic extramedullary hematopoiesis in larger species can have diagnostic hepatorenal fibrocystic disorders of humans.", [["hepatic extramedullary", "ANATOMY", 14, 36], ["hepatorenal fibrocystic", "ANATOMY", 89, 112], ["hepatic extramedullary hematopoiesis", "DISEASE", 14, 50], ["hepatorenal fibrocystic disorders", "DISEASE", 89, 122], ["hepatic extramedullary", "PATHOLOGICAL_FORMATION", 14, 36], ["hepatorenal fibrocystic", "PATHOLOGICAL_FORMATION", 89, 112], ["humans", "ORGANISM", 126, 132], ["humans", "SPECIES", 126, 132], ["humans", "SPECIES", 126, 132], ["hepatic extramedullary hematopoiesis", "PROBLEM", 14, 50], ["larger species", "PROBLEM", 54, 68], ["hepatorenal fibrocystic disorders of humans", "PROBLEM", 89, 132], ["degree", "OBSERVATION_MODIFIER", 4, 10], ["hepatic", "ANATOMY", 14, 21], ["extramedullary hematopoiesis", "OBSERVATION", 22, 50], ["larger", "OBSERVATION_MODIFIER", 54, 60], ["hepatorenal", "ANATOMY", 89, 100], ["fibrocystic", "OBSERVATION", 101, 112]]], ["Cysts may also be found in the pancreas or other organs.", [["Cysts", "ANATOMY", 0, 5], ["pancreas", "ANATOMY", 31, 39], ["organs", "ANATOMY", 49, 55], ["pancreas", "ORGAN", 31, 39], ["organs", "ORGAN", 49, 55], ["Cysts", "PROBLEM", 0, 5], ["may also be found", "UNCERTAINTY", 6, 23], ["pancreas", "ANATOMY", 31, 39], ["organs", "ANATOMY", 49, 55]]], ["Animals may die from progressive renal insufficiency, and/or from hepatic dysfunction and portal hypertension associated with hepatic fibrosis.", [["renal", "ANATOMY", 33, 38], ["hepatic", "ANATOMY", 66, 73], ["portal", "ANATOMY", 90, 96], ["hepatic", "ANATOMY", 126, 133], ["renal insufficiency", "DISEASE", 33, 52], ["hepatic dysfunction", "DISEASE", 66, 85], ["hypertension", "DISEASE", 97, 109], ["hepatic fibrosis", "DISEASE", 126, 142], ["Animals", "ORGANISM", 0, 7], ["renal", "ORGAN", 33, 38], ["hepatic", "ORGAN", 66, 73], ["portal", "MULTI-TISSUE_STRUCTURE", 90, 96], ["hepatic", "ORGAN", 126, 133], ["progressive renal insufficiency", "PROBLEM", 21, 52], ["hepatic dysfunction", "PROBLEM", 66, 85], ["portal hypertension", "PROBLEM", 90, 109], ["hepatic fibrosis", "PROBLEM", 126, 142], ["progressive", "OBSERVATION_MODIFIER", 21, 32], ["renal", "ANATOMY", 33, 38], ["insufficiency", "OBSERVATION", 39, 52], ["hepatic", "ANATOMY", 66, 73], ["dysfunction", "OBSERVATION", 74, 85], ["portal", "ANATOMY", 90, 96], ["hypertension", "OBSERVATION", 97, 109], ["hepatic", "ANATOMY", 126, 133], ["fibrosis", "OBSERVATION", 134, 142]]], ["Hepatic fibrosis and cysts are present in a significant proportion of cats with polycystic kidney disease, inherited in Persian cats, exotic shorthaired, and other related breeds as an autosomal dominant C\u2192A transversion mutation in exon 29 of the feline PKD1 gene, resembling the adult form of polycystic kidney disease in humans.", [["Hepatic", "ANATOMY", 0, 7], ["cysts", "ANATOMY", 21, 26], ["kidney", "ANATOMY", 91, 97], ["kidney", "ANATOMY", 306, 312], ["fibrosis", "DISEASE", 8, 16], ["polycystic kidney disease", "DISEASE", 80, 105], ["polycystic kidney disease", "DISEASE", 295, 320], ["Hepatic", "ORGAN", 0, 7], ["cysts", "PATHOLOGICAL_FORMATION", 21, 26], ["cats", "ORGANISM", 70, 74], ["kidney", "ORGAN", 91, 97], ["cats", "ORGANISM", 128, 132], ["C\u2192A", "GENE_OR_GENE_PRODUCT", 204, 207], ["feline", "ORGANISM", 248, 254], ["PKD1", "GENE_OR_GENE_PRODUCT", 255, 259], ["kidney", "ORGAN", 306, 312], ["humans", "ORGANISM", 324, 330], ["exon 29", "DNA", 233, 240], ["feline PKD1 gene", "DNA", 248, 264], ["cats", "SPECIES", 70, 74], ["cats", "SPECIES", 128, 132], ["feline", "SPECIES", 248, 254], ["humans", "SPECIES", 324, 330], ["Persian cats", "SPECIES", 120, 132], ["humans", "SPECIES", 324, 330], ["Hepatic fibrosis", "PROBLEM", 0, 16], ["cysts", "PROBLEM", 21, 26], ["polycystic kidney disease", "PROBLEM", 80, 105], ["an autosomal dominant C", "PROBLEM", 182, 205], ["A transversion mutation", "TREATMENT", 206, 229], ["polycystic kidney disease in humans", "PROBLEM", 295, 330], ["fibrosis", "OBSERVATION", 8, 16], ["cysts", "OBSERVATION", 21, 26], ["significant", "OBSERVATION_MODIFIER", 44, 55], ["cats", "OBSERVATION", 70, 74], ["polycystic", "OBSERVATION_MODIFIER", 80, 90], ["kidney", "ANATOMY", 91, 97], ["disease", "OBSERVATION", 98, 105], ["exotic shorthaired", "OBSERVATION_MODIFIER", 134, 152], ["autosomal", "OBSERVATION_MODIFIER", 185, 194], ["dominant", "OBSERVATION_MODIFIER", 195, 203], ["polycystic", "OBSERVATION", 295, 305], ["kidney", "ANATOMY", 306, 312], ["disease", "OBSERVATION", 313, 320]]], ["The liver lesions have been more difficult to classify, and may appear as multiple large cysts resembling adult-type polycystic disease, as congenital hepatic fibrosis characterized by portoportal bridging fibrosis with excess abnormally formed bile ductules ( Fig. 2-7) , or as combinations of both lesions.", [["liver lesions", "ANATOMY", 4, 17], ["cysts", "ANATOMY", 89, 94], ["polycystic", "ANATOMY", 117, 127], ["hepatic", "ANATOMY", 151, 158], ["portoportal", "ANATOMY", 185, 196], ["bile ductules", "ANATOMY", 245, 258], ["lesions", "ANATOMY", 300, 307], ["liver lesions", "DISEASE", 4, 17], ["cysts", "DISEASE", 89, 94], ["adult-type polycystic disease", "DISEASE", 106, 135], ["congenital hepatic fibrosis", "DISEASE", 140, 167], ["fibrosis", "DISEASE", 206, 214], ["liver lesions", "CANCER", 4, 17], ["polycystic", "ORGAN", 117, 127], ["hepatic", "ORGAN", 151, 158], ["bile ductules", "MULTI-TISSUE_STRUCTURE", 245, 258], ["lesions", "PATHOLOGICAL_FORMATION", 300, 307], ["The liver lesions", "PROBLEM", 0, 17], ["multiple large cysts", "PROBLEM", 74, 94], ["adult-type polycystic disease", "PROBLEM", 106, 135], ["congenital hepatic fibrosis", "PROBLEM", 140, 167], ["portoportal bridging fibrosis", "PROBLEM", 185, 214], ["excess abnormally formed bile ductules", "PROBLEM", 220, 258], ["both lesions", "PROBLEM", 295, 307], ["liver", "ANATOMY", 4, 9], ["lesions", "OBSERVATION", 10, 17], ["more difficult to classify", "OBSERVATION_MODIFIER", 28, 54], ["may appear", "UNCERTAINTY", 60, 70], ["multiple", "OBSERVATION_MODIFIER", 74, 82], ["large", "OBSERVATION_MODIFIER", 83, 88], ["cysts", "OBSERVATION", 89, 94], ["adult", "OBSERVATION_MODIFIER", 106, 111], ["-type", "OBSERVATION_MODIFIER", 111, 116], ["polycystic", "OBSERVATION_MODIFIER", 117, 127], ["disease", "OBSERVATION", 128, 135], ["congenital", "OBSERVATION_MODIFIER", 140, 150], ["hepatic", "ANATOMY", 151, 158], ["fibrosis", "OBSERVATION", 159, 167], ["portoportal", "OBSERVATION_MODIFIER", 185, 196], ["bridging", "OBSERVATION_MODIFIER", 197, 205], ["fibrosis", "OBSERVATION", 206, 214], ["excess", "OBSERVATION_MODIFIER", 220, 226], ["abnormally", "OBSERVATION_MODIFIER", 227, 237], ["bile ductules", "ANATOMY", 245, 258], ["both", "OBSERVATION_MODIFIER", 295, 299], ["lesions", "OBSERVATION", 300, 307]]], ["Polycystic kidney and liver disease reported in West Highland White and Cairn Terrier litters resembles the autosomal recessive polycystic kidney disease of children.", [["Polycystic kidney", "ANATOMY", 0, 17], ["liver", "ANATOMY", 22, 27], ["kidney", "ANATOMY", 139, 145], ["Polycystic kidney and liver disease", "DISEASE", 0, 35], ["autosomal recessive polycystic kidney disease", "DISEASE", 108, 153], ["Polycystic kidney", "MULTI-TISSUE_STRUCTURE", 0, 17], ["liver", "ORGAN", 22, 27], ["kidney", "ORGAN", 139, 145], ["children", "ORGANISM", 157, 165], ["children", "SPECIES", 157, 165], ["Polycystic kidney and liver disease", "PROBLEM", 0, 35], ["the autosomal recessive polycystic kidney disease of children", "PROBLEM", 104, 165], ["kidney", "ANATOMY", 11, 17], ["liver", "ANATOMY", 22, 27], ["disease", "OBSERVATION", 28, 35], ["autosomal", "OBSERVATION_MODIFIER", 108, 117], ["recessive", "OBSERVATION_MODIFIER", 118, 127], ["polycystic", "OBSERVATION_MODIFIER", 128, 138], ["kidney", "ANATOMY", 139, 145], ["disease", "OBSERVATION", 146, 153]]], ["Congenital hepatic fibrosis has been described in dogs.", [["hepatic", "ANATOMY", 11, 18], ["Congenital hepatic fibrosis", "DISEASE", 0, 27], ["hepatic", "ORGAN", 11, 18], ["dogs", "ORGANISM", 50, 54], ["dogs", "SPECIES", 50, 54], ["Congenital hepatic fibrosis", "PROBLEM", 0, 27], ["hepatic", "ANATOMY", 11, 18], ["fibrosis", "OBSERVATION", 19, 27]]], ["Affected animals are presented at or before a year of age with clinical signs of liver disease, including ascites, microhepatica, and extrahepatic portosystemic shunts.", [["liver", "ANATOMY", 81, 86], ["ascites", "ANATOMY", 106, 113], ["microhepatica", "ANATOMY", 115, 128], ["extrahepatic portosystemic shunts", "ANATOMY", 134, 167], ["liver disease", "DISEASE", 81, 94], ["ascites", "DISEASE", 106, 113], ["microhepatica", "DISEASE", 115, 128], ["extrahepatic portosystemic shunts", "DISEASE", 134, 167], ["animals", "ORGANISM", 9, 16], ["liver", "ORGAN", 81, 86], ["extrahepatic portosystemic", "MULTI-TISSUE_STRUCTURE", 134, 160], ["liver disease", "PROBLEM", 81, 94], ["ascites", "PROBLEM", 106, 113], ["microhepatica, and extrahepatic portosystemic shunts", "PROBLEM", 115, 167], ["liver", "ANATOMY", 81, 86], ["disease", "OBSERVATION", 87, 94], ["ascites", "OBSERVATION", 106, 113], ["extrahepatic", "ANATOMY_MODIFIER", 134, 146], ["portosystemic shunts", "OBSERVATION", 147, 167]]], ["Histologically, these dogs had livers with extensive bands of portal bridging fibrosis containing numerous small irregular, tortuous bile ducts, often accompanied by absent or hypoplastic portal veins and compensatory arteriolar proliferation, and with no evidence of nodular regeneration and minimal inflammation, allowing differentiation of this congenital condition from acquired chronic liver disease.", [["livers", "ANATOMY", 31, 37], ["tortuous bile ducts", "ANATOMY", 124, 143], ["hypoplastic portal veins", "ANATOMY", 176, 200], ["arteriolar", "ANATOMY", 218, 228], ["nodular", "ANATOMY", 268, 275], ["liver", "ANATOMY", 391, 396], ["fibrosis", "DISEASE", 78, 86], ["inflammation", "DISEASE", 301, 313], ["chronic liver disease", "DISEASE", 383, 404], ["dogs", "ORGANISM", 22, 26], ["livers", "ORGAN", 31, 37], ["portal", "PATHOLOGICAL_FORMATION", 62, 68], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 133, 143], ["portal veins", "MULTI-TISSUE_STRUCTURE", 188, 200], ["arteriolar", "MULTI-TISSUE_STRUCTURE", 218, 228], ["nodular", "PATHOLOGICAL_FORMATION", 268, 275], ["liver", "ORGAN", 391, 396], ["dogs", "SPECIES", 22, 26], ["portal bridging fibrosis", "PROBLEM", 62, 86], ["numerous small irregular, tortuous bile ducts", "PROBLEM", 98, 143], ["absent or hypoplastic portal veins", "PROBLEM", 166, 200], ["compensatory arteriolar proliferation", "PROBLEM", 205, 242], ["nodular regeneration", "PROBLEM", 268, 288], ["minimal inflammation", "PROBLEM", 293, 313], ["this congenital condition", "PROBLEM", 343, 368], ["acquired chronic liver disease", "PROBLEM", 374, 404], ["livers", "ANATOMY", 31, 37], ["extensive", "OBSERVATION_MODIFIER", 43, 52], ["bands", "OBSERVATION_MODIFIER", 53, 58], ["portal", "ANATOMY", 62, 68], ["bridging fibrosis", "OBSERVATION", 69, 86], ["numerous", "OBSERVATION_MODIFIER", 98, 106], ["small", "OBSERVATION_MODIFIER", 107, 112], ["irregular", "OBSERVATION_MODIFIER", 113, 122], ["tortuous", "OBSERVATION", 124, 132], ["bile ducts", "ANATOMY", 133, 143], ["absent", "OBSERVATION", 166, 172], ["hypoplastic", "OBSERVATION", 176, 187], ["portal veins", "ANATOMY", 188, 200], ["compensatory", "OBSERVATION_MODIFIER", 205, 217], ["arteriolar proliferation", "OBSERVATION", 218, 242], ["no evidence of", "UNCERTAINTY", 253, 267], ["nodular", "OBSERVATION_MODIFIER", 268, 275], ["regeneration", "OBSERVATION", 276, 288], ["minimal", "OBSERVATION_MODIFIER", 293, 300], ["inflammation", "OBSERVATION", 301, 313], ["chronic", "OBSERVATION_MODIFIER", 383, 390], ["liver", "ANATOMY", 391, 396], ["disease", "OBSERVATION", 397, 404]]], ["Congenital hepatic fibrosis has also been reported in aborted and neonatal calves, in the latter case accompanied by cyst formation in the kidney and lung.", [["hepatic", "ANATOMY", 11, 18], ["cyst", "ANATOMY", 117, 121], ["kidney", "ANATOMY", 139, 145], ["lung", "ANATOMY", 150, 154], ["Congenital hepatic fibrosis", "DISEASE", 0, 27], ["hepatic", "ORGAN", 11, 18], ["calves", "ORGANISM", 75, 81], ["cyst", "TISSUE", 117, 121], ["kidney", "ORGAN", 139, 145], ["lung", "ORGAN", 150, 154], ["calves", "SPECIES", 75, 81], ["Congenital hepatic fibrosis", "PROBLEM", 0, 27], ["cyst formation in the kidney and lung", "PROBLEM", 117, 154], ["hepatic", "ANATOMY", 11, 18], ["fibrosis", "OBSERVATION", 19, 27], ["neonatal", "OBSERVATION_MODIFIER", 66, 74], ["calves", "OBSERVATION", 75, 81], ["cyst", "OBSERVATION", 117, 121], ["kidney", "ANATOMY", 139, 145], ["lung", "ANATOMY", 150, 154]]], ["Congenital hepatic fibrosis with cystic bile ducts has been described in Swiss Freiberger foals ( Fig. 2-8) and is seen occasionally in other breeds, with generalized portal bridging fibrosis containing many small, irregularly formed and occasionally cystic bile ducts.", [["hepatic", "ANATOMY", 11, 18], ["cystic bile ducts", "ANATOMY", 33, 50], ["cystic bile ducts", "ANATOMY", 251, 268], ["Congenital hepatic fibrosis", "DISEASE", 0, 27], ["cystic bile ducts", "DISEASE", 33, 50], ["fibrosis", "DISEASE", 183, 191], ["hepatic", "ORGAN", 11, 18], ["cystic bile ducts", "MULTI-TISSUE_STRUCTURE", 33, 50], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 258, 268], ["Congenital hepatic fibrosis", "PROBLEM", 0, 27], ["cystic bile ducts", "PROBLEM", 33, 50], ["generalized portal bridging fibrosis", "PROBLEM", 155, 191], ["many small, irregularly formed and occasionally cystic bile ducts", "PROBLEM", 203, 268], ["hepatic", "ANATOMY", 11, 18], ["fibrosis", "OBSERVATION", 19, 27], ["cystic", "OBSERVATION", 33, 39], ["bile ducts", "ANATOMY", 40, 50], ["generalized", "OBSERVATION_MODIFIER", 155, 166], ["portal", "ANATOMY", 167, 173], ["bridging fibrosis", "OBSERVATION", 174, 191], ["many", "OBSERVATION_MODIFIER", 203, 207], ["small", "OBSERVATION_MODIFIER", 208, 213], ["irregularly", "OBSERVATION_MODIFIER", 215, 226], ["occasionally", "OBSERVATION_MODIFIER", 238, 250], ["cystic", "OBSERVATION", 251, 257], ["bile ducts", "ANATOMY", 258, 268]]], ["Macroscopic congenital dilation of the large and segmental bile ducts and diffuse cystic kidney disease, resembling Caroli disease, has been reported in dogs.Extrahepatic biliary anomaliesCats occasionally have divided or bipartite gallbladders.", [["segmental bile ducts", "ANATOMY", 49, 69], ["diffuse cystic kidney", "ANATOMY", 74, 95], ["Extrahepatic biliary", "ANATOMY", 158, 178], ["gallbladders", "ANATOMY", 232, 244], ["cystic kidney disease", "DISEASE", 82, 103], ["Caroli disease", "DISEASE", 116, 130], ["Extrahepatic biliary anomalies", "DISEASE", 158, 188], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 59, 69], ["kidney", "ORGAN", 89, 95], ["Caroli", "ORGAN", 116, 122], ["dogs", "ORGANISM", 153, 157], ["Extrahepatic biliary", "MULTI-TISSUE_STRUCTURE", 158, 178], ["gallbladders", "ORGAN", 232, 244], ["dogs", "SPECIES", 153, 157], ["Macroscopic congenital dilation of the large and segmental bile ducts", "PROBLEM", 0, 69], ["diffuse cystic kidney disease", "PROBLEM", 74, 103], ["Caroli disease", "PROBLEM", 116, 130], ["Extrahepatic biliary anomalies", "PROBLEM", 158, 188], ["congenital", "OBSERVATION_MODIFIER", 12, 22], ["dilation", "OBSERVATION", 23, 31], ["large", "OBSERVATION_MODIFIER", 39, 44], ["segmental", "ANATOMY_MODIFIER", 49, 58], ["bile ducts", "ANATOMY", 59, 69], ["diffuse", "OBSERVATION_MODIFIER", 74, 81], ["cystic", "OBSERVATION_MODIFIER", 82, 88], ["kidney", "ANATOMY", 89, 95], ["disease", "OBSERVATION", 96, 103], ["Caroli disease", "OBSERVATION", 116, 130], ["biliary", "ANATOMY", 171, 178], ["anomalies", "OBSERVATION", 179, 188], ["bipartite", "OBSERVATION", 222, 231], ["gallbladders", "ANATOMY", 232, 244]]], ["Reduplication of the gallbladder has also been reported in swine.", [["gallbladder", "ANATOMY", 21, 32], ["gallbladder", "ORGAN", 21, 32], ["swine", "ORGANISM", 59, 64], ["swine", "SPECIES", 59, 64], ["swine", "SPECIES", 59, 64], ["Reduplication of the gallbladder", "PROBLEM", 0, 32], ["gallbladder", "ANATOMY", 21, 32]]], ["Other anomalies of the extrahepatic biliary system include agenesis of the gallbladder reported in dogs, and absence orDuctal plate malformationsPersistence and/or aberrant remodeling of the embryonic ductal plate can give rise to a spectrum of cystic biliary diseases.", [["extrahepatic biliary system", "ANATOMY", 23, 50], ["gallbladder", "ANATOMY", 75, 86], ["embryonic ductal plate", "ANATOMY", 191, 213], ["cystic biliary", "ANATOMY", 245, 259], ["extrahepatic biliary system", "DISEASE", 23, 50], ["agenesis of the gallbladder", "DISEASE", 59, 86], ["absence orDuctal plate malformations", "DISEASE", 109, 145], ["cystic biliary diseases", "DISEASE", 245, 268], ["extrahepatic biliary", "MULTI-TISSUE_STRUCTURE", 23, 43], ["gallbladder", "ORGAN", 75, 86], ["dogs", "ORGANISM", 99, 103], ["cystic biliary", "PATHOLOGICAL_FORMATION", 245, 259], ["dogs", "SPECIES", 99, 103], ["Other anomalies of the extrahepatic biliary system", "PROBLEM", 0, 50], ["agenesis of the gallbladder", "PROBLEM", 59, 86], ["absence orDuctal plate malformations", "PROBLEM", 109, 145], ["aberrant remodeling of the embryonic ductal plate", "PROBLEM", 164, 213], ["cystic biliary diseases", "PROBLEM", 245, 268], ["anomalies", "OBSERVATION", 6, 15], ["extrahepatic", "ANATOMY_MODIFIER", 23, 35], ["biliary system", "ANATOMY", 36, 50], ["agenesis", "OBSERVATION", 59, 67], ["gallbladder", "ANATOMY", 75, 86], ["dogs", "OBSERVATION", 99, 103], ["orDuctal plate malformations", "OBSERVATION", 117, 145], ["aberrant", "OBSERVATION_MODIFIER", 164, 172], ["remodeling", "OBSERVATION", 173, 183], ["embryonic", "ANATOMY_MODIFIER", 191, 200], ["ductal plate", "ANATOMY", 201, 213], ["cystic", "OBSERVATION_MODIFIER", 245, 251], ["biliary", "ANATOMY", 252, 259], ["diseases", "OBSERVATION", 260, 268]]], ["Congenital hepatic fibrocystic diseases, part of the group of hepatorenal fibrocystic disease that includes the polycystic kidney diseases, are a product of ductal plate malformations occurring at different levels of the biliary tree.", [["hepatic fibrocystic", "ANATOMY", 11, 30], ["hepatorenal fibrocystic", "ANATOMY", 62, 85], ["kidney", "ANATOMY", 123, 129], ["ductal plate", "ANATOMY", 157, 169], ["biliary tree", "ANATOMY", 221, 233], ["Congenital hepatic fibrocystic diseases", "DISEASE", 0, 39], ["hepatorenal fibrocystic disease", "DISEASE", 62, 93], ["polycystic kidney diseases", "DISEASE", 112, 138], ["ductal plate malformations", "DISEASE", 157, 183], ["kidney", "ORGAN", 123, 129], ["ductal plate malformations", "PATHOLOGICAL_FORMATION", 157, 183], ["biliary tree", "MULTI-TISSUE_STRUCTURE", 221, 233], ["Congenital hepatic fibrocystic diseases", "PROBLEM", 0, 39], ["hepatorenal fibrocystic disease", "PROBLEM", 62, 93], ["the polycystic kidney diseases", "PROBLEM", 108, 138], ["ductal plate malformations", "PROBLEM", 157, 183], ["hepatic", "ANATOMY", 11, 18], ["fibrocystic", "OBSERVATION", 19, 30], ["hepatorenal", "ANATOMY", 62, 73], ["fibrocystic", "OBSERVATION", 74, 85], ["polycystic", "OBSERVATION_MODIFIER", 112, 122], ["kidney", "ANATOMY", 123, 129], ["diseases", "OBSERVATION", 130, 138], ["ductal", "ANATOMY_MODIFIER", 157, 163], ["plate malformations", "OBSERVATION", 164, 183], ["biliary", "ANATOMY", 221, 228], ["tree", "ANATOMY_MODIFIER", 229, 233]]], ["Analysis of the underlying genetic basis of the human hepatorenal fibrocystic diseases has identified defective protein components in primary cilia and associated basal bodies.", [["hepatorenal fibrocystic", "ANATOMY", 54, 77], ["primary cilia", "ANATOMY", 134, 147], ["basal bodies", "ANATOMY", 163, 175], ["hepatorenal fibrocystic diseases", "DISEASE", 54, 86], ["human", "ORGANISM", 48, 53], ["hepatorenal fibrocystic", "PATHOLOGICAL_FORMATION", 54, 77], ["cilia", "CELLULAR_COMPONENT", 142, 147], ["basal bodies", "CELLULAR_COMPONENT", 163, 175], ["protein components", "PROTEIN", 112, 130], ["primary cilia", "CELL_TYPE", 134, 147], ["human", "SPECIES", 48, 53], ["human", "SPECIES", 48, 53], ["Analysis", "TEST", 0, 8], ["the human hepatorenal fibrocystic diseases", "PROBLEM", 44, 86], ["defective protein components in primary cilia and associated basal bodies", "PROBLEM", 102, 175], ["hepatorenal", "ANATOMY", 54, 65], ["fibrocystic", "OBSERVATION", 66, 77], ["defective", "OBSERVATION_MODIFIER", 102, 111], ["protein components", "OBSERVATION", 112, 130], ["primary cilia", "OBSERVATION", 134, 147], ["basal", "ANATOMY_MODIFIER", 163, 168], ["bodies", "ANATOMY_MODIFIER", 169, 175]]], ["These mechanotransducer organelles are involved in environmental monitoring, signal transduction, and cell proliferation, and are important in the normal development of the biliary system in the liver, as well as renal tubules.", [["mechanotransducer organelles", "ANATOMY", 6, 34], ["cell", "ANATOMY", 102, 106], ["biliary system", "ANATOMY", 173, 187], ["liver", "ANATOMY", 195, 200], ["renal tubules", "ANATOMY", 213, 226], ["mechanotransducer organelles", "CELLULAR_COMPONENT", 6, 34], ["cell", "CELL", 102, 106], ["biliary system", "ANATOMICAL_SYSTEM", 173, 187], ["liver", "ORGAN", 195, 200], ["renal tubules", "MULTI-TISSUE_STRUCTURE", 213, 226], ["environmental monitoring", "TEST", 51, 75], ["signal transduction", "TEST", 77, 96], ["cell proliferation", "PROBLEM", 102, 120], ["cell proliferation", "OBSERVATION", 102, 120], ["normal", "OBSERVATION", 147, 153], ["biliary system", "ANATOMY", 173, 187], ["liver", "ANATOMY", 195, 200], ["renal", "ANATOMY", 213, 218], ["tubules", "ANATOMY_MODIFIER", 219, 226]]], ["As such, many of these diseases are now considered \"ciliopathies.\"Ductal plate malformationsIn human hepatopathology, the hepatorenal fibrocystic diseases can be grouped into 3 descriptive categories: (1) polycystic liver disease (often seen in association with autosomal dominant polycystic kidney disease of adults), characterized by isolated microscopic to macroscopic unilocular or multilocular cysts in a fibrous stroma, with no continuity with the intrahepatic biliary tree, thought to originate from von Meyenburg complexes in the most peripheral branches of the biliary tree; (2) congenital hepatic fibrosis (often seen in association with autosomal recessive polycystic kidney disease of childhood), characterized by defective remodeling of the ductal plate at the level of interlobular ducts, with excess abnormally shaped embryonic bile ducts retained in the primitive ductal plate configuration, abnormal portal veins, and progressive fibrosis of the portal tracts; and (3) Caroli disease, characterized by non-obstructive saccular or fusiform dilation of medium-and large-sized intrahepatic bile ducts, with maintenance of continuity with the biliary system.", [["Ductal plate malformations", "ANATOMY", 66, 92], ["hepatorenal fibrocystic", "ANATOMY", 122, 145], ["liver", "ANATOMY", 216, 221], ["kidney", "ANATOMY", 292, 298], ["multilocular cysts", "ANATOMY", 386, 404], ["fibrous stroma", "ANATOMY", 410, 424], ["intrahepatic biliary tree", "ANATOMY", 454, 479], ["peripheral branches", "ANATOMY", 543, 562], ["biliary tree", "ANATOMY", 570, 582], ["hepatic", "ANATOMY", 599, 606], ["kidney", "ANATOMY", 679, 685], ["ductal plate", "ANATOMY", 754, 766], ["interlobular ducts", "ANATOMY", 783, 801], ["embryonic bile ducts", "ANATOMY", 833, 853], ["ductal plate", "ANATOMY", 880, 892], ["portal veins", "ANATOMY", 917, 929], ["portal tracts", "ANATOMY", 963, 976], ["saccular", "ANATOMY", 1035, 1043], ["intrahepatic bile ducts", "ANATOMY", 1091, 1114], ["biliary system", "ANATOMY", 1156, 1170], ["ciliopathies", "DISEASE", 52, 64], ["Ductal plate malformations", "DISEASE", 66, 92], ["hepatorenal fibrocystic diseases", "DISEASE", 122, 154], ["polycystic liver disease", "DISEASE", 205, 229], ["autosomal dominant polycystic kidney disease", "DISEASE", 262, 306], ["cysts", "DISEASE", 399, 404], ["congenital hepatic fibrosis", "DISEASE", 588, 615], ["autosomal recessive polycystic kidney disease", "DISEASE", 648, 693], ["abnormal portal veins", "DISEASE", 908, 929], ["fibrosis of the portal tracts", "DISEASE", 947, 976], ["Caroli disease", "DISEASE", 986, 1000], ["ciliopathies", "CANCER", 52, 64], ["Ductal plate malformations", "PATHOLOGICAL_FORMATION", 66, 92], ["human", "ORGANISM", 95, 100], ["liver", "ORGAN", 216, 221], ["kidney", "ORGAN", 292, 298], ["multilocular cysts", "PATHOLOGICAL_FORMATION", 386, 404], ["fibrous stroma", "TISSUE", 410, 424], ["intrahepatic biliary tree", "MULTI-TISSUE_STRUCTURE", 454, 479], ["von Meyenburg complexes", "GENE_OR_GENE_PRODUCT", 507, 530], ["peripheral branches", "MULTI-TISSUE_STRUCTURE", 543, 562], ["biliary tree", "MULTI-TISSUE_STRUCTURE", 570, 582], ["hepatic", "ORGAN", 599, 606], ["kidney", "ORGAN", 679, 685], ["ductal plate", "TISSUE", 754, 766], ["interlobular ducts", "MULTI-TISSUE_STRUCTURE", 783, 801], ["embryonic bile ducts", "MULTI-TISSUE_STRUCTURE", 833, 853], ["portal veins", "MULTI-TISSUE_STRUCTURE", 917, 929], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 963, 976], ["Caroli", "ORGAN", 986, 992], ["intrahepatic bile ducts", "MULTI-TISSUE_STRUCTURE", 1091, 1114], ["biliary system", "MULTI-TISSUE_STRUCTURE", 1156, 1170], ["von Meyenburg complexes", "PROTEIN", 507, 530], ["human", "SPECIES", 95, 100], ["human", "SPECIES", 95, 100], ["these diseases", "PROBLEM", 17, 31], ["ciliopathies", "PROBLEM", 52, 64], ["Ductal plate malformations", "PROBLEM", 66, 92], ["the hepatorenal fibrocystic diseases", "PROBLEM", 118, 154], ["polycystic liver disease", "PROBLEM", 205, 229], ["autosomal dominant polycystic kidney disease", "PROBLEM", 262, 306], ["isolated microscopic to macroscopic unilocular or multilocular cysts", "PROBLEM", 336, 404], ["a fibrous stroma", "PROBLEM", 408, 424], ["continuity with the intrahepatic biliary tree", "PROBLEM", 434, 479], ["congenital hepatic fibrosis", "PROBLEM", 588, 615], ["autosomal recessive polycystic kidney disease", "PROBLEM", 648, 693], ["defective remodeling of the ductal plate", "PROBLEM", 726, 766], ["excess abnormally shaped embryonic bile ducts", "PROBLEM", 808, 853], ["abnormal portal veins", "PROBLEM", 908, 929], ["progressive fibrosis of the portal tracts", "PROBLEM", 935, 976], ["(3) Caroli disease", "PROBLEM", 982, 1000], ["non-obstructive saccular or fusiform dilation of medium-and large-sized intrahepatic bile ducts", "PROBLEM", 1019, 1114], ["diseases", "OBSERVATION", 23, 31], ["plate malformations", "OBSERVATION", 73, 92], ["hepatorenal", "ANATOMY", 122, 133], ["fibrocystic", "OBSERVATION", 134, 145], ["polycystic", "OBSERVATION_MODIFIER", 205, 215], ["liver", "ANATOMY", 216, 221], ["disease", "OBSERVATION", 222, 229], ["dominant", "OBSERVATION_MODIFIER", 272, 280], ["polycystic", "OBSERVATION", 281, 291], ["kidney", "ANATOMY", 292, 298], ["disease", "OBSERVATION", 299, 306], ["macroscopic", "OBSERVATION_MODIFIER", 360, 371], ["unilocular", "OBSERVATION_MODIFIER", 372, 382], ["multilocular", "OBSERVATION_MODIFIER", 386, 398], ["cysts", "OBSERVATION", 399, 404], ["fibrous stroma", "OBSERVATION", 410, 424], ["no", "UNCERTAINTY", 431, 433], ["intrahepatic", "ANATOMY_MODIFIER", 454, 466], ["biliary tree", "ANATOMY", 467, 479], ["von", "OBSERVATION", 507, 510], ["most", "ANATOMY_MODIFIER", 538, 542], ["peripheral", "ANATOMY_MODIFIER", 543, 553], ["branches", "ANATOMY_MODIFIER", 554, 562], ["biliary tree", "ANATOMY", 570, 582], ["congenital", "OBSERVATION_MODIFIER", 588, 598], ["hepatic", "ANATOMY", 599, 606], ["fibrosis", "OBSERVATION", 607, 615], ["autosomal", "OBSERVATION_MODIFIER", 648, 657], ["recessive", "OBSERVATION_MODIFIER", 658, 667], ["polycystic", "OBSERVATION_MODIFIER", 668, 678], ["kidney", "ANATOMY", 679, 685], ["disease", "OBSERVATION", 686, 693], ["defective", "OBSERVATION_MODIFIER", 726, 735], ["remodeling", "OBSERVATION", 736, 746], ["ductal", "ANATOMY_MODIFIER", 754, 760], ["plate", "ANATOMY_MODIFIER", 761, 766], ["interlobular", "ANATOMY_MODIFIER", 783, 795], ["ducts", "ANATOMY", 796, 801], ["excess", "OBSERVATION_MODIFIER", 808, 814], ["abnormally", "OBSERVATION_MODIFIER", 815, 825], ["shaped", "OBSERVATION_MODIFIER", 826, 832], ["embryonic", "OBSERVATION", 833, 842], ["bile ducts", "ANATOMY", 843, 853], ["primitive", "ANATOMY_MODIFIER", 870, 879], ["ductal", "ANATOMY_MODIFIER", 880, 886], ["plate configuration", "OBSERVATION", 887, 906], ["abnormal", "OBSERVATION_MODIFIER", 908, 916], ["portal veins", "ANATOMY", 917, 929], ["progressive", "OBSERVATION_MODIFIER", 935, 946], ["fibrosis", "OBSERVATION", 947, 955], ["portal tracts", "ANATOMY", 963, 976], ["Caroli disease", "OBSERVATION", 986, 1000], ["non-obstructive", "OBSERVATION_MODIFIER", 1019, 1034], ["saccular", "OBSERVATION_MODIFIER", 1035, 1043], ["fusiform", "OBSERVATION_MODIFIER", 1047, 1055], ["dilation", "OBSERVATION", 1056, 1064], ["medium", "OBSERVATION_MODIFIER", 1068, 1074], ["large", "OBSERVATION_MODIFIER", 1079, 1084], ["sized", "ANATOMY_MODIFIER", 1085, 1090], ["intrahepatic", "ANATOMY_MODIFIER", 1091, 1103], ["bile ducts", "ANATOMY", 1104, 1114], ["biliary system", "ANATOMY", 1156, 1170]]], ["Caroli syndrome refers to Caroli disease co-occurring with congenital hepatic fibrosis.", [["hepatic", "ANATOMY", 70, 77], ["Caroli syndrome", "DISEASE", 0, 15], ["Caroli disease", "DISEASE", 26, 40], ["congenital hepatic fibrosis", "DISEASE", 59, 86], ["Caroli", "ORGAN", 0, 6], ["Caroli", "ORGAN", 26, 32], ["hepatic", "ORGAN", 70, 77], ["Caroli syndrome", "PROBLEM", 0, 15], ["Caroli disease", "PROBLEM", 26, 40], ["congenital hepatic fibrosis", "PROBLEM", 59, 86], ["syndrome", "OBSERVATION", 7, 15], ["Caroli", "ANATOMY", 26, 32], ["congenital", "OBSERVATION_MODIFIER", 59, 69], ["hepatic", "ANATOMY", 70, 77], ["fibrosis", "OBSERVATION", 78, 86]]], ["In veterinary medicine, a similar classification of the liver lesions has been proposed: adult polycystic disease (including von Meyenburg complexes), juvenile polycystic disease/congenital hepatic fibrosis, and congenital dilation of the large and segmental bile ducts (resembling Caroli disease).Ductal plate malformationsCongenital cystic lesions involving the hepatic biliary system and kidneys have been reported in juvenile dogs, cats, pigs, goats, and foals, and have been compared to congenital can arise with other congenital abnormalities, such as arteriovenous malformations or hypoplasia or dysplasia of portal veins, as a consequence of portal hypertension.", [["liver lesions", "ANATOMY", 56, 69], ["polycystic", "ANATOMY", 95, 105], ["polycystic", "ANATOMY", 160, 170], ["hepatic", "ANATOMY", 190, 197], ["segmental bile ducts", "ANATOMY", 249, 269], ["Ductal plate malformations", "ANATOMY", 298, 324], ["cystic lesions", "ANATOMY", 335, 349], ["hepatic biliary system", "ANATOMY", 364, 386], ["kidneys", "ANATOMY", 391, 398], ["arteriovenous", "ANATOMY", 558, 571], ["portal veins", "ANATOMY", 616, 628], ["portal", "ANATOMY", 650, 656], ["liver lesions", "DISEASE", 56, 69], ["adult polycystic disease", "DISEASE", 89, 113], ["juvenile polycystic disease", "DISEASE", 151, 178], ["congenital hepatic fibrosis", "DISEASE", 179, 206], ["congenital dilation of the large and segmental bile ducts", "DISEASE", 212, 269], ["Caroli disease", "DISEASE", 282, 296], ["Ductal plate malformations", "DISEASE", 298, 324], ["Congenital cystic lesions involving the hepatic biliary system", "DISEASE", 324, 386], ["congenital abnormalities", "DISEASE", 524, 548], ["arteriovenous malformations", "DISEASE", 558, 585], ["hypoplasia", "DISEASE", 589, 599], ["dysplasia of portal veins", "DISEASE", 603, 628], ["portal hypertension", "DISEASE", 650, 669], ["liver lesions", "CANCER", 56, 69], ["polycystic", "ORGAN", 95, 105], ["polycystic", "ORGAN", 160, 170], ["hepatic", "ORGAN", 190, 197], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 259, 269], ["Caroli", "ORGAN", 282, 288], ["Ductal plate malformations", "PATHOLOGICAL_FORMATION", 298, 324], ["cystic lesions", "PATHOLOGICAL_FORMATION", 335, 349], ["hepatic biliary", "MULTI-TISSUE_STRUCTURE", 364, 379], ["kidneys", "ORGAN", 391, 398], ["dogs", "ORGANISM", 430, 434], ["cats", "ORGANISM", 436, 440], ["pigs", "ORGANISM", 442, 446], ["goats", "ORGANISM", 448, 453], ["foals", "ORGANISM", 459, 464], ["arteriovenous malformations", "PATHOLOGICAL_FORMATION", 558, 585], ["portal veins", "MULTI-TISSUE_STRUCTURE", 616, 628], ["portal", "MULTI-TISSUE_STRUCTURE", 650, 656], ["dogs", "SPECIES", 430, 434], ["cats", "SPECIES", 436, 440], ["pigs", "SPECIES", 442, 446], ["goats", "SPECIES", 448, 453], ["foals", "SPECIES", 459, 464], ["pigs", "SPECIES", 442, 446], ["goats", "SPECIES", 448, 453], ["the liver lesions", "PROBLEM", 52, 69], ["adult polycystic disease", "PROBLEM", 89, 113], ["von Meyenburg complexes", "PROBLEM", 125, 148], ["juvenile polycystic disease", "PROBLEM", 151, 178], ["congenital hepatic fibrosis", "PROBLEM", 179, 206], ["congenital dilation of the large and segmental bile ducts", "PROBLEM", 212, 269], ["Caroli disease)", "PROBLEM", 282, 297], ["Ductal plate malformations", "PROBLEM", 298, 324], ["Congenital cystic lesions involving the hepatic biliary system and kidneys", "PROBLEM", 324, 398], ["other congenital abnormalities", "PROBLEM", 518, 548], ["arteriovenous malformations", "PROBLEM", 558, 585], ["hypoplasia", "PROBLEM", 589, 599], ["dysplasia of portal veins", "PROBLEM", 603, 628], ["portal hypertension", "PROBLEM", 650, 669], ["liver", "ANATOMY", 56, 61], ["lesions", "OBSERVATION", 62, 69], ["adult", "OBSERVATION_MODIFIER", 89, 94], ["polycystic", "OBSERVATION_MODIFIER", 95, 105], ["disease", "OBSERVATION", 106, 113], ["juvenile", "OBSERVATION_MODIFIER", 151, 159], ["polycystic disease", "OBSERVATION", 160, 178], ["congenital", "OBSERVATION_MODIFIER", 179, 189], ["hepatic", "ANATOMY", 190, 197], ["fibrosis", "OBSERVATION", 198, 206], ["congenital", "OBSERVATION_MODIFIER", 212, 222], ["dilation", "OBSERVATION", 223, 231], ["large", "OBSERVATION_MODIFIER", 239, 244], ["segmental", "ANATOMY_MODIFIER", 249, 258], ["bile ducts", "ANATOMY", 259, 269], ["Caroli disease", "OBSERVATION", 282, 296], ["plate malformations", "OBSERVATION", 305, 324], ["cystic", "OBSERVATION_MODIFIER", 335, 341], ["lesions", "OBSERVATION", 342, 349], ["hepatic", "ANATOMY", 364, 371], ["biliary system", "ANATOMY", 372, 386], ["kidneys", "ANATOMY", 391, 398], ["juvenile", "OBSERVATION_MODIFIER", 421, 429], ["dogs", "OBSERVATION", 430, 434], ["congenital", "OBSERVATION_MODIFIER", 524, 534], ["abnormalities", "OBSERVATION", 535, 548], ["arteriovenous", "ANATOMY", 558, 571], ["malformations", "OBSERVATION", 572, 585], ["hypoplasia", "OBSERVATION", 589, 599], ["dysplasia", "OBSERVATION", 603, 612], ["portal veins", "ANATOMY", 616, 628], ["portal", "ANATOMY", 650, 656], ["hypertension", "OBSERVATION", 657, 669]]], ["Acquired shunts resulting from portal hypertension secondary to liver injury and repair are discussed later in the section Vascular factors in hepatic injury and circulatory disorders.", [["portal", "ANATOMY", 31, 37], ["liver", "ANATOMY", 64, 69], ["Vascular", "ANATOMY", 123, 131], ["hepatic", "ANATOMY", 143, 150], ["circulatory", "ANATOMY", 162, 173], ["portal hypertension", "DISEASE", 31, 50], ["liver injury", "DISEASE", 64, 76], ["hepatic injury", "DISEASE", 143, 157], ["circulatory disorders", "DISEASE", 162, 183], ["portal", "MULTI-TISSUE_STRUCTURE", 31, 37], ["liver", "ORGAN", 64, 69], ["Vascular", "MULTI-TISSUE_STRUCTURE", 123, 131], ["hepatic", "MULTI-TISSUE_STRUCTURE", 143, 150], ["Vascular factors", "PROTEIN", 123, 139], ["Acquired shunts", "PROBLEM", 0, 15], ["portal hypertension", "PROBLEM", 31, 50], ["liver injury", "PROBLEM", 64, 76], ["repair", "TREATMENT", 81, 87], ["hepatic injury", "PROBLEM", 143, 157], ["circulatory disorders", "PROBLEM", 162, 183], ["shunts", "OBSERVATION", 9, 15], ["portal", "ANATOMY", 31, 37], ["hypertension", "OBSERVATION", 38, 50], ["liver", "ANATOMY", 64, 69], ["injury", "OBSERVATION", 70, 76], ["repair", "OBSERVATION", 81, 87], ["hepatic", "ANATOMY", 143, 150], ["injury", "OBSERVATION", 151, 157], ["circulatory disorders", "OBSERVATION", 162, 183]]], ["Portal vein aneurysms, both congenital and acquired as a consequence of concurrent liver disease, have been described in dogs.", [["Portal vein aneurysms", "ANATOMY", 0, 21], ["liver", "ANATOMY", 83, 88], ["Portal vein aneurysms", "DISEASE", 0, 21], ["liver disease", "DISEASE", 83, 96], ["Portal vein", "MULTI-TISSUE_STRUCTURE", 0, 11], ["liver", "ORGAN", 83, 88], ["dogs", "ORGANISM", 121, 125], ["dogs", "SPECIES", 121, 125], ["Portal vein aneurysms", "PROBLEM", 0, 21], ["congenital", "PROBLEM", 28, 38], ["concurrent liver disease", "PROBLEM", 72, 96], ["vein", "ANATOMY", 7, 11], ["aneurysms", "OBSERVATION", 12, 21], ["congenital", "OBSERVATION", 28, 38], ["liver", "ANATOMY", 83, 88], ["disease", "OBSERVATION", 89, 96]]], ["Extrahepatic aneurysms were always located at the level of the gastroduodenal vein insertion.", [["Extrahepatic aneurysms", "ANATOMY", 0, 22], ["gastroduodenal vein", "ANATOMY", 63, 82], ["Extrahepatic aneurysms", "DISEASE", 0, 22], ["Extrahepatic aneurysms", "PATHOLOGICAL_FORMATION", 0, 22], ["gastroduodenal vein", "MULTI-TISSUE_STRUCTURE", 63, 82], ["Extrahepatic aneurysms", "PROBLEM", 0, 22], ["aneurysms", "OBSERVATION", 13, 22], ["gastroduodenal vein", "ANATOMY", 63, 82]]], ["All were asymptomatic, although predisposed to portal vein thrombosis.Ductal plate malformationsHepatic arteriovenous malformations have been reported in dogs and cats.", [["portal vein", "ANATOMY", 47, 58], ["Ductal plate malformations", "ANATOMY", 70, 96], ["Hepatic arteriovenous", "ANATOMY", 96, 117], ["portal vein thrombosis", "DISEASE", 47, 69], ["Ductal plate malformations", "DISEASE", 70, 96], ["Hepatic arteriovenous malformations", "DISEASE", 96, 131], ["portal vein", "MULTI-TISSUE_STRUCTURE", 47, 58], ["Ductal plate malformations", "PATHOLOGICAL_FORMATION", 70, 96], ["Hepatic arteriovenous malformations", "PATHOLOGICAL_FORMATION", 96, 131], ["dogs", "ORGANISM", 154, 158], ["cats", "ORGANISM", 163, 167], ["dogs", "SPECIES", 154, 158], ["cats", "SPECIES", 163, 167], ["asymptomatic", "PROBLEM", 9, 21], ["portal vein thrombosis", "PROBLEM", 47, 69], ["Ductal plate malformations", "PROBLEM", 70, 96], ["Hepatic arteriovenous malformations", "PROBLEM", 96, 131], ["asymptomatic", "OBSERVATION", 9, 21], ["portal vein", "ANATOMY", 47, 58], ["thrombosis", "OBSERVATION", 59, 69], ["plate malformations", "OBSERVATION", 77, 96], ["arteriovenous", "ANATOMY", 104, 117], ["malformations", "OBSERVATION", 118, 131]]], ["These are congenital or, in some instances, acquired communications between branches of the hepatic artery, and more rarely, the gastroduodenal artery and left gastric artery and portal vein.", [["hepatic artery", "ANATOMY", 92, 106], ["gastroduodenal artery", "ANATOMY", 129, 150], ["left gastric artery", "ANATOMY", 155, 174], ["portal vein", "ANATOMY", 179, 190], ["hepatic artery", "MULTI-TISSUE_STRUCTURE", 92, 106], ["gastroduodenal artery", "MULTI-TISSUE_STRUCTURE", 129, 150], ["gastric artery", "MULTI-TISSUE_STRUCTURE", 160, 174], ["portal vein", "MULTI-TISSUE_STRUCTURE", 179, 190], ["congenital", "PROBLEM", 10, 20], ["congenital", "OBSERVATION", 10, 20], ["branches", "ANATOMY_MODIFIER", 76, 84], ["hepatic artery", "ANATOMY", 92, 106], ["gastroduodenal artery", "ANATOMY", 129, 150], ["left gastric artery", "ANATOMY", 155, 174], ["portal vein", "ANATOMY", 179, 190]]], ["Mixing of higher-pressure arterial blood with venous blood results in retrograde flow into the portal vein, arterialization of the portal circulation, and development of portal hypertension, with the opening of vestigial, low-resistance, collateral, extrahepatic portosystemic communications (acquired extrahepatic shunts).", [["arterial blood", "ANATOMY", 26, 40], ["venous blood", "ANATOMY", 46, 58], ["portal vein", "ANATOMY", 95, 106], ["portal", "ANATOMY", 131, 137], ["portal", "ANATOMY", 170, 176], ["collateral", "ANATOMY", 238, 248], ["extrahepatic portosystemic", "ANATOMY", 250, 276], ["extrahepatic", "ANATOMY", 302, 314], ["portal hypertension", "DISEASE", 170, 189], ["extrahepatic shunts", "DISEASE", 302, 321], ["arterial", "MULTI-TISSUE_STRUCTURE", 26, 34], ["blood", "ORGANISM_SUBSTANCE", 35, 40], ["venous", "ORGANISM_SUBSTANCE", 46, 52], ["blood", "ORGANISM_SUBSTANCE", 53, 58], ["portal vein", "MULTI-TISSUE_STRUCTURE", 95, 106], ["portal", "MULTI-TISSUE_STRUCTURE", 131, 137], ["portal", "MULTI-TISSUE_STRUCTURE", 170, 176], ["collateral", "MULTI-TISSUE_STRUCTURE", 238, 248], ["extrahepatic portosystemic", "MULTI-TISSUE_STRUCTURE", 250, 276], ["extrahepatic shunts", "MULTI-TISSUE_STRUCTURE", 302, 321], ["venous blood", "TEST", 46, 58], ["portal hypertension", "PROBLEM", 170, 189], ["acquired extrahepatic shunts", "TREATMENT", 293, 321], ["higher", "OBSERVATION_MODIFIER", 10, 16], ["pressure", "OBSERVATION_MODIFIER", 17, 25], ["arterial", "ANATOMY_MODIFIER", 26, 34], ["venous", "ANATOMY", 46, 52], ["retrograde flow", "OBSERVATION", 70, 85], ["portal vein", "ANATOMY", 95, 106], ["arterialization", "OBSERVATION", 108, 123], ["portal circulation", "ANATOMY", 131, 149], ["portal", "ANATOMY", 170, 176], ["hypertension", "OBSERVATION", 177, 189], ["vestigial", "OBSERVATION_MODIFIER", 211, 220], ["low", "OBSERVATION_MODIFIER", 222, 225], ["resistance", "OBSERVATION_MODIFIER", 226, 236], ["collateral", "OBSERVATION_MODIFIER", 238, 248], ["extrahepatic", "ANATOMY_MODIFIER", 250, 262], ["portosystemic communications", "OBSERVATION", 263, 291], ["extrahepatic shunts", "OBSERVATION", 302, 321]]], ["The fistulae may be macroscopic or microscopic, are typically multiple, and may involve one or more lobes of the liver.", [["fistulae", "ANATOMY", 4, 12], ["lobes", "ANATOMY", 100, 105], ["liver", "ANATOMY", 113, 118], ["fistulae", "DISEASE", 4, 12], ["fistulae", "PATHOLOGICAL_FORMATION", 4, 12], ["liver", "ORGAN", 113, 118], ["The fistulae", "PROBLEM", 0, 12], ["macroscopic or microscopic", "PROBLEM", 20, 46], ["fistulae", "OBSERVATION", 4, 12], ["may be", "UNCERTAINTY", 13, 19], ["macroscopic", "OBSERVATION", 20, 31], ["microscopic", "OBSERVATION", 35, 46], ["multiple", "OBSERVATION_MODIFIER", 62, 70], ["more lobes", "ANATOMY_MODIFIER", 95, 105], ["liver", "ANATOMY", 113, 118]]], ["The hepatic parenchyma of affected lobes may be atrophied, with dilated, tortuous, pulsatile vessels visible on the capsular surface.", [["hepatic parenchyma", "ANATOMY", 4, 22], ["lobes", "ANATOMY", 35, 40], ["vessels", "ANATOMY", 93, 100], ["capsular surface", "ANATOMY", 116, 132], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 4, 22], ["lobes", "ORGAN", 35, 40], ["vessels", "MULTI-TISSUE_STRUCTURE", 93, 100], ["capsular surface", "CELLULAR_COMPONENT", 116, 132], ["atrophied", "PROBLEM", 48, 57], ["dilated, tortuous, pulsatile vessels", "PROBLEM", 64, 100], ["hepatic", "ANATOMY", 4, 11], ["parenchyma", "ANATOMY_MODIFIER", 12, 22], ["affected lobes", "ANATOMY", 26, 40], ["may be", "UNCERTAINTY", 41, 47], ["atrophied", "OBSERVATION", 48, 57], ["dilated", "OBSERVATION", 64, 71], ["tortuous", "OBSERVATION_MODIFIER", 73, 81], ["pulsatile vessels", "OBSERVATION", 83, 100], ["visible", "OBSERVATION_MODIFIER", 101, 108], ["capsular", "OBSERVATION_MODIFIER", 116, 124], ["surface", "OBSERVATION_MODIFIER", 125, 132]]], ["Histopathologic findings include hyperplasia and anastomoses of arterioles and venules ( Fig. 2-10 ).", [["arterioles", "ANATOMY", 64, 74], ["venules", "ANATOMY", 79, 86], ["hyperplasia", "DISEASE", 33, 44], ["arterioles", "MULTI-TISSUE_STRUCTURE", 64, 74], ["venules", "MULTI-TISSUE_STRUCTURE", 79, 86], ["Histopathologic findings", "TEST", 0, 24], ["hyperplasia", "PROBLEM", 33, 44], ["anastomoses of arterioles", "PROBLEM", 49, 74], ["hyperplasia", "OBSERVATION", 33, 44], ["anastomoses", "OBSERVATION", 49, 60], ["arterioles", "ANATOMY_MODIFIER", 64, 74], ["venules", "ANATOMY", 79, 86]]], ["Affected vessels have irregularly thickened walls with intimal hyperplasia consisting of smooth muscle proliferation and deposition of elastin fibers, focal subintimal fibromuscular proliferation, and smooth muscle hyperplasia of the tunica media.", [["vessels", "ANATOMY", 9, 16], ["walls", "ANATOMY", 44, 49], ["intimal hyperplasia", "ANATOMY", 55, 74], ["smooth muscle", "ANATOMY", 89, 102], ["elastin fibers", "ANATOMY", 135, 149], ["subintimal fibromuscular", "ANATOMY", 157, 181], ["smooth muscle", "ANATOMY", 201, 214], ["hyperplasia", "DISEASE", 63, 74], ["vessels", "MULTI-TISSUE_STRUCTURE", 9, 16], ["walls", "PATHOLOGICAL_FORMATION", 44, 49], ["intimal", "TISSUE", 55, 62], ["smooth muscle", "TISSUE", 89, 102], ["elastin fibers", "CELLULAR_COMPONENT", 135, 149], ["fibromuscular", "TISSUE", 168, 181], ["smooth muscle", "TISSUE", 201, 214], ["tunica", "TISSUE", 234, 240], ["Affected vessels", "PROBLEM", 0, 16], ["irregularly thickened walls", "PROBLEM", 22, 49], ["intimal hyperplasia", "PROBLEM", 55, 74], ["smooth muscle proliferation", "PROBLEM", 89, 116], ["deposition of elastin fibers", "PROBLEM", 121, 149], ["focal subintimal fibromuscular proliferation", "PROBLEM", 151, 195], ["smooth muscle hyperplasia of the tunica media", "PROBLEM", 201, 246], ["vessels", "ANATOMY", 9, 16], ["irregularly", "OBSERVATION_MODIFIER", 22, 33], ["thickened", "OBSERVATION", 34, 43], ["walls", "ANATOMY_MODIFIER", 44, 49], ["intimal", "ANATOMY", 55, 62], ["hyperplasia", "OBSERVATION", 63, 74], ["smooth muscle proliferation", "OBSERVATION", 89, 116], ["deposition", "OBSERVATION_MODIFIER", 121, 131], ["elastin fibers", "OBSERVATION", 135, 149], ["focal", "OBSERVATION_MODIFIER", 151, 156], ["subintimal", "OBSERVATION_MODIFIER", 157, 167], ["fibromuscular proliferation", "OBSERVATION", 168, 195], ["smooth", "OBSERVATION_MODIFIER", 201, 207], ["muscle", "ANATOMY", 208, 214], ["hyperplasia", "OBSERVATION", 215, 226], ["tunica media", "ANATOMY", 234, 246]]], ["Degenerative changes characterized by deposition of mucinous material and mineral in the intima and media of arterioles, as well as thrombosis and recanalization of portal veins, are also observed.", [["mucinous material", "ANATOMY", 52, 69], ["intima", "ANATOMY", 89, 95], ["arterioles", "ANATOMY", 109, 119], ["portal veins", "ANATOMY", 165, 177], ["thrombosis", "DISEASE", 132, 142], ["recanalization of portal veins", "DISEASE", 147, 177], ["mucinous material", "TISSUE", 52, 69], ["mineral", "TISSUE", 74, 81], ["intima", "TISSUE", 89, 95], ["arterioles", "MULTI-TISSUE_STRUCTURE", 109, 119], ["portal veins", "MULTI-TISSUE_STRUCTURE", 165, 177], ["Degenerative changes", "PROBLEM", 0, 20], ["deposition of mucinous material", "PROBLEM", 38, 69], ["thrombosis", "PROBLEM", 132, 142], ["recanalization of portal veins", "PROBLEM", 147, 177], ["deposition", "OBSERVATION_MODIFIER", 38, 48], ["mucinous material", "OBSERVATION", 52, 69], ["mineral", "OBSERVATION_MODIFIER", 74, 81], ["intima", "ANATOMY", 89, 95], ["media", "ANATOMY_MODIFIER", 100, 105], ["arterioles", "ANATOMY", 109, 119], ["thrombosis", "OBSERVATION", 132, 142], ["recanalization", "OBSERVATION", 147, 161], ["portal veins", "ANATOMY", 165, 177]]], ["Adjacent hepatic parenchyma may be atrophic, with periportal fibrosis, and bile duct hyperplasia, arteriolar proliferation, and relative collapse of portal vein branches within portal tracts.", [["hepatic parenchyma", "ANATOMY", 9, 27], ["periportal", "ANATOMY", 50, 60], ["bile duct", "ANATOMY", 75, 84], ["arteriolar", "ANATOMY", 98, 108], ["portal vein", "ANATOMY", 149, 160], ["portal tracts", "ANATOMY", 177, 190], ["fibrosis", "DISEASE", 61, 69], ["bile duct hyperplasia", "DISEASE", 75, 96], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 9, 27], ["bile duct", "MULTI-TISSUE_STRUCTURE", 75, 84], ["arteriolar", "MULTI-TISSUE_STRUCTURE", 98, 108], ["portal vein branches", "MULTI-TISSUE_STRUCTURE", 149, 169], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 177, 190], ["atrophic", "PROBLEM", 35, 43], ["periportal fibrosis", "PROBLEM", 50, 69], ["bile duct hyperplasia", "PROBLEM", 75, 96], ["arteriolar proliferation", "PROBLEM", 98, 122], ["relative collapse of portal vein branches within portal tracts", "PROBLEM", 128, 190], ["hepatic", "ANATOMY", 9, 16], ["parenchyma", "ANATOMY_MODIFIER", 17, 27], ["may be", "UNCERTAINTY", 28, 34], ["atrophic", "OBSERVATION", 35, 43], ["periportal", "ANATOMY_MODIFIER", 50, 60], ["fibrosis", "OBSERVATION", 61, 69], ["bile duct", "ANATOMY", 75, 84], ["hyperplasia", "OBSERVATION", 85, 96], ["arteriolar proliferation", "OBSERVATION", 98, 122], ["collapse", "OBSERVATION", 137, 145], ["portal vein", "ANATOMY", 149, 160], ["branches", "ANATOMY_MODIFIER", 161, 169], ["portal tracts", "ANATOMY", 177, 190]]], ["Arteriovenous fistulae may also be acquired, developing subsequent to abdominal trauma, rupture of hepatic artery aneurysms, and secondary to hepatic vein obstruction or cirrhosis with extreme portal hypertension. atresia of one or more ducts, reported in lambs, calves (eFig.", [["Arteriovenous fistulae", "ANATOMY", 0, 22], ["abdominal", "ANATOMY", 70, 79], ["hepatic artery", "ANATOMY", 99, 113], ["hepatic vein", "ANATOMY", 142, 154], ["portal", "ANATOMY", 193, 199], ["ducts", "ANATOMY", 237, 242], ["Arteriovenous fistulae", "DISEASE", 0, 22], ["abdominal trauma", "DISEASE", 70, 86], ["rupture", "DISEASE", 88, 95], ["hepatic artery aneurysms", "DISEASE", 99, 123], ["hepatic vein obstruction", "DISEASE", 142, 166], ["cirrhosis", "DISEASE", 170, 179], ["portal hypertension", "DISEASE", 193, 212], ["atresia of one or more ducts", "DISEASE", 214, 242], ["Arteriovenous fistulae", "PATHOLOGICAL_FORMATION", 0, 22], ["abdominal", "ORGANISM_SUBDIVISION", 70, 79], ["hepatic artery", "MULTI-TISSUE_STRUCTURE", 99, 113], ["hepatic vein", "MULTI-TISSUE_STRUCTURE", 142, 154], ["portal", "MULTI-TISSUE_STRUCTURE", 193, 199], ["ducts", "MULTI-TISSUE_STRUCTURE", 237, 242], ["lambs", "ORGANISM", 256, 261], ["calves", "ORGANISM", 263, 269], ["lambs", "SPECIES", 256, 261], ["calves", "SPECIES", 263, 269], ["Arteriovenous fistulae", "PROBLEM", 0, 22], ["abdominal trauma", "PROBLEM", 70, 86], ["rupture of hepatic artery aneurysms", "PROBLEM", 88, 123], ["hepatic vein obstruction", "PROBLEM", 142, 166], ["cirrhosis", "PROBLEM", 170, 179], ["extreme portal hypertension", "PROBLEM", 185, 212], ["atresia", "PROBLEM", 214, 221], ["fistulae", "OBSERVATION", 14, 22], ["may also be", "UNCERTAINTY", 23, 34], ["abdominal", "ANATOMY", 70, 79], ["trauma", "OBSERVATION", 80, 86], ["rupture", "OBSERVATION", 88, 95], ["hepatic artery", "ANATOMY", 99, 113], ["aneurysms", "OBSERVATION", 114, 123], ["hepatic vein", "ANATOMY", 142, 154], ["obstruction", "OBSERVATION", 155, 166], ["cirrhosis", "OBSERVATION", 170, 179], ["extreme", "OBSERVATION_MODIFIER", 185, 192], ["portal", "ANATOMY", 193, 199], ["hypertension", "OBSERVATION", 200, 212], ["one", "OBSERVATION_MODIFIER", 225, 228], ["ducts", "ANATOMY", 237, 242], ["calves", "ANATOMY", 263, 269]]], ["2-1), foals, a cat, a dog, and a pig.", [["foals", "ORGANISM", 6, 11], ["cat", "ORGANISM", 15, 18], ["dog", "ORGANISM", 22, 25], ["pig", "ORGANISM", 33, 36], ["cat", "SPECIES", 15, 18], ["dog", "SPECIES", 22, 25], ["pig", "SPECIES", 33, 36], ["pig", "SPECIES", 33, 36], ["a pig", "TREATMENT", 31, 36]]], ["In carnivores, bile duct atresia may lead not only to jaundice, but also to vitamin D-deficiency rickets, because of their inability to absorb fatsoluble vitamins.", [["bile duct", "ANATOMY", 15, 24], ["bile duct atresia", "DISEASE", 15, 32], ["jaundice", "DISEASE", 54, 62], ["vitamin D", "CHEMICAL", 76, 85], ["rickets", "DISEASE", 97, 104], ["fatsoluble vitamins", "CHEMICAL", 143, 162], ["vitamin D", "CHEMICAL", 76, 85], ["fatsoluble vitamins", "CHEMICAL", 143, 162], ["bile duct", "MULTI-TISSUE_STRUCTURE", 15, 24], ["vitamin D", "SIMPLE_CHEMICAL", 76, 85], ["fatsoluble vitamins", "SIMPLE_CHEMICAL", 143, 162], ["bile duct atresia", "PROBLEM", 15, 32], ["jaundice", "PROBLEM", 54, 62], ["vitamin D-deficiency rickets", "PROBLEM", 76, 104], ["fatsoluble vitamins", "TREATMENT", 143, 162], ["bile duct", "ANATOMY", 15, 24], ["atresia", "OBSERVATION", 25, 32], ["jaundice", "OBSERVATION", 54, 62]]], ["Congenital atresia may be associated with defects in the developmental morphogenesis of bile ducts, or in utero vascular, inflammatory, or toxic insults to the biliary tree that culminate in the obliteration of the lumen.Ductal plate malformationsCholedochal cysts arising from the cystic or common bile duct have been described in cats.Congenital vascular anomaliesThese include congenital portal vein aneurysms, hepatic arteriovenous malformations, congenital portosystemic shunts between the portal vein and other systemic veins, and primary hypoplasia of the portal vein.", [["bile ducts", "ANATOMY", 88, 98], ["vascular", "ANATOMY", 112, 120], ["biliary tree", "ANATOMY", 160, 172], ["lumen", "ANATOMY", 215, 220], ["Ductal plate malformationsCholedochal cysts", "ANATOMY", 221, 264], ["cystic", "ANATOMY", 282, 288], ["bile duct", "ANATOMY", 299, 308], ["vascular", "ANATOMY", 348, 356], ["congenital portal vein aneurysms", "ANATOMY", 380, 412], ["hepatic arteriovenous", "ANATOMY", 414, 435], ["portal vein", "ANATOMY", 495, 506], ["systemic veins", "ANATOMY", 517, 531], ["portal vein", "ANATOMY", 563, 574], ["Congenital atresia", "DISEASE", 0, 18], ["Ductal plate malformations", "DISEASE", 221, 247], ["Choledochal cysts", "DISEASE", 247, 264], ["cystic or common bile duct", "DISEASE", 282, 308], ["Congenital vascular anomalies", "DISEASE", 337, 366], ["congenital portal vein aneurysms", "DISEASE", 380, 412], ["hepatic arteriovenous malformations", "DISEASE", 414, 449], ["congenital portosystemic shunts", "DISEASE", 451, 482], ["primary hypoplasia of the portal vein", "DISEASE", 537, 574], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 88, 98], ["vascular", "MULTI-TISSUE_STRUCTURE", 112, 120], ["biliary tree", "MULTI-TISSUE_STRUCTURE", 160, 172], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 215, 220], ["Ductal plate", "PATHOLOGICAL_FORMATION", 221, 233], ["Choledochal cysts", "CANCER", 247, 264], ["cystic", "ORGAN", 282, 288], ["bile duct", "MULTI-TISSUE_STRUCTURE", 299, 308], ["cats", "ORGANISM", 332, 336], ["vascular", "MULTI-TISSUE_STRUCTURE", 348, 356], ["portal vein", "MULTI-TISSUE_STRUCTURE", 391, 402], ["hepatic arteriovenous malformations", "PATHOLOGICAL_FORMATION", 414, 449], ["portal vein", "MULTI-TISSUE_STRUCTURE", 495, 506], ["systemic veins", "MULTI-TISSUE_STRUCTURE", 517, 531], ["portal vein", "MULTI-TISSUE_STRUCTURE", 563, 574], ["cats", "SPECIES", 332, 336], ["Congenital atresia", "PROBLEM", 0, 18], ["defects in the developmental morphogenesis of bile ducts", "PROBLEM", 42, 98], ["utero vascular, inflammatory", "PROBLEM", 106, 134], ["toxic insults to the biliary tree", "PROBLEM", 139, 172], ["the obliteration of the lumen", "PROBLEM", 191, 220], ["Ductal plate malformations", "PROBLEM", 221, 247], ["Choledochal cysts", "PROBLEM", 247, 264], ["Congenital vascular anomalies", "PROBLEM", 337, 366], ["congenital portal vein aneurysms", "PROBLEM", 380, 412], ["hepatic arteriovenous malformations", "PROBLEM", 414, 449], ["congenital portosystemic shunts between the portal vein and other systemic veins", "PROBLEM", 451, 531], ["primary hypoplasia of the portal vein", "PROBLEM", 537, 574], ["atresia", "OBSERVATION", 11, 18], ["may be associated with", "UNCERTAINTY", 19, 41], ["defects", "OBSERVATION", 42, 49], ["developmental", "OBSERVATION_MODIFIER", 57, 70], ["morphogenesis", "OBSERVATION", 71, 84], ["bile ducts", "ANATOMY", 88, 98], ["utero", "ANATOMY_MODIFIER", 106, 111], ["vascular", "ANATOMY", 112, 120], ["inflammatory", "OBSERVATION_MODIFIER", 122, 134], ["toxic", "OBSERVATION_MODIFIER", 139, 144], ["biliary", "ANATOMY", 160, 167], ["tree", "ANATOMY_MODIFIER", 168, 172], ["obliteration", "OBSERVATION", 195, 207], ["lumen", "ANATOMY_MODIFIER", 215, 220], ["plate", "OBSERVATION_MODIFIER", 228, 233], ["malformations", "OBSERVATION", 234, 247], ["Choledochal", "OBSERVATION_MODIFIER", 247, 258], ["cysts", "OBSERVATION", 259, 264], ["cystic", "OBSERVATION", 282, 288], ["common", "ANATOMY_MODIFIER", 292, 298], ["bile duct", "ANATOMY", 299, 308], ["vascular", "ANATOMY", 348, 356], ["anomalies", "OBSERVATION", 357, 366], ["congenital", "OBSERVATION", 380, 390], ["portal vein", "ANATOMY", 391, 402], ["aneurysms", "OBSERVATION", 403, 412], ["hepatic", "ANATOMY", 414, 421], ["arteriovenous", "ANATOMY_MODIFIER", 422, 435], ["malformations", "OBSERVATION", 436, 449], ["congenital", "OBSERVATION", 451, 461], ["portosystemic shunts", "OBSERVATION", 462, 482], ["portal vein", "ANATOMY", 495, 506], ["systemic veins", "ANATOMY", 517, 531], ["primary", "OBSERVATION_MODIFIER", 537, 544], ["hypoplasia", "OBSERVATION", 545, 555], ["portal vein", "ANATOMY", 563, 574]]], ["Extrahepatic congenital portosystemic shunts are readily distinguished from shunts that are acquired during portal hypertension, as acquired shunts are typically multiple, thin-walled, tortuous collateral venous connections between the portal vein or its tributaries and caudal vena cava, renal vein, or azygos vein (Fig. 2-9 ).", [["portal", "ANATOMY", 108, 114], ["tortuous collateral venous", "ANATOMY", 185, 211], ["portal vein", "ANATOMY", 236, 247], ["tributaries", "ANATOMY", 255, 266], ["caudal vena cava", "ANATOMY", 271, 287], ["renal vein", "ANATOMY", 289, 299], ["azygos vein", "ANATOMY", 304, 315], ["Extrahepatic congenital portosystemic shunts", "DISEASE", 0, 44], ["hypertension", "DISEASE", 115, 127], ["portal", "MULTI-TISSUE_STRUCTURE", 108, 114], ["collateral venous", "MULTI-TISSUE_STRUCTURE", 194, 211], ["portal vein", "MULTI-TISSUE_STRUCTURE", 236, 247], ["caudal vena cava", "MULTI-TISSUE_STRUCTURE", 271, 287], ["renal vein", "MULTI-TISSUE_STRUCTURE", 289, 299], ["azygos vein", "MULTI-TISSUE_STRUCTURE", 304, 315], ["Extrahepatic congenital portosystemic shunts", "PROBLEM", 0, 44], ["shunts", "TREATMENT", 76, 82], ["portal hypertension", "PROBLEM", 108, 127], ["acquired shunts", "PROBLEM", 132, 147], ["thin-walled, tortuous collateral venous connections", "PROBLEM", 172, 223], ["congenital", "OBSERVATION", 13, 23], ["portosystemic shunts", "OBSERVATION", 24, 44], ["shunts", "OBSERVATION", 76, 82], ["portal", "ANATOMY", 108, 114], ["hypertension", "OBSERVATION", 115, 127], ["shunts", "OBSERVATION", 141, 147], ["typically", "OBSERVATION_MODIFIER", 152, 161], ["multiple", "OBSERVATION_MODIFIER", 162, 170], ["thin", "OBSERVATION_MODIFIER", 172, 176], ["walled", "OBSERVATION_MODIFIER", 177, 183], ["tortuous", "OBSERVATION_MODIFIER", 185, 193], ["collateral venous connections", "OBSERVATION", 194, 223], ["portal vein", "ANATOMY", 236, 247], ["tributaries", "ANATOMY_MODIFIER", 255, 266], ["caudal vena cava", "ANATOMY", 271, 287], ["renal vein", "ANATOMY", 289, 299], ["azygos vein", "ANATOMY", 304, 315]]], ["Although multiple acquired shunts do not develop in the presence of congenital PSS, they 266.e1 eFigure 2-1 Congenital biliary atresia and gallbladder agenesis in a calf.", [["biliary", "ANATOMY", 119, 126], ["gallbladder", "ANATOMY", 139, 150], ["congenital PSS", "DISEASE", 68, 82], ["Congenital biliary atresia", "DISEASE", 108, 134], ["gallbladder agenesis", "DISEASE", 139, 159], ["biliary atresia", "PATHOLOGICAL_FORMATION", 119, 134], ["gallbladder", "ORGAN", 139, 150], ["calf", "ORGANISM_SUBDIVISION", 165, 169], ["calf", "SPECIES", 165, 169], ["multiple acquired shunts", "PROBLEM", 9, 33], ["congenital PSS", "PROBLEM", 68, 82], ["eFigure", "TEST", 96, 103], ["Congenital biliary atresia", "PROBLEM", 108, 134], ["gallbladder agenesis in a calf", "PROBLEM", 139, 169], ["shunts", "OBSERVATION", 27, 33], ["congenital", "OBSERVATION_MODIFIER", 68, 78], ["PSS", "OBSERVATION", 79, 82], ["biliary", "ANATOMY", 119, 126], ["atresia", "OBSERVATION", 127, 134], ["gallbladder", "ANATOMY", 139, 150], ["agenesis", "OBSERVATION", 151, 159], ["calf", "ANATOMY", 165, 169]]], ["(Courtesy B. Njaa.) several breeds, including Irish Wolfhounds, Maltese, Yorkshire Terriers, and Australian cattle dogs.Congenital vascular anomaliesAffected dogs are usually presented in adolescence with failure to thrive or with the neurobehavioral manifestations of hepatic encephalopathy.", [["vascular", "ANATOMY", 131, 139], ["hepatic", "ANATOMY", 269, 276], ["Congenital vascular anomalies", "DISEASE", 120, 149], ["hepatic encephalopathy", "DISEASE", 269, 291], ["cattle", "ORGANISM", 108, 114], ["dogs", "ORGANISM", 115, 119], ["vascular", "MULTI-TISSUE_STRUCTURE", 131, 139], ["dogs", "ORGANISM", 158, 162], ["hepatic", "ORGAN", 269, 276], ["cattle", "SPECIES", 108, 114], ["dogs", "SPECIES", 115, 119], ["dogs", "SPECIES", 158, 162], ["cattle", "SPECIES", 108, 114], ["Congenital vascular anomaliesAffected dogs", "PROBLEM", 120, 162], ["failure to thrive", "PROBLEM", 205, 222], ["hepatic encephalopathy", "PROBLEM", 269, 291], ["vascular", "ANATOMY", 131, 139], ["anomalies", "OBSERVATION", 140, 149], ["hepatic", "ANATOMY", 269, 276], ["encephalopathy", "OBSERVATION", 277, 291]]], ["Often, there is a clinical history of depression, convulsions, and other nervous signs that are exacerbated by a high-protein diet, and may be alleviated by dietary control.", [["nervous", "ANATOMY", 73, 80], ["depression", "DISEASE", 38, 48], ["convulsions", "DISEASE", 50, 61], ["nervous", "ANATOMICAL_SYSTEM", 73, 80], ["depression", "PROBLEM", 38, 48], ["convulsions", "PROBLEM", 50, 61], ["other nervous signs", "PROBLEM", 67, 86], ["a high-protein diet", "TREATMENT", 111, 130], ["depression", "OBSERVATION", 38, 48]]], ["Because there is no cause of portal hypertension, these dogs do not develop ascites.Congenital vascular anomaliesThe liver that has been bypassed by a congenital shunt is hypoplastic, largely because of diversion of hepatotrophic factors, including insulin, glucagon, and epidermal growth factor that originate in the intestine and pancreas.", [["portal", "ANATOMY", 29, 35], ["ascites", "ANATOMY", 76, 83], ["vascular", "ANATOMY", 95, 103], ["liver", "ANATOMY", 117, 122], ["intestine", "ANATOMY", 318, 327], ["pancreas", "ANATOMY", 332, 340], ["portal hypertension", "DISEASE", 29, 48], ["ascites", "DISEASE", 76, 83], ["Congenital vascular anomalies", "DISEASE", 84, 113], ["congenital shunt", "DISEASE", 151, 167], ["portal", "MULTI-TISSUE_STRUCTURE", 29, 35], ["dogs", "ORGANISM", 56, 60], ["vascular", "MULTI-TISSUE_STRUCTURE", 95, 103], ["liver", "ORGAN", 117, 122], ["hepatotrophic factors", "GENE_OR_GENE_PRODUCT", 216, 237], ["insulin", "GENE_OR_GENE_PRODUCT", 249, 256], ["glucagon", "GENE_OR_GENE_PRODUCT", 258, 266], ["epidermal growth factor", "GENE_OR_GENE_PRODUCT", 272, 295], ["intestine", "ORGAN", 318, 327], ["pancreas", "ORGAN", 332, 340], ["hepatotrophic factors", "PROTEIN", 216, 237], ["insulin", "PROTEIN", 249, 256], ["epidermal growth factor", "PROTEIN", 272, 295], ["dogs", "SPECIES", 56, 60], ["portal hypertension", "PROBLEM", 29, 48], ["ascites", "PROBLEM", 76, 83], ["Congenital vascular anomalies", "PROBLEM", 84, 113], ["a congenital shunt", "PROBLEM", 149, 167], ["hypoplastic", "PROBLEM", 171, 182], ["hepatotrophic factors", "PROBLEM", 216, 237], ["insulin", "TREATMENT", 249, 256], ["glucagon", "TREATMENT", 258, 266], ["epidermal growth factor", "PROBLEM", 272, 295], ["no cause of", "UNCERTAINTY", 17, 28], ["portal", "ANATOMY", 29, 35], ["hypertension", "OBSERVATION", 36, 48], ["ascites", "OBSERVATION", 76, 83], ["vascular", "ANATOMY", 95, 103], ["anomalies", "OBSERVATION", 104, 113], ["liver", "ANATOMY", 117, 122], ["congenital", "OBSERVATION_MODIFIER", 151, 161], ["shunt", "OBSERVATION", 162, 167], ["hypoplastic", "OBSERVATION", 171, 182], ["diversion", "OBSERVATION", 203, 212], ["hepatotrophic factors", "OBSERVATION", 216, 237], ["intestine", "ANATOMY", 318, 327], ["pancreas", "ANATOMY", 332, 340]]], ["Affected livers may be smooth surfaced with normal color and texture.", [["livers", "ANATOMY", 9, 15], ["livers", "ORGAN", 9, 15], ["Affected livers", "PROBLEM", 0, 15], ["livers", "ANATOMY", 9, 15], ["may be", "UNCERTAINTY", 16, 22], ["smooth", "OBSERVATION_MODIFIER", 23, 29], ["normal", "OBSERVATION", 44, 50], ["color", "OBSERVATION_MODIFIER", 51, 56], ["texture", "OBSERVATION_MODIFIER", 61, 68]]], ["Histologically, hepatocytes and hepatic lobules are small with close and irregular spacing of portal triads.", [["hepatocytes", "ANATOMY", 16, 27], ["hepatic lobules", "ANATOMY", 32, 47], ["portal triads", "ANATOMY", 94, 107], ["hepatocytes", "CELL", 16, 27], ["hepatic lobules", "CANCER", 32, 47], ["portal triads", "MULTI-TISSUE_STRUCTURE", 94, 107], ["hepatocytes", "CELL_TYPE", 16, 27], ["irregular spacing of portal triads", "PROBLEM", 73, 107], ["hepatocytes", "ANATOMY", 16, 27], ["hepatic", "ANATOMY", 32, 39], ["lobules", "ANATOMY_MODIFIER", 40, 47], ["small", "OBSERVATION_MODIFIER", 52, 57], ["irregular", "OBSERVATION_MODIFIER", 73, 82], ["spacing", "OBSERVATION_MODIFIER", 83, 90], ["portal triads", "ANATOMY", 94, 107]]], ["Larger portal veins may be inapparent or appear collapsed and empty of circulating blood elements; portal veins in smaller triads may be small, collapsed, absent, or indistinguishable.", [["portal veins", "ANATOMY", 7, 19], ["blood", "ANATOMY", 83, 88], ["portal veins", "ANATOMY", 99, 111], ["portal veins", "MULTI-TISSUE_STRUCTURE", 7, 19], ["blood", "ORGANISM_SUBSTANCE", 83, 88], ["portal veins", "MULTI-TISSUE_STRUCTURE", 99, 111], ["portal veins", "ANATOMY", 7, 19], ["may be", "UNCERTAINTY", 20, 26], ["inapparent", "OBSERVATION", 27, 37], ["collapsed", "OBSERVATION", 48, 57], ["empty", "OBSERVATION", 62, 67], ["circulating blood elements", "OBSERVATION", 71, 97], ["portal veins", "ANATOMY", 99, 111], ["smaller triads", "OBSERVATION", 115, 129], ["may be", "UNCERTAINTY", 130, 136], ["small", "OBSERVATION_MODIFIER", 137, 142], ["collapsed", "OBSERVATION", 144, 153]]], ["Hepatic arterioles are often more prominent, and may be multiple and tortuous , related to increased compensatory arterial perfusion.", [["Hepatic arterioles", "ANATOMY", 0, 18], ["arterial", "ANATOMY", 114, 122], ["Hepatic arterioles", "MULTI-TISSUE_STRUCTURE", 0, 18], ["arterial", "MULTI-TISSUE_STRUCTURE", 114, 122], ["increased compensatory arterial perfusion", "PROBLEM", 91, 132], ["arterioles", "ANATOMY", 8, 18], ["more prominent", "OBSERVATION_MODIFIER", 29, 43], ["may be", "UNCERTAINTY", 49, 55], ["multiple", "OBSERVATION_MODIFIER", 56, 64], ["tortuous", "OBSERVATION", 69, 77], ["increased", "OBSERVATION_MODIFIER", 91, 100], ["compensatory", "OBSERVATION", 101, 113], ["arterial perfusion", "OBSERVATION", 114, 132]]], ["Numbers of arteriolar structures within triads may also appear increased, as small caliber and usually inapparent arterioles become evident histologically after compensatory hypertrophy.", [["arteriolar structures", "ANATOMY", 11, 32], ["arterioles", "ANATOMY", 114, 124], ["hypertrophy", "DISEASE", 174, 185], ["arteriolar structures", "MULTI-TISSUE_STRUCTURE", 11, 32], ["triads", "MULTI-TISSUE_STRUCTURE", 40, 46], ["arterioles", "MULTI-TISSUE_STRUCTURE", 114, 124], ["small caliber and usually inapparent arterioles", "PROBLEM", 77, 124], ["compensatory hypertrophy", "PROBLEM", 161, 185], ["arteriolar", "ANATOMY_MODIFIER", 11, 21], ["may also appear", "UNCERTAINTY", 47, 62], ["increased", "OBSERVATION_MODIFIER", 63, 72], ["small", "OBSERVATION_MODIFIER", 77, 82], ["caliber", "OBSERVATION_MODIFIER", 83, 90], ["compensatory", "OBSERVATION_MODIFIER", 161, 173], ["hypertrophy", "OBSERVATION", 174, 185]]], ["A proliferation of small caliber bile ducts (ductular reaction) has been confirmed in some cases by cytokeratin 19 immunohistochemistry.", [["bile ducts", "ANATOMY", 33, 43], ["ductular", "ANATOMY", 45, 53], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 33, 43], ["ductular", "MULTI-TISSUE_STRUCTURE", 45, 53], ["cytokeratin 19", "GENE_OR_GENE_PRODUCT", 100, 114], ["cytokeratin 19", "PROTEIN", 100, 114], ["A proliferation of small caliber bile ducts (ductular reaction", "PROBLEM", 0, 62], ["cytokeratin 19 immunohistochemistry", "TEST", 100, 135], ["proliferation", "OBSERVATION", 2, 15], ["small", "OBSERVATION_MODIFIER", 19, 24], ["caliber", "OBSERVATION_MODIFIER", 25, 32], ["bile ducts", "ANATOMY", 33, 43], ["ductular", "ANATOMY_MODIFIER", 45, 53]]], ["Dilated vascular structures devoid of blood, presumably small-and large-caliber lymphatics, are often prominent in the periphery of some portal triads.", [["vascular structures", "ANATOMY", 8, 27], ["blood", "ANATOMY", 38, 43], ["large-caliber lymphatics", "ANATOMY", 66, 90], ["portal triads", "ANATOMY", 137, 150], ["vascular structures", "MULTI-TISSUE_STRUCTURE", 8, 27], ["blood", "ORGANISM_SUBSTANCE", 38, 43], ["lymphatics", "MULTI-TISSUE_STRUCTURE", 80, 90], ["portal triads", "MULTI-TISSUE_STRUCTURE", 137, 150], ["Dilated vascular structures", "PROBLEM", 0, 27], ["presumably small-and large-caliber lymphatics", "PROBLEM", 45, 90], ["vascular", "ANATOMY", 8, 16], ["blood", "OBSERVATION_MODIFIER", 38, 43], ["presumably", "UNCERTAINTY", 45, 55], ["small", "OBSERVATION_MODIFIER", 56, 61], ["large", "OBSERVATION_MODIFIER", 66, 71], ["caliber", "OBSERVATION_MODIFIER", 72, 79], ["lymphatics", "OBSERVATION", 80, 90], ["often", "OBSERVATION_MODIFIER", 96, 101], ["prominent", "OBSERVATION_MODIFIER", 102, 111], ["periphery", "ANATOMY_MODIFIER", 119, 128], ["some", "ANATOMY_MODIFIER", 132, 136], ["portal triads", "ANATOMY", 137, 150]]], ["Dilated lymphatics may also be present in the connective tissue surrounding hepatic veins.", [["lymphatics", "ANATOMY", 8, 18], ["connective tissue", "ANATOMY", 46, 63], ["hepatic veins", "ANATOMY", 76, 89], ["lymphatics", "MULTI-TISSUE_STRUCTURE", 8, 18], ["connective tissue", "TISSUE", 46, 63], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 76, 89], ["Dilated lymphatics", "PROBLEM", 0, 18], ["lymphatics", "OBSERVATION", 8, 18], ["may also be", "UNCERTAINTY", 19, 30], ["connective tissue", "OBSERVATION", 46, 63], ["hepatic veins", "ANATOMY", 76, 89]]], ["In dogs, the spiral smooth muscle in the wall of the hepatic vein may be more prominent in dogs with shunts than normal dogs.", [["spiral smooth muscle", "ANATOMY", 13, 33], ["wall", "ANATOMY", 41, 45], ["hepatic vein", "ANATOMY", 53, 65], ["dogs", "ORGANISM", 3, 7], ["spiral smooth muscle", "TISSUE", 13, 33], ["wall", "MULTI-TISSUE_STRUCTURE", 41, 45], ["hepatic vein", "MULTI-TISSUE_STRUCTURE", 53, 65], ["dogs", "ORGANISM", 91, 95], ["dogs", "SPECIES", 3, 7], ["dogs", "SPECIES", 120, 124], ["shunts", "TREATMENT", 101, 107], ["dogs", "OBSERVATION", 3, 7], ["spiral", "ANATOMY_MODIFIER", 13, 19], ["smooth muscle", "ANATOMY", 20, 33], ["wall", "ANATOMY_MODIFIER", 41, 45], ["hepatic vein", "ANATOMY", 53, 65], ["may be", "UNCERTAINTY", 66, 72], ["more prominent", "OBSERVATION_MODIFIER", 73, 87], ["shunts", "OBSERVATION", 101, 107]]], ["There may be increased deposition of fibrous connective tissue surrounding portal triads and hepatic veins.", [["fibrous connective tissue", "ANATOMY", 37, 62], ["portal triads", "ANATOMY", 75, 88], ["hepatic veins", "ANATOMY", 93, 106], ["fibrous connective tissue", "TISSUE", 37, 62], ["portal triads", "MULTI-TISSUE_STRUCTURE", 75, 88], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 93, 106], ["increased deposition of fibrous connective tissue", "PROBLEM", 13, 62], ["may be", "UNCERTAINTY", 6, 12], ["increased", "OBSERVATION_MODIFIER", 13, 22], ["deposition", "OBSERVATION", 23, 33], ["fibrous connective tissue", "OBSERVATION", 37, 62], ["portal triads", "ANATOMY", 75, 88], ["hepatic veins", "ANATOMY", 93, 106]]], ["Hepatocytes may contain cytoplasmic lipid droplets, and multiple small lipogranulomatous foci with hemosiderin and ceroid in Kupffer cells, and macrophages are typically present throughout the liver, especially in animals >1 year of age.Congenital vascular anomaliesPrimary portal vein hypoplasia (PVH) has been reported in dogs, particularly Cairn and Yorkshire Terriers, and Congenital portosystemic vascular anomalies are typically single anomalous vessels that directly connect the portal venous system with the systemic venous circulation, bypassing the hepatic sinusoids and hepatic parenchyma.", [["Hepatocytes", "ANATOMY", 0, 11], ["cytoplasmic lipid droplets", "ANATOMY", 24, 50], ["foci", "ANATOMY", 89, 93], ["Kupffer cells", "ANATOMY", 125, 138], ["macrophages", "ANATOMY", 144, 155], ["liver", "ANATOMY", 193, 198], ["vascular", "ANATOMY", 248, 256], ["Primary portal vein", "ANATOMY", 266, 285], ["vascular", "ANATOMY", 402, 410], ["anomalous vessels", "ANATOMY", 442, 459], ["portal venous system", "ANATOMY", 486, 506], ["venous", "ANATOMY", 525, 531], ["hepatic sinusoids", "ANATOMY", 559, 576], ["hepatic parenchyma", "ANATOMY", 581, 599], ["ceroid", "DISEASE", 115, 121], ["vascular anomalies", "DISEASE", 248, 266], ["portal vein hypoplasia", "DISEASE", 274, 296], ["PVH", "DISEASE", 298, 301], ["Congenital portosystemic vascular anomalies", "DISEASE", 377, 420], ["Hepatocytes", "CELL", 0, 11], ["cytoplasmic", "ORGANISM_SUBSTANCE", 24, 35], ["lipid droplets", "CELLULAR_COMPONENT", 36, 50], ["hemosiderin", "SIMPLE_CHEMICAL", 99, 110], ["Kupffer cells", "CELL", 125, 138], ["macrophages", "CELL", 144, 155], ["liver", "ORGAN", 193, 198], ["vascular", "MULTI-TISSUE_STRUCTURE", 248, 256], ["portal vein", "MULTI-TISSUE_STRUCTURE", 274, 285], ["dogs", "ORGANISM", 324, 328], ["vascular", "MULTI-TISSUE_STRUCTURE", 402, 410], ["anomalous vessels", "MULTI-TISSUE_STRUCTURE", 442, 459], ["portal venous", "MULTI-TISSUE_STRUCTURE", 486, 499], ["venous circulation", "MULTI-TISSUE_STRUCTURE", 525, 543], ["hepatic sinusoids", "MULTI-TISSUE_STRUCTURE", 559, 576], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 581, 599], ["Kupffer cells", "CELL_TYPE", 125, 138], ["macrophages", "CELL_TYPE", 144, 155], ["dogs", "SPECIES", 324, 328], ["Hepatocytes", "TEST", 0, 11], ["cytoplasmic lipid droplets", "TEST", 24, 50], ["multiple small lipogranulomatous foci", "PROBLEM", 56, 93], ["hemosiderin and ceroid in Kupffer cells", "PROBLEM", 99, 138], ["macrophages", "PROBLEM", 144, 155], ["Congenital vascular anomalies", "PROBLEM", 237, 266], ["Primary portal vein hypoplasia", "PROBLEM", 266, 296], ["Congenital portosystemic vascular anomalies", "PROBLEM", 377, 420], ["single anomalous vessels", "PROBLEM", 435, 459], ["cytoplasmic lipid droplets", "OBSERVATION", 24, 50], ["multiple", "OBSERVATION_MODIFIER", 56, 64], ["small", "OBSERVATION_MODIFIER", 65, 70], ["lipogranulomatous", "OBSERVATION_MODIFIER", 71, 88], ["foci", "OBSERVATION", 89, 93], ["hemosiderin", "OBSERVATION", 99, 110], ["ceroid", "OBSERVATION_MODIFIER", 115, 121], ["Kupffer cells", "OBSERVATION", 125, 138], ["macrophages", "OBSERVATION", 144, 155], ["liver", "ANATOMY", 193, 198], ["vascular", "ANATOMY", 248, 256], ["anomalies", "OBSERVATION", 257, 266], ["portal vein", "ANATOMY", 274, 285], ["hypoplasia", "OBSERVATION", 286, 296], ["Congenital", "OBSERVATION_MODIFIER", 377, 387], ["portosystemic", "ANATOMY_MODIFIER", 388, 401], ["vascular", "ANATOMY", 402, 410], ["anomalies", "OBSERVATION", 411, 420], ["anomalous vessels", "OBSERVATION", 442, 459], ["portal venous", "ANATOMY", 486, 499], ["systemic venous", "ANATOMY", 516, 531], ["circulation", "ANATOMY_MODIFIER", 532, 543], ["hepatic", "ANATOMY", 559, 566], ["sinusoids", "ANATOMY_MODIFIER", 567, 576], ["hepatic", "ANATOMY", 581, 588], ["parenchyma", "ANATOMY_MODIFIER", 589, 599]]], ["They occur in dogs and cats, and, rarely, in pigs, foals, goats and calves.", [["dogs", "ORGANISM", 14, 18], ["cats", "ORGANISM", 23, 27], ["pigs", "ORGANISM", 45, 49], ["foals", "ORGANISM_SUBDIVISION", 51, 56], ["goats", "ORGANISM", 58, 63], ["calves", "ORGANISM", 68, 74], ["dogs", "SPECIES", 14, 18], ["cats", "SPECIES", 23, 27], ["pigs", "SPECIES", 45, 49], ["goats", "SPECIES", 58, 63], ["calves", "SPECIES", 68, 74], ["pigs", "SPECIES", 45, 49], ["goats", "SPECIES", 58, 63], ["calves", "ANATOMY", 68, 74]]], ["These portosystemic shunts (PSS) may be either intrahepatic or extrahepatic in location.", [["intrahepatic", "ANATOMY", 47, 59], ["extrahepatic", "ANATOMY", 63, 75], ["PSS", "DISEASE", 28, 31], ["portosystemic", "MULTI-TISSUE_STRUCTURE", 6, 19], ["These portosystemic shunts (PSS", "TREATMENT", 0, 31], ["intrahepatic or extrahepatic in location", "PROBLEM", 47, 87], ["portosystemic shunts", "OBSERVATION", 6, 26], ["may be", "UNCERTAINTY", 33, 39], ["intrahepatic", "ANATOMY_MODIFIER", 47, 59], ["extrahepatic", "ANATOMY", 63, 75]]], ["The most common intrahepatic shunt, located in the left hepatic division, is a persistent patent ductus venosus .", [["intrahepatic shunt", "ANATOMY", 16, 34], ["left hepatic division", "ANATOMY", 51, 72], ["ductus venosus", "ANATOMY", 97, 111], ["intrahepatic shunt", "PATHOLOGICAL_FORMATION", 16, 34], ["hepatic", "ORGAN", 56, 63], ["ductus venosus", "MULTI-TISSUE_STRUCTURE", 97, 111], ["The most common intrahepatic shunt", "TREATMENT", 0, 34], ["a persistent patent ductus venosus", "PROBLEM", 77, 111], ["most", "ANATOMY_MODIFIER", 4, 8], ["common", "ANATOMY_MODIFIER", 9, 15], ["intrahepatic", "ANATOMY_MODIFIER", 16, 28], ["shunt", "OBSERVATION", 29, 34], ["left", "ANATOMY_MODIFIER", 51, 55], ["hepatic", "ANATOMY", 56, 63], ["division", "ANATOMY_MODIFIER", 64, 72], ["persistent", "OBSERVATION_MODIFIER", 79, 89], ["patent", "OBSERVATION", 90, 96], ["ductus venosus", "ANATOMY", 97, 111]]], ["Central and right divisional intrahepatic shunts have also been described in dogs and cats.", [["right divisional intrahepatic shunts", "ANATOMY", 12, 48], ["intrahepatic shunts", "MULTI-TISSUE_STRUCTURE", 29, 48], ["dogs", "ORGANISM", 77, 81], ["cats", "ORGANISM", 86, 90], ["dogs", "SPECIES", 77, 81], ["cats", "SPECIES", 86, 90], ["Central and right divisional intrahepatic shunts", "TREATMENT", 0, 48], ["right", "ANATOMY_MODIFIER", 12, 17], ["divisional", "ANATOMY_MODIFIER", 18, 28], ["intrahepatic", "ANATOMY", 29, 41], ["shunts", "OBSERVATION", 42, 48]]], ["The major types of extrahepatic shunts include direct shunting from the portal vein or major tributary (typically left gastric or splenic veins, less commonly the gastroduodenal or mesenteric veins) to the caudal vena cava (portocaval shunt) ( Fig. 2- blood supply may not always be compromised; however, individual displaced lobes may be severely congested and may rupture, or, given time, become indurated.Congenital vascular anomaliesPartial or complete liver lobe torsions have been reported in pigs, dogs, cats, and horses.", [["extrahepatic", "ANATOMY", 19, 31], ["portal vein", "ANATOMY", 72, 83], ["left gastric", "ANATOMY", 114, 126], ["splenic veins", "ANATOMY", 130, 143], ["gastroduodenal", "ANATOMY", 163, 177], ["mesenteric veins", "ANATOMY", 181, 197], ["caudal vena cava", "ANATOMY", 206, 222], ["portocaval", "ANATOMY", 224, 234], ["blood", "ANATOMY", 252, 257], ["lobes", "ANATOMY", 326, 331], ["vascular", "ANATOMY", 419, 427], ["liver lobe", "ANATOMY", 457, 467], ["extrahepatic shunts", "DISEASE", 19, 38], ["rupture", "DISEASE", 366, 373], ["Congenital vascular anomalies", "DISEASE", 408, 437], ["liver lobe torsions", "DISEASE", 457, 476], ["extrahepatic shunts", "MULTI-TISSUE_STRUCTURE", 19, 38], ["portal vein", "MULTI-TISSUE_STRUCTURE", 72, 83], ["gastric", "ORGAN", 119, 126], ["splenic veins", "MULTI-TISSUE_STRUCTURE", 130, 143], ["gastroduodenal", "MULTI-TISSUE_STRUCTURE", 163, 177], ["mesenteric veins", "MULTI-TISSUE_STRUCTURE", 181, 197], ["caudal vena cava", "MULTI-TISSUE_STRUCTURE", 206, 222], ["portocaval shunt", "MULTI-TISSUE_STRUCTURE", 224, 240], ["blood", "ORGANISM_SUBSTANCE", 252, 257], ["lobes", "MULTI-TISSUE_STRUCTURE", 326, 331], ["vascular", "MULTI-TISSUE_STRUCTURE", 419, 427], ["liver lobe", "MULTI-TISSUE_STRUCTURE", 457, 467], ["pigs", "ORGANISM", 499, 503], ["dogs", "ORGANISM", 505, 509], ["cats", "ORGANISM", 511, 515], ["pigs", "SPECIES", 499, 503], ["dogs", "SPECIES", 505, 509], ["cats", "SPECIES", 511, 515], ["pigs", "SPECIES", 499, 503], ["extrahepatic shunts", "TREATMENT", 19, 38], ["direct shunting", "TREATMENT", 47, 62], ["portocaval shunt", "TREATMENT", 224, 240], ["individual displaced lobes", "PROBLEM", 305, 331], ["severely congested", "PROBLEM", 339, 357], ["rupture", "PROBLEM", 366, 373], ["indurated", "PROBLEM", 398, 407], ["Congenital vascular anomalies", "PROBLEM", 408, 437], ["Partial or complete liver lobe torsions", "PROBLEM", 437, 476], ["extrahepatic", "ANATOMY", 19, 31], ["shunts", "OBSERVATION", 32, 38], ["shunting", "OBSERVATION", 54, 62], ["portal vein", "ANATOMY", 72, 83], ["major", "OBSERVATION_MODIFIER", 87, 92], ["tributary", "OBSERVATION", 93, 102], ["left", "ANATOMY_MODIFIER", 114, 118], ["gastric", "ANATOMY", 119, 126], ["splenic veins", "ANATOMY", 130, 143], ["gastroduodenal", "ANATOMY", 163, 177], ["mesenteric veins", "ANATOMY", 181, 197], ["caudal vena cava", "ANATOMY", 206, 222], ["portocaval shunt", "OBSERVATION", 224, 240], ["may not always be", "UNCERTAINTY", 265, 282], ["compromised", "OBSERVATION", 283, 294], ["displaced", "OBSERVATION_MODIFIER", 316, 325], ["lobes", "OBSERVATION_MODIFIER", 326, 331], ["may be", "UNCERTAINTY", 332, 338], ["severely", "OBSERVATION_MODIFIER", 339, 347], ["congested", "OBSERVATION", 348, 357], ["rupture", "OBSERVATION", 366, 373], ["indurated", "OBSERVATION", 398, 407], ["vascular", "ANATOMY", 419, 427], ["anomalies", "OBSERVATION", 428, 437], ["complete", "OBSERVATION_MODIFIER", 448, 456], ["liver", "ANATOMY", 457, 462], ["lobe", "ANATOMY_MODIFIER", 463, 467], ["torsions", "OBSERVATION", 468, 476]]], ["The left lateral lobe may be predisposed because of its mobility, large size, and relative separation from other lobes; however, torsions of other lobes, in particular the left medial lobe, as well as double-lobe torsions have been reported in dogs and horses.", [["left lateral lobe", "ANATOMY", 4, 21], ["lobes", "ANATOMY", 113, 118], ["lobes", "ANATOMY", 147, 152], ["left medial lobe", "ANATOMY", 172, 188], ["lateral lobe", "MULTI-TISSUE_STRUCTURE", 9, 21], ["lobes", "ORGAN", 113, 118], ["lobes", "MULTI-TISSUE_STRUCTURE", 147, 152], ["medial lobe", "MULTI-TISSUE_STRUCTURE", 177, 188], ["dogs", "ORGANISM", 244, 248], ["dogs", "SPECIES", 244, 248], ["relative separation from other lobes", "PROBLEM", 82, 118], ["torsions of other lobes", "PROBLEM", 129, 152], ["double-lobe torsions", "PROBLEM", 201, 221], ["left lateral lobe", "ANATOMY", 4, 21], ["mobility", "OBSERVATION_MODIFIER", 56, 64], ["large", "OBSERVATION_MODIFIER", 66, 71], ["size", "OBSERVATION_MODIFIER", 72, 76], ["relative", "OBSERVATION_MODIFIER", 82, 90], ["separation", "OBSERVATION_MODIFIER", 91, 101], ["lobes", "ANATOMY_MODIFIER", 113, 118], ["torsions", "OBSERVATION", 129, 137], ["lobes", "ANATOMY_MODIFIER", 147, 152], ["left medial lobe", "ANATOMY", 172, 188], ["lobe torsions", "OBSERVATION", 208, 221]]], ["Other predisposing causes include absence of or damage to the ligamentous attachments that provide spatial support for the liver, trauma, or the presence of a mass lesion in the affected lobe.", [["ligamentous", "ANATOMY", 62, 73], ["liver", "ANATOMY", 123, 128], ["mass lesion", "ANATOMY", 159, 170], ["lobe", "ANATOMY", 187, 191], ["trauma", "DISEASE", 130, 136], ["liver", "ORGAN", 123, 128], ["lobe", "ORGAN", 187, 191], ["damage to the ligamentous attachments", "PROBLEM", 48, 85], ["spatial support", "TREATMENT", 99, 114], ["trauma", "PROBLEM", 130, 136], ["a mass lesion in the affected lobe", "PROBLEM", 157, 191], ["ligamentous attachments", "OBSERVATION", 62, 85], ["liver", "ANATOMY", 123, 128], ["trauma", "OBSERVATION", 130, 136], ["mass", "OBSERVATION", 159, 163], ["lesion", "OBSERVATION", 164, 170], ["affected lobe", "ANATOMY", 178, 191]]], ["Torsed lobes undergo various degrees of ischemia, culminating in infarction caused by venous occlusion or venous and/or arterial thrombosis, and affected animals may die because of shock, hemorrhage, or development of septic peritonitis.", [["Torsed lobes", "ANATOMY", 0, 12], ["venous", "ANATOMY", 86, 92], ["venous", "ANATOMY", 106, 112], ["arterial", "ANATOMY", 120, 128], ["ischemia", "DISEASE", 40, 48], ["infarction", "DISEASE", 65, 75], ["venous occlusion or venous and/or arterial thrombosis", "DISEASE", 86, 139], ["shock", "DISEASE", 181, 186], ["hemorrhage", "DISEASE", 188, 198], ["septic peritonitis", "DISEASE", 218, 236], ["Torsed lobes", "MULTI-TISSUE_STRUCTURE", 0, 12], ["venous", "MULTI-TISSUE_STRUCTURE", 86, 92], ["venous", "MULTI-TISSUE_STRUCTURE", 106, 112], ["arterial", "MULTI-TISSUE_STRUCTURE", 120, 128], ["ischemia", "PROBLEM", 40, 48], ["infarction", "PROBLEM", 65, 75], ["venous occlusion", "PROBLEM", 86, 102], ["venous and/or arterial thrombosis", "PROBLEM", 106, 139], ["shock", "PROBLEM", 181, 186], ["hemorrhage", "PROBLEM", 188, 198], ["septic peritonitis", "PROBLEM", 218, 236], ["various degrees", "OBSERVATION_MODIFIER", 21, 36], ["ischemia", "OBSERVATION", 40, 48], ["infarction", "OBSERVATION", 65, 75], ["venous", "ANATOMY", 86, 92], ["occlusion", "OBSERVATION", 93, 102], ["venous", "ANATOMY", 106, 112], ["arterial", "ANATOMY", 120, 128], ["thrombosis", "OBSERVATION", 129, 139], ["shock", "OBSERVATION", 181, 186], ["hemorrhage", "OBSERVATION", 188, 198], ["septic", "OBSERVATION_MODIFIER", 218, 224], ["peritonitis", "OBSERVATION", 225, 236]]], ["Ischemia may favor overgrowth of Clostridium spp. with development of necrosis and emphysema.", [["Ischemia", "DISEASE", 0, 8], ["necrosis", "DISEASE", 70, 78], ["emphysema", "DISEASE", 83, 92], ["Clostridium spp", "ORGANISM", 33, 48], ["emphysema", "PATHOLOGICAL_FORMATION", 83, 92], ["Ischemia", "PROBLEM", 0, 8], ["overgrowth of Clostridium spp", "PROBLEM", 19, 48], ["necrosis", "PROBLEM", 70, 78], ["emphysema", "PROBLEM", 83, 92], ["may favor", "UNCERTAINTY", 9, 18], ["overgrowth", "OBSERVATION_MODIFIER", 19, 29], ["Clostridium spp", "OBSERVATION", 33, 48], ["necrosis", "OBSERVATION", 70, 78], ["emphysema", "OBSERVATION", 83, 92]]], ["Subacute cases may develop hepatic abscessation, and if the animal survives, fibrosis and chronic inflammation.Congenital vascular anomaliesRupture of the liver occurs commonly as the result of trauma because the organ is fragile relative to its mass.", [["hepatic", "ANATOMY", 27, 34], ["vascular", "ANATOMY", 122, 130], ["liver", "ANATOMY", 155, 160], ["organ", "ANATOMY", 213, 218], ["hepatic abscessation", "DISEASE", 27, 47], ["fibrosis", "DISEASE", 77, 85], ["inflammation", "DISEASE", 98, 110], ["vascular anomalies", "DISEASE", 122, 140], ["Rupture of the liver", "DISEASE", 140, 160], ["trauma", "DISEASE", 194, 200], ["hepatic", "ORGAN", 27, 34], ["vascular", "MULTI-TISSUE_STRUCTURE", 122, 130], ["liver", "ORGAN", 155, 160], ["organ", "ORGAN", 213, 218], ["Subacute cases", "PROBLEM", 0, 14], ["hepatic abscessation", "PROBLEM", 27, 47], ["the animal survives", "PROBLEM", 56, 75], ["fibrosis", "PROBLEM", 77, 85], ["chronic inflammation", "PROBLEM", 90, 110], ["Congenital vascular anomaliesRupture of the liver", "PROBLEM", 111, 160], ["trauma", "PROBLEM", 194, 200], ["fragile", "PROBLEM", 222, 229], ["its mass", "PROBLEM", 242, 250], ["hepatic", "ANATOMY", 27, 34], ["abscessation", "OBSERVATION", 35, 47], ["fibrosis", "OBSERVATION", 77, 85], ["chronic", "OBSERVATION_MODIFIER", 90, 97], ["inflammation", "OBSERVATION", 98, 110], ["vascular", "ANATOMY", 122, 130], ["anomalies", "OBSERVATION", 131, 140], ["Rupture", "OBSERVATION", 140, 147], ["liver", "ANATOMY", 155, 160], ["trauma", "OBSERVATION", 194, 200], ["organ", "ANATOMY", 213, 218], ["fragile", "OBSERVATION", 222, 229], ["mass", "OBSERVATION", 246, 250]]], ["Fatal liver rupture may be produced by the sudden accelerations and pressures of vehicle collisions without much evidence of trauma to other parts of the body.", [["liver", "ANATOMY", 6, 11], ["body", "ANATOMY", 154, 158], ["liver rupture", "DISEASE", 6, 19], ["trauma", "DISEASE", 125, 131], ["liver", "ORGAN", 6, 11], ["body", "ORGANISM_SUBDIVISION", 154, 158], ["Fatal liver rupture", "PROBLEM", 0, 19], ["the sudden accelerations and pressures of vehicle collisions", "PROBLEM", 39, 99], ["trauma to other parts of the body", "PROBLEM", 125, 158], ["liver", "ANATOMY", 6, 11], ["rupture", "OBSERVATION", 12, 19], ["pressures", "OBSERVATION_MODIFIER", 68, 77], ["trauma", "OBSERVATION", 125, 131], ["body", "ANATOMY", 154, 158]]], ["Large tears may be obvious in the liver capsule and hepatic parenchyma after trauma; however, anastomosing linear patterns of fine shallow capsular fissures may be concealed in part by clotted blood.", [["tears", "ANATOMY", 6, 11], ["liver capsule", "ANATOMY", 34, 47], ["hepatic parenchyma", "ANATOMY", 52, 70], ["capsular", "ANATOMY", 139, 147], ["blood", "ANATOMY", 193, 198], ["trauma", "DISEASE", 77, 83], ["liver capsule", "MULTI-TISSUE_STRUCTURE", 34, 47], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 52, 70], ["blood", "ORGANISM_SUBSTANCE", 193, 198], ["Large tears", "PROBLEM", 0, 11], ["obvious in the liver capsule", "PROBLEM", 19, 47], ["trauma", "PROBLEM", 77, 83], ["anastomosing linear patterns of fine shallow capsular fissures", "PROBLEM", 94, 156], ["clotted blood", "PROBLEM", 185, 198], ["tears", "OBSERVATION", 6, 11], ["may be", "UNCERTAINTY", 12, 18], ["obvious", "OBSERVATION_MODIFIER", 19, 26], ["liver", "ANATOMY", 34, 39], ["capsule", "ANATOMY_MODIFIER", 40, 47], ["hepatic", "ANATOMY", 52, 59], ["parenchyma", "ANATOMY_MODIFIER", 60, 70], ["trauma", "OBSERVATION", 77, 83], ["anastomosing", "OBSERVATION_MODIFIER", 94, 106], ["linear", "OBSERVATION_MODIFIER", 107, 113], ["fine", "OBSERVATION_MODIFIER", 126, 130], ["shallow", "OBSERVATION_MODIFIER", 131, 138], ["capsular fissures", "OBSERVATION", 139, 156], ["clotted", "OBSERVATION", 185, 192]]], ["Liver rupture is often clinically occult, because quite large ruptures may not disturb liver function unless severe enough to cause rapid exsanguination, or unless the biliary tract is involved.", [["Liver", "ANATOMY", 0, 5], ["liver", "ANATOMY", 87, 92], ["biliary tract", "ANATOMY", 168, 181], ["Liver rupture", "DISEASE", 0, 13], ["exsanguination", "DISEASE", 138, 152], ["Liver", "ORGAN", 0, 5], ["liver", "ORGAN", 87, 92], ["biliary tract", "ORGAN", 168, 181], ["Liver rupture", "PROBLEM", 0, 13], ["quite large ruptures", "PROBLEM", 50, 70], ["rapid exsanguination", "PROBLEM", 132, 152], ["rupture", "OBSERVATION", 6, 13], ["large", "OBSERVATION_MODIFIER", 56, 61], ["ruptures", "OBSERVATION", 62, 70], ["liver", "ANATOMY", 87, 92], ["rapid", "OBSERVATION_MODIFIER", 132, 137], ["exsanguination", "OBSERVATION", 138, 152], ["biliary tract", "ANATOMY", 168, 181]]], ["Intrahepatic bile duct rupture results in bile extravasation into the hepatic parenchyma or beneath the hepatic capsule, forming bile lakes or bile infarcts, areas of hepatocyte degeneration, and necrosis surrounded by reactive macrophages; larger accumulations of bile may be walled off by a pseudocapsule, forming biliary pseudocysts.", [["Intrahepatic bile duct", "ANATOMY", 0, 22], ["bile", "ANATOMY", 42, 46], ["hepatic parenchyma", "ANATOMY", 70, 88], ["hepatic capsule", "ANATOMY", 104, 119], ["bile lakes", "ANATOMY", 129, 139], ["bile infarcts", "ANATOMY", 143, 156], ["hepatocyte", "ANATOMY", 167, 177], ["macrophages", "ANATOMY", 228, 239], ["bile", "ANATOMY", 265, 269], ["pseudocapsule", "ANATOMY", 293, 306], ["biliary pseudocysts", "ANATOMY", 316, 335], ["Intrahepatic bile duct rupture", "DISEASE", 0, 30], ["bile infarcts", "DISEASE", 143, 156], ["hepatocyte degeneration", "DISEASE", 167, 190], ["necrosis", "DISEASE", 196, 204], ["pseudocapsule", "DISEASE", 293, 306], ["biliary pseudocysts", "DISEASE", 316, 335], ["Intrahepatic bile duct", "MULTI-TISSUE_STRUCTURE", 0, 22], ["bile", "PATHOLOGICAL_FORMATION", 42, 46], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 70, 88], ["hepatic capsule", "PATHOLOGICAL_FORMATION", 104, 119], ["bile lakes", "PATHOLOGICAL_FORMATION", 129, 139], ["bile infarcts", "PATHOLOGICAL_FORMATION", 143, 156], ["hepatocyte", "CELL", 167, 177], ["macrophages", "CELL", 228, 239], ["bile", "MULTI-TISSUE_STRUCTURE", 265, 269], ["biliary pseudocysts", "PATHOLOGICAL_FORMATION", 316, 335], ["reactive macrophages", "CELL_TYPE", 219, 239], ["Intrahepatic bile duct rupture", "PROBLEM", 0, 30], ["bile extravasation into the hepatic parenchyma", "PROBLEM", 42, 88], ["bile lakes", "PROBLEM", 129, 139], ["bile infarcts", "PROBLEM", 143, 156], ["hepatocyte degeneration", "PROBLEM", 167, 190], ["necrosis", "PROBLEM", 196, 204], ["reactive macrophages", "PROBLEM", 219, 239], ["larger accumulations of bile", "PROBLEM", 241, 269], ["a pseudocapsule", "PROBLEM", 291, 306], ["forming biliary pseudocysts", "PROBLEM", 308, 335], ["bile duct", "ANATOMY", 13, 22], ["rupture", "OBSERVATION", 23, 30], ["bile", "ANATOMY", 42, 46], ["extravasation", "OBSERVATION", 47, 60], ["hepatic", "ANATOMY", 70, 77], ["parenchyma", "ANATOMY_MODIFIER", 78, 88], ["hepatic", "ANATOMY", 104, 111], ["capsule", "ANATOMY_MODIFIER", 112, 119], ["bile", "ANATOMY", 129, 133], ["lakes", "OBSERVATION_MODIFIER", 134, 139], ["bile", "ANATOMY", 143, 147], ["infarcts", "OBSERVATION", 148, 156], ["areas", "OBSERVATION_MODIFIER", 158, 163], ["hepatocyte degeneration", "OBSERVATION", 167, 190], ["necrosis", "OBSERVATION", 196, 204], ["reactive macrophages", "OBSERVATION", 219, 239], ["larger", "OBSERVATION_MODIFIER", 241, 247], ["accumulations", "OBSERVATION_MODIFIER", 248, 261], ["bile", "ANATOMY", 265, 269], ["walled", "OBSERVATION_MODIFIER", 277, 283], ["pseudocapsule", "OBSERVATION", 293, 306], ["biliary", "ANATOMY", 316, 323], ["pseudocysts", "OBSERVATION", 324, 335]]], ["Rupture of major bile ducts or the gallbladder results in yellow-stained bile peritonitis, which may remain sterile and become chronic, or may be fatal, particularly if infected by enterohepatic circulation of bacteria such as clostridia.Congenital vascular anomaliesThe liver is more likely to rupture after trauma in young animals.", [["bile ducts", "ANATOMY", 17, 27], ["gallbladder", "ANATOMY", 35, 46], ["bile", "ANATOMY", 73, 77], ["vascular", "ANATOMY", 249, 257], ["liver", "ANATOMY", 271, 276], ["Rupture of major bile ducts", "DISEASE", 0, 27], ["peritonitis", "DISEASE", 78, 89], ["Congenital vascular anomalies", "DISEASE", 238, 267], ["rupture", "DISEASE", 295, 302], ["trauma", "DISEASE", 309, 315], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 17, 27], ["gallbladder", "ORGAN", 35, 46], ["enterohepatic", "IMMATERIAL_ANATOMICAL_ENTITY", 181, 194], ["vascular", "MULTI-TISSUE_STRUCTURE", 249, 257], ["liver", "ORGAN", 271, 276], ["Rupture of major bile ducts", "PROBLEM", 0, 27], ["yellow-stained bile peritonitis", "PROBLEM", 58, 89], ["bacteria", "PROBLEM", 210, 218], ["clostridia", "PROBLEM", 227, 237], ["Congenital vascular anomalies", "PROBLEM", 238, 267], ["rupture", "PROBLEM", 295, 302], ["trauma", "PROBLEM", 309, 315], ["major", "ANATOMY_MODIFIER", 11, 16], ["bile ducts", "ANATOMY", 17, 27], ["gallbladder", "ANATOMY", 35, 46], ["yellow", "OBSERVATION_MODIFIER", 58, 64], ["bile", "ANATOMY", 73, 77], ["peritonitis", "OBSERVATION", 78, 89], ["chronic", "OBSERVATION_MODIFIER", 127, 134], ["may be", "UNCERTAINTY", 139, 145], ["fatal", "OBSERVATION", 146, 151], ["bacteria", "OBSERVATION", 210, 218], ["vascular", "ANATOMY", 249, 257], ["anomalies", "OBSERVATION", 258, 267], ["liver", "ANATOMY", 271, 276], ["more likely to", "UNCERTAINTY", 280, 294], ["rupture", "OBSERVATION", 295, 302], ["trauma", "OBSERVATION", 309, 315]]], ["Fatal ruptures occur in foals during parturition, sometimes concurrently with costal fractures, and in the smaller species subject to energetic emergency resuscitation.", [["ruptures", "DISEASE", 6, 14], ["costal fractures", "DISEASE", 78, 94], ["Fatal ruptures", "PROBLEM", 0, 14], ["costal fractures", "PROBLEM", 78, 94], ["energetic emergency resuscitation", "TREATMENT", 134, 167], ["ruptures", "OBSERVATION", 6, 14], ["costal", "ANATOMY", 78, 84], ["fractures", "OBSERVATION", 85, 94]]], ["Diffuse hepatic conditions with enlarged friable parenchyma (e.g., acute hepatitis, amyloidosis, severe congestion, severe lipidosis, and infiltrating neoplasms) are more likely to rupture, sometimes spontaneously, and the clinical consequences are related to the extent of hemorrhage.", [["hepatic", "ANATOMY", 8, 15], ["friable parenchyma", "ANATOMY", 41, 59], ["infiltrating neoplasms", "ANATOMY", 138, 160], ["hepatitis", "DISEASE", 73, 82], ["amyloidosis", "DISEASE", 84, 95], ["congestion", "DISEASE", 104, 114], ["lipidosis", "DISEASE", 123, 132], ["neoplasms", "DISEASE", 151, 160], ["rupture", "DISEASE", 181, 188], ["hemorrhage", "DISEASE", 274, 284], ["hepatic", "ORGAN", 8, 15], ["friable parenchyma", "MULTI-TISSUE_STRUCTURE", 41, 59], ["infiltrating neoplasms", "CANCER", 138, 160], ["Diffuse hepatic conditions", "PROBLEM", 0, 26], ["enlarged friable parenchyma", "PROBLEM", 32, 59], ["acute hepatitis", "PROBLEM", 67, 82], ["amyloidosis", "PROBLEM", 84, 95], ["severe congestion", "PROBLEM", 97, 114], ["severe lipidosis", "PROBLEM", 116, 132], ["infiltrating neoplasms", "PROBLEM", 138, 160], ["rupture", "PROBLEM", 181, 188], ["hemorrhage", "PROBLEM", 274, 284], ["hepatic", "ANATOMY", 8, 15], ["enlarged", "OBSERVATION_MODIFIER", 32, 40], ["friable", "OBSERVATION_MODIFIER", 41, 48], ["parenchyma", "OBSERVATION", 49, 59], ["acute", "OBSERVATION_MODIFIER", 67, 72], ["hepatitis", "OBSERVATION", 73, 82], ["amyloidosis", "OBSERVATION", 84, 95], ["severe", "OBSERVATION_MODIFIER", 97, 103], ["congestion", "OBSERVATION", 104, 114], ["severe", "OBSERVATION_MODIFIER", 116, 122], ["lipidosis", "OBSERVATION", 123, 132], ["infiltrating", "OBSERVATION_MODIFIER", 138, 150], ["neoplasms", "OBSERVATION", 151, 160], ["more likely to", "UNCERTAINTY", 166, 180], ["rupture", "OBSERVATION", 181, 188], ["hemorrhage", "OBSERVATION", 274, 284]]], ["Parasites that penetrate the capsule cause numerous small ruptures but seldom lead to significant hemorrhage.", [["capsule", "ANATOMY", 29, 36], ["ruptures", "DISEASE", 58, 66], ["hemorrhage", "DISEASE", 98, 108], ["capsule", "CANCER", 29, 36], ["Parasites", "TREATMENT", 0, 9], ["numerous small ruptures", "PROBLEM", 43, 66], ["significant hemorrhage", "PROBLEM", 86, 108], ["capsule", "OBSERVATION_MODIFIER", 29, 36], ["numerous", "OBSERVATION_MODIFIER", 43, 51], ["small", "OBSERVATION_MODIFIER", 52, 57], ["ruptures", "OBSERVATION", 58, 66], ["significant", "OBSERVATION_MODIFIER", 86, 97], ["hemorrhage", "OBSERVATION", 98, 108]]], ["Banz occasionally in cats, affecting either the extrahepatic or intrahepatic portal vein, or both.", [["extrahepatic", "ANATOMY", 48, 60], ["intrahepatic portal vein", "ANATOMY", 64, 88], ["Banz", "CHEMICAL", 0, 4], ["Banz", "SIMPLE_CHEMICAL", 0, 4], ["cats", "ORGANISM", 21, 25], ["extrahepatic", "MULTI-TISSUE_STRUCTURE", 48, 60], ["intrahepatic portal vein", "MULTI-TISSUE_STRUCTURE", 64, 88], ["cats", "SPECIES", 21, 25], ["Banz", "TREATMENT", 0, 4], ["extrahepatic", "ANATOMY", 48, 60], ["intrahepatic", "ANATOMY_MODIFIER", 64, 76], ["portal vein", "ANATOMY", 77, 88], ["both", "OBSERVATION_MODIFIER", 93, 97]]], ["Intrahepatic portal vein hypoplasia is considered to be the underlying lesion in conditions previously described as microvascular dysplasia, hepatoportal fibrosis, and idiopathic noncirrhotic portal hypertension in some young dogs.", [["Intrahepatic portal vein", "ANATOMY", 0, 24], ["lesion", "ANATOMY", 71, 77], ["microvascular", "ANATOMY", 116, 129], ["hepatoportal", "ANATOMY", 141, 153], ["portal", "ANATOMY", 192, 198], ["Intrahepatic portal vein hypoplasia", "DISEASE", 0, 35], ["microvascular dysplasia", "DISEASE", 116, 139], ["fibrosis", "DISEASE", 154, 162], ["idiopathic noncirrhotic portal hypertension", "DISEASE", 168, 211], ["Intrahepatic portal vein", "MULTI-TISSUE_STRUCTURE", 0, 24], ["microvascular dysplasia", "PATHOLOGICAL_FORMATION", 116, 139], ["portal", "MULTI-TISSUE_STRUCTURE", 192, 198], ["dogs", "ORGANISM", 226, 230], ["dogs", "SPECIES", 226, 230], ["Intrahepatic portal vein hypoplasia", "PROBLEM", 0, 35], ["the underlying lesion in conditions", "PROBLEM", 56, 91], ["microvascular dysplasia", "PROBLEM", 116, 139], ["hepatoportal fibrosis", "PROBLEM", 141, 162], ["idiopathic noncirrhotic portal hypertension", "PROBLEM", 168, 211], ["portal vein", "ANATOMY", 13, 24], ["hypoplasia", "OBSERVATION", 25, 35], ["considered to be", "UNCERTAINTY", 39, 55], ["lesion", "OBSERVATION", 71, 77], ["microvascular", "ANATOMY", 116, 129], ["dysplasia", "OBSERVATION", 130, 139], ["hepatoportal", "OBSERVATION_MODIFIER", 141, 153], ["fibrosis", "OBSERVATION", 154, 162], ["idiopathic", "OBSERVATION_MODIFIER", 168, 178], ["noncirrhotic", "OBSERVATION_MODIFIER", 179, 191], ["portal", "ANATOMY", 192, 198], ["hypertension", "OBSERVATION", 199, 211], ["some", "OBSERVATION_MODIFIER", 215, 219], ["young dogs", "OBSERVATION", 220, 230]]], ["Depending on the level of the abnormality and extent of involvement of the lobes of liver, PVH may be accompanied by portal hypertension, ascites and the development of multiple collateral portosystemic shunts.", [["lobes", "ANATOMY", 75, 80], ["liver", "ANATOMY", 84, 89], ["portal", "ANATOMY", 117, 123], ["ascites", "ANATOMY", 138, 145], ["PVH", "DISEASE", 91, 94], ["portal hypertension", "DISEASE", 117, 136], ["ascites", "DISEASE", 138, 145], ["collateral portosystemic shunts", "DISEASE", 178, 209], ["lobes", "ORGAN", 75, 80], ["liver", "ORGAN", 84, 89], ["portal", "MULTI-TISSUE_STRUCTURE", 117, 123], ["collateral portosystemic", "MULTI-TISSUE_STRUCTURE", 178, 202], ["the abnormality", "PROBLEM", 26, 41], ["involvement of the lobes of liver", "PROBLEM", 56, 89], ["PVH", "PROBLEM", 91, 94], ["portal hypertension", "PROBLEM", 117, 136], ["ascites", "PROBLEM", 138, 145], ["multiple collateral portosystemic shunts", "PROBLEM", 169, 209], ["abnormality", "OBSERVATION", 30, 41], ["extent", "OBSERVATION_MODIFIER", 46, 52], ["involvement", "OBSERVATION", 56, 67], ["lobes", "ANATOMY_MODIFIER", 75, 80], ["liver", "ANATOMY", 84, 89], ["PVH", "OBSERVATION", 91, 94], ["may be accompanied", "UNCERTAINTY", 95, 113], ["portal", "ANATOMY", 117, 123], ["hypertension", "OBSERVATION", 124, 136], ["ascites", "OBSERVATION", 138, 145], ["multiple", "OBSERVATION_MODIFIER", 169, 177], ["collateral", "OBSERVATION_MODIFIER", 178, 188], ["portosystemic shunts", "OBSERVATION", 189, 209]]], ["Histologically, there is hypoplasia or absence of portal vein radicles, secondary arteriolar proliferation, and atrophy of hepatocytes.", [["portal vein", "ANATOMY", 50, 61], ["arteriolar", "ANATOMY", 82, 92], ["hepatocytes", "ANATOMY", 123, 134], ["hypoplasia", "DISEASE", 25, 35], ["absence of portal vein radicles", "DISEASE", 39, 70], ["atrophy", "DISEASE", 112, 119], ["portal vein", "MULTI-TISSUE_STRUCTURE", 50, 61], ["arteriolar", "MULTI-TISSUE_STRUCTURE", 82, 92], ["hepatocytes", "CELL", 123, 134], ["hepatocytes", "CELL_TYPE", 123, 134], ["hypoplasia", "PROBLEM", 25, 35], ["portal vein radicles", "PROBLEM", 50, 70], ["secondary arteriolar proliferation", "PROBLEM", 72, 106], ["atrophy of hepatocytes", "PROBLEM", 112, 134], ["hypoplasia", "OBSERVATION", 25, 35], ["portal vein", "ANATOMY", 50, 61], ["radicles", "ANATOMY_MODIFIER", 62, 70], ["secondary", "OBSERVATION_MODIFIER", 72, 81], ["arteriolar proliferation", "OBSERVATION", 82, 106], ["atrophy", "OBSERVATION", 112, 119], ["hepatocytes", "ANATOMY", 123, 134]]], ["Moderate to marked portal fibrosis may also be present, with biliary hyperplasia.", [["portal", "ANATOMY", 19, 25], ["biliary", "ANATOMY", 61, 68], ["fibrosis", "DISEASE", 26, 34], ["biliary hyperplasia", "DISEASE", 61, 80], ["portal", "MULTI-TISSUE_STRUCTURE", 19, 25], ["biliary hyperplasia", "PATHOLOGICAL_FORMATION", 61, 80], ["Moderate to marked portal fibrosis", "PROBLEM", 0, 34], ["biliary hyperplasia", "PROBLEM", 61, 80], ["marked", "OBSERVATION_MODIFIER", 12, 18], ["portal", "ANATOMY", 19, 25], ["fibrosis", "OBSERVATION", 26, 34], ["may also be", "UNCERTAINTY", 35, 46], ["biliary", "ANATOMY", 61, 68], ["hyperplasia", "OBSERVATION", 69, 80]]], ["These changes represent stereotypic sequelae to under-perfusion and thus can be indistinguishable histologically from congenital portosystemic shunts; however, development of portal hypertension is a distinguishing feature of PVH.", [["portal", "ANATOMY", 175, 181], ["congenital portosystemic shunts", "DISEASE", 118, 149], ["portal hypertension", "DISEASE", 175, 194], ["PVH", "DISEASE", 226, 229], ["portosystemic", "IMMATERIAL_ANATOMICAL_ENTITY", 129, 142], ["portal", "MULTI-TISSUE_STRUCTURE", 175, 181], ["PVH", "CANCER", 226, 229], ["stereotypic sequelae", "PROBLEM", 24, 44], ["congenital portosystemic shunts", "PROBLEM", 118, 149], ["portal hypertension", "PROBLEM", 175, 194], ["PVH", "PROBLEM", 226, 229], ["stereotypic", "OBSERVATION_MODIFIER", 24, 35], ["sequelae", "OBSERVATION", 36, 44], ["congenital", "OBSERVATION_MODIFIER", 118, 128], ["portosystemic shunts", "OBSERVATION", 129, 149], ["portal", "ANATOMY", 175, 181], ["hypertension", "OBSERVATION", 182, 194], ["PVH", "OBSERVATION", 226, 229]]], ["Macroscopic PSS and microscopic portosystemic vascular anomalies may co-occur in dogs, as evidenced by a lack of resolution of clinical signs, and persistence of histologic changes in additional liver biopsies subsequent to macroscopic shunt ligation.", [["vascular", "ANATOMY", 46, 54], ["liver biopsies", "ANATOMY", 195, 209], ["PSS", "DISEASE", 12, 15], ["portosystemic vascular anomalies", "DISEASE", 32, 64], ["vascular", "MULTI-TISSUE_STRUCTURE", 46, 54], ["dogs", "ORGANISM", 81, 85], ["liver biopsies", "MULTI-TISSUE_STRUCTURE", 195, 209], ["dogs", "SPECIES", 81, 85], ["Macroscopic PSS", "TEST", 0, 15], ["microscopic portosystemic vascular anomalies", "PROBLEM", 20, 64], ["clinical signs", "PROBLEM", 127, 141], ["histologic changes", "PROBLEM", 162, 180], ["additional liver biopsies", "TREATMENT", 184, 209], ["macroscopic shunt ligation", "TREATMENT", 224, 250], ["portosystemic", "ANATOMY_MODIFIER", 32, 45], ["vascular", "ANATOMY", 46, 54], ["anomalies", "OBSERVATION", 55, 64], ["liver", "ANATOMY", 195, 200], ["biopsies", "OBSERVATION", 201, 209], ["shunt ligation", "OBSERVATION", 236, 250]]], ["Decreased tolerance of complete surgical shunt attenuation has been associated with lack of identifiable portal veins and the presence of a ductular reaction in biopsies taken during the initial surgical shunt attenuation procedure, although an earlier study showed no association of severity of several histologic findings, such as arteriolar proliferation, biliary hyperplasia, and fibrosis, with survival time after shunt attenuation.DISPLACEMENT, TORSION, AND RUPTUREThe position of the liver should be observed as soon as the abdomen is opened at postmortem examination.", [["portal veins", "ANATOMY", 105, 117], ["ductular", "ANATOMY", 140, 148], ["biopsies", "ANATOMY", 161, 169], ["arteriolar", "ANATOMY", 333, 343], ["biliary", "ANATOMY", 359, 366], ["liver", "ANATOMY", 491, 496], ["abdomen", "ANATOMY", 531, 538], ["biliary hyperplasia", "DISEASE", 359, 378], ["fibrosis", "DISEASE", 384, 392], ["portal veins", "MULTI-TISSUE_STRUCTURE", 105, 117], ["ductular", "TISSUE", 140, 148], ["biopsies", "CANCER", 161, 169], ["arteriolar", "MULTI-TISSUE_STRUCTURE", 333, 343], ["biliary", "MULTI-TISSUE_STRUCTURE", 359, 366], ["liver", "ORGAN", 491, 496], ["abdomen", "ORGAN", 531, 538], ["Decreased tolerance of complete surgical shunt attenuation", "PROBLEM", 0, 58], ["identifiable portal veins", "PROBLEM", 92, 117], ["a ductular reaction", "PROBLEM", 138, 157], ["biopsies", "TEST", 161, 169], ["the initial surgical shunt attenuation procedure", "TREATMENT", 183, 231], ["an earlier study", "TEST", 242, 258], ["several histologic findings", "PROBLEM", 296, 323], ["arteriolar proliferation", "PROBLEM", 333, 357], ["biliary hyperplasia", "PROBLEM", 359, 378], ["fibrosis", "PROBLEM", 384, 392], ["shunt attenuation", "PROBLEM", 419, 436], ["DISPLACEMENT, TORSION, AND RUPTUREThe position of the liver", "PROBLEM", 437, 496], ["postmortem examination", "TEST", 552, 574], ["tolerance", "OBSERVATION_MODIFIER", 10, 19], ["complete", "OBSERVATION_MODIFIER", 23, 31], ["surgical", "OBSERVATION", 32, 40], ["shunt attenuation", "OBSERVATION", 41, 58], ["portal veins", "ANATOMY", 105, 117], ["ductular", "OBSERVATION_MODIFIER", 140, 148], ["reaction", "OBSERVATION", 149, 157], ["shunt attenuation", "OBSERVATION", 204, 221], ["no association of", "UNCERTAINTY", 266, 283], ["several", "OBSERVATION_MODIFIER", 296, 303], ["histologic", "OBSERVATION", 304, 314], ["arteriolar", "OBSERVATION_MODIFIER", 333, 343], ["proliferation", "OBSERVATION", 344, 357], ["biliary", "ANATOMY", 359, 366], ["hyperplasia", "OBSERVATION", 367, 378], ["fibrosis", "OBSERVATION", 384, 392], ["shunt attenuation", "OBSERVATION", 419, 436], ["TORSION", "OBSERVATION", 451, 458], ["liver", "ANATOMY", 491, 496], ["abdomen", "ANATOMY", 531, 538]]], ["Caudal displacements resulting in extension of the margins of the liver beyond the costal arch may be the result of hepatic enlargement or of displacement of the diaphragm secondary to pleural effusion or other space-occupying lesions in the thorax.", [["Caudal", "ANATOMY", 0, 6], ["margins", "ANATOMY", 51, 58], ["liver", "ANATOMY", 66, 71], ["costal arch", "ANATOMY", 83, 94], ["hepatic", "ANATOMY", 116, 123], ["diaphragm", "ANATOMY", 162, 171], ["pleural", "ANATOMY", 185, 192], ["lesions", "ANATOMY", 227, 234], ["thorax", "ANATOMY", 242, 248], ["hepatic enlargement", "DISEASE", 116, 135], ["pleural effusion", "DISEASE", 185, 201], ["liver", "ORGAN", 66, 71], ["costal arch", "MULTI-TISSUE_STRUCTURE", 83, 94], ["hepatic", "ORGAN", 116, 123], ["diaphragm", "ORGAN", 162, 171], ["pleural", "PATHOLOGICAL_FORMATION", 185, 192], ["space-occupying lesions", "PATHOLOGICAL_FORMATION", 211, 234], ["thorax", "ORGAN", 242, 248], ["Caudal displacements", "PROBLEM", 0, 20], ["hepatic enlargement", "PROBLEM", 116, 135], ["displacement of the diaphragm", "PROBLEM", 142, 171], ["pleural effusion", "PROBLEM", 185, 201], ["other space-occupying lesions in the thorax", "PROBLEM", 205, 248], ["displacements", "OBSERVATION_MODIFIER", 7, 20], ["margins", "OBSERVATION_MODIFIER", 51, 58], ["liver", "ANATOMY", 66, 71], ["costal arch", "ANATOMY", 83, 94], ["may be the result of", "UNCERTAINTY", 95, 115], ["hepatic", "ANATOMY", 116, 123], ["enlargement", "OBSERVATION", 124, 135], ["displacement", "OBSERVATION_MODIFIER", 142, 154], ["diaphragm", "ANATOMY", 162, 171], ["pleural", "ANATOMY", 185, 192], ["effusion", "OBSERVATION", 193, 201], ["space", "OBSERVATION_MODIFIER", 211, 216], ["occupying", "OBSERVATION_MODIFIER", 217, 226], ["lesions", "OBSERVATION", 227, 234], ["thorax", "ANATOMY", 242, 248]]], ["Congenital or acquired displacements associated with ventral and diaphragmatic hernias are common.", [["ventral", "ANATOMY", 53, 60], ["diaphragmatic hernias", "ANATOMY", 65, 86], ["ventral and diaphragmatic hernias", "DISEASE", 53, 86], ["ventral", "MULTI-TISSUE_STRUCTURE", 53, 60], ["Congenital or acquired displacements", "PROBLEM", 0, 36], ["ventral and diaphragmatic hernias", "PROBLEM", 53, 86], ["displacements", "OBSERVATION_MODIFIER", 23, 36], ["ventral", "ANATOMY_MODIFIER", 53, 60], ["diaphragmatic", "ANATOMY", 65, 78], ["hernias", "OBSERVATION", 79, 86]]], ["Individual lobes or the entire organ may be displaced into the subcutis, pleural cavity, or pericardial sac, often along with other viscera; lobar cyte growth factor and insulin-like growth factors, and many hormones, including insulin, glucagon, and catecholamines.", [["lobes", "ANATOMY", 11, 16], ["organ", "ANATOMY", 31, 36], ["subcutis", "ANATOMY", 63, 71], ["pleural cavity", "ANATOMY", 73, 87], ["pericardial sac", "ANATOMY", 92, 107], ["viscera", "ANATOMY", 132, 139], ["catecholamines", "CHEMICAL", 251, 265], ["catecholamines", "CHEMICAL", 251, 265], ["lobes", "MULTI-TISSUE_STRUCTURE", 11, 16], ["organ", "ORGAN", 31, 36], ["subcutis", "TISSUE", 63, 71], ["pleural cavity", "MULTI-TISSUE_STRUCTURE", 73, 87], ["pericardial sac", "MULTI-TISSUE_STRUCTURE", 92, 107], ["viscera", "ORGAN", 132, 139], ["lobar cyte growth factor", "GENE_OR_GENE_PRODUCT", 141, 165], ["insulin-like growth factors", "GENE_OR_GENE_PRODUCT", 170, 197], ["insulin", "GENE_OR_GENE_PRODUCT", 228, 235], ["glucagon", "GENE_OR_GENE_PRODUCT", 237, 245], ["catecholamines", "SIMPLE_CHEMICAL", 251, 265], ["lobar cyte growth factor", "PROTEIN", 141, 165], ["insulin", "PROTEIN", 170, 177], ["pericardial sac", "PROBLEM", 92, 107], ["other viscera", "PROBLEM", 126, 139], ["lobar cyte growth factor", "PROBLEM", 141, 165], ["insulin", "TREATMENT", 170, 177], ["insulin", "TREATMENT", 228, 235], ["glucagon", "TREATMENT", 237, 245], ["catecholamines", "TREATMENT", 251, 265], ["lobes", "ANATOMY_MODIFIER", 11, 16], ["may be", "UNCERTAINTY", 37, 43], ["displaced", "OBSERVATION", 44, 53], ["subcutis", "ANATOMY", 63, 71], ["pleural", "ANATOMY", 73, 80], ["cavity", "ANATOMY_MODIFIER", 81, 87], ["pericardial sac", "ANATOMY", 92, 107], ["viscera", "ANATOMY", 132, 139], ["lobar", "OBSERVATION_MODIFIER", 141, 146]]], ["Atrophy of only a part of the liver may be a response to pressure or to impairment of blood or bile flow.", [["liver", "ANATOMY", 30, 35], ["blood", "ANATOMY", 86, 91], ["bile", "ANATOMY", 95, 99], ["Atrophy", "DISEASE", 0, 7], ["impairment of blood or bile flow", "DISEASE", 72, 104], ["liver", "ORGAN", 30, 35], ["blood", "ORGANISM_SUBSTANCE", 86, 91], ["bile", "ORGANISM_SUBSTANCE", 95, 99], ["Atrophy", "PROBLEM", 0, 7], ["impairment of blood or bile flow", "PROBLEM", 72, 104], ["liver", "ANATOMY", 30, 35], ["may be", "UNCERTAINTY", 36, 42], ["pressure", "OBSERVATION_MODIFIER", 57, 65], ["bile flow", "OBSERVATION", 95, 104]]], ["The histologic features of this atrophy are similar to those of starvation atrophy.", [["atrophy", "DISEASE", 32, 39], ["atrophy", "DISEASE", 75, 82], ["this atrophy", "PROBLEM", 27, 39], ["starvation atrophy", "PROBLEM", 64, 82], ["atrophy", "OBSERVATION", 32, 39], ["starvation", "OBSERVATION_MODIFIER", 64, 74], ["atrophy", "OBSERVATION", 75, 82]]], ["However, the functional consequences of focal hepatic atrophy are minor because the remaining liver can compensate and adapt by a process that involves replication and enlargement of hepatocytes.", [["focal hepatic", "ANATOMY", 40, 53], ["liver", "ANATOMY", 94, 99], ["hepatocytes", "ANATOMY", 183, 194], ["hepatic atrophy", "DISEASE", 46, 61], ["hepatic", "ORGAN", 46, 53], ["liver", "ORGAN", 94, 99], ["hepatocytes", "CELL", 183, 194], ["hepatocytes", "CELL_TYPE", 183, 194], ["focal hepatic atrophy", "PROBLEM", 40, 61], ["enlargement of hepatocytes", "PROBLEM", 168, 194], ["focal", "OBSERVATION_MODIFIER", 40, 45], ["hepatic", "ANATOMY", 46, 53], ["atrophy", "OBSERVATION", 54, 61], ["liver", "ANATOMY", 94, 99], ["enlargement", "OBSERVATION", 168, 179], ["hepatocytes", "ANATOMY", 183, 194]]], ["Local pressure atrophy occurs adjacent to space-occupying lesions in the liver, or as a result of chronic pressures from neighboring organs, such as distended rumen in the ox.", [["lesions", "ANATOMY", 58, 65], ["liver", "ANATOMY", 73, 78], ["organs", "ANATOMY", 133, 139], ["atrophy", "DISEASE", 15, 22], ["lesions", "PATHOLOGICAL_FORMATION", 58, 65], ["liver", "ORGAN", 73, 78], ["organs", "ORGAN", 133, 139], ["Local pressure atrophy", "PROBLEM", 0, 22], ["space-occupying lesions in the liver", "PROBLEM", 42, 78], ["chronic pressures from neighboring organs", "PROBLEM", 98, 139], ["distended rumen in the ox", "PROBLEM", 149, 174], ["pressure", "OBSERVATION_MODIFIER", 6, 14], ["atrophy", "OBSERVATION", 15, 22], ["space", "OBSERVATION_MODIFIER", 42, 47], ["occupying", "OBSERVATION_MODIFIER", 48, 57], ["lesions", "OBSERVATION", 58, 65], ["liver", "ANATOMY", 73, 78], ["chronic", "OBSERVATION_MODIFIER", 98, 105], ["pressures", "OBSERVATION", 106, 115], ["organs", "ANATOMY", 133, 139], ["distended", "OBSERVATION_MODIFIER", 149, 158], ["rumen", "OBSERVATION_MODIFIER", 159, 164], ["ox", "ANATOMY", 172, 174]]], ["It has been suggested that right hepatic lobe atrophy, reported in horses, results from long-term compression from abnormal distension of the right dorsal colon and base of the cecum (eFig.", [["right hepatic lobe", "ANATOMY", 27, 45], ["right dorsal colon", "ANATOMY", 142, 160], ["cecum", "ANATOMY", 177, 182], ["right hepatic lobe atrophy", "DISEASE", 27, 53], ["hepatic lobe", "MULTI-TISSUE_STRUCTURE", 33, 45], ["dorsal colon", "ORGAN", 148, 160], ["cecum", "ORGAN", 177, 182], ["right hepatic lobe atrophy", "PROBLEM", 27, 53], ["long-term compression", "PROBLEM", 88, 109], ["abnormal distension of the right dorsal colon", "PROBLEM", 115, 160], ["right", "ANATOMY_MODIFIER", 27, 32], ["hepatic", "ANATOMY", 33, 40], ["lobe", "ANATOMY_MODIFIER", 41, 45], ["atrophy", "OBSERVATION", 46, 53], ["long-term", "OBSERVATION_MODIFIER", 88, 97], ["compression", "OBSERVATION", 98, 109], ["abnormal", "OBSERVATION_MODIFIER", 115, 123], ["distension", "OBSERVATION", 124, 134], ["right", "ANATOMY_MODIFIER", 142, 147], ["dorsal", "ANATOMY_MODIFIER", 148, 154], ["colon", "ANATOMY", 155, 160], ["base", "ANATOMY_MODIFIER", 165, 169], ["cecum", "ANATOMY", 177, 182]]], ["Chronic diffuse diseases of the biliary tract, such as sporidesmin poisoning and fascioliasis, are likely to cause atrophy of the left lobe in ruminants, possibly as a result of the greater difficulty in maintaining adequate biliary drainage from this lobe, whose bile ducts are longer than those of the right in these species.", [["biliary tract", "ANATOMY", 32, 45], ["left lobe", "ANATOMY", 130, 139], ["biliary", "ANATOMY", 225, 232], ["lobe", "ANATOMY", 252, 256], ["bile ducts", "ANATOMY", 264, 274], ["diseases of the biliary tract", "DISEASE", 16, 45], ["sporidesmin poisoning", "DISEASE", 55, 76], ["fascioliasis", "DISEASE", 81, 93], ["atrophy of the left lobe", "DISEASE", 115, 139], ["biliary tract", "ORGANISM_SUBDIVISION", 32, 45], ["sporidesmin", "GENE_OR_GENE_PRODUCT", 55, 66], ["lobe", "ORGAN", 135, 139], ["biliary drainage", "PATHOLOGICAL_FORMATION", 225, 241], ["lobe", "ORGAN", 252, 256], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 264, 274], ["Chronic diffuse diseases of the biliary tract", "PROBLEM", 0, 45], ["sporidesmin poisoning", "PROBLEM", 55, 76], ["fascioliasis", "PROBLEM", 81, 93], ["atrophy of the left lobe", "PROBLEM", 115, 139], ["the greater difficulty in maintaining adequate biliary drainage from this lobe", "PROBLEM", 178, 256], ["diffuse", "OBSERVATION_MODIFIER", 8, 15], ["diseases", "OBSERVATION", 16, 24], ["biliary tract", "ANATOMY", 32, 45], ["fascioliasis", "OBSERVATION", 81, 93], ["likely to cause", "UNCERTAINTY", 99, 114], ["atrophy", "OBSERVATION", 115, 122], ["left lobe", "ANATOMY", 130, 139], ["greater", "OBSERVATION_MODIFIER", 182, 189], ["difficulty", "OBSERVATION", 190, 200], ["adequate", "OBSERVATION_MODIFIER", 216, 224], ["biliary", "ANATOMY", 225, 232], ["drainage", "OBSERVATION", 233, 241], ["lobe", "ANATOMY_MODIFIER", 252, 256], ["bile ducts", "ANATOMY", 264, 274], ["right", "ANATOMY_MODIFIER", 304, 309], ["species", "OBSERVATION", 319, 326]]], ["The atrophy of biliary obstruction is complicated by some degree of superimposed inflammation and fibrosis.Hepatocellular hypertrophyHypertrophy is the term used for the increase in liver size caused by an increase in hepatocyte volume that may result from expansion of one or more organellar components of the hepatocytes.", [["biliary", "ANATOMY", 15, 22], ["Hepatocellular", "ANATOMY", 107, 121], ["liver", "ANATOMY", 182, 187], ["hepatocyte", "ANATOMY", 218, 228], ["organellar components", "ANATOMY", 282, 303], ["hepatocytes", "ANATOMY", 311, 322], ["atrophy", "DISEASE", 4, 11], ["biliary obstruction", "DISEASE", 15, 34], ["inflammation", "DISEASE", 81, 93], ["fibrosis", "DISEASE", 98, 106], ["Hepatocellular hypertrophy", "DISEASE", 107, 133], ["Hypertrophy", "DISEASE", 133, 144], ["biliary obstruction", "PATHOLOGICAL_FORMATION", 15, 34], ["Hepatocellular", "ORGAN", 107, 121], ["liver", "ORGAN", 182, 187], ["hepatocyte", "CELL", 218, 228], ["hepatocytes", "CELL", 311, 322], ["hepatocytes", "CELL_TYPE", 311, 322], ["The atrophy of biliary obstruction", "PROBLEM", 0, 34], ["superimposed inflammation", "PROBLEM", 68, 93], ["fibrosis", "PROBLEM", 98, 106], ["Hepatocellular hypertrophy", "PROBLEM", 107, 133], ["Hypertrophy", "PROBLEM", 133, 144], ["the increase in liver size", "PROBLEM", 166, 192], ["an increase in hepatocyte volume", "PROBLEM", 203, 235], ["expansion of one or more organellar components of the hepatocytes", "PROBLEM", 257, 322], ["atrophy", "OBSERVATION", 4, 11], ["biliary", "ANATOMY", 15, 22], ["obstruction", "OBSERVATION", 23, 34], ["some degree", "OBSERVATION_MODIFIER", 53, 64], ["superimposed", "OBSERVATION_MODIFIER", 68, 80], ["inflammation", "OBSERVATION", 81, 93], ["fibrosis", "OBSERVATION", 98, 106], ["hypertrophy", "OBSERVATION", 122, 133], ["increase", "OBSERVATION_MODIFIER", 170, 178], ["liver", "ANATOMY", 182, 187], ["size", "OBSERVATION_MODIFIER", 188, 192], ["increase", "OBSERVATION_MODIFIER", 206, 214], ["hepatocyte volume", "OBSERVATION", 218, 235], ["expansion", "OBSERVATION_MODIFIER", 257, 266], ["one", "OBSERVATION_MODIFIER", 270, 273], ["more", "OBSERVATION_MODIFIER", 277, 281], ["organellar components", "OBSERVATION", 282, 303], ["hepatocytes", "ANATOMY", 311, 322]]], ["Exposure to various xenobiotics can induce the expression of many genes, leading to expansion of the smooth endoplasmic reticulum (SER), resulting in hepatocyte hypertrophy.", [["smooth endoplasmic reticulum", "ANATOMY", 101, 129], ["SER", "ANATOMY", 131, 134], ["hepatocyte", "ANATOMY", 150, 160], ["hypertrophy", "DISEASE", 161, 172], ["smooth endoplasmic reticulum", "CELLULAR_COMPONENT", 101, 129], ["SER", "CELLULAR_COMPONENT", 131, 134], ["hepatocyte", "CELL", 150, 160], ["various xenobiotics", "TREATMENT", 12, 31], ["hepatocyte hypertrophy", "PROBLEM", 150, 172], ["expansion", "OBSERVATION_MODIFIER", 84, 93], ["smooth", "OBSERVATION_MODIFIER", 101, 107], ["endoplasmic reticulum", "OBSERVATION", 108, 129], ["hepatocyte", "ANATOMY", 150, 160], ["hypertrophy", "OBSERVATION", 161, 172]]], ["Agents that elicit this response act via nuclear receptors, such as the arylhydrocarbon-activated receptor, the constitutive androstane receptor, or the pregnane X receptor.", [["nuclear", "ANATOMY", 41, 48], ["arylhydrocarbon", "CHEMICAL", 72, 87], ["androstane", "CHEMICAL", 125, 135], ["pregnane", "CHEMICAL", 153, 161], ["arylhydrocarbon-activated receptor", "GENE_OR_GENE_PRODUCT", 72, 106], ["constitutive androstane receptor", "GENE_OR_GENE_PRODUCT", 112, 144], ["pregnane X receptor", "GENE_OR_GENE_PRODUCT", 153, 172], ["nuclear receptors", "PROTEIN", 41, 58], ["arylhydrocarbon-activated receptor", "PROTEIN", 72, 106], ["constitutive androstane receptor", "PROTEIN", 112, 144], ["pregnane X receptor", "PROTEIN", 153, 172], ["Agents", "TREATMENT", 0, 6], ["the arylhydrocarbon-activated receptor", "TREATMENT", 68, 106], ["the constitutive androstane receptor", "TREATMENT", 108, 144], ["the pregnane X receptor", "TREATMENT", 149, 172]]], ["Phenobarbital, for example, is a potent inducer of the various enzyme systems of the SER, including several cytochromes P450 (CYPs).", [["Phenobarbital", "CHEMICAL", 0, 13], ["Phenobarbital", "CHEMICAL", 0, 13], ["Phenobarbital", "SIMPLE_CHEMICAL", 0, 13], ["SER", "SIMPLE_CHEMICAL", 85, 88], ["cytochromes P450", "GENE_OR_GENE_PRODUCT", 108, 124], ["CYPs", "GENE_OR_GENE_PRODUCT", 126, 130], ["cytochromes P450", "PROTEIN", 108, 124], ["CYPs", "PROTEIN", 126, 130], ["Phenobarbital", "TREATMENT", 0, 13], ["several cytochromes P450", "TEST", 100, 124]]], ["Hypertrophy may occur in defined lobular regions, typically the centrilobular region or may affect the entire lobule in more advanced cases, depending upon the activity and dose level of the xenobiotic (Fig. 2-15 ).", [["lobular regions", "ANATOMY", 33, 48], ["centrilobular region", "ANATOMY", 64, 84], ["lobule", "ANATOMY", 110, 116], ["Hypertrophy", "DISEASE", 0, 11], ["lobular regions", "PATHOLOGICAL_FORMATION", 33, 48], ["lobule", "ORGAN", 110, 116], ["Hypertrophy", "PROBLEM", 0, 11], ["lobular", "ANATOMY_MODIFIER", 33, 40], ["centrilobular", "OBSERVATION_MODIFIER", 64, 77], ["entire", "OBSERVATION_MODIFIER", 103, 109], ["lobule", "OBSERVATION_MODIFIER", 110, 116], ["more advanced", "OBSERVATION_MODIFIER", 120, 133]]], ["Even when it is restricted to the centrilobular region, hypertrophy usually enlarges the entire liver.", [["centrilobular region", "ANATOMY", 34, 54], ["liver", "ANATOMY", 96, 101], ["hypertrophy", "DISEASE", 56, 67], ["liver", "ORGAN", 96, 101], ["hypertrophy", "PROBLEM", 56, 67], ["centrilobular", "ANATOMY_MODIFIER", 34, 47], ["hypertrophy", "OBSERVATION", 56, 67], ["enlarges", "OBSERVATION", 76, 84], ["entire", "ANATOMY_MODIFIER", 89, 95], ["liver", "ANATOMY", 96, 101]]], ["Although hepatocellular hypertrophy is most often associated with preferential increase in SER,HEPATOCELLULAR ADAPTATIONS AND INTRACELLULAR ACCUMULATIONThe liver must be highly adaptable to balance function with changing demand.", [["hepatocellular", "ANATOMY", 9, 23], ["liver", "ANATOMY", 156, 161], ["hepatocellular hypertrophy", "DISEASE", 9, 35], ["hepatocellular", "ORGAN", 9, 23], ["liver", "ORGAN", 156, 161], ["hepatocellular hypertrophy", "PROBLEM", 9, 35], ["preferential increase in SER,HEPATOCELLULAR ADAPTATIONS", "PROBLEM", 66, 121], ["INTRACELLULAR ACCUMULATION", "PROBLEM", 126, 152], ["changing demand", "TREATMENT", 212, 227], ["hepatocellular", "ANATOMY", 9, 23], ["hypertrophy", "OBSERVATION", 24, 35], ["preferential", "OBSERVATION_MODIFIER", 66, 78], ["increase", "OBSERVATION_MODIFIER", 79, 87], ["SER", "OBSERVATION_MODIFIER", 91, 94], ["HEPATOCELLULAR", "ANATOMY", 95, 109], ["INTRACELLULAR ACCUMULATION", "OBSERVATION", 126, 152], ["liver", "ANATOMY", 156, 161]]], ["Increases in the size of hepatocytes (hypertrophy) and their numbers (hyperplasia) collectively bring a larger mass of hepatocytes into service.", [["hepatocytes", "ANATOMY", 25, 36], ["hepatocytes", "ANATOMY", 119, 130], ["hypertrophy", "DISEASE", 38, 49], ["hyperplasia", "DISEASE", 70, 81], ["hepatocytes", "CELL", 25, 36], ["hepatocytes", "CELL", 119, 130], ["hepatocytes", "CELL_TYPE", 25, 36], ["hepatocytes", "CELL_TYPE", 119, 130], ["hepatocytes (hypertrophy", "PROBLEM", 25, 49], ["their numbers (hyperplasia)", "PROBLEM", 55, 82], ["a larger mass of hepatocytes", "PROBLEM", 102, 130], ["size", "OBSERVATION_MODIFIER", 17, 21], ["hepatocytes", "ANATOMY", 25, 36], ["hypertrophy", "OBSERVATION", 38, 49], ["numbers", "OBSERVATION_MODIFIER", 61, 68], ["hyperplasia", "OBSERVATION", 70, 81], ["larger", "OBSERVATION_MODIFIER", 104, 110], ["mass", "OBSERVATION", 111, 115], ["hepatocytes", "ANATOMY", 119, 130]]], ["Such adaptations in hepatic volume and function result from alterations in the expression of many genes.", [["hepatic", "ANATOMY", 20, 27], ["hepatic", "MULTI-TISSUE_STRUCTURE", 20, 27], ["hepatic volume", "TEST", 20, 34], ["hepatic", "ANATOMY", 20, 27], ["volume", "OBSERVATION", 28, 34]]], ["These responses are more evident in smaller species, notably in laboratory rodents that have a very pronounced liver growth response after exposure to various xenobiotics.", [["liver", "ANATOMY", 111, 116], ["liver", "ORGAN", 111, 116], ["smaller species", "PROBLEM", 36, 51], ["various xenobiotics", "TREATMENT", 151, 170], ["smaller", "OBSERVATION_MODIFIER", 36, 43], ["species", "OBSERVATION", 44, 51], ["very", "OBSERVATION_MODIFIER", 95, 99], ["pronounced", "OBSERVATION_MODIFIER", 100, 110], ["liver", "ANATOMY", 111, 116], ["growth", "OBSERVATION", 117, 123]]], ["The liver can also adapt to reduced demand or oxygen supply by a combination of cellular atrophy and apoptosis.", [["liver", "ANATOMY", 4, 9], ["cellular", "ANATOMY", 80, 88], ["oxygen", "CHEMICAL", 46, 52], ["atrophy", "DISEASE", 89, 96], ["oxygen", "CHEMICAL", 46, 52], ["liver", "ORGAN", 4, 9], ["oxygen", "SIMPLE_CHEMICAL", 46, 52], ["cellular", "CELL", 80, 88], ["reduced demand", "PROBLEM", 28, 42], ["oxygen supply", "TREATMENT", 46, 59], ["cellular atrophy", "PROBLEM", 80, 96], ["apoptosis", "PROBLEM", 101, 110], ["liver", "ANATOMY", 4, 9], ["reduced", "OBSERVATION_MODIFIER", 28, 35], ["demand", "OBSERVATION", 36, 42], ["oxygen supply", "OBSERVATION", 46, 59], ["cellular atrophy", "OBSERVATION", 80, 96], ["apoptosis", "OBSERVATION_MODIFIER", 101, 110]]], ["Hepatocytes can be lost by apoptosis in substantial numbers, with minimal elevation in serum enzymes of hepatic origin such as alanine aminotransferase.Hepatocellular atrophyHepatic mass readily adapts to metabolic demands, and the liver can undergo marked atrophy during illness and/or starvation without much evidence of impaired hepatic function.", [["Hepatocytes", "ANATOMY", 0, 11], ["serum", "ANATOMY", 87, 92], ["hepatic", "ANATOMY", 104, 111], ["Hepatocellular atrophyHepatic mass", "ANATOMY", 152, 186], ["liver", "ANATOMY", 232, 237], ["hepatic", "ANATOMY", 332, 339], ["alanine", "CHEMICAL", 127, 134], ["atrophy", "DISEASE", 257, 264], ["illness", "DISEASE", 272, 279], ["impaired hepatic function", "DISEASE", 323, 348], ["alanine", "CHEMICAL", 127, 134], ["Hepatocytes", "CELL", 0, 11], ["serum", "ORGANISM_SUBSTANCE", 87, 92], ["hepatic", "ORGAN", 104, 111], ["alanine", "AMINO_ACID", 127, 134], ["aminotransferase", "GENE_OR_GENE_PRODUCT", 135, 151], ["Hepatocellular", "CANCER", 152, 166], ["liver", "ORGAN", 232, 237], ["hepatic", "ORGAN", 332, 339], ["Hepatocytes", "CELL_TYPE", 0, 11], ["serum enzymes", "PROTEIN", 87, 100], ["alanine aminotransferase", "PROTEIN", 127, 151], ["minimal elevation", "PROBLEM", 66, 83], ["serum enzymes", "TEST", 87, 100], ["alanine aminotransferase", "TEST", 127, 151], ["Hepatocellular atrophyHepatic mass", "PROBLEM", 152, 186], ["marked atrophy", "PROBLEM", 250, 264], ["illness", "PROBLEM", 272, 279], ["impaired hepatic function", "PROBLEM", 323, 348], ["apoptosis", "OBSERVATION_MODIFIER", 27, 36], ["substantial", "OBSERVATION_MODIFIER", 40, 51], ["numbers", "OBSERVATION_MODIFIER", 52, 59], ["minimal", "OBSERVATION_MODIFIER", 66, 73], ["elevation", "OBSERVATION", 74, 83], ["hepatic", "ANATOMY", 104, 111], ["origin", "ANATOMY_MODIFIER", 112, 118], ["alanine aminotransferase", "OBSERVATION", 127, 151], ["mass", "OBSERVATION", 182, 186], ["metabolic demands", "OBSERVATION", 205, 222], ["liver", "ANATOMY", 232, 237], ["marked", "OBSERVATION_MODIFIER", 250, 256], ["atrophy", "OBSERVATION", 257, 264], ["impaired", "OBSERVATION", 323, 331], ["hepatic", "ANATOMY", 332, 339], ["function", "OBSERVATION", 340, 348]]], ["During prolonged starvation, some hepatocytes are removed by apoptosis without replacement, but most of the atrophy is explained by loss of cytoplasmic mass.", [["hepatocytes", "ANATOMY", 34, 45], ["cytoplasmic", "ANATOMY", 140, 151], ["atrophy", "DISEASE", 108, 115], ["hepatocytes", "CELL", 34, 45], ["cytoplasmic", "ORGANISM_SUBSTANCE", 140, 151], ["hepatocytes", "CELL_TYPE", 34, 45], ["some hepatocytes", "PROBLEM", 29, 45], ["replacement", "TREATMENT", 79, 90], ["the atrophy", "PROBLEM", 104, 115], ["loss of cytoplasmic mass", "PROBLEM", 132, 156], ["hepatocytes", "ANATOMY", 34, 45], ["apoptosis", "OBSERVATION_MODIFIER", 61, 70], ["without", "UNCERTAINTY", 71, 78], ["replacement", "OBSERVATION_MODIFIER", 79, 90], ["atrophy", "OBSERVATION", 108, 115], ["loss", "OBSERVATION_MODIFIER", 132, 136], ["cytoplasmic", "OBSERVATION_MODIFIER", 140, 151], ["mass", "OBSERVATION", 152, 156]]], ["Atrophic livers, as seen, for example, in old grazing herbivores with poor teeth, are dark and small, and the capsule may appear too large for the organ, showing fine wrinkles on handling.", [["livers", "ANATOMY", 9, 15], ["teeth", "ANATOMY", 75, 80], ["capsule", "ANATOMY", 110, 117], ["organ", "ANATOMY", 147, 152], ["livers", "ORGAN", 9, 15], ["teeth", "ORGAN", 75, 80], ["capsule", "CANCER", 110, 117], ["organ", "ORGAN", 147, 152], ["Atrophic livers", "PROBLEM", 0, 15], ["poor teeth", "PROBLEM", 70, 80], ["dark and small, and the capsule", "PROBLEM", 86, 117], ["fine wrinkles", "PROBLEM", 162, 175], ["livers", "ANATOMY", 9, 15], ["grazing herbivores", "OBSERVATION", 46, 64], ["poor teeth", "OBSERVATION", 70, 80], ["dark", "OBSERVATION_MODIFIER", 86, 90], ["small", "OBSERVATION_MODIFIER", 95, 100], ["capsule", "ANATOMY", 110, 117], ["may appear", "UNCERTAINTY", 118, 128], ["too", "OBSERVATION_MODIFIER", 129, 132], ["large", "OBSERVATION", 133, 138], ["organ", "ANATOMY", 147, 152], ["fine", "OBSERVATION_MODIFIER", 162, 166], ["wrinkles", "OBSERVATION", 167, 175]]], ["These livers may even appear to be firmer than normal because of condensation of normal stroma.", [["livers", "ANATOMY", 6, 12], ["stroma", "ANATOMY", 88, 94], ["livers", "ORGAN", 6, 12], ["stroma", "TISSUE", 88, 94], ["condensation of normal stroma", "PROBLEM", 65, 94], ["livers", "ANATOMY", 6, 12], ["may even appear to be", "UNCERTAINTY", 13, 34], ["firmer", "OBSERVATION", 35, 41], ["normal stroma", "OBSERVATION", 81, 94]]], ["Histologically, portal triads and hepatic venules are closer together, and lobules contain increased numbers of smaller hepatocytes with scanty cytoplasm (Fig. 2-14) .", [["portal triads", "ANATOMY", 16, 29], ["hepatic venules", "ANATOMY", 34, 49], ["lobules", "ANATOMY", 75, 82], ["hepatocytes", "ANATOMY", 120, 131], ["cytoplasm", "ANATOMY", 144, 153], ["portal triads", "MULTI-TISSUE_STRUCTURE", 16, 29], ["hepatic venules", "MULTI-TISSUE_STRUCTURE", 34, 49], ["lobules", "CANCER", 75, 82], ["hepatocytes", "CELL", 120, 131], ["cytoplasm", "ORGANISM_SUBSTANCE", 144, 153], ["hepatocytes", "CELL_TYPE", 120, 131], ["increased numbers of smaller hepatocytes", "PROBLEM", 91, 131], ["scanty cytoplasm", "PROBLEM", 137, 153], ["portal triads", "ANATOMY", 16, 29], ["hepatic", "ANATOMY", 34, 41], ["venules", "ANATOMY_MODIFIER", 42, 49], ["lobules", "OBSERVATION_MODIFIER", 75, 82], ["increased", "OBSERVATION_MODIFIER", 91, 100], ["numbers", "OBSERVATION_MODIFIER", 101, 108], ["smaller", "OBSERVATION_MODIFIER", 112, 119], ["hepatocytes", "ANATOMY", 120, 131], ["scanty", "OBSERVATION_MODIFIER", 137, 143], ["cytoplasm", "OBSERVATION_MODIFIER", 144, 153]]], ["Hepatocellular mass can be rapidly lost by autophagy and apoptosis (see later section on Types and patterns of cell death in the liver).Hepatocellular atrophyHepatic atrophy, rather than hepatocellular atrophy, can also result from impaired replication of hepatocytes.", [["Hepatocellular mass", "ANATOMY", 0, 19], ["cell", "ANATOMY", 111, 115], ["liver", "ANATOMY", 129, 134], ["Hepatocellular atrophyHepatic", "ANATOMY", 136, 165], ["hepatocellular", "ANATOMY", 187, 201], ["hepatocytes", "ANATOMY", 256, 267], ["death", "DISEASE", 116, 121], ["Hepatocellular atrophyHepatic atrophy", "DISEASE", 136, 173], ["hepatocellular atrophy", "DISEASE", 187, 209], ["Hepatocellular", "ORGAN", 0, 14], ["cell", "CELL", 111, 115], ["liver", "ORGAN", 129, 134], ["Hepatocellular atrophyHepatic", "PATHOLOGICAL_FORMATION", 136, 165], ["hepatocellular", "CANCER", 187, 201], ["hepatocytes", "CELL", 256, 267], ["hepatocytes", "CELL_TYPE", 256, 267], ["Hepatocellular mass", "PROBLEM", 0, 19], ["autophagy", "PROBLEM", 43, 52], ["apoptosis", "PROBLEM", 57, 66], ["cell death in the liver", "PROBLEM", 111, 134], ["Hepatocellular atrophyHepatic atrophy", "PROBLEM", 136, 173], ["hepatocellular atrophy", "PROBLEM", 187, 209], ["impaired replication of hepatocytes", "PROBLEM", 232, 267], ["mass", "OBSERVATION", 15, 19], ["apoptosis", "OBSERVATION_MODIFIER", 57, 66], ["cell death", "OBSERVATION", 111, 121], ["liver", "ANATOMY", 129, 134], ["atrophyHepatic", "OBSERVATION_MODIFIER", 151, 165], ["atrophy", "OBSERVATION", 166, 173], ["hepatocellular", "ANATOMY", 187, 201], ["atrophy", "OBSERVATION", 202, 209], ["impaired", "OBSERVATION_MODIFIER", 232, 240], ["replication", "OBSERVATION", 241, 252], ["hepatocytes", "ANATOMY", 256, 267]]], ["Most adult hepatocytes are replicatively competent, although mitotic figures are infrequent because healthy hepatocytes have a relatively long life-span of several months.", [["hepatocytes", "ANATOMY", 11, 22], ["hepatocytes", "ANATOMY", 108, 119], ["hepatocytes", "CELL", 11, 22], ["hepatocytes", "CELL", 108, 119], ["adult hepatocytes", "CELL_TYPE", 5, 22], ["healthy hepatocytes", "CELL_TYPE", 100, 119], ["mitotic figures", "PROBLEM", 61, 76], ["healthy hepatocytes", "PROBLEM", 100, 119], ["hepatocytes", "ANATOMY", 11, 22], ["mitotic figures", "OBSERVATION", 61, 76]]], ["Diminished portal blood flow not only limits oxygen, but also trophic factors that act to regulate replication and mass of the liver.", [["portal blood", "ANATOMY", 11, 23], ["liver", "ANATOMY", 127, 132], ["oxygen", "CHEMICAL", 45, 51], ["oxygen", "CHEMICAL", 45, 51], ["portal", "MULTI-TISSUE_STRUCTURE", 11, 17], ["blood", "ORGANISM_SUBSTANCE", 18, 23], ["oxygen", "SIMPLE_CHEMICAL", 45, 51], ["liver", "ORGAN", 127, 132], ["trophic factors", "PROTEIN", 62, 77], ["Diminished portal blood flow", "PROBLEM", 0, 28], ["trophic factors", "PROBLEM", 62, 77], ["mass of the liver", "PROBLEM", 115, 132], ["portal blood", "ANATOMY", 11, 23], ["flow", "OBSERVATION", 24, 28], ["oxygen", "OBSERVATION_MODIFIER", 45, 51], ["mass", "OBSERVATION", 115, 119], ["liver", "ANATOMY", 127, 132]]], ["These trophic factors include several polypeptide growth factors, including hepato-Intranuclear inclusionsIn addition to the various nuclear inclusions associated with some viral infections, 3 types of inclusions may be found in hepatocyte nuclei.", [["nuclear", "ANATOMY", 133, 140], ["hepatocyte nuclei", "ANATOMY", 229, 246], ["viral infections", "DISEASE", 173, 189], ["nuclear", "CELLULAR_COMPONENT", 133, 140], ["hepatocyte nuclei", "CELLULAR_COMPONENT", 229, 246], ["trophic factors", "PROTEIN", 6, 21], ["polypeptide growth factors", "PROTEIN", 38, 64], ["These trophic factors", "PROBLEM", 0, 21], ["several polypeptide growth factors", "PROBLEM", 30, 64], ["Intranuclear inclusions", "PROBLEM", 83, 106], ["the various nuclear inclusions", "PROBLEM", 121, 151], ["some viral infections", "PROBLEM", 168, 189], ["inclusions", "PROBLEM", 202, 212], ["hepatocyte nuclei", "PROBLEM", 229, 246], ["Intranuclear inclusions", "OBSERVATION", 83, 106], ["inclusions", "OBSERVATION", 141, 151], ["viral", "OBSERVATION_MODIFIER", 173, 178], ["infections", "OBSERVATION", 179, 189], ["may be found", "UNCERTAINTY", 213, 225], ["hepatocyte nuclei", "ANATOMY", 229, 246]]], ["Spherical, apparently hollow globules within the body of the nucleus are membrane-bound entrapped nuclear membrane invaginations that ultrastructurally contain cytoplasmic components such as glycogen and mitochondria.", [["hollow globules", "ANATOMY", 22, 37], ["body", "ANATOMY", 49, 53], ["nucleus", "ANATOMY", 61, 68], ["membrane", "ANATOMY", 73, 81], ["nuclear membrane invaginations", "ANATOMY", 98, 128], ["cytoplasmic components", "ANATOMY", 160, 182], ["mitochondria", "ANATOMY", 204, 216], ["body", "ORGANISM_SUBDIVISION", 49, 53], ["nucleus", "CELLULAR_COMPONENT", 61, 68], ["membrane", "CELLULAR_COMPONENT", 73, 81], ["nuclear", "CELLULAR_COMPONENT", 98, 105], ["membrane invaginations", "CELLULAR_COMPONENT", 106, 128], ["cytoplasmic components", "CELLULAR_COMPONENT", 160, 182], ["glycogen", "SIMPLE_CHEMICAL", 191, 199], ["mitochondria", "CELLULAR_COMPONENT", 204, 216], ["nuclear membrane invaginations", "PROBLEM", 98, 128], ["cytoplasmic components", "PROBLEM", 160, 182], ["hollow globules", "OBSERVATION", 22, 37], ["body", "ANATOMY_MODIFIER", 49, 53], ["nucleus", "ANATOMY_MODIFIER", 61, 68], ["membrane", "OBSERVATION_MODIFIER", 73, 81], ["bound", "OBSERVATION_MODIFIER", 82, 87], ["entrapped", "OBSERVATION_MODIFIER", 88, 97], ["nuclear membrane invaginations", "OBSERVATION", 98, 128], ["cytoplasmic components", "OBSERVATION", 160, 182]]], ["These inclusions are infrequent in otherwise normal livers but are more often seen in chronically injured livers, especially in chronic pyrrolizidine alkaloid poisoning, in which polyploid nuclei are more likely to indent and invaginate.", [["livers", "ANATOMY", 52, 58], ["livers", "ANATOMY", 106, 112], ["nuclei", "ANATOMY", 189, 195], ["pyrrolizidine alkaloid", "CHEMICAL", 136, 158], ["poisoning", "DISEASE", 159, 168], ["pyrrolizidine alkaloid", "CHEMICAL", 136, 158], ["livers", "ORGAN", 52, 58], ["livers", "ORGAN", 106, 112], ["pyrrolizidine alkaloid", "SIMPLE_CHEMICAL", 136, 158], ["nuclei", "CELLULAR_COMPONENT", 189, 195], ["chronically injured livers", "PROBLEM", 86, 112], ["chronic pyrrolizidine alkaloid poisoning", "PROBLEM", 128, 168], ["polyploid nuclei", "PROBLEM", 179, 195], ["inclusions", "OBSERVATION", 6, 16], ["infrequent", "OBSERVATION_MODIFIER", 21, 31], ["otherwise", "OBSERVATION_MODIFIER", 35, 44], ["normal", "OBSERVATION", 45, 51], ["livers", "ANATOMY", 52, 58], ["more often", "OBSERVATION_MODIFIER", 67, 77], ["chronically", "OBSERVATION_MODIFIER", 86, 97], ["injured", "OBSERVATION", 98, 105], ["livers", "ANATOMY", 106, 112], ["chronic", "OBSERVATION_MODIFIER", 128, 135], ["pyrrolizidine", "OBSERVATION", 136, 149], ["alkaloid poisoning", "OBSERVATION", 150, 168], ["polyploid nuclei", "OBSERVATION", 179, 195], ["more likely", "UNCERTAINTY", 200, 211]]], ["Eosinophilic block-like intranuclear inclusions with a regular crystal lattice (\"brick inclusions\") are common in hepatocytes and renal proximal tubular epithelium.", [["hepatocytes", "ANATOMY", 114, 125], ["renal proximal tubular epithelium", "ANATOMY", 130, 163], ["hepatocytes", "CELL", 114, 125], ["renal proximal tubular epithelium", "TISSUE", 130, 163], ["hepatocytes", "CELL_TYPE", 114, 125], ["Eosinophilic block", "PROBLEM", 0, 18], ["intranuclear inclusions", "PROBLEM", 24, 47], ["a regular crystal lattice (\"brick inclusions\"", "PROBLEM", 53, 98], ["renal proximal tubular epithelium", "PROBLEM", 130, 163], ["intranuclear inclusions", "OBSERVATION", 24, 47], ["crystal lattice", "OBSERVATION", 63, 78], ["brick inclusions", "OBSERVATION", 81, 97], ["hepatocytes", "ANATOMY", 114, 125], ["renal", "ANATOMY", 130, 135], ["proximal", "ANATOMY_MODIFIER", 136, 144], ["tubular", "ANATOMY_MODIFIER", 145, 152], ["epithelium", "ANATOMY_MODIFIER", 153, 163]]], ["They are more numerous in old animals, particularly dogs.", [["dogs", "ORGANISM", 52, 56], ["dogs", "SPECIES", 52, 56], ["more", "OBSERVATION_MODIFIER", 9, 13], ["numerous", "OBSERVATION_MODIFIER", 14, 22]]], ["Their composition and pathogenesis are still unknown, but they evidently have little effect on the health of the cells in which they occur, even when they are large enough to distort the nucleus.", [["cells", "ANATOMY", 113, 118], ["nucleus", "ANATOMY", 187, 194], ["cells", "CELL", 113, 118], ["nucleus", "CELLULAR_COMPONENT", 187, 194], ["pathogenesis", "PROBLEM", 22, 34], ["large", "OBSERVATION", 159, 164], ["nucleus", "ANATOMY", 187, 194]]], ["They do not contain heavy metals and can be distinguished from the acid-fast, noncrystalline intranuclear inclusions observed in renal epithelial cells and occasionally in hepatocytes in lead poisoning.", [["renal epithelial cells", "ANATOMY", 129, 151], ["hepatocytes", "ANATOMY", 172, 183], ["poisoning", "DISEASE", 192, 201], ["renal epithelial cells", "CELL", 129, 151], ["hepatocytes", "CELL", 172, 183], ["renal epithelial cells", "CELL_TYPE", 129, 151], ["hepatocytes", "CELL_TYPE", 172, 183], ["the acid-fast", "TEST", 63, 76], ["noncrystalline intranuclear inclusions", "PROBLEM", 78, 116], ["renal epithelial cells", "PROBLEM", 129, 151], ["heavy", "OBSERVATION_MODIFIER", 20, 25], ["metals", "OBSERVATION", 26, 32], ["intranuclear inclusions", "OBSERVATION", 93, 116], ["renal", "ANATOMY", 129, 134], ["epithelial cells", "OBSERVATION", 135, 151], ["hepatocytes", "ANATOMY", 172, 183], ["lead poisoning", "OBSERVATION", 187, 201]]], ["Lead inclusions consist of a lead-protein complex and have a characteristic furry electron-dense ultrastructure.PigmentationCongenital melanosis occurs in calves and occasionally in lambs and swine.", [["calves", "ANATOMY", 155, 161], ["Congenital melanosis", "DISEASE", 124, 144], ["electron", "SIMPLE_CHEMICAL", 82, 90], ["calves", "ORGANISM", 155, 161], ["lambs", "ORGANISM_SUBDIVISION", 182, 187], ["protein complex", "PROTEIN", 34, 49], ["calves", "SPECIES", 155, 161], ["lambs", "SPECIES", 182, 187], ["swine", "SPECIES", 192, 197], ["swine", "SPECIES", 192, 197], ["Lead inclusions", "PROBLEM", 0, 15], ["a lead-protein complex", "PROBLEM", 27, 49], ["a characteristic furry electron-dense ultrastructure", "PROBLEM", 59, 111], ["Pigmentation", "PROBLEM", 112, 124], ["Congenital melanosis", "PROBLEM", 124, 144], ["inclusions", "OBSERVATION", 5, 15], ["dense", "OBSERVATION_MODIFIER", 91, 96], ["ultrastructure", "OBSERVATION", 97, 111], ["Congenital", "OBSERVATION_MODIFIER", 124, 134], ["melanosis", "OBSERVATION", 135, 144], ["calves", "OBSERVATION_MODIFIER", 155, 161]]], ["The melanin deposits may be numerous, and vary in size from flecks, to irregular, blue-black areas 2 cm or more in diameter.", [["melanin deposits", "ANATOMY", 4, 20], ["flecks", "ANATOMY", 60, 66], ["flecks", "DISEASE", 60, 66], ["melanin", "SIMPLE_CHEMICAL", 4, 11], ["The melanin deposits", "PROBLEM", 0, 20], ["flecks", "PROBLEM", 60, 66], ["irregular, blue-black areas", "PROBLEM", 71, 98], ["melanin deposits", "OBSERVATION", 4, 20], ["may be", "UNCERTAINTY", 21, 27], ["numerous", "OBSERVATION_MODIFIER", 28, 36], ["vary", "OBSERVATION_MODIFIER", 42, 46], ["size", "OBSERVATION_MODIFIER", 50, 54], ["flecks", "OBSERVATION", 60, 66], ["irregular", "OBSERVATION_MODIFIER", 71, 80], ["blue", "OBSERVATION_MODIFIER", 82, 86], ["black", "OBSERVATION_MODIFIER", 87, 92], ["areas", "OBSERVATION_MODIFIER", 93, 98], ["2 cm", "OBSERVATION_MODIFIER", 99, 103], ["more", "OBSERVATION_MODIFIER", 107, 111], ["diameter", "OBSERVATION_MODIFIER", 115, 123]]], ["The melanin is confined to the capsule and the stroma.", [["capsule", "ANATOMY", 31, 38], ["stroma", "ANATOMY", 47, 53], ["melanin", "CHEMICAL", 4, 11], ["melanin", "SIMPLE_CHEMICAL", 4, 11], ["capsule", "CANCER", 31, 38], ["stroma", "TISSUE", 47, 53], ["The melanin", "PROBLEM", 0, 11], ["melanin", "OBSERVATION", 4, 11], ["capsule", "ANATOMY", 31, 38], ["stroma", "OBSERVATION", 47, 53]]], ["These deposits are sharply defined in young animals, but become more diffuse and fade with age (eFig.", [["deposits", "OBSERVATION", 6, 14], ["sharply", "OBSERVATION_MODIFIER", 19, 26], ["young animals", "OBSERVATION_MODIFIER", 38, 51], ["more", "OBSERVATION_MODIFIER", 64, 68], ["diffuse", "OBSERVATION_MODIFIER", 69, 76]]], ["A condition known as acquired melanosis is the massive accumulation of black pigment (not melanin) in hepatocytes and Kupffer cells of mature sheep and, less frequently cattle, after prolonged grazing on extensive unimproved pastures in inland eastern Australia, the Falkland Islands, and Scandinavia.", [["hepatocytes", "ANATOMY", 102, 113], ["Kupffer cells", "ANATOMY", 118, 131], ["melanosis", "DISEASE", 30, 39], ["melanin", "SIMPLE_CHEMICAL", 90, 97], ["hepatocytes", "CELL", 102, 113], ["Kupffer cells", "CELL", 118, 131], ["sheep", "ORGANISM", 142, 147], ["hepatocytes", "CELL_TYPE", 102, 113], ["Kupffer cells", "CELL_TYPE", 118, 131], ["sheep", "SPECIES", 142, 147], ["cattle", "SPECIES", 169, 175], ["sheep", "SPECIES", 142, 147], ["cattle", "SPECIES", 169, 175], ["A condition", "PROBLEM", 0, 11], ["acquired melanosis", "PROBLEM", 21, 39], ["black pigment", "PROBLEM", 71, 84], ["melanosis", "OBSERVATION", 30, 39], ["massive", "OBSERVATION_MODIFIER", 47, 54], ["accumulation", "OBSERVATION_MODIFIER", 55, 67], ["black pigment", "OBSERVATION", 71, 84], ["hepatocytes", "ANATOMY", 102, 113], ["Kupffer cells", "OBSERVATION", 118, 131], ["mature", "OBSERVATION_MODIFIER", 135, 141], ["sheep", "OBSERVATION_MODIFIER", 142, 147], ["extensive", "OBSERVATION_MODIFIER", 204, 213], ["unimproved", "OBSERVATION_MODIFIER", 214, 224], ["pastures", "OBSERVATION", 225, 233], ["Falkland Islands", "OBSERVATION", 267, 283]]], ["The condition in Norway has also been described as hepatic lipofuscinosis.", [["hepatic", "ANATOMY", 51, 58], ["hepatic lipofuscinosis", "DISEASE", 51, 73], ["hepatic", "ORGAN", 51, 58], ["hepatic lipofuscinosis", "PROBLEM", 51, 73], ["hepatic", "ANATOMY", 51, 58], ["lipofuscinosis", "OBSERVATION", 59, 73]]], ["The color of the affected livers ranges from a dull gray to uniform black, and there is usually a prominent acinar pattern.", [["livers", "ANATOMY", 26, 32], ["acinar", "ANATOMY", 108, 114], ["livers", "ORGAN", 26, 32], ["acinar", "CANCER", 108, 114], ["a dull gray", "PROBLEM", 45, 56], ["a prominent acinar pattern", "PROBLEM", 96, 122], ["color", "OBSERVATION_MODIFIER", 4, 9], ["affected", "OBSERVATION", 17, 25], ["livers", "ANATOMY", 26, 32], ["ranges", "OBSERVATION_MODIFIER", 33, 39], ["dull gray", "OBSERVATION_MODIFIER", 47, 56], ["uniform", "OBSERVATION_MODIFIER", 60, 67], ["black", "OBSERVATION_MODIFIER", 68, 73], ["prominent", "OBSERVATION_MODIFIER", 98, 107], ["acinar pattern", "OBSERVATION", 108, 122]]], ["In severe cases, there is also pigmentation of the hepatic lymph nodes, lungs, and renal cortex.", [["hepatic lymph nodes", "ANATOMY", 51, 70], ["lungs", "ANATOMY", 72, 77], ["renal cortex", "ANATOMY", 83, 95], ["hepatic lymph nodes", "MULTI-TISSUE_STRUCTURE", 51, 70], ["lungs", "ORGAN", 72, 77], ["renal cortex", "MULTI-TISSUE_STRUCTURE", 83, 95], ["pigmentation of the hepatic lymph nodes, lungs, and renal cortex", "PROBLEM", 31, 95], ["severe", "OBSERVATION_MODIFIER", 3, 9], ["cases", "OBSERVATION", 10, 15], ["pigmentation", "OBSERVATION_MODIFIER", 31, 43], ["hepatic", "ANATOMY", 51, 58], ["lymph nodes", "OBSERVATION", 59, 70], ["lungs", "ANATOMY", 72, 77], ["renal", "ANATOMY", 83, 88], ["cortex", "ANATOMY_MODIFIER", 89, 95]]], ["Histologically, the pigment is present as granules in lysosomes in periportal and midzonal hepatocytes and macrophages of the liver, the proximal tubular epithelium of the kidneys, and in alveolar and interstitial macrophages in the lung.", [["pigment", "ANATOMY", 20, 27], ["granules", "ANATOMY", 42, 50], ["lysosomes", "ANATOMY", 54, 63], ["periportal", "ANATOMY", 67, 77], ["midzonal hepatocytes", "ANATOMY", 82, 102], ["macrophages", "ANATOMY", 107, 118], ["liver", "ANATOMY", 126, 131], ["tubular epithelium", "ANATOMY", 146, 164], ["kidneys", "ANATOMY", 172, 179], ["alveolar", "ANATOMY", 188, 196], ["interstitial macrophages", "ANATOMY", 201, 225], ["lung", "ANATOMY", 233, 237], ["granules", "ORGANISM_SUBSTANCE", 42, 50], ["lysosomes", "CELLULAR_COMPONENT", 54, 63], ["periportal", "CELL", 67, 77], ["midzonal hepatocytes", "CELL", 82, 102], ["macrophages", "CELL", 107, 118], ["liver", "ORGAN", 126, 131], ["tubular epithelium", "TISSUE", 146, 164], ["kidneys", "ORGAN", 172, 179], ["alveolar", "CELL", 188, 196], ["interstitial macrophages", "CELL", 201, 225], ["lung", "ORGAN", 233, 237], ["periportal and midzonal hepatocytes", "CELL_TYPE", 67, 102], ["macrophages", "CELL_TYPE", 107, 118], ["alveolar and interstitial macrophages", "CELL_TYPE", 188, 225], ["alveolar and interstitial macrophages in the lung", "PROBLEM", 188, 237], ["pigment", "OBSERVATION", 20, 27], ["lysosomes", "OBSERVATION", 54, 63], ["periportal", "ANATOMY_MODIFIER", 67, 77], ["midzonal", "ANATOMY_MODIFIER", 82, 90], ["hepatocytes", "ANATOMY", 91, 102], ["macrophages", "OBSERVATION", 107, 118], ["liver", "ANATOMY", 126, 131], ["proximal", "ANATOMY_MODIFIER", 137, 145], ["tubular", "ANATOMY_MODIFIER", 146, 153], ["epithelium", "ANATOMY_MODIFIER", 154, 164], ["kidneys", "ANATOMY", 172, 179], ["alveolar", "ANATOMY_MODIFIER", 188, 196], ["interstitial", "ANATOMY_MODIFIER", 201, 213], ["macrophages", "OBSERVATION", 214, 225], ["lung", "ANATOMY", 233, 237]]], ["There is no evidence of liver dysfunction, even in the blackest livers.", [["liver", "ANATOMY", 24, 29], ["livers", "ANATOMY", 64, 70], ["liver dysfunction", "DISEASE", 24, 41], ["liver", "ORGAN", 24, 29], ["livers", "ORGAN", 64, 70], ["liver dysfunction", "PROBLEM", 24, 41], ["no evidence of", "UNCERTAINTY", 9, 23], ["liver", "ANATOMY", 24, 29], ["dysfunction", "OBSERVATION", 30, 41], ["livers", "ANATOMY", 64, 70]]], ["The source of this pigment is not known, but the epidemiologic features of its occurrence indicate that it is derived from a component of the diet that is sequestered within lysosomes.PigmentationBile pigmentation may impart an olive-green color to the liver in diffuse or segmental obstructive biliary disease or intrahepatic cholestasis.", [["lysosomes", "ANATOMY", 174, 183], ["liver", "ANATOMY", 253, 258], ["biliary", "ANATOMY", 295, 302], ["intrahepatic cholestasis", "ANATOMY", 314, 338], ["obstructive biliary disease", "DISEASE", 283, 310], ["intrahepatic cholestasis", "DISEASE", 314, 338], ["lysosomes", "CELLULAR_COMPONENT", 174, 183], ["liver", "ORGAN", 253, 258], ["biliary", "ORGAN", 295, 302], ["this pigment", "PROBLEM", 14, 26], ["PigmentationBile pigmentation", "PROBLEM", 184, 213], ["diffuse or segmental obstructive biliary disease", "PROBLEM", 262, 310], ["intrahepatic cholestasis", "PROBLEM", 314, 338], ["pigment", "OBSERVATION", 19, 26], ["not known", "UNCERTAINTY", 30, 39], ["pigmentation", "OBSERVATION", 201, 213], ["green color", "OBSERVATION", 234, 245], ["liver", "ANATOMY", 253, 258], ["diffuse", "OBSERVATION_MODIFIER", 262, 269], ["segmental", "ANATOMY_MODIFIER", 273, 282], ["obstructive", "OBSERVATION_MODIFIER", 283, 294], ["biliary", "ANATOMY", 295, 302], ["disease", "OBSERVATION", 303, 310], ["intrahepatic", "ANATOMY_MODIFIER", 314, 326], ["cholestasis", "OBSERVATION", 327, 338]]], ["Histologically, conjugated bile pigments may distend bile canaliculi, visible microscopically as golden-brown linear streaks arrayed in a chicken wire-like pattern between the hepatocytes (Fig. 2-16 ).", [["bile pigments", "ANATOMY", 27, 40], ["bile canaliculi", "ANATOMY", 53, 68], ["hepatocytes", "ANATOMY", 176, 187], ["bile pigments", "SIMPLE_CHEMICAL", 27, 40], ["bile canaliculi", "MULTI-TISSUE_STRUCTURE", 53, 68], ["chicken", "ORGANISM", 138, 145], ["hepatocytes", "CELL", 176, 187], ["hepatocytes", "CELL_TYPE", 176, 187], ["chicken", "SPECIES", 138, 145], ["chicken", "SPECIES", 138, 145], ["bile canaliculi", "PROBLEM", 53, 68], ["brown linear streaks", "PROBLEM", 104, 124], ["a chicken wire", "TREATMENT", 136, 150], ["bile", "ANATOMY", 27, 31], ["bile canaliculi", "ANATOMY", 53, 68], ["golden", "OBSERVATION_MODIFIER", 97, 103], ["brown linear", "OBSERVATION_MODIFIER", 104, 116], ["streaks", "OBSERVATION_MODIFIER", 117, 124], ["arrayed", "OBSERVATION_MODIFIER", 125, 132], ["chicken wire", "OBSERVATION_MODIFIER", 138, 150], ["hepatocytes", "ANATOMY", 176, 187]]], ["In this case, the identity of the pigment is obvious, but when it is present in granular form in Kupffer cell cytoplasm, it may easily be confused with hemosiderin and hematin.", [["pigment", "ANATOMY", 34, 41], ["Kupffer cell cytoplasm", "ANATOMY", 97, 119], ["hematin", "CHEMICAL", 168, 175], ["pigment", "TISSUE", 34, 41], ["Kupffer cell", "CELL", 97, 109], ["cytoplasm", "ORGANISM_SUBSTANCE", 110, 119], ["hemosiderin", "SIMPLE_CHEMICAL", 152, 163], ["hematin", "SIMPLE_CHEMICAL", 168, 175], ["hemosiderin and hematin", "PROBLEM", 152, 175], ["pigment", "OBSERVATION", 34, 41], ["obvious", "OBSERVATION_MODIFIER", 45, 52], ["granular", "OBSERVATION_MODIFIER", 80, 88], ["Kupffer cell cytoplasm", "OBSERVATION", 97, 119], ["hemosiderin", "OBSERVATION", 152, 163]]], ["Bile pigment is encountered infrequently in hepatocyte cytoplasm, almost never in proliferation of peroxisomes, or mitochondria can also cause hepatocellular hypertrophy.", [["Bile pigment", "ANATOMY", 0, 12], ["hepatocyte cytoplasm", "ANATOMY", 44, 64], ["peroxisomes", "ANATOMY", 99, 110], ["mitochondria", "ANATOMY", 115, 127], ["hepatocellular", "ANATOMY", 143, 157], ["hepatocellular hypertrophy", "DISEASE", 143, 169], ["Bile pigment", "TISSUE", 0, 12], ["hepatocyte cytoplasm", "ORGANISM_SUBSTANCE", 44, 64], ["peroxisomes", "CELLULAR_COMPONENT", 99, 110], ["mitochondria", "CELLULAR_COMPONENT", 115, 127], ["hepatocellular", "ORGAN", 143, 157], ["Bile pigment", "PROBLEM", 0, 12], ["hepatocyte cytoplasm", "PROBLEM", 44, 64], ["proliferation of peroxisomes", "PROBLEM", 82, 110], ["hepatocellular hypertrophy", "PROBLEM", 143, 169], ["pigment", "OBSERVATION", 5, 12], ["hepatocyte", "ANATOMY", 44, 54], ["cytoplasm", "OBSERVATION", 55, 64], ["proliferation", "OBSERVATION_MODIFIER", 82, 95], ["can also cause", "UNCERTAINTY", 128, 142], ["hepatocellular", "ANATOMY", 143, 157], ["hypertrophy", "OBSERVATION", 158, 169]]], ["The light microscopic appearance of hypertrophy upon routine hematoxylin and eosin (H&E) staining will sometimes suggest the selective involvement of one organelle.", [["organelle", "ANATOMY", 154, 163], ["hypertrophy", "DISEASE", 36, 47], ["hematoxylin", "CHEMICAL", 61, 72], ["eosin", "CHEMICAL", 77, 82], ["hematoxylin", "SIMPLE_CHEMICAL", 61, 72], ["organelle", "CELLULAR_COMPONENT", 154, 163], ["hypertrophy", "PROBLEM", 36, 47], ["routine hematoxylin", "TREATMENT", 53, 72], ["eosin", "TREATMENT", 77, 82], ["light microscopic", "OBSERVATION_MODIFIER", 4, 21], ["hypertrophy", "OBSERVATION", 36, 47]]], ["If total SER volume is increased, the cytoplasm will typically have an eosinophilic ground-glass appearance upon light microscopy.", [["cytoplasm", "ANATOMY", 38, 47], ["SER", "SIMPLE_CHEMICAL", 9, 12], ["cytoplasm", "ORGANISM_SUBSTANCE", 38, 47], ["total SER volume", "TEST", 3, 19], ["an eosinophilic ground-glass appearance", "PROBLEM", 68, 107], ["light microscopy", "TEST", 113, 129], ["volume", "OBSERVATION_MODIFIER", 13, 19], ["increased", "OBSERVATION_MODIFIER", 23, 32], ["eosinophilic", "OBSERVATION_MODIFIER", 71, 83], ["ground-glass appearance", "OBSERVATION", 84, 107]]], ["If total peroxisomal volume is increased, the cytoplasm is often noted to have an eosinophilic granular appearance.", [["peroxisomal", "ANATOMY", 9, 20], ["cytoplasm", "ANATOMY", 46, 55], ["peroxisomal", "CELLULAR_COMPONENT", 9, 20], ["cytoplasm", "ORGANISM_SUBSTANCE", 46, 55], ["total peroxisomal volume", "TEST", 3, 27], ["an eosinophilic granular appearance", "PROBLEM", 79, 114], ["total", "OBSERVATION_MODIFIER", 3, 8], ["peroxisomal volume", "OBSERVATION", 9, 27], ["increased", "OBSERVATION_MODIFIER", 31, 40], ["cytoplasm", "OBSERVATION_MODIFIER", 46, 55], ["eosinophilic", "OBSERVATION_MODIFIER", 82, 94], ["granular appearance", "OBSERVATION", 95, 114]]], ["The response can be seen within a few days after exposure to various drugs and other xenobiotic compounds.", [["various drugs", "TREATMENT", 61, 74], ["other xenobiotic compounds", "TREATMENT", 79, 105], ["xenobiotic compounds", "OBSERVATION", 85, 105]]], ["Accordingly, the liver becomes grossly enlarged.", [["liver", "ANATOMY", 17, 22], ["liver", "ORGAN", 17, 22], ["grossly enlarged", "PROBLEM", 31, 47], ["liver", "ANATOMY", 17, 22], ["grossly", "OBSERVATION_MODIFIER", 31, 38], ["enlarged", "OBSERVATION", 39, 47]]], ["This induction of SER or peroxisomes is reversible, and after discontinuation of exposure to the inducing agent, the expanded SER or excess peroxisomes are removed by autophagy, and many hepatocytes undergo apoptosis.", [["peroxisomes", "ANATOMY", 25, 36], ["peroxisomes", "ANATOMY", 140, 151], ["hepatocytes", "ANATOMY", 187, 198], ["SER", "GENE_OR_GENE_PRODUCT", 18, 21], ["peroxisomes", "CELLULAR_COMPONENT", 25, 36], ["SER", "CELL", 126, 129], ["peroxisomes", "CELLULAR_COMPONENT", 140, 151], ["hepatocytes", "CELL", 187, 198], ["hepatocytes", "CELL_TYPE", 187, 198], ["SER or peroxisomes", "PROBLEM", 18, 36], ["exposure", "TREATMENT", 81, 89], ["the inducing agent", "TREATMENT", 93, 111], ["excess peroxisomes", "PROBLEM", 133, 151], ["apoptosis", "PROBLEM", 207, 216], ["reversible", "OBSERVATION_MODIFIER", 40, 50], ["excess peroxisomes", "OBSERVATION", 133, 151], ["hepatocytes", "ANATOMY", 187, 198], ["apoptosis", "OBSERVATION", 207, 216]]], ["Although these changes are considered physiologic adaptations, there are potential adverse sequelae; accordingly, this response has toxicologic significance, and will be dealt with later in the section on Toxic hepatic disease.Polyploidy and multinucleationMost mature mammalian hepatocytes are tetraploid or octaploid, whereas many immature and replicating hepatocytes are diploid.", [["hepatic", "ANATOMY", 211, 218], ["hepatocytes", "ANATOMY", 279, 290], ["hepatocytes", "ANATOMY", 358, 369], ["Toxic hepatic disease", "DISEASE", 205, 226], ["Polyploidy", "DISEASE", 227, 237], ["hepatic", "ORGAN", 211, 218], ["mammalian hepatocytes", "CELL", 269, 290], ["hepatocytes", "CELL", 358, 369], ["mature mammalian hepatocytes", "CELL_TYPE", 262, 290], ["immature and replicating hepatocytes", "CELL_TYPE", 333, 369], ["potential adverse sequelae", "PROBLEM", 73, 99], ["Toxic hepatic disease", "PROBLEM", 205, 226], ["Polyploidy", "PROBLEM", 227, 237], ["tetraploid", "PROBLEM", 295, 305], ["octaploid", "PROBLEM", 309, 318], ["adverse", "OBSERVATION_MODIFIER", 83, 90], ["sequelae", "OBSERVATION", 91, 99], ["Toxic", "OBSERVATION_MODIFIER", 205, 210], ["hepatic", "ANATOMY", 211, 218], ["disease", "OBSERVATION", 219, 226], ["multinucleation", "OBSERVATION_MODIFIER", 242, 257], ["Most mature", "OBSERVATION_MODIFIER", 257, 268], ["mammalian hepatocytes", "OBSERVATION", 269, 290], ["tetraploid", "OBSERVATION_MODIFIER", 295, 305], ["octaploid", "OBSERVATION_MODIFIER", 309, 318], ["many", "OBSERVATION_MODIFIER", 328, 332], ["immature", "OBSERVATION_MODIFIER", 333, 341], ["hepatocytes", "ANATOMY", 358, 369]]], ["The relative proportion of polyploid hepatocytes varies among species, and polyploidy increases with age.", [["hepatocytes", "ANATOMY", 37, 48], ["polyploidy", "DISEASE", 75, 85], ["hepatocytes", "CELL", 37, 48], ["polyploid hepatocytes", "CELL_TYPE", 27, 48], ["polyploid hepatocytes", "PROBLEM", 27, 48], ["polyploidy", "PROBLEM", 75, 85], ["polyploid hepatocytes", "OBSERVATION", 27, 48], ["species", "OBSERVATION_MODIFIER", 62, 69], ["polyploidy", "OBSERVATION_MODIFIER", 75, 85], ["increases", "OBSERVATION_MODIFIER", 86, 95]]], ["Polyploidy is more common in rodents and is believed to result from asynchrony of cell division in which binucleated diploid cells undergo a second round of DNA replication, giving rise to 2 tetraploid daughter cells.", [["cell", "ANATOMY", 82, 86], ["cells", "ANATOMY", 125, 130], ["cells", "ANATOMY", 211, 216], ["Polyploidy", "DISEASE", 0, 10], ["cell", "CELL", 82, 86], ["diploid cells", "CELL", 117, 130], ["DNA", "CELLULAR_COMPONENT", 157, 160], ["daughter cells", "CELL", 202, 216], ["binucleated diploid cells", "CELL_TYPE", 105, 130], ["tetraploid daughter cells", "CELL_TYPE", 191, 216], ["Polyploidy", "PROBLEM", 0, 10], ["asynchrony of cell division", "PROBLEM", 68, 95], ["binucleated diploid cells", "PROBLEM", 105, 130], ["DNA replication", "TREATMENT", 157, 172], ["more common", "OBSERVATION_MODIFIER", 14, 25], ["cell division", "OBSERVATION", 82, 95], ["binucleated diploid cells", "OBSERVATION", 105, 130], ["DNA replication", "OBSERVATION", 157, 172]]], ["Impaired replication can also increase the number of polyploid cells.", [["cells", "ANATOMY", 63, 68], ["polyploid cells", "CELL", 53, 68], ["polyploid cells", "CELL_TYPE", 53, 68], ["Impaired replication", "PROBLEM", 0, 20], ["polyploid cells", "PROBLEM", 53, 68], ["replication", "OBSERVATION", 9, 20], ["number", "OBSERVATION_MODIFIER", 43, 49], ["polyploid cells", "OBSERVATION", 53, 68]]], ["The term megalocytosis was first used to describe the changes of liver cell cytoplasm and nucleus that occur in pyrrolizidine alkaloid poisoning.", [["liver cell cytoplasm", "ANATOMY", 65, 85], ["nucleus", "ANATOMY", 90, 97], ["pyrrolizidine alkaloid", "CHEMICAL", 112, 134], ["poisoning", "DISEASE", 135, 144], ["pyrrolizidine alkaloid", "CHEMICAL", 112, 134], ["liver cell", "ORGANISM_SUBSTANCE", 65, 75], ["cytoplasm", "ORGANISM_SUBSTANCE", 76, 85], ["nucleus", "CELLULAR_COMPONENT", 90, 97], ["pyrrolizidine alkaloid", "SIMPLE_CHEMICAL", 112, 134], ["The term megalocytosis", "PROBLEM", 0, 22], ["liver cell cytoplasm", "PROBLEM", 65, 85], ["pyrrolizidine alkaloid poisoning", "PROBLEM", 112, 144], ["liver", "ANATOMY", 65, 70], ["cell cytoplasm", "OBSERVATION", 71, 85], ["nucleus", "ANATOMY_MODIFIER", 90, 97], ["pyrrolizidine", "OBSERVATION", 112, 125], ["alkaloid poisoning", "OBSERVATION", 126, 144]]], ["This form of megalocytosis has some specific features and is described in the later section on Chronic hepatotoxicity.", [["megalocytosis", "DISEASE", 13, 26], ["hepatotoxicity", "DISEASE", 103, 117], ["megalocytosis", "CANCER", 13, 26], ["megalocytosis", "PROBLEM", 13, 26], ["Chronic hepatotoxicity", "PROBLEM", 95, 117], ["megalocytosis", "OBSERVATION", 13, 26], ["Chronic", "OBSERVATION_MODIFIER", 95, 102], ["hepatotoxicity", "OBSERVATION", 103, 117]]], ["Impaired regeneration, atrophy and >4N polyploidy can also be produced by other DNA-damaging agents such as aflatoxins.", [["atrophy", "DISEASE", 23, 30], ["aflatoxins", "CHEMICAL", 108, 118], ["aflatoxins", "CHEMICAL", 108, 118], ["DNA", "CELLULAR_COMPONENT", 80, 83], ["aflatoxins", "SIMPLE_CHEMICAL", 108, 118], ["Impaired regeneration", "PROBLEM", 0, 21], ["atrophy", "PROBLEM", 23, 30], ["4N polyploidy", "PROBLEM", 36, 49], ["damaging agents", "TREATMENT", 84, 99], ["aflatoxins", "TREATMENT", 108, 118], ["regeneration", "OBSERVATION", 9, 21], ["atrophy", "OBSERVATION", 23, 30], [">", "OBSERVATION_MODIFIER", 35, 36], ["4N polyploidy", "OBSERVATION", 36, 49]]], ["A feature of these patterns of atrophy with polyploidy is the persistence of larger replicatively impaired polyploid hepatocytes amid regenerating smaller diploid hepatocytes, hepatocellular nodules, and hyperplastic bile ductules.Polyploidy and multinucleationMost hepatocytes are mononuclear, but a variable proportion is binucleated, especially in young or regenerating livers of small animals.", [["hepatocytes", "ANATOMY", 117, 128], ["hepatocytes", "ANATOMY", 163, 174], ["hepatocellular nodules", "ANATOMY", 176, 198], ["hyperplastic bile ductules", "ANATOMY", 204, 230], ["hepatocytes", "ANATOMY", 266, 277], ["mononuclear", "ANATOMY", 282, 293], ["livers", "ANATOMY", 373, 379], ["atrophy", "DISEASE", 31, 38], ["polyploidy", "DISEASE", 44, 54], ["Polyploidy", "DISEASE", 231, 241], ["hepatocytes", "CELL", 117, 128], ["hepatocytes", "CELL", 163, 174], ["hepatocellular nodules", "CANCER", 176, 198], ["bile ductules", "MULTI-TISSUE_STRUCTURE", 217, 230], ["hepatocytes", "CELL", 266, 277], ["mononuclear", "CELL", 282, 293], ["livers", "ORGAN", 373, 379], ["polyploid hepatocytes", "CELL_TYPE", 107, 128], ["diploid hepatocytes", "CELL_TYPE", 155, 174], ["hepatocytes", "CELL_TYPE", 266, 277], ["mononuclear", "CELL_TYPE", 282, 293], ["atrophy", "PROBLEM", 31, 38], ["polyploidy", "PROBLEM", 44, 54], ["larger replicatively impaired polyploid hepatocytes", "PROBLEM", 77, 128], ["regenerating smaller diploid hepatocytes", "PROBLEM", 134, 174], ["hepatocellular nodules", "PROBLEM", 176, 198], ["hyperplastic bile ductules", "PROBLEM", 204, 230], ["Polyploidy", "PROBLEM", 231, 241], ["atrophy", "OBSERVATION", 31, 38], ["polyploidy", "OBSERVATION", 44, 54], ["larger", "OBSERVATION_MODIFIER", 77, 83], ["replicatively", "OBSERVATION_MODIFIER", 84, 97], ["impaired", "OBSERVATION_MODIFIER", 98, 106], ["polyploid hepatocytes", "OBSERVATION", 107, 128], ["amid", "OBSERVATION_MODIFIER", 129, 133], ["regenerating", "OBSERVATION_MODIFIER", 134, 146], ["smaller", "OBSERVATION_MODIFIER", 147, 154], ["diploid hepatocytes", "OBSERVATION", 155, 174], ["hepatocellular", "ANATOMY", 176, 190], ["nodules", "OBSERVATION", 191, 198], ["hyperplastic", "OBSERVATION", 204, 216], ["bile ductules", "ANATOMY", 217, 230], ["multinucleation", "OBSERVATION_MODIFIER", 246, 261], ["Most", "ANATOMY_MODIFIER", 261, 265], ["hepatocytes", "ANATOMY", 266, 277], ["mononuclear", "OBSERVATION_MODIFIER", 282, 293], ["variable", "OBSERVATION_MODIFIER", 301, 309], ["proportion", "OBSERVATION_MODIFIER", 310, 320], ["binucleated", "OBSERVATION", 324, 335], ["livers", "ANATOMY", 373, 379], ["small", "OBSERVATION_MODIFIER", 383, 388], ["animals", "OBSERVATION_MODIFIER", 389, 396]]], ["Multinucleation by more than 2 nuclei of nonneoplastic hepatocytes is a rare phenomenon in domestic mammals, and its diagnostic or pathogenetic significance is usually unclear.", [["nuclei", "ANATOMY", 31, 37], ["nonneoplastic hepatocytes", "ANATOMY", 41, 66], ["Multinucleation", "DISEASE", 0, 15], ["nuclei", "CELLULAR_COMPONENT", 31, 37], ["nonneoplastic hepatocytes", "CELL", 41, 66], ["nonneoplastic hepatocytes", "CELL_TYPE", 41, 66], ["nonneoplastic hepatocytes", "PROBLEM", 41, 66], ["a rare phenomenon in domestic mammals", "PROBLEM", 70, 107], ["nonneoplastic hepatocytes", "OBSERVATION", 41, 66], ["rare", "OBSERVATION_MODIFIER", 72, 76], ["phenomenon", "OBSERVATION", 77, 87], ["domestic mammals", "OBSERVATION", 91, 107]]], ["Multinucleation can result from incomplete cell division or cell fusion, but this distinction is difficult to determine.", [["cell", "ANATOMY", 43, 47], ["cell", "ANATOMY", 60, 64], ["Multinucleation", "DISEASE", 0, 15], ["cell", "CELL", 43, 47], ["cell", "CELL", 60, 64], ["Multinucleation", "PROBLEM", 0, 15], ["incomplete cell division", "PROBLEM", 32, 56], ["cell fusion", "PROBLEM", 60, 71], ["incomplete cell division", "OBSERVATION", 32, 56], ["cell fusion", "OBSERVATION", 60, 71]]], ["Hepatocytes can fuse during severe steatosis, but the degree of multinucleation in fatty livers is hard to discern because the plasma membrane perimeters of fatty hepatocytes are ill defined.", [["Hepatocytes", "ANATOMY", 0, 11], ["fatty livers", "ANATOMY", 83, 95], ["plasma membrane", "ANATOMY", 127, 142], ["fatty hepatocytes", "ANATOMY", 157, 174], ["steatosis", "DISEASE", 35, 44], ["Hepatocytes", "CELL", 0, 11], ["livers", "ORGAN", 89, 95], ["plasma membrane", "CELLULAR_COMPONENT", 127, 142], ["hepatocytes", "CELL", 163, 174], ["Hepatocytes", "CELL_TYPE", 0, 11], ["fatty hepatocytes", "CELL_TYPE", 157, 174], ["severe steatosis", "PROBLEM", 28, 44], ["multinucleation in fatty livers", "PROBLEM", 64, 95], ["the plasma membrane perimeters", "TEST", 123, 153], ["fatty hepatocytes", "PROBLEM", 157, 174], ["severe", "OBSERVATION_MODIFIER", 28, 34], ["steatosis", "OBSERVATION", 35, 44], ["degree", "OBSERVATION_MODIFIER", 54, 60], ["multinucleation", "OBSERVATION", 64, 79], ["fatty livers", "OBSERVATION", 83, 95], ["fatty hepatocytes", "OBSERVATION", 157, 174], ["ill", "OBSERVATION_MODIFIER", 179, 182]]], ["Syncytial multinucleation of hepatocytes has been observed in various degenerative and regenerative conditions.", [["hepatocytes", "ANATOMY", 29, 40], ["hepatocytes", "CELL", 29, 40], ["hepatocytes", "CELL_TYPE", 29, 40], ["Syncytial multinucleation of hepatocytes", "PROBLEM", 0, 40], ["various degenerative and regenerative conditions", "PROBLEM", 62, 110], ["multinucleation", "OBSERVATION", 10, 25], ["hepatocytes", "ANATOMY", 29, 40], ["various", "OBSERVATION_MODIFIER", 62, 69], ["degenerative", "OBSERVATION", 70, 82], ["regenerative conditions", "OBSERVATION", 87, 110]]], ["In protoporphyria of Limousin cattle, small clusters of hepatocytes contain 4-10 or more closely packed nuclei, but it is not clear whether this represents fusion or multiple nuclear divisions.", [["hepatocytes", "ANATOMY", 56, 67], ["nuclei", "ANATOMY", 104, 110], ["nuclear", "ANATOMY", 175, 182], ["protoporphyria", "DISEASE", 3, 17], ["Limousin cattle", "ORGANISM", 21, 36], ["hepatocytes", "CELL", 56, 67], ["nuclei", "CELLULAR_COMPONENT", 104, 110], ["nuclear", "CELLULAR_COMPONENT", 175, 182], ["hepatocytes", "CELL_TYPE", 56, 67], ["cattle", "SPECIES", 30, 36], ["cattle", "SPECIES", 30, 36], ["small clusters of hepatocytes", "PROBLEM", 38, 67], ["fusion", "PROBLEM", 156, 162], ["protoporphyria", "OBSERVATION_MODIFIER", 3, 17], ["Limousin cattle", "OBSERVATION", 21, 36], ["small", "OBSERVATION_MODIFIER", 38, 43], ["clusters", "OBSERVATION_MODIFIER", 44, 52], ["hepatocytes", "ANATOMY", 56, 67], ["4-10", "OBSERVATION_MODIFIER", 76, 80], ["closely packed nuclei", "OBSERVATION_MODIFIER", 89, 110], ["fusion", "OBSERVATION", 156, 162], ["multiple", "OBSERVATION_MODIFIER", 166, 174], ["nuclear divisions", "OBSERVATION", 175, 192]]], ["Syncytial hepatocytes are a characteristic of postinfantile giant cell hepatitis of children, and similar hepatocyte multinucleation can be observed in association with some forms of hepatitis in newborn cats, foals, and piglets (see Inflammatory diseases of the liver and biliary tract).", [["Syncytial hepatocytes", "ANATOMY", 0, 21], ["giant cell", "ANATOMY", 60, 70], ["hepatocyte", "ANATOMY", 106, 116], ["foals", "ANATOMY", 210, 215], ["liver", "ANATOMY", 263, 268], ["biliary tract", "ANATOMY", 273, 286], ["giant cell hepatitis", "DISEASE", 60, 80], ["hepatitis", "DISEASE", 183, 192], ["Inflammatory diseases of the liver and biliary tract", "DISEASE", 234, 286], ["Syncytial hepatocytes", "CELL", 0, 21], ["giant cell", "CELL", 60, 70], ["children", "ORGANISM", 84, 92], ["hepatocyte", "CELL", 106, 116], ["cats", "ORGANISM", 204, 208], ["foals", "ORGANISM_SUBDIVISION", 210, 215], ["piglets", "ORGANISM", 221, 228], ["liver", "ORGAN", 263, 268], ["biliary tract", "MULTI-TISSUE_STRUCTURE", 273, 286], ["Syncytial hepatocytes", "CELL_TYPE", 0, 21], ["children", "SPECIES", 84, 92], ["cats", "SPECIES", 204, 208], ["piglets", "SPECIES", 221, 228], ["Syncytial hepatocytes", "PROBLEM", 0, 21], ["postinfantile giant cell hepatitis of children", "PROBLEM", 46, 92], ["similar hepatocyte multinucleation", "PROBLEM", 98, 132], ["hepatitis in newborn cats", "PROBLEM", 183, 208], ["Inflammatory diseases of the liver and biliary tract", "PROBLEM", 234, 286], ["hepatocytes", "ANATOMY", 10, 21], ["giant cell hepatitis", "OBSERVATION", 60, 80], ["hepatocyte", "ANATOMY", 106, 116], ["multinucleation", "OBSERVATION", 117, 132], ["hepatitis", "OBSERVATION", 183, 192], ["liver", "ANATOMY", 263, 268], ["biliary tract", "ANATOMY", 273, 286]]], ["Multinucleated hepatocytes have been described in young cats with thymic lymphomas, and in cats with experimental dioxin poisoning.270.e1eFigure 2-4 Congenital melanosis in a calf.270.e1aggregates in Kupffer cells but can also be seen as finer particles in hepatocytes.", [["Multinucleated hepatocytes", "ANATOMY", 0, 26], ["thymic lymphomas", "ANATOMY", 66, 82], ["Kupffer cells", "ANATOMY", 200, 213], ["hepatocytes", "ANATOMY", 257, 268], ["thymic lymphomas", "DISEASE", 66, 82], ["dioxin poisoning", "DISEASE", 114, 130], ["Congenital melanosis", "DISEASE", 149, 169], ["dioxin", "CHEMICAL", 114, 120], ["hepatocytes", "CELL", 15, 26], ["cats", "ORGANISM", 56, 60], ["thymic lymphomas", "CANCER", 66, 82], ["cats", "ORGANISM", 91, 95], ["dioxin", "SIMPLE_CHEMICAL", 114, 120], ["calf", "ORGANISM_SUBDIVISION", 175, 179], ["Kupffer cells", "CELL", 200, 213], ["hepatocytes", "CELL", 257, 268], ["Multinucleated hepatocytes", "CELL_TYPE", 0, 26], ["Kupffer cells", "CELL_TYPE", 200, 213], ["hepatocytes", "CELL_TYPE", 257, 268], ["cats", "SPECIES", 56, 60], ["cats", "SPECIES", 91, 95], ["calf", "SPECIES", 175, 179], ["Multinucleated hepatocytes", "PROBLEM", 0, 26], ["thymic lymphomas", "PROBLEM", 66, 82], ["experimental dioxin poisoning", "PROBLEM", 101, 130], ["Congenital melanosis in a calf", "PROBLEM", 149, 179], ["hepatocytes", "ANATOMY", 15, 26], ["thymic lymphomas", "OBSERVATION", 66, 82], ["dioxin poisoning", "OBSERVATION", 114, 130], ["Congenital", "OBSERVATION_MODIFIER", 149, 159], ["melanosis", "OBSERVATION", 160, 169], ["calf", "ANATOMY", 175, 179], ["aggregates", "OBSERVATION", 186, 196], ["Kupffer cells", "OBSERVATION", 200, 213], ["hepatocytes", "ANATOMY", 257, 268]]], ["Diffuse hemosiderin deposits in Kupffer cells occur quite commonly in all species, and its presence is usually suggestive of excess hemolytic activity relative to the rate of reutilization of iron.", [["Kupffer cells", "ANATOMY", 32, 45], ["hemolytic", "DISEASE", 132, 141], ["iron", "CHEMICAL", 192, 196], ["iron", "CHEMICAL", 192, 196], ["Kupffer cells", "CELL", 32, 45], ["iron", "SIMPLE_CHEMICAL", 192, 196], ["Kupffer cells", "CELL_TYPE", 32, 45], ["Diffuse hemosiderin deposits in Kupffer cells", "PROBLEM", 0, 45], ["excess hemolytic activity", "PROBLEM", 125, 150], ["reutilization of iron", "TREATMENT", 175, 196], ["hemosiderin deposits", "OBSERVATION", 8, 28], ["Kupffer cells", "OBSERVATION", 32, 45], ["usually suggestive of", "UNCERTAINTY", 103, 124], ["excess hemolytic activity", "OBSERVATION", 125, 150]]], ["Thus it is seen in hemolytic anemia, anemia of copper deficiency, in cachexia, and after blood transfusions or iron injections.", [["cachexia", "ANATOMY", 69, 77], ["blood", "ANATOMY", 89, 94], ["hemolytic anemia", "DISEASE", 19, 35], ["anemia", "DISEASE", 37, 43], ["copper", "CHEMICAL", 47, 53], ["cachexia", "DISEASE", 69, 77], ["iron", "CHEMICAL", 111, 115], ["copper", "CHEMICAL", 47, 53], ["iron", "CHEMICAL", 111, 115], ["copper", "SIMPLE_CHEMICAL", 47, 53], ["cachexia", "CANCER", 69, 77], ["blood", "ORGANISM_SUBSTANCE", 89, 94], ["iron", "SIMPLE_CHEMICAL", 111, 115], ["hemolytic anemia", "PROBLEM", 19, 35], ["anemia of copper deficiency", "PROBLEM", 37, 64], ["cachexia", "PROBLEM", 69, 77], ["blood transfusions", "TREATMENT", 89, 107], ["iron injections", "TREATMENT", 111, 126], ["hemolytic", "OBSERVATION_MODIFIER", 19, 28], ["anemia", "OBSERVATION", 29, 35], ["anemia", "OBSERVATION", 37, 43], ["copper deficiency", "OBSERVATION", 47, 64], ["cachexia", "OBSERVATION", 69, 77]]], ["It may be seen in Kupffer cells of the centrilobular zones in severe chronic passive congestion of the liver.", [["Kupffer cells", "ANATOMY", 18, 31], ["centrilobular zones", "ANATOMY", 39, 58], ["liver", "ANATOMY", 103, 108], ["chronic passive congestion of the liver", "DISEASE", 69, 108], ["Kupffer cells", "CELL", 18, 31], ["centrilobular zones", "TISSUE", 39, 58], ["liver", "ORGAN", 103, 108], ["Kupffer cells", "CELL_TYPE", 18, 31], ["severe chronic passive congestion of the liver", "PROBLEM", 62, 108], ["may be seen", "UNCERTAINTY", 3, 14], ["Kupffer cells", "OBSERVATION", 18, 31], ["centrilobular", "ANATOMY_MODIFIER", 39, 52], ["severe", "OBSERVATION_MODIFIER", 62, 68], ["chronic", "OBSERVATION_MODIFIER", 69, 76], ["passive", "OBSERVATION_MODIFIER", 77, 84], ["congestion", "OBSERVATION", 85, 95], ["liver", "ANATOMY", 103, 108]]], ["Localized hemosiderin deposition occurs in areas of hemorrhage.", [["hemosiderin", "ANATOMY", 10, 21], ["hemorrhage", "DISEASE", 52, 62], ["hemosiderin", "SIMPLE_CHEMICAL", 10, 21], ["Localized hemosiderin deposition", "PROBLEM", 0, 32], ["hemorrhage", "PROBLEM", 52, 62], ["hemosiderin deposition", "OBSERVATION", 10, 32], ["areas", "OBSERVATION_MODIFIER", 43, 48], ["hemorrhage", "OBSERVATION", 52, 62]]], ["Hemosiderin is normally present in the liver in the early neonatal period, when fetal hemoglobin is being replaced by mature hemoglobin.270.e1Hemosiderin should be distinguished from hematin, which is produced by the action of formic acid on hemoglobin following a prolonged postmortem interval, and is usually regarded as a histologic artifact.", [["liver", "ANATOMY", 39, 44], ["fetal", "ANATOMY", 80, 85], ["Hemosiderin", "CHEMICAL", 0, 11], ["270.e1Hemosiderin", "CHEMICAL", 136, 153], ["hematin", "CHEMICAL", 183, 190], ["formic acid", "CHEMICAL", 227, 238], ["270.e1Hemosiderin", "CHEMICAL", 136, 153], ["hematin", "CHEMICAL", 183, 190], ["formic acid", "CHEMICAL", 227, 238], ["Hemosiderin", "GENE_OR_GENE_PRODUCT", 0, 11], ["liver", "ORGAN", 39, 44], ["fetal", "ORGANISM_SUBDIVISION", 80, 85], ["hemoglobin", "GENE_OR_GENE_PRODUCT", 86, 96], ["hemoglobin", "GENE_OR_GENE_PRODUCT", 125, 135], ["270.e1Hemosiderin", "SIMPLE_CHEMICAL", 136, 153], ["hematin", "SIMPLE_CHEMICAL", 183, 190], ["formic acid", "SIMPLE_CHEMICAL", 227, 238], ["hemoglobin", "GENE_OR_GENE_PRODUCT", 242, 252], ["Hemosiderin", "PROTEIN", 0, 11], ["fetal hemoglobin", "PROTEIN", 80, 96], ["hemoglobin", "PROTEIN", 125, 135], ["hemoglobin", "PROTEIN", 242, 252], ["Hemosiderin", "PROBLEM", 0, 11], ["fetal hemoglobin", "TEST", 80, 96], ["a histologic artifact", "PROBLEM", 323, 344], ["liver", "ANATOMY", 39, 44], ["early", "OBSERVATION_MODIFIER", 52, 57], ["neonatal", "OBSERVATION_MODIFIER", 58, 66], ["hemoglobin", "OBSERVATION_MODIFIER", 86, 96], ["mature", "OBSERVATION_MODIFIER", 118, 124], ["hemoglobin", "OBSERVATION_MODIFIER", 125, 135], ["artifact", "OBSERVATION", 336, 344]]], ["Hematin is also an ironcontaining pigment, but the iron is in the reduced ferrous state and does not stain with ferricyanide.", [["Hematin", "CHEMICAL", 0, 7], ["iron", "CHEMICAL", 51, 55], ["ferrous", "CHEMICAL", 74, 81], ["ferricyanide", "CHEMICAL", 112, 124], ["Hematin", "CHEMICAL", 0, 7], ["iron", "CHEMICAL", 51, 55], ["ferrous", "CHEMICAL", 74, 81], ["ferricyanide", "CHEMICAL", 112, 124], ["Hematin", "SIMPLE_CHEMICAL", 0, 7], ["iron", "SIMPLE_CHEMICAL", 51, 55], ["ferrous", "SIMPLE_CHEMICAL", 74, 81], ["ferricyanide", "SIMPLE_CHEMICAL", 112, 124], ["Hematin", "TREATMENT", 0, 7], ["an ironcontaining pigment", "TREATMENT", 16, 41], ["the iron", "TEST", 47, 55], ["the reduced ferrous state", "PROBLEM", 62, 87], ["ferricyanide", "TREATMENT", 112, 124], ["ironcontaining pigment", "OBSERVATION", 19, 41], ["ferrous state", "OBSERVATION", 74, 87]]], ["It takes the form of crystalline brown deposits that are birefringent under polarized light, mainly within hemoglobin-rich areas such as blood vessels.", [["blood vessels", "ANATOMY", 137, 150], ["hemoglobin", "GENE_OR_GENE_PRODUCT", 107, 117], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 137, 150], ["hemoglobin", "PROTEIN", 107, 117], ["crystalline brown deposits", "PROBLEM", 21, 47], ["crystalline", "OBSERVATION_MODIFIER", 21, 32], ["brown deposits", "OBSERVATION", 33, 47], ["birefringent", "OBSERVATION_MODIFIER", 57, 69], ["polarized light", "OBSERVATION_MODIFIER", 76, 91], ["rich", "OBSERVATION_MODIFIER", 118, 122], ["blood vessels", "ANATOMY", 137, 150]]], ["Hematin is darker than hemosiderin and occurs in irregular clumps, often extracellularly.", [["clumps", "ANATOMY", 59, 65], ["Hematin", "CHEMICAL", 0, 7], ["Hematin", "SIMPLE_CHEMICAL", 0, 7], ["hemosiderin", "SIMPLE_CHEMICAL", 23, 34], ["hemosiderin", "PROBLEM", 23, 34], ["irregular clumps", "PROBLEM", 49, 65], ["darker", "OBSERVATION_MODIFIER", 11, 17], ["than hemosiderin", "OBSERVATION_MODIFIER", 18, 34], ["irregular", "OBSERVATION_MODIFIER", 49, 58], ["clumps", "OBSERVATION_MODIFIER", 59, 65]]], ["Hematin may, however, be found in Kupffer cells and macrophages in small amounts. dogs, except in rare cases with dramatic cholestasis.", [["Kupffer cells", "ANATOMY", 34, 47], ["macrophages", "ANATOMY", 52, 63], ["Hematin", "CHEMICAL", 0, 7], ["cholestasis", "DISEASE", 123, 134], ["Hematin", "SIMPLE_CHEMICAL", 0, 7], ["Kupffer cells", "CELL", 34, 47], ["macrophages", "CELL", 52, 63], ["dogs", "ORGANISM", 82, 86], ["Kupffer cells", "CELL_TYPE", 34, 47], ["macrophages", "CELL_TYPE", 52, 63], ["dogs", "SPECIES", 82, 86], ["Hematin", "TREATMENT", 0, 7], ["dramatic cholestasis", "PROBLEM", 114, 134], ["Kupffer cells", "OBSERVATION", 34, 47], ["macrophages", "OBSERVATION", 52, 63], ["small", "OBSERVATION_MODIFIER", 67, 72], ["amounts", "OBSERVATION_MODIFIER", 73, 80], ["dramatic", "OBSERVATION_MODIFIER", 114, 122], ["cholestasis", "OBSERVATION", 123, 134]]], ["Death of individual hepatocytes releases the canalicular plugs into the space of Disse and the sinusoids, where they may be phagocytosed by Kupffer cells.270.e1Lipofuscin is the term given to small, golden, granular cytoplasmic deposits derived from the lipid component of membranous organelles, more obvious in hepatocytes near the centrilobular areas.", [["hepatocytes", "ANATOMY", 20, 31], ["canalicular plugs", "ANATOMY", 45, 62], ["sinusoids", "ANATOMY", 95, 104], ["Kupffer cells", "ANATOMY", 140, 153], ["cytoplasmic", "ANATOMY", 216, 227], ["membranous organelles", "ANATOMY", 273, 294], ["hepatocytes", "ANATOMY", 312, 323], ["centrilobular areas", "ANATOMY", 333, 352], ["Death", "DISEASE", 0, 5], ["270.e1Lipofuscin", "CHEMICAL", 154, 170], ["hepatocytes", "CELL", 20, 31], ["canalicular plugs", "PATHOLOGICAL_FORMATION", 45, 62], ["sinusoids", "TISSUE", 95, 104], ["Kupffer cells", "CELL", 140, 153], ["270.e1Lipofuscin", "SIMPLE_CHEMICAL", 154, 170], ["cytoplasmic", "ORGANISM_SUBSTANCE", 216, 227], ["membranous organelles", "CELLULAR_COMPONENT", 273, 294], ["hepatocytes", "CELL", 312, 323], ["centrilobular areas", "TISSUE", 333, 352], ["hepatocytes", "CELL_TYPE", 20, 31], ["Kupffer cells", "CELL_TYPE", 140, 153], ["hepatocytes", "CELL_TYPE", 312, 323], ["individual hepatocytes", "PROBLEM", 9, 31], ["small, golden, granular cytoplasmic deposits", "PROBLEM", 192, 236], ["membranous organelles", "PROBLEM", 273, 294], ["hepatocytes", "ANATOMY", 20, 31], ["canalicular", "OBSERVATION_MODIFIER", 45, 56], ["plugs", "OBSERVATION", 57, 62], ["space", "ANATOMY_MODIFIER", 72, 77], ["Disse", "OBSERVATION", 81, 86], ["sinusoids", "ANATOMY", 95, 104], ["may be", "UNCERTAINTY", 117, 123], ["phagocytosed", "OBSERVATION", 124, 136], ["Kupffer cells", "OBSERVATION", 140, 153], ["small", "OBSERVATION_MODIFIER", 192, 197], ["golden", "OBSERVATION_MODIFIER", 199, 205], ["granular cytoplasmic deposits", "OBSERVATION", 207, 236], ["lipid", "OBSERVATION_MODIFIER", 254, 259], ["component", "OBSERVATION_MODIFIER", 260, 269], ["membranous organelles", "OBSERVATION", 273, 294], ["more", "OBSERVATION_MODIFIER", 296, 300], ["obvious", "OBSERVATION_MODIFIER", 301, 308], ["hepatocytes", "ANATOMY", 312, 323], ["centrilobular", "ANATOMY_MODIFIER", 333, 346]]], ["Lipofuscin accumulates in hepatocellular lysosomes and indicates senility, atrophy, or increased turnover of membrane lipids.", [["hepatocellular lysosomes", "ANATOMY", 26, 50], ["membrane lipids", "ANATOMY", 109, 124], ["Lipofuscin", "CHEMICAL", 0, 10], ["atrophy", "DISEASE", 75, 82], ["Lipofuscin", "CHEMICAL", 0, 10], ["Lipofuscin", "SIMPLE_CHEMICAL", 0, 10], ["hepatocellular lysosomes", "MULTI-TISSUE_STRUCTURE", 26, 50], ["membrane lipids", "CELLULAR_COMPONENT", 109, 124], ["Lipofuscin", "PROTEIN", 0, 10], ["Lipofuscin accumulates in hepatocellular lysosomes", "PROBLEM", 0, 50], ["senility", "PROBLEM", 65, 73], ["atrophy", "PROBLEM", 75, 82], ["increased turnover of membrane lipids", "TREATMENT", 87, 124], ["hepatocellular lysosomes", "OBSERVATION", 26, 50], ["senility", "OBSERVATION_MODIFIER", 65, 73], ["atrophy", "OBSERVATION", 75, 82], ["increased", "OBSERVATION_MODIFIER", 87, 96]]], ["The pigment is particularly common in the centrilobular regions of the liver of cats after they reach maturity.", [["centrilobular regions", "ANATOMY", 42, 63], ["liver", "ANATOMY", 71, 76], ["centrilobular regions", "MULTI-TISSUE_STRUCTURE", 42, 63], ["liver", "ORGAN", 71, 76], ["cats", "ORGANISM", 80, 84], ["cats", "SPECIES", 80, 84], ["pigment", "OBSERVATION_MODIFIER", 4, 11], ["common", "OBSERVATION_MODIFIER", 28, 34], ["centrilobular", "ANATOMY_MODIFIER", 42, 55], ["liver", "ANATOMY", 71, 76]]], ["Ceroid is a yellow pigment similar to lipofuscin and is associated with peroxidation of fat deposits.270.e1Black pigment also accumulates in hepatocellular lysosomes of mutant Corriedale sheep with hyperbilirubinemia.", [["fat deposits", "ANATOMY", 88, 100], ["hepatocellular lysosomes", "ANATOMY", 141, 165], ["lipofuscin", "CHEMICAL", 38, 48], ["hyperbilirubinemia", "DISEASE", 198, 216], ["lipofuscin", "SIMPLE_CHEMICAL", 38, 48], ["fat", "TISSUE", 88, 91], ["hepatocellular lysosomes", "MULTI-TISSUE_STRUCTURE", 141, 165], ["Corriedale sheep", "ORGANISM", 176, 192], ["sheep", "SPECIES", 187, 192], ["Corriedale sheep", "SPECIES", 176, 192], ["a yellow pigment", "PROBLEM", 10, 26], ["fat deposits", "PROBLEM", 88, 100], ["Black pigment", "PROBLEM", 107, 120], ["hepatocellular lysosomes", "PROBLEM", 141, 165], ["hyperbilirubinemia", "PROBLEM", 198, 216], ["yellow pigment", "OBSERVATION", 12, 26], ["lipofuscin", "OBSERVATION", 38, 48], ["associated with", "UNCERTAINTY", 56, 71], ["peroxidation", "OBSERVATION_MODIFIER", 72, 84], ["fat deposits", "OBSERVATION", 88, 100], ["Black pigment", "OBSERVATION", 107, 120], ["hepatocellular lysosomes", "OBSERVATION", 141, 165], ["mutant", "OBSERVATION_MODIFIER", 169, 175], ["Corriedale sheep", "OBSERVATION", 176, 192], ["hyperbilirubinemia", "OBSERVATION", 198, 216]]], ["These sheep have a condition resembling the human Dubin-Johnson syndrome, in which there is mutation in the canalicular transporter in the organic anion-transporting polypeptide family.", [["canalicular", "ANATOMY", 108, 119], ["Dubin-Johnson syndrome", "DISEASE", 50, 72], ["sheep", "ORGANISM", 6, 11], ["human", "ORGANISM", 44, 49], ["canalicular", "MULTI-TISSUE_STRUCTURE", 108, 119], ["canalicular transporter", "PROTEIN", 108, 131], ["organic anion-transporting polypeptide family", "PROTEIN", 139, 184], ["sheep", "SPECIES", 6, 11], ["human", "SPECIES", 44, 49], ["sheep", "SPECIES", 6, 11], ["human Dubin-Johnson syndrome", "SPECIES", 44, 72], ["Johnson syndrome", "PROBLEM", 56, 72], ["mutation", "PROBLEM", 92, 100], ["Johnson syndrome", "OBSERVATION", 56, 72]]], ["This suggests that retention of the pigment might be a sequel to a hepatic excretory defect.270.e1In congenital erythrocytic protoporphyria (ferrochelatase deficiency) of Limousin and Blonde d'Aquitaine cattle, a dark golden-brown lipofuscin-like lysosomal material is present in portal areas, Kupffer cells, and sinusoidal endothelial cells, and is heavily concentrated in the cytoplasm of hepatocytes.270.e1Acquired protoporphyria ( Fig. 2-17A , B) with liver injury has been described in German Shepherd dogs as an idiopathic syndrome and in a group of Beagle dogs treated with an experimental drug.", [["hepatic excretory", "ANATOMY", 67, 84], ["portal areas", "ANATOMY", 280, 292], ["Kupffer cells", "ANATOMY", 294, 307], ["sinusoidal endothelial cells", "ANATOMY", 313, 341], ["cytoplasm", "ANATOMY", 378, 387], ["hepatocytes", "ANATOMY", 391, 402], ["liver", "ANATOMY", 456, 461], ["hepatic excretory defect", "DISEASE", 67, 91], ["congenital erythrocytic protoporphyria", "DISEASE", 101, 139], ["ferrochelatase deficiency", "DISEASE", 141, 166], ["protoporphyria", "DISEASE", 418, 432], ["liver injury", "DISEASE", 456, 468], ["idiopathic syndrome", "DISEASE", 518, 537], ["pigment", "TISSUE", 36, 43], ["hepatic excretory", "MULTI-TISSUE_STRUCTURE", 67, 84], ["ferrochelatase", "GENE_OR_GENE_PRODUCT", 141, 155], ["lipofuscin", "SIMPLE_CHEMICAL", 231, 241], ["lysosomal material", "CELLULAR_COMPONENT", 247, 265], ["Kupffer cells", "CELL", 294, 307], ["sinusoidal endothelial cells", "CELL", 313, 341], ["cytoplasm", "ORGANISM_SUBSTANCE", 378, 387], ["hepatocytes", "CELL", 391, 402], ["B", "GENE_OR_GENE_PRODUCT", 448, 449], ["liver", "ORGAN", 456, 461], ["dogs", "ORGANISM", 563, 567], ["ferrochelatase", "PROTEIN", 141, 155], ["Kupffer cells", "CELL_TYPE", 294, 307], ["sinusoidal endothelial cells", "CELL_TYPE", 313, 341], ["hepatocytes", "CELL_TYPE", 391, 402], ["cattle", "SPECIES", 203, 209], ["dogs", "SPECIES", 507, 511], ["dogs", "SPECIES", 563, 567], ["Blonde d'Aquitaine cattle", "SPECIES", 184, 209], ["retention of the pigment", "PROBLEM", 19, 43], ["a hepatic excretory defect", "PROBLEM", 65, 91], ["congenital erythrocytic protoporphyria (ferrochelatase deficiency", "PROBLEM", 101, 166], ["a dark golden-brown lipofuscin", "PROBLEM", 211, 241], ["lysosomal material", "PROBLEM", 247, 265], ["sinusoidal endothelial cells", "PROBLEM", 313, 341], ["liver injury", "PROBLEM", 456, 468], ["an idiopathic syndrome", "PROBLEM", 515, 537], ["Beagle dogs", "TREATMENT", 556, 567], ["an experimental drug", "TREATMENT", 581, 601], ["retention", "OBSERVATION_MODIFIER", 19, 28], ["pigment", "OBSERVATION", 36, 43], ["hepatic", "ANATOMY", 67, 74], ["excretory", "ANATOMY_MODIFIER", 75, 84], ["defect", "OBSERVATION", 85, 91], ["erythrocytic protoporphyria", "OBSERVATION", 112, 139], ["ferrochelatase deficiency", "OBSERVATION", 141, 166], ["brown lipofuscin", "OBSERVATION", 225, 241], ["lysosomal material", "OBSERVATION", 247, 265], ["portal", "ANATOMY", 280, 286], ["areas", "ANATOMY_MODIFIER", 287, 292], ["Kupffer cells", "OBSERVATION", 294, 307], ["sinusoidal endothelial cells", "OBSERVATION", 313, 341], ["heavily", "OBSERVATION_MODIFIER", 350, 357], ["concentrated", "OBSERVATION_MODIFIER", 358, 370], ["cytoplasm", "OBSERVATION", 378, 387], ["hepatocytes", "ANATOMY", 391, 402], ["liver", "ANATOMY", 456, 461], ["injury", "OBSERVATION", 462, 468], ["idiopathic syndrome", "OBSERVATION", 518, 537]]], ["Grossly, affected German Shepherd dogs had dark livers that contained multiple regenerative nodules.", [["livers", "ANATOMY", 48, 54], ["regenerative nodules", "ANATOMY", 79, 99], ["dogs", "ORGANISM", 34, 38], ["livers", "ORGAN", 48, 54], ["regenerative nodules", "PATHOLOGICAL_FORMATION", 79, 99], ["dogs", "SPECIES", 34, 38], ["dark livers", "PROBLEM", 43, 54], ["multiple regenerative nodules", "PROBLEM", 70, 99], ["dark", "OBSERVATION_MODIFIER", 43, 47], ["livers", "ANATOMY", 48, 54], ["multiple", "OBSERVATION_MODIFIER", 70, 78], ["regenerative", "OBSERVATION_MODIFIER", 79, 91], ["nodules", "OBSERVATION", 92, 99]]], ["Histologically, there was abundant bridging portal fibrosis and typical orange birefringent protoporphyrin crystals in hepatocytes.", [["portal", "ANATOMY", 44, 50], ["hepatocytes", "ANATOMY", 119, 130], ["fibrosis", "DISEASE", 51, 59], ["protoporphyrin", "CHEMICAL", 92, 106], ["portal", "MULTI-TISSUE_STRUCTURE", 44, 50], ["protoporphyrin crystals", "SIMPLE_CHEMICAL", 92, 115], ["hepatocytes", "CELL", 119, 130], ["hepatocytes", "CELL_TYPE", 119, 130], ["abundant bridging portal fibrosis", "PROBLEM", 26, 59], ["typical orange birefringent protoporphyrin crystals in hepatocytes", "PROBLEM", 64, 130], ["abundant", "OBSERVATION_MODIFIER", 26, 34], ["bridging", "OBSERVATION_MODIFIER", 35, 43], ["portal", "ANATOMY", 44, 50], ["fibrosis", "OBSERVATION", 51, 59], ["orange birefringent", "OBSERVATION", 72, 91], ["protoporphyrin crystals", "OBSERVATION", 92, 115], ["hepatocytes", "ANATOMY", 119, 130]]], ["Photosensitization was not evident.", [["Photosensitization", "TREATMENT", 0, 18], ["not evident", "UNCERTAINTY", 23, 34]]], ["Hepatic vacuolation and nodule formation has also been described in a cat with porphyria.270.e1Hemosiderin deposits are seldom sufficient to give gross discoloration, but when this occurs, the color is dark brown.", [["Hepatic", "ANATOMY", 0, 7], ["nodule", "ANATOMY", 24, 30], ["porphyria", "DISEASE", 79, 88], ["270.e1Hemosiderin", "CHEMICAL", 89, 106], ["Hepatic", "PATHOLOGICAL_FORMATION", 0, 7], ["nodule", "PATHOLOGICAL_FORMATION", 24, 30], ["cat", "ORGANISM", 70, 73], ["270.e1Hemosiderin", "SIMPLE_CHEMICAL", 89, 106], ["Hepatic vacuolation", "PROBLEM", 0, 19], ["nodule formation", "PROBLEM", 24, 40], ["porphyria", "PROBLEM", 79, 88], ["gross discoloration", "PROBLEM", 146, 165], ["vacuolation", "OBSERVATION", 8, 19], ["nodule", "OBSERVATION", 24, 30], ["deposits", "OBSERVATION", 107, 115], ["gross", "OBSERVATION_MODIFIER", 146, 151], ["discoloration", "OBSERVATION", 152, 165], ["dark brown", "OBSERVATION", 202, 212]]], ["The pigment is detected microscopically as yellow or brown crystals chiefly in the Kupffer cells, although small amounts may be found in hepatic cells.", [["Kupffer cells", "ANATOMY", 83, 96], ["hepatic cells", "ANATOMY", 137, 150], ["Kupffer cells", "CELL", 83, 96], ["hepatic cells", "CELL", 137, 150], ["Kupffer cells", "CELL_TYPE", 83, 96], ["hepatic cells", "CELL_TYPE", 137, 150], ["brown crystals", "PROBLEM", 53, 67], ["small amounts", "PROBLEM", 107, 120], ["pigment", "OBSERVATION_MODIFIER", 4, 11], ["brown crystals", "OBSERVATION_MODIFIER", 53, 67], ["Kupffer cells", "ANATOMY", 83, 96], ["small", "OBSERVATION_MODIFIER", 107, 112], ["hepatic", "ANATOMY", 137, 144], ["cells", "OBSERVATION", 145, 150]]], ["The ferric iron component of this pigment can be demonstrated by staining with Prussian blue; otherwise, it can easily be confused with lipofuscin.", [["ferric iron", "CHEMICAL", 4, 15], ["Prussian blue", "CHEMICAL", 79, 92], ["lipofuscin", "CHEMICAL", 136, 146], ["ferric iron", "CHEMICAL", 4, 15], ["Prussian blue", "CHEMICAL", 79, 92], ["ferric iron", "SIMPLE_CHEMICAL", 4, 15], ["lipofuscin", "SIMPLE_CHEMICAL", 136, 146], ["The ferric iron component", "TREATMENT", 0, 25], ["this pigment", "PROBLEM", 29, 41], ["lipofuscin", "TREATMENT", 136, 146], ["ferric", "OBSERVATION_MODIFIER", 4, 10], ["iron component", "OBSERVATION_MODIFIER", 11, 25], ["Prussian blue", "OBSERVATION", 79, 92]]], ["Most hemosiderin deposits are punctate Prussian blue staining A B compartments of mitochondria, lysosomes, and endoplasmic reticulum (ER).", [["hemosiderin deposits", "ANATOMY", 5, 25], ["mitochondria", "ANATOMY", 82, 94], ["lysosomes", "ANATOMY", 96, 105], ["endoplasmic reticulum", "ANATOMY", 111, 132], ["ER", "ANATOMY", 134, 136], ["Prussian blue", "CHEMICAL", 39, 52], ["Prussian blue", "CHEMICAL", 39, 52], ["hemosiderin", "SIMPLE_CHEMICAL", 5, 16], ["Prussian blue staining A B", "GENE_OR_GENE_PRODUCT", 39, 65], ["mitochondria", "CELLULAR_COMPONENT", 82, 94], ["lysosomes", "CELLULAR_COMPONENT", 96, 105], ["endoplasmic reticulum", "CELLULAR_COMPONENT", 111, 132], ["ER", "GENE_OR_GENE_PRODUCT", 134, 136], ["ER", "PROTEIN", 134, 136], ["Most hemosiderin deposits", "PROBLEM", 0, 25], ["punctate Prussian blue staining", "PROBLEM", 30, 61], ["hemosiderin", "OBSERVATION_MODIFIER", 5, 16], ["deposits", "OBSERVATION", 17, 25], ["punctate", "OBSERVATION_MODIFIER", 30, 38], ["Prussian blue staining", "OBSERVATION", 39, 61], ["endoplasmic reticulum", "OBSERVATION", 111, 132]]], ["The term feathery degeneration is applied to the type of hydropic change that occurs in hepatocytes in which there has been prolonged cholestasis.", [["hepatocytes", "ANATOMY", 88, 99], ["feathery degeneration", "DISEASE", 9, 30], ["cholestasis", "DISEASE", 134, 145], ["hepatocytes", "CELL", 88, 99], ["hepatocytes", "CELL_TYPE", 88, 99], ["The term feathery degeneration", "PROBLEM", 0, 30], ["hydropic change", "PROBLEM", 57, 72], ["prolonged cholestasis", "PROBLEM", 124, 145], ["term feathery", "OBSERVATION_MODIFIER", 4, 17], ["degeneration", "OBSERVATION", 18, 30], ["hydropic", "OBSERVATION", 57, 65], ["hepatocytes", "ANATOMY", 88, 99], ["prolonged", "OBSERVATION_MODIFIER", 124, 133], ["cholestasis", "OBSERVATION", 134, 145]]], ["The cells are swollen and vacuolated and crisscrossed by a fine protoplasmic network that is brown with bile pigments (Fig. 2-18 ).", [["cells", "ANATOMY", 4, 9], ["protoplasmic network", "ANATOMY", 64, 84], ["bile pigments", "ANATOMY", 104, 117], ["cells", "CELL", 4, 9], ["protoplasmic network", "MULTI-TISSUE_STRUCTURE", 64, 84], ["bile pigments", "SIMPLE_CHEMICAL", 104, 117], ["swollen", "PROBLEM", 14, 21], ["vacuolated", "PROBLEM", 26, 36], ["cells", "ANATOMY", 4, 9], ["swollen", "OBSERVATION", 14, 21], ["vacuolated", "OBSERVATION_MODIFIER", 26, 36], ["brown", "OBSERVATION_MODIFIER", 93, 98], ["bile", "ANATOMY", 104, 108]]], ["This change is uncommon in cats and dogs.270.e1Hepatic glycogenosis or glucocorticoid hepatopathy, often referred to as steroid-induced hepatopathy, is probably the most severe example of hepatocellular vacuolar change in dogs.", [["hepatocellular vacuolar", "ANATOMY", 188, 211], ["glycogenosis", "DISEASE", 55, 67], ["hepatopathy", "DISEASE", 86, 97], ["steroid", "CHEMICAL", 120, 127], ["hepatopathy", "DISEASE", 136, 147], ["steroid", "CHEMICAL", 120, 127], ["cats", "ORGANISM", 27, 31], ["dogs", "ORGANISM", 36, 40], ["steroid", "SIMPLE_CHEMICAL", 120, 127], ["hepatocellular vacuolar", "MULTI-TISSUE_STRUCTURE", 188, 211], ["dogs", "ORGANISM", 222, 226], ["cats", "SPECIES", 27, 31], ["dogs", "SPECIES", 36, 40], ["dogs", "SPECIES", 222, 226], ["glycogenosis", "PROBLEM", 55, 67], ["glucocorticoid hepatopathy", "PROBLEM", 71, 97], ["steroid-induced hepatopathy", "PROBLEM", 120, 147], ["hepatocellular vacuolar change in dogs", "PROBLEM", 188, 226], ["uncommon", "OBSERVATION_MODIFIER", 15, 23], ["glucocorticoid hepatopathy", "OBSERVATION", 71, 97], ["hepatopathy", "OBSERVATION", 136, 147], ["probably the", "UNCERTAINTY", 152, 164], ["most severe", "OBSERVATION_MODIFIER", 165, 176], ["hepatocellular", "ANATOMY", 188, 202], ["vacuolar change", "OBSERVATION", 203, 218]]], ["It involves glycogen accumulation induced by hyperadrenocorticism, because of either functional adrenocortical or pituitary tumors, or to treatment with glucocorticoids.", [["adrenocortical", "ANATOMY", 96, 110], ["pituitary tumors", "ANATOMY", 114, 130], ["glycogen", "CHEMICAL", 12, 20], ["hyperadrenocorticism", "DISEASE", 45, 65], ["adrenocortical or pituitary tumors", "DISEASE", 96, 130], ["glucocorticoids", "CHEMICAL", 153, 168], ["glycogen", "SIMPLE_CHEMICAL", 12, 20], ["adrenocortical", "CANCER", 96, 110], ["pituitary tumors", "CANCER", 114, 130], ["glucocorticoids", "SIMPLE_CHEMICAL", 153, 168], ["glycogen accumulation", "PROBLEM", 12, 33], ["hyperadrenocorticism", "PROBLEM", 45, 65], ["functional adrenocortical or pituitary tumors", "PROBLEM", 85, 130], ["glucocorticoids", "TREATMENT", 153, 168], ["glycogen accumulation", "OBSERVATION", 12, 33], ["hyperadrenocorticism", "OBSERVATION", 45, 65], ["functional", "OBSERVATION_MODIFIER", 85, 95], ["adrenocortical", "ANATOMY", 96, 110], ["pituitary", "ANATOMY", 114, 123], ["tumors", "OBSERVATION", 124, 130]]], ["The liver is enlarged and pale tan.", [["liver", "ANATOMY", 4, 9], ["liver", "ORGAN", 4, 9], ["enlarged", "PROBLEM", 13, 21], ["pale tan", "PROBLEM", 26, 34], ["liver", "ANATOMY", 4, 9], ["enlarged", "OBSERVATION", 13, 21], ["pale tan", "OBSERVATION", 26, 34]]], ["Hepatocytes are swollen, and the cytoplasm appears as fine, diaphanous strands that enclose multiple spaces with poorly demarcated edges.", [["Hepatocytes", "ANATOMY", 0, 11], ["cytoplasm", "ANATOMY", 33, 42], ["Hepatocytes", "CELL", 0, 11], ["cytoplasm", "ORGANISM_SUBSTANCE", 33, 42], ["Hepatocytes", "CELL_TYPE", 0, 11], ["swollen", "PROBLEM", 16, 23], ["diaphanous strands", "PROBLEM", 60, 78], ["poorly demarcated edges", "PROBLEM", 113, 136], ["swollen", "OBSERVATION", 16, 23], ["fine", "OBSERVATION_MODIFIER", 54, 58], ["diaphanous strands", "OBSERVATION", 60, 78], ["multiple", "OBSERVATION_MODIFIER", 92, 100], ["spaces", "OBSERVATION_MODIFIER", 101, 107], ["poorly demarcated", "OBSERVATION_MODIFIER", 113, 130], ["edges", "OBSERVATION_MODIFIER", 131, 136]]], ["Vacuolar change may range from mild to severe, with swelling of hepatocytes from 2-10 times normal size and displacement of the nucleus and organelles to the cellular periphery ( Fig. 2-19 ).", [["Vacuolar", "ANATOMY", 0, 8], ["hepatocytes", "ANATOMY", 64, 75], ["nucleus", "ANATOMY", 128, 135], ["organelles", "ANATOMY", 140, 150], ["cellular periphery", "ANATOMY", 158, 176], ["swelling", "DISEASE", 52, 60], ["Vacuolar", "CELLULAR_COMPONENT", 0, 8], ["hepatocytes", "CELL", 64, 75], ["nucleus", "CELLULAR_COMPONENT", 128, 135], ["organelles", "CELLULAR_COMPONENT", 140, 150], ["cellular periphery", "CELLULAR_COMPONENT", 158, 176], ["hepatocytes", "CELL_TYPE", 64, 75], ["Vacuolar change", "PROBLEM", 0, 15], ["mild to severe", "PROBLEM", 31, 45], ["swelling of hepatocytes", "PROBLEM", 52, 75], ["change", "OBSERVATION", 9, 15], ["mild", "OBSERVATION_MODIFIER", 31, 35], ["severe", "OBSERVATION_MODIFIER", 39, 45], ["swelling", "OBSERVATION", 52, 60], ["hepatocytes", "ANATOMY", 64, 75], ["size", "OBSERVATION_MODIFIER", 99, 103], ["displacement", "OBSERVATION_MODIFIER", 108, 120], ["nucleus", "ANATOMY_MODIFIER", 128, 135], ["organelles", "ANATOMY_MODIFIER", 140, 150], ["cellular", "ANATOMY_MODIFIER", 158, 166], ["periphery", "ANATOMY_MODIFIER", 167, 176]]], ["The zonal distribution may be very variable and may become diffuse in long-standing cases or with higher doses.", [["diffuse", "OBSERVATION_MODIFIER", 59, 66]]], ["Single-cell drop-out, multifocal small aggregates of neutrophils along sinusoids, and Hepatic iron overload has previously been divided into hemosiderosis when there is only an excess accumulation of hepatocellular iron and hemochromatosis when the excess iron storage has produced fibrosis and inflammation and hepatic injury, although this terminology is not used consistently.", [["cell", "ANATOMY", 7, 11], ["neutrophils", "ANATOMY", 53, 64], ["sinusoids", "ANATOMY", 71, 80], ["Hepatic", "ANATOMY", 86, 93], ["hepatocellular", "ANATOMY", 200, 214], ["hepatic", "ANATOMY", 312, 319], ["iron", "CHEMICAL", 94, 98], ["hemosiderosis", "DISEASE", 141, 154], ["iron", "CHEMICAL", 215, 219], ["hemochromatosis", "DISEASE", 224, 239], ["iron", "CHEMICAL", 256, 260], ["fibrosis", "DISEASE", 282, 290], ["inflammation", "DISEASE", 295, 307], ["hepatic injury", "DISEASE", 312, 326], ["iron", "CHEMICAL", 94, 98], ["iron", "CHEMICAL", 215, 219], ["iron", "CHEMICAL", 256, 260], ["cell", "CELL", 7, 11], ["neutrophils", "CELL", 53, 64], ["sinusoids", "TISSUE", 71, 80], ["hepatocellular iron", "SIMPLE_CHEMICAL", 200, 219], ["iron", "SIMPLE_CHEMICAL", 256, 260], ["hepatic", "ORGAN", 312, 319], ["neutrophils", "CELL_TYPE", 53, 64], ["Single-cell drop", "TEST", 0, 16], ["multifocal small aggregates of neutrophils along sinusoids", "PROBLEM", 22, 80], ["Hepatic iron overload", "PROBLEM", 86, 107], ["hemosiderosis", "PROBLEM", 141, 154], ["hepatocellular iron", "PROBLEM", 200, 219], ["hemochromatosis", "PROBLEM", 224, 239], ["the excess iron storage", "PROBLEM", 245, 268], ["fibrosis", "PROBLEM", 282, 290], ["inflammation", "PROBLEM", 295, 307], ["hepatic injury", "PROBLEM", 312, 326], ["cell drop", "OBSERVATION", 7, 16], ["multifocal", "OBSERVATION_MODIFIER", 22, 32], ["small", "OBSERVATION_MODIFIER", 33, 38], ["aggregates", "OBSERVATION", 39, 49], ["neutrophils", "OBSERVATION", 53, 64], ["Hepatic", "ANATOMY", 86, 93], ["iron overload", "OBSERVATION", 94, 107], ["hemosiderosis", "OBSERVATION", 141, 154], ["excess", "OBSERVATION_MODIFIER", 177, 183], ["accumulation", "OBSERVATION_MODIFIER", 184, 196], ["hepatocellular iron", "OBSERVATION", 200, 219], ["hemochromatosis", "OBSERVATION", 224, 239], ["iron storage", "OBSERVATION", 256, 268], ["fibrosis", "OBSERVATION", 282, 290], ["inflammation", "OBSERVATION", 295, 307], ["hepatic", "ANATOMY", 312, 319], ["injury", "OBSERVATION", 320, 326]]], ["Hemochromatosis, as an inherited disorder is relatively common in humans with specific mutations.", [["Hemochromatosis", "DISEASE", 0, 15], ["inherited disorder", "DISEASE", 23, 41], ["humans", "ORGANISM", 66, 72], ["humans", "SPECIES", 66, 72], ["humans", "SPECIES", 66, 72], ["Hemochromatosis", "PROBLEM", 0, 15], ["an inherited disorder", "PROBLEM", 20, 41], ["disorder", "OBSERVATION", 33, 41]]], ["Iron overload is common in some birds, such as mynahs, and in lemurs, but rare in domestic mammals.", [["Iron", "CHEMICAL", 0, 4], ["Iron", "CHEMICAL", 0, 4], ["Iron", "SIMPLE_CHEMICAL", 0, 4], ["Iron overload", "PROBLEM", 0, 13], ["overload", "OBSERVATION", 5, 13], ["some birds", "OBSERVATION_MODIFIER", 27, 37], ["lemurs", "ANATOMY", 62, 68], ["domestic mammals", "OBSERVATION", 82, 98]]], ["A form resembling heritable hemochromatosis has been reported in Salers or Salers-cross cattle.", [["hemochromatosis", "DISEASE", 28, 43], ["cattle", "ORGANISM", 88, 94], ["cattle", "SPECIES", 88, 94], ["cattle", "SPECIES", 88, 94], ["heritable hemochromatosis", "PROBLEM", 18, 43], ["heritable", "OBSERVATION_MODIFIER", 18, 27], ["hemochromatosis", "OBSERVATION", 28, 43]]], ["Affected animals develop a wasting disease at ~1-2 years of age, have a 30-100 fold increase in liver iron content, with dark-brown discolored, firm livers, hemosiderin accumulation in hepatocytes, and periportal and perivenular bridging fibrosis with nodular regeneration.", [["liver", "ANATOMY", 96, 101], ["livers", "ANATOMY", 149, 155], ["hemosiderin", "ANATOMY", 157, 168], ["hepatocytes", "ANATOMY", 185, 196], ["periportal", "ANATOMY", 202, 212], ["perivenular", "ANATOMY", 217, 228], ["nodular", "ANATOMY", 252, 259], ["wasting disease", "DISEASE", 27, 42], ["iron", "CHEMICAL", 102, 106], ["fibrosis", "DISEASE", 238, 246], ["iron", "CHEMICAL", 102, 106], ["liver", "ORGAN", 96, 101], ["iron", "SIMPLE_CHEMICAL", 102, 106], ["livers", "ORGAN", 149, 155], ["hemosiderin", "SIMPLE_CHEMICAL", 157, 168], ["hepatocytes", "CELL", 185, 196], ["hepatocytes", "CELL_TYPE", 185, 196], ["Affected animals", "PROBLEM", 0, 16], ["a wasting disease", "PROBLEM", 25, 42], ["a 30-100 fold increase in liver iron content", "PROBLEM", 70, 114], ["dark-brown discolored, firm livers", "PROBLEM", 121, 155], ["hemosiderin accumulation in hepatocytes", "PROBLEM", 157, 196], ["periportal and perivenular bridging fibrosis", "PROBLEM", 202, 246], ["nodular regeneration", "PROBLEM", 252, 272], ["wasting", "OBSERVATION_MODIFIER", 27, 34], ["disease", "OBSERVATION", 35, 42], ["liver", "ANATOMY", 96, 101], ["iron content", "OBSERVATION", 102, 114], ["brown discolored", "OBSERVATION_MODIFIER", 126, 142], ["firm", "OBSERVATION_MODIFIER", 144, 148], ["livers", "ANATOMY", 149, 155], ["hemosiderin accumulation", "OBSERVATION", 157, 181], ["hepatocytes", "ANATOMY", 185, 196], ["periportal", "ANATOMY", 202, 212], ["perivenular", "ANATOMY_MODIFIER", 217, 228], ["bridging", "OBSERVATION_MODIFIER", 229, 237], ["fibrosis", "OBSERVATION", 238, 246], ["nodular", "OBSERVATION_MODIFIER", 252, 259], ["regeneration", "OBSERVATION_MODIFIER", 260, 272]]], ["Hemosiderin also accumulates in Kupffer cells, lymph nodes, kidney, pancreas, spleen, and other organs.270.e1Iron overload from dietary excess has been observed in sheep and cattle exposed to high levels of iron in pasture and water.", [["Kupffer cells", "ANATOMY", 32, 45], ["lymph nodes", "ANATOMY", 47, 58], ["kidney", "ANATOMY", 60, 66], ["pancreas", "ANATOMY", 68, 76], ["spleen", "ANATOMY", 78, 84], ["organs", "ANATOMY", 96, 102], ["Hemosiderin", "CHEMICAL", 0, 11], ["Iron", "CHEMICAL", 109, 113], ["iron", "CHEMICAL", 207, 211], ["Hemosiderin", "CHEMICAL", 0, 11], ["Iron", "CHEMICAL", 109, 113], ["iron", "CHEMICAL", 207, 211], ["Hemosiderin", "GENE_OR_GENE_PRODUCT", 0, 11], ["Kupffer cells", "CELL", 32, 45], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 47, 58], ["kidney", "ORGAN", 60, 66], ["pancreas", "ORGAN", 68, 76], ["spleen", "ORGAN", 78, 84], ["organs", "ORGAN", 96, 102], ["Iron", "SIMPLE_CHEMICAL", 109, 113], ["sheep", "ORGANISM", 164, 169], ["cattle", "ORGANISM", 174, 180], ["iron", "SIMPLE_CHEMICAL", 207, 211], ["Hemosiderin", "PROTEIN", 0, 11], ["Kupffer cells", "CELL_TYPE", 32, 45], ["sheep", "SPECIES", 164, 169], ["cattle", "SPECIES", 174, 180], ["sheep", "SPECIES", 164, 169], ["cattle", "SPECIES", 174, 180], ["Hemosiderin", "PROBLEM", 0, 11], ["lymph nodes, kidney, pancreas, spleen, and other organs", "PROBLEM", 47, 102], ["Iron overload", "PROBLEM", 109, 122], ["dietary excess", "PROBLEM", 128, 142], ["iron in pasture", "TREATMENT", 207, 222], ["Kupffer cells", "OBSERVATION", 32, 45], ["lymph nodes", "OBSERVATION", 47, 58], ["kidney", "ANATOMY", 60, 66], ["pancreas", "ANATOMY", 68, 76], ["spleen", "ANATOMY", 78, 84], ["organs", "ANATOMY", 96, 102], ["overload", "OBSERVATION", 114, 122], ["dietary excess", "OBSERVATION", 128, 142]]], ["The liver is enlarged and brown with diffuse fine nodularity, and the hepatic and adjacent lymph nodes are also darkened.", [["liver", "ANATOMY", 4, 9], ["hepatic", "ANATOMY", 70, 77], ["lymph nodes", "ANATOMY", 91, 102], ["liver", "ORGAN", 4, 9], ["hepatic", "ORGAN", 70, 77], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 91, 102], ["enlarged", "PROBLEM", 13, 21], ["diffuse fine nodularity", "PROBLEM", 37, 60], ["the hepatic and adjacent lymph nodes", "PROBLEM", 66, 102], ["liver", "ANATOMY", 4, 9], ["enlarged", "OBSERVATION", 13, 21], ["brown", "OBSERVATION_MODIFIER", 26, 31], ["diffuse", "OBSERVATION_MODIFIER", 37, 44], ["fine", "OBSERVATION_MODIFIER", 45, 49], ["nodularity", "OBSERVATION", 50, 60], ["hepatic", "ANATOMY", 70, 77], ["lymph nodes", "OBSERVATION", 91, 102], ["darkened", "OBSERVATION_MODIFIER", 112, 120]]], ["Large amounts of iron are present in the hepatic parenchyma, the biliary epithelium, and the cortex of lymph nodes, and lesser amounts are present in the broad fibrous septa.", [["hepatic parenchyma", "ANATOMY", 41, 59], ["biliary epithelium", "ANATOMY", 65, 83], ["cortex", "ANATOMY", 93, 99], ["lymph nodes", "ANATOMY", 103, 114], ["fibrous septa", "ANATOMY", 160, 173], ["iron", "CHEMICAL", 17, 21], ["iron", "CHEMICAL", 17, 21], ["iron", "SIMPLE_CHEMICAL", 17, 21], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 41, 59], ["biliary epithelium", "TISSUE", 65, 83], ["cortex", "ORGAN", 93, 99], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 103, 114], ["fibrous septa", "TISSUE", 160, 173], ["Large amounts of iron", "PROBLEM", 0, 21], ["lymph nodes", "PROBLEM", 103, 114], ["amounts", "OBSERVATION_MODIFIER", 6, 13], ["iron", "OBSERVATION", 17, 21], ["hepatic", "ANATOMY", 41, 48], ["parenchyma", "ANATOMY_MODIFIER", 49, 59], ["biliary epithelium", "ANATOMY", 65, 83], ["cortex", "ANATOMY_MODIFIER", 93, 99], ["lymph nodes", "OBSERVATION", 103, 114], ["lesser", "OBSERVATION_MODIFIER", 120, 126], ["amounts", "OBSERVATION_MODIFIER", 127, 134], ["broad", "OBSERVATION_MODIFIER", 154, 159], ["fibrous septa", "OBSERVATION", 160, 173]]], ["The iron is stored predominantly in lysosomes.", [["lysosomes", "ANATOMY", 36, 45], ["iron", "CHEMICAL", 4, 8], ["iron", "CHEMICAL", 4, 8], ["iron", "SIMPLE_CHEMICAL", 4, 8], ["lysosomes", "CELLULAR_COMPONENT", 36, 45]]], ["Brown discoloration of bone marrow resembles the osseous pigmentation of porphyria.", [["bone marrow", "ANATOMY", 23, 34], ["osseous", "ANATOMY", 49, 56], ["porphyria", "DISEASE", 73, 82], ["bone marrow", "MULTI-TISSUE_STRUCTURE", 23, 34], ["osseous", "TISSUE", 49, 56], ["Brown discoloration of bone marrow", "PROBLEM", 0, 34], ["the osseous pigmentation of porphyria", "PROBLEM", 45, 82], ["discoloration", "OBSERVATION", 6, 19], ["bone", "ANATOMY", 23, 27], ["marrow", "OBSERVATION", 28, 34], ["osseous", "ANATOMY", 49, 56], ["pigmentation", "OBSERVATION", 57, 69], ["porphyria", "OBSERVATION", 73, 82]]], ["The pathogenesis of nutritional iron overload is unknown.", [["iron", "CHEMICAL", 32, 36], ["iron", "CHEMICAL", 32, 36], ["iron", "SIMPLE_CHEMICAL", 32, 36], ["nutritional iron overload", "PROBLEM", 20, 45], ["nutritional iron overload", "OBSERVATION", 20, 45]]], ["Iron overload has also been described in horses, with animals displaying signs of liver failure and neurologic impairment.", [["liver", "ANATOMY", 82, 87], ["neurologic", "ANATOMY", 100, 110], ["Iron", "CHEMICAL", 0, 4], ["liver failure", "DISEASE", 82, 95], ["neurologic impairment", "DISEASE", 100, 121], ["Iron", "CHEMICAL", 0, 4], ["Iron", "SIMPLE_CHEMICAL", 0, 4], ["horses", "ORGANISM", 41, 47], ["liver", "ORGAN", 82, 87], ["Iron overload", "PROBLEM", 0, 13], ["liver failure", "PROBLEM", 82, 95], ["neurologic impairment", "PROBLEM", 100, 121], ["overload", "OBSERVATION", 5, 13], ["liver", "ANATOMY", 82, 87], ["failure", "OBSERVATION", 88, 95], ["neurologic impairment", "OBSERVATION", 100, 121]]], ["The microscopic lesions in the livers of these animals are similar to those for other species.270.e1Brown crystalline deposits of 2,8-dihydroxyadenine (2,8-DHA) have been described in hepatocytes and in other tissues in slaughtered cattle with no evidence of other disease.", [["lesions", "ANATOMY", 16, 23], ["livers", "ANATOMY", 31, 37], ["hepatocytes", "ANATOMY", 184, 195], ["tissues", "ANATOMY", 209, 216], ["2,8-dihydroxyadenine", "CHEMICAL", 130, 150], ["2,8-DHA", "CHEMICAL", 152, 159], ["2,8-dihydroxyadenine", "CHEMICAL", 130, 150], ["2,8-DHA", "CHEMICAL", 152, 159], ["lesions", "PATHOLOGICAL_FORMATION", 16, 23], ["livers", "ORGAN", 31, 37], ["2,8-dihydroxyadenine", "SIMPLE_CHEMICAL", 130, 150], ["2,8-DHA", "SIMPLE_CHEMICAL", 152, 159], ["hepatocytes", "CELL", 184, 195], ["tissues", "TISSUE", 209, 216], ["cattle", "ORGANISM", 232, 238], ["hepatocytes", "CELL_TYPE", 184, 195], ["cattle", "SPECIES", 232, 238], ["cattle", "SPECIES", 232, 238], ["The microscopic lesions", "PROBLEM", 0, 23], ["other species", "PROBLEM", 80, 93], ["Brown crystalline deposits", "PROBLEM", 100, 126], ["dihydroxyadenine", "TREATMENT", 134, 150], ["other disease", "PROBLEM", 259, 272], ["microscopic", "OBSERVATION_MODIFIER", 4, 15], ["lesions", "OBSERVATION", 16, 23], ["livers", "ANATOMY", 31, 37], ["species", "OBSERVATION", 86, 93], ["crystalline deposits", "OBSERVATION", 106, 126], ["hepatocytes", "ANATOMY", 184, 195], ["no evidence of", "UNCERTAINTY", 244, 258], ["disease", "OBSERVATION", 265, 272]]], ["These accumulations are strongly birefringent under polarized light, and are seen in the cytoplasm of hepatocytes and macrophages of hepatic lymph nodes and as extracellular deposits in portal stroma and renal tubular lumens.", [["cytoplasm", "ANATOMY", 89, 98], ["hepatocytes", "ANATOMY", 102, 113], ["macrophages", "ANATOMY", 118, 129], ["hepatic lymph nodes", "ANATOMY", 133, 152], ["extracellular deposits", "ANATOMY", 160, 182], ["portal stroma", "ANATOMY", 186, 199], ["renal tubular lumens", "ANATOMY", 204, 224], ["cytoplasm", "ORGANISM_SUBSTANCE", 89, 98], ["hepatocytes", "CELL", 102, 113], ["macrophages", "CELL", 118, 129], ["hepatic lymph nodes", "MULTI-TISSUE_STRUCTURE", 133, 152], ["extracellular deposits", "CELLULAR_COMPONENT", 160, 182], ["portal stroma", "TISSUE", 186, 199], ["renal tubular lumens", "TISSUE", 204, 224], ["hepatocytes", "CELL_TYPE", 102, 113], ["macrophages", "CELL_TYPE", 118, 129], ["These accumulations", "PROBLEM", 0, 19], ["hepatic lymph nodes", "PROBLEM", 133, 152], ["extracellular deposits in portal stroma", "PROBLEM", 160, 199], ["birefringent", "OBSERVATION_MODIFIER", 33, 45], ["polarized light", "OBSERVATION_MODIFIER", 52, 67], ["cytoplasm", "OBSERVATION", 89, 98], ["hepatocytes", "ANATOMY", 102, 113], ["macrophages", "OBSERVATION_MODIFIER", 118, 129], ["hepatic", "ANATOMY", 133, 140], ["lymph nodes", "OBSERVATION", 141, 152], ["extracellular", "OBSERVATION_MODIFIER", 160, 173], ["deposits", "OBSERVATION", 174, 182], ["portal stroma", "ANATOMY", 186, 199], ["renal", "ANATOMY", 204, 209], ["tubular", "ANATOMY_MODIFIER", 210, 217], ["lumens", "ANATOMY_MODIFIER", 218, 224]]], ["Grossly, the portal stroma stands out as a green network, and affected lymph nodes were enlarged, and the medullary sinusoids were distended with green pasty material.", [["portal stroma", "ANATOMY", 13, 26], ["lymph nodes", "ANATOMY", 71, 82], ["medullary sinusoids", "ANATOMY", 106, 125], ["portal stroma", "TISSUE", 13, 26], ["green network", "MULTI-TISSUE_STRUCTURE", 43, 56], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 71, 82], ["medullary sinusoids", "MULTI-TISSUE_STRUCTURE", 106, 125], ["affected lymph nodes", "PROBLEM", 62, 82], ["distended", "PROBLEM", 131, 140], ["green pasty material", "PROBLEM", 146, 166], ["portal stroma", "ANATOMY", 13, 26], ["green network", "OBSERVATION", 43, 56], ["affected", "OBSERVATION_MODIFIER", 62, 70], ["lymph nodes", "OBSERVATION", 71, 82], ["enlarged", "OBSERVATION_MODIFIER", 88, 96], ["medullary sinusoids", "ANATOMY", 106, 125], ["distended", "OBSERVATION", 131, 140], ["green pasty material", "OBSERVATION", 146, 166]]], ["The crystals were identified as 2,8-DHA by a panel of crystallographic methods and mass spectrometry.", [["2,8-DHA", "CHEMICAL", 32, 39], ["2,8-DHA", "CHEMICAL", 32, 39], ["2,8-DHA", "SIMPLE_CHEMICAL", 32, 39], ["The crystals", "TEST", 0, 12], ["crystallographic methods", "TEST", 54, 78], ["mass spectrometry", "PROBLEM", 83, 100], ["crystals", "OBSERVATION_MODIFIER", 4, 12], ["mass spectrometry", "OBSERVATION", 83, 100]]], ["The pathogenesis is unknown.270.e1Pigments of parasitic origin are particularly associated with flukes.", [["flukes", "ANATOMY", 96, 102], ["flukes", "ORGANISM_SUBDIVISION", 96, 102], ["parasitic origin", "PROBLEM", 46, 62], ["flukes", "PROBLEM", 96, 102], ["parasitic origin", "OBSERVATION", 46, 62], ["flukes", "OBSERVATION", 96, 102]]], ["Heavy deposits of black iron-porphyrin compound are formed around the cysts and migratory pathways of Fascioloides magna.", [["cysts", "ANATOMY", 70, 75], ["iron-porphyrin", "CHEMICAL", 24, 38], ["iron-porphyrin", "CHEMICAL", 24, 38], ["black iron-porphyrin compound", "SIMPLE_CHEMICAL", 18, 47], ["Fascioloides magna", "ORGANISM", 102, 120], ["Fascioloides magna", "SPECIES", 102, 120], ["Fascioloides magna", "SPECIES", 102, 120], ["Heavy deposits of black iron-porphyrin compound", "PROBLEM", 0, 47], ["the cysts", "PROBLEM", 66, 75], ["deposits", "OBSERVATION", 6, 14], ["black", "OBSERVATION_MODIFIER", 18, 23], ["iron-porphyrin compound", "OBSERVATION", 24, 47], ["cysts", "OBSERVATION", 70, 75], ["migratory", "OBSERVATION_MODIFIER", 80, 89], ["Fascioloides magna", "OBSERVATION", 102, 120]]], ["Lesser amounts of similar pigment are deposited in bile ducts infested by Fasciola hepatica (see later section on Helminthic infections).", [["bile ducts", "ANATOMY", 51, 61], ["Fasciola hepatica", "DISEASE", 74, 91], ["Helminthic infections", "DISEASE", 114, 135], ["pigment", "TISSUE", 26, 33], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 51, 61], ["Fasciola hepatica", "ORGANISM", 74, 91], ["Fasciola hepatica", "SPECIES", 74, 91], ["Fasciola hepatica", "SPECIES", 74, 91], ["Fasciola hepatica", "PROBLEM", 74, 91], ["Helminthic infections", "PROBLEM", 114, 135], ["amounts", "OBSERVATION_MODIFIER", 7, 14], ["similar pigment", "OBSERVATION", 18, 33], ["deposited", "OBSERVATION_MODIFIER", 38, 47], ["bile ducts", "ANATOMY", 51, 61], ["Fasciola hepatica", "OBSERVATION", 74, 91], ["infections", "OBSERVATION", 125, 135]]], ["The presence of this pigment in the hilar nodes should suggest otherwise inapparent infestations by flukes.", [["hilar nodes", "ANATOMY", 36, 47], ["flukes", "ANATOMY", 100, 106], ["infestations", "DISEASE", 84, 96], ["hilar nodes", "MULTI-TISSUE_STRUCTURE", 36, 47], ["flukes", "ORGAN", 100, 106], ["this pigment in the hilar nodes", "PROBLEM", 16, 47], ["otherwise inapparent infestations", "PROBLEM", 63, 96], ["pigment", "OBSERVATION_MODIFIER", 21, 28], ["hilar", "ANATOMY", 36, 41], ["nodes", "OBSERVATION", 42, 47], ["otherwise", "OBSERVATION_MODIFIER", 63, 72], ["inapparent", "OBSERVATION_MODIFIER", 73, 83], ["infestations", "OBSERVATION", 84, 96], ["flukes", "OBSERVATION", 100, 106]]], ["In schistosomiasis, the liver may be gray because of the accumulation of black pigment in Kupffer cells.VacuolationThe term \"vacuolar hepatopathy\" has been used to denote multifocal or diffuse zonal hepatocellular cytoplasmic vacuolation before a more specific term can be applied, for example, before contents of vacuoles are identified.", [["liver", "ANATOMY", 24, 29], ["Kupffer cells", "ANATOMY", 90, 103], ["vacuolar", "ANATOMY", 125, 133], ["hepatocellular cytoplasmic", "ANATOMY", 199, 225], ["vacuoles", "ANATOMY", 314, 322], ["schistosomiasis", "DISEASE", 3, 18], ["hepatopathy", "DISEASE", 134, 145], ["liver", "ORGAN", 24, 29], ["Kupffer cells", "CELL", 90, 103], ["vacuolar", "CELLULAR_COMPONENT", 125, 133], ["cytoplasmic", "ORGANISM_SUBSTANCE", 214, 225], ["vacuoles", "CELLULAR_COMPONENT", 314, 322], ["Kupffer cells", "CELL_TYPE", 90, 103], ["schistosomiasis", "PROBLEM", 3, 18], ["black pigment in Kupffer cells", "PROBLEM", 73, 103], ["VacuolationThe term \"vacuolar hepatopathy", "PROBLEM", 104, 145], ["multifocal or diffuse zonal hepatocellular cytoplasmic vacuolation", "PROBLEM", 171, 237], ["vacuoles", "PROBLEM", 314, 322], ["schistosomiasis", "OBSERVATION", 3, 18], ["liver", "ANATOMY", 24, 29], ["may be", "UNCERTAINTY", 30, 36], ["accumulation", "OBSERVATION_MODIFIER", 57, 69], ["black pigment", "OBSERVATION", 73, 86], ["Kupffer cells", "OBSERVATION", 90, 103], ["term \"", "OBSERVATION_MODIFIER", 119, 125], ["vacuolar hepatopathy", "OBSERVATION", 125, 145], ["multifocal", "OBSERVATION_MODIFIER", 171, 181], ["diffuse", "OBSERVATION_MODIFIER", 185, 192], ["zonal", "OBSERVATION_MODIFIER", 193, 198], ["hepatocellular cytoplasmic vacuolation", "OBSERVATION", 199, 237], ["vacuoles", "OBSERVATION", 314, 322]]], ["Specific forms of hepatocyte vacuolar change include hydropic swelling, glycogenosis, and steatosis (lipidosis).", [["hepatocyte vacuolar", "ANATOMY", 18, 37], ["hydropic", "ANATOMY", 53, 61], ["hydropic swelling", "DISEASE", 53, 70], ["glycogenosis", "DISEASE", 72, 84], ["steatosis", "DISEASE", 90, 99], ["lipidosis", "DISEASE", 101, 110], ["hepatocyte", "CELL", 18, 28], ["hepatocyte vacuolar change", "PROBLEM", 18, 44], ["hydropic swelling", "PROBLEM", 53, 70], ["glycogenosis", "PROBLEM", 72, 84], ["steatosis", "PROBLEM", 90, 99], ["lipidosis", "PROBLEM", 101, 110], ["hepatocyte", "ANATOMY", 18, 28], ["vacuolar change", "OBSERVATION", 29, 44], ["hydropic", "OBSERVATION_MODIFIER", 53, 61], ["swelling", "OBSERVATION", 62, 70], ["glycogenosis", "OBSERVATION", 72, 84], ["steatosis", "OBSERVATION", 90, 99], ["lipidosis", "OBSERVATION", 101, 110]]], ["Hydropic degeneration can only be appreciated in carefully controlled experimental circumstances and is an early cytoplasmic ballooning seen after various toxic and metabolic insults, hypoxia, and cholestasis.", [["cytoplasmic", "ANATOMY", 113, 124], ["Hydropic degeneration", "DISEASE", 0, 21], ["hypoxia", "DISEASE", 184, 191], ["cholestasis", "DISEASE", 197, 208], ["cytoplasmic", "ORGANISM_SUBSTANCE", 113, 124], ["Hydropic degeneration", "PROBLEM", 0, 21], ["an early cytoplasmic ballooning", "PROBLEM", 104, 135], ["various toxic and metabolic insults", "PROBLEM", 147, 182], ["hypoxia", "PROBLEM", 184, 191], ["cholestasis", "PROBLEM", 197, 208], ["degeneration", "OBSERVATION", 9, 21], ["early", "OBSERVATION_MODIFIER", 107, 112], ["cytoplasmic", "OBSERVATION_MODIFIER", 113, 124], ["ballooning", "OBSERVATION", 125, 135], ["toxic", "OBSERVATION_MODIFIER", 155, 160], ["metabolic insults", "OBSERVATION", 165, 182], ["hypoxia", "OBSERVATION", 184, 191], ["cholestasis", "OBSERVATION", 197, 208]]], ["Water and sodium ion influx expands membranous steatosis in lactating cows.", [["sodium", "CHEMICAL", 10, 16], ["steatosis", "DISEASE", 47, 56], ["sodium", "CHEMICAL", 10, 16], ["sodium ion", "SIMPLE_CHEMICAL", 10, 20], ["cows", "ORGANISM_SUBDIVISION", 70, 74], ["cows", "SPECIES", 70, 74], ["membranous steatosis in lactating cows", "PROBLEM", 36, 74], ["membranous", "OBSERVATION_MODIFIER", 36, 46], ["steatosis", "OBSERVATION", 47, 56], ["lactating cows", "OBSERVATION", 60, 74]]], ["In some of these animals, severe energy deficiency can also lead to clinical ketosis with metabolic acidosis.", [["energy deficiency", "DISEASE", 33, 50], ["ketosis", "DISEASE", 77, 84], ["metabolic acidosis", "DISEASE", 90, 108], ["severe energy deficiency", "PROBLEM", 26, 50], ["clinical ketosis", "PROBLEM", 68, 84], ["metabolic acidosis", "PROBLEM", 90, 108], ["severe", "OBSERVATION_MODIFIER", 26, 32], ["energy deficiency", "OBSERVATION", 33, 50], ["metabolic acidosis", "OBSERVATION", 90, 108]]], ["In addition, severe steatosis occurs in highproducing dairy cows fed diets in which either the mix of available fatty acids is incorrect or lipids are oxidized and rancid.VacuolationHepatocellular steatosis is common in injured hepatocytes because the normal high throughput of fatty acids and triglycerides can be readily impeded at various points in the complex pathway of hepatic lipid metabolism and secretion of verylow-density lipoproteins (VLDLs).", [["Hepatocellular", "ANATOMY", 182, 196], ["hepatocytes", "ANATOMY", 228, 239], ["hepatic", "ANATOMY", 375, 382], ["steatosis", "DISEASE", 20, 29], ["fatty acids", "CHEMICAL", 112, 123], ["steatosis", "DISEASE", 197, 206], ["fatty acids", "CHEMICAL", 278, 289], ["triglycerides", "CHEMICAL", 294, 307], ["fatty acids", "CHEMICAL", 112, 123], ["fatty acids", "CHEMICAL", 278, 289], ["triglycerides", "CHEMICAL", 294, 307], ["fatty acids", "SIMPLE_CHEMICAL", 112, 123], ["lipids", "SIMPLE_CHEMICAL", 140, 146], ["Hepatocellular", "ORGAN", 182, 196], ["hepatocytes", "CELL", 228, 239], ["fatty acids", "AMINO_ACID", 278, 289], ["triglycerides", "SIMPLE_CHEMICAL", 294, 307], ["hepatic lipid", "MULTI-TISSUE_STRUCTURE", 375, 388], ["verylow-density lipoproteins", "GENE_OR_GENE_PRODUCT", 417, 445], ["VLDLs", "SIMPLE_CHEMICAL", 447, 452], ["injured hepatocytes", "CELL_TYPE", 220, 239], ["verylow-density lipoproteins", "PROTEIN", 417, 445], ["VLDLs", "PROTEIN", 447, 452], ["cows", "SPECIES", 60, 64], ["severe steatosis", "PROBLEM", 13, 29], ["available fatty acids", "TREATMENT", 102, 123], ["VacuolationHepatocellular steatosis", "PROBLEM", 171, 206], ["injured hepatocytes", "PROBLEM", 220, 239], ["fatty acids", "TEST", 278, 289], ["triglycerides", "TEST", 294, 307], ["hepatic lipid metabolism", "PROBLEM", 375, 399], ["severe", "OBSERVATION_MODIFIER", 13, 19], ["steatosis", "OBSERVATION", 20, 29], ["Hepatocellular", "ANATOMY", 182, 196], ["steatosis", "OBSERVATION", 197, 206], ["hepatocytes", "ANATOMY", 228, 239], ["normal", "OBSERVATION_MODIFIER", 252, 258], ["high", "OBSERVATION_MODIFIER", 259, 263], ["fatty acids", "OBSERVATION", 278, 289], ["hepatic", "ANATOMY", 375, 382], ["lipid metabolism", "OBSERVATION", 383, 399], ["density lipoproteins", "OBSERVATION", 425, 445]]], ["Hepatocytes obtain some fatty acids from albumin and other carrier proteins in the portal blood, but most is hydrolyzed by sinusoidal endothelial hepatic lipase from triglyceride in chylomicrons or VLDL in plasma.", [["Hepatocytes", "ANATOMY", 0, 11], ["portal blood", "ANATOMY", 83, 95], ["sinusoidal endothelial hepatic", "ANATOMY", 123, 153], ["chylomicrons", "ANATOMY", 182, 194], ["VLDL", "ANATOMY", 198, 202], ["plasma", "ANATOMY", 206, 212], ["fatty acids", "CHEMICAL", 24, 35], ["triglyceride", "CHEMICAL", 166, 178], ["fatty acids", "CHEMICAL", 24, 35], ["triglyceride", "CHEMICAL", 166, 178], ["Hepatocytes", "CELL", 0, 11], ["fatty acids", "AMINO_ACID", 24, 35], ["albumin", "GENE_OR_GENE_PRODUCT", 41, 48], ["portal", "MULTI-TISSUE_STRUCTURE", 83, 89], ["blood", "ORGANISM_SUBSTANCE", 90, 95], ["sinusoidal endothelial", "TISSUE", 123, 145], ["hepatic lipase", "GENE_OR_GENE_PRODUCT", 146, 160], ["triglyceride", "SIMPLE_CHEMICAL", 166, 178], ["chylomicrons", "SIMPLE_CHEMICAL", 182, 194], ["VLDL", "SIMPLE_CHEMICAL", 198, 202], ["plasma", "ORGANISM_SUBSTANCE", 206, 212], ["albumin", "PROTEIN", 41, 48], ["carrier proteins", "PROTEIN", 59, 75], ["sinusoidal endothelial hepatic lipase", "PROTEIN", 123, 160], ["Hepatocytes", "TEST", 0, 11], ["some fatty acids", "PROBLEM", 19, 35], ["albumin", "TEST", 41, 48], ["other carrier proteins in the portal blood", "PROBLEM", 53, 95], ["sinusoidal endothelial hepatic lipase", "TEST", 123, 160], ["triglyceride in chylomicrons", "TREATMENT", 166, 194], ["VLDL in plasma", "TEST", 198, 212], ["fatty acids", "OBSERVATION", 24, 35], ["portal blood", "ANATOMY", 83, 95], ["hepatic", "ANATOMY", 146, 153], ["lipase", "OBSERVATION", 154, 160]]], ["Very-long-chain fatty acids are initially oxidized by acyl-coenzyme A oxidase in peroxisomes to shorter acylcoenzyme A that can be transported via a carnitine-dependent process into mitochondria for further oxidation.", [["peroxisomes", "ANATOMY", 81, 92], ["mitochondria", "ANATOMY", 182, 194], ["fatty acids", "CHEMICAL", 16, 27], ["acyl-coenzyme A", "CHEMICAL", 54, 69], ["acylcoenzyme A", "CHEMICAL", 104, 118], ["carnitine", "CHEMICAL", 149, 158], ["fatty acids", "CHEMICAL", 16, 27], ["acyl-coenzyme A", "CHEMICAL", 54, 69], ["acylcoenzyme A", "CHEMICAL", 104, 118], ["carnitine", "CHEMICAL", 149, 158], ["long-chain fatty acids", "SIMPLE_CHEMICAL", 5, 27], ["acyl-coenzyme A oxidase", "GENE_OR_GENE_PRODUCT", 54, 77], ["peroxisomes", "CELLULAR_COMPONENT", 81, 92], ["acylcoenzyme A", "SIMPLE_CHEMICAL", 104, 118], ["carnitine", "SIMPLE_CHEMICAL", 149, 158], ["mitochondria", "CELLULAR_COMPONENT", 182, 194], ["acyl-coenzyme A oxidase", "PROTEIN", 54, 77], ["Very-long-chain fatty acids", "PROBLEM", 0, 27], ["acyl-coenzyme A oxidase", "TREATMENT", 54, 77], ["a carnitine-dependent process", "TREATMENT", 147, 176], ["further oxidation", "TREATMENT", 199, 216], ["fatty acids", "OBSERVATION", 16, 27]]], ["Although some fatty acid is used for energy in hepatic mitochondria, most from dietary or adipose sources is converted to triglycerides that are further processed into lipoproteins in the hepatocyte ER and actively secreted into the plasma as VLDL.", [["hepatic mitochondria", "ANATOMY", 47, 67], ["adipose", "ANATOMY", 90, 97], ["hepatocyte ER", "ANATOMY", 188, 201], ["plasma", "ANATOMY", 233, 239], ["fatty acid", "CHEMICAL", 14, 24], ["fatty acid", "CHEMICAL", 14, 24], ["triglycerides", "CHEMICAL", 122, 135], ["fatty acid", "SIMPLE_CHEMICAL", 14, 24], ["hepatic mitochondria", "MULTI-TISSUE_STRUCTURE", 47, 67], ["adipose", "TISSUE", 90, 97], ["triglycerides", "SIMPLE_CHEMICAL", 122, 135], ["hepatocyte ER", "GENE_OR_GENE_PRODUCT", 188, 201], ["plasma", "ORGANISM_SUBSTANCE", 233, 239], ["VLDL", "SIMPLE_CHEMICAL", 243, 247], ["lipoproteins", "PROTEIN", 168, 180], ["hepatocyte ER", "PROTEIN", 188, 201], ["some fatty acid", "PROBLEM", 9, 24], ["energy in hepatic mitochondria", "PROBLEM", 37, 67], ["triglycerides", "TEST", 122, 135], ["fatty acid", "OBSERVATION", 14, 24], ["hepatic", "ANATOMY", 47, 54], ["hepatocyte", "ANATOMY", 188, 198]]], ["Endothelial lipoprotein lipase in muscle and adipose tissue hydrolyzes triglycerides in the VLDL, and the fatty acids released are used locally by \u03b2-oxidation in mitochondria of muscle or re-esterified into triglyceride in adipocytes.", [["Endothelial", "ANATOMY", 0, 11], ["muscle", "ANATOMY", 34, 40], ["adipose tissue", "ANATOMY", 45, 59], ["VLDL", "ANATOMY", 92, 96], ["mitochondria", "ANATOMY", 162, 174], ["muscle", "ANATOMY", 178, 184], ["adipocytes", "ANATOMY", 223, 233], ["fatty acids", "CHEMICAL", 106, 117], ["triglyceride", "CHEMICAL", 207, 219], ["triglycerides", "CHEMICAL", 71, 84], ["fatty acids", "CHEMICAL", 106, 117], ["triglyceride", "CHEMICAL", 207, 219], ["Endothelial lipoprotein lipase", "GENE_OR_GENE_PRODUCT", 0, 30], ["muscle", "TISSUE", 34, 40], ["adipose tissue", "TISSUE", 45, 59], ["triglycerides", "SIMPLE_CHEMICAL", 71, 84], ["VLDL", "SIMPLE_CHEMICAL", 92, 96], ["fatty acids", "SIMPLE_CHEMICAL", 106, 117], ["mitochondria", "CELLULAR_COMPONENT", 162, 174], ["muscle", "ORGAN", 178, 184], ["triglyceride", "SIMPLE_CHEMICAL", 207, 219], ["adipocytes", "CELL", 223, 233], ["Endothelial lipoprotein lipase", "PROTEIN", 0, 30], ["adipocytes", "CELL_TYPE", 223, 233], ["Endothelial lipoprotein lipase", "TEST", 0, 30], ["adipose tissue hydrolyzes triglycerides", "TEST", 45, 84], ["the VLDL", "TEST", 88, 96], ["the fatty acids", "PROBLEM", 102, 117], ["lipoprotein lipase", "OBSERVATION", 12, 30], ["muscle", "ANATOMY", 34, 40], ["adipose tissue", "ANATOMY", 45, 59], ["VLDL", "ANATOMY", 92, 96], ["muscle", "ANATOMY", 178, 184], ["adipocytes", "ANATOMY", 223, 233]]], ["The depleted VLDLs are returned by receptor-mediated endocytosis to hepatocytes, where their constituents are catabolized and recycled.VacuolationThe synthesis and export of VLDL in hepatocytes are energy-and resource-dependent, so any disturbance of the supply of apoproteins (apoprotein B primarily), phospholipids, cholesterol, or ATP, or physical disruption of the organelles involved in synthesis, assembly, and secretion, has the potential to inhibit lipoprotein synthesis or secretion.", [["VLDLs", "ANATOMY", 13, 18], ["hepatocytes", "ANATOMY", 68, 79], ["hepatocytes", "ANATOMY", 182, 193], ["organelles", "ANATOMY", 369, 379], ["cholesterol", "CHEMICAL", 318, 329], ["ATP", "CHEMICAL", 334, 337], ["cholesterol", "CHEMICAL", 318, 329], ["ATP", "CHEMICAL", 334, 337], ["VLDLs", "GENE_OR_GENE_PRODUCT", 13, 18], ["hepatocytes", "CELL", 68, 79], ["VLDL", "SIMPLE_CHEMICAL", 174, 178], ["hepatocytes", "CELL", 182, 193], ["apoproteins", "GENE_OR_GENE_PRODUCT", 265, 276], ["apoprotein B", "GENE_OR_GENE_PRODUCT", 278, 290], ["phospholipids", "SIMPLE_CHEMICAL", 303, 316], ["cholesterol", "SIMPLE_CHEMICAL", 318, 329], ["ATP", "SIMPLE_CHEMICAL", 334, 337], ["organelles", "CELLULAR_COMPONENT", 369, 379], ["lipoprotein", "SIMPLE_CHEMICAL", 457, 468], ["VLDLs", "PROTEIN", 13, 18], ["hepatocytes", "CELL_TYPE", 68, 79], ["VLDL", "PROTEIN", 174, 178], ["hepatocytes", "CELL_TYPE", 182, 193], ["apoprotein B", "PROTEIN", 278, 290], ["The depleted VLDLs", "PROBLEM", 0, 18], ["apoproteins (apoprotein B", "TREATMENT", 265, 290], ["phospholipids", "TREATMENT", 303, 316], ["cholesterol", "TEST", 318, 329], ["ATP", "PROBLEM", 334, 337], ["physical disruption of the organelles", "PROBLEM", 342, 379], ["lipoprotein synthesis", "PROBLEM", 457, 478], ["secretion", "PROBLEM", 482, 491], ["depleted", "OBSERVATION", 4, 12], ["hepatocytes", "ANATOMY", 68, 79], ["hepatocytes", "ANATOMY", 182, 193]]], ["Fatty acids can continue to enter hepatocytes, allowing triglyceride globules to accumulate in the hepatocyte cytoplasm.", [["hepatocytes", "ANATOMY", 34, 45], ["triglyceride globules", "ANATOMY", 56, 77], ["hepatocyte cytoplasm", "ANATOMY", 99, 119], ["Fatty acids", "CHEMICAL", 0, 11], ["Fatty acids", "CHEMICAL", 0, 11], ["triglyceride", "CHEMICAL", 56, 68], ["Fatty acids", "SIMPLE_CHEMICAL", 0, 11], ["hepatocytes", "CELL", 34, 45], ["triglyceride", "SIMPLE_CHEMICAL", 56, 68], ["hepatocyte cytoplasm", "ORGANISM_SUBSTANCE", 99, 119], ["hepatocytes", "CELL_TYPE", 34, 45], ["Fatty acids", "PROBLEM", 0, 11], ["triglyceride globules", "TEST", 56, 77], ["hepatocytes", "ANATOMY", 34, 45], ["hepatocyte", "ANATOMY", 99, 109], ["cytoplasm", "ANATOMY_MODIFIER", 110, 119]]], ["In some species, damage to peroxisomes reduces the initial peroxisomal oxidation step for catabolism of long-chain fatty acids and also upregulates various genes regulated by peroxisome proliferator-activated receptor-\u03b1.", [["peroxisomes", "ANATOMY", 27, 38], ["peroxisomal", "ANATOMY", 59, 70], ["fatty acids", "CHEMICAL", 115, 126], ["fatty acids", "CHEMICAL", 115, 126], ["peroxisomes", "CELLULAR_COMPONENT", 27, 38], ["peroxisomal", "CELLULAR_COMPONENT", 59, 70], ["long-chain fatty acids", "SIMPLE_CHEMICAL", 104, 126], ["peroxisome proliferator-activated receptor", "GENE_OR_GENE_PRODUCT", 175, 217], ["peroxisome proliferator-activated receptor", "PROTEIN", 175, 217], ["some species", "PROBLEM", 3, 15], ["damage to peroxisomes", "PROBLEM", 17, 38], ["catabolism of long-chain fatty acids", "TREATMENT", 90, 126], ["species", "OBSERVATION", 8, 15], ["peroxisomal oxidation", "OBSERVATION", 59, 80], ["peroxisome proliferator", "OBSERVATION", 175, 198]]], ["Lipoproteins in the ER, Golgi, and membrane-bound secretory vesicles can also accumulate if there is selective damage to the distal secretory apparatus.", [["ER", "ANATOMY", 20, 22], ["Golgi", "ANATOMY", 24, 29], ["membrane", "ANATOMY", 35, 43], ["secretory vesicles", "ANATOMY", 50, 68], ["distal secretory apparatus", "ANATOMY", 125, 151], ["ER", "GENE_OR_GENE_PRODUCT", 20, 22], ["Golgi", "CELLULAR_COMPONENT", 24, 29], ["membrane", "CELLULAR_COMPONENT", 35, 43], ["secretory vesicles", "CELLULAR_COMPONENT", 50, 68], ["secretory apparatus", "CELLULAR_COMPONENT", 132, 151], ["ER", "PROTEIN", 20, 22], ["Lipoproteins", "TEST", 0, 12], ["selective damage to the distal secretory apparatus", "PROBLEM", 101, 151], ["secretory vesicles", "OBSERVATION", 50, 68], ["selective", "OBSERVATION_MODIFIER", 101, 110], ["damage", "OBSERVATION", 111, 117], ["distal", "ANATOMY_MODIFIER", 125, 131], ["secretory apparatus", "OBSERVATION", 132, 151]]], ["Damage by various toxic and hypoxic insults will not lead to triglyceride accumulation in hepatocytes if supplies of mobile triglycerides from adipose tissue or the diet are low.VacuolationThe microscopic appearance of triglyceride globules in hepatocytes ranges from small discrete microvesicles to large coalescing macrovesicles.", [["hepatocytes", "ANATOMY", 90, 101], ["adipose tissue", "ANATOMY", 143, 157], ["triglyceride globules", "ANATOMY", 219, 240], ["hepatocytes", "ANATOMY", 244, 255], ["microvesicles", "ANATOMY", 283, 296], ["macrovesicles", "ANATOMY", 317, 330], ["triglyceride", "CHEMICAL", 61, 73], ["triglyceride", "CHEMICAL", 61, 73], ["triglycerides", "CHEMICAL", 124, 137], ["triglyceride", "CHEMICAL", 219, 231], ["triglyceride", "SIMPLE_CHEMICAL", 61, 73], ["hepatocytes", "CELL", 90, 101], ["triglycerides", "SIMPLE_CHEMICAL", 124, 137], ["adipose tissue", "TISSUE", 143, 157], ["triglyceride", "SIMPLE_CHEMICAL", 219, 231], ["hepatocytes", "CELL", 244, 255], ["microvesicles", "CELL", 283, 296], ["macrovesicles", "PATHOLOGICAL_FORMATION", 317, 330], ["hepatocytes", "CELL_TYPE", 90, 101], ["hepatocytes", "CELL_TYPE", 244, 255], ["Damage", "PROBLEM", 0, 6], ["various toxic and hypoxic insults", "PROBLEM", 10, 43], ["triglyceride accumulation in hepatocytes", "PROBLEM", 61, 101], ["mobile triglycerides", "PROBLEM", 117, 137], ["adipose tissue", "PROBLEM", 143, 157], ["triglyceride globules", "TEST", 219, 240], ["small discrete microvesicles", "PROBLEM", 268, 296], ["large coalescing macrovesicles", "PROBLEM", 300, 330], ["various", "OBSERVATION_MODIFIER", 10, 17], ["toxic", "OBSERVATION_MODIFIER", 18, 23], ["hypoxic insults", "OBSERVATION", 28, 43], ["hepatocytes", "ANATOMY", 90, 101], ["triglyceride globules", "OBSERVATION", 219, 240], ["hepatocytes", "ANATOMY", 244, 255], ["ranges", "OBSERVATION_MODIFIER", 256, 262], ["small", "OBSERVATION_MODIFIER", 268, 273], ["discrete", "OBSERVATION_MODIFIER", 274, 282], ["microvesicles", "OBSERVATION", 283, 296], ["large", "OBSERVATION_MODIFIER", 300, 305], ["coalescing", "OBSERVATION_MODIFIER", 306, 316], ["macrovesicles", "OBSERVATION", 317, 330]]], ["Microvesicular lipid vacuoles are smaller than the nucleus and tend not to displace the nucleus (Fig. 2-20) .", [["Microvesicular lipid vacuoles", "ANATOMY", 0, 29], ["nucleus", "ANATOMY", 51, 58], ["nucleus", "ANATOMY", 88, 95], ["lipid vacuoles", "CELLULAR_COMPONENT", 15, 29], ["nucleus", "CELLULAR_COMPONENT", 51, 58], ["nucleus", "CELLULAR_COMPONENT", 88, 95], ["Microvesicular lipid vacuoles", "TEST", 0, 29], ["Fig.", "TEST", 97, 101], ["lipid vacuoles", "OBSERVATION", 15, 29], ["smaller", "OBSERVATION_MODIFIER", 34, 41], ["nucleus", "ANATOMY", 51, 58], ["nucleus", "ANATOMY", 88, 95]]], ["Microvesicular steatosis can be a hallmark of more severe hepatic dysfunction than macrovesicular steatosis.", [["hepatic", "ANATOMY", 58, 65], ["macrovesicular", "ANATOMY", 83, 97], ["steatosis", "DISEASE", 15, 24], ["hepatic dysfunction", "DISEASE", 58, 77], ["steatosis", "DISEASE", 98, 107], ["hepatic", "ORGAN", 58, 65], ["macrovesicular steatosis", "PATHOLOGICAL_FORMATION", 83, 107], ["Microvesicular steatosis", "PROBLEM", 0, 24], ["more severe hepatic dysfunction", "PROBLEM", 46, 77], ["macrovesicular steatosis", "PROBLEM", 83, 107], ["steatosis", "OBSERVATION", 15, 24], ["more", "OBSERVATION_MODIFIER", 46, 50], ["severe", "OBSERVATION_MODIFIER", 51, 57], ["hepatic", "ANATOMY", 58, 65], ["dysfunction", "OBSERVATION", 66, 77], ["macrovesicular", "OBSERVATION_MODIFIER", 83, 97], ["steatosis", "OBSERVATION", 98, 107]]], ["This pattern can occur in several toxic hepatopathies causing mitochondrial injury, including some drug toxicities, such as antiviral nucleosides, aspirin in Reye's syndrome, and excessive tetracycline administration, all of which can be fatal.", [["mitochondrial", "ANATOMY", 62, 75], ["hepatopathies", "DISEASE", 40, 53], ["mitochondrial injury", "DISEASE", 62, 82], ["toxicities", "DISEASE", 104, 114], ["nucleosides", "CHEMICAL", 134, 145], ["aspirin", "CHEMICAL", 147, 154], ["Reye's syndrome", "DISEASE", 158, 173], ["tetracycline", "CHEMICAL", 189, 201], ["nucleosides", "CHEMICAL", 134, 145], ["aspirin", "CHEMICAL", 147, 154], ["tetracycline", "CHEMICAL", 189, 201], ["mitochondrial", "CELLULAR_COMPONENT", 62, 75], ["aspirin", "SIMPLE_CHEMICAL", 147, 154], ["tetracycline", "SIMPLE_CHEMICAL", 189, 201], ["several toxic hepatopathies", "PROBLEM", 26, 53], ["mitochondrial injury", "PROBLEM", 62, 82], ["some drug toxicities", "PROBLEM", 94, 114], ["antiviral nucleosides", "TREATMENT", 124, 145], ["aspirin", "TREATMENT", 147, 154], ["Reye's syndrome", "PROBLEM", 158, 173], ["excessive tetracycline administration", "TREATMENT", 179, 216], ["several", "OBSERVATION_MODIFIER", 26, 33], ["toxic", "OBSERVATION_MODIFIER", 34, 39], ["mitochondrial injury", "OBSERVATION", 62, 82], ["drug toxicities", "OBSERVATION", 99, 114], ["excessive tetracycline", "OBSERVATION", 179, 201]]], ["These toxicities tend to target: mitochondria, disrupting energy production; the normal electron transfer chain, causing oxidative injury; and interfere with \u03b2-oxidation of lipids.", [["mitochondria", "ANATOMY", 33, 45], ["toxicities", "DISEASE", 6, 16], ["mitochondria", "CELLULAR_COMPONENT", 33, 45], ["lipids", "SIMPLE_CHEMICAL", 173, 179], ["These toxicities", "PROBLEM", 0, 16], ["disrupting energy production", "PROBLEM", 47, 75], ["oxidative injury", "PROBLEM", 121, 137], ["\u03b2-oxidation of lipids", "TREATMENT", 158, 179], ["oxidative injury", "OBSERVATION", 121, 137]]], ["Partially oxidized lipids typically have a lower surface tension than triglycerides and therefore form smaller vesicles in the aqueous medium of the cytoplasm.", [["surface", "ANATOMY", 49, 56], ["vesicles", "ANATOMY", 111, 119], ["cytoplasm", "ANATOMY", 149, 158], ["triglycerides", "CHEMICAL", 70, 83], ["triglycerides", "SIMPLE_CHEMICAL", 70, 83], ["vesicles", "CELLULAR_COMPONENT", 111, 119], ["aqueous", "ORGANISM_SUBSTANCE", 127, 134], ["cytoplasm", "ORGANISM_SUBSTANCE", 149, 158], ["Partially oxidized lipids", "PROBLEM", 0, 25], ["a lower surface tension than triglycerides", "PROBLEM", 41, 83], ["smaller vesicles", "PROBLEM", 103, 119], ["oxidized", "OBSERVATION", 10, 18], ["lower", "OBSERVATION_MODIFIER", 43, 48], ["surface", "OBSERVATION_MODIFIER", 49, 56], ["tension", "OBSERVATION", 57, 64], ["smaller", "OBSERVATION_MODIFIER", 103, 110], ["vesicles", "OBSERVATION_MODIFIER", 111, 119], ["aqueous medium", "ANATOMY_MODIFIER", 127, 141], ["cytoplasm", "OBSERVATION", 149, 158]]], ["Uncontrolled diabetes mellitus and feline fatty liver syndrome can produce microvesicular hepatic scattered small foci of extracellular hematopoiesis are also commonly observed.", [["fatty liver", "ANATOMY", 42, 53], ["hepatic", "ANATOMY", 90, 97], ["foci", "ANATOMY", 114, 118], ["extracellular", "ANATOMY", 122, 135], ["diabetes mellitus", "DISEASE", 13, 30], ["fatty liver syndrome", "DISEASE", 42, 62], ["feline", "ORGANISM", 35, 41], ["liver", "ORGAN", 48, 53], ["extracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 122, 135], ["feline", "SPECIES", 35, 41], ["Uncontrolled diabetes mellitus", "PROBLEM", 0, 30], ["feline fatty liver syndrome", "PROBLEM", 35, 62], ["microvesicular hepatic scattered small foci of extracellular hematopoiesis", "PROBLEM", 75, 149], ["diabetes mellitus", "OBSERVATION", 13, 30], ["feline", "OBSERVATION_MODIFIER", 35, 41], ["fatty liver syndrome", "OBSERVATION", 42, 62], ["microvesicular", "OBSERVATION_MODIFIER", 75, 89], ["hepatic", "ANATOMY", 90, 97], ["scattered", "OBSERVATION_MODIFIER", 98, 107], ["small", "OBSERVATION_MODIFIER", 108, 113], ["foci", "OBSERVATION", 114, 118], ["extracellular hematopoiesis", "OBSERVATION", 122, 149]]], ["The ill-defined vacuolar boundaries in steroid hepatopathy are readily distinguishable from spherical lipid vacuoles in hepatic steatosis.", [["vacuolar", "ANATOMY", 16, 24], ["lipid vacuoles", "ANATOMY", 102, 116], ["hepatic", "ANATOMY", 120, 127], ["steroid", "CHEMICAL", 39, 46], ["hepatopathy", "DISEASE", 47, 58], ["hepatic steatosis", "DISEASE", 120, 137], ["steroid", "CHEMICAL", 39, 46], ["vacuolar", "IMMATERIAL_ANATOMICAL_ENTITY", 16, 24], ["lipid vacuoles", "CELLULAR_COMPONENT", 102, 116], ["hepatic steatosis", "PATHOLOGICAL_FORMATION", 120, 137], ["The ill-defined vacuolar boundaries in steroid hepatopathy", "PROBLEM", 0, 58], ["hepatic steatosis", "PROBLEM", 120, 137], ["ill", "OBSERVATION_MODIFIER", 4, 7], ["vacuolar boundaries", "OBSERVATION", 16, 35], ["steroid hepatopathy", "OBSERVATION", 39, 58], ["spherical", "OBSERVATION_MODIFIER", 92, 101], ["lipid vacuoles", "OBSERVATION", 102, 116], ["hepatic", "ANATOMY", 120, 127], ["steatosis", "OBSERVATION", 128, 137]]], ["The pathogenesis of this condition is uncertain, because glycogen storage alone does not fully explain the influx of fluid, and possible perturbations in hepatocellular ion channels or aquaporins have not been assessed.", [["fluid", "ANATOMY", 117, 122], ["hepatocellular", "ANATOMY", 154, 168], ["glycogen", "CHEMICAL", 57, 65], ["glycogen", "SIMPLE_CHEMICAL", 57, 65], ["fluid", "ORGANISM_SUBSTANCE", 117, 122], ["hepatocellular", "MULTI-TISSUE_STRUCTURE", 154, 168], ["aquaporins", "GENE_OR_GENE_PRODUCT", 185, 195], ["hepatocellular ion channels", "PROTEIN", 154, 181], ["aquaporins", "PROTEIN", 185, 195], ["this condition", "PROBLEM", 20, 34], ["glycogen storage", "PROBLEM", 57, 73], ["the influx of fluid", "PROBLEM", 103, 122], ["perturbations in hepatocellular ion channels", "PROBLEM", 137, 181], ["aquaporins", "TREATMENT", 185, 195], ["fluid", "OBSERVATION", 117, 122]]], ["The amount of glycogen remaining in affected cells is widely variable, a function of the original glycogen concentration, recent catabolism, and postmortem dissolution.", [["cells", "ANATOMY", 45, 50], ["glycogen", "CHEMICAL", 14, 22], ["glycogen", "CHEMICAL", 98, 106], ["glycogen", "SIMPLE_CHEMICAL", 14, 22], ["cells", "CELL", 45, 50], ["glycogen", "SIMPLE_CHEMICAL", 98, 106], ["affected cells", "CELL_TYPE", 36, 50], ["glycogen remaining in affected cells", "PROBLEM", 14, 50], ["the original glycogen concentration", "TREATMENT", 85, 120], ["recent catabolism", "TREATMENT", 122, 139], ["postmortem dissolution", "TREATMENT", 145, 167], ["amount", "OBSERVATION_MODIFIER", 4, 10], ["glycogen remaining", "OBSERVATION", 14, 32], ["affected cells", "OBSERVATION", 36, 50], ["widely", "OBSERVATION_MODIFIER", 54, 60], ["variable", "OBSERVATION_MODIFIER", 61, 69]]], ["Glycogen content can best be demonstrated in frozen section, followed by staining with periodic acid-Schiff, and can be confirmed as glycogen by its sensitivity to digestion with diastase.", [["glycogen", "CHEMICAL", 133, 141], ["Glycogen", "SIMPLE_CHEMICAL", 0, 8], ["glycogen", "SIMPLE_CHEMICAL", 133, 141], ["Glycogen content", "PROBLEM", 0, 16], ["frozen section", "TREATMENT", 45, 59], ["periodic acid-Schiff", "TEST", 87, 107], ["diastase", "PROBLEM", 179, 187], ["diastase", "OBSERVATION", 179, 187]]], ["Livers affected by glucocorticoid hepatopathy maintain normal hepatocyte functions, but the condition can be confirmed by the induction and serum increase of glucocorticoidinducible alkaline phosphatase, with minor or negligible increases in alanine aminotransferase.", [["Livers", "ANATOMY", 0, 6], ["hepatocyte", "ANATOMY", 62, 72], ["serum", "ANATOMY", 140, 145], ["hepatopathy", "DISEASE", 34, 45], ["alanine", "CHEMICAL", 242, 249], ["alanine", "CHEMICAL", 242, 249], ["Livers", "ORGAN", 0, 6], ["hepatocyte", "CELL", 62, 72], ["serum", "ORGANISM_SUBSTANCE", 140, 145], ["glucocorticoidinducible alkaline phosphatase", "GENE_OR_GENE_PRODUCT", 158, 202], ["alanine", "AMINO_ACID", 242, 249], ["aminotransferase", "GENE_OR_GENE_PRODUCT", 250, 266], ["glucocorticoidinducible alkaline phosphatase", "PROTEIN", 158, 202], ["alanine aminotransferase", "PROTEIN", 242, 266], ["glucocorticoid hepatopathy", "PROBLEM", 19, 45], ["the induction", "TEST", 122, 135], ["glucocorticoidinducible alkaline phosphatase", "TEST", 158, 202], ["negligible increases in alanine aminotransferase", "PROBLEM", 218, 266], ["glucocorticoid hepatopathy", "OBSERVATION", 19, 45], ["normal", "OBSERVATION", 55, 61], ["hepatocyte functions", "OBSERVATION", 62, 82], ["negligible", "OBSERVATION_MODIFIER", 218, 228], ["increases", "OBSERVATION_MODIFIER", 229, 238], ["alanine aminotransferase", "OBSERVATION", 242, 266]]], ["Similar vacuoles may be created by other adrenocortical steroids, possibly progestins, as occasionally seen in older, female dogs that appear to have overproduction of adrenal cortical hormones other than cortisol and alkaline phosphatase elevation, although the specific pathogenesis is unknown.", [["vacuoles", "ANATOMY", 8, 16], ["adrenocortical", "ANATOMY", 41, 55], ["adrenal cortical", "ANATOMY", 168, 184], ["steroids", "CHEMICAL", 56, 64], ["progestins", "CHEMICAL", 75, 85], ["cortisol", "CHEMICAL", 205, 213], ["steroids", "CHEMICAL", 56, 64], ["progestins", "CHEMICAL", 75, 85], ["cortisol", "CHEMICAL", 205, 213], ["vacuoles", "CELLULAR_COMPONENT", 8, 16], ["adrenocortical", "ORGAN", 41, 55], ["progestins", "SIMPLE_CHEMICAL", 75, 85], ["dogs", "ORGANISM", 125, 129], ["adrenal cortical", "MULTI-TISSUE_STRUCTURE", 168, 184], ["cortisol", "GENE_OR_GENE_PRODUCT", 205, 213], ["alkaline phosphatase", "GENE_OR_GENE_PRODUCT", 218, 238], ["alkaline phosphatase", "PROTEIN", 218, 238], ["dogs", "SPECIES", 125, 129], ["other adrenocortical steroids", "TREATMENT", 35, 64], ["progestins", "PROBLEM", 75, 85], ["overproduction of adrenal cortical hormones", "PROBLEM", 150, 193], ["cortisol", "TEST", 205, 213], ["alkaline phosphatase elevation", "PROBLEM", 218, 248], ["vacuoles", "OBSERVATION", 8, 16], ["may be", "UNCERTAINTY", 17, 23], ["adrenocortical steroids", "OBSERVATION", 41, 64], ["possibly", "UNCERTAINTY", 66, 74], ["progestins", "OBSERVATION_MODIFIER", 75, 85], ["adrenal", "ANATOMY", 168, 175], ["cortical hormones", "OBSERVATION", 176, 193], ["alkaline phosphatase", "OBSERVATION", 218, 238]]], ["Some drugs, such as the chelator D-penicillamine, can produce similar vacuolation.VacuolationLoss-of-function mutations in hepatic and renal glucose-6phosphatase resulting in increased hepatic glycogen storage have been reported in Maltese puppies or related crossbred dogs, and these dogs serve as an animal model of glycogen storage disease (glycogenosis) type Ia.", [["hepatic", "ANATOMY", 123, 130], ["renal", "ANATOMY", 135, 140], ["hepatic", "ANATOMY", 185, 192], ["D-penicillamine", "CHEMICAL", 33, 48], ["glycogen", "CHEMICAL", 193, 201], ["glycogen storage disease", "DISEASE", 318, 342], ["glycogenosis", "DISEASE", 344, 356], ["D-penicillamine", "CHEMICAL", 33, 48], ["glucose", "CHEMICAL", 141, 148], ["chelator D-penicillamine", "SIMPLE_CHEMICAL", 24, 48], ["hepatic", "MULTI-TISSUE_STRUCTURE", 123, 130], ["renal", "ORGAN", 135, 140], ["glucose-6phosphatase", "GENE_OR_GENE_PRODUCT", 141, 161], ["glycogen", "SIMPLE_CHEMICAL", 193, 201], ["Maltese puppies", "ORGANISM", 232, 247], ["dogs", "ORGANISM", 269, 273], ["dogs", "ORGANISM", 285, 289], ["glycogen", "SIMPLE_CHEMICAL", 318, 326], ["hepatic and renal glucose-6phosphatase", "PROTEIN", 123, 161], ["dogs", "SPECIES", 269, 273], ["dogs", "SPECIES", 285, 289], ["Some drugs", "TREATMENT", 0, 10], ["the chelator D-penicillamine", "TREATMENT", 20, 48], ["similar vacuolation", "PROBLEM", 62, 81], ["VacuolationLoss", "TEST", 82, 97], ["renal glucose", "TEST", 135, 148], ["phosphatase", "TEST", 150, 161], ["increased hepatic glycogen storage", "PROBLEM", 175, 209], ["crossbred dogs", "PROBLEM", 259, 273], ["glycogen storage disease (glycogenosis) type Ia", "PROBLEM", 318, 365], ["vacuolation", "OBSERVATION", 70, 81], ["hepatic", "ANATOMY", 123, 130], ["renal", "ANATOMY", 135, 140], ["increased", "OBSERVATION_MODIFIER", 175, 184], ["hepatic", "ANATOMY", 185, 192], ["glycogen storage", "OBSERVATION", 193, 209], ["glycogen storage disease", "OBSERVATION", 318, 342]]], ["These dogs have severely debilitating problems in maintaining their blood glucose because dephosphorylation of glucose-6-phosphate is a key step in both glycogenolysis and gluconeogenesis.", [["blood", "ANATOMY", 68, 73], ["glucose", "CHEMICAL", 74, 81], ["glucose-6-phosphate", "CHEMICAL", 111, 130], ["glucose", "CHEMICAL", 74, 81], ["glucose-6-phosphate", "CHEMICAL", 111, 130], ["dogs", "ORGANISM", 6, 10], ["blood", "ORGANISM_SUBSTANCE", 68, 73], ["glucose", "SIMPLE_CHEMICAL", 74, 81], ["glucose-6-phosphate", "SIMPLE_CHEMICAL", 111, 130], ["dogs", "SPECIES", 6, 10], ["severely debilitating problems", "PROBLEM", 16, 46], ["their blood glucose", "TEST", 62, 81], ["glucose", "TEST", 111, 118], ["phosphate", "TREATMENT", 121, 130], ["severely", "OBSERVATION_MODIFIER", 16, 24], ["debilitating", "OBSERVATION_MODIFIER", 25, 37]]], ["The condition is typified by severe hepatocellular glycogenosis.", [["hepatocellular", "ANATOMY", 36, 50], ["glycogenosis", "DISEASE", 51, 63], ["hepatocellular glycogenosis", "CANCER", 36, 63], ["severe hepatocellular glycogenosis", "PROBLEM", 29, 63], ["severe", "OBSERVATION_MODIFIER", 29, 35], ["hepatocellular glycogenosis", "OBSERVATION", 36, 63]]], ["Livers are markedly enlarged, pale, and have diffuse vacuolation of hepatocytes with large amounts of glycogen and small amounts of lipid.", [["Livers", "ANATOMY", 0, 6], ["hepatocytes", "ANATOMY", 68, 79], ["glycogen", "CHEMICAL", 102, 110], ["Livers", "ORGAN", 0, 6], ["hepatocytes", "CELL", 68, 79], ["glycogen", "SIMPLE_CHEMICAL", 102, 110], ["lipid", "SIMPLE_CHEMICAL", 132, 137], ["hepatocytes", "CELL_TYPE", 68, 79], ["markedly enlarged", "PROBLEM", 11, 28], ["diffuse vacuolation of hepatocytes", "PROBLEM", 45, 79], ["glycogen", "TREATMENT", 102, 110], ["markedly", "OBSERVATION_MODIFIER", 11, 19], ["enlarged", "OBSERVATION", 20, 28], ["pale", "OBSERVATION_MODIFIER", 30, 34], ["diffuse", "OBSERVATION_MODIFIER", 45, 52], ["vacuolation", "OBSERVATION", 53, 64], ["hepatocytes", "ANATOMY", 68, 79], ["large", "OBSERVATION_MODIFIER", 85, 90], ["amounts", "OBSERVATION_MODIFIER", 91, 98], ["small", "OBSERVATION_MODIFIER", 115, 120], ["amounts", "OBSERVATION_MODIFIER", 121, 128]]], ["Hepatic fibrosis and nodular regeneration can develop with time.", [["Hepatic", "ANATOMY", 0, 7], ["nodular", "ANATOMY", 21, 28], ["fibrosis", "DISEASE", 8, 16], ["Hepatic", "MULTI-TISSUE_STRUCTURE", 0, 7], ["Hepatic fibrosis", "PROBLEM", 0, 16], ["nodular regeneration", "PROBLEM", 21, 41], ["fibrosis", "OBSERVATION", 8, 16], ["nodular", "OBSERVATION_MODIFIER", 21, 28], ["regeneration", "OBSERVATION", 29, 41]]], ["Renal tubular epithelium is also vacuolated.", [["Renal tubular epithelium", "ANATOMY", 0, 24], ["Renal tubular epithelium", "TISSUE", 0, 24], ["Renal tubular epithelium", "PROBLEM", 0, 24], ["vacuolated", "PROBLEM", 33, 43], ["tubular epithelium", "OBSERVATION", 6, 24], ["vacuolated", "OBSERVATION_MODIFIER", 33, 43]]], ["Glycogen storage disease type III, with hepatic glycogen storage, has been reported in dogs, predominantly German Shepherd dogs.", [["hepatic", "ANATOMY", 40, 47], ["glycogen", "CHEMICAL", 48, 56], ["Glycogen storage disease type III", "GENE_OR_GENE_PRODUCT", 0, 33], ["hepatic", "ORGAN", 40, 47], ["glycogen", "SIMPLE_CHEMICAL", 48, 56], ["dogs", "ORGANISM", 87, 91], ["Shepherd dogs", "ORGANISM", 114, 127], ["dogs", "SPECIES", 87, 91], ["dogs", "SPECIES", 123, 127], ["Glycogen storage disease type III", "PROBLEM", 0, 33], ["hepatic glycogen storage", "TREATMENT", 40, 64], ["storage disease", "OBSERVATION", 9, 24], ["type III", "OBSERVATION_MODIFIER", 25, 33], ["hepatic", "ANATOMY", 40, 47], ["glycogen storage", "OBSERVATION", 48, 64], ["Shepherd dogs", "OBSERVATION", 114, 127]]], ["Type IV glycogenosis has been reported in Norwegian Forest cats, although this disorder causes pale blue granules in hepatocellular cytoplasm rather than clear vacuoles.VacuolationCharacteristic hepatocellular vacuolation is also described in dogs with end-stage nodular livers presented clinically with hepatocutaneous syndrome.Hepatocellular steatosis (lipidosis)Hepatocellular steatosis is the term used to describe fatty livers of animals.", [["pale blue granules", "ANATOMY", 95, 113], ["hepatocellular cytoplasm", "ANATOMY", 117, 141], ["vacuoles", "ANATOMY", 160, 168], ["hepatocellular", "ANATOMY", 195, 209], ["nodular livers", "ANATOMY", 263, 277], ["Hepatocellular", "ANATOMY", 329, 343], ["Hepatocellular", "ANATOMY", 365, 379], ["fatty livers", "ANATOMY", 419, 431], ["Type IV glycogenosis", "DISEASE", 0, 20], ["disorder", "DISEASE", 79, 87], ["hepatocutaneous syndrome", "DISEASE", 304, 328], ["Hepatocellular steatosis", "DISEASE", 329, 353], ["lipidosis", "DISEASE", 355, 364], ["Hepatocellular steatosis", "DISEASE", 365, 389], ["Forest cats", "ORGANISM", 52, 63], ["granules", "ORGANISM_SUBSTANCE", 105, 113], ["hepatocellular cytoplasm", "ORGANISM_SUBSTANCE", 117, 141], ["vacuoles", "CELLULAR_COMPONENT", 160, 168], ["hepatocellular", "CANCER", 195, 209], ["dogs", "ORGANISM", 243, 247], ["livers", "ORGAN", 271, 277], ["Hepatocellular steatosis", "PATHOLOGICAL_FORMATION", 329, 353], ["Hepatocellular", "ORGAN", 365, 379], ["livers", "ORGAN", 425, 431], ["cats", "SPECIES", 59, 63], ["dogs", "SPECIES", 243, 247], ["Type IV glycogenosis", "PROBLEM", 0, 20], ["this disorder", "PROBLEM", 74, 87], ["pale blue granules in hepatocellular cytoplasm", "PROBLEM", 95, 141], ["VacuolationCharacteristic hepatocellular vacuolation", "PROBLEM", 169, 221], ["end-stage nodular livers", "PROBLEM", 253, 277], ["hepatocutaneous syndrome", "PROBLEM", 304, 328], ["Hepatocellular steatosis", "PROBLEM", 329, 353], ["lipidosis)", "PROBLEM", 355, 365], ["Hepatocellular steatosis", "PROBLEM", 365, 389], ["fatty livers of animals", "PROBLEM", 419, 442], ["pale", "OBSERVATION_MODIFIER", 95, 99], ["blue granules", "OBSERVATION", 100, 113], ["hepatocellular cytoplasm", "OBSERVATION", 117, 141], ["vacuoles", "OBSERVATION", 160, 168], ["Characteristic", "OBSERVATION_MODIFIER", 180, 194], ["hepatocellular vacuolation", "OBSERVATION", 195, 221], ["stage", "OBSERVATION_MODIFIER", 257, 262], ["nodular", "OBSERVATION_MODIFIER", 263, 270], ["livers", "ANATOMY", 271, 277], ["hepatocutaneous syndrome", "OBSERVATION", 304, 328], ["steatosis", "OBSERVATION", 344, 353], ["lipidosis", "OBSERVATION", 355, 364], ["Hepatocellular", "ANATOMY", 365, 379], ["steatosis", "OBSERVATION", 380, 389]]], ["However, the terms steatosis, lipidosis, and fatty change tend to also be used interchangeably.", [["steatosis", "DISEASE", 19, 28], ["lipidosis", "DISEASE", 30, 39], ["the terms steatosis", "PROBLEM", 9, 28], ["lipidosis", "PROBLEM", 30, 39], ["fatty change", "PROBLEM", 45, 57], ["terms", "OBSERVATION_MODIFIER", 13, 18], ["steatosis", "OBSERVATION", 19, 28], ["lipidosis", "OBSERVATION", 30, 39], ["fatty change", "OBSERVATION", 45, 57]]], ["All of these terms refer to the visible accumulation of triglycerides (triacylglycerols) as round globules in the cytoplasm of hepatocytes.", [["round globules", "ANATOMY", 92, 106], ["cytoplasm", "ANATOMY", 114, 123], ["hepatocytes", "ANATOMY", 127, 138], ["triglycerides", "CHEMICAL", 56, 69], ["triacylglycerols", "CHEMICAL", 71, 87], ["triglycerides", "CHEMICAL", 56, 69], ["triacylglycerols", "CHEMICAL", 71, 87], ["triglycerides", "SIMPLE_CHEMICAL", 56, 69], ["triacylglycerols", "SIMPLE_CHEMICAL", 71, 87], ["cytoplasm", "ORGANISM_SUBSTANCE", 114, 123], ["hepatocytes", "CELL", 127, 138], ["hepatocytes", "CELL_TYPE", 127, 138], ["triglycerides (triacylglycerols", "TREATMENT", 56, 87], ["round globules in the cytoplasm of hepatocytes", "PROBLEM", 92, 138], ["round", "OBSERVATION_MODIFIER", 92, 97], ["globules", "OBSERVATION", 98, 106], ["hepatocytes", "ANATOMY", 127, 138]]], ["The threshold for application of these terms is vague because triglyceride storage and transport are normal hepatic functions, but they are appropriate when the amounts are greater than would normally be seen.", [["hepatic", "ANATOMY", 108, 115], ["triglyceride", "CHEMICAL", 62, 74], ["triglyceride", "CHEMICAL", 62, 74], ["triglyceride", "SIMPLE_CHEMICAL", 62, 74], ["hepatic", "MULTI-TISSUE_STRUCTURE", 108, 115], ["triglyceride storage", "TEST", 62, 82], ["normal", "OBSERVATION", 101, 107], ["hepatic", "ANATOMY", 108, 115], ["greater", "OBSERVATION_MODIFIER", 173, 180]]], ["Hepatocellular steatosis can be physiologic or pathologic.", [["Hepatocellular", "ANATOMY", 0, 14], ["Hepatocellular steatosis", "DISEASE", 0, 24], ["Hepatocellular", "ORGAN", 0, 14], ["Hepatocellular steatosis", "PROBLEM", 0, 24], ["steatosis", "OBSERVATION", 15, 24], ["pathologic", "OBSERVATION", 47, 57]]], ["Any circumstance in which hepatic uptake of lipids exceeds oxidation or secretion can lead to hepatocellular steatosis.", [["hepatic", "ANATOMY", 26, 33], ["hepatocellular", "ANATOMY", 94, 108], ["steatosis", "DISEASE", 109, 118], ["hepatic", "MULTI-TISSUE_STRUCTURE", 26, 33], ["lipids", "SIMPLE_CHEMICAL", 44, 50], ["hepatocellular", "PATHOLOGICAL_FORMATION", 94, 108], ["Any circumstance", "PROBLEM", 0, 16], ["secretion", "PROBLEM", 72, 81], ["hepatocellular steatosis", "PROBLEM", 94, 118], ["hepatic", "ANATOMY", 26, 33], ["uptake", "OBSERVATION", 34, 40], ["hepatocellular", "ANATOMY", 94, 108], ["steatosis", "OBSERVATION", 109, 118]]], ["Increased mobilization of triglycerides during late pregnancy or heavy lactation in ruminants is associated with hepatocellular steatosis.", [["hepatocellular", "ANATOMY", 113, 127], ["triglycerides", "CHEMICAL", 26, 39], ["steatosis", "DISEASE", 128, 137], ["triglycerides", "CHEMICAL", 26, 39], ["triglycerides", "SIMPLE_CHEMICAL", 26, 39], ["hepatocellular steatosis", "PATHOLOGICAL_FORMATION", 113, 137], ["Increased mobilization of triglycerides", "TREATMENT", 0, 39], ["late pregnancy", "PROBLEM", 47, 61], ["hepatocellular steatosis", "PROBLEM", 113, 137], ["mobilization", "OBSERVATION_MODIFIER", 10, 22], ["triglycerides", "OBSERVATION_MODIFIER", 26, 39], ["heavy", "OBSERVATION_MODIFIER", 65, 70], ["lactation", "OBSERVATION", 71, 80], ["associated with", "UNCERTAINTY", 97, 112], ["hepatocellular", "ANATOMY", 113, 127], ["steatosis", "OBSERVATION", 128, 137]]], ["The lipid represents increased transit of triglycerides in an otherwise healthy liver, so there is little diagnostic significance in mild degrees of hepatocellular smooth (eFig.", [["liver", "ANATOMY", 80, 85], ["hepatocellular smooth", "ANATOMY", 149, 170], ["triglycerides", "CHEMICAL", 42, 55], ["lipid", "SIMPLE_CHEMICAL", 4, 9], ["triglycerides", "SIMPLE_CHEMICAL", 42, 55], ["liver", "ORGAN", 80, 85], ["hepatocellular smooth", "TISSUE", 149, 170], ["increased transit of triglycerides", "PROBLEM", 21, 55], ["mild degrees of hepatocellular smooth (eFig", "PROBLEM", 133, 176], ["lipid", "OBSERVATION_MODIFIER", 4, 9], ["increased", "OBSERVATION_MODIFIER", 21, 30], ["transit of triglycerides", "OBSERVATION", 31, 55], ["otherwise", "OBSERVATION_MODIFIER", 62, 71], ["healthy", "OBSERVATION", 72, 79], ["liver", "ANATOMY", 80, 85], ["mild", "OBSERVATION_MODIFIER", 133, 137], ["degrees", "OBSERVATION_MODIFIER", 138, 145], ["hepatocellular smooth", "OBSERVATION", 149, 170]]], ["The cut surface has a diffuse greasy appearance or a red and yellow lobular pattern if there is also hepatic congestion or zonal necrosis.", [["surface", "ANATOMY", 8, 15], ["lobular", "ANATOMY", 68, 75], ["hepatic", "ANATOMY", 101, 108], ["hepatic congestion", "DISEASE", 101, 119], ["necrosis", "DISEASE", 129, 137], ["lobular", "CANCER", 68, 75], ["hepatic", "ORGAN", 101, 108], ["a diffuse greasy appearance", "PROBLEM", 20, 47], ["a red and yellow lobular pattern", "PROBLEM", 51, 83], ["hepatic congestion", "PROBLEM", 101, 119], ["zonal necrosis", "PROBLEM", 123, 137], ["cut", "OBSERVATION_MODIFIER", 4, 7], ["surface", "OBSERVATION_MODIFIER", 8, 15], ["diffuse", "OBSERVATION_MODIFIER", 22, 29], ["greasy", "OBSERVATION_MODIFIER", 30, 36], ["red", "OBSERVATION_MODIFIER", 53, 56], ["yellow", "OBSERVATION_MODIFIER", 61, 67], ["lobular pattern", "OBSERVATION", 68, 83], ["hepatic", "ANATOMY", 101, 108], ["congestion", "OBSERVATION", 109, 119], ["zonal", "OBSERVATION_MODIFIER", 123, 128], ["necrosis", "OBSERVATION", 129, 137]]], ["In severe diffuse hepatic steatosis, the parenchyma is less dense, and portions will float in water or fixative.Hepatocellular steatosis (lipidosis)Assessment of the functional significance of steatosis depends on the differentiation of physiologic steatosis caused by increased mobilization by otherwise normal hepatocytes from pathologic changes that represent some degenerative change in hepatocytes.", [["hepatic", "ANATOMY", 18, 25], ["parenchyma", "ANATOMY", 41, 51], ["Hepatocellular", "ANATOMY", 112, 126], ["hepatocytes", "ANATOMY", 312, 323], ["hepatocytes", "ANATOMY", 391, 402], ["hepatic steatosis", "DISEASE", 18, 35], ["Hepatocellular steatosis", "DISEASE", 112, 136], ["lipidosis", "DISEASE", 138, 147], ["steatosis", "DISEASE", 193, 202], ["steatosis", "DISEASE", 249, 258], ["hepatic steatosis", "PATHOLOGICAL_FORMATION", 18, 35], ["parenchyma", "MULTI-TISSUE_STRUCTURE", 41, 51], ["Hepatocellular", "PATHOLOGICAL_FORMATION", 112, 126], ["hepatocytes", "CELL", 312, 323], ["hepatocytes", "CELL", 391, 402], ["normal hepatocytes", "CELL_TYPE", 305, 323], ["hepatocytes", "CELL_TYPE", 391, 402], ["severe diffuse hepatic steatosis", "PROBLEM", 3, 35], ["fixative", "TREATMENT", 103, 111], ["Hepatocellular steatosis", "PROBLEM", 112, 136], ["steatosis", "PROBLEM", 193, 202], ["physiologic steatosis", "PROBLEM", 237, 258], ["increased mobilization", "PROBLEM", 269, 291], ["pathologic changes", "PROBLEM", 329, 347], ["some degenerative change in hepatocytes", "PROBLEM", 363, 402], ["severe", "OBSERVATION_MODIFIER", 3, 9], ["diffuse", "OBSERVATION_MODIFIER", 10, 17], ["hepatic", "ANATOMY", 18, 25], ["steatosis", "OBSERVATION", 26, 35], ["parenchyma", "ANATOMY", 41, 51], ["less", "OBSERVATION_MODIFIER", 55, 59], ["dense", "OBSERVATION_MODIFIER", 60, 65], ["steatosis", "OBSERVATION", 127, 136], ["lipidosis", "OBSERVATION", 138, 147], ["steatosis", "OBSERVATION", 193, 202], ["physiologic", "OBSERVATION_MODIFIER", 237, 248], ["steatosis", "OBSERVATION", 249, 258], ["increased", "OBSERVATION_MODIFIER", 269, 278], ["mobilization", "OBSERVATION_MODIFIER", 279, 291], ["otherwise", "OBSERVATION_MODIFIER", 295, 304], ["normal", "OBSERVATION", 305, 311], ["hepatocytes", "ANATOMY", 312, 323], ["pathologic", "OBSERVATION", 329, 339], ["some", "OBSERVATION_MODIFIER", 363, 367], ["degenerative", "OBSERVATION", 368, 380], ["hepatocytes", "ANATOMY", 391, 402]]], ["However, fat accumulation is a sensitive response to hepatocellular injury and can occur in the absence of other obvious alterations in hepatic structure or function.", [["fat", "ANATOMY", 9, 12], ["hepatocellular", "ANATOMY", 53, 67], ["hepatic", "ANATOMY", 136, 143], ["hepatocellular injury", "DISEASE", 53, 74], ["fat", "TISSUE", 9, 12], ["hepatocellular", "ORGAN", 53, 67], ["hepatic", "MULTI-TISSUE_STRUCTURE", 136, 143], ["fat accumulation", "PROBLEM", 9, 25], ["hepatocellular injury", "PROBLEM", 53, 74], ["other obvious alterations in hepatic structure", "PROBLEM", 107, 153], ["fat accumulation", "OBSERVATION", 9, 25], ["hepatocellular", "ANATOMY", 53, 67], ["injury", "OBSERVATION", 68, 74], ["obvious", "OBSERVATION_MODIFIER", 113, 120], ["alterations", "OBSERVATION", 121, 132], ["hepatic", "ANATOMY", 136, 143]]], ["The triglyceride globules themselves are not harmful to hepatocytes, so the amount of fat present is more an indicator of the duration of insult and triglyceride supply than of the severity of hepatic injury.", [["triglyceride globules", "ANATOMY", 4, 25], ["hepatocytes", "ANATOMY", 56, 67], ["fat", "ANATOMY", 86, 89], ["hepatic", "ANATOMY", 193, 200], ["triglyceride", "CHEMICAL", 149, 161], ["hepatic injury", "DISEASE", 193, 207], ["triglyceride", "CHEMICAL", 4, 16], ["triglyceride", "CHEMICAL", 149, 161], ["triglyceride", "SIMPLE_CHEMICAL", 4, 16], ["hepatocytes", "CELL", 56, 67], ["fat", "TISSUE", 86, 89], ["triglyceride", "SIMPLE_CHEMICAL", 149, 161], ["hepatic", "ORGAN", 193, 200], ["hepatocytes", "CELL_TYPE", 56, 67], ["The triglyceride globules", "TEST", 0, 25], ["insult", "PROBLEM", 138, 144], ["triglyceride supply", "TREATMENT", 149, 168], ["hepatic injury", "PROBLEM", 193, 207], ["triglyceride globules", "OBSERVATION", 4, 25], ["not", "UNCERTAINTY", 41, 44], ["harmful", "OBSERVATION_MODIFIER", 45, 52], ["amount", "OBSERVATION_MODIFIER", 76, 82], ["fat", "OBSERVATION", 86, 89], ["hepatic", "ANATOMY", 193, 200], ["injury", "OBSERVATION", 201, 207]]], ["Steatosis is usually reversible, although a liver that has been fatty for some time is more likely to have concurrent damage, including fibrosis, pigment accumulation, and nodular hyperplasia, mostly attributable to ongoing peroxidative damage, cell turnover, and activation of stellate cells.Hepatocellular steatosis (lipidosis)Hepatocellular steatosis is now recognized as a more significant indicator of potential, more severe liver injury than previously appreciated.", [["liver", "ANATOMY", 44, 49], ["pigment", "ANATOMY", 146, 153], ["nodular hyperplasia", "ANATOMY", 172, 191], ["cell", "ANATOMY", 245, 249], ["stellate cells", "ANATOMY", 278, 292], ["Hepatocellular", "ANATOMY", 293, 307], ["Hepatocellular", "ANATOMY", 329, 343], ["liver", "ANATOMY", 430, 435], ["Steatosis", "DISEASE", 0, 9], ["fibrosis", "DISEASE", 136, 144], ["hyperplasia", "DISEASE", 180, 191], ["Hepatocellular steatosis", "DISEASE", 293, 317], ["lipidosis", "DISEASE", 319, 328], ["Hepatocellular steatosis", "DISEASE", 329, 353], ["liver injury", "DISEASE", 430, 442], ["liver", "ORGAN", 44, 49], ["nodular hyperplasia", "PATHOLOGICAL_FORMATION", 172, 191], ["cell", "CELL", 245, 249], ["stellate cells", "CELL", 278, 292], ["Hepatocellular steatosis", "PATHOLOGICAL_FORMATION", 293, 317], ["Hepatocellular", "ORGAN", 329, 343], ["liver", "ORGAN", 430, 435], ["stellate cells", "CELL_TYPE", 278, 292], ["Steatosis", "PROBLEM", 0, 9], ["concurrent damage", "PROBLEM", 107, 124], ["fibrosis", "PROBLEM", 136, 144], ["pigment accumulation", "PROBLEM", 146, 166], ["nodular hyperplasia", "PROBLEM", 172, 191], ["ongoing peroxidative damage", "PROBLEM", 216, 243], ["cell turnover", "PROBLEM", 245, 258], ["activation of stellate cells", "PROBLEM", 264, 292], ["Hepatocellular steatosis", "PROBLEM", 293, 317], ["lipidosis)", "PROBLEM", 319, 329], ["Hepatocellular steatosis", "PROBLEM", 329, 353], ["more severe liver injury", "PROBLEM", 418, 442], ["reversible", "OBSERVATION_MODIFIER", 21, 31], ["liver", "ANATOMY", 44, 49], ["more likely", "UNCERTAINTY", 87, 98], ["damage", "OBSERVATION", 118, 124], ["fibrosis", "OBSERVATION", 136, 144], ["pigment accumulation", "OBSERVATION", 146, 166], ["nodular", "OBSERVATION_MODIFIER", 172, 179], ["hyperplasia", "OBSERVATION", 180, 191], ["mostly attributable to", "UNCERTAINTY", 193, 215], ["ongoing", "OBSERVATION_MODIFIER", 216, 223], ["peroxidative damage", "OBSERVATION", 224, 243], ["cell turnover", "OBSERVATION", 245, 258], ["stellate cells", "OBSERVATION", 278, 292], ["steatosis", "OBSERVATION", 308, 317], ["lipidosis", "OBSERVATION", 319, 328], ["Hepatocellular", "ANATOMY", 329, 343], ["steatosis", "OBSERVATION", 344, 353], ["more", "OBSERVATION_MODIFIER", 418, 422], ["severe", "OBSERVATION_MODIFIER", 423, 429], ["liver", "ANATOMY", 430, 435], ["injury", "OBSERVATION", 436, 442]]], ["In ruminants, the association between hepatic steatosis, ketosis, and displaced abomasum are well recognized.", [["hepatic", "ANATOMY", 38, 45], ["abomasum", "ANATOMY", 80, 88], ["hepatic steatosis", "DISEASE", 38, 55], ["ketosis", "DISEASE", 57, 64], ["hepatic", "ORGAN", 38, 45], ["abomasum", "ORGAN", 80, 88], ["hepatic steatosis", "PROBLEM", 38, 55], ["ketosis", "PROBLEM", 57, 64], ["displaced abomasum", "PROBLEM", 70, 88], ["ruminants", "OBSERVATION_MODIFIER", 3, 12], ["hepatic", "ANATOMY", 38, 45], ["steatosis", "OBSERVATION", 46, 55], ["ketosis", "OBSERVATION", 57, 64], ["displaced", "OBSERVATION_MODIFIER", 70, 79], ["abomasum", "ANATOMY", 80, 88]]], ["Infectious diseases, such as metritis and mastitis, may be more likely or prolonged.", [["Infectious diseases", "DISEASE", 0, 19], ["metritis", "DISEASE", 29, 37], ["mastitis", "DISEASE", 42, 50], ["Infectious diseases", "PROBLEM", 0, 19], ["metritis", "PROBLEM", 29, 37], ["mastitis", "PROBLEM", 42, 50], ["metritis", "OBSERVATION", 29, 37], ["mastitis", "OBSERVATION", 42, 50], ["may be more likely", "UNCERTAINTY", 52, 70], ["prolonged", "OBSERVATION_MODIFIER", 74, 83]]], ["Neutrophil function is suppressed, as is interferon production by lymphocytes, and endotoxin clearance is also reduced.", [["Neutrophil", "ANATOMY", 0, 10], ["lymphocytes", "ANATOMY", 66, 77], ["endotoxin", "CHEMICAL", 83, 92], ["Neutrophil", "CELL", 0, 10], ["interferon", "GENE_OR_GENE_PRODUCT", 41, 51], ["lymphocytes", "CELL", 66, 77], ["endotoxin", "SIMPLE_CHEMICAL", 83, 92], ["interferon", "PROTEIN", 41, 51], ["lymphocytes", "CELL_TYPE", 66, 77], ["Neutrophil function", "TEST", 0, 19], ["interferon production by lymphocytes", "PROBLEM", 41, 77], ["endotoxin clearance", "TEST", 83, 102], ["suppressed", "OBSERVATION_MODIFIER", 23, 33], ["reduced", "OBSERVATION_MODIFIER", 111, 118]]], ["Hepatocytes become more sensitive to injury following exposure to cytokines such as tumor necrosis factor-\u03b1 or endotoxin as well.", [["Hepatocytes", "ANATOMY", 0, 11], ["tumor", "DISEASE", 84, 89], ["Hepatocytes", "CELL", 0, 11], ["tumor necrosis factor-\u03b1", "GENE_OR_GENE_PRODUCT", 84, 107], ["endotoxin", "GENE_OR_GENE_PRODUCT", 111, 120], ["Hepatocytes", "CELL_TYPE", 0, 11], ["cytokines", "PROTEIN", 66, 75], ["tumor necrosis factor-\u03b1", "PROTEIN", 84, 107], ["endotoxin", "PROTEIN", 111, 120], ["injury", "PROBLEM", 37, 43], ["cytokines", "TREATMENT", 66, 75], ["tumor necrosis factor", "PROBLEM", 84, 105], ["endotoxin", "PROBLEM", 111, 120], ["injury", "OBSERVATION", 37, 43], ["tumor", "OBSERVATION", 84, 89]]], ["Consequently, fatty livers are more vulnerable to a wide range of toxic and nutritional insults, so other necrogenic insults and responses can be concurrent.", [["fatty livers", "ANATOMY", 14, 26], ["livers", "ORGAN", 20, 26], ["fatty livers", "PROBLEM", 14, 26], ["toxic and nutritional insults", "PROBLEM", 66, 95], ["other necrogenic insults", "PROBLEM", 100, 124], ["fatty livers", "OBSERVATION", 14, 26], ["wide range", "OBSERVATION_MODIFIER", 52, 62], ["toxic", "OBSERVATION_MODIFIER", 66, 71], ["nutritional insults", "OBSERVATION", 76, 95]]], ["Increased levels of fatty acids in the liver increase the oxidative stress and contribute to membrane lipid peroxidation, reduced hepatocyte life-span, and some local repair responses.Hepatocellular steatosis (lipidosis)When lipid accumulates in large amounts, there is a tendency for groups of the fat-laden cells to rupture or fuse and eventually form a multinucleated rim about a foamy mass of lipid.", [["liver", "ANATOMY", 39, 44], ["membrane", "ANATOMY", 93, 101], ["hepatocyte", "ANATOMY", 130, 140], ["Hepatocellular", "ANATOMY", 184, 198], ["fat-laden cells", "ANATOMY", 299, 314], ["fatty acids", "CHEMICAL", 20, 31], ["Hepatocellular steatosis", "DISEASE", 184, 208], ["fatty acids", "CHEMICAL", 20, 31], ["fatty acids", "SIMPLE_CHEMICAL", 20, 31], ["liver", "ORGAN", 39, 44], ["membrane", "CELLULAR_COMPONENT", 93, 101], ["lipid", "SIMPLE_CHEMICAL", 102, 107], ["hepatocyte", "CELL", 130, 140], ["Hepatocellular steatosis", "PATHOLOGICAL_FORMATION", 184, 208], ["fat", "TISSUE", 299, 302], ["cells", "CELL", 309, 314], ["lipid", "SIMPLE_CHEMICAL", 397, 402], ["fat-laden cells", "CELL_TYPE", 299, 314], ["Increased levels of fatty acids", "PROBLEM", 0, 31], ["the oxidative stress", "PROBLEM", 54, 74], ["membrane lipid peroxidation", "PROBLEM", 93, 120], ["Hepatocellular steatosis", "PROBLEM", 184, 208], ["rupture", "PROBLEM", 318, 325], ["a multinucleated rim", "PROBLEM", 354, 374], ["a foamy mass of lipid", "PROBLEM", 381, 402], ["fatty acids", "OBSERVATION", 20, 31], ["liver", "ANATOMY", 39, 44], ["oxidative stress", "OBSERVATION", 58, 74], ["lipid peroxidation", "OBSERVATION", 102, 120], ["hepatocyte", "ANATOMY", 130, 140], ["local repair", "OBSERVATION", 161, 173], ["steatosis", "OBSERVATION", 199, 208], ["lipidosis", "OBSERVATION", 210, 219], ["large", "OBSERVATION_MODIFIER", 246, 251], ["amounts", "OBSERVATION_MODIFIER", 252, 259], ["laden cells", "OBSERVATION", 303, 314], ["rupture", "OBSERVATION", 318, 325], ["multinucleated", "OBSERVATION_MODIFIER", 356, 370], ["rim", "OBSERVATION_MODIFIER", 371, 374], ["foamy", "OBSERVATION_MODIFIER", 383, 388], ["mass", "OBSERVATION", 389, 393]]], ["This epithelial structure is known as a fatty cyst .", [["epithelial structure", "ANATOMY", 5, 25], ["fatty cyst", "ANATOMY", 40, 50], ["fatty cyst", "DISEASE", 40, 50], ["epithelial", "TISSUE", 5, 15], ["fatty cyst", "PATHOLOGICAL_FORMATION", 40, 50], ["a fatty cyst", "PROBLEM", 38, 50], ["epithelial structure", "OBSERVATION", 5, 25], ["fatty", "OBSERVATION_MODIFIER", 40, 45], ["cyst", "OBSERVATION", 46, 50]]], ["The next stage, which occurs when released lipid is picked up by macrophages that form foamy aggregations in sinusoids, in the stroma of portal tracts, and hepatic venules is termed a lipogranuloma.", [["macrophages", "ANATOMY", 65, 76], ["sinusoids", "ANATOMY", 109, 118], ["stroma", "ANATOMY", 127, 133], ["portal tracts", "ANATOMY", 137, 150], ["hepatic venules", "ANATOMY", 156, 171], ["lipogranuloma", "ANATOMY", 184, 197], ["lipogranuloma", "DISEASE", 184, 197], ["macrophages", "CELL", 65, 76], ["sinusoids", "TISSUE", 109, 118], ["stroma", "TISSUE", 127, 133], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 137, 150], ["hepatic venules", "MULTI-TISSUE_STRUCTURE", 156, 171], ["lipogranuloma", "CANCER", 184, 197], ["macrophages", "CELL_TYPE", 65, 76], ["hepatic venules", "CELL_TYPE", 156, 171], ["foamy aggregations in sinusoids", "PROBLEM", 87, 118], ["a lipogranuloma", "PROBLEM", 182, 197], ["foamy aggregations", "OBSERVATION", 87, 105], ["stroma", "ANATOMY_MODIFIER", 127, 133], ["portal tracts", "ANATOMY", 137, 150], ["hepatic", "ANATOMY", 156, 163], ["venules", "ANATOMY_MODIFIER", 164, 171], ["lipogranuloma", "OBSERVATION", 184, 197]]], ["Subsequent peroxidation of the less saturated fatty acids and covalent modification and steatosis or a mixture of microvesicular and macrovesicular steatosis.", [["microvesicular", "ANATOMY", 114, 128], ["fatty acids", "CHEMICAL", 46, 57], ["steatosis", "DISEASE", 88, 97], ["steatosis", "DISEASE", 148, 157], ["fatty acids", "CHEMICAL", 46, 57], ["saturated fatty acids", "SIMPLE_CHEMICAL", 36, 57], ["the less saturated fatty acids", "TREATMENT", 27, 57], ["covalent modification", "TREATMENT", 62, 83], ["steatosis", "PROBLEM", 88, 97], ["microvesicular and macrovesicular steatosis", "PROBLEM", 114, 157], ["peroxidation", "OBSERVATION_MODIFIER", 11, 23], ["less saturated", "OBSERVATION_MODIFIER", 31, 45], ["fatty acids", "OBSERVATION", 46, 57], ["covalent modification", "OBSERVATION", 62, 83], ["steatosis", "OBSERVATION", 88, 97], ["microvesicular", "OBSERVATION_MODIFIER", 114, 128], ["macrovesicular steatosis", "OBSERVATION", 133, 157]]], ["Acute steatosis with predominantly microvesicular accumulation tends to result in a modestly enlarged pale liver without much change in texture, whereas macrovesicular hepatic steatosis more often produces an enlarged liver.Hepatocellular steatosis (lipidosis)In some more protracted toxic injuries, smaller lipid globules can coalesce into large central macrovesicles that displace the nucleus.", [["microvesicular", "ANATOMY", 35, 49], ["pale liver", "ANATOMY", 102, 112], ["hepatic", "ANATOMY", 168, 175], ["liver", "ANATOMY", 218, 223], ["Hepatocellular", "ANATOMY", 224, 238], ["lipid globules", "ANATOMY", 308, 322], ["nucleus", "ANATOMY", 387, 394], ["steatosis", "DISEASE", 6, 15], ["steatosis", "DISEASE", 176, 185], ["Hepatocellular steatosis", "DISEASE", 224, 248], ["lipidosis", "DISEASE", 250, 259], ["toxic injuries", "DISEASE", 284, 298], ["liver", "ORGAN", 107, 112], ["hepatic", "ORGAN", 168, 175], ["liver", "ORGAN", 218, 223], ["Hepatocellular", "PATHOLOGICAL_FORMATION", 224, 238], ["nucleus", "CELLULAR_COMPONENT", 387, 394], ["Acute steatosis", "PROBLEM", 0, 15], ["predominantly microvesicular accumulation", "PROBLEM", 21, 62], ["a modestly enlarged pale liver", "PROBLEM", 82, 112], ["much change in texture", "PROBLEM", 121, 143], ["macrovesicular hepatic steatosis", "PROBLEM", 153, 185], ["an enlarged liver", "PROBLEM", 206, 223], ["Hepatocellular steatosis", "PROBLEM", 224, 248], ["lipidosis)", "PROBLEM", 250, 260], ["some more protracted toxic injuries", "PROBLEM", 263, 298], ["smaller lipid globules", "PROBLEM", 300, 322], ["steatosis", "OBSERVATION", 6, 15], ["predominantly", "OBSERVATION_MODIFIER", 21, 34], ["microvesicular accumulation", "OBSERVATION", 35, 62], ["modestly", "OBSERVATION_MODIFIER", 84, 92], ["enlarged", "OBSERVATION_MODIFIER", 93, 101], ["pale", "OBSERVATION", 102, 106], ["liver", "ANATOMY", 107, 112], ["without", "UNCERTAINTY", 113, 120], ["much", "OBSERVATION_MODIFIER", 121, 125], ["change", "OBSERVATION_MODIFIER", 126, 132], ["texture", "OBSERVATION_MODIFIER", 136, 143], ["macrovesicular", "ANATOMY_MODIFIER", 153, 167], ["hepatic", "ANATOMY", 168, 175], ["steatosis", "OBSERVATION", 176, 185], ["enlarged", "OBSERVATION", 209, 217], ["liver", "ANATOMY", 218, 223], ["steatosis", "OBSERVATION", 239, 248], ["lipidosis", "OBSERVATION", 250, 259], ["more", "OBSERVATION_MODIFIER", 268, 272], ["protracted", "OBSERVATION_MODIFIER", 273, 283], ["toxic", "OBSERVATION_MODIFIER", 284, 289], ["injuries", "OBSERVATION", 290, 298], ["smaller", "OBSERVATION_MODIFIER", 300, 307], ["lipid globules", "OBSERVATION", 308, 322], ["large", "OBSERVATION_MODIFIER", 341, 346], ["central", "ANATOMY_MODIFIER", 347, 354], ["macrovesicles", "ANATOMY", 355, 368], ["nucleus", "ANATOMY_MODIFIER", 387, 394]]], ["The pathogenesis of the larger globules is not well understood, but it involves some alteration of the globulecytoplasm interface that normally prevents coalescence of the small micellar globules, possibly the greater hydrophobicity of the triglycerides.", [["globules", "ANATOMY", 31, 39], ["micellar globules", "ANATOMY", 178, 195], ["triglycerides", "CHEMICAL", 240, 253], ["triglycerides", "SIMPLE_CHEMICAL", 240, 253], ["some alteration of the globulecytoplasm interface", "PROBLEM", 80, 129], ["the small micellar globules", "PROBLEM", 168, 195], ["larger", "OBSERVATION_MODIFIER", 24, 30], ["globules", "OBSERVATION", 31, 39], ["not", "UNCERTAINTY", 43, 46], ["well understood", "OBSERVATION_MODIFIER", 47, 62], ["some", "OBSERVATION_MODIFIER", 80, 84], ["alteration", "OBSERVATION", 85, 95], ["globulecytoplasm interface", "OBSERVATION", 103, 129], ["coalescence", "OBSERVATION_MODIFIER", 153, 164], ["small", "OBSERVATION_MODIFIER", 172, 177], ["micellar globules", "OBSERVATION", 178, 195], ["greater", "OBSERVATION_MODIFIER", 210, 217], ["hydrophobicity", "OBSERVATION_MODIFIER", 218, 232], ["triglycerides", "OBSERVATION_MODIFIER", 240, 253]]], ["These fatty livers tend to be more yellow and enlarged, and the texture is more friable than livers with microvesicular steatosis.", [["fatty livers", "ANATOMY", 6, 18], ["livers", "ANATOMY", 93, 99], ["steatosis", "DISEASE", 120, 129], ["livers", "ORGAN", 12, 18], ["livers", "ORGAN", 93, 99], ["yellow", "PROBLEM", 35, 41], ["microvesicular steatosis", "PROBLEM", 105, 129], ["livers", "ANATOMY", 12, 18], ["more", "OBSERVATION_MODIFIER", 30, 34], ["yellow", "OBSERVATION", 35, 41], ["enlarged", "OBSERVATION", 46, 54], ["texture", "OBSERVATION_MODIFIER", 64, 71], ["more", "OBSERVATION_MODIFIER", 75, 79], ["friable", "OBSERVATION", 80, 87], ["livers", "ANATOMY", 93, 99], ["microvesicular steatosis", "OBSERVATION", 105, 129]]], ["Each hepatocyte usually contains one large globule (macrovesicle) that alters the contour of the cell and displaces the nucleus (Fig. 2-21) .", [["hepatocyte", "ANATOMY", 5, 15], ["macrovesicle", "ANATOMY", 52, 64], ["cell", "ANATOMY", 97, 101], ["nucleus", "ANATOMY", 120, 127], ["hepatocyte", "CELL", 5, 15], ["macrovesicle", "CANCER", 52, 64], ["cell", "CELL", 97, 101], ["nucleus", "CELLULAR_COMPONENT", 120, 127], ["one large globule (macrovesicle)", "PROBLEM", 33, 65], ["hepatocyte", "ANATOMY", 5, 15], ["one", "OBSERVATION_MODIFIER", 33, 36], ["large", "OBSERVATION_MODIFIER", 37, 42], ["globule", "OBSERVATION_MODIFIER", 43, 50], ["contour", "OBSERVATION_MODIFIER", 82, 89], ["cell", "ANATOMY_MODIFIER", 97, 101], ["nucleus", "ANATOMY_MODIFIER", 120, 127]]], ["The sinusoids are compressed and appear under-perfused, and the tissue at low magnification resembles adipose tissue.", [["sinusoids", "ANATOMY", 4, 13], ["tissue", "ANATOMY", 64, 70], ["adipose tissue", "ANATOMY", 102, 116], ["sinusoids", "MULTI-TISSUE_STRUCTURE", 4, 13], ["tissue", "TISSUE", 64, 70], ["adipose tissue", "TISSUE", 102, 116], ["sinusoids", "ANATOMY", 4, 13], ["compressed", "OBSERVATION", 18, 28], ["perfused", "OBSERVATION_MODIFIER", 46, 54], ["tissue", "OBSERVATION_MODIFIER", 64, 70], ["low magnification", "OBSERVATION_MODIFIER", 74, 91], ["adipose tissue", "OBSERVATION", 102, 116]]], ["In severe degeneration, the liver is moderately or greatly enlarged, with a uniform light yellow color.", [["liver", "ANATOMY", 28, 33], ["liver", "ORGAN", 28, 33], ["severe degeneration", "PROBLEM", 3, 22], ["greatly enlarged", "PROBLEM", 51, 67], ["a uniform light yellow color", "PROBLEM", 74, 102], ["severe", "OBSERVATION_MODIFIER", 3, 9], ["degeneration", "OBSERVATION", 10, 22], ["liver", "ANATOMY", 28, 33], ["moderately", "OBSERVATION_MODIFIER", 37, 47], ["greatly", "OBSERVATION_MODIFIER", 51, 58], ["enlarged", "OBSERVATION", 59, 67], ["uniform", "OBSERVATION_MODIFIER", 76, 83], ["light", "OBSERVATION_MODIFIER", 84, 89], ["yellow color", "OBSERVATION", 90, 102]]], ["The edges are rounded, and the surface is274.e1eFigure 2-5 Hepatomegaly, steatosis associated with equine hyperlipemia in a donkey. on a wet weight basis, severe or clinical fatty liver ensues.", [["surface", "ANATOMY", 31, 38], ["fatty liver", "ANATOMY", 174, 185], ["steatosis", "DISEASE", 73, 82], ["hyperlipemia", "DISEASE", 106, 118], ["fatty liver", "DISEASE", 174, 185], ["surface", "CELLULAR_COMPONENT", 31, 38], ["donkey", "ORGANISM", 124, 130], ["liver", "ORGAN", 180, 185], ["donkey", "SPECIES", 124, 130], ["equine", "SPECIES", 99, 105], ["the surface", "TEST", 27, 38], ["Figure", "TEST", 48, 54], ["Hepatomegaly", "PROBLEM", 59, 71], ["steatosis", "PROBLEM", 73, 82], ["equine hyperlipemia", "PROBLEM", 99, 118], ["a wet weight basis", "TEST", 135, 153], ["severe or clinical fatty liver ensues", "PROBLEM", 155, 192], ["edges", "OBSERVATION_MODIFIER", 4, 9], ["rounded", "OBSERVATION_MODIFIER", 14, 21], ["surface", "OBSERVATION_MODIFIER", 31, 38], ["Hepatomegaly", "OBSERVATION", 59, 71], ["steatosis", "OBSERVATION", 73, 82], ["equine", "OBSERVATION_MODIFIER", 99, 105], ["hyperlipemia", "OBSERVATION", 106, 118], ["donkey", "OBSERVATION_MODIFIER", 124, 130], ["severe", "OBSERVATION_MODIFIER", 155, 161], ["liver", "ANATOMY", 180, 185]]], ["At this time, urinary ketones are elevated, and body weight loss and appetite depression can occur.", [["urinary", "ANATOMY", 14, 21], ["body", "ANATOMY", 48, 52], ["ketones", "CHEMICAL", 22, 29], ["weight loss", "DISEASE", 53, 64], ["appetite depression", "DISEASE", 69, 88], ["ketones", "CHEMICAL", 22, 29], ["urinary ketones", "SIMPLE_CHEMICAL", 14, 29], ["body", "ORGANISM_SUBDIVISION", 48, 52], ["urinary ketones", "TEST", 14, 29], ["elevated", "PROBLEM", 34, 42], ["body weight loss", "PROBLEM", 48, 64], ["appetite depression", "PROBLEM", 69, 88], ["urinary", "ANATOMY", 14, 21], ["ketones", "OBSERVATION", 22, 29], ["elevated", "OBSERVATION", 34, 42]]], ["In severe cases, cattle can suffer from hepatoencephalopathy.", [["hepatoencephalopathy", "DISEASE", 40, 60], ["cattle", "ORGANISM", 17, 23], ["cattle", "SPECIES", 17, 23], ["cattle", "SPECIES", 17, 23], ["hepatoencephalopathy", "PROBLEM", 40, 60], ["severe", "OBSERVATION_MODIFIER", 3, 9], ["hepatoencephalopathy", "OBSERVATION", 40, 60]]], ["It is estimated that in the first month after parturition 5-10% of dairy cattle severe fatty liver, and 30-40% have moderate fatty liver (5-10% liver triglyceride by wet weight basis).", [["fatty liver", "ANATOMY", 87, 98], ["fatty liver", "ANATOMY", 125, 136], ["liver", "ANATOMY", 144, 149], ["fatty liver", "DISEASE", 87, 98], ["fatty liver", "DISEASE", 125, 136], ["triglyceride", "CHEMICAL", 150, 162], ["triglyceride", "CHEMICAL", 150, 162], ["cattle", "ORGANISM", 73, 79], ["liver", "ORGAN", 93, 98], ["liver", "ORGAN", 131, 136], ["liver", "ORGAN", 144, 149], ["triglyceride", "SIMPLE_CHEMICAL", 150, 162], ["cattle", "SPECIES", 73, 79], ["cattle", "SPECIES", 73, 79], ["parturition", "TEST", 46, 57], ["dairy cattle severe fatty liver", "PROBLEM", 67, 98], ["moderate fatty liver", "PROBLEM", 116, 136], ["liver triglyceride", "TEST", 144, 162], ["severe", "OBSERVATION_MODIFIER", 80, 86], ["fatty", "OBSERVATION", 87, 92], ["liver", "ANATOMY", 93, 98], ["moderate", "OBSERVATION_MODIFIER", 116, 124], ["fatty", "OBSERVATION", 125, 130], ["liver", "ANATOMY", 131, 136], ["liver", "ANATOMY", 144, 149]]], ["The liver depends primarily on fatty acid oxidation for its own considerable energy needs.", [["liver", "ANATOMY", 4, 9], ["fatty acid", "CHEMICAL", 31, 41], ["fatty acid", "CHEMICAL", 31, 41], ["liver", "ORGAN", 4, 9], ["fatty acid", "SIMPLE_CHEMICAL", 31, 41], ["fatty acid oxidation", "TREATMENT", 31, 51], ["liver", "ANATOMY", 4, 9], ["fatty acid oxidation", "OBSERVATION", 31, 51]]], ["It must also synthesize a large amount of protein and phospholipids for lipoprotein export to other tissues, and this can be rate limiting, resulting in accumulation of triglyceride in the cytoplasm.", [["tissues", "ANATOMY", 100, 107], ["cytoplasm", "ANATOMY", 189, 198], ["triglyceride", "CHEMICAL", 169, 181], ["triglyceride", "CHEMICAL", 169, 181], ["phospholipids", "SIMPLE_CHEMICAL", 54, 67], ["lipoprotein", "SIMPLE_CHEMICAL", 72, 83], ["tissues", "TISSUE", 100, 107], ["triglyceride", "SIMPLE_CHEMICAL", 169, 181], ["cytoplasm", "ORGANISM_SUBSTANCE", 189, 198], ["protein and phospholipids", "TREATMENT", 42, 67], ["lipoprotein export", "TEST", 72, 90], ["accumulation of triglyceride in the cytoplasm", "PROBLEM", 153, 198]]], ["In starvation, the reduced availability of protein and lipotrope cofactors, such as choline, can exacerbate the bottleneck.", [["choline", "CHEMICAL", 84, 91], ["choline", "CHEMICAL", 84, 91], ["lipotrope", "SIMPLE_CHEMICAL", 55, 64], ["choline", "SIMPLE_CHEMICAL", 84, 91], ["protein and lipotrope cofactors", "PROBLEM", 43, 74]]], ["The liver is the main supplier of glucose for the brain and milk saccharides, and it adapts by converting fatty acid metabolites to glucose (gluconeogenesis) and ketones.274.e1Acute ketosis of lactating dairy cows with intake insufficiency or secondary to abomasal displacement is usually associated with fatty liver with a predominantly diffuse microvesicular pattern.", [["liver", "ANATOMY", 4, 9], ["brain", "ANATOMY", 50, 55], ["milk", "ANATOMY", 60, 64], ["abomasal", "ANATOMY", 256, 264], ["fatty liver", "ANATOMY", 305, 316], ["microvesicular", "ANATOMY", 346, 360], ["glucose", "CHEMICAL", 34, 41], ["fatty acid", "CHEMICAL", 106, 116], ["glucose", "CHEMICAL", 132, 139], ["ketosis", "DISEASE", 182, 189], ["intake insufficiency", "DISEASE", 219, 239], ["fatty liver", "DISEASE", 305, 316], ["glucose", "CHEMICAL", 34, 41], ["fatty acid", "CHEMICAL", 106, 116], ["glucose", "CHEMICAL", 132, 139], ["ketones", "CHEMICAL", 162, 169], ["liver", "ORGAN", 4, 9], ["glucose", "SIMPLE_CHEMICAL", 34, 41], ["brain", "ORGAN", 50, 55], ["milk", "ORGANISM_SUBSTANCE", 60, 64], ["fatty acid", "SIMPLE_CHEMICAL", 106, 116], ["glucose", "SIMPLE_CHEMICAL", 132, 139], ["gluconeogenesis", "SIMPLE_CHEMICAL", 141, 156], ["ketones", "SIMPLE_CHEMICAL", 162, 169], ["abomasal", "ORGANISM_SUBDIVISION", 256, 264], ["liver", "ORGAN", 311, 316], ["cows", "SPECIES", 209, 213], ["milk saccharides", "TREATMENT", 60, 76], ["converting fatty acid metabolites", "TEST", 95, 128], ["glucose (gluconeogenesis", "TEST", 132, 156], ["ketones", "TEST", 162, 169], ["Acute ketosis", "PROBLEM", 176, 189], ["lactating dairy cows", "TREATMENT", 193, 213], ["intake insufficiency", "PROBLEM", 219, 239], ["abomasal displacement", "PROBLEM", 256, 277], ["fatty liver", "PROBLEM", 305, 316], ["a predominantly diffuse microvesicular pattern", "PROBLEM", 322, 368], ["liver", "ANATOMY", 4, 9], ["main", "OBSERVATION_MODIFIER", 17, 21], ["brain", "ANATOMY", 50, 55], ["Acute", "OBSERVATION_MODIFIER", 176, 181], ["ketosis", "OBSERVATION", 182, 189], ["abomasal displacement", "OBSERVATION", 256, 277], ["liver", "ANATOMY", 311, 316], ["predominantly", "OBSERVATION_MODIFIER", 324, 337], ["diffuse", "OBSERVATION_MODIFIER", 338, 345], ["microvesicular pattern", "OBSERVATION", 346, 368]]], ["Cows are more tolerant of ketosis associated with lactation than are pregnant ewes that can die from starvation-induced pregnancy toxemia and ketoacidosis.", [["ketosis", "DISEASE", 26, 33], ["pregnancy toxemia", "DISEASE", 120, 137], ["ketoacidosis", "DISEASE", 142, 154], ["Cows", "SPECIES", 0, 4], ["ketosis", "PROBLEM", 26, 33], ["pregnancy toxemia", "PROBLEM", 120, 137], ["ketoacidosis", "PROBLEM", 142, 154], ["more tolerant", "OBSERVATION_MODIFIER", 9, 22], ["ketosis", "OBSERVATION", 26, 33], ["ketoacidosis", "OBSERVATION", 142, 154]]], ["In cows, hepatic steatosis is predominantly centrilobular, whereas it is most severe in the periportal zone in pregnancy toxemia of sheep.", [["hepatic", "ANATOMY", 9, 16], ["centrilobular", "ANATOMY", 44, 57], ["periportal zone", "ANATOMY", 92, 107], ["hepatic steatosis", "DISEASE", 9, 26], ["toxemia", "DISEASE", 121, 128], ["cows", "ORGANISM", 3, 7], ["hepatic", "ORGAN", 9, 16], ["periportal zone", "TISSUE", 92, 107], ["sheep", "ORGANISM", 132, 137], ["sheep", "SPECIES", 132, 137], ["sheep", "SPECIES", 132, 137], ["hepatic steatosis", "PROBLEM", 9, 26], ["centrilobular", "PROBLEM", 44, 57], ["pregnancy toxemia of sheep", "PROBLEM", 111, 137], ["hepatic", "ANATOMY", 9, 16], ["steatosis", "OBSERVATION", 17, 26], ["predominantly", "OBSERVATION_MODIFIER", 30, 43], ["centrilobular", "OBSERVATION_MODIFIER", 44, 57], ["most", "OBSERVATION_MODIFIER", 73, 77], ["severe", "OBSERVATION_MODIFIER", 78, 84], ["periportal", "ANATOMY", 92, 102], ["zone", "ANATOMY_MODIFIER", 103, 107], ["pregnancy", "OBSERVATION_MODIFIER", 111, 120], ["toxemia", "OBSERVATION", 121, 128], ["sheep", "OBSERVATION_MODIFIER", 132, 137]]], ["The hepatic changes reflect increased mobilization of triglycerides from adipose tissue rather than hepatic disease per se.", [["hepatic", "ANATOMY", 4, 11], ["adipose tissue", "ANATOMY", 73, 87], ["hepatic", "ANATOMY", 100, 107], ["hepatic disease", "DISEASE", 100, 115], ["triglycerides", "CHEMICAL", 54, 67], ["hepatic", "MULTI-TISSUE_STRUCTURE", 4, 11], ["triglycerides", "SIMPLE_CHEMICAL", 54, 67], ["adipose tissue", "TISSUE", 73, 87], ["hepatic", "ORGAN", 100, 107], ["The hepatic changes", "PROBLEM", 0, 19], ["increased mobilization of triglycerides", "PROBLEM", 28, 67], ["adipose tissue", "PROBLEM", 73, 87], ["hepatic disease", "PROBLEM", 100, 115], ["hepatic", "ANATOMY", 4, 11], ["increased", "OBSERVATION_MODIFIER", 28, 37], ["mobilization", "OBSERVATION", 38, 50], ["triglycerides", "OBSERVATION_MODIFIER", 54, 67], ["adipose tissue", "OBSERVATION", 73, 87], ["hepatic", "ANATOMY", 100, 107], ["disease", "OBSERVATION", 108, 115]]], ["In cows and ewes with increased mobilization of triglycerides, there may be indistinct foci of white discoloration of abdominal fat that tend to be obscured when adipose tissue solidifies postmortem.274.e1Fatty liver of diabetes occurs when insulin is deficient or inactive because of lack of functioning receptors.", [["foci", "ANATOMY", 87, 91], ["abdominal fat", "ANATOMY", 118, 131], ["adipose tissue", "ANATOMY", 162, 176], ["Fatty liver", "ANATOMY", 205, 216], ["274.e1", "CHEMICAL", 199, 205], ["Fatty liver", "DISEASE", 205, 216], ["diabetes", "DISEASE", 220, 228], ["triglycerides", "CHEMICAL", 48, 61], ["cows", "ORGANISM", 3, 7], ["triglycerides", "SIMPLE_CHEMICAL", 48, 61], ["abdominal fat", "TISSUE", 118, 131], ["adipose tissue", "TISSUE", 162, 176], ["liver", "ORGAN", 211, 216], ["insulin", "GENE_OR_GENE_PRODUCT", 241, 248], ["insulin", "PROTEIN", 241, 248], ["cows", "SPECIES", 3, 7], ["increased mobilization of triglycerides", "TREATMENT", 22, 61], ["indistinct foci", "PROBLEM", 76, 91], ["white discoloration of abdominal fat", "PROBLEM", 95, 131], ["Fatty liver of diabetes", "PROBLEM", 205, 228], ["insulin", "TREATMENT", 241, 248], ["lack of functioning receptors", "PROBLEM", 285, 314], ["increased", "OBSERVATION_MODIFIER", 22, 31], ["mobilization", "OBSERVATION_MODIFIER", 32, 44], ["may be", "UNCERTAINTY", 69, 75], ["indistinct", "OBSERVATION_MODIFIER", 76, 86], ["foci", "OBSERVATION", 87, 91], ["white discoloration", "OBSERVATION", 95, 114], ["abdominal fat", "ANATOMY", 118, 131], ["liver", "ANATOMY", 211, 216], ["diabetes", "OBSERVATION", 220, 228]]], ["Reduced insulindependent glucose uptake by cells leads to accelerated lipolysis from adipose tissue in much the same way as when energy intake is limiting.", [["cells", "ANATOMY", 43, 48], ["adipose tissue", "ANATOMY", 85, 99], ["glucose", "CHEMICAL", 25, 32], ["glucose", "CHEMICAL", 25, 32], ["glucose", "SIMPLE_CHEMICAL", 25, 32], ["cells", "CELL", 43, 48], ["adipose tissue", "TISSUE", 85, 99], ["Reduced insulindependent glucose uptake", "PROBLEM", 0, 39], ["accelerated lipolysis", "PROBLEM", 58, 79], ["adipose tissue", "PROBLEM", 85, 99], ["glucose uptake", "OBSERVATION", 25, 39], ["lipolysis", "OBSERVATION", 70, 79], ["adipose tissue", "OBSERVATION", 85, 99]]], ["The liver is thus presented with a large load of fatty acids, and the rate by which this moves through the liver can be impeded in various ways.", [["liver", "ANATOMY", 4, 9], ["liver", "ANATOMY", 107, 112], ["fatty acids", "CHEMICAL", 49, 60], ["fatty acids", "CHEMICAL", 49, 60], ["liver", "ORGAN", 4, 9], ["fatty acids", "SIMPLE_CHEMICAL", 49, 60], ["liver", "ORGAN", 107, 112], ["a large load of fatty acids", "PROBLEM", 33, 60], ["the rate", "TEST", 66, 74], ["liver", "ANATOMY", 4, 9], ["large", "OBSERVATION_MODIFIER", 35, 40], ["fatty acids", "OBSERVATION", 49, 60], ["liver", "ANATOMY", 107, 112]]], ["Insulin deficiency alone will produce fatty liver.", [["fatty liver", "ANATOMY", 38, 49], ["Insulin", "CHEMICAL", 0, 7], ["fatty liver", "DISEASE", 38, 49], ["Insulin", "GENE_OR_GENE_PRODUCT", 0, 7], ["liver", "ORGAN", 44, 49], ["Insulin deficiency", "PROBLEM", 0, 18], ["fatty liver", "PROBLEM", 38, 49], ["fatty", "OBSERVATION", 38, 43], ["liver", "ANATOMY", 44, 49]]], ["Some cases in carnivores are also complicated by concurrent exocrine pancreatic insufficiency, so protein malabsorption can be a contributing influence on diabetic hepatic steatosis.", [["exocrine pancreatic", "ANATOMY", 60, 79], ["hepatic", "ANATOMY", 164, 171], ["exocrine pancreatic insufficiency", "DISEASE", 60, 93], ["malabsorption", "DISEASE", 106, 119], ["diabetic hepatic steatosis", "DISEASE", 155, 181], ["carnivores", "ORGANISM", 14, 24], ["exocrine pancreatic", "MULTI-TISSUE_STRUCTURE", 60, 79], ["hepatic", "ORGAN", 164, 171], ["Some cases in carnivores", "PROBLEM", 0, 24], ["concurrent exocrine pancreatic insufficiency", "PROBLEM", 49, 93], ["protein malabsorption", "PROBLEM", 98, 119], ["diabetic hepatic steatosis", "PROBLEM", 155, 181], ["pancreatic", "ANATOMY", 69, 79], ["insufficiency", "OBSERVATION", 80, 93], ["diabetic", "OBSERVATION_MODIFIER", 155, 163], ["hepatic", "ANATOMY", 164, 171], ["steatosis", "OBSERVATION", 172, 181]]], ["The centrilobular hepatocytes usually show the greatest degree of steatosis, but in advanced long-standing diabetes, the change is often diffuse and marked.274.e1Lipoprotein synthesis and transport are dependent on oxidative metabolism, so hypoxia of hepatocytes leads to triglyceride accumulation.", [["centrilobular hepatocytes", "ANATOMY", 4, 29], ["hepatocytes", "ANATOMY", 251, 262], ["steatosis", "DISEASE", 66, 75], ["diabetes", "DISEASE", 107, 115], ["hypoxia", "DISEASE", 240, 247], ["triglyceride", "CHEMICAL", 272, 284], ["triglyceride", "CHEMICAL", 272, 284], ["centrilobular hepatocytes", "CELL", 4, 29], [".e1Lipoprotein", "SIMPLE_CHEMICAL", 159, 173], ["hepatocytes", "CELL", 251, 262], ["triglyceride", "SIMPLE_CHEMICAL", 272, 284], ["centrilobular hepatocytes", "CELL_TYPE", 4, 29], ["hepatocytes", "CELL_TYPE", 251, 262], ["steatosis", "PROBLEM", 66, 75], ["advanced long-standing diabetes", "PROBLEM", 84, 115], ["oxidative metabolism", "PROBLEM", 215, 235], ["hypoxia of hepatocytes", "PROBLEM", 240, 262], ["triglyceride accumulation", "PROBLEM", 272, 297], ["centrilobular", "ANATOMY_MODIFIER", 4, 17], ["hepatocytes", "ANATOMY", 18, 29], ["greatest", "OBSERVATION_MODIFIER", 47, 55], ["degree", "OBSERVATION_MODIFIER", 56, 62], ["steatosis", "OBSERVATION", 66, 75], ["advanced", "OBSERVATION_MODIFIER", 84, 92], ["long-standing", "OBSERVATION_MODIFIER", 93, 106], ["diabetes", "OBSERVATION", 107, 115], ["diffuse", "OBSERVATION_MODIFIER", 137, 144], ["marked", "OBSERVATION_MODIFIER", 149, 155], ["hepatocytes", "ANATOMY", 251, 262], ["triglyceride accumulation", "OBSERVATION", 272, 297]]], ["The 2 most common causes of hepatocellular hypoxia are anemia and reduced sinusoidal perfusion in passive venous congestion.", [["hepatocellular", "ANATOMY", 28, 42], ["sinusoidal", "ANATOMY", 74, 84], ["venous", "ANATOMY", 106, 112], ["hypoxia", "DISEASE", 43, 50], ["anemia", "DISEASE", 55, 61], ["venous congestion", "DISEASE", 106, 123], ["hepatocellular", "ORGAN", 28, 42], ["sinusoidal", "MULTI-TISSUE_STRUCTURE", 74, 84], ["venous congestion", "PATHOLOGICAL_FORMATION", 106, 123], ["hepatocellular hypoxia", "PROBLEM", 28, 50], ["anemia", "PROBLEM", 55, 61], ["reduced sinusoidal perfusion", "PROBLEM", 66, 94], ["passive venous congestion", "PROBLEM", 98, 123], ["hepatocellular", "ANATOMY", 28, 42], ["hypoxia", "OBSERVATION", 43, 50], ["anemia", "OBSERVATION", 55, 61], ["reduced", "OBSERVATION_MODIFIER", 66, 73], ["sinusoidal perfusion", "OBSERVATION", 74, 94], ["passive", "OBSERVATION_MODIFIER", 98, 105], ["venous", "ANATOMY", 106, 112], ["congestion", "OBSERVATION", 113, 123]]], ["In these situations, hepatic steatosis is most severe in the centrilobular zone, provided that the adipose and dietary supply of triglyceride is sufficient.", [["hepatic", "ANATOMY", 21, 28], ["centrilobular zone", "ANATOMY", 61, 79], ["adipose", "ANATOMY", 99, 106], ["hepatic steatosis", "DISEASE", 21, 38], ["triglyceride", "CHEMICAL", 129, 141], ["triglyceride", "CHEMICAL", 129, 141], ["hepatic", "ORGAN", 21, 28], ["centrilobular zone", "TISSUE", 61, 79], ["adipose", "TISSUE", 99, 106], ["triglyceride", "SIMPLE_CHEMICAL", 129, 141], ["hepatic steatosis", "PROBLEM", 21, 38], ["severe in the centrilobular zone", "PROBLEM", 47, 79], ["hepatic", "ANATOMY", 21, 28], ["steatosis", "OBSERVATION", 29, 38], ["most", "OBSERVATION_MODIFIER", 42, 46], ["severe", "OBSERVATION_MODIFIER", 47, 53], ["centrilobular", "ANATOMY_MODIFIER", 61, 74], ["zone", "ANATOMY_MODIFIER", 75, 79], ["adipose", "ANATOMY", 99, 106]]], ["Hepatic steatosis can be grossly visible as a yellow zonal pattern in chronic passive congestion of the bovine liver, but is less obvious in carnivores with passive hepatic congestion.274.e1Local hypoxia is probably the basis for another example of fatty liver.", [["Hepatic", "ANATOMY", 0, 7], ["liver", "ANATOMY", 111, 116], ["hepatic", "ANATOMY", 165, 172], ["fatty liver", "ANATOMY", 249, 260], ["steatosis", "DISEASE", 8, 17], ["congestion of the bovine liver", "DISEASE", 86, 116], ["hepatic congestion", "DISEASE", 165, 183], ["hypoxia", "DISEASE", 196, 203], ["fatty liver", "DISEASE", 249, 260], ["Hepatic", "ORGAN", 0, 7], ["bovine", "ORGANISM", 104, 110], ["liver", "ORGAN", 111, 116], ["hepatic", "ORGAN", 165, 172], ["274.e1Local", "SIMPLE_CHEMICAL", 184, 195], ["liver", "ORGAN", 255, 260], ["bovine", "SPECIES", 104, 110], ["bovine", "SPECIES", 104, 110], ["Hepatic steatosis", "PROBLEM", 0, 17], ["a yellow zonal pattern", "PROBLEM", 44, 66], ["chronic passive congestion of the bovine liver", "PROBLEM", 70, 116], ["passive hepatic congestion", "PROBLEM", 157, 183], ["hypoxia", "PROBLEM", 196, 203], ["fatty liver", "PROBLEM", 249, 260], ["steatosis", "OBSERVATION", 8, 17], ["grossly", "OBSERVATION_MODIFIER", 25, 32], ["visible", "OBSERVATION", 33, 40], ["yellow zonal", "OBSERVATION_MODIFIER", 46, 58], ["pattern", "OBSERVATION_MODIFIER", 59, 66], ["chronic", "OBSERVATION_MODIFIER", 70, 77], ["passive", "OBSERVATION_MODIFIER", 78, 85], ["congestion", "OBSERVATION", 86, 96], ["bovine", "ANATOMY_MODIFIER", 104, 110], ["liver", "ANATOMY", 111, 116], ["less", "OBSERVATION_MODIFIER", 125, 129], ["obvious", "OBSERVATION_MODIFIER", 130, 137], ["carnivores", "OBSERVATION", 141, 151], ["passive", "OBSERVATION_MODIFIER", 157, 164], ["hepatic", "ANATOMY", 165, 172], ["congestion", "OBSERVATION", 173, 183], ["hypoxia", "OBSERVATION", 196, 203], ["fatty", "OBSERVATION", 249, 254], ["liver", "ANATOMY", 255, 260]]], ["Small, sharply demarcated patches of intense fatty infiltration are often seen in bovine livers at or adjacent to sites of capsular fibrous adhesions-so-called \"tension lipidosis.\"", [["livers", "ANATOMY", 89, 95], ["sites", "ANATOMY", 114, 119], ["fibrous adhesions", "ANATOMY", 132, 149], ["fatty infiltration", "DISEASE", 45, 63], ["lipidosis", "DISEASE", 169, 178], ["bovine", "ORGANISM", 82, 88], ["livers", "ORGAN", 89, 95], ["bovine", "SPECIES", 82, 88], ["bovine", "SPECIES", 82, 88], ["Small, sharply demarcated patches", "PROBLEM", 0, 33], ["intense fatty infiltration", "PROBLEM", 37, 63], ["capsular fibrous adhesions", "PROBLEM", 123, 149], ["tension lipidosis", "PROBLEM", 161, 178], ["sharply", "OBSERVATION_MODIFIER", 7, 14], ["demarcated", "OBSERVATION_MODIFIER", 15, 25], ["patches", "OBSERVATION_MODIFIER", 26, 33], ["intense", "OBSERVATION_MODIFIER", 37, 44], ["fatty infiltration", "OBSERVATION", 45, 63], ["bovine", "ANATOMY_MODIFIER", 82, 88], ["livers", "ANATOMY", 89, 95], ["capsular", "OBSERVATION_MODIFIER", 123, 131], ["fibrous adhesions", "OBSERVATION", 132, 149], ["tension lipidosis", "OBSERVATION", 161, 178]]], ["These patches are neither swollen nor shrunken, usually extend <1 cm into the parenchyma, and are of the same consistency as normal liver (Fig. 2-24) .", [["patches", "ANATOMY", 6, 13], ["parenchyma", "ANATOMY", 78, 88], ["liver", "ANATOMY", 132, 137], ["parenchyma", "TISSUE", 78, 88], ["liver", "ORGAN", 132, 137], ["swollen", "PROBLEM", 26, 33], ["shrunken", "PROBLEM", 38, 46], ["swollen", "OBSERVATION", 26, 33], ["shrunken", "OBSERVATION_MODIFIER", 38, 46], ["<1 cm", "OBSERVATION_MODIFIER", 63, 68], ["parenchyma", "ANATOMY", 78, 88], ["normal", "OBSERVATION", 125, 131], ["liver", "ANATOMY", 132, 137]]], ["The acinar structure of these lesions is undisturbed, but the hepatocytes therein show polymerization of oxidized lipids form a complex of lysosomal residues known collectively as ceroid.", [["acinar", "ANATOMY", 4, 10], ["lesions", "ANATOMY", 30, 37], ["hepatocytes", "ANATOMY", 62, 73], ["lysosomal", "ANATOMY", 139, 148], ["ceroid", "DISEASE", 180, 186], ["acinar", "MULTI-TISSUE_STRUCTURE", 4, 10], ["lesions", "PATHOLOGICAL_FORMATION", 30, 37], ["hepatocytes", "CELL", 62, 73], ["oxidized lipids", "SIMPLE_CHEMICAL", 105, 120], ["hepatocytes", "CELL_TYPE", 62, 73], ["these lesions", "PROBLEM", 24, 37], ["polymerization of oxidized lipids", "PROBLEM", 87, 120], ["lysosomal residues", "PROBLEM", 139, 157], ["acinar", "ANATOMY", 4, 10], ["lesions", "OBSERVATION", 30, 37], ["undisturbed", "OBSERVATION_MODIFIER", 41, 52], ["hepatocytes", "ANATOMY", 62, 73], ["polymerization", "OBSERVATION_MODIFIER", 87, 101], ["oxidized lipids", "OBSERVATION", 105, 120], ["complex", "OBSERVATION_MODIFIER", 128, 135], ["lysosomal residues", "OBSERVATION", 139, 157], ["ceroid", "OBSERVATION_MODIFIER", 180, 186]]], ["This material is only slightly soluble in lipid solvents and is periodic acid-Schiff positive, diastase resistant, variably acid fast, and autofluorescent.", [["Schiff", "CHEMICAL", 78, 84], ["lipid solvents", "SIMPLE_CHEMICAL", 42, 56], ["slightly soluble in lipid solvents", "PROBLEM", 22, 56], ["periodic acid", "TEST", 64, 77], ["diastase resistant", "PROBLEM", 95, 113], ["variably acid fast", "PROBLEM", 115, 133], ["slightly soluble", "OBSERVATION_MODIFIER", 22, 38], ["diastase resistant", "OBSERVATION", 95, 113], ["variably", "OBSERVATION_MODIFIER", 115, 123], ["acid fast", "OBSERVATION", 124, 133]]], ["In histologic sections, ceroid pigment appears as colorless or yellow irregular fragments associated with the lipid globules in macrophages and, to a lesser extent, hepatocytes.", [["sections", "ANATOMY", 14, 22], ["ceroid pigment", "ANATOMY", 24, 38], ["fragments", "ANATOMY", 80, 89], ["lipid globules", "ANATOMY", 110, 124], ["macrophages", "ANATOMY", 128, 139], ["hepatocytes", "ANATOMY", 165, 176], ["ceroid", "DISEASE", 24, 30], ["lipid globules", "CELLULAR_COMPONENT", 110, 124], ["macrophages", "CELL", 128, 139], ["hepatocytes", "CELL", 165, 176], ["macrophages", "CELL_TYPE", 128, 139], ["hepatocytes", "CELL_TYPE", 165, 176], ["ceroid pigment", "PROBLEM", 24, 38], ["yellow irregular fragments", "PROBLEM", 63, 89], ["the lipid globules in macrophages", "PROBLEM", 106, 139], ["ceroid pigment", "OBSERVATION", 24, 38], ["colorless", "OBSERVATION_MODIFIER", 50, 59], ["yellow", "OBSERVATION_MODIFIER", 63, 69], ["irregular", "OBSERVATION_MODIFIER", 70, 79], ["fragments", "OBSERVATION", 80, 89], ["lipid globules", "OBSERVATION", 110, 124], ["macrophages", "OBSERVATION", 128, 139], ["lesser extent", "OBSERVATION_MODIFIER", 150, 163], ["hepatocytes", "ANATOMY", 165, 176]]], ["Affected portal lymph nodes become slightly enlarged, yellowgreen, and rather oily on section.", [["portal lymph nodes", "ANATOMY", 9, 27], ["yellowgreen", "ANATOMY", 54, 65], ["portal lymph nodes", "MULTI-TISSUE_STRUCTURE", 9, 27], ["Affected portal lymph nodes", "PROBLEM", 0, 27], ["slightly enlarged", "PROBLEM", 35, 52], ["portal", "ANATOMY", 9, 15], ["lymph nodes", "OBSERVATION", 16, 27], ["slightly", "OBSERVATION_MODIFIER", 35, 43], ["enlarged", "OBSERVATION", 44, 52], ["yellowgreen", "OBSERVATION_MODIFIER", 54, 65], ["oily", "OBSERVATION_MODIFIER", 78, 82]]], ["If iron accumulates along with the ceroid, the lesion is more correctly termed a pigment granuloma ( Fig. 2-23 ).", [["lesion", "ANATOMY", 47, 53], ["pigment granuloma", "ANATOMY", 81, 98], ["iron", "CHEMICAL", 3, 7], ["ceroid", "DISEASE", 35, 41], ["pigment granuloma", "DISEASE", 81, 98], ["iron", "CHEMICAL", 3, 7], ["iron", "SIMPLE_CHEMICAL", 3, 7], ["pigment granuloma", "PATHOLOGICAL_FORMATION", 81, 98], ["iron accumulates", "PROBLEM", 3, 19], ["the lesion", "PROBLEM", 43, 53], ["a pigment granuloma", "PROBLEM", 79, 98], ["ceroid", "OBSERVATION_MODIFIER", 35, 41], ["lesion", "OBSERVATION", 47, 53], ["pigment", "OBSERVATION_MODIFIER", 81, 88], ["granuloma", "OBSERVATION", 89, 98]]], ["These are discrete perisinusoidal clusters of macrophages, containing cytoplasmic lipid vacuoles, lipofuscin, and hemosiderin, and often contain lymphocytes or plasma cells.", [["macrophages", "ANATOMY", 46, 57], ["cytoplasmic lipid vacuoles", "ANATOMY", 70, 96], ["lipofuscin", "ANATOMY", 98, 108], ["hemosiderin", "ANATOMY", 114, 125], ["lymphocytes", "ANATOMY", 145, 156], ["plasma cells", "ANATOMY", 160, 172], ["macrophages", "CELL", 46, 57], ["cytoplasmic", "ORGANISM_SUBSTANCE", 70, 81], ["lipid vacuoles", "CELLULAR_COMPONENT", 82, 96], ["lipofuscin", "SIMPLE_CHEMICAL", 98, 108], ["hemosiderin", "SIMPLE_CHEMICAL", 114, 125], ["lymphocytes", "CELL", 145, 156], ["plasma cells", "CELL", 160, 172], ["macrophages", "CELL_TYPE", 46, 57], ["lymphocytes", "CELL_TYPE", 145, 156], ["plasma cells", "CELL_TYPE", 160, 172], ["discrete perisinusoidal clusters of macrophages", "PROBLEM", 10, 57], ["cytoplasmic lipid vacuoles", "TEST", 70, 96], ["lipofuscin", "PROBLEM", 98, 108], ["hemosiderin", "PROBLEM", 114, 125], ["lymphocytes", "PROBLEM", 145, 156], ["plasma cells", "PROBLEM", 160, 172], ["discrete", "OBSERVATION_MODIFIER", 10, 18], ["perisinusoidal clusters", "OBSERVATION", 19, 42], ["macrophages", "OBSERVATION", 46, 57], ["cytoplasmic", "OBSERVATION_MODIFIER", 70, 81], ["lipid vacuoles", "OBSERVATION", 82, 96], ["lipofuscin", "OBSERVATION_MODIFIER", 98, 108], ["hemosiderin", "OBSERVATION", 114, 125], ["lymphocytes", "OBSERVATION", 145, 156], ["plasma cells", "OBSERVATION", 160, 172]]], ["They accumulate and congregate with age and hepatocellular turnover, but have no known clinical significance.274.e1Some chronic changes commonly seen in the livers of old dogs can be associated with fatty liver; these include lipogranulomas, fatty cysts, and ceroid accumulation.", [["hepatocellular", "ANATOMY", 44, 58], ["livers", "ANATOMY", 157, 163], ["fatty liver", "ANATOMY", 199, 210], ["lipogranulomas", "ANATOMY", 226, 240], ["fatty cysts", "ANATOMY", 242, 253], ["274.e1", "CHEMICAL", 109, 115], ["fatty liver", "DISEASE", 199, 210], ["lipogranulomas", "DISEASE", 226, 240], ["fatty cysts", "DISEASE", 242, 253], ["ceroid", "DISEASE", 259, 265], ["hepatocellular", "CANCER", 44, 58], ["livers", "ORGAN", 157, 163], ["dogs", "ORGANISM", 171, 175], ["liver", "ORGAN", 205, 210], ["fatty cysts", "PATHOLOGICAL_FORMATION", 242, 253], ["dogs", "SPECIES", 171, 175], ["hepatocellular turnover", "PROBLEM", 44, 67], ["Some chronic changes", "PROBLEM", 115, 135], ["old dogs", "PROBLEM", 167, 175], ["fatty liver", "PROBLEM", 199, 210], ["lipogranulomas", "PROBLEM", 226, 240], ["fatty cysts", "PROBLEM", 242, 253], ["ceroid accumulation", "PROBLEM", 259, 278], ["congregate", "OBSERVATION_MODIFIER", 20, 30], ["hepatocellular", "ANATOMY", 44, 58], ["no known", "UNCERTAINTY", 78, 86], ["chronic", "OBSERVATION_MODIFIER", 120, 127], ["changes", "OBSERVATION", 128, 135], ["livers", "ANATOMY", 157, 163], ["dogs", "OBSERVATION", 171, 175], ["liver", "ANATOMY", 205, 210], ["lipogranulomas", "OBSERVATION", 226, 240], ["fatty cysts", "OBSERVATION", 242, 253], ["ceroid accumulation", "OBSERVATION", 259, 278]]], ["Occasionally, there can be found sharply defined, fibrous, stony, hard masses, usually close to the surface, sometimes as much as 3-4 cm in diameter.", [["fibrous", "ANATOMY", 50, 57], ["masses", "ANATOMY", 71, 77], ["surface", "ANATOMY", 100, 107], ["fibrous", "TISSUE", 50, 57], ["masses", "CANCER", 71, 77], ["surface", "CELLULAR_COMPONENT", 100, 107], ["fibrous, stony", "PROBLEM", 50, 64], ["hard masses", "PROBLEM", 66, 77], ["sharply", "OBSERVATION_MODIFIER", 33, 40], ["fibrous", "OBSERVATION_MODIFIER", 50, 57], ["stony", "OBSERVATION_MODIFIER", 59, 64], ["hard", "OBSERVATION_MODIFIER", 66, 70], ["masses", "OBSERVATION", 71, 77], ["surface", "ANATOMY_MODIFIER", 100, 107], ["3-4 cm", "OBSERVATION_MODIFIER", 130, 136], ["diameter", "OBSERVATION_MODIFIER", 140, 148]]], ["These masses are usually sufficiently mineralized to show up distinctly on clinical radiographs.", [["masses", "ANATOMY", 6, 12], ["masses", "CANCER", 6, 12], ["These masses", "PROBLEM", 0, 12], ["clinical radiographs", "TEST", 75, 95], ["masses", "OBSERVATION", 6, 12]]], ["The mineral appears to be deposited on a matrix of degenerate collagen, laid down about perivascular foci of foamy macrophages and accumulations of cholesterol.", [["matrix", "ANATOMY", 41, 47], ["perivascular foci", "ANATOMY", 88, 105], ["foamy macrophages", "ANATOMY", 109, 126], ["cholesterol", "CHEMICAL", 148, 159], ["cholesterol", "CHEMICAL", 148, 159], ["matrix", "CELLULAR_COMPONENT", 41, 47], ["collagen", "GENE_OR_GENE_PRODUCT", 62, 70], ["perivascular foci", "CELL", 88, 105], ["foamy macrophages", "CELL", 109, 126], ["cholesterol", "SIMPLE_CHEMICAL", 148, 159], ["collagen", "PROTEIN", 62, 70], ["foamy macrophages", "CELL_TYPE", 109, 126], ["foamy macrophages", "PROBLEM", 109, 126], ["mineral", "OBSERVATION_MODIFIER", 4, 11], ["appears to be", "UNCERTAINTY", 12, 25], ["deposited", "OBSERVATION", 26, 35], ["collagen", "OBSERVATION", 62, 70], ["perivascular", "ANATOMY_MODIFIER", 88, 100], ["foci", "OBSERVATION", 101, 105], ["foamy macrophages", "OBSERVATION", 109, 126], ["accumulations", "OBSERVATION_MODIFIER", 131, 144], ["cholesterol", "OBSERVATION_MODIFIER", 148, 159]]], ["The fibrous tissue may be laid down in response to the continued presence of fat, ceroid, or cholesterol, but no reason is apparent for the strictly localized distribution of the reaction.", [["fibrous tissue", "ANATOMY", 4, 18], ["fat", "ANATOMY", 77, 80], ["ceroid", "DISEASE", 82, 88], ["cholesterol", "CHEMICAL", 93, 104], ["cholesterol", "CHEMICAL", 93, 104], ["fibrous tissue", "TISSUE", 4, 18], ["fat", "TISSUE", 77, 80], ["cholesterol", "SIMPLE_CHEMICAL", 93, 104], ["The fibrous tissue", "PROBLEM", 0, 18], ["the reaction", "PROBLEM", 175, 187], ["fibrous tissue", "OBSERVATION", 4, 18], ["may be", "UNCERTAINTY", 19, 25], ["fat", "ANATOMY", 77, 80], ["ceroid", "OBSERVATION_MODIFIER", 82, 88], ["cholesterol", "OBSERVATION_MODIFIER", 93, 104], ["no reason is apparent", "UNCERTAINTY", 110, 131], ["reaction", "OBSERVATION", 179, 187]]], ["There are no recognizable hepatocytes in these lesions.274.e1Physiologic steatosis (fatty liver) occurs in late pregnancy and heavy lactation, particularly in ruminants and llamas.", [["hepatocytes", "ANATOMY", 26, 37], ["lesions", "ANATOMY", 47, 54], ["fatty liver", "ANATOMY", 84, 95], ["steatosis", "DISEASE", 73, 82], ["fatty liver", "DISEASE", 84, 95], ["hepatocytes", "CELL", 26, 37], ["lesions", "PATHOLOGICAL_FORMATION", 47, 54], ["liver", "ORGAN", 90, 95], ["llamas", "ORGANISM_SUBDIVISION", 173, 179], ["hepatocytes", "CELL_TYPE", 26, 37], ["recognizable hepatocytes in these lesions", "PROBLEM", 13, 54], ["e1Physiologic steatosis (fatty liver", "PROBLEM", 59, 95], ["late pregnancy", "PROBLEM", 107, 121], ["heavy lactation", "PROBLEM", 126, 141], ["no", "UNCERTAINTY", 10, 12], ["recognizable", "OBSERVATION_MODIFIER", 13, 25], ["hepatocytes", "OBSERVATION", 26, 37], ["lesions", "OBSERVATION", 47, 54], ["steatosis", "OBSERVATION", 73, 82], ["fatty", "OBSERVATION", 84, 89], ["liver", "ANATOMY", 90, 95], ["heavy", "OBSERVATION_MODIFIER", 126, 131], ["lactation", "OBSERVATION", 132, 141], ["llamas", "ANATOMY", 173, 179]]], ["In this circumstance, the lipid is typically macrovesicular, with large, round, clear vacuoles that tend to displace the nucleus.", [["vacuoles", "ANATOMY", 86, 94], ["nucleus", "ANATOMY", 121, 128], ["vacuoles", "CELLULAR_COMPONENT", 86, 94], ["nucleus", "CELLULAR_COMPONENT", 121, 128], ["large, round, clear vacuoles", "PROBLEM", 66, 94], ["lipid", "ANATOMY", 26, 31], ["typically", "OBSERVATION_MODIFIER", 35, 44], ["macrovesicular", "OBSERVATION", 45, 59], ["large", "OBSERVATION_MODIFIER", 66, 71], ["round", "OBSERVATION_MODIFIER", 73, 78], ["clear vacuoles", "OBSERVATION", 80, 94], ["nucleus", "ANATOMY", 121, 128]]], ["Obvious steatosis is also seen in neonates, especially in those species whose milk is relatively rich in fat.", [["milk", "ANATOMY", 78, 82], ["fat", "ANATOMY", 105, 108], ["steatosis", "DISEASE", 8, 17], ["milk", "ORGANISM_SUBSTANCE", 78, 82], ["fat", "TISSUE", 105, 108], ["Obvious steatosis", "PROBLEM", 0, 17], ["steatosis", "OBSERVATION", 8, 17], ["neonates", "OBSERVATION", 34, 42], ["relatively", "OBSERVATION_MODIFIER", 86, 96], ["rich", "OBSERVATION_MODIFIER", 97, 101], ["fat", "ANATOMY", 105, 108]]], ["These livers are fatty enough to be pale to the naked eye.", [["livers", "ANATOMY", 6, 12], ["eye", "ANATOMY", 54, 57], ["livers", "ORGAN", 6, 12], ["eye", "ORGAN", 54, 57], ["livers", "ANATOMY", 6, 12], ["fatty", "OBSERVATION", 17, 22], ["pale", "OBSERVATION", 36, 40], ["eye", "ANATOMY", 54, 57]]], ["The high rate of mobilization of triglycerides from body fat stores is mainly responsible for fatty liver in lactating ruminants.", [["body fat", "ANATOMY", 52, 60], ["fatty liver", "ANATOMY", 94, 105], ["triglycerides", "CHEMICAL", 33, 46], ["fatty liver", "DISEASE", 94, 105], ["triglycerides", "CHEMICAL", 33, 46], ["triglycerides", "SIMPLE_CHEMICAL", 33, 46], ["body fat", "TISSUE", 52, 60], ["liver", "ORGAN", 100, 105], ["mobilization of triglycerides", "TREATMENT", 17, 46], ["body fat stores", "PROBLEM", 52, 67], ["fatty liver in lactating ruminants", "PROBLEM", 94, 128], ["high", "OBSERVATION_MODIFIER", 4, 8], ["mobilization", "OBSERVATION_MODIFIER", 17, 29], ["mainly responsible for", "UNCERTAINTY", 71, 93], ["fatty", "OBSERVATION", 94, 99], ["liver", "ANATOMY", 100, 105], ["lactating ruminants", "OBSERVATION", 109, 128]]], ["However, fatty liver is a concern because lipid mobilization also increases when the dietary energy intake is insufficient relative to the production demands that are greatest in early lactation of high-producing cows.", [["fatty liver", "ANATOMY", 9, 20], ["fatty liver", "DISEASE", 9, 20], ["liver", "ORGAN", 15, 20], ["lipid", "SIMPLE_CHEMICAL", 42, 47], ["cows", "ORGANISM", 213, 217], ["cows", "SPECIES", 213, 217], ["fatty liver", "PROBLEM", 9, 20], ["lipid mobilization", "PROBLEM", 42, 60], ["the production demands", "PROBLEM", 135, 157], ["fatty", "OBSERVATION", 9, 14], ["liver", "ANATOMY", 15, 20]]], ["Insufficient dietary intake by an animal with adequate fat reserves depletes hepatocellular glycogen and initiates a heavy demand for triglycerides from adipose tissue.", [["fat", "ANATOMY", 55, 58], ["hepatocellular", "ANATOMY", 77, 91], ["adipose tissue", "ANATOMY", 153, 167], ["glycogen", "CHEMICAL", 92, 100], ["triglycerides", "CHEMICAL", 134, 147], ["fat", "TISSUE", 55, 58], ["hepatocellular", "ORGAN", 77, 91], ["glycogen", "SIMPLE_CHEMICAL", 92, 100], ["triglycerides", "SIMPLE_CHEMICAL", 134, 147], ["adipose tissue", "TISSUE", 153, 167], ["hepatocellular glycogen", "TREATMENT", 77, 100], ["a heavy demand", "TREATMENT", 115, 129], ["triglycerides from adipose tissue", "PROBLEM", 134, 167], ["hepatocellular", "ANATOMY", 77, 91], ["adipose tissue", "OBSERVATION", 153, 167]]], ["When hepatic triglyceride concentrations exceed 10% ill-thrift to emaciation, anorexia, and mild normocytic normochromic anemia, occasionally with photosensitization and icterus.", [["hepatic", "ANATOMY", 5, 12], ["triglyceride", "CHEMICAL", 13, 25], ["emaciation", "DISEASE", 66, 76], ["anorexia", "DISEASE", 78, 86], ["anemia", "DISEASE", 121, 127], ["photosensitization", "DISEASE", 147, 165], ["icterus", "DISEASE", 170, 177], ["triglyceride", "CHEMICAL", 13, 25], ["hepatic", "ORGAN", 5, 12], ["triglyceride", "SIMPLE_CHEMICAL", 13, 25], ["hepatic triglyceride concentrations", "TEST", 5, 40], ["emaciation", "PROBLEM", 66, 76], ["anorexia", "PROBLEM", 78, 86], ["mild normocytic normochromic anemia", "PROBLEM", 92, 127], ["photosensitization", "PROBLEM", 147, 165], ["icterus", "PROBLEM", 170, 177], ["hepatic", "ANATOMY", 5, 12], ["anorexia", "OBSERVATION", 78, 86], ["mild", "OBSERVATION_MODIFIER", 92, 96], ["normocytic normochromic anemia", "OBSERVATION", 97, 127], ["icterus", "OBSERVATION", 170, 177]]], ["The condition is associated with low liver cobalt levels and low plasma concentrations of vitamin B 12 , and the disease has been shown to be cobalt and vitamin B 12 responsive.", [["liver", "ANATOMY", 37, 42], ["plasma", "ANATOMY", 65, 71], ["cobalt", "CHEMICAL", 43, 49], ["vitamin B 12", "CHEMICAL", 90, 102], ["cobalt", "CHEMICAL", 142, 148], ["vitamin B", "CHEMICAL", 153, 162], ["cobalt", "CHEMICAL", 43, 49], ["vitamin B 12", "CHEMICAL", 90, 102], ["cobalt", "CHEMICAL", 142, 148], ["vitamin B 12", "CHEMICAL", 153, 165], ["liver", "ORGAN", 37, 42], ["cobalt", "SIMPLE_CHEMICAL", 43, 49], ["plasma", "ORGANISM_SUBSTANCE", 65, 71], ["vitamin B 12", "GENE_OR_GENE_PRODUCT", 90, 102], ["cobalt", "SIMPLE_CHEMICAL", 142, 148], ["vitamin B 12", "SIMPLE_CHEMICAL", 153, 165], ["low liver cobalt levels", "PROBLEM", 33, 56], ["low plasma concentrations", "PROBLEM", 61, 86], ["vitamin B", "TREATMENT", 90, 99], ["the disease", "PROBLEM", 109, 120], ["cobalt", "TEST", 142, 148], ["vitamin B", "TREATMENT", 153, 162], ["liver", "ANATOMY", 37, 42], ["disease", "OBSERVATION", 113, 120]]], ["Lambs up to 1 year of age are more commonly affected than ewes, and pastures are likely to be adequate at the times of peak incidence in late spring and early summer.274.e1In the early stages, the liver changes consist of vacuolar accumulation of triglyceride in hepatocytes, usually most severe in the centrilobular zones.", [["liver", "ANATOMY", 197, 202], ["vacuolar", "ANATOMY", 222, 230], ["hepatocytes", "ANATOMY", 263, 274], ["centrilobular zones", "ANATOMY", 303, 322], ["274.e1", "CHEMICAL", 166, 172], ["triglyceride", "CHEMICAL", 247, 259], ["triglyceride", "CHEMICAL", 247, 259], ["liver", "ORGAN", 197, 202], ["vacuolar", "IMMATERIAL_ANATOMICAL_ENTITY", 222, 230], ["triglyceride", "SIMPLE_CHEMICAL", 247, 259], ["hepatocytes", "CELL", 263, 274], ["centrilobular zones", "TISSUE", 303, 322], ["hepatocytes", "CELL_TYPE", 263, 274], ["Lambs", "TEST", 0, 5], ["the liver changes", "PROBLEM", 193, 210], ["vacuolar accumulation of triglyceride in hepatocytes", "PROBLEM", 222, 274], ["more commonly", "OBSERVATION_MODIFIER", 30, 43], ["liver", "ANATOMY", 197, 202], ["vacuolar accumulation", "OBSERVATION", 222, 243], ["triglyceride", "OBSERVATION_MODIFIER", 247, 259], ["hepatocytes", "ANATOMY", 263, 274], ["most severe", "OBSERVATION_MODIFIER", 284, 295], ["centrilobular", "ANATOMY_MODIFIER", 303, 316], ["zones", "ANATOMY_MODIFIER", 317, 322]]], ["In addition, ceroid pigment is present in all cases, early in hepatocytes and later also in sinusoidal cells and macrophages.", [["ceroid pigment", "ANATOMY", 13, 27], ["hepatocytes", "ANATOMY", 62, 73], ["sinusoidal cells", "ANATOMY", 92, 108], ["macrophages", "ANATOMY", 113, 124], ["ceroid", "DISEASE", 13, 19], ["hepatocytes", "CELL", 62, 73], ["sinusoidal cells", "CELL", 92, 108], ["macrophages", "CELL", 113, 124], ["hepatocytes", "CELL_TYPE", 62, 73], ["sinusoidal cells", "CELL_TYPE", 92, 108], ["macrophages", "CELL_TYPE", 113, 124], ["ceroid pigment", "PROBLEM", 13, 27], ["ceroid pigment", "OBSERVATION", 13, 27], ["hepatocytes", "ANATOMY", 62, 73], ["sinusoidal cells", "OBSERVATION", 92, 108], ["macrophages", "ANATOMY", 113, 124]]], ["The fatty change may be very severe in the early stage, the liver being grossly swollen.", [["liver", "ANATOMY", 60, 65], ["fatty change", "DISEASE", 4, 16], ["liver", "ORGAN", 60, 65], ["The fatty change", "PROBLEM", 0, 16], ["grossly swollen", "PROBLEM", 72, 87], ["fatty change", "OBSERVATION", 4, 16], ["may be", "UNCERTAINTY", 17, 23], ["very", "OBSERVATION_MODIFIER", 24, 28], ["severe", "OBSERVATION_MODIFIER", 29, 35], ["early stage", "OBSERVATION_MODIFIER", 43, 54], ["liver", "ANATOMY", 60, 65], ["grossly", "OBSERVATION_MODIFIER", 72, 79], ["swollen", "OBSERVATION", 80, 87]]], ["A moderate degree of bile ductular proliferation is also a consistent feature, and the epithelium of the smaller ductules in the triads is dysplastic.", [["bile ductular", "ANATOMY", 21, 34], ["epithelium", "ANATOMY", 87, 97], ["ductules", "ANATOMY", 113, 121], ["bile ductular", "PATHOLOGICAL_FORMATION", 21, 34], ["epithelium", "TISSUE", 87, 97], ["ductules", "MULTI-TISSUE_STRUCTURE", 113, 121], ["A moderate degree of bile ductular proliferation", "PROBLEM", 0, 48], ["dysplastic", "PROBLEM", 139, 149], ["moderate", "OBSERVATION_MODIFIER", 2, 10], ["degree", "OBSERVATION_MODIFIER", 11, 17], ["bile", "ANATOMY", 21, 25], ["ductular proliferation", "OBSERVATION", 26, 48], ["consistent feature", "UNCERTAINTY", 59, 77], ["epithelium", "ANATOMY_MODIFIER", 87, 97], ["smaller", "OBSERVATION_MODIFIER", 105, 112], ["ductules", "OBSERVATION_MODIFIER", 113, 121], ["dysplastic", "OBSERVATION", 139, 149]]], ["Spongy degeneration of cerebral white matter, typical of the hyperammonemia of hepatic failure, is present in some cases.274.e1Experimental feeding of a diet low in cobalt to sheep resulted in reduced growth rate, anorexia, lacrimation, alopecia, emaciation, and marked reduction in plasma and liver vitamin B 12 concentrations.", [["cerebral white matter", "ANATOMY", 23, 44], ["hepatic", "ANATOMY", 79, 86], ["plasma", "ANATOMY", 283, 289], ["liver", "ANATOMY", 294, 299], ["cerebral white matter", "DISEASE", 23, 44], ["hyperammonemia", "DISEASE", 61, 75], ["hepatic failure", "DISEASE", 79, 94], ["cobalt", "CHEMICAL", 165, 171], ["anorexia", "DISEASE", 214, 222], ["alopecia", "DISEASE", 237, 245], ["emaciation", "DISEASE", 247, 257], ["vitamin B", "CHEMICAL", 300, 309], ["cobalt", "CHEMICAL", 165, 171], ["vitamin B 12", "CHEMICAL", 300, 312], ["cerebral", "ORGAN", 23, 31], ["hepatic", "ORGAN", 79, 86], ["cobalt", "SIMPLE_CHEMICAL", 165, 171], ["sheep", "ORGANISM", 175, 180], ["plasma", "ORGANISM_SUBSTANCE", 283, 289], ["liver", "ORGAN", 294, 299], ["vitamin B 12", "GENE_OR_GENE_PRODUCT", 300, 312], ["sheep", "SPECIES", 175, 180], ["sheep", "SPECIES", 175, 180], ["Spongy degeneration of cerebral white matter", "PROBLEM", 0, 44], ["the hyperammonemia of hepatic failure", "PROBLEM", 57, 94], ["reduced growth rate", "PROBLEM", 193, 212], ["anorexia", "PROBLEM", 214, 222], ["lacrimation", "PROBLEM", 224, 235], ["alopecia", "PROBLEM", 237, 245], ["emaciation", "PROBLEM", 247, 257], ["marked reduction in plasma", "TREATMENT", 263, 289], ["liver vitamin B", "TREATMENT", 294, 309], ["degeneration", "OBSERVATION", 7, 19], ["cerebral white matter", "ANATOMY", 23, 44], ["hyperammonemia", "OBSERVATION", 61, 75], ["hepatic", "ANATOMY", 79, 86], ["failure", "OBSERVATION", 87, 94], ["alopecia", "OBSERVATION", 237, 245], ["emaciation", "OBSERVATION", 247, 257], ["marked", "OBSERVATION_MODIFIER", 263, 269], ["reduction", "OBSERVATION_MODIFIER", 270, 279], ["liver", "ANATOMY", 294, 299]]], ["At autopsy, livers were pale, swollen, and fatty.", [["livers", "ANATOMY", 12, 18], ["livers", "ORGAN", 12, 18], ["swollen", "PROBLEM", 30, 37], ["livers", "ANATOMY", 12, 18], ["pale", "OBSERVATION_MODIFIER", 24, 28], ["swollen", "OBSERVATION", 30, 37], ["fatty", "OBSERVATION_MODIFIER", 43, 48]]], ["Histologically, livers with severe fatty degeneration were characterized by widespread hepatocyte disassociation, accumulation of lipid droplets, eosinophilic inclusions and lipofuscin in hepatocyte and Kupffer cell cytoplasm, nuclear lipid inclusions, ductular proliferation, and hepatocyte apoptosis.", [["livers", "ANATOMY", 16, 22], ["hepatocyte", "ANATOMY", 87, 97], ["lipid droplets", "ANATOMY", 130, 144], ["eosinophilic inclusions", "ANATOMY", 146, 169], ["lipofuscin", "ANATOMY", 174, 184], ["hepatocyte", "ANATOMY", 188, 198], ["Kupffer cell cytoplasm", "ANATOMY", 203, 225], ["nuclear", "ANATOMY", 227, 234], ["ductular", "ANATOMY", 253, 261], ["hepatocyte", "ANATOMY", 281, 291], ["fatty degeneration", "DISEASE", 35, 53], ["livers", "ORGAN", 16, 22], ["hepatocyte", "CELL", 87, 97], ["lipid droplets", "CELLULAR_COMPONENT", 130, 144], ["eosinophilic inclusions", "CELLULAR_COMPONENT", 146, 169], ["lipofuscin", "SIMPLE_CHEMICAL", 174, 184], ["hepatocyte", "CELL", 188, 198], ["Kupffer cell", "CELLULAR_COMPONENT", 203, 215], ["cytoplasm", "ORGANISM_SUBSTANCE", 216, 225], ["nuclear", "CELLULAR_COMPONENT", 227, 234], ["lipid inclusions", "CELLULAR_COMPONENT", 235, 251], ["ductular", "TISSUE", 253, 261], ["hepatocyte", "CELL", 281, 291], ["severe fatty degeneration", "PROBLEM", 28, 53], ["widespread hepatocyte disassociation", "PROBLEM", 76, 112], ["lipid droplets", "PROBLEM", 130, 144], ["eosinophilic inclusions", "PROBLEM", 146, 169], ["lipofuscin in hepatocyte", "PROBLEM", 174, 198], ["Kupffer cell cytoplasm", "PROBLEM", 203, 225], ["nuclear lipid inclusions", "PROBLEM", 227, 251], ["ductular proliferation", "PROBLEM", 253, 275], ["hepatocyte apoptosis", "PROBLEM", 281, 301], ["livers", "ANATOMY", 16, 22], ["severe", "OBSERVATION_MODIFIER", 28, 34], ["fatty degeneration", "OBSERVATION", 35, 53], ["widespread", "OBSERVATION_MODIFIER", 76, 86], ["hepatocyte disassociation", "OBSERVATION", 87, 112], ["lipid droplets", "OBSERVATION", 130, 144], ["eosinophilic inclusions", "OBSERVATION", 146, 169], ["lipofuscin", "OBSERVATION", 174, 184], ["hepatocyte", "ANATOMY", 188, 198], ["Kupffer cell cytoplasm", "OBSERVATION", 203, 225], ["lipid inclusions", "OBSERVATION", 235, 251], ["ductular proliferation", "OBSERVATION", 253, 275], ["hepatocyte apoptosis", "OBSERVATION", 281, 301]]], ["These lesions are characteristic of spontaneous cases of ovine white-liver disease.", [["lesions", "ANATOMY", 6, 13], ["liver", "ANATOMY", 69, 74], ["white-liver disease", "DISEASE", 63, 82], ["lesions", "PATHOLOGICAL_FORMATION", 6, 13], ["ovine", "ORGANISM", 57, 62], ["liver", "ORGAN", 69, 74], ["These lesions", "PROBLEM", 0, 13], ["ovine white-liver disease", "PROBLEM", 57, 82], ["lesions", "OBSERVATION", 6, 13], ["spontaneous", "OBSERVATION_MODIFIER", 36, 47], ["ovine", "OBSERVATION_MODIFIER", 57, 62], ["white", "OBSERVATION_MODIFIER", 63, 68], ["liver", "ANATOMY", 69, 74], ["disease", "OBSERVATION", 75, 82]]], ["Ultrastructurally, degeneration of mitochondria and proliferation of the smooth endoplasmic reticulum are evident.", [["mitochondria", "ANATOMY", 35, 47], ["smooth endoplasmic reticulum", "ANATOMY", 73, 101], ["mitochondria", "CELLULAR_COMPONENT", 35, 47], ["smooth endoplasmic reticulum", "CELLULAR_COMPONENT", 73, 101], ["degeneration of mitochondria", "PROBLEM", 19, 47], ["proliferation of the smooth endoplasmic reticulum", "PROBLEM", 52, 101], ["degeneration", "OBSERVATION", 19, 31], ["mitochondria", "OBSERVATION_MODIFIER", 35, 47], ["proliferation", "OBSERVATION_MODIFIER", 52, 65], ["smooth", "OBSERVATION_MODIFIER", 73, 79], ["endoplasmic reticulum", "OBSERVATION", 80, 101]]], ["The disease can be produced in cobalt-deficient sheep fed diets high in propionate precursors, which may help explain the explosive nature of outbreaks on lush pasture.274.e1Hepatic lesions similar to lipotrope-deficient forms of experimental nutritional cirrhosis have been reported in sheep, goats, cattle, deer, and pronghorn antelope from Texas, New Mexico, and northeastern Mexico.", [["274.e1Hepatic lesions", "ANATOMY", 168, 189], ["cobalt", "CHEMICAL", 31, 37], ["propionate", "CHEMICAL", 72, 82], ["nutritional cirrhosis", "DISEASE", 243, 264], ["cobalt", "CHEMICAL", 31, 37], ["propionate", "CHEMICAL", 72, 82], ["cobalt", "SIMPLE_CHEMICAL", 31, 37], ["sheep", "ORGANISM", 48, 53], ["propionate", "SIMPLE_CHEMICAL", 72, 82], ["274.e1Hepatic lesions", "PATHOLOGICAL_FORMATION", 168, 189], ["sheep", "ORGANISM", 287, 292], ["goats", "ORGANISM", 294, 299], ["cattle", "ORGANISM", 301, 307], ["deer", "ORGANISM", 309, 313], ["pronghorn antelope", "ORGANISM", 319, 337], ["sheep", "SPECIES", 48, 53], ["sheep", "SPECIES", 287, 292], ["goats", "SPECIES", 294, 299], ["cattle", "SPECIES", 301, 307], ["deer", "SPECIES", 309, 313], ["sheep", "SPECIES", 48, 53], ["sheep", "SPECIES", 287, 292], ["goats", "SPECIES", 294, 299], ["cattle", "SPECIES", 301, 307], ["The disease", "PROBLEM", 0, 11], ["cobalt-deficient sheep fed diets", "TREATMENT", 31, 63], ["274.e1Hepatic lesions", "PROBLEM", 168, 189], ["lipotrope", "TEST", 201, 210], ["experimental nutritional cirrhosis", "PROBLEM", 230, 264], ["disease", "OBSERVATION", 4, 11], ["lesions", "OBSERVATION", 182, 189], ["lipotrope-deficient", "OBSERVATION_MODIFIER", 201, 220], ["experimental", "OBSERVATION_MODIFIER", 230, 242], ["nutritional cirrhosis", "OBSERVATION", 243, 264]]], ["Hard yellow-liver disease, or hepatic fatty cirrhosis, is a progressive, chronic disease characterized by weight loss and hepatic encephalopathy (eFig.", [["liver", "ANATOMY", 12, 17], ["hepatic fatty cirrhosis", "ANATOMY", 30, 53], ["hepatic", "ANATOMY", 122, 129], ["Hard yellow-liver disease", "DISEASE", 0, 25], ["hepatic fatty cirrhosis", "DISEASE", 30, 53], ["weight loss", "DISEASE", 106, 117], ["hepatic encephalopathy", "DISEASE", 122, 144], ["liver", "ORGAN", 12, 17], ["hepatic", "ORGAN", 122, 129], ["Hard yellow-liver disease", "PROBLEM", 0, 25], ["hepatic fatty cirrhosis", "PROBLEM", 30, 53], ["a progressive, chronic disease", "PROBLEM", 58, 88], ["weight loss", "PROBLEM", 106, 117], ["hepatic encephalopathy", "PROBLEM", 122, 144], ["eFig", "TEST", 146, 150], ["liver", "ANATOMY", 12, 17], ["disease", "OBSERVATION", 18, 25], ["hepatic", "ANATOMY", 30, 37], ["fatty cirrhosis", "OBSERVATION", 38, 53], ["progressive", "OBSERVATION_MODIFIER", 60, 71], ["chronic", "OBSERVATION_MODIFIER", 73, 80], ["disease", "OBSERVATION", 81, 88], ["weight loss", "OBSERVATION", 106, 117], ["hepatic", "ANATOMY", 122, 129], ["encephalopathy", "OBSERVATION", 130, 144]]], ["The disease typically appears in years following above-average winter rains, followed by drought conditions in the summer months.", [["The disease", "PROBLEM", 0, 11], ["disease", "OBSERVATION", 4, 11]]], ["Grossly visible liver lesions in sheep begin in the subcapsular hepatic parenchyma along the porta hepatis as pale yellow, firm areas, spreading peripherally to involve ~80% of the liver in the final stages of the disease.", [["liver lesions", "ANATOMY", 16, 29], ["subcapsular hepatic parenchyma", "ANATOMY", 52, 82], ["porta hepatis", "ANATOMY", 93, 106], ["firm areas", "ANATOMY", 123, 133], ["peripherally", "ANATOMY", 145, 157], ["liver", "ANATOMY", 181, 186], ["liver lesions", "DISEASE", 16, 29], ["liver lesions", "PATHOLOGICAL_FORMATION", 16, 29], ["sheep", "ORGANISM", 33, 38], ["subcapsular hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 52, 82], ["porta hepatis", "ORGAN", 93, 106], ["liver", "ORGAN", 181, 186], ["sheep", "SPECIES", 33, 38], ["sheep", "SPECIES", 33, 38], ["Grossly visible liver lesions", "PROBLEM", 0, 29], ["pale yellow", "PROBLEM", 110, 121], ["firm areas", "PROBLEM", 123, 133], ["the disease", "PROBLEM", 210, 221], ["visible", "OBSERVATION_MODIFIER", 8, 15], ["liver", "ANATOMY", 16, 21], ["lesions", "OBSERVATION", 22, 29], ["sheep", "OBSERVATION", 33, 38], ["subcapsular", "ANATOMY_MODIFIER", 52, 63], ["hepatic", "ANATOMY", 64, 71], ["parenchyma", "ANATOMY_MODIFIER", 72, 82], ["porta hepatis", "ANATOMY", 93, 106], ["pale", "OBSERVATION_MODIFIER", 110, 114], ["yellow", "OBSERVATION_MODIFIER", 115, 121], ["firm", "OBSERVATION_MODIFIER", 123, 127], ["areas", "OBSERVATION_MODIFIER", 128, 133], ["80%", "OBSERVATION_MODIFIER", 170, 173], ["liver", "ANATOMY", 181, 186], ["final stages", "OBSERVATION_MODIFIER", 194, 206], ["disease", "OBSERVATION", 214, 221]]], ["Microscopic changes include accumulation of fine cytoplasmic lipid droplets in centrilobular hepatocytes, later involving the entire lobule, with rupture and formation of fatty cysts.", [["cytoplasmic lipid droplets", "ANATOMY", 49, 75], ["centrilobular hepatocytes", "ANATOMY", 79, 104], ["lobule", "ANATOMY", 133, 139], ["fatty cysts", "ANATOMY", 171, 182], ["rupture", "DISEASE", 146, 153], ["fatty cysts", "DISEASE", 171, 182], ["cytoplasmic", "ORGANISM_SUBSTANCE", 49, 60], ["lipid droplets", "CELLULAR_COMPONENT", 61, 75], ["centrilobular hepatocytes", "CELL", 79, 104], ["lobule", "ORGAN", 133, 139], ["fatty cysts", "PATHOLOGICAL_FORMATION", 171, 182], ["centrilobular hepatocytes", "CELL_TYPE", 79, 104], ["Microscopic changes", "PROBLEM", 0, 19], ["fine cytoplasmic lipid droplets", "TEST", 44, 75], ["centrilobular hepatocytes", "PROBLEM", 79, 104], ["rupture", "PROBLEM", 146, 153], ["fatty cysts", "PROBLEM", 171, 182], ["accumulation", "OBSERVATION_MODIFIER", 28, 40], ["fine", "OBSERVATION_MODIFIER", 44, 48], ["cytoplasmic lipid droplets", "OBSERVATION", 49, 75], ["centrilobular", "ANATOMY_MODIFIER", 79, 92], ["hepatocytes", "ANATOMY", 93, 104], ["entire", "OBSERVATION_MODIFIER", 126, 132], ["lobule", "OBSERVATION_MODIFIER", 133, 139], ["rupture", "OBSERVATION", 146, 153], ["fatty cysts", "OBSERVATION", 171, 182]]], ["Centrilobular fibrosis accompanies the ruptured fatty cysts, progressing to widespread bridging centrilobular fibrosis, with islands of regenerating hepatocytes.", [["Centrilobular", "ANATOMY", 0, 13], ["fatty cysts", "ANATOMY", 48, 59], ["centrilobular", "ANATOMY", 96, 109], ["hepatocytes", "ANATOMY", 149, 160], ["fibrosis", "DISEASE", 14, 22], ["fatty cysts", "DISEASE", 48, 59], ["fibrosis", "DISEASE", 110, 118], ["fatty cysts", "PATHOLOGICAL_FORMATION", 48, 59], ["centrilobular", "PATHOLOGICAL_FORMATION", 96, 109], ["hepatocytes", "CELL", 149, 160], ["regenerating hepatocytes", "CELL_TYPE", 136, 160], ["Centrilobular fibrosis", "PROBLEM", 0, 22], ["the ruptured fatty cysts", "PROBLEM", 35, 59], ["widespread bridging centrilobular fibrosis", "PROBLEM", 76, 118], ["regenerating hepatocytes", "PROBLEM", 136, 160], ["fibrosis", "OBSERVATION", 14, 22], ["ruptured", "OBSERVATION_MODIFIER", 39, 47], ["fatty cysts", "OBSERVATION", 48, 59], ["widespread", "OBSERVATION_MODIFIER", 76, 86], ["bridging", "OBSERVATION_MODIFIER", 87, 95], ["centrilobular", "OBSERVATION_MODIFIER", 96, 109], ["fibrosis", "OBSERVATION", 110, 118], ["islands", "OBSERVATION_MODIFIER", 125, 132], ["regenerating hepatocytes", "OBSERVATION", 136, 160]]], ["Kupffer cells and macrophages in regional lymph nodes, spleen, and lung contain abundant ceroid.", [["Kupffer cells", "ANATOMY", 0, 13], ["macrophages", "ANATOMY", 18, 29], ["lymph nodes", "ANATOMY", 42, 53], ["spleen", "ANATOMY", 55, 61], ["lung", "ANATOMY", 67, 71], ["ceroid", "DISEASE", 89, 95], ["Kupffer cells", "CELL", 0, 13], ["macrophages", "CELL", 18, 29], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 42, 53], ["spleen", "ORGAN", 55, 61], ["lung", "ORGAN", 67, 71], ["Kupffer cells", "CELL_TYPE", 0, 13], ["macrophages", "CELL_TYPE", 18, 29], ["macrophages", "OBSERVATION_MODIFIER", 18, 29], ["regional", "ANATOMY_MODIFIER", 33, 41], ["lymph nodes", "OBSERVATION", 42, 53], ["spleen", "ANATOMY", 55, 61], ["lung", "ANATOMY", 67, 71], ["abundant", "OBSERVATION_MODIFIER", 80, 88], ["ceroid", "OBSERVATION", 89, 95]]], ["The etiology of this condition is unknown, although unidentified hepatotoxins, possibly altering lipoprotein synthesis and secretion, combined with nutritional stress, have been postulated.274.e1Equine hyperlipemia is almost exclusively a disease of donkeys, miniature horses, and ponies, and among these, the Shetland breed predominates.", [["274.e1", "CHEMICAL", 189, 195], ["hyperlipemia", "DISEASE", 202, 214], ["hepatotoxins", "GENE_OR_GENE_PRODUCT", 65, 77], ["lipoprotein", "SIMPLE_CHEMICAL", 97, 108], ["Equine", "ORGANISM", 195, 201], ["this condition", "PROBLEM", 16, 30], ["unidentified hepatotoxins", "PROBLEM", 52, 77], ["altering lipoprotein synthesis", "PROBLEM", 88, 118], ["secretion", "PROBLEM", 123, 132], ["nutritional stress", "PROBLEM", 148, 166], ["Equine hyperlipemia", "PROBLEM", 195, 214], ["a disease of donkeys", "PROBLEM", 237, 257], ["hepatotoxins", "OBSERVATION", 65, 77], ["possibly", "UNCERTAINTY", 79, 87], ["hyperlipemia", "OBSERVATION", 202, 214], ["disease", "OBSERVATION", 239, 246]]], ["The syndrome is characterized by marked elevation of serum triglyceride concentration, predominantly very-low-density lipoprotein (VLDL), but other pronounced steatosis, presumably related to interference with local perfusion caused by tensions transmitted to the parenchyma by the adhesion.274.e1Hepatic steatosis caused by intoxication is common.", [["serum", "ANATOMY", 53, 58], ["parenchyma", "ANATOMY", 264, 274], ["triglyceride", "CHEMICAL", 59, 71], ["steatosis", "DISEASE", 159, 168], ["steatosis", "DISEASE", 305, 314], ["triglyceride", "CHEMICAL", 59, 71], ["serum", "ORGANISM_SUBSTANCE", 53, 58], ["triglyceride", "SIMPLE_CHEMICAL", 59, 71], ["low-density lipoprotein", "SIMPLE_CHEMICAL", 106, 129], ["VLDL", "SIMPLE_CHEMICAL", 131, 135], ["parenchyma", "TISSUE", 264, 274], ["low-density lipoprotein", "PROTEIN", 106, 129], ["VLDL", "PROTEIN", 131, 135], ["The syndrome", "PROBLEM", 0, 12], ["marked elevation of serum triglyceride concentration", "PROBLEM", 33, 85], ["other pronounced steatosis", "PROBLEM", 142, 168], ["local perfusion", "TREATMENT", 210, 225], ["steatosis", "PROBLEM", 305, 314], ["intoxication", "PROBLEM", 325, 337], ["syndrome", "OBSERVATION", 4, 12], ["marked", "OBSERVATION_MODIFIER", 33, 39], ["elevation", "OBSERVATION_MODIFIER", 40, 49], ["predominantly", "OBSERVATION_MODIFIER", 87, 100], ["very", "OBSERVATION_MODIFIER", 101, 105], ["low-density lipoprotein", "OBSERVATION_MODIFIER", 106, 129], ["pronounced", "OBSERVATION_MODIFIER", 148, 158], ["steatosis", "OBSERVATION", 159, 168], ["presumably related to", "UNCERTAINTY", 170, 191], ["interference", "OBSERVATION", 192, 204], ["local perfusion", "OBSERVATION", 210, 225], ["tensions", "OBSERVATION", 236, 244], ["parenchyma", "ANATOMY_MODIFIER", 264, 274], ["adhesion", "OBSERVATION", 282, 290], ["steatosis", "OBSERVATION", 305, 314], ["intoxication", "OBSERVATION", 325, 337]]], ["There are several stages of the cycle of hepatic lipid metabolism that can be affected selectively by various toxins to produce fatty liver.", [["hepatic", "ANATOMY", 41, 48], ["fatty liver", "ANATOMY", 128, 139], ["fatty liver", "DISEASE", 128, 139], ["hepatic lipid", "MULTI-TISSUE_STRUCTURE", 41, 54], ["liver", "ORGAN", 134, 139], ["hepatic lipid metabolism", "TREATMENT", 41, 65], ["fatty liver", "PROBLEM", 128, 139], ["several", "OBSERVATION_MODIFIER", 10, 17], ["stages", "OBSERVATION_MODIFIER", 18, 24], ["hepatic", "ANATOMY", 41, 48], ["lipid metabolism", "OBSERVATION", 49, 65], ["fatty", "OBSERVATION", 128, 133], ["liver", "ANATOMY", 134, 139]]], ["For example, it is possible experimentally to cause triglyceride accumulation by interfering with mitochondrial fatty acid oxidation with sublethal doses of cyanide, or by inhibiting apolipoprotein synthesis by administration of orotic acid.", [["mitochondrial", "ANATOMY", 98, 111], ["triglyceride", "CHEMICAL", 52, 64], ["fatty acid", "CHEMICAL", 112, 122], ["cyanide", "CHEMICAL", 157, 164], ["orotic acid", "CHEMICAL", 229, 240], ["triglyceride", "CHEMICAL", 52, 64], ["fatty acid", "CHEMICAL", 112, 122], ["cyanide", "CHEMICAL", 157, 164], ["orotic acid", "CHEMICAL", 229, 240], ["triglyceride", "SIMPLE_CHEMICAL", 52, 64], ["mitochondrial", "CELLULAR_COMPONENT", 98, 111], ["fatty acid", "SIMPLE_CHEMICAL", 112, 122], ["cyanide", "SIMPLE_CHEMICAL", 157, 164], ["apolipoprotein", "SIMPLE_CHEMICAL", 183, 197], ["orotic acid", "SIMPLE_CHEMICAL", 229, 240], ["triglyceride accumulation", "PROBLEM", 52, 77], ["mitochondrial fatty acid oxidation", "TREATMENT", 98, 132], ["sublethal doses of cyanide", "TREATMENT", 138, 164], ["inhibiting apolipoprotein synthesis", "TREATMENT", 172, 207], ["orotic acid", "TREATMENT", 229, 240], ["fatty acid oxidation", "OBSERVATION", 112, 132]]], ["Most toxins that cause fatty liver in naturally occurring situations, however, also produce a greater or lesser degree of hepatocellular necrosis.", [["fatty liver", "ANATOMY", 23, 34], ["hepatocellular", "ANATOMY", 122, 136], ["fatty liver", "DISEASE", 23, 34], ["necrosis", "DISEASE", 137, 145], ["liver", "ORGAN", 29, 34], ["hepatocellular", "CANCER", 122, 136], ["fatty liver", "PROBLEM", 23, 34], ["hepatocellular necrosis", "PROBLEM", 122, 145], ["fatty", "OBSERVATION", 23, 28], ["liver", "ANATOMY", 29, 34], ["greater", "OBSERVATION_MODIFIER", 94, 101], ["lesser degree", "OBSERVATION_MODIFIER", 105, 118], ["hepatocellular", "ANATOMY", 122, 136], ["necrosis", "OBSERVATION", 137, 145]]], ["Fatty liver occurring as a manifestation of toxic hepatic disease will be further discussed in the later section on Toxic hepatic disease, but the generalization may be made here that most important veterinary hepatic intoxications cause widespread membrane damage and/or disturbance of protein synthesis.", [["Fatty liver", "ANATOMY", 0, 11], ["hepatic", "ANATOMY", 50, 57], ["hepatic", "ANATOMY", 122, 129], ["hepatic", "ANATOMY", 210, 217], ["membrane", "ANATOMY", 249, 257], ["Fatty liver", "DISEASE", 0, 11], ["toxic hepatic disease", "DISEASE", 44, 65], ["Toxic hepatic disease", "DISEASE", 116, 137], ["hepatic intoxications", "DISEASE", 210, 231], ["liver", "ORGAN", 6, 11], ["hepatic", "ORGAN", 50, 57], ["hepatic", "ORGAN", 122, 129], ["hepatic", "ORGAN", 210, 217], ["membrane", "CELLULAR_COMPONENT", 249, 257], ["Fatty liver", "PROBLEM", 0, 11], ["toxic hepatic disease", "PROBLEM", 44, 65], ["Toxic hepatic disease", "PROBLEM", 116, 137], ["widespread membrane damage", "PROBLEM", 238, 264], ["disturbance of protein synthesis", "PROBLEM", 272, 304], ["liver", "ANATOMY", 6, 11], ["toxic", "OBSERVATION_MODIFIER", 44, 49], ["hepatic", "ANATOMY", 50, 57], ["disease", "OBSERVATION", 58, 65], ["Toxic", "OBSERVATION_MODIFIER", 116, 121], ["hepatic", "ANATOMY", 122, 129], ["disease", "OBSERVATION", 130, 137], ["hepatic", "ANATOMY", 210, 217], ["widespread", "OBSERVATION_MODIFIER", 238, 248], ["membrane damage", "OBSERVATION", 249, 264], ["protein synthesis", "OBSERVATION", 287, 304]]], ["These cause lipid accumulation in the hepatocyte by interfering with lipoprotein synthesis and export, as well as with fatty acid oxidation.", [["hepatocyte", "ANATOMY", 38, 48], ["fatty acid", "CHEMICAL", 119, 129], ["fatty acid", "CHEMICAL", 119, 129], ["lipid", "SIMPLE_CHEMICAL", 12, 17], ["hepatocyte", "CELL", 38, 48], ["lipoprotein", "SIMPLE_CHEMICAL", 69, 80], ["fatty acid", "SIMPLE_CHEMICAL", 119, 129], ["lipid accumulation", "PROBLEM", 12, 30], ["lipoprotein synthesis", "TREATMENT", 69, 90], ["fatty acid oxidation", "TREATMENT", 119, 139], ["lipid accumulation", "OBSERVATION", 12, 30], ["hepatocyte", "ANATOMY", 38, 48]]], ["Steatosis requires time and a negative energy balance to develop, so it is more likely to occur in toxicoses with a longer clinical course.", [["Steatosis", "DISEASE", 0, 9], ["Steatosis", "PROBLEM", 0, 9], ["more likely", "UNCERTAINTY", 75, 86]]], ["However, if adipose reserves are depleted, there is less lipid available to accumulate in the liver.274.e1Although fatty liver in domestic animals is more frequently associated with generalized interferences with energy metabolism, there are some specific nutritional deficiencies that will produce fatty liver.", [["adipose", "ANATOMY", 12, 19], ["liver", "ANATOMY", 94, 99], ["fatty liver", "ANATOMY", 115, 126], ["fatty liver", "ANATOMY", 299, 310], ["fatty liver", "DISEASE", 115, 126], ["fatty liver", "DISEASE", 299, 310], ["adipose", "TISSUE", 12, 19], ["lipid", "SIMPLE_CHEMICAL", 57, 62], ["liver", "ORGAN", 94, 99], ["liver", "ORGAN", 121, 126], ["liver", "ORGAN", 305, 310], ["fatty liver", "PROBLEM", 115, 126], ["generalized interferences with energy metabolism", "PROBLEM", 182, 230], ["some specific nutritional deficiencies", "PROBLEM", 242, 280], ["fatty liver", "PROBLEM", 299, 310], ["liver", "ANATOMY", 94, 99], ["liver", "ANATOMY", 121, 126], ["more frequently", "OBSERVATION_MODIFIER", 150, 165], ["nutritional deficiencies", "OBSERVATION", 256, 280], ["fatty", "OBSERVATION", 299, 304], ["liver", "ANATOMY", 305, 310]]], ["These have usually been defined under experimental conditions.", [["experimental conditions", "OBSERVATION", 38, 61]]], ["Choline deficiency, in conjunction with deficiency of other lipotropic factors, such as L-methionine and vitamin B 12 , rapidly produces fatty liver, largely as a result of reduced synthesis of phosphatidylcholine, a component of secreted lipoproteins.", [["fatty liver", "ANATOMY", 137, 148], ["Choline", "CHEMICAL", 0, 7], ["L-methionine", "CHEMICAL", 88, 100], ["vitamin B 12", "CHEMICAL", 105, 117], ["fatty liver", "DISEASE", 137, 148], ["phosphatidylcholine", "CHEMICAL", 194, 213], ["Choline", "CHEMICAL", 0, 7], ["L-methionine", "CHEMICAL", 88, 100], ["vitamin B 12", "CHEMICAL", 105, 117], ["phosphatidylcholine", "CHEMICAL", 194, 213], ["Choline", "SIMPLE_CHEMICAL", 0, 7], ["L-methionine", "SIMPLE_CHEMICAL", 88, 100], ["vitamin B 12", "SIMPLE_CHEMICAL", 105, 117], ["liver", "ORGAN", 143, 148], ["phosphatidylcholine", "SIMPLE_CHEMICAL", 194, 213], ["lipotropic factors", "PROTEIN", 60, 78], ["secreted lipoproteins", "PROTEIN", 230, 251], ["Choline deficiency", "PROBLEM", 0, 18], ["deficiency of other lipotropic factors", "PROBLEM", 40, 78], ["L-methionine and vitamin B", "TREATMENT", 88, 114], ["fatty liver", "PROBLEM", 137, 148], ["reduced synthesis of phosphatidylcholine", "TREATMENT", 173, 213], ["secreted lipoproteins", "PROBLEM", 230, 251], ["deficiency", "OBSERVATION", 8, 18], ["liver", "ANATOMY", 143, 148], ["secreted lipoproteins", "OBSERVATION", 230, 251]]], ["Fatty liver in experimental choline deficiency involves lipid peroxidation and increased hepatocellular turnover, leading to cirrhosis and neoplasia.", [["Fatty liver", "ANATOMY", 0, 11], ["hepatocellular", "ANATOMY", 89, 103], ["neoplasia", "ANATOMY", 139, 148], ["Fatty liver", "DISEASE", 0, 11], ["choline", "CHEMICAL", 28, 35], ["cirrhosis", "DISEASE", 125, 134], ["neoplasia", "DISEASE", 139, 148], ["choline", "CHEMICAL", 28, 35], ["liver", "ORGAN", 6, 11], ["choline", "SIMPLE_CHEMICAL", 28, 35], ["lipid", "SIMPLE_CHEMICAL", 56, 61], ["hepatocellular", "CANCER", 89, 103], ["neoplasia", "CANCER", 139, 148], ["Fatty liver", "PROBLEM", 0, 11], ["experimental choline deficiency", "PROBLEM", 15, 46], ["lipid peroxidation", "PROBLEM", 56, 74], ["increased hepatocellular turnover", "PROBLEM", 79, 112], ["cirrhosis", "PROBLEM", 125, 134], ["neoplasia", "PROBLEM", 139, 148], ["liver", "ANATOMY", 6, 11], ["experimental choline deficiency", "OBSERVATION", 15, 46], ["lipid peroxidation", "OBSERVATION", 56, 74], ["increased", "OBSERVATION_MODIFIER", 79, 88], ["hepatocellular turnover", "OBSERVATION", 89, 112], ["cirrhosis", "OBSERVATION", 125, 134], ["neoplasia", "OBSERVATION", 139, 148]]], ["It is unlikely that primary choline deficiency occurs in domestic animals, but other lipotrope deficiencies have been reported.274.e1Ovine white-liver disease, first described in lambs in New Zealand, also occurs in southern Australia, the United Kingdom, and continental Europe.", [["liver", "ANATOMY", 145, 150], ["choline", "CHEMICAL", 28, 35], ["274.e1", "CHEMICAL", 127, 133], ["white-liver disease", "DISEASE", 139, 158], ["primary choline", "CHEMICAL", 20, 35], ["choline", "SIMPLE_CHEMICAL", 28, 35], ["Ovine", "ORGANISM", 133, 138], ["liver", "ORGAN", 145, 150], ["lambs", "ORGANISM", 179, 184], ["primary choline deficiency", "PROBLEM", 20, 46], ["other lipotrope deficiencies", "PROBLEM", 79, 107], ["Ovine white-liver disease", "PROBLEM", 133, 158], ["unlikely", "UNCERTAINTY", 6, 14], ["primary", "OBSERVATION_MODIFIER", 20, 27], ["choline deficiency", "OBSERVATION", 28, 46], ["white", "OBSERVATION_MODIFIER", 139, 144], ["liver", "ANATOMY", 145, 150], ["disease", "OBSERVATION", 151, 158], ["New", "OBSERVATION_MODIFIER", 188, 191], ["Zealand", "OBSERVATION_MODIFIER", 192, 199]]], ["Goats are also susceptible.", [["Goats", "ORGANISM", 0, 5]]], ["Ovine white-liver disease is characterized by a syndrome of The syndrome of feline hepatic steatosis most commonly occurs in obese, nutritionally stressed female cats, which display vomiting, anorexia, weakness and weight loss, jaundice, and hepatomegaly ( Fig. 2-25 ).", [["liver", "ANATOMY", 12, 17], ["hepatic", "ANATOMY", 83, 90], ["white-liver disease", "DISEASE", 6, 25], ["feline hepatic steatosis", "DISEASE", 76, 100], ["vomiting", "DISEASE", 182, 190], ["anorexia", "DISEASE", 192, 200], ["weakness", "DISEASE", 202, 210], ["weight loss", "DISEASE", 215, 226], ["jaundice", "DISEASE", 228, 236], ["hepatomegaly", "DISEASE", 242, 254], ["Ovine", "ORGANISM", 0, 5], ["liver", "ORGAN", 12, 17], ["feline", "ORGANISM", 76, 82], ["hepatic", "ORGAN", 83, 90], ["cats", "ORGANISM", 162, 166], ["feline", "SPECIES", 76, 82], ["cats", "SPECIES", 162, 166], ["Ovine white-liver disease", "PROBLEM", 0, 25], ["a syndrome", "PROBLEM", 46, 56], ["The syndrome of feline hepatic steatosis", "PROBLEM", 60, 100], ["vomiting", "PROBLEM", 182, 190], ["anorexia", "PROBLEM", 192, 200], ["weakness", "PROBLEM", 202, 210], ["weight loss", "PROBLEM", 215, 226], ["jaundice", "PROBLEM", 228, 236], ["hepatomegaly", "PROBLEM", 242, 254], ["Fig.", "TEST", 257, 261], ["liver", "ANATOMY", 12, 17], ["disease", "OBSERVATION", 18, 25], ["syndrome", "OBSERVATION", 48, 56], ["syndrome", "OBSERVATION", 64, 72], ["hepatic", "ANATOMY", 83, 90], ["steatosis", "OBSERVATION", 91, 100], ["obese", "OBSERVATION", 125, 130], ["anorexia", "OBSERVATION", 192, 200], ["weakness", "OBSERVATION", 202, 210], ["weight loss", "OBSERVATION", 215, 226], ["jaundice", "OBSERVATION", 228, 236], ["hepatomegaly", "OBSERVATION", 242, 254]]], ["Neurobehavioral signs indicative of hepatic encephalopathy, other than drooling and depression, are rarely reported.", [["hepatic", "ANATOMY", 36, 43], ["hepatic encephalopathy", "DISEASE", 36, 58], ["drooling", "DISEASE", 71, 79], ["depression", "DISEASE", 84, 94], ["hepatic", "ORGAN", 36, 43], ["Neurobehavioral signs", "TEST", 0, 21], ["hepatic encephalopathy", "PROBLEM", 36, 58], ["drooling", "PROBLEM", 71, 79], ["depression", "PROBLEM", 84, 94], ["indicative of", "UNCERTAINTY", 22, 35], ["hepatic", "ANATOMY", 36, 43], ["encephalopathy", "OBSERVATION", 44, 58], ["depression", "OBSERVATION", 84, 94]]], ["Affected cats generally have hyperbilirubinemia, and a significant increase in serum alkaline phosphatase activity, in the face of normal or modest increases in \u03b3-glutamyltranspeptidase activity, a key diagnostic feature of this syndrome.", [["serum", "ANATOMY", 79, 84], ["hyperbilirubinemia", "DISEASE", 29, 47], ["cats", "ORGANISM", 9, 13], ["serum", "ORGANISM_SUBSTANCE", 79, 84], ["alkaline phosphatase", "GENE_OR_GENE_PRODUCT", 85, 105], ["\u03b3-glutamyltranspeptidase", "GENE_OR_GENE_PRODUCT", 161, 185], ["serum alkaline phosphatase", "PROTEIN", 79, 105], ["\u03b3-glutamyltranspeptidase", "PROTEIN", 161, 185], ["cats", "SPECIES", 9, 13], ["Affected cats", "PROBLEM", 0, 13], ["hyperbilirubinemia", "PROBLEM", 29, 47], ["a significant increase in serum alkaline phosphatase activity", "PROBLEM", 53, 114], ["modest increases in \u03b3-glutamyltranspeptidase activity", "PROBLEM", 141, 194], ["this syndrome", "PROBLEM", 224, 237], ["hyperbilirubinemia", "OBSERVATION", 29, 47], ["significant", "OBSERVATION_MODIFIER", 55, 66], ["increase", "OBSERVATION_MODIFIER", 67, 75], ["serum", "OBSERVATION_MODIFIER", 79, 84], ["alkaline phosphatase activity", "OBSERVATION", 85, 114], ["normal", "OBSERVATION", 131, 137], ["modest", "OBSERVATION_MODIFIER", 141, 147], ["increases", "OBSERVATION_MODIFIER", 148, 157], ["\u03b3-glutamyltranspeptidase activity", "OBSERVATION", 161, 194]]], ["Untreated, the mortality rate is high.", [["the mortality rate", "TEST", 11, 29], ["high", "OBSERVATION_MODIFIER", 33, 37]]], ["The liver has diffuse, macrovesicular or microvesicular steatosis, by definition affecting >50% of hepatocytes.", [["liver", "ANATOMY", 4, 9], ["macrovesicular", "ANATOMY", 23, 37], ["microvesicular", "ANATOMY", 41, 55], ["hepatocytes", "ANATOMY", 99, 110], ["steatosis", "DISEASE", 56, 65], ["liver", "ORGAN", 4, 9], ["hepatocytes", "CELL", 99, 110], ["hepatocytes", "CELL_TYPE", 99, 110], ["diffuse, macrovesicular or microvesicular steatosis", "PROBLEM", 14, 65], ["liver", "ANATOMY", 4, 9], ["diffuse", "OBSERVATION_MODIFIER", 14, 21], ["macrovesicular", "OBSERVATION_MODIFIER", 23, 37], ["microvesicular steatosis", "OBSERVATION", 41, 65], ["hepatocytes", "ANATOMY", 99, 110]]], ["Focal or zonal lipid accumulation in <50% of the parenchyma is considered more likely to be physiologic, or associated with other systemic abnormalities, rather than idiopathic feline hepatic steatosis.", [["parenchyma", "ANATOMY", 49, 59], ["hepatic", "ANATOMY", 184, 191], ["feline hepatic steatosis", "DISEASE", 177, 201], ["parenchyma", "TISSUE", 49, 59], ["feline", "ORGANISM", 177, 183], ["hepatic", "ORGAN", 184, 191], ["Focal or zonal lipid accumulation", "PROBLEM", 0, 33], ["other systemic abnormalities", "PROBLEM", 124, 152], ["idiopathic feline hepatic steatosis", "PROBLEM", 166, 201], ["zonal", "OBSERVATION_MODIFIER", 9, 14], ["lipid accumulation", "OBSERVATION", 15, 33], ["parenchyma", "ANATOMY", 49, 59], ["considered more likely", "UNCERTAINTY", 63, 85], ["physiologic", "OBSERVATION", 92, 103], ["systemic", "OBSERVATION_MODIFIER", 130, 138], ["abnormalities", "OBSERVATION", 139, 152], ["rather than", "UNCERTAINTY", 154, 165], ["idiopathic", "OBSERVATION_MODIFIER", 166, 176], ["hepatic", "ANATOMY", 184, 191], ["steatosis", "OBSERVATION", 192, 201]]], ["Bile pigment accumulates in canaliculi or Kupffer cells and can be confused with lipofuscin and ceroid.274.e1The pathogenesis of hepatocellular triglyceride accumulation in this disease is obscure, and likely multifactorial, involving increased mobilization and uptake of nonesterified fatty acids by the liver, alterations in formation and release of VLDL, and impaired oxidation of fatty acids within hepatocytes.", [["Bile pigment", "ANATOMY", 0, 12], ["canaliculi", "ANATOMY", 28, 38], ["Kupffer cells", "ANATOMY", 42, 55], ["hepatocellular", "ANATOMY", 129, 143], ["liver", "ANATOMY", 305, 310], ["hepatocytes", "ANATOMY", 403, 414], ["lipofuscin", "CHEMICAL", 81, 91], ["ceroid", "DISEASE", 96, 102], ["triglyceride", "CHEMICAL", 144, 156], ["nonesterified fatty acids", "CHEMICAL", 272, 297], ["fatty acids", "CHEMICAL", 384, 395], ["triglyceride", "CHEMICAL", 144, 156], ["nonesterified fatty acids", "CHEMICAL", 272, 297], ["fatty acids", "CHEMICAL", 384, 395], ["Bile pigment", "TISSUE", 0, 12], ["canaliculi", "ORGANISM_SUBSTANCE", 28, 38], ["Kupffer cells", "CELL", 42, 55], ["lipofuscin", "SIMPLE_CHEMICAL", 81, 91], ["hepatocellular", "PATHOLOGICAL_FORMATION", 129, 143], ["triglyceride", "SIMPLE_CHEMICAL", 144, 156], ["nonesterified fatty acids", "SIMPLE_CHEMICAL", 272, 297], ["liver", "ORGAN", 305, 310], ["VLDL", "SIMPLE_CHEMICAL", 352, 356], ["fatty acids", "SIMPLE_CHEMICAL", 384, 395], ["hepatocytes", "CELL", 403, 414], ["Kupffer cells", "CELL_TYPE", 42, 55], ["hepatocytes", "CELL_TYPE", 403, 414], ["Bile pigment accumulates in canaliculi or Kupffer cells", "PROBLEM", 0, 55], ["lipofuscin", "PROBLEM", 81, 91], ["hepatocellular triglyceride accumulation", "PROBLEM", 129, 169], ["this disease", "PROBLEM", 173, 185], ["increased mobilization", "PROBLEM", 235, 257], ["nonesterified fatty acids", "TEST", 272, 297], ["VLDL", "TEST", 352, 356], ["impaired oxidation of fatty acids within hepatocytes", "PROBLEM", 362, 414], ["pigment", "OBSERVATION", 5, 12], ["canaliculi", "ANATOMY_MODIFIER", 28, 38], ["Kupffer cells", "OBSERVATION", 42, 55], ["ceroid", "OBSERVATION", 96, 102], ["hepatocellular", "ANATOMY", 129, 143], ["triglyceride accumulation", "OBSERVATION", 144, 169], ["disease", "OBSERVATION", 178, 185], ["likely", "UNCERTAINTY", 202, 208], ["multifactorial", "OBSERVATION_MODIFIER", 209, 223], ["increased", "OBSERVATION_MODIFIER", 235, 244], ["mobilization", "OBSERVATION_MODIFIER", 245, 257], ["fatty acids", "OBSERVATION", 286, 297], ["liver", "ANATOMY", 305, 310], ["VLDL", "ANATOMY", 352, 356], ["impaired", "OBSERVATION_MODIFIER", 362, 370], ["oxidation", "OBSERVATION_MODIFIER", 371, 380], ["fatty acids", "OBSERVATION", 384, 395], ["hepatocytes", "ANATOMY", 403, 414]]], ["Ultrastructural studies have demonstrated decreased numbers and abnormal morphology of hepatic peroxisomes as well as mitochondria, both of which are important in the oxidization of fatty acids, but whether these changes are significant or simply adaptive responses is unknown.", [["hepatic peroxisomes", "ANATOMY", 87, 106], ["mitochondria", "ANATOMY", 118, 130], ["fatty acids", "CHEMICAL", 182, 193], ["fatty acids", "CHEMICAL", 182, 193], ["hepatic peroxisomes", "MULTI-TISSUE_STRUCTURE", 87, 106], ["mitochondria", "CELLULAR_COMPONENT", 118, 130], ["fatty acids", "SIMPLE_CHEMICAL", 182, 193], ["Ultrastructural studies", "TEST", 0, 23], ["decreased numbers", "PROBLEM", 42, 59], ["abnormal morphology of hepatic peroxisomes", "PROBLEM", 64, 106], ["fatty acids", "TREATMENT", 182, 193], ["decreased", "OBSERVATION_MODIFIER", 42, 51], ["numbers", "OBSERVATION_MODIFIER", 52, 59], ["abnormal", "OBSERVATION_MODIFIER", 64, 72], ["morphology", "OBSERVATION_MODIFIER", 73, 83], ["hepatic", "ANATOMY", 87, 94], ["peroxisomes", "ANATOMY_MODIFIER", 95, 106]]], ["Starvation may reduce the availability of proteins, choline, and other precursors necessary for lipoprotein synthesis.274.e1Severe hepatic steatosis can also develop in cats, concurrent with or secondary to other major medical problems such as diabetes mellitus, which alter metabolism of fat.", [["hepatic", "ANATOMY", 131, 138], ["fat", "ANATOMY", 289, 292], ["choline", "CHEMICAL", 52, 59], ["274.e1", "CHEMICAL", 118, 124], ["hepatic steatosis", "DISEASE", 131, 148], ["diabetes mellitus", "DISEASE", 244, 261], ["choline", "CHEMICAL", 52, 59], ["choline", "SIMPLE_CHEMICAL", 52, 59], ["lipoprotein", "SIMPLE_CHEMICAL", 96, 107], ["hepatic", "ORGAN", 131, 138], ["cats", "ORGANISM", 169, 173], ["fat", "TISSUE", 289, 292], ["cats", "SPECIES", 169, 173], ["Starvation", "TREATMENT", 0, 10], ["choline", "TREATMENT", 52, 59], ["lipoprotein synthesis", "PROBLEM", 96, 117], ["Severe hepatic steatosis", "PROBLEM", 124, 148], ["other major medical problems", "PROBLEM", 207, 235], ["diabetes mellitus", "PROBLEM", 244, 261], ["hepatic", "ANATOMY", 131, 138], ["steatosis", "OBSERVATION", 139, 148], ["diabetes", "OBSERVATION", 244, 252], ["fat", "ANATOMY", 289, 292]]], ["Acute pancreatitis appears to be an important predisposing disease to secondary hepatic steatosis in cats-an association with clinical significance as it has a poorer prognosis than uncomplicated idiopathic hepatic steatosis.", [["hepatic", "ANATOMY", 80, 87], ["hepatic", "ANATOMY", 207, 214], ["pancreatitis", "DISEASE", 6, 18], ["hepatic steatosis", "DISEASE", 80, 97], ["idiopathic hepatic steatosis", "DISEASE", 196, 224], ["hepatic steatosis", "PATHOLOGICAL_FORMATION", 80, 97], ["cats", "ORGANISM", 101, 105], ["hepatic", "ORGAN", 207, 214], ["Acute pancreatitis", "PROBLEM", 0, 18], ["an important predisposing disease", "PROBLEM", 33, 66], ["secondary hepatic steatosis in cats", "PROBLEM", 70, 105], ["uncomplicated idiopathic hepatic steatosis", "PROBLEM", 182, 224], ["pancreatitis", "OBSERVATION", 6, 18], ["disease", "OBSERVATION", 59, 66], ["secondary", "OBSERVATION_MODIFIER", 70, 79], ["hepatic", "ANATOMY", 80, 87], ["steatosis", "OBSERVATION", 88, 97], ["idiopathic", "OBSERVATION_MODIFIER", 196, 206], ["hepatic", "ANATOMY", 207, 214], ["steatosis", "OBSERVATION", 215, 224]]], ["Secondary hepatic steatosis has also been reported with concurrent inflammatory liver disease, such as cholangitis, renal disease, small intestinal disease, neoplasia, and hyperthyroidism.", [["hepatic", "ANATOMY", 10, 17], ["liver", "ANATOMY", 80, 85], ["renal", "ANATOMY", 116, 121], ["intestinal", "ANATOMY", 137, 147], ["neoplasia", "ANATOMY", 157, 166], ["Secondary hepatic steatosis", "DISEASE", 0, 27], ["inflammatory liver disease", "DISEASE", 67, 93], ["cholangitis", "DISEASE", 103, 114], ["renal disease", "DISEASE", 116, 129], ["intestinal disease", "DISEASE", 137, 155], ["neoplasia", "DISEASE", 157, 166], ["hyperthyroidism", "DISEASE", 172, 187], ["hepatic", "ORGAN", 10, 17], ["liver", "ORGAN", 80, 85], ["renal", "ORGAN", 116, 121], ["intestinal", "ORGAN", 137, 147], ["neoplasia", "CANCER", 157, 166], ["Secondary hepatic steatosis", "PROBLEM", 0, 27], ["concurrent inflammatory liver disease", "PROBLEM", 56, 93], ["cholangitis", "PROBLEM", 103, 114], ["renal disease", "PROBLEM", 116, 129], ["small intestinal disease", "PROBLEM", 131, 155], ["neoplasia", "PROBLEM", 157, 166], ["hyperthyroidism", "PROBLEM", 172, 187], ["hepatic", "ANATOMY", 10, 17], ["steatosis", "OBSERVATION", 18, 27], ["inflammatory", "OBSERVATION_MODIFIER", 67, 79], ["liver", "ANATOMY", 80, 85], ["disease", "OBSERVATION", 86, 93], ["cholangitis", "OBSERVATION", 103, 114], ["renal", "ANATOMY", 116, 121], ["disease", "OBSERVATION", 122, 129], ["small", "OBSERVATION_MODIFIER", 131, 136], ["intestinal", "ANATOMY", 137, 147], ["disease", "OBSERVATION", 148, 155], ["neoplasia", "OBSERVATION", 157, 166], ["hyperthyroidism", "OBSERVATION", 172, 187]]], ["Familial hyperlipoproteinemia has been described in cats, associated with congenital lipoprotein lipase deficiency.", [["Familial hyperlipoproteinemia", "DISEASE", 0, 29], ["congenital lipoprotein lipase deficiency", "DISEASE", 74, 114], ["cats", "ORGANISM", 52, 56], ["lipoprotein lipase", "GENE_OR_GENE_PRODUCT", 85, 103], ["lipoprotein lipase", "PROTEIN", 85, 103], ["cats", "SPECIES", 52, 56], ["Familial hyperlipoproteinemia", "PROBLEM", 0, 29], ["congenital lipoprotein lipase deficiency", "PROBLEM", 74, 114], ["hyperlipoproteinemia", "OBSERVATION", 9, 29], ["congenital", "OBSERVATION_MODIFIER", 74, 84], ["lipoprotein lipase deficiency", "OBSERVATION", 85, 114]]], ["The condition is characterized by lipid vacuoles and ceroid accumulation in liver, spleen, lymph nodes, kidney and adrenal lipid fractions are also elevated, with visible prominent lipemia and hepatic steatosis.", [["lipid vacuoles", "ANATOMY", 34, 48], ["liver", "ANATOMY", 76, 81], ["spleen", "ANATOMY", 83, 89], ["lymph nodes", "ANATOMY", 91, 102], ["kidney", "ANATOMY", 104, 110], ["adrenal lipid fractions", "ANATOMY", 115, 138], ["hepatic", "ANATOMY", 193, 200], ["ceroid", "DISEASE", 53, 59], ["lipemia", "DISEASE", 181, 188], ["hepatic steatosis", "DISEASE", 193, 210], ["lipid vacuoles", "CELLULAR_COMPONENT", 34, 48], ["liver", "ORGAN", 76, 81], ["spleen", "ORGAN", 83, 89], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 91, 102], ["kidney", "ORGAN", 104, 110], ["adrenal", "ORGAN", 115, 122], ["lipid fractions", "ORGANISM_SUBSTANCE", 123, 138], ["hepatic steatosis", "PATHOLOGICAL_FORMATION", 193, 210], ["lipid vacuoles", "TEST", 34, 48], ["ceroid accumulation in liver, spleen, lymph nodes, kidney and adrenal lipid fractions", "PROBLEM", 53, 138], ["elevated", "PROBLEM", 148, 156], ["visible prominent lipemia", "PROBLEM", 163, 188], ["hepatic steatosis", "PROBLEM", 193, 210], ["lipid vacuoles", "OBSERVATION", 34, 48], ["ceroid accumulation", "OBSERVATION", 53, 72], ["liver", "ANATOMY", 76, 81], ["spleen", "ANATOMY", 83, 89], ["lymph nodes", "OBSERVATION", 91, 102], ["kidney", "ANATOMY", 104, 110], ["adrenal", "ANATOMY", 115, 122], ["lipid fractions", "OBSERVATION", 123, 138], ["elevated", "OBSERVATION_MODIFIER", 148, 156], ["visible", "OBSERVATION_MODIFIER", 163, 170], ["prominent", "OBSERVATION_MODIFIER", 171, 180], ["lipemia", "OBSERVATION", 181, 188], ["hepatic", "ANATOMY", 193, 200], ["steatosis", "OBSERVATION", 201, 210]]], ["A negative energy balance is a key feature.", [["negative", "OBSERVATION", 2, 10], ["energy balance", "OBSERVATION", 11, 25]]], ["Pregnant or lactating mares are most likely to develop the disease, particularly if they are older, excessively fat, and have recently suffered reduced feed intake because of onset of parturition, conditions such as laminitis or parasitism, or other causes of stress.", [["fat", "ANATOMY", 112, 115], ["laminitis", "DISEASE", 216, 225], ["parasitism", "DISEASE", 229, 239], ["mares", "ORGANISM", 22, 27], ["fat", "TISSUE", 112, 115], ["the disease", "PROBLEM", 55, 66], ["reduced feed intake", "PROBLEM", 144, 163], ["parturition, conditions", "PROBLEM", 184, 207], ["laminitis", "PROBLEM", 216, 225], ["parasitism", "PROBLEM", 229, 239], ["stress", "PROBLEM", 260, 266], ["most likely", "UNCERTAINTY", 32, 43], ["disease", "OBSERVATION", 59, 66], ["parasitism", "OBSERVATION", 229, 239]]], ["The clinical course is marked by somnolence, complete anorexia, and colic, progressing to mania in some cases, although most simply become progressively more depressed.", [["somnolence", "DISEASE", 33, 43], ["anorexia", "DISEASE", 54, 62], ["colic", "DISEASE", 68, 73], ["mania", "DISEASE", 90, 95], ["depressed", "DISEASE", 158, 167], ["somnolence", "PROBLEM", 33, 43], ["complete anorexia", "PROBLEM", 45, 62], ["colic", "PROBLEM", 68, 73], ["mania", "PROBLEM", 90, 95], ["marked", "OBSERVATION_MODIFIER", 23, 29], ["somnolence", "OBSERVATION", 33, 43], ["anorexia", "OBSERVATION", 54, 62], ["colic", "ANATOMY", 68, 73], ["progressively", "OBSERVATION_MODIFIER", 139, 152], ["more", "OBSERVATION_MODIFIER", 153, 157], ["depressed", "OBSERVATION", 158, 167]]], ["Some ponies develop ventral subcutaneous edema and most develop moderate diarrhea.", [["ventral subcutaneous edema", "ANATOMY", 20, 46], ["subcutaneous edema", "DISEASE", 28, 46], ["diarrhea", "DISEASE", 73, 81], ["ponies", "ORGANISM", 5, 11], ["subcutaneous edema", "PATHOLOGICAL_FORMATION", 28, 46], ["Some ponies", "PROBLEM", 0, 11], ["ventral subcutaneous edema", "PROBLEM", 20, 46], ["moderate diarrhea", "PROBLEM", 64, 81], ["ponies", "OBSERVATION_MODIFIER", 5, 11], ["ventral", "ANATOMY_MODIFIER", 20, 27], ["subcutaneous", "ANATOMY", 28, 40], ["edema", "OBSERVATION", 41, 46], ["moderate", "OBSERVATION_MODIFIER", 64, 72], ["diarrhea", "OBSERVATION", 73, 81]]], ["Metabolic acidosis is a consistent feature in animals that die.274.e1The liver at autopsy is severely fatty and may have ruptured; the steatosis also extends to heart and skeletal muscle, kidney, and adrenal cortex.", [["liver", "ANATOMY", 73, 78], ["heart", "ANATOMY", 161, 166], ["skeletal muscle", "ANATOMY", 171, 186], ["kidney", "ANATOMY", 188, 194], ["adrenal cortex", "ANATOMY", 200, 214], ["Metabolic acidosis", "DISEASE", 0, 18], ["steatosis", "DISEASE", 135, 144], ["liver", "ORGAN", 73, 78], ["heart", "ORGAN", 161, 166], ["skeletal muscle", "TISSUE", 171, 186], ["kidney", "ORGAN", 188, 194], ["adrenal cortex", "MULTI-TISSUE_STRUCTURE", 200, 214], ["Metabolic acidosis", "PROBLEM", 0, 18], ["severely fatty", "PROBLEM", 93, 107], ["ruptured", "PROBLEM", 121, 129], ["the steatosis", "PROBLEM", 131, 144], ["acidosis", "OBSERVATION", 10, 18], ["liver", "ANATOMY", 73, 78], ["autopsy", "OBSERVATION", 82, 89], ["severely", "OBSERVATION_MODIFIER", 93, 101], ["fatty", "OBSERVATION", 102, 107], ["ruptured", "OBSERVATION_MODIFIER", 121, 129], ["steatosis", "OBSERVATION", 135, 144], ["heart", "ANATOMY", 161, 166], ["skeletal muscle", "ANATOMY", 171, 186], ["kidney", "ANATOMY", 188, 194], ["adrenal", "ANATOMY", 200, 207], ["cortex", "ANATOMY_MODIFIER", 208, 214]]], ["The hepatic steatosis is remarkable only by its severity; there may be some focal hepatocellular necrosis, and there is consistent prolongation of bromosulfophthalein retention times and elevation of serum alkaline phosphatase levels.", [["hepatic", "ANATOMY", 4, 11], ["hepatocellular", "ANATOMY", 82, 96], ["serum", "ANATOMY", 200, 205], ["hepatic steatosis", "DISEASE", 4, 21], ["focal hepatocellular necrosis", "DISEASE", 76, 105], ["bromosulfophthalein", "CHEMICAL", 147, 166], ["bromosulfophthalein", "CHEMICAL", 147, 166], ["hepatic", "ORGAN", 4, 11], ["hepatocellular", "CANCER", 82, 96], ["bromosulfophthalein", "SIMPLE_CHEMICAL", 147, 166], ["serum", "ORGANISM_SUBSTANCE", 200, 205], ["alkaline phosphatase", "GENE_OR_GENE_PRODUCT", 206, 226], ["serum alkaline phosphatase", "PROTEIN", 200, 226], ["The hepatic steatosis", "PROBLEM", 0, 21], ["some focal hepatocellular necrosis", "PROBLEM", 71, 105], ["bromosulfophthalein retention times", "PROBLEM", 147, 182], ["serum alkaline phosphatase levels", "TEST", 200, 233], ["hepatic", "ANATOMY", 4, 11], ["steatosis", "OBSERVATION", 12, 21], ["severity", "OBSERVATION_MODIFIER", 48, 56], ["may be", "UNCERTAINTY", 64, 70], ["some", "OBSERVATION_MODIFIER", 71, 75], ["focal", "OBSERVATION_MODIFIER", 76, 81], ["hepatocellular", "OBSERVATION_MODIFIER", 82, 96], ["necrosis", "OBSERVATION", 97, 105], ["consistent", "UNCERTAINTY", 120, 130], ["prolongation", "OBSERVATION_MODIFIER", 131, 143], ["bromosulfophthalein retention", "OBSERVATION", 147, 176], ["elevation", "OBSERVATION_MODIFIER", 187, 196], ["alkaline phosphatase", "OBSERVATION_MODIFIER", 206, 226]]], ["Evidence of disseminated intravascular coagulation is seen as serosal hemorrhages and microscopic thrombi in various organs, and even gross infarction of myocardium and kidney.", [["intravascular", "ANATOMY", 25, 38], ["serosal", "ANATOMY", 62, 69], ["thrombi", "ANATOMY", 98, 105], ["organs", "ANATOMY", 117, 123], ["myocardium", "ANATOMY", 154, 164], ["kidney", "ANATOMY", 169, 175], ["intravascular coagulation", "DISEASE", 25, 50], ["hemorrhages", "DISEASE", 70, 81], ["thrombi", "DISEASE", 98, 105], ["infarction", "DISEASE", 140, 150], ["intravascular", "IMMATERIAL_ANATOMICAL_ENTITY", 25, 38], ["serosal hemorrhages", "PATHOLOGICAL_FORMATION", 62, 81], ["organs", "ORGAN", 117, 123], ["myocardium", "MULTI-TISSUE_STRUCTURE", 154, 164], ["kidney", "ORGAN", 169, 175], ["disseminated intravascular coagulation", "PROBLEM", 12, 50], ["serosal hemorrhages", "PROBLEM", 62, 81], ["microscopic thrombi in various organs", "PROBLEM", 86, 123], ["gross infarction of myocardium and kidney", "PROBLEM", 134, 175], ["disseminated", "OBSERVATION_MODIFIER", 12, 24], ["intravascular coagulation", "OBSERVATION", 25, 50], ["serosal", "ANATOMY", 62, 69], ["hemorrhages", "OBSERVATION", 70, 81], ["microscopic", "OBSERVATION_MODIFIER", 86, 97], ["thrombi", "OBSERVATION", 98, 105], ["various", "ANATOMY_MODIFIER", 109, 116], ["organs", "ANATOMY", 117, 123], ["gross", "OBSERVATION_MODIFIER", 134, 139], ["infarction", "OBSERVATION", 140, 150], ["myocardium", "ANATOMY", 154, 164], ["kidney", "ANATOMY", 169, 175]]], ["Small lipid emboli may be detected in frozen sections of lung, myocardium, and brain in these animals; their relationship to the microthrombosis is uncertain.274.e1The pathogenesis of this disease is obscure.", [["lipid emboli", "ANATOMY", 6, 18], ["sections", "ANATOMY", 45, 53], ["lung", "ANATOMY", 57, 61], ["myocardium", "ANATOMY", 63, 73], ["brain", "ANATOMY", 79, 84], ["microthrombosis", "DISEASE", 129, 144], ["lipid emboli", "PATHOLOGICAL_FORMATION", 6, 18], ["lung", "ORGAN", 57, 61], ["myocardium", "MULTI-TISSUE_STRUCTURE", 63, 73], ["brain", "ORGAN", 79, 84], ["Small lipid emboli", "PROBLEM", 0, 18], ["the microthrombosis", "PROBLEM", 125, 144], ["this disease", "PROBLEM", 184, 196], ["lipid emboli", "OBSERVATION", 6, 18], ["may be detected", "UNCERTAINTY", 19, 34], ["frozen sections", "OBSERVATION", 38, 53], ["lung", "ANATOMY", 57, 61], ["myocardium", "ANATOMY", 63, 73], ["brain", "ANATOMY", 79, 84], ["microthrombosis", "OBSERVATION", 129, 144], ["disease", "OBSERVATION", 189, 196]]], ["Because the excess lipid in liver and blood is in the form of triglyceride, the implication is that the liver is capable of esterifying fatty acid mobilized from depot fat.", [["liver", "ANATOMY", 28, 33], ["blood", "ANATOMY", 38, 43], ["liver", "ANATOMY", 104, 109], ["depot fat", "ANATOMY", 162, 171], ["triglyceride", "CHEMICAL", 62, 74], ["fatty acid", "CHEMICAL", 136, 146], ["triglyceride", "CHEMICAL", 62, 74], ["fatty acid", "CHEMICAL", 136, 146], ["lipid", "SIMPLE_CHEMICAL", 19, 24], ["liver", "ORGAN", 28, 33], ["blood", "ORGANISM_SUBSTANCE", 38, 43], ["triglyceride", "SIMPLE_CHEMICAL", 62, 74], ["liver", "ORGAN", 104, 109], ["esterifying fatty acid", "SIMPLE_CHEMICAL", 124, 146], ["depot fat", "TISSUE", 162, 171], ["the excess lipid in liver", "PROBLEM", 8, 33], ["triglyceride", "TEST", 62, 74], ["esterifying fatty acid", "PROBLEM", 124, 146], ["excess lipid", "OBSERVATION", 12, 24], ["liver", "ANATOMY", 28, 33], ["blood", "ANATOMY", 38, 43], ["liver", "ANATOMY", 104, 109], ["depot fat", "OBSERVATION", 162, 171]]], ["The triglyceride thus formed is presumably then exported to the plasma as VLDL.", [["plasma", "ANATOMY", 64, 70], ["triglyceride", "CHEMICAL", 4, 16], ["triglyceride", "CHEMICAL", 4, 16], ["triglyceride", "SIMPLE_CHEMICAL", 4, 16], ["plasma", "ORGANISM_SUBSTANCE", 64, 70], ["VLDL", "SIMPLE_CHEMICAL", 74, 78], ["The triglyceride", "TEST", 0, 16]]], ["It is believed that the primary cause of hyperlipemia is increased production via an increased rate of adipocyte lipolysis, leading to fatty acids and glycerol being released into the bloodstream and the increased hepatic synthesis of triglyceride as VLDL, rather than reduced clearance of VLDL from the serum.", [["adipocyte", "ANATOMY", 103, 112], ["bloodstream", "ANATOMY", 184, 195], ["hepatic", "ANATOMY", 214, 221], ["serum", "ANATOMY", 304, 309], ["hyperlipemia", "DISEASE", 41, 53], ["fatty acids", "CHEMICAL", 135, 146], ["glycerol", "CHEMICAL", 151, 159], ["triglyceride", "CHEMICAL", 235, 247], ["fatty acids", "CHEMICAL", 135, 146], ["glycerol", "CHEMICAL", 151, 159], ["triglyceride", "CHEMICAL", 235, 247], ["adipocyte", "CELL", 103, 112], ["fatty acids", "SIMPLE_CHEMICAL", 135, 146], ["glycerol", "SIMPLE_CHEMICAL", 151, 159], ["hepatic", "MULTI-TISSUE_STRUCTURE", 214, 221], ["triglyceride", "SIMPLE_CHEMICAL", 235, 247], ["VLDL", "SIMPLE_CHEMICAL", 251, 255], ["VLDL", "SIMPLE_CHEMICAL", 290, 294], ["serum", "ORGANISM_SUBSTANCE", 304, 309], ["VLDL", "PROTEIN", 290, 294], ["hyperlipemia", "PROBLEM", 41, 53], ["increased production", "PROBLEM", 57, 77], ["adipocyte lipolysis", "TREATMENT", 103, 122], ["fatty acids", "TREATMENT", 135, 146], ["glycerol", "TREATMENT", 151, 159], ["the increased hepatic synthesis of triglyceride", "PROBLEM", 200, 247], ["reduced clearance of VLDL", "PROBLEM", 269, 294], ["the serum", "TEST", 300, 309], ["hyperlipemia", "OBSERVATION", 41, 53], ["increased", "OBSERVATION_MODIFIER", 57, 66], ["increased", "OBSERVATION_MODIFIER", 85, 94], ["adipocyte lipolysis", "OBSERVATION", 103, 122], ["bloodstream", "ANATOMY", 184, 195], ["increased", "OBSERVATION_MODIFIER", 204, 213], ["hepatic", "ANATOMY", 214, 221]]], ["Another possibility is that there is an inability on the part of all tissues other than the liver to use fatty acids from VLDL at the normal rate, whereas triglyceride synthesis from fatty acids continues in the liver.", [["tissues", "ANATOMY", 69, 76], ["liver", "ANATOMY", 92, 97], ["liver", "ANATOMY", 212, 217], ["fatty acids", "CHEMICAL", 105, 116], ["triglyceride", "CHEMICAL", 155, 167], ["fatty acids", "CHEMICAL", 183, 194], ["fatty acids", "CHEMICAL", 105, 116], ["triglyceride", "CHEMICAL", 155, 167], ["fatty acids", "CHEMICAL", 183, 194], ["tissues", "TISSUE", 69, 76], ["liver", "ORGAN", 92, 97], ["fatty acids", "AMINO_ACID", 105, 116], ["VLDL", "SIMPLE_CHEMICAL", 122, 126], ["triglyceride", "SIMPLE_CHEMICAL", 155, 167], ["fatty acids", "SIMPLE_CHEMICAL", 183, 194], ["liver", "ORGAN", 212, 217], ["an inability", "PROBLEM", 37, 49], ["fatty acids", "TEST", 105, 116], ["VLDL", "TEST", 122, 126], ["triglyceride synthesis", "TEST", 155, 177], ["fatty acids", "TEST", 183, 194], ["liver", "ANATOMY", 92, 97], ["normal rate", "OBSERVATION_MODIFIER", 134, 145], ["fatty acids", "OBSERVATION", 183, 194], ["liver", "ANATOMY", 212, 217]]], ["In any event, at this stage lipids begin to accumulate in hepatocytes.274.e1It has been proposed that an underlying cause of pony hyperlipemia is a comparative resistance to insulin in susceptible animals, and that this is compounded in stressful episodes by increased levels of circulating cortisol.", [["hepatocytes", "ANATOMY", 58, 69], ["274.e1", "CHEMICAL", 70, 76], ["hyperlipemia", "DISEASE", 130, 142], ["cortisol", "CHEMICAL", 291, 299], ["cortisol", "CHEMICAL", 291, 299], ["lipids", "SIMPLE_CHEMICAL", 28, 34], ["hepatocytes", "CELL", 58, 69], ["pony", "ORGANISM_SUBDIVISION", 125, 129], ["insulin", "GENE_OR_GENE_PRODUCT", 174, 181], ["cortisol", "GENE_OR_GENE_PRODUCT", 291, 299], ["hepatocytes", "CELL_TYPE", 58, 69], ["insulin", "PROTEIN", 174, 181], ["this stage lipids", "TREATMENT", 17, 34], ["pony hyperlipemia", "PROBLEM", 125, 142], ["insulin", "TREATMENT", 174, 181], ["stressful episodes", "PROBLEM", 237, 255], ["increased levels of circulating cortisol", "PROBLEM", 259, 299], ["hepatocytes", "ANATOMY", 58, 69], ["pony hyperlipemia", "OBSERVATION", 125, 142]]], ["Various steroid hormones, including glucocorticoids, have been shown to interfere with insulin action, and hyperlipemic ponies often have elevated plasma insulin levels, which suggests reduced function of insulin receptors.", [["plasma", "ANATOMY", 147, 153], ["steroid", "CHEMICAL", 8, 15], ["glucocorticoids", "CHEMICAL", 36, 51], ["steroid", "CHEMICAL", 8, 15], ["insulin", "GENE_OR_GENE_PRODUCT", 87, 94], ["hyperlipemic ponies", "ORGANISM", 107, 126], ["plasma", "ORGANISM_SUBSTANCE", 147, 153], ["insulin", "GENE_OR_GENE_PRODUCT", 154, 161], ["insulin receptors", "GENE_OR_GENE_PRODUCT", 205, 222], ["insulin receptors", "PROTEIN", 205, 222], ["Various steroid hormones", "TREATMENT", 0, 24], ["glucocorticoids", "TREATMENT", 36, 51], ["insulin action", "TREATMENT", 87, 101], ["hyperlipemic ponies", "PROBLEM", 107, 126], ["elevated plasma insulin levels", "PROBLEM", 138, 168], ["insulin receptors", "TREATMENT", 205, 222], ["steroid hormones", "OBSERVATION", 8, 24], ["reduced function", "OBSERVATION", 185, 201]]], ["However, plasma ketones are much less consistently elevated, which appears to be characteristic of equids; this suggests that the increased ketogenesis that one might expect in insulin resistance is not a typical feature in horses.274.e1Hepatic steatosis is common in companion animals.", [["plasma", "ANATOMY", 9, 15], ["ketones", "CHEMICAL", 16, 23], ["steatosis", "DISEASE", 245, 254], ["ketones", "CHEMICAL", 16, 23], ["plasma", "ORGANISM_SUBSTANCE", 9, 15], ["ketones", "SIMPLE_CHEMICAL", 16, 23], ["insulin", "GENE_OR_GENE_PRODUCT", 177, 184], ["horses", "ORGANISM_SUBDIVISION", 224, 230], ["plasma ketones", "TEST", 9, 23], ["the increased ketogenesis", "PROBLEM", 126, 151], ["insulin resistance", "PROBLEM", 177, 195], ["steatosis", "PROBLEM", 245, 254], ["plasma ketones", "OBSERVATION", 9, 23], ["appears to be", "UNCERTAINTY", 67, 80], ["increased", "OBSERVATION_MODIFIER", 130, 139], ["ketogenesis", "OBSERVATION", 140, 151], ["insulin resistance", "OBSERVATION", 177, 195], ["steatosis", "OBSERVATION", 245, 254], ["common", "OBSERVATION_MODIFIER", 258, 264]]], ["Following periods of stress or fasting, toy-breed dogs can develop profound hypoglycemia and a striking microvesicular hepatic steatosis.", [["hepatic", "ANATOMY", 119, 126], ["hypoglycemia", "DISEASE", 76, 88], ["steatosis", "DISEASE", 127, 136], ["dogs", "ORGANISM", 50, 54], ["microvesicular", "PATHOLOGICAL_FORMATION", 104, 118], ["hepatic steatosis", "PATHOLOGICAL_FORMATION", 119, 136], ["dogs", "SPECIES", 50, 54], ["stress or fasting", "PROBLEM", 21, 38], ["profound hypoglycemia", "PROBLEM", 67, 88], ["a striking microvesicular hepatic steatosis", "PROBLEM", 93, 136], ["profound", "OBSERVATION_MODIFIER", 67, 75], ["hypoglycemia", "OBSERVATION", 76, 88], ["striking", "OBSERVATION_MODIFIER", 95, 103], ["microvesicular", "OBSERVATION_MODIFIER", 104, 118], ["hepatic", "ANATOMY", 119, 126], ["steatosis", "OBSERVATION", 127, 136]]], ["This may be the result of poor homeostasis of blood glucose levels.", [["blood", "ANATOMY", 46, 51], ["glucose", "CHEMICAL", 52, 59], ["glucose", "CHEMICAL", 52, 59], ["blood", "ORGANISM_SUBSTANCE", 46, 51], ["glucose", "SIMPLE_CHEMICAL", 52, 59], ["poor homeostasis of blood glucose levels", "PROBLEM", 26, 66]]], ["Most often, affected pups die from cerebral complications of hypoglycemia, but significant liver dysfunction also occurs.", [["cerebral", "ANATOMY", 35, 43], ["liver", "ANATOMY", 91, 96], ["cerebral complications", "DISEASE", 35, 57], ["hypoglycemia", "DISEASE", 61, 73], ["liver dysfunction", "DISEASE", 91, 108], ["pups", "ORGANISM_SUBDIVISION", 21, 25], ["cerebral", "ORGAN", 35, 43], ["liver", "ORGAN", 91, 96], ["cerebral complications", "PROBLEM", 35, 57], ["hypoglycemia", "PROBLEM", 61, 73], ["significant liver dysfunction", "PROBLEM", 79, 108], ["cerebral", "ANATOMY", 35, 43], ["complications", "OBSERVATION", 44, 57], ["hypoglycemia", "OBSERVATION", 61, 73], ["significant", "OBSERVATION_MODIFIER", 79, 90], ["liver", "ANATOMY", 91, 96], ["dysfunction", "OBSERVATION", 97, 108]]], ["Dogs eating diets deficient in vitamin E may develop severe hepatic steatosis, but there are many circumstances in companion animals where the exact cause for individual cases of steatosis cannot be determined. deficiency) in dogs, and \u03b1-mannosidosis in cats.", [["hepatic", "ANATOMY", 60, 67], ["vitamin E", "CHEMICAL", 31, 40], ["hepatic steatosis", "DISEASE", 60, 77], ["steatosis", "DISEASE", 179, 188], ["\u03b1-mannosidosis", "DISEASE", 236, 250], ["vitamin E", "CHEMICAL", 31, 40], ["Dogs", "ORGANISM", 0, 4], ["vitamin E", "SIMPLE_CHEMICAL", 31, 40], ["hepatic steatosis", "PATHOLOGICAL_FORMATION", 60, 77], ["dogs", "ORGANISM", 226, 230], ["cats", "ORGANISM", 254, 258], ["dogs", "SPECIES", 226, 230], ["cats", "SPECIES", 254, 258], ["vitamin E", "TREATMENT", 31, 40], ["severe hepatic steatosis", "PROBLEM", 53, 77], ["steatosis", "PROBLEM", 179, 188], ["deficiency) in dogs", "PROBLEM", 211, 230], ["severe", "OBSERVATION_MODIFIER", 53, 59], ["hepatic", "ANATOMY", 60, 67], ["steatosis", "OBSERVATION", 68, 77], ["steatosis", "OBSERVATION", 179, 188]]], ["1, Nervous system.274.e1Hepatic phospholipidosis is an excessive accumulation of phospholipids within the cytoplasm of hepatocytes.", [["Nervous system", "ANATOMY", 3, 17], ["cytoplasm", "ANATOMY", 106, 115], ["hepatocytes", "ANATOMY", 119, 130], ["phospholipids", "SIMPLE_CHEMICAL", 81, 94], ["cytoplasm", "ORGANISM_SUBSTANCE", 106, 115], ["hepatocytes", "CELL", 119, 130], ["hepatocytes", "CELL_TYPE", 119, 130], ["phospholipidosis", "PROBLEM", 32, 48], ["an excessive accumulation of phospholipids", "PROBLEM", 52, 94], ["Nervous system", "ANATOMY", 3, 17], ["excessive", "OBSERVATION_MODIFIER", 55, 64], ["accumulation of phospholipids", "OBSERVATION", 65, 94], ["hepatocytes", "ANATOMY", 119, 130]]], ["This condition is an acquired storage disorder caused by some therapeutic drugs and chemicals, including amiodarone and chlorphentermine.", [["storage disorder", "DISEASE", 30, 46], ["amiodarone", "CHEMICAL", 105, 115], ["chlorphentermine", "CHEMICAL", 120, 136], ["amiodarone", "CHEMICAL", 105, 115], ["chlorphentermine", "CHEMICAL", 120, 136], ["amiodarone", "SIMPLE_CHEMICAL", 105, 115], ["chlorphentermine", "SIMPLE_CHEMICAL", 120, 136], ["an acquired storage disorder", "PROBLEM", 18, 46], ["some therapeutic drugs", "TREATMENT", 57, 79], ["chemicals", "TREATMENT", 84, 93], ["amiodarone", "TREATMENT", 105, 115], ["chlorphentermine", "TREATMENT", 120, 136]]], ["Despite the diversity of agents capable of causing phospholipidosis, most of these are cationic amphipathic molecules.", [["phospholipidosis", "DISEASE", 51, 67], ["cationic amphipathic molecules", "PROTEIN", 87, 117], ["agents", "TREATMENT", 25, 31], ["phospholipidosis", "PROBLEM", 51, 67], ["cationic amphipathic molecules", "PROBLEM", 87, 117], ["amphipathic molecules", "OBSERVATION", 96, 117]]], ["Mechanistically, phospholipidosis is caused by cationic amphipathic molecules binding to cellular phospholipids and inhibiting complete digestion by lysosomal phospholipase A1, A2, or C within lysosomes; although less often, direct inhibition of phospholipase can occur, as in the case of gentamicin.", [["cellular", "ANATOMY", 89, 97], ["lysosomal", "ANATOMY", 149, 158], ["lysosomes", "ANATOMY", 193, 202], ["phospholipidosis", "DISEASE", 17, 33], ["gentamicin", "CHEMICAL", 289, 299], ["gentamicin", "CHEMICAL", 289, 299], ["cellular", "CELL", 89, 97], ["lysosomal phospholipase A1", "GENE_OR_GENE_PRODUCT", 149, 175], ["A2", "GENE_OR_GENE_PRODUCT", 177, 179], ["C", "GENE_OR_GENE_PRODUCT", 184, 185], ["lysosomes", "CELLULAR_COMPONENT", 193, 202], ["phospholipase", "GENE_OR_GENE_PRODUCT", 246, 259], ["gentamicin", "SIMPLE_CHEMICAL", 289, 299], ["cationic amphipathic molecules", "PROTEIN", 47, 77], ["lysosomal phospholipase A1", "PROTEIN", 149, 175], ["A2", "PROTEIN", 177, 179], ["phospholipase", "PROTEIN", 246, 259], ["phospholipidosis", "PROBLEM", 17, 33], ["cationic amphipathic molecules binding", "PROBLEM", 47, 85], ["cellular phospholipids", "TEST", 89, 111], ["complete digestion", "PROBLEM", 127, 145], ["lysosomal phospholipase A1", "TEST", 149, 175], ["C within lysosomes", "PROBLEM", 184, 202], ["direct inhibition of phospholipase", "PROBLEM", 225, 259], ["gentamicin", "TREATMENT", 289, 299], ["phospholipidosis", "OBSERVATION", 17, 33]]], ["This leads to an accumulation of lysosomal phospholipids that can develop acutely or only following long-term drug administration.", [["lysosomal", "ANATOMY", 33, 42], ["lysosomal phospholipids", "SIMPLE_CHEMICAL", 33, 56], ["lysosomal phospholipids", "TREATMENT", 33, 56], ["long-term drug administration", "TREATMENT", 100, 129], ["accumulation", "OBSERVATION_MODIFIER", 17, 29], ["lysosomal phospholipids", "OBSERVATION", 33, 56]]], ["The histologic appearance of phospholipidosis can be quite variable, but typically, hepatocellular and Kupffer cell cytoplasm contains numerous round clear vacuoles that are smaller than the diameter of the nucleus or larger, imparting a foamy appearance to the cytoplasm.", [["hepatocellular", "ANATOMY", 84, 98], ["Kupffer cell cytoplasm", "ANATOMY", 103, 125], ["vacuoles", "ANATOMY", 156, 164], ["nucleus", "ANATOMY", 207, 214], ["cytoplasm", "ANATOMY", 262, 271], ["phospholipidosis", "DISEASE", 29, 45], ["hepatocellular", "CANCER", 84, 98], ["Kupffer cell", "CELL", 103, 115], ["cytoplasm", "ORGANISM_SUBSTANCE", 116, 125], ["vacuoles", "CELLULAR_COMPONENT", 156, 164], ["nucleus", "CELLULAR_COMPONENT", 207, 214], ["cytoplasm", "ORGANISM_SUBSTANCE", 262, 271], ["phospholipidosis", "PROBLEM", 29, 45], ["Kupffer cell cytoplasm", "TEST", 103, 125], ["numerous round clear vacuoles", "PROBLEM", 135, 164], ["phospholipidosis", "OBSERVATION", 29, 45], ["hepatocellular", "ANATOMY", 84, 98], ["Kupffer cell cytoplasm", "OBSERVATION", 103, 125], ["numerous", "OBSERVATION_MODIFIER", 135, 143], ["round", "OBSERVATION_MODIFIER", 144, 149], ["clear vacuoles", "OBSERVATION", 150, 164], ["smaller", "OBSERVATION_MODIFIER", 174, 181], ["diameter", "OBSERVATION_MODIFIER", 191, 199], ["nucleus", "ANATOMY_MODIFIER", 207, 214], ["larger", "OBSERVATION_MODIFIER", 218, 224], ["foamy", "OBSERVATION_MODIFIER", 238, 243], ["cytoplasm", "OBSERVATION_MODIFIER", 262, 271]]], ["Fine vacuoles are most often apparent adjacent to canaliculi.", [["vacuoles", "ANATOMY", 5, 13], ["canaliculi", "ANATOMY", 50, 60], ["Fine vacuoles", "CELLULAR_COMPONENT", 0, 13], ["canaliculi", "MULTI-TISSUE_STRUCTURE", 50, 60], ["vacuoles", "OBSERVATION", 5, 13], ["most often", "OBSERVATION_MODIFIER", 18, 28], ["canaliculi", "ANATOMY", 50, 60]]], ["Biliary epithelium can also be affected, with or without hepatocellular involvement.", [["Biliary epithelium", "ANATOMY", 0, 18], ["hepatocellular", "ANATOMY", 57, 71], ["Biliary epithelium", "TISSUE", 0, 18], ["hepatocellular", "CANCER", 57, 71], ["Biliary epithelium", "PROBLEM", 0, 18], ["hepatocellular involvement", "PROBLEM", 57, 83], ["epithelium", "OBSERVATION", 8, 18], ["without", "UNCERTAINTY", 49, 56], ["hepatocellular", "ANATOMY", 57, 71]]], ["The clear vacuoles can be confused with microvesicular steatosis, and in most cases, ultrastructural examination is needed to identify phospholipidosis with certainty.", [["vacuoles", "ANATOMY", 10, 18], ["steatosis", "DISEASE", 55, 64], ["phospholipidosis", "DISEASE", 135, 151], ["vacuoles", "ORGANISM_SUBSTANCE", 10, 18], ["confused", "PROBLEM", 26, 34], ["microvesicular steatosis", "PROBLEM", 40, 64], ["ultrastructural examination", "TEST", 85, 112], ["phospholipidosis", "PROBLEM", 135, 151], ["clear vacuoles", "OBSERVATION", 4, 18], ["microvesicular", "OBSERVATION_MODIFIER", 40, 54], ["steatosis", "OBSERVATION", 55, 64]]], ["At the ultrastructural level, there is a characteristic multilaminated whorl of material with a \"fingerprint\" pattern, termed myeloid bodies, within affected lysosomes.AmyloidosisIn most species, hepatic amyloidosis is usually part of generalized amyloidosis.", [["myeloid bodies", "ANATOMY", 126, 140], ["lysosomes", "ANATOMY", 158, 167], ["hepatic", "ANATOMY", 196, 203], ["hepatic amyloidosis", "DISEASE", 196, 215], ["amyloidosis", "DISEASE", 247, 258], ["myeloid bodies", "CELLULAR_COMPONENT", 126, 140], ["lysosomes", "CELLULAR_COMPONENT", 158, 167], ["hepatic", "ORGAN", 196, 203], ["a characteristic multilaminated whorl of material", "PROBLEM", 39, 88], ["a \"fingerprint\" pattern", "PROBLEM", 94, 117], ["termed myeloid bodies", "PROBLEM", 119, 140], ["affected lysosomes", "PROBLEM", 149, 167], ["AmyloidosisIn most species", "PROBLEM", 168, 194], ["hepatic amyloidosis", "PROBLEM", 196, 215], ["generalized amyloidosis", "PROBLEM", 235, 258], ["characteristic", "OBSERVATION_MODIFIER", 41, 55], ["multilaminated", "OBSERVATION_MODIFIER", 56, 70], ["whorl", "OBSERVATION_MODIFIER", 71, 76], ["myeloid bodies", "OBSERVATION", 126, 140], ["affected", "OBSERVATION_MODIFIER", 149, 157], ["lysosomes", "OBSERVATION_MODIFIER", 158, 167], ["hepatic", "ANATOMY", 196, 203], ["amyloidosis", "OBSERVATION", 204, 215], ["generalized", "OBSERVATION_MODIFIER", 235, 246], ["amyloidosis", "OBSERVATION", 247, 258]]], ["Systemic amyloidosis of domestic animals is typically associated with overproduction of amyloid A (AA), an amino-terminal fragment of serum amyloid A, a highly inducible acute-phase protein in most species.", [["serum", "ANATOMY", 134, 139], ["amyloidosis", "DISEASE", 9, 20], ["AA", "CHEMICAL", 99, 101], ["amino", "CHEMICAL", 107, 112], ["amyloid A", "SIMPLE_CHEMICAL", 88, 97], ["AA", "SIMPLE_CHEMICAL", 99, 101], ["serum", "ORGANISM_SUBSTANCE", 134, 139], ["amyloid A", "GENE_OR_GENE_PRODUCT", 140, 149], ["amyloid A", "PROTEIN", 88, 97], ["amino-terminal fragment", "PROTEIN", 107, 130], ["serum amyloid A", "PROTEIN", 134, 149], ["acute-phase protein", "PROTEIN", 170, 189], ["Systemic amyloidosis of domestic animals", "PROBLEM", 0, 40], ["amyloid A (AA)", "PROBLEM", 88, 102], ["an amino-terminal fragment of serum amyloid A", "PROBLEM", 104, 149], ["a highly inducible acute-phase protein in most species", "PROBLEM", 151, 205], ["amyloidosis", "OBSERVATION", 9, 20], ["domestic animals", "OBSERVATION", 24, 40], ["amyloid", "OBSERVATION", 88, 95], ["-terminal fragment", "OBSERVATION", 112, 130], ["serum amyloid", "OBSERVATION", 134, 147], ["acute", "OBSERVATION_MODIFIER", 170, 175], ["most species", "OBSERVATION_MODIFIER", 193, 205]]], ["In humans, AA amyloidosis occurs either as a familial trait (familial Mediterranean fever), or secondary to a sustained acute-phase reaction in chronic inflammatory or neoplastic diseases.", [["neoplastic", "ANATOMY", 168, 178], ["AA", "CHEMICAL", 11, 13], ["amyloidosis", "DISEASE", 14, 25], ["familial Mediterranean fever", "DISEASE", 61, 89], ["neoplastic diseases", "DISEASE", 168, 187], ["humans", "ORGANISM", 3, 9], ["humans", "SPECIES", 3, 9], ["humans", "SPECIES", 3, 9], ["AA amyloidosis", "PROBLEM", 11, 25], ["a familial trait (familial Mediterranean fever", "PROBLEM", 43, 89], ["a sustained acute-phase reaction", "PROBLEM", 108, 140], ["chronic inflammatory or neoplastic diseases", "PROBLEM", 144, 187], ["amyloidosis", "OBSERVATION", 14, 25], ["acute", "OBSERVATION_MODIFIER", 120, 125], ["chronic", "OBSERVATION_MODIFIER", 144, 151], ["inflammatory", "OBSERVATION_MODIFIER", 152, 164], ["neoplastic diseases", "OBSERVATION", 168, 187]]], ["Amyloid infiltration of the liver occurs sporadically in cattle, horses, dogs, and cats as a secondary response to chronic disease or tissuedestructive process.", [["liver", "ANATOMY", 28, 33], ["Amyloid infiltration of the liver", "DISEASE", 0, 33], ["liver", "ORGAN", 28, 33], ["horses", "ORGANISM_SUBDIVISION", 65, 71], ["dogs", "ORGANISM", 73, 77], ["cats", "ORGANISM", 83, 87], ["cattle", "SPECIES", 57, 63], ["dogs", "SPECIES", 73, 77], ["cats", "SPECIES", 83, 87], ["cattle", "SPECIES", 57, 63], ["Amyloid infiltration of the liver", "PROBLEM", 0, 33], ["chronic disease", "PROBLEM", 115, 130], ["tissuedestructive process", "PROBLEM", 134, 159], ["infiltration", "OBSERVATION", 8, 20], ["liver", "ANATOMY", 28, 33], ["chronic", "OBSERVATION_MODIFIER", 115, 122], ["disease", "OBSERVATION", 123, 130], ["tissuedestructive process", "OBSERVATION", 134, 159]]], ["In horses, hepatic amyloidosis occurs chiefly as a result of chronic inflammation and has been well recognized in horses used for the production of hyperimmune serum.", [["hepatic", "ANATOMY", 11, 18], ["serum", "ANATOMY", 160, 165], ["hepatic amyloidosis", "DISEASE", 11, 30], ["inflammation", "DISEASE", 69, 81], ["hepatic", "ORGAN", 11, 18], ["horses", "ORGANISM", 114, 120], ["hyperimmune", "ORGANISM", 148, 159], ["serum", "ORGANISM_SUBSTANCE", 160, 165], ["hepatic amyloidosis", "PROBLEM", 11, 30], ["chronic inflammation", "PROBLEM", 61, 81], ["hyperimmune serum", "PROBLEM", 148, 165], ["hepatic", "ANATOMY", 11, 18], ["amyloidosis", "OBSERVATION", 19, 30], ["chronic", "OBSERVATION_MODIFIER", 61, 68], ["inflammation", "OBSERVATION", 69, 81]]], ["Horses may develop icterus and other signs of hepatic failure, but cattle die first of the primary disease or from uremia resulting from concurrent renal amyloidosis.", [["hepatic", "ANATOMY", 46, 53], ["renal", "ANATOMY", 148, 153], ["icterus", "DISEASE", 19, 26], ["hepatic failure", "DISEASE", 46, 61], ["primary disease", "DISEASE", 91, 106], ["uremia", "DISEASE", 115, 121], ["renal amyloidosis", "DISEASE", 148, 165], ["Horses", "ORGANISM", 0, 6], ["hepatic", "ORGAN", 46, 53], ["renal", "ORGAN", 148, 153], ["cattle", "SPECIES", 67, 73], ["cattle", "SPECIES", 67, 73], ["icterus", "PROBLEM", 19, 26], ["hepatic failure", "PROBLEM", 46, 61], ["the primary disease", "PROBLEM", 87, 106], ["uremia", "PROBLEM", 115, 121], ["concurrent renal amyloidosis", "PROBLEM", 137, 165], ["icterus", "OBSERVATION", 19, 26], ["hepatic", "ANATOMY", 46, 53], ["failure", "OBSERVATION", 54, 61], ["primary", "OBSERVATION_MODIFIER", 91, 98], ["disease", "OBSERVATION", 99, 106], ["uremia", "OBSERVATION", 115, 121], ["renal", "ANATOMY", 148, 153], ["amyloidosis", "OBSERVATION", 154, 165]]], ["Dogs and cats typically develop signs of renal dysfunction, although cats may be presented with spontaneous hepatic rupture.", [["renal", "ANATOMY", 41, 46], ["hepatic", "ANATOMY", 108, 115], ["renal dysfunction", "DISEASE", 41, 58], ["hepatic rupture", "DISEASE", 108, 123], ["Dogs", "ORGANISM", 0, 4], ["cats", "ORGANISM", 9, 13], ["renal", "ORGAN", 41, 46], ["cats", "ORGANISM", 69, 73], ["hepatic", "ORGAN", 108, 115], ["Dogs", "SPECIES", 0, 4], ["cats", "SPECIES", 9, 13], ["cats", "SPECIES", 69, 73], ["renal dysfunction", "PROBLEM", 41, 58], ["spontaneous hepatic rupture", "PROBLEM", 96, 123], ["renal", "ANATOMY", 41, 46], ["dysfunction", "OBSERVATION", 47, 58], ["hepatic", "ANATOMY", 108, 115], ["rupture", "OBSERVATION", 116, 123]]], ["Familial AA amyloidosis is recognized in Chinese Shar-Pei dogs.", [["AA amyloidosis", "DISEASE", 9, 23], ["dogs", "ORGANISM", 58, 62], ["dogs", "SPECIES", 58, 62], ["Familial AA amyloidosis", "PROBLEM", 0, 23], ["amyloidosis", "OBSERVATION", 12, 23]]], ["The condition resembles familial Mediterranean fever in humans, and is characterized by febrile episodes, swollen hock syndrome, and the development of renal and sometimes hepatic amyloidosis.", [["renal", "ANATOMY", 152, 157], ["hepatic", "ANATOMY", 172, 179], ["familial Mediterranean fever", "DISEASE", 24, 52], ["febrile episodes", "DISEASE", 88, 104], ["swollen hock syndrome", "DISEASE", 106, 127], ["renal and sometimes hepatic amyloidosis", "DISEASE", 152, 191], ["humans", "ORGANISM", 56, 62], ["renal", "ORGAN", 152, 157], ["hepatic", "ORGAN", 172, 179], ["humans", "SPECIES", 56, 62], ["humans", "SPECIES", 56, 62], ["familial Mediterranean fever", "PROBLEM", 24, 52], ["febrile episodes", "PROBLEM", 88, 104], ["swollen hock syndrome", "PROBLEM", 106, 127], ["renal and sometimes hepatic amyloidosis", "PROBLEM", 152, 191], ["familial", "OBSERVATION_MODIFIER", 24, 32], ["Mediterranean", "OBSERVATION_MODIFIER", 33, 46], ["fever", "OBSERVATION", 47, 52], ["febrile", "OBSERVATION_MODIFIER", 88, 95], ["swollen", "OBSERVATION_MODIFIER", 106, 113], ["hock syndrome", "OBSERVATION", 114, 127], ["renal", "ANATOMY", 152, 157], ["hepatic", "ANATOMY", 172, 179], ["amyloidosis", "OBSERVATION", 180, 191]]], ["Familial AA amyloidosis is also recognized in Abyssinian cats and suspected in Siamese and Oriental cats.AmyloidosisAffected livers in horses are pale, enlarged with rounded edges, friable, and prone to fracture; in cattle, affected livers may be firm.", [["livers", "ANATOMY", 125, 131], ["livers", "ANATOMY", 233, 239], ["AA amyloidosis", "DISEASE", 9, 23], ["Amyloidosis", "DISEASE", 105, 116], ["fracture", "DISEASE", 203, 211], ["cats", "ORGANISM", 57, 61], ["cats", "ORGANISM", 100, 104], ["livers", "ORGAN", 125, 131], ["cattle", "ORGANISM", 216, 222], ["livers", "ORGAN", 233, 239], ["cats", "SPECIES", 57, 61], ["cats", "SPECIES", 100, 104], ["cattle", "SPECIES", 216, 222], ["cattle", "SPECIES", 216, 222], ["Familial AA amyloidosis", "PROBLEM", 0, 23], ["AmyloidosisAffected livers in horses", "PROBLEM", 105, 141], ["pale", "PROBLEM", 146, 150], ["rounded edges", "PROBLEM", 166, 179], ["friable", "PROBLEM", 181, 188], ["fracture", "PROBLEM", 203, 211], ["firm", "PROBLEM", 247, 251], ["amyloidosis", "OBSERVATION", 12, 23], ["livers", "ANATOMY", 125, 131], ["horses", "OBSERVATION_MODIFIER", 135, 141], ["pale", "OBSERVATION_MODIFIER", 146, 150], ["enlarged", "OBSERVATION_MODIFIER", 152, 160], ["rounded", "OBSERVATION_MODIFIER", 166, 173], ["edges", "OBSERVATION_MODIFIER", 174, 179], ["friable", "OBSERVATION_MODIFIER", 181, 188], ["fracture", "OBSERVATION", 203, 211], ["livers", "ANATOMY", 233, 239], ["may be", "UNCERTAINTY", 240, 246], ["firm", "OBSERVATION", 247, 251]]], ["Affected livers in all species are predisposed to rupture and bleeding (eFig.", [["livers", "ANATOMY", 9, 15], ["rupture", "DISEASE", 50, 57], ["bleeding", "DISEASE", 62, 70], ["livers", "ORGAN", 9, 15], ["Affected livers in all species", "PROBLEM", 0, 30], ["rupture", "PROBLEM", 50, 57], ["bleeding (eFig", "PROBLEM", 62, 76], ["livers", "ANATOMY", 9, 15], ["all species", "OBSERVATION", 19, 30], ["predisposed to", "UNCERTAINTY", 35, 49], ["rupture", "OBSERVATION", 50, 57], ["bleeding", "OBSERVATION", 62, 70]]], ["Amyloid is deposited first in the parenchyma about the portal tracts and appears gray and waxy.", [["parenchyma", "ANATOMY", 34, 44], ["portal tracts", "ANATOMY", 55, 68], ["Amyloid", "DISEASE", 0, 7], ["Amyloid", "GENE_OR_GENE_PRODUCT", 0, 7], ["parenchyma", "TISSUE", 34, 44], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 55, 68], ["Amyloid", "PROBLEM", 0, 7], ["deposited", "OBSERVATION", 11, 20], ["parenchyma", "ANATOMY_MODIFIER", 34, 44], ["portal tracts", "ANATOMY", 55, 68], ["appears", "UNCERTAINTY", 73, 80], ["gray", "OBSERVATION_MODIFIER", 81, 85], ["waxy", "OBSERVATION_MODIFIER", 90, 94]]], ["Amyloid is deposited in the perisinusoidal space between the sinusoidal lining and hepatocytes and is sometimes found in the walls of the afferent vessels.", [["perisinusoidal space", "ANATOMY", 28, 48], ["sinusoidal lining", "ANATOMY", 61, 78], ["hepatocytes", "ANATOMY", 83, 94], ["walls", "ANATOMY", 125, 130], ["afferent vessels", "ANATOMY", 138, 154], ["Amyloid", "DISEASE", 0, 7], ["Amyloid", "GENE_OR_GENE_PRODUCT", 0, 7], ["sinusoidal lining", "TISSUE", 61, 78], ["hepatocytes", "CELL", 83, 94], ["afferent vessels", "MULTI-TISSUE_STRUCTURE", 138, 154], ["hepatocytes", "CELL_TYPE", 83, 94], ["Amyloid", "PROBLEM", 0, 7], ["deposited", "OBSERVATION", 11, 20], ["perisinusoidal", "ANATOMY_MODIFIER", 28, 42], ["sinusoidal", "ANATOMY_MODIFIER", 61, 71], ["lining", "ANATOMY_MODIFIER", 72, 78], ["hepatocytes", "ANATOMY", 83, 94], ["walls", "ANATOMY_MODIFIER", 125, 130], ["afferent", "ANATOMY_MODIFIER", 138, 146], ["vessels", "ANATOMY", 147, 154]]], ["The surrounded glands, multifocal xanthomas, and focal arterial degenerative changes.", [["glands", "ANATOMY", 15, 21], ["xanthomas", "ANATOMY", 34, 43], ["focal arterial", "ANATOMY", 49, 63], ["xanthomas", "DISEASE", 34, 43], ["glands", "ORGAN", 15, 21], ["xanthomas", "PATHOLOGICAL_FORMATION", 34, 43], ["arterial", "MULTI-TISSUE_STRUCTURE", 55, 63], ["multifocal xanthomas", "PROBLEM", 23, 43], ["focal arterial degenerative changes", "PROBLEM", 49, 84], ["glands", "ANATOMY", 15, 21], ["multifocal", "OBSERVATION_MODIFIER", 23, 33], ["xanthomas", "OBSERVATION", 34, 43], ["focal", "OBSERVATION_MODIFIER", 49, 54], ["arterial", "ANATOMY", 55, 63], ["degenerative", "OBSERVATION", 64, 76]]], ["An autosomal recessive mode of inheritance is suspected.", [["autosomal recessive mode of inheritance", "DISEASE", 3, 42], ["An autosomal recessive mode of inheritance", "PROBLEM", 0, 42], ["autosomal", "OBSERVATION_MODIFIER", 3, 12], ["recessive", "OBSERVATION", 13, 22]]], ["Primary idiopathic hyperlipidemia has also been reported in Miniature Schnauzer dogs and Beagles, although the metabolic defect has not been identified.", [["idiopathic hyperlipidemia", "DISEASE", 8, 33], ["Schnauzer dogs", "ORGANISM", 70, 84], ["dogs", "SPECIES", 80, 84], ["Primary idiopathic hyperlipidemia", "PROBLEM", 0, 33], ["the metabolic defect", "PROBLEM", 107, 127], ["idiopathic", "OBSERVATION_MODIFIER", 8, 18], ["hyperlipidemia", "OBSERVATION", 19, 33], ["metabolic defect", "OBSERVATION", 111, 127]]], ["Affected dogs have fasting lipemia, elevated plasma VLDL, and may have hyperchylomicronemia.", [["plasma", "ANATOMY", 45, 51], ["fasting lipemia", "DISEASE", 19, 34], ["hyperchylomicronemia", "DISEASE", 71, 91], ["dogs", "ORGANISM", 9, 13], ["plasma", "ORGANISM_SUBSTANCE", 45, 51], ["VLDL", "SIMPLE_CHEMICAL", 52, 56], ["dogs", "SPECIES", 9, 13], ["Affected dogs", "PROBLEM", 0, 13], ["fasting lipemia", "PROBLEM", 19, 34], ["elevated plasma VLDL", "PROBLEM", 36, 56], ["hyperchylomicronemia", "PROBLEM", 71, 91], ["lipemia", "OBSERVATION", 27, 34], ["hyperchylomicronemia", "OBSERVATION", 71, 91]]], ["Affected animals may develop severe vacuolar hepatopathy associated with both glycogen and triglyceride accumulation, with eventual stromal collapse and regenerative nodule formation.", [["vacuolar", "ANATOMY", 36, 44], ["stromal", "ANATOMY", 132, 139], ["nodule", "ANATOMY", 166, 172], ["hepatopathy", "DISEASE", 45, 56], ["glycogen", "CHEMICAL", 78, 86], ["triglyceride", "CHEMICAL", 91, 103], ["triglyceride", "CHEMICAL", 91, 103], ["animals", "ORGANISM", 9, 16], ["vacuolar", "ORGANISM_SUBSTANCE", 36, 44], ["glycogen", "SIMPLE_CHEMICAL", 78, 86], ["triglyceride", "SIMPLE_CHEMICAL", 91, 103], ["stromal", "TISSUE", 132, 139], ["nodule", "PATHOLOGICAL_FORMATION", 166, 172], ["Affected animals", "PROBLEM", 0, 16], ["severe vacuolar hepatopathy", "PROBLEM", 29, 56], ["both glycogen and triglyceride accumulation", "PROBLEM", 73, 116], ["eventual stromal collapse", "PROBLEM", 123, 148], ["regenerative nodule formation", "PROBLEM", 153, 182], ["severe", "OBSERVATION_MODIFIER", 29, 35], ["vacuolar hepatopathy", "OBSERVATION", 36, 56], ["triglyceride accumulation", "OBSERVATION", 91, 116], ["stromal collapse", "OBSERVATION", 132, 148], ["regenerative", "OBSERVATION_MODIFIER", 153, 165], ["nodule", "OBSERVATION", 166, 172]]], ["There is also an association between hyperlipidemia and gallbladder mucocele.AmyloidosisAn incompletely characterized condition known as hepatic lipodystrophy has been recognized in pedigree Galloway calves since 1965.", [["gallbladder mucocele", "ANATOMY", 56, 76], ["hepatic", "ANATOMY", 137, 144], ["hyperlipidemia", "DISEASE", 37, 51], ["gallbladder mucocele", "DISEASE", 56, 76], ["hepatic lipodystrophy", "DISEASE", 137, 158], ["gallbladder mucocele", "PATHOLOGICAL_FORMATION", 56, 76], ["hepatic", "ORGAN", 137, 144], ["calves", "SPECIES", 200, 206], ["hyperlipidemia", "PROBLEM", 37, 51], ["gallbladder mucocele", "PROBLEM", 56, 76], ["hepatic lipodystrophy", "PROBLEM", 137, 158], ["hyperlipidemia", "OBSERVATION", 37, 51], ["gallbladder", "ANATOMY", 56, 67], ["mucocele", "OBSERVATION", 68, 76], ["hepatic", "ANATOMY", 137, 144], ["lipodystrophy", "OBSERVATION", 145, 158]]], ["Calves initially appear normal but develop lethargy, tremors, and opisthotonos, and die by 5 months of age.", [["lethargy", "DISEASE", 43, 51], ["tremors", "DISEASE", 53, 60], ["opisthotonos", "DISEASE", 66, 78], ["Calves", "ORGANISM", 0, 6], ["Calves", "SPECIES", 0, 6], ["lethargy", "PROBLEM", 43, 51], ["tremors", "PROBLEM", 53, 60], ["normal", "OBSERVATION", 24, 30], ["lethargy", "OBSERVATION", 43, 51]]], ["On postmortem examination, affected calves have an enlarged, pale, mottled liver.", [["liver", "ANATOMY", 75, 80], ["calves", "ORGANISM", 36, 42], ["liver", "ORGAN", 75, 80], ["calves", "SPECIES", 36, 42], ["postmortem examination", "TEST", 3, 25], ["affected calves", "PROBLEM", 27, 42], ["an enlarged, pale, mottled liver", "PROBLEM", 48, 80], ["enlarged", "OBSERVATION", 51, 59], ["pale", "OBSERVATION", 61, 65], ["mottled", "OBSERVATION", 67, 74], ["liver", "ANATOMY", 75, 80]]], ["Histologically, there is marked hepatic steatosis with portal fibrosis and ductular reaction ( Fig. 2-26 ).", [["hepatic", "ANATOMY", 32, 39], ["portal", "ANATOMY", 55, 61], ["ductular", "ANATOMY", 75, 83], ["steatosis", "DISEASE", 40, 49], ["fibrosis", "DISEASE", 62, 70], ["hepatic steatosis", "PATHOLOGICAL_FORMATION", 32, 49], ["portal", "MULTI-TISSUE_STRUCTURE", 55, 61], ["ductular", "ORGAN", 75, 83], ["marked hepatic steatosis", "PROBLEM", 25, 49], ["portal fibrosis", "PROBLEM", 55, 70], ["ductular reaction", "PROBLEM", 75, 92], ["marked", "OBSERVATION_MODIFIER", 25, 31], ["hepatic", "ANATOMY", 32, 39], ["steatosis", "OBSERVATION", 40, 49], ["portal", "ANATOMY", 55, 61], ["fibrosis", "OBSERVATION", 62, 70], ["ductular", "ANATOMY_MODIFIER", 75, 83]]], ["Vacuolar changes in the white matter of the brain are consistent with hepatic encephalopathy.", [["Vacuolar", "ANATOMY", 0, 8], ["white matter", "ANATOMY", 24, 36], ["brain", "ANATOMY", 44, 49], ["hepatic", "ANATOMY", 70, 77], ["hepatic encephalopathy", "DISEASE", 70, 92], ["Vacuolar", "CELLULAR_COMPONENT", 0, 8], ["brain", "ORGAN", 44, 49], ["hepatic", "ORGAN", 70, 77], ["Vacuolar changes in the white matter of the brain", "PROBLEM", 0, 49], ["hepatic encephalopathy", "PROBLEM", 70, 92], ["white matter", "ANATOMY_MODIFIER", 24, 36], ["brain", "ANATOMY", 44, 49], ["consistent with", "UNCERTAINTY", 54, 69], ["hepatic", "ANATOMY", 70, 77], ["encephalopathy", "OBSERVATION", 78, 92]]], ["A metabolic defect has been proposed.Lysosomal storage diseasesIn common with other tissues in animals with a heritable deficiency of specific lysosomal enzymes, liver cells may accumulate substrates normally catabolized by the missing enzyme.", [["Lysosomal", "ANATOMY", 37, 46], ["tissues", "ANATOMY", 84, 91], ["lysosomal", "ANATOMY", 143, 152], ["liver cells", "ANATOMY", 162, 173], ["Lysosomal storage diseases", "DISEASE", 37, 63], ["tissues", "TISSUE", 84, 91], ["liver cells", "CELL", 162, 173], ["lysosomal enzymes", "PROTEIN", 143, 160], ["liver cells", "CELL_TYPE", 162, 173], ["A metabolic defect", "PROBLEM", 0, 18], ["Lysosomal storage diseases", "PROBLEM", 37, 63], ["a heritable deficiency of specific lysosomal enzymes", "PROBLEM", 108, 160], ["liver cells", "PROBLEM", 162, 173], ["the missing enzyme", "TEST", 224, 242], ["metabolic defect", "OBSERVATION", 2, 18], ["storage diseases", "OBSERVATION", 47, 63], ["heritable", "OBSERVATION_MODIFIER", 110, 119], ["deficiency", "OBSERVATION", 120, 130], ["liver", "ANATOMY", 162, 167]]], ["These lysosomal stores can be less obvious in the liver than in other tissues such as the central nervous system, and although they are unlikely to affect hepatic function, they can sometimes be recognized in liver biopsies (eFig.", [["lysosomal", "ANATOMY", 6, 15], ["liver", "ANATOMY", 50, 55], ["tissues", "ANATOMY", 70, 77], ["central nervous system", "ANATOMY", 90, 112], ["hepatic", "ANATOMY", 155, 162], ["liver biopsies", "ANATOMY", 209, 223], ["lysosomal", "CELLULAR_COMPONENT", 6, 15], ["liver", "ORGAN", 50, 55], ["tissues", "TISSUE", 70, 77], ["central nervous system", "ANATOMICAL_SYSTEM", 90, 112], ["hepatic", "ORGAN", 155, 162], ["liver biopsies", "MULTI-TISSUE_STRUCTURE", 209, 223], ["liver biopsies", "TEST", 209, 223], ["eFig", "TEST", 225, 229], ["lysosomal stores", "OBSERVATION", 6, 22], ["less", "OBSERVATION_MODIFIER", 30, 34], ["obvious", "OBSERVATION_MODIFIER", 35, 42], ["liver", "ANATOMY", 50, 55], ["central", "ANATOMY_MODIFIER", 90, 97], ["nervous system", "ANATOMY", 98, 112], ["hepatic", "ANATOMY", 155, 162], ["liver", "ANATOMY", 209, 214], ["biopsies", "OBSERVATION", 215, 223]]], ["However, hydropic and fatty changes in hepatocytes can obscure or lead to misidentification of lysosomal storage vacuoles.", [["hepatocytes", "ANATOMY", 39, 50], ["lysosomal storage vacuoles", "ANATOMY", 95, 121], ["hepatocytes", "CELL", 39, 50], ["lysosomal", "CELLULAR_COMPONENT", 95, 104], ["vacuoles", "CELLULAR_COMPONENT", 113, 121], ["hepatocytes", "CELL_TYPE", 39, 50], ["hydropic and fatty changes in hepatocytes", "PROBLEM", 9, 50], ["lysosomal storage vacuoles", "PROBLEM", 95, 121], ["hydropic", "OBSERVATION", 9, 17], ["fatty changes", "OBSERVATION", 22, 35], ["hepatocytes", "ANATOMY", 39, 50], ["lysosomal storage vacuoles", "OBSERVATION", 95, 121]]], ["Kupffer cells and bile duct epithelium may be more severely affected than hepatocytes, which have additional catabolic and excretory pathways, including the ability for lysosomal exocytosis into the bile canaliculi.", [["Kupffer cells", "ANATOMY", 0, 13], ["bile duct epithelium", "ANATOMY", 18, 38], ["hepatocytes", "ANATOMY", 74, 85], ["lysosomal", "ANATOMY", 169, 178], ["bile canaliculi", "ANATOMY", 199, 214], ["Kupffer cells", "CELL", 0, 13], ["bile duct epithelium", "TISSUE", 18, 38], ["hepatocytes", "CELL", 74, 85], ["lysosomal", "CELLULAR_COMPONENT", 169, 178], ["bile canaliculi", "MULTI-TISSUE_STRUCTURE", 199, 214], ["Kupffer cells", "CELL_TYPE", 0, 13], ["hepatocytes", "CELL_TYPE", 74, 85], ["severely affected than hepatocytes", "PROBLEM", 51, 85], ["additional catabolic and excretory pathways", "PROBLEM", 98, 141], ["lysosomal exocytosis into the bile canaliculi", "PROBLEM", 169, 214], ["bile duct", "ANATOMY", 18, 27], ["more severely", "OBSERVATION_MODIFIER", 46, 59], ["affected", "OBSERVATION", 60, 68], ["bile canaliculi", "ANATOMY", 199, 214]]], ["In animals with ceroid lipofuscinosis, lysosomal storage is minimal in hepatocytes compared to that in the brain.", [["lysosomal", "ANATOMY", 39, 48], ["hepatocytes", "ANATOMY", 71, 82], ["brain", "ANATOMY", 107, 112], ["ceroid lipofuscinosis", "DISEASE", 16, 37], ["lysosomal", "CELLULAR_COMPONENT", 39, 48], ["hepatocytes", "CELL", 71, 82], ["brain", "ORGAN", 107, 112], ["hepatocytes", "CELL_TYPE", 71, 82], ["ceroid lipofuscinosis", "PROBLEM", 16, 37], ["lysosomal storage", "PROBLEM", 39, 56], ["minimal in hepatocytes", "PROBLEM", 60, 82], ["ceroid lipofuscinosis", "OBSERVATION", 16, 37], ["lysosomal storage", "OBSERVATION", 39, 56], ["minimal", "OBSERVATION_MODIFIER", 60, 67], ["hepatocytes", "ANATOMY", 71, 82], ["brain", "ANATOMY", 107, 112]]], ["Examples of storage disorders associated with hepatomegaly and abnormal hepatic or Kupffer cell lysosomal inclusions include GM 1 gangliosidosis (\u03b2-1-galactosidase deficiency) in cats, mucopolysaccharidosis type I (\u03b1-L-iduronidase H&E-stained sections of liver.", [["hepatic", "ANATOMY", 72, 79], ["Kupffer cell", "ANATOMY", 83, 95], ["sections", "ANATOMY", 243, 251], ["liver", "ANATOMY", 255, 260], ["hepatomegaly", "DISEASE", 46, 58], ["GM", "CHEMICAL", 125, 127], ["gangliosidosis", "DISEASE", 130, 144], ["mucopolysaccharidosis type I", "DISEASE", 185, 213], ["hepatic", "MULTI-TISSUE_STRUCTURE", 72, 79], ["Kupffer cell", "CELL", 83, 95], ["GM 1 gangliosidosis", "GENE_OR_GENE_PRODUCT", 125, 144], ["\u03b2-1-galactosidase", "GENE_OR_GENE_PRODUCT", 146, 163], ["cats", "ORGANISM", 179, 183], ["mucopolysaccharidosis type I", "GENE_OR_GENE_PRODUCT", 185, 213], ["\u03b1-L-iduronidase", "GENE_OR_GENE_PRODUCT", 215, 230], ["sections", "MULTI-TISSUE_STRUCTURE", 243, 251], ["liver", "ORGAN", 255, 260], ["cats", "SPECIES", 179, 183], ["mucopolysaccharidosis type I", "SPECIES", 185, 213], ["storage disorders", "PROBLEM", 12, 29], ["hepatomegaly", "PROBLEM", 46, 58], ["abnormal hepatic or Kupffer cell lysosomal inclusions", "PROBLEM", 63, 116], ["GM 1 gangliosidosis", "PROBLEM", 125, 144], ["galactosidase deficiency) in cats", "PROBLEM", 150, 183], ["mucopolysaccharidosis type I", "PROBLEM", 185, 213], ["\u03b1-L-iduronidase H&E", "TEST", 215, 234], ["stained sections of liver", "PROBLEM", 235, 260], ["storage disorders", "OBSERVATION", 12, 29], ["hepatomegaly", "OBSERVATION", 46, 58], ["abnormal", "OBSERVATION_MODIFIER", 63, 71], ["hepatic", "ANATOMY", 72, 79], ["Kupffer cell", "OBSERVATION", 83, 95], ["lysosomal inclusions", "OBSERVATION", 96, 116], ["GM 1", "OBSERVATION_MODIFIER", 125, 129], ["gangliosidosis", "OBSERVATION", 130, 144], ["mucopolysaccharidosis", "OBSERVATION", 185, 206], ["liver", "ANATOMY", 255, 260]]], ["There have been attempts to refine the terminology and criteria for cell death in the liver, but this is still hindered by our incomplete understanding of different cell death pathways and cellular responses in various diseases.ApoptosisApoptosis is a form of programmed cell death that permits removal of cell debris without much leakage of cell contents or inflammation.", [["cell", "ANATOMY", 68, 72], ["liver", "ANATOMY", 86, 91], ["cell", "ANATOMY", 165, 169], ["cellular", "ANATOMY", 189, 197], ["cell", "ANATOMY", 271, 275], ["cell", "ANATOMY", 306, 310], ["cell", "ANATOMY", 342, 346], ["death", "DISEASE", 73, 78], ["ApoptosisApoptosis", "DISEASE", 228, 246], ["inflammation", "DISEASE", 359, 371], ["cell", "CELL", 68, 72], ["liver", "ORGAN", 86, 91], ["cell", "CELL", 165, 169], ["cellular", "CELL", 189, 197], ["cell", "CELL", 271, 275], ["cell", "CELL", 306, 310], ["cell", "CELL", 342, 346], ["cell death in the liver", "PROBLEM", 68, 91], ["different cell death pathways", "PROBLEM", 155, 184], ["various diseases", "PROBLEM", 211, 227], ["ApoptosisApoptosis", "PROBLEM", 228, 246], ["programmed cell death", "PROBLEM", 260, 281], ["removal", "TREATMENT", 295, 302], ["cell debris", "PROBLEM", 306, 317], ["much leakage of cell contents", "PROBLEM", 326, 355], ["inflammation", "PROBLEM", 359, 371], ["liver", "ANATOMY", 86, 91], ["different cell death", "OBSERVATION", 155, 175], ["cellular responses", "OBSERVATION", 189, 207], ["various", "OBSERVATION_MODIFIER", 211, 218], ["diseases", "OBSERVATION", 219, 227], ["cell death", "OBSERVATION", 271, 281], ["cell debris", "OBSERVATION", 306, 317], ["leakage", "OBSERVATION_MODIFIER", 331, 338], ["cell contents", "OBSERVATION", 342, 355], ["inflammation", "OBSERVATION", 359, 371]]], ["Key features of apoptosis include retention of plasma membrane integrity until the later stages of the process; proteolysis of intracellular cytoskeletal proteins by aspartatespecific proteases, leading to collapse of subcellular components; chromatin condensation and marginalization; nuclear fragmentation; plasma membrane bleb formation; and eventual cell fragmentation into smaller apoptotic bodies bound by intact plasma membrane ( Fig. 2-28 ).", [["plasma membrane", "ANATOMY", 47, 62], ["intracellular", "ANATOMY", 127, 140], ["subcellular", "ANATOMY", 218, 229], ["chromatin", "ANATOMY", 242, 251], ["nuclear", "ANATOMY", 286, 293], ["plasma membrane bleb", "ANATOMY", 309, 329], ["cell", "ANATOMY", 354, 358], ["bodies", "ANATOMY", 396, 402], ["plasma membrane", "ANATOMY", 419, 434], ["plasma membrane", "CELLULAR_COMPONENT", 47, 62], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 127, 140], ["aspartatespecific proteases", "GENE_OR_GENE_PRODUCT", 166, 193], ["chromatin", "CELLULAR_COMPONENT", 242, 251], ["nuclear", "CELLULAR_COMPONENT", 286, 293], ["plasma", "CELLULAR_COMPONENT", 309, 315], ["membrane bleb", "CELLULAR_COMPONENT", 316, 329], ["cell", "CELL", 354, 358], ["apoptotic bodies", "CELLULAR_COMPONENT", 386, 402], ["plasma membrane", "CELLULAR_COMPONENT", 419, 434], ["intracellular cytoskeletal proteins", "PROTEIN", 127, 162], ["aspartatespecific proteases", "PROTEIN", 166, 193], ["apoptosis", "PROBLEM", 16, 25], ["retention of plasma membrane integrity", "PROBLEM", 34, 72], ["intracellular cytoskeletal proteins", "PROBLEM", 127, 162], ["aspartatespecific proteases", "PROBLEM", 166, 193], ["collapse of subcellular components", "PROBLEM", 206, 240], ["chromatin condensation", "PROBLEM", 242, 264], ["nuclear fragmentation", "PROBLEM", 286, 307], ["plasma membrane bleb formation", "PROBLEM", 309, 339], ["eventual cell fragmentation", "PROBLEM", 345, 372], ["smaller apoptotic bodies bound", "PROBLEM", 378, 408], ["apoptosis", "OBSERVATION", 16, 25], ["retention", "OBSERVATION_MODIFIER", 34, 43], ["plasma membrane integrity", "OBSERVATION", 47, 72], ["intracellular cytoskeletal proteins", "OBSERVATION", 127, 162], ["collapse", "OBSERVATION", 206, 214], ["subcellular components", "OBSERVATION", 218, 240], ["chromatin condensation", "OBSERVATION", 242, 264], ["marginalization", "OBSERVATION_MODIFIER", 269, 284], ["fragmentation", "OBSERVATION_MODIFIER", 294, 307], ["plasma membrane", "OBSERVATION", 309, 324], ["bleb formation", "OBSERVATION", 325, 339], ["eventual cell fragmentation", "OBSERVATION", 345, 372], ["smaller", "OBSERVATION_MODIFIER", 378, 385], ["apoptotic bodies", "OBSERVATION", 386, 402], ["intact", "OBSERVATION_MODIFIER", 412, 418], ["plasma membrane", "OBSERVATION", 419, 434]]], ["These bodies are rapidly phagocytosed and degraded by neighboring hepatocytes or Kupffer cells.", [["bodies", "ANATOMY", 6, 12], ["hepatocytes", "ANATOMY", 66, 77], ["Kupffer cells", "ANATOMY", 81, 94], ["hepatocytes", "CELL", 66, 77], ["Kupffer cells", "CELL", 81, 94], ["neighboring hepatocytes", "CELL_TYPE", 54, 77], ["Kupffer cells", "CELL_TYPE", 81, 94], ["rapidly phagocytosed", "PROBLEM", 17, 37], ["bodies", "ANATOMY_MODIFIER", 6, 12], ["rapidly", "OBSERVATION_MODIFIER", 17, 24], ["phagocytosed", "OBSERVATION", 25, 37], ["hepatocytes", "ANATOMY", 66, 77], ["Kupffer cells", "OBSERVATION", 81, 94]]], ["The rapid disappearance of these fragments means that very few apoptotic bodies in a section can indicate a rapid rate of hepatocellular death and turnover.", [["fragments", "ANATOMY", 33, 42], ["bodies", "ANATOMY", 73, 79], ["hepatocellular", "ANATOMY", 122, 136], ["death", "DISEASE", 137, 142], ["hepatocellular", "CANCER", 122, 136], ["these fragments", "PROBLEM", 27, 42], ["very few apoptotic bodies", "PROBLEM", 54, 79], ["hepatocellular death", "PROBLEM", 122, 142], ["rapid", "OBSERVATION_MODIFIER", 4, 9], ["disappearance", "OBSERVATION_MODIFIER", 10, 23], ["fragments", "OBSERVATION", 33, 42], ["very", "OBSERVATION_MODIFIER", 54, 58], ["few", "OBSERVATION_MODIFIER", 59, 62], ["apoptotic bodies", "OBSERVATION", 63, 79], ["rapid", "OBSERVATION_MODIFIER", 108, 113], ["hepatocellular death", "OBSERVATION", 122, 142]]], ["Biochemically, apoptotic cells are characterized by phosphatidylserine on the outer surface of the cell membrane, increased mitochondrial permeability with release of internal proteins and activation of caspases.ApoptosisApoptosis is the main means of physiologic removal of damaged or aged cells and for remodeling of tissue.", [["cells", "ANATOMY", 25, 30], ["outer surface", "ANATOMY", 78, 91], ["cell membrane", "ANATOMY", 99, 112], ["mitochondrial", "ANATOMY", 124, 137], ["cells", "ANATOMY", 291, 296], ["tissue", "ANATOMY", 319, 325], ["phosphatidylserine", "CHEMICAL", 52, 70], ["ApoptosisApoptosis", "DISEASE", 212, 230], ["phosphatidylserine", "CHEMICAL", 52, 70], ["cells", "CELL", 25, 30], ["phosphatidylserine", "AMINO_ACID", 52, 70], ["outer surface", "CELLULAR_COMPONENT", 78, 91], ["cell membrane", "CELLULAR_COMPONENT", 99, 112], ["mitochondrial", "CELLULAR_COMPONENT", 124, 137], ["caspases", "GENE_OR_GENE_PRODUCT", 203, 211], ["cells", "CELL", 291, 296], ["tissue", "TISSUE", 319, 325], ["apoptotic cells", "CELL_TYPE", 15, 30], ["internal proteins", "PROTEIN", 167, 184], ["caspases", "PROTEIN", 203, 211], ["damaged or aged cells", "CELL_TYPE", 275, 296], ["apoptotic cells", "PROBLEM", 15, 30], ["increased mitochondrial permeability", "PROBLEM", 114, 150], ["internal proteins", "TREATMENT", 167, 184], ["activation of caspases", "TREATMENT", 189, 211], ["ApoptosisApoptosis", "PROBLEM", 212, 230], ["physiologic removal", "TREATMENT", 252, 271], ["damaged or aged cells", "TREATMENT", 275, 296], ["remodeling of tissue", "PROBLEM", 305, 325], ["apoptotic cells", "OBSERVATION", 15, 30], ["phosphatidylserine", "OBSERVATION_MODIFIER", 52, 70], ["outer", "ANATOMY_MODIFIER", 78, 83], ["surface", "ANATOMY_MODIFIER", 84, 91], ["cell membrane", "OBSERVATION", 99, 112], ["increased", "OBSERVATION_MODIFIER", 114, 123], ["mitochondrial permeability", "OBSERVATION", 124, 150], ["internal proteins", "OBSERVATION", 167, 184], ["main", "OBSERVATION_MODIFIER", 238, 242], ["physiologic removal", "OBSERVATION", 252, 271], ["tissue", "OBSERVATION", 319, 325]]], ["Liver mass is maintained by a balance of mitosis and apoptosis.", [["Liver mass", "ANATOMY", 0, 10], ["Liver", "ORGAN", 0, 5], ["Liver mass", "PROBLEM", 0, 10], ["mitosis", "PROBLEM", 41, 48], ["apoptosis", "PROBLEM", 53, 62], ["mass", "OBSERVATION", 6, 10], ["balance", "OBSERVATION_MODIFIER", 30, 37], ["mitosis", "OBSERVATION", 41, 48], ["apoptosis", "OBSERVATION_MODIFIER", 53, 62]]], ["Experimental support for the importance of this balance comes from studies of mutant mice deficient in the principal mediator of apoptosis, the receptor Fas (Fas/CD95), which develop prominent hepatocellular hyperplasia over time.ApoptosisApoptosis can be initiated by extrinsic or intrinsic events involving the death receptors or mitochondria, respectively.", [["hepatocellular hyperplasia", "ANATOMY", 193, 219], ["mitochondria", "ANATOMY", 332, 344], ["hepatocellular hyperplasia", "DISEASE", 193, 219], ["ApoptosisApoptosis", "DISEASE", 230, 248], ["death", "DISEASE", 313, 318], ["mutant mice", "ORGANISM", 78, 89], ["Fas", "GENE_OR_GENE_PRODUCT", 153, 156], ["Fas", "GENE_OR_GENE_PRODUCT", 158, 161], ["CD95", "GENE_OR_GENE_PRODUCT", 162, 166], ["hepatocellular hyperplasia", "PATHOLOGICAL_FORMATION", 193, 219], ["mitochondria", "CELLULAR_COMPONENT", 332, 344], ["receptor Fas", "PROTEIN", 144, 156], ["Fas", "PROTEIN", 158, 161], ["CD95", "PROTEIN", 162, 166], ["death receptors", "PROTEIN", 313, 328], ["mice", "SPECIES", 85, 89], ["mice", "SPECIES", 85, 89], ["Experimental support", "TREATMENT", 0, 20], ["mutant mice deficient", "PROBLEM", 78, 99], ["apoptosis", "PROBLEM", 129, 138], ["the receptor Fas", "TEST", 140, 156], ["Fas/CD95)", "TEST", 158, 167], ["prominent hepatocellular hyperplasia", "PROBLEM", 183, 219], ["ApoptosisApoptosis", "PROBLEM", 230, 248], ["extrinsic or intrinsic events", "PROBLEM", 269, 298], ["prominent", "OBSERVATION_MODIFIER", 183, 192], ["hepatocellular", "ANATOMY", 193, 207], ["hyperplasia", "OBSERVATION", 208, 219]]], ["Extrinsic mechanisms can be activated via cell surface receptors termed death receptors when they bind their cognate ligands.", [["cell surface", "ANATOMY", 42, 54], ["death", "DISEASE", 72, 77], ["cell", "CELL", 42, 46], ["cell surface receptors", "PROTEIN", 42, 64], ["death receptors", "PROTEIN", 72, 87], ["Extrinsic mechanisms", "PROBLEM", 0, 20]]], ["Death receptors include Fas, tumor necrosis factor-\u03b1 (TNF-\u03b1) receptor and death receptor 4 (DR4) and 5 (DR5).", [["Death", "DISEASE", 0, 5], ["necrosis", "DISEASE", 35, 43], ["Fas", "GENE_OR_GENE_PRODUCT", 24, 27], ["tumor necrosis factor-\u03b1", "GENE_OR_GENE_PRODUCT", 29, 52], ["TNF-\u03b1) receptor", "GENE_OR_GENE_PRODUCT", 54, 69], ["death receptor 4", "GENE_OR_GENE_PRODUCT", 74, 90], ["DR4", "GENE_OR_GENE_PRODUCT", 92, 95], ["5", "GENE_OR_GENE_PRODUCT", 101, 102], ["DR5", "GENE_OR_GENE_PRODUCT", 104, 107], ["Fas", "PROTEIN", 24, 27], ["tumor necrosis factor-\u03b1 (TNF-\u03b1) receptor", "PROTEIN", 29, 69], ["death receptor 4", "PROTEIN", 74, 90], ["DR4", "PROTEIN", 92, 95], ["DR5", "PROTEIN", 104, 107], ["Death receptors", "TEST", 0, 15], ["Fas", "TEST", 24, 27], ["tumor necrosis factor", "PROBLEM", 29, 50], ["TNF", "TEST", 54, 57], ["receptor and death receptor", "TREATMENT", 61, 88], ["tumor", "OBSERVATION_MODIFIER", 29, 34], ["necrosis", "OBSERVATION", 35, 43]]], ["The main signaling molecules in the liver are the Fas ligand (FasL), TNF-related apoptosis-inducing ligand (TRAIL), and TNF-\u03b1.", [["liver", "ANATOMY", 36, 41], ["liver", "ORGAN", 36, 41], ["Fas ligand", "GENE_OR_GENE_PRODUCT", 50, 60], ["FasL", "GENE_OR_GENE_PRODUCT", 62, 66], ["TNF-related apoptosis-inducing ligand", "GENE_OR_GENE_PRODUCT", 69, 106], ["TRAIL", "GENE_OR_GENE_PRODUCT", 108, 113], ["TNF-\u03b1.", "GENE_OR_GENE_PRODUCT", 120, 126], ["Fas ligand", "PROTEIN", 50, 60], ["FasL", "PROTEIN", 62, 66], ["TNF-related apoptosis-inducing ligand", "PROTEIN", 69, 106], ["TRAIL", "PROTEIN", 108, 113], ["TNF", "PROTEIN", 120, 123], ["TNF", "TEST", 69, 72], ["TNF", "TEST", 120, 123], ["main", "OBSERVATION_MODIFIER", 4, 8], ["signaling molecules", "OBSERVATION", 9, 28], ["liver", "ANATOMY", 36, 41], ["apoptosis", "OBSERVATION_MODIFIER", 81, 90]]], ["When the membrane-bound death receptors bind their ligand, they trigger formation of a multiprotein complex, the hepatocellular cords atrophy.", [["membrane", "ANATOMY", 9, 17], ["hepatocellular cords", "ANATOMY", 113, 133], ["death", "DISEASE", 24, 29], ["atrophy", "DISEASE", 134, 141], ["membrane", "CELLULAR_COMPONENT", 9, 17], ["hepatocellular cords", "TISSUE", 113, 133], ["death receptors", "PROTEIN", 24, 39], ["multiprotein complex", "PROTEIN", 87, 107], ["a multiprotein complex", "PROBLEM", 85, 107], ["the hepatocellular cords atrophy", "PROBLEM", 109, 141], ["hepatocellular cords", "ANATOMY", 113, 133], ["atrophy", "OBSERVATION", 134, 141]]], ["On H&E staining, amyloid appears as homogeneous eosinophilic amorphous extracellular material .", [["extracellular material", "ANATOMY", 71, 93], ["H&E", "SIMPLE_CHEMICAL", 3, 6], ["amyloid", "GENE_OR_GENE_PRODUCT", 17, 24], ["extracellular material", "CELLULAR_COMPONENT", 71, 93], ["H&E staining", "TEST", 3, 15], ["amyloid", "PROBLEM", 17, 24], ["homogeneous eosinophilic amorphous extracellular material", "PROBLEM", 36, 93], ["amyloid", "OBSERVATION", 17, 24], ["homogeneous", "OBSERVATION_MODIFIER", 36, 47], ["eosinophilic", "OBSERVATION_MODIFIER", 48, 60], ["amorphous", "OBSERVATION_MODIFIER", 61, 70], ["extracellular material", "OBSERVATION", 71, 93]]], ["Staining with Congo red results in applegreen birefringence when viewed with polarized light.", [["Congo red", "CHEMICAL", 14, 23]]], ["Thioflavine T stain produces yellow-green fluorescent staining of amyloid when viewed under ultraviolet light.", [["Thioflavine T", "CHEMICAL", 0, 13], ["Thioflavine T", "CHEMICAL", 0, 13], ["Thioflavine T", "GENE_OR_GENE_PRODUCT", 0, 13], ["amyloid", "GENE_OR_GENE_PRODUCT", 66, 73], ["Thioflavine T stain", "TEST", 0, 19], ["yellow-green fluorescent staining of amyloid", "PROBLEM", 29, 73], ["green fluorescent staining", "OBSERVATION", 36, 62], ["amyloid", "OBSERVATION", 66, 73]]], ["ArmstrongTYPES AND PATTERNS OF CELL DEATH IN THE LIVERIrreversible damage leads to cell death that is evident histologically as long as the affected animal survives for a sufficient period of time, usually hours.", [["cell", "ANATOMY", 83, 87], ["LIVERIrreversible damage", "DISEASE", 49, 73], ["death", "DISEASE", 88, 93], ["cell", "CELL", 83, 87], ["CELL DEATH", "PROBLEM", 31, 41], ["THE LIVERIrreversible damage", "PROBLEM", 45, 73], ["cell death", "PROBLEM", 83, 93], ["CELL DEATH", "OBSERVATION", 31, 41], ["LIVERIrreversible", "OBSERVATION_MODIFIER", 49, 66], ["damage", "OBSERVATION", 67, 73], ["cell death", "OBSERVATION", 83, 93]]], ["Although all cells in the liver are susceptible, most interest and evaluation has been directed toward hepatocytes, biliary epithelium, and sinusoidal endothelium.", [["cells", "ANATOMY", 13, 18], ["liver", "ANATOMY", 26, 31], ["hepatocytes", "ANATOMY", 103, 114], ["biliary epithelium", "ANATOMY", 116, 134], ["sinusoidal endothelium", "ANATOMY", 140, 162], ["cells", "CELL", 13, 18], ["liver", "ORGAN", 26, 31], ["hepatocytes", "CELL", 103, 114], ["biliary epithelium", "TISSUE", 116, 134], ["sinusoidal endothelium", "TISSUE", 140, 162], ["hepatocytes", "CELL_TYPE", 103, 114], ["all cells in the liver", "PROBLEM", 9, 31], ["evaluation", "TEST", 67, 77], ["all cells", "OBSERVATION", 9, 18], ["liver", "ANATOMY", 26, 31], ["susceptible", "OBSERVATION", 36, 47], ["biliary epithelium", "ANATOMY", 116, 134], ["sinusoidal endothelium", "OBSERVATION", 140, 162]]], ["The 2 predominant types of cell death are necrosis, also termed oncotic necrosis, and apoptosis, although there are other less common forms of cell death.", [["cell", "ANATOMY", 27, 31], ["oncotic", "ANATOMY", 64, 71], ["cell", "ANATOMY", 143, 147], ["death", "DISEASE", 32, 37], ["necrosis", "DISEASE", 42, 50], ["necrosis", "DISEASE", 72, 80], ["death", "DISEASE", 148, 153], ["cell", "CELL", 27, 31], ["cell", "CELL", 143, 147], ["cell death", "PROBLEM", 27, 37], ["necrosis", "PROBLEM", 42, 50], ["oncotic necrosis", "PROBLEM", 64, 80], ["apoptosis", "PROBLEM", 86, 95], ["cell death", "PROBLEM", 143, 153], ["predominant", "OBSERVATION_MODIFIER", 6, 17], ["types", "OBSERVATION_MODIFIER", 18, 23], ["cell death", "OBSERVATION", 27, 37], ["necrosis", "OBSERVATION", 42, 50], ["oncotic", "OBSERVATION_MODIFIER", 64, 71], ["necrosis", "OBSERVATION", 72, 80], ["apoptosis", "OBSERVATION_MODIFIER", 86, 95], ["less common", "OBSERVATION_MODIFIER", 122, 133], ["cell death", "OBSERVATION", 143, 153]]], ["These types of cell death can be separated mechanistically and histologically to a certain extent.Types of cell deathIn routine diagnostic settings, the terms apoptosis and necrosis can be based on descriptive criteria recognized in routine to the extracellular matrix, but it is still unknown how loss of these contributes to cell death of hepatocytes in the intact liver.", [["cell", "ANATOMY", 15, 19], ["cell", "ANATOMY", 107, 111], ["extracellular matrix", "ANATOMY", 248, 268], ["cell", "ANATOMY", 327, 331], ["hepatocytes", "ANATOMY", 341, 352], ["liver", "ANATOMY", 367, 372], ["death", "DISEASE", 20, 25], ["necrosis", "DISEASE", 173, 181], ["death", "DISEASE", 332, 337], ["cell", "CELL", 15, 19], ["cell", "CELL", 107, 111], ["extracellular matrix", "CELLULAR_COMPONENT", 248, 268], ["cell", "CELL", 327, 331], ["hepatocytes", "CELL", 341, 352], ["liver", "ORGAN", 367, 372], ["hepatocytes", "CELL_TYPE", 341, 352], ["cell death", "PROBLEM", 15, 25], ["the terms apoptosis", "PROBLEM", 149, 168], ["necrosis", "PROBLEM", 173, 181], ["cell death of hepatocytes", "PROBLEM", 327, 352], ["cell death", "OBSERVATION", 15, 25], ["certain extent", "OBSERVATION_MODIFIER", 83, 97], ["necrosis", "OBSERVATION", 173, 181], ["cell death", "OBSERVATION", 327, 337], ["hepatocytes", "ANATOMY", 341, 352], ["intact", "ANATOMY_MODIFIER", 360, 366], ["liver", "ANATOMY", 367, 372]]], ["Phagocytosis of apoptotic fragments follows flipping of phosphatidylserine from the inner leaflet of the plasma membrane to the outer leaf, where it can then be recognized by the phosphatidylserine scavenger receptor.", [["fragments", "ANATOMY", 26, 35], ["inner leaflet", "ANATOMY", 84, 97], ["plasma membrane", "ANATOMY", 105, 120], ["outer leaf", "ANATOMY", 128, 138], ["phosphatidylserine", "CHEMICAL", 56, 74], ["phosphatidylserine", "CHEMICAL", 179, 197], ["phosphatidylserine", "CHEMICAL", 56, 74], ["phosphatidylserine", "CHEMICAL", 179, 197], ["phosphatidylserine", "AMINO_ACID", 56, 74], ["inner leaflet", "CELLULAR_COMPONENT", 84, 97], ["plasma membrane", "CELLULAR_COMPONENT", 105, 120], ["outer leaf", "CELLULAR_COMPONENT", 128, 138], ["phosphatidylserine scavenger receptor", "GENE_OR_GENE_PRODUCT", 179, 216], ["phosphatidylserine scavenger receptor", "PROTEIN", 179, 216], ["Phagocytosis of apoptotic fragments", "PROBLEM", 0, 35], ["phosphatidylserine", "TREATMENT", 56, 74], ["the phosphatidylserine scavenger receptor", "TREATMENT", 175, 216], ["apoptotic fragments", "OBSERVATION", 16, 35], ["inner", "ANATOMY_MODIFIER", 84, 89], ["leaflet", "ANATOMY_MODIFIER", 90, 97], ["plasma membrane", "OBSERVATION", 105, 120], ["outer leaf", "ANATOMY_MODIFIER", 128, 138]]], ["Various assays can be used to detect portions of these pathways in hepatocytes; caspase-cleaved cytokeratin 18 can be recognized by antibodies to an internal domain, whereas chromatin fragmented by a calcium-activated endonuclease generates double-strand breaks that can be tagged by the terminal deoxynucleotide transferase-mediated dUTP nick-end labeling (TUNEL) technique.", [["hepatocytes", "ANATOMY", 67, 78], ["chromatin", "ANATOMY", 174, 183], ["calcium", "CHEMICAL", 200, 207], ["deoxynucleotide", "CHEMICAL", 297, 312], ["calcium", "CHEMICAL", 200, 207], ["deoxynucleotide", "CHEMICAL", 297, 312], ["dUTP", "CHEMICAL", 334, 338], ["hepatocytes", "CELL", 67, 78], ["caspase", "GENE_OR_GENE_PRODUCT", 80, 87], ["cytokeratin 18", "GENE_OR_GENE_PRODUCT", 96, 110], ["chromatin", "CELLULAR_COMPONENT", 174, 183], ["calcium", "SIMPLE_CHEMICAL", 200, 207], ["terminal deoxynucleotide transferase", "GENE_OR_GENE_PRODUCT", 288, 324], ["dUTP", "SIMPLE_CHEMICAL", 334, 338], ["hepatocytes", "CELL_TYPE", 67, 78], ["caspase", "PROTEIN", 80, 87], ["cytokeratin 18", "PROTEIN", 96, 110], ["antibodies", "PROTEIN", 132, 142], ["chromatin", "DNA", 174, 183], ["calcium-activated endonuclease", "PROTEIN", 200, 230], ["terminal deoxynucleotide transferase", "PROTEIN", 288, 324], ["Various assays", "TEST", 0, 14], ["caspase-cleaved cytokeratin", "TREATMENT", 80, 107], ["an internal domain", "PROBLEM", 146, 164], ["a calcium-activated endonuclease", "TREATMENT", 198, 230], ["double-strand breaks", "TREATMENT", 241, 261], ["the terminal deoxynucleotide transferase", "TEST", 284, 324], ["hepatocytes", "ANATOMY", 67, 78], ["strand breaks", "OBSERVATION", 248, 261]]], ["However, there are still few diagnostic situations in which these indicators have been shown to be useful.", [["few", "OBSERVATION_MODIFIER", 25, 28]]], ["Increased numbers of apoptotic hepatocytes can be more readily assessed with a suitable cytologic marker.", [["hepatocytes", "ANATOMY", 31, 42], ["hepatocytes", "CELL", 31, 42], ["apoptotic hepatocytes", "CELL_TYPE", 21, 42], ["Increased numbers of apoptotic hepatocytes", "PROBLEM", 0, 42], ["a suitable cytologic marker", "TEST", 77, 104], ["numbers", "OBSERVATION_MODIFIER", 10, 17], ["apoptotic hepatocytes", "OBSERVATION", 21, 42]]], ["In routine sections, a previous increase in apoptosis can be suggested by increased amounts of lysosomal debris and pigment in Kupffer cells, but this is not specific for apoptosis.Types of cell deathRapid phagocytic removal of apoptotic hepatocyte fragments can minimize secondary inflammation in cases of minor injury.", [["sections", "ANATOMY", 11, 19], ["lysosomal debris", "ANATOMY", 95, 111], ["Kupffer cells", "ANATOMY", 127, 140], ["cell", "ANATOMY", 190, 194], ["hepatocyte fragments", "ANATOMY", 238, 258], ["inflammation", "DISEASE", 282, 294], ["lysosomal debris", "CELLULAR_COMPONENT", 95, 111], ["pigment", "CELLULAR_COMPONENT", 116, 123], ["Kupffer cells", "CELL", 127, 140], ["cell", "CELL", 190, 194], ["Kupffer cells", "CELL_TYPE", 127, 140], ["a previous increase in apoptosis", "PROBLEM", 21, 53], ["lysosomal debris", "PROBLEM", 95, 111], ["pigment in Kupffer cells", "PROBLEM", 116, 140], ["apoptosis", "PROBLEM", 171, 180], ["cell deathRapid phagocytic removal", "TREATMENT", 190, 224], ["apoptotic hepatocyte fragments", "PROBLEM", 228, 258], ["secondary inflammation", "PROBLEM", 272, 294], ["minor injury", "PROBLEM", 307, 319], ["increase", "OBSERVATION_MODIFIER", 32, 40], ["apoptosis", "OBSERVATION", 44, 53], ["increased", "OBSERVATION_MODIFIER", 74, 83], ["amounts", "OBSERVATION_MODIFIER", 84, 91], ["lysosomal debris", "OBSERVATION", 95, 111], ["pigment", "OBSERVATION_MODIFIER", 116, 123], ["Kupffer cells", "OBSERVATION", 127, 140], ["not specific for", "UNCERTAINTY", 154, 170], ["cell deathRapid phagocytic removal", "OBSERVATION", 190, 224], ["apoptotic hepatocyte fragments", "OBSERVATION", 228, 258], ["secondary", "OBSERVATION_MODIFIER", 272, 281], ["inflammation", "OBSERVATION", 282, 294], ["minor", "OBSERVATION_MODIFIER", 307, 312], ["injury", "OBSERVATION", 313, 319]]], ["However, phagocytosis of apoptotic bodies by Kupffer cells and hepatic stellate cells is not innocuous and can engender inflammation and fibrosis.", [["bodies", "ANATOMY", 35, 41], ["Kupffer cells", "ANATOMY", 45, 58], ["hepatic stellate cells", "ANATOMY", 63, 85], ["inflammation", "DISEASE", 120, 132], ["fibrosis", "DISEASE", 137, 145], ["apoptotic bodies", "CELLULAR_COMPONENT", 25, 41], ["Kupffer cells", "CELL", 45, 58], ["hepatic stellate cells", "CELL", 63, 85], ["Kupffer cells", "CELL_TYPE", 45, 58], ["hepatic stellate cells", "CELL_TYPE", 63, 85], ["phagocytosis of apoptotic bodies", "PROBLEM", 9, 41], ["hepatic stellate cells", "PROBLEM", 63, 85], ["inflammation", "PROBLEM", 120, 132], ["fibrosis", "PROBLEM", 137, 145], ["apoptotic bodies", "OBSERVATION", 25, 41], ["Kupffer cells", "OBSERVATION", 45, 58], ["hepatic", "ANATOMY", 63, 70], ["stellate cells", "OBSERVATION", 71, 85], ["inflammation", "OBSERVATION", 120, 132], ["fibrosis", "OBSERVATION", 137, 145]]], ["Kupffer cells and resident macrophages express several ligands (TNF-\u03b1, TRAIL, and Fas ligand) that lead to increased hepatocyte apoptosis.", [["Kupffer cells", "ANATOMY", 0, 13], ["macrophages", "ANATOMY", 27, 38], ["hepatocyte", "ANATOMY", 117, 127], ["Kupffer cells", "CELL", 0, 13], ["resident macrophages", "CELL", 18, 38], ["TNF-\u03b1", "GENE_OR_GENE_PRODUCT", 64, 69], ["TRAIL", "GENE_OR_GENE_PRODUCT", 71, 76], ["Fas ligand", "GENE_OR_GENE_PRODUCT", 82, 92], ["hepatocyte", "CELL", 117, 127], ["Kupffer cells", "CELL_TYPE", 0, 13], ["resident macrophages", "CELL_TYPE", 18, 38], ["TNF", "PROTEIN", 64, 67], ["\u03b1", "PROTEIN", 68, 69], ["TRAIL", "PROTEIN", 71, 76], ["Fas ligand", "PROTEIN", 82, 92], ["TNF", "TEST", 64, 67], ["TRAIL", "TREATMENT", 71, 76], ["increased hepatocyte apoptosis", "PROBLEM", 107, 137], ["increased", "OBSERVATION_MODIFIER", 107, 116], ["hepatocyte apoptosis", "OBSERVATION", 117, 137]]], ["Similarly, hepatic stellate cells are stimulated to release profibrotic cytokines and type 1 collagen following phagocytosis of apoptotic bodies.", [["hepatic stellate cells", "ANATOMY", 11, 33], ["bodies", "ANATOMY", 138, 144], ["hepatic stellate cells", "CELL", 11, 33], ["type 1 collagen", "GENE_OR_GENE_PRODUCT", 86, 101], ["apoptotic bodies", "CELLULAR_COMPONENT", 128, 144], ["hepatic stellate cells", "CELL_TYPE", 11, 33], ["profibrotic cytokines", "PROTEIN", 60, 81], ["type 1 collagen", "PROTEIN", 86, 101], ["hepatic stellate cells", "PROBLEM", 11, 33], ["profibrotic cytokines", "TEST", 60, 81], ["apoptotic bodies", "PROBLEM", 128, 144], ["hepatic", "ANATOMY", 11, 18], ["stellate cells", "OBSERVATION", 19, 33], ["profibrotic cytokines", "OBSERVATION", 60, 81], ["apoptotic bodies", "OBSERVATION", 128, 144]]], ["In addition, apoptotic cells release nucleotides ATP and uridine triphosphate (UTP), which can bind to purinergic receptors on macrophages and hepatic stellate cells and which may provide additional stimulus for fibrosis and inflammation.", [["cells", "ANATOMY", 23, 28], ["macrophages", "ANATOMY", 127, 138], ["hepatic stellate cells", "ANATOMY", 143, 165], ["ATP", "CHEMICAL", 49, 52], ["uridine triphosphate", "CHEMICAL", 57, 77], ["UTP", "CHEMICAL", 79, 82], ["fibrosis", "DISEASE", 212, 220], ["inflammation", "DISEASE", 225, 237], ["ATP", "CHEMICAL", 49, 52], ["uridine triphosphate", "CHEMICAL", 57, 77], ["UTP", "CHEMICAL", 79, 82], ["cells", "CELL", 23, 28], ["ATP", "SIMPLE_CHEMICAL", 49, 52], ["uridine triphosphate", "SIMPLE_CHEMICAL", 57, 77], ["UTP", "SIMPLE_CHEMICAL", 79, 82], ["macrophages", "CELL", 127, 138], ["hepatic stellate cells", "CELL", 143, 165], ["apoptotic cells", "CELL_TYPE", 13, 28], ["purinergic receptors", "PROTEIN", 103, 123], ["macrophages", "CELL_TYPE", 127, 138], ["hepatic stellate cells", "CELL_TYPE", 143, 165], ["apoptotic cells", "TREATMENT", 13, 28], ["nucleotides ATP", "TEST", 37, 52], ["uridine triphosphate (UTP)", "TEST", 57, 83], ["purinergic receptors", "TEST", 103, 123], ["fibrosis", "PROBLEM", 212, 220], ["inflammation", "PROBLEM", 225, 237], ["apoptotic cells", "OBSERVATION", 13, 28], ["hepatic", "ANATOMY", 143, 150], ["stellate cells", "OBSERVATION", 151, 165], ["fibrosis", "OBSERVATION", 212, 220], ["inflammation", "OBSERVATION", 225, 237]]], ["Excessive apoptosis is currently viewed as a driver of hepatic inflammation and fibrosis.NecrosisNecrosis is morphologically recognizable by initial cell swelling and subsequent loss of plasma membrane integrity, leading to large organelle-free blebs and cell lysis.", [["hepatic", "ANATOMY", 55, 62], ["cell", "ANATOMY", 149, 153], ["plasma membrane", "ANATOMY", 186, 201], ["organelle", "ANATOMY", 230, 239], ["blebs", "ANATOMY", 245, 250], ["cell", "ANATOMY", 255, 259], ["hepatic inflammation", "DISEASE", 55, 75], ["fibrosis", "DISEASE", 80, 88], ["NecrosisNecrosis", "DISEASE", 89, 105], ["hepatic", "ORGAN", 55, 62], ["cell", "CELL", 149, 153], ["plasma membrane", "CELLULAR_COMPONENT", 186, 201], ["organelle", "CELLULAR_COMPONENT", 230, 239], ["blebs", "CELLULAR_COMPONENT", 245, 250], ["cell", "CELL", 255, 259], ["Excessive apoptosis", "PROBLEM", 0, 19], ["hepatic inflammation", "PROBLEM", 55, 75], ["fibrosis", "PROBLEM", 80, 88], ["NecrosisNecrosis", "PROBLEM", 89, 105], ["initial cell swelling", "PROBLEM", 141, 162], ["subsequent loss of plasma membrane integrity", "PROBLEM", 167, 211], ["large organelle-free blebs", "PROBLEM", 224, 250], ["cell lysis", "TREATMENT", 255, 265], ["apoptosis", "OBSERVATION", 10, 19], ["hepatic", "ANATOMY", 55, 62], ["inflammation", "OBSERVATION", 63, 75], ["fibrosis", "OBSERVATION", 80, 88], ["initial cell swelling", "OBSERVATION", 141, 162], ["loss", "OBSERVATION_MODIFIER", 178, 182], ["plasma membrane integrity", "OBSERVATION", 186, 211], ["large", "OBSERVATION_MODIFIER", 224, 229], ["organelle", "OBSERVATION_MODIFIER", 230, 239], ["free blebs", "OBSERVATION", 240, 250], ["cell lysis", "OBSERVATION", 255, 265]]], ["Some authors prefer the term \"oncosis\" to emphasize the cell swelling response in necrosis to contrast with cell shrinkage in apoptosis .", [["cell", "ANATOMY", 56, 60], ["cell", "ANATOMY", 108, 112], ["necrosis", "DISEASE", 82, 90], ["cell", "CELL", 56, 60], ["cell", "CELL", 108, 112], ["the cell swelling", "PROBLEM", 52, 69], ["necrosis", "PROBLEM", 82, 90], ["cell shrinkage in apoptosis", "PROBLEM", 108, 135], ["necrosis", "OBSERVATION", 82, 90], ["cell shrinkage", "OBSERVATION", 108, 122], ["apoptosis", "OBSERVATION", 126, 135]]], ["Necrosis occurs when cells are depleted of ATP and death-inducing signaling complex (DISC).", [["cells", "ANATOMY", 21, 26], ["Necrosis", "DISEASE", 0, 8], ["ATP", "CHEMICAL", 43, 46], ["death", "DISEASE", 51, 56], ["ATP", "CHEMICAL", 43, 46], ["cells", "CELL", 21, 26], ["ATP", "SIMPLE_CHEMICAL", 43, 46], ["death-inducing signaling complex", "GENE_OR_GENE_PRODUCT", 51, 83], ["DISC", "GENE_OR_GENE_PRODUCT", 85, 89], ["signaling complex", "PROTEIN", 66, 83], ["DISC", "PROTEIN", 85, 89], ["Necrosis", "PROBLEM", 0, 8], ["ATP", "PROBLEM", 43, 46], ["death", "PROBLEM", 51, 56], ["signaling complex (DISC)", "PROBLEM", 66, 90], ["complex", "OBSERVATION_MODIFIER", 76, 83], ["DISC", "ANATOMY", 85, 89]]], ["Conformational changes in this complex trigger the activation of caspase 8, the key mediator of apoptosis and subsequent activation of the effector caspases: caspases 3, 6, and 7.", [["caspase 8", "GENE_OR_GENE_PRODUCT", 65, 74], ["caspases", "GENE_OR_GENE_PRODUCT", 148, 156], ["caspases 3", "GENE_OR_GENE_PRODUCT", 158, 168], ["6", "GENE_OR_GENE_PRODUCT", 170, 171], ["7", "GENE_OR_GENE_PRODUCT", 177, 178], ["caspase 8", "PROTEIN", 65, 74], ["effector caspases", "PROTEIN", 139, 156], ["caspases 3, 6, and 7", "PROTEIN", 158, 178], ["Conformational changes", "PROBLEM", 0, 22], ["caspase", "TREATMENT", 65, 72], ["apoptosis", "PROBLEM", 96, 105], ["caspases", "TREATMENT", 158, 166], ["apoptosis", "OBSERVATION", 96, 105]]], ["More details on hepatocellular apoptosis are available in recent reviews.NecrosisIntrinsic mechanisms involve mitochondrial injury with release of proapoptotic factors.", [["hepatocellular", "ANATOMY", 16, 30], ["mitochondrial", "ANATOMY", 110, 123], ["mitochondrial injury", "DISEASE", 110, 130], ["hepatocellular", "CANCER", 16, 30], ["mitochondrial", "CELLULAR_COMPONENT", 110, 123], ["proapoptotic factors", "PROTEIN", 147, 167], ["hepatocellular apoptosis", "PROBLEM", 16, 40], ["NecrosisIntrinsic mechanisms", "PROBLEM", 73, 101], ["mitochondrial injury", "PROBLEM", 110, 130], ["proapoptotic factors", "PROBLEM", 147, 167], ["hepatocellular", "ANATOMY", 16, 30], ["apoptosis", "OBSERVATION", 31, 40], ["mitochondrial injury", "OBSERVATION", 110, 130], ["proapoptotic factors", "OBSERVATION", 147, 167]]], ["Activators of the latter pathway include oxidative stress, DNA damage, toxins, endoplasmic reticulum (ER) stress, including the unfolded protein response, lipid peroxidation, ultraviolet and \u03b3-irradiation, and deprivation of growth factors.", [["endoplasmic reticulum", "ANATOMY", 79, 100], ["ER", "ANATOMY", 102, 104], ["DNA", "CELLULAR_COMPONENT", 59, 62], ["endoplasmic reticulum", "CELLULAR_COMPONENT", 79, 100], ["ER", "GENE_OR_GENE_PRODUCT", 102, 104], ["lipid", "SIMPLE_CHEMICAL", 155, 160], ["growth factors", "PROTEIN", 225, 239], ["oxidative stress", "PROBLEM", 41, 57], ["DNA damage", "PROBLEM", 59, 69], ["toxins", "PROBLEM", 71, 77], ["endoplasmic reticulum (ER) stress", "PROBLEM", 79, 112], ["the unfolded protein response", "PROBLEM", 124, 153], ["lipid peroxidation", "TREATMENT", 155, 173], ["ultraviolet", "TREATMENT", 175, 186], ["\u03b3-irradiation", "TREATMENT", 191, 204], ["growth factors", "PROBLEM", 225, 239], ["oxidative stress", "OBSERVATION", 41, 57], ["endoplasmic reticulum", "ANATOMY", 79, 100], ["protein response", "OBSERVATION", 137, 153], ["lipid peroxidation", "OBSERVATION", 155, 173]]], ["All of the pathways initiated by these agents converge on the mitochondria, leading to mitochondrial outer membrane permeabilization (MOMP).", [["mitochondria", "ANATOMY", 62, 74], ["mitochondrial outer membrane", "ANATOMY", 87, 115], ["mitochondria", "CELLULAR_COMPONENT", 62, 74], ["mitochondrial", "CELLULAR_COMPONENT", 87, 100], ["outer membrane", "CELLULAR_COMPONENT", 101, 115], ["MOMP", "CELLULAR_COMPONENT", 134, 138], ["mitochondrial outer membrane permeabilization", "TREATMENT", 87, 132], ["outer", "ANATOMY_MODIFIER", 101, 106], ["membrane permeabilization", "OBSERVATION", 107, 132]]], ["Mitochondrial membrane permeability is effected either through direct membrane damage, or more commonly by opening of regulated transmembrane pores by bax and other proapoptotic members of the Bcl-2 family.", [["Mitochondrial membrane", "ANATOMY", 0, 22], ["membrane", "ANATOMY", 70, 78], ["transmembrane pores", "ANATOMY", 128, 147], ["Mitochondrial membrane", "CELLULAR_COMPONENT", 0, 22], ["membrane", "CELLULAR_COMPONENT", 70, 78], ["transmembrane pores", "CELLULAR_COMPONENT", 128, 147], ["bax", "GENE_OR_GENE_PRODUCT", 151, 154], ["Bcl-2", "GENE_OR_GENE_PRODUCT", 193, 198], ["bax", "PROTEIN", 151, 154], ["proapoptotic members", "PROTEIN", 165, 185], ["Bcl-2 family", "PROTEIN", 193, 205], ["Mitochondrial membrane permeability", "PROBLEM", 0, 35], ["direct membrane damage", "PROBLEM", 63, 85], ["membrane permeability", "OBSERVATION", 14, 35]]], ["Cytochrome C and other intermembrane mitochondrial factors released from the mitochondrion form an apoptosomal complex in the cytoplasm that activates the distal caspase pathways, including caspase 9, that execute many of the cell fragmentation events.", [["intermembrane mitochondrial", "ANATOMY", 23, 50], ["mitochondrion", "ANATOMY", 77, 90], ["cytoplasm", "ANATOMY", 126, 135], ["cell", "ANATOMY", 226, 230], ["Cytochrome C", "GENE_OR_GENE_PRODUCT", 0, 12], ["intermembrane", "CELLULAR_COMPONENT", 23, 36], ["mitochondrial", "CELLULAR_COMPONENT", 37, 50], ["mitochondrion", "CELLULAR_COMPONENT", 77, 90], ["cytoplasm", "ORGANISM_SUBSTANCE", 126, 135], ["caspase", "GENE_OR_GENE_PRODUCT", 162, 169], ["caspase 9", "GENE_OR_GENE_PRODUCT", 190, 199], ["cell", "CELL", 226, 230], ["Cytochrome C", "PROTEIN", 0, 12], ["intermembrane mitochondrial factors", "PROTEIN", 23, 58], ["apoptosomal complex", "PROTEIN", 99, 118], ["caspase 9", "PROTEIN", 190, 199], ["Cytochrome C", "PROBLEM", 0, 12], ["other intermembrane mitochondrial factors", "PROBLEM", 17, 58], ["an apoptosomal complex in the cytoplasm", "PROBLEM", 96, 135], ["the distal caspase pathways", "TREATMENT", 151, 178], ["caspase", "TREATMENT", 190, 197], ["the cell fragmentation events", "PROBLEM", 222, 251], ["distal", "ANATOMY_MODIFIER", 155, 161], ["cell fragmentation", "OBSERVATION", 226, 244]]], ["Alternatively, MOMP can be triggered by another mechanism involving multiprotein channels within the mitochondria, leading to swelling and release of proapoptotic molecules.NecrosisFunctional classification of cell death has been developed on the basis of chemical rather than the histologic-morphologic criteria because different pathways can lead to similar morphologies.", [["mitochondria", "ANATOMY", 101, 113], ["cell", "ANATOMY", 210, 214], ["swelling", "DISEASE", 126, 134], ["death", "DISEASE", 215, 220], ["MOMP", "GENE_OR_GENE_PRODUCT", 15, 19], ["mitochondria", "CELLULAR_COMPONENT", 101, 113], ["cell", "CELL", 210, 214], ["MOMP", "PROTEIN", 15, 19], ["multiprotein channels", "PROTEIN", 68, 89], ["proapoptotic molecules", "PROTEIN", 150, 172], ["multiprotein channels", "PROBLEM", 68, 89], ["swelling", "PROBLEM", 126, 134], ["proapoptotic molecules", "PROBLEM", 150, 172], ["cell death", "PROBLEM", 210, 220], ["swelling", "OBSERVATION", 126, 134], ["proapoptotic molecules", "OBSERVATION", 150, 172], ["cell death", "OBSERVATION", 210, 220]]], ["For example, intrinsic pathways can be divided into caspase-dependent and caspase-independent pathways.NecrosisInjury to the ER via oxidative stress, hypoxia, calcium depletion, inflammation, and altered glycosylation, among other mechanisms, leads to the \"unfolded protein response (UPR)\" that can also activate the distal caspase pathway by a separate mechanism.", [["ER", "ANATOMY", 125, 127], ["hypoxia", "DISEASE", 150, 157], ["calcium", "CHEMICAL", 159, 166], ["inflammation", "DISEASE", 178, 190], ["calcium", "CHEMICAL", 159, 166], ["caspase", "GENE_OR_GENE_PRODUCT", 52, 59], ["caspase", "GENE_OR_GENE_PRODUCT", 74, 81], ["ER", "GENE_OR_GENE_PRODUCT", 125, 127], ["calcium", "SIMPLE_CHEMICAL", 159, 166], ["UPR", "GENE_OR_GENE_PRODUCT", 284, 287], ["caspase", "GENE_OR_GENE_PRODUCT", 324, 331], ["caspase", "PROTEIN", 52, 59], ["caspase", "PROTEIN", 74, 81], ["ER", "PROTEIN", 125, 127], ["UPR", "PROTEIN", 284, 287], ["caspase", "PROTEIN", 324, 331], ["oxidative stress", "PROBLEM", 132, 148], ["hypoxia", "PROBLEM", 150, 157], ["calcium depletion", "PROBLEM", 159, 176], ["inflammation", "PROBLEM", 178, 190], ["altered glycosylation", "PROBLEM", 196, 217], ["oxidative stress", "OBSERVATION", 132, 148], ["hypoxia", "OBSERVATION", 150, 157], ["calcium depletion", "OBSERVATION", 159, 176], ["inflammation", "OBSERVATION", 178, 190], ["altered", "OBSERVATION_MODIFIER", 196, 203], ["glycosylation", "OBSERVATION", 204, 217], ["distal", "OBSERVATION_MODIFIER", 317, 323], ["caspase", "OBSERVATION", 324, 331]]], ["Hepatocytes are also susceptible to an intrinsic mechanism of apoptosis that is active after removal of hepatotrophic influences, including those that function via the constitutive androstane receptor, and other nuclear receptors.", [["Hepatocytes", "ANATOMY", 0, 11], ["nuclear", "ANATOMY", 212, 219], ["androstane", "CHEMICAL", 181, 191], ["Hepatocytes", "CELL", 0, 11], ["constitutive androstane receptor", "GENE_OR_GENE_PRODUCT", 168, 200], ["Hepatocytes", "CELL_TYPE", 0, 11], ["constitutive androstane receptor", "PROTEIN", 168, 200], ["nuclear receptors", "PROTEIN", 212, 229], ["apoptosis", "PROBLEM", 62, 71], ["removal", "TREATMENT", 93, 100], ["hepatotrophic influences", "PROBLEM", 104, 128], ["the constitutive androstane receptor", "TEST", 164, 200], ["apoptosis", "OBSERVATION", 62, 71], ["active", "OBSERVATION_MODIFIER", 80, 86]]], ["In addition, lysosomes can undergo selective membrane permeabilization, leading to a partial release of their contents in response to death signaling mediated by oxidative stress, some lipid mediators, and by Bcl-2 family members.", [["lysosomes", "ANATOMY", 13, 22], ["membrane", "ANATOMY", 45, 53], ["death", "DISEASE", 134, 139], ["lysosomes", "CELLULAR_COMPONENT", 13, 22], ["membrane", "CELLULAR_COMPONENT", 45, 53], ["Bcl-2", "GENE_OR_GENE_PRODUCT", 209, 214], ["lipid mediators", "PROTEIN", 185, 200], ["Bcl-2 family members", "PROTEIN", 209, 229], ["selective membrane permeabilization", "TREATMENT", 35, 70], ["death signaling", "PROBLEM", 134, 149], ["selective", "OBSERVATION_MODIFIER", 35, 44], ["membrane permeabilization", "OBSERVATION", 45, 70]]], ["Release of lysosomal proteases can cooperate with the caspase cascade or act in a caspase-independent fashion.NecrosisBoth extrinsic and intrinsic pathways lead, in turn, to disruption of the cytoskeleton and nucleus primarily through the activation and direct action of caspases 3, 6, and 7.", [["lysosomal", "ANATOMY", 11, 20], ["cytoskeleton", "ANATOMY", 192, 204], ["nucleus", "ANATOMY", 209, 216], ["caspase", "GENE_OR_GENE_PRODUCT", 54, 61], ["caspase", "GENE_OR_GENE_PRODUCT", 82, 89], ["cytoskeleton", "CELLULAR_COMPONENT", 192, 204], ["nucleus", "CELLULAR_COMPONENT", 209, 216], ["caspases 3", "GENE_OR_GENE_PRODUCT", 271, 281], ["6", "GENE_OR_GENE_PRODUCT", 283, 284], ["7", "GENE_OR_GENE_PRODUCT", 290, 291], ["lysosomal proteases", "PROTEIN", 11, 30], ["caspase", "PROTEIN", 54, 61], ["caspases 3, 6, and 7", "PROTEIN", 271, 291], ["lysosomal proteases", "TREATMENT", 11, 30], ["the caspase cascade", "TREATMENT", 50, 69], ["NecrosisBoth extrinsic and intrinsic pathways lead", "PROBLEM", 110, 160], ["caspases", "TEST", 271, 279], ["lysosomal proteases", "OBSERVATION", 11, 30], ["intrinsic", "OBSERVATION_MODIFIER", 137, 146], ["pathways lead", "OBSERVATION", 147, 160], ["cytoskeleton", "ANATOMY_MODIFIER", 192, 204], ["nucleus", "ANATOMY_MODIFIER", 209, 216]]], ["An important feature of apoptosis is the requirement for adenosine triphosphate (ATP) to initiate the execution phase.", [["adenosine triphosphate", "CHEMICAL", 57, 79], ["ATP", "CHEMICAL", 81, 84], ["adenosine triphosphate", "CHEMICAL", 57, 79], ["ATP", "CHEMICAL", 81, 84], ["adenosine triphosphate", "SIMPLE_CHEMICAL", 57, 79], ["ATP", "SIMPLE_CHEMICAL", 81, 84], ["apoptosis", "PROBLEM", 24, 33], ["adenosine triphosphate (ATP", "TREATMENT", 57, 84], ["the execution phase", "TEST", 98, 117], ["apoptosis", "OBSERVATION", 24, 33]]], ["If the degree of mitochondrial damage is sufficient to exhaust ATP stores, membrane ion homeostasis deteriorates and leads to a mechanism of cell death more consistent with necrosis.", [["mitochondrial", "ANATOMY", 17, 30], ["membrane", "ANATOMY", 75, 83], ["cell", "ANATOMY", 141, 145], ["mitochondrial damage", "DISEASE", 17, 37], ["ATP", "CHEMICAL", 63, 66], ["death", "DISEASE", 146, 151], ["necrosis", "DISEASE", 173, 181], ["ATP", "CHEMICAL", 63, 66], ["mitochondrial", "CELLULAR_COMPONENT", 17, 30], ["ATP", "SIMPLE_CHEMICAL", 63, 66], ["membrane", "CELLULAR_COMPONENT", 75, 83], ["cell", "CELL", 141, 145], ["mitochondrial damage", "PROBLEM", 17, 37], ["ATP stores", "PROBLEM", 63, 73], ["membrane ion homeostasis", "PROBLEM", 75, 99], ["cell death", "PROBLEM", 141, 151], ["necrosis", "PROBLEM", 173, 181], ["mitochondrial damage", "OBSERVATION", 17, 37], ["cell death", "OBSERVATION", 141, 151], ["consistent with", "UNCERTAINTY", 157, 172], ["necrosis", "OBSERVATION", 173, 181]]], ["For example, although mild to moderate oxidative stress may initiate intrinsic pathways of apoptotic cell death, processes leading to marked oxidative stress typically cause cell death by necrosis, not only resulting from the severity of mitochondrial damage, but also by direct inhibition of the proapoptotic caspase cascade.NecrosisLoss of cell anchorage to the extracellular matrix can activate a form of programmed cell death related to apoptosis that is termed anoikis.", [["cell", "ANATOMY", 101, 105], ["cell", "ANATOMY", 174, 178], ["mitochondrial", "ANATOMY", 238, 251], ["cell", "ANATOMY", 342, 346], ["extracellular matrix", "ANATOMY", 364, 384], ["cell", "ANATOMY", 419, 423], ["death", "DISEASE", 179, 184], ["necrosis", "DISEASE", 188, 196], ["mitochondrial damage", "DISEASE", 238, 258], ["death", "DISEASE", 424, 429], ["cell", "CELL", 101, 105], ["cell", "CELL", 174, 178], ["mitochondrial", "CELLULAR_COMPONENT", 238, 251], ["caspase", "GENE_OR_GENE_PRODUCT", 310, 317], ["cell", "CELL", 342, 346], ["extracellular matrix", "CELLULAR_COMPONENT", 364, 384], ["cell", "CELL", 419, 423], ["caspase", "PROTEIN", 310, 317], ["mild to moderate oxidative stress", "PROBLEM", 22, 55], ["apoptotic cell death", "PROBLEM", 91, 111], ["marked oxidative stress", "PROBLEM", 134, 157], ["cell death", "PROBLEM", 174, 184], ["necrosis", "PROBLEM", 188, 196], ["mitochondrial damage", "PROBLEM", 238, 258], ["the proapoptotic caspase cascade", "TREATMENT", 293, 325], ["NecrosisLoss of cell anchorage", "PROBLEM", 326, 356], ["programmed cell death", "PROBLEM", 408, 429], ["apoptosis", "PROBLEM", 441, 450], ["mild", "OBSERVATION_MODIFIER", 22, 26], ["moderate", "OBSERVATION_MODIFIER", 30, 38], ["oxidative stress", "OBSERVATION", 39, 55], ["apoptotic cell death", "OBSERVATION", 91, 111], ["marked", "OBSERVATION_MODIFIER", 134, 140], ["oxidative stress", "OBSERVATION", 141, 157], ["cell death", "OBSERVATION", 174, 184], ["necrosis", "OBSERVATION", 188, 196], ["mitochondrial damage", "OBSERVATION", 238, 258], ["cell anchorage", "OBSERVATION", 342, 356], ["programmed cell death", "OBSERVATION", 408, 429], ["apoptosis", "OBSERVATION", 441, 450], ["anoikis", "OBSERVATION", 466, 473]]], ["Detached cells can die intact, as in exfoliation, or undergo typical fragmentation into apoptotic bodies.", [["cells", "ANATOMY", 9, 14], ["exfoliation", "DISEASE", 37, 48], ["cells", "CELL", 9, 14], ["Detached cells", "PROBLEM", 0, 14], ["exfoliation", "PROBLEM", 37, 48], ["typical fragmentation into apoptotic bodies", "PROBLEM", 61, 104], ["typical", "OBSERVATION_MODIFIER", 61, 68], ["fragmentation", "OBSERVATION", 69, 82], ["apoptotic bodies", "OBSERVATION", 88, 104]]], ["Hepatocyte survival in vitro depends on their integrins that adhere unlike apoptosis, the removal of water is not an active process, and the affected cells do not undergo spontaneous fragmentation.", [["Hepatocyte", "ANATOMY", 0, 10], ["cells", "ANATOMY", 150, 155], ["Hepatocyte", "CELL", 0, 10], ["integrins", "GENE_OR_GENE_PRODUCT", 46, 55], ["water", "SIMPLE_CHEMICAL", 101, 106], ["cells", "CELL", 150, 155], ["integrins", "PROTEIN", 46, 55], ["Hepatocyte survival", "TREATMENT", 0, 19], ["apoptosis", "PROBLEM", 75, 84], ["the removal of water", "TREATMENT", 86, 106], ["an active process", "PROBLEM", 114, 131], ["the affected cells", "PROBLEM", 137, 155], ["spontaneous fragmentation", "PROBLEM", 171, 196], ["survival", "OBSERVATION_MODIFIER", 11, 19], ["apoptosis", "OBSERVATION", 75, 84], ["active", "OBSERVATION_MODIFIER", 117, 123], ["process", "OBSERVATION", 124, 131], ["spontaneous", "OBSERVATION_MODIFIER", 171, 182], ["fragmentation", "OBSERVATION", 183, 196]]], ["It seems that coagulative necrosis, which is often seen in acute hepatotoxicity, is the result of sudden and catastrophic denaturation of cytosolic protein, which imparts a rather dense, rigid texture to the dead cells, somewhat preserving their shape.", [["cytosolic", "ANATOMY", 138, 147], ["cells", "ANATOMY", 213, 218], ["necrosis", "DISEASE", 26, 34], ["hepatotoxicity", "DISEASE", 65, 79], ["cells", "CELL", 213, 218], ["cytosolic protein", "PROTEIN", 138, 155], ["dead cells", "CELL_TYPE", 208, 218], ["coagulative necrosis", "PROBLEM", 14, 34], ["acute hepatotoxicity", "PROBLEM", 59, 79], ["sudden and catastrophic denaturation of cytosolic protein", "PROBLEM", 98, 155], ["a rather dense, rigid texture to the dead cells", "PROBLEM", 171, 218], ["coagulative", "OBSERVATION_MODIFIER", 14, 25], ["necrosis", "OBSERVATION", 26, 34], ["acute", "OBSERVATION_MODIFIER", 59, 64], ["hepatotoxicity", "OBSERVATION", 65, 79], ["sudden", "OBSERVATION_MODIFIER", 98, 104], ["catastrophic", "OBSERVATION_MODIFIER", 109, 121], ["denaturation", "OBSERVATION", 122, 134], ["cytosolic protein", "OBSERVATION", 138, 155], ["dense", "OBSERVATION_MODIFIER", 180, 185], ["rigid texture", "OBSERVATION", 187, 200], ["dead cells", "OBSERVATION", 208, 218], ["shape", "OBSERVATION_MODIFIER", 246, 251]]], ["The term lytic necrosis has been used for areas of necrosis in which the hepatocytes are disintegrating, usually in the presence of infiltrating phagocytes, especially neutrophils.", [["hepatocytes", "ANATOMY", 73, 84], ["infiltrating phagocytes", "ANATOMY", 132, 155], ["neutrophils", "ANATOMY", 168, 179], ["necrosis", "DISEASE", 15, 23], ["necrosis", "DISEASE", 51, 59], ["hepatocytes", "CELL", 73, 84], ["phagocytes", "CELL", 145, 155], ["neutrophils", "CELL", 168, 179], ["hepatocytes", "CELL_TYPE", 73, 84], ["infiltrating phagocytes", "CELL_TYPE", 132, 155], ["neutrophils", "CELL_TYPE", 168, 179], ["The term lytic necrosis", "PROBLEM", 0, 23], ["necrosis", "PROBLEM", 51, 59], ["infiltrating phagocytes", "PROBLEM", 132, 155], ["neutrophils", "PROBLEM", 168, 179], ["term", "OBSERVATION_MODIFIER", 4, 8], ["lytic", "OBSERVATION_MODIFIER", 9, 14], ["necrosis", "OBSERVATION", 15, 23], ["necrosis", "OBSERVATION", 51, 59], ["hepatocytes", "ANATOMY", 73, 84], ["infiltrating phagocytes", "OBSERVATION", 132, 155]]], ["This is consistent with the later stages of postnecrotic inflammation that follow necrosis rather than apoptosis.NecrosisOne might expect that the different types of cell death might be informative in relation to causes and pathogenesis.", [["cell", "ANATOMY", 166, 170], ["inflammation", "DISEASE", 57, 69], ["necrosis", "DISEASE", 82, 90], ["Necrosis", "DISEASE", 113, 121], ["death", "DISEASE", 171, 176], ["cell", "CELL", 166, 170], ["postnecrotic inflammation", "PROBLEM", 44, 69], ["necrosis", "PROBLEM", 82, 90], ["apoptosis", "PROBLEM", 103, 112], ["Necrosis", "PROBLEM", 113, 121], ["cell death", "PROBLEM", 166, 176], ["pathogenesis", "PROBLEM", 224, 236], ["consistent with", "UNCERTAINTY", 8, 23], ["postnecrotic", "OBSERVATION_MODIFIER", 44, 56], ["inflammation", "OBSERVATION", 57, 69], ["necrosis", "OBSERVATION", 82, 90], ["cell death", "OBSERVATION", 166, 176]]], ["However, apoptosis, necrosis, and mixed responses are common in liver injury in vivo.", [["liver", "ANATOMY", 64, 69], ["necrosis", "DISEASE", 20, 28], ["liver injury", "DISEASE", 64, 76], ["liver", "ORGAN", 64, 69], ["apoptosis", "PROBLEM", 9, 18], ["necrosis", "PROBLEM", 20, 28], ["liver injury", "PROBLEM", 64, 76], ["apoptosis", "OBSERVATION_MODIFIER", 9, 18], ["necrosis", "OBSERVATION", 20, 28], ["mixed", "OBSERVATION_MODIFIER", 34, 39], ["liver", "ANATOMY", 64, 69], ["injury", "OBSERVATION", 70, 76]]], ["Many insults can initiate either necrosis or apoptosis of hepatocytes; these include hypoxia, reactive oxygen metabolites, hepatotoxic chemicals, viral infections, bacterial toxins, and inflammation.", [["hepatocytes", "ANATOMY", 58, 69], ["necrosis", "DISEASE", 33, 41], ["hypoxia", "DISEASE", 85, 92], ["oxygen", "CHEMICAL", 103, 109], ["viral infections", "DISEASE", 146, 162], ["inflammation", "DISEASE", 186, 198], ["oxygen", "CHEMICAL", 103, 109], ["hepatocytes", "CELL", 58, 69], ["reactive oxygen metabolites", "SIMPLE_CHEMICAL", 94, 121], ["hepatocytes", "CELL_TYPE", 58, 69], ["Many insults", "PROBLEM", 0, 12], ["necrosis", "PROBLEM", 33, 41], ["apoptosis of hepatocytes", "PROBLEM", 45, 69], ["hypoxia", "PROBLEM", 85, 92], ["reactive oxygen metabolites", "PROBLEM", 94, 121], ["hepatotoxic chemicals", "PROBLEM", 123, 144], ["viral infections", "PROBLEM", 146, 162], ["bacterial toxins", "PROBLEM", 164, 180], ["inflammation", "PROBLEM", 186, 198], ["necrosis", "OBSERVATION", 33, 41], ["hepatocytes", "ANATOMY", 58, 69], ["hypoxia", "OBSERVATION", 85, 92], ["reactive", "OBSERVATION_MODIFIER", 94, 102], ["oxygen metabolites", "OBSERVATION", 103, 121], ["hepatotoxic chemicals", "OBSERVATION", 123, 144], ["viral", "OBSERVATION_MODIFIER", 146, 151], ["infections", "OBSERVATION", 152, 162], ["bacterial toxins", "OBSERVATION", 164, 180], ["inflammation", "OBSERVATION", 186, 198]]], ["Some of the molecular events are common to both.", [["the molecular events", "PROBLEM", 8, 28]]], ["Mitochondrial damage and several other activation responses are common to apoptosis and necrosis, and programmed cell death responses can be activated before they are overwhelmed by more intense injury responsible for necrosis.", [["Mitochondrial", "ANATOMY", 0, 13], ["cell", "ANATOMY", 113, 117], ["necrosis", "DISEASE", 88, 96], ["necrosis", "DISEASE", 218, 226], ["Mitochondrial", "CELLULAR_COMPONENT", 0, 13], ["cell", "CELL", 113, 117], ["Mitochondrial damage", "PROBLEM", 0, 20], ["several other activation responses", "PROBLEM", 25, 59], ["apoptosis", "PROBLEM", 74, 83], ["necrosis", "PROBLEM", 88, 96], ["necrosis", "PROBLEM", 218, 226], ["damage", "OBSERVATION", 14, 20], ["necrosis", "OBSERVATION", 88, 96], ["necrosis", "OBSERVATION", 218, 226]]], ["Susceptibility therefore depends on many factors, including the level and duration of insults, replication status, and integrity of the various homeostatic and cytoprotective functions.", [["insults", "PROBLEM", 86, 93], ["cytoprotective functions", "OBSERVATION", 160, 184]]], ["Indeed, review of caspasecleaved substrates reveals that different toxic drugs do not cause a uniform pattern of caspase activation and that it is likely that there are distinct pathophysiologic pathways of apoptosis.", [["caspase", "GENE_OR_GENE_PRODUCT", 113, 120], ["caspase", "PROTEIN", 113, 120], ["different toxic drugs", "PROBLEM", 57, 78], ["caspase activation", "PROBLEM", 113, 131], ["apoptosis", "PROBLEM", 207, 216], ["caspase activation", "OBSERVATION", 113, 131], ["is likely", "UNCERTAINTY", 144, 153], ["distinct", "OBSERVATION_MODIFIER", 169, 177], ["apoptosis", "OBSERVATION", 207, 216]]], ["Clearly, apoptosis is not a consistent and stereotypic response.NecrosisThere are important misconceptions regarding differences between apoptosis and necrosis and their effects on the liver.", [["liver", "ANATOMY", 185, 190], ["Necrosis", "DISEASE", 64, 72], ["necrosis", "DISEASE", 151, 159], ["liver", "ORGAN", 185, 190], ["Necrosis", "PROBLEM", 64, 72], ["apoptosis", "PROBLEM", 137, 146], ["necrosis", "PROBLEM", 151, 159], ["their effects on the liver", "PROBLEM", 164, 190], ["apoptosis", "OBSERVATION", 9, 18], ["not a consistent", "UNCERTAINTY", 22, 38], ["necrosis", "OBSERVATION", 151, 159], ["liver", "ANATOMY", 185, 190]]], ["It is often assumed that apoptosis, unlike necrosis, leads to a \"clean\" death that does not provoke inflammation or elevation of transaminases and other markers of inflammation.", [["necrosis", "DISEASE", 43, 51], ["death", "DISEASE", 72, 77], ["inflammation", "DISEASE", 100, 112], ["inflammation", "DISEASE", 164, 176], ["transaminases", "SIMPLE_CHEMICAL", 129, 142], ["apoptosis", "PROBLEM", 25, 34], ["necrosis", "PROBLEM", 43, 51], ["a \"clean\" death", "PROBLEM", 62, 77], ["inflammation", "PROBLEM", 100, 112], ["elevation of transaminases", "PROBLEM", 116, 142], ["inflammation", "PROBLEM", 164, 176], ["apoptosis", "OBSERVATION", 25, 34], ["necrosis", "OBSERVATION", 43, 51], ["not provoke", "UNCERTAINTY", 88, 99], ["inflammation", "OBSERVATION", 100, 112], ["elevation", "OBSERVATION_MODIFIER", 116, 125], ["transaminases", "OBSERVATION", 129, 142], ["inflammation", "OBSERVATION", 164, 176]]], ["However, there is evidence that phagocytosis of apoptotic bodies, termed efferocytosis, particularly by Kupffer cells can, in fact, activate the Kupffer cells and stimulate additional cell death.", [["bodies", "ANATOMY", 58, 64], ["Kupffer cells", "ANATOMY", 104, 117], ["Kupffer cells", "ANATOMY", 145, 158], ["cell", "ANATOMY", 184, 188], ["death", "DISEASE", 189, 194], ["apoptotic bodies", "CELLULAR_COMPONENT", 48, 64], ["Kupffer cells", "CELL", 104, 117], ["Kupffer cells", "CELL", 145, 158], ["cell", "CELL", 184, 188], ["Kupffer cells", "CELL_TYPE", 104, 117], ["Kupffer cells", "CELL_TYPE", 145, 158], ["phagocytosis of apoptotic bodies", "PROBLEM", 32, 64], ["termed efferocytosis", "PROBLEM", 66, 86], ["the Kupffer cells", "TREATMENT", 141, 158], ["additional cell death", "PROBLEM", 173, 194], ["phagocytosis", "OBSERVATION_MODIFIER", 32, 44], ["apoptotic bodies", "OBSERVATION", 48, 64], ["efferocytosis", "OBSERVATION", 73, 86]]], ["Various inflammatory markers are elevated in both acute and chronic apoptosis.", [["inflammatory markers", "PROTEIN", 8, 28], ["Various inflammatory markers", "TEST", 0, 28], ["elevated", "PROBLEM", 33, 41], ["both acute and chronic apoptosis", "PROBLEM", 45, 77], ["inflammatory", "OBSERVATION", 8, 20], ["elevated", "OBSERVATION_MODIFIER", 33, 41], ["both", "OBSERVATION_MODIFIER", 45, 49], ["acute", "OBSERVATION_MODIFIER", 50, 55], ["chronic", "OBSERVATION_MODIFIER", 60, 67], ["apoptosis", "OBSERVATION", 68, 77]]], ["The view that apoptosis, because it involves release of intact membrane bodies, does not lead to transaminase elevation has been shown to be incorrect in several studies.", [["membrane bodies", "ANATOMY", 63, 78], ["membrane bodies", "CELLULAR_COMPONENT", 63, 78], ["transaminase", "SIMPLE_CHEMICAL", 97, 109], ["apoptosis", "PROBLEM", 14, 23], ["transaminase elevation", "PROBLEM", 97, 119], ["several studies", "TEST", 154, 169], ["apoptosis", "OBSERVATION", 14, 23], ["intact membrane bodies", "OBSERVATION", 56, 78]]], ["Injection of Fas ligands has been shown to produce significant increases in serum transaminases within hours and that this response is blocked in Bcl-2 transgenic mice.", [["serum", "ANATOMY", 76, 81], ["Fas", "GENE_OR_GENE_PRODUCT", 13, 16], ["serum", "ORGANISM_SUBSTANCE", 76, 81], ["transaminases", "SIMPLE_CHEMICAL", 82, 95], ["Bcl-2", "GENE_OR_GENE_PRODUCT", 146, 151], ["mice", "ORGANISM", 163, 167], ["Fas ligands", "PROTEIN", 13, 24], ["serum transaminases", "PROTEIN", 76, 95], ["Bcl", "PROTEIN", 146, 149], ["mice", "SPECIES", 163, 167], ["mice", "SPECIES", 163, 167], ["Fas ligands", "TEST", 13, 24], ["significant increases in serum transaminases", "PROBLEM", 51, 95], ["Bcl", "TEST", 146, 149], ["significant", "OBSERVATION_MODIFIER", 51, 62], ["increases", "OBSERVATION_MODIFIER", 63, 72]]], ["In addition, deletion of anti-apoptotic proteins results in elevated transaminase levels.Other forms of cell deathThere are a number of other forms of cell death.", [["cell", "ANATOMY", 104, 108], ["cell", "ANATOMY", 151, 155], ["death", "DISEASE", 156, 161], ["cell", "CELL", 104, 108], ["cell", "CELL", 151, 155], ["anti-apoptotic proteins", "PROTEIN", 25, 48], ["anti-apoptotic proteins", "TEST", 25, 48], ["elevated transaminase levels", "PROBLEM", 60, 88], ["cell deathThere", "PROBLEM", 104, 119], ["cell death", "PROBLEM", 151, 161], ["elevated", "OBSERVATION_MODIFIER", 60, 68], ["transaminase levels", "OBSERVATION", 69, 88], ["cell deathThere", "OBSERVATION", 104, 119], ["cell death", "OBSERVATION", 151, 161]]], ["These include autophagy, pyroptosis, necroptosis, entosis, netosis, and parthanatos, which can be identified by biochemical means and specific forms of inhibition.", [["pyroptosis", "DISEASE", 25, 35], ["necroptosis", "DISEASE", 37, 48], ["entosis", "DISEASE", 50, 57], ["netosis", "DISEASE", 59, 66], ["autophagy", "PROBLEM", 14, 23], ["pyroptosis", "PROBLEM", 25, 35], ["necroptosis", "PROBLEM", 37, 48], ["entosis", "PROBLEM", 50, 57], ["netosis", "PROBLEM", 59, 66], ["parthanatos", "PROBLEM", 72, 83], ["autophagy", "OBSERVATION", 14, 23], ["pyroptosis", "OBSERVATION", 25, 35], ["necroptosis", "OBSERVATION", 37, 48]]], ["A complete description is beyond the scope of this text.Tissue patterns of cell death Focal necrosisFocal necrosis is very common in autopsy material.", [["Tissue", "ANATOMY", 56, 62], ["cell", "ANATOMY", 75, 79], ["death", "DISEASE", 80, 85], ["necrosis", "DISEASE", 106, 114], ["Tissue", "TISSUE", 56, 62], ["cell", "CELL", 75, 79], ["cell death", "PROBLEM", 75, 85], ["Focal necrosisFocal necrosis", "PROBLEM", 86, 114], ["cell death", "OBSERVATION", 75, 85], ["Focal", "OBSERVATION_MODIFIER", 86, 91], ["necrosisFocal", "OBSERVATION_MODIFIER", 92, 105], ["necrosis", "OBSERVATION", 106, 114]]], ["The lesions are microscopic or barely visible to the naked eye and are usually numerous.", [["lesions", "ANATOMY", 4, 11], ["eye", "ANATOMY", 59, 62], ["lesions", "CANCER", 4, 11], ["eye", "ORGAN", 59, 62], ["The lesions", "PROBLEM", 0, 11], ["lesions", "OBSERVATION", 4, 11], ["microscopic", "OBSERVATION", 16, 27], ["barely", "OBSERVATION_MODIFIER", 31, 37], ["visible", "OBSERVATION_MODIFIER", 38, 45], ["eye", "ANATOMY", 59, 62]]], ["Their designation as focal depends on their size and on a random distribution relative to the lobules.", [["lobules", "ANATOMY", 94, 101], ["lobules", "MULTI-TISSUE_STRUCTURE", 94, 101], ["focal", "OBSERVATION_MODIFIER", 21, 26], ["size", "OBSERVATION_MODIFIER", 44, 48], ["lobules", "ANATOMY", 94, 101]]], ["There lack sufficient energy to maintain membrane associated ionic pumps, leading to swelling and gross calcium influxes that result in disruption of the mitochondrial and plasma membranes, including release of lysosomal enzymes.", [["membrane", "ANATOMY", 41, 49], ["mitochondrial", "ANATOMY", 154, 167], ["plasma membranes", "ANATOMY", 172, 188], ["lysosomal", "ANATOMY", 211, 220], ["swelling", "DISEASE", 85, 93], ["calcium", "CHEMICAL", 104, 111], ["calcium", "CHEMICAL", 104, 111], ["membrane", "CELLULAR_COMPONENT", 41, 49], ["calcium", "SIMPLE_CHEMICAL", 104, 111], ["mitochondrial", "CELLULAR_COMPONENT", 154, 167], ["plasma membranes", "CELLULAR_COMPONENT", 172, 188], ["lysosomal enzymes", "GENE_OR_GENE_PRODUCT", 211, 228], ["lysosomal enzymes", "PROTEIN", 211, 228], ["membrane associated ionic pumps", "PROBLEM", 41, 72], ["swelling", "PROBLEM", 85, 93], ["gross calcium influxes", "PROBLEM", 98, 120], ["disruption of the mitochondrial and plasma membranes", "PROBLEM", 136, 188], ["lysosomal enzymes", "TEST", 211, 228], ["ionic pumps", "OBSERVATION", 61, 72], ["swelling", "OBSERVATION", 85, 93], ["gross", "OBSERVATION_MODIFIER", 98, 103], ["calcium influxes", "OBSERVATION", 104, 120], ["mitochondrial", "ANATOMY", 154, 167], ["plasma membranes", "OBSERVATION", 172, 188]]], ["Oncosis is generally regarded as a severe injury to cell membrane integrity or other vital functions, leading to enzyme leakage, inflammation, and tissue repair.", [["cell membrane", "ANATOMY", 52, 65], ["tissue", "ANATOMY", 147, 153], ["Oncosis", "DISEASE", 0, 7], ["inflammation", "DISEASE", 129, 141], ["cell membrane", "CELLULAR_COMPONENT", 52, 65], ["tissue", "TISSUE", 147, 153], ["a severe injury", "PROBLEM", 33, 48], ["cell membrane integrity", "PROBLEM", 52, 75], ["enzyme leakage", "PROBLEM", 113, 127], ["inflammation", "PROBLEM", 129, 141], ["tissue repair", "TREATMENT", 147, 160], ["severe", "OBSERVATION_MODIFIER", 35, 41], ["injury", "OBSERVATION", 42, 48], ["cell membrane", "OBSERVATION", 52, 65], ["leakage", "OBSERVATION", 120, 127], ["inflammation", "OBSERVATION", 129, 141], ["tissue repair", "OBSERVATION", 147, 160]]], ["Release of cellular contents typically elicits a secondary inflammatory response and provides the serum enzymes that are useful clinically to detect liver necrosis.", [["cellular", "ANATOMY", 11, 19], ["serum", "ANATOMY", 98, 103], ["liver", "ANATOMY", 149, 154], ["liver necrosis", "DISEASE", 149, 163], ["cellular", "CELL", 11, 19], ["serum", "ORGANISM_SUBSTANCE", 98, 103], ["liver", "ORGAN", 149, 154], ["serum enzymes", "PROTEIN", 98, 111], ["a secondary inflammatory response", "PROBLEM", 47, 80], ["the serum enzymes", "TEST", 94, 111], ["liver necrosis", "PROBLEM", 149, 163], ["cellular contents", "OBSERVATION", 11, 28], ["secondary", "OBSERVATION_MODIFIER", 49, 58], ["inflammatory", "OBSERVATION", 59, 71], ["liver", "ANATOMY", 149, 154], ["necrosis", "OBSERVATION", 155, 163]]], ["However, these sequelae can also occur after hepatocyte apoptosis, either because the capacity for phagocytic removal of dead cells is exceeded, or because the insult worsens such that necrosis may supervene.Tissue patterns of cell death Focal necrosisNecrosis is often a consequence of profound loss of mitochondrial function involving the opening of the membrane permeability transition (MPT) pore, a megachannel composed of inner-and outer-membrane proteins.", [["hepatocyte", "ANATOMY", 45, 55], ["cells", "ANATOMY", 126, 131], ["Tissue", "ANATOMY", 208, 214], ["cell", "ANATOMY", 227, 231], ["mitochondrial", "ANATOMY", 304, 317], ["membrane", "ANATOMY", 356, 364], ["outer-membrane", "ANATOMY", 437, 451], ["necrosis", "DISEASE", 185, 193], ["death", "DISEASE", 232, 237], ["necrosis", "DISEASE", 244, 252], ["Necrosis", "DISEASE", 252, 260], ["hepatocyte", "CELL", 45, 55], ["cells", "CELL", 126, 131], ["Tissue", "TISSUE", 208, 214], ["cell", "CELL", 227, 231], ["mitochondrial", "CELLULAR_COMPONENT", 304, 317], ["membrane", "CELLULAR_COMPONENT", 356, 364], ["outer-membrane", "CELLULAR_COMPONENT", 437, 451], ["dead cells", "CELL_TYPE", 121, 131], ["inner-and outer-membrane proteins", "PROTEIN", 427, 460], ["these sequelae", "PROBLEM", 9, 23], ["hepatocyte apoptosis", "PROBLEM", 45, 65], ["the capacity", "PROBLEM", 82, 94], ["phagocytic removal", "TREATMENT", 99, 117], ["dead cells", "PROBLEM", 121, 131], ["the insult", "PROBLEM", 156, 166], ["necrosis", "PROBLEM", 185, 193], ["cell death", "PROBLEM", 227, 237], ["Focal necrosisNecrosis", "PROBLEM", 238, 260], ["profound loss of mitochondrial function", "PROBLEM", 287, 326], ["inner-and outer-membrane proteins", "TREATMENT", 427, 460], ["sequelae", "OBSERVATION", 15, 23], ["dead cells", "OBSERVATION", 121, 131], ["necrosis", "OBSERVATION", 185, 193], ["cell", "OBSERVATION", 227, 231], ["death", "OBSERVATION_MODIFIER", 232, 237], ["Focal", "OBSERVATION_MODIFIER", 238, 243], ["necrosis", "OBSERVATION_MODIFIER", 244, 252], ["Necrosis", "OBSERVATION", 252, 260], ["profound", "OBSERVATION_MODIFIER", 287, 295], ["loss", "OBSERVATION_MODIFIER", 296, 300], ["mitochondrial function", "OBSERVATION", 304, 326], ["membrane permeability", "OBSERVATION", 356, 377], ["membrane proteins", "OBSERVATION", 443, 460]]], ["This results in mitochondrial depolarization and ATP depletion because of inhibited oxidative phosphorylation.", [["mitochondrial", "ANATOMY", 16, 29], ["ATP", "CHEMICAL", 49, 52], ["ATP", "CHEMICAL", 49, 52], ["mitochondrial", "CELLULAR_COMPONENT", 16, 29], ["ATP", "SIMPLE_CHEMICAL", 49, 52], ["mitochondrial depolarization", "PROBLEM", 16, 44], ["ATP depletion", "PROBLEM", 49, 62], ["inhibited oxidative phosphorylation", "PROBLEM", 74, 109], ["mitochondrial depolarization", "OBSERVATION", 16, 44], ["ATP depletion", "OBSERVATION", 49, 62], ["oxidative phosphorylation", "OBSERVATION", 84, 109]]], ["Poly-ADP-ribose polymerase (PARP) is a DNA repair enzyme that can deplete injured cells of available ATP when it is activated to repair the multitude of DNA strand breaks induced by cell damage.", [["cells", "ANATOMY", 82, 87], ["cell", "ANATOMY", 182, 186], ["Poly-ADP-ribose", "CHEMICAL", 0, 15], ["ATP", "CHEMICAL", 101, 104], ["Poly-ADP-ribose", "CHEMICAL", 0, 15], ["ATP", "CHEMICAL", 101, 104], ["Poly-ADP-ribose polymerase", "GENE_OR_GENE_PRODUCT", 0, 26], ["PARP", "GENE_OR_GENE_PRODUCT", 28, 32], ["DNA", "CELLULAR_COMPONENT", 39, 42], ["cells", "CELL", 82, 87], ["ATP", "SIMPLE_CHEMICAL", 101, 104], ["DNA", "CELLULAR_COMPONENT", 153, 156], ["cell", "CELL", 182, 186], ["Poly-ADP-ribose polymerase", "PROTEIN", 0, 26], ["PARP", "PROTEIN", 28, 32], ["DNA repair enzyme", "PROTEIN", 39, 56], ["injured cells", "CELL_TYPE", 74, 87], ["Poly-ADP-ribose polymerase (PARP", "TREATMENT", 0, 32], ["a DNA repair enzyme", "TREATMENT", 37, 56], ["injured cells", "PROBLEM", 74, 87], ["ATP", "PROBLEM", 101, 104], ["repair", "TREATMENT", 129, 135], ["DNA strand breaks", "PROBLEM", 153, 170], ["cell damage", "PROBLEM", 182, 193], ["strand breaks", "OBSERVATION", 157, 170], ["cell damage", "OBSERVATION", 182, 193]]], ["Conversely, PARP is swiftly cleaved in apoptosis to maintain ATP levels.", [["ATP", "CHEMICAL", 61, 64], ["ATP", "CHEMICAL", 61, 64], ["PARP", "GENE_OR_GENE_PRODUCT", 12, 16], ["ATP", "SIMPLE_CHEMICAL", 61, 64], ["PARP", "PROTEIN", 12, 16], ["PARP", "PROBLEM", 12, 16], ["ATP levels", "TEST", 61, 71]]], ["Much of the ATP in hepatocytes is used for membrane homeostasis of Na + , K + , and Ca 2+ ions.", [["hepatocytes", "ANATOMY", 19, 30], ["membrane", "ANATOMY", 43, 51], ["ATP", "CHEMICAL", 12, 15], ["Na", "CHEMICAL", 67, 69], ["K", "CHEMICAL", 74, 75], ["Ca", "CHEMICAL", 84, 86], ["ATP", "CHEMICAL", 12, 15], ["Na +", "CHEMICAL", 67, 71], ["K +", "CHEMICAL", 74, 77], ["Ca 2+", "CHEMICAL", 84, 89], ["ATP", "SIMPLE_CHEMICAL", 12, 15], ["hepatocytes", "CELL", 19, 30], ["membrane", "CELLULAR_COMPONENT", 43, 51], ["Na +", "SIMPLE_CHEMICAL", 67, 71], ["K +", "SIMPLE_CHEMICAL", 74, 77], ["Ca 2+ ions", "SIMPLE_CHEMICAL", 84, 94], ["hepatocytes", "CELL_TYPE", 19, 30], ["the ATP in hepatocytes", "TEST", 8, 30], ["membrane homeostasis", "TEST", 43, 63], ["Na", "TEST", 67, 69], ["K", "TEST", 74, 75], ["Ca", "TEST", 84, 86], ["hepatocytes", "ANATOMY", 19, 30]]], ["ATP depletion or physical damage to membranes of the cell surface, mitochondria, and ER leads to loss of ion homeostasis, altered cellular volume regulation, and increased intracellular calcium ion concentrations.", [["membranes", "ANATOMY", 36, 45], ["cell surface", "ANATOMY", 53, 65], ["mitochondria", "ANATOMY", 67, 79], ["ER", "ANATOMY", 85, 87], ["cellular", "ANATOMY", 130, 138], ["intracellular", "ANATOMY", 172, 185], ["ATP", "CHEMICAL", 0, 3], ["calcium", "CHEMICAL", 186, 193], ["ATP", "CHEMICAL", 0, 3], ["calcium", "CHEMICAL", 186, 193], ["ATP", "SIMPLE_CHEMICAL", 0, 3], ["membranes", "CELLULAR_COMPONENT", 36, 45], ["cell surface", "CELLULAR_COMPONENT", 53, 65], ["mitochondria", "CELLULAR_COMPONENT", 67, 79], ["ER", "GENE_OR_GENE_PRODUCT", 85, 87], ["ion", "SIMPLE_CHEMICAL", 105, 108], ["cellular", "CELL", 130, 138], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 172, 185], ["calcium", "SIMPLE_CHEMICAL", 186, 193], ["ER", "PROTEIN", 85, 87], ["ATP depletion", "PROBLEM", 0, 13], ["physical damage to membranes", "PROBLEM", 17, 45], ["loss of ion homeostasis", "PROBLEM", 97, 120], ["altered cellular volume regulation", "PROBLEM", 122, 156], ["increased intracellular calcium ion concentrations", "PROBLEM", 162, 212], ["depletion", "OBSERVATION", 4, 13], ["physical", "OBSERVATION_MODIFIER", 17, 25], ["damage", "OBSERVATION", 26, 32], ["cell", "OBSERVATION", 53, 57], ["surface", "OBSERVATION_MODIFIER", 58, 65], ["ion homeostasis", "OBSERVATION", 105, 120], ["cellular volume regulation", "OBSERVATION", 130, 156], ["increased", "OBSERVATION_MODIFIER", 162, 171], ["intracellular calcium", "OBSERVATION", 172, 193]]], ["Activation of calcium-dependent endonucleases, proteases (e.g., calpains), and phospholipases is responsible for the terminal events in necrosis.", [["calcium", "CHEMICAL", 14, 21], ["necrosis", "DISEASE", 136, 144], ["calcium", "CHEMICAL", 14, 21], ["calcium", "SIMPLE_CHEMICAL", 14, 21], ["calpains", "GENE_OR_GENE_PRODUCT", 64, 72], ["calcium-dependent endonucleases", "PROTEIN", 14, 45], ["proteases", "PROTEIN", 47, 56], ["calpains", "PROTEIN", 64, 72], ["phospholipases", "PROTEIN", 79, 93], ["calcium-dependent endonucleases", "TREATMENT", 14, 45], ["proteases", "PROBLEM", 47, 56], ["phospholipases", "PROBLEM", 79, 93], ["the terminal events", "PROBLEM", 113, 132], ["necrosis", "PROBLEM", 136, 144], ["necrosis", "OBSERVATION", 136, 144]]], ["The source of calcium may influence the type of cell death, as calcium influx from the plasma membrane is associated with necrosis, but calcium released from the ER is more likely to trigger apoptosis.", [["cell", "ANATOMY", 48, 52], ["plasma membrane", "ANATOMY", 87, 102], ["ER", "ANATOMY", 162, 164], ["calcium", "CHEMICAL", 14, 21], ["death", "DISEASE", 53, 58], ["calcium", "CHEMICAL", 63, 70], ["necrosis", "DISEASE", 122, 130], ["calcium", "CHEMICAL", 136, 143], ["calcium", "CHEMICAL", 14, 21], ["calcium", "CHEMICAL", 63, 70], ["calcium", "CHEMICAL", 136, 143], ["calcium", "SIMPLE_CHEMICAL", 14, 21], ["cell", "CELL", 48, 52], ["calcium", "SIMPLE_CHEMICAL", 63, 70], ["plasma membrane", "CELLULAR_COMPONENT", 87, 102], ["calcium", "SIMPLE_CHEMICAL", 136, 143], ["ER", "GENE_OR_GENE_PRODUCT", 162, 164], ["ER", "PROTEIN", 162, 164], ["calcium", "TREATMENT", 14, 21], ["cell death", "PROBLEM", 48, 58], ["calcium influx from the plasma membrane", "PROBLEM", 63, 102], ["necrosis", "PROBLEM", 122, 130], ["calcium", "TEST", 136, 143], ["apoptosis", "PROBLEM", 191, 200], ["plasma membrane", "OBSERVATION_MODIFIER", 87, 102], ["associated with", "UNCERTAINTY", 106, 121], ["necrosis", "OBSERVATION", 122, 130], ["more likely to", "UNCERTAINTY", 168, 182], ["apoptosis", "OBSERVATION", 191, 200]]], ["Newer evidence suggests that necrosis is not entirely a passive process.", [["necrosis", "DISEASE", 29, 37], ["necrosis", "PROBLEM", 29, 37], ["a passive process", "PROBLEM", 54, 71], ["necrosis", "OBSERVATION", 29, 37], ["not entirely", "UNCERTAINTY", 41, 53], ["passive", "OBSERVATION_MODIFIER", 56, 63], ["process", "OBSERVATION", 64, 71]]], ["For example, necrosis can be initiated via cell surface receptor-driven processes when TNF is present in high concentrations.Tissue patterns of cell death Focal necrosisThe term coagulative necrosis may be applied to groups or zones of intact, but dead hepatocytes that have shrunken slightly, stain intensely with eosin, and may have visible but distorted nuclei ( Fig. 2-30 ).", [["cell surface", "ANATOMY", 43, 55], ["Tissue", "ANATOMY", 125, 131], ["cell", "ANATOMY", 144, 148], ["hepatocytes", "ANATOMY", 253, 264], ["nuclei", "ANATOMY", 357, 363], ["necrosis", "DISEASE", 13, 21], ["death", "DISEASE", 149, 154], ["necrosis", "DISEASE", 161, 169], ["necrosis", "DISEASE", 190, 198], ["eosin", "CHEMICAL", 315, 320], ["cell", "CELL", 43, 47], ["TNF", "GENE_OR_GENE_PRODUCT", 87, 90], ["Tissue", "TISSUE", 125, 131], ["cell", "CELL", 144, 148], ["hepatocytes", "CELL", 253, 264], ["eosin", "GENE_OR_GENE_PRODUCT", 315, 320], ["nuclei", "CELLULAR_COMPONENT", 357, 363], ["cell surface receptor", "PROTEIN", 43, 64], ["TNF", "PROTEIN", 87, 90], ["dead hepatocytes", "CELL_TYPE", 248, 264], ["necrosis", "PROBLEM", 13, 21], ["cell surface receptor", "TREATMENT", 43, 64], ["TNF", "PROBLEM", 87, 90], ["cell death", "PROBLEM", 144, 154], ["Focal necrosis", "PROBLEM", 155, 169], ["The term coagulative necrosis", "PROBLEM", 169, 198], ["dead hepatocytes", "PROBLEM", 248, 264], ["eosin", "TEST", 315, 320], ["distorted nuclei", "PROBLEM", 347, 363], ["Fig.", "TEST", 366, 370], ["necrosis", "OBSERVATION", 13, 21], ["high concentrations", "OBSERVATION_MODIFIER", 105, 124], ["cell death", "OBSERVATION", 144, 154], ["Focal", "OBSERVATION_MODIFIER", 155, 160], ["necrosis", "OBSERVATION", 161, 169], ["term", "OBSERVATION_MODIFIER", 173, 177], ["coagulative", "OBSERVATION_MODIFIER", 178, 189], ["necrosis", "OBSERVATION", 190, 198], ["intact", "OBSERVATION", 236, 242], ["hepatocytes", "ANATOMY", 253, 264], ["shrunken", "OBSERVATION_MODIFIER", 275, 283], ["slightly", "OBSERVATION_MODIFIER", 284, 292], ["distorted", "OBSERVATION_MODIFIER", 347, 356], ["nuclei", "OBSERVATION_MODIFIER", 357, 363]]], ["These cells may also be dehydrated but, frank suppuration does not occur.", [["cells", "ANATOMY", 6, 11], ["suppuration", "DISEASE", 46, 57], ["cells", "CELL", 6, 11], ["dehydrated", "PROBLEM", 24, 34], ["frank suppuration", "PROBLEM", 40, 57], ["may also be", "UNCERTAINTY", 12, 23], ["dehydrated", "OBSERVATION", 24, 34], ["frank", "OBSERVATION_MODIFIER", 40, 45], ["suppuration", "OBSERVATION", 46, 57]]], ["This lesion is said to be more frequent in livers from feedlot-fattened cattle.Tissue patterns of cell death Focal necrosisFocal necrosis in biliary obstruction follows rupture of distended canaliculi or smaller cholangioles, with the formation of small bile lakes.", [["lesion", "ANATOMY", 5, 11], ["livers", "ANATOMY", 43, 49], ["Tissue", "ANATOMY", 79, 85], ["cell", "ANATOMY", 98, 102], ["biliary", "ANATOMY", 141, 148], ["canaliculi", "ANATOMY", 190, 200], ["cholangioles", "ANATOMY", 212, 224], ["bile lakes", "ANATOMY", 254, 264], ["death", "DISEASE", 103, 108], ["necrosis", "DISEASE", 129, 137], ["biliary obstruction", "DISEASE", 141, 160], ["cholangioles", "DISEASE", 212, 224], ["livers", "ORGAN", 43, 49], ["cattle", "ORGANISM", 72, 78], ["Tissue", "TISSUE", 79, 85], ["cell", "CELL", 98, 102], ["biliary obstruction", "PATHOLOGICAL_FORMATION", 141, 160], ["canaliculi", "MULTI-TISSUE_STRUCTURE", 190, 200], ["cattle", "SPECIES", 72, 78], ["cattle", "SPECIES", 72, 78], ["This lesion", "PROBLEM", 0, 11], ["cell death", "PROBLEM", 98, 108], ["Focal necrosisFocal necrosis", "PROBLEM", 109, 137], ["biliary obstruction", "PROBLEM", 141, 160], ["rupture of distended canaliculi", "PROBLEM", 169, 200], ["smaller cholangioles", "PROBLEM", 204, 224], ["small bile lakes", "PROBLEM", 248, 264], ["lesion", "OBSERVATION", 5, 11], ["livers", "ANATOMY", 43, 49], ["cell death", "OBSERVATION", 98, 108], ["Focal", "OBSERVATION_MODIFIER", 109, 114], ["necrosisFocal", "OBSERVATION_MODIFIER", 115, 128], ["necrosis", "OBSERVATION", 129, 137], ["biliary", "ANATOMY", 141, 148], ["obstruction", "OBSERVATION", 149, 160], ["rupture", "OBSERVATION", 169, 176], ["distended", "OBSERVATION_MODIFIER", 180, 189], ["canaliculi", "OBSERVATION", 190, 200], ["smaller", "OBSERVATION_MODIFIER", 204, 211], ["cholangioles", "OBSERVATION", 212, 224], ["small", "OBSERVATION_MODIFIER", 248, 253], ["bile lakes", "OBSERVATION", 254, 264]]], ["Necrosis of larger bile ducts caused by neutrophilic cholangitis or destructive cholangitis can also release bile.", [["bile ducts", "ANATOMY", 19, 29], ["neutrophilic cholangitis", "ANATOMY", 40, 64], ["bile", "ANATOMY", 109, 113], ["Necrosis", "DISEASE", 0, 8], ["cholangitis", "DISEASE", 53, 64], ["cholangitis", "DISEASE", 80, 91], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 19, 29], ["neutrophilic cholangitis", "PATHOLOGICAL_FORMATION", 40, 64], ["bile", "MULTI-TISSUE_STRUCTURE", 109, 113], ["Necrosis of larger bile ducts", "PROBLEM", 0, 29], ["neutrophilic cholangitis", "PROBLEM", 40, 64], ["destructive cholangitis", "PROBLEM", 68, 91], ["larger", "OBSERVATION_MODIFIER", 12, 18], ["bile ducts", "ANATOMY", 19, 29], ["neutrophilic", "OBSERVATION_MODIFIER", 40, 52], ["cholangitis", "OBSERVATION", 53, 64], ["destructive", "OBSERVATION_MODIFIER", 68, 79], ["cholangitis", "OBSERVATION", 80, 91], ["bile", "ANATOMY", 109, 113]]], ["The yellow pigment is readily visible microscopically and provokes small granulomas with giant cells.Tissue patterns of cell death Focal necrosisFocal necrosis is of very little functional significance for the liver, even when numerous.", [["yellow pigment", "ANATOMY", 4, 18], ["granulomas", "ANATOMY", 73, 83], ["giant cells", "ANATOMY", 89, 100], ["Tissue", "ANATOMY", 101, 107], ["cell", "ANATOMY", 120, 124], ["liver", "ANATOMY", 210, 215], ["granulomas", "DISEASE", 73, 83], ["death", "DISEASE", 125, 130], ["necrosis", "DISEASE", 151, 159], ["yellow pigment", "TISSUE", 4, 18], ["granulomas", "PATHOLOGICAL_FORMATION", 73, 83], ["giant cells", "CELL", 89, 100], ["Tissue", "TISSUE", 101, 107], ["cell", "CELL", 120, 124], ["liver", "ORGAN", 210, 215], ["giant cells", "CELL_TYPE", 89, 100], ["The yellow pigment", "PROBLEM", 0, 18], ["small granulomas", "PROBLEM", 67, 83], ["giant cells", "PROBLEM", 89, 100], ["cell death", "PROBLEM", 120, 130], ["Focal necrosisFocal necrosis", "PROBLEM", 131, 159], ["yellow pigment", "OBSERVATION", 4, 18], ["visible", "OBSERVATION_MODIFIER", 30, 37], ["small", "OBSERVATION_MODIFIER", 67, 72], ["granulomas", "OBSERVATION", 73, 83], ["giant cells", "OBSERVATION", 89, 100], ["cell death", "OBSERVATION", 120, 130], ["Focal", "OBSERVATION_MODIFIER", 131, 136], ["necrosisFocal", "OBSERVATION_MODIFIER", 137, 150], ["necrosis", "OBSERVATION", 151, 159], ["very little functional", "OBSERVATION_MODIFIER", 166, 188], ["liver", "ANATOMY", 210, 215]]], ["The lesions heal with some scarring, but this too probably disappears in time.", [["lesions", "ANATOMY", 4, 11], ["scarring", "DISEASE", 27, 35], ["lesions", "PATHOLOGICAL_FORMATION", 4, 11], ["The lesions heal", "PROBLEM", 0, 16], ["some scarring", "PROBLEM", 22, 35], ["lesions", "OBSERVATION", 4, 11], ["heal", "OBSERVATION_MODIFIER", 12, 16], ["some", "OBSERVATION_MODIFIER", 22, 26], ["scarring", "OBSERVATION", 27, 35]]], ["They are of diagnostic importance in some diseases such as salmonellosis, and as indicators of possible bacteremia for meat inspectors.Lobular necrosisAlthough various terms are used, the simplest way to visualize these patterns of necrosis is by using the hepatic lobule concept.Lobular necrosisThe time-honored designation \"centrilobular necrosis\" is a common lesion in response to intoxication or hypoxia.", [["meat", "ANATOMY", 119, 123], ["Lobular", "ANATOMY", 135, 142], ["hepatic lobule", "ANATOMY", 257, 271], ["centrilobular", "ANATOMY", 326, 339], ["lesion", "ANATOMY", 362, 368], ["salmonellosis", "DISEASE", 59, 72], ["bacteremia", "DISEASE", 104, 114], ["necrosis", "DISEASE", 232, 240], ["necrosis", "DISEASE", 288, 296], ["necrosis", "DISEASE", 340, 348], ["hypoxia", "DISEASE", 400, 407], ["meat", "ORGANISM_SUBDIVISION", 119, 123], ["hepatic lobule", "MULTI-TISSUE_STRUCTURE", 257, 271], ["some diseases", "PROBLEM", 37, 50], ["salmonellosis", "PROBLEM", 59, 72], ["bacteremia", "PROBLEM", 104, 114], ["Lobular necrosisAlthough various terms", "PROBLEM", 135, 173], ["necrosis", "PROBLEM", 232, 240], ["Lobular necrosis", "PROBLEM", 280, 296], ["centrilobular necrosis", "PROBLEM", 326, 348], ["a common lesion", "PROBLEM", 353, 368], ["intoxication", "PROBLEM", 384, 396], ["hypoxia", "PROBLEM", 400, 407], ["salmonellosis", "OBSERVATION", 59, 72], ["possible", "UNCERTAINTY", 95, 103], ["bacteremia", "OBSERVATION", 104, 114], ["necrosis", "OBSERVATION", 232, 240], ["hepatic", "ANATOMY", 257, 264], ["lobule", "ANATOMY_MODIFIER", 265, 271], ["necrosis", "OBSERVATION", 288, 296], ["centrilobular", "OBSERVATION_MODIFIER", 326, 339], ["necrosis", "OBSERVATION", 340, 348], ["common", "OBSERVATION_MODIFIER", 355, 361], ["lesion", "OBSERVATION", 362, 368], ["hypoxia", "OBSERVATION", 400, 407]]], ["Centrilobular (zone 3) necrosis is the most common form of zonal necrosis in domestic animals.", [["necrosis", "DISEASE", 23, 31], ["necrosis", "DISEASE", 65, 73], ["Centrilobular (zone 3) necrosis", "PROBLEM", 0, 31], ["zonal necrosis", "PROBLEM", 59, 73], ["zone", "OBSERVATION_MODIFIER", 15, 19], ["necrosis", "OBSERVATION", 23, 31], ["most common", "OBSERVATION_MODIFIER", 39, 50], ["zonal", "OBSERVATION_MODIFIER", 59, 64], ["necrosis", "OBSERVATION", 65, 73], ["domestic animals", "OBSERVATION", 77, 93]]], ["The hepatocytes in the centrilobular zone are particularly vulnerable to necrosis, in part because they are farthest from incoming arterial and portal venous blood bearing oxygen and essential nutrients.", [["hepatocytes", "ANATOMY", 4, 15], ["centrilobular zone", "ANATOMY", 23, 41], ["arterial", "ANATOMY", 131, 139], ["portal venous blood", "ANATOMY", 144, 163], ["necrosis", "DISEASE", 73, 81], ["oxygen", "CHEMICAL", 172, 178], ["oxygen", "CHEMICAL", 172, 178], ["hepatocytes", "CELL", 4, 15], ["centrilobular zone", "MULTI-TISSUE_STRUCTURE", 23, 41], ["arterial", "MULTI-TISSUE_STRUCTURE", 131, 139], ["portal venous", "MULTI-TISSUE_STRUCTURE", 144, 157], ["blood", "ORGANISM_SUBSTANCE", 158, 163], ["oxygen", "SIMPLE_CHEMICAL", 172, 178], ["hepatocytes", "CELL_TYPE", 4, 15], ["necrosis", "PROBLEM", 73, 81], ["portal venous blood bearing oxygen", "TREATMENT", 144, 178], ["hepatocytes", "ANATOMY", 4, 15], ["centrilobular", "ANATOMY_MODIFIER", 23, 36], ["zone", "ANATOMY_MODIFIER", 37, 41], ["necrosis", "OBSERVATION", 73, 81], ["arterial", "ANATOMY_MODIFIER", 131, 139], ["portal venous", "ANATOMY", 144, 157], ["blood bearing", "OBSERVATION", 158, 171], ["oxygen", "OBSERVATION_MODIFIER", 172, 178], ["nutrients", "OBSERVATION_MODIFIER", 193, 202]]], ["They also contain the greatest concentration of cytochromes P450 that activate various exogenous compounds into reactive metabolites capable of injuring or killing hepatocytes (see later section on Toxic hepatic disease).Lobular necrosisSevere viral infections, such as canine adenovirus 1 and Rift Valley fever virus, can produce centrilobular necrosis, and the reasons for the increased susceptibility of the hepatocytes of this zone in these diseases are not established.", [["hepatocytes", "ANATOMY", 164, 175], ["hepatic", "ANATOMY", 204, 211], ["centrilobular", "ANATOMY", 331, 344], ["hepatocytes", "ANATOMY", 411, 422], ["Toxic hepatic disease", "DISEASE", 198, 219], ["necrosis", "DISEASE", 229, 237], ["viral infections", "DISEASE", 244, 260], ["Rift Valley fever", "DISEASE", 294, 311], ["necrosis", "DISEASE", 345, 353], ["cytochromes P450", "GENE_OR_GENE_PRODUCT", 48, 64], ["hepatocytes", "CELL", 164, 175], ["hepatic", "ORGAN", 204, 211], ["canine adenovirus 1", "ORGANISM", 270, 289], ["Rift Valley fever virus", "ORGANISM", 294, 317], ["hepatocytes", "CELL", 411, 422], ["cytochromes P450", "PROTEIN", 48, 64], ["killing hepatocytes", "CELL_TYPE", 156, 175], ["hepatocytes", "CELL_TYPE", 411, 422], ["canine adenovirus 1", "SPECIES", 270, 289], ["Rift Valley fever virus", "SPECIES", 294, 317], ["canine adenovirus 1", "SPECIES", 270, 289], ["Rift Valley fever virus", "SPECIES", 294, 317], ["the greatest concentration of cytochromes P450", "TREATMENT", 18, 64], ["injuring", "PROBLEM", 144, 152], ["killing hepatocytes", "PROBLEM", 156, 175], ["Toxic hepatic disease", "PROBLEM", 198, 219], ["Lobular necrosis", "PROBLEM", 221, 237], ["Severe viral infections", "PROBLEM", 237, 260], ["canine adenovirus", "PROBLEM", 270, 287], ["Rift Valley fever virus", "PROBLEM", 294, 317], ["centrilobular necrosis", "PROBLEM", 331, 353], ["the increased susceptibility of the hepatocytes", "PROBLEM", 375, 422], ["these diseases", "PROBLEM", 439, 453], ["reactive", "OBSERVATION_MODIFIER", 112, 120], ["hepatic", "ANATOMY", 204, 211], ["disease", "OBSERVATION", 212, 219], ["necrosis", "OBSERVATION", 229, 237], ["viral", "OBSERVATION_MODIFIER", 244, 249], ["infections", "OBSERVATION", 250, 260], ["centrilobular", "OBSERVATION_MODIFIER", 331, 344], ["necrosis", "OBSERVATION", 345, 353], ["increased", "OBSERVATION_MODIFIER", 379, 388], ["susceptibility", "OBSERVATION", 389, 403], ["hepatocytes", "ANATOMY", 411, 422], ["diseases", "OBSERVATION", 445, 453]]], ["Plausible explanations include zonal expression of entry receptors used by viruses to infect hepatocytes or ischemia-related hepatocellular swelling and sinusoidal damage because of virus-induced endothelial injury that reduce effective perfusion of the centrilobular hepatocytes.Lobular necrosisCentrilobular degeneration and necrosis are seen commonly in animals that have died rather slowly.", [["hepatocytes", "ANATOMY", 93, 104], ["hepatocellular", "ANATOMY", 125, 139], ["sinusoidal", "ANATOMY", 153, 163], ["endothelial", "ANATOMY", 196, 207], ["centrilobular hepatocytes", "ANATOMY", 254, 279], ["Lobular", "ANATOMY", 280, 287], ["ischemia", "DISEASE", 108, 116], ["hepatocellular swelling", "DISEASE", 125, 148], ["necrosis", "DISEASE", 288, 296], ["Centrilobular degeneration", "DISEASE", 296, 322], ["necrosis", "DISEASE", 327, 335], ["hepatocytes", "CELL", 93, 104], ["hepatocellular swelling", "PATHOLOGICAL_FORMATION", 125, 148], ["sinusoidal", "TISSUE", 153, 163], ["endothelial", "TISSUE", 196, 207], ["centrilobular hepatocytes", "TISSUE", 254, 279], ["entry receptors", "PROTEIN", 51, 66], ["hepatocytes", "CELL_TYPE", 93, 104], ["centrilobular hepatocytes", "CELL_TYPE", 254, 279], ["entry receptors", "TREATMENT", 51, 66], ["ischemia", "PROBLEM", 108, 116], ["hepatocellular swelling", "PROBLEM", 125, 148], ["sinusoidal damage", "PROBLEM", 153, 170], ["virus", "PROBLEM", 182, 187], ["endothelial injury", "PROBLEM", 196, 214], ["the centrilobular hepatocytes", "PROBLEM", 250, 279], ["Lobular necrosis", "PROBLEM", 280, 296], ["Centrilobular degeneration", "PROBLEM", 296, 322], ["necrosis", "PROBLEM", 327, 335], ["ischemia", "OBSERVATION", 108, 116], ["hepatocellular", "ANATOMY", 125, 139], ["swelling", "OBSERVATION", 140, 148], ["sinusoidal damage", "OBSERVATION", 153, 170], ["virus", "OBSERVATION", 182, 187], ["endothelial", "ANATOMY", 196, 207], ["injury", "OBSERVATION", 208, 214], ["effective", "OBSERVATION_MODIFIER", 227, 236], ["perfusion", "OBSERVATION_MODIFIER", 237, 246], ["centrilobular", "ANATOMY_MODIFIER", 254, 267], ["hepatocytes", "ANATOMY", 268, 279], ["necrosis", "OBSERVATION_MODIFIER", 288, 296], ["Centrilobular", "OBSERVATION_MODIFIER", 296, 309], ["degeneration", "OBSERVATION", 310, 322], ["necrosis", "OBSERVATION", 327, 335], ["slowly", "OBSERVATION_MODIFIER", 387, 393]]], ["It is assumed that, in the agonal period, the hepatocytes in this zone are disproportionately affected by tissue hypoxia as a result of the failing circulation.", [["hepatocytes", "ANATOMY", 46, 57], ["tissue", "ANATOMY", 106, 112], ["hypoxia", "DISEASE", 113, 120], ["hepatocytes", "CELL", 46, 57], ["tissue", "TISSUE", 106, 112], ["hepatocytes", "CELL_TYPE", 46, 57], ["tissue hypoxia", "PROBLEM", 106, 120], ["hepatocytes", "ANATOMY", 46, 57], ["zone", "ANATOMY_MODIFIER", 66, 70], ["tissue", "OBSERVATION_MODIFIER", 106, 112], ["hypoxia", "OBSERVATION", 113, 120], ["circulation", "OBSERVATION_MODIFIER", 148, 159]]], ["This necrosis is more extensive if the animal is anemic.", [["necrosis", "DISEASE", 5, 13], ["anemic", "DISEASE", 49, 55], ["This necrosis", "PROBLEM", 0, 13], ["anemic", "PROBLEM", 49, 55], ["necrosis", "OBSERVATION", 5, 13], ["more", "OBSERVATION_MODIFIER", 17, 21], ["extensive", "OBSERVATION_MODIFIER", 22, 31], ["anemic", "OBSERVATION", 49, 55]]], ["Centrilobular necrosis is also seen in passive venous congestion of the liver, most often in cases of acute and dramatic decompensation of cardiac function, as atrophy of hepatocytes is a more common outcome.Lobular necrosisIn the liver with centrilobular necrosis, there is usually a prominent zonal pattern, which takes the form of a fine, regular, pallid network of surviving, often fatty, hepatocytes in the periportal zone, which stands up above the red, collapsed areas adjacent to the hepatic venules ( Fig. 2-33 ).", [["venous", "ANATOMY", 47, 53], ["liver", "ANATOMY", 72, 77], ["cardiac", "ANATOMY", 139, 146], ["hepatocytes", "ANATOMY", 171, 182], ["liver", "ANATOMY", 231, 236], ["centrilobular", "ANATOMY", 242, 255], ["hepatocytes", "ANATOMY", 393, 404], ["periportal zone", "ANATOMY", 412, 427], ["hepatic venules", "ANATOMY", 492, 507], ["necrosis", "DISEASE", 14, 22], ["venous congestion of the liver", "DISEASE", 47, 77], ["atrophy", "DISEASE", 160, 167], ["necrosis", "DISEASE", 216, 224], ["necrosis", "DISEASE", 256, 264], ["venous", "PATHOLOGICAL_FORMATION", 47, 53], ["liver", "ORGAN", 72, 77], ["cardiac", "ORGAN", 139, 146], ["hepatocytes", "CELL", 171, 182], ["liver", "ORGAN", 231, 236], ["hepatocytes", "CELL", 393, 404], ["periportal zone", "TISSUE", 412, 427], ["hepatic venules", "MULTI-TISSUE_STRUCTURE", 492, 507], ["hepatocytes", "CELL_TYPE", 171, 182], ["hepatocytes", "CELL_TYPE", 393, 404], ["hepatic venules", "CELL_TYPE", 492, 507], ["Centrilobular necrosis", "PROBLEM", 0, 22], ["passive venous congestion of the liver", "PROBLEM", 39, 77], ["acute and dramatic decompensation of cardiac function", "PROBLEM", 102, 155], ["atrophy of hepatocytes", "PROBLEM", 160, 182], ["Lobular necrosis", "PROBLEM", 208, 224], ["centrilobular necrosis", "PROBLEM", 242, 264], ["a prominent zonal pattern", "PROBLEM", 283, 308], ["often fatty, hepatocytes in the periportal zone", "PROBLEM", 380, 427], ["necrosis", "OBSERVATION", 14, 22], ["passive", "OBSERVATION_MODIFIER", 39, 46], ["venous", "ANATOMY", 47, 53], ["congestion", "OBSERVATION", 54, 64], ["liver", "ANATOMY", 72, 77], ["acute", "OBSERVATION_MODIFIER", 102, 107], ["dramatic", "OBSERVATION_MODIFIER", 112, 120], ["decompensation", "OBSERVATION", 121, 135], ["cardiac function", "OBSERVATION", 139, 155], ["hepatocytes", "ANATOMY", 171, 182], ["more common", "OBSERVATION_MODIFIER", 188, 199], ["necrosis", "OBSERVATION", 216, 224], ["liver", "ANATOMY", 231, 236], ["centrilobular", "OBSERVATION_MODIFIER", 242, 255], ["necrosis", "OBSERVATION", 256, 264], ["prominent", "OBSERVATION_MODIFIER", 285, 294], ["zonal", "OBSERVATION_MODIFIER", 295, 300], ["pattern", "OBSERVATION_MODIFIER", 301, 308], ["fine", "OBSERVATION_MODIFIER", 336, 340], ["surviving", "OBSERVATION_MODIFIER", 369, 378], ["fatty", "OBSERVATION_MODIFIER", 386, 391], ["hepatocytes", "ANATOMY", 393, 404], ["periportal", "ANATOMY", 412, 422], ["zone", "ANATOMY_MODIFIER", 423, 427], ["red", "OBSERVATION", 455, 458], ["collapsed", "OBSERVATION", 460, 469], ["hepatic", "ANATOMY", 492, 499], ["venules", "ANATOMY_MODIFIER", 500, 507]]], ["The zonal necrotic insult frequently affects the sinusoidal endothelium, allowing erythrocytes to enter the perisinusoidal space and contribute to the redness of the necrotic zones.", [["sinusoidal endothelium", "ANATOMY", 49, 71], ["erythrocytes", "ANATOMY", 82, 94], ["perisinusoidal space", "ANATOMY", 108, 128], ["necrotic zones", "ANATOMY", 166, 180], ["necrotic", "DISEASE", 10, 18], ["necrotic", "DISEASE", 166, 174], ["sinusoidal endothelium", "TISSUE", 49, 71], ["erythrocytes", "CELL", 82, 94], ["necrotic zones", "TISSUE", 166, 180], ["erythrocytes", "CELL_TYPE", 82, 94], ["The zonal necrotic insult", "PROBLEM", 0, 25], ["the redness of the necrotic zones", "PROBLEM", 147, 180], ["zonal", "OBSERVATION_MODIFIER", 4, 9], ["necrotic", "OBSERVATION_MODIFIER", 10, 18], ["insult", "OBSERVATION", 19, 25], ["sinusoidal endothelium", "OBSERVATION", 49, 71], ["perisinusoidal", "ANATOMY", 108, 122], ["redness", "OBSERVATION", 151, 158], ["necrotic", "OBSERVATION_MODIFIER", 166, 174], ["zones", "OBSERVATION_MODIFIER", 175, 180]]], ["Histologically, necrosis is confined to the centrilobular region ( Fig. 2-34) , although bridging can occur in more severe cases ( Fig. 2-35 ).", [["centrilobular region", "ANATOMY", 44, 64], ["necrosis", "DISEASE", 16, 24], ["necrosis", "PROBLEM", 16, 24], ["necrosis", "OBSERVATION", 16, 24], ["centrilobular", "ANATOMY_MODIFIER", 44, 57]]], ["Necrotic cells that are removed can be replaced by stagnant blood, at least in the acute phase.", [["Necrotic cells", "ANATOMY", 0, 14], ["blood", "ANATOMY", 60, 65], ["Necrotic cells", "CELL", 0, 14], ["blood", "ORGANISM_SUBSTANCE", 60, 65], ["Necrotic cells", "CELL_TYPE", 0, 14], ["Necrotic cells", "PROBLEM", 0, 14], ["stagnant blood", "TEST", 51, 65], ["cells", "OBSERVATION", 9, 14], ["stagnant", "OBSERVATION", 51, 59], ["acute phase", "OBSERVATION_MODIFIER", 83, 94]]], ["However, this red-on-yellow zonal pattern is difficult to interpret grossly because hepatic steatosis may also have a zonal distribution without having significant necrosis. may be a tendency for focal necrosis to occur nearer to the portal vessels than to the periphery of the circulatory fields, and to be concentrated in some lobular agglomerates rather than others.Lobular necrosisFocal necrosis occurs in many infections, parasitic migrations, and instances of biliary obstruction, and in these, the designation focal hepatitis will often be more appropriate, because most are attended by some degree of focal inflammation.", [["hepatic", "ANATOMY", 84, 91], ["portal vessels", "ANATOMY", 234, 248], ["circulatory", "ANATOMY", 278, 289], ["lobular agglomerates", "ANATOMY", 329, 349], ["biliary", "ANATOMY", 466, 473], ["steatosis", "DISEASE", 92, 101], ["necrosis", "DISEASE", 164, 172], ["necrosis", "DISEASE", 202, 210], ["necrosis", "DISEASE", 391, 399], ["infections", "DISEASE", 415, 425], ["biliary obstruction", "DISEASE", 466, 485], ["hepatitis", "DISEASE", 523, 532], ["inflammation", "DISEASE", 615, 627], ["hepatic", "ORGAN", 84, 91], ["portal vessels", "MULTI-TISSUE_STRUCTURE", 234, 248], ["lobular", "PATHOLOGICAL_FORMATION", 329, 336], ["biliary obstruction", "PATHOLOGICAL_FORMATION", 466, 485], ["this red-on-yellow zonal pattern", "PROBLEM", 9, 41], ["hepatic steatosis", "PROBLEM", 84, 101], ["significant necrosis", "PROBLEM", 152, 172], ["focal necrosis", "PROBLEM", 196, 210], ["some lobular agglomerates", "PROBLEM", 324, 349], ["Lobular necrosisFocal necrosis", "PROBLEM", 369, 399], ["many infections", "PROBLEM", 410, 425], ["parasitic migrations", "PROBLEM", 427, 447], ["biliary obstruction", "PROBLEM", 466, 485], ["the designation focal hepatitis", "PROBLEM", 501, 532], ["focal inflammation", "PROBLEM", 609, 627], ["hepatic", "ANATOMY", 84, 91], ["steatosis", "OBSERVATION", 92, 101], ["zonal distribution", "OBSERVATION_MODIFIER", 118, 136], ["without having", "UNCERTAINTY", 137, 151], ["significant", "OBSERVATION_MODIFIER", 152, 163], ["necrosis", "OBSERVATION", 164, 172], ["focal", "OBSERVATION_MODIFIER", 196, 201], ["necrosis", "OBSERVATION", 202, 210], ["portal vessels", "ANATOMY", 234, 248], ["periphery", "ANATOMY_MODIFIER", 261, 270], ["circulatory fields", "ANATOMY", 278, 296], ["concentrated", "OBSERVATION_MODIFIER", 308, 320], ["some", "OBSERVATION_MODIFIER", 324, 328], ["lobular", "OBSERVATION_MODIFIER", 329, 336], ["agglomerates", "OBSERVATION", 337, 349], ["necrosisFocal", "OBSERVATION_MODIFIER", 377, 390], ["necrosis", "OBSERVATION", 391, 399], ["many", "OBSERVATION_MODIFIER", 410, 414], ["infections", "OBSERVATION", 415, 425], ["parasitic", "OBSERVATION_MODIFIER", 427, 436], ["migrations", "OBSERVATION_MODIFIER", 437, 447], ["biliary", "ANATOMY", 466, 473], ["obstruction", "OBSERVATION", 474, 485], ["focal", "OBSERVATION_MODIFIER", 517, 522], ["hepatitis", "OBSERVATION", 523, 532], ["some degree", "OBSERVATION_MODIFIER", 594, 605], ["focal", "OBSERVATION_MODIFIER", 609, 614], ["inflammation", "OBSERVATION", 615, 627]]], ["The infectious causes may be viral ( Fig. 2-31 ) or bacterial.", [["The infectious causes", "PROBLEM", 0, 21], ["viral ( Fig.", "TEST", 29, 41], ["bacterial", "PROBLEM", 52, 61], ["infectious", "OBSERVATION", 4, 14], ["may be", "UNCERTAINTY", 22, 28]]], ["Many septicemic bacterial infections consistently produce focal hepatic lesions; examples are salmonellosis, tularemia, pseudotuberculosis, listeriosis in the fetus and newborn, and Mannheimia haemolytica septicemia in lambs.", [["focal hepatic lesions", "ANATOMY", 58, 79], ["fetus", "ANATOMY", 159, 164], ["bacterial infections", "DISEASE", 16, 36], ["focal hepatic lesions", "DISEASE", 58, 79], ["salmonellosis", "DISEASE", 94, 107], ["tularemia", "DISEASE", 109, 118], ["pseudotuberculosis", "DISEASE", 120, 138], ["listeriosis", "DISEASE", 140, 151], ["Mannheimia haemolytica septicemia", "DISEASE", 182, 215], ["focal", "PATHOLOGICAL_FORMATION", 58, 63], ["hepatic lesions", "PATHOLOGICAL_FORMATION", 64, 79], ["fetus", "ORGAN", 159, 164], ["newborn", "ORGANISM_SUBDIVISION", 169, 176], ["Mannheimia haemolytica", "ORGANISM", 182, 204], ["lambs", "ORGANISM", 219, 224], ["Mannheimia haemolytica", "SPECIES", 182, 204], ["lambs", "SPECIES", 219, 224], ["Mannheimia haemolytica", "SPECIES", 182, 204], ["Many septicemic bacterial infections", "PROBLEM", 0, 36], ["focal hepatic lesions", "PROBLEM", 58, 79], ["salmonellosis", "PROBLEM", 94, 107], ["tularemia", "PROBLEM", 109, 118], ["pseudotuberculosis", "PROBLEM", 120, 138], ["listeriosis in the fetus", "PROBLEM", 140, 164], ["Mannheimia haemolytica septicemia in lambs", "PROBLEM", 182, 224], ["septicemic", "OBSERVATION_MODIFIER", 5, 15], ["bacterial", "OBSERVATION_MODIFIER", 16, 25], ["infections", "OBSERVATION", 26, 36], ["focal", "OBSERVATION_MODIFIER", 58, 63], ["hepatic", "ANATOMY", 64, 71], ["lesions", "OBSERVATION", 72, 79], ["salmonellosis", "OBSERVATION", 94, 107], ["tularemia", "OBSERVATION", 109, 118], ["pseudotuberculosis", "OBSERVATION", 120, 138], ["listeriosis", "OBSERVATION", 140, 151], ["fetus", "ANATOMY", 159, 164], ["newborn", "OBSERVATION_MODIFIER", 169, 176], ["Mannheimia", "OBSERVATION_MODIFIER", 182, 192], ["haemolytica", "OBSERVATION_MODIFIER", 193, 204], ["septicemia", "OBSERVATION", 205, 215]]], ["The focal necrosis may be the outcome of a Kupffer cell reaction, as in salmonellosis, or of bacterial embolism.", [["Kupffer cell", "ANATOMY", 43, 55], ["necrosis", "DISEASE", 10, 18], ["salmonellosis", "DISEASE", 72, 85], ["bacterial embolism", "DISEASE", 93, 111], ["Kupffer cell", "CELL", 43, 55], ["salmonellosis", "SPECIES", 72, 85], ["The focal necrosis", "PROBLEM", 0, 18], ["a Kupffer cell reaction", "PROBLEM", 41, 64], ["salmonellosis", "PROBLEM", 72, 85], ["bacterial embolism", "PROBLEM", 93, 111], ["focal", "OBSERVATION_MODIFIER", 4, 9], ["necrosis", "OBSERVATION", 10, 18], ["Kupffer cell reaction", "OBSERVATION", 43, 64], ["salmonellosis", "OBSERVATION", 72, 85], ["bacterial embolism", "OBSERVATION", 93, 111]]], ["The cause can usually be determined by histologic examination.Lobular necrosisIn cattle, focal necrosis in a few or many visible foci is common at autopsy and is common enough to be important at slaughter; it is responsible for the descriptive appellation \"sawdust liver\" (Fig. 2-32 ).", [["foci", "ANATOMY", 129, 133], ["liver", "ANATOMY", 265, 270], ["necrosis", "DISEASE", 95, 103], ["liver", "ORGAN", 265, 270], ["cattle", "SPECIES", 81, 87], ["cattle", "SPECIES", 81, 87], ["histologic examination", "TEST", 39, 61], ["Lobular necrosisIn cattle", "PROBLEM", 62, 87], ["focal necrosis", "PROBLEM", 89, 103], ["many visible foci", "PROBLEM", 116, 133], ["focal", "OBSERVATION_MODIFIER", 89, 94], ["necrosis", "OBSERVATION", 95, 103], ["few", "OBSERVATION_MODIFIER", 109, 112], ["visible", "OBSERVATION_MODIFIER", 121, 128], ["foci", "OBSERVATION", 129, 133], ["liver", "ANATOMY", 265, 270]]], ["The pathogenesis is not known and probably varies, but it may be caused by organisms from the gut that reach the liver in the portal blood.", [["gut", "ANATOMY", 94, 97], ["liver", "ANATOMY", 113, 118], ["portal blood", "ANATOMY", 126, 138], ["gut", "ORGANISM_SUBDIVISION", 94, 97], ["liver", "ORGAN", 113, 118], ["portal blood", "ORGANISM_SUBSTANCE", 126, 138], ["organisms", "PROBLEM", 75, 84], ["not known", "UNCERTAINTY", 20, 29], ["organisms", "OBSERVATION", 75, 84], ["liver", "ANATOMY", 113, 118], ["portal blood", "ANATOMY", 126, 138]]], ["The lesion is not specific and consists of focal parenchymal necrosis with disruption of reticulin fibers and infiltration of neutrophils and lymphocytes; circulatory fields of the hepatic lobules.", [["lesion", "ANATOMY", 4, 10], ["parenchymal", "ANATOMY", 49, 60], ["reticulin fibers", "ANATOMY", 89, 105], ["neutrophils", "ANATOMY", 126, 137], ["lymphocytes", "ANATOMY", 142, 153], ["hepatic lobules", "ANATOMY", 181, 196], ["necrosis", "DISEASE", 61, 69], ["lesion", "CANCER", 4, 10], ["reticulin fibers", "CELLULAR_COMPONENT", 89, 105], ["neutrophils", "CELL", 126, 137], ["lymphocytes", "CELL", 142, 153], ["hepatic lobules", "MULTI-TISSUE_STRUCTURE", 181, 196], ["neutrophils", "CELL_TYPE", 126, 137], ["lymphocytes", "CELL_TYPE", 142, 153], ["The lesion", "PROBLEM", 0, 10], ["focal parenchymal necrosis", "PROBLEM", 43, 69], ["disruption of reticulin fibers", "PROBLEM", 75, 105], ["infiltration of neutrophils and lymphocytes", "PROBLEM", 110, 153], ["circulatory fields of the hepatic lobules", "PROBLEM", 155, 196], ["lesion", "OBSERVATION", 4, 10], ["not specific", "UNCERTAINTY", 14, 26], ["focal", "OBSERVATION_MODIFIER", 43, 48], ["parenchymal", "ANATOMY_MODIFIER", 49, 60], ["necrosis", "OBSERVATION", 61, 69], ["reticulin fibers", "OBSERVATION", 89, 105], ["infiltration", "OBSERVATION_MODIFIER", 110, 122], ["neutrophils", "OBSERVATION_MODIFIER", 126, 137], ["lymphocytes", "ANATOMY", 142, 153], ["circulatory", "ANATOMY_MODIFIER", 155, 166], ["fields", "ANATOMY_MODIFIER", 167, 173], ["hepatic", "ANATOMY", 181, 188], ["lobules", "ANATOMY_MODIFIER", 189, 196]]], ["Some of these areas of necrosis extend up to larger portal triads, because the periphery of some lobules may lie against the larger portal tracts.", [["portal triads", "ANATOMY", 52, 65], ["lobules", "ANATOMY", 97, 104], ["portal tracts", "ANATOMY", 132, 145], ["necrosis", "DISEASE", 23, 31], ["portal triads", "MULTI-TISSUE_STRUCTURE", 52, 65], ["lobules", "MULTI-TISSUE_STRUCTURE", 97, 104], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 132, 145], ["necrosis", "PROBLEM", 23, 31], ["some lobules", "PROBLEM", 92, 104], ["areas", "OBSERVATION_MODIFIER", 14, 19], ["necrosis", "OBSERVATION", 23, 31], ["larger", "OBSERVATION_MODIFIER", 45, 51], ["portal triads", "ANATOMY", 52, 65], ["periphery", "OBSERVATION_MODIFIER", 79, 88], ["some", "OBSERVATION_MODIFIER", 92, 96], ["lobules", "OBSERVATION", 97, 104], ["larger", "OBSERVATION_MODIFIER", 125, 131], ["portal tracts", "ANATOMY", 132, 145]]], ["Often, the hepatocytes between the necrotic and more normal zones show hydropic degeneration or fatty change.Lobular necrosisIf the insult is of short duration, quite extensive centrilobular necrosis may be followed by phagocytic infiltration and hepatocellular proliferation and complete restoration of normal structure and function within a few days.", [["hepatocytes", "ANATOMY", 11, 22], ["centrilobular", "ANATOMY", 177, 190], ["hepatocellular", "ANATOMY", 247, 261], ["necrotic", "DISEASE", 35, 43], ["fatty change", "DISEASE", 96, 108], ["necrosis", "DISEASE", 117, 125], ["necrosis", "DISEASE", 191, 199], ["hepatocytes", "CELL", 11, 22], ["hepatocellular", "CANCER", 247, 261], ["hepatocytes", "CELL_TYPE", 11, 22], ["hydropic degeneration", "PROBLEM", 71, 92], ["fatty change", "PROBLEM", 96, 108], ["Lobular necrosis", "PROBLEM", 109, 125], ["the insult", "PROBLEM", 128, 138], ["quite extensive centrilobular necrosis", "PROBLEM", 161, 199], ["phagocytic infiltration", "PROBLEM", 219, 242], ["hepatocellular proliferation", "PROBLEM", 247, 275], ["hepatocytes", "ANATOMY", 11, 22], ["necrotic", "OBSERVATION_MODIFIER", 35, 43], ["more", "OBSERVATION_MODIFIER", 48, 52], ["normal", "OBSERVATION", 53, 59], ["zones", "OBSERVATION_MODIFIER", 60, 65], ["hydropic", "OBSERVATION_MODIFIER", 71, 79], ["degeneration", "OBSERVATION", 80, 92], ["fatty change", "OBSERVATION", 96, 108], ["necrosis", "OBSERVATION", 117, 125], ["short duration", "OBSERVATION_MODIFIER", 145, 159], ["extensive", "OBSERVATION_MODIFIER", 167, 176], ["centrilobular", "OBSERVATION_MODIFIER", 177, 190], ["necrosis", "OBSERVATION", 191, 199], ["may be", "UNCERTAINTY", 200, 206], ["phagocytic infiltration", "OBSERVATION", 219, 242], ["hepatocellular proliferation", "OBSERVATION", 247, 275], ["normal", "OBSERVATION", 304, 310], ["structure", "OBSERVATION_MODIFIER", 311, 320]]], ["Severe centrilobular necrosis may be followed shortly by proliferation of bipotential progenitor cells found near cholangioles, termed the ductular reaction, and mature bile duct epithelia that also respond to the regenerative stimulus.", [["centrilobular", "ANATOMY", 7, 20], ["bipotential progenitor cells", "ANATOMY", 74, 102], ["cholangioles", "ANATOMY", 114, 126], ["ductular", "ANATOMY", 139, 147], ["bile duct epithelia", "ANATOMY", 169, 188], ["necrosis", "DISEASE", 21, 29], ["bipotential progenitor cells", "CELL", 74, 102], ["ductular", "TISSUE", 139, 147], ["bile duct epithelia", "TISSUE", 169, 188], ["bipotential progenitor cells", "CELL_TYPE", 74, 102], ["Severe centrilobular necrosis", "PROBLEM", 0, 29], ["bipotential progenitor cells", "PROBLEM", 74, 102], ["the ductular reaction", "PROBLEM", 135, 156], ["mature bile duct epithelia", "PROBLEM", 162, 188], ["the regenerative stimulus", "TEST", 210, 235], ["centrilobular", "OBSERVATION_MODIFIER", 7, 20], ["necrosis", "OBSERVATION", 21, 29], ["bipotential progenitor cells", "OBSERVATION", 74, 102], ["ductular reaction", "OBSERVATION", 139, 156], ["bile duct", "ANATOMY", 169, 178], ["epithelia", "ANATOMY_MODIFIER", 179, 188], ["regenerative stimulus", "OBSERVATION", 214, 235]]], ["With restitution of the normal complement of hepatocytes, the proliferative response in the progenitor cells and biliary tract subsides unless the original insult is continuous or repeated.Lobular necrosisSome intoxications can produce selective midzonal (zone 2) necrosis, affecting only a narrow, sharply defined band of hepatocytes ( Fig. 2-36 ).", [["hepatocytes", "ANATOMY", 45, 56], ["progenitor cells", "ANATOMY", 92, 108], ["biliary tract", "ANATOMY", 113, 126], ["Lobular", "ANATOMY", 189, 196], ["hepatocytes", "ANATOMY", 323, 334], ["necrosis", "DISEASE", 264, 272], ["hepatocytes", "CELL", 45, 56], ["progenitor cells", "CELL", 92, 108], ["biliary tract", "MULTI-TISSUE_STRUCTURE", 113, 126], ["hepatocytes", "CELL", 323, 334], ["hepatocytes", "CELL_TYPE", 45, 56], ["progenitor cells", "CELL_TYPE", 92, 108], ["hepatocytes", "CELL_TYPE", 323, 334], ["the proliferative response in the progenitor cells", "PROBLEM", 58, 108], ["biliary tract", "PROBLEM", 113, 126], ["the original insult", "PROBLEM", 143, 162], ["Lobular necrosisSome intoxications", "PROBLEM", 189, 223], ["selective midzonal (zone 2) necrosis", "PROBLEM", 236, 272], ["a narrow, sharply defined band of hepatocytes", "PROBLEM", 289, 334], ["normal", "OBSERVATION", 24, 30], ["hepatocytes", "ANATOMY", 45, 56], ["proliferative response", "OBSERVATION", 62, 84], ["progenitor cells", "OBSERVATION", 92, 108], ["biliary tract", "ANATOMY", 113, 126], ["selective", "OBSERVATION_MODIFIER", 236, 245], ["midzonal", "OBSERVATION_MODIFIER", 246, 254], ["zone", "OBSERVATION_MODIFIER", 256, 260], ["necrosis", "OBSERVATION", 264, 272], ["narrow", "OBSERVATION_MODIFIER", 291, 297], ["sharply", "OBSERVATION_MODIFIER", 299, 306], ["band", "OBSERVATION_MODIFIER", 315, 319], ["hepatocytes", "ANATOMY", 323, 334]]], ["It may be more diffuse within the lobule, so that periportal or centrilobular degeneration may be superimposed on the more severe midzonal lesion.Lobular necrosisPeriportal (zone 1) necrosis is also an uncommon lesion, perhaps more often seen than midzonal necrosis, and can be caused by direct-acting hepatotoxins that do not require metabolism by the cytochromes P450 to produce toxic moieties.", [["lobule", "ANATOMY", 34, 40], ["periportal", "ANATOMY", 50, 60], ["centrilobular", "ANATOMY", 64, 77], ["midzonal lesion", "ANATOMY", 130, 145], ["lesion", "ANATOMY", 211, 217], ["necrosis", "DISEASE", 182, 190], ["necrosis", "DISEASE", 257, 265], ["lobule", "CANCER", 34, 40], ["centrilobular", "TISSUE", 64, 77], ["midzonal lesion", "CANCER", 130, 145], ["hepatotoxins", "SIMPLE_CHEMICAL", 302, 314], ["cytochromes P450", "GENE_OR_GENE_PRODUCT", 353, 369], ["cytochromes P450", "PROTEIN", 353, 369], ["periportal or centrilobular degeneration", "PROBLEM", 50, 90], ["the more severe midzonal lesion", "PROBLEM", 114, 145], ["Lobular necrosisPeriportal (zone 1) necrosis", "PROBLEM", 146, 190], ["an uncommon lesion", "PROBLEM", 199, 217], ["midzonal necrosis", "PROBLEM", 248, 265], ["direct-acting hepatotoxins", "PROBLEM", 288, 314], ["the cytochromes P450", "TEST", 349, 369], ["toxic moieties", "PROBLEM", 381, 395], ["may be", "UNCERTAINTY", 3, 9], ["more", "OBSERVATION_MODIFIER", 10, 14], ["diffuse", "OBSERVATION_MODIFIER", 15, 22], ["lobule", "ANATOMY", 34, 40], ["periportal", "ANATOMY", 50, 60], ["centrilobular", "OBSERVATION_MODIFIER", 64, 77], ["degeneration", "OBSERVATION", 78, 90], ["may be", "UNCERTAINTY", 91, 97], ["more", "OBSERVATION_MODIFIER", 118, 122], ["severe", "OBSERVATION_MODIFIER", 123, 129], ["midzonal", "OBSERVATION_MODIFIER", 130, 138], ["lesion", "OBSERVATION", 139, 145], ["necrosisPeriportal", "OBSERVATION_MODIFIER", 154, 172], ["zone", "OBSERVATION_MODIFIER", 174, 178], ["necrosis", "OBSERVATION", 182, 190], ["uncommon", "OBSERVATION_MODIFIER", 202, 210], ["lesion", "OBSERVATION", 211, 217], ["perhaps", "UNCERTAINTY", 219, 226], ["more often", "OBSERVATION_MODIFIER", 227, 237], ["necrosis", "OBSERVATION", 257, 265], ["toxic moieties", "OBSERVATION", 381, 395]]], ["More than one pattern of zonal necrosis can be found in the same liver.", [["liver", "ANATOMY", 65, 70], ["necrosis", "DISEASE", 31, 39], ["liver", "ORGAN", 65, 70], ["zonal necrosis", "PROBLEM", 25, 39], ["zonal", "OBSERVATION_MODIFIER", 25, 30], ["necrosis", "OBSERVATION", 31, 39], ["liver", "ANATOMY", 65, 70]]], ["The various forms of zonal necrosis cannot reliably be distinguished from one another grossly, but one may expect to see in periportal necrosis a reversal of the pattern seen in centrilobular necrosis; that is, in periportal necrosis, the surviving hepatocytes about the hepatic venules may appear as pale, raised islands within a regular network of red, collapsed periportal tissue.", [["centrilobular", "ANATOMY", 178, 191], ["hepatocytes", "ANATOMY", 249, 260], ["hepatic venules", "ANATOMY", 271, 286], ["periportal tissue", "ANATOMY", 365, 382], ["necrosis", "DISEASE", 27, 35], ["necrosis", "DISEASE", 135, 143], ["necrosis", "DISEASE", 192, 200], ["necrosis", "DISEASE", 225, 233], ["hepatocytes", "CELL", 249, 260], ["hepatic venules", "MULTI-TISSUE_STRUCTURE", 271, 286], ["periportal tissue", "TISSUE", 365, 382], ["surviving hepatocytes", "CELL_TYPE", 239, 260], ["zonal necrosis", "PROBLEM", 21, 35], ["periportal necrosis", "PROBLEM", 124, 143], ["centrilobular necrosis", "PROBLEM", 178, 200], ["periportal necrosis", "PROBLEM", 214, 233], ["pale", "PROBLEM", 301, 305], ["red, collapsed periportal tissue", "PROBLEM", 350, 382], ["zonal", "OBSERVATION_MODIFIER", 21, 26], ["necrosis", "OBSERVATION", 27, 35], ["cannot reliably be distinguished", "UNCERTAINTY", 36, 68], ["periportal", "ANATOMY", 124, 134], ["necrosis", "OBSERVATION", 135, 143], ["reversal", "OBSERVATION_MODIFIER", 146, 154], ["centrilobular", "OBSERVATION_MODIFIER", 178, 191], ["necrosis", "OBSERVATION", 192, 200], ["periportal", "ANATOMY", 214, 224], ["necrosis", "OBSERVATION", 225, 233], ["surviving hepatocytes", "OBSERVATION", 239, 260], ["hepatic", "ANATOMY", 271, 278], ["venules", "ANATOMY_MODIFIER", 279, 286], ["may appear", "UNCERTAINTY", 287, 297], ["pale", "OBSERVATION_MODIFIER", 301, 305], ["red", "OBSERVATION", 350, 353], ["collapsed", "OBSERVATION_MODIFIER", 355, 364], ["periportal tissue", "OBSERVATION", 365, 382]]], ["Careful scrutiny may reveal the smallest hepatic venules at the center of the pale islands.Lobular necrosisParacentral necrosis, a form of coagulative necrosis, occurs when an isolated portion of the centrilobular region of the lobule (or complete hepatic acinus of Rappaport-perhaps visualized more easily as an entire acinus) dies and is viewed in transverse section ( Fig. 2-37 ).", [["hepatic venules", "ANATOMY", 41, 56], ["pale islands", "ANATOMY", 78, 90], ["centrilobular region", "ANATOMY", 200, 220], ["lobule", "ANATOMY", 228, 234], ["hepatic acinus", "ANATOMY", 248, 262], ["acinus", "ANATOMY", 320, 326], ["necrosis", "DISEASE", 119, 127], ["coagulative necrosis", "DISEASE", 139, 159], ["hepatic venules", "MULTI-TISSUE_STRUCTURE", 41, 56], ["lobule", "MULTI-TISSUE_STRUCTURE", 228, 234], ["hepatic acinus", "MULTI-TISSUE_STRUCTURE", 248, 262], ["acinus", "ORGAN", 320, 326], ["hepatic venules", "CELL_TYPE", 41, 56], ["the smallest hepatic venules", "PROBLEM", 28, 56], ["the pale islands", "PROBLEM", 74, 90], ["Lobular necrosisParacentral necrosis", "PROBLEM", 91, 127], ["coagulative necrosis", "PROBLEM", 139, 159], ["smallest", "OBSERVATION_MODIFIER", 32, 40], ["hepatic", "ANATOMY", 41, 48], ["venules", "OBSERVATION", 49, 56], ["center", "OBSERVATION_MODIFIER", 64, 70], ["pale islands", "OBSERVATION", 78, 90], ["necrosisParacentral", "OBSERVATION_MODIFIER", 99, 118], ["necrosis", "OBSERVATION", 119, 127], ["coagulative", "OBSERVATION_MODIFIER", 139, 150], ["necrosis", "OBSERVATION", 151, 159], ["isolated", "OBSERVATION_MODIFIER", 176, 184], ["portion", "OBSERVATION_MODIFIER", 185, 192], ["centrilobular", "ANATOMY_MODIFIER", 200, 213], ["lobule", "ANATOMY_MODIFIER", 228, 234], ["hepatic", "ANATOMY", 248, 255], ["acinus", "ANATOMY_MODIFIER", 256, 262]]], ["It is possibly an ischemic lesion or infarct produced by an occlusion of a terminal portal venule, such as may occur in disseminated intravascular coagulation.", [["lesion", "ANATOMY", 27, 33], ["terminal portal venule", "ANATOMY", 75, 97], ["intravascular", "ANATOMY", 133, 146], ["infarct", "DISEASE", 37, 44], ["intravascular coagulation", "DISEASE", 133, 158], ["portal venule", "MULTI-TISSUE_STRUCTURE", 84, 97], ["intravascular", "IMMATERIAL_ANATOMICAL_ENTITY", 133, 146], ["an ischemic lesion", "PROBLEM", 15, 33], ["infarct", "PROBLEM", 37, 44], ["a terminal portal venule", "PROBLEM", 73, 97], ["disseminated intravascular coagulation", "PROBLEM", 120, 158], ["possibly", "UNCERTAINTY", 6, 14], ["ischemic", "OBSERVATION_MODIFIER", 18, 26], ["lesion", "OBSERVATION", 27, 33], ["infarct", "OBSERVATION", 37, 44], ["occlusion", "OBSERVATION", 60, 69], ["terminal", "ANATOMY_MODIFIER", 75, 83], ["portal venule", "ANATOMY", 84, 97], ["may occur", "UNCERTAINTY", 107, 116], ["disseminated", "OBSERVATION_MODIFIER", 120, 132], ["intravascular coagulation", "OBSERVATION", 133, 158]]], ["Its appearance in certain of the acute hepatotoxicities probably However, vascular influences on the susceptibility to necrosis mean that segments of the lobule can be differentially affected.", [["vascular", "ANATOMY", 74, 82], ["lobule", "ANATOMY", 154, 160], ["hepatotoxicities", "DISEASE", 39, 55], ["necrosis", "DISEASE", 119, 127], ["vascular", "MULTI-TISSUE_STRUCTURE", 74, 82], ["lobule", "MULTI-TISSUE_STRUCTURE", 154, 160], ["the acute hepatotoxicities", "PROBLEM", 29, 55], ["the susceptibility to necrosis", "PROBLEM", 97, 127], ["acute", "OBSERVATION_MODIFIER", 33, 38], ["hepatotoxicities", "OBSERVATION", 39, 55], ["vascular", "ANATOMY", 74, 82], ["necrosis", "OBSERVATION", 119, 127], ["segments", "ANATOMY_MODIFIER", 138, 146], ["lobule", "ANATOMY", 154, 160]]], ["Frequently, the areas of necrosis are joined to one another, thus cutting the conventional lobules into segments, and at the same time, outlining the periphery of the often relates to the distribution of larger vessels.", [["lobules", "ANATOMY", 91, 98], ["vessels", "ANATOMY", 211, 218], ["necrosis", "DISEASE", 25, 33], ["lobules", "TISSUE", 91, 98], ["vessels", "MULTI-TISSUE_STRUCTURE", 211, 218], ["necrosis", "PROBLEM", 25, 33], ["areas", "OBSERVATION_MODIFIER", 16, 21], ["necrosis", "OBSERVATION", 25, 33], ["lobules", "OBSERVATION_MODIFIER", 91, 98], ["segments", "ANATOMY_MODIFIER", 104, 112], ["periphery", "ANATOMY_MODIFIER", 150, 159], ["distribution", "OBSERVATION_MODIFIER", 188, 200], ["larger", "OBSERVATION_MODIFIER", 204, 210], ["vessels", "ANATOMY", 211, 218]]], ["Collapse, condensation, and subsequent scarring are characteristic, the end result being known as postnecrotic scarring.", [["scarring", "DISEASE", 39, 47], ["scarring", "DISEASE", 111, 119], ["Collapse", "PROBLEM", 0, 8], ["condensation", "PROBLEM", 10, 22], ["subsequent scarring", "PROBLEM", 28, 47], ["postnecrotic scarring", "PROBLEM", 98, 119], ["condensation", "OBSERVATION_MODIFIER", 10, 22], ["scarring", "OBSERVATION", 39, 47], ["postnecrotic", "OBSERVATION_MODIFIER", 98, 110], ["scarring", "OBSERVATION", 111, 119]]], ["The liver is not uniformly involved typically.", [["liver", "ANATOMY", 4, 9], ["liver", "ORGAN", 4, 9], ["liver", "ANATOMY", 4, 9], ["not", "UNCERTAINTY", 13, 16], ["uniformly", "OBSERVATION_MODIFIER", 17, 26], ["involved", "OBSERVATION", 27, 35]]], ["Large areas of parenchyma remain intact, and these enlarge amid scarring areas during compensatory regeneration.Lobular necrosisA liver that is the seat of massive necrosis may be of normal size or smaller.", [["parenchyma", "ANATOMY", 15, 25], ["liver", "ANATOMY", 130, 135], ["scarring", "DISEASE", 64, 72], ["necrosis", "DISEASE", 164, 172], ["parenchyma", "MULTI-TISSUE_STRUCTURE", 15, 25], ["liver", "ORGAN", 130, 135], ["these enlarge amid scarring areas", "PROBLEM", 45, 78], ["compensatory regeneration", "PROBLEM", 86, 111], ["Lobular necrosisA liver", "PROBLEM", 112, 135], ["massive necrosis", "PROBLEM", 156, 172], ["areas", "OBSERVATION_MODIFIER", 6, 11], ["parenchyma", "ANATOMY_MODIFIER", 15, 25], ["intact", "OBSERVATION", 33, 39], ["enlarge", "OBSERVATION_MODIFIER", 51, 58], ["amid", "OBSERVATION_MODIFIER", 59, 63], ["scarring", "OBSERVATION", 64, 72], ["compensatory regeneration", "OBSERVATION", 86, 111], ["necrosisA", "OBSERVATION", 120, 129], ["liver", "ANATOMY", 130, 135], ["massive", "OBSERVATION_MODIFIER", 156, 163], ["necrosis", "OBSERVATION", 164, 172], ["may be", "UNCERTAINTY", 173, 179], ["normal", "OBSERVATION", 183, 189], ["size", "OBSERVATION_MODIFIER", 190, 194], ["smaller", "OBSERVATION_MODIFIER", 198, 205]]], ["Fine red threads of fibrin may be present on the surface, especially in the grooves between the lobes.", [["surface", "ANATOMY", 49, 56], ["lobes", "ANATOMY", 96, 101], ["fibrin", "GENE_OR_GENE_PRODUCT", 20, 26], ["surface", "CELLULAR_COMPONENT", 49, 56], ["lobes", "MULTI-TISSUE_STRUCTURE", 96, 101], ["fibrin", "PROTEIN", 20, 26], ["Fine red threads of fibrin", "PROBLEM", 0, 26], ["red", "OBSERVATION_MODIFIER", 5, 8], ["threads", "OBSERVATION_MODIFIER", 9, 16], ["fibrin", "OBSERVATION", 20, 26], ["may be", "UNCERTAINTY", 27, 33], ["surface", "OBSERVATION_MODIFIER", 49, 56], ["grooves", "ANATOMY_MODIFIER", 76, 83], ["lobes", "ANATOMY_MODIFIER", 96, 101]]], ["There is a surface mosaic appearance of red, gray, or yellow areas intermingled with areas of dark red.", [["surface", "ANATOMY", 11, 18], ["a surface mosaic appearance of red, gray", "PROBLEM", 9, 49], ["yellow areas", "PROBLEM", 54, 66], ["dark red", "PROBLEM", 94, 102], ["surface", "OBSERVATION_MODIFIER", 11, 18], ["mosaic", "OBSERVATION_MODIFIER", 19, 25], ["red", "OBSERVATION_MODIFIER", 40, 43], ["gray", "OBSERVATION_MODIFIER", 45, 49], ["yellow", "OBSERVATION_MODIFIER", 54, 60], ["areas", "OBSERVATION_MODIFIER", 61, 66], ["intermingled", "OBSERVATION_MODIFIER", 67, 79], ["areas", "OBSERVATION_MODIFIER", 85, 90], ["dark red", "OBSERVATION", 94, 102]]], ["The gray or yellow areas of parenchyma, representing surviving tissue, form irregular, coalescing patches that may be <1.0 cm in diameter.", [["parenchyma", "ANATOMY", 28, 38], ["tissue", "ANATOMY", 63, 69], ["parenchyma", "TISSUE", 28, 38], ["tissue", "TISSUE", 63, 69], ["The gray or yellow areas of parenchyma", "PROBLEM", 0, 38], ["surviving tissue", "PROBLEM", 53, 69], ["irregular, coalescing patches", "PROBLEM", 76, 105], ["gray", "ANATOMY", 4, 8], ["yellow", "OBSERVATION_MODIFIER", 12, 18], ["areas", "OBSERVATION_MODIFIER", 19, 24], ["parenchyma", "ANATOMY", 28, 38], ["surviving tissue", "OBSERVATION", 53, 69], ["irregular", "OBSERVATION_MODIFIER", 76, 85], ["coalescing", "OBSERVATION_MODIFIER", 87, 97], ["patches", "OBSERVATION_MODIFIER", 98, 105], ["may be", "UNCERTAINTY", 111, 117], ["<1.0 cm", "OBSERVATION_MODIFIER", 118, 125], ["diameter", "OBSERVATION_MODIFIER", 129, 137]]], ["The intermingled red areas represent areas of necrosis, hemorrhage, and collapse, and these are depressed a few millimeters below the surface.", [["red areas", "ANATOMY", 17, 26], ["surface", "ANATOMY", 134, 141], ["necrosis", "DISEASE", 46, 54], ["hemorrhage", "DISEASE", 56, 66], ["depressed", "DISEASE", 96, 105], ["surface", "CELLULAR_COMPONENT", 134, 141], ["necrosis", "PROBLEM", 46, 54], ["hemorrhage", "PROBLEM", 56, 66], ["collapse", "PROBLEM", 72, 80], ["intermingled", "OBSERVATION_MODIFIER", 4, 16], ["red", "OBSERVATION_MODIFIER", 17, 20], ["areas", "OBSERVATION_MODIFIER", 21, 26], ["areas", "OBSERVATION_MODIFIER", 37, 42], ["necrosis", "OBSERVATION", 46, 54], ["hemorrhage", "OBSERVATION", 56, 66], ["collapse", "OBSERVATION", 72, 80], ["depressed", "OBSERVATION_MODIFIER", 96, 105], ["few", "OBSERVATION_MODIFIER", 108, 111], ["millimeters", "OBSERVATION_MODIFIER", 112, 123], ["surface", "OBSERVATION_MODIFIER", 134, 141]]], ["In the healing stage, the depressed areas of hemorrhage and necrosis are condensed, shrunken, and scarified so that the surface of the liver is traversed by fine or heavy scars that separate large nodules of regenerative hyperplasia.", [["surface", "ANATOMY", 120, 127], ["liver", "ANATOMY", 135, 140], ["nodules", "ANATOMY", 197, 204], ["regenerative hyperplasia", "ANATOMY", 208, 232], ["depressed", "DISEASE", 26, 35], ["hemorrhage", "DISEASE", 45, 55], ["necrosis", "DISEASE", 60, 68], ["hyperplasia", "DISEASE", 221, 232], ["surface", "CELLULAR_COMPONENT", 120, 127], ["liver", "ORGAN", 135, 140], ["regenerative hyperplasia", "PATHOLOGICAL_FORMATION", 208, 232], ["the depressed areas of hemorrhage", "PROBLEM", 22, 55], ["necrosis", "PROBLEM", 60, 68], ["fine or heavy scars", "PROBLEM", 157, 176], ["large nodules", "PROBLEM", 191, 204], ["regenerative hyperplasia", "PROBLEM", 208, 232], ["healing stage", "OBSERVATION_MODIFIER", 7, 20], ["depressed", "OBSERVATION_MODIFIER", 26, 35], ["areas", "OBSERVATION_MODIFIER", 36, 41], ["hemorrhage", "OBSERVATION", 45, 55], ["necrosis", "OBSERVATION", 60, 68], ["condensed", "OBSERVATION_MODIFIER", 73, 82], ["shrunken", "OBSERVATION_MODIFIER", 84, 92], ["surface", "ANATOMY_MODIFIER", 120, 127], ["liver", "ANATOMY", 135, 140], ["traversed", "OBSERVATION_MODIFIER", 144, 153], ["fine", "OBSERVATION_MODIFIER", 157, 161], ["heavy", "OBSERVATION_MODIFIER", 165, 170], ["scars", "OBSERVATION", 171, 176], ["separate", "OBSERVATION_MODIFIER", 182, 190], ["large", "OBSERVATION_MODIFIER", 191, 196], ["nodules", "OBSERVATION", 197, 204], ["regenerative", "OBSERVATION_MODIFIER", 208, 220], ["hyperplasia", "OBSERVATION", 221, 232]]], ["Further acute episodes may be superimposed so that the presented lesion may be a mixture of acute massive necrosis and postnecrotic scarring.Lobular necrosisHepatosis dietetica of swine is a now uncommon syndrome of massive hepatic necrosis in association with its immediate or late effects, namely \"yellow-fat disease,\" degeneration of skeletal and cardiac muscle, serous effusions, ulceration of the squamous mucosa of the stomach, and fibrinoid necrosis of arterioles.", [["lesion", "ANATOMY", 65, 71], ["hepatic", "ANATOMY", 224, 231], ["fat", "ANATOMY", 307, 310], ["skeletal", "ANATOMY", 337, 345], ["cardiac muscle", "ANATOMY", 350, 364], ["serous effusions", "ANATOMY", 366, 382], ["squamous mucosa", "ANATOMY", 402, 417], ["stomach", "ANATOMY", 425, 432], ["fibrinoid", "ANATOMY", 438, 447], ["arterioles", "ANATOMY", 460, 470], ["necrosis", "DISEASE", 106, 114], ["scarring", "DISEASE", 132, 140], ["necrosisHepatosis dietetica", "DISEASE", 149, 176], ["massive hepatic necrosis", "DISEASE", 216, 240], ["fat disease", "DISEASE", 307, 318], ["degeneration of skeletal and cardiac muscle", "DISEASE", 321, 364], ["serous effusions", "DISEASE", 366, 382], ["necrosis", "DISEASE", 448, 456], ["swine", "ORGANISM", 180, 185], ["hepatic", "ORGAN", 224, 231], ["fat", "TISSUE", 307, 310], ["skeletal", "TISSUE", 337, 345], ["cardiac muscle", "TISSUE", 350, 364], ["serous effusions", "PATHOLOGICAL_FORMATION", 366, 382], ["squamous mucosa", "MULTI-TISSUE_STRUCTURE", 402, 417], ["stomach", "ORGAN", 425, 432], ["arterioles", "MULTI-TISSUE_STRUCTURE", 460, 470], ["swine", "SPECIES", 180, 185], ["Further acute episodes", "PROBLEM", 0, 22], ["the presented lesion", "PROBLEM", 51, 71], ["acute massive necrosis", "PROBLEM", 92, 114], ["postnecrotic scarring", "PROBLEM", 119, 140], ["Lobular necrosisHepatosis dietetica of swine", "PROBLEM", 141, 185], ["a now uncommon syndrome", "PROBLEM", 189, 212], ["massive hepatic necrosis", "PROBLEM", 216, 240], ["yellow-fat disease", "PROBLEM", 300, 318], ["degeneration of skeletal and cardiac muscle", "PROBLEM", 321, 364], ["serous effusions", "PROBLEM", 366, 382], ["ulceration of the squamous mucosa of the stomach", "PROBLEM", 384, 432], ["fibrinoid necrosis of arterioles", "PROBLEM", 438, 470], ["acute", "OBSERVATION_MODIFIER", 8, 13], ["episodes", "OBSERVATION", 14, 22], ["lesion", "OBSERVATION", 65, 71], ["may be", "UNCERTAINTY", 72, 78], ["acute", "OBSERVATION_MODIFIER", 92, 97], ["massive", "OBSERVATION_MODIFIER", 98, 105], ["necrosis", "OBSERVATION", 106, 114], ["postnecrotic", "OBSERVATION_MODIFIER", 119, 131], ["scarring", "OBSERVATION", 132, 140], ["necrosisHepatosis", "OBSERVATION", 149, 166], ["swine", "OBSERVATION", 180, 185], ["massive", "OBSERVATION_MODIFIER", 216, 223], ["hepatic", "ANATOMY", 224, 231], ["necrosis", "OBSERVATION", 232, 240], ["yellow", "OBSERVATION_MODIFIER", 300, 306], ["fat disease", "OBSERVATION", 307, 318], ["degeneration", "OBSERVATION", 321, 333], ["skeletal", "ANATOMY", 337, 345], ["cardiac muscle", "ANATOMY", 350, 364], ["serous", "OBSERVATION_MODIFIER", 366, 372], ["effusions", "OBSERVATION", 373, 382], ["ulceration", "OBSERVATION", 384, 394], ["squamous mucosa", "ANATOMY", 402, 417], ["stomach", "ANATOMY", 425, 432], ["fibrinoid", "OBSERVATION_MODIFIER", 438, 447], ["necrosis", "OBSERVATION", 448, 456], ["arterioles", "ANATOMY", 460, 470]]], ["These lesions may occur alone or in any combination, although all seldom occur in one animal.", [["lesions", "ANATOMY", 6, 13], ["lesions", "PATHOLOGICAL_FORMATION", 6, 13], ["These lesions", "PROBLEM", 0, 13], ["lesions", "OBSERVATION", 6, 13]]], ["They are known to be of nutritional origin, and the fact that the various lesions can occur separately indicates the complexity of the pathogenesis.", [["lesions", "ANATOMY", 74, 81], ["lesions", "PATHOLOGICAL_FORMATION", 74, 81], ["the various lesions", "PROBLEM", 62, 81], ["the pathogenesis", "PROBLEM", 131, 147], ["known to be", "UNCERTAINTY", 9, 20], ["nutritional origin", "OBSERVATION_MODIFIER", 24, 42], ["various", "OBSERVATION_MODIFIER", 66, 73], ["lesions", "OBSERVATION", 74, 81], ["pathogenesis", "OBSERVATION", 135, 147]]], ["Experimental observations have revealed the need for concurrent deficiencies of sulfur-containing amino acids, tocopherols, and trace amounts of selenium if hepatic necrosis is to develop.", [["hepatic", "ANATOMY", 157, 164], ["sulfur", "CHEMICAL", 80, 86], ["amino acids", "CHEMICAL", 98, 109], ["tocopherols", "CHEMICAL", 111, 122], ["selenium", "CHEMICAL", 145, 153], ["hepatic necrosis", "DISEASE", 157, 173], ["sulfur", "CHEMICAL", 80, 86], ["amino acids", "CHEMICAL", 98, 109], ["tocopherols", "CHEMICAL", 111, 122], ["selenium", "CHEMICAL", 145, 153], ["sulfur", "SIMPLE_CHEMICAL", 80, 86], ["amino acids", "AMINO_ACID", 98, 109], ["tocopherols", "SIMPLE_CHEMICAL", 111, 122], ["selenium", "SIMPLE_CHEMICAL", 145, 153], ["hepatic", "ORGAN", 157, 164], ["Experimental observations", "TEST", 0, 25], ["concurrent deficiencies of sulfur", "TREATMENT", 53, 86], ["amino acids", "TREATMENT", 98, 109], ["tocopherols", "TREATMENT", 111, 122], ["hepatic necrosis", "PROBLEM", 157, 173], ["trace amounts", "OBSERVATION_MODIFIER", 128, 141], ["hepatic", "ANATOMY", 157, 164], ["necrosis", "OBSERVATION", 165, 173]]], ["Selenium protects efficiently against the hepatic necrosis and massive effusions, and tocopherols are probably protective against other lesions that occur as part of the syndrome.", [["hepatic", "ANATOMY", 42, 49], ["lesions", "ANATOMY", 136, 143], ["Selenium", "CHEMICAL", 0, 8], ["hepatic necrosis", "DISEASE", 42, 58], ["effusions", "DISEASE", 71, 80], ["tocopherols", "CHEMICAL", 86, 97], ["Selenium", "CHEMICAL", 0, 8], ["tocopherols", "CHEMICAL", 86, 97], ["Selenium", "SIMPLE_CHEMICAL", 0, 8], ["tocopherols", "SIMPLE_CHEMICAL", 86, 97], ["lesions", "PATHOLOGICAL_FORMATION", 136, 143], ["Selenium protects", "TREATMENT", 0, 17], ["the hepatic necrosis", "PROBLEM", 38, 58], ["massive effusions", "PROBLEM", 63, 80], ["tocopherols", "TREATMENT", 86, 97], ["other lesions", "PROBLEM", 130, 143], ["the syndrome", "PROBLEM", 166, 178], ["hepatic", "ANATOMY", 42, 49], ["necrosis", "OBSERVATION", 50, 58], ["massive", "OBSERVATION_MODIFIER", 63, 70], ["effusions", "OBSERVATION", 71, 80], ["probably protective", "UNCERTAINTY", 102, 121], ["lesions", "OBSERVATION", 136, 143], ["syndrome", "OBSERVATION", 170, 178]]], ["The pathogenesis is incompletely understood, but is in part related to the generation of free radicals, exacerbated by deficiency of free-radical scavengers such as vitamin E, and selenium, protective against reactive oxygen radicals through its role in glutathione peroxidase and some other selenoproteins.", [["vitamin E", "CHEMICAL", 165, 174], ["selenium", "CHEMICAL", 180, 188], ["oxygen", "CHEMICAL", 218, 224], ["glutathione", "CHEMICAL", 254, 265], ["vitamin E", "CHEMICAL", 165, 174], ["selenium", "CHEMICAL", 180, 188], ["oxygen", "CHEMICAL", 218, 224], ["glutathione", "CHEMICAL", 254, 265], ["free-radical scavengers", "SIMPLE_CHEMICAL", 133, 156], ["vitamin E", "SIMPLE_CHEMICAL", 165, 174], ["selenium", "SIMPLE_CHEMICAL", 180, 188], ["reactive oxygen radicals", "SIMPLE_CHEMICAL", 209, 233], ["glutathione peroxidase", "GENE_OR_GENE_PRODUCT", 254, 276], ["glutathione peroxidase", "PROTEIN", 254, 276], ["selenoproteins", "PROTEIN", 292, 306], ["free radicals", "PROBLEM", 89, 102], ["free-radical scavengers", "TREATMENT", 133, 156], ["vitamin E", "TREATMENT", 165, 174], ["selenium", "TREATMENT", 180, 188], ["reactive oxygen radicals", "TREATMENT", 209, 233], ["glutathione peroxidase", "TREATMENT", 254, 276], ["incompletely understood", "OBSERVATION_MODIFIER", 20, 43], ["free radicals", "OBSERVATION", 89, 102], ["reactive", "OBSERVATION_MODIFIER", 209, 217], ["oxygen radicals", "OBSERVATION", 218, 233]]], ["Hepatosis dietetica occurs in rapidly growing pigs fed diets largely of grain and containing protein supplements lacking in either quality or quantity.", [["Hepatosis dietetica", "DISEASE", 0, 19], ["pigs", "ORGANISM", 46, 50], ["grain", "ORGANISM_SUBDIVISION", 72, 77], ["pigs", "SPECIES", 46, 50], ["Hepatosis dietetica", "SPECIES", 0, 19], ["pigs", "SPECIES", 46, 50], ["Hepatosis dietetica", "PROBLEM", 0, 19], ["protein supplements", "TREATMENT", 93, 112], ["rapidly", "OBSERVATION_MODIFIER", 30, 37]]], ["There is some evidence that in pigs that are nutritionally predisposed, a cold and damp environment or some other stress may precipitate the disease.", [["pigs", "ORGANISM", 31, 35], ["pigs", "SPECIES", 31, 35], ["pigs", "SPECIES", 31, 35], ["a cold and damp environment", "PROBLEM", 72, 99], ["the disease", "PROBLEM", 137, 148], ["disease", "OBSERVATION", 141, 148]]], ["Death usually occurs without signs of illness or after a short period of dullness.", [["Death", "DISEASE", 0, 5], ["illness", "DISEASE", 38, 45], ["Death", "PROBLEM", 0, 5], ["illness", "PROBLEM", 38, 45], ["dullness", "PROBLEM", 73, 81], ["dullness", "OBSERVATION", 73, 81]]], ["Melena, dyspnea, weakness, and trembling may be observed in some cases.", [["Melena", "DISEASE", 0, 6], ["dyspnea", "DISEASE", 8, 15], ["weakness", "DISEASE", 17, 25], ["trembling", "DISEASE", 31, 40], ["Melena", "PROBLEM", 0, 6], ["dyspnea", "PROBLEM", 8, 15], ["weakness", "PROBLEM", 17, 25], ["trembling", "PROBLEM", 31, 40], ["dyspnea", "OBSERVATION", 8, 15], ["weakness", "OBSERVATION", 17, 25]]], ["Jaundice is indicative of a relapsing course.Lobular necrosisAffected pigs are usually in good condition.", [["Jaundice", "DISEASE", 0, 8], ["pigs", "ORGANISM", 70, 74], ["pigs", "SPECIES", 70, 74], ["Jaundice", "PROBLEM", 0, 8], ["Lobular necrosisAffected pigs", "PROBLEM", 45, 74], ["indicative of", "UNCERTAINTY", 12, 25], ["relapsing", "OBSERVATION_MODIFIER", 28, 37], ["course", "OBSERVATION_MODIFIER", 38, 44], ["necrosisAffected pigs", "OBSERVATION", 53, 74], ["good", "OBSERVATION_MODIFIER", 90, 94]]], ["The carcass may be anemic if ulceration of the gastric mucosa has occurred, and, in these cases, free and digested blood may be found in the stomach and intestine.", [["carcass", "ANATOMY", 4, 11], ["gastric mucosa", "ANATOMY", 47, 61], ["blood", "ANATOMY", 115, 120], ["stomach", "ANATOMY", 141, 148], ["intestine", "ANATOMY", 153, 162], ["carcass", "ORGANISM_SUBDIVISION", 4, 11], ["gastric mucosa", "MULTI-TISSUE_STRUCTURE", 47, 61], ["blood", "ORGANISM_SUBSTANCE", 115, 120], ["stomach", "ORGAN", 141, 148], ["intestine", "ORGAN", 153, 162], ["anemic", "PROBLEM", 19, 25], ["ulceration of the gastric mucosa", "PROBLEM", 29, 61], ["digested blood", "PROBLEM", 106, 120], ["may be", "UNCERTAINTY", 12, 18], ["anemic", "OBSERVATION", 19, 25], ["ulceration", "OBSERVATION", 29, 39], ["gastric mucosa", "ANATOMY", 47, 61], ["stomach", "ANATOMY", 141, 148], ["intestine", "ANATOMY", 153, 162]]], ["Jaundice is not common, but yellow staining of adipose tissues (yellow-fat disease) is.", [["adipose tissues", "ANATOMY", 47, 62], ["yellow-fat", "ANATOMY", 64, 74], ["Jaundice", "DISEASE", 0, 8], ["yellow-fat disease", "DISEASE", 64, 82], ["adipose tissues", "TISSUE", 47, 62], ["yellow-fat", "TISSUE", 64, 74], ["Jaundice", "PROBLEM", 0, 8], ["yellow staining of adipose tissues", "PROBLEM", 28, 62], ["yellow-fat disease)", "PROBLEM", 64, 83], ["not", "UNCERTAINTY", 12, 15], ["common", "OBSERVATION_MODIFIER", 16, 22], ["yellow", "OBSERVATION", 28, 34], ["adipose tissues", "ANATOMY", 47, 62], ["yellow", "OBSERVATION_MODIFIER", 64, 70], ["fat disease", "OBSERVATION", 71, 82]]], ["In relapsing cases, hemorrhagic diathesis may occur, manifested mainly by hemorrhage into and about joints.", [["joints", "ANATOMY", 100, 106], ["hemorrhagic diathesis", "DISEASE", 20, 41], ["hemorrhage", "DISEASE", 74, 84], ["joints", "MULTI-TISSUE_STRUCTURE", 100, 106], ["hemorrhagic diathesis", "PROBLEM", 20, 41], ["hemorrhage", "PROBLEM", 74, 84], ["relapsing", "OBSERVATION_MODIFIER", 3, 12], ["hemorrhagic", "OBSERVATION_MODIFIER", 20, 31], ["diathesis", "OBSERVATION", 32, 41], ["hemorrhage", "OBSERVATION", 74, 84], ["joints", "ANATOMY", 100, 106]]], ["Protein-rich fluid collects in the serous cavities in small volume.", [["serous cavities", "ANATOMY", 35, 50], ["serous cavities", "PATHOLOGICAL_FORMATION", 35, 50], ["Protein", "TEST", 0, 7], ["rich", "OBSERVATION_MODIFIER", 8, 12], ["fluid collects", "OBSERVATION", 13, 27], ["serous cavities", "OBSERVATION", 35, 50], ["small", "OBSERVATION_MODIFIER", 54, 59], ["volume", "OBSERVATION_MODIFIER", 60, 66]]], ["Fine strands of fibrin are present in the peritoneal cavity.Lobular necrosisPulmonary edema accompanies myocardial lesions that consist of intramural and subendocardial hemorrhages with focal areas of hyaline degeneration.", [["peritoneal cavity", "ANATOMY", 42, 59], ["Lobular necrosisPulmonary edema", "ANATOMY", 60, 91], ["myocardial lesions", "ANATOMY", 104, 122], ["intramural", "ANATOMY", 139, 149], ["subendocardial", "ANATOMY", 154, 168], ["hyaline", "ANATOMY", 201, 208], ["necrosisPulmonary edema", "DISEASE", 68, 91], ["myocardial lesions", "DISEASE", 104, 122], ["hemorrhages", "DISEASE", 169, 180], ["fibrin", "GENE_OR_GENE_PRODUCT", 16, 22], ["peritoneal cavity", "MULTI-TISSUE_STRUCTURE", 42, 59], ["Lobular necrosisPulmonary edema", "PATHOLOGICAL_FORMATION", 60, 91], ["myocardial lesions", "PATHOLOGICAL_FORMATION", 104, 122], ["subendocardial hemorrhages", "PATHOLOGICAL_FORMATION", 154, 180], ["hyaline", "TISSUE", 201, 208], ["fibrin", "PROTEIN", 16, 22], ["fibrin", "PROBLEM", 16, 22], ["Lobular necrosisPulmonary edema", "PROBLEM", 60, 91], ["myocardial lesions", "PROBLEM", 104, 122], ["intramural and subendocardial hemorrhages", "PROBLEM", 139, 180], ["hyaline degeneration", "PROBLEM", 201, 221], ["strands", "OBSERVATION_MODIFIER", 5, 12], ["fibrin", "OBSERVATION", 16, 22], ["peritoneal", "ANATOMY", 42, 52], ["cavity", "ANATOMY_MODIFIER", 53, 59], ["edema", "OBSERVATION", 86, 91], ["myocardial", "ANATOMY", 104, 114], ["lesions", "OBSERVATION", 115, 122], ["intramural", "ANATOMY_MODIFIER", 139, 149], ["subendocardial", "ANATOMY", 154, 168], ["hemorrhages", "OBSERVATION", 169, 180], ["focal", "OBSERVATION_MODIFIER", 186, 191], ["areas", "OBSERVATION_MODIFIER", 192, 197], ["hyaline degeneration", "OBSERVATION", 201, 221]]], ["The changes in the liver dominate the autopsy findings.", [["liver", "ANATOMY", 19, 24], ["liver", "ORGAN", 19, 24], ["The changes in the liver", "PROBLEM", 0, 24], ["liver", "ANATOMY", 19, 24], ["autopsy", "OBSERVATION", 38, 45]]], ["The massive hepatic necrosis represents the death of a single complete acinus as a result of local vascular insufficiency, although, theoretically, high local microsomal enzyme activity or local deficiency of hepatocellular protective factors may play a part.", [["hepatic", "ANATOMY", 12, 19], ["acinus", "ANATOMY", 71, 77], ["vascular", "ANATOMY", 99, 107], ["hepatocellular", "ANATOMY", 209, 223], ["hepatic necrosis", "DISEASE", 12, 28], ["death", "DISEASE", 44, 49], ["vascular insufficiency", "DISEASE", 99, 121], ["hepatic", "ORGAN", 12, 19], ["acinus", "ORGAN", 71, 77], ["vascular", "MULTI-TISSUE_STRUCTURE", 99, 107], ["hepatocellular", "CANCER", 209, 223], ["hepatocellular protective factors", "PROTEIN", 209, 242], ["The massive hepatic necrosis", "PROBLEM", 0, 28], ["a single complete acinus", "PROBLEM", 53, 77], ["local vascular insufficiency", "PROBLEM", 93, 121], ["high local microsomal enzyme activity", "PROBLEM", 148, 185], ["local deficiency of hepatocellular protective factors", "PROBLEM", 189, 242], ["massive", "OBSERVATION_MODIFIER", 4, 11], ["hepatic", "ANATOMY", 12, 19], ["necrosis", "OBSERVATION", 20, 28], ["acinus", "OBSERVATION", 71, 77], ["local", "OBSERVATION_MODIFIER", 93, 98], ["vascular", "ANATOMY", 99, 107], ["insufficiency", "OBSERVATION", 108, 121], ["high", "OBSERVATION_MODIFIER", 148, 152], ["enzyme activity", "OBSERVATION", 170, 185], ["local deficiency", "OBSERVATION", 189, 205], ["hepatocellular", "OBSERVATION", 209, 223]]], ["Occlusion and rupture of a bile ductule or cholangiole are other potential causes of paracentral necrosis.Massive necrosisMassive necrosis refers to necrosis of an entire hepatic lobule, not necessarily necrosis of the liver as a whole.", [["bile ductule", "ANATOMY", 27, 39], ["hepatic lobule", "ANATOMY", 171, 185], ["liver", "ANATOMY", 219, 224], ["rupture", "DISEASE", 14, 21], ["cholangiole", "DISEASE", 43, 54], ["paracentral necrosis", "DISEASE", 85, 105], ["necrosis", "DISEASE", 130, 138], ["necrosis", "DISEASE", 149, 157], ["necrosis", "DISEASE", 203, 211], ["bile ductule", "CANCER", 27, 39], ["cholangiole", "SIMPLE_CHEMICAL", 43, 54], ["hepatic lobule", "MULTI-TISSUE_STRUCTURE", 171, 185], ["liver", "ORGAN", 219, 224], ["Occlusion", "PROBLEM", 0, 9], ["rupture", "PROBLEM", 14, 21], ["a bile ductule", "PROBLEM", 25, 39], ["paracentral necrosis", "PROBLEM", 85, 105], ["Massive necrosisMassive necrosis", "PROBLEM", 106, 138], ["necrosis of an entire hepatic lobule", "PROBLEM", 149, 185], ["necrosis of the liver", "PROBLEM", 203, 224], ["rupture", "OBSERVATION", 14, 21], ["bile", "ANATOMY", 27, 31], ["paracentral", "OBSERVATION_MODIFIER", 85, 96], ["necrosis", "OBSERVATION", 97, 105], ["necrosisMassive", "OBSERVATION_MODIFIER", 114, 129], ["necrosis", "OBSERVATION", 130, 138], ["necrosis", "OBSERVATION", 149, 157], ["entire", "ANATOMY_MODIFIER", 164, 170], ["hepatic", "ANATOMY", 171, 178], ["lobule", "ANATOMY_MODIFIER", 179, 185], ["not necessarily", "UNCERTAINTY", 187, 202], ["necrosis", "OBSERVATION", 203, 211], ["liver", "ANATOMY", 219, 224]]], ["By accepted definition, every cell in the affected lobule is dead, including the hepatocytes of the limiting plate ( Fig. 2-38 ).", [["cell", "ANATOMY", 30, 34], ["lobule", "ANATOMY", 51, 57], ["hepatocytes", "ANATOMY", 81, 92], ["cell", "CELL", 30, 34], ["lobule", "ORGAN", 51, 57], ["hepatocytes", "CELL", 81, 92], ["hepatocytes", "CELL_TYPE", 81, 92], ["dead", "PROBLEM", 61, 65], ["affected lobule", "ANATOMY", 42, 57], ["dead", "OBSERVATION", 61, 65], ["hepatocytes", "ANATOMY", 81, 92], ["plate", "OBSERVATION_MODIFIER", 109, 114]]], ["Without surviving parenchyma to support regeneration, affected lobules collapse, so that portal areas and hepatic venules are approximated and the intervening stroma is condensed.", [["parenchyma", "ANATOMY", 18, 28], ["lobules", "ANATOMY", 63, 70], ["portal areas", "ANATOMY", 89, 101], ["hepatic venules", "ANATOMY", 106, 121], ["stroma", "ANATOMY", 159, 165], ["parenchyma", "TISSUE", 18, 28], ["lobules", "MULTI-TISSUE_STRUCTURE", 63, 70], ["portal areas", "MULTI-TISSUE_STRUCTURE", 89, 101], ["hepatic venules", "MULTI-TISSUE_STRUCTURE", 106, 121], ["stroma", "TISSUE", 159, 165], ["hepatic venules", "CELL_TYPE", 106, 121], ["surviving parenchyma", "PROBLEM", 8, 28], ["affected lobules collapse", "PROBLEM", 54, 79], ["support regeneration", "OBSERVATION", 32, 52], ["affected", "OBSERVATION_MODIFIER", 54, 62], ["lobules", "OBSERVATION_MODIFIER", 63, 70], ["collapse", "OBSERVATION", 71, 79], ["portal", "ANATOMY", 89, 95], ["areas", "ANATOMY_MODIFIER", 96, 101], ["hepatic venules", "ANATOMY", 106, 121], ["condensed", "OBSERVATION_MODIFIER", 169, 178]]], ["Such a liver must regenerate from surviving hepatocytes in other, less severely affected lobules or by proliferation of progenitor cells that mature into hepatocytes.", [["liver", "ANATOMY", 7, 12], ["hepatocytes", "ANATOMY", 44, 55], ["lobules", "ANATOMY", 89, 96], ["progenitor cells", "ANATOMY", 120, 136], ["hepatocytes", "ANATOMY", 154, 165], ["liver", "ORGAN", 7, 12], ["hepatocytes", "CELL", 44, 55], ["lobules", "CANCER", 89, 96], ["progenitor cells", "CELL", 120, 136], ["hepatocytes", "CELL", 154, 165], ["surviving hepatocytes", "CELL_TYPE", 34, 55], ["progenitor cells", "CELL_TYPE", 120, 136], ["hepatocytes", "CELL_TYPE", 154, 165], ["surviving hepatocytes", "PROBLEM", 34, 55], ["severely affected lobules", "PROBLEM", 71, 96], ["proliferation of progenitor cells", "PROBLEM", 103, 136], ["liver", "ANATOMY", 7, 12], ["less", "OBSERVATION_MODIFIER", 66, 70], ["severely", "OBSERVATION_MODIFIER", 71, 79], ["affected", "OBSERVATION_MODIFIER", 80, 88], ["lobules", "OBSERVATION", 89, 96], ["proliferation", "OBSERVATION_MODIFIER", 103, 116], ["progenitor cells", "OBSERVATION", 120, 136], ["hepatocytes", "ANATOMY", 154, 165]]], ["The distribution of massive hepatic necrosis meshwork of the hepatic \"reticulin\" or detach completely forming microemboli in the sinusoid downstream.", [["hepatic", "ANATOMY", 28, 35], ["hepatic", "ANATOMY", 61, 68], ["microemboli", "ANATOMY", 110, 121], ["sinusoid", "ANATOMY", 129, 137], ["necrosis", "DISEASE", 36, 44], ["microemboli", "DISEASE", 110, 121], ["hepatic", "ORGAN", 61, 68], ["massive hepatic necrosis", "PROBLEM", 20, 44], ["the hepatic \"reticulin\"", "PROBLEM", 57, 80], ["detach completely forming microemboli in the sinusoid downstream", "PROBLEM", 84, 148], ["distribution", "OBSERVATION_MODIFIER", 4, 16], ["massive", "OBSERVATION_MODIFIER", 20, 27], ["hepatic", "ANATOMY", 28, 35], ["necrosis", "OBSERVATION", 36, 44], ["meshwork", "OBSERVATION_MODIFIER", 45, 53], ["hepatic", "ANATOMY", 61, 68], ["reticulin\"", "OBSERVATION", 70, 80], ["completely", "OBSERVATION_MODIFIER", 91, 101], ["forming", "OBSERVATION_MODIFIER", 102, 109], ["microemboli", "OBSERVATION", 110, 121], ["sinusoid", "OBSERVATION_MODIFIER", 129, 137], ["downstream", "OBSERVATION_MODIFIER", 138, 148]]], ["In addition, the residual, exposed space of Disse has an increased risk of sinusoidal thrombosis.", [["sinusoidal", "ANATOMY", 75, 85], ["thrombosis", "DISEASE", 86, 96], ["sinusoidal", "MULTI-TISSUE_STRUCTURE", 75, 85], ["sinusoidal thrombosis", "PROBLEM", 75, 96], ["residual", "OBSERVATION_MODIFIER", 17, 25], ["exposed", "OBSERVATION_MODIFIER", 27, 34], ["space", "OBSERVATION_MODIFIER", 35, 40], ["Disse", "OBSERVATION_MODIFIER", 44, 49], ["increased", "OBSERVATION_MODIFIER", 57, 66], ["sinusoidal thrombosis", "OBSERVATION", 75, 96]]], ["Acute endothelial injury can occur as a result of ischemia-reperfusion injury, acetaminophen or pyrrolizidine toxicity, and effects of endotoxin, all of which can lead to localized ischemia and necrosis.", [["endothelial", "ANATOMY", 6, 17], ["endothelial injury", "DISEASE", 6, 24], ["ischemia-reperfusion injury", "DISEASE", 50, 77], ["acetaminophen", "CHEMICAL", 79, 92], ["pyrrolizidine toxicity", "DISEASE", 96, 118], ["endotoxin", "CHEMICAL", 135, 144], ["ischemia", "DISEASE", 181, 189], ["necrosis", "DISEASE", 194, 202], ["acetaminophen", "CHEMICAL", 79, 92], ["pyrrolizidine", "CHEMICAL", 96, 109], ["endothelial", "TISSUE", 6, 17], ["acetaminophen", "SIMPLE_CHEMICAL", 79, 92], ["pyrrolizidine", "SIMPLE_CHEMICAL", 96, 109], ["endotoxin", "SIMPLE_CHEMICAL", 135, 144], ["Acute endothelial injury", "PROBLEM", 0, 24], ["ischemia-reperfusion injury", "PROBLEM", 50, 77], ["acetaminophen", "TREATMENT", 79, 92], ["pyrrolizidine toxicity", "PROBLEM", 96, 118], ["endotoxin", "TREATMENT", 135, 144], ["localized ischemia", "PROBLEM", 171, 189], ["necrosis", "PROBLEM", 194, 202], ["endothelial", "ANATOMY", 6, 17], ["injury", "OBSERVATION", 18, 24], ["ischemia-reperfusion", "OBSERVATION_MODIFIER", 50, 70], ["injury", "OBSERVATION", 71, 77], ["localized", "OBSERVATION_MODIFIER", 171, 180], ["ischemia", "OBSERVATION", 181, 189], ["necrosis", "OBSERVATION", 194, 202]]], ["Other endothelial toxins include ngaione poisoning and microcystin-LR, a highly toxic cyclic heptapeptide produced by Microcystis aeruginosa, an aquatic cyanobacterium (blue-green alga).", [["endothelial", "ANATOMY", 6, 17], ["poisoning", "DISEASE", 41, 50], ["microcystin-LR", "CHEMICAL", 55, 69], ["ngaione", "CHEMICAL", 33, 40], ["microcystin-LR", "CHEMICAL", 55, 69], ["cyclic heptapeptide", "CHEMICAL", 86, 105], ["endothelial", "CELL", 6, 17], ["ngaione", "SIMPLE_CHEMICAL", 33, 40], ["microcystin-LR", "SIMPLE_CHEMICAL", 55, 69], ["cyclic heptapeptide", "SIMPLE_CHEMICAL", 86, 105], ["Microcystis aeruginosa", "ORGANISM", 118, 140], ["blue-green alga", "ORGANISM", 169, 184], ["Microcystis aeruginosa", "SPECIES", 118, 140], ["Microcystis aeruginosa", "SPECIES", 118, 140], ["blue-green alga", "SPECIES", 169, 184], ["Other endothelial toxins", "TEST", 0, 24], ["ngaione poisoning", "PROBLEM", 33, 50], ["microcystin", "TEST", 55, 66], ["LR", "TREATMENT", 67, 69], ["a highly toxic cyclic heptapeptide", "PROBLEM", 71, 105], ["Microcystis aeruginosa", "PROBLEM", 118, 140], ["an aquatic cyanobacterium", "PROBLEM", 142, 167], ["endothelial", "ANATOMY", 6, 17], ["Microcystis aeruginosa", "OBSERVATION", 118, 140], ["aquatic cyanobacterium", "OBSERVATION", 145, 167]]], ["Microcystin-LR is selectively injurious to hepatic sinusoidal endothelial cells by inhibiting protein phosphatases.", [["hepatic sinusoidal endothelial cells", "ANATOMY", 43, 79], ["Microcystin", "CHEMICAL", 0, 11], ["Microcystin-LR", "GENE_OR_GENE_PRODUCT", 0, 14], ["hepatic sinusoidal endothelial cells", "CELL", 43, 79], ["protein phosphatases", "GENE_OR_GENE_PRODUCT", 94, 114], ["LR", "PROTEIN", 12, 14], ["hepatic sinusoidal endothelial cells", "CELL_TYPE", 43, 79], ["protein phosphatases", "PROTEIN", 94, 114], ["Microcystin", "TEST", 0, 11], ["inhibiting protein phosphatases", "TEST", 83, 114], ["hepatic", "ANATOMY", 43, 50], ["sinusoidal", "ANATOMY_MODIFIER", 51, 61], ["endothelial cells", "OBSERVATION", 62, 79]]], ["When the cytoskeleton becomes hyperphosphorylated, endothelial cells undergo apoptosis, leading to hemorrhagic necrosis.Massive necrosisSome forms of peliosis hepatis may develop following endothelial necrosis.", [["cytoskeleton", "ANATOMY", 9, 21], ["endothelial cells", "ANATOMY", 51, 68], ["peliosis hepatis", "ANATOMY", 150, 166], ["endothelial", "ANATOMY", 189, 200], ["hemorrhagic", "DISEASE", 99, 110], ["necrosis", "DISEASE", 111, 119], ["peliosis hepatis", "DISEASE", 150, 166], ["necrosis", "DISEASE", 201, 209], ["cytoskeleton", "CELLULAR_COMPONENT", 9, 21], ["endothelial cells", "CELL", 51, 68], ["hepatis", "ORGAN", 159, 166], ["endothelial", "TISSUE", 189, 200], ["endothelial cells", "CELL_TYPE", 51, 68], ["hyperphosphorylated", "PROBLEM", 30, 49], ["endothelial cells", "PROBLEM", 51, 68], ["apoptosis", "PROBLEM", 77, 86], ["hemorrhagic necrosis", "PROBLEM", 99, 119], ["Massive necrosisSome forms of peliosis hepatis", "PROBLEM", 120, 166], ["endothelial necrosis", "PROBLEM", 189, 209], ["hyperphosphorylated", "OBSERVATION", 30, 49], ["endothelial cells", "OBSERVATION", 51, 68], ["apoptosis", "OBSERVATION_MODIFIER", 77, 86], ["hemorrhagic", "OBSERVATION_MODIFIER", 99, 110], ["necrosis", "OBSERVATION", 111, 119], ["necrosisSome", "OBSERVATION", 128, 140], ["peliosis", "OBSERVATION", 150, 158], ["hepatis", "ANATOMY", 159, 166], ["endothelial", "OBSERVATION_MODIFIER", 189, 200], ["necrosis", "OBSERVATION", 201, 209]]], ["More chronic injury can produce fibrosis, leading to diminished or disrupted sinusoidal blood flow.", [["sinusoidal blood", "ANATOMY", 77, 93], ["chronic injury", "DISEASE", 5, 19], ["fibrosis", "DISEASE", 32, 40], ["sinusoidal", "MULTI-TISSUE_STRUCTURE", 77, 87], ["blood", "ORGANISM_SUBSTANCE", 88, 93], ["More chronic injury", "PROBLEM", 0, 19], ["fibrosis", "PROBLEM", 32, 40], ["diminished or disrupted sinusoidal blood flow", "PROBLEM", 53, 98], ["chronic", "OBSERVATION_MODIFIER", 5, 12], ["injury", "OBSERVATION", 13, 19], ["fibrosis", "OBSERVATION", 32, 40], ["diminished", "OBSERVATION_MODIFIER", 53, 63], ["sinusoidal blood flow", "OBSERVATION", 77, 98]]], ["Alteration of the sinusoidal blood flow can be a primary event leading to hepatocyte hypoxia with liver dysfunction and disruption of the portal circulation.", [["sinusoidal blood", "ANATOMY", 18, 34], ["hepatocyte", "ANATOMY", 74, 84], ["liver", "ANATOMY", 98, 103], ["portal", "ANATOMY", 138, 144], ["hypoxia", "DISEASE", 85, 92], ["liver dysfunction", "DISEASE", 98, 115], ["sinusoidal blood", "MULTI-TISSUE_STRUCTURE", 18, 34], ["hepatocyte", "CELL", 74, 84], ["liver", "ORGAN", 98, 103], ["portal circulation", "MULTI-TISSUE_STRUCTURE", 138, 156], ["the sinusoidal blood flow", "TEST", 14, 39], ["hepatocyte hypoxia", "PROBLEM", 74, 92], ["liver dysfunction", "PROBLEM", 98, 115], ["disruption of the portal circulation", "PROBLEM", 120, 156], ["sinusoidal blood flow", "OBSERVATION", 18, 39], ["hepatocyte", "ANATOMY", 74, 84], ["hypoxia", "OBSERVATION", 85, 92], ["liver", "ANATOMY", 98, 103], ["dysfunction", "OBSERVATION", 104, 115], ["portal circulation", "ANATOMY", 138, 156]]], ["Secondary endothelial cell injury can result when hepatocytes are being destroyed by the elaboration of toxic molecules within their cytoplasm, it is to be expected that the sinusoidal lining cells may also suffer should the products of these biotransformations spill into the space of Disse.", [["endothelial cell", "ANATOMY", 10, 26], ["hepatocytes", "ANATOMY", 50, 61], ["cytoplasm", "ANATOMY", 133, 142], ["sinusoidal lining cells", "ANATOMY", 174, 197], ["endothelial cell", "CELL", 10, 26], ["hepatocytes", "CELL", 50, 61], ["cytoplasm", "ORGANISM_SUBSTANCE", 133, 142], ["sinusoidal lining cells", "CELL", 174, 197], ["hepatocytes", "CELL_TYPE", 50, 61], ["sinusoidal lining cells", "CELL_TYPE", 174, 197], ["Secondary endothelial cell injury", "PROBLEM", 0, 33], ["toxic molecules", "PROBLEM", 104, 119], ["the sinusoidal lining cells", "PROBLEM", 170, 197], ["endothelial cell injury", "OBSERVATION", 10, 33], ["toxic", "OBSERVATION_MODIFIER", 104, 109], ["biotransformations spill", "OBSERVATION", 243, 267], ["Disse", "ANATOMY", 286, 291]]], ["Erythrocytes increase in the perisinusoidal space and, when endothelial damage is severe, the regions of necrosis are hemorrhagic.", [["Erythrocytes", "ANATOMY", 0, 12], ["perisinusoidal space", "ANATOMY", 29, 49], ["endothelial", "ANATOMY", 60, 71], ["endothelial damage", "DISEASE", 60, 78], ["necrosis", "DISEASE", 105, 113], ["hemorrhagic", "DISEASE", 118, 129], ["Erythrocytes", "CELL", 0, 12], ["endothelial", "CELL", 60, 71], ["Erythrocytes", "CELL_TYPE", 0, 12], ["Erythrocytes increase in the perisinusoidal space", "PROBLEM", 0, 49], ["endothelial damage", "PROBLEM", 60, 78], ["necrosis", "PROBLEM", 105, 113], ["hemorrhagic", "PROBLEM", 118, 129], ["increase", "OBSERVATION_MODIFIER", 13, 21], ["perisinusoidal space", "ANATOMY", 29, 49], ["endothelial", "ANATOMY", 60, 71], ["damage", "OBSERVATION", 72, 78], ["severe", "OBSERVATION_MODIFIER", 82, 88], ["regions", "OBSERVATION_MODIFIER", 94, 101], ["necrosis", "OBSERVATION", 105, 113], ["hemorrhagic", "OBSERVATION_MODIFIER", 118, 129]]], ["Necrosis of sinusoidal endothelial cells is seen very early in the course of many hepatotoxicities.Massive necrosisSinusoidal phagocytes are sometimes vulnerable to necrosis by virtue of their role in clearing the portal blood of particulate or colloidal material; should these particles be toxic or infectious, Kupffer cell necrosis may occur alone, but more usually, there is damage to surrounding hepatocytes as well.Necrosis of bile duct epitheliumIt is unusual for the bile duct epithelium to be singled out by specific lethal insults, but this is seen in intoxication by sporidesmin (see section on Toxic hepatic disease).", [["sinusoidal endothelial cells", "ANATOMY", 12, 40], ["necrosisSinusoidal phagocytes", "ANATOMY", 107, 136], ["portal blood", "ANATOMY", 214, 226], ["Kupffer cell", "ANATOMY", 312, 324], ["hepatocytes", "ANATOMY", 400, 411], ["bile duct epithelium", "ANATOMY", 432, 452], ["bile duct epithelium", "ANATOMY", 474, 494], ["hepatic", "ANATOMY", 611, 618], ["hepatotoxicities", "DISEASE", 82, 98], ["necrosis", "DISEASE", 165, 173], ["necrosis", "DISEASE", 325, 333], ["sporidesmin", "CHEMICAL", 577, 588], ["Toxic hepatic disease", "DISEASE", 605, 626], ["sporidesmin", "CHEMICAL", 577, 588], ["sinusoidal endothelial cells", "CELL", 12, 40], ["necrosisSinusoidal phagocytes", "CELL", 107, 136], ["blood", "ORGANISM_SUBSTANCE", 221, 226], ["Kupffer cell", "CELL", 312, 324], ["hepatocytes", "CELL", 400, 411], ["bile duct epithelium", "TISSUE", 432, 452], ["bile duct epithelium", "TISSUE", 474, 494], ["sporidesmin", "SIMPLE_CHEMICAL", 577, 588], ["hepatic", "ORGAN", 611, 618], ["sinusoidal endothelial cells", "CELL_TYPE", 12, 40], ["necrosisSinusoidal phagocytes", "CELL_TYPE", 107, 136], ["hepatocytes", "CELL_TYPE", 400, 411], ["Necrosis of sinusoidal endothelial cells", "PROBLEM", 0, 40], ["many hepatotoxicities", "PROBLEM", 77, 98], ["Massive necrosisSinusoidal phagocytes", "PROBLEM", 99, 136], ["necrosis", "PROBLEM", 165, 173], ["colloidal material", "PROBLEM", 245, 263], ["infectious", "PROBLEM", 300, 310], ["Kupffer cell necrosis", "PROBLEM", 312, 333], ["damage to surrounding hepatocytes", "PROBLEM", 378, 411], ["Necrosis of bile duct epithelium", "PROBLEM", 420, 452], ["the bile duct epithelium", "PROBLEM", 470, 494], ["specific lethal insults", "PROBLEM", 516, 539], ["intoxication", "PROBLEM", 561, 573], ["Toxic hepatic disease", "PROBLEM", 605, 626], ["sinusoidal endothelial cells", "OBSERVATION", 12, 40], ["many", "OBSERVATION_MODIFIER", 77, 81], ["hepatotoxicities", "OBSERVATION", 82, 98], ["necrosisSinusoidal phagocytes", "OBSERVATION", 107, 136], ["necrosis", "OBSERVATION", 165, 173], ["portal blood", "ANATOMY", 214, 226], ["colloidal material", "OBSERVATION", 245, 263], ["toxic", "OBSERVATION_MODIFIER", 291, 296], ["infectious", "OBSERVATION_MODIFIER", 300, 310], ["Kupffer cell necrosis", "OBSERVATION", 312, 333], ["damage", "OBSERVATION", 378, 384], ["hepatocytes", "ANATOMY", 400, 411], ["bile duct", "ANATOMY", 432, 441], ["epithelium", "ANATOMY_MODIFIER", 442, 452], ["bile duct", "ANATOMY", 474, 483], ["hepatic", "ANATOMY", 611, 618], ["disease", "OBSERVATION", 619, 626]]], ["Usually, there is accompanying portal inflammation.", [["portal", "ANATOMY", 31, 37], ["portal inflammation", "DISEASE", 31, 50], ["portal", "MULTI-TISSUE_STRUCTURE", 31, 37], ["accompanying portal inflammation", "PROBLEM", 18, 50], ["portal", "ANATOMY", 31, 37], ["inflammation", "OBSERVATION", 38, 50]]], ["Some experimental toxicants, such as \u03b1-naphthylisothiocyanate, are lethal to bile duct epithelia and elicit a local inflammatory cholangitis.", [["bile duct epithelia", "ANATOMY", 77, 96], ["\u03b1-naphthylisothiocyanate", "CHEMICAL", 37, 61], ["cholangitis", "DISEASE", 129, 140], ["\u03b1-naphthylisothiocyanate", "CHEMICAL", 37, 61], ["\u03b1-naphthylisothiocyanate", "SIMPLE_CHEMICAL", 37, 61], ["bile duct epithelia", "TISSUE", 77, 96], ["Some experimental toxicants", "PROBLEM", 0, 27], ["\u03b1-naphthylisothiocyanate", "TREATMENT", 37, 61], ["lethal to bile duct epithelia", "PROBLEM", 67, 96], ["a local inflammatory cholangitis", "PROBLEM", 108, 140], ["experimental toxicants", "OBSERVATION", 5, 27], ["bile duct", "ANATOMY", 77, 86], ["local", "OBSERVATION_MODIFIER", 110, 115], ["inflammatory", "OBSERVATION_MODIFIER", 116, 128], ["cholangitis", "OBSERVATION", 129, 140]]], ["Idiosyncratic drug-induced destructive cholangitis can lead to acute cholangiolar injury as well as chronic cholestasis with damage and loss of bile ducts (destructive cholangitis).", [["cholangiolar", "ANATOMY", 69, 81], ["bile ducts", "ANATOMY", 144, 154], ["cholangitis", "DISEASE", 39, 50], ["cholangiolar injury", "DISEASE", 69, 88], ["cholestasis", "DISEASE", 108, 119], ["loss of bile ducts", "DISEASE", 136, 154], ["cholangitis", "DISEASE", 168, 179], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 144, 154], ["Idiosyncratic drug-induced destructive cholangitis", "PROBLEM", 0, 50], ["acute cholangiolar injury", "PROBLEM", 63, 88], ["chronic cholestasis", "PROBLEM", 100, 119], ["damage", "PROBLEM", 125, 131], ["loss of bile ducts (destructive cholangitis", "PROBLEM", 136, 179], ["destructive", "OBSERVATION_MODIFIER", 27, 38], ["cholangitis", "OBSERVATION", 39, 50], ["acute", "OBSERVATION_MODIFIER", 63, 68], ["cholangiolar", "OBSERVATION_MODIFIER", 69, 81], ["injury", "OBSERVATION", 82, 88], ["chronic", "OBSERVATION_MODIFIER", 100, 107], ["cholestasis", "OBSERVATION", 108, 119], ["damage", "OBSERVATION", 125, 131], ["loss", "OBSERVATION_MODIFIER", 136, 140], ["bile ducts", "ANATOMY", 144, 154], ["destructive", "OBSERVATION_MODIFIER", 156, 167], ["cholangitis", "OBSERVATION", 168, 179]]], ["Treatment with sulfonamides, other drugs, and viral infection have been linked to this response ( Fig. 2-40 ).", [["sulfonamides", "CHEMICAL", 15, 27], ["viral infection", "DISEASE", 46, 61], ["sulfonamides", "CHEMICAL", 15, 27], ["sulfonamides", "SIMPLE_CHEMICAL", 15, 27], ["sulfonamides", "TREATMENT", 15, 27], ["other drugs", "TREATMENT", 29, 40], ["viral infection", "PROBLEM", 46, 61]]], ["Guicciardi ME, etRESPONSES OF THE LIVER TO INJURYThe liver is a remarkably versatile organ.", [["liver", "ANATOMY", 53, 58], ["organ", "ANATOMY", 85, 90], ["liver", "ORGAN", 53, 58], ["organ", "ORGAN", 85, 90], ["LIVER", "ANATOMY", 34, 39], ["INJURY", "OBSERVATION", 43, 49], ["liver", "ANATOMY", 53, 58], ["remarkably", "OBSERVATION_MODIFIER", 64, 74], ["versatile", "OBSERVATION", 75, 84]]], ["Given its central position in the body, supplied by blood draining the gastrointestinal tract, and the fact that it is the key organ involved in detoxification of exogenous (xenobiotics) and endogenous compounds (endobiotics), the liver must respond to injury, including metabolic, infectious, and hemodynamic insults.RESPONSES OF THE LIVER TO INJURYis of the typical appearance described earlier, and in a number of cases, both acute and chronic lesions are found ( Fig. 2-39 ).RESPONSES OF THE LIVER TO INJURYThe sites of severest injury are the dorsal parts on the diaphragmatic surface.", [["body", "ANATOMY", 34, 38], ["blood", "ANATOMY", 52, 57], ["gastrointestinal tract", "ANATOMY", 71, 93], ["organ", "ANATOMY", 127, 132], ["liver", "ANATOMY", 231, 236], ["lesions", "ANATOMY", 447, 454], ["sites", "ANATOMY", 515, 520], ["dorsal parts", "ANATOMY", 548, 560], ["diaphragmatic surface", "ANATOMY", 568, 589], ["metabolic, infectious, and hemodynamic insults", "DISEASE", 271, 317], ["body", "ORGANISM_SUBDIVISION", 34, 38], ["blood", "ORGANISM_SUBSTANCE", 52, 57], ["gastrointestinal tract", "ORGANISM_SUBDIVISION", 71, 93], ["organ", "ORGAN", 127, 132], ["liver", "ORGAN", 231, 236], ["lesions", "PATHOLOGICAL_FORMATION", 447, 454], ["dorsal parts", "MULTI-TISSUE_STRUCTURE", 548, 560], ["diaphragmatic surface", "MULTI-TISSUE_STRUCTURE", 568, 589], ["blood draining the gastrointestinal tract", "PROBLEM", 52, 93], ["exogenous (xenobiotics", "TREATMENT", 163, 185], ["endogenous compounds", "PROBLEM", 191, 211], ["injury", "PROBLEM", 253, 259], ["hemodynamic insults", "PROBLEM", 298, 317], ["both acute and chronic lesions", "PROBLEM", 424, 454], ["severest injury", "PROBLEM", 524, 539], ["central", "OBSERVATION_MODIFIER", 10, 17], ["position", "OBSERVATION_MODIFIER", 18, 26], ["body", "ANATOMY_MODIFIER", 34, 38], ["blood draining", "OBSERVATION", 52, 66], ["gastrointestinal tract", "ANATOMY", 71, 93], ["liver", "ANATOMY", 231, 236], ["injury", "OBSERVATION", 253, 259], ["infectious", "OBSERVATION", 282, 292], ["hemodynamic insults", "OBSERVATION", 298, 317], ["LIVER", "ANATOMY", 335, 340], ["typical", "OBSERVATION_MODIFIER", 360, 367], ["both", "OBSERVATION_MODIFIER", 424, 428], ["acute", "OBSERVATION_MODIFIER", 429, 434], ["chronic", "OBSERVATION_MODIFIER", 439, 446], ["lesions", "OBSERVATION", 447, 454], ["LIVER", "ANATOMY", 496, 501], ["INJURY", "OBSERVATION", 505, 511], ["sites", "OBSERVATION_MODIFIER", 515, 520], ["severest", "OBSERVATION_MODIFIER", 524, 532], ["injury", "OBSERVATION", 533, 539], ["dorsal", "ANATOMY_MODIFIER", 548, 554], ["parts", "ANATOMY_MODIFIER", 555, 560], ["diaphragmatic", "ANATOMY", 568, 581], ["surface", "ANATOMY_MODIFIER", 582, 589]]], ["The right lobe may escape and later undergo marked hypertrophy.", [["right lobe", "ANATOMY", 4, 14], ["hypertrophy", "DISEASE", 51, 62], ["lobe", "ORGAN", 10, 14], ["marked hypertrophy", "PROBLEM", 44, 62], ["right lobe", "ANATOMY", 4, 14], ["marked", "OBSERVATION_MODIFIER", 44, 50], ["hypertrophy", "OBSERVATION", 51, 62]]], ["The gallbladder is often edematous.RESPONSES OF THE LIVER TO INJURYThe histologic changes that occur in this syndrome are described elsewhere with the particular organs involved.", [["gallbladder", "ANATOMY", 4, 15], ["organs", "ANATOMY", 162, 168], ["gallbladder", "ORGAN", 4, 15], ["organs", "ORGAN", 162, 168], ["edematous", "PROBLEM", 25, 34], ["INJURYThe histologic changes", "PROBLEM", 61, 89], ["this syndrome", "PROBLEM", 104, 117], ["gallbladder", "ANATOMY", 4, 15], ["often", "OBSERVATION_MODIFIER", 19, 24], ["edematous", "OBSERVATION", 25, 34], ["LIVER", "ANATOMY", 52, 57], ["histologic", "OBSERVATION", 71, 81]]], ["Briefly, centrilobular necrosis of the liver is typical (eFig.", [["centrilobular", "ANATOMY", 9, 22], ["liver", "ANATOMY", 39, 44], ["necrosis", "DISEASE", 23, 31], ["liver", "ORGAN", 39, 44], ["centrilobular necrosis of the liver", "PROBLEM", 9, 44], ["centrilobular", "OBSERVATION_MODIFIER", 9, 22], ["necrosis", "OBSERVATION", 23, 31], ["liver", "ANATOMY", 39, 44], ["typical", "OBSERVATION_MODIFIER", 48, 55]]], ["2-9).", [["2-9", "CHEMICAL", 0, 3]]], ["Additionally, fibrinoid degeneration of small arteries occurs in some cases.", [["fibrinoid", "ANATOMY", 14, 23], ["small arteries", "ANATOMY", 40, 54], ["fibrinoid", "TISSUE", 14, 23], ["small arteries", "MULTI-TISSUE_STRUCTURE", 40, 54], ["fibrinoid degeneration of small arteries", "PROBLEM", 14, 54], ["fibrinoid", "OBSERVATION_MODIFIER", 14, 23], ["degeneration", "OBSERVATION", 24, 36], ["small arteries", "ANATOMY", 40, 54]]], ["The arterial degeneration may occur in any organ or in most organs but is relatively common in only the small vessels of the mesentery, gut, and heart (see Mulberry heart disease, in Vol.", [["arterial", "ANATOMY", 4, 12], ["organ", "ANATOMY", 43, 48], ["organs", "ANATOMY", 60, 66], ["small vessels", "ANATOMY", 104, 117], ["mesentery", "ANATOMY", 125, 134], ["gut", "ANATOMY", 136, 139], ["heart", "ANATOMY", 145, 150], ["heart", "ANATOMY", 165, 170], ["arterial degeneration", "DISEASE", 4, 25], ["heart disease", "DISEASE", 165, 178], ["arterial", "MULTI-TISSUE_STRUCTURE", 4, 12], ["organ", "ORGAN", 43, 48], ["organs", "ORGAN", 60, 66], ["small vessels", "MULTI-TISSUE_STRUCTURE", 104, 117], ["mesentery", "MULTI-TISSUE_STRUCTURE", 125, 134], ["gut", "ORGANISM_SUBDIVISION", 136, 139], ["heart", "ORGAN", 145, 150], ["heart", "ORGAN", 165, 170], ["The arterial degeneration", "PROBLEM", 0, 25], ["Mulberry heart disease", "PROBLEM", 156, 178], ["arterial", "ANATOMY", 4, 12], ["degeneration", "OBSERVATION", 13, 25], ["relatively", "OBSERVATION_MODIFIER", 74, 84], ["common", "OBSERVATION", 85, 91], ["small", "OBSERVATION_MODIFIER", 104, 109], ["vessels", "OBSERVATION", 110, 117], ["mesentery", "ANATOMY", 125, 134], ["gut", "ANATOMY", 136, 139], ["heart", "ANATOMY", 145, 150], ["heart", "ANATOMY", 165, 170], ["disease", "OBSERVATION", 171, 178]]], ["3, Cardiovascular system).Piecemeal necrosisModels of immune-mediated hepatocyte necrosis have emerged from studies of human viral hepatitis and some forms of druginduced chronic hepatitis.", [["Cardiovascular", "ANATOMY", 3, 17], ["hepatocyte", "ANATOMY", 70, 80], ["necrosis", "DISEASE", 81, 89], ["viral hepatitis", "DISEASE", 125, 140], ["chronic hepatitis", "DISEASE", 171, 188], ["hepatocyte", "CELL", 70, 80], ["human", "ORGANISM", 119, 124], ["human", "SPECIES", 119, 124], ["human", "SPECIES", 119, 124], ["Piecemeal necrosisModels", "PROBLEM", 26, 50], ["immune-mediated hepatocyte necrosis", "PROBLEM", 54, 89], ["human viral hepatitis", "PROBLEM", 119, 140], ["druginduced chronic hepatitis", "PROBLEM", 159, 188], ["Cardiovascular system", "ANATOMY", 3, 24], ["hepatocyte", "ANATOMY", 70, 80], ["necrosis", "OBSERVATION", 81, 89], ["viral hepatitis", "OBSERVATION", 125, 140], ["druginduced", "OBSERVATION_MODIFIER", 159, 170], ["chronic", "OBSERVATION_MODIFIER", 171, 178], ["hepatitis", "OBSERVATION", 179, 188]]], ["This pattern of necrosis amid sites of more active inflammation at the limiting plate of hepatocytes immediately adjacent to the edge of the portal tract is referred to as piecemeal necrosis.", [["hepatocytes", "ANATOMY", 89, 100], ["portal tract", "ANATOMY", 141, 153], ["necrosis", "DISEASE", 16, 24], ["inflammation", "DISEASE", 51, 63], ["necrosis", "DISEASE", 182, 190], ["hepatocytes", "CELL", 89, 100], ["portal tract", "MULTI-TISSUE_STRUCTURE", 141, 153], ["hepatocytes", "CELL_TYPE", 89, 100], ["necrosis amid sites", "PROBLEM", 16, 35], ["more active inflammation", "PROBLEM", 39, 63], ["piecemeal necrosis", "PROBLEM", 172, 190], ["necrosis", "OBSERVATION", 16, 24], ["more", "OBSERVATION_MODIFIER", 39, 43], ["active", "OBSERVATION_MODIFIER", 44, 50], ["inflammation", "OBSERVATION", 51, 63], ["plate", "OBSERVATION_MODIFIER", 80, 85], ["hepatocytes", "ANATOMY", 89, 100], ["edge", "ANATOMY_MODIFIER", 129, 133], ["portal tract", "ANATOMY", 141, 153], ["piecemeal", "OBSERVATION_MODIFIER", 172, 181], ["necrosis", "OBSERVATION", 182, 190]]], ["The mechanisms may involve either direct damage to hepatocytes by the uptake of antigenantibody complexes, or cooperation between macrophages and T lymphocytes.", [["hepatocytes", "ANATOMY", 51, 62], ["macrophages", "ANATOMY", 130, 141], ["T lymphocytes", "ANATOMY", 146, 159], ["hepatocytes", "CELL", 51, 62], ["macrophages", "CELL", 130, 141], ["T lymphocytes", "CELL", 146, 159], ["hepatocytes", "CELL_TYPE", 51, 62], ["antigenantibody complexes", "PROTEIN", 80, 105], ["macrophages", "CELL_TYPE", 130, 141], ["T lymphocytes", "CELL_TYPE", 146, 159], ["direct damage to hepatocytes", "PROBLEM", 34, 62], ["the uptake of antigenantibody complexes", "PROBLEM", 66, 105], ["macrophages", "PROBLEM", 130, 141], ["hepatocytes", "ANATOMY", 51, 62]]], ["These may cause cell-mediated destruction of hepatocytes that have taken up these complexes or, perhaps, native antigen or virus.", [["cell", "ANATOMY", 16, 20], ["hepatocytes", "ANATOMY", 45, 56], ["cell", "CELL", 16, 20], ["hepatocytes", "CELL", 45, 56], ["antigen", "GENE_OR_GENE_PRODUCT", 112, 119], ["hepatocytes", "CELL_TYPE", 45, 56], ["native antigen", "PROTEIN", 105, 119], ["cell-mediated destruction of hepatocytes", "PROBLEM", 16, 56], ["native antigen or virus", "PROBLEM", 105, 128], ["destruction", "OBSERVATION", 30, 41], ["hepatocytes", "ANATOMY", 45, 56], ["virus", "OBSERVATION", 123, 128]]], ["Whatever the agency, the mode of cell removal in this sort of injury often takes the form of single-cell necrosis or apoptosis, which may be directly triggered by immunologically competent cells.", [["cell", "ANATOMY", 33, 37], ["cell", "ANATOMY", 100, 104], ["cells", "ANATOMY", 189, 194], ["necrosis", "DISEASE", 105, 113], ["cell", "CELL", 33, 37], ["cell", "CELL", 100, 104], ["cells", "CELL", 189, 194], ["immunologically competent cells", "CELL_TYPE", 163, 194], ["cell removal", "TREATMENT", 33, 45], ["injury", "PROBLEM", 62, 68], ["single-cell necrosis", "PROBLEM", 93, 113], ["apoptosis", "PROBLEM", 117, 126], ["cell removal", "OBSERVATION", 33, 45], ["injury", "OBSERVATION", 62, 68], ["cell", "OBSERVATION", 100, 104], ["necrosis", "OBSERVATION", 105, 113], ["apoptosis", "OBSERVATION", 117, 126]]], ["This type of liver injury, in which inflammation characteristically disrupts the limiting plate, giving an irregular appearance to the periportal zone, is discussed further in the section on Chronic hepatitis.Necrosis of sinusoidal lining cellsInjury to the endothelium of hepatic sinusoids can develop in a variety of forms.", [["liver", "ANATOMY", 13, 18], ["periportal zone", "ANATOMY", 135, 150], ["sinusoidal lining cells", "ANATOMY", 221, 244], ["endothelium", "ANATOMY", 258, 269], ["hepatic sinusoids", "ANATOMY", 273, 290], ["liver injury", "DISEASE", 13, 25], ["inflammation", "DISEASE", 36, 48], ["Chronic hepatitis", "DISEASE", 191, 208], ["liver", "ORGAN", 13, 18], ["periportal zone", "TISSUE", 135, 150], ["sinusoidal lining cells", "CELL", 221, 244], ["endothelium", "TISSUE", 258, 269], ["hepatic sinusoids", "MULTI-TISSUE_STRUCTURE", 273, 290], ["sinusoidal lining cells", "CELL_TYPE", 221, 244], ["liver injury", "PROBLEM", 13, 25], ["inflammation", "PROBLEM", 36, 48], ["an irregular appearance to the periportal zone", "PROBLEM", 104, 150], ["Chronic hepatitis", "PROBLEM", 191, 208], ["Necrosis of sinusoidal lining cells", "PROBLEM", 209, 244], ["Injury", "PROBLEM", 244, 250], ["hepatic sinusoids", "PROBLEM", 273, 290], ["liver", "ANATOMY", 13, 18], ["injury", "OBSERVATION", 19, 25], ["inflammation", "OBSERVATION", 36, 48], ["limiting", "OBSERVATION_MODIFIER", 81, 89], ["plate", "OBSERVATION_MODIFIER", 90, 95], ["irregular", "OBSERVATION_MODIFIER", 107, 116], ["periportal", "ANATOMY", 135, 145], ["zone", "ANATOMY_MODIFIER", 146, 150], ["Chronic", "OBSERVATION_MODIFIER", 191, 198], ["hepatitis", "OBSERVATION", 199, 208], ["sinusoidal lining cells", "OBSERVATION", 221, 244], ["endothelium", "OBSERVATION", 258, 269], ["hepatic", "ANATOMY", 273, 280], ["sinusoids", "ANATOMY_MODIFIER", 281, 290]]], ["The sinusoidal endothelial cells may lose their typical fenestrae or pores, limiting contact between plasma and hepatocellular microvilli, and if there is an increased deposition of extracellular matrix (ECM) beneath the altered endothelium, the alteration is termed \"capillarization of sinusoids,\" leading to reduced hepatic function.", [["sinusoidal endothelial cells", "ANATOMY", 4, 32], ["fenestrae", "ANATOMY", 56, 65], ["pores", "ANATOMY", 69, 74], ["plasma", "ANATOMY", 101, 107], ["hepatocellular microvilli", "ANATOMY", 112, 137], ["extracellular matrix", "ANATOMY", 182, 202], ["ECM", "ANATOMY", 204, 207], ["endothelium", "ANATOMY", 229, 240], ["sinusoids", "ANATOMY", 287, 296], ["hepatic", "ANATOMY", 318, 325], ["sinusoidal endothelial cells", "CELL", 4, 32], ["plasma", "ORGANISM_SUBSTANCE", 101, 107], ["hepatocellular microvilli", "TISSUE", 112, 137], ["extracellular matrix", "CELLULAR_COMPONENT", 182, 202], ["ECM", "CELLULAR_COMPONENT", 204, 207], ["endothelium", "TISSUE", 229, 240], ["sinusoids", "TISSUE", 287, 296], ["hepatic", "ORGAN", 318, 325], ["sinusoidal endothelial cells", "CELL_TYPE", 4, 32], ["The sinusoidal endothelial cells", "TEST", 0, 32], ["an increased deposition of extracellular matrix", "PROBLEM", 155, 202], ["the altered endothelium", "PROBLEM", 217, 240], ["reduced hepatic function", "PROBLEM", 310, 334], ["sinusoidal endothelial cells", "OBSERVATION", 4, 32], ["typical", "OBSERVATION_MODIFIER", 48, 55], ["fenestrae", "OBSERVATION", 56, 65], ["pores", "OBSERVATION_MODIFIER", 69, 74], ["hepatocellular", "ANATOMY", 112, 126], ["microvilli", "ANATOMY_MODIFIER", 127, 137], ["increased", "OBSERVATION_MODIFIER", 158, 167], ["deposition", "OBSERVATION_MODIFIER", 168, 178], ["extracellular matrix", "OBSERVATION", 182, 202], ["altered endothelium", "OBSERVATION", 221, 240], ["reduced", "OBSERVATION_MODIFIER", 310, 317], ["hepatic", "ANATOMY", 318, 325]]], ["Sinusoidal endothelial cells may relax their connections to the fine to regrow and be eaten again.", [["Sinusoidal endothelial cells", "ANATOMY", 0, 28], ["endothelial cells", "CELL", 11, 28], ["Sinusoidal endothelial cells", "CELL_TYPE", 0, 28], ["Sinusoidal endothelial cells", "PROBLEM", 0, 28], ["endothelial cells", "OBSERVATION", 11, 28]]], ["Although the mythical daily regrowth of hepatic mass is more prodigious than the realworld response, hepatic regeneration is nonetheless remarkable.", [["hepatic mass", "ANATOMY", 40, 52], ["hepatic", "ANATOMY", 101, 108], ["hepatic", "ORGAN", 40, 47], ["hepatic", "ORGAN", 101, 108], ["hepatic mass", "PROBLEM", 40, 52], ["hepatic", "ANATOMY", 40, 47], ["mass", "OBSERVATION", 48, 52], ["more prodigious", "OBSERVATION_MODIFIER", 56, 71], ["hepatic", "ANATOMY", 101, 108], ["regeneration", "OBSERVATION", 109, 121]]], ["In rodents, partial hepatectomies can be repeated more than 10 times, followed by restoration of normal hepatic mass.", [["hepatic mass", "ANATOMY", 104, 116], ["hepatic", "ORGAN", 104, 111], ["partial hepatectomies", "TREATMENT", 12, 33], ["normal hepatic mass", "PROBLEM", 97, 116], ["partial", "OBSERVATION_MODIFIER", 12, 19], ["hepatectomies", "OBSERVATION", 20, 33], ["normal", "OBSERVATION", 97, 103], ["hepatic", "ANATOMY", 104, 111], ["mass", "OBSERVATION", 112, 116]]], ["Individual hepatocytes are able to replicate up to 70 times.", [["hepatocytes", "ANATOMY", 11, 22], ["hepatocytes", "CELL", 11, 22], ["hepatocytes", "CELL_TYPE", 11, 22], ["Individual hepatocytes", "PROBLEM", 0, 22], ["hepatocytes", "ANATOMY", 11, 22]]], ["Simple replacement of missing hepatocytes alone does not truly constitute regeneration because normal liver microscopic architecture is essential to maintain normal hepatic function.", [["hepatocytes", "ANATOMY", 30, 41], ["liver", "ANATOMY", 102, 107], ["hepatic", "ANATOMY", 165, 172], ["hepatocytes", "CELL", 30, 41], ["liver", "ORGAN", 102, 107], ["hepatic", "ORGAN", 165, 172], ["hepatocytes", "CELL_TYPE", 30, 41], ["Simple replacement", "TREATMENT", 0, 18], ["missing hepatocytes", "PROBLEM", 22, 41], ["replacement", "OBSERVATION", 7, 18], ["hepatocytes", "ANATOMY", 30, 41], ["regeneration", "OBSERVATION", 74, 86], ["liver", "ANATOMY", 102, 107], ["microscopic architecture", "OBSERVATION", 108, 132], ["normal", "OBSERVATION", 158, 164], ["hepatic", "ANATOMY", 165, 172]]], ["Although new lobes are not regenerated following hepatectomy, the remaining lobes enlarge, and the proliferated hepatocytes and other cellular elements progress through a series of steps that involve interaction of hepatocytes and angiogenic processes to restore the normal relationships between the hepatocytes and the sinusoids.", [["lobes", "ANATOMY", 13, 18], ["lobes", "ANATOMY", 76, 81], ["hepatocytes", "ANATOMY", 112, 123], ["cellular", "ANATOMY", 134, 142], ["hepatocytes", "ANATOMY", 215, 226], ["hepatocytes", "ANATOMY", 300, 311], ["sinusoids", "ANATOMY", 320, 329], ["lobes", "MULTI-TISSUE_STRUCTURE", 13, 18], ["lobes", "ORGAN", 76, 81], ["hepatocytes", "CELL", 112, 123], ["cellular", "CELL", 134, 142], ["hepatocytes", "CELL", 215, 226], ["hepatocytes", "CELL", 300, 311], ["sinusoids", "TISSUE", 320, 329], ["proliferated hepatocytes", "CELL_TYPE", 99, 123], ["cellular elements", "DNA", 134, 151], ["hepatocytes", "CELL_TYPE", 215, 226], ["hepatocytes", "CELL_TYPE", 300, 311], ["new lobes", "PROBLEM", 9, 18], ["hepatectomy", "TREATMENT", 49, 60], ["the proliferated hepatocytes", "PROBLEM", 95, 123], ["hepatocytes and angiogenic processes", "PROBLEM", 215, 251], ["new", "OBSERVATION_MODIFIER", 9, 12], ["lobes", "ANATOMY_MODIFIER", 13, 18], ["not", "UNCERTAINTY", 23, 26], ["regenerated", "OBSERVATION_MODIFIER", 27, 38], ["hepatectomy", "OBSERVATION", 49, 60], ["remaining", "OBSERVATION_MODIFIER", 66, 75], ["lobes", "OBSERVATION_MODIFIER", 76, 81], ["enlarge", "OBSERVATION_MODIFIER", 82, 89], ["hepatocytes", "ANATOMY", 112, 123], ["cellular elements", "OBSERVATION", 134, 151], ["hepatocytes", "ANATOMY", 215, 226], ["normal", "OBSERVATION", 267, 273], ["hepatocytes", "ANATOMY", 300, 311], ["sinusoids", "ANATOMY", 320, 329]]], ["Regeneration of mature hepatocytes is stimulated by several factors.", [["hepatocytes", "ANATOMY", 23, 34], ["hepatocytes", "CELL", 23, 34], ["mature hepatocytes", "CELL_TYPE", 16, 34], ["Regeneration of mature hepatocytes", "PROBLEM", 0, 34], ["mature", "OBSERVATION", 16, 22], ["hepatocytes", "ANATOMY", 23, 34]]], ["These include polypeptide growth factors, such as hepatocyte growth factor, epidermal growth factor, transforming growth factor-\u03b1 (TGF-\u03b1), and insulin-like growth factors.", [["hepatocyte growth factor", "GENE_OR_GENE_PRODUCT", 50, 74], ["epidermal growth factor", "GENE_OR_GENE_PRODUCT", 76, 99], ["transforming growth factor-\u03b1", "GENE_OR_GENE_PRODUCT", 101, 129], ["TGF-\u03b1", "GENE_OR_GENE_PRODUCT", 131, 136], ["insulin-like growth factors", "GENE_OR_GENE_PRODUCT", 143, 170], ["polypeptide growth factors", "PROTEIN", 14, 40], ["hepatocyte growth factor", "PROTEIN", 50, 74], ["epidermal growth factor", "PROTEIN", 76, 99], ["transforming growth factor-\u03b1", "PROTEIN", 101, 129], ["TGF-\u03b1", "PROTEIN", 131, 136], ["insulin-like growth factors", "PROTEIN", 143, 170], ["polypeptide growth factors", "PROBLEM", 14, 40], ["hepatocyte growth factor", "PROBLEM", 50, 74], ["epidermal growth factor", "PROBLEM", 76, 99], ["transforming growth factor", "PROBLEM", 101, 127], ["TGF", "TEST", 131, 134], ["insulin", "TREATMENT", 143, 150], ["growth factors", "OBSERVATION", 26, 40], ["hepatocyte", "ANATOMY", 50, 60]]], ["Hepatocyte growth factor is the most potent mitogen and is released by hepatic stellate cells to stimulate hepatocytes in a paracrine fashion.", [["hepatic stellate cells", "ANATOMY", 71, 93], ["hepatocytes", "ANATOMY", 107, 118], ["Hepatocyte growth factor", "GENE_OR_GENE_PRODUCT", 0, 24], ["hepatic stellate cells", "CELL", 71, 93], ["hepatocytes", "CELL", 107, 118], ["Hepatocyte growth factor", "PROTEIN", 0, 24], ["mitogen", "PROTEIN", 44, 51], ["hepatic stellate cells", "CELL_TYPE", 71, 93], ["hepatocytes", "CELL_TYPE", 107, 118], ["Hepatocyte growth factor", "PROBLEM", 0, 24], ["most potent", "OBSERVATION_MODIFIER", 32, 43], ["hepatic", "ANATOMY", 71, 78], ["stellate cells", "OBSERVATION", 79, 93], ["hepatocytes", "ANATOMY", 107, 118]]], ["This growth factor can also be embedded in the ECM to be released by proteases.", [["ECM", "ANATOMY", 47, 50], ["ECM", "CELLULAR_COMPONENT", 47, 50], ["growth factor", "PROTEIN", 5, 18], ["ECM", "PROTEIN", 47, 50], ["proteases", "PROTEIN", 69, 78], ["This growth factor", "PROBLEM", 0, 18]]], ["Hepatic regeneration is also enhanced by nutrition, with fasting slowing and dietary protein promoting regeneration.", [["Hepatic", "ANATOMY", 0, 7], ["Hepatic", "MULTI-TISSUE_STRUCTURE", 0, 7], ["Hepatic regeneration", "PROBLEM", 0, 20], ["fasting slowing", "PROBLEM", 57, 72], ["dietary protein promoting regeneration", "PROBLEM", 77, 115], ["regeneration", "OBSERVATION", 8, 20], ["enhanced", "OBSERVATION_MODIFIER", 29, 37], ["slowing", "OBSERVATION_MODIFIER", 65, 72], ["dietary protein", "OBSERVATION", 77, 92], ["promoting regeneration", "OBSERVATION", 93, 115]]], ["In addition, catecholamines and a broad variety of hormones support regeneration, with insulin, glucagon being the most significant.", [["catecholamines", "CHEMICAL", 13, 27], ["catecholamines", "CHEMICAL", 13, 27], ["catecholamines", "SIMPLE_CHEMICAL", 13, 27], ["insulin", "GENE_OR_GENE_PRODUCT", 87, 94], ["glucagon", "GENE_OR_GENE_PRODUCT", 96, 104], ["catecholamines", "TREATMENT", 13, 27], ["a broad variety of hormones support regeneration", "TREATMENT", 32, 80], ["insulin", "TREATMENT", 87, 94], ["glucagon", "TREATMENT", 96, 104], ["most significant", "OBSERVATION_MODIFIER", 115, 131]]], ["Cytokines, such as IL-6, produced by TNF-\u03b1-stimulated Kupffer cells, are other important effectors.", [["Kupffer cells", "ANATOMY", 54, 67], ["IL-6", "GENE_OR_GENE_PRODUCT", 19, 23], ["TNF-\u03b1-", "GENE_OR_GENE_PRODUCT", 37, 43], ["Kupffer cells", "CELL", 54, 67], ["Cytokines", "PROTEIN", 0, 9], ["IL-6", "PROTEIN", 19, 23], ["TNF", "PROTEIN", 37, 40], ["Kupffer cells", "CELL_TYPE", 54, 67], ["Cytokines", "TEST", 0, 9], ["IL", "TEST", 19, 21], ["TNF", "TEST", 37, 40]]], ["When IL-6 binds its receptor, it stimulates mitogenic intracellular signaling and potentiates signaling by other growth factors.", [["intracellular", "ANATOMY", 54, 67], ["IL-6", "GENE_OR_GENE_PRODUCT", 5, 9], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 54, 67], ["IL-6", "PROTEIN", 5, 9], ["growth factors", "PROTEIN", 113, 127], ["mitogenic intracellular signaling", "PROBLEM", 44, 77], ["other growth factors", "PROBLEM", 107, 127]]], ["These effectors are examples of the important role of the innate immune system in hepatic regeneration.", [["hepatic", "ANATOMY", 82, 89], ["hepatic", "ORGAN", 82, 89], ["hepatic", "ANATOMY", 82, 89], ["regeneration", "OBSERVATION", 90, 102]]], ["The autonomic nervous system also plays a role in hepatic regeneration, as denervation of the liver can significantly limit hepatic regeneration.Further readingFollowing hepatocyte proliferation, normal liver architecture must be preserved to maintain hepatic function.", [["autonomic nervous system", "ANATOMY", 4, 28], ["hepatic", "ANATOMY", 50, 57], ["liver", "ANATOMY", 94, 99], ["hepatic", "ANATOMY", 124, 131], ["hepatocyte", "ANATOMY", 170, 180], ["liver", "ANATOMY", 203, 208], ["hepatic", "ANATOMY", 252, 259], ["autonomic nervous system", "ANATOMICAL_SYSTEM", 4, 28], ["hepatic", "MULTI-TISSUE_STRUCTURE", 50, 57], ["liver", "ORGAN", 94, 99], ["hepatic", "ORGAN", 124, 131], ["hepatocyte", "CELL", 170, 180], ["liver", "ORGAN", 203, 208], ["hepatic", "ORGAN", 252, 259], ["hepatic regeneration", "TREATMENT", 50, 70], ["denervation of the liver", "PROBLEM", 75, 99], ["hepatic regeneration", "PROBLEM", 124, 144], ["hepatocyte proliferation", "TEST", 170, 194], ["autonomic", "OBSERVATION", 4, 13], ["nervous system", "ANATOMY", 14, 28], ["hepatic", "ANATOMY", 50, 57], ["regeneration", "OBSERVATION", 58, 70], ["denervation", "OBSERVATION", 75, 86], ["liver", "ANATOMY", 94, 99], ["hepatic", "ANATOMY", 124, 131], ["regeneration", "OBSERVATION", 132, 144], ["hepatocyte proliferation", "OBSERVATION", 170, 194], ["normal", "OBSERVATION", 196, 202], ["liver", "ANATOMY", 203, 208], ["hepatic", "ANATOMY", 252, 259], ["function", "OBSERVATION", 260, 268]]], ["Several cell types are involved in this process.", [["cell", "ANATOMY", 8, 12], ["cell", "CELL", 8, 12], ["Several cell types", "PROBLEM", 0, 18], ["cell types", "OBSERVATION", 8, 18]]], ["Following partial hepatectomy, the initial proliferation creates aggregates of hepatocytes 10-14 cells thick.", [["hepatocytes", "ANATOMY", 79, 90], ["cells", "ANATOMY", 97, 102], ["hepatocytes", "CELL", 79, 90], ["cells", "CELL", 97, 102], ["hepatocytes", "CELL_TYPE", 79, 90], ["partial hepatectomy", "TREATMENT", 10, 29], ["the initial proliferation", "TEST", 31, 56], ["hepatocytes", "TEST", 79, 90], ["partial", "OBSERVATION_MODIFIER", 10, 17], ["hepatectomy", "OBSERVATION", 18, 29], ["proliferation", "OBSERVATION_MODIFIER", 43, 56], ["hepatocytes", "ANATOMY", 79, 90], ["10-14 cells", "OBSERVATION_MODIFIER", 91, 102]]], ["These aggregates are penetrated by endothelial buds that eventually establish sinusoidal channels.", [["endothelial buds", "ANATOMY", 35, 51], ["sinusoidal channels", "ANATOMY", 78, 97], ["endothelial buds", "TISSUE", 35, 51], ["sinusoidal channels", "PROTEIN", 78, 97], ["sinusoidal channels", "OBSERVATION", 78, 97]]], ["Ingrowth of the endothelial cells is driven by regulators of angiogenesis, such as vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF).", [["endothelial cells", "ANATOMY", 16, 33], ["endothelial cells", "CELL", 16, 33], ["vascular endothelial growth factor", "GENE_OR_GENE_PRODUCT", 83, 117], ["VEGF", "GENE_OR_GENE_PRODUCT", 119, 123], ["platelet-derived growth factor", "GENE_OR_GENE_PRODUCT", 129, 159], ["PDGF", "GENE_OR_GENE_PRODUCT", 161, 165], ["endothelial cells", "CELL_TYPE", 16, 33], ["vascular endothelial growth factor", "PROTEIN", 83, 117], ["VEGF", "PROTEIN", 119, 123], ["platelet-derived growth factor", "PROTEIN", 129, 159], ["PDGF", "PROTEIN", 161, 165], ["the endothelial cells", "PROBLEM", 12, 33], ["angiogenesis", "PROBLEM", 61, 73], ["vascular endothelial growth factor", "PROBLEM", 83, 117], ["platelet", "TEST", 129, 137], ["endothelial cells", "OBSERVATION", 16, 33], ["angiogenesis", "OBSERVATION", 61, 73], ["vascular endothelial", "ANATOMY", 83, 103]]], ["Hepatic stellate cells replicate and synthesize ECM within ~4 days of partial hepatectomy and help establish normal hepatocytematrix interactions.Further readingOnce the needed hepatic mass has been replaced, the regenerative process must be regulated to terminate cell proliferation.", [["Hepatic stellate cells", "ANATOMY", 0, 22], ["ECM", "ANATOMY", 48, 51], ["hepatocytematrix", "ANATOMY", 116, 132], ["hepatic mass", "ANATOMY", 177, 189], ["cell", "ANATOMY", 265, 269], ["Hepatic stellate cells", "CELL", 0, 22], ["ECM", "CELLULAR_COMPONENT", 48, 51], ["hepatocytematrix", "GENE_OR_GENE_PRODUCT", 116, 132], ["hepatic", "ORGAN", 177, 184], ["cell", "CELL", 265, 269], ["Hepatic stellate cells", "CELL_TYPE", 0, 22], ["Hepatic stellate cells", "PROBLEM", 0, 22], ["partial hepatectomy", "TREATMENT", 70, 89], ["the needed hepatic mass", "PROBLEM", 166, 189], ["the regenerative process", "PROBLEM", 209, 233], ["stellate cells", "OBSERVATION", 8, 22], ["hepatectomy", "OBSERVATION", 78, 89], ["normal hepatocytematrix", "OBSERVATION", 109, 132], ["hepatic", "ANATOMY", 177, 184], ["mass", "OBSERVATION", 185, 189], ["regenerative", "OBSERVATION_MODIFIER", 213, 225], ["cell proliferation", "OBSERVATION", 265, 283]]], ["TGF-\u03b2 and related family members, including activin, are the best known mediators responsible for curtailing hepatocyte proliferation.", [["hepatocyte", "ANATOMY", 109, 119], ["TGF-\u03b2", "GENE_OR_GENE_PRODUCT", 0, 5], ["activin", "GENE_OR_GENE_PRODUCT", 44, 51], ["hepatocyte", "CELL", 109, 119], ["TGF-\u03b2", "PROTEIN", 0, 5], ["activin", "PROTEIN", 44, 51], ["curtailing hepatocyte proliferation", "PROBLEM", 98, 133], ["hepatocyte", "ANATOMY", 109, 119], ["proliferation", "OBSERVATION", 120, 133]]], ["These mediators are produced primarily by the hepatic stellate cells.", [["hepatic stellate cells", "ANATOMY", 46, 68], ["hepatic stellate cells", "CELL", 46, 68], ["hepatic stellate cells", "CELL_TYPE", 46, 68], ["hepatic", "ANATOMY", 46, 53], ["stellate cells", "OBSERVATION", 54, 68]]], ["They can increase ECM production as well as suppress hepatocellular replication, are downregulated during proliferation, and increase once appropriate hepatic mass has been achieved.Further readingIn severe, often toxic, liver injury, mature hepatocytes cannot replace damaged hepatic mass, and bipotential progenitor cells are engaged to restore the hepatic mass.", [["ECM", "ANATOMY", 18, 21], ["hepatocellular", "ANATOMY", 53, 67], ["hepatic mass", "ANATOMY", 151, 163], ["liver", "ANATOMY", 221, 226], ["hepatocytes", "ANATOMY", 242, 253], ["hepatic mass", "ANATOMY", 277, 289], ["bipotential progenitor cells", "ANATOMY", 295, 323], ["hepatic mass", "ANATOMY", 351, 363], ["liver injury", "DISEASE", 221, 233], ["ECM", "CELLULAR_COMPONENT", 18, 21], ["hepatocellular", "CANCER", 53, 67], ["hepatic", "ORGAN", 151, 158], ["liver", "ORGAN", 221, 226], ["hepatocytes", "CELL", 242, 253], ["hepatic", "ORGAN", 277, 284], ["bipotential progenitor cells", "CELL", 295, 323], ["hepatic", "ORGAN", 351, 358], ["ECM", "PROTEIN", 18, 21], ["mature hepatocytes", "CELL_TYPE", 235, 253], ["bipotential progenitor cells", "CELL_TYPE", 295, 323], ["hepatocellular replication", "PROBLEM", 53, 79], ["appropriate hepatic mass", "PROBLEM", 139, 163], ["liver injury", "PROBLEM", 221, 233], ["mature hepatocytes", "PROBLEM", 235, 253], ["damaged hepatic mass", "PROBLEM", 269, 289], ["bipotential progenitor cells", "PROBLEM", 295, 323], ["the hepatic mass", "PROBLEM", 347, 363], ["hepatocellular", "ANATOMY", 53, 67], ["proliferation", "OBSERVATION_MODIFIER", 106, 119], ["increase", "OBSERVATION_MODIFIER", 125, 133], ["hepatic", "ANATOMY", 151, 158], ["mass", "OBSERVATION", 159, 163], ["severe", "OBSERVATION_MODIFIER", 200, 206], ["toxic", "OBSERVATION_MODIFIER", 214, 219], ["liver", "ANATOMY", 221, 226], ["injury", "OBSERVATION", 227, 233], ["hepatocytes", "ANATOMY", 242, 253], ["hepatic", "ANATOMY", 277, 284], ["mass", "OBSERVATION", 285, 289], ["bipotential progenitor cells", "OBSERVATION", 295, 323], ["hepatic", "ANATOMY", 351, 358], ["mass", "OBSERVATION", 359, 363]]], ["At the interface of the portal tract connective tissue and the hepatic parenchyma, and in the vicinity of the canals of Hering, there is a compartment that serves as the site of quiescent progenitor cells.", [["portal tract connective tissue", "ANATOMY", 24, 54], ["hepatic parenchyma", "ANATOMY", 63, 81], ["canals", "ANATOMY", 110, 116], ["site", "ANATOMY", 170, 174], ["progenitor cells", "ANATOMY", 188, 204], ["portal tract", "TISSUE", 24, 36], ["connective tissue", "TISSUE", 37, 54], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 63, 81], ["progenitor cells", "CELL", 188, 204], ["quiescent progenitor cells", "CELL_TYPE", 178, 204], ["quiescent progenitor cells", "TREATMENT", 178, 204], ["interface", "ANATOMY_MODIFIER", 7, 16], ["portal tract", "ANATOMY", 24, 36], ["connective tissue", "OBSERVATION", 37, 54], ["hepatic", "ANATOMY", 63, 70], ["parenchyma", "ANATOMY_MODIFIER", 71, 81], ["canals", "ANATOMY_MODIFIER", 110, 116], ["quiescent progenitor cells", "OBSERVATION", 178, 204]]], ["Proliferation of these cells gives rise to the \"ductular This section describes the 3 main categories of liver response to injury: regeneration, fibrosis, and ductular reaction (biliary hyperplasia).Hepatic regenerationMild injury involving the hepatocytes, biliary epithelium, endothelial cells, and mesenchymal elements typically is completely resolved quickly through regeneration.", [["cells", "ANATOMY", 23, 28], ["ductular", "ANATOMY", 48, 56], ["liver", "ANATOMY", 105, 110], ["ductular", "ANATOMY", 159, 167], ["biliary hyperplasia", "ANATOMY", 178, 197], ["Hepatic", "ANATOMY", 199, 206], ["hepatocytes", "ANATOMY", 245, 256], ["biliary epithelium", "ANATOMY", 258, 276], ["endothelial cells", "ANATOMY", 278, 295], ["mesenchymal elements", "ANATOMY", 301, 321], ["fibrosis", "DISEASE", 145, 153], ["biliary hyperplasia", "DISEASE", 178, 197], ["cells", "CELL", 23, 28], ["liver", "ORGAN", 105, 110], ["ductular", "PATHOLOGICAL_FORMATION", 159, 167], ["biliary hyperplasia", "PATHOLOGICAL_FORMATION", 178, 197], ["Hepatic", "ORGAN", 199, 206], ["hepatocytes", "CELL", 245, 256], ["biliary epithelium", "CELL", 258, 276], ["endothelial cells", "CELL", 278, 295], ["mesenchymal", "CELL", 301, 312], ["hepatocytes", "CELL_TYPE", 245, 256], ["endothelial cells", "CELL_TYPE", 278, 295], ["mesenchymal elements", "DNA", 301, 321], ["Proliferation of these cells", "PROBLEM", 0, 28], ["injury", "PROBLEM", 123, 129], ["regeneration", "PROBLEM", 131, 143], ["fibrosis", "PROBLEM", 145, 153], ["ductular reaction", "PROBLEM", 159, 176], ["biliary hyperplasia", "PROBLEM", 178, 197], ["Hepatic regeneration", "PROBLEM", 199, 219], ["Mild injury involving the hepatocytes", "PROBLEM", 219, 256], ["biliary epithelium, endothelial cells", "PROBLEM", 258, 295], ["liver", "ANATOMY", 105, 110], ["regeneration", "OBSERVATION", 131, 143], ["fibrosis", "OBSERVATION", 145, 153], ["ductular", "ANATOMY_MODIFIER", 159, 167], ["biliary", "ANATOMY", 178, 185], ["hyperplasia", "OBSERVATION", 186, 197], ["regeneration", "OBSERVATION", 207, 219], ["injury", "OBSERVATION", 224, 230], ["hepatocytes", "ANATOMY", 245, 256], ["biliary epithelium", "ANATOMY", 258, 276], ["endothelial cells", "OBSERVATION", 278, 295], ["mesenchymal elements", "OBSERVATION", 301, 321], ["completely", "OBSERVATION_MODIFIER", 335, 345], ["resolved", "OBSERVATION_MODIFIER", 346, 354], ["regeneration", "OBSERVATION_MODIFIER", 371, 383]]], ["This is particularly true in younger animals, as the vigor of regeneration diminishes with age.", [["true", "OBSERVATION_MODIFIER", 21, 25], ["regeneration", "OBSERVATION_MODIFIER", 62, 74], ["diminishes", "OBSERVATION_MODIFIER", 75, 85]]], ["Even in cases of massive hepatocellular necrosis, complete recovery is possible if the reticulin framework of the liver persists and surviving hepatocytes have sufficient time to regenerate and replace the lost hepatic mass.Hepatic regenerationIn adulthood, the liver is a stable organ with limited replication of mature hepatocytes, biliary epithelium, and other cells in the liver.", [["hepatocellular", "ANATOMY", 25, 39], ["liver", "ANATOMY", 114, 119], ["hepatocytes", "ANATOMY", 143, 154], ["hepatic mass", "ANATOMY", 211, 223], ["Hepatic", "ANATOMY", 224, 231], ["liver", "ANATOMY", 262, 267], ["organ", "ANATOMY", 280, 285], ["hepatocytes", "ANATOMY", 321, 332], ["biliary epithelium", "ANATOMY", 334, 352], ["cells", "ANATOMY", 364, 369], ["liver", "ANATOMY", 377, 382], ["massive hepatocellular necrosis", "DISEASE", 17, 48], ["hepatocellular", "CANCER", 25, 39], ["liver", "ORGAN", 114, 119], ["hepatocytes", "CELL", 143, 154], ["hepatic", "ORGAN", 211, 218], ["Hepatic", "ORGAN", 224, 231], ["liver", "ORGAN", 262, 267], ["organ", "ORGAN", 280, 285], ["hepatocytes", "CELL", 321, 332], ["biliary epithelium", "TISSUE", 334, 352], ["cells", "CELL", 364, 369], ["liver", "ORGAN", 377, 382], ["surviving hepatocytes", "CELL_TYPE", 133, 154], ["mature hepatocytes", "CELL_TYPE", 314, 332], ["massive hepatocellular necrosis", "PROBLEM", 17, 48], ["the reticulin framework of the liver", "PROBLEM", 83, 119], ["surviving hepatocytes", "PROBLEM", 133, 154], ["the lost hepatic mass", "PROBLEM", 202, 223], ["Hepatic regeneration", "PROBLEM", 224, 244], ["mature hepatocytes, biliary epithelium, and other cells in the liver", "PROBLEM", 314, 382], ["massive", "OBSERVATION_MODIFIER", 17, 24], ["hepatocellular", "ANATOMY", 25, 39], ["necrosis", "OBSERVATION", 40, 48], ["liver", "ANATOMY", 114, 119], ["hepatic", "ANATOMY", 211, 218], ["mass", "OBSERVATION", 219, 223], ["regeneration", "OBSERVATION", 232, 244], ["liver", "ANATOMY", 262, 267], ["stable", "OBSERVATION", 273, 279], ["replication", "OBSERVATION", 299, 310], ["mature", "OBSERVATION_MODIFIER", 314, 320], ["hepatocytes", "OBSERVATION", 321, 332], ["biliary epithelium", "ANATOMY", 334, 352], ["liver", "ANATOMY", 377, 382]]], ["However, loss of hepatic mass through injury, such as infections, toxic insult, or surgical removal, will transform the mature hepatocytes, biliary epithelium, and/or bipotential progenitor cells, as well as hepatic stellate cells and endothelial cells, into actively proliferating cells until normal functional mass has been replaced.", [["hepatic mass", "ANATOMY", 17, 29], ["hepatocytes", "ANATOMY", 127, 138], ["biliary epithelium", "ANATOMY", 140, 158], ["bipotential progenitor cells", "ANATOMY", 167, 195], ["hepatic stellate cells", "ANATOMY", 208, 230], ["endothelial cells", "ANATOMY", 235, 252], ["cells", "ANATOMY", 282, 287], ["loss of hepatic mass", "DISEASE", 9, 29], ["infections", "DISEASE", 54, 64], ["toxic insult", "DISEASE", 66, 78], ["hepatic", "ORGAN", 17, 24], ["hepatocytes", "CELL", 127, 138], ["biliary epithelium", "TISSUE", 140, 158], ["bipotential progenitor cells", "CELL", 167, 195], ["hepatic stellate cells", "CELL", 208, 230], ["endothelial cells", "CELL", 235, 252], ["cells", "CELL", 282, 287], ["mature hepatocytes", "CELL_TYPE", 120, 138], ["bipotential progenitor cells", "CELL_TYPE", 167, 195], ["hepatic stellate cells", "CELL_TYPE", 208, 230], ["endothelial cells", "CELL_TYPE", 235, 252], ["actively proliferating cells", "CELL_TYPE", 259, 287], ["hepatic mass through injury", "PROBLEM", 17, 44], ["infections", "PROBLEM", 54, 64], ["toxic insult", "PROBLEM", 66, 78], ["surgical removal", "TREATMENT", 83, 99], ["bipotential progenitor cells", "PROBLEM", 167, 195], ["endothelial cells", "PROBLEM", 235, 252], ["actively proliferating cells", "PROBLEM", 259, 287], ["loss", "OBSERVATION_MODIFIER", 9, 13], ["hepatic", "ANATOMY", 17, 24], ["mass", "OBSERVATION", 25, 29], ["injury", "OBSERVATION", 38, 44], ["infections", "OBSERVATION", 54, 64], ["toxic", "OBSERVATION_MODIFIER", 66, 71], ["hepatocytes", "ANATOMY", 127, 138], ["biliary epithelium", "ANATOMY", 140, 158], ["bipotential progenitor cells", "OBSERVATION", 167, 195], ["hepatic", "ANATOMY", 208, 215], ["stellate cells", "OBSERVATION", 216, 230], ["endothelial cells", "OBSERVATION", 235, 252], ["proliferating cells", "OBSERVATION", 268, 287], ["functional", "OBSERVATION_MODIFIER", 301, 311], ["mass", "OBSERVATION", 312, 316]]], ["As much as 70% of the normal liver can be removed surgically without clinical insufficiency, and in the course of a few weeks, it is back to its normal mass.", [["liver", "ANATOMY", 29, 34], ["liver", "ORGAN", 29, 34], ["clinical insufficiency", "PROBLEM", 69, 91], ["normal", "OBSERVATION", 22, 28], ["liver", "ANATOMY", 29, 34], ["insufficiency", "OBSERVATION", 78, 91], ["normal", "OBSERVATION_MODIFIER", 145, 151], ["mass", "OBSERVATION", 152, 156]]], ["Depending on the nature of the injury, regeneration occurs via one of 2 pathways.", [["the injury", "PROBLEM", 27, 37], ["injury", "OBSERVATION", 31, 37]]], ["In cases of moderate injury, cell loss is replaced by proliferation of mature hepatocytes or biliary epithelium, providing swift replacement of parenchymal loss.", [["cell", "ANATOMY", 29, 33], ["hepatocytes", "ANATOMY", 78, 89], ["biliary epithelium", "ANATOMY", 93, 111], ["parenchymal", "ANATOMY", 144, 155], ["parenchymal loss", "DISEASE", 144, 160], ["cell", "CELL", 29, 33], ["hepatocytes", "CELL", 78, 89], ["biliary epithelium", "TISSUE", 93, 111], ["parenchymal", "TISSUE", 144, 155], ["mature hepatocytes", "CELL_TYPE", 71, 89], ["moderate injury", "PROBLEM", 12, 27], ["cell loss", "PROBLEM", 29, 38], ["mature hepatocytes", "PROBLEM", 71, 89], ["biliary epithelium", "PROBLEM", 93, 111], ["swift replacement", "TREATMENT", 123, 140], ["parenchymal loss", "PROBLEM", 144, 160], ["moderate", "OBSERVATION_MODIFIER", 12, 20], ["injury", "OBSERVATION", 21, 27], ["cell loss", "OBSERVATION", 29, 38], ["proliferation", "OBSERVATION_MODIFIER", 54, 67], ["mature", "OBSERVATION_MODIFIER", 71, 77], ["hepatocytes", "OBSERVATION", 78, 89], ["biliary epithelium", "ANATOMY", 93, 111], ["swift replacement", "OBSERVATION", 123, 140], ["parenchymal", "ANATOMY_MODIFIER", 144, 155], ["loss", "OBSERVATION", 156, 160]]], ["In cases of more severe injury, or conditions that inhibit replication of mature cells, there is proliferation of bipotential progenitor cells, called a ductular reaction.", [["cells", "ANATOMY", 81, 86], ["bipotential progenitor cells", "ANATOMY", 114, 142], ["ductular", "ANATOMY", 153, 161], ["cells", "CELL", 81, 86], ["bipotential progenitor cells", "CELL", 114, 142], ["ductular", "TISSUE", 153, 161], ["mature cells", "CELL_TYPE", 74, 86], ["bipotential progenitor cells", "CELL_TYPE", 114, 142], ["more severe injury", "PROBLEM", 12, 30], ["mature cells", "PROBLEM", 74, 86], ["bipotential progenitor cells", "PROBLEM", 114, 142], ["a ductular reaction", "PROBLEM", 151, 170], ["severe", "OBSERVATION_MODIFIER", 17, 23], ["injury", "OBSERVATION", 24, 30], ["mature cells", "OBSERVATION", 74, 86], ["bipotential progenitor cells", "OBSERVATION", 114, 142]]], ["These cells reside in the periportal region of the lobule at the level of the canals of Hering, the site where bile canaliculi and biliary epithelial cells first join and form the beginning of the epithelium-lined biliary tree.", [["cells", "ANATOMY", 6, 11], ["periportal region", "ANATOMY", 26, 43], ["lobule", "ANATOMY", 51, 57], ["canals", "ANATOMY", 78, 84], ["site", "ANATOMY", 100, 104], ["bile canaliculi", "ANATOMY", 111, 126], ["biliary epithelial cells", "ANATOMY", 131, 155], ["epithelium", "ANATOMY", 197, 207], ["biliary tree", "ANATOMY", 214, 226], ["cells", "CELL", 6, 11], ["periportal region", "IMMATERIAL_ANATOMICAL_ENTITY", 26, 43], ["lobule", "ORGAN", 51, 57], ["bile canaliculi", "CELL", 111, 126], ["biliary epithelial cells", "CELL", 131, 155], ["epithelium", "TISSUE", 197, 207], ["biliary tree", "MULTI-TISSUE_STRUCTURE", 214, 226], ["biliary epithelial cells", "CELL_TYPE", 131, 155], ["cells", "OBSERVATION", 6, 11], ["periportal", "ANATOMY_MODIFIER", 26, 36], ["region", "ANATOMY_MODIFIER", 37, 43], ["lobule", "ANATOMY_MODIFIER", 51, 57], ["canals", "ANATOMY_MODIFIER", 78, 84], ["bile canaliculi", "ANATOMY", 111, 126], ["biliary", "ANATOMY", 131, 138], ["epithelial cells", "OBSERVATION", 139, 155], ["epithelium", "ANATOMY_MODIFIER", 197, 207], ["lined", "ANATOMY_MODIFIER", 208, 213], ["biliary", "ANATOMY", 214, 221], ["tree", "ANATOMY_MODIFIER", 222, 226]]], ["They are recognized histologically as small, basophilic cells that form single-cell arrays or ductules with narrow lumens.", [["basophilic cells", "ANATOMY", 45, 61], ["cell", "ANATOMY", 79, 83], ["ductules", "ANATOMY", 94, 102], ["lumens", "ANATOMY", 115, 121], ["basophilic cells", "CELL", 45, 61], ["ductules", "MULTI-TISSUE_STRUCTURE", 94, 102], ["lumens", "MULTI-TISSUE_STRUCTURE", 115, 121], ["small, basophilic cells", "CELL_TYPE", 38, 61], ["small, basophilic cells", "PROBLEM", 38, 61], ["narrow lumens", "PROBLEM", 108, 121], ["small", "OBSERVATION_MODIFIER", 38, 43], ["basophilic cells", "OBSERVATION", 45, 61], ["cell arrays", "OBSERVATION", 79, 90], ["narrow lumens", "OBSERVATION", 108, 121]]], ["Depending on the differentiation pathway that is followed, they can mature into hepatocytes or bile duct epithelium.Hepatic regenerationRegeneration of mature hepatocytes following surgical removal is well known.", [["hepatocytes", "ANATOMY", 80, 91], ["bile duct epithelium", "ANATOMY", 95, 115], ["Hepatic", "ANATOMY", 116, 123], ["hepatocytes", "ANATOMY", 159, 170], ["hepatocytes", "CELL", 80, 91], ["bile duct epithelium", "TISSUE", 95, 115], ["Hepatic", "ORGAN", 116, 123], ["hepatocytes", "CELL", 159, 170], ["hepatocytes", "CELL_TYPE", 80, 91], ["mature hepatocytes", "CELL_TYPE", 152, 170], ["bile duct epithelium", "PROBLEM", 95, 115], ["Hepatic regeneration", "PROBLEM", 116, 136], ["Regeneration of mature hepatocytes", "PROBLEM", 136, 170], ["surgical removal", "TREATMENT", 181, 197], ["bile duct", "ANATOMY", 95, 104], ["regeneration", "OBSERVATION", 124, 136], ["mature", "OBSERVATION_MODIFIER", 152, 158], ["hepatocytes", "OBSERVATION", 159, 170], ["surgical removal", "OBSERVATION", 181, 197]]], ["An example from Greek mythology is Prometheus, punished for giving fire to the mortals, daily had his liver partially eaten by an eagle (a symbol of Zeus), only remaining hepatocytes are likely to initiate a replicative response, whereas random focal necrosis will engender a local proliferation of hepatocytes.", [["liver", "ANATOMY", 102, 107], ["hepatocytes", "ANATOMY", 171, 182], ["hepatocytes", "ANATOMY", 299, 310], ["necrosis", "DISEASE", 251, 259], ["liver", "ORGAN", 102, 107], ["hepatocytes", "CELL", 171, 182], ["hepatocytes", "CELL", 299, 310], ["hepatocytes", "CELL_TYPE", 171, 182], ["hepatocytes", "CELL_TYPE", 299, 310], ["random focal necrosis", "PROBLEM", 238, 259], ["a local proliferation of hepatocytes", "PROBLEM", 274, 310], ["liver", "ANATOMY", 102, 107], ["hepatocytes", "ANATOMY", 171, 182], ["replicative response", "OBSERVATION", 208, 228], ["focal", "OBSERVATION_MODIFIER", 245, 250], ["necrosis", "OBSERVATION", 251, 259], ["local", "OBSERVATION_MODIFIER", 276, 281], ["proliferation", "OBSERVATION", 282, 295], ["hepatocytes", "ANATOMY", 299, 310]]], ["Scattered individual cell necrosis is repaired almost imperceptibly.", [["cell", "ANATOMY", 21, 25], ["necrosis", "DISEASE", 26, 34], ["cell", "CELL", 21, 25], ["Scattered individual cell necrosis", "PROBLEM", 0, 34], ["individual cell necrosis", "OBSERVATION", 10, 34]]], ["In the more common pattern of centrilobular necrosis, seen in many toxic insults, complete repair is usually evident with a 24-48 hour period.", [["centrilobular", "ANATOMY", 30, 43], ["necrosis", "DISEASE", 44, 52], ["toxic insults", "DISEASE", 67, 80], ["centrilobular", "PATHOLOGICAL_FORMATION", 30, 43], ["centrilobular necrosis", "PROBLEM", 30, 52], ["many toxic insults", "PROBLEM", 62, 80], ["complete repair", "TREATMENT", 82, 97], ["more common", "OBSERVATION_MODIFIER", 7, 18], ["centrilobular", "OBSERVATION_MODIFIER", 30, 43], ["necrosis", "OBSERVATION", 44, 52], ["many", "OBSERVATION_MODIFIER", 62, 66], ["toxic", "OBSERVATION_MODIFIER", 67, 72], ["insults", "OBSERVATION", 73, 80], ["complete", "OBSERVATION_MODIFIER", 82, 90], ["repair", "OBSERVATION", 91, 97]]], ["Chronic or repetitive injury often results in nodule formation as discussed in the section on Fibrosis.Ductular reaction (bile duct hyperplasia)Ductular reaction (biliary hyperplasia) is a characteristic reaction of the liver to various types of insult involving proliferation of bile duct epithelium, hepatic progenitor cells, and possibly metaplasia of mature hepatocytes.", [["nodule", "ANATOMY", 46, 52], ["Ductular", "ANATOMY", 103, 111], ["bile duct", "ANATOMY", 122, 131], ["biliary", "ANATOMY", 163, 170], ["liver", "ANATOMY", 220, 225], ["bile duct epithelium", "ANATOMY", 280, 300], ["hepatic progenitor cells", "ANATOMY", 302, 326], ["metaplasia", "ANATOMY", 341, 351], ["hepatocytes", "ANATOMY", 362, 373], ["Fibrosis", "DISEASE", 94, 102], ["Ductular reaction", "DISEASE", 103, 120], ["bile duct hyperplasia", "DISEASE", 122, 143], ["biliary hyperplasia", "DISEASE", 163, 182], ["nodule", "PATHOLOGICAL_FORMATION", 46, 52], ["bile duct", "MULTI-TISSUE_STRUCTURE", 122, 131], ["biliary hyperplasia", "PATHOLOGICAL_FORMATION", 163, 182], ["liver", "ORGAN", 220, 225], ["bile duct epithelium", "TISSUE", 280, 300], ["hepatic progenitor cells", "CELL", 302, 326], ["metaplasia", "CANCER", 341, 351], ["hepatocytes", "CELL", 362, 373], ["hepatic progenitor cells", "CELL_TYPE", 302, 326], ["mature hepatocytes", "CELL_TYPE", 355, 373], ["Chronic or repetitive injury", "PROBLEM", 0, 28], ["nodule formation", "PROBLEM", 46, 62], ["Fibrosis", "PROBLEM", 94, 102], ["Ductular reaction", "PROBLEM", 103, 120], ["bile duct hyperplasia", "PROBLEM", 122, 143], ["Ductular reaction", "PROBLEM", 144, 161], ["biliary hyperplasia", "PROBLEM", 163, 182], ["a characteristic reaction of the liver", "PROBLEM", 187, 225], ["insult", "PROBLEM", 246, 252], ["proliferation of bile duct epithelium", "PROBLEM", 263, 300], ["hepatic progenitor cells", "PROBLEM", 302, 326], ["metaplasia of mature hepatocytes", "PROBLEM", 341, 373], ["repetitive", "OBSERVATION_MODIFIER", 11, 21], ["injury", "OBSERVATION", 22, 28], ["nodule", "OBSERVATION", 46, 52], ["Fibrosis", "OBSERVATION", 94, 102], ["bile duct", "ANATOMY", 122, 131], ["hyperplasia", "OBSERVATION", 132, 143], ["Ductular", "ANATOMY_MODIFIER", 144, 152], ["biliary", "ANATOMY", 163, 170], ["hyperplasia", "OBSERVATION", 171, 182], ["liver", "ANATOMY", 220, 225], ["insult", "OBSERVATION", 246, 252], ["proliferation", "OBSERVATION", 263, 276], ["bile duct", "ANATOMY", 280, 289], ["epithelium", "ANATOMY_MODIFIER", 290, 300], ["hepatic", "ANATOMY", 302, 309], ["progenitor cells", "OBSERVATION", 310, 326], ["possibly", "UNCERTAINTY", 332, 340], ["metaplasia", "OBSERVATION", 341, 351], ["mature", "OBSERVATION_MODIFIER", 355, 361], ["hepatocytes", "ANATOMY", 362, 373]]], ["The histologic hallmark of the ductular reaction is the formation of new, irregular, and tortuous ductules or chains of cells formed from flattened or cuboidal basophilic epithelium.Ductular reaction (bile duct hyperplasia)There are 3 main types of ductular reactions.", [["ductular", "ANATOMY", 31, 39], ["tortuous ductules", "ANATOMY", 89, 106], ["cells", "ANATOMY", 120, 125], ["cuboidal basophilic epithelium", "ANATOMY", 151, 181], ["Ductular", "ANATOMY", 182, 190], ["bile duct", "ANATOMY", 201, 210], ["ductular", "ANATOMY", 249, 257], ["Ductular reaction", "DISEASE", 182, 199], ["bile duct hyperplasia", "DISEASE", 201, 222], ["ductular", "ORGAN", 31, 39], ["ductules", "MULTI-TISSUE_STRUCTURE", 98, 106], ["cells", "CELL", 120, 125], ["cuboidal basophilic epithelium", "TISSUE", 151, 181], ["bile duct", "MULTI-TISSUE_STRUCTURE", 201, 210], ["ductular", "MULTI-TISSUE_STRUCTURE", 249, 257], ["the ductular reaction", "PROBLEM", 27, 48], ["new, irregular, and tortuous ductules or chains of cells", "PROBLEM", 69, 125], ["flattened or cuboidal basophilic epithelium", "PROBLEM", 138, 181], ["Ductular reaction (bile duct hyperplasia", "PROBLEM", 182, 222], ["ductular reactions", "PROBLEM", 249, 267], ["histologic", "OBSERVATION_MODIFIER", 4, 14], ["hallmark", "OBSERVATION_MODIFIER", 15, 23], ["ductular reaction", "OBSERVATION", 31, 48], ["new", "OBSERVATION_MODIFIER", 69, 72], ["irregular", "OBSERVATION_MODIFIER", 74, 83], ["tortuous", "OBSERVATION_MODIFIER", 89, 97], ["ductules", "OBSERVATION_MODIFIER", 98, 106], ["chains", "OBSERVATION_MODIFIER", 110, 116], ["flattened", "OBSERVATION_MODIFIER", 138, 147], ["cuboidal", "OBSERVATION_MODIFIER", 151, 159], ["basophilic epithelium", "OBSERVATION", 160, 181], ["bile duct", "ANATOMY", 201, 210], ["hyperplasia", "OBSERVATION", 211, 222], ["3 main", "OBSERVATION_MODIFIER", 233, 239], ["ductular reactions", "OBSERVATION", 249, 267]]], ["(1) A common association with acute bile duct obstruction is proliferation of preformed bile duct epithelium, creating a rapid increase in bile duct surface area.", [["bile duct", "ANATOMY", 36, 45], ["bile duct epithelium", "ANATOMY", 88, 108], ["bile duct surface area", "ANATOMY", 139, 161], ["acute bile duct obstruction", "DISEASE", 30, 57], ["bile duct", "MULTI-TISSUE_STRUCTURE", 36, 45], ["bile duct epithelium", "TISSUE", 88, 108], ["bile duct", "MULTI-TISSUE_STRUCTURE", 139, 148], ["acute bile duct obstruction", "PROBLEM", 30, 57], ["proliferation of preformed bile duct epithelium", "PROBLEM", 61, 108], ["a rapid increase in bile duct surface area", "PROBLEM", 119, 161], ["acute", "OBSERVATION_MODIFIER", 30, 35], ["bile duct", "ANATOMY", 36, 45], ["obstruction", "OBSERVATION", 46, 57], ["proliferation", "OBSERVATION", 61, 74], ["bile duct", "ANATOMY", 88, 97], ["epithelium", "ANATOMY_MODIFIER", 98, 108], ["rapid", "OBSERVATION_MODIFIER", 121, 126], ["increase", "OBSERVATION_MODIFIER", 127, 135], ["bile duct", "ANATOMY", 139, 148], ["surface", "OBSERVATION_MODIFIER", 149, 156]]], ["This can protect hepatocytes from bile acid buildup through a recirculation process termed cholehepatic recirculation.Ductular reaction (bile duct hyperplasia)(2) In cases of serious injury to hepatocytes, particularly when mature hepatocytes are not able to replicate, there is a prominent ductular reaction originating from hepatic bipotential progenitor cells (or oval cells).", [["hepatocytes", "ANATOMY", 17, 28], ["bile", "ANATOMY", 34, 38], ["Ductular", "ANATOMY", 118, 126], ["bile duct hyperplasia", "ANATOMY", 137, 158], ["hepatocytes", "ANATOMY", 193, 204], ["hepatocytes", "ANATOMY", 231, 242], ["ductular", "ANATOMY", 291, 299], ["hepatic bipotential progenitor cells", "ANATOMY", 326, 362], ["oval cells", "ANATOMY", 367, 377], ["bile acid", "CHEMICAL", 34, 43], ["Ductular reaction", "DISEASE", 118, 135], ["bile duct hyperplasia", "DISEASE", 137, 158], ["bile acid", "CHEMICAL", 34, 43], ["hepatocytes", "CELL", 17, 28], ["bile acid", "SIMPLE_CHEMICAL", 34, 43], ["cholehepatic", "SIMPLE_CHEMICAL", 91, 103], ["bile duct", "MULTI-TISSUE_STRUCTURE", 137, 146], ["hepatocytes", "CELL", 193, 204], ["hepatocytes", "CELL", 231, 242], ["ductular", "PATHOLOGICAL_FORMATION", 291, 299], ["hepatic bipotential progenitor cells", "CELL", 326, 362], ["oval cells", "CELL", 367, 377], ["hepatocytes", "CELL_TYPE", 17, 28], ["hepatocytes", "CELL_TYPE", 193, 204], ["mature hepatocytes", "CELL_TYPE", 224, 242], ["hepatic bipotential progenitor cells", "CELL_TYPE", 326, 362], ["oval cells", "CELL_TYPE", 367, 377], ["bile acid buildup", "PROBLEM", 34, 51], ["a recirculation process termed cholehepatic recirculation", "TREATMENT", 60, 117], ["Ductular reaction (bile duct hyperplasia)", "PROBLEM", 118, 159], ["serious injury to hepatocytes", "PROBLEM", 175, 204], ["mature hepatocytes", "PROBLEM", 224, 242], ["a prominent ductular reaction", "PROBLEM", 279, 308], ["oval cells", "PROBLEM", 367, 377], ["hepatocytes", "ANATOMY", 17, 28], ["bile", "ANATOMY", 34, 38], ["acid buildup", "OBSERVATION", 39, 51], ["recirculation process", "OBSERVATION", 62, 83], ["cholehepatic recirculation", "OBSERVATION", 91, 117], ["bile duct", "ANATOMY", 137, 146], ["hyperplasia", "OBSERVATION", 147, 158], ["serious", "OBSERVATION_MODIFIER", 175, 182], ["injury", "OBSERVATION", 183, 189], ["hepatocytes", "ANATOMY", 193, 204], ["prominent", "OBSERVATION_MODIFIER", 281, 290], ["ductular reaction", "OBSERVATION", 291, 308], ["hepatic", "ANATOMY", 326, 333], ["bipotential progenitor cells", "OBSERVATION", 334, 362], ["oval cells", "OBSERVATION", 367, 377]]], ["The bipotential nature of these cells is supported by the detection of biliary epithelial cytokeratins 7 and 19 in cells with an otherwise hepatocellular phenotype.", [["cells", "ANATOMY", 32, 37], ["biliary epithelial", "ANATOMY", 71, 89], ["cells", "ANATOMY", 115, 120], ["hepatocellular", "ANATOMY", 139, 153], ["cells", "CELL", 32, 37], ["biliary epithelial cytokeratins 7", "GENE_OR_GENE_PRODUCT", 71, 104], ["cells", "CELL", 115, 120], ["hepatocellular", "CANCER", 139, 153], ["biliary epithelial cytokeratins 7 and 19", "PROTEIN", 71, 111], ["biliary epithelial cytokeratins", "TEST", 71, 102], ["an otherwise hepatocellular phenotype", "PROBLEM", 126, 163], ["bipotential", "OBSERVATION_MODIFIER", 4, 15], ["these cells", "OBSERVATION", 26, 37], ["biliary epithelial", "ANATOMY", 71, 89], ["cytokeratins", "OBSERVATION", 90, 102], ["otherwise", "OBSERVATION_MODIFIER", 129, 138], ["hepatocellular phenotype", "OBSERVATION", 139, 163]]], ["A dramatic presentation of ductular proliferation is often evident in animals that succumb several days after a fatal hepatic intoxication or in horses with Theiler's disease.Ductular reaction (bile duct hyperplasia)(3) Ductular reaction may also result from metaplasia of mature hepatocytes in regions of hypoxia.Ductular reaction (bile duct hyperplasia)Ductular reaction may also develop secondary to local portal inflammation and fibrosis.", [["ductular", "ANATOMY", 27, 35], ["hepatic", "ANATOMY", 118, 125], ["Ductular", "ANATOMY", 175, 183], ["bile duct hyperplasia", "ANATOMY", 194, 215], ["metaplasia", "ANATOMY", 259, 269], ["hepatocytes", "ANATOMY", 280, 291], ["Ductular", "ANATOMY", 314, 322], ["bile duct", "ANATOMY", 333, 342], ["portal", "ANATOMY", 409, 415], ["hepatic intoxication", "DISEASE", 118, 138], ["Theiler's disease", "DISEASE", 157, 174], ["Ductular reaction", "DISEASE", 175, 192], ["bile duct hyperplasia", "DISEASE", 194, 215], ["hypoxia", "DISEASE", 306, 313], ["Ductular reaction", "DISEASE", 314, 331], ["bile duct hyperplasia", "DISEASE", 333, 354], ["inflammation", "DISEASE", 416, 428], ["fibrosis", "DISEASE", 433, 441], ["ductular", "MULTI-TISSUE_STRUCTURE", 27, 35], ["hepatic", "ORGAN", 118, 125], ["bile duct", "MULTI-TISSUE_STRUCTURE", 194, 203], ["metaplasia", "CANCER", 259, 269], ["hepatocytes", "CELL", 280, 291], ["bile duct", "MULTI-TISSUE_STRUCTURE", 333, 342], ["portal", "MULTI-TISSUE_STRUCTURE", 409, 415], ["mature hepatocytes", "CELL_TYPE", 273, 291], ["ductular proliferation", "PROBLEM", 27, 49], ["a fatal hepatic intoxication", "PROBLEM", 110, 138], ["Theiler's disease", "PROBLEM", 157, 174], ["Ductular reaction (bile duct hyperplasia)", "PROBLEM", 175, 216], ["Ductular reaction", "PROBLEM", 220, 237], ["metaplasia of mature hepatocytes", "PROBLEM", 259, 291], ["hypoxia", "PROBLEM", 306, 313], ["Ductular reaction", "PROBLEM", 314, 331], ["bile duct hyperplasia", "PROBLEM", 333, 354], ["Ductular reaction", "PROBLEM", 355, 372], ["local portal inflammation", "PROBLEM", 403, 428], ["fibrosis", "PROBLEM", 433, 441], ["dramatic", "OBSERVATION_MODIFIER", 2, 10], ["ductular proliferation", "OBSERVATION", 27, 49], ["hepatic", "ANATOMY", 118, 125], ["intoxication", "OBSERVATION", 126, 138], ["bile duct", "ANATOMY", 194, 203], ["hyperplasia", "OBSERVATION", 204, 215], ["metaplasia", "OBSERVATION", 259, 269], ["mature", "OBSERVATION_MODIFIER", 273, 279], ["hepatocytes", "OBSERVATION", 280, 291], ["hypoxia", "OBSERVATION", 306, 313], ["bile duct", "ANATOMY", 333, 342], ["hyperplasia", "OBSERVATION", 343, 354], ["Ductular", "ANATOMY_MODIFIER", 355, 363], ["local", "OBSERVATION_MODIFIER", 403, 408], ["portal", "ANATOMY", 409, 415], ["inflammation", "OBSERVATION", 416, 428], ["fibrosis", "OBSERVATION", 433, 441]]], ["Ductular formation can also occur in areas of hypoxia.", [["Ductular", "ANATOMY", 0, 8], ["hypoxia", "DISEASE", 46, 53], ["Ductular", "MULTI-TISSUE_STRUCTURE", 0, 8], ["Ductular formation", "PROBLEM", 0, 18], ["hypoxia", "PROBLEM", 46, 53], ["hypoxia", "OBSERVATION", 46, 53]]], ["Such ducts formed by metaplasia of mature hepatocytes can be found in centrilobular areas in animals with chronic heart failure and passive congestion, for example ( Fig. 2-42) .Ductular reaction (bile duct hyperplasia)However, reabsorption of bile constituents by biliary epithelium leads to a neutrophilic inflammatory reaction and local edema formation, which can be confused with a reaction,\" characterized by ductular structures lined by cuboidal, basophilic cells ( Fig. 2-41A ).", [["ducts", "ANATOMY", 5, 10], ["metaplasia", "ANATOMY", 21, 31], ["hepatocytes", "ANATOMY", 42, 53], ["centrilobular areas", "ANATOMY", 70, 89], ["heart", "ANATOMY", 114, 119], ["Ductular", "ANATOMY", 178, 186], ["bile duct hyperplasia", "ANATOMY", 197, 218], ["bile constituents", "ANATOMY", 244, 261], ["biliary epithelium", "ANATOMY", 265, 283], ["edema", "ANATOMY", 340, 345], ["ductular structures", "ANATOMY", 414, 433], ["cuboidal", "ANATOMY", 443, 451], ["basophilic cells", "ANATOMY", 453, 469], ["heart failure", "DISEASE", 114, 127], ["congestion", "DISEASE", 140, 150], ["Ductular reaction", "DISEASE", 178, 195], ["bile duct hyperplasia", "DISEASE", 197, 218], ["edema", "DISEASE", 340, 345], ["ducts", "MULTI-TISSUE_STRUCTURE", 5, 10], ["metaplasia", "CANCER", 21, 31], ["hepatocytes", "CELL", 42, 53], ["centrilobular areas", "PATHOLOGICAL_FORMATION", 70, 89], ["heart", "ORGAN", 114, 119], ["bile duct", "MULTI-TISSUE_STRUCTURE", 197, 206], ["bile constituents", "PATHOLOGICAL_FORMATION", 244, 261], ["biliary epithelium", "TISSUE", 265, 283], ["edema", "PATHOLOGICAL_FORMATION", 340, 345], ["ductular structures", "TISSUE", 414, 433], ["basophilic cells", "CELL", 453, 469], ["Fig. 2-41A", "CELL", 472, 482], ["mature hepatocytes", "CELL_TYPE", 35, 53], ["cuboidal, basophilic cells", "CELL_TYPE", 443, 469], ["Such ducts", "PROBLEM", 0, 10], ["metaplasia of mature hepatocytes", "PROBLEM", 21, 53], ["centrilobular areas", "PROBLEM", 70, 89], ["chronic heart failure", "PROBLEM", 106, 127], ["passive congestion", "PROBLEM", 132, 150], ["Ductular reaction", "PROBLEM", 178, 195], ["bile duct hyperplasia", "PROBLEM", 197, 218], ["reabsorption of bile constituents", "PROBLEM", 228, 261], ["biliary epithelium", "PROBLEM", 265, 283], ["a neutrophilic inflammatory reaction", "PROBLEM", 293, 329], ["local edema formation", "PROBLEM", 334, 355], ["a reaction", "PROBLEM", 384, 394], ["ducts", "ANATOMY", 5, 10], ["metaplasia", "OBSERVATION", 21, 31], ["mature hepatocytes", "OBSERVATION", 35, 53], ["centrilobular", "OBSERVATION_MODIFIER", 70, 83], ["chronic", "OBSERVATION_MODIFIER", 106, 113], ["heart", "ANATOMY", 114, 119], ["failure", "OBSERVATION", 120, 127], ["passive", "OBSERVATION_MODIFIER", 132, 139], ["congestion", "OBSERVATION", 140, 150], ["bile duct", "ANATOMY", 197, 206], ["hyperplasia", "OBSERVATION", 207, 218], ["bile", "ANATOMY", 244, 248], ["biliary epithelium", "ANATOMY", 265, 283], ["neutrophilic", "OBSERVATION_MODIFIER", 295, 307], ["inflammatory", "OBSERVATION_MODIFIER", 308, 320], ["local", "OBSERVATION_MODIFIER", 334, 339], ["edema", "OBSERVATION", 340, 345], ["ductular", "ANATOMY_MODIFIER", 414, 422], ["cuboidal", "OBSERVATION_MODIFIER", 443, 451], ["basophilic cells", "OBSERVATION", 453, 469]]], ["The relationship between the \"oval cells\" described in rodents and the ductular reaction still requires some clarification, but it is likely that the same cell type is involved.", [["oval cells", "ANATOMY", 30, 40], ["ductular", "ANATOMY", 71, 79], ["cell", "ANATOMY", 155, 159], ["oval cells", "CELL", 30, 40], ["ductular", "MULTI-TISSUE_STRUCTURE", 71, 79], ["cell type", "CELL", 155, 164], ["oval cells", "CELL_TYPE", 30, 40], ["the \"oval cells", "PROBLEM", 25, 40], ["the ductular reaction", "PROBLEM", 67, 88], ["oval cells", "OBSERVATION", 30, 40]]], ["In addition, there may be progenitor cells among the mature biliary epithelial cells, and others may be marrow derived and blood-borne to the liver.", [["progenitor cells", "ANATOMY", 26, 42], ["biliary epithelial cells", "ANATOMY", 60, 84], ["marrow", "ANATOMY", 104, 110], ["blood", "ANATOMY", 123, 128], ["liver", "ANATOMY", 142, 147], ["progenitor cells", "CELL", 26, 42], ["biliary epithelial cells", "CELL", 60, 84], ["marrow", "TISSUE", 104, 110], ["blood", "ORGANISM_SUBSTANCE", 123, 128], ["liver", "ORGAN", 142, 147], ["progenitor cells", "CELL_TYPE", 26, 42], ["mature biliary epithelial cells", "CELL_TYPE", 53, 84], ["progenitor cells", "PROBLEM", 26, 42], ["the mature biliary epithelial cells", "PROBLEM", 49, 84], ["may be", "UNCERTAINTY", 19, 25], ["progenitor cells", "OBSERVATION", 26, 42], ["mature", "OBSERVATION_MODIFIER", 53, 59], ["biliary epithelial cells", "OBSERVATION", 60, 84], ["may be", "UNCERTAINTY", 97, 103], ["marrow", "OBSERVATION", 104, 110], ["liver", "ANATOMY", 142, 147]]], ["Immunohistochemical staining of these cells in humans and rodents reveals that they contain cytokeratin markers of biliary epithelium and, simultaneously, hepatocyte markers such as albumin ( Fig. 2-41B ).", [["cells", "ANATOMY", 38, 43], ["biliary epithelium", "ANATOMY", 115, 133], ["hepatocyte", "ANATOMY", 155, 165], ["cells", "CELL", 38, 43], ["humans", "ORGANISM", 47, 53], ["cytokeratin", "GENE_OR_GENE_PRODUCT", 92, 103], ["biliary epithelium", "TISSUE", 115, 133], ["hepatocyte", "CELL", 155, 165], ["albumin", "GENE_OR_GENE_PRODUCT", 182, 189], ["Fig. 2-41B", "GENE_OR_GENE_PRODUCT", 192, 202], ["cytokeratin markers", "PROTEIN", 92, 111], ["hepatocyte markers", "PROTEIN", 155, 173], ["albumin", "PROTEIN", 182, 189], ["humans", "SPECIES", 47, 53], ["humans", "SPECIES", 47, 53], ["Immunohistochemical staining", "TEST", 0, 28], ["cytokeratin markers", "TEST", 92, 111], ["hepatocyte markers", "TEST", 155, 173], ["albumin ( Fig.", "TEST", 182, 196], ["these cells", "OBSERVATION", 32, 43], ["cytokeratin markers", "OBSERVATION", 92, 111], ["biliary epithelium", "ANATOMY", 115, 133]]], ["Similar cells are present in animals as well.", [["cells", "ANATOMY", 8, 13], ["cells", "CELL", 8, 13], ["cells", "OBSERVATION", 8, 13]]], ["There are several circumstances that can trigger the ductular reaction other than massive necrosis, although this is the best recognized form.", [["ductular", "ANATOMY", 53, 61], ["necrosis", "DISEASE", 90, 98], ["ductular", "MULTI-TISSUE_STRUCTURE", 53, 61], ["the ductular reaction", "PROBLEM", 49, 70], ["massive necrosis", "PROBLEM", 82, 98], ["ductular", "OBSERVATION_MODIFIER", 53, 61], ["massive", "OBSERVATION_MODIFIER", 82, 89], ["necrosis", "OBSERVATION", 90, 98]]], ["Both cholestasis and hypoxia can drive the ductular reaction causing proliferation in the periportal region for the former, and in the centrilobular region in the latter instance.", [["ductular", "ANATOMY", 43, 51], ["periportal region", "ANATOMY", 90, 107], ["centrilobular region", "ANATOMY", 135, 155], ["cholestasis", "DISEASE", 5, 16], ["hypoxia", "DISEASE", 21, 28], ["ductular", "PATHOLOGICAL_FORMATION", 43, 51], ["Both cholestasis", "PROBLEM", 0, 16], ["hypoxia", "PROBLEM", 21, 28], ["the ductular reaction", "PROBLEM", 39, 60], ["proliferation in the periportal region", "PROBLEM", 69, 107], ["cholestasis", "OBSERVATION", 5, 16], ["hypoxia", "OBSERVATION", 21, 28], ["proliferation", "OBSERVATION_MODIFIER", 69, 82], ["periportal", "ANATOMY", 90, 100], ["region", "ANATOMY_MODIFIER", 101, 107], ["centrilobular", "ANATOMY_MODIFIER", 135, 148]]], ["The ability of these cells in the ductular reaction to differentiate into mature biliary or hepatocellular phenotypes is well established.", [["cells", "ANATOMY", 21, 26], ["ductular", "ANATOMY", 34, 42], ["biliary", "ANATOMY", 81, 88], ["hepatocellular", "ANATOMY", 92, 106], ["cells", "CELL", 21, 26], ["ductular", "MULTI-TISSUE_STRUCTURE", 34, 42], ["biliary", "MULTI-TISSUE_STRUCTURE", 81, 88], ["hepatocellular", "CANCER", 92, 106], ["the ductular reaction", "PROBLEM", 30, 51], ["mature biliary or hepatocellular phenotypes", "PROBLEM", 74, 117], ["ductular", "ANATOMY", 34, 42], ["biliary", "ANATOMY", 81, 88], ["hepatocellular phenotypes", "OBSERVATION", 92, 117]]], ["It should be appreciated that in most clinical circumstances, hepatic regeneration is a less orderly process than that which occurs in healthy experimental animals.", [["hepatic", "ANATOMY", 62, 69], ["hepatic", "ORGAN", 62, 69], ["hepatic regeneration", "PROBLEM", 62, 82], ["hepatic", "ANATOMY", 62, 69], ["regeneration", "OBSERVATION", 70, 82], ["less orderly", "OBSERVATION_MODIFIER", 88, 100]]], ["Regeneration requires normal arterial and venous inflow as well as venous and biliary drainage.", [["arterial", "ANATOMY", 29, 37], ["venous", "ANATOMY", 42, 48], ["venous", "ANATOMY", 67, 73], ["biliary", "ANATOMY", 78, 85], ["arterial", "MULTI-TISSUE_STRUCTURE", 29, 37], ["venous", "MULTI-TISSUE_STRUCTURE", 42, 48], ["venous", "MULTI-TISSUE_STRUCTURE", 67, 73], ["biliary drainage", "PATHOLOGICAL_FORMATION", 78, 94], ["venous inflow", "TREATMENT", 42, 55], ["venous and biliary drainage", "TREATMENT", 67, 94], ["normal", "OBSERVATION", 22, 28], ["arterial", "ANATOMY_MODIFIER", 29, 37], ["venous", "ANATOMY", 42, 48], ["inflow", "OBSERVATION", 49, 55], ["venous", "ANATOMY", 67, 73], ["biliary", "ANATOMY", 78, 85], ["drainage", "OBSERVATION", 86, 94]]], ["Without a supportive environment, hepatic regeneration of hepatocytes, biliary epithelium, and nonparenchymal cells may be quite variable within different regions of the liver.", [["hepatic", "ANATOMY", 34, 41], ["hepatocytes", "ANATOMY", 58, 69], ["biliary epithelium", "ANATOMY", 71, 89], ["nonparenchymal cells", "ANATOMY", 95, 115], ["liver", "ANATOMY", 170, 175], ["hepatic", "MULTI-TISSUE_STRUCTURE", 34, 41], ["hepatocytes", "CELL", 58, 69], ["biliary epithelium", "TISSUE", 71, 89], ["nonparenchymal cells", "CELL", 95, 115], ["liver", "ORGAN", 170, 175], ["hepatocytes", "CELL_TYPE", 58, 69], ["nonparenchymal cells", "CELL_TYPE", 95, 115], ["hepatic regeneration of hepatocytes, biliary epithelium, and nonparenchymal cells", "PROBLEM", 34, 115], ["supportive", "OBSERVATION_MODIFIER", 10, 20], ["environment", "OBSERVATION", 21, 32], ["hepatic", "ANATOMY", 34, 41], ["regeneration", "OBSERVATION", 42, 54], ["hepatocytes", "ANATOMY", 58, 69], ["biliary epithelium", "ANATOMY", 71, 89], ["nonparenchymal cells", "OBSERVATION", 95, 115], ["liver", "ANATOMY", 170, 175]]], ["Following massive necrosis, all spindle-shaped myofibroblast.", [["spindle", "ANATOMY", 32, 39], ["myofibroblast", "ANATOMY", 47, 60], ["necrosis", "DISEASE", 18, 26], ["myofibroblast", "CELL", 47, 60], ["spindle-shaped myofibroblast", "CELL_TYPE", 32, 60], ["massive necrosis", "PROBLEM", 10, 26], ["massive", "OBSERVATION_MODIFIER", 10, 17], ["necrosis", "OBSERVATION", 18, 26], ["all", "OBSERVATION_MODIFIER", 28, 31], ["spindle", "OBSERVATION_MODIFIER", 32, 39], ["shaped", "OBSERVATION_MODIFIER", 40, 46], ["myofibroblast", "OBSERVATION", 47, 60]]], ["In some species, stellate cells contain immunohistochemically detectable \u03b1-smooth muscle actin before activation, and in other species, activation is required for expression of this protein.", [["stellate cells", "ANATOMY", 17, 31], ["\u03b1-smooth muscle", "ANATOMY", 73, 88], ["stellate cells", "CELL", 17, 31], ["\u03b1-smooth muscle actin", "GENE_OR_GENE_PRODUCT", 73, 94], ["stellate cells", "CELL_TYPE", 17, 31], ["\u03b1-smooth muscle actin", "PROTEIN", 73, 94], ["stellate cells", "TEST", 17, 31], ["this protein", "PROBLEM", 177, 189], ["species", "OBSERVATION_MODIFIER", 8, 15], ["stellate cells", "OBSERVATION", 17, 31], ["immunohistochemically", "OBSERVATION_MODIFIER", 40, 61], ["detectable", "OBSERVATION_MODIFIER", 62, 72], ["\u03b1-smooth muscle actin", "OBSERVATION", 73, 94]]], ["When activated, they replicate robustly at sites of injury and are the main source of collagen and other ECM components, such as proteoglycans, fibronectin, and hyaluronan, lining the space of Disse.", [["ECM components", "ANATOMY", 105, 119], ["collagen", "GENE_OR_GENE_PRODUCT", 86, 94], ["ECM components", "CELLULAR_COMPONENT", 105, 119], ["proteoglycans", "GENE_OR_GENE_PRODUCT", 129, 142], ["fibronectin", "GENE_OR_GENE_PRODUCT", 144, 155], ["hyaluronan", "GENE_OR_GENE_PRODUCT", 161, 171], ["collagen", "PROTEIN", 86, 94], ["ECM components", "PROTEIN", 105, 119], ["proteoglycans", "PROTEIN", 129, 142], ["fibronectin", "PROTEIN", 144, 155], ["injury", "PROBLEM", 52, 58], ["collagen and other ECM components", "PROBLEM", 86, 119], ["proteoglycans", "TREATMENT", 129, 142], ["fibronectin", "TREATMENT", 144, 155], ["hyaluronan", "TREATMENT", 161, 171], ["injury", "OBSERVATION", 52, 58], ["collagen", "OBSERVATION", 86, 94], ["Disse", "OBSERVATION", 193, 198]]], ["Activated stellate cells also release proinflammatory, profibrogenic, and promitotic cytokines.", [["stellate cells", "ANATOMY", 10, 24], ["stellate cells", "CELL", 10, 24], ["Activated stellate cells", "CELL_TYPE", 0, 24], ["proinflammatory, profibrogenic, and promitotic cytokines", "PROTEIN", 38, 94], ["Activated stellate cells", "TREATMENT", 0, 24], ["promitotic cytokines", "PROBLEM", 74, 94], ["stellate cells", "OBSERVATION", 10, 24]]], ["Other features of stellate cells include the ability to present antigen and their consistent contact with individual fibers of autonomic nerve endings.Ductular reaction (bile duct hyperplasia)Hepatic blood flow can be significantly modified by activated stellate cells.", [["stellate cells", "ANATOMY", 18, 32], ["fibers", "ANATOMY", 117, 123], ["autonomic nerve endings", "ANATOMY", 127, 150], ["Ductular", "ANATOMY", 151, 159], ["bile duct", "ANATOMY", 170, 179], ["Hepatic blood", "ANATOMY", 192, 205], ["stellate cells", "ANATOMY", 254, 268], ["Ductular reaction", "DISEASE", 151, 168], ["bile duct hyperplasia", "DISEASE", 170, 191], ["stellate cells", "CELL", 18, 32], ["fibers", "CELLULAR_COMPONENT", 117, 123], ["nerve endings", "MULTI-TISSUE_STRUCTURE", 137, 150], ["bile duct", "MULTI-TISSUE_STRUCTURE", 170, 179], ["Hepatic", "ORGANISM_SUBSTANCE", 192, 199], ["blood", "ORGANISM_SUBSTANCE", 200, 205], ["stellate cells", "CELL", 254, 268], ["stellate cells", "CELL_TYPE", 18, 32], ["activated stellate cells", "CELL_TYPE", 244, 268], ["stellate cells", "PROBLEM", 18, 32], ["autonomic nerve endings", "PROBLEM", 127, 150], ["Ductular reaction (bile duct hyperplasia", "PROBLEM", 151, 191], ["Hepatic blood flow", "TEST", 192, 210], ["stellate cells", "OBSERVATION", 18, 32], ["autonomic nerve", "ANATOMY", 127, 142], ["bile duct", "ANATOMY", 170, 179], ["hyperplasia", "OBSERVATION", 180, 191], ["blood", "ANATOMY", 200, 205], ["flow", "OBSERVATION", 206, 210], ["stellate cells", "OBSERVATION", 254, 268]]], ["Blood flow through sinusoids can be restricted by the contraction of the stellate cells that extend processes around the sinusoidal endothelial cells.", [["Blood", "ANATOMY", 0, 5], ["sinusoids", "ANATOMY", 19, 28], ["stellate cells", "ANATOMY", 73, 87], ["sinusoidal endothelial cells", "ANATOMY", 121, 149], ["Blood", "ORGANISM_SUBSTANCE", 0, 5], ["sinusoids", "TISSUE", 19, 28], ["stellate cells", "CELL", 73, 87], ["sinusoidal endothelial cells", "CELL", 121, 149], ["stellate cells", "CELL_TYPE", 73, 87], ["sinusoidal endothelial cells", "CELL_TYPE", 121, 149], ["Blood flow through sinusoids", "TEST", 0, 28], ["flow", "OBSERVATION", 6, 10], ["contraction", "OBSERVATION", 54, 65], ["stellate cells", "OBSERVATION", 73, 87], ["sinusoidal endothelial cells", "OBSERVATION", 121, 149]]], ["In health, there is a balance between the nitric oxide-stimulated vasodilation and endothelin-1-driven vasoconstriction.", [["nitric oxide", "CHEMICAL", 42, 54], ["nitric oxide", "CHEMICAL", 42, 54], ["nitric oxide", "SIMPLE_CHEMICAL", 42, 54], ["endothelin-1", "GENE_OR_GENE_PRODUCT", 83, 95], ["the nitric oxide", "TREATMENT", 38, 54], ["stimulated vasodilation", "TREATMENT", 55, 78], ["endothelin", "TEST", 83, 93], ["vasoconstriction", "PROBLEM", 103, 119]]], ["During active fibrosis and cirrhosis, there is an increase of endothelin-1, produced by sinusoidal endothelial cells causing contraction of the stellate cell-derived myofibroblasts.Ductular reaction (bile duct hyperplasia)Fibrosis can form within portal tracts expanding their area, or as septa extending into the parenchyma and eventually bridging between portal tracts or central veins.", [["sinusoidal endothelial cells", "ANATOMY", 88, 116], ["stellate cell-derived myofibroblasts", "ANATOMY", 144, 180], ["Ductular", "ANATOMY", 181, 189], ["bile duct hyperplasia", "ANATOMY", 200, 221], ["portal tracts", "ANATOMY", 247, 260], ["area", "ANATOMY", 277, 281], ["septa", "ANATOMY", 289, 294], ["parenchyma", "ANATOMY", 314, 324], ["portal tracts", "ANATOMY", 357, 370], ["central veins", "ANATOMY", 374, 387], ["fibrosis", "DISEASE", 14, 22], ["cirrhosis", "DISEASE", 27, 36], ["Ductular reaction", "DISEASE", 181, 198], ["bile duct hyperplasia", "DISEASE", 200, 221], ["Fibrosis", "DISEASE", 222, 230], ["endothelin-1", "GENE_OR_GENE_PRODUCT", 62, 74], ["sinusoidal endothelial cells", "CELL", 88, 116], ["stellate cell-derived myofibroblasts", "CELL", 144, 180], ["bile duct", "MULTI-TISSUE_STRUCTURE", 200, 209], ["portal tracts", "PATHOLOGICAL_FORMATION", 247, 260], ["septa", "TISSUE", 289, 294], ["parenchyma", "TISSUE", 314, 324], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 357, 370], ["central veins", "MULTI-TISSUE_STRUCTURE", 374, 387], ["endothelin-1", "PROTEIN", 62, 74], ["sinusoidal endothelial cells", "CELL_TYPE", 88, 116], ["stellate cell-derived myofibroblasts", "CELL_TYPE", 144, 180], ["active fibrosis", "PROBLEM", 7, 22], ["cirrhosis", "PROBLEM", 27, 36], ["an increase of endothelin", "PROBLEM", 47, 72], ["sinusoidal endothelial cells", "PROBLEM", 88, 116], ["Ductular reaction", "PROBLEM", 181, 198], ["bile duct hyperplasia)Fibrosis", "PROBLEM", 200, 230], ["active", "OBSERVATION_MODIFIER", 7, 13], ["fibrosis", "OBSERVATION", 14, 22], ["cirrhosis", "OBSERVATION", 27, 36], ["increase", "OBSERVATION_MODIFIER", 50, 58], ["endothelin", "OBSERVATION", 62, 72], ["sinusoidal endothelial cells", "OBSERVATION", 88, 116], ["contraction", "OBSERVATION_MODIFIER", 125, 136], ["stellate cell", "OBSERVATION", 144, 157], ["myofibroblasts", "OBSERVATION", 166, 180], ["bile duct", "ANATOMY", 200, 209], ["hyperplasia", "OBSERVATION", 210, 221], ["Fibrosis", "OBSERVATION", 222, 230], ["portal tracts", "ANATOMY", 247, 260], ["area", "OBSERVATION_MODIFIER", 277, 281], ["septa", "OBSERVATION", 289, 294], ["parenchyma", "ANATOMY_MODIFIER", 314, 324], ["eventually", "OBSERVATION_MODIFIER", 329, 339], ["bridging", "OBSERVATION", 340, 348], ["portal tracts", "ANATOMY", 357, 370], ["central", "ANATOMY_MODIFIER", 374, 381], ["veins", "ANATOMY", 382, 387]]], ["Fibrosis in the portal tracts is primarily generated by the activity of portal fibroblasts, rather than hepatic stellate cells.", [["portal tracts", "ANATOMY", 16, 29], ["portal fibroblasts", "ANATOMY", 72, 90], ["hepatic stellate cells", "ANATOMY", 104, 126], ["Fibrosis", "DISEASE", 0, 8], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 16, 29], ["portal fibroblasts", "CELL", 72, 90], ["hepatic stellate cells", "CELL", 104, 126], ["portal fibroblasts", "CELL_TYPE", 72, 90], ["hepatic stellate cells", "CELL_TYPE", 104, 126], ["Fibrosis in the portal tracts", "PROBLEM", 0, 29], ["portal fibroblasts", "PROBLEM", 72, 90], ["portal tracts", "ANATOMY", 16, 29], ["activity", "OBSERVATION_MODIFIER", 60, 68], ["portal fibroblasts", "ANATOMY", 72, 90], ["hepatic", "ANATOMY", 104, 111], ["stellate cells", "OBSERVATION", 112, 126]]], ["Biliary injury leads to a rapid proliferation of periductular myofibroblasts derived from portal fibroblasts and ECM production.", [["Biliary", "ANATOMY", 0, 7], ["periductular myofibroblasts", "ANATOMY", 49, 76], ["portal fibroblasts", "ANATOMY", 90, 108], ["ECM", "ANATOMY", 113, 116], ["Biliary injury", "DISEASE", 0, 14], ["Biliary", "ORGAN", 0, 7], ["periductular myofibroblasts", "CELL", 49, 76], ["portal fibroblasts", "CELL", 90, 108], ["ECM", "CELLULAR_COMPONENT", 113, 116], ["periductular myofibroblasts", "CELL_TYPE", 49, 76], ["portal fibroblasts", "CELL_TYPE", 90, 108], ["Biliary injury", "PROBLEM", 0, 14], ["a rapid proliferation", "PROBLEM", 24, 45], ["periductular myofibroblasts", "PROBLEM", 49, 76], ["portal fibroblasts", "PROBLEM", 90, 108], ["ECM production", "PROBLEM", 113, 127], ["injury", "OBSERVATION", 8, 14], ["rapid", "OBSERVATION_MODIFIER", 26, 31], ["proliferation", "OBSERVATION_MODIFIER", 32, 45], ["periductular", "OBSERVATION_MODIFIER", 49, 61], ["myofibroblasts", "OBSERVATION", 62, 76], ["portal", "ANATOMY", 90, 96], ["fibroblasts", "OBSERVATION", 97, 108], ["ECM production", "OBSERVATION", 113, 127]]], ["The volume of the portal tracts is increased by the generation of the ECM, ductular proliferation, myofibroblast proliferation, and edema.Ductular reaction (bile duct hyperplasia)Fibrosis can be less florid and more insidious when it lines the space of Disse, disrupting the normal exchange between the plasma and hepatocyte microvilli.", [["portal tracts", "ANATOMY", 18, 31], ["ECM", "ANATOMY", 70, 73], ["ductular", "ANATOMY", 75, 83], ["myofibroblast", "ANATOMY", 99, 112], ["edema", "ANATOMY", 132, 137], ["Ductular", "ANATOMY", 138, 146], ["bile duct hyperplasia", "ANATOMY", 157, 178], ["plasma", "ANATOMY", 303, 309], ["hepatocyte microvilli", "ANATOMY", 314, 335], ["edema", "DISEASE", 132, 137], ["Ductular reaction", "DISEASE", 138, 155], ["bile duct hyperplasia", "DISEASE", 157, 178], ["Fibrosis", "DISEASE", 179, 187], ["florid", "DISEASE", 200, 206], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 18, 31], ["ECM", "CELLULAR_COMPONENT", 70, 73], ["ductular", "CELL", 75, 83], ["myofibroblast", "CELL", 99, 112], ["edema", "PATHOLOGICAL_FORMATION", 132, 137], ["bile duct", "MULTI-TISSUE_STRUCTURE", 157, 166], ["plasma", "ORGANISM_SUBSTANCE", 303, 309], ["hepatocyte microvilli", "CELLULAR_COMPONENT", 314, 335], ["ductular proliferation", "PROBLEM", 75, 97], ["myofibroblast proliferation", "PROBLEM", 99, 126], ["edema", "PROBLEM", 132, 137], ["Ductular reaction", "PROBLEM", 138, 155], ["bile duct hyperplasia)Fibrosis", "PROBLEM", 157, 187], ["less florid", "PROBLEM", 195, 206], ["volume", "OBSERVATION_MODIFIER", 4, 10], ["portal tracts", "ANATOMY", 18, 31], ["increased", "OBSERVATION_MODIFIER", 35, 44], ["generation", "OBSERVATION_MODIFIER", 52, 62], ["ECM", "OBSERVATION_MODIFIER", 70, 73], ["ductular", "OBSERVATION_MODIFIER", 75, 83], ["proliferation", "OBSERVATION_MODIFIER", 84, 97], ["myofibroblast proliferation", "OBSERVATION", 99, 126], ["edema", "OBSERVATION", 132, 137], ["bile duct", "ANATOMY", 157, 166], ["hyperplasia", "OBSERVATION", 167, 178], ["Fibrosis", "OBSERVATION", 179, 187], ["less florid", "OBSERVATION_MODIFIER", 195, 206], ["insidious", "OBSERVATION_MODIFIER", 216, 225], ["Disse", "OBSERVATION", 253, 258], ["normal", "OBSERVATION", 275, 281], ["hepatocyte", "ANATOMY", 314, 324], ["microvilli", "ANATOMY_MODIFIER", 325, 335]]], ["The essential microvascular unit of the liver is the sinusoid, lined by fenestrated endothelial cells, and separated from the hepatocytes by the space of Disse.", [["microvascular unit", "ANATOMY", 14, 32], ["liver", "ANATOMY", 40, 45], ["sinusoid", "ANATOMY", 53, 61], ["endothelial cells", "ANATOMY", 84, 101], ["hepatocytes", "ANATOMY", 126, 137], ["microvascular unit", "MULTI-TISSUE_STRUCTURE", 14, 32], ["liver", "ORGAN", 40, 45], ["sinusoid", "TISSUE", 53, 61], ["endothelial cells", "CELL", 84, 101], ["hepatocytes", "CELL", 126, 137], ["fenestrated endothelial cells", "CELL_TYPE", 72, 101], ["hepatocytes", "CELL_TYPE", 126, 137], ["fenestrated endothelial cells", "PROBLEM", 72, 101], ["essential", "OBSERVATION_MODIFIER", 4, 13], ["microvascular", "OBSERVATION", 14, 27], ["liver", "ANATOMY", 40, 45], ["sinusoid", "OBSERVATION", 53, 61], ["fenestrated endothelial cells", "OBSERVATION", 72, 101], ["hepatocytes", "ANATOMY", 126, 137], ["space", "ANATOMY_MODIFIER", 145, 150], ["Disse", "OBSERVATION", 154, 159]]], ["A porous basal membrane-like matrix in the space of Disse helps to maintain the differentiated states of the hepatocytes and hepatic stellate cells that inhabit the space of Disse.", [["membrane-like matrix", "ANATOMY", 15, 35], ["hepatocytes", "ANATOMY", 109, 120], ["hepatic stellate cells", "ANATOMY", 125, 147], ["basal membrane", "CELLULAR_COMPONENT", 9, 23], ["matrix", "CELLULAR_COMPONENT", 29, 35], ["hepatocytes", "CELL", 109, 120], ["hepatic stellate cells", "CELL", 125, 147], ["hepatocytes", "CELL_TYPE", 109, 120], ["hepatic stellate cells", "CELL_TYPE", 125, 147], ["A porous basal membrane", "TREATMENT", 0, 23], ["hepatic stellate cells", "PROBLEM", 125, 147], ["porous", "OBSERVATION_MODIFIER", 2, 8], ["basal membrane", "OBSERVATION", 9, 23], ["like matrix", "OBSERVATION_MODIFIER", 24, 35], ["Disse", "OBSERVATION", 52, 57], ["hepatocytes", "ANATOMY", 109, 120], ["hepatic", "ANATOMY", 125, 132], ["stellate cells", "OBSERVATION", 133, 147], ["space", "OBSERVATION_MODIFIER", 165, 170], ["Disse", "OBSERVATION", 174, 179]]], ["When there is excess ECM lining the space of Disse, the adjacent sinusoidal endothelial cells lose their characteristic fenestrations, and the sinusoids are transformed functionally into capillaries.", [["ECM lining", "ANATOMY", 21, 31], ["sinusoidal endothelial cells", "ANATOMY", 65, 93], ["fenestrations", "ANATOMY", 120, 133], ["sinusoids", "ANATOMY", 143, 152], ["capillaries", "ANATOMY", 187, 198], ["ECM", "CELLULAR_COMPONENT", 21, 24], ["sinusoidal endothelial cells", "CELL", 65, 93], ["fenestrations", "TISSUE", 120, 133], ["sinusoids", "TISSUE", 143, 152], ["capillaries", "TISSUE", 187, 198], ["adjacent sinusoidal endothelial cells", "CELL_TYPE", 56, 93], ["the adjacent sinusoidal endothelial cells", "PROBLEM", 52, 93], ["excess", "OBSERVATION_MODIFIER", 14, 20], ["ECM", "OBSERVATION_MODIFIER", 21, 24], ["lining", "OBSERVATION_MODIFIER", 25, 31], ["space", "ANATOMY_MODIFIER", 36, 41], ["Disse", "OBSERVATION", 45, 50], ["adjacent", "ANATOMY_MODIFIER", 56, 64], ["sinusoidal endothelial cells", "OBSERVATION", 65, 93], ["characteristic", "OBSERVATION_MODIFIER", 105, 119], ["fenestrations", "OBSERVATION_MODIFIER", 120, 133], ["sinusoids", "ANATOMY", 143, 152], ["capillaries", "OBSERVATION_MODIFIER", 187, 198]]], ["This process is known as capillarization and leads to significantly impaired exchange between the hepatocytes and the plasma.", [["hepatocytes", "ANATOMY", 98, 109], ["plasma", "ANATOMY", 118, 124], ["hepatocytes", "CELL", 98, 109], ["plasma", "ORGANISM_SUBSTANCE", 118, 124], ["hepatocytes", "CELL_TYPE", 98, 109], ["significantly impaired exchange between the hepatocytes", "PROBLEM", 54, 109], ["the plasma", "TEST", 114, 124], ["significantly", "OBSERVATION_MODIFIER", 54, 67], ["impaired", "OBSERVATION", 68, 76], ["hepatocytes", "ANATOMY", 98, 109]]], ["This causes diminished hepatic function when the lesion is extensive.", [["hepatic", "ANATOMY", 23, 30], ["lesion", "ANATOMY", 49, 55], ["hepatic", "ORGAN", 23, 30], ["diminished hepatic function", "PROBLEM", 12, 39], ["the lesion", "PROBLEM", 45, 55], ["diminished", "OBSERVATION_MODIFIER", 12, 22], ["hepatic", "ANATOMY", 23, 30], ["lesion", "OBSERVATION", 49, 55], ["extensive", "OBSERVATION_MODIFIER", 59, 68]]], ["The cells responsible for the ECM deposition are primarily in the myofibroblast family, including hepatic stellate cells.Ductular reaction (bile duct hyperplasia)Because collagen has a finite half-life, and as hepatic fibrosis exists in a balance of synthesis and removal, it is potentially reversible.", [["cells", "ANATOMY", 4, 9], ["ECM", "ANATOMY", 30, 33], ["myofibroblast family", "ANATOMY", 66, 86], ["hepatic stellate cells", "ANATOMY", 98, 120], ["Ductular", "ANATOMY", 121, 129], ["bile duct", "ANATOMY", 140, 149], ["hepatic", "ANATOMY", 210, 217], ["Ductular reaction", "DISEASE", 121, 138], ["bile duct hyperplasia", "DISEASE", 140, 161], ["fibrosis", "DISEASE", 218, 226], ["cells", "CELL", 4, 9], ["ECM", "CELLULAR_COMPONENT", 30, 33], ["myofibroblast", "CELL", 66, 79], ["hepatic stellate cells", "CELL", 98, 120], ["bile duct", "MULTI-TISSUE_STRUCTURE", 140, 149], ["collagen", "GENE_OR_GENE_PRODUCT", 170, 178], ["hepatic", "ORGAN", 210, 217], ["hepatic stellate cells", "CELL_TYPE", 98, 120], ["collagen", "PROTEIN", 170, 178], ["the ECM deposition", "PROBLEM", 26, 44], ["hepatic stellate cells", "PROBLEM", 98, 120], ["Ductular reaction (bile duct hyperplasia", "PROBLEM", 121, 161], ["hepatic fibrosis", "PROBLEM", 210, 226], ["synthesis", "TREATMENT", 250, 259], ["removal", "TREATMENT", 264, 271], ["ECM deposition", "OBSERVATION", 30, 44], ["myofibroblast", "OBSERVATION", 66, 79], ["hepatic", "ANATOMY", 98, 105], ["stellate cells", "OBSERVATION", 106, 120], ["bile duct", "ANATOMY", 140, 149], ["hyperplasia", "OBSERVATION", 150, 161], ["hepatic", "ANATOMY", 210, 217], ["fibrosis", "OBSERVATION", 218, 226], ["potentially reversible", "UNCERTAINTY", 279, 301]]], ["Elimination of the source of injury or successful therapy can lead to stellate cell apoptosis and a reduction in the synthesis of inhibitors of the enzymes responsible for the degradation of the collagen and other ECM elements, primarily matrix metalloproteinases.", [["stellate cell", "ANATOMY", 70, 83], ["ECM", "ANATOMY", 214, 217], ["stellate cell", "CELL", 70, 83], ["collagen", "GENE_OR_GENE_PRODUCT", 195, 203], ["ECM elements", "CELLULAR_COMPONENT", 214, 226], ["matrix metalloproteinases", "GENE_OR_GENE_PRODUCT", 238, 263], ["collagen", "PROTEIN", 195, 203], ["ECM elements", "DNA", 214, 226], ["matrix metalloproteinases", "PROTEIN", 238, 263], ["injury", "PROBLEM", 29, 35], ["successful therapy", "TREATMENT", 39, 57], ["stellate cell apoptosis", "PROBLEM", 70, 93], ["a reduction", "TREATMENT", 98, 109], ["the synthesis of inhibitors", "TREATMENT", 113, 140], ["the enzymes", "TEST", 144, 155], ["the degradation of the collagen and other ECM elements", "PROBLEM", 172, 226], ["injury", "OBSERVATION", 29, 35], ["stellate cell apoptosis", "OBSERVATION", 70, 93], ["reduction", "OBSERVATION_MODIFIER", 100, 109]]], ["This has been demonstrated in rodent models of hepatic fibrosis produced by bile duct ligation, and models using carbon tetrachloride.", [["hepatic", "ANATOMY", 47, 54], ["bile duct", "ANATOMY", 76, 85], ["hepatic fibrosis", "DISEASE", 47, 63], ["carbon tetrachloride", "CHEMICAL", 113, 133], ["carbon tetrachloride", "CHEMICAL", 113, 133], ["hepatic", "ORGAN", 47, 54], ["bile duct", "MULTI-TISSUE_STRUCTURE", 76, 85], ["carbon tetrachloride", "SIMPLE_CHEMICAL", 113, 133], ["hepatic fibrosis", "PROBLEM", 47, 63], ["bile duct ligation", "TREATMENT", 76, 94], ["carbon tetrachloride", "TREATMENT", 113, 133], ["hepatic", "ANATOMY", 47, 54], ["fibrosis", "OBSERVATION", 55, 63], ["bile duct", "ANATOMY", 76, 85], ["ligation", "OBSERVATION", 86, 94]]], ["However, over time, collagen can mature and fibrils can cross-link and become resistant to enzymatic degradation, leading to permanent fibrosis.", [["fibrils", "ANATOMY", 44, 51], ["fibrosis", "DISEASE", 135, 143], ["collagen", "GENE_OR_GENE_PRODUCT", 20, 28], ["collagen", "PROTEIN", 20, 28], ["fibrils", "PROBLEM", 44, 51], ["enzymatic degradation", "PROBLEM", 91, 112], ["permanent fibrosis", "PROBLEM", 125, 143], ["permanent", "OBSERVATION_MODIFIER", 125, 134], ["fibrosis", "OBSERVATION", 135, 143]]], ["Long-term or permanent fibrotic changes can also be caused by severe acute injury that leads to an initial focus of fibrosis and is so severe that it affects local vascular supply.Ductular reaction (bile duct hyperplasia)The distribution of fibrosis in the liver can reflect the pathogenesis of the injury responsible. bacterial infection.", [["vascular", "ANATOMY", 164, 172], ["Ductular", "ANATOMY", 180, 188], ["bile duct", "ANATOMY", 199, 208], ["liver", "ANATOMY", 257, 262], ["fibrosis", "DISEASE", 116, 124], ["Ductular reaction", "DISEASE", 180, 197], ["bile duct hyperplasia", "DISEASE", 199, 220], ["fibrosis", "DISEASE", 241, 249], ["bacterial infection", "DISEASE", 319, 338], ["vascular", "MULTI-TISSUE_STRUCTURE", 164, 172], ["bile duct", "MULTI-TISSUE_STRUCTURE", 199, 208], ["liver", "ORGAN", 257, 262], ["Long-term", "PROBLEM", 0, 9], ["permanent fibrotic changes", "PROBLEM", 13, 39], ["severe acute injury", "PROBLEM", 62, 81], ["fibrosis", "PROBLEM", 116, 124], ["Ductular reaction (bile duct hyperplasia", "PROBLEM", 180, 220], ["fibrosis in the liver", "PROBLEM", 241, 262], ["the injury", "PROBLEM", 295, 305], ["bacterial infection", "PROBLEM", 319, 338], ["-term", "OBSERVATION_MODIFIER", 4, 9], ["permanent", "OBSERVATION_MODIFIER", 13, 22], ["fibrotic", "OBSERVATION", 23, 31], ["can also be caused", "UNCERTAINTY", 40, 58], ["severe", "OBSERVATION_MODIFIER", 62, 68], ["acute", "OBSERVATION_MODIFIER", 69, 74], ["injury", "OBSERVATION", 75, 81], ["initial", "OBSERVATION_MODIFIER", 99, 106], ["focus", "OBSERVATION_MODIFIER", 107, 112], ["fibrosis", "OBSERVATION", 116, 124], ["severe", "OBSERVATION_MODIFIER", 135, 141], ["local", "OBSERVATION_MODIFIER", 158, 163], ["vascular", "ANATOMY", 164, 172], ["supply", "OBSERVATION_MODIFIER", 173, 179], ["bile duct", "ANATOMY", 199, 208], ["hyperplasia", "OBSERVATION", 209, 220], ["distribution", "OBSERVATION_MODIFIER", 225, 237], ["fibrosis", "OBSERVATION", 241, 249], ["liver", "ANATOMY", 257, 262], ["injury", "OBSERVATION", 299, 305], ["infection", "OBSERVATION", 329, 338]]], ["With persistence, the ductular reaction can contribute to portal and periportal fibrosis as the ductular cells secrete profibrogenic growth factors, cytokines, and chemokines.Ductular reaction (bile duct hyperplasia)Illustrative examples from natural disease are provided by the toxicoses of phomopsin, pyrrolizidine alkaloids, and aflatoxin, and by equine serum hepatitis and ovine white-liver disease.FibrosisHepatic fibrosis is a potentially reversible form of wound healing in which there is an accumulation of various ECM components.", [["ductular", "ANATOMY", 22, 30], ["portal", "ANATOMY", 58, 64], ["periportal", "ANATOMY", 69, 79], ["ductular cells", "ANATOMY", 96, 110], ["Ductular", "ANATOMY", 175, 183], ["bile duct", "ANATOMY", 194, 203], ["serum", "ANATOMY", 357, 362], ["liver", "ANATOMY", 389, 394], ["wound", "ANATOMY", 464, 469], ["ECM", "ANATOMY", 523, 526], ["fibrosis", "DISEASE", 80, 88], ["Ductular reaction", "DISEASE", 175, 192], ["bile duct hyperplasia", "DISEASE", 194, 215], ["phomopsin", "CHEMICAL", 292, 301], ["pyrrolizidine alkaloids", "CHEMICAL", 303, 326], ["aflatoxin", "CHEMICAL", 332, 341], ["serum hepatitis", "DISEASE", 357, 372], ["white-liver disease", "DISEASE", 383, 402], ["fibrosis", "DISEASE", 419, 427], ["phomopsin", "CHEMICAL", 292, 301], ["pyrrolizidine alkaloids", "CHEMICAL", 303, 326], ["aflatoxin", "CHEMICAL", 332, 341], ["ductular", "MULTI-TISSUE_STRUCTURE", 22, 30], ["portal", "MULTI-TISSUE_STRUCTURE", 58, 64], ["periportal", "MULTI-TISSUE_STRUCTURE", 69, 79], ["ductular cells", "CELL", 96, 110], ["bile duct", "MULTI-TISSUE_STRUCTURE", 194, 203], ["phomopsin", "SIMPLE_CHEMICAL", 292, 301], ["pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 303, 326], ["aflatoxin", "SIMPLE_CHEMICAL", 332, 341], ["equine", "ORGANISM", 350, 356], ["serum", "ORGANISM_SUBSTANCE", 357, 362], ["hepatitis", "ORGANISM", 363, 372], ["ovine", "ORGANISM", 377, 382], ["liver", "ORGAN", 389, 394], ["wound", "PATHOLOGICAL_FORMATION", 464, 469], ["ECM components", "CELLULAR_COMPONENT", 523, 537], ["ductular cells", "CELL_TYPE", 96, 110], ["profibrogenic growth factors", "PROTEIN", 119, 147], ["cytokines", "PROTEIN", 149, 158], ["chemokines", "PROTEIN", 164, 174], ["ECM components", "PROTEIN", 523, 537], ["equine", "SPECIES", 350, 356], ["the ductular reaction", "PROBLEM", 18, 39], ["portal and periportal fibrosis", "PROBLEM", 58, 88], ["the ductular cells secrete profibrogenic growth factors", "PROBLEM", 92, 147], ["cytokines", "TREATMENT", 149, 158], ["chemokines", "TREATMENT", 164, 174], ["Ductular reaction", "PROBLEM", 175, 192], ["bile duct hyperplasia", "PROBLEM", 194, 215], ["natural disease", "PROBLEM", 243, 258], ["phomopsin", "TREATMENT", 292, 301], ["pyrrolizidine alkaloids", "TREATMENT", 303, 326], ["aflatoxin", "TREATMENT", 332, 341], ["equine serum hepatitis", "PROBLEM", 350, 372], ["ovine white-liver disease", "PROBLEM", 377, 402], ["FibrosisHepatic fibrosis", "PROBLEM", 403, 427], ["wound healing", "PROBLEM", 464, 477], ["an accumulation of various ECM components", "PROBLEM", 496, 537], ["persistence", "OBSERVATION_MODIFIER", 5, 16], ["ductular", "OBSERVATION", 22, 30], ["portal", "ANATOMY", 58, 64], ["periportal", "ANATOMY", 69, 79], ["fibrosis", "OBSERVATION", 80, 88], ["ductular cells", "OBSERVATION", 96, 110], ["secrete", "OBSERVATION_MODIFIER", 111, 118], ["profibrogenic", "OBSERVATION_MODIFIER", 119, 132], ["growth", "OBSERVATION_MODIFIER", 133, 139], ["bile duct", "ANATOMY", 194, 203], ["hyperplasia", "OBSERVATION", 204, 215], ["natural disease", "OBSERVATION", 243, 258], ["liver", "ANATOMY", 389, 394], ["disease", "OBSERVATION", 395, 402], ["fibrosis", "OBSERVATION", 419, 427], ["potentially", "UNCERTAINTY", 433, 444], ["reversible", "OBSERVATION_MODIFIER", 445, 455], ["wound", "OBSERVATION_MODIFIER", 464, 469], ["healing", "OBSERVATION", 470, 477], ["accumulation", "OBSERVATION_MODIFIER", 499, 511], ["various", "OBSERVATION_MODIFIER", 515, 522], ["ECM", "OBSERVATION_MODIFIER", 523, 526], ["components", "OBSERVATION_MODIFIER", 527, 537]]], ["In cases of acute or self-limited injury, fibrosis may resolve completely and normal liver architecture can be restored, but when damage is too extensive to be repaired, a scar may be permanent, and if the injury is persistent, there is progressive deposition of ECM, leading to the \"final common pathway\" and ending in fibrosis and cirrhosis.", [["liver", "ANATOMY", 85, 90], ["scar", "ANATOMY", 172, 176], ["ECM", "ANATOMY", 263, 266], ["fibrosis", "DISEASE", 42, 50], ["scar", "DISEASE", 172, 176], ["fibrosis", "DISEASE", 320, 328], ["cirrhosis", "DISEASE", 333, 342], ["liver", "ORGAN", 85, 90], ["scar", "PATHOLOGICAL_FORMATION", 172, 176], ["ECM", "CELLULAR_COMPONENT", 263, 266], ["self-limited injury", "PROBLEM", 21, 40], ["fibrosis", "PROBLEM", 42, 50], ["damage", "PROBLEM", 130, 136], ["a scar", "PROBLEM", 170, 176], ["the injury", "PROBLEM", 202, 212], ["progressive deposition of ECM", "PROBLEM", 237, 266], ["fibrosis", "PROBLEM", 320, 328], ["cirrhosis", "PROBLEM", 333, 342], ["acute", "OBSERVATION_MODIFIER", 12, 17], ["injury", "OBSERVATION", 34, 40], ["fibrosis", "OBSERVATION", 42, 50], ["normal", "OBSERVATION", 78, 84], ["liver", "ANATOMY", 85, 90], ["scar", "OBSERVATION", 172, 176], ["may be", "UNCERTAINTY", 177, 183], ["persistent", "OBSERVATION_MODIFIER", 216, 226], ["progressive", "OBSERVATION_MODIFIER", 237, 248], ["deposition", "OBSERVATION_MODIFIER", 249, 259], ["fibrosis", "OBSERVATION", 320, 328], ["cirrhosis", "OBSERVATION", 333, 342]]], ["In normal liver, the ECM exists in a state of dynamic balance, with synthesis and degradation occurring in balance to maintain normal levels of all constituents.", [["liver", "ANATOMY", 10, 15], ["ECM", "ANATOMY", 21, 24], ["liver", "ORGAN", 10, 15], ["ECM", "CELLULAR_COMPONENT", 21, 24], ["ECM", "PROTEIN", 21, 24], ["synthesis and degradation", "PROBLEM", 68, 93], ["normal", "OBSERVATION", 3, 9], ["liver", "ANATOMY", 10, 15]]], ["It is found in the portal tracts, along the sinusoids in the space of Disse, around the central vein and in Glisson's capsule.", [["portal tracts", "ANATOMY", 19, 32], ["sinusoids", "ANATOMY", 44, 53], ["central vein", "ANATOMY", 88, 100], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 19, 32], ["sinusoids", "TISSUE", 44, 53], ["central vein", "MULTI-TISSUE_STRUCTURE", 88, 100], ["Glisson's capsule", "CANCER", 108, 125], ["portal tracts", "ANATOMY", 19, 32], ["sinusoids", "ANATOMY_MODIFIER", 44, 53], ["space", "ANATOMY_MODIFIER", 61, 66], ["Disse", "OBSERVATION", 70, 75], ["central vein", "ANATOMY", 88, 100], ["capsule", "OBSERVATION_MODIFIER", 118, 125]]], ["Normally, the hepatic ECM constitutes only 3% of the relative areas on a tissue section and only 0.5% of the total liver wet weight.", [["hepatic ECM", "ANATOMY", 14, 25], ["tissue section", "ANATOMY", 73, 87], ["liver", "ANATOMY", 115, 120], ["hepatic ECM", "MULTI-TISSUE_STRUCTURE", 14, 25], ["tissue", "TISSUE", 73, 79], ["liver", "ORGAN", 115, 120], ["a tissue section", "TREATMENT", 71, 87], ["hepatic", "ANATOMY", 14, 21], ["ECM", "OBSERVATION", 22, 25], ["relative", "OBSERVATION_MODIFIER", 53, 61], ["areas", "OBSERVATION_MODIFIER", 62, 67], ["liver", "ANATOMY", 115, 120], ["wet", "OBSERVATION", 121, 124]]], ["The main constituents of the hepatic ECM are collagen, proteoglycans, laminin, fibronectin, and matricellular proteins.", [["hepatic ECM", "ANATOMY", 29, 40], ["hepatic ECM", "MULTI-TISSUE_STRUCTURE", 29, 40], ["collagen", "GENE_OR_GENE_PRODUCT", 45, 53], ["proteoglycans", "GENE_OR_GENE_PRODUCT", 55, 68], ["laminin", "GENE_OR_GENE_PRODUCT", 70, 77], ["fibronectin", "GENE_OR_GENE_PRODUCT", 79, 90], ["hepatic ECM", "PROTEIN", 29, 40], ["collagen", "PROTEIN", 45, 53], ["proteoglycans", "PROTEIN", 55, 68], ["laminin", "PROTEIN", 70, 77], ["fibronectin", "PROTEIN", 79, 90], ["matricellular proteins", "PROTEIN", 96, 118], ["laminin, fibronectin", "TREATMENT", 70, 90], ["main", "OBSERVATION_MODIFIER", 4, 8], ["hepatic", "ANATOMY", 29, 36], ["ECM", "ANATOMY_MODIFIER", 37, 40], ["collagen", "OBSERVATION", 45, 53], ["matricellular proteins", "OBSERVATION", 96, 118]]], ["In the space of Disse, the matrix is composed primarily of collagens IV and VI.", [["matrix", "ANATOMY", 27, 33], ["matrix", "CELLULAR_COMPONENT", 27, 33], ["collagens IV", "GENE_OR_GENE_PRODUCT", 59, 71], ["collagens IV and VI", "PROTEIN", 59, 78], ["space", "ANATOMY_MODIFIER", 7, 12], ["Disse", "OBSERVATION", 16, 21], ["collagens", "OBSERVATION", 59, 68]]], ["Following injury, however, fibrillar collagens I and III as well as fibronectin are deposited.", [["fibrillar collagens I", "GENE_OR_GENE_PRODUCT", 27, 48], ["fibronectin", "GENE_OR_GENE_PRODUCT", 68, 79], ["fibrillar collagens I and III", "PROTEIN", 27, 56], ["fibronectin", "PROTEIN", 68, 79], ["injury", "PROBLEM", 10, 16], ["fibrillar collagens I and III", "PROBLEM", 27, 56], ["injury", "OBSERVATION", 10, 16]]], ["These deposits disrupt the normal structure and function of the sinusoids, leading to capillarization of sinusoids, discussed later.", [["sinusoids", "ANATOMY", 64, 73], ["sinusoids", "ANATOMY", 105, 114], ["sinusoids", "TISSUE", 64, 73], ["sinusoids", "TISSUE", 105, 114], ["These deposits", "PROBLEM", 0, 14], ["capillarization of sinusoids", "PROBLEM", 86, 114], ["deposits", "OBSERVATION", 6, 14], ["normal structure", "OBSERVATION", 27, 43], ["sinusoids", "ANATOMY", 64, 73], ["capillarization", "OBSERVATION_MODIFIER", 86, 101], ["sinusoids", "OBSERVATION_MODIFIER", 105, 114]]], ["The ECM is not merely scaffolding for the liver.", [["ECM", "ANATOMY", 4, 7], ["liver", "ANATOMY", 42, 47], ["ECM", "CELLULAR_COMPONENT", 4, 7], ["liver", "ORGAN", 42, 47], ["ECM", "PROTEIN", 4, 7], ["not merely", "UNCERTAINTY", 11, 21], ["scaffolding", "OBSERVATION", 22, 33], ["liver", "ANATOMY", 42, 47]]], ["It also functions as a repository for various growth factors and metalloproteinases in latent form, and it can bind a variety of survival factors, such as hepatocyte growth factor and TNF-\u03b1, that may protect the growth factors and inhibit hepatocyte apoptosis.", [["hepatocyte", "ANATOMY", 239, 249], ["metalloproteinases", "GENE_OR_GENE_PRODUCT", 65, 83], ["hepatocyte growth factor", "GENE_OR_GENE_PRODUCT", 155, 179], ["TNF-\u03b1", "GENE_OR_GENE_PRODUCT", 184, 189], ["hepatocyte", "CELL", 239, 249], ["growth factors", "PROTEIN", 46, 60], ["metalloproteinases", "PROTEIN", 65, 83], ["survival factors", "PROTEIN", 129, 145], ["hepatocyte growth factor", "PROTEIN", 155, 179], ["TNF-\u03b1", "PROTEIN", 184, 189], ["growth factors", "PROTEIN", 212, 226], ["various growth factors", "PROBLEM", 38, 60], ["metalloproteinases", "PROBLEM", 65, 83], ["survival factors", "PROBLEM", 129, 145], ["hepatocyte growth factor", "TEST", 155, 179], ["TNF", "TEST", 184, 187], ["the growth factors", "PROBLEM", 208, 226], ["hepatocyte apoptosis", "PROBLEM", 239, 259], ["hepatocyte apoptosis", "OBSERVATION", 239, 259]]], ["In addition, interactions between cells and the ECM can affect the phenotype of the hepatocytes and stellate cells and the composition of the ECM.", [["cells", "ANATOMY", 34, 39], ["ECM", "ANATOMY", 48, 51], ["hepatocytes", "ANATOMY", 84, 95], ["stellate cells", "ANATOMY", 100, 114], ["ECM", "ANATOMY", 142, 145], ["cells", "CELL", 34, 39], ["ECM", "CELLULAR_COMPONENT", 48, 51], ["hepatocytes", "CELL", 84, 95], ["stellate cells", "CELL", 100, 114], ["ECM", "CELLULAR_COMPONENT", 142, 145], ["ECM", "PROTEIN", 48, 51], ["hepatocytes", "CELL_TYPE", 84, 95], ["stellate cells", "CELL_TYPE", 100, 114], ["hepatocytes", "ANATOMY", 84, 95], ["stellate cells", "OBSERVATION", 100, 114]]], ["Thus the process of hepatic fibrosis is distinct from the condensation of the hepatic reticular framework that can be seen following hepatocyte loss.FibrosisThe process of ECM production in the injured liver is initiated by a process that activates hepatic mesenchymal cells into myofibroblasts.", [["hepatic", "ANATOMY", 20, 27], ["hepatic reticular", "ANATOMY", 78, 95], ["hepatocyte", "ANATOMY", 133, 143], ["ECM", "ANATOMY", 172, 175], ["liver", "ANATOMY", 202, 207], ["hepatic mesenchymal cells", "ANATOMY", 249, 274], ["myofibroblasts", "ANATOMY", 280, 294], ["fibrosis", "DISEASE", 28, 36], ["hepatocyte loss", "DISEASE", 133, 148], ["Fibrosis", "DISEASE", 149, 157], ["hepatic", "ORGAN", 20, 27], ["hepatic reticular", "MULTI-TISSUE_STRUCTURE", 78, 95], ["hepatocyte", "CELL", 133, 143], ["ECM", "CELLULAR_COMPONENT", 172, 175], ["liver", "ORGAN", 202, 207], ["hepatic mesenchymal cells", "CELL", 249, 274], ["myofibroblasts", "CELL", 280, 294], ["ECM", "PROTEIN", 172, 175], ["hepatic mesenchymal cells", "CELL_TYPE", 249, 274], ["myofibroblasts", "CELL_TYPE", 280, 294], ["hepatic fibrosis", "PROBLEM", 20, 36], ["the condensation of the hepatic reticular framework", "PROBLEM", 54, 105], ["hepatocyte loss", "PROBLEM", 133, 148], ["Fibrosis", "PROBLEM", 149, 157], ["ECM production in the injured liver", "PROBLEM", 172, 207], ["hepatic", "ANATOMY", 20, 27], ["fibrosis", "OBSERVATION", 28, 36], ["distinct", "OBSERVATION_MODIFIER", 40, 48], ["hepatic", "ANATOMY", 78, 85], ["reticular", "ANATOMY_MODIFIER", 86, 95], ["can be seen", "UNCERTAINTY", 111, 122], ["hepatocyte loss", "OBSERVATION", 133, 148], ["ECM production", "OBSERVATION", 172, 186], ["injured", "ANATOMY_MODIFIER", 194, 201], ["liver", "ANATOMY", 202, 207], ["hepatic", "ANATOMY", 249, 256], ["mesenchymal cells", "OBSERVATION", 257, 274], ["myofibroblasts", "OBSERVATION", 280, 294]]], ["These mesenchymal cells constitute a prototypical mesenchymal cell type that mediates injury and repair in a number of tissues, including the kidney, skin, lung, and bone marrow.", [["mesenchymal cells", "ANATOMY", 6, 23], ["mesenchymal cell type", "ANATOMY", 50, 71], ["tissues", "ANATOMY", 119, 126], ["kidney", "ANATOMY", 142, 148], ["skin", "ANATOMY", 150, 154], ["lung", "ANATOMY", 156, 160], ["bone marrow", "ANATOMY", 166, 177], ["mesenchymal cells", "CELL", 6, 23], ["mesenchymal cell type", "CELL", 50, 71], ["tissues", "TISSUE", 119, 126], ["kidney", "ORGAN", 142, 148], ["skin", "ORGAN", 150, 154], ["lung", "ORGAN", 156, 160], ["bone marrow", "MULTI-TISSUE_STRUCTURE", 166, 177], ["mesenchymal cells", "CELL_TYPE", 6, 23], ["These mesenchymal cells", "PROBLEM", 0, 23], ["a prototypical mesenchymal cell type", "PROBLEM", 35, 71], ["injury", "PROBLEM", 86, 92], ["repair", "TREATMENT", 97, 103], ["the kidney, skin, lung, and bone marrow", "PROBLEM", 138, 177], ["mesenchymal cells", "OBSERVATION", 6, 23], ["prototypical", "OBSERVATION_MODIFIER", 37, 49], ["mesenchymal cell type", "OBSERVATION", 50, 71], ["injury", "OBSERVATION", 86, 92], ["repair", "OBSERVATION", 97, 103], ["kidney", "ANATOMY", 142, 148], ["skin", "ANATOMY", 150, 154], ["lung", "ANATOMY", 156, 160], ["bone marrow", "ANATOMY", 166, 177]]], ["All of these cell types have the ability to produce ECM, and have contractile ability.", [["cell", "ANATOMY", 13, 17], ["ECM", "ANATOMY", 52, 55], ["cell", "CELL", 13, 17], ["ECM", "CELLULAR_COMPONENT", 52, 55], ["ECM", "PROTEIN", 52, 55], ["cell types", "OBSERVATION", 13, 23]]], ["The best recognized group in this family is the hepatic stellate cells, but there are other important groups in this family, including portal fibroblasts, bone marrow-derived cells, and, via epithelial-mesenchymal transition, hepatocytes that can acquire a mesenchymal phenotype.", [["hepatic stellate cells", "ANATOMY", 48, 70], ["portal fibroblasts", "ANATOMY", 135, 153], ["bone marrow-derived cells", "ANATOMY", 155, 180], ["epithelial", "ANATOMY", 191, 201], ["mesenchymal", "ANATOMY", 202, 213], ["hepatocytes", "ANATOMY", 226, 237], ["mesenchymal", "ANATOMY", 257, 268], ["hepatic stellate cells", "CELL", 48, 70], ["portal fibroblasts", "CELL", 135, 153], ["bone marrow-derived cells", "CELL", 155, 180], ["epithelial", "CELL", 191, 201], ["mesenchymal", "CELL", 202, 213], ["hepatocytes", "CELL", 226, 237], ["mesenchymal", "CELL", 257, 268], ["hepatic stellate cells", "CELL_TYPE", 48, 70], ["portal fibroblasts", "CELL_TYPE", 135, 153], ["bone marrow-derived cells", "CELL_TYPE", 155, 180], ["hepatocytes", "CELL_TYPE", 226, 237], ["portal fibroblasts", "PROBLEM", 135, 153], ["a mesenchymal phenotype", "PROBLEM", 255, 278], ["hepatic", "ANATOMY", 48, 55], ["stellate cells", "OBSERVATION", 56, 70], ["portal fibroblasts", "ANATOMY", 135, 153], ["bone marrow", "ANATOMY", 155, 166], ["epithelial", "ANATOMY_MODIFIER", 191, 201], ["mesenchymal transition", "OBSERVATION", 202, 224], ["hepatocytes", "ANATOMY", 226, 237], ["mesenchymal phenotype", "OBSERVATION", 257, 278]]], ["Portal fibroblasts, particularly those surrounding the bile ducts, are an important source of ECM formation in the portal tracts.", [["Portal fibroblasts", "ANATOMY", 0, 18], ["bile ducts", "ANATOMY", 55, 65], ["ECM", "ANATOMY", 94, 97], ["portal tracts", "ANATOMY", 115, 128], ["Portal fibroblasts", "CELL", 0, 18], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 55, 65], ["ECM", "CELLULAR_COMPONENT", 94, 97], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 115, 128], ["Portal fibroblasts", "CELL_TYPE", 0, 18], ["Portal fibroblasts", "PROBLEM", 0, 18], ["ECM formation in the portal tracts", "PROBLEM", 94, 128], ["fibroblasts", "OBSERVATION", 7, 18], ["bile ducts", "ANATOMY", 55, 65], ["ECM formation", "OBSERVATION", 94, 107], ["portal tracts", "ANATOMY", 115, 128]]], ["This is particularly evident in cases of biliary tree injury.", [["biliary tree", "ANATOMY", 41, 53], ["biliary tree injury", "DISEASE", 41, 60], ["biliary tree", "MULTI-TISSUE_STRUCTURE", 41, 53], ["biliary tree injury", "PROBLEM", 41, 60], ["biliary", "ANATOMY", 41, 48], ["tree", "ANATOMY_MODIFIER", 49, 53], ["injury", "OBSERVATION", 54, 60]]], ["Portal fibroblasts/myofibroblasts are distinct from stellate cells based on distinct protein markers.FibrosisHepatic stellate cells are found in the space of Disse, often between hepatocytes.", [["Portal fibroblasts", "ANATOMY", 0, 18], ["myofibroblasts", "ANATOMY", 19, 33], ["stellate cells", "ANATOMY", 52, 66], ["Hepatic stellate cells", "ANATOMY", 109, 131], ["hepatocytes", "ANATOMY", 179, 190], ["Fibrosis", "DISEASE", 101, 109], ["Portal fibroblasts", "CELL", 0, 18], ["myofibroblasts", "CELL", 19, 33], ["stellate cells", "CELL", 52, 66], ["Hepatic stellate cells", "CELL", 109, 131], ["hepatocytes", "CELL", 179, 190], ["Portal fibroblasts", "CELL_TYPE", 0, 18], ["myofibroblasts", "CELL_TYPE", 19, 33], ["stellate cells", "CELL_TYPE", 52, 66], ["protein markers", "PROTEIN", 85, 100], ["Hepatic stellate cells", "CELL_TYPE", 109, 131], ["hepatocytes", "CELL_TYPE", 179, 190], ["Portal fibroblasts/myofibroblasts", "PROBLEM", 0, 33], ["stellate cells", "PROBLEM", 52, 66], ["distinct protein markers", "TEST", 76, 100], ["FibrosisHepatic stellate cells", "PROBLEM", 101, 131], ["fibroblasts", "OBSERVATION", 7, 18], ["myofibroblasts", "OBSERVATION", 19, 33], ["stellate cells", "OBSERVATION", 52, 66], ["distinct", "OBSERVATION_MODIFIER", 76, 84], ["protein markers", "OBSERVATION", 85, 100], ["Hepatic", "ANATOMY", 109, 116], ["stellate cells", "OBSERVATION", 117, 131], ["space", "ANATOMY_MODIFIER", 149, 154], ["Disse", "ANATOMY_MODIFIER", 158, 163], ["hepatocytes", "ANATOMY", 179, 190]]], ["In normal circumstances, these cells store lipid, primarily vitamin A (retinyl esters), in characteristic large round vacuoles.", [["cells", "ANATOMY", 31, 36], ["round vacuoles", "ANATOMY", 112, 126], ["vitamin A", "CHEMICAL", 60, 69], ["retinyl esters", "CHEMICAL", 71, 85], ["vitamin A", "CHEMICAL", 60, 69], ["retinyl esters", "CHEMICAL", 71, 85], ["cells", "CELL", 31, 36], ["lipid", "SIMPLE_CHEMICAL", 43, 48], ["vitamin A", "SIMPLE_CHEMICAL", 60, 69], ["retinyl esters", "SIMPLE_CHEMICAL", 71, 85], ["vacuoles", "CELLULAR_COMPONENT", 118, 126], ["vitamin A (retinyl esters", "TEST", 60, 85], ["normal circumstances", "OBSERVATION", 3, 23], ["large", "OBSERVATION_MODIFIER", 106, 111], ["round vacuoles", "OBSERVATION", 112, 126]]], ["In injured liver, hepatic stellate cells become activated.", [["liver", "ANATOMY", 11, 16], ["hepatic stellate cells", "ANATOMY", 18, 40], ["liver", "ORGAN", 11, 16], ["hepatic stellate cells", "CELL", 18, 40], ["hepatic stellate cells", "CELL_TYPE", 18, 40], ["injured", "OBSERVATION", 3, 10], ["liver", "ANATOMY", 11, 16], ["hepatic", "ANATOMY", 18, 25], ["stellate cells", "OBSERVATION", 26, 40]]], ["A principal morphologic change involves the loss of the lipid vacuole and transformation into a lobules bridges connective-tissue tracts in portal areas and hepatic venules to produce pseudolobulation, in which small areas of parenchyma are separated by a pattern of fibrosis on the scale of true lobules.", [["lipid vacuole", "ANATOMY", 56, 69], ["lobules", "ANATOMY", 96, 103], ["connective-tissue tracts", "ANATOMY", 112, 136], ["portal areas", "ANATOMY", 140, 152], ["hepatic venules", "ANATOMY", 157, 172], ["parenchyma", "ANATOMY", 226, 236], ["lobules", "ANATOMY", 297, 304], ["fibrosis", "DISEASE", 267, 275], ["lipid vacuole", "CELLULAR_COMPONENT", 56, 69], ["lobules", "TISSUE", 96, 103], ["connective-tissue tracts", "TISSUE", 112, 136], ["portal areas", "MULTI-TISSUE_STRUCTURE", 140, 152], ["hepatic venules", "MULTI-TISSUE_STRUCTURE", 157, 172], ["parenchyma", "TISSUE", 226, 236], ["lobules", "MULTI-TISSUE_STRUCTURE", 297, 304], ["hepatic venules", "CELL_TYPE", 157, 172], ["A principal morphologic change", "PROBLEM", 0, 30], ["the loss of the lipid vacuole", "PROBLEM", 40, 69], ["a lobules bridges connective-tissue tracts", "PROBLEM", 94, 136], ["pseudolobulation", "PROBLEM", 184, 200], ["fibrosis", "PROBLEM", 267, 275], ["true lobules", "PROBLEM", 292, 304], ["principal", "OBSERVATION_MODIFIER", 2, 11], ["morphologic change", "OBSERVATION", 12, 30], ["loss", "OBSERVATION_MODIFIER", 44, 48], ["lipid vacuole", "OBSERVATION", 56, 69], ["lobules", "OBSERVATION_MODIFIER", 96, 103], ["bridges", "OBSERVATION_MODIFIER", 104, 111], ["connective", "OBSERVATION_MODIFIER", 112, 122], ["-tissue", "OBSERVATION_MODIFIER", 122, 129], ["tracts", "ANATOMY_MODIFIER", 130, 136], ["portal", "ANATOMY", 140, 146], ["areas", "ANATOMY_MODIFIER", 147, 152], ["hepatic", "ANATOMY", 157, 164], ["venules", "ANATOMY_MODIFIER", 165, 172], ["pseudolobulation", "OBSERVATION", 184, 200], ["small", "OBSERVATION_MODIFIER", 211, 216], ["areas", "OBSERVATION_MODIFIER", 217, 222], ["parenchyma", "ANATOMY_MODIFIER", 226, 236], ["pattern", "OBSERVATION_MODIFIER", 256, 263], ["fibrosis", "OBSERVATION", 267, 275], ["true lobules", "OBSERVATION", 292, 304]]], ["This pattern of fibrosis can lead to capillarization of sinusoids, or intrahepatic bypass of portal and arterial blood, both of which can reduce the influences of growth factors and nutrients on liver regeneration.", [["sinusoids", "ANATOMY", 56, 65], ["intrahepatic", "ANATOMY", 70, 82], ["portal", "ANATOMY", 93, 99], ["arterial blood", "ANATOMY", 104, 118], ["liver", "ANATOMY", 195, 200], ["fibrosis", "DISEASE", 16, 24], ["sinusoids", "MULTI-TISSUE_STRUCTURE", 56, 65], ["portal", "MULTI-TISSUE_STRUCTURE", 93, 99], ["arterial blood", "MULTI-TISSUE_STRUCTURE", 104, 118], ["liver", "ORGAN", 195, 200], ["growth factors", "PROTEIN", 163, 177], ["fibrosis", "PROBLEM", 16, 24], ["capillarization of sinusoids", "PROBLEM", 37, 65], ["intrahepatic bypass", "TREATMENT", 70, 89], ["portal and arterial blood", "PROBLEM", 93, 118], ["growth factors", "PROBLEM", 163, 177], ["liver regeneration", "TREATMENT", 195, 213], ["fibrosis", "OBSERVATION", 16, 24], ["sinusoids", "OBSERVATION", 56, 65], ["intrahepatic", "ANATOMY_MODIFIER", 70, 82], ["bypass", "OBSERVATION", 83, 89], ["portal", "ANATOMY", 93, 99], ["arterial blood", "ANATOMY", 104, 118], ["liver", "ANATOMY", 195, 200], ["regeneration", "OBSERVATION", 201, 213]]], ["The accompanying hypoxia is important in the genesis of the hepatocellular atrophy that is almost always concomitant with diffuse hepatic fibrosis.Fibrosis\u2022 Centrilobular (periacinar) fibrosis is the most common pattern following zonal necrosis in hypoxic and toxic injury.", [["hepatocellular", "ANATOMY", 60, 74], ["hepatic", "ANATOMY", 130, 137], ["Centrilobular", "ANATOMY", 157, 170], ["periacinar", "ANATOMY", 172, 182], ["hypoxia", "DISEASE", 17, 24], ["hepatocellular atrophy", "DISEASE", 60, 82], ["hepatic fibrosis", "DISEASE", 130, 146], ["Fibrosis", "DISEASE", 147, 155], ["fibrosis", "DISEASE", 184, 192], ["necrosis", "DISEASE", 236, 244], ["toxic injury", "DISEASE", 260, 272], ["hepatocellular", "ORGAN", 60, 74], ["hepatic", "ORGAN", 130, 137], ["The accompanying hypoxia", "PROBLEM", 0, 24], ["the hepatocellular atrophy", "PROBLEM", 56, 82], ["diffuse hepatic fibrosis", "PROBLEM", 122, 146], ["Fibrosis", "PROBLEM", 147, 155], ["Centrilobular (periacinar) fibrosis", "PROBLEM", 157, 192], ["zonal necrosis", "PROBLEM", 230, 244], ["hypoxic and toxic injury", "PROBLEM", 248, 272], ["hypoxia", "OBSERVATION", 17, 24], ["hepatocellular", "ANATOMY", 60, 74], ["atrophy", "OBSERVATION", 75, 82], ["diffuse", "OBSERVATION_MODIFIER", 122, 129], ["hepatic", "ANATOMY", 130, 137], ["fibrosis", "OBSERVATION", 138, 146], ["Centrilobular", "OBSERVATION_MODIFIER", 157, 170], ["fibrosis", "OBSERVATION", 184, 192], ["most common", "OBSERVATION_MODIFIER", 200, 211], ["zonal", "OBSERVATION_MODIFIER", 230, 235], ["necrosis", "OBSERVATION", 236, 244], ["hypoxic", "OBSERVATION_MODIFIER", 248, 255], ["toxic", "OBSERVATION_MODIFIER", 260, 265], ["injury", "OBSERVATION", 266, 272]]], ["Good examples are seen in animals with prolonged passive venous congestion of the liver, especially when this is caused by extracardiac sources of increased venous pressure, rather than to congestive heart failure ( Fig. 2-45 ).FibrosisOtherwise, this pattern of fibrosis is a response to toxic injury; poisoning by pyrrolizidine alkaloids may cause it in ruminants, and extraordinary development of periacinar fibrosis may follow accidental exposure to nitrosamines in several species.CirrhosisCirrhosis has several definitions, and consensus regarding the essential features is difficult to obtain.", [["venous", "ANATOMY", 57, 63], ["liver", "ANATOMY", 82, 87], ["extracardiac", "ANATOMY", 123, 135], ["venous", "ANATOMY", 157, 163], ["heart", "ANATOMY", 200, 205], ["periacinar", "ANATOMY", 400, 410], ["venous congestion of the liver", "DISEASE", 57, 87], ["congestive heart failure", "DISEASE", 189, 213], ["fibrosis", "DISEASE", 263, 271], ["toxic injury", "DISEASE", 289, 301], ["poisoning", "DISEASE", 303, 312], ["pyrrolizidine alkaloids", "CHEMICAL", 316, 339], ["fibrosis", "DISEASE", 411, 419], ["nitrosamines", "CHEMICAL", 454, 466], ["CirrhosisCirrhosis", "DISEASE", 486, 504], ["pyrrolizidine alkaloids", "CHEMICAL", 316, 339], ["nitrosamines", "CHEMICAL", 454, 466], ["venous", "ORGANISM_SUBDIVISION", 57, 63], ["liver", "ORGAN", 82, 87], ["venous", "MULTI-TISSUE_STRUCTURE", 157, 163], ["heart", "ORGAN", 200, 205], ["pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 316, 339], ["nitrosamines", "SIMPLE_CHEMICAL", 454, 466], ["prolonged passive venous congestion of the liver", "PROBLEM", 39, 87], ["increased venous pressure", "PROBLEM", 147, 172], ["congestive heart failure", "PROBLEM", 189, 213], ["fibrosis", "PROBLEM", 263, 271], ["toxic injury", "PROBLEM", 289, 301], ["pyrrolizidine alkaloids", "TREATMENT", 316, 339], ["periacinar fibrosis", "PROBLEM", 400, 419], ["nitrosamines", "TREATMENT", 454, 466], ["CirrhosisCirrhosis", "PROBLEM", 486, 504], ["prolonged", "OBSERVATION_MODIFIER", 39, 48], ["passive", "OBSERVATION", 49, 56], ["venous", "ANATOMY", 57, 63], ["congestion", "OBSERVATION", 64, 74], ["liver", "ANATOMY", 82, 87], ["extracardiac", "ANATOMY", 123, 135], ["increased", "OBSERVATION", 147, 156], ["venous pressure", "OBSERVATION", 157, 172], ["congestive", "OBSERVATION_MODIFIER", 189, 199], ["heart", "ANATOMY", 200, 205], ["failure", "OBSERVATION", 206, 213], ["fibrosis", "OBSERVATION", 263, 271], ["toxic", "OBSERVATION_MODIFIER", 289, 294], ["injury", "OBSERVATION", 295, 301], ["periacinar", "OBSERVATION_MODIFIER", 400, 410], ["fibrosis", "OBSERVATION", 411, 419]]], ["In general, it is agreed that cirrhosis is not merely an end stage of ECM accumulation in the liver, but, in fact, is a multifaceted distortion of hepatic parenchymal architecture and hepatic vascular anatomy.", [["ECM", "ANATOMY", 70, 73], ["liver", "ANATOMY", 94, 99], ["hepatic parenchymal", "ANATOMY", 147, 166], ["hepatic vascular", "ANATOMY", 184, 200], ["cirrhosis", "DISEASE", 30, 39], ["ECM", "CELLULAR_COMPONENT", 70, 73], ["liver", "ORGAN", 94, 99], ["hepatic parenchymal", "MULTI-TISSUE_STRUCTURE", 147, 166], ["hepatic vascular", "MULTI-TISSUE_STRUCTURE", 184, 200], ["cirrhosis", "PROBLEM", 30, 39], ["ECM accumulation in the liver", "PROBLEM", 70, 99], ["a multifaceted distortion of hepatic parenchymal architecture and hepatic vascular anatomy", "PROBLEM", 118, 208], ["cirrhosis", "OBSERVATION", 30, 39], ["ECM accumulation", "OBSERVATION", 70, 86], ["liver", "ANATOMY", 94, 99], ["multifaceted", "OBSERVATION_MODIFIER", 120, 132], ["distortion", "OBSERVATION", 133, 143], ["hepatic", "ANATOMY", 147, 154], ["parenchymal", "ANATOMY_MODIFIER", 155, 166], ["architecture", "ANATOMY_MODIFIER", 167, 179], ["hepatic", "ANATOMY_MODIFIER", 184, 191], ["vascular", "ANATOMY", 192, 200], ["anatomy", "OBSERVATION", 201, 208]]], ["By one definition, cirrhosis is \"a diffuse process characterized by fibrosis and the conversion of normal liver architecture into structurally abnormal nodules.\"", [["liver", "ANATOMY", 106, 111], ["nodules", "ANATOMY", 152, 159], ["cirrhosis", "DISEASE", 19, 28], ["fibrosis", "DISEASE", 68, 76], ["liver", "ORGAN", 106, 111], ["nodules", "CANCER", 152, 159], ["cirrhosis", "PROBLEM", 19, 28], ["a diffuse process", "PROBLEM", 33, 50], ["fibrosis", "PROBLEM", 68, 76], ["structurally abnormal nodules", "PROBLEM", 130, 159], ["cirrhosis", "OBSERVATION", 19, 28], ["diffuse", "OBSERVATION_MODIFIER", 35, 42], ["process", "OBSERVATION", 43, 50], ["fibrosis", "OBSERVATION", 68, 76], ["liver", "ANATOMY", 106, 111], ["structurally", "OBSERVATION_MODIFIER", 130, 142], ["abnormal", "OBSERVATION_MODIFIER", 143, 151], ["nodules", "OBSERVATION", 152, 159]]], ["The key features are the formation of regenerative nodules of hepatocytes surrounded by fibrous septa and vascular disorders that often integrate both central veins and portal tracts.", [["regenerative nodules", "ANATOMY", 38, 58], ["hepatocytes", "ANATOMY", 62, 73], ["fibrous septa", "ANATOMY", 88, 101], ["vascular", "ANATOMY", 106, 114], ["central veins", "ANATOMY", 151, 164], ["portal tracts", "ANATOMY", 169, 182], ["vascular disorders", "DISEASE", 106, 124], ["hepatocytes", "CELL", 62, 73], ["fibrous septa", "TISSUE", 88, 101], ["vascular", "MULTI-TISSUE_STRUCTURE", 106, 114], ["central veins", "MULTI-TISSUE_STRUCTURE", 151, 164], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 169, 182], ["hepatocytes", "CELL_TYPE", 62, 73], ["regenerative nodules of hepatocytes", "PROBLEM", 38, 73], ["fibrous septa and vascular disorders", "PROBLEM", 88, 124], ["regenerative", "OBSERVATION_MODIFIER", 38, 50], ["nodules", "OBSERVATION", 51, 58], ["hepatocytes", "ANATOMY", 62, 73], ["fibrous septa", "OBSERVATION", 88, 101], ["vascular", "ANATOMY", 106, 114], ["disorders", "OBSERVATION", 115, 124], ["both", "ANATOMY_MODIFIER", 146, 150], ["central", "ANATOMY_MODIFIER", 151, 158], ["veins", "ANATOMY", 159, 164], ["portal tracts", "ANATOMY", 169, 182]]], ["Other than dogs, most veterinary species develop diffuse hepatic fibrosis following chronic injury, but do not develop regenerative nodules.", [["hepatic", "ANATOMY", 57, 64], ["regenerative nodules", "ANATOMY", 119, 139], ["hepatic fibrosis", "DISEASE", 57, 73], ["chronic injury", "DISEASE", 84, 98], ["dogs", "ORGANISM", 11, 15], ["hepatic", "ORGAN", 57, 64], ["regenerative nodules", "CANCER", 119, 139], ["dogs", "SPECIES", 11, 15], ["diffuse hepatic fibrosis", "PROBLEM", 49, 73], ["chronic injury", "PROBLEM", 84, 98], ["regenerative nodules", "PROBLEM", 119, 139], ["diffuse", "OBSERVATION_MODIFIER", 49, 56], ["hepatic", "ANATOMY", 57, 64], ["fibrosis", "OBSERVATION", 65, 73], ["chronic", "OBSERVATION_MODIFIER", 84, 91], ["injury", "OBSERVATION", 92, 98], ["regenerative", "OBSERVATION_MODIFIER", 119, 131], ["nodules", "OBSERVATION", 132, 139]]], ["Chronically injured canine livers often have a robust formation of regenerative nodules separated by fibrous septa typical of cirrhosis ( Clinically, cirrhosis results in hepatic insufficiency, mainly in the form of ascites and hypoproteinemia rather than excretory \u2022 Inflammatory disorders that produce piecemeal necrosis of hepatocytes, typically viral hepatitis in humans and often an idiopathic disorder in veterinary species, can evolve to form portal-to-portal, or portal-to-central, fibrous septa. \u2022 In the event of inflammation or obstruction involving the bile ducts, proliferation of periductular myofibroblasts and prominent ductular reaction can lead to biliary fibrosis or a pattern of portal-to-portal bridging termed biliary cirrhosis when accompanied by nodular regenerative proliferation of hepatocytes ( Fig. 2-43 ). \u2022 Postnecrotic scarring occurs after massive necrosis, where large areas of parenchyma are destroyed.", [["livers", "ANATOMY", 27, 33], ["nodules", "ANATOMY", 80, 87], ["fibrous septa", "ANATOMY", 101, 114], ["cirrhosis", "ANATOMY", 126, 135], ["hepatic", "ANATOMY", 171, 178], ["ascites", "ANATOMY", 216, 223], ["hepatocytes", "ANATOMY", 326, 337], ["portal", "ANATOMY", 450, 456], ["portal", "ANATOMY", 460, 466], ["portal", "ANATOMY", 471, 477], ["fibrous septa", "ANATOMY", 490, 503], ["bile ducts", "ANATOMY", 565, 575], ["periductular myofibroblasts", "ANATOMY", 594, 621], ["ductular", "ANATOMY", 636, 644], ["biliary", "ANATOMY", 666, 673], ["portal", "ANATOMY", 699, 705], ["portal", "ANATOMY", 709, 715], ["biliary cirrhosis", "ANATOMY", 732, 749], ["hepatocytes", "ANATOMY", 808, 819], ["parenchyma", "ANATOMY", 911, 921], ["cirrhosis", "DISEASE", 126, 135], ["cirrhosis", "DISEASE", 150, 159], ["hepatic insufficiency", "DISEASE", 171, 192], ["ascites", "DISEASE", 216, 223], ["hypoproteinemia", "DISEASE", 228, 243], ["Inflammatory disorders", "DISEASE", 268, 290], ["necrosis", "DISEASE", 314, 322], ["viral hepatitis", "DISEASE", 349, 364], ["idiopathic disorder", "DISEASE", 388, 407], ["inflammation", "DISEASE", 523, 535], ["obstruction", "DISEASE", 539, 550], ["fibrosis", "DISEASE", 674, 682], ["biliary cirrhosis", "DISEASE", 732, 749], ["scarring", "DISEASE", 850, 858], ["necrosis", "DISEASE", 880, 888], ["canine", "ORGANISM", 20, 26], ["livers", "ORGAN", 27, 33], ["nodules", "CANCER", 80, 87], ["fibrous septa", "TISSUE", 101, 114], ["hepatic", "ORGAN", 171, 178], ["hepatocytes", "CELL", 326, 337], ["humans", "ORGANISM", 368, 374], ["portal", "MULTI-TISSUE_STRUCTURE", 460, 466], ["fibrous septa", "TISSUE", 490, 503], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 565, 575], ["periductular myofibroblasts", "CELL", 594, 621], ["ductular", "ORGAN", 636, 644], ["biliary", "ORGAN", 666, 673], ["portal", "MULTI-TISSUE_STRUCTURE", 709, 715], ["biliary cirrhosis", "PATHOLOGICAL_FORMATION", 732, 749], ["hepatocytes", "CELL", 808, 819], ["parenchyma", "TISSUE", 911, 921], ["hepatocytes", "CELL_TYPE", 326, 337], ["periductular myofibroblasts", "CELL_TYPE", 594, 621], ["hepatocytes", "CELL_TYPE", 808, 819], ["humans", "SPECIES", 368, 374], ["canine", "SPECIES", 20, 26], ["humans", "SPECIES", 368, 374], ["Chronically injured canine livers", "PROBLEM", 0, 33], ["regenerative nodules", "PROBLEM", 67, 87], ["fibrous septa", "PROBLEM", 101, 114], ["cirrhosis", "PROBLEM", 126, 135], ["cirrhosis", "PROBLEM", 150, 159], ["hepatic insufficiency", "PROBLEM", 171, 192], ["ascites", "PROBLEM", 216, 223], ["hypoproteinemia", "PROBLEM", 228, 243], ["excretory \u2022 Inflammatory disorders", "PROBLEM", 256, 290], ["piecemeal necrosis of hepatocytes", "PROBLEM", 304, 337], ["typically viral hepatitis in humans", "PROBLEM", 339, 374], ["an idiopathic disorder in veterinary species", "PROBLEM", 385, 429], ["fibrous septa", "PROBLEM", 490, 503], ["inflammation", "PROBLEM", 523, 535], ["obstruction involving the bile ducts", "PROBLEM", 539, 575], ["periductular myofibroblasts", "PROBLEM", 594, 621], ["prominent ductular reaction", "PROBLEM", 626, 653], ["biliary fibrosis", "PROBLEM", 666, 682], ["portal-to-portal bridging termed biliary cirrhosis", "PROBLEM", 699, 749], ["nodular regenerative proliferation of hepatocytes", "PROBLEM", 770, 819], ["Postnecrotic scarring", "PROBLEM", 837, 858], ["massive necrosis", "PROBLEM", 872, 888], ["injured", "OBSERVATION", 12, 19], ["livers", "ANATOMY", 27, 33], ["regenerative", "OBSERVATION_MODIFIER", 67, 79], ["nodules", "OBSERVATION", 80, 87], ["fibrous septa", "OBSERVATION_MODIFIER", 101, 114], ["cirrhosis", "OBSERVATION", 126, 135], ["cirrhosis", "OBSERVATION", 150, 159], ["hepatic", "ANATOMY", 171, 178], ["insufficiency", "OBSERVATION", 179, 192], ["ascites", "OBSERVATION", 216, 223], ["hypoproteinemia", "OBSERVATION", 228, 243], ["Inflammatory", "OBSERVATION", 268, 280], ["piecemeal", "OBSERVATION_MODIFIER", 304, 313], ["necrosis", "OBSERVATION", 314, 322], ["hepatocytes", "ANATOMY", 326, 337], ["typically", "OBSERVATION_MODIFIER", 339, 348], ["viral", "OBSERVATION_MODIFIER", 349, 354], ["hepatitis", "OBSERVATION", 355, 364], ["idiopathic", "OBSERVATION_MODIFIER", 388, 398], ["portal", "ANATOMY", 450, 456], ["portal", "ANATOMY", 460, 466], ["portal", "ANATOMY", 471, 477], ["central", "ANATOMY_MODIFIER", 481, 488], ["fibrous septa", "OBSERVATION", 490, 503], ["inflammation", "OBSERVATION", 523, 535], ["obstruction", "OBSERVATION", 539, 550], ["bile ducts", "ANATOMY", 565, 575], ["proliferation", "OBSERVATION_MODIFIER", 577, 590], ["periductular myofibroblasts", "OBSERVATION", 594, 621], ["prominent", "OBSERVATION_MODIFIER", 626, 635], ["ductular reaction", "OBSERVATION", 636, 653], ["biliary", "ANATOMY", 666, 673], ["fibrosis", "OBSERVATION", 674, 682], ["portal", "ANATOMY", 699, 705], ["portal", "ANATOMY", 709, 715], ["bridging", "OBSERVATION", 716, 724], ["biliary", "ANATOMY", 732, 739], ["cirrhosis", "OBSERVATION", 740, 749], ["nodular", "OBSERVATION_MODIFIER", 770, 777], ["regenerative", "OBSERVATION_MODIFIER", 778, 790], ["proliferation", "OBSERVATION", 791, 804], ["hepatocytes", "ANATOMY", 808, 819], ["Postnecrotic", "OBSERVATION_MODIFIER", 837, 849], ["scarring", "OBSERVATION", 850, 858], ["massive", "OBSERVATION_MODIFIER", 872, 879], ["necrosis", "OBSERVATION", 880, 888], ["large", "OBSERVATION_MODIFIER", 896, 901], ["areas", "OBSERVATION_MODIFIER", 902, 907], ["parenchyma", "ANATOMY_MODIFIER", 911, 921], ["destroyed", "OBSERVATION", 926, 935]]], ["The reticulin network collapses and condenses and portal areas converge, resulting in broad, irregular bands of scar tissue with variable irregular areas of parenchymal regeneration interspersed ( Fig. 2-44 ). \u2022 Diffuse hepatic fibrosis is the outcome of chronic parenchymal injury, such as prolonged inflammation or multiple episodes of zonal necrosis.", [["reticulin network", "ANATOMY", 4, 21], ["portal areas", "ANATOMY", 50, 62], ["scar tissue", "ANATOMY", 112, 123], ["parenchymal", "ANATOMY", 157, 168], ["hepatic", "ANATOMY", 220, 227], ["parenchymal", "ANATOMY", 263, 274], ["hepatic fibrosis", "DISEASE", 220, 236], ["parenchymal injury", "DISEASE", 263, 281], ["inflammation", "DISEASE", 301, 313], ["necrosis", "DISEASE", 344, 352], ["reticulin network", "MULTI-TISSUE_STRUCTURE", 4, 21], ["scar tissue", "TISSUE", 112, 123], ["parenchymal", "TISSUE", 157, 168], ["hepatic", "ORGAN", 220, 227], ["parenchymal", "ORGAN", 263, 274], ["The reticulin network collapses and condenses and portal areas converge", "PROBLEM", 0, 71], ["broad, irregular bands of scar tissue", "PROBLEM", 86, 123], ["variable irregular areas of parenchymal regeneration", "PROBLEM", 129, 181], ["Diffuse hepatic fibrosis", "PROBLEM", 212, 236], ["chronic parenchymal injury", "PROBLEM", 255, 281], ["prolonged inflammation", "PROBLEM", 291, 313], ["zonal necrosis", "PROBLEM", 338, 352], ["reticulin network collapses", "OBSERVATION", 4, 31], ["portal", "ANATOMY", 50, 56], ["areas", "ANATOMY_MODIFIER", 57, 62], ["broad", "OBSERVATION_MODIFIER", 86, 91], ["irregular", "OBSERVATION_MODIFIER", 93, 102], ["bands", "OBSERVATION_MODIFIER", 103, 108], ["scar tissue", "OBSERVATION", 112, 123], ["variable", "OBSERVATION_MODIFIER", 129, 137], ["irregular", "OBSERVATION_MODIFIER", 138, 147], ["areas", "OBSERVATION_MODIFIER", 148, 153], ["parenchymal", "ANATOMY_MODIFIER", 157, 168], ["regeneration", "OBSERVATION_MODIFIER", 169, 181], ["interspersed", "OBSERVATION_MODIFIER", 182, 194], ["hepatic", "ANATOMY", 220, 227], ["fibrosis", "OBSERVATION", 228, 236], ["chronic", "OBSERVATION_MODIFIER", 255, 262], ["parenchymal", "ANATOMY_MODIFIER", 263, 274], ["injury", "OBSERVATION", 275, 281], ["prolonged", "OBSERVATION_MODIFIER", 291, 300], ["inflammation", "OBSERVATION", 301, 313], ["multiple", "OBSERVATION_MODIFIER", 317, 325], ["episodes", "OBSERVATION_MODIFIER", 326, 334], ["zonal", "OBSERVATION_MODIFIER", 338, 343], ["necrosis", "OBSERVATION", 344, 352]]], ["The fibrosis throughout the 3.", [["fibrosis", "DISEASE", 4, 12], ["The fibrosis", "PROBLEM", 0, 12], ["fibrosis", "OBSERVATION", 4, 12]]], ["Parenchymal nodules, created by the regenerative attempts of entrapped hepatocytes, and varying in size from <3 mm in diameter (micronodular) to several centimeters in diameter (macronodular).", [["Parenchymal nodules", "ANATOMY", 0, 19], ["hepatocytes", "ANATOMY", 71, 82], ["micronodular", "ANATOMY", 128, 140], ["centimeters", "ANATOMY", 153, 164], ["Parenchymal nodules", "PATHOLOGICAL_FORMATION", 0, 19], ["hepatocytes", "CELL", 71, 82], ["entrapped hepatocytes", "CELL_TYPE", 61, 82], ["Parenchymal nodules", "PROBLEM", 0, 19], ["entrapped hepatocytes", "PROBLEM", 61, 82], ["nodules", "OBSERVATION", 12, 19], ["regenerative", "OBSERVATION_MODIFIER", 36, 48], ["entrapped", "OBSERVATION_MODIFIER", 61, 70], ["hepatocytes", "OBSERVATION", 71, 82], ["varying", "OBSERVATION_MODIFIER", 88, 95], ["size", "OBSERVATION_MODIFIER", 99, 103], ["<3 mm", "OBSERVATION_MODIFIER", 109, 114], ["diameter", "OBSERVATION_MODIFIER", 118, 126], ["micronodular", "OBSERVATION_MODIFIER", 128, 140], ["several centimeters", "OBSERVATION_MODIFIER", 145, 164], ["diameter", "OBSERVATION_MODIFIER", 168, 176], ["macronodular", "OBSERVATION_MODIFIER", 178, 190]]], ["These nodules are composed of trabeculae that are typically 2 or more cells thick, with relative reduction of sinusoidal space.", [["nodules", "ANATOMY", 6, 13], ["trabeculae", "ANATOMY", 30, 40], ["cells", "ANATOMY", 70, 75], ["sinusoidal space", "ANATOMY", 110, 126], ["nodules", "CANCER", 6, 13], ["trabeculae", "TISSUE", 30, 40], ["cells", "CELL", 70, 75], ["sinusoidal space", "MULTI-TISSUE_STRUCTURE", 110, 126], ["These nodules", "PROBLEM", 0, 13], ["trabeculae", "PROBLEM", 30, 40], ["more cells thick", "PROBLEM", 65, 81], ["relative reduction of sinusoidal space", "PROBLEM", 88, 126], ["nodules", "OBSERVATION", 6, 13], ["trabeculae", "ANATOMY", 30, 40], ["more cells", "OBSERVATION_MODIFIER", 65, 75], ["thick", "OBSERVATION_MODIFIER", 76, 81], ["relative", "OBSERVATION_MODIFIER", 88, 96], ["reduction", "OBSERVATION_MODIFIER", 97, 106], ["sinusoidal space", "OBSERVATION", 110, 126]]], ["Some expanding nodules may compress the vessels within fibrous septa, contributing to portal hypertension.", [["nodules", "ANATOMY", 15, 22], ["vessels", "ANATOMY", 40, 47], ["fibrous septa", "ANATOMY", 55, 68], ["portal", "ANATOMY", 86, 92], ["hypertension", "DISEASE", 93, 105], ["nodules", "CANCER", 15, 22], ["vessels", "MULTI-TISSUE_STRUCTURE", 40, 47], ["fibrous septa", "TISSUE", 55, 68], ["portal", "MULTI-TISSUE_STRUCTURE", 86, 92], ["Some expanding nodules", "PROBLEM", 0, 22], ["fibrous septa", "PROBLEM", 55, 68], ["portal hypertension", "PROBLEM", 86, 105], ["expanding", "OBSERVATION_MODIFIER", 5, 14], ["nodules", "OBSERVATION", 15, 22], ["vessels", "ANATOMY", 40, 47], ["fibrous septa", "OBSERVATION", 55, 68], ["portal", "ANATOMY", 86, 92], ["hypertension", "OBSERVATION", 93, 105]]], ["Nodule formation is prominent in dogs, but significantly less so in most other domestic species.", [["Nodule", "ANATOMY", 0, 6], ["Nodule", "DISEASE", 0, 6], ["Nodule", "PATHOLOGICAL_FORMATION", 0, 6], ["dogs", "ORGANISM", 33, 37], ["dogs", "SPECIES", 33, 37], ["Nodule formation", "PROBLEM", 0, 16], ["prominent", "OBSERVATION_MODIFIER", 20, 29], ["dogs", "OBSERVATION_MODIFIER", 33, 37], ["significantly", "OBSERVATION_MODIFIER", 43, 56], ["less", "OBSERVATION_MODIFIER", 57, 61], ["most other", "OBSERVATION_MODIFIER", 68, 78], ["domestic species", "OBSERVATION", 79, 95]]], ["Ongoing damage and reorganization of the hepatic connective tissue, sometimes with areas of portal and arterial thrombosis and segmental ischemia is typical, but not always present.CirrhosisCirrhosis is usually the end result of several pathogenic processes, namely, cell death (necrosis or apoptosis) and active inflammation with chronic fibrosis.", [["hepatic connective tissue", "ANATOMY", 41, 66], ["portal", "ANATOMY", 92, 98], ["arterial", "ANATOMY", 103, 111], ["cell", "ANATOMY", 267, 271], ["thrombosis", "DISEASE", 112, 122], ["ischemia", "DISEASE", 137, 145], ["CirrhosisCirrhosis", "DISEASE", 181, 199], ["death", "DISEASE", 272, 277], ["necrosis", "DISEASE", 279, 287], ["inflammation", "DISEASE", 313, 325], ["fibrosis", "DISEASE", 339, 347], ["hepatic connective tissue", "TISSUE", 41, 66], ["portal", "MULTI-TISSUE_STRUCTURE", 92, 98], ["arterial", "MULTI-TISSUE_STRUCTURE", 103, 111], ["cell", "CELL", 267, 271], ["Ongoing damage", "PROBLEM", 0, 14], ["the hepatic connective tissue", "PROBLEM", 37, 66], ["portal and arterial thrombosis", "PROBLEM", 92, 122], ["segmental ischemia", "PROBLEM", 127, 145], ["CirrhosisCirrhosis", "PROBLEM", 181, 199], ["several pathogenic processes", "PROBLEM", 229, 257], ["cell death (necrosis", "PROBLEM", 267, 287], ["apoptosis", "PROBLEM", 291, 300], ["active inflammation", "PROBLEM", 306, 325], ["chronic fibrosis", "PROBLEM", 331, 347], ["damage", "OBSERVATION", 8, 14], ["hepatic", "ANATOMY", 41, 48], ["connective tissue", "OBSERVATION", 49, 66], ["portal", "ANATOMY", 92, 98], ["arterial", "ANATOMY", 103, 111], ["thrombosis", "OBSERVATION", 112, 122], ["segmental", "OBSERVATION_MODIFIER", 127, 136], ["ischemia", "OBSERVATION", 137, 145], ["several", "OBSERVATION_MODIFIER", 229, 236], ["pathogenic", "OBSERVATION", 237, 247], ["cell death", "OBSERVATION", 267, 277], ["necrosis", "OBSERVATION", 279, 287], ["apoptosis", "OBSERVATION_MODIFIER", 291, 300], ["active", "OBSERVATION_MODIFIER", 306, 312], ["inflammation", "OBSERVATION", 313, 325], ["chronic", "OBSERVATION_MODIFIER", 331, 338], ["fibrosis", "OBSERVATION", 339, 347]]], ["Cirrhosis is not a synonym for chronic hepatic fibrosis, although some insults that cause chronic diffuse fibrosis in the liver can lead to cirrhosis.", [["hepatic", "ANATOMY", 39, 46], ["liver", "ANATOMY", 122, 127], ["Cirrhosis", "DISEASE", 0, 9], ["chronic hepatic fibrosis", "DISEASE", 31, 55], ["fibrosis", "DISEASE", 106, 114], ["cirrhosis", "DISEASE", 140, 149], ["hepatic", "ORGAN", 39, 46], ["liver", "ORGAN", 122, 127], ["Cirrhosis", "PROBLEM", 0, 9], ["chronic hepatic fibrosis", "PROBLEM", 31, 55], ["some insults", "PROBLEM", 66, 78], ["chronic diffuse fibrosis in the liver", "PROBLEM", 90, 127], ["cirrhosis", "PROBLEM", 140, 149], ["chronic", "OBSERVATION_MODIFIER", 31, 38], ["hepatic", "ANATOMY", 39, 46], ["fibrosis", "OBSERVATION", 47, 55], ["chronic", "OBSERVATION_MODIFIER", 90, 97], ["diffuse", "OBSERVATION_MODIFIER", 98, 105], ["fibrosis", "OBSERVATION", 106, 114], ["liver", "ANATOMY", 122, 127], ["cirrhosis", "OBSERVATION", 140, 149]]], ["The nodular pattern of regeneration in cirrhosis is caused by expanding islands of surviving parenchyma entrapped between bands of scar tissue.", [["cirrhosis", "ANATOMY", 39, 48], ["parenchyma", "ANATOMY", 93, 103], ["scar tissue", "ANATOMY", 131, 142], ["cirrhosis", "DISEASE", 39, 48], ["cirrhosis", "CANCER", 39, 48], ["parenchyma", "TISSUE", 93, 103], ["scar tissue", "TISSUE", 131, 142], ["regeneration in cirrhosis", "PROBLEM", 23, 48], ["surviving parenchyma", "PROBLEM", 83, 103], ["scar tissue", "PROBLEM", 131, 142], ["nodular", "OBSERVATION_MODIFIER", 4, 11], ["pattern", "OBSERVATION_MODIFIER", 12, 19], ["regeneration", "OBSERVATION_MODIFIER", 23, 35], ["cirrhosis", "OBSERVATION", 39, 48], ["expanding", "OBSERVATION_MODIFIER", 62, 71], ["islands", "OBSERVATION_MODIFIER", 72, 79], ["surviving", "OBSERVATION_MODIFIER", 83, 92], ["parenchyma", "OBSERVATION_MODIFIER", 93, 103], ["entrapped", "OBSERVATION_MODIFIER", 104, 113], ["bands", "OBSERVATION_MODIFIER", 122, 127], ["scar tissue", "OBSERVATION", 131, 142]]], ["At the point of liver failure, these regenerative attempts are insufficient to restore function.", [["liver", "ANATOMY", 16, 21], ["liver failure", "DISEASE", 16, 29], ["liver", "ORGAN", 16, 21], ["liver failure", "PROBLEM", 16, 29], ["these regenerative attempts", "TREATMENT", 31, 58], ["liver", "ANATOMY", 16, 21], ["failure", "OBSERVATION", 22, 29], ["regenerative", "OBSERVATION_MODIFIER", 37, 49]]], ["Despite the increased hepatocellular mass, the inability to restore normal function is attributed to altered circulation through the bridging scar tissue, portal hypertension and shunting, deposition of ECM in the perisinusoidal space, reduced supply of portal growth factors, inhibition of proliferation of ECM, and toxic inhibition of hepatocellular proliferation.", [["hepatocellular mass", "ANATOMY", 22, 41], ["scar tissue", "ANATOMY", 142, 153], ["portal", "ANATOMY", 155, 161], ["ECM", "ANATOMY", 203, 206], ["perisinusoidal space", "ANATOMY", 214, 234], ["ECM", "ANATOMY", 308, 311], ["hepatocellular", "ANATOMY", 337, 351], ["hypertension", "DISEASE", 162, 174], ["hepatocellular", "CANCER", 22, 36], ["scar tissue", "TISSUE", 142, 153], ["portal", "MULTI-TISSUE_STRUCTURE", 155, 161], ["ECM", "CELLULAR_COMPONENT", 203, 206], ["portal growth factors", "GENE_OR_GENE_PRODUCT", 254, 275], ["ECM", "CELLULAR_COMPONENT", 308, 311], ["hepatocellular", "CANCER", 337, 351], ["ECM", "PROTEIN", 203, 206], ["portal growth factors", "PROTEIN", 254, 275], ["the increased hepatocellular mass", "PROBLEM", 8, 41], ["altered circulation", "PROBLEM", 101, 120], ["the bridging scar tissue", "PROBLEM", 129, 153], ["portal hypertension", "PROBLEM", 155, 174], ["shunting", "PROBLEM", 179, 187], ["deposition of ECM in the perisinusoidal space", "PROBLEM", 189, 234], ["portal growth factors", "PROBLEM", 254, 275], ["proliferation of ECM", "PROBLEM", 291, 311], ["hepatocellular proliferation", "PROBLEM", 337, 365], ["increased", "OBSERVATION_MODIFIER", 12, 21], ["hepatocellular", "ANATOMY", 22, 36], ["mass", "OBSERVATION", 37, 41], ["normal function", "OBSERVATION", 68, 83], ["altered", "OBSERVATION_MODIFIER", 101, 108], ["circulation", "OBSERVATION", 109, 120], ["bridging", "OBSERVATION_MODIFIER", 133, 141], ["scar", "OBSERVATION", 142, 146], ["portal", "ANATOMY", 155, 161], ["hypertension", "OBSERVATION", 162, 174], ["shunting", "OBSERVATION", 179, 187], ["deposition", "OBSERVATION_MODIFIER", 189, 199], ["ECM", "OBSERVATION_MODIFIER", 203, 206], ["perisinusoidal space", "OBSERVATION", 214, 234], ["reduced", "OBSERVATION_MODIFIER", 236, 243], ["supply", "OBSERVATION_MODIFIER", 244, 250], ["portal", "ANATOMY", 254, 260], ["growth factors", "OBSERVATION", 261, 275], ["proliferation", "OBSERVATION_MODIFIER", 291, 304], ["ECM", "OBSERVATION_MODIFIER", 308, 311], ["toxic", "OBSERVATION_MODIFIER", 317, 322], ["inhibition", "OBSERVATION_MODIFIER", 323, 333], ["hepatocellular proliferation", "OBSERVATION", 337, 365]]], ["The characteristic fibrovascular septa that bridge portal and central vascular tracts are readily observed in liver sections, but the portal-hepatic shunting therein can be difficult to identify.", [["fibrovascular septa", "ANATOMY", 19, 38], ["portal", "ANATOMY", 51, 57], ["central vascular tracts", "ANATOMY", 62, 85], ["liver sections", "ANATOMY", 110, 124], ["hepatic", "ANATOMY", 141, 148], ["fibrovascular septa", "TISSUE", 19, 38], ["portal", "MULTI-TISSUE_STRUCTURE", 51, 57], ["central vascular tracts", "MULTI-TISSUE_STRUCTURE", 62, 85], ["liver sections", "MULTI-TISSUE_STRUCTURE", 110, 124], ["portal", "MULTI-TISSUE_STRUCTURE", 134, 140], ["hepatic", "MULTI-TISSUE_STRUCTURE", 141, 148], ["The characteristic fibrovascular septa", "PROBLEM", 0, 38], ["characteristic", "OBSERVATION_MODIFIER", 4, 18], ["fibrovascular septa", "OBSERVATION", 19, 38], ["bridge", "ANATOMY_MODIFIER", 44, 50], ["portal", "ANATOMY", 51, 57], ["central", "ANATOMY_MODIFIER", 62, 69], ["vascular tracts", "ANATOMY", 70, 85], ["liver", "ANATOMY", 110, 115], ["portal", "ANATOMY", 134, 140], ["hepatic", "ANATOMY", 141, 148], ["shunting", "OBSERVATION", 149, 157]]], ["Clinical evidence for portosystemic shunting, such as impaired ammonia or bile acid clearance, can reflect acquired portocaval shunts that often develop as a result of portal hypertension from chronic hepatic fibrosis.Acquired portosystemic shuntingAny chronic liver disease that causes sufficient fibrosis or atrophy to restrict portal blood flow significantly and produce portal hypertension has the potential to cause the development of collateral portosystemic shunts.", [["bile", "ANATOMY", 74, 78], ["portocaval", "ANATOMY", 116, 126], ["portal", "ANATOMY", 168, 174], ["hepatic", "ANATOMY", 201, 208], ["liver", "ANATOMY", 261, 266], ["portal blood", "ANATOMY", 330, 342], ["portal", "ANATOMY", 374, 380], ["collateral portosystemic", "ANATOMY", 440, 464], ["ammonia", "CHEMICAL", 63, 70], ["bile acid", "CHEMICAL", 74, 83], ["portocaval shunts", "DISEASE", 116, 133], ["hypertension", "DISEASE", 175, 187], ["chronic hepatic fibrosis", "DISEASE", 193, 217], ["Acquired portosystemic shunting", "DISEASE", 218, 249], ["chronic liver disease", "DISEASE", 253, 274], ["fibrosis", "DISEASE", 298, 306], ["atrophy", "DISEASE", 310, 317], ["hypertension", "DISEASE", 381, 393], ["collateral portosystemic shunts", "DISEASE", 440, 471], ["ammonia", "CHEMICAL", 63, 70], ["bile acid", "CHEMICAL", 74, 83], ["portosystemic", "MULTI-TISSUE_STRUCTURE", 22, 35], ["ammonia", "SIMPLE_CHEMICAL", 63, 70], ["bile acid", "SIMPLE_CHEMICAL", 74, 83], ["portal", "MULTI-TISSUE_STRUCTURE", 168, 174], ["hepatic", "ORGAN", 201, 208], ["liver", "ORGAN", 261, 266], ["portal", "MULTI-TISSUE_STRUCTURE", 330, 336], ["blood", "ORGANISM_SUBSTANCE", 337, 342], ["portal", "MULTI-TISSUE_STRUCTURE", 374, 380], ["collateral portosystemic", "MULTI-TISSUE_STRUCTURE", 440, 464], ["portosystemic shunting", "PROBLEM", 22, 44], ["impaired ammonia", "PROBLEM", 54, 70], ["bile acid clearance", "PROBLEM", 74, 93], ["acquired portocaval shunts", "PROBLEM", 107, 133], ["portal hypertension", "PROBLEM", 168, 187], ["chronic hepatic fibrosis", "PROBLEM", 193, 217], ["Acquired portosystemic shunting", "PROBLEM", 218, 249], ["Any chronic liver disease", "PROBLEM", 249, 274], ["sufficient fibrosis", "PROBLEM", 287, 306], ["atrophy", "PROBLEM", 310, 317], ["portal blood flow", "TEST", 330, 347], ["portal hypertension", "PROBLEM", 374, 393], ["collateral portosystemic shunts", "PROBLEM", 440, 471], ["evidence for", "UNCERTAINTY", 9, 21], ["portosystemic shunting", "OBSERVATION", 22, 44], ["impaired", "OBSERVATION_MODIFIER", 54, 62], ["ammonia", "OBSERVATION", 63, 70], ["bile", "ANATOMY", 74, 78], ["portocaval shunts", "OBSERVATION", 116, 133], ["portal", "ANATOMY", 168, 174], ["hypertension", "OBSERVATION", 175, 187], ["chronic", "OBSERVATION_MODIFIER", 193, 200], ["hepatic", "ANATOMY", 201, 208], ["fibrosis", "OBSERVATION", 209, 217], ["portosystemic shunting", "OBSERVATION", 227, 249], ["chronic", "OBSERVATION_MODIFIER", 253, 260], ["liver", "ANATOMY", 261, 266], ["disease", "OBSERVATION", 267, 274], ["sufficient", "OBSERVATION_MODIFIER", 287, 297], ["fibrosis", "OBSERVATION", 298, 306], ["atrophy", "OBSERVATION", 310, 317], ["portal blood flow", "OBSERVATION", 330, 347], ["portal", "ANATOMY", 374, 380], ["hypertension", "OBSERVATION", 381, 393], ["collateral", "OBSERVATION_MODIFIER", 440, 450], ["portosystemic shunts", "OBSERVATION", 451, 471]]], ["These are described later in the section on Vascular factors in hepatic injury and circulatory disorders.", [["Vascular", "ANATOMY", 44, 52], ["hepatic", "ANATOMY", 64, 71], ["circulatory", "ANATOMY", 83, 94], ["hepatic injury", "DISEASE", 64, 78], ["circulatory disorders", "DISEASE", 83, 104], ["Vascular", "MULTI-TISSUE_STRUCTURE", 44, 52], ["hepatic", "MULTI-TISSUE_STRUCTURE", 64, 71], ["Vascular factors", "PROTEIN", 44, 60], ["hepatic injury", "PROBLEM", 64, 78], ["circulatory disorders", "PROBLEM", 83, 104], ["Vascular", "ANATOMY", 44, 52], ["hepatic", "ANATOMY", 64, 71], ["injury", "OBSERVATION", 72, 78], ["circulatory disorders", "OBSERVATION", 83, 104]]], ["DesmetHEPATIC DYSFUNCTIONHepatic failure is a syndrome that results from inadequate hepatic function.", [["hepatic", "ANATOMY", 84, 91], ["hepatic", "ORGAN", 84, 91], ["DesmetHEPATIC DYSFUNCTIONHepatic failure", "PROBLEM", 0, 40], ["a syndrome", "PROBLEM", 44, 54], ["inadequate hepatic function", "PROBLEM", 73, 100], ["failure", "OBSERVATION", 33, 40], ["hepatic", "ANATOMY", 84, 91]]], ["The liver provides numerous essential processes, and liver failure can affect metabolic, synthetic, catabolic (detoxification), and immune functions.", [["liver", "ANATOMY", 4, 9], ["liver", "ANATOMY", 53, 58], ["liver failure", "DISEASE", 53, 66], ["liver", "ORGAN", 4, 9], ["liver", "ORGAN", 53, 58], ["liver failure", "PROBLEM", 53, 66], ["liver", "ANATOMY", 4, 9], ["numerous", "OBSERVATION_MODIFIER", 19, 27], ["essential", "OBSERVATION_MODIFIER", 28, 37], ["processes", "OBSERVATION", 38, 47], ["liver", "ANATOMY", 53, 58], ["failure", "OBSERVATION", 59, 66]]], ["There is no specific point at which diminished function can clearly be C dysfunction and icterus, although, in advanced cases, all manifestations of fatal liver failure can occur.", [["liver", "ANATOMY", 155, 160], ["icterus", "DISEASE", 89, 96], ["liver failure", "DISEASE", 155, 168], ["liver", "ORGAN", 155, 160], ["C dysfunction", "PROBLEM", 71, 84], ["icterus", "PROBLEM", 89, 96], ["fatal liver failure", "PROBLEM", 149, 168], ["no specific", "UNCERTAINTY", 9, 20], ["diminished", "OBSERVATION", 36, 46], ["dysfunction", "OBSERVATION", 73, 84], ["icterus", "OBSERVATION", 89, 96], ["fatal", "OBSERVATION_MODIFIER", 149, 154], ["liver", "ANATOMY", 155, 160], ["failure", "OBSERVATION", 161, 168]]], ["The hallmarks of cirrhosis are: 1.", [["cirrhosis", "DISEASE", 17, 26], ["cirrhosis", "CANCER", 17, 26], ["cirrhosis", "PROBLEM", 17, 26], ["hallmarks", "OBSERVATION_MODIFIER", 4, 13], ["cirrhosis", "OBSERVATION", 17, 26]]], ["Bridging fibrous septa, ranging from delicate bands to broad scars that replace multiple adjacent lobules.", [["fibrous septa", "ANATOMY", 9, 22], ["lobules", "ANATOMY", 98, 105], ["fibrous septa", "TISSUE", 9, 22], ["scars", "PATHOLOGICAL_FORMATION", 61, 66], ["lobules", "MULTI-TISSUE_STRUCTURE", 98, 105], ["Bridging fibrous septa", "PROBLEM", 0, 22], ["delicate bands", "PROBLEM", 37, 51], ["broad scars", "PROBLEM", 55, 66], ["multiple adjacent lobules", "PROBLEM", 80, 105], ["fibrous septa", "OBSERVATION", 9, 22], ["ranging", "OBSERVATION_MODIFIER", 24, 31], ["bands", "OBSERVATION_MODIFIER", 46, 51], ["broad", "OBSERVATION_MODIFIER", 55, 60], ["scars", "OBSERVATION", 61, 66], ["multiple", "OBSERVATION_MODIFIER", 80, 88], ["adjacent", "OBSERVATION_MODIFIER", 89, 97], ["lobules", "OBSERVATION", 98, 105]]], ["These fibrous septa contain vascular channels, originating from sinusoids in collapsed parenchyma or angiogenesis that allow a considerable portion of blood to bypass hepatocytes.", [["fibrous septa", "ANATOMY", 6, 19], ["vascular", "ANATOMY", 28, 36], ["sinusoids", "ANATOMY", 64, 73], ["parenchyma", "ANATOMY", 87, 97], ["blood", "ANATOMY", 151, 156], ["hepatocytes", "ANATOMY", 167, 178], ["fibrous septa", "TISSUE", 6, 19], ["vascular", "MULTI-TISSUE_STRUCTURE", 28, 36], ["sinusoids", "TISSUE", 64, 73], ["parenchyma", "TISSUE", 87, 97], ["blood", "ORGANISM_SUBSTANCE", 151, 156], ["hepatocytes", "CELL", 167, 178], ["vascular channels", "PROTEIN", 28, 45], ["hepatocytes", "CELL_TYPE", 167, 178], ["These fibrous septa contain vascular channels", "PROBLEM", 0, 45], ["collapsed parenchyma", "PROBLEM", 77, 97], ["angiogenesis", "PROBLEM", 101, 113], ["bypass hepatocytes", "TREATMENT", 160, 178], ["fibrous septa", "OBSERVATION", 6, 19], ["vascular channels", "ANATOMY", 28, 45], ["sinusoids", "OBSERVATION_MODIFIER", 64, 73], ["collapsed", "OBSERVATION_MODIFIER", 77, 86], ["parenchyma", "OBSERVATION", 87, 97], ["angiogenesis", "OBSERVATION", 101, 113], ["bypass hepatocytes", "OBSERVATION", 160, 178]]], ["These microvascular channels in fibrous septa resist flow more than normal sinusoids.", [["microvascular", "ANATOMY", 6, 19], ["fibrous septa", "ANATOMY", 32, 45], ["sinusoids", "ANATOMY", 75, 84], ["microvascular", "MULTI-TISSUE_STRUCTURE", 6, 19], ["fibrous septa", "TISSUE", 32, 45], ["sinusoids", "TISSUE", 75, 84], ["microvascular channels", "ANATOMY", 6, 28], ["fibrous septa", "OBSERVATION", 32, 45], ["resist flow", "OBSERVATION", 46, 57], ["sinusoids", "OBSERVATION_MODIFIER", 75, 84]]], ["This factor, as well as the relative increase in flow in these vessels shunting around the nodules, contributes to portal hypertension.", [["vessels", "ANATOMY", 63, 70], ["nodules", "ANATOMY", 91, 98], ["portal", "ANATOMY", 115, 121], ["hypertension", "DISEASE", 122, 134], ["vessels", "MULTI-TISSUE_STRUCTURE", 63, 70], ["portal", "MULTI-TISSUE_STRUCTURE", 115, 121], ["the relative increase in flow in these vessels shunting", "PROBLEM", 24, 79], ["the nodules", "PROBLEM", 87, 98], ["portal hypertension", "PROBLEM", 115, 134], ["increase", "OBSERVATION_MODIFIER", 37, 45], ["flow", "OBSERVATION", 49, 53], ["vessels", "ANATOMY", 63, 70], ["shunting", "OBSERVATION", 71, 79], ["nodules", "OBSERVATION", 91, 98], ["portal", "ANATOMY", 115, 121], ["hypertension", "OBSERVATION", 122, 134]]], ["Impaired exchange between hepatocytes and sinusoidal blood, because of the increase in perisinusoidal ECM.290.e1Further reading clinical signs of hepatic encephalopathy between different species.", [["hepatocytes", "ANATOMY", 26, 37], ["sinusoidal blood", "ANATOMY", 42, 58], ["hepatic", "ANATOMY", 146, 153], ["hepatic encephalopathy", "DISEASE", 146, 168], ["hepatocytes", "CELL", 26, 37], ["sinusoidal blood", "MULTI-TISSUE_STRUCTURE", 42, 58], ["hepatic", "ORGAN", 146, 153], ["hepatocytes", "CELL_TYPE", 26, 37], ["ECM", "PROTEIN", 102, 105], ["Impaired exchange between hepatocytes", "PROBLEM", 0, 37], ["sinusoidal blood", "TEST", 42, 58], ["the increase in perisinusoidal ECM", "PROBLEM", 71, 105], ["hepatic encephalopathy", "PROBLEM", 146, 168], ["different species", "PROBLEM", 177, 194], ["exchange", "OBSERVATION", 9, 17], ["hepatocytes", "ANATOMY", 26, 37], ["sinusoidal blood", "ANATOMY", 42, 58], ["increase", "OBSERVATION_MODIFIER", 75, 83], ["perisinusoidal", "ANATOMY_MODIFIER", 87, 101], ["hepatic", "ANATOMY", 146, 153], ["encephalopathy", "OBSERVATION", 154, 168], ["different species", "OBSERVATION", 177, 194]]], ["Sheep rarely show more than dullness and central blindness, with perhaps some compulsive chewing movements and tremor.", [["dullness", "DISEASE", 28, 36], ["blindness", "DISEASE", 49, 58], ["compulsive chewing movements", "DISEASE", 78, 106], ["tremor", "DISEASE", 111, 117], ["Sheep", "ORGANISM", 0, 5], ["Sheep", "SPECIES", 0, 5], ["dullness", "PROBLEM", 28, 36], ["central blindness", "PROBLEM", 41, 58], ["some compulsive chewing movements", "PROBLEM", 73, 106], ["tremor", "PROBLEM", 111, 117], ["more", "OBSERVATION_MODIFIER", 18, 22], ["central", "ANATOMY_MODIFIER", 41, 48], ["blindness", "OBSERVATION", 49, 58], ["compulsive", "OBSERVATION_MODIFIER", 78, 88], ["chewing movements", "OBSERVATION", 89, 106]]], ["The picture in cattle is similar, but mania and aggression may also be seen, whereas frenzy is more often recorded in horses.", [["mania", "DISEASE", 38, 43], ["aggression", "DISEASE", 48, 58], ["cattle", "ORGANISM", 15, 21], ["horses", "ORGANISM_SUBDIVISION", 118, 124], ["cattle", "SPECIES", 15, 21], ["cattle", "SPECIES", 15, 21], ["mania", "PROBLEM", 38, 43], ["may also be seen", "UNCERTAINTY", 59, 75]]], ["The closer clinical observation of cats and dogs may reveal more subtle behavioral changes, and inappetence and vomiting are commonly reported in carnivores with portosystemic shunts.", [["inappetence", "DISEASE", 96, 107], ["vomiting", "DISEASE", 112, 120], ["cats", "ORGANISM", 35, 39], ["dogs", "ORGANISM", 44, 48], ["portosystemic shunts", "PATHOLOGICAL_FORMATION", 162, 182], ["cats", "SPECIES", 35, 39], ["dogs", "SPECIES", 44, 48], ["subtle behavioral changes", "PROBLEM", 65, 90], ["inappetence", "PROBLEM", 96, 107], ["vomiting", "PROBLEM", 112, 120], ["portosystemic shunts", "TREATMENT", 162, 182], ["subtle", "OBSERVATION_MODIFIER", 65, 71], ["behavioral", "OBSERVATION", 72, 82], ["portosystemic shunts", "OBSERVATION", 162, 182]]], ["Ptyalism is common in cats with HE.", [["Ptyalism", "DISEASE", 0, 8], ["HE", "DISEASE", 32, 34], ["cats", "ORGANISM", 22, 26], ["cats", "SPECIES", 22, 26]]], ["The clinical context in which HE occurs can be important.", [["HE", "DISEASE", 30, 32]]], ["In animals with acute hepatic disease, HE is a serious sign, usually indicating imminent death.", [["hepatic", "ANATOMY", 22, 29], ["acute hepatic disease", "DISEASE", 16, 37], ["HE", "DISEASE", 39, 41], ["death", "DISEASE", 89, 94], ["hepatic", "ORGAN", 22, 29], ["acute hepatic disease", "PROBLEM", 16, 37], ["imminent death", "PROBLEM", 80, 94], ["acute", "OBSERVATION_MODIFIER", 16, 21], ["hepatic", "ANATOMY", 22, 29], ["disease", "OBSERVATION", 30, 37]]], ["However, in animals with more chronic conditions, such as portosystemic shunting or deficiency of a urea cycle enzyme, neurologic signs can be intermittent for many months, and may disappear after appropriate dietary modification.", [["neurologic", "ANATOMY", 119, 129], ["urea", "CHEMICAL", 100, 104], ["neurologic signs", "DISEASE", 119, 135], ["urea", "CHEMICAL", 100, 104], ["urea", "SIMPLE_CHEMICAL", 100, 104], ["urea cycle enzyme", "PROTEIN", 100, 117], ["more chronic conditions", "PROBLEM", 25, 48], ["portosystemic shunting", "PROBLEM", 58, 80], ["deficiency", "PROBLEM", 84, 94], ["a urea cycle enzyme", "TEST", 98, 117], ["neurologic signs", "PROBLEM", 119, 135], ["chronic", "OBSERVATION_MODIFIER", 30, 37], ["conditions", "OBSERVATION", 38, 48], ["portosystemic shunting", "OBSERVATION", 58, 80]]], ["The pathogenesis of HE involves more than just neurons, as astrocyte and glial cell responses are now evident.", [["neurons", "ANATOMY", 47, 54], ["astrocyte", "ANATOMY", 59, 68], ["glial cell", "ANATOMY", 73, 83], ["HE", "DISEASE", 20, 22], ["neurons", "CELL", 47, 54], ["astrocyte", "CELL", 59, 68], ["glial cell", "CELL", 73, 83], ["glial cell", "OBSERVATION", 73, 83]]], ["Older literature, particularly in vitro studies, which did not take all of these features into account, will likely need reinterpretation.290.e1Ammonia toxicity is regarded as the major part of the clinical signs and the brain lesions; however, there are a number of other factors that may play a role.", [["brain lesions", "ANATOMY", 221, 234], ["290.e1Ammonia", "CHEMICAL", 138, 151], ["toxicity", "DISEASE", 152, 160], ["brain lesions", "DISEASE", 221, 234], ["290.e1Ammonia", "SIMPLE_CHEMICAL", 138, 151], ["brain lesions", "CANCER", 221, 234], ["vitro studies", "TEST", 34, 47], ["the brain lesions", "PROBLEM", 217, 234], ["brain", "ANATOMY", 221, 226], ["lesions", "OBSERVATION", 227, 234]]], ["Blood ammonia is largely of dietary origin, derived from protein and urea by microflora in the large bowel.", [["Blood", "ANATOMY", 0, 5], ["bowel", "ANATOMY", 101, 106], ["ammonia", "CHEMICAL", 6, 13], ["urea", "CHEMICAL", 69, 73], ["ammonia", "CHEMICAL", 6, 13], ["urea", "CHEMICAL", 69, 73], ["Blood", "ORGANISM_SUBSTANCE", 0, 5], ["ammonia", "SIMPLE_CHEMICAL", 6, 13], ["urea", "SIMPLE_CHEMICAL", 69, 73], ["bowel", "ORGAN", 101, 106], ["Blood ammonia", "TEST", 0, 13], ["protein and urea", "TEST", 57, 73], ["large", "ANATOMY_MODIFIER", 95, 100], ["bowel", "ANATOMY", 101, 106]]], ["Ammonia is also derived from hepatic deamination of amino acids and from metabolism of glutamine in peripheral tissues.", [["hepatic", "ANATOMY", 29, 36], ["peripheral tissues", "ANATOMY", 100, 118], ["Ammonia", "CHEMICAL", 0, 7], ["amino acids", "CHEMICAL", 52, 63], ["glutamine", "CHEMICAL", 87, 96], ["Ammonia", "CHEMICAL", 0, 7], ["amino acids", "CHEMICAL", 52, 63], ["glutamine", "CHEMICAL", 87, 96], ["Ammonia", "SIMPLE_CHEMICAL", 0, 7], ["hepatic", "ORGAN", 29, 36], ["amino acids", "AMINO_ACID", 52, 63], ["glutamine", "AMINO_ACID", 87, 96], ["peripheral tissues", "TISSUE", 100, 118], ["Ammonia", "TEST", 0, 7], ["hepatic deamination of amino acids", "TREATMENT", 29, 63], ["glutamine in peripheral tissues", "TREATMENT", 87, 118], ["hepatic", "ANATOMY", 29, 36], ["amino acids", "OBSERVATION", 52, 63], ["peripheral tissues", "ANATOMY", 100, 118]]], ["Ammonia is normally removed in the first pass of portal blood through the liver, wherein it is incorporated with carbon dioxide into carbamoyl phosphate that enters the urea cycle.", [["portal blood", "ANATOMY", 49, 61], ["liver", "ANATOMY", 74, 79], ["Ammonia", "CHEMICAL", 0, 7], ["carbon dioxide", "CHEMICAL", 113, 127], ["carbamoyl phosphate", "CHEMICAL", 133, 152], ["urea", "CHEMICAL", 169, 173], ["Ammonia", "CHEMICAL", 0, 7], ["carbon dioxide", "CHEMICAL", 113, 127], ["carbamoyl phosphate", "CHEMICAL", 133, 152], ["urea", "CHEMICAL", 169, 173], ["Ammonia", "SIMPLE_CHEMICAL", 0, 7], ["portal", "MULTI-TISSUE_STRUCTURE", 49, 55], ["blood", "ORGANISM_SUBSTANCE", 56, 61], ["liver", "ORGAN", 74, 79], ["carbon dioxide", "SIMPLE_CHEMICAL", 113, 127], ["carbamoyl phosphate", "SIMPLE_CHEMICAL", 133, 152], ["urea", "SIMPLE_CHEMICAL", 169, 173], ["Ammonia", "TEST", 0, 7], ["carbon dioxide into carbamoyl phosphate", "TREATMENT", 113, 152], ["normally", "OBSERVATION_MODIFIER", 11, 19], ["removed", "OBSERVATION", 20, 27], ["portal blood", "ANATOMY", 49, 61], ["liver", "ANATOMY", 74, 79]]], ["In shunting or hepatic failure, ammonia that bypasses hepatic clearance accumulates in the circulation.", [["hepatic", "ANATOMY", 15, 22], ["hepatic", "ANATOMY", 54, 61], ["hepatic failure", "DISEASE", 15, 30], ["ammonia", "CHEMICAL", 32, 39], ["ammonia", "CHEMICAL", 32, 39], ["hepatic", "ORGAN", 15, 22], ["ammonia", "SIMPLE_CHEMICAL", 32, 39], ["hepatic", "ORGAN", 54, 61], ["hepatic failure", "PROBLEM", 15, 30], ["shunting", "OBSERVATION", 3, 11], ["hepatic", "ANATOMY", 15, 22], ["failure", "OBSERVATION", 23, 30], ["ammonia", "OBSERVATION_MODIFIER", 32, 39], ["hepatic", "ANATOMY", 54, 61], ["clearance", "OBSERVATION", 62, 71], ["circulation", "OBSERVATION_MODIFIER", 91, 102]]], ["Ammonia is able to cross the blood-brain barrier, and initially, this influx leads to astrocyte injury.", [["blood-brain barrier", "ANATOMY", 29, 48], ["astrocyte", "ANATOMY", 86, 95], ["Ammonia", "CHEMICAL", 0, 7], ["Ammonia", "CHEMICAL", 0, 7], ["Ammonia", "SIMPLE_CHEMICAL", 0, 7], ["blood-", "MULTI-TISSUE_STRUCTURE", 29, 35], ["brain barrier", "MULTI-TISSUE_STRUCTURE", 35, 48], ["astrocyte", "CELL", 86, 95], ["Ammonia", "TEST", 0, 7], ["astrocyte injury", "PROBLEM", 86, 102], ["brain", "ANATOMY", 35, 40], ["astrocyte injury", "OBSERVATION", 86, 102]]], ["Astrocytes are the site of ammonia detoxification in the brain, and they eliminate ammonia by the synthesis of glutamine through amidation of glutamate by the enzyme glutamine synthetase.", [["Astrocytes", "ANATOMY", 0, 10], ["brain", "ANATOMY", 57, 62], ["ammonia", "CHEMICAL", 27, 34], ["ammonia", "CHEMICAL", 83, 90], ["glutamine", "CHEMICAL", 111, 120], ["glutamate", "CHEMICAL", 142, 151], ["glutamine", "CHEMICAL", 166, 175], ["ammonia", "CHEMICAL", 27, 34], ["ammonia", "CHEMICAL", 83, 90], ["glutamine", "CHEMICAL", 111, 120], ["glutamate", "CHEMICAL", 142, 151], ["glutamine", "CHEMICAL", 166, 175], ["Astrocytes", "CELL", 0, 10], ["ammonia", "SIMPLE_CHEMICAL", 27, 34], ["brain", "ORGAN", 57, 62], ["ammonia", "SIMPLE_CHEMICAL", 83, 90], ["glutamine", "AMINO_ACID", 111, 120], ["glutamate", "SIMPLE_CHEMICAL", 142, 151], ["glutamine synthetase", "GENE_OR_GENE_PRODUCT", 166, 186], ["Astrocytes", "CELL_TYPE", 0, 10], ["enzyme glutamine synthetase", "PROTEIN", 159, 186], ["Astrocytes", "PROBLEM", 0, 10], ["ammonia detoxification in the brain", "PROBLEM", 27, 62], ["glutamine through amidation of glutamate", "TREATMENT", 111, 151], ["the enzyme glutamine synthetase", "TREATMENT", 155, 186], ["ammonia detoxification", "OBSERVATION", 27, 49], ["brain", "ANATOMY", 57, 62]]], ["Elevated blood ammonia increases the accumulation of glutamine in astrocytes, resulting in osmotic stress and astrocyte swelling caused by cytotoxic edema.", [["blood", "ANATOMY", 9, 14], ["astrocytes", "ANATOMY", 66, 76], ["astrocyte", "ANATOMY", 110, 119], ["ammonia", "CHEMICAL", 15, 22], ["glutamine", "CHEMICAL", 53, 62], ["swelling", "DISEASE", 120, 128], ["edema", "DISEASE", 149, 154], ["ammonia", "CHEMICAL", 15, 22], ["glutamine", "CHEMICAL", 53, 62], ["blood", "ORGANISM_SUBSTANCE", 9, 14], ["ammonia", "SIMPLE_CHEMICAL", 15, 22], ["glutamine", "AMINO_ACID", 53, 62], ["astrocytes", "CELL", 66, 76], ["astrocyte", "CELL", 110, 119], ["edema", "PATHOLOGICAL_FORMATION", 149, 154], ["astrocytes", "CELL_TYPE", 66, 76], ["Elevated blood ammonia", "PROBLEM", 0, 22], ["glutamine in astrocytes", "TREATMENT", 53, 76], ["osmotic stress", "PROBLEM", 91, 105], ["astrocyte swelling", "PROBLEM", 110, 128], ["cytotoxic edema", "PROBLEM", 139, 154], ["blood", "ANATOMY", 9, 14], ["ammonia increases", "OBSERVATION", 15, 32], ["accumulation of glutamine", "OBSERVATION", 37, 62], ["osmotic stress", "OBSERVATION", 91, 105], ["astrocyte swelling", "OBSERVATION", 110, 128], ["cytotoxic", "OBSERVATION_MODIFIER", 139, 148], ["edema", "OBSERVATION", 149, 154]]], ["Affected astrocytes that are adjacent to endothelium cannot maintain the blood-brain barrier, and this permits increased ammonia entry into the brain.", [["astrocytes", "ANATOMY", 9, 19], ["endothelium", "ANATOMY", 41, 52], ["blood-brain barrier", "ANATOMY", 73, 92], ["brain", "ANATOMY", 144, 149], ["ammonia", "CHEMICAL", 121, 128], ["ammonia", "CHEMICAL", 121, 128], ["astrocytes", "CELL", 9, 19], ["endothelium", "TISSUE", 41, 52], ["blood-brain barrier", "TISSUE", 73, 92], ["ammonia", "SIMPLE_CHEMICAL", 121, 128], ["brain", "ORGAN", 144, 149], ["astrocytes", "CELL_TYPE", 9, 19], ["Affected astrocytes", "PROBLEM", 0, 19], ["increased ammonia entry into the brain", "PROBLEM", 111, 149], ["astrocytes", "OBSERVATION", 9, 19], ["endothelium", "ANATOMY", 41, 52], ["brain", "ANATOMY", 79, 84], ["brain", "ANATOMY", 144, 149]]], ["Direct ammonia-induced effects on brain endothelial cells are also possible.", [["brain endothelial cells", "ANATOMY", 34, 57], ["ammonia", "CHEMICAL", 7, 14], ["ammonia", "CHEMICAL", 7, 14], ["ammonia", "SIMPLE_CHEMICAL", 7, 14], ["brain endothelial cells", "CELL", 34, 57], ["brain endothelial cells", "CELL_TYPE", 34, 57], ["Direct ammonia", "TEST", 0, 14], ["brain endothelial cells", "PROBLEM", 34, 57], ["brain", "ANATOMY", 34, 39], ["endothelial cells", "OBSERVATION", 40, 57]]], ["Briefly, the consequences of increased ammonia in the brain include a net decrease in energy metabolism within the brain, increased edema formation because of astrocyte dysfunction, and injury to neurons, leading to an imbalance in neurotransmitters that emphasizes neural inhibition.290.e1The pathogenesis of HE may vary depending on the type of liver failure-acute or chronic-that produces the cerebral injury.", [["brain", "ANATOMY", 54, 59], ["brain", "ANATOMY", 115, 120], ["edema", "ANATOMY", 132, 137], ["astrocyte", "ANATOMY", 159, 168], ["neurons", "ANATOMY", 196, 203], ["neural", "ANATOMY", 266, 272], ["liver", "ANATOMY", 347, 352], ["cerebral", "ANATOMY", 396, 404], ["ammonia", "CHEMICAL", 39, 46], ["edema", "DISEASE", 132, 137], ["astrocyte dysfunction", "DISEASE", 159, 180], ["HE", "DISEASE", 310, 312], ["liver failure", "DISEASE", 347, 360], ["cerebral injury", "DISEASE", 396, 411], ["ammonia", "CHEMICAL", 39, 46], ["ammonia", "SIMPLE_CHEMICAL", 39, 46], ["brain", "ORGAN", 54, 59], ["brain", "ORGAN", 115, 120], ["edema", "PATHOLOGICAL_FORMATION", 132, 137], ["astrocyte", "CELL", 159, 168], ["neurons", "CELL", 196, 203], ["liver", "ORGAN", 347, 352], ["cerebral", "ORGAN", 396, 404], ["increased ammonia in the brain", "PROBLEM", 29, 59], ["a net decrease in energy metabolism within the brain", "PROBLEM", 68, 120], ["increased edema formation", "PROBLEM", 122, 147], ["astrocyte dysfunction", "PROBLEM", 159, 180], ["injury to neurons", "PROBLEM", 186, 203], ["an imbalance in neurotransmitters", "PROBLEM", 216, 249], ["liver failure", "PROBLEM", 347, 360], ["the cerebral injury", "PROBLEM", 392, 411], ["increased", "OBSERVATION_MODIFIER", 29, 38], ["ammonia", "OBSERVATION", 39, 46], ["brain", "ANATOMY", 54, 59], ["net", "OBSERVATION_MODIFIER", 70, 73], ["decrease", "OBSERVATION_MODIFIER", 74, 82], ["energy metabolism", "OBSERVATION", 86, 103], ["brain", "ANATOMY", 115, 120], ["increased", "OBSERVATION_MODIFIER", 122, 131], ["edema", "OBSERVATION", 132, 137], ["astrocyte dysfunction", "OBSERVATION", 159, 180], ["imbalance", "OBSERVATION", 219, 228], ["neural inhibition", "OBSERVATION", 266, 283], ["liver", "ANATOMY", 347, 352], ["failure", "OBSERVATION", 353, 360], ["acute", "OBSERVATION_MODIFIER", 361, 366], ["chronic", "OBSERVATION_MODIFIER", 370, 377], ["cerebral", "ANATOMY", 396, 404], ["injury", "OBSERVATION", 405, 411]]], ["Also, not all parts of the brain are affected in a similar fashion.", [["brain", "ANATOMY", 27, 32], ["brain", "ORGAN", 27, 32], ["brain", "ANATOMY", 27, 32], ["affected", "OBSERVATION", 37, 45]]], ["In acute hepatic failure, cerebral edema may be the leading cause of death because of increased intracerebral pressure with possible herniation.", [["hepatic", "ANATOMY", 9, 16], ["cerebral", "ANATOMY", 26, 34], ["intracerebral", "ANATOMY", 96, 109], ["acute hepatic failure", "DISEASE", 3, 24], ["cerebral edema", "DISEASE", 26, 40], ["death", "DISEASE", 69, 74], ["herniation", "DISEASE", 133, 143], ["hepatic", "ORGAN", 9, 16], ["cerebral edema", "PATHOLOGICAL_FORMATION", 26, 40], ["intracerebral", "IMMATERIAL_ANATOMICAL_ENTITY", 96, 109], ["acute hepatic failure", "PROBLEM", 3, 24], ["cerebral edema", "PROBLEM", 26, 40], ["death", "PROBLEM", 69, 74], ["increased intracerebral pressure", "PROBLEM", 86, 118], ["herniation", "PROBLEM", 133, 143], ["acute", "OBSERVATION_MODIFIER", 3, 8], ["hepatic", "ANATOMY", 9, 16], ["failure", "OBSERVATION", 17, 24], ["cerebral", "ANATOMY", 26, 34], ["edema", "OBSERVATION", 35, 40], ["increased", "OBSERVATION_MODIFIER", 86, 95], ["intracerebral pressure", "OBSERVATION", 96, 118], ["possible", "UNCERTAINTY", 124, 132], ["herniation", "OBSERVATION", 133, 143]]], ["The increase in intracranial pressure is, however, linked to brain ammonia levels.", [["intracranial", "ANATOMY", 16, 28], ["brain", "ANATOMY", 61, 66], ["ammonia", "CHEMICAL", 67, 74], ["ammonia", "CHEMICAL", 67, 74], ["intracranial", "MULTI-TISSUE_STRUCTURE", 16, 28], ["brain", "ORGAN", 61, 66], ["ammonia", "SIMPLE_CHEMICAL", 67, 74], ["The increase in intracranial pressure", "PROBLEM", 0, 37], ["brain ammonia levels", "TEST", 61, 81], ["increase", "OBSERVATION_MODIFIER", 4, 12], ["intracranial pressure", "OBSERVATION", 16, 37], ["ammonia levels", "OBSERVATION", 67, 81]]], ["Currently, it is thought that swollen astrocytes release vasogenic factors, such as nitric oxide, causing intracerebral hyperemia, and that this leads to edema formation.", [["swollen astrocytes", "ANATOMY", 30, 48], ["intracerebral", "ANATOMY", 106, 119], ["edema", "ANATOMY", 154, 159], ["vasogenic", "DISEASE", 57, 66], ["nitric oxide", "CHEMICAL", 84, 96], ["intracerebral hyperemia", "DISEASE", 106, 129], ["edema", "DISEASE", 154, 159], ["nitric oxide", "CHEMICAL", 84, 96], ["astrocytes", "CELL", 38, 48], ["vasogenic factors", "GENE_OR_GENE_PRODUCT", 57, 74], ["nitric oxide", "SIMPLE_CHEMICAL", 84, 96], ["intracerebral", "IMMATERIAL_ANATOMICAL_ENTITY", 106, 119], ["edema", "PATHOLOGICAL_FORMATION", 154, 159], ["swollen astrocytes", "CELL_TYPE", 30, 48], ["vasogenic factors", "PROTEIN", 57, 74], ["swollen astrocytes release vasogenic factors", "PROBLEM", 30, 74], ["nitric oxide", "TREATMENT", 84, 96], ["intracerebral hyperemia", "PROBLEM", 106, 129], ["edema formation", "PROBLEM", 154, 169], ["swollen", "OBSERVATION", 30, 37], ["intracerebral", "OBSERVATION_MODIFIER", 106, 119], ["hyperemia", "OBSERVATION", 120, 129], ["edema", "OBSERVATION", 154, 159]]], ["Systemic inflammatory responses can enhance the severity of HE.", [["HE", "DISEASE", 60, 62], ["Systemic inflammatory responses", "PROBLEM", 0, 31], ["inflammatory", "OBSERVATION", 9, 21]]], ["Neuroinflammation, mediated by microglia, is evident in acute liver failure and tends to increase with increasing duration of HE.", [["microglia", "ANATOMY", 31, 40], ["liver", "ANATOMY", 62, 67], ["Neuroinflammation", "DISEASE", 0, 17], ["acute liver failure", "DISEASE", 56, 75], ["HE", "DISEASE", 126, 128], ["microglia", "CELL", 31, 40], ["liver", "ORGAN", 62, 67], ["microglia", "CELL_TYPE", 31, 40], ["Neuroinflammation", "PROBLEM", 0, 17], ["acute liver failure", "PROBLEM", 56, 75], ["acute", "OBSERVATION_MODIFIER", 56, 61], ["liver", "ANATOMY", 62, 67], ["failure", "OBSERVATION", 68, 75], ["increase", "OBSERVATION_MODIFIER", 89, 97], ["increasing", "OBSERVATION_MODIFIER", 103, 113]]], ["Synergetic interactions between increased ammonia and systemic or neuroinflammation can increase the severity of HE. defined as \"failure,\" given the various functions of the liver, but it is best understood as the point at which liver function is not capable of sustaining life.", [["liver", "ANATOMY", 174, 179], ["liver", "ANATOMY", 229, 234], ["ammonia", "CHEMICAL", 42, 49], ["neuroinflammation", "DISEASE", 66, 83], ["HE", "DISEASE", 113, 115], ["ammonia", "CHEMICAL", 42, 49], ["ammonia", "SIMPLE_CHEMICAL", 42, 49], ["liver", "ORGAN", 174, 179], ["liver", "ORGAN", 229, 234], ["Synergetic interactions", "PROBLEM", 0, 23], ["increased ammonia", "PROBLEM", 32, 49], ["neuroinflammation", "PROBLEM", 66, 83], ["\"failure", "PROBLEM", 128, 136], ["increased", "OBSERVATION_MODIFIER", 32, 41], ["ammonia", "OBSERVATION", 42, 49], ["failure", "OBSERVATION", 129, 136], ["liver", "ANATOMY", 174, 179], ["liver", "ANATOMY", 229, 234], ["not capable", "UNCERTAINTY", 247, 258]]], ["The liver is an organ with very large functional capacity and regenerative potential.", [["liver", "ANATOMY", 4, 9], ["organ", "ANATOMY", 16, 21], ["liver", "ORGAN", 4, 9], ["organ", "ORGAN", 16, 21], ["very large functional capacity", "PROBLEM", 27, 57], ["liver", "ANATOMY", 4, 9], ["organ", "ANATOMY", 16, 21], ["very", "OBSERVATION_MODIFIER", 27, 31], ["large", "OBSERVATION_MODIFIER", 32, 37], ["functional capacity", "OBSERVATION", 38, 57], ["regenerative potential", "OBSERVATION", 62, 84]]], ["Signs of insufficiency do not develop until the reserves in production, supply, and recovery are exhausted.", [["insufficiency", "DISEASE", 9, 22], ["Signs of insufficiency", "PROBLEM", 0, 22], ["insufficiency", "OBSERVATION", 9, 22]]], ["The central role of the liver in many systemic functions means that liver disease can be manifested as lesions or dysfunctions elsewhere, for example, in the brain, skin, blood, and gut.", [["liver", "ANATOMY", 24, 29], ["liver", "ANATOMY", 68, 73], ["lesions", "ANATOMY", 103, 110], ["brain", "ANATOMY", 158, 163], ["skin", "ANATOMY", 165, 169], ["blood", "ANATOMY", 171, 176], ["gut", "ANATOMY", 182, 185], ["liver disease", "DISEASE", 68, 81], ["liver", "ORGAN", 24, 29], ["liver", "ORGAN", 68, 73], ["lesions", "PATHOLOGICAL_FORMATION", 103, 110], ["brain", "ORGAN", 158, 163], ["skin", "ORGAN", 165, 169], ["blood", "ORGANISM_SUBSTANCE", 171, 176], ["gut", "ORGANISM_SUBDIVISION", 182, 185], ["liver disease", "PROBLEM", 68, 81], ["lesions", "PROBLEM", 103, 110], ["dysfunctions", "PROBLEM", 114, 126], ["central", "ANATOMY_MODIFIER", 4, 11], ["liver", "ANATOMY", 24, 29], ["many", "OBSERVATION_MODIFIER", 33, 37], ["systemic", "OBSERVATION", 38, 46], ["liver", "ANATOMY", 68, 73], ["disease", "OBSERVATION", 74, 81], ["lesions", "OBSERVATION", 103, 110], ["dysfunctions", "OBSERVATION", 114, 126], ["brain", "ANATOMY", 158, 163], ["skin", "ANATOMY", 165, 169], ["blood", "ANATOMY", 171, 176], ["gut", "ANATOMY", 182, 185]]], ["Failure may develop suddenly, frequently following exposure to toxic compounds, or failure may develop in a slow inexorable fashion as a chronic disease processes.", [["Failure", "PROBLEM", 0, 7], ["toxic compounds", "PROBLEM", 63, 78], ["failure", "PROBLEM", 83, 90], ["a slow inexorable fashion", "PROBLEM", 106, 131], ["a chronic disease processes", "PROBLEM", 135, 162], ["toxic compounds", "OBSERVATION", 63, 78], ["chronic", "OBSERVATION_MODIFIER", 137, 144], ["disease", "OBSERVATION", 145, 152]]], ["Hepatic failure, particularly chronic liver failure, may not affect all processes equally, and one or more features of liver failure may predominate in individual cases.290.e1Acute liver failure is uncommon, and is clinically evidenced as a severe and rapid liver injury.", [["Hepatic", "ANATOMY", 0, 7], ["liver", "ANATOMY", 38, 43], ["liver", "ANATOMY", 119, 124], ["liver", "ANATOMY", 181, 186], ["liver", "ANATOMY", 258, 263], ["Hepatic failure", "DISEASE", 0, 15], ["chronic liver failure", "DISEASE", 30, 51], ["liver failure", "DISEASE", 119, 132], ["liver failure", "DISEASE", 181, 194], ["liver injury", "DISEASE", 258, 270], ["Hepatic", "ORGAN", 0, 7], ["liver", "ORGAN", 38, 43], ["liver", "ORGAN", 119, 124], ["liver", "ORGAN", 181, 186], ["liver", "ORGAN", 258, 263], ["Hepatic failure", "PROBLEM", 0, 15], ["chronic liver failure", "PROBLEM", 30, 51], ["liver failure", "PROBLEM", 119, 132], ["Acute liver failure", "PROBLEM", 175, 194], ["a severe and rapid liver injury", "PROBLEM", 239, 270], ["failure", "OBSERVATION", 8, 15], ["chronic", "OBSERVATION_MODIFIER", 30, 37], ["liver", "ANATOMY", 38, 43], ["failure", "OBSERVATION", 44, 51], ["liver", "ANATOMY", 119, 124], ["failure", "OBSERVATION", 125, 132], ["Acute", "OBSERVATION_MODIFIER", 175, 180], ["liver", "ANATOMY", 181, 186], ["failure", "OBSERVATION", 187, 194], ["severe", "OBSERVATION_MODIFIER", 241, 247], ["rapid", "OBSERVATION_MODIFIER", 252, 257], ["liver", "ANATOMY", 258, 263], ["injury", "OBSERVATION", 264, 270]]], ["There are a number of causes.", [["number", "OBSERVATION_MODIFIER", 12, 18]]], ["The consequences are also multiple and varied, including abrupt loss of normal metabolic and immunologic functions, as well as hepatic encephalopathy, coagulopathy, jaundice, photosensitization (in herbivores), and possibly dysfunction of other organs.", [["hepatic", "ANATOMY", 127, 134], ["organs", "ANATOMY", 245, 251], ["hepatic encephalopathy", "DISEASE", 127, 149], ["coagulopathy", "DISEASE", 151, 163], ["jaundice", "DISEASE", 165, 173], ["photosensitization", "DISEASE", 175, 193], ["hepatic", "ORGAN", 127, 134], ["organs", "ORGAN", 245, 251], ["abrupt loss of normal metabolic and immunologic functions", "PROBLEM", 57, 114], ["hepatic encephalopathy", "PROBLEM", 127, 149], ["coagulopathy", "PROBLEM", 151, 163], ["jaundice", "PROBLEM", 165, 173], ["photosensitization", "PROBLEM", 175, 193], ["dysfunction of other organs", "PROBLEM", 224, 251], ["multiple", "OBSERVATION_MODIFIER", 26, 34], ["abrupt", "OBSERVATION_MODIFIER", 57, 63], ["loss", "OBSERVATION_MODIFIER", 64, 68], ["normal metabolic", "OBSERVATION", 72, 88], ["immunologic functions", "OBSERVATION", 93, 114], ["hepatic", "ANATOMY", 127, 134], ["encephalopathy", "OBSERVATION", 135, 149], ["coagulopathy", "OBSERVATION", 151, 163], ["jaundice", "OBSERVATION", 165, 173], ["possibly", "UNCERTAINTY", 215, 223], ["dysfunction", "OBSERVATION", 224, 235], ["organs", "ANATOMY", 245, 251]]], ["In humans, there are recognized viral infections that can cause acute liver failure, but there are currently no known animal viruses capable of causing this syndrome, although recent studies suggest that equine serum hepatitis (Theiler's disease) may be caused by an equine pegivirus.", [["liver", "ANATOMY", 70, 75], ["serum", "ANATOMY", 211, 216], ["viral infections", "DISEASE", 32, 48], ["acute liver failure", "DISEASE", 64, 83], ["equine serum hepatitis", "DISEASE", 204, 226], ["Theiler's disease", "DISEASE", 228, 245], ["humans", "ORGANISM", 3, 9], ["liver", "ORGAN", 70, 75], ["equine", "ORGANISM", 204, 210], ["serum hepatitis", "ORGANISM", 211, 226], ["Theiler's disease", "ORGANISM", 228, 245], ["humans", "SPECIES", 3, 9], ["equine", "SPECIES", 204, 210], ["Theiler", "SPECIES", 228, 235], ["humans", "SPECIES", 3, 9], ["equine pegivirus", "SPECIES", 267, 283], ["recognized viral infections", "PROBLEM", 21, 48], ["acute liver failure", "PROBLEM", 64, 83], ["known animal viruses", "PROBLEM", 112, 132], ["this syndrome", "PROBLEM", 152, 165], ["recent studies", "TEST", 176, 190], ["equine serum hepatitis", "PROBLEM", 204, 226], ["Theiler's disease", "PROBLEM", 228, 245], ["an equine pegivirus", "PROBLEM", 264, 283], ["viral infections", "OBSERVATION", 32, 48], ["acute", "OBSERVATION_MODIFIER", 64, 69], ["liver", "ANATOMY", 70, 75], ["failure", "OBSERVATION", 76, 83], ["viruses", "OBSERVATION", 125, 132]]], ["Toxin-induced acute liver failure is likely the most common form in veterinary medicine.", [["liver", "ANATOMY", 20, 25], ["Toxin", "CHEMICAL", 0, 5], ["acute liver failure", "DISEASE", 14, 33], ["Toxin", "GENE_OR_GENE_PRODUCT", 0, 5], ["liver", "ORGAN", 20, 25], ["Toxin", "TEST", 0, 5], ["acute liver failure", "PROBLEM", 14, 33], ["acute", "OBSERVATION_MODIFIER", 14, 19], ["liver", "ANATOMY", 20, 25], ["failure", "OBSERVATION", 26, 33]]], ["The toxic injury may come from natural sources, such as those found in plants and fungi, or from overdose of or idiosyncratic reactions to therapeutic drugs.", [["toxic injury", "DISEASE", 4, 16], ["overdose", "DISEASE", 97, 105], ["The toxic injury", "PROBLEM", 0, 16], ["fungi", "PROBLEM", 82, 87], ["idiosyncratic reactions", "PROBLEM", 112, 135], ["therapeutic drugs", "TREATMENT", 139, 156], ["toxic", "OBSERVATION_MODIFIER", 4, 9], ["injury", "OBSERVATION", 10, 16]]], ["Hyperthermia from environmental heating or prolonged seizure activity can also cause acute hepatic failure.", [["hepatic", "ANATOMY", 91, 98], ["Hyperthermia", "DISEASE", 0, 12], ["seizure", "DISEASE", 53, 60], ["acute hepatic failure", "DISEASE", 85, 106], ["hepatic", "ORGAN", 91, 98], ["Hyperthermia", "PROBLEM", 0, 12], ["environmental heating", "TREATMENT", 18, 39], ["prolonged seizure activity", "PROBLEM", 43, 69], ["acute hepatic failure", "PROBLEM", 85, 106], ["acute", "OBSERVATION_MODIFIER", 85, 90], ["hepatic", "ANATOMY", 91, 98], ["failure", "OBSERVATION", 99, 106]]], ["Acute ischemic injury from profound hypotension secondary to sepsis or cardiac failure may also occur.290.e1Chronic liver failure results from progressive destructive processes, such as fibrosis or inflammation, or a combination of the two.", [["cardiac", "ANATOMY", 71, 78], ["liver", "ANATOMY", 116, 121], ["ischemic injury", "DISEASE", 6, 21], ["hypotension", "DISEASE", 36, 47], ["sepsis", "DISEASE", 61, 67], ["cardiac failure", "DISEASE", 71, 86], ["liver failure", "DISEASE", 116, 129], ["fibrosis", "DISEASE", 186, 194], ["inflammation", "DISEASE", 198, 210], ["cardiac", "ORGAN", 71, 78], ["liver", "ORGAN", 116, 121], ["Acute ischemic injury", "PROBLEM", 0, 21], ["profound hypotension", "PROBLEM", 27, 47], ["sepsis", "PROBLEM", 61, 67], ["cardiac failure", "PROBLEM", 71, 86], ["Chronic liver failure", "PROBLEM", 108, 129], ["progressive destructive processes", "PROBLEM", 143, 176], ["fibrosis", "PROBLEM", 186, 194], ["inflammation", "PROBLEM", 198, 210], ["ischemic", "OBSERVATION_MODIFIER", 6, 14], ["injury", "OBSERVATION", 15, 21], ["profound", "OBSERVATION_MODIFIER", 27, 35], ["hypotension", "OBSERVATION", 36, 47], ["sepsis", "OBSERVATION", 61, 67], ["cardiac", "ANATOMY", 71, 78], ["failure", "OBSERVATION", 79, 86], ["Chronic", "OBSERVATION_MODIFIER", 108, 115], ["liver", "ANATOMY", 116, 121], ["failure", "OBSERVATION", 122, 129], ["progressive", "OBSERVATION_MODIFIER", 143, 154], ["destructive", "OBSERVATION_MODIFIER", 155, 166], ["fibrosis", "OBSERVATION", 186, 194], ["inflammation", "OBSERVATION", 198, 210]]], ["The hallmarks of chronic liver failure in dogs are fibrosis and nodular regeneration, but other species are more prone to a fibrotic response alone.", [["liver", "ANATOMY", 25, 30], ["nodular", "ANATOMY", 64, 71], ["chronic liver failure", "DISEASE", 17, 38], ["fibrosis", "DISEASE", 51, 59], ["liver", "ORGAN", 25, 30], ["dogs", "ORGANISM", 42, 46], ["nodular", "PATHOLOGICAL_FORMATION", 64, 71], ["dogs", "SPECIES", 42, 46], ["chronic liver failure", "PROBLEM", 17, 38], ["fibrosis", "PROBLEM", 51, 59], ["nodular regeneration", "PROBLEM", 64, 84], ["other species", "PROBLEM", 90, 103], ["hallmarks", "OBSERVATION_MODIFIER", 4, 13], ["chronic", "OBSERVATION_MODIFIER", 17, 24], ["liver", "ANATOMY", 25, 30], ["failure", "OBSERVATION", 31, 38], ["fibrosis", "OBSERVATION", 51, 59], ["nodular", "OBSERVATION_MODIFIER", 64, 71], ["regeneration", "OBSERVATION", 72, 84], ["fibrotic", "OBSERVATION", 124, 132]]], ["The progressive loss of critical functional hepatic mass caused by ongoing hepatocyte injury, shunting of portal blood within fibrous septa bypassing hepatocytes, and abnormal bile drainage, lead to a terminal stage of hepatic insufficiency.290.e1Chronic liver failure can be subdivided into 2 forms: endstage liver, the typical fibrotic liver with progressive loss of functional hepatic mass, and \"acute on chronic failure,\" a circumstance in which a patient with compensated chronic liver disease acutely develops failure.", [["hepatic mass", "ANATOMY", 44, 56], ["hepatocyte", "ANATOMY", 75, 85], ["portal blood", "ANATOMY", 106, 118], ["fibrous septa", "ANATOMY", 126, 139], ["hepatocytes", "ANATOMY", 150, 161], ["bile", "ANATOMY", 176, 180], ["hepatic", "ANATOMY", 219, 226], ["liver", "ANATOMY", 255, 260], ["liver", "ANATOMY", 310, 315], ["liver", "ANATOMY", 338, 343], ["hepatic mass", "ANATOMY", 380, 392], ["liver", "ANATOMY", 485, 490], ["abnormal bile drainage", "DISEASE", 167, 189], ["hepatic insufficiency", "DISEASE", 219, 240], ["Chronic liver failure", "DISEASE", 247, 268], ["loss of functional hepatic mass", "DISEASE", 361, 392], ["chronic failure", "DISEASE", 408, 423], ["chronic liver disease", "DISEASE", 477, 498], ["hepatic", "ORGAN", 44, 51], ["hepatocyte", "CELL", 75, 85], ["blood", "ORGANISM_SUBSTANCE", 113, 118], ["fibrous septa", "TISSUE", 126, 139], ["hepatocytes", "CELL", 150, 161], ["bile", "IMMATERIAL_ANATOMICAL_ENTITY", 176, 180], ["hepatic", "ORGAN", 219, 226], ["liver", "ORGAN", 255, 260], ["liver", "ORGAN", 310, 315], ["liver", "ORGAN", 338, 343], ["hepatic", "ORGAN", 380, 387], ["patient", "ORGANISM", 452, 459], ["liver", "ORGAN", 485, 490], ["patient", "SPECIES", 452, 459], ["The progressive loss of critical functional hepatic mass", "PROBLEM", 0, 56], ["ongoing hepatocyte injury", "PROBLEM", 67, 92], ["portal blood within fibrous septa bypassing hepatocytes", "PROBLEM", 106, 161], ["abnormal bile drainage", "PROBLEM", 167, 189], ["a terminal stage of hepatic insufficiency", "PROBLEM", 199, 240], ["Chronic liver failure", "PROBLEM", 247, 268], ["endstage liver", "PROBLEM", 301, 315], ["the typical fibrotic liver", "PROBLEM", 317, 343], ["progressive loss of functional hepatic mass", "PROBLEM", 349, 392], ["chronic failure", "PROBLEM", 408, 423], ["compensated chronic liver disease", "PROBLEM", 465, 498], ["failure", "PROBLEM", 516, 523], ["progressive", "OBSERVATION_MODIFIER", 4, 15], ["loss", "OBSERVATION_MODIFIER", 16, 20], ["critical", "OBSERVATION_MODIFIER", 24, 32], ["functional", "OBSERVATION_MODIFIER", 33, 43], ["hepatic", "ANATOMY", 44, 51], ["mass", "OBSERVATION", 52, 56], ["hepatocyte", "ANATOMY", 75, 85], ["injury", "OBSERVATION", 86, 92], ["shunting", "OBSERVATION", 94, 102], ["portal blood", "ANATOMY", 106, 118], ["fibrous septa", "OBSERVATION", 126, 139], ["hepatocytes", "ANATOMY", 150, 161], ["abnormal", "OBSERVATION_MODIFIER", 167, 175], ["bile drainage", "OBSERVATION", 176, 189], ["terminal", "OBSERVATION_MODIFIER", 201, 209], ["stage", "OBSERVATION_MODIFIER", 210, 215], ["hepatic", "ANATOMY", 219, 226], ["insufficiency", "OBSERVATION", 227, 240], ["Chronic", "OBSERVATION_MODIFIER", 247, 254], ["liver", "ANATOMY", 255, 260], ["failure", "OBSERVATION", 261, 268], ["endstage", "OBSERVATION", 301, 309], ["liver", "ANATOMY", 310, 315], ["typical", "OBSERVATION_MODIFIER", 321, 328], ["fibrotic", "OBSERVATION", 329, 337], ["liver", "ANATOMY", 338, 343], ["progressive", "OBSERVATION_MODIFIER", 349, 360], ["loss", "OBSERVATION_MODIFIER", 361, 365], ["functional", "OBSERVATION_MODIFIER", 369, 379], ["hepatic", "ANATOMY", 380, 387], ["mass", "OBSERVATION", 388, 392], ["acute", "OBSERVATION_MODIFIER", 399, 404], ["chronic", "OBSERVATION_MODIFIER", 408, 415], ["failure", "OBSERVATION", 416, 423], ["compensated", "OBSERVATION_MODIFIER", 465, 476], ["chronic", "OBSERVATION_MODIFIER", 477, 484], ["liver", "ANATOMY", 485, 490], ["disease", "OBSERVATION", 491, 498], ["failure", "OBSERVATION", 516, 523]]], ["The causes for the acute transition to failure are not certain, but the buildup of various toxins, such as aromatic amino acids, benzodiazepines, and ammonia, among others, may be involved.", [["aromatic amino acids", "CHEMICAL", 107, 127], ["benzodiazepines", "CHEMICAL", 129, 144], ["ammonia", "CHEMICAL", 150, 157], ["aromatic amino acids", "CHEMICAL", 107, 127], ["benzodiazepines", "CHEMICAL", 129, 144], ["ammonia", "CHEMICAL", 150, 157], ["aromatic amino acids", "SIMPLE_CHEMICAL", 107, 127], ["benzodiazepines", "SIMPLE_CHEMICAL", 129, 144], ["ammonia", "SIMPLE_CHEMICAL", 150, 157], ["the acute transition to failure", "PROBLEM", 15, 46], ["various toxins", "PROBLEM", 83, 97], ["aromatic amino acids", "TEST", 107, 127], ["benzodiazepines", "TREATMENT", 129, 144], ["acute", "OBSERVATION_MODIFIER", 19, 24], ["transition", "OBSERVATION", 25, 35], ["failure", "OBSERVATION", 39, 46]]], ["Other theories include increased bacterial or fungal translocation from the gut, leading to hepatic infection and sepsis.290.e1Liver failure, whether acute or chronic, affects a number of critical processes.", [["gut", "ANATOMY", 76, 79], ["hepatic", "ANATOMY", 92, 99], ["hepatic infection", "DISEASE", 92, 109], ["sepsis", "DISEASE", 114, 120], ["gut", "ORGANISM_SUBDIVISION", 76, 79], ["hepatic", "MULTI-TISSUE_STRUCTURE", 92, 99], ["increased bacterial or fungal translocation", "PROBLEM", 23, 66], ["hepatic infection", "PROBLEM", 92, 109], ["sepsis", "PROBLEM", 114, 120], ["failure", "PROBLEM", 133, 140], ["increased", "OBSERVATION_MODIFIER", 23, 32], ["bacterial", "OBSERVATION_MODIFIER", 33, 42], ["fungal translocation", "OBSERVATION", 46, 66], ["gut", "ANATOMY", 76, 79], ["hepatic", "ANATOMY", 92, 99], ["infection", "OBSERVATION", 100, 109], ["sepsis", "OBSERVATION", 114, 120], ["failure", "OBSERVATION", 133, 140], ["acute", "OBSERVATION_MODIFIER", 150, 155], ["chronic", "OBSERVATION_MODIFIER", 159, 166]]], ["These disturbances include hepatic encephalopathy, cholestasis and jaundice, hepatogenous photosensitization, hemorrhagic diathesis, hepatorenal syndrome, ascites, and hepatocutaneous syndrome.Hepatic encephalopathy (HE)The neurologic manifestations of hepatic failure are variable and nonspecific; they range from dullness, through complete unawareness and compulsive aimless movement, to mania and generalized convulsions.", [["hepatic", "ANATOMY", 27, 34], ["ascites", "ANATOMY", 155, 162], ["neurologic", "ANATOMY", 224, 234], ["hepatic", "ANATOMY", 253, 260], ["hepatic encephalopathy", "DISEASE", 27, 49], ["cholestasis", "DISEASE", 51, 62], ["jaundice", "DISEASE", 67, 75], ["photosensitization", "DISEASE", 90, 108], ["hemorrhagic diathesis", "DISEASE", 110, 131], ["hepatorenal syndrome", "DISEASE", 133, 153], ["ascites", "DISEASE", 155, 162], ["hepatocutaneous syndrome", "DISEASE", 168, 192], ["Hepatic encephalopathy", "DISEASE", 193, 215], ["HE", "DISEASE", 217, 219], ["hepatic failure", "DISEASE", 253, 268], ["dullness", "DISEASE", 315, 323], ["unawareness", "DISEASE", 342, 353], ["compulsive aimless movement", "DISEASE", 358, 385], ["mania", "DISEASE", 390, 395], ["convulsions", "DISEASE", 412, 423], ["hepatic", "ORGAN", 27, 34], ["Hepatic", "ORGAN", 193, 200], ["hepatic", "ORGAN", 253, 260], ["These disturbances", "PROBLEM", 0, 18], ["hepatic encephalopathy", "PROBLEM", 27, 49], ["cholestasis", "PROBLEM", 51, 62], ["jaundice", "PROBLEM", 67, 75], ["hepatogenous photosensitization", "PROBLEM", 77, 108], ["hemorrhagic diathesis", "PROBLEM", 110, 131], ["hepatorenal syndrome", "PROBLEM", 133, 153], ["ascites", "PROBLEM", 155, 162], ["hepatocutaneous syndrome", "PROBLEM", 168, 192], ["Hepatic encephalopathy", "PROBLEM", 193, 215], ["hepatic failure", "PROBLEM", 253, 268], ["dullness", "PROBLEM", 315, 323], ["compulsive aimless movement", "PROBLEM", 358, 385], ["mania", "PROBLEM", 390, 395], ["generalized convulsions", "PROBLEM", 400, 423], ["hepatic", "ANATOMY", 27, 34], ["encephalopathy", "OBSERVATION", 35, 49], ["cholestasis", "OBSERVATION", 51, 62], ["jaundice", "OBSERVATION", 67, 75], ["hepatogenous photosensitization", "OBSERVATION", 77, 108], ["hemorrhagic", "OBSERVATION_MODIFIER", 110, 121], ["diathesis", "OBSERVATION", 122, 131], ["hepatorenal syndrome", "OBSERVATION", 133, 153], ["ascites", "OBSERVATION", 155, 162], ["hepatocutaneous syndrome", "OBSERVATION", 168, 192], ["encephalopathy", "OBSERVATION", 201, 215], ["hepatic", "ANATOMY", 253, 260], ["failure", "OBSERVATION", 261, 268], ["nonspecific", "OBSERVATION_MODIFIER", 286, 297], ["generalized", "OBSERVATION_MODIFIER", 400, 411], ["convulsions", "OBSERVATION", 412, 423]]], ["There is considerable variation in the hepatocytes, and biliary epithelium.", [["hepatocytes", "ANATOMY", 39, 50], ["biliary epithelium", "ANATOMY", 56, 74], ["hepatocytes", "CELL", 39, 50], ["biliary epithelium", "TISSUE", 56, 74], ["hepatocytes", "CELL_TYPE", 39, 50], ["considerable variation in the hepatocytes", "PROBLEM", 9, 50], ["considerable", "OBSERVATION_MODIFIER", 9, 21], ["variation", "OBSERVATION_MODIFIER", 22, 31], ["hepatocytes", "ANATOMY", 39, 50], ["biliary epithelium", "ANATOMY", 56, 74]]], ["In rare cases, hereditary mutations can lead to cholestasis, but more often, cholestasis is caused by exposure to injurious drugs, hormones, proinflammatory cytokines, or obstruction.", [["hereditary mutations", "DISEASE", 15, 35], ["cholestasis", "DISEASE", 48, 59], ["cholestasis", "DISEASE", 77, 88], ["obstruction", "DISEASE", 171, 182], ["proinflammatory cytokines", "PROTEIN", 141, 166], ["hereditary mutations", "PROBLEM", 15, 35], ["cholestasis", "PROBLEM", 48, 59], ["cholestasis", "PROBLEM", 77, 88], ["injurious drugs", "TREATMENT", 114, 129], ["proinflammatory cytokines", "PROBLEM", 141, 166], ["obstruction", "PROBLEM", 171, 182], ["cholestasis", "OBSERVATION", 48, 59], ["cholestasis", "OBSERVATION", 77, 88], ["proinflammatory cytokines", "OBSERVATION", 141, 166], ["obstruction", "OBSERVATION", 171, 182]]], ["Clinically, cholestasis leads to increased levels of bilirubin and bile acids in the blood because of retention.", [["blood", "ANATOMY", 85, 90], ["cholestasis", "DISEASE", 12, 23], ["bilirubin", "CHEMICAL", 53, 62], ["bile acids", "CHEMICAL", 67, 77], ["bilirubin", "CHEMICAL", 53, 62], ["bile acids", "CHEMICAL", 67, 77], ["bilirubin", "SIMPLE_CHEMICAL", 53, 62], ["bile acids", "SIMPLE_CHEMICAL", 67, 77], ["blood", "ORGANISM_SUBSTANCE", 85, 90], ["cholestasis", "PROBLEM", 12, 23], ["increased levels of bilirubin", "PROBLEM", 33, 62], ["bile acids", "TEST", 67, 77], ["retention", "PROBLEM", 102, 111], ["cholestasis", "OBSERVATION", 12, 23], ["increased", "OBSERVATION_MODIFIER", 33, 42], ["levels", "OBSERVATION_MODIFIER", 43, 49], ["bile", "ANATOMY", 67, 71], ["retention", "OBSERVATION", 102, 111]]], ["Injury to the biliary tree leads to increases in serum alkaline phosphatase.", [["biliary tree", "ANATOMY", 14, 26], ["serum", "ANATOMY", 49, 54], ["Injury", "DISEASE", 0, 6], ["biliary tree", "MULTI-TISSUE_STRUCTURE", 14, 26], ["serum", "ORGANISM_SUBSTANCE", 49, 54], ["alkaline phosphatase", "GENE_OR_GENE_PRODUCT", 55, 75], ["serum alkaline phosphatase", "PROTEIN", 49, 75], ["Injury to the biliary tree", "PROBLEM", 0, 26], ["serum alkaline phosphatase", "TEST", 49, 75], ["biliary", "ANATOMY", 14, 21], ["tree", "ANATOMY_MODIFIER", 22, 26], ["increases", "OBSERVATION_MODIFIER", 36, 45], ["alkaline phosphatase", "OBSERVATION_MODIFIER", 55, 75]]], ["Disturbance of bile flow can originate from altered function of hepatocytes, termed hepatocellular cholestasis, or because of obstruction of the biliary tree, termed obstructive cholestasis.", [["bile", "ANATOMY", 15, 19], ["hepatocytes", "ANATOMY", 64, 75], ["hepatocellular", "ANATOMY", 84, 98], ["biliary tree", "ANATOMY", 145, 157], ["hepatocellular cholestasis", "DISEASE", 84, 110], ["obstruction of the biliary tree", "DISEASE", 126, 157], ["obstructive cholestasis", "DISEASE", 166, 189], ["bile", "MULTI-TISSUE_STRUCTURE", 15, 19], ["hepatocytes", "CELL", 64, 75], ["hepatocellular", "ORGAN", 84, 98], ["biliary tree", "MULTI-TISSUE_STRUCTURE", 145, 157], ["hepatocytes", "CELL_TYPE", 64, 75], ["Disturbance of bile flow", "PROBLEM", 0, 24], ["altered function of hepatocytes", "PROBLEM", 44, 75], ["termed hepatocellular cholestasis", "PROBLEM", 77, 110], ["obstruction of the biliary tree", "PROBLEM", 126, 157], ["termed obstructive cholestasis", "PROBLEM", 159, 189], ["bile", "ANATOMY", 15, 19], ["flow", "OBSERVATION", 20, 24], ["hepatocytes", "ANATOMY", 64, 75], ["hepatocellular", "ANATOMY", 84, 98], ["cholestasis", "OBSERVATION", 99, 110], ["obstruction", "OBSERVATION", 126, 137], ["biliary tree", "ANATOMY", 145, 157], ["obstructive", "OBSERVATION_MODIFIER", 166, 177], ["cholestasis", "OBSERVATION", 178, 189]]], ["Hepatocellular cholestasis can be attributed to impaired uptake, metabolism, secretion, or transport of bile constituents.", [["Hepatocellular", "ANATOMY", 0, 14], ["bile constituents", "ANATOMY", 104, 121], ["Hepatocellular cholestasis", "DISEASE", 0, 26], ["Hepatocellular", "ORGAN", 0, 14], ["bile constituents", "SIMPLE_CHEMICAL", 104, 121], ["Hepatocellular cholestasis", "PROBLEM", 0, 26], ["impaired uptake", "PROBLEM", 48, 63], ["cholestasis", "OBSERVATION", 15, 26], ["impaired", "OBSERVATION_MODIFIER", 48, 56], ["uptake", "OBSERVATION", 57, 63], ["bile", "ANATOMY", 104, 108]]], ["Obstructive cholestasis is related to obstruction of bile flow at the level of the major bile ducts or gallbladder.", [["bile", "ANATOMY", 53, 57], ["bile ducts", "ANATOMY", 89, 99], ["gallbladder", "ANATOMY", 103, 114], ["Obstructive cholestasis", "DISEASE", 0, 23], ["bile", "MULTI-TISSUE_STRUCTURE", 53, 57], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 89, 99], ["gallbladder", "ORGAN", 103, 114], ["Obstructive cholestasis", "PROBLEM", 0, 23], ["obstruction of bile flow", "PROBLEM", 38, 62], ["cholestasis", "OBSERVATION", 12, 23], ["obstruction", "OBSERVATION", 38, 49], ["bile flow", "OBSERVATION", 53, 62], ["major", "ANATOMY_MODIFIER", 83, 88], ["bile ducts", "ANATOMY", 89, 99], ["gallbladder", "ANATOMY", 103, 114]]], ["Jaundice (icterus) occurs when the tissues, particularly the sclerae, are pigmented yellow because of an excess of bile pigments, primarily bilirubin, in the plasma.", [["tissues", "ANATOMY", 35, 42], ["sclerae", "ANATOMY", 61, 68], ["bile pigments", "ANATOMY", 115, 128], ["plasma", "ANATOMY", 158, 164], ["Jaundice", "DISEASE", 0, 8], ["icterus", "DISEASE", 10, 17], ["bilirubin", "CHEMICAL", 140, 149], ["bilirubin", "CHEMICAL", 140, 149], ["tissues", "TISSUE", 35, 42], ["bile pigments", "SIMPLE_CHEMICAL", 115, 128], ["bilirubin", "SIMPLE_CHEMICAL", 140, 149], ["plasma", "ORGANISM_SUBSTANCE", 158, 164], ["Jaundice (icterus)", "PROBLEM", 0, 18], ["pigmented yellow", "PROBLEM", 74, 90], ["an excess of bile pigments", "PROBLEM", 102, 128], ["bilirubin", "TEST", 140, 149], ["the plasma", "TEST", 154, 164], ["icterus", "OBSERVATION", 10, 17], ["tissues", "ANATOMY", 35, 42], ["sclerae", "ANATOMY", 61, 68], ["pigmented", "OBSERVATION", 74, 83], ["bile", "ANATOMY", 115, 119]]], ["Jaundice can arise from hepatocellular cholestasis or obstructive cholestasis and, in addition, from prehepatic causes, such as an overproduction of bilirubin from heme catabolism in hemolytic diseases .", [["hepatocellular", "ANATOMY", 24, 38], ["Jaundice", "DISEASE", 0, 8], ["cholestasis", "DISEASE", 39, 50], ["obstructive cholestasis", "DISEASE", 54, 77], ["bilirubin", "CHEMICAL", 149, 158], ["hemolytic diseases", "DISEASE", 183, 201], ["bilirubin", "CHEMICAL", 149, 158], ["heme", "CHEMICAL", 164, 168], ["hepatocellular", "ORGAN", 24, 38], ["bilirubin", "SIMPLE_CHEMICAL", 149, 158], ["heme", "SIMPLE_CHEMICAL", 164, 168], ["Jaundice", "PROBLEM", 0, 8], ["hepatocellular cholestasis", "PROBLEM", 24, 50], ["obstructive cholestasis", "PROBLEM", 54, 77], ["prehepatic causes", "PROBLEM", 101, 118], ["an overproduction of bilirubin", "PROBLEM", 128, 158], ["heme catabolism", "PROBLEM", 164, 179], ["hemolytic diseases", "PROBLEM", 183, 201], ["hepatocellular", "ANATOMY", 24, 38], ["cholestasis", "OBSERVATION", 39, 50], ["obstructive", "OBSERVATION_MODIFIER", 54, 65], ["cholestasis", "OBSERVATION", 66, 77], ["heme catabolism", "OBSERVATION", 164, 179], ["hemolytic diseases", "OBSERVATION", 183, 201]]], ["The associated hypoxia caused by anemia may facilitate cholestasis in hemolytic diseases.Hepatic encephalopathy (HE)Histologically, both forms of cholestasis share common features, but there are additional lesions associated with duct obstruction in the portal tracts and bile ducts.", [["Hepatic", "ANATOMY", 89, 96], ["lesions", "ANATOMY", 206, 213], ["duct", "ANATOMY", 230, 234], ["portal tracts", "ANATOMY", 254, 267], ["bile ducts", "ANATOMY", 272, 282], ["hypoxia", "DISEASE", 15, 22], ["anemia", "DISEASE", 33, 39], ["cholestasis", "DISEASE", 55, 66], ["hemolytic diseases", "DISEASE", 70, 88], ["Hepatic encephalopathy", "DISEASE", 89, 111], ["HE", "DISEASE", 113, 115], ["cholestasis", "DISEASE", 146, 157], ["duct obstruction", "DISEASE", 230, 246], ["Hepatic", "ORGAN", 89, 96], ["lesions", "PATHOLOGICAL_FORMATION", 206, 213], ["duct obstruction", "PATHOLOGICAL_FORMATION", 230, 246], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 254, 267], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 272, 282], ["The associated hypoxia", "PROBLEM", 0, 22], ["anemia", "PROBLEM", 33, 39], ["cholestasis", "PROBLEM", 55, 66], ["hemolytic diseases", "PROBLEM", 70, 88], ["Hepatic encephalopathy", "PROBLEM", 89, 111], ["cholestasis", "PROBLEM", 146, 157], ["additional lesions", "PROBLEM", 195, 213], ["duct obstruction in the portal tracts and bile ducts", "PROBLEM", 230, 282], ["hypoxia", "OBSERVATION", 15, 22], ["anemia", "OBSERVATION", 33, 39], ["cholestasis", "OBSERVATION", 55, 66], ["hemolytic", "OBSERVATION_MODIFIER", 70, 79], ["encephalopathy", "OBSERVATION", 97, 111], ["cholestasis", "OBSERVATION", 146, 157], ["lesions", "OBSERVATION", 206, 213], ["duct", "ANATOMY", 230, 234], ["obstruction", "OBSERVATION", 235, 246], ["portal tracts", "ANATOMY", 254, 267], ["bile ducts", "ANATOMY", 272, 282]]], ["The main histologic manifestation of cholestasis is accumulation of homogeneous waxy brown bile pigment in bile canaliculi.", [["brown bile pigment", "ANATOMY", 85, 103], ["bile canaliculi", "ANATOMY", 107, 122], ["cholestasis", "DISEASE", 37, 48], ["bile pigment", "TISSUE", 91, 103], ["bile canaliculi", "MULTI-TISSUE_STRUCTURE", 107, 122], ["cholestasis", "PROBLEM", 37, 48], ["homogeneous waxy brown bile pigment in bile canaliculi", "PROBLEM", 68, 122], ["main", "OBSERVATION_MODIFIER", 4, 8], ["histologic", "OBSERVATION_MODIFIER", 9, 19], ["cholestasis", "OBSERVATION", 37, 48], ["accumulation", "OBSERVATION_MODIFIER", 52, 64], ["homogeneous", "OBSERVATION_MODIFIER", 68, 79], ["waxy", "OBSERVATION_MODIFIER", 80, 84], ["brown bile pigment", "OBSERVATION", 85, 103], ["bile canaliculi", "ANATOMY", 107, 122]]], ["Bile regurgitated from hepatocytes can also be found in Kupffer cells following phagocytosis.", [["Bile", "ANATOMY", 0, 4], ["hepatocytes", "ANATOMY", 23, 34], ["Kupffer cells", "ANATOMY", 56, 69], ["Bile", "ORGANISM_SUBSTANCE", 0, 4], ["hepatocytes", "CELL", 23, 34], ["Kupffer cells", "CELL", 56, 69], ["hepatocytes", "CELL_TYPE", 23, 34], ["Kupffer cells", "CELL_TYPE", 56, 69], ["Bile regurgitated from hepatocytes", "PROBLEM", 0, 34], ["phagocytosis", "PROBLEM", 80, 92], ["hepatocytes", "ANATOMY", 23, 34], ["Kupffer cells", "OBSERVATION", 56, 69]]], ["Bilirubin can be found in the hepatocellular cytoplasm in most species, especially if frozen sections are examined, but it is quite rare for bile to be evident in canine hepatocytes.", [["hepatocellular cytoplasm", "ANATOMY", 30, 54], ["sections", "ANATOMY", 93, 101], ["bile", "ANATOMY", 141, 145], ["hepatocytes", "ANATOMY", 170, 181], ["Bilirubin", "CHEMICAL", 0, 9], ["Bilirubin", "CHEMICAL", 0, 9], ["Bilirubin", "SIMPLE_CHEMICAL", 0, 9], ["hepatocellular cytoplasm", "ORGANISM_SUBSTANCE", 30, 54], ["bile", "ORGAN", 141, 145], ["canine", "ORGANISM", 163, 169], ["hepatocytes", "CELL", 170, 181], ["canine hepatocytes", "CELL_TYPE", 163, 181], ["canine", "SPECIES", 163, 169], ["canine", "SPECIES", 163, 169], ["Bilirubin", "TEST", 0, 9], ["the hepatocellular cytoplasm", "PROBLEM", 26, 54], ["frozen sections", "TEST", 86, 101], ["hepatocellular", "ANATOMY", 30, 44], ["cytoplasm", "OBSERVATION", 45, 54], ["most species", "OBSERVATION_MODIFIER", 58, 70], ["hepatocytes", "ANATOMY", 170, 181]]], ["Bile accumulation is more severe in the centrilobular regions of the lobules, but can extend to the periportal regions in severe cases.", [["Bile", "ANATOMY", 0, 4], ["centrilobular regions", "ANATOMY", 40, 61], ["lobules", "ANATOMY", 69, 76], ["periportal regions", "ANATOMY", 100, 118], ["Bile", "MULTI-TISSUE_STRUCTURE", 0, 4], ["centrilobular regions", "PATHOLOGICAL_FORMATION", 40, 61], ["lobules", "MULTI-TISSUE_STRUCTURE", 69, 76], ["Bile accumulation", "PROBLEM", 0, 17], ["accumulation", "OBSERVATION", 5, 17], ["more severe", "OBSERVATION_MODIFIER", 21, 32], ["centrilobular", "ANATOMY_MODIFIER", 40, 53], ["regions", "ANATOMY_MODIFIER", 54, 61], ["lobules", "ANATOMY_MODIFIER", 69, 76], ["periportal", "ANATOMY", 100, 110], ["severe", "OBSERVATION_MODIFIER", 122, 128], ["cases", "OBSERVATION", 129, 134]]], ["With time, canalicular plugs are cleared, and they may not be evident in more chronic cases of cholestasis.", [["canalicular plugs", "ANATOMY", 11, 28], ["cholestasis", "DISEASE", 95, 106], ["canalicular plugs", "MULTI-TISSUE_STRUCTURE", 11, 28], ["cholestasis", "PATHOLOGICAL_FORMATION", 95, 106], ["canalicular plugs", "PROBLEM", 11, 28], ["cholestasis", "PROBLEM", 95, 106], ["canalicular", "OBSERVATION_MODIFIER", 11, 22], ["plugs", "OBSERVATION", 23, 28], ["may not be", "UNCERTAINTY", 51, 61], ["cholestasis", "OBSERVATION", 95, 106]]], ["Hepatocyte rosettes, collections of 2 or more hepatocytes surrounding a dilated canaliculus are common.", [["Hepatocyte rosettes", "ANATOMY", 0, 19], ["hepatocytes", "ANATOMY", 46, 57], ["canaliculus", "ANATOMY", 80, 91], ["Hepatocyte rosettes", "CELL", 0, 19], ["hepatocytes", "CELL", 46, 57], ["canaliculus", "MULTI-TISSUE_STRUCTURE", 80, 91], ["Hepatocyte rosettes", "CELL_TYPE", 0, 19], ["hepatocytes", "CELL_TYPE", 46, 57], ["Hepatocyte rosettes", "TEST", 0, 19], ["collections of 2 or more hepatocytes", "PROBLEM", 21, 57], ["a dilated canaliculus", "PROBLEM", 70, 91], ["rosettes", "OBSERVATION_MODIFIER", 11, 19], ["collections", "OBSERVATION", 21, 32], ["more", "OBSERVATION_MODIFIER", 41, 45], ["hepatocytes", "OBSERVATION", 46, 57], ["dilated", "OBSERVATION", 72, 79], ["canaliculus", "ANATOMY_MODIFIER", 80, 91], ["common", "OBSERVATION_MODIFIER", 96, 102]]], ["Hepatocellular degeneration may also be evident, sometimes with bile staining of the cytoplasm of injured hepatocytes.", [["Hepatocellular", "ANATOMY", 0, 14], ["bile", "ANATOMY", 64, 68], ["cytoplasm", "ANATOMY", 85, 94], ["hepatocytes", "ANATOMY", 106, 117], ["Hepatocellular degeneration", "DISEASE", 0, 27], ["Hepatocellular", "CANCER", 0, 14], ["cytoplasm", "ORGANISM_SUBSTANCE", 85, 94], ["hepatocytes", "CELL", 106, 117], ["injured hepatocytes", "CELL_TYPE", 98, 117], ["Hepatocellular degeneration", "PROBLEM", 0, 27], ["bile staining of the cytoplasm of injured hepatocytes", "PROBLEM", 64, 117], ["degeneration", "OBSERVATION", 15, 27], ["may also be", "UNCERTAINTY", 28, 39], ["cytoplasm", "OBSERVATION_MODIFIER", 85, 94], ["injured", "OBSERVATION", 98, 105], ["hepatocytes", "ANATOMY", 106, 117]]], ["Scattered apoptotic cells may be present, although significant However, the specific mechanisms by which systemic inflammation triggers neuroinflammation are not currently known.Hepatic encephalopathy (HE)In chronic hepatic failure, ammonia and neuroinflammation are likely to contribute synergistically to HE.", [["cells", "ANATOMY", 20, 25], ["hepatic", "ANATOMY", 216, 223], ["inflammation", "DISEASE", 114, 126], ["neuroinflammation", "DISEASE", 136, 153], ["Hepatic encephalopathy", "DISEASE", 178, 200], ["HE", "DISEASE", 202, 204], ["chronic hepatic failure", "DISEASE", 208, 231], ["ammonia", "CHEMICAL", 233, 240], ["neuroinflammation", "DISEASE", 245, 262], ["HE", "DISEASE", 307, 309], ["ammonia", "CHEMICAL", 233, 240], ["cells", "CELL", 20, 25], ["Hepatic", "ORGAN", 178, 185], ["hepatic", "ORGAN", 216, 223], ["ammonia", "SIMPLE_CHEMICAL", 233, 240], ["apoptotic cells", "CELL_TYPE", 10, 25], ["Scattered apoptotic cells", "PROBLEM", 0, 25], ["systemic inflammation", "PROBLEM", 105, 126], ["neuroinflammation", "PROBLEM", 136, 153], ["Hepatic encephalopathy", "PROBLEM", 178, 200], ["chronic hepatic failure", "PROBLEM", 208, 231], ["ammonia", "PROBLEM", 233, 240], ["neuroinflammation", "PROBLEM", 245, 262], ["apoptotic cells", "OBSERVATION", 10, 25], ["may be", "UNCERTAINTY", 26, 32], ["significant", "OBSERVATION_MODIFIER", 51, 62], ["systemic", "OBSERVATION_MODIFIER", 105, 113], ["inflammation", "OBSERVATION", 114, 126], ["encephalopathy", "OBSERVATION", 186, 200], ["chronic", "OBSERVATION_MODIFIER", 208, 215], ["hepatic", "ANATOMY", 216, 223], ["failure", "OBSERVATION", 224, 231], ["neuroinflammation", "OBSERVATION", 245, 262]]], ["Ammonia plays a role as a directly neurotoxic agent, altering neurotransmission, and potentially contributing to cerebral energy failure through inhibition of \u03b1-ketoglutarate dehydrogenase, a rate-limiting enzyme in the tricarboxylic acid cycle.", [["cerebral", "ANATOMY", 113, 121], ["Ammonia", "CHEMICAL", 0, 7], ["neurotoxic", "DISEASE", 35, 45], ["cerebral energy failure", "DISEASE", 113, 136], ["\u03b1-ketoglutarate", "CHEMICAL", 159, 174], ["tricarboxylic acid", "CHEMICAL", 220, 238], ["Ammonia", "CHEMICAL", 0, 7], ["\u03b1-ketoglutarate", "CHEMICAL", 159, 174], ["tricarboxylic acid", "CHEMICAL", 220, 238], ["Ammonia", "SIMPLE_CHEMICAL", 0, 7], ["cerebral", "ORGAN", 113, 121], ["\u03b1-ketoglutarate dehydrogenase", "GENE_OR_GENE_PRODUCT", 159, 188], ["tricarboxylic acid", "SIMPLE_CHEMICAL", 220, 238], ["\u03b1-ketoglutarate dehydrogenase", "PROTEIN", 159, 188], ["a directly neurotoxic agent", "TREATMENT", 24, 51], ["cerebral energy failure", "PROBLEM", 113, 136], ["\u03b1-ketoglutarate dehydrogenase", "PROBLEM", 159, 188], ["a rate", "TEST", 190, 196], ["cerebral", "ANATOMY", 113, 121], ["energy failure", "OBSERVATION", 122, 136], ["tricarboxylic", "OBSERVATION", 220, 233], ["acid cycle", "OBSERVATION", 234, 244]]], ["Chronic increase in brain ammonia is associated with disrupted neural transmission involving all of the different neurotransmitter systems of the brain.", [["brain", "ANATOMY", 20, 25], ["neural", "ANATOMY", 63, 69], ["brain", "ANATOMY", 146, 151], ["ammonia", "CHEMICAL", 26, 33], ["ammonia", "CHEMICAL", 26, 33], ["brain", "ORGAN", 20, 25], ["brain", "ORGAN", 146, 151], ["Chronic increase in brain ammonia", "PROBLEM", 0, 33], ["disrupted neural transmission", "PROBLEM", 53, 82], ["increase", "OBSERVATION_MODIFIER", 8, 16], ["brain", "ANATOMY", 20, 25], ["ammonia", "OBSERVATION", 26, 33], ["neural transmission", "OBSERVATION", 63, 82], ["different", "ANATOMY_MODIFIER", 104, 113], ["neurotransmitter systems", "ANATOMY_MODIFIER", 114, 138], ["brain", "ANATOMY", 146, 151]]], ["The main neurotransmitter systems affected involve neuropeptides, with an evolution toward an increase in the inhibitory \u03b3-aminobutyric acid (GABA)ergic system, and downregulation of the excitatory glutaminergic system.", [["excitatory glutaminergic system", "ANATOMY", 187, 218], ["\u03b3-aminobutyric acid", "CHEMICAL", 121, 140], ["GABA", "CHEMICAL", 142, 146], ["\u03b3-aminobutyric acid", "CHEMICAL", 121, 140], ["GABA", "CHEMICAL", 142, 146], ["\u03b3-aminobutyric acid", "SIMPLE_CHEMICAL", 121, 140], ["GABA", "SIMPLE_CHEMICAL", 142, 146], ["an increase in the inhibitory \u03b3-aminobutyric acid (GABA)ergic system", "PROBLEM", 91, 159], ["downregulation of the excitatory glutaminergic system", "PROBLEM", 165, 218], ["main", "OBSERVATION_MODIFIER", 4, 8], ["increase", "OBSERVATION_MODIFIER", 94, 102], ["excitatory glutaminergic", "OBSERVATION", 187, 211]]], ["Increased intracerebral ammonia leads to an increase in extracellular glutamate, which will initially drive upregulation of N-methyl-D-aspartate (NMDA) receptors, causing neuronal damage, but eventually, there is a reduction in NMDA receptors and glutaminergic signaling, leading to neuroinhibition.", [["intracerebral", "ANATOMY", 10, 23], ["extracellular", "ANATOMY", 56, 69], ["neuronal", "ANATOMY", 171, 179], ["ammonia", "CHEMICAL", 24, 31], ["glutamate", "CHEMICAL", 70, 79], ["N-methyl-D-aspartate", "CHEMICAL", 124, 144], ["NMDA", "CHEMICAL", 146, 150], ["neuronal damage", "DISEASE", 171, 186], ["NMDA", "CHEMICAL", 228, 232], ["ammonia", "CHEMICAL", 24, 31], ["glutamate", "CHEMICAL", 70, 79], ["N-methyl-D-aspartate", "CHEMICAL", 124, 144], ["NMDA", "CHEMICAL", 146, 150], ["NMDA", "CHEMICAL", 228, 232], ["intracerebral", "IMMATERIAL_ANATOMICAL_ENTITY", 10, 23], ["ammonia", "SIMPLE_CHEMICAL", 24, 31], ["extracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 56, 69], ["glutamate", "SIMPLE_CHEMICAL", 70, 79], ["N-methyl-D-aspartate", "SIMPLE_CHEMICAL", 124, 144], ["NMDA", "SIMPLE_CHEMICAL", 146, 150], ["neuronal", "CELL", 171, 179], ["NMDA", "SIMPLE_CHEMICAL", 228, 232], ["glutaminergic", "SIMPLE_CHEMICAL", 247, 260], ["N-methyl-D-aspartate (NMDA) receptors", "PROTEIN", 124, 161], ["NMDA receptors", "PROTEIN", 228, 242], ["Increased intracerebral ammonia", "PROBLEM", 0, 31], ["an increase in extracellular glutamate", "PROBLEM", 41, 79], ["D-aspartate (NMDA) receptors", "TREATMENT", 133, 161], ["neuronal damage", "PROBLEM", 171, 186], ["a reduction in NMDA receptors", "PROBLEM", 213, 242], ["glutaminergic signaling", "PROBLEM", 247, 270], ["intracerebral", "ANATOMY", 10, 23], ["ammonia leads", "OBSERVATION", 24, 37], ["increase", "OBSERVATION_MODIFIER", 44, 52], ["neuronal damage", "OBSERVATION", 171, 186], ["reduction", "OBSERVATION_MODIFIER", 215, 224], ["NMDA receptors", "OBSERVATION", 228, 242]]], ["In addition, increased ammonia alone has been linked to neuroinflammation, possibly through direct activation of microglia, which also interferes with normal neural transmission.Hepatic encephalopathy (HE)Newer studies in animal models have demonstrated that agents acting on specific targets in the brain, including phosphodiesterase 5, type A GABA receptors, and mitogenactivated kinase (p38), can improve cognitive function in mild forms of experimental hepatic encephalopathy.", [["microglia", "ANATOMY", 113, 122], ["neural", "ANATOMY", 158, 164], ["Hepatic", "ANATOMY", 178, 185], ["brain", "ANATOMY", 300, 305], ["hepatic", "ANATOMY", 457, 464], ["ammonia", "CHEMICAL", 23, 30], ["neuroinflammation", "DISEASE", 56, 73], ["Hepatic encephalopathy", "DISEASE", 178, 200], ["HE", "DISEASE", 202, 204], ["GABA", "CHEMICAL", 345, 349], ["hepatic encephalopathy", "DISEASE", 457, 479], ["ammonia", "CHEMICAL", 23, 30], ["GABA", "CHEMICAL", 345, 349], ["ammonia", "SIMPLE_CHEMICAL", 23, 30], ["microglia", "CELL", 113, 122], ["Hepatic", "ORGAN", 178, 185], ["brain", "ORGAN", 300, 305], ["phosphodiesterase 5", "GENE_OR_GENE_PRODUCT", 317, 336], ["type A GABA receptors", "GENE_OR_GENE_PRODUCT", 338, 359], ["mitogenactivated kinase", "GENE_OR_GENE_PRODUCT", 365, 388], ["p38", "GENE_OR_GENE_PRODUCT", 390, 393], ["hepatic", "ORGAN", 457, 464], ["microglia", "CELL_TYPE", 113, 122], ["phosphodiesterase 5, type A GABA receptors", "PROTEIN", 317, 359], ["mitogenactivated kinase", "PROTEIN", 365, 388], ["p38", "PROTEIN", 390, 393], ["increased ammonia", "PROBLEM", 13, 30], ["neuroinflammation", "PROBLEM", 56, 73], ["direct activation of microglia", "PROBLEM", 92, 122], ["Hepatic encephalopathy", "PROBLEM", 178, 200], ["Newer studies in animal models", "TEST", 205, 235], ["phosphodiesterase", "TREATMENT", 317, 334], ["type A GABA receptors", "TEST", 338, 359], ["experimental hepatic encephalopathy", "PROBLEM", 444, 479], ["increased", "OBSERVATION_MODIFIER", 13, 22], ["ammonia", "OBSERVATION", 23, 30], ["neuroinflammation", "OBSERVATION", 56, 73], ["microglia", "OBSERVATION", 113, 122], ["normal neural transmission", "OBSERVATION", 151, 177], ["encephalopathy", "OBSERVATION", 186, 200], ["brain", "ANATOMY", 300, 305], ["mild", "OBSERVATION_MODIFIER", 430, 434], ["hepatic", "ANATOMY", 457, 464], ["encephalopathy", "OBSERVATION", 465, 479]]], ["Survival can be increased by treatment with NMDA receptor agonists.", [["NMDA", "CHEMICAL", 44, 48], ["NMDA", "CHEMICAL", 44, 48], ["NMDA", "SIMPLE_CHEMICAL", 44, 48], ["Survival", "TREATMENT", 0, 8], ["NMDA receptor agonists", "TREATMENT", 44, 66], ["increased", "OBSERVATION_MODIFIER", 16, 25]]], ["Studies have also implicated alterations in inhibitory and excitatory neurotransmitters, including endogenous benzodiazepines, and serotonin, as well as their receptors.", [["benzodiazepines", "CHEMICAL", 110, 125], ["serotonin", "CHEMICAL", 131, 140], ["benzodiazepines", "CHEMICAL", 110, 125], ["serotonin", "CHEMICAL", 131, 140], ["benzodiazepines", "SIMPLE_CHEMICAL", 110, 125], ["serotonin", "SIMPLE_CHEMICAL", 131, 140], ["alterations in inhibitory and excitatory neurotransmitters", "PROBLEM", 29, 87], ["endogenous benzodiazepines", "TREATMENT", 99, 125], ["serotonin", "PROBLEM", 131, 140]]], ["Although infusion of ammonia or hyperammonemia caused by deficiency of urea cycle enzymes reproduces similar neurologic signs and vacuolar lesions, other noxious substances in the alimentary tract are also believed to contribute to hepatic encephalopathy resulting from liver failure.", [["neurologic", "ANATOMY", 109, 119], ["vacuolar lesions", "ANATOMY", 130, 146], ["alimentary tract", "ANATOMY", 180, 196], ["hepatic", "ANATOMY", 232, 239], ["liver", "ANATOMY", 270, 275], ["ammonia", "CHEMICAL", 21, 28], ["hyperammonemia", "DISEASE", 32, 46], ["urea", "CHEMICAL", 71, 75], ["neurologic signs", "DISEASE", 109, 125], ["hepatic encephalopathy", "DISEASE", 232, 254], ["liver failure", "DISEASE", 270, 283], ["ammonia", "CHEMICAL", 21, 28], ["urea", "CHEMICAL", 71, 75], ["ammonia", "SIMPLE_CHEMICAL", 21, 28], ["urea", "SIMPLE_CHEMICAL", 71, 75], ["vacuolar lesions", "PATHOLOGICAL_FORMATION", 130, 146], ["alimentary tract", "ORGAN", 180, 196], ["hepatic", "ORGAN", 232, 239], ["liver", "ORGAN", 270, 275], ["urea cycle enzymes", "PROTEIN", 71, 89], ["infusion of ammonia", "TREATMENT", 9, 28], ["hyperammonemia", "PROBLEM", 32, 46], ["deficiency of urea cycle enzymes", "PROBLEM", 57, 89], ["similar neurologic signs", "PROBLEM", 101, 125], ["vacuolar lesions", "PROBLEM", 130, 146], ["other noxious substances in the alimentary tract", "PROBLEM", 148, 196], ["hepatic encephalopathy", "PROBLEM", 232, 254], ["liver failure", "PROBLEM", 270, 283], ["hyperammonemia", "OBSERVATION", 32, 46], ["vacuolar lesions", "OBSERVATION", 130, 146], ["alimentary tract", "ANATOMY", 180, 196], ["hepatic", "ANATOMY", 232, 239], ["encephalopathy", "OBSERVATION", 240, 254], ["liver", "ANATOMY", 270, 275], ["failure", "OBSERVATION", 276, 283]]], ["These include variably toxic amines, captans, thiols, and short-chain fatty acids, which are normally removed from the portal blood in one passage through the liver after production in the large bowel.", [["portal blood", "ANATOMY", 119, 131], ["liver", "ANATOMY", 159, 164], ["bowel", "ANATOMY", 195, 200], ["amines", "CHEMICAL", 29, 35], ["captans", "CHEMICAL", 37, 44], ["thiols", "CHEMICAL", 46, 52], ["amines", "CHEMICAL", 29, 35], ["captans", "CHEMICAL", 37, 44], ["thiols", "CHEMICAL", 46, 52], ["short-chain fatty acids", "CHEMICAL", 58, 81], ["amines", "SIMPLE_CHEMICAL", 29, 35], ["captans", "SIMPLE_CHEMICAL", 37, 44], ["thiols", "SIMPLE_CHEMICAL", 46, 52], ["short-chain fatty acids", "SIMPLE_CHEMICAL", 58, 81], ["portal blood", "ORGANISM_SUBSTANCE", 119, 131], ["liver", "ORGAN", 159, 164], ["bowel", "ORGAN", 195, 200], ["variably toxic amines", "PROBLEM", 14, 35], ["captans", "TEST", 37, 44], ["thiols", "TREATMENT", 46, 52], ["short-chain fatty acids", "PROBLEM", 58, 81], ["variably", "OBSERVATION_MODIFIER", 14, 22], ["toxic amines", "OBSERVATION", 23, 35], ["portal blood", "ANATOMY", 119, 131], ["liver", "ANATOMY", 159, 164], ["large", "ANATOMY_MODIFIER", 189, 194], ["bowel", "ANATOMY", 195, 200]]], ["Thus there are many factors to consider in the pathogenesis of HE.Hepatic encephalopathy (HE)The microscopic lesions of HE are subtle and variable, likely because postmortem examinations of the brain are performed at various time points of chronicity and clinical severity.", [["lesions", "ANATOMY", 109, 116], ["brain", "ANATOMY", 194, 199], ["HE", "DISEASE", 63, 65], ["Hepatic encephalopathy", "DISEASE", 66, 88], ["HE", "DISEASE", 90, 92], ["HE", "DISEASE", 120, 122], ["Hepatic", "ORGAN", 66, 73], ["lesions", "PATHOLOGICAL_FORMATION", 109, 116], ["brain", "ORGAN", 194, 199], ["Hepatic encephalopathy", "PROBLEM", 66, 88], ["The microscopic lesions", "PROBLEM", 93, 116], ["postmortem examinations of the brain", "TEST", 163, 199], ["chronicity", "PROBLEM", 240, 250], ["clinical severity", "PROBLEM", 255, 272], ["encephalopathy", "OBSERVATION", 74, 88], ["lesions", "OBSERVATION", 109, 116], ["subtle", "OBSERVATION_MODIFIER", 127, 133], ["variable", "OBSERVATION_MODIFIER", 138, 146], ["brain", "ANATOMY", 194, 199]]], ["There are also significant differences in the microscopic lesions between species.", [["lesions", "ANATOMY", 58, 65], ["lesions", "PATHOLOGICAL_FORMATION", 58, 65], ["the microscopic lesions between species", "PROBLEM", 42, 81], ["significant", "OBSERVATION_MODIFIER", 15, 26], ["differences", "OBSERVATION_MODIFIER", 27, 38], ["microscopic", "OBSERVATION_MODIFIER", 46, 57], ["lesions", "OBSERVATION", 58, 65]]], ["In humans, the hallmark of HE is Alzheimer type II astrocytosis, in which astrocytes are enlarged with swollen nuclei, margination of chromatin, and prominent nucleoli.", [["astrocytes", "ANATOMY", 74, 84], ["nuclei", "ANATOMY", 111, 117], ["chromatin", "ANATOMY", 134, 143], ["nucleoli", "ANATOMY", 159, 167], ["HE", "DISEASE", 27, 29], ["Alzheimer type II astrocytosis", "DISEASE", 33, 63], ["humans", "ORGANISM", 3, 9], ["astrocytes", "CELL", 74, 84], ["nuclei", "CELLULAR_COMPONENT", 111, 117], ["chromatin", "CELLULAR_COMPONENT", 134, 143], ["nucleoli", "CELLULAR_COMPONENT", 159, 167], ["astrocytes", "CELL_TYPE", 74, 84], ["humans", "SPECIES", 3, 9], ["humans", "SPECIES", 3, 9], ["Alzheimer type II astrocytosis", "PROBLEM", 33, 63], ["swollen nuclei", "PROBLEM", 103, 117], ["margination of chromatin", "PROBLEM", 119, 143], ["prominent nucleoli", "PROBLEM", 149, 167], ["Alzheimer", "OBSERVATION", 33, 42], ["type II", "OBSERVATION_MODIFIER", 43, 50], ["astrocytosis", "OBSERVATION", 51, 63], ["astrocytes", "ANATOMY", 74, 84], ["enlarged", "OBSERVATION_MODIFIER", 89, 97], ["swollen nuclei", "OBSERVATION", 103, 117], ["margination", "OBSERVATION_MODIFIER", 119, 130], ["chromatin", "OBSERVATION", 134, 143], ["prominent", "OBSERVATION_MODIFIER", 149, 158], ["nucleoli", "OBSERVATION", 159, 167]]], ["These can be found in large animals, particularly horses.", [["large", "OBSERVATION_MODIFIER", 22, 27], ["animals", "OBSERVATION", 28, 35]]], ["In dogs, Alzheimer type II changes are rare if they occur at all, but vacuoles in gray matter, particularly in brain stem nuclei, predominate.", [["vacuoles", "ANATOMY", 70, 78], ["gray matter", "ANATOMY", 82, 93], ["brain stem nuclei", "ANATOMY", 111, 128], ["Alzheimer type II", "DISEASE", 9, 26], ["dogs", "ORGANISM", 3, 7], ["Alzheimer type II", "GENE_OR_GENE_PRODUCT", 9, 26], ["vacuoles", "CELLULAR_COMPONENT", 70, 78], ["brain stem nuclei", "CELL", 111, 128], ["dogs", "SPECIES", 3, 7], ["Alzheimer type II changes", "PROBLEM", 9, 34], ["vacuoles in gray matter", "PROBLEM", 70, 93], ["Alzheimer", "OBSERVATION", 9, 18], ["gray matter", "ANATOMY", 82, 93], ["brain stem nuclei", "ANATOMY", 111, 128]]], ["Lesions in cats have features of both the dog and the horse (see Vol.", [["cats", "ORGANISM", 11, 15], ["dog", "ORGANISM", 42, 45], ["horse", "ORGANISM_SUBDIVISION", 54, 59], ["cats", "SPECIES", 11, 15], ["dog", "SPECIES", 42, 45], ["horse", "SPECIES", 54, 59], ["Lesions in cats", "PROBLEM", 0, 15]]], ["1, Nervous system).", [["Nervous system", "ANATOMY", 3, 17]]], ["These changes can be observed best in animals with chronic liver disease and portosystemic shunts; the brain lesions can be minimal in animals with acute liver failure.Cholestasis and jaundiceCholestasis is the term for impaired bile secretion and flow as well as a failure to secrete organic and inorganic components of bile, with accumulation of these elements in blood.", [["liver", "ANATOMY", 59, 64], ["brain lesions", "ANATOMY", 103, 116], ["liver", "ANATOMY", 154, 159], ["bile", "ANATOMY", 229, 233], ["bile", "ANATOMY", 321, 325], ["blood", "ANATOMY", 366, 371], ["chronic liver disease", "DISEASE", 51, 72], ["brain lesions", "DISEASE", 103, 116], ["acute liver failure", "DISEASE", 148, 167], ["Cholestasis", "DISEASE", 168, 179], ["jaundice", "DISEASE", 184, 192], ["Cholestasis", "DISEASE", 192, 203], ["impaired bile secretion", "DISEASE", 220, 243], ["liver", "ORGAN", 59, 64], ["portosystemic shunts", "PATHOLOGICAL_FORMATION", 77, 97], ["brain lesions", "PATHOLOGICAL_FORMATION", 103, 116], ["liver", "ORGAN", 154, 159], ["bile", "MULTI-TISSUE_STRUCTURE", 229, 233], ["bile", "MULTI-TISSUE_STRUCTURE", 321, 325], ["blood", "ORGANISM_SUBSTANCE", 366, 371], ["chronic liver disease", "PROBLEM", 51, 72], ["portosystemic shunts", "TREATMENT", 77, 97], ["the brain lesions", "PROBLEM", 99, 116], ["acute liver failure", "PROBLEM", 148, 167], ["Cholestasis", "PROBLEM", 168, 179], ["jaundice", "PROBLEM", 184, 192], ["Cholestasis", "PROBLEM", 192, 203], ["impaired bile secretion and flow", "PROBLEM", 220, 252], ["a failure to secrete organic and inorganic components of bile", "PROBLEM", 264, 325], ["these elements in blood", "PROBLEM", 348, 371], ["chronic", "OBSERVATION_MODIFIER", 51, 58], ["liver", "ANATOMY", 59, 64], ["disease", "OBSERVATION", 65, 72], ["portosystemic shunts", "OBSERVATION", 77, 97], ["brain", "ANATOMY", 103, 108], ["lesions", "OBSERVATION", 109, 116], ["minimal", "OBSERVATION_MODIFIER", 124, 131], ["acute", "OBSERVATION_MODIFIER", 148, 153], ["liver", "ANATOMY", 154, 159], ["failure", "OBSERVATION", 160, 167], ["jaundice", "OBSERVATION", 184, 192], ["bile", "ANATOMY", 229, 233], ["secretion", "OBSERVATION", 234, 243], ["flow", "OBSERVATION", 248, 252], ["failure", "OBSERVATION", 266, 273], ["organic", "OBSERVATION_MODIFIER", 285, 292], ["inorganic", "OBSERVATION_MODIFIER", 297, 306], ["components", "OBSERVATION_MODIFIER", 307, 317], ["bile", "ANATOMY", 321, 325], ["these elements", "OBSERVATION", 348, 362], ["blood", "OBSERVATION_MODIFIER", 366, 371]]], ["Normal bile formation and flow is dependent on the activity of a series of membrane transporters found in enterocytes, sure both reduces activity of OATP and NCTP, but also interferes with the activity of BSEP and MRP-2.Cholestasis and jaundiceHepatocellular cholestasis can also occur through disruption of the structural integrity of the canaliculi, as discussed later for Lantana camara toxicity.", [["bile", "ANATOMY", 7, 11], ["membrane", "ANATOMY", 75, 83], ["enterocytes", "ANATOMY", 106, 117], ["Hepatocellular", "ANATOMY", 244, 258], ["canaliculi", "ANATOMY", 340, 350], ["Cholestasis", "DISEASE", 220, 231], ["jaundice", "DISEASE", 236, 244], ["Hepatocellular cholestasis", "DISEASE", 244, 270], ["toxicity", "DISEASE", 390, 398], ["bile", "MULTI-TISSUE_STRUCTURE", 7, 11], ["membrane", "CELLULAR_COMPONENT", 75, 83], ["enterocytes", "CELLULAR_COMPONENT", 106, 117], ["OATP", "GENE_OR_GENE_PRODUCT", 149, 153], ["NCTP", "GENE_OR_GENE_PRODUCT", 158, 162], ["BSEP", "GENE_OR_GENE_PRODUCT", 205, 209], ["MRP-2", "GENE_OR_GENE_PRODUCT", 214, 219], ["Hepatocellular", "ORGAN", 244, 258], ["canaliculi", "MULTI-TISSUE_STRUCTURE", 340, 350], ["Lantana camara", "SIMPLE_CHEMICAL", 375, 389], ["membrane transporters", "PROTEIN", 75, 96], ["enterocytes", "CELL_TYPE", 106, 117], ["OATP", "PROTEIN", 149, 153], ["NCTP", "PROTEIN", 158, 162], ["BSEP", "PROTEIN", 205, 209], ["MRP", "PROTEIN", 214, 217], ["Lantana camara", "SPECIES", 375, 389], ["membrane transporters", "TREATMENT", 75, 96], ["OATP and NCTP", "TREATMENT", 149, 162], ["MRP", "TEST", 214, 217], ["Cholestasis", "PROBLEM", 220, 231], ["jaundice", "PROBLEM", 236, 244], ["Hepatocellular cholestasis", "PROBLEM", 244, 270], ["Lantana camara toxicity", "PROBLEM", 375, 398], ["bile", "ANATOMY", 7, 11], ["flow", "OBSERVATION_MODIFIER", 26, 30], ["dependent", "OBSERVATION_MODIFIER", 34, 43], ["enterocytes", "ANATOMY", 106, 117], ["jaundice", "OBSERVATION", 236, 244], ["cholestasis", "OBSERVATION", 259, 270], ["structural", "OBSERVATION_MODIFIER", 312, 322], ["integrity", "OBSERVATION_MODIFIER", 323, 332], ["canaliculi", "ANATOMY", 340, 350]]], ["Poisons such as phalloidin and cytochalasin, which disrupt the polymerization cycle of pericanalicular actin microfilaments, are cholestatic because these contractile filaments are required for propelling bile along the canaliculi.", [["microfilaments", "ANATOMY", 109, 123], ["contractile filaments", "ANATOMY", 155, 176], ["bile", "ANATOMY", 205, 209], ["canaliculi", "ANATOMY", 220, 230], ["cytochalasin", "CHEMICAL", 31, 43], ["cholestatic", "DISEASE", 129, 140], ["phalloidin", "CHEMICAL", 16, 26], ["cytochalasin", "CHEMICAL", 31, 43], ["phalloidin", "SIMPLE_CHEMICAL", 16, 26], ["cytochalasin", "SIMPLE_CHEMICAL", 31, 43], ["pericanalicular actin", "GENE_OR_GENE_PRODUCT", 87, 108], ["microfilaments", "CELLULAR_COMPONENT", 109, 123], ["bile", "MULTI-TISSUE_STRUCTURE", 205, 209], ["canaliculi", "MULTI-TISSUE_STRUCTURE", 220, 230], ["cytochalasin", "TREATMENT", 31, 43], ["cholestatic", "PROBLEM", 129, 140], ["these contractile filaments", "PROBLEM", 149, 176], ["propelling bile along the canaliculi", "PROBLEM", 194, 230], ["polymerization cycle", "OBSERVATION", 63, 83], ["pericanalicular", "ANATOMY_MODIFIER", 87, 102], ["actin microfilaments", "OBSERVATION", 103, 123], ["cholestatic", "OBSERVATION_MODIFIER", 129, 140], ["contractile filaments", "OBSERVATION", 155, 176], ["canaliculi", "ANATOMY", 220, 230]]], ["In horses, fasting can cause plasma bilirubin increases and jaundice.", [["plasma", "ANATOMY", 29, 35], ["bilirubin", "CHEMICAL", 36, 45], ["jaundice", "DISEASE", 60, 68], ["bilirubin", "CHEMICAL", 36, 45], ["horses", "ORGANISM", 3, 9], ["plasma", "ORGANISM_SUBSTANCE", 29, 35], ["bilirubin", "SIMPLE_CHEMICAL", 36, 45], ["plasma bilirubin increases", "PROBLEM", 29, 55], ["jaundice", "PROBLEM", 60, 68], ["jaundice", "OBSERVATION", 60, 68]]], ["The mechanism may be the impaired uptake of bilirubin from the plasma or possibly impaired conjugation of bilirubin when energy supplies are low.", [["plasma", "ANATOMY", 63, 69], ["bilirubin", "CHEMICAL", 44, 53], ["bilirubin", "CHEMICAL", 106, 115], ["bilirubin", "CHEMICAL", 44, 53], ["bilirubin", "CHEMICAL", 106, 115], ["bilirubin", "SIMPLE_CHEMICAL", 44, 53], ["plasma", "ORGANISM_SUBSTANCE", 63, 69], ["bilirubin", "SIMPLE_CHEMICAL", 106, 115], ["bilirubin", "PROTEIN", 44, 53], ["the impaired uptake of bilirubin", "PROBLEM", 21, 53], ["the plasma", "TEST", 59, 69], ["impaired conjugation of bilirubin", "PROBLEM", 82, 115], ["may be", "UNCERTAINTY", 14, 20], ["impaired", "OBSERVATION_MODIFIER", 25, 33], ["uptake", "OBSERVATION", 34, 40], ["possibly", "UNCERTAINTY", 73, 81], ["impaired", "OBSERVATION_MODIFIER", 82, 90], ["conjugation", "OBSERVATION", 91, 102], ["low", "OBSERVATION_MODIFIER", 141, 144]]], ["Rarely, cholestasis and its indicators can occur in the absence of significant hepatocellular damage and other signs of liver failure.", [["hepatocellular", "ANATOMY", 79, 93], ["liver", "ANATOMY", 120, 125], ["cholestasis", "DISEASE", 8, 19], ["hepatocellular damage", "DISEASE", 79, 100], ["liver failure", "DISEASE", 120, 133], ["hepatocellular", "CANCER", 79, 93], ["liver", "ORGAN", 120, 125], ["cholestasis", "PROBLEM", 8, 19], ["significant hepatocellular damage", "PROBLEM", 67, 100], ["liver failure", "PROBLEM", 120, 133], ["cholestasis", "OBSERVATION", 8, 19], ["significant", "OBSERVATION_MODIFIER", 67, 78], ["hepatocellular", "ANATOMY", 79, 93], ["damage", "OBSERVATION", 94, 100], ["liver", "ANATOMY", 120, 125], ["failure", "OBSERVATION", 126, 133]]], ["This can occur in toxicity by L. camara in ruminants and as an idiosyncratic reaction to some drugs.Cholestasis and jaundiceIn obstructive cholestasis, the activities of NTCP and OATP transporters are both reduced, causing bile acids and bilirubin to accumulate in the blood.", [["blood", "ANATOMY", 269, 274], ["toxicity", "DISEASE", 18, 26], ["Cholestasis", "DISEASE", 100, 111], ["obstructive cholestasis", "DISEASE", 127, 150], ["bile acids", "CHEMICAL", 223, 233], ["bilirubin", "CHEMICAL", 238, 247], ["bile acids", "CHEMICAL", 223, 233], ["bilirubin", "CHEMICAL", 238, 247], ["L. camara", "ORGANISM", 30, 39], ["NTCP", "GENE_OR_GENE_PRODUCT", 170, 174], ["OATP transporters", "GENE_OR_GENE_PRODUCT", 179, 196], ["bile acids", "SIMPLE_CHEMICAL", 223, 233], ["bilirubin", "SIMPLE_CHEMICAL", 238, 247], ["blood", "ORGANISM_SUBSTANCE", 269, 274], ["NTCP", "PROTEIN", 170, 174], ["OATP transporters", "PROTEIN", 179, 196], ["L. camara", "SPECIES", 30, 39], ["L. camara", "SPECIES", 30, 39], ["an idiosyncratic reaction", "PROBLEM", 60, 85], ["some drugs", "TREATMENT", 89, 99], ["Cholestasis", "PROBLEM", 100, 111], ["jaundiceIn obstructive cholestasis", "PROBLEM", 116, 150], ["OATP transporters", "TREATMENT", 179, 196], ["bile acids", "TEST", 223, 233], ["bilirubin", "TEST", 238, 247], ["the blood", "TEST", 265, 274], ["jaundiceIn", "OBSERVATION_MODIFIER", 116, 126], ["obstructive", "OBSERVATION_MODIFIER", 127, 138], ["cholestasis", "OBSERVATION", 139, 150], ["bile", "ANATOMY", 223, 227], ["blood", "ANATOMY", 269, 274]]], ["Transport of bile acids out of the hepatocyte and into the canaliculus is maintained by BSEP.", [["bile", "ANATOMY", 13, 17], ["hepatocyte", "ANATOMY", 35, 45], ["canaliculus", "ANATOMY", 59, 70], ["bile acids", "CHEMICAL", 13, 23], ["bile acids", "CHEMICAL", 13, 23], ["bile acids", "AMINO_ACID", 13, 23], ["hepatocyte", "CELL", 35, 45], ["canaliculus", "MULTI-TISSUE_STRUCTURE", 59, 70], ["BSEP", "SIMPLE_CHEMICAL", 88, 92], ["BSEP", "PROTEIN", 88, 92], ["bile acids", "TEST", 13, 23], ["bile", "ANATOMY", 13, 17], ["hepatocyte", "ANATOMY", 35, 45], ["canaliculus", "ANATOMY", 59, 70], ["maintained", "OBSERVATION", 74, 84], ["BSEP", "OBSERVATION", 88, 92]]], ["The regulation of transcription of the various transporters in hepatocellular or obstructive cholestasis is controlled by the interaction of bilirubin or bile acids with several nuclear receptors, primarily PXR (pregnane X receptor) and, to a lesser extent, others, such as CAR (constitutive androstane receptor) and FXR (farnesoid X receptor).", [["hepatocellular", "ANATOMY", 63, 77], ["nuclear", "ANATOMY", 178, 185], ["cholestasis", "DISEASE", 93, 104], ["bilirubin", "CHEMICAL", 141, 150], ["bile acids", "CHEMICAL", 154, 164], ["bilirubin", "CHEMICAL", 141, 150], ["bile acids", "CHEMICAL", 154, 164], ["androstane", "CHEMICAL", 292, 302], ["hepatocellular", "CANCER", 63, 77], ["bilirubin", "GENE_OR_GENE_PRODUCT", 141, 150], ["bile acids", "SIMPLE_CHEMICAL", 154, 164], ["PXR", "GENE_OR_GENE_PRODUCT", 207, 210], ["pregnane X receptor", "GENE_OR_GENE_PRODUCT", 212, 231], ["CAR", "GENE_OR_GENE_PRODUCT", 274, 277], ["constitutive androstane receptor", "GENE_OR_GENE_PRODUCT", 279, 311], ["FXR", "GENE_OR_GENE_PRODUCT", 317, 320], ["farnesoid X receptor", "GENE_OR_GENE_PRODUCT", 322, 342], ["bilirubin", "PROTEIN", 141, 150], ["nuclear receptors", "PROTEIN", 178, 195], ["PXR", "PROTEIN", 207, 210], ["pregnane X receptor", "PROTEIN", 212, 231], ["CAR", "PROTEIN", 274, 277], ["constitutive androstane receptor", "PROTEIN", 279, 311], ["FXR", "PROTEIN", 317, 320], ["farnesoid X receptor", "PROTEIN", 322, 342], ["the various transporters", "TREATMENT", 35, 59], ["hepatocellular or obstructive cholestasis", "PROBLEM", 63, 104], ["bilirubin", "TEST", 141, 150], ["bile acids", "TREATMENT", 154, 164], ["several nuclear receptors", "TEST", 170, 195], ["CAR (constitutive androstane receptor", "TREATMENT", 274, 311], ["FXR (farnesoid X receptor)", "TREATMENT", 317, 343], ["hepatocellular", "ANATOMY", 63, 77], ["obstructive", "OBSERVATION_MODIFIER", 81, 92], ["cholestasis", "OBSERVATION", 93, 104], ["lesser extent", "OBSERVATION_MODIFIER", 243, 256], ["FXR", "ANATOMY", 317, 320]]], ["During cholestasis, nuclear receptors orchestrate protection of hepatocytes from injury by reducing the expression of basolateral uptake transporters and increasing the expression of basolateral export pumps, as well as reducing new bile acid synthesis and increasing the rate of intrahepatic metabolism of bile acids.", [["nuclear", "ANATOMY", 20, 27], ["hepatocytes", "ANATOMY", 64, 75], ["basolateral", "ANATOMY", 118, 129], ["basolateral", "ANATOMY", 183, 194], ["intrahepatic", "ANATOMY", 280, 292], ["bile", "ANATOMY", 307, 311], ["cholestasis", "DISEASE", 7, 18], ["bile acid", "CHEMICAL", 233, 242], ["bile acids", "CHEMICAL", 307, 317], ["bile acid", "CHEMICAL", 233, 242], ["bile acids", "CHEMICAL", 307, 317], ["nuclear", "CELLULAR_COMPONENT", 20, 27], ["hepatocytes", "CELL", 64, 75], ["basolateral", "IMMATERIAL_ANATOMICAL_ENTITY", 118, 129], ["basolateral", "CELLULAR_COMPONENT", 183, 194], ["bile acid", "SIMPLE_CHEMICAL", 233, 242], ["intrahepatic", "IMMATERIAL_ANATOMICAL_ENTITY", 280, 292], ["bile acids", "SIMPLE_CHEMICAL", 307, 317], ["nuclear receptors", "PROTEIN", 20, 37], ["hepatocytes", "CELL_TYPE", 64, 75], ["basolateral uptake transporters", "PROTEIN", 118, 149], ["cholestasis", "PROBLEM", 7, 18], ["nuclear receptors", "TREATMENT", 20, 37], ["hepatocytes from injury", "PROBLEM", 64, 87], ["basolateral uptake transporters", "TREATMENT", 118, 149], ["basolateral export pumps", "TREATMENT", 183, 207], ["new bile acid synthesis", "PROBLEM", 229, 252], ["bile acids", "TREATMENT", 307, 317], ["cholestasis", "OBSERVATION", 7, 18], ["hepatocytes", "ANATOMY", 64, 75], ["injury", "OBSERVATION", 81, 87], ["basolateral", "ANATOMY_MODIFIER", 183, 194], ["export pumps", "OBSERVATION", 195, 207], ["bile", "ANATOMY", 233, 237], ["acid synthesis", "OBSERVATION", 238, 252], ["intrahepatic", "ANATOMY_MODIFIER", 280, 292], ["bile acids", "OBSERVATION", 307, 317]]], ["However, these adaptive responses are not always sufficient to prevent cholate-induced hepatotoxicity.Cholestasis and jaundiceSevere diffuse liver necrosis obviously impairs bile excretion at various levels, but the severity of cholestasis or of jaundice depends on the amount of liver affected, the chronicity, the supply of heme for catabolism, and nonhepatic routes of bilirubin excretion.", [["liver", "ANATOMY", 141, 146], ["bile", "ANATOMY", 174, 178], ["liver", "ANATOMY", 280, 285], ["cholate", "CHEMICAL", 71, 78], ["hepatotoxicity", "DISEASE", 87, 101], ["Cholestasis", "DISEASE", 102, 113], ["liver necrosis", "DISEASE", 141, 155], ["cholestasis", "DISEASE", 228, 239], ["jaundice", "DISEASE", 246, 254], ["bilirubin", "CHEMICAL", 372, 381], ["cholate", "CHEMICAL", 71, 78], ["heme", "CHEMICAL", 326, 330], ["bilirubin", "CHEMICAL", 372, 381], ["cholate", "SIMPLE_CHEMICAL", 71, 78], ["liver", "ORGAN", 141, 146], ["bile", "MULTI-TISSUE_STRUCTURE", 174, 178], ["liver", "ORGAN", 280, 285], ["heme", "SIMPLE_CHEMICAL", 326, 330], ["bilirubin", "SIMPLE_CHEMICAL", 372, 381], ["heme", "PROTEIN", 326, 330], ["cholate-induced hepatotoxicity", "PROBLEM", 71, 101], ["Cholestasis", "PROBLEM", 102, 113], ["jaundiceSevere diffuse liver necrosis", "PROBLEM", 118, 155], ["bile excretion at various levels", "PROBLEM", 174, 206], ["cholestasis", "PROBLEM", 228, 239], ["jaundice", "PROBLEM", 246, 254], ["catabolism", "TEST", 335, 345], ["bilirubin excretion", "TEST", 372, 391], ["hepatotoxicity", "OBSERVATION", 87, 101], ["diffuse", "OBSERVATION_MODIFIER", 133, 140], ["liver", "ANATOMY", 141, 146], ["necrosis", "OBSERVATION", 147, 155], ["bile excretion", "OBSERVATION", 174, 188], ["severity", "OBSERVATION_MODIFIER", 216, 224], ["cholestasis", "OBSERVATION", 228, 239], ["jaundice", "OBSERVATION", 246, 254], ["amount", "OBSERVATION_MODIFIER", 270, 276], ["liver", "ANATOMY", 280, 285], ["affected", "OBSERVATION", 286, 294], ["nonhepatic", "ANATOMY", 351, 361], ["bilirubin excretion", "OBSERVATION", 372, 391]]], ["Focal liver injury can have substantial local cholestasis, but clinically detectable cholestasis does not occur because bilirubin can be cleared by unaffected parts of the liver.", [["liver", "ANATOMY", 6, 11], ["liver", "ANATOMY", 172, 177], ["liver injury", "DISEASE", 6, 18], ["cholestasis", "DISEASE", 46, 57], ["cholestasis", "DISEASE", 85, 96], ["bilirubin", "CHEMICAL", 120, 129], ["bilirubin", "CHEMICAL", 120, 129], ["liver", "ORGAN", 6, 11], ["bilirubin", "SIMPLE_CHEMICAL", 120, 129], ["liver", "ORGAN", 172, 177], ["Focal liver injury", "PROBLEM", 0, 18], ["substantial local cholestasis", "PROBLEM", 28, 57], ["cholestasis", "PROBLEM", 85, 96], ["bilirubin", "TEST", 120, 129], ["liver", "ANATOMY", 6, 11], ["injury", "OBSERVATION", 12, 18], ["substantial", "OBSERVATION_MODIFIER", 28, 39], ["local", "OBSERVATION_MODIFIER", 40, 45], ["cholestasis", "OBSERVATION", 46, 57], ["cholestasis", "OBSERVATION", 85, 96], ["liver", "ANATOMY", 172, 177]]], ["Similarly, segmental duct obstructions that spare some parts of the liver can lead to cholestasis but not jaundice.", [["segmental duct", "ANATOMY", 11, 25], ["liver", "ANATOMY", 68, 73], ["segmental duct obstructions", "DISEASE", 11, 38], ["cholestasis", "DISEASE", 86, 97], ["jaundice", "DISEASE", 106, 114], ["duct obstructions", "PATHOLOGICAL_FORMATION", 21, 38], ["liver", "ORGAN", 68, 73], ["segmental duct obstructions", "PROBLEM", 11, 38], ["cholestasis", "PROBLEM", 86, 97], ["jaundice", "PROBLEM", 106, 114], ["segmental", "ANATOMY_MODIFIER", 11, 20], ["duct", "ANATOMY", 21, 25], ["obstructions", "OBSERVATION", 26, 38], ["liver", "ANATOMY", 68, 73], ["cholestasis", "OBSERVATION", 86, 97], ["not", "UNCERTAINTY", 102, 105], ["jaundice", "OBSERVATION", 106, 114]]], ["This can occur in anorexic or dehydrated cats, in which bile may become dehydrated and viscous, causing ductal obstruction.Cholestasis and jaundiceSome of the various transporters and conjugating enzymes involved in bilirubin excretion can be genetically defective.", [["bile", "ANATOMY", 56, 60], ["ductal", "ANATOMY", 104, 110], ["ductal obstruction", "DISEASE", 104, 122], ["Cholestasis", "DISEASE", 123, 134], ["bilirubin", "CHEMICAL", 216, 225], ["bilirubin", "CHEMICAL", 216, 225], ["cats", "ORGANISM", 41, 45], ["bile", "MULTI-TISSUE_STRUCTURE", 56, 60], ["ductal obstruction", "PATHOLOGICAL_FORMATION", 104, 122], ["bilirubin", "GENE_OR_GENE_PRODUCT", 216, 225], ["conjugating enzymes", "PROTEIN", 184, 203], ["anorexic", "PROBLEM", 18, 26], ["dehydrated cats", "PROBLEM", 30, 45], ["dehydrated", "PROBLEM", 72, 82], ["viscous", "PROBLEM", 87, 94], ["ductal obstruction", "PROBLEM", 104, 122], ["Cholestasis", "PROBLEM", 123, 134], ["jaundiceSome of the various transporters", "PROBLEM", 139, 179], ["conjugating enzymes", "TEST", 184, 203], ["bilirubin excretion", "TEST", 216, 235], ["bile", "ANATOMY", 56, 60], ["dehydrated", "OBSERVATION", 72, 82], ["viscous", "OBSERVATION_MODIFIER", 87, 94], ["ductal", "ANATOMY", 104, 110], ["obstruction", "OBSERVATION", 111, 122]]], ["Congenital hyperbilirubinemia in mutant Southdown sheep is the result of impaired hepatic uptake of unconjugated bilirubin.", [["hepatic", "ANATOMY", 82, 89], ["Congenital hyperbilirubinemia", "DISEASE", 0, 29], ["bilirubin", "CHEMICAL", 113, 122], ["bilirubin", "CHEMICAL", 113, 122], ["Southdown sheep", "ORGANISM", 40, 55], ["hepatic", "ORGAN", 82, 89], ["bilirubin", "SIMPLE_CHEMICAL", 113, 122], ["sheep", "SPECIES", 50, 55], ["sheep", "SPECIES", 50, 55], ["Congenital hyperbilirubinemia", "PROBLEM", 0, 29], ["impaired hepatic uptake of unconjugated bilirubin", "PROBLEM", 73, 122], ["hyperbilirubinemia", "OBSERVATION", 11, 29], ["impaired", "OBSERVATION_MODIFIER", 73, 81], ["hepatic", "ANATOMY", 82, 89], ["uptake", "OBSERVATION", 90, 96], ["unconjugated bilirubin", "OBSERVATION", 100, 122]]], ["These animals have few liver lesions, but eventually develop chronic renal disease, the reason for which is not clear.", [["liver lesions", "ANATOMY", 23, 36], ["renal", "ANATOMY", 69, 74], ["liver lesions", "DISEASE", 23, 36], ["chronic renal disease", "DISEASE", 61, 82], ["liver lesions", "CANCER", 23, 36], ["renal", "ORGAN", 69, 74], ["few liver lesions", "PROBLEM", 19, 36], ["chronic renal disease", "PROBLEM", 61, 82], ["few", "OBSERVATION_MODIFIER", 19, 22], ["liver", "ANATOMY", 23, 28], ["lesions", "OBSERVATION", 29, 36], ["chronic", "OBSERVATION_MODIFIER", 61, 68], ["renal", "ANATOMY", 69, 74], ["disease", "OBSERVATION", 75, 82], ["clear", "OBSERVATION", 112, 117]]], ["Unconjugated bilirubin levels in the plasma are consistently elevated, but sufficient excretion takes place to prevent them from becoming icteric.", [["plasma", "ANATOMY", 37, 43], ["bilirubin", "CHEMICAL", 13, 22], ["icteric", "DISEASE", 138, 145], ["bilirubin", "CHEMICAL", 13, 22], ["bilirubin", "GENE_OR_GENE_PRODUCT", 13, 22], ["plasma", "ORGANISM_SUBSTANCE", 37, 43], ["Unconjugated bilirubin levels", "TEST", 0, 29], ["the plasma", "TEST", 33, 43], ["consistently elevated", "PROBLEM", 48, 69], ["icteric", "PROBLEM", 138, 145], ["bilirubin", "OBSERVATION", 13, 22], ["elevated", "OBSERVATION", 61, 69], ["icteric", "OBSERVATION", 138, 145]]], ["They become photosensitized, indicating that excretion of phylloerythrin (phytoporphyrin) is less efficient than that of bilirubin.Cholestasis and jaundiceHyperbilirubinemia in mutant Corriedale sheep is a defect in excretion of conjugated bilirubin similar to Dubin-Johnson syndrome in humans and mutant rat strains.", [["phylloerythrin", "CHEMICAL", 58, 72], ["phytoporphyrin", "CHEMICAL", 74, 88], ["bilirubin", "CHEMICAL", 121, 130], ["Cholestasis", "DISEASE", 131, 142], ["jaundice", "DISEASE", 147, 155], ["Hyperbilirubinemia", "DISEASE", 155, 173], ["bilirubin", "CHEMICAL", 240, 249], ["Dubin-Johnson syndrome", "DISEASE", 261, 283], ["phylloerythrin", "CHEMICAL", 58, 72], ["phytoporphyrin", "CHEMICAL", 74, 88], ["bilirubin", "CHEMICAL", 121, 130], ["bilirubin", "CHEMICAL", 240, 249], ["phylloerythrin", "SIMPLE_CHEMICAL", 58, 72], ["phytoporphyrin", "SIMPLE_CHEMICAL", 74, 88], ["bilirubin", "SIMPLE_CHEMICAL", 121, 130], ["mutant Corriedale sheep", "ORGANISM", 177, 200], ["bilirubin", "GENE_OR_GENE_PRODUCT", 240, 249], ["Dubin-Johnson", "ORGANISM", 261, 274], ["humans", "ORGANISM", 287, 293], ["mutant rat", "ORGANISM", 298, 308], ["sheep", "SPECIES", 195, 200], ["humans", "SPECIES", 287, 293], ["rat", "SPECIES", 305, 308], ["Corriedale sheep", "SPECIES", 184, 200], ["humans", "SPECIES", 287, 293], ["rat", "SPECIES", 305, 308], ["excretion of phylloerythrin (phytoporphyrin)", "PROBLEM", 45, 89], ["bilirubin", "TEST", 121, 130], ["Cholestasis", "PROBLEM", 131, 142], ["jaundice", "PROBLEM", 147, 155], ["Hyperbilirubinemia", "PROBLEM", 155, 173], ["a defect in excretion of conjugated bilirubin", "PROBLEM", 204, 249], ["Johnson syndrome", "PROBLEM", 267, 283], ["mutant rat strains", "PROBLEM", 298, 316], ["photosensitized", "OBSERVATION", 12, 27], ["jaundice", "OBSERVATION", 147, 155], ["Corriedale sheep", "OBSERVATION_MODIFIER", 184, 200], ["defect", "OBSERVATION", 206, 212], ["excretion", "OBSERVATION_MODIFIER", 216, 225], ["conjugated bilirubin", "OBSERVATION", 229, 249], ["Johnson syndrome", "OBSERVATION", 267, 283], ["rat strains", "OBSERVATION", 305, 316]]], ["In humans and rats, there is a mutation in Mrp-2 causing hypofunction and a similar mutation is likely in affected sheep.", [["hypofunction", "DISEASE", 57, 69], ["humans", "ORGANISM", 3, 9], ["rats", "ORGANISM", 14, 18], ["Mrp-2", "GENE_OR_GENE_PRODUCT", 43, 48], ["sheep", "ORGANISM", 115, 120], ["Mrp-2", "DNA", 43, 48], ["humans", "SPECIES", 3, 9], ["rats", "SPECIES", 14, 18], ["sheep", "SPECIES", 115, 120], ["humans", "SPECIES", 3, 9], ["sheep", "SPECIES", 115, 120], ["a mutation in Mrp", "PROBLEM", 29, 46], ["hypofunction", "PROBLEM", 57, 69], ["a similar mutation", "PROBLEM", 74, 92]]], ["Affected sheep have an elevation of plasma bilirubin (just over half of which is conjugated), but there is no obvious jaundice.", [["plasma", "ANATOMY", 36, 42], ["bilirubin", "CHEMICAL", 43, 52], ["jaundice", "DISEASE", 118, 126], ["bilirubin", "CHEMICAL", 43, 52], ["sheep", "ORGANISM", 9, 14], ["plasma", "ORGANISM_SUBSTANCE", 36, 42], ["bilirubin", "GENE_OR_GENE_PRODUCT", 43, 52], ["sheep", "SPECIES", 9, 14], ["sheep", "SPECIES", 9, 14], ["Affected sheep", "PROBLEM", 0, 14], ["an elevation of plasma bilirubin", "PROBLEM", 20, 52], ["obvious jaundice", "PROBLEM", 110, 126], ["elevation", "OBSERVATION", 23, 32], ["no", "UNCERTAINTY", 107, 109], ["obvious", "OBSERVATION_MODIFIER", 110, 117], ["jaundice", "OBSERVATION", 118, 126]]], ["Nevertheless, phylloerythrin (phytoporphyrin) excretion in these necrosis is not usually a feature of cholestasis.", [["phylloerythrin", "CHEMICAL", 14, 28], ["phytoporphyrin", "CHEMICAL", 30, 44], ["necrosis", "DISEASE", 65, 73], ["cholestasis", "DISEASE", 102, 113], ["phylloerythrin", "CHEMICAL", 14, 28], ["phytoporphyrin", "CHEMICAL", 30, 44], ["phylloerythrin", "SIMPLE_CHEMICAL", 14, 28], ["phytoporphyrin", "SIMPLE_CHEMICAL", 30, 44], ["cholestasis", "PATHOLOGICAL_FORMATION", 102, 113], ["phylloerythrin (phytoporphyrin) excretion", "TREATMENT", 14, 55], ["these necrosis", "PROBLEM", 59, 73], ["cholestasis", "PROBLEM", 102, 113], ["necrosis", "OBSERVATION", 65, 73], ["cholestasis", "OBSERVATION", 102, 113]]], ["In more severe cases of obstructive cholestasis, confluent areas of bile-stained hepatocellular necrosis, termed bile infarcts, can develop.", [["bile", "ANATOMY", 68, 72], ["hepatocellular", "ANATOMY", 81, 95], ["bile infarcts", "ANATOMY", 113, 126], ["obstructive cholestasis", "DISEASE", 24, 47], ["necrosis", "DISEASE", 96, 104], ["bile infarcts", "DISEASE", 113, 126], ["bile", "PATHOLOGICAL_FORMATION", 68, 72], ["hepatocellular", "MULTI-TISSUE_STRUCTURE", 81, 95], ["bile", "MULTI-TISSUE_STRUCTURE", 113, 117], ["obstructive cholestasis", "PROBLEM", 24, 47], ["bile-stained hepatocellular necrosis", "PROBLEM", 68, 104], ["termed bile infarcts", "PROBLEM", 106, 126], ["severe", "OBSERVATION_MODIFIER", 8, 14], ["obstructive", "OBSERVATION_MODIFIER", 24, 35], ["cholestasis", "OBSERVATION", 36, 47], ["confluent", "OBSERVATION_MODIFIER", 49, 58], ["areas", "OBSERVATION_MODIFIER", 59, 64], ["bile", "ANATOMY", 68, 72], ["stained", "OBSERVATION_MODIFIER", 73, 80], ["hepatocellular necrosis", "OBSERVATION", 81, 104], ["bile", "ANATOMY", 113, 117], ["infarcts", "OBSERVATION", 118, 126]]], ["Bile infarcts are rare in dogs and cats, but can be found in other species.", [["Bile infarcts", "ANATOMY", 0, 13], ["Bile infarcts", "DISEASE", 0, 13], ["Bile", "PATHOLOGICAL_FORMATION", 0, 4], ["dogs", "ORGANISM", 26, 30], ["cats", "ORGANISM", 35, 39], ["dogs", "SPECIES", 26, 30], ["cats", "SPECIES", 35, 39], ["Bile infarcts", "PROBLEM", 0, 13], ["infarcts", "OBSERVATION", 5, 13], ["rare", "OBSERVATION_MODIFIER", 18, 22], ["species", "OBSERVATION", 67, 74]]], ["Cholate stasis refers to hepatocellular degeneration in the periportal region, often accompanied by a proliferation of small-caliber bile ducts (ductular reaction).", [["hepatocellular", "ANATOMY", 25, 39], ["periportal region", "ANATOMY", 60, 77], ["bile ducts", "ANATOMY", 133, 143], ["ductular", "ANATOMY", 145, 153], ["Cholate", "CHEMICAL", 0, 7], ["hepatocellular degeneration", "DISEASE", 25, 52], ["Cholate", "SIMPLE_CHEMICAL", 0, 7], ["hepatocellular", "CANCER", 25, 39], ["periportal region", "TISSUE", 60, 77], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 133, 143], ["ductular", "MULTI-TISSUE_STRUCTURE", 145, 153], ["Cholate stasis", "PROBLEM", 0, 14], ["hepatocellular degeneration in the periportal region", "PROBLEM", 25, 77], ["a proliferation of small-caliber bile ducts (ductular reaction", "PROBLEM", 100, 162], ["stasis", "OBSERVATION", 8, 14], ["hepatocellular degeneration", "OBSERVATION", 25, 52], ["periportal", "ANATOMY", 60, 70], ["proliferation", "OBSERVATION", 102, 115], ["small", "OBSERVATION_MODIFIER", 119, 124], ["caliber", "ANATOMY_MODIFIER", 125, 132], ["bile ducts", "ANATOMY", 133, 143], ["ductular", "ANATOMY_MODIFIER", 145, 153]]], ["Affected hepatocytes have swollen pale cytoplasm, and they may contain copper granules.", [["hepatocytes", "ANATOMY", 9, 20], ["pale cytoplasm", "ANATOMY", 34, 48], ["copper", "CHEMICAL", 71, 77], ["copper", "CHEMICAL", 71, 77], ["hepatocytes", "CELL", 9, 20], ["cytoplasm", "ORGANISM_SUBSTANCE", 39, 48], ["copper", "SIMPLE_CHEMICAL", 71, 77], ["granules", "CELLULAR_COMPONENT", 78, 86], ["hepatocytes", "CELL_TYPE", 9, 20], ["Affected hepatocytes", "PROBLEM", 0, 20], ["swollen pale cytoplasm", "PROBLEM", 26, 48], ["copper granules", "PROBLEM", 71, 86], ["hepatocytes", "ANATOMY", 9, 20], ["swollen", "OBSERVATION_MODIFIER", 26, 33], ["pale", "OBSERVATION_MODIFIER", 34, 38], ["cytoplasm", "OBSERVATION", 39, 48], ["copper granules", "OBSERVATION", 71, 86]]], ["This lesion is most common in horses with obstruction and rare in dogs.", [["lesion", "ANATOMY", 5, 11], ["obstruction", "DISEASE", 42, 53], ["horses", "ORGANISM", 30, 36], ["dogs", "ORGANISM", 66, 70], ["dogs", "SPECIES", 66, 70], ["This lesion", "PROBLEM", 0, 11], ["obstruction", "PROBLEM", 42, 53], ["rare in dogs", "PROBLEM", 58, 70], ["lesion", "OBSERVATION", 5, 11], ["most common", "OBSERVATION_MODIFIER", 15, 26], ["obstruction", "OBSERVATION", 42, 53], ["rare", "OBSERVATION_MODIFIER", 58, 62]]], ["In hepatocellular cholestasis, there are no distinctive lesions in the portal tracts.", [["hepatocellular cholestasis", "ANATOMY", 3, 29], ["lesions", "ANATOMY", 56, 63], ["portal tracts", "ANATOMY", 71, 84], ["hepatocellular cholestasis", "DISEASE", 3, 29], ["hepatocellular cholestasis", "CANCER", 3, 29], ["lesions", "PATHOLOGICAL_FORMATION", 56, 63], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 71, 84], ["hepatocellular cholestasis", "PROBLEM", 3, 29], ["distinctive lesions in the portal tracts", "PROBLEM", 44, 84], ["hepatocellular", "ANATOMY", 3, 17], ["cholestasis", "OBSERVATION", 18, 29], ["no", "UNCERTAINTY", 41, 43], ["distinctive", "OBSERVATION_MODIFIER", 44, 55], ["lesions", "OBSERVATION", 56, 63], ["portal tracts", "ANATOMY", 71, 84]]], ["However, in obstructive cholestasis, there are a number of distinctive changes.", [["obstructive cholestasis", "DISEASE", 12, 35], ["obstructive cholestasis", "PROBLEM", 12, 35], ["distinctive changes", "PROBLEM", 59, 78], ["obstructive", "OBSERVATION_MODIFIER", 12, 23], ["cholestasis", "OBSERVATION", 24, 35], ["number", "OBSERVATION_MODIFIER", 49, 55], ["distinctive", "OBSERVATION_MODIFIER", 59, 70], ["changes", "OBSERVATION", 71, 78]]], ["Initially, there is edema in the portal tract and an inflammatory infiltrate that is most often predominantly neutrophilic.", [["edema", "ANATOMY", 20, 25], ["portal tract", "ANATOMY", 33, 45], ["edema", "DISEASE", 20, 25], ["edema", "PATHOLOGICAL_FORMATION", 20, 25], ["portal tract", "MULTI-TISSUE_STRUCTURE", 33, 45], ["edema in the portal tract", "PROBLEM", 20, 45], ["an inflammatory infiltrate", "PROBLEM", 50, 76], ["edema", "OBSERVATION", 20, 25], ["portal tract", "ANATOMY", 33, 45], ["inflammatory", "OBSERVATION_MODIFIER", 53, 65], ["infiltrate", "OBSERVATION", 66, 76], ["most often", "UNCERTAINTY", 85, 95], ["predominantly", "OBSERVATION_MODIFIER", 96, 109], ["neutrophilic", "OBSERVATION", 110, 122]]], ["There is an accompanying proliferation of smallcaliber bile ducts arranged in an apparently haphazard fashion (ductular reaction).", [["smallcaliber bile ducts", "ANATOMY", 42, 65], ["ductular", "ANATOMY", 111, 119], ["smallcaliber bile ducts", "MULTI-TISSUE_STRUCTURE", 42, 65], ["ductular", "MULTI-TISSUE_STRUCTURE", 111, 119], ["an accompanying proliferation of smallcaliber bile ducts", "PROBLEM", 9, 65], ["ductular reaction", "PROBLEM", 111, 128], ["proliferation", "OBSERVATION", 25, 38], ["smallcaliber", "ANATOMY_MODIFIER", 42, 54], ["bile ducts", "ANATOMY", 55, 65], ["ductular", "OBSERVATION_MODIFIER", 111, 119]]], ["There may be degeneration or proliferative changes in pre-existing interlobular bile ducts, often associated with inflammation, depending on the cause of the obstruction.", [["interlobular bile ducts", "ANATOMY", 67, 90], ["interlobular bile ducts", "DISEASE", 67, 90], ["inflammation", "DISEASE", 114, 126], ["obstruction", "DISEASE", 158, 169], ["interlobular bile ducts", "MULTI-TISSUE_STRUCTURE", 67, 90], ["obstruction", "PATHOLOGICAL_FORMATION", 158, 169], ["degeneration", "PROBLEM", 13, 25], ["proliferative changes in pre-existing interlobular bile ducts", "PROBLEM", 29, 90], ["inflammation", "PROBLEM", 114, 126], ["the obstruction", "PROBLEM", 154, 169], ["may be", "UNCERTAINTY", 6, 12], ["degeneration", "OBSERVATION", 13, 25], ["proliferative", "OBSERVATION_MODIFIER", 29, 42], ["interlobular", "ANATOMY_MODIFIER", 67, 79], ["bile ducts", "ANATOMY", 80, 90], ["inflammation", "OBSERVATION", 114, 126], ["obstruction", "OBSERVATION", 158, 169]]], ["Ductal ectasia may also be present.", [["Ductal", "ANATOMY", 0, 6], ["Ductal ectasia", "DISEASE", 0, 14], ["Ductal", "MULTI-TISSUE_STRUCTURE", 0, 6], ["Ductal ectasia", "PROBLEM", 0, 14], ["ectasia", "OBSERVATION", 7, 14], ["may also be", "UNCERTAINTY", 15, 26]]], ["With time, there is an increase of fibrosis that expands the portal tract outline and can bridge between portal tracts in cases of severe obstruction.", [["portal tract", "ANATOMY", 61, 73], ["portal tracts", "ANATOMY", 105, 118], ["fibrosis", "DISEASE", 35, 43], ["obstruction", "DISEASE", 138, 149], ["portal tract", "ORGANISM_SUBDIVISION", 61, 73], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 105, 118], ["an increase of fibrosis", "PROBLEM", 20, 43], ["severe obstruction", "PROBLEM", 131, 149], ["increase", "OBSERVATION_MODIFIER", 23, 31], ["fibrosis", "OBSERVATION", 35, 43], ["portal tract", "ANATOMY", 61, 73], ["portal tracts", "ANATOMY", 105, 118], ["severe", "OBSERVATION_MODIFIER", 131, 137], ["obstruction", "OBSERVATION", 138, 149]]], ["In addition, there is concentric fibrosis surrounding the bile ducts.", [["bile ducts", "ANATOMY", 58, 68], ["fibrosis", "DISEASE", 33, 41], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 58, 68], ["concentric fibrosis surrounding the bile ducts", "PROBLEM", 22, 68], ["concentric", "OBSERVATION_MODIFIER", 22, 32], ["fibrosis", "OBSERVATION", 33, 41], ["bile ducts", "ANATOMY", 58, 68]]], ["Proliferation of bile ducts, termed ductular reaction, is a constant feature.", [["bile ducts", "ANATOMY", 17, 27], ["ductular", "ANATOMY", 36, 44], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 17, 27], ["ductular", "MULTI-TISSUE_STRUCTURE", 36, 44], ["Proliferation of bile ducts", "PROBLEM", 0, 27], ["termed ductular reaction", "PROBLEM", 29, 53], ["bile ducts", "ANATOMY", 17, 27], ["ductular reaction", "OBSERVATION", 36, 53]]], ["Mixed inflammatory cells, usually with fewer neutrophils than that seen in acute cholestasis, as well as macrophages containing pigment found in the portal tract.Cholestasis and jaundiceHepatocellular cholestasis arises when there is a disturbance in 1 or more of the 3 main steps involved in bile excretion.", [["inflammatory cells", "ANATOMY", 6, 24], ["neutrophils", "ANATOMY", 45, 56], ["macrophages", "ANATOMY", 105, 116], ["pigment", "ANATOMY", 128, 135], ["portal tract", "ANATOMY", 149, 161], ["Hepatocellular", "ANATOMY", 186, 200], ["bile", "ANATOMY", 293, 297], ["cholestasis", "DISEASE", 81, 92], ["Cholestasis", "DISEASE", 162, 173], ["jaundice", "DISEASE", 178, 186], ["Hepatocellular cholestasis", "DISEASE", 186, 212], ["Mixed inflammatory cells", "CELL", 0, 24], ["neutrophils", "CELL", 45, 56], ["macrophages", "CELL", 105, 116], ["pigment", "TISSUE", 128, 135], ["portal tract", "MULTI-TISSUE_STRUCTURE", 149, 161], ["Hepatocellular cholestasis", "PATHOLOGICAL_FORMATION", 186, 212], ["bile", "MULTI-TISSUE_STRUCTURE", 293, 297], ["inflammatory cells", "CELL_TYPE", 6, 24], ["neutrophils", "CELL_TYPE", 45, 56], ["macrophages", "CELL_TYPE", 105, 116], ["Mixed inflammatory cells", "PROBLEM", 0, 24], ["fewer neutrophils", "PROBLEM", 39, 56], ["acute cholestasis", "PROBLEM", 75, 92], ["macrophages containing pigment", "PROBLEM", 105, 135], ["Cholestasis", "PROBLEM", 162, 173], ["jaundice", "PROBLEM", 178, 186], ["Hepatocellular cholestasis", "PROBLEM", 186, 212], ["a disturbance in 1", "PROBLEM", 234, 252], ["inflammatory cells", "OBSERVATION", 6, 24], ["acute", "OBSERVATION_MODIFIER", 75, 80], ["cholestasis", "OBSERVATION", 81, 92], ["macrophages", "OBSERVATION", 105, 116], ["pigment", "OBSERVATION_MODIFIER", 128, 135], ["portal tract", "ANATOMY", 149, 161], ["jaundice", "OBSERVATION", 178, 186], ["cholestasis", "OBSERVATION", 201, 212], ["disturbance", "OBSERVATION", 236, 247], ["bile", "ANATOMY", 293, 297]]], ["They include failure (1) to take up bilirubin, bile acids, or other bile constituents; (2) to conjugate bilirubin, bile acids, or other constituents; and (3) to transport and excrete conjugated bilirubin, bile acids, or other bile constituents into canaliculi.", [["bile", "ANATOMY", 47, 51], ["bile", "ANATOMY", 68, 72], ["bile", "ANATOMY", 115, 119], ["bile", "ANATOMY", 205, 209], ["bile constituents", "ANATOMY", 226, 243], ["canaliculi", "ANATOMY", 249, 259], ["bilirubin", "CHEMICAL", 36, 45], ["bile acids", "CHEMICAL", 47, 57], ["bilirubin", "CHEMICAL", 104, 113], ["bile acids", "CHEMICAL", 115, 125], ["bilirubin", "CHEMICAL", 194, 203], ["bile acids", "CHEMICAL", 205, 215], ["bilirubin", "CHEMICAL", 36, 45], ["bile acids", "CHEMICAL", 47, 57], ["bilirubin", "CHEMICAL", 104, 113], ["bile acids", "CHEMICAL", 115, 125], ["bilirubin", "CHEMICAL", 194, 203], ["bile acids", "CHEMICAL", 205, 215], ["bilirubin", "SIMPLE_CHEMICAL", 36, 45], ["bile acids", "SIMPLE_CHEMICAL", 47, 57], ["bile constituents", "SIMPLE_CHEMICAL", 68, 85], ["bilirubin", "SIMPLE_CHEMICAL", 104, 113], ["bile acids", "SIMPLE_CHEMICAL", 115, 125], ["conjugated", "SIMPLE_CHEMICAL", 183, 193], ["bilirubin", "SIMPLE_CHEMICAL", 194, 203], ["bile acids", "SIMPLE_CHEMICAL", 205, 215], ["bile constituents", "SIMPLE_CHEMICAL", 226, 243], ["canaliculi", "MULTI-TISSUE_STRUCTURE", 249, 259], ["take up bilirubin", "TEST", 28, 45], ["bile acids", "TEST", 47, 57], ["other bile constituents", "PROBLEM", 62, 85], ["conjugate bilirubin", "TEST", 94, 113], ["bile acids", "TEST", 115, 125], ["transport and excrete conjugated bilirubin", "TEST", 161, 203], ["bile acids", "TEST", 205, 215], ["other bile constituents into canaliculi", "PROBLEM", 220, 259], ["failure", "OBSERVATION", 13, 20], ["bile", "ANATOMY", 47, 51], ["bile", "ANATOMY", 68, 72], ["bile", "ANATOMY", 115, 119], ["bile", "ANATOMY", 205, 209], ["bile", "ANATOMY", 226, 230], ["canaliculi", "ANATOMY", 249, 259]]], ["Most of these bile metabolism issues are mediated by a series of hepatobiliary transporters, molecular pumps involved in the transport of bilirubin, bile acids, and other organic ions in hepatocytes, canaliculi, and biliary epithelium, although some pumps serve to export substances as well.", [["bile", "ANATOMY", 14, 18], ["hepatocytes", "ANATOMY", 187, 198], ["canaliculi", "ANATOMY", 200, 210], ["biliary epithelium", "ANATOMY", 216, 234], ["bilirubin", "CHEMICAL", 138, 147], ["bile acids", "CHEMICAL", 149, 159], ["bilirubin", "CHEMICAL", 138, 147], ["bile acids", "CHEMICAL", 149, 159], ["bile", "MULTI-TISSUE_STRUCTURE", 14, 18], ["bilirubin", "SIMPLE_CHEMICAL", 138, 147], ["bile acids", "SIMPLE_CHEMICAL", 149, 159], ["hepatocytes", "CELL", 187, 198], ["canaliculi", "MULTI-TISSUE_STRUCTURE", 200, 210], ["biliary epithelium", "TISSUE", 216, 234], ["hepatocytes", "CELL_TYPE", 187, 198], ["these bile metabolism issues", "PROBLEM", 8, 36], ["hepatobiliary transporters", "TREATMENT", 65, 91], ["molecular pumps", "TREATMENT", 93, 108], ["the transport of bilirubin", "TEST", 121, 147], ["bile acids", "TEST", 149, 159], ["other organic ions in hepatocytes", "PROBLEM", 165, 198], ["canaliculi, and biliary epithelium", "PROBLEM", 200, 234], ["some pumps", "TREATMENT", 245, 255], ["bile", "ANATOMY", 14, 18], ["metabolism", "OBSERVATION", 19, 29], ["bile", "ANATOMY", 149, 153], ["organic ions", "OBSERVATION", 171, 183], ["hepatocytes", "ANATOMY", 187, 198], ["canaliculi", "ANATOMY_MODIFIER", 200, 210], ["biliary epithelium", "ANATOMY", 216, 234], ["substances", "OBSERVATION", 272, 282]]], ["Hepatocellular uptake of unconjugated and conjugated bilirubin, like other organic ions, is mediated by members of the organic anion-transporting polypeptide (OATP) family found on the basolateral aspects of hepatocytes.", [["Hepatocellular", "ANATOMY", 0, 14], ["basolateral aspects", "ANATOMY", 185, 204], ["hepatocytes", "ANATOMY", 208, 219], ["bilirubin", "CHEMICAL", 53, 62], ["bilirubin", "CHEMICAL", 53, 62], ["Hepatocellular", "CANCER", 0, 14], ["unconjugated", "SIMPLE_CHEMICAL", 25, 37], ["conjugated bilirubin", "SIMPLE_CHEMICAL", 42, 62], ["organic anion-transporting polypeptide", "GENE_OR_GENE_PRODUCT", 119, 157], ["OATP", "GENE_OR_GENE_PRODUCT", 159, 163], ["hepatocytes", "CELL", 208, 219], ["organic anion-transporting polypeptide (OATP) family", "PROTEIN", 119, 171], ["hepatocytes", "CELL_TYPE", 208, 219], ["Hepatocellular uptake of unconjugated and conjugated bilirubin", "PROBLEM", 0, 62], ["other organic ions", "PROBLEM", 69, 87], ["unconjugated", "OBSERVATION_MODIFIER", 25, 37], ["conjugated bilirubin", "OBSERVATION", 42, 62], ["organic ions", "OBSERVATION", 75, 87], ["basolateral", "ANATOMY_MODIFIER", 185, 196], ["hepatocytes", "ANATOMY", 208, 219]]], ["Bilirubin is conjugated by uridine diphosphate-glucuronyl transferase in the endoplasmic reticulum of hepatocytes.", [["endoplasmic reticulum", "ANATOMY", 77, 98], ["hepatocytes", "ANATOMY", 102, 113], ["Bilirubin", "CHEMICAL", 0, 9], ["uridine diphosphate", "CHEMICAL", 27, 46], ["Bilirubin", "CHEMICAL", 0, 9], ["uridine diphosphate", "CHEMICAL", 27, 46], ["glucuronyl", "CHEMICAL", 47, 57], ["Bilirubin", "SIMPLE_CHEMICAL", 0, 9], ["uridine diphosphate-glucuronyl transferase", "GENE_OR_GENE_PRODUCT", 27, 69], ["endoplasmic reticulum", "CELLULAR_COMPONENT", 77, 98], ["hepatocytes", "CELL", 102, 113], ["uridine diphosphate-glucuronyl transferase", "PROTEIN", 27, 69], ["hepatocytes", "CELL_TYPE", 102, 113], ["Bilirubin", "TEST", 0, 9], ["uridine diphosphate", "TEST", 27, 46], ["endoplasmic reticulum", "OBSERVATION", 77, 98], ["hepatocytes", "ANATOMY", 102, 113]]], ["From there it is transported into the bile.", [["bile", "ANATOMY", 38, 42], ["bile", "MULTI-TISSUE_STRUCTURE", 38, 42], ["bile", "ANATOMY", 38, 42]]], ["Bile acids are imported from the plasma by the Na + -taurocholate cotransporting polypeptide (NTCP).", [["Bile", "ANATOMY", 0, 4], ["plasma", "ANATOMY", 33, 39], ["Bile acids", "CHEMICAL", 0, 10], ["Na", "CHEMICAL", 47, 49], ["taurocholate", "CHEMICAL", 53, 65], ["Bile acids", "CHEMICAL", 0, 10], ["Na +", "CHEMICAL", 47, 51], ["taurocholate", "CHEMICAL", 53, 65], ["Bile acids", "SIMPLE_CHEMICAL", 0, 10], ["plasma", "ORGANISM_SUBSTANCE", 33, 39], ["Na + -taurocholate cotransporting polypeptide", "GENE_OR_GENE_PRODUCT", 47, 92], ["Na + -taurocholate cotransporting polypeptide", "PROTEIN", 47, 92], ["NTCP", "PROTEIN", 94, 98], ["Bile acids", "TEST", 0, 10], ["the plasma", "TEST", 29, 39], ["the Na", "TEST", 43, 49], ["taurocholate cotransporting polypeptide", "TREATMENT", 53, 92], ["acids", "OBSERVATION", 5, 10]]], ["Transport of bile acids, the main osmotic driving force for bile formation (bile acid-dependent flow), into the canaliculus is performed by the bile salt export pump (BSEP).", [["bile", "ANATOMY", 13, 17], ["bile", "ANATOMY", 60, 64], ["bile", "ANATOMY", 76, 80], ["canaliculus", "ANATOMY", 112, 123], ["bile", "ANATOMY", 144, 148], ["bile acids", "CHEMICAL", 13, 23], ["bile acid", "CHEMICAL", 76, 85], ["bile acids", "CHEMICAL", 13, 23], ["bile acid", "CHEMICAL", 76, 85], ["bile salt", "CHEMICAL", 144, 153], ["bile acids", "SIMPLE_CHEMICAL", 13, 23], ["bile", "SIMPLE_CHEMICAL", 60, 64], ["bile acid", "SIMPLE_CHEMICAL", 76, 85], ["canaliculus", "MULTI-TISSUE_STRUCTURE", 112, 123], ["bile salt", "SIMPLE_CHEMICAL", 144, 153], ["bile acids", "TEST", 13, 23], ["bile formation", "PROBLEM", 60, 74], ["bile acid", "TEST", 76, 85], ["bile", "ANATOMY", 13, 17], ["bile", "ANATOMY", 60, 64], ["bile", "ANATOMY", 76, 80], ["canaliculus", "ANATOMY", 112, 123], ["bile", "ANATOMY", 144, 148]]], ["Aquaporin channels facilitate the movement of water into the canaliculus in response to the osmotic forces produced by the bile acids.", [["canaliculus", "ANATOMY", 61, 72], ["bile", "ANATOMY", 123, 127], ["bile acids", "CHEMICAL", 123, 133], ["bile acids", "CHEMICAL", 123, 133], ["Aquaporin", "GENE_OR_GENE_PRODUCT", 0, 9], ["water", "SIMPLE_CHEMICAL", 46, 51], ["canaliculus", "MULTI-TISSUE_STRUCTURE", 61, 72], ["bile acids", "SIMPLE_CHEMICAL", 123, 133], ["Aquaporin channels", "PROTEIN", 0, 18], ["Aquaporin channels", "TREATMENT", 0, 18], ["the osmotic forces", "TREATMENT", 88, 106], ["the bile acids", "TEST", 119, 133], ["canaliculus", "ANATOMY", 61, 72], ["osmotic forces", "OBSERVATION", 92, 106], ["bile", "ANATOMY", 123, 127]]], ["Movement of bilirubin into the canaliculus for excretion is accomplished by the multidrug-resistance-associated protein-2 (MRP-2).", [["canaliculus", "ANATOMY", 31, 42], ["bilirubin", "CHEMICAL", 12, 21], ["bilirubin", "CHEMICAL", 12, 21], ["bilirubin", "GENE_OR_GENE_PRODUCT", 12, 21], ["canaliculus", "MULTI-TISSUE_STRUCTURE", 31, 42], ["multidrug-resistance-associated protein-2", "GENE_OR_GENE_PRODUCT", 80, 121], ["MRP-2", "GENE_OR_GENE_PRODUCT", 123, 128], ["bilirubin", "PROTEIN", 12, 21], ["multidrug-resistance-associated protein-2 (MRP-2", "PROTEIN", 80, 128], ["Movement of bilirubin", "TEST", 0, 21], ["protein", "TEST", 112, 119], ["MRP", "TEST", 123, 126], ["bilirubin", "ANATOMY", 12, 21], ["canaliculus", "ANATOMY", 31, 42], ["excretion", "OBSERVATION", 47, 56]]], ["Reduced glutathione is also a substrate for MRP-2, and it is reduced glutathione and bicarbonate that are the main elements of the bile acid-independent portion of bile flow, the second most significant force in bile flow.", [["bile", "ANATOMY", 131, 135], ["bile", "ANATOMY", 164, 168], ["bile", "ANATOMY", 212, 216], ["glutathione", "CHEMICAL", 8, 19], ["glutathione", "CHEMICAL", 69, 80], ["bicarbonate", "CHEMICAL", 85, 96], ["glutathione", "CHEMICAL", 8, 19], ["glutathione", "CHEMICAL", 69, 80], ["bicarbonate", "CHEMICAL", 85, 96], ["glutathione", "SIMPLE_CHEMICAL", 8, 19], ["MRP-2", "GENE_OR_GENE_PRODUCT", 44, 49], ["glutathione", "SIMPLE_CHEMICAL", 69, 80], ["bicarbonate", "SIMPLE_CHEMICAL", 85, 96], ["bile", "SIMPLE_CHEMICAL", 131, 135], ["bile", "SIMPLE_CHEMICAL", 164, 168], ["bile", "MULTI-TISSUE_STRUCTURE", 212, 216], ["MRP", "PROTEIN", 44, 47], ["Reduced glutathione", "PROBLEM", 0, 19], ["MRP", "TEST", 44, 47], ["bicarbonate", "TREATMENT", 85, 96], ["main", "OBSERVATION_MODIFIER", 110, 114], ["bile", "ANATOMY", 131, 135], ["bile flow", "OBSERVATION", 164, 173], ["significant", "OBSERVATION_MODIFIER", 191, 202], ["force", "OBSERVATION", 203, 208], ["bile flow", "OBSERVATION", 212, 221]]], ["Bile is continually modified by transporter-driven processes of secretion and absorption during its transit to the duodenum.Cholestasis and jaundiceIn hepatocellular cholestasis, drugs or endotoxin-induced proinflammatory cytokines interfere with the activities of molecular pumps or inhibit their synthesis.", [["Bile", "ANATOMY", 0, 4], ["duodenum", "ANATOMY", 115, 123], ["hepatocellular", "ANATOMY", 151, 165], ["Cholestasis", "DISEASE", 124, 135], ["cholestasis", "DISEASE", 166, 177], ["endotoxin", "CHEMICAL", 188, 197], ["Bile", "MULTI-TISSUE_STRUCTURE", 0, 4], ["duodenum", "ORGAN", 115, 123], ["hepatocellular", "ORGAN", 151, 165], ["endotoxin", "SIMPLE_CHEMICAL", 188, 197], ["proinflammatory cytokines", "PROTEIN", 206, 231], ["secretion", "PROBLEM", 64, 73], ["Cholestasis", "PROBLEM", 124, 135], ["jaundiceIn hepatocellular cholestasis", "PROBLEM", 140, 177], ["drugs", "TREATMENT", 179, 184], ["endotoxin", "TREATMENT", 188, 197], ["proinflammatory cytokines", "PROBLEM", 206, 231], ["molecular pumps", "TREATMENT", 265, 280], ["their synthesis", "PROBLEM", 292, 307], ["secretion", "OBSERVATION", 64, 73], ["duodenum", "ANATOMY", 115, 123], ["hepatocellular", "ANATOMY", 151, 165], ["cholestasis", "OBSERVATION", 166, 177]]], ["Endotoxin expo-significant hemorrhage is not common in acute liver failure.", [["liver", "ANATOMY", 61, 66], ["Endotoxin", "CHEMICAL", 0, 9], ["hemorrhage", "DISEASE", 27, 37], ["acute liver failure", "DISEASE", 55, 74], ["liver", "ORGAN", 61, 66], ["Endotoxin expo-significant hemorrhage", "PROBLEM", 0, 37], ["acute liver failure", "PROBLEM", 55, 74], ["hemorrhage", "OBSERVATION", 27, 37], ["not common", "UNCERTAINTY", 41, 51], ["acute", "OBSERVATION_MODIFIER", 55, 60], ["liver", "ANATOMY", 61, 66], ["failure", "OBSERVATION", 67, 74]]], ["The liver is the source of plasma proteins involved in the clotting cascade, but these are normally supplied in substantial excess, and can be induced as part of the acute-phase response to inflammation.", [["liver", "ANATOMY", 4, 9], ["plasma", "ANATOMY", 27, 33], ["inflammation", "DISEASE", 190, 202], ["liver", "ORGAN", 4, 9], ["plasma", "ORGANISM_SUBSTANCE", 27, 33], ["plasma proteins", "PROTEIN", 27, 42], ["plasma proteins", "PROBLEM", 27, 42], ["the clotting cascade", "PROBLEM", 55, 75], ["inflammation", "PROBLEM", 190, 202], ["liver", "ANATOMY", 4, 9], ["plasma proteins", "OBSERVATION", 27, 42], ["clotting cascade", "OBSERVATION", 59, 75], ["substantial", "OBSERVATION_MODIFIER", 112, 123], ["excess", "OBSERVATION", 124, 130], ["acute", "OBSERVATION_MODIFIER", 166, 171], ["inflammation", "OBSERVATION", 190, 202]]], ["Thus coagulopathy with hemorrhage is most likely to occur when there is acute liver necrosis, for example, in acute canine infectious hepatitis or xylitol toxicity.", [["liver", "ANATOMY", 78, 83], ["coagulopathy", "DISEASE", 5, 17], ["hemorrhage", "DISEASE", 23, 33], ["acute liver necrosis", "DISEASE", 72, 92], ["hepatitis", "DISEASE", 134, 143], ["xylitol", "CHEMICAL", 147, 154], ["toxicity", "DISEASE", 155, 163], ["xylitol", "CHEMICAL", 147, 154], ["liver", "ORGAN", 78, 83], ["canine", "ORGANISM", 116, 122], ["xylitol", "SIMPLE_CHEMICAL", 147, 154], ["canine", "SPECIES", 116, 122], ["coagulopathy", "PROBLEM", 5, 17], ["hemorrhage", "PROBLEM", 23, 33], ["acute liver necrosis", "PROBLEM", 72, 92], ["acute canine infectious hepatitis", "PROBLEM", 110, 143], ["xylitol toxicity", "PROBLEM", 147, 163], ["coagulopathy", "OBSERVATION", 5, 17], ["hemorrhage", "OBSERVATION", 23, 33], ["most likely", "UNCERTAINTY", 37, 48], ["acute", "OBSERVATION_MODIFIER", 72, 77], ["liver", "ANATOMY", 78, 83], ["necrosis", "OBSERVATION", 84, 92], ["acute", "OBSERVATION_MODIFIER", 110, 115], ["canine", "OBSERVATION_MODIFIER", 116, 122], ["infectious", "OBSERVATION_MODIFIER", 123, 133], ["hepatitis", "OBSERVATION", 134, 143], ["xylitol toxicity", "OBSERVATION", 147, 163]]], ["Under these conditions, there is significant intrahepatic consumption of clotting factors at sites of endothelial necrosis in the damaged liver.", [["intrahepatic", "ANATOMY", 45, 57], ["endothelial", "ANATOMY", 102, 113], ["liver", "ANATOMY", 138, 143], ["necrosis", "DISEASE", 114, 122], ["clotting factors", "GENE_OR_GENE_PRODUCT", 73, 89], ["endothelial", "CELL", 102, 113], ["liver", "ORGAN", 138, 143], ["clotting factors", "PROTEIN", 73, 89], ["clotting factors", "PROBLEM", 73, 89], ["endothelial necrosis in the damaged liver", "PROBLEM", 102, 143], ["significant", "OBSERVATION_MODIFIER", 33, 44], ["intrahepatic", "ANATOMY", 45, 57], ["consumption", "OBSERVATION", 58, 69], ["clotting factors", "OBSERVATION", 73, 89], ["endothelial", "OBSERVATION_MODIFIER", 102, 113], ["necrosis", "OBSERVATION", 114, 122], ["damaged", "ANATOMY_MODIFIER", 130, 137], ["liver", "ANATOMY", 138, 143]]], ["Although the damaged liver also fails to resupply the clotting factors, consumption is probably a minor contributing influence.", [["liver", "ANATOMY", 21, 26], ["liver", "ORGAN", 21, 26], ["clotting factors", "PROTEIN", 54, 70], ["the clotting factors", "PROBLEM", 50, 70], ["a minor contributing influence", "PROBLEM", 96, 126], ["liver", "ANATOMY", 21, 26], ["clotting", "OBSERVATION", 54, 62], ["minor", "OBSERVATION_MODIFIER", 98, 103], ["contributing", "OBSERVATION_MODIFIER", 104, 116], ["influence", "OBSERVATION", 117, 126]]], ["In more chronic liver diseases with hypoproteinemia, coagulation tests may be prolonged, but hemorrhagic diathesis is unlikely, unless there is an additional demand for hemostasis, for example, during the trauma of surgery.", [["liver", "ANATOMY", 16, 21], ["chronic liver diseases", "DISEASE", 8, 30], ["hypoproteinemia", "DISEASE", 36, 51], ["hemorrhagic diathesis", "DISEASE", 93, 114], ["trauma", "DISEASE", 205, 211], ["liver", "ORGAN", 16, 21], ["more chronic liver diseases", "PROBLEM", 3, 30], ["hypoproteinemia", "PROBLEM", 36, 51], ["coagulation tests", "TEST", 53, 70], ["hemorrhagic diathesis", "PROBLEM", 93, 114], ["hemostasis", "TREATMENT", 169, 179], ["surgery", "TREATMENT", 215, 222], ["more", "OBSERVATION_MODIFIER", 3, 7], ["chronic", "OBSERVATION_MODIFIER", 8, 15], ["liver", "ANATOMY", 16, 21], ["diseases", "OBSERVATION", 22, 30], ["hypoproteinemia", "OBSERVATION", 36, 51], ["may be", "UNCERTAINTY", 71, 77], ["prolonged", "OBSERVATION_MODIFIER", 78, 87], ["hemorrhagic", "OBSERVATION_MODIFIER", 93, 104], ["diathesis", "OBSERVATION", 105, 114], ["surgery", "OBSERVATION", 215, 222]]], ["Although production of clotting factors is often reduced in liver failure, there is a commensurate reduction in anticoagulant synthesis as well.", [["liver", "ANATOMY", 60, 65], ["liver failure", "DISEASE", 60, 73], ["clotting factors", "GENE_OR_GENE_PRODUCT", 23, 39], ["liver", "ORGAN", 60, 65], ["clotting factors", "PROTEIN", 23, 39], ["clotting factors", "PROBLEM", 23, 39], ["liver failure", "PROBLEM", 60, 73], ["a commensurate reduction", "PROBLEM", 84, 108], ["anticoagulant synthesis", "TREATMENT", 112, 135], ["clotting factors", "OBSERVATION", 23, 39], ["reduced", "OBSERVATION_MODIFIER", 49, 56], ["liver", "ANATOMY", 60, 65], ["failure", "OBSERVATION", 66, 73], ["commensurate", "OBSERVATION_MODIFIER", 86, 98], ["reduction", "OBSERVATION_MODIFIER", 99, 108], ["anticoagulant synthesis", "OBSERVATION", 112, 135]]], ["Portal hypertension and endothelial cell dysfunction may also be a contributing cause for bleeding in chronic liver disease.", [["Portal", "ANATOMY", 0, 6], ["endothelial cell", "ANATOMY", 24, 40], ["liver", "ANATOMY", 110, 115], ["hypertension", "DISEASE", 7, 19], ["endothelial cell dysfunction", "DISEASE", 24, 52], ["bleeding", "DISEASE", 90, 98], ["chronic liver disease", "DISEASE", 102, 123], ["endothelial cell", "CELL", 24, 40], ["liver", "ORGAN", 110, 115], ["Portal hypertension", "PROBLEM", 0, 19], ["endothelial cell dysfunction", "PROBLEM", 24, 52], ["bleeding", "PROBLEM", 90, 98], ["chronic liver disease", "PROBLEM", 102, 123], ["hypertension", "OBSERVATION", 7, 19], ["endothelial cell dysfunction", "OBSERVATION", 24, 52], ["may also be", "UNCERTAINTY", 53, 64], ["bleeding", "OBSERVATION", 90, 98], ["chronic", "OBSERVATION_MODIFIER", 102, 109], ["liver", "ANATOMY", 110, 115], ["disease", "OBSERVATION", 116, 123]]], ["Overall, the pathogenesis of hemorrhagic tendencies in chronic liver disease is complex, multifactorial, and incompletely understood.", [["liver", "ANATOMY", 63, 68], ["hemorrhagic tendencies", "DISEASE", 29, 51], ["chronic liver disease", "DISEASE", 55, 76], ["liver", "ORGAN", 63, 68], ["hemorrhagic tendencies", "PROBLEM", 29, 51], ["chronic liver disease", "PROBLEM", 55, 76], ["hemorrhagic", "OBSERVATION_MODIFIER", 29, 40], ["tendencies", "OBSERVATION", 41, 51], ["chronic", "OBSERVATION_MODIFIER", 55, 62], ["liver", "ANATOMY", 63, 68], ["disease", "OBSERVATION", 69, 76], ["complex", "OBSERVATION_MODIFIER", 80, 87]]], ["Consumption of clotting factors can also occur in septic diseases that affect the liver and other tissues.NephropathyAcute liver failure may be accompanied by oliguria and biochemical indications of renal failure.", [["liver", "ANATOMY", 82, 87], ["tissues", "ANATOMY", 98, 105], ["liver", "ANATOMY", 123, 128], ["renal", "ANATOMY", 199, 204], ["septic diseases", "DISEASE", 50, 65], ["NephropathyAcute liver failure", "DISEASE", 106, 136], ["oliguria", "DISEASE", 159, 167], ["renal failure", "DISEASE", 199, 212], ["clotting factors", "GENE_OR_GENE_PRODUCT", 15, 31], ["liver", "ORGAN", 82, 87], ["tissues", "TISSUE", 98, 105], ["liver", "ORGAN", 123, 128], ["renal", "ORGAN", 199, 204], ["clotting factors", "PROTEIN", 15, 31], ["clotting factors", "PROBLEM", 15, 31], ["septic diseases", "PROBLEM", 50, 65], ["NephropathyAcute liver failure", "PROBLEM", 106, 136], ["oliguria", "PROBLEM", 159, 167], ["renal failure", "PROBLEM", 199, 212], ["clotting", "OBSERVATION", 15, 23], ["septic", "OBSERVATION", 50, 56], ["liver", "ANATOMY", 82, 87], ["other tissues", "ANATOMY", 92, 105], ["liver", "ANATOMY", 123, 128], ["failure", "OBSERVATION", 129, 136], ["oliguria", "OBSERVATION", 159, 167], ["renal", "ANATOMY", 199, 204], ["failure", "OBSERVATION", 205, 212]]], ["Hepatorenal syndrome is a complication of advanced cirrhosis in humans, characterized by renal failure in which there are no intrinsic renal morphologic or functional causes.", [["renal", "ANATOMY", 89, 94], ["renal", "ANATOMY", 135, 140], ["Hepatorenal syndrome", "DISEASE", 0, 20], ["cirrhosis", "DISEASE", 51, 60], ["renal failure", "DISEASE", 89, 102], ["humans", "ORGANISM", 64, 70], ["renal", "ORGAN", 89, 94], ["renal", "ORGAN", 135, 140], ["humans", "SPECIES", 64, 70], ["humans", "SPECIES", 64, 70], ["Hepatorenal syndrome", "PROBLEM", 0, 20], ["advanced cirrhosis", "PROBLEM", 42, 60], ["renal failure", "PROBLEM", 89, 102], ["intrinsic renal morphologic", "PROBLEM", 125, 152], ["syndrome", "OBSERVATION", 12, 20], ["advanced", "OBSERVATION_MODIFIER", 42, 50], ["cirrhosis", "OBSERVATION", 51, 60], ["renal", "ANATOMY", 89, 94], ["failure", "OBSERVATION", 95, 102], ["no", "UNCERTAINTY", 122, 124], ["renal", "ANATOMY", 135, 140], ["morphologic", "OBSERVATION", 141, 152], ["functional causes", "OBSERVATION", 156, 173]]], ["The pathogenesis of hepatorenal syndrome is related to deterioration in effective arterial blood volume because of splanchnic arterial vasodilation and reduced venous return and cardiac output.", [["arterial blood", "ANATOMY", 82, 96], ["splanchnic arterial", "ANATOMY", 115, 134], ["venous", "ANATOMY", 160, 166], ["cardiac", "ANATOMY", 178, 185], ["hepatorenal syndrome", "DISEASE", 20, 40], ["reduced venous return and cardiac output", "DISEASE", 152, 192], ["arterial blood", "MULTI-TISSUE_STRUCTURE", 82, 96], ["splanchnic arterial", "MULTI-TISSUE_STRUCTURE", 115, 134], ["venous", "MULTI-TISSUE_STRUCTURE", 160, 166], ["cardiac", "ORGAN", 178, 185], ["hepatorenal syndrome", "PROBLEM", 20, 40], ["deterioration in effective arterial blood volume", "PROBLEM", 55, 103], ["splanchnic arterial vasodilation", "PROBLEM", 115, 147], ["reduced venous return", "PROBLEM", 152, 173], ["cardiac output", "TEST", 178, 192], ["hepatorenal syndrome", "OBSERVATION", 20, 40], ["related to", "UNCERTAINTY", 44, 54], ["deterioration", "OBSERVATION", 55, 68], ["arterial", "ANATOMY_MODIFIER", 82, 90], ["splanchnic", "ANATOMY_MODIFIER", 115, 125], ["arterial", "ANATOMY", 126, 134], ["vasodilation", "OBSERVATION", 135, 147], ["reduced", "OBSERVATION_MODIFIER", 152, 159], ["venous", "ANATOMY", 160, 166], ["cardiac", "ANATOMY", 178, 185], ["output", "OBSERVATION", 186, 192]]], ["Intense compensatory vasoconstriction of the renal circulation results in decreased glomerular filtration and resultant renal failure.", [["renal", "ANATOMY", 45, 50], ["glomerular", "ANATOMY", 84, 94], ["renal", "ANATOMY", 120, 125], ["renal failure", "DISEASE", 120, 133], ["renal", "ORGAN", 45, 50], ["glomerular", "TISSUE", 84, 94], ["renal", "ORGAN", 120, 125], ["Intense compensatory vasoconstriction of the renal circulation", "PROBLEM", 0, 62], ["decreased glomerular filtration", "PROBLEM", 74, 105], ["resultant renal failure", "PROBLEM", 110, 133], ["compensatory", "OBSERVATION_MODIFIER", 8, 20], ["vasoconstriction", "OBSERVATION", 21, 37], ["renal", "ANATOMY", 45, 50], ["circulation", "ANATOMY_MODIFIER", 51, 62], ["decreased", "OBSERVATION_MODIFIER", 74, 83], ["glomerular filtration", "OBSERVATION", 84, 105], ["resultant", "OBSERVATION_MODIFIER", 110, 119], ["renal", "ANATOMY", 120, 125], ["failure", "OBSERVATION", 126, 133]]], ["In addition, some hepatic toxins such as acetaminophen may produce injury in the nephrons as well.Edema and ascitesAscites (retention of excess low-protein peritoneal fluid) is a feature of chronic liver failure, but is more frequently associated Corriedale sheep is also sufficiently impaired to produce photosensitization.", [["hepatic", "ANATOMY", 18, 25], ["nephrons", "ANATOMY", 81, 89], ["Edema", "ANATOMY", 98, 103], ["peritoneal fluid", "ANATOMY", 156, 172], ["liver", "ANATOMY", 198, 203], ["acetaminophen", "CHEMICAL", 41, 54], ["injury in the nephrons", "DISEASE", 67, 89], ["Edema", "DISEASE", 98, 103], ["ascitesAscites", "DISEASE", 108, 122], ["chronic liver failure", "DISEASE", 190, 211], ["photosensitization", "DISEASE", 305, 323], ["acetaminophen", "CHEMICAL", 41, 54], ["hepatic", "ORGAN", 18, 25], ["acetaminophen", "SIMPLE_CHEMICAL", 41, 54], ["nephrons", "MULTI-TISSUE_STRUCTURE", 81, 89], ["peritoneal fluid", "MULTI-TISSUE_STRUCTURE", 156, 172], ["liver", "ORGAN", 198, 203], ["Corriedale sheep", "ORGANISM", 247, 263], ["sheep", "SPECIES", 258, 263], ["sheep", "SPECIES", 258, 263], ["some hepatic toxins", "PROBLEM", 13, 32], ["acetaminophen", "TREATMENT", 41, 54], ["injury in the nephrons", "PROBLEM", 67, 89], ["Edema", "PROBLEM", 98, 103], ["ascitesAscites", "PROBLEM", 108, 122], ["excess low-protein peritoneal fluid", "PROBLEM", 137, 172], ["chronic liver failure", "PROBLEM", 190, 211], ["photosensitization", "PROBLEM", 305, 323], ["hepatic", "ANATOMY", 18, 25], ["toxins", "OBSERVATION", 26, 32], ["injury", "OBSERVATION", 67, 73], ["nephrons", "ANATOMY", 81, 89], ["ascitesAscites", "OBSERVATION", 108, 122], ["retention", "OBSERVATION_MODIFIER", 124, 133], ["peritoneal", "ANATOMY", 156, 166], ["fluid", "OBSERVATION", 167, 172], ["feature of", "UNCERTAINTY", 179, 189], ["chronic", "OBSERVATION_MODIFIER", 190, 197], ["liver", "ANATOMY", 198, 203], ["failure", "OBSERVATION", 204, 211], ["more frequently", "OBSERVATION_MODIFIER", 220, 235]]], ["There is impaired excretion of other conjugated metabolites, and there is dark pigmentation of the liver by polymerized residues of retained catecholamine metabolites.", [["liver", "ANATOMY", 99, 104], ["catecholamine", "CHEMICAL", 141, 154], ["catecholamine", "CHEMICAL", 141, 154], ["liver", "ORGAN", 99, 104], ["catecholamine", "SIMPLE_CHEMICAL", 141, 154], ["impaired excretion of other conjugated metabolites", "PROBLEM", 9, 59], ["dark pigmentation of the liver", "PROBLEM", 74, 104], ["retained catecholamine metabolites", "PROBLEM", 132, 166], ["impaired", "OBSERVATION_MODIFIER", 9, 17], ["excretion", "OBSERVATION_MODIFIER", 18, 27], ["conjugated metabolites", "OBSERVATION", 37, 59], ["dark pigmentation", "OBSERVATION", 74, 91], ["liver", "ANATOMY", 99, 104], ["polymerized residues", "OBSERVATION", 108, 128], ["retained", "OBSERVATION_MODIFIER", 132, 140], ["catecholamine metabolites", "OBSERVATION", 141, 166]]], ["This pigment, resembling lipofuscin, accumulates in lysosomes in the pericanalicular cytoplasm.Edema and ascitesThe recognition of jaundice at postmortem sometimes involves differentiation of bile staining of tissues from the yellow staining caused by accumulation of carotenoid pigments.", [["pigment", "ANATOMY", 5, 12], ["lysosomes", "ANATOMY", 52, 61], ["pericanalicular cytoplasm", "ANATOMY", 69, 94], ["ascites", "ANATOMY", 105, 112], ["bile", "ANATOMY", 192, 196], ["tissues", "ANATOMY", 209, 216], ["Edema", "DISEASE", 95, 100], ["ascites", "DISEASE", 105, 112], ["jaundice", "DISEASE", 131, 139], ["lipofuscin", "SIMPLE_CHEMICAL", 25, 35], ["lysosomes", "CELLULAR_COMPONENT", 52, 61], ["pericanalicular cytoplasm", "ORGANISM_SUBSTANCE", 69, 94], ["bile", "MULTI-TISSUE_STRUCTURE", 192, 196], ["tissues", "TISSUE", 209, 216], ["carotenoid pigments", "SIMPLE_CHEMICAL", 268, 287], ["This pigment", "PROBLEM", 0, 12], ["lipofuscin", "PROBLEM", 25, 35], ["Edema", "PROBLEM", 95, 100], ["ascites", "PROBLEM", 105, 112], ["jaundice", "PROBLEM", 131, 139], ["bile staining of tissues", "PROBLEM", 192, 216], ["the yellow staining", "PROBLEM", 222, 241], ["accumulation of carotenoid pigments", "PROBLEM", 252, 287], ["lipofuscin", "OBSERVATION", 25, 35], ["lysosomes", "OBSERVATION_MODIFIER", 52, 61], ["pericanalicular", "ANATOMY", 69, 84], ["cytoplasm", "ANATOMY_MODIFIER", 85, 94], ["ascites", "OBSERVATION", 105, 112], ["jaundice", "OBSERVATION", 131, 139], ["bile", "ANATOMY", 192, 196], ["tissues", "ANATOMY", 209, 216], ["yellow staining", "OBSERVATION", 226, 241], ["accumulation of", "OBSERVATION", 252, 267], ["carotenoid pigments", "OBSERVATION", 268, 287]]], ["These latter are limited to fat depots and are to be expected in certain species such as horses; sometimes there are breed influences, as seen in the yellow fat of Channel Island breeds of dairy cattle.", [["fat depots", "ANATOMY", 28, 38], ["yellow fat", "ANATOMY", 150, 160], ["fat depots", "TISSUE", 28, 38], ["fat", "TISSUE", 157, 160], ["cattle", "SPECIES", 195, 201], ["cattle", "SPECIES", 195, 201], ["breed influences", "PROBLEM", 117, 133]]], ["The yellow discoloration of fat depots of older cats is less well understood.", [["fat depots", "ANATOMY", 28, 38], ["fat depots", "TISSUE", 28, 38], ["cats", "ORGANISM", 48, 52], ["cats", "SPECIES", 48, 52], ["The yellow discoloration of fat depots", "PROBLEM", 0, 38], ["yellow", "OBSERVATION_MODIFIER", 4, 10], ["discoloration", "OBSERVATION_MODIFIER", 11, 24], ["fat depots", "OBSERVATION", 28, 38]]], ["In animals fed ox liver, carotenoids may again be responsible, and in others, there may be some contribution by ceroid-type pigments.", [["liver", "ANATOMY", 18, 23], ["carotenoids", "CHEMICAL", 25, 36], ["ceroid", "DISEASE", 112, 118], ["ox", "ORGANISM", 15, 17], ["liver", "ORGAN", 18, 23], ["carotenoids", "SIMPLE_CHEMICAL", 25, 36], ["ox", "SPECIES", 15, 17], ["carotenoids", "TREATMENT", 25, 36], ["liver", "ANATOMY", 18, 23], ["ceroid", "OBSERVATION", 112, 118], ["type pigments", "OBSERVATION", 119, 132]]], ["Distinction of the fatty pigments from bile depends on the absence of the former from pale, nonfatty tissues, such as periosteum and dermal collagen.PhotosensitizationPhotosensitization is the term applied to inflammation of skin (usually unpigmented) because of the action of ultraviolet light of wavelengths 290-400 nm on photodynamic compounds that have become bound to dermal cells.", [["fatty pigments", "ANATOMY", 19, 33], ["bile", "ANATOMY", 39, 43], ["nonfatty tissues", "ANATOMY", 92, 108], ["periosteum", "ANATOMY", 118, 128], ["dermal", "ANATOMY", 133, 139], ["skin", "ANATOMY", 225, 229], ["dermal cells", "ANATOMY", 373, 385], ["inflammation", "DISEASE", 209, 221], ["fatty pigments", "TISSUE", 19, 33], ["bile", "MULTI-TISSUE_STRUCTURE", 39, 43], ["nonfatty tissues", "TISSUE", 92, 108], ["periosteum", "TISSUE", 118, 128], ["dermal collagen", "GENE_OR_GENE_PRODUCT", 133, 148], ["skin", "ORGAN", 225, 229], ["dermal cells", "CELL", 373, 385], ["dermal collagen", "PROTEIN", 133, 148], ["dermal cells", "CELL_TYPE", 373, 385], ["the fatty pigments", "PROBLEM", 15, 33], ["pale, nonfatty tissues", "PROBLEM", 86, 108], ["periosteum and dermal collagen", "TREATMENT", 118, 148], ["PhotosensitizationPhotosensitization", "TREATMENT", 149, 185], ["inflammation of skin", "PROBLEM", 209, 229], ["ultraviolet light of wavelengths", "TREATMENT", 277, 309], ["photodynamic compounds", "TREATMENT", 324, 346], ["fatty pigments", "OBSERVATION", 19, 33], ["bile", "ANATOMY", 39, 43], ["pale", "OBSERVATION", 86, 90], ["nonfatty tissues", "OBSERVATION", 92, 108], ["periosteum", "ANATOMY", 118, 128], ["dermal", "ANATOMY", 133, 139], ["collagen", "OBSERVATION", 140, 148], ["inflammation", "OBSERVATION", 209, 221], ["skin", "ANATOMY", 225, 229], ["dermal cells", "OBSERVATION", 373, 385]]], ["In primary photosensitization, these compounds may have been deposited unchanged in the skin after ingestion, before the normal liver is capable of excreting the native compound.", [["skin", "ANATOMY", 88, 92], ["liver", "ANATOMY", 128, 133], ["primary photosensitization", "DISEASE", 3, 29], ["skin", "ORGAN", 88, 92], ["liver", "ORGAN", 128, 133], ["primary photosensitization", "TREATMENT", 3, 29], ["primary photosensitization", "OBSERVATION", 3, 29], ["deposited", "OBSERVATION_MODIFIER", 61, 70], ["unchanged", "OBSERVATION_MODIFIER", 71, 80], ["skin", "ANATOMY", 88, 92], ["normal", "OBSERVATION", 121, 127], ["liver", "ANATOMY", 128, 133], ["native", "OBSERVATION_MODIFIER", 162, 168], ["compound", "OBSERVATION_MODIFIER", 169, 177]]], ["This is seen, for example, after ingestion of hypericin in St. John's wort (Hypericum perforatum).", [["hypericin", "CHEMICAL", 46, 55], ["Hypericum perforatum", "CHEMICAL", 76, 96], ["hypericin", "CHEMICAL", 46, 55], ["hypericin", "SIMPLE_CHEMICAL", 46, 55], ["St. John's wort", "ORGANISM", 59, 74], ["Hypericum perforatum", "ORGANISM", 76, 96], ["wort", "SPECIES", 70, 74], ["Hypericum perforatum", "SPECIES", 76, 96], ["John's wort", "SPECIES", 63, 74], ["Hypericum perforatum", "SPECIES", 76, 96], ["hypericin", "TREATMENT", 46, 55], ["Hypericum perforatum", "TREATMENT", 76, 96]]], ["Photodynamic agents may also be produced by aberrant endogenous metabolism.", [["Photodynamic agents", "TREATMENT", 0, 19], ["aberrant endogenous metabolism", "PROBLEM", 44, 74], ["may also be", "UNCERTAINTY", 20, 31], ["aberrant", "OBSERVATION_MODIFIER", 44, 52], ["endogenous metabolism", "OBSERVATION", 53, 74]]], ["This can occur, for example, in congenital erythropoietic protoporphyria caused by ferrochelatase deficiency in Limousin and Blonde d'Aquitaine calves.PhotosensitizationHepatogenous photosensitization almost always accompanies cholestasis of more than a few days' duration in herbivores that are kept in sunlight and that have been eating green feed.", [["congenital erythropoietic protoporphyria", "DISEASE", 32, 72], ["ferrochelatase deficiency", "DISEASE", 83, 108], ["photosensitization", "DISEASE", 182, 200], ["cholestasis", "DISEASE", 227, 238], ["ferrochelatase", "GENE_OR_GENE_PRODUCT", 83, 97], ["calves", "ORGANISM", 144, 150], ["ferrochelatase", "PROTEIN", 83, 97], ["calves", "SPECIES", 144, 150], ["congenital erythropoietic protoporphyria", "PROBLEM", 32, 72], ["ferrochelatase deficiency", "PROBLEM", 83, 108], ["PhotosensitizationHepatogenous photosensitization", "TREATMENT", 151, 200], ["cholestasis", "PROBLEM", 227, 238], ["congenital", "OBSERVATION_MODIFIER", 32, 42], ["erythropoietic protoporphyria", "OBSERVATION", 43, 72], ["ferrochelatase deficiency", "OBSERVATION", 83, 108], ["cholestasis", "OBSERVATION", 227, 238]]], ["Phytoporphyrins (formerly termed phylloerythrins) are green photoactive catabolites of plant porphyrins (mainly chlorophyll) that are generated by the alimentary microflora of herbivores.", [["alimentary microflora", "ANATOMY", 151, 172], ["Phytoporphyrins", "CHEMICAL", 0, 15], ["Phytoporphyrins", "CHEMICAL", 0, 15], ["phylloerythrins", "CHEMICAL", 33, 48], ["porphyrins", "CHEMICAL", 93, 103], ["chlorophyll", "CHEMICAL", 112, 123], ["Phytoporphyrins", "SIMPLE_CHEMICAL", 0, 15], ["phylloerythrins", "GENE_OR_GENE_PRODUCT", 33, 48], ["porphyrins", "SIMPLE_CHEMICAL", 93, 103], ["chlorophyll", "SIMPLE_CHEMICAL", 112, 123], ["alimentary microflora", "MULTI-TISSUE_STRUCTURE", 151, 172], ["Phytoporphyrins (formerly termed phylloerythrins", "PROBLEM", 0, 48], ["plant porphyrins (mainly chlorophyll)", "TREATMENT", 87, 124], ["plant porphyrins", "OBSERVATION", 87, 103]]], ["Some phytoporphyrin is absorbed and normally excreted in the bile by the transporters that eliminate bilirubin.", [["bile", "ANATOMY", 61, 65], ["phytoporphyrin", "CHEMICAL", 5, 19], ["bilirubin", "CHEMICAL", 101, 110], ["phytoporphyrin", "CHEMICAL", 5, 19], ["bilirubin", "CHEMICAL", 101, 110], ["phytoporphyrin", "SIMPLE_CHEMICAL", 5, 19], ["bile", "MULTI-TISSUE_STRUCTURE", 61, 65], ["bilirubin", "GENE_OR_GENE_PRODUCT", 101, 110], ["bilirubin", "PROTEIN", 101, 110], ["Some phytoporphyrin", "PROBLEM", 0, 19], ["bilirubin", "TEST", 101, 110], ["phytoporphyrin", "OBSERVATION", 5, 19], ["absorbed", "OBSERVATION_MODIFIER", 23, 31], ["excreted", "OBSERVATION_MODIFIER", 45, 53], ["bile", "ANATOMY", 61, 65], ["bilirubin", "OBSERVATION", 101, 110]]], ["Cholestasis in herbivores can increase retention of phytoporphyrin in the blood, and it can result in photosensitive dermatitis of unpigmented areas of skin exposed to sunlight for several days (Fig. 2-48) .", [["blood", "ANATOMY", 74, 79], ["skin", "ANATOMY", 152, 156], ["Cholestasis", "DISEASE", 0, 11], ["phytoporphyrin", "CHEMICAL", 52, 66], ["dermatitis", "DISEASE", 117, 127], ["phytoporphyrin", "CHEMICAL", 52, 66], ["phytoporphyrin", "SIMPLE_CHEMICAL", 52, 66], ["blood", "ORGANISM_SUBSTANCE", 74, 79], ["skin", "ORGAN", 152, 156], ["Cholestasis in herbivores", "PROBLEM", 0, 25], ["phytoporphyrin", "TREATMENT", 52, 66], ["photosensitive dermatitis of unpigmented areas of skin", "PROBLEM", 102, 156], ["herbivores", "OBSERVATION", 15, 25], ["increase", "OBSERVATION_MODIFIER", 30, 38], ["retention", "OBSERVATION_MODIFIER", 39, 48], ["blood", "ANATOMY", 74, 79], ["photosensitive", "OBSERVATION_MODIFIER", 102, 116], ["dermatitis", "OBSERVATION", 117, 127], ["unpigmented", "OBSERVATION_MODIFIER", 131, 142], ["areas", "OBSERVATION_MODIFIER", 143, 148], ["skin", "ANATOMY", 152, 156]]], ["It is possible, however, for mild photosensitization to appear in the absence of gross or microscopic evidence of cholestasis in animals grazing alfalfa, Paspalum, pangola, or Panicum grasses; however, it is unclear if these are related to phytoporphyrin or other photoactive products of these forages.", [["photosensitization", "DISEASE", 34, 52], ["cholestasis", "DISEASE", 114, 125], ["phytoporphyrin", "CHEMICAL", 240, 254], ["phytoporphyrin", "CHEMICAL", 240, 254], ["alfalfa", "ORGANISM_SUBDIVISION", 145, 152], ["Panicum grasses", "ORGANISM", 176, 191], ["phytoporphyrin", "SIMPLE_CHEMICAL", 240, 254], ["alfalfa", "SPECIES", 145, 152], ["mild photosensitization", "PROBLEM", 29, 52], ["cholestasis", "PROBLEM", 114, 125], ["animals grazing alfalfa", "PROBLEM", 129, 152], ["Paspalum, pangola", "PROBLEM", 154, 171], ["Panicum grasses", "PROBLEM", 176, 191], ["phytoporphyrin", "PROBLEM", 240, 254], ["evidence of", "UNCERTAINTY", 102, 113], ["cholestasis", "OBSERVATION", 114, 125], ["Panicum grasses", "OBSERVATION", 176, 191], ["photoactive products", "OBSERVATION", 264, 284]]], ["Absence of serum biochemical evidence for cholestasis or liver damage is used to differentiate primary from secondary photosensitization in these circumstances.PhotosensitizationIf no hepatic changes can be discerned in photosensitized animals, the possibility of primary photosensitization must be considered, but hepatogenous photosensitization cannot be excluded unless adequate liver function tests are performed.Hemorrhage and liver failureHemorrhagic diathesis characterized by widespread ecchymoses and petechiae can occur when the liver is injured and becomes the site of significant clotting factor consumption.", [["serum", "ANATOMY", 11, 16], ["liver", "ANATOMY", 57, 62], ["hepatic", "ANATOMY", 184, 191], ["hepatogenous", "ANATOMY", 315, 327], ["liver", "ANATOMY", 382, 387], ["liver", "ANATOMY", 432, 437], ["ecchymoses", "ANATOMY", 495, 505], ["petechiae", "ANATOMY", 510, 519], ["liver", "ANATOMY", 539, 544], ["cholestasis", "DISEASE", 42, 53], ["liver damage", "DISEASE", 57, 69], ["photosensitization", "DISEASE", 118, 136], ["photosensitization", "DISEASE", 272, 290], ["Hemorrhage", "DISEASE", 417, 427], ["liver failure", "DISEASE", 432, 445], ["Hemorrhagic diathesis", "DISEASE", 445, 466], ["ecchymoses", "DISEASE", 495, 505], ["petechiae", "DISEASE", 510, 519], ["serum", "ORGANISM_SUBSTANCE", 11, 16], ["liver", "ORGAN", 57, 62], ["hepatic", "MULTI-TISSUE_STRUCTURE", 184, 191], ["liver", "ORGAN", 382, 387], ["liver", "ORGAN", 432, 437], ["petechiae", "PATHOLOGICAL_FORMATION", 510, 519], ["liver", "ORGAN", 539, 544], ["clotting factor", "GENE_OR_GENE_PRODUCT", 592, 607], ["clotting factor", "PROTEIN", 592, 607], ["cholestasis", "PROBLEM", 42, 53], ["liver damage", "PROBLEM", 57, 69], ["secondary photosensitization", "PROBLEM", 108, 136], ["Photosensitization", "TREATMENT", 160, 178], ["hepatic changes", "PROBLEM", 184, 199], ["primary photosensitization", "PROBLEM", 264, 290], ["hepatogenous photosensitization", "PROBLEM", 315, 346], ["adequate liver function tests", "TEST", 373, 402], ["Hemorrhage", "PROBLEM", 417, 427], ["liver failure", "PROBLEM", 432, 445], ["Hemorrhagic diathesis", "PROBLEM", 445, 466], ["widespread ecchymoses", "PROBLEM", 484, 505], ["petechiae", "PROBLEM", 510, 519], ["significant clotting factor consumption", "PROBLEM", 580, 619], ["evidence for", "UNCERTAINTY", 29, 41], ["cholestasis", "OBSERVATION", 42, 53], ["liver", "ANATOMY", 57, 62], ["damage", "OBSERVATION", 63, 69], ["secondary photosensitization", "OBSERVATION", 108, 136], ["no", "UNCERTAINTY", 181, 183], ["hepatic", "ANATOMY", 184, 191], ["cannot be excluded", "UNCERTAINTY", 347, 365], ["liver", "ANATOMY", 382, 387], ["liver", "ANATOMY", 432, 437], ["failure", "OBSERVATION", 438, 445], ["Hemorrhagic", "OBSERVATION_MODIFIER", 445, 456], ["diathesis", "OBSERVATION", 457, 466], ["widespread", "OBSERVATION_MODIFIER", 484, 494], ["ecchymoses", "OBSERVATION", 495, 505], ["petechiae", "OBSERVATION", 510, 519], ["liver", "ANATOMY", 539, 544], ["injured", "OBSERVATION", 548, 555], ["significant", "OBSERVATION_MODIFIER", 580, 591], ["clotting", "OBSERVATION", 592, 600]]], ["However, recent investigations suggest that clinically individuals with hepatitis, cirrhosis, celiac disease, chronic malabsorption, and inflammatory bowel disease.", [["bowel", "ANATOMY", 150, 155], ["hepatitis", "DISEASE", 72, 81], ["cirrhosis", "DISEASE", 83, 92], ["celiac disease", "DISEASE", 94, 108], ["chronic malabsorption", "DISEASE", 110, 131], ["inflammatory bowel disease", "DISEASE", 137, 163], ["bowel", "ORGAN", 150, 155], ["recent investigations", "TEST", 9, 30], ["hepatitis", "PROBLEM", 72, 81], ["cirrhosis", "PROBLEM", 83, 92], ["celiac disease", "PROBLEM", 94, 108], ["chronic malabsorption", "PROBLEM", 110, 131], ["inflammatory bowel disease", "PROBLEM", 137, 163], ["hepatitis", "OBSERVATION", 72, 81], ["cirrhosis", "OBSERVATION", 83, 92], ["celiac", "ANATOMY", 94, 100], ["chronic", "OBSERVATION_MODIFIER", 110, 117], ["malabsorption", "OBSERVATION", 118, 131], ["inflammatory", "OBSERVATION_MODIFIER", 137, 149], ["bowel", "ANATOMY", 150, 155], ["disease", "OBSERVATION", 156, 163]]], ["In dogs, hepatocutaneous syndrome is most commonly associated with liver disease, including severe vacuolar hepatopathy, idiopathic hepatocellular collapse, and hepatopathy secondary to anticonvulsant drug administration, and more rarely with glucagonoma and gastric carcinoma.Hemorrhage and liver failureClinical presentation is typically because of the dermatitis; skin lesions include erythema, crusting, exudation, ulceration, and alopecia, affecting footpads, periocular, perioral, anogenital regions, and pressure points.", [["liver", "ANATOMY", 67, 72], ["vacuolar", "ANATOMY", 99, 107], ["hepatocellular", "ANATOMY", 132, 146], ["glucagonoma", "ANATOMY", 243, 254], ["gastric carcinoma", "ANATOMY", 259, 276], ["liver", "ANATOMY", 292, 297], ["skin lesions", "ANATOMY", 367, 379], ["erythema", "ANATOMY", 388, 396], ["footpads", "ANATOMY", 455, 463], ["periocular", "ANATOMY", 465, 475], ["perioral", "ANATOMY", 477, 485], ["anogenital regions", "ANATOMY", 487, 505], ["hepatocutaneous syndrome", "DISEASE", 9, 33], ["liver disease", "DISEASE", 67, 80], ["hepatopathy", "DISEASE", 108, 119], ["idiopathic hepatocellular collapse", "DISEASE", 121, 155], ["hepatopathy", "DISEASE", 161, 172], ["glucagonoma", "DISEASE", 243, 254], ["gastric carcinoma", "DISEASE", 259, 276], ["Hemorrhage", "DISEASE", 277, 287], ["dermatitis", "DISEASE", 355, 365], ["skin lesions", "DISEASE", 367, 379], ["erythema", "DISEASE", 388, 396], ["crusting", "DISEASE", 398, 406], ["exudation", "DISEASE", 408, 417], ["ulceration", "DISEASE", 419, 429], ["alopecia", "DISEASE", 435, 443], ["dogs", "ORGANISM", 3, 7], ["liver", "ORGAN", 67, 72], ["hepatocellular", "ORGAN", 132, 146], ["glucagonoma", "CANCER", 243, 254], ["gastric carcinoma", "CANCER", 259, 276], ["liver", "ORGAN", 292, 297], ["skin lesions", "PATHOLOGICAL_FORMATION", 367, 379], ["footpads", "ORGANISM_SUBDIVISION", 455, 463], ["perioral", "ORGANISM_SUBDIVISION", 477, 485], ["anogenital", "ORGANISM_SUBDIVISION", 487, 497], ["dogs", "SPECIES", 3, 7], ["hepatocutaneous syndrome", "PROBLEM", 9, 33], ["liver disease", "PROBLEM", 67, 80], ["severe vacuolar hepatopathy", "PROBLEM", 92, 119], ["idiopathic hepatocellular collapse", "PROBLEM", 121, 155], ["hepatopathy", "PROBLEM", 161, 172], ["anticonvulsant drug administration", "TREATMENT", 186, 220], ["glucagonoma", "PROBLEM", 243, 254], ["gastric carcinoma", "PROBLEM", 259, 276], ["Hemorrhage", "PROBLEM", 277, 287], ["liver failureClinical presentation", "PROBLEM", 292, 326], ["the dermatitis", "PROBLEM", 351, 365], ["skin lesions", "PROBLEM", 367, 379], ["erythema", "PROBLEM", 388, 396], ["crusting", "PROBLEM", 398, 406], ["exudation", "PROBLEM", 408, 417], ["ulceration", "PROBLEM", 419, 429], ["alopecia", "PROBLEM", 435, 443], ["affecting footpads, periocular, perioral, anogenital regions", "PROBLEM", 445, 505], ["hepatocutaneous syndrome", "OBSERVATION", 9, 33], ["most commonly associated with", "UNCERTAINTY", 37, 66], ["liver", "ANATOMY", 67, 72], ["disease", "OBSERVATION", 73, 80], ["severe", "OBSERVATION_MODIFIER", 92, 98], ["vacuolar hepatopathy", "OBSERVATION", 99, 119], ["idiopathic", "OBSERVATION_MODIFIER", 121, 131], ["hepatocellular", "ANATOMY", 132, 146], ["collapse", "OBSERVATION", 147, 155], ["hepatopathy", "OBSERVATION", 161, 172], ["anticonvulsant drug", "OBSERVATION", 186, 205], ["glucagonoma", "OBSERVATION", 243, 254], ["gastric", "ANATOMY", 259, 266], ["carcinoma", "OBSERVATION", 267, 276], ["liver", "ANATOMY", 292, 297], ["dermatitis", "OBSERVATION", 355, 365], ["skin", "ANATOMY", 367, 371], ["lesions", "OBSERVATION", 372, 379], ["erythema", "OBSERVATION", 388, 396], ["crusting", "OBSERVATION_MODIFIER", 398, 406], ["exudation", "OBSERVATION_MODIFIER", 408, 417], ["ulceration", "OBSERVATION", 419, 429], ["alopecia", "OBSERVATION", 435, 443], ["footpads", "ANATOMY", 455, 463], ["periocular", "ANATOMY", 465, 475], ["perioral", "ANATOMY_MODIFIER", 477, 485], ["anogenital regions", "ANATOMY", 487, 505], ["pressure points", "OBSERVATION", 511, 526]]], ["The dermatologic lesions are described more fully in Vol.", [["dermatologic lesions", "ANATOMY", 4, 24], ["dermatologic lesions", "CANCER", 4, 24], ["The dermatologic lesions", "PROBLEM", 0, 24], ["dermatologic", "OBSERVATION_MODIFIER", 4, 16], ["lesions", "OBSERVATION", 17, 24], ["more fully", "OBSERVATION_MODIFIER", 39, 49]]], ["1, Integumentary system.", [["Integumentary system", "ANATOMY", 3, 23]]], ["Affected dogs have depressed plasma amino acid concentrations, inconsistent elevations of plasma glucagon levels, and may also become diabetic.", [["plasma", "ANATOMY", 29, 35], ["plasma", "ANATOMY", 90, 96], ["depressed", "DISEASE", 19, 28], ["amino acid", "CHEMICAL", 36, 46], ["glucagon", "CHEMICAL", 97, 105], ["diabetic", "DISEASE", 134, 142], ["amino acid", "CHEMICAL", 36, 46], ["dogs", "ORGANISM", 9, 13], ["plasma", "ORGANISM_SUBSTANCE", 29, 35], ["amino acid", "AMINO_ACID", 36, 46], ["plasma", "ORGANISM_SUBSTANCE", 90, 96], ["glucagon", "GENE_OR_GENE_PRODUCT", 97, 105], ["dogs", "SPECIES", 9, 13], ["Affected dogs", "PROBLEM", 0, 13], ["depressed plasma amino acid concentrations", "PROBLEM", 19, 61], ["inconsistent elevations of plasma glucagon levels", "PROBLEM", 63, 112], ["diabetic", "PROBLEM", 134, 142], ["diabetic", "OBSERVATION", 134, 142]]], ["The liver of affected dogs is usually grossly nodular, resembling cirrhosis (eFig.", [["liver", "ANATOMY", 4, 9], ["nodular", "ANATOMY", 46, 53], ["cirrhosis", "ANATOMY", 66, 75], ["cirrhosis", "DISEASE", 66, 75], ["liver", "ORGAN", 4, 9], ["dogs", "ORGANISM", 22, 26], ["cirrhosis", "CANCER", 66, 75], ["dogs", "SPECIES", 22, 26], ["affected dogs", "PROBLEM", 13, 26], ["grossly nodular", "PROBLEM", 38, 53], ["cirrhosis", "PROBLEM", 66, 75], ["eFig", "TEST", 77, 81], ["liver", "ANATOMY", 4, 9], ["affected", "OBSERVATION_MODIFIER", 13, 21], ["dogs", "OBSERVATION", 22, 26], ["grossly", "OBSERVATION_MODIFIER", 38, 45], ["nodular", "OBSERVATION", 46, 53], ["cirrhosis", "OBSERVATION", 66, 75]]], ["2-10A); however, histologically, there is typically moderate to severe vacuolation of hepatocytes, with parenchymal collapse accompanied by nodular regeneration (eFig.", [["hepatocytes", "ANATOMY", 86, 97], ["parenchymal", "ANATOMY", 104, 115], ["nodular", "ANATOMY", 140, 147], ["2-10A", "CHEMICAL", 0, 5], ["parenchymal collapse", "DISEASE", 104, 124], ["hepatocytes", "CELL", 86, 97], ["parenchymal", "TISSUE", 104, 115], ["hepatocytes", "CELL_TYPE", 86, 97], ["typically moderate to severe vacuolation of hepatocytes", "PROBLEM", 42, 97], ["parenchymal collapse", "PROBLEM", 104, 124], ["nodular regeneration", "PROBLEM", 140, 160], ["eFig", "TEST", 162, 166], ["moderate", "OBSERVATION_MODIFIER", 52, 60], ["severe", "OBSERVATION_MODIFIER", 64, 70], ["vacuolation", "OBSERVATION", 71, 82], ["hepatocytes", "ANATOMY", 86, 97], ["parenchymal", "ANATOMY_MODIFIER", 104, 115], ["collapse", "OBSERVATION", 116, 124], ["nodular", "OBSERVATION_MODIFIER", 140, 147], ["regeneration", "OBSERVATION_MODIFIER", 148, 160]]], ["2-10B).", [["2-10B", "CHEMICAL", 0, 5], ["2-10B", "SIMPLE_CHEMICAL", 0, 5]]], ["Inflammation, necrosis, and fibrosis are not usually prominent.", [["Inflammation", "DISEASE", 0, 12], ["necrosis", "DISEASE", 14, 22], ["fibrosis", "DISEASE", 28, 36], ["Inflammation", "PROBLEM", 0, 12], ["necrosis", "PROBLEM", 14, 22], ["fibrosis", "PROBLEM", 28, 36], ["necrosis", "OBSERVATION", 14, 22], ["fibrosis", "OBSERVATION", 28, 36], ["not usually", "UNCERTAINTY", 41, 52], ["prominent", "OBSERVATION_MODIFIER", 53, 62]]], ["Although some studies report fibrosis typical of cirrhosis, more characteristically, there is a network of reticulin and fine collagen fibers representing the remnants of collapsed hepatic lobules, with proliferation of bile ductules.", [["fine collagen fibers", "ANATOMY", 121, 141], ["hepatic lobules", "ANATOMY", 181, 196], ["bile ductules", "ANATOMY", 220, 233], ["fibrosis", "DISEASE", 29, 37], ["cirrhosis", "DISEASE", 49, 58], ["cirrhosis", "CANCER", 49, 58], ["reticulin", "GENE_OR_GENE_PRODUCT", 107, 116], ["collagen", "GENE_OR_GENE_PRODUCT", 126, 134], ["fibers", "CELLULAR_COMPONENT", 135, 141], ["hepatic lobules", "MULTI-TISSUE_STRUCTURE", 181, 196], ["bile ductules", "MULTI-TISSUE_STRUCTURE", 220, 233], ["some studies", "TEST", 9, 21], ["fibrosis", "PROBLEM", 29, 37], ["cirrhosis", "PROBLEM", 49, 58], ["reticulin and fine collagen fibers", "PROBLEM", 107, 141], ["collapsed hepatic lobules", "PROBLEM", 171, 196], ["proliferation of bile ductules", "PROBLEM", 203, 233], ["fibrosis", "OBSERVATION", 29, 37], ["cirrhosis", "OBSERVATION", 49, 58], ["more characteristically", "OBSERVATION_MODIFIER", 60, 83], ["reticulin", "OBSERVATION", 107, 116], ["fine", "OBSERVATION_MODIFIER", 121, 125], ["collagen fibers", "OBSERVATION", 126, 141], ["remnants", "OBSERVATION_MODIFIER", 159, 167], ["collapsed", "OBSERVATION", 171, 180], ["hepatic", "ANATOMY", 181, 188], ["lobules", "ANATOMY_MODIFIER", 189, 196], ["proliferation", "OBSERVATION_MODIFIER", 203, 216], ["bile ductules", "ANATOMY", 220, 233]]], ["The vacuolated hepatocytes stain with oil red O for lipids.", [["vacuolated hepatocytes", "ANATOMY", 4, 26], ["oil", "ANATOMY", 38, 41], ["vacuolated hepatocytes", "CELL", 4, 26], ["oil red O", "SIMPLE_CHEMICAL", 38, 47], ["lipids", "SIMPLE_CHEMICAL", 52, 58], ["vacuolated hepatocytes", "CELL_TYPE", 4, 26], ["The vacuolated hepatocytes stain", "TEST", 0, 32], ["lipids", "TREATMENT", 52, 58], ["vacuolated hepatocytes stain", "OBSERVATION", 4, 32]]], ["The hepatic lesions have been suggested to support an underlying metabolic, hormonal, or toxic etiology.", [["hepatic lesions", "ANATOMY", 4, 19], ["hepatic lesions", "DISEASE", 4, 19], ["hepatic lesions", "CANCER", 4, 19], ["The hepatic lesions", "PROBLEM", 0, 19], ["an underlying metabolic, hormonal, or toxic etiology", "PROBLEM", 51, 103], ["hepatic", "ANATOMY", 4, 11], ["lesions", "OBSERVATION", 12, 19], ["metabolic", "OBSERVATION", 65, 74], ["toxic", "OBSERVATION_MODIFIER", 89, 94]]], ["In humans, persistent hyperglucagonemia stimulates prolonged gluconeogenesis, resulting in secondary hypoaminoacidemia.", [["hyperglucagonemia", "DISEASE", 22, 39], ["hypoaminoacidemia", "DISEASE", 101, 118], ["humans", "ORGANISM", 3, 9], ["humans", "SPECIES", 3, 9], ["humans", "SPECIES", 3, 9], ["persistent hyperglucagonemia", "PROBLEM", 11, 39], ["prolonged gluconeogenesis", "PROBLEM", 51, 76], ["secondary hypoaminoacidemia", "PROBLEM", 91, 118], ["persistent", "OBSERVATION_MODIFIER", 11, 21], ["hyperglucagonemia", "OBSERVATION", 22, 39], ["prolonged gluconeogenesis", "OBSERVATION", 51, 76], ["secondary hypoaminoacidemia", "OBSERVATION", 91, 118]]], ["Although hepatic insufficiency can increase glucagon levels in animal models, in dogs, the link between liver disease and hypoaminoacidemia remains unclear.", [["hepatic", "ANATOMY", 9, 16], ["liver", "ANATOMY", 104, 109], ["hepatic insufficiency", "DISEASE", 9, 30], ["glucagon", "CHEMICAL", 44, 52], ["liver disease", "DISEASE", 104, 117], ["hypoaminoacidemia", "DISEASE", 122, 139], ["hepatic", "ORGAN", 9, 16], ["glucagon", "GENE_OR_GENE_PRODUCT", 44, 52], ["dogs", "ORGANISM", 81, 85], ["liver", "ORGAN", 104, 109], ["dogs", "SPECIES", 81, 85], ["hepatic insufficiency", "PROBLEM", 9, 30], ["glucagon levels", "TEST", 44, 59], ["liver disease", "PROBLEM", 104, 117], ["hypoaminoacidemia", "PROBLEM", 122, 139], ["hepatic", "ANATOMY", 9, 16], ["insufficiency", "OBSERVATION", 17, 30], ["glucagon levels", "OBSERVATION", 44, 59], ["liver", "ANATOMY", 104, 109], ["disease", "OBSERVATION", 110, 117]]], ["A hypermetabolic state with exaggerated amino acid catabolism has, however, been suggested.", [["amino acid", "CHEMICAL", 40, 50], ["amino acid", "CHEMICAL", 40, 50], ["amino acid", "AMINO_ACID", 40, 50], ["A hypermetabolic state", "PROBLEM", 0, 22], ["exaggerated amino acid catabolism", "PROBLEM", 28, 61], ["hypermetabolic state", "OBSERVATION", 2, 22], ["exaggerated", "OBSERVATION_MODIFIER", 28, 39], ["amino acid", "OBSERVATION", 40, 50]]], ["Other biologically active molecules that are normally cleared by the normal liver or generated by a damaged liver should also be considered.POSTMORTEM AND AGONAL CHANGES IN LIVERThe liver, rich in nutrients for bacteria and freely exposed to agonal invaders from the intestine, undergoes postmortem decomposition very rapidly.", [["liver", "ANATOMY", 76, 81], ["liver", "ANATOMY", 108, 113], ["liver", "ANATOMY", 182, 187], ["intestine", "ANATOMY", 267, 276], ["liver", "ORGAN", 76, 81], ["liver", "ORGAN", 108, 113], ["liver", "ORGAN", 182, 187], ["intestine", "ORGAN", 267, 276], ["POSTMORTEM AND AGONAL CHANGES", "PROBLEM", 140, 169], ["bacteria", "PROBLEM", 211, 219], ["active", "OBSERVATION_MODIFIER", 19, 25], ["molecules", "OBSERVATION", 26, 35], ["normal", "OBSERVATION", 69, 75], ["liver", "ANATOMY", 76, 81], ["liver", "ANATOMY", 108, 113], ["should also be considered", "UNCERTAINTY", 114, 139], ["AGONAL", "OBSERVATION", 155, 161], ["LIVER", "ANATOMY", 173, 178], ["liver", "ANATOMY", 182, 187], ["agonal invaders", "OBSERVATION", 242, 257], ["intestine", "ANATOMY", 267, 276]]], ["Gas bubbles generated by anaerobic saprophytes form first in the hepatic blood vessels, but soon suffuse large portions of the organ.", [["hepatic blood vessels", "ANATOMY", 65, 86], ["organ", "ANATOMY", 127, 132], ["hepatic blood vessels", "MULTI-TISSUE_STRUCTURE", 65, 86], ["organ", "ORGAN", 127, 132], ["Gas bubbles", "PROBLEM", 0, 11], ["anaerobic saprophytes", "TREATMENT", 25, 46], ["bubbles", "OBSERVATION_MODIFIER", 4, 11], ["anaerobic saprophytes", "OBSERVATION", 25, 46], ["hepatic", "ANATOMY", 65, 72], ["blood vessels", "ANATOMY", 73, 86], ["organ", "ANATOMY", 127, 132]]], ["The vessels and adjacent parenchyma are stained by hemoglobin.", [["vessels", "ANATOMY", 4, 11], ["parenchyma", "ANATOMY", 25, 35], ["vessels", "MULTI-TISSUE_STRUCTURE", 4, 11], ["parenchyma", "TISSUE", 25, 35], ["hemoglobin", "GENE_OR_GENE_PRODUCT", 51, 61], ["hemoglobin", "PROTEIN", 51, 61], ["hemoglobin", "TEST", 51, 61], ["vessels", "ANATOMY", 4, 11], ["adjacent", "ANATOMY_MODIFIER", 16, 24], ["parenchyma", "ANATOMY", 25, 35], ["hemoglobin", "OBSERVATION_MODIFIER", 51, 61]]], ["The substance of the organ becomes soft and clay-like, and the formation of putrefactive gases may make it foamy.", [["organ", "ANATOMY", 21, 26], ["organ", "ORGAN", 21, 26], ["putrefactive gases", "PROBLEM", 76, 94], ["organ", "ANATOMY", 21, 26], ["soft", "OBSERVATION", 35, 39]]], ["On the capsular surface, irregular, pale foci are visible; they superficially may resemble infarcts or fatty areas but can be observed to increase in size during the postmortem interval, and microscopically are without cellular reaction.", [["capsular surface", "ANATOMY", 7, 23], ["pale foci", "ANATOMY", 36, 45], ["infarcts", "ANATOMY", 91, 99], ["fatty areas", "ANATOMY", 103, 114], ["cellular", "ANATOMY", 219, 227], ["infarcts", "DISEASE", 91, 99], ["capsular surface", "CELLULAR_COMPONENT", 7, 23], ["cellular", "CELL", 219, 227], ["irregular, pale foci", "PROBLEM", 25, 45], ["infarcts", "PROBLEM", 91, 99], ["fatty areas", "PROBLEM", 103, 114], ["the postmortem interval", "TEST", 162, 185], ["cellular reaction", "PROBLEM", 219, 236], ["capsular", "ANATOMY_MODIFIER", 7, 15], ["surface", "OBSERVATION_MODIFIER", 16, 23], ["irregular", "OBSERVATION_MODIFIER", 25, 34], ["pale", "OBSERVATION_MODIFIER", 36, 40], ["foci", "OBSERVATION", 41, 45], ["visible", "OBSERVATION_MODIFIER", 50, 57], ["infarcts", "OBSERVATION", 91, 99], ["fatty areas", "OBSERVATION", 103, 114], ["increase", "OBSERVATION_MODIFIER", 138, 146], ["size", "OBSERVATION_MODIFIER", 150, 154], ["without", "UNCERTAINTY", 211, 218], ["cellular reaction", "OBSERVATION", 219, 236]]], ["Bacilli are present in large numbers with systemic venous congestion (e.g., right-sided heart failure) or hypoproteinemia secondary to protein-losing renal or alimentary tract conditions.", [["venous", "ANATOMY", 51, 57], ["heart", "ANATOMY", 88, 93], ["renal", "ANATOMY", 150, 155], ["alimentary tract", "ANATOMY", 159, 175], ["systemic venous congestion", "DISEASE", 42, 68], ["heart failure", "DISEASE", 88, 101], ["hypoproteinemia", "DISEASE", 106, 121], ["losing renal or alimentary tract conditions", "DISEASE", 143, 186], ["venous", "PATHOLOGICAL_FORMATION", 51, 57], ["heart", "ORGAN", 88, 93], ["renal", "ORGAN", 150, 155], ["alimentary tract", "ORGANISM_SUBDIVISION", 159, 175], ["Bacilli", "PROBLEM", 0, 7], ["systemic venous congestion", "PROBLEM", 42, 68], ["right-sided heart failure", "PROBLEM", 76, 101], ["hypoproteinemia", "PROBLEM", 106, 121], ["protein", "TEST", 135, 142], ["alimentary tract conditions", "PROBLEM", 159, 186], ["large", "OBSERVATION_MODIFIER", 23, 28], ["numbers", "OBSERVATION_MODIFIER", 29, 36], ["systemic venous", "ANATOMY", 42, 57], ["congestion", "OBSERVATION", 58, 68], ["right", "ANATOMY_MODIFIER", 76, 81], ["sided", "ANATOMY_MODIFIER", 82, 87], ["heart", "ANATOMY", 88, 93], ["failure", "OBSERVATION", 94, 101], ["hypoproteinemia", "OBSERVATION", 106, 121], ["renal", "ANATOMY", 150, 155], ["alimentary tract", "ANATOMY", 159, 175]]], ["It is likely that ascites in advanced liver disease is influenced by both mechanical and dynamic influences on blood flow through a damaged liver.", [["ascites", "ANATOMY", 18, 25], ["liver", "ANATOMY", 38, 43], ["blood", "ANATOMY", 111, 116], ["liver", "ANATOMY", 140, 145], ["ascites", "DISEASE", 18, 25], ["liver disease", "DISEASE", 38, 51], ["liver", "ORGAN", 38, 43], ["blood", "ORGANISM_SUBSTANCE", 111, 116], ["liver", "ORGAN", 140, 145], ["ascites", "PROBLEM", 18, 25], ["advanced liver disease", "PROBLEM", 29, 51], ["blood flow", "TEST", 111, 121], ["is likely", "UNCERTAINTY", 3, 12], ["ascites", "OBSERVATION", 18, 25], ["advanced", "OBSERVATION_MODIFIER", 29, 37], ["liver", "ANATOMY", 38, 43], ["disease", "OBSERVATION", 44, 51], ["both", "OBSERVATION_MODIFIER", 69, 73], ["mechanical", "OBSERVATION", 74, 84], ["damaged", "OBSERVATION", 132, 139], ["liver", "ANATOMY", 140, 145]]], ["Reduced synthesis of albumin and globulins by the failing liver can reduce vascular oncotic pressure, but edema resulting from this mechanism is generalized.", [["liver", "ANATOMY", 58, 63], ["vascular oncotic", "ANATOMY", 75, 91], ["edema", "ANATOMY", 106, 111], ["edema", "DISEASE", 106, 111], ["albumin", "GENE_OR_GENE_PRODUCT", 21, 28], ["globulins", "GENE_OR_GENE_PRODUCT", 33, 42], ["liver", "ORGAN", 58, 63], ["vascular", "MULTI-TISSUE_STRUCTURE", 75, 83], ["oncotic", "MULTI-TISSUE_STRUCTURE", 84, 91], ["edema", "PATHOLOGICAL_FORMATION", 106, 111], ["albumin", "PROTEIN", 21, 28], ["globulins", "PROTEIN", 33, 42], ["Reduced synthesis of albumin", "TREATMENT", 0, 28], ["globulins", "TREATMENT", 33, 42], ["vascular oncotic pressure", "TEST", 75, 100], ["edema", "PROBLEM", 106, 111], ["liver", "ANATOMY", 58, 63], ["vascular", "ANATOMY", 75, 83], ["oncotic pressure", "OBSERVATION", 84, 100], ["edema", "OBSERVATION", 106, 111], ["generalized", "OBSERVATION_MODIFIER", 145, 156]]], ["Experimentally, restriction of blood flow from the liver leads to a swift increase in sinusoidal plasma within the space of Disse, leading to increased lymph flow into the thoracic duct and through the hepatic capsule.", [["blood", "ANATOMY", 31, 36], ["liver", "ANATOMY", 51, 56], ["sinusoidal plasma", "ANATOMY", 86, 103], ["lymph", "ANATOMY", 152, 157], ["thoracic duct", "ANATOMY", 172, 185], ["hepatic capsule", "ANATOMY", 202, 217], ["blood", "ORGANISM_SUBSTANCE", 31, 36], ["liver", "ORGAN", 51, 56], ["sinusoidal", "MULTI-TISSUE_STRUCTURE", 86, 96], ["plasma", "ORGANISM_SUBSTANCE", 97, 103], ["lymph", "ORGAN", 152, 157], ["thoracic duct", "MULTI-TISSUE_STRUCTURE", 172, 185], ["hepatic capsule", "CANCER", 202, 217], ["blood flow", "TEST", 31, 41], ["increased lymph flow into the thoracic duct", "PROBLEM", 142, 185], ["blood flow", "OBSERVATION", 31, 41], ["liver", "ANATOMY", 51, 56], ["swift", "OBSERVATION_MODIFIER", 68, 73], ["increase", "OBSERVATION_MODIFIER", 74, 82], ["sinusoidal plasma", "OBSERVATION", 86, 103], ["space", "ANATOMY_MODIFIER", 115, 120], ["Disse", "OBSERVATION", 124, 129], ["increased", "OBSERVATION_MODIFIER", 142, 151], ["lymph flow", "OBSERVATION", 152, 162], ["thoracic duct", "ANATOMY", 172, 185], ["hepatic", "ANATOMY", 202, 209], ["capsule", "ANATOMY_MODIFIER", 210, 217]]], ["This explains rapid ascites formation in cases of hepatic outflow obstruction or veno-occlusive diseases.POSTMORTEM AND AGONAL CHANGES IN LIVERThere are several theories that explain the complicated process of ascites formation in chronic liver disease.", [["ascites", "ANATOMY", 20, 27], ["hepatic outflow", "ANATOMY", 50, 65], ["ascites", "ANATOMY", 210, 217], ["liver", "ANATOMY", 239, 244], ["ascites", "DISEASE", 20, 27], ["hepatic outflow obstruction", "DISEASE", 50, 77], ["veno-occlusive diseases", "DISEASE", 81, 104], ["ascites", "DISEASE", 210, 217], ["chronic liver disease", "DISEASE", 231, 252], ["ascites", "CANCER", 20, 27], ["hepatic outflow obstruction", "PATHOLOGICAL_FORMATION", 50, 77], ["ascites", "CANCER", 210, 217], ["liver", "ORGAN", 239, 244], ["rapid ascites formation", "PROBLEM", 14, 37], ["hepatic outflow obstruction", "PROBLEM", 50, 77], ["veno-occlusive diseases", "PROBLEM", 81, 104], ["POSTMORTEM AND AGONAL CHANGES", "PROBLEM", 105, 134], ["ascites formation", "PROBLEM", 210, 227], ["chronic liver disease", "PROBLEM", 231, 252], ["rapid", "OBSERVATION_MODIFIER", 14, 19], ["ascites", "OBSERVATION", 20, 27], ["hepatic", "ANATOMY", 50, 57], ["outflow", "ANATOMY_MODIFIER", 58, 65], ["obstruction", "OBSERVATION", 66, 77], ["veno-occlusive", "OBSERVATION_MODIFIER", 81, 95], ["diseases", "OBSERVATION", 96, 104], ["ascites", "OBSERVATION", 210, 217], ["chronic", "OBSERVATION_MODIFIER", 231, 238], ["liver", "ANATOMY", 239, 244], ["disease", "OBSERVATION", 245, 252]]], ["The theory that best encompasses the known circulatory changes is known as the peripheral arteriolar vasodilation hypothesis.", [["arteriolar", "ANATOMY", 90, 100], ["peripheral arteriolar", "MULTI-TISSUE_STRUCTURE", 79, 100], ["the known circulatory changes", "PROBLEM", 33, 62], ["the peripheral arteriolar vasodilation hypothesis", "PROBLEM", 75, 124], ["circulatory changes", "OBSERVATION", 43, 62], ["peripheral", "ANATOMY_MODIFIER", 79, 89], ["arteriolar", "ANATOMY_MODIFIER", 90, 100], ["vasodilation", "OBSERVATION_MODIFIER", 101, 113], ["hypothesis", "OBSERVATION", 114, 124]]], ["In end-stage livers, there is progressive sinusoidal and portal vein hypertension with collateral vein formation and acquisition of shunting vessels to the systemic vasculature.", [["livers", "ANATOMY", 13, 19], ["sinusoidal", "ANATOMY", 42, 52], ["portal vein", "ANATOMY", 57, 68], ["collateral vein", "ANATOMY", 87, 102], ["shunting vessels", "ANATOMY", 132, 148], ["systemic vasculature", "ANATOMY", 156, 176], ["hypertension", "DISEASE", 69, 81], ["livers", "ORGAN", 13, 19], ["sinusoidal", "MULTI-TISSUE_STRUCTURE", 42, 52], ["portal vein", "MULTI-TISSUE_STRUCTURE", 57, 68], ["collateral vein", "MULTI-TISSUE_STRUCTURE", 87, 102], ["shunting vessels", "MULTI-TISSUE_STRUCTURE", 132, 148], ["systemic vasculature", "MULTI-TISSUE_STRUCTURE", 156, 176], ["progressive sinusoidal and portal vein hypertension", "PROBLEM", 30, 81], ["collateral vein formation", "PROBLEM", 87, 112], ["shunting vessels to the systemic vasculature", "PROBLEM", 132, 176], ["stage", "OBSERVATION_MODIFIER", 7, 12], ["livers", "ANATOMY", 13, 19], ["progressive", "OBSERVATION_MODIFIER", 30, 41], ["sinusoidal", "ANATOMY_MODIFIER", 42, 52], ["portal vein", "ANATOMY", 57, 68], ["hypertension", "OBSERVATION", 69, 81], ["collateral vein", "OBSERVATION", 87, 102], ["shunting vessels", "OBSERVATION", 132, 148], ["systemic", "ANATOMY_MODIFIER", 156, 164], ["vasculature", "ANATOMY", 165, 176]]], ["Sinusoidal hypertension appears to be an important feature as ascites rarely develops with prehepatic portal hypertension.", [["ascites", "ANATOMY", 62, 69], ["prehepatic portal", "ANATOMY", 91, 108], ["hypertension", "DISEASE", 11, 23], ["ascites", "DISEASE", 62, 69], ["prehepatic portal hypertension", "DISEASE", 91, 121], ["prehepatic portal", "MULTI-TISSUE_STRUCTURE", 91, 108], ["Sinusoidal hypertension", "PROBLEM", 0, 23], ["ascites", "PROBLEM", 62, 69], ["prehepatic portal hypertension", "PROBLEM", 91, 121], ["hypertension", "OBSERVATION", 11, 23], ["ascites", "OBSERVATION", 62, 69], ["portal", "ANATOMY", 102, 108], ["hypertension", "OBSERVATION", 109, 121]]], ["The main factor leading to ascites formation is splanchnic vasodilation.", [["ascites", "ANATOMY", 27, 34], ["splanchnic", "ANATOMY", 48, 58], ["ascites", "DISEASE", 27, 34], ["ascites", "CANCER", 27, 34], ["splanchnic", "MULTI-TISSUE_STRUCTURE", 48, 58], ["The main factor", "PROBLEM", 0, 15], ["ascites formation", "PROBLEM", 27, 44], ["splanchnic vasodilation", "PROBLEM", 48, 71], ["main", "OBSERVATION_MODIFIER", 4, 8], ["ascites", "OBSERVATION", 27, 34], ["splanchnic vasodilation", "OBSERVATION", 48, 71]]], ["In chronic liver failure, there is increasing portal vein hypertension and a local release of vasodilators, such as nitric oxide, leading to splanchnic arterial dilation.", [["liver", "ANATOMY", 11, 16], ["portal vein", "ANATOMY", 46, 57], ["splanchnic arterial", "ANATOMY", 141, 160], ["chronic liver failure", "DISEASE", 3, 24], ["hypertension", "DISEASE", 58, 70], ["nitric oxide", "CHEMICAL", 116, 128], ["nitric oxide", "CHEMICAL", 116, 128], ["liver", "ORGAN", 11, 16], ["portal vein", "MULTI-TISSUE_STRUCTURE", 46, 57], ["nitric oxide", "SIMPLE_CHEMICAL", 116, 128], ["splanchnic arterial", "MULTI-TISSUE_STRUCTURE", 141, 160], ["chronic liver failure", "PROBLEM", 3, 24], ["increasing portal vein hypertension", "PROBLEM", 35, 70], ["a local release of vasodilators", "TREATMENT", 75, 106], ["nitric oxide", "TREATMENT", 116, 128], ["splanchnic arterial dilation", "PROBLEM", 141, 169], ["chronic", "OBSERVATION_MODIFIER", 3, 10], ["liver", "ANATOMY", 11, 16], ["failure", "OBSERVATION", 17, 24], ["increasing", "OBSERVATION_MODIFIER", 35, 45], ["portal vein", "ANATOMY", 46, 57], ["hypertension", "OBSERVATION", 58, 70], ["vasodilators", "OBSERVATION", 94, 106], ["nitric oxide", "OBSERVATION", 116, 128], ["splanchnic", "ANATOMY_MODIFIER", 141, 151], ["arterial", "ANATOMY", 152, 160], ["dilation", "OBSERVATION", 161, 169]]], ["With progression, the extent of the arterial vasodilation increases to the point that effective arterial volume and pressure drops, leading to activation of vasoconstrictor and antinatriuretic factors, including activation of the renin-angiotensin-aldosterone system and the sympathetic nervous system, promoting retention of sodium and fluid.", [["arterial", "ANATOMY", 36, 44], ["arterial", "ANATOMY", 96, 104], ["sympathetic nervous system", "ANATOMY", 275, 301], ["angiotensin", "CHEMICAL", 236, 247], ["aldosterone", "CHEMICAL", 248, 259], ["sodium", "CHEMICAL", 326, 332], ["aldosterone", "CHEMICAL", 248, 259], ["sodium", "CHEMICAL", 326, 332], ["arterial", "MULTI-TISSUE_STRUCTURE", 36, 44], ["arterial", "MULTI-TISSUE_STRUCTURE", 96, 104], ["antinatriuretic factors", "GENE_OR_GENE_PRODUCT", 177, 200], ["renin-angiotensin-aldosterone", "GENE_OR_GENE_PRODUCT", 230, 259], ["sympathetic nervous system", "ANATOMICAL_SYSTEM", 275, 301], ["sodium", "SIMPLE_CHEMICAL", 326, 332], ["antinatriuretic factors", "PROTEIN", 177, 200], ["renin", "PROTEIN", 230, 235], ["the arterial vasodilation", "PROBLEM", 32, 57], ["effective arterial volume", "TEST", 86, 111], ["pressure drops", "TREATMENT", 116, 130], ["vasoconstrictor and antinatriuretic factors", "PROBLEM", 157, 200], ["the renin", "TEST", 226, 235], ["the sympathetic nervous system", "PROBLEM", 271, 301], ["retention of sodium and fluid", "PROBLEM", 313, 342], ["progression", "OBSERVATION_MODIFIER", 5, 16], ["extent", "OBSERVATION_MODIFIER", 22, 28], ["arterial", "ANATOMY", 36, 44], ["vasodilation", "OBSERVATION", 45, 57], ["effective", "OBSERVATION_MODIFIER", 86, 95], ["arterial volume", "OBSERVATION", 96, 111], ["pressure drops", "OBSERVATION", 116, 130], ["sympathetic nervous", "ANATOMY", 275, 294], ["retention", "OBSERVATION_MODIFIER", 313, 322], ["fluid", "OBSERVATION", 337, 342]]], ["Intestinal capillary pressure and permeability are increased as a result of the increased portal vein hypertension, promoting excess fluid transit to the abdominal cavity.", [["Intestinal capillary", "ANATOMY", 0, 20], ["portal vein", "ANATOMY", 90, 101], ["fluid", "ANATOMY", 133, 138], ["abdominal cavity", "ANATOMY", 154, 170], ["portal vein hypertension", "DISEASE", 90, 114], ["Intestinal capillary", "TISSUE", 0, 20], ["portal vein", "MULTI-TISSUE_STRUCTURE", 90, 101], ["fluid", "ORGANISM_SUBSTANCE", 133, 138], ["abdominal cavity", "MULTI-TISSUE_STRUCTURE", 154, 170], ["Intestinal capillary pressure", "TEST", 0, 29], ["the increased portal vein hypertension", "PROBLEM", 76, 114], ["excess fluid transit to the abdominal cavity", "PROBLEM", 126, 170], ["capillary pressure", "OBSERVATION", 11, 29], ["permeability", "OBSERVATION_MODIFIER", 34, 46], ["increased", "OBSERVATION_MODIFIER", 51, 60], ["increased", "OBSERVATION_MODIFIER", 80, 89], ["portal vein", "ANATOMY", 90, 101], ["hypertension", "OBSERVATION", 102, 114], ["excess", "OBSERVATION_MODIFIER", 126, 132], ["fluid transit", "OBSERVATION", 133, 146], ["abdominal cavity", "ANATOMY", 154, 170]]], ["Over time, sodium retention by the kidneys is insufficient to compensate for the progressive arteriolar vasodilation as well as the movement of sodium and fluid to the extracellular space of the abdomen.", [["kidneys", "ANATOMY", 35, 42], ["arteriolar", "ANATOMY", 93, 103], ["extracellular space", "ANATOMY", 168, 187], ["abdomen", "ANATOMY", 195, 202], ["sodium", "CHEMICAL", 11, 17], ["sodium", "CHEMICAL", 144, 150], ["sodium", "CHEMICAL", 11, 17], ["sodium", "CHEMICAL", 144, 150], ["sodium", "SIMPLE_CHEMICAL", 11, 17], ["kidneys", "ORGAN", 35, 42], ["arteriolar", "MULTI-TISSUE_STRUCTURE", 93, 103], ["sodium", "SIMPLE_CHEMICAL", 144, 150], ["extracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 168, 181], ["abdomen", "ORGAN", 195, 202], ["sodium retention", "PROBLEM", 11, 27], ["the progressive arteriolar vasodilation", "PROBLEM", 77, 116], ["retention", "OBSERVATION", 18, 27], ["kidneys", "ANATOMY", 35, 42], ["insufficient", "OBSERVATION", 46, 58], ["progressive", "OBSERVATION_MODIFIER", 81, 92], ["arteriolar", "OBSERVATION_MODIFIER", 93, 103], ["vasodilation", "OBSERVATION", 104, 116], ["fluid", "OBSERVATION", 155, 160], ["extracellular", "ANATOMY_MODIFIER", 168, 181], ["space", "ANATOMY_MODIFIER", 182, 187], ["abdomen", "ANATOMY", 195, 202]]], ["This movement is enhanced by hypoproteinemia caused by reduced synthesis by the liver and dilution secondary to fluid retention.", [["liver", "ANATOMY", 80, 85], ["fluid", "ANATOMY", 112, 117], ["hypoproteinemia", "DISEASE", 29, 44], ["liver", "ORGAN", 80, 85], ["fluid", "ORGANISM_SUBSTANCE", 112, 117], ["hypoproteinemia", "PROBLEM", 29, 44], ["reduced synthesis", "PROBLEM", 55, 72], ["fluid retention", "PROBLEM", 112, 127], ["hypoproteinemia", "OBSERVATION", 29, 44], ["reduced", "OBSERVATION_MODIFIER", 55, 62], ["synthesis", "OBSERVATION", 63, 72], ["liver", "ANATOMY", 80, 85], ["fluid retention", "OBSERVATION", 112, 127]]], ["Consequently, there is persistent activation of antinatriuretic systems, and fluid continues to accumulate.", [["persistent activation of antinatriuretic systems", "PROBLEM", 23, 71], ["fluid", "PROBLEM", 77, 82], ["persistent", "OBSERVATION_MODIFIER", 23, 33], ["activation", "OBSERVATION", 34, 44], ["antinatriuretic systems", "OBSERVATION", 48, 71], ["fluid", "OBSERVATION", 77, 82]]], ["There is evidence that increased venous return caused by reduced peripheral arterial vasodilation stimulates endogenous natriuretic substances, but this response is insufficient to counteract the more significant release of antinatriuretic signals.POSTMORTEM AND AGONAL CHANGES IN LIVERRetention of peritoneal fluid can also sometimes result from mechanical obstructions to mesenteric and peritoneal lymphatics by inflammatory or neoplastic lesions.", [["venous", "ANATOMY", 33, 39], ["peripheral arterial", "ANATOMY", 65, 84], ["peritoneal fluid", "ANATOMY", 299, 315], ["mesenteric", "ANATOMY", 374, 384], ["peritoneal lymphatics", "ANATOMY", 389, 410], ["neoplastic lesions", "ANATOMY", 430, 448], ["venous", "MULTI-TISSUE_STRUCTURE", 33, 39], ["peripheral arterial", "MULTI-TISSUE_STRUCTURE", 65, 84], ["peritoneal", "MULTI-TISSUE_STRUCTURE", 299, 309], ["fluid", "ORGANISM_SUBSTANCE", 310, 315], ["mesenteric", "MULTI-TISSUE_STRUCTURE", 374, 384], ["peritoneal lymphatics", "MULTI-TISSUE_STRUCTURE", 389, 410], ["neoplastic lesions", "PATHOLOGICAL_FORMATION", 430, 448], ["increased venous return", "PROBLEM", 23, 46], ["reduced peripheral arterial vasodilation", "TREATMENT", 57, 97], ["endogenous natriuretic substances", "TREATMENT", 109, 142], ["POSTMORTEM AND AGONAL CHANGES", "PROBLEM", 248, 277], ["peritoneal fluid", "PROBLEM", 299, 315], ["mechanical obstructions to mesenteric and peritoneal lymphatics", "PROBLEM", 347, 410], ["inflammatory or neoplastic lesions", "PROBLEM", 414, 448], ["increased", "OBSERVATION_MODIFIER", 23, 32], ["venous return", "OBSERVATION", 33, 46], ["reduced", "OBSERVATION_MODIFIER", 57, 64], ["peripheral", "ANATOMY_MODIFIER", 65, 75], ["arterial", "ANATOMY", 76, 84], ["vasodilation", "OBSERVATION", 85, 97], ["natriuretic substances", "OBSERVATION", 120, 142], ["peritoneal", "ANATOMY", 299, 309], ["fluid", "OBSERVATION", 310, 315], ["mechanical", "OBSERVATION_MODIFIER", 347, 357], ["obstructions", "OBSERVATION", 358, 370], ["mesenteric", "ANATOMY", 374, 384], ["peritoneal", "ANATOMY", 389, 399], ["lymphatics", "OBSERVATION", 400, 410], ["inflammatory", "OBSERVATION_MODIFIER", 414, 426], ["neoplastic", "OBSERVATION_MODIFIER", 430, 440], ["lesions", "OBSERVATION", 441, 448]]], ["Peritoneal fluids with a higher protein and cell content that accumulate in various abdominal inflammatory conditions are considered exudates (see section on Peritonitis in Vol.", [["Peritoneal fluids", "ANATOMY", 0, 17], ["cell", "ANATOMY", 44, 48], ["abdominal", "ANATOMY", 84, 93], ["exudates", "ANATOMY", 133, 141], ["Peritonitis", "DISEASE", 158, 169], ["Peritoneal fluids", "ORGANISM_SUBSTANCE", 0, 17], ["cell", "CELL", 44, 48], ["Peritoneal fluids", "TEST", 0, 17], ["a higher protein and cell content", "PROBLEM", 23, 56], ["various abdominal inflammatory conditions", "PROBLEM", 76, 117], ["exudates", "PROBLEM", 133, 141], ["Peritonitis", "PROBLEM", 158, 169], ["fluids", "OBSERVATION", 11, 17], ["higher protein", "OBSERVATION_MODIFIER", 25, 39], ["cell content", "OBSERVATION", 44, 56], ["various", "OBSERVATION_MODIFIER", 76, 83], ["abdominal", "ANATOMY", 84, 93], ["inflammatory", "OBSERVATION", 94, 106], ["exudates", "OBSERVATION_MODIFIER", 133, 141], ["Peritonitis", "OBSERVATION", 158, 169]]], ["2, Alimentary system and peritoneum).Hepatocutaneous syndromeAn idiopathic vacuolar hepatopathy with parenchymal collapse and nodular regeneration has been reported in dogs and cats that have been presented clinically with hepatocutaneous syndrome (necrolytic migratory erythema, superficial necrolytic dermatitis).", [["peritoneum", "ANATOMY", 25, 35], ["vacuolar", "ANATOMY", 75, 83], ["parenchymal", "ANATOMY", 101, 112], ["nodular", "ANATOMY", 126, 133], ["idiopathic vacuolar hepatopathy", "DISEASE", 64, 95], ["parenchymal collapse", "DISEASE", 101, 121], ["hepatocutaneous syndrome", "DISEASE", 223, 247], ["erythema", "DISEASE", 270, 278], ["necrolytic dermatitis", "DISEASE", 292, 313], ["peritoneum", "MULTI-TISSUE_STRUCTURE", 25, 35], ["parenchymal", "PATHOLOGICAL_FORMATION", 101, 112], ["nodular", "PATHOLOGICAL_FORMATION", 126, 133], ["dogs", "ORGANISM", 168, 172], ["cats", "ORGANISM", 177, 181], ["dogs", "SPECIES", 168, 172], ["cats", "SPECIES", 177, 181], ["Hepatocutaneous syndromeAn idiopathic vacuolar hepatopathy", "PROBLEM", 37, 95], ["parenchymal collapse", "PROBLEM", 101, 121], ["nodular regeneration", "PROBLEM", 126, 146], ["hepatocutaneous syndrome", "PROBLEM", 223, 247], ["necrolytic migratory erythema", "PROBLEM", 249, 278], ["superficial necrolytic dermatitis", "PROBLEM", 280, 313], ["Alimentary system", "ANATOMY", 3, 20], ["peritoneum", "ANATOMY", 25, 35], ["idiopathic", "OBSERVATION_MODIFIER", 64, 74], ["vacuolar hepatopathy", "OBSERVATION", 75, 95], ["parenchymal", "ANATOMY_MODIFIER", 101, 112], ["collapse", "OBSERVATION", 113, 121], ["nodular", "OBSERVATION_MODIFIER", 126, 133], ["regeneration", "OBSERVATION", 134, 146], ["hepatocutaneous syndrome", "OBSERVATION", 223, 247], ["necrolytic", "OBSERVATION_MODIFIER", 249, 259], ["migratory", "OBSERVATION_MODIFIER", 260, 269], ["erythema", "OBSERVATION_MODIFIER", 270, 278], ["superficial", "OBSERVATION_MODIFIER", 280, 291], ["necrolytic dermatitis", "OBSERVATION", 292, 313]]], ["The skin disease resembles necrolytic migratory erythema in humans, a well-defined paraneoplastic syndrome typically associated with hyperglucagonemia secondary to glucagon-secreting pancreatic neoplasia, but also reported in295.e2Further reading blood has considerably more oxygen than most systemic venous blood and contributes ~60% of the liver's oxygen needs.", [["skin", "ANATOMY", 4, 8], ["pancreatic neoplasia", "ANATOMY", 183, 203], ["blood", "ANATOMY", 247, 252], ["venous blood", "ANATOMY", 301, 313], ["liver", "ANATOMY", 342, 347], ["skin disease", "DISEASE", 4, 16], ["erythema", "DISEASE", 48, 56], ["paraneoplastic syndrome", "DISEASE", 83, 106], ["hyperglucagonemia", "DISEASE", 133, 150], ["glucagon", "CHEMICAL", 164, 172], ["pancreatic neoplasia", "DISEASE", 183, 203], ["oxygen", "CHEMICAL", 275, 281], ["oxygen", "CHEMICAL", 350, 356], ["oxygen", "CHEMICAL", 275, 281], ["oxygen", "CHEMICAL", 350, 356], ["skin", "ORGAN", 4, 8], ["humans", "ORGANISM", 60, 66], ["glucagon", "GENE_OR_GENE_PRODUCT", 164, 172], ["pancreatic neoplasia", "CANCER", 183, 203], ["blood", "ORGANISM_SUBSTANCE", 247, 252], ["oxygen", "SIMPLE_CHEMICAL", 275, 281], ["venous blood", "ORGANISM_SUBSTANCE", 301, 313], ["liver", "ORGAN", 342, 347], ["oxygen", "SIMPLE_CHEMICAL", 350, 356], ["humans", "SPECIES", 60, 66], ["humans", "SPECIES", 60, 66], ["The skin disease", "PROBLEM", 0, 16], ["necrolytic migratory erythema in humans", "PROBLEM", 27, 66], ["a well-defined paraneoplastic syndrome", "PROBLEM", 68, 106], ["hyperglucagonemia", "PROBLEM", 133, 150], ["glucagon", "TREATMENT", 164, 172], ["secreting pancreatic neoplasia", "PROBLEM", 173, 203], ["Further reading blood", "TEST", 231, 252], ["most systemic venous blood", "PROBLEM", 287, 313], ["skin", "ANATOMY", 4, 8], ["disease", "OBSERVATION", 9, 16], ["necrolytic", "OBSERVATION_MODIFIER", 27, 37], ["migratory", "OBSERVATION_MODIFIER", 38, 47], ["erythema", "OBSERVATION", 48, 56], ["well-defined", "OBSERVATION_MODIFIER", 70, 82], ["paraneoplastic syndrome", "OBSERVATION", 83, 106], ["hyperglucagonemia", "OBSERVATION", 133, 150], ["pancreatic", "ANATOMY", 183, 193], ["neoplasia", "OBSERVATION", 194, 203], ["considerably", "OBSERVATION_MODIFIER", 257, 269], ["more oxygen", "OBSERVATION_MODIFIER", 270, 281], ["venous blood", "ANATOMY", 301, 313], ["liver", "ANATOMY", 342, 347]]], ["The portal vein branches successively until the finest branches, the terminal portal venules, drain into the sinusoids via side branches, the inlet venules.", [["portal vein branches", "ANATOMY", 4, 24], ["terminal portal venules", "ANATOMY", 69, 92], ["sinusoids", "ANATOMY", 109, 118], ["side branches", "ANATOMY", 123, 136], ["inlet venules", "ANATOMY", 142, 155], ["portal vein branches", "MULTI-TISSUE_STRUCTURE", 4, 24], ["portal venules", "MULTI-TISSUE_STRUCTURE", 78, 92], ["sinusoids", "TISSUE", 109, 118], ["inlet venules", "MULTI-TISSUE_STRUCTURE", 142, 155], ["drain", "TREATMENT", 94, 99], ["the inlet venules", "PROBLEM", 138, 155], ["portal vein", "ANATOMY", 4, 15], ["branches", "ANATOMY_MODIFIER", 16, 24], ["finest", "OBSERVATION_MODIFIER", 48, 54], ["branches", "OBSERVATION_MODIFIER", 55, 63], ["terminal", "ANATOMY_MODIFIER", 69, 77], ["portal venules", "ANATOMY", 78, 92], ["drain", "OBSERVATION", 94, 99], ["sinusoids", "ANATOMY_MODIFIER", 109, 118], ["side", "OBSERVATION_MODIFIER", 123, 127], ["branches", "OBSERVATION_MODIFIER", 128, 136], ["inlet venules", "OBSERVATION", 142, 155]]], ["Entry of blood into the sinusoids is regulated via sphincters in the terminal inlet venules.", [["blood", "ANATOMY", 9, 14], ["sinusoids", "ANATOMY", 24, 33], ["sphincters", "ANATOMY", 51, 61], ["terminal inlet venules", "ANATOMY", 69, 91], ["blood", "ORGANISM_SUBSTANCE", 9, 14], ["sinusoids", "TISSUE", 24, 33], ["sphincters", "MULTI-TISSUE_STRUCTURE", 51, 61], ["inlet venules", "MULTI-TISSUE_STRUCTURE", 78, 91], ["terminal inlet venules", "CELL_TYPE", 69, 91], ["sinusoids", "ANATOMY", 24, 33], ["sphincters", "ANATOMY", 51, 61], ["terminal", "ANATOMY_MODIFIER", 69, 77], ["inlet venules", "OBSERVATION", 78, 91]]], ["Portal blood flow is likely streamlined, rather than turbulent, but there is little agreement regarding existence of specific patterns of flow.", [["Portal blood", "ANATOMY", 0, 12], ["blood", "ORGANISM_SUBSTANCE", 7, 12], ["Portal blood flow", "TEST", 0, 17], ["blood", "ANATOMY", 7, 12], ["flow", "OBSERVATION", 13, 17], ["likely", "UNCERTAINTY", 21, 27], ["streamlined", "OBSERVATION_MODIFIER", 28, 39], ["turbulent", "OBSERVATION_MODIFIER", 53, 62], ["flow", "OBSERVATION", 138, 142]]], ["Streamlining may account for the different regional distributions sometimes observed with metastatic tumors and infections.", [["metastatic tumors", "ANATOMY", 90, 107], ["tumors", "DISEASE", 101, 107], ["infections", "DISEASE", 112, 122], ["metastatic tumors", "CANCER", 90, 107], ["the different regional distributions", "PROBLEM", 29, 65], ["metastatic tumors", "PROBLEM", 90, 107], ["infections", "PROBLEM", 112, 122], ["may account for", "UNCERTAINTY", 13, 28], ["metastatic", "OBSERVATION_MODIFIER", 90, 100], ["tumors", "OBSERVATION", 101, 107], ["infections", "OBSERVATION", 112, 122]]], ["The umbilical vein usually drains to the left lobe, so hematogenous umbilical infections tend to localize in the left lobe.295.e2The liver cannot regulate portal venous flow, so hepatic blood flow is largely balanced by arterial supply that varies with the portal venous supply to maintain a relatively consistent hepatic perfusion.", [["umbilical vein", "ANATOMY", 4, 18], ["left lobe", "ANATOMY", 41, 50], ["hematogenous umbilical", "ANATOMY", 55, 77], ["left lobe", "ANATOMY", 113, 122], ["liver", "ANATOMY", 133, 138], ["portal venous", "ANATOMY", 155, 168], ["hepatic blood", "ANATOMY", 178, 191], ["arterial", "ANATOMY", 220, 228], ["portal venous", "ANATOMY", 257, 270], ["hepatic", "ANATOMY", 314, 321], ["umbilical infections", "DISEASE", 68, 88], ["umbilical vein", "MULTI-TISSUE_STRUCTURE", 4, 18], ["lobe", "ORGAN", 46, 50], ["left lobe", "MULTI-TISSUE_STRUCTURE", 113, 122], ["liver", "ORGAN", 133, 138], ["portal venous", "MULTI-TISSUE_STRUCTURE", 155, 168], ["hepatic blood", "MULTI-TISSUE_STRUCTURE", 178, 191], ["arterial", "MULTI-TISSUE_STRUCTURE", 220, 228], ["portal venous", "MULTI-TISSUE_STRUCTURE", 257, 270], ["hepatic", "ORGAN", 314, 321], ["The umbilical vein", "TREATMENT", 0, 18], ["drains to the left lobe", "TREATMENT", 27, 50], ["hematogenous umbilical infections", "PROBLEM", 55, 88], ["hepatic blood flow", "TEST", 178, 196], ["umbilical vein", "ANATOMY", 4, 18], ["drains", "OBSERVATION", 27, 33], ["left lobe", "ANATOMY", 41, 50], ["hematogenous", "OBSERVATION_MODIFIER", 55, 67], ["umbilical", "ANATOMY", 68, 77], ["infections", "OBSERVATION", 78, 88], ["left lobe", "ANATOMY", 113, 122], ["liver", "ANATOMY", 133, 138], ["portal venous", "ANATOMY", 155, 168], ["flow", "OBSERVATION", 169, 173], ["hepatic", "ANATOMY", 178, 185], ["blood flow", "OBSERVATION", 186, 196], ["arterial supply", "OBSERVATION", 220, 235], ["portal venous", "ANATOMY", 257, 270], ["relatively", "OBSERVATION_MODIFIER", 292, 302], ["consistent", "OBSERVATION", 303, 313], ["hepatic", "ANATOMY", 314, 321], ["perfusion", "OBSERVATION", 322, 331]]], ["Hepatic microcirculation is well regulated at the level of inflow by sphincters in the finest branches of the portal venules, the inlet venules, as well as the terminal branches of the hepatic arterioles and at the level of outflow by sphincters that regulate passage of blood from the sinusoids to the terminal hepatic venules.", [["Hepatic", "ANATOMY", 0, 7], ["sphincters", "ANATOMY", 69, 79], ["portal venules", "ANATOMY", 110, 124], ["inlet venules", "ANATOMY", 130, 143], ["terminal branches", "ANATOMY", 160, 177], ["hepatic arterioles", "ANATOMY", 185, 203], ["sphincters", "ANATOMY", 235, 245], ["blood", "ANATOMY", 271, 276], ["sinusoids", "ANATOMY", 286, 295], ["terminal hepatic venules", "ANATOMY", 303, 327], ["Hepatic microcirculation", "MULTI-TISSUE_STRUCTURE", 0, 24], ["sphincters", "ORGANISM_SUBDIVISION", 69, 79], ["portal venules", "MULTI-TISSUE_STRUCTURE", 110, 124], ["inlet venules", "MULTI-TISSUE_STRUCTURE", 130, 143], ["hepatic arterioles", "MULTI-TISSUE_STRUCTURE", 185, 203], ["sphincters", "ORGANISM_SUBDIVISION", 235, 245], ["blood", "ORGANISM_SUBSTANCE", 271, 276], ["sinusoids", "TISSUE", 286, 295], ["hepatic venules", "MULTI-TISSUE_STRUCTURE", 312, 327], ["terminal hepatic venules", "CELL_TYPE", 303, 327], ["microcirculation", "OBSERVATION", 8, 24], ["inflow", "OBSERVATION", 59, 65], ["sphincters", "OBSERVATION", 69, 79], ["finest", "ANATOMY_MODIFIER", 87, 93], ["branches", "ANATOMY_MODIFIER", 94, 102], ["portal venules", "ANATOMY", 110, 124], ["inlet venules", "OBSERVATION", 130, 143], ["terminal", "ANATOMY_MODIFIER", 160, 168], ["branches", "ANATOMY_MODIFIER", 169, 177], ["hepatic", "ANATOMY", 185, 192], ["arterioles", "ANATOMY_MODIFIER", 193, 203], ["outflow", "ANATOMY_MODIFIER", 224, 231], ["sphincters", "ANATOMY", 235, 245], ["passage", "OBSERVATION_MODIFIER", 260, 267], ["sinusoids", "ANATOMY_MODIFIER", 286, 295], ["terminal", "ANATOMY_MODIFIER", 303, 311], ["hepatic", "ANATOMY", 312, 319], ["venules", "ANATOMY_MODIFIER", 320, 327]]], ["In dogs, the spiral smooth muscle that invests the wall of sublobular hepatic veins can contract and alter hepatic venous outflow in various conditions, particularly in shock, where contraction leads to acute congestion and pooling of blood in the liver and the organs that drain into the portal vein.", [["spiral smooth muscle", "ANATOMY", 13, 33], ["wall", "ANATOMY", 51, 55], ["sublobular hepatic veins", "ANATOMY", 59, 83], ["hepatic venous", "ANATOMY", 107, 121], ["blood", "ANATOMY", 235, 240], ["liver", "ANATOMY", 248, 253], ["organs", "ANATOMY", 262, 268], ["portal vein", "ANATOMY", 289, 300], ["shock", "DISEASE", 169, 174], ["dogs", "ORGANISM", 3, 7], ["spiral smooth muscle", "TISSUE", 13, 33], ["wall", "MULTI-TISSUE_STRUCTURE", 51, 55], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 70, 83], ["hepatic venous outflow", "MULTI-TISSUE_STRUCTURE", 107, 129], ["blood", "ORGANISM_SUBSTANCE", 235, 240], ["liver", "ORGAN", 248, 253], ["organs", "ORGAN", 262, 268], ["portal vein", "MULTI-TISSUE_STRUCTURE", 289, 300], ["dogs", "SPECIES", 3, 7], ["shock", "PROBLEM", 169, 174], ["acute congestion", "PROBLEM", 203, 219], ["pooling of blood in the liver", "PROBLEM", 224, 253], ["dogs", "OBSERVATION", 3, 7], ["spiral", "ANATOMY_MODIFIER", 13, 19], ["smooth muscle", "ANATOMY", 20, 33], ["wall", "ANATOMY_MODIFIER", 51, 55], ["sublobular", "ANATOMY_MODIFIER", 59, 69], ["hepatic veins", "ANATOMY", 70, 83], ["hepatic venous", "ANATOMY", 107, 121], ["outflow", "ANATOMY_MODIFIER", 122, 129], ["various conditions", "OBSERVATION", 133, 151], ["shock", "OBSERVATION", 169, 174], ["acute", "OBSERVATION_MODIFIER", 203, 208], ["congestion", "OBSERVATION", 209, 219], ["blood", "OBSERVATION_MODIFIER", 235, 240], ["liver", "ANATOMY", 248, 253], ["organs", "ANATOMY", 262, 268], ["drain", "OBSERVATION", 274, 279], ["portal vein", "ANATOMY", 289, 300]]], ["Hepatic blood thus flows evenly through the sinusoids under a very-low-pressure gradient.", [["Hepatic blood", "ANATOMY", 0, 13], ["sinusoids", "ANATOMY", 44, 53], ["Hepatic blood", "MULTI-TISSUE_STRUCTURE", 0, 13], ["sinusoids", "TISSUE", 44, 53], ["Hepatic blood", "TEST", 0, 13], ["blood", "ANATOMY", 8, 13], ["flows", "OBSERVATION", 19, 24], ["very", "OBSERVATION_MODIFIER", 62, 66], ["low", "OBSERVATION_MODIFIER", 67, 70], ["pressure gradient", "OBSERVATION", 71, 88]]], ["The liver receives ~25% of the cardiac output, even though it represents only ~2.5% of body mass.", [["liver", "ANATOMY", 4, 9], ["cardiac", "ANATOMY", 31, 38], ["body", "ANATOMY", 87, 91], ["liver", "ORGAN", 4, 9], ["cardiac", "ORGAN", 31, 38], ["body", "ORGANISM_SUBDIVISION", 87, 91], ["the cardiac output", "TEST", 27, 45], ["body mass", "PROBLEM", 87, 96], ["liver", "ANATOMY", 4, 9], ["25%", "OBSERVATION_MODIFIER", 20, 23], ["cardiac", "ANATOMY", 31, 38], ["output", "OBSERVATION", 39, 45], ["body", "ANATOMY_MODIFIER", 87, 91], ["mass", "OBSERVATION", 92, 96]]], ["Approximately 25% of the weight of the liver in situ is blood.295.e2Obstruction of the portal vein, if sudden and complete, can produce a condition akin to strangulation of the gut, and death occurs quickly without significant hepatic change; however, surgical diversion of the portal vein into the vena cava produces only transient injury to the liver.", [["liver in situ", "ANATOMY", 39, 52], ["blood", "ANATOMY", 56, 61], ["portal vein", "ANATOMY", 87, 98], ["gut", "ANATOMY", 177, 180], ["hepatic", "ANATOMY", 227, 234], ["portal vein", "ANATOMY", 278, 289], ["vena cava", "ANATOMY", 299, 308], ["liver", "ANATOMY", 347, 352], ["strangulation of the gut", "DISEASE", 156, 180], ["death", "DISEASE", 186, 191], ["injury to the liver", "DISEASE", 333, 352], ["liver", "ORGAN", 39, 44], ["blood", "ORGANISM_SUBSTANCE", 56, 61], ["portal vein", "MULTI-TISSUE_STRUCTURE", 87, 98], ["gut", "ORGANISM_SUBDIVISION", 177, 180], ["hepatic", "ORGAN", 227, 234], ["portal vein", "MULTI-TISSUE_STRUCTURE", 278, 289], ["vena cava", "MULTI-TISSUE_STRUCTURE", 299, 308], ["liver", "ORGAN", 347, 352], ["strangulation of the gut", "PROBLEM", 156, 180], ["death", "PROBLEM", 186, 191], ["significant hepatic change", "PROBLEM", 215, 241], ["surgical diversion", "TREATMENT", 252, 270], ["transient injury to the liver", "PROBLEM", 323, 352], ["liver", "ANATOMY", 39, 44], ["blood", "OBSERVATION", 56, 61], ["portal vein", "ANATOMY", 87, 98], ["strangulation", "OBSERVATION", 156, 169], ["gut", "ANATOMY", 177, 180], ["hepatic", "ANATOMY", 227, 234], ["change", "OBSERVATION", 235, 241], ["surgical diversion", "OBSERVATION", 252, 270], ["portal vein", "ANATOMY", 278, 289], ["vena cava", "ANATOMY", 299, 308], ["transient", "OBSERVATION_MODIFIER", 323, 332], ["injury", "OBSERVATION", 333, 339], ["liver", "ANATOMY", 347, 352]]], ["Obstruction of a large branch of the portal vein in cattle, sheep, and cats leads to acute ischemia of a wedge of tissue in which necrosis may be zonal or massive.", [["portal vein", "ANATOMY", 37, 48], ["sheep", "ANATOMY", 60, 65], ["tissue", "ANATOMY", 114, 120], ["ischemia", "DISEASE", 91, 99], ["necrosis", "DISEASE", 130, 138], ["portal vein", "MULTI-TISSUE_STRUCTURE", 37, 48], ["sheep", "ORGANISM_SUBDIVISION", 60, 65], ["cats", "ORGANISM", 71, 75], ["tissue", "TISSUE", 114, 120], ["cattle", "SPECIES", 52, 58], ["sheep", "SPECIES", 60, 65], ["cats", "SPECIES", 71, 75], ["cattle", "SPECIES", 52, 58], ["sheep", "SPECIES", 60, 65], ["Obstruction", "PROBLEM", 0, 11], ["acute ischemia", "PROBLEM", 85, 99], ["a wedge of tissue", "PROBLEM", 103, 120], ["necrosis", "PROBLEM", 130, 138], ["large", "OBSERVATION_MODIFIER", 17, 22], ["branch", "ANATOMY_MODIFIER", 23, 29], ["portal vein", "ANATOMY", 37, 48], ["cattle", "OBSERVATION_MODIFIER", 52, 58], ["acute", "OBSERVATION_MODIFIER", 85, 90], ["ischemia", "OBSERVATION", 91, 99], ["wedge of tissue", "OBSERVATION_MODIFIER", 105, 120], ["necrosis", "OBSERVATION", 130, 138], ["may be", "UNCERTAINTY", 139, 145], ["zonal", "OBSERVATION_MODIFIER", 146, 151], ["massive", "OBSERVATION_MODIFIER", 155, 162]]], ["Obstruction of many small portal radicles is common, with necrosis of many lobules.", [["small portal radicles", "ANATOMY", 20, 41], ["lobules", "ANATOMY", 75, 82], ["necrosis", "DISEASE", 58, 66], ["portal radicles", "MULTI-TISSUE_STRUCTURE", 26, 41], ["lobules", "CANCER", 75, 82], ["Obstruction of many small portal radicles", "PROBLEM", 0, 41], ["necrosis of many lobules", "PROBLEM", 58, 82], ["many", "OBSERVATION_MODIFIER", 15, 19], ["small", "OBSERVATION_MODIFIER", 20, 25], ["portal radicles", "ANATOMY", 26, 41], ["common", "OBSERVATION_MODIFIER", 45, 51], ["necrosis", "OBSERVATION", 58, 66], ["many", "OBSERVATION_MODIFIER", 70, 74], ["lobules", "OBSERVATION", 75, 82]]], ["It is evident that if a collateral supply develops and oxygenation remains adequate, obstruction of portal radicles will have no immediate effect on the hepatic parenchyma, save perhaps to make it more sensitive to toxic injury.", [["collateral", "ANATOMY", 24, 34], ["portal radicles", "ANATOMY", 100, 115], ["hepatic parenchyma", "ANATOMY", 153, 171], ["toxic injury", "DISEASE", 215, 227], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 153, 171], ["a collateral supply", "PROBLEM", 22, 41], ["obstruction of portal radicles", "PROBLEM", 85, 115], ["immediate effect on the hepatic parenchyma", "PROBLEM", 129, 171], ["toxic injury", "PROBLEM", 215, 227], ["collateral", "OBSERVATION", 24, 34], ["obstruction", "OBSERVATION", 85, 96], ["portal", "ANATOMY", 100, 106], ["radicles", "ANATOMY_MODIFIER", 107, 115], ["no", "UNCERTAINTY", 126, 128], ["immediate", "OBSERVATION_MODIFIER", 129, 138], ["effect", "OBSERVATION", 139, 145], ["hepatic", "ANATOMY", 153, 160], ["parenchyma", "ANATOMY_MODIFIER", 161, 171], ["toxic", "OBSERVATION_MODIFIER", 215, 220], ["injury", "OBSERVATION", 221, 227]]], ["The parenchyma in the affected lobe, deprived of hepatotrophic factors, loses much of its regenerative power and atrophies fairly rapidly, allowing condensation and scarification of the stromal tissues.", [["parenchyma", "ANATOMY", 4, 14], ["lobe", "ANATOMY", 31, 35], ["stromal tissues", "ANATOMY", 186, 201], ["parenchyma", "TISSUE", 4, 14], ["lobe", "ORGAN", 31, 35], ["stromal tissues", "TISSUE", 186, 201], ["hepatotrophic factors", "PROTEIN", 49, 70], ["hepatotrophic factors", "PROBLEM", 49, 70], ["atrophies", "PROBLEM", 113, 122], ["condensation and scarification of the stromal tissues", "PROBLEM", 148, 201], ["parenchyma", "ANATOMY", 4, 14], ["affected lobe", "ANATOMY", 22, 35], ["hepatotrophic factors", "OBSERVATION", 49, 70], ["regenerative", "OBSERVATION_MODIFIER", 90, 102], ["power", "OBSERVATION_MODIFIER", 103, 108], ["atrophies", "OBSERVATION", 113, 122], ["scarification", "OBSERVATION_MODIFIER", 165, 178], ["stromal tissues", "OBSERVATION", 186, 201]]], ["Loss of portal venous inflow and obstruction of hepatic venous outflow, a double-hit insult, can lead to complete infarction of the liver as seen in hepatic lobe torsion.", [["portal venous", "ANATOMY", 8, 21], ["hepatic venous", "ANATOMY", 48, 62], ["liver", "ANATOMY", 132, 137], ["hepatic lobe", "ANATOMY", 149, 161], ["infarction of the liver", "DISEASE", 114, 137], ["hepatic lobe torsion", "DISEASE", 149, 169], ["portal venous", "MULTI-TISSUE_STRUCTURE", 8, 21], ["hepatic venous", "MULTI-TISSUE_STRUCTURE", 48, 62], ["liver", "ORGAN", 132, 137], ["hepatic lobe", "MULTI-TISSUE_STRUCTURE", 149, 161], ["Loss of portal venous inflow", "PROBLEM", 0, 28], ["obstruction of hepatic venous outflow", "PROBLEM", 33, 70], ["a double-hit insult", "PROBLEM", 72, 91], ["complete infarction of the liver", "PROBLEM", 105, 137], ["hepatic lobe torsion", "PROBLEM", 149, 169], ["portal venous", "ANATOMY", 8, 21], ["inflow", "ANATOMY_MODIFIER", 22, 28], ["obstruction", "OBSERVATION", 33, 44], ["hepatic venous", "ANATOMY", 48, 62], ["outflow", "ANATOMY_MODIFIER", 63, 70], ["double", "OBSERVATION_MODIFIER", 74, 80], ["hit insult", "OBSERVATION", 81, 91], ["complete", "OBSERVATION_MODIFIER", 105, 113], ["infarction", "OBSERVATION", 114, 124], ["liver", "ANATOMY", 132, 137], ["hepatic", "ANATOMY", 149, 156], ["lobe", "ANATOMY_MODIFIER", 157, 161], ["torsion", "OBSERVATION", 162, 169]]], ["Arterial supply can be obstructed as well in this situation.295.e2Acute increase in pressure in the portal vein may occur in any severe episode of widespread acute hepatic necrosis; the cause appears to be simple obstruction of the sinusoidal flow by thrombosis and actual sinusoidal disruption.", [["Arterial", "ANATOMY", 0, 8], ["portal vein", "ANATOMY", 100, 111], ["hepatic", "ANATOMY", 164, 171], ["sinusoidal", "ANATOMY", 232, 242], ["sinusoidal", "ANATOMY", 273, 283], ["acute hepatic necrosis", "DISEASE", 158, 180], ["thrombosis", "DISEASE", 251, 261], ["Arterial", "MULTI-TISSUE_STRUCTURE", 0, 8], ["portal vein", "MULTI-TISSUE_STRUCTURE", 100, 111], ["hepatic", "ORGAN", 164, 171], ["sinusoidal", "MULTI-TISSUE_STRUCTURE", 232, 242], ["sinusoidal", "MULTI-TISSUE_STRUCTURE", 273, 283], ["Acute increase in pressure in the portal vein", "PROBLEM", 66, 111], ["widespread acute hepatic necrosis", "PROBLEM", 147, 180], ["simple obstruction", "PROBLEM", 206, 224], ["the sinusoidal flow", "PROBLEM", 228, 247], ["thrombosis", "PROBLEM", 251, 261], ["actual sinusoidal disruption", "PROBLEM", 266, 294], ["obstructed", "OBSERVATION", 23, 33], ["increase", "OBSERVATION_MODIFIER", 72, 80], ["pressure", "OBSERVATION_MODIFIER", 84, 92], ["portal vein", "ANATOMY", 100, 111], ["severe", "OBSERVATION_MODIFIER", 129, 135], ["widespread", "OBSERVATION_MODIFIER", 147, 157], ["acute", "OBSERVATION_MODIFIER", 158, 163], ["hepatic", "ANATOMY", 164, 171], ["necrosis", "OBSERVATION", 172, 180], ["appears to be", "UNCERTAINTY", 192, 205], ["simple", "OBSERVATION_MODIFIER", 206, 212], ["obstruction", "OBSERVATION", 213, 224], ["sinusoidal flow", "OBSERVATION", 232, 247], ["thrombosis", "OBSERVATION", 251, 261], ["sinusoidal disruption", "OBSERVATION", 273, 294]]], ["In such animals, there is severe acute congestion of the liver, slight ascites, free fibrin accumulations in the abdomen (not the firm capsular adhesions seen in passive congestion), and distended portal lymphatics.295.e2Obstruction of the extrahepatic portal vein is quite uncommon.", [["liver", "ANATOMY", 57, 62], ["ascites", "ANATOMY", 71, 78], ["abdomen", "ANATOMY", 113, 120], ["capsular adhesions", "ANATOMY", 135, 153], ["portal lymphatics", "ANATOMY", 197, 214], ["extrahepatic portal vein", "ANATOMY", 240, 264], ["congestion of the liver", "DISEASE", 39, 62], ["ascites", "DISEASE", 71, 78], ["extrahepatic portal vein", "DISEASE", 240, 264], ["liver", "ORGAN", 57, 62], ["fibrin", "GENE_OR_GENE_PRODUCT", 85, 91], ["abdomen", "ORGAN", 113, 120], ["portal lymphatics", "MULTI-TISSUE_STRUCTURE", 197, 214], ["extrahepatic portal vein", "MULTI-TISSUE_STRUCTURE", 240, 264], ["severe acute congestion of the liver", "PROBLEM", 26, 62], ["slight ascites", "PROBLEM", 64, 78], ["free fibrin accumulations in the abdomen", "PROBLEM", 80, 120], ["the firm capsular adhesions", "PROBLEM", 126, 153], ["passive congestion", "PROBLEM", 162, 180], ["distended portal lymphatics", "PROBLEM", 187, 214], ["severe", "OBSERVATION_MODIFIER", 26, 32], ["acute", "OBSERVATION_MODIFIER", 33, 38], ["congestion", "OBSERVATION", 39, 49], ["liver", "ANATOMY", 57, 62], ["slight", "OBSERVATION_MODIFIER", 64, 70], ["ascites", "OBSERVATION", 71, 78], ["free", "OBSERVATION_MODIFIER", 80, 84], ["fibrin accumulations", "OBSERVATION", 85, 105], ["abdomen", "ANATOMY", 113, 120], ["firm", "OBSERVATION_MODIFIER", 130, 134], ["capsular", "OBSERVATION_MODIFIER", 135, 143], ["adhesions", "OBSERVATION", 144, 153], ["passive", "OBSERVATION_MODIFIER", 162, 169], ["congestion", "OBSERVATION", 170, 180], ["distended", "OBSERVATION", 187, 196], ["portal lymphatics", "ANATOMY", 197, 214], ["extrahepatic", "ANATOMY_MODIFIER", 240, 252], ["portal vein", "ANATOMY", 253, 264], ["uncommon", "OBSERVATION", 274, 282]]], ["External compression may occur because of adjacent abscesses or neoplasms.", [["abscesses", "ANATOMY", 51, 60], ["neoplasms", "ANATOMY", 64, 73], ["abscesses", "DISEASE", 51, 60], ["neoplasms", "DISEASE", 64, 73], ["abscesses", "PATHOLOGICAL_FORMATION", 51, 60], ["neoplasms", "CANCER", 64, 73], ["External compression", "TREATMENT", 0, 20], ["adjacent abscesses", "PROBLEM", 42, 60], ["neoplasms", "PROBLEM", 64, 73], ["compression", "OBSERVATION", 9, 20], ["abscesses", "OBSERVATION", 51, 60], ["neoplasms", "OBSERVATION", 64, 73]]], ["Portal vein thrombosis may be caused by damage to the portal vein by local inflammatory processes in such foci.", [["Portal vein", "ANATOMY", 0, 11], ["portal vein", "ANATOMY", 54, 65], ["foci", "ANATOMY", 106, 110], ["Portal vein thrombosis", "DISEASE", 0, 22], ["damage to the portal vein", "DISEASE", 40, 65], ["Portal vein", "MULTI-TISSUE_STRUCTURE", 0, 11], ["portal vein", "MULTI-TISSUE_STRUCTURE", 54, 65], ["Portal vein thrombosis", "PROBLEM", 0, 22], ["damage to the portal vein", "PROBLEM", 40, 65], ["local inflammatory processes", "PROBLEM", 69, 97], ["such foci", "PROBLEM", 101, 110], ["vein", "ANATOMY", 7, 11], ["thrombosis", "OBSERVATION", 12, 22], ["damage", "OBSERVATION", 40, 46], ["portal vein", "ANATOMY", 54, 65], ["local", "OBSERVATION_MODIFIER", 69, 74], ["inflammatory", "OBSERVATION", 75, 87], ["foci", "OBSERVATION", 106, 110]]], ["Green-black pigmentation of the capsule and superficial parenchyma occurs where the liver is in contact with gut, and the lobes surrounding the gallbladder become stained by bile.295.e2Microscopic structural changes occur in the liver, approaching and immediately following death.", [["capsule", "ANATOMY", 32, 39], ["superficial parenchyma", "ANATOMY", 44, 66], ["liver", "ANATOMY", 84, 89], ["gut", "ANATOMY", 109, 112], ["lobes", "ANATOMY", 122, 127], ["gallbladder", "ANATOMY", 144, 155], ["bile", "ANATOMY", 174, 178], ["liver", "ANATOMY", 229, 234], ["death", "DISEASE", 274, 279], ["capsule", "CANCER", 32, 39], ["superficial parenchyma", "MULTI-TISSUE_STRUCTURE", 44, 66], ["liver", "ORGAN", 84, 89], ["gut", "ORGANISM_SUBDIVISION", 109, 112], ["lobes", "ORGAN", 122, 127], ["gallbladder", "ORGAN", 144, 155], ["bile", "MULTI-TISSUE_STRUCTURE", 174, 178], ["liver", "ORGAN", 229, 234], ["Green-black pigmentation of the capsule and superficial parenchyma", "PROBLEM", 0, 66], ["black pigmentation", "OBSERVATION", 6, 24], ["capsule", "ANATOMY_MODIFIER", 32, 39], ["superficial", "ANATOMY_MODIFIER", 44, 55], ["parenchyma", "ANATOMY_MODIFIER", 56, 66], ["liver", "ANATOMY", 84, 89], ["contact", "OBSERVATION", 96, 103], ["lobes", "ANATOMY_MODIFIER", 122, 127], ["gallbladder", "ANATOMY", 144, 155], ["stained", "OBSERVATION", 163, 170], ["bile", "ANATOMY", 174, 178], ["liver", "ANATOMY", 229, 234]]], ["Shrinkage of liver cells, possibly because of a period of anaerobic catabolism of glycogen, and widening of centrilobular (periacinar) sinusoids because of hepatic congestion, are seen after death.", [["liver cells", "ANATOMY", 13, 24], ["centrilobular", "ANATOMY", 108, 121], ["periacinar) sinusoids", "ANATOMY", 123, 144], ["hepatic", "ANATOMY", 156, 163], ["glycogen", "CHEMICAL", 82, 90], ["hepatic congestion", "DISEASE", 156, 174], ["death", "DISEASE", 191, 196], ["liver cells", "CELL", 13, 24], ["glycogen", "SIMPLE_CHEMICAL", 82, 90], ["centrilobular", "MULTI-TISSUE_STRUCTURE", 108, 121], ["sinusoids", "MULTI-TISSUE_STRUCTURE", 135, 144], ["hepatic", "ORGAN", 156, 163], ["liver cells", "CELL_TYPE", 13, 24], ["Shrinkage of liver cells", "PROBLEM", 0, 24], ["anaerobic catabolism of glycogen", "PROBLEM", 58, 90], ["widening of centrilobular (periacinar) sinusoids", "PROBLEM", 96, 144], ["hepatic congestion", "PROBLEM", 156, 174], ["death", "PROBLEM", 191, 196], ["liver", "ANATOMY", 13, 18], ["cells", "OBSERVATION", 19, 24], ["anaerobic catabolism", "OBSERVATION", 58, 78], ["widening", "OBSERVATION_MODIFIER", 96, 104], ["centrilobular", "OBSERVATION_MODIFIER", 108, 121], ["hepatic", "ANATOMY", 156, 163], ["congestion", "OBSERVATION", 164, 174]]], ["Dissociation of liver cells may be complete, with every cell in every cord separated and free from adjacent cells, so architectural patterns are lost.", [["liver cells", "ANATOMY", 16, 27], ["cell", "ANATOMY", 56, 60], ["cord", "ANATOMY", 70, 74], ["cells", "ANATOMY", 108, 113], ["liver cells", "CELL", 16, 27], ["cell", "CELL", 56, 60], ["cord", "ORGAN", 70, 74], ["cells", "CELL", 108, 113], ["liver cells", "CELL_TYPE", 16, 27], ["adjacent cells", "CELL_TYPE", 99, 113], ["Dissociation of liver cells", "PROBLEM", 0, 27], ["every cell in every cord", "PROBLEM", 50, 74], ["liver", "ANATOMY", 16, 21], ["cord", "ANATOMY", 70, 74], ["adjacent cells", "OBSERVATION", 99, 113], ["architectural patterns", "OBSERVATION", 118, 140]]], ["The early expression of this change affects centrilobular cells, which become detached, rounded in contour, condensed, and hyperchromatic.", [["centrilobular cells", "ANATOMY", 44, 63], ["centrilobular cells", "CELL", 44, 63], ["centrilobular cells", "CELL_TYPE", 44, 63], ["this change affects centrilobular cells", "PROBLEM", 24, 63], ["rounded in contour", "PROBLEM", 88, 106], ["hyperchromatic", "PROBLEM", 123, 137], ["early", "OBSERVATION_MODIFIER", 4, 9], ["expression", "OBSERVATION_MODIFIER", 10, 20], ["centrilobular cells", "OBSERVATION", 44, 63], ["detached", "OBSERVATION_MODIFIER", 78, 86], ["rounded", "OBSERVATION_MODIFIER", 88, 95], ["contour", "OBSERVATION_MODIFIER", 99, 106], ["condensed", "OBSERVATION_MODIFIER", 108, 117], ["hyperchromatic", "OBSERVATION_MODIFIER", 123, 137]]], ["The dissociation is particularly evident in feline panleukopenia and leptospirosis, related in part to antemortem changes.Hepatic arteryThe hepatic artery delivers approximately 1 3 of the afferent hepatic blood supply, but ~40-50% of the oxygen.", [["Hepatic artery", "ANATOMY", 122, 136], ["hepatic artery", "ANATOMY", 140, 154], ["afferent hepatic blood", "ANATOMY", 189, 211], ["feline panleukopenia", "DISEASE", 44, 64], ["leptospirosis", "DISEASE", 69, 82], ["oxygen", "CHEMICAL", 239, 245], ["oxygen", "CHEMICAL", 239, 245], ["feline", "ORGANISM", 44, 50], ["Hepatic artery", "MULTI-TISSUE_STRUCTURE", 122, 136], ["hepatic artery", "MULTI-TISSUE_STRUCTURE", 140, 154], ["afferent hepatic", "MULTI-TISSUE_STRUCTURE", 189, 205], ["blood", "ORGANISM_SUBSTANCE", 206, 211], ["oxygen", "SIMPLE_CHEMICAL", 239, 245], ["feline", "SPECIES", 44, 50], ["feline panleukopenia", "SPECIES", 44, 64], ["The dissociation", "PROBLEM", 0, 16], ["feline panleukopenia", "PROBLEM", 44, 64], ["leptospirosis", "PROBLEM", 69, 82], ["the oxygen", "TREATMENT", 235, 245], ["dissociation", "OBSERVATION", 4, 16], ["particularly evident", "UNCERTAINTY", 20, 40], ["feline panleukopenia", "OBSERVATION", 44, 64], ["leptospirosis", "OBSERVATION", 69, 82], ["artery", "ANATOMY", 130, 136], ["hepatic artery", "ANATOMY", 140, 154], ["afferent", "ANATOMY_MODIFIER", 189, 197], ["hepatic", "ANATOMY", 198, 205], ["blood supply", "OBSERVATION", 206, 218], ["~", "OBSERVATION_MODIFIER", 224, 225], ["40-50", "OBSERVATION_MODIFIER", 225, 230], ["oxygen", "OBSERVATION_MODIFIER", 239, 245]]], ["Hepatic artery flow responds to alterations in portal vein flow to sustain overall perfusion of the liver at a nearly consistent level via what is termed the hepatic arterial buffer response.", [["Hepatic artery", "ANATOMY", 0, 14], ["portal vein", "ANATOMY", 47, 58], ["liver", "ANATOMY", 100, 105], ["hepatic arterial", "ANATOMY", 158, 174], ["Hepatic artery", "MULTI-TISSUE_STRUCTURE", 0, 14], ["portal vein", "MULTI-TISSUE_STRUCTURE", 47, 58], ["liver", "ORGAN", 100, 105], ["hepatic arterial", "MULTI-TISSUE_STRUCTURE", 158, 174], ["Hepatic artery flow", "PROBLEM", 0, 19], ["portal vein flow", "TEST", 47, 63], ["artery", "ANATOMY", 8, 14], ["flow", "OBSERVATION", 15, 19], ["portal vein", "ANATOMY", 47, 58], ["overall", "OBSERVATION_MODIFIER", 75, 82], ["perfusion", "OBSERVATION", 83, 92], ["liver", "ANATOMY", 100, 105], ["hepatic", "ANATOMY", 158, 165], ["arterial", "ANATOMY_MODIFIER", 166, 174], ["buffer response", "OBSERVATION", 175, 190]]], ["Hepatic arterial flow is believed to be regulated via adenosine levels in the space of Mall.", [["Hepatic arterial", "ANATOMY", 0, 16], ["adenosine", "CHEMICAL", 54, 63], ["adenosine", "CHEMICAL", 54, 63], ["Hepatic arterial", "MULTI-TISSUE_STRUCTURE", 0, 16], ["adenosine", "SIMPLE_CHEMICAL", 54, 63], ["Hepatic arterial flow", "TEST", 0, 21], ["adenosine levels", "TEST", 54, 70], ["arterial", "ANATOMY", 8, 16], ["flow", "OBSERVATION", 17, 21], ["believed to be", "UNCERTAINTY", 25, 39], ["adenosine levels", "OBSERVATION", 54, 70], ["space", "OBSERVATION_MODIFIER", 78, 83], ["Mall", "OBSERVATION_MODIFIER", 87, 91]]], ["Adenosine is produced at a constant level, but with decreased portal flow less adenosine is washed out, raising local concentrations and causing the hepatic artery to dilate and increase arterial flow.", [["portal", "ANATOMY", 62, 68], ["hepatic artery", "ANATOMY", 149, 163], ["arterial", "ANATOMY", 187, 195], ["Adenosine", "CHEMICAL", 0, 9], ["adenosine", "CHEMICAL", 79, 88], ["Adenosine", "CHEMICAL", 0, 9], ["adenosine", "CHEMICAL", 79, 88], ["Adenosine", "SIMPLE_CHEMICAL", 0, 9], ["portal", "MULTI-TISSUE_STRUCTURE", 62, 68], ["adenosine", "SIMPLE_CHEMICAL", 79, 88], ["hepatic artery", "MULTI-TISSUE_STRUCTURE", 149, 163], ["arterial", "MULTI-TISSUE_STRUCTURE", 187, 195], ["Adenosine", "TREATMENT", 0, 9], ["decreased portal flow less adenosine", "PROBLEM", 52, 88], ["increase arterial flow", "PROBLEM", 178, 200], ["decreased", "OBSERVATION_MODIFIER", 52, 61], ["portal", "ANATOMY", 62, 68], ["flow", "OBSERVATION", 69, 73], ["hepatic artery", "ANATOMY", 149, 163], ["dilate", "OBSERVATION", 167, 173], ["increase", "OBSERVATION_MODIFIER", 178, 186], ["arterial flow", "OBSERVATION", 187, 200]]], ["Other mediators of arterial flow are recognized, and they include hydrogen sulfide, nitric oxide, and the autonomic nervous system.Hepatic arteryComplete loss of arterial flow can be, after a brief period of injury, compensated for via the portal flow because the liver normally only extracts ~40% of the oxygen supplied by the portal vein.", [["arterial", "ANATOMY", 19, 27], ["autonomic nervous system", "ANATOMY", 106, 130], ["Hepatic arteryComplete", "ANATOMY", 131, 153], ["arterial", "ANATOMY", 162, 170], ["portal", "ANATOMY", 240, 246], ["liver", "ANATOMY", 264, 269], ["portal vein", "ANATOMY", 328, 339], ["hydrogen sulfide", "CHEMICAL", 66, 82], ["nitric oxide", "CHEMICAL", 84, 96], ["oxygen", "CHEMICAL", 305, 311], ["hydrogen sulfide", "CHEMICAL", 66, 82], ["nitric oxide", "CHEMICAL", 84, 96], ["oxygen", "CHEMICAL", 305, 311], ["arterial", "MULTI-TISSUE_STRUCTURE", 19, 27], ["hydrogen sulfide", "SIMPLE_CHEMICAL", 66, 82], ["nitric oxide", "SIMPLE_CHEMICAL", 84, 96], ["autonomic nervous system", "ANATOMICAL_SYSTEM", 106, 130], ["arterial", "MULTI-TISSUE_STRUCTURE", 162, 170], ["portal", "MULTI-TISSUE_STRUCTURE", 240, 246], ["liver", "ORGAN", 264, 269], ["oxygen", "SIMPLE_CHEMICAL", 305, 311], ["portal vein", "MULTI-TISSUE_STRUCTURE", 328, 339], ["arterial flow", "TEST", 19, 32], ["hydrogen sulfide", "TREATMENT", 66, 82], ["nitric oxide", "TREATMENT", 84, 96], ["the autonomic nervous system", "PROBLEM", 102, 130], ["Hepatic arteryComplete loss of arterial flow", "PROBLEM", 131, 175], ["injury", "PROBLEM", 208, 214], ["the portal flow", "TEST", 236, 251], ["arterial", "ANATOMY", 19, 27], ["flow", "OBSERVATION", 28, 32], ["hydrogen sulfide", "OBSERVATION", 66, 82], ["autonomic nervous", "ANATOMY", 106, 123], ["arteryComplete", "OBSERVATION_MODIFIER", 139, 153], ["loss", "OBSERVATION", 154, 158], ["arterial", "ANATOMY", 162, 170], ["flow", "OBSERVATION", 171, 175], ["injury", "OBSERVATION", 208, 214], ["portal", "ANATOMY", 240, 246], ["flow", "OBSERVATION", 247, 251], ["liver", "ANATOMY", 264, 269], ["40%", "OBSERVATION_MODIFIER", 294, 297], ["oxygen", "OBSERVATION_MODIFIER", 305, 311], ["portal vein", "ANATOMY", 328, 339]]], ["Within the liver, branches of the hepatic artery form several patterns, including (1) a peribiliary plexus, (2) a vasa vasorum for the portal vein, or (3) an array of terminal hepatic arterioles that drain directly into the sinusoids.", [["liver", "ANATOMY", 11, 16], ["hepatic artery", "ANATOMY", 34, 48], ["peribiliary plexus", "ANATOMY", 88, 106], ["vasa vasorum", "ANATOMY", 114, 126], ["portal vein", "ANATOMY", 135, 146], ["hepatic arterioles", "ANATOMY", 176, 194], ["sinusoids", "ANATOMY", 224, 233], ["liver", "ORGAN", 11, 16], ["hepatic artery", "MULTI-TISSUE_STRUCTURE", 34, 48], ["peribiliary plexus", "MULTI-TISSUE_STRUCTURE", 88, 106], ["vasa vasorum", "MULTI-TISSUE_STRUCTURE", 114, 126], ["portal vein", "MULTI-TISSUE_STRUCTURE", 135, 146], ["hepatic arterioles", "MULTI-TISSUE_STRUCTURE", 176, 194], ["sinusoids", "TISSUE", 224, 233], ["terminal hepatic arterioles that drain", "TREATMENT", 167, 205], ["liver", "ANATOMY", 11, 16], ["branches", "ANATOMY_MODIFIER", 18, 26], ["hepatic artery", "ANATOMY", 34, 48], ["several", "OBSERVATION_MODIFIER", 54, 61], ["patterns", "OBSERVATION_MODIFIER", 62, 70], ["peribiliary plexus", "ANATOMY", 88, 106], ["vasa", "ANATOMY", 114, 118], ["vasorum", "OBSERVATION", 119, 126], ["portal vein", "ANATOMY", 135, 146], ["terminal", "ANATOMY_MODIFIER", 167, 175], ["hepatic", "ANATOMY", 176, 183], ["arterioles", "ANATOMY_MODIFIER", 184, 194], ["drain", "OBSERVATION", 200, 205], ["sinusoids", "ANATOMY", 224, 233]]], ["In addition, the hepatic artery provides branches to supply the liver capsule.", [["hepatic artery", "ANATOMY", 17, 31], ["liver capsule", "ANATOMY", 64, 77], ["hepatic artery", "MULTI-TISSUE_STRUCTURE", 17, 31], ["liver capsule", "CANCER", 64, 77], ["hepatic artery", "ANATOMY", 17, 31], ["branches", "ANATOMY_MODIFIER", 41, 49], ["liver", "ANATOMY", 64, 69], ["capsule", "ANATOMY_MODIFIER", 70, 77]]], ["The peribiliary plexus surrounds intrahepatic bile ducts and likely plays a role in an exchange of bile constituents and vasoactive factors.", [["peribiliary plexus", "ANATOMY", 4, 22], ["intrahepatic bile ducts", "ANATOMY", 33, 56], ["bile", "ANATOMY", 99, 103], ["peribiliary plexus", "MULTI-TISSUE_STRUCTURE", 4, 22], ["intrahepatic bile ducts", "MULTI-TISSUE_STRUCTURE", 33, 56], ["bile constituents", "SIMPLE_CHEMICAL", 99, 116], ["vasoactive factors", "PROTEIN", 121, 139], ["an exchange of bile constituents", "TREATMENT", 84, 116], ["vasoactive factors", "TREATMENT", 121, 139], ["peribiliary plexus", "ANATOMY", 4, 22], ["intrahepatic", "ANATOMY_MODIFIER", 33, 45], ["bile ducts", "ANATOMY", 46, 56], ["bile", "ANATOMY", 99, 103], ["vasoactive factors", "OBSERVATION", 121, 139]]], ["Hepatic arterial occlusions occur rather commonly in animals but usually involve small intrahepatic branches and are of little consequence.", [["Hepatic arterial", "ANATOMY", 0, 16], ["intrahepatic branches", "ANATOMY", 87, 108], ["Hepatic arterial occlusions", "DISEASE", 0, 27], ["Hepatic arterial", "MULTI-TISSUE_STRUCTURE", 0, 16], ["intrahepatic branches", "MULTI-TISSUE_STRUCTURE", 87, 108], ["Hepatic arterial occlusions", "PROBLEM", 0, 27], ["arterial", "ANATOMY", 8, 16], ["occlusions", "OBSERVATION", 17, 27], ["small", "OBSERVATION_MODIFIER", 81, 86], ["intrahepatic", "ANATOMY", 87, 99], ["branches", "ANATOMY_MODIFIER", 100, 108]]], ["Large segments of the liver may be necrotic in cats as a result of thrombosis of the aorta and hepatic artery.", [["liver", "ANATOMY", 22, 27], ["aorta", "ANATOMY", 85, 90], ["hepatic artery", "ANATOMY", 95, 109], ["necrotic", "DISEASE", 35, 43], ["thrombosis", "DISEASE", 67, 77], ["liver", "ORGAN", 22, 27], ["cats", "ORGANISM", 47, 51], ["aorta", "MULTI-TISSUE_STRUCTURE", 85, 90], ["hepatic artery", "MULTI-TISSUE_STRUCTURE", 95, 109], ["Large segments of the liver", "PROBLEM", 0, 27], ["necrotic in cats", "PROBLEM", 35, 51], ["thrombosis of the aorta and hepatic artery", "PROBLEM", 67, 109], ["segments", "ANATOMY_MODIFIER", 6, 14], ["liver", "ANATOMY", 22, 27], ["may be", "UNCERTAINTY", 28, 34], ["necrotic", "OBSERVATION", 35, 43], ["cats", "OBSERVATION", 47, 51], ["thrombosis", "OBSERVATION", 67, 77], ["aorta", "ANATOMY", 85, 90], ["hepatic artery", "ANATOMY", 95, 109]]], ["Verminous arteritis may occlude the hepatic artery in horses.", [["hepatic artery", "ANATOMY", 36, 50], ["arteritis", "DISEASE", 10, 19], ["hepatic artery", "MULTI-TISSUE_STRUCTURE", 36, 50], ["Verminous arteritis", "PROBLEM", 0, 19], ["arteritis", "OBSERVATION", 10, 19], ["hepatic artery", "ANATOMY", 36, 50]]], ["The extent of necrosis depends on how completely the obstruction excludes collateral circulation and also on the oxygen tension of the portal blood.", [["collateral", "ANATOMY", 74, 84], ["portal blood", "ANATOMY", 135, 147], ["necrosis", "DISEASE", 14, 22], ["obstruction", "DISEASE", 53, 64], ["oxygen", "CHEMICAL", 113, 119], ["oxygen", "CHEMICAL", 113, 119], ["collateral", "MULTI-TISSUE_STRUCTURE", 74, 84], ["oxygen", "SIMPLE_CHEMICAL", 113, 119], ["portal", "MULTI-TISSUE_STRUCTURE", 135, 141], ["blood", "ORGANISM_SUBSTANCE", 142, 147], ["necrosis", "PROBLEM", 14, 22], ["the obstruction", "PROBLEM", 49, 64], ["the oxygen tension of the portal blood", "PROBLEM", 109, 147], ["extent", "OBSERVATION_MODIFIER", 4, 10], ["necrosis", "OBSERVATION", 14, 22], ["obstruction", "OBSERVATION", 53, 64], ["collateral circulation", "OBSERVATION", 74, 96], ["oxygen tension", "OBSERVATION", 113, 127], ["portal blood", "ANATOMY", 135, 147]]], ["Ischemic areas of liver can be sequestered, but in some instances, bacteria such as clostridia and other anaerobes can flourish and release potent toxins with systemic effects.Portal veinThe portal vein drains the large and small intestine, stomach, pancreas, gallbladder, and spleen and normally contributes 2 3 of hepatic blood flow.", [["liver", "ANATOMY", 18, 23], ["Portal vein", "ANATOMY", 176, 187], ["portal vein", "ANATOMY", 191, 202], ["small intestine", "ANATOMY", 224, 239], ["stomach", "ANATOMY", 241, 248], ["pancreas", "ANATOMY", 250, 258], ["gallbladder", "ANATOMY", 260, 271], ["spleen", "ANATOMY", 277, 283], ["hepatic blood", "ANATOMY", 316, 329], ["liver", "ORGAN", 18, 23], ["Portal vein", "MULTI-TISSUE_STRUCTURE", 176, 187], ["portal vein", "MULTI-TISSUE_STRUCTURE", 191, 202], ["intestine", "ORGAN", 230, 239], ["stomach", "ORGAN", 241, 248], ["pancreas", "ORGAN", 250, 258], ["gallbladder", "ORGAN", 260, 271], ["spleen", "ORGAN", 277, 283], ["hepatic", "MULTI-TISSUE_STRUCTURE", 316, 323], ["blood", "ORGANISM_SUBSTANCE", 324, 329], ["Ischemic areas of liver", "PROBLEM", 0, 23], ["bacteria", "PROBLEM", 67, 75], ["clostridia", "PROBLEM", 84, 94], ["other anaerobes", "PROBLEM", 99, 114], ["systemic effects", "PROBLEM", 159, 175], ["the large and small intestine, stomach, pancreas, gallbladder, and spleen", "PROBLEM", 210, 283], ["hepatic blood flow", "TEST", 316, 334], ["liver", "ANATOMY", 18, 23], ["bacteria", "OBSERVATION", 67, 75], ["vein", "ANATOMY", 183, 187], ["portal vein", "ANATOMY", 191, 202], ["drains", "OBSERVATION", 203, 209], ["large", "OBSERVATION_MODIFIER", 214, 219], ["small intestine", "ANATOMY", 224, 239], ["stomach", "ANATOMY", 241, 248], ["pancreas", "ANATOMY", 250, 258], ["gallbladder", "ANATOMY", 260, 271], ["spleen", "ANATOMY", 277, 283], ["hepatic", "ANATOMY", 316, 323], ["blood flow", "OBSERVATION", 324, 334]]], ["Because the portal vein collects blood from the abdominal viscera, the rate of flow is variable, depending on physiologic factors such as eating, which increases, or stress, which decreases, portal flow.", [["portal vein", "ANATOMY", 12, 23], ["blood", "ANATOMY", 33, 38], ["abdominal viscera", "ANATOMY", 48, 65], ["portal", "ANATOMY", 191, 197], ["portal vein", "MULTI-TISSUE_STRUCTURE", 12, 23], ["blood", "ORGANISM_SUBSTANCE", 33, 38], ["abdominal viscera", "ORGAN", 48, 65], ["portal", "MULTI-TISSUE_STRUCTURE", 191, 197], ["physiologic factors", "PROBLEM", 110, 129], ["stress", "PROBLEM", 166, 172], ["portal vein", "ANATOMY", 12, 23], ["abdominal viscera", "ANATOMY", 48, 65], ["flow", "OBSERVATION", 79, 83], ["portal", "ANATOMY", 191, 197], ["flow", "OBSERVATION", 198, 202]]], ["Portal venous Regardless of cause, persistent portal hypertension can lead to acquired portosystemic shunts (discussed later), with the exception of passive congestion, which rarely, if ever, results in the development of shunt vessels.", [["Portal venous", "ANATOMY", 0, 13], ["portal", "ANATOMY", 46, 52], ["shunt vessels", "ANATOMY", 222, 235], ["portal hypertension", "DISEASE", 46, 65], ["portosystemic shunts", "DISEASE", 87, 107], ["congestion", "DISEASE", 157, 167], ["Portal venous", "MULTI-TISSUE_STRUCTURE", 0, 13], ["portal", "MULTI-TISSUE_STRUCTURE", 46, 52], ["portosystemic shunts", "PATHOLOGICAL_FORMATION", 87, 107], ["shunt vessels", "MULTI-TISSUE_STRUCTURE", 222, 235], ["persistent portal hypertension", "PROBLEM", 35, 65], ["acquired portosystemic shunts", "PROBLEM", 78, 107], ["passive congestion", "PROBLEM", 149, 167], ["shunt vessels", "TREATMENT", 222, 235], ["venous", "ANATOMY", 7, 13], ["persistent", "OBSERVATION_MODIFIER", 35, 45], ["portal", "ANATOMY", 46, 52], ["hypertension", "OBSERVATION", 53, 65], ["portosystemic shunts", "OBSERVATION", 87, 107], ["passive", "OBSERVATION_MODIFIER", 149, 156], ["congestion", "OBSERVATION", 157, 167], ["shunt vessels", "OBSERVATION", 222, 235]]], ["These shunts are usually numerous and composed of distended thin-walled veins, which may connect the mesenteric veins and the caudal vena cava.", [["thin-walled veins", "ANATOMY", 60, 77], ["mesenteric veins", "ANATOMY", 101, 117], ["caudal vena cava", "ANATOMY", 126, 142], ["walled veins", "MULTI-TISSUE_STRUCTURE", 65, 77], ["mesenteric veins", "MULTI-TISSUE_STRUCTURE", 101, 117], ["caudal vena cava", "MULTI-TISSUE_STRUCTURE", 126, 142], ["These shunts", "TREATMENT", 0, 12], ["distended thin-walled veins", "PROBLEM", 50, 77], ["shunts", "OBSERVATION", 6, 12], ["distended", "OBSERVATION", 50, 59], ["thin", "OBSERVATION_MODIFIER", 60, 64], ["walled veins", "ANATOMY", 65, 77], ["mesenteric veins", "ANATOMY", 101, 117], ["caudal vena cava", "ANATOMY", 126, 142]]], ["Ascites is common in conditions that develop acquired shunts because of the associated portal hypertension.Efferent hepatic vesselsEfferent flow begins in the sinusoids and passes through terminal hepatic venules and larger hepatic veins to the vena cava.", [["Ascites", "ANATOMY", 0, 7], ["portal", "ANATOMY", 87, 93], ["Efferent hepatic vessels", "ANATOMY", 107, 131], ["Efferent", "ANATOMY", 131, 139], ["sinusoids", "ANATOMY", 159, 168], ["hepatic venules", "ANATOMY", 197, 212], ["hepatic veins", "ANATOMY", 224, 237], ["vena cava", "ANATOMY", 245, 254], ["Ascites", "DISEASE", 0, 7], ["portal hypertension", "DISEASE", 87, 106], ["Ascites", "CANCER", 0, 7], ["portal", "MULTI-TISSUE_STRUCTURE", 87, 93], ["Efferent hepatic vessels", "MULTI-TISSUE_STRUCTURE", 107, 131], ["sinusoids", "TISSUE", 159, 168], ["hepatic venules", "MULTI-TISSUE_STRUCTURE", 197, 212], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 224, 237], ["vena cava", "MULTI-TISSUE_STRUCTURE", 245, 254], ["terminal hepatic venules", "CELL_TYPE", 188, 212], ["Ascites", "PROBLEM", 0, 7], ["acquired shunts", "PROBLEM", 45, 60], ["the associated portal hypertension", "PROBLEM", 72, 106], ["Efferent flow", "TREATMENT", 131, 144], ["shunts", "OBSERVATION", 54, 60], ["portal", "ANATOMY", 87, 93], ["hypertension", "OBSERVATION", 94, 106], ["hepatic vessels", "ANATOMY", 116, 131], ["flow", "OBSERVATION", 140, 144], ["sinusoids", "ANATOMY", 159, 168], ["terminal", "ANATOMY_MODIFIER", 188, 196], ["hepatic", "ANATOMY", 197, 204], ["venules", "ANATOMY_MODIFIER", 205, 212], ["larger", "OBSERVATION_MODIFIER", 217, 223], ["hepatic veins", "ANATOMY", 224, 237], ["vena cava", "ANATOMY", 245, 254]]], ["In the sinusoidal network, flow is interconnected in many directions.", [["sinusoidal network", "ANATOMY", 7, 25], ["sinusoidal network", "MULTI-TISSUE_STRUCTURE", 7, 25], ["sinusoidal network", "OBSERVATION", 7, 25], ["flow", "OBSERVATION", 27, 31]]], ["However, in normal conditions, lobule outflow is closely matched to inflow.", [["lobule outflow", "ANATOMY", 31, 45], ["lobule outflow", "MULTI-TISSUE_STRUCTURE", 31, 45], ["normal conditions", "OBSERVATION", 12, 29], ["lobule", "OBSERVATION_MODIFIER", 31, 37], ["outflow", "OBSERVATION_MODIFIER", 38, 45]]], ["In dogs, hepatic veins have substantial spiral smooth-muscle sphincters that regulate outflow, but these are not evident in other domestic species.", [["hepatic veins", "ANATOMY", 9, 22], ["smooth-muscle sphincters", "ANATOMY", 47, 71], ["dogs", "ORGANISM", 3, 7], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 9, 22], ["spiral smooth-muscle sphincters", "TISSUE", 40, 71], ["dogs", "SPECIES", 3, 7], ["dogs", "OBSERVATION", 3, 7], ["hepatic veins", "ANATOMY", 9, 22], ["substantial", "OBSERVATION_MODIFIER", 28, 39], ["spiral", "OBSERVATION_MODIFIER", 40, 46], ["smooth", "OBSERVATION", 47, 53], ["muscle sphincters", "ANATOMY", 54, 71], ["outflow", "OBSERVATION_MODIFIER", 86, 93], ["not evident", "UNCERTAINTY", 109, 120], ["domestic species", "OBSERVATION", 130, 146]]], ["Splanchnic engorgement during anesthesia and anaphylaxis is an indication that these smooth muscles control canine hepatic outflow in a dynamic manner.", [["Splanchnic", "ANATOMY", 0, 10], ["smooth muscles", "ANATOMY", 85, 99], ["hepatic", "ANATOMY", 115, 122], ["Splanchnic engorgement", "DISEASE", 0, 22], ["anaphylaxis", "DISEASE", 45, 56], ["smooth muscles", "TISSUE", 85, 99], ["canine", "ORGANISM", 108, 114], ["hepatic outflow", "MULTI-TISSUE_STRUCTURE", 115, 130], ["canine", "SPECIES", 108, 114], ["Splanchnic engorgement", "PROBLEM", 0, 22], ["anesthesia", "TREATMENT", 30, 40], ["anaphylaxis", "PROBLEM", 45, 56], ["engorgement", "OBSERVATION", 11, 22], ["hepatic", "ANATOMY", 115, 122], ["outflow", "ANATOMY_MODIFIER", 123, 130]]], ["Obstruction at the level of the large hepatic veins can occasionally occur because of suppurative phlebitis, hepatic abscesses, neoplasms, or other physical obstacles that impinge on the hepatic veins.", [["hepatic veins", "ANATOMY", 38, 51], ["hepatic abscesses", "ANATOMY", 109, 126], ["neoplasms", "ANATOMY", 128, 137], ["hepatic veins", "ANATOMY", 187, 200], ["Obstruction", "DISEASE", 0, 11], ["phlebitis", "DISEASE", 98, 107], ["hepatic abscesses", "DISEASE", 109, 126], ["neoplasms", "DISEASE", 128, 137], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 38, 51], ["suppurative phlebitis", "PATHOLOGICAL_FORMATION", 86, 107], ["hepatic abscesses", "PATHOLOGICAL_FORMATION", 109, 126], ["neoplasms", "CANCER", 128, 137], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 187, 200], ["Obstruction", "PROBLEM", 0, 11], ["suppurative phlebitis", "PROBLEM", 86, 107], ["hepatic abscesses", "PROBLEM", 109, 126], ["neoplasms", "PROBLEM", 128, 137], ["other physical obstacles", "PROBLEM", 142, 166], ["large", "ANATOMY_MODIFIER", 32, 37], ["hepatic veins", "ANATOMY", 38, 51], ["suppurative", "OBSERVATION_MODIFIER", 86, 97], ["phlebitis", "OBSERVATION", 98, 107], ["hepatic", "ANATOMY", 109, 116], ["abscesses", "OBSERVATION", 117, 126], ["neoplasms", "OBSERVATION", 128, 137], ["hepatic veins", "ANATOMY", 187, 200]]], ["Similar spaceoccupying lesions in or around the vena cava in the diaphragm or mediastinum can also affect hepatic outflow, along with systemic venous return.Efferent hepatic vesselsThe amount and arrangement of conventional connective tissue around the terminal hepatic veins and larger hepatic veins influence the patterns of fibrosis observed in various patterns of centrilobular injury.", [["spaceoccupying lesions", "ANATOMY", 8, 30], ["vena cava", "ANATOMY", 48, 57], ["diaphragm", "ANATOMY", 65, 74], ["mediastinum", "ANATOMY", 78, 89], ["hepatic", "ANATOMY", 106, 113], ["venous", "ANATOMY", 143, 149], ["Efferent hepatic vessels", "ANATOMY", 157, 181], ["connective tissue", "ANATOMY", 224, 241], ["terminal hepatic veins", "ANATOMY", 253, 275], ["hepatic veins", "ANATOMY", 287, 300], ["centrilobular", "ANATOMY", 368, 381], ["fibrosis", "DISEASE", 327, 335], ["centrilobular injury", "DISEASE", 368, 388], ["spaceoccupying lesions", "CANCER", 8, 30], ["vena cava", "MULTI-TISSUE_STRUCTURE", 48, 57], ["diaphragm", "ORGAN", 65, 74], ["mediastinum", "ORGAN", 78, 89], ["hepatic outflow", "MULTI-TISSUE_STRUCTURE", 106, 121], ["venous", "MULTI-TISSUE_STRUCTURE", 143, 149], ["Efferent hepatic vessels", "MULTI-TISSUE_STRUCTURE", 157, 181], ["connective tissue", "TISSUE", 224, 241], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 262, 275], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 287, 300], ["centrilobular", "MULTI-TISSUE_STRUCTURE", 368, 381], ["Similar spaceoccupying lesions", "PROBLEM", 0, 30], ["conventional connective tissue", "PROBLEM", 211, 241], ["fibrosis", "PROBLEM", 327, 335], ["centrilobular injury", "PROBLEM", 368, 388], ["spaceoccupying", "OBSERVATION_MODIFIER", 8, 22], ["lesions", "OBSERVATION", 23, 30], ["vena cava", "ANATOMY", 48, 57], ["diaphragm", "ANATOMY", 65, 74], ["mediastinum", "ANATOMY", 78, 89], ["hepatic", "ANATOMY", 106, 113], ["outflow", "ANATOMY_MODIFIER", 114, 121], ["systemic venous", "ANATOMY", 134, 149], ["return", "OBSERVATION", 150, 156], ["hepatic vessels", "ANATOMY", 166, 181], ["amount", "OBSERVATION_MODIFIER", 185, 191], ["connective tissue", "OBSERVATION", 224, 241], ["terminal", "ANATOMY_MODIFIER", 253, 261], ["hepatic veins", "ANATOMY", 262, 275], ["larger", "OBSERVATION_MODIFIER", 280, 286], ["hepatic veins", "ANATOMY", 287, 300], ["patterns", "OBSERVATION_MODIFIER", 315, 323], ["fibrosis", "OBSERVATION", 327, 335], ["various", "OBSERVATION_MODIFIER", 348, 355], ["patterns", "OBSERVATION_MODIFIER", 356, 364], ["centrilobular", "OBSERVATION_MODIFIER", 368, 381], ["injury", "OBSERVATION", 382, 388]]], ["Hypoxia from anemia, heart failure, or shock can cause centrilobular necrosis, as can many toxic agents that are preferentially injurious to zone 3 hepatocytes.", [["heart", "ANATOMY", 21, 26], ["centrilobular", "ANATOMY", 55, 68], ["zone 3 hepatocytes", "ANATOMY", 141, 159], ["Hypoxia", "DISEASE", 0, 7], ["anemia", "DISEASE", 13, 19], ["heart failure", "DISEASE", 21, 34], ["shock", "DISEASE", 39, 44], ["necrosis", "DISEASE", 69, 77], ["heart", "ORGAN", 21, 26], ["hepatocytes", "CELL", 148, 159], ["zone 3 hepatocytes", "CELL_TYPE", 141, 159], ["Hypoxia", "PROBLEM", 0, 7], ["anemia", "PROBLEM", 13, 19], ["heart failure", "PROBLEM", 21, 34], ["shock", "PROBLEM", 39, 44], ["centrilobular necrosis", "PROBLEM", 55, 77], ["anemia", "OBSERVATION", 13, 19], ["heart", "ANATOMY", 21, 26], ["failure", "OBSERVATION", 27, 34], ["centrilobular", "OBSERVATION_MODIFIER", 55, 68], ["necrosis", "OBSERVATION", 69, 77], ["hepatocytes", "ANATOMY", 148, 159]]], ["Necrosis at this level elicits a tissue repair response involving the fibrous connective tissue along the terminal hepatic venules.", [["tissue", "ANATOMY", 33, 39], ["fibrous connective tissue", "ANATOMY", 70, 95], ["terminal hepatic venules", "ANATOMY", 106, 130], ["Necrosis", "DISEASE", 0, 8], ["tissue", "TISSUE", 33, 39], ["fibrous connective tissue", "TISSUE", 70, 95], ["hepatic venules", "MULTI-TISSUE_STRUCTURE", 115, 130], ["terminal hepatic venules", "CELL_TYPE", 106, 130], ["Necrosis", "PROBLEM", 0, 8], ["a tissue repair", "TREATMENT", 31, 46], ["the fibrous connective tissue", "PROBLEM", 66, 95], ["tissue repair", "OBSERVATION", 33, 46], ["response", "OBSERVATION_MODIFIER", 47, 55], ["fibrous", "OBSERVATION_MODIFIER", 70, 77], ["connective tissue", "OBSERVATION", 78, 95], ["terminal", "ANATOMY_MODIFIER", 106, 114], ["hepatic", "ANATOMY", 115, 122], ["venules", "ANATOMY_MODIFIER", 123, 130]]], ["Tissue fibrosis can increase the resistance of the hepatic parenchyma and slow local outflow.", [["Tissue", "ANATOMY", 0, 6], ["hepatic parenchyma", "ANATOMY", 51, 69], ["fibrosis", "DISEASE", 7, 15], ["Tissue", "TISSUE", 0, 6], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 51, 69], ["Tissue fibrosis", "PROBLEM", 0, 15], ["the resistance of the hepatic parenchyma", "PROBLEM", 29, 69], ["slow local outflow", "PROBLEM", 74, 92], ["fibrosis", "OBSERVATION", 7, 15], ["resistance", "OBSERVATION_MODIFIER", 33, 43], ["hepatic", "ANATOMY", 51, 58], ["parenchyma", "ANATOMY_MODIFIER", 59, 69], ["slow", "OBSERVATION_MODIFIER", 74, 78], ["local", "OBSERVATION_MODIFIER", 79, 84], ["outflow", "OBSERVATION_MODIFIER", 85, 92]]], ["This can redirect sinusoidal blood to alternative less-affected venules, unless the necrosis is extensive.", [["sinusoidal blood", "ANATOMY", 18, 34], ["venules", "ANATOMY", 64, 71], ["necrosis", "DISEASE", 84, 92], ["blood", "ORGANISM_SUBSTANCE", 29, 34], ["venules", "MULTI-TISSUE_STRUCTURE", 64, 71], ["affected venules", "PROBLEM", 55, 71], ["the necrosis", "PROBLEM", 80, 92], ["affected", "OBSERVATION_MODIFIER", 55, 63], ["venules", "ANATOMY", 64, 71], ["necrosis", "OBSERVATION", 84, 92], ["extensive", "OBSERVATION_MODIFIER", 96, 105]]], ["Hepatic veno-occlusive disease is the obliteration of small intrahepatic veins that may begin with damage to the sinusoidal endothelium, accumulation of red cells and fibrin in the subintimal space, and subsequent subendothelial fibrosis.", [["Hepatic", "ANATOMY", 0, 7], ["intrahepatic veins", "ANATOMY", 60, 78], ["sinusoidal endothelium", "ANATOMY", 113, 135], ["red cells", "ANATOMY", 153, 162], ["fibrin", "ANATOMY", 167, 173], ["subintimal space", "ANATOMY", 181, 197], ["subendothelial", "ANATOMY", 214, 228], ["Hepatic veno-occlusive disease", "DISEASE", 0, 30], ["fibrosis", "DISEASE", 229, 237], ["intrahepatic veins", "MULTI-TISSUE_STRUCTURE", 60, 78], ["sinusoidal endothelium", "TISSUE", 113, 135], ["red cells", "CELL", 153, 162], ["fibrin", "GENE_OR_GENE_PRODUCT", 167, 173], ["subintimal space", "CELLULAR_COMPONENT", 181, 197], ["subendothelial", "TISSUE", 214, 228], ["red cells", "CELL_TYPE", 153, 162], ["fibrin", "PROTEIN", 167, 173], ["Hepatic veno-occlusive disease", "PROBLEM", 0, 30], ["the obliteration of small intrahepatic veins", "PROBLEM", 34, 78], ["damage to the sinusoidal endothelium", "PROBLEM", 99, 135], ["red cells", "PROBLEM", 153, 162], ["fibrin in the subintimal space", "PROBLEM", 167, 197], ["subsequent subendothelial fibrosis", "PROBLEM", 203, 237], ["veno-occlusive", "OBSERVATION", 8, 22], ["obliteration", "OBSERVATION", 38, 50], ["small", "OBSERVATION_MODIFIER", 54, 59], ["intrahepatic veins", "ANATOMY", 60, 78], ["sinusoidal endothelium", "OBSERVATION", 113, 135], ["accumulation", "OBSERVATION_MODIFIER", 137, 149], ["red cells", "OBSERVATION", 153, 162], ["fibrin", "OBSERVATION_MODIFIER", 167, 173], ["subintimal", "ANATOMY_MODIFIER", 181, 191], ["subendothelial", "OBSERVATION_MODIFIER", 214, 228], ["fibrosis", "OBSERVATION", 229, 237]]], ["This pattern of postnecrotic fibrosis can contribute to the development of portal hypertension.", [["portal", "ANATOMY", 75, 81], ["fibrosis", "DISEASE", 29, 37], ["portal hypertension", "DISEASE", 75, 94], ["portal", "MULTI-TISSUE_STRUCTURE", 75, 81], ["postnecrotic fibrosis", "PROBLEM", 16, 37], ["portal hypertension", "PROBLEM", 75, 94], ["postnecrotic", "OBSERVATION_MODIFIER", 16, 28], ["fibrosis", "OBSERVATION", 29, 37], ["portal", "ANATOMY", 75, 81], ["hypertension", "OBSERVATION", 82, 94]]], ["Veno-occlusive disease is a feature of pyrrolizidine toxicosis in humans ingesting these alkaloids in so-called bush tea.", [["tea", "ANATOMY", 117, 120], ["Veno-occlusive disease", "DISEASE", 0, 22], ["pyrrolizidine toxicosis", "DISEASE", 39, 62], ["pyrrolizidine", "CHEMICAL", 39, 52], ["pyrrolizidine", "SIMPLE_CHEMICAL", 39, 52], ["humans", "ORGANISM", 66, 72], ["tea", "ORGANISM_SUBDIVISION", 117, 120], ["humans", "SPECIES", 66, 72], ["humans", "SPECIES", 66, 72], ["Veno-occlusive disease", "PROBLEM", 0, 22], ["pyrrolizidine toxicosis", "PROBLEM", 39, 62], ["disease", "OBSERVATION", 15, 22], ["pyrrolizidine toxicosis", "OBSERVATION", 39, 62]]], ["In domestic animals, occlusive changes in terminal venules are notable in poisoning by ragwort (Senecio jacobea) in cattle and also in dogs treated experimentally with the pyrrolizidine alkaloid monocrotaline.", [["occlusive", "ANATOMY", 21, 30], ["terminal venules", "ANATOMY", 42, 58], ["poisoning", "DISEASE", 74, 83], ["pyrrolizidine alkaloid", "CHEMICAL", 172, 194], ["monocrotaline", "CHEMICAL", 195, 208], ["pyrrolizidine alkaloid", "CHEMICAL", 172, 194], ["monocrotaline", "CHEMICAL", 195, 208], ["terminal venules", "MULTI-TISSUE_STRUCTURE", 42, 58], ["Senecio jacobea", "ORGANISM", 96, 111], ["cattle", "ORGANISM", 116, 122], ["dogs", "ORGANISM", 135, 139], ["pyrrolizidine alkaloid", "SIMPLE_CHEMICAL", 172, 194], ["monocrotaline", "SIMPLE_CHEMICAL", 195, 208], ["Senecio jacobea", "SPECIES", 96, 111], ["cattle", "SPECIES", 116, 122], ["dogs", "SPECIES", 135, 139], ["Senecio jacobea", "SPECIES", 96, 111], ["cattle", "SPECIES", 116, 122], ["occlusive changes in terminal venules", "PROBLEM", 21, 58], ["the pyrrolizidine alkaloid monocrotaline", "TREATMENT", 168, 208], ["occlusive", "OBSERVATION", 21, 30], ["terminal", "ANATOMY_MODIFIER", 42, 50], ["venules", "ANATOMY", 51, 58], ["pyrrolizidine", "OBSERVATION", 172, 185], ["alkaloid monocrotaline", "OBSERVATION", 186, 208]]], ["Veno-occlusive disease has also been reported as a consequence of prolonged chemotherapy, radiotherapy, and bone marrow transplantation in humans, and similarly in dogs treated with irradiation or busulfan.", [["bone marrow", "ANATOMY", 108, 119], ["Veno-occlusive disease", "DISEASE", 0, 22], ["busulfan", "CHEMICAL", 197, 205], ["busulfan", "CHEMICAL", 197, 205], ["bone marrow", "MULTI-TISSUE_STRUCTURE", 108, 119], ["humans", "ORGANISM", 139, 145], ["dogs", "ORGANISM", 164, 168], ["busulfan", "SIMPLE_CHEMICAL", 197, 205], ["humans", "SPECIES", 139, 145], ["dogs", "SPECIES", 164, 168], ["humans", "SPECIES", 139, 145], ["Veno-occlusive disease", "PROBLEM", 0, 22], ["prolonged chemotherapy", "TREATMENT", 66, 88], ["radiotherapy", "TREATMENT", 90, 102], ["bone marrow transplantation", "TREATMENT", 108, 135], ["irradiation", "TREATMENT", 182, 193], ["busulfan", "TREATMENT", 197, 205], ["disease", "OBSERVATION", 15, 22], ["prolonged", "OBSERVATION_MODIFIER", 66, 75], ["chemotherapy", "OBSERVATION", 76, 88], ["bone", "ANATOMY", 108, 112], ["marrow transplantation", "OBSERVATION", 113, 135]]], ["Idiopathic veno-occlusive disease with perivenular fibrosis around central and sublobular veins, causing Budd-Chiari-like syndrome (see later), has also been reported as a rare occurrence in the dog and cat.", [["veno-occlusive", "ANATOMY", 11, 25], ["perivenular", "ANATOMY", 39, 50], ["sublobular veins", "ANATOMY", 79, 95], ["Idiopathic veno-occlusive disease", "DISEASE", 0, 33], ["fibrosis", "DISEASE", 51, 59], ["Budd-Chiari-like syndrome", "DISEASE", 105, 130], ["sublobular veins", "MULTI-TISSUE_STRUCTURE", 79, 95], ["dog", "ORGANISM", 195, 198], ["cat", "ORGANISM", 203, 206], ["dog", "SPECIES", 195, 198], ["cat", "SPECIES", 203, 206], ["Idiopathic veno-occlusive disease", "PROBLEM", 0, 33], ["perivenular fibrosis", "PROBLEM", 39, 59], ["central and sublobular veins", "PROBLEM", 67, 95], ["Budd-Chiari-like syndrome", "PROBLEM", 105, 130], ["veno-occlusive", "OBSERVATION", 11, 25], ["perivenular", "ANATOMY_MODIFIER", 39, 50], ["fibrosis", "OBSERVATION", 51, 59], ["central", "ANATOMY_MODIFIER", 67, 74], ["sublobular veins", "ANATOMY", 79, 95], ["Chiari", "OBSERVATION", 110, 116]]], ["Total or subtotal obliteration of central hepatic or sublobular veins by subintimal accumulation of collagen and fibrous tissue has also been reported in captive snow leopards and cheetahs.Efferent hepatic vesselsPassive congestion of the liver develops when the blood pressure in the hepatic veins increases relative to that of the hepatic portal veins and can occur in any species.", [["hepatic", "ANATOMY", 42, 49], ["sublobular veins", "ANATOMY", 53, 69], ["subintimal", "ANATOMY", 73, 83], ["fibrous tissue", "ANATOMY", 113, 127], ["Efferent hepatic vessels", "ANATOMY", 189, 213], ["liver", "ANATOMY", 239, 244], ["blood", "ANATOMY", 263, 268], ["hepatic veins", "ANATOMY", 285, 298], ["hepatic portal veins", "ANATOMY", 333, 353], ["congestion of the liver", "DISEASE", 221, 244], ["hepatic", "MULTI-TISSUE_STRUCTURE", 42, 49], ["sublobular veins", "MULTI-TISSUE_STRUCTURE", 53, 69], ["subintimal", "IMMATERIAL_ANATOMICAL_ENTITY", 73, 83], ["collagen", "GENE_OR_GENE_PRODUCT", 100, 108], ["fibrous tissue", "TISSUE", 113, 127], ["Efferent hepatic vessels", "MULTI-TISSUE_STRUCTURE", 189, 213], ["liver", "ORGAN", 239, 244], ["blood", "ORGANISM_SUBSTANCE", 263, 268], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 285, 298], ["hepatic portal veins", "MULTI-TISSUE_STRUCTURE", 333, 353], ["collagen", "PROTEIN", 100, 108], ["captive snow leopards", "SPECIES", 154, 175], ["subtotal obliteration of central hepatic or sublobular veins", "PROBLEM", 9, 69], ["subintimal accumulation of collagen and fibrous tissue", "PROBLEM", 73, 127], ["Passive congestion of the liver", "PROBLEM", 213, 244], ["the blood pressure", "TEST", 259, 277], ["subtotal", "OBSERVATION_MODIFIER", 9, 17], ["obliteration", "OBSERVATION", 18, 30], ["central", "ANATOMY_MODIFIER", 34, 41], ["hepatic", "ANATOMY", 42, 49], ["sublobular veins", "ANATOMY", 53, 69], ["subintimal", "OBSERVATION_MODIFIER", 73, 83], ["accumulation", "OBSERVATION", 84, 96], ["collagen", "OBSERVATION", 100, 108], ["fibrous tissue", "OBSERVATION", 113, 127], ["captive", "OBSERVATION_MODIFIER", 154, 161], ["snow leopards", "OBSERVATION", 162, 175], ["hepatic vessels", "ANATOMY", 198, 213], ["congestion", "OBSERVATION", 221, 231], ["liver", "ANATOMY", 239, 244], ["pressure", "OBSERVATION_MODIFIER", 269, 277], ["hepatic veins", "ANATOMY", 285, 298], ["hepatic", "ANATOMY", 333, 340], ["portal veins", "ANATOMY", 341, 353]]], ["It is almost always the consequence of cardiac dysfunction, including acute and chronic heart failure, pericardial disease, and processes or be associated with states of hypercoagulability or retrograde intravascular growth of hepatic neoplasms.", [["cardiac", "ANATOMY", 39, 46], ["heart", "ANATOMY", 88, 93], ["pericardial", "ANATOMY", 103, 114], ["intravascular", "ANATOMY", 203, 216], ["hepatic neoplasms", "ANATOMY", 227, 244], ["cardiac dysfunction", "DISEASE", 39, 58], ["heart failure", "DISEASE", 88, 101], ["pericardial disease", "DISEASE", 103, 122], ["hypercoagulability", "DISEASE", 170, 188], ["hepatic neoplasms", "DISEASE", 227, 244], ["cardiac", "ORGAN", 39, 46], ["heart", "ORGAN", 88, 93], ["pericardial", "ORGAN", 103, 114], ["retrograde", "IMMATERIAL_ANATOMICAL_ENTITY", 192, 202], ["intravascular", "IMMATERIAL_ANATOMICAL_ENTITY", 203, 216], ["hepatic neoplasms", "CANCER", 227, 244], ["cardiac dysfunction", "PROBLEM", 39, 58], ["acute and chronic heart failure", "PROBLEM", 70, 101], ["pericardial disease", "PROBLEM", 103, 122], ["hypercoagulability", "PROBLEM", 170, 188], ["retrograde intravascular growth of hepatic neoplasms", "PROBLEM", 192, 244], ["cardiac", "ANATOMY", 39, 46], ["dysfunction", "OBSERVATION", 47, 58], ["acute", "OBSERVATION_MODIFIER", 70, 75], ["chronic", "OBSERVATION_MODIFIER", 80, 87], ["heart", "ANATOMY", 88, 93], ["failure", "OBSERVATION", 94, 101], ["pericardial", "ANATOMY", 103, 114], ["disease", "OBSERVATION", 115, 122], ["hypercoagulability", "OBSERVATION", 170, 188], ["retrograde", "OBSERVATION_MODIFIER", 192, 202], ["intravascular", "OBSERVATION_MODIFIER", 203, 216], ["growth", "OBSERVATION_MODIFIER", 217, 223], ["hepatic", "ANATOMY", 227, 234], ["neoplasms", "OBSERVATION", 235, 244]]], ["In dogs, thrombosis of the portal vein has been associated with distant neoplasia, immune-mediated hemolytic anemia, protein-losing nephropathy and enteropathy, pancreatitis, peritonitis, and corticosteroid administration (Fig. 2-49) .", [["portal vein", "ANATOMY", 27, 38], ["neoplasia", "ANATOMY", 72, 81], ["thrombosis", "DISEASE", 9, 19], ["neoplasia", "DISEASE", 72, 81], ["hemolytic anemia", "DISEASE", 99, 115], ["protein-losing nephropathy", "DISEASE", 117, 143], ["enteropathy", "DISEASE", 148, 159], ["pancreatitis", "DISEASE", 161, 173], ["peritonitis", "DISEASE", 175, 186], ["dogs", "ORGANISM", 3, 7], ["portal vein", "MULTI-TISSUE_STRUCTURE", 27, 38], ["neoplasia", "CANCER", 72, 81], ["corticosteroid", "SIMPLE_CHEMICAL", 192, 206], ["dogs", "SPECIES", 3, 7], ["thrombosis of the portal vein", "PROBLEM", 9, 38], ["distant neoplasia", "PROBLEM", 64, 81], ["immune-mediated hemolytic anemia", "PROBLEM", 83, 115], ["protein-losing nephropathy", "PROBLEM", 117, 143], ["enteropathy", "PROBLEM", 148, 159], ["pancreatitis", "PROBLEM", 161, 173], ["peritonitis", "PROBLEM", 175, 186], ["corticosteroid administration", "TREATMENT", 192, 221], ["dogs", "OBSERVATION", 3, 7], ["thrombosis", "OBSERVATION", 9, 19], ["portal vein", "ANATOMY", 27, 38], ["associated with", "UNCERTAINTY", 48, 63], ["distant", "OBSERVATION_MODIFIER", 64, 71], ["neoplasia", "OBSERVATION", 72, 81], ["hemolytic", "OBSERVATION_MODIFIER", 99, 108], ["anemia", "OBSERVATION", 109, 115], ["losing nephropathy", "OBSERVATION", 125, 143], ["enteropathy", "OBSERVATION", 148, 159], ["pancreatitis", "OBSERVATION", 161, 173], ["peritonitis", "OBSERVATION", 175, 186]]], ["Portal vein obstructions of slow development are expected to lead to portal hypertension and its consequences.", [["Portal vein", "ANATOMY", 0, 11], ["portal", "ANATOMY", 69, 75], ["Portal vein obstructions", "DISEASE", 0, 24], ["hypertension", "DISEASE", 76, 88], ["Portal vein", "MULTI-TISSUE_STRUCTURE", 0, 11], ["portal", "MULTI-TISSUE_STRUCTURE", 69, 75], ["Portal vein obstructions", "PROBLEM", 0, 24], ["slow development", "PROBLEM", 28, 44], ["portal hypertension", "PROBLEM", 69, 88], ["vein", "ANATOMY", 7, 11], ["obstructions", "OBSERVATION", 12, 24], ["slow", "OBSERVATION_MODIFIER", 28, 32], ["portal", "ANATOMY", 69, 75], ["hypertension", "OBSERVATION", 76, 88]]], ["Atresia or hypoplasia of the extrahepatic portal vein can be demonstrated in some cases of primary portal vein hypoplasia and is discussed previously in the section on Developmental disorders.Efferent hepatic vesselsObstruction of intrahepatic portal vessels is a consequence of progressive fibrosing lesions of primary hepatic disease centered on the portal triads.", [["extrahepatic portal vein", "ANATOMY", 29, 53], ["primary portal vein", "ANATOMY", 91, 110], ["hepatic", "ANATOMY", 201, 208], ["intrahepatic portal vessels", "ANATOMY", 231, 258], ["fibrosing lesions", "ANATOMY", 291, 308], ["hepatic", "ANATOMY", 320, 327], ["portal triads", "ANATOMY", 352, 365], ["Atresia", "DISEASE", 0, 7], ["hypoplasia of the extrahepatic portal vein", "DISEASE", 11, 53], ["primary portal vein hypoplasia", "DISEASE", 91, 121], ["Developmental disorders", "DISEASE", 168, 191], ["primary hepatic disease", "DISEASE", 312, 335], ["extrahepatic portal vein", "MULTI-TISSUE_STRUCTURE", 29, 53], ["portal vein", "MULTI-TISSUE_STRUCTURE", 99, 110], ["Efferent hepatic", "MULTI-TISSUE_STRUCTURE", 192, 208], ["intrahepatic portal vessels", "MULTI-TISSUE_STRUCTURE", 231, 258], ["fibrosing lesions", "PATHOLOGICAL_FORMATION", 291, 308], ["hepatic", "ORGAN", 320, 327], ["portal triads", "MULTI-TISSUE_STRUCTURE", 352, 365], ["Atresia", "PROBLEM", 0, 7], ["hypoplasia of the extrahepatic portal vein", "PROBLEM", 11, 53], ["primary portal vein hypoplasia", "PROBLEM", 91, 121], ["Developmental disorders", "PROBLEM", 168, 191], ["Efferent hepatic vesselsObstruction of intrahepatic portal vessels", "PROBLEM", 192, 258], ["progressive fibrosing lesions", "PROBLEM", 279, 308], ["primary hepatic disease", "PROBLEM", 312, 335], ["hypoplasia", "OBSERVATION", 11, 21], ["extrahepatic", "ANATOMY_MODIFIER", 29, 41], ["portal vein", "ANATOMY", 42, 53], ["primary", "OBSERVATION_MODIFIER", 91, 98], ["portal vein", "ANATOMY", 99, 110], ["hypoplasia", "OBSERVATION", 111, 121], ["hepatic", "ANATOMY", 201, 208], ["vesselsObstruction", "OBSERVATION", 209, 227], ["intrahepatic", "ANATOMY_MODIFIER", 231, 243], ["portal vessels", "ANATOMY", 244, 258], ["progressive", "OBSERVATION_MODIFIER", 279, 290], ["fibrosing", "OBSERVATION_MODIFIER", 291, 300], ["lesions", "OBSERVATION", 301, 308], ["primary", "OBSERVATION_MODIFIER", 312, 319], ["hepatic", "ANATOMY", 320, 327], ["disease", "OBSERVATION", 328, 335], ["portal triads", "ANATOMY", 352, 365]]], ["The small portal vessels may be obliterated in the proliferative portal lesions, and new connections may be established, including small functional arteriovenous communications.", [["small portal vessels", "ANATOMY", 4, 24], ["proliferative portal lesions", "ANATOMY", 51, 79], ["arteriovenous", "ANATOMY", 148, 161], ["portal vessels", "MULTI-TISSUE_STRUCTURE", 10, 24], ["portal lesions", "PATHOLOGICAL_FORMATION", 65, 79], ["arteriovenous", "MULTI-TISSUE_STRUCTURE", 148, 161], ["the proliferative portal lesions", "PROBLEM", 47, 79], ["small functional arteriovenous communications", "PROBLEM", 131, 176], ["small", "OBSERVATION_MODIFIER", 4, 9], ["portal vessels", "ANATOMY", 10, 24], ["may be", "UNCERTAINTY", 25, 31], ["obliterated", "OBSERVATION", 32, 43], ["proliferative", "OBSERVATION_MODIFIER", 51, 64], ["portal", "ANATOMY", 65, 71], ["lesions", "OBSERVATION", 72, 79], ["new", "OBSERVATION_MODIFIER", 85, 88], ["small", "OBSERVATION_MODIFIER", 131, 136], ["functional", "OBSERVATION_MODIFIER", 137, 147], ["arteriovenous communications", "OBSERVATION", 148, 176]]], ["Regenerative hepatic nodules and neoplasms may deform and compress portal vessels in some locations.Efferent hepatic vesselsPortal hypertension is defined as increased blood pressure within the portal vein caused by resistance to normal flow rates.", [["hepatic nodules", "ANATOMY", 13, 28], ["neoplasms", "ANATOMY", 33, 42], ["portal vessels", "ANATOMY", 67, 81], ["Efferent hepatic vessels", "ANATOMY", 100, 124], ["blood", "ANATOMY", 168, 173], ["portal vein", "ANATOMY", 194, 205], ["neoplasms", "DISEASE", 33, 42], ["Portal hypertension", "DISEASE", 124, 143], ["hepatic nodules", "CANCER", 13, 28], ["neoplasms", "CANCER", 33, 42], ["portal vessels", "MULTI-TISSUE_STRUCTURE", 67, 81], ["Efferent hepatic vessels", "MULTI-TISSUE_STRUCTURE", 100, 124], ["Portal", "MULTI-TISSUE_STRUCTURE", 124, 130], ["blood", "ORGANISM_SUBSTANCE", 168, 173], ["portal vein", "MULTI-TISSUE_STRUCTURE", 194, 205], ["Regenerative hepatic nodules", "PROBLEM", 0, 28], ["neoplasms", "PROBLEM", 33, 42], ["Portal hypertension", "PROBLEM", 124, 143], ["increased blood pressure within the portal vein", "PROBLEM", 158, 205], ["hepatic", "ANATOMY", 13, 20], ["nodules", "OBSERVATION", 21, 28], ["neoplasms", "OBSERVATION", 33, 42], ["portal vessels", "ANATOMY", 67, 81], ["hepatic vessels", "ANATOMY", 109, 124], ["hypertension", "OBSERVATION", 131, 143], ["increased", "OBSERVATION_MODIFIER", 158, 167], ["blood pressure", "OBSERVATION", 168, 182], ["portal vein", "ANATOMY", 194, 205], ["resistance", "OBSERVATION", 216, 226], ["normal flow rates", "OBSERVATION", 230, 247]]], ["Portal hypertension can arise from disturbances of venous blood flow in any of the following 3 sites: prehepatic, intrahepatic, and posthepatic.Efferent hepatic vesselsPrehepatic portal hypertension is relatively uncommon and occurs when blood flow through the portal vein is impaired before it enters the liver.", [["Portal", "ANATOMY", 0, 6], ["venous blood", "ANATOMY", 51, 63], ["sites", "ANATOMY", 95, 100], ["prehepatic", "ANATOMY", 102, 112], ["intrahepatic", "ANATOMY", 114, 126], ["Efferent hepatic vessels", "ANATOMY", 144, 168], ["Prehepatic portal", "ANATOMY", 168, 185], ["blood", "ANATOMY", 238, 243], ["portal vein", "ANATOMY", 261, 272], ["liver", "ANATOMY", 306, 311], ["Portal hypertension", "DISEASE", 0, 19], ["disturbances of venous blood flow", "DISEASE", 35, 68], ["hypertension", "DISEASE", 186, 198], ["Portal", "MULTI-TISSUE_STRUCTURE", 0, 6], ["venous", "MULTI-TISSUE_STRUCTURE", 51, 57], ["blood", "ORGANISM_SUBSTANCE", 58, 63], ["Efferent hepatic vessels", "MULTI-TISSUE_STRUCTURE", 144, 168], ["Prehepatic portal", "MULTI-TISSUE_STRUCTURE", 168, 185], ["blood", "ORGANISM_SUBSTANCE", 238, 243], ["portal vein", "MULTI-TISSUE_STRUCTURE", 261, 272], ["liver", "ORGAN", 306, 311], ["Portal hypertension", "PROBLEM", 0, 19], ["venous blood flow", "TEST", 51, 68], ["prehepatic, intrahepatic, and posthepatic", "PROBLEM", 102, 143], ["Prehepatic portal hypertension", "PROBLEM", 168, 198], ["blood flow", "TEST", 238, 248], ["hypertension", "OBSERVATION", 7, 19], ["venous", "ANATOMY", 51, 57], ["blood flow", "OBSERVATION", 58, 68], ["prehepatic", "ANATOMY", 102, 112], ["intrahepatic", "ANATOMY", 114, 126], ["posthepatic", "ANATOMY_MODIFIER", 132, 143], ["hepatic vessels", "ANATOMY", 153, 168], ["portal", "ANATOMY", 179, 185], ["hypertension", "OBSERVATION", 186, 198], ["relatively", "OBSERVATION_MODIFIER", 202, 212], ["uncommon", "OBSERVATION", 213, 221], ["portal vein", "ANATOMY", 261, 272], ["impaired", "OBSERVATION", 276, 284], ["liver", "ANATOMY", 306, 311]]], ["The most common cause is portal vein thrombosis.", [["portal vein", "ANATOMY", 25, 36], ["portal vein thrombosis", "DISEASE", 25, 47], ["portal vein", "MULTI-TISSUE_STRUCTURE", 25, 36], ["portal vein thrombosis", "PROBLEM", 25, 47], ["most common", "OBSERVATION_MODIFIER", 4, 15], ["portal vein", "ANATOMY", 25, 36], ["thrombosis", "OBSERVATION", 37, 47]]], ["Intrahepatic portal hypertension arises from increased resistance to blood flow at the level of the hepatic parenchyma.", [["Intrahepatic portal", "ANATOMY", 0, 19], ["blood", "ANATOMY", 69, 74], ["hepatic parenchyma", "ANATOMY", 100, 118], ["Intrahepatic portal hypertension", "DISEASE", 0, 32], ["Intrahepatic portal", "MULTI-TISSUE_STRUCTURE", 0, 19], ["blood", "ORGANISM_SUBSTANCE", 69, 74], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 100, 118], ["Intrahepatic portal hypertension", "PROBLEM", 0, 32], ["increased resistance", "PROBLEM", 45, 65], ["blood flow", "TEST", 69, 79], ["portal", "ANATOMY", 13, 19], ["hypertension", "OBSERVATION", 20, 32], ["increased", "OBSERVATION_MODIFIER", 45, 54], ["resistance", "OBSERVATION", 55, 65], ["blood flow", "OBSERVATION", 69, 79], ["hepatic", "ANATOMY", 100, 107], ["parenchyma", "ANATOMY_MODIFIER", 108, 118]]], ["Intrahepatic portal hypertension can be subdivided into 3 forms: presinusoidal (including intrahepatic portal vein hypoplasia, intrahepatic arterioportal fistulae, periportal neoplastic or inflammatory infiltrates, and periportal fibrosis), sinusoidal (cirrhosis or long-term inflammatory disease with fibrosis and capillarization of sinusoids, amyloidosis, neoplastic infiltrations), and postsinusoidal (perivenular fibrosis, venoocclusive disease).Efferent hepatic vesselsPosthepatic causes of portal hypertension are uncommon, but can result from increased resistance to blood flow in the major hepatic veins, caudal vena cava, or right heart.", [["Intrahepatic portal", "ANATOMY", 0, 19], ["presinusoidal", "ANATOMY", 65, 78], ["intrahepatic portal vein", "ANATOMY", 90, 114], ["intrahepatic arterioportal fistulae", "ANATOMY", 127, 162], ["periportal neoplastic", "ANATOMY", 164, 185], ["inflammatory infiltrates", "ANATOMY", 189, 213], ["periportal", "ANATOMY", 219, 229], ["sinusoidal", "ANATOMY", 241, 251], ["sinusoids", "ANATOMY", 334, 343], ["neoplastic", "ANATOMY", 358, 368], ["perivenular", "ANATOMY", 405, 416], ["Efferent hepatic vessels", "ANATOMY", 450, 474], ["portal", "ANATOMY", 496, 502], ["blood", "ANATOMY", 574, 579], ["hepatic veins", "ANATOMY", 598, 611], ["caudal vena cava", "ANATOMY", 613, 629], ["right heart", "ANATOMY", 634, 645], ["Intrahepatic portal hypertension", "DISEASE", 0, 32], ["intrahepatic portal vein hypoplasia", "DISEASE", 90, 125], ["intrahepatic arterioportal fistulae", "DISEASE", 127, 162], ["fibrosis", "DISEASE", 230, 238], ["cirrhosis", "DISEASE", 253, 262], ["fibrosis", "DISEASE", 302, 310], ["amyloidosis", "DISEASE", 345, 356], ["fibrosis", "DISEASE", 417, 425], ["venoocclusive disease", "DISEASE", 427, 448], ["portal hypertension", "DISEASE", 496, 515], ["Intrahepatic portal", "MULTI-TISSUE_STRUCTURE", 0, 19], ["intrahepatic portal vein", "MULTI-TISSUE_STRUCTURE", 90, 114], ["intrahepatic arterioportal fistulae", "PATHOLOGICAL_FORMATION", 127, 162], ["sinusoids", "TISSUE", 334, 343], ["Efferent hepatic vessels", "MULTI-TISSUE_STRUCTURE", 450, 474], ["portal", "MULTI-TISSUE_STRUCTURE", 496, 502], ["blood", "ORGANISM_SUBSTANCE", 574, 579], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 598, 611], ["caudal vena cava", "MULTI-TISSUE_STRUCTURE", 613, 629], ["heart", "ORGAN", 640, 645], ["Intrahepatic portal hypertension", "PROBLEM", 0, 32], ["presinusoidal (including intrahepatic portal vein hypoplasia", "PROBLEM", 65, 125], ["intrahepatic arterioportal fistulae", "PROBLEM", 127, 162], ["periportal neoplastic", "PROBLEM", 164, 185], ["inflammatory infiltrates", "PROBLEM", 189, 213], ["periportal fibrosis", "PROBLEM", 219, 238], ["sinusoidal (cirrhosis", "PROBLEM", 241, 262], ["long-term inflammatory disease", "PROBLEM", 266, 296], ["fibrosis", "PROBLEM", 302, 310], ["capillarization of sinusoids", "PROBLEM", 315, 343], ["amyloidosis", "PROBLEM", 345, 356], ["neoplastic infiltrations)", "PROBLEM", 358, 383], ["postsinusoidal (perivenular fibrosis", "PROBLEM", 389, 425], ["venoocclusive disease)", "PROBLEM", 427, 449], ["portal hypertension", "PROBLEM", 496, 515], ["increased resistance", "PROBLEM", 550, 570], ["blood flow", "TEST", 574, 584], ["portal", "ANATOMY", 13, 19], ["hypertension", "OBSERVATION", 20, 32], ["intrahepatic", "ANATOMY_MODIFIER", 90, 102], ["portal vein", "ANATOMY", 103, 114], ["hypoplasia", "OBSERVATION", 115, 125], ["intrahepatic", "ANATOMY_MODIFIER", 127, 139], ["arterioportal", "ANATOMY", 140, 153], ["fistulae", "OBSERVATION", 154, 162], ["periportal", "ANATOMY", 164, 174], ["neoplastic", "OBSERVATION", 175, 185], ["inflammatory", "OBSERVATION_MODIFIER", 189, 201], ["infiltrates", "OBSERVATION", 202, 213], ["periportal", "ANATOMY_MODIFIER", 219, 229], ["fibrosis", "OBSERVATION", 230, 238], ["sinusoidal", "OBSERVATION_MODIFIER", 241, 251], ["cirrhosis", "OBSERVATION", 253, 262], ["long-term", "OBSERVATION_MODIFIER", 266, 275], ["inflammatory", "OBSERVATION_MODIFIER", 276, 288], ["disease", "OBSERVATION", 289, 296], ["fibrosis", "OBSERVATION", 302, 310], ["sinusoids", "ANATOMY", 334, 343], ["amyloidosis", "OBSERVATION", 345, 356], ["neoplastic infiltrations", "OBSERVATION", 358, 382], ["postsinusoidal", "ANATOMY_MODIFIER", 389, 403], ["perivenular", "OBSERVATION_MODIFIER", 405, 416], ["fibrosis", "OBSERVATION", 417, 425], ["venoocclusive disease", "OBSERVATION", 427, 448], ["hepatic vessels", "ANATOMY", 459, 474], ["portal", "ANATOMY", 496, 502], ["hypertension", "OBSERVATION", 503, 515], ["increased", "OBSERVATION_MODIFIER", 550, 559], ["resistance", "OBSERVATION", 560, 570], ["blood flow", "OBSERVATION", 574, 584], ["major", "ANATOMY_MODIFIER", 592, 597], ["hepatic veins", "ANATOMY", 598, 611], ["caudal vena cava", "ANATOMY", 613, 629], ["right", "ANATOMY_MODIFIER", 634, 639], ["heart", "ANATOMY", 640, 645]]], ["Causes include partial or complete thrombosis of the hepatic veins, which is very rare; obstruction of the hepatic veins by neoplastic occlusion (e.g., pheochromocytoma); and kinking of the caudal vena cava, associated with abdominal trauma.", [["hepatic veins", "ANATOMY", 53, 66], ["hepatic veins", "ANATOMY", 107, 120], ["neoplastic", "ANATOMY", 124, 134], ["pheochromocytoma", "ANATOMY", 152, 168], ["caudal vena cava", "ANATOMY", 190, 206], ["abdominal", "ANATOMY", 224, 233], ["thrombosis", "DISEASE", 35, 45], ["of the hepatic veins", "DISEASE", 46, 66], ["obstruction of the hepatic veins", "DISEASE", 88, 120], ["neoplastic occlusion", "DISEASE", 124, 144], ["pheochromocytoma", "DISEASE", 152, 168], ["kinking of the caudal vena cava", "DISEASE", 175, 206], ["abdominal trauma", "DISEASE", 224, 240], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 53, 66], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 107, 120], ["pheochromocytoma", "CANCER", 152, 168], ["caudal vena cava", "MULTI-TISSUE_STRUCTURE", 190, 206], ["abdominal", "ORGANISM_SUBDIVISION", 224, 233], ["partial or complete thrombosis of the hepatic veins", "PROBLEM", 15, 66], ["obstruction of the hepatic veins", "PROBLEM", 88, 120], ["neoplastic occlusion", "PROBLEM", 124, 144], ["pheochromocytoma", "PROBLEM", 152, 168], ["kinking of the caudal vena cava", "PROBLEM", 175, 206], ["abdominal trauma", "PROBLEM", 224, 240], ["partial", "OBSERVATION_MODIFIER", 15, 22], ["complete", "OBSERVATION_MODIFIER", 26, 34], ["thrombosis", "OBSERVATION", 35, 45], ["hepatic veins", "ANATOMY", 53, 66], ["very", "OBSERVATION_MODIFIER", 77, 81], ["rare", "OBSERVATION", 82, 86], ["obstruction", "OBSERVATION", 88, 99], ["hepatic veins", "ANATOMY", 107, 120], ["neoplastic", "OBSERVATION_MODIFIER", 124, 134], ["occlusion", "OBSERVATION", 135, 144], ["pheochromocytoma", "OBSERVATION", 152, 168], ["kinking", "OBSERVATION", 175, 182], ["caudal vena cava", "ANATOMY", 190, 206], ["abdominal", "ANATOMY", 224, 233], ["trauma", "OBSERVATION", 234, 240]]], ["Congestive heart failure can also lead to portal hypertension. congestion is still present, there is usually copious ascites at this stage.", [["heart", "ANATOMY", 11, 16], ["portal", "ANATOMY", 42, 48], ["ascites", "ANATOMY", 117, 124], ["Congestive heart failure", "DISEASE", 0, 24], ["hypertension", "DISEASE", 49, 61], ["congestion", "DISEASE", 63, 73], ["ascites", "DISEASE", 117, 124], ["heart", "ORGAN", 11, 16], ["portal", "MULTI-TISSUE_STRUCTURE", 42, 48], ["ascites", "CANCER", 117, 124], ["Congestive heart failure", "PROBLEM", 0, 24], ["portal hypertension", "PROBLEM", 42, 61], ["congestion", "PROBLEM", 63, 73], ["usually copious ascites", "PROBLEM", 101, 124], ["heart", "ANATOMY", 11, 16], ["failure", "OBSERVATION", 17, 24], ["portal", "ANATOMY", 42, 48], ["hypertension", "OBSERVATION", 49, 61], ["copious", "OBSERVATION_MODIFIER", 109, 116], ["ascites", "OBSERVATION", 117, 124]]], ["In species in which fibrosis is more pronounced, a chronically congested liver has a distinct reticulated acinar pattern, often more obvious beneath the capsule than in deeper parenchyma.", [["liver", "ANATOMY", 73, 78], ["acinar", "ANATOMY", 106, 112], ["capsule", "ANATOMY", 153, 160], ["parenchyma", "ANATOMY", 176, 186], ["fibrosis", "DISEASE", 20, 28], ["liver", "ORGAN", 73, 78], ["acinar", "CANCER", 106, 112], ["capsule", "CANCER", 153, 160], ["deeper parenchyma", "TISSUE", 169, 186], ["fibrosis", "PROBLEM", 20, 28], ["a chronically congested liver", "PROBLEM", 49, 78], ["a distinct reticulated acinar pattern", "PROBLEM", 83, 120], ["species", "OBSERVATION", 3, 10], ["fibrosis", "OBSERVATION", 20, 28], ["more pronounced", "OBSERVATION_MODIFIER", 32, 47], ["chronically", "OBSERVATION_MODIFIER", 51, 62], ["congested", "OBSERVATION", 63, 72], ["liver", "ANATOMY", 73, 78], ["distinct", "OBSERVATION_MODIFIER", 85, 93], ["reticulated", "OBSERVATION_MODIFIER", 94, 105], ["acinar pattern", "OBSERVATION", 106, 120], ["capsule", "OBSERVATION_MODIFIER", 153, 160], ["deeper", "ANATOMY_MODIFIER", 169, 175], ["parenchyma", "ANATOMY", 176, 186]]], ["This pattern is known as \"nutmeg liver\" and is the result of the contrast of red centrilobular zones of congestion with loss of hepatocytes, among pale swollen periportal parenchyma composed of viable hepatocytes that are fatty (eFig.", [["liver", "ANATOMY", 33, 38], ["red centrilobular zones", "ANATOMY", 77, 100], ["hepatocytes", "ANATOMY", 128, 139], ["periportal parenchyma", "ANATOMY", 160, 181], ["hepatocytes", "ANATOMY", 201, 212], ["congestion", "DISEASE", 104, 114], ["liver", "ORGAN", 33, 38], ["hepatocytes", "CELL", 128, 139], ["pale swollen periportal parenchyma", "TISSUE", 147, 181], ["hepatocytes", "CELL", 201, 212], ["hepatocytes", "CELL_TYPE", 128, 139], ["hepatocytes", "CELL_TYPE", 201, 212], ["red centrilobular zones of congestion", "PROBLEM", 77, 114], ["loss of hepatocytes", "PROBLEM", 120, 139], ["pale swollen periportal parenchyma", "PROBLEM", 147, 181], ["viable hepatocytes", "PROBLEM", 194, 212], ["fatty (eFig", "PROBLEM", 222, 233], ["liver", "ANATOMY", 33, 38], ["centrilobular", "OBSERVATION_MODIFIER", 81, 94], ["zones", "OBSERVATION_MODIFIER", 95, 100], ["congestion", "OBSERVATION", 104, 114], ["loss", "OBSERVATION_MODIFIER", 120, 124], ["hepatocytes", "ANATOMY", 128, 139], ["pale", "OBSERVATION_MODIFIER", 147, 151], ["swollen", "OBSERVATION", 152, 159], ["periportal", "ANATOMY_MODIFIER", 160, 170], ["parenchyma", "ANATOMY_MODIFIER", 171, 181], ["viable hepatocytes", "OBSERVATION", 194, 212], ["fatty", "OBSERVATION_MODIFIER", 222, 227]]], ["2-11B).", [["2-11B", "CHEMICAL", 0, 5]]], ["This classic pattern of chronic passive congestion is most obvious in ruminants and horses.", [["congestion", "DISEASE", 40, 50], ["horses", "ORGANISM_SUBDIVISION", 84, 90], ["ruminants", "SPECIES", 70, 79], ["chronic passive congestion", "PROBLEM", 24, 50], ["pattern", "OBSERVATION_MODIFIER", 13, 20], ["chronic", "OBSERVATION_MODIFIER", 24, 31], ["passive", "OBSERVATION_MODIFIER", 32, 39], ["congestion", "OBSERVATION", 40, 50], ["most obvious", "UNCERTAINTY", 54, 66]]], ["The \"nutmeg\" pattern can be mimicked by some forms of toxic periacinar necrosis or fatty change but should always be distinguishable from them by the presence of fibrous plaques in Glisson's capsule in the passively congested liver.", [["fibrous plaques", "ANATOMY", 162, 177], ["capsule", "ANATOMY", 191, 198], ["liver", "ANATOMY", 226, 231], ["necrosis", "DISEASE", 71, 79], ["fatty change", "DISEASE", 83, 95], ["fibrous plaques", "DISEASE", 162, 177], ["nutmeg", "ORGANISM_SUBDIVISION", 5, 11], ["fibrous plaques", "PATHOLOGICAL_FORMATION", 162, 177], ["capsule", "CANCER", 191, 198], ["liver", "ORGAN", 226, 231], ["toxic periacinar necrosis", "PROBLEM", 54, 79], ["fatty change", "PROBLEM", 83, 95], ["fibrous plaques", "PROBLEM", 162, 177], ["the passively congested liver", "PROBLEM", 202, 231], ["toxic", "OBSERVATION_MODIFIER", 54, 59], ["periacinar", "OBSERVATION_MODIFIER", 60, 70], ["necrosis", "OBSERVATION", 71, 79], ["fatty change", "OBSERVATION", 83, 95], ["fibrous", "OBSERVATION_MODIFIER", 162, 169], ["plaques", "OBSERVATION", 170, 177], ["passively", "ANATOMY_MODIFIER", 206, 215], ["congested", "OBSERVATION", 216, 225], ["liver", "ANATOMY", 226, 231]]], ["The pale lobular pattern is less obvious in carnivores and should not be expected in animals that have insufficient adipose reserves for mobilization.", [["pale lobular", "ANATOMY", 4, 16], ["adipose", "ANATOMY", 116, 123], ["pale lobular", "CANCER", 4, 16], ["adipose", "TISSUE", 116, 123], ["The pale lobular pattern", "PROBLEM", 0, 24], ["pale", "OBSERVATION_MODIFIER", 4, 8], ["lobular", "OBSERVATION", 9, 16], ["less", "OBSERVATION_MODIFIER", 28, 32], ["obvious", "OBSERVATION_MODIFIER", 33, 40]]], ["Over longer periods, centrilobular fibrosis links terminal hepatic venules with one another and with the larger portal triads in a pattern known as cardiac fibrosis.Efferent hepatic vesselsInflammatory changes in the outflow veins are sometimes observed.", [["centrilobular", "ANATOMY", 21, 34], ["hepatic venules", "ANATOMY", 59, 74], ["portal triads", "ANATOMY", 112, 125], ["cardiac", "ANATOMY", 148, 155], ["Efferent hepatic vessels", "ANATOMY", 165, 189], ["outflow veins", "ANATOMY", 217, 230], ["fibrosis", "DISEASE", 35, 43], ["cardiac fibrosis", "DISEASE", 148, 164], ["centrilobular", "PATHOLOGICAL_FORMATION", 21, 34], ["hepatic venules", "MULTI-TISSUE_STRUCTURE", 59, 74], ["portal triads", "MULTI-TISSUE_STRUCTURE", 112, 125], ["cardiac", "ORGAN", 148, 155], ["Efferent hepatic vessels", "MULTI-TISSUE_STRUCTURE", 165, 189], ["outflow veins", "MULTI-TISSUE_STRUCTURE", 217, 230], ["centrilobular fibrosis links terminal hepatic venules", "PROBLEM", 21, 74], ["cardiac fibrosis", "PROBLEM", 148, 164], ["Inflammatory changes in the outflow veins", "PROBLEM", 189, 230], ["centrilobular", "OBSERVATION_MODIFIER", 21, 34], ["fibrosis", "OBSERVATION", 35, 43], ["terminal", "OBSERVATION_MODIFIER", 50, 58], ["hepatic", "ANATOMY", 59, 66], ["venules", "ANATOMY_MODIFIER", 67, 74], ["larger", "OBSERVATION_MODIFIER", 105, 111], ["portal", "ANATOMY", 112, 118], ["triads", "OBSERVATION", 119, 125], ["cardiac", "ANATOMY", 148, 155], ["fibrosis", "OBSERVATION", 156, 164], ["hepatic vessels", "ANATOMY", 174, 189], ["outflow veins", "ANATOMY", 217, 230]]], ["Acute inflammation and thrombosis of sublobular veins are typical of acute salmonellosis in many species, but these changes are terminal and not associated with hepatic dysfunction.", [["sublobular veins", "ANATOMY", 37, 53], ["hepatic", "ANATOMY", 161, 168], ["inflammation", "DISEASE", 6, 18], ["thrombosis", "DISEASE", 23, 33], ["salmonellosis", "DISEASE", 75, 88], ["hepatic dysfunction", "DISEASE", 161, 180], ["sublobular veins", "MULTI-TISSUE_STRUCTURE", 37, 53], ["hepatic", "ORGAN", 161, 168], ["Acute inflammation", "PROBLEM", 0, 18], ["thrombosis of sublobular veins", "PROBLEM", 23, 53], ["acute salmonellosis", "PROBLEM", 69, 88], ["many species", "PROBLEM", 92, 104], ["hepatic dysfunction", "PROBLEM", 161, 180], ["inflammation", "OBSERVATION", 6, 18], ["thrombosis", "OBSERVATION", 23, 33], ["sublobular", "ANATOMY_MODIFIER", 37, 47], ["veins", "ANATOMY", 48, 53], ["typical of", "UNCERTAINTY", 58, 68], ["acute", "OBSERVATION_MODIFIER", 69, 74], ["salmonellosis", "OBSERVATION", 75, 88], ["many", "OBSERVATION_MODIFIER", 92, 96], ["species", "OBSERVATION", 97, 104], ["terminal", "OBSERVATION_MODIFIER", 128, 136], ["not associated with", "UNCERTAINTY", 141, 160], ["hepatic", "ANATOMY", 161, 168], ["dysfunction", "OBSERVATION", 169, 180]]], ["Inflammatory cell infiltrates are occasionally observed in the larger hepatic veins, and have been described in dogs with parvoviral myocarditis.", [["Inflammatory cell", "ANATOMY", 0, 17], ["hepatic veins", "ANATOMY", 70, 83], ["parvoviral myocarditis", "DISEASE", 122, 144], ["Inflammatory cell", "CELL", 0, 17], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 70, 83], ["dogs", "ORGANISM", 112, 116], ["dogs", "SPECIES", 112, 116], ["Inflammatory cell infiltrates", "PROBLEM", 0, 29], ["parvoviral myocarditis", "PROBLEM", 122, 144], ["cell infiltrates", "OBSERVATION", 13, 29], ["larger", "ANATOMY_MODIFIER", 63, 69], ["hepatic veins", "ANATOMY", 70, 83], ["parvoviral", "OBSERVATION_MODIFIER", 122, 132], ["myocarditis", "OBSERVATION", 133, 144]]], ["Muscular hypertrophy of walls of hepatic veins has been described in dogs with arteriovenous fistulae.", [["Muscular", "ANATOMY", 0, 8], ["walls", "ANATOMY", 24, 29], ["hepatic veins", "ANATOMY", 33, 46], ["arteriovenous", "ANATOMY", 79, 92], ["Muscular hypertrophy", "DISEASE", 0, 20], ["arteriovenous fistulae", "DISEASE", 79, 101], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 33, 46], ["dogs", "ORGANISM", 69, 73], ["arteriovenous fistulae", "PATHOLOGICAL_FORMATION", 79, 101], ["dogs", "SPECIES", 69, 73], ["Muscular hypertrophy of walls of hepatic veins", "PROBLEM", 0, 46], ["arteriovenous fistulae", "PROBLEM", 79, 101], ["hypertrophy", "OBSERVATION", 9, 20], ["walls", "ANATOMY_MODIFIER", 24, 29], ["hepatic veins", "ANATOMY", 33, 46], ["arteriovenous", "OBSERVATION_MODIFIER", 79, 92], ["fistulae", "OBSERVATION", 93, 101]]], ["Fibrous remodeling of these veins has been associated with nitrosamine intoxication in domestic animals.Efferent hepatic vesselsThe term Budd-Chiari syndrome is used to describe the clinical features associated with hepatic venous outflow obstruction caused by thrombosis of the main hepatic veins in humans.", [["Fibrous", "ANATOMY", 0, 7], ["veins", "ANATOMY", 28, 33], ["Efferent hepatic vessels", "ANATOMY", 104, 128], ["hepatic venous", "ANATOMY", 216, 230], ["hepatic veins", "ANATOMY", 284, 297], ["nitrosamine", "CHEMICAL", 59, 70], ["Budd-Chiari syndrome", "DISEASE", 137, 157], ["hepatic venous outflow obstruction", "DISEASE", 216, 250], ["thrombosis", "DISEASE", 261, 271], ["nitrosamine", "CHEMICAL", 59, 70], ["Fibrous", "TISSUE", 0, 7], ["veins", "MULTI-TISSUE_STRUCTURE", 28, 33], ["nitrosamine", "SIMPLE_CHEMICAL", 59, 70], ["Efferent hepatic vessels", "MULTI-TISSUE_STRUCTURE", 104, 128], ["hepatic venous", "MULTI-TISSUE_STRUCTURE", 216, 230], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 284, 297], ["humans", "ORGANISM", 301, 307], ["humans", "SPECIES", 301, 307], ["humans", "SPECIES", 301, 307], ["Fibrous remodeling of these veins", "PROBLEM", 0, 33], ["nitrosamine intoxication", "PROBLEM", 59, 83], ["The term Budd-Chiari syndrome", "PROBLEM", 128, 157], ["hepatic venous outflow obstruction", "PROBLEM", 216, 250], ["thrombosis of the main hepatic veins in humans", "PROBLEM", 261, 307], ["remodeling", "OBSERVATION", 8, 18], ["these", "ANATOMY_MODIFIER", 22, 27], ["veins", "ANATOMY", 28, 33], ["associated with", "UNCERTAINTY", 43, 58], ["nitrosamine intoxication", "OBSERVATION", 59, 83], ["hepatic vessels", "ANATOMY", 113, 128], ["Chiari syndrome", "OBSERVATION", 142, 157], ["hepatic", "ANATOMY_MODIFIER", 216, 223], ["venous", "ANATOMY", 224, 230], ["outflow", "ANATOMY_MODIFIER", 231, 238], ["obstruction", "OBSERVATION", 239, 250], ["thrombosis", "OBSERVATION", 261, 271], ["main", "ANATOMY_MODIFIER", 279, 283], ["hepatic veins", "ANATOMY", 284, 297]]], ["Hepatic vein thrombosis is a rare occurrence in dogs and cats.", [["Hepatic vein", "ANATOMY", 0, 12], ["Hepatic vein thrombosis", "DISEASE", 0, 23], ["Hepatic vein", "MULTI-TISSUE_STRUCTURE", 0, 12], ["dogs", "ORGANISM", 48, 52], ["cats", "ORGANISM", 57, 61], ["dogs", "SPECIES", 48, 52], ["cats", "SPECIES", 57, 61], ["Hepatic vein thrombosis", "PROBLEM", 0, 23], ["vein", "ANATOMY", 8, 12], ["thrombosis", "OBSERVATION", 13, 23], ["rare", "OBSERVATION_MODIFIER", 29, 33]]], ["In veterinary medicine, it is more appropriate to use specific morphologic diagnostic terms to describe pathologic changes that develop in response to various mechanical causes of postsinusoidal obstruction of hepatic venous flow, resulting in development of hepatomegaly, postsinusoidal portal hypertension, high-protein ascites, and acquired portosystemic collateral shunting.", [["hepatic venous", "ANATOMY", 210, 224], ["portal", "ANATOMY", 288, 294], ["ascites", "ANATOMY", 322, 329], ["collateral", "ANATOMY", 358, 368], ["obstruction of hepatic venous flow", "DISEASE", 195, 229], ["hepatomegaly", "DISEASE", 259, 271], ["portal hypertension", "DISEASE", 288, 307], ["ascites", "DISEASE", 322, 329], ["hepatic venous", "MULTI-TISSUE_STRUCTURE", 210, 224], ["portal", "MULTI-TISSUE_STRUCTURE", 288, 294], ["portosystemic collateral", "MULTI-TISSUE_STRUCTURE", 344, 368], ["pathologic changes", "PROBLEM", 104, 122], ["postsinusoidal obstruction of hepatic venous flow", "PROBLEM", 180, 229], ["hepatomegaly", "PROBLEM", 259, 271], ["postsinusoidal portal hypertension", "PROBLEM", 273, 307], ["high-protein ascites", "PROBLEM", 309, 329], ["acquired portosystemic collateral shunting", "PROBLEM", 335, 377], ["postsinusoidal obstruction", "OBSERVATION", 180, 206], ["hepatic venous", "ANATOMY", 210, 224], ["flow", "OBSERVATION", 225, 229], ["hepatomegaly", "OBSERVATION", 259, 271], ["postsinusoidal", "ANATOMY_MODIFIER", 273, 287], ["portal", "ANATOMY", 288, 294], ["hypertension", "OBSERVATION", 295, 307], ["high", "OBSERVATION_MODIFIER", 309, 313], ["protein ascites", "OBSERVATION", 314, 329], ["portosystemic", "OBSERVATION_MODIFIER", 344, 357], ["collateral shunting", "OBSERVATION", 358, 377]]], ["Causes include obstruction of flow caused by tumors (e.g., intraluminal leiomyosarcoma or other sarcoma, adrenal pheochromocytoma with extensive invasion into the caudal vena cava in the dog) or abscesses in the liver or caudal vena cava, hepatic venous or vena caval thrombosis, congenital malformation (fibrous web), kink or acquired stricture occluding the lumen of the vena cava or hepatic veins (intrahepatic postsinusoidal venous obstruction), or cardiac abnormalities impairing right atrial function (cor triatrium dexter, neoplasia).", [["tumors", "ANATOMY", 45, 51], ["intraluminal leiomyosarcoma", "ANATOMY", 59, 86], ["sarcoma", "ANATOMY", 96, 103], ["adrenal pheochromocytoma", "ANATOMY", 105, 129], ["caudal vena cava", "ANATOMY", 163, 179], ["abscesses", "ANATOMY", 195, 204], ["liver", "ANATOMY", 212, 217], ["caudal vena cava", "ANATOMY", 221, 237], ["hepatic venous", "ANATOMY", 239, 253], ["vena caval", "ANATOMY", 257, 267], ["fibrous web", "ANATOMY", 305, 316], ["stricture", "ANATOMY", 336, 345], ["lumen", "ANATOMY", 360, 365], ["vena cava", "ANATOMY", 373, 382], ["hepatic veins", "ANATOMY", 386, 399], ["intrahepatic postsinusoidal venous", "ANATOMY", 401, 435], ["cardiac", "ANATOMY", 453, 460], ["right atrial", "ANATOMY", 485, 497], ["neoplasia", "ANATOMY", 530, 539], ["obstruction of flow", "DISEASE", 15, 34], ["tumors", "DISEASE", 45, 51], ["intraluminal leiomyosarcoma", "DISEASE", 59, 86], ["sarcoma", "DISEASE", 96, 103], ["adrenal pheochromocytoma", "DISEASE", 105, 129], ["abscesses", "DISEASE", 195, 204], ["hepatic venous or vena caval thrombosis", "DISEASE", 239, 278], ["congenital malformation", "DISEASE", 280, 303], ["fibrous web", "DISEASE", 305, 316], ["stricture", "DISEASE", 336, 345], ["intrahepatic postsinusoidal venous obstruction", "DISEASE", 401, 447], ["cardiac abnormalities", "DISEASE", 453, 474], ["neoplasia", "DISEASE", 530, 539], ["tumors", "CANCER", 45, 51], ["intraluminal leiomyosarcoma", "CANCER", 59, 86], ["sarcoma", "CANCER", 96, 103], ["adrenal pheochromocytoma", "CANCER", 105, 129], ["caudal", "MULTI-TISSUE_STRUCTURE", 163, 169], ["vena cava", "MULTI-TISSUE_STRUCTURE", 170, 179], ["dog", "ORGANISM", 187, 190], ["liver", "ORGAN", 212, 217], ["caudal vena cava", "MULTI-TISSUE_STRUCTURE", 221, 237], ["hepatic venous", "MULTI-TISSUE_STRUCTURE", 239, 253], ["vena caval", "MULTI-TISSUE_STRUCTURE", 257, 267], ["stricture", "PATHOLOGICAL_FORMATION", 336, 345], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 360, 365], ["vena cava", "MULTI-TISSUE_STRUCTURE", 373, 382], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 386, 399], ["intrahepatic postsinusoidal venous obstruction", "PATHOLOGICAL_FORMATION", 401, 447], ["cardiac", "ORGAN", 453, 460], ["atrial", "MULTI-TISSUE_STRUCTURE", 491, 497], ["neoplasia", "CANCER", 530, 539], ["obstruction of flow", "PROBLEM", 15, 34], ["tumors", "PROBLEM", 45, 51], ["intraluminal leiomyosarcoma", "PROBLEM", 59, 86], ["other sarcoma", "PROBLEM", 90, 103], ["adrenal pheochromocytoma", "PROBLEM", 105, 129], ["extensive invasion into the caudal vena cava", "PROBLEM", 135, 179], ["abscesses in the liver", "PROBLEM", 195, 217], ["caudal vena cava", "PROBLEM", 221, 237], ["hepatic venous or vena caval thrombosis", "PROBLEM", 239, 278], ["congenital malformation (fibrous web)", "PROBLEM", 280, 317], ["kink", "PROBLEM", 319, 323], ["acquired stricture", "PROBLEM", 327, 345], ["intrahepatic postsinusoidal venous obstruction", "PROBLEM", 401, 447], ["cardiac abnormalities impairing right atrial function", "PROBLEM", 453, 506], ["neoplasia", "PROBLEM", 530, 539], ["obstruction", "OBSERVATION", 15, 26], ["flow", "OBSERVATION_MODIFIER", 30, 34], ["tumors", "OBSERVATION", 45, 51], ["intraluminal", "ANATOMY_MODIFIER", 59, 71], ["leiomyosarcoma", "OBSERVATION", 72, 86], ["sarcoma", "OBSERVATION", 96, 103], ["adrenal", "ANATOMY", 105, 112], ["pheochromocytoma", "OBSERVATION", 113, 129], ["extensive", "OBSERVATION_MODIFIER", 135, 144], ["invasion", "OBSERVATION", 145, 153], ["caudal vena cava", "ANATOMY", 163, 179], ["abscesses", "OBSERVATION", 195, 204], ["liver", "ANATOMY", 212, 217], ["caudal vena cava", "ANATOMY", 221, 237], ["hepatic venous", "ANATOMY", 239, 253], ["vena caval", "ANATOMY", 257, 267], ["thrombosis", "OBSERVATION", 268, 278], ["congenital", "OBSERVATION_MODIFIER", 280, 290], ["malformation", "OBSERVATION", 291, 303], ["fibrous web", "OBSERVATION", 305, 316], ["kink", "OBSERVATION_MODIFIER", 319, 323], ["stricture", "OBSERVATION", 336, 345], ["lumen", "ANATOMY_MODIFIER", 360, 365], ["vena cava", "ANATOMY", 373, 382], ["hepatic veins", "ANATOMY", 386, 399], ["intrahepatic", "ANATOMY_MODIFIER", 401, 413], ["postsinusoidal venous", "ANATOMY", 414, 435], ["obstruction", "OBSERVATION", 436, 447], ["cardiac", "ANATOMY", 453, 460], ["abnormalities", "OBSERVATION", 461, 474], ["right atrial", "ANATOMY", 485, 497], ["neoplasia", "OBSERVATION", 530, 539]]], ["Histologic changes include distension of the hepatic veins and perivenous sinusoidal congestion, which, with chronicity, leads to perivenous fibrosis typical of chronic passive congestion.Efferent hepatic vesselsThrombosis of the caudal vena cava has been described in detail in cattle, where rupture of a hepatic abscess into the caudal vena cava is the most common etiology (Fig. 2-51) .", [["hepatic veins", "ANATOMY", 45, 58], ["perivenous sinusoidal", "ANATOMY", 63, 84], ["perivenous", "ANATOMY", 130, 140], ["Efferent hepatic vessels", "ANATOMY", 188, 212], ["caudal vena cava", "ANATOMY", 230, 246], ["hepatic abscess", "ANATOMY", 306, 321], ["caudal vena cava", "ANATOMY", 331, 347], ["distension of the hepatic veins", "DISEASE", 27, 58], ["fibrosis", "DISEASE", 141, 149], ["Thrombosis", "DISEASE", 212, 222], ["rupture", "DISEASE", 293, 300], ["hepatic abscess", "DISEASE", 306, 321], ["caudal vena cava", "DISEASE", 331, 347], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 45, 58], ["perivenous sinusoidal", "TISSUE", 63, 84], ["perivenous", "TISSUE", 130, 140], ["Efferent hepatic vessels", "MULTI-TISSUE_STRUCTURE", 188, 212], ["caudal vena cava", "MULTI-TISSUE_STRUCTURE", 230, 246], ["cattle", "ORGANISM", 279, 285], ["hepatic abscess", "PATHOLOGICAL_FORMATION", 306, 321], ["caudal vena cava", "MULTI-TISSUE_STRUCTURE", 331, 347], ["cattle", "SPECIES", 279, 285], ["cattle", "SPECIES", 279, 285], ["Histologic changes", "PROBLEM", 0, 18], ["distension of the hepatic veins", "PROBLEM", 27, 58], ["perivenous sinusoidal congestion", "PROBLEM", 63, 95], ["perivenous fibrosis", "PROBLEM", 130, 149], ["chronic passive congestion", "PROBLEM", 161, 187], ["Thrombosis of the caudal vena cava", "PROBLEM", 212, 246], ["rupture", "PROBLEM", 293, 300], ["a hepatic abscess into the caudal vena cava", "PROBLEM", 304, 347], ["distension", "OBSERVATION", 27, 37], ["hepatic veins", "ANATOMY", 45, 58], ["perivenous", "ANATOMY_MODIFIER", 63, 73], ["sinusoidal", "ANATOMY_MODIFIER", 74, 84], ["congestion", "OBSERVATION", 85, 95], ["perivenous", "ANATOMY_MODIFIER", 130, 140], ["fibrosis", "OBSERVATION", 141, 149], ["chronic", "OBSERVATION_MODIFIER", 161, 168], ["passive", "OBSERVATION_MODIFIER", 169, 176], ["congestion", "OBSERVATION", 177, 187], ["hepatic vessels", "ANATOMY", 197, 212], ["caudal vena cava", "ANATOMY", 230, 246], ["rupture", "OBSERVATION", 293, 300], ["hepatic", "ANATOMY", 306, 313], ["abscess", "OBSERVATION", 314, 321], ["caudal vena cava", "ANATOMY", 331, 347], ["most common", "OBSERVATION_MODIFIER", 355, 366]]], ["Sequelae include pulmonary emboli, endoarteritis, multifocal pulmonary abscessation, and chronic suppurative bronchopneumonia.Acquired portosystemic shuntsCongenital shunts have been described previously in the section on Developmental disorders.", [["pulmonary emboli", "ANATOMY", 17, 33], ["pulmonary", "ANATOMY", 61, 70], ["pulmonary emboli", "DISEASE", 17, 33], ["endoarteritis", "DISEASE", 35, 48], ["multifocal pulmonary abscessation", "DISEASE", 50, 83], ["bronchopneumonia", "DISEASE", 109, 125], ["Acquired portosystemic shunts", "DISEASE", 126, 155], ["Congenital shunts", "DISEASE", 155, 172], ["Developmental disorders", "DISEASE", 222, 245], ["pulmonary emboli", "PATHOLOGICAL_FORMATION", 17, 33], ["pulmonary", "ORGAN", 61, 70], ["pulmonary emboli", "PROBLEM", 17, 33], ["endoarteritis", "PROBLEM", 35, 48], ["multifocal pulmonary abscessation", "PROBLEM", 50, 83], ["chronic suppurative bronchopneumonia", "PROBLEM", 89, 125], ["Acquired portosystemic shunts", "TREATMENT", 126, 155], ["Congenital shunts", "PROBLEM", 155, 172], ["Developmental disorders", "PROBLEM", 222, 245], ["pulmonary", "ANATOMY", 17, 26], ["emboli", "OBSERVATION", 27, 33], ["multifocal", "OBSERVATION_MODIFIER", 50, 60], ["pulmonary", "ANATOMY", 61, 70], ["abscessation", "OBSERVATION", 71, 83], ["chronic", "OBSERVATION_MODIFIER", 89, 96], ["suppurative", "OBSERVATION_MODIFIER", 97, 108], ["bronchopneumonia", "OBSERVATION", 109, 125], ["portosystemic shunts", "OBSERVATION", 135, 155], ["shunts", "OBSERVATION", 166, 172]]], ["Acquired portosystemic shunts within and external to the liver can develop in association that obstruct the flow of blood into or out of the heart, such as abscesses, heartworm disease, and local neoplasia.", [["liver", "ANATOMY", 57, 62], ["blood", "ANATOMY", 116, 121], ["heart", "ANATOMY", 141, 146], ["abscesses", "ANATOMY", 156, 165], ["heartworm", "ANATOMY", 167, 176], ["neoplasia", "ANATOMY", 196, 205], ["abscesses", "DISEASE", 156, 165], ["heartworm disease", "DISEASE", 167, 184], ["neoplasia", "DISEASE", 196, 205], ["liver", "ORGAN", 57, 62], ["blood", "ORGANISM_SUBSTANCE", 116, 121], ["heart", "ORGAN", 141, 146], ["abscesses", "PATHOLOGICAL_FORMATION", 156, 165], ["neoplasia", "CANCER", 196, 205], ["Acquired portosystemic shunts", "TREATMENT", 0, 29], ["abscesses", "PROBLEM", 156, 165], ["heartworm disease", "PROBLEM", 167, 184], ["local neoplasia", "PROBLEM", 190, 205], ["portosystemic shunts", "OBSERVATION", 9, 29], ["liver", "ANATOMY", 57, 62], ["flow", "OBSERVATION", 108, 112], ["heart", "ANATOMY", 141, 146], ["abscesses", "OBSERVATION", 156, 165], ["heartworm disease", "OBSERVATION", 167, 184], ["local", "OBSERVATION_MODIFIER", 190, 195], ["neoplasia", "OBSERVATION", 196, 205]]], ["Rightsided heart failure, in particular, produces elevated pressure within the caudal vena cava that later involves the hepatic vein and its tributaries.Acquired portosystemic shuntsAcute passive congestion of the liver occurs when there is sudden cardiac decompensation, particularly on the right side of the heart, or shock.", [["heart", "ANATOMY", 11, 16], ["caudal vena cava", "ANATOMY", 79, 95], ["hepatic vein", "ANATOMY", 120, 132], ["liver", "ANATOMY", 214, 219], ["cardiac", "ANATOMY", 248, 255], ["heart", "ANATOMY", 310, 315], ["heart failure", "DISEASE", 11, 24], ["Acquired portosystemic shunts", "DISEASE", 153, 182], ["congestion of the liver", "DISEASE", 196, 219], ["cardiac decompensation", "DISEASE", 248, 270], ["shock", "DISEASE", 320, 325], ["heart", "ORGAN", 11, 16], ["caudal vena cava", "MULTI-TISSUE_STRUCTURE", 79, 95], ["hepatic vein", "MULTI-TISSUE_STRUCTURE", 120, 132], ["liver", "ORGAN", 214, 219], ["cardiac", "ORGAN", 248, 255], ["heart", "ORGAN", 310, 315], ["Rightsided heart failure", "PROBLEM", 0, 24], ["elevated pressure within the caudal vena cava", "PROBLEM", 50, 95], ["Acquired portosystemic shunts", "TREATMENT", 153, 182], ["Acute passive congestion of the liver", "PROBLEM", 182, 219], ["sudden cardiac decompensation", "PROBLEM", 241, 270], ["shock", "PROBLEM", 320, 325], ["heart", "ANATOMY", 11, 16], ["failure", "OBSERVATION", 17, 24], ["elevated", "OBSERVATION_MODIFIER", 50, 58], ["pressure", "OBSERVATION_MODIFIER", 59, 67], ["caudal vena cava", "ANATOMY", 79, 95], ["hepatic vein", "ANATOMY", 120, 132], ["tributaries", "OBSERVATION_MODIFIER", 141, 152], ["portosystemic shunts", "OBSERVATION", 162, 182], ["passive", "OBSERVATION_MODIFIER", 188, 195], ["congestion", "OBSERVATION", 196, 206], ["liver", "ANATOMY", 214, 219], ["sudden", "OBSERVATION_MODIFIER", 241, 247], ["cardiac", "ANATOMY", 248, 255], ["decompensation", "OBSERVATION", 256, 270], ["right", "ANATOMY_MODIFIER", 292, 297], ["heart", "ANATOMY", 310, 315], ["shock", "OBSERVATION", 320, 325]]], ["Grossly, there is slight enlargement of the liver, which is typically dark red, and blood flows freely from any cut surface (Fig. 2-50) .", [["liver", "ANATOMY", 44, 49], ["blood", "ANATOMY", 84, 89], ["surface", "ANATOMY", 116, 123], ["enlargement of the liver", "DISEASE", 25, 49], ["liver", "ORGAN", 44, 49], ["blood", "ORGANISM_SUBSTANCE", 84, 89], ["slight enlargement of the liver", "PROBLEM", 18, 49], ["dark red", "PROBLEM", 70, 78], ["blood flows freely", "TEST", 84, 102], ["Fig.", "TEST", 125, 129], ["slight", "OBSERVATION_MODIFIER", 18, 24], ["enlargement", "OBSERVATION", 25, 36], ["liver", "ANATOMY", 44, 49], ["typically", "OBSERVATION_MODIFIER", 60, 69], ["dark", "OBSERVATION_MODIFIER", 70, 74], ["red", "OBSERVATION", 75, 78], ["flows", "OBSERVATION_MODIFIER", 90, 95], ["cut", "OBSERVATION_MODIFIER", 112, 115], ["surface", "OBSERVATION_MODIFIER", 116, 123]]], ["The intrinsic lobular pattern of the liver may be slightly more pronounced, particularly on the cut surface, because centrilobular areas are congested (dark red) in contrast to the more normal color of the remainder of the lobule.", [["lobular", "ANATOMY", 14, 21], ["liver", "ANATOMY", 37, 42], ["surface", "ANATOMY", 100, 107], ["centrilobular areas", "ANATOMY", 117, 136], ["lobule", "ANATOMY", 223, 229], ["lobular", "CANCER", 14, 21], ["liver", "ORGAN", 37, 42], ["lobule", "MULTI-TISSUE_STRUCTURE", 223, 229], ["centrilobular areas", "PROBLEM", 117, 136], ["congested (dark red) in contrast", "PROBLEM", 141, 173], ["intrinsic", "OBSERVATION_MODIFIER", 4, 13], ["lobular", "OBSERVATION", 14, 21], ["liver", "ANATOMY", 37, 42], ["may be", "UNCERTAINTY", 43, 49], ["slightly", "OBSERVATION_MODIFIER", 50, 58], ["more pronounced", "OBSERVATION_MODIFIER", 59, 74], ["centrilobular", "OBSERVATION_MODIFIER", 117, 130], ["areas", "OBSERVATION_MODIFIER", 131, 136], ["congested", "OBSERVATION", 141, 150], ["dark red", "OBSERVATION_MODIFIER", 152, 160], ["more", "OBSERVATION_MODIFIER", 181, 185], ["normal", "OBSERVATION", 186, 192], ["color", "OBSERVATION_MODIFIER", 193, 198], ["remainder", "ANATOMY_MODIFIER", 206, 215], ["lobule", "ANATOMY", 223, 229]]], ["The microscopic picture in acute passive congestion is initially characterized by distention of central veins and adjacent sinusoids, with accompanying distension of lymphatics in the stroma of hepatic veins, portal triads, and the capsule.", [["central veins", "ANATOMY", 96, 109], ["sinusoids", "ANATOMY", 123, 132], ["lymphatics", "ANATOMY", 166, 176], ["stroma", "ANATOMY", 184, 190], ["hepatic veins", "ANATOMY", 194, 207], ["portal triads", "ANATOMY", 209, 222], ["capsule", "ANATOMY", 232, 239], ["central veins", "MULTI-TISSUE_STRUCTURE", 96, 109], ["sinusoids", "TISSUE", 123, 132], ["lymphatics", "MULTI-TISSUE_STRUCTURE", 166, 176], ["stroma", "TISSUE", 184, 190], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 194, 207], ["portal triads", "MULTI-TISSUE_STRUCTURE", 209, 222], ["capsule", "CANCER", 232, 239], ["The microscopic picture", "TEST", 0, 23], ["acute passive congestion", "PROBLEM", 27, 51], ["distention of central veins and adjacent sinusoids", "PROBLEM", 82, 132], ["accompanying distension of lymphatics", "PROBLEM", 139, 176], ["acute", "OBSERVATION_MODIFIER", 27, 32], ["passive", "OBSERVATION_MODIFIER", 33, 40], ["congestion", "OBSERVATION", 41, 51], ["distention", "OBSERVATION", 82, 92], ["central", "ANATOMY_MODIFIER", 96, 103], ["veins", "ANATOMY", 104, 109], ["sinusoids", "OBSERVATION_MODIFIER", 123, 132], ["distension", "OBSERVATION", 152, 162], ["lymphatics", "OBSERVATION", 166, 176], ["stroma", "ANATOMY_MODIFIER", 184, 190], ["hepatic veins", "ANATOMY", 194, 207], ["portal triads", "ANATOMY", 209, 222], ["capsule", "OBSERVATION_MODIFIER", 232, 239]]], ["The appearance of the liver differs with the duration and severity of the congestion.", [["liver", "ANATOMY", 22, 27], ["congestion", "DISEASE", 74, 84], ["liver", "ORGAN", 22, 27], ["the congestion", "PROBLEM", 70, 84], ["liver", "ANATOMY", 22, 27], ["congestion", "OBSERVATION", 74, 84]]], ["Fatty change, trabecular atrophy, and necrosis of centrilobular hepatocytes with retention of the perisinusoidal reticulum framework develop quickly.", [["trabecular", "ANATOMY", 14, 24], ["centrilobular hepatocytes", "ANATOMY", 50, 75], ["perisinusoidal reticulum", "ANATOMY", 98, 122], ["trabecular atrophy", "DISEASE", 14, 32], ["necrosis", "DISEASE", 38, 46], ["trabecular", "TISSUE", 14, 24], ["centrilobular hepatocytes", "CELL", 50, 75], ["perisinusoidal reticulum", "MULTI-TISSUE_STRUCTURE", 98, 122], ["centrilobular hepatocytes", "CELL_TYPE", 50, 75], ["Fatty change", "PROBLEM", 0, 12], ["trabecular atrophy", "PROBLEM", 14, 32], ["necrosis of centrilobular hepatocytes", "PROBLEM", 38, 75], ["trabecular", "ANATOMY_MODIFIER", 14, 24], ["atrophy", "OBSERVATION", 25, 32], ["necrosis", "OBSERVATION", 38, 46], ["centrilobular", "ANATOMY_MODIFIER", 50, 63], ["hepatocytes", "ANATOMY", 64, 75], ["retention", "OBSERVATION_MODIFIER", 81, 90], ["perisinusoidal reticulum framework", "OBSERVATION", 98, 132]]], ["Erythrocytes tend to move into the perisinusoidal spaces left by the lost hepatocytes, and may be seen trapped there when blood drains from sinusoids and veins in freshly fixed sections.", [["Erythrocytes", "ANATOMY", 0, 12], ["hepatocytes", "ANATOMY", 74, 85], ["blood", "ANATOMY", 122, 127], ["sinusoids", "ANATOMY", 140, 149], ["veins", "ANATOMY", 154, 159], ["sections", "ANATOMY", 177, 185], ["Erythrocytes", "CELL", 0, 12], ["hepatocytes", "CELL", 74, 85], ["blood", "ORGANISM_SUBSTANCE", 122, 127], ["sinusoids", "TISSUE", 140, 149], ["veins", "MULTI-TISSUE_STRUCTURE", 154, 159], ["Erythrocytes", "CELL_TYPE", 0, 12], ["lost hepatocytes", "CELL_TYPE", 69, 85], ["Erythrocytes", "TEST", 0, 12], ["blood drains", "TREATMENT", 122, 134], ["perisinusoidal", "ANATOMY_MODIFIER", 35, 49], ["left", "ANATOMY_MODIFIER", 57, 61], ["lost", "OBSERVATION", 69, 73], ["hepatocytes", "ANATOMY", 74, 85], ["may be seen", "UNCERTAINTY", 91, 102], ["drains", "OBSERVATION", 128, 134], ["veins", "ANATOMY", 154, 159], ["freshly fixed", "OBSERVATION", 163, 176]]], ["The intrahepatic network of lymphatics at this stage becomes very distended and may form extensive cavernous channels about hepatic veins and venules, in portal triads, and just beneath the capsule.", [["intrahepatic network", "ANATOMY", 4, 24], ["lymphatics", "ANATOMY", 28, 38], ["cavernous channels", "ANATOMY", 99, 117], ["hepatic veins", "ANATOMY", 124, 137], ["venules", "ANATOMY", 142, 149], ["portal triads", "ANATOMY", 154, 167], ["capsule", "ANATOMY", 190, 197], ["intrahepatic network", "MULTI-TISSUE_STRUCTURE", 4, 24], ["lymphatics", "MULTI-TISSUE_STRUCTURE", 28, 38], ["cavernous channels", "PATHOLOGICAL_FORMATION", 99, 117], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 124, 137], ["venules", "MULTI-TISSUE_STRUCTURE", 142, 149], ["portal triads", "MULTI-TISSUE_STRUCTURE", 154, 167], ["capsule", "CANCER", 190, 197], ["very distended", "PROBLEM", 61, 75], ["extensive cavernous channels", "PROBLEM", 89, 117], ["intrahepatic", "ANATOMY_MODIFIER", 4, 16], ["lymphatics", "OBSERVATION", 28, 38], ["very", "OBSERVATION_MODIFIER", 61, 65], ["distended", "OBSERVATION", 66, 75], ["extensive", "OBSERVATION_MODIFIER", 89, 98], ["cavernous channels", "OBSERVATION", 99, 117], ["hepatic veins", "ANATOMY", 124, 137], ["venules", "ANATOMY", 142, 149], ["portal triads", "ANATOMY", 154, 167], ["capsule", "ANATOMY", 190, 197]]], ["With increased venous pressure, transudation of red blood cells and high-protein-content edema can develop, leading to polymerization of released fibrinogen on the capsular surface that yields a fibrin coating of the capsule and blood-tinged abdominal fluid.", [["venous", "ANATOMY", 15, 21], ["red blood cells", "ANATOMY", 48, 63], ["edema", "ANATOMY", 89, 94], ["capsular surface", "ANATOMY", 164, 180], ["capsule", "ANATOMY", 217, 224], ["blood", "ANATOMY", 229, 234], ["abdominal fluid", "ANATOMY", 242, 257], ["edema", "DISEASE", 89, 94], ["venous", "MULTI-TISSUE_STRUCTURE", 15, 21], ["red blood cells", "CELL", 48, 63], ["edema", "PATHOLOGICAL_FORMATION", 89, 94], ["fibrinogen", "GENE_OR_GENE_PRODUCT", 146, 156], ["capsular surface", "CELLULAR_COMPONENT", 164, 180], ["fibrin", "GENE_OR_GENE_PRODUCT", 195, 201], ["capsule", "CANCER", 217, 224], ["blood", "ORGANISM_SUBSTANCE", 229, 234], ["abdominal fluid", "ORGANISM_SUBSTANCE", 242, 257], ["red blood cells", "CELL_TYPE", 48, 63], ["fibrinogen", "PROTEIN", 146, 156], ["increased venous pressure", "PROBLEM", 5, 30], ["red blood cells", "TEST", 48, 63], ["high-protein", "PROBLEM", 68, 80], ["content edema", "PROBLEM", 81, 94], ["polymerization of released fibrinogen", "PROBLEM", 119, 156], ["a fibrin coating of the capsule", "TREATMENT", 193, 224], ["blood-tinged abdominal fluid", "PROBLEM", 229, 257], ["increased", "OBSERVATION_MODIFIER", 5, 14], ["venous", "ANATOMY", 15, 21], ["pressure", "OBSERVATION_MODIFIER", 22, 30], ["edema", "OBSERVATION", 89, 94], ["fibrinogen", "OBSERVATION", 146, 156], ["capsular surface", "OBSERVATION_MODIFIER", 164, 180], ["fibrin coating", "OBSERVATION", 195, 209], ["capsule", "ANATOMY", 217, 224], ["blood", "ANATOMY", 229, 234], ["tinged", "OBSERVATION_MODIFIER", 235, 241], ["abdominal", "ANATOMY", 242, 251], ["fluid", "OBSERVATION", 252, 257]]], ["Distension of the space of Disse may be seen, but rarely, if ever, in tissue well fixed soon after death, and is best regarded as a postmortem artifact.", [["tissue", "ANATOMY", 70, 76], ["death", "DISEASE", 99, 104], ["tissue", "TISSUE", 70, 76], ["Distension of the space of Disse", "PROBLEM", 0, 32], ["a postmortem artifact", "PROBLEM", 130, 151], ["space", "ANATOMY_MODIFIER", 18, 23], ["Disse", "OBSERVATION", 27, 32], ["may be seen", "UNCERTAINTY", 33, 44]]], ["By comparison, perisinusoidal edema is more obvious in hepatic congestion associated with shock or inflammatory conditions.Acquired portosystemic shuntsIn chronic passive congestion, the amounts of fibrous connective tissue in the liver increase in various patterns that differ among species.", [["perisinusoidal edema", "ANATOMY", 15, 35], ["hepatic", "ANATOMY", 55, 62], ["fibrous connective tissue", "ANATOMY", 198, 223], ["liver", "ANATOMY", 231, 236], ["edema", "DISEASE", 30, 35], ["hepatic congestion", "DISEASE", 55, 73], ["shock", "DISEASE", 90, 95], ["Acquired portosystemic shunts", "DISEASE", 123, 152], ["edema", "PATHOLOGICAL_FORMATION", 30, 35], ["hepatic", "ORGAN", 55, 62], ["fibrous connective tissue", "TISSUE", 198, 223], ["liver", "ORGAN", 231, 236], ["perisinusoidal edema", "PROBLEM", 15, 35], ["hepatic congestion", "PROBLEM", 55, 73], ["shock", "PROBLEM", 90, 95], ["inflammatory conditions", "PROBLEM", 99, 122], ["Acquired portosystemic shunts", "TREATMENT", 123, 152], ["chronic passive congestion", "PROBLEM", 155, 181], ["fibrous connective tissue", "PROBLEM", 198, 223], ["perisinusoidal", "ANATOMY", 15, 29], ["edema", "OBSERVATION", 30, 35], ["more", "OBSERVATION_MODIFIER", 39, 43], ["obvious", "OBSERVATION_MODIFIER", 44, 51], ["hepatic", "ANATOMY", 55, 62], ["congestion", "OBSERVATION", 63, 73], ["shock", "OBSERVATION", 90, 95], ["inflammatory", "OBSERVATION_MODIFIER", 99, 111], ["portosystemic shunts", "OBSERVATION", 132, 152], ["chronic", "OBSERVATION_MODIFIER", 155, 162], ["passive", "OBSERVATION_MODIFIER", 163, 170], ["congestion", "OBSERVATION", 171, 181], ["amounts", "OBSERVATION_MODIFIER", 187, 194], ["fibrous connective tissue", "OBSERVATION", 198, 223], ["liver", "ANATOMY", 231, 236], ["increase", "OBSERVATION_MODIFIER", 237, 245], ["various patterns", "OBSERVATION_MODIFIER", 249, 265]]], ["The capsular surface becomes thicker and more opaque, and can develop a finely nodular texture with the formation of capsular plaques (eFig.", [["capsular surface", "ANATOMY", 4, 20], ["capsular plaques", "ANATOMY", 117, 133], ["capsular surface", "CELLULAR_COMPONENT", 4, 20], ["capsular plaques", "PATHOLOGICAL_FORMATION", 117, 133], ["a finely nodular texture", "PROBLEM", 70, 94], ["capsular plaques", "PROBLEM", 117, 133], ["capsular", "OBSERVATION_MODIFIER", 4, 12], ["surface", "OBSERVATION_MODIFIER", 13, 20], ["thicker", "OBSERVATION_MODIFIER", 29, 36], ["more opaque", "OBSERVATION_MODIFIER", 41, 52], ["finely", "OBSERVATION_MODIFIER", 72, 78], ["nodular", "OBSERVATION_MODIFIER", 79, 86], ["texture", "OBSERVATION_MODIFIER", 87, 94], ["capsular", "OBSERVATION_MODIFIER", 117, 125], ["plaques", "OBSERVATION", 126, 133]]], ["2-11A).", [["2-11A", "CHEMICAL", 0, 5]]], ["In dogs and cats, the edges of the central lobes become rounded, whereas the margins of lateral and caudate lobes are sharpened by peripheral atrophy and fibrosis.", [["central lobes", "ANATOMY", 35, 48], ["lateral", "ANATOMY", 88, 95], ["caudate lobes", "ANATOMY", 100, 113], ["peripheral atrophy", "DISEASE", 131, 149], ["fibrosis", "DISEASE", 154, 162], ["dogs", "ORGANISM", 3, 7], ["cats", "ORGANISM", 12, 16], ["central lobes", "MULTI-TISSUE_STRUCTURE", 35, 48], ["lateral", "MULTI-TISSUE_STRUCTURE", 88, 95], ["caudate lobes", "MULTI-TISSUE_STRUCTURE", 100, 113], ["peripheral", "TISSUE", 131, 141], ["dogs", "SPECIES", 3, 7], ["cats", "SPECIES", 12, 16], ["peripheral atrophy", "PROBLEM", 131, 149], ["fibrosis", "PROBLEM", 154, 162], ["dogs", "OBSERVATION", 3, 7], ["cats", "OBSERVATION", 12, 16], ["edges", "ANATOMY_MODIFIER", 22, 27], ["central lobes", "ANATOMY", 35, 48], ["rounded", "OBSERVATION_MODIFIER", 56, 63], ["margins", "OBSERVATION_MODIFIER", 77, 84], ["lateral", "ANATOMY_MODIFIER", 88, 95], ["caudate lobes", "ANATOMY", 100, 113], ["sharpened", "OBSERVATION_MODIFIER", 118, 127], ["peripheral", "ANATOMY_MODIFIER", 131, 141], ["atrophy", "OBSERVATION", 142, 149], ["fibrosis", "OBSERVATION", 154, 162]]], ["If the cause of theA BThere are 2 forms of peliosis hepatis, although both can appear in the same animal.", [["peliosis hepatis", "ANATOMY", 43, 59], ["peliosis hepatis", "DISEASE", 43, 59], ["hepatis", "ORGAN", 52, 59], ["peliosis hepatis", "PROBLEM", 43, 59], ["peliosis", "OBSERVATION", 43, 51], ["hepatis", "ANATOMY", 52, 59]]], ["Intrinsic weakness of the local reticulin framework leading to sinusoidal dilation is the hallmark of the phlebectatic form of peliosis hepatis, and the other form is characterized by death of hepatocytes and sinusoidal distention (parenchymal type).", [["sinusoidal", "ANATOMY", 63, 73], ["peliosis hepatis", "ANATOMY", 127, 143], ["hepatocytes", "ANATOMY", 193, 204], ["sinusoidal", "ANATOMY", 209, 219], ["parenchymal type", "ANATOMY", 232, 248], ["peliosis hepatis", "DISEASE", 127, 143], ["death", "DISEASE", 184, 189], ["sinusoidal", "MULTI-TISSUE_STRUCTURE", 63, 73], ["hepatis", "ORGAN", 136, 143], ["hepatocytes", "CELL", 193, 204], ["sinusoidal distention", "PATHOLOGICAL_FORMATION", 209, 230], ["parenchymal type", "CANCER", 232, 248], ["hepatocytes", "CELL_TYPE", 193, 204], ["Intrinsic weakness", "PROBLEM", 0, 18], ["the local reticulin framework", "PROBLEM", 22, 51], ["sinusoidal dilation", "PROBLEM", 63, 82], ["peliosis hepatis", "PROBLEM", 127, 143], ["hepatocytes", "PROBLEM", 193, 204], ["sinusoidal distention (parenchymal type)", "PROBLEM", 209, 249], ["weakness", "OBSERVATION", 10, 18], ["local", "OBSERVATION_MODIFIER", 26, 31], ["reticulin framework", "OBSERVATION", 32, 51], ["sinusoidal dilation", "OBSERVATION", 63, 82], ["hallmark", "OBSERVATION_MODIFIER", 90, 98], ["peliosis", "OBSERVATION", 127, 135], ["hepatis", "ANATOMY", 136, 143], ["hepatocytes", "ANATOMY", 193, 204], ["sinusoidal distention", "OBSERVATION", 209, 230], ["parenchymal", "ANATOMY_MODIFIER", 232, 243]]], ["Peliosis hepatis lesions occur throughout the liver as dark red areas, irregular in shape but well circumscribed, and ranging from pinpoints to many centimeters in size ( Fig. 2-53, eFig 2-12) .", [["hepatis lesions", "ANATOMY", 9, 24], ["liver", "ANATOMY", 46, 51], ["Peliosis hepatis lesions", "DISEASE", 0, 24], ["Peliosis hepatis lesions", "PATHOLOGICAL_FORMATION", 0, 24], ["liver", "ORGAN", 46, 51], ["Peliosis hepatis lesions", "PROBLEM", 0, 24], ["dark red areas", "PROBLEM", 55, 69], ["irregular in shape", "PROBLEM", 71, 89], ["Fig.", "TEST", 171, 175], ["Fig", "TEST", 183, 186], ["hepatis", "ANATOMY", 9, 16], ["lesions", "OBSERVATION", 17, 24], ["liver", "ANATOMY", 46, 51], ["dark", "OBSERVATION_MODIFIER", 55, 59], ["red", "OBSERVATION_MODIFIER", 60, 63], ["areas", "OBSERVATION_MODIFIER", 64, 69], ["irregular", "OBSERVATION_MODIFIER", 71, 80], ["shape", "OBSERVATION_MODIFIER", 84, 89], ["well", "OBSERVATION_MODIFIER", 94, 98], ["circumscribed", "OBSERVATION_MODIFIER", 99, 112], ["ranging", "OBSERVATION_MODIFIER", 118, 125], ["many", "OBSERVATION_MODIFIER", 144, 148], ["centimeters", "OBSERVATION_MODIFIER", 149, 160], ["size", "OBSERVATION_MODIFIER", 164, 168]]], ["Sectioned or capsular surfaces are depressed after death, and on cutting, they appear as cavities from which the blood drains to reveal a delicate network of residual stroma.", [["capsular surfaces", "ANATOMY", 13, 30], ["blood", "ANATOMY", 113, 118], ["stroma", "ANATOMY", 167, 173], ["depressed", "DISEASE", 35, 44], ["death", "DISEASE", 51, 56], ["blood", "ORGANISM_SUBSTANCE", 113, 118], ["stroma", "TISSUE", 167, 173], ["depressed", "PROBLEM", 35, 44], ["death", "PROBLEM", 51, 56], ["the blood drains", "TREATMENT", 109, 125], ["residual stroma", "PROBLEM", 158, 173], ["capsular", "OBSERVATION_MODIFIER", 13, 21], ["surfaces", "OBSERVATION_MODIFIER", 22, 30], ["depressed", "OBSERVATION_MODIFIER", 35, 44], ["cavities", "OBSERVATION", 89, 97], ["residual stroma", "OBSERVATION", 158, 173]]], ["The histologic lesion is characterized by multiple, dilated, blood-filled spaces sometimes surrounded by fibromyxoid stroma.", [["lesion", "ANATOMY", 15, 21], ["blood", "ANATOMY", 61, 66], ["fibromyxoid stroma", "ANATOMY", 105, 123], ["blood", "ORGANISM_SUBSTANCE", 61, 66], ["fibromyxoid stroma", "TISSUE", 105, 123], ["The histologic lesion", "PROBLEM", 0, 21], ["multiple, dilated, blood-filled spaces", "PROBLEM", 42, 80], ["fibromyxoid stroma", "PROBLEM", 105, 123], ["histologic", "OBSERVATION_MODIFIER", 4, 14], ["lesion", "OBSERVATION", 15, 21], ["multiple", "OBSERVATION_MODIFIER", 42, 50], ["dilated", "OBSERVATION", 52, 59], ["blood", "ANATOMY", 61, 66], ["filled spaces", "OBSERVATION", 67, 80], ["fibromyxoid stroma", "OBSERVATION", 105, 123]]], ["The blood-filled cystic spaces may be lined by endothelium.", [["blood", "ANATOMY", 4, 9], ["cystic spaces", "ANATOMY", 17, 30], ["endothelium", "ANATOMY", 47, 58], ["blood", "ORGANISM_SUBSTANCE", 4, 9], ["cystic spaces", "PATHOLOGICAL_FORMATION", 17, 30], ["endothelium", "TISSUE", 47, 58], ["The blood-filled cystic spaces", "PROBLEM", 0, 30], ["blood", "ANATOMY", 4, 9], ["filled", "OBSERVATION_MODIFIER", 10, 16], ["cystic spaces", "OBSERVATION", 17, 30], ["may be", "UNCERTAINTY", 31, 37], ["endothelium", "OBSERVATION", 47, 58]]], ["In humans, these lesions have an idiosyncratic association with administration of various drugs, including anabolic and contraceptive steroids.", [["lesions", "ANATOMY", 17, 24], ["steroids", "CHEMICAL", 134, 142], ["steroids", "CHEMICAL", 134, 142], ["humans", "ORGANISM", 3, 9], ["lesions", "PATHOLOGICAL_FORMATION", 17, 24], ["humans", "SPECIES", 3, 9], ["humans", "SPECIES", 3, 9], ["these lesions", "PROBLEM", 11, 24], ["various drugs", "TREATMENT", 82, 95], ["anabolic", "TREATMENT", 107, 115], ["contraceptive steroids", "TREATMENT", 120, 142], ["lesions", "OBSERVATION", 17, 24], ["idiosyncratic", "OBSERVATION_MODIFIER", 33, 46]]], ["Infectious peliosis hepatis caused by Bartonella henselae or B. quintana infection has also been described in immunosuppressed human patients.A BPeliosis hepatis has been reported in cattle, dogs, and cats, but the pathogenesis is unknown.", [["Infectious peliosis hepatis", "DISEASE", 0, 27], ["Bartonella henselae", "DISEASE", 38, 57], ["B. quintana infection", "DISEASE", 61, 82], ["BPeliosis hepatis", "DISEASE", 144, 161], ["peliosis hepatis", "ORGAN", 11, 27], ["Bartonella henselae", "ORGANISM", 38, 57], ["B. quintana", "ORGANISM", 61, 72], ["human", "ORGANISM", 127, 132], ["patients", "ORGANISM", 133, 141], ["BPeliosis hepatis", "CANCER", 144, 161], ["cattle", "ORGANISM", 183, 189], ["dogs", "ORGANISM", 191, 195], ["cats", "ORGANISM", 201, 205], ["Bartonella henselae", "SPECIES", 38, 57], ["B. quintana", "SPECIES", 61, 72], ["human", "SPECIES", 127, 132], ["patients", "SPECIES", 133, 141], ["cattle", "SPECIES", 183, 189], ["dogs", "SPECIES", 191, 195], ["cats", "SPECIES", 201, 205], ["Bartonella henselae", "SPECIES", 38, 57], ["B. quintana", "SPECIES", 61, 72], ["human", "SPECIES", 127, 132], ["cattle", "SPECIES", 183, 189], ["Infectious peliosis hepatis", "PROBLEM", 0, 27], ["Bartonella henselae", "PROBLEM", 38, 57], ["B. quintana infection", "PROBLEM", 61, 82], ["A BPeliosis hepatis", "PROBLEM", 142, 161], ["hepatis", "ANATOMY", 20, 27], ["Bartonella henselae", "OBSERVATION", 38, 57], ["quintana infection", "OBSERVATION", 64, 82], ["hepatis", "ANATOMY", 154, 161]]], ["B. henselae DNA has been identified by PCR from the liver of a single canine case, but does not seem to be involved in the feline disorder.", [["liver", "ANATOMY", 52, 57], ["feline disorder", "DISEASE", 123, 138], ["B. henselae", "ORGANISM", 0, 11], ["DNA", "CELLULAR_COMPONENT", 12, 15], ["liver", "ORGAN", 52, 57], ["canine", "ORGANISM", 70, 76], ["feline", "ORGANISM", 123, 129], ["B. henselae", "SPECIES", 0, 11], ["B. henselae", "SPECIES", 0, 11], ["canine", "SPECIES", 70, 76], ["B. henselae DNA", "PROBLEM", 0, 15], ["PCR", "TEST", 39, 42], ["the feline disorder", "PROBLEM", 119, 138], ["henselae DNA", "OBSERVATION", 3, 15], ["liver", "ANATOMY", 52, 57]]], ["Bovine hepatic peliosis hepatis (telangiectasis) and human peliosis hepatis have been suggested to share a similar pathogenesis.", [["hepatic peliosis hepatis", "ANATOMY", 7, 31], ["peliosis hepatis", "ANATOMY", 59, 75], ["Bovine hepatic peliosis hepatis (telangiectasis", "DISEASE", 0, 47], ["peliosis hepatis", "DISEASE", 59, 75], ["Bovine", "ORGANISM", 0, 6], ["hepatic peliosis hepatis", "MULTI-TISSUE_STRUCTURE", 7, 31], ["telangiectasis", "CANCER", 33, 47], ["human", "ORGANISM", 53, 58], ["peliosis hepatis", "ORGAN", 59, 75], ["Bovine", "SPECIES", 0, 6], ["human", "SPECIES", 53, 58], ["human peliosis", "SPECIES", 53, 67], ["Bovine hepatic peliosis hepatis (telangiectasis", "PROBLEM", 0, 47], ["human peliosis hepatis", "PROBLEM", 53, 75], ["a similar pathogenesis", "PROBLEM", 105, 127], ["hepatic", "ANATOMY", 7, 14], ["peliosis", "OBSERVATION", 15, 23], ["hepatis", "ANATOMY", 24, 31], ["telangiectasis", "OBSERVATION", 33, 47], ["peliosis", "OBSERVATION", 59, 67], ["hepatis", "ANATOMY", 68, 75], ["similar", "OBSERVATION_MODIFIER", 107, 114], ["pathogenesis", "OBSERVATION", 115, 127]]], ["Primary alteration of the sinusoidal barrier, with rupture of the reticulin fibers and increased deposition of basement membrane components in the perisinusoidal region and fibrosis, may alter oxygen and substrate exchange between hepatocytes and the blood, leading to hemodynamic imbalance, hepatocyte atrophy, and eventually to sinusoidal disruption.", [["sinusoidal barrier", "ANATOMY", 26, 44], ["reticulin fibers", "ANATOMY", 66, 82], ["basement membrane components", "ANATOMY", 111, 139], ["perisinusoidal region", "ANATOMY", 147, 168], ["hepatocytes", "ANATOMY", 231, 242], ["blood", "ANATOMY", 251, 256], ["hepatocyte", "ANATOMY", 292, 302], ["sinusoidal", "ANATOMY", 330, 340], ["fibrosis", "DISEASE", 173, 181], ["oxygen", "CHEMICAL", 193, 199], ["atrophy", "DISEASE", 303, 310], ["oxygen", "CHEMICAL", 193, 199], ["sinusoidal barrier", "TISSUE", 26, 44], ["reticulin fibers", "CELLULAR_COMPONENT", 66, 82], ["basement membrane components", "CELLULAR_COMPONENT", 111, 139], ["oxygen", "SIMPLE_CHEMICAL", 193, 199], ["hepatocytes", "CELL", 231, 242], ["blood", "ORGANISM_SUBSTANCE", 251, 256], ["hepatocyte", "CELL", 292, 302], ["sinusoidal", "MULTI-TISSUE_STRUCTURE", 330, 340], ["hepatocytes", "CELL_TYPE", 231, 242], ["the sinusoidal barrier", "PROBLEM", 22, 44], ["rupture of the reticulin fibers", "PROBLEM", 51, 82], ["increased deposition of basement membrane components", "PROBLEM", 87, 139], ["fibrosis", "PROBLEM", 173, 181], ["oxygen", "TREATMENT", 193, 199], ["the blood", "TEST", 247, 256], ["hemodynamic imbalance", "PROBLEM", 269, 290], ["hepatocyte atrophy", "PROBLEM", 292, 310], ["sinusoidal disruption", "PROBLEM", 330, 351], ["sinusoidal barrier", "OBSERVATION", 26, 44], ["rupture", "OBSERVATION", 51, 58], ["reticulin fibers", "OBSERVATION", 66, 82], ["increased", "OBSERVATION_MODIFIER", 87, 96], ["deposition", "OBSERVATION_MODIFIER", 97, 107], ["basement membrane components", "OBSERVATION", 111, 139], ["perisinusoidal", "ANATOMY_MODIFIER", 147, 161], ["fibrosis", "OBSERVATION", 173, 181], ["oxygen", "OBSERVATION_MODIFIER", 193, 199], ["blood", "ANATOMY", 251, 256], ["hemodynamic imbalance", "OBSERVATION", 269, 290], ["hepatocyte", "ANATOMY", 292, 302], ["atrophy", "OBSERVATION", 303, 310], ["sinusoidal disruption", "OBSERVATION", 330, 351]]], ["Peliosis hepatis in livers is quite common in older cats and cattle ( Fig. 2-54 ).", [["livers", "ANATOMY", 20, 26], ["Peliosis hepatis", "DISEASE", 0, 16], ["Peliosis hepatis", "MULTI-TISSUE_STRUCTURE", 0, 16], ["livers", "ORGAN", 20, 26], ["cats", "ORGANISM", 52, 56], ["cats", "SPECIES", 52, 56], ["cattle", "SPECIES", 61, 67], ["cattle", "SPECIES", 61, 67], ["Peliosis hepatis in livers", "PROBLEM", 0, 26], ["cattle ( Fig.", "TEST", 61, 74], ["hepatis", "ANATOMY", 9, 16], ["livers", "ANATOMY", 20, 26], ["common", "OBSERVATION_MODIFIER", 36, 42]]], ["There is no evidence clinically of related liver dysfunction.", [["liver", "ANATOMY", 43, 48], ["liver dysfunction", "DISEASE", 43, 60], ["liver", "ORGAN", 43, 48], ["related liver dysfunction", "PROBLEM", 35, 60], ["no evidence clinically of", "UNCERTAINTY", 9, 34], ["liver", "ANATOMY", 43, 48], ["dysfunction", "OBSERVATION", 49, 60]]], ["In cats, the cavities are rather more frequent in the subcapsular zone and rarely exceed 2-3 mm in size.", [["cavities", "ANATOMY", 13, 21], ["subcapsular zone", "ANATOMY", 54, 70], ["cats", "ORGANISM", 3, 7], ["cavities", "ORGAN", 13, 21], ["subcapsular zone", "MULTI-TISSUE_STRUCTURE", 54, 70], ["cats", "SPECIES", 3, 7], ["cavities", "OBSERVATION", 13, 21], ["more", "OBSERVATION_MODIFIER", 33, 37], ["frequent", "OBSERVATION_MODIFIER", 38, 46], ["subcapsular", "ANATOMY_MODIFIER", 54, 65], ["zone", "ANATOMY_MODIFIER", 66, 70], ["rarely", "OBSERVATION_MODIFIER", 75, 81], ["exceed 2-3 mm", "OBSERVATION_MODIFIER", 82, 95], ["size", "OBSERVATION_MODIFIER", 99, 103]]], ["There are often other senile changes in these livers, such as chronic fatty change, nodular hyperplasia, and chronic hepatitis.A BA specific condition termed \"peliosis\" develops in cattle poisoned by plants of Pimelea spp.", [["livers", "ANATOMY", 46, 52], ["nodular hyperplasia", "ANATOMY", 84, 103], ["fatty change", "DISEASE", 70, 82], ["nodular hyperplasia", "DISEASE", 84, 103], ["chronic hepatitis", "DISEASE", 109, 126], ["BA", "CHEMICAL", 129, 131], ["livers", "ORGAN", 46, 52], ["nodular hyperplasia", "PATHOLOGICAL_FORMATION", 84, 103], ["cattle", "ORGANISM", 181, 187], ["Pimelea spp", "ORGANISM", 210, 221], ["cattle", "SPECIES", 181, 187], ["cattle", "SPECIES", 181, 187], ["Pimelea spp", "SPECIES", 210, 221], ["often other senile changes in these livers", "PROBLEM", 10, 52], ["chronic fatty change", "PROBLEM", 62, 82], ["nodular hyperplasia", "PROBLEM", 84, 103], ["chronic hepatitis", "PROBLEM", 109, 126], ["peliosis", "PROBLEM", 159, 167], ["Pimelea spp", "PROBLEM", 210, 221], ["senile", "OBSERVATION", 22, 28], ["livers", "ANATOMY", 46, 52], ["chronic", "OBSERVATION_MODIFIER", 62, 69], ["fatty change", "OBSERVATION", 70, 82], ["nodular", "OBSERVATION_MODIFIER", 84, 91], ["hyperplasia", "OBSERVATION", 92, 103], ["chronic", "OBSERVATION_MODIFIER", 109, 116], ["hepatitis", "OBSERVATION", 117, 126], ["peliosis", "OBSERVATION", 159, 167]]], ["This form begins as diffuse periportal sinusoidal dilation.", [["periportal sinusoidal", "ANATOMY", 28, 49], ["periportal sinusoidal", "MULTI-TISSUE_STRUCTURE", 28, 49], ["diffuse periportal sinusoidal dilation", "PROBLEM", 20, 58], ["diffuse", "OBSERVATION_MODIFIER", 20, 27], ["periportal", "ANATOMY_MODIFIER", 28, 38], ["sinusoidal dilation", "OBSERVATION", 39, 58]]], ["Because these changes are also found in these animals in the spleen and in other organs with sinusoidal microcirculation, it seems that the lesions may be adaptive to progressive and dramatic increases in total blood volume.", [["spleen", "ANATOMY", 61, 67], ["organs", "ANATOMY", 81, 87], ["lesions", "ANATOMY", 140, 147], ["blood", "ANATOMY", 211, 216], ["increases in total blood volume", "DISEASE", 192, 223], ["spleen", "ORGAN", 61, 67], ["organs", "ORGAN", 81, 87], ["sinusoidal microcirculation", "MULTI-TISSUE_STRUCTURE", 93, 120], ["lesions", "PATHOLOGICAL_FORMATION", 140, 147], ["blood", "ORGANISM_SUBSTANCE", 211, 216], ["sinusoidal microcirculation", "PROBLEM", 93, 120], ["the lesions", "PROBLEM", 136, 147], ["dramatic increases in total blood volume", "PROBLEM", 183, 223], ["spleen", "ANATOMY", 61, 67], ["sinusoidal microcirculation", "OBSERVATION", 93, 120], ["lesions", "OBSERVATION", 140, 147], ["may be", "UNCERTAINTY", 148, 154], ["progressive", "OBSERVATION_MODIFIER", 167, 178], ["dramatic", "OBSERVATION_MODIFIER", 183, 191], ["increases", "OBSERVATION_MODIFIER", 192, 201], ["total blood volume", "OBSERVATION", 205, 223]]], ["In the late stages of the intoxication by Pimelea, the with various chronic liver diseases that lead to portal hypertension.", [["liver", "ANATOMY", 76, 81], ["portal", "ANATOMY", 104, 110], ["chronic liver diseases", "DISEASE", 68, 90], ["portal hypertension", "DISEASE", 104, 123], ["liver", "ORGAN", 76, 81], ["portal", "MULTI-TISSUE_STRUCTURE", 104, 110], ["the intoxication", "PROBLEM", 22, 38], ["various chronic liver diseases", "PROBLEM", 60, 90], ["portal hypertension", "PROBLEM", 104, 123], ["late stages", "OBSERVATION_MODIFIER", 7, 18], ["intoxication", "OBSERVATION", 26, 38], ["chronic", "OBSERVATION_MODIFIER", 68, 75], ["liver", "ANATOMY", 76, 81], ["diseases", "OBSERVATION", 82, 90], ["portal", "ANATOMY", 104, 110], ["hypertension", "OBSERVATION", 111, 123]]], ["These shunts tend to be multiple, small, and tortuous ( Fig. 2-52) .", [["These shunts", "TREATMENT", 0, 12], ["multiple, small, and tortuous ( Fig. 2", "PROBLEM", 24, 62], ["shunts", "OBSERVATION", 6, 12], ["multiple", "OBSERVATION_MODIFIER", 24, 32], ["small", "OBSERVATION_MODIFIER", 34, 39], ["tortuous", "OBSERVATION_MODIFIER", 45, 53]]], ["They may be difficult to identify postmortem when they are collapsed.", [["collapsed", "OBSERVATION", 59, 68]]], ["They are easily destroyed by routine dissection, so they must be noted before removal of the abdominal viscera.", [["abdominal viscera", "ANATOMY", 93, 110], ["abdominal viscera", "ORGAN", 93, 110], ["routine dissection", "TREATMENT", 29, 47], ["removal", "TREATMENT", 78, 85], ["dissection", "OBSERVATION", 37, 47], ["abdominal viscera", "ANATOMY", 93, 110]]], ["Acquired shunts can be associated with evidence of portal hypertension, such as distension of the portal veins and ascites, but when shunts are multiple and well established, portal hypertension is somewhat relieved.", [["portal", "ANATOMY", 51, 57], ["portal veins", "ANATOMY", 98, 110], ["ascites", "ANATOMY", 115, 122], ["portal", "ANATOMY", 175, 181], ["Acquired shunts", "DISEASE", 0, 15], ["portal hypertension", "DISEASE", 51, 70], ["distension of the portal veins", "DISEASE", 80, 110], ["ascites", "DISEASE", 115, 122], ["hypertension", "DISEASE", 182, 194], ["portal", "MULTI-TISSUE_STRUCTURE", 51, 57], ["portal veins", "MULTI-TISSUE_STRUCTURE", 98, 110], ["portal", "MULTI-TISSUE_STRUCTURE", 175, 181], ["Acquired shunts", "TREATMENT", 0, 15], ["portal hypertension", "PROBLEM", 51, 70], ["distension of the portal veins", "PROBLEM", 80, 110], ["ascites", "PROBLEM", 115, 122], ["shunts", "TREATMENT", 133, 139], ["portal hypertension", "PROBLEM", 175, 194], ["shunts", "OBSERVATION", 9, 15], ["portal", "ANATOMY", 51, 57], ["hypertension", "OBSERVATION", 58, 70], ["distension", "OBSERVATION", 80, 90], ["portal veins", "ANATOMY", 98, 110], ["ascites", "OBSERVATION", 115, 122], ["portal", "ANATOMY", 175, 181], ["hypertension", "OBSERVATION", 182, 194], ["somewhat", "OBSERVATION_MODIFIER", 198, 206], ["relieved", "OBSERVATION_MODIFIER", 207, 215]]], ["It is important to distinguish these varicose dilations that develop in response to portal hypertension from true congenital portosystemic shunts.", [["varicose", "ANATOMY", 37, 45], ["portal", "ANATOMY", 84, 90], ["hypertension", "DISEASE", 91, 103], ["congenital portosystemic shunts", "DISEASE", 114, 145], ["varicose", "TISSUE", 37, 45], ["portal", "MULTI-TISSUE_STRUCTURE", 84, 90], ["portosystemic shunts", "PATHOLOGICAL_FORMATION", 125, 145], ["these varicose dilations", "PROBLEM", 31, 55], ["portal hypertension", "PROBLEM", 84, 103], ["true congenital portosystemic shunts", "PROBLEM", 109, 145], ["varicose", "OBSERVATION", 37, 45], ["portal", "ANATOMY", 84, 90], ["hypertension", "OBSERVATION", 91, 103], ["true", "OBSERVATION_MODIFIER", 109, 113], ["congenital", "OBSERVATION_MODIFIER", 114, 124], ["portosystemic shunts", "OBSERVATION", 125, 145]]], ["Acquired shunts arise in vestigial nonfunctional portosystemic communications that dilate and become functional in response to portal hypertension.", [["portal", "ANATOMY", 127, 133], ["hypertension", "DISEASE", 134, 146], ["portal", "MULTI-TISSUE_STRUCTURE", 127, 133], ["Acquired shunts", "TREATMENT", 0, 15], ["vestigial nonfunctional portosystemic communications", "TREATMENT", 25, 77], ["portal hypertension", "PROBLEM", 127, 146], ["shunts", "OBSERVATION", 9, 15], ["vestigial", "ANATOMY_MODIFIER", 25, 34], ["nonfunctional", "OBSERVATION", 35, 48], ["portosystemic communications", "OBSERVATION", 49, 77], ["functional", "OBSERVATION", 101, 111], ["portal", "ANATOMY", 127, 133], ["hypertension", "OBSERVATION", 134, 146]]], ["They tend to develop between mesenteric veins and the caudal vena cava, right renal vein, or gonadal veins, and are multiple, taking the form of a plexus of tortuous, thin-walled vessels.", [["mesenteric veins", "ANATOMY", 29, 45], ["caudal vena cava", "ANATOMY", 54, 70], ["right renal vein", "ANATOMY", 72, 88], ["gonadal veins", "ANATOMY", 93, 106], ["plexus", "ANATOMY", 147, 153], ["tortuous", "ANATOMY", 157, 165], ["thin-walled vessels", "ANATOMY", 167, 186], ["mesenteric veins", "MULTI-TISSUE_STRUCTURE", 29, 45], ["caudal vena cava", "MULTI-TISSUE_STRUCTURE", 54, 70], ["right renal vein", "MULTI-TISSUE_STRUCTURE", 72, 88], ["gonadal veins", "MULTI-TISSUE_STRUCTURE", 93, 106], ["plexus", "MULTI-TISSUE_STRUCTURE", 147, 153], ["walled vessels", "MULTI-TISSUE_STRUCTURE", 172, 186], ["mesenteric veins", "ANATOMY", 29, 45], ["caudal vena cava", "ANATOMY", 54, 70], ["right", "ANATOMY_MODIFIER", 72, 77], ["renal vein", "ANATOMY", 78, 88], ["gonadal veins", "ANATOMY", 93, 106], ["multiple", "OBSERVATION_MODIFIER", 116, 124], ["plexus", "ANATOMY", 147, 153], ["tortuous", "OBSERVATION", 157, 165], ["thin", "OBSERVATION_MODIFIER", 167, 171], ["walled", "ANATOMY_MODIFIER", 172, 178], ["vessels", "ANATOMY", 179, 186]]], ["Esophageal shunts and varicosities are common in humans with cirrhosis, but are much less important in domestic animals.", [["Esophageal", "ANATOMY", 0, 10], ["varicosities", "ANATOMY", 22, 34], ["Esophageal shunts", "DISEASE", 0, 17], ["cirrhosis", "DISEASE", 61, 70], ["Esophageal shunts", "PATHOLOGICAL_FORMATION", 0, 17], ["varicosities", "MULTI-TISSUE_STRUCTURE", 22, 34], ["humans", "ORGANISM", 49, 55], ["humans", "SPECIES", 49, 55], ["humans", "SPECIES", 49, 55], ["Esophageal shunts", "TREATMENT", 0, 17], ["varicosities", "PROBLEM", 22, 34], ["cirrhosis", "PROBLEM", 61, 70], ["shunts", "OBSERVATION", 11, 17], ["varicosities", "OBSERVATION", 22, 34], ["common", "OBSERVATION_MODIFIER", 39, 45], ["cirrhosis", "OBSERVATION", 61, 70], ["much less", "OBSERVATION_MODIFIER", 80, 89]]], ["This may be related to postural differences such that shunts are more likely to enter the vena cava, where central venous pressure is least.", [["vena cava", "ANATOMY", 90, 99], ["venous", "ANATOMY", 115, 121], ["vena cava", "MULTI-TISSUE_STRUCTURE", 90, 99], ["central venous", "MULTI-TISSUE_STRUCTURE", 107, 121], ["postural differences", "PROBLEM", 23, 43], ["shunts", "TREATMENT", 54, 60], ["central venous pressure", "TEST", 107, 130], ["may be related to", "UNCERTAINTY", 5, 22], ["postural differences", "OBSERVATION", 23, 43], ["shunts", "OBSERVATION", 54, 60], ["vena cava", "ANATOMY", 90, 99], ["central", "ANATOMY_MODIFIER", 107, 114], ["venous", "ANATOMY", 115, 121], ["pressure", "OBSERVATION_MODIFIER", 122, 130]]], ["In dogs, acquired shunts are most numerous along the caudal mesentery.Peliosis hepatis/telangiectasisPeliosis hepatis is a term used to designate a hepatic vascular disorder characterized by cystic, blood-filled spaces in the liver.", [["caudal mesentery", "ANATOMY", 53, 69], ["hepatic vascular", "ANATOMY", 148, 164], ["cystic", "ANATOMY", 191, 197], ["blood", "ANATOMY", 199, 204], ["liver", "ANATOMY", 226, 231], ["Peliosis hepatis/telangiectasis", "DISEASE", 70, 101], ["Peliosis hepatis", "DISEASE", 101, 117], ["hepatic vascular disorder", "DISEASE", 148, 173], ["dogs", "ORGANISM", 3, 7], ["caudal mesentery", "MULTI-TISSUE_STRUCTURE", 53, 69], ["hepatic vascular", "MULTI-TISSUE_STRUCTURE", 148, 164], ["blood", "ORGANISM_SUBSTANCE", 199, 204], ["liver", "ORGAN", 226, 231], ["dogs", "SPECIES", 3, 7], ["Peliosis hepatis/telangiectasis", "SPECIES", 70, 101], ["acquired shunts", "TREATMENT", 9, 24], ["Peliosis hepatis/telangiectasis", "PROBLEM", 70, 101], ["Peliosis hepatis", "PROBLEM", 101, 117], ["a hepatic vascular disorder", "PROBLEM", 146, 173], ["cystic, blood-filled spaces in the liver", "PROBLEM", 191, 231], ["dogs", "OBSERVATION", 3, 7], ["shunts", "OBSERVATION", 18, 24], ["caudal", "ANATOMY_MODIFIER", 53, 59], ["mesentery", "ANATOMY", 60, 69], ["hepatis", "ANATOMY", 79, 86], ["telangiectasis", "OBSERVATION", 87, 101], ["hepatis", "ANATOMY", 110, 117], ["hepatic", "ANATOMY", 148, 155], ["vascular", "ANATOMY", 156, 164], ["disorder", "OBSERVATION", 165, 173], ["cystic", "OBSERVATION", 191, 197], ["blood", "OBSERVATION", 199, 204], ["filled spaces", "OBSERVATION", 205, 218], ["liver", "ANATOMY", 226, 231]]], ["The distinction between telangiectasis and peliosis hepatis is subtle at best, and both conditions can be considered together.", [["peliosis hepatis", "ANATOMY", 43, 59], ["telangiectasis", "DISEASE", 24, 38], ["peliosis", "DISEASE", 43, 51], ["telangiectasis", "CANCER", 24, 38], ["hepatis", "ORGAN", 52, 59], ["telangiectasis", "PROBLEM", 24, 38], ["peliosis hepatis", "PROBLEM", 43, 59], ["telangiectasis", "OBSERVATION", 24, 38], ["peliosis", "OBSERVATION", 43, 51], ["hepatis", "ANATOMY", 52, 59], ["subtle", "OBSERVATION_MODIFIER", 63, 69]]], ["Microvascular permeability to plasma proteins, a hallmark of acute inflammation in most tissues, is a normal property of the fenestrated sinusoidal endothelium of the liver.", [["Microvascular", "ANATOMY", 0, 13], ["plasma", "ANATOMY", 30, 36], ["tissues", "ANATOMY", 88, 95], ["sinusoidal endothelium", "ANATOMY", 137, 159], ["liver", "ANATOMY", 167, 172], ["inflammation", "DISEASE", 67, 79], ["Microvascular", "TISSUE", 0, 13], ["plasma", "ORGANISM_SUBSTANCE", 30, 36], ["tissues", "TISSUE", 88, 95], ["fenestrated sinusoidal endothelium", "TISSUE", 125, 159], ["liver", "ORGAN", 167, 172], ["plasma proteins", "PROTEIN", 30, 45], ["Microvascular permeability", "TEST", 0, 26], ["plasma proteins", "TEST", 30, 45], ["acute inflammation in most tissues", "PROBLEM", 61, 95], ["hallmark", "OBSERVATION_MODIFIER", 49, 57], ["acute", "OBSERVATION_MODIFIER", 61, 66], ["inflammation", "OBSERVATION", 67, 79], ["most tissues", "OBSERVATION_MODIFIER", 83, 95], ["normal", "OBSERVATION", 102, 108], ["fenestrated", "OBSERVATION", 125, 136], ["sinusoidal endothelium", "OBSERVATION", 137, 159], ["liver", "ANATOMY", 167, 172]]], ["Thus sinusoidal edema is not a prominent feature of acute parenchymal inflammation, although edema can be observed in the capsule, portal tracts, connective tissue of the terminal and sublobular hepatic veins (particularly in dogs), and in the wall of the gallbladder.", [["sinusoidal edema", "ANATOMY", 5, 21], ["parenchymal", "ANATOMY", 58, 69], ["edema", "ANATOMY", 93, 98], ["capsule", "ANATOMY", 122, 129], ["portal tracts", "ANATOMY", 131, 144], ["connective tissue", "ANATOMY", 146, 163], ["terminal", "ANATOMY", 171, 179], ["sublobular hepatic veins", "ANATOMY", 184, 208], ["wall", "ANATOMY", 244, 248], ["gallbladder", "ANATOMY", 256, 267], ["edema", "DISEASE", 16, 21], ["inflammation", "DISEASE", 70, 82], ["edema", "DISEASE", 93, 98], ["sinusoidal edema", "PATHOLOGICAL_FORMATION", 5, 21], ["parenchymal inflammation", "PATHOLOGICAL_FORMATION", 58, 82], ["edema", "PATHOLOGICAL_FORMATION", 93, 98], ["capsule", "CANCER", 122, 129], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 131, 144], ["connective tissue", "TISSUE", 146, 163], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 195, 208], ["dogs", "ORGANISM", 226, 230], ["wall", "TISSUE", 244, 248], ["gallbladder", "ORGAN", 256, 267], ["dogs", "SPECIES", 226, 230], ["sinusoidal edema", "PROBLEM", 5, 21], ["acute parenchymal inflammation", "PROBLEM", 52, 82], ["edema", "PROBLEM", 93, 98], ["sinusoidal", "OBSERVATION_MODIFIER", 5, 15], ["edema", "OBSERVATION", 16, 21], ["not a prominent", "OBSERVATION_MODIFIER", 25, 40], ["acute", "OBSERVATION_MODIFIER", 52, 57], ["parenchymal", "ANATOMY_MODIFIER", 58, 69], ["inflammation", "OBSERVATION", 70, 82], ["edema", "OBSERVATION", 93, 98], ["capsule", "ANATOMY_MODIFIER", 122, 129], ["portal tracts", "ANATOMY", 131, 144], ["connective tissue", "OBSERVATION", 146, 163], ["terminal", "ANATOMY_MODIFIER", 171, 179], ["sublobular", "ANATOMY_MODIFIER", 184, 194], ["hepatic veins", "ANATOMY", 195, 208], ["wall", "ANATOMY_MODIFIER", 244, 248], ["gallbladder", "ANATOMY", 256, 267]]], ["Microvascular blood flow in hepatic sinusoids is also less responsive to the actions of various vasoactive mediators that alter blood flow in most other acutely inflamed tissues.", [["Microvascular", "ANATOMY", 0, 13], ["blood", "ANATOMY", 14, 19], ["hepatic sinusoids", "ANATOMY", 28, 45], ["blood", "ANATOMY", 128, 133], ["tissues", "ANATOMY", 170, 177], ["Microvascular", "TISSUE", 0, 13], ["blood", "ORGANISM_SUBSTANCE", 14, 19], ["hepatic sinusoids", "MULTI-TISSUE_STRUCTURE", 28, 45], ["blood", "ORGANISM_SUBSTANCE", 128, 133], ["tissues", "TISSUE", 170, 177], ["Microvascular blood flow", "TEST", 0, 24], ["hepatic sinusoids", "PROBLEM", 28, 45], ["various vasoactive mediators", "TREATMENT", 88, 116], ["blood flow", "TEST", 128, 138], ["blood flow", "OBSERVATION", 14, 24], ["hepatic", "ANATOMY", 28, 35], ["sinusoids", "ANATOMY_MODIFIER", 36, 45], ["acutely", "OBSERVATION_MODIFIER", 153, 160], ["inflamed", "OBSERVATION", 161, 169]]], ["Second, resident Kupffer cells play an important and complex role in liver inflammation, injury, and repair.", [["Kupffer cells", "ANATOMY", 17, 30], ["liver", "ANATOMY", 69, 74], ["liver inflammation", "DISEASE", 69, 87], ["Kupffer cells", "CELL", 17, 30], ["liver", "ORGAN", 69, 74], ["resident Kupffer cells", "CELL_TYPE", 8, 30], ["liver inflammation", "PROBLEM", 69, 87], ["injury", "PROBLEM", 89, 95], ["repair", "TREATMENT", 101, 107], ["liver", "ANATOMY", 69, 74], ["inflammation", "OBSERVATION", 75, 87], ["injury", "OBSERVATION", 89, 95], ["repair", "OBSERVATION", 101, 107]]], ["Kupffer cells function in the innate immune response, acting as the final component of the gut barrier by phagocytosing pathogens, immunoreactive material, and endotoxin entering the liver via the portal circulation.", [["Kupffer cells", "ANATOMY", 0, 13], ["gut barrier", "ANATOMY", 91, 102], ["liver", "ANATOMY", 183, 188], ["portal", "ANATOMY", 197, 203], ["Kupffer cells", "CELL", 0, 13], ["gut barrier", "TISSUE", 91, 102], ["endotoxin", "SIMPLE_CHEMICAL", 160, 169], ["liver", "ORGAN", 183, 188], ["portal circulation", "MULTI-TISSUE_STRUCTURE", 197, 215], ["Kupffer cells", "CELL_TYPE", 0, 13], ["immunoreactive material", "TEST", 131, 154], ["liver", "ANATOMY", 183, 188], ["portal circulation", "ANATOMY", 197, 215]]], ["However, Kupffer cells also exhibit a range of different activated phenotypes, depending on the local metabolic and immune environment.", [["Kupffer cells", "ANATOMY", 9, 22], ["Kupffer cells", "CELL", 9, 22], ["Kupffer cells", "CELL_TYPE", 9, 22], ["different activated phenotypes", "PROBLEM", 47, 77]]], ["Classically activated macrophages secrete proinflammatory cytokines, including tumor necrosis factor-\u03b1, interleukin-1 (IL-1), IL-6, IL-12, and inducible nitric oxide synthase (iNOS), influencing cell populations in the liver and elsewhere, whereas alternatively, activated macrophages express anti-inflammatory mediators, including IL-10 and contribute to resolution of inflammation and promote repair.", [["macrophages", "ANATOMY", 22, 33], ["cell", "ANATOMY", 195, 199], ["liver", "ANATOMY", 219, 224], ["macrophages", "ANATOMY", 273, 284], ["necrosis", "DISEASE", 85, 93], ["nitric oxide", "CHEMICAL", 153, 165], ["inflammation", "DISEASE", 370, 382], ["nitric oxide", "CHEMICAL", 153, 165], ["macrophages", "CELL", 22, 33], ["tumor necrosis factor-\u03b1", "GENE_OR_GENE_PRODUCT", 79, 102], ["interleukin-1", "GENE_OR_GENE_PRODUCT", 104, 117], ["IL-1", "GENE_OR_GENE_PRODUCT", 119, 123], ["IL-6", "GENE_OR_GENE_PRODUCT", 126, 130], ["IL-12", "GENE_OR_GENE_PRODUCT", 132, 137], ["inducible nitric oxide synthase", "GENE_OR_GENE_PRODUCT", 143, 174], ["iNOS", "GENE_OR_GENE_PRODUCT", 176, 180], ["cell populations", "CELL", 195, 211], ["liver", "ORGAN", 219, 224], ["macrophages", "CELL", 273, 284], ["IL-10", "GENE_OR_GENE_PRODUCT", 332, 337], ["activated macrophages", "CELL_TYPE", 12, 33], ["proinflammatory cytokines", "PROTEIN", 42, 67], ["tumor necrosis factor-\u03b1", "PROTEIN", 79, 102], ["interleukin-1 (IL-1", "PROTEIN", 104, 123], ["IL-12", "PROTEIN", 132, 137], ["nitric oxide synthase", "PROTEIN", 153, 174], ["iNOS", "PROTEIN", 176, 180], ["activated macrophages", "CELL_TYPE", 263, 284], ["anti-inflammatory mediators", "PROTEIN", 293, 320], ["IL-10", "PROTEIN", 332, 337], ["Classically activated macrophages secrete proinflammatory cytokines", "PROBLEM", 0, 67], ["tumor necrosis factor", "PROBLEM", 79, 100], ["interleukin", "TEST", 104, 115], ["IL", "TEST", 126, 128], ["IL", "TREATMENT", 132, 134], ["inducible nitric oxide synthase", "TREATMENT", 143, 174], ["influencing cell populations in the liver", "PROBLEM", 183, 224], ["anti-inflammatory mediators", "TREATMENT", 293, 320], ["inflammation", "PROBLEM", 370, 382], ["promote repair", "TREATMENT", 387, 401], ["macrophages", "OBSERVATION_MODIFIER", 22, 33], ["secrete", "OBSERVATION_MODIFIER", 34, 41], ["proinflammatory cytokines", "OBSERVATION", 42, 67], ["tumor", "OBSERVATION_MODIFIER", 79, 84], ["necrosis", "OBSERVATION", 85, 93], ["nitric oxide synthase", "OBSERVATION", 153, 174], ["cell populations", "OBSERVATION", 195, 211], ["liver", "ANATOMY", 219, 224], ["inflammation", "OBSERVATION", 370, 382], ["repair", "OBSERVATION", 395, 401]]], ["Dysregulation of the complex control of inflammatory responses in Kupffer cells can contribute to chronic inflammation in the liver.", [["Kupffer cells", "ANATOMY", 66, 79], ["liver", "ANATOMY", 126, 131], ["inflammation", "DISEASE", 106, 118], ["Kupffer cells", "CELL", 66, 79], ["liver", "ORGAN", 126, 131], ["Kupffer cells", "CELL_TYPE", 66, 79], ["inflammatory responses in Kupffer cells", "PROBLEM", 40, 79], ["chronic inflammation in the liver", "PROBLEM", 98, 131], ["complex", "OBSERVATION_MODIFIER", 21, 28], ["inflammatory", "OBSERVATION_MODIFIER", 40, 52], ["Kupffer cells", "OBSERVATION", 66, 79], ["chronic", "OBSERVATION_MODIFIER", 98, 105], ["inflammation", "OBSERVATION", 106, 118], ["liver", "ANATOMY", 126, 131]]], ["Third, the liver has central regulatory influences on many proinflammatory insults and inflammatory mediators.", [["liver", "ANATOMY", 11, 16], ["liver", "ORGAN", 11, 16], ["inflammatory mediators", "PROTEIN", 87, 109], ["central regulatory influences", "PROBLEM", 21, 50], ["many proinflammatory insults", "TREATMENT", 54, 82], ["inflammatory mediators", "TREATMENT", 87, 109], ["liver", "ANATOMY", 11, 16], ["central regulatory", "OBSERVATION", 21, 39], ["many", "OBSERVATION_MODIFIER", 54, 58], ["proinflammatory insults", "OBSERVATION", 59, 82], ["inflammatory", "OBSERVATION_MODIFIER", 87, 99]]], ["As the major source of acute-phase proteins, including secreted pathogen recognition receptors (PRRs), short pentraxins, components of the complement system, and regulators of iron metabolism, hepatocytes are essential constituents of innate immunity and largely contribute to the control of a systemic inflammatory response.", [["hepatocytes", "ANATOMY", 193, 204], ["iron", "CHEMICAL", 176, 180], ["iron", "CHEMICAL", 176, 180], ["pathogen recognition receptors", "GENE_OR_GENE_PRODUCT", 64, 94], ["PRRs", "GENE_OR_GENE_PRODUCT", 96, 100], ["pentraxins", "GENE_OR_GENE_PRODUCT", 109, 119], ["iron", "SIMPLE_CHEMICAL", 176, 180], ["hepatocytes", "CELL", 193, 204], ["acute-phase proteins", "PROTEIN", 23, 43], ["secreted pathogen recognition receptors", "PROTEIN", 55, 94], ["PRRs", "PROTEIN", 96, 100], ["pentraxins", "PROTEIN", 109, 119], ["hepatocytes", "CELL_TYPE", 193, 204], ["acute-phase proteins", "PROBLEM", 23, 43], ["short pentraxins", "PROBLEM", 103, 119], ["the complement system", "TEST", 135, 156], ["iron metabolism", "PROBLEM", 176, 191], ["innate immunity", "TREATMENT", 235, 250], ["a systemic inflammatory response", "PROBLEM", 292, 324], ["acute", "OBSERVATION_MODIFIER", 23, 28], ["hepatocytes", "ANATOMY", 193, 204], ["systemic", "OBSERVATION_MODIFIER", 294, 302], ["inflammatory", "OBSERVATION", 303, 315]]], ["The liver is also the site of degradation of most soluble plasma proteins, and Kupffer cells are the main site of clearance of immune complexes from the circulation, playing an important role in the development of immunotolerance to potential antigenic substances absorbed from the intestine.", [["liver", "ANATOMY", 4, 9], ["plasma", "ANATOMY", 58, 64], ["Kupffer cells", "ANATOMY", 79, 92], ["intestine", "ANATOMY", 282, 291], ["liver", "ORGAN", 4, 9], ["plasma", "ORGANISM_SUBSTANCE", 58, 64], ["Kupffer cells", "CELL", 79, 92], ["intestine", "ORGAN", 282, 291], ["plasma proteins", "PROTEIN", 58, 73], ["Kupffer cells", "CELL_TYPE", 79, 92], ["immune complexes", "PROTEIN", 127, 143], ["most soluble plasma proteins", "TEST", 45, 73], ["immune complexes", "PROBLEM", 127, 143], ["liver", "ANATOMY", 4, 9], ["Kupffer cells", "OBSERVATION", 79, 92], ["main", "OBSERVATION_MODIFIER", 101, 105], ["clearance", "OBSERVATION", 114, 123], ["immune complexes", "OBSERVATION", 127, 143], ["circulation", "OBSERVATION_MODIFIER", 153, 164], ["intestine", "ANATOMY", 282, 291]]], ["A full discussion of immune surveillance, and the complex innate and adaptive immune responses involved in initiation and regulation of liver inflammation, is beyond the scope of this chapter, and readers are directed to current review articles on the subject.Peliosis hepatis/telangiectasisThese unusual aspects of the inflammatory response in the liver can make it more difficult to differentiate certain degenerative and inflammatory conditions in this organ.", [["liver", "ANATOMY", 136, 141], ["liver", "ANATOMY", 349, 354], ["organ", "ANATOMY", 456, 461], ["liver inflammation", "DISEASE", 136, 154], ["Peliosis hepatis/telangiectasis", "DISEASE", 260, 291], ["liver", "ORGAN", 136, 141], ["liver", "ORGAN", 349, 354], ["organ", "ORGAN", 456, 461], ["Peliosis hepatis/telangiectasis", "SPECIES", 260, 291], ["immune surveillance", "TEST", 21, 40], ["liver inflammation", "PROBLEM", 136, 154], ["Peliosis hepatis/telangiectasis", "PROBLEM", 260, 291], ["the inflammatory response in the liver", "PROBLEM", 316, 354], ["degenerative and inflammatory conditions", "PROBLEM", 407, 447], ["liver", "ANATOMY", 136, 141], ["inflammation", "OBSERVATION", 142, 154], ["hepatis", "ANATOMY", 269, 276], ["telangiectasis", "OBSERVATION", 277, 291], ["inflammatory", "OBSERVATION", 320, 332], ["liver", "ANATOMY", 349, 354], ["degenerative", "OBSERVATION", 407, 419], ["inflammatory", "OBSERVATION", 424, 436]]], ["Ongoing cell death and repair can appear inflammatory, and acute leukocyte responses can cause necrosis and apoptosis in the liver.", [["cell", "ANATOMY", 8, 12], ["leukocyte", "ANATOMY", 65, 74], ["liver", "ANATOMY", 125, 130], ["death", "DISEASE", 13, 18], ["necrosis", "DISEASE", 95, 103], ["cell", "CELL", 8, 12], ["leukocyte", "CELL", 65, 74], ["liver", "ORGAN", 125, 130], ["Ongoing cell death", "PROBLEM", 0, 18], ["repair", "TREATMENT", 23, 29], ["inflammatory", "PROBLEM", 41, 53], ["acute leukocyte responses", "PROBLEM", 59, 84], ["necrosis", "PROBLEM", 95, 103], ["apoptosis in the liver", "PROBLEM", 108, 130], ["cell death", "OBSERVATION", 8, 18], ["repair", "OBSERVATION", 23, 29], ["appear", "UNCERTAINTY", 34, 40], ["inflammatory", "OBSERVATION_MODIFIER", 41, 53], ["acute", "OBSERVATION_MODIFIER", 59, 64], ["leukocyte", "OBSERVATION", 65, 74], ["necrosis", "OBSERVATION", 95, 103], ["apoptosis", "OBSERVATION", 108, 117], ["liver", "ANATOMY", 125, 130]]], ["The term \"necroinflammatory\" is convenient when the underlying pathogenetic mechanisms of necrosis and inflammation are unknown.Peliosis hepatis/telangiectasisIncreased numbers of leukocytes (sinusoidal leukocytosis) are observed in hepatic sinusoids in many acute or subacute bacteremias, as well as in conditions of steroid excess in dogs.", [["leukocytes", "ANATOMY", 180, 190], ["sinusoidal", "ANATOMY", 192, 202], ["hepatic sinusoids", "ANATOMY", 233, 250], ["necrosis", "DISEASE", 90, 98], ["inflammation", "DISEASE", 103, 115], ["Peliosis hepatis/telangiectasis", "DISEASE", 128, 159], ["bacteremias", "DISEASE", 277, 288], ["steroid", "CHEMICAL", 318, 325], ["steroid", "CHEMICAL", 318, 325], ["leukocytes", "CELL", 180, 190], ["sinusoidal", "MULTI-TISSUE_STRUCTURE", 192, 202], ["hepatic sinusoids", "MULTI-TISSUE_STRUCTURE", 233, 250], ["steroid", "SIMPLE_CHEMICAL", 318, 325], ["dogs", "ORGANISM", 336, 340], ["leukocytes", "CELL_TYPE", 180, 190], ["dogs", "SPECIES", 336, 340], ["Peliosis hepatis/telangiectasis", "SPECIES", 128, 159], ["The term \"necroinflammatory\"", "PROBLEM", 0, 28], ["necrosis", "PROBLEM", 90, 98], ["inflammation", "PROBLEM", 103, 115], ["Peliosis hepatis/telangiectasis", "PROBLEM", 128, 159], ["Increased numbers of leukocytes", "PROBLEM", 159, 190], ["sinusoidal leukocytosis", "PROBLEM", 192, 215], ["hepatic sinusoids", "PROBLEM", 233, 250], ["subacute bacteremias", "PROBLEM", 268, 288], ["steroid excess in dogs", "PROBLEM", 318, 340], ["necroinflammatory", "OBSERVATION_MODIFIER", 10, 27], ["necrosis", "OBSERVATION", 90, 98], ["inflammation", "OBSERVATION", 103, 115], ["hepatis", "ANATOMY", 137, 144], ["telangiectasis", "OBSERVATION", 145, 159], ["numbers", "OBSERVATION_MODIFIER", 169, 176], ["leukocytes", "OBSERVATION_MODIFIER", 180, 190], ["sinusoidal", "OBSERVATION_MODIFIER", 192, 202], ["leukocytosis", "OBSERVATION", 203, 215], ["hepatic", "ANATOMY", 233, 240], ["sinusoids", "ANATOMY_MODIFIER", 241, 250], ["many", "OBSERVATION_MODIFIER", 254, 258], ["acute", "OBSERVATION_MODIFIER", 259, 264], ["subacute", "OBSERVATION_MODIFIER", 268, 276], ["bacteremias", "OBSERVATION", 277, 288], ["steroid excess", "OBSERVATION", 318, 332]]], ["This change can be diagnostically useful but does not constitute evidence of hepatitis unless there is obvious infiltration of granulocytes, monocytes, or lymphocytes into the perisinusoidal space.", [["granulocytes", "ANATOMY", 127, 139], ["monocytes", "ANATOMY", 141, 150], ["lymphocytes", "ANATOMY", 155, 166], ["perisinusoidal space", "ANATOMY", 176, 196], ["hepatitis", "DISEASE", 77, 86], ["granulocytes", "CELL", 127, 139], ["monocytes", "CELL", 141, 150], ["lymphocytes", "CELL", 155, 166], ["granulocytes", "CELL_TYPE", 127, 139], ["monocytes", "CELL_TYPE", 141, 150], ["lymphocytes", "CELL_TYPE", 155, 166], ["hepatitis", "PROBLEM", 77, 86], ["infiltration of granulocytes", "PROBLEM", 111, 139], ["monocytes", "TEST", 141, 150], ["lymphocytes into the perisinusoidal space", "PROBLEM", 155, 196], ["hepatitis", "OBSERVATION", 77, 86], ["obvious", "OBSERVATION_MODIFIER", 103, 110], ["infiltration", "OBSERVATION", 111, 123], ["granulocytes", "OBSERVATION", 127, 139], ["monocytes", "OBSERVATION_MODIFIER", 141, 150], ["lymphocytes", "OBSERVATION", 155, 166], ["perisinusoidal", "ANATOMY_MODIFIER", 176, 190]]], ["Extramedullary hematopoiesis can also appear as focal aggregates of myeloid cells in the perisinusoidal compartment.", [["focal aggregates", "ANATOMY", 48, 64], ["myeloid cells", "ANATOMY", 68, 81], ["perisinusoidal compartment", "ANATOMY", 89, 115], ["myeloid cells", "CELL", 68, 81], ["perisinusoidal compartment", "MULTI-TISSUE_STRUCTURE", 89, 115], ["myeloid cells", "CELL_TYPE", 68, 81], ["Extramedullary hematopoiesis", "PROBLEM", 0, 28], ["focal aggregates of myeloid cells in the perisinusoidal compartment", "PROBLEM", 48, 115], ["hematopoiesis", "OBSERVATION", 15, 28], ["focal", "OBSERVATION_MODIFIER", 48, 53], ["aggregates", "OBSERVATION", 54, 64], ["myeloid cells", "OBSERVATION", 68, 81], ["perisinusoidal", "ANATOMY_MODIFIER", 89, 103]]], ["This change can be distinguished from inflammatory infiltrates by the presence of immature myeloid cells.", [["myeloid cells", "ANATOMY", 91, 104], ["myeloid cells", "CELL", 91, 104], ["immature myeloid cells", "CELL_TYPE", 82, 104], ["inflammatory infiltrates", "PROBLEM", 38, 62], ["immature myeloid cells", "PROBLEM", 82, 104], ["inflammatory", "OBSERVATION_MODIFIER", 38, 50], ["infiltrates", "OBSERVATION", 51, 62], ["immature myeloid cells", "OBSERVATION", 82, 104]]], ["Occasionally, hematopoietic cells from the splenic red pulp can be artifactually extruded into the portal vasculature and liver may resemble a huge, blood-filled sponge (Fig. 2-55) .", [["hematopoietic cells", "ANATOMY", 14, 33], ["splenic red pulp", "ANATOMY", 43, 59], ["portal vasculature", "ANATOMY", 99, 117], ["liver", "ANATOMY", 122, 127], ["blood", "ANATOMY", 149, 154], ["hematopoietic cells", "CELL", 14, 33], ["splenic red pulp", "TISSUE", 43, 59], ["portal vasculature", "MULTI-TISSUE_STRUCTURE", 99, 117], ["liver", "ORGAN", 122, 127], ["blood", "ORGANISM_SUBSTANCE", 149, 154], ["hematopoietic cells", "CELL_TYPE", 14, 33], ["hematopoietic cells", "PROBLEM", 14, 33], ["a huge, blood-filled sponge", "PROBLEM", 141, 168], ["hematopoietic cells", "OBSERVATION", 14, 33], ["splenic", "ANATOMY", 43, 50], ["red pulp", "OBSERVATION", 51, 59], ["portal vasculature", "ANATOMY", 99, 117], ["liver", "ANATOMY", 122, 127], ["huge", "OBSERVATION_MODIFIER", 143, 147], ["filled sponge", "OBSERVATION", 155, 168]]], ["The animals eventually die of a combination of hemodilutional anemia and circulatory failure.INFLAMMATORY DISEASES OF THE LIVER AND BILIARY TRACTThe inflammatory response in the liver is unusual for 3 main reasons.", [["circulatory", "ANATOMY", 73, 84], ["liver", "ANATOMY", 178, 183], ["anemia", "DISEASE", 62, 68], ["circulatory failure", "DISEASE", 73, 92], ["animals", "ORGANISM", 4, 11], ["liver", "ORGAN", 178, 183], ["hemodilutional anemia", "PROBLEM", 47, 68], ["circulatory failure", "PROBLEM", 73, 92], ["INFLAMMATORY DISEASES OF THE LIVER AND BILIARY TRACT", "PROBLEM", 93, 145], ["The inflammatory response in the liver", "PROBLEM", 145, 183], ["anemia", "OBSERVATION", 62, 68], ["circulatory failure", "OBSERVATION", 73, 92], ["LIVER", "ANATOMY", 122, 127], ["BILIARY TRACT", "ANATOMY", 132, 145], ["inflammatory", "OBSERVATION", 149, 161], ["liver", "ANATOMY", 178, 183]]], ["First, hepatic microvasculature is structurally and functionally different from tissues with capillary vasculature. large extrahepatic bile ducts, hepatic lymph nodes, and sometimes in the capsule.", [["hepatic microvasculature", "ANATOMY", 7, 31], ["tissues", "ANATOMY", 80, 87], ["capillary vasculature", "ANATOMY", 93, 114], ["extrahepatic bile ducts", "ANATOMY", 122, 145], ["hepatic lymph nodes", "ANATOMY", 147, 166], ["capsule", "ANATOMY", 189, 196], ["hepatic microvasculature", "TISSUE", 7, 31], ["tissues", "TISSUE", 80, 87], ["capillary vasculature", "MULTI-TISSUE_STRUCTURE", 93, 114], ["extrahepatic bile ducts", "MULTI-TISSUE_STRUCTURE", 122, 145], ["hepatic lymph nodes", "MULTI-TISSUE_STRUCTURE", 147, 166], ["capsule", "CANCER", 189, 196], ["large extrahepatic bile ducts, hepatic lymph nodes", "PROBLEM", 116, 166], ["hepatic", "ANATOMY", 7, 14], ["microvasculature", "ANATOMY_MODIFIER", 15, 31], ["capillary", "ANATOMY_MODIFIER", 93, 102], ["vasculature", "ANATOMY", 103, 114], ["extrahepatic", "ANATOMY_MODIFIER", 122, 134], ["bile ducts", "ANATOMY", 135, 145], ["hepatic", "ANATOMY", 147, 154], ["lymph nodes", "OBSERVATION", 155, 166], ["capsule", "ANATOMY", 189, 196]]], ["Microscopically, edema is also evident in the portal triads, in the connective tissue of the terminal and sublobular veins, and sometimes by an increase in the perisinusoidal space.INFLAMMATORY DISEASES OF THE LIVER AND BILIARY TRACTKupffer cells are key participants in the acute inflammatory responses in the liver.", [["edema", "ANATOMY", 17, 22], ["portal triads", "ANATOMY", 46, 59], ["connective tissue", "ANATOMY", 68, 85], ["terminal", "ANATOMY", 93, 101], ["sublobular veins", "ANATOMY", 106, 122], ["perisinusoidal space", "ANATOMY", 160, 180], ["TRACTKupffer cells", "ANATOMY", 228, 246], ["liver", "ANATOMY", 311, 316], ["edema", "DISEASE", 17, 22], ["edema", "PATHOLOGICAL_FORMATION", 17, 22], ["portal triads", "MULTI-TISSUE_STRUCTURE", 46, 59], ["connective tissue", "TISSUE", 68, 85], ["sublobular veins", "MULTI-TISSUE_STRUCTURE", 106, 122], ["BILIARY TRACTKupffer cells", "CELL", 220, 246], ["liver", "ORGAN", 311, 316], ["participants", "SPECIES", 255, 267], ["edema", "PROBLEM", 17, 22], ["an increase in the perisinusoidal space", "PROBLEM", 141, 180], ["INFLAMMATORY DISEASES OF THE LIVER AND BILIARY TRACTKupffer cells", "PROBLEM", 181, 246], ["the acute inflammatory responses in the liver", "PROBLEM", 271, 316], ["edema", "OBSERVATION", 17, 22], ["portal triads", "ANATOMY", 46, 59], ["connective tissue", "ANATOMY_MODIFIER", 68, 85], ["terminal", "ANATOMY_MODIFIER", 93, 101], ["sublobular veins", "ANATOMY", 106, 122], ["increase", "OBSERVATION_MODIFIER", 144, 152], ["perisinusoidal space", "OBSERVATION", 160, 180], ["DISEASES", "OBSERVATION", 194, 202], ["LIVER", "ANATOMY", 210, 215], ["BILIARY", "ANATOMY", 220, 227], ["acute", "OBSERVATION_MODIFIER", 275, 280], ["inflammatory", "OBSERVATION", 281, 293], ["liver", "ANATOMY", 311, 316]]], ["They can enlarge and accumulate vacuoles and lysosomal debris during regular phagocytic removal of microorganisms, cell debris, and extravascular erythrocytes.", [["vacuoles", "ANATOMY", 32, 40], ["lysosomal debris", "ANATOMY", 45, 61], ["cell", "ANATOMY", 115, 119], ["extravascular erythrocytes", "ANATOMY", 132, 158], ["vacuoles", "CELLULAR_COMPONENT", 32, 40], ["lysosomal debris", "CELLULAR_COMPONENT", 45, 61], ["cell", "CELL", 115, 119], ["extravascular erythrocytes", "CELL", 132, 158], ["extravascular erythrocytes", "CELL_TYPE", 132, 158], ["lysosomal debris", "PROBLEM", 45, 61], ["regular phagocytic removal", "TREATMENT", 69, 95], ["microorganisms", "PROBLEM", 99, 113], ["cell debris", "PROBLEM", 115, 126], ["extravascular erythrocytes", "PROBLEM", 132, 158], ["vacuoles", "OBSERVATION_MODIFIER", 32, 40], ["lysosomal debris", "OBSERVATION", 45, 61], ["phagocytic removal", "OBSERVATION", 77, 95], ["microorganisms", "OBSERVATION", 99, 113], ["cell debris", "OBSERVATION", 115, 126], ["extravascular erythrocytes", "OBSERVATION", 132, 158]]], ["They can also be activated to secretory histiocytes that release various cytokines and other mediators that induce hypertrophic or proliferative responses of hepatocytes, stellate cells, and endothelium.", [["secretory histiocytes", "ANATOMY", 30, 51], ["hepatocytes", "ANATOMY", 158, 169], ["stellate cells", "ANATOMY", 171, 185], ["endothelium", "ANATOMY", 191, 202], ["secretory histiocytes", "CELL", 30, 51], ["hepatocytes", "CELL", 158, 169], ["stellate cells", "CELL", 171, 185], ["endothelium", "TISSUE", 191, 202], ["secretory histiocytes", "CELL_TYPE", 30, 51], ["cytokines", "PROTEIN", 73, 82], ["hepatocytes", "CELL_TYPE", 158, 169], ["stellate cells", "CELL_TYPE", 171, 185], ["secretory histiocytes", "PROBLEM", 30, 51], ["various cytokines", "TEST", 65, 82], ["hypertrophic or proliferative responses of hepatocytes", "PROBLEM", 115, 169], ["stellate cells", "PROBLEM", 171, 185], ["histiocytes", "OBSERVATION", 40, 51], ["hypertrophic", "OBSERVATION_MODIFIER", 115, 127], ["proliferative", "OBSERVATION_MODIFIER", 131, 144], ["hepatocytes", "ANATOMY", 158, 169], ["stellate cells", "OBSERVATION", 171, 185], ["endothelium", "ANATOMY", 191, 202]]], ["Activated Kupffer cells are larger and more prominent or numerous in sections, their nuclei are larger and vesicular, and their cytoplasm is basophilic and may contain vacuoles or ingested particulate matter.", [["Kupffer cells", "ANATOMY", 10, 23], ["sections", "ANATOMY", 69, 77], ["nuclei", "ANATOMY", 85, 91], ["vesicular", "ANATOMY", 107, 116], ["cytoplasm", "ANATOMY", 128, 137], ["basophilic", "ANATOMY", 141, 151], ["vacuoles", "ANATOMY", 168, 176], ["particulate matter", "ANATOMY", 189, 207], ["Kupffer cells", "CELL", 10, 23], ["sections", "CANCER", 69, 77], ["nuclei", "CELLULAR_COMPONENT", 85, 91], ["cytoplasm", "ORGANISM_SUBSTANCE", 128, 137], ["vacuoles", "CELLULAR_COMPONENT", 168, 176], ["Kupffer cells", "CELL_TYPE", 10, 23], ["Activated Kupffer cells", "TREATMENT", 0, 23], ["Kupffer cells", "OBSERVATION", 10, 23], ["larger", "OBSERVATION_MODIFIER", 28, 34], ["more prominent", "OBSERVATION_MODIFIER", 39, 53], ["numerous", "OBSERVATION_MODIFIER", 57, 65], ["nuclei", "ANATOMY", 85, 91], ["larger", "OBSERVATION_MODIFIER", 96, 102], ["vesicular", "OBSERVATION_MODIFIER", 107, 116], ["basophilic", "OBSERVATION", 141, 151], ["may contain", "UNCERTAINTY", 156, 167], ["vacuoles", "OBSERVATION", 168, 176], ["ingested", "OBSERVATION_MODIFIER", 180, 188], ["particulate matter", "OBSERVATION", 189, 207]]], ["In overwhelming infections, many of the Kupffer cells and adjacent sinusoidal endothelial cells and hepatocytes undergo necrosis.Chronic hepatitisChronic liver disease in domestic animals has historically been classified into several different entities based on morphologic criteria, but fibrosis is a consistent feature.", [["Kupffer cells", "ANATOMY", 40, 53], ["sinusoidal endothelial cells", "ANATOMY", 67, 95], ["hepatocytes", "ANATOMY", 100, 111], ["liver", "ANATOMY", 154, 159], ["infections", "DISEASE", 16, 26], ["necrosis", "DISEASE", 120, 128], ["Chronic hepatitis", "DISEASE", 129, 146], ["Chronic liver disease", "DISEASE", 146, 167], ["fibrosis", "DISEASE", 288, 296], ["Kupffer cells", "CELL", 40, 53], ["adjacent sinusoidal endothelial cells", "CELL", 58, 95], ["hepatocytes", "CELL", 100, 111], ["liver", "ORGAN", 154, 159], ["Kupffer cells", "CELL_TYPE", 40, 53], ["adjacent sinusoidal endothelial cells", "CELL_TYPE", 58, 95], ["hepatocytes", "CELL_TYPE", 100, 111], ["overwhelming infections", "PROBLEM", 3, 26], ["the Kupffer cells", "PROBLEM", 36, 53], ["adjacent sinusoidal endothelial cells", "PROBLEM", 58, 95], ["necrosis", "PROBLEM", 120, 128], ["Chronic hepatitis", "PROBLEM", 129, 146], ["Chronic liver disease", "PROBLEM", 146, 167], ["fibrosis", "PROBLEM", 288, 296], ["overwhelming", "OBSERVATION_MODIFIER", 3, 15], ["infections", "OBSERVATION", 16, 26], ["Kupffer cells", "OBSERVATION", 40, 53], ["sinusoidal endothelial cells", "OBSERVATION", 67, 95], ["hepatocytes", "ANATOMY", 100, 111], ["necrosis", "OBSERVATION", 120, 128], ["hepatitis", "OBSERVATION", 137, 146], ["liver", "ANATOMY", 154, 159], ["disease", "OBSERVATION", 160, 167], ["several different", "OBSERVATION_MODIFIER", 226, 243], ["fibrosis", "OBSERVATION", 288, 296], ["consistent feature", "UNCERTAINTY", 302, 320]]], ["In human medicine, classification of chronic hepatitis has been simplified, and morphologic divisions such as chronic active hepatitis and chronic persistent hepatitis, originally defined in specific clinical contexts, have been abandoned because of problems of evolving definitions and application, and lack of correspondence with prognosis.", [["chronic hepatitis", "DISEASE", 37, 54], ["chronic active hepatitis", "DISEASE", 110, 134], ["hepatitis", "DISEASE", 158, 167], ["human", "ORGANISM", 3, 8], ["human", "SPECIES", 3, 8], ["human", "SPECIES", 3, 8], ["chronic hepatitis", "PROBLEM", 37, 54], ["chronic active hepatitis", "PROBLEM", 110, 134], ["chronic persistent hepatitis", "PROBLEM", 139, 167], ["chronic", "OBSERVATION_MODIFIER", 37, 44], ["hepatitis", "OBSERVATION", 45, 54], ["chronic", "OBSERVATION_MODIFIER", 110, 117], ["active", "OBSERVATION_MODIFIER", 118, 124], ["hepatitis", "OBSERVATION", 125, 134], ["chronic", "OBSERVATION_MODIFIER", 139, 146], ["persistent", "OBSERVATION_MODIFIER", 147, 157], ["hepatitis", "OBSERVATION", 158, 167]]], ["The single designation \"chronic hepatitis\" is now used for chronic necroinflammatory disease lasting more than 6 months, further modified by specifying the etiology, type and severity of inflammation, and degree and distribution of apoptosis and/or necrosis (disease activity or grade), and the degree of fibrosis (disease chronicity or stage).", [["chronic hepatitis", "DISEASE", 24, 41], ["necroinflammatory disease", "DISEASE", 67, 92], ["inflammation", "DISEASE", 187, 199], ["necrosis", "DISEASE", 249, 257], ["fibrosis", "DISEASE", 305, 313], ["The single designation \"chronic hepatitis\"", "PROBLEM", 0, 42], ["chronic necroinflammatory disease", "PROBLEM", 59, 92], ["inflammation", "PROBLEM", 187, 199], ["apoptosis", "PROBLEM", 232, 241], ["necrosis (disease activity", "PROBLEM", 249, 275], ["fibrosis (disease chronicity", "PROBLEM", 305, 333], ["chronic", "OBSERVATION_MODIFIER", 24, 31], ["hepatitis", "OBSERVATION", 32, 41], ["chronic", "OBSERVATION_MODIFIER", 59, 66], ["necroinflammatory", "OBSERVATION", 67, 84], ["inflammation", "OBSERVATION", 187, 199], ["degree", "OBSERVATION_MODIFIER", 205, 211], ["distribution", "OBSERVATION_MODIFIER", 216, 228], ["apoptosis", "OBSERVATION", 232, 241], ["necrosis", "OBSERVATION", 249, 257], ["degree", "OBSERVATION_MODIFIER", 295, 301], ["fibrosis", "OBSERVATION", 305, 313]]], ["Numerous systems for grading and staging chronic hepatitis have been developed.", [["chronic hepatitis", "DISEASE", 41, 58], ["grading", "TEST", 21, 28], ["staging chronic hepatitis", "PROBLEM", 33, 58], ["chronic", "OBSERVATION_MODIFIER", 41, 48], ["hepatitis", "OBSERVATION", 49, 58]]], ["In human medicine, chronic hepatitis is usually the result of chronic infection with hepatotropic viruses, and, less commonly, autoimmune, drug-induced, or associated with inherited metabolic diseases, such as Wilson disease.", [["chronic hepatitis", "DISEASE", 19, 36], ["infection", "DISEASE", 70, 79], ["hepatotropic viruses", "DISEASE", 85, 105], ["metabolic diseases", "DISEASE", 182, 200], ["Wilson disease", "DISEASE", 210, 224], ["human", "ORGANISM", 3, 8], ["human", "SPECIES", 3, 8], ["human", "SPECIES", 3, 8], ["chronic hepatitis", "PROBLEM", 19, 36], ["chronic infection", "PROBLEM", 62, 79], ["hepatotropic viruses", "PROBLEM", 85, 105], ["autoimmune", "PROBLEM", 127, 137], ["inherited metabolic diseases", "PROBLEM", 172, 200], ["Wilson disease", "PROBLEM", 210, 224], ["chronic", "OBSERVATION_MODIFIER", 19, 26], ["hepatitis", "OBSERVATION", 27, 36], ["chronic", "OBSERVATION_MODIFIER", 62, 69], ["infection", "OBSERVATION", 70, 79], ["hepatotropic viruses", "OBSERVATION", 85, 105], ["less commonly", "OBSERVATION_MODIFIER", 112, 125], ["metabolic diseases", "OBSERVATION", 182, 200]]], ["In veterinary medicine, chronic liver disease may develop following chronic bile duct obstruction, infection with hepatotropic infectious agents, familial or hereditary metabolic diseases, or may be toxic, drug-induced, or possibly autoimmune in origin.", [["liver", "ANATOMY", 32, 37], ["bile duct", "ANATOMY", 76, 85], ["chronic liver disease", "DISEASE", 24, 45], ["chronic bile duct obstruction", "DISEASE", 68, 97], ["infection", "DISEASE", 99, 108], ["hereditary metabolic diseases", "DISEASE", 158, 187], ["liver", "ORGAN", 32, 37], ["bile duct", "MULTI-TISSUE_STRUCTURE", 76, 85], ["chronic liver disease", "PROBLEM", 24, 45], ["chronic bile duct obstruction", "PROBLEM", 68, 97], ["infection", "PROBLEM", 99, 108], ["hepatotropic infectious agents", "TREATMENT", 114, 144], ["familial or hereditary metabolic diseases", "PROBLEM", 146, 187], ["autoimmune in origin", "PROBLEM", 232, 252], ["chronic", "OBSERVATION_MODIFIER", 24, 31], ["liver", "ANATOMY", 32, 37], ["disease", "OBSERVATION", 38, 45], ["chronic", "OBSERVATION_MODIFIER", 68, 75], ["bile duct", "ANATOMY", 76, 85], ["obstruction", "OBSERVATION", 86, 97], ["infection", "OBSERVATION", 99, 108], ["hepatotropic", "OBSERVATION_MODIFIER", 114, 126], ["infectious", "OBSERVATION", 127, 137], ["hereditary", "OBSERVATION_MODIFIER", 158, 168], ["metabolic diseases", "OBSERVATION", 169, 187], ["may be", "UNCERTAINTY", 192, 198], ["toxic", "OBSERVATION_MODIFIER", 199, 204], ["possibly", "UNCERTAINTY", 223, 231], ["autoimmune", "OBSERVATION", 232, 242]]], ["However, the majority of chronic liver disease is idiopathic, reflecting deficiencies in our current level of understanding of the etiologic, pathophysiologic, and clinical implications of the patterns of inflammation and necrosis seen in domestic animals.Chronic hepatitisRegardless of the etiology, initial acute liver damage will not progress to fibrosis or cirrhosis unless the inflammation and damage are protracted, for example, by ongoing hepatocellular injury mediated by immunologic mechanisms, including antibody-and lymphocyte-mediated cytotoxicity, or ongoing oxidative damage.", [["liver", "ANATOMY", 33, 38], ["liver", "ANATOMY", 315, 320], ["hepatocellular", "ANATOMY", 446, 460], ["lymphocyte", "ANATOMY", 527, 537], ["chronic liver disease", "DISEASE", 25, 46], ["idiopathic", "DISEASE", 50, 60], ["inflammation", "DISEASE", 205, 217], ["necrosis", "DISEASE", 222, 230], ["Chronic hepatitis", "DISEASE", 256, 273], ["acute liver damage", "DISEASE", 309, 327], ["fibrosis", "DISEASE", 349, 357], ["cirrhosis", "DISEASE", 361, 370], ["inflammation", "DISEASE", 382, 394], ["hepatocellular injury", "DISEASE", 446, 467], ["liver", "ORGAN", 33, 38], ["liver", "ORGAN", 315, 320], ["hepatocellular", "ORGAN", 446, 460], ["lymphocyte", "CELL", 527, 537], ["chronic liver disease", "PROBLEM", 25, 46], ["idiopathic", "PROBLEM", 50, 60], ["deficiencies", "PROBLEM", 73, 85], ["inflammation", "PROBLEM", 205, 217], ["necrosis", "PROBLEM", 222, 230], ["Chronic hepatitis", "PROBLEM", 256, 273], ["initial acute liver damage", "PROBLEM", 301, 327], ["fibrosis", "PROBLEM", 349, 357], ["cirrhosis", "PROBLEM", 361, 370], ["the inflammation", "PROBLEM", 378, 394], ["damage", "PROBLEM", 399, 405], ["ongoing hepatocellular injury", "PROBLEM", 438, 467], ["immunologic mechanisms", "PROBLEM", 480, 502], ["antibody", "TEST", 514, 522], ["lymphocyte-mediated cytotoxicity", "PROBLEM", 527, 559], ["ongoing oxidative damage", "PROBLEM", 564, 588], ["majority", "OBSERVATION_MODIFIER", 13, 21], ["chronic", "OBSERVATION_MODIFIER", 25, 32], ["liver", "ANATOMY", 33, 38], ["disease", "OBSERVATION", 39, 46], ["idiopathic", "OBSERVATION", 50, 60], ["inflammation", "OBSERVATION", 205, 217], ["necrosis", "OBSERVATION", 222, 230], ["hepatitis", "OBSERVATION", 264, 273], ["acute", "OBSERVATION_MODIFIER", 309, 314], ["liver", "ANATOMY", 315, 320], ["damage", "OBSERVATION", 321, 327], ["fibrosis", "OBSERVATION", 349, 357], ["cirrhosis", "OBSERVATION", 361, 370], ["inflammation", "OBSERVATION", 382, 394], ["damage", "OBSERVATION", 399, 405], ["protracted", "OBSERVATION_MODIFIER", 410, 420], ["hepatocellular", "ANATOMY", 446, 460], ["injury", "OBSERVATION", 461, 467], ["oxidative damage", "OBSERVATION", 572, 588]]], ["Clinical signs are nonspecific in the early stages, but as the disease progresses to involve more of the liver and impair regeneration, icterus, ascites, and hepatic encephalopathy may develop as typical correlates with hepatic insufficiency.Chronic hepatitisChronic hepatitis of humans has several characteristic lesions.", [["liver", "ANATOMY", 105, 110], ["ascites", "ANATOMY", 145, 152], ["hepatic", "ANATOMY", 158, 165], ["hepatic", "ANATOMY", 220, 227], ["lesions", "ANATOMY", 314, 321], ["icterus", "DISEASE", 136, 143], ["ascites", "DISEASE", 145, 152], ["hepatic encephalopathy", "DISEASE", 158, 180], ["hepatic insufficiency", "DISEASE", 220, 241], ["Chronic hepatitis", "DISEASE", 242, 259], ["Chronic hepatitis of humans", "DISEASE", 259, 286], ["liver", "ORGAN", 105, 110], ["hepatic", "ORGAN", 158, 165], ["hepatic", "ORGAN", 220, 227], ["humans", "ORGANISM", 280, 286], ["lesions", "PATHOLOGICAL_FORMATION", 314, 321], ["humans", "SPECIES", 280, 286], ["humans", "SPECIES", 280, 286], ["Clinical signs", "TEST", 0, 14], ["the disease", "PROBLEM", 59, 70], ["impair regeneration", "PROBLEM", 115, 134], ["icterus", "PROBLEM", 136, 143], ["ascites", "PROBLEM", 145, 152], ["hepatic encephalopathy", "PROBLEM", 158, 180], ["hepatic insufficiency", "PROBLEM", 220, 241], ["Chronic hepatitis", "PROBLEM", 242, 259], ["Chronic hepatitis of humans", "PROBLEM", 259, 286], ["several characteristic lesions", "PROBLEM", 291, 321], ["nonspecific", "OBSERVATION_MODIFIER", 19, 30], ["early stages", "OBSERVATION_MODIFIER", 38, 50], ["disease", "OBSERVATION", 63, 70], ["liver", "ANATOMY", 105, 110], ["impair", "OBSERVATION_MODIFIER", 115, 121], ["regeneration", "OBSERVATION_MODIFIER", 122, 134], ["icterus", "OBSERVATION", 136, 143], ["ascites", "OBSERVATION", 145, 152], ["hepatic", "ANATOMY", 158, 165], ["encephalopathy", "OBSERVATION", 166, 180], ["hepatic", "ANATOMY", 220, 227], ["insufficiency", "OBSERVATION", 228, 241], ["hepatitis", "OBSERVATION", 250, 259], ["hepatitis", "OBSERVATION", 267, 276], ["several", "OBSERVATION_MODIFIER", 291, 298], ["characteristic", "OBSERVATION_MODIFIER", 299, 313], ["lesions", "OBSERVATION", 314, 321]]], ["These are also evident in animals, although not always to the same degree or frequency as described in the various forms of viral, immune-mediated, and idiosyncratic hepatitis in humans.", [["hepatitis", "DISEASE", 166, 175], ["humans", "ORGANISM", 179, 185], ["humans", "SPECIES", 179, 185], ["humans", "SPECIES", 179, 185], ["idiosyncratic hepatitis in humans", "PROBLEM", 152, 185], ["idiosyncratic", "OBSERVATION_MODIFIER", 152, 165], ["hepatitis", "OBSERVATION", 166, 175]]], ["The first is periportal interface hepatitis, sometimes referred to as \"piecemeal necrosis\" (Fig. 2-56) .", [["periportal interface", "ANATOMY", 13, 33], ["hepatitis", "DISEASE", 34, 43], ["necrosis", "DISEASE", 81, 89], ["periportal interface hepatitis", "PROBLEM", 13, 43], ["piecemeal necrosis", "PROBLEM", 71, 89], ["periportal", "ANATOMY", 13, 23], ["interface hepatitis", "OBSERVATION", 24, 43], ["piecemeal", "OBSERVATION_MODIFIER", 71, 80], ["necrosis", "OBSERVATION", 81, 89]]], ["This appear in the liver, usually as nucleated cell aggregates in the larger portal veins.Chronic hepatitisInfectious agents capable of causing hepatitis include viruses, bacteria, fungi, protozoa, and helminths.", [["liver", "ANATOMY", 19, 24], ["nucleated cell aggregates", "ANATOMY", 37, 62], ["portal veins", "ANATOMY", 77, 89], ["Chronic hepatitis", "DISEASE", 90, 107], ["hepatitis", "DISEASE", 144, 153], ["helminths", "DISEASE", 202, 211], ["liver", "ORGAN", 19, 24], ["nucleated cell aggregates", "CELL", 37, 62], ["portal veins", "MULTI-TISSUE_STRUCTURE", 77, 89], ["nucleated cell aggregates", "CELL_TYPE", 37, 62], ["Chronic hepatitis", "PROBLEM", 90, 107], ["Infectious agents", "TREATMENT", 107, 124], ["hepatitis", "PROBLEM", 144, 153], ["viruses", "PROBLEM", 162, 169], ["bacteria", "PROBLEM", 171, 179], ["fungi", "PROBLEM", 181, 186], ["protozoa", "PROBLEM", 188, 196], ["liver", "ANATOMY", 19, 24], ["nucleated cell aggregates", "OBSERVATION", 37, 62], ["larger", "ANATOMY_MODIFIER", 70, 76], ["portal veins", "ANATOMY", 77, 89], ["hepatitis", "OBSERVATION", 98, 107], ["hepatitis", "OBSERVATION", 144, 153], ["viruses", "OBSERVATION", 162, 169]]], ["Autoimmune and idiosyncratic drug responses also occur, but often the etiology of acute or chronic hepatitis cannot be determined.Hepatic inflammationThe liver is subject to infectious and degenerative insults that elicit inflammatory responses in various patterns, for which the general term hepatitis is appropriate.", [["Hepatic", "ANATOMY", 130, 137], ["liver", "ANATOMY", 154, 159], ["hepatitis", "DISEASE", 99, 108], ["Hepatic inflammation", "DISEASE", 130, 150], ["hepatitis", "DISEASE", 293, 302], ["Hepatic", "ORGAN", 130, 137], ["liver", "ORGAN", 154, 159], ["Autoimmune", "PROBLEM", 0, 10], ["idiosyncratic drug responses", "PROBLEM", 15, 43], ["acute or chronic hepatitis", "PROBLEM", 82, 108], ["Hepatic inflammation", "PROBLEM", 130, 150], ["infectious", "PROBLEM", 174, 184], ["degenerative insults", "PROBLEM", 189, 209], ["inflammatory responses in various patterns", "PROBLEM", 222, 264], ["the general term hepatitis", "PROBLEM", 276, 302], ["idiosyncratic", "OBSERVATION_MODIFIER", 15, 28], ["drug responses", "OBSERVATION", 29, 43], ["acute", "OBSERVATION_MODIFIER", 82, 87], ["chronic", "OBSERVATION_MODIFIER", 91, 98], ["hepatitis", "OBSERVATION", 99, 108], ["inflammation", "OBSERVATION", 138, 150], ["liver", "ANATOMY", 154, 159], ["infectious", "OBSERVATION", 174, 184], ["degenerative", "OBSERVATION_MODIFIER", 189, 201], ["inflammatory", "OBSERVATION_MODIFIER", 222, 234], ["hepatitis", "OBSERVATION", 293, 302]]], ["The term hepatitis is used for focal or diffuse hepatic conditions that are either caused by infectious agents or characterized by a leukocytic infiltrative inflammatory response, irrespective of the cause.", [["hepatic", "ANATOMY", 48, 55], ["leukocytic", "ANATOMY", 133, 143], ["hepatitis", "DISEASE", 9, 18], ["hepatic", "ORGAN", 48, 55], ["The term hepatitis", "PROBLEM", 0, 18], ["focal or diffuse hepatic conditions", "PROBLEM", 31, 66], ["a leukocytic infiltrative inflammatory response", "PROBLEM", 131, 178], ["term", "OBSERVATION_MODIFIER", 4, 8], ["hepatitis", "OBSERVATION", 9, 18], ["focal", "OBSERVATION_MODIFIER", 31, 36], ["diffuse", "OBSERVATION_MODIFIER", 40, 47], ["hepatic", "ANATOMY", 48, 55], ["conditions", "OBSERVATION", 56, 66], ["infectious", "OBSERVATION", 93, 103], ["leukocytic", "OBSERVATION_MODIFIER", 133, 143], ["infiltrative", "OBSERVATION_MODIFIER", 144, 156], ["inflammatory", "OBSERVATION", 157, 169]]], ["This definition allows inclusion of viral infections that are hepatotropic, even though the lesions are mainly characterized by hepatocellular necrosis or apoptosis rather than by the inflammatory response to the agent.", [["lesions", "ANATOMY", 92, 99], ["hepatocellular", "ANATOMY", 128, 142], ["viral infections", "DISEASE", 36, 52], ["necrosis", "DISEASE", 143, 151], ["lesions", "PATHOLOGICAL_FORMATION", 92, 99], ["hepatocellular", "CANCER", 128, 142], ["viral infections", "PROBLEM", 36, 52], ["hepatotropic", "PROBLEM", 62, 74], ["the lesions", "PROBLEM", 88, 99], ["hepatocellular necrosis", "PROBLEM", 128, 151], ["apoptosis", "PROBLEM", 155, 164], ["the inflammatory response", "PROBLEM", 180, 205], ["the agent", "TREATMENT", 209, 218], ["viral", "OBSERVATION_MODIFIER", 36, 41], ["infections", "OBSERVATION", 42, 52], ["hepatotropic", "OBSERVATION_MODIFIER", 62, 74], ["lesions", "OBSERVATION", 92, 99], ["hepatocellular", "ANATOMY", 128, 142], ["necrosis", "OBSERVATION", 143, 151], ["apoptosis", "OBSERVATION", 155, 164], ["inflammatory", "OBSERVATION", 184, 196]]], ["The term hepatitis is also used for responses to some hepatic toxicants, metals, or drug metabolic idiosyncrasies in which there is a prominent leukocytic response to damaged cells.", [["hepatic", "ANATOMY", 54, 61], ["leukocytic", "ANATOMY", 144, 154], ["cells", "ANATOMY", 175, 180], ["hepatitis", "DISEASE", 9, 18], ["metals", "CHEMICAL", 73, 79], ["hepatic", "ORGAN", 54, 61], ["metals", "SIMPLE_CHEMICAL", 73, 79], ["leukocytic", "CELL", 144, 154], ["cells", "CELL", 175, 180], ["damaged cells", "CELL_TYPE", 167, 180], ["The term hepatitis", "PROBLEM", 0, 18], ["some hepatic toxicants", "PROBLEM", 49, 71], ["drug metabolic idiosyncrasies", "PROBLEM", 84, 113], ["a prominent leukocytic response to damaged cells", "PROBLEM", 132, 180], ["term", "OBSERVATION_MODIFIER", 4, 8], ["hepatitis", "OBSERVATION", 9, 18], ["hepatic", "ANATOMY", 54, 61], ["prominent", "OBSERVATION_MODIFIER", 134, 143], ["leukocytic response", "OBSERVATION", 144, 163], ["damaged cells", "OBSERVATION", 167, 180]]], ["However, in responses in which single necrotic hepatocytes elicit a mild neutrophilic or histiocytic response, the term hepatitis is less appropriate because the pattern of injury is primarily degenerative.", [["necrotic hepatocytes", "ANATOMY", 38, 58], ["neutrophilic", "ANATOMY", 73, 85], ["necrotic", "DISEASE", 38, 46], ["hepatitis", "DISEASE", 120, 129], ["hepatocytes", "CELL", 47, 58], ["necrotic hepatocytes", "CELL_TYPE", 38, 58], ["single necrotic hepatocytes", "PROBLEM", 31, 58], ["a mild neutrophilic or histiocytic response", "PROBLEM", 66, 109], ["the term hepatitis", "PROBLEM", 111, 129], ["injury", "PROBLEM", 173, 179], ["degenerative", "PROBLEM", 193, 205], ["necrotic", "OBSERVATION_MODIFIER", 38, 46], ["hepatocytes", "ANATOMY", 47, 58], ["mild", "OBSERVATION_MODIFIER", 68, 72], ["neutrophilic", "OBSERVATION_MODIFIER", 73, 85], ["histiocytic response", "OBSERVATION", 89, 109], ["term", "OBSERVATION_MODIFIER", 115, 119], ["hepatitis", "OBSERVATION", 120, 129], ["less appropriate", "OBSERVATION_MODIFIER", 133, 149], ["injury", "OBSERVATION", 173, 179], ["degenerative", "OBSERVATION", 193, 205]]], ["Cholangitis refers to inflammation of the biliary tree.", [["biliary tree", "ANATOMY", 42, 54], ["Cholangitis", "DISEASE", 0, 11], ["inflammation", "DISEASE", 22, 34], ["biliary tree", "MULTI-TISSUE_STRUCTURE", 42, 54], ["Cholangitis", "PROBLEM", 0, 11], ["inflammation of the biliary tree", "PROBLEM", 22, 54], ["inflammation", "OBSERVATION", 22, 34], ["biliary", "ANATOMY", 42, 49], ["tree", "ANATOMY_MODIFIER", 50, 54]]], ["More specifically, choledochitis refers to inflammation of the bile ducts, and cholecystitis refers to inflammation of the gallbladder.", [["bile ducts", "ANATOMY", 63, 73], ["gallbladder", "ANATOMY", 123, 134], ["choledochitis", "DISEASE", 19, 32], ["inflammation of the bile ducts", "DISEASE", 43, 73], ["cholecystitis", "DISEASE", 79, 92], ["inflammation of the gallbladder", "DISEASE", 103, 134], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 63, 73], ["gallbladder", "ORGAN", 123, 134], ["choledochitis", "PROBLEM", 19, 32], ["inflammation of the bile ducts", "PROBLEM", 43, 73], ["cholecystitis", "PROBLEM", 79, 92], ["inflammation of the gallbladder", "PROBLEM", 103, 134], ["choledochitis", "OBSERVATION", 19, 32], ["inflammation", "OBSERVATION", 43, 55], ["bile ducts", "ANATOMY", 63, 73], ["cholecystitis", "OBSERVATION", 79, 92], ["inflammation", "OBSERVATION", 103, 115], ["gallbladder", "ANATOMY", 123, 134]]], ["Cholangiohepatitis applies to hepatic inflammation centered on the biliary tract and extending into adjacent hepatic parenchyma.Hepatic inflammationPatterns and character of inflammation in hepatitis vary according to causative agent, severity and stage of disease, the route of entry into the liver, and pathogenesis of liver injury.", [["hepatic", "ANATOMY", 30, 37], ["biliary tract", "ANATOMY", 67, 80], ["hepatic parenchyma", "ANATOMY", 109, 127], ["Hepatic", "ANATOMY", 128, 135], ["liver", "ANATOMY", 294, 299], ["liver", "ANATOMY", 321, 326], ["Cholangiohepatitis", "DISEASE", 0, 18], ["hepatic inflammation", "DISEASE", 30, 50], ["Hepatic inflammation", "DISEASE", 128, 148], ["inflammation", "DISEASE", 174, 186], ["hepatitis", "DISEASE", 190, 199], ["liver injury", "DISEASE", 321, 333], ["hepatic", "ORGAN", 30, 37], ["biliary tract", "ORGAN", 67, 80], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 109, 127], ["Hepatic", "ORGAN", 128, 135], ["liver", "ORGAN", 294, 299], ["liver", "ORGAN", 321, 326], ["Cholangiohepatitis", "PROBLEM", 0, 18], ["hepatic inflammation", "PROBLEM", 30, 50], ["Hepatic inflammation", "PROBLEM", 128, 148], ["inflammation", "PROBLEM", 174, 186], ["hepatitis vary", "PROBLEM", 190, 204], ["severity", "PROBLEM", 235, 243], ["disease", "PROBLEM", 257, 264], ["liver injury", "PROBLEM", 321, 333], ["hepatic", "ANATOMY", 30, 37], ["inflammation", "OBSERVATION", 38, 50], ["biliary tract", "ANATOMY", 67, 80], ["hepatic", "ANATOMY", 109, 116], ["parenchyma", "ANATOMY_MODIFIER", 117, 127], ["inflammation", "OBSERVATION", 136, 148], ["inflammation", "OBSERVATION", 174, 186], ["hepatitis", "OBSERVATION", 190, 199], ["disease", "OBSERVATION", 257, 264], ["liver", "ANATOMY", 294, 299], ["liver", "ANATOMY", 321, 326], ["injury", "OBSERVATION", 327, 333]]], ["Some viral pathogens, such as canine adenovirus 1, can cause acute and diffuse hepatitis, with centrilobular to widespread hepatocellular necrosis, mixed leukocyte infiltrates, sinusoidal congestion, and edema.", [["centrilobular", "ANATOMY", 95, 108], ["hepatocellular", "ANATOMY", 123, 137], ["leukocyte", "ANATOMY", 154, 163], ["sinusoidal", "ANATOMY", 177, 187], ["edema", "ANATOMY", 204, 209], ["viral pathogens", "DISEASE", 5, 20], ["hepatitis", "DISEASE", 79, 88], ["necrosis", "DISEASE", 138, 146], ["sinusoidal congestion", "DISEASE", 177, 198], ["edema", "DISEASE", 204, 209], ["canine adenovirus 1", "ORGANISM", 30, 49], ["hepatocellular", "CANCER", 123, 137], ["leukocyte", "CELL", 154, 163], ["sinusoidal", "MULTI-TISSUE_STRUCTURE", 177, 187], ["edema", "PATHOLOGICAL_FORMATION", 204, 209], ["canine adenovirus 1", "SPECIES", 30, 49], ["canine adenovirus 1", "SPECIES", 30, 49], ["Some viral pathogens", "PROBLEM", 0, 20], ["canine adenovirus", "PROBLEM", 30, 47], ["acute and diffuse hepatitis", "PROBLEM", 61, 88], ["centrilobular to widespread hepatocellular necrosis", "PROBLEM", 95, 146], ["mixed leukocyte infiltrates", "PROBLEM", 148, 175], ["sinusoidal congestion", "PROBLEM", 177, 198], ["edema", "PROBLEM", 204, 209], ["viral", "OBSERVATION_MODIFIER", 5, 10], ["pathogens", "OBSERVATION", 11, 20], ["acute", "OBSERVATION_MODIFIER", 61, 66], ["diffuse", "OBSERVATION_MODIFIER", 71, 78], ["hepatitis", "OBSERVATION", 79, 88], ["centrilobular", "OBSERVATION_MODIFIER", 95, 108], ["widespread", "OBSERVATION_MODIFIER", 112, 122], ["hepatocellular", "ANATOMY", 123, 137], ["necrosis", "OBSERVATION", 138, 146], ["mixed", "OBSERVATION_MODIFIER", 148, 153], ["leukocyte infiltrates", "OBSERVATION", 154, 175], ["sinusoidal congestion", "OBSERVATION", 177, 198], ["edema", "OBSERVATION", 204, 209]]], ["By comparison, most infectious causes of hepatitis, for example, toxoplasmosis, various herpesviruses, and various bacteria, produce a more patchy pattern of inflammation with focally intense leukocyte and Kupffer cell responses in the vicinity of areas of necrosis.", [["leukocyte", "ANATOMY", 192, 201], ["Kupffer cell", "ANATOMY", 206, 218], ["hepatitis", "DISEASE", 41, 50], ["toxoplasmosis", "DISEASE", 65, 78], ["herpesviruses", "DISEASE", 88, 101], ["inflammation", "DISEASE", 158, 170], ["necrosis", "DISEASE", 257, 265], ["leukocyte", "CELL", 192, 201], ["Kupffer cell", "CELL", 206, 218], ["hepatitis", "PROBLEM", 41, 50], ["toxoplasmosis", "PROBLEM", 65, 78], ["various herpesviruses", "PROBLEM", 80, 101], ["various bacteria", "PROBLEM", 107, 123], ["a more patchy pattern of inflammation", "PROBLEM", 133, 170], ["focally intense leukocyte", "PROBLEM", 176, 201], ["Kupffer cell responses", "TEST", 206, 228], ["necrosis", "PROBLEM", 257, 265], ["infectious", "OBSERVATION_MODIFIER", 20, 30], ["hepatitis", "OBSERVATION", 41, 50], ["more", "OBSERVATION_MODIFIER", 135, 139], ["patchy", "OBSERVATION_MODIFIER", 140, 146], ["pattern", "OBSERVATION_MODIFIER", 147, 154], ["inflammation", "OBSERVATION", 158, 170], ["focally", "OBSERVATION_MODIFIER", 176, 183], ["intense", "OBSERVATION_MODIFIER", 184, 191], ["leukocyte", "OBSERVATION", 192, 201], ["Kupffer cell responses", "OBSERVATION", 206, 228], ["areas", "OBSERVATION_MODIFIER", 248, 253], ["necrosis", "OBSERVATION", 257, 265]]], ["The distribution, character, and chronicity of these focal lesions are important diagnostically, but they typically do not damage enough functional hepatic parenchyma, ducts, or vasculature to produce systemic signs of liver failure.", [["focal lesions", "ANATOMY", 53, 66], ["hepatic parenchyma", "ANATOMY", 148, 166], ["ducts", "ANATOMY", 168, 173], ["vasculature", "ANATOMY", 178, 189], ["liver", "ANATOMY", 219, 224], ["liver failure", "DISEASE", 219, 232], ["focal lesions", "CANCER", 53, 66], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 148, 166], ["ducts", "MULTI-TISSUE_STRUCTURE", 168, 173], ["vasculature", "MULTI-TISSUE_STRUCTURE", 178, 189], ["liver", "ORGAN", 219, 224], ["these focal lesions", "PROBLEM", 47, 66], ["liver failure", "PROBLEM", 219, 232], ["distribution", "OBSERVATION_MODIFIER", 4, 16], ["character", "OBSERVATION_MODIFIER", 18, 27], ["chronicity", "OBSERVATION_MODIFIER", 33, 43], ["focal", "OBSERVATION_MODIFIER", 53, 58], ["lesions", "OBSERVATION", 59, 66], ["hepatic", "ANATOMY", 148, 155], ["parenchyma", "ANATOMY_MODIFIER", 156, 166], ["ducts", "ANATOMY", 168, 173], ["vasculature", "ANATOMY", 178, 189], ["liver", "ANATOMY", 219, 224], ["failure", "OBSERVATION", 225, 232]]], ["Foci of hepatitis with necrosis are common incidental findings, and these are assumed to reflect localized responses to bacteria that arrive via the portal system.", [["portal system", "ANATOMY", 149, 162], ["hepatitis", "DISEASE", 8, 17], ["necrosis", "DISEASE", 23, 31], ["portal system", "MULTI-TISSUE_STRUCTURE", 149, 162], ["hepatitis", "PROBLEM", 8, 17], ["necrosis", "PROBLEM", 23, 31], ["bacteria", "PROBLEM", 120, 128], ["hepatitis", "OBSERVATION", 8, 17], ["necrosis", "OBSERVATION", 23, 31], ["bacteria", "OBSERVATION", 120, 128], ["portal system", "ANATOMY", 149, 162]]], ["Occasionally, such focal necroinflammatory lesions are large and numerous, for example, in cattle with rumenitis.Acute hepatitisHallmarks of acute hepatitis typically include a combination of inflammation, typically a granulocytic inflammatory cell infiltrate, foci of hepatocellular apoptosis and necrosis, and in some instances, evidence of regeneration.", [["focal necroinflammatory lesions", "ANATOMY", 19, 50], ["granulocytic inflammatory cell", "ANATOMY", 218, 248], ["foci", "ANATOMY", 261, 265], ["hepatocellular", "ANATOMY", 269, 283], ["rumenitis", "DISEASE", 103, 112], ["hepatitis", "DISEASE", 119, 128], ["hepatitis", "DISEASE", 147, 156], ["inflammation", "DISEASE", 192, 204], ["necrosis", "DISEASE", 298, 306], ["focal necroinflammatory lesions", "PATHOLOGICAL_FORMATION", 19, 50], ["cattle", "ORGANISM", 91, 97], ["granulocytic inflammatory cell", "CELL", 218, 248], ["hepatocellular", "CANCER", 269, 283], ["cattle", "SPECIES", 91, 97], ["cattle", "SPECIES", 91, 97], ["such focal necroinflammatory lesions", "PROBLEM", 14, 50], ["rumenitis", "PROBLEM", 103, 112], ["Acute hepatitis", "PROBLEM", 113, 128], ["acute hepatitis", "PROBLEM", 141, 156], ["inflammation", "PROBLEM", 192, 204], ["a granulocytic inflammatory cell infiltrate", "PROBLEM", 216, 259], ["hepatocellular apoptosis", "PROBLEM", 269, 293], ["necrosis", "PROBLEM", 298, 306], ["regeneration", "PROBLEM", 343, 355], ["focal", "OBSERVATION_MODIFIER", 19, 24], ["necroinflammatory", "OBSERVATION_MODIFIER", 25, 42], ["lesions", "OBSERVATION", 43, 50], ["large", "OBSERVATION_MODIFIER", 55, 60], ["numerous", "OBSERVATION_MODIFIER", 65, 73], ["hepatitis", "OBSERVATION", 119, 128], ["acute", "OBSERVATION_MODIFIER", 141, 146], ["hepatitis", "OBSERVATION", 147, 156], ["inflammation", "OBSERVATION", 192, 204], ["granulocytic", "OBSERVATION_MODIFIER", 218, 230], ["inflammatory", "OBSERVATION_MODIFIER", 231, 243], ["cell infiltrate", "OBSERVATION", 244, 259], ["foci", "OBSERVATION_MODIFIER", 261, 265], ["hepatocellular apoptosis", "OBSERVATION", 269, 293], ["necrosis", "OBSERVATION", 298, 306], ["evidence of", "UNCERTAINTY", 331, 342], ["regeneration", "OBSERVATION", 343, 355]]], ["Leukocyte infiltrates in acute diffuse hepatitis tend to accumulate mainly in the vicinity of the portal tracts, around major bile ducts, or sometimes in the capsule and around the central veins.", [["Leukocyte", "ANATOMY", 0, 9], ["portal tracts", "ANATOMY", 98, 111], ["bile ducts", "ANATOMY", 126, 136], ["capsule", "ANATOMY", 158, 165], ["central veins", "ANATOMY", 181, 194], ["hepatitis", "DISEASE", 39, 48], ["Leukocyte", "CELL", 0, 9], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 98, 111], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 126, 136], ["capsule", "CANCER", 158, 165], ["central veins", "MULTI-TISSUE_STRUCTURE", 181, 194], ["Leukocyte infiltrates", "PROBLEM", 0, 21], ["acute diffuse hepatitis", "PROBLEM", 25, 48], ["infiltrates", "OBSERVATION", 10, 21], ["acute", "OBSERVATION_MODIFIER", 25, 30], ["diffuse", "OBSERVATION_MODIFIER", 31, 38], ["hepatitis", "OBSERVATION", 39, 48], ["vicinity", "ANATOMY_MODIFIER", 82, 90], ["portal tracts", "ANATOMY", 98, 111], ["major", "ANATOMY_MODIFIER", 120, 125], ["bile ducts", "ANATOMY", 126, 136], ["capsule", "ANATOMY_MODIFIER", 158, 165], ["central", "ANATOMY_MODIFIER", 181, 188], ["veins", "ANATOMY", 189, 194]]], ["Small but important numbers of neutrophils and mononuclear cells, including lymphocytes, are usually seen in the perisinusoidal space and among hepatocytes, and are often focally concentrated in sites of necrosis, or adjacent to infectious organisms.", [["neutrophils", "ANATOMY", 31, 42], ["mononuclear cells", "ANATOMY", 47, 64], ["lymphocytes", "ANATOMY", 76, 87], ["perisinusoidal space", "ANATOMY", 113, 133], ["hepatocytes", "ANATOMY", 144, 155], ["sites", "ANATOMY", 195, 200], ["necrosis", "DISEASE", 204, 212], ["neutrophils", "CELL", 31, 42], ["mononuclear cells", "CELL", 47, 64], ["lymphocytes", "CELL", 76, 87], ["hepatocytes", "CELL", 144, 155], ["neutrophils", "CELL_TYPE", 31, 42], ["mononuclear cells", "CELL_TYPE", 47, 64], ["lymphocytes", "CELL_TYPE", 76, 87], ["hepatocytes", "CELL_TYPE", 144, 155], ["neutrophils", "TEST", 31, 42], ["mononuclear cells", "TEST", 47, 64], ["lymphocytes", "TEST", 76, 87], ["necrosis", "PROBLEM", 204, 212], ["infectious organisms", "PROBLEM", 229, 249], ["important", "OBSERVATION_MODIFIER", 10, 19], ["numbers", "OBSERVATION_MODIFIER", 20, 27], ["neutrophils", "OBSERVATION", 31, 42], ["mononuclear cells", "OBSERVATION", 47, 64], ["lymphocytes", "ANATOMY", 76, 87], ["perisinusoidal", "ANATOMY_MODIFIER", 113, 127], ["hepatocytes", "ANATOMY", 144, 155], ["focally", "OBSERVATION_MODIFIER", 171, 178], ["concentrated", "OBSERVATION_MODIFIER", 179, 191], ["sites", "OBSERVATION_MODIFIER", 195, 200], ["necrosis", "OBSERVATION", 204, 212], ["infectious", "OBSERVATION_MODIFIER", 229, 239]]], ["Edema is an unusual feature of acute hepatitis, but is seen in severe injury, for example, in infectious canine hepatitis.", [["Edema", "DISEASE", 0, 5], ["hepatitis", "DISEASE", 37, 46], ["infectious canine hepatitis", "DISEASE", 94, 121], ["canine hepatitis", "ORGANISM", 105, 121], ["Edema", "PROBLEM", 0, 5], ["acute hepatitis", "PROBLEM", 31, 46], ["severe injury", "PROBLEM", 63, 76], ["infectious canine hepatitis", "PROBLEM", 94, 121], ["acute", "OBSERVATION_MODIFIER", 31, 36], ["hepatitis", "OBSERVATION", 37, 46], ["severe", "OBSERVATION_MODIFIER", 63, 69], ["injury", "OBSERVATION", 70, 76], ["infectious", "OBSERVATION_MODIFIER", 94, 104], ["hepatitis", "OBSERVATION", 112, 121]]], ["Grossly, hepatic edema is most obvious in the gallbladder, drug-and toxin-induced chronic hepatic disease have been described, the majority remains idiopathic, although excess hepatic copper accumulation is the best characterized cause of chronic hepatitis in the dog.", [["hepatic edema", "ANATOMY", 9, 22], ["gallbladder", "ANATOMY", 46, 57], ["hepatic", "ANATOMY", 90, 97], ["hepatic", "ANATOMY", 176, 183], ["hepatic edema", "DISEASE", 9, 22], ["chronic hepatic disease", "DISEASE", 82, 105], ["copper", "CHEMICAL", 184, 190], ["chronic hepatitis", "DISEASE", 239, 256], ["copper", "CHEMICAL", 184, 190], ["hepatic edema", "PATHOLOGICAL_FORMATION", 9, 22], ["gallbladder", "ORGAN", 46, 57], ["toxin", "SIMPLE_CHEMICAL", 68, 73], ["hepatic", "ORGAN", 90, 97], ["hepatic", "ORGAN", 176, 183], ["copper", "SIMPLE_CHEMICAL", 184, 190], ["dog", "ORGANISM", 264, 267], ["dog", "SPECIES", 264, 267], ["hepatic edema", "PROBLEM", 9, 22], ["toxin", "PROBLEM", 68, 73], ["chronic hepatic disease", "PROBLEM", 82, 105], ["idiopathic", "PROBLEM", 148, 158], ["excess hepatic copper accumulation", "PROBLEM", 169, 203], ["chronic hepatitis in the dog", "PROBLEM", 239, 267], ["hepatic", "ANATOMY", 9, 16], ["edema", "OBSERVATION", 17, 22], ["gallbladder", "ANATOMY", 46, 57], ["chronic", "OBSERVATION_MODIFIER", 82, 89], ["hepatic", "ANATOMY", 90, 97], ["disease", "OBSERVATION", 98, 105], ["majority", "OBSERVATION_MODIFIER", 131, 139], ["idiopathic", "OBSERVATION", 148, 158], ["hepatic", "ANATOMY", 176, 183], ["copper accumulation", "OBSERVATION", 184, 203], ["chronic", "OBSERVATION_MODIFIER", 239, 246], ["hepatitis", "OBSERVATION", 247, 256]]], ["Breeds of dogs reported to be at increased risk for chronic hepatitis include the Bedlington Terrier, Doberman Pinscher, West Highland White Terrier, Labrador Retriever, American and English Cocker Spaniel, Skye Terrier, Standard Poodle, Dalmatian, and English Springer Spaniel.", [["chronic hepatitis", "DISEASE", 52, 69], ["dogs", "ORGANISM", 10, 14], ["dogs", "SPECIES", 10, 14], ["chronic hepatitis", "PROBLEM", 52, 69], ["chronic", "OBSERVATION_MODIFIER", 52, 59], ["hepatitis", "OBSERVATION", 60, 69], ["Labrador Retriever", "OBSERVATION", 150, 168]]], ["Hepatic copper accumulation in association with chronic hepatitis has been documented in most of these breeds, but apart from the recognized genetic mutation in the COMMD1 gene in Bedlington Terriers, leading to a primary copper storage disease with impaired copper excretion, the pathogenesis of the breed-related copper accumulation remains unclear.Acute hepatitisIn the dog, disease grade is correlated with increasing hepatocellular apoptosis, proliferation, expression of nitric oxide synthase isoforms, and total hepatic iron, whereas disease stage is correlated with increasing \u03b1-smooth muscle actin-labeled periductular myofibroblasts and perisinusoidal stellate cells, CK7-positive ductular cells, the extracellular matrix protein tenascin-C, and expression of genes important in the production and regulation of hepatic fibrosis, including platelet-derived growth factors PDGFB and PDGFD, thrombospondin 1, transforming growth factors \u03b21 and \u03b22 (TGFB1 and TGFB2), matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinase 1, and the collagen genes COL1A1 and COL3A1.Acute hepatitisGiven the importance of autoimmune hepatitis in human medicine, several studies have evaluated the possible contributions of immune mechanisms in dogs.", [["Hepatic", "ANATOMY", 0, 7], ["hepatocellular", "ANATOMY", 422, 436], ["hepatic", "ANATOMY", 519, 526], ["muscle", "ANATOMY", 594, 600], ["periductular myofibroblasts", "ANATOMY", 615, 642], ["perisinusoidal stellate cells", "ANATOMY", 647, 676], ["CK7-positive ductular cells", "ANATOMY", 678, 705], ["extracellular matrix", "ANATOMY", 711, 731], ["hepatic", "ANATOMY", 822, 829], ["copper", "CHEMICAL", 8, 14], ["chronic hepatitis", "DISEASE", 48, 65], ["copper", "CHEMICAL", 222, 228], ["copper", "CHEMICAL", 259, 265], ["copper", "CHEMICAL", 315, 321], ["hepatitis", "DISEASE", 357, 366], ["nitric oxide", "CHEMICAL", 477, 489], ["iron", "CHEMICAL", 527, 531], ["fibrosis", "DISEASE", 830, 838], ["hepatitis", "DISEASE", 1100, 1109], ["autoimmune hepatitis", "DISEASE", 1133, 1153], ["copper", "CHEMICAL", 8, 14], ["copper", "CHEMICAL", 222, 228], ["copper", "CHEMICAL", 259, 265], ["copper", "CHEMICAL", 315, 321], ["nitric oxide", "CHEMICAL", 477, 489], ["iron", "CHEMICAL", 527, 531], ["Hepatic", "MULTI-TISSUE_STRUCTURE", 0, 7], ["copper", "SIMPLE_CHEMICAL", 8, 14], ["COMMD1", "GENE_OR_GENE_PRODUCT", 165, 171], ["copper", "SIMPLE_CHEMICAL", 222, 228], ["copper", "SIMPLE_CHEMICAL", 259, 265], ["copper", "SIMPLE_CHEMICAL", 315, 321], ["dog", "ORGANISM", 373, 376], ["hepatocellular", "CANCER", 422, 436], ["nitric oxide synthase", "GENE_OR_GENE_PRODUCT", 477, 498], ["hepatic", "ORGAN", 519, 526], ["iron", "SIMPLE_CHEMICAL", 527, 531], ["\u03b1-smooth muscle actin", "GENE_OR_GENE_PRODUCT", 585, 606], ["periductular myofibroblasts", "CELL", 615, 642], ["perisinusoidal stellate cells", "CELL", 647, 676], ["CK7", "GENE_OR_GENE_PRODUCT", 678, 681], ["extracellular matrix", "CELLULAR_COMPONENT", 711, 731], ["tenascin-C", "GENE_OR_GENE_PRODUCT", 740, 750], ["hepatic", "ORGAN", 822, 829], ["platelet-derived growth factors", "GENE_OR_GENE_PRODUCT", 850, 881], ["PDGFB", "GENE_OR_GENE_PRODUCT", 882, 887], ["PDGFD", "GENE_OR_GENE_PRODUCT", 892, 897], ["thrombospondin 1", "GENE_OR_GENE_PRODUCT", 899, 915], ["transforming growth factors \u03b21", "GENE_OR_GENE_PRODUCT", 917, 947], ["\u03b22", "GENE_OR_GENE_PRODUCT", 952, 954], ["TGFB1", "GENE_OR_GENE_PRODUCT", 956, 961], ["TGFB2", "GENE_OR_GENE_PRODUCT", 966, 971], ["matrix metalloproteinase 2", "GENE_OR_GENE_PRODUCT", 974, 1000], ["tissue inhibitor of matrix metalloproteinase 1", "GENE_OR_GENE_PRODUCT", 1005, 1051], ["collagen", "GENE_OR_GENE_PRODUCT", 1061, 1069], ["COL1A1", "GENE_OR_GENE_PRODUCT", 1076, 1082], ["COL3A1", "GENE_OR_GENE_PRODUCT", 1087, 1093], ["human", "ORGANISM", 1157, 1162], ["dogs", "ORGANISM", 1255, 1259], ["COMMD1 gene", "DNA", 165, 176], ["nitric oxide synthase isoforms", "PROTEIN", 477, 507], ["\u03b1-smooth muscle actin", "PROTEIN", 585, 606], ["periductular myofibroblasts", "CELL_TYPE", 615, 642], ["perisinusoidal stellate cells", "CELL_TYPE", 647, 676], ["CK7-positive ductular cells", "CELL_TYPE", 678, 705], ["extracellular matrix protein tenascin-C", "PROTEIN", 711, 750], ["platelet-derived growth factors", "PROTEIN", 850, 881], ["PDGFB", "PROTEIN", 882, 887], ["PDGFD", "PROTEIN", 892, 897], ["thrombospondin 1", "PROTEIN", 899, 915], ["transforming growth factors", "PROTEIN", 917, 944], ["\u03b21", "PROTEIN", 945, 947], ["\u03b22", "PROTEIN", 952, 954], ["TGFB1", "PROTEIN", 956, 961], ["TGFB2", "PROTEIN", 966, 971], ["matrix metalloproteinase 2", "PROTEIN", 974, 1000], ["tissue inhibitor of matrix metalloproteinase 1", "PROTEIN", 1005, 1051], ["collagen genes", "DNA", 1061, 1075], ["COL1A1", "DNA", 1076, 1082], ["COL3A1", "DNA", 1087, 1093], ["dog", "SPECIES", 373, 376], ["human", "SPECIES", 1157, 1162], ["dogs", "SPECIES", 1255, 1259], ["human", "SPECIES", 1157, 1162], ["Hepatic copper accumulation", "PROBLEM", 0, 27], ["chronic hepatitis", "PROBLEM", 48, 65], ["a primary copper storage disease", "PROBLEM", 212, 244], ["impaired copper excretion", "PROBLEM", 250, 275], ["the breed", "PROBLEM", 297, 306], ["copper accumulation", "PROBLEM", 315, 334], ["Acute hepatitis", "PROBLEM", 351, 366], ["disease grade", "PROBLEM", 378, 391], ["increasing hepatocellular apoptosis", "PROBLEM", 411, 446], ["nitric oxide synthase isoforms", "TREATMENT", 477, 507], ["total hepatic iron", "TEST", 513, 531], ["increasing \u03b1-smooth muscle actin-labeled periductular myofibroblasts", "PROBLEM", 574, 642], ["perisinusoidal stellate cells", "PROBLEM", 647, 676], ["CK7", "TEST", 678, 681], ["positive ductular cells", "PROBLEM", 682, 705], ["the extracellular matrix protein tenascin", "TEST", 707, 748], ["expression of genes", "PROBLEM", 756, 775], ["hepatic fibrosis", "PROBLEM", 822, 838], ["platelet", "TEST", 850, 858], ["growth factors PDGFB", "PROBLEM", 867, 887], ["PDGFD", "TREATMENT", 892, 897], ["thrombospondin 1", "PROBLEM", 899, 915], ["transforming growth factors", "PROBLEM", 917, 944], ["TGFB1", "TEST", 956, 961], ["TGFB2", "TEST", 966, 971], ["matrix metalloproteinase 2", "TREATMENT", 974, 1000], ["tissue inhibitor of matrix metalloproteinase", "TREATMENT", 1005, 1049], ["Acute hepatitis", "PROBLEM", 1094, 1109], ["autoimmune hepatitis", "PROBLEM", 1133, 1153], ["human medicine", "TREATMENT", 1157, 1171], ["several studies", "TEST", 1173, 1188], ["immune mechanisms in dogs", "PROBLEM", 1234, 1259], ["copper accumulation", "OBSERVATION", 8, 27], ["chronic", "OBSERVATION_MODIFIER", 48, 55], ["hepatitis", "OBSERVATION", 56, 65], ["storage disease", "OBSERVATION", 229, 244], ["impaired", "OBSERVATION_MODIFIER", 250, 258], ["copper excretion", "OBSERVATION_MODIFIER", 259, 275], ["copper accumulation", "OBSERVATION", 315, 334], ["hepatitis", "OBSERVATION", 357, 366], ["disease", "OBSERVATION", 378, 385], ["increasing", "OBSERVATION_MODIFIER", 411, 421], ["hepatocellular apoptosis", "OBSERVATION", 422, 446], ["hepatic", "ANATOMY", 519, 526], ["muscle", "ANATOMY", 594, 600], ["perisinusoidal", "ANATOMY_MODIFIER", 647, 661], ["stellate cells", "OBSERVATION", 662, 676], ["positive", "OBSERVATION_MODIFIER", 682, 690], ["ductular cells", "OBSERVATION", 691, 705], ["hepatic", "ANATOMY", 822, 829], ["fibrosis", "OBSERVATION", 830, 838], ["hepatitis", "OBSERVATION", 1100, 1109], ["autoimmune hepatitis", "OBSERVATION", 1133, 1153]]], ["Upregulation of major histocompatibility complex class II antigen expression in hepatocytes has been demonstrated in Doberman hepatitis in association with lymphocyte infiltration, and it has been proposed that hepatocytes presenting a putative major histocompatibility complex class II molecule-associated autoantigen could be targets for T-cell-mediated immune attack.", [["hepatocytes", "ANATOMY", 80, 91], ["lymphocyte", "ANATOMY", 156, 166], ["hepatocytes", "ANATOMY", 211, 222], ["T-cell", "ANATOMY", 340, 346], ["hepatitis", "DISEASE", 126, 135], ["major histocompatibility complex class II antigen", "GENE_OR_GENE_PRODUCT", 16, 65], ["hepatocytes", "CELL", 80, 91], ["Doberman hepatitis", "ORGANISM", 117, 135], ["lymphocyte", "CELL", 156, 166], ["hepatocytes", "CELL", 211, 222], ["major histocompatibility complex class II", "GENE_OR_GENE_PRODUCT", 245, 286], ["T-cell", "CELL", 340, 346], ["major histocompatibility complex class II antigen", "PROTEIN", 16, 65], ["hepatocytes", "CELL_TYPE", 80, 91], ["hepatocytes", "CELL_TYPE", 211, 222], ["putative major histocompatibility complex class II molecule", "PROTEIN", 236, 295], ["autoantigen", "PROTEIN", 307, 318], ["major histocompatibility complex class II antigen expression in hepatocytes", "PROBLEM", 16, 91], ["Doberman hepatitis", "PROBLEM", 117, 135], ["lymphocyte infiltration", "PROBLEM", 156, 179], ["associated autoantigen", "PROBLEM", 296, 318], ["T-cell", "PROBLEM", 340, 346], ["immune attack", "PROBLEM", 356, 369], ["hepatocytes", "ANATOMY", 80, 91], ["Doberman", "OBSERVATION_MODIFIER", 117, 125], ["hepatitis", "OBSERVATION", 126, 135], ["lymphocyte infiltration", "OBSERVATION", 156, 179], ["hepatocytes", "ANATOMY", 211, 222]]], ["An association with specific major histocompatibility complex DLA class II haplotypes has been described in Doberman Pinschers and English Springer Spaniels with subclinical or clinical hepatitis, and it has been suggested that the highly polymorphic DLA genes may be involved in altered susceptibility to chronic hepatitis.", [["hepatitis", "DISEASE", 186, 195], ["chronic hepatitis", "DISEASE", 306, 323], ["DLA class II", "GENE_OR_GENE_PRODUCT", 62, 74], ["DLA", "GENE_OR_GENE_PRODUCT", 251, 254], ["major histocompatibility complex DLA class II haplotypes", "DNA", 29, 85], ["DLA genes", "DNA", 251, 260], ["subclinical or clinical hepatitis", "PROBLEM", 162, 195], ["the highly polymorphic DLA genes", "PROBLEM", 228, 260], ["chronic hepatitis", "PROBLEM", 306, 323], ["hepatitis", "OBSERVATION", 186, 195], ["chronic", "OBSERVATION_MODIFIER", 306, 313], ["hepatitis", "OBSERVATION", 314, 323]]], ["However, a primary autoimmune pathogenesis has yet to be demonstrated.Acute hepatitisThe presence, mechanism, and role of hepatic copper accumulation in dogs continues to generate ongoing interest.", [["hepatic", "ANATOMY", 122, 129], ["hepatitis", "DISEASE", 76, 85], ["copper", "CHEMICAL", 130, 136], ["copper", "CHEMICAL", 130, 136], ["hepatic copper", "SIMPLE_CHEMICAL", 122, 136], ["dogs", "ORGANISM", 153, 157], ["dogs", "SPECIES", 153, 157], ["a primary autoimmune pathogenesis", "PROBLEM", 9, 42], ["Acute hepatitis", "PROBLEM", 70, 85], ["hepatic copper accumulation in dogs", "PROBLEM", 122, 157], ["primary", "OBSERVATION_MODIFIER", 11, 18], ["autoimmune", "OBSERVATION", 19, 29], ["hepatitis", "OBSERVATION", 76, 85], ["hepatic", "ANATOMY", 122, 129], ["copper accumulation", "OBSERVATION", 130, 149]]], ["Although copper is an essential metal cofactor for cuproenzymes, free copper ions can catalyze the formation of reactive hydroxyl radicals capable of causing oxidative injury (see the Copper section later in Toxic hepatic disease).", [["hepatic", "ANATOMY", 214, 221], ["copper", "CHEMICAL", 9, 15], ["copper", "CHEMICAL", 70, 76], ["hydroxyl", "CHEMICAL", 121, 129], ["Copper", "CHEMICAL", 184, 190], ["Toxic hepatic disease", "DISEASE", 208, 229], ["copper", "CHEMICAL", 9, 15], ["copper", "CHEMICAL", 70, 76], ["hydroxyl", "CHEMICAL", 121, 129], ["Copper", "CHEMICAL", 184, 190], ["copper", "SIMPLE_CHEMICAL", 9, 15], ["cuproenzymes", "SIMPLE_CHEMICAL", 51, 63], ["copper ions", "SIMPLE_CHEMICAL", 70, 81], ["reactive hydroxyl radicals", "SIMPLE_CHEMICAL", 112, 138], ["hepatic", "ORGAN", 214, 221], ["free copper ions", "PROBLEM", 65, 81], ["reactive hydroxyl radicals", "PROBLEM", 112, 138], ["oxidative injury", "PROBLEM", 158, 174], ["Toxic hepatic disease", "PROBLEM", 208, 229], ["reactive", "OBSERVATION_MODIFIER", 112, 120], ["hydroxyl radicals", "OBSERVATION", 121, 138], ["oxidative injury", "OBSERVATION", 158, 174], ["hepatic", "ANATOMY", 214, 221], ["disease", "OBSERVATION", 222, 229]]], ["The liver is central to copper homeostasis, and biliary excretion is the major route for regulating levels of copper in the body.", [["liver", "ANATOMY", 4, 9], ["biliary", "ANATOMY", 48, 55], ["body", "ANATOMY", 124, 128], ["copper", "CHEMICAL", 24, 30], ["copper", "CHEMICAL", 110, 116], ["copper", "CHEMICAL", 24, 30], ["copper", "CHEMICAL", 110, 116], ["liver", "ORGAN", 4, 9], ["copper", "SIMPLE_CHEMICAL", 24, 30], ["biliary", "MULTI-TISSUE_STRUCTURE", 48, 55], ["copper", "SIMPLE_CHEMICAL", 110, 116], ["body", "ORGANISM_SUBDIVISION", 124, 128], ["liver", "ANATOMY", 4, 9], ["central", "OBSERVATION_MODIFIER", 13, 20], ["copper homeostasis", "OBSERVATION", 24, 42], ["biliary", "ANATOMY", 48, 55], ["excretion", "OBSERVATION", 56, 65], ["copper", "OBSERVATION", 110, 116], ["body", "ANATOMY", 124, 128]]], ["Hepatic copper accumulation can arise (1) as the result of a primary metabolic defect in hepatic copper metabolism, (2) secondary to abnormal hepatic function with cholestasis and altered biliary copper excretion, or (3) as a consequence of excess dietary copper intake.", [["Hepatic", "ANATOMY", 0, 7], ["hepatic", "ANATOMY", 89, 96], ["hepatic", "ANATOMY", 142, 149], ["biliary", "ANATOMY", 188, 195], ["copper", "CHEMICAL", 8, 14], ["copper", "CHEMICAL", 97, 103], ["abnormal hepatic function", "DISEASE", 133, 158], ["cholestasis", "DISEASE", 164, 175], ["copper", "CHEMICAL", 196, 202], ["copper", "CHEMICAL", 256, 262], ["copper", "CHEMICAL", 8, 14], ["copper", "CHEMICAL", 97, 103], ["copper", "CHEMICAL", 196, 202], ["copper", "CHEMICAL", 256, 262], ["Hepatic", "ORGAN", 0, 7], ["copper", "SIMPLE_CHEMICAL", 8, 14], ["hepatic", "ORGAN", 89, 96], ["copper", "SIMPLE_CHEMICAL", 97, 103], ["hepatic", "ORGAN", 142, 149], ["biliary", "ORGAN", 188, 195], ["copper", "SIMPLE_CHEMICAL", 196, 202], ["copper", "SIMPLE_CHEMICAL", 256, 262], ["Hepatic copper accumulation", "PROBLEM", 0, 27], ["a primary metabolic defect", "PROBLEM", 59, 85], ["hepatic copper metabolism", "PROBLEM", 89, 114], ["abnormal hepatic function", "PROBLEM", 133, 158], ["cholestasis", "PROBLEM", 164, 175], ["altered biliary copper excretion", "PROBLEM", 180, 212], ["excess dietary copper intake", "PROBLEM", 241, 269], ["copper accumulation", "OBSERVATION", 8, 27], ["primary", "OBSERVATION_MODIFIER", 61, 68], ["metabolic defect", "OBSERVATION", 69, 85], ["hepatic", "ANATOMY", 89, 96], ["copper metabolism", "OBSERVATION", 97, 114], ["abnormal", "OBSERVATION_MODIFIER", 133, 141], ["hepatic", "ANATOMY", 142, 149], ["cholestasis", "OBSERVATION", 164, 175], ["altered", "OBSERVATION_MODIFIER", 180, 187], ["biliary", "ANATOMY", 188, 195], ["copper excretion", "OBSERVATION", 196, 212]]], ["Secondary copper accumulation occurs in the majority of human patients with primary biliary cirrhosis, prolonged extrahepatic bile duct obstruction, or chronic liver disease; however, dogs appear to be relatively resistant to hepatocellular copper accumulation as a result of cholestasis, at least in experimental studies following ligation of the common bile duct.Acute hepatitisnecroinflammatory change initially destroys the limiting plate of periportal hepatocytes, and may continue to erode into the hepatic parenchyma, expanding the portal areas.", [["primary biliary cirrhosis", "ANATOMY", 76, 101], ["extrahepatic bile duct", "ANATOMY", 113, 135], ["liver", "ANATOMY", 160, 165], ["hepatocellular", "ANATOMY", 226, 240], ["bile duct", "ANATOMY", 355, 364], ["periportal hepatocytes", "ANATOMY", 446, 468], ["hepatic parenchyma", "ANATOMY", 505, 523], ["portal areas", "ANATOMY", 539, 551], ["copper", "CHEMICAL", 10, 16], ["primary biliary cirrhosis", "DISEASE", 76, 101], ["extrahepatic bile duct obstruction", "DISEASE", 113, 147], ["chronic liver disease", "DISEASE", 152, 173], ["copper", "CHEMICAL", 241, 247], ["cholestasis", "DISEASE", 276, 287], ["copper", "CHEMICAL", 10, 16], ["copper", "CHEMICAL", 241, 247], ["copper", "SIMPLE_CHEMICAL", 10, 16], ["human", "ORGANISM", 56, 61], ["patients", "ORGANISM", 62, 70], ["biliary", "ORGAN", 84, 91], ["extrahepatic bile duct", "MULTI-TISSUE_STRUCTURE", 113, 135], ["liver", "ORGAN", 160, 165], ["dogs", "ORGANISM", 184, 188], ["hepatocellular copper", "SIMPLE_CHEMICAL", 226, 247], ["bile duct", "MULTI-TISSUE_STRUCTURE", 355, 364], ["periportal hepatocytes", "CELL", 446, 468], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 505, 523], ["portal areas", "MULTI-TISSUE_STRUCTURE", 539, 551], ["periportal hepatocytes", "CELL_TYPE", 446, 468], ["human", "SPECIES", 56, 61], ["patients", "SPECIES", 62, 70], ["dogs", "SPECIES", 184, 188], ["human", "SPECIES", 56, 61], ["Secondary copper accumulation", "PROBLEM", 0, 29], ["primary biliary cirrhosis", "PROBLEM", 76, 101], ["prolonged extrahepatic bile duct obstruction", "PROBLEM", 103, 147], ["chronic liver disease", "PROBLEM", 152, 173], ["dogs", "PROBLEM", 184, 188], ["hepatocellular copper accumulation", "PROBLEM", 226, 260], ["cholestasis", "PROBLEM", 276, 287], ["experimental studies", "TEST", 301, 321], ["ligation", "TREATMENT", 332, 340], ["Acute hepatitisnecroinflammatory change", "PROBLEM", 365, 404], ["periportal hepatocytes", "PROBLEM", 446, 468], ["copper accumulation", "OBSERVATION", 10, 29], ["primary", "OBSERVATION_MODIFIER", 76, 83], ["biliary", "ANATOMY", 84, 91], ["cirrhosis", "OBSERVATION", 92, 101], ["prolonged", "OBSERVATION_MODIFIER", 103, 112], ["extrahepatic", "ANATOMY_MODIFIER", 113, 125], ["bile duct", "ANATOMY", 126, 135], ["obstruction", "OBSERVATION", 136, 147], ["chronic", "OBSERVATION_MODIFIER", 152, 159], ["liver", "ANATOMY", 160, 165], ["disease", "OBSERVATION", 166, 173], ["hepatocellular", "ANATOMY", 226, 240], ["copper accumulation", "OBSERVATION", 241, 260], ["cholestasis", "OBSERVATION", 276, 287], ["ligation", "OBSERVATION", 332, 340], ["common", "ANATOMY_MODIFIER", 348, 354], ["bile duct", "ANATOMY", 355, 364], ["hepatitisnecroinflammatory", "OBSERVATION", 371, 397], ["plate", "OBSERVATION_MODIFIER", 437, 442], ["periportal", "ANATOMY_MODIFIER", 446, 456], ["hepatocytes", "ANATOMY", 457, 468], ["hepatic", "ANATOMY", 505, 512], ["parenchyma", "ANATOMY_MODIFIER", 513, 523], ["portal", "ANATOMY", 539, 545], ["areas", "ANATOMY_MODIFIER", 546, 551]]], ["Portal inflammation is variable in intensity, and includes infiltration by lymphocytes and plasma cells.", [["Portal", "ANATOMY", 0, 6], ["lymphocytes", "ANATOMY", 75, 86], ["plasma cells", "ANATOMY", 91, 103], ["Portal inflammation", "DISEASE", 0, 19], ["Portal", "MULTI-TISSUE_STRUCTURE", 0, 6], ["lymphocytes", "CELL", 75, 86], ["plasma cells", "CELL", 91, 103], ["lymphocytes", "CELL_TYPE", 75, 86], ["plasma cells", "CELL_TYPE", 91, 103], ["Portal inflammation", "PROBLEM", 0, 19], ["infiltration", "PROBLEM", 59, 71], ["lymphocytes", "TEST", 75, 86], ["plasma cells", "PROBLEM", 91, 103], ["inflammation", "OBSERVATION", 7, 19], ["variable", "OBSERVATION_MODIFIER", 23, 31], ["intensity", "OBSERVATION_MODIFIER", 35, 44], ["infiltration", "OBSERVATION", 59, 71], ["lymphocytes", "ANATOMY", 75, 86], ["plasma cells", "OBSERVATION", 91, 103]]], ["Bridging necrosis, with tracts of necrosis dissecting across the hepatic lobule between portal triads or between portal areas and central veins, may also develop.", [["hepatic lobule", "ANATOMY", 65, 79], ["portal triads", "ANATOMY", 88, 101], ["portal areas", "ANATOMY", 113, 125], ["central veins", "ANATOMY", 130, 143], ["necrosis", "DISEASE", 9, 17], ["necrosis", "DISEASE", 34, 42], ["hepatic lobule", "MULTI-TISSUE_STRUCTURE", 65, 79], ["portal triads", "MULTI-TISSUE_STRUCTURE", 88, 101], ["portal areas", "MULTI-TISSUE_STRUCTURE", 113, 125], ["central veins", "MULTI-TISSUE_STRUCTURE", 130, 143], ["Bridging necrosis", "PROBLEM", 0, 17], ["tracts of necrosis", "PROBLEM", 24, 42], ["necrosis", "OBSERVATION", 9, 17], ["necrosis", "OBSERVATION", 34, 42], ["hepatic", "ANATOMY", 65, 72], ["lobule", "ANATOMY_MODIFIER", 73, 79], ["portal triads", "ANATOMY", 88, 101], ["portal", "ANATOMY", 113, 119], ["areas", "ANATOMY_MODIFIER", 120, 125], ["central veins", "ANATOMY", 130, 143], ["may also develop", "UNCERTAINTY", 145, 161]]], ["Degenerative changes affecting hepatocytes in areas of interface hepatitis include cell swelling and apoptosis.", [["hepatocytes", "ANATOMY", 31, 42], ["cell", "ANATOMY", 83, 87], ["hepatitis", "DISEASE", 65, 74], ["hepatocytes", "CELL", 31, 42], ["cell", "CELL", 83, 87], ["hepatocytes", "CELL_TYPE", 31, 42], ["Degenerative changes", "PROBLEM", 0, 20], ["interface hepatitis", "PROBLEM", 55, 74], ["cell swelling", "PROBLEM", 83, 96], ["apoptosis", "PROBLEM", 101, 110], ["hepatocytes", "ANATOMY", 31, 42], ["areas", "OBSERVATION_MODIFIER", 46, 51], ["interface hepatitis", "OBSERVATION", 55, 74], ["cell swelling", "OBSERVATION", 83, 96], ["apoptosis", "OBSERVATION_MODIFIER", 101, 110]]], ["Bile duct degeneration, multifocal necrosis, and hepatocellular regeneration, in the form of 2-cell-thick hepatic plates and mitotic figures, may also be seen.", [["Bile duct", "ANATOMY", 0, 9], ["hepatocellular", "ANATOMY", 49, 63], ["cell", "ANATOMY", 95, 99], ["hepatic plates", "ANATOMY", 106, 120], ["Bile duct degeneration", "DISEASE", 0, 22], ["necrosis", "DISEASE", 35, 43], ["Bile duct", "MULTI-TISSUE_STRUCTURE", 0, 9], ["hepatocellular", "CANCER", 49, 63], ["cell", "CELL", 95, 99], ["Bile duct degeneration", "PROBLEM", 0, 22], ["multifocal necrosis", "PROBLEM", 24, 43], ["hepatocellular regeneration", "PROBLEM", 49, 76], ["thick hepatic plates", "PROBLEM", 100, 120], ["mitotic figures", "PROBLEM", 125, 140], ["duct", "ANATOMY", 5, 9], ["degeneration", "OBSERVATION", 10, 22], ["multifocal", "OBSERVATION_MODIFIER", 24, 34], ["necrosis", "OBSERVATION", 35, 43], ["hepatocellular regeneration", "OBSERVATION", 49, 76], ["thick", "OBSERVATION_MODIFIER", 100, 105], ["hepatic", "ANATOMY", 106, 113], ["plates", "ANATOMY_MODIFIER", 114, 120], ["mitotic figures", "OBSERVATION", 125, 140], ["may also be seen", "UNCERTAINTY", 142, 158]]], ["Deposition of collagen and basement membrane material in the space of Disse leads to capillarization of hepatic sinusoids.", [["basement membrane", "ANATOMY", 27, 44], ["hepatic sinusoids", "ANATOMY", 104, 121], ["collagen", "GENE_OR_GENE_PRODUCT", 14, 22], ["basement membrane material", "CELLULAR_COMPONENT", 27, 53], ["hepatic sinusoids", "MULTI-TISSUE_STRUCTURE", 104, 121], ["collagen", "PROTEIN", 14, 22], ["Deposition of collagen and basement membrane material", "TREATMENT", 0, 53], ["collagen", "OBSERVATION", 14, 22], ["basement", "OBSERVATION_MODIFIER", 27, 35], ["membrane material", "OBSERVATION", 36, 53], ["space", "ANATOMY_MODIFIER", 61, 66], ["Disse", "OBSERVATION", 70, 75], ["capillarization", "OBSERVATION_MODIFIER", 85, 100], ["hepatic", "ANATOMY", 104, 111], ["sinusoids", "ANATOMY_MODIFIER", 112, 121]]], ["Single or small groups of hepatocytes may be isolated and entrapped in expanded portal areas.", [["hepatocytes", "ANATOMY", 26, 37], ["portal areas", "ANATOMY", 80, 92], ["hepatocytes", "CELL", 26, 37], ["portal areas", "MULTI-TISSUE_STRUCTURE", 80, 92], ["hepatocytes", "CELL_TYPE", 26, 37], ["Single or small groups of hepatocytes", "PROBLEM", 0, 37], ["small", "OBSERVATION_MODIFIER", 10, 15], ["hepatocytes", "ANATOMY", 26, 37], ["may be", "UNCERTAINTY", 38, 44], ["entrapped", "OBSERVATION_MODIFIER", 58, 67], ["expanded", "OBSERVATION_MODIFIER", 71, 79], ["portal", "ANATOMY", 80, 86], ["areas", "ANATOMY_MODIFIER", 87, 92]]], ["Fibrosis may progress to bridge portal tracts and central veins, disrupting hepatic lobular architecture and culminating in the development of cirrhosis.Chronic hepatitis in dogsChronic hepatitis is a relatively common diagnosis in dogs, characterized by hepatocellular apoptosis or necrosis, a variable mononuclear or mixed inflammatory cell infiltrate, evidence of regenerative attempts, and fibrosis of variable extent and pattern.", [["portal tracts", "ANATOMY", 32, 45], ["central veins", "ANATOMY", 50, 63], ["hepatic lobular", "ANATOMY", 76, 91], ["hepatocellular", "ANATOMY", 255, 269], ["mononuclear", "ANATOMY", 304, 315], ["inflammatory cell", "ANATOMY", 325, 342], ["Fibrosis", "DISEASE", 0, 8], ["cirrhosis", "DISEASE", 143, 152], ["Chronic hepatitis", "DISEASE", 153, 170], ["Chronic hepatitis", "DISEASE", 178, 195], ["necrosis", "DISEASE", 283, 291], ["fibrosis", "DISEASE", 394, 402], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 32, 45], ["central veins", "MULTI-TISSUE_STRUCTURE", 50, 63], ["hepatic lobular", "MULTI-TISSUE_STRUCTURE", 76, 91], ["cirrhosis", "CANCER", 143, 152], ["dogs", "ORGANISM", 174, 178], ["dogs", "ORGANISM", 232, 236], ["hepatocellular", "CANCER", 255, 269], ["mononuclear", "CELL", 304, 315], ["inflammatory cell", "CELL", 325, 342], ["dogs", "SPECIES", 174, 178], ["dogs", "SPECIES", 232, 236], ["Fibrosis", "PROBLEM", 0, 8], ["bridge portal tracts and central veins", "PROBLEM", 25, 63], ["disrupting hepatic lobular architecture", "PROBLEM", 65, 104], ["cirrhosis", "PROBLEM", 143, 152], ["Chronic hepatitis in dogs", "PROBLEM", 153, 178], ["Chronic hepatitis", "PROBLEM", 178, 195], ["hepatocellular apoptosis", "PROBLEM", 255, 279], ["necrosis", "PROBLEM", 283, 291], ["a variable mononuclear or mixed inflammatory cell infiltrate", "PROBLEM", 293, 353], ["fibrosis", "PROBLEM", 394, 402], ["bridge", "ANATOMY_MODIFIER", 25, 31], ["portal tracts", "ANATOMY", 32, 45], ["central", "ANATOMY_MODIFIER", 50, 57], ["veins", "ANATOMY", 58, 63], ["hepatic", "ANATOMY", 76, 83], ["lobular", "ANATOMY_MODIFIER", 84, 91], ["cirrhosis", "OBSERVATION", 143, 152], ["hepatitis", "OBSERVATION", 161, 170], ["hepatitis", "OBSERVATION", 186, 195], ["relatively common", "OBSERVATION_MODIFIER", 201, 218], ["hepatocellular", "ANATOMY", 255, 269], ["apoptosis", "OBSERVATION", 270, 279], ["necrosis", "OBSERVATION", 283, 291], ["variable", "OBSERVATION_MODIFIER", 295, 303], ["mononuclear", "OBSERVATION_MODIFIER", 304, 315], ["mixed", "OBSERVATION_MODIFIER", 319, 324], ["inflammatory", "OBSERVATION_MODIFIER", 325, 337], ["cell infiltrate", "OBSERVATION", 338, 353], ["evidence of", "UNCERTAINTY", 355, 366], ["regenerative attempts", "OBSERVATION", 367, 388], ["fibrosis", "OBSERVATION", 394, 402], ["variable", "OBSERVATION_MODIFIER", 406, 414], ["extent", "OBSERVATION_MODIFIER", 415, 421]]], ["Although various infectious etiologies and from drugs or other factors, may influence the relationship between copper concentration and injury.", [["copper", "CHEMICAL", 111, 117], ["copper", "CHEMICAL", 111, 117], ["copper", "SIMPLE_CHEMICAL", 111, 117], ["various infectious etiologies", "PROBLEM", 9, 38], ["drugs", "TREATMENT", 48, 53], ["injury", "PROBLEM", 136, 142], ["various", "OBSERVATION_MODIFIER", 9, 16], ["infectious", "OBSERVATION", 17, 27], ["injury", "OBSERVATION", 136, 142]]], ["A hereditary, autosomal recessive copper-associated hepatopathy associated with impaired biliary copper excretion and progressive accumulation of copper within hepatocytes has been well documented in Bedlington Terriers.", [["biliary", "ANATOMY", 89, 96], ["hepatocytes", "ANATOMY", 160, 171], ["hereditary", "DISEASE", 2, 12], ["autosomal recessive copper", "DISEASE", 14, 40], ["hepatopathy", "DISEASE", 52, 63], ["copper", "CHEMICAL", 97, 103], ["copper", "CHEMICAL", 146, 152], ["copper", "CHEMICAL", 34, 40], ["copper", "CHEMICAL", 97, 103], ["copper", "CHEMICAL", 146, 152], ["biliary", "MULTI-TISSUE_STRUCTURE", 89, 96], ["copper", "SIMPLE_CHEMICAL", 97, 103], ["copper", "SIMPLE_CHEMICAL", 146, 152], ["hepatocytes", "CELL", 160, 171], ["hepatocytes", "CELL_TYPE", 160, 171], ["A hereditary, autosomal recessive copper-associated hepatopathy", "PROBLEM", 0, 63], ["impaired biliary copper excretion", "PROBLEM", 80, 113], ["progressive accumulation of copper within hepatocytes", "PROBLEM", 118, 171], ["hereditary", "OBSERVATION_MODIFIER", 2, 12], ["autosomal", "OBSERVATION_MODIFIER", 14, 23], ["recessive", "OBSERVATION_MODIFIER", 24, 33], ["copper-associated", "OBSERVATION_MODIFIER", 34, 51], ["hepatopathy", "OBSERVATION", 52, 63], ["impaired", "OBSERVATION_MODIFIER", 80, 88], ["biliary", "ANATOMY", 89, 96], ["copper excretion", "OBSERVATION", 97, 113], ["progressive", "OBSERVATION_MODIFIER", 118, 129], ["accumulation of copper", "OBSERVATION", 130, 152], ["hepatocytes", "ANATOMY", 160, 171]]], ["The majority of affected Bedlington Terriers have been found deficient in a protein, COMMD1 (copper metabolism MURR1 domain protein 1), caused by deletion of exon 2 in the COMMD1 gene, although there are other less common mutations that can also occur.", [["copper", "CHEMICAL", 93, 99], ["copper", "CHEMICAL", 93, 99], ["COMMD1", "GENE_OR_GENE_PRODUCT", 85, 91], ["copper metabolism MURR1 domain protein 1", "GENE_OR_GENE_PRODUCT", 93, 133], ["COMMD1", "GENE_OR_GENE_PRODUCT", 172, 178], ["COMMD1", "PROTEIN", 85, 91], ["copper metabolism MURR1 domain protein 1", "PROTEIN", 93, 133], ["exon 2", "DNA", 158, 164], ["COMMD1 gene", "DNA", 172, 183], ["affected Bedlington Terriers", "PROBLEM", 16, 44], ["a protein", "TEST", 74, 83], ["copper metabolism MURR1 domain protein", "TEST", 93, 131], ["deletion of exon", "PROBLEM", 146, 162], ["other less common mutations", "PROBLEM", 204, 231], ["deficient", "OBSERVATION_MODIFIER", 61, 70]]], ["Although its function is not fully understood, the COMMD1 protein has been shown to interact with the copper transporter ATP7B, important in Wilson disease, a copper storage disorder in humans, and its absence in affected dogs may impair ATP7B-mediated copper export from hepatocytes into the canaliculus.", [["hepatocytes", "ANATOMY", 272, 283], ["canaliculus", "ANATOMY", 293, 304], ["copper", "CHEMICAL", 102, 108], ["Wilson disease", "DISEASE", 141, 155], ["copper storage disorder", "DISEASE", 159, 182], ["copper", "CHEMICAL", 253, 259], ["copper", "CHEMICAL", 102, 108], ["copper", "CHEMICAL", 159, 165], ["copper", "CHEMICAL", 253, 259], ["COMMD1", "GENE_OR_GENE_PRODUCT", 51, 57], ["copper", "GENE_OR_GENE_PRODUCT", 102, 108], ["ATP7B", "GENE_OR_GENE_PRODUCT", 121, 126], ["humans", "ORGANISM", 186, 192], ["dogs", "ORGANISM", 222, 226], ["ATP7B", "GENE_OR_GENE_PRODUCT", 238, 243], ["copper", "SIMPLE_CHEMICAL", 253, 259], ["hepatocytes", "CELL", 272, 283], ["canaliculus", "MULTI-TISSUE_STRUCTURE", 293, 304], ["COMMD1 protein", "PROTEIN", 51, 65], ["copper transporter", "PROTEIN", 102, 120], ["ATP7B", "PROTEIN", 121, 126], ["ATP7B", "PROTEIN", 238, 243], ["hepatocytes", "CELL_TYPE", 272, 283], ["humans", "SPECIES", 186, 192], ["dogs", "SPECIES", 222, 226], ["humans", "SPECIES", 186, 192], ["the copper transporter ATP7B", "TREATMENT", 98, 126], ["a copper storage disorder", "PROBLEM", 157, 182], ["affected dogs", "PROBLEM", 213, 226], ["hepatocytes", "ANATOMY", 272, 283], ["canaliculus", "ANATOMY", 293, 304]]], ["Homozygous affected dogs have the highest copper levels.", [["copper", "CHEMICAL", 42, 48], ["copper", "CHEMICAL", 42, 48], ["dogs", "ORGANISM", 20, 24], ["copper", "SIMPLE_CHEMICAL", 42, 48], ["dogs", "SPECIES", 20, 24], ["Homozygous affected dogs", "PROBLEM", 0, 24]]], ["Bedlington Terriers are the only breed to date shown to accumulate copper continuously throughout life, and hepatic copper concentrations in these animals may be very high; as much as 12,000 \u00b5g/g DW has been recorded, and levels >5,000 \u00b5g/g are common.", [["hepatic", "ANATOMY", 108, 115], ["copper", "CHEMICAL", 67, 73], ["copper", "CHEMICAL", 116, 122], ["copper", "CHEMICAL", 67, 73], ["copper", "CHEMICAL", 116, 122], ["copper", "SIMPLE_CHEMICAL", 67, 73], ["hepatic", "ORGAN", 108, 115], ["copper", "SIMPLE_CHEMICAL", 116, 122], ["hepatic copper concentrations", "TREATMENT", 108, 137], ["levels", "TEST", 222, 228], ["hepatic", "ANATOMY", 108, 115]]], ["Affected dogs are usually presented with signs of progressive liver failure, including illthrift, wasting, ascites, and signs of encephalopathy.", [["liver", "ANATOMY", 62, 67], ["ascites", "ANATOMY", 107, 114], ["liver failure", "DISEASE", 62, 75], ["illthrift", "DISEASE", 87, 96], ["wasting", "DISEASE", 98, 105], ["ascites", "DISEASE", 107, 114], ["encephalopathy", "DISEASE", 129, 143], ["dogs", "ORGANISM", 9, 13], ["liver", "ORGAN", 62, 67], ["dogs", "SPECIES", 9, 13], ["Affected dogs", "PROBLEM", 0, 13], ["progressive liver failure", "PROBLEM", 50, 75], ["illthrift", "PROBLEM", 87, 96], ["wasting", "PROBLEM", 98, 105], ["ascites", "PROBLEM", 107, 114], ["encephalopathy", "PROBLEM", 129, 143], ["progressive", "OBSERVATION_MODIFIER", 50, 61], ["liver", "ANATOMY", 62, 67], ["failure", "OBSERVATION", 68, 75], ["wasting", "OBSERVATION", 98, 105], ["ascites", "OBSERVATION", 107, 114], ["encephalopathy", "OBSERVATION", 129, 143]]], ["An acute form may occur in some dogs, with acute hepatic necrosis and release of copper into the systemic circulation, where it provokes a hemolytic crisis and rapidly developing anemia and icterus (eFig.", [["hepatic", "ANATOMY", 49, 56], ["acute hepatic necrosis", "DISEASE", 43, 65], ["copper", "CHEMICAL", 81, 87], ["hemolytic crisis", "DISEASE", 139, 155], ["anemia", "DISEASE", 179, 185], ["icterus", "DISEASE", 190, 197], ["copper", "CHEMICAL", 81, 87], ["dogs", "ORGANISM", 32, 36], ["hepatic", "ORGAN", 49, 56], ["copper", "SIMPLE_CHEMICAL", 81, 87], ["dogs", "SPECIES", 32, 36], ["some dogs", "PROBLEM", 27, 36], ["acute hepatic necrosis", "PROBLEM", 43, 65], ["a hemolytic crisis", "PROBLEM", 137, 155], ["rapidly developing anemia", "PROBLEM", 160, 185], ["icterus (eFig", "PROBLEM", 190, 203], ["acute", "OBSERVATION_MODIFIER", 3, 8], ["acute", "OBSERVATION_MODIFIER", 43, 48], ["hepatic", "ANATOMY", 49, 56], ["necrosis", "OBSERVATION", 57, 65], ["systemic circulation", "ANATOMY", 97, 117], ["hemolytic crisis", "OBSERVATION", 139, 155], ["rapidly", "OBSERVATION_MODIFIER", 160, 167], ["anemia", "OBSERVATION", 179, 185], ["icterus", "OBSERVATION", 190, 197]]], ["The initial histologic lesion is multifocal centrilobular hepatitis, with foci of macrophages, lymphocytes, plasma cells, and neutrophils among the copper-laden hepatocytes in zone 3.", [["lesion", "ANATOMY", 23, 29], ["centrilobular", "ANATOMY", 44, 57], ["foci", "ANATOMY", 74, 78], ["macrophages", "ANATOMY", 82, 93], ["lymphocytes", "ANATOMY", 95, 106], ["plasma cells", "ANATOMY", 108, 120], ["neutrophils", "ANATOMY", 126, 137], ["hepatocytes", "ANATOMY", 161, 172], ["hepatitis", "DISEASE", 58, 67], ["macrophages", "CELL", 82, 93], ["lymphocytes", "CELL", 95, 106], ["plasma cells", "CELL", 108, 120], ["neutrophils", "CELL", 126, 137], ["hepatocytes", "CELL", 161, 172], ["macrophages", "CELL_TYPE", 82, 93], ["lymphocytes", "CELL_TYPE", 95, 106], ["plasma cells", "CELL_TYPE", 108, 120], ["neutrophils", "CELL_TYPE", 126, 137], ["copper-laden hepatocytes", "CELL_TYPE", 148, 172], ["The initial histologic lesion", "PROBLEM", 0, 29], ["multifocal centrilobular hepatitis", "PROBLEM", 33, 67], ["foci of macrophages", "PROBLEM", 74, 93], ["lymphocytes", "TEST", 95, 106], ["plasma cells", "TEST", 108, 120], ["neutrophils", "TEST", 126, 137], ["histologic", "OBSERVATION_MODIFIER", 12, 22], ["lesion", "OBSERVATION", 23, 29], ["multifocal", "OBSERVATION_MODIFIER", 33, 43], ["centrilobular", "OBSERVATION_MODIFIER", 44, 57], ["hepatitis", "OBSERVATION", 58, 67], ["foci", "OBSERVATION_MODIFIER", 74, 78], ["macrophages", "OBSERVATION", 82, 93], ["lymphocytes", "ANATOMY", 95, 106], ["plasma cells", "OBSERVATION", 108, 120], ["neutrophils", "OBSERVATION_MODIFIER", 126, 137], ["laden hepatocytes", "OBSERVATION", 155, 172], ["zone 3", "ANATOMY_MODIFIER", 176, 182]]], ["Apoptotic hepatocytes, some containing copper granules, appear at the periphery of some foci.", [["hepatocytes", "ANATOMY", 10, 21], ["copper granules", "ANATOMY", 39, 54], ["foci", "ANATOMY", 88, 92], ["copper", "CHEMICAL", 39, 45], ["hepatocytes", "CELL", 10, 21], ["copper granules", "CELLULAR_COMPONENT", 39, 54], ["Apoptotic hepatocytes", "CELL_TYPE", 0, 21], ["Apoptotic hepatocytes", "PROBLEM", 0, 21], ["some containing copper granules", "PROBLEM", 23, 54], ["some foci", "PROBLEM", 83, 92], ["hepatocytes", "ANATOMY", 10, 21], ["copper granules", "OBSERVATION", 39, 54], ["periphery", "OBSERVATION_MODIFIER", 70, 79], ["some", "OBSERVATION_MODIFIER", 83, 87], ["foci", "OBSERVATION", 88, 92]]], ["Copper levels >3,000 \u00b5g/g DW result in widespread massive necrosis in some dogs.", [["Copper", "CHEMICAL", 0, 6], ["necrosis", "DISEASE", 58, 66], ["Copper", "CHEMICAL", 0, 6], ["Copper", "SIMPLE_CHEMICAL", 0, 6], ["dogs", "ORGANISM", 75, 79], ["dogs", "SPECIES", 75, 79], ["Copper levels", "TEST", 0, 13], ["widespread massive necrosis in some dogs", "PROBLEM", 39, 79], ["widespread", "OBSERVATION_MODIFIER", 39, 49], ["massive", "OBSERVATION_MODIFIER", 50, 57], ["necrosis", "OBSERVATION", 58, 66], ["some dogs", "OBSERVATION", 70, 79]]], ["Survivors may progress to develop postnecrotic cirrhosis.", [["cirrhosis", "DISEASE", 47, 56], ["postnecrotic cirrhosis", "CANCER", 34, 56], ["postnecrotic cirrhosis", "PROBLEM", 34, 56], ["cirrhosis", "OBSERVATION", 47, 56]]], ["Grossly, the livers in later stages are fibrotic, pale, and finely nodular.Chronic hepatitis in dogsChronic hepatitis is well documented in Doberman Pinschers.", [["livers", "ANATOMY", 13, 19], ["Chronic hepatitis", "DISEASE", 75, 92], ["Chronic hepatitis", "DISEASE", 100, 117], ["livers", "ORGAN", 13, 19], ["dogs", "ORGANISM", 96, 100], ["dogs", "SPECIES", 96, 100], ["fibrotic", "PROBLEM", 40, 48], ["finely nodular", "PROBLEM", 60, 74], ["Chronic hepatitis in dogs", "PROBLEM", 75, 100], ["Chronic hepatitis", "PROBLEM", 100, 117], ["livers", "ANATOMY", 13, 19], ["later stages", "OBSERVATION_MODIFIER", 23, 35], ["fibrotic", "OBSERVATION", 40, 48], ["pale", "OBSERVATION_MODIFIER", 50, 54], ["finely", "OBSERVATION_MODIFIER", 60, 66], ["nodular", "OBSERVATION", 67, 74], ["hepatitis", "OBSERVATION", 83, 92], ["hepatitis", "OBSERVATION", 108, 117]]], ["The disease is more common in middle-aged female dogs.", [["dogs", "ORGANISM", 49, 53], ["dogs", "SPECIES", 49, 53], ["The disease", "PROBLEM", 0, 11], ["disease", "OBSERVATION", 4, 11], ["more common", "OBSERVATION_MODIFIER", 15, 26]]], ["Histologic changes in the livers of dogs exhibiting clinical signs of advanced hepatic disease include piecemeal necrosis of periportal zone 1 hepatocytes, with a mixed inflammatory cell infiltrate, as well as necrosis of zone 3 hepatocytes with bridging necrosis crossing the lobule (Fig. 2-58) .", [["livers", "ANATOMY", 26, 32], ["hepatic", "ANATOMY", 79, 86], ["periportal zone 1 hepatocytes", "ANATOMY", 125, 154], ["inflammatory cell", "ANATOMY", 169, 186], ["zone 3 hepatocytes", "ANATOMY", 222, 240], ["lobule", "ANATOMY", 277, 283], ["hepatic disease", "DISEASE", 79, 94], ["necrosis", "DISEASE", 113, 121], ["necrosis", "DISEASE", 210, 218], ["necrosis", "DISEASE", 255, 263], ["livers", "ORGAN", 26, 32], ["dogs", "ORGANISM", 36, 40], ["hepatic", "ORGAN", 79, 86], ["periportal zone 1 hepatocytes", "CELL", 125, 154], ["inflammatory cell", "CELL", 169, 186], ["lobule", "MULTI-TISSUE_STRUCTURE", 277, 283], ["periportal zone 1 hepatocytes", "CELL_TYPE", 125, 154], ["zone 3 hepatocytes", "CELL_TYPE", 222, 240], ["dogs", "SPECIES", 36, 40], ["Histologic changes in the livers of dogs", "PROBLEM", 0, 40], ["advanced hepatic disease", "PROBLEM", 70, 94], ["piecemeal necrosis of periportal zone 1 hepatocytes", "PROBLEM", 103, 154], ["a mixed inflammatory cell infiltrate", "PROBLEM", 161, 197], ["necrosis of zone 3 hepatocytes", "PROBLEM", 210, 240], ["bridging necrosis", "PROBLEM", 246, 263], ["livers", "ANATOMY", 26, 32], ["advanced", "OBSERVATION_MODIFIER", 70, 78], ["hepatic", "ANATOMY", 79, 86], ["disease", "OBSERVATION", 87, 94], ["piecemeal", "OBSERVATION_MODIFIER", 103, 112], ["necrosis", "OBSERVATION", 113, 121], ["periportal", "ANATOMY_MODIFIER", 125, 135], ["zone", "ANATOMY_MODIFIER", 136, 140], ["hepatocytes", "ANATOMY", 143, 154], ["mixed", "OBSERVATION_MODIFIER", 163, 168], ["inflammatory", "OBSERVATION_MODIFIER", 169, 181], ["cell infiltrate", "OBSERVATION", 182, 197], ["necrosis", "OBSERVATION", 210, 218], ["zone", "OBSERVATION_MODIFIER", 222, 226], ["hepatocytes", "ANATOMY", 229, 240], ["bridging", "OBSERVATION_MODIFIER", 246, 254], ["necrosis", "OBSERVATION", 255, 263], ["lobule", "OBSERVATION_MODIFIER", 277, 283]]], ["Copper accumulation is evident in centrilobular hepatocytes, with various degrees of portal fibrosis, bile duct proliferation, bridging fibrosis, and development of cirrhosis in the most severely affected dogs.", [["centrilobular hepatocytes", "ANATOMY", 34, 59], ["portal", "ANATOMY", 85, 91], ["bile duct", "ANATOMY", 102, 111], ["Copper", "CHEMICAL", 0, 6], ["fibrosis", "DISEASE", 92, 100], ["fibrosis", "DISEASE", 136, 144], ["cirrhosis", "DISEASE", 165, 174], ["Copper", "CHEMICAL", 0, 6], ["Copper", "SIMPLE_CHEMICAL", 0, 6], ["centrilobular hepatocytes", "CELL", 34, 59], ["portal", "MULTI-TISSUE_STRUCTURE", 85, 91], ["bile duct", "MULTI-TISSUE_STRUCTURE", 102, 111], ["dogs", "ORGANISM", 205, 209], ["centrilobular hepatocytes", "CELL_TYPE", 34, 59], ["dogs", "SPECIES", 205, 209], ["Copper accumulation", "PROBLEM", 0, 19], ["centrilobular hepatocytes", "PROBLEM", 34, 59], ["portal fibrosis", "PROBLEM", 85, 100], ["bile duct proliferation", "PROBLEM", 102, 125], ["bridging fibrosis", "PROBLEM", 127, 144], ["cirrhosis", "PROBLEM", 165, 174], ["severely affected dogs", "PROBLEM", 187, 209], ["accumulation", "OBSERVATION", 7, 19], ["centrilobular", "ANATOMY_MODIFIER", 34, 47], ["hepatocytes", "ANATOMY", 48, 59], ["various degrees", "OBSERVATION_MODIFIER", 66, 81], ["portal", "ANATOMY", 85, 91], ["fibrosis", "OBSERVATION", 92, 100], ["bile duct", "ANATOMY", 102, 111], ["proliferation", "OBSERVATION_MODIFIER", 112, 125], ["bridging", "OBSERVATION_MODIFIER", 127, 135], ["fibrosis", "OBSERVATION", 136, 144], ["cirrhosis", "OBSERVATION", 165, 174], ["most severely", "OBSERVATION_MODIFIER", 182, 195], ["affected", "OBSERVATION_MODIFIER", 196, 204], ["dogs", "OBSERVATION", 205, 209]]], ["Intrahepatocyte bile pigment accumulation and intracanalicular bile stasis are present in periportal zones, along with iron accumulation in Kupffer cells and macrophages.Chronic hepatitis in dogsElevated concentrations of hepatic copper have been reported in many, but not all, Doberman Pinschers with chronic hepatitis, and the significance of increased hepatic copper concentration in this breed remains controversial.", [["bile pigment", "ANATOMY", 16, 28], ["intracanalicular bile", "ANATOMY", 46, 67], ["periportal zones", "ANATOMY", 90, 106], ["Kupffer cells", "ANATOMY", 140, 153], ["macrophages", "ANATOMY", 158, 169], ["hepatic", "ANATOMY", 222, 229], ["hepatic", "ANATOMY", 355, 362], ["iron", "CHEMICAL", 119, 123], ["Chronic hepatitis", "DISEASE", 170, 187], ["copper", "CHEMICAL", 230, 236], ["chronic hepatitis", "DISEASE", 302, 319], ["copper", "CHEMICAL", 363, 369], ["iron", "CHEMICAL", 119, 123], ["copper", "CHEMICAL", 230, 236], ["copper", "CHEMICAL", 363, 369], ["bile stasis", "PATHOLOGICAL_FORMATION", 63, 74], ["periportal zones", "TISSUE", 90, 106], ["iron", "SIMPLE_CHEMICAL", 119, 123], ["Kupffer cells", "CELL", 140, 153], ["macrophages", "CELL", 158, 169], ["dogs", "ORGANISM", 191, 195], ["hepatic", "ORGAN", 222, 229], ["copper", "SIMPLE_CHEMICAL", 230, 236], ["Doberman Pinschers", "ORGANISM", 278, 296], ["hepatic", "ORGAN", 355, 362], ["copper", "SIMPLE_CHEMICAL", 363, 369], ["Kupffer cells", "CELL_TYPE", 140, 153], ["macrophages", "CELL_TYPE", 158, 169], ["dogs", "SPECIES", 191, 195], ["Intrahepatocyte bile pigment accumulation", "PROBLEM", 0, 41], ["intracanalicular bile stasis", "PROBLEM", 46, 74], ["iron accumulation in Kupffer cells and macrophages", "PROBLEM", 119, 169], ["Chronic hepatitis in dogs", "PROBLEM", 170, 195], ["Elevated concentrations of hepatic copper", "PROBLEM", 195, 236], ["chronic hepatitis", "PROBLEM", 302, 319], ["increased hepatic copper concentration", "PROBLEM", 345, 383], ["bile", "ANATOMY", 16, 20], ["pigment accumulation", "OBSERVATION", 21, 41], ["intracanalicular", "ANATOMY_MODIFIER", 46, 62], ["bile", "ANATOMY", 63, 67], ["stasis", "OBSERVATION", 68, 74], ["periportal", "ANATOMY", 90, 100], ["zones", "ANATOMY_MODIFIER", 101, 106], ["iron accumulation", "OBSERVATION", 119, 136], ["Kupffer cells", "OBSERVATION", 140, 153], ["macrophages", "OBSERVATION_MODIFIER", 158, 169], ["hepatitis", "OBSERVATION", 178, 187], ["concentrations", "OBSERVATION_MODIFIER", 204, 218], ["hepatic", "ANATOMY", 222, 229], ["copper", "OBSERVATION", 230, 236], ["chronic", "OBSERVATION_MODIFIER", 302, 309], ["hepatitis", "OBSERVATION", 310, 319], ["increased", "OBSERVATION_MODIFIER", 345, 354], ["hepatic", "ANATOMY", 355, 362], ["copper concentration", "OBSERVATION", 363, 383]]], ["A recent investigation into the possibility of impaired copper excretion in affected Doberman Pinschers reported that 5 dogs with elevated liver copper and persistent subclinical hepatitis but without demonstrable cholestasis had comparable rates of plasma copper clearance to control dogs, but reduced rates of biliary excretion of 64 Cu, suggesting that impaired copper excretion may play a role in disease in this breed.", [["liver", "ANATOMY", 139, 144], ["plasma", "ANATOMY", 250, 256], ["biliary", "ANATOMY", 312, 319], ["copper", "CHEMICAL", 56, 62], ["copper", "CHEMICAL", 145, 151], ["hepatitis", "DISEASE", 179, 188], ["cholestasis", "DISEASE", 214, 225], ["copper", "CHEMICAL", 257, 263], ["Cu", "CHEMICAL", 336, 338], ["copper", "CHEMICAL", 365, 371], ["copper", "CHEMICAL", 56, 62], ["copper", "CHEMICAL", 145, 151], ["copper", "CHEMICAL", 257, 263], ["Cu", "CHEMICAL", 336, 338], ["copper", "CHEMICAL", 365, 371], ["copper", "SIMPLE_CHEMICAL", 56, 62], ["dogs", "ORGANISM", 120, 124], ["liver", "ORGAN", 139, 144], ["copper", "SIMPLE_CHEMICAL", 145, 151], ["plasma", "ORGANISM_SUBSTANCE", 250, 256], ["copper", "SIMPLE_CHEMICAL", 257, 263], ["dogs", "ORGANISM", 285, 289], ["biliary", "MULTI-TISSUE_STRUCTURE", 312, 319], ["Cu", "SIMPLE_CHEMICAL", 336, 338], ["copper", "SIMPLE_CHEMICAL", 365, 371], ["dogs", "SPECIES", 120, 124], ["A recent investigation", "TEST", 0, 22], ["impaired copper excretion in affected Doberman Pinschers", "PROBLEM", 47, 103], ["elevated liver copper", "PROBLEM", 130, 151], ["persistent subclinical hepatitis", "PROBLEM", 156, 188], ["demonstrable cholestasis", "PROBLEM", 201, 225], ["plasma copper clearance", "TREATMENT", 250, 273], ["biliary excretion", "TEST", 312, 329], ["impaired copper excretion", "PROBLEM", 356, 381], ["disease", "PROBLEM", 401, 408], ["liver", "ANATOMY", 139, 144], ["persistent", "OBSERVATION_MODIFIER", 156, 166], ["subclinical", "OBSERVATION_MODIFIER", 167, 178], ["hepatitis", "OBSERVATION", 179, 188], ["without", "UNCERTAINTY", 193, 200], ["cholestasis", "OBSERVATION", 214, 225], ["reduced", "OBSERVATION_MODIFIER", 295, 302], ["biliary", "ANATOMY", 312, 319], ["impaired", "OBSERVATION_MODIFIER", 356, 364], ["copper excretion", "OBSERVATION", 365, 381]]], ["Significantly reduced levels of mRNA of various proteins involved in copper binding, transport, and excretion, including ATP7A, ATP7B, ceruloplasmin, and metallothionein, have been documented in Dobermans with clinical hepatitis with high hepatic In the dog, the reference range for hepatic copper is generally considered to be \u2264400 \u00b5g/g dry weight (DW);.concentrations >1,800-2,000 \u00b5g/g DW are considered pathogenic.", [["hepatic", "ANATOMY", 239, 246], ["hepatic", "ANATOMY", 283, 290], ["copper", "CHEMICAL", 69, 75], ["hepatitis", "DISEASE", 219, 228], ["copper", "CHEMICAL", 291, 297], ["copper", "CHEMICAL", 69, 75], ["copper", "CHEMICAL", 291, 297], ["copper", "SIMPLE_CHEMICAL", 69, 75], ["ATP7A", "GENE_OR_GENE_PRODUCT", 121, 126], ["ATP7B", "GENE_OR_GENE_PRODUCT", 128, 133], ["ceruloplasmin", "GENE_OR_GENE_PRODUCT", 135, 148], ["metallothionein", "GENE_OR_GENE_PRODUCT", 154, 169], ["hepatic", "ORGAN", 239, 246], ["dog", "ORGANISM", 254, 257], ["hepatic", "ORGAN", 283, 290], ["copper", "SIMPLE_CHEMICAL", 291, 297], ["mRNA", "RNA", 32, 36], ["ATP7A", "PROTEIN", 121, 126], ["ATP7B", "PROTEIN", 128, 133], ["ceruloplasmin", "PROTEIN", 135, 148], ["metallothionein", "PROTEIN", 154, 169], ["dog", "SPECIES", 254, 257], ["Significantly reduced levels of mRNA of various proteins", "PROBLEM", 0, 56], ["ATP7A", "TEST", 121, 126], ["ceruloplasmin", "TREATMENT", 135, 148], ["metallothionein", "TREATMENT", 154, 169], ["clinical hepatitis", "PROBLEM", 210, 228], ["concentrations", "TEST", 355, 369], ["pathogenic", "PROBLEM", 406, 416], ["hepatitis", "OBSERVATION", 219, 228], ["hepatic", "ANATOMY", 239, 246], ["hepatic", "ANATOMY", 283, 290], ["pathogenic", "OBSERVATION_MODIFIER", 406, 416]]], ["In primary genetic copper storage disorders and excess copper intake, copper accumulation appears at least initially to be primarily centrilobular, extending throughout the lobule as the condition progresses, with hepatic copper concentrations usually >2,000 \u00b5g/g DW.", [["centrilobular", "ANATOMY", 133, 146], ["lobule", "ANATOMY", 173, 179], ["hepatic", "ANATOMY", 214, 221], ["copper storage disorders", "DISEASE", 19, 43], ["copper", "CHEMICAL", 55, 61], ["copper", "CHEMICAL", 70, 76], ["copper", "CHEMICAL", 222, 228], ["copper", "CHEMICAL", 19, 25], ["copper", "CHEMICAL", 55, 61], ["copper", "CHEMICAL", 70, 76], ["copper", "CHEMICAL", 222, 228], ["copper", "SIMPLE_CHEMICAL", 19, 25], ["copper", "SIMPLE_CHEMICAL", 55, 61], ["copper", "SIMPLE_CHEMICAL", 70, 76], ["lobule", "ORGAN", 173, 179], ["hepatic", "ORGAN", 214, 221], ["copper", "SIMPLE_CHEMICAL", 222, 228], ["primary genetic copper storage disorders", "PROBLEM", 3, 43], ["excess copper intake", "PROBLEM", 48, 68], ["copper accumulation", "PROBLEM", 70, 89], ["centrilobular", "PROBLEM", 133, 146], ["hepatic copper concentrations", "PROBLEM", 214, 243], ["copper storage disorders", "OBSERVATION", 19, 43], ["at least", "OBSERVATION_MODIFIER", 98, 106], ["centrilobular", "OBSERVATION", 133, 146], ["lobule", "ANATOMY_MODIFIER", 173, 179], ["hepatic", "ANATOMY", 214, 221]]], ["In copper storage secondary to abnormal hepatic function, copper usually accumulates in smaller amounts in the periportal parenchyma or without a consistent pattern, in concentrations typically <2,000 \u00b5g/g DW.Chronic hepatitis in dogsWhen the hepatic concentration of copper surpasses 400 \u00b5g/g DW, the excess begins to accumulate within lysosomes.", [["hepatic", "ANATOMY", 40, 47], ["periportal parenchyma", "ANATOMY", 111, 132], ["hepatic", "ANATOMY", 243, 250], ["lysosomes", "ANATOMY", 337, 346], ["copper", "CHEMICAL", 3, 9], ["copper", "CHEMICAL", 58, 64], ["Chronic hepatitis", "DISEASE", 209, 226], ["copper", "CHEMICAL", 268, 274], ["copper", "CHEMICAL", 3, 9], ["copper", "CHEMICAL", 58, 64], ["copper", "CHEMICAL", 268, 274], ["copper", "SIMPLE_CHEMICAL", 3, 9], ["hepatic", "ORGAN", 40, 47], ["copper", "SIMPLE_CHEMICAL", 58, 64], ["periportal parenchyma", "TISSUE", 111, 132], ["dogs", "ORGANISM", 230, 234], ["hepatic", "ORGAN", 243, 250], ["copper", "SIMPLE_CHEMICAL", 268, 274], ["lysosomes", "CELLULAR_COMPONENT", 337, 346], ["dogs", "SPECIES", 230, 234], ["abnormal hepatic function", "PROBLEM", 31, 56], ["Chronic hepatitis in dogs", "PROBLEM", 209, 234], ["copper surpasses", "TREATMENT", 268, 284], ["the excess", "PROBLEM", 298, 308], ["abnormal", "OBSERVATION_MODIFIER", 31, 39], ["hepatic", "ANATOMY", 40, 47], ["function", "OBSERVATION", 48, 56], ["smaller", "OBSERVATION_MODIFIER", 88, 95], ["amounts", "OBSERVATION_MODIFIER", 96, 103], ["periportal", "ANATOMY", 111, 121], ["parenchyma", "ANATOMY_MODIFIER", 122, 132], ["without a consistent", "UNCERTAINTY", 136, 156], ["pattern", "OBSERVATION_MODIFIER", 157, 164], ["hepatitis", "OBSERVATION", 217, 226], ["hepatic", "ANATOMY", 243, 250], ["within lysosomes", "OBSERVATION", 330, 346]]], ["These copper-laden lysosomes become consistently demonstrable by the histochemical stains rubeanic acid and rhodanine, at copper concentrations exceeding 400 \u00b5g/g DW (Fig. 2-57) , although some studies note visible copper granules at hepatic copper concentrations as low as 200 \u00b5g/g DW.", [["copper-laden lysosomes", "ANATOMY", 6, 28], ["hepatic", "ANATOMY", 234, 241], ["rubeanic acid", "CHEMICAL", 90, 103], ["rhodanine", "CHEMICAL", 108, 117], ["copper", "CHEMICAL", 122, 128], ["copper", "CHEMICAL", 215, 221], ["copper", "CHEMICAL", 242, 248], ["rubeanic acid", "CHEMICAL", 90, 103], ["rhodanine", "CHEMICAL", 108, 117], ["copper", "CHEMICAL", 122, 128], ["copper", "CHEMICAL", 215, 221], ["copper", "CHEMICAL", 242, 248], ["rubeanic acid", "SIMPLE_CHEMICAL", 90, 103], ["rhodanine", "SIMPLE_CHEMICAL", 108, 117], ["copper", "SIMPLE_CHEMICAL", 122, 128], ["copper", "SIMPLE_CHEMICAL", 215, 221], ["granules", "ORGANISM_SUBSTANCE", 222, 230], ["hepatic", "ORGAN", 234, 241], ["copper", "SIMPLE_CHEMICAL", 242, 248], ["the histochemical stains", "TEST", 65, 89], ["rhodanine", "TREATMENT", 108, 117], ["copper concentrations", "TEST", 122, 143], ["some studies", "TEST", 189, 201], ["copper granules", "PROBLEM", 215, 230], ["hepatic copper concentrations", "TEST", 234, 263], ["hepatic", "ANATOMY", 234, 241]]], ["A reasonable estimate of copper burden can be made from stained sections; however, biochemical determination of copper is more reliable and can be useful to follow the effectiveness of copper chelation therapy.", [["sections", "ANATOMY", 64, 72], ["copper", "CHEMICAL", 25, 31], ["copper", "CHEMICAL", 112, 118], ["copper", "CHEMICAL", 185, 191], ["copper", "CHEMICAL", 25, 31], ["copper", "CHEMICAL", 112, 118], ["copper", "CHEMICAL", 185, 191], ["copper", "SIMPLE_CHEMICAL", 25, 31], ["copper", "SIMPLE_CHEMICAL", 112, 118], ["copper", "SIMPLE_CHEMICAL", 185, 191], ["copper burden", "PROBLEM", 25, 38], ["stained sections", "TEST", 56, 72], ["biochemical determination", "TEST", 83, 108], ["copper chelation therapy", "TREATMENT", 185, 209]]], ["Care should be taken when collecting liver for copper levels, as once the normal lobular architecture is lost because of injury and regenerative nodule formation, copper distribution within the liver becomes heterogeneous.", [["liver", "ANATOMY", 37, 42], ["lobular architecture", "ANATOMY", 81, 101], ["nodule", "ANATOMY", 145, 151], ["liver", "ANATOMY", 194, 199], ["copper", "CHEMICAL", 47, 53], ["copper", "CHEMICAL", 163, 169], ["copper", "CHEMICAL", 47, 53], ["copper", "CHEMICAL", 163, 169], ["liver", "ORGAN", 37, 42], ["copper", "SIMPLE_CHEMICAL", 47, 53], ["lobular architecture", "MULTI-TISSUE_STRUCTURE", 81, 101], ["nodule", "PATHOLOGICAL_FORMATION", 145, 151], ["copper", "SIMPLE_CHEMICAL", 163, 169], ["liver", "ORGAN", 194, 199], ["copper levels", "TEST", 47, 60], ["injury", "PROBLEM", 121, 127], ["regenerative nodule formation", "PROBLEM", 132, 161], ["liver", "ANATOMY", 37, 42], ["lobular", "OBSERVATION_MODIFIER", 81, 88], ["injury", "OBSERVATION", 121, 127], ["regenerative", "OBSERVATION_MODIFIER", 132, 144], ["nodule", "OBSERVATION", 145, 151], ["copper", "OBSERVATION_MODIFIER", 163, 169], ["distribution", "OBSERVATION_MODIFIER", 170, 182], ["liver", "ANATOMY", 194, 199], ["heterogeneous", "OBSERVATION_MODIFIER", 208, 221]]], ["Hepatocytes in regenerative nodules often have relatively low levels of copper, possibly as an adaptation that facilitates their ability to proliferate and form nodules, or as a function of inadequate time for significant copper accumulation in the hepatocytes forming nodules.", [["Hepatocytes", "ANATOMY", 0, 11], ["regenerative nodules", "ANATOMY", 15, 35], ["nodules", "ANATOMY", 161, 168], ["hepatocytes", "ANATOMY", 249, 260], ["nodules", "ANATOMY", 269, 276], ["copper", "CHEMICAL", 72, 78], ["copper", "CHEMICAL", 222, 228], ["copper", "CHEMICAL", 72, 78], ["copper", "CHEMICAL", 222, 228], ["Hepatocytes", "CELL", 0, 11], ["regenerative nodules", "PATHOLOGICAL_FORMATION", 15, 35], ["copper", "SIMPLE_CHEMICAL", 72, 78], ["nodules", "PATHOLOGICAL_FORMATION", 161, 168], ["copper", "SIMPLE_CHEMICAL", 222, 228], ["hepatocytes", "CELL", 249, 260], ["nodules", "CANCER", 269, 276], ["hepatocytes", "CELL_TYPE", 249, 260], ["Hepatocytes in regenerative nodules", "PROBLEM", 0, 35], ["relatively low levels of copper", "PROBLEM", 47, 78], ["nodules", "PROBLEM", 161, 168], ["significant copper accumulation in the hepatocytes forming nodules", "PROBLEM", 210, 276], ["regenerative", "OBSERVATION_MODIFIER", 15, 27], ["nodules", "OBSERVATION", 28, 35], ["relatively", "OBSERVATION_MODIFIER", 47, 57], ["low levels", "OBSERVATION_MODIFIER", 58, 68], ["nodules", "OBSERVATION", 161, 168], ["accumulation", "OBSERVATION_MODIFIER", 229, 241], ["hepatocytes", "ANATOMY", 249, 260], ["nodules", "OBSERVATION", 269, 276]]], ["The intervening areas of parenchymal collapse may contain an abundance of copper.", [["parenchymal", "ANATOMY", 25, 36], ["copper", "CHEMICAL", 74, 80], ["copper", "CHEMICAL", 74, 80], ["parenchymal", "MULTI-TISSUE_STRUCTURE", 25, 36], ["copper", "SIMPLE_CHEMICAL", 74, 80], ["parenchymal collapse", "PROBLEM", 25, 45], ["intervening", "OBSERVATION_MODIFIER", 4, 15], ["areas", "OBSERVATION_MODIFIER", 16, 21], ["parenchymal", "ANATOMY_MODIFIER", 25, 36], ["collapse", "OBSERVATION", 37, 45], ["abundance", "OBSERVATION_MODIFIER", 61, 70], ["copper", "OBSERVATION_MODIFIER", 74, 80]]], ["Because of this regional variation, small samples, such as those taken from needle biopsies, are often inaccurate, and larger samples are required.Chronic hepatitis in dogsRegardless of the reasons for copper accumulation, lysosomal copper can exceed a threshold or be released when hepatocytes die, and thereby contribute to the development of hepatitis.", [["samples", "ANATOMY", 42, 49], ["samples", "ANATOMY", 126, 133], ["lysosomal", "ANATOMY", 223, 232], ["hepatocytes", "ANATOMY", 283, 294], ["Chronic hepatitis", "DISEASE", 147, 164], ["copper", "CHEMICAL", 202, 208], ["copper", "CHEMICAL", 233, 239], ["hepatitis", "DISEASE", 345, 354], ["copper", "CHEMICAL", 202, 208], ["copper", "CHEMICAL", 233, 239], ["needle biopsies", "MULTI-TISSUE_STRUCTURE", 76, 91], ["samples", "CANCER", 126, 133], ["dogs", "ORGANISM", 168, 172], ["copper", "SIMPLE_CHEMICAL", 202, 208], ["lysosomal copper", "SIMPLE_CHEMICAL", 223, 239], ["hepatocytes", "CELL", 283, 294], ["hepatocytes", "CELL_TYPE", 283, 294], ["dogs", "SPECIES", 168, 172], ["this regional variation", "PROBLEM", 11, 34], ["small samples", "PROBLEM", 36, 49], ["needle biopsies", "TEST", 76, 91], ["Chronic hepatitis in dogs", "PROBLEM", 147, 172], ["copper accumulation", "PROBLEM", 202, 221], ["lysosomal copper", "TREATMENT", 223, 239], ["hepatitis", "PROBLEM", 345, 354], ["small", "OBSERVATION_MODIFIER", 36, 41], ["hepatitis", "OBSERVATION", 155, 164], ["hepatitis", "OBSERVATION", 345, 354]]], ["Hepatic pathology does not typically occur at concentrations <2,000 \u00b5g/g DW, although higher values can still be found in some dogs with normal liver histology, and other factors, such as antioxidant levels and other oxidative stress303.e1eFigure 2-13 Icteric Bedlington Terrier with an acute hemolytic crisis concurrent with chronic copper-associated hepatitis.", [["Hepatic", "ANATOMY", 0, 7], ["liver", "ANATOMY", 144, 149], ["acute hemolytic crisis", "DISEASE", 287, 309], ["chronic copper-associated hepatitis", "DISEASE", 326, 361], ["Hepatic", "ORGAN", 0, 7], ["dogs", "ORGANISM", 127, 131], ["liver", "ORGAN", 144, 149], ["dogs", "SPECIES", 127, 131], ["Hepatic pathology", "TEST", 0, 17], ["antioxidant levels", "TEST", 188, 206], ["other oxidative stress", "TEST", 211, 233], ["an acute hemolytic crisis", "PROBLEM", 284, 309], ["chronic copper-associated hepatitis", "PROBLEM", 326, 361], ["pathology", "OBSERVATION", 8, 17], ["liver", "ANATOMY", 144, 149], ["acute", "OBSERVATION_MODIFIER", 287, 292], ["hemolytic crisis", "OBSERVATION", 293, 309], ["chronic", "OBSERVATION_MODIFIER", 326, 333], ["copper-associated", "OBSERVATION_MODIFIER", 334, 351], ["hepatitis", "OBSERVATION", 352, 361]]], ["(Courtesy University of Guelph.) of macrophages containing intracytoplasmic copper and hemosiderin, fewer neutrophils, mononuclear inflammatory cells, as well as scattered foci of hepatocellular necrosis, lobular collapse, periacinar to bridging fibrosis, nodular regeneration, and in some cases cirrhosis.", [["macrophages", "ANATOMY", 36, 47], ["intracytoplasmic", "ANATOMY", 59, 75], ["neutrophils", "ANATOMY", 106, 117], ["mononuclear inflammatory cells", "ANATOMY", 119, 149], ["foci", "ANATOMY", 172, 176], ["hepatocellular", "ANATOMY", 180, 194], ["lobular", "ANATOMY", 205, 212], ["periacinar", "ANATOMY", 223, 233], ["nodular", "ANATOMY", 256, 263], ["hepatocellular necrosis", "DISEASE", 180, 203], ["fibrosis", "DISEASE", 246, 254], ["cirrhosis", "DISEASE", 296, 305], ["copper", "CHEMICAL", 76, 82], ["macrophages", "CELL", 36, 47], ["intracytoplasmic", "IMMATERIAL_ANATOMICAL_ENTITY", 59, 75], ["copper", "SIMPLE_CHEMICAL", 76, 82], ["hemosiderin", "SIMPLE_CHEMICAL", 87, 98], ["neutrophils", "CELL", 106, 117], ["mononuclear inflammatory cells", "CELL", 119, 149], ["hepatocellular", "PATHOLOGICAL_FORMATION", 180, 194], ["lobular", "MULTI-TISSUE_STRUCTURE", 205, 212], ["macrophages", "CELL_TYPE", 36, 47], ["neutrophils", "CELL_TYPE", 106, 117], ["mononuclear inflammatory cells", "CELL_TYPE", 119, 149], ["macrophages", "PROBLEM", 36, 47], ["intracytoplasmic copper and hemosiderin", "PROBLEM", 59, 98], ["neutrophils", "TEST", 106, 117], ["mononuclear inflammatory cells", "PROBLEM", 119, 149], ["hepatocellular necrosis", "PROBLEM", 180, 203], ["lobular collapse", "PROBLEM", 205, 221], ["periacinar", "PROBLEM", 223, 233], ["bridging fibrosis", "PROBLEM", 237, 254], ["nodular regeneration", "PROBLEM", 256, 276], ["some cases cirrhosis", "PROBLEM", 285, 305], ["macrophages", "ANATOMY", 36, 47], ["intracytoplasmic copper", "OBSERVATION", 59, 82], ["hemosiderin", "OBSERVATION_MODIFIER", 87, 98], ["fewer", "OBSERVATION_MODIFIER", 100, 105], ["neutrophils", "OBSERVATION", 106, 117], ["mononuclear", "OBSERVATION_MODIFIER", 119, 130], ["inflammatory cells", "OBSERVATION", 131, 149], ["scattered", "OBSERVATION_MODIFIER", 162, 171], ["foci", "OBSERVATION_MODIFIER", 172, 176], ["hepatocellular", "ANATOMY", 180, 194], ["necrosis", "OBSERVATION", 195, 203], ["lobular", "OBSERVATION_MODIFIER", 205, 212], ["collapse", "OBSERVATION", 213, 221], ["bridging", "OBSERVATION_MODIFIER", 237, 245], ["fibrosis", "OBSERVATION", 246, 254], ["nodular", "OBSERVATION_MODIFIER", 256, 263], ["regeneration", "OBSERVATION_MODIFIER", 264, 276], ["cirrhosis", "OBSERVATION", 296, 305]]], ["Hepatic copper concentrations in one study were typically >2,000 \u00b5g/g, whereas mean hepatic copper concentrations in a separate study were also found to be significantly higher in affected dogs (614 \u00b5g/g, range 104-4,234 \u00b5g/g) compared to age-and sex-matched control dogs (299 \u00b5g/g, 93-3,810 \u00b5g/g).", [["Hepatic", "ANATOMY", 0, 7], ["hepatic", "ANATOMY", 84, 91], ["copper", "CHEMICAL", 8, 14], ["copper", "CHEMICAL", 92, 98], ["copper", "CHEMICAL", 8, 14], ["copper", "CHEMICAL", 92, 98], ["Hepatic", "ORGAN", 0, 7], ["copper", "SIMPLE_CHEMICAL", 8, 14], ["hepatic", "ORGAN", 84, 91], ["copper", "SIMPLE_CHEMICAL", 92, 98], ["dogs", "ORGANISM", 189, 193], ["dogs", "ORGANISM", 267, 271], ["dogs", "SPECIES", 189, 193], ["dogs", "SPECIES", 267, 271], ["Hepatic copper concentrations", "PROBLEM", 0, 29], ["one study", "TEST", 33, 42], ["mean hepatic copper concentrations", "PROBLEM", 79, 113], ["a separate study", "TEST", 117, 133], ["affected dogs", "PROBLEM", 180, 193], ["range", "TEST", 205, 210], ["age", "TEST", 239, 242], ["g", "TEST", 280, 281], ["copper concentrations", "OBSERVATION", 8, 29], ["hepatic", "ANATOMY", 84, 91], ["copper concentrations", "OBSERVATION", 92, 113], ["significantly", "OBSERVATION_MODIFIER", 156, 169], ["higher", "OBSERVATION_MODIFIER", 170, 176]]], ["A concurrent general increase in hepatic copper concentrations in a study population of Labrador Retrievers spanning 30 years was postulated to be associated with increased dietary copper availability, the result of a change in the form and bioavailability of supplemental copper added to commercially produced dog foods.", [["hepatic", "ANATOMY", 33, 40], ["copper", "CHEMICAL", 41, 47], ["copper", "CHEMICAL", 181, 187], ["copper", "CHEMICAL", 273, 279], ["copper", "CHEMICAL", 41, 47], ["copper", "CHEMICAL", 181, 187], ["copper", "CHEMICAL", 273, 279], ["hepatic", "ORGAN", 33, 40], ["copper", "SIMPLE_CHEMICAL", 41, 47], ["copper", "SIMPLE_CHEMICAL", 181, 187], ["copper", "SIMPLE_CHEMICAL", 273, 279], ["dog", "ORGANISM", 311, 314], ["dog", "SPECIES", 311, 314], ["A concurrent general increase in hepatic copper concentrations", "PROBLEM", 0, 62], ["increased dietary copper availability", "PROBLEM", 163, 200], ["supplemental copper", "TREATMENT", 260, 279], ["increase", "OBSERVATION_MODIFIER", 21, 29], ["hepatic", "ANATOMY", 33, 40], ["copper concentrations", "OBSERVATION", 41, 62]]], ["A positive association between dietary copper levels and hepatic copper concentrations has been demonstrated, and high dietary copper has been suggested as a risk factor for development of copperassociated hepatitis in susceptible animals within the breed.", [["hepatic", "ANATOMY", 57, 64], ["copper", "CHEMICAL", 39, 45], ["copper", "CHEMICAL", 65, 71], ["copper", "CHEMICAL", 127, 133], ["hepatitis", "DISEASE", 206, 215], ["copper", "CHEMICAL", 39, 45], ["copper", "CHEMICAL", 65, 71], ["copper", "CHEMICAL", 127, 133], ["copper", "SIMPLE_CHEMICAL", 39, 45], ["hepatic", "ORGAN", 57, 64], ["copper", "SIMPLE_CHEMICAL", 65, 71], ["copper", "SIMPLE_CHEMICAL", 127, 133], ["A positive association between dietary copper levels", "PROBLEM", 0, 52], ["hepatic copper concentrations", "PROBLEM", 57, 86], ["a risk factor", "PROBLEM", 156, 169], ["copperassociated hepatitis", "PROBLEM", 189, 215], ["positive", "OBSERVATION", 2, 10], ["hepatic", "ANATOMY", 57, 64], ["copper concentrations", "OBSERVATION", 65, 86], ["hepatitis", "OBSERVATION", 206, 215]]], ["Concurrent renal proximal tubular dysfunction with glucosuria, and increased renal copper has been described in some Labrador Retrievers with copper-associated hepatitis, and sporadically in other breeds.303.e1Chronic liver disease associated with elevated hepatic copper concentrations has also been reported in Dalmatians.", [["renal", "ANATOMY", 11, 16], ["tubular", "ANATOMY", 26, 33], ["renal", "ANATOMY", 77, 82], ["liver", "ANATOMY", 218, 223], ["hepatic", "ANATOMY", 257, 264], ["renal proximal tubular dysfunction", "DISEASE", 11, 45], ["glucosuria", "DISEASE", 51, 61], ["copper", "CHEMICAL", 83, 89], ["hepatitis", "DISEASE", 160, 169], ["Chronic liver disease", "DISEASE", 210, 231], ["copper", "CHEMICAL", 265, 271], ["copper", "CHEMICAL", 83, 89], ["copper", "CHEMICAL", 265, 271], ["renal", "ORGAN", 11, 16], ["tubular", "MULTI-TISSUE_STRUCTURE", 26, 33], ["renal", "ORGAN", 77, 82], ["copper", "SIMPLE_CHEMICAL", 83, 89], ["liver", "ORGAN", 218, 223], ["hepatic", "ORGAN", 257, 264], ["copper", "SIMPLE_CHEMICAL", 265, 271], ["Concurrent renal proximal tubular dysfunction", "PROBLEM", 0, 45], ["glucosuria", "PROBLEM", 51, 61], ["increased renal copper", "PROBLEM", 67, 89], ["copper-associated hepatitis", "PROBLEM", 142, 169], ["Chronic liver disease", "PROBLEM", 210, 231], ["elevated hepatic copper concentrations", "PROBLEM", 248, 286], ["renal", "ANATOMY", 11, 16], ["proximal", "ANATOMY_MODIFIER", 17, 25], ["tubular", "ANATOMY_MODIFIER", 26, 33], ["dysfunction", "OBSERVATION", 34, 45], ["glucosuria", "OBSERVATION", 51, 61], ["increased", "OBSERVATION_MODIFIER", 67, 76], ["renal", "ANATOMY", 77, 82], ["copper", "OBSERVATION", 83, 89], ["Labrador Retrievers", "OBSERVATION", 117, 136], ["copper-associated", "OBSERVATION_MODIFIER", 142, 159], ["hepatitis", "OBSERVATION", 160, 169], ["Chronic", "OBSERVATION_MODIFIER", 210, 217], ["liver", "ANATOMY", 218, 223], ["disease", "OBSERVATION", 224, 231], ["elevated", "OBSERVATION", 248, 256], ["hepatic", "ANATOMY", 257, 264], ["copper concentrations", "OBSERVATION", 265, 286]]], ["A range of necroinflammatory changes has been reported, including multifocal, piecemeal, centrilobular to massive hepatic necrosis, and cirrhosis, although, in one study of 10 dogs, various degrees of piecemeal necrosis and bridging fibrosis were the most common histologic change, with either primarily lymphocytic or neutrophilic inflammatory infiltrates.", [["centrilobular", "ANATOMY", 89, 102], ["hepatic", "ANATOMY", 114, 121], ["piecemeal", "ANATOMY", 201, 210], ["lymphocytic", "ANATOMY", 304, 315], ["massive hepatic necrosis", "DISEASE", 106, 130], ["cirrhosis", "DISEASE", 136, 145], ["necrosis", "DISEASE", 211, 219], ["fibrosis", "DISEASE", 233, 241], ["hepatic", "ORGAN", 114, 121], ["dogs", "ORGANISM", 176, 180], ["dogs", "SPECIES", 176, 180], ["necroinflammatory changes", "PROBLEM", 11, 36], ["multifocal, piecemeal, centrilobular to massive hepatic necrosis", "PROBLEM", 66, 130], ["cirrhosis", "PROBLEM", 136, 145], ["one study", "TEST", 160, 169], ["piecemeal necrosis", "PROBLEM", 201, 219], ["bridging fibrosis", "PROBLEM", 224, 241], ["primarily lymphocytic or neutrophilic inflammatory infiltrates", "PROBLEM", 294, 356], ["range", "OBSERVATION_MODIFIER", 2, 7], ["necroinflammatory", "OBSERVATION", 11, 28], ["multifocal", "OBSERVATION_MODIFIER", 66, 76], ["piecemeal", "OBSERVATION_MODIFIER", 78, 87], ["centrilobular", "OBSERVATION_MODIFIER", 89, 102], ["massive", "OBSERVATION_MODIFIER", 106, 113], ["hepatic", "ANATOMY", 114, 121], ["necrosis", "OBSERVATION", 122, 130], ["cirrhosis", "OBSERVATION", 136, 145], ["various degrees", "OBSERVATION_MODIFIER", 182, 197], ["piecemeal", "OBSERVATION_MODIFIER", 201, 210], ["necrosis", "OBSERVATION", 211, 219], ["bridging", "OBSERVATION_MODIFIER", 224, 232], ["fibrosis", "OBSERVATION", 233, 241], ["most common", "OBSERVATION_MODIFIER", 251, 262], ["histologic", "OBSERVATION", 263, 273], ["primarily", "OBSERVATION_MODIFIER", 294, 303], ["lymphocytic", "OBSERVATION_MODIFIER", 304, 315], ["neutrophilic", "OBSERVATION_MODIFIER", 319, 331], ["inflammatory", "OBSERVATION_MODIFIER", 332, 344], ["infiltrates", "OBSERVATION", 345, 356]]], ["Morphologic or biochemical evidence of cholestatic liver disease was not prominent.", [["liver", "ANATOMY", 51, 56], ["cholestatic liver disease", "DISEASE", 39, 64], ["liver", "ORGAN", 51, 56], ["cholestatic liver disease", "PROBLEM", 39, 64], ["evidence of", "UNCERTAINTY", 27, 38], ["cholestatic", "OBSERVATION_MODIFIER", 39, 50], ["liver", "ANATOMY", 51, 56], ["disease", "OBSERVATION", 57, 64], ["not", "UNCERTAINTY", 69, 72], ["prominent", "OBSERVATION_MODIFIER", 73, 82]]], ["Hepatic copper concentrations ranged from 745-8,390 \u00b5g/g DW (mean 3,197 \u00b5g/g) in one report of 10 dogs, aged 2-10 years, with a variable zonal distribution.", [["Hepatic", "ANATOMY", 0, 7], ["copper", "CHEMICAL", 8, 14], ["copper", "CHEMICAL", 8, 14], ["Hepatic", "ORGAN", 0, 7], ["copper", "SIMPLE_CHEMICAL", 8, 14], ["dogs", "ORGANISM", 98, 102], ["dogs", "SPECIES", 98, 102], ["Hepatic copper concentrations", "TEST", 0, 29]]], ["Three previous cases in young Dalmatians reported hepatic copper concentrations of 7,940 \u00b5g/g DW, 1,916 \u00b5g/g wet weight, and 2,356 \u00b5g/g wet weight, and 2 of these reports describe diffuse positive staining for copper in all hepatocytes, with the strongest staining observed in centrilobular hepatocytes.303.e1Chronic hepatitis has been reported in American and English Cocker Spaniels and English Springer Spaniels, characterized clinically in the later stages by ascites, weight loss, and icterus.", [["hepatic", "ANATOMY", 50, 57], ["hepatocytes", "ANATOMY", 224, 235], ["centrilobular hepatocytes", "ANATOMY", 277, 302], ["ascites", "ANATOMY", 464, 471], ["copper", "CHEMICAL", 58, 64], ["copper", "CHEMICAL", 210, 216], ["Chronic hepatitis", "DISEASE", 309, 326], ["ascites", "DISEASE", 464, 471], ["weight loss", "DISEASE", 473, 484], ["icterus", "DISEASE", 490, 497], ["copper", "CHEMICAL", 58, 64], ["copper", "CHEMICAL", 210, 216], ["Dalmatians", "ORGANISM", 30, 40], ["hepatic", "ORGAN", 50, 57], ["copper", "SIMPLE_CHEMICAL", 58, 64], ["copper", "SIMPLE_CHEMICAL", 210, 216], ["hepatocytes", "CELL", 224, 235], ["centrilobular hepatocytes", "CELL", 277, 302], ["hepatocytes", "CELL_TYPE", 224, 235], ["centrilobular hepatocytes", "CELL_TYPE", 277, 302], ["hepatic copper concentrations", "TEST", 50, 79], ["weight", "TEST", 113, 119], ["wet weight", "TEST", 136, 146], ["diffuse positive staining", "PROBLEM", 180, 205], ["copper in all hepatocytes", "PROBLEM", 210, 235], ["centrilobular hepatocytes", "PROBLEM", 277, 302], ["Chronic hepatitis", "PROBLEM", 309, 326], ["ascites", "PROBLEM", 464, 471], ["weight loss", "PROBLEM", 473, 484], ["icterus", "PROBLEM", 490, 497], ["hepatic", "ANATOMY", 50, 57], ["diffuse", "OBSERVATION_MODIFIER", 180, 187], ["positive staining", "OBSERVATION", 188, 205], ["hepatocytes", "ANATOMY", 224, 235], ["centrilobular", "ANATOMY_MODIFIER", 277, 290], ["hepatocytes", "ANATOMY", 291, 302], ["Chronic", "OBSERVATION_MODIFIER", 309, 316], ["hepatitis", "OBSERVATION", 317, 326], ["ascites", "OBSERVATION", 464, 471], ["icterus", "OBSERVATION", 490, 497]]], ["Affected dogs develop chronic hepatitis and cirrhosis, and, at postmortem, livers are typically small and firm, with multiple small regenerative nodules (Fig. 2-59) .", [["livers", "ANATOMY", 75, 81], ["nodules", "ANATOMY", 145, 152], ["chronic hepatitis", "DISEASE", 22, 39], ["cirrhosis", "DISEASE", 44, 53], ["dogs", "ORGANISM", 9, 13], ["livers", "ORGAN", 75, 81], ["regenerative nodules", "CANCER", 132, 152], ["dogs", "SPECIES", 9, 13], ["Affected dogs", "PROBLEM", 0, 13], ["chronic hepatitis", "PROBLEM", 22, 39], ["cirrhosis", "PROBLEM", 44, 53], ["typically small and firm", "PROBLEM", 86, 110], ["multiple small regenerative nodules", "PROBLEM", 117, 152], ["chronic", "OBSERVATION_MODIFIER", 22, 29], ["hepatitis", "OBSERVATION", 30, 39], ["cirrhosis", "OBSERVATION", 44, 53], ["livers", "ANATOMY", 75, 81], ["typically", "OBSERVATION_MODIFIER", 86, 95], ["small", "OBSERVATION_MODIFIER", 96, 101], ["firm", "OBSERVATION_MODIFIER", 106, 110], ["multiple", "OBSERVATION_MODIFIER", 117, 125], ["small", "OBSERVATION_MODIFIER", 126, 131], ["regenerative", "OBSERVATION_MODIFIER", 132, 144], ["nodules", "OBSERVATION", 145, 152]]], ["Histologically, there is moderate to severe portal hepatitis, with inflammatory infiltrates of predominantly lymphocytes, plasma cells, and fewer neutrophils, and variable degrees of portal fibrosis and bridging fibrosis.", [["lymphocytes", "ANATOMY", 109, 120], ["plasma cells", "ANATOMY", 122, 134], ["neutrophils", "ANATOMY", 146, 157], ["portal", "ANATOMY", 183, 189], ["portal hepatitis", "DISEASE", 44, 60], ["fibrosis", "DISEASE", 190, 198], ["fibrosis", "DISEASE", 212, 220], ["lymphocytes", "CELL", 109, 120], ["plasma cells", "CELL", 122, 134], ["neutrophils", "CELL", 146, 157], ["portal", "MULTI-TISSUE_STRUCTURE", 183, 189], ["lymphocytes", "CELL_TYPE", 109, 120], ["plasma cells", "CELL_TYPE", 122, 134], ["neutrophils", "CELL_TYPE", 146, 157], ["moderate to severe portal hepatitis", "PROBLEM", 25, 60], ["inflammatory infiltrates of predominantly lymphocytes", "PROBLEM", 67, 120], ["plasma cells", "TEST", 122, 134], ["fewer neutrophils", "PROBLEM", 140, 157], ["portal fibrosis", "PROBLEM", 183, 198], ["bridging fibrosis", "PROBLEM", 203, 220], ["moderate", "OBSERVATION_MODIFIER", 25, 33], ["severe", "OBSERVATION_MODIFIER", 37, 43], ["portal", "ANATOMY", 44, 50], ["hepatitis", "OBSERVATION", 51, 60], ["inflammatory", "OBSERVATION_MODIFIER", 67, 79], ["predominantly lymphocytes", "OBSERVATION", 95, 120], ["plasma cells", "OBSERVATION", 122, 134], ["fewer neutrophils", "OBSERVATION", 140, 157], ["variable degrees", "OBSERVATION_MODIFIER", 163, 179], ["portal", "ANATOMY", 183, 189], ["fibrosis", "OBSERVATION", 190, 198], ["bridging", "OBSERVATION_MODIFIER", 203, 211], ["fibrosis", "OBSERVATION", 212, 220]]], ["One study of American Cocker Spaniels reported diffuse fibrosis typical of lobular dissecting hepatitis in 7 of 13 affected dogs, in addition to patterns of fibrosis more typical of cirrhosis.", [["lobular", "ANATOMY", 75, 82], ["fibrosis", "DISEASE", 55, 63], ["lobular dissecting hepatitis", "DISEASE", 75, 103], ["fibrosis", "DISEASE", 157, 165], ["cirrhosis", "DISEASE", 182, 191], ["lobular", "PATHOLOGICAL_FORMATION", 75, 82], ["dogs", "ORGANISM", 124, 128], ["cirrhosis", "CANCER", 182, 191], ["dogs", "SPECIES", 124, 128], ["One study", "TEST", 0, 9], ["diffuse fibrosis", "PROBLEM", 47, 63], ["lobular dissecting hepatitis", "PROBLEM", 75, 103], ["13 affected dogs", "PROBLEM", 112, 128], ["fibrosis", "PROBLEM", 157, 165], ["cirrhosis", "PROBLEM", 182, 191], ["diffuse", "OBSERVATION_MODIFIER", 47, 54], ["fibrosis", "OBSERVATION", 55, 63], ["lobular", "OBSERVATION_MODIFIER", 75, 82], ["dissecting", "OBSERVATION_MODIFIER", 83, 93], ["hepatitis", "OBSERVATION", 94, 103], ["fibrosis", "OBSERVATION", 157, 165], ["cirrhosis", "OBSERVATION", 182, 191]]], ["Piecemeal necrosis and limiting plate destruction have been reported in Cocker Spaniels, whereas in English Springer Spaniels, hepatocyte necrosis and apoptosis in areas of inflammatory infiltrates in both portal areas and scattered throughout the hepatic parenchyma was more typical.", [["hepatocyte", "ANATOMY", 127, 137], ["portal areas", "ANATOMY", 206, 218], ["hepatic parenchyma", "ANATOMY", 248, 266], ["necrosis", "DISEASE", 10, 18], ["necrosis", "DISEASE", 138, 146], ["hepatocyte", "CELL", 127, 137], ["portal areas", "MULTI-TISSUE_STRUCTURE", 206, 218], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 248, 266], ["Piecemeal necrosis", "PROBLEM", 0, 18], ["limiting plate destruction", "PROBLEM", 23, 49], ["hepatocyte necrosis", "PROBLEM", 127, 146], ["apoptosis", "PROBLEM", 151, 160], ["inflammatory infiltrates in both portal areas", "PROBLEM", 173, 218], ["necrosis", "OBSERVATION", 10, 18], ["plate", "OBSERVATION_MODIFIER", 32, 37], ["destruction", "OBSERVATION", 38, 49], ["hepatocyte", "ANATOMY", 127, 137], ["necrosis", "OBSERVATION", 138, 146], ["apoptosis", "OBSERVATION_MODIFIER", 151, 160], ["areas", "OBSERVATION_MODIFIER", 164, 169], ["inflammatory", "OBSERVATION_MODIFIER", 173, 185], ["infiltrates", "OBSERVATION", 186, 197], ["both", "ANATOMY_MODIFIER", 201, 205], ["portal", "ANATOMY", 206, 212], ["areas", "ANATOMY_MODIFIER", 213, 218], ["scattered", "OBSERVATION_MODIFIER", 223, 232], ["hepatic", "ANATOMY", 248, 255], ["parenchyma", "ANATOMY_MODIFIER", 256, 266], ["more typical", "OBSERVATION_MODIFIER", 271, 283]]], ["Biliary hyperplasia or marked ductular reaction was noted in affected Cocker Spaniels.", [["Biliary", "ANATOMY", 0, 7], ["ductular", "ANATOMY", 30, 38], ["Biliary hyperplasia", "DISEASE", 0, 19], ["Biliary hyperplasia", "PATHOLOGICAL_FORMATION", 0, 19], ["ductular", "MULTI-TISSUE_STRUCTURE", 30, 38], ["Biliary hyperplasia", "PROBLEM", 0, 19], ["marked ductular reaction", "PROBLEM", 23, 47], ["hyperplasia", "OBSERVATION", 8, 19], ["marked", "OBSERVATION_MODIFIER", 23, 29], ["ductular", "OBSERVATION_MODIFIER", 30, 38], ["reaction", "OBSERVATION", 39, 47], ["affected", "OBSERVATION_MODIFIER", 61, 69], ["Cocker Spaniels", "OBSERVATION", 70, 85]]], ["Hepatic copper staining is variable, and hepatic copper accumulation is not a consistent feature.303.e1\u03b11-Antitrypsin (\u03b11-AT) deficiency has been suggested to play a role in chronic hepatitis in some dog breeds, including English Cocker Spaniels, although whether this is an copper concentrations, along with a reduction in gene expression of components of the antioxidant defense system, including SOD1, catalase, as well as reduced levels of glutathione, so continued investigations are needed to further clarify the pathogenesis of chronic hepatitis in Dobermans.West Highland White Terriers are at increased risk of developing chronic hepatitis and cirrhosis.There is evidence to support familial hepatic copper accumulation in some West Highland White Terriers, although the mode of inheritance is not completely understood.", [["Hepatic", "ANATOMY", 0, 7], ["hepatic", "ANATOMY", 41, 48], ["hepatic", "ANATOMY", 701, 708], ["copper", "CHEMICAL", 8, 14], ["copper", "CHEMICAL", 49, 55], ["hepatitis", "DISEASE", 182, 191], ["copper", "CHEMICAL", 275, 281], ["glutathione", "CHEMICAL", 444, 455], ["chronic hepatitis", "DISEASE", 535, 552], ["chronic hepatitis", "DISEASE", 631, 648], ["cirrhosis", "DISEASE", 653, 662], ["copper", "CHEMICAL", 709, 715], ["copper", "CHEMICAL", 8, 14], ["copper", "CHEMICAL", 49, 55], ["copper", "CHEMICAL", 275, 281], ["glutathione", "CHEMICAL", 444, 455], ["copper", "CHEMICAL", 709, 715], ["Hepatic", "MULTI-TISSUE_STRUCTURE", 0, 7], ["copper", "SIMPLE_CHEMICAL", 8, 14], ["hepatic", "ORGAN", 41, 48], ["copper", "SIMPLE_CHEMICAL", 49, 55], ["e1\u03b11-Antitrypsin", "GENE_OR_GENE_PRODUCT", 101, 117], ["\u03b11-AT", "GENE_OR_GENE_PRODUCT", 119, 124], ["dog", "ORGANISM", 200, 203], ["copper", "SIMPLE_CHEMICAL", 275, 281], ["SOD1", "GENE_OR_GENE_PRODUCT", 399, 403], ["catalase", "GENE_OR_GENE_PRODUCT", 405, 413], ["glutathione", "SIMPLE_CHEMICAL", 444, 455], ["hepatic", "ORGAN", 701, 708], ["copper", "SIMPLE_CHEMICAL", 709, 715], ["\u03b11", "PROTEIN", 103, 105], ["\u03b11", "PROTEIN", 119, 121], ["SOD1", "PROTEIN", 399, 403], ["catalase", "PROTEIN", 405, 413], ["Hepatic copper staining", "PROBLEM", 0, 23], ["hepatic copper accumulation", "PROBLEM", 41, 68], ["e1", "TEST", 101, 103], ["Antitrypsin", "TEST", 106, 117], ["deficiency", "PROBLEM", 126, 136], ["chronic hepatitis", "PROBLEM", 174, 191], ["an copper concentrations", "PROBLEM", 272, 296], ["a reduction", "TREATMENT", 309, 320], ["the antioxidant defense system", "PROBLEM", 357, 387], ["SOD1, catalase", "PROBLEM", 399, 413], ["reduced levels of glutathione", "PROBLEM", 426, 455], ["continued investigations", "TEST", 460, 484], ["chronic hepatitis in Dobermans", "PROBLEM", 535, 565], ["developing chronic hepatitis", "PROBLEM", 620, 648], ["cirrhosis", "PROBLEM", 653, 662], ["familial hepatic copper accumulation", "PROBLEM", 692, 728], ["copper staining", "OBSERVATION", 8, 23], ["variable", "OBSERVATION_MODIFIER", 27, 35], ["hepatic", "ANATOMY", 41, 48], ["copper accumulation", "OBSERVATION", 49, 68], ["not a consistent feature", "UNCERTAINTY", 72, 96], ["chronic", "OBSERVATION_MODIFIER", 174, 181], ["hepatitis", "OBSERVATION", 182, 191], ["chronic", "OBSERVATION_MODIFIER", 535, 542], ["hepatitis", "OBSERVATION", 543, 552], ["chronic", "OBSERVATION_MODIFIER", 631, 638], ["hepatitis", "OBSERVATION", 639, 648], ["cirrhosis", "OBSERVATION", 653, 662], ["hepatic", "ANATOMY", 701, 708], ["copper accumulation", "OBSERVATION", 709, 728]]], ["Hepatic copper accumulates in zone 3 hepatocytes, up to ~8 months of age, with concentrations rarely >2,000 \u00b5g/g DW.", [["Hepatic", "ANATOMY", 0, 7], ["zone 3 hepatocytes", "ANATOMY", 30, 48], ["copper", "CHEMICAL", 8, 14], ["copper", "CHEMICAL", 8, 14], ["Hepatic", "ORGAN", 0, 7], ["copper", "SIMPLE_CHEMICAL", 8, 14], ["zone 3 hepatocytes", "CELL", 30, 48], ["zone 3 hepatocytes", "CELL_TYPE", 30, 48], ["concentrations", "TEST", 79, 93], ["copper", "OBSERVATION", 8, 14], ["zone", "OBSERVATION_MODIFIER", 30, 34], ["hepatocytes", "ANATOMY", 37, 48]]], ["Clinical illness directly attributable to copper hepatotoxicity (concentrations >2,000 \u00b5g/g DW) in West Highland White Terriers is, however, apparently uncommon.", [["illness", "DISEASE", 9, 16], ["copper", "CHEMICAL", 42, 48], ["hepatotoxicity", "DISEASE", 49, 63], ["copper", "CHEMICAL", 42, 48], ["copper", "SIMPLE_CHEMICAL", 42, 48], ["Clinical illness", "PROBLEM", 0, 16], ["copper hepatotoxicity", "PROBLEM", 42, 63], ["concentrations", "TEST", 65, 79], ["hepatotoxicity", "OBSERVATION", 49, 63]]], ["Idiopathic chronic hepatitis progressing to cirrhosis does also occur in this breed, and may be distinguished on the basis of a different zonal location and morphology of the inflammatory lesions.", [["inflammatory lesions", "ANATOMY", 175, 195], ["Idiopathic chronic hepatitis", "DISEASE", 0, 28], ["cirrhosis", "DISEASE", 44, 53], ["inflammatory lesions", "PATHOLOGICAL_FORMATION", 175, 195], ["Idiopathic chronic hepatitis", "PROBLEM", 0, 28], ["cirrhosis", "PROBLEM", 44, 53], ["the inflammatory lesions", "PROBLEM", 171, 195], ["chronic", "OBSERVATION_MODIFIER", 11, 18], ["hepatitis", "OBSERVATION", 19, 28], ["cirrhosis", "OBSERVATION", 44, 53], ["may be", "UNCERTAINTY", 89, 95], ["different", "OBSERVATION_MODIFIER", 128, 137], ["zonal", "OBSERVATION_MODIFIER", 138, 143], ["morphology", "OBSERVATION_MODIFIER", 157, 167], ["inflammatory", "OBSERVATION_MODIFIER", 175, 187], ["lesions", "OBSERVATION", 188, 195]]], ["In the idiopathic disease, inflammatory foci are smaller, composed of a single apoptotic hepatocyte or fragments of cells accompanied by a few lymphocytes and plasma cells, and are commonly localized to zone 1, or may be random in distribution.", [["foci", "ANATOMY", 40, 44], ["hepatocyte", "ANATOMY", 89, 99], ["fragments", "ANATOMY", 103, 112], ["cells", "ANATOMY", 116, 121], ["lymphocytes", "ANATOMY", 143, 154], ["plasma cells", "ANATOMY", 159, 171], ["idiopathic disease", "DISEASE", 7, 25], ["hepatocyte", "CELL", 89, 99], ["cells", "CELL", 116, 121], ["lymphocytes", "CELL", 143, 154], ["plasma cells", "CELL", 159, 171], ["lymphocytes", "CELL_TYPE", 143, 154], ["plasma cells", "CELL_TYPE", 159, 171], ["the idiopathic disease", "PROBLEM", 3, 25], ["inflammatory foci", "PROBLEM", 27, 44], ["a single apoptotic hepatocyte or fragments of cells", "PROBLEM", 70, 121], ["a few lymphocytes and plasma cells", "PROBLEM", 137, 171], ["idiopathic", "OBSERVATION_MODIFIER", 7, 17], ["disease", "OBSERVATION", 18, 25], ["inflammatory", "OBSERVATION_MODIFIER", 27, 39], ["foci", "OBSERVATION", 40, 44], ["smaller", "OBSERVATION_MODIFIER", 49, 56], ["single", "OBSERVATION_MODIFIER", 72, 78], ["apoptotic", "OBSERVATION_MODIFIER", 79, 88], ["hepatocyte", "ANATOMY", 89, 99], ["fragments of cells", "OBSERVATION", 103, 121], ["few", "OBSERVATION_MODIFIER", 139, 142], ["lymphocytes", "OBSERVATION", 143, 154], ["plasma cells", "OBSERVATION", 159, 171], ["may be", "UNCERTAINTY", 214, 220], ["random", "OBSERVATION", 221, 227]]], ["In dogs with copper toxicosis, foci of inflammation and necrosis were larger, always found around the central vein among copper-laden hepatocytes, and were composed of debris-filled macrophages, lymphocytes, plasma cells, and scattered neutrophils, with occasional apoptotic hepatocytes around the periphery.", [["foci", "ANATOMY", 31, 35], ["central vein", "ANATOMY", 102, 114], ["hepatocytes", "ANATOMY", 134, 145], ["macrophages", "ANATOMY", 182, 193], ["lymphocytes", "ANATOMY", 195, 206], ["plasma cells", "ANATOMY", 208, 220], ["neutrophils", "ANATOMY", 236, 247], ["hepatocytes", "ANATOMY", 275, 286], ["copper", "CHEMICAL", 13, 19], ["toxicosis", "DISEASE", 20, 29], ["inflammation", "DISEASE", 39, 51], ["necrosis", "DISEASE", 56, 64], ["copper", "CHEMICAL", 121, 127], ["copper", "CHEMICAL", 13, 19], ["copper", "CHEMICAL", 121, 127], ["dogs", "ORGANISM", 3, 7], ["copper", "SIMPLE_CHEMICAL", 13, 19], ["central vein", "MULTI-TISSUE_STRUCTURE", 102, 114], ["copper", "SIMPLE_CHEMICAL", 121, 127], ["hepatocytes", "CELL", 134, 145], ["macrophages", "CELL", 182, 193], ["lymphocytes", "CELL", 195, 206], ["plasma cells", "CELL", 208, 220], ["neutrophils", "CELL", 236, 247], ["hepatocytes", "CELL", 275, 286], ["copper-laden hepatocytes", "CELL_TYPE", 121, 145], ["debris-filled macrophages", "CELL_TYPE", 168, 193], ["lymphocytes", "CELL_TYPE", 195, 206], ["plasma cells", "CELL_TYPE", 208, 220], ["scattered neutrophils", "CELL_TYPE", 226, 247], ["apoptotic hepatocytes", "CELL_TYPE", 265, 286], ["dogs", "SPECIES", 3, 7], ["copper toxicosis", "PROBLEM", 13, 29], ["inflammation", "PROBLEM", 39, 51], ["necrosis", "PROBLEM", 56, 64], ["debris-filled macrophages", "PROBLEM", 168, 193], ["lymphocytes", "TEST", 195, 206], ["plasma cells", "TEST", 208, 220], ["scattered neutrophils", "PROBLEM", 226, 247], ["occasional apoptotic hepatocytes around the periphery", "PROBLEM", 254, 307], ["foci", "OBSERVATION_MODIFIER", 31, 35], ["inflammation", "OBSERVATION", 39, 51], ["necrosis", "OBSERVATION", 56, 64], ["larger", "OBSERVATION_MODIFIER", 70, 76], ["central", "ANATOMY_MODIFIER", 102, 109], ["vein", "ANATOMY", 110, 114], ["copper", "OBSERVATION_MODIFIER", 121, 127], ["laden hepatocytes", "OBSERVATION", 128, 145], ["debris", "OBSERVATION", 168, 174], ["filled macrophages", "OBSERVATION", 175, 193], ["lymphocytes", "ANATOMY", 195, 206], ["plasma cells", "OBSERVATION", 208, 220], ["scattered", "OBSERVATION_MODIFIER", 226, 235], ["neutrophils", "OBSERVATION", 236, 247], ["occasional", "OBSERVATION_MODIFIER", 254, 264], ["apoptotic hepatocytes", "OBSERVATION", 265, 286], ["periphery", "ANATOMY_MODIFIER", 298, 307]]], ["Distinguishing between copper toxicosis and idiopathic chronic hepatic disease may be difficult in cirrhotic livers, which, irrespective of the underlying cause, may have reduced copper burdens because of connectivetissue displacement of hepatic parenchyma, and typically lower concentrations of copper in regenerative nodules.West Highland White Terriers are at increased risk of developing chronic hepatitis and cirrhosis.Chronic hepatitis been reported in genetically related Skye Terriers, accompanied by modest and somewhat inconsistent hepatic copper accumulation.", [["hepatic", "ANATOMY", 63, 70], ["livers", "ANATOMY", 109, 115], ["hepatic parenchyma", "ANATOMY", 238, 256], ["regenerative nodules", "ANATOMY", 306, 326], ["hepatic", "ANATOMY", 542, 549], ["copper", "CHEMICAL", 23, 29], ["toxicosis", "DISEASE", 30, 39], ["idiopathic chronic hepatic disease", "DISEASE", 44, 78], ["copper", "CHEMICAL", 179, 185], ["copper", "CHEMICAL", 296, 302], ["chronic hepatitis", "DISEASE", 392, 409], ["cirrhosis", "DISEASE", 414, 423], ["Chronic hepatitis", "DISEASE", 424, 441], ["copper", "CHEMICAL", 550, 556], ["copper", "CHEMICAL", 23, 29], ["copper", "CHEMICAL", 179, 185], ["copper", "CHEMICAL", 296, 302], ["copper", "CHEMICAL", 550, 556], ["copper", "SIMPLE_CHEMICAL", 23, 29], ["hepatic", "ORGAN", 63, 70], ["livers", "ORGAN", 109, 115], ["copper", "SIMPLE_CHEMICAL", 179, 185], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 238, 256], ["copper", "SIMPLE_CHEMICAL", 296, 302], ["regenerative nodules", "CANCER", 306, 326], ["hepatic", "ORGAN", 542, 549], ["copper", "SIMPLE_CHEMICAL", 550, 556], ["copper toxicosis", "PROBLEM", 23, 39], ["idiopathic chronic hepatic disease", "PROBLEM", 44, 78], ["cirrhotic livers", "PROBLEM", 99, 115], ["reduced copper burdens", "PROBLEM", 171, 193], ["connectivetissue displacement of hepatic parenchyma", "PROBLEM", 205, 256], ["typically lower concentrations of copper in regenerative nodules", "PROBLEM", 262, 326], ["developing chronic hepatitis", "PROBLEM", 381, 409], ["cirrhosis", "PROBLEM", 414, 423], ["Chronic hepatitis", "PROBLEM", 424, 441], ["Skye Terriers", "PROBLEM", 479, 492], ["somewhat inconsistent hepatic copper accumulation", "PROBLEM", 520, 569], ["toxicosis", "OBSERVATION", 30, 39], ["idiopathic", "OBSERVATION_MODIFIER", 44, 54], ["chronic", "OBSERVATION_MODIFIER", 55, 62], ["hepatic", "ANATOMY", 63, 70], ["disease", "OBSERVATION", 71, 78], ["cirrhotic", "OBSERVATION", 99, 108], ["livers", "ANATOMY", 109, 115], ["reduced", "OBSERVATION_MODIFIER", 171, 178], ["copper", "OBSERVATION_MODIFIER", 179, 185], ["burdens", "OBSERVATION", 186, 193], ["connectivetissue displacement", "OBSERVATION", 205, 234], ["hepatic", "ANATOMY", 238, 245], ["parenchyma", "ANATOMY_MODIFIER", 246, 256], ["typically", "OBSERVATION_MODIFIER", 262, 271], ["lower concentrations", "OBSERVATION_MODIFIER", 272, 292], ["copper", "OBSERVATION_MODIFIER", 296, 302], ["regenerative", "OBSERVATION_MODIFIER", 306, 318], ["nodules", "OBSERVATION", 319, 326], ["chronic", "OBSERVATION_MODIFIER", 392, 399], ["hepatitis", "OBSERVATION", 400, 409], ["cirrhosis", "OBSERVATION", 414, 423], ["hepatitis", "OBSERVATION", 432, 441], ["Skye Terriers", "OBSERVATION", 479, 492], ["modest", "OBSERVATION_MODIFIER", 509, 515], ["somewhat", "OBSERVATION_MODIFIER", 520, 528], ["inconsistent", "OBSERVATION_MODIFIER", 529, 541], ["hepatic", "ANATOMY", 542, 549], ["copper accumulation", "OBSERVATION", 550, 569]]], ["Lesions ranged from hepatocellular degeneration and necrosis with mild inflammation in zone 3, to chronic hepatitis and cirrhosis with marked intracanalicular cholestasis.", [["hepatocellular", "ANATOMY", 20, 34], ["hepatocellular degeneration", "DISEASE", 20, 47], ["necrosis", "DISEASE", 52, 60], ["inflammation", "DISEASE", 71, 83], ["chronic hepatitis", "DISEASE", 98, 115], ["cirrhosis", "DISEASE", 120, 129], ["cholestasis", "DISEASE", 159, 170], ["hepatocellular", "CANCER", 20, 34], ["Lesions", "PROBLEM", 0, 7], ["hepatocellular degeneration", "PROBLEM", 20, 47], ["necrosis", "PROBLEM", 52, 60], ["mild inflammation in zone 3", "PROBLEM", 66, 93], ["chronic hepatitis", "PROBLEM", 98, 115], ["cirrhosis", "PROBLEM", 120, 129], ["marked intracanalicular cholestasis", "PROBLEM", 135, 170], ["hepatocellular", "ANATOMY", 20, 34], ["degeneration", "OBSERVATION", 35, 47], ["necrosis", "OBSERVATION", 52, 60], ["mild", "OBSERVATION_MODIFIER", 66, 70], ["inflammation", "OBSERVATION", 71, 83], ["zone", "OBSERVATION_MODIFIER", 87, 91], ["chronic", "OBSERVATION_MODIFIER", 98, 105], ["hepatitis", "OBSERVATION", 106, 115], ["cirrhosis", "OBSERVATION", 120, 129], ["marked", "OBSERVATION_MODIFIER", 135, 141], ["intracanalicular", "OBSERVATION_MODIFIER", 142, 158], ["cholestasis", "OBSERVATION", 159, 170]]], ["Hepatic copper concentrations ranged from 800-2,200 \u00b5g/g DW, and copper-containing hepatocytes were found predominantly in zone 3.West Highland White Terriers are at increased risk of developing chronic hepatitis and cirrhosis.Copper-associated chronic hepatitis has been described in Labrador Retrievers, characterized by centrilobular infiltrates consistent with glycogen accumulation, fibrillar collagen in the perivenular region, and variable mild parenchymal collapse, with bridging fibrosis in one cat.", [["Hepatic", "ANATOMY", 0, 7], ["hepatocytes", "ANATOMY", 83, 94], ["centrilobular infiltrates", "ANATOMY", 323, 348], ["perivenular region", "ANATOMY", 414, 432], ["parenchymal", "ANATOMY", 452, 463], ["copper", "CHEMICAL", 8, 14], ["chronic hepatitis", "DISEASE", 195, 212], ["cirrhosis", "DISEASE", 217, 226], ["Copper", "CHEMICAL", 227, 233], ["chronic hepatitis", "DISEASE", 245, 262], ["glycogen", "CHEMICAL", 365, 373], ["parenchymal collapse", "DISEASE", 452, 472], ["fibrosis", "DISEASE", 488, 496], ["copper", "CHEMICAL", 8, 14], ["Copper", "CHEMICAL", 227, 233], ["Hepatic", "ORGAN", 0, 7], ["copper", "SIMPLE_CHEMICAL", 8, 14], ["hepatocytes", "CELL", 83, 94], ["Copper", "SIMPLE_CHEMICAL", 227, 233], ["centrilobular infiltrates", "PATHOLOGICAL_FORMATION", 323, 348], ["glycogen", "SIMPLE_CHEMICAL", 365, 373], ["fibrillar collagen", "GENE_OR_GENE_PRODUCT", 388, 406], ["parenchymal", "ORGAN", 452, 463], ["cat", "ORGANISM", 504, 507], ["copper-containing hepatocytes", "CELL_TYPE", 65, 94], ["fibrillar collagen", "PROTEIN", 388, 406], ["Hepatic copper concentrations", "TEST", 0, 29], ["copper-containing hepatocytes", "PROBLEM", 65, 94], ["developing chronic hepatitis", "PROBLEM", 184, 212], ["cirrhosis", "PROBLEM", 217, 226], ["Copper-associated chronic hepatitis", "PROBLEM", 227, 262], ["centrilobular infiltrates", "PROBLEM", 323, 348], ["glycogen accumulation", "PROBLEM", 365, 386], ["fibrillar collagen in the perivenular region", "PROBLEM", 388, 432], ["variable mild parenchymal collapse", "PROBLEM", 438, 472], ["bridging fibrosis", "PROBLEM", 479, 496], ["hepatocytes", "ANATOMY", 83, 94], ["predominantly", "OBSERVATION_MODIFIER", 106, 119], ["chronic", "OBSERVATION_MODIFIER", 195, 202], ["hepatitis", "OBSERVATION", 203, 212], ["cirrhosis", "OBSERVATION", 217, 226], ["chronic", "OBSERVATION_MODIFIER", 245, 252], ["hepatitis", "OBSERVATION", 253, 262], ["Labrador Retrievers", "OBSERVATION", 285, 304], ["centrilobular", "OBSERVATION_MODIFIER", 323, 336], ["infiltrates", "OBSERVATION", 337, 348], ["consistent with", "UNCERTAINTY", 349, 364], ["glycogen accumulation", "OBSERVATION", 365, 386], ["fibrillar collagen", "OBSERVATION", 388, 406], ["perivenular", "ANATOMY_MODIFIER", 414, 425], ["variable", "OBSERVATION_MODIFIER", 438, 446], ["mild", "OBSERVATION_MODIFIER", 447, 451], ["parenchymal", "ANATOMY_MODIFIER", 452, 463], ["collapse", "OBSERVATION", 464, 472], ["bridging", "OBSERVATION_MODIFIER", 479, 487], ["fibrosis", "OBSERVATION", 488, 496]]], ["Cats also accumulate copper in the liver secondary to other cholestatic hepatobiliary disorders, such as chronic cholangitis/cholangiohepatitis, or extrahepatic bile duct obstruction, although copper staining in these cases is principally in hepatocytes in portal and intermediate zones.West Highland White Terriers are at increased risk of developing chronic hepatitis and cirrhosis.Chronic hepatitis seen as end-stage livers occurs in horses (eFig.", [["liver", "ANATOMY", 35, 40], ["hepatobiliary", "ANATOMY", 72, 85], ["extrahepatic bile duct", "ANATOMY", 148, 170], ["hepatocytes", "ANATOMY", 242, 253], ["portal", "ANATOMY", 257, 263], ["livers", "ANATOMY", 420, 426], ["copper", "CHEMICAL", 21, 27], ["cholestatic hepatobiliary disorders", "DISEASE", 60, 95], ["cholangitis", "DISEASE", 113, 124], ["cholangiohepatitis", "DISEASE", 125, 143], ["extrahepatic bile duct obstruction", "DISEASE", 148, 182], ["copper", "CHEMICAL", 193, 199], ["chronic hepatitis", "DISEASE", 352, 369], ["cirrhosis", "DISEASE", 374, 383], ["hepatitis", "DISEASE", 392, 401], ["copper", "CHEMICAL", 21, 27], ["copper", "CHEMICAL", 193, 199], ["Cats", "ORGANISM", 0, 4], ["copper", "SIMPLE_CHEMICAL", 21, 27], ["liver", "ORGAN", 35, 40], ["hepatobiliary", "ORGAN", 72, 85], ["extrahepatic bile duct", "MULTI-TISSUE_STRUCTURE", 148, 170], ["copper", "SIMPLE_CHEMICAL", 193, 199], ["hepatocytes", "CELL", 242, 253], ["portal", "MULTI-TISSUE_STRUCTURE", 257, 263], ["livers", "ORGAN", 420, 426], ["horses", "ORGANISM_SUBDIVISION", 437, 443], ["hepatocytes", "CELL_TYPE", 242, 253], ["other cholestatic hepatobiliary disorders", "PROBLEM", 54, 95], ["chronic cholangitis", "PROBLEM", 105, 124], ["cholangiohepatitis", "PROBLEM", 125, 143], ["extrahepatic bile duct obstruction", "PROBLEM", 148, 182], ["copper staining in these cases", "PROBLEM", 193, 223], ["developing chronic hepatitis", "PROBLEM", 341, 369], ["cirrhosis", "PROBLEM", 374, 383], ["Chronic hepatitis", "PROBLEM", 384, 401], ["accumulate copper", "OBSERVATION", 10, 27], ["liver", "ANATOMY", 35, 40], ["cholestatic", "OBSERVATION_MODIFIER", 60, 71], ["hepatobiliary", "ANATOMY", 72, 85], ["disorders", "OBSERVATION", 86, 95], ["chronic", "OBSERVATION_MODIFIER", 105, 112], ["cholangitis", "OBSERVATION", 113, 124], ["cholangiohepatitis", "OBSERVATION", 125, 143], ["extrahepatic", "ANATOMY_MODIFIER", 148, 160], ["bile duct", "ANATOMY", 161, 170], ["obstruction", "OBSERVATION", 171, 182], ["hepatocytes", "ANATOMY", 242, 253], ["portal", "ANATOMY", 257, 263], ["intermediate", "OBSERVATION_MODIFIER", 268, 280], ["zones", "ANATOMY_MODIFIER", 281, 286], ["chronic", "OBSERVATION_MODIFIER", 352, 359], ["hepatitis", "OBSERVATION", 360, 369], ["cirrhosis", "OBSERVATION", 374, 383], ["hepatitis", "OBSERVATION", 392, 401], ["end-stage", "OBSERVATION_MODIFIER", 410, 419], ["livers", "ANATOMY", 420, 426]]], ["2-15) and ruminants, particularly cattle, and is often assumed to be associated with ingestion of hepatotoxins, such as pyrrolizidine alkaloids in forage, or a consequence of prolonged administration of hepatotoxic therapeutics, although in the absence of specific histologic lesions and/or a corroborative clinical history, the underlying causes are rarely discovered.", [["lesions", "ANATOMY", 276, 283], ["2-15)", "CHEMICAL", 0, 5], ["pyrrolizidine alkaloids", "CHEMICAL", 120, 143], ["hepatotoxic", "DISEASE", 203, 214], ["pyrrolizidine alkaloids", "CHEMICAL", 120, 143], ["ruminants", "ORGANISM", 10, 19], ["cattle", "ORGANISM", 34, 40], ["hepatotoxins", "SIMPLE_CHEMICAL", 98, 110], ["pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 120, 143], ["histologic lesions", "CANCER", 265, 283], ["cattle", "SPECIES", 34, 40], ["ruminants", "SPECIES", 10, 19], ["cattle", "SPECIES", 34, 40], ["hepatotoxins", "TREATMENT", 98, 110], ["pyrrolizidine alkaloids", "TREATMENT", 120, 143], ["hepatotoxic therapeutics", "TREATMENT", 203, 227], ["specific histologic lesions", "PROBLEM", 256, 283], ["histologic", "OBSERVATION_MODIFIER", 265, 275], ["lesions", "OBSERVATION", 276, 283]]], ["Bexfield epiphenomenon or cause of chronic liver disease has not yet been proven. \u03b11-AT, a plasma glycoprotein synthesized mainly by hepatocytes, is a member of the serine proteinase inhibitor (serpin) superfamily, and is a potent inhibitor of neutrophil elastase.", [["liver", "ANATOMY", 43, 48], ["plasma", "ANATOMY", 91, 97], ["hepatocytes", "ANATOMY", 133, 144], ["neutrophil", "ANATOMY", 244, 254], ["chronic liver disease", "DISEASE", 35, 56], ["\u03b11-AT", "CHEMICAL", 82, 87], ["serine", "CHEMICAL", 165, 171], ["liver", "ORGAN", 43, 48], ["\u03b11-AT", "GENE_OR_GENE_PRODUCT", 82, 87], ["plasma", "ORGANISM_SUBSTANCE", 91, 97], ["hepatocytes", "CELL", 133, 144], ["serpin", "GENE_OR_GENE_PRODUCT", 194, 200], ["neutrophil elastase", "GENE_OR_GENE_PRODUCT", 244, 263], ["\u03b11-AT", "PROTEIN", 82, 87], ["plasma glycoprotein", "PROTEIN", 91, 110], ["hepatocytes", "CELL_TYPE", 133, 144], ["serine proteinase inhibitor (serpin) superfamily", "PROTEIN", 165, 213], ["neutrophil elastase", "PROTEIN", 244, 263], ["Bexfield epiphenomenon", "PROBLEM", 0, 22], ["chronic liver disease", "PROBLEM", 35, 56], ["a plasma glycoprotein synthesized", "TREATMENT", 89, 122], ["the serine proteinase inhibitor", "TREATMENT", 161, 192], ["neutrophil elastase", "PROBLEM", 244, 263], ["chronic", "OBSERVATION_MODIFIER", 35, 42], ["liver", "ANATOMY", 43, 48], ["disease", "OBSERVATION", 49, 56], ["hepatocytes", "ANATOMY", 133, 144], ["neutrophil elastase", "OBSERVATION", 244, 263]]], ["Hereditary \u03b11-AT deficiency in humans is associated with mutations that perturb the protein's tertiary structure and promote polymerization.", [["\u03b11-AT", "GENE_OR_GENE_PRODUCT", 11, 16], ["humans", "ORGANISM", 31, 37], ["humans", "SPECIES", 31, 37], ["humans", "SPECIES", 31, 37], ["Hereditary \u03b11-AT deficiency in humans", "PROBLEM", 0, 37], ["mutations", "PROBLEM", 57, 66], ["promote polymerization", "TREATMENT", 117, 139], ["polymerization", "OBSERVATION_MODIFIER", 125, 139]]], ["These misfolded forms of \u03b11-AT accumulate within the rough endoplasmic reticulum of hepatocytes, forming PAS-positive globules. \u03b11-AT deficiency has been associated in humans with neonatal hepatitis, juvenile cirrhosis, and adult hepatocellular carcinoma.", [["endoplasmic reticulum", "ANATOMY", 59, 80], ["hepatocytes", "ANATOMY", 84, 95], ["globules", "ANATOMY", 118, 126], ["adult hepatocellular carcinoma", "ANATOMY", 224, 254], ["neonatal hepatitis", "DISEASE", 180, 198], ["juvenile cirrhosis", "DISEASE", 200, 218], ["adult hepatocellular carcinoma", "DISEASE", 224, 254], ["\u03b11-AT", "GENE_OR_GENE_PRODUCT", 25, 30], ["endoplasmic reticulum", "CELLULAR_COMPONENT", 59, 80], ["hepatocytes", "CELL", 84, 95], ["PAS", "SIMPLE_CHEMICAL", 105, 108], ["\u03b11-AT", "GENE_OR_GENE_PRODUCT", 128, 133], ["humans", "ORGANISM", 168, 174], ["hepatocellular carcinoma", "CANCER", 230, 254], ["\u03b11", "PROTEIN", 25, 27], ["hepatocytes", "CELL_TYPE", 84, 95], ["PAS", "PROTEIN", 105, 108], ["\u03b11", "PROTEIN", 128, 130], ["humans", "SPECIES", 168, 174], ["humans", "SPECIES", 168, 174], ["\u03b11-AT deficiency", "PROBLEM", 128, 144], ["neonatal hepatitis", "PROBLEM", 180, 198], ["juvenile cirrhosis", "PROBLEM", 200, 218], ["adult hepatocellular carcinoma", "PROBLEM", 224, 254], ["misfolded", "OBSERVATION", 6, 15], ["rough", "ANATOMY_MODIFIER", 53, 58], ["endoplasmic reticulum", "OBSERVATION", 59, 80], ["hepatocytes", "ANATOMY", 84, 95], ["positive globules", "OBSERVATION", 109, 126], ["hepatitis", "OBSERVATION", 189, 198], ["juvenile", "OBSERVATION_MODIFIER", 200, 208], ["cirrhosis", "OBSERVATION", 209, 218], ["adult", "OBSERVATION_MODIFIER", 224, 229], ["hepatocellular carcinoma", "OBSERVATION", 230, 254]]], ["Lobular dissecting hepatitis, associated with predominantly sinusoidal inflammation and fibrosis, has been described in young dogs with ascites and acquired portosystemic shunts.", [["Lobular", "ANATOMY", 0, 7], ["sinusoidal", "ANATOMY", 60, 70], ["ascites", "ANATOMY", 136, 143], ["hepatitis", "DISEASE", 19, 28], ["inflammation", "DISEASE", 71, 83], ["fibrosis", "DISEASE", 88, 96], ["ascites", "DISEASE", 136, 143], ["acquired portosystemic shunts", "DISEASE", 148, 177], ["sinusoidal", "TISSUE", 60, 70], ["dogs", "ORGANISM", 126, 130], ["portosystemic shunts", "PATHOLOGICAL_FORMATION", 157, 177], ["dogs", "SPECIES", 126, 130], ["Lobular dissecting hepatitis", "PROBLEM", 0, 28], ["predominantly sinusoidal inflammation", "PROBLEM", 46, 83], ["fibrosis", "PROBLEM", 88, 96], ["ascites", "PROBLEM", 136, 143], ["acquired portosystemic shunts", "PROBLEM", 148, 177], ["hepatitis", "OBSERVATION", 19, 28], ["predominantly", "OBSERVATION_MODIFIER", 46, 59], ["sinusoidal", "OBSERVATION_MODIFIER", 60, 70], ["inflammation", "OBSERVATION", 71, 83], ["fibrosis", "OBSERVATION", 88, 96], ["ascites", "OBSERVATION", 136, 143], ["portosystemic shunts", "OBSERVATION", 157, 177]]], ["The liver is usually small, pale with a predominantly smooth surface, and occasional hyperplastic nodules (eFig.", [["liver", "ANATOMY", 4, 9], ["smooth surface", "ANATOMY", 54, 68], ["hyperplastic nodules", "ANATOMY", 85, 105], ["liver", "ORGAN", 4, 9], ["smooth surface", "TISSUE", 54, 68], ["hyperplastic nodules", "CANCER", 85, 105], ["occasional hyperplastic nodules", "PROBLEM", 74, 105], ["liver", "ANATOMY", 4, 9], ["usually", "OBSERVATION_MODIFIER", 13, 20], ["small", "OBSERVATION", 21, 26], ["pale", "OBSERVATION", 28, 32], ["predominantly", "OBSERVATION_MODIFIER", 40, 53], ["smooth", "OBSERVATION_MODIFIER", 54, 60], ["surface", "OBSERVATION_MODIFIER", 61, 68], ["occasional", "OBSERVATION_MODIFIER", 74, 84], ["hyperplastic", "OBSERVATION_MODIFIER", 85, 97], ["nodules", "OBSERVATION", 98, 105]]], ["The histologic lesion is characterized by dissection of lobular parenchyma by reticulin and fine collagen fibers into individual and small groups of hepatocytes, accompanied by a variable, mixed inflammatory infiltrate of lymphocytes, plasma cells, and lesser numbers of neutrophils and macrophages ( Fig. 2-60A, B) .", [["lesion", "ANATOMY", 15, 21], ["lobular parenchyma", "ANATOMY", 56, 74], ["fine collagen fibers", "ANATOMY", 92, 112], ["hepatocytes", "ANATOMY", 149, 160], ["lymphocytes", "ANATOMY", 222, 233], ["plasma cells", "ANATOMY", 235, 247], ["neutrophils", "ANATOMY", 271, 282], ["macrophages", "ANATOMY", 287, 298], ["lobular parenchyma", "TISSUE", 56, 74], ["reticulin", "GENE_OR_GENE_PRODUCT", 78, 87], ["collagen", "GENE_OR_GENE_PRODUCT", 97, 105], ["fibers", "CELLULAR_COMPONENT", 106, 112], ["hepatocytes", "CELL", 149, 160], ["lymphocytes", "CELL", 222, 233], ["plasma cells", "CELL", 235, 247], ["neutrophils", "CELL", 271, 282], ["macrophages", "CELL", 287, 298], ["B", "GENE_OR_GENE_PRODUCT", 313, 314], ["hepatocytes", "CELL_TYPE", 149, 160], ["lymphocytes", "CELL_TYPE", 222, 233], ["plasma cells", "CELL_TYPE", 235, 247], ["neutrophils", "CELL_TYPE", 271, 282], ["macrophages", "CELL_TYPE", 287, 298], ["The histologic lesion", "PROBLEM", 0, 21], ["dissection of lobular parenchyma", "PROBLEM", 42, 74], ["reticulin and fine collagen fibers into individual and small groups of hepatocytes", "PROBLEM", 78, 160], ["a variable, mixed inflammatory infiltrate of lymphocytes", "PROBLEM", 177, 233], ["plasma cells", "TEST", 235, 247], ["neutrophils", "TEST", 271, 282], ["macrophages", "TEST", 287, 298], ["Fig.", "TEST", 301, 305], ["histologic", "OBSERVATION_MODIFIER", 4, 14], ["lesion", "OBSERVATION", 15, 21], ["dissection", "OBSERVATION", 42, 52], ["lobular", "ANATOMY_MODIFIER", 56, 63], ["parenchyma", "ANATOMY_MODIFIER", 64, 74], ["reticulin", "OBSERVATION", 78, 87], ["fine", "OBSERVATION_MODIFIER", 92, 96], ["collagen fibers", "OBSERVATION", 97, 112], ["small", "OBSERVATION_MODIFIER", 133, 138], ["groups", "OBSERVATION_MODIFIER", 139, 145], ["hepatocytes", "ANATOMY", 149, 160], ["variable", "OBSERVATION_MODIFIER", 179, 187], ["mixed", "OBSERVATION_MODIFIER", 189, 194], ["inflammatory", "OBSERVATION_MODIFIER", 195, 207], ["infiltrate", "OBSERVATION", 208, 218], ["lymphocytes", "ANATOMY", 222, 233], ["plasma cells", "OBSERVATION", 235, 247], ["lesser", "OBSERVATION_MODIFIER", 253, 259], ["numbers", "OBSERVATION_MODIFIER", 260, 267], ["neutrophils", "OBSERVATION_MODIFIER", 271, 282], ["macrophages", "OBSERVATION_MODIFIER", 287, 298]]], ["Activated fibroblastic cells, likely hepatic stellate cells, may also be prominent along sinusoids.", [["fibroblastic cells", "ANATOMY", 10, 28], ["hepatic stellate cells", "ANATOMY", 37, 59], ["sinusoids", "ANATOMY", 89, 98], ["fibroblastic cells", "CELL", 10, 28], ["hepatic stellate cells", "CELL", 37, 59], ["sinusoids", "TISSUE", 89, 98], ["Activated fibroblastic cells", "CELL_TYPE", 0, 28], ["hepatic stellate cells", "CELL_TYPE", 37, 59], ["Activated fibroblastic cells", "PROBLEM", 0, 28], ["hepatic stellate cells", "PROBLEM", 37, 59], ["fibroblastic cells", "OBSERVATION", 10, 28], ["likely", "UNCERTAINTY", 30, 36], ["hepatic", "ANATOMY", 37, 44], ["stellate cells", "OBSERVATION", 45, 59], ["may also be", "UNCERTAINTY", 61, 72], ["prominent", "OBSERVATION_MODIFIER", 73, 82]]], ["Hepatocytes form rosettes or pseudoductular structures, and regenerative nodules may be present.", [["Hepatocytes", "ANATOMY", 0, 11], ["rosettes", "ANATOMY", 17, 25], ["pseudoductular structures", "ANATOMY", 29, 54], ["regenerative nodules", "ANATOMY", 60, 80], ["Hepatocytes", "CELL", 0, 11], ["rosettes", "CELL", 17, 25], ["pseudoductular structures", "TISSUE", 29, 54], ["nodules", "CANCER", 73, 80], ["Hepatocytes form rosettes or pseudoductular structures", "PROBLEM", 0, 54], ["regenerative nodules", "PROBLEM", 60, 80], ["rosettes", "OBSERVATION_MODIFIER", 17, 25], ["pseudoductular structures", "OBSERVATION", 29, 54], ["regenerative", "OBSERVATION_MODIFIER", 60, 72], ["nodules", "OBSERVATION", 73, 80], ["may be", "UNCERTAINTY", 81, 87]]], ["Portal inflammation and periportal fibrosis are not conspicuous features of this disease.", [["Portal", "ANATOMY", 0, 6], ["periportal", "ANATOMY", 24, 34], ["Portal inflammation", "DISEASE", 0, 19], ["fibrosis", "DISEASE", 35, 43], ["Portal", "MULTI-TISSUE_STRUCTURE", 0, 6], ["periportal", "MULTI-TISSUE_STRUCTURE", 24, 34], ["Portal inflammation", "PROBLEM", 0, 19], ["periportal fibrosis", "PROBLEM", 24, 43], ["this disease", "PROBLEM", 76, 88], ["inflammation", "OBSERVATION", 7, 19], ["periportal", "ANATOMY", 24, 34], ["fibrosis", "OBSERVATION", 35, 43], ["disease", "OBSERVATION", 81, 88]]], ["The etiology of this disorder remains unknown.Chronic hepatitis in other speciesCopper-associated liver disease has also been described in domestic cats.", [["liver", "ANATOMY", 98, 103], ["Chronic hepatitis", "DISEASE", 46, 63], ["Copper", "CHEMICAL", 80, 86], ["liver disease", "DISEASE", 98, 111], ["Copper", "CHEMICAL", 80, 86], ["liver", "ORGAN", 98, 103], ["cats", "ORGANISM", 148, 152], ["cats", "SPECIES", 148, 152], ["this disorder", "PROBLEM", 16, 29], ["Chronic hepatitis", "PROBLEM", 46, 63], ["other species", "PROBLEM", 67, 80], ["liver disease", "PROBLEM", 98, 111], ["hepatitis", "OBSERVATION", 54, 63], ["speciesCopper", "OBSERVATION", 73, 86], ["liver", "ANATOMY", 98, 103], ["disease", "OBSERVATION", 104, 111]]], ["A hepatopathy with excess hepatic copper (4,074 \u00b5g/g DW) was first reported in a Siamese cat, characterized by enlarged, finely vacuolated, and individual necrotic hepatocytes with centrilobular and midzonal copper accumulation.", [["hepatic", "ANATOMY", 26, 33], ["necrotic hepatocytes", "ANATOMY", 155, 175], ["centrilobular", "ANATOMY", 181, 194], ["hepatopathy", "DISEASE", 2, 13], ["copper", "CHEMICAL", 34, 40], ["necrotic", "DISEASE", 155, 163], ["copper", "CHEMICAL", 208, 214], ["copper", "CHEMICAL", 34, 40], ["copper", "CHEMICAL", 208, 214], ["hepatic", "ORGAN", 26, 33], ["copper", "SIMPLE_CHEMICAL", 34, 40], ["cat", "ORGANISM", 89, 92], ["necrotic hepatocytes", "CELL", 155, 175], ["copper", "SIMPLE_CHEMICAL", 208, 214], ["necrotic hepatocytes", "CELL_TYPE", 155, 175], ["Siamese cat", "SPECIES", 81, 92], ["A hepatopathy", "PROBLEM", 0, 13], ["excess hepatic copper", "PROBLEM", 19, 40], ["enlarged, finely vacuolated", "PROBLEM", 111, 138], ["individual necrotic hepatocytes", "PROBLEM", 144, 175], ["centrilobular and midzonal copper accumulation", "PROBLEM", 181, 227], ["hepatopathy", "OBSERVATION", 2, 13], ["excess", "OBSERVATION_MODIFIER", 19, 25], ["hepatic", "ANATOMY", 26, 33], ["copper", "OBSERVATION", 34, 40], ["enlarged", "OBSERVATION_MODIFIER", 111, 119], ["finely", "OBSERVATION_MODIFIER", 121, 127], ["vacuolated", "OBSERVATION_MODIFIER", 128, 138], ["individual", "OBSERVATION_MODIFIER", 144, 154], ["necrotic", "OBSERVATION_MODIFIER", 155, 163], ["hepatocytes", "ANATOMY", 164, 175], ["centrilobular", "OBSERVATION_MODIFIER", 181, 194], ["midzonal", "OBSERVATION_MODIFIER", 199, 207], ["copper accumulation", "OBSERVATION", 208, 227]]], ["Chronic hepatitis and cirrhosis, with marked accumulation of stainable copper in macrophages in fibrous septa and with sparser staining in regenerative nodules, was reported in a European Shorthair cat with similarly elevated liver copper concentrations (4,170 \u00b5g/g DW; the upper reference range limit for hepatic copper concentration is cats is <180 \u00b5g/g DW).", [["macrophages", "ANATOMY", 81, 92], ["fibrous septa", "ANATOMY", 96, 109], ["regenerative nodules", "ANATOMY", 139, 159], ["liver", "ANATOMY", 226, 231], ["hepatic", "ANATOMY", 306, 313], ["Chronic hepatitis", "DISEASE", 0, 17], ["cirrhosis", "DISEASE", 22, 31], ["copper", "CHEMICAL", 71, 77], ["copper", "CHEMICAL", 232, 238], ["copper", "CHEMICAL", 314, 320], ["copper", "CHEMICAL", 71, 77], ["copper", "CHEMICAL", 232, 238], ["copper", "CHEMICAL", 314, 320], ["copper", "SIMPLE_CHEMICAL", 71, 77], ["macrophages", "CELL", 81, 92], ["fibrous septa", "TISSUE", 96, 109], ["nodules", "CANCER", 152, 159], ["cat", "ORGANISM", 198, 201], ["liver", "ORGAN", 226, 231], ["copper", "SIMPLE_CHEMICAL", 232, 238], ["hepatic", "ORGAN", 306, 313], ["copper", "SIMPLE_CHEMICAL", 314, 320], ["macrophages", "CELL_TYPE", 81, 92], ["cat", "SPECIES", 198, 201], ["Chronic hepatitis", "PROBLEM", 0, 17], ["cirrhosis", "PROBLEM", 22, 31], ["marked accumulation of stainable copper in macrophages in fibrous septa", "PROBLEM", 38, 109], ["sparser staining", "PROBLEM", 119, 135], ["regenerative nodules", "PROBLEM", 139, 159], ["similarly elevated liver copper concentrations", "PROBLEM", 207, 253], ["hepatic copper concentration", "TREATMENT", 306, 334], ["hepatitis", "OBSERVATION", 8, 17], ["cirrhosis", "OBSERVATION", 22, 31], ["marked", "OBSERVATION_MODIFIER", 38, 44], ["accumulation", "OBSERVATION_MODIFIER", 45, 57], ["stainable", "OBSERVATION_MODIFIER", 61, 70], ["copper", "OBSERVATION_MODIFIER", 71, 77], ["macrophages", "OBSERVATION_MODIFIER", 81, 92], ["fibrous septa", "OBSERVATION", 96, 109], ["sparser", "OBSERVATION_MODIFIER", 119, 126], ["staining", "OBSERVATION_MODIFIER", 127, 135], ["regenerative", "OBSERVATION_MODIFIER", 139, 151], ["nodules", "OBSERVATION", 152, 159], ["elevated", "OBSERVATION", 217, 225], ["liver", "ANATOMY", 226, 231], ["copper concentrations", "OBSERVATION", 232, 253], ["upper", "ANATOMY_MODIFIER", 274, 279], ["hepatic", "ANATOMY", 306, 313]]], ["A recent retrospective study described an additional 11 cats with presumed primary copper-associated hepatopathy, characterized by elevated hepatic copper concentrations (>700 \u00b5g/g DW), diffuse or centrilobular and intermediate zone copper staining, without any other co-occurring cholestatic disorders.", [["hepatic", "ANATOMY", 140, 147], ["centrilobular", "ANATOMY", 197, 210], ["hepatopathy", "DISEASE", 101, 112], ["copper", "CHEMICAL", 148, 154], ["cholestatic disorders", "DISEASE", 281, 302], ["copper", "CHEMICAL", 148, 154], ["copper", "CHEMICAL", 233, 239], ["cats", "ORGANISM", 56, 60], ["hepatic", "ORGAN", 140, 147], ["copper", "SIMPLE_CHEMICAL", 148, 154], ["copper", "SIMPLE_CHEMICAL", 233, 239], ["cats", "SPECIES", 56, 60], ["A recent retrospective study", "TEST", 0, 28], ["primary copper-associated hepatopathy", "PROBLEM", 75, 112], ["elevated hepatic copper concentrations", "PROBLEM", 131, 169], ["diffuse or centrilobular and intermediate zone copper staining", "PROBLEM", 186, 248], ["cholestatic disorders", "PROBLEM", 281, 302], ["hepatopathy", "OBSERVATION", 101, 112], ["elevated", "OBSERVATION_MODIFIER", 131, 139], ["hepatic", "ANATOMY", 140, 147], ["copper concentrations", "OBSERVATION", 148, 169], ["diffuse", "OBSERVATION_MODIFIER", 186, 193], ["centrilobular", "OBSERVATION_MODIFIER", 197, 210], ["intermediate", "OBSERVATION_MODIFIER", 215, 227], ["zone", "OBSERVATION_MODIFIER", 228, 232], ["copper staining", "OBSERVATION", 233, 248], ["co-occurring", "OBSERVATION_MODIFIER", 268, 280], ["cholestatic", "OBSERVATION", 281, 292]]], ["Affected cats had hepatocyte vacuolationwide range of disorders supports an alternative conclusion that giant cell formation represents a nonspecific reaction of the infant's hepatocytes to various types of injury.Hypertrophic hepatic cirrhosis in calves is described from Germany and occasionally observed elsewhere.", [["hepatocyte", "ANATOMY", 18, 28], ["giant cell", "ANATOMY", 104, 114], ["hepatocytes", "ANATOMY", 175, 186], ["hepatic cirrhosis", "ANATOMY", 227, 244], ["Hypertrophic hepatic cirrhosis", "DISEASE", 214, 244], ["cats", "ORGANISM", 9, 13], ["hepatocyte", "CELL", 18, 28], ["giant cell", "CELL", 104, 114], ["infant", "ORGANISM", 166, 172], ["hepatocytes", "CELL", 175, 186], ["hepatic", "ORGAN", 227, 234], ["calves", "ORGANISM", 248, 254], ["infant's hepatocytes", "CELL_TYPE", 166, 186], ["cats", "SPECIES", 9, 13], ["infant", "SPECIES", 166, 172], ["calves", "SPECIES", 248, 254], ["Affected cats", "PROBLEM", 0, 13], ["hepatocyte vacuolationwide range of disorders", "PROBLEM", 18, 63], ["giant cell formation", "PROBLEM", 104, 124], ["a nonspecific reaction", "PROBLEM", 136, 158], ["the infant's hepatocytes", "PROBLEM", 162, 186], ["injury", "PROBLEM", 207, 213], ["Hypertrophic hepatic cirrhosis in calves", "PROBLEM", 214, 254], ["hepatocyte", "ANATOMY", 18, 28], ["vacuolationwide range", "OBSERVATION", 29, 50], ["giant cell formation", "OBSERVATION", 104, 124], ["nonspecific", "OBSERVATION_MODIFIER", 138, 149], ["hepatocytes", "ANATOMY", 175, 186], ["injury", "OBSERVATION", 207, 213], ["hepatic", "ANATOMY", 227, 234], ["cirrhosis", "OBSERVATION", 235, 244], ["calves", "OBSERVATION", 248, 254]]], ["Death may occur in liver failure within a few days to weeks of birth, or the disease may be discovered at slaughter for veal.", [["liver", "ANATOMY", 19, 24], ["Death", "DISEASE", 0, 5], ["liver failure", "DISEASE", 19, 32], ["liver", "ORGAN", 19, 24], ["Death", "PROBLEM", 0, 5], ["liver failure", "PROBLEM", 19, 32], ["the disease", "PROBLEM", 73, 84], ["liver", "ANATOMY", 19, 24], ["failure", "OBSERVATION", 25, 32]]], ["The liver is moderately enlarged with rounded borders, very firm but smooth on the surface, and gray.", [["liver", "ANATOMY", 4, 9], ["surface", "ANATOMY", 83, 90], ["liver", "ORGAN", 4, 9], ["surface", "CELLULAR_COMPONENT", 83, 90], ["moderately enlarged", "PROBLEM", 13, 32], ["rounded borders", "PROBLEM", 38, 53], ["very firm", "PROBLEM", 55, 64], ["liver", "ANATOMY", 4, 9], ["moderately", "OBSERVATION_MODIFIER", 13, 23], ["enlarged", "OBSERVATION", 24, 32], ["rounded", "OBSERVATION_MODIFIER", 38, 45], ["borders", "OBSERVATION_MODIFIER", 46, 53], ["very", "OBSERVATION_MODIFIER", 55, 59], ["firm", "OBSERVATION", 60, 64], ["smooth", "OBSERVATION_MODIFIER", 69, 75], ["surface", "OBSERVATION_MODIFIER", 83, 90]]], ["Histologically, there is some biliary hyperplasia, but the lesion is dominated by diffuse fibrosis infiltrated in the early stages by mononuclear inflammatory cells.", [["biliary hyperplasia", "ANATOMY", 30, 49], ["lesion", "ANATOMY", 59, 65], ["mononuclear inflammatory cells", "ANATOMY", 134, 164], ["biliary hyperplasia", "DISEASE", 30, 49], ["fibrosis", "DISEASE", 90, 98], ["biliary hyperplasia", "PATHOLOGICAL_FORMATION", 30, 49], ["mononuclear inflammatory cells", "CELL", 134, 164], ["mononuclear inflammatory cells", "CELL_TYPE", 134, 164], ["some biliary hyperplasia", "PROBLEM", 25, 49], ["the lesion", "PROBLEM", 55, 65], ["diffuse fibrosis infiltrated", "PROBLEM", 82, 110], ["mononuclear inflammatory cells", "PROBLEM", 134, 164], ["some", "OBSERVATION_MODIFIER", 25, 29], ["biliary", "ANATOMY", 30, 37], ["hyperplasia", "OBSERVATION", 38, 49], ["lesion", "OBSERVATION", 59, 65], ["diffuse", "OBSERVATION_MODIFIER", 82, 89], ["fibrosis", "OBSERVATION", 90, 98], ["early stages", "OBSERVATION_MODIFIER", 118, 130], ["mononuclear", "OBSERVATION_MODIFIER", 134, 145], ["inflammatory cells", "OBSERVATION", 146, 164]]], ["Similar lesions of congenital hepatic fibrosis may be found in unborn or aborted calves.wide range of disorders supports an alternative conclusion that giant cell formation represents a nonspecific reaction of the infant's hepatocytes to various types of injury.Systemic granulomatous disease has been reported in cattle grazing hairy vetch (Vicia villosa).", [["lesions", "ANATOMY", 8, 15], ["hepatic", "ANATOMY", 30, 37], ["calves", "ANATOMY", 81, 87], ["giant cell", "ANATOMY", 152, 162], ["hepatocytes", "ANATOMY", 223, 234], ["granulomatous", "ANATOMY", 271, 284], ["congenital hepatic fibrosis", "DISEASE", 19, 46], ["Systemic granulomatous disease", "DISEASE", 262, 292], ["lesions", "PATHOLOGICAL_FORMATION", 8, 15], ["hepatic", "ORGAN", 30, 37], ["calves", "ORGANISM", 81, 87], ["giant cell", "CELL", 152, 162], ["infant", "ORGANISM", 214, 220], ["hepatocytes", "CELL", 223, 234], ["cattle", "ORGANISM", 314, 320], ["Vicia villosa", "ORGANISM", 342, 355], ["infant's hepatocytes", "CELL_TYPE", 214, 234], ["calves", "SPECIES", 81, 87], ["infant", "SPECIES", 214, 220], ["cattle", "SPECIES", 314, 320], ["Vicia villosa", "SPECIES", 342, 355], ["cattle", "SPECIES", 314, 320], ["Vicia villosa", "SPECIES", 342, 355], ["Similar lesions", "PROBLEM", 0, 15], ["congenital hepatic fibrosis", "PROBLEM", 19, 46], ["aborted calves", "PROBLEM", 73, 87], ["wide range of disorders", "PROBLEM", 88, 111], ["giant cell formation", "PROBLEM", 152, 172], ["a nonspecific reaction", "PROBLEM", 184, 206], ["the infant's hepatocytes", "PROBLEM", 210, 234], ["injury", "PROBLEM", 255, 261], ["Systemic granulomatous disease", "PROBLEM", 262, 292], ["lesions", "OBSERVATION", 8, 15], ["congenital", "OBSERVATION", 19, 29], ["hepatic", "ANATOMY", 30, 37], ["fibrosis", "OBSERVATION", 38, 46], ["calves", "OBSERVATION", 81, 87], ["giant cell formation", "OBSERVATION", 152, 172], ["nonspecific", "OBSERVATION_MODIFIER", 186, 197], ["hepatocytes", "ANATOMY", 223, 234], ["injury", "OBSERVATION", 255, 261], ["granulomatous", "OBSERVATION", 271, 284], ["grazing", "OBSERVATION_MODIFIER", 321, 328], ["hairy vetch", "OBSERVATION", 329, 340]]], ["The disease is characterized clinically by dermatitis, pruritus, diarrhea, wasting, and high mortality.", [["dermatitis", "DISEASE", 43, 53], ["pruritus", "DISEASE", 55, 63], ["diarrhea", "DISEASE", 65, 73], ["wasting", "DISEASE", 75, 82], ["The disease", "PROBLEM", 0, 11], ["dermatitis", "PROBLEM", 43, 53], ["pruritus", "PROBLEM", 55, 63], ["diarrhea", "PROBLEM", 65, 73], ["wasting", "PROBLEM", 75, 82], ["high mortality", "PROBLEM", 88, 102], ["disease", "OBSERVATION", 4, 11], ["dermatitis", "OBSERVATION", 43, 53], ["pruritus", "OBSERVATION_MODIFIER", 55, 63], ["high", "OBSERVATION_MODIFIER", 88, 92], ["mortality", "OBSERVATION_MODIFIER", 93, 102]]], ["Histologic lesions include infiltration of skin and internal organs, including portal areas of the liver, by monocytes, lymphocytes, plasma cells, eosinophils, and multinucleated giant cells.", [["lesions", "ANATOMY", 11, 18], ["skin", "ANATOMY", 43, 47], ["internal organs", "ANATOMY", 52, 67], ["portal areas", "ANATOMY", 79, 91], ["liver", "ANATOMY", 99, 104], ["monocytes", "ANATOMY", 109, 118], ["lymphocytes", "ANATOMY", 120, 131], ["plasma cells", "ANATOMY", 133, 145], ["eosinophils", "ANATOMY", 147, 158], ["multinucleated giant cells", "ANATOMY", 164, 190], ["Histologic lesions", "PATHOLOGICAL_FORMATION", 0, 18], ["skin", "ORGAN", 43, 47], ["organs", "ORGAN", 61, 67], ["portal areas", "MULTI-TISSUE_STRUCTURE", 79, 91], ["liver", "ORGAN", 99, 104], ["monocytes", "CELL", 109, 118], ["lymphocytes", "CELL", 120, 131], ["plasma cells", "CELL", 133, 145], ["eosinophils", "CELL", 147, 158], ["multinucleated giant cells", "CELL", 164, 190], ["monocytes", "CELL_TYPE", 109, 118], ["lymphocytes", "CELL_TYPE", 120, 131], ["plasma cells", "CELL_TYPE", 133, 145], ["eosinophils", "CELL_TYPE", 147, 158], ["multinucleated giant cells", "CELL_TYPE", 164, 190], ["Histologic lesions", "PROBLEM", 0, 18], ["infiltration of skin and internal organs", "PROBLEM", 27, 67], ["monocytes", "TEST", 109, 118], ["lymphocytes", "TEST", 120, 131], ["plasma cells", "TEST", 133, 145], ["eosinophils", "TEST", 147, 158], ["multinucleated giant cells", "PROBLEM", 164, 190], ["lesions", "OBSERVATION", 11, 18], ["infiltration", "OBSERVATION", 27, 39], ["skin", "ANATOMY", 43, 47], ["internal organs", "ANATOMY", 52, 67], ["portal", "ANATOMY", 79, 85], ["areas", "ANATOMY_MODIFIER", 86, 91], ["liver", "ANATOMY", 99, 104], ["monocytes", "ANATOMY", 109, 118], ["lymphocytes", "ANATOMY", 120, 131], ["plasma cells", "OBSERVATION", 133, 145], ["multinucleated", "OBSERVATION_MODIFIER", 164, 178], ["giant cells", "OBSERVATION", 179, 190]]], ["The pathogenesis is unknown, although the inflammatory reaction has characteristics of a type IV hypersensitivity reaction.", [["type IV hypersensitivity reaction", "DISEASE", 89, 122], ["the inflammatory reaction", "PROBLEM", 38, 63], ["a type IV hypersensitivity reaction", "PROBLEM", 87, 122], ["inflammatory", "OBSERVATION_MODIFIER", 42, 54], ["type IV", "OBSERVATION_MODIFIER", 89, 96], ["hypersensitivity reaction", "OBSERVATION", 97, 122]]], ["Alternatively, vetch lectin may act to activate T lymphocytes directly to initiate the cellular response.Inflammation of the gallbladder is termed cholecystitis.", [["T lymphocytes", "ANATOMY", 48, 61], ["cellular", "ANATOMY", 87, 95], ["gallbladder", "ANATOMY", 125, 136], ["Inflammation", "DISEASE", 105, 117], ["cholecystitis", "DISEASE", 147, 160], ["vetch lectin", "GENE_OR_GENE_PRODUCT", 15, 27], ["T lymphocytes", "CELL", 48, 61], ["cellular", "CELL", 87, 95], ["gallbladder", "ORGAN", 125, 136], ["vetch lectin", "PROTEIN", 15, 27], ["T lymphocytes", "CELL_TYPE", 48, 61], ["vetch lectin", "TEST", 15, 27], ["Inflammation of the gallbladder", "PROBLEM", 105, 136], ["cholecystitis", "PROBLEM", 147, 160], ["gallbladder", "ANATOMY", 125, 136], ["termed", "OBSERVATION_MODIFIER", 140, 146], ["cholecystitis", "OBSERVATION", 147, 160]]], ["Inflammation of the large bile ducts is cholangitis, whereas inflammation of the smallest intrahepatic bile ductules is termed cholangiolitis.Cholangiolitis is uncommon in animals, and occurs mainly in conjunction with inflammation of larger ducts.", [["bile ducts", "ANATOMY", 26, 36], ["intrahepatic bile ductules", "ANATOMY", 90, 116], ["cholangiolitis", "ANATOMY", 127, 141], ["ducts", "ANATOMY", 242, 247], ["Inflammation", "DISEASE", 0, 12], ["cholangitis", "DISEASE", 40, 51], ["inflammation", "DISEASE", 61, 73], ["cholangiolitis", "DISEASE", 127, 141], ["Cholangiolitis", "DISEASE", 142, 156], ["inflammation", "DISEASE", 219, 231], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 26, 36], ["intrahepatic bile ductules", "MULTI-TISSUE_STRUCTURE", 90, 116], ["ducts", "MULTI-TISSUE_STRUCTURE", 242, 247], ["Inflammation of the large bile ducts", "PROBLEM", 0, 36], ["cholangitis", "PROBLEM", 40, 51], ["inflammation of the smallest intrahepatic bile ductules", "PROBLEM", 61, 116], ["termed cholangiolitis", "PROBLEM", 120, 141], ["Cholangiolitis", "PROBLEM", 142, 156], ["inflammation of larger ducts", "PROBLEM", 219, 247], ["large", "OBSERVATION_MODIFIER", 20, 25], ["bile ducts", "ANATOMY", 26, 36], ["cholangitis", "OBSERVATION", 40, 51], ["inflammation", "OBSERVATION", 61, 73], ["smallest", "OBSERVATION_MODIFIER", 81, 89], ["intrahepatic", "ANATOMY_MODIFIER", 90, 102], ["bile ductules", "ANATOMY", 103, 116], ["cholangiolitis", "OBSERVATION", 127, 141], ["uncommon", "OBSERVATION_MODIFIER", 160, 168], ["inflammation", "OBSERVATION", 219, 231], ["larger", "OBSERVATION_MODIFIER", 235, 241], ["ducts", "ANATOMY", 242, 247]]], ["Destructive cholangiolitis has been observed in dogs, and is associated with adverse drug reactions in humans.CholecystitisCholecystitis is uncommon and is often associated with concurrent cholelithiasis, although acalculous cholecystitis has been reported in the dog, with a single case report in a pig.Cholecystitis is thought to be caused by reflux of intestinal bacteria into the gallbladder via the bile ducts, or to hematogenous entry of bacteria from the adjacent hepatic circulation.Aerobic gram-negative bacteria are the most frequent isolates from canine cases, although occasionally anaerobic bacteria such as clostridia have been cultured.", [["intestinal", "ANATOMY", 355, 365], ["gallbladder", "ANATOMY", 384, 395], ["bile ducts", "ANATOMY", 404, 414], ["hepatic", "ANATOMY", 471, 478], ["cholangiolitis", "DISEASE", 12, 26], ["adverse drug reactions", "DISEASE", 77, 99], ["Cholecystitis", "DISEASE", 123, 136], ["cholelithiasis", "DISEASE", 189, 203], ["acalculous cholecystitis", "DISEASE", 214, 238], ["Cholecystitis", "DISEASE", 304, 317], ["dogs", "ORGANISM", 48, 52], ["humans", "ORGANISM", 103, 109], ["dog", "ORGANISM", 264, 267], ["pig", "ORGANISM", 300, 303], ["intestinal", "ORGAN", 355, 365], ["gallbladder", "ORGAN", 384, 395], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 404, 414], ["hepatic circulation", "MULTI-TISSUE_STRUCTURE", 471, 490], ["canine", "ORGANISM", 558, 564], ["dogs", "SPECIES", 48, 52], ["humans", "SPECIES", 103, 109], ["dog", "SPECIES", 264, 267], ["pig", "SPECIES", 300, 303], ["humans", "SPECIES", 103, 109], ["pig", "SPECIES", 300, 303], ["canine", "SPECIES", 558, 564], ["Destructive cholangiolitis", "PROBLEM", 0, 26], ["adverse drug reactions in humans", "PROBLEM", 77, 109], ["CholecystitisCholecystitis", "PROBLEM", 110, 136], ["concurrent cholelithiasis", "PROBLEM", 178, 203], ["acalculous cholecystitis", "PROBLEM", 214, 238], ["Cholecystitis", "PROBLEM", 304, 317], ["reflux of intestinal bacteria into the gallbladder via the bile ducts", "PROBLEM", 345, 414], ["hematogenous entry of bacteria", "PROBLEM", 422, 452], ["Aerobic gram", "TEST", 491, 503], ["negative bacteria", "PROBLEM", 504, 521], ["canine cases", "TEST", 558, 570], ["occasionally anaerobic bacteria", "PROBLEM", 581, 612], ["clostridia", "PROBLEM", 621, 631], ["associated with", "UNCERTAINTY", 61, 76], ["Cholecystitis", "OBSERVATION", 123, 136], ["cholelithiasis", "OBSERVATION", 189, 203], ["acalculous", "OBSERVATION_MODIFIER", 214, 224], ["cholecystitis", "OBSERVATION", 225, 238], ["thought to be", "UNCERTAINTY", 321, 334], ["reflux", "OBSERVATION", 345, 351], ["intestinal", "ANATOMY", 355, 365], ["bacteria", "OBSERVATION", 366, 374], ["gallbladder", "ANATOMY", 384, 395], ["bile ducts", "ANATOMY", 404, 414], ["hematogenous", "OBSERVATION_MODIFIER", 422, 434], ["bacteria", "OBSERVATION", 444, 452], ["adjacent", "ANATOMY_MODIFIER", 462, 470], ["hepatic", "ANATOMY", 471, 478], ["circulation", "ANATOMY_MODIFIER", 479, 490], ["negative bacteria", "OBSERVATION_MODIFIER", 504, 521]]], ["Campylobacter jejuni has been isolated from 2 dogs with bacteremia and cholecystitis.", [["Campylobacter jejuni", "DISEASE", 0, 20], ["bacteremia", "DISEASE", 56, 66], ["cholecystitis", "DISEASE", 71, 84], ["Campylobacter jejuni", "ORGANISM", 0, 20], ["dogs", "ORGANISM", 46, 50], ["Campylobacter jejuni", "SPECIES", 0, 20], ["dogs", "SPECIES", 46, 50], ["Campylobacter jejuni", "SPECIES", 0, 20], ["Campylobacter jejuni", "PROBLEM", 0, 20], ["bacteremia", "PROBLEM", 56, 66], ["cholecystitis", "PROBLEM", 71, 84], ["jejuni", "OBSERVATION", 14, 20], ["bacteremia", "OBSERVATION", 56, 66], ["cholecystitis", "OBSERVATION", 71, 84]]], ["Occasionally, parasites, such as flukes that colonize the bile ducts, can enter the gallbladder and cause cholecystitis.", [["flukes", "ANATOMY", 33, 39], ["bile ducts", "ANATOMY", 58, 68], ["gallbladder", "ANATOMY", 84, 95], ["cholecystitis", "DISEASE", 106, 119], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 58, 68], ["gallbladder", "ORGAN", 84, 95], ["parasites", "PROBLEM", 14, 23], ["cholecystitis", "PROBLEM", 106, 119], ["parasites", "OBSERVATION", 14, 23], ["bile ducts", "ANATOMY", 58, 68], ["gallbladder", "ANATOMY", 84, 95], ["cholecystitis", "OBSERVATION", 106, 119]]], ["Canine cholecystitis has been associated with various systemic disorders, including diabetes mellitus, severe enteritis, biliary stasis, septicemia, as well as with the use of immunosuppressive drugs, each of which may promote bacterial colonization of the gallbladder.", [["biliary", "ANATOMY", 121, 128], ["gallbladder", "ANATOMY", 257, 268], ["Canine cholecystitis", "DISEASE", 0, 20], ["systemic disorders", "DISEASE", 54, 72], ["diabetes mellitus", "DISEASE", 84, 101], ["enteritis", "DISEASE", 110, 119], ["biliary stasis", "DISEASE", 121, 135], ["septicemia", "DISEASE", 137, 147], ["Canine", "ORGANISM", 0, 6], ["biliary", "PATHOLOGICAL_FORMATION", 121, 128], ["gallbladder", "ORGAN", 257, 268], ["Canine", "SPECIES", 0, 6], ["Canine cholecystitis", "PROBLEM", 0, 20], ["various systemic disorders", "PROBLEM", 46, 72], ["diabetes mellitus", "PROBLEM", 84, 101], ["severe enteritis", "PROBLEM", 103, 119], ["biliary stasis", "PROBLEM", 121, 135], ["septicemia", "PROBLEM", 137, 147], ["immunosuppressive drugs", "TREATMENT", 176, 199], ["bacterial colonization of the gallbladder", "PROBLEM", 227, 268], ["cholecystitis", "OBSERVATION", 7, 20], ["associated with", "UNCERTAINTY", 30, 45], ["various", "OBSERVATION_MODIFIER", 46, 53], ["systemic", "OBSERVATION_MODIFIER", 54, 62], ["disorders", "OBSERVATION", 63, 72], ["diabetes mellitus", "OBSERVATION", 84, 101], ["severe", "OBSERVATION_MODIFIER", 103, 109], ["enteritis", "OBSERVATION", 110, 119], ["biliary", "ANATOMY", 121, 128], ["stasis", "OBSERVATION", 129, 135], ["septicemia", "OBSERVATION", 137, 147], ["bacterial colonization", "OBSERVATION", 227, 249], ["gallbladder", "ANATOMY", 257, 268]]], ["In the acute lesion, histologic changes include neutrophilic inflammatory infiltrates in the wall and lumen of the gallbladder, with focal erosion or ulceration, and edema.Miscellaneous inflammatory liver diseaseNonspecific reactive hepatitis refers to hepatic inflammation characterized by light inflammatory infiltrates, primarily in the portal tracts, without any evidence of hepatocellular necrosis.", [["lesion", "ANATOMY", 13, 19], ["wall", "ANATOMY", 93, 97], ["lumen", "ANATOMY", 102, 107], ["gallbladder", "ANATOMY", 115, 126], ["edema", "ANATOMY", 166, 171], ["liver", "ANATOMY", 199, 204], ["hepatic", "ANATOMY", 253, 260], ["portal tracts", "ANATOMY", 340, 353], ["hepatocellular", "ANATOMY", 379, 393], ["ulceration", "DISEASE", 150, 160], ["edema", "DISEASE", 166, 171], ["liver disease", "DISEASE", 199, 212], ["reactive hepatitis", "DISEASE", 224, 242], ["hepatic inflammation", "DISEASE", 253, 273], ["hepatocellular necrosis", "DISEASE", 379, 402], ["wall", "TISSUE", 93, 97], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 102, 107], ["gallbladder", "ORGAN", 115, 126], ["edema", "PATHOLOGICAL_FORMATION", 166, 171], ["liver", "ORGAN", 199, 204], ["hepatic", "ORGAN", 253, 260], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 340, 353], ["hepatocellular necrosis", "CANCER", 379, 402], ["the acute lesion", "PROBLEM", 3, 19], ["histologic changes", "PROBLEM", 21, 39], ["neutrophilic inflammatory infiltrates in the wall and lumen of the gallbladder", "PROBLEM", 48, 126], ["focal erosion", "PROBLEM", 133, 146], ["ulceration", "PROBLEM", 150, 160], ["edema", "PROBLEM", 166, 171], ["Miscellaneous inflammatory liver disease", "PROBLEM", 172, 212], ["Nonspecific reactive hepatitis", "PROBLEM", 212, 242], ["hepatic inflammation", "PROBLEM", 253, 273], ["light inflammatory infiltrates", "PROBLEM", 291, 321], ["hepatocellular necrosis", "PROBLEM", 379, 402], ["acute", "OBSERVATION_MODIFIER", 7, 12], ["lesion", "OBSERVATION", 13, 19], ["histologic", "OBSERVATION_MODIFIER", 21, 31], ["neutrophilic", "OBSERVATION_MODIFIER", 48, 60], ["inflammatory", "OBSERVATION_MODIFIER", 61, 73], ["infiltrates", "OBSERVATION", 74, 85], ["wall", "ANATOMY_MODIFIER", 93, 97], ["lumen", "ANATOMY_MODIFIER", 102, 107], ["gallbladder", "ANATOMY", 115, 126], ["focal", "OBSERVATION_MODIFIER", 133, 138], ["erosion", "OBSERVATION", 139, 146], ["ulceration", "OBSERVATION", 150, 160], ["edema", "OBSERVATION", 166, 171], ["inflammatory", "OBSERVATION_MODIFIER", 186, 198], ["liver", "ANATOMY", 199, 204], ["disease", "OBSERVATION", 205, 212], ["Nonspecific", "OBSERVATION_MODIFIER", 212, 223], ["reactive", "OBSERVATION_MODIFIER", 224, 232], ["hepatitis", "OBSERVATION", 233, 242], ["hepatic", "ANATOMY", 253, 260], ["inflammation", "OBSERVATION", 261, 273], ["light", "OBSERVATION_MODIFIER", 291, 296], ["inflammatory", "OBSERVATION_MODIFIER", 297, 309], ["infiltrates", "OBSERVATION", 310, 321], ["portal tracts", "ANATOMY", 340, 353], ["without any evidence of", "UNCERTAINTY", 355, 378], ["hepatocellular", "ANATOMY", 379, 393], ["necrosis", "OBSERVATION", 394, 402]]], ["It is often observed during inflammation of the splanchnic organs and is a reactive response, rather than primary inflammation of the liver.", [["splanchnic organs", "ANATOMY", 48, 65], ["liver", "ANATOMY", 134, 139], ["inflammation", "DISEASE", 28, 40], ["inflammation of the liver", "DISEASE", 114, 139], ["splanchnic organs", "ORGAN", 48, 65], ["liver", "ORGAN", 134, 139], ["inflammation of the splanchnic organs", "PROBLEM", 28, 65], ["a reactive response", "PROBLEM", 73, 92], ["primary inflammation of the liver", "PROBLEM", 106, 139], ["inflammation", "OBSERVATION", 28, 40], ["splanchnic", "ANATOMY_MODIFIER", 48, 58], ["organs", "ANATOMY", 59, 65], ["reactive response", "OBSERVATION", 75, 92], ["inflammation", "OBSERVATION", 114, 126], ["liver", "ANATOMY", 134, 139]]], ["There is evidence for maternal leptospirosis in some cases reported in foals.", [["leptospirosis", "DISEASE", 31, 44], ["foals", "ORGANISM_SUBDIVISION", 71, 76], ["maternal leptospirosis", "PROBLEM", 22, 44], ["evidence for", "UNCERTAINTY", 9, 21], ["maternal", "OBSERVATION_MODIFIER", 22, 30], ["leptospirosis", "OBSERVATION", 31, 44]]], ["Two cases are reported in young cats with concurrent thymic lymphomas.", [["thymic lymphomas", "ANATOMY", 53, 69], ["thymic lymphomas", "DISEASE", 53, 69], ["cats", "ORGANISM", 32, 36], ["thymic lymphomas", "CANCER", 53, 69], ["cats", "SPECIES", 32, 36], ["concurrent thymic lymphomas", "PROBLEM", 42, 69], ["thymic lymphomas", "OBSERVATION", 53, 69]]], ["The liver is deeply bile stained.", [["liver", "ANATOMY", 4, 9], ["bile", "ANATOMY", 20, 24], ["liver", "ORGAN", 4, 9], ["bile", "ORGANISM_SUBSTANCE", 20, 24], ["liver", "ANATOMY", 4, 9], ["deeply", "OBSERVATION_MODIFIER", 13, 19], ["bile", "ANATOMY", 20, 24], ["stained", "OBSERVATION", 25, 32]]], ["Histologically, the acinar structure is effaced, and the blood vessels engorged.", [["acinar structure", "ANATOMY", 20, 36], ["blood vessels", "ANATOMY", 57, 70], ["acinar", "MULTI-TISSUE_STRUCTURE", 20, 26], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 57, 70], ["the blood vessels engorged", "PROBLEM", 53, 79], ["acinar structure", "OBSERVATION", 20, 36], ["effaced", "OBSERVATION", 40, 47], ["blood vessels", "ANATOMY", 57, 70], ["engorged", "OBSERVATION", 71, 79]]], ["Hepatocytes are large and syncytial and may contain 10 or more nuclei.", [["Hepatocytes", "ANATOMY", 0, 11], ["nuclei", "ANATOMY", 63, 69], ["Hepatocytes", "CELL", 0, 11], ["nuclei", "CELLULAR_COMPONENT", 63, 69], ["Hepatocytes", "CELL_TYPE", 0, 11], ["syncytial", "PROBLEM", 26, 35], ["large", "OBSERVATION", 16, 21], ["syncytial", "OBSERVATION", 26, 35]]], ["The pale or ballooned cytoplasm contains bile pigments, and cytoplasmic invaginations into hepatocyte nuclei are common.", [["cytoplasm", "ANATOMY", 22, 31], ["bile pigments", "ANATOMY", 41, 54], ["cytoplasmic invaginations", "ANATOMY", 60, 85], ["hepatocyte nuclei", "ANATOMY", 91, 108], ["cytoplasm", "ORGANISM_SUBSTANCE", 22, 31], ["bile pigments", "PATHOLOGICAL_FORMATION", 41, 54], ["cytoplasmic invaginations", "CELLULAR_COMPONENT", 60, 85], ["hepatocyte nuclei", "CELLULAR_COMPONENT", 91, 108], ["The pale or ballooned cytoplasm contains bile pigments", "PROBLEM", 0, 54], ["cytoplasmic invaginations into hepatocyte nuclei", "PROBLEM", 60, 108], ["pale", "OBSERVATION_MODIFIER", 4, 8], ["ballooned", "OBSERVATION_MODIFIER", 12, 21], ["cytoplasm", "OBSERVATION_MODIFIER", 22, 31], ["bile pigments", "OBSERVATION", 41, 54], ["cytoplasmic invaginations", "OBSERVATION", 60, 85], ["hepatocyte", "ANATOMY", 91, 101], ["nuclei", "ANATOMY_MODIFIER", 102, 108], ["common", "OBSERVATION_MODIFIER", 113, 119]]], ["Inflammatory cells are not conspicuous.", [["Inflammatory cells", "ANATOMY", 0, 18], ["Inflammatory cells", "CELL", 0, 18], ["Inflammatory cells", "CELL_TYPE", 0, 18], ["Inflammatory cells", "PROBLEM", 0, 18], ["cells", "OBSERVATION", 13, 18], ["not", "UNCERTAINTY", 23, 26], ["conspicuous", "OBSERVATION_MODIFIER", 27, 38]]], ["Liver parenchymal giant cell transformation occurs in humans in a wide variety of congenital and neonatal liver disorders, including bile duct obstruction associated with biliary atresia, viral and bacterial infections, some metabolic disorders such as galactosemia, some cases of Down syndrome and other genetic disorders, as well as in idiopathic neonatal hepatitis, a cholestatic condition of undetermined cause.", [["Liver parenchymal giant cell", "ANATOMY", 0, 28], ["liver", "ANATOMY", 106, 111], ["bile duct", "ANATOMY", 133, 142], ["biliary", "ANATOMY", 171, 178], ["giant cell transformation", "DISEASE", 18, 43], ["congenital and neonatal liver disorders", "DISEASE", 82, 121], ["bile duct obstruction", "DISEASE", 133, 154], ["biliary atresia", "DISEASE", 171, 186], ["viral and bacterial infections", "DISEASE", 188, 218], ["metabolic disorders", "DISEASE", 225, 244], ["galactosemia", "DISEASE", 253, 265], ["Down syndrome", "DISEASE", 281, 294], ["genetic disorders", "DISEASE", 305, 322], ["idiopathic neonatal hepatitis", "DISEASE", 338, 367], ["cholestatic condition", "DISEASE", 371, 392], ["Liver parenchymal giant cell", "CELL", 0, 28], ["humans", "ORGANISM", 54, 60], ["liver", "ORGAN", 106, 111], ["bile duct", "MULTI-TISSUE_STRUCTURE", 133, 142], ["biliary atresia", "PATHOLOGICAL_FORMATION", 171, 186], ["humans", "SPECIES", 54, 60], ["humans", "SPECIES", 54, 60], ["Liver parenchymal giant cell transformation", "PROBLEM", 0, 43], ["congenital and neonatal liver disorders", "PROBLEM", 82, 121], ["bile duct obstruction", "PROBLEM", 133, 154], ["biliary atresia", "PROBLEM", 171, 186], ["viral and bacterial infections", "PROBLEM", 188, 218], ["some metabolic disorders", "PROBLEM", 220, 244], ["galactosemia", "PROBLEM", 253, 265], ["Down syndrome", "PROBLEM", 281, 294], ["other genetic disorders", "PROBLEM", 299, 322], ["idiopathic neonatal hepatitis", "PROBLEM", 338, 367], ["a cholestatic condition", "PROBLEM", 369, 392], ["parenchymal", "ANATOMY_MODIFIER", 6, 17], ["giant cell transformation", "OBSERVATION", 18, 43], ["wide", "OBSERVATION_MODIFIER", 66, 70], ["variety", "OBSERVATION_MODIFIER", 71, 78], ["congenital", "OBSERVATION", 82, 92], ["liver", "ANATOMY", 106, 111], ["disorders", "OBSERVATION", 112, 121], ["bile duct", "ANATOMY", 133, 142], ["obstruction", "OBSERVATION", 143, 154], ["biliary", "ANATOMY", 171, 178], ["atresia", "OBSERVATION", 179, 186], ["viral", "OBSERVATION_MODIFIER", 188, 193], ["bacterial", "OBSERVATION_MODIFIER", 198, 207], ["infections", "OBSERVATION", 208, 218], ["metabolic disorders", "OBSERVATION", 225, 244], ["galactosemia", "OBSERVATION", 253, 265], ["Down syndrome", "OBSERVATION", 281, 294], ["idiopathic", "OBSERVATION_MODIFIER", 338, 348], ["hepatitis", "OBSERVATION", 358, 367], ["cholestatic", "OBSERVATION_MODIFIER", 371, 382]]], ["Idiopathic acute hepatic disease in horses: 12 cases (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) mechanical or functional obstructions.", [["hepatic", "ANATOMY", 17, 24], ["Idiopathic acute hepatic disease", "DISEASE", 0, 32], ["functional obstructions", "DISEASE", 144, 167], ["hepatic", "ORGAN", 17, 24], ["obstructions", "PATHOLOGICAL_FORMATION", 155, 167], ["Idiopathic acute hepatic disease", "PROBLEM", 0, 32], ["mechanical or functional obstructions", "PROBLEM", 130, 167], ["acute", "OBSERVATION_MODIFIER", 11, 16], ["hepatic", "ANATOMY", 17, 24], ["disease", "OBSERVATION", 25, 32], ["obstructions", "OBSERVATION", 155, 167]]], ["The inflammatory and proliferative responses in cholangitis further interfere with bile flow and exacerbate the ductular spread of bacterial infections once they are established.", [["bile", "ANATOMY", 83, 87], ["ductular", "ANATOMY", 112, 120], ["cholangitis", "DISEASE", 48, 59], ["bacterial infections", "DISEASE", 131, 151], ["bile", "MULTI-TISSUE_STRUCTURE", 83, 87], ["ductular", "MULTI-TISSUE_STRUCTURE", 112, 120], ["The inflammatory and proliferative responses", "PROBLEM", 0, 44], ["cholangitis", "PROBLEM", 48, 59], ["bile flow", "PROBLEM", 83, 92], ["bacterial infections", "PROBLEM", 131, 151], ["inflammatory", "OBSERVATION_MODIFIER", 4, 16], ["proliferative", "OBSERVATION_MODIFIER", 21, 34], ["cholangitis", "OBSERVATION", 48, 59], ["ductular", "OBSERVATION_MODIFIER", 112, 120], ["spread", "OBSERVATION_MODIFIER", 121, 127], ["bacterial", "OBSERVATION_MODIFIER", 131, 140], ["infections", "OBSERVATION", 141, 151]]], ["Again, these lesions can be quite regionally variable, and may be missed on hepatic biopsy if only small areas are sampled.", [["lesions", "ANATOMY", 13, 20], ["hepatic biopsy", "ANATOMY", 76, 90], ["lesions", "PATHOLOGICAL_FORMATION", 13, 20], ["hepatic biopsy", "MULTI-TISSUE_STRUCTURE", 76, 90], ["these lesions", "PROBLEM", 7, 20], ["hepatic biopsy", "TEST", 76, 90], ["small areas", "PROBLEM", 99, 110], ["lesions", "OBSERVATION", 13, 20], ["may be", "UNCERTAINTY", 59, 65], ["hepatic", "ANATOMY", 76, 83], ["biopsy", "OBSERVATION", 84, 90], ["small", "OBSERVATION_MODIFIER", 99, 104], ["areas", "OBSERVATION", 105, 110]]], ["The course and pathologic changes in cholangiohepatitis vary greatly, from fulminating suppurative infection to persistent mild inflammation that, over a period of months or years, leads to hepatic fibrosis of biliary distribution.", [["hepatic", "ANATOMY", 190, 197], ["biliary", "ANATOMY", 210, 217], ["cholangiohepatitis", "DISEASE", 37, 55], ["infection", "DISEASE", 99, 108], ["inflammation", "DISEASE", 128, 140], ["fibrosis", "DISEASE", 198, 206], ["hepatic", "ORGAN", 190, 197], ["biliary", "ORGAN", 210, 217], ["pathologic changes in cholangiohepatitis", "PROBLEM", 15, 55], ["fulminating suppurative infection", "PROBLEM", 75, 108], ["persistent mild inflammation", "PROBLEM", 112, 140], ["hepatic fibrosis of biliary distribution", "PROBLEM", 190, 230], ["pathologic", "OBSERVATION", 15, 25], ["fulminating", "OBSERVATION_MODIFIER", 75, 86], ["suppurative", "OBSERVATION_MODIFIER", 87, 98], ["infection", "OBSERVATION", 99, 108], ["persistent", "OBSERVATION_MODIFIER", 112, 122], ["mild", "OBSERVATION_MODIFIER", 123, 127], ["inflammation", "OBSERVATION", 128, 140], ["hepatic", "ANATOMY", 190, 197], ["fibrosis", "OBSERVATION", 198, 206], ["biliary", "ANATOMY", 210, 217]]], ["Severe suppurative cholangiohepatitis may follow a short course to death, the effects being those of the infection itself, which may become septicemic, rather than of hepatic injury.", [["hepatic", "ANATOMY", 167, 174], ["cholangiohepatitis", "DISEASE", 19, 37], ["death", "DISEASE", 67, 72], ["infection", "DISEASE", 105, 114], ["septicemic", "DISEASE", 140, 150], ["hepatic injury", "DISEASE", 167, 181], ["hepatic", "ORGAN", 167, 174], ["Severe suppurative cholangiohepatitis", "PROBLEM", 0, 37], ["the infection", "PROBLEM", 101, 114], ["septicemic", "PROBLEM", 140, 150], ["hepatic injury", "PROBLEM", 167, 181], ["suppurative", "OBSERVATION_MODIFIER", 7, 18], ["cholangiohepatitis", "OBSERVATION", 19, 37], ["infection", "OBSERVATION", 105, 114], ["septicemic", "OBSERVATION", 140, 150], ["hepatic", "ANATOMY", 167, 174], ["injury", "OBSERVATION", 175, 181]]], ["At autopsy, the liver is swollen, soft, and pale, and its architecture is blurred.", [["liver", "ANATOMY", 16, 21], ["liver", "ORGAN", 16, 21], ["swollen", "PROBLEM", 25, 32], ["blurred", "PROBLEM", 74, 81], ["liver", "ANATOMY", 16, 21], ["swollen", "OBSERVATION", 25, 32], ["soft", "OBSERVATION", 34, 38], ["pale", "OBSERVATION", 44, 48], ["architecture", "OBSERVATION_MODIFIER", 58, 70], ["blurred", "OBSERVATION", 74, 81]]], ["Few or many suppurative foci may be visible beneath the capsule and on the cut surface (eFig.", [["suppurative foci", "ANATOMY", 12, 28], ["capsule", "ANATOMY", 56, 63], ["surface", "ANATOMY", 79, 86], ["capsule", "CANCER", 56, 63], ["many suppurative foci", "PROBLEM", 7, 28], ["many", "OBSERVATION_MODIFIER", 7, 11], ["suppurative", "OBSERVATION_MODIFIER", 12, 23], ["foci", "OBSERVATION", 24, 28], ["may be", "UNCERTAINTY", 29, 35], ["visible", "OBSERVATION_MODIFIER", 36, 43], ["capsule", "OBSERVATION_MODIFIER", 56, 63]]], ["They are small, sometimes miliary in distribution, and not encapsulated.", [["miliary", "DISEASE", 26, 33], ["small", "OBSERVATION_MODIFIER", 9, 14], ["sometimes", "OBSERVATION_MODIFIER", 16, 25], ["miliary", "OBSERVATION", 26, 33], ["distribution", "OBSERVATION_MODIFIER", 37, 49], ["not", "UNCERTAINTY", 55, 58], ["encapsulated", "OBSERVATION_MODIFIER", 59, 71]]], ["Lesions in other organs may be those of septicemia and jaundice.", [["organs", "ANATOMY", 17, 23], ["septicemia", "DISEASE", 40, 50], ["jaundice", "DISEASE", 55, 63], ["organs", "ORGAN", 17, 23], ["Lesions in other organs", "PROBLEM", 0, 23], ["septicemia", "PROBLEM", 40, 50], ["jaundice", "PROBLEM", 55, 63], ["organs", "ANATOMY", 17, 23], ["may be those of", "UNCERTAINTY", 24, 39], ["septicemia", "OBSERVATION", 40, 50], ["jaundice", "OBSERVATION", 55, 63]]], ["Microscopically, the larger ducts contain purulent exudate, and the smaller ones are disintegrated.", [["ducts", "ANATOMY", 28, 33], ["purulent exudate", "ANATOMY", 42, 58], ["ducts", "MULTI-TISSUE_STRUCTURE", 28, 33], ["exudate", "ORGANISM_SUBSTANCE", 51, 58], ["purulent exudate", "PROBLEM", 42, 58], ["larger", "OBSERVATION_MODIFIER", 21, 27], ["ducts", "ANATOMY", 28, 33], ["purulent", "OBSERVATION_MODIFIER", 42, 50], ["exudate", "OBSERVATION", 51, 58], ["smaller", "OBSERVATION_MODIFIER", 68, 75], ["disintegrated", "OBSERVATION_MODIFIER", 85, 98]]], ["Dense masses of neutrophils, liquefied or not, are present in the portal triads and infiltrate the degenerate parenchyma.Further readingIn subacute and chronic cholangiohepatitis, the inflammation is more proliferative than exudative.", [["Dense masses", "ANATOMY", 0, 12], ["neutrophils", "ANATOMY", 16, 27], ["portal triads", "ANATOMY", 66, 79], ["parenchyma", "ANATOMY", 110, 120], ["cholangiohepatitis", "DISEASE", 160, 178], ["inflammation", "DISEASE", 184, 196], ["neutrophils", "CELL", 16, 27], ["portal triads", "MULTI-TISSUE_STRUCTURE", 66, 79], ["parenchyma", "TISSUE", 110, 120], ["neutrophils", "CELL_TYPE", 16, 27], ["Dense masses of neutrophils", "PROBLEM", 0, 27], ["infiltrate the degenerate parenchyma", "PROBLEM", 84, 120], ["subacute and chronic cholangiohepatitis", "PROBLEM", 139, 178], ["the inflammation", "PROBLEM", 180, 196], ["exudative", "PROBLEM", 224, 233], ["masses", "OBSERVATION", 6, 12], ["neutrophils", "OBSERVATION", 16, 27], ["liquefied", "OBSERVATION_MODIFIER", 29, 38], ["portal triads", "ANATOMY", 66, 79], ["infiltrate", "OBSERVATION", 84, 94], ["degenerate parenchyma", "OBSERVATION", 99, 120], ["subacute", "OBSERVATION_MODIFIER", 139, 147], ["chronic", "OBSERVATION_MODIFIER", 152, 159], ["cholangiohepatitis", "OBSERVATION", 160, 178], ["inflammation", "OBSERVATION", 184, 196], ["more proliferative", "OBSERVATION_MODIFIER", 200, 218]]], ["The liver is enlarged and may be of normal shape, or distorted because of irregular areas of atrophy and regenerative hyperplasia.", [["liver", "ANATOMY", 4, 9], ["atrophy", "DISEASE", 93, 100], ["hyperplasia", "DISEASE", 118, 129], ["liver", "ORGAN", 4, 9], ["enlarged", "PROBLEM", 13, 21], ["irregular areas of atrophy", "PROBLEM", 74, 100], ["regenerative hyperplasia", "PROBLEM", 105, 129], ["liver", "ANATOMY", 4, 9], ["enlarged", "OBSERVATION", 13, 21], ["may be", "UNCERTAINTY", 26, 32], ["normal", "OBSERVATION", 36, 42], ["shape", "OBSERVATION_MODIFIER", 43, 48], ["irregular", "OBSERVATION_MODIFIER", 74, 83], ["areas", "OBSERVATION_MODIFIER", 84, 89], ["atrophy", "OBSERVATION", 93, 100], ["regenerative", "OBSERVATION_MODIFIER", 105, 117], ["hyperplasia", "OBSERVATION", 118, 129]]], ["Its surface may be smooth or finely granular; the capsule is thickened and may bear fibrous tags or be adherent to adjacent viscera.", [["surface", "ANATOMY", 4, 11], ["capsule", "ANATOMY", 50, 57], ["fibrous tags", "ANATOMY", 84, 96], ["viscera", "ANATOMY", 124, 131], ["surface", "CELLULAR_COMPONENT", 4, 11], ["capsule", "CANCER", 50, 57], ["viscera", "ORGAN", 124, 131], ["thickened", "PROBLEM", 61, 70], ["fibrous tags", "PROBLEM", 84, 96], ["surface", "OBSERVATION_MODIFIER", 4, 11], ["may be", "UNCERTAINTY", 12, 18], ["smooth", "OBSERVATION_MODIFIER", 19, 25], ["finely", "OBSERVATION_MODIFIER", 29, 35], ["granular", "OBSERVATION_MODIFIER", 36, 44], ["capsule", "ANATOMY", 50, 57], ["thickened", "OBSERVATION", 61, 70], ["may bear", "UNCERTAINTY", 75, 83], ["fibrous tags", "OBSERVATION", 84, 96], ["adherent", "OBSERVATION_MODIFIER", 103, 111], ["viscera", "ANATOMY", 124, 131]]], ["Within areas of duct obstruction, retention of bile pigments can be found in the regions served by the occluded ducts, but systemic icterus (or photosensitization in herbivores) is unlikely unless a large portion of liver is affected.", [["duct", "ANATOMY", 16, 20], ["bile pigments", "ANATOMY", 47, 60], ["ducts", "ANATOMY", 112, 117], ["liver", "ANATOMY", 216, 221], ["duct obstruction", "DISEASE", 16, 32], ["icterus", "DISEASE", 132, 139], ["photosensitization", "DISEASE", 144, 162], ["duct", "MULTI-TISSUE_STRUCTURE", 16, 20], ["bile pigments", "SIMPLE_CHEMICAL", 47, 60], ["ducts", "MULTI-TISSUE_STRUCTURE", 112, 117], ["liver", "ORGAN", 216, 221], ["duct obstruction", "PROBLEM", 16, 32], ["retention of bile pigments", "PROBLEM", 34, 60], ["the occluded ducts", "PROBLEM", 99, 117], ["systemic icterus", "PROBLEM", 123, 139], ["photosensitization in herbivores", "TREATMENT", 144, 176], ["duct", "ANATOMY", 16, 20], ["obstruction", "OBSERVATION", 21, 32], ["retention", "OBSERVATION_MODIFIER", 34, 43], ["bile pigments", "OBSERVATION", 47, 60], ["occluded", "OBSERVATION", 103, 111], ["ducts", "ANATOMY", 112, 117], ["systemic", "OBSERVATION_MODIFIER", 123, 131], ["icterus", "OBSERVATION", 132, 139], ["large", "OBSERVATION_MODIFIER", 199, 204], ["liver", "ANATOMY", 216, 221], ["affected", "OBSERVATION", 225, 233]]], ["On cut surface, the enlarged portal tracts are easily visible and accentuate the architecture of the organ.", [["surface", "ANATOMY", 7, 14], ["portal tracts", "ANATOMY", 29, 42], ["organ", "ANATOMY", 101, 106], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 29, 42], ["organ", "ORGAN", 101, 106], ["the enlarged portal tracts", "PROBLEM", 16, 42], ["enlarged", "OBSERVATION", 20, 28], ["portal tracts", "ANATOMY", 29, 42], ["visible", "OBSERVATION", 54, 61], ["organ", "ANATOMY", 101, 106]]], ["Eventually, the new fibrous tissue replaces the parenchyma, and in chronic diffuse cases in which the original infection persists, continuous fibroplasia may produce hepatic enlargement, the organ becoming huge, gray, and gristly.", [["fibrous tissue", "ANATOMY", 20, 34], ["parenchyma", "ANATOMY", 48, 58], ["hepatic", "ANATOMY", 166, 173], ["organ", "ANATOMY", 191, 196], ["infection", "DISEASE", 111, 120], ["fibroplasia", "DISEASE", 142, 153], ["hepatic enlargement", "DISEASE", 166, 185], ["fibrous tissue", "TISSUE", 20, 34], ["parenchyma", "TISSUE", 48, 58], ["hepatic", "ORGAN", 166, 173], ["organ", "ORGAN", 191, 196], ["the new fibrous tissue", "PROBLEM", 12, 34], ["chronic diffuse cases", "PROBLEM", 67, 88], ["the original infection", "PROBLEM", 98, 120], ["continuous fibroplasia", "PROBLEM", 131, 153], ["hepatic enlargement", "PROBLEM", 166, 185], ["new", "OBSERVATION_MODIFIER", 16, 19], ["fibrous tissue", "OBSERVATION", 20, 34], ["parenchyma", "ANATOMY", 48, 58], ["chronic", "OBSERVATION_MODIFIER", 67, 74], ["diffuse", "OBSERVATION_MODIFIER", 75, 82], ["cases", "OBSERVATION", 83, 88], ["original", "OBSERVATION_MODIFIER", 102, 110], ["infection", "OBSERVATION", 111, 120], ["fibroplasia", "OBSERVATION", 142, 153], ["hepatic", "ANATOMY", 166, 173], ["enlargement", "OBSERVATION", 174, 185], ["huge", "OBSERVATION_MODIFIER", 206, 210]]], ["This spectrum of liver changes is typical of alsike clover poisoning (\"big-liver disease\") in horses (discussed in the later section on Toxic hepatic disease).", [["liver", "ANATOMY", 17, 22], ["liver", "ANATOMY", 75, 80], ["hepatic", "ANATOMY", 142, 149], ["liver changes", "DISEASE", 17, 30], ["poisoning", "DISEASE", 59, 68], ["liver disease", "DISEASE", 75, 88], ["Toxic hepatic disease", "DISEASE", 136, 157], ["liver", "ORGAN", 17, 22], ["liver", "ORGAN", 75, 80], ["hepatic", "ORGAN", 142, 149], ["liver changes", "PROBLEM", 17, 30], ["alsike clover poisoning", "PROBLEM", 45, 68], ["big-liver disease\"", "PROBLEM", 71, 89], ["Toxic hepatic disease", "PROBLEM", 136, 157], ["liver", "ANATOMY", 17, 22], ["clover poisoning", "OBSERVATION", 52, 68], ["liver", "ANATOMY", 75, 80], ["disease", "OBSERVATION", 81, 88], ["hepatic", "ANATOMY", 142, 149], ["disease", "OBSERVATION", 150, 157]]], ["Alternatively, the chronic fibrosis may occur in wedge-shaped areas oriented to a small bile duct.", [["bile duct", "ANATOMY", 88, 97], ["fibrosis", "DISEASE", 27, 35], ["bile duct", "MULTI-TISSUE_STRUCTURE", 88, 97], ["the chronic fibrosis", "PROBLEM", 15, 35], ["wedge-shaped areas", "PROBLEM", 49, 67], ["a small bile duct", "PROBLEM", 80, 97], ["chronic", "OBSERVATION_MODIFIER", 19, 26], ["fibrosis", "OBSERVATION", 27, 35], ["wedge", "OBSERVATION_MODIFIER", 49, 54], ["shaped", "OBSERVATION_MODIFIER", 55, 61], ["areas", "OBSERVATION_MODIFIER", 62, 67], ["small", "OBSERVATION_MODIFIER", 82, 87], ["bile duct", "ANATOMY", 88, 97]]], ["The enlarged interlobular ducts may be readily visible and frequently contain plugs of inspissated secretion and debris.Further readingMicroscopically, the reaction remains centered on portal tracts.", [["interlobular ducts", "ANATOMY", 13, 31], ["portal tracts", "ANATOMY", 185, 198], ["interlobular ducts", "MULTI-TISSUE_STRUCTURE", 13, 31], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 185, 198], ["The enlarged interlobular ducts", "PROBLEM", 0, 31], ["inspissated secretion", "PROBLEM", 87, 108], ["debris", "PROBLEM", 113, 119], ["the reaction", "PROBLEM", 152, 164], ["enlarged", "OBSERVATION", 4, 12], ["interlobular", "ANATOMY_MODIFIER", 13, 25], ["ducts", "ANATOMY", 26, 31], ["may be", "UNCERTAINTY", 32, 38], ["plugs", "OBSERVATION", 78, 83], ["inspissated secretion", "OBSERVATION", 87, 108], ["debris", "OBSERVATION", 113, 119], ["portal tracts", "ANATOMY", 185, 198]]], ["These are expanded in subacute cases by infiltration of leukocytes and macrophages and the proliferation of small ducts and, in chronic cases, chiefly by organizing fibrous tissue and proliferating bile ducts.", [["leukocytes", "ANATOMY", 56, 66], ["macrophages", "ANATOMY", 71, 82], ["small ducts", "ANATOMY", 108, 119], ["fibrous tissue", "ANATOMY", 165, 179], ["bile ducts", "ANATOMY", 198, 208], ["leukocytes", "CELL", 56, 66], ["macrophages", "CELL", 71, 82], ["ducts", "MULTI-TISSUE_STRUCTURE", 114, 119], ["fibrous tissue", "TISSUE", 165, 179], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 198, 208], ["leukocytes", "CELL_TYPE", 56, 66], ["macrophages", "CELL_TYPE", 71, 82], ["infiltration of leukocytes", "PROBLEM", 40, 66], ["macrophages", "PROBLEM", 71, 82], ["the proliferation of small ducts", "PROBLEM", 87, 119], ["proliferating bile ducts", "PROBLEM", 184, 208], ["expanded", "OBSERVATION_MODIFIER", 10, 18], ["subacute", "OBSERVATION_MODIFIER", 22, 30], ["infiltration", "OBSERVATION", 40, 52], ["leukocytes", "OBSERVATION", 56, 66], ["macrophages", "OBSERVATION_MODIFIER", 71, 82], ["proliferation", "OBSERVATION_MODIFIER", 91, 104], ["small", "OBSERVATION_MODIFIER", 108, 113], ["ducts", "ANATOMY", 114, 119], ["chronic", "OBSERVATION_MODIFIER", 128, 135], ["cases", "OBSERVATION", 136, 141], ["fibrous tissue", "OBSERVATION", 165, 179], ["proliferating", "OBSERVATION_MODIFIER", 184, 197], ["bile ducts", "ANATOMY", 198, 208]]], ["Encroachment on the parenchyma is minimal but inevitable.", [["parenchyma", "ANATOMY", 20, 30], ["Encroachment", "DISEASE", 0, 12], ["parenchyma", "TISSUE", 20, 30], ["Encroachment on the parenchyma", "PROBLEM", 0, 30], ["parenchyma", "ANATOMY", 20, 30], ["minimal", "OBSERVATION_MODIFIER", 34, 41]]], ["Continued degeneration of the periportal parenchyma is probably an additional stimulus to local fibroplasia, which, as well as thickening the smallest portal triads, extends along their length and links up with neighboring triads, thus subdividing the acini into segments.", [["periportal parenchyma", "ANATOMY", 30, 51], ["portal triads", "ANATOMY", 151, 164], ["acini", "ANATOMY", 252, 257], ["fibroplasia", "DISEASE", 96, 107], ["periportal parenchyma", "MULTI-TISSUE_STRUCTURE", 30, 51], ["fibroplasia", "PATHOLOGICAL_FORMATION", 96, 107], ["portal triads", "MULTI-TISSUE_STRUCTURE", 151, 164], ["acini", "MULTI-TISSUE_STRUCTURE", 252, 257], ["Continued degeneration of the periportal parenchyma", "PROBLEM", 0, 51], ["local fibroplasia", "PROBLEM", 90, 107], ["thickening the smallest portal triads", "PROBLEM", 127, 164], ["degeneration", "OBSERVATION", 10, 22], ["periportal", "ANATOMY", 30, 40], ["parenchyma", "ANATOMY_MODIFIER", 41, 51], ["probably", "UNCERTAINTY", 55, 63], ["local", "OBSERVATION_MODIFIER", 90, 95], ["fibroplasia", "OBSERVATION", 96, 107], ["thickening", "OBSERVATION", 127, 137], ["smallest", "OBSERVATION_MODIFIER", 142, 150], ["portal triads", "ANATOMY", 151, 164], ["length", "OBSERVATION_MODIFIER", 186, 192], ["acini", "ANATOMY_MODIFIER", 252, 257], ["segments", "ANATOMY_MODIFIER", 263, 271]]], ["The hepatic venules and sublobular veins are involved.", [["hepatic venules", "ANATOMY", 4, 19], ["sublobular veins", "ANATOMY", 24, 40], ["hepatic venules", "MULTI-TISSUE_STRUCTURE", 4, 19], ["sublobular veins", "MULTI-TISSUE_STRUCTURE", 24, 40], ["hepatic venules", "CELL_TYPE", 4, 19], ["hepatic", "ANATOMY", 4, 11], ["venules", "ANATOMY_MODIFIER", 12, 19], ["sublobular veins", "ANATOMY", 24, 40]]], ["Regenerative nodules are not a prominent feature of cholangiohepatitis unless large areas of parenchyma have been destroyed, in which case the least damaged lobes are expanded by coarse nodules.Further readingNeutrophilic cholangitis (suppurative or exudative cholangitis/cholangiohepatitis) is a relatively common disorder of cats and, much less commonly, dogs.", [["nodules", "ANATOMY", 13, 20], ["parenchyma", "ANATOMY", 93, 103], ["lobes", "ANATOMY", 157, 162], ["nodules", "ANATOMY", 186, 193], ["suppurative", "ANATOMY", 235, 246], ["cholangiohepatitis", "DISEASE", 52, 70], ["Neutrophilic cholangitis", "DISEASE", 209, 233], ["cholangitis", "DISEASE", 260, 271], ["cholangiohepatitis", "DISEASE", 272, 290], ["Regenerative nodules", "CANCER", 0, 20], ["cholangiohepatitis", "CANCER", 52, 70], ["parenchyma", "TISSUE", 93, 103], ["lobes", "CANCER", 157, 162], ["coarse nodules", "CANCER", 179, 193], ["cats", "ORGANISM", 327, 331], ["dogs", "ORGANISM", 357, 361], ["cats", "SPECIES", 327, 331], ["dogs", "SPECIES", 357, 361], ["Regenerative nodules", "PROBLEM", 0, 20], ["cholangiohepatitis", "PROBLEM", 52, 70], ["coarse nodules", "PROBLEM", 179, 193], ["Neutrophilic cholangitis", "PROBLEM", 209, 233], ["suppurative", "PROBLEM", 235, 246], ["exudative cholangitis", "PROBLEM", 250, 271], ["cholangiohepatitis", "PROBLEM", 272, 290], ["a relatively common disorder of cats", "PROBLEM", 295, 331], ["nodules", "OBSERVATION", 13, 20], ["prominent", "OBSERVATION_MODIFIER", 31, 40], ["cholangiohepatitis", "OBSERVATION", 52, 70], ["large", "OBSERVATION_MODIFIER", 78, 83], ["areas", "OBSERVATION_MODIFIER", 84, 89], ["parenchyma", "ANATOMY_MODIFIER", 93, 103], ["destroyed", "OBSERVATION_MODIFIER", 114, 123], ["least", "OBSERVATION_MODIFIER", 143, 148], ["damaged", "OBSERVATION_MODIFIER", 149, 156], ["lobes", "OBSERVATION_MODIFIER", 157, 162], ["expanded", "OBSERVATION_MODIFIER", 167, 175], ["coarse", "OBSERVATION_MODIFIER", 179, 185], ["nodules", "OBSERVATION", 186, 193], ["Neutrophilic", "OBSERVATION_MODIFIER", 209, 221], ["cholangitis", "OBSERVATION", 222, 233], ["suppurative", "OBSERVATION_MODIFIER", 235, 246], ["exudative", "OBSERVATION_MODIFIER", 250, 259], ["cholangitis", "OBSERVATION", 260, 271]]], ["This condition has been suggested to be the result of acute inflammation in the biliary More chronic stages develop typical mixed inflammatory infiltrates, with fibrosis.", [["biliary", "ANATOMY", 80, 87], ["inflammation", "DISEASE", 60, 72], ["fibrosis", "DISEASE", 161, 169], ["biliary", "ORGAN", 80, 87], ["acute inflammation", "PROBLEM", 54, 72], ["typical mixed inflammatory infiltrates", "PROBLEM", 116, 154], ["fibrosis", "PROBLEM", 161, 169], ["suggested to be the result of", "UNCERTAINTY", 24, 53], ["acute", "OBSERVATION_MODIFIER", 54, 59], ["inflammation", "OBSERVATION", 60, 72], ["biliary", "ANATOMY", 80, 87], ["More chronic", "OBSERVATION_MODIFIER", 88, 100], ["typical", "OBSERVATION_MODIFIER", 116, 123], ["mixed", "OBSERVATION_MODIFIER", 124, 129], ["inflammatory", "OBSERVATION_MODIFIER", 130, 142], ["infiltrates", "OBSERVATION", 143, 154], ["fibrosis", "OBSERVATION", 161, 169]]], ["Occasionally, the infiltrate may be predominantly lymphoplasmacytic, with formation of lymphoid follicles within the mucosa.Further readingGallbladder infarction characterized by transmural coagulative necrosis of the gallbladder wall with intravascular fibrin thrombi has been reported in dogs (Fig. 2-62) .", [["lymphoid follicles", "ANATOMY", 87, 105], ["mucosa", "ANATOMY", 117, 123], ["Gallbladder", "ANATOMY", 139, 150], ["gallbladder wall", "ANATOMY", 218, 234], ["intravascular fibrin thrombi", "ANATOMY", 240, 268], ["Gallbladder infarction", "DISEASE", 139, 161], ["necrosis", "DISEASE", 202, 210], ["intravascular fibrin thrombi", "DISEASE", 240, 268], ["lymphoid follicles", "MULTI-TISSUE_STRUCTURE", 87, 105], ["mucosa", "MULTI-TISSUE_STRUCTURE", 117, 123], ["Gallbladder", "MULTI-TISSUE_STRUCTURE", 139, 150], ["gallbladder wall", "MULTI-TISSUE_STRUCTURE", 218, 234], ["intravascular", "IMMATERIAL_ANATOMICAL_ENTITY", 240, 253], ["fibrin", "GENE_OR_GENE_PRODUCT", 254, 260], ["dogs", "SPECIES", 290, 294], ["the infiltrate", "PROBLEM", 14, 28], ["lymphoplasmacytic", "PROBLEM", 50, 67], ["lymphoid follicles within the mucosa", "PROBLEM", 87, 123], ["Further readingGallbladder infarction", "PROBLEM", 124, 161], ["transmural coagulative necrosis of the gallbladder wall", "PROBLEM", 179, 234], ["intravascular fibrin thrombi", "PROBLEM", 240, 268], ["infiltrate", "OBSERVATION", 18, 28], ["may be", "UNCERTAINTY", 29, 35], ["predominantly", "OBSERVATION_MODIFIER", 36, 49], ["lymphoplasmacytic", "OBSERVATION", 50, 67], ["lymphoid follicles", "OBSERVATION", 87, 105], ["mucosa", "ANATOMY", 117, 123], ["Gallbladder", "ANATOMY", 139, 150], ["infarction", "OBSERVATION", 151, 161], ["transmural", "OBSERVATION_MODIFIER", 179, 189], ["coagulative", "OBSERVATION_MODIFIER", 190, 201], ["necrosis", "OBSERVATION", 202, 210], ["gallbladder", "ANATOMY", 218, 229], ["wall", "ANATOMY_MODIFIER", 230, 234], ["intravascular", "OBSERVATION_MODIFIER", 240, 253], ["fibrin thrombi", "OBSERVATION", 254, 268]]], ["The arterial blood supply to the gallbladder is the cystic artery, a branch of the hepatic artery, and occlusion may cause partial or complete infarction.", [["arterial blood", "ANATOMY", 4, 18], ["gallbladder", "ANATOMY", 33, 44], ["cystic artery", "ANATOMY", 52, 65], ["hepatic artery", "ANATOMY", 83, 97], ["infarction", "DISEASE", 143, 153], ["arterial blood", "MULTI-TISSUE_STRUCTURE", 4, 18], ["gallbladder", "ORGAN", 33, 44], ["cystic artery", "MULTI-TISSUE_STRUCTURE", 52, 65], ["hepatic artery", "MULTI-TISSUE_STRUCTURE", 83, 97], ["occlusion", "PROBLEM", 103, 112], ["partial or complete infarction", "PROBLEM", 123, 153], ["arterial", "ANATOMY_MODIFIER", 4, 12], ["gallbladder", "ANATOMY", 33, 44], ["cystic artery", "ANATOMY", 52, 65], ["branch", "ANATOMY_MODIFIER", 69, 75], ["hepatic artery", "ANATOMY", 83, 97], ["occlusion", "OBSERVATION", 103, 112], ["may cause", "UNCERTAINTY", 113, 122], ["partial", "OBSERVATION_MODIFIER", 123, 130], ["complete", "OBSERVATION_MODIFIER", 134, 142], ["infarction", "OBSERVATION", 143, 153]]], ["Predisposing factors have not been identified; however, the lack of significant concurrent inflammatory response suggests that this is not simply a sequela to underlying cholecystitis.Further readingGallbladder mucocele is discussed further under Ectopic, hyperplastic, and metaplastic lesions.Although pure cholangitis does occur, extension of inflammation from the ducts into the adjacent hepatic parenchyma can occur, and such lesions can quite accurately be regarded as cholangiohepatitis.Bile contains various antimicrobial factors, including \u03b2-defensins and bile acids that are inhospitable to most bacteria, except for some species with particular capsule adaptations.", [["Gallbladder mucocele", "ANATOMY", 199, 219], ["hyperplastic", "ANATOMY", 256, 268], ["metaplastic lesions", "ANATOMY", 274, 293], ["ducts", "ANATOMY", 367, 372], ["hepatic parenchyma", "ANATOMY", 391, 409], ["lesions", "ANATOMY", 430, 437], ["Bile", "ANATOMY", 493, 497], ["capsule", "ANATOMY", 655, 662], ["cholecystitis", "DISEASE", 170, 183], ["Gallbladder mucocele", "DISEASE", 199, 219], ["cholangitis", "DISEASE", 308, 319], ["inflammation", "DISEASE", 345, 357], ["cholangiohepatitis", "DISEASE", 474, 492], ["bile acids", "CHEMICAL", 564, 574], ["Gallbladder mucocele", "CANCER", 199, 219], ["hyperplastic", "CANCER", 256, 268], ["metaplastic lesions", "CANCER", 274, 293], ["ducts", "MULTI-TISSUE_STRUCTURE", 367, 372], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 391, 409], ["lesions", "PATHOLOGICAL_FORMATION", 430, 437], ["Bile", "MULTI-TISSUE_STRUCTURE", 493, 497], ["\u03b2-defensins", "SIMPLE_CHEMICAL", 548, 559], ["bile acids", "SIMPLE_CHEMICAL", 564, 574], ["capsule", "CANCER", 655, 662], ["antimicrobial factors", "PROTEIN", 515, 536], ["\u03b2-defensins", "PROTEIN", 548, 559], ["significant concurrent inflammatory response", "PROBLEM", 68, 112], ["underlying cholecystitis", "PROBLEM", 159, 183], ["Further readingGallbladder mucocele", "PROBLEM", 184, 219], ["Ectopic, hyperplastic, and metaplastic lesions", "PROBLEM", 247, 293], ["pure cholangitis", "PROBLEM", 303, 319], ["inflammation from the ducts into the adjacent hepatic parenchyma", "PROBLEM", 345, 409], ["such lesions", "PROBLEM", 425, 437], ["cholangiohepatitis", "PROBLEM", 474, 492], ["Bile contains various antimicrobial factors", "PROBLEM", 493, 536], ["\u03b2-defensins", "PROBLEM", 548, 559], ["bile acids", "PROBLEM", 564, 574], ["most bacteria", "PROBLEM", 600, 613], ["some species", "PROBLEM", 626, 638], ["significant", "OBSERVATION_MODIFIER", 68, 79], ["inflammatory", "OBSERVATION", 91, 103], ["not simply", "UNCERTAINTY", 135, 145], ["sequela", "OBSERVATION", 148, 155], ["cholecystitis", "OBSERVATION", 170, 183], ["Gallbladder", "ANATOMY", 199, 210], ["mucocele", "OBSERVATION", 211, 219], ["Ectopic", "OBSERVATION_MODIFIER", 247, 254], ["hyperplastic", "OBSERVATION_MODIFIER", 256, 268], ["metaplastic", "OBSERVATION_MODIFIER", 274, 285], ["lesions", "OBSERVATION", 286, 293], ["pure", "OBSERVATION_MODIFIER", 303, 307], ["cholangitis", "OBSERVATION", 308, 319], ["inflammation", "OBSERVATION", 345, 357], ["ducts", "ANATOMY", 367, 372], ["adjacent", "ANATOMY_MODIFIER", 382, 390], ["hepatic", "ANATOMY", 391, 398], ["parenchyma", "ANATOMY_MODIFIER", 399, 409], ["lesions", "OBSERVATION", 430, 437], ["various", "OBSERVATION_MODIFIER", 507, 514], ["antimicrobial factors", "OBSERVATION", 515, 536], ["bile", "ANATOMY", 564, 568], ["most bacteria", "OBSERVATION_MODIFIER", 600, 613]]], ["Bacterial cholangiohepatitis is usually caused by common opportunists of enteric origin, such as coliforms and streptococci.", [["cholangiohepatitis", "DISEASE", 10, 28], ["Bacterial cholangiohepatitis", "PROBLEM", 0, 28], ["coliforms", "PROBLEM", 97, 106], ["streptococci", "PROBLEM", 111, 123], ["cholangiohepatitis", "OBSERVATION", 10, 28], ["enteric origin", "ANATOMY", 73, 87], ["coliforms", "OBSERVATION", 97, 106], ["streptococci", "OBSERVATION", 111, 123]]], ["Some bacteremic organisms, including some Salmonella, can be cultured from the bile, but the mechanism by which they get there is unknown.", [["bile", "ANATOMY", 79, 83], ["bile", "ORGAN", 79, 83], ["Salmonella", "SPECIES", 42, 52], ["Some bacteremic organisms", "PROBLEM", 0, 25], ["some Salmonella", "PROBLEM", 37, 52], ["bacteremic", "OBSERVATION", 5, 15], ["Salmonella", "OBSERVATION", 42, 52], ["bile", "ANATOMY", 79, 83]]], ["Salmonellosis is a distinctive cause of fibrinous cholecystitis in cattle, especially calves.Although pure cholangitis does occur, extension of inflammation from the ducts into the adjacent hepatic parenchyma can occur, and such lesions can quite accurately be regarded as cholangiohepatitis.The pathogenesis of bacterial cholangitis/cholangiohepatitis depends on various predisposing conditions, similar to those involved in the pathogenesis of pyelonephritis.", [["ducts", "ANATOMY", 166, 171], ["hepatic parenchyma", "ANATOMY", 190, 208], ["lesions", "ANATOMY", 229, 236], ["Salmonellosis", "DISEASE", 0, 13], ["fibrinous cholecystitis", "DISEASE", 40, 63], ["cholangitis", "DISEASE", 107, 118], ["inflammation", "DISEASE", 144, 156], ["cholangiohepatitis", "DISEASE", 273, 291], ["bacterial cholangitis", "DISEASE", 312, 333], ["cholangiohepatitis", "DISEASE", 334, 352], ["pyelonephritis", "DISEASE", 446, 460], ["fibrinous cholecystitis", "PATHOLOGICAL_FORMATION", 40, 63], ["cattle", "ORGANISM", 67, 73], ["calves", "ORGANISM", 86, 92], ["ducts", "MULTI-TISSUE_STRUCTURE", 166, 171], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 190, 208], ["lesions", "PATHOLOGICAL_FORMATION", 229, 236], ["pyelonephritis", "PATHOLOGICAL_FORMATION", 446, 460], ["cattle", "SPECIES", 67, 73], ["calves", "SPECIES", 86, 92], ["cattle", "SPECIES", 67, 73], ["Salmonellosis", "PROBLEM", 0, 13], ["fibrinous cholecystitis", "PROBLEM", 40, 63], ["pure cholangitis", "PROBLEM", 102, 118], ["inflammation from the ducts into the adjacent hepatic parenchyma", "PROBLEM", 144, 208], ["such lesions", "PROBLEM", 224, 236], ["cholangiohepatitis", "PROBLEM", 273, 291], ["bacterial cholangitis", "PROBLEM", 312, 333], ["cholangiohepatitis", "PROBLEM", 334, 352], ["various predisposing conditions", "PROBLEM", 364, 395], ["pyelonephritis", "PROBLEM", 446, 460], ["fibrinous", "OBSERVATION_MODIFIER", 40, 49], ["cholecystitis", "OBSERVATION", 50, 63], ["cattle", "OBSERVATION_MODIFIER", 67, 73], ["pure", "OBSERVATION_MODIFIER", 102, 106], ["cholangitis", "OBSERVATION", 107, 118], ["inflammation", "OBSERVATION", 144, 156], ["ducts", "ANATOMY", 166, 171], ["adjacent", "ANATOMY_MODIFIER", 181, 189], ["hepatic", "ANATOMY", 190, 197], ["parenchyma", "ANATOMY_MODIFIER", 198, 208], ["lesions", "OBSERVATION", 229, 236], ["bacterial", "OBSERVATION_MODIFIER", 312, 321], ["cholangitis", "OBSERVATION", 322, 333], ["pyelonephritis", "OBSERVATION", 446, 460]]], ["These include infection by bacteria that reach the ducts hematogenously, facilitated by localization in the peribiliary plexus or by extension from sinusoidal Kupffer cells or foci of necrosis.", [["ducts", "ANATOMY", 51, 56], ["peribiliary plexus", "ANATOMY", 108, 126], ["sinusoidal Kupffer cells", "ANATOMY", 148, 172], ["foci", "ANATOMY", 176, 180], ["infection", "DISEASE", 14, 23], ["necrosis", "DISEASE", 184, 192], ["ducts", "MULTI-TISSUE_STRUCTURE", 51, 56], ["peribiliary plexus", "MULTI-TISSUE_STRUCTURE", 108, 126], ["sinusoidal Kupffer cells", "CELL", 148, 172], ["sinusoidal Kupffer cells", "CELL_TYPE", 148, 172], ["infection", "PROBLEM", 14, 23], ["bacteria", "PROBLEM", 27, 35], ["sinusoidal Kupffer cells", "PROBLEM", 148, 172], ["necrosis", "PROBLEM", 184, 192], ["infection", "OBSERVATION", 14, 23], ["ducts", "ANATOMY", 51, 56], ["peribiliary plexus", "ANATOMY", 108, 126], ["sinusoidal", "ANATOMY_MODIFIER", 148, 158], ["Kupffer cells", "OBSERVATION", 159, 172], ["foci", "OBSERVATION_MODIFIER", 176, 180], ["necrosis", "OBSERVATION", 184, 192]]], ["Descending cholangitis is occasionally observed in cattle with suppurative hepatitis with extension from abscesses directly into the ducts or via the portal lymphatics.", [["abscesses", "ANATOMY", 105, 114], ["ducts", "ANATOMY", 133, 138], ["portal lymphatics", "ANATOMY", 150, 167], ["cholangitis", "DISEASE", 11, 22], ["suppurative hepatitis", "DISEASE", 63, 84], ["abscesses", "DISEASE", 105, 114], ["abscesses", "PATHOLOGICAL_FORMATION", 105, 114], ["ducts", "MULTI-TISSUE_STRUCTURE", 133, 138], ["portal lymphatics", "MULTI-TISSUE_STRUCTURE", 150, 167], ["cattle", "SPECIES", 51, 57], ["cattle", "SPECIES", 51, 57], ["Descending cholangitis", "PROBLEM", 0, 22], ["suppurative hepatitis", "PROBLEM", 63, 84], ["abscesses", "PROBLEM", 105, 114], ["cholangitis", "OBSERVATION", 11, 22], ["suppurative", "OBSERVATION_MODIFIER", 63, 74], ["hepatitis", "OBSERVATION", 75, 84], ["abscesses", "OBSERVATION", 105, 114], ["ducts", "ANATOMY", 133, 138], ["portal lymphatics", "ANATOMY", 150, 167]]], ["Cholangiohepatitis of this origin may be restricted in its distribution to biliary fields, but in some cases, it does become quite diffuse in the biliary system.", [["biliary fields", "ANATOMY", 75, 89], ["biliary system", "ANATOMY", 146, 160], ["Cholangiohepatitis", "DISEASE", 0, 18], ["biliary", "PATHOLOGICAL_FORMATION", 75, 82], ["biliary system", "MULTI-TISSUE_STRUCTURE", 146, 160], ["Cholangiohepatitis of this origin", "PROBLEM", 0, 33], ["quite diffuse in the biliary system", "PROBLEM", 125, 160], ["biliary", "ANATOMY", 75, 82], ["diffuse", "OBSERVATION_MODIFIER", 131, 138], ["biliary system", "ANATOMY", 146, 160]]], ["Alternatively, bacteria can ascend the ducts from the intestine, facilitated by bile stasis caused by composed of pigment-laden macrophages, neutrophils, and/or eosinophils, and in some instances, fibrosis.", [["ducts", "ANATOMY", 39, 44], ["intestine", "ANATOMY", 54, 63], ["bile", "ANATOMY", 80, 84], ["pigment", "ANATOMY", 114, 121], ["macrophages", "ANATOMY", 128, 139], ["neutrophils", "ANATOMY", 141, 152], ["eosinophils", "ANATOMY", 161, 172], ["bile stasis", "DISEASE", 80, 91], ["fibrosis", "DISEASE", 197, 205], ["ducts", "MULTI-TISSUE_STRUCTURE", 39, 44], ["intestine", "ORGAN", 54, 63], ["bile", "PATHOLOGICAL_FORMATION", 80, 84], ["macrophages", "CELL", 128, 139], ["neutrophils", "CELL", 141, 152], ["eosinophils", "CELL", 161, 172], ["pigment-laden macrophages", "CELL_TYPE", 114, 139], ["neutrophils", "CELL_TYPE", 141, 152], ["eosinophils", "CELL_TYPE", 161, 172], ["bacteria", "PROBLEM", 15, 23], ["bile stasis", "PROBLEM", 80, 91], ["pigment-laden macrophages", "PROBLEM", 114, 139], ["neutrophils", "TEST", 141, 152], ["eosinophils", "TEST", 161, 172], ["fibrosis", "PROBLEM", 197, 205], ["bacteria", "OBSERVATION", 15, 23], ["ducts", "ANATOMY", 39, 44], ["intestine", "ANATOMY", 54, 63], ["bile", "ANATOMY", 80, 84], ["stasis", "OBSERVATION", 85, 91], ["pigment", "OBSERVATION_MODIFIER", 114, 121], ["laden macrophages", "OBSERVATION", 122, 139], ["eosinophils", "ANATOMY", 161, 172], ["fibrosis", "OBSERVATION", 197, 205]]], ["The extent of injury may be sufficient to cause marked icterus and acholic feces because of marked intrahepatic cholestasis.", [["icterus", "ANATOMY", 55, 62], ["acholic feces", "ANATOMY", 67, 80], ["intrahepatic", "ANATOMY", 99, 111], ["icterus", "DISEASE", 55, 62], ["intrahepatic cholestasis", "DISEASE", 99, 123], ["icterus", "PATHOLOGICAL_FORMATION", 55, 62], ["feces", "ORGANISM_SUBSTANCE", 75, 80], ["intrahepatic cholestasis", "PATHOLOGICAL_FORMATION", 99, 123], ["injury", "PROBLEM", 14, 20], ["marked icterus", "PROBLEM", 48, 62], ["acholic feces", "PROBLEM", 67, 80], ["marked intrahepatic cholestasis", "PROBLEM", 92, 123], ["extent", "OBSERVATION_MODIFIER", 4, 10], ["injury", "OBSERVATION", 14, 20], ["marked", "OBSERVATION_MODIFIER", 48, 54], ["icterus", "OBSERVATION", 55, 62], ["acholic feces", "OBSERVATION", 67, 80], ["marked", "OBSERVATION_MODIFIER", 92, 98], ["intrahepatic", "ANATOMY_MODIFIER", 99, 111], ["cholestasis", "OBSERVATION", 112, 123]]], ["The pathogenesis of this lesion is unclear; however, toxic injury, idiosyncratic drug reactions (see Fig. 2Biliary tract obstructionCholelithiasis (gallstone formation) is seldom observed in animals.", [["lesion", "ANATOMY", 25, 31], ["gallstone", "ANATOMY", 148, 157], ["toxic injury", "DISEASE", 53, 65], ["Cholelithiasis", "DISEASE", 132, 146], ["gallstone", "DISEASE", 148, 157], ["gallstone", "PATHOLOGICAL_FORMATION", 148, 157], ["this lesion", "PROBLEM", 20, 31], ["toxic injury", "PROBLEM", 53, 65], ["idiosyncratic drug reactions", "PROBLEM", 67, 95], ["2Biliary tract obstructionCholelithiasis", "PROBLEM", 106, 146], ["gallstone formation", "PROBLEM", 148, 167], ["lesion", "OBSERVATION", 25, 31], ["toxic", "OBSERVATION_MODIFIER", 53, 58], ["injury", "OBSERVATION", 59, 65], ["tract obstruction", "OBSERVATION", 115, 132], ["Cholelithiasis", "OBSERVATION", 132, 146], ["gallstone", "OBSERVATION", 148, 157]]], ["The choleliths usually form in the gallbladder and are composed of a mixture of cholesterols, bile pigments, salts of bile acids, calcium salts, and a proteinaceous matrix.", [["choleliths", "ANATOMY", 4, 14], ["gallbladder", "ANATOMY", 35, 46], ["bile pigments", "ANATOMY", 94, 107], ["bile", "ANATOMY", 118, 122], ["matrix", "ANATOMY", 165, 171], ["choleliths", "DISEASE", 4, 14], ["bile acids", "CHEMICAL", 118, 128], ["calcium salts", "CHEMICAL", 130, 143], ["cholesterols", "CHEMICAL", 80, 92], ["bile acids", "CHEMICAL", 118, 128], ["calcium", "CHEMICAL", 130, 137], ["gallbladder", "ORGAN", 35, 46], ["cholesterols", "SIMPLE_CHEMICAL", 80, 92], ["bile pigments", "SIMPLE_CHEMICAL", 94, 107], ["salts", "SIMPLE_CHEMICAL", 109, 114], ["bile acids", "SIMPLE_CHEMICAL", 118, 128], ["calcium salts", "SIMPLE_CHEMICAL", 130, 143], ["matrix", "CELLULAR_COMPONENT", 165, 171], ["bile acids", "TEST", 118, 128], ["calcium salts", "TREATMENT", 130, 143], ["a proteinaceous matrix", "PROBLEM", 149, 171], ["gallbladder", "ANATOMY", 35, 46], ["cholesterols", "OBSERVATION", 80, 92], ["bile", "ANATOMY", 94, 98], ["bile", "ANATOMY", 118, 122], ["proteinaceous matrix", "OBSERVATION", 151, 171]]], ["Choleliths of mixed composition are yellow-black or green-black and are friable.", [["Choleliths", "DISEASE", 0, 10], ["black", "PROBLEM", 43, 48], ["friable", "PROBLEM", 72, 79], ["mixed", "OBSERVATION_MODIFIER", 14, 19], ["composition", "OBSERVATION_MODIFIER", 20, 31], ["yellow", "OBSERVATION_MODIFIER", 36, 42], ["black", "OBSERVATION_MODIFIER", 43, 48], ["black", "OBSERVATION_MODIFIER", 58, 63], ["friable", "OBSERVATION", 72, 79]]], ["Pigment stones, composed of calcium bilirubinate, and cholesterol stones have also been reported in dogs.", [["Pigment stones", "ANATOMY", 0, 14], ["cholesterol stones", "ANATOMY", 54, 72], ["Pigment stones", "DISEASE", 0, 14], ["calcium", "CHEMICAL", 28, 35], ["cholesterol", "CHEMICAL", 54, 65], ["calcium bilirubinate", "CHEMICAL", 28, 48], ["cholesterol", "CHEMICAL", 54, 65], ["calcium bilirubinate", "SIMPLE_CHEMICAL", 28, 48], ["cholesterol stones", "SIMPLE_CHEMICAL", 54, 72], ["dogs", "ORGANISM", 100, 104], ["dogs", "SPECIES", 100, 104], ["Pigment stones", "PROBLEM", 0, 14], ["calcium bilirubinate", "PROBLEM", 28, 48], ["cholesterol stones", "PROBLEM", 54, 72], ["stones", "OBSERVATION", 8, 14], ["calcium bilirubinate", "OBSERVATION", 28, 48], ["cholesterol", "OBSERVATION_MODIFIER", 54, 65], ["stones", "OBSERVATION", 66, 72]]], ["There may be hundreds of small stones or a few large ones.", [["stones", "ANATOMY", 31, 37], ["small stones", "PROBLEM", 25, 37], ["a few large ones", "PROBLEM", 41, 57], ["may be", "UNCERTAINTY", 6, 12], ["hundreds", "OBSERVATION_MODIFIER", 13, 21], ["small", "OBSERVATION_MODIFIER", 25, 30], ["stones", "OBSERVATION", 31, 37], ["few", "OBSERVATION_MODIFIER", 43, 46], ["large", "OBSERVATION_MODIFIER", 47, 52], ["ones", "OBSERVATION", 53, 57]]], ["The large stones are usually faceted.", [["stones", "ANATOMY", 10, 16], ["The large stones", "PROBLEM", 0, 16], ["large", "OBSERVATION_MODIFIER", 4, 9], ["stones", "OBSERVATION", 10, 16], ["faceted", "OBSERVATION_MODIFIER", 29, 36]]], ["The origin of these mixed gallstones is uncertain, but their development is probably secondary to chronic mild cholecystitis and related to disturbances of the resorptive activities of the gallbladder, whereby the bile salts are removed faster than the stone-forming compounds.", [["gallbladder", "ANATOMY", 189, 200], ["bile", "ANATOMY", 214, 218], ["stone", "ANATOMY", 253, 258], ["gallstones", "DISEASE", 26, 36], ["cholecystitis", "DISEASE", 111, 124], ["bile salts", "CHEMICAL", 214, 224], ["bile salts", "CHEMICAL", 214, 224], ["gallbladder", "ORGAN", 189, 200], ["bile salts", "SIMPLE_CHEMICAL", 214, 224], ["these mixed gallstones", "PROBLEM", 14, 36], ["chronic mild cholecystitis", "PROBLEM", 98, 124], ["disturbances of the resorptive activities of the gallbladder", "PROBLEM", 140, 200], ["the bile salts", "TREATMENT", 210, 224], ["the stone", "PROBLEM", 249, 258], ["origin", "ANATOMY_MODIFIER", 4, 10], ["mixed", "OBSERVATION_MODIFIER", 20, 25], ["gallstones", "OBSERVATION", 26, 36], ["probably secondary to", "UNCERTAINTY", 76, 97], ["chronic", "OBSERVATION_MODIFIER", 98, 105], ["mild", "OBSERVATION_MODIFIER", 106, 110], ["cholecystitis", "OBSERVATION", 111, 124], ["resorptive", "OBSERVATION_MODIFIER", 160, 170], ["activities", "OBSERVATION_MODIFIER", 171, 181], ["gallbladder", "ANATOMY", 189, 200], ["bile", "ANATOMY", 214, 218], ["stone", "OBSERVATION", 253, 258], ["compounds", "OBSERVATION_MODIFIER", 267, 276]]], ["Gallstones are usually asymptomatic.", [["Gallstones", "DISEASE", 0, 10], ["Gallstones", "PROBLEM", 0, 10], ["asymptomatic", "OBSERVATION_MODIFIER", 23, 35]]], ["Occasionally, they lodge in and obstruct bile ducts and cause jaundice.", [["bile ducts", "ANATOMY", 41, 51], ["jaundice", "DISEASE", 62, 70], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 41, 51], ["bile ducts", "PROBLEM", 41, 51], ["jaundice", "PROBLEM", 62, 70], ["bile ducts", "ANATOMY", 41, 51], ["jaundice", "OBSERVATION", 62, 70]]], ["The larger stones may cause pressure necrosis and ulceration of the mucosa, local dilations of the bile ducts, and saccular diverticula of the gallbladder.", [["stones", "ANATOMY", 11, 17], ["mucosa", "ANATOMY", 68, 74], ["bile ducts", "ANATOMY", 99, 109], ["saccular diverticula", "ANATOMY", 115, 135], ["gallbladder", "ANATOMY", 143, 154], ["necrosis", "DISEASE", 37, 45], ["saccular diverticula of the gallbladder", "DISEASE", 115, 154], ["mucosa", "MULTI-TISSUE_STRUCTURE", 68, 74], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 99, 109], ["saccular diverticula", "PATHOLOGICAL_FORMATION", 115, 135], ["gallbladder", "ORGAN", 143, 154], ["The larger stones", "PROBLEM", 0, 17], ["pressure necrosis", "PROBLEM", 28, 45], ["ulceration of the mucosa", "PROBLEM", 50, 74], ["local dilations of the bile ducts", "PROBLEM", 76, 109], ["saccular diverticula of the gallbladder", "PROBLEM", 115, 154], ["larger", "OBSERVATION_MODIFIER", 4, 10], ["stones", "OBSERVATION", 11, 17], ["may cause", "UNCERTAINTY", 18, 27], ["pressure", "OBSERVATION_MODIFIER", 28, 36], ["necrosis", "OBSERVATION", 37, 45], ["ulceration", "OBSERVATION", 50, 60], ["mucosa", "ANATOMY", 68, 74], ["local", "OBSERVATION_MODIFIER", 76, 81], ["dilations", "OBSERVATION", 82, 91], ["bile ducts", "ANATOMY", 99, 109], ["saccular", "OBSERVATION_MODIFIER", 115, 123], ["diverticula", "OBSERVATION", 124, 135], ["gallbladder", "ANATOMY", 143, 154]]], ["Calculi seldom form in the ducts, although calcareous deposits often do so in fascioliasis of cattle.", [["ducts", "ANATOMY", 27, 32], ["fascioliasis", "DISEASE", 78, 90], ["ducts", "MULTI-TISSUE_STRUCTURE", 27, 32], ["cattle", "ORGANISM", 94, 100], ["cattle", "SPECIES", 94, 100], ["cattle", "SPECIES", 94, 100], ["Calculi seldom form in the ducts", "PROBLEM", 0, 32], ["calcareous deposits", "PROBLEM", 43, 62], ["ducts", "ANATOMY", 27, 32], ["calcareous", "OBSERVATION_MODIFIER", 43, 53], ["deposits", "OBSERVATION", 54, 62], ["fascioliasis", "OBSERVATION", 78, 90]]], ["Calcium bilirubinate calculi have been reported in the bile ducts of horses ( Fig. 2-65) , associated with intermittent jaundice.Biliary tract obstructionOccasionally, particles of solid ingesta may find their way into the gallbladder; sand has been seen in sheep, and seeds in pigs.Biliary tract obstructionBiliary obstruction is rarely caused by impacted gallstones.", [["bile ducts", "ANATOMY", 55, 65], ["Biliary tract", "ANATOMY", 129, 142], ["solid ingesta", "ANATOMY", 181, 194], ["gallbladder", "ANATOMY", 223, 234], ["Biliary tract", "ANATOMY", 283, 296], ["Calcium", "CHEMICAL", 0, 7], ["intermittent jaundice", "DISEASE", 107, 128], ["Biliary tract obstructionOccasionally", "DISEASE", 129, 166], ["Biliary tract obstructionBiliary obstruction", "DISEASE", 283, 327], ["gallstones", "DISEASE", 357, 367], ["Calcium", "CHEMICAL", 0, 7], ["Calcium", "SIMPLE_CHEMICAL", 0, 7], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 55, 65], ["Biliary tract", "PATHOLOGICAL_FORMATION", 129, 142], ["gallbladder", "ORGAN", 223, 234], ["sheep", "ORGANISM", 258, 263], ["seeds", "ORGANISM_SUBDIVISION", 269, 274], ["pigs", "ORGANISM", 278, 282], ["Biliary tract", "PATHOLOGICAL_FORMATION", 283, 296], ["gallstones", "PATHOLOGICAL_FORMATION", 357, 367], ["sheep", "SPECIES", 258, 263], ["pigs", "SPECIES", 278, 282], ["sheep", "SPECIES", 258, 263], ["pigs", "SPECIES", 278, 282], ["Calcium bilirubinate calculi", "PROBLEM", 0, 28], ["intermittent jaundice", "PROBLEM", 107, 128], ["Biliary tract obstructionOccasionally", "PROBLEM", 129, 166], ["solid ingesta", "PROBLEM", 181, 194], ["Biliary tract obstructionBiliary obstruction", "PROBLEM", 283, 327], ["impacted gallstones", "PROBLEM", 348, 367], ["calculi", "OBSERVATION", 21, 28], ["bile ducts", "ANATOMY", 55, 65], ["intermittent", "OBSERVATION_MODIFIER", 107, 119], ["jaundice", "OBSERVATION", 120, 128], ["tract", "OBSERVATION", 137, 142], ["particles", "OBSERVATION_MODIFIER", 168, 177], ["solid ingesta", "OBSERVATION", 181, 194], ["gallbladder", "ANATOMY", 223, 234], ["tract", "OBSERVATION", 291, 296], ["obstruction", "OBSERVATION", 316, 327], ["impacted", "OBSERVATION_MODIFIER", 348, 356], ["gallstones", "OBSERVATION", 357, 367]]], ["Usually, it is the result of cholangitis or cholecystitis, the obstruction being produced by masses of detritus and biliary constituents, parasites, or cicatricial stenosis of the ducts.", [["masses", "ANATOMY", 93, 99], ["detritus", "ANATOMY", 103, 111], ["biliary", "ANATOMY", 116, 123], ["parasites", "ANATOMY", 138, 147], ["ducts", "ANATOMY", 180, 185], ["cholangitis", "DISEASE", 29, 40], ["cholecystitis", "DISEASE", 44, 57], ["obstruction", "DISEASE", 63, 74], ["stenosis of the ducts", "DISEASE", 164, 185], ["biliary", "PATHOLOGICAL_FORMATION", 116, 123], ["ducts", "MULTI-TISSUE_STRUCTURE", 180, 185], ["cholangitis", "PROBLEM", 29, 40], ["cholecystitis", "PROBLEM", 44, 57], ["the obstruction", "PROBLEM", 59, 74], ["masses of detritus", "PROBLEM", 93, 111], ["biliary constituents", "PROBLEM", 116, 136], ["parasites", "PROBLEM", 138, 147], ["cicatricial stenosis of the ducts", "PROBLEM", 152, 185], ["cholangitis", "OBSERVATION", 29, 40], ["cholecystitis", "OBSERVATION", 44, 57], ["obstruction", "OBSERVATION", 63, 74], ["masses", "OBSERVATION", 93, 99], ["detritus", "OBSERVATION", 103, 111], ["biliary", "ANATOMY", 116, 123], ["parasites", "OBSERVATION_MODIFIER", 138, 147], ["cicatricial", "OBSERVATION_MODIFIER", 152, 163], ["stenosis", "OBSERVATION", 164, 172], ["ducts", "ANATOMY", 180, 185]]], ["Adult ascarids may cause mechanical obstruction.", [["ascarids", "ANATOMY", 6, 14], ["ascarids", "DISEASE", 6, 14], ["mechanical obstruction", "DISEASE", 25, 47], ["Adult ascarids", "TREATMENT", 0, 14], ["mechanical obstruction", "PROBLEM", 25, 47], ["may cause", "UNCERTAINTY", 15, 24], ["mechanical", "OBSERVATION_MODIFIER", 25, 35], ["obstruction", "OBSERVATION", 36, 47]]], ["Inspissated bile-stained friable plugs are occasionally responsible for obstructions in segments of the liver in horses.", [["friable plugs", "ANATOMY", 25, 38], ["liver", "ANATOMY", 104, 109], ["bile", "PATHOLOGICAL_FORMATION", 12, 16], ["friable plugs", "PATHOLOGICAL_FORMATION", 25, 38], ["obstructions", "PATHOLOGICAL_FORMATION", 72, 84], ["liver", "ORGAN", 104, 109], ["Inspissated bile-stained friable plugs", "PROBLEM", 0, 38], ["obstructions in segments of the liver in horses", "PROBLEM", 72, 119], ["bile", "ANATOMY", 12, 16], ["stained", "OBSERVATION_MODIFIER", 17, 24], ["friable", "OBSERVATION_MODIFIER", 25, 32], ["plugs", "OBSERVATION", 33, 38], ["occasionally responsible for", "UNCERTAINTY", 43, 71], ["obstructions", "OBSERVATION", 72, 84], ["segments", "ANATOMY_MODIFIER", 88, 96], ["liver", "ANATOMY", 104, 109], ["horses", "ANATOMY_MODIFIER", 113, 119]]], ["Tumors of the pancreas and duodenum, and tumors and abscesses of the hilus of the liver and portal nodes, may cause compression stenosis of the ducts.", [["Tumors", "ANATOMY", 0, 6], ["pancreas", "ANATOMY", 14, 22], ["duodenum", "ANATOMY", 27, 35], ["tumors", "ANATOMY", 41, 47], ["abscesses", "ANATOMY", 52, 61], ["hilus", "ANATOMY", 69, 74], ["liver", "ANATOMY", 82, 87], ["portal nodes", "ANATOMY", 92, 104], ["ducts", "ANATOMY", 144, 149], ["Tumors of the pancreas and duodenum", "DISEASE", 0, 35], ["tumors", "DISEASE", 41, 47], ["abscesses", "DISEASE", 52, 61], ["compression stenosis of the ducts", "DISEASE", 116, 149], ["Tumors", "CANCER", 0, 6], ["pancreas", "ORGAN", 14, 22], ["duodenum", "ORGAN", 27, 35], ["tumors", "CANCER", 41, 47], ["hilus", "MULTI-TISSUE_STRUCTURE", 69, 74], ["liver", "ORGAN", 82, 87], ["portal nodes", "MULTI-TISSUE_STRUCTURE", 92, 104], ["ducts", "MULTI-TISSUE_STRUCTURE", 144, 149], ["Tumors of the pancreas and duodenum", "PROBLEM", 0, 35], ["tumors", "PROBLEM", 41, 47], ["abscesses of the hilus of the liver and portal nodes", "PROBLEM", 52, 104], ["compression stenosis of the ducts", "PROBLEM", 116, 149], ["pancreas", "ANATOMY", 14, 22], ["duodenum", "ANATOMY", 27, 35], ["tumors", "OBSERVATION", 41, 47], ["abscesses", "OBSERVATION", 52, 61], ["hilus", "ANATOMY_MODIFIER", 69, 74], ["liver", "ANATOMY", 82, 87], ["portal nodes", "ANATOMY", 92, 104], ["may cause", "UNCERTAINTY", 106, 115], ["compression", "OBSERVATION_MODIFIER", 116, 127], ["stenosis", "OBSERVATION", 128, 136], ["ducts", "ANATOMY", 144, 149]]], ["Edematous swelling of the papilla in enteritis may also be of tree associated with ascending bacterial infection, and in cats, the condition often occurs in conjunction with other disorders, including acute extrahepatic bile duct obstruction, pancreatitis, or inflammatory bowel disease.", [["papilla", "ANATOMY", 26, 33], ["extrahepatic bile duct", "ANATOMY", 207, 229], ["bowel", "ANATOMY", 273, 278], ["swelling", "DISEASE", 10, 18], ["enteritis", "DISEASE", 37, 46], ["ascending bacterial infection", "DISEASE", 83, 112], ["acute extrahepatic bile duct obstruction", "DISEASE", 201, 241], ["pancreatitis", "DISEASE", 243, 255], ["inflammatory bowel disease", "DISEASE", 260, 286], ["papilla", "MULTI-TISSUE_STRUCTURE", 26, 33], ["cats", "ORGANISM", 121, 125], ["bile duct", "MULTI-TISSUE_STRUCTURE", 220, 229], ["bowel", "ORGAN", 273, 278], ["cats", "SPECIES", 121, 125], ["Edematous swelling of the papilla", "PROBLEM", 0, 33], ["enteritis", "PROBLEM", 37, 46], ["ascending bacterial infection", "PROBLEM", 83, 112], ["other disorders", "PROBLEM", 174, 189], ["acute extrahepatic bile duct obstruction", "PROBLEM", 201, 241], ["pancreatitis", "PROBLEM", 243, 255], ["inflammatory bowel disease", "PROBLEM", 260, 286], ["swelling", "OBSERVATION", 10, 18], ["papilla", "ANATOMY", 26, 33], ["enteritis", "OBSERVATION", 37, 46], ["may also be of", "UNCERTAINTY", 47, 61], ["ascending", "OBSERVATION_MODIFIER", 83, 92], ["bacterial", "OBSERVATION_MODIFIER", 93, 102], ["infection", "OBSERVATION", 103, 112], ["acute", "OBSERVATION_MODIFIER", 201, 206], ["extrahepatic", "ANATOMY_MODIFIER", 207, 219], ["bile duct", "ANATOMY", 220, 229], ["obstruction", "OBSERVATION", 230, 241], ["pancreatitis", "OBSERVATION", 243, 255], ["inflammatory", "OBSERVATION_MODIFIER", 260, 272], ["bowel", "ANATOMY", 273, 278], ["disease", "OBSERVATION", 279, 286]]], ["In the cat, the biliary and pancreatic ducts share a common entry to the duodenum, and simultaneous infectious inflammation of these systems is common.", [["biliary", "ANATOMY", 16, 23], ["pancreatic ducts", "ANATOMY", 28, 44], ["duodenum", "ANATOMY", 73, 81], ["biliary and pancreatic ducts", "DISEASE", 16, 44], ["inflammation", "DISEASE", 111, 123], ["cat", "ORGANISM", 7, 10], ["biliary", "MULTI-TISSUE_STRUCTURE", 16, 23], ["pancreatic ducts", "MULTI-TISSUE_STRUCTURE", 28, 44], ["duodenum", "ORGAN", 73, 81], ["simultaneous infectious inflammation of these systems", "PROBLEM", 87, 140], ["biliary", "ANATOMY", 16, 23], ["pancreatic ducts", "ANATOMY", 28, 44], ["common", "OBSERVATION", 53, 59], ["duodenum", "ANATOMY", 73, 81], ["simultaneous", "OBSERVATION_MODIFIER", 87, 99], ["infectious", "OBSERVATION", 100, 110]]], ["Escherichia coli is the most frequent bacterial isolate; however, Bacteroides, Klebsiella, hemolytic Streptococcus, and clostridia have also been reported.", [["Bacteroides", "CHEMICAL", 66, 77], ["hemolytic Streptococcus", "DISEASE", 91, 114], ["Escherichia coli", "ORGANISM", 0, 16], ["Bacteroides", "ORGANISM", 66, 77], ["Klebsiella, hemolytic Streptococcus", "ORGANISM", 79, 114], ["Escherichia coli", "SPECIES", 0, 16], ["Escherichia coli", "SPECIES", 0, 16], ["Escherichia coli", "PROBLEM", 0, 16], ["the most frequent bacterial isolate", "PROBLEM", 20, 55], ["Bacteroides", "PROBLEM", 66, 77], ["Klebsiella", "PROBLEM", 79, 89], ["hemolytic Streptococcus", "PROBLEM", 91, 114], ["clostridia", "PROBLEM", 120, 130], ["coli", "OBSERVATION", 12, 16], ["most frequent", "OBSERVATION_MODIFIER", 24, 37], ["bacterial isolate", "OBSERVATION", 38, 55], ["Klebsiella", "OBSERVATION_MODIFIER", 79, 89], ["hemolytic Streptococcus", "OBSERVATION", 91, 114]]], ["The acute stage is characterized by edema and neutrophilic portal infiltrates, inflammation and degeneration of bile ducts with neutrophils in ductular lumens and emigrating through the ductular epithelium.", [["edema", "ANATOMY", 36, 41], ["neutrophilic portal infiltrates", "ANATOMY", 46, 77], ["bile ducts", "ANATOMY", 112, 122], ["neutrophils", "ANATOMY", 128, 139], ["ductular lumens", "ANATOMY", 143, 158], ["ductular epithelium", "ANATOMY", 186, 205], ["edema", "DISEASE", 36, 41], ["inflammation", "DISEASE", 79, 91], ["degeneration of bile ducts", "DISEASE", 96, 122], ["edema", "PATHOLOGICAL_FORMATION", 36, 41], ["neutrophilic portal infiltrates", "PATHOLOGICAL_FORMATION", 46, 77], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 112, 122], ["neutrophils", "CELL", 128, 139], ["ductular lumens", "TISSUE", 143, 158], ["ductular epithelium", "TISSUE", 186, 205], ["neutrophils", "CELL_TYPE", 128, 139], ["edema", "PROBLEM", 36, 41], ["neutrophilic portal infiltrates", "PROBLEM", 46, 77], ["inflammation", "PROBLEM", 79, 91], ["degeneration of bile ducts", "PROBLEM", 96, 122], ["neutrophils in ductular lumens", "PROBLEM", 128, 158], ["acute", "OBSERVATION_MODIFIER", 4, 9], ["edema", "OBSERVATION", 36, 41], ["neutrophilic", "OBSERVATION_MODIFIER", 46, 58], ["portal", "ANATOMY", 59, 65], ["infiltrates", "OBSERVATION", 66, 77], ["inflammation", "OBSERVATION", 79, 91], ["degeneration", "OBSERVATION", 96, 108], ["bile ducts", "ANATOMY", 112, 122], ["neutrophils", "OBSERVATION", 128, 139], ["ductular lumens", "OBSERVATION", 143, 158], ["ductular", "ANATOMY_MODIFIER", 186, 194], ["epithelium", "ANATOMY_MODIFIER", 195, 205]]], ["Some cases may progress to cholangiohepatitis, with infiltration of inflammatory cells into hepatic lobules and periportal hepatocellular necrosis.", [["inflammatory cells", "ANATOMY", 68, 86], ["hepatic lobules", "ANATOMY", 92, 107], ["periportal hepatocellular", "ANATOMY", 112, 137], ["cholangiohepatitis", "DISEASE", 27, 45], ["periportal hepatocellular necrosis", "DISEASE", 112, 146], ["inflammatory cells", "CELL", 68, 86], ["hepatic lobules", "TISSUE", 92, 107], ["periportal hepatocellular necrosis", "CANCER", 112, 146], ["inflammatory cells", "CELL_TYPE", 68, 86], ["cholangiohepatitis", "PROBLEM", 27, 45], ["infiltration of inflammatory cells into hepatic lobules", "PROBLEM", 52, 107], ["periportal hepatocellular necrosis", "PROBLEM", 112, 146], ["infiltration", "OBSERVATION", 52, 64], ["inflammatory cells", "OBSERVATION", 68, 86], ["hepatic", "ANATOMY", 92, 99], ["lobules", "ANATOMY_MODIFIER", 100, 107], ["periportal", "ANATOMY_MODIFIER", 112, 122], ["hepatocellular", "ANATOMY", 123, 137], ["necrosis", "OBSERVATION", 138, 146]]], ["Areas of suppuration and hepatic abscessation may occur.", [["hepatic", "ANATOMY", 25, 32], ["suppuration", "DISEASE", 9, 20], ["hepatic abscessation", "DISEASE", 25, 45], ["hepatic", "ORGAN", 25, 32], ["suppuration", "PROBLEM", 9, 20], ["hepatic abscessation", "PROBLEM", 25, 45], ["suppuration", "OBSERVATION", 9, 20], ["hepatic", "ANATOMY", 25, 32], ["abscessation", "OBSERVATION", 33, 45]]], ["Mixed cholangiohepatitis, with neutrophils, lymphocytes, and plasma cells infiltrating portal areas accompanied by bile duct proliferation, biliary epithelial degeneration, and various degrees of periportal to bridging fibrosis, may represent the subacute stage ( Fig. 2-63) , whereas concentric periportal fibrosis and pseudolobule formation may represent the most chronic stage of the disease.Biliary tract obstructionAn apparently distinct condition of cats, lymphocytic cholangitis (lymphocytic portal hepatitis, nonsuppurative cholangitis/ cholangiohepatitis) is a slowly progressive disease characterized by lymphocytic infiltrates within the portal area, with variable degrees of bile duct or oval cell proliferation and peribiliary, portal-to-bridging fibrosis (Fig. 2-64 ).", [["neutrophils", "ANATOMY", 31, 42], ["lymphocytes", "ANATOMY", 44, 55], ["plasma cells", "ANATOMY", 61, 73], ["portal areas", "ANATOMY", 87, 99], ["bile duct", "ANATOMY", 115, 124], ["biliary epithelial", "ANATOMY", 140, 158], ["periportal", "ANATOMY", 196, 206], ["periportal", "ANATOMY", 296, 306], ["pseudolobule", "ANATOMY", 320, 332], ["Biliary tract", "ANATOMY", 395, 408], ["lymphocytic cholangitis", "ANATOMY", 462, 485], ["lymphocytic infiltrates", "ANATOMY", 614, 637], ["portal area", "ANATOMY", 649, 660], ["bile duct", "ANATOMY", 687, 696], ["oval cell", "ANATOMY", 700, 709], ["peribiliary", "ANATOMY", 728, 739], ["portal", "ANATOMY", 741, 747], ["cholangiohepatitis", "DISEASE", 6, 24], ["biliary epithelial degeneration", "DISEASE", 140, 171], ["fibrosis", "DISEASE", 219, 227], ["fibrosis", "DISEASE", 307, 315], ["pseudolobule", "DISEASE", 320, 332], ["Biliary tract obstructionAn", "DISEASE", 395, 422], ["lymphocytic cholangitis", "DISEASE", 462, 485], ["lymphocytic portal hepatitis", "DISEASE", 487, 515], ["cholangitis", "DISEASE", 532, 543], ["cholangiohepatitis", "DISEASE", 545, 563], ["fibrosis", "DISEASE", 760, 768], ["neutrophils", "CELL", 31, 42], ["lymphocytes", "CELL", 44, 55], ["plasma cells", "CELL", 61, 73], ["portal areas", "MULTI-TISSUE_STRUCTURE", 87, 99], ["bile duct", "MULTI-TISSUE_STRUCTURE", 115, 124], ["biliary epithelial", "TISSUE", 140, 158], ["periportal", "MULTI-TISSUE_STRUCTURE", 296, 306], ["pseudolobule", "CANCER", 320, 332], ["Biliary tract", "PATHOLOGICAL_FORMATION", 395, 408], ["cats", "ORGANISM", 456, 460], ["lymphocytic cholangitis", "PATHOLOGICAL_FORMATION", 462, 485], ["lymphocytic portal", "PATHOLOGICAL_FORMATION", 487, 505], ["lymphocytic infiltrates", "PATHOLOGICAL_FORMATION", 614, 637], ["portal area", "MULTI-TISSUE_STRUCTURE", 649, 660], ["bile duct", "MULTI-TISSUE_STRUCTURE", 687, 696], ["oval cell", "CELL", 700, 709], ["neutrophils", "CELL_TYPE", 31, 42], ["lymphocytes", "CELL_TYPE", 44, 55], ["plasma cells", "CELL_TYPE", 61, 73], ["cats", "SPECIES", 456, 460], ["Mixed cholangiohepatitis", "PROBLEM", 0, 24], ["neutrophils", "TEST", 31, 42], ["lymphocytes", "TEST", 44, 55], ["plasma cells infiltrating portal areas", "PROBLEM", 61, 99], ["bile duct proliferation", "PROBLEM", 115, 138], ["biliary epithelial degeneration", "PROBLEM", 140, 171], ["periportal to bridging fibrosis", "PROBLEM", 196, 227], ["the subacute stage ( Fig. 2", "PROBLEM", 243, 270], ["concentric periportal fibrosis", "PROBLEM", 285, 315], ["pseudolobule formation", "PROBLEM", 320, 342], ["the disease", "PROBLEM", 383, 394], ["Biliary tract obstructionAn", "PROBLEM", 395, 422], ["distinct condition of cats", "PROBLEM", 434, 460], ["lymphocytic cholangitis", "PROBLEM", 462, 485], ["lymphocytic portal hepatitis", "PROBLEM", 487, 515], ["nonsuppurative cholangitis", "PROBLEM", 517, 543], ["cholangiohepatitis", "PROBLEM", 545, 563], ["a slowly progressive disease", "PROBLEM", 568, 596], ["lymphocytic infiltrates within the portal area", "PROBLEM", 614, 660], ["variable degrees of bile duct", "PROBLEM", 667, 696], ["oval cell proliferation", "PROBLEM", 700, 723], ["bridging fibrosis", "PROBLEM", 751, 768], ["cholangiohepatitis", "OBSERVATION", 6, 24], ["neutrophils", "OBSERVATION", 31, 42], ["lymphocytes", "ANATOMY", 44, 55], ["plasma cells", "OBSERVATION", 61, 73], ["portal", "ANATOMY", 87, 93], ["bile duct", "ANATOMY", 115, 124], ["proliferation", "OBSERVATION", 125, 138], ["biliary", "ANATOMY", 140, 147], ["epithelial", "ANATOMY_MODIFIER", 148, 158], ["degeneration", "OBSERVATION", 159, 171], ["various degrees", "OBSERVATION_MODIFIER", 177, 192], ["periportal", "ANATOMY", 196, 206], ["bridging", "OBSERVATION_MODIFIER", 210, 218], ["fibrosis", "OBSERVATION", 219, 227], ["may represent", "UNCERTAINTY", 229, 242], ["subacute", "OBSERVATION_MODIFIER", 247, 255], ["concentric", "OBSERVATION_MODIFIER", 285, 295], ["periportal", "ANATOMY", 296, 306], ["fibrosis", "OBSERVATION", 307, 315], ["pseudolobule formation", "OBSERVATION", 320, 342], ["may represent", "UNCERTAINTY", 343, 356], ["most chronic", "OBSERVATION_MODIFIER", 361, 373], ["disease", "OBSERVATION", 387, 394], ["tract", "OBSERVATION", 403, 408], ["distinct", "OBSERVATION_MODIFIER", 434, 442], ["lymphocytic cholangitis", "OBSERVATION", 462, 485], ["lymphocytic", "OBSERVATION_MODIFIER", 487, 498], ["portal", "ANATOMY", 499, 505], ["hepatitis", "OBSERVATION", 506, 515], ["nonsuppurative", "OBSERVATION_MODIFIER", 517, 531], ["cholangitis", "OBSERVATION", 532, 543], ["slowly", "OBSERVATION_MODIFIER", 570, 576], ["progressive", "OBSERVATION_MODIFIER", 577, 588], ["disease", "OBSERVATION", 589, 596], ["lymphocytic infiltrates", "OBSERVATION", 614, 637], ["portal", "ANATOMY", 649, 655], ["area", "ANATOMY_MODIFIER", 656, 660], ["variable", "OBSERVATION_MODIFIER", 667, 675], ["degrees", "OBSERVATION_MODIFIER", 676, 683], ["bile duct", "ANATOMY", 687, 696], ["oval cell proliferation", "OBSERVATION", 700, 723], ["peribiliary", "ANATOMY_MODIFIER", 728, 739], ["portal", "ANATOMY", 741, 747], ["bridging", "OBSERVATION_MODIFIER", 751, 759], ["fibrosis", "OBSERVATION", 760, 768]]], ["An immune-mediated pathogenesis has been proposed, and in one study, most cats with lymphocytic cholangitis had T-cell-predominant portal infiltrates, often with accompanying portal B-cell aggregates.", [["lymphocytic cholangitis", "ANATOMY", 84, 107], ["T-cell", "ANATOMY", 112, 118], ["portal infiltrates", "ANATOMY", 131, 149], ["portal B-cell aggregates", "ANATOMY", 175, 199], ["lymphocytic cholangitis", "DISEASE", 84, 107], ["cats", "ORGANISM", 74, 78], ["lymphocytic cholangitis", "CANCER", 84, 107], ["T-cell", "CELL", 112, 118], ["portal infiltrates", "PATHOLOGICAL_FORMATION", 131, 149], ["portal B-cell aggregates", "CELL", 175, 199], ["cats", "SPECIES", 74, 78], ["one study", "TEST", 58, 67], ["lymphocytic cholangitis", "PROBLEM", 84, 107], ["portal infiltrates", "PROBLEM", 131, 149], ["accompanying portal B-cell aggregates", "PROBLEM", 162, 199], ["lymphocytic cholangitis", "OBSERVATION", 84, 107], ["-cell", "OBSERVATION_MODIFIER", 113, 118], ["predominant", "OBSERVATION_MODIFIER", 119, 130], ["portal", "ANATOMY", 131, 137], ["infiltrates", "OBSERVATION", 138, 149], ["portal", "ANATOMY", 175, 181], ["B-cell aggregates", "OBSERVATION", 182, 199]]], ["The presence of various degrees of lymphocytic targeting and infiltration of bile ductules with concurrent degenerative changes in ductular epithelium, destructive cholangitis leading to ductopenia, and portal lipogranulomas may be useful in distinguishing this condition from hepatic lymphoma in the cat, along with T-cell receptor clonality assays.Biliary tract obstructionDestructive cholangitis has also been described in dogs, and is characterized by destruction and loss of bile ducts in the smaller portal tracts, with subsequent inflammationINFECTIOUS DISEASES OF THE LIVER Viral infectionsVarious systemic viral diseases may affect the liver.", [["lymphocytic", "ANATOMY", 35, 46], ["bile ductules", "ANATOMY", 77, 90], ["ductular epithelium", "ANATOMY", 131, 150], ["ductopenia", "ANATOMY", 187, 197], ["portal lipogranulomas", "ANATOMY", 203, 224], ["hepatic lymphoma", "ANATOMY", 277, 293], ["T-cell", "ANATOMY", 317, 323], ["Biliary tract", "ANATOMY", 350, 363], ["bile ducts", "ANATOMY", 480, 490], ["portal tracts", "ANATOMY", 506, 519], ["liver", "ANATOMY", 645, 650], ["cholangitis", "DISEASE", 164, 175], ["ductopenia", "DISEASE", 187, 197], ["portal lipogranulomas", "DISEASE", 203, 224], ["hepatic lymphoma", "DISEASE", 277, 293], ["Biliary tract obstruction", "DISEASE", 350, 375], ["cholangitis", "DISEASE", 387, 398], ["loss of bile ducts", "DISEASE", 472, 490], ["Viral infections", "DISEASE", 582, 598], ["viral diseases", "DISEASE", 615, 629], ["lymphocytic", "CANCER", 35, 46], ["bile ductules", "MULTI-TISSUE_STRUCTURE", 77, 90], ["ductular epithelium", "TISSUE", 131, 150], ["hepatic lymphoma", "CANCER", 277, 293], ["cat", "ORGANISM", 301, 304], ["T-cell receptor", "GENE_OR_GENE_PRODUCT", 317, 332], ["Biliary tract", "PATHOLOGICAL_FORMATION", 350, 363], ["dogs", "ORGANISM", 426, 430], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 480, 490], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 506, 519], ["liver", "ORGAN", 645, 650], ["dogs", "SPECIES", 426, 430], ["lymphocytic targeting", "PROBLEM", 35, 56], ["infiltration of bile ductules", "PROBLEM", 61, 90], ["concurrent degenerative changes in ductular epithelium", "PROBLEM", 96, 150], ["destructive cholangitis", "PROBLEM", 152, 175], ["ductopenia", "PROBLEM", 187, 197], ["portal lipogranulomas", "PROBLEM", 203, 224], ["this condition", "PROBLEM", 257, 271], ["hepatic lymphoma", "PROBLEM", 277, 293], ["Biliary tract obstruction", "PROBLEM", 350, 375], ["Destructive cholangitis", "PROBLEM", 375, 398], ["destruction", "PROBLEM", 456, 467], ["loss of bile ducts in the smaller portal tracts", "PROBLEM", 472, 519], ["subsequent inflammationINFECTIOUS DISEASES", "PROBLEM", 526, 568], ["THE LIVER Viral infections", "PROBLEM", 572, 598], ["Various systemic viral diseases", "PROBLEM", 598, 629], ["various degrees", "OBSERVATION_MODIFIER", 16, 31], ["lymphocytic", "OBSERVATION", 35, 46], ["infiltration", "OBSERVATION", 61, 73], ["bile ductules", "ANATOMY", 77, 90], ["degenerative", "OBSERVATION", 107, 119], ["ductular", "ANATOMY_MODIFIER", 131, 139], ["epithelium", "ANATOMY_MODIFIER", 140, 150], ["destructive", "OBSERVATION_MODIFIER", 152, 163], ["cholangitis", "OBSERVATION", 164, 175], ["portal", "ANATOMY", 203, 209], ["lipogranulomas", "OBSERVATION", 210, 224], ["hepatic", "ANATOMY", 277, 284], ["lymphoma", "OBSERVATION", 285, 293], ["tract", "ANATOMY_MODIFIER", 358, 363], ["obstruction", "OBSERVATION", 364, 375], ["Destructive", "OBSERVATION_MODIFIER", 375, 386], ["cholangitis", "OBSERVATION", 387, 398], ["destruction", "OBSERVATION", 456, 467], ["loss", "OBSERVATION", 472, 476], ["bile ducts", "ANATOMY", 480, 490], ["smaller", "ANATOMY_MODIFIER", 498, 505], ["portal tracts", "ANATOMY", 506, 519], ["inflammationINFECTIOUS DISEASES", "OBSERVATION", 537, 568], ["LIVER", "ANATOMY", 576, 581], ["Viral", "OBSERVATION_MODIFIER", 582, 587], ["infections", "OBSERVATION", 588, 598], ["systemic", "OBSERVATION_MODIFIER", 606, 614], ["viral diseases", "OBSERVATION", 615, 629], ["liver", "ANATOMY", 645, 650]]], ["Adenoviral infections of lambs, calves, and goat kids can cause multifocal hepatic necrosis and cholangitis, in addition to pneumonia.", [["calves", "ANATOMY", 32, 38], ["hepatic", "ANATOMY", 75, 82], ["Adenoviral infections", "DISEASE", 0, 21], ["multifocal hepatic necrosis", "DISEASE", 64, 91], ["cholangitis", "DISEASE", 96, 107], ["pneumonia", "DISEASE", 124, 133], ["Adenoviral", "ORGANISM", 0, 10], ["lambs", "ORGANISM", 25, 30], ["calves", "ORGANISM", 32, 38], ["goat", "ORGANISM", 44, 48], ["hepatic", "ORGAN", 75, 82], ["lambs", "SPECIES", 25, 30], ["calves", "SPECIES", 32, 38], ["goat", "SPECIES", 44, 48], ["Adenoviral", "SPECIES", 0, 10], ["goat", "SPECIES", 44, 48], ["Adenoviral infections of lambs, calves, and goat kids", "PROBLEM", 0, 53], ["multifocal hepatic necrosis", "PROBLEM", 64, 91], ["cholangitis", "PROBLEM", 96, 107], ["pneumonia", "PROBLEM", 124, 133], ["infections", "OBSERVATION", 11, 21], ["calves", "ANATOMY", 32, 38], ["multifocal", "OBSERVATION_MODIFIER", 64, 74], ["hepatic", "ANATOMY", 75, 82], ["necrosis", "OBSERVATION", 83, 91], ["cholangitis", "OBSERVATION", 96, 107], ["pneumonia", "OBSERVATION", 124, 133]]], ["Lymphohistiocytic hepatitis, with jaundice and various degrees of apoptosis of hepatocytes, disorganization of hepatic plates, and perilobular stromal condensation, is seen in some cases of porcine circovirus 2-associated disease ( Fig. 2-66A, B) .", [["hepatocytes", "ANATOMY", 79, 90], ["hepatic plates", "ANATOMY", 111, 125], ["perilobular stromal", "ANATOMY", 131, 150], ["Lymphohistiocytic hepatitis", "DISEASE", 0, 27], ["jaundice", "DISEASE", 34, 42], ["disorganization of hepatic plates", "DISEASE", 92, 125], ["porcine circovirus 2-associated disease", "DISEASE", 190, 229], ["hepatocytes", "CELL", 79, 90], ["porcine circovirus 2", "ORGANISM", 190, 210], ["hepatocytes", "CELL_TYPE", 79, 90], ["porcine circovirus", "SPECIES", 190, 208], ["porcine circovirus 2", "SPECIES", 190, 210], ["Lymphohistiocytic hepatitis", "PROBLEM", 0, 27], ["jaundice", "PROBLEM", 34, 42], ["apoptosis of hepatocytes", "PROBLEM", 66, 90], ["disorganization of hepatic plates", "PROBLEM", 92, 125], ["perilobular stromal condensation", "PROBLEM", 131, 163], ["porcine circovirus", "PROBLEM", 190, 208], ["associated disease", "PROBLEM", 211, 229], ["hepatitis", "OBSERVATION", 18, 27], ["jaundice", "OBSERVATION", 34, 42], ["various degrees", "OBSERVATION_MODIFIER", 47, 62], ["apoptosis", "OBSERVATION", 66, 75], ["hepatocytes", "ANATOMY", 79, 90], ["disorganization", "OBSERVATION_MODIFIER", 92, 107], ["hepatic", "ANATOMY", 111, 118], ["plates", "ANATOMY_MODIFIER", 119, 125], ["perilobular", "OBSERVATION_MODIFIER", 131, 142], ["stromal condensation", "OBSERVATION", 143, 163], ["porcine circovirus", "OBSERVATION", 190, 208]]], ["Canid herpesvirus 1 infection in puppies and, more rarely, in adult dogs causes disseminated focal necrosis and hemorrhages in parenchymal organs, including the liver, with formation of amphophilic intranuclear inclusion bodies in epithelial cells of kidney, lung, and liver.", [["parenchymal organs", "ANATOMY", 127, 145], ["liver", "ANATOMY", 161, 166], ["intranuclear inclusion bodies", "ANATOMY", 198, 227], ["epithelial cells", "ANATOMY", 231, 247], ["kidney", "ANATOMY", 251, 257], ["lung", "ANATOMY", 259, 263], ["liver", "ANATOMY", 269, 274], ["infection", "DISEASE", 20, 29], ["necrosis", "DISEASE", 99, 107], ["hemorrhages", "DISEASE", 112, 123], ["Canid herpesvirus 1", "ORGANISM", 0, 19], ["puppies", "ORGANISM", 33, 40], ["dogs", "ORGANISM", 68, 72], ["parenchymal", "TISSUE", 127, 138], ["organs", "ORGAN", 139, 145], ["liver", "ORGAN", 161, 166], ["epithelial cells", "CELL", 231, 247], ["kidney", "ORGAN", 251, 257], ["lung", "ORGAN", 259, 263], ["liver", "ORGAN", 269, 274], ["epithelial cells", "CELL_TYPE", 231, 247], ["dogs", "SPECIES", 68, 72], ["Canid herpesvirus 1", "SPECIES", 0, 19], ["Canid herpesvirus 1 infection in puppies", "PROBLEM", 0, 40], ["disseminated focal necrosis", "PROBLEM", 80, 107], ["hemorrhages in parenchymal organs", "PROBLEM", 112, 145], ["amphophilic intranuclear inclusion bodies in epithelial cells of kidney, lung, and liver", "PROBLEM", 186, 274], ["infection", "OBSERVATION", 20, 29], ["disseminated", "OBSERVATION_MODIFIER", 80, 92], ["focal", "OBSERVATION_MODIFIER", 93, 98], ["necrosis", "OBSERVATION", 99, 107], ["hemorrhages", "OBSERVATION", 112, 123], ["parenchymal", "ANATOMY_MODIFIER", 127, 138], ["organs", "ANATOMY", 139, 145], ["liver", "ANATOMY", 161, 166], ["amphophilic", "OBSERVATION_MODIFIER", 186, 197], ["intranuclear inclusion bodies", "OBSERVATION", 198, 227], ["epithelial cells", "OBSERVATION", 231, 247], ["kidney", "ANATOMY", 251, 257], ["lung", "ANATOMY", 259, 263], ["liver", "ANATOMY", 269, 274]]], ["Similar microfoci of hepatic necrosis sometimes occur in aborted or newborn foals with congenital equid herpesvirus 1 infections (Fig. 2-67) , in neonatal calves infected with bovine herpesvirus 1, in piglets with suid herpesvirus 1 infections, and in feline fetuses following significance.", [["microfoci", "ANATOMY", 8, 17], ["hepatic", "ANATOMY", 21, 28], ["fetuses", "ANATOMY", 259, 266], ["hepatic necrosis", "DISEASE", 21, 37], ["congenital equid herpesvirus 1 infections", "DISEASE", 87, 128], ["Fig. 2-67", "CHEMICAL", 130, 139], ["suid herpesvirus 1 infections", "DISEASE", 214, 243], ["hepatic", "PATHOLOGICAL_FORMATION", 21, 28], ["foals", "ORGANISM_SUBDIVISION", 76, 81], ["equid herpesvirus 1", "ORGANISM", 98, 117], ["calves", "ORGANISM", 155, 161], ["bovine herpesvirus 1", "ORGANISM", 176, 196], ["piglets", "ORGANISM", 201, 208], ["suid herpesvirus 1", "ORGANISM", 214, 232], ["feline", "ORGANISM", 252, 258], ["fetuses", "ORGAN", 259, 266], ["calves", "SPECIES", 155, 161], ["bovine", "SPECIES", 176, 182], ["piglets", "SPECIES", 201, 208], ["feline", "SPECIES", 252, 258], ["bovine herpesvirus 1", "SPECIES", 176, 196], ["suid herpesvirus 1", "SPECIES", 214, 232], ["hepatic necrosis", "PROBLEM", 21, 37], ["congenital equid herpesvirus 1 infections", "PROBLEM", 87, 128], ["neonatal calves", "PROBLEM", 146, 161], ["bovine herpesvirus 1", "PROBLEM", 176, 196], ["suid herpesvirus 1 infections", "PROBLEM", 214, 243], ["hepatic", "ANATOMY", 21, 28], ["necrosis", "OBSERVATION", 29, 37], ["congenital", "OBSERVATION_MODIFIER", 87, 97], ["equid herpesvirus", "OBSERVATION", 98, 115], ["neonatal calves", "ANATOMY", 146, 161], ["infected", "OBSERVATION", 162, 170], ["bovine herpesvirus", "OBSERVATION", 176, 194], ["infections", "OBSERVATION", 233, 243]]], ["Biliary obstruction by abnormal intraluminal mucoid secretion (gallbladder mucocele) has been reported in dogs (see later section on Ectopic, metaplastic, and hyperplastic lesions).INFECTIOUS DISEASES OF THE LIVER Viral infectionsThe consequences of biliary obstruction depend on the site and duration of the obstruction.", [["Biliary", "ANATOMY", 0, 7], ["intraluminal mucoid", "ANATOMY", 32, 51], ["gallbladder mucocele", "ANATOMY", 63, 83], ["metaplastic", "ANATOMY", 142, 153], ["hyperplastic lesions", "ANATOMY", 159, 179], ["biliary", "ANATOMY", 250, 257], ["Biliary obstruction", "DISEASE", 0, 19], ["gallbladder mucocele", "DISEASE", 63, 83], ["Viral infections", "DISEASE", 214, 230], ["biliary obstruction", "DISEASE", 250, 269], ["obstruction", "DISEASE", 309, 320], ["Biliary obstruction", "PATHOLOGICAL_FORMATION", 0, 19], ["intraluminal", "IMMATERIAL_ANATOMICAL_ENTITY", 32, 44], ["mucoid", "PATHOLOGICAL_FORMATION", 45, 51], ["gallbladder mucocele", "PATHOLOGICAL_FORMATION", 63, 83], ["dogs", "ORGANISM", 106, 110], ["metaplastic", "CANCER", 142, 153], ["hyperplastic lesions", "CANCER", 159, 179], ["biliary obstruction", "PATHOLOGICAL_FORMATION", 250, 269], ["obstruction", "PATHOLOGICAL_FORMATION", 309, 320], ["dogs", "SPECIES", 106, 110], ["Biliary obstruction", "PROBLEM", 0, 19], ["abnormal intraluminal mucoid secretion (gallbladder mucocele", "PROBLEM", 23, 83], ["Ectopic, metaplastic, and hyperplastic lesions", "PROBLEM", 133, 179], ["THE LIVER Viral infections", "PROBLEM", 204, 230], ["biliary obstruction", "PROBLEM", 250, 269], ["the obstruction", "PROBLEM", 305, 320], ["obstruction", "OBSERVATION", 8, 19], ["abnormal", "OBSERVATION_MODIFIER", 23, 31], ["intraluminal", "ANATOMY_MODIFIER", 32, 44], ["mucoid secretion", "OBSERVATION", 45, 61], ["gallbladder", "ANATOMY", 63, 74], ["mucocele", "OBSERVATION", 75, 83], ["metaplastic", "OBSERVATION", 142, 153], ["hyperplastic", "OBSERVATION_MODIFIER", 159, 171], ["lesions", "OBSERVATION", 172, 179], ["LIVER", "ANATOMY", 208, 213], ["Viral infections", "OBSERVATION", 214, 230], ["biliary", "ANATOMY", 250, 257], ["obstruction", "OBSERVATION", 258, 269], ["obstruction", "OBSERVATION", 309, 320]]], ["When the main duct is involved, there is jaundice.", [["duct", "ANATOMY", 14, 18], ["jaundice", "DISEASE", 41, 49], ["duct", "MULTI-TISSUE_STRUCTURE", 14, 18], ["jaundice", "PROBLEM", 41, 49], ["main duct", "ANATOMY", 9, 18], ["jaundice", "OBSERVATION", 41, 49]]], ["When one of the hepatic ducts is involved, there is no jaundice, and depending on the efficiency of biliary collaterals, there may be no pigmentation of the obstructed segments of liver.", [["hepatic ducts", "ANATOMY", 16, 29], ["biliary collaterals", "ANATOMY", 100, 119], ["liver", "ANATOMY", 180, 185], ["jaundice", "DISEASE", 55, 63], ["hepatic ducts", "MULTI-TISSUE_STRUCTURE", 16, 29], ["biliary collaterals", "MULTI-TISSUE_STRUCTURE", 100, 119], ["liver", "ORGAN", 180, 185], ["jaundice", "PROBLEM", 55, 63], ["pigmentation of the obstructed segments of liver", "PROBLEM", 137, 185], ["hepatic", "ANATOMY", 16, 23], ["ducts", "ANATOMY_MODIFIER", 24, 29], ["no", "UNCERTAINTY", 52, 54], ["jaundice", "OBSERVATION", 55, 63], ["biliary", "ANATOMY", 100, 107], ["collaterals", "OBSERVATION", 108, 119], ["may be no", "UNCERTAINTY", 127, 136], ["pigmentation", "OBSERVATION", 137, 149], ["obstructed", "OBSERVATION", 157, 167], ["segments", "ANATOMY_MODIFIER", 168, 176], ["liver", "ANATOMY", 180, 185]]], ["Increases in serum \u03b3-glutamyltranspeptidase and alkaline phosphatase usually occur when a sufficiently large amount of the duct system is affected.", [["serum", "ANATOMY", 13, 18], ["duct system", "ANATOMY", 123, 134], ["serum", "ORGANISM_SUBSTANCE", 13, 18], ["\u03b3-glutamyltranspeptidase", "GENE_OR_GENE_PRODUCT", 19, 43], ["alkaline phosphatase", "GENE_OR_GENE_PRODUCT", 48, 68], ["duct", "MULTI-TISSUE_STRUCTURE", 123, 127], ["serum \u03b3-glutamyltranspeptidase", "PROTEIN", 13, 43], ["alkaline phosphatase", "PROTEIN", 48, 68], ["serum \u03b3-glutamyltranspeptidase", "TEST", 13, 43], ["alkaline phosphatase", "TEST", 48, 68], ["large", "OBSERVATION_MODIFIER", 103, 108], ["amount", "OBSERVATION_MODIFIER", 109, 115], ["duct system", "ANATOMY", 123, 134]]], ["The ducts undergo progressive cylindrical dilation, which may be extreme.", [["ducts", "ANATOMY", 4, 9], ["ducts", "MULTI-TISSUE_STRUCTURE", 4, 9], ["progressive cylindrical dilation", "PROBLEM", 18, 50], ["ducts", "ANATOMY", 4, 9], ["progressive", "OBSERVATION_MODIFIER", 18, 29], ["cylindrical", "OBSERVATION_MODIFIER", 30, 41], ["dilation", "OBSERVATION", 42, 50], ["may be", "UNCERTAINTY", 58, 64], ["extreme", "OBSERVATION_MODIFIER", 65, 72]]], ["The smallest interlobular ducts and the cholangioles proliferate.", [["interlobular ducts", "ANATOMY", 13, 31], ["cholangioles", "ANATOMY", 40, 52], ["interlobular ducts", "MULTI-TISSUE_STRUCTURE", 13, 31], ["the cholangioles proliferate", "PROBLEM", 36, 64], ["smallest", "OBSERVATION_MODIFIER", 4, 12], ["interlobular", "ANATOMY_MODIFIER", 13, 25], ["ducts", "ANATOMY", 26, 31], ["cholangioles proliferate", "OBSERVATION", 40, 64]]], ["There is inflammation in the walls of the ducts and the portal triads, and this is probably due in part to chemical irritation by bile acids but is largely caused by secondary bacterial infections.", [["ducts", "ANATOMY", 42, 47], ["portal triads", "ANATOMY", 56, 69], ["inflammation", "DISEASE", 9, 21], ["bile acids", "CHEMICAL", 130, 140], ["bacterial infections", "DISEASE", 176, 196], ["bile acids", "CHEMICAL", 130, 140], ["ducts", "MULTI-TISSUE_STRUCTURE", 42, 47], ["portal triads", "MULTI-TISSUE_STRUCTURE", 56, 69], ["bile acids", "SIMPLE_CHEMICAL", 130, 140], ["inflammation in the walls of the ducts", "PROBLEM", 9, 47], ["chemical irritation", "PROBLEM", 107, 126], ["bile acids", "PROBLEM", 130, 140], ["secondary bacterial infections", "PROBLEM", 166, 196], ["inflammation", "OBSERVATION", 9, 21], ["walls", "ANATOMY_MODIFIER", 29, 34], ["ducts", "ANATOMY", 42, 47], ["portal triads", "ANATOMY", 56, 69], ["probably due in part to", "UNCERTAINTY", 83, 106], ["chemical", "OBSERVATION_MODIFIER", 107, 115], ["irritation", "OBSERVATION", 116, 126], ["bile acids", "OBSERVATION", 130, 140], ["secondary", "OBSERVATION_MODIFIER", 166, 175], ["bacterial", "OBSERVATION_MODIFIER", 176, 185], ["infections", "OBSERVATION", 186, 196]]], ["These infections may be acute and purulent, or low grade; in these cases, bacteria may not be easily cultured.", [["infections", "DISEASE", 6, 16], ["These infections", "PROBLEM", 0, 16], ["purulent", "PROBLEM", 34, 42], ["low grade", "PROBLEM", 47, 56], ["bacteria", "PROBLEM", 74, 82], ["infections", "OBSERVATION", 6, 16], ["may be", "UNCERTAINTY", 17, 23], ["acute", "OBSERVATION_MODIFIER", 24, 29], ["purulent", "OBSERVATION", 34, 42], ["low grade", "OBSERVATION_MODIFIER", 47, 56]]], ["The cholangiohepatitis that almost inevitably follows has been described previously.INFECTIOUS DISEASES OF THE LIVER Viral infectionsRupture of the biliary tract or the gallbladder causes steady leakage of bile into the peritoneal cavity, the omentum being unable to seal even small defects.", [["biliary tract", "ANATOMY", 148, 161], ["gallbladder", "ANATOMY", 169, 180], ["bile", "ANATOMY", 206, 210], ["peritoneal cavity", "ANATOMY", 220, 237], ["omentum", "ANATOMY", 243, 250], ["cholangiohepatitis", "DISEASE", 4, 22], ["Viral infections", "DISEASE", 117, 133], ["Rupture of the biliary tract", "DISEASE", 133, 161], ["biliary tract", "PATHOLOGICAL_FORMATION", 148, 161], ["gallbladder", "ORGAN", 169, 180], ["bile", "MULTI-TISSUE_STRUCTURE", 206, 210], ["peritoneal cavity", "MULTI-TISSUE_STRUCTURE", 220, 237], ["omentum", "ORGAN", 243, 250], ["The cholangiohepatitis", "PROBLEM", 0, 22], ["THE LIVER Viral infections", "PROBLEM", 107, 133], ["Rupture of the biliary tract", "PROBLEM", 133, 161], ["the gallbladder", "PROBLEM", 165, 180], ["steady leakage of bile into the peritoneal cavity", "PROBLEM", 188, 237], ["the omentum", "PROBLEM", 239, 250], ["small defects", "PROBLEM", 277, 290], ["cholangiohepatitis", "OBSERVATION", 4, 22], ["LIVER", "ANATOMY", 111, 116], ["Viral", "OBSERVATION_MODIFIER", 117, 122], ["infections", "OBSERVATION", 123, 133], ["biliary tract", "ANATOMY", 148, 161], ["gallbladder", "ANATOMY", 169, 180], ["steady", "OBSERVATION_MODIFIER", 188, 194], ["leakage", "OBSERVATION", 195, 202], ["bile", "ANATOMY", 206, 210], ["peritoneal cavity", "ANATOMY", 220, 237], ["omentum", "ANATOMY", 243, 250], ["small", "OBSERVATION_MODIFIER", 277, 282], ["defects", "OBSERVATION", 283, 290]]], ["The bile salts are very irritating and may cause acute chemical peritonitis.", [["bile", "ANATOMY", 4, 8], ["bile salts", "CHEMICAL", 4, 14], ["peritonitis", "DISEASE", 64, 75], ["bile salts", "CHEMICAL", 4, 14], ["bile salts", "SIMPLE_CHEMICAL", 4, 14], ["very irritating", "PROBLEM", 19, 34], ["acute chemical peritonitis", "PROBLEM", 49, 75], ["bile", "ANATOMY", 4, 8], ["may cause", "UNCERTAINTY", 39, 48], ["acute", "OBSERVATION_MODIFIER", 49, 54], ["chemical", "OBSERVATION_MODIFIER", 55, 63], ["peritonitis", "OBSERVATION", 64, 75]]], ["The peritoneal effusion that follows may remain sterile; more often it is infected by enteric bacteria, and severe diffuse peritonitis ensues.", [["peritoneal effusion", "ANATOMY", 4, 23], ["peritoneal effusion", "DISEASE", 4, 23], ["peritonitis", "DISEASE", 123, 134], ["peritoneal", "MULTI-TISSUE_STRUCTURE", 4, 14], ["The peritoneal effusion", "PROBLEM", 0, 23], ["enteric bacteria", "PROBLEM", 86, 102], ["severe diffuse peritonitis", "PROBLEM", 108, 134], ["peritoneal", "ANATOMY", 4, 14], ["effusion", "OBSERVATION", 15, 23], ["infected", "OBSERVATION", 74, 82], ["enteric bacteria", "OBSERVATION_MODIFIER", 86, 102], ["severe", "OBSERVATION_MODIFIER", 108, 114], ["diffuse", "OBSERVATION_MODIFIER", 115, 122], ["peritonitis", "OBSERVATION", 123, 134]]], ["This may be rapidly fatal, particularly if clostridia are involved.", [["clostridia", "PROBLEM", 43, 53], ["may be", "UNCERTAINTY", 5, 11], ["rapidly", "OBSERVATION_MODIFIER", 12, 19], ["fatal", "OBSERVATION", 20, 25]]], ["Many perforations of the biliary tract are traumatic in origin; however, in dogs, cholecystitis, gallbladder necrosis/ infarction, and gallbladder mucocele have all been associated with gallbladder rupture. as well as in birds, including some species of ducks, geese, and herons.", [["biliary tract", "ANATOMY", 25, 38], ["gallbladder", "ANATOMY", 97, 108], ["gallbladder mucocele", "ANATOMY", 135, 155], ["gallbladder", "ANATOMY", 186, 197], ["perforations of the biliary tract", "DISEASE", 5, 38], ["traumatic", "DISEASE", 43, 52], ["cholecystitis", "DISEASE", 82, 95], ["gallbladder necrosis", "DISEASE", 97, 117], ["infarction", "DISEASE", 119, 129], ["gallbladder mucocele", "DISEASE", 135, 155], ["gallbladder rupture", "DISEASE", 186, 205], ["biliary tract", "PATHOLOGICAL_FORMATION", 25, 38], ["dogs", "ORGANISM", 76, 80], ["gallbladder", "ORGAN", 97, 108], ["gallbladder mucocele", "PATHOLOGICAL_FORMATION", 135, 155], ["gallbladder", "ORGAN", 186, 197], ["birds", "ORGANISM", 221, 226], ["ducks", "ORGANISM", 254, 259], ["geese", "ORGANISM", 261, 266], ["herons", "ORGANISM", 272, 278], ["dogs", "SPECIES", 76, 80], ["ducks", "SPECIES", 254, 259], ["Many perforations of the biliary tract", "PROBLEM", 0, 38], ["traumatic", "PROBLEM", 43, 52], ["cholecystitis", "PROBLEM", 82, 95], ["gallbladder necrosis", "PROBLEM", 97, 117], ["infarction", "PROBLEM", 119, 129], ["gallbladder mucocele", "PROBLEM", 135, 155], ["gallbladder rupture", "PROBLEM", 186, 205], ["some species of ducks", "PROBLEM", 238, 259], ["perforations", "OBSERVATION", 5, 17], ["biliary tract", "ANATOMY", 25, 38], ["traumatic", "OBSERVATION", 43, 52], ["origin", "OBSERVATION_MODIFIER", 56, 62], ["cholecystitis", "OBSERVATION", 82, 95], ["gallbladder", "ANATOMY", 97, 108], ["necrosis", "OBSERVATION", 109, 117], ["infarction", "OBSERVATION", 119, 129], ["gallbladder", "ANATOMY", 135, 146], ["mucocele", "OBSERVATION", 147, 155], ["gallbladder", "ANATOMY", 186, 197], ["rupture", "OBSERVATION", 198, 205]]], ["Infection with hepatitis E virus (HEV) genotypes 3 and 4 is common in domestic and wild pigs, and although clinical disease is not apparent in infected swine, they may serve as reservoirs for this potentially zoonotic pathogen.", [["Infection with hepatitis E", "DISEASE", 0, 26], ["hepatitis E virus", "ORGANISM", 15, 32], ["HEV", "ORGANISM", 34, 37], ["pigs", "ORGANISM", 88, 92], ["swine", "ORGANISM", 152, 157], ["hepatitis E virus", "SPECIES", 15, 32], ["pigs", "SPECIES", 88, 92], ["swine", "SPECIES", 152, 157], ["hepatitis E virus", "SPECIES", 15, 32], ["HEV", "SPECIES", 34, 37], ["pigs", "SPECIES", 88, 92], ["swine", "SPECIES", 152, 157], ["Infection", "PROBLEM", 0, 9], ["hepatitis E virus", "PROBLEM", 15, 32], ["clinical disease", "PROBLEM", 107, 123], ["this potentially zoonotic pathogen", "PROBLEM", 192, 226], ["hepatitis", "OBSERVATION", 15, 24], ["wild pigs", "OBSERVATION", 83, 92], ["not apparent", "UNCERTAINTY", 127, 139]]], ["Lesions of mild multifocal lymphoplasmacytic hepatitis with focal hepatocellular necrosis have been reported in pigs experimentally inoculated with HEV, but lesions in natural infections are not recognized.", [["hepatocellular", "ANATOMY", 66, 80], ["lesions", "ANATOMY", 157, 164], ["lymphoplasmacytic hepatitis", "DISEASE", 27, 54], ["focal hepatocellular necrosis", "DISEASE", 60, 89], ["infections", "DISEASE", 176, 186], ["hepatocellular necrosis", "CANCER", 66, 89], ["pigs", "ORGANISM", 112, 116], ["HEV", "ORGANISM", 148, 151], ["lesions", "PATHOLOGICAL_FORMATION", 157, 164], ["pigs", "SPECIES", 112, 116], ["pigs", "SPECIES", 112, 116], ["HEV", "SPECIES", 148, 151], ["Lesions of mild multifocal lymphoplasmacytic hepatitis", "PROBLEM", 0, 54], ["focal hepatocellular necrosis", "PROBLEM", 60, 89], ["HEV", "PROBLEM", 148, 151], ["lesions", "PROBLEM", 157, 164], ["natural infections", "PROBLEM", 168, 186], ["mild", "OBSERVATION_MODIFIER", 11, 15], ["multifocal", "OBSERVATION_MODIFIER", 16, 26], ["lymphoplasmacytic hepatitis", "OBSERVATION", 27, 54], ["focal", "OBSERVATION_MODIFIER", 60, 65], ["hepatocellular necrosis", "OBSERVATION", 66, 89], ["pigs experimentally", "OBSERVATION_MODIFIER", 112, 131], ["inoculated", "OBSERVATION_MODIFIER", 132, 142], ["HEV", "OBSERVATION_MODIFIER", 148, 151], ["lesions", "OBSERVATION", 157, 164], ["natural", "OBSERVATION_MODIFIER", 168, 175], ["infections", "OBSERVATION", 176, 186]]], ["Flaviviruses, including a nonprimate hepacivirus and a GB-virus-like virus (pegivirus) have recently been described in horses, although their potential clinical significance is unknown.", [["Flaviviruses", "DISEASE", 0, 12], ["nonprimate hepacivirus", "ORGANISM", 26, 48], ["GB-virus-like virus", "ORGANISM", 55, 74], ["pegivirus", "CANCER", 76, 85], ["horses", "ORGANISM", 119, 125], ["GB-virus-like virus", "SPECIES", 55, 74], ["GB-virus-like virus", "SPECIES", 55, 74], ["Flaviviruses", "PROBLEM", 0, 12], ["a nonprimate hepacivirus", "PROBLEM", 24, 48], ["a GB-virus", "PROBLEM", 53, 63], ["like virus (pegivirus", "PROBLEM", 64, 85], ["GB", "ANATOMY", 55, 57], ["virus", "OBSERVATION", 58, 63]]], ["A second novel pegivirus species of horses, Theiler's disease-associated virus, is described in more detail later.Infectious canine hepatitisCanine adenovirus 1 (CAdV-1) infection is the cause of infectious canine hepatitis, a severe liver disease in dogs; other canids, including coyotes, foxes, wolves; and in bears.", [["liver", "ANATOMY", 234, 239], ["Theiler's disease", "DISEASE", 44, 61], ["canine hepatitis", "DISEASE", 125, 141], ["infection", "DISEASE", 170, 179], ["canine hepatitis", "DISEASE", 207, 223], ["liver disease", "DISEASE", 234, 247], ["pegivirus", "ORGANISM", 15, 24], ["horses", "ORGANISM", 36, 42], ["Theiler's disease-associated virus", "ORGANISM", 44, 78], ["canine hepatitis", "ORGANISM", 125, 141], ["Canine adenovirus 1", "ORGANISM", 141, 160], ["CAdV-1", "ORGANISM", 162, 168], ["canine", "ORGANISM", 207, 213], ["liver", "ORGAN", 234, 239], ["dogs", "ORGANISM", 251, 255], ["horses", "SPECIES", 36, 42], ["Theiler", "SPECIES", 44, 51], ["canine hepatitis", "SPECIES", 125, 141], ["Canine adenovirus 1", "SPECIES", 141, 160], ["CAdV-1", "SPECIES", 162, 168], ["dogs", "SPECIES", 251, 255], ["Theiler's disease-associated virus", "SPECIES", 44, 78], ["Canine adenovirus 1", "SPECIES", 141, 160], ["CAdV-1", "SPECIES", 162, 168], ["A second novel pegivirus species of horses", "PROBLEM", 0, 42], ["Theiler's disease", "PROBLEM", 44, 61], ["associated virus", "PROBLEM", 62, 78], ["Infectious canine hepatitisCanine adenovirus", "PROBLEM", 114, 158], ["CAdV", "TEST", 162, 166], ["infection", "PROBLEM", 170, 179], ["infectious canine hepatitis", "PROBLEM", 196, 223], ["a severe liver disease in dogs", "PROBLEM", 225, 255], ["virus", "OBSERVATION", 73, 78], ["hepatitis", "OBSERVATION", 132, 141], ["infection", "OBSERVATION", 170, 179], ["cause of", "UNCERTAINTY", 187, 195], ["infectious canine hepatitis", "OBSERVATION", 196, 223], ["severe", "OBSERVATION_MODIFIER", 227, 233], ["liver", "ANATOMY", 234, 239], ["disease", "OBSERVATION", 240, 247]]], ["Vaccination has made the disease rare in many countries in which it was endemic.", [["Vaccination", "TREATMENT", 0, 11], ["the disease", "PROBLEM", 21, 32]]], ["Deaths from infectious canine hepatitis are usually sporadic, although small outbreaks can occur among young dogs in kennels.", [["infectious canine hepatitis", "DISEASE", 12, 39], ["canine", "ORGANISM", 23, 29], ["dogs", "ORGANISM", 109, 113], ["canine", "SPECIES", 23, 29], ["dogs", "SPECIES", 109, 113], ["infectious canine hepatitis", "PROBLEM", 12, 39], ["small outbreaks", "PROBLEM", 71, 86], ["infectious", "OBSERVATION_MODIFIER", 12, 22], ["hepatitis", "OBSERVATION", 30, 39], ["small", "OBSERVATION_MODIFIER", 71, 76], ["outbreaks", "OBSERVATION", 77, 86]]], ["Fatalities seldom occur among dogs >2 years of age.", [["dogs", "SPECIES", 30, 34]]], ["In areas where the disease is not controlled by vaccination, it is probable that most dogs in the general population contact CAdV-1 in the first 2 years of life and suffer either inapparent infection or mild febrile illness with pharyngitis and tonsillitis.", [["infection", "DISEASE", 190, 199], ["febrile illness", "DISEASE", 208, 223], ["pharyngitis", "DISEASE", 229, 240], ["tonsillitis", "DISEASE", 245, 256], ["dogs", "ORGANISM", 86, 90], ["CAdV-1", "CELL", 125, 131], ["dogs", "SPECIES", 86, 90], ["the disease", "PROBLEM", 15, 26], ["inapparent infection", "PROBLEM", 179, 199], ["mild febrile illness", "PROBLEM", 203, 223], ["pharyngitis", "PROBLEM", 229, 240], ["tonsillitis", "PROBLEM", 245, 256], ["disease", "OBSERVATION", 19, 26], ["not", "UNCERTAINTY", 30, 33], ["inapparent", "OBSERVATION_MODIFIER", 179, 189], ["infection", "OBSERVATION", 190, 199], ["mild", "OBSERVATION_MODIFIER", 203, 207], ["febrile", "OBSERVATION_MODIFIER", 208, 215], ["pharyngitis", "OBSERVATION", 229, 240], ["tonsillitis", "OBSERVATION", 245, 256]]], ["In more severe cases, there is vomiting, melena, high fever, and abdominal pain.", [["abdominal", "ANATOMY", 65, 74], ["vomiting", "DISEASE", 31, 39], ["melena", "DISEASE", 41, 47], ["fever", "DISEASE", 54, 59], ["abdominal pain", "DISEASE", 65, 79], ["melena", "PATHOLOGICAL_FORMATION", 41, 47], ["abdominal", "ORGANISM_SUBDIVISION", 65, 74], ["vomiting", "PROBLEM", 31, 39], ["melena", "PROBLEM", 41, 47], ["high fever", "PROBLEM", 49, 59], ["abdominal pain", "PROBLEM", 65, 79], ["severe", "OBSERVATION_MODIFIER", 8, 14], ["melena", "OBSERVATION", 41, 47], ["high", "OBSERVATION_MODIFIER", 49, 53], ["fever", "OBSERVATION", 54, 59], ["abdominal", "ANATOMY", 65, 74], ["pain", "OBSERVATION", 75, 79]]], ["There may be petechiae on the gums; the mucous membranes are pale and occasionally slightly jaundiced.", [["petechiae", "ANATOMY", 13, 22], ["gums", "ANATOMY", 30, 34], ["mucous membranes", "ANATOMY", 40, 56], ["petechiae", "DISEASE", 13, 22], ["petechiae", "PATHOLOGICAL_FORMATION", 13, 22], ["gums", "ORGANISM_SUBDIVISION", 30, 34], ["mucous membranes", "MULTI-TISSUE_STRUCTURE", 40, 56], ["petechiae on the gums", "PROBLEM", 13, 34], ["occasionally slightly jaundiced", "PROBLEM", 70, 101], ["may be", "UNCERTAINTY", 6, 12], ["petechiae", "OBSERVATION", 13, 22], ["gums", "ANATOMY", 30, 34], ["mucous membranes", "ANATOMY", 40, 56], ["pale", "OBSERVATION", 61, 65], ["occasionally", "OBSERVATION_MODIFIER", 70, 82], ["slightly", "OBSERVATION_MODIFIER", 83, 91], ["jaundiced", "OBSERVATION", 92, 101]]], ["Nonspecific nervous signs occur in a few cases.", [["nervous", "ANATOMY", 12, 19], ["Nonspecific nervous signs", "DISEASE", 0, 25], ["nervous", "ANATOMICAL_SYSTEM", 12, 19], ["Nonspecific nervous signs", "PROBLEM", 0, 25], ["nervous", "ANATOMY", 12, 19]]], ["There is also a peracute form of the disease in which the animal is found dead without signs of illness, or after an illness of only a few hours.", [["illness", "DISEASE", 96, 103], ["the disease", "PROBLEM", 33, 44], ["illness", "PROBLEM", 96, 103], ["disease", "OBSERVATION", 37, 44]]], ["In convalescence, there may be a unilateral or bilateral opacity of the cornea caused by corneal edema (so-called blue eye, a type III hypersensitivity reaction with immune-complex-mediated corneal injury) (Fig. 2-69) , which disappears spontaneously.Infectious canine hepatitisCAdV-1 has special tropism for endothelium, mesothelium, and hepatic parenchyma, and it is injury to these that is responsible for the pathologic features of edema, serosal hemorrhage, and hepatic necrosis.", [["cornea", "ANATOMY", 72, 78], ["corneal", "ANATOMY", 89, 96], ["eye", "ANATOMY", 119, 122], ["corneal", "ANATOMY", 190, 197], ["endothelium", "ANATOMY", 309, 320], ["mesothelium", "ANATOMY", 322, 333], ["hepatic parenchyma", "ANATOMY", 339, 357], ["edema", "ANATOMY", 436, 441], ["serosal", "ANATOMY", 443, 450], ["hepatic", "ANATOMY", 467, 474], ["corneal edema", "DISEASE", 89, 102], ["hypersensitivity", "DISEASE", 135, 151], ["corneal injury", "DISEASE", 190, 204], ["edema", "DISEASE", 436, 441], ["serosal hemorrhage", "DISEASE", 443, 461], ["hepatic necrosis", "DISEASE", 467, 483], ["cornea", "TISSUE", 72, 78], ["corneal edema", "PATHOLOGICAL_FORMATION", 89, 102], ["eye", "ORGAN", 119, 122], ["immune-complex", "GENE_OR_GENE_PRODUCT", 166, 180], ["corneal", "TISSUE", 190, 197], ["hepatitisCAdV-1", "GENE_OR_GENE_PRODUCT", 269, 284], ["endothelium", "TISSUE", 309, 320], ["mesothelium", "TISSUE", 322, 333], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 339, 357], ["edema", "PATHOLOGICAL_FORMATION", 436, 441], ["serosal", "MULTI-TISSUE_STRUCTURE", 443, 450], ["hepatic", "ORGAN", 467, 474], ["canine hepatitisCAdV", "SPECIES", 262, 282], ["canine hepatitisCAdV-1", "SPECIES", 262, 284], ["a unilateral or bilateral opacity of the cornea", "PROBLEM", 31, 78], ["corneal edema", "PROBLEM", 89, 102], ["so-called blue eye", "PROBLEM", 104, 122], ["a type III hypersensitivity reaction", "PROBLEM", 124, 160], ["corneal injury", "PROBLEM", 190, 204], ["Infectious canine hepatitisCAdV", "TEST", 251, 282], ["endothelium, mesothelium, and hepatic parenchyma", "PROBLEM", 309, 357], ["injury", "PROBLEM", 369, 375], ["edema", "PROBLEM", 436, 441], ["serosal hemorrhage", "PROBLEM", 443, 461], ["hepatic necrosis", "PROBLEM", 467, 483], ["may be", "UNCERTAINTY", 24, 30], ["unilateral", "OBSERVATION_MODIFIER", 33, 43], ["bilateral", "ANATOMY_MODIFIER", 47, 56], ["opacity", "OBSERVATION", 57, 64], ["cornea", "ANATOMY", 72, 78], ["corneal", "ANATOMY", 89, 96], ["edema", "OBSERVATION", 97, 102], ["eye", "ANATOMY", 119, 122], ["corneal", "ANATOMY", 190, 197], ["injury", "OBSERVATION", 198, 204], ["mesothelium", "ANATOMY", 322, 333], ["hepatic", "ANATOMY", 339, 346], ["parenchyma", "ANATOMY_MODIFIER", 347, 357], ["injury", "OBSERVATION", 369, 375], ["responsible for", "UNCERTAINTY", 393, 408], ["pathologic", "OBSERVATION", 413, 423], ["edema", "OBSERVATION", 436, 441], ["serosal hemorrhage", "OBSERVATION", 443, 461], ["hepatic", "ANATOMY", 467, 474], ["necrosis", "OBSERVATION", 475, 483]]], ["The histologic specificity of the lesions depends on the demonstration of large, solid intranuclear inclusion bodies in endothelium or hepatic parenchyma intravenous feline herpesvirus 1 inoculation of the pregnant queen.", [["lesions", "ANATOMY", 34, 41], ["endothelium", "ANATOMY", 120, 131], ["hepatic parenchyma", "ANATOMY", 135, 153], ["lesions", "PATHOLOGICAL_FORMATION", 34, 41], ["endothelium", "TISSUE", 120, 131], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 135, 153], ["feline herpesvirus 1", "ORGANISM", 166, 186], ["feline herpesvirus", "SPECIES", 166, 184], ["feline herpesvirus 1", "SPECIES", 166, 186], ["the lesions", "PROBLEM", 30, 41], ["large, solid intranuclear inclusion bodies in endothelium", "PROBLEM", 74, 131], ["lesions", "OBSERVATION", 34, 41], ["large", "OBSERVATION_MODIFIER", 74, 79], ["solid", "OBSERVATION_MODIFIER", 81, 86], ["intranuclear", "OBSERVATION_MODIFIER", 87, 99], ["inclusion bodies", "OBSERVATION", 100, 116], ["endothelium", "ANATOMY_MODIFIER", 120, 131], ["hepatic", "ANATOMY", 135, 142], ["parenchyma", "ANATOMY_MODIFIER", 143, 153], ["intravenous feline herpesvirus", "OBSERVATION", 154, 184]]], ["Feline coronavirus infection can cause granulomatous hepatitis in some infected cats, as part of feline infectious peritonitis (Fig. 2-68) .", [["Feline coronavirus infection", "DISEASE", 0, 28], ["granulomatous hepatitis", "DISEASE", 39, 62], ["infectious peritonitis", "DISEASE", 104, 126], ["Feline coronavirus", "ORGANISM", 0, 18], ["cats", "ORGANISM", 80, 84], ["feline", "ORGANISM", 97, 103], ["Feline coronavirus", "SPECIES", 0, 18], ["cats", "SPECIES", 80, 84], ["feline", "SPECIES", 97, 103], ["Feline coronavirus", "SPECIES", 0, 18], ["Feline coronavirus infection", "PROBLEM", 0, 28], ["granulomatous hepatitis", "PROBLEM", 39, 62], ["some infected cats", "PROBLEM", 66, 84], ["feline infectious peritonitis", "PROBLEM", 97, 126], ["coronavirus", "OBSERVATION_MODIFIER", 7, 18], ["infection", "OBSERVATION", 19, 28], ["granulomatous", "OBSERVATION_MODIFIER", 39, 52], ["hepatitis", "OBSERVATION", 53, 62], ["infected", "OBSERVATION_MODIFIER", 71, 79], ["cats", "OBSERVATION", 80, 84], ["infectious", "OBSERVATION_MODIFIER", 104, 114], ["peritonitis", "OBSERVATION", 115, 126]]], ["Multifocal hepatic necrosis has been described in large felids and domestic cats infected with highly pathogenic influenza A virus H5N1.", [["hepatic", "ANATOMY", 11, 18], ["Multifocal hepatic necrosis", "DISEASE", 0, 27], ["influenza A virus H5N1", "DISEASE", 113, 135], ["hepatic", "ORGAN", 11, 18], ["cats", "ORGANISM", 76, 80], ["highly pathogenic", "ORGANISM", 95, 112], ["influenza A virus H5N1", "ORGANISM", 113, 135], ["cats", "SPECIES", 76, 80], ["influenza A virus H5N1", "SPECIES", 113, 135], ["influenza A virus H5N1", "SPECIES", 113, 135], ["Multifocal hepatic necrosis", "PROBLEM", 0, 27], ["large felids", "PROBLEM", 50, 62], ["domestic cats infected", "PROBLEM", 67, 89], ["highly pathogenic influenza A virus H5N1", "PROBLEM", 95, 135], ["hepatic", "ANATOMY", 11, 18], ["necrosis", "OBSERVATION", 19, 27], ["large", "OBSERVATION_MODIFIER", 50, 55], ["felids", "OBSERVATION_MODIFIER", 56, 62], ["highly", "OBSERVATION_MODIFIER", 95, 101], ["pathogenic", "OBSERVATION_MODIFIER", 102, 112], ["influenza", "OBSERVATION", 113, 122], ["virus H5N1", "OBSERVATION", 125, 135]]], ["Hepatocellular and Kupffer cell necrosis with mild mononuclear portal inflammation was reported in outbreaks caused by virulent systemic strains of feline calicivirus in cats in the United States and United Kingdom.", [["Hepatocellular", "ANATOMY", 0, 14], ["Kupffer cell", "ANATOMY", 19, 31], ["mononuclear portal", "ANATOMY", 51, 69], ["necrosis", "DISEASE", 32, 40], ["mononuclear portal inflammation", "DISEASE", 51, 82], ["feline calicivirus", "DISEASE", 148, 166], ["Hepatocellular", "CELL", 0, 14], ["Kupffer cell", "CELL", 19, 31], ["mononuclear portal", "MULTI-TISSUE_STRUCTURE", 51, 69], ["feline calicivirus", "ORGANISM", 148, 166], ["cats", "ORGANISM", 170, 174], ["feline calicivirus", "SPECIES", 148, 166], ["cats", "SPECIES", 170, 174], ["feline calicivirus", "SPECIES", 148, 166], ["Hepatocellular and Kupffer cell necrosis", "PROBLEM", 0, 40], ["mild mononuclear portal inflammation", "PROBLEM", 46, 82], ["virulent systemic strains of feline calicivirus", "PROBLEM", 119, 166], ["Kupffer cell necrosis", "OBSERVATION", 19, 40], ["mild", "OBSERVATION_MODIFIER", 46, 50], ["mononuclear", "ANATOMY_MODIFIER", 51, 62], ["portal", "ANATOMY", 63, 69], ["inflammation", "OBSERVATION", 70, 82], ["virulent", "OBSERVATION_MODIFIER", 119, 127], ["systemic strains", "OBSERVATION", 128, 144], ["feline calicivirus", "OBSERVATION", 148, 166]]], ["Systemic cowpox virus infection with foci of hepatic necrosis containing immunoreactive cowpox viral antigen has been reported in a cat.Infectious canine hepatitisThe viral diseases discussed in more detail later are those in which the liver is the major target organ, causing substantial hepatic injury that sometimes culminates in hepatic failure.", [["foci", "ANATOMY", 37, 41], ["hepatic", "ANATOMY", 45, 52], ["liver", "ANATOMY", 236, 241], ["organ", "ANATOMY", 262, 267], ["hepatic", "ANATOMY", 289, 296], ["hepatic", "ANATOMY", 333, 340], ["cowpox virus infection", "DISEASE", 9, 31], ["hepatic necrosis", "DISEASE", 45, 61], ["canine hepatitis", "DISEASE", 147, 163], ["viral diseases", "DISEASE", 167, 181], ["hepatic injury", "DISEASE", 289, 303], ["hepatic failure", "DISEASE", 333, 348], ["cowpox virus", "ORGANISM", 9, 21], ["hepatic", "ORGAN", 45, 52], ["cowpox", "ORGANISM", 88, 94], ["cat", "ORGANISM", 132, 135], ["canine", "ORGANISM", 147, 153], ["liver", "ORGAN", 236, 241], ["organ", "ORGAN", 262, 267], ["hepatic", "ORGAN", 289, 296], ["hepatic", "ORGAN", 333, 340], ["immunoreactive cowpox viral antigen", "PROTEIN", 73, 108], ["cowpox virus", "SPECIES", 9, 21], ["canine", "SPECIES", 147, 153], ["cowpox virus", "SPECIES", 9, 21], ["canine hepatitis", "SPECIES", 147, 163], ["Systemic cowpox virus infection", "PROBLEM", 0, 31], ["hepatic necrosis", "PROBLEM", 45, 61], ["immunoreactive cowpox viral antigen", "PROBLEM", 73, 108], ["Infectious canine hepatitis", "PROBLEM", 136, 163], ["The viral diseases", "PROBLEM", 163, 181], ["substantial hepatic injury", "PROBLEM", 277, 303], ["hepatic failure", "PROBLEM", 333, 348], ["cowpox virus infection", "OBSERVATION", 9, 31], ["foci", "OBSERVATION_MODIFIER", 37, 41], ["hepatic", "ANATOMY", 45, 52], ["necrosis", "OBSERVATION", 53, 61], ["immunoreactive", "OBSERVATION_MODIFIER", 73, 87], ["cowpox viral antigen", "OBSERVATION", 88, 108], ["hepatitis", "OBSERVATION", 154, 163], ["viral diseases", "OBSERVATION", 167, 181], ["liver", "ANATOMY", 236, 241], ["substantial", "OBSERVATION_MODIFIER", 277, 288], ["hepatic", "ANATOMY", 289, 296], ["injury", "OBSERVATION", 297, 303], ["hepatic", "ANATOMY", 333, 340], ["failure", "OBSERVATION", 341, 348]]], ["Unlike humans, in which several pathogenic hepatitis viruses from various families are well described, few viruses that specifically target the liver have been identified in the major domestic mammals.", [["liver", "ANATOMY", 144, 149], ["hepatitis viruses", "DISEASE", 43, 60], ["humans", "ORGANISM", 7, 13], ["hepatitis viruses", "ORGANISM", 43, 60], ["liver", "ORGAN", 144, 149], ["humans", "SPECIES", 7, 13], ["humans", "SPECIES", 7, 13], ["several pathogenic hepatitis viruses", "PROBLEM", 24, 60], ["few viruses", "PROBLEM", 103, 114], ["pathogenic", "OBSERVATION_MODIFIER", 32, 42], ["hepatitis", "OBSERVATION", 43, 52], ["liver", "ANATOMY", 144, 149], ["major", "OBSERVATION_MODIFIER", 178, 183], ["domestic mammals", "OBSERVATION", 184, 200]]], ["Hepadnaviruses have been found in members of the squirrel family, including woodchucks and various species of ground squirrels and arctic ground squirrels, dead cells do not remain long, so the sinusoids become dilated and filled with blood.", [["cells", "ANATOMY", 161, 166], ["sinusoids", "ANATOMY", 194, 203], ["blood", "ANATOMY", 235, 240], ["Hepadnaviruses", "GENE_OR_GENE_PRODUCT", 0, 14], ["squirrel", "ORGANISM", 49, 57], ["ground squirrels", "ORGANISM", 110, 126], ["squirrels", "ORGANISM", 145, 154], ["dead cells", "CELL", 156, 166], ["sinusoids", "TISSUE", 194, 203], ["blood", "ORGANISM_SUBSTANCE", 235, 240], ["dead cells", "CELL_TYPE", 156, 166], ["ground squirrels", "SPECIES", 110, 126], ["arctic ground squirrels", "SPECIES", 131, 154], ["Hepadnaviruses", "TREATMENT", 0, 14], ["dead cells", "PROBLEM", 156, 166], ["dilated", "PROBLEM", 211, 218], ["dilated", "OBSERVATION", 211, 218]]], ["The reticulin framework remains intact, an observation in keeping with the fact that, in recovered cases, restitution of the liver is complete.", [["liver", "ANATOMY", 125, 130], ["liver", "ORGAN", 125, 130], ["an observation", "TEST", 40, 54], ["reticulin framework", "OBSERVATION", 4, 23], ["intact", "OBSERVATION", 32, 38], ["liver", "ANATOMY", 125, 130]]], ["Massive necrosis with collapse does not occur.", [["necrosis", "DISEASE", 8, 16], ["Massive necrosis", "PROBLEM", 0, 16], ["collapse", "PROBLEM", 22, 30], ["necrosis", "OBSERVATION", 8, 16], ["collapse", "OBSERVATION", 22, 30]]], ["As is typical of severe centrilobular necrosis, the necrotic zones, initially eccentric areas about hepatic venules, extend and link up to isolate portal units.", [["centrilobular", "ANATOMY", 24, 37], ["necrotic zones", "ANATOMY", 52, 66], ["hepatic venules", "ANATOMY", 100, 115], ["necrosis", "DISEASE", 38, 46], ["necrotic", "DISEASE", 52, 60], ["necrotic zones", "PATHOLOGICAL_FORMATION", 52, 66], ["hepatic venules", "MULTI-TISSUE_STRUCTURE", 100, 115], ["severe centrilobular necrosis", "PROBLEM", 17, 46], ["the necrotic zones", "PROBLEM", 48, 66], ["hepatic venules", "PROBLEM", 100, 115], ["typical of", "UNCERTAINTY", 6, 16], ["severe", "OBSERVATION_MODIFIER", 17, 23], ["centrilobular", "OBSERVATION_MODIFIER", 24, 37], ["necrosis", "OBSERVATION", 38, 46], ["necrotic", "OBSERVATION_MODIFIER", 52, 60], ["zones", "OBSERVATION_MODIFIER", 61, 66], ["initially", "OBSERVATION_MODIFIER", 68, 77], ["eccentric", "OBSERVATION_MODIFIER", 78, 87], ["areas", "OBSERVATION_MODIFIER", 88, 93], ["hepatic venules", "ANATOMY", 100, 115], ["portal units", "ANATOMY", 147, 159]]], ["Intranuclear inclusions can be found in Kupffer cells in variable numbers.", [["Kupffer cells", "ANATOMY", 40, 53], ["Kupffer cells", "CELL", 40, 53], ["Kupffer cells", "CELL_TYPE", 40, 53], ["Intranuclear inclusions", "PROBLEM", 0, 23], ["inclusions", "OBSERVATION", 13, 23], ["Kupffer cells", "OBSERVATION", 40, 53], ["variable", "OBSERVATION_MODIFIER", 57, 65], ["numbers", "OBSERVATION_MODIFIER", 66, 73]]], ["Many of the Kupffer cells are dead, others are proliferating, and others are actively phagocytic in the removal of debris.", [["Kupffer cells", "ANATOMY", 12, 25], ["Kupffer cells", "CELL", 12, 25], ["Kupffer cells", "CELL_TYPE", 12, 25], ["debris", "PROBLEM", 115, 121], ["Kupffer cells", "OBSERVATION", 12, 25], ["proliferating", "OBSERVATION_MODIFIER", 47, 60], ["actively", "OBSERVATION_MODIFIER", 77, 85], ["phagocytic", "OBSERVATION_MODIFIER", 86, 96], ["removal", "OBSERVATION_MODIFIER", 104, 111], ["debris", "OBSERVATION", 115, 121]]], ["Leukocytic reactions in the liver are mild and are directed against the necrotic tissue; mononuclear cells are present, but neutrophils, many degenerating, predominate.", [["Leukocytic", "ANATOMY", 0, 10], ["liver", "ANATOMY", 28, 33], ["necrotic tissue", "ANATOMY", 72, 87], ["mononuclear cells", "ANATOMY", 89, 106], ["neutrophils", "ANATOMY", 124, 135], ["necrotic", "DISEASE", 72, 80], ["liver", "ORGAN", 28, 33], ["necrotic tissue", "TISSUE", 72, 87], ["mononuclear cells", "CELL", 89, 106], ["neutrophils", "CELL", 124, 135], ["mononuclear cells", "CELL_TYPE", 89, 106], ["neutrophils", "CELL_TYPE", 124, 135], ["Leukocytic reactions in the liver", "PROBLEM", 0, 33], ["the necrotic tissue", "PROBLEM", 68, 87], ["mononuclear cells", "PROBLEM", 89, 106], ["neutrophils", "TEST", 124, 135], ["liver", "ANATOMY", 28, 33], ["mild", "OBSERVATION_MODIFIER", 38, 42], ["necrotic", "OBSERVATION_MODIFIER", 72, 80], ["tissue", "OBSERVATION", 81, 87], ["mononuclear cells", "OBSERVATION", 89, 106], ["neutrophils", "OBSERVATION_MODIFIER", 124, 135], ["many", "OBSERVATION_MODIFIER", 137, 141], ["degenerating", "OBSERVATION_MODIFIER", 142, 154], ["predominate", "OBSERVATION_MODIFIER", 156, 167]]], ["There is some collection of bile pigment, but it is moderate, in keeping with the short course of the disease.Infectious canine hepatitisMicroscopic lesions in other organs are largely the result of injury to endothelium.", [["bile pigment", "ANATOMY", 28, 40], ["lesions", "ANATOMY", 149, 156], ["organs", "ANATOMY", 166, 172], ["endothelium", "ANATOMY", 209, 220], ["canine hepatitis", "DISEASE", 121, 137], ["bile pigment", "TISSUE", 28, 40], ["canine", "ORGANISM", 121, 127], ["lesions", "PATHOLOGICAL_FORMATION", 149, 156], ["organs", "ORGAN", 166, 172], ["endothelium", "TISSUE", 209, 220], ["canine", "SPECIES", 121, 127], ["some collection of bile pigment", "PROBLEM", 9, 40], ["the disease", "PROBLEM", 98, 109], ["Infectious canine hepatitisMicroscopic lesions in other organs", "PROBLEM", 110, 172], ["injury to endothelium", "PROBLEM", 199, 220], ["some", "OBSERVATION_MODIFIER", 9, 13], ["collection", "OBSERVATION", 14, 24], ["bile pigment", "OBSERVATION", 28, 40], ["moderate", "OBSERVATION_MODIFIER", 52, 60], ["short course", "OBSERVATION_MODIFIER", 82, 94], ["disease", "OBSERVATION", 102, 109], ["hepatitis", "OBSERVATION_MODIFIER", 128, 137], ["lesions", "OBSERVATION", 149, 156], ["organs", "ANATOMY", 166, 172], ["injury", "OBSERVATION", 199, 205], ["endothelium", "OBSERVATION", 209, 220]]], ["Inclusion bodies in endothelial cells can be difficult to find and are looked for, with most profit in renal glomeruli, where endothelium is concentrated.", [["bodies", "ANATOMY", 10, 16], ["endothelial cells", "ANATOMY", 20, 37], ["renal glomeruli", "ANATOMY", 103, 118], ["endothelium", "ANATOMY", 126, 137], ["endothelial cells", "CELL", 20, 37], ["renal glomeruli", "TISSUE", 103, 118], ["endothelium", "TISSUE", 126, 137], ["endothelial cells", "CELL_TYPE", 20, 37], ["Inclusion bodies in endothelial cells", "PROBLEM", 0, 37], ["bodies", "ANATOMY_MODIFIER", 10, 16], ["endothelial cells", "OBSERVATION", 20, 37], ["renal glomeruli", "ANATOMY", 103, 118], ["endothelium", "ANATOMY", 126, 137], ["concentrated", "OBSERVATION_MODIFIER", 141, 153]]], ["Occasionally, they are found in the epithelium of collecting tubules.", [["epithelium", "ANATOMY", 36, 46], ["collecting tubules", "ANATOMY", 50, 68], ["epithelium", "TISSUE", 36, 46], ["collecting tubules", "TISSUE", 50, 68], ["epithelium", "ANATOMY_MODIFIER", 36, 46]]], ["When areas of hemorrhagic consolidation of the lungs are present, there is hemorrhage, edema, and fibrin formation in the alveoli, and in these consolidated areas, inclusions are often common in alveolar capillaries and even in dying cells of the bronchial epithelium.", [["lungs", "ANATOMY", 47, 52], ["edema", "ANATOMY", 87, 92], ["fibrin", "ANATOMY", 98, 104], ["alveoli", "ANATOMY", 122, 129], ["alveolar capillaries", "ANATOMY", 195, 215], ["cells", "ANATOMY", 234, 239], ["bronchial epithelium", "ANATOMY", 247, 267], ["hemorrhagic", "DISEASE", 14, 25], ["hemorrhage", "DISEASE", 75, 85], ["edema", "DISEASE", 87, 92], ["lungs", "ORGAN", 47, 52], ["edema", "PATHOLOGICAL_FORMATION", 87, 92], ["fibrin", "GENE_OR_GENE_PRODUCT", 98, 104], ["alveoli", "MULTI-TISSUE_STRUCTURE", 122, 129], ["alveolar capillaries", "TISSUE", 195, 215], ["cells", "CELL", 234, 239], ["bronchial epithelium", "TISSUE", 247, 267], ["dying cells", "CELL_TYPE", 228, 239], ["hemorrhagic consolidation of the lungs", "PROBLEM", 14, 52], ["hemorrhage", "PROBLEM", 75, 85], ["edema", "PROBLEM", 87, 92], ["fibrin formation in the alveoli", "PROBLEM", 98, 129], ["hemorrhagic", "OBSERVATION_MODIFIER", 14, 25], ["consolidation", "OBSERVATION", 26, 39], ["lungs", "ANATOMY", 47, 52], ["hemorrhage", "OBSERVATION", 75, 85], ["edema", "OBSERVATION", 87, 92], ["fibrin formation", "OBSERVATION", 98, 114], ["alveoli", "ANATOMY_MODIFIER", 122, 129], ["consolidated", "OBSERVATION_MODIFIER", 144, 156], ["areas", "OBSERVATION", 157, 162], ["alveolar capillaries", "OBSERVATION", 195, 215], ["dying cells", "OBSERVATION", 228, 239], ["bronchial", "ANATOMY", 247, 256], ["epithelium", "ANATOMY_MODIFIER", 257, 267]]], ["Changes in the brain are secondary to vascular injury.", [["brain", "ANATOMY", 15, 20], ["vascular", "ANATOMY", 38, 46], ["vascular injury", "DISEASE", 38, 53], ["brain", "ORGAN", 15, 20], ["vascular", "MULTI-TISSUE_STRUCTURE", 38, 46], ["Changes in the brain", "PROBLEM", 0, 20], ["vascular injury", "PROBLEM", 38, 53], ["brain", "ANATOMY", 15, 20], ["vascular", "ANATOMY", 38, 46], ["injury", "OBSERVATION", 47, 53]]], ["Hemorrhages, if present, are from capillaries and small venules, and inclusions in endothelial nuclei can usually be found in vessels that have bled.", [["capillaries", "ANATOMY", 34, 45], ["small venules", "ANATOMY", 50, 63], ["endothelial nuclei", "ANATOMY", 83, 101], ["vessels", "ANATOMY", 126, 133], ["Hemorrhages", "DISEASE", 0, 11], ["capillaries", "TISSUE", 34, 45], ["venules", "MULTI-TISSUE_STRUCTURE", 56, 63], ["endothelial nuclei", "CELLULAR_COMPONENT", 83, 101], ["vessels", "MULTI-TISSUE_STRUCTURE", 126, 133], ["Hemorrhages", "PROBLEM", 0, 11], ["small venules", "PROBLEM", 50, 63], ["inclusions in endothelial nuclei", "PROBLEM", 69, 101], ["small", "OBSERVATION_MODIFIER", 50, 55], ["venules", "ANATOMY", 56, 63], ["endothelial nuclei", "ANATOMY", 83, 101], ["vessels", "ANATOMY", 126, 133]]], ["Other endothelial and adventitial cells are hyperplastic and mixed with a few lymphocytes.", [["endothelial", "ANATOMY", 6, 17], ["adventitial cells", "ANATOMY", 22, 39], ["hyperplastic", "ANATOMY", 44, 56], ["lymphocytes", "ANATOMY", 78, 89], ["endothelial", "CELL", 6, 17], ["adventitial cells", "CELL", 22, 39], ["lymphocytes", "CELL", 78, 89], ["endothelial and adventitial cells", "CELL_TYPE", 6, 39], ["lymphocytes", "CELL_TYPE", 78, 89], ["Other endothelial and adventitial cells", "PROBLEM", 0, 39], ["hyperplastic", "PROBLEM", 44, 56], ["endothelial", "ANATOMY", 6, 17], ["adventitial cells", "ANATOMY", 22, 39], ["hyperplastic", "OBSERVATION", 44, 56], ["mixed", "OBSERVATION_MODIFIER", 61, 66], ["few", "OBSERVATION_MODIFIER", 74, 77], ["lymphocytes", "OBSERVATION", 78, 89]]], ["Small foci of softening or demyelination may be present in relation to the hemorrhages.", [["foci", "ANATOMY", 6, 10], ["demyelination", "DISEASE", 27, 40], ["hemorrhages", "DISEASE", 75, 86], ["Small foci of softening", "PROBLEM", 0, 23], ["demyelination", "PROBLEM", 27, 40], ["the hemorrhages", "PROBLEM", 71, 86], ["foci", "OBSERVATION", 6, 10], ["softening", "OBSERVATION_MODIFIER", 14, 23], ["demyelination", "OBSERVATION", 27, 40], ["may be", "UNCERTAINTY", 41, 47], ["hemorrhages", "OBSERVATION", 75, 86]]], ["Lymphoreticular tissues are congested, and inclusions may be found in reticulum cells of follicles, in the red pulp of the spleen, and in macrophages anywhere.Infectious canine hepatitisFollowing natural oronasal exposure, viral multiplication occurs in the tonsils and leads to tonsillitis, which may be quite severe with extensive edema of the throat and larynx.", [["Lymphoreticular tissues", "ANATOMY", 0, 23], ["reticulum cells", "ANATOMY", 70, 85], ["follicles", "ANATOMY", 89, 98], ["red pulp", "ANATOMY", 107, 115], ["spleen", "ANATOMY", 123, 129], ["macrophages", "ANATOMY", 138, 149], ["tonsils", "ANATOMY", 258, 265], ["throat", "ANATOMY", 346, 352], ["larynx", "ANATOMY", 357, 363], ["canine hepatitis", "DISEASE", 170, 186], ["tonsillitis", "DISEASE", 279, 290], ["edema of the throat", "DISEASE", 333, 352], ["Lymphoreticular tissues", "TISSUE", 0, 23], ["reticulum cells", "CELL", 70, 85], ["follicles", "MULTI-TISSUE_STRUCTURE", 89, 98], ["red pulp", "TISSUE", 107, 115], ["spleen", "ORGAN", 123, 129], ["macrophages", "CELL", 138, 149], ["canine hepatitis", "ORGANISM", 170, 186], ["tonsils", "ORGAN", 258, 265], ["edema", "PATHOLOGICAL_FORMATION", 333, 338], ["throat", "ORGANISM_SUBDIVISION", 346, 352], ["larynx", "ORGAN", 357, 363], ["reticulum cells", "CELL_TYPE", 70, 85], ["macrophages", "CELL_TYPE", 138, 149], ["canine", "SPECIES", 170, 176], ["Lymphoreticular tissues", "PROBLEM", 0, 23], ["congested", "PROBLEM", 28, 37], ["reticulum cells of follicles", "PROBLEM", 70, 98], ["Infectious canine hepatitis", "PROBLEM", 159, 186], ["natural oronasal exposure", "PROBLEM", 196, 221], ["viral multiplication", "PROBLEM", 223, 243], ["tonsillitis", "PROBLEM", 279, 290], ["extensive edema of the throat and larynx", "PROBLEM", 323, 363], ["congested", "OBSERVATION", 28, 37], ["may be", "UNCERTAINTY", 54, 60], ["reticulum cells", "OBSERVATION", 70, 85], ["follicles", "OBSERVATION", 89, 98], ["red pulp", "ANATOMY_MODIFIER", 107, 115], ["spleen", "ANATOMY", 123, 129], ["macrophages", "OBSERVATION", 138, 149], ["hepatitis", "OBSERVATION", 177, 186], ["oronasal exposure", "OBSERVATION", 204, 221], ["viral multiplication", "OBSERVATION", 223, 243], ["tonsils", "ANATOMY", 258, 265], ["tonsillitis", "OBSERVATION", 279, 290], ["may be quite", "UNCERTAINTY", 298, 310], ["severe", "OBSERVATION_MODIFIER", 311, 317], ["extensive", "OBSERVATION_MODIFIER", 323, 332], ["edema", "OBSERVATION", 333, 338], ["throat", "ANATOMY", 346, 352], ["larynx", "ANATOMY", 357, 363]]], ["Fever accompanies the tonsillitis and precedes the viremic phase, which lasts 4-8 days, accompanied by leukopenia.Infectious canine hepatitisHepatic necrosis develops at about day 7 of experimental infection; however, an immune response with adequate neutralizing antibodies may clear the virus from the blood and limit the extent of hepatic damage.", [["Hepatic", "ANATOMY", 141, 148], ["blood", "ANATOMY", 304, 309], ["hepatic", "ANATOMY", 334, 341], ["Fever", "DISEASE", 0, 5], ["tonsillitis", "DISEASE", 22, 33], ["leukopenia", "DISEASE", 103, 113], ["canine hepatitis", "DISEASE", 125, 141], ["Hepatic necrosis", "DISEASE", 141, 157], ["infection", "DISEASE", 198, 207], ["hepatic damage", "DISEASE", 334, 348], ["canine", "ORGANISM", 125, 131], ["blood", "ORGANISM_SUBSTANCE", 304, 309], ["hepatic", "ORGAN", 334, 341], ["neutralizing antibodies", "PROTEIN", 251, 274], ["canine", "SPECIES", 125, 131], ["Fever", "PROBLEM", 0, 5], ["the tonsillitis", "PROBLEM", 18, 33], ["the viremic phase", "PROBLEM", 47, 64], ["leukopenia", "PROBLEM", 103, 113], ["Infectious canine hepatitisHepatic necrosis", "PROBLEM", 114, 157], ["experimental infection", "PROBLEM", 185, 207], ["an immune response", "PROBLEM", 218, 236], ["adequate neutralizing antibodies", "TREATMENT", 242, 274], ["the virus", "PROBLEM", 285, 294], ["the blood", "TEST", 300, 309], ["hepatic damage", "PROBLEM", 334, 348], ["tonsillitis", "OBSERVATION", 22, 33], ["viremic phase", "OBSERVATION_MODIFIER", 51, 64], ["leukopenia", "OBSERVATION", 103, 113], ["hepatitis", "OBSERVATION_MODIFIER", 132, 141], ["Hepatic", "ANATOMY", 141, 148], ["necrosis", "OBSERVATION", 149, 157], ["infection", "OBSERVATION", 198, 207], ["hepatic", "ANATOMY", 334, 341], ["damage", "OBSERVATION", 342, 348]]], ["In surviving animals, hepatic regeneration occurs rapidly, and there do not appear to be any significant residual lesions.", [["hepatic", "ANATOMY", 22, 29], ["lesions", "ANATOMY", 114, 121], ["hepatic", "MULTI-TISSUE_STRUCTURE", 22, 29], ["lesions", "PATHOLOGICAL_FORMATION", 114, 121], ["hepatic regeneration", "PROBLEM", 22, 42], ["any significant residual lesions", "PROBLEM", 89, 121], ["hepatic", "ANATOMY", 22, 29], ["regeneration", "OBSERVATION", 30, 42], ["do not appear to be", "UNCERTAINTY", 69, 88], ["significant", "OBSERVATION_MODIFIER", 93, 104], ["residual", "OBSERVATION_MODIFIER", 105, 113], ["lesions", "OBSERVATION", 114, 121]]], ["Small foci of hepatocellular necrosis may still be present at 2 weeks, and foci of proliferated Kupffer cells may be detectable for another week or 2.", [["foci", "ANATOMY", 6, 10], ["hepatocellular", "ANATOMY", 14, 28], ["foci", "ANATOMY", 75, 79], ["Kupffer cells", "ANATOMY", 96, 109], ["hepatocellular necrosis", "DISEASE", 14, 37], ["hepatocellular necrosis", "CANCER", 14, 37], ["Kupffer cells", "CELL", 96, 109], ["proliferated Kupffer cells", "CELL_TYPE", 83, 109], ["Small foci", "PROBLEM", 0, 10], ["hepatocellular necrosis", "PROBLEM", 14, 37], ["proliferated Kupffer cells", "PROBLEM", 83, 109], ["foci", "OBSERVATION", 6, 10], ["hepatocellular", "ANATOMY", 14, 28], ["necrosis", "OBSERVATION", 29, 37], ["foci", "OBSERVATION_MODIFIER", 75, 79], ["proliferated", "OBSERVATION_MODIFIER", 83, 95], ["Kupffer cells", "OBSERVATION", 96, 109]]], ["Progressive hepatic injury does not seem to follow the acute phase of the natural disease, although chronic hepatitis has been experimentally reproduced in partially immunized dogs challenged with the virus.", [["hepatic", "ANATOMY", 12, 19], ["hepatic injury", "DISEASE", 12, 26], ["hepatitis", "DISEASE", 108, 117], ["hepatic", "ORGAN", 12, 19], ["dogs", "ORGANISM", 176, 180], ["dogs", "SPECIES", 176, 180], ["Progressive hepatic injury", "PROBLEM", 0, 26], ["the natural disease", "PROBLEM", 70, 89], ["chronic hepatitis", "PROBLEM", 100, 117], ["the virus", "PROBLEM", 197, 206], ["hepatic", "ANATOMY", 12, 19], ["injury", "OBSERVATION", 20, 26], ["natural disease", "OBSERVATION", 74, 89], ["chronic", "OBSERVATION_MODIFIER", 100, 107], ["hepatitis", "OBSERVATION", 108, 117]]], ["Adenoviral antigen has been detected immunohistochemically in occasional Kupffer cells in 5 dogs with a range of chronic hepatic inflammatory lesions and in one dog with a patent ductus venosus; however, a retrospective study of formalin-fixed paraffin-embedded liver from 45 dogs with chronic hepatitis or cirrhosis failed to reveal CAdV-1 by either PCR or immunohistochemistry, although the possibility that the virus initiates hepatic damage by provoking self-perpetuating hepatitis could not be excluded.", [["Kupffer cells", "ANATOMY", 73, 86], ["hepatic inflammatory lesions", "ANATOMY", 121, 149], ["ductus venosus", "ANATOMY", 179, 193], ["liver", "ANATOMY", 262, 267], ["hepatic", "ANATOMY", 430, 437], ["hepatic inflammatory lesions", "DISEASE", 121, 149], ["patent ductus venosus", "DISEASE", 172, 193], ["formalin", "CHEMICAL", 229, 237], ["chronic hepatitis", "DISEASE", 286, 303], ["cirrhosis", "DISEASE", 307, 316], ["hepatic damage", "DISEASE", 430, 444], ["hepatitis", "DISEASE", 476, 485], ["formalin", "CHEMICAL", 229, 237], ["paraffin", "CHEMICAL", 244, 252], ["Adenoviral", "ORGANISM", 0, 10], ["Kupffer cells", "CELL", 73, 86], ["dogs", "ORGANISM", 92, 96], ["hepatic inflammatory lesions", "PATHOLOGICAL_FORMATION", 121, 149], ["dog", "ORGANISM", 161, 164], ["ductus venosus", "MULTI-TISSUE_STRUCTURE", 179, 193], ["liver", "ORGAN", 262, 267], ["dogs", "ORGANISM", 276, 280], ["CAdV-1", "GENE_OR_GENE_PRODUCT", 334, 340], ["hepatic", "ORGAN", 430, 437], ["Adenoviral antigen", "PROTEIN", 0, 18], ["Kupffer cells", "CELL_TYPE", 73, 86], ["CAdV", "PROTEIN", 334, 338], ["dogs", "SPECIES", 92, 96], ["dog", "SPECIES", 161, 164], ["dogs", "SPECIES", 276, 280], ["Adenoviral", "SPECIES", 0, 10], ["Adenoviral antigen", "TEST", 0, 18], ["chronic hepatic inflammatory lesions", "PROBLEM", 113, 149], ["a patent ductus venosus", "PROBLEM", 170, 193], ["a retrospective study", "TEST", 204, 225], ["formalin", "TEST", 229, 237], ["fixed paraffin", "TEST", 238, 252], ["chronic hepatitis", "PROBLEM", 286, 303], ["cirrhosis", "PROBLEM", 307, 316], ["CAdV", "TEST", 334, 338], ["PCR", "TEST", 351, 354], ["immunohistochemistry", "TEST", 358, 378], ["the virus", "PROBLEM", 410, 419], ["hepatic damage", "PROBLEM", 430, 444], ["self-perpetuating hepatitis", "PROBLEM", 458, 485], ["Kupffer cells", "OBSERVATION", 73, 86], ["chronic", "OBSERVATION_MODIFIER", 113, 120], ["hepatic", "ANATOMY", 121, 128], ["inflammatory", "OBSERVATION_MODIFIER", 129, 141], ["lesions", "OBSERVATION", 142, 149], ["patent", "OBSERVATION", 172, 178], ["ductus venosus", "ANATOMY", 179, 193], ["liver", "ANATOMY", 262, 267], ["chronic", "OBSERVATION_MODIFIER", 286, 293], ["hepatitis", "OBSERVATION", 294, 303], ["cirrhosis", "OBSERVATION", 307, 316], ["virus", "OBSERVATION", 414, 419], ["hepatic", "ANATOMY", 430, 437], ["damage", "OBSERVATION", 438, 444], ["hepatitis", "OBSERVATION", 476, 485], ["could not be excluded", "UNCERTAINTY", 486, 507]]], ["Focal interstitial nephritis occurs commonly, and the cellular infiltrates are persistent but not functionally significant.", [["interstitial", "ANATOMY", 6, 18], ["cellular infiltrates", "ANATOMY", 54, 74], ["interstitial nephritis", "DISEASE", 6, 28], ["cellular", "CELL", 54, 62], ["Focal interstitial nephritis", "PROBLEM", 0, 28], ["the cellular infiltrates", "PROBLEM", 50, 74], ["interstitial", "ANATOMY_MODIFIER", 6, 18], ["nephritis", "OBSERVATION", 19, 28], ["cellular", "OBSERVATION_MODIFIER", 54, 62], ["infiltrates", "OBSERVATION", 63, 74], ["persistent", "OBSERVATION_MODIFIER", 79, 89], ["not", "UNCERTAINTY", 94, 97], ["functionally", "OBSERVATION_MODIFIER", 98, 110], ["significant", "OBSERVATION_MODIFIER", 111, 122]]], ["They consist of interstitial lymphocytic accumulations, especially about the corticomedullary junction and in the stroma of the pelvis.", [["interstitial lymphocytic", "ANATOMY", 16, 40], ["corticomedullary junction", "ANATOMY", 77, 102], ["stroma", "ANATOMY", 114, 120], ["pelvis", "ANATOMY", 128, 134], ["interstitial lymphocytic", "PATHOLOGICAL_FORMATION", 16, 40], ["corticomedullary junction", "MULTI-TISSUE_STRUCTURE", 77, 102], ["stroma", "TISSUE", 114, 120], ["pelvis", "ORGAN", 128, 134], ["interstitial lymphocytic accumulations", "PROBLEM", 16, 54], ["interstitial", "ANATOMY_MODIFIER", 16, 28], ["lymphocytic accumulations", "OBSERVATION", 29, 54], ["corticomedullary junction", "ANATOMY", 77, 102], ["stroma", "OBSERVATION", 114, 120], ["pelvis", "ANATOMY", 128, 134]]], ["The morbid picture of spontaneously fatal cases is usually distinct enough to allow a diagnosis to be made at gross postmortem.", [["spontaneously fatal cases", "PROBLEM", 22, 47], ["morbid", "OBSERVATION", 4, 10]]], ["Superficial lymph nodes are edematous, slightly congested, and often hemorrhagic.", [["lymph nodes", "ANATOMY", 12, 23], ["hemorrhagic", "DISEASE", 69, 80], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 12, 23], ["Superficial lymph nodes", "PROBLEM", 0, 23], ["edematous", "PROBLEM", 28, 37], ["slightly congested", "PROBLEM", 39, 57], ["hemorrhagic", "PROBLEM", 69, 80], ["lymph nodes", "OBSERVATION", 12, 23], ["edematous", "OBSERVATION_MODIFIER", 28, 37], ["slightly", "OBSERVATION_MODIFIER", 39, 47], ["congested", "OBSERVATION", 48, 57], ["often", "OBSERVATION_MODIFIER", 63, 68], ["hemorrhagic", "OBSERVATION_MODIFIER", 69, 80]]], ["Blotchy or paintbrush hemorrhages may be present on intestinal and gastric serosae, and there is usually a small quantity of clear or blood-stained fluid in the abdomen.", [["intestinal", "ANATOMY", 52, 62], ["gastric serosae", "ANATOMY", 67, 82], ["blood", "ANATOMY", 134, 139], ["fluid", "ANATOMY", 148, 153], ["abdomen", "ANATOMY", 161, 168], ["hemorrhages", "DISEASE", 22, 33], ["intestinal", "ORGAN", 52, 62], ["gastric serosae", "CANCER", 67, 82], ["blood", "ORGANISM_SUBSTANCE", 134, 139], ["fluid", "ORGANISM_SUBSTANCE", 148, 153], ["abdomen", "ORGAN", 161, 168], ["Blotchy", "PROBLEM", 0, 7], ["paintbrush hemorrhages", "PROBLEM", 11, 33], ["intestinal and gastric serosae", "PROBLEM", 52, 82], ["clear or blood-stained fluid in the abdomen", "PROBLEM", 125, 168], ["paintbrush", "OBSERVATION_MODIFIER", 11, 21], ["hemorrhages", "OBSERVATION", 22, 33], ["may be", "UNCERTAINTY", 34, 40], ["intestinal", "ANATOMY", 52, 62], ["gastric", "ANATOMY", 67, 74], ["serosae", "OBSERVATION", 75, 82], ["small", "OBSERVATION_MODIFIER", 107, 112], ["quantity", "OBSERVATION_MODIFIER", 113, 121], ["clear", "OBSERVATION", 125, 130], ["blood-stained", "OBSERVATION_MODIFIER", 134, 147], ["fluid", "OBSERVATION", 148, 153], ["abdomen", "ANATOMY", 161, 168]]], ["Jaundice, if present, is slight.", [["Jaundice", "DISEASE", 0, 8], ["Jaundice", "PROBLEM", 0, 8], ["slight", "OBSERVATION_MODIFIER", 25, 31]]], ["The liver is slightly enlarged, with sharp edges, and is turgid and friable, sometimes congested, with a fine, uniform, yellow mottling (eFig.", [["liver", "ANATOMY", 4, 9], ["liver", "ORGAN", 4, 9], ["slightly enlarged", "PROBLEM", 13, 30], ["congested", "PROBLEM", 87, 96], ["yellow mottling (eFig", "PROBLEM", 120, 141], ["liver", "ANATOMY", 4, 9], ["slightly", "OBSERVATION_MODIFIER", 13, 21], ["enlarged", "OBSERVATION", 22, 30], ["sharp", "OBSERVATION_MODIFIER", 37, 42], ["edges", "OBSERVATION_MODIFIER", 43, 48], ["turgid", "OBSERVATION_MODIFIER", 57, 63], ["friable", "OBSERVATION_MODIFIER", 68, 75], ["sometimes", "OBSERVATION_MODIFIER", 77, 86], ["congested", "OBSERVATION", 87, 96], ["fine", "OBSERVATION_MODIFIER", 105, 109], ["uniform", "OBSERVATION_MODIFIER", 111, 118], ["yellow", "OBSERVATION_MODIFIER", 120, 126], ["mottling", "OBSERVATION", 127, 135]]], ["2-17A).", [["2-17A", "CHEMICAL", 0, 5], ["2-17A", "SIMPLE_CHEMICAL", 0, 5]]], ["Red strands of fibrin can be found on its capsule, especially between the lobes.", [["capsule", "ANATOMY", 42, 49], ["lobes", "ANATOMY", 74, 79], ["fibrin", "GENE_OR_GENE_PRODUCT", 15, 21], ["capsule", "CANCER", 42, 49], ["lobes", "ORGAN", 74, 79], ["fibrin", "PROTEIN", 15, 21], ["Red strands of fibrin", "PROBLEM", 0, 21], ["strands", "OBSERVATION_MODIFIER", 4, 11], ["fibrin", "OBSERVATION", 15, 21], ["capsule", "OBSERVATION_MODIFIER", 42, 49], ["lobes", "ANATOMY_MODIFIER", 74, 79]]], ["In the majority of cases, the wall of the gallbladder is edematous (eFig.", [["wall", "ANATOMY", 30, 34], ["gallbladder", "ANATOMY", 42, 53], ["wall", "TISSUE", 30, 34], ["gallbladder", "ORGAN", 42, 53], ["edematous", "PROBLEM", 57, 66], ["wall", "ANATOMY_MODIFIER", 30, 34], ["gallbladder", "ANATOMY", 42, 53], ["edematous", "OBSERVATION", 57, 66]]], ["2-17B), and may have intramural hemorrhages; when edema is mild, it may be detected only in the attachments of the gallbladder.Infectious canine hepatitisGross lesions in other organs are inconstant.", [["edema", "ANATOMY", 50, 55], ["gallbladder", "ANATOMY", 115, 126], ["lesions", "ANATOMY", 160, 167], ["organs", "ANATOMY", 177, 183], ["2-17B", "CHEMICAL", 0, 5], ["hemorrhages", "DISEASE", 32, 43], ["edema", "DISEASE", 50, 55], ["canine hepatitis", "DISEASE", 138, 154], ["2-17B", "SIMPLE_CHEMICAL", 0, 5], ["intramural hemorrhages", "PATHOLOGICAL_FORMATION", 21, 43], ["edema", "PATHOLOGICAL_FORMATION", 50, 55], ["gallbladder", "ORGAN", 115, 126], ["canine", "ORGANISM", 138, 144], ["lesions", "PATHOLOGICAL_FORMATION", 160, 167], ["organs", "ORGAN", 177, 183], ["canine", "SPECIES", 138, 144], ["intramural hemorrhages", "PROBLEM", 21, 43], ["edema", "PROBLEM", 50, 55], ["Infectious canine hepatitisGross lesions in other organs", "PROBLEM", 127, 183], ["intramural", "OBSERVATION_MODIFIER", 21, 31], ["hemorrhages", "OBSERVATION", 32, 43], ["edema", "OBSERVATION", 50, 55], ["mild", "OBSERVATION_MODIFIER", 59, 63], ["may be", "UNCERTAINTY", 68, 74], ["attachments", "ANATOMY_MODIFIER", 96, 107], ["gallbladder", "ANATOMY", 115, 126], ["hepatitis", "OBSERVATION_MODIFIER", 145, 154], ["Gross", "OBSERVATION_MODIFIER", 154, 159], ["lesions", "OBSERVATION", 160, 167], ["organs", "ANATOMY", 177, 183], ["inconstant", "OBSERVATION_MODIFIER", 188, 198]]], ["Small hemorrhagic infarcts may be found in the renal cortices of young puppies.", [["renal cortices", "ANATOMY", 47, 61], ["hemorrhagic infarcts", "DISEASE", 6, 26], ["renal cortices", "MULTI-TISSUE_STRUCTURE", 47, 61], ["puppies", "ORGANISM_SUBDIVISION", 71, 78], ["Small hemorrhagic infarcts", "PROBLEM", 0, 26], ["young puppies", "PROBLEM", 65, 78], ["hemorrhagic", "OBSERVATION_MODIFIER", 6, 17], ["infarcts", "OBSERVATION", 18, 26], ["renal", "ANATOMY", 47, 52], ["cortices", "ANATOMY_MODIFIER", 53, 61], ["young", "OBSERVATION_MODIFIER", 65, 70], ["puppies", "OBSERVATION", 71, 78]]], ["Hemorrhages may occur in the lungs, and occasionally, there are irregular areas of hemorrhagic consolidation in the caudal lobes.", [["lungs", "ANATOMY", 29, 34], ["caudal lobes", "ANATOMY", 116, 128], ["Hemorrhages", "DISEASE", 0, 11], ["hemorrhagic", "DISEASE", 83, 94], ["lungs", "ORGAN", 29, 34], ["caudal lobes", "MULTI-TISSUE_STRUCTURE", 116, 128], ["Hemorrhages", "PROBLEM", 0, 11], ["irregular areas of hemorrhagic consolidation in the caudal lobes", "PROBLEM", 64, 128], ["lungs", "ANATOMY", 29, 34], ["irregular", "OBSERVATION_MODIFIER", 64, 73], ["areas", "OBSERVATION_MODIFIER", 74, 79], ["hemorrhagic", "OBSERVATION_MODIFIER", 83, 94], ["consolidation", "OBSERVATION", 95, 108], ["caudal lobes", "ANATOMY", 116, 128]]], ["Hemorrhages in the brain occur in a small percentage of cases, typically only grossly visible in the midbrain and brainstem.", [["brain", "ANATOMY", 19, 24], ["midbrain", "ANATOMY", 101, 109], ["brainstem", "ANATOMY", 114, 123], ["Hemorrhages", "DISEASE", 0, 11], ["brain", "ORGAN", 19, 24], ["midbrain", "CANCER", 101, 109], ["brainstem", "ORGAN", 114, 123], ["Hemorrhages in the brain", "PROBLEM", 0, 24], ["brain", "ANATOMY", 19, 24], ["small", "OBSERVATION_MODIFIER", 36, 41], ["percentage", "OBSERVATION_MODIFIER", 42, 52], ["cases", "OBSERVATION", 56, 61], ["grossly", "OBSERVATION_MODIFIER", 78, 85], ["visible", "OBSERVATION", 86, 93], ["midbrain", "ANATOMY", 101, 109], ["brainstem", "ANATOMY", 114, 123]]], ["Hemorrhagic necrosis of medullary and endosteal elements occurs in the metaphyses of long bones in young dogs, and the hemorrhages are readily visible through the thin cortex of the distal ends of the ribs.Infectious canine hepatitisAt low magnification, the histologic changes in the liver are of centrilobular (periacinar) zonal necrosis, resembling the zonal pattern of some acute hepatotoxicities.", [["medullary", "ANATOMY", 24, 33], ["endosteal", "ANATOMY", 38, 47], ["metaphyses", "ANATOMY", 71, 81], ["long bones", "ANATOMY", 85, 95], ["cortex", "ANATOMY", 168, 174], ["distal ends", "ANATOMY", 182, 193], ["ribs", "ANATOMY", 201, 205], ["liver", "ANATOMY", 285, 290], ["centrilobular", "ANATOMY", 298, 311], ["necrosis", "DISEASE", 12, 20], ["hemorrhages", "DISEASE", 119, 130], ["canine hepatitis", "DISEASE", 217, 233], ["necrosis", "DISEASE", 331, 339], ["hepatotoxicities", "DISEASE", 384, 400], ["medullary", "MULTI-TISSUE_STRUCTURE", 24, 33], ["endosteal", "TISSUE", 38, 47], ["long bones", "TISSUE", 85, 95], ["dogs", "ORGANISM", 105, 109], ["cortex", "CANCER", 168, 174], ["ribs", "ORGAN", 201, 205], ["canine", "ORGANISM", 217, 223], ["liver", "ORGAN", 285, 290], ["dogs", "SPECIES", 105, 109], ["canine", "SPECIES", 217, 223], ["canine hepatitis", "SPECIES", 217, 233], ["Hemorrhagic necrosis of medullary and endosteal elements", "PROBLEM", 0, 56], ["the hemorrhages", "PROBLEM", 115, 130], ["Infectious canine hepatitis", "PROBLEM", 206, 233], ["the histologic changes in the liver", "PROBLEM", 255, 290], ["centrilobular (periacinar) zonal necrosis", "PROBLEM", 298, 339], ["some acute hepatotoxicities", "PROBLEM", 373, 400], ["necrosis", "OBSERVATION", 12, 20], ["medullary", "ANATOMY", 24, 33], ["endosteal elements", "OBSERVATION", 38, 56], ["metaphyses", "ANATOMY_MODIFIER", 71, 81], ["long", "ANATOMY_MODIFIER", 85, 89], ["bones", "ANATOMY", 90, 95], ["young", "OBSERVATION_MODIFIER", 99, 104], ["dogs", "OBSERVATION", 105, 109], ["hemorrhages", "OBSERVATION", 119, 130], ["visible", "OBSERVATION_MODIFIER", 143, 150], ["thin", "OBSERVATION_MODIFIER", 163, 167], ["cortex", "ANATOMY_MODIFIER", 168, 174], ["distal", "ANATOMY_MODIFIER", 182, 188], ["ends", "ANATOMY_MODIFIER", 189, 193], ["ribs", "ANATOMY", 201, 205], ["hepatitis", "OBSERVATION", 224, 233], ["low magnification", "OBSERVATION_MODIFIER", 236, 253], ["histologic", "OBSERVATION", 259, 269], ["liver", "ANATOMY", 285, 290], ["centrilobular", "OBSERVATION_MODIFIER", 298, 311], ["zonal", "OBSERVATION_MODIFIER", 325, 330], ["necrosis", "OBSERVATION", 331, 339], ["zonal", "OBSERVATION_MODIFIER", 356, 361], ["pattern", "OBSERVATION_MODIFIER", 362, 369], ["some", "OBSERVATION_MODIFIER", 373, 377], ["acute", "OBSERVATION_MODIFIER", 378, 383], ["hepatotoxicities", "OBSERVATION", 384, 400]]], ["The susceptibility of centrilobular parenchyma to necrosis in this disease is as yet unexplained.", [["centrilobular parenchyma", "ANATOMY", 22, 46], ["necrosis", "DISEASE", 50, 58], ["centrilobular parenchyma", "MULTI-TISSUE_STRUCTURE", 22, 46], ["centrilobular parenchyma", "PROBLEM", 22, 46], ["necrosis", "PROBLEM", 50, 58], ["this disease", "PROBLEM", 62, 74], ["susceptibility", "OBSERVATION_MODIFIER", 4, 18], ["centrilobular", "ANATOMY_MODIFIER", 22, 35], ["parenchyma", "ANATOMY", 36, 46], ["necrosis", "OBSERVATION", 50, 58]]], ["Close to the portal triads, the hepatocytes may be nearly normal in appearance, except for loss of basophilia and the presence of a scattering of inclusion bodies.", [["portal triads", "ANATOMY", 13, 26], ["hepatocytes", "ANATOMY", 32, 43], ["loss of basophilia", "DISEASE", 91, 109], ["portal triads", "MULTI-TISSUE_STRUCTURE", 13, 26], ["hepatocytes", "CELL", 32, 43], ["hepatocytes", "CELL_TYPE", 32, 43], ["loss of basophilia", "PROBLEM", 91, 109], ["a scattering of inclusion bodies", "PROBLEM", 130, 162], ["portal triads", "ANATOMY", 13, 26], ["hepatocytes", "ANATOMY", 32, 43], ["may be", "UNCERTAINTY", 44, 50], ["nearly", "OBSERVATION_MODIFIER", 51, 57], ["normal", "OBSERVATION", 58, 64], ["basophilia", "OBSERVATION", 99, 109], ["scattering", "OBSERVATION_MODIFIER", 132, 142], ["inclusion bodies", "OBSERVATION", 146, 162]]], ["In spontaneously fatal cases, most of the parenchyma of the peripheral and central portions of the lobules (acini) is dead, the hepatocytes having undergone coagulative necrosis, and in some of these, ghosts of inclusion bodies may be detectable.", [["parenchyma", "ANATOMY", 42, 52], ["peripheral", "ANATOMY", 60, 70], ["central portions", "ANATOMY", 75, 91], ["lobules", "ANATOMY", 99, 106], ["acini", "ANATOMY", 108, 113], ["hepatocytes", "ANATOMY", 128, 139], ["necrosis", "DISEASE", 169, 177], ["parenchyma", "TISSUE", 42, 52], ["peripheral", "TISSUE", 60, 70], ["central portions", "MULTI-TISSUE_STRUCTURE", 75, 91], ["lobules", "TISSUE", 99, 106], ["acini", "MULTI-TISSUE_STRUCTURE", 108, 113], ["hepatocytes", "CELL", 128, 139], ["hepatocytes", "CELL_TYPE", 128, 139], ["dead", "PROBLEM", 118, 122], ["coagulative necrosis", "PROBLEM", 157, 177], ["spontaneously", "OBSERVATION_MODIFIER", 3, 16], ["fatal", "OBSERVATION_MODIFIER", 17, 22], ["cases", "OBSERVATION", 23, 28], ["parenchyma", "ANATOMY_MODIFIER", 42, 52], ["peripheral", "ANATOMY_MODIFIER", 60, 70], ["central", "ANATOMY_MODIFIER", 75, 82], ["portions", "ANATOMY_MODIFIER", 83, 91], ["lobules", "ANATOMY_MODIFIER", 99, 106], ["hepatocytes", "ANATOMY", 128, 139], ["coagulative", "OBSERVATION_MODIFIER", 157, 168], ["necrosis", "OBSERVATION", 169, 177], ["inclusion bodies", "OBSERVATION", 211, 227], ["may be detectable", "UNCERTAINTY", 228, 245]]], ["The margin between necrotic parenchyma and viable tissue is usually quite sharp, although in the viable tissue, there are many individual hepatocytes undergoing apoptosis, most of them without inclusion bodies.", [["necrotic parenchyma", "ANATOMY", 19, 38], ["tissue", "ANATOMY", 50, 56], ["tissue", "ANATOMY", 104, 110], ["hepatocytes", "ANATOMY", 138, 149], ["necrotic", "DISEASE", 19, 27], ["necrotic parenchyma", "TISSUE", 19, 38], ["tissue", "TISSUE", 50, 56], ["tissue", "TISSUE", 104, 110], ["hepatocytes", "CELL", 138, 149], ["hepatocytes", "CELL_TYPE", 138, 149], ["necrotic parenchyma and viable tissue", "PROBLEM", 19, 56], ["many individual hepatocytes undergoing apoptosis", "PROBLEM", 122, 170], ["inclusion bodies", "PROBLEM", 193, 209], ["margin", "OBSERVATION_MODIFIER", 4, 10], ["necrotic", "OBSERVATION_MODIFIER", 19, 27], ["parenchyma", "OBSERVATION", 28, 38], ["viable tissue", "OBSERVATION", 43, 56], ["sharp", "OBSERVATION_MODIFIER", 74, 79], ["viable", "OBSERVATION_MODIFIER", 97, 103], ["tissue", "OBSERVATION", 104, 110], ["many", "OBSERVATION_MODIFIER", 122, 126], ["individual", "OBSERVATION_MODIFIER", 127, 137], ["hepatocytes", "ANATOMY", 138, 149], ["undergoing apoptosis", "OBSERVATION", 150, 170], ["without", "UNCERTAINTY", 185, 192], ["inclusion", "OBSERVATION", 193, 202]]], ["Fatty change is common.", [["Fatty", "SIMPLE_CHEMICAL", 0, 5], ["Fatty change", "PROBLEM", 0, 12]]], ["The losses.", [["The losses", "PROBLEM", 0, 10], ["losses", "OBSERVATION_MODIFIER", 4, 10]]], ["Morbidity and mortality may occur in adult sheep; death sometimes occurs in adult cattle, but it is chiefly a disease of the young, causing heavy mortality among lambs, kids, and calves, and abortion in ewes, does, and cows.", [["death", "DISEASE", 50, 55], ["abortion", "DISEASE", 191, 199], ["sheep", "ORGANISM", 43, 48], ["lambs", "ORGANISM", 162, 167], ["calves", "ORGANISM", 179, 185], ["ewes", "ORGANISM_SUBDIVISION", 203, 207], ["sheep", "SPECIES", 43, 48], ["cattle", "SPECIES", 82, 88], ["lambs", "SPECIES", 162, 167], ["calves", "SPECIES", 179, 185], ["cows", "SPECIES", 219, 223], ["sheep", "SPECIES", 43, 48], ["cattle", "SPECIES", 82, 88], ["Morbidity", "PROBLEM", 0, 9], ["death", "PROBLEM", 50, 55], ["calves", "ANATOMY", 179, 185]]], ["The infection in enzootic form is widespread in eastern and southern Africa, but it has, in plague-like proportions, extended to West Africa, Egypt, and the Arabian Peninsula.", [["infection", "DISEASE", 4, 13], ["The infection in enzootic form", "PROBLEM", 0, 30], ["infection", "OBSERVATION", 4, 13], ["enzootic", "OBSERVATION_MODIFIER", 17, 25], ["widespread", "OBSERVATION_MODIFIER", 34, 44], ["eastern", "OBSERVATION_MODIFIER", 48, 55], ["southern", "OBSERVATION_MODIFIER", 60, 68], ["Africa", "OBSERVATION", 69, 75], ["plague", "OBSERVATION", 92, 98], ["Arabian Peninsula", "ANATOMY", 157, 174]]], ["RVFV is a member of the Phlebovirus genus, 1 of the 5 genera in the family Bunyaviridae.", [["RVFV", "DISEASE", 0, 4], ["Bunyaviridae", "DISEASE", 75, 87], ["RVFV", "ORGANISM", 0, 4], ["Phlebovirus genus", "ORGANISM", 24, 41], ["RVFV", "SPECIES", 0, 4], ["the Phlebovirus genus", "PROBLEM", 20, 41]]], ["It is transmitted by many species of mosquito of the genera Culex and Aedes, in which transovarial passage can occur.", [["many", "OBSERVATION_MODIFIER", 21, 25], ["species", "OBSERVATION_MODIFIER", 26, 33], ["genera Culex", "OBSERVATION", 53, 65]]], ["Mosquitoes, once infected, remain so, and in them, the virus is not pathogenic.", [["the virus", "PROBLEM", 51, 60], ["pathogenic", "PROBLEM", 68, 78], ["virus", "OBSERVATION", 55, 60], ["not", "UNCERTAINTY", 64, 67], ["pathogenic", "OBSERVATION", 68, 78]]], ["High levels of viremia occur in sheep and cattle and are maintained for up to 5 days.", [["viremia", "DISEASE", 15, 22], ["sheep", "ORGANISM", 32, 37], ["cattle", "ORGANISM", 42, 48], ["sheep", "SPECIES", 32, 37], ["cattle", "SPECIES", 42, 48], ["sheep", "SPECIES", 32, 37], ["cattle", "SPECIES", 42, 48], ["High levels of viremia", "PROBLEM", 0, 22], ["viremia", "OBSERVATION", 15, 22]]], ["During epizootics, the virus may be spread by fomites, aerosols, and mechanically by other biting insects.Infectious canine hepatitisIn endemic situations, the disease in adults is usually mild, but in epidemics in sheep and goats, severe illness occurs with fever, mucopurulent nasal discharge, and dysentery.", [["nasal", "ANATOMY", 279, 284], ["epizootics", "DISEASE", 7, 17], ["canine hepatitis", "DISEASE", 117, 133], ["illness", "DISEASE", 239, 246], ["fever", "DISEASE", 259, 264], ["dysentery", "DISEASE", 300, 309], ["canine", "ORGANISM", 117, 123], ["sheep", "ORGANISM", 215, 220], ["goats", "ORGANISM", 225, 230], ["nasal", "ORGANISM_SUBDIVISION", 279, 284], ["canine", "SPECIES", 117, 123], ["sheep", "SPECIES", 215, 220], ["goats", "SPECIES", 225, 230], ["canine hepatitis", "SPECIES", 117, 133], ["sheep", "SPECIES", 215, 220], ["goats", "SPECIES", 225, 230], ["the virus", "PROBLEM", 19, 28], ["Infectious canine hepatitis", "PROBLEM", 106, 133], ["the disease in adults", "PROBLEM", 156, 177], ["severe illness", "PROBLEM", 232, 246], ["fever", "PROBLEM", 259, 264], ["mucopurulent nasal discharge", "PROBLEM", 266, 294], ["dysentery", "PROBLEM", 300, 309], ["virus", "OBSERVATION", 23, 28], ["may be", "UNCERTAINTY", 29, 35], ["spread", "OBSERVATION_MODIFIER", 36, 42], ["hepatitis", "OBSERVATION", 124, 133], ["endemic", "OBSERVATION_MODIFIER", 136, 143], ["disease", "OBSERVATION", 160, 167], ["mild", "OBSERVATION_MODIFIER", 189, 193], ["severe", "OBSERVATION_MODIFIER", 232, 238], ["dysentery", "OBSERVATION", 300, 309]]], ["The mortality rate is then very high, reaching 90-100% in lambs and 10-30% in adults.", [["lambs", "ORGANISM", 58, 63], ["The mortality rate", "TEST", 0, 18], ["lambs", "TEST", 58, 63], ["very", "OBSERVATION_MODIFIER", 27, 31], ["high", "OBSERVATION_MODIFIER", 32, 36]]], ["The disease in cattle is less severe, but pregnant animals abort, and the mortality rate in adult animals is 5-10%, whereas in calves it may reach 70%.Infectious canine hepatitisAs in Wesselsbron disease, the gross postmortem picture is dominated by widespread hemorrhage, ranging from serosal petechiae to severe gastrointestinal bleeding.", [["serosal petechiae", "ANATOMY", 286, 303], ["gastrointestinal", "ANATOMY", 314, 330], ["canine hepatitisAs", "DISEASE", 162, 180], ["Wesselsbron disease", "DISEASE", 184, 203], ["hemorrhage", "DISEASE", 261, 271], ["petechiae", "DISEASE", 294, 303], ["gastrointestinal bleeding", "DISEASE", 314, 339], ["cattle", "ORGANISM", 15, 21], ["calves", "ORGANISM", 127, 133], ["canine", "ORGANISM", 162, 168], ["serosal petechiae", "PATHOLOGICAL_FORMATION", 286, 303], ["gastrointestinal bleeding", "PATHOLOGICAL_FORMATION", 314, 339], ["cattle", "SPECIES", 15, 21], ["calves", "SPECIES", 127, 133], ["canine", "SPECIES", 162, 168], ["cattle", "SPECIES", 15, 21], ["canine", "SPECIES", 162, 168], ["The disease in cattle", "PROBLEM", 0, 21], ["the mortality rate", "TEST", 70, 88], ["Infectious canine hepatitisAs", "PROBLEM", 151, 180], ["Wesselsbron disease", "PROBLEM", 184, 203], ["the gross postmortem picture", "TEST", 205, 233], ["widespread hemorrhage", "PROBLEM", 250, 271], ["serosal petechiae", "PROBLEM", 286, 303], ["severe gastrointestinal bleeding", "PROBLEM", 307, 339], ["disease", "OBSERVATION", 4, 11], ["less", "OBSERVATION_MODIFIER", 25, 29], ["severe", "OBSERVATION_MODIFIER", 30, 36], ["Wesselsbron disease", "OBSERVATION", 184, 203], ["widespread", "OBSERVATION_MODIFIER", 250, 260], ["hemorrhage", "OBSERVATION", 261, 271], ["ranging", "OBSERVATION_MODIFIER", 273, 280], ["serosal", "ANATOMY", 286, 293], ["petechiae", "OBSERVATION", 294, 303], ["severe", "OBSERVATION_MODIFIER", 307, 313], ["gastrointestinal", "ANATOMY", 314, 330], ["bleeding", "OBSERVATION", 331, 339]]], ["The liver in the acute cases in neonatal lambs is similar to that in cases of Wesselsbron disease, being yellow, swollen, soft, and patchily congested or hemorrhagic.", [["liver", "ANATOMY", 4, 9], ["Wesselsbron disease", "DISEASE", 78, 97], ["hemorrhagic", "DISEASE", 154, 165], ["liver", "ORGAN", 4, 9], ["lambs", "ORGANISM", 41, 46], ["lambs", "SPECIES", 41, 46], ["Wesselsbron disease", "PROBLEM", 78, 97], ["yellow", "PROBLEM", 105, 111], ["swollen", "PROBLEM", 113, 120], ["patchily congested", "PROBLEM", 132, 150], ["hemorrhagic", "PROBLEM", 154, 165], ["liver", "ANATOMY", 4, 9], ["acute", "OBSERVATION_MODIFIER", 17, 22], ["cases", "OBSERVATION", 23, 28], ["Wesselsbron disease", "OBSERVATION", 78, 97], ["yellow", "OBSERVATION_MODIFIER", 105, 111], ["swollen", "OBSERVATION_MODIFIER", 113, 120], ["soft", "ANATOMY", 122, 126], ["patchily", "OBSERVATION_MODIFIER", 132, 140], ["congested", "OBSERVATION", 141, 150], ["hemorrhagic", "OBSERVATION_MODIFIER", 154, 165]]], ["In older animals and in less acute cases, however, the liver tends to be darker and shows scattered pale foci of necrosis 1-2 mm in diameter.", [["liver", "ANATOMY", 55, 60], ["pale foci", "ANATOMY", 100, 109], ["necrosis", "DISEASE", 113, 121], ["liver", "ORGAN", 55, 60], ["scattered pale foci of necrosis", "PROBLEM", 90, 121], ["less", "OBSERVATION_MODIFIER", 24, 28], ["acute", "OBSERVATION_MODIFIER", 29, 34], ["cases", "OBSERVATION", 35, 40], ["liver", "ANATOMY", 55, 60], ["scattered", "OBSERVATION_MODIFIER", 90, 99], ["pale", "OBSERVATION_MODIFIER", 100, 104], ["foci", "OBSERVATION_MODIFIER", 105, 109], ["necrosis", "OBSERVATION", 113, 121], ["1-2 mm", "OBSERVATION_MODIFIER", 122, 128], ["diameter", "OBSERVATION_MODIFIER", 132, 140]]], ["There may be fibrinous perihepatitis, edema of the gallbladder wall, and moderate, blood-tinged ascites.", [["fibrinous perihepatitis", "ANATOMY", 13, 36], ["edema", "ANATOMY", 38, 43], ["gallbladder wall", "ANATOMY", 51, 67], ["blood", "ANATOMY", 83, 88], ["ascites", "ANATOMY", 96, 103], ["perihepatitis", "DISEASE", 23, 36], ["edema", "DISEASE", 38, 43], ["ascites", "DISEASE", 96, 103], ["edema", "PATHOLOGICAL_FORMATION", 38, 43], ["gallbladder wall", "MULTI-TISSUE_STRUCTURE", 51, 67], ["blood", "ORGANISM_SUBSTANCE", 83, 88], ["fibrinous perihepatitis", "PROBLEM", 13, 36], ["edema of the gallbladder wall", "PROBLEM", 38, 67], ["moderate, blood-tinged ascites", "PROBLEM", 73, 103], ["may be", "UNCERTAINTY", 6, 12], ["fibrinous perihepatitis", "OBSERVATION", 13, 36], ["edema", "OBSERVATION", 38, 43], ["gallbladder", "ANATOMY", 51, 62], ["wall", "ANATOMY_MODIFIER", 63, 67], ["moderate", "OBSERVATION_MODIFIER", 73, 81], ["tinged", "OBSERVATION_MODIFIER", 89, 95], ["ascites", "OBSERVATION", 96, 103]]], ["Experimental infection of calves produced encephalomyelitis in an animal that survived the initial viremic stage.Infectious canine hepatitisWithin 12 hours of experimental infection of lambs, there are randomly distributed foci of hepatocellular necrosis in the liver.", [["foci", "ANATOMY", 223, 227], ["hepatocellular", "ANATOMY", 231, 245], ["liver", "ANATOMY", 262, 267], ["infection", "DISEASE", 13, 22], ["encephalomyelitis", "DISEASE", 42, 59], ["infection", "DISEASE", 172, 181], ["hepatocellular necrosis", "DISEASE", 231, 254], ["calves", "ORGANISM", 26, 32], ["canine", "ORGANISM", 124, 130], ["lambs", "ORGANISM", 185, 190], ["foci", "CELL", 223, 227], ["hepatocellular", "CANCER", 231, 245], ["liver", "ORGAN", 262, 267], ["calves", "SPECIES", 26, 32], ["canine", "SPECIES", 124, 130], ["lambs", "SPECIES", 185, 190], ["Experimental infection of calves", "PROBLEM", 0, 32], ["encephalomyelitis", "PROBLEM", 42, 59], ["experimental infection of lambs", "PROBLEM", 159, 190], ["hepatocellular necrosis in the liver", "PROBLEM", 231, 267], ["infection", "OBSERVATION", 13, 22], ["calves", "ANATOMY", 26, 32], ["encephalomyelitis", "OBSERVATION", 42, 59], ["infection", "OBSERVATION", 172, 181], ["randomly", "OBSERVATION_MODIFIER", 202, 210], ["distributed", "OBSERVATION_MODIFIER", 211, 222], ["foci", "OBSERVATION", 223, 227], ["hepatocellular", "ANATOMY", 231, 245], ["necrosis", "OBSERVATION", 246, 254], ["liver", "ANATOMY", 262, 267]]], ["These foci include aggregates of inflammatory cells and prominent apoptotic bodies and initially involve about a half dozen hepatocytes .", [["foci", "ANATOMY", 6, 10], ["inflammatory cells", "ANATOMY", 33, 51], ["bodies", "ANATOMY", 76, 82], ["hepatocytes", "ANATOMY", 124, 135], ["inflammatory cells", "CELL", 33, 51], ["apoptotic bodies", "CELLULAR_COMPONENT", 66, 82], ["hepatocytes", "CELL", 124, 135], ["inflammatory cells", "CELL_TYPE", 33, 51], ["hepatocytes", "CELL_TYPE", 124, 135], ["These foci", "PROBLEM", 0, 10], ["inflammatory cells", "PROBLEM", 33, 51], ["prominent apoptotic bodies", "PROBLEM", 56, 82], ["foci", "OBSERVATION", 6, 10], ["aggregates", "OBSERVATION_MODIFIER", 19, 29], ["inflammatory cells", "OBSERVATION", 33, 51], ["prominent", "OBSERVATION_MODIFIER", 56, 65], ["apoptotic bodies", "OBSERVATION", 66, 82], ["hepatocytes", "ANATOMY", 124, 135]]], ["Within a few hours, however, these primary foci enlarge and may become almost confluent.", [["primary foci", "ANATOMY", 35, 47], ["these primary foci", "PROBLEM", 29, 47], ["primary", "OBSERVATION_MODIFIER", 35, 42], ["foci", "OBSERVATION", 43, 47], ["enlarge", "OBSERVATION_MODIFIER", 48, 55], ["may become", "UNCERTAINTY", 60, 70], ["almost", "OBSERVATION_MODIFIER", 71, 77], ["confluent", "OBSERVATION_MODIFIER", 78, 87]]], ["In the meantime, the remaining parenchyma may rapidly undergo necrosis that spares only a small rim of periportal hepatocytes.", [["parenchyma", "ANATOMY", 31, 41], ["periportal hepatocytes", "ANATOMY", 103, 125], ["necrosis", "DISEASE", 62, 70], ["parenchyma", "TISSUE", 31, 41], ["periportal hepatocytes", "CELL", 103, 125], ["periportal hepatocytes", "CELL_TYPE", 103, 125], ["necrosis", "PROBLEM", 62, 70], ["a small rim of periportal hepatocytes", "PROBLEM", 88, 125], ["remaining", "ANATOMY_MODIFIER", 21, 30], ["parenchyma", "ANATOMY", 31, 41], ["necrosis", "OBSERVATION", 62, 70], ["small", "OBSERVATION_MODIFIER", 90, 95], ["rim", "OBSERVATION_MODIFIER", 96, 99], ["periportal", "ANATOMY_MODIFIER", 103, 113], ["hepatocytes", "ANATOMY", 114, 125]]], ["In naturally infected calves, the primary foci of necrosis undergo lysis more rapidly than the surrounding parenchyma; these foci thus have a striking \"washed-out\" appearance.", [["calves", "ANATOMY", 22, 28], ["primary foci", "ANATOMY", 34, 46], ["parenchyma", "ANATOMY", 107, 117], ["foci", "ANATOMY", 125, 129], ["necrosis", "DISEASE", 50, 58], ["calves", "ORGANISM", 22, 28], ["parenchyma", "TISSUE", 107, 117], ["calves", "SPECIES", 22, 28], ["necrosis", "PROBLEM", 50, 58], ["lysis", "TREATMENT", 67, 72], ["these foci", "PROBLEM", 119, 129], ["naturally", "OBSERVATION_MODIFIER", 3, 12], ["infected calves", "OBSERVATION", 13, 28], ["primary", "OBSERVATION_MODIFIER", 34, 41], ["foci", "OBSERVATION_MODIFIER", 42, 46], ["necrosis", "OBSERVATION", 50, 58], ["lysis", "OBSERVATION", 67, 72], ["surrounding", "ANATOMY_MODIFIER", 95, 106], ["parenchyma", "ANATOMY", 107, 117], ["foci", "OBSERVATION", 125, 129]]], ["Where the expanding foci of necrosis include portal triads, there may follow fibrinous vasculitis and thrombosis.", [["foci", "ANATOMY", 20, 24], ["portal triads", "ANATOMY", 45, 58], ["necrosis", "DISEASE", 28, 36], ["vasculitis", "DISEASE", 87, 97], ["thrombosis", "DISEASE", 102, 112], ["foci", "CELL", 20, 24], ["portal triads", "MULTI-TISSUE_STRUCTURE", 45, 58], ["necrosis", "PROBLEM", 28, 36], ["fibrinous vasculitis", "PROBLEM", 77, 97], ["thrombosis", "PROBLEM", 102, 112], ["expanding", "OBSERVATION_MODIFIER", 10, 19], ["foci", "OBSERVATION", 20, 24], ["necrosis", "OBSERVATION", 28, 36], ["portal triads", "ANATOMY", 45, 58], ["fibrinous", "OBSERVATION_MODIFIER", 77, 86], ["vasculitis", "OBSERVATION", 87, 97], ["thrombosis", "OBSERVATION", 102, 112]]], ["Fibrin deposition in sinusoids is common, and so is mineralization of necrotic hepatocytes.", [["sinusoids", "ANATOMY", 21, 30], ["necrotic hepatocytes", "ANATOMY", 70, 90], ["necrotic", "DISEASE", 70, 78], ["Fibrin", "GENE_OR_GENE_PRODUCT", 0, 6], ["sinusoids", "TISSUE", 21, 30], ["necrotic hepatocytes", "CELL", 70, 90], ["necrotic hepatocytes", "CELL_TYPE", 70, 90], ["Fibrin deposition in sinusoids", "PROBLEM", 0, 30], ["necrotic hepatocytes", "PROBLEM", 70, 90], ["deposition", "OBSERVATION", 7, 17], ["sinusoids", "ANATOMY", 21, 30], ["common", "OBSERVATION_MODIFIER", 34, 40], ["mineralization", "OBSERVATION_MODIFIER", 52, 66], ["necrotic", "OBSERVATION_MODIFIER", 70, 78], ["hepatocytes", "OBSERVATION", 79, 90]]], ["Cholestasis is apparent in sections but is not a prominent feature.Infectious canine hepatitisEosinophilic intranuclear inclusion bodies, often elongated, are sometimes seen in degenerate hepatocytes; there is associated nuclear vesiculation and chromatin margination.", [["sections", "ANATOMY", 27, 35], ["intranuclear inclusion bodies", "ANATOMY", 107, 136], ["hepatocytes", "ANATOMY", 188, 199], ["nuclear", "ANATOMY", 221, 228], ["chromatin", "ANATOMY", 246, 255], ["Cholestasis", "DISEASE", 0, 11], ["hepatitis", "DISEASE", 85, 94], ["canine hepatitis", "ORGANISM", 78, 94], ["hepatocytes", "CELL", 188, 199], ["nuclear", "CELLULAR_COMPONENT", 221, 228], ["chromatin", "CELLULAR_COMPONENT", 246, 255], ["degenerate hepatocytes", "CELL_TYPE", 177, 199], ["chromatin", "DNA", 246, 255], ["canine", "SPECIES", 78, 84], ["Cholestasis", "PROBLEM", 0, 11], ["Infectious canine hepatitisEosinophilic intranuclear inclusion bodies", "PROBLEM", 67, 136], ["degenerate hepatocytes", "PROBLEM", 177, 199], ["nuclear vesiculation", "PROBLEM", 221, 241], ["chromatin margination", "PROBLEM", 246, 267], ["not a prominent", "OBSERVATION_MODIFIER", 43, 58], ["hepatitis", "OBSERVATION_MODIFIER", 85, 94], ["Eosinophilic", "OBSERVATION_MODIFIER", 94, 106], ["intranuclear inclusion bodies", "OBSERVATION", 107, 136], ["elongated", "OBSERVATION_MODIFIER", 144, 153], ["hepatocytes", "ANATOMY", 188, 199], ["nuclear", "OBSERVATION_MODIFIER", 221, 228], ["vesiculation", "OBSERVATION", 229, 241], ["chromatin margination", "OBSERVATION", 246, 267]]], ["There is necrosis in germinal centers of lymphoid follicles in lymph nodes and spleen similar to that seen in Wesselsbron disease.", [["germinal centers", "ANATOMY", 21, 37], ["lymphoid follicles", "ANATOMY", 41, 59], ["lymph nodes", "ANATOMY", 63, 74], ["spleen", "ANATOMY", 79, 85], ["necrosis", "DISEASE", 9, 17], ["Wesselsbron disease", "DISEASE", 110, 129], ["germinal centers", "MULTI-TISSUE_STRUCTURE", 21, 37], ["lymphoid follicles", "MULTI-TISSUE_STRUCTURE", 41, 59], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 63, 74], ["spleen", "ORGAN", 79, 85], ["necrosis", "PROBLEM", 9, 17], ["lymphoid follicles in lymph nodes and spleen", "PROBLEM", 41, 85], ["Wesselsbron disease", "PROBLEM", 110, 129], ["necrosis", "OBSERVATION", 9, 17], ["germinal", "ANATOMY_MODIFIER", 21, 29], ["centers", "OBSERVATION_MODIFIER", 30, 37], ["lymphoid follicles", "OBSERVATION", 41, 59], ["lymph nodes", "OBSERVATION", 63, 74], ["spleen", "ANATOMY", 79, 85], ["disease", "OBSERVATION", 122, 129]]], ["Renal glomerular hypercellularity and necrosis have been described in the experimental disease.", [["Renal glomerular", "ANATOMY", 0, 16], ["necrosis", "DISEASE", 38, 46], ["Renal glomerular", "TISSUE", 0, 16], ["Renal glomerular hypercellularity", "PROBLEM", 0, 33], ["necrosis", "PROBLEM", 38, 46], ["the experimental disease", "PROBLEM", 70, 94], ["glomerular", "ANATOMY", 6, 16], ["hypercellularity", "OBSERVATION", 17, 33], ["necrosis", "OBSERVATION", 38, 46], ["experimental", "OBSERVATION_MODIFIER", 74, 86], ["disease", "OBSERVATION", 87, 94]]], ["By immunohistochemistry, RVFV antigen can be detected in focal areas in cytoplasm of degenerating and necrotic hepatocytes but not in nonparenchymal cells.Infectious canine hepatitisUltrastructural studies have shown condensation of degenerate hepatocytes, abundant apoptosis, and the presence of membrane-bound fragments of hepatocellular cytoplasm, but Corneal edema is a late development, corresponding temporally to increasing neutralizing antibody titer.", [["focal areas", "ANATOMY", 57, 68], ["cytoplasm", "ANATOMY", 72, 81], ["necrotic hepatocytes", "ANATOMY", 102, 122], ["nonparenchymal cells", "ANATOMY", 134, 154], ["hepatocytes", "ANATOMY", 244, 255], ["membrane", "ANATOMY", 297, 305], ["fragments", "ANATOMY", 312, 321], ["hepatocellular cytoplasm", "ANATOMY", 325, 349], ["Corneal edema", "ANATOMY", 355, 368], ["necrotic", "DISEASE", 102, 110], ["canine hepatitis", "DISEASE", 166, 182], ["Corneal edema", "DISEASE", 355, 368], ["RVFV antigen", "GENE_OR_GENE_PRODUCT", 25, 37], ["focal areas", "CELLULAR_COMPONENT", 57, 68], ["cytoplasm", "ORGANISM_SUBSTANCE", 72, 81], ["hepatocytes", "CELL", 111, 122], ["nonparenchymal cells", "CELL", 134, 154], ["hepatocytes", "CELL", 244, 255], ["membrane", "CELLULAR_COMPONENT", 297, 305], ["hepatocellular cytoplasm", "ORGANISM_SUBSTANCE", 325, 349], ["RVFV antigen", "PROTEIN", 25, 37], ["degenerating and necrotic hepatocytes", "CELL_TYPE", 85, 122], ["nonparenchymal cells", "CELL_TYPE", 134, 154], ["degenerate hepatocytes", "CELL_TYPE", 233, 255], ["RVFV", "SPECIES", 25, 29], ["immunohistochemistry", "TEST", 3, 23], ["RVFV antigen", "TEST", 25, 37], ["degenerating and necrotic hepatocytes", "PROBLEM", 85, 122], ["Infectious canine hepatitisUltrastructural studies", "TEST", 155, 205], ["condensation of degenerate hepatocytes", "PROBLEM", 217, 255], ["abundant apoptosis", "PROBLEM", 257, 275], ["membrane-bound fragments", "PROBLEM", 297, 321], ["hepatocellular cytoplasm", "PROBLEM", 325, 349], ["Corneal edema", "PROBLEM", 355, 368], ["increasing neutralizing antibody titer", "PROBLEM", 420, 458], ["focal", "OBSERVATION_MODIFIER", 57, 62], ["cytoplasm", "OBSERVATION_MODIFIER", 72, 81], ["degenerating", "OBSERVATION_MODIFIER", 85, 97], ["necrotic hepatocytes", "OBSERVATION", 102, 122], ["not in", "UNCERTAINTY", 127, 133], ["nonparenchymal cells", "OBSERVATION", 134, 154], ["hepatitis", "OBSERVATION", 173, 182], ["degenerate hepatocytes", "OBSERVATION", 233, 255], ["abundant", "OBSERVATION_MODIFIER", 257, 265], ["apoptosis", "OBSERVATION_MODIFIER", 266, 275], ["membrane", "OBSERVATION_MODIFIER", 297, 305], ["bound fragments", "OBSERVATION", 306, 321], ["hepatocellular cytoplasm", "OBSERVATION", 325, 349], ["Corneal", "ANATOMY", 355, 362], ["edema", "OBSERVATION", 363, 368], ["increasing", "OBSERVATION_MODIFIER", 420, 430], ["neutralizing antibody titer", "OBSERVATION", 431, 458]]], ["It may occur as early as day 7 of infection, but is usually delayed to between 14 and 21 days.", [["infection", "DISEASE", 34, 43], ["infection", "PROBLEM", 34, 43], ["infection", "OBSERVATION", 34, 43]]], ["Viral antigen can be detected in these eyes by fluorescent techniques, but not in the corneal structures.", [["eyes", "ANATOMY", 39, 43], ["corneal structures", "ANATOMY", 86, 104], ["Viral", "ORGANISM", 0, 5], ["eyes", "ORGAN", 39, 43], ["corneal structures", "TISSUE", 86, 104], ["Viral antigen", "PROTEIN", 0, 13], ["Viral antigen", "TEST", 0, 13], ["fluorescent techniques", "TEST", 47, 69], ["corneal", "ANATOMY", 86, 93]]], ["Inflammatory edema is present in the iris, ciliary apparatus, and corneal propria, and inflammatory cells are abundant in the filtration angle and iris.", [["iris", "ANATOMY", 37, 41], ["ciliary apparatus", "ANATOMY", 43, 60], ["corneal propria", "ANATOMY", 66, 81], ["inflammatory cells", "ANATOMY", 87, 105], ["iris", "ANATOMY", 147, 151], ["edema", "DISEASE", 13, 18], ["edema", "PATHOLOGICAL_FORMATION", 13, 18], ["iris", "TISSUE", 37, 41], ["ciliary apparatus", "TISSUE", 43, 60], ["corneal propria", "TISSUE", 66, 81], ["inflammatory cells", "CELL", 87, 105], ["iris", "TISSUE", 147, 151], ["inflammatory cells", "CELL_TYPE", 87, 105], ["Inflammatory edema", "PROBLEM", 0, 18], ["inflammatory cells", "PROBLEM", 87, 105], ["edema", "OBSERVATION", 13, 18], ["iris", "ANATOMY", 37, 41], ["ciliary apparatus", "ANATOMY", 43, 60], ["corneal propria", "ANATOMY", 66, 81], ["inflammatory cells", "OBSERVATION", 87, 105], ["abundant", "OBSERVATION_MODIFIER", 110, 118], ["filtration", "OBSERVATION_MODIFIER", 126, 136], ["angle", "OBSERVATION_MODIFIER", 137, 142], ["iris", "ANATOMY", 147, 151]]], ["The infiltrates are principally plasma cells, and there is evidence that the ocular lesion is a hypersensitivity reaction to circulating immune complex deposition, with complement fixation, inflammatory cell chemotaxis, and corneal endothelial damage resulting in an anterior uveitis with corneal stromal edema.Infectious canine hepatitisOriginally, it was assumed that the widespread tendency to hemorrhage in this disease was because of leakage from damaged vascular endothelium, coupled with an inability on the part of the damaged liver to replace clotting factors.", [["infiltrates", "ANATOMY", 4, 15], ["plasma cells", "ANATOMY", 32, 44], ["ocular lesion", "ANATOMY", 77, 90], ["inflammatory cell", "ANATOMY", 190, 207], ["corneal endothelial", "ANATOMY", 224, 243], ["corneal stromal edema", "ANATOMY", 289, 310], ["vascular endothelium", "ANATOMY", 460, 480], ["liver", "ANATOMY", 535, 540], ["ocular lesion", "DISEASE", 77, 90], ["hypersensitivity", "DISEASE", 96, 112], ["corneal endothelial damage", "DISEASE", 224, 250], ["uveitis", "DISEASE", 276, 283], ["corneal stromal edema", "DISEASE", 289, 310], ["Infectious canine hepatitis", "DISEASE", 311, 338], ["hemorrhage", "DISEASE", 397, 407], ["plasma cells", "CELL", 32, 44], ["ocular lesion", "PATHOLOGICAL_FORMATION", 77, 90], ["circulating immune complex", "GENE_OR_GENE_PRODUCT", 125, 151], ["inflammatory cell", "CELL", 190, 207], ["corneal endothelial", "TISSUE", 224, 243], ["corneal stromal edema", "PATHOLOGICAL_FORMATION", 289, 310], ["canine", "ORGANISM", 322, 328], ["vascular endothelium", "TISSUE", 460, 480], ["liver", "ORGAN", 535, 540], ["clotting factors", "GENE_OR_GENE_PRODUCT", 552, 568], ["plasma cells", "CELL_TYPE", 32, 44], ["clotting factors", "PROTEIN", 552, 568], ["canine", "SPECIES", 322, 328], ["The infiltrates", "PROBLEM", 0, 15], ["principally plasma cells", "PROBLEM", 20, 44], ["the ocular lesion", "PROBLEM", 73, 90], ["a hypersensitivity reaction", "PROBLEM", 94, 121], ["circulating immune complex deposition", "TREATMENT", 125, 162], ["complement fixation", "TREATMENT", 169, 188], ["inflammatory cell chemotaxis", "PROBLEM", 190, 218], ["corneal endothelial damage", "PROBLEM", 224, 250], ["an anterior uveitis", "PROBLEM", 264, 283], ["corneal stromal edema", "PROBLEM", 289, 310], ["Infectious canine hepatitis", "PROBLEM", 311, 338], ["the widespread tendency to hemorrhage", "PROBLEM", 370, 407], ["this disease", "PROBLEM", 411, 423], ["leakage from damaged vascular endothelium", "PROBLEM", 439, 480], ["clotting factors", "PROBLEM", 552, 568], ["infiltrates", "OBSERVATION", 4, 15], ["principally", "OBSERVATION_MODIFIER", 20, 31], ["plasma cells", "OBSERVATION", 32, 44], ["ocular", "ANATOMY", 77, 83], ["lesion", "OBSERVATION", 84, 90], ["hypersensitivity reaction", "OBSERVATION", 96, 121], ["circulating immune", "OBSERVATION", 125, 143], ["complex deposition", "OBSERVATION", 144, 162], ["fixation", "OBSERVATION_MODIFIER", 180, 188], ["inflammatory cell chemotaxis", "OBSERVATION", 190, 218], ["corneal endothelial damage", "OBSERVATION", 224, 250], ["anterior", "ANATOMY_MODIFIER", 267, 275], ["uveitis", "OBSERVATION", 276, 283], ["corneal stromal edema", "OBSERVATION", 289, 310], ["hepatitis", "OBSERVATION", 329, 338], ["widespread", "OBSERVATION_MODIFIER", 374, 384], ["tendency", "OBSERVATION_MODIFIER", 385, 393], ["hemorrhage", "OBSERVATION", 397, 407], ["leakage", "OBSERVATION", 439, 446], ["vascular endothelium", "ANATOMY", 460, 480], ["liver", "ANATOMY", 535, 540], ["clotting", "OBSERVATION", 552, 560]]], ["Although these effects play a role, it is now known that the exhaustion of clotting factors is in large part the result of their accelerated consumption, as the widespread endothelial damage is a potent initiator of the clotting cascade.Wesselsbron diseaseThis disease is caused by Wesselsbron virus, an arthropodborne flavivirus that, according to serologic surveys, is widespread in Africa in various species of animals and birds.", [["endothelial", "ANATOMY", 172, 183], ["endothelial damage", "DISEASE", 172, 190], ["Wesselsbron disease", "DISEASE", 237, 256], ["flavivirus", "DISEASE", 319, 329], ["clotting factors", "GENE_OR_GENE_PRODUCT", 75, 91], ["endothelial", "CELL", 172, 183], ["Wesselsbron virus", "ORGANISM", 282, 299], ["arthropodborne flavivirus", "ORGANISM", 304, 329], ["birds", "ORGANISM", 426, 431], ["clotting factors", "PROTEIN", 75, 91], ["Wesselsbron virus", "SPECIES", 282, 299], ["clotting factors", "PROBLEM", 75, 91], ["the widespread endothelial damage", "PROBLEM", 157, 190], ["the clotting cascade", "TREATMENT", 216, 236], ["Wesselsbron disease", "PROBLEM", 237, 256], ["This disease", "PROBLEM", 256, 268], ["Wesselsbron virus", "PROBLEM", 282, 299], ["an arthropodborne flavivirus", "PROBLEM", 301, 329], ["serologic surveys", "TEST", 349, 366], ["widespread", "OBSERVATION_MODIFIER", 161, 171], ["endothelial damage", "OBSERVATION", 172, 190], ["clotting cascade", "OBSERVATION", 220, 236], ["disease", "OBSERVATION", 249, 256], ["disease", "OBSERVATION", 261, 268], ["Wesselsbron virus", "OBSERVATION", 282, 299], ["widespread", "OBSERVATION_MODIFIER", 371, 381]]], ["Various Aedes mosquitoes are the vectors.", [["Aedes mosquitoes", "ORGANISM", 8, 24], ["Aedes mosquitoes", "SPECIES", 8, 24], ["Aedes mosquitoes", "OBSERVATION", 8, 24]]], ["Humans are also susceptible to clinical and inapparent infection.", [["infection", "DISEASE", 55, 64], ["Humans", "ORGANISM", 0, 6], ["inapparent infection", "PROBLEM", 44, 64], ["inapparent", "OBSERVATION_MODIFIER", 44, 54], ["infection", "OBSERVATION", 55, 64]]], ["The virus produces outbreaks of abortion and perinatal death in sheep.", [["abortion", "DISEASE", 32, 40], ["death", "DISEASE", 55, 60], ["sheep", "ORGANISM", 64, 69], ["sheep", "SPECIES", 64, 69], ["sheep", "SPECIES", 64, 69], ["The virus", "PROBLEM", 0, 9], ["abortion", "PROBLEM", 32, 40], ["perinatal death in sheep", "PROBLEM", 45, 69], ["virus", "OBSERVATION", 4, 9], ["outbreaks", "OBSERVATION_MODIFIER", 19, 28], ["abortion", "OBSERVATION", 32, 40]]], ["Susceptible adults rarely show clinical signs but may have a biphasic febrile response to infection; other clinical signs, when present, are of hepatitis and jaundice.Wesselsbron diseaseThe lesions in lambs dying within 12 hours of birth consist mainly of widespread petechiae and gastrointestinal hemorrhage; longer survival allows jaundice to develop, and the liver becomes orange-yellow, enlarged, friable, and patchily congested.", [["lesions", "ANATOMY", 190, 197], ["petechiae", "ANATOMY", 267, 276], ["gastrointestinal", "ANATOMY", 281, 297], ["liver", "ANATOMY", 362, 367], ["febrile", "DISEASE", 70, 77], ["infection", "DISEASE", 90, 99], ["hepatitis", "DISEASE", 144, 153], ["jaundice", "DISEASE", 158, 166], ["Wesselsbron disease", "DISEASE", 167, 186], ["petechiae", "DISEASE", 267, 276], ["gastrointestinal hemorrhage", "DISEASE", 281, 308], ["jaundice", "DISEASE", 333, 341], ["adults", "ORGANISM", 12, 18], ["lesions", "PATHOLOGICAL_FORMATION", 190, 197], ["lambs", "ORGANISM", 201, 206], ["petechiae", "PATHOLOGICAL_FORMATION", 267, 276], ["gastrointestinal", "ORGAN", 281, 297], ["liver", "ORGAN", 362, 367], ["lambs", "SPECIES", 201, 206], ["clinical signs", "PROBLEM", 31, 45], ["a biphasic febrile response to infection", "PROBLEM", 59, 99], ["hepatitis", "PROBLEM", 144, 153], ["jaundice", "PROBLEM", 158, 166], ["Wesselsbron disease", "PROBLEM", 167, 186], ["The lesions", "PROBLEM", 186, 197], ["widespread petechiae", "PROBLEM", 256, 276], ["gastrointestinal hemorrhage", "PROBLEM", 281, 308], ["jaundice", "PROBLEM", 333, 341], ["yellow", "PROBLEM", 383, 389], ["patchily congested", "PROBLEM", 414, 432], ["biphasic", "OBSERVATION_MODIFIER", 61, 69], ["febrile", "OBSERVATION_MODIFIER", 70, 77], ["infection", "OBSERVATION", 90, 99], ["hepatitis", "OBSERVATION", 144, 153], ["jaundice", "OBSERVATION", 158, 166], ["disease", "OBSERVATION", 179, 186], ["lesions", "OBSERVATION", 190, 197], ["lambs", "OBSERVATION_MODIFIER", 201, 206], ["widespread", "OBSERVATION_MODIFIER", 256, 266], ["petechiae", "OBSERVATION", 267, 276], ["gastrointestinal", "ANATOMY", 281, 297], ["hemorrhage", "OBSERVATION", 298, 308], ["liver", "ANATOMY", 362, 367], ["orange", "OBSERVATION", 376, 382], ["yellow", "OBSERVATION", 383, 389], ["enlarged", "OBSERVATION_MODIFIER", 391, 399], ["friable", "OBSERVATION_MODIFIER", 401, 408], ["patchily", "OBSERVATION_MODIFIER", 414, 422], ["congested", "OBSERVATION", 423, 432]]], ["The bile in the gallbladder becomes thick and dark in some cases, but this may be due more to hemorrhage into the gallbladder than to hemolysis.", [["bile", "ANATOMY", 4, 8], ["gallbladder", "ANATOMY", 16, 27], ["gallbladder", "ANATOMY", 114, 125], ["hemorrhage", "DISEASE", 94, 104], ["hemolysis", "DISEASE", 134, 143], ["bile", "MULTI-TISSUE_STRUCTURE", 4, 8], ["gallbladder", "ORGAN", 16, 27], ["gallbladder", "ORGAN", 114, 125], ["thick and dark in some cases", "PROBLEM", 36, 64], ["hemorrhage into the gallbladder", "PROBLEM", 94, 125], ["hemolysis", "PROBLEM", 134, 143], ["bile", "ANATOMY", 4, 8], ["gallbladder", "ANATOMY", 16, 27], ["thick", "OBSERVATION", 36, 41], ["dark", "OBSERVATION_MODIFIER", 46, 50], ["some cases", "OBSERVATION_MODIFIER", 54, 64], ["may be due more to", "UNCERTAINTY", 75, 93], ["hemorrhage", "OBSERVATION", 94, 104], ["gallbladder", "ANATOMY", 114, 125], ["hemolysis", "OBSERVATION", 134, 143]]], ["Lymph nodes are rather constantly enlarged, congested, and edematous.Wesselsbron diseaseThe most characteristic histologic changes are seen in the liver.", [["Lymph nodes", "ANATOMY", 0, 11], ["liver", "ANATOMY", 147, 152], ["Wesselsbron disease", "DISEASE", 69, 88], ["Lymph nodes", "MULTI-TISSUE_STRUCTURE", 0, 11], ["liver", "ORGAN", 147, 152], ["Lymph nodes", "PROBLEM", 0, 11], ["constantly enlarged", "PROBLEM", 23, 42], ["congested", "PROBLEM", 44, 53], ["edematous", "PROBLEM", 59, 68], ["Wesselsbron disease", "PROBLEM", 69, 88], ["The most characteristic histologic changes", "PROBLEM", 88, 130], ["Lymph nodes", "OBSERVATION", 0, 11], ["constantly", "OBSERVATION_MODIFIER", 23, 33], ["enlarged", "OBSERVATION_MODIFIER", 34, 42], ["congested", "OBSERVATION_MODIFIER", 44, 53], ["edematous", "OBSERVATION", 59, 68], ["disease", "OBSERVATION", 81, 88], ["most characteristic", "OBSERVATION_MODIFIER", 92, 111], ["histologic", "OBSERVATION", 112, 122], ["liver", "ANATOMY", 147, 152]]], ["There are randomly scattered foci of necrosis, with apoptosis and proliferation of sinusoidal lining cells (Fig. 2-71) .", [["foci", "ANATOMY", 29, 33], ["sinusoidal lining cells", "ANATOMY", 83, 106], ["necrosis", "DISEASE", 37, 45], ["sinusoidal lining cells", "CELL", 83, 106], ["sinusoidal lining cells", "CELL_TYPE", 83, 106], ["randomly scattered foci of necrosis", "PROBLEM", 10, 45], ["apoptosis", "PROBLEM", 52, 61], ["proliferation of sinusoidal lining cells", "PROBLEM", 66, 106], ["randomly", "OBSERVATION_MODIFIER", 10, 18], ["scattered", "OBSERVATION_MODIFIER", 19, 28], ["foci", "OBSERVATION", 29, 33], ["necrosis", "OBSERVATION", 37, 45], ["apoptosis", "OBSERVATION_MODIFIER", 52, 61], ["proliferation", "OBSERVATION_MODIFIER", 66, 79], ["sinusoidal lining cells", "OBSERVATION", 83, 106]]], ["Mononuclear cells and pigment-filled macrophages accumulate in the portal stroma as well as in the sinusoids.", [["Mononuclear cells", "ANATOMY", 0, 17], ["pigment", "ANATOMY", 22, 29], ["macrophages", "ANATOMY", 37, 48], ["portal stroma", "ANATOMY", 67, 80], ["sinusoids", "ANATOMY", 99, 108], ["Mononuclear cells", "CELL", 0, 17], ["pigment-filled macrophages", "CELL", 22, 48], ["portal stroma", "TISSUE", 67, 80], ["sinusoids", "TISSUE", 99, 108], ["Mononuclear cells", "CELL_TYPE", 0, 17], ["pigment-filled macrophages", "CELL_TYPE", 22, 48], ["Mononuclear cells", "TEST", 0, 17], ["pigment-filled macrophages", "PROBLEM", 22, 48], ["pigment", "OBSERVATION_MODIFIER", 22, 29], ["filled macrophages", "OBSERVATION", 30, 48], ["portal stroma", "ANATOMY", 67, 80], ["sinusoids", "ANATOMY", 99, 108]]], ["In a variable proportion of cases, hepatocyte nuclei may contain eosinophilic, irregular inclusions.", [["hepatocyte nuclei", "ANATOMY", 35, 52], ["eosinophilic", "ANATOMY", 65, 77], ["hepatocyte nuclei", "CELL", 35, 52], ["eosinophilic, irregular inclusions", "PROBLEM", 65, 99], ["hepatocyte", "ANATOMY", 35, 45], ["eosinophilic", "OBSERVATION_MODIFIER", 65, 77], ["irregular", "OBSERVATION_MODIFIER", 79, 88], ["inclusions", "OBSERVATION", 89, 99]]], ["These are not accompanied by as much margination of nuclear chromatin as that associated with conventional viral inclusions, and their significance is obscure.", [["nuclear chromatin", "ANATOMY", 52, 69], ["nuclear", "CELLULAR_COMPONENT", 52, 59], ["chromatin", "CELLULAR_COMPONENT", 60, 69], ["nuclear chromatin", "DNA", 52, 69], ["conventional viral inclusions", "PROBLEM", 94, 123], ["not accompanied", "UNCERTAINTY", 10, 25], ["margination", "OBSERVATION_MODIFIER", 37, 48], ["nuclear chromatin", "OBSERVATION", 52, 69], ["viral", "OBSERVATION_MODIFIER", 107, 112], ["inclusions", "OBSERVATION", 113, 123]]], ["Wesselsbron viral antigen can be demonstrated in necrotic acidophilic and degenerating hepatocytes and rarely in the inclusions.", [["hepatocytes", "ANATOMY", 87, 98], ["hepatocytes", "CELL", 87, 98], ["Wesselsbron viral antigen", "PROTEIN", 0, 25], ["necrotic acidophilic and degenerating hepatocytes", "CELL_TYPE", 49, 98], ["Wesselsbron viral antigen", "TEST", 0, 25], ["necrotic acidophilic and degenerating hepatocytes", "PROBLEM", 49, 98], ["necrotic", "OBSERVATION_MODIFIER", 49, 57], ["acidophilic", "OBSERVATION_MODIFIER", 58, 69], ["degenerating hepatocytes", "OBSERVATION", 74, 98], ["inclusions", "OBSERVATION", 117, 127]]], ["In jaundiced animals, there may be considerable canalicular cholestasis; whether or not this is the result of hemolysis does not appear to have been determined.", [["canalicular", "ANATOMY", 48, 59], ["cholestasis", "DISEASE", 60, 71], ["hemolysis", "DISEASE", 110, 119], ["canalicular", "MULTI-TISSUE_STRUCTURE", 48, 59], ["considerable canalicular cholestasis", "PROBLEM", 35, 71], ["hemolysis", "PROBLEM", 110, 119], ["jaundiced", "OBSERVATION", 3, 12], ["may be", "UNCERTAINTY", 28, 34], ["considerable", "OBSERVATION_MODIFIER", 35, 47], ["canalicular", "OBSERVATION_MODIFIER", 48, 59], ["cholestasis", "OBSERVATION", 60, 71], ["hemolysis", "OBSERVATION", 110, 119]]], ["Hepatocellular proliferation is apparent in the less acute cases.", [["Hepatocellular", "ANATOMY", 0, 14], ["Hepatocellular", "CANCER", 0, 14], ["Hepatocellular proliferation", "PROBLEM", 0, 28], ["proliferation", "OBSERVATION", 15, 28], ["less", "OBSERVATION_MODIFIER", 48, 52], ["acute", "OBSERVATION_MODIFIER", 53, 58], ["cases", "OBSERVATION", 59, 64]]], ["Lymphoid follicles in lymph nodes and spleen show pronounced lymphocyte necrosis and stimulation of lymphoblasts.Rift Valley feverThis is an arthropod-borne viral infection of ruminants and humans, in many respects similar to Wesselsbron disease.", [["Lymphoid follicles", "ANATOMY", 0, 18], ["lymph nodes", "ANATOMY", 22, 33], ["spleen", "ANATOMY", 38, 44], ["lymphocyte", "ANATOMY", 61, 71], ["lymphoblasts", "ANATOMY", 100, 112], ["necrosis", "DISEASE", 72, 80], ["fever", "DISEASE", 125, 130], ["viral infection", "DISEASE", 157, 172], ["Wesselsbron disease", "DISEASE", 226, 245], ["Lymphoid follicles", "MULTI-TISSUE_STRUCTURE", 0, 18], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 22, 33], ["spleen", "ORGAN", 38, 44], ["lymphocyte", "CELL", 61, 71], ["lymphoblasts", "CELL", 100, 112], ["Rift Valley fever", "ORGANISM", 113, 130], ["humans", "ORGANISM", 190, 196], ["lymphoblasts", "CELL_TYPE", 100, 112], ["ruminants", "SPECIES", 176, 185], ["humans", "SPECIES", 190, 196], ["Rift Valley fever", "SPECIES", 113, 130], ["humans", "SPECIES", 190, 196], ["Lymphoid follicles in lymph nodes", "PROBLEM", 0, 33], ["pronounced lymphocyte necrosis", "PROBLEM", 50, 80], ["stimulation of lymphoblasts", "TREATMENT", 85, 112], ["Rift Valley fever", "PROBLEM", 113, 130], ["an arthropod-borne viral infection of ruminants", "PROBLEM", 138, 185], ["Wesselsbron disease", "PROBLEM", 226, 245], ["follicles", "OBSERVATION", 9, 18], ["lymph nodes", "OBSERVATION", 22, 33], ["spleen", "ANATOMY", 38, 44], ["pronounced", "OBSERVATION_MODIFIER", 50, 60], ["lymphocyte necrosis", "OBSERVATION", 61, 80], ["stimulation of lymphoblasts", "OBSERVATION", 85, 112], ["arthropod", "OBSERVATION", 141, 150], ["borne viral", "OBSERVATION_MODIFIER", 151, 162], ["infection", "OBSERVATION", 163, 172], ["Wesselsbron disease", "OBSERVATION", 226, 245]]], ["Rift Valley fever virus (RVFV) is, however, responsible for greater 312.e1 passively immunized against botulism, as well as from the equine hyperimmune plasma product administered before the outbreak, identified a previously unknown and highly divergent member of the Flaviviridae family, designated \"Theiler's disease-associated virus\" (TDAV) .", [["plasma", "ANATOMY", 152, 158], ["Rift Valley fever", "DISEASE", 0, 17], ["botulism", "DISEASE", 103, 111], ["Theiler's disease", "DISEASE", 301, 318], ["Rift Valley fever virus", "ORGANISM", 0, 23], ["RVFV", "ORGANISM", 25, 29], ["equine", "ORGANISM", 133, 139], ["hyperimmune", "ORGANISM", 140, 151], ["plasma", "ORGANISM_SUBSTANCE", 152, 158], ["Theiler's disease-associated virus", "ORGANISM", 301, 335], ["Rift Valley fever virus", "SPECIES", 0, 23], ["equine", "SPECIES", 133, 139], ["Theiler", "SPECIES", 301, 308], ["Rift Valley fever virus", "SPECIES", 0, 23], ["RVFV", "SPECIES", 25, 29], ["equine", "SPECIES", 133, 139], ["TDAV", "SPECIES", 338, 342], ["Rift Valley fever virus", "PROBLEM", 0, 23], ["botulism", "PROBLEM", 103, 111], ["the equine hyperimmune plasma product", "TREATMENT", 129, 166], ["Theiler's disease", "PROBLEM", 301, 318], ["associated virus\"", "PROBLEM", 319, 336]]], ["In this outbreak, 8 of 22 horses developed serum biochemical evidence of liver injury, although only the 2 index cases developed clinical signs of acute hepatic insufficiency.", [["serum", "ANATOMY", 43, 48], ["liver", "ANATOMY", 73, 78], ["hepatic", "ANATOMY", 153, 160], ["liver injury", "DISEASE", 73, 85], ["acute hepatic insufficiency", "DISEASE", 147, 174], ["horses", "ORGANISM", 26, 32], ["serum", "ORGANISM_SUBSTANCE", 43, 48], ["liver", "ORGAN", 73, 78], ["hepatic", "ORGAN", 153, 160], ["horses", "SPECIES", 26, 32], ["liver injury", "PROBLEM", 73, 85], ["acute hepatic insufficiency", "PROBLEM", 147, 174], ["liver", "ANATOMY", 73, 78], ["injury", "OBSERVATION", 79, 85], ["acute", "OBSERVATION_MODIFIER", 147, 152], ["hepatic", "ANATOMY", 153, 160], ["insufficiency", "OBSERVATION", 161, 174]]], ["A qRT-PCR-based assay found evidence of TDAV in serum from 15 of 17 horses treated with the botulinum antitoxin, as well as in 1 of the 3 donor horses used to produce the antitoxin, whereas 20 in-contact untreated horses and 20 additional horses from a separate premises were assay negative.", [["serum", "ANATOMY", 48, 53], ["TDAV", "CHEMICAL", 40, 44], ["TDAV", "SIMPLE_CHEMICAL", 40, 44], ["serum", "ORGANISM_SUBSTANCE", 48, 53], ["horses", "ORGANISM", 68, 74], ["botulinum antitoxin", "GENE_OR_GENE_PRODUCT", 92, 111], ["horses", "ORGANISM", 144, 150], ["antitoxin", "GENE_OR_GENE_PRODUCT", 171, 180], ["horses", "ORGANISM", 214, 220], ["horses", "ORGANISM", 239, 245], ["TDAV", "PROTEIN", 40, 44], ["antitoxin", "PROTEIN", 171, 180], ["A qRT-PCR", "TEST", 0, 9], ["based assay", "TEST", 10, 21], ["TDAV in serum", "PROBLEM", 40, 53], ["the botulinum antitoxin", "TREATMENT", 88, 111], ["the 3 donor horses", "TREATMENT", 132, 150], ["the antitoxin", "TREATMENT", 167, 180], ["evidence of", "UNCERTAINTY", 28, 39], ["TDAV", "OBSERVATION", 40, 44]]], ["Viral load did not, however, appear to be predictive of biochemical or clinical extent of hepatic injury.", [["hepatic", "ANATOMY", 90, 97], ["hepatic injury", "DISEASE", 90, 104], ["Viral", "ORGANISM", 0, 5], ["hepatic", "ORGAN", 90, 97], ["Viral load", "TEST", 0, 10], ["hepatic injury", "PROBLEM", 90, 104], ["hepatic", "ANATOMY", 90, 97], ["injury", "OBSERVATION", 98, 104]]], ["One of 4 horses experimentally inoculated with the virus developed elevated serum liver enzymes.", [["serum liver", "ANATOMY", 76, 87], ["horses", "ORGANISM", 9, 15], ["serum", "ORGANISM_SUBSTANCE", 76, 81], ["liver", "ORGAN", 82, 87], ["serum liver enzymes", "PROTEIN", 76, 95], ["the virus", "PROBLEM", 47, 56], ["elevated serum liver enzymes", "PROBLEM", 67, 95], ["liver", "ANATOMY", 82, 87]]], ["Four of the original 17 horses continued to be asymptomatically positive for TDAV 1 year later, demonstrating chronic infection, whereas horses that tested negative initially continued to test negative at 1 year, suggesting that horizontal transmission is inefficient.", [["chronic infection", "DISEASE", 110, 127], ["horses", "ORGANISM", 24, 30], ["horses", "ORGANISM", 137, 143], ["TDAV", "SPECIES", 77, 81], ["horses", "SPECIES", 137, 143], ["TDAV", "PROBLEM", 77, 81], ["chronic infection", "PROBLEM", 110, 127], ["horizontal transmission", "PROBLEM", 229, 252], ["chronic", "OBSERVATION_MODIFIER", 110, 117], ["infection", "OBSERVATION", 118, 127]]], ["Although Koch's postulates remain to be fulfilled, TDAV appears to be a plausible candidate viral cause of this disease.", [["TDAV", "CHEMICAL", 51, 55], ["TDAV", "GENE_OR_GENE_PRODUCT", 51, 55], ["TDAV", "PROTEIN", 51, 55], ["Koch's postulates", "PROBLEM", 9, 26], ["this disease", "PROBLEM", 107, 119], ["disease", "OBSERVATION", 112, 119]]], ["Further research is necessary to establish the precise role of this virus in the disease.Rift Valley feverThe incubation period of disease is typically 42-60 days, sometimes up to 90 days.", [["fever", "DISEASE", 101, 106], ["Rift Valley fever", "ORGANISM", 89, 106], ["Rift Valley fever", "SPECIES", 89, 106], ["this virus in the disease", "PROBLEM", 63, 88], ["Rift Valley fever", "PROBLEM", 89, 106], ["disease", "PROBLEM", 131, 138], ["disease", "OBSERVATION", 81, 88], ["disease", "OBSERVATION", 131, 138]]], ["Onset of the typical clinical syndrome is sudden, with death occurring in 6-24 hours.", [["death", "DISEASE", 55, 60], ["the typical clinical syndrome", "PROBLEM", 9, 38], ["death", "PROBLEM", 55, 60]]], ["Clinically, there is lethargy; jaundice; photosensitivity; hyperexcitability, often with mania; continuous walking and pushing; apparent blindness; and ataxia.", [["lethargy", "DISEASE", 21, 29], ["jaundice", "DISEASE", 31, 39], ["photosensitivity", "DISEASE", 41, 57], ["hyperexcitability", "DISEASE", 59, 76], ["mania", "DISEASE", 89, 94], ["blindness", "DISEASE", 137, 146], ["ataxia", "DISEASE", 152, 158], ["lethargy", "PROBLEM", 21, 29], ["jaundice", "PROBLEM", 31, 39], ["photosensitivity", "PROBLEM", 41, 57], ["hyperexcitability", "PROBLEM", 59, 76], ["mania", "PROBLEM", 89, 94], ["apparent blindness", "PROBLEM", 128, 146], ["ataxia", "PROBLEM", 152, 158], ["lethargy", "OBSERVATION", 21, 29], ["jaundice", "OBSERVATION", 31, 39], ["blindness", "OBSERVATION", 137, 146]]], ["Death occurs suddenly without a period of prostration.Rift Valley feverAt autopsy, icterus is present, with moderate ascites; the spleen is normal or congested, and there may be petechial hemorrhages on serous membranes and renal cortices, and some congestion of the intestine with hemorrhage into its lumen.", [["ascites", "ANATOMY", 117, 124], ["spleen", "ANATOMY", 130, 136], ["petechial", "ANATOMY", 178, 187], ["serous membranes", "ANATOMY", 203, 219], ["renal cortices", "ANATOMY", 224, 238], ["intestine", "ANATOMY", 267, 276], ["lumen", "ANATOMY", 302, 307], ["Death", "DISEASE", 0, 5], ["icterus", "DISEASE", 83, 90], ["ascites", "DISEASE", 117, 124], ["hemorrhages", "DISEASE", 188, 199], ["hemorrhage", "DISEASE", 282, 292], ["spleen", "ORGAN", 130, 136], ["serous membranes", "MULTI-TISSUE_STRUCTURE", 203, 219], ["renal cortices", "MULTI-TISSUE_STRUCTURE", 224, 238], ["intestine", "ORGAN", 267, 276], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 302, 307], ["Rift Valley feverAt", "SPECIES", 54, 73], ["Death", "PROBLEM", 0, 5], ["prostration", "PROBLEM", 42, 53], ["icterus", "PROBLEM", 83, 90], ["moderate ascites", "PROBLEM", 108, 124], ["congested", "PROBLEM", 150, 159], ["petechial hemorrhages on serous membranes and renal cortices", "PROBLEM", 178, 238], ["some congestion of the intestine", "PROBLEM", 244, 276], ["hemorrhage into its lumen", "PROBLEM", 282, 307], ["prostration", "OBSERVATION", 42, 53], ["Valley", "OBSERVATION", 59, 65], ["feverAt autopsy", "OBSERVATION", 66, 81], ["icterus", "OBSERVATION", 83, 90], ["moderate", "OBSERVATION_MODIFIER", 108, 116], ["ascites", "OBSERVATION", 117, 124], ["spleen", "ANATOMY", 130, 136], ["normal", "OBSERVATION", 140, 146], ["congested", "OBSERVATION", 150, 159], ["may be", "UNCERTAINTY", 171, 177], ["petechial", "OBSERVATION_MODIFIER", 178, 187], ["hemorrhages", "OBSERVATION", 188, 199], ["serous membranes", "OBSERVATION", 203, 219], ["renal", "ANATOMY", 224, 229], ["cortices", "ANATOMY_MODIFIER", 230, 238], ["some", "OBSERVATION_MODIFIER", 244, 248], ["congestion", "OBSERVATION", 249, 259], ["intestine", "ANATOMY", 267, 276], ["hemorrhage", "OBSERVATION", 282, 292], ["lumen", "ANATOMY_MODIFIER", 302, 307]]], ["Grossly, the liver usually appears atrophic, small, and flabby because of the acute loss of many hepatocytes (Fig. 2-72A ).", [["liver", "ANATOMY", 13, 18], ["hepatocytes", "ANATOMY", 97, 108], ["liver", "ORGAN", 13, 18], ["hepatocytes", "CELL", 97, 108], ["hepatocytes", "CELL_TYPE", 97, 108], ["atrophic", "PROBLEM", 35, 43], ["the acute loss of many hepatocytes", "PROBLEM", 74, 108], ["liver", "ANATOMY", 13, 18], ["atrophic", "OBSERVATION", 35, 43], ["small", "OBSERVATION_MODIFIER", 45, 50], ["acute", "OBSERVATION_MODIFIER", 78, 83], ["loss", "OBSERVATION", 84, 88], ["many", "OBSERVATION_MODIFIER", 92, 96], ["hepatocytes", "ANATOMY", 97, 108]]], ["The liver may be stained by bile pigments, and its surface mottled with a few strands of fresh fibrin.", [["liver", "ANATOMY", 4, 9], ["bile pigments", "ANATOMY", 28, 41], ["surface", "ANATOMY", 51, 58], ["liver", "ORGAN", 4, 9], ["bile pigments", "SIMPLE_CHEMICAL", 28, 41], ["fibrin", "GENE_OR_GENE_PRODUCT", 95, 101], ["fibrin", "PROTEIN", 95, 101], ["bile pigments", "PROBLEM", 28, 41], ["its surface mottled", "PROBLEM", 47, 66], ["fresh fibrin", "PROBLEM", 89, 101], ["liver", "ANATOMY", 4, 9], ["may be", "UNCERTAINTY", 10, 16], ["stained", "OBSERVATION", 17, 24], ["bile", "ANATOMY", 28, 32], ["pigments", "OBSERVATION", 33, 41], ["surface", "OBSERVATION_MODIFIER", 51, 58], ["mottled", "OBSERVATION_MODIFIER", 59, 66], ["few", "OBSERVATION_MODIFIER", 74, 77], ["strands", "OBSERVATION_MODIFIER", 78, 85], ["fresh fibrin", "OBSERVATION", 89, 101]]], ["The mottling is more evident on the cut surface, which may be severely congested with an apparent zonal pattern, and sometimes fatty ( Fig. 2-72B) .Rift Valley feverMicroscopically, the hepatic lesion is considerably older than the clinical course would suggest.", [["surface", "ANATOMY", 40, 47], ["hepatic lesion", "ANATOMY", 186, 200], ["hepatic lesion", "DISEASE", 186, 200], ["hepatic lesion", "PATHOLOGICAL_FORMATION", 186, 200], ["The mottling", "PROBLEM", 0, 12], ["severely congested", "PROBLEM", 62, 80], ["an apparent zonal pattern", "PROBLEM", 86, 111], ["the hepatic lesion", "PROBLEM", 182, 200], ["mottling", "OBSERVATION", 4, 12], ["more evident", "OBSERVATION_MODIFIER", 16, 28], ["cut surface", "OBSERVATION_MODIFIER", 36, 47], ["may be", "UNCERTAINTY", 55, 61], ["severely", "OBSERVATION_MODIFIER", 62, 70], ["congested", "OBSERVATION", 71, 80], ["zonal pattern", "OBSERVATION", 98, 111], ["hepatic", "ANATOMY", 186, 193], ["lesion", "OBSERVATION", 194, 200], ["considerably", "OBSERVATION_MODIFIER", 204, 216], ["older", "OBSERVATION_MODIFIER", 217, 222]]], ["There may be a few surviving swollen and vacuolated periportal hepatocytes or sometimes complete depletion of parenchymal cells in the section.", [["periportal hepatocytes", "ANATOMY", 52, 74], ["parenchymal cells", "ANATOMY", 110, 127], ["periportal hepatocytes", "CELL", 52, 74], ["parenchymal cells", "CELL", 110, 127], ["vacuolated periportal hepatocytes", "CELL_TYPE", 41, 74], ["parenchymal cells", "CELL_TYPE", 110, 127], ["a few surviving swollen and vacuolated periportal hepatocytes", "PROBLEM", 13, 74], ["parenchymal cells", "PROBLEM", 110, 127], ["may be", "UNCERTAINTY", 6, 12], ["few", "OBSERVATION_MODIFIER", 15, 18], ["surviving", "OBSERVATION_MODIFIER", 19, 28], ["swollen", "OBSERVATION", 29, 36], ["vacuolated", "OBSERVATION_MODIFIER", 41, 51], ["periportal", "ANATOMY_MODIFIER", 52, 62], ["hepatocytes", "ANATOMY", 63, 74], ["complete", "OBSERVATION_MODIFIER", 88, 96], ["depletion", "OBSERVATION_MODIFIER", 97, 106], ["parenchymal cells", "OBSERVATION", 110, 127]]], ["In less-affected regions in animals with adequate dietary or adipose reserves to mobilize, there is severe macrovesicular fatty change in most remaining hepatocytes.", [["adipose", "ANATOMY", 61, 68], ["hepatocytes", "ANATOMY", 153, 164], ["adipose", "TISSUE", 61, 68], ["macrovesicular fatty", "PATHOLOGICAL_FORMATION", 107, 127], ["hepatocytes", "CELL", 153, 164], ["hepatocytes", "CELL_TYPE", 153, 164], ["severe macrovesicular fatty change in most remaining hepatocytes", "PROBLEM", 100, 164], ["less", "OBSERVATION_MODIFIER", 3, 7], ["affected", "OBSERVATION_MODIFIER", 8, 16], ["severe", "OBSERVATION_MODIFIER", 100, 106], ["macrovesicular", "OBSERVATION_MODIFIER", 107, 121], ["fatty change", "OBSERVATION", 122, 134], ["most remaining", "OBSERVATION_MODIFIER", 138, 152], ["hepatocytes", "ANATOMY", 153, 164]]], ["Acute necrosis is typically not seen, and there is no significant hemorrhage.", [["necrosis", "DISEASE", 6, 14], ["hemorrhage", "DISEASE", 66, 76], ["Acute necrosis", "PROBLEM", 0, 14], ["significant hemorrhage", "PROBLEM", 54, 76], ["necrosis", "OBSERVATION", 6, 14], ["typically not seen", "UNCERTAINTY", 18, 36], ["no", "UNCERTAINTY", 51, 53], ["significant", "OBSERVATION_MODIFIER", 54, 65], ["hemorrhage", "OBSERVATION", 66, 76]]], ["Variable numbers of apoptotic hepatocytes are expected.", [["hepatocytes", "ANATOMY", 30, 41], ["hepatocytes", "CELL", 30, 41], ["apoptotic hepatocytes", "CELL_TYPE", 20, 41], ["apoptotic hepatocytes", "PROBLEM", 20, 41], ["numbers", "OBSERVATION_MODIFIER", 9, 16], ["apoptotic hepatocytes", "OBSERVATION", 20, 41]]], ["In the periphery of the acini, severely ballooned cells undergo dissolution to leave scattered fatty cysts, but most of them disappear to leave either sinusoids that are dilated and filled with blood or a condensed and distorted reticulin framework.", [["acini", "ANATOMY", 24, 29], ["cells", "ANATOMY", 50, 55], ["fatty cysts", "ANATOMY", 95, 106], ["sinusoids", "ANATOMY", 151, 160], ["blood", "ANATOMY", 194, 199], ["fatty cysts", "DISEASE", 95, 106], ["acini", "MULTI-TISSUE_STRUCTURE", 24, 29], ["cells", "CELL", 50, 55], ["fatty cysts", "PATHOLOGICAL_FORMATION", 95, 106], ["sinusoids", "TISSUE", 151, 160], ["blood", "ORGANISM_SUBSTANCE", 194, 199], ["severely ballooned cells", "CELL_TYPE", 31, 55], ["severely ballooned cells", "PROBLEM", 31, 55], ["scattered fatty cysts", "PROBLEM", 85, 106], ["dilated", "PROBLEM", 170, 177], ["blood", "PROBLEM", 194, 199], ["a condensed and distorted reticulin framework", "PROBLEM", 203, 248], ["periphery", "ANATOMY_MODIFIER", 7, 16], ["acini", "ANATOMY", 24, 29], ["severely", "OBSERVATION_MODIFIER", 31, 39], ["ballooned cells", "OBSERVATION", 40, 55], ["dissolution", "OBSERVATION_MODIFIER", 64, 75], ["scattered", "OBSERVATION_MODIFIER", 85, 94], ["fatty cysts", "OBSERVATION", 95, 106], ["dilated", "OBSERVATION", 170, 177], ["distorted", "OBSERVATION_MODIFIER", 219, 228], ["reticulin framework", "OBSERVATION", 229, 248]]], ["Extensive deposits of bile pigments are present in Kupffer cells and hepatocytes.", [["bile pigments", "ANATOMY", 22, 35], ["Kupffer cells", "ANATOMY", 51, 64], ["hepatocytes", "ANATOMY", 69, 80], ["bile pigments", "SIMPLE_CHEMICAL", 22, 35], ["Kupffer cells", "CELL", 51, 64], ["hepatocytes", "CELL", 69, 80], ["Kupffer cells", "CELL_TYPE", 51, 64], ["hepatocytes", "CELL_TYPE", 69, 80], ["Extensive deposits of bile pigments", "PROBLEM", 0, 35], ["deposits", "OBSERVATION", 10, 18], ["bile pigments", "OBSERVATION", 22, 35], ["Kupffer cells", "OBSERVATION", 51, 64], ["hepatocytes", "ANATOMY", 69, 80]]], ["Leukocytes, including lymphocytes, plasma cells, histiocytes, and a few neutrophils, may infiltrate diffusely, but not in large numbers.", [["Leukocytes", "ANATOMY", 0, 10], ["lymphocytes", "ANATOMY", 22, 33], ["plasma cells", "ANATOMY", 35, 47], ["histiocytes", "ANATOMY", 49, 60], ["neutrophils", "ANATOMY", 72, 83], ["Leukocytes", "CELL", 0, 10], ["lymphocytes", "CELL", 22, 33], ["plasma cells", "CELL", 35, 47], ["histiocytes", "CELL", 49, 60], ["neutrophils", "CELL", 72, 83], ["Leukocytes", "CELL_TYPE", 0, 10], ["lymphocytes", "CELL_TYPE", 22, 33], ["plasma cells", "CELL_TYPE", 35, 47], ["histiocytes", "CELL_TYPE", 49, 60], ["neutrophils", "CELL_TYPE", 72, 83], ["Leukocytes", "TEST", 0, 10], ["lymphocytes", "TEST", 22, 33], ["plasma cells", "TEST", 35, 47], ["histiocytes", "TEST", 49, 60], ["a few neutrophils", "PROBLEM", 66, 83], ["infiltrate diffusely", "PROBLEM", 89, 109], ["lymphocytes", "ANATOMY", 22, 33], ["plasma cells", "OBSERVATION", 35, 47], ["histiocytes", "OBSERVATION", 49, 60], ["few", "OBSERVATION_MODIFIER", 68, 71], ["neutrophils", "OBSERVATION_MODIFIER", 72, 83], ["may", "UNCERTAINTY", 85, 88], ["infiltrate", "OBSERVATION", 89, 99], ["diffusely", "OBSERVATION_MODIFIER", 100, 109], ["large", "OBSERVATION_MODIFIER", 122, 127], ["numbers", "OBSERVATION_MODIFIER", 128, 135]]], ["There is diffuse but very slight fibroplasia, especially in the portal units.", [["fibroplasia", "DISEASE", 33, 44], ["portal units", "MULTI-TISSUE_STRUCTURE", 64, 76], ["very slight fibroplasia", "PROBLEM", 21, 44], ["diffuse", "OBSERVATION_MODIFIER", 9, 16], ["very", "OBSERVATION_MODIFIER", 21, 25], ["slight", "OBSERVATION_MODIFIER", 26, 32], ["fibroplasia", "OBSERVATION", 33, 44], ["portal units", "ANATOMY", 64, 76]]], ["In some livers, there is a ductular reaction, with small irregular clusters of proliferating ductular cells evident in the portal areas.Rift Valley feversinusoidal lining cells are not notably damaged; the Kupffer cells instead participate in the uptake of the necrotic and apoptotic hepatocytes.", [["livers", "ANATOMY", 8, 14], ["ductular", "ANATOMY", 27, 35], ["ductular cells", "ANATOMY", 93, 107], ["portal areas", "ANATOMY", 123, 135], ["feversinusoidal lining cells", "ANATOMY", 148, 176], ["Kupffer cells", "ANATOMY", 206, 219], ["necrotic", "ANATOMY", 261, 269], ["hepatocytes", "ANATOMY", 284, 295], ["necrotic", "DISEASE", 261, 269], ["livers", "ORGAN", 8, 14], ["ductular cells", "CELL", 93, 107], ["portal areas", "MULTI-TISSUE_STRUCTURE", 123, 135], ["feversinusoidal lining cells", "CELL", 148, 176], ["Kupffer cells", "CELL", 206, 219], ["hepatocytes", "CELL", 284, 295], ["proliferating ductular cells", "CELL_TYPE", 79, 107], ["Rift Valley feversinusoidal lining cells", "CELL_TYPE", 136, 176], ["Kupffer cells", "CELL_TYPE", 206, 219], ["necrotic and apoptotic hepatocytes", "CELL_TYPE", 261, 295], ["a ductular reaction", "PROBLEM", 25, 44], ["small irregular clusters of proliferating ductular cells", "PROBLEM", 51, 107], ["Rift Valley feversinusoidal lining cells", "PROBLEM", 136, 176], ["the Kupffer cells", "TREATMENT", 202, 219], ["the necrotic and apoptotic hepatocytes", "PROBLEM", 257, 295], ["some", "ANATOMY_MODIFIER", 3, 7], ["livers", "ANATOMY", 8, 14], ["ductular", "OBSERVATION_MODIFIER", 27, 35], ["small", "OBSERVATION_MODIFIER", 51, 56], ["irregular", "OBSERVATION_MODIFIER", 57, 66], ["clusters", "OBSERVATION_MODIFIER", 67, 75], ["proliferating", "OBSERVATION_MODIFIER", 79, 92], ["ductular cells", "OBSERVATION", 93, 107], ["portal", "ANATOMY", 123, 129], ["areas", "ANATOMY_MODIFIER", 130, 135], ["lining cells", "OBSERVATION", 164, 176], ["not notably", "UNCERTAINTY", 181, 192], ["Kupffer cells", "OBSERVATION", 206, 219], ["necrotic", "OBSERVATION_MODIFIER", 261, 269], ["apoptotic hepatocytes", "OBSERVATION", 274, 295]]], ["There is abundant fibrin in sinusoids in the vicinity of the primary foci of necrosis.", [["sinusoids", "ANATOMY", 28, 37], ["primary foci", "ANATOMY", 61, 73], ["necrosis", "DISEASE", 77, 85], ["fibrin", "GENE_OR_GENE_PRODUCT", 18, 24], ["sinusoids", "TISSUE", 28, 37], ["fibrin", "PROTEIN", 18, 24], ["abundant fibrin in sinusoids", "PROBLEM", 9, 37], ["necrosis", "PROBLEM", 77, 85], ["abundant", "OBSERVATION_MODIFIER", 9, 17], ["fibrin", "OBSERVATION", 18, 24], ["sinusoids", "OBSERVATION_MODIFIER", 28, 37], ["primary", "OBSERVATION_MODIFIER", 61, 68], ["foci", "OBSERVATION", 69, 73], ["necrosis", "OBSERVATION", 77, 85]]], ["The intranuclear inclusions are composed not of recognizable viral particles but of filaments.", [["intranuclear inclusions", "ANATOMY", 4, 27], ["filaments", "ANATOMY", 84, 93], ["filaments", "CELLULAR_COMPONENT", 84, 93], ["recognizable viral particles", "PROBLEM", 48, 76], ["intranuclear inclusions", "OBSERVATION", 4, 27], ["not of", "UNCERTAINTY", 41, 47], ["viral particles", "OBSERVATION", 61, 76]]], ["Virus is occasionally discernible in the cytoplasm, associated with tubular membranes.Rift Valley feverIt seems that the primary infection of the liver produces the primary necrotic foci, from which more virus spreads to damage neighboring parenchyma; the virus clearly has a marked preference for hepatocytes.", [["cytoplasm", "ANATOMY", 41, 50], ["tubular membranes", "ANATOMY", 68, 85], ["liver", "ANATOMY", 146, 151], ["necrotic foci", "ANATOMY", 173, 186], ["parenchyma", "ANATOMY", 240, 250], ["hepatocytes", "ANATOMY", 298, 309], ["fever", "DISEASE", 98, 103], ["primary infection", "DISEASE", 121, 138], ["necrotic", "DISEASE", 173, 181], ["Virus", "ORGANISM", 0, 5], ["cytoplasm", "ORGANISM_SUBSTANCE", 41, 50], ["tubular membranes", "CELLULAR_COMPONENT", 68, 85], ["Rift Valley fever", "ORGANISM", 86, 103], ["liver", "ORGAN", 146, 151], ["necrotic foci", "PATHOLOGICAL_FORMATION", 173, 186], ["parenchyma", "TISSUE", 240, 250], ["hepatocytes", "CELL", 298, 309], ["hepatocytes", "CELL_TYPE", 298, 309], ["Rift Valley fever", "SPECIES", 86, 103], ["Virus", "PROBLEM", 0, 5], ["tubular membranes", "PROBLEM", 68, 85], ["Rift Valley fever", "PROBLEM", 86, 103], ["the primary infection of the liver", "PROBLEM", 117, 151], ["the primary necrotic foci", "PROBLEM", 161, 186], ["damage neighboring parenchyma", "PROBLEM", 221, 250], ["the virus", "PROBLEM", 252, 261], ["hepatocytes", "PROBLEM", 298, 309], ["cytoplasm", "OBSERVATION", 41, 50], ["tubular membranes", "OBSERVATION", 68, 85], ["primary", "OBSERVATION_MODIFIER", 121, 128], ["infection", "OBSERVATION", 129, 138], ["liver", "ANATOMY", 146, 151], ["primary", "OBSERVATION_MODIFIER", 165, 172], ["necrotic", "OBSERVATION_MODIFIER", 173, 181], ["foci", "OBSERVATION", 182, 186], ["marked", "OBSERVATION_MODIFIER", 276, 282], ["hepatocytes", "ANATOMY", 298, 309]]], ["The hemorrhagic component of the syndrome is probably related to consumption of clotting factors; there is no direct evidence for the endothelial damage seen in infectious canine hepatitis.Rift Valley feverIn summary, Rift Valley fever is characterized by obvious focal hepatic necrosis, on which is superimposed an extensive centrilobular and midzonal necrosis; cholestasis is not as prominent as it is in Wesselsbron disease.", [["endothelial", "ANATOMY", 134, 145], ["hepatic", "ANATOMY", 270, 277], ["centrilobular", "ANATOMY", 326, 339], ["hemorrhagic", "DISEASE", 4, 15], ["endothelial damage", "DISEASE", 134, 152], ["infectious canine hepatitis", "DISEASE", 161, 188], ["fever", "DISEASE", 201, 206], ["Rift Valley fever", "DISEASE", 218, 235], ["focal hepatic necrosis", "DISEASE", 264, 286], ["necrosis", "DISEASE", 353, 361], ["cholestasis", "DISEASE", 363, 374], ["Wesselsbron disease", "DISEASE", 407, 426], ["clotting factors", "GENE_OR_GENE_PRODUCT", 80, 96], ["endothelial", "TISSUE", 134, 145], ["canine hepatitis", "ORGANISM", 172, 188], ["Rift Valley fever", "ORGANISM", 189, 206], ["Rift Valley fever", "ORGANISM", 218, 235], ["hepatic", "ORGAN", 270, 277], ["clotting factors", "PROTEIN", 80, 96], ["Rift Valley fever", "SPECIES", 189, 206], ["Rift Valley fever", "SPECIES", 218, 235], ["The hemorrhagic component", "PROBLEM", 0, 25], ["the syndrome", "PROBLEM", 29, 41], ["clotting factors", "PROBLEM", 80, 96], ["the endothelial damage", "PROBLEM", 130, 152], ["infectious canine hepatitis", "PROBLEM", 161, 188], ["Rift Valley fever", "PROBLEM", 189, 206], ["Rift Valley fever", "PROBLEM", 218, 235], ["obvious focal hepatic necrosis", "PROBLEM", 256, 286], ["an extensive centrilobular and midzonal necrosis", "PROBLEM", 313, 361], ["cholestasis", "PROBLEM", 363, 374], ["Wesselsbron disease", "PROBLEM", 407, 426], ["hemorrhagic", "OBSERVATION_MODIFIER", 4, 15], ["component", "OBSERVATION_MODIFIER", 16, 25], ["syndrome", "OBSERVATION", 33, 41], ["probably related to", "UNCERTAINTY", 45, 64], ["clotting", "OBSERVATION", 80, 88], ["no direct evidence for", "UNCERTAINTY", 107, 129], ["endothelial", "ANATOMY", 134, 145], ["damage", "OBSERVATION", 146, 152], ["infectious", "OBSERVATION_MODIFIER", 161, 171], ["canine", "OBSERVATION_MODIFIER", 172, 178], ["hepatitis", "OBSERVATION", 179, 188], ["obvious", "OBSERVATION_MODIFIER", 256, 263], ["focal", "OBSERVATION_MODIFIER", 264, 269], ["hepatic", "ANATOMY", 270, 277], ["necrosis", "OBSERVATION", 278, 286], ["extensive", "OBSERVATION_MODIFIER", 316, 325], ["centrilobular", "OBSERVATION_MODIFIER", 326, 339], ["midzonal", "OBSERVATION_MODIFIER", 344, 352], ["necrosis", "OBSERVATION", 353, 361], ["cholestasis", "OBSERVATION", 363, 374], ["not as", "UNCERTAINTY", 378, 384], ["prominent", "OBSERVATION_MODIFIER", 385, 394], ["Wesselsbron disease", "OBSERVATION", 407, 426]]], ["The liver lesions in the latter disease consist of smaller, randomly distributed foci of hepatocellular necrosis, more active reaction by the sinusoidal lining cells, and more obvious cholestasis.Equine serum hepatitis (Theiler's disease)Equine serum hepatitis is a common cause of acute hepatic failure in horses.", [["liver lesions", "ANATOMY", 4, 17], ["foci", "ANATOMY", 81, 85], ["hepatocellular", "ANATOMY", 89, 103], ["sinusoidal lining cells", "ANATOMY", 142, 165], ["serum", "ANATOMY", 203, 208], ["serum", "ANATOMY", 245, 250], ["hepatic", "ANATOMY", 288, 295], ["liver lesions", "DISEASE", 4, 17], ["necrosis", "DISEASE", 104, 112], ["cholestasis", "DISEASE", 184, 195], ["Equine serum hepatitis", "DISEASE", 196, 218], ["Theiler's disease", "DISEASE", 220, 237], ["Equine serum hepatitis", "DISEASE", 238, 260], ["acute hepatic failure", "DISEASE", 282, 303], ["liver lesions", "CANCER", 4, 17], ["hepatocellular", "CANCER", 89, 103], ["sinusoidal lining cells", "CELL", 142, 165], ["Equine", "ORGANISM", 196, 202], ["serum", "ORGANISM_SUBSTANCE", 203, 208], ["Theiler's disease", "ORGANISM", 220, 237], ["Equine", "ORGANISM", 238, 244], ["serum", "ORGANISM_SUBSTANCE", 245, 250], ["hepatic", "ORGAN", 288, 295], ["sinusoidal lining cells", "CELL_TYPE", 142, 165], ["Equine", "SPECIES", 196, 202], ["Theiler", "SPECIES", 220, 227], ["The liver lesions", "PROBLEM", 0, 17], ["the latter disease", "PROBLEM", 21, 39], ["hepatocellular necrosis", "PROBLEM", 89, 112], ["active reaction", "PROBLEM", 119, 134], ["the sinusoidal lining cells", "PROBLEM", 138, 165], ["obvious cholestasis", "PROBLEM", 176, 195], ["Equine serum hepatitis", "PROBLEM", 196, 218], ["Theiler's disease)", "PROBLEM", 220, 238], ["Equine serum hepatitis", "PROBLEM", 238, 260], ["acute hepatic failure in horses", "PROBLEM", 282, 313], ["liver", "ANATOMY", 4, 9], ["lesions", "OBSERVATION", 10, 17], ["latter", "OBSERVATION_MODIFIER", 25, 31], ["disease", "OBSERVATION", 32, 39], ["smaller", "OBSERVATION_MODIFIER", 51, 58], ["randomly", "OBSERVATION_MODIFIER", 60, 68], ["distributed", "OBSERVATION_MODIFIER", 69, 80], ["foci", "OBSERVATION", 81, 85], ["hepatocellular", "ANATOMY", 89, 103], ["necrosis", "OBSERVATION", 104, 112], ["more", "OBSERVATION_MODIFIER", 114, 118], ["active", "OBSERVATION_MODIFIER", 119, 125], ["reaction", "OBSERVATION", 126, 134], ["sinusoidal lining cells", "OBSERVATION", 142, 165], ["more", "OBSERVATION_MODIFIER", 171, 175], ["obvious", "OBSERVATION_MODIFIER", 176, 183], ["cholestasis", "OBSERVATION", 184, 195], ["hepatitis", "OBSERVATION", 209, 218], ["acute", "OBSERVATION_MODIFIER", 282, 287], ["hepatic", "ANATOMY", 288, 295], ["failure", "OBSERVATION", 296, 303]]], ["The disease was originally described in 1919 by Arnold Theiler, in horses passively immunized with equine serum against African horse sickness, and was later recognized in horses passively immunized against anthrax, tetanus, and equine encephalomyelitis.", [["serum", "ANATOMY", 106, 111], ["horse sickness", "DISEASE", 128, 142], ["anthrax", "DISEASE", 207, 214], ["tetanus", "DISEASE", 216, 223], ["equine encephalomyelitis", "DISEASE", 229, 253], ["Theiler", "ORGANISM", 55, 62], ["horses", "ORGANISM", 67, 73], ["equine", "ORGANISM", 99, 105], ["serum", "ORGANISM_SUBSTANCE", 106, 111], ["horse", "ORGANISM", 128, 133], ["horses", "ORGANISM", 172, 178], ["Theiler", "SPECIES", 55, 62], ["equine", "SPECIES", 99, 105], ["horse", "SPECIES", 128, 133], ["equine", "SPECIES", 229, 235], ["equine", "SPECIES", 99, 105], ["African horse", "SPECIES", 120, 133], ["horses", "SPECIES", 172, 178], ["equine encephalomyelitis", "SPECIES", 229, 253], ["The disease", "PROBLEM", 0, 11], ["African horse sickness", "PROBLEM", 120, 142], ["anthrax", "PROBLEM", 207, 214], ["tetanus", "PROBLEM", 216, 223], ["equine encephalomyelitis", "PROBLEM", 229, 253], ["disease", "OBSERVATION", 4, 11], ["equine encephalomyelitis", "OBSERVATION", 229, 253]]], ["Various injectable biologics of equine origin have been associated with the disease, including Clostridium perfringens toxoids, tetanus antitoxin, and equine herpesviral vaccines prepared from equine fetal tissue and pregnant mare serum.", [["fetal tissue", "ANATOMY", 200, 212], ["serum", "ANATOMY", 231, 236], ["Clostridium perfringens toxoids", "DISEASE", 95, 126], ["tetanus", "DISEASE", 128, 135], ["equine", "ORGANISM", 32, 38], ["Clostridium perfringens toxoids", "ORGANISM", 95, 126], ["tetanus antitoxin", "SIMPLE_CHEMICAL", 128, 145], ["equine", "ORGANISM", 151, 157], ["equine", "ORGANISM", 193, 199], ["fetal tissue", "TISSUE", 200, 212], ["serum", "ORGANISM_SUBSTANCE", 231, 236], ["Clostridium perfringens toxoids", "SPECIES", 95, 126], ["equine", "SPECIES", 151, 157], ["equine", "SPECIES", 193, 199], ["Clostridium perfringens", "SPECIES", 95, 118], ["equine", "SPECIES", 151, 157], ["equine", "SPECIES", 193, 199], ["Various injectable biologics of equine origin", "TREATMENT", 0, 45], ["the disease", "PROBLEM", 72, 83], ["Clostridium perfringens toxoids", "TREATMENT", 95, 126], ["tetanus antitoxin", "TREATMENT", 128, 145], ["equine herpesviral vaccines", "TREATMENT", 151, 178], ["equine fetal tissue", "TREATMENT", 193, 212], ["injectable", "OBSERVATION_MODIFIER", 8, 18], ["biologics", "OBSERVATION", 19, 28], ["equine origin", "OBSERVATION_MODIFIER", 32, 45], ["disease", "OBSERVATION", 76, 83]]], ["However, although such an association holds for the majority of cases, there are many, usually sporadic, cases in horses that have not received any injections.", [["horses", "ORGANISM", 114, 120], ["any injections", "TREATMENT", 144, 158]]], ["It is unknown how many exposed horses get subclinical disease, because the condition is seldom diagnosed before the onset of hepatic failure.", [["hepatic", "ANATOMY", 125, 132], ["hepatic failure", "DISEASE", 125, 140], ["horses", "ORGANISM", 31, 37], ["hepatic", "ORGAN", 125, 132], ["subclinical disease", "PROBLEM", 42, 61], ["hepatic failure", "PROBLEM", 125, 140], ["hepatic", "ANATOMY", 125, 132], ["failure", "OBSERVATION", 133, 140]]], ["However, some horses do recover after transient illness with jaundice, and some can survive with residual neurologic problems.Equine serum hepatitis (Theiler's disease)Recent metatranscriptomic analysis of serum from 2 index clinical cases in an outbreak of serum hepatitis in horsesBacterial infectionsBacterial hepatitis is common, but, with a few important exceptions, is usually focally distributed and of little clinical significance.", [["neurologic", "ANATOMY", 106, 116], ["serum", "ANATOMY", 133, 138], ["serum", "ANATOMY", 206, 211], ["serum", "ANATOMY", 258, 263], ["jaundice", "DISEASE", 61, 69], ["Equine serum hepatitis", "DISEASE", 126, 148], ["Theiler's disease", "DISEASE", 150, 167], ["serum hepatitis", "DISEASE", 258, 273], ["Bacterial infections", "DISEASE", 283, 303], ["Bacterial hepatitis", "DISEASE", 303, 322], ["horses", "ORGANISM", 14, 20], ["Equine", "ORGANISM", 126, 132], ["serum", "ORGANISM_SUBSTANCE", 133, 138], ["Theiler", "ORGANISM", 150, 157], ["serum", "ORGANISM_SUBSTANCE", 206, 211], ["serum", "ORGANISM_SUBSTANCE", 258, 263], ["Equine", "SPECIES", 126, 132], ["Theiler", "SPECIES", 150, 157], ["horses", "SPECIES", 277, 283], ["transient illness", "PROBLEM", 38, 55], ["jaundice", "PROBLEM", 61, 69], ["residual neurologic problems", "PROBLEM", 97, 125], ["Equine serum hepatitis", "PROBLEM", 126, 148], ["Theiler's disease", "PROBLEM", 150, 167], ["Recent metatranscriptomic analysis", "TEST", 168, 202], ["serum", "TEST", 206, 211], ["serum hepatitis", "PROBLEM", 258, 273], ["horsesBacterial infectionsBacterial hepatitis", "PROBLEM", 277, 322], ["jaundice", "OBSERVATION", 61, 69], ["hepatitis", "OBSERVATION", 139, 148], ["Bacterial", "OBSERVATION_MODIFIER", 283, 292], ["infections", "OBSERVATION", 293, 303], ["hepatitis", "OBSERVATION", 313, 322], ["few", "OBSERVATION_MODIFIER", 346, 349], ["focally", "OBSERVATION_MODIFIER", 383, 390]]], ["Bacteria may gain entrance to the liver in various ways: by direct implantation, for example, by foreign-body penetration from the reticulum; by invasion of the capsule from an adjacent focus of suppurative peritonitis; hematogenously via the hepatic artery or portal and umbilical veins; or via the bile ducts.Bacterial infectionsExcepting peracute septicemias, there are few specific bacterial infections that have a sustained or repeated bacteremic phase without producing hepatic lesions.", [["liver", "ANATOMY", 34, 39], ["body", "ANATOMY", 105, 109], ["reticulum", "ANATOMY", 131, 140], ["capsule", "ANATOMY", 161, 168], ["hematogenously", "ANATOMY", 220, 234], ["hepatic artery", "ANATOMY", 243, 257], ["portal", "ANATOMY", 261, 267], ["umbilical veins", "ANATOMY", 272, 287], ["bile ducts", "ANATOMY", 300, 310], ["hepatic lesions", "ANATOMY", 476, 491], ["peritonitis", "DISEASE", 207, 218], ["Bacterial infections", "DISEASE", 311, 331], ["septicemias", "DISEASE", 350, 361], ["infections", "DISEASE", 396, 406], ["hepatic lesions", "DISEASE", 476, 491], ["liver", "ORGAN", 34, 39], ["body", "ORGANISM_SUBDIVISION", 105, 109], ["reticulum", "CELLULAR_COMPONENT", 131, 140], ["capsule", "CANCER", 161, 168], ["hepatic artery", "MULTI-TISSUE_STRUCTURE", 243, 257], ["portal", "MULTI-TISSUE_STRUCTURE", 261, 267], ["umbilical veins", "MULTI-TISSUE_STRUCTURE", 272, 287], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 300, 310], ["hepatic lesions", "PATHOLOGICAL_FORMATION", 476, 491], ["Bacteria", "PROBLEM", 0, 8], ["direct implantation", "TREATMENT", 60, 79], ["foreign-body penetration from the reticulum", "PROBLEM", 97, 140], ["suppurative peritonitis", "PROBLEM", 195, 218], ["Bacterial infections", "PROBLEM", 311, 331], ["peracute septicemias", "PROBLEM", 341, 361], ["few specific bacterial infections", "PROBLEM", 373, 406], ["repeated bacteremic phase", "PROBLEM", 432, 457], ["hepatic lesions", "PROBLEM", 476, 491], ["liver", "ANATOMY", 34, 39], ["body penetration", "OBSERVATION", 105, 121], ["reticulum", "ANATOMY", 131, 140], ["invasion", "OBSERVATION", 145, 153], ["capsule", "ANATOMY", 161, 168], ["suppurative", "OBSERVATION_MODIFIER", 195, 206], ["peritonitis", "OBSERVATION", 207, 218], ["hepatic artery", "ANATOMY", 243, 257], ["portal", "ANATOMY", 261, 267], ["umbilical veins", "ANATOMY", 272, 287], ["bile ducts", "ANATOMY", 300, 310], ["infections", "OBSERVATION", 321, 331], ["septicemias", "OBSERVATION", 350, 361], ["few", "OBSERVATION_MODIFIER", 373, 376], ["specific", "OBSERVATION_MODIFIER", 377, 385], ["bacterial", "OBSERVATION_MODIFIER", 386, 395], ["infections", "OBSERVATION", 396, 406], ["hepatic", "ANATOMY", 476, 483], ["lesions", "OBSERVATION", 484, 491]]], ["There are, in addition, many cases of nonspecific bacteremia, especially those originating in the drainage field of the portal vein, in which focal hepatitis occurs.", [["portal vein", "ANATOMY", 120, 131], ["bacteremia", "DISEASE", 50, 60], ["hepatitis", "DISEASE", 148, 157], ["portal vein", "MULTI-TISSUE_STRUCTURE", 120, 131], ["nonspecific bacteremia", "PROBLEM", 38, 60], ["focal hepatitis", "PROBLEM", 142, 157], ["nonspecific", "OBSERVATION_MODIFIER", 38, 49], ["bacteremia", "OBSERVATION", 50, 60], ["drainage", "OBSERVATION", 98, 106], ["portal vein", "ANATOMY", 120, 131], ["focal", "OBSERVATION_MODIFIER", 142, 147], ["hepatitis", "OBSERVATION", 148, 157]]], ["Because their differential diagnosis is of some importance, it is probably useful to list here those specific bacterial diseases in which focal hepatitis is expected or characteristic, but not constant.", [["bacterial diseases", "DISEASE", 110, 128], ["hepatitis", "DISEASE", 144, 153], ["those specific bacterial diseases", "PROBLEM", 95, 128], ["focal hepatitis", "PROBLEM", 138, 153], ["bacterial diseases", "OBSERVATION", 110, 128], ["focal", "OBSERVATION_MODIFIER", 138, 143], ["hepatitis", "OBSERVATION", 144, 153], ["constant", "OBSERVATION_MODIFIER", 193, 201]]], ["The specific infections may occur as fetal or perinatal infections.", [["fetal", "ANATOMY", 37, 42], ["infections", "DISEASE", 13, 23], ["infections", "DISEASE", 56, 66], ["fetal", "ANATOMICAL_SYSTEM", 37, 42], ["The specific infections", "PROBLEM", 0, 23], ["fetal or perinatal infections", "PROBLEM", 37, 66], ["infections", "OBSERVATION", 13, 23], ["perinatal", "OBSERVATION_MODIFIER", 46, 55], ["infections", "OBSERVATION", 56, 66]]], ["The list includes Listeria monocytogenes in fetal and neonatal lambs, calves, foals, and piglets ( Fig. 2-73) ; Campylobacter fetus in fetal and neonatal lambs (Fig. 2-74) ; Actinobacillus equuli in foals; A. suis in pigs; Yersinia pseudotuberculosis in lambs and occasionally in dogs and cats;Hepatic abscessHepatic abscesses, quite apart from the lesions of the specific infections just given, are common, especially in cattle.", [["fetal", "ANATOMY", 44, 49], ["foals", "ANATOMY", 78, 83], ["fetus", "ANATOMY", 126, 131], ["fetal", "ANATOMY", 135, 140], ["lambs", "ANATOMY", 254, 259], ["Hepatic abscessHepatic abscesses", "ANATOMY", 294, 326], ["lesions", "ANATOMY", 349, 356], ["Campylobacter fetus", "DISEASE", 112, 131], ["Actinobacillus equuli", "DISEASE", 174, 195], ["Yersinia pseudotuberculosis", "DISEASE", 223, 250], ["Hepatic abscess", "DISEASE", 294, 309], ["Hepatic abscesses", "DISEASE", 309, 326], ["infections", "DISEASE", 373, 383], ["Listeria monocytogenes", "ORGANISM", 18, 40], ["fetal", "DEVELOPING_ANATOMICAL_STRUCTURE", 44, 49], ["lambs", "ORGANISM", 63, 68], ["calves", "ORGANISM", 70, 76], ["foals", "ORGANISM_SUBDIVISION", 78, 83], ["piglets", "ORGANISM", 89, 96], ["Fig. 2-73", "ORGANISM", 99, 108], ["Campylobacter fetus", "ORGANISM", 112, 131], ["fetal", "DEVELOPING_ANATOMICAL_STRUCTURE", 135, 140], ["lambs", "ORGANISM", 154, 159], ["Actinobacillus equuli", "ORGANISM", 174, 195], ["foals", "ORGANISM", 199, 204], ["A. suis", "ORGANISM", 206, 213], ["pigs", "ORGANISM", 217, 221], ["Yersinia pseudotuberculosis", "ORGANISM", 223, 250], ["lambs", "ORGANISM", 254, 259], ["dogs", "ORGANISM", 280, 284], ["cats", "ORGANISM", 289, 293], ["Hepatic abscess", "PATHOLOGICAL_FORMATION", 294, 309], ["Hepatic abscesses", "PATHOLOGICAL_FORMATION", 309, 326], ["lesions", "PATHOLOGICAL_FORMATION", 349, 356], ["cattle", "ORGANISM", 422, 428], ["Listeria monocytogenes", "SPECIES", 18, 40], ["lambs", "SPECIES", 63, 68], ["calves", "SPECIES", 70, 76], ["foals", "SPECIES", 78, 83], ["piglets", "SPECIES", 89, 96], ["Campylobacter fetus", "SPECIES", 112, 131], ["lambs", "SPECIES", 154, 159], ["Actinobacillus equuli", "SPECIES", 174, 195], ["foals", "SPECIES", 199, 204], ["A. suis", "SPECIES", 206, 213], ["pigs", "SPECIES", 217, 221], ["Yersinia pseudotuberculosis", "SPECIES", 223, 250], ["lambs", "SPECIES", 254, 259], ["dogs", "SPECIES", 280, 284], ["cats", "SPECIES", 289, 293], ["cattle", "SPECIES", 422, 428], ["Listeria monocytogenes", "SPECIES", 18, 40], ["Actinobacillus equuli", "SPECIES", 174, 195], ["A. suis", "SPECIES", 206, 213], ["pigs", "SPECIES", 217, 221], ["Yersinia pseudotuberculosis", "SPECIES", 223, 250], ["cattle", "SPECIES", 422, 428], ["Listeria monocytogenes", "PROBLEM", 18, 40], ["Campylobacter fetus", "PROBLEM", 112, 131], ["neonatal lambs", "TEST", 145, 159], ["Actinobacillus equuli in foals", "PROBLEM", 174, 204], ["Yersinia pseudotuberculosis in lambs and occasionally in dogs and cats", "PROBLEM", 223, 293], ["Hepatic abscess", "PROBLEM", 294, 309], ["Hepatic abscesses", "PROBLEM", 309, 326], ["the lesions", "PROBLEM", 345, 356], ["the specific infections", "PROBLEM", 360, 383], ["Listeria monocytogenes", "OBSERVATION", 18, 40], ["fetal", "ANATOMY", 135, 140], ["Yersinia pseudotuberculosis", "OBSERVATION", 223, 250], ["Hepatic", "ANATOMY", 294, 301], ["abscess", "OBSERVATION", 302, 309], ["Hepatic", "ANATOMY", 309, 316], ["abscesses", "OBSERVATION", 317, 326], ["lesions", "OBSERVATION", 349, 356], ["specific", "OBSERVATION_MODIFIER", 364, 372], ["infections", "OBSERVATION", 373, 383]]], ["They may arise by direct implantation of a foreign body from the reticulum or by direct invasion of the capsule from a suppurative lesion of traumatic reticulitis and may be single or multiple, but in either case, they are often preferentially distributed to the left lobe.", [["body", "ANATOMY", 51, 55], ["reticulum", "ANATOMY", 65, 74], ["capsule", "ANATOMY", 104, 111], ["suppurative lesion", "ANATOMY", 119, 137], ["left lobe", "ANATOMY", 263, 272], ["traumatic reticulitis", "DISEASE", 141, 162], ["reticulum", "CELLULAR_COMPONENT", 65, 74], ["capsule", "CANCER", 104, 111], ["reticulitis", "CANCER", 151, 162], ["left lobe", "MULTI-TISSUE_STRUCTURE", 263, 272], ["a foreign body", "PROBLEM", 41, 55], ["direct invasion of the capsule", "PROBLEM", 81, 111], ["a suppurative lesion", "PROBLEM", 117, 137], ["traumatic reticulitis", "PROBLEM", 141, 162], ["implantation", "OBSERVATION", 25, 37], ["foreign body", "OBSERVATION", 43, 55], ["reticulum", "ANATOMY", 65, 74], ["invasion", "OBSERVATION_MODIFIER", 88, 96], ["capsule", "ANATOMY", 104, 111], ["suppurative", "OBSERVATION_MODIFIER", 119, 130], ["lesion", "OBSERVATION", 131, 137], ["traumatic", "OBSERVATION_MODIFIER", 141, 150], ["reticulitis", "OBSERVATION", 151, 162], ["may be", "UNCERTAINTY", 167, 173], ["single", "OBSERVATION_MODIFIER", 174, 180], ["multiple", "OBSERVATION_MODIFIER", 184, 192], ["left lobe", "ANATOMY", 263, 272]]], ["They may be hematogenous from portal vein emboli, or by direct extension of omphalophlebitis.", [["portal vein emboli", "ANATOMY", 30, 48], ["portal vein emboli", "DISEASE", 30, 48], ["omphalophlebitis", "DISEASE", 76, 92], ["portal vein", "MULTI-TISSUE_STRUCTURE", 30, 41], ["hematogenous", "PROBLEM", 12, 24], ["portal vein emboli", "PROBLEM", 30, 48], ["omphalophlebitis", "PROBLEM", 76, 92], ["may be", "UNCERTAINTY", 5, 11], ["hematogenous", "OBSERVATION", 12, 24], ["portal vein", "ANATOMY", 30, 41], ["emboli", "OBSERVATION", 42, 48], ["omphalophlebitis", "OBSERVATION", 76, 92]]], ["Arteriogenic abscesses via the hepatic artery may occur in pyemias but are quite uncommon.Hepatic abscessOmphalogenic abscesses are more common in calves than in other species but occur in all.", [["abscesses", "ANATOMY", 13, 22], ["hepatic artery", "ANATOMY", 31, 45], ["Hepatic abscessOmphalogenic abscesses", "ANATOMY", 90, 127], ["abscesses", "DISEASE", 13, 22], ["hepatic artery", "DISEASE", 31, 45], ["pyemias", "DISEASE", 59, 66], ["Hepatic abscessOmphalogenic abscesses", "DISEASE", 90, 127], ["Arteriogenic abscesses", "PATHOLOGICAL_FORMATION", 0, 22], ["hepatic artery", "MULTI-TISSUE_STRUCTURE", 31, 45], ["Hepatic abscessOmphalogenic abscesses", "PATHOLOGICAL_FORMATION", 90, 127], ["calves", "ORGANISM", 147, 153], ["calves", "SPECIES", 147, 153], ["Arteriogenic abscesses", "PROBLEM", 0, 22], ["Hepatic abscessOmphalogenic abscesses", "PROBLEM", 90, 127], ["abscesses", "OBSERVATION", 13, 22], ["hepatic artery", "ANATOMY", 31, 45], ["abscessOmphalogenic", "OBSERVATION_MODIFIER", 98, 117], ["abscesses", "OBSERVATION", 118, 127], ["more common", "OBSERVATION_MODIFIER", 132, 143], ["calves", "OBSERVATION", 147, 153]]], ["The bacterial flora is frequently mixed, but Arcanobacterium pyogenes, Fusobacterium necrophorum, streptococci, and staphylococci usually predominate.", [["staphylococci", "DISEASE", 116, 129], ["Arcanobacterium pyogenes", "ORGANISM", 45, 69], ["Fusobacterium necrophorum", "ORGANISM", 71, 96], ["streptococci", "CELL", 98, 110], ["staphylococci", "CANCER", 116, 129], ["Arcanobacterium pyogenes", "SPECIES", 45, 69], ["Fusobacterium necrophorum", "SPECIES", 71, 96], ["Arcanobacterium pyogenes", "SPECIES", 45, 69], ["Fusobacterium necrophorum", "SPECIES", 71, 96], ["The bacterial flora", "TEST", 0, 19], ["Arcanobacterium pyogenes", "PROBLEM", 45, 69], ["Fusobacterium necrophorum", "PROBLEM", 71, 96], ["streptococci", "PROBLEM", 98, 110], ["staphylococci", "PROBLEM", 116, 129], ["bacterial flora", "OBSERVATION", 4, 19], ["Arcanobacterium pyogenes", "OBSERVATION", 45, 69], ["staphylococci", "OBSERVATION", 116, 129]]], ["Hepatic abscesses are not inevitable sequelae to omphalitis or even to omphalophlebitis, but they do not develop from navel infections in the absence of omphalophlebitis.", [["Hepatic abscesses", "ANATOMY", 0, 17], ["navel", "ANATOMY", 118, 123], ["Hepatic abscesses", "DISEASE", 0, 17], ["omphalitis", "DISEASE", 49, 59], ["omphalophlebitis", "DISEASE", 71, 87], ["infections", "DISEASE", 124, 134], ["omphalophlebitis", "DISEASE", 153, 169], ["Hepatic abscesses", "PATHOLOGICAL_FORMATION", 0, 17], ["navel", "ORGANISM_SUBDIVISION", 118, 123], ["omphalophlebitis", "CANCER", 153, 169], ["Hepatic abscesses", "PROBLEM", 0, 17], ["omphalitis", "PROBLEM", 49, 59], ["omphalophlebitis", "PROBLEM", 71, 87], ["navel infections", "PROBLEM", 118, 134], ["omphalophlebitis", "PROBLEM", 153, 169], ["abscesses", "OBSERVATION", 8, 17], ["not", "UNCERTAINTY", 22, 25], ["omphalophlebitis", "OBSERVATION", 71, 87], ["infections", "OBSERVATION", 124, 134], ["omphalophlebitis", "OBSERVATION", 153, 169]]], ["As there is no flow of blood in these vessels after birth, involvement of the liver is by direct growth along the physiologic thrombus.", [["blood", "ANATOMY", 23, 28], ["vessels", "ANATOMY", 38, 45], ["liver", "ANATOMY", 78, 83], ["thrombus", "ANATOMY", 126, 134], ["thrombus", "DISEASE", 126, 134], ["blood", "ORGANISM_SUBSTANCE", 23, 28], ["vessels", "MULTI-TISSUE_STRUCTURE", 38, 45], ["liver", "ORGAN", 78, 83], ["thrombus", "PATHOLOGICAL_FORMATION", 126, 134], ["flow of blood in these vessels", "PROBLEM", 15, 45], ["involvement of the liver", "PROBLEM", 59, 83], ["direct growth along the physiologic thrombus", "PROBLEM", 90, 134], ["no", "UNCERTAINTY", 12, 14], ["flow", "OBSERVATION", 15, 19], ["blood", "OBSERVATION", 23, 28], ["vessels", "ANATOMY", 38, 45], ["liver", "ANATOMY", 78, 83], ["growth", "OBSERVATION_MODIFIER", 97, 103], ["physiologic", "OBSERVATION_MODIFIER", 114, 125], ["thrombus", "OBSERVATION", 126, 134]]], ["Omphalophlebitis can be quite severe without extension to the liver.", [["liver", "ANATOMY", 62, 67], ["Omphalophlebitis", "DISEASE", 0, 16], ["liver", "ORGAN", 62, 67], ["Omphalophlebitis", "PROBLEM", 0, 16], ["extension to the liver", "PROBLEM", 45, 67], ["liver", "ANATOMY", 62, 67]]], ["Hepatic abscesses of omphalogenic origin are often restricted to the left lobe ( Fig. 2-77 ), but they may be restricted to the right or be generalized in their distribution.Hepatic abscessHepatic abscesses are also common and of economic importance in feedlot cattle.", [["Hepatic abscesses", "ANATOMY", 0, 17], ["left lobe", "ANATOMY", 69, 78], ["Hepatic abscess", "ANATOMY", 174, 189], ["Hepatic abscesses", "ANATOMY", 189, 206], ["abscesses", "DISEASE", 8, 17], ["Hepatic abscess", "DISEASE", 174, 189], ["Hepatic abscesses", "DISEASE", 189, 206], ["Hepatic abscesses", "PATHOLOGICAL_FORMATION", 0, 17], ["left lobe", "MULTI-TISSUE_STRUCTURE", 69, 78], ["Hepatic abscess", "PATHOLOGICAL_FORMATION", 174, 189], ["Hepatic abscesses", "PATHOLOGICAL_FORMATION", 189, 206], ["cattle", "SPECIES", 261, 267], ["cattle", "SPECIES", 261, 267], ["Hepatic abscesses of omphalogenic origin", "PROBLEM", 0, 40], ["Hepatic abscess", "PROBLEM", 174, 189], ["Hepatic abscesses", "PROBLEM", 189, 206], ["abscesses", "OBSERVATION", 8, 17], ["omphalogenic origin", "OBSERVATION", 21, 40], ["left lobe", "ANATOMY", 69, 78], ["may be", "UNCERTAINTY", 103, 109], ["right", "ANATOMY_MODIFIER", 128, 133], ["generalized", "OBSERVATION_MODIFIER", 140, 151], ["abscess", "OBSERVATION", 182, 189], ["abscesses", "OBSERVATION", 197, 206]]], ["They are usually found at slaughter but, when numerous, may be fatal after a few days of vague digestive illness.", [["digestive", "ANATOMY", 95, 104], ["digestive illness", "DISEASE", 95, 112], ["digestive", "ORGAN", 95, 104], ["vague digestive illness", "PROBLEM", 89, 112]]], ["2, Alimentary system and peritoneum).", [["peritoneum", "ANATOMY", 25, 35], ["peritoneum", "MULTI-TISSUE_STRUCTURE", 25, 35], ["Alimentary system", "ANATOMY", 3, 20], ["peritoneum", "ANATOMY", 25, 35]]], ["Liver abscesses in feedlot sheep likely have a similar pathogenesis, with F. necrophorum as the primary isolate.", [["Liver abscesses", "ANATOMY", 0, 15], ["Liver abscesses", "DISEASE", 0, 15], ["F. necrophorum", "DISEASE", 74, 88], ["Liver", "ORGAN", 0, 5], ["sheep", "ORGANISM", 27, 32], ["F. necrophorum", "ORGANISM", 74, 88], ["sheep", "SPECIES", 27, 32], ["F. necrophorum", "SPECIES", 74, 88], ["sheep", "SPECIES", 27, 32], ["F. necrophorum", "SPECIES", 74, 88], ["Liver abscesses", "PROBLEM", 0, 15], ["a similar pathogenesis", "PROBLEM", 45, 67], ["F. necrophorum", "PROBLEM", 74, 88], ["abscesses", "OBSERVATION", 6, 15], ["similar", "OBSERVATION_MODIFIER", 47, 54], ["pathogenesis", "OBSERVATION", 55, 67]]], ["A second category includes parasitic granulomas populated by various opportunistic bacteria.Hepatic abscessHepatic abscesses of biliary origin occur in all animals.", [["granulomas", "ANATOMY", 37, 47], ["Hepatic abscess", "ANATOMY", 92, 107], ["Hepatic abscesses", "ANATOMY", 107, 124], ["biliary", "ANATOMY", 128, 135], ["granulomas", "DISEASE", 37, 47], ["Hepatic abscess", "DISEASE", 92, 107], ["Hepatic abscesses", "DISEASE", 107, 124], ["parasitic granulomas", "PATHOLOGICAL_FORMATION", 27, 47], ["Hepatic abscess", "PATHOLOGICAL_FORMATION", 92, 107], ["Hepatic abscesses", "PATHOLOGICAL_FORMATION", 107, 124], ["biliary", "ORGAN", 128, 135], ["parasitic granulomas", "PROBLEM", 27, 47], ["various opportunistic bacteria", "PROBLEM", 61, 91], ["Hepatic abscess", "PROBLEM", 92, 107], ["Hepatic abscesses of biliary origin", "PROBLEM", 107, 142], ["parasitic", "OBSERVATION_MODIFIER", 27, 36], ["granulomas", "OBSERVATION", 37, 47], ["various", "OBSERVATION_MODIFIER", 61, 68], ["opportunistic bacteria", "OBSERVATION", 69, 91], ["abscess", "OBSERVATION", 100, 107], ["abscesses", "OBSERVATION", 115, 124], ["biliary origin", "ANATOMY", 128, 142]]], ["They occur in pigs in which ascarids have migrated into the bile ducts.", [["ascarids", "ANATOMY", 28, 36], ["bile ducts", "ANATOMY", 60, 70], ["pigs", "ORGANISM", 14, 18], ["ascarids", "GENE_OR_GENE_PRODUCT", 28, 36], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 60, 70], ["pigs", "SPECIES", 14, 18], ["pigs", "SPECIES", 14, 18], ["bile ducts", "ANATOMY", 60, 70]]], ["Cholangitic abscesses in horses, dogs, and cats are usually caused by enterobacteria as part of a fulminating ascending cholangiohepatitis that is fatal after a short course.Hepatic abscessThe sequelae of hepatic abscessation are variable.", [["Cholangitic abscesses", "ANATOMY", 0, 21], ["Hepatic abscess", "ANATOMY", 174, 189], ["hepatic", "ANATOMY", 205, 212], ["Cholangitic abscesses", "DISEASE", 0, 21], ["cholangiohepatitis", "DISEASE", 120, 138], ["Hepatic abscess", "DISEASE", 174, 189], ["hepatic abscessation", "DISEASE", 205, 225], ["Cholangitic abscesses", "PATHOLOGICAL_FORMATION", 0, 21], ["dogs", "ORGANISM", 33, 37], ["cats", "ORGANISM", 43, 47], ["Hepatic abscess", "PATHOLOGICAL_FORMATION", 174, 189], ["hepatic", "ORGAN", 205, 212], ["dogs", "SPECIES", 33, 37], ["cats", "SPECIES", 43, 47], ["Cholangitic abscesses in horses", "PROBLEM", 0, 31], ["dogs", "PROBLEM", 33, 37], ["enterobacteria", "PROBLEM", 70, 84], ["a fulminating ascending cholangiohepatitis", "PROBLEM", 96, 138], ["Hepatic abscess", "PROBLEM", 174, 189], ["hepatic abscessation", "PROBLEM", 205, 225], ["abscesses", "OBSERVATION", 12, 21], ["enterobacteria", "OBSERVATION", 70, 84], ["fulminating", "OBSERVATION_MODIFIER", 98, 109], ["ascending", "OBSERVATION_MODIFIER", 110, 119], ["cholangiohepatitis", "OBSERVATION", 120, 138], ["fatal", "OBSERVATION_MODIFIER", 147, 152], ["abscess", "OBSERVATION", 182, 189], ["sequelae", "OBSERVATION_MODIFIER", 193, 201], ["hepatic", "ANATOMY", 205, 212], ["abscessation", "OBSERVATION", 213, 225], ["variable", "OBSERVATION_MODIFIER", 230, 238]]], ["Usually, they are insignificant and asymptomatic.", [["asymptomatic", "PROBLEM", 36, 48], ["insignificant", "OBSERVATION_MODIFIER", 18, 31], ["asymptomatic", "OBSERVATION_MODIFIER", 36, 48]]], ["Sterilization of the focus with either resorption and complete healing or encapsulation is common.", [["Sterilization", "TREATMENT", 0, 13], ["either resorption", "PROBLEM", 32, 49], ["complete healing", "PROBLEM", 54, 70], ["resorption", "OBSERVATION", 39, 49], ["healing", "OBSERVATION_MODIFIER", 63, 70], ["encapsulation", "OBSERVATION", 74, 87]]], ["Those near the surface of the liver regularly produce fibrinous and then fibrous inflammation of the capsule and adhesion to adjacent viscera.", [["surface", "ANATOMY", 15, 22], ["liver", "ANATOMY", 30, 35], ["fibrous", "ANATOMY", 73, 80], ["capsule", "ANATOMY", 101, 108], ["viscera", "ANATOMY", 134, 141], ["fibrinous", "DISEASE", 54, 63], ["surface", "CELLULAR_COMPONENT", 15, 22], ["liver", "ORGAN", 30, 35], ["capsule", "CANCER", 101, 108], ["viscera", "ORGAN", 134, 141], ["fibrinous and then fibrous inflammation of the capsule", "PROBLEM", 54, 108], ["surface", "ANATOMY_MODIFIER", 15, 22], ["liver", "ANATOMY", 30, 35], ["fibrinous", "OBSERVATION", 54, 63], ["fibrous", "OBSERVATION_MODIFIER", 73, 80], ["inflammation", "OBSERVATION", 81, 93], ["capsule", "ANATOMY", 101, 108], ["adhesion", "OBSERVATION_MODIFIER", 113, 121], ["viscera", "ANATOMY", 134, 141]]], ["They seldom Francisella (Yersinia) tularensis in lambs and cats; Mannheimia haemolytica and Histophilus somni (Haemophilus agni) in lambs; Salmonella spp. in all hosts; Clostridium piliforme (Tyzzer's disease) in foals and dogs; Nocardia asteroides in dogs; and the mycobacteria in all hosts (Figs.", [["Francisella (Yersinia) tularensis", "DISEASE", 12, 45], ["Clostridium piliforme", "DISEASE", 169, 190], ["Tyzzer's disease", "DISEASE", 192, 208], ["Nocardia asteroides", "DISEASE", 229, 248], ["Francisella (", "ORGANISM", 12, 25], ["Yersinia) tularensis", "ORGANISM", 25, 45], ["lambs", "ORGANISM", 49, 54], ["cats", "ORGANISM", 59, 63], ["Mannheimia haemolytica", "ORGANISM", 65, 87], ["Histophilus somni", "ORGANISM", 92, 109], ["Haemophilus agni", "ORGANISM", 111, 127], ["lambs", "ORGANISM", 132, 137], ["Salmonella spp", "ORGANISM", 139, 153], ["Clostridium piliforme", "ORGANISM", 169, 190], ["Tyzzer's disease", "ORGANISM", 192, 208], ["foals", "ORGANISM", 213, 218], ["dogs", "ORGANISM", 223, 227], ["Nocardia asteroides", "ORGANISM", 229, 248], ["dogs", "ORGANISM", 252, 256], ["Yersinia) tularensis", "SPECIES", 25, 45], ["lambs", "SPECIES", 49, 54], ["cats", "SPECIES", 59, 63], ["Mannheimia haemolytica", "SPECIES", 65, 87], ["Histophilus somni", "SPECIES", 92, 109], ["Haemophilus agni", "SPECIES", 111, 127], ["lambs", "SPECIES", 132, 137], ["Salmonella spp", "SPECIES", 139, 153], ["Clostridium piliforme", "SPECIES", 169, 190], ["foals", "SPECIES", 213, 218], ["dogs", "SPECIES", 223, 227], ["Nocardia asteroides", "SPECIES", 229, 248], ["dogs", "SPECIES", 252, 256], ["Yersinia) tularensis", "SPECIES", 25, 45], ["Mannheimia haemolytica", "SPECIES", 65, 87], ["Histophilus somni", "SPECIES", 92, 109], ["Haemophilus agni", "SPECIES", 111, 127], ["Clostridium piliforme", "SPECIES", 169, 190], ["Nocardia asteroides", "SPECIES", 229, 248], ["Francisella (Yersinia) tularensis in lambs and cats", "PROBLEM", 12, 63], ["Mannheimia haemolytica", "PROBLEM", 65, 87], ["Histophilus somni (Haemophilus agni", "PROBLEM", 92, 127], ["Salmonella spp", "PROBLEM", 139, 153], ["Clostridium piliforme (Tyzzer's disease)", "PROBLEM", 169, 209], ["Nocardia asteroides in dogs", "PROBLEM", 229, 256], ["the mycobacteria", "PROBLEM", 262, 278], ["Francisella", "OBSERVATION", 12, 23], ["Yersinia", "OBSERVATION_MODIFIER", 25, 33], ["Mannheimia haemolytica", "OBSERVATION", 65, 87], ["Nocardia asteroides", "OBSERVATION", 229, 248], ["mycobacteria", "OBSERVATION", 266, 278]]], ["2-75, 2-76A, B) . many months.", [["2-75, 2-76A, B", "CHEMICAL", 0, 14], ["B", "GENE_OR_GENE_PRODUCT", 13, 14]]], ["In endemic areas, many healthy sheep, cattle, and dogs harbor latent infections in their livers.", [["livers", "ANATOMY", 89, 95], ["infections", "DISEASE", 69, 79], ["sheep", "ORGANISM", 31, 36], ["cattle", "ORGANISM", 38, 44], ["dogs", "ORGANISM", 50, 54], ["livers", "ORGAN", 89, 95], ["sheep", "SPECIES", 31, 36], ["cattle", "SPECIES", 38, 44], ["dogs", "SPECIES", 50, 54], ["sheep", "SPECIES", 31, 36], ["cattle", "SPECIES", 38, 44], ["dogs harbor latent infections in their livers", "PROBLEM", 50, 95], ["endemic", "OBSERVATION_MODIFIER", 3, 10], ["areas", "OBSERVATION_MODIFIER", 11, 16], ["many", "OBSERVATION_MODIFIER", 18, 22], ["healthy sheep", "OBSERVATION_MODIFIER", 23, 36], ["latent", "OBSERVATION_MODIFIER", 62, 68], ["infections", "OBSERVATION", 69, 79], ["livers", "ANATOMY", 89, 95]]], ["Black disease is principally an acutely fatal disease of sheep in regions where the inciting helminths are endemic.", [["Black disease", "DISEASE", 0, 13], ["helminths", "DISEASE", 93, 102], ["sheep", "ORGANISM", 57, 62], ["sheep", "SPECIES", 57, 62], ["sheep", "SPECIES", 57, 62], ["Black disease", "PROBLEM", 0, 13], ["an acutely fatal disease of sheep in regions", "PROBLEM", 29, 73], ["disease", "OBSERVATION", 6, 13], ["acutely", "OBSERVATION_MODIFIER", 32, 39], ["fatal", "OBSERVATION_MODIFIER", 40, 45], ["disease", "OBSERVATION", 46, 53], ["sheep", "OBSERVATION_MODIFIER", 57, 62], ["inciting", "OBSERVATION_MODIFIER", 84, 92], ["helminths", "OBSERVATION", 93, 102], ["endemic", "OBSERVATION_MODIFIER", 107, 114]]], ["The disease is most commonly initiated by migrating larvae of the common liver fluke Fasciola hepatica.", [["liver", "ANATOMY", 73, 78], ["liver fluke Fasciola hepatica", "DISEASE", 73, 102], ["liver", "ORGAN", 73, 78], ["Fasciola hepatica", "ORGANISM", 85, 102], ["Fasciola hepatica", "SPECIES", 85, 102], ["Fasciola hepatica", "SPECIES", 85, 102], ["The disease", "PROBLEM", 0, 11], ["disease", "OBSERVATION", 4, 11], ["most commonly", "OBSERVATION_MODIFIER", 15, 28], ["common", "ANATOMY_MODIFIER", 66, 72], ["liver", "ANATOMY", 73, 78], ["fluke", "OBSERVATION", 79, 84], ["hepatica", "ANATOMY", 94, 102]]], ["In Bessarabia and France, it is endemically related to the distribution of Dicrocoelium dendriticum, the lancet liver fluke.", [["liver fluke", "ANATOMY", 112, 123], ["liver fluke", "DISEASE", 112, 123], ["Dicrocoelium dendriticum", "ORGANISM", 75, 99], ["liver", "ORGAN", 112, 117], ["fluke", "ORGAN", 118, 123], ["Dicrocoelium dendriticum", "SPECIES", 75, 99], ["Dicrocoelium dendriticum", "SPECIES", 75, 99], ["Dicrocoelium dendriticum", "PROBLEM", 75, 99], ["the lancet liver fluke", "PROBLEM", 101, 123], ["France", "OBSERVATION_MODIFIER", 18, 24], ["Dicrocoelium dendriticum", "OBSERVATION", 75, 99], ["lancet", "OBSERVATION_MODIFIER", 105, 111], ["liver", "ANATOMY", 112, 117], ["fluke", "OBSERVATION_MODIFIER", 118, 123]]], ["Sporadic cases may be related to Cysticercus tenuicollis infection or may be idiopathic.Hepatic abscessDeaths in sheep from black disease occur rapidly and usually without warning signs.", [["Hepatic abscess", "ANATOMY", 88, 103], ["Cysticercus tenuicollis infection", "DISEASE", 33, 66], ["Hepatic abscess", "DISEASE", 88, 103], ["black disease", "DISEASE", 124, 137], ["Cysticercus tenuicollis", "ORGANISM", 33, 56], ["Hepatic abscess", "PATHOLOGICAL_FORMATION", 88, 103], ["sheep", "ORGANISM", 113, 118], ["Cysticercus tenuicollis", "SPECIES", 33, 56], ["sheep", "SPECIES", 113, 118], ["Cysticercus tenuicollis", "SPECIES", 33, 56], ["sheep", "SPECIES", 113, 118], ["Sporadic cases", "PROBLEM", 0, 14], ["Cysticercus tenuicollis infection", "PROBLEM", 33, 66], ["idiopathic", "PROBLEM", 77, 87], ["Hepatic abscess", "PROBLEM", 88, 103], ["black disease", "PROBLEM", 124, 137], ["warning signs", "PROBLEM", 172, 185], ["may be related to", "UNCERTAINTY", 15, 32], ["Cysticercus tenuicollis", "OBSERVATION", 33, 56], ["infection", "OBSERVATION", 57, 66], ["may be", "UNCERTAINTY", 70, 76], ["idiopathic", "OBSERVATION", 77, 87], ["abscess", "OBSERVATION", 96, 103], ["black disease", "OBSERVATION", 124, 137]]], ["Illness, if observed, is brief and characterized by reluctance to move, drowsiness, rapid respiration, and quiet subsidence.", [["Illness", "PROBLEM", 0, 7], ["drowsiness", "PROBLEM", 72, 82], ["rapid respiration", "PROBLEM", 84, 101], ["quiet subsidence", "PROBLEM", 107, 123]]], ["Affected animals are usually in good nutritional condition.", [["Affected animals", "PROBLEM", 0, 16]]], ["Postmortem decomposition occurs rapidly.", [["rapidly", "OBSERVATION_MODIFIER", 32, 39]]], ["The name of the disease is derived from the appearance of flayed skins, the dark coloration being caused by an unusual degree of subcutaneous venous congestion.", [["skins", "ANATOMY", 65, 70], ["subcutaneous venous", "ANATOMY", 129, 148], ["venous congestion", "DISEASE", 142, 159], ["skins", "ORGAN", 65, 70], ["subcutaneous venous", "MULTI-TISSUE_STRUCTURE", 129, 148], ["the disease", "PROBLEM", 12, 23], ["flayed skins", "PROBLEM", 58, 70], ["the dark coloration", "PROBLEM", 72, 91], ["subcutaneous venous congestion", "PROBLEM", 129, 159], ["disease", "OBSERVATION", 16, 23], ["dark coloration", "OBSERVATION", 76, 91], ["unusual", "OBSERVATION_MODIFIER", 111, 118], ["degree", "OBSERVATION_MODIFIER", 119, 125], ["subcutaneous", "ANATOMY_MODIFIER", 129, 141], ["venous", "ANATOMY", 142, 148], ["congestion", "OBSERVATION", 149, 159]]], ["Frequently, there is edema of the sternal subcutis, and airways contain stable foam.", [["edema", "ANATOMY", 21, 26], ["sternal subcutis", "ANATOMY", 34, 50], ["airways", "ANATOMY", 56, 63], ["edema", "DISEASE", 21, 26], ["edema", "PATHOLOGICAL_FORMATION", 21, 26], ["sternal subcutis", "PATHOLOGICAL_FORMATION", 34, 50], ["airways", "MULTI-TISSUE_STRUCTURE", 56, 63], ["edema of the sternal subcutis", "PROBLEM", 21, 50], ["edema", "OBSERVATION", 21, 26], ["sternal subcutis", "ANATOMY", 34, 50], ["airways", "ANATOMY", 56, 63], ["stable", "OBSERVATION_MODIFIER", 72, 78], ["foam", "OBSERVATION", 79, 83]]], ["Serous cavities contain an abundance of fluid that clots on exposure to air.", [["Serous cavities", "ANATOMY", 0, 15], ["fluid", "ANATOMY", 40, 45], ["clots", "ANATOMY", 51, 56], ["Serous cavities", "PATHOLOGICAL_FORMATION", 0, 15], ["fluid", "ORGANISM_SUBSTANCE", 40, 45], ["clots", "ORGANISM_SUBSTANCE", 51, 56], ["Serous cavities", "PROBLEM", 0, 15], ["fluid that clots", "PROBLEM", 40, 56], ["cavities", "OBSERVATION", 7, 15], ["abundance", "OBSERVATION_MODIFIER", 27, 36], ["fluid", "OBSERVATION", 40, 45], ["clots", "OBSERVATION", 51, 56], ["air", "OBSERVATION", 72, 75]]], ["The fluid is usually straw colored, but that in the abdomen may be tinged with blood.", [["fluid", "ANATOMY", 4, 9], ["abdomen", "ANATOMY", 52, 59], ["blood", "ANATOMY", 79, 84], ["fluid", "ORGANISM_SUBSTANCE", 4, 9], ["abdomen", "ORGAN", 52, 59], ["blood", "ORGANISM_SUBSTANCE", 79, 84], ["tinged with blood", "PROBLEM", 67, 84], ["fluid", "OBSERVATION", 4, 9], ["usually straw colored", "OBSERVATION_MODIFIER", 13, 34], ["abdomen", "ANATOMY", 52, 59], ["may be", "UNCERTAINTY", 60, 66], ["tinged", "OBSERVATION", 67, 73]]], ["The volume of fluid in the abdomen and thorax may vary from about 50 mL to 1.5 L. The pericardial sac is distended with similar fluid in amounts up to ~300 mL.", [["fluid", "ANATOMY", 14, 19], ["abdomen", "ANATOMY", 27, 34], ["thorax", "ANATOMY", 39, 45], ["pericardial sac", "ANATOMY", 86, 101], ["fluid", "ANATOMY", 128, 133], ["fluid", "ORGANISM_SUBSTANCE", 14, 19], ["abdomen", "ORGAN", 27, 34], ["thorax", "ORGAN", 39, 45], ["pericardial sac", "MULTI-TISSUE_STRUCTURE", 86, 101], ["fluid", "ORGANISM_SUBSTANCE", 128, 133], ["fluid in the abdomen and thorax", "PROBLEM", 14, 45], ["distended", "PROBLEM", 105, 114], ["similar fluid in amounts", "PROBLEM", 120, 144], ["volume", "OBSERVATION_MODIFIER", 4, 10], ["fluid", "OBSERVATION", 14, 19], ["abdomen", "ANATOMY", 27, 34], ["thorax", "ANATOMY", 39, 45], ["pericardial", "ANATOMY", 86, 97], ["sac", "ANATOMY_MODIFIER", 98, 101], ["distended", "OBSERVATION", 105, 114], ["similar", "OBSERVATION_MODIFIER", 120, 127], ["fluid", "OBSERVATION", 128, 133], ["amounts", "OBSERVATION_MODIFIER", 137, 144], ["~300 mL", "OBSERVATION_MODIFIER", 151, 158]]], ["Subendocardial hemorrhages in the left ventricle are almost constant.", [["Subendocardial", "ANATOMY", 0, 14], ["left ventricle", "ANATOMY", 34, 48], ["hemorrhages", "DISEASE", 15, 26], ["left ventricle", "MULTI-TISSUE_STRUCTURE", 34, 48], ["Subendocardial hemorrhages in the left ventricle", "PROBLEM", 0, 48], ["hemorrhages", "OBSERVATION", 15, 26], ["left ventricle", "ANATOMY", 34, 48], ["almost", "OBSERVATION_MODIFIER", 53, 59], ["constant", "OBSERVATION_MODIFIER", 60, 68]]], ["Patchy areas of congestion and hemorrhage may be present in the pyloric part of the abomasum and in the small intestine.Hepatic abscessThe typical and diagnostic lesions occur in the liver and are always present.", [["pyloric part", "ANATOMY", 64, 76], ["abomasum", "ANATOMY", 84, 92], ["small intestine", "ANATOMY", 104, 119], ["Hepatic abscess", "ANATOMY", 120, 135], ["lesions", "ANATOMY", 162, 169], ["liver", "ANATOMY", 183, 188], ["congestion", "DISEASE", 16, 26], ["hemorrhage", "DISEASE", 31, 41], ["Hepatic abscess", "DISEASE", 120, 135], ["pyloric part", "MULTI-TISSUE_STRUCTURE", 64, 76], ["abomasum", "ORGAN", 84, 92], ["small intestine", "ORGAN", 104, 119], ["Hepatic abscess", "PATHOLOGICAL_FORMATION", 120, 135], ["lesions", "CANCER", 162, 169], ["liver", "ORGAN", 183, 188], ["congestion", "PROBLEM", 16, 26], ["hemorrhage", "PROBLEM", 31, 41], ["Hepatic abscess", "PROBLEM", 120, 135], ["The typical and diagnostic lesions", "PROBLEM", 135, 169], ["areas", "OBSERVATION_MODIFIER", 7, 12], ["congestion", "OBSERVATION", 16, 26], ["hemorrhage", "OBSERVATION", 31, 41], ["pyloric", "ANATOMY", 64, 71], ["abomasum", "ANATOMY", 84, 92], ["small intestine", "ANATOMY", 104, 119], ["abscess", "OBSERVATION", 128, 135], ["typical", "OBSERVATION_MODIFIER", 139, 146], ["diagnostic", "OBSERVATION_MODIFIER", 151, 161], ["lesions", "OBSERVATION", 162, 169], ["liver", "ANATOMY", 183, 188]]], ["They are usually clearly evident on the capsular surface, the diaphragmatic surface especially, but the organ may have to be sliced carefully to find them.", [["capsular surface", "ANATOMY", 40, 56], ["diaphragmatic surface", "ANATOMY", 62, 83], ["organ", "ANATOMY", 104, 109], ["capsular surface", "CELLULAR_COMPONENT", 40, 56], ["diaphragmatic surface", "CELLULAR_COMPONENT", 62, 83], ["organ", "ORGAN", 104, 109], ["capsular", "ANATOMY_MODIFIER", 40, 48], ["surface", "ANATOMY_MODIFIER", 49, 56], ["diaphragmatic", "ANATOMY", 62, 75], ["surface", "ANATOMY_MODIFIER", 76, 83]]], ["The liver will be the seat of either the acute traumatic hemorrhagic lesions of acute fascioliasis, the cholangiohepatitis of the chronic disease, or both.", [["liver", "ANATOMY", 4, 9], ["lesions", "ANATOMY", 69, 76], ["hemorrhagic", "DISEASE", 57, 68], ["fascioliasis", "DISEASE", 86, 98], ["cholangiohepatitis", "DISEASE", 104, 122], ["chronic disease", "DISEASE", 130, 145], ["liver", "ORGAN", 4, 9], ["hemorrhagic lesions", "PATHOLOGICAL_FORMATION", 57, 76], ["the acute traumatic hemorrhagic lesions", "PROBLEM", 37, 76], ["acute fascioliasis", "PROBLEM", 80, 98], ["the chronic disease", "PROBLEM", 126, 145], ["liver", "ANATOMY", 4, 9], ["acute", "OBSERVATION_MODIFIER", 41, 46], ["traumatic", "OBSERVATION_MODIFIER", 47, 56], ["hemorrhagic", "OBSERVATION_MODIFIER", 57, 68], ["lesions", "OBSERVATION", 69, 76], ["acute", "OBSERVATION_MODIFIER", 80, 85], ["fascioliasis", "OBSERVATION", 86, 98], ["chronic", "OBSERVATION_MODIFIER", 130, 137], ["disease", "OBSERVATION", 138, 145]]], ["The lesion of black disease, and occasionally there are several, is a yellow-white area of necrosis 2-3 cm in diameter, surrounded by a broad zone of intense hyperemia, roughly circular in outline, and extending hemispherically into the substance of the organ.", [["lesion", "ANATOMY", 4, 10], ["hemispherically", "ANATOMY", 212, 227], ["organ", "ANATOMY", 254, 259], ["black disease", "DISEASE", 14, 27], ["necrosis", "DISEASE", 91, 99], ["hyperemia", "DISEASE", 158, 167], ["organ", "ORGAN", 254, 259], ["black disease", "PROBLEM", 14, 27], ["a yellow-white area of necrosis", "PROBLEM", 68, 99], ["a broad zone of intense hyperemia", "PROBLEM", 134, 167], ["lesion", "OBSERVATION", 4, 10], ["black", "OBSERVATION_MODIFIER", 14, 19], ["disease", "OBSERVATION", 20, 27], ["occasionally", "OBSERVATION_MODIFIER", 33, 45], ["several", "OBSERVATION_MODIFIER", 56, 63], ["yellow", "OBSERVATION_MODIFIER", 70, 76], ["white", "OBSERVATION_MODIFIER", 77, 82], ["area", "OBSERVATION_MODIFIER", 83, 87], ["necrosis", "OBSERVATION", 91, 99], ["2-3 cm", "OBSERVATION_MODIFIER", 100, 106], ["diameter", "OBSERVATION_MODIFIER", 110, 118], ["broad", "OBSERVATION_MODIFIER", 136, 141], ["zone", "OBSERVATION_MODIFIER", 142, 146], ["intense", "OBSERVATION_MODIFIER", 150, 157], ["hyperemia", "OBSERVATION", 158, 167], ["roughly", "OBSERVATION_MODIFIER", 169, 176], ["circular", "OBSERVATION_MODIFIER", 177, 185], ["substance", "OBSERVATION_MODIFIER", 237, 246], ["organ", "ANATOMY", 254, 259]]], ["There may be a coagulum of fibrin on the capsular surface overlying the necrotic area.", [["coagulum", "ANATOMY", 15, 23], ["capsular surface", "ANATOMY", 41, 57], ["necrotic area", "ANATOMY", 72, 85], ["necrotic", "DISEASE", 72, 80], ["fibrin", "GENE_OR_GENE_PRODUCT", 27, 33], ["capsular surface", "CELLULAR_COMPONENT", 41, 57], ["necrotic area", "PATHOLOGICAL_FORMATION", 72, 85], ["fibrin", "PROTEIN", 27, 33], ["a coagulum of fibrin", "PROBLEM", 13, 33], ["may be", "UNCERTAINTY", 6, 12], ["coagulum", "OBSERVATION_MODIFIER", 15, 23], ["fibrin", "OBSERVATION", 27, 33], ["capsular", "OBSERVATION_MODIFIER", 41, 49], ["surface", "OBSERVATION_MODIFIER", 50, 57], ["necrotic", "OBSERVATION_MODIFIER", 72, 80], ["area", "OBSERVATION_MODIFIER", 81, 85]]], ["Occasionally, the essential lesions are rectilinear in shape or very irregular.", [["lesions", "ANATOMY", 28, 35], ["lesions", "PATHOLOGICAL_FORMATION", 28, 35], ["the essential lesions", "PROBLEM", 14, 35], ["very irregular", "PROBLEM", 64, 78], ["essential", "OBSERVATION_MODIFIER", 18, 27], ["lesions", "OBSERVATION", 28, 35], ["rectilinear", "OBSERVATION_MODIFIER", 40, 51], ["shape", "OBSERVATION_MODIFIER", 55, 60], ["very", "OBSERVATION_MODIFIER", 64, 68], ["irregular", "OBSERVATION_MODIFIER", 69, 78]]], ["The lesions appear homogeneous on the cut surface, but some contain poorly defined centers of soft or caseous material.Hepatic abscessThe histologic evolution of the hepatic lesions begins with the necrotic and hemorrhagic tracts caused by wandering immature flukes.", [["lesions", "ANATOMY", 4, 11], ["surface", "ANATOMY", 42, 49], ["Hepatic abscess", "ANATOMY", 119, 134], ["hepatic lesions", "ANATOMY", 166, 181], ["necrotic", "ANATOMY", 198, 206], ["hemorrhagic tracts", "ANATOMY", 211, 229], ["flukes", "ANATOMY", 259, 265], ["Hepatic abscess", "DISEASE", 119, 134], ["hepatic lesions", "DISEASE", 166, 181], ["necrotic", "DISEASE", 198, 206], ["hemorrhagic", "DISEASE", 211, 222], ["lesions", "PATHOLOGICAL_FORMATION", 4, 11], ["Hepatic abscess", "PATHOLOGICAL_FORMATION", 119, 134], ["hepatic lesions", "PATHOLOGICAL_FORMATION", 166, 181], ["flukes", "ORGAN", 259, 265], ["The lesions", "PROBLEM", 0, 11], ["soft or caseous material", "PROBLEM", 94, 118], ["Hepatic abscess", "PROBLEM", 119, 134], ["the hepatic lesions", "PROBLEM", 162, 181], ["the necrotic and hemorrhagic tracts", "PROBLEM", 194, 229], ["wandering immature flukes", "PROBLEM", 240, 265], ["lesions", "OBSERVATION", 4, 11], ["homogeneous", "OBSERVATION_MODIFIER", 19, 30], ["cut surface", "OBSERVATION_MODIFIER", 38, 49], ["poorly defined", "OBSERVATION_MODIFIER", 68, 82], ["centers", "OBSERVATION_MODIFIER", 83, 90], ["soft", "ANATOMY", 94, 98], ["caseous", "OBSERVATION_MODIFIER", 102, 109], ["abscess", "OBSERVATION", 127, 134], ["histologic", "OBSERVATION_MODIFIER", 138, 148], ["hepatic", "ANATOMY", 166, 173], ["lesions", "OBSERVATION", 174, 181], ["necrotic", "OBSERVATION_MODIFIER", 198, 206], ["hemorrhagic tracts", "OBSERVATION", 211, 229], ["wandering immature flukes", "OBSERVATION", 240, 265]]], ["These are sinuous tunnels ~0.5 cm in diameter that contain blood, necrotic hepatic cells, and the leukocytes, chiefly eosinophils, attracted by the flukes.", [["blood", "ANATOMY", 59, 64], ["necrotic hepatic cells", "ANATOMY", 66, 88], ["leukocytes", "ANATOMY", 98, 108], ["eosinophils", "ANATOMY", 118, 129], ["flukes", "ANATOMY", 148, 154], ["necrotic", "DISEASE", 66, 74], ["blood", "ORGANISM_SUBSTANCE", 59, 64], ["necrotic hepatic cells", "CELL", 66, 88], ["leukocytes", "CELL", 98, 108], ["eosinophils", "CELL", 118, 129], ["flukes", "TISSUE", 148, 154], ["blood, necrotic hepatic cells", "CELL_TYPE", 59, 88], ["leukocytes", "CELL_TYPE", 98, 108], ["eosinophils", "CELL_TYPE", 118, 129], ["sinuous tunnels", "TREATMENT", 10, 25], ["blood, necrotic hepatic cells", "PROBLEM", 59, 88], ["the leukocytes", "PROBLEM", 94, 108], ["sinuous", "OBSERVATION_MODIFIER", 10, 17], ["tunnels", "OBSERVATION", 18, 25], ["0.5 cm", "OBSERVATION_MODIFIER", 27, 33], ["blood", "ANATOMY", 59, 64], ["necrotic", "OBSERVATION_MODIFIER", 66, 74], ["hepatic", "ANATOMY", 75, 82], ["cells", "OBSERVATION", 83, 88], ["leukocytes", "ANATOMY", 98, 108], ["chiefly", "OBSERVATION_MODIFIER", 110, 117], ["eosinophils", "OBSERVATION", 118, 129], ["flukes", "OBSERVATION", 148, 154]]], ["About the tunnels is a narrow zone of coagulative necrosis, also produced by the flukes.", [["flukes", "ANATOMY", 81, 87], ["necrosis", "DISEASE", 50, 58], ["flukes", "ORGAN", 81, 87], ["a narrow zone of coagulative necrosis", "PROBLEM", 21, 58], ["tunnels", "OBSERVATION", 10, 17], ["narrow", "OBSERVATION_MODIFIER", 23, 29], ["zone", "OBSERVATION_MODIFIER", 30, 34], ["coagulative", "OBSERVATION_MODIFIER", 38, 49], ["necrosis", "OBSERVATION", 50, 58], ["flukes", "OBSERVATION", 81, 87]]], ["As usual, the necrotic tissue is demarcated by a thin zone of scavenger cells, chiefly neutrophils.", [["necrotic tissue", "ANATOMY", 14, 29], ["cells", "ANATOMY", 72, 77], ["neutrophils", "ANATOMY", 87, 98], ["necrotic", "DISEASE", 14, 22], ["necrotic tissue", "TISSUE", 14, 29], ["cells", "CELL", 72, 77], ["neutrophils", "CELL", 87, 98], ["scavenger cells", "CELL_TYPE", 62, 77], ["neutrophils", "CELL_TYPE", 87, 98], ["the necrotic tissue", "PROBLEM", 10, 29], ["a thin zone of scavenger cells", "PROBLEM", 47, 77], ["necrotic", "OBSERVATION_MODIFIER", 14, 22], ["tissue", "OBSERVATION", 23, 29], ["demarcated", "OBSERVATION_MODIFIER", 33, 43], ["thin zone", "OBSERVATION_MODIFIER", 49, 58], ["scavenger cells", "OBSERVATION", 62, 77]]], ["If latent spores are present in the necrotic areas, they quickly vegetate and are visible in sections as large, gram-positive bacilli.", [["spores", "ANATOMY", 10, 16], ["necrotic areas", "ANATOMY", 36, 50], ["sections", "ANATOMY", 93, 101], ["necrotic", "DISEASE", 36, 44], ["necrotic areas", "PATHOLOGICAL_FORMATION", 36, 50], ["latent spores", "PROBLEM", 3, 16], ["the necrotic areas", "PROBLEM", 32, 50], ["gram", "TEST", 112, 116], ["positive bacilli", "PROBLEM", 117, 133], ["latent", "OBSERVATION_MODIFIER", 3, 9], ["spores", "OBSERVATION", 10, 16], ["necrotic", "OBSERVATION_MODIFIER", 36, 44], ["large", "OBSERVATION_MODIFIER", 105, 110], ["positive bacilli", "OBSERVATION", 117, 133]]], ["In nonimmune animals, the vegetative organisms elaborate exotoxins that cause necrosis of the surrounding tissue, including the eosinophils of the fluke tunnel.", [["tissue", "ANATOMY", 106, 112], ["eosinophils", "ANATOMY", 128, 139], ["necrosis", "DISEASE", 78, 86], ["tissue", "TISSUE", 106, 112], ["eosinophils", "CELL", 128, 139], ["fluke", "ORGANISM", 147, 152], ["exotoxins", "PROTEIN", 57, 66], ["eosinophils", "CELL_TYPE", 128, 139], ["nonimmune animals", "PROBLEM", 3, 20], ["the vegetative organisms elaborate exotoxins", "PROBLEM", 22, 66], ["necrosis of the surrounding tissue", "PROBLEM", 78, 112], ["necrosis", "OBSERVATION", 78, 86], ["surrounding tissue", "ANATOMY", 94, 112], ["eosinophils", "OBSERVATION", 128, 139], ["fluke tunnel", "OBSERVATION", 147, 159]]], ["As the area of necrosis expands, the bacterial proliferation keeps pace so that bacilli can be found in all parts of the necrotic focus but not in the surrounding viable tissue.", [["necrotic focus", "ANATOMY", 121, 135], ["tissue", "ANATOMY", 170, 176], ["necrosis", "DISEASE", 15, 23], ["necrotic", "DISEASE", 121, 129], ["tissue", "TISSUE", 170, 176], ["necrosis", "PROBLEM", 15, 23], ["the bacterial proliferation", "PROBLEM", 33, 60], ["bacilli", "PROBLEM", 80, 87], ["area", "OBSERVATION_MODIFIER", 7, 11], ["necrosis", "OBSERVATION", 15, 23], ["bacterial proliferation", "OBSERVATION", 37, 60], ["bacilli", "OBSERVATION", 80, 87], ["necrotic", "OBSERVATION_MODIFIER", 121, 129], ["focus", "OBSERVATION", 130, 135], ["viable tissue", "OBSERVATION", 163, 176]]], ["Usually, bacteria are concentrated at the advancing margin of the lesion, just inside a zone of infiltrated neutrophils.", [["lesion", "ANATOMY", 66, 72], ["neutrophils", "ANATOMY", 108, 119], ["lesion", "CANCER", 66, 72], ["neutrophils", "CELL", 108, 119], ["infiltrated neutrophils", "CELL_TYPE", 96, 119], ["bacteria", "PROBLEM", 9, 17], ["the lesion", "PROBLEM", 62, 72], ["infiltrated neutrophils", "PROBLEM", 96, 119], ["bacteria", "OBSERVATION_MODIFIER", 9, 17], ["concentrated", "OBSERVATION_MODIFIER", 22, 34], ["margin", "OBSERVATION_MODIFIER", 52, 58], ["lesion", "OBSERVATION", 66, 72], ["zone", "OBSERVATION_MODIFIER", 88, 92], ["infiltrated neutrophils", "OBSERVATION", 96, 119]]], ["At about the time of death and immediately afterward, the bacilli scatter in the liver and to other organs.Hepatic abscessperforate the capsule but do commonly break into hepatic veins to produce any one or a combination of thrombophlebitis of the vena cava, endocarditis, or pulmonary abscesses or embolism.", [["liver", "ANATOMY", 81, 86], ["organs", "ANATOMY", 100, 106], ["Hepatic", "ANATOMY", 107, 114], ["capsule", "ANATOMY", 136, 143], ["hepatic veins", "ANATOMY", 171, 184], ["vena cava", "ANATOMY", 248, 257], ["pulmonary abscesses", "ANATOMY", 276, 295], ["death", "DISEASE", 21, 26], ["thrombophlebitis of the vena cava", "DISEASE", 224, 257], ["endocarditis", "DISEASE", 259, 271], ["pulmonary abscesses", "DISEASE", 276, 295], ["embolism", "DISEASE", 299, 307], ["liver", "ORGAN", 81, 86], ["organs", "ORGAN", 100, 106], ["Hepatic", "ORGAN", 107, 114], ["capsule", "CANCER", 136, 143], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 171, 184], ["vena cava", "MULTI-TISSUE_STRUCTURE", 248, 257], ["pulmonary abscesses", "PATHOLOGICAL_FORMATION", 276, 295], ["the bacilli scatter in the liver", "PROBLEM", 54, 86], ["Hepatic abscessperforate the capsule", "TREATMENT", 107, 143], ["thrombophlebitis of the vena cava", "PROBLEM", 224, 257], ["endocarditis", "PROBLEM", 259, 271], ["pulmonary abscesses", "PROBLEM", 276, 295], ["embolism", "PROBLEM", 299, 307], ["bacilli", "OBSERVATION", 58, 65], ["liver", "ANATOMY", 81, 86], ["organs", "ANATOMY", 100, 106], ["abscessperforate", "OBSERVATION", 115, 131], ["capsule", "OBSERVATION_MODIFIER", 136, 143], ["hepatic veins", "ANATOMY", 171, 184], ["thrombophlebitis", "OBSERVATION", 224, 240], ["vena cava", "ANATOMY", 248, 257], ["endocarditis", "OBSERVATION", 259, 271], ["pulmonary", "ANATOMY", 276, 285], ["abscesses", "OBSERVATION", 286, 295], ["embolism", "OBSERVATION", 299, 307]]], ["Acute extension of a hepatic abscess into the major hepatic vein can lead to pulmonary embolism that can be acutely fatal.", [["hepatic abscess", "ANATOMY", 21, 36], ["hepatic vein", "ANATOMY", 52, 64], ["pulmonary", "ANATOMY", 77, 86], ["hepatic abscess", "DISEASE", 21, 36], ["pulmonary embolism", "DISEASE", 77, 95], ["hepatic abscess", "PATHOLOGICAL_FORMATION", 21, 36], ["hepatic vein", "MULTI-TISSUE_STRUCTURE", 52, 64], ["pulmonary", "ORGAN", 77, 86], ["Acute extension", "PROBLEM", 0, 15], ["a hepatic abscess", "PROBLEM", 19, 36], ["pulmonary embolism", "PROBLEM", 77, 95], ["hepatic", "ANATOMY", 21, 28], ["abscess", "OBSERVATION", 29, 36], ["major", "ANATOMY_MODIFIER", 46, 51], ["hepatic vein", "ANATOMY", 52, 64], ["pulmonary", "ANATOMY", 77, 86], ["embolism", "OBSERVATION", 87, 95], ["acutely", "OBSERVATION_MODIFIER", 108, 115], ["fatal", "OBSERVATION_MODIFIER", 116, 121]]], ["In adults, death may occur if the hepatic abscesses are multiple and fresh, and especially if they are necrobacillary in origin; death is probably the result of toxemia.Hepatic necrobacillosisOccasionally, F. necrophorum infection of the liver is observed following omphalophlebitis in lambs and calves, or as a complication of rumenitis in adult cattle.", [["hepatic abscesses", "ANATOMY", 34, 51], ["Hepatic", "ANATOMY", 169, 176], ["liver", "ANATOMY", 238, 243], ["calves", "ANATOMY", 296, 302], ["death", "DISEASE", 11, 16], ["hepatic abscesses", "DISEASE", 34, 51], ["death", "DISEASE", 129, 134], ["toxemia", "DISEASE", 161, 168], ["F. necrophorum infection of the liver", "DISEASE", 206, 243], ["omphalophlebitis", "DISEASE", 266, 282], ["rumenitis", "DISEASE", 328, 337], ["hepatic abscesses", "PATHOLOGICAL_FORMATION", 34, 51], ["F. necrophorum", "ORGANISM", 206, 220], ["liver", "ORGAN", 238, 243], ["lambs", "ORGANISM", 286, 291], ["calves", "ORGANISM", 296, 302], ["cattle", "ORGANISM", 347, 353], ["F. necrophorum", "SPECIES", 206, 220], ["lambs", "SPECIES", 286, 291], ["calves", "SPECIES", 296, 302], ["cattle", "SPECIES", 347, 353], ["F. necrophorum", "SPECIES", 206, 220], ["cattle", "SPECIES", 347, 353], ["death", "PROBLEM", 11, 16], ["the hepatic abscesses", "PROBLEM", 30, 51], ["death", "PROBLEM", 129, 134], ["toxemia", "PROBLEM", 161, 168], ["Hepatic necrobacillosisOccasionally", "PROBLEM", 169, 204], ["F. necrophorum infection of the liver", "PROBLEM", 206, 243], ["omphalophlebitis in lambs and calves", "PROBLEM", 266, 302], ["a complication of rumenitis", "PROBLEM", 310, 337], ["hepatic", "ANATOMY", 34, 41], ["abscesses", "OBSERVATION", 42, 51], ["multiple", "OBSERVATION_MODIFIER", 56, 64], ["probably the result of", "UNCERTAINTY", 138, 160], ["toxemia", "OBSERVATION", 161, 168], ["necrobacillosisOccasionally", "OBSERVATION", 177, 204], ["necrophorum", "OBSERVATION_MODIFIER", 209, 220], ["infection", "OBSERVATION", 221, 230], ["liver", "ANATOMY", 238, 243], ["omphalophlebitis", "OBSERVATION", 266, 282], ["calves", "ANATOMY", 296, 302]]], ["In feedlot cattle, both F. necrophorum subsp. necrophorum (biotype A) and subsp. funduliforme (biotype B) have been isolated.", [["necrophorum", "DISEASE", 46, 57], ["F. necrophorum", "ORGANISM", 24, 38], ["necrophorum", "ORGANISM", 46, 57], ["biotype B", "GENE_OR_GENE_PRODUCT", 95, 104], ["cattle", "SPECIES", 11, 17], ["F. necrophorum subsp", "SPECIES", 24, 44], ["necrophorum", "SPECIES", 46, 57], ["cattle", "SPECIES", 11, 17], ["F. necrophorum subsp", "SPECIES", 24, 44], ["necrophorum", "PROBLEM", 46, 57], ["subsp", "PROBLEM", 74, 79], ["funduliforme (biotype B)", "PROBLEM", 81, 105], ["necrophorum subsp", "OBSERVATION", 27, 44]]], ["The hepatic lesions are multiple slightly elevated, rounded, dry areas of coagulative necrosis, sometimes a few centimeters in diameter and surrounded by a zone of intense hyperemia.", [["hepatic lesions", "ANATOMY", 4, 19], ["hepatic lesions", "DISEASE", 4, 19], ["necrosis", "DISEASE", 86, 94], ["hyperemia", "DISEASE", 172, 181], ["hepatic lesions", "PATHOLOGICAL_FORMATION", 4, 19], ["The hepatic lesions", "PROBLEM", 0, 19], ["multiple slightly elevated, rounded, dry areas of coagulative necrosis", "PROBLEM", 24, 94], ["intense hyperemia", "PROBLEM", 164, 181], ["hepatic", "ANATOMY", 4, 11], ["lesions", "OBSERVATION", 12, 19], ["multiple", "OBSERVATION_MODIFIER", 24, 32], ["slightly", "OBSERVATION_MODIFIER", 33, 41], ["elevated", "OBSERVATION_MODIFIER", 42, 50], ["rounded", "OBSERVATION_MODIFIER", 52, 59], ["dry", "OBSERVATION_MODIFIER", 61, 64], ["areas", "OBSERVATION_MODIFIER", 65, 70], ["coagulative", "OBSERVATION_MODIFIER", 74, 85], ["necrosis", "OBSERVATION", 86, 94], ["few", "OBSERVATION_MODIFIER", 108, 111], ["centimeters", "OBSERVATION_MODIFIER", 112, 123], ["diameter", "OBSERVATION_MODIFIER", 127, 135], ["zone", "OBSERVATION_MODIFIER", 156, 160], ["intense", "OBSERVATION_MODIFIER", 164, 171], ["hyperemia", "OBSERVATION", 172, 181]]], ["Affected neonates seldom live long enough for the necrotic foci to liquefy and assume the appearance of ordinary abscesses, but this may be seen in adult cattle.", [["necrotic foci", "ANATOMY", 50, 63], ["abscesses", "ANATOMY", 113, 122], ["necrotic", "DISEASE", 50, 58], ["abscesses", "DISEASE", 113, 122], ["neonates", "ORGANISM", 9, 17], ["abscesses", "PATHOLOGICAL_FORMATION", 113, 122], ["cattle", "ORGANISM", 154, 160], ["cattle", "SPECIES", 154, 160], ["cattle", "SPECIES", 154, 160], ["Affected neonates seldom", "PROBLEM", 0, 24], ["the necrotic foci", "PROBLEM", 46, 63], ["ordinary abscesses", "PROBLEM", 104, 122], ["necrotic", "OBSERVATION_MODIFIER", 50, 58], ["foci", "OBSERVATION", 59, 63], ["ordinary", "OBSERVATION_MODIFIER", 104, 112], ["abscesses", "OBSERVATION", 113, 122]]], ["The histologic appearance of the foci in the stage of coagulative necrosis is quite characteristic.", [["foci", "ANATOMY", 33, 37], ["necrosis", "DISEASE", 66, 74], ["the foci", "PROBLEM", 29, 37], ["coagulative necrosis", "PROBLEM", 54, 74], ["histologic", "OBSERVATION_MODIFIER", 4, 14], ["foci", "OBSERVATION", 33, 37], ["stage", "OBSERVATION_MODIFIER", 45, 50], ["coagulative", "OBSERVATION_MODIFIER", 54, 65], ["necrosis", "OBSERVATION", 66, 74]]], ["The necrotic amorphous central area is bordered by a zone of wholesale destruction of leukocytes, whose nuclear chromatin is dissipated in a finely divided form, and among which the filamentous fusobacteria are mostly concentrated.", [["necrotic amorphous central area", "ANATOMY", 4, 35], ["leukocytes", "ANATOMY", 86, 96], ["nuclear chromatin", "ANATOMY", 104, 121], ["filamentous fusobacteria", "ANATOMY", 182, 206], ["necrotic", "DISEASE", 4, 12], ["central area", "PATHOLOGICAL_FORMATION", 23, 35], ["leukocytes", "CELL", 86, 96], ["nuclear", "CELLULAR_COMPONENT", 104, 111], ["chromatin", "CELLULAR_COMPONENT", 112, 121], ["fusobacteria", "GENE_OR_GENE_PRODUCT", 194, 206], ["leukocytes", "CELL_TYPE", 86, 96], ["The necrotic amorphous central area", "PROBLEM", 0, 35], ["wholesale destruction of leukocytes", "PROBLEM", 61, 96], ["the filamentous fusobacteria", "PROBLEM", 178, 206], ["necrotic", "OBSERVATION_MODIFIER", 4, 12], ["amorphous", "OBSERVATION_MODIFIER", 13, 22], ["central", "OBSERVATION_MODIFIER", 23, 30], ["area", "OBSERVATION_MODIFIER", 31, 35], ["bordered", "OBSERVATION_MODIFIER", 39, 47], ["zone", "OBSERVATION_MODIFIER", 53, 57], ["wholesale", "OBSERVATION_MODIFIER", 61, 70], ["destruction", "OBSERVATION", 71, 82], ["leukocytes", "OBSERVATION_MODIFIER", 86, 96], ["nuclear chromatin", "OBSERVATION", 104, 121], ["filamentous", "OBSERVATION_MODIFIER", 182, 193], ["fusobacteria", "OBSERVATION", 194, 206], ["mostly", "OBSERVATION_MODIFIER", 211, 217], ["concentrated", "OBSERVATION_MODIFIER", 218, 230]]], ["Outside this zone, there is severe hyperemia and hemorrhage, and thrombosis of local vessels is common.", [["vessels", "ANATOMY", 85, 92], ["hyperemia", "DISEASE", 35, 44], ["hemorrhage", "DISEASE", 49, 59], ["thrombosis", "DISEASE", 65, 75], ["vessels", "MULTI-TISSUE_STRUCTURE", 85, 92], ["severe hyperemia", "PROBLEM", 28, 44], ["hemorrhage", "PROBLEM", 49, 59], ["thrombosis of local vessels", "PROBLEM", 65, 92], ["severe", "OBSERVATION_MODIFIER", 28, 34], ["hyperemia", "OBSERVATION", 35, 44], ["hemorrhage", "OBSERVATION", 49, 59], ["thrombosis", "OBSERVATION", 65, 75], ["local", "ANATOMY_MODIFIER", 79, 84], ["vessels", "ANATOMY", 85, 92]]], ["The lesion in neonatal lambs is to be distinguished from that caused by Campylobacter fetus.Hepatic necrobacillosisThe pathogenic mechanisms of F. necrophorum involve various toxins, in particular, a high-molecular-weight leukotoxin specifically toxic to ruminant neutrophils.", [["lesion", "ANATOMY", 4, 10], ["fetus", "ANATOMY", 86, 91], ["Hepatic necrobacillosis", "ANATOMY", 92, 115], ["neutrophils", "ANATOMY", 264, 275], ["Campylobacter fetus", "DISEASE", 72, 91], ["F. necrophorum", "DISEASE", 144, 158], ["lesion", "CANCER", 4, 10], ["lambs", "ORGANISM", 23, 28], ["Campylobacter fetus", "ORGANISM", 72, 91], ["F. necrophorum", "ORGANISM", 144, 158], ["ruminant", "ORGANISM", 255, 263], ["neutrophils", "CELL", 264, 275], ["leukotoxin", "PROTEIN", 222, 232], ["ruminant neutrophils", "CELL_TYPE", 255, 275], ["lambs", "SPECIES", 23, 28], ["F. necrophorum", "SPECIES", 144, 158], ["F. necrophorum", "SPECIES", 144, 158], ["The lesion in neonatal lambs", "PROBLEM", 0, 28], ["Campylobacter fetus", "PROBLEM", 72, 91], ["Hepatic necrobacillosis", "PROBLEM", 92, 115], ["F. necrophorum", "PROBLEM", 144, 158], ["various toxins", "PROBLEM", 167, 181], ["weight leukotoxin", "PROBLEM", 215, 232], ["toxic to ruminant neutrophils", "PROBLEM", 246, 275], ["lesion", "OBSERVATION", 4, 10], ["neonatal lambs", "OBSERVATION", 14, 28], ["Campylobacter", "OBSERVATION", 72, 85], ["necrobacillosis", "OBSERVATION", 100, 115], ["ruminant neutrophils", "OBSERVATION", 255, 275]]], ["This unique toxin activates neutrophils and induces their apoptosis, consistent with the remarkable abscess-inducing propensity of F. necrophorum in ruminants.", [["neutrophils", "ANATOMY", 28, 39], ["abscess", "ANATOMY", 100, 107], ["abscess", "DISEASE", 100, 107], ["F. necrophorum", "DISEASE", 131, 145], ["neutrophils", "CELL", 28, 39], ["F. necrophorum", "ORGANISM", 131, 145], ["ruminants", "ORGANISM", 149, 158], ["neutrophils", "CELL_TYPE", 28, 39], ["F. necrophorum", "SPECIES", 131, 145], ["F. necrophorum", "SPECIES", 131, 145], ["their apoptosis", "PROBLEM", 52, 67], ["the remarkable abscess", "PROBLEM", 85, 107], ["F. necrophorum", "PROBLEM", 131, 145], ["consistent with", "UNCERTAINTY", 69, 84], ["remarkable", "OBSERVATION_MODIFIER", 89, 99], ["abscess", "OBSERVATION", 100, 107], ["necrophorum", "OBSERVATION", 134, 145]]], ["However, other toxins, endotoxic lipopolysaccharide (LPS), and hemagglutinins are also implicated as virulence factors.", [["lipopolysaccharide", "CHEMICAL", 33, 51], ["LPS", "CHEMICAL", 53, 56], ["endotoxic lipopolysaccharide", "SIMPLE_CHEMICAL", 23, 51], ["LPS", "SIMPLE_CHEMICAL", 53, 56], ["virulence factors", "PROTEIN", 101, 118], ["other toxins", "PROBLEM", 9, 21], ["endotoxic lipopolysaccharide (LPS)", "TEST", 23, 57], ["hemagglutinins", "PROBLEM", 63, 77], ["endotoxic", "OBSERVATION_MODIFIER", 23, 32]]], ["Mixed infections are frequent, and synergism between F. necrophorum and other pathogens, such as Arcanobacterium pyogenes, may also play a role in the pathogenesis of liver necrosis and abscessation.Necrotic hepatitis (black disease)Organisms of the genus Clostridium are notably circuitous in their means of producing disease.", [["liver", "ANATOMY", 167, 172], ["infections", "DISEASE", 6, 16], ["F. necrophorum", "DISEASE", 53, 67], ["liver necrosis", "DISEASE", 167, 181], ["abscessation", "DISEASE", 186, 198], ["Necrotic hepatitis", "DISEASE", 199, 217], ["black disease", "DISEASE", 219, 232], ["F. necrophorum", "ORGANISM", 53, 67], ["Arcanobacterium pyogenes", "ORGANISM", 97, 121], ["liver", "ORGAN", 167, 172], ["F. necrophorum", "SPECIES", 53, 67], ["Arcanobacterium pyogenes", "SPECIES", 97, 121], ["F. necrophorum", "SPECIES", 53, 67], ["Arcanobacterium pyogenes", "SPECIES", 97, 121], ["Mixed infections", "PROBLEM", 0, 16], ["synergism between F. necrophorum", "PROBLEM", 35, 67], ["other pathogens", "PROBLEM", 72, 87], ["Arcanobacterium pyogenes", "PROBLEM", 97, 121], ["liver necrosis", "PROBLEM", 167, 181], ["abscessation", "PROBLEM", 186, 198], ["Necrotic hepatitis (black disease)", "PROBLEM", 199, 233], ["Organisms of the genus Clostridium", "PROBLEM", 233, 267], ["producing disease", "PROBLEM", 309, 326], ["infections", "OBSERVATION", 6, 16], ["pathogens", "OBSERVATION", 78, 87], ["Arcanobacterium pyogenes", "OBSERVATION", 97, 121], ["liver", "ANATOMY", 167, 172], ["necrosis", "OBSERVATION", 173, 181], ["hepatitis", "OBSERVATION", 208, 217], ["black disease", "OBSERVATION", 219, 232], ["genus Clostridium", "OBSERVATION", 250, 267], ["circuitous", "OBSERVATION_MODIFIER", 280, 290], ["disease", "OBSERVATION", 319, 326]]], ["This is true of C. novyi; type B strains, which produce potent exotoxins and are the cause of black disease (infectious necrotic hepatitis).", [["black disease", "DISEASE", 94, 107], ["infectious necrotic hepatitis", "DISEASE", 109, 138], ["C. novyi", "ORGANISM", 16, 24], ["type B strains", "ORGANISM", 26, 40], ["C. novyi", "SPECIES", 16, 24], ["C. novyi", "SPECIES", 16, 24], ["C. novyi", "PROBLEM", 16, 24], ["type B strains", "PROBLEM", 26, 40], ["potent exotoxins", "PROBLEM", 56, 72], ["black disease (infectious necrotic hepatitis", "PROBLEM", 94, 138], ["black disease", "OBSERVATION", 94, 107], ["infectious", "OBSERVATION_MODIFIER", 109, 119], ["necrotic", "OBSERVATION_MODIFIER", 120, 128], ["hepatitis", "OBSERVATION", 129, 138]]], ["The alpha toxin of C. novyi is related to the large clostridial cytotoxins produced by C. difficile and C. sordelli.", [["alpha toxin", "CHEMICAL", 4, 15], ["alpha toxin", "GENE_OR_GENE_PRODUCT", 4, 15], ["C. novyi", "ORGANISM", 19, 27], ["C. difficile", "ORGANISM", 87, 99], ["C. sordelli", "ORGANISM", 104, 115], ["alpha toxin", "PROTEIN", 4, 15], ["C. novyi", "SPECIES", 19, 27], ["C. difficile", "SPECIES", 87, 99], ["C. sordelli", "SPECIES", 104, 115], ["C. novyi", "SPECIES", 19, 27], ["C. difficile", "SPECIES", 87, 99], ["C. sordelli", "SPECIES", 104, 115], ["The alpha toxin", "TEST", 0, 15], ["C. novyi", "PROBLEM", 19, 27], ["the large clostridial cytotoxins", "PROBLEM", 42, 74], ["C. difficile", "PROBLEM", 87, 99], ["C. sordelli", "PROBLEM", 104, 115], ["large", "OBSERVATION_MODIFIER", 46, 51], ["clostridial", "OBSERVATION", 52, 63], ["difficile", "OBSERVATION", 90, 99]]], ["These toxins enter cells by receptor-mediated endocytosis and inhibit ras and rho guanosine triphosphatases by glycosylation.", [["cells", "ANATOMY", 19, 24], ["guanosine", "CHEMICAL", 82, 91], ["guanosine", "CHEMICAL", 82, 91], ["cells", "CELL", 19, 24], ["ras", "GENE_OR_GENE_PRODUCT", 70, 73], ["rho guanosine triphosphatases", "GENE_OR_GENE_PRODUCT", 78, 107], ["ras and rho guanosine triphosphatases", "PROTEIN", 70, 107], ["These toxins enter cells", "PROBLEM", 0, 24], ["receptor-mediated endocytosis", "TREATMENT", 28, 57], ["rho guanosine triphosphatases", "TREATMENT", 78, 107], ["glycosylation", "TREATMENT", 111, 124], ["guanosine triphosphatases", "OBSERVATION", 82, 107]]], ["The beta toxin is a necrotizing and hemolytic phospholipase C (lecithinase).", [["beta toxin", "GENE_OR_GENE_PRODUCT", 4, 14], ["hemolytic phospholipase C", "GENE_OR_GENE_PRODUCT", 36, 61], ["lecithinase", "SIMPLE_CHEMICAL", 63, 74], ["beta toxin", "PROTEIN", 4, 14], ["necrotizing and hemolytic phospholipase C", "PROTEIN", 20, 61], ["lecithinase", "PROTEIN", 63, 74], ["The beta toxin", "TEST", 0, 14], ["a necrotizing and hemolytic phospholipase C (lecithinase)", "PROBLEM", 18, 75], ["necrotizing", "OBSERVATION_MODIFIER", 20, 31], ["hemolytic", "OBSERVATION_MODIFIER", 36, 45]]], ["Black disease occurs in nonimmune animals when these exotoxins are released by C. novyi within an anaerobic focus in the liver.", [["liver", "ANATOMY", 121, 126], ["Black disease", "DISEASE", 0, 13], ["exotoxins", "GENE_OR_GENE_PRODUCT", 53, 62], ["C. novyi", "ORGANISM", 79, 87], ["liver", "ORGAN", 121, 126], ["exotoxins", "PROTEIN", 53, 62], ["C. novyi", "SPECIES", 79, 87], ["C. novyi", "SPECIES", 79, 87], ["Black disease", "PROBLEM", 0, 13], ["nonimmune animals", "PROBLEM", 24, 41], ["these exotoxins", "PROBLEM", 47, 62], ["disease", "OBSERVATION", 6, 13], ["anaerobic", "OBSERVATION_MODIFIER", 98, 107], ["focus", "OBSERVATION", 108, 113], ["liver", "ANATOMY", 121, 126]]], ["These anaerobic sites, which provide a suitable environment for germination of C. novyi spores, are most commonly a result of migrating liver flukes.Necrotic hepatitis (black disease)C. novyi is widely distributed in soil, and the spores are continually ingested by grazing animals in areas where black disease occurs.", [["anaerobic sites", "ANATOMY", 6, 21], ["liver flukes", "ANATOMY", 136, 148], ["spores", "ANATOMY", 231, 237], ["liver flukes", "DISEASE", 136, 148], ["Necrotic hepatitis", "DISEASE", 149, 167], ["black disease", "DISEASE", 169, 182], ["black disease", "DISEASE", 297, 310], ["C. novyi spores", "ORGANISM", 79, 94], ["liver flukes", "MULTI-TISSUE_STRUCTURE", 136, 148], ["C. novyi", "ORGANISM", 183, 191], ["C. novyi", "SPECIES", 79, 87], ["C. novyi", "SPECIES", 183, 191], ["C. novyi", "SPECIES", 79, 87], ["C. novyi", "SPECIES", 183, 191], ["These anaerobic sites", "PROBLEM", 0, 21], ["C. novyi spores", "PROBLEM", 79, 94], ["migrating liver flukes", "PROBLEM", 126, 148], ["Necrotic hepatitis (black disease)", "PROBLEM", 149, 183], ["C. novyi", "PROBLEM", 183, 191], ["the spores", "PROBLEM", 227, 237], ["black disease", "PROBLEM", 297, 310], ["anaerobic sites", "OBSERVATION", 6, 21], ["liver", "ANATOMY", 136, 141], ["flukes", "OBSERVATION", 142, 148], ["hepatitis", "OBSERVATION", 158, 167], ["black disease", "OBSERVATION", 169, 182], ["widely", "OBSERVATION_MODIFIER", 195, 201], ["distributed", "OBSERVATION_MODIFIER", 202, 213], ["soil", "OBSERVATION_MODIFIER", 217, 221], ["black disease", "OBSERVATION", 297, 310]]], ["Some spores cross the mucous membranes, probably in phagocytes, and remain as latent infections in macrophages, mainly in the liver, spleen, and bone marrow.", [["mucous membranes", "ANATOMY", 22, 38], ["phagocytes", "ANATOMY", 52, 62], ["macrophages", "ANATOMY", 99, 110], ["liver", "ANATOMY", 126, 131], ["spleen", "ANATOMY", 133, 139], ["bone marrow", "ANATOMY", 145, 156], ["infections", "DISEASE", 85, 95], ["mucous membranes", "MULTI-TISSUE_STRUCTURE", 22, 38], ["phagocytes", "CELL", 52, 62], ["macrophages", "CELL", 99, 110], ["liver", "ORGAN", 126, 131], ["spleen", "ORGAN", 133, 139], ["bone marrow", "MULTI-TISSUE_STRUCTURE", 145, 156], ["phagocytes", "CELL_TYPE", 52, 62], ["macrophages", "CELL_TYPE", 99, 110], ["Some spores cross the mucous membranes", "PROBLEM", 0, 38], ["latent infections in macrophages", "PROBLEM", 78, 110], ["spores", "OBSERVATION", 5, 11], ["mucous membranes", "ANATOMY", 22, 38], ["probably in", "UNCERTAINTY", 40, 51], ["phagocytes", "OBSERVATION", 52, 62], ["latent", "OBSERVATION_MODIFIER", 78, 84], ["infections", "OBSERVATION", 85, 95], ["macrophages", "OBSERVATION", 99, 110], ["liver", "ANATOMY", 126, 131], ["spleen", "ANATOMY", 133, 139], ["bone marrow", "ANATOMY", 145, 156]]], ["The duration of latency in tissue is not known, but it can be eFigure 2-19 Hepatic necrobacillosis (Fusobacterium necrophorum infection) in an ox.", [["tissue", "ANATOMY", 27, 33], ["Fusobacterium necrophorum infection", "DISEASE", 100, 135], ["tissue", "TISSUE", 27, 33], ["Fusobacterium necrophorum", "ORGANISM", 100, 125], ["Fusobacterium necrophorum", "SPECIES", 100, 125], ["Fusobacterium necrophorum", "SPECIES", 100, 125], ["latency in tissue", "PROBLEM", 16, 33], ["Hepatic necrobacillosis (Fusobacterium necrophorum infection", "PROBLEM", 75, 135], ["latency", "OBSERVATION_MODIFIER", 16, 23], ["Hepatic", "ANATOMY", 75, 82]]], ["Pale slightly raised areas of dry coagulative necrosis bordered by acute inflammation.", [["necrosis", "DISEASE", 46, 54], ["inflammation", "DISEASE", 73, 85], ["Pale slightly raised areas", "PROBLEM", 0, 26], ["dry coagulative necrosis", "PROBLEM", 30, 54], ["acute inflammation", "PROBLEM", 67, 85], ["slightly", "OBSERVATION_MODIFIER", 5, 13], ["raised", "OBSERVATION_MODIFIER", 14, 20], ["areas", "OBSERVATION_MODIFIER", 21, 26], ["dry", "OBSERVATION_MODIFIER", 30, 33], ["coagulative", "OBSERVATION_MODIFIER", 34, 45], ["necrosis", "OBSERVATION", 46, 54], ["acute", "OBSERVATION_MODIFIER", 67, 72], ["inflammation", "OBSERVATION", 73, 85]]], ["(Courtesy University of Guelph.) specific and constant than those in the liver, which consist of focal hepatitis and necrosis.Necrotic hepatitis (black disease)Affected foals usually die between the ages of 1-4 weeks; often they are found dead after a short illness.", [["liver", "ANATOMY", 73, 78], ["focal hepatitis", "DISEASE", 97, 112], ["necrosis", "DISEASE", 117, 125], ["Necrotic hepatitis", "DISEASE", 126, 144], ["black disease", "DISEASE", 146, 159], ["liver", "ORGAN", 73, 78], ["foals", "ORGANISM", 169, 174], ["focal hepatitis", "PROBLEM", 97, 112], ["necrosis", "PROBLEM", 117, 125], ["Necrotic hepatitis (black disease)", "PROBLEM", 126, 160], ["Affected foals", "PROBLEM", 160, 174], ["a short illness", "PROBLEM", 250, 265], ["liver", "ANATOMY", 73, 78], ["focal", "OBSERVATION_MODIFIER", 97, 102], ["hepatitis", "OBSERVATION", 103, 112], ["necrosis", "OBSERVATION", 117, 125], ["hepatitis", "OBSERVATION", 135, 144], ["black disease", "OBSERVATION", 146, 159]]], ["The liver shows pale foci up to a few millimeters across (Fig. 2-79) ; these are represented microscopically by randomly distributed foci of coagulative necrosis with moderate neutrophilic infiltrate ( Fig. 2-80A ).", [["liver", "ANATOMY", 4, 9], ["pale foci", "ANATOMY", 16, 25], ["foci", "ANATOMY", 133, 137], ["necrosis", "DISEASE", 153, 161], ["liver", "ORGAN", 4, 9], ["pale foci", "PROBLEM", 16, 25], ["Fig.", "TEST", 58, 62], ["coagulative necrosis", "PROBLEM", 141, 161], ["moderate neutrophilic infiltrate", "PROBLEM", 167, 199], ["liver", "ANATOMY", 4, 9], ["pale", "OBSERVATION_MODIFIER", 16, 20], ["foci", "OBSERVATION", 21, 25], ["few millimeters", "OBSERVATION_MODIFIER", 34, 49], ["microscopically", "OBSERVATION_MODIFIER", 93, 108], ["randomly", "OBSERVATION_MODIFIER", 112, 120], ["distributed", "OBSERVATION_MODIFIER", 121, 132], ["foci", "OBSERVATION", 133, 137], ["coagulative", "OBSERVATION_MODIFIER", 141, 152], ["necrosis", "OBSERVATION", 153, 161], ["moderate", "OBSERVATION_MODIFIER", 167, 175], ["neutrophilic", "OBSERVATION_MODIFIER", 176, 188], ["infiltrate", "OBSERVATION", 189, 199]]], ["This lesion is not diagnostic in itself; its specificity depends on the presence of the causal organism in hepatocytes in the periphery of the necrotic zones.", [["lesion", "ANATOMY", 5, 11], ["hepatocytes", "ANATOMY", 107, 118], ["necrotic zones", "ANATOMY", 143, 157], ["necrotic", "DISEASE", 143, 151], ["hepatocytes", "CELL", 107, 118], ["necrotic zones", "TISSUE", 143, 157], ["hepatocytes", "CELL_TYPE", 107, 118], ["This lesion", "PROBLEM", 0, 11], ["lesion", "OBSERVATION", 5, 11], ["not", "UNCERTAINTY", 15, 18], ["causal", "OBSERVATION_MODIFIER", 88, 94], ["organism", "OBSERVATION", 95, 103], ["hepatocytes", "ANATOMY", 107, 118], ["periphery", "ANATOMY_MODIFIER", 126, 135], ["necrotic", "OBSERVATION_MODIFIER", 143, 151], ["zones", "OBSERVATION_MODIFIER", 152, 157]]], ["At present, C. piliforme can only be isolated with difficulty on artificial media, so diagnosis is usually based on demonstration of the large, long bacilli in the cytoplasm of degenerate and also otherwise apparently normal hepatocytes at the periphery of the necrotic zones.", [["cytoplasm", "ANATOMY", 164, 173], ["hepatocytes", "ANATOMY", 225, 236], ["necrotic zones", "ANATOMY", 261, 275], ["necrotic", "DISEASE", 261, 269], ["C. piliforme", "ORGANISM", 12, 24], ["long bacilli", "CELLULAR_COMPONENT", 144, 156], ["cytoplasm", "ORGANISM_SUBSTANCE", 164, 173], ["hepatocytes", "CELL", 225, 236], ["necrotic zones", "TISSUE", 261, 275], ["normal hepatocytes", "CELL_TYPE", 218, 236], ["C. piliforme", "SPECIES", 12, 24], ["C. piliforme", "SPECIES", 12, 24], ["the large, long bacilli in the cytoplasm of degenerate", "PROBLEM", 133, 187], ["large", "OBSERVATION_MODIFIER", 137, 142], ["long", "OBSERVATION_MODIFIER", 144, 148], ["bacilli", "OBSERVATION", 149, 156], ["otherwise", "OBSERVATION_MODIFIER", 197, 206], ["apparently", "OBSERVATION_MODIFIER", 207, 217], ["normal", "OBSERVATION", 218, 224], ["hepatocytes", "ANATOMY", 225, 236], ["periphery", "ANATOMY_MODIFIER", 244, 253], ["necrotic", "OBSERVATION_MODIFIER", 261, 269], ["zones", "OBSERVATION_MODIFIER", 270, 275]]], ["The organisms are gram negative and are best delineated with silver impregnation techniques, such as that of Warthin-Starry, but they may be seen with routine stains, such as Giemsa, particularly when the material is fresh.", [["silver", "CHEMICAL", 61, 67], ["silver", "CHEMICAL", 61, 67], ["silver", "SIMPLE_CHEMICAL", 61, 67], ["Giemsa", "SIMPLE_CHEMICAL", 175, 181], ["The organisms", "TEST", 0, 13], ["gram", "TEST", 18, 22], ["silver impregnation techniques", "TREATMENT", 61, 91], ["Warthin", "PROBLEM", 109, 116], ["routine stains", "TEST", 151, 165], ["Giemsa", "TEST", 175, 181]]], ["Differentiation from other organisms, including postmortem saprophytes, can be achieved by immunohistochemistry or immunofluorescence.", [["saprophytes", "ANATOMY", 59, 70], ["other organisms", "PROBLEM", 21, 36], ["postmortem saprophytes", "PROBLEM", 48, 70], ["immunohistochemistry", "TEST", 91, 111], ["immunofluorescence", "TEST", 115, 133]]], ["The bacilli tend to lie in sheaves or bundles (Fig. 2-80B ).", [["The bacilli", "PROBLEM", 0, 11], ["bacilli", "OBSERVATION", 4, 11]]], ["There may also be colitis sufficiently severe to cause diarrhea, but not as severe as that seen in rabbits with this disease.Necrotic hepatitis (black disease)Fewer cases of Tyzzer's disease have been reported in dogs and cats.", [["colitis", "DISEASE", 18, 25], ["diarrhea", "DISEASE", 55, 63], ["Necrotic hepatitis", "DISEASE", 125, 143], ["black disease", "DISEASE", 145, 158], ["Tyzzer's disease", "DISEASE", 174, 190], ["colitis", "PATHOLOGICAL_FORMATION", 18, 25], ["rabbits", "ORGANISM", 99, 106], ["dogs", "ORGANISM", 213, 217], ["cats", "ORGANISM", 222, 226], ["rabbits", "SPECIES", 99, 106], ["dogs", "SPECIES", 213, 217], ["cats", "SPECIES", 222, 226], ["rabbits", "SPECIES", 99, 106], ["colitis", "PROBLEM", 18, 25], ["diarrhea", "PROBLEM", 55, 63], ["this disease", "PROBLEM", 112, 124], ["Necrotic hepatitis (black disease)", "PROBLEM", 125, 159], ["Tyzzer's disease", "PROBLEM", 174, 190], ["may also be", "UNCERTAINTY", 6, 17], ["colitis", "OBSERVATION", 18, 25], ["diarrhea", "OBSERVATION", 55, 63], ["disease", "OBSERVATION", 117, 124], ["hepatitis", "OBSERVATION", 134, 143], ["black disease", "OBSERVATION", 145, 158]]], ["The liver lesions are essentially the same as those in foals and rodents, and there is also enteritis or enterocolitis.", [["liver lesions", "ANATOMY", 4, 17], ["liver lesions", "DISEASE", 4, 17], ["enteritis", "DISEASE", 92, 101], ["enterocolitis", "DISEASE", 105, 118], ["liver lesions", "CANCER", 4, 17], ["The liver lesions", "PROBLEM", 0, 17], ["enteritis", "PROBLEM", 92, 101], ["enterocolitis", "PROBLEM", 105, 118], ["liver", "ANATOMY", 4, 9], ["lesions", "OBSERVATION", 10, 17], ["enteritis", "OBSERVATION", 92, 101], ["enterocolitis", "OBSERVATION", 105, 118]]], ["Immunodeficiency predisposes to the disease because it occurs sporadically in dogs that have undergone immunosuppressive or anticancer therapy.", [["anticancer", "ANATOMY", 124, 134], ["Immunodeficiency", "DISEASE", 0, 16], ["dogs", "ORGANISM", 78, 82], ["anticancer", "CANCER", 124, 134], ["dogs", "SPECIES", 78, 82], ["Immunodeficiency", "PROBLEM", 0, 16], ["the disease", "PROBLEM", 32, 43], ["immunosuppressive or anticancer therapy", "TREATMENT", 103, 142], ["disease", "OBSERVATION", 36, 43], ["anticancer therapy", "OBSERVATION", 124, 142]]], ["Such cases may be complicated by concurrent viral, mycotic, or protozoal infections.LeptospirosisLeptospirosis is a systemic disease characterized by acute jaundice, cholestatic liver injury, and renal failure in dogs, and is discussed in more detail in Vol.", [["liver", "ANATOMY", 178, 183], ["renal", "ANATOMY", 196, 201], ["viral, mycotic, or protozoal infections", "DISEASE", 44, 83], ["LeptospirosisLeptospirosis", "DISEASE", 84, 110], ["systemic disease", "DISEASE", 116, 132], ["jaundice", "DISEASE", 156, 164], ["cholestatic liver injury", "DISEASE", 166, 190], ["renal failure", "DISEASE", 196, 209], ["liver", "ORGAN", 178, 183], ["renal", "ORGAN", 196, 201], ["dogs", "ORGANISM", 213, 217], ["dogs", "SPECIES", 213, 217], ["concurrent viral, mycotic", "PROBLEM", 33, 58], ["protozoal infections", "PROBLEM", 63, 83], ["LeptospirosisLeptospirosis", "PROBLEM", 84, 110], ["a systemic disease", "PROBLEM", 114, 132], ["acute jaundice", "PROBLEM", 150, 164], ["cholestatic liver injury", "PROBLEM", 166, 190], ["renal failure in dogs", "PROBLEM", 196, 217], ["viral", "OBSERVATION", 44, 49], ["mycotic", "OBSERVATION", 51, 58], ["protozoal", "OBSERVATION_MODIFIER", 63, 72], ["infections", "OBSERVATION", 73, 83], ["systemic disease", "OBSERVATION", 116, 132], ["acute", "OBSERVATION_MODIFIER", 150, 155], ["jaundice", "OBSERVATION", 156, 164], ["cholestatic", "OBSERVATION_MODIFIER", 166, 177], ["liver", "ANATOMY", 178, 183], ["injury", "OBSERVATION", 184, 190], ["renal", "ANATOMY", 196, 201], ["failure", "OBSERVATION", 202, 209]]], ["2, Urinary system.", [["Urinary system", "ANATOMY", 3, 17]]], ["The hepatic lesions described following acute experimental infection of dogs with Leptospira kirschneri serovar grippotyphosa include mixed perivascular periportal infiltrates of neutrophils, lymphocytes, and plasma cells, with mild hepatic lipidosis, dissociation of hepatocytes, and intracanalicular bile plugs evident by day 12 postinfection, along with increased hepatocellular mitotic activity.", [["hepatic lesions", "ANATOMY", 4, 19], ["perivascular periportal infiltrates", "ANATOMY", 140, 175], ["neutrophils", "ANATOMY", 179, 190], ["lymphocytes", "ANATOMY", 192, 203], ["plasma cells", "ANATOMY", 209, 221], ["hepatic", "ANATOMY", 233, 240], ["hepatocytes", "ANATOMY", 268, 279], ["bile plugs", "ANATOMY", 302, 312], ["hepatocellular", "ANATOMY", 367, 381], ["hepatic lesions", "DISEASE", 4, 19], ["infection", "DISEASE", 59, 68], ["Leptospira kirschneri serovar grippotyphosa", "DISEASE", 82, 125], ["hepatic lipidosis", "DISEASE", 233, 250], ["hepatic lesions", "PATHOLOGICAL_FORMATION", 4, 19], ["dogs", "ORGANISM", 72, 76], ["Leptospira", "ORGANISM", 82, 92], ["kirschneri serovar grippotyphosa", "ORGANISM", 93, 125], ["perivascular periportal", "PATHOLOGICAL_FORMATION", 140, 163], ["infiltrates", "PATHOLOGICAL_FORMATION", 164, 175], ["neutrophils", "CELL", 179, 190], ["lymphocytes", "CELL", 192, 203], ["plasma cells", "CELL", 209, 221], ["hepatic", "ORGAN", 233, 240], ["hepatocytes", "CELL", 268, 279], ["bile plugs", "PATHOLOGICAL_FORMATION", 302, 312], ["hepatocellular", "CANCER", 367, 381], ["neutrophils", "CELL_TYPE", 179, 190], ["lymphocytes", "CELL_TYPE", 192, 203], ["plasma cells", "CELL_TYPE", 209, 221], ["hepatocytes", "CELL_TYPE", 268, 279], ["dogs", "SPECIES", 72, 76], ["Leptospira", "SPECIES", 82, 92], ["kirschneri serovar grippotyphosa", "SPECIES", 93, 125], ["Leptospira kirschneri serovar grippotyphosa", "SPECIES", 82, 125], ["The hepatic lesions", "PROBLEM", 0, 19], ["acute experimental infection of dogs", "PROBLEM", 40, 76], ["Leptospira kirschneri serovar grippotyphosa", "TEST", 82, 125], ["mixed perivascular periportal infiltrates of neutrophils", "PROBLEM", 134, 190], ["lymphocytes", "TEST", 192, 203], ["plasma cells", "PROBLEM", 209, 221], ["mild hepatic lipidosis", "PROBLEM", 228, 250], ["dissociation of hepatocytes", "PROBLEM", 252, 279], ["intracanalicular bile plugs", "PROBLEM", 285, 312], ["increased hepatocellular mitotic activity", "PROBLEM", 357, 398], ["hepatic", "ANATOMY", 4, 11], ["lesions", "OBSERVATION", 12, 19], ["acute", "OBSERVATION_MODIFIER", 40, 45], ["experimental", "OBSERVATION_MODIFIER", 46, 58], ["infection", "OBSERVATION", 59, 68], ["Leptospira", "OBSERVATION_MODIFIER", 82, 92], ["mixed", "OBSERVATION_MODIFIER", 134, 139], ["perivascular", "ANATOMY_MODIFIER", 140, 152], ["periportal", "ANATOMY", 153, 163], ["infiltrates", "OBSERVATION", 164, 175], ["neutrophils", "ANATOMY", 179, 190], ["lymphocytes", "ANATOMY", 192, 203], ["plasma cells", "OBSERVATION", 209, 221], ["mild", "OBSERVATION_MODIFIER", 228, 232], ["hepatic", "ANATOMY", 233, 240], ["lipidosis", "OBSERVATION", 241, 250], ["hepatocytes", "ANATOMY", 268, 279], ["intracanalicular", "ANATOMY_MODIFIER", 285, 301], ["bile", "ANATOMY", 302, 306], ["plugs", "OBSERVATION", 307, 312], ["postinfection", "OBSERVATION", 331, 344], ["increased", "OBSERVATION_MODIFIER", 357, 366], ["hepatocellular mitotic activity", "OBSERVATION", 367, 398]]], ["Clinical icterus has been attributed to cholestasis caused by dissociation of hepatocytes (eFig.", [["hepatocytes", "ANATOMY", 78, 89], ["icterus", "DISEASE", 9, 16], ["cholestasis", "DISEASE", 40, 51], ["hepatocytes", "CELL", 78, 89], ["hepatocytes", "CELL_TYPE", 78, 89], ["Clinical icterus", "PROBLEM", 0, 16], ["cholestasis", "PROBLEM", 40, 51], ["dissociation of hepatocytes", "PROBLEM", 62, 89], ["eFig", "TEST", 91, 95], ["icterus", "OBSERVATION", 9, 16], ["cholestasis", "OBSERVATION", 40, 51], ["dissociation", "OBSERVATION", 62, 74], ["hepatocytes", "ANATOMY", 78, 89]]], ["Dogs experimentally infected with Leptospira interrogans serovar pomonaBacillary hemoglobinuriaBacillary hemoglobinuria is a counterpart of black disease.", [["hemoglobinuria", "DISEASE", 105, 119], ["black disease", "DISEASE", 140, 153], ["Dogs", "ORGANISM", 0, 4], ["Leptospira interrogans", "ORGANISM", 34, 56], ["Dogs", "SPECIES", 0, 4], ["Leptospira interrogans serovar pomonaBacillary", "SPECIES", 34, 80], ["Leptospira interrogans", "SPECIES", 34, 56], ["Leptospira interrogans serovar pomonaBacillary hemoglobinuriaBacillary hemoglobinuria", "PROBLEM", 34, 119], ["black disease", "PROBLEM", 140, 153], ["infected", "OBSERVATION_MODIFIER", 20, 28], ["Leptospira", "OBSERVATION_MODIFIER", 34, 44], ["interrogans", "OBSERVATION_MODIFIER", 45, 56], ["serovar", "OBSERVATION_MODIFIER", 57, 64], ["pomonaBacillary", "OBSERVATION_MODIFIER", 65, 80], ["hemoglobinuriaBacillary hemoglobinuria", "OBSERVATION", 81, 119], ["black disease", "OBSERVATION", 140, 153]]], ["The cause is Clostridium haemolyticum, which is closely related to C. novyi.", [["Clostridium haemolyticum", "DISEASE", 13, 37], ["Clostridium haemolyticum", "ORGANISM", 13, 37], ["C. novyi", "ORGANISM", 67, 75], ["Clostridium haemolyticum", "SPECIES", 13, 37], ["C. novyi", "SPECIES", 67, 75], ["Clostridium haemolyticum", "SPECIES", 13, 37], ["C. novyi", "SPECIES", 67, 75], ["Clostridium haemolyticum", "PROBLEM", 13, 37], ["Clostridium haemolyticum", "OBSERVATION", 13, 37]]], ["Both species produce the beta toxin, a necrotizing and hemolytic lecithinase (phospholipase C).", [["beta toxin", "GENE_OR_GENE_PRODUCT", 25, 35], ["hemolytic lecithinase", "SIMPLE_CHEMICAL", 55, 76], ["phospholipase C", "GENE_OR_GENE_PRODUCT", 78, 93], ["beta toxin", "PROTEIN", 25, 35], ["necrotizing and hemolytic lecithinase", "PROTEIN", 39, 76], ["phospholipase C", "PROTEIN", 78, 93], ["the beta toxin", "TEST", 21, 35], ["a necrotizing and hemolytic lecithinase (phospholipase C", "PROBLEM", 37, 93], ["necrotizing", "OBSERVATION_MODIFIER", 39, 50], ["hemolytic", "OBSERVATION_MODIFIER", 55, 64]]], ["The pathogenesis of the 2 diseases is comparable, as both depend on a focus of hepatic injury within which latent spores can germinate.", [["hepatic", "ANATOMY", 79, 86], ["spores", "ANATOMY", 114, 120], ["hepatic injury", "DISEASE", 79, 93], ["hepatic", "ORGAN", 79, 86], ["the 2 diseases", "PROBLEM", 20, 34], ["hepatic injury", "PROBLEM", 79, 93], ["latent spores", "PROBLEM", 107, 120], ["diseases", "OBSERVATION", 26, 34], ["hepatic", "ANATOMY", 79, 86], ["injury", "OBSERVATION", 87, 93], ["latent", "OBSERVATION_MODIFIER", 107, 113], ["spores", "OBSERVATION_MODIFIER", 114, 120]]], ["Bacillary hemoglobinuria as an endemic disease exists only in areas where Fasciola hepatica abounds, and it is probable that flukes are the primary cause of the initiating lesion.", [["flukes", "ANATOMY", 125, 131], ["lesion", "ANATOMY", 172, 178], ["hemoglobinuria", "DISEASE", 10, 24], ["Fasciola hepatica abounds", "DISEASE", 74, 99], ["Fasciola hepatica", "ORGANISM", 74, 91], ["flukes", "ORGAN", 125, 131], ["lesion", "CANCER", 172, 178], ["Fasciola hepatica", "SPECIES", 74, 91], ["Fasciola hepatica", "SPECIES", 74, 91], ["Bacillary hemoglobinuria", "PROBLEM", 0, 24], ["an endemic disease", "PROBLEM", 28, 46], ["Fasciola hepatica", "PROBLEM", 74, 91], ["flukes", "PROBLEM", 125, 131], ["the initiating lesion", "PROBLEM", 157, 178], ["hemoglobinuria", "OBSERVATION", 10, 24], ["endemic", "OBSERVATION_MODIFIER", 31, 38], ["disease", "OBSERVATION", 39, 46], ["Fasciola", "OBSERVATION_MODIFIER", 74, 82], ["hepatica", "ANATOMY", 83, 91], ["is probable", "UNCERTAINTY", 108, 119], ["flukes", "OBSERVATION", 125, 131], ["lesion", "OBSERVATION", 172, 178]]], ["The disease does occur sporadically where there are no flukes and may be prompted by other parasites or other diverse focal lesions, which are smudged out in the expanding areas of necrosis.", [["flukes", "ANATOMY", 55, 61], ["focal lesions", "ANATOMY", 118, 131], ["necrosis", "DISEASE", 181, 189], ["focal lesions", "PATHOLOGICAL_FORMATION", 118, 131], ["The disease", "PROBLEM", 0, 11], ["flukes", "PROBLEM", 55, 61], ["other parasites", "PROBLEM", 85, 100], ["other diverse focal lesions", "PROBLEM", 104, 131], ["necrosis", "PROBLEM", 181, 189], ["disease", "OBSERVATION", 4, 11], ["no", "UNCERTAINTY", 52, 54], ["flukes", "OBSERVATION", 55, 61], ["may be", "UNCERTAINTY", 66, 72], ["diverse", "OBSERVATION_MODIFIER", 110, 117], ["focal", "OBSERVATION_MODIFIER", 118, 123], ["lesions", "OBSERVATION", 124, 131], ["expanding", "OBSERVATION_MODIFIER", 162, 171], ["areas", "OBSERVATION_MODIFIER", 172, 177], ["necrosis", "OBSERVATION", 181, 189]]], ["There is scant information on the ecology of the organism, but it is clear that it has its own environmental requirements, and the disease will not persist in areas where these requirements are not met.", [["the disease", "PROBLEM", 127, 138], ["scant", "OBSERVATION", 9, 14]]], ["The spores will remain in the livers of cattle for several months after removal from pastures where the disease is endemic.", [["spores", "ANATOMY", 4, 10], ["livers", "ANATOMY", 30, 36], ["livers", "ORGAN", 30, 36], ["cattle", "ORGANISM", 40, 46], ["cattle", "SPECIES", 40, 46], ["cattle", "SPECIES", 40, 46], ["removal", "TREATMENT", 72, 79], ["the disease", "PROBLEM", 100, 111], ["endemic", "PROBLEM", 115, 122], ["livers", "ANATOMY", 30, 36], ["disease", "OBSERVATION", 104, 111], ["endemic", "OBSERVATION_MODIFIER", 115, 122]]], ["Spores may persist in the bones of cadavers for 2 years.", [["Spores", "ANATOMY", 0, 6], ["bones", "ANATOMY", 26, 31], ["cadavers", "ANATOMY", 35, 43], ["bones", "ORGAN", 26, 31], ["cadavers", "ORGAN", 35, 43], ["Spores", "PROBLEM", 0, 6], ["bones", "ANATOMY", 26, 31]]], ["Spores of this and other sporulating anaerobes can frequently be demonstrated in the liver, where they are probably retained in Kupffer cells.Bacillary hemoglobinuriaBacillary hemoglobinuria occurs in cattle and sheep.", [["liver", "ANATOMY", 85, 90], ["Kupffer cells", "ANATOMY", 128, 141], ["hemoglobinuria", "DISEASE", 176, 190], ["liver", "ORGAN", 85, 90], ["Kupffer cells", "CELL", 128, 141], ["cattle", "ORGANISM", 201, 207], ["sheep", "ORGANISM", 212, 217], ["Kupffer cells", "CELL_TYPE", 128, 141], ["cattle", "SPECIES", 201, 207], ["sheep", "SPECIES", 212, 217], ["cattle", "SPECIES", 201, 207], ["sheep", "SPECIES", 212, 217], ["other sporulating anaerobes", "PROBLEM", 19, 46], ["Bacillary hemoglobinuriaBacillary hemoglobinuria", "PROBLEM", 142, 190], ["anaerobes", "OBSERVATION", 37, 46], ["liver", "ANATOMY", 85, 90], ["probably", "UNCERTAINTY", 107, 115], ["retained", "OBSERVATION", 116, 124], ["Kupffer cells", "OBSERVATION", 128, 141], ["hemoglobinuriaBacillary hemoglobinuria", "OBSERVATION", 152, 190]]], ["It is characterized clinically by intravascular hemolysis with anemia and hemoglobinuria, but, perhaps reflecting variety in exotoxins between strains of the organism, hemolysis may not be a feature.", [["intravascular", "ANATOMY", 34, 47], ["intravascular hemolysis", "DISEASE", 34, 57], ["anemia", "DISEASE", 63, 69], ["hemoglobinuria", "DISEASE", 74, 88], ["hemolysis", "DISEASE", 168, 177], ["intravascular", "IMMATERIAL_ANATOMICAL_ENTITY", 34, 47], ["intravascular hemolysis", "PROBLEM", 34, 57], ["anemia", "PROBLEM", 63, 69], ["hemoglobinuria", "PROBLEM", 74, 88], ["exotoxins", "PROBLEM", 125, 134], ["the organism", "PROBLEM", 154, 166], ["hemolysis", "PROBLEM", 168, 177], ["intravascular hemolysis", "OBSERVATION", 34, 57], ["anemia", "OBSERVATION", 63, 69], ["hemoglobinuria", "OBSERVATION", 74, 88], ["variety", "OBSERVATION_MODIFIER", 114, 121], ["exotoxins", "OBSERVATION", 125, 134], ["hemolysis", "OBSERVATION", 168, 177], ["may not be", "UNCERTAINTY", 178, 188]]], ["The essential lesion is hepatic and similar to that of black disease but is much larger and usually single (Fig. 2-78 ).", [["lesion", "ANATOMY", 14, 20], ["hepatic", "ANATOMY", 24, 31], ["black disease", "DISEASE", 55, 68], ["lesion", "CANCER", 14, 20], ["hepatic", "CANCER", 24, 31], ["The essential lesion", "PROBLEM", 0, 20], ["black disease", "PROBLEM", 55, 68], ["essential", "OBSERVATION_MODIFIER", 4, 13], ["lesion", "OBSERVATION", 14, 20], ["hepatic", "ANATOMY", 24, 31], ["black", "OBSERVATION_MODIFIER", 55, 60], ["disease", "OBSERVATION", 61, 68], ["much", "OBSERVATION_MODIFIER", 76, 80], ["larger", "OBSERVATION_MODIFIER", 81, 87]]], ["It has been described as an infarct secondary to portal thrombosis, and although this may occur in isolated cases, it is scarcely a creditable pathogenesis for a disease of endemic occurrence.", [["portal", "ANATOMY", 49, 55], ["infarct", "DISEASE", 28, 35], ["portal thrombosis", "DISEASE", 49, 66], ["portal", "MULTI-TISSUE_STRUCTURE", 49, 55], ["an infarct", "PROBLEM", 25, 35], ["portal thrombosis", "PROBLEM", 49, 66], ["a disease of endemic occurrence", "PROBLEM", 160, 191], ["infarct", "OBSERVATION", 28, 35], ["portal", "ANATOMY", 49, 55], ["thrombosis", "OBSERVATION", 56, 66], ["endemic", "OBSERVATION_MODIFIER", 173, 180]]], ["Thrombosis does occur in the affected areas but can be a result, rather than a cause, of the initial lesion and is found more frequently in the hepatic venules than in branches of the portal vein.", [["lesion", "ANATOMY", 101, 107], ["hepatic venules", "ANATOMY", 144, 159], ["branches", "ANATOMY", 168, 176], ["portal vein", "ANATOMY", 184, 195], ["Thrombosis", "DISEASE", 0, 10], ["lesion", "CANCER", 101, 107], ["hepatic venules", "MULTI-TISSUE_STRUCTURE", 144, 159], ["portal vein", "MULTI-TISSUE_STRUCTURE", 184, 195], ["Thrombosis", "PROBLEM", 0, 10], ["the initial lesion", "PROBLEM", 89, 107], ["affected", "OBSERVATION_MODIFIER", 29, 37], ["initial", "OBSERVATION_MODIFIER", 93, 100], ["lesion", "OBSERVATION", 101, 107], ["hepatic", "ANATOMY", 144, 151], ["venules", "ANATOMY_MODIFIER", 152, 159], ["branches", "ANATOMY_MODIFIER", 168, 176], ["portal vein", "ANATOMY", 184, 195]]], ["There is severe anemia, the kidneys are speckled red or brown by hemoglobin, and the urine is of port-wine color.", [["kidneys", "ANATOMY", 28, 35], ["urine", "ANATOMY", 85, 90], ["anemia", "DISEASE", 16, 22], ["kidneys", "ORGAN", 28, 35], ["hemoglobin", "GENE_OR_GENE_PRODUCT", 65, 75], ["urine", "ORGANISM_SUBSTANCE", 85, 90], ["hemoglobin", "PROTEIN", 65, 75], ["severe anemia", "PROBLEM", 9, 22], ["hemoglobin", "TEST", 65, 75], ["the urine", "TEST", 81, 90], ["severe", "OBSERVATION_MODIFIER", 9, 15], ["anemia", "OBSERVATION", 16, 22], ["kidneys", "ANATOMY", 28, 35], ["speckled", "OBSERVATION_MODIFIER", 40, 48], ["red", "OBSERVATION", 49, 52], ["brown", "OBSERVATION_MODIFIER", 56, 61], ["urine", "OBSERVATION", 85, 90], ["wine color", "OBSERVATION", 102, 112]]], ["Peritoneal vessels are injected, and in some cases, there is severe, dry, fibrinohemorrhagic peritonitis.Clostridium piliforme infectionClostridium piliforme (formerly Bacillus piliformis) infection has long been known as Tyzzer's disease, a cause of severe losses in laboratory rodents; however, it has also been reported in foals, calves, dogs, and cats.", [["Peritoneal vessels", "ANATOMY", 0, 18], ["peritonitis", "DISEASE", 93, 104], ["Clostridium piliforme infection", "DISEASE", 105, 136], ["Clostridium piliforme", "DISEASE", 136, 157], ["Bacillus piliformis) infection", "DISEASE", 168, 198], ["Tyzzer's disease", "DISEASE", 222, 238], ["Peritoneal vessels", "MULTI-TISSUE_STRUCTURE", 0, 18], ["Clostridium piliforme", "ORGANISM", 105, 126], ["Clostridium piliforme", "ORGANISM", 136, 157], ["Bacillus piliformis", "ORGANISM", 168, 187], ["foals", "ORGANISM_SUBDIVISION", 326, 331], ["calves", "ORGANISM", 333, 339], ["dogs", "ORGANISM", 341, 345], ["cats", "ORGANISM", 351, 355], ["Clostridium piliforme", "SPECIES", 105, 126], ["Clostridium piliforme", "SPECIES", 136, 157], ["Bacillus piliformis", "SPECIES", 168, 187], ["calves", "SPECIES", 333, 339], ["dogs", "SPECIES", 341, 345], ["cats", "SPECIES", 351, 355], ["Clostridium piliforme", "SPECIES", 105, 126], ["Clostridium piliforme", "SPECIES", 136, 157], ["Bacillus piliformis", "SPECIES", 168, 187], ["severe, dry, fibrinohemorrhagic peritonitis", "PROBLEM", 61, 104], ["Clostridium piliforme infection", "PROBLEM", 105, 136], ["Clostridium piliforme (formerly Bacillus piliformis) infection", "PROBLEM", 136, 198], ["Tyzzer's disease", "PROBLEM", 222, 238], ["severe losses in laboratory rodents", "PROBLEM", 251, 286], ["vessels", "ANATOMY", 11, 18], ["severe", "OBSERVATION_MODIFIER", 61, 67], ["dry", "OBSERVATION", 69, 72], ["fibrinohemorrhagic", "OBSERVATION_MODIFIER", 74, 92], ["peritonitis", "OBSERVATION", 93, 104], ["infection", "OBSERVATION", 127, 136], ["infection", "OBSERVATION", 189, 198], ["severe", "OBSERVATION_MODIFIER", 251, 257], ["losses", "OBSERVATION", 258, 264]]], ["Although the disease is probably initiated by an intestinal infection, lesions in the gut are less317.e1eFigure 2-20 Leptospirosis with dissociation of hepatocytes in a dog.317.e1peracute disease causing weakness and vomiting before death.", [["intestinal", "ANATOMY", 49, 59], ["lesions", "ANATOMY", 71, 78], ["gut", "ANATOMY", 86, 89], ["hepatocytes", "ANATOMY", 152, 163], ["intestinal infection", "DISEASE", 49, 69], ["Leptospirosis", "DISEASE", 117, 130], ["weakness", "DISEASE", 204, 212], ["vomiting", "DISEASE", 217, 225], ["death", "DISEASE", 233, 238], ["intestinal", "ORGAN", 49, 59], ["lesions", "PATHOLOGICAL_FORMATION", 71, 78], ["gut", "ORGAN", 86, 89], ["hepatocytes", "CELL", 152, 163], ["dog", "ORGANISM", 169, 172], ["hepatocytes", "CELL_TYPE", 152, 163], ["dog", "SPECIES", 169, 172], ["the disease", "PROBLEM", 9, 20], ["an intestinal infection", "PROBLEM", 46, 69], ["lesions in the gut", "PROBLEM", 71, 89], ["Leptospirosis", "PROBLEM", 117, 130], ["dissociation of hepatocytes", "PROBLEM", 136, 163], ["e1peracute disease", "PROBLEM", 177, 195], ["weakness", "PROBLEM", 204, 212], ["vomiting", "PROBLEM", 217, 225], ["death", "PROBLEM", 233, 238], ["disease", "OBSERVATION", 13, 20], ["probably initiated", "UNCERTAINTY", 24, 42], ["intestinal", "ANATOMY", 49, 59], ["infection", "OBSERVATION", 60, 69], ["lesions", "OBSERVATION", 71, 78], ["gut", "ANATOMY", 86, 89], ["less", "OBSERVATION_MODIFIER", 94, 98], ["hepatocytes", "ANATOMY", 152, 163], ["peracute disease", "OBSERVATION", 179, 195], ["weakness", "OBSERVATION", 204, 212]]], ["Multiple coalescing yellow foci in the liver up to 1.5 cm in diameter consisted of hepatocellular coagulative necrosis with infiltrating mononuclear cells and neutrophils.", [["yellow foci", "ANATOMY", 20, 31], ["liver", "ANATOMY", 39, 44], ["hepatocellular coagulative", "ANATOMY", 83, 109], ["infiltrating mononuclear cells", "ANATOMY", 124, 154], ["neutrophils", "ANATOMY", 159, 170], ["necrosis", "DISEASE", 110, 118], ["liver", "ORGAN", 39, 44], ["infiltrating mononuclear cells", "CELL", 124, 154], ["neutrophils", "CELL", 159, 170], ["infiltrating mononuclear cells", "CELL_TYPE", 124, 154], ["neutrophils", "CELL_TYPE", 159, 170], ["Multiple coalescing yellow foci in the liver", "PROBLEM", 0, 44], ["hepatocellular coagulative necrosis", "PROBLEM", 83, 118], ["infiltrating mononuclear cells", "PROBLEM", 124, 154], ["neutrophils", "TEST", 159, 170], ["coalescing", "OBSERVATION_MODIFIER", 9, 19], ["yellow", "OBSERVATION_MODIFIER", 20, 26], ["foci", "OBSERVATION", 27, 31], ["liver", "ANATOMY", 39, 44], ["up to 1.5 cm", "OBSERVATION_MODIFIER", 45, 57], ["diameter", "OBSERVATION_MODIFIER", 61, 69], ["hepatocellular", "ANATOMY", 83, 97], ["coagulative", "OBSERVATION_MODIFIER", 98, 109], ["necrosis", "OBSERVATION", 110, 118], ["infiltrating mononuclear cells", "OBSERVATION", 124, 154], ["neutrophils", "OBSERVATION_MODIFIER", 159, 170]]], ["Spiral bacteria were visualized by Warthin-Starry silver stains in area of necrosis, within bile canaliculi, and occasionally in bile duct lumens.", [["bile canaliculi", "ANATOMY", 92, 107], ["bile duct lumens", "ANATOMY", 129, 145], ["necrosis", "DISEASE", 75, 83], ["silver", "CHEMICAL", 50, 56], ["bile canaliculi", "MULTI-TISSUE_STRUCTURE", 92, 107], ["bile duct lumens", "MULTI-TISSUE_STRUCTURE", 129, 145], ["Spiral bacteria", "PROBLEM", 0, 15], ["Warthin", "TEST", 35, 42], ["necrosis", "PROBLEM", 75, 83], ["bacteria", "OBSERVATION", 7, 15], ["silver stains", "OBSERVATION_MODIFIER", 50, 63], ["area", "OBSERVATION_MODIFIER", 67, 71], ["necrosis", "OBSERVATION", 75, 83], ["bile canaliculi", "ANATOMY", 92, 107], ["bile duct", "ANATOMY", 129, 138], ["lumens", "ANATOMY_MODIFIER", 139, 145]]], ["This organism has previously been identified in the blood of diarrheic children, and in the feces of 4% of dogs in an epidemiologic study examining the incidence of Campylobacter-like organisms in 1,000 dogs.", [["blood", "ANATOMY", 52, 57], ["feces", "ANATOMY", 92, 97], ["Campylobacter-like organisms", "DISEASE", 165, 193], ["blood", "ORGANISM_SUBSTANCE", 52, 57], ["children", "ORGANISM", 71, 79], ["feces", "ORGANISM_SUBDIVISION", 92, 97], ["dogs", "ORGANISM", 107, 111], ["dogs", "ORGANISM", 203, 207], ["children", "SPECIES", 71, 79], ["dogs", "SPECIES", 107, 111], ["dogs", "SPECIES", 203, 207], ["an epidemiologic study", "TEST", 115, 137], ["Campylobacter", "PROBLEM", 165, 178], ["Campylobacter", "OBSERVATION", 165, 178]]], ["Bartonella spp. infection has been associated with a wide variety of granulomatous syndromes and peliosis hepatis in humans, often in association with immunosuppression.", [["granulomatous", "ANATOMY", 69, 82], ["Bartonella spp. infection", "DISEASE", 0, 25], ["granulomatous syndromes", "DISEASE", 69, 92], ["peliosis hepatis", "DISEASE", 97, 113], ["Bartonella spp.", "ORGANISM", 0, 15], ["hepatis", "ORGAN", 106, 113], ["humans", "ORGANISM", 117, 123], ["Bartonella spp.", "SPECIES", 0, 15], ["humans", "SPECIES", 117, 123], ["Bartonella spp.", "SPECIES", 0, 15], ["humans", "SPECIES", 117, 123], ["Bartonella spp. infection", "PROBLEM", 0, 25], ["granulomatous syndromes", "PROBLEM", 69, 92], ["peliosis hepatis in humans", "PROBLEM", 97, 123], ["immunosuppression", "TREATMENT", 151, 168], ["spp.", "OBSERVATION_MODIFIER", 11, 15], ["infection", "OBSERVATION", 16, 25], ["wide", "OBSERVATION_MODIFIER", 53, 57], ["variety", "OBSERVATION_MODIFIER", 58, 65], ["granulomatous syndromes", "OBSERVATION", 69, 92], ["peliosis", "OBSERVATION", 97, 105], ["hepatis", "ANATOMY", 106, 113], ["immunosuppression", "OBSERVATION", 151, 168]]], ["Bartonella henselae and B. clarridgeae are associated with selflimiting illness and persistent intravascular infection in cats; mild lymphocytic cholangitis/pericholangitis and lymphocytic hepatitis have been reported with experimental infection of cats with B. henselae.", [["intravascular", "ANATOMY", 95, 108], ["pericholangitis", "ANATOMY", 157, 172], ["Bartonella henselae", "DISEASE", 0, 19], ["selflimiting illness", "DISEASE", 59, 79], ["intravascular infection", "DISEASE", 95, 118], ["lymphocytic cholangitis", "DISEASE", 133, 156], ["pericholangitis", "DISEASE", 157, 172], ["lymphocytic hepatitis", "DISEASE", 177, 198], ["infection", "DISEASE", 236, 245], ["B. henselae", "DISEASE", 259, 270], ["Bartonella henselae", "ORGANISM", 0, 19], ["B. clarridgeae", "ORGANISM", 24, 38], ["intravascular", "IMMATERIAL_ANATOMICAL_ENTITY", 95, 108], ["cats", "ORGANISM", 122, 126], ["lymphocytic cholangitis", "PATHOLOGICAL_FORMATION", 133, 156], ["cats", "ORGANISM", 249, 253], ["B. henselae", "ORGANISM", 259, 270], ["Bartonella henselae", "SPECIES", 0, 19], ["B. clarridgeae", "SPECIES", 24, 38], ["cats", "SPECIES", 122, 126], ["cats", "SPECIES", 249, 253], ["B. henselae", "SPECIES", 259, 270], ["Bartonella henselae", "SPECIES", 0, 19], ["B. clarridgeae", "SPECIES", 24, 38], ["B. henselae", "SPECIES", 259, 270], ["Bartonella henselae", "PROBLEM", 0, 19], ["selflimiting illness", "PROBLEM", 59, 79], ["persistent intravascular infection in cats", "PROBLEM", 84, 126], ["mild lymphocytic cholangitis", "PROBLEM", 128, 156], ["pericholangitis", "PROBLEM", 157, 172], ["lymphocytic hepatitis", "PROBLEM", 177, 198], ["experimental infection of cats", "PROBLEM", 223, 253], ["B. henselae", "PROBLEM", 259, 270], ["henselae", "OBSERVATION", 11, 19], ["persistent", "OBSERVATION_MODIFIER", 84, 94], ["intravascular", "OBSERVATION_MODIFIER", 95, 108], ["infection", "OBSERVATION", 109, 118], ["mild", "OBSERVATION_MODIFIER", 128, 132], ["lymphocytic cholangitis", "OBSERVATION", 133, 156], ["lymphocytic hepatitis", "OBSERVATION", 177, 198], ["experimental", "OBSERVATION_MODIFIER", 223, 235], ["infection", "OBSERVATION", 236, 245], ["henselae", "OBSERVATION", 262, 270]]], ["B. henselae has been identified in liver tissue by PCR from a single case of peliosis hepatis in a Golden Retriever and granulomatous hepatitis in a Basset Hound, whereas B. clarridgeae DNA was identified in liver tissue from a Doberman Pinscher with histologic lesions of Doberman hepatitis, however, the extent to which infection induces disease in dogs is currently unknown.Helminthic infectionsVarious helminths, including cestodes, nematodes, and trematodes, as well as the larval pentastome Linguatula serrata, can produce inflammation of liver and bile ducts.", [["liver tissue", "ANATOMY", 35, 47], ["liver tissue", "ANATOMY", 208, 220], ["lesions", "ANATOMY", 262, 269], ["liver", "ANATOMY", 545, 550], ["bile ducts", "ANATOMY", 555, 565], ["B. henselae", "DISEASE", 0, 11], ["peliosis hepatis", "DISEASE", 77, 93], ["granulomatous hepatitis", "DISEASE", 120, 143], ["Doberman hepatitis", "DISEASE", 273, 291], ["infection", "DISEASE", 322, 331], ["Helminthic infections", "DISEASE", 377, 398], ["helminths", "DISEASE", 406, 415], ["cestodes, nematodes, and trematodes", "DISEASE", 427, 462], ["inflammation of liver and bile ducts", "DISEASE", 529, 565], ["B. henselae", "ORGANISM", 0, 11], ["liver tissue", "TISSUE", 35, 47], ["hepatis", "ORGAN", 86, 93], ["B. clarridgeae", "ORGANISM", 171, 185], ["DNA", "CELLULAR_COMPONENT", 186, 189], ["liver tissue", "TISSUE", 208, 220], ["lesions", "PATHOLOGICAL_FORMATION", 262, 269], ["dogs", "ORGANISM", 351, 355], ["Linguatula serrata", "ORGANISM", 497, 515], ["liver", "ORGAN", 545, 550], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 555, 565], ["B. clarridgeae DNA", "DNA", 171, 189], ["B. henselae", "SPECIES", 0, 11], ["B. clarridgeae", "SPECIES", 171, 185], ["dogs", "SPECIES", 351, 355], ["Linguatula serrata", "SPECIES", 497, 515], ["B. henselae", "SPECIES", 0, 11], ["Golden Retriever", "SPECIES", 99, 115], ["B. clarridgeae", "SPECIES", 171, 185], ["Linguatula serrata", "SPECIES", 497, 515], ["B. henselae", "PROBLEM", 0, 11], ["PCR", "TEST", 51, 54], ["peliosis hepatis", "PROBLEM", 77, 93], ["granulomatous hepatitis", "PROBLEM", 120, 143], ["B. clarridgeae DNA", "PROBLEM", 171, 189], ["liver tissue", "PROBLEM", 208, 220], ["histologic lesions", "PROBLEM", 251, 269], ["Doberman hepatitis", "PROBLEM", 273, 291], ["infection induces disease in dogs", "PROBLEM", 322, 355], ["Helminthic infections", "PROBLEM", 377, 398], ["trematodes", "TREATMENT", 452, 462], ["the larval pentastome Linguatula serrata", "TREATMENT", 475, 515], ["inflammation of liver and bile ducts", "PROBLEM", 529, 565], ["henselae", "OBSERVATION", 3, 11], ["liver", "ANATOMY", 35, 40], ["peliosis", "OBSERVATION", 77, 85], ["hepatis", "ANATOMY", 86, 93], ["Golden Retriever", "OBSERVATION", 99, 115], ["granulomatous", "OBSERVATION_MODIFIER", 120, 133], ["hepatitis", "OBSERVATION", 134, 143], ["clarridgeae DNA", "OBSERVATION", 174, 189], ["liver", "ANATOMY", 208, 213], ["Doberman", "OBSERVATION", 228, 236], ["histologic", "OBSERVATION_MODIFIER", 251, 261], ["lesions", "OBSERVATION", 262, 269], ["Doberman hepatitis", "OBSERVATION", 273, 291], ["infection", "OBSERVATION", 322, 331], ["infections", "OBSERVATION", 388, 398], ["helminths", "OBSERVATION", 406, 415], ["inflammation", "OBSERVATION", 529, 541], ["liver", "ANATOMY", 545, 550], ["bile ducts", "ANATOMY", 555, 565]]], ["Those parasites that have the biliary system as their final habitat will be discussed in detail later.", [["biliary system", "ANATOMY", 30, 44], ["biliary system", "MULTI-TISSUE_STRUCTURE", 30, 44], ["Those parasites", "PROBLEM", 0, 15], ["biliary", "ANATOMY", 30, 37]]], ["The others produce hepatic lesions in the course of their natural or accidental migrations, and are discussed under the organ (for most of them, the gut) that is their final habitat.", [["hepatic lesions", "ANATOMY", 19, 34], ["organ", "ANATOMY", 120, 125], ["gut", "ANATOMY", 149, 152], ["hepatic lesions", "DISEASE", 19, 34], ["hepatic lesions", "PATHOLOGICAL_FORMATION", 19, 34], ["organ", "ORGAN", 120, 125], ["gut", "ORGANISM_SUBDIVISION", 149, 152], ["hepatic lesions", "PROBLEM", 19, 34], ["hepatic", "ANATOMY", 19, 26], ["lesions", "OBSERVATION", 27, 34]]], ["It is useful, however, to describe briefly here the lesions produced by larvae in transit.", [["lesions", "ANATOMY", 52, 59], ["lesions", "PATHOLOGICAL_FORMATION", 52, 59], ["the lesions", "PROBLEM", 48, 59], ["lesions", "OBSERVATION", 52, 59]]], ["The initial lesion produced by wandering larvae is traumatic.", [["lesion", "ANATOMY", 12, 18], ["traumatic", "DISEASE", 51, 60], ["The initial lesion", "PROBLEM", 0, 18], ["wandering larvae", "PROBLEM", 31, 47], ["traumatic", "PROBLEM", 51, 60], ["initial", "OBSERVATION_MODIFIER", 4, 11], ["lesion", "OBSERVATION", 12, 18], ["wandering larvae", "OBSERVATION", 31, 47], ["traumatic", "OBSERVATION_MODIFIER", 51, 60]]], ["Sinuous tunnels permeate the parenchyma and often breach the capsule.", [["parenchyma", "ANATOMY", 29, 39], ["capsule", "ANATOMY", 61, 68], ["parenchyma", "TISSUE", 29, 39], ["capsule", "CANCER", 61, 68], ["tunnels", "OBSERVATION", 8, 15], ["parenchyma", "ANATOMY", 29, 39], ["capsule", "OBSERVATION_MODIFIER", 61, 68]]], ["In the tunnels, there are free red cells, degenerating hepatocytes, and leukocytes, chiefly eosinophils, which react to the parasites.", [["red cells", "ANATOMY", 31, 40], ["hepatocytes", "ANATOMY", 55, 66], ["leukocytes", "ANATOMY", 72, 82], ["eosinophils", "ANATOMY", 92, 103], ["red cells", "CELL", 31, 40], ["hepatocytes", "CELL", 55, 66], ["leukocytes", "CELL", 72, 82], ["eosinophils", "CELL", 92, 103], ["red cells", "CELL_TYPE", 31, 40], ["degenerating hepatocytes", "CELL_TYPE", 42, 66], ["leukocytes", "CELL_TYPE", 72, 82], ["eosinophils", "CELL_TYPE", 92, 103], ["free red cells", "PROBLEM", 26, 40], ["degenerating hepatocytes", "PROBLEM", 42, 66], ["leukocytes", "TEST", 72, 82], ["eosinophils", "TEST", 92, 103], ["tunnels", "ANATOMY_MODIFIER", 7, 14], ["free red cells", "OBSERVATION", 26, 40], ["degenerating", "OBSERVATION_MODIFIER", 42, 54], ["hepatocytes", "ANATOMY", 55, 66], ["leukocytes", "ANATOMY", 72, 82], ["chiefly eosinophils", "OBSERVATION", 84, 103], ["parasites", "OBSERVATION_MODIFIER", 124, 133]]], ["Bordering the tunnel is a narrow zone of coagulative necrosis of parenchyma with neutrophils at its margin.", [["parenchyma", "ANATOMY", 65, 75], ["neutrophils", "ANATOMY", 81, 92], ["necrosis", "DISEASE", 53, 61], ["parenchyma", "TISSUE", 65, 75], ["neutrophils", "CELL", 81, 92], ["neutrophils", "CELL_TYPE", 81, 92], ["a narrow zone of coagulative necrosis of parenchyma", "PROBLEM", 24, 75], ["tunnel", "OBSERVATION", 14, 20], ["narrow", "OBSERVATION_MODIFIER", 26, 32], ["zone", "OBSERVATION_MODIFIER", 33, 37], ["coagulative", "OBSERVATION_MODIFIER", 41, 52], ["necrosis", "OBSERVATION", 53, 61], ["parenchyma", "ANATOMY_MODIFIER", 65, 75], ["neutrophils", "OBSERVATION_MODIFIER", 81, 92], ["margin", "OBSERVATION_MODIFIER", 100, 106]]], ["Eosinophils also infiltrate the portal triads.", [["Eosinophils", "ANATOMY", 0, 11], ["portal triads", "ANATOMY", 32, 45], ["Eosinophils", "CELL", 0, 11], ["portal triads", "MULTI-TISSUE_STRUCTURE", 32, 45], ["Eosinophils", "CELL_TYPE", 0, 11], ["Eosinophils", "TEST", 0, 11], ["infiltrate the portal triads", "PROBLEM", 17, 45], ["infiltrate", "OBSERVATION", 17, 27], ["portal triads", "ANATOMY", 32, 45]]], ["The necrotic parasitic tracts heal by scarification, and the fibroblastic tissue, infiltrated with eosinophils, is eventually incorporated into the portal units.", [["necrotic parasitic tracts", "ANATOMY", 4, 29], ["fibroblastic tissue", "ANATOMY", 61, 80], ["eosinophils", "ANATOMY", 99, 110], ["necrotic", "DISEASE", 4, 12], ["necrotic parasitic tracts", "PATHOLOGICAL_FORMATION", 4, 29], ["fibroblastic tissue", "TISSUE", 61, 80], ["eosinophils", "CELL", 99, 110], ["eosinophils", "CELL_TYPE", 99, 110], ["The necrotic parasitic tracts heal", "PROBLEM", 0, 34], ["scarification", "PROBLEM", 38, 51], ["the fibroblastic tissue", "PROBLEM", 57, 80], ["eosinophils", "TREATMENT", 99, 110], ["necrotic", "OBSERVATION_MODIFIER", 4, 12], ["parasitic", "OBSERVATION_MODIFIER", 13, 22], ["tracts", "OBSERVATION_MODIFIER", 23, 29], ["heal", "OBSERVATION_MODIFIER", 30, 34], ["scarification", "OBSERVATION", 38, 51], ["fibroblastic tissue", "OBSERVATION", 61, 80], ["infiltrated", "OBSERVATION_MODIFIER", 82, 93], ["eosinophils", "OBSERVATION", 99, 110], ["portal units", "ANATOMY", 148, 160]]], ["Most larvae escape from the liver, but some eventually become encapsulated in the liver in abscesses containing numerous eosinophils.", [["liver", "ANATOMY", 28, 33], ["liver", "ANATOMY", 82, 87], ["abscesses", "ANATOMY", 91, 100], ["eosinophils", "ANATOMY", 121, 132], ["abscesses", "DISEASE", 91, 100], ["liver", "ORGAN", 28, 33], ["liver", "ORGAN", 82, 87], ["eosinophils", "CELL", 121, 132], ["eosinophils", "CELL_TYPE", 121, 132], ["abscesses", "PROBLEM", 91, 100], ["numerous eosinophils", "PROBLEM", 112, 132], ["escape", "OBSERVATION", 12, 18], ["liver", "ANATOMY", 28, 33], ["encapsulated", "OBSERVATION", 62, 74], ["liver", "ANATOMY", 82, 87], ["abscesses", "OBSERVATION", 91, 100], ["numerous", "OBSERVATION_MODIFIER", 112, 120], ["eosinophils", "OBSERVATION", 121, 132]]], ["The abscesses may caseate and come to resemble tubercles, and eventually many are heavily mineralized to form permanent pearly nodules.", [["abscesses", "ANATOMY", 4, 13], ["tubercles", "ANATOMY", 47, 56], ["nodules", "ANATOMY", 127, 134], ["abscesses", "DISEASE", 4, 13], ["abscesses", "PATHOLOGICAL_FORMATION", 4, 13], ["tubercles", "ORGAN", 47, 56], ["pearly nodules", "CANCER", 120, 134], ["The abscesses", "PROBLEM", 0, 13], ["permanent pearly nodules", "PROBLEM", 110, 134], ["abscesses", "OBSERVATION", 4, 13], ["tubercles", "OBSERVATION_MODIFIER", 47, 56], ["heavily", "OBSERVATION_MODIFIER", 82, 89], ["mineralized", "OBSERVATION", 90, 101], ["permanent", "OBSERVATION_MODIFIER", 110, 119], ["pearly", "OBSERVATION_MODIFIER", 120, 126], ["nodules", "OBSERVATION", 127, 134]]], ["In sheep, the most common cause of this type of hepatitis (aside from liver fluke) is Cysticercus tenuicollis in its wandering phase.", [["liver fluke", "ANATOMY", 70, 81], ["hepatitis", "DISEASE", 48, 57], ["liver fluke", "DISEASE", 70, 81], ["sheep", "ORGANISM", 3, 8], ["liver", "ORGAN", 70, 75], ["fluke", "ORGAN", 76, 81], ["Cysticercus tenuicollis", "ORGANISM", 86, 109], ["sheep", "SPECIES", 3, 8], ["Cysticercus tenuicollis", "SPECIES", 86, 109], ["sheep", "SPECIES", 3, 8], ["Cysticercus tenuicollis", "SPECIES", 86, 109], ["hepatitis", "PROBLEM", 48, 57], ["liver fluke", "PROBLEM", 70, 81], ["Cysticercus tenuicollis", "PROBLEM", 86, 109], ["most common", "OBSERVATION_MODIFIER", 14, 25], ["hepatitis", "OBSERVATION", 48, 57], ["liver", "ANATOMY", 70, 75], ["fluke", "OBSERVATION", 76, 81], ["Cysticercus tenuicollis", "OBSERVATION", 86, 109]]], ["Lambs may die of severe hemorrhagic hepatitis (Fig. developed pulmonary and renal petechial hemorrhages, and friable livers with multifocal 1-2 mm raised white foci corresponding to periportal inflammatory infiltrates of lymphocytes, plasma cells, neutrophils, and macrophages; small foci of hepatic necrosis; and bile plugs in canaliculi, in addition to renal, pulmonary, and cardiac lesions.", [["pulmonary", "ANATOMY", 62, 71], ["renal petechial", "ANATOMY", 76, 91], ["livers", "ANATOMY", 117, 123], ["white foci", "ANATOMY", 154, 164], ["periportal inflammatory infiltrates", "ANATOMY", 182, 217], ["lymphocytes", "ANATOMY", 221, 232], ["plasma cells", "ANATOMY", 234, 246], ["neutrophils", "ANATOMY", 248, 259], ["macrophages", "ANATOMY", 265, 276], ["foci", "ANATOMY", 284, 288], ["hepatic", "ANATOMY", 292, 299], ["bile plugs", "ANATOMY", 314, 324], ["canaliculi", "ANATOMY", 328, 338], ["renal", "ANATOMY", 355, 360], ["pulmonary", "ANATOMY", 362, 371], ["cardiac lesions", "ANATOMY", 377, 392], ["hemorrhagic hepatitis", "DISEASE", 24, 45], ["hemorrhages", "DISEASE", 92, 103], ["hepatic necrosis", "DISEASE", 292, 308], ["renal, pulmonary, and cardiac lesions", "DISEASE", 355, 392], ["Lambs", "ORGANISM", 0, 5], ["pulmonary", "ORGAN", 62, 71], ["renal petechial", "PATHOLOGICAL_FORMATION", 76, 91], ["livers", "ORGAN", 117, 123], ["lymphocytes", "CELL", 221, 232], ["plasma cells", "CELL", 234, 246], ["neutrophils", "CELL", 248, 259], ["macrophages", "CELL", 265, 276], ["hepatic", "ORGAN", 292, 299], ["bile plugs", "PATHOLOGICAL_FORMATION", 314, 324], ["canaliculi", "MULTI-TISSUE_STRUCTURE", 328, 338], ["renal", "CANCER", 355, 360], ["pulmonary", "ORGAN", 362, 371], ["cardiac lesions", "PATHOLOGICAL_FORMATION", 377, 392], ["lymphocytes", "CELL_TYPE", 221, 232], ["plasma cells", "CELL_TYPE", 234, 246], ["neutrophils", "CELL_TYPE", 248, 259], ["macrophages", "CELL_TYPE", 265, 276], ["Lambs", "SPECIES", 0, 5], ["severe hemorrhagic hepatitis", "PROBLEM", 17, 45], ["pulmonary and renal petechial hemorrhages", "PROBLEM", 62, 103], ["friable livers", "PROBLEM", 109, 123], ["multifocal 1-2 mm raised white foci", "PROBLEM", 129, 164], ["periportal inflammatory infiltrates of lymphocytes", "PROBLEM", 182, 232], ["plasma cells", "TEST", 234, 246], ["neutrophils", "TEST", 248, 259], ["macrophages", "PROBLEM", 265, 276], ["small foci of hepatic necrosis", "PROBLEM", 278, 308], ["bile plugs in canaliculi", "PROBLEM", 314, 338], ["renal, pulmonary, and cardiac lesions", "PROBLEM", 355, 392], ["severe", "OBSERVATION_MODIFIER", 17, 23], ["hemorrhagic", "OBSERVATION_MODIFIER", 24, 35], ["hepatitis", "OBSERVATION", 36, 45], ["pulmonary", "ANATOMY", 62, 71], ["renal", "ANATOMY", 76, 81], ["petechial", "OBSERVATION_MODIFIER", 82, 91], ["hemorrhages", "OBSERVATION", 92, 103], ["friable", "OBSERVATION_MODIFIER", 109, 116], ["livers", "ANATOMY", 117, 123], ["multifocal", "OBSERVATION_MODIFIER", 129, 139], ["1-2 mm", "OBSERVATION_MODIFIER", 140, 146], ["raised", "OBSERVATION_MODIFIER", 147, 153], ["white", "OBSERVATION_MODIFIER", 154, 159], ["foci", "OBSERVATION", 160, 164], ["periportal", "ANATOMY", 182, 192], ["inflammatory", "OBSERVATION_MODIFIER", 193, 205], ["infiltrates", "OBSERVATION", 206, 217], ["lymphocytes", "ANATOMY", 221, 232], ["plasma cells", "OBSERVATION", 234, 246], ["neutrophils", "OBSERVATION_MODIFIER", 248, 259], ["macrophages", "ANATOMY", 265, 276], ["small", "OBSERVATION_MODIFIER", 278, 283], ["foci", "OBSERVATION_MODIFIER", 284, 288], ["hepatic", "ANATOMY", 292, 299], ["necrosis", "OBSERVATION", 300, 308], ["bile", "ANATOMY", 314, 318], ["plugs", "OBSERVATION", 319, 324], ["canaliculi", "ANATOMY", 328, 338], ["renal", "ANATOMY", 355, 360], ["pulmonary", "ANATOMY", 362, 371], ["cardiac", "ANATOMY", 377, 384], ["lesions", "OBSERVATION", 385, 392]]], ["Organisms were identified by immunohistochemistry at the brush borders of renal proximal convoluted tubules as well as at the luminal surface of bile duct epithelium.", [["brush borders", "ANATOMY", 57, 70], ["renal proximal convoluted tubules", "ANATOMY", 74, 107], ["luminal surface", "ANATOMY", 126, 141], ["bile duct epithelium", "ANATOMY", 145, 165], ["luminal", "CHEMICAL", 126, 133], ["renal proximal convoluted tubules", "TISSUE", 74, 107], ["luminal surface", "CELLULAR_COMPONENT", 126, 141], ["bile duct epithelium", "TISSUE", 145, 165], ["Organisms", "PROBLEM", 0, 9], ["immunohistochemistry", "TEST", 29, 49], ["renal", "ANATOMY", 74, 79], ["proximal", "ANATOMY_MODIFIER", 80, 88], ["convoluted tubules", "OBSERVATION", 89, 107], ["luminal", "ANATOMY_MODIFIER", 126, 133], ["surface", "ANATOMY_MODIFIER", 134, 141], ["bile duct", "ANATOMY", 145, 154], ["epithelium", "ANATOMY_MODIFIER", 155, 165]]], ["In a retrospective study of dogs with supportive clinical signs and microscopic agglutination test titers of \u2265320 for one or more serovars tested, including autumnalis, bratislava, canicola, grippotyphosa, icterohaemorrhagiae, and pomona, histologic lesions in the liver were subtle, with sinusoidal neutrophil margination, Kupffer cell hypertrophy, and low levels of hepatocellular single-cell necrosis and mitoses.", [["canicola", "ANATOMY", 181, 189], ["grippotyphosa", "ANATOMY", 191, 204], ["icterohaemorrhagiae", "ANATOMY", 206, 225], ["lesions", "ANATOMY", 250, 257], ["liver", "ANATOMY", 265, 270], ["sinusoidal neutrophil", "ANATOMY", 289, 310], ["Kupffer cell", "ANATOMY", 324, 336], ["hepatocellular", "ANATOMY", 368, 382], ["cell", "ANATOMY", 390, 394], ["necrosis", "DISEASE", 395, 403], ["dogs", "ORGANISM", 28, 32], ["bratislava", "ORGANISM", 169, 179], ["canicola", "ORGANISM", 181, 189], ["grippotyphosa", "CANCER", 191, 204], ["icterohaemorrhagiae", "CANCER", 206, 225], ["histologic lesions", "CANCER", 239, 257], ["liver", "ORGAN", 265, 270], ["sinusoidal neutrophil", "CELL", 289, 310], ["Kupffer cell", "CELL", 324, 336], ["hepatocellular single-cell", "CELL", 368, 394], ["dogs", "SPECIES", 28, 32], ["a retrospective study", "TEST", 3, 24], ["supportive clinical signs", "TEST", 38, 63], ["microscopic agglutination test titers", "TEST", 68, 105], ["autumnalis", "PROBLEM", 157, 167], ["canicola", "PROBLEM", 181, 189], ["grippotyphosa", "PROBLEM", 191, 204], ["icterohaemorrhagiae", "PROBLEM", 206, 225], ["pomona, histologic lesions in the liver", "PROBLEM", 231, 270], ["sinusoidal neutrophil margination", "PROBLEM", 289, 322], ["Kupffer cell hypertrophy", "PROBLEM", 324, 348], ["hepatocellular single-cell necrosis", "PROBLEM", 368, 403], ["histologic", "OBSERVATION_MODIFIER", 239, 249], ["lesions", "OBSERVATION", 250, 257], ["liver", "ANATOMY", 265, 270], ["sinusoidal neutrophil margination", "OBSERVATION", 289, 322], ["Kupffer cell hypertrophy", "OBSERVATION", 324, 348], ["low levels", "OBSERVATION_MODIFIER", 354, 364], ["hepatocellular", "ANATOMY", 368, 382], ["cell necrosis", "OBSERVATION", 390, 403]]], ["Some livers had diffuse interstitial lymphocytic hepatitis, with mitotic figures, anisokaryosis, binucleation, and some degree of lobular collapse.", [["livers", "ANATOMY", 5, 11], ["interstitial lymphocytic", "ANATOMY", 24, 48], ["lobular", "ANATOMY", 130, 137], ["interstitial lymphocytic hepatitis", "DISEASE", 24, 58], ["anisokaryosis", "DISEASE", 82, 95], ["binucleation", "DISEASE", 97, 109], ["livers", "ORGAN", 5, 11], ["interstitial lymphocytic", "CANCER", 24, 48], ["lobular", "CANCER", 130, 137], ["diffuse interstitial lymphocytic hepatitis", "PROBLEM", 16, 58], ["mitotic figures", "PROBLEM", 65, 80], ["anisokaryosis", "PROBLEM", 82, 95], ["binucleation", "PROBLEM", 97, 109], ["lobular collapse", "PROBLEM", 130, 146], ["livers", "ANATOMY", 5, 11], ["diffuse", "OBSERVATION_MODIFIER", 16, 23], ["interstitial lymphocytic hepatitis", "OBSERVATION", 24, 58], ["mitotic figures", "OBSERVATION", 65, 80], ["binucleation", "OBSERVATION_MODIFIER", 97, 109], ["some", "OBSERVATION_MODIFIER", 115, 119], ["degree", "OBSERVATION_MODIFIER", 120, 126], ["lobular", "OBSERVATION_MODIFIER", 130, 137], ["collapse", "OBSERVATION", 138, 146]]], ["Chronic hepatitis has also been experimentally produced by leptospiral infection in dogs; however, clinical cases are rarely documented.Other bacteriaA single case of clinical disease associated with Helicobacter canis has been reported in a 2-month-old puppy with A B horses even after the widespread use of effective anthelmintics, and their precise etiology remains unknown (Fig. 2-83) .Other bacteriaParasites can produce hepatic lesions by other means.", [["hepatic lesions", "ANATOMY", 426, 441], ["Chronic hepatitis", "DISEASE", 0, 17], ["leptospiral infection", "DISEASE", 59, 80], ["Helicobacter canis", "DISEASE", 200, 218], ["hepatic lesions", "DISEASE", 426, 441], ["leptospiral", "ORGANISM", 59, 70], ["dogs", "ORGANISM", 84, 88], ["Helicobacter canis", "ORGANISM", 200, 218], ["puppy", "ORGANISM", 254, 259], ["A B horses", "ORGANISM", 265, 275], ["hepatic lesions", "PATHOLOGICAL_FORMATION", 426, 441], ["dogs", "SPECIES", 84, 88], ["Helicobacter canis", "SPECIES", 200, 218], ["Helicobacter canis", "SPECIES", 200, 218], ["A B horses", "SPECIES", 265, 275], ["Chronic hepatitis", "PROBLEM", 0, 17], ["leptospiral infection in dogs", "PROBLEM", 59, 88], ["clinical disease", "PROBLEM", 167, 183], ["Helicobacter canis", "PROBLEM", 200, 218], ["effective anthelmintics", "TREATMENT", 309, 332], ["Other bacteriaParasites", "PROBLEM", 390, 413], ["hepatic lesions", "PROBLEM", 426, 441], ["hepatitis", "OBSERVATION", 8, 17], ["leptospiral", "OBSERVATION_MODIFIER", 59, 70], ["infection", "OBSERVATION", 71, 80], ["Helicobacter canis", "OBSERVATION", 200, 218], ["hepatic", "ANATOMY", 426, 433], ["lesions", "OBSERVATION", 434, 441]]], ["The hydatid intermediate stages of Echinococcus encyst in the liver and may destroy much of it; the larvae of Ascaris suum in cattle add to the usual insult by causing portal phlebitis and small areas of infarction; the adults of Ascaris in all species, but especially in pigs, may migrate into the bile ducts; and the eggs of schistosomes enter in the portal blood to lodge in the intrahepatic portal vessels and provoke granulomatous inflammation.CestodesStilesia hepatica and Thysanosoma actinioides, the \"fringed tapeworm,\" are the only cestodes that inhabit the bile ducts.", [["liver", "ANATOMY", 62, 67], ["portal phlebitis", "ANATOMY", 168, 184], ["bile ducts", "ANATOMY", 299, 309], ["eggs", "ANATOMY", 319, 323], ["portal blood", "ANATOMY", 353, 365], ["intrahepatic portal vessels", "ANATOMY", 382, 409], ["granulomatous", "ANATOMY", 422, 435], ["bile ducts", "ANATOMY", 567, 577], ["Echinococcus encyst", "DISEASE", 35, 54], ["Ascaris suum", "DISEASE", 110, 122], ["portal phlebitis", "DISEASE", 168, 184], ["infarction", "DISEASE", 204, 214], ["inflammation", "DISEASE", 436, 448], ["CestodesStilesia hepatica", "DISEASE", 449, 474], ["fringed tapeworm", "DISEASE", 509, 525], ["Echinococcus", "ORGANISM", 35, 47], ["liver", "ORGAN", 62, 67], ["Ascaris suum", "ORGANISM", 110, 122], ["cattle", "ORGANISM", 126, 132], ["portal phlebitis", "PATHOLOGICAL_FORMATION", 168, 184], ["Ascaris", "ORGANISM_SUBDIVISION", 230, 237], ["pigs", "ORGANISM", 272, 276], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 299, 309], ["schistosomes", "ORGANISM", 327, 339], ["portal", "MULTI-TISSUE_STRUCTURE", 353, 359], ["blood", "ORGANISM_SUBSTANCE", 360, 365], ["intrahepatic portal vessels", "MULTI-TISSUE_STRUCTURE", 382, 409], ["granulomatous inflammation", "PATHOLOGICAL_FORMATION", 422, 448], ["CestodesStilesia hepatica", "ORGANISM", 449, 474], ["Thysanosoma actinioides", "ORGANISM", 479, 502], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 567, 577], ["Ascaris suum", "SPECIES", 110, 122], ["cattle", "SPECIES", 126, 132], ["pigs", "SPECIES", 272, 276], ["CestodesStilesia hepatica", "SPECIES", 449, 474], ["Thysanosoma actinioides", "SPECIES", 479, 502], ["Echinococcus encyst", "SPECIES", 35, 54], ["Ascaris suum", "SPECIES", 110, 122], ["cattle", "SPECIES", 126, 132], ["pigs", "SPECIES", 272, 276], ["CestodesStilesia hepatica", "SPECIES", 449, 474], ["Thysanosoma actinioides", "SPECIES", 479, 502], ["Echinococcus encyst in the liver", "PROBLEM", 35, 67], ["Ascaris suum", "PROBLEM", 110, 122], ["portal phlebitis", "PROBLEM", 168, 184], ["infarction", "PROBLEM", 204, 214], ["Ascaris in all species", "PROBLEM", 230, 252], ["the eggs of schistosomes", "PROBLEM", 315, 339], ["granulomatous inflammation", "PROBLEM", 422, 448], ["CestodesStilesia hepatica and Thysanosoma actinioides", "PROBLEM", 449, 502], ["the \"fringed tapeworm", "PROBLEM", 504, 525], ["hydatid", "OBSERVATION_MODIFIER", 4, 11], ["intermediate stages", "OBSERVATION_MODIFIER", 12, 31], ["Echinococcus encyst", "OBSERVATION", 35, 54], ["liver", "ANATOMY", 62, 67], ["portal", "ANATOMY", 168, 174], ["phlebitis", "OBSERVATION", 175, 184], ["small", "OBSERVATION_MODIFIER", 189, 194], ["areas", "OBSERVATION_MODIFIER", 195, 200], ["infarction", "OBSERVATION", 204, 214], ["Ascaris", "OBSERVATION", 230, 237], ["all species", "OBSERVATION_MODIFIER", 241, 252], ["bile ducts", "ANATOMY", 299, 309], ["schistosomes", "OBSERVATION", 327, 339], ["portal blood", "ANATOMY", 353, 365], ["intrahepatic", "ANATOMY_MODIFIER", 382, 394], ["portal vessels", "ANATOMY", 395, 409], ["granulomatous", "OBSERVATION_MODIFIER", 422, 435], ["inflammation", "OBSERVATION", 436, 448], ["hepatica", "ANATOMY", 466, 474], ["bile ducts", "ANATOMY", 567, 577]]], ["They are parasites of ruminants, Stilesia occurring in Africa, Thysanosoma in North and South America.", [["Stilesia", "PROBLEM", 33, 41], ["parasites", "OBSERVATION", 9, 18], ["ruminants", "OBSERVATION_MODIFIER", 22, 31], ["Africa", "OBSERVATION_MODIFIER", 55, 61]]], ["The life cycles of the parasites are not completely known but may involve oribatid mites as intermediate hosts.", [["oribatid mites", "ORGANISM", 74, 88], ["the parasites", "PROBLEM", 19, 32], ["parasites", "OBSERVATION", 23, 32]]], ["T. actinioides may also be found in the pancreatic ducts and small intestine.", [["pancreatic ducts", "ANATOMY", 40, 56], ["small intestine", "ANATOMY", 61, 76], ["T. actinioides", "ORGANISM", 0, 14], ["pancreatic ducts", "MULTI-TISSUE_STRUCTURE", 40, 56], ["small intestine", "ORGAN", 61, 76], ["T. actinioides", "SPECIES", 0, 14], ["T. actinioides", "SPECIES", 0, 14], ["may also be found", "UNCERTAINTY", 15, 32], ["pancreatic ducts", "ANATOMY", 40, 56], ["small intestine", "ANATOMY", 61, 76]]], ["Usually, the infestations are light but, even when heavy, are not of much significance (eFig.", [["infestations", "OBSERVATION", 13, 25]]], ["Very heavy infestations by S. hepatica occur without signs of illness, although the bile ducts may be nearly occluded, slightly thickened, and dilated.", [["bile ducts", "ANATOMY", 84, 94], ["S. hepatica", "DISEASE", 27, 38], ["S. hepatica", "ORGANISM", 27, 38], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 84, 94], ["S. hepatica", "SPECIES", 27, 38], ["S. hepatica", "SPECIES", 27, 38], ["Very heavy infestations", "PROBLEM", 0, 23], ["illness", "PROBLEM", 62, 69], ["slightly thickened", "PROBLEM", 119, 137], ["dilated", "PROBLEM", 143, 150], ["heavy", "OBSERVATION_MODIFIER", 5, 10], ["infestations", "OBSERVATION", 11, 23], ["hepatica", "ANATOMY", 30, 38], ["without signs of", "UNCERTAINTY", 45, 61], ["illness", "OBSERVATION", 62, 69], ["bile ducts", "ANATOMY", 84, 94], ["may be", "UNCERTAINTY", 95, 101], ["nearly", "OBSERVATION_MODIFIER", 102, 108], ["occluded", "OBSERVATION", 109, 117], ["slightly", "OBSERVATION_MODIFIER", 119, 127], ["thickened", "OBSERVATION", 128, 137], ["dilated", "OBSERVATION", 143, 150]]], ["Saccular dilations of the ducts may occur and be filled with worms.", [["Saccular", "ANATOMY", 0, 8], ["ducts", "ANATOMY", 26, 31], ["ducts", "MULTI-TISSUE_STRUCTURE", 26, 31], ["worms", "SPECIES", 61, 66], ["Saccular dilations of the ducts", "PROBLEM", 0, 31], ["dilations", "OBSERVATION", 9, 18], ["ducts", "ANATOMY", 26, 31]]], ["The fringed tapeworm is perhaps more pathogenic, and unthriftiness may accompany heavy infestations.CestodesEchinococcus granulosus hydatid cysts occur most commonly in the liver of ruminants in endemic areas (Fig. 2-84 ) but have been reported as incidental postmortem findings in the liver of pigs and horses.", [["hydatid cysts", "ANATOMY", 132, 145], ["liver", "ANATOMY", 173, 178], ["liver", "ANATOMY", 286, 291], ["tapeworm", "DISEASE", 12, 20], ["unthriftiness", "DISEASE", 53, 66], ["Echinococcus granulosus hydatid cysts", "DISEASE", 108, 145], ["Cestodes", "ORGANISM", 100, 108], ["Echinococcus granulosus", "ORGANISM", 108, 131], ["hydatid cysts", "PATHOLOGICAL_FORMATION", 132, 145], ["liver", "ORGAN", 173, 178], ["liver", "ORGAN", 286, 291], ["pigs", "ORGANISM", 295, 299], ["horses", "ORGANISM_SUBDIVISION", 304, 310], ["Echinococcus granulosus", "SPECIES", 108, 131], ["pigs", "SPECIES", 295, 299], ["Echinococcus granulosus", "SPECIES", 108, 131], ["pigs", "SPECIES", 295, 299], ["The fringed tapeworm", "PROBLEM", 0, 20], ["heavy infestations", "PROBLEM", 81, 99], ["CestodesEchinococcus granulosus hydatid cysts", "PROBLEM", 100, 145], ["perhaps", "UNCERTAINTY", 24, 31], ["more", "OBSERVATION_MODIFIER", 32, 36], ["pathogenic", "OBSERVATION", 37, 47], ["heavy", "OBSERVATION_MODIFIER", 81, 86], ["infestations", "OBSERVATION", 87, 99], ["liver", "ANATOMY", 173, 178], ["ruminants", "OBSERVATION_MODIFIER", 182, 191], ["endemic", "OBSERVATION_MODIFIER", 195, 202], ["liver", "ANATOMY", 286, 291]]], ["The cysticerci and hydatids, which in the intermediate stages invade the liver, are discussed further in Vol.", [["cysticerci", "ANATOMY", 4, 14], ["hydatids", "ANATOMY", 19, 27], ["liver", "ANATOMY", 73, 78], ["cysticerci", "DISEASE", 4, 14], ["cysticerci", "ORGANISM_SUBSTANCE", 4, 14], ["hydatids", "CANCER", 19, 27], ["liver", "ORGAN", 73, 78], ["The cysticerci and hydatids", "PROBLEM", 0, 27], ["cysticerci", "OBSERVATION", 4, 14], ["hydatids", "OBSERVATION_MODIFIER", 19, 27], ["intermediate stages", "OBSERVATION_MODIFIER", 42, 61], ["liver", "ANATOMY", 73, 78]]], ["2, Alimentary system and peritoneum.CestodesEchinococcus multilocularis is found in Europe, parts of northern Asia, and North America, where it has a sylvatic life cycle.", [["peritoneum", "ANATOMY", 25, 35], ["Echinococcus multilocularis", "DISEASE", 44, 71], ["peritoneum", "MULTI-TISSUE_STRUCTURE", 25, 35], ["Cestodes", "ORGANISM", 36, 44], ["Echinococcus multilocularis", "ORGANISM", 44, 71], ["Echinococcus multilocularis", "SPECIES", 44, 71], ["Echinococcus multilocularis", "SPECIES", 44, 71], ["CestodesEchinococcus multilocularis", "PROBLEM", 36, 71], ["Alimentary system", "ANATOMY", 3, 20], ["peritoneum", "ANATOMY", 25, 35]]], ["Red and arctic foxes are the most important definitive hosts, although coyotes, raccoon-dogs, and wolves can also be infected.", [["arctic foxes", "ORGANISM", 8, 20], ["raccoon-dogs", "ORGANISM", 80, 92], ["dogs", "SPECIES", 88, 92], ["arctic foxes", "SPECIES", 8, 20], ["coyotes", "SPECIES", 71, 78], ["Red and arctic foxes", "PROBLEM", 0, 20], ["arctic foxes", "OBSERVATION", 8, 20], ["infected", "OBSERVATION", 117, 125]]], ["In North America, there are few documented cases of intestinal infection by E. multilocularis tapeworms in domestic dogs and even fewer in cats.", [["intestinal", "ANATOMY", 52, 62], ["intestinal infection", "DISEASE", 52, 72], ["E. multilocularis tapeworms", "DISEASE", 76, 103], ["intestinal", "ORGAN", 52, 62], ["E. multilocularis tapeworms", "ORGANISM", 76, 103], ["dogs", "ORGANISM", 116, 120], ["cats", "ORGANISM", 139, 143], ["E. multilocularis", "SPECIES", 76, 93], ["dogs", "SPECIES", 116, 120], ["cats", "SPECIES", 139, 143], ["E. multilocularis", "SPECIES", 76, 93], ["intestinal infection", "PROBLEM", 52, 72], ["few", "OBSERVATION_MODIFIER", 28, 31], ["intestinal", "ANATOMY", 52, 62], ["infection", "OBSERVATION", 63, 72], ["multilocularis", "OBSERVATION_MODIFIER", 79, 93], ["tapeworms", "OBSERVATION_MODIFIER", 94, 103]]], ["The adult tapeworm is small, 5 mm, and infective eggs are shed in the feces to be ingested by the intermediate host, which in temperate areas are typically various species of rodents, including voles, lemmings, and deer mice.", [["eggs", "ANATOMY", 49, 53], ["feces", "ANATOMY", 70, 75], ["tapeworm", "DISEASE", 10, 18], ["feces", "ORGANISM_SUBDIVISION", 70, 75], ["deer mice", "ORGANISM", 215, 224], ["deer", "SPECIES", 215, 219], ["mice", "SPECIES", 220, 224], ["mice", "SPECIES", 220, 224], ["infective eggs", "PROBLEM", 39, 53], ["adult", "OBSERVATION_MODIFIER", 4, 9], ["tapeworm", "OBSERVATION", 10, 18], ["small", "OBSERVATION_MODIFIER", 22, 27], ["5 mm", "OBSERVATION_MODIFIER", 29, 33], ["infective", "OBSERVATION_MODIFIER", 39, 48], ["eggs", "OBSERVATION", 49, 53], ["intermediate host", "OBSERVATION_MODIFIER", 98, 115]]], ["The hexacanth embryo is released from the egg, travels through the intestinal wall, and migrates to the liver via the hepatic portal circulation.", [["embryo", "ANATOMY", 14, 20], ["egg", "ANATOMY", 42, 45], ["intestinal wall", "ANATOMY", 67, 82], ["liver", "ANATOMY", 104, 109], ["hepatic portal", "ANATOMY", 118, 132], ["hexacanth embryo", "MULTI-TISSUE_STRUCTURE", 4, 20], ["egg", "ORGANISM_SUBDIVISION", 42, 45], ["intestinal wall", "MULTI-TISSUE_STRUCTURE", 67, 82], ["liver", "ORGAN", 104, 109], ["hepatic portal", "MULTI-TISSUE_STRUCTURE", 118, 132], ["The hexacanth embryo", "TREATMENT", 0, 20], ["embryo", "OBSERVATION", 14, 20], ["egg", "ANATOMY", 42, 45], ["intestinal wall", "ANATOMY", 67, 82], ["liver", "ANATOMY", 104, 109], ["hepatic", "ANATOMY", 118, 125], ["portal circulation", "ANATOMY", 126, 144]]], ["The metacestode 2-81) caused by very heavy infections of this parasite, and in pigs, an aberrant host, C. tenuicollis can produce a very intense inflammatory reaction.CestodesIn pigs, larvae of Ascaris suum and Stephanurus dentatus produce similar but distinct patterns of focal interstitial hepatitis.", [["focal interstitial", "ANATOMY", 273, 291], ["metacestode 2-81", "CHEMICAL", 4, 20], ["infections", "DISEASE", 43, 53], ["Ascaris suum", "DISEASE", 194, 206], ["interstitial hepatitis", "DISEASE", 279, 301], ["pigs", "ORGANISM", 79, 83], ["C. tenuicollis", "ORGANISM", 103, 117], ["pigs", "ORGANISM", 178, 182], ["Ascaris suum", "ORGANISM", 194, 206], ["Stephanurus dentatus", "ORGANISM", 211, 231], ["pigs", "SPECIES", 79, 83], ["C. tenuicollis", "SPECIES", 103, 117], ["pigs", "SPECIES", 178, 182], ["Ascaris suum", "SPECIES", 194, 206], ["Stephanurus dentatus", "SPECIES", 211, 231], ["pigs", "SPECIES", 79, 83], ["C. tenuicollis", "SPECIES", 103, 117], ["pigs", "SPECIES", 178, 182], ["Ascaris suum", "SPECIES", 194, 206], ["Stephanurus dentatus", "SPECIES", 211, 231], ["this parasite", "PROBLEM", 57, 70], ["an aberrant host", "PROBLEM", 85, 101], ["C. tenuicollis", "PROBLEM", 103, 117], ["a very intense inflammatory reaction", "PROBLEM", 130, 166], ["Ascaris suum", "PROBLEM", 194, 206], ["focal interstitial hepatitis", "PROBLEM", 273, 301], ["very", "OBSERVATION_MODIFIER", 32, 36], ["heavy", "OBSERVATION_MODIFIER", 37, 42], ["infections", "OBSERVATION", 43, 53], ["very", "OBSERVATION_MODIFIER", 132, 136], ["intense", "OBSERVATION_MODIFIER", 137, 144], ["inflammatory", "OBSERVATION", 145, 157], ["Ascaris suum", "OBSERVATION", 194, 206], ["distinct", "OBSERVATION_MODIFIER", 252, 260], ["patterns", "OBSERVATION_MODIFIER", 261, 269], ["focal", "OBSERVATION_MODIFIER", 273, 278], ["interstitial", "ANATOMY_MODIFIER", 279, 291], ["hepatitis", "OBSERVATION", 292, 301]]], ["The ascarids produce their distinctive accentuation of the stroma (\"milk spots\") ( Fig. 2-82 ) when quite small larvae are immobilized by the host's inflammatory reaction; thus the foci are relatively small.", [["stroma", "ANATOMY", 59, 65], ["milk spots", "ANATOMY", 68, 78], ["foci", "ANATOMY", 181, 185], ["stroma", "TISSUE", 59, 65], ["milk", "ORGANISM_SUBDIVISION", 68, 72], ["the stroma", "PROBLEM", 55, 65], ["quite small larvae", "PROBLEM", 100, 118], ["the host's inflammatory reaction", "PROBLEM", 138, 170], ["the foci", "PROBLEM", 177, 185], ["distinctive", "OBSERVATION_MODIFIER", 27, 38], ["accentuation", "OBSERVATION_MODIFIER", 39, 51], ["stroma", "OBSERVATION", 59, 65], ["small", "OBSERVATION_MODIFIER", 106, 111], ["larvae", "OBSERVATION", 112, 118], ["inflammatory", "OBSERVATION_MODIFIER", 149, 161], ["foci", "OBSERVATION", 181, 185], ["relatively", "OBSERVATION_MODIFIER", 190, 200], ["small", "OBSERVATION_MODIFIER", 201, 206]]], ["The fibrotic lesion produced by S. dentatus larvae, on the other hand, is less focal and more in the nature of a track, and there are usually small, inflamed, capsular craters where the larvae have emerged from the liver to migrate to their preferred perirenal site.", [["fibrotic lesion", "ANATOMY", 4, 19], ["liver", "ANATOMY", 215, 220], ["perirenal site", "ANATOMY", 251, 265], ["fibrotic lesion", "PATHOLOGICAL_FORMATION", 4, 19], ["S. dentatus larvae", "ORGANISM", 32, 50], ["liver", "ORGAN", 215, 220], ["perirenal site", "MULTI-TISSUE_STRUCTURE", 251, 265], ["S. dentatus", "SPECIES", 32, 43], ["S. dentatus", "SPECIES", 32, 43], ["The fibrotic lesion", "PROBLEM", 0, 19], ["S. dentatus larvae", "PROBLEM", 32, 50], ["usually small, inflamed, capsular craters", "PROBLEM", 134, 175], ["fibrotic", "OBSERVATION_MODIFIER", 4, 12], ["lesion", "OBSERVATION", 13, 19], ["dentatus larvae", "OBSERVATION", 35, 50], ["hand", "ANATOMY", 65, 69], ["less", "OBSERVATION_MODIFIER", 74, 78], ["focal", "OBSERVATION_MODIFIER", 79, 84], ["small", "OBSERVATION_MODIFIER", 142, 147], ["inflamed", "OBSERVATION_MODIFIER", 149, 157], ["capsular craters", "OBSERVATION_MODIFIER", 159, 175], ["liver", "ANATOMY", 215, 220], ["perirenal", "ANATOMY", 251, 260]]], ["There will be obvious portal phlebitis at the hepatic hilus when infection by S. dentatus has been by the oral route, and in these livers, the parenchymal lesion is more severe in this vicinity.CestodesMigration tracks left by larval strongyles can be found under the liver capsule in young horses, and historically, these have been thought to relate to the dense, discrete, capsular fibrous tags and plaques that are almost universally found on the diaphragmatic surface of the liver of mature horses.", [["portal phlebitis", "ANATOMY", 22, 38], ["hepatic hilus", "ANATOMY", 46, 59], ["oral", "ANATOMY", 106, 110], ["livers", "ANATOMY", 131, 137], ["parenchymal lesion", "ANATOMY", 143, 161], ["strongyles", "ANATOMY", 234, 244], ["liver capsule", "ANATOMY", 268, 281], ["fibrous tags", "ANATOMY", 384, 396], ["plaques", "ANATOMY", 401, 408], ["diaphragmatic surface", "ANATOMY", 450, 471], ["liver", "ANATOMY", 479, 484], ["phlebitis", "DISEASE", 29, 38], ["infection", "DISEASE", 65, 74], ["parenchymal lesion", "DISEASE", 143, 161], ["portal phlebitis", "PATHOLOGICAL_FORMATION", 22, 38], ["hepatic hilus", "MULTI-TISSUE_STRUCTURE", 46, 59], ["S. dentatus", "ORGANISM", 78, 89], ["oral", "ORGANISM_SUBDIVISION", 106, 110], ["livers", "ORGAN", 131, 137], ["parenchymal lesion", "PATHOLOGICAL_FORMATION", 143, 161], ["liver capsule", "MULTI-TISSUE_STRUCTURE", 268, 281], ["fibrous tags", "TISSUE", 384, 396], ["diaphragmatic surface", "MULTI-TISSUE_STRUCTURE", 450, 471], ["liver", "ORGAN", 479, 484], ["horses", "ORGANISM_SUBDIVISION", 495, 501], ["S. dentatus", "SPECIES", 78, 89], ["S. dentatus", "SPECIES", 78, 89], ["portal phlebitis at the hepatic hilus", "PROBLEM", 22, 59], ["infection", "PROBLEM", 65, 74], ["the parenchymal lesion", "PROBLEM", 139, 161], ["the dense, discrete, capsular fibrous tags", "PROBLEM", 354, 396], ["plaques", "PROBLEM", 401, 408], ["obvious", "OBSERVATION_MODIFIER", 14, 21], ["portal", "ANATOMY", 22, 28], ["phlebitis", "OBSERVATION", 29, 38], ["hepatic", "ANATOMY", 46, 53], ["hilus", "ANATOMY_MODIFIER", 54, 59], ["infection", "OBSERVATION", 65, 74], ["livers", "ANATOMY", 131, 137], ["parenchymal", "ANATOMY_MODIFIER", 143, 154], ["lesion", "OBSERVATION", 155, 161], ["more severe", "OBSERVATION_MODIFIER", 165, 176], ["left", "ANATOMY_MODIFIER", 219, 223], ["larval strongyles", "OBSERVATION", 227, 244], ["liver", "ANATOMY", 268, 273], ["capsule", "ANATOMY_MODIFIER", 274, 281], ["thought to relate to", "UNCERTAINTY", 333, 353], ["dense", "OBSERVATION_MODIFIER", 358, 363], ["discrete", "OBSERVATION_MODIFIER", 365, 373], ["capsular", "OBSERVATION_MODIFIER", 375, 383], ["fibrous tags", "OBSERVATION", 384, 396], ["plaques", "OBSERVATION", 401, 408], ["diaphragmatic", "ANATOMY", 450, 463], ["surface", "ANATOMY_MODIFIER", 464, 471], ["liver", "ANATOMY", 479, 484], ["mature", "OBSERVATION_MODIFIER", 488, 494], ["horses", "OBSERVATION", 495, 501]]], ["However, these hepatic fibrotic lesions remain common inNematodesCalodium hepaticum (Capillaria hepatica) is the one nematode that in the adult phase inhabits the liver.", [["hepatic fibrotic lesions", "ANATOMY", 15, 39], ["liver", "ANATOMY", 163, 168], ["hepatic fibrotic lesions", "DISEASE", 15, 39], ["Capillaria hepatica", "DISEASE", 85, 104], ["hepatic fibrotic lesions", "PATHOLOGICAL_FORMATION", 15, 39], ["inNematodes", "ORGANISM", 54, 65], ["Calodium hepaticum", "ORGANISM", 65, 83], ["Capillaria hepatica", "ORGANISM", 85, 104], ["liver", "ORGAN", 163, 168], ["Calodium hepaticum", "SPECIES", 65, 83], ["Capillaria hepatica", "SPECIES", 85, 104], ["Calodium hepaticum", "SPECIES", 65, 83], ["Capillaria hepatica", "SPECIES", 85, 104], ["these hepatic fibrotic lesions", "PROBLEM", 9, 39], ["hepatic", "ANATOMY", 15, 22], ["fibrotic", "OBSERVATION_MODIFIER", 23, 31], ["lesions", "OBSERVATION", 32, 39], ["Capillaria hepatica", "ANATOMY", 85, 104], ["liver", "ANATOMY", 163, 168]]], ["It is a slender worm, morphologically resembling the whipworms, and it lives in the parenchyma rather than in the bile ducts.", [["worm", "ANATOMY", 16, 20], ["whipworms", "ANATOMY", 53, 62], ["parenchyma", "ANATOMY", 84, 94], ["bile ducts", "ANATOMY", 114, 124], ["whipworms", "CANCER", 53, 62], ["parenchyma", "TISSUE", 84, 94], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 114, 124], ["a slender worm", "PROBLEM", 6, 20], ["slender worm", "OBSERVATION_MODIFIER", 8, 20], ["parenchyma", "ANATOMY_MODIFIER", 84, 94], ["bile ducts", "ANATOMY", 114, 124]]], ["The usual hosts of the adult stage are rodents, but sporadic infestations are observed in dogs.", [["dogs", "ORGANISM", 90, 94], ["dogs", "SPECIES", 90, 94], ["sporadic infestations", "PROBLEM", 52, 73]]], ["These worms are not highly pathogenic.", [["worms", "SPECIES", 6, 11], ["worms", "OBSERVATION", 6, 11], ["not", "UNCERTAINTY", 16, 19], ["highly", "OBSERVATION_MODIFIER", 20, 26], ["pathogenic", "OBSERVATION", 27, 37]]], ["The adults provoke some traumatic hepatitis, and the eggs, which are deposited in clusters, provoke the development of localized granulomas.", [["eggs", "ANATOMY", 53, 57], ["granulomas", "ANATOMY", 129, 139], ["traumatic hepatitis", "DISEASE", 24, 43], ["granulomas", "DISEASE", 129, 139], ["adults", "ORGANISM", 4, 10], ["granulomas", "PATHOLOGICAL_FORMATION", 129, 139], ["some traumatic hepatitis", "PROBLEM", 19, 43], ["the eggs", "PROBLEM", 49, 57], ["localized granulomas", "PROBLEM", 119, 139], ["traumatic", "OBSERVATION_MODIFIER", 24, 33], ["hepatitis", "OBSERVATION", 34, 43], ["eggs", "ANATOMY", 53, 57], ["clusters", "OBSERVATION_MODIFIER", 82, 90], ["localized", "OBSERVATION_MODIFIER", 119, 128], ["granulomas", "OBSERVATION", 129, 139]]], ["The eggs are readily recognized by their ovoid shape and polar caps.", [["eggs", "ANATOMY", 4, 8], ["eggs", "ORGANISM_SUBSTANCE", 4, 8], ["ovoid", "OBSERVATION_MODIFIER", 41, 46], ["shape", "OBSERVATION_MODIFIER", 47, 52], ["polar caps", "OBSERVATION", 57, 67]]], ["The granulomas can be seen through the capsule or in the substance of the liver as yellow streaks or patches.", [["granulomas", "ANATOMY", 4, 14], ["capsule", "ANATOMY", 39, 46], ["liver", "ANATOMY", 74, 79], ["granulomas", "DISEASE", 4, 14], ["granulomas", "PATHOLOGICAL_FORMATION", 4, 14], ["capsule", "CANCER", 39, 46], ["liver", "ORGAN", 74, 79], ["The granulomas", "PROBLEM", 0, 14], ["yellow streaks", "PROBLEM", 83, 97], ["granulomas", "OBSERVATION", 4, 14], ["capsule", "OBSERVATION_MODIFIER", 39, 46], ["substance", "OBSERVATION", 57, 66], ["liver", "ANATOMY", 74, 79], ["yellow streaks", "OBSERVATION", 83, 97], ["patches", "OBSERVATION_MODIFIER", 101, 108]]], ["The eggs cannot escape from the liver unless a predator eats them.", [["eggs", "ANATOMY", 4, 8], ["liver", "ANATOMY", 32, 37], ["eggs", "ORGANISM_SUBSTANCE", 4, 8], ["liver", "ORGAN", 32, 37], ["liver", "ANATOMY", 32, 37]]], ["Predators, however, act only as transport hosts, and the ingested eggs are passed in the feces.", [["eggs", "ANATOMY", 66, 70], ["feces", "ANATOMY", 89, 94], ["eggs", "DEVELOPING_ANATOMICAL_STRUCTURE", 66, 70], ["feces", "ORGANISM_SUBDIVISION", 89, 94], ["feces", "ANATOMY", 89, 94]]], ["Larvae develop in the eggs only in the external environment, and the cycle is completed when a suitable host eats the mature larvae in the eggs.TrematodesVarious trematodes (flukes) are parasitic in the livers of animals.", [["eggs", "ANATOMY", 22, 26], ["eggs", "ANATOMY", 139, 143], ["flukes", "ANATOMY", 174, 180], ["livers", "ANATOMY", 203, 209], ["eggs", "DEVELOPING_ANATOMICAL_STRUCTURE", 22, 26], ["larvae", "DEVELOPING_ANATOMICAL_STRUCTURE", 125, 131], ["eggs", "DEVELOPING_ANATOMICAL_STRUCTURE", 139, 143], ["TrematodesVarious trematodes", "ORGANISM", 144, 172], ["flukes", "ORGAN", 174, 180], ["livers", "ORGAN", 203, 209], ["Larvae", "TREATMENT", 0, 6], ["TrematodesVarious trematodes (flukes", "PROBLEM", 144, 180], ["eggs", "ANATOMY", 139, 143], ["trematodes", "OBSERVATION", 162, 172], ["flukes", "OBSERVATION_MODIFIER", 174, 180], ["parasitic", "OBSERVATION_MODIFIER", 186, 195], ["livers", "ANATOMY", 203, 209]]], ["They belong to the families Fasciolidae (Fasciola hepatica, F. gigantica, Fascioloides magna), Dicrocoeliidae (Dicrocoelium dendriticum, D. hospes, Platynosomum concinnum), Schistosomatidae (Heterobilharzia americana), and Opisthorchiidae (including Metorchis spp., Opisthorchis felineus, Clonorchis sinensis, Pseudamphistomum truncatum).", [["Fasciola hepatica", "DISEASE", 41, 58], ["Opisthorchis felineus", "DISEASE", 266, 287], ["Fasciolidae", "GENE_OR_GENE_PRODUCT", 28, 39], ["Fasciola hepatica", "ORGANISM", 41, 58], ["F. gigantica", "ORGANISM", 60, 72], ["Fascioloides magna", "ORGANISM", 74, 92], ["Dicrocoeliidae", "GENE_OR_GENE_PRODUCT", 95, 109], ["Dicrocoelium dendriticum", "ORGANISM", 111, 135], ["D. hospes", "ORGANISM", 137, 146], ["Platynosomum concinnum", "ORGANISM", 148, 170], ["Schistosomatidae", "ORGANISM", 173, 189], ["Heterobilharzia americana", "ORGANISM", 191, 216], ["Opisthorchiidae", "GENE_OR_GENE_PRODUCT", 223, 238], ["Metorchis spp.", "ORGANISM", 250, 264], ["Opisthorchis felineus", "ORGANISM", 266, 287], ["Clonorchis sinensis", "ORGANISM", 289, 308], ["Pseudamphistomum truncatum", "ORGANISM", 310, 336], ["Fasciola hepatica", "SPECIES", 41, 58], ["F. gigantica", "SPECIES", 60, 72], ["Fascioloides magna", "SPECIES", 74, 92], ["Dicrocoeliidae", "SPECIES", 95, 109], ["Dicrocoelium dendriticum", "SPECIES", 111, 135], ["D. hospes", "SPECIES", 137, 146], ["Platynosomum concinnum", "SPECIES", 148, 170], ["Schistosomatidae", "SPECIES", 173, 189], ["Heterobilharzia americana", "SPECIES", 191, 216], ["Opisthorchiidae", "SPECIES", 223, 238], ["Metorchis spp.", "SPECIES", 250, 264], ["Opisthorchis felineus", "SPECIES", 266, 287], ["Clonorchis sinensis", "SPECIES", 289, 308], ["Pseudamphistomum truncatum", "SPECIES", 310, 336], ["Fasciola hepatica", "SPECIES", 41, 58], ["F. gigantica", "SPECIES", 60, 72], ["Fascioloides magna", "SPECIES", 74, 92], ["Dicrocoelium dendriticum", "SPECIES", 111, 135], ["D. hospes", "SPECIES", 137, 146], ["Platynosomum concinnum", "SPECIES", 148, 170], ["Heterobilharzia americana", "SPECIES", 191, 216], ["Metorchis spp.", "SPECIES", 250, 264], ["Opisthorchis felineus", "SPECIES", 266, 287], ["Clonorchis sinensis", "SPECIES", 289, 308], ["Pseudamphistomum truncatum", "SPECIES", 310, 336], ["Dicrocoeliidae", "TREATMENT", 95, 109], ["Schistosomatidae (Heterobilharzia americana", "PROBLEM", 173, 216], ["Opisthorchiidae", "PROBLEM", 223, 238], ["Metorchis spp.", "TREATMENT", 250, 264], ["Opisthorchis felineus", "PROBLEM", 266, 287], ["Clonorchis sinensis", "PROBLEM", 289, 308], ["hepatica", "ANATOMY", 50, 58]]], ["The diseases produced are known collectively as distomiasis.TrematodesFasciola hepatica, the common liver fluke of sheep and cattle, is the most widespread and important of the group.", [["liver fluke", "ANATOMY", 100, 111], ["distomiasis", "DISEASE", 48, 59], ["Fasciola hepatica", "DISEASE", 70, 87], ["liver fluke", "DISEASE", 100, 111], ["Trematodes", "ORGANISM", 60, 70], ["Fasciola hepatica", "ORGANISM", 70, 87], ["liver", "ORGAN", 100, 105], ["fluke", "ORGANISM", 106, 111], ["sheep", "ORGANISM", 115, 120], ["Fasciola hepatica", "SPECIES", 70, 87], ["sheep", "SPECIES", 115, 120], ["cattle", "SPECIES", 125, 131], ["Fasciola hepatica", "SPECIES", 70, 87], ["sheep", "SPECIES", 115, 120], ["cattle", "SPECIES", 125, 131], ["The diseases", "PROBLEM", 0, 12], ["distomiasis", "PROBLEM", 48, 59], ["TrematodesFasciola hepatica", "PROBLEM", 60, 87], ["diseases", "OBSERVATION", 4, 12], ["Fasciola hepatica", "OBSERVATION", 70, 87], ["common", "ANATOMY_MODIFIER", 93, 99], ["liver", "ANATOMY", 100, 105], ["fluke", "OBSERVATION", 106, 111], ["sheep", "OBSERVATION_MODIFIER", 115, 120], ["cattle", "OBSERVATION_MODIFIER", 125, 131], ["most widespread", "OBSERVATION_MODIFIER", 140, 155]]], ["Patent infestations can develop in other wild and domestic animals and in humans.", [["humans", "ORGANISM", 74, 80], ["humans", "SPECIES", 74, 80], ["humans", "SPECIES", 74, 80], ["Patent infestations", "PROBLEM", 0, 19], ["infestations", "OBSERVATION", 7, 19]]], ["These flukes are leaf shaped and ~2.5 cm long in sheep and slightly larger in cattle.", [["flukes", "ANATOMY", 6, 12], ["leaf", "ANATOMY", 17, 21], ["leaf", "ORGAN", 17, 21], ["sheep", "ORGANISM", 49, 54], ["cattle", "ORGANISM", 78, 84], ["sheep", "SPECIES", 49, 54], ["cattle", "SPECIES", 78, 84], ["sheep", "SPECIES", 49, 54], ["cattle", "SPECIES", 78, 84], ["flukes", "OBSERVATION", 6, 12], ["leaf", "OBSERVATION_MODIFIER", 17, 21], ["shaped", "OBSERVATION_MODIFIER", 22, 28], ["~", "OBSERVATION_MODIFIER", 33, 34], ["2.5 cm", "OBSERVATION_MODIFIER", 34, 40], ["long", "OBSERVATION_MODIFIER", 41, 45], ["slightly", "OBSERVATION_MODIFIER", 59, 67], ["larger", "OBSERVATION_MODIFIER", 68, 74]]], ["They are found in the bile ducts.", [["bile ducts", "ANATOMY", 22, 32], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 22, 32], ["bile ducts", "ANATOMY", 22, 32]]], ["Being hermaphroditic, only one fluke is necessary to establish a patent infestation, and each adult may produce 20,000 eggs per day.", [["fluke", "ORGANISM", 31, 36], ["a patent infestation", "PROBLEM", 63, 83], ["hermaphroditic", "OBSERVATION", 6, 20], ["patent", "OBSERVATION_MODIFIER", 65, 71], ["infestation", "OBSERVATION", 72, 83]]], ["The longevity of the adult flukes is amazing and is potentially as great as or greater than that of the host; they have been known to survive for 11 years, and it seems that they can produce eggs all this time.", [["adult flukes", "ANATOMY", 21, 33], ["adult flukes", "ORGAN", 21, 33], ["longevity", "OBSERVATION_MODIFIER", 4, 13], ["adult", "OBSERVATION_MODIFIER", 21, 26], ["flukes", "OBSERVATION", 27, 33], ["amazing", "OBSERVATION_MODIFIER", 37, 44]]], ["The eggs are eliminated in bile, and on pasture, in conditions of suitable warmth and moisture, hatch a larva (miracidium) in ~9 days.", [["eggs", "ANATOMY", 4, 8], ["bile", "ANATOMY", 27, 31], ["bile", "MULTI-TISSUE_STRUCTURE", 27, 31], ["moisture", "TREATMENT", 86, 94], ["hatch a larva (miracidium)", "TREATMENT", 96, 122], ["bile", "ANATOMY", 27, 31]]], ["If the environmental temperature is low, the incubation period may be delayed for some months.", [["the environmental temperature", "TEST", 3, 32]]], ["The miracidium can survive only in moisture.", [["miracidium", "CHEMICAL", 4, 14], ["miracidium", "SIMPLE_CHEMICAL", 4, 14]]], ["It is actively motile and penetrates the tissues of the intermediate host, which is an aquatic snail.", [["tissues", "ANATOMY", 41, 48], ["tissues", "TISSUE", 41, 48], ["motile", "OBSERVATION_MODIFIER", 15, 21], ["intermediate host", "OBSERVATION_MODIFIER", 56, 73], ["aquatic", "OBSERVATION_MODIFIER", 87, 94], ["snail", "OBSERVATION", 95, 100]]], ["Different snails serve this purpose in different countries, but all of them belong to the genus Lymnaea.TrematodesEach miracidium, on penetrating a snail, develops into a mother sporocyst that reproduces, probably parthenogenetically, giving rise to a small number of the second generation, the redia.", [["sporocyst", "ANATOMY", 178, 187], ["miracidium", "CHEMICAL", 119, 129], ["Lymnaea", "ORGANISM", 96, 103], ["penetrating a snail", "TREATMENT", 134, 153], ["a mother sporocyst", "PROBLEM", 169, 187], ["genus Lymnaea", "ANATOMY", 90, 103], ["small", "OBSERVATION_MODIFIER", 252, 257]]], ["Cercariae, the larval stage of the third (sexual) generation, first appear 1-2 months after the miracidium penetrates.", [["miracidium", "CHEMICAL", 96, 106], ["miracidium", "CHEMICAL", 96, 106], ["miracidium", "SIMPLE_CHEMICAL", 96, 106], ["the miracidium penetrates", "TREATMENT", 92, 117]]], ["Cercariae continue to escape daily for the life of the snail, but even so, total cercarial production is only 500-1,000.", [["total cercarial production", "TEST", 75, 101]]], ["They actively escape from the snail and are attracted to green plants, where they encyst and become infective metacercariae in 1 day.", [["infective metacercariae", "PROBLEM", 100, 123], ["escape", "OBSERVATION_MODIFIER", 14, 20], ["infective", "OBSERVATION", 100, 109]]], ["These can remain infective for 1 month in summer and up to 3 months in winter.", [["infective", "OBSERVATION", 17, 26]]], ["The developmental events from egg to this stage take 1-2 months under favorable conditions.", [["egg", "ANATOMY", 30, 33], ["egg", "DEVELOPING_ANATOMICAL_STRUCTURE", 30, 33], ["The developmental events", "PROBLEM", 0, 24]]], ["Infestation occurs by ingestion.", [["Infestation", "DISEASE", 0, 11], ["Infestation", "PROBLEM", 0, 11]]], ["Excystment occurs in the duodenum.", [["duodenum", "ANATOMY", 25, 33], ["duodenum", "ORGAN", 25, 33], ["duodenum", "ANATOMY", 25, 33]]], ["The young flukes penetrate the intestinal wall and stage is an alveolar hydatid cyst, composed of numerous small vesicles lined by a PAS-positive acellular laminated membrane or cuticle layer and a layer of germinal epithelium from which protoscolices develop.", [["flukes", "ANATOMY", 10, 16], ["intestinal wall", "ANATOMY", 31, 46], ["alveolar hydatid cyst", "ANATOMY", 63, 84], ["vesicles", "ANATOMY", 113, 121], ["membrane", "ANATOMY", 166, 174], ["cuticle layer", "ANATOMY", 178, 191], ["germinal epithelium", "ANATOMY", 207, 226], ["protoscolices", "ANATOMY", 238, 251], ["hydatid cyst", "DISEASE", 72, 84], ["flukes", "ORGAN", 10, 16], ["intestinal wall", "MULTI-TISSUE_STRUCTURE", 31, 46], ["alveolar hydatid cyst", "PATHOLOGICAL_FORMATION", 63, 84], ["small vesicles", "CELLULAR_COMPONENT", 107, 121], ["PAS", "SIMPLE_CHEMICAL", 133, 136], ["laminated membrane", "CELLULAR_COMPONENT", 156, 174], ["cuticle layer", "CELLULAR_COMPONENT", 178, 191], ["germinal epithelium", "TISSUE", 207, 226], ["protoscolices", "CANCER", 238, 251], ["PAS", "PROTEIN", 133, 136], ["an alveolar hydatid cyst", "PROBLEM", 60, 84], ["numerous small vesicles", "PROBLEM", 98, 121], ["a PAS-positive acellular laminated membrane", "PROBLEM", 131, 174], ["cuticle layer", "PROBLEM", 178, 191], ["germinal epithelium", "PROBLEM", 207, 226], ["young", "OBSERVATION_MODIFIER", 4, 9], ["flukes", "OBSERVATION", 10, 16], ["intestinal wall", "ANATOMY", 31, 46], ["stage", "OBSERVATION_MODIFIER", 51, 56], ["alveolar", "ANATOMY_MODIFIER", 63, 71], ["hydatid", "OBSERVATION_MODIFIER", 72, 79], ["cyst", "OBSERVATION", 80, 84], ["numerous", "OBSERVATION_MODIFIER", 98, 106], ["small", "OBSERVATION_MODIFIER", 107, 112], ["vesicles lined", "OBSERVATION", 113, 127], ["PAS", "OBSERVATION_MODIFIER", 133, 136], ["positive", "OBSERVATION_MODIFIER", 137, 145], ["acellular", "ANATOMY_MODIFIER", 146, 155], ["laminated membrane", "OBSERVATION", 156, 174], ["cuticle", "OBSERVATION_MODIFIER", 178, 185], ["layer", "OBSERVATION_MODIFIER", 186, 191], ["layer", "OBSERVATION_MODIFIER", 198, 203], ["germinal epithelium", "OBSERVATION", 207, 226]]], ["Some infections in dogs do not progress to form protoscolices, and instead form irregular large cysts with a PAS-positive laminated membrane (Fig. 2-85) .", [["cysts", "ANATOMY", 96, 101], ["membrane", "ANATOMY", 132, 140], ["infections", "DISEASE", 5, 15], ["dogs", "ORGANISM", 19, 23], ["cysts", "CANCER", 96, 101], ["PAS", "SIMPLE_CHEMICAL", 109, 112], ["membrane", "CELLULAR_COMPONENT", 132, 140], ["PAS", "PROTEIN", 109, 112], ["dogs", "SPECIES", 19, 23], ["Some infections in dogs", "PROBLEM", 0, 23], ["irregular large cysts", "PROBLEM", 80, 101], ["a PAS", "TEST", 107, 112], ["infections", "OBSERVATION", 5, 15], ["irregular", "OBSERVATION_MODIFIER", 80, 89], ["large", "OBSERVATION_MODIFIER", 90, 95], ["cysts", "OBSERVATION", 96, 101], ["positive laminated", "OBSERVATION_MODIFIER", 113, 131], ["membrane", "OBSERVATION_MODIFIER", 132, 140]]], ["Additional exogenous budding results in spread of the metacestodes to other internal locations.", [["Additional exogenous budding", "PROBLEM", 0, 28], ["exogenous budding", "OBSERVATION", 11, 28], ["spread", "OBSERVATION_MODIFIER", 40, 46], ["metacestodes", "OBSERVATION", 54, 66], ["internal", "ANATOMY_MODIFIER", 76, 84]]], ["The life cycle is completed when the infected intermediate host is consumed by a definitive host, where the protoscolices attach to the intestinal wall and mature.", [["protoscolices", "ANATOMY", 108, 121], ["intestinal wall", "ANATOMY", 136, 151], ["intestinal wall", "MULTI-TISSUE_STRUCTURE", 136, 151], ["intestinal wall", "ANATOMY", 136, 151], ["mature", "OBSERVATION", 156, 162]]], ["Other species can occasionally act as aberrant intermediate hosts, including pigs, horses, and humans; human alveolar echinococcosis is a serious zoonosis.", [["alveolar echinococcosis", "ANATOMY", 109, 132], ["alveolar echinococcosis", "DISEASE", 109, 132], ["zoonosis", "DISEASE", 146, 154], ["pigs", "ORGANISM", 77, 81], ["humans", "ORGANISM", 95, 101], ["human", "ORGANISM", 103, 108], ["alveolar echinococcosis", "MULTI-TISSUE_STRUCTURE", 109, 132], ["pigs", "SPECIES", 77, 81], ["humans", "SPECIES", 95, 101], ["human", "SPECIES", 103, 108], ["pigs", "SPECIES", 77, 81], ["humans", "SPECIES", 95, 101], ["human", "SPECIES", 103, 108], ["human alveolar echinococcosis", "PROBLEM", 103, 132], ["a serious zoonosis", "PROBLEM", 136, 154], ["intermediate hosts", "OBSERVATION", 47, 65], ["alveolar", "ANATOMY", 109, 117], ["echinococcosis", "OBSERVATION", 118, 132]]], ["Dogs can simultaneously act as definitive and intermediate hosts for this parasite.", [["Dogs", "ORGANISM", 0, 4], ["this parasite", "PROBLEM", 69, 82]]], ["Cases of hepatic alveolar hydatid cysts have been reported in dogs from highly endemic areas in Belgium, Germany, Switzerland, and most recently in Canada (British Columbia, Ontario).", [["hepatic alveolar hydatid cysts", "ANATOMY", 9, 39], ["hepatic alveolar hydatid cysts", "DISEASE", 9, 39], ["hepatic alveolar hydatid cysts", "PATHOLOGICAL_FORMATION", 9, 39], ["dogs", "ORGANISM", 62, 66], ["dogs", "SPECIES", 62, 66], ["hepatic alveolar hydatid cysts", "PROBLEM", 9, 39], ["hepatic", "ANATOMY", 9, 16], ["alveolar", "ANATOMY_MODIFIER", 17, 25], ["hydatid", "OBSERVATION", 26, 33], ["highly", "OBSERVATION_MODIFIER", 72, 78], ["endemic", "OBSERVATION_MODIFIER", 79, 86]]], ["Affected dogs display progressive abdominal enlargement, intermittent inappetance, and vomiting, and the cysts may be found in the liver, omentum, abdominal cavity, or lungs. moderate irregular fibrosis.", [["abdominal", "ANATOMY", 34, 43], ["cysts", "ANATOMY", 105, 110], ["liver", "ANATOMY", 131, 136], ["omentum", "ANATOMY", 138, 145], ["abdominal cavity", "ANATOMY", 147, 163], ["lungs", "ANATOMY", 168, 173], ["abdominal enlargement", "DISEASE", 34, 55], ["inappetance", "DISEASE", 70, 81], ["vomiting", "DISEASE", 87, 95], ["cysts", "DISEASE", 105, 110], ["fibrosis", "DISEASE", 194, 202], ["dogs", "ORGANISM", 9, 13], ["abdominal", "ORGANISM_SUBDIVISION", 34, 43], ["cysts", "PATHOLOGICAL_FORMATION", 105, 110], ["liver", "ORGAN", 131, 136], ["omentum", "ORGAN", 138, 145], ["abdominal cavity", "MULTI-TISSUE_STRUCTURE", 147, 163], ["lungs", "ORGAN", 168, 173], ["dogs", "SPECIES", 9, 13], ["Affected dogs", "PROBLEM", 0, 13], ["progressive abdominal enlargement", "PROBLEM", 22, 55], ["intermittent inappetance", "PROBLEM", 57, 81], ["vomiting", "PROBLEM", 87, 95], ["the cysts", "PROBLEM", 101, 110], ["moderate irregular fibrosis", "PROBLEM", 175, 202], ["progressive", "OBSERVATION_MODIFIER", 22, 33], ["abdominal", "ANATOMY", 34, 43], ["enlargement", "OBSERVATION", 44, 55], ["intermittent", "OBSERVATION_MODIFIER", 57, 69], ["inappetance", "OBSERVATION", 70, 81], ["cysts", "OBSERVATION", 105, 110], ["liver", "ANATOMY", 131, 136], ["omentum", "ANATOMY", 138, 145], ["abdominal cavity", "ANATOMY", 147, 163], ["lungs", "ANATOMY", 168, 173], ["irregular", "OBSERVATION_MODIFIER", 184, 193], ["fibrosis", "OBSERVATION", 194, 202]]], ["There may, as yet, be no change in the bile ducts.", [["bile ducts", "ANATOMY", 39, 49], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 39, 49], ["change in the bile ducts", "PROBLEM", 25, 49], ["bile ducts", "ANATOMY", 39, 49]]], ["Probably, most of the young flukes reach the bile ducts, but some do not and become encysted in the parenchyma.", [["flukes", "ANATOMY", 28, 34], ["bile ducts", "ANATOMY", 45, 55], ["parenchyma", "ANATOMY", 100, 110], ["flukes", "ORGANISM", 28, 34], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 45, 55], ["parenchyma", "TISSUE", 100, 110], ["young", "OBSERVATION_MODIFIER", 22, 27], ["flukes", "OBSERVATION", 28, 34], ["bile ducts", "ANATOMY", 45, 55], ["encysted", "OBSERVATION", 84, 92], ["parenchyma", "ANATOMY_MODIFIER", 100, 110]]], ["One or more flukes may be present in each cyst, which consists of a connective-tissue capsule and a dirty brown content of blood, detritus, and excrement from flukes.", [["flukes", "ANATOMY", 12, 18], ["cyst", "ANATOMY", 42, 46], ["connective-tissue capsule", "ANATOMY", 68, 93], ["blood", "ANATOMY", 123, 128], ["flukes", "ANATOMY", 159, 165], ["flukes", "ORGANISM", 12, 18], ["cyst", "CANCER", 42, 46], ["connective-tissue capsule", "TISSUE", 68, 93], ["blood", "ORGANISM_SUBSTANCE", 123, 128], ["flukes", "ORGAN", 159, 165], ["each cyst", "PROBLEM", 37, 46], ["a connective-tissue capsule", "PROBLEM", 66, 93], ["a dirty brown content of blood", "PROBLEM", 98, 128], ["more", "OBSERVATION_MODIFIER", 7, 11], ["flukes", "OBSERVATION", 12, 18], ["may be", "UNCERTAINTY", 19, 25], ["each", "OBSERVATION_MODIFIER", 37, 41], ["cyst", "OBSERVATION", 42, 46], ["connective-tissue", "OBSERVATION_MODIFIER", 68, 85], ["capsule", "OBSERVATION_MODIFIER", 86, 93], ["dirty brown content", "OBSERVATION_MODIFIER", 100, 119], ["blood", "ANATOMY", 123, 128], ["detritus", "OBSERVATION_MODIFIER", 130, 138], ["flukes", "OBSERVATION", 159, 165]]], ["The cysts ultimately caseate and may mineralize or are obliterated by fibrous tissue.", [["cysts", "ANATOMY", 4, 9], ["fibrous tissue", "ANATOMY", 70, 84], ["cysts", "CANCER", 4, 9], ["fibrous tissue", "TISSUE", 70, 84], ["The cysts", "PROBLEM", 0, 9], ["fibrous tissue", "PROBLEM", 70, 84], ["cysts", "OBSERVATION", 4, 9], ["obliterated", "OBSERVATION", 55, 66], ["fibrous tissue", "OBSERVATION", 70, 84]]], ["These cysts are most frequent on the visceral surface, where they cause bulging of the capsule.TrematodesHeavy infestations by immature flukes may cause death at the stage of acute hepatitis.", [["cysts", "ANATOMY", 6, 11], ["visceral surface", "ANATOMY", 37, 53], ["capsule", "ANATOMY", 87, 94], ["flukes", "ANATOMY", 136, 142], ["cysts", "DISEASE", 6, 11], ["immature flukes", "DISEASE", 127, 142], ["death", "DISEASE", 153, 158], ["hepatitis", "DISEASE", 181, 190], ["cysts", "CANCER", 6, 11], ["visceral surface", "MULTI-TISSUE_STRUCTURE", 37, 53], ["capsule", "CANCER", 87, 94], ["flukes", "ORGAN", 136, 142], ["These cysts", "PROBLEM", 0, 11], ["bulging of the capsule", "PROBLEM", 72, 94], ["immature flukes", "PROBLEM", 127, 142], ["death", "PROBLEM", 153, 158], ["acute hepatitis", "PROBLEM", 175, 190], ["cysts", "OBSERVATION", 6, 11], ["most", "OBSERVATION_MODIFIER", 16, 20], ["frequent", "OBSERVATION_MODIFIER", 21, 29], ["visceral", "ANATOMY", 37, 45], ["surface", "ANATOMY_MODIFIER", 46, 53], ["bulging", "OBSERVATION", 72, 79], ["capsule", "ANATOMY", 87, 94], ["immature flukes", "OBSERVATION", 127, 142], ["acute", "OBSERVATION_MODIFIER", 175, 180], ["hepatitis", "OBSERVATION", 181, 190]]], ["Such an outcome is not common, but occurs in sheep.", [["sheep", "ORGANISM", 45, 50], ["sheep", "SPECIES", 45, 50], ["sheep", "SPECIES", 45, 50]]], ["It is estimated that 10,000 metacercariae ingested over a short period are necessary to produce acute death in sheep.", [["death", "DISEASE", 102, 107], ["sheep", "ORGANISM", 111, 116], ["sheep", "SPECIES", 111, 116], ["sheep", "SPECIES", 111, 116], ["acute death in sheep", "PROBLEM", 96, 116], ["acute", "OBSERVATION_MODIFIER", 96, 101], ["death", "OBSERVATION", 102, 107]]], ["Death may occur suddenly or after a few days of fever, lassitude, inappetance, and abdominal tenderness.", [["abdominal", "ANATOMY", 83, 92], ["Death", "DISEASE", 0, 5], ["fever", "DISEASE", 48, 53], ["lassitude", "DISEASE", 55, 64], ["inappetance", "DISEASE", 66, 77], ["abdominal tenderness", "DISEASE", 83, 103], ["abdominal", "ORGANISM_SUBDIVISION", 83, 92], ["Death", "PROBLEM", 0, 5], ["fever", "PROBLEM", 48, 53], ["abdominal tenderness", "PROBLEM", 83, 103], ["abdominal", "ANATOMY", 83, 92], ["tenderness", "OBSERVATION", 93, 103]]], ["This is also the stage of the parasitism in which black disease occurs.TrematodesMature flukes are present in the larger bile ducts and cause cholangitis.", [["flukes", "ANATOMY", 88, 94], ["bile ducts", "ANATOMY", 121, 131], ["black disease", "DISEASE", 50, 63], ["cholangitis", "DISEASE", 142, 153], ["flukes", "ORGANISM", 88, 94], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 121, 131], ["the parasitism", "PROBLEM", 26, 40], ["black disease", "PROBLEM", 50, 63], ["TrematodesMature flukes", "PROBLEM", 71, 94], ["cholangitis", "PROBLEM", 142, 153], ["parasitism", "OBSERVATION", 30, 40], ["black", "OBSERVATION_MODIFIER", 50, 55], ["disease", "OBSERVATION", 56, 63], ["flukes", "OBSERVATION", 88, 94], ["larger", "ANATOMY_MODIFIER", 114, 120], ["bile ducts", "ANATOMY", 121, 131], ["cholangitis", "OBSERVATION", 142, 153]]], ["The relative importance of different factors in their pathogenicity is not known, but they cause mechanical irritation by the action of their suckers and scales, cause obstruction of the ducts with some degree of biliary retention, predispose to bacterial infections, suck blood, and probably produce toxic and irritative metabolic excretions.TrematodesThe biliary changes occur in all lobes but are usually most severe in the left, and the right may be moderately hypertrophied.", [["suckers", "ANATOMY", 142, 149], ["ducts", "ANATOMY", 187, 192], ["biliary", "ANATOMY", 213, 220], ["blood", "ANATOMY", 273, 278], ["biliary", "ANATOMY", 357, 364], ["lobes", "ANATOMY", 386, 391], ["left", "ANATOMY", 427, 431], ["obstruction of the ducts", "DISEASE", 168, 192], ["biliary retention", "DISEASE", 213, 230], ["bacterial infections", "DISEASE", 246, 266], ["suckers", "ORGANISM_SUBDIVISION", 142, 149], ["ducts", "MULTI-TISSUE_STRUCTURE", 187, 192], ["biliary", "MULTI-TISSUE_STRUCTURE", 213, 220], ["blood", "ORGANISM_SUBSTANCE", 273, 278], ["biliary", "MULTI-TISSUE_STRUCTURE", 357, 364], ["lobes", "ORGAN", 386, 391], ["mechanical irritation", "PROBLEM", 97, 118], ["obstruction of the ducts", "PROBLEM", 168, 192], ["biliary retention", "PROBLEM", 213, 230], ["bacterial infections", "PROBLEM", 246, 266], ["suck blood", "PROBLEM", 268, 278], ["toxic and irritative metabolic excretions", "PROBLEM", 301, 342], ["The biliary changes", "PROBLEM", 353, 372], ["moderately hypertrophied", "PROBLEM", 454, 478], ["irritation", "OBSERVATION", 108, 118], ["obstruction", "OBSERVATION", 168, 179], ["ducts", "ANATOMY", 187, 192], ["biliary", "ANATOMY", 213, 220], ["retention", "OBSERVATION", 221, 230], ["bacterial", "OBSERVATION_MODIFIER", 246, 255], ["infections", "OBSERVATION", 256, 266], ["toxic", "OBSERVATION_MODIFIER", 301, 306], ["irritative", "OBSERVATION_MODIFIER", 311, 321], ["metabolic excretions", "OBSERVATION", 322, 342], ["biliary", "ANATOMY", 357, 364], ["all lobes", "ANATOMY", 382, 391], ["most severe", "OBSERVATION_MODIFIER", 408, 419], ["left", "ANATOMY_MODIFIER", 427, 431], ["right", "ANATOMY_MODIFIER", 441, 446], ["may be", "UNCERTAINTY", 447, 453], ["moderately", "OBSERVATION_MODIFIER", 454, 464], ["hypertrophied", "OBSERVATION", 465, 478]]], ["From the hilus, the bile ducts on the visceral surface stand out as white, firm, branching cords that in extreme instances may be 2 cm in diameter and allow detectable fluctuation over extended segments or in localized areas of ectasia.", [["hilus", "ANATOMY", 9, 14], ["bile ducts", "ANATOMY", 20, 30], ["visceral surface", "ANATOMY", 38, 54], ["cords", "ANATOMY", 91, 96], ["ectasia", "DISEASE", 228, 235], ["hilus", "MULTI-TISSUE_STRUCTURE", 9, 14], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 20, 30], ["visceral surface", "MULTI-TISSUE_STRUCTURE", 38, 54], ["ectasia", "PATHOLOGICAL_FORMATION", 228, 235], ["white, firm, branching cords", "PROBLEM", 68, 96], ["detectable fluctuation over extended segments", "PROBLEM", 157, 202], ["ectasia", "PROBLEM", 228, 235], ["hilus", "ANATOMY", 9, 14], ["bile ducts", "ANATOMY", 20, 30], ["visceral", "ANATOMY", 38, 46], ["surface", "ANATOMY_MODIFIER", 47, 54], ["white", "OBSERVATION_MODIFIER", 68, 73], ["firm", "OBSERVATION_MODIFIER", 75, 79], ["branching cords", "OBSERVATION", 81, 96], ["extreme", "OBSERVATION_MODIFIER", 105, 112], ["2 cm", "OBSERVATION_MODIFIER", 130, 134], ["diameter", "OBSERVATION_MODIFIER", 138, 146], ["detectable", "OBSERVATION_MODIFIER", 157, 167], ["fluctuation", "OBSERVATION_MODIFIER", 168, 179], ["segments", "OBSERVATION_MODIFIER", 194, 202], ["localized", "OBSERVATION_MODIFIER", 209, 218], ["areas", "OBSERVATION_MODIFIER", 219, 224], ["ectasia", "OBSERVATION", 228, 235]]], ["This dilation of the ducts in sheep, swine, and horses is largely mechanical and is caused by distension by masses of flukes and bile.", [["ducts", "ANATOMY", 21, 26], ["flukes", "ANATOMY", 118, 124], ["bile", "ANATOMY", 129, 133], ["ducts", "MULTI-TISSUE_STRUCTURE", 21, 26], ["sheep", "ORGANISM", 30, 35], ["flukes", "TISSUE", 118, 124], ["bile", "MULTI-TISSUE_STRUCTURE", 129, 133], ["sheep", "SPECIES", 30, 35], ["swine", "SPECIES", 37, 42], ["sheep", "SPECIES", 30, 35], ["swine", "SPECIES", 37, 42], ["This dilation of the ducts in sheep", "PROBLEM", 0, 35], ["distension", "PROBLEM", 94, 104], ["masses of flukes", "PROBLEM", 108, 124], ["dilation", "OBSERVATION", 5, 13], ["ducts", "ANATOMY", 21, 26], ["sheep", "OBSERVATION_MODIFIER", 30, 35], ["swine", "OBSERVATION_MODIFIER", 37, 42], ["largely", "OBSERVATION_MODIFIER", 58, 65], ["mechanical", "OBSERVATION", 66, 76], ["distension", "OBSERVATION", 94, 104], ["masses", "OBSERVATION", 108, 114], ["flukes", "OBSERVATION", 118, 124], ["bile", "ANATOMY", 129, 133]]], ["It is permitted by the relative paucity of new connectivetissue formation in the walls of the ducts in these species; this in turn is probably related to the rather mild catarrhal type of inflammation in the lumina of the ducts.", [["connectivetissue", "ANATOMY", 47, 63], ["ducts", "ANATOMY", 94, 99], ["lumina", "ANATOMY", 208, 214], ["ducts", "ANATOMY", 222, 227], ["inflammation", "DISEASE", 188, 200], ["connectivetissue", "CANCER", 47, 63], ["ducts", "MULTI-TISSUE_STRUCTURE", 94, 99], ["lumina", "IMMATERIAL_ANATOMICAL_ENTITY", 208, 214], ["ducts", "MULTI-TISSUE_STRUCTURE", 222, 227], ["new connectivetissue formation", "PROBLEM", 43, 73], ["the rather mild catarrhal type of inflammation in the lumina of the ducts", "PROBLEM", 154, 227], ["paucity", "OBSERVATION_MODIFIER", 32, 39], ["new", "OBSERVATION_MODIFIER", 43, 46], ["connectivetissue formation", "OBSERVATION", 47, 73], ["walls", "ANATOMY_MODIFIER", 81, 86], ["ducts", "ANATOMY", 94, 99], ["species", "OBSERVATION_MODIFIER", 109, 116], ["probably related to", "UNCERTAINTY", 134, 153], ["mild", "OBSERVATION_MODIFIER", 165, 169], ["catarrhal", "OBSERVATION", 170, 179], ["inflammation", "OBSERVATION", 188, 200], ["lumina", "ANATOMY_MODIFIER", 208, 214], ["ducts", "ANATOMY", 222, 227]]], ["In cattle, desquamative and ulcerative lesions in the large bile ducts are more severe than in other species, and there is a correspondingly greater proliferation of granulation tissue in and about the walls of the ducts (Fig. 2-86) .", [["ulcerative lesions", "ANATOMY", 28, 46], ["bile ducts", "ANATOMY", 60, 70], ["granulation tissue", "ANATOMY", 166, 184], ["ducts", "ANATOMY", 215, 220], ["ulcerative lesions", "PATHOLOGICAL_FORMATION", 28, 46], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 60, 70], ["granulation tissue", "TISSUE", 166, 184], ["ducts", "MULTI-TISSUE_STRUCTURE", 215, 220], ["cattle", "SPECIES", 3, 9], ["cattle", "SPECIES", 3, 9], ["desquamative and ulcerative lesions in the large bile ducts", "PROBLEM", 11, 70], ["a correspondingly greater proliferation of granulation tissue", "PROBLEM", 123, 184], ["desquamative", "OBSERVATION_MODIFIER", 11, 23], ["ulcerative", "OBSERVATION_MODIFIER", 28, 38], ["lesions", "OBSERVATION", 39, 46], ["large", "ANATOMY_MODIFIER", 54, 59], ["bile ducts", "ANATOMY", 60, 70], ["more", "OBSERVATION_MODIFIER", 75, 79], ["severe", "OBSERVATION_MODIFIER", 80, 86], ["species", "OBSERVATION", 101, 108], ["correspondingly", "OBSERVATION_MODIFIER", 125, 140], ["greater", "OBSERVATION_MODIFIER", 141, 148], ["proliferation", "OBSERVATION_MODIFIER", 149, 162], ["granulation tissue", "OBSERVATION", 166, 184], ["walls", "ANATOMY_MODIFIER", 202, 207], ["ducts", "ANATOMY", 215, 220]]], ["The walls of the ducts in cattle are, in consequence, much thickened, and the lumen is irregularly stenotic and dilated and lined largely by granulation tissue.", [["ducts", "ANATOMY", 17, 22], ["lumen", "ANATOMY", 78, 83], ["granulation tissue", "ANATOMY", 141, 159], ["ducts", "MULTI-TISSUE_STRUCTURE", 17, 22], ["cattle", "ORGANISM", 26, 32], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 78, 83], ["granulation tissue", "TISSUE", 141, 159], ["cattle", "SPECIES", 26, 32], ["cattle", "SPECIES", 26, 32], ["much thickened", "PROBLEM", 54, 68], ["irregularly stenotic", "PROBLEM", 87, 107], ["dilated", "PROBLEM", 112, 119], ["granulation tissue", "PROBLEM", 141, 159], ["walls", "ANATOMY_MODIFIER", 4, 9], ["ducts", "ANATOMY", 17, 22], ["cattle", "OBSERVATION_MODIFIER", 26, 32], ["much", "OBSERVATION_MODIFIER", 54, 58], ["thickened", "OBSERVATION", 59, 68], ["lumen", "ANATOMY_MODIFIER", 78, 83], ["irregularly", "OBSERVATION_MODIFIER", 87, 98], ["stenotic", "OBSERVATION", 99, 107], ["dilated", "OBSERVATION", 112, 119], ["lined", "OBSERVATION_MODIFIER", 124, 129], ["largely", "OBSERVATION_MODIFIER", 130, 137], ["granulation tissue", "OBSERVATION", 141, 159]]], ["This contributes the typical \"pipe stem\" appearance to the ducts in cattle; the connective tissue may be, in addition, cross the peritoneal cavity, attaching here and there to suck blood and penetrate the liver through its capsule; a few no doubt pass in the portal vessels or migrate up the bile duct.", [["ducts", "ANATOMY", 59, 64], ["connective tissue", "ANATOMY", 80, 97], ["peritoneal cavity", "ANATOMY", 129, 146], ["blood", "ANATOMY", 181, 186], ["liver", "ANATOMY", 205, 210], ["capsule", "ANATOMY", 223, 230], ["portal vessels", "ANATOMY", 259, 273], ["bile duct", "ANATOMY", 292, 301], ["ducts", "MULTI-TISSUE_STRUCTURE", 59, 64], ["connective tissue", "TISSUE", 80, 97], ["peritoneal cavity", "MULTI-TISSUE_STRUCTURE", 129, 146], ["blood", "ORGANISM_SUBSTANCE", 181, 186], ["liver", "ORGAN", 205, 210], ["capsule", "CANCER", 223, 230], ["portal vessels", "MULTI-TISSUE_STRUCTURE", 259, 273], ["bile duct", "MULTI-TISSUE_STRUCTURE", 292, 301], ["cattle", "SPECIES", 68, 74], ["cattle", "SPECIES", 68, 74], ["suck blood", "TEST", 176, 186], ["typical", "OBSERVATION_MODIFIER", 21, 28], ["\"", "OBSERVATION_MODIFIER", 29, 30], ["pipe stem\"", "OBSERVATION", 30, 40], ["ducts", "ANATOMY", 59, 64], ["connective tissue", "ANATOMY", 80, 97], ["may be", "UNCERTAINTY", 98, 104], ["peritoneal cavity", "ANATOMY", 129, 146], ["liver", "ANATOMY", 205, 210], ["no doubt", "UNCERTAINTY", 238, 246], ["pass", "OBSERVATION", 247, 251], ["portal vessels", "ANATOMY", 259, 273], ["bile duct", "ANATOMY", 292, 301]]], ["They wander in the liver for a month or more before settling down in the bile ducts to mature, which they do in 2-3 months.", [["liver", "ANATOMY", 19, 24], ["bile ducts", "ANATOMY", 73, 83], ["liver", "ORGAN", 19, 24], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 73, 83], ["liver", "ANATOMY", 19, 24], ["bile ducts", "ANATOMY", 73, 83]]], ["Some may, by accident, enter the hepatic veins and systemic circulation to lodge in unusual sites; intrauterine infestations are on record.", [["hepatic veins", "ANATOMY", 33, 46], ["sites", "ANATOMY", 92, 97], ["intrauterine", "ANATOMY", 99, 111], ["intrauterine infestations", "DISEASE", 99, 124], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 33, 46], ["intrauterine infestations", "PROBLEM", 99, 124], ["hepatic veins", "ANATOMY", 33, 46], ["systemic circulation", "ANATOMY", 51, 71]]], ["Lesions caused by aberrant flukes are quite common in bovine lung.", [["flukes", "ANATOMY", 27, 33], ["lung", "ANATOMY", 61, 65], ["flukes", "ORGAN", 27, 33], ["bovine", "ORGANISM", 54, 60], ["lung", "ORGAN", 61, 65], ["bovine", "SPECIES", 54, 60], ["bovine", "SPECIES", 54, 60], ["Lesions", "PROBLEM", 0, 7], ["aberrant flukes", "PROBLEM", 18, 33], ["aberrant", "OBSERVATION_MODIFIER", 18, 26], ["flukes", "OBSERVATION", 27, 33], ["bovine", "ANATOMY_MODIFIER", 54, 60], ["lung", "ANATOMY", 61, 65]]], ["They consist of resilient nodules just under the pleura of the peripheral parts of the lung.", [["nodules", "ANATOMY", 26, 33], ["pleura", "ANATOMY", 49, 55], ["peripheral parts", "ANATOMY", 63, 79], ["lung", "ANATOMY", 87, 91], ["nodules", "CANCER", 26, 33], ["pleura", "ORGAN", 49, 55], ["peripheral parts", "MULTI-TISSUE_STRUCTURE", 63, 79], ["lung", "ORGAN", 87, 91], ["resilient nodules", "PROBLEM", 16, 33], ["resilient", "OBSERVATION_MODIFIER", 16, 25], ["nodules", "OBSERVATION", 26, 33], ["pleura", "ANATOMY", 49, 55], ["peripheral", "ANATOMY_MODIFIER", 63, 73], ["parts", "ANATOMY_MODIFIER", 74, 79], ["lung", "ANATOMY", 87, 91]]], ["They range in diameter from ~1 to many centimeters and consist of thinly encapsulated abscesses situated at the ends of bronchi.", [["abscesses", "ANATOMY", 86, 95], ["bronchi", "ANATOMY", 120, 127], ["abscesses", "DISEASE", 86, 95], ["abscesses", "PATHOLOGICAL_FORMATION", 86, 95], ["bronchi", "MULTI-TISSUE_STRUCTURE", 120, 127], ["thinly encapsulated abscesses", "PROBLEM", 66, 95], ["range", "OBSERVATION_MODIFIER", 5, 10], ["diameter", "OBSERVATION_MODIFIER", 14, 22], ["~1 to many centimeters", "OBSERVATION_MODIFIER", 28, 50], ["thinly", "OBSERVATION_MODIFIER", 66, 72], ["encapsulated", "OBSERVATION_MODIFIER", 73, 85], ["abscesses", "OBSERVATION", 86, 95], ["ends", "ANATOMY_MODIFIER", 112, 116], ["bronchi", "ANATOMY", 120, 127]]], ["The content is slightly mucoid, unevenly coagulated brown fluid; in some lesions, the reaction is predominantly caseous.", [["brown fluid", "ANATOMY", 52, 63], ["lesions", "ANATOMY", 73, 80], ["lesions", "PATHOLOGICAL_FORMATION", 73, 80], ["slightly mucoid", "PROBLEM", 15, 30], ["unevenly coagulated brown fluid", "PROBLEM", 32, 63], ["some lesions", "PROBLEM", 68, 80], ["the reaction", "PROBLEM", 82, 94], ["caseous", "PROBLEM", 112, 119], ["slightly", "OBSERVATION_MODIFIER", 15, 23], ["mucoid", "OBSERVATION_MODIFIER", 24, 30], ["unevenly", "OBSERVATION_MODIFIER", 32, 40], ["coagulated", "OBSERVATION_MODIFIER", 41, 51], ["brown", "OBSERVATION_MODIFIER", 52, 57], ["fluid", "OBSERVATION", 58, 63], ["some", "OBSERVATION_MODIFIER", 68, 72], ["lesions", "OBSERVATION", 73, 80], ["predominantly", "OBSERVATION_MODIFIER", 98, 111], ["caseous", "OBSERVATION_MODIFIER", 112, 119]]], ["The location of the lesion suggests that it begins as a peripheral bronchiectasis that later becomes sealed off.", [["lesion", "ANATOMY", 20, 26], ["bronchiectasis", "DISEASE", 67, 81], ["the lesion", "PROBLEM", 16, 26], ["a peripheral bronchiectasis", "PROBLEM", 54, 81], ["lesion", "OBSERVATION", 20, 26], ["peripheral", "OBSERVATION_MODIFIER", 56, 66], ["bronchiectasis", "OBSERVATION", 67, 81], ["sealed", "OBSERVATION_MODIFIER", 101, 107]]], ["The fluke persists in the debris, but is small and hard to find.TrematodesThe essential lesions produced by F. hepatica occur in the liver and may be described, first, as those produced by the migratory larvae, and second, as those produced by the mature flukes in the bile ducts; the two often intermingle (eFig.", [["fluke", "ANATOMY", 4, 9], ["lesions", "ANATOMY", 88, 95], ["liver", "ANATOMY", 133, 138], ["larvae", "ANATOMY", 203, 209], ["flukes", "ANATOMY", 255, 261], ["bile ducts", "ANATOMY", 269, 279], ["F. hepatica", "DISEASE", 108, 119], ["fluke", "ORGAN", 4, 9], ["lesions", "PATHOLOGICAL_FORMATION", 88, 95], ["F. hepatica", "ORGANISM", 108, 119], ["liver", "ORGAN", 133, 138], ["flukes", "ORGAN", 255, 261], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 269, 279], ["F. hepatica", "SPECIES", 108, 119], ["F. hepatica", "SPECIES", 108, 119], ["the debris", "PROBLEM", 22, 32], ["The essential lesions", "PROBLEM", 74, 95], ["the mature flukes in the bile ducts", "PROBLEM", 244, 279], ["fluke", "OBSERVATION", 4, 9], ["debris", "OBSERVATION", 26, 32], ["small", "OBSERVATION_MODIFIER", 41, 46], ["essential", "OBSERVATION_MODIFIER", 78, 87], ["lesions", "OBSERVATION", 88, 95], ["hepatica", "ANATOMY", 111, 119], ["liver", "ANATOMY", 133, 138], ["may be", "UNCERTAINTY", 143, 149], ["mature", "OBSERVATION_MODIFIER", 248, 254], ["flukes", "OBSERVATION", 255, 261], ["bile ducts", "ANATOMY", 269, 279]]], ["There is the further incidence of peritonitis, which is produced by the young flukes on their way to the liver and, perhaps also, by some that break out through the capsule.TrematodesUsually, there is no obvious reaction to the passage of young flukes through the intestinal wall and across the peritoneal cavity, except for small hemorrhagic foci on the peritoneum, where the flukes have been temporarily attached.", [["flukes", "ANATOMY", 78, 84], ["liver", "ANATOMY", 105, 110], ["capsule", "ANATOMY", 165, 172], ["flukes", "ANATOMY", 245, 251], ["intestinal wall", "ANATOMY", 264, 279], ["peritoneal cavity", "ANATOMY", 295, 312], ["foci", "ANATOMY", 343, 347], ["peritoneum", "ANATOMY", 355, 365], ["flukes", "ANATOMY", 377, 383], ["peritonitis", "DISEASE", 34, 45], ["hemorrhagic", "DISEASE", 331, 342], ["flukes", "ORGAN", 78, 84], ["liver", "ORGAN", 105, 110], ["capsule", "CANCER", 165, 172], ["flukes", "ORGAN", 245, 251], ["intestinal wall", "MULTI-TISSUE_STRUCTURE", 264, 279], ["peritoneal cavity", "MULTI-TISSUE_STRUCTURE", 295, 312], ["peritoneum", "MULTI-TISSUE_STRUCTURE", 355, 365], ["flukes", "ORGAN", 377, 383], ["peritonitis", "PROBLEM", 34, 45], ["obvious reaction", "PROBLEM", 204, 220], ["small hemorrhagic foci on the peritoneum", "PROBLEM", 325, 365], ["the flukes", "PROBLEM", 373, 383], ["peritonitis", "OBSERVATION", 34, 45], ["young", "OBSERVATION_MODIFIER", 72, 77], ["flukes", "OBSERVATION", 78, 84], ["liver", "ANATOMY", 105, 110], ["capsule", "ANATOMY", 165, 172], ["no obvious", "UNCERTAINTY", 201, 211], ["reaction", "OBSERVATION", 212, 220], ["passage", "OBSERVATION_MODIFIER", 228, 235], ["intestinal", "ANATOMY", 264, 274], ["wall", "ANATOMY_MODIFIER", 275, 279], ["peritoneal cavity", "ANATOMY", 295, 312], ["except for", "UNCERTAINTY", 314, 324], ["small", "OBSERVATION_MODIFIER", 325, 330], ["hemorrhagic", "OBSERVATION_MODIFIER", 331, 342], ["foci", "OBSERVATION", 343, 347], ["peritoneum", "ANATOMY", 355, 365], ["flukes", "OBSERVATION", 377, 383], ["temporarily", "OBSERVATION_MODIFIER", 394, 405], ["attached", "OBSERVATION_MODIFIER", 406, 414]]], ["Few or many parasites may be found in any ascitic fluid and attached to the peritoneum of the diaphragm and the mesenteries.", [["ascitic fluid", "ANATOMY", 42, 55], ["peritoneum", "ANATOMY", 76, 86], ["diaphragm", "ANATOMY", 94, 103], ["mesenteries", "ANATOMY", 112, 123], ["ascitic fluid", "ORGANISM_SUBSTANCE", 42, 55], ["peritoneum", "MULTI-TISSUE_STRUCTURE", 76, 86], ["diaphragm", "ORGAN", 94, 103], ["mesenteries", "CANCER", 112, 123], ["many parasites", "PROBLEM", 7, 21], ["any ascitic fluid", "PROBLEM", 38, 55], ["many", "OBSERVATION_MODIFIER", 7, 11], ["parasites", "OBSERVATION", 12, 21], ["ascitic", "ANATOMY", 42, 49], ["fluid", "OBSERVATION", 50, 55], ["peritoneum", "ANATOMY", 76, 86], ["diaphragm", "ANATOMY", 94, 103], ["mesenteries", "ANATOMY", 112, 123]]], ["When the infestations are heavy and repeated, such as may be observed in sheep, cattle, and swine, peritonitis occurs.", [["peritonitis", "DISEASE", 99, 110], ["sheep", "ORGANISM", 73, 78], ["cattle", "ORGANISM", 80, 86], ["sheep", "SPECIES", 73, 78], ["cattle", "SPECIES", 80, 86], ["swine", "SPECIES", 92, 97], ["sheep", "SPECIES", 73, 78], ["cattle", "SPECIES", 80, 86], ["swine", "SPECIES", 92, 97], ["the infestations", "PROBLEM", 5, 21], ["peritonitis", "PROBLEM", 99, 110], ["peritonitis", "OBSERVATION", 99, 110]]], ["The young flukes at this stage are <1.0 mm long.", [["flukes", "ANATOMY", 10, 16], ["flukes", "ORGAN", 10, 16], ["young", "OBSERVATION_MODIFIER", 4, 9], ["flukes", "OBSERVATION", 10, 16]]], ["The peritonitis may be acute and exudative or chronic and proliferative.", [["peritonitis", "DISEASE", 4, 15], ["The peritonitis", "PROBLEM", 0, 15], ["acute", "PROBLEM", 23, 28], ["exudative", "PROBLEM", 33, 42], ["chronic and proliferative", "PROBLEM", 46, 71], ["peritonitis", "OBSERVATION", 4, 15], ["may be", "UNCERTAINTY", 16, 22], ["acute", "OBSERVATION_MODIFIER", 23, 28], ["exudative", "OBSERVATION_MODIFIER", 33, 42], ["chronic", "OBSERVATION_MODIFIER", 46, 53], ["proliferative", "OBSERVATION_MODIFIER", 58, 71]]], ["It is usually concentrated on the hepatic capsule, especially its visceral surface, but may be restricted to the parietal peritoneum or to the visceral peritoneum, including the mesenteries of the gut.", [["hepatic capsule", "ANATOMY", 34, 49], ["visceral surface", "ANATOMY", 66, 82], ["parietal peritoneum", "ANATOMY", 113, 132], ["visceral peritoneum", "ANATOMY", 143, 162], ["mesenteries", "ANATOMY", 178, 189], ["gut", "ANATOMY", 197, 200], ["hepatic capsule", "CANCER", 34, 49], ["visceral surface", "TISSUE", 66, 82], ["parietal peritoneum", "MULTI-TISSUE_STRUCTURE", 113, 132], ["visceral peritoneum", "MULTI-TISSUE_STRUCTURE", 143, 162], ["gut", "ORGANISM_SUBDIVISION", 197, 200], ["concentrated", "OBSERVATION_MODIFIER", 14, 26], ["hepatic", "ANATOMY", 34, 41], ["capsule", "ANATOMY_MODIFIER", 42, 49], ["visceral", "ANATOMY", 66, 74], ["surface", "ANATOMY_MODIFIER", 75, 82], ["may be", "UNCERTAINTY", 88, 94], ["parietal", "ANATOMY_MODIFIER", 113, 121], ["peritoneum", "ANATOMY", 122, 132], ["visceral", "ANATOMY_MODIFIER", 143, 151], ["peritoneum", "ANATOMY", 152, 162], ["gut", "ANATOMY", 197, 200]]], ["In acute cases, there are fibrinohemorrhagic deposits on the serous surfaces, and in chronic cases, there may be fibrous tags, with adhesions or a more or less diffuse thickening by connective tissue.", [["serous surfaces", "ANATOMY", 61, 76], ["fibrous tags", "ANATOMY", 113, 125], ["adhesions", "ANATOMY", 132, 141], ["connective tissue", "ANATOMY", 182, 199], ["serous surfaces", "TISSUE", 61, 76], ["connective tissue", "TISSUE", 182, 199], ["fibrinohemorrhagic deposits on the serous surfaces", "PROBLEM", 26, 76], ["fibrous tags", "PROBLEM", 113, 125], ["adhesions", "PROBLEM", 132, 141], ["less diffuse thickening by connective tissue", "PROBLEM", 155, 199], ["acute", "OBSERVATION_MODIFIER", 3, 8], ["cases", "OBSERVATION", 9, 14], ["fibrinohemorrhagic", "OBSERVATION_MODIFIER", 26, 44], ["deposits", "OBSERVATION", 45, 53], ["serous", "OBSERVATION_MODIFIER", 61, 67], ["surfaces", "OBSERVATION_MODIFIER", 68, 76], ["chronic", "OBSERVATION_MODIFIER", 85, 92], ["cases", "OBSERVATION", 93, 98], ["may be", "UNCERTAINTY", 106, 112], ["fibrous tags", "OBSERVATION", 113, 125], ["adhesions", "OBSERVATION", 132, 141], ["less", "OBSERVATION_MODIFIER", 155, 159], ["diffuse", "OBSERVATION_MODIFIER", 160, 167], ["thickening", "OBSERVATION", 168, 178], ["connective tissue", "OBSERVATION", 182, 199]]], ["Many young flukes can be found microscopically in the fibrinous deposits, and in the diffuse peritoneal thickenings, there are tortuous migration tunnels containing blood, debris, and the young parasites.", [["flukes", "ANATOMY", 11, 17], ["fibrinous deposits", "ANATOMY", 54, 72], ["peritoneal thickenings", "ANATOMY", 93, 115], ["blood", "ANATOMY", 165, 170], ["debris", "ANATOMY", 172, 178], ["fibrinous", "DISEASE", 54, 63], ["flukes", "ORGANISM", 11, 17], ["fibrinous deposits", "PATHOLOGICAL_FORMATION", 54, 72], ["peritoneal thickenings", "PATHOLOGICAL_FORMATION", 93, 115], ["blood", "ORGANISM_SUBSTANCE", 165, 170], ["Many young flukes", "PROBLEM", 0, 17], ["the fibrinous deposits", "PROBLEM", 50, 72], ["the diffuse peritoneal thickenings", "PROBLEM", 81, 115], ["tortuous migration tunnels containing blood", "PROBLEM", 127, 170], ["debris", "PROBLEM", 172, 178], ["flukes", "OBSERVATION", 11, 17], ["microscopically", "OBSERVATION_MODIFIER", 31, 46], ["fibrinous", "OBSERVATION_MODIFIER", 54, 63], ["deposits", "OBSERVATION", 64, 72], ["diffuse", "OBSERVATION_MODIFIER", 85, 92], ["peritoneal", "ANATOMY", 93, 103], ["thickenings", "OBSERVATION", 104, 115], ["tortuous", "OBSERVATION_MODIFIER", 127, 135], ["migration tunnels", "OBSERVATION", 136, 153], ["blood", "OBSERVATION_MODIFIER", 165, 170], ["debris", "OBSERVATION_MODIFIER", 172, 178], ["young", "OBSERVATION_MODIFIER", 188, 193], ["parasites", "OBSERVATION_MODIFIER", 194, 203]]], ["In cases with involvement of the visceral peritoneum, young flukes can be found in enlarged mesenteric lymph nodes.TrematodesThe acute lesions in the liver caused by the wandering flukes are basically traumatic, but there is an element of coagulative necrosis, which is possibly related to toxic excretions of the flukes.", [["visceral peritoneum", "ANATOMY", 33, 52], ["flukes", "ANATOMY", 60, 66], ["mesenteric lymph nodes", "ANATOMY", 92, 114], ["lesions", "ANATOMY", 135, 142], ["liver", "ANATOMY", 150, 155], ["flukes", "ANATOMY", 180, 186], ["flukes", "ANATOMY", 314, 320], ["acute lesions in the liver", "DISEASE", 129, 155], ["traumatic", "DISEASE", 201, 210], ["necrosis", "DISEASE", 251, 259], ["visceral peritoneum", "MULTI-TISSUE_STRUCTURE", 33, 52], ["flukes", "ORGAN", 60, 66], ["mesenteric lymph nodes", "MULTI-TISSUE_STRUCTURE", 92, 114], ["acute lesions", "PATHOLOGICAL_FORMATION", 129, 142], ["liver", "ORGAN", 150, 155], ["flukes", "ORGAN", 180, 186], ["flukes", "ORGAN", 314, 320], ["involvement of the visceral peritoneum", "PROBLEM", 14, 52], ["young flukes", "PROBLEM", 54, 66], ["enlarged mesenteric lymph nodes", "PROBLEM", 83, 114], ["The acute lesions in the liver", "PROBLEM", 125, 155], ["the wandering flukes", "PROBLEM", 166, 186], ["traumatic", "PROBLEM", 201, 210], ["coagulative necrosis", "PROBLEM", 239, 259], ["toxic excretions of the flukes", "PROBLEM", 290, 320], ["visceral", "ANATOMY_MODIFIER", 33, 41], ["peritoneum", "ANATOMY", 42, 52], ["young flukes", "OBSERVATION", 54, 66], ["enlarged", "OBSERVATION_MODIFIER", 83, 91], ["mesenteric", "ANATOMY", 92, 102], ["lymph nodes", "OBSERVATION", 103, 114], ["acute", "OBSERVATION_MODIFIER", 129, 134], ["lesions", "OBSERVATION", 135, 142], ["liver", "ANATOMY", 150, 155], ["wandering flukes", "OBSERVATION", 170, 186], ["traumatic", "OBSERVATION_MODIFIER", 201, 210], ["element", "OBSERVATION_MODIFIER", 228, 235], ["coagulative", "OBSERVATION_MODIFIER", 239, 250], ["necrosis", "OBSERVATION", 251, 259], ["possibly related to", "UNCERTAINTY", 270, 289], ["toxic", "OBSERVATION_MODIFIER", 290, 295], ["excretions", "OBSERVATION", 296, 306], ["flukes", "OBSERVATION", 314, 320]]], ["The migratory pathways are tortuous tunnels that appear on cross-section as hemorrhagic foci 2-3 mm in diameter.", [["tortuous tunnels", "ANATOMY", 27, 43], ["foci", "ANATOMY", 88, 92], ["hemorrhagic", "DISEASE", 76, 87], ["tortuous tunnels", "PROBLEM", 27, 43], ["hemorrhagic foci", "PROBLEM", 76, 92], ["migratory", "OBSERVATION_MODIFIER", 4, 13], ["tortuous", "OBSERVATION_MODIFIER", 27, 35], ["tunnels", "OBSERVATION", 36, 43], ["hemorrhagic", "OBSERVATION_MODIFIER", 76, 87], ["foci", "OBSERVATION", 88, 92], ["2-3 mm", "OBSERVATION_MODIFIER", 93, 99], ["diameter", "OBSERVATION_MODIFIER", 103, 111]]], ["If a tunnel is followed, a young fluke <1.0 mm long can be found at the end.", [["tunnel", "OBSERVATION", 5, 11]]], ["When the infestation is heavy, the liver may appear to be permeated by dark hemorrhagic streaks and foci.", [["liver", "ANATOMY", 35, 40], ["foci", "ANATOMY", 100, 104], ["infestation", "DISEASE", 9, 20], ["hemorrhagic streaks", "DISEASE", 76, 95], ["liver", "ORGAN", 35, 40], ["dark hemorrhagic streaks", "PROBLEM", 71, 95], ["foci", "PROBLEM", 100, 104], ["infestation", "OBSERVATION", 9, 20], ["heavy", "OBSERVATION_MODIFIER", 24, 29], ["liver", "ANATOMY", 35, 40], ["may appear to be", "UNCERTAINTY", 41, 57], ["dark", "OBSERVATION_MODIFIER", 71, 75], ["hemorrhagic", "OBSERVATION_MODIFIER", 76, 87], ["streaks", "OBSERVATION", 88, 95], ["foci", "OBSERVATION", 100, 104]]], ["Older tunnels from which the debris has been cleared may appear as light yellow streaks because of infiltration of eosinophils.", [["eosinophils", "ANATOMY", 115, 126], ["eosinophils", "CELL", 115, 126], ["eosinophils", "CELL_TYPE", 115, 126], ["Older tunnels", "TREATMENT", 0, 13], ["the debris", "PROBLEM", 25, 35], ["light yellow streaks", "PROBLEM", 67, 87], ["infiltration of eosinophils", "PROBLEM", 99, 126], ["tunnels", "OBSERVATION", 6, 13], ["debris", "OBSERVATION", 29, 35], ["infiltration", "OBSERVATION", 99, 111], ["eosinophils", "OBSERVATION", 115, 126]]], ["Microscopically, fresh tunnels are filled with blood and degenerate hepatocytes and are soon infiltrated by eosinophils.", [["blood", "ANATOMY", 47, 52], ["hepatocytes", "ANATOMY", 68, 79], ["eosinophils", "ANATOMY", 108, 119], ["blood", "ORGANISM_SUBSTANCE", 47, 52], ["hepatocytes", "CELL", 68, 79], ["eosinophils", "CELL", 108, 119], ["blood and degenerate hepatocytes", "CELL_TYPE", 47, 79], ["eosinophils", "CELL_TYPE", 108, 119], ["fresh tunnels", "TREATMENT", 17, 30], ["blood and degenerate hepatocytes", "PROBLEM", 47, 79], ["eosinophils", "TEST", 108, 119], ["fresh tunnels", "OBSERVATION", 17, 30], ["hepatocytes", "ANATOMY", 68, 79]]], ["Later, macrophages and giant cells arrange themselves about the debris and remove it, and healing occurs by granulation tissue, which is rich in lymphocytes and eosinophils.", [["macrophages", "ANATOMY", 7, 18], ["giant cells", "ANATOMY", 23, 34], ["debris", "ANATOMY", 64, 70], ["granulation tissue", "ANATOMY", 108, 126], ["lymphocytes", "ANATOMY", 145, 156], ["eosinophils", "ANATOMY", 161, 172], ["macrophages", "CELL", 7, 18], ["giant cells", "CELL", 23, 34], ["granulation tissue", "TISSUE", 108, 126], ["lymphocytes", "CELL", 145, 156], ["eosinophils", "CELL", 161, 172], ["macrophages", "CELL_TYPE", 7, 18], ["giant cells", "CELL_TYPE", 23, 34], ["lymphocytes", "CELL_TYPE", 145, 156], ["eosinophils", "CELL_TYPE", 161, 172], ["giant cells", "PROBLEM", 23, 34], ["the debris", "PROBLEM", 60, 70], ["granulation tissue", "PROBLEM", 108, 126], ["eosinophils", "TEST", 161, 172], ["giant cells", "OBSERVATION", 23, 34], ["debris", "OBSERVATION", 64, 70], ["healing", "OBSERVATION_MODIFIER", 90, 97], ["granulation tissue", "OBSERVATION", 108, 126], ["rich", "OBSERVATION_MODIFIER", 137, 141], ["lymphocytes", "ANATOMY", 145, 156], ["eosinophils", "OBSERVATION", 161, 172]]], ["In light infestations, the scars may disappear, but in heavy infestations, they may fuse with each other and with portal areas to produce found in the bile ducts.", [["scars", "ANATOMY", 27, 32], ["bile ducts", "ANATOMY", 151, 161], ["scars", "DISEASE", 27, 32], ["scars", "PATHOLOGICAL_FORMATION", 27, 32], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 151, 161], ["light infestations", "PROBLEM", 3, 21], ["the scars", "PROBLEM", 23, 32], ["infestations", "OBSERVATION", 9, 21], ["scars", "OBSERVATION", 27, 32], ["portal", "ANATOMY", 114, 120], ["bile ducts", "ANATOMY", 151, 161]]], ["Dicrocoelium and Platynosomum prefer the bile ducts.", [["bile ducts", "ANATOMY", 41, 51], ["Dicrocoelium", "CHEMICAL", 0, 12], ["Dicrocoelium", "SIMPLE_CHEMICAL", 0, 12], ["Platynosomum", "SIMPLE_CHEMICAL", 17, 29], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 41, 51], ["Dicrocoelium", "TREATMENT", 0, 12], ["Platynosomum", "TREATMENT", 17, 29], ["bile ducts", "ANATOMY", 41, 51]]], ["These are small, narrow flukes, 0.5-1.0 cm long, and may easily be mistaken for small masses of inspissated bile pigment.", [["flukes", "ANATOMY", 24, 30], ["masses", "ANATOMY", 86, 92], ["bile pigment", "ANATOMY", 108, 120], ["bile pigment", "TISSUE", 108, 120], ["small, narrow flukes", "PROBLEM", 10, 30], ["small masses", "PROBLEM", 80, 92], ["inspissated bile pigment", "PROBLEM", 96, 120], ["small", "OBSERVATION_MODIFIER", 10, 15], ["narrow", "OBSERVATION_MODIFIER", 17, 23], ["flukes", "OBSERVATION_MODIFIER", 24, 30], ["0.5-1.0 cm", "OBSERVATION_MODIFIER", 32, 42], ["may easily be", "UNCERTAINTY", 53, 66], ["small", "OBSERVATION_MODIFIER", 80, 85], ["masses", "OBSERVATION", 86, 92], ["inspissated bile pigment", "OBSERVATION", 96, 120]]], ["They are not highly pathogenic, and even in heavy infestations, there may be no signs of the toxemia observed in infestations by F. hepatica.", [["toxemia", "DISEASE", 93, 100], ["F. hepatica", "DISEASE", 129, 140], ["F. hepatica", "ORGANISM", 129, 140], ["F. hepatica", "SPECIES", 129, 140], ["F. hepatica", "SPECIES", 129, 140], ["the toxemia", "PROBLEM", 89, 100], ["infestations", "PROBLEM", 113, 125], ["not", "UNCERTAINTY", 9, 12], ["highly", "OBSERVATION_MODIFIER", 13, 19], ["pathogenic", "OBSERVATION", 20, 30], ["may be", "UNCERTAINTY", 70, 76], ["no signs of", "UNCERTAINTY", 77, 88], ["toxemia", "OBSERVATION", 93, 100], ["hepatica", "ANATOMY", 132, 140]]], ["These flukes may occur as mixed infestations.TrematodesPlatynosomum fastosum is a small fluke inhabiting the biliary ducts and gallbladder of cats from southern North America, Central and South America, Malaysia, and the Pacific Islands.", [["flukes", "ANATOMY", 6, 12], ["fluke", "ANATOMY", 88, 93], ["biliary ducts", "ANATOMY", 109, 122], ["gallbladder", "ANATOMY", 127, 138], ["Trematodes", "ORGANISM", 45, 55], ["Platynosomum fastosum", "ORGANISM", 55, 76], ["biliary ducts", "MULTI-TISSUE_STRUCTURE", 109, 122], ["gallbladder", "ORGAN", 127, 138], ["cats", "ORGANISM", 142, 146], ["Platynosomum fastosum", "SPECIES", 55, 76], ["cats", "SPECIES", 142, 146], ["Platynosomum fastosum", "SPECIES", 55, 76], ["These flukes", "PROBLEM", 0, 12], ["mixed infestations", "PROBLEM", 26, 44], ["TrematodesPlatynosomum fastosum", "PROBLEM", 45, 76], ["a small fluke inhabiting the biliary ducts", "PROBLEM", 80, 122], ["flukes", "OBSERVATION", 6, 12], ["mixed", "OBSERVATION_MODIFIER", 26, 31], ["infestations", "OBSERVATION", 32, 44], ["Platynosomum fastosum", "OBSERVATION", 55, 76], ["small", "OBSERVATION_MODIFIER", 82, 87], ["fluke", "OBSERVATION", 88, 93], ["biliary ducts", "ANATOMY", 109, 122], ["gallbladder", "ANATOMY", 127, 138], ["cats", "OBSERVATION", 142, 146], ["Central", "OBSERVATION_MODIFIER", 176, 183], ["South", "OBSERVATION_MODIFIER", 188, 193], ["America", "OBSERVATION_MODIFIER", 194, 201], ["Malaysia", "OBSERVATION_MODIFIER", 203, 211], ["Pacific Islands", "OBSERVATION", 221, 236]]], ["The life cycle includes Sublima octona snails as the first intermediate host, and Anolis spp. lizards, marine toads (Bufo marinis), geckos, and various arthropods as second intermediate or paratenic hosts.", [["Sublima octona snails", "ORGANISM", 24, 45], ["Anolis spp", "ORGANISM", 82, 92], ["marine toads", "ORGANISM", 103, 115], ["Bufo marinis", "ORGANISM", 117, 129], ["Sublima octona", "SPECIES", 24, 38], ["Bufo marinis", "SPECIES", 117, 129], ["Sublima octona", "SPECIES", 24, 38], ["Bufo marinis", "SPECIES", 117, 129], ["Sublima octona snails", "TREATMENT", 24, 45], ["lizards", "TREATMENT", 94, 101], ["marine toads (Bufo marinis", "TREATMENT", 103, 129], ["geckos", "TREATMENT", 132, 138], ["various arthropods", "TREATMENT", 144, 162]]], ["Cats become infected after ingestion of the second intermediate or paratenic hosts, the cercariae are released into the upper digestive tract, enter the biliary tree, and complete their life cycle.", [["upper digestive tract", "ANATOMY", 120, 141], ["biliary tree", "ANATOMY", 153, 165], ["cercariae", "ORGANISM", 88, 97], ["upper digestive", "ORGANISM_SUBDIVISION", 120, 135], ["tract", "ORGANISM_SUBDIVISION", 136, 141], ["biliary tree", "MULTI-TISSUE_STRUCTURE", 153, 165], ["infected", "OBSERVATION", 12, 20], ["upper", "ANATOMY_MODIFIER", 120, 125], ["digestive tract", "ANATOMY", 126, 141], ["biliary", "ANATOMY", 153, 160], ["tree", "ANATOMY_MODIFIER", 161, 165]]], ["Mature flukes are found in the gallbladder and bile ducts, and after 8-13 weeks, eggs are shed into the feces (Fig. 2-87) .", [["flukes", "ANATOMY", 7, 13], ["gallbladder", "ANATOMY", 31, 42], ["bile ducts", "ANATOMY", 47, 57], ["eggs", "ANATOMY", 81, 85], ["feces", "ANATOMY", 104, 109], ["flukes", "ORGAN", 7, 13], ["gallbladder", "ORGAN", 31, 42], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 47, 57], ["feces", "ORGANISM_SUBDIVISION", 104, 109], ["Mature flukes", "PROBLEM", 0, 13], ["eggs", "TREATMENT", 81, 85], ["flukes", "OBSERVATION", 7, 13], ["gallbladder", "ANATOMY", 31, 42], ["bile ducts", "ANATOMY", 47, 57], ["feces", "ANATOMY", 104, 109]]], ["Although the majority of infections are subclinical, heavy infestations may cause anorexia, vomiting, lethargy, jaundice, and death.", [["infections", "DISEASE", 25, 35], ["anorexia", "DISEASE", 82, 90], ["vomiting", "DISEASE", 92, 100], ["lethargy", "DISEASE", 102, 110], ["jaundice", "DISEASE", 112, 120], ["death", "DISEASE", 126, 131], ["infections", "PROBLEM", 25, 35], ["heavy infestations", "PROBLEM", 53, 71], ["anorexia", "PROBLEM", 82, 90], ["vomiting", "PROBLEM", 92, 100], ["lethargy", "PROBLEM", 102, 110], ["jaundice", "PROBLEM", 112, 120], ["death", "PROBLEM", 126, 131], ["majority", "OBSERVATION_MODIFIER", 13, 21], ["infections", "OBSERVATION", 25, 35], ["heavy", "OBSERVATION_MODIFIER", 53, 58], ["infestations", "OBSERVATION", 59, 71], ["jaundice", "OBSERVATION", 112, 120]]], ["Severely affected livers are enlarged, friable, and may be bile stained, with thickened, distended gallbladders, dilated and/or thickened common bile ducts and cystic ducts, and dilated intrahepatic ducts.", [["livers", "ANATOMY", 18, 24], ["bile", "ANATOMY", 59, 63], ["gallbladders", "ANATOMY", 99, 111], ["bile ducts", "ANATOMY", 145, 155], ["cystic ducts", "ANATOMY", 160, 172], ["intrahepatic ducts", "ANATOMY", 186, 204], ["dilated intrahepatic ducts", "DISEASE", 178, 204], ["livers", "ORGAN", 18, 24], ["gallbladders", "ORGAN", 99, 111], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 145, 155], ["cystic ducts", "MULTI-TISSUE_STRUCTURE", 160, 172], ["intrahepatic ducts", "MULTI-TISSUE_STRUCTURE", 186, 204], ["Severely affected livers", "PROBLEM", 0, 24], ["friable", "PROBLEM", 39, 46], ["thickened, distended gallbladders", "PROBLEM", 78, 111], ["dilated and/or thickened common bile ducts and cystic ducts", "PROBLEM", 113, 172], ["dilated intrahepatic ducts", "PROBLEM", 178, 204], ["affected", "OBSERVATION", 9, 17], ["livers", "ANATOMY", 18, 24], ["enlarged", "OBSERVATION", 29, 37], ["friable", "OBSERVATION_MODIFIER", 39, 46], ["may be", "UNCERTAINTY", 52, 58], ["bile", "ANATOMY", 59, 63], ["stained", "OBSERVATION", 64, 71], ["thickened", "OBSERVATION", 78, 87], ["distended", "OBSERVATION", 89, 98], ["gallbladders", "ANATOMY", 99, 111], ["dilated", "OBSERVATION", 113, 120], ["thickened", "OBSERVATION", 128, 137], ["common", "ANATOMY_MODIFIER", 138, 144], ["bile ducts", "ANATOMY", 145, 155], ["cystic ducts", "ANATOMY", 160, 172], ["dilated", "OBSERVATION", 178, 185], ["intrahepatic", "ANATOMY_MODIFIER", 186, 198], ["ducts", "ANATOMY", 199, 204]]], ["Histologically, there are various degrees of chronic cholangitis, fibrosing cholangiohepatitis, and cholecystitis, with dilated and hyperplastic ducts surrounded by lymphocytes, plasma cells, and eosinophils, and in some cases neutrophils, with fluke eggs within or adjacent to ducts.", [["hyperplastic ducts", "ANATOMY", 132, 150], ["lymphocytes", "ANATOMY", 165, 176], ["plasma cells", "ANATOMY", 178, 190], ["eosinophils", "ANATOMY", 196, 207], ["neutrophils", "ANATOMY", 227, 238], ["eggs", "ANATOMY", 251, 255], ["ducts", "ANATOMY", 278, 283], ["cholangitis", "DISEASE", 53, 64], ["fibrosing cholangiohepatitis", "DISEASE", 66, 94], ["cholecystitis", "DISEASE", 100, 113], ["hyperplastic ducts", "MULTI-TISSUE_STRUCTURE", 132, 150], ["lymphocytes", "CELL", 165, 176], ["plasma cells", "CELL", 178, 190], ["eosinophils", "CELL", 196, 207], ["neutrophils", "CELL", 227, 238], ["ducts", "MULTI-TISSUE_STRUCTURE", 278, 283], ["lymphocytes", "CELL_TYPE", 165, 176], ["plasma cells", "CELL_TYPE", 178, 190], ["eosinophils", "CELL_TYPE", 196, 207], ["neutrophils", "CELL_TYPE", 227, 238], ["chronic cholangitis", "PROBLEM", 45, 64], ["fibrosing cholangiohepatitis", "PROBLEM", 66, 94], ["cholecystitis", "PROBLEM", 100, 113], ["dilated and hyperplastic ducts", "PROBLEM", 120, 150], ["lymphocytes", "PROBLEM", 165, 176], ["plasma cells", "TEST", 178, 190], ["eosinophils", "TEST", 196, 207], ["some cases neutrophils", "PROBLEM", 216, 238], ["fluke eggs", "PROBLEM", 245, 255], ["various degrees", "OBSERVATION_MODIFIER", 26, 41], ["chronic", "OBSERVATION_MODIFIER", 45, 52], ["cholangitis", "OBSERVATION", 53, 64], ["fibrosing cholangiohepatitis", "OBSERVATION", 66, 94], ["cholecystitis", "OBSERVATION", 100, 113], ["dilated", "OBSERVATION", 120, 127], ["hyperplastic", "OBSERVATION", 132, 144], ["ducts", "ANATOMY_MODIFIER", 145, 150], ["lymphocytes", "ANATOMY", 165, 176], ["plasma cells", "OBSERVATION", 178, 190], ["eosinophils", "OBSERVATION_MODIFIER", 196, 207], ["some", "OBSERVATION_MODIFIER", 216, 220], ["cases neutrophils", "OBSERVATION", 221, 238], ["fluke eggs", "OBSERVATION", 245, 255], ["ducts", "ANATOMY", 278, 283]]], ["Eggs and adults may be difficult to find.", [["Eggs", "ANATOMY", 0, 4], ["Eggs", "ORGANISM_SUBSTANCE", 0, 4]]], ["Infection has been reported to co-occur with cholangiocarcinoma in some cats.TrematodesDicrocoelium hospes is found in cattle in countries south of the Sahara.", [["cholangiocarcinoma", "ANATOMY", 45, 63], ["Infection", "DISEASE", 0, 9], ["cholangiocarcinoma", "DISEASE", 45, 63], ["cholangiocarcinoma", "CANCER", 45, 63], ["cats", "ORGANISM", 72, 76], ["Dicrocoelium hospes", "ORGANISM", 87, 106], ["cats", "SPECIES", 72, 76], ["Dicrocoelium hospes", "SPECIES", 87, 106], ["cattle", "SPECIES", 119, 125], ["Dicrocoelium hospes", "SPECIES", 87, 106], ["cattle", "SPECIES", 119, 125], ["Infection", "PROBLEM", 0, 9], ["cholangiocarcinoma", "PROBLEM", 45, 63], ["cholangiocarcinoma", "OBSERVATION", 45, 63], ["Sahara", "ANATOMY", 152, 158]]], ["Little is known of it, but it is presumed to be comparable in all respects to the better-known D. dendriticum, which is common in Europe and Asia and sparsely distributed in the Americas and North Africa.", [["D. dendriticum", "ORGANISM", 95, 109], ["D. dendriticum", "SPECIES", 95, 109], ["D. dendriticum", "SPECIES", 95, 109], ["presumed to be", "UNCERTAINTY", 33, 47], ["dendriticum", "OBSERVATION", 98, 109]]], ["Dicrocoelium spp. are found in dry lowland or mountain pastures, whereas Fasciola spp. occur in wetter habitats, so the prevalence of Dicrocoelium is increasing with desertification.", [["Dicrocoelium", "CHEMICAL", 0, 12], ["Dicrocoelium", "CHEMICAL", 134, 146], ["Dicrocoelium spp.", "ORGANISM", 0, 17], ["Fasciola spp", "ORGANISM", 73, 85], ["Dicrocoelium spp.", "SPECIES", 0, 17], ["Fasciola spp", "SPECIES", 73, 85], ["Dicrocoelium spp.", "SPECIES", 0, 17], ["Fasciola spp", "SPECIES", 73, 85], ["Dicrocoelium spp.", "TREATMENT", 0, 17], ["Fasciola spp", "PROBLEM", 73, 85], ["Dicrocoelium", "PROBLEM", 134, 146], ["mountain pastures", "OBSERVATION", 46, 63], ["Fasciola spp", "OBSERVATION", 73, 85], ["increasing", "OBSERVATION_MODIFIER", 150, 160]]], ["This fluke is no more fastidious in its choice of final hosts than many other species of fluke, and, depending on opportunity, it can infest all domestic species, with the possible exception of cats.", [["fluke", "ANATOMY", 5, 10], ["fluke", "ANATOMY", 89, 94], ["fluke", "ORGAN", 5, 10], ["fluke", "ORGAN", 89, 94], ["cats", "ORGANISM", 194, 198], ["cats", "SPECIES", 194, 198], ["no more", "UNCERTAINTY", 14, 21], ["fastidious", "OBSERVATION_MODIFIER", 22, 32], ["fluke", "OBSERVATION", 89, 94]]], ["It is, however, of most importance as a parasite of sheep and cattle, in which it mineralized, sometimes so heavily that it cannot be cut with a knife.", [["sheep", "ORGANISM", 52, 57], ["cattle", "ORGANISM", 62, 68], ["sheep", "SPECIES", 52, 57], ["cattle", "SPECIES", 62, 68], ["sheep", "SPECIES", 52, 57], ["cattle", "SPECIES", 62, 68], ["a knife", "TREATMENT", 143, 150]]], ["The bile ducts contain dirty dark brown fluid of a mucinous or tough consistency, formed from degenerate floccular bile, pus, desquamated cells and detritus, clumps of flukes, and small masses of eggs in dark brown granular aggregates (eFig.", [["bile ducts", "ANATOMY", 4, 14], ["brown fluid", "ANATOMY", 34, 45], ["mucinous", "ANATOMY", 51, 59], ["floccular bile", "ANATOMY", 105, 119], ["pus", "ANATOMY", 121, 124], ["cells", "ANATOMY", 138, 143], ["detritus", "ANATOMY", 148, 156], ["flukes", "ANATOMY", 168, 174], ["masses", "ANATOMY", 186, 192], ["eggs", "ANATOMY", 196, 200], ["brown granular aggregates", "ANATOMY", 209, 234], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 4, 14], ["floccular bile", "MULTI-TISSUE_STRUCTURE", 105, 119], ["pus", "ORGANISM_SUBSTANCE", 121, 124], ["cells", "CELL", 138, 143], ["granular aggregates", "ORGANISM_SUBSTANCE", 215, 234], ["desquamated cells", "CELL_TYPE", 126, 143], ["dirty dark brown fluid of a mucinous or tough consistency", "PROBLEM", 23, 80], ["degenerate floccular bile", "PROBLEM", 94, 119], ["pus", "PROBLEM", 121, 124], ["desquamated cells", "PROBLEM", 126, 143], ["detritus", "PROBLEM", 148, 156], ["clumps of flukes", "PROBLEM", 158, 174], ["small masses of eggs", "PROBLEM", 180, 200], ["dark brown granular aggregates", "PROBLEM", 204, 234], ["bile ducts", "ANATOMY", 4, 14], ["dirty", "OBSERVATION_MODIFIER", 23, 28], ["dark", "OBSERVATION_MODIFIER", 29, 33], ["brown fluid", "OBSERVATION", 34, 45], ["tough consistency", "OBSERVATION_MODIFIER", 63, 80], ["floccular", "ANATOMY_MODIFIER", 105, 114], ["bile", "ANATOMY", 115, 119], ["pus", "OBSERVATION", 121, 124], ["desquamated cells", "OBSERVATION", 126, 143], ["detritus", "OBSERVATION_MODIFIER", 148, 156], ["clumps", "OBSERVATION_MODIFIER", 158, 164], ["flukes", "OBSERVATION_MODIFIER", 168, 174], ["small", "OBSERVATION_MODIFIER", 180, 185], ["masses", "OBSERVATION", 186, 192], ["eggs", "ANATOMY", 196, 200], ["dark brown", "OBSERVATION_MODIFIER", 204, 214], ["granular aggregates", "OBSERVATION", 215, 234]]], ["2-23).TrematodesAlthough the lesions are most obvious in ducts large enough to contain the flukes, there is, with time and severe or repeated infestations, progressive inflammation in the smaller portal units because of direct irritation by the flukes, superimposed infections, and biliary stasis.", [["lesions", "ANATOMY", 29, 36], ["ducts", "ANATOMY", 57, 62], ["flukes", "ANATOMY", 91, 97], ["flukes", "ANATOMY", 245, 251], ["biliary", "ANATOMY", 282, 289], ["infestations", "DISEASE", 142, 154], ["inflammation", "DISEASE", 168, 180], ["infections", "DISEASE", 266, 276], ["biliary stasis", "DISEASE", 282, 296], ["lesions", "PATHOLOGICAL_FORMATION", 29, 36], ["ducts", "MULTI-TISSUE_STRUCTURE", 57, 62], ["flukes", "ORGAN", 91, 97], ["biliary", "PATHOLOGICAL_FORMATION", 282, 289], ["the lesions", "PROBLEM", 25, 36], ["the flukes", "PROBLEM", 87, 97], ["severe or repeated infestations", "PROBLEM", 123, 154], ["progressive inflammation in the smaller portal units", "PROBLEM", 156, 208], ["direct irritation", "PROBLEM", 220, 237], ["the flukes", "PROBLEM", 241, 251], ["superimposed infections", "PROBLEM", 253, 276], ["biliary stasis", "PROBLEM", 282, 296], ["lesions", "OBSERVATION", 29, 36], ["most obvious", "UNCERTAINTY", 41, 53], ["ducts", "ANATOMY", 57, 62], ["large", "OBSERVATION", 63, 68], ["flukes", "OBSERVATION", 91, 97], ["severe", "OBSERVATION_MODIFIER", 123, 129], ["repeated", "OBSERVATION_MODIFIER", 133, 141], ["infestations", "OBSERVATION", 142, 154], ["progressive", "OBSERVATION_MODIFIER", 156, 167], ["inflammation", "OBSERVATION", 168, 180], ["smaller", "OBSERVATION_MODIFIER", 188, 195], ["portal units", "OBSERVATION_MODIFIER", 196, 208], ["irritation", "OBSERVATION", 227, 237], ["flukes", "OBSERVATION_MODIFIER", 245, 251], ["superimposed", "OBSERVATION_MODIFIER", 253, 265], ["infections", "OBSERVATION", 266, 276], ["biliary", "ANATOMY", 282, 289], ["stasis", "OBSERVATION", 290, 296]]], ["The course of events is as described earlier for subacute and chronic cholangitis.", [["cholangitis", "DISEASE", 70, 81], ["subacute and chronic cholangitis", "PROBLEM", 49, 81], ["chronic", "OBSERVATION_MODIFIER", 62, 69], ["cholangitis", "OBSERVATION", 70, 81]]], ["The proliferating connective tissue and bile ductules in individual portal areas extend to join each other and the scars left over from the migratory phase, so that inflammatory fibrosis may obliterate parenchyma in many foci.", [["connective tissue", "ANATOMY", 18, 35], ["bile ductules", "ANATOMY", 40, 53], ["portal areas", "ANATOMY", 68, 80], ["scars", "ANATOMY", 115, 120], ["parenchyma", "ANATOMY", 202, 212], ["foci", "ANATOMY", 221, 225], ["fibrosis", "DISEASE", 178, 186], ["connective tissue", "TISSUE", 18, 35], ["bile ductules", "MULTI-TISSUE_STRUCTURE", 40, 53], ["portal areas", "MULTI-TISSUE_STRUCTURE", 68, 80], ["scars", "PATHOLOGICAL_FORMATION", 115, 120], ["parenchyma", "TISSUE", 202, 212], ["The proliferating connective tissue and bile ductules in individual portal areas", "PROBLEM", 0, 80], ["the scars", "PROBLEM", 111, 120], ["inflammatory fibrosis", "PROBLEM", 165, 186], ["many foci", "PROBLEM", 216, 225], ["proliferating", "OBSERVATION_MODIFIER", 4, 17], ["connective tissue", "OBSERVATION", 18, 35], ["bile", "ANATOMY", 40, 44], ["ductules", "ANATOMY_MODIFIER", 45, 53], ["individual", "ANATOMY_MODIFIER", 57, 67], ["portal", "ANATOMY", 68, 74], ["areas", "ANATOMY_MODIFIER", 75, 80], ["scars", "OBSERVATION", 115, 120], ["left", "ANATOMY_MODIFIER", 121, 125], ["migratory phase", "OBSERVATION_MODIFIER", 140, 155], ["inflammatory", "OBSERVATION_MODIFIER", 165, 177], ["fibrosis", "OBSERVATION", 178, 186], ["parenchyma", "ANATOMY_MODIFIER", 202, 212], ["many", "OBSERVATION_MODIFIER", 216, 220], ["foci", "OBSERVATION", 221, 225]]], ["In such livers, the left lobe, which is the one most severely affected, may be atrophied, indurated, and irregular.TrematodesThe development of cholangitis of the degree described depends on long-standing or heavy infestations.", [["livers", "ANATOMY", 8, 14], ["left lobe", "ANATOMY", 20, 29], ["Trematodes", "DISEASE", 115, 125], ["cholangitis", "DISEASE", 144, 155], ["livers", "ORGAN", 8, 14], ["left lobe", "MULTI-TISSUE_STRUCTURE", 20, 29], ["atrophied", "PROBLEM", 79, 88], ["indurated", "PROBLEM", 90, 99], ["cholangitis of the degree", "PROBLEM", 144, 169], ["heavy infestations", "PROBLEM", 208, 226], ["livers", "ANATOMY", 8, 14], ["left lobe", "ANATOMY", 20, 29], ["one most severely", "OBSERVATION_MODIFIER", 44, 61], ["may be", "UNCERTAINTY", 72, 78], ["atrophied", "OBSERVATION", 79, 88], ["indurated", "OBSERVATION_MODIFIER", 90, 99], ["irregular", "OBSERVATION_MODIFIER", 105, 114], ["cholangitis", "OBSERVATION", 144, 155], ["degree", "OBSERVATION_MODIFIER", 163, 169], ["heavy", "OBSERVATION_MODIFIER", 208, 213], ["infestations", "OBSERVATION", 214, 226]]], ["Lesions of lesser severity, or those less fully developed, are associated with light infestations of short duration.", [["Lesions of lesser severity", "PROBLEM", 0, 26], ["light infestations of short duration", "PROBLEM", 79, 115], ["lesser", "OBSERVATION_MODIFIER", 11, 17], ["severity", "OBSERVATION_MODIFIER", 18, 26], ["less fully", "OBSERVATION_MODIFIER", 37, 47], ["light", "OBSERVATION_MODIFIER", 79, 84], ["infestations", "OBSERVATION", 85, 97], ["short duration", "OBSERVATION_MODIFIER", 101, 115]]], ["They may then be recognized only by local dilations of the ducts, or even these may not be readily apparent.", [["ducts", "ANATOMY", 59, 64], ["ducts", "MULTI-TISSUE_STRUCTURE", 59, 64], ["local dilations of the ducts", "PROBLEM", 36, 64], ["local", "OBSERVATION_MODIFIER", 36, 41], ["dilations", "OBSERVATION", 42, 51], ["ducts", "ANATOMY", 59, 64], ["may not be readily apparent", "UNCERTAINTY", 80, 107]]], ["In such mild infestations, the fact of past or present parasitism may only be suggested by the detection of characteristic black iron-porphyrin pigments, grossly visible in the hilar nodes.", [["hilar nodes", "ANATOMY", 177, 188], ["iron-porphyrin", "CHEMICAL", 129, 143], ["iron-porphyrin", "SIMPLE_CHEMICAL", 129, 143], ["hilar nodes", "MULTI-TISSUE_STRUCTURE", 177, 188], ["such mild infestations", "PROBLEM", 3, 25], ["characteristic black iron-porphyrin pigments", "PROBLEM", 108, 152], ["mild", "OBSERVATION_MODIFIER", 8, 12], ["infestations", "OBSERVATION", 13, 25], ["parasitism", "OBSERVATION", 55, 65], ["may only be suggested", "UNCERTAINTY", 66, 87], ["black", "OBSERVATION_MODIFIER", 123, 128], ["iron-porphyrin pigments", "OBSERVATION", 129, 152], ["grossly", "OBSERVATION_MODIFIER", 154, 161], ["visible", "OBSERVATION_MODIFIER", 162, 169], ["hilar", "ANATOMY", 177, 182], ["nodes", "OBSERVATION", 183, 188]]], ["It also contributes to the character of the biliary contents.TrematodesChronic debility with vague digestive disturbances is common in chronic fascioliasis, and deaths are common among sheep.", [["biliary", "ANATOMY", 44, 51], ["digestive", "ANATOMY", 99, 108], ["digestive disturbances", "DISEASE", 99, 121], ["fascioliasis", "DISEASE", 143, 155], ["deaths", "DISEASE", 161, 167], ["biliary", "ORGAN", 44, 51], ["digestive", "ORGAN", 99, 108], ["sheep", "ORGANISM", 185, 190], ["sheep", "SPECIES", 185, 190], ["sheep", "SPECIES", 185, 190], ["TrematodesChronic debility", "PROBLEM", 61, 87], ["vague digestive disturbances", "PROBLEM", 93, 121], ["chronic fascioliasis", "PROBLEM", 135, 155], ["biliary", "ANATOMY", 44, 51], ["contents", "OBSERVATION", 52, 60], ["Chronic", "OBSERVATION_MODIFIER", 71, 78], ["debility", "OBSERVATION", 79, 87], ["vague", "OBSERVATION_MODIFIER", 93, 98], ["digestive disturbances", "OBSERVATION", 99, 121], ["chronic", "OBSERVATION_MODIFIER", 135, 142], ["fascioliasis", "OBSERVATION", 143, 155]]], ["Clinically and at postmortem, there are, in addition to the essential lesions, more or less severe anemia, moderate anasarca, and cachexia.", [["lesions", "ANATOMY", 70, 77], ["cachexia", "ANATOMY", 130, 138], ["anemia", "DISEASE", 99, 105], ["anasarca", "DISEASE", 116, 124], ["cachexia", "DISEASE", 130, 138], ["lesions", "PATHOLOGICAL_FORMATION", 70, 77], ["cachexia", "CANCER", 130, 138], ["the essential lesions", "PROBLEM", 56, 77], ["less severe anemia", "PROBLEM", 87, 105], ["moderate anasarca", "PROBLEM", 107, 124], ["cachexia", "PROBLEM", 130, 138], ["essential", "OBSERVATION_MODIFIER", 60, 69], ["lesions", "OBSERVATION", 70, 77], ["less", "OBSERVATION_MODIFIER", 87, 91], ["severe", "OBSERVATION_MODIFIER", 92, 98], ["anemia", "OBSERVATION", 99, 105], ["moderate", "OBSERVATION_MODIFIER", 107, 115], ["anasarca", "OBSERVATION", 116, 124], ["cachexia", "OBSERVATION", 130, 138]]], ["Jaundice is seldom seen.TrematodesFasciola gigantica displaces F. hepatica as the common liver fluke in many parts of Africa and in nearby countries, southeast Asia, and the Hawaiian Islands.", [["liver fluke", "ANATOMY", 89, 100], ["Jaundice", "DISEASE", 0, 8], ["Fasciola gigantica", "DISEASE", 34, 52], ["F. hepatica", "DISEASE", 63, 74], ["liver fluke", "DISEASE", 89, 100], ["Trematodes", "ORGANISM", 24, 34], ["Fasciola gigantica", "ORGANISM", 34, 52], ["F. hepatica", "ORGANISM", 63, 74], ["liver", "ORGAN", 89, 94], ["fluke", "ORGANISM", 95, 100], ["Fasciola gigantica", "SPECIES", 34, 52], ["F. hepatica", "SPECIES", 63, 74], ["Fasciola gigantica", "SPECIES", 34, 52], ["F. hepatica", "SPECIES", 63, 74], ["Jaundice", "PROBLEM", 0, 8], ["TrematodesFasciola gigantica displaces", "PROBLEM", 24, 62], ["seldom", "OBSERVATION", 12, 18], ["hepatica", "ANATOMY", 66, 74], ["common", "ANATOMY_MODIFIER", 82, 88], ["liver", "ANATOMY", 89, 94], ["fluke", "OBSERVATION", 95, 100], ["Africa", "OBSERVATION_MODIFIER", 118, 124], ["Hawaiian Islands", "OBSERVATION", 174, 190]]], ["It is 2 or 3 times as large as F. hepatica, but its life cycle and pathogenicity are comparable.TrematodesFascioloides magna is the large liver fluke of North America; cervids are the definitive hosts.", [["liver fluke", "ANATOMY", 138, 149], ["cervids", "ANATOMY", 168, 175], ["Fascioloides magna", "DISEASE", 106, 124], ["F. hepatica", "ORGANISM", 31, 42], ["Trematodes", "ORGANISM", 96, 106], ["Fascioloides magna", "ORGANISM", 106, 124], ["liver", "ORGAN", 138, 143], ["fluke", "ORGAN", 144, 149], ["cervids", "CANCER", 168, 175], ["F. hepatica", "SPECIES", 31, 42], ["Fascioloides magna", "SPECIES", 106, 124], ["F. hepatica", "SPECIES", 31, 42], ["Fascioloides magna", "SPECIES", 106, 124], ["pathogenicity", "PROBLEM", 67, 80], ["TrematodesFascioloides magna", "TREATMENT", 96, 124], ["large", "OBSERVATION_MODIFIER", 22, 27], ["hepatica", "ANATOMY", 34, 42], ["pathogenicity", "OBSERVATION", 67, 80], ["large", "OBSERVATION_MODIFIER", 132, 137], ["liver", "ANATOMY", 138, 143], ["fluke", "OBSERVATION_MODIFIER", 144, 149], ["North", "OBSERVATION_MODIFIER", 153, 158], ["America", "OBSERVATION_MODIFIER", 159, 166]]], ["It is a parasite of ruminants and lives in the hepatic parenchyma, not in the bile ducts, although in tolerant hosts (cervids) the cysts in which it localizes communicate with the bile ducts to provide an exit for ova and excrement.", [["hepatic parenchyma", "ANATOMY", 47, 65], ["bile ducts", "ANATOMY", 78, 88], ["cervids", "ANATOMY", 118, 125], ["cysts", "ANATOMY", 131, 136], ["bile ducts", "ANATOMY", 180, 190], ["ova", "ANATOMY", 214, 217], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 47, 65], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 78, 88], ["cervids", "CANCER", 118, 125], ["cysts", "CANCER", 131, 136], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 180, 190], ["the cysts", "PROBLEM", 127, 136], ["parasite", "OBSERVATION_MODIFIER", 8, 16], ["ruminants", "OBSERVATION_MODIFIER", 20, 29], ["hepatic", "ANATOMY", 47, 54], ["parenchyma", "ANATOMY_MODIFIER", 55, 65], ["bile ducts", "ANATOMY", 78, 88], ["cysts", "OBSERVATION", 131, 136], ["bile ducts", "ANATOMY", 180, 190]]], ["The life cycle of this parasite generally parallels that of Fasciola hepatica.", [["Fasciola hepatica", "DISEASE", 60, 77], ["Fasciola hepatica", "ORGANISM", 60, 77], ["Fasciola hepatica", "SPECIES", 60, 77], ["Fasciola hepatica", "SPECIES", 60, 77], ["this parasite", "PROBLEM", 18, 31], ["Fasciola hepatica", "PROBLEM", 60, 77], ["Fasciola", "OBSERVATION", 60, 68], ["hepatica", "ANATOMY", 69, 77]]], ["The young flukes are very destructive as they wander in the liver.", [["flukes", "ANATOMY", 10, 16], ["liver", "ANATOMY", 60, 65], ["flukes", "ORGAN", 10, 16], ["liver", "ORGAN", 60, 65], ["very destructive", "PROBLEM", 21, 37], ["young", "OBSERVATION_MODIFIER", 4, 9], ["flukes", "OBSERVATION", 10, 16], ["very", "OBSERVATION_MODIFIER", 21, 25], ["destructive", "OBSERVATION", 26, 37], ["liver", "ANATOMY", 60, 65]]], ["In cattle, they wander briefly, producing large necrotic tunnels before becoming encysted.", [["necrotic", "DISEASE", 48, 56], ["cattle", "ORGANISM", 3, 9], ["necrotic tunnels", "PATHOLOGICAL_FORMATION", 48, 64], ["cattle", "SPECIES", 3, 9], ["cattle", "SPECIES", 3, 9], ["large necrotic tunnels", "PROBLEM", 42, 64], ["large", "OBSERVATION_MODIFIER", 42, 47], ["necrotic", "OBSERVATION_MODIFIER", 48, 56], ["tunnels", "OBSERVATION", 57, 64], ["encysted", "OBSERVATION", 81, 89]]], ["The cysts, enclosed by connective tissue, do not communicate with bile ducts but form permanent enclosures for the flukes, their excreta, and ova.", [["cysts", "ANATOMY", 4, 9], ["connective tissue", "ANATOMY", 23, 40], ["bile ducts", "ANATOMY", 66, 76], ["flukes", "ANATOMY", 115, 121], ["excreta", "ANATOMY", 129, 136], ["ova", "ANATOMY", 142, 145], ["cysts", "DISEASE", 4, 9], ["cysts", "CANCER", 4, 9], ["connective tissue", "TISSUE", 23, 40], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 66, 76], ["flukes", "ORGAN", 115, 121], ["ova", "ORGANISM_SUBDIVISION", 142, 145], ["The cysts", "PROBLEM", 0, 9], ["bile ducts", "PROBLEM", 66, 76], ["permanent enclosures", "TREATMENT", 86, 106], ["the flukes", "PROBLEM", 111, 121], ["ova", "PROBLEM", 142, 145], ["cysts", "OBSERVATION", 4, 9], ["connective tissue", "OBSERVATION", 23, 40], ["bile ducts", "ANATOMY", 66, 76], ["permanent enclosures", "OBSERVATION", 86, 106]]], ["The cysts, which may be 2-5 cm in diameter, are remarkable for the large deposits of jet black, sooty iron-porphyrin pigment they contain (eFig.", [["cysts", "ANATOMY", 4, 9], ["cysts", "DISEASE", 4, 9], ["cysts", "CANCER", 4, 9], ["sooty", "ORGANISM", 96, 101], ["The cysts", "PROBLEM", 0, 9], ["the large deposits of jet black", "PROBLEM", 63, 94], ["cysts", "OBSERVATION", 4, 9], ["may be", "UNCERTAINTY", 17, 23], ["2-5 cm", "OBSERVATION_MODIFIER", 24, 30], ["remarkable for", "UNCERTAINTY", 48, 62], ["large", "OBSERVATION_MODIFIER", 67, 72], ["deposits", "OBSERVATION", 73, 81], ["jet", "OBSERVATION_MODIFIER", 85, 88], ["black", "OBSERVATION_MODIFIER", 89, 94], ["sooty iron-porphyrin pigment", "OBSERVATION", 96, 124]]], ["2-24), and except for the flukes and soft contents, they superficially resemble heavily pigmented melanotic tumors.", [["flukes", "ANATOMY", 26, 32], ["melanotic tumors", "ANATOMY", 98, 114], ["melanotic tumors", "DISEASE", 98, 114], ["flukes", "TISSUE", 26, 32], ["pigmented melanotic tumors", "CANCER", 88, 114], ["the flukes and soft contents", "PROBLEM", 22, 50], ["heavily pigmented melanotic tumors", "PROBLEM", 80, 114], ["flukes", "OBSERVATION", 26, 32], ["soft contents", "OBSERVATION", 37, 50], ["heavily", "OBSERVATION_MODIFIER", 80, 87], ["pigmented", "OBSERVATION_MODIFIER", 88, 97], ["melanotic tumors", "OBSERVATION", 98, 114]]], ["Commonly, these flukes pass from the liver to the lungs of cattle, to produce lesions of similar character.", [["flukes", "ANATOMY", 16, 22], ["liver", "ANATOMY", 37, 42], ["lungs", "ANATOMY", 50, 55], ["lesions", "ANATOMY", 78, 85], ["flukes", "ORGANISM", 16, 22], ["liver", "ORGAN", 37, 42], ["lungs", "ORGAN", 50, 55], ["cattle", "ORGANISM", 59, 65], ["lesions", "PATHOLOGICAL_FORMATION", 78, 85], ["cattle", "SPECIES", 59, 65], ["cattle", "SPECIES", 59, 65], ["lesions", "PROBLEM", 78, 85], ["flukes", "OBSERVATION", 16, 22], ["liver", "ANATOMY", 37, 42], ["lungs", "ANATOMY", 50, 55], ["lesions", "OBSERVATION", 78, 85], ["similar", "OBSERVATION_MODIFIER", 89, 96], ["character", "OBSERVATION_MODIFIER", 97, 106]]], ["In sheep, this parasite wanders continuously in the liver, producing black, tortuous tracts, which may be 2 cm in diameter, and extensive parenchymal destruction.", [["liver", "ANATOMY", 52, 57], ["tortuous tracts", "ANATOMY", 76, 91], ["parenchymal", "ANATOMY", 138, 149], ["parenchymal destruction", "DISEASE", 138, 161], ["sheep", "ORGANISM", 3, 8], ["liver", "ORGAN", 52, 57], ["tortuous tracts", "MULTI-TISSUE_STRUCTURE", 76, 91], ["parenchymal", "TISSUE", 138, 149], ["sheep", "SPECIES", 3, 8], ["sheep", "SPECIES", 3, 8], ["black, tortuous tracts", "PROBLEM", 69, 91], ["extensive parenchymal destruction", "PROBLEM", 128, 161], ["liver", "ANATOMY", 52, 57], ["black", "OBSERVATION_MODIFIER", 69, 74], ["tortuous", "OBSERVATION_MODIFIER", 76, 84], ["tracts", "OBSERVATION_MODIFIER", 85, 91], ["may be", "UNCERTAINTY", 99, 105], ["2 cm", "OBSERVATION_MODIFIER", 106, 110], ["diameter", "OBSERVATION_MODIFIER", 114, 122], ["extensive", "OBSERVATION_MODIFIER", 128, 137], ["parenchymal", "ANATOMY_MODIFIER", 138, 149], ["destruction", "OBSERVATION", 150, 161]]], ["Even a few flukes may kill a sheep.", [["flukes", "ANATOMY", 11, 17], ["flukes", "ORGANISM", 11, 17], ["sheep", "ORGANISM", 29, 34], ["sheep", "SPECIES", 29, 34], ["sheep", "SPECIES", 29, 34], ["few", "OBSERVATION_MODIFIER", 7, 10], ["flukes", "OBSERVATION", 11, 17]]], ["There is a single case report of natural infection in a horse.TrematodesThe dicrocoelid flukes inhabit both biliary and pancreatic ducts.", [["dicrocoelid flukes", "ANATOMY", 76, 94], ["biliary", "ANATOMY", 108, 115], ["pancreatic ducts", "ANATOMY", 120, 136], ["infection", "DISEASE", 41, 50], ["biliary and pancreatic ducts", "DISEASE", 108, 136], ["horse", "ORGANISM", 56, 61], ["dicrocoelid flukes", "ORGANISM", 76, 94], ["biliary", "MULTI-TISSUE_STRUCTURE", 108, 115], ["pancreatic ducts", "MULTI-TISSUE_STRUCTURE", 120, 136], ["horse", "SPECIES", 56, 61], ["natural infection", "PROBLEM", 33, 50], ["natural", "OBSERVATION_MODIFIER", 33, 40], ["infection", "OBSERVATION", 41, 50], ["dicrocoelid flukes", "OBSERVATION", 76, 94], ["both", "ANATOMY_MODIFIER", 103, 107], ["biliary", "ANATOMY", 108, 115], ["pancreatic ducts", "ANATOMY", 120, 136]]], ["Eurytrema pancreaticum prefers the pancreas (and is described with that organ) but in heavy infestations can be portal veins to mate, and release eggs that migrate through mesenteric venules, crossing into the bowel lumen by means of proteolytic enzymes.", [["pancreas", "ANATOMY", 35, 43], ["organ", "ANATOMY", 72, 77], ["portal veins", "ANATOMY", 112, 124], ["eggs", "ANATOMY", 146, 150], ["mesenteric venules", "ANATOMY", 172, 190], ["bowel lumen", "ANATOMY", 210, 221], ["Eurytrema pancreaticum", "ORGANISM", 0, 22], ["pancreas", "ORGAN", 35, 43], ["organ", "ORGAN", 72, 77], ["portal veins", "MULTI-TISSUE_STRUCTURE", 112, 124], ["mesenteric venules", "MULTI-TISSUE_STRUCTURE", 172, 190], ["bowel lumen", "MULTI-TISSUE_STRUCTURE", 210, 221], ["proteolytic enzymes", "PROTEIN", 234, 253], ["Eurytrema pancreaticum", "SPECIES", 0, 22], ["Eurytrema pancreaticum", "SPECIES", 0, 22], ["proteolytic enzymes", "TEST", 234, 253], ["pancreas", "ANATOMY", 35, 43], ["portal veins", "ANATOMY", 112, 124], ["mesenteric venules", "ANATOMY", 172, 190], ["bowel", "ANATOMY", 210, 215], ["lumen", "ANATOMY_MODIFIER", 216, 221]]], ["Aberrant migration of eggs results in multifocal eosinophilic and granulomatous inflammation in intestines, pancreas, and liver.", [["eggs", "ANATOMY", 22, 26], ["eosinophilic", "ANATOMY", 49, 61], ["granulomatous", "ANATOMY", 66, 79], ["intestines", "ANATOMY", 96, 106], ["pancreas", "ANATOMY", 108, 116], ["liver", "ANATOMY", 122, 127], ["inflammation", "DISEASE", 80, 92], ["intestines", "ORGAN", 96, 106], ["pancreas", "ORGAN", 108, 116], ["liver", "ORGAN", 122, 127], ["Aberrant migration of eggs", "PROBLEM", 0, 26], ["multifocal eosinophilic and granulomatous inflammation in intestines, pancreas, and liver", "PROBLEM", 38, 127], ["migration", "OBSERVATION_MODIFIER", 9, 18], ["eggs", "ANATOMY", 22, 26], ["multifocal", "OBSERVATION_MODIFIER", 38, 48], ["eosinophilic", "OBSERVATION_MODIFIER", 49, 61], ["granulomatous", "OBSERVATION_MODIFIER", 66, 79], ["inflammation", "OBSERVATION", 80, 92], ["intestines", "ANATOMY", 96, 106], ["pancreas", "ANATOMY", 108, 116], ["liver", "ANATOMY", 122, 127]]], ["Adult trematodes may occasionally be found in hepatic vessels.", [["hepatic vessels", "ANATOMY", 46, 61], ["hepatic vessels", "MULTI-TISSUE_STRUCTURE", 46, 61], ["Adult trematodes", "PROBLEM", 0, 16], ["trematodes", "OBSERVATION", 6, 16], ["hepatic", "ANATOMY", 46, 53], ["vessels", "ANATOMY", 54, 61]]], ["Clinical signs in affected dogs include diarrhea, vomiting, weight loss, and lethargy, and ~50% of cases in dogs are associated with hypercalcemia, thought to be the result of unregulated calcitriol synthesis by macrophages in the granulomatous lesions.", [["macrophages", "ANATOMY", 212, 223], ["granulomatous lesions", "ANATOMY", 231, 252], ["diarrhea", "DISEASE", 40, 48], ["vomiting", "DISEASE", 50, 58], ["weight loss", "DISEASE", 60, 71], ["lethargy", "DISEASE", 77, 85], ["hypercalcemia", "DISEASE", 133, 146], ["calcitriol", "CHEMICAL", 188, 198], ["calcitriol", "CHEMICAL", 188, 198], ["dogs", "ORGANISM", 27, 31], ["dogs", "ORGANISM", 108, 112], ["calcitriol", "SIMPLE_CHEMICAL", 188, 198], ["macrophages", "CELL", 212, 223], ["granulomatous lesions", "PATHOLOGICAL_FORMATION", 231, 252], ["macrophages", "CELL_TYPE", 212, 223], ["dogs", "SPECIES", 27, 31], ["dogs", "SPECIES", 108, 112], ["Clinical signs in affected dogs", "PROBLEM", 0, 31], ["diarrhea", "PROBLEM", 40, 48], ["vomiting", "PROBLEM", 50, 58], ["weight loss", "PROBLEM", 60, 71], ["lethargy", "PROBLEM", 77, 85], ["cases in dogs", "PROBLEM", 99, 112], ["hypercalcemia", "PROBLEM", 133, 146], ["unregulated calcitriol synthesis", "TREATMENT", 176, 208], ["the granulomatous lesions", "PROBLEM", 227, 252], ["diarrhea", "OBSERVATION", 40, 48], ["hypercalcemia", "OBSERVATION", 133, 146], ["unregulated", "OBSERVATION_MODIFIER", 176, 187], ["calcitriol", "OBSERVATION", 188, 198], ["macrophages", "OBSERVATION_MODIFIER", 212, 223], ["granulomatous", "OBSERVATION_MODIFIER", 231, 244], ["lesions", "OBSERVATION", 245, 252]]], ["In horses, multiple small fibrosing granulomas scattered throughout the liver, with rare intact or fragmented eggs, are typical and are usually clinically inapparent.TrematodesThe opisthorchid flukes are parasites in the bile ducts of carnivores.", [["granulomas", "ANATOMY", 36, 46], ["liver", "ANATOMY", 72, 77], ["eggs", "ANATOMY", 110, 114], ["opisthorchid flukes", "ANATOMY", 180, 199], ["bile ducts", "ANATOMY", 221, 231], ["granulomas", "DISEASE", 36, 46], ["fibrosing granulomas", "PATHOLOGICAL_FORMATION", 26, 46], ["liver", "ORGAN", 72, 77], ["opisthorchid flukes", "ORGANISM", 180, 199], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 221, 231], ["multiple small fibrosing granulomas", "PROBLEM", 11, 46], ["rare intact or fragmented eggs", "PROBLEM", 84, 114], ["parasites in the bile ducts of carnivores", "PROBLEM", 204, 245], ["multiple", "OBSERVATION_MODIFIER", 11, 19], ["small", "OBSERVATION_MODIFIER", 20, 25], ["fibrosing", "OBSERVATION_MODIFIER", 26, 35], ["granulomas", "OBSERVATION", 36, 46], ["scattered", "OBSERVATION_MODIFIER", 47, 56], ["liver", "ANATOMY", 72, 77], ["rare", "OBSERVATION_MODIFIER", 84, 88], ["intact", "OBSERVATION", 89, 95], ["fragmented", "OBSERVATION_MODIFIER", 99, 109], ["eggs", "OBSERVATION", 110, 114], ["opisthorchid flukes", "OBSERVATION", 180, 199], ["parasites", "OBSERVATION_MODIFIER", 204, 213], ["bile ducts", "ANATOMY", 221, 231], ["carnivores", "OBSERVATION", 235, 245]]], ["They may also occur in swine and humans, and one species, Clonorchis sinensis (Opisthorchis sinensis), is an important human parasite.", [["Clonorchis sinensis", "DISEASE", 58, 77], ["humans", "ORGANISM", 33, 39], ["Clonorchis sinensis", "ORGANISM", 58, 77], ["Opisthorchis sinensis", "ORGANISM", 79, 100], ["human", "ORGANISM", 119, 124], ["swine", "SPECIES", 23, 28], ["humans", "SPECIES", 33, 39], ["Clonorchis sinensis", "SPECIES", 58, 77], ["Opisthorchis sinensis", "SPECIES", 79, 100], ["human", "SPECIES", 119, 124], ["swine", "SPECIES", 23, 28], ["humans", "SPECIES", 33, 39], ["Clonorchis sinensis", "SPECIES", 58, 77], ["Opisthorchis sinensis", "SPECIES", 79, 100], ["human", "SPECIES", 119, 124], ["Clonorchis sinensis", "PROBLEM", 58, 77]]], ["The life cycles, where known, include mollusks as the first intermediate hosts and freshwater fish as the second.TrematodesMetorchis conjunctus is the common liver fluke of cats and dogs in North America and is important as a parasite of sled dogs in the Canadian Northwest Territories.", [["liver fluke", "ANATOMY", 158, 169], ["liver fluke", "DISEASE", 158, 169], ["Trematodes", "ORGANISM", 113, 123], ["Metorchis conjunctus", "ORGANISM", 123, 143], ["liver", "ORGAN", 158, 163], ["fluke", "ORGAN", 164, 169], ["cats", "ORGANISM", 173, 177], ["sled dogs", "ORGANISM", 238, 247], ["Metorchis conjunctus", "SPECIES", 123, 143], ["cats", "SPECIES", 173, 177], ["dogs", "SPECIES", 182, 186], ["dogs", "SPECIES", 243, 247], ["Metorchis conjunctus", "SPECIES", 123, 143], ["common", "ANATOMY_MODIFIER", 151, 157], ["liver", "ANATOMY", 158, 163], ["fluke", "OBSERVATION", 164, 169], ["cats", "OBSERVATION", 173, 177], ["parasite", "OBSERVATION_MODIFIER", 226, 234]]], ["The first intermediate host is the snail Amnicola limosa porosa, and the second is the common sucker-fish Catostomus commersonii.", [["Amnicola limosa porosa", "ORGANISM", 41, 63], ["sucker", "ORGANISM_SUBDIVISION", 94, 100], ["Catostomus commersonii", "ORGANISM", 106, 128], ["Amnicola limosa porosa", "SPECIES", 41, 63], ["Catostomus commersonii", "SPECIES", 106, 128], ["Amnicola limosa porosa", "SPECIES", 41, 63], ["Catostomus commersonii", "SPECIES", 106, 128], ["intermediate", "OBSERVATION_MODIFIER", 10, 22], ["host", "OBSERVATION_MODIFIER", 23, 27], ["snail", "OBSERVATION", 35, 40], ["fish Catostomus", "OBSERVATION", 101, 116]]], ["The cercariae actively burrow into the musculature of the fish to encyst and become infective.", [["musculature", "ANATOMY", 39, 50], ["cercariae", "ORGANISM", 4, 13], ["musculature", "ORGANISM_SUBDIVISION", 39, 50], ["fish", "ORGANISM", 58, 62], ["infective", "PROBLEM", 84, 93], ["musculature", "ANATOMY", 39, 50], ["fish", "ANATOMY", 58, 62], ["infective", "OBSERVATION", 84, 93]]], ["The immature flukes crawl into the bile ducts from the duodenum and mature in ~28 days.", [["flukes", "ANATOMY", 13, 19], ["bile ducts", "ANATOMY", 35, 45], ["duodenum", "ANATOMY", 55, 63], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 35, 45], ["duodenum", "ORGAN", 55, 63], ["immature", "OBSERVATION_MODIFIER", 4, 12], ["flukes crawl", "OBSERVATION", 13, 25], ["bile ducts", "ANATOMY", 35, 45], ["duodenum", "ANATOMY", 55, 63], ["mature", "OBSERVATION_MODIFIER", 68, 74]]], ["Infestations may persist for more than 5 years.", [["Infestations", "PROBLEM", 0, 12]]], ["Metorchis albidis has been described in a dog from Alaska, Parametorchis complexus in cats in the United States, and Amphimerus pseudofelineus in cats and coyotes in the United States and Panama; the life cycles are not known but are presumed to include fish.", [["Parametorchis complexus", "DISEASE", 59, 82], ["Metorchis albidis", "ORGANISM", 0, 17], ["dog", "ORGANISM", 42, 45], ["Parametorchis complexus", "ORGANISM", 59, 82], ["cats", "ORGANISM", 86, 90], ["Amphimerus pseudofelineus", "ORGANISM", 117, 142], ["cats", "ORGANISM", 146, 150], ["fish", "ORGANISM_SUBDIVISION", 254, 258], ["Metorchis albidis", "SPECIES", 0, 17], ["dog", "SPECIES", 42, 45], ["cats", "SPECIES", 86, 90], ["Amphimerus pseudofelineus", "SPECIES", 117, 142], ["cats", "SPECIES", 146, 150], ["Metorchis albidis", "SPECIES", 0, 17], ["Amphimerus pseudofelineus", "SPECIES", 117, 142]]], ["Metorchis bilis has been reported in red foxes and occasionally in cats from Germany.TrematodesOpisthorchis felineus (O. tenuicollis) is the lanceolate fluke of the bile ducts of cats, dogs, and foxes in Europe and Russia.", [["lanceolate fluke", "ANATOMY", 141, 157], ["bile ducts", "ANATOMY", 165, 175], ["Metorchis bilis", "ORGANISM", 0, 15], ["red foxes", "ORGANISM", 37, 46], ["cats", "ORGANISM", 67, 71], ["TrematodesOpisthorchis felineus", "ORGANISM", 85, 116], ["O. tenuicollis", "ORGANISM", 118, 132], ["fluke", "ORGANISM", 152, 157], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 165, 175], ["cats", "ORGANISM", 179, 183], ["Metorchis bilis", "SPECIES", 0, 15], ["cats", "SPECIES", 67, 71], ["TrematodesOpisthorchis felineus", "SPECIES", 85, 116], ["O. tenuicollis", "SPECIES", 118, 132], ["cats", "SPECIES", 179, 183], ["dogs", "SPECIES", 185, 189], ["Metorchis bilis", "SPECIES", 0, 15], ["red foxes", "SPECIES", 37, 46], ["TrematodesOpisthorchis felineus", "SPECIES", 85, 116], ["O. tenuicollis", "SPECIES", 118, 132], ["red foxes", "OBSERVATION", 37, 46], ["bile ducts", "ANATOMY", 165, 175]]], ["It is particularly common in eastern Europe and Siberia and is more sparse in other areas.", [["common", "OBSERVATION_MODIFIER", 19, 25], ["more", "OBSERVATION_MODIFIER", 63, 67], ["sparse", "OBSERVATION_MODIFIER", 68, 74]]], ["Clonorchis sinensis, the Oriental or Chinese liver fluke is an important human pathogen endemic in Japan, Korea, southern China, and southeast Asia; dogs, cats and swine can act as reservoir hosts.", [["liver fluke", "ANATOMY", 45, 56], ["Clonorchis sinensis", "DISEASE", 0, 19], ["liver fluke", "DISEASE", 45, 56], ["Clonorchis sinensis", "ORGANISM", 0, 19], ["liver", "ORGAN", 45, 50], ["fluke", "ORGANISM", 51, 56], ["human", "ORGANISM", 73, 78], ["dogs", "ORGANISM", 149, 153], ["cats", "ORGANISM", 155, 159], ["swine", "ORGANISM", 164, 169], ["Clonorchis sinensis", "SPECIES", 0, 19], ["human", "SPECIES", 73, 78], ["dogs", "SPECIES", 149, 153], ["cats", "SPECIES", 155, 159], ["swine", "SPECIES", 164, 169], ["Clonorchis sinensis", "SPECIES", 0, 19], ["Chinese liver fluke", "SPECIES", 37, 56], ["human", "SPECIES", 73, 78], ["swine", "SPECIES", 164, 169], ["Clonorchis sinensis", "PROBLEM", 0, 19], ["Chinese liver fluke", "PROBLEM", 37, 56], ["liver", "ANATOMY", 45, 50]]], ["There are additional, less well-known, species of Opisthorchis in humans and inhabits the bile ducts.", [["bile ducts", "ANATOMY", 90, 100], ["Opisthorchis", "ORGANISM", 50, 62], ["humans", "ORGANISM", 66, 72], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 90, 100], ["humans", "SPECIES", 66, 72], ["humans", "SPECIES", 66, 72], ["less", "OBSERVATION_MODIFIER", 22, 26], ["well-known", "OBSERVATION_MODIFIER", 27, 37], ["species", "OBSERVATION_MODIFIER", 39, 46], ["Opisthorchis", "OBSERVATION", 50, 62], ["bile ducts", "ANATOMY", 90, 100]]], ["Other domestic species and rodents are important as reservoirs.TrematodesThe life cycle of Dicrocoelium dendriticum, the lancet fluke or small liver fluke, differs in some details from that of F. hepatica.", [["lancet fluke", "ANATOMY", 121, 133], ["liver fluke", "ANATOMY", 143, 154], ["liver fluke", "DISEASE", 143, 154], ["F. hepatica", "DISEASE", 193, 204], ["Dicrocoelium dendriticum", "ORGANISM", 91, 115], ["lancet fluke", "ORGANISM", 121, 133], ["liver fluke", "ORGAN", 143, 154], ["F. hepatica", "ORGANISM", 193, 204], ["Dicrocoelium dendriticum", "SPECIES", 91, 115], ["F. hepatica", "SPECIES", 193, 204], ["Dicrocoelium dendriticum", "SPECIES", 91, 115], ["F. hepatica", "SPECIES", 193, 204], ["Other domestic species", "PROBLEM", 0, 22], ["Dicrocoelium dendriticum", "PROBLEM", 91, 115], ["the lancet fluke", "TEST", 117, 133], ["small liver fluke", "PROBLEM", 137, 154], ["domestic species", "OBSERVATION", 6, 22], ["lancet fluke", "OBSERVATION", 121, 133], ["small", "OBSERVATION_MODIFIER", 137, 142], ["liver", "ANATOMY", 143, 148], ["fluke", "OBSERVATION", 149, 154], ["hepatica", "ANATOMY", 196, 204]]], ["The eggs are embryonated when laid and do not hatch until swallowed by one of the many genera of land snails that are the first intermediate hosts.", [["eggs", "ANATOMY", 4, 8], ["eggs", "ORGANISM_SUBSTANCE", 4, 8], ["land snails", "ORGANISM", 97, 108]]], ["In the snails, the mother sporocyst produces a second generation of daughter sporocysts, which in turn produce cercariae.", [["mother sporocyst", "ANATOMY", 19, 35], ["sporocysts", "ANATOMY", 77, 87], ["cercariae", "ORGANISM", 111, 120], ["daughter sporocysts", "PROBLEM", 68, 87], ["snails", "ANATOMY", 7, 13], ["sporocyst", "OBSERVATION", 26, 35], ["sporocysts", "OBSERVATION", 77, 87], ["cercariae", "OBSERVATION", 111, 120]]], ["The cercariae leave the snail in damp weather and are expelled from the snail's lung, clumped together in slime balls.", [["lung", "ANATOMY", 80, 84], ["cercariae", "ORGANISM", 4, 13], ["lung", "ORGAN", 80, 84], ["snail", "OBSERVATION", 24, 29], ["damp weather", "OBSERVATION", 33, 45], ["snail", "ANATOMY", 72, 77], ["lung", "ANATOMY", 80, 84], ["clumped", "OBSERVATION_MODIFIER", 86, 93], ["slime balls", "OBSERVATION", 106, 117]]], ["The slime balls are not infective until the cercariae are swallowed by, and encyst in, the ant Formica fusca; other ants may be involved in different countries.", [["cercariae", "ORGANISM", 44, 53], ["Formica fusca", "ORGANISM", 95, 108], ["Formica fusca", "SPECIES", 95, 108], ["Formica fusca", "SPECIES", 95, 108], ["The slime balls", "PROBLEM", 0, 15], ["infective", "PROBLEM", 24, 33], ["slime balls", "OBSERVATION", 4, 15], ["not", "UNCERTAINTY", 20, 23], ["infective", "OBSERVATION", 24, 33]]], ["The route of migration of the larvae from the gut to the liver is probably via the bile ducts from the duodenum.TrematodesThe pathologic changes in the liver produced by D. dendriticum are those of cholangiohepatitis that is less severe than that produced by Fasciola hepatica (Fig. 2-88, eFig.", [["gut", "ANATOMY", 46, 49], ["liver", "ANATOMY", 57, 62], ["bile ducts", "ANATOMY", 83, 93], ["duodenum", "ANATOMY", 103, 111], ["liver", "ANATOMY", 152, 157], ["cholangiohepatitis", "DISEASE", 198, 216], ["Fasciola hepatica", "DISEASE", 259, 276], ["gut", "ORGANISM_SUBDIVISION", 46, 49], ["liver", "ORGAN", 57, 62], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 83, 93], ["duodenum", "ORGAN", 103, 111], ["liver", "ORGAN", 152, 157], ["D. dendriticum", "ORGANISM", 170, 184], ["cholangiohepatitis", "CANCER", 198, 216], ["Fasciola hepatica", "ORGANISM", 259, 276], ["Fig. 2-88", "ORGANISM", 278, 287], ["eFig", "GENE_OR_GENE_PRODUCT", 289, 293], ["D. dendriticum", "SPECIES", 170, 184], ["Fasciola hepatica", "SPECIES", 259, 276], ["D. dendriticum", "SPECIES", 170, 184], ["Fasciola hepatica", "SPECIES", 259, 276], ["migration of the larvae", "TREATMENT", 13, 36], ["The pathologic changes in the liver", "PROBLEM", 122, 157], ["cholangiohepatitis", "PROBLEM", 198, 216], ["Fasciola hepatica", "TEST", 259, 276], ["migration", "OBSERVATION", 13, 22], ["liver", "ANATOMY", 57, 62], ["bile ducts", "ANATOMY", 83, 93], ["duodenum", "ANATOMY", 103, 111], ["pathologic", "OBSERVATION", 126, 136], ["liver", "ANATOMY", 152, 157], ["D. dendriticum", "OBSERVATION", 170, 184], ["cholangiohepatitis", "OBSERVATION", 198, 216], ["less severe", "OBSERVATION_MODIFIER", 225, 236], ["Fasciola", "OBSERVATION", 259, 267], ["hepatica", "ANATOMY", 268, 276]]], ["The severity and diffuseness of the hepatic lesion are determined by the number of lancet flukes present, and they may be in the thousands.", [["hepatic lesion", "ANATOMY", 36, 50], ["flukes", "ANATOMY", 90, 96], ["hepatic lesion", "DISEASE", 36, 50], ["hepatic lesion", "PATHOLOGICAL_FORMATION", 36, 50], ["The severity", "PROBLEM", 0, 12], ["diffuseness of the hepatic lesion", "PROBLEM", 17, 50], ["lancet flukes", "PROBLEM", 83, 96], ["severity", "OBSERVATION_MODIFIER", 4, 12], ["diffuseness", "OBSERVATION_MODIFIER", 17, 28], ["hepatic", "ANATOMY", 36, 43], ["lesion", "OBSERVATION", 44, 50], ["number", "OBSERVATION_MODIFIER", 73, 79], ["lancet flukes", "OBSERVATION", 83, 96], ["may be", "UNCERTAINTY", 115, 121]]], ["The flukes and their eggs darken the dilated ducts.", [["flukes", "ANATOMY", 4, 10], ["eggs", "ANATOMY", 21, 25], ["ducts", "ANATOMY", 45, 50], ["flukes", "ORGAN", 4, 10], ["dilated ducts", "MULTI-TISSUE_STRUCTURE", 37, 50], ["The flukes", "PROBLEM", 0, 10], ["the dilated ducts", "PROBLEM", 33, 50], ["flukes", "OBSERVATION", 4, 10], ["dilated", "OBSERVATION", 37, 44], ["ducts", "ANATOMY", 45, 50]]], ["Even in early infestations, there may be some scarring of the organ at its periphery.", [["organ", "ANATOMY", 62, 67], ["organ", "ORGAN", 62, 67], ["some scarring of the organ at its periphery", "PROBLEM", 41, 84], ["early", "OBSERVATION_MODIFIER", 8, 13], ["infestations", "OBSERVATION", 14, 26], ["may be", "UNCERTAINTY", 34, 40], ["some", "OBSERVATION_MODIFIER", 41, 45], ["scarring", "OBSERVATION", 46, 54], ["organ", "ANATOMY", 62, 67], ["periphery", "ANATOMY_MODIFIER", 75, 84]]], ["In heavy infestations of long standing, there is extensive biliary fibrosis, producing an organ that is indurated, scarred, and lumpy and that at the margins may bear areas that are shrunken and completely sclerotic.", [["biliary", "ANATOMY", 59, 66], ["organ", "ANATOMY", 90, 95], ["fibrosis", "DISEASE", 67, 75], ["lumpy", "DISEASE", 128, 133], ["biliary", "ORGAN", 59, 66], ["organ", "ORGAN", 90, 95], ["extensive biliary fibrosis", "PROBLEM", 49, 75], ["indurated", "PROBLEM", 104, 113], ["scarred", "PROBLEM", 115, 122], ["completely sclerotic", "PROBLEM", 195, 215], ["heavy", "OBSERVATION_MODIFIER", 3, 8], ["infestations", "OBSERVATION", 9, 21], ["long standing", "OBSERVATION_MODIFIER", 25, 38], ["extensive", "OBSERVATION_MODIFIER", 49, 58], ["biliary", "ANATOMY", 59, 66], ["fibrosis", "OBSERVATION", 67, 75], ["organ", "ANATOMY", 90, 95], ["indurated", "OBSERVATION_MODIFIER", 104, 113], ["scarred", "OBSERVATION_MODIFIER", 115, 122], ["lumpy", "OBSERVATION_MODIFIER", 128, 133], ["margins", "OBSERVATION_MODIFIER", 150, 157], ["shrunken", "OBSERVATION_MODIFIER", 182, 190], ["completely", "OBSERVATION_MODIFIER", 195, 205], ["sclerotic", "OBSERVATION", 206, 215]]], ["The histologic changes are the same as those in fascioliasis, with perhaps more remarkable hyperplasia of the mucous glands of the large ducts (Fig. 2-89) .TrematodesHeterobilharzia americana, a trematode in the family Schistosomatidae, is the causative agent of canine schistosomiasis in North America, primarily reported from the south Atlantic and Gulf Coast states.", [["mucous glands", "ANATOMY", 110, 123], ["ducts", "ANATOMY", 137, 142], ["fascioliasis", "DISEASE", 48, 60], ["canine schistosomiasis", "DISEASE", 263, 285], ["mucous glands", "ORGAN", 110, 123], ["ducts", "MULTI-TISSUE_STRUCTURE", 137, 142], ["Trematodes", "ORGANISM", 156, 166], ["Heterobilharzia americana", "ORGANISM", 166, 191], ["Schistosomatidae", "GENE_OR_GENE_PRODUCT", 219, 235], ["canine", "ORGANISM", 263, 269], ["Heterobilharzia americana", "SPECIES", 166, 191], ["canine", "SPECIES", 263, 269], ["Heterobilharzia americana", "SPECIES", 166, 191], ["canine", "SPECIES", 263, 269], ["The histologic changes", "PROBLEM", 0, 22], ["fascioliasis", "PROBLEM", 48, 60], ["remarkable hyperplasia of the mucous glands of the large ducts", "PROBLEM", 80, 142], ["TrematodesHeterobilharzia americana", "PROBLEM", 156, 191], ["histologic", "OBSERVATION", 4, 14], ["fascioliasis", "OBSERVATION", 48, 60], ["remarkable", "OBSERVATION_MODIFIER", 80, 90], ["hyperplasia", "OBSERVATION", 91, 102], ["mucous glands", "ANATOMY", 110, 123], ["large", "OBSERVATION_MODIFIER", 131, 136], ["ducts", "ANATOMY", 137, 142], ["trematode", "OBSERVATION_MODIFIER", 195, 204], ["schistosomiasis", "OBSERVATION", 270, 285]]], ["Raccoons are the most common definitive hosts, although in addition to dogs, several other diverse mammalian species may become naturally infected, including domestic horses.", [["Raccoons", "GENE_OR_GENE_PRODUCT", 0, 8], ["dogs", "ORGANISM", 71, 75], ["horses", "ORGANISM_SUBDIVISION", 167, 173], ["dogs", "SPECIES", 71, 75], ["several other diverse mammalian species", "PROBLEM", 77, 116], ["most common", "OBSERVATION_MODIFIER", 17, 28], ["mammalian species", "OBSERVATION", 99, 116], ["infected", "OBSERVATION", 138, 146]]], ["Eggs shed in feces hatch in water and release motile miracidia, which penetrate the tissues of the intermediate host, lymnaeid freshwater snails.", [["Eggs", "ANATOMY", 0, 4], ["feces", "ANATOMY", 13, 18], ["miracidia", "ANATOMY", 53, 62], ["tissues", "ANATOMY", 84, 91], ["Eggs", "ORGANISM_SUBSTANCE", 0, 4], ["feces", "ORGANISM_SUBDIVISION", 13, 18], ["tissues", "TISSUE", 84, 91], ["Eggs", "TREATMENT", 0, 4], ["release motile miracidia", "TREATMENT", 38, 62], ["intermediate host", "OBSERVATION", 99, 116]]], ["Larval stages multiply in the snail, and free-swimming cercariae are released into freshwater.", [["cercariae", "ORGANISM", 55, 64], ["stages", "OBSERVATION_MODIFIER", 7, 13], ["multiply", "OBSERVATION_MODIFIER", 14, 22], ["snail", "ANATOMY", 30, 35], ["free", "OBSERVATION_MODIFIER", 41, 45]]], ["These penetrate the intact epidermis of the definitive host, migrate to the lung, and finally the liver, where they mature, move to the mesenteric and intrahepatic Pseudamphistomum truncatum occurs in carnivores and humans sporadically in Europe and Asia.", [["epidermis", "ANATOMY", 27, 36], ["lung", "ANATOMY", 76, 80], ["liver", "ANATOMY", 98, 103], ["mesenteric", "ANATOMY", 136, 146], ["intrahepatic Pseudamphistomum truncatum", "ANATOMY", 151, 190], ["epidermis", "ORGAN", 27, 36], ["lung", "ORGAN", 76, 80], ["liver", "ORGAN", 98, 103], ["mesenteric", "MULTI-TISSUE_STRUCTURE", 136, 146], ["Pseudamphistomum truncatum", "ORGANISM", 164, 190], ["humans", "ORGANISM", 216, 222], ["Pseudamphistomum truncatum", "SPECIES", 164, 190], ["humans", "SPECIES", 216, 222], ["Pseudamphistomum truncatum", "SPECIES", 164, 190], ["humans", "SPECIES", 216, 222], ["intact", "OBSERVATION", 20, 26], ["epidermis", "OBSERVATION_MODIFIER", 27, 36], ["definitive host", "OBSERVATION", 44, 59], ["lung", "ANATOMY", 76, 80], ["liver", "ANATOMY", 98, 103], ["mesenteric", "ANATOMY", 136, 146], ["intrahepatic", "ANATOMY", 151, 163], ["Pseudamphistomum truncatum", "OBSERVATION", 164, 190], ["carnivores", "OBSERVATION", 201, 211]]], ["Its life cycle is as for Opisthorchis.TrematodesThe opisthorchid flukes, so far as known, resemble Dicrocoelium in migrating up the bile ducts to their habitat.", [["opisthorchid flukes", "ANATOMY", 52, 71], ["bile ducts", "ANATOMY", 132, 142], ["Dicrocoelium", "CHEMICAL", 99, 111], ["opisthorchid flukes", "ORGANISM", 52, 71], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 132, 142], ["Opisthorchis", "PROBLEM", 25, 37], ["TrematodesThe opisthorchid flukes", "PROBLEM", 38, 71], ["Dicrocoelium", "TREATMENT", 99, 111], ["opisthorchid flukes", "OBSERVATION", 52, 71], ["bile ducts", "ANATOMY", 132, 142]]], ["This may be the reason that they are more numerous in the left than in the right lobes of the liver.", [["left", "ANATOMY", 58, 62], ["right lobes", "ANATOMY", 75, 86], ["liver", "ANATOMY", 94, 99], ["right lobes", "MULTI-TISSUE_STRUCTURE", 75, 86], ["liver", "ORGAN", 94, 99], ["may be the reason", "UNCERTAINTY", 5, 22], ["more", "OBSERVATION_MODIFIER", 37, 41], ["numerous", "OBSERVATION_MODIFIER", 42, 50], ["left", "ANATOMY_MODIFIER", 58, 62], ["right lobes", "ANATOMY_MODIFIER", 75, 86], ["liver", "ANATOMY", 94, 99]]], ["They can probably live in the liver for as long as the host lives.", [["liver", "ANATOMY", 30, 35], ["liver", "ORGAN", 30, 35], ["liver", "ANATOMY", 30, 35]]], ["The pathologic effects are comparable to those of D. dendriticum.", [["D. dendriticum", "ORGANISM", 50, 64], ["D. dendriticum", "SPECIES", 50, 64], ["D. dendriticum", "SPECIES", 50, 64], ["pathologic", "OBSERVATION", 4, 14], ["dendriticum", "OBSERVATION", 53, 64]]], ["Light infestations may be asymptomatic, and heavy infestations may cause jaundice, chronic cholangiohepatitis, and severe biliary fibrosis.", [["biliary", "ANATOMY", 122, 129], ["jaundice", "DISEASE", 73, 81], ["cholangiohepatitis", "DISEASE", 91, 109], ["biliary fibrosis", "DISEASE", 122, 138], ["biliary", "ORGAN", 122, 129], ["Light infestations", "PROBLEM", 0, 18], ["asymptomatic", "PROBLEM", 26, 38], ["heavy infestations", "PROBLEM", 44, 62], ["jaundice", "PROBLEM", 73, 81], ["chronic cholangiohepatitis", "PROBLEM", 83, 109], ["severe biliary fibrosis", "PROBLEM", 115, 138], ["jaundice", "OBSERVATION", 73, 81], ["chronic", "OBSERVATION_MODIFIER", 83, 90], ["cholangiohepatitis", "OBSERVATION", 91, 109], ["severe", "OBSERVATION_MODIFIER", 115, 121], ["biliary", "ANATOMY", 122, 129], ["fibrosis", "OBSERVATION", 130, 138]]], ["Both in humans and animals, adenomatous and carcinomatous changes of the biliary glands have occurred in association with these parasites; the association is probably more than coincidental.Protozoal infectionsProtozoal hepatitis is due mainly to infection with Toxoplasma ( Fig. 2-90) , Neospora, and Leishmania.", [["adenomatous", "ANATOMY", 28, 39], ["carcinomatous", "ANATOMY", 44, 57], ["biliary glands", "ANATOMY", 73, 87], ["adenomatous", "DISEASE", 28, 39], ["Protozoal infections", "DISEASE", 190, 210], ["Protozoal hepatitis", "DISEASE", 210, 229], ["infection", "DISEASE", 247, 256], ["Toxoplasma ( Fig. 2-90)", "CHEMICAL", 262, 285], ["humans", "ORGANISM", 8, 14], ["adenomatous", "CANCER", 28, 39], ["carcinomatous", "CANCER", 44, 57], ["biliary glands", "ORGAN", 73, 87], ["Toxoplasma", "ORGANISM", 262, 272], ["Fig. 2-90", "ORGANISM", 275, 284], ["Neospora", "ORGANISM", 288, 296], ["Leishmania", "ORGANISM", 302, 312], ["humans", "SPECIES", 8, 14], ["humans", "SPECIES", 8, 14], ["adenomatous and carcinomatous changes of the biliary glands", "PROBLEM", 28, 87], ["these parasites", "PROBLEM", 122, 137], ["Protozoal infections", "PROBLEM", 190, 210], ["Protozoal hepatitis", "PROBLEM", 210, 229], ["infection", "PROBLEM", 247, 256], ["Toxoplasma ( Fig.", "TEST", 262, 279], ["Neospora", "PROBLEM", 288, 296], ["Leishmania", "PROBLEM", 302, 312], ["animals", "OBSERVATION_MODIFIER", 19, 26], ["adenomatous", "OBSERVATION", 28, 39], ["carcinomatous", "OBSERVATION", 44, 57], ["biliary glands", "ANATOMY", 73, 87], ["parasites", "OBSERVATION", 128, 137], ["probably more than", "UNCERTAINTY", 158, 176], ["infections", "OBSERVATION", 200, 210], ["hepatitis", "OBSERVATION", 220, 229], ["infection", "OBSERVATION", 247, 256], ["Neospora", "OBSERVATION", 288, 296], ["Leishmania", "OBSERVATION", 302, 312]]], ["Granulomatous hepatitis has been described in dogs associated with systemic infections by Hepatozoon canis.", [["Granulomatous hepatitis", "DISEASE", 0, 23], ["systemic infections", "DISEASE", 67, 86], ["Hepatozoon canis", "DISEASE", 90, 106], ["dogs", "ORGANISM", 46, 50], ["Hepatozoon canis", "ORGANISM", 90, 106], ["dogs", "SPECIES", 46, 50], ["Hepatozoon canis", "SPECIES", 90, 106], ["Hepatozoon canis", "SPECIES", 90, 106], ["Granulomatous hepatitis", "PROBLEM", 0, 23], ["systemic infections", "PROBLEM", 67, 86], ["Hepatozoon canis", "PROBLEM", 90, 106], ["hepatitis", "OBSERVATION", 14, 23], ["systemic", "OBSERVATION_MODIFIER", 67, 75], ["infections", "OBSERVATION", 76, 86], ["Hepatozoon canis", "OBSERVATION", 90, 106]]], ["Vascular occlusion by enlarged monocytes bearing Cytauxzoon felis merozoites can be found in the liver of infected cats.", [["Vascular", "ANATOMY", 0, 8], ["monocytes", "ANATOMY", 31, 40], ["merozoites", "ANATOMY", 66, 76], ["liver", "ANATOMY", 97, 102], ["Vascular occlusion", "DISEASE", 0, 18], ["Vascular", "MULTI-TISSUE_STRUCTURE", 0, 8], ["monocytes", "CELL", 31, 40], ["Cytauxzoon felis", "ORGANISM", 49, 65], ["liver", "ORGAN", 97, 102], ["cats", "ORGANISM", 115, 119], ["enlarged monocytes", "CELL_TYPE", 22, 40], ["Cytauxzoon felis", "SPECIES", 49, 65], ["cats", "SPECIES", 115, 119], ["Cytauxzoon felis", "SPECIES", 49, 65], ["Vascular occlusion", "PROBLEM", 0, 18], ["enlarged monocytes bearing Cytauxzoon felis merozoites", "PROBLEM", 22, 76], ["occlusion", "OBSERVATION", 9, 18], ["enlarged", "OBSERVATION_MODIFIER", 22, 30], ["monocytes", "OBSERVATION", 31, 40], ["liver", "ANATOMY", 97, 102], ["infected", "OBSERVATION", 106, 114]]], ["Sarcocystis neurona schizonts were reported in the liver of a dog with systemic, multi-organ infection, and schizonts from an unspeciated Sarcocystis were observed in hepatocytes in a horse with suppurative and necrotizing hepatitis.Protozoal infectionsHepatic coccidiosis causing acute cholangiohepatitis similar to that in mink and rabbits has been observed in isolated cases in the goat, calf, and dog ( Fig. 2-91) .", [["liver", "ANATOMY", 51, 56], ["multi-organ", "ANATOMY", 81, 92], ["schizonts", "ANATOMY", 108, 117], ["hepatocytes", "ANATOMY", 167, 178], ["Hepatic", "ANATOMY", 253, 260], ["calf", "ANATOMY", 391, 395], ["Sarcocystis neurona schizonts", "DISEASE", 0, 29], ["multi-organ infection", "DISEASE", 81, 102], ["necrotizing hepatitis", "DISEASE", 211, 232], ["Protozoal infections", "DISEASE", 233, 253], ["coccidiosis", "DISEASE", 261, 272], ["cholangiohepatitis", "DISEASE", 287, 305], ["Sarcocystis neurona schizonts", "ORGANISM", 0, 29], ["liver", "ORGAN", 51, 56], ["dog", "ORGANISM", 62, 65], ["Sarcocystis", "ORGANISM", 138, 149], ["hepatocytes", "CELL", 167, 178], ["horse", "ORGANISM", 184, 189], ["Hepatic", "ORGAN", 253, 260], ["mink", "ORGANISM", 325, 329], ["rabbits", "ORGANISM", 334, 341], ["goat", "ORGANISM", 385, 389], ["calf", "ORGANISM_SUBDIVISION", 391, 395], ["dog", "ORGANISM", 401, 404], ["hepatocytes", "CELL_TYPE", 167, 178], ["Sarcocystis neurona", "SPECIES", 0, 19], ["dog", "SPECIES", 62, 65], ["horse", "SPECIES", 184, 189], ["mink", "SPECIES", 325, 329], ["rabbits", "SPECIES", 334, 341], ["goat", "SPECIES", 385, 389], ["calf", "SPECIES", 391, 395], ["dog", "SPECIES", 401, 404], ["Sarcocystis neurona", "SPECIES", 0, 19], ["mink", "SPECIES", 325, 329], ["rabbits", "SPECIES", 334, 341], ["goat", "SPECIES", 385, 389], ["Sarcocystis neurona schizonts", "PROBLEM", 0, 29], ["multi-organ infection", "PROBLEM", 81, 102], ["schizonts", "PROBLEM", 108, 117], ["an unspeciated Sarcocystis", "PROBLEM", 123, 149], ["suppurative and necrotizing hepatitis", "PROBLEM", 195, 232], ["Protozoal infections", "PROBLEM", 233, 253], ["Hepatic coccidiosis", "PROBLEM", 253, 272], ["acute cholangiohepatitis", "PROBLEM", 281, 305], ["neurona schizonts", "OBSERVATION", 12, 29], ["liver", "ANATOMY", 51, 56], ["multi-organ", "ANATOMY", 81, 92], ["infection", "OBSERVATION", 93, 102], ["Sarcocystis", "OBSERVATION", 138, 149], ["hepatocytes", "ANATOMY", 167, 178], ["suppurative", "OBSERVATION_MODIFIER", 195, 206], ["necrotizing", "OBSERVATION_MODIFIER", 211, 222], ["hepatitis", "OBSERVATION", 223, 232], ["infections", "OBSERVATION", 243, 253], ["coccidiosis", "OBSERVATION", 261, 272], ["acute", "OBSERVATION_MODIFIER", 281, 286], ["cholangiohepatitis", "OBSERVATION", 287, 305], ["isolated", "OBSERVATION_MODIFIER", 363, 371], ["cases", "OBSERVATION", 372, 377], ["goat", "ANATOMY", 385, 389], ["calf", "ANATOMY", 391, 395]]], ["These infections are usually considered aberrant, and often coincide with intestinal coccidiosis.", [["intestinal", "ANATOMY", 74, 84], ["infections", "DISEASE", 6, 16], ["intestinal coccidiosis", "DISEASE", 74, 96], ["intestinal", "ORGAN", 74, 84], ["These infections", "PROBLEM", 0, 16], ["intestinal coccidiosis", "PROBLEM", 74, 96], ["infections", "OBSERVATION", 6, 16], ["intestinal", "ANATOMY", 74, 84], ["coccidiosis", "OBSERVATION", 85, 96]]], ["Coccidial meronts and, in some cases, gamonts are present within the cytoplasm of biliary epithelium.", [["cytoplasm", "ANATOMY", 69, 78], ["biliary epithelium", "ANATOMY", 82, 100], ["gamonts", "GENE_OR_GENE_PRODUCT", 38, 45], ["cytoplasm", "ORGANISM_SUBSTANCE", 69, 78], ["biliary epithelium", "TISSUE", 82, 100], ["Coccidial meronts", "TREATMENT", 0, 17], ["biliary epithelium", "ANATOMY", 82, 100]]], ["The organisms are presently unclassified.Fungal infectionsFungal infections of the forestomachs with hematogenous dissemination to the liver occur occasionally in cattle and sheep, usually as a complication of rumenitis.", [["forestomachs", "ANATOMY", 83, 95], ["liver", "ANATOMY", 135, 140], ["Fungal infections", "DISEASE", 41, 58], ["Fungal infections", "DISEASE", 58, 75], ["hematogenous dissemination to the liver", "DISEASE", 101, 140], ["rumenitis", "DISEASE", 210, 219], ["forestomachs", "CANCER", 83, 95], ["liver", "ORGAN", 135, 140], ["cattle", "ORGANISM", 163, 169], ["sheep", "ORGANISM", 174, 179], ["cattle", "SPECIES", 163, 169], ["sheep", "SPECIES", 174, 179], ["cattle", "SPECIES", 163, 169], ["sheep", "SPECIES", 174, 179], ["Fungal infectionsFungal infections of the forestomachs", "PROBLEM", 41, 95], ["hematogenous dissemination to the liver", "PROBLEM", 101, 140], ["a complication of rumenitis", "PROBLEM", 192, 219], ["unclassified", "OBSERVATION", 28, 40], ["infections", "OBSERVATION", 48, 58], ["Fungal", "OBSERVATION_MODIFIER", 58, 64], ["infections", "OBSERVATION", 65, 75], ["hematogenous", "OBSERVATION_MODIFIER", 101, 113], ["dissemination", "OBSERVATION", 114, 127], ["liver", "ANATOMY", 135, 140]]], ["Lesions in the O 2 .", [["O 2", "CHEMICAL", 15, 18], ["Lesions", "PROBLEM", 0, 7]]], ["Most of these phase 1 enzymes are found in the smooth endoplasmic reticulum of the hepatocyte. \u2022 Phase 2 reactions are typically conjugation reactions in which a polar molecule, such as glucuronic acid, sulfate, or glutathione, is added to carboxyl, hydroxyl, amino, or sulfhydryl groups on phase 1 metabolites, making them typically less toxic and more water soluble.", [["smooth endoplasmic reticulum", "ANATOMY", 47, 75], ["hepatocyte", "ANATOMY", 83, 93], ["glucuronic acid", "CHEMICAL", 186, 201], ["glutathione", "CHEMICAL", 215, 226], ["hydroxyl", "CHEMICAL", 250, 258], ["amino", "CHEMICAL", 260, 265], ["sulfhydryl", "CHEMICAL", 270, 280], ["glucuronic acid", "CHEMICAL", 186, 201], ["sulfate", "CHEMICAL", 203, 210], ["glutathione", "CHEMICAL", 215, 226], ["carboxyl", "CHEMICAL", 240, 248], ["hydroxyl", "CHEMICAL", 250, 258], ["amino", "CHEMICAL", 260, 265], ["sulfhydryl", "CHEMICAL", 270, 280], ["smooth endoplasmic reticulum", "CELLULAR_COMPONENT", 47, 75], ["hepatocyte", "CELL", 83, 93], ["glucuronic acid", "SIMPLE_CHEMICAL", 186, 201], ["sulfate", "SIMPLE_CHEMICAL", 203, 210], ["glutathione", "SIMPLE_CHEMICAL", 215, 226], ["carboxyl", "SIMPLE_CHEMICAL", 240, 248], ["hydroxyl", "SIMPLE_CHEMICAL", 250, 258], ["amino", "AMINO_ACID", 260, 265], ["sulfhydryl", "SIMPLE_CHEMICAL", 270, 280], ["phase 1 enzymes", "PROTEIN", 14, 29], ["these phase 1 enzymes", "TEST", 8, 29], ["Phase 2 reactions", "PROBLEM", 97, 114], ["typically conjugation reactions", "PROBLEM", 119, 150], ["a polar molecule", "TREATMENT", 160, 176], ["glucuronic acid, sulfate", "TREATMENT", 186, 210], ["glutathione", "TREATMENT", 215, 226], ["carboxyl", "TREATMENT", 240, 248], ["hydroxyl", "TREATMENT", 250, 258], ["amino", "TREATMENT", 260, 265], ["sulfhydryl groups", "TREATMENT", 270, 287], ["smooth", "OBSERVATION_MODIFIER", 47, 53], ["endoplasmic reticulum", "OBSERVATION", 54, 75], ["hepatocyte", "ANATOMY", 83, 93], ["conjugation reactions", "OBSERVATION", 129, 150]]], ["Most of these enzymes are found in the cytosol. \u2022 In phase 3 reactions, conjugated molecules are transported by various transporter molecules across the modified hepatocyte membrane that lines the canaliculus.", [["cytosol", "ANATOMY", 39, 46], ["hepatocyte membrane", "ANATOMY", 162, 181], ["canaliculus", "ANATOMY", 197, 208], ["cytosol", "CELLULAR_COMPONENT", 39, 46], ["conjugated molecules", "SIMPLE_CHEMICAL", 72, 92], ["hepatocyte membrane", "CELLULAR_COMPONENT", 162, 181], ["canaliculus", "MULTI-TISSUE_STRUCTURE", 197, 208], ["enzymes", "PROTEIN", 14, 21], ["transporter molecules", "PROTEIN", 120, 141], ["these enzymes", "TEST", 8, 21], ["conjugated molecules", "PROBLEM", 72, 92], ["hepatocyte membrane", "ANATOMY", 162, 181], ["canaliculus", "ANATOMY", 197, 208]]], ["Phase 1 reactions may either increase (bioactivate) or eliminate the biological activity of the xenobiotic substrate.", [["Phase 1 reactions", "PROBLEM", 0, 17], ["increase", "OBSERVATION_MODIFIER", 29, 37]]], ["Although this step is necessary to prepare the substrate to form a covalent bond with polar compound in phase 2, it creates, if only transiently, reactive intermediates, such as free radicals and epoxides.", [["epoxides", "CHEMICAL", 196, 204], ["free radicals", "SIMPLE_CHEMICAL", 178, 191], ["epoxides", "SIMPLE_CHEMICAL", 196, 204], ["reactive intermediates", "PROBLEM", 146, 168], ["free radicals and epoxides", "TREATMENT", 178, 204]]], ["These reactive intermediates can bind to cellular macromolecules, such as the CYP enzymes, that produced them, other cellular enzymes or structural proteins, or RNA and DNA, leading to hepatocyte injury, death, or neoplastic transformation.", [["cellular", "ANATOMY", 41, 49], ["cellular", "ANATOMY", 117, 125], ["hepatocyte", "ANATOMY", 185, 195], ["neoplastic", "ANATOMY", 214, 224], ["hepatocyte injury", "DISEASE", 185, 202], ["death", "DISEASE", 204, 209], ["cellular", "CELL", 41, 49], ["CYP enzymes", "GENE_OR_GENE_PRODUCT", 78, 89], ["cellular", "CELL", 117, 125], ["DNA", "CELLULAR_COMPONENT", 169, 172], ["hepatocyte", "CELL", 185, 195], ["CYP enzymes", "PROTEIN", 78, 89], ["cellular enzymes", "PROTEIN", 117, 133], ["structural proteins", "PROTEIN", 137, 156], ["These reactive intermediates", "PROBLEM", 0, 28], ["the CYP enzymes", "TEST", 74, 89], ["other cellular enzymes", "PROBLEM", 111, 133], ["structural proteins", "PROBLEM", 137, 156], ["RNA and DNA", "PROBLEM", 161, 172], ["hepatocyte injury", "PROBLEM", 185, 202], ["death", "PROBLEM", 204, 209], ["neoplastic transformation", "PROBLEM", 214, 239], ["reactive", "OBSERVATION_MODIFIER", 6, 14], ["hepatocyte", "ANATOMY", 185, 195], ["injury", "OBSERVATION", 196, 202], ["neoplastic transformation", "OBSERVATION", 214, 239]]], ["The CYPs can be found in all parts of the hepatic lobule, but the hepatocytes of centrilobular region have a higher content than those of the periportal region, which apparently accounts for the centrilobular predominance of injury produced by compounds metabolized by this system, including carbon tetrachloride and acetaminophen.", [["hepatic lobule", "ANATOMY", 42, 56], ["hepatocytes", "ANATOMY", 66, 77], ["centrilobular region", "ANATOMY", 81, 101], ["periportal region", "ANATOMY", 142, 159], ["centrilobular", "ANATOMY", 195, 208], ["carbon tetrachloride", "CHEMICAL", 292, 312], ["acetaminophen", "CHEMICAL", 317, 330], ["carbon tetrachloride", "CHEMICAL", 292, 312], ["acetaminophen", "CHEMICAL", 317, 330], ["CYPs", "GENE_OR_GENE_PRODUCT", 4, 8], ["hepatic lobule", "MULTI-TISSUE_STRUCTURE", 42, 56], ["hepatocytes", "CELL", 66, 77], ["centrilobular region", "MULTI-TISSUE_STRUCTURE", 81, 101], ["carbon tetrachloride", "SIMPLE_CHEMICAL", 292, 312], ["acetaminophen", "SIMPLE_CHEMICAL", 317, 330], ["CYPs", "PROTEIN", 4, 8], ["hepatocytes", "CELL_TYPE", 66, 77], ["centrilobular region", "PROBLEM", 81, 101], ["the centrilobular predominance of injury", "PROBLEM", 191, 231], ["carbon tetrachloride", "TREATMENT", 292, 312], ["acetaminophen", "TREATMENT", 317, 330], ["CYPs", "ANATOMY", 4, 8], ["all", "ANATOMY_MODIFIER", 25, 28], ["parts", "ANATOMY_MODIFIER", 29, 34], ["hepatic", "ANATOMY", 42, 49], ["lobule", "ANATOMY_MODIFIER", 50, 56], ["hepatocytes", "ANATOMY", 66, 77], ["centrilobular", "ANATOMY_MODIFIER", 81, 94], ["higher", "OBSERVATION_MODIFIER", 109, 115], ["content", "OBSERVATION_MODIFIER", 116, 123], ["periportal", "ANATOMY", 142, 152], ["region", "ANATOMY_MODIFIER", 153, 159], ["apparently accounts for", "UNCERTAINTY", 167, 190], ["centrilobular", "OBSERVATION_MODIFIER", 195, 208], ["predominance", "OBSERVATION", 209, 221], ["injury", "OBSERVATION", 225, 231]]], ["In contrast, hepatocytes in the periportal zone are more susceptible to direct-acting toxicants, such as metal salts, because of their proximity to incoming portal and arterial vascular flow.Fungal infectionsSo-called \"drug-drug\" interactions can arise when 2 drugs are metabolized by the same CYP, so that metabolism of one or both of the compounds is altered by competition or interference with the relevant CYP enzyme function.Fungal infectionsPhase 2 reactions inactivate the phase 1 metabolite through conjugation with a polar molecule and facilitate its export by transforming the lipophilic molecule into a watersoluble molecule that can be transported out of the hepatocyte and into the bile or the circulation for removal via the kidney.", [["hepatocytes", "ANATOMY", 13, 24], ["periportal zone", "ANATOMY", 32, 47], ["portal", "ANATOMY", 157, 163], ["arterial vascular", "ANATOMY", 168, 185], ["hepatocyte", "ANATOMY", 671, 681], ["bile", "ANATOMY", 695, 699], ["kidney", "ANATOMY", 739, 745], ["Fungal infections", "DISEASE", 191, 208], ["Fungal infections", "DISEASE", 430, 447], ["hepatocytes", "CELL", 13, 24], ["periportal zone", "MULTI-TISSUE_STRUCTURE", 32, 47], ["metal salts", "SIMPLE_CHEMICAL", 105, 116], ["portal", "MULTI-TISSUE_STRUCTURE", 157, 163], ["arterial vascular", "MULTI-TISSUE_STRUCTURE", 168, 185], ["CYP", "GENE_OR_GENE_PRODUCT", 294, 297], ["CYP enzyme", "GENE_OR_GENE_PRODUCT", 410, 420], ["hepatocyte", "CELL", 671, 681], ["bile", "MULTI-TISSUE_STRUCTURE", 695, 699], ["kidney", "ORGAN", 739, 745], ["hepatocytes", "CELL_TYPE", 13, 24], ["CYP", "PROTEIN", 294, 297], ["CYP enzyme", "PROTEIN", 410, 420], ["watersoluble molecule", "PROTEIN", 614, 635], ["hepatocytes in the periportal zone", "PROBLEM", 13, 47], ["direct-acting toxicants", "PROBLEM", 72, 95], ["metal salts", "TREATMENT", 105, 116], ["Fungal infections", "PROBLEM", 191, 208], ["Fungal infections", "PROBLEM", 430, 447], ["Phase 2 reactions", "PROBLEM", 447, 464], ["a polar molecule", "TREATMENT", 524, 540], ["a watersoluble molecule", "PROBLEM", 612, 635], ["removal via the kidney", "TREATMENT", 723, 745], ["hepatocytes", "ANATOMY", 13, 24], ["periportal", "ANATOMY", 32, 42], ["zone", "ANATOMY_MODIFIER", 43, 47], ["portal", "ANATOMY", 157, 163], ["arterial", "ANATOMY_MODIFIER", 168, 176], ["vascular", "ANATOMY", 177, 185], ["flow", "OBSERVATION", 186, 190], ["infections", "OBSERVATION", 198, 208], ["infections", "OBSERVATION", 437, 447], ["hepatocyte", "ANATOMY", 671, 681], ["bile", "ANATOMY", 695, 699], ["kidney", "ANATOMY", 739, 745]]], ["Reduced glutathione is a major substrate for phase 2 reactions mediated by glutathione S-transferases.", [["glutathione", "CHEMICAL", 8, 19], ["glutathione", "CHEMICAL", 75, 86], ["glutathione", "CHEMICAL", 8, 19], ["glutathione", "CHEMICAL", 75, 86], ["glutathione", "SIMPLE_CHEMICAL", 8, 19], ["glutathione S-transferases", "GENE_OR_GENE_PRODUCT", 75, 101], ["glutathione S-transferases", "PROTEIN", 75, 101], ["Reduced glutathione", "PROBLEM", 0, 19], ["phase 2 reactions", "PROBLEM", 45, 62], ["glutathione", "OBSERVATION", 8, 19]]], ["Active metabolites of many compounds, including acetaminophen are detoxified by conjugation with glutathione.", [["acetaminophen", "CHEMICAL", 48, 61], ["glutathione", "CHEMICAL", 97, 108], ["acetaminophen", "CHEMICAL", 48, 61], ["glutathione", "CHEMICAL", 97, 108], ["acetaminophen", "SIMPLE_CHEMICAL", 48, 61], ["glutathione", "SIMPLE_CHEMICAL", 97, 108], ["many compounds", "PROBLEM", 22, 36], ["acetaminophen", "TREATMENT", 48, 61], ["glutathione", "TREATMENT", 97, 108], ["metabolites", "OBSERVATION_MODIFIER", 7, 18], ["many", "OBSERVATION_MODIFIER", 22, 26], ["compounds", "OBSERVATION_MODIFIER", 27, 36]]], ["Depletion of glutathione can greatly enhance the toxicity of many compounds.", [["glutathione", "CHEMICAL", 13, 24], ["toxicity", "DISEASE", 49, 57], ["glutathione", "CHEMICAL", 13, 24], ["glutathione", "SIMPLE_CHEMICAL", 13, 24], ["Depletion of glutathione", "PROBLEM", 0, 24], ["the toxicity", "PROBLEM", 45, 57], ["toxicity", "OBSERVATION_MODIFIER", 49, 57], ["many", "OBSERVATION_MODIFIER", 61, 65], ["compounds", "OBSERVATION", 66, 75]]], ["Hepatic glutathione is also important in the removal of various free radicals and reactive oxygen species generated by normal metabolic processes as well as detoxification pathways through the action of glutathione peroxidase.", [["Hepatic", "ANATOMY", 0, 7], ["glutathione", "CHEMICAL", 8, 19], ["oxygen", "CHEMICAL", 91, 97], ["glutathione", "CHEMICAL", 203, 214], ["glutathione", "CHEMICAL", 8, 19], ["oxygen", "CHEMICAL", 91, 97], ["glutathione", "CHEMICAL", 203, 214], ["Hepatic", "MULTI-TISSUE_STRUCTURE", 0, 7], ["glutathione", "SIMPLE_CHEMICAL", 8, 19], ["reactive oxygen species", "SIMPLE_CHEMICAL", 82, 105], ["glutathione peroxidase", "GENE_OR_GENE_PRODUCT", 203, 225], ["glutathione peroxidase", "PROTEIN", 203, 225], ["Hepatic glutathione", "TREATMENT", 0, 19], ["the removal", "TREATMENT", 41, 52], ["various free radicals", "TREATMENT", 56, 77], ["reactive oxygen species", "TREATMENT", 82, 105], ["detoxification pathways", "TREATMENT", 157, 180], ["glutathione peroxidase", "TREATMENT", 203, 225], ["glutathione", "OBSERVATION", 8, 19], ["free radicals", "OBSERVATION", 64, 77], ["reactive", "OBSERVATION_MODIFIER", 82, 90], ["oxygen species", "OBSERVATION", 91, 105], ["metabolic processes", "OBSERVATION", 126, 145]]], ["Different species and different breeds of animals possess a divergent array of phase 1 and phase 2 types with differing levels of activity and target substrates that contribute to the differences in metabolism and toxicity of xenobiotics observed in different species.", [["toxicity", "DISEASE", 214, 222], ["Different species", "PROBLEM", 0, 17], ["differing levels of activity and target substrates", "PROBLEM", 110, 160], ["the differences in metabolism", "PROBLEM", 180, 209], ["toxicity of xenobiotics", "PROBLEM", 214, 237], ["different breeds", "OBSERVATION", 22, 38]]], ["Acetaminophen toxicity in the cat is a relevant example.", [["Acetaminophen", "CHEMICAL", 0, 13], ["toxicity", "DISEASE", 14, 22], ["Acetaminophen", "CHEMICAL", 0, 13], ["Acetaminophen", "SIMPLE_CHEMICAL", 0, 13], ["cat", "ORGANISM", 30, 33], ["Acetaminophen toxicity", "PROBLEM", 0, 22]]], ["Felids have limited phase 2 metabolism caused, in part, from diminished activity of uridine diphosphate (UDP)glucuronosyl transferase, an enzyme involved in glucuronidation of bioactivated molecules.", [["uridine diphosphate", "CHEMICAL", 84, 103], ["UDP", "CHEMICAL", 105, 108], ["uridine diphosphate", "CHEMICAL", 84, 103], ["UDP", "CHEMICAL", 105, 108], ["glucuronosyl", "CHEMICAL", 109, 121], ["uridine diphosphate", "SIMPLE_CHEMICAL", 84, 103], ["UDP)glucuronosyl transferase", "GENE_OR_GENE_PRODUCT", 105, 133], ["uridine diphosphate (UDP)glucuronosyl transferase", "PROTEIN", 84, 133], ["bioactivated molecules", "PROTEIN", 176, 198], ["uridine diphosphate (UDP)glucuronosyl transferase", "TEST", 84, 133], ["an enzyme", "TEST", 135, 144], ["bioactivated molecules", "PROBLEM", 176, 198], ["bioactivated molecules", "OBSERVATION", 176, 198]]], ["Limited glucuronidation of acetaminophen metabolites leads to saturation of other detoxification pathways and depletion of glutathione.", [["acetaminophen", "CHEMICAL", 27, 40], ["glutathione", "CHEMICAL", 123, 134], ["acetaminophen", "CHEMICAL", 27, 40], ["glutathione", "CHEMICAL", 123, 134], ["acetaminophen", "SIMPLE_CHEMICAL", 27, 40], ["glutathione", "SIMPLE_CHEMICAL", 123, 134], ["acetaminophen metabolites", "TREATMENT", 27, 52], ["depletion of glutathione", "TREATMENT", 110, 134]]], ["The lack of glutathione then enables a highly toxic metabolite of acetaminophen, N-acetyl-para-benzoquinoneimine (NAPQI) to bind to cellular proteins and membranes, causing cell injuryTOXIC HEPATIC DISEASE Hepatic susceptibilityThe liver is particularly vulnerable to toxic injury because it is exposed to virtually everything that is absorbed.", [["cellular", "ANATOMY", 132, 140], ["membranes", "ANATOMY", 154, 163], ["cell", "ANATOMY", 173, 177], ["Hepatic", "ANATOMY", 206, 213], ["liver", "ANATOMY", 232, 237], ["glutathione", "CHEMICAL", 12, 23], ["acetaminophen", "CHEMICAL", 66, 79], ["N-acetyl-para-benzoquinoneimine", "CHEMICAL", 81, 112], ["NAPQI", "CHEMICAL", 114, 119], ["toxic injury", "DISEASE", 268, 280], ["glutathione", "CHEMICAL", 12, 23], ["acetaminophen", "CHEMICAL", 66, 79], ["N-acetyl-para-benzoquinoneimine", "CHEMICAL", 81, 112], ["NAPQI", "CHEMICAL", 114, 119], ["glutathione", "SIMPLE_CHEMICAL", 12, 23], ["acetaminophen", "SIMPLE_CHEMICAL", 66, 79], ["N-acetyl-para-benzoquinoneimine", "SIMPLE_CHEMICAL", 81, 112], ["NAPQI", "SIMPLE_CHEMICAL", 114, 119], ["cellular", "CELL", 132, 140], ["membranes", "CELLULAR_COMPONENT", 154, 163], ["cell", "CELL", 173, 177], ["liver", "ORGAN", 232, 237], ["cellular proteins", "PROTEIN", 132, 149], ["acetaminophen", "TREATMENT", 66, 79], ["acetyl", "TREATMENT", 83, 89], ["para", "TREATMENT", 90, 94], ["benzoquinoneimine (NAPQI)", "TREATMENT", 95, 120], ["cellular proteins and membranes", "PROBLEM", 132, 163], ["cell injuryTOXIC HEPATIC DISEASE Hepatic susceptibility", "PROBLEM", 173, 228], ["toxic injury", "PROBLEM", 268, 280], ["cell", "OBSERVATION", 173, 177], ["injuryTOXIC", "ANATOMY_MODIFIER", 178, 189], ["HEPATIC", "ANATOMY", 190, 197], ["DISEASE", "OBSERVATION", 198, 205], ["Hepatic", "ANATOMY", 206, 213], ["susceptibility", "OBSERVATION", 214, 228], ["liver", "ANATOMY", 232, 237], ["toxic", "OBSERVATION_MODIFIER", 268, 273], ["injury", "OBSERVATION", 274, 280]]], ["The portal vein that drains the stomach and intestines flows directly to the liver.", [["portal vein", "ANATOMY", 4, 15], ["stomach", "ANATOMY", 32, 39], ["intestines", "ANATOMY", 44, 54], ["liver", "ANATOMY", 77, 82], ["portal vein", "MULTI-TISSUE_STRUCTURE", 4, 15], ["stomach", "ORGAN", 32, 39], ["intestines", "ORGAN", 44, 54], ["liver", "ORGAN", 77, 82], ["portal vein", "ANATOMY", 4, 15], ["drains", "OBSERVATION", 21, 27], ["stomach", "ANATOMY", 32, 39], ["intestines", "ANATOMY", 44, 54], ["liver", "ANATOMY", 77, 82]]], ["This facilitates high hepatic concentrations of ingested foreign chemicals or drugs termed xenobiotics, as well as many naturally occurring substances with toxic potential.", [["hepatic", "ANATOMY", 22, 29], ["hepatic", "MULTI-TISSUE_STRUCTURE", 22, 29], ["drugs termed xenobiotics", "TREATMENT", 78, 102], ["high", "OBSERVATION_MODIFIER", 17, 21], ["hepatic", "ANATOMY", 22, 29], ["foreign chemicals", "OBSERVATION", 57, 74]]], ["Most xenobiotics are unable to directly enter the hepatocyte and require specific transporters to pass through the lipid bilayer of the hepatocyte membrane.", [["hepatocyte", "ANATOMY", 50, 60], ["lipid bilayer", "ANATOMY", 115, 128], ["hepatocyte membrane", "ANATOMY", 136, 155], ["hepatocyte", "CELL", 50, 60], ["lipid bilayer", "CELLULAR_COMPONENT", 115, 128], ["hepatocyte membrane", "CELLULAR_COMPONENT", 136, 155], ["specific transporters", "TREATMENT", 73, 94], ["hepatocyte", "ANATOMY", 50, 60], ["hepatocyte membrane", "ANATOMY", 136, 155]]], ["The uptake of exogenous and endogenous compounds from the sinusoidal blood is facilitated by a number of basolaterally located transporters.", [["sinusoidal blood", "ANATOMY", 58, 74], ["sinusoidal blood", "MULTI-TISSUE_STRUCTURE", 58, 74], ["basolaterally located transporters", "PROTEIN", 105, 139], ["The uptake of exogenous and endogenous compounds", "PROBLEM", 0, 48], ["uptake", "OBSERVATION_MODIFIER", 4, 10], ["exogenous", "OBSERVATION_MODIFIER", 14, 23], ["endogenous compounds", "OBSERVATION", 28, 48], ["sinusoidal blood", "OBSERVATION", 58, 74]]], ["These transporters are members of a large group of sodiumindependent solute transporters known as organic anion transporting polypeptides (OATP).", [["organic anion transporting polypeptides", "GENE_OR_GENE_PRODUCT", 98, 137], ["OATP", "GENE_OR_GENE_PRODUCT", 139, 143], ["sodiumindependent solute transporters", "PROTEIN", 51, 88], ["organic anion transporting polypeptides", "PROTEIN", 98, 137], ["OATP", "PROTEIN", 139, 143], ["a large group of sodiumindependent solute transporters", "TREATMENT", 34, 88], ["organic anion transporting polypeptides", "TREATMENT", 98, 137]]], ["Xenobiotics may be concentrated in hepatocytes to various degrees by mechanisms that remain obscure, but which are associated with special binding proteins of hepatocytes, attachment to enzymatic sites where metabolic conversions occur, and inhibition of export into the bile.", [["hepatocytes", "ANATOMY", 35, 46], ["hepatocytes", "ANATOMY", 159, 170], ["bile", "ANATOMY", 271, 275], ["Xenobiotics", "SIMPLE_CHEMICAL", 0, 11], ["hepatocytes", "CELL", 35, 46], ["hepatocytes", "CELL", 159, 170], ["bile", "MULTI-TISSUE_STRUCTURE", 271, 275], ["hepatocytes", "CELL_TYPE", 35, 46], ["special binding proteins", "PROTEIN", 131, 155], ["hepatocytes", "CELL_TYPE", 159, 170], ["Xenobiotics", "TREATMENT", 0, 11], ["special binding proteins of hepatocytes", "PROBLEM", 131, 170], ["enzymatic sites", "PROBLEM", 186, 201], ["metabolic conversions", "TREATMENT", 208, 229], ["hepatocytes", "ANATOMY", 35, 46], ["various degrees", "OBSERVATION_MODIFIER", 50, 65], ["hepatocytes", "ANATOMY", 159, 170], ["metabolic conversions", "OBSERVATION", 208, 229], ["bile", "ANATOMY", 271, 275]]], ["The liver is exposed to high concentrations of toxic metabolites because of its role as the primary site of biotransformation for many therapeutic agents and endogenous substances.", [["liver", "ANATOMY", 4, 9], ["liver", "ORGAN", 4, 9], ["toxic metabolites", "PROBLEM", 47, 64], ["many therapeutic agents", "TREATMENT", 130, 153], ["endogenous substances", "TREATMENT", 158, 179], ["liver", "ANATOMY", 4, 9], ["exposed", "OBSERVATION", 13, 20], ["high concentrations", "OBSERVATION_MODIFIER", 24, 43], ["toxic metabolites", "OBSERVATION", 47, 64], ["endogenous substances", "OBSERVATION", 158, 179]]], ["Some metabolites may produce hepatocellular injury, and others may cause biliary injury once they are transported into the canaliculi.", [["hepatocellular", "ANATOMY", 29, 43], ["biliary", "ANATOMY", 73, 80], ["canaliculi", "ANATOMY", 123, 133], ["hepatocellular injury", "DISEASE", 29, 50], ["biliary injury", "DISEASE", 73, 87], ["hepatocellular", "CANCER", 29, 43], ["biliary", "ORGAN", 73, 80], ["canaliculi", "MULTI-TISSUE_STRUCTURE", 123, 133], ["Some metabolites", "PROBLEM", 0, 16], ["hepatocellular injury", "PROBLEM", 29, 50], ["biliary injury", "PROBLEM", 73, 87], ["may produce", "UNCERTAINTY", 17, 28], ["hepatocellular injury", "OBSERVATION", 29, 50], ["biliary", "ANATOMY", 73, 80], ["injury", "OBSERVATION", 81, 87], ["canaliculi", "ANATOMY", 123, 133]]], ["Certain drug metabolites may be reabsorbed in the enterohepatic circulation in a fashion similar to bile acids, facilitating repeated exposure to the drug in question.", [["bile", "ANATOMY", 100, 104], ["bile acids", "CHEMICAL", 100, 110], ["bile acids", "CHEMICAL", 100, 110], ["enterohepatic circulation", "MULTI-TISSUE_STRUCTURE", 50, 75], ["bile acids", "SIMPLE_CHEMICAL", 100, 110], ["Certain drug metabolites", "PROBLEM", 0, 24], ["bile acids", "TREATMENT", 100, 110], ["enterohepatic circulation", "ANATOMY", 50, 75], ["bile", "ANATOMY", 100, 104]]], ["In addition, many drug administration regimens may achieve relatively high millimolar concentrations, resulting in depletion of conjugating cofactors such as glutathione, which can reach the lower limits required for other cytoprotective roles.Role of hepatic biotransformation in hepatotoxicityAn understanding of hepatic biotransformation is essential for an appreciation of the hepatotoxic potential of foreign compounds.", [["hepatic", "ANATOMY", 252, 259], ["hepatic", "ANATOMY", 315, 322], ["millimolar", "CHEMICAL", 75, 85], ["glutathione", "CHEMICAL", 158, 169], ["hepatotoxicity", "DISEASE", 281, 295], ["hepatotoxic", "DISEASE", 381, 392], ["glutathione", "CHEMICAL", 158, 169], ["glutathione", "SIMPLE_CHEMICAL", 158, 169], ["hepatic", "ORGAN", 252, 259], ["hepatic", "MULTI-TISSUE_STRUCTURE", 315, 322], ["many drug administration regimens", "TREATMENT", 13, 46], ["relatively high millimolar concentrations", "PROBLEM", 59, 100], ["conjugating cofactors", "PROBLEM", 128, 149], ["glutathione", "TREATMENT", 158, 169], ["hepatic biotransformation", "PROBLEM", 252, 277], ["hepatotoxicity", "PROBLEM", 281, 295], ["foreign compounds", "PROBLEM", 406, 423], ["conjugating cofactors", "OBSERVATION", 128, 149], ["lower limits", "OBSERVATION_MODIFIER", 191, 203], ["hepatic", "ANATOMY", 252, 259], ["biotransformation", "OBSERVATION", 260, 277], ["hepatotoxicity", "OBSERVATION", 281, 295], ["hepatic", "ANATOMY", 315, 322], ["biotransformation", "OBSERVATION", 323, 340], ["foreign compounds", "OBSERVATION", 406, 423]]], ["Hepatocytes are the major site of metabolism of endogenous substances and xenobiotics, including plant-or fungalderived secondary metabolites consumed in food, environmental chemicals and drugs.", [["Hepatocytes", "ANATOMY", 0, 11], ["Hepatocytes", "CELL", 0, 11], ["Hepatocytes", "CELL_TYPE", 0, 11], ["Hepatocytes", "TREATMENT", 0, 11], ["xenobiotics", "TREATMENT", 74, 85], ["metabolism of", "OBSERVATION", 34, 47], ["endogenous substances", "OBSERVATION", 48, 69]]], ["Given the numerous enzymes and the magnitude of their expression, the liver easily exceeds the metabolic capacity of all other organs.", [["liver", "ANATOMY", 70, 75], ["organs", "ANATOMY", 127, 133], ["liver", "ORGAN", 70, 75], ["organs", "ORGAN", 127, 133], ["the numerous enzymes", "TEST", 6, 26], ["liver", "ANATOMY", 70, 75], ["metabolic capacity", "OBSERVATION", 95, 113]]], ["A major metabolic function of the liver is to transform lipophilic substances, including endogenous steroid hormones and most xenobiotics, into more water-soluble polar molecules to be excreted in bile or urine.", [["liver", "ANATOMY", 34, 39], ["bile", "ANATOMY", 197, 201], ["urine", "ANATOMY", 205, 210], ["steroid", "CHEMICAL", 100, 107], ["steroid", "CHEMICAL", 100, 107], ["liver", "ORGAN", 34, 39], ["bile", "SIMPLE_CHEMICAL", 197, 201], ["urine", "ORGANISM_SUBSTANCE", 205, 210], ["lipophilic substances", "PROBLEM", 56, 77], ["endogenous steroid hormones", "TREATMENT", 89, 116], ["most xenobiotics", "TREATMENT", 121, 137], ["water-soluble polar molecules", "TREATMENT", 149, 178], ["metabolic function", "OBSERVATION", 8, 26], ["liver", "ANATOMY", 34, 39], ["lipophilic substances", "OBSERVATION", 56, 77], ["endogenous steroid hormones", "OBSERVATION", 89, 116], ["bile", "ANATOMY", 197, 201]]], ["Relevant hepatic enzymes involved in biotransformation and their associated activities can be grouped into 3 major categories.Role of hepatic biotransformation in hepatotoxicity\u2022 Phase 1 reactions promote oxidation, reduction, hydrolysis, cyclization, and decyclization of the parent compounds.", [["hepatic", "ANATOMY", 9, 16], ["hepatic", "ANATOMY", 134, 141], ["hepatotoxicity", "DISEASE", 163, 177], ["hepatic", "MULTI-TISSUE_STRUCTURE", 9, 16], ["hepatic", "MULTI-TISSUE_STRUCTURE", 134, 141], ["hepatic enzymes", "PROTEIN", 9, 24], ["Relevant hepatic enzymes", "TEST", 0, 24], ["hepatic biotransformation", "PROBLEM", 134, 159], ["hepatotoxicity", "PROBLEM", 163, 177], ["oxidation", "TREATMENT", 205, 214], ["reduction", "TREATMENT", 216, 225], ["hydrolysis", "TREATMENT", 227, 237], ["cyclization", "TREATMENT", 239, 250], ["decyclization", "TREATMENT", 256, 269], ["hepatic", "ANATOMY", 9, 16], ["hepatic", "ANATOMY", 134, 141], ["biotransformation", "OBSERVATION", 142, 159], ["hepatotoxicity", "OBSERVATION", 163, 177]]], ["This is typically accomplished through addition of oxygen or removal of hydrogen, carried out by mixed-function oxidases that are usually CYP enzymes (also known as cytochrome P450 monooxygenases), using NADPH andRole of inflammation in hepatotoxicityThe extent of liver injury following exposure to xenobiotics is not, however, determined by the chemistry of drug metabolism alone.", [["liver", "ANATOMY", 265, 270], ["oxygen", "CHEMICAL", 51, 57], ["hydrogen", "CHEMICAL", 72, 80], ["NADPH", "CHEMICAL", 204, 209], ["inflammation", "DISEASE", 221, 233], ["hepatotoxicity", "DISEASE", 237, 251], ["liver injury", "DISEASE", 265, 277], ["xenobiotics", "CHEMICAL", 300, 311], ["oxygen", "CHEMICAL", 51, 57], ["hydrogen", "CHEMICAL", 72, 80], ["NADPH", "CHEMICAL", 204, 209], ["oxygen", "SIMPLE_CHEMICAL", 51, 57], ["hydrogen", "SIMPLE_CHEMICAL", 72, 80], ["CYP enzymes", "GENE_OR_GENE_PRODUCT", 138, 149], ["cytochrome P450 monooxygenases", "GENE_OR_GENE_PRODUCT", 165, 195], ["NADPH", "SIMPLE_CHEMICAL", 204, 209], ["liver", "ORGAN", 265, 270], ["CYP enzymes", "PROTEIN", 138, 149], ["cytochrome P450 monooxygenases", "PROTEIN", 165, 195], ["oxygen", "TREATMENT", 51, 57], ["removal", "TREATMENT", 61, 68], ["hydrogen", "TREATMENT", 72, 80], ["mixed-function oxidases", "PROBLEM", 97, 120], ["CYP enzymes", "TEST", 138, 149], ["cytochrome P450 monooxygenases", "TREATMENT", 165, 195], ["NADPH", "TREATMENT", 204, 209], ["inflammation in hepatotoxicity", "PROBLEM", 221, 251], ["liver injury", "PROBLEM", 265, 277], ["xenobiotics", "TREATMENT", 300, 311], ["oxygen", "OBSERVATION_MODIFIER", 51, 57], ["inflammation", "OBSERVATION", 221, 233], ["hepatotoxicity", "OBSERVATION", 237, 251], ["extent", "OBSERVATION_MODIFIER", 255, 261], ["liver", "ANATOMY", 265, 270], ["injury", "OBSERVATION", 271, 277]]], ["Following exposure to injurious compounds, the inflammatory response, particularly the innate immune response, can significantly influence the extent of hepatocellular injury.", [["hepatocellular", "ANATOMY", 153, 167], ["hepatocellular injury", "DISEASE", 153, 174], ["hepatocellular", "ORGAN", 153, 167], ["injurious compounds", "PROBLEM", 22, 41], ["the inflammatory response", "PROBLEM", 43, 68], ["hepatocellular injury", "PROBLEM", 153, 174], ["injurious compounds", "OBSERVATION", 22, 41], ["inflammatory", "OBSERVATION_MODIFIER", 47, 59], ["hepatocellular", "ANATOMY", 153, 167], ["injury", "OBSERVATION", 168, 174]]], ["Studies using acetaminophen have provided most relevant information on this issue; however, the effects of inflammation are complex, and not all studies are in agreement.", [["acetaminophen", "CHEMICAL", 14, 27], ["inflammation", "DISEASE", 107, 119], ["acetaminophen", "CHEMICAL", 14, 27], ["acetaminophen", "SIMPLE_CHEMICAL", 14, 27], ["acetaminophen", "TREATMENT", 14, 27], ["inflammation", "PROBLEM", 107, 119], ["inflammation", "OBSERVATION", 107, 119]]], ["There are conflicting studies demonstrating either proinflammatory or anti-inflammatory effects of Kupffer cells following drug-induced injury.", [["Kupffer cells", "ANATOMY", 99, 112], ["Kupffer cells", "CELL", 99, 112], ["Kupffer cells", "CELL_TYPE", 99, 112], ["conflicting studies", "TEST", 10, 29], ["Kupffer cells", "TREATMENT", 99, 112], ["drug-induced injury", "PROBLEM", 123, 142], ["proinflammatory", "OBSERVATION_MODIFIER", 51, 66], ["anti-inflammatory", "OBSERVATION_MODIFIER", 70, 87], ["Kupffer cells", "OBSERVATION", 99, 112], ["injury", "OBSERVATION", 136, 142]]], ["Some clarification of this controversy has been facilitated by the identification of subsets of intrahepatic macrophages following injury.", [["intrahepatic macrophages", "ANATOMY", 96, 120], ["intrahepatic macrophages", "CELL", 96, 120], ["intrahepatic macrophages", "CELL_TYPE", 96, 120], ["intrahepatic macrophages", "PROBLEM", 96, 120], ["injury", "PROBLEM", 131, 137], ["intrahepatic", "ANATOMY", 96, 108], ["macrophages", "OBSERVATION", 109, 120], ["injury", "OBSERVATION", 131, 137]]], ["In addition to the resident Kupffer cells, a population of infiltrating macrophages can be detected quite soon (within 12 hours) after acetaminophen intoxication.", [["Kupffer cells", "ANATOMY", 28, 41], ["infiltrating macrophages", "ANATOMY", 59, 83], ["acetaminophen", "CHEMICAL", 135, 148], ["acetaminophen", "CHEMICAL", 135, 148], ["Kupffer cells", "CELL", 28, 41], ["macrophages", "CELL", 72, 83], ["acetaminophen", "SIMPLE_CHEMICAL", 135, 148], ["resident Kupffer cells", "CELL_TYPE", 19, 41], ["infiltrating macrophages", "CELL_TYPE", 59, 83], ["infiltrating macrophages", "PROBLEM", 59, 83], ["acetaminophen intoxication", "PROBLEM", 135, 161], ["Kupffer cells", "ANATOMY", 28, 41], ["infiltrating macrophages", "OBSERVATION", 59, 83]]], ["There are 2 major phenotypes of intrahepatic macrophages.", [["intrahepatic macrophages", "ANATOMY", 32, 56], ["intrahepatic macrophages", "CELL", 32, 56], ["intrahepatic macrophages", "CELL_TYPE", 32, 56], ["2 major phenotypes of intrahepatic macrophages", "PROBLEM", 10, 56], ["major", "OBSERVATION_MODIFIER", 12, 17], ["phenotypes", "OBSERVATION", 18, 28], ["intrahepatic", "ANATOMY", 32, 44], ["macrophages", "OBSERVATION", 45, 56]]], ["M1 macrophages are proinflammatory, a source for tumor necrosis factor-\u03b1, interleukin-1\u03b2 (IL-1\u03b2) and nitric oxide, which stimulates hepatocellular injury, and these macrophages constitute the majority of the Kupffer cell population.", [["M1 macrophages", "ANATOMY", 0, 14], ["hepatocellular", "ANATOMY", 132, 146], ["macrophages", "ANATOMY", 165, 176], ["Kupffer cell", "ANATOMY", 208, 220], ["tumor", "DISEASE", 49, 54], ["nitric oxide", "CHEMICAL", 101, 113], ["hepatocellular injury", "DISEASE", 132, 153], ["nitric oxide", "CHEMICAL", 101, 113], ["M1 macrophages", "CELL", 0, 14], ["tumor necrosis factor-\u03b1", "GENE_OR_GENE_PRODUCT", 49, 72], ["interleukin-1\u03b2", "GENE_OR_GENE_PRODUCT", 74, 88], ["IL-1\u03b2", "GENE_OR_GENE_PRODUCT", 90, 95], ["nitric oxide", "SIMPLE_CHEMICAL", 101, 113], ["hepatocellular", "ORGAN", 132, 146], ["macrophages", "CELL", 165, 176], ["Kupffer cell population", "CELL", 208, 231], ["M1 macrophages", "CELL_TYPE", 0, 14], ["tumor necrosis factor-\u03b1", "PROTEIN", 49, 72], ["interleukin-1\u03b2 (IL-1\u03b2", "PROTEIN", 74, 95], ["macrophages", "CELL_TYPE", 165, 176], ["Kupffer cell population", "CELL_TYPE", 208, 231], ["proinflammatory", "PROBLEM", 19, 34], ["tumor necrosis factor", "PROBLEM", 49, 70], ["interleukin", "TEST", 74, 85], ["IL", "TEST", 90, 92], ["nitric oxide", "TREATMENT", 101, 113], ["hepatocellular injury", "PROBLEM", 132, 153], ["the Kupffer cell population", "TREATMENT", 204, 231], ["proinflammatory", "OBSERVATION_MODIFIER", 19, 34], ["tumor", "OBSERVATION", 49, 54], ["hepatocellular", "ANATOMY", 132, 146], ["injury", "OBSERVATION", 147, 153], ["Kupffer cell population", "OBSERVATION", 208, 231]]], ["M2 macrophages are anti-inflammatory, secreting IL-10-, IL-6-and IL-18-binding proteins, which modulate inflammation, and comprise the majority of the infiltrating macrophages.", [["macrophages", "ANATOMY", 3, 14], ["infiltrating macrophages", "ANATOMY", 151, 175], ["inflammation", "DISEASE", 104, 116], ["M2 macrophages", "CELL", 0, 14], ["IL-10", "GENE_OR_GENE_PRODUCT", 48, 53], ["IL-6", "GENE_OR_GENE_PRODUCT", 56, 60], ["IL-18", "GENE_OR_GENE_PRODUCT", 65, 70], ["macrophages", "CELL", 164, 175], ["M2 macrophages", "CELL_TYPE", 0, 14], ["binding proteins", "PROTEIN", 71, 87], ["infiltrating macrophages", "CELL_TYPE", 151, 175], ["anti-inflammatory", "TEST", 19, 36], ["secreting IL", "TEST", 38, 50], ["IL", "TEST", 56, 58], ["IL", "TEST", 65, 67], ["binding proteins", "PROBLEM", 71, 87], ["modulate inflammation", "PROBLEM", 95, 116], ["the infiltrating macrophages", "PROBLEM", 147, 175], ["anti-inflammatory", "OBSERVATION_MODIFIER", 19, 36], ["inflammation", "OBSERVATION", 104, 116], ["infiltrating macrophages", "OBSERVATION", 151, 175]]], ["Stimulation of other members of the innate immune system, such as natural killer and natural killer T cells can accentuate acetaminophen toxicity.", [["natural killer", "ANATOMY", 66, 80], ["natural killer T cells", "ANATOMY", 85, 107], ["acetaminophen", "CHEMICAL", 123, 136], ["toxicity", "DISEASE", 137, 145], ["acetaminophen", "CHEMICAL", 123, 136], ["natural killer", "CELL", 66, 80], ["natural killer T cells", "CELL", 85, 107], ["acetaminophen", "SIMPLE_CHEMICAL", 123, 136], ["natural killer", "CELL_TYPE", 66, 80], ["natural killer T cells", "CELL_TYPE", 85, 107], ["the innate immune system", "TREATMENT", 32, 56], ["natural killer", "TREATMENT", 66, 80], ["natural killer T cells", "TREATMENT", 85, 107], ["acetaminophen toxicity", "PROBLEM", 123, 145]]], ["Neutrophils recruited to the liver by the release of damage-associated molecular pattern (DAMP) molecules from necrotic hepatocytes also augment tissue injury.", [["Neutrophils", "ANATOMY", 0, 11], ["liver", "ANATOMY", 29, 34], ["necrotic hepatocytes", "ANATOMY", 111, 131], ["tissue", "ANATOMY", 145, 151], ["necrotic", "DISEASE", 111, 119], ["tissue injury", "DISEASE", 145, 158], ["Neutrophils", "CELL", 0, 11], ["liver", "ORGAN", 29, 34], ["damage-associated molecular pattern", "GENE_OR_GENE_PRODUCT", 53, 88], ["necrotic hepatocytes", "CELL", 111, 131], ["tissue", "TISSUE", 145, 151], ["Neutrophils", "CELL_TYPE", 0, 11], ["damage-associated molecular pattern (DAMP) molecules", "PROTEIN", 53, 105], ["necrotic hepatocytes", "CELL_TYPE", 111, 131], ["Neutrophils", "TEST", 0, 11], ["damage-associated molecular pattern (DAMP) molecules", "PROBLEM", 53, 105], ["necrotic hepatocytes", "PROBLEM", 111, 131], ["augment tissue injury", "PROBLEM", 137, 158], ["liver", "ANATOMY", 29, 34], ["damage", "OBSERVATION", 53, 59], ["molecular pattern", "OBSERVATION", 71, 88], ["necrotic", "OBSERVATION_MODIFIER", 111, 119], ["hepatocytes", "ANATOMY", 120, 131], ["augment tissue injury", "OBSERVATION", 137, 158]]], ["Thus it is clear that altered inflammation can influence drug-induced hepatic injury, but the subtleties remain to be unraveled.Mechanisms of injuryThere are many mechanisms underlying hepatotoxicity.", [["hepatic", "ANATOMY", 70, 77], ["inflammation", "DISEASE", 30, 42], ["hepatic injury", "DISEASE", 70, 84], ["injury", "DISEASE", 142, 148], ["hepatotoxicity", "DISEASE", 185, 199], ["hepatic", "ORGAN", 70, 77], ["altered inflammation", "PROBLEM", 22, 42], ["hepatic injury", "PROBLEM", 70, 84], ["injury", "PROBLEM", 142, 148], ["many mechanisms underlying hepatotoxicity", "PROBLEM", 158, 199], ["altered", "OBSERVATION_MODIFIER", 22, 29], ["inflammation", "OBSERVATION", 30, 42], ["hepatic", "ANATOMY", 70, 77], ["injury", "OBSERVATION", 78, 84], ["injury", "OBSERVATION", 142, 148], ["hepatotoxicity", "OBSERVATION", 185, 199]]], ["These include (1) covalent binding of cellular proteins by bioactivated metabolites, which leads to intracellular dysfunction manifested by loss of normal intracellular ionic gradients altering intracellular calcium homeostasis, by actin filament disruption, and by cell membrane damage, such as cell blebbing or swelling and total disruption.", [["cellular", "ANATOMY", 38, 46], ["intracellular", "ANATOMY", 100, 113], ["intracellular", "ANATOMY", 155, 168], ["intracellular", "ANATOMY", 194, 207], ["cell membrane", "ANATOMY", 266, 279], ["cell", "ANATOMY", 296, 300], ["calcium", "CHEMICAL", 208, 215], ["swelling", "DISEASE", 313, 321], ["calcium", "CHEMICAL", 208, 215], ["cellular", "CELL", 38, 46], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 100, 113], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 155, 168], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 194, 207], ["calcium", "SIMPLE_CHEMICAL", 208, 215], ["actin", "GENE_OR_GENE_PRODUCT", 232, 237], ["cell membrane", "CELLULAR_COMPONENT", 266, 279], ["cell", "CELL", 296, 300], ["cellular proteins", "PROTEIN", 38, 55], ["actin", "PROTEIN", 232, 237], ["covalent binding of cellular proteins", "PROBLEM", 18, 55], ["bioactivated metabolites", "PROBLEM", 59, 83], ["intracellular dysfunction", "PROBLEM", 100, 125], ["loss of normal intracellular ionic gradients", "PROBLEM", 140, 184], ["intracellular calcium homeostasis", "PROBLEM", 194, 227], ["actin filament disruption", "PROBLEM", 232, 257], ["cell membrane damage", "PROBLEM", 266, 286], ["cell blebbing", "PROBLEM", 296, 309], ["swelling", "PROBLEM", 313, 321], ["total disruption", "PROBLEM", 326, 342], ["cellular proteins", "OBSERVATION", 38, 55], ["intracellular dysfunction", "OBSERVATION", 100, 125], ["loss", "OBSERVATION_MODIFIER", 140, 144], ["normal", "OBSERVATION_MODIFIER", 148, 154], ["intracellular ionic gradients", "OBSERVATION", 155, 184], ["intracellular calcium homeostasis", "OBSERVATION", 194, 227], ["actin filament disruption", "OBSERVATION", 232, 257], ["cell membrane damage", "OBSERVATION", 266, 286], ["cell blebbing", "OBSERVATION", 296, 309], ["swelling", "OBSERVATION", 313, 321], ["total disruption", "OBSERVATION", 326, 342]]], ["A consequence of actin filament disruption can be cholestasis because of the loss of pulsatile contractions that drive canalicular bile flow;Mechanisms of injury(2) druginduced disruption of canalicular transport pump function, leading to cholestasis and jaundice; (3) inhibition of cellular enzyme pathways of drug metabolism because of covalent binding of CYPs by bioactivated metabolites; (4) covalent binding of the drug to cell proteins, which creates new adducts that serve as immune targets for cytotoxic T-cell attack or antibody formation when transported to the cell surface in vesicles, inciting an immunologic reaction; (5) programmed cell death (apoptosis), occurring through tumor necrosis factor and Fas pathways; and (6) inhibition of mitochondrial function, limiting \u03b2-oxidation of fat and ATP generation, leading to accumulation of reactive oxygen species and lipid peroxidation, microvesicular fat accumulation, lactic acidosis, and inability to generate ATP.", [["filament", "ANATOMY", 23, 31], ["canalicular bile", "ANATOMY", 119, 135], ["canalicular", "ANATOMY", 191, 202], ["cellular", "ANATOMY", 283, 291], ["cell", "ANATOMY", 428, 432], ["T-cell", "ANATOMY", 512, 518], ["cell surface", "ANATOMY", 572, 584], ["vesicles", "ANATOMY", 588, 596], ["cell", "ANATOMY", 647, 651], ["mitochondrial", "ANATOMY", 751, 764], ["fat", "ANATOMY", 799, 802], ["microvesicular fat", "ANATOMY", 898, 916], ["cholestasis", "DISEASE", 50, 61], ["cholestasis", "DISEASE", 239, 250], ["jaundice", "DISEASE", 255, 263], ["tumor", "DISEASE", 689, 694], ["necrosis", "DISEASE", 695, 703], ["ATP", "CHEMICAL", 807, 810], ["oxygen", "CHEMICAL", 859, 865], ["lactic acidosis", "DISEASE", 931, 946], ["ATP", "CHEMICAL", 974, 977], ["ATP", "CHEMICAL", 807, 810], ["oxygen", "CHEMICAL", 859, 865], ["ATP", "CHEMICAL", 974, 977], ["actin", "GENE_OR_GENE_PRODUCT", 17, 22], ["canalicular bile", "MULTI-TISSUE_STRUCTURE", 119, 135], ["canalicular", "MULTI-TISSUE_STRUCTURE", 191, 202], ["cellular", "CELL", 283, 291], ["CYPs", "GENE_OR_GENE_PRODUCT", 358, 362], ["cell", "CELL", 428, 432], ["T-cell", "CELL", 512, 518], ["cell surface", "CELLULAR_COMPONENT", 572, 584], ["vesicles", "CELLULAR_COMPONENT", 588, 596], ["cell", "CELL", 647, 651], ["tumor necrosis factor", "GENE_OR_GENE_PRODUCT", 689, 710], ["Fas", "GENE_OR_GENE_PRODUCT", 715, 718], ["mitochondrial", "CELLULAR_COMPONENT", 751, 764], ["fat", "TISSUE", 799, 802], ["ATP", "SIMPLE_CHEMICAL", 807, 810], ["reactive oxygen species", "SIMPLE_CHEMICAL", 850, 873], ["lipid", "SIMPLE_CHEMICAL", 878, 883], ["fat", "TISSUE", 913, 916], ["lactic", "SIMPLE_CHEMICAL", 931, 937], ["ATP", "SIMPLE_CHEMICAL", 974, 977], ["actin", "PROTEIN", 17, 22], ["cellular enzyme", "PROTEIN", 283, 298], ["CYPs", "PROTEIN", 358, 362], ["cell proteins", "PROTEIN", 428, 441], ["tumor necrosis factor", "PROTEIN", 689, 710], ["Fas", "PROTEIN", 715, 718], ["actin filament disruption", "PROBLEM", 17, 42], ["cholestasis", "PROBLEM", 50, 61], ["the loss of pulsatile contractions", "PROBLEM", 73, 107], ["canalicular bile flow", "PROBLEM", 119, 140], ["injury", "PROBLEM", 155, 161], ["canalicular transport pump function", "TREATMENT", 191, 226], ["cholestasis", "PROBLEM", 239, 250], ["jaundice", "PROBLEM", 255, 263], ["cellular enzyme pathways", "PROBLEM", 283, 307], ["drug metabolism", "PROBLEM", 311, 326], ["covalent binding of CYPs", "PROBLEM", 338, 362], ["bioactivated metabolites", "PROBLEM", 366, 390], ["covalent binding", "PROBLEM", 396, 412], ["the drug to cell proteins", "PROBLEM", 416, 441], ["new adducts", "PROBLEM", 457, 468], ["cytotoxic T-cell attack", "PROBLEM", 502, 525], ["antibody formation", "PROBLEM", 529, 547], ["an immunologic reaction", "PROBLEM", 607, 630], ["programmed cell death", "PROBLEM", 636, 657], ["apoptosis", "PROBLEM", 659, 668], ["tumor necrosis factor", "PROBLEM", 689, 710], ["Fas pathways", "TEST", 715, 727], ["mitochondrial function", "PROBLEM", 751, 773], ["ATP generation", "PROBLEM", 807, 821], ["reactive oxygen species", "PROBLEM", 850, 873], ["lipid peroxidation", "PROBLEM", 878, 896], ["microvesicular fat accumulation", "PROBLEM", 898, 929], ["lactic acidosis", "PROBLEM", 931, 946], ["inability to generate ATP", "PROBLEM", 952, 977], ["actin filament disruption", "OBSERVATION", 17, 42], ["cholestasis", "OBSERVATION", 50, 61], ["pulsatile contractions", "OBSERVATION", 85, 107], ["bile", "ANATOMY", 131, 135], ["canalicular", "ANATOMY_MODIFIER", 191, 202], ["cholestasis", "OBSERVATION", 239, 250], ["jaundice", "OBSERVATION", 255, 263], ["covalent binding", "OBSERVATION", 338, 354], ["vesicles", "ANATOMY", 588, 596], ["tumor", "OBSERVATION_MODIFIER", 689, 694], ["necrosis", "OBSERVATION", 695, 703], ["mitochondrial function", "OBSERVATION", 751, 773], ["reactive", "OBSERVATION_MODIFIER", 850, 858], ["oxygen species", "OBSERVATION", 859, 873], ["lipid peroxidation", "OBSERVATION", 878, 896], ["microvesicular fat accumulation", "OBSERVATION", 898, 929], ["lactic acidosis", "OBSERVATION", 931, 946]]], ["The liver is composed of several cell types, not only hepatocytes, and similar types of injury can also affect the biliary epithelium and sinusoidal endothelium, and to a lesser extent, hepatic stellate cells, Kupffer cells, and other immune cells. and death.", [["liver", "ANATOMY", 4, 9], ["cell", "ANATOMY", 33, 37], ["hepatocytes", "ANATOMY", 54, 65], ["biliary epithelium", "ANATOMY", 115, 133], ["sinusoidal endothelium", "ANATOMY", 138, 160], ["hepatic stellate cells", "ANATOMY", 186, 208], ["Kupffer cells", "ANATOMY", 210, 223], ["immune cells", "ANATOMY", 235, 247], ["death", "DISEASE", 253, 258], ["liver", "ORGAN", 4, 9], ["cell", "CELL", 33, 37], ["hepatocytes", "CELL", 54, 65], ["biliary epithelium", "TISSUE", 115, 133], ["sinusoidal endothelium", "TISSUE", 138, 160], ["hepatic stellate cells", "CELL", 186, 208], ["Kupffer cells", "CELL", 210, 223], ["immune cells", "CELL", 235, 247], ["hepatocytes", "CELL_TYPE", 54, 65], ["hepatic stellate cells", "CELL_TYPE", 186, 208], ["Kupffer cells", "CELL_TYPE", 210, 223], ["immune cells", "CELL_TYPE", 235, 247], ["several cell types", "PROBLEM", 25, 43], ["injury", "PROBLEM", 88, 94], ["Kupffer cells", "TEST", 210, 223], ["other immune cells", "PROBLEM", 229, 247], ["death", "PROBLEM", 253, 258], ["liver", "ANATOMY", 4, 9], ["several cell types", "OBSERVATION", 25, 43], ["hepatocytes", "ANATOMY", 54, 65], ["injury", "OBSERVATION", 88, 94], ["biliary epithelium", "ANATOMY", 115, 133], ["sinusoidal endothelium", "OBSERVATION", 138, 160], ["lesser extent", "OBSERVATION_MODIFIER", 171, 184], ["hepatic", "ANATOMY", 186, 193], ["stellate cells", "OBSERVATION", 194, 208], ["Kupffer cells", "OBSERVATION", 210, 223], ["immune cells", "OBSERVATION", 235, 247]]], ["NAPQI is also responsible for the prominent methemoglobinemia seen in intoxicated cats.", [["methemoglobinemia", "DISEASE", 44, 61], ["NAPQI", "SIMPLE_CHEMICAL", 0, 5], ["cats", "ORGANISM", 82, 86], ["cats", "SPECIES", 82, 86], ["NAPQI", "TREATMENT", 0, 5], ["the prominent methemoglobinemia", "PROBLEM", 30, 61], ["prominent", "OBSERVATION_MODIFIER", 34, 43], ["methemoglobinemia", "OBSERVATION", 44, 61]]], ["Toxic hepatic injury depends on the balance between the production of reactive metabolites and their detoxification by conjugation and other protective mechanisms.Mechanisms of injuryThe enzyme complex involved in bioactivation is not limited to metabolism of foreign substances, but is also involved in the metabolism or synthesis of a number of lipophilic endogenous substances.", [["hepatic", "ANATOMY", 6, 13], ["hepatic injury", "DISEASE", 6, 20], ["injury", "DISEASE", 177, 183], ["hepatic", "ORGAN", 6, 13], ["enzyme complex", "PROTEIN", 187, 201], ["Toxic hepatic injury", "PROBLEM", 0, 20], ["reactive metabolites", "PROBLEM", 70, 90], ["injury", "PROBLEM", 177, 183], ["The enzyme complex", "TEST", 183, 201], ["foreign substances", "PROBLEM", 260, 278], ["hepatic", "ANATOMY", 6, 13], ["injury", "OBSERVATION", 14, 20], ["reactive metabolites", "OBSERVATION", 70, 90], ["injury", "OBSERVATION", 177, 183], ["complex", "OBSERVATION_MODIFIER", 194, 201], ["foreign substances", "OBSERVATION", 260, 278], ["lipophilic endogenous substances", "OBSERVATION", 347, 379]]], ["The principal endogenous substrates include arachidonic acid, eicosanoids, cholesterol, bile acids, steroids, and vitamin D.Mechanisms of injuryPhase 3 reactions involve movement of conjugated substrates across the membrane of the canaliculus.", [["membrane", "ANATOMY", 215, 223], ["canaliculus", "ANATOMY", 231, 242], ["arachidonic acid", "CHEMICAL", 44, 60], ["eicosanoids", "CHEMICAL", 62, 73], ["cholesterol", "CHEMICAL", 75, 86], ["bile acids", "CHEMICAL", 88, 98], ["steroids", "CHEMICAL", 100, 108], ["vitamin D.Mechanisms", "CHEMICAL", 114, 134], ["injury", "DISEASE", 138, 144], ["arachidonic acid", "CHEMICAL", 44, 60], ["eicosanoids", "CHEMICAL", 62, 73], ["cholesterol", "CHEMICAL", 75, 86], ["bile acids", "CHEMICAL", 88, 98], ["steroids", "CHEMICAL", 100, 108], ["vitamin D.Mechanisms", "CHEMICAL", 114, 134], ["arachidonic acid", "SIMPLE_CHEMICAL", 44, 60], ["eicosanoids", "SIMPLE_CHEMICAL", 62, 73], ["cholesterol", "SIMPLE_CHEMICAL", 75, 86], ["bile acids", "SIMPLE_CHEMICAL", 88, 98], ["steroids", "SIMPLE_CHEMICAL", 100, 108], ["vitamin D.Mechanisms", "SIMPLE_CHEMICAL", 114, 134], ["membrane", "CELLULAR_COMPONENT", 215, 223], ["canaliculus", "MULTI-TISSUE_STRUCTURE", 231, 242], ["arachidonic acid", "TEST", 44, 60], ["cholesterol", "TREATMENT", 75, 86], ["bile acids", "TREATMENT", 88, 98], ["steroids", "TREATMENT", 100, 108], ["vitamin", "TREATMENT", 114, 121], ["injury", "PROBLEM", 138, 144], ["Phase 3 reactions", "PROBLEM", 144, 161], ["endogenous substrates", "OBSERVATION", 14, 35], ["arachidonic acid", "OBSERVATION", 44, 60], ["bile", "ANATOMY", 88, 92], ["injury", "OBSERVATION", 138, 144], ["movement", "OBSERVATION_MODIFIER", 170, 178], ["membrane", "ANATOMY_MODIFIER", 215, 223], ["canaliculus", "ANATOMY", 231, 242]]], ["As with the processes involved in uptake of substances from the plasma, several transporters embedded in the canalicular membrane are responsible for the movement of the water-soluble conjugated substrates from the cytoplasm into the lumen of the canaliculus.", [["plasma", "ANATOMY", 64, 70], ["canalicular membrane", "ANATOMY", 109, 129], ["cytoplasm", "ANATOMY", 215, 224], ["lumen", "ANATOMY", 234, 239], ["canaliculus", "ANATOMY", 247, 258], ["plasma", "ORGANISM_SUBSTANCE", 64, 70], ["canalicular membrane", "CELLULAR_COMPONENT", 109, 129], ["cytoplasm", "ORGANISM_SUBSTANCE", 215, 224], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 234, 239], ["canaliculus", "MULTI-TISSUE_STRUCTURE", 247, 258], ["the plasma", "TEST", 60, 70], ["canalicular membrane", "ANATOMY", 109, 129], ["lumen", "ANATOMY_MODIFIER", 234, 239], ["canaliculus", "ANATOMY", 247, 258]]], ["These transporters have a range of occasionally overlapping substrates, including bile acids and conjugates of glutathione, glucuronate, and sulfonate.", [["glutathione", "CHEMICAL", 111, 122], ["glucuronate", "CHEMICAL", 124, 135], ["sulfonate", "CHEMICAL", 141, 150], ["bile acids", "CHEMICAL", 82, 92], ["glutathione", "CHEMICAL", 111, 122], ["glucuronate", "CHEMICAL", 124, 135], ["sulfonate", "CHEMICAL", 141, 150], ["bile acids", "SIMPLE_CHEMICAL", 82, 92], ["glutathione", "SIMPLE_CHEMICAL", 111, 122], ["glucuronate", "SIMPLE_CHEMICAL", 124, 135], ["sulfonate", "SIMPLE_CHEMICAL", 141, 150], ["bile acids", "TREATMENT", 82, 92], ["conjugates of glutathione", "TREATMENT", 97, 122], ["glucuronate", "TREATMENT", 124, 135], ["sulfonate", "TREATMENT", 141, 150], ["bile", "ANATOMY", 82, 86]]], ["These water-soluble metabolites are excreted in the bile via members of the ATPbinding cassette (ABC) superfamily of transport proteins located on the apical canalicular membrane.", [["bile", "ANATOMY", 52, 56], ["apical canalicular membrane", "ANATOMY", 151, 178], ["bile", "MULTI-TISSUE_STRUCTURE", 52, 56], ["ABC", "GENE_OR_GENE_PRODUCT", 97, 100], ["apical canalicular membrane", "CELLULAR_COMPONENT", 151, 178], ["ATPbinding cassette (ABC) superfamily", "PROTEIN", 76, 113], ["transport proteins", "PROTEIN", 117, 135], ["These water-soluble metabolites", "TREATMENT", 0, 31], ["transport proteins", "PROBLEM", 117, 135], ["bile", "ANATOMY", 52, 56], ["apical", "ANATOMY_MODIFIER", 151, 157], ["canalicular membrane", "ANATOMY", 158, 178]]], ["These include the most significant transporter in humans, the multidrugresistance protein-1 (MDR1).", [["humans", "ORGANISM", 50, 56], ["multidrugresistance protein-1", "GENE_OR_GENE_PRODUCT", 62, 91], ["MDR1", "GENE_OR_GENE_PRODUCT", 93, 97], ["multidrugresistance protein-1", "PROTEIN", 62, 91], ["MDR1", "PROTEIN", 93, 97], ["humans", "SPECIES", 50, 56], ["humans", "SPECIES", 50, 56]]], ["Multidrug-resistance-associated protein-2 (MRP2) is responsible for export of glutathione conjugates, such as bilirubin conjugates, and shows a striking species difference in expression, with very low expression in the dog and very high expression in the rat.", [["glutathione", "CHEMICAL", 78, 89], ["bilirubin", "CHEMICAL", 110, 119], ["glutathione", "CHEMICAL", 78, 89], ["bilirubin", "CHEMICAL", 110, 119], ["Multidrug-resistance-associated protein-2", "GENE_OR_GENE_PRODUCT", 0, 41], ["MRP2", "GENE_OR_GENE_PRODUCT", 43, 47], ["glutathione conjugates", "SIMPLE_CHEMICAL", 78, 100], ["bilirubin conjugates", "SIMPLE_CHEMICAL", 110, 130], ["dog", "ORGANISM", 219, 222], ["rat", "ORGANISM", 255, 258], ["Multidrug-resistance-associated protein-2", "PROTEIN", 0, 41], ["MRP2", "PROTEIN", 43, 47], ["rat", "SPECIES", 255, 258], ["rat", "SPECIES", 255, 258], ["glutathione conjugates", "PROBLEM", 78, 100], ["bilirubin conjugates", "TEST", 110, 130], ["a striking species difference", "PROBLEM", 142, 171], ["very low expression in the dog", "PROBLEM", 192, 222], ["resistance", "OBSERVATION", 10, 20], ["low expression", "OBSERVATION_MODIFIER", 197, 211], ["high expression", "OBSERVATION", 232, 247]]], ["This influences biliary excretion of drug conjugates from the liver and may influence toxicity in the liver or elsewhere.Mechanisms of injuryThe mechanism by which xenobiotics and some endogenous substances can cause CYP enzyme induction in the liver, as well as induction of phase 2 reactions, and hepatocellular hypertrophy is mediated by the activation of nuclear receptors that function as transcription factors.", [["biliary", "ANATOMY", 16, 23], ["liver", "ANATOMY", 62, 67], ["liver", "ANATOMY", 102, 107], ["liver", "ANATOMY", 245, 250], ["hepatocellular", "ANATOMY", 299, 313], ["nuclear", "ANATOMY", 359, 366], ["toxicity", "DISEASE", 86, 94], ["injury", "DISEASE", 135, 141], ["hepatocellular hypertrophy", "DISEASE", 299, 325], ["biliary", "MULTI-TISSUE_STRUCTURE", 16, 23], ["liver", "ORGAN", 62, 67], ["liver", "ORGAN", 102, 107], ["CYP enzyme", "GENE_OR_GENE_PRODUCT", 217, 227], ["liver", "ORGAN", 245, 250], ["hepatocellular", "ORGAN", 299, 313], ["CYP enzyme", "PROTEIN", 217, 227], ["nuclear receptors", "PROTEIN", 359, 376], ["transcription factors", "PROTEIN", 394, 415], ["drug conjugates", "TEST", 37, 52], ["influence toxicity in the liver", "PROBLEM", 76, 107], ["injury", "PROBLEM", 135, 141], ["xenobiotics", "TREATMENT", 164, 175], ["some endogenous substances", "TREATMENT", 180, 206], ["CYP enzyme induction in the liver", "PROBLEM", 217, 250], ["phase 2 reactions", "PROBLEM", 276, 293], ["hepatocellular hypertrophy", "PROBLEM", 299, 325], ["biliary", "ANATOMY", 16, 23], ["drug conjugates", "OBSERVATION", 37, 52], ["liver", "ANATOMY", 62, 67], ["toxicity", "OBSERVATION", 86, 94], ["liver", "ANATOMY", 102, 107], ["injury", "OBSERVATION", 135, 141], ["liver", "ANATOMY", 245, 250], ["hepatocellular", "ANATOMY", 299, 313], ["hypertrophy", "OBSERVATION", 314, 325]]], ["These transcription factors include aryl hydrocarbon hydroxylase receptor (AHR), constitutive androstane receptor (CAR), pregnane X receptor (PXR), and peroxisome proliferator-activated receptor-\u03b1 (PPAR-\u03b1).", [["aryl hydrocarbon", "CHEMICAL", 36, 52], ["androstane", "CHEMICAL", 94, 104], ["pregnane", "CHEMICAL", 121, 129], ["aryl hydrocarbon hydroxylase receptor", "GENE_OR_GENE_PRODUCT", 36, 73], ["AHR", "GENE_OR_GENE_PRODUCT", 75, 78], ["constitutive androstane receptor", "GENE_OR_GENE_PRODUCT", 81, 113], ["CAR", "GENE_OR_GENE_PRODUCT", 115, 118], ["pregnane X receptor", "GENE_OR_GENE_PRODUCT", 121, 140], ["PXR", "GENE_OR_GENE_PRODUCT", 142, 145], ["peroxisome proliferator-activated receptor-\u03b1", "GENE_OR_GENE_PRODUCT", 152, 196], ["PPAR-\u03b1", "GENE_OR_GENE_PRODUCT", 198, 204], ["transcription factors", "PROTEIN", 6, 27], ["aryl hydrocarbon hydroxylase receptor", "PROTEIN", 36, 73], ["AHR", "PROTEIN", 75, 78], ["constitutive androstane receptor", "PROTEIN", 81, 113], ["CAR", "PROTEIN", 115, 118], ["pregnane X receptor", "PROTEIN", 121, 140], ["PXR", "PROTEIN", 142, 145], ["peroxisome proliferator-activated receptor-\u03b1", "PROTEIN", 152, 196], ["PPAR", "PROTEIN", 198, 202], ["\u03b1", "PROTEIN", 203, 204], ["These transcription factors", "TREATMENT", 0, 27], ["aryl hydrocarbon hydroxylase receptor", "TREATMENT", 36, 73], ["constitutive androstane receptor (CAR)", "TREATMENT", 81, 119], ["pregnane X receptor (PXR)", "TREATMENT", 121, 146]]], ["These nuclear receptors are also important mediators of hepatocellular metabolism, including hepatic lipid metabolism, bile acid homeostasis, as well as liver regeneration, inflammation, fibrosis, cell differentiation, and tumor formation.", [["nuclear", "ANATOMY", 6, 13], ["hepatocellular", "ANATOMY", 56, 70], ["hepatic", "ANATOMY", 93, 100], ["bile", "ANATOMY", 119, 123], ["liver", "ANATOMY", 153, 158], ["cell", "ANATOMY", 197, 201], ["tumor", "ANATOMY", 223, 228], ["liver regeneration", "DISEASE", 153, 171], ["inflammation", "DISEASE", 173, 185], ["fibrosis", "DISEASE", 187, 195], ["tumor", "DISEASE", 223, 228], ["bile acid", "CHEMICAL", 119, 128], ["hepatocellular", "MULTI-TISSUE_STRUCTURE", 56, 70], ["hepatic", "MULTI-TISSUE_STRUCTURE", 93, 100], ["lipid", "SIMPLE_CHEMICAL", 101, 106], ["bile acid", "SIMPLE_CHEMICAL", 119, 128], ["liver", "ORGAN", 153, 158], ["cell", "CELL", 197, 201], ["tumor", "CANCER", 223, 228], ["nuclear receptors", "PROTEIN", 6, 23], ["hepatocellular metabolism", "PROBLEM", 56, 81], ["hepatic lipid metabolism", "TREATMENT", 93, 117], ["bile acid homeostasis", "PROBLEM", 119, 140], ["liver regeneration", "PROBLEM", 153, 171], ["inflammation", "PROBLEM", 173, 185], ["fibrosis", "PROBLEM", 187, 195], ["cell differentiation", "PROBLEM", 197, 217], ["tumor formation", "PROBLEM", 223, 238], ["hepatocellular metabolism", "OBSERVATION", 56, 81], ["hepatic", "ANATOMY", 93, 100], ["lipid metabolism", "OBSERVATION", 101, 117], ["bile", "ANATOMY", 119, 123], ["acid homeostasis", "OBSERVATION", 124, 140], ["liver", "ANATOMY", 153, 158], ["regeneration", "OBSERVATION", 159, 171], ["inflammation", "OBSERVATION", 173, 185], ["fibrosis", "OBSERVATION", 187, 195], ["cell differentiation", "OBSERVATION", 197, 217], ["tumor", "OBSERVATION", 223, 228]]], ["Each of these receptors may be directly activated by the binding of the xenobiotic (or its metabolite) to the receptor, although some activators of CAR do not bind to the receptor but rather phosphorylate the receptor, which results in nuclear translocation.", [["nuclear", "ANATOMY", 236, 243], ["CAR", "GENE_OR_GENE_PRODUCT", 148, 151], ["nuclear", "CELLULAR_COMPONENT", 236, 243], ["CAR", "PROTEIN", 148, 151], ["nuclear translocation", "PROBLEM", 236, 257], ["nuclear translocation", "OBSERVATION", 236, 257]]], ["The nuclear receptor genes vary among species, and there are many species differences and gene polymorphisms that affect the receptors or the genes that they stimulate.Mechanisms of injuryIn summary, a broad variety of factors can influence the mechanisms and extent of drug-induced liver injury (DILI), the term for hepatic injury from xenobiotics.", [["nuclear", "ANATOMY", 4, 11], ["liver", "ANATOMY", 283, 288], ["hepatic", "ANATOMY", 317, 324], ["injury", "DISEASE", 182, 188], ["liver injury", "DISEASE", 283, 295], ["DILI", "DISEASE", 297, 301], ["hepatic injury", "DISEASE", 317, 331], ["nuclear receptor", "GENE_OR_GENE_PRODUCT", 4, 20], ["liver", "ORGAN", 283, 288], ["hepatic", "ORGAN", 317, 324], ["nuclear receptor genes", "DNA", 4, 26], ["many species differences", "PROBLEM", 61, 85], ["gene polymorphisms", "PROBLEM", 90, 108], ["injury", "PROBLEM", 182, 188], ["drug-induced liver injury", "PROBLEM", 270, 295], ["hepatic injury", "PROBLEM", 317, 331], ["xenobiotics", "TREATMENT", 337, 348], ["many", "OBSERVATION_MODIFIER", 61, 65], ["species", "OBSERVATION", 66, 73], ["injury", "OBSERVATION", 182, 188], ["liver", "ANATOMY", 283, 288], ["injury", "OBSERVATION", 289, 295], ["hepatic", "ANATOMY", 317, 324], ["injury", "OBSERVATION", 325, 331]]], ["There is a variety of alternative pathways for metabolism, supported by a variety of isoforms of different gene families, particularly the CYP enzymes and the many genetic polymorphisms within individual alleles that code for the different isoforms.", [["CYP enzymes", "GENE_OR_GENE_PRODUCT", 139, 150], ["CYP enzymes", "PROTEIN", 139, 150], ["alleles", "DNA", 204, 211], ["the CYP enzymes", "TEST", 135, 150]]], ["Other factors such as age, nutritional status, sex, diet, prior or concurrent exposure to environmental compounds, or intercurrent disease all influence the response to toxic injury.", [["toxic injury", "DISEASE", 169, 181], ["Other factors", "PROBLEM", 0, 13], ["environmental compounds", "PROBLEM", 90, 113], ["intercurrent disease", "PROBLEM", 118, 138], ["toxic injury", "PROBLEM", 169, 181], ["toxic", "OBSERVATION_MODIFIER", 169, 174], ["injury", "OBSERVATION", 175, 181]]], ["Some of these variables contribute to the variations seen in responses among species and individuals to liver injury.Mechanisms of injuryhaplotypes have been associated with idiosyncratic drug toxicity in humans for several drugs, reflecting the development of pharmacogenomics.Mechanisms of injuryToxic metabolite-dependent idiosyncrasies involve excessive generation of a regular toxic metabolite, or altered metabolism to unusual hepatotoxic metabolites.", [["liver", "ANATOMY", 104, 109], ["liver injury", "DISEASE", 104, 116], ["drug toxicity", "DISEASE", 188, 201], ["hepatotoxic", "DISEASE", 433, 444], ["liver", "ORGAN", 104, 109], ["humans", "ORGANISM", 205, 211], ["humans", "SPECIES", 205, 211], ["humans", "SPECIES", 205, 211], ["the variations", "PROBLEM", 38, 52], ["liver injury", "PROBLEM", 104, 116], ["injuryhaplotypes", "PROBLEM", 131, 147], ["idiosyncratic drug toxicity", "PROBLEM", 174, 201], ["several drugs", "TREATMENT", 216, 229], ["injuryToxic metabolite", "PROBLEM", 292, 314], ["dependent idiosyncrasies", "PROBLEM", 315, 339], ["a regular toxic metabolite", "PROBLEM", 372, 398], ["altered metabolism to unusual hepatotoxic metabolites", "PROBLEM", 403, 456], ["liver", "ANATOMY", 104, 109], ["injury", "OBSERVATION", 110, 116], ["associated with", "UNCERTAINTY", 158, 173], ["idiosyncratic", "OBSERVATION_MODIFIER", 174, 187], ["drug toxicity", "OBSERVATION", 188, 201], ["injuryToxic metabolite", "OBSERVATION", 292, 314], ["excessive", "OBSERVATION_MODIFIER", 348, 357], ["toxic metabolite", "OBSERVATION", 382, 398], ["hepatotoxic metabolites", "OBSERVATION", 433, 456]]], ["There is accumulating evidence of considerable genetic diversity (polymorphisms) in hepatic drug metabolism among individual humans and domestic animals, and these may explain many unusual responses to drugs.", [["hepatic", "ANATOMY", 84, 91], ["hepatic", "ORGAN", 84, 91], ["humans", "ORGANISM", 125, 131], ["humans", "SPECIES", 125, 131], ["humans", "SPECIES", 125, 131], ["considerable genetic diversity (polymorphisms)", "PROBLEM", 34, 80], ["hepatic drug metabolism", "PROBLEM", 84, 107], ["drugs", "TREATMENT", 202, 207], ["accumulating evidence of", "UNCERTAINTY", 9, 33], ["considerable", "OBSERVATION_MODIFIER", 34, 46], ["genetic", "OBSERVATION_MODIFIER", 47, 54], ["diversity", "OBSERVATION", 55, 64], ["hepatic", "ANATOMY", 84, 91], ["drug metabolism", "OBSERVATION", 92, 107], ["domestic animals", "OBSERVATION", 136, 152]]], ["This variation could be qualitative, with the production of a toxic metabolite not normally produced, or quantitative, with overproduction of a normally minor hepatotoxic metabolite.Morphology of toxic injury to the liverThe morphologic forms of hepatic injury produced by hepatotoxins are varied.", [["liver", "ANATOMY", 216, 221], ["hepatic", "ANATOMY", 246, 253], ["hepatotoxic", "DISEASE", 159, 170], ["injury to the liver", "DISEASE", 202, 221], ["hepatic injury", "DISEASE", 246, 260], ["liver", "ORGAN", 216, 221], ["hepatic", "ORGAN", 246, 253], ["hepatotoxins", "SIMPLE_CHEMICAL", 273, 285], ["a toxic metabolite", "PROBLEM", 60, 78], ["a normally minor hepatotoxic metabolite", "PROBLEM", 142, 181], ["toxic injury to the liver", "PROBLEM", 196, 221], ["hepatic injury", "PROBLEM", 246, 260], ["hepatotoxins", "PROBLEM", 273, 285], ["minor", "OBSERVATION_MODIFIER", 153, 158], ["hepatotoxic metabolite", "OBSERVATION", 159, 181], ["toxic", "OBSERVATION_MODIFIER", 196, 201], ["injury", "OBSERVATION", 202, 208], ["liver", "ANATOMY", 216, 221], ["hepatic", "ANATOMY", 246, 253], ["injury", "OBSERVATION", 254, 260], ["hepatotoxins", "OBSERVATION", 273, 285]]], ["Acute toxic injury to the liver can be cytotoxic (hepatocellular), cholestatic, or mixed.", [["liver", "ANATOMY", 26, 31], ["hepatocellular", "ANATOMY", 50, 64], ["injury to the liver", "DISEASE", 12, 31], ["cholestatic", "DISEASE", 67, 78], ["liver", "ORGAN", 26, 31], ["hepatocellular", "CANCER", 50, 64], ["Acute toxic injury to the liver", "PROBLEM", 0, 31], ["cytotoxic (hepatocellular)", "PROBLEM", 39, 65], ["cholestatic", "PROBLEM", 67, 78], ["toxic", "OBSERVATION_MODIFIER", 6, 11], ["injury", "OBSERVATION", 12, 18], ["liver", "ANATOMY", 26, 31], ["cytotoxic", "OBSERVATION_MODIFIER", 39, 48], ["hepatocellular", "OBSERVATION", 50, 64], ["cholestatic", "OBSERVATION_MODIFIER", 67, 78], ["mixed", "OBSERVATION_MODIFIER", 83, 88]]], ["Cytotoxic hepatocellular injury results in hepatic degeneration, zonal necrosis, focal and nonzonal necrosis (apoptosis), or lipidosis, accompanied by the clinicopathologic features of acute hepatic injury.", [["hepatocellular", "ANATOMY", 10, 24], ["hepatic", "ANATOMY", 43, 50], ["hepatic", "ANATOMY", 191, 198], ["Cytotoxic hepatocellular injury", "DISEASE", 0, 31], ["hepatic degeneration", "DISEASE", 43, 63], ["necrosis", "DISEASE", 71, 79], ["necrosis", "DISEASE", 100, 108], ["lipidosis", "DISEASE", 125, 134], ["acute hepatic injury", "DISEASE", 185, 205], ["hepatocellular", "CANCER", 10, 24], ["hepatic", "ORGAN", 43, 50], ["hepatic", "ORGAN", 191, 198], ["Cytotoxic hepatocellular injury", "PROBLEM", 0, 31], ["hepatic degeneration", "PROBLEM", 43, 63], ["zonal necrosis", "PROBLEM", 65, 79], ["focal and nonzonal necrosis (apoptosis)", "PROBLEM", 81, 120], ["lipidosis", "PROBLEM", 125, 134], ["acute hepatic injury", "PROBLEM", 185, 205], ["hepatocellular", "ANATOMY", 10, 24], ["hepatic", "ANATOMY", 43, 50], ["degeneration", "OBSERVATION", 51, 63], ["zonal", "OBSERVATION_MODIFIER", 65, 70], ["necrosis", "OBSERVATION", 71, 79], ["focal", "OBSERVATION_MODIFIER", 81, 86], ["nonzonal", "OBSERVATION_MODIFIER", 91, 99], ["necrosis", "OBSERVATION", 100, 108], ["apoptosis", "OBSERVATION_MODIFIER", 110, 119], ["lipidosis", "OBSERVATION", 125, 134], ["acute", "OBSERVATION_MODIFIER", 185, 190], ["hepatic", "ANATOMY", 191, 198], ["injury", "OBSERVATION", 199, 205]]], ["In general, necrosis produced by intrinsic hepatotoxins is zonal.", [["necrosis", "DISEASE", 12, 20], ["necrosis", "PROBLEM", 12, 20], ["necrosis", "OBSERVATION", 12, 20], ["hepatotoxins", "OBSERVATION", 43, 55]]], ["Acute cytotoxic injury is often manifested as steatosis (lipidosis), a result of impairment of movement of triglycerides through the liver, interference with very-lowdensity lipoprotein synthesis or transport, or impaired hepatic consumption of fatty acids by mitochondrial oxidation.", [["liver", "ANATOMY", 133, 138], ["hepatic", "ANATOMY", 222, 229], ["mitochondrial", "ANATOMY", 260, 273], ["cytotoxic injury", "DISEASE", 6, 22], ["steatosis", "DISEASE", 46, 55], ["lipidosis", "DISEASE", 57, 66], ["fatty acids", "CHEMICAL", 245, 256], ["triglycerides", "CHEMICAL", 107, 120], ["fatty acids", "CHEMICAL", 245, 256], ["triglycerides", "SIMPLE_CHEMICAL", 107, 120], ["liver", "ORGAN", 133, 138], ["lipoprotein", "SIMPLE_CHEMICAL", 174, 185], ["hepatic", "MULTI-TISSUE_STRUCTURE", 222, 229], ["fatty acids", "SIMPLE_CHEMICAL", 245, 256], ["mitochondrial", "CELLULAR_COMPONENT", 260, 273], ["Acute cytotoxic injury", "PROBLEM", 0, 22], ["steatosis", "PROBLEM", 46, 55], ["lipidosis", "PROBLEM", 57, 66], ["movement of triglycerides through the liver", "PROBLEM", 95, 138], ["very-lowdensity lipoprotein synthesis", "PROBLEM", 158, 195], ["fatty acids", "TREATMENT", 245, 256], ["mitochondrial oxidation", "TREATMENT", 260, 283], ["cytotoxic", "OBSERVATION_MODIFIER", 6, 15], ["injury", "OBSERVATION", 16, 22], ["steatosis", "OBSERVATION", 46, 55], ["lipidosis", "OBSERVATION", 57, 66], ["movement", "OBSERVATION_MODIFIER", 95, 103], ["liver", "ANATOMY", 133, 138], ["hepatic", "ANATOMY", 222, 229], ["fatty acids", "OBSERVATION", 245, 256], ["mitochondrial oxidation", "OBSERVATION", 260, 283]]], ["Cholestatic injury is a reflection of failure of bile excretion associated with biliary epithelial or canalicular injury or other alteration of bile secretion, and displays the features of obstructive jaundice.", [["bile", "ANATOMY", 49, 53], ["biliary epithelial", "ANATOMY", 80, 98], ["canalicular", "ANATOMY", 102, 113], ["bile", "ANATOMY", 144, 148], ["Cholestatic injury", "DISEASE", 0, 18], ["obstructive jaundice", "DISEASE", 189, 209], ["bile", "IMMATERIAL_ANATOMICAL_ENTITY", 49, 53], ["biliary epithelial", "TISSUE", 80, 98], ["canalicular", "MULTI-TISSUE_STRUCTURE", 102, 113], ["bile", "MULTI-TISSUE_STRUCTURE", 144, 148], ["Cholestatic injury", "PROBLEM", 0, 18], ["failure of bile excretion", "PROBLEM", 38, 63], ["biliary epithelial or canalicular injury", "PROBLEM", 80, 120], ["bile secretion", "PROBLEM", 144, 158], ["obstructive jaundice", "PROBLEM", 189, 209], ["injury", "OBSERVATION", 12, 18], ["failure", "OBSERVATION", 38, 45], ["bile excretion", "OBSERVATION", 49, 63], ["biliary", "ANATOMY", 80, 87], ["epithelial", "ANATOMY_MODIFIER", 88, 98], ["canalicular", "ANATOMY_MODIFIER", 102, 113], ["injury", "OBSERVATION", 114, 120], ["bile secretion", "OBSERVATION", 144, 158], ["obstructive", "OBSERVATION_MODIFIER", 189, 200], ["jaundice", "OBSERVATION", 201, 209]]], ["The typical histologic manifestation consists of bile casts in canalicular spaces, with variable parenchymal injury.", [["bile", "ANATOMY", 49, 53], ["canalicular spaces", "ANATOMY", 63, 81], ["parenchymal", "ANATOMY", 97, 108], ["parenchymal injury", "DISEASE", 97, 115], ["bile", "PATHOLOGICAL_FORMATION", 49, 53], ["canalicular", "MULTI-TISSUE_STRUCTURE", 63, 74], ["parenchymal", "TISSUE", 97, 108], ["bile casts in canalicular spaces", "PROBLEM", 49, 81], ["variable parenchymal injury", "PROBLEM", 88, 115], ["bile", "ANATOMY", 49, 53], ["casts", "OBSERVATION", 54, 59], ["canalicular spaces", "ANATOMY", 63, 81], ["variable", "OBSERVATION_MODIFIER", 88, 96], ["parenchymal", "ANATOMY_MODIFIER", 97, 108], ["injury", "OBSERVATION", 109, 115]]], ["An exception to this pattern can be seen in some plant intoxications, such as those produced by steroidal sapogenins and Lantana spp., which can cause cholestasis with minimal evidence of canalicular plugging.", [["canalicular", "ANATOMY", 188, 199], ["cholestasis", "DISEASE", 151, 162], ["steroidal sapogenins", "CHEMICAL", 96, 116], ["steroidal sapogenins", "SIMPLE_CHEMICAL", 96, 116], ["Lantana spp.", "ORGANISM", 121, 133], ["canalicular", "MULTI-TISSUE_STRUCTURE", 188, 199], ["Lantana spp.", "SPECIES", 121, 133], ["Lantana spp.", "SPECIES", 121, 133], ["some plant intoxications", "PROBLEM", 44, 68], ["steroidal sapogenins", "TREATMENT", 96, 116], ["Lantana spp.", "TREATMENT", 121, 133], ["cholestasis", "PROBLEM", 151, 162], ["canalicular plugging", "PROBLEM", 188, 208], ["intoxications", "OBSERVATION", 55, 68], ["cholestasis", "OBSERVATION", 151, 162], ["minimal", "OBSERVATION_MODIFIER", 168, 175], ["canalicular", "ANATOMY_MODIFIER", 188, 199], ["plugging", "OBSERVATION", 200, 208]]], ["Mixed toxic insults display the morphologic and clinical features of both hepatocellular and obstructive injury.", [["hepatocellular", "ANATOMY", 74, 88], ["hepatocellular and obstructive injury", "DISEASE", 74, 111], ["hepatocellular", "CANCER", 74, 88], ["Mixed toxic insults", "PROBLEM", 0, 19], ["both hepatocellular and obstructive injury", "PROBLEM", 69, 111], ["toxic", "OBSERVATION_MODIFIER", 6, 11], ["both", "OBSERVATION_MODIFIER", 69, 73], ["hepatocellular", "OBSERVATION", 74, 88], ["obstructive", "OBSERVATION_MODIFIER", 93, 104], ["injury", "OBSERVATION", 105, 111]]], ["Chronic toxic injury to the liver may be manifested as chronic hepatitis, with fibrosis progressing to cirrhosis; vascular injury, such as veno-occlusive disease; and neoplasia.Morphology of toxic injury to the liverThe histologic changes in acute toxic hepatic injury are rather stereotyped.", [["liver", "ANATOMY", 28, 33], ["vascular", "ANATOMY", 114, 122], ["neoplasia", "ANATOMY", 167, 176], ["liver", "ANATOMY", 211, 216], ["hepatic", "ANATOMY", 254, 261], ["toxic injury to the liver", "DISEASE", 8, 33], ["hepatitis", "DISEASE", 63, 72], ["fibrosis", "DISEASE", 79, 87], ["cirrhosis", "DISEASE", 103, 112], ["vascular injury", "DISEASE", 114, 129], ["veno-occlusive disease", "DISEASE", 139, 161], ["neoplasia", "DISEASE", 167, 176], ["injury to the liver", "DISEASE", 197, 216], ["toxic hepatic injury", "DISEASE", 248, 268], ["liver", "ORGAN", 28, 33], ["vascular", "MULTI-TISSUE_STRUCTURE", 114, 122], ["neoplasia", "CANCER", 167, 176], ["liver", "ORGAN", 211, 216], ["hepatic", "ORGAN", 254, 261], ["Chronic toxic injury to the liver", "PROBLEM", 0, 33], ["chronic hepatitis", "PROBLEM", 55, 72], ["fibrosis", "PROBLEM", 79, 87], ["cirrhosis", "PROBLEM", 103, 112], ["vascular injury", "PROBLEM", 114, 129], ["veno-occlusive disease", "PROBLEM", 139, 161], ["neoplasia", "PROBLEM", 167, 176], ["toxic injury to the liver", "PROBLEM", 191, 216], ["The histologic changes", "PROBLEM", 216, 238], ["acute toxic hepatic injury", "PROBLEM", 242, 268], ["toxic", "OBSERVATION_MODIFIER", 8, 13], ["injury", "OBSERVATION", 14, 20], ["liver", "ANATOMY", 28, 33], ["may be manifested", "UNCERTAINTY", 34, 51], ["chronic", "OBSERVATION_MODIFIER", 55, 62], ["hepatitis", "OBSERVATION", 63, 72], ["fibrosis", "OBSERVATION", 79, 87], ["cirrhosis", "OBSERVATION", 103, 112], ["vascular", "ANATOMY", 114, 122], ["injury", "OBSERVATION", 123, 129], ["veno-occlusive", "OBSERVATION_MODIFIER", 139, 153], ["disease", "OBSERVATION", 154, 161], ["neoplasia", "OBSERVATION", 167, 176], ["toxic", "OBSERVATION_MODIFIER", 191, 196], ["injury", "OBSERVATION", 197, 203], ["liver", "ANATOMY", 211, 216], ["histologic", "OBSERVATION", 220, 230], ["acute", "OBSERVATION_MODIFIER", 242, 247], ["toxic", "OBSERVATION_MODIFIER", 248, 253], ["hepatic", "ANATOMY", 254, 261], ["injury", "OBSERVATION", 262, 268], ["stereotyped", "OBSERVATION_MODIFIER", 280, 291]]], ["They range from apoptosis, through confluent coagulative and zonal necrosis, to massive hemorrhagic destruction that includes sinusoidal lining cells (Fig. 2-93) .", [["sinusoidal lining cells", "ANATOMY", 126, 149], ["necrosis", "DISEASE", 67, 75], ["hemorrhagic", "DISEASE", 88, 99], ["sinusoidal lining cells", "CELL", 126, 149], ["sinusoidal lining cells", "CELL_TYPE", 126, 149], ["apoptosis", "PROBLEM", 16, 25], ["confluent coagulative and zonal necrosis", "PROBLEM", 35, 75], ["massive hemorrhagic destruction", "PROBLEM", 80, 111], ["sinusoidal lining cells", "PROBLEM", 126, 149], ["confluent", "OBSERVATION_MODIFIER", 35, 44], ["coagulative", "OBSERVATION_MODIFIER", 45, 56], ["zonal", "OBSERVATION_MODIFIER", 61, 66], ["necrosis", "OBSERVATION", 67, 75], ["massive", "OBSERVATION_MODIFIER", 80, 87], ["hemorrhagic", "OBSERVATION_MODIFIER", 88, 99], ["destruction", "OBSERVATION", 100, 111], ["sinusoidal lining cells", "OBSERVATION", 126, 149]]], ["The histology of these acute intoxications is often characterized by centrilobular necrosis, usually coagulative ( Fig. 2-94) .", [["centrilobular", "ANATOMY", 69, 82], ["necrosis", "DISEASE", 83, 91], ["these acute intoxications", "PROBLEM", 17, 42], ["centrilobular necrosis", "PROBLEM", 69, 91], ["acute", "OBSERVATION_MODIFIER", 23, 28], ["intoxications", "OBSERVATION", 29, 42], ["centrilobular", "OBSERVATION_MODIFIER", 69, 82], ["necrosis", "OBSERVATION", 83, 91], ["coagulative", "OBSERVATION_MODIFIER", 101, 112]]], ["Rarely, the pattern of necrosis may be periportal or midzonal.", [["necrosis", "DISEASE", 23, 31], ["necrosis", "PROBLEM", 23, 31], ["necrosis", "OBSERVATION", 23, 31], ["may be", "UNCERTAINTY", 32, 38], ["periportal", "ANATOMY_MODIFIER", 39, 49], ["midzonal", "ANATOMY_MODIFIER", 53, 61]]], ["Depending on the nutritional status of the animal, there may be variably severe fatty or hydropic change in hepatocytes adjacent to the necrotic zones.", [["hepatocytes", "ANATOMY", 108, 119], ["necrotic zones", "ANATOMY", 136, 150], ["necrotic", "DISEASE", 136, 144], ["hepatocytes", "CELL", 108, 119], ["necrotic zones", "TISSUE", 136, 150], ["hepatocytes", "CELL_TYPE", 108, 119], ["variably severe fatty or hydropic change in hepatocytes", "PROBLEM", 64, 119], ["the necrotic zones", "PROBLEM", 132, 150], ["may be", "UNCERTAINTY", 57, 63], ["variably", "OBSERVATION_MODIFIER", 64, 72], ["severe", "OBSERVATION_MODIFIER", 73, 79], ["fatty", "OBSERVATION", 80, 85], ["hydropic", "OBSERVATION", 89, 97], ["hepatocytes", "ANATOMY", 108, 119], ["necrotic", "OBSERVATION_MODIFIER", 136, 144], ["zones", "OBSERVATION_MODIFIER", 145, 150]]], ["The necrotic cells may accumulate calcium.", [["necrotic cells", "ANATOMY", 4, 18], ["necrotic", "DISEASE", 4, 12], ["calcium", "CHEMICAL", 34, 41], ["calcium", "CHEMICAL", 34, 41], ["necrotic cells", "CELL", 4, 18], ["calcium", "SIMPLE_CHEMICAL", 34, 41], ["necrotic cells", "CELL_TYPE", 4, 18], ["The necrotic cells", "PROBLEM", 0, 18], ["calcium", "TEST", 34, 41], ["necrotic cells", "OBSERVATION", 4, 18], ["calcium", "OBSERVATION_MODIFIER", 34, 41]]], ["Variations on the general process of hepatocellular necrosis have little diagnostic or pathogenetic specificity.", [["hepatocellular", "ANATOMY", 37, 51], ["necrosis", "DISEASE", 52, 60], ["hepatocellular necrosis", "CANCER", 37, 60], ["hepatocellular necrosis", "PROBLEM", 37, 60], ["hepatocellular", "ANATOMY", 37, 51], ["necrosis", "OBSERVATION", 52, 60]]], ["In sublethally injured cells, there may be prominent but nonspecific clumping of smooth endoplasmic reticulum, particularly in the centrilobular zones.Morphology of toxic injury to the liverThe clinical and gross characteristics of fatal acute intoxications that destroy liver parenchyma are rather consistent, regardless of the origin of the toxin.", [["cells", "ANATOMY", 23, 28], ["smooth endoplasmic reticulum", "ANATOMY", 81, 109], ["centrilobular zones", "ANATOMY", 131, 150], ["liver", "ANATOMY", 185, 190], ["liver parenchyma", "ANATOMY", 271, 287], ["injury to the liver", "DISEASE", 171, 190], ["cells", "CELL", 23, 28], ["smooth endoplasmic reticulum", "CELLULAR_COMPONENT", 81, 109], ["centrilobular zones", "TISSUE", 131, 150], ["liver", "ORGAN", 185, 190], ["liver parenchyma", "MULTI-TISSUE_STRUCTURE", 271, 287], ["sublethally injured cells", "CELL_TYPE", 3, 28], ["nonspecific clumping of smooth endoplasmic reticulum", "PROBLEM", 57, 109], ["toxic injury to the liver", "PROBLEM", 165, 190], ["fatal acute intoxications that destroy liver parenchyma", "PROBLEM", 232, 287], ["sublethally", "OBSERVATION", 3, 14], ["injured cells", "OBSERVATION", 15, 28], ["may be", "UNCERTAINTY", 36, 42], ["prominent", "OBSERVATION_MODIFIER", 43, 52], ["nonspecific", "OBSERVATION_MODIFIER", 57, 68], ["clumping", "OBSERVATION", 69, 77], ["smooth endoplasmic reticulum", "OBSERVATION", 81, 109], ["centrilobular", "ANATOMY_MODIFIER", 131, 144], ["zones", "ANATOMY_MODIFIER", 145, 150], ["toxic", "OBSERVATION_MODIFIER", 165, 170], ["injury", "OBSERVATION", 171, 177], ["liver", "ANATOMY", 185, 190], ["fatal", "OBSERVATION_MODIFIER", 232, 237], ["acute", "OBSERVATION_MODIFIER", 238, 243], ["intoxications", "OBSERVATION", 244, 257], ["liver", "ANATOMY", 271, 276], ["parenchyma", "ANATOMY_MODIFIER", 277, 287]]], ["The animal dies after a brief period of dullness, anorexia, colic, and various neurologic disturbances, including convulsions; these are attributed to hepatic encephalopathy.", [["neurologic", "ANATOMY", 79, 89], ["hepatic", "ANATOMY", 151, 158], ["dullness", "DISEASE", 40, 48], ["anorexia", "DISEASE", 50, 58], ["colic", "DISEASE", 60, 65], ["neurologic disturbances", "DISEASE", 79, 102], ["convulsions", "DISEASE", 114, 125], ["hepatic encephalopathy", "DISEASE", 151, 173], ["hepatic", "ORGAN", 151, 158], ["dullness", "PROBLEM", 40, 48], ["anorexia", "PROBLEM", 50, 58], ["colic", "PROBLEM", 60, 65], ["various neurologic disturbances", "PROBLEM", 71, 102], ["convulsions", "PROBLEM", 114, 125], ["hepatic encephalopathy", "PROBLEM", 151, 173], ["dullness", "OBSERVATION", 40, 48], ["anorexia", "OBSERVATION", 50, 58], ["colic", "ANATOMY", 60, 65], ["hepatic", "ANATOMY", 151, 158], ["encephalopathy", "OBSERVATION", 159, 173]]], ["Postmortem examination reveals a slight excess of clear, yellow abdominal fluid, which containsClassification of hepatotoxinsHepatotoxins can be classified as intrinsic or idiosyncratic, and these categories apply as well to the types of drug-induced hepatotoxicity that are observed in humans and animals.", [["abdominal fluid", "ANATOMY", 64, 79], ["hepatotoxicity", "DISEASE", 251, 265], ["abdominal fluid", "ORGANISM_SUBSTANCE", 64, 79], ["hepatotoxins", "SIMPLE_CHEMICAL", 113, 125], ["Hepatotoxins", "SIMPLE_CHEMICAL", 125, 137], ["humans", "ORGANISM", 287, 293], ["humans", "SPECIES", 287, 293], ["humans", "SPECIES", 287, 293], ["Postmortem examination", "TEST", 0, 22], ["a slight excess of clear, yellow abdominal fluid", "PROBLEM", 31, 79], ["hepatotoxinsHepatotoxins", "PROBLEM", 113, 137], ["drug-induced hepatotoxicity", "PROBLEM", 238, 265], ["slight", "OBSERVATION_MODIFIER", 33, 39], ["excess", "OBSERVATION_MODIFIER", 40, 46], ["clear", "OBSERVATION", 50, 55], ["abdominal", "ANATOMY", 64, 73], ["fluid", "OBSERVATION", 74, 79], ["hepatotoxicity", "OBSERVATION", 251, 265]]], ["The effects of intrinsic hepatotoxins are considered to be dose related, predictable, and reproducible in experimental animals, and the underlying mechanisms are typically at least partially understood.", [["hepatotoxins", "SIMPLE_CHEMICAL", 25, 37], ["intrinsic hepatotoxins", "PROBLEM", 15, 37], ["hepatotoxins", "OBSERVATION", 25, 37], ["reproducible", "OBSERVATION_MODIFIER", 90, 102]]], ["Intrinsic hepatotoxins can cause liver injury in overdose situations in most normal recipients but are also capable of inducing similar liver damage at lower doses in individuals with genetic or acquired abnormalities in drug metabolism.", [["liver", "ANATOMY", 33, 38], ["liver", "ANATOMY", 136, 141], ["hepatotoxins", "CHEMICAL", 10, 22], ["liver injury", "DISEASE", 33, 45], ["overdose", "DISEASE", 49, 57], ["liver damage", "DISEASE", 136, 148], ["hepatotoxins", "SIMPLE_CHEMICAL", 10, 22], ["liver", "ORGAN", 33, 38], ["recipients", "ORGANISM", 84, 94], ["liver", "ORGAN", 136, 141], ["Intrinsic hepatotoxins", "PROBLEM", 0, 22], ["liver injury", "PROBLEM", 33, 45], ["overdose situations", "PROBLEM", 49, 68], ["similar liver damage", "PROBLEM", 128, 148], ["acquired abnormalities in drug metabolism", "PROBLEM", 195, 236], ["hepatotoxins", "OBSERVATION", 10, 22], ["liver", "ANATOMY", 33, 38], ["injury", "OBSERVATION", 39, 45], ["liver", "ANATOMY", 136, 141], ["damage", "OBSERVATION", 142, 148], ["lower doses", "OBSERVATION_MODIFIER", 152, 163], ["drug metabolism", "OBSERVATION", 221, 236]]], ["The majority of intrinsic hepatotoxicants are converted to reactive metabolites, including lipoperoxidative free radicals.Classification of hepatotoxinsThe analgesic acetaminophen represents a wellcharacterized example of an intrinsic hepatotoxin, with species differences in metabolism and associated susceptibility to oxidative and hepatic injury.", [["hepatic", "ANATOMY", 334, 341], ["hepatotoxins", "CHEMICAL", 140, 152], ["acetaminophen", "CHEMICAL", 166, 179], ["hepatic injury", "DISEASE", 334, 348], ["hepatotoxins", "CHEMICAL", 140, 152], ["acetaminophen", "CHEMICAL", 166, 179], ["hepatotoxicants", "SIMPLE_CHEMICAL", 26, 41], ["lipoperoxidative free radicals", "SIMPLE_CHEMICAL", 91, 121], ["hepatotoxins", "GENE_OR_GENE_PRODUCT", 140, 152], ["acetaminophen", "SIMPLE_CHEMICAL", 166, 179], ["hepatotoxin", "SIMPLE_CHEMICAL", 235, 246], ["hepatic", "ORGAN", 334, 341], ["intrinsic hepatotoxicants", "PROBLEM", 16, 41], ["reactive metabolites", "TEST", 59, 79], ["lipoperoxidative free radicals", "PROBLEM", 91, 121], ["hepatotoxins", "PROBLEM", 140, 152], ["The analgesic acetaminophen", "TREATMENT", 152, 179], ["an intrinsic hepatotoxin", "PROBLEM", 222, 246], ["species differences in metabolism", "PROBLEM", 253, 286], ["associated susceptibility to oxidative and hepatic injury", "PROBLEM", 291, 348], ["intrinsic hepatotoxicants", "OBSERVATION", 16, 41], ["reactive metabolites", "OBSERVATION", 59, 79], ["free radicals", "OBSERVATION", 108, 121], ["hepatotoxins", "ANATOMY", 140, 152], ["hepatotoxin", "OBSERVATION", 235, 246], ["hepatic", "ANATOMY", 334, 341], ["injury", "OBSERVATION", 342, 348]]], ["Dogs and cats can tolerate doses within therapeutic levels; however, higher doses may saturate the glucuronidation and sulfation detoxification pathways, resulting in increased formation of the reactive benzoquinone-imine metabolite NAPQI via a third cytochrome P450-mediated pathway.", [["benzoquinone", "CHEMICAL", 203, 215], ["NAPQI", "CHEMICAL", 233, 238], ["benzoquinone", "CHEMICAL", 203, 215], ["imine", "CHEMICAL", 216, 221], ["NAPQI", "CHEMICAL", 233, 238], ["Dogs", "ORGANISM", 0, 4], ["cats", "ORGANISM", 9, 13], ["benzoquinone-imine", "SIMPLE_CHEMICAL", 203, 221], ["NAPQI", "SIMPLE_CHEMICAL", 233, 238], ["cytochrome P450", "GENE_OR_GENE_PRODUCT", 251, 266], ["cytochrome P450", "PROTEIN", 251, 266], ["cats", "SPECIES", 9, 13], ["the reactive benzoquinone", "TREATMENT", 190, 215], ["imine metabolite NAPQI", "TREATMENT", 216, 238], ["a third cytochrome P450-mediated pathway", "TREATMENT", 243, 283], ["increased", "OBSERVATION_MODIFIER", 167, 176], ["reactive benzoquinone", "OBSERVATION", 194, 215]]], ["These can be scavenged by glutathione conjugation; however, massive doses can cause lethal acute hepatic failure, associated with overproduction of reactive metabolites, and depletion of hepatic and erythrocyte glutathione.", [["hepatic", "ANATOMY", 97, 104], ["hepatic", "ANATOMY", 187, 194], ["erythrocyte", "ANATOMY", 199, 210], ["glutathione", "CHEMICAL", 26, 37], ["acute hepatic failure", "DISEASE", 91, 112], ["glutathione", "CHEMICAL", 211, 222], ["glutathione", "CHEMICAL", 26, 37], ["glutathione", "CHEMICAL", 211, 222], ["glutathione", "SIMPLE_CHEMICAL", 26, 37], ["hepatic", "ORGAN", 97, 104], ["hepatic", "MULTI-TISSUE_STRUCTURE", 187, 194], ["erythrocyte", "CELL", 199, 210], ["glutathione", "SIMPLE_CHEMICAL", 211, 222], ["glutathione conjugation", "TREATMENT", 26, 49], ["lethal acute hepatic failure", "PROBLEM", 84, 112], ["overproduction of reactive metabolites", "PROBLEM", 130, 168], ["hepatic and erythrocyte glutathione", "TREATMENT", 187, 222], ["lethal", "OBSERVATION_MODIFIER", 84, 90], ["acute", "OBSERVATION_MODIFIER", 91, 96], ["hepatic", "ANATOMY", 97, 104], ["failure", "OBSERVATION", 105, 112], ["reactive metabolites", "OBSERVATION", 148, 168], ["hepatic", "ANATOMY", 187, 194], ["erythrocyte glutathione", "OBSERVATION", 199, 222]]], ["As discussed previously, clinical toxicity occurs at lower doses and is more severe in cats because they express fewer hepatic isoforms of glucuronyltransferase as part of phase 2 hepatic metabolism and are unable to accelerate excretion of excess metabolites through glucuronide conjugation.", [["hepatic", "ANATOMY", 119, 126], ["hepatic", "ANATOMY", 180, 187], ["toxicity", "DISEASE", 34, 42], ["glucuronide", "CHEMICAL", 268, 279], ["glucuronide", "CHEMICAL", 268, 279], ["cats", "ORGANISM", 87, 91], ["glucuronyltransferase", "GENE_OR_GENE_PRODUCT", 139, 160], ["hepatic", "MULTI-TISSUE_STRUCTURE", 180, 187], ["glucuronide", "SIMPLE_CHEMICAL", 268, 279], ["hepatic isoforms", "PROTEIN", 119, 135], ["glucuronyltransferase", "PROTEIN", 139, 160], ["cats", "SPECIES", 87, 91], ["clinical toxicity", "PROBLEM", 25, 42], ["more severe in cats", "PROBLEM", 72, 91], ["excess metabolites", "PROBLEM", 241, 259], ["glucuronide conjugation", "TREATMENT", 268, 291], ["more severe", "OBSERVATION_MODIFIER", 72, 83], ["hepatic", "ANATOMY", 119, 126], ["hepatic", "ANATOMY", 180, 187]]], ["This is compounded by a propensity for hemoglobin oxidation, resulting in methemoglobinemia.", [["methemoglobinemia", "DISEASE", 74, 91], ["hemoglobin", "GENE_OR_GENE_PRODUCT", 39, 49], ["hemoglobin", "PROTEIN", 39, 49], ["hemoglobin oxidation", "PROBLEM", 39, 59], ["methemoglobinemia", "PROBLEM", 74, 91], ["hemoglobin oxidation", "OBSERVATION", 39, 59], ["methemoglobinemia", "OBSERVATION", 74, 91]]], ["Toxicity results when reduced glutathione levels drop below a threshold level, resulting in marked oxidative stress, and allowing reactive metabolites to bind covalently to cellular macromolecules.Classification of hepatotoxinsBy comparison, idiosyncratic hepatotoxins are typically less dose related (although there is likely a minimum threshold), more unpredictable, and importantly, occur in only a very small proportion of exposed individuals (i.e., <1 in 10,000-100,000) .", [["cellular", "ANATOMY", 173, 181], ["Toxicity", "DISEASE", 0, 8], ["glutathione", "CHEMICAL", 30, 41], ["glutathione", "CHEMICAL", 30, 41], ["glutathione", "SIMPLE_CHEMICAL", 30, 41], ["cellular", "CELL", 173, 181], ["reduced glutathione levels drop", "PROBLEM", 22, 53], ["marked oxidative stress", "PROBLEM", 92, 115], ["idiosyncratic hepatotoxins", "PROBLEM", 242, 268], ["marked", "OBSERVATION_MODIFIER", 92, 98], ["oxidative stress", "OBSERVATION", 99, 115], ["reactive metabolites", "OBSERVATION", 130, 150], ["cellular macromolecules", "OBSERVATION", 173, 196], ["idiosyncratic", "OBSERVATION_MODIFIER", 242, 255], ["hepatotoxins", "OBSERVATION", 256, 268], ["less dose", "OBSERVATION_MODIFIER", 283, 292], ["unpredictable", "OBSERVATION_MODIFIER", 354, 367], ["very", "OBSERVATION_MODIFIER", 402, 406], ["small", "OBSERVATION_MODIFIER", 407, 412]]], ["The mechanisms of idiosyncratic hepatotoxicity are generally not known, but reflect an unusual susceptibility of individual recipients to effects that are unrelated to the drug's therapeutic action or overdose toxicity.", [["hepatotoxicity", "DISEASE", 32, 46], ["overdose", "DISEASE", 201, 209], ["toxicity", "DISEASE", 210, 218], ["idiosyncratic hepatotoxicity", "PROBLEM", 18, 46], ["overdose toxicity", "PROBLEM", 201, 218], ["idiosyncratic", "OBSERVATION_MODIFIER", 18, 31], ["hepatotoxicity", "OBSERVATION", 32, 46]]], ["Idiosyncratic hepatotoxicity is more likely a series of rare drug-related toxicities with different forms of pathogenesis than a single entity.", [["hepatotoxicity", "DISEASE", 14, 28], ["toxicities", "DISEASE", 74, 84], ["Idiosyncratic hepatotoxicity", "PROBLEM", 0, 28], ["rare drug-related toxicities", "PROBLEM", 56, 84], ["pathogenesis", "PROBLEM", 109, 121], ["hepatotoxicity", "OBSERVATION", 14, 28], ["more likely", "UNCERTAINTY", 32, 43]]], ["There are 2 main categories of idiosyncratic hepatotoxicity recognized in humans: hypersensitivity-related drug-induced liver injury (drug allergy) and toxic metabolite-dependent drug-induced liver injury.Classification of hepatotoxinsHypersensitivity-related idiosyncrasies are characterized by a latency period before toxicity is evident and reoccur promptly upon re-exposure.", [["liver", "ANATOMY", 120, 125], ["liver", "ANATOMY", 192, 197], ["hepatotoxicity", "DISEASE", 45, 59], ["hypersensitivity", "DISEASE", 82, 98], ["liver injury", "DISEASE", 120, 132], ["drug allergy", "DISEASE", 134, 146], ["liver injury", "DISEASE", 192, 204], ["Hypersensitivity", "DISEASE", 235, 251], ["toxicity", "DISEASE", 320, 328], ["humans", "ORGANISM", 74, 80], ["liver", "ORGAN", 120, 125], ["liver", "ORGAN", 192, 197], ["humans", "SPECIES", 74, 80], ["humans", "SPECIES", 74, 80], ["idiosyncratic hepatotoxicity", "PROBLEM", 31, 59], ["hypersensitivity", "PROBLEM", 82, 98], ["liver injury", "PROBLEM", 120, 132], ["drug allergy", "PROBLEM", 134, 146], ["toxic metabolite", "PROBLEM", 152, 168], ["liver injury", "PROBLEM", 192, 204], ["hepatotoxinsHypersensitivity", "PROBLEM", 223, 251], ["idiosyncrasies", "PROBLEM", 260, 274], ["toxicity", "PROBLEM", 320, 328], ["idiosyncratic", "OBSERVATION_MODIFIER", 31, 44], ["hepatotoxicity", "OBSERVATION", 45, 59], ["liver", "ANATOMY", 120, 125], ["injury", "OBSERVATION", 126, 132], ["liver", "ANATOMY", 192, 197], ["injury", "OBSERVATION", 198, 204], ["hepatotoxins", "OBSERVATION", 223, 235], ["latency", "OBSERVATION_MODIFIER", 298, 305]]], ["Typically, they involve immunemediated hypersensitivity responses to the drug metabolites that covalently bind to liver proteins, forming neoantigens that may be recognized as foreign by the immune system, with further liver injury resulting from the ensuing specific immune response or upregulation of components of the innate immune system.", [["liver", "ANATOMY", 114, 119], ["immune system", "ANATOMY", 191, 204], ["liver", "ANATOMY", 219, 224], ["hypersensitivity", "DISEASE", 39, 55], ["liver injury", "DISEASE", 219, 231], ["liver", "ORGAN", 114, 119], ["neoantigens", "GENE_OR_GENE_PRODUCT", 138, 149], ["liver", "ORGAN", 219, 224], ["liver proteins", "PROTEIN", 114, 128], ["immunemediated hypersensitivity responses", "PROBLEM", 24, 65], ["the drug metabolites", "PROBLEM", 69, 89], ["liver proteins", "PROBLEM", 114, 128], ["forming neoantigens", "PROBLEM", 130, 149], ["further liver injury", "PROBLEM", 211, 231], ["the innate immune system", "TREATMENT", 317, 341], ["liver", "ANATOMY", 114, 119], ["liver", "ANATOMY", 219, 224], ["injury", "OBSERVATION", 225, 231]]], ["In humans, a genetic component to hypersensitivity-related idiosyncratic hepatic toxicity is strongly suspected.", [["hepatic", "ANATOMY", 73, 80], ["hypersensitivity", "DISEASE", 34, 50], ["idiosyncratic hepatic toxicity", "DISEASE", 59, 89], ["humans", "ORGANISM", 3, 9], ["hepatic", "ORGAN", 73, 80], ["humans", "SPECIES", 3, 9], ["humans", "SPECIES", 3, 9], ["hypersensitivity", "PROBLEM", 34, 50], ["idiosyncratic hepatic toxicity", "PROBLEM", 59, 89], ["idiosyncratic", "OBSERVATION_MODIFIER", 59, 72], ["hepatic", "ANATOMY", 73, 80], ["toxicity", "OBSERVATION", 81, 89]]], ["Single nucleotide polymorphisms in the human leukocyte antigen (HLA) region or particular HLA factors undoubtedly becomes important when these factors are consumed.", [["nucleotide", "CHEMICAL", 7, 17], ["human leukocyte antigen", "GENE_OR_GENE_PRODUCT", 39, 62], ["HLA factors", "GENE_OR_GENE_PRODUCT", 90, 101], ["human leukocyte antigen (HLA) region", "DNA", 39, 75], ["HLA factors", "PROTEIN", 90, 101], ["human", "SPECIES", 39, 44], ["human", "SPECIES", 39, 44], ["Single nucleotide polymorphisms", "PROBLEM", 0, 31], ["the human leukocyte antigen", "TEST", 35, 62], ["particular HLA factors", "PROBLEM", 79, 101], ["human leukocyte", "ANATOMY", 39, 54]]], ["Gross lesions, such as icterus, and photosensitization, which reflect failure of biotransformation or excretion of endogenous materials, develop too slowly to be a feature of acutely fatal hepatotoxicities.", [["Gross lesions", "ANATOMY", 0, 13], ["icterus", "DISEASE", 23, 30], ["photosensitization", "DISEASE", 36, 54], ["hepatotoxicities", "DISEASE", 189, 205], ["Gross lesions", "PATHOLOGICAL_FORMATION", 0, 13], ["Gross lesions", "PROBLEM", 0, 13], ["icterus", "PROBLEM", 23, 30], ["photosensitization", "PROBLEM", 36, 54], ["failure of biotransformation", "PROBLEM", 70, 98], ["excretion of endogenous materials", "PROBLEM", 102, 135], ["acutely fatal hepatotoxicities", "PROBLEM", 175, 205], ["lesions", "OBSERVATION", 6, 13], ["icterus", "OBSERVATION", 23, 30], ["endogenous materials", "OBSERVATION", 115, 135], ["acutely", "OBSERVATION_MODIFIER", 175, 182], ["fatal", "OBSERVATION_MODIFIER", 183, 188], ["hepatotoxicities", "OBSERVATION", 189, 205]]], ["However, the rate of accumulation of bilirubin increases when hemorrhage occurs in the necrotic liver or as a consequence of coagulopathy.Classification of hepatotoxinsChronic hepatotoxic injury may manifest in many patterns, as previously described.", [["necrotic liver", "ANATOMY", 87, 101], ["bilirubin", "CHEMICAL", 37, 46], ["hemorrhage", "DISEASE", 62, 72], ["necrotic", "DISEASE", 87, 95], ["coagulopathy", "DISEASE", 125, 137], ["hepatotoxic injury", "DISEASE", 176, 194], ["bilirubin", "CHEMICAL", 37, 46], ["bilirubin", "GENE_OR_GENE_PRODUCT", 37, 46], ["liver", "ORGAN", 96, 101], ["bilirubin", "PROTEIN", 37, 46], ["accumulation of bilirubin", "PROBLEM", 21, 46], ["hemorrhage", "PROBLEM", 62, 72], ["the necrotic liver", "PROBLEM", 83, 101], ["coagulopathy", "PROBLEM", 125, 137], ["hepatotoxinsChronic hepatotoxic injury", "PROBLEM", 156, 194], ["hemorrhage", "OBSERVATION", 62, 72], ["necrotic", "OBSERVATION_MODIFIER", 87, 95], ["liver", "ANATOMY", 96, 101], ["coagulopathy", "OBSERVATION", 125, 137], ["hepatotoxins", "OBSERVATION_MODIFIER", 156, 168], ["Chronic", "OBSERVATION_MODIFIER", 168, 175], ["hepatotoxic", "OBSERVATION_MODIFIER", 176, 187], ["injury", "OBSERVATION", 188, 194]]], ["These include areas of necrosis with primarily mononuclear inflammatory infiltrates, steatosis, cirrhosis, atrophy with nodules, hepatic vein thrombosis, venoocclusive disease, peliosis hepatis, cholangitis, ductular reaction (biliary hyperplasia), and carcinogenesis.", [["nodules", "ANATOMY", 120, 127], ["hepatic vein", "ANATOMY", 129, 141], ["venoocclusive", "ANATOMY", 154, 167], ["peliosis hepatis", "ANATOMY", 177, 193], ["ductular", "ANATOMY", 208, 216], ["biliary", "ANATOMY", 227, 234], ["necrosis", "DISEASE", 23, 31], ["steatosis", "DISEASE", 85, 94], ["cirrhosis", "DISEASE", 96, 105], ["atrophy", "DISEASE", 107, 114], ["hepatic vein thrombosis", "DISEASE", 129, 152], ["venoocclusive disease", "DISEASE", 154, 175], ["peliosis hepatis", "DISEASE", 177, 193], ["cholangitis", "DISEASE", 195, 206], ["ductular reaction", "DISEASE", 208, 225], ["biliary hyperplasia", "DISEASE", 227, 246], ["carcinogenesis", "DISEASE", 253, 267], ["mononuclear", "CELL", 47, 58], ["hepatic vein", "MULTI-TISSUE_STRUCTURE", 129, 141], ["ductular", "MULTI-TISSUE_STRUCTURE", 208, 216], ["biliary hyperplasia", "PATHOLOGICAL_FORMATION", 227, 246], ["necrosis", "PROBLEM", 23, 31], ["primarily mononuclear inflammatory infiltrates", "PROBLEM", 37, 83], ["steatosis", "PROBLEM", 85, 94], ["cirrhosis", "PROBLEM", 96, 105], ["atrophy", "PROBLEM", 107, 114], ["nodules", "PROBLEM", 120, 127], ["hepatic vein thrombosis", "PROBLEM", 129, 152], ["venoocclusive disease", "PROBLEM", 154, 175], ["peliosis hepatis", "PROBLEM", 177, 193], ["cholangitis", "PROBLEM", 195, 206], ["ductular reaction", "PROBLEM", 208, 225], ["biliary hyperplasia)", "PROBLEM", 227, 247], ["carcinogenesis", "PROBLEM", 253, 267], ["necrosis", "OBSERVATION", 23, 31], ["primarily", "OBSERVATION_MODIFIER", 37, 46], ["mononuclear", "OBSERVATION_MODIFIER", 47, 58], ["inflammatory", "OBSERVATION_MODIFIER", 59, 71], ["infiltrates", "OBSERVATION", 72, 83], ["steatosis", "OBSERVATION", 85, 94], ["cirrhosis", "OBSERVATION", 96, 105], ["atrophy", "OBSERVATION", 107, 114], ["nodules", "OBSERVATION", 120, 127], ["hepatic vein", "ANATOMY", 129, 141], ["thrombosis", "OBSERVATION", 142, 152], ["venoocclusive disease", "OBSERVATION", 154, 175], ["peliosis", "OBSERVATION_MODIFIER", 177, 185], ["hepatis", "ANATOMY", 186, 193], ["cholangitis", "OBSERVATION", 195, 206], ["ductular", "ANATOMY_MODIFIER", 208, 216], ["biliary", "ANATOMY", 227, 234], ["hyperplasia", "OBSERVATION", 235, 246], ["carcinogenesis", "OBSERVATION", 253, 267]]], ["In contrast to the acute intoxications, chronic hepatotoxicities are more likely to display a mix of these responses, and this can provide more diagnostic specificity.", [["the acute intoxications", "PROBLEM", 15, 38], ["chronic hepatotoxicities", "PROBLEM", 40, 64], ["acute", "OBSERVATION_MODIFIER", 19, 24], ["intoxications", "OBSERVATION", 25, 38], ["chronic", "OBSERVATION_MODIFIER", 40, 47], ["hepatotoxicities", "OBSERVATION", 48, 64], ["more likely", "UNCERTAINTY", 69, 80]]], ["For example, agents that impair hepatocellular regeneration might not be potent necrogens but tend to produce hepatic apoptosis and atrophy, fibrosis of various patterns, compensatory bile duct hyperplasia, nodular regeneration, some degree of cholestasis, and frequently megalocytosis (polyploidy).", [["hepatocellular", "ANATOMY", 32, 46], ["hepatic", "ANATOMY", 110, 117], ["bile duct", "ANATOMY", 184, 193], ["nodular", "ANATOMY", 207, 214], ["atrophy", "DISEASE", 132, 139], ["fibrosis", "DISEASE", 141, 149], ["bile duct hyperplasia", "DISEASE", 184, 205], ["cholestasis", "DISEASE", 244, 255], ["megalocytosis", "DISEASE", 272, 285], ["polyploidy", "DISEASE", 287, 297], ["hepatocellular", "ORGAN", 32, 46], ["hepatic", "MULTI-TISSUE_STRUCTURE", 110, 117], ["bile duct", "MULTI-TISSUE_STRUCTURE", 184, 193], ["agents", "TREATMENT", 13, 19], ["hepatocellular regeneration", "PROBLEM", 32, 59], ["potent necrogens", "PROBLEM", 73, 89], ["hepatic apoptosis", "PROBLEM", 110, 127], ["atrophy", "PROBLEM", 132, 139], ["fibrosis of various patterns", "PROBLEM", 141, 169], ["compensatory bile duct hyperplasia", "PROBLEM", 171, 205], ["nodular regeneration", "PROBLEM", 207, 227], ["cholestasis", "PROBLEM", 244, 255], ["frequently megalocytosis (polyploidy)", "PROBLEM", 261, 298], ["hepatocellular", "ANATOMY", 32, 46], ["hepatic", "ANATOMY", 110, 117], ["apoptosis", "OBSERVATION", 118, 127], ["atrophy", "OBSERVATION", 132, 139], ["fibrosis", "OBSERVATION", 141, 149], ["compensatory", "OBSERVATION_MODIFIER", 171, 183], ["bile duct", "ANATOMY", 184, 193], ["hyperplasia", "OBSERVATION", 194, 205], ["nodular", "OBSERVATION_MODIFIER", 207, 214], ["regeneration", "OBSERVATION_MODIFIER", 215, 227], ["some", "OBSERVATION_MODIFIER", 229, 233], ["degree", "OBSERVATION_MODIFIER", 234, 240], ["cholestasis", "OBSERVATION", 244, 255], ["frequently", "OBSERVATION_MODIFIER", 261, 271], ["megalocytosis", "OBSERVATION", 272, 285]]], ["Such hepatotoxins are potential carcinogens because they favor the selective growth of hepatocellular nodules that are resistant to mitoinhibitory effects.Classification of hepatotoxinsClinical signs of chronic hepatotoxicity are usually problems resulting from inadequate detoxification and excretion; these include jaundice, photosensitization, and hepatic encephalopathy.", [["hepatocellular nodules", "ANATOMY", 87, 109], ["hepatic", "ANATOMY", 351, 358], ["hepatotoxicity", "DISEASE", 211, 225], ["jaundice", "DISEASE", 317, 325], ["photosensitization", "DISEASE", 327, 345], ["hepatic encephalopathy", "DISEASE", 351, 373], ["hepatotoxins", "SIMPLE_CHEMICAL", 5, 17], ["hepatocellular nodules", "CANCER", 87, 109], ["hepatic", "ORGAN", 351, 358], ["Such hepatotoxins", "PROBLEM", 0, 17], ["potential carcinogens", "PROBLEM", 22, 43], ["hepatocellular nodules", "PROBLEM", 87, 109], ["mitoinhibitory effects", "TREATMENT", 132, 154], ["hepatotoxins", "PROBLEM", 173, 185], ["chronic hepatotoxicity", "PROBLEM", 203, 225], ["inadequate detoxification and excretion", "PROBLEM", 262, 301], ["jaundice", "PROBLEM", 317, 325], ["photosensitization", "PROBLEM", 327, 345], ["hepatic encephalopathy", "PROBLEM", 351, 373], ["selective", "OBSERVATION_MODIFIER", 67, 76], ["growth", "OBSERVATION_MODIFIER", 77, 83], ["hepatocellular", "ANATOMY", 87, 101], ["nodules", "OBSERVATION", 102, 109], ["hepatotoxins", "OBSERVATION", 173, 185], ["chronic", "OBSERVATION_MODIFIER", 203, 210], ["hepatotoxicity", "OBSERVATION", 211, 225], ["jaundice", "OBSERVATION", 317, 325], ["hepatic", "ANATOMY", 351, 358], ["encephalopathy", "OBSERVATION", 359, 373]]], ["Most of the toxins responsible for chronic hepatotoxicity may produce acute nonspecific zonal or massive necrosis if experimentally administered at dose rates higher than those to which animals are likely to be exposed in the field, although such acute toxicity is only occasionally observed in field cases of the diseases.Toxic agentsThe range of substances that can cause hepatotoxicity is so broad that it encompasses virtually all categories of natural and synthetic chemicals.", [["hepatotoxicity", "DISEASE", 43, 57], ["necrosis", "DISEASE", 105, 113], ["toxicity", "DISEASE", 253, 261], ["hepatotoxicity", "DISEASE", 374, 388], ["the toxins", "PROBLEM", 8, 18], ["chronic hepatotoxicity", "PROBLEM", 35, 57], ["acute nonspecific zonal or massive necrosis", "PROBLEM", 70, 113], ["acute toxicity", "PROBLEM", 247, 261], ["the diseases", "PROBLEM", 310, 322], ["Toxic agents", "TREATMENT", 323, 335], ["hepatotoxicity", "PROBLEM", 374, 388], ["chronic", "OBSERVATION_MODIFIER", 35, 42], ["hepatotoxicity", "OBSERVATION", 43, 57], ["acute", "OBSERVATION_MODIFIER", 70, 75], ["nonspecific", "OBSERVATION_MODIFIER", 76, 87], ["zonal", "OBSERVATION_MODIFIER", 88, 93], ["massive", "OBSERVATION_MODIFIER", 97, 104], ["necrosis", "OBSERVATION", 105, 113], ["likely to be", "UNCERTAINTY", 198, 210], ["acute", "OBSERVATION_MODIFIER", 247, 252], ["toxicity", "OBSERVATION", 253, 261], ["diseases", "OBSERVATION", 314, 322]]], ["These include metals (iron, copper), drugs (e.g., acetaminophen), plant components (phytotoxins), fungal metabolites (mycotoxins), bacterial products (e.g., cyanobacterial microcystin-LR), and various industrial products (especially aromatic solvents).", [["metals", "CHEMICAL", 14, 20], ["iron", "CHEMICAL", 22, 26], ["copper", "CHEMICAL", 28, 34], ["acetaminophen", "CHEMICAL", 50, 63], ["microcystin-LR", "CHEMICAL", 172, 186], ["iron", "CHEMICAL", 22, 26], ["copper", "CHEMICAL", 28, 34], ["acetaminophen", "CHEMICAL", 50, 63], ["metals", "SIMPLE_CHEMICAL", 14, 20], ["iron", "SIMPLE_CHEMICAL", 22, 26], ["copper", "SIMPLE_CHEMICAL", 28, 34], ["acetaminophen", "SIMPLE_CHEMICAL", 50, 63], ["phytotoxins", "SIMPLE_CHEMICAL", 84, 95], ["microcystin-LR", "SIMPLE_CHEMICAL", 172, 186], ["metals (iron, copper)", "TREATMENT", 14, 35], ["drugs", "TREATMENT", 37, 42], ["acetaminophen", "TREATMENT", 50, 63], ["plant components (phytotoxins)", "TREATMENT", 66, 96], ["fungal metabolites (mycotoxins", "TREATMENT", 98, 128], ["bacterial products", "TREATMENT", 131, 149], ["cyanobacterial microcystin-LR", "TREATMENT", 157, 186], ["various industrial products", "TREATMENT", 193, 220], ["industrial products", "OBSERVATION", 201, 220], ["aromatic solvents", "OBSERVATION", 233, 250]]], ["Many drugs are also hepatotoxic.", [["hepatotoxic", "DISEASE", 20, 31], ["hepatotoxic", "PROBLEM", 20, 31], ["drugs", "OBSERVATION", 5, 10], ["hepatotoxic", "OBSERVATION_MODIFIER", 20, 31]]], ["Differences in individual susceptibility to hepatotoxic responses likely occur for all classes of chemicals that are metabolized in the liver.Toxic agentsIn the following sections, toxic hepatic disease will be separated into drug-or pharmaceutical-induced hepatotoxicity (so-called adverse drug reactions), and hepatotoxicity associated with exposure to plant or environmental toxins, including metals.", [["liver", "ANATOMY", 136, 141], ["sections", "ANATOMY", 171, 179], ["hepatic", "ANATOMY", 187, 194], ["hepatotoxic", "DISEASE", 44, 55], ["toxic hepatic disease", "DISEASE", 181, 202], ["hepatotoxicity", "DISEASE", 257, 271], ["adverse drug reactions", "DISEASE", 283, 305], ["hepatotoxicity", "DISEASE", 312, 326], ["metals", "CHEMICAL", 396, 402], ["liver", "ORGAN", 136, 141], ["hepatic", "ORGAN", 187, 194], ["metals", "SIMPLE_CHEMICAL", 396, 402], ["Toxic agents", "TREATMENT", 142, 154], ["toxic hepatic disease", "PROBLEM", 181, 202], ["pharmaceutical-induced hepatotoxicity", "PROBLEM", 234, 271], ["adverse drug reactions", "PROBLEM", 283, 305], ["hepatotoxicity", "PROBLEM", 312, 326], ["environmental toxins", "PROBLEM", 364, 384], ["chemicals", "OBSERVATION", 98, 107], ["liver", "ANATOMY", 136, 141], ["toxic", "OBSERVATION_MODIFIER", 181, 186], ["hepatic", "ANATOMY", 187, 194], ["disease", "OBSERVATION", 195, 202], ["hepatotoxicity", "OBSERVATION", 257, 271]]], ["The latter have been somewhat arbitrarily divided into acute and chronic, and although it is recognized that the difference between acute and chronic hepatotoxicity is often simply a matter of dose rate, it is convenient to categorize the sources according to the syndrome of liver damage that they most commonly produce.", [["liver", "ANATOMY", 276, 281], ["hepatotoxicity", "DISEASE", 150, 164], ["liver damage", "DISEASE", 276, 288], ["liver", "ORGAN", 276, 281], ["acute and chronic hepatotoxicity", "PROBLEM", 132, 164], ["liver damage", "PROBLEM", 276, 288], ["somewhat", "OBSERVATION_MODIFIER", 21, 29], ["arbitrarily divided", "OBSERVATION_MODIFIER", 30, 49], ["acute", "OBSERVATION_MODIFIER", 55, 60], ["chronic", "OBSERVATION_MODIFIER", 65, 72], ["acute", "OBSERVATION_MODIFIER", 132, 137], ["chronic", "OBSERVATION_MODIFIER", 142, 149], ["hepatotoxicity", "OBSERVATION", 150, 164], ["liver", "ANATOMY", 276, 281], ["damage", "OBSERVATION", 282, 288]]], ["Various plants and moldy feeds are hepatotoxic, and some phytotoxins (e.g., pyrrolizidine alkaloids) and mycotoxins (e.g., aflatoxins) are notorious hepatotoxins and hepatocarcinogens.", [["hepatotoxic", "DISEASE", 35, 46], ["pyrrolizidine alkaloids", "CHEMICAL", 76, 99], ["mycotoxins", "CHEMICAL", 105, 115], ["aflatoxins", "CHEMICAL", 123, 133], ["pyrrolizidine alkaloids", "CHEMICAL", 76, 99], ["aflatoxins", "CHEMICAL", 123, 133], ["phytotoxins", "SIMPLE_CHEMICAL", 57, 68], ["pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 76, 99], ["aflatoxins", "SIMPLE_CHEMICAL", 123, 133], ["hepatotoxins", "SIMPLE_CHEMICAL", 149, 161], ["moldy feeds", "TREATMENT", 19, 30], ["hepatotoxic", "PROBLEM", 35, 46], ["some phytotoxins", "PROBLEM", 52, 68], ["pyrrolizidine alkaloids", "TREATMENT", 76, 99], ["mycotoxins", "PROBLEM", 105, 115], ["aflatoxins", "TREATMENT", 123, 133], ["notorious hepatotoxins", "PROBLEM", 139, 161], ["hepatocarcinogens", "PROBLEM", 166, 183], ["moldy feeds", "OBSERVATION", 19, 30], ["hepatocarcinogens", "OBSERVATION", 166, 183]]], ["Many phytotoxins and mycotoxins target other organ systems or have physiologic rather than pathologic effects.", [["organ systems", "ANATOMY", 45, 58], ["phytotoxins", "GENE_OR_GENE_PRODUCT", 5, 16], ["organ", "ORGAN", 45, 50], ["Many phytotoxins", "PROBLEM", 0, 16], ["mycotoxins target other organ systems", "PROBLEM", 21, 58], ["pathologic effects", "PROBLEM", 91, 109], ["mycotoxins", "OBSERVATION", 21, 31]]], ["Some of those that cause diagnostic lesions are discussed under the respective target tissues elsewhere.", [["lesions", "ANATOMY", 36, 43], ["tissues", "ANATOMY", 86, 93], ["lesions", "PATHOLOGICAL_FORMATION", 36, 43], ["tissues", "TISSUE", 86, 93], ["diagnostic lesions", "PROBLEM", 25, 43], ["lesions", "OBSERVATION", 36, 43]]], ["Generally, these areas of toxicology are better accessed in comprehensive references on phytotoxins or mycotoxins. sufficient fibrinogen to form a loose, nonadherent clot.", [["clot", "ANATOMY", 166, 170], ["phytotoxins", "SIMPLE_CHEMICAL", 88, 99], ["fibrinogen", "GENE_OR_GENE_PRODUCT", 126, 136], ["clot", "ORGANISM_SUBSTANCE", 166, 170], ["fibrinogen", "PROTEIN", 126, 136], ["phytotoxins", "TREATMENT", 88, 99], ["mycotoxins", "TREATMENT", 103, 113], ["sufficient fibrinogen", "TEST", 115, 136], ["a loose, nonadherent clot", "PROBLEM", 145, 170], ["fibrinogen", "OBSERVATION", 126, 136], ["loose", "OBSERVATION_MODIFIER", 147, 152], ["nonadherent", "OBSERVATION_MODIFIER", 154, 165], ["clot", "OBSERVATION", 166, 170]]], ["The appearance of the liver depends on the severity and stage of the injury.", [["liver", "ANATOMY", 22, 27], ["liver", "ORGAN", 22, 27], ["the injury", "PROBLEM", 65, 75], ["liver", "ANATOMY", 22, 27], ["injury", "OBSERVATION", 69, 75]]], ["Severe acute toxicity that destroys endothelium typically results in a hemorrhagic zonal pattern, in which case the liver may be deep red-purple and obviously swollen and turgid.", [["endothelium", "ANATOMY", 36, 47], ["liver", "ANATOMY", 116, 121], ["toxicity", "DISEASE", 13, 21], ["hemorrhagic", "DISEASE", 71, 82], ["endothelium", "TISSUE", 36, 47], ["liver", "ORGAN", 116, 121], ["Severe acute toxicity", "PROBLEM", 0, 21], ["a hemorrhagic zonal pattern", "PROBLEM", 69, 96], ["swollen", "PROBLEM", 159, 166], ["turgid", "PROBLEM", 171, 177], ["acute", "OBSERVATION_MODIFIER", 7, 12], ["toxicity", "OBSERVATION", 13, 21], ["hemorrhagic", "OBSERVATION_MODIFIER", 71, 82], ["zonal pattern", "OBSERVATION", 83, 96], ["liver", "ANATOMY", 116, 121], ["may be", "UNCERTAINTY", 122, 128], ["deep", "OBSERVATION_MODIFIER", 129, 133], ["red-purple", "OBSERVATION", 134, 144], ["obviously", "OBSERVATION_MODIFIER", 149, 158], ["swollen", "OBSERVATION", 159, 166]]], ["In less severe injury without hemorrhage, the liver tends to be lighter brown because of a combination of edema (exclusion of sinusoidal blood), destruction of cytochrome pigments, and accumulation of bile pigments and/or fat.", [["liver", "ANATOMY", 46, 51], ["edema", "ANATOMY", 106, 111], ["sinusoidal blood", "ANATOMY", 126, 142], ["bile pigments", "ANATOMY", 201, 214], ["fat", "ANATOMY", 222, 225], ["hemorrhage", "DISEASE", 30, 40], ["edema", "DISEASE", 106, 111], ["liver", "ORGAN", 46, 51], ["edema", "PATHOLOGICAL_FORMATION", 106, 111], ["sinusoidal", "MULTI-TISSUE_STRUCTURE", 126, 136], ["blood", "ORGANISM_SUBSTANCE", 137, 142], ["cytochrome pigments", "GENE_OR_GENE_PRODUCT", 160, 179], ["bile pigments", "SIMPLE_CHEMICAL", 201, 214], ["fat", "TISSUE", 222, 225], ["less severe injury", "PROBLEM", 3, 21], ["hemorrhage", "PROBLEM", 30, 40], ["lighter brown", "PROBLEM", 64, 77], ["edema", "PROBLEM", 106, 111], ["sinusoidal blood", "PROBLEM", 126, 142], ["destruction of cytochrome pigments", "PROBLEM", 145, 179], ["accumulation of bile pigments", "PROBLEM", 185, 214], ["less", "OBSERVATION_MODIFIER", 3, 7], ["severe", "OBSERVATION_MODIFIER", 8, 14], ["injury", "OBSERVATION", 15, 21], ["without", "UNCERTAINTY", 22, 29], ["hemorrhage", "OBSERVATION", 30, 40], ["liver", "ANATOMY", 46, 51], ["edema", "OBSERVATION", 106, 111], ["sinusoidal blood", "OBSERVATION", 126, 142], ["destruction", "OBSERVATION_MODIFIER", 145, 156], ["cytochrome pigments", "OBSERVATION", 160, 179], ["accumulation", "OBSERVATION_MODIFIER", 185, 197], ["bile pigments", "OBSERVATION", 201, 214], ["fat", "ANATOMY", 222, 225]]], ["If the animal survives for several days, the liver develops a typical zonal yellow fatty change as triglyceride accumulates in sublethally injured hepatocytes.Toxic agentsIn acute fatal hepatotoxicities, there may be widespread hemorrhage resulting from lack of coagulation factors.", [["liver", "ANATOMY", 45, 50], ["hepatocytes", "ANATOMY", 147, 158], ["triglyceride", "CHEMICAL", 99, 111], ["hepatotoxicities", "DISEASE", 186, 202], ["hemorrhage", "DISEASE", 228, 238], ["triglyceride", "CHEMICAL", 99, 111], ["liver", "ORGAN", 45, 50], ["triglyceride", "SIMPLE_CHEMICAL", 99, 111], ["hepatocytes", "CELL", 147, 158], ["coagulation factors", "GENE_OR_GENE_PRODUCT", 262, 281], ["sublethally injured hepatocytes", "CELL_TYPE", 127, 158], ["coagulation factors", "PROTEIN", 262, 281], ["a typical zonal yellow fatty change", "PROBLEM", 60, 95], ["sublethally injured hepatocytes", "PROBLEM", 127, 158], ["Toxic agents", "TREATMENT", 159, 171], ["acute fatal hepatotoxicities", "PROBLEM", 174, 202], ["widespread hemorrhage", "PROBLEM", 217, 238], ["coagulation factors", "PROBLEM", 262, 281], ["liver", "ANATOMY", 45, 50], ["typical", "OBSERVATION_MODIFIER", 62, 69], ["zonal", "OBSERVATION_MODIFIER", 70, 75], ["yellow", "OBSERVATION", 76, 82], ["fatty change", "OBSERVATION", 83, 95], ["sublethally injured hepatocytes", "OBSERVATION", 127, 158], ["acute", "OBSERVATION_MODIFIER", 174, 179], ["fatal", "OBSERVATION_MODIFIER", 180, 185], ["hepatotoxicities", "OBSERVATION", 186, 202], ["may be", "UNCERTAINTY", 210, 216], ["widespread", "OBSERVATION_MODIFIER", 217, 227], ["hemorrhage", "OBSERVATION", 228, 238]]], ["Petechiae and ecchymoses are seen most consistently on serous membranes, especially on the epicardium and endocardium and abdominal viscera.", [["Petechiae", "ANATOMY", 0, 9], ["ecchymoses", "ANATOMY", 14, 24], ["serous membranes", "ANATOMY", 55, 71], ["epicardium", "ANATOMY", 91, 101], ["endocardium", "ANATOMY", 106, 117], ["abdominal viscera", "ANATOMY", 122, 139], ["ecchymoses", "DISEASE", 14, 24], ["ecchymoses", "CANCER", 14, 24], ["serous membranes", "MULTI-TISSUE_STRUCTURE", 55, 71], ["epicardium", "TISSUE", 91, 101], ["endocardium", "MULTI-TISSUE_STRUCTURE", 106, 117], ["abdominal viscera", "ORGAN", 122, 139], ["Petechiae", "PROBLEM", 0, 9], ["ecchymoses", "PROBLEM", 14, 24], ["serous membranes", "PROBLEM", 55, 71], ["ecchymoses", "OBSERVATION", 14, 24], ["most consistently", "OBSERVATION_MODIFIER", 34, 51], ["serous membranes", "OBSERVATION", 55, 71], ["epicardium", "ANATOMY", 91, 101], ["endocardium", "ANATOMY", 106, 117], ["abdominal viscera", "ANATOMY", 122, 139]]], ["Diffuse hemorrhage into the gut, particularly the duodenum in ruminants, is also common, as are hemorrhages into the wall of the gallbladder.", [["gut", "ANATOMY", 28, 31], ["duodenum", "ANATOMY", 50, 58], ["wall", "ANATOMY", 117, 121], ["gallbladder", "ANATOMY", 129, 140], ["hemorrhage", "DISEASE", 8, 18], ["hemorrhages", "DISEASE", 96, 107], ["gut", "ORGANISM_SUBDIVISION", 28, 31], ["duodenum", "ORGAN", 50, 58], ["wall", "TISSUE", 117, 121], ["gallbladder", "ORGAN", 129, 140], ["Diffuse hemorrhage into the gut", "PROBLEM", 0, 31], ["hemorrhages into the wall of the gallbladder", "PROBLEM", 96, 140], ["hemorrhage", "OBSERVATION", 8, 18], ["gut", "ANATOMY", 28, 31], ["duodenum", "ANATOMY", 50, 58], ["ruminants", "OBSERVATION_MODIFIER", 62, 71], ["common", "OBSERVATION_MODIFIER", 81, 87], ["hemorrhages", "OBSERVATION", 96, 107], ["wall", "ANATOMY_MODIFIER", 117, 121], ["gallbladder", "ANATOMY", 129, 140]]], ["Hemorrhages are largely the result of excessive consumption of clotting factors and platelets within the areas of necrosis in the liver, although the concurrent failure of the damaged liver to replace those coagulation reported in dogs administered therapeutic dosages of carprofen.", [["platelets", "ANATOMY", 84, 93], ["liver", "ANATOMY", 130, 135], ["liver", "ANATOMY", 184, 189], ["Hemorrhages", "DISEASE", 0, 11], ["necrosis", "DISEASE", 114, 122], ["carprofen", "CHEMICAL", 272, 281], ["carprofen", "CHEMICAL", 272, 281], ["clotting factors", "GENE_OR_GENE_PRODUCT", 63, 79], ["platelets", "CELL", 84, 93], ["liver", "ORGAN", 130, 135], ["liver", "ORGAN", 184, 189], ["dogs", "ORGANISM", 231, 235], ["carprofen", "SIMPLE_CHEMICAL", 272, 281], ["clotting factors", "PROTEIN", 63, 79], ["platelets", "CELL_TYPE", 84, 93], ["dogs", "SPECIES", 231, 235], ["Hemorrhages", "PROBLEM", 0, 11], ["clotting factors", "PROBLEM", 63, 79], ["platelets", "PROBLEM", 84, 93], ["necrosis in the liver", "PROBLEM", 114, 135], ["the damaged liver", "PROBLEM", 172, 189], ["those coagulation", "TEST", 201, 218], ["dogs", "TREATMENT", 231, 235], ["carprofen", "TREATMENT", 272, 281], ["excessive", "OBSERVATION_MODIFIER", 38, 47], ["consumption", "OBSERVATION_MODIFIER", 48, 59], ["clotting factors", "OBSERVATION", 63, 79], ["areas", "OBSERVATION_MODIFIER", 105, 110], ["necrosis", "OBSERVATION", 114, 122], ["liver", "ANATOMY", 130, 135], ["failure", "OBSERVATION", 161, 168], ["damaged", "OBSERVATION", 176, 183], ["liver", "ANATOMY", 184, 189]]], ["The injurious response is likely to be idiosyncratic as a chronic experimental study did not produce injury.", [["a chronic experimental study", "TEST", 56, 84], ["injury", "PROBLEM", 101, 107], ["injurious", "OBSERVATION", 4, 13], ["likely to be", "UNCERTAINTY", 26, 38], ["idiosyncratic", "OBSERVATION_MODIFIER", 39, 52], ["chronic", "OBSERVATION_MODIFIER", 58, 65], ["injury", "OBSERVATION", 101, 107]]], ["A related nonsteroidal anti-inflammatory drug, diclofenac, causes idiosyncratic liver injury in humans.Toxic agentsThe anticonvulsant drugs primidone, phenytoin, and phenobarbital have been associated with the development of chronic hepatic disease and cirrhosis in dogs.", [["nonsteroidal", "ANATOMY", 10, 22], ["liver", "ANATOMY", 80, 85], ["hepatic", "ANATOMY", 233, 240], ["diclofenac", "CHEMICAL", 47, 57], ["liver injury", "DISEASE", 80, 92], ["primidone", "CHEMICAL", 140, 149], ["phenytoin", "CHEMICAL", 151, 160], ["phenobarbital", "CHEMICAL", 166, 179], ["chronic hepatic disease", "DISEASE", 225, 248], ["cirrhosis", "DISEASE", 253, 262], ["diclofenac", "CHEMICAL", 47, 57], ["primidone", "CHEMICAL", 140, 149], ["phenytoin", "CHEMICAL", 151, 160], ["phenobarbital", "CHEMICAL", 166, 179], ["diclofenac", "SIMPLE_CHEMICAL", 47, 57], ["liver", "ORGAN", 80, 85], ["humans", "ORGANISM", 96, 102], ["primidone", "SIMPLE_CHEMICAL", 140, 149], ["phenytoin", "SIMPLE_CHEMICAL", 151, 160], ["phenobarbital", "SIMPLE_CHEMICAL", 166, 179], ["hepatic", "ORGAN", 233, 240], ["dogs", "ORGANISM", 266, 270], ["humans", "SPECIES", 96, 102], ["dogs", "SPECIES", 266, 270], ["humans", "SPECIES", 96, 102], ["A related nonsteroidal anti-inflammatory drug", "TREATMENT", 0, 45], ["diclofenac", "TREATMENT", 47, 57], ["idiosyncratic liver injury in humans", "PROBLEM", 66, 102], ["Toxic agents", "TREATMENT", 103, 115], ["The anticonvulsant drugs primidone", "TREATMENT", 115, 149], ["phenytoin", "TREATMENT", 151, 160], ["phenobarbital", "TREATMENT", 166, 179], ["chronic hepatic disease", "PROBLEM", 225, 248], ["cirrhosis in dogs", "PROBLEM", 253, 270], ["nonsteroidal anti-inflammatory drug", "OBSERVATION", 10, 45], ["idiosyncratic", "OBSERVATION_MODIFIER", 66, 79], ["liver", "ANATOMY", 80, 85], ["injury", "OBSERVATION", 86, 92], ["chronic", "OBSERVATION_MODIFIER", 225, 232], ["hepatic", "ANATOMY", 233, 240], ["disease", "OBSERVATION", 241, 248], ["cirrhosis", "OBSERVATION", 253, 262]]], ["These drugs, used either alone or in combination, can cause biochemical and clinical signs of hepatic dysfunction in up to 14% of dogs treated for >6 months, but only a small percentage of cases progress to cirrhosis and hepatic failure.", [["hepatic", "ANATOMY", 94, 101], ["hepatic", "ANATOMY", 221, 228], ["hepatic dysfunction", "DISEASE", 94, 113], ["cirrhosis", "DISEASE", 207, 216], ["hepatic failure", "DISEASE", 221, 236], ["hepatic", "ORGAN", 94, 101], ["dogs", "ORGANISM", 130, 134], ["hepatic", "ORGAN", 221, 228], ["dogs", "SPECIES", 130, 134], ["These drugs", "TREATMENT", 0, 11], ["hepatic dysfunction", "PROBLEM", 94, 113], ["cirrhosis", "PROBLEM", 207, 216], ["hepatic failure", "PROBLEM", 221, 236], ["hepatic", "ANATOMY", 94, 101], ["dysfunction", "OBSERVATION", 102, 113], ["small percentage", "OBSERVATION_MODIFIER", 169, 185], ["cirrhosis", "OBSERVATION", 207, 216], ["hepatic", "ANATOMY", 221, 228], ["failure", "OBSERVATION", 229, 236]]], ["Currently, monitoring blood levels and adjusting dosages of these drugs to a nontoxic level has significantly reduced the incidence of liver injury.", [["blood", "ANATOMY", 22, 27], ["liver", "ANATOMY", 135, 140], ["liver injury", "DISEASE", 135, 147], ["blood", "ORGANISM_SUBSTANCE", 22, 27], ["liver", "ORGAN", 135, 140], ["monitoring blood levels", "TEST", 11, 34], ["these drugs", "TREATMENT", 60, 71], ["liver injury", "PROBLEM", 135, 147], ["liver", "ANATOMY", 135, 140], ["injury", "OBSERVATION", 141, 147]]], ["The most consistent histologic finding in the majority of dogs treated with phenobarbital is proliferation of the hepatocellular smooth endoplasmic reticulum resulting from induction of microsomal enzymes, including various subfamilies of cytochrome P450.", [["hepatocellular smooth endoplasmic reticulum", "ANATOMY", 114, 157], ["microsomal", "ANATOMY", 186, 196], ["phenobarbital", "CHEMICAL", 76, 89], ["phenobarbital", "CHEMICAL", 76, 89], ["dogs", "ORGANISM", 58, 62], ["phenobarbital", "SIMPLE_CHEMICAL", 76, 89], ["hepatocellular smooth", "TISSUE", 114, 135], ["endoplasmic reticulum", "CELLULAR_COMPONENT", 136, 157], ["microsomal enzymes", "GENE_OR_GENE_PRODUCT", 186, 204], ["cytochrome P450", "GENE_OR_GENE_PRODUCT", 239, 254], ["microsomal enzymes", "PROTEIN", 186, 204], ["cytochrome P450", "PROTEIN", 239, 254], ["dogs", "SPECIES", 58, 62], ["phenobarbital", "TREATMENT", 76, 89], ["the hepatocellular smooth endoplasmic reticulum", "PROBLEM", 110, 157], ["microsomal enzymes", "TEST", 186, 204], ["cytochrome P450", "PROBLEM", 239, 254], ["most consistent", "UNCERTAINTY", 4, 19], ["histologic", "OBSERVATION", 20, 30], ["hepatocellular smooth", "OBSERVATION", 114, 135], ["endoplasmic reticulum", "OBSERVATION", 136, 157], ["cytochrome P450", "OBSERVATION", 239, 254]]], ["This results in hepatocellular swelling with fine diffuse granularity, a so-called \"ground-glass\" appearance to hepatocyte cytoplasm.", [["hepatocellular", "ANATOMY", 16, 30], ["hepatocyte cytoplasm", "ANATOMY", 112, 132], ["swelling", "DISEASE", 31, 39], ["hepatocellular", "CANCER", 16, 30], ["hepatocyte cytoplasm", "ORGANISM_SUBSTANCE", 112, 132], ["hepatocellular swelling", "PROBLEM", 16, 39], ["fine diffuse granularity", "PROBLEM", 45, 69], ["a so-called \"ground-glass\" appearance", "PROBLEM", 71, 108], ["hepatocyte cytoplasm", "PROBLEM", 112, 132], ["hepatocellular", "ANATOMY", 16, 30], ["swelling", "OBSERVATION", 31, 39], ["fine", "OBSERVATION_MODIFIER", 45, 49], ["diffuse", "OBSERVATION_MODIFIER", 50, 57], ["granularity", "OBSERVATION", 58, 69], ["ground-glass", "OBSERVATION_MODIFIER", 84, 96], ["hepatocyte", "ANATOMY", 112, 122], ["cytoplasm", "ANATOMY_MODIFIER", 123, 132]]], ["This histologic change is an adaptive response, reflected clinically by increases in serum concentrations of alkaline phosphatase, alanine aminotransferase, and \u03b3-glutamyl transpeptidase, but is not indicative of hepatocellular injury.", [["serum", "ANATOMY", 85, 90], ["hepatocellular", "ANATOMY", 213, 227], ["alanine", "CHEMICAL", 131, 138], ["hepatocellular injury", "DISEASE", 213, 234], ["alanine", "CHEMICAL", 131, 138], ["\u03b3-glutamyl", "CHEMICAL", 161, 171], ["serum", "ORGANISM_SUBSTANCE", 85, 90], ["alkaline phosphatase", "GENE_OR_GENE_PRODUCT", 109, 129], ["alanine", "AMINO_ACID", 131, 138], ["aminotransferase", "SIMPLE_CHEMICAL", 139, 155], ["\u03b3-glutamyl transpeptidase", "GENE_OR_GENE_PRODUCT", 161, 186], ["hepatocellular", "ORGAN", 213, 227], ["alkaline phosphatase", "PROTEIN", 109, 129], ["alanine aminotransferase", "PROTEIN", 131, 155], ["\u03b3-glutamyl transpeptidase", "PROTEIN", 161, 186], ["This histologic change", "PROBLEM", 0, 22], ["serum concentrations", "TEST", 85, 105], ["alkaline phosphatase", "TEST", 109, 129], ["alanine aminotransferase", "TEST", 131, 155], ["\u03b3-glutamyl transpeptidase", "TEST", 161, 186], ["hepatocellular injury", "PROBLEM", 213, 234], ["adaptive response", "OBSERVATION", 29, 46], ["increases", "OBSERVATION_MODIFIER", 72, 81], ["not indicative of", "UNCERTAINTY", 195, 212], ["hepatocellular", "ANATOMY", 213, 227], ["injury", "OBSERVATION", 228, 234]]], ["Actual hepatotoxicity may represent an idiosyncratic reaction in a small percentage of treated dogs, although the possibility of dose-dependent intrinsic hepatotoxicity with long-term treatment has not been ruled out.", [["hepatotoxicity", "DISEASE", 7, 21], ["hepatotoxicity", "DISEASE", 154, 168], ["dogs", "ORGANISM", 95, 99], ["dogs", "SPECIES", 95, 99], ["Actual hepatotoxicity", "PROBLEM", 0, 21], ["an idiosyncratic reaction", "PROBLEM", 36, 61], ["treated dogs", "PROBLEM", 87, 99], ["dose-dependent intrinsic hepatotoxicity", "PROBLEM", 129, 168], ["long-term treatment", "TREATMENT", 174, 193], ["hepatotoxicity", "OBSERVATION", 7, 21], ["may represent", "UNCERTAINTY", 22, 35], ["idiosyncratic", "OBSERVATION_MODIFIER", 39, 52], ["reaction", "OBSERVATION", 53, 61], ["small", "OBSERVATION_MODIFIER", 67, 72], ["percentage", "OBSERVATION_MODIFIER", 73, 83], ["treated dogs", "OBSERVATION", 87, 99], ["hepatotoxicity", "OBSERVATION", 154, 168], ["long-term", "OBSERVATION_MODIFIER", 174, 183]]], ["It is also possible that the enzyme induction associated with anticonvulsant therapy may alter the ability of the liver to detoxify other nonspecified compounds that could be the effectors of liver damage.", [["liver", "ANATOMY", 114, 119], ["liver", "ANATOMY", 192, 197], ["liver damage", "DISEASE", 192, 204], ["liver", "ORGAN", 114, 119], ["liver", "ORGAN", 192, 197], ["the enzyme induction", "TREATMENT", 25, 45], ["anticonvulsant therapy", "TREATMENT", 62, 84], ["liver damage", "PROBLEM", 192, 204], ["is also possible", "UNCERTAINTY", 3, 19], ["liver", "ANATOMY", 114, 119], ["liver", "ANATOMY", 192, 197], ["damage", "OBSERVATION", 198, 204]]], ["Certainly, enzyme induction may alter the pharmacokinetics of other co-administered drugs.", [["enzyme induction", "TREATMENT", 11, 27], ["other co-administered drugs", "TREATMENT", 62, 89]]], ["Chronic hepatitis associated with anticonvulsant therapy is characterized by bridging portal fibrosis, biliary hyperplasia, nodular regeneration, and mild inflammatory cell infiltrates.", [["portal", "ANATOMY", 86, 92], ["biliary", "ANATOMY", 103, 110], ["nodular", "ANATOMY", 124, 131], ["inflammatory cell", "ANATOMY", 155, 172], ["Chronic hepatitis", "DISEASE", 0, 17], ["fibrosis", "DISEASE", 93, 101], ["biliary hyperplasia", "DISEASE", 103, 122], ["portal", "MULTI-TISSUE_STRUCTURE", 86, 92], ["biliary hyperplasia", "PATHOLOGICAL_FORMATION", 103, 122], ["inflammatory cell", "CELL", 155, 172], ["Chronic hepatitis", "PROBLEM", 0, 17], ["anticonvulsant therapy", "TREATMENT", 34, 56], ["bridging portal fibrosis", "PROBLEM", 77, 101], ["biliary hyperplasia", "PROBLEM", 103, 122], ["nodular regeneration", "PROBLEM", 124, 144], ["mild inflammatory cell infiltrates", "PROBLEM", 150, 184], ["hepatitis", "OBSERVATION", 8, 17], ["anticonvulsant therapy", "OBSERVATION", 34, 56], ["bridging", "OBSERVATION_MODIFIER", 77, 85], ["portal", "ANATOMY", 86, 92], ["fibrosis", "OBSERVATION", 93, 101], ["biliary", "ANATOMY", 103, 110], ["hyperplasia", "OBSERVATION", 111, 122], ["nodular", "OBSERVATION_MODIFIER", 124, 131], ["regeneration", "OBSERVATION_MODIFIER", 132, 144], ["mild", "OBSERVATION_MODIFIER", 150, 154], ["inflammatory", "OBSERVATION_MODIFIER", 155, 167], ["cell infiltrates", "OBSERVATION", 168, 184]]], ["A separate syndrome of cholestatic hepatotoxic injury with jaundice has also been described in dogs receiving high doses of phenytoin in combination with primidone or phenobarbital.", [["cholestatic hepatotoxic injury", "DISEASE", 23, 53], ["jaundice", "DISEASE", 59, 67], ["phenytoin", "CHEMICAL", 124, 133], ["primidone", "CHEMICAL", 154, 163], ["phenobarbital", "CHEMICAL", 167, 180], ["phenytoin", "CHEMICAL", 124, 133], ["primidone", "CHEMICAL", 154, 163], ["phenobarbital", "CHEMICAL", 167, 180], ["dogs", "ORGANISM", 95, 99], ["phenytoin", "SIMPLE_CHEMICAL", 124, 133], ["primidone", "SIMPLE_CHEMICAL", 154, 163], ["phenobarbital", "SIMPLE_CHEMICAL", 167, 180], ["dogs", "SPECIES", 95, 99], ["A separate syndrome", "PROBLEM", 0, 19], ["cholestatic hepatotoxic injury", "PROBLEM", 23, 53], ["jaundice", "PROBLEM", 59, 67], ["phenytoin", "TREATMENT", 124, 133], ["primidone", "TREATMENT", 154, 163], ["phenobarbital", "TREATMENT", 167, 180], ["syndrome", "OBSERVATION", 11, 19], ["cholestatic", "OBSERVATION_MODIFIER", 23, 34], ["hepatotoxic", "OBSERVATION_MODIFIER", 35, 46], ["injury", "OBSERVATION", 47, 53], ["jaundice", "OBSERVATION", 59, 67]]], ["This is characterized by intrahepatic cholestasis, with hepatocellular swelling, vacuolation, and small multifocal areas of hepatocellular necrosis, and has been suggested to represent a metabolic disturbance rather than direct cytotoxic hepatocellular injury.", [["intrahepatic", "ANATOMY", 25, 37], ["hepatocellular", "ANATOMY", 56, 70], ["hepatocellular", "ANATOMY", 124, 138], ["hepatocellular", "ANATOMY", 238, 252], ["intrahepatic cholestasis", "DISEASE", 25, 49], ["hepatocellular swelling", "DISEASE", 56, 79], ["hepatocellular necrosis", "DISEASE", 124, 147], ["hepatocellular injury", "DISEASE", 238, 259], ["intrahepatic cholestasis", "PATHOLOGICAL_FORMATION", 25, 49], ["hepatocellular", "CANCER", 56, 70], ["hepatocellular", "CANCER", 124, 138], ["hepatocellular", "CANCER", 238, 252], ["intrahepatic cholestasis", "PROBLEM", 25, 49], ["hepatocellular swelling", "PROBLEM", 56, 79], ["vacuolation", "PROBLEM", 81, 92], ["small multifocal areas of hepatocellular necrosis", "PROBLEM", 98, 147], ["a metabolic disturbance", "PROBLEM", 185, 208], ["direct cytotoxic hepatocellular injury", "PROBLEM", 221, 259], ["intrahepatic", "ANATOMY_MODIFIER", 25, 37], ["cholestasis", "OBSERVATION", 38, 49], ["hepatocellular", "ANATOMY", 56, 70], ["swelling", "OBSERVATION", 71, 79], ["vacuolation", "OBSERVATION_MODIFIER", 81, 92], ["small", "OBSERVATION_MODIFIER", 98, 103], ["multifocal", "OBSERVATION_MODIFIER", 104, 114], ["areas", "OBSERVATION_MODIFIER", 115, 120], ["hepatocellular", "ANATOMY", 124, 138], ["necrosis", "OBSERVATION", 139, 147], ["suggested to represent", "UNCERTAINTY", 162, 184], ["metabolic disturbance", "OBSERVATION", 187, 208], ["cytotoxic", "OBSERVATION_MODIFIER", 228, 237], ["hepatocellular injury", "OBSERVATION", 238, 259]]], ["Hepatocutaneous syndrome (superficial necrolytic dermatitis) associated with typical hepatic pathology of parenchymal collapse, vacuolation, and nodular regeneration has also been reported as a separate syndrome in dogs with a history of chronic phenobarbital therapy.Toxic agentsAcute and chronic hepatic disease, characterized by periportal hepatitis, periportal fibrosis, and biliary hyperplasia, have been reported in dogs treated with oxibendazolediethylcarbamazine combination therapy for prevention of hookworm and heartworm.", [["hepatic", "ANATOMY", 85, 92], ["parenchymal", "ANATOMY", 106, 117], ["nodular", "ANATOMY", 145, 152], ["hepatic", "ANATOMY", 298, 305], ["periportal", "ANATOMY", 354, 364], ["biliary hyperplasia", "ANATOMY", 379, 398], ["Hepatocutaneous syndrome", "DISEASE", 0, 24], ["superficial necrolytic dermatitis", "DISEASE", 26, 59], ["parenchymal collapse", "DISEASE", 106, 126], ["phenobarbital", "CHEMICAL", 246, 259], ["chronic hepatic disease", "DISEASE", 290, 313], ["periportal hepatitis", "DISEASE", 332, 352], ["fibrosis", "DISEASE", 365, 373], ["biliary hyperplasia", "DISEASE", 379, 398], ["oxibendazolediethylcarbamazine", "CHEMICAL", 440, 470], ["hookworm and heartworm", "DISEASE", 509, 531], ["phenobarbital", "CHEMICAL", 246, 259], ["oxibendazolediethylcarbamazine", "CHEMICAL", 440, 470], ["hepatic", "ORGAN", 85, 92], ["parenchymal", "MULTI-TISSUE_STRUCTURE", 106, 117], ["nodular", "PATHOLOGICAL_FORMATION", 145, 152], ["dogs", "ORGANISM", 215, 219], ["phenobarbital", "SIMPLE_CHEMICAL", 246, 259], ["hepatic", "ORGAN", 298, 305], ["periportal", "MULTI-TISSUE_STRUCTURE", 354, 364], ["biliary hyperplasia", "PATHOLOGICAL_FORMATION", 379, 398], ["dogs", "ORGANISM", 422, 426], ["oxibendazolediethylcarbamazine", "SIMPLE_CHEMICAL", 440, 470], ["hookworm", "ORGANISM", 509, 517], ["heartworm", "ORGANISM_SUBDIVISION", 522, 531], ["dogs", "SPECIES", 215, 219], ["dogs", "SPECIES", 422, 426], ["Hepatocutaneous syndrome", "PROBLEM", 0, 24], ["superficial necrolytic dermatitis", "PROBLEM", 26, 59], ["typical hepatic pathology", "PROBLEM", 77, 102], ["parenchymal collapse", "PROBLEM", 106, 126], ["vacuolation", "PROBLEM", 128, 139], ["nodular regeneration", "PROBLEM", 145, 165], ["a separate syndrome in dogs", "PROBLEM", 192, 219], ["chronic phenobarbital therapy", "TREATMENT", 238, 267], ["Toxic agents", "TREATMENT", 268, 280], ["Acute and chronic hepatic disease", "PROBLEM", 280, 313], ["periportal hepatitis", "PROBLEM", 332, 352], ["periportal fibrosis", "PROBLEM", 354, 373], ["biliary hyperplasia", "PROBLEM", 379, 398], ["oxibendazolediethylcarbamazine combination therapy", "TREATMENT", 440, 490], ["hookworm and heartworm", "PROBLEM", 509, 531], ["superficial", "OBSERVATION_MODIFIER", 26, 37], ["necrolytic dermatitis", "OBSERVATION", 38, 59], ["typical", "OBSERVATION_MODIFIER", 77, 84], ["hepatic", "ANATOMY", 85, 92], ["pathology", "OBSERVATION", 93, 102], ["parenchymal", "ANATOMY_MODIFIER", 106, 117], ["collapse", "OBSERVATION", 118, 126], ["vacuolation", "OBSERVATION_MODIFIER", 128, 139], ["nodular", "OBSERVATION_MODIFIER", 145, 152], ["regeneration", "OBSERVATION", 153, 165], ["syndrome", "OBSERVATION", 203, 211], ["chronic", "OBSERVATION_MODIFIER", 238, 245], ["phenobarbital therapy", "OBSERVATION", 246, 267], ["chronic", "OBSERVATION_MODIFIER", 290, 297], ["hepatic", "ANATOMY", 298, 305], ["disease", "OBSERVATION", 306, 313], ["periportal", "ANATOMY_MODIFIER", 332, 342], ["hepatitis", "OBSERVATION", 343, 352], ["periportal", "ANATOMY_MODIFIER", 354, 364], ["fibrosis", "OBSERVATION", 365, 373], ["biliary", "ANATOMY", 379, 386], ["hyperplasia", "OBSERVATION", 387, 398], ["hookworm", "OBSERVATION", 509, 517], ["heartworm", "OBSERVATION", 522, 531]]], ["Chronic hepatic disease has also been reported following administration of mibolerone, methotrexate and CCNU (1-(2-chloroethyl)-3-cyclohexyl-1nitrosourea) in dogs, ketoconazole in dogs and cats, and megestrol acetate and griseofulvin in cats.Hepatotoxic plantsHepatotoxic plants occur in botanical families as diverse as the relatively primitive Cycadaceae through the Compositae and Solanaceae.", [["hepatic", "ANATOMY", 8, 15], ["Chronic hepatic disease", "DISEASE", 0, 23], ["mibolerone", "CHEMICAL", 75, 85], ["methotrexate", "CHEMICAL", 87, 99], ["CCNU", "CHEMICAL", 104, 108], ["1-(2-chloroethyl)-3-cyclohexyl-1nitrosourea", "CHEMICAL", 110, 153], ["ketoconazole", "CHEMICAL", 164, 176], ["megestrol acetate", "CHEMICAL", 199, 216], ["griseofulvin", "CHEMICAL", 221, 233], ["mibolerone", "CHEMICAL", 75, 85], ["methotrexate", "CHEMICAL", 87, 99], ["CCNU", "CHEMICAL", 104, 108], ["1-(2-chloroethyl)-3-cyclohexyl-1nitrosourea", "CHEMICAL", 110, 153], ["ketoconazole", "CHEMICAL", 164, 176], ["megestrol acetate", "CHEMICAL", 199, 216], ["griseofulvin", "CHEMICAL", 221, 233], ["hepatic", "ORGAN", 8, 15], ["mibolerone", "SIMPLE_CHEMICAL", 75, 85], ["methotrexate", "SIMPLE_CHEMICAL", 87, 99], ["CCNU", "SIMPLE_CHEMICAL", 104, 108], ["1-(2-chloroethyl)-3-cyclohexyl-1nitrosourea", "SIMPLE_CHEMICAL", 110, 153], ["dogs", "ORGANISM", 158, 162], ["ketoconazole", "SIMPLE_CHEMICAL", 164, 176], ["dogs", "ORGANISM", 180, 184], ["cats", "ORGANISM", 189, 193], ["megestrol acetate", "SIMPLE_CHEMICAL", 199, 216], ["griseofulvin", "SIMPLE_CHEMICAL", 221, 233], ["cats", "ORGANISM", 237, 241], ["Cycadaceae", "GENE_OR_GENE_PRODUCT", 346, 356], ["dogs", "SPECIES", 158, 162], ["dogs", "SPECIES", 180, 184], ["cats", "SPECIES", 189, 193], ["cats", "SPECIES", 237, 241], ["Chronic hepatic disease", "PROBLEM", 0, 23], ["mibolerone", "TREATMENT", 75, 85], ["methotrexate", "TREATMENT", 87, 99], ["CCNU", "TREATMENT", 104, 108], ["cyclohexyl", "TREATMENT", 130, 140], ["1nitrosourea", "TREATMENT", 141, 153], ["ketoconazole", "TREATMENT", 164, 176], ["cats", "TREATMENT", 189, 193], ["megestrol acetate", "TREATMENT", 199, 216], ["griseofulvin", "TREATMENT", 221, 233], ["Hepatotoxic plantsHepatotoxic plants", "TREATMENT", 242, 278], ["hepatic", "ANATOMY", 8, 15], ["disease", "OBSERVATION", 16, 23], ["Hepatotoxic", "OBSERVATION_MODIFIER", 260, 271]]], ["The evolutionary relationships between herbivores and toxic plants are complex; in some situations, Adverse drug reactions: drug-induced liver injury (DILI)Hepatotoxic plantsThe definition of an adverse drug reaction is any injurious or unintended response to a drug that occurs at a normal dose for normal use.", [["liver", "ANATOMY", 137, 142], ["liver injury", "DISEASE", 137, 149], ["DILI", "DISEASE", 151, 155], ["adverse drug reaction", "DISEASE", 195, 216], ["liver", "ORGAN", 137, 142], ["Adverse drug reactions", "PROBLEM", 100, 122], ["liver injury", "PROBLEM", 137, 149], ["Hepatotoxic plants", "PROBLEM", 156, 174], ["an adverse drug reaction", "PROBLEM", 192, 216], ["toxic plants", "OBSERVATION", 54, 66], ["liver", "ANATOMY", 137, 142], ["injury", "OBSERVATION", 143, 149]]], ["DILI is the most common form of adverse drug reaction in humans, and although hepatotoxic drug reactions are recognized in dogs and cats, the true prevalence of DILI in domestic animals is unknown.", [["DILI", "DISEASE", 0, 4], ["adverse drug reaction", "DISEASE", 32, 53], ["hepatotoxic drug reactions", "DISEASE", 78, 104], ["DILI", "DISEASE", 161, 165], ["humans", "ORGANISM", 57, 63], ["dogs", "ORGANISM", 123, 127], ["cats", "ORGANISM", 132, 136], ["humans", "SPECIES", 57, 63], ["dogs", "SPECIES", 123, 127], ["cats", "SPECIES", 132, 136], ["humans", "SPECIES", 57, 63], ["DILI", "PROBLEM", 0, 4], ["adverse drug reaction", "PROBLEM", 32, 53], ["hepatotoxic drug reactions", "PROBLEM", 78, 104], ["DILI", "PROBLEM", 161, 165], ["most common", "OBSERVATION_MODIFIER", 12, 23], ["adverse", "OBSERVATION_MODIFIER", 32, 39], ["drug reaction", "OBSERVATION", 40, 53], ["DILI", "OBSERVATION", 161, 165]]], ["DILI should not be considered as a single disease, given the diverse array of drugs that can trigger injury.Hepatotoxic plantsAcute hepatic disease has been attributed to adverse reactions to a wide variety of therapeutic drugs, particularly in companion animals.", [["hepatic", "ANATOMY", 132, 139], ["DILI", "DISEASE", 0, 4], ["Acute hepatic disease", "DISEASE", 126, 147], ["hepatic", "ORGAN", 132, 139], ["DILI", "TREATMENT", 0, 4], ["a single disease", "PROBLEM", 33, 49], ["drugs", "TREATMENT", 78, 83], ["injury", "PROBLEM", 101, 107], ["Hepatotoxic plants", "PROBLEM", 108, 126], ["Acute hepatic disease", "PROBLEM", 126, 147], ["adverse reactions", "PROBLEM", 171, 188], ["therapeutic drugs", "TREATMENT", 210, 227], ["hepatic", "ANATOMY", 132, 139], ["disease", "OBSERVATION", 140, 147]]], ["Submassive to massive hepatic necrosis and cholestatic hepatitis have been reported in dogs as an idiosyncratic reaction to trimethoprim-sulfonamide combination therapy and the related sulfonamide-based anticonvulsant drug zonisamide, although zonisamide is in a different chemical category, is less likely to form toxic adducts, and is not likely to share a similar pathogenesis of liver injury.", [["hepatic", "ANATOMY", 22, 29], ["liver", "ANATOMY", 383, 388], ["massive hepatic necrosis", "DISEASE", 14, 38], ["cholestatic hepatitis", "DISEASE", 43, 64], ["trimethoprim-sulfonamide", "CHEMICAL", 124, 148], ["sulfonamide", "CHEMICAL", 185, 196], ["zonisamide", "CHEMICAL", 223, 233], ["zonisamide", "CHEMICAL", 244, 254], ["liver injury", "DISEASE", 383, 395], ["trimethoprim", "CHEMICAL", 124, 136], ["sulfonamide", "CHEMICAL", 137, 148], ["sulfonamide", "CHEMICAL", 185, 196], ["zonisamide", "CHEMICAL", 223, 233], ["zonisamide", "CHEMICAL", 244, 254], ["hepatic", "ORGAN", 22, 29], ["dogs", "ORGANISM", 87, 91], ["trimethoprim-sulfonamide", "SIMPLE_CHEMICAL", 124, 148], ["sulfonamide", "SIMPLE_CHEMICAL", 185, 196], ["zonisamide", "SIMPLE_CHEMICAL", 223, 233], ["zonisamide", "SIMPLE_CHEMICAL", 244, 254], ["liver", "ORGAN", 383, 388], ["dogs", "SPECIES", 87, 91], ["Submassive to massive hepatic necrosis", "PROBLEM", 0, 38], ["cholestatic hepatitis", "PROBLEM", 43, 64], ["an idiosyncratic reaction", "PROBLEM", 95, 120], ["trimethoprim", "TREATMENT", 124, 136], ["sulfonamide combination therapy", "TREATMENT", 137, 168], ["the related sulfonamide", "TREATMENT", 173, 196], ["anticonvulsant drug zonisamide", "TREATMENT", 203, 233], ["zonisamide", "TREATMENT", 244, 254], ["toxic adducts", "PROBLEM", 315, 328], ["liver injury", "PROBLEM", 383, 395], ["massive", "OBSERVATION_MODIFIER", 14, 21], ["hepatic", "ANATOMY", 22, 29], ["necrosis", "OBSERVATION", 30, 38], ["cholestatic", "OBSERVATION_MODIFIER", 43, 54], ["hepatitis", "OBSERVATION", 55, 64], ["less likely", "UNCERTAINTY", 295, 306], ["toxic", "OBSERVATION_MODIFIER", 315, 320], ["adducts", "OBSERVATION", 321, 328], ["not likely", "UNCERTAINTY", 337, 347], ["liver", "ANATOMY", 383, 388], ["injury", "OBSERVATION", 389, 395]]], ["Severe lobular to massive hepatic necrosis may occur in cats associated with repeated oral administration of diazepam at recommended doses.", [["lobular", "ANATOMY", 7, 14], ["hepatic", "ANATOMY", 26, 33], ["oral", "ANATOMY", 86, 90], ["hepatic necrosis", "DISEASE", 26, 42], ["diazepam", "CHEMICAL", 109, 117], ["diazepam", "CHEMICAL", 109, 117], ["lobular", "CANCER", 7, 14], ["hepatic", "ORGAN", 26, 33], ["cats", "ORGANISM", 56, 60], ["oral", "ORGANISM_SUBDIVISION", 86, 90], ["diazepam", "SIMPLE_CHEMICAL", 109, 117], ["cats", "SPECIES", 56, 60], ["Severe lobular to massive hepatic necrosis", "PROBLEM", 0, 42], ["repeated oral administration of diazepam", "TREATMENT", 77, 117], ["lobular", "OBSERVATION_MODIFIER", 7, 14], ["massive", "OBSERVATION_MODIFIER", 18, 25], ["hepatic", "ANATOMY", 26, 33], ["necrosis", "OBSERVATION", 34, 42]]], ["Severe centrilobular hepatic necrosis has been associated with use of the anthelmintic mebendazole in dogs.", [["centrilobular hepatic", "ANATOMY", 7, 28], ["centrilobular hepatic necrosis", "DISEASE", 7, 37], ["mebendazole", "CHEMICAL", 87, 98], ["mebendazole", "CHEMICAL", 87, 98], ["mebendazole", "SIMPLE_CHEMICAL", 87, 98], ["dogs", "ORGANISM", 102, 106], ["dogs", "SPECIES", 102, 106], ["Severe centrilobular hepatic necrosis", "PROBLEM", 0, 37], ["the anthelmintic mebendazole in dogs", "TREATMENT", 70, 106], ["centrilobular", "ANATOMY_MODIFIER", 7, 20], ["hepatic", "ANATOMY", 21, 28], ["necrosis", "OBSERVATION", 29, 37]]], ["Hepatotoxicity has been reported in 4 dogs treated with amiodarone, a class III antiarrhythmic agent.", [["Hepatotoxicity", "DISEASE", 0, 14], ["amiodarone", "CHEMICAL", 56, 66], ["amiodarone", "CHEMICAL", 56, 66], ["dogs", "ORGANISM", 38, 42], ["amiodarone", "SIMPLE_CHEMICAL", 56, 66], ["Hepatotoxicity", "PROBLEM", 0, 14], ["amiodarone", "TREATMENT", 56, 66], ["a class III antiarrhythmic agent", "TREATMENT", 68, 100]]], ["This is one of the more commonly reported adverse effects of amiodarone in humans and is related to the drug's effect on lipid metabolism.", [["amiodarone", "CHEMICAL", 61, 71], ["amiodarone", "CHEMICAL", 61, 71], ["amiodarone", "SIMPLE_CHEMICAL", 61, 71], ["humans", "ORGANISM", 75, 81], ["lipid", "SIMPLE_CHEMICAL", 121, 126], ["humans", "SPECIES", 75, 81], ["humans", "SPECIES", 75, 81], ["amiodarone", "TREATMENT", 61, 71], ["lipid metabolism", "TREATMENT", 121, 137], ["lipid metabolism", "OBSERVATION", 121, 137]]], ["Administration of the anabolic steroid stanozolol has also been associated with elevated alanine aminotransferase, coagulopathy, and development of hepatic lipidosis with cholestasis in cats.", [["hepatic", "ANATOMY", 148, 155], ["steroid", "CHEMICAL", 31, 38], ["stanozolol", "CHEMICAL", 39, 49], ["alanine", "CHEMICAL", 89, 96], ["coagulopathy", "DISEASE", 115, 127], ["hepatic lipidosis", "DISEASE", 148, 165], ["cholestasis", "DISEASE", 171, 182], ["steroid", "CHEMICAL", 31, 38], ["stanozolol", "CHEMICAL", 39, 49], ["alanine", "CHEMICAL", 89, 96], ["stanozolol", "SIMPLE_CHEMICAL", 39, 49], ["alanine", "AMINO_ACID", 89, 96], ["aminotransferase", "AMINO_ACID", 97, 113], ["hepatic", "ORGAN", 148, 155], ["cats", "ORGANISM", 186, 190], ["alanine aminotransferase", "PROTEIN", 89, 113], ["cats", "SPECIES", 186, 190], ["the anabolic steroid stanozolol", "TREATMENT", 18, 49], ["elevated alanine aminotransferase", "PROBLEM", 80, 113], ["coagulopathy", "PROBLEM", 115, 127], ["hepatic lipidosis", "PROBLEM", 148, 165], ["cholestasis in cats", "PROBLEM", 171, 190], ["alanine aminotransferase", "OBSERVATION", 89, 113], ["coagulopathy", "OBSERVATION", 115, 127], ["hepatic", "ANATOMY", 148, 155], ["lipidosis", "OBSERVATION", 156, 165], ["cholestasis", "OBSERVATION", 171, 182]]], ["Adult beef cattle testing positive for stanozolol in urine also had hepatic changes, including cholestasis, periportal fibrosis and inflammation, and focal necrosis, although the changes could not conclusively be attributed to anabolic steroid administration.", [["urine", "ANATOMY", 53, 58], ["hepatic", "ANATOMY", 68, 75], ["periportal", "ANATOMY", 108, 118], ["stanozolol", "CHEMICAL", 39, 49], ["cholestasis", "DISEASE", 95, 106], ["fibrosis", "DISEASE", 119, 127], ["inflammation", "DISEASE", 132, 144], ["necrosis", "DISEASE", 156, 164], ["steroid", "CHEMICAL", 236, 243], ["stanozolol", "CHEMICAL", 39, 49], ["steroid", "CHEMICAL", 236, 243], ["cattle", "ORGANISM", 11, 17], ["stanozolol", "SIMPLE_CHEMICAL", 39, 49], ["urine", "ORGANISM_SUBSTANCE", 53, 58], ["hepatic", "MULTI-TISSUE_STRUCTURE", 68, 75], ["steroid", "SIMPLE_CHEMICAL", 236, 243], ["beef", "SPECIES", 6, 10], ["cattle", "SPECIES", 11, 17], ["beef", "SPECIES", 6, 10], ["cattle", "SPECIES", 11, 17], ["Adult beef cattle testing", "TEST", 0, 25], ["stanozolol in urine", "TEST", 39, 58], ["hepatic changes", "PROBLEM", 68, 83], ["cholestasis", "PROBLEM", 95, 106], ["periportal fibrosis", "PROBLEM", 108, 127], ["inflammation", "PROBLEM", 132, 144], ["focal necrosis", "PROBLEM", 150, 164], ["anabolic steroid administration", "TREATMENT", 227, 258], ["hepatic", "ANATOMY", 68, 75], ["changes", "OBSERVATION", 76, 83], ["cholestasis", "OBSERVATION", 95, 106], ["periportal", "ANATOMY", 108, 118], ["fibrosis", "OBSERVATION", 119, 127], ["inflammation", "OBSERVATION", 132, 144], ["focal", "OBSERVATION_MODIFIER", 150, 155], ["necrosis", "OBSERVATION", 156, 164], ["could not conclusively be attributed to", "UNCERTAINTY", 187, 226], ["anabolic steroid", "OBSERVATION", 227, 243]]], ["Other pharmacologic agents associated with acute hepatic injury include thiacetarsemide, methoxyflurane, halothane, oil of pennyroyal, intravenous injection of manganese chloride and inadvertent subcutaneous injection of intranasal Bordetella bronchiseptica/canine parainfluenza vaccine in dogs, methimazole, glipizide, and the photodynamic therapy agent aluminum phthalocyanine tetrasulfonate in cats.Hepatotoxic plantsXylitol is an artificial sweetener used commonly in baked goods or chewing gum intended for use by diabetics or dieters.", [["hepatic", "ANATOMY", 49, 56], ["intravenous", "ANATOMY", 135, 146], ["subcutaneous", "ANATOMY", 195, 207], ["acute hepatic injury", "DISEASE", 43, 63], ["thiacetarsemide", "CHEMICAL", 72, 87], ["methoxyflurane", "CHEMICAL", 89, 103], ["halothane", "CHEMICAL", 105, 114], ["pennyroyal", "CHEMICAL", 123, 133], ["manganese chloride", "CHEMICAL", 160, 178], ["parainfluenza", "DISEASE", 265, 278], ["methimazole", "CHEMICAL", 296, 307], ["glipizide", "CHEMICAL", 309, 318], ["aluminum phthalocyanine", "CHEMICAL", 355, 378], ["tetrasulfonate", "CHEMICAL", 379, 393], ["plantsXylitol", "CHEMICAL", 414, 427], ["thiacetarsemide", "CHEMICAL", 72, 87], ["methoxyflurane", "CHEMICAL", 89, 103], ["halothane", "CHEMICAL", 105, 114], ["manganese chloride", "CHEMICAL", 160, 178], ["methimazole", "CHEMICAL", 296, 307], ["glipizide", "CHEMICAL", 309, 318], ["aluminum phthalocyanine", "CHEMICAL", 355, 378], ["tetrasulfonate", "CHEMICAL", 379, 393], ["plantsXylitol", "CHEMICAL", 414, 427], ["hepatic", "ORGAN", 49, 56], ["thiacetarsemide", "SIMPLE_CHEMICAL", 72, 87], ["methoxyflurane", "SIMPLE_CHEMICAL", 89, 103], ["halothane", "SIMPLE_CHEMICAL", 105, 114], ["oil", "ORGANISM_SUBSTANCE", 116, 119], ["pennyroyal", "SIMPLE_CHEMICAL", 123, 133], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 135, 146], ["manganese chloride", "SIMPLE_CHEMICAL", 160, 178], ["Bordetella bronchiseptica", "ORGANISM", 232, 257], ["canine parainfluenza", "ORGANISM", 258, 278], ["dogs", "ORGANISM", 290, 294], ["methimazole", "SIMPLE_CHEMICAL", 296, 307], ["glipizide", "SIMPLE_CHEMICAL", 309, 318], ["aluminum phthalocyanine tetrasulfonate", "SIMPLE_CHEMICAL", 355, 393], ["cats", "ORGANISM", 397, 401], ["plantsXylitol", "SIMPLE_CHEMICAL", 414, 427], ["gum", "ORGANISM_SUBDIVISION", 495, 498], ["Bordetella bronchiseptica", "SPECIES", 232, 257], ["canine parainfluenza vaccine", "SPECIES", 258, 286], ["dogs", "SPECIES", 290, 294], ["cats", "SPECIES", 397, 401], ["Bordetella bronchiseptica", "SPECIES", 232, 257], ["Other pharmacologic agents", "TREATMENT", 0, 26], ["acute hepatic injury", "PROBLEM", 43, 63], ["thiacetarsemide", "TREATMENT", 72, 87], ["methoxyflurane", "TREATMENT", 89, 103], ["halothane", "TREATMENT", 105, 114], ["pennyroyal", "TREATMENT", 123, 133], ["intravenous injection of manganese chloride", "TREATMENT", 135, 178], ["inadvertent subcutaneous injection", "TREATMENT", 183, 217], ["intranasal Bordetella bronchiseptica", "TREATMENT", 221, 257], ["canine parainfluenza vaccine", "TREATMENT", 258, 286], ["methimazole", "TREATMENT", 296, 307], ["glipizide", "TREATMENT", 309, 318], ["the photodynamic therapy agent aluminum phthalocyanine tetrasulfonate", "TREATMENT", 324, 393], ["Hepatotoxic plantsXylitol", "TREATMENT", 402, 427], ["an artificial sweetener", "TREATMENT", 431, 454], ["acute", "OBSERVATION_MODIFIER", 43, 48], ["hepatic", "ANATOMY", 49, 56], ["injury", "OBSERVATION", 57, 63]]], ["Although high doses can be tolerated by most species, there is a particular sensitivity in dogs.", [["dogs", "ORGANISM", 91, 95], ["dogs", "SPECIES", 91, 95], ["a particular sensitivity in dogs", "PROBLEM", 63, 95]]], ["Dogs that ingest >0.5 g/kg can be at risk to develop acute severe hepatic necrosis.", [["hepatic", "ANATOMY", 66, 73], ["hepatic necrosis", "DISEASE", 66, 82], ["Dogs", "ORGANISM", 0, 4], ["hepatic", "ORGAN", 66, 73], ["acute severe hepatic necrosis", "PROBLEM", 53, 82], ["acute", "OBSERVATION_MODIFIER", 53, 58], ["severe", "OBSERVATION_MODIFIER", 59, 65], ["hepatic", "ANATOMY", 66, 73], ["necrosis", "OBSERVATION", 74, 82]]], ["Dogs exposed to fatal doses have centrilobular to massive lytic necrosis of hepatocytes and widespread hemorrhage.", [["centrilobular", "ANATOMY", 33, 46], ["hepatocytes", "ANATOMY", 76, 87], ["necrosis", "DISEASE", 64, 72], ["hemorrhage", "DISEASE", 103, 113], ["Dogs", "ORGANISM", 0, 4], ["hepatocytes", "CELL", 76, 87], ["hepatocytes", "CELL_TYPE", 76, 87], ["centrilobular to massive lytic necrosis of hepatocytes", "PROBLEM", 33, 87], ["widespread hemorrhage", "PROBLEM", 92, 113], ["centrilobular", "OBSERVATION_MODIFIER", 33, 46], ["massive", "OBSERVATION_MODIFIER", 50, 57], ["lytic", "OBSERVATION_MODIFIER", 58, 63], ["necrosis", "OBSERVATION", 64, 72], ["hepatocytes", "ANATOMY", 76, 87], ["widespread", "OBSERVATION_MODIFIER", 92, 102], ["hemorrhage", "OBSERVATION", 103, 113]]], ["Affected dogs also develop hypoglycemia and hyperinsulinemia.", [["hypoglycemia", "DISEASE", 27, 39], ["hyperinsulinemia", "DISEASE", 44, 60], ["dogs", "ORGANISM", 9, 13], ["dogs", "SPECIES", 9, 13], ["Affected dogs", "PROBLEM", 0, 13], ["hypoglycemia", "PROBLEM", 27, 39], ["hyperinsulinemia", "PROBLEM", 44, 60], ["hypoglycemia", "OBSERVATION", 27, 39], ["hyperinsulinemia", "OBSERVATION", 44, 60]]], ["There may be an element of idiosyncratic toxicity involved as dogs have tolerated higher doses in experimental settings, so there may be breed-related or other factors influencing acute toxicity.", [["toxicity", "DISEASE", 41, 49], ["toxicity", "DISEASE", 186, 194], ["dogs", "ORGANISM", 62, 66], ["idiosyncratic toxicity", "PROBLEM", 27, 49], ["acute toxicity", "PROBLEM", 180, 194], ["may be", "UNCERTAINTY", 6, 12], ["idiosyncratic", "OBSERVATION_MODIFIER", 27, 40], ["toxicity", "OBSERVATION", 41, 49], ["acute", "OBSERVATION_MODIFIER", 180, 185], ["toxicity", "OBSERVATION", 186, 194]]], ["The mechanism of toxicity is not currently known, but intracellular ATP depletion and generation of reactive oxygen species have been suggested as possible mechanisms for hepatocyte injury.Hepatotoxic plantsCarprofen is a nonsteroidal anti-inflammatory drug used in the treatment of degenerative joint disease and management of acute pain in dogs primarily.", [["intracellular", "ANATOMY", 54, 67], ["hepatocyte", "ANATOMY", 171, 181], ["nonsteroidal", "ANATOMY", 222, 234], ["joint", "ANATOMY", 296, 301], ["toxicity", "DISEASE", 17, 25], ["ATP", "CHEMICAL", 68, 71], ["oxygen", "CHEMICAL", 109, 115], ["hepatocyte injury", "DISEASE", 171, 188], ["Carprofen", "CHEMICAL", 207, 216], ["degenerative joint disease", "DISEASE", 283, 309], ["acute pain", "DISEASE", 328, 338], ["ATP", "CHEMICAL", 68, 71], ["oxygen", "CHEMICAL", 109, 115], ["Carprofen", "CHEMICAL", 207, 216], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 54, 67], ["ATP", "SIMPLE_CHEMICAL", 68, 71], ["reactive oxygen species", "SIMPLE_CHEMICAL", 100, 123], ["hepatocyte", "CELL", 171, 181], ["Carprofen", "SIMPLE_CHEMICAL", 207, 216], ["joint", "MULTI-TISSUE_STRUCTURE", 296, 301], ["dogs", "ORGANISM", 342, 346], ["dogs", "SPECIES", 342, 346], ["toxicity", "PROBLEM", 17, 25], ["intracellular ATP depletion", "PROBLEM", 54, 81], ["reactive oxygen species", "PROBLEM", 100, 123], ["hepatocyte injury", "PROBLEM", 171, 188], ["Hepatotoxic plants", "PROBLEM", 189, 207], ["Carprofen", "TREATMENT", 207, 216], ["a nonsteroidal anti-inflammatory drug", "TREATMENT", 220, 257], ["degenerative joint disease", "PROBLEM", 283, 309], ["acute pain in dogs", "PROBLEM", 328, 346], ["toxicity", "OBSERVATION", 17, 25], ["ATP depletion", "OBSERVATION", 68, 81], ["reactive", "OBSERVATION_MODIFIER", 100, 108], ["oxygen species", "OBSERVATION", 109, 123], ["hepatocyte", "ANATOMY", 171, 181], ["injury", "OBSERVATION", 182, 188], ["degenerative joint disease", "OBSERVATION", 283, 309], ["acute", "OBSERVATION_MODIFIER", 328, 333], ["pain", "OBSERVATION", 334, 338]]], ["Diffuse and massive hepatocellular injury, characterized by hepatocellular vacuolar change, lytic necrosis, apoptosis, and bridging necrosis, with mild secondary inflammation and cholestasis, has been manifested as convulsions and death within a few minutes; there are no specific lesions in this form of the toxicosis.Hepatotoxic plantsThe most well-understood cyanobacterial hepatotoxin is microcystin-LR, a highly potent cyclic heptapeptide protein phosphatase inhibitor.", [["hepatocellular", "ANATOMY", 20, 34], ["hepatocellular vacuolar", "ANATOMY", 60, 83], ["lesions", "ANATOMY", 281, 288], ["massive hepatocellular injury", "DISEASE", 12, 41], ["necrosis", "DISEASE", 98, 106], ["necrosis", "DISEASE", 132, 140], ["inflammation", "DISEASE", 162, 174], ["cholestasis", "DISEASE", 179, 190], ["convulsions", "DISEASE", 215, 226], ["death", "DISEASE", 231, 236], ["toxicosis", "DISEASE", 309, 318], ["microcystin-LR", "CHEMICAL", 392, 406], ["hepatotoxin", "CHEMICAL", 377, 388], ["microcystin-LR", "CHEMICAL", 392, 406], ["hepatocellular", "CANCER", 20, 34], ["hepatocellular vacuolar", "MULTI-TISSUE_STRUCTURE", 60, 83], ["lesions", "PATHOLOGICAL_FORMATION", 281, 288], ["hepatotoxin", "SIMPLE_CHEMICAL", 377, 388], ["microcystin-LR", "SIMPLE_CHEMICAL", 392, 406], ["Diffuse and massive hepatocellular injury", "PROBLEM", 0, 41], ["hepatocellular vacuolar change", "PROBLEM", 60, 90], ["lytic necrosis", "PROBLEM", 92, 106], ["apoptosis", "PROBLEM", 108, 117], ["bridging necrosis", "PROBLEM", 123, 140], ["mild secondary inflammation", "PROBLEM", 147, 174], ["cholestasis", "PROBLEM", 179, 190], ["convulsions", "PROBLEM", 215, 226], ["death", "PROBLEM", 231, 236], ["specific lesions", "PROBLEM", 272, 288], ["the toxicosis", "PROBLEM", 305, 318], ["Hepatotoxic plants", "PROBLEM", 319, 337], ["LR", "TREATMENT", 404, 406], ["a highly potent cyclic heptapeptide protein phosphatase inhibitor", "TREATMENT", 408, 473], ["massive", "OBSERVATION_MODIFIER", 12, 19], ["hepatocellular injury", "OBSERVATION", 20, 41], ["hepatocellular", "ANATOMY", 60, 74], ["vacuolar change", "OBSERVATION", 75, 90], ["lytic", "OBSERVATION_MODIFIER", 92, 97], ["necrosis", "OBSERVATION", 98, 106], ["apoptosis", "OBSERVATION_MODIFIER", 108, 117], ["bridging", "OBSERVATION_MODIFIER", 123, 131], ["necrosis", "OBSERVATION", 132, 140], ["mild", "OBSERVATION_MODIFIER", 147, 151], ["secondary", "OBSERVATION_MODIFIER", 152, 161], ["inflammation", "OBSERVATION", 162, 174], ["cholestasis", "OBSERVATION", 179, 190], ["convulsions", "OBSERVATION", 215, 226], ["no", "UNCERTAINTY", 269, 271], ["specific", "OBSERVATION_MODIFIER", 272, 280], ["lesions", "OBSERVATION", 281, 288], ["toxicosis", "OBSERVATION", 309, 318]]], ["Other species of cyanobacteria, such as Nodularia spumigenia found in New Zealand and the Baltic region, contain different, but still potent toxins such as nodularin.", [["nodularin", "CHEMICAL", 156, 165], ["nodularin", "CHEMICAL", 156, 165], ["Nodularia spumigenia", "ORGANISM", 40, 60], ["nodularin", "GENE_OR_GENE_PRODUCT", 156, 165], ["nodularin", "PROTEIN", 156, 165], ["Nodularia spumigenia", "SPECIES", 40, 60], ["Nodularia spumigenia", "SPECIES", 40, 60], ["cyanobacteria", "PROBLEM", 17, 30], ["Nodularia spumigenia", "PROBLEM", 40, 60], ["nodularin", "PROBLEM", 156, 165], ["cyanobacteria", "OBSERVATION", 17, 30], ["New", "OBSERVATION_MODIFIER", 70, 73], ["Zealand", "OBSERVATION_MODIFIER", 74, 81], ["Baltic", "ANATOMY_MODIFIER", 90, 96], ["region", "ANATOMY_MODIFIER", 97, 103], ["different", "OBSERVATION_MODIFIER", 113, 122], ["nodularin", "OBSERVATION", 156, 165]]], ["Ruminants are most commonly poisoned, but poisoning has been reported in horses, sheep, dogs, and domestic poultry.", [["poisoning", "DISEASE", 42, 51], ["horses", "ORGANISM_SUBDIVISION", 73, 79], ["sheep", "ORGANISM", 81, 86], ["dogs", "ORGANISM", 88, 92], ["sheep", "SPECIES", 81, 86], ["dogs", "SPECIES", 88, 92], ["horses", "SPECIES", 73, 79], ["sheep", "SPECIES", 81, 86]]], ["The cyanobacterial toxin is released when the microorganisms disintegrate, which may occur spontaneously in bodies of water or after the application of copper sulfate for algae control, or in the rumen or stomach after ingestion.", [["rumen", "ANATOMY", 196, 201], ["stomach", "ANATOMY", 205, 212], ["copper sulfate", "CHEMICAL", 152, 166], ["copper sulfate", "CHEMICAL", 152, 166], ["copper sulfate", "SIMPLE_CHEMICAL", 152, 166], ["rumen", "ORGANISM_SUBDIVISION", 196, 201], ["stomach", "ORGAN", 205, 212], ["The cyanobacterial toxin", "TEST", 0, 24], ["copper sulfate", "TREATMENT", 152, 166], ["algae control", "TREATMENT", 171, 184], ["rumen", "ANATOMY_MODIFIER", 196, 201], ["stomach", "ANATOMY", 205, 212]]], ["Microcystin-LR is very stable and persists in water at typical ambient conditions, with a 10-week half-life.", [["Microcystin", "CHEMICAL", 0, 11], ["Microcystin-LR", "SIMPLE_CHEMICAL", 0, 14], ["Microcystin", "TEST", 0, 11], ["very", "OBSERVATION_MODIFIER", 18, 22], ["stable", "OBSERVATION_MODIFIER", 23, 29]]], ["It is stable following boiling as well.", [["stable", "OBSERVATION_MODIFIER", 6, 12]]], ["The toxin is taken into hepatocytes by organic anion-transporting polypeptide (OATP) membrane transporters and causes cell damage by inhibiting cytoplasmic protein phosphatase 1 and 2A.", [["hepatocytes", "ANATOMY", 24, 35], ["membrane", "ANATOMY", 85, 93], ["cell", "ANATOMY", 118, 122], ["cytoplasmic", "ANATOMY", 144, 155], ["hepatocytes", "CELL", 24, 35], ["organic anion-transporting polypeptide", "GENE_OR_GENE_PRODUCT", 39, 77], ["OATP", "GENE_OR_GENE_PRODUCT", 79, 83], ["cell", "CELL", 118, 122], ["cytoplasmic", "ORGANISM_SUBSTANCE", 144, 155], ["protein phosphatase 1", "GENE_OR_GENE_PRODUCT", 156, 177], ["2A", "GENE_OR_GENE_PRODUCT", 182, 184], ["toxin", "PROTEIN", 4, 9], ["hepatocytes", "CELL_TYPE", 24, 35], ["organic anion-transporting polypeptide (OATP) membrane transporters", "PROTEIN", 39, 106], ["cytoplasmic protein phosphatase 1 and 2A", "PROTEIN", 144, 184], ["The toxin", "TEST", 0, 9], ["organic anion-transporting polypeptide (OATP) membrane transporters", "TREATMENT", 39, 106], ["cell damage", "PROBLEM", 118, 129], ["cytoplasmic protein phosphatase", "TEST", 144, 175], ["cell damage", "OBSERVATION", 118, 129]]], ["This leads to disorganization of hepatocyte and endothelial cytoskeletal actin filaments, and disruption of their shape and integrity, leading to necrosis, apoptosis, and perisinusoidal hemorrhage.", [["hepatocyte", "ANATOMY", 33, 43], ["endothelial cytoskeletal", "ANATOMY", 48, 72], ["filaments", "ANATOMY", 79, 88], ["necrosis", "DISEASE", 146, 154], ["perisinusoidal hemorrhage", "DISEASE", 171, 196], ["hepatocyte", "CELL", 33, 43], ["endothelial cytoskeletal", "CELLULAR_COMPONENT", 48, 72], ["actin", "GENE_OR_GENE_PRODUCT", 73, 78], ["filaments", "CELLULAR_COMPONENT", 79, 88], ["disorganization of hepatocyte and endothelial cytoskeletal actin filaments", "PROBLEM", 14, 88], ["disruption of their shape", "PROBLEM", 94, 119], ["necrosis", "PROBLEM", 146, 154], ["apoptosis", "PROBLEM", 156, 165], ["perisinusoidal hemorrhage", "PROBLEM", 171, 196], ["disorganization", "OBSERVATION", 14, 29], ["hepatocyte", "ANATOMY", 33, 43], ["endothelial cytoskeletal", "OBSERVATION", 48, 72], ["actin filaments", "OBSERVATION", 73, 88], ["shape", "OBSERVATION_MODIFIER", 114, 119], ["integrity", "OBSERVATION_MODIFIER", 124, 133], ["leading to", "UNCERTAINTY", 135, 145], ["necrosis", "OBSERVATION", 146, 154], ["apoptosis", "OBSERVATION_MODIFIER", 156, 165], ["perisinusoidal", "OBSERVATION_MODIFIER", 171, 185], ["hemorrhage", "OBSERVATION", 186, 196]]], ["The distribution of the necrosis is usually centrilobular to massive.", [["centrilobular", "ANATOMY", 44, 57], ["necrosis", "DISEASE", 24, 32], ["the necrosis", "PROBLEM", 20, 32], ["distribution", "OBSERVATION_MODIFIER", 4, 16], ["necrosis", "OBSERVATION", 24, 32], ["centrilobular", "OBSERVATION_MODIFIER", 44, 57], ["massive", "OBSERVATION_MODIFIER", 61, 68]]], ["The pattern may vary within the individual liver and from case to case.", [["liver", "ANATOMY", 43, 48], ["liver", "ORGAN", 43, 48], ["liver", "ANATOMY", 43, 48]]], ["In subacute intoxications, the liver is severely fatty, and necrosis is limited to individual hepatocytes or small groups, rather than being zonal.", [["liver", "ANATOMY", 31, 36], ["hepatocytes", "ANATOMY", 94, 105], ["necrosis", "DISEASE", 60, 68], ["liver", "ORGAN", 31, 36], ["hepatocytes", "CELL", 94, 105], ["hepatocytes", "CELL_TYPE", 94, 105], ["subacute intoxications", "PROBLEM", 3, 25], ["severely fatty", "PROBLEM", 40, 54], ["necrosis", "PROBLEM", 60, 68], ["subacute", "OBSERVATION_MODIFIER", 3, 11], ["intoxications", "OBSERVATION", 12, 25], ["liver", "ANATOMY", 31, 36], ["severely", "OBSERVATION_MODIFIER", 40, 48], ["fatty", "OBSERVATION", 49, 54], ["necrosis", "OBSERVATION", 60, 68], ["small", "OBSERVATION_MODIFIER", 109, 114], ["groups", "OBSERVATION_MODIFIER", 115, 121]]], ["Phagolysosomes and bile pigments accumulate in the cytoplasm, and there is slight biliary proliferation and fibrosis.", [["Phagolysosomes", "ANATOMY", 0, 14], ["bile pigments", "ANATOMY", 19, 32], ["cytoplasm", "ANATOMY", 51, 60], ["biliary", "ANATOMY", 82, 89], ["fibrosis", "DISEASE", 108, 116], ["Phagolysosomes", "GENE_OR_GENE_PRODUCT", 0, 14], ["bile pigments", "SIMPLE_CHEMICAL", 19, 32], ["cytoplasm", "ORGANISM_SUBSTANCE", 51, 60], ["biliary", "MULTI-TISSUE_STRUCTURE", 82, 89], ["Phagolysosomes", "TEST", 0, 14], ["bile pigments accumulate in the cytoplasm", "PROBLEM", 19, 60], ["slight biliary proliferation", "PROBLEM", 75, 103], ["fibrosis", "PROBLEM", 108, 116], ["bile", "ANATOMY", 19, 23], ["pigments accumulate", "OBSERVATION", 24, 43], ["cytoplasm", "OBSERVATION_MODIFIER", 51, 60], ["slight", "OBSERVATION_MODIFIER", 75, 81], ["biliary", "ANATOMY", 82, 89], ["proliferation", "OBSERVATION", 90, 103], ["fibrosis", "OBSERVATION", 108, 116]]], ["Necrosis of the renal tubules can also occur.", [["renal tubules", "ANATOMY", 16, 29], ["renal tubules", "MULTI-TISSUE_STRUCTURE", 16, 29], ["Necrosis of the renal tubules", "PROBLEM", 0, 29], ["renal tubules", "ANATOMY", 16, 29]]], ["Diagnosis can be made by detection of microcystin in vomitus or liver.Toxic fungiAmanitins are potent hepatotoxins found in several mushroom genera, including Amanita, Galerina, and Lepiota.", [["vomitus", "ANATOMY", 53, 60], ["liver", "ANATOMY", 64, 69], ["microcystin", "CHEMICAL", 38, 49], ["fungiAmanitins", "CHEMICAL", 76, 90], ["microcystin", "CHEMICAL", 38, 49], ["fungiAmanitins", "CHEMICAL", 76, 90], ["microcystin", "SIMPLE_CHEMICAL", 38, 49], ["vomitus", "CANCER", 53, 60], ["liver", "ORGAN", 64, 69], ["fungiAmanitins", "SIMPLE_CHEMICAL", 76, 90], ["microcystin in vomitus or liver", "PROBLEM", 38, 69], ["Toxic fungiAmanitins", "PROBLEM", 70, 90], ["potent hepatotoxins", "PROBLEM", 95, 114], ["microcystin", "OBSERVATION", 38, 49], ["liver", "ANATOMY", 64, 69], ["potent", "OBSERVATION_MODIFIER", 95, 101], ["hepatotoxins", "OBSERVATION", 102, 114], ["mushroom genera", "OBSERVATION", 132, 147], ["Galerina", "ANATOMY", 168, 176]]], ["The genus Amanita contains several species, including A. phalloides, A. verna, A. virosa, and A. ocreata , which are considered extremely toxic.", [["A. phalloides", "ORGANISM", 54, 67], ["A. verna", "ORGANISM", 69, 77], ["A. virosa", "ORGANISM", 79, 88], ["A. ocreata", "ORGANISM", 94, 104], ["A. phalloides", "SPECIES", 54, 67], ["A. verna", "SPECIES", 69, 77], ["A. virosa", "SPECIES", 79, 88], ["A. ocreata", "SPECIES", 94, 104], ["A. phalloides", "SPECIES", 54, 67], ["A. verna", "SPECIES", 69, 77], ["A. virosa", "SPECIES", 79, 88], ["A. ocreata", "SPECIES", 94, 104], ["several species", "PROBLEM", 27, 42], ["A. phalloides", "TEST", 54, 67], ["extremely toxic", "PROBLEM", 128, 143], ["genus", "ANATOMY", 4, 9], ["Amanita", "OBSERVATION", 10, 17], ["several", "OBSERVATION_MODIFIER", 27, 34], ["species", "OBSERVATION_MODIFIER", 35, 42]]], ["These mushrooms are mycorrhizal with various species of deciduous and coniferous trees, and may be found in urban, suburban, and rural areas.", [["deciduous", "ORGANISM_SUBDIVISION", 56, 65], ["deciduous and coniferous trees", "PROBLEM", 56, 86], ["deciduous", "OBSERVATION_MODIFIER", 56, 65], ["coniferous trees", "OBSERVATION", 70, 86], ["rural", "ANATOMY", 129, 134]]], ["The amanitins are bicyclic octapeptides, ingestion of which is responsible for gastroenteritis, hypoglycemia, and fulminant liver failure in humans, dogs, cats, cattle, and other animals.", [["liver", "ANATOMY", 124, 129], ["amanitins", "CHEMICAL", 4, 13], ["gastroenteritis", "DISEASE", 79, 94], ["hypoglycemia", "DISEASE", 96, 108], ["fulminant liver failure", "DISEASE", 114, 137], ["amanitins", "CHEMICAL", 4, 13], ["bicyclic octapeptides", "CHEMICAL", 18, 39], ["amanitins", "SIMPLE_CHEMICAL", 4, 13], ["bicyclic octapeptides", "SIMPLE_CHEMICAL", 18, 39], ["liver", "ORGAN", 124, 129], ["humans", "ORGANISM", 141, 147], ["cats", "ORGANISM", 155, 159], ["humans", "SPECIES", 141, 147], ["dogs", "SPECIES", 149, 153], ["cats", "SPECIES", 155, 159], ["cattle", "SPECIES", 161, 167], ["humans", "SPECIES", 141, 147], ["cattle", "SPECIES", 161, 167], ["The amanitins", "TREATMENT", 0, 13], ["bicyclic octapeptides", "TREATMENT", 18, 39], ["gastroenteritis", "PROBLEM", 79, 94], ["hypoglycemia", "PROBLEM", 96, 108], ["fulminant liver failure", "PROBLEM", 114, 137], ["bicyclic octapeptides", "OBSERVATION", 18, 39], ["responsible for", "UNCERTAINTY", 63, 78], ["gastroenteritis", "OBSERVATION", 79, 94], ["hypoglycemia", "OBSERVATION", 96, 108], ["fulminant", "OBSERVATION_MODIFIER", 114, 123], ["liver", "ANATOMY", 124, 129], ["failure", "OBSERVATION", 130, 137]]], ["They are stable compounds and persist in the acid environment of the stomach and following cooking.", [["stomach", "ANATOMY", 69, 76], ["stomach", "ORGAN", 69, 76], ["stable", "OBSERVATION_MODIFIER", 9, 15], ["compounds", "OBSERVATION", 16, 25], ["stomach", "ANATOMY", 69, 76]]], ["Amanitin is transported from the systemic circulation to hepatocytes by a specific OATP transporter on the hepatocyte surface.", [["hepatocytes", "ANATOMY", 57, 68], ["hepatocyte surface", "ANATOMY", 107, 125], ["Amanitin", "CHEMICAL", 0, 8], ["Amanitin", "CHEMICAL", 0, 8], ["Amanitin", "SIMPLE_CHEMICAL", 0, 8], ["hepatocytes", "CELL", 57, 68], ["OATP", "GENE_OR_GENE_PRODUCT", 83, 87], ["hepatocyte surface", "CELLULAR_COMPONENT", 107, 125], ["hepatocytes", "CELL_TYPE", 57, 68], ["OATP transporter", "PROTEIN", 83, 99], ["Amanitin", "TREATMENT", 0, 8], ["hepatocytes", "ANATOMY", 57, 68], ["hepatocyte", "ANATOMY", 107, 117], ["surface", "ANATOMY_MODIFIER", 118, 125]]], ["Toxicity is accentuated by enterohepatic circulation of the toxin, causing repeated hepatic exposure.", [["hepatic", "ANATOMY", 84, 91], ["Toxicity", "DISEASE", 0, 8], ["enterohepatic", "IMMATERIAL_ANATOMICAL_ENTITY", 27, 40], ["hepatic", "ORGAN", 84, 91], ["Toxicity", "PROBLEM", 0, 8], ["the toxin", "PROBLEM", 56, 65], ["repeated hepatic exposure", "PROBLEM", 75, 100], ["enterohepatic circulation", "OBSERVATION", 27, 52], ["hepatic", "ANATOMY", 84, 91], ["exposure", "OBSERVATION", 92, 100]]], ["Amanitin inhibits nuclear RNA polymerase II, thus interfering with transcription and inhibiting protein synthesis, resulting in cell death.", [["nuclear", "ANATOMY", 18, 25], ["cell", "ANATOMY", 128, 132], ["Amanitin", "CHEMICAL", 0, 8], ["death", "DISEASE", 133, 138], ["Amanitin", "CHEMICAL", 0, 8], ["Amanitin", "SIMPLE_CHEMICAL", 0, 8], ["nuclear", "CELLULAR_COMPONENT", 18, 25], ["RNA polymerase II", "GENE_OR_GENE_PRODUCT", 26, 43], ["cell", "CELL", 128, 132], ["nuclear RNA polymerase II", "PROTEIN", 18, 43], ["Amanitin", "TREATMENT", 0, 8], ["inhibiting protein synthesis", "PROBLEM", 85, 113], ["cell death", "PROBLEM", 128, 138], ["cell death", "OBSERVATION", 128, 138]]], ["Dogs or cats dying after ingestion of Amanita spp. have massive hepatocellular necrosis with focal areas of hemorrhage (see Fig. 2-93) .", [["hepatocellular", "ANATOMY", 64, 78], ["Amanita spp", "DISEASE", 38, 49], ["necrosis", "DISEASE", 79, 87], ["hemorrhage", "DISEASE", 108, 118], ["Dogs", "ORGANISM", 0, 4], ["cats", "ORGANISM", 8, 12], ["Amanita spp", "ORGANISM", 38, 49], ["hepatocellular", "CANCER", 64, 78], ["Dogs", "SPECIES", 0, 4], ["cats", "SPECIES", 8, 12], ["Amanita spp", "PROBLEM", 38, 49], ["massive hepatocellular necrosis", "PROBLEM", 56, 87], ["hemorrhage", "PROBLEM", 108, 118], ["massive", "OBSERVATION_MODIFIER", 56, 63], ["hepatocellular", "ANATOMY", 64, 78], ["necrosis", "OBSERVATION", 79, 87], ["focal", "OBSERVATION_MODIFIER", 93, 98], ["areas", "OBSERVATION_MODIFIER", 99, 104], ["hemorrhage", "OBSERVATION", 108, 118]]], ["Surviving periportal hepatocytes have vesicular nuclei with loss or fragmentation of nucleoli, consistent with ultrastructural reports of chromatin condensation, dissolution of the nucleolus, and decline in nucleolar RNA content.", [["periportal hepatocytes", "ANATOMY", 10, 32], ["vesicular nuclei", "ANATOMY", 38, 54], ["nucleoli", "ANATOMY", 85, 93], ["chromatin", "ANATOMY", 138, 147], ["nucleolus", "ANATOMY", 181, 190], ["nucleolar", "ANATOMY", 207, 216], ["periportal hepatocytes", "CELL", 10, 32], ["vesicular nuclei", "CELLULAR_COMPONENT", 38, 54], ["nucleoli", "CELLULAR_COMPONENT", 85, 93], ["chromatin", "CELLULAR_COMPONENT", 138, 147], ["nucleolus", "CELLULAR_COMPONENT", 181, 190], ["nucleolar", "CELLULAR_COMPONENT", 207, 216], ["periportal hepatocytes", "CELL_TYPE", 10, 32], ["chromatin", "DNA", 138, 147], ["nucleolar RNA", "RNA", 207, 220], ["vesicular nuclei", "PROBLEM", 38, 54], ["loss or fragmentation of nucleoli", "PROBLEM", 60, 93], ["chromatin condensation", "PROBLEM", 138, 160], ["the nucleolus", "PROBLEM", 177, 190], ["decline in nucleolar RNA content", "PROBLEM", 196, 228], ["periportal", "ANATOMY_MODIFIER", 10, 20], ["hepatocytes", "ANATOMY", 21, 32], ["vesicular nuclei", "OBSERVATION", 38, 54], ["loss", "OBSERVATION_MODIFIER", 60, 64], ["fragmentation", "OBSERVATION_MODIFIER", 68, 81], ["consistent with", "UNCERTAINTY", 95, 110], ["chromatin condensation", "OBSERVATION", 138, 160], ["dissolution", "OBSERVATION_MODIFIER", 162, 173], ["nucleolus", "ANATOMY", 181, 190], ["decline", "OBSERVATION_MODIFIER", 196, 203], ["nucleolar RNA content", "OBSERVATION", 207, 228]]], ["Necrosis of the proximal convoluted tubules often accompanies the hepatic injury and can aid in the index of suspicion for amanitin intoxication.", [["proximal convoluted tubules", "ANATOMY", 16, 43], ["hepatic", "ANATOMY", 66, 73], ["hepatic injury", "DISEASE", 66, 80], ["amanitin", "CHEMICAL", 123, 131], ["amanitin", "CHEMICAL", 123, 131], ["convoluted tubules", "MULTI-TISSUE_STRUCTURE", 25, 43], ["hepatic", "ORGAN", 66, 73], ["amanitin", "SIMPLE_CHEMICAL", 123, 131], ["Necrosis of the proximal convoluted tubules", "PROBLEM", 0, 43], ["the hepatic injury", "PROBLEM", 62, 80], ["amanitin intoxication", "PROBLEM", 123, 144], ["proximal", "ANATOMY_MODIFIER", 16, 24], ["convoluted", "ANATOMY_MODIFIER", 25, 35], ["tubules", "ANATOMY_MODIFIER", 36, 43], ["hepatic", "ANATOMY", 66, 73], ["injury", "OBSERVATION", 74, 80]]], ["Because the histologic lesions are nonspecific, and previously, it was difficult to obtain a definitive diagnosis of amanitin intoxication, under-diagnosis was likely.", [["histologic lesions", "ANATOMY", 12, 30], ["amanitin", "CHEMICAL", 117, 125], ["amanitin", "CHEMICAL", 117, 125], ["histologic lesions", "CANCER", 12, 30], ["amanitin", "SIMPLE_CHEMICAL", 117, 125], ["the histologic lesions", "PROBLEM", 8, 30], ["amanitin intoxication", "PROBLEM", 117, 138], ["histologic", "OBSERVATION_MODIFIER", 12, 22], ["lesions", "OBSERVATION", 23, 30], ["nonspecific", "OBSERVATION_MODIFIER", 35, 46]]], ["Confirmatory testing consumption of plants by herbivores has competitive or neutral advantage for the plant, especially those that are lush and prolific, so toxicity is counterproductive or unnecessary.", [["toxicity", "DISEASE", 157, 165], ["Confirmatory testing", "TEST", 0, 20]]], ["For example, Xanthium pungens (Noogoora burr) concentrates its toxin in the cotyledons.", [["cotyledons", "ANATOMY", 76, 86], ["Xanthium pungens", "ORGANISM", 13, 29], ["cotyledons", "ORGAN", 76, 86], ["Xanthium pungens", "SPECIES", 13, 29], ["Xanthium pungens", "SPECIES", 13, 29], ["Xanthium pungens (Noogoora burr", "TREATMENT", 13, 44], ["Xanthium pungens", "OBSERVATION", 13, 29], ["cotyledons", "ANATOMY", 76, 86]]], ["The seeds are rarely eaten, even by cattle, but intoxications can occur when this plant is eaten shortly after germination.", [["seeds", "ANATOMY", 4, 9], ["cattle", "SPECIES", 36, 42], ["cattle", "SPECIES", 36, 42], ["seeds", "OBSERVATION_MODIFIER", 4, 9]]], ["Phytotoxic liver disease is therefore more frequently encountered in animals grazing pastures at particular times of the year, with limited choice or supply, or when hungry animals are introduced to plants for which their natural or induced resistance is low.", [["liver", "ANATOMY", 11, 16], ["liver disease", "DISEASE", 11, 24], ["liver", "ORGAN", 11, 16], ["Phytotoxic liver disease", "PROBLEM", 0, 24], ["liver", "ANATOMY", 11, 16], ["disease", "OBSERVATION", 17, 24], ["more frequently", "OBSERVATION_MODIFIER", 38, 53], ["low", "OBSERVATION_MODIFIER", 255, 258]]], ["The patterns of liver disease resulting from consumption of toxic plants are for the most part quite consistent in comparison with what is seen with exposure to other classes of hepatotoxins.", [["liver", "ANATOMY", 16, 21], ["liver disease", "DISEASE", 16, 29], ["liver", "ORGAN", 16, 21], ["hepatotoxins", "GENE_OR_GENE_PRODUCT", 178, 190], ["liver disease", "PROBLEM", 16, 29], ["toxic plants", "PROBLEM", 60, 72], ["hepatotoxins", "PROBLEM", 178, 190], ["liver", "ANATOMY", 16, 21], ["disease", "OBSERVATION", 22, 29], ["toxic plants", "OBSERVATION", 60, 72]]], ["An exhaustive review of the toxicity of all such plants would be repetitive.", [["toxicity", "DISEASE", 28, 36], ["the toxicity", "PROBLEM", 24, 36]]], ["However, some plants that do produce more distinctive patterns of liver lesions will be discussed in more detail.Toxic fungiflooding or rain has allowed germination.", [["liver lesions", "ANATOMY", 66, 79], ["liver lesions", "DISEASE", 66, 79], ["liver lesions", "CANCER", 66, 79], ["liver lesions", "PROBLEM", 66, 79], ["Toxic fungiflooding", "PROBLEM", 113, 132], ["liver", "ANATOMY", 66, 71], ["lesions", "OBSERVATION", 72, 79], ["rain", "OBSERVATION_MODIFIER", 136, 140]]], ["The clinical signs and lesions are not specific, being those described for acute hepatotoxins in general.", [["lesions", "ANATOMY", 23, 30], ["lesions", "PATHOLOGICAL_FORMATION", 23, 30], ["The clinical signs", "TEST", 0, 18], ["lesions", "PROBLEM", 23, 30], ["acute hepatotoxins", "PROBLEM", 75, 93], ["lesions", "OBSERVATION", 23, 30], ["hepatotoxins", "OBSERVATION", 81, 93]]], ["The toxic principle is a diterpenoid glycoside, carboxyatractyloside, although there may be other closely related toxic glycosides in some plants.", [["carboxyatractyloside", "CHEMICAL", 48, 68], ["diterpenoid glycoside", "CHEMICAL", 25, 46], ["carboxyatractyloside", "CHEMICAL", 48, 68], ["diterpenoid glycoside", "SIMPLE_CHEMICAL", 25, 46], ["carboxyatractyloside", "SIMPLE_CHEMICAL", 48, 68], ["a diterpenoid glycoside", "TREATMENT", 23, 46], ["carboxyatractyloside", "TREATMENT", 48, 68], ["toxic glycosides", "PROBLEM", 114, 130], ["toxic", "OBSERVATION_MODIFIER", 4, 9], ["toxic glycosides", "OBSERVATION", 114, 130]]], ["Wedelia glauca also contains atractyloside and causes acute hepatotoxicity in cattle and sheep in Uruguay and Argentina.", [["atractyloside", "CHEMICAL", 29, 42], ["hepatotoxicity", "DISEASE", 60, 74], ["atractyloside", "CHEMICAL", 29, 42], ["Wedelia glauca", "ORGANISM", 0, 14], ["atractyloside", "SIMPLE_CHEMICAL", 29, 42], ["cattle", "ORGANISM", 78, 84], ["sheep", "ORGANISM", 89, 94], ["Wedelia glauca", "SPECIES", 0, 14], ["cattle", "SPECIES", 78, 84], ["sheep", "SPECIES", 89, 94], ["Wedelia glauca", "SPECIES", 0, 14], ["cattle", "SPECIES", 78, 84], ["sheep", "SPECIES", 89, 94], ["Wedelia glauca", "PROBLEM", 0, 14], ["atractyloside", "TREATMENT", 29, 42], ["acute hepatotoxicity", "PROBLEM", 54, 74], ["glauca", "ANATOMY", 8, 14], ["acute", "OBSERVATION_MODIFIER", 54, 59], ["hepatotoxicity", "OBSERVATION", 60, 74]]], ["The condition has been reproduced experimentally in sheep and cattle and rats.Toxic fungiAtractyloside toxins inhibit exchange of ATP from the mitochondria with adenosine diphosphate (ADP) in the cytosol, a process essential for oxidative phosphorylation.", [["mitochondria", "ANATOMY", 143, 155], ["cytosol", "ANATOMY", 196, 203], ["fungiAtractyloside", "CHEMICAL", 84, 102], ["ATP", "CHEMICAL", 130, 133], ["adenosine diphosphate", "CHEMICAL", 161, 182], ["ADP", "CHEMICAL", 184, 187], ["fungiAtractyloside", "CHEMICAL", 84, 102], ["ATP", "CHEMICAL", 130, 133], ["adenosine diphosphate", "CHEMICAL", 161, 182], ["ADP", "CHEMICAL", 184, 187], ["sheep", "ORGANISM", 52, 57], ["cattle", "ORGANISM", 62, 68], ["rats", "ORGANISM", 73, 77], ["fungiAtractyloside toxins", "SIMPLE_CHEMICAL", 84, 109], ["ATP", "SIMPLE_CHEMICAL", 130, 133], ["mitochondria", "CELLULAR_COMPONENT", 143, 155], ["adenosine diphosphate", "SIMPLE_CHEMICAL", 161, 182], ["ADP", "SIMPLE_CHEMICAL", 184, 187], ["cytosol", "CELLULAR_COMPONENT", 196, 203], ["sheep", "SPECIES", 52, 57], ["cattle", "SPECIES", 62, 68], ["rats", "SPECIES", 73, 77], ["sheep", "SPECIES", 52, 57], ["cattle", "SPECIES", 62, 68], ["Toxic fungiAtractyloside toxins", "PROBLEM", 78, 109], ["ATP", "PROBLEM", 130, 133], ["adenosine diphosphate (ADP)", "TREATMENT", 161, 188], ["oxidative phosphorylation", "TREATMENT", 229, 254], ["oxidative phosphorylation", "OBSERVATION", 229, 254]]], ["Atractylosides inhibit the ADP/ATP carriers (AACs), including the form expressed in the liver.", [["liver", "ANATOMY", 88, 93], ["Atractylosides", "CHEMICAL", 0, 14], ["ADP", "CHEMICAL", 27, 30], ["ATP", "CHEMICAL", 31, 34], ["Atractylosides", "CHEMICAL", 0, 14], ["ADP", "CHEMICAL", 27, 30], ["ATP", "CHEMICAL", 31, 34], ["Atractylosides", "SIMPLE_CHEMICAL", 0, 14], ["ADP", "SIMPLE_CHEMICAL", 27, 30], ["ATP", "SIMPLE_CHEMICAL", 31, 34], ["AACs", "SIMPLE_CHEMICAL", 45, 49], ["liver", "ORGAN", 88, 93], ["Atractylosides", "TREATMENT", 0, 14], ["the ADP/ATP carriers", "PROBLEM", 23, 43], ["liver", "ANATOMY", 88, 93]]], ["Carboxyatractyloside blocks exchange by binding to a cationic functional domain of bovine AAC1.", [["Carboxyatractyloside", "CHEMICAL", 0, 20], ["Carboxyatractyloside", "CHEMICAL", 0, 20], ["Carboxyatractyloside", "SIMPLE_CHEMICAL", 0, 20], ["bovine", "ORGANISM", 83, 89], ["AAC1", "GENE_OR_GENE_PRODUCT", 90, 94], ["cationic functional domain", "PROTEIN", 53, 79], ["bovine AAC1", "PROTEIN", 83, 94], ["bovine", "SPECIES", 83, 89], ["Carboxyatractyloside blocks exchange", "TREATMENT", 0, 36], ["a cationic functional domain of bovine AAC1", "TREATMENT", 51, 94]]], ["Lack of ATP and mitochondrial pore leakage lead to apoptosis and necrosis, with ion pump failure, lipid peroxidation, and glutathione depletion.", [["mitochondrial pore", "ANATOMY", 16, 34], ["ATP", "CHEMICAL", 8, 11], ["necrosis", "DISEASE", 65, 73], ["glutathione", "CHEMICAL", 122, 133], ["ATP", "CHEMICAL", 8, 11], ["glutathione", "CHEMICAL", 122, 133], ["ATP", "SIMPLE_CHEMICAL", 8, 11], ["mitochondrial pore", "CELLULAR_COMPONENT", 16, 34], ["lipid", "SIMPLE_CHEMICAL", 98, 103], ["glutathione", "SIMPLE_CHEMICAL", 122, 133], ["ATP", "PROBLEM", 8, 11], ["mitochondrial pore leakage", "PROBLEM", 16, 42], ["apoptosis", "PROBLEM", 51, 60], ["necrosis", "PROBLEM", 65, 73], ["ion pump failure", "PROBLEM", 80, 96], ["lipid peroxidation", "PROBLEM", 98, 116], ["glutathione depletion", "PROBLEM", 122, 143], ["mitochondrial pore", "OBSERVATION", 16, 34], ["leakage lead", "OBSERVATION", 35, 47], ["apoptosis", "OBSERVATION_MODIFIER", 51, 60], ["necrosis", "OBSERVATION", 65, 73], ["pump failure", "OBSERVATION", 84, 96], ["lipid peroxidation", "OBSERVATION", 98, 116], ["glutathione depletion", "OBSERVATION", 122, 143]]], ["The extent of necrosis depends on dosage.", [["necrosis", "DISEASE", 14, 22], ["necrosis", "PROBLEM", 14, 22], ["extent", "OBSERVATION_MODIFIER", 4, 10], ["necrosis", "OBSERVATION", 14, 22]]], ["In lethal poisoning with hepatic failure, there is typically midzonal vacuolation and centrilobular necrosis, but it can be panlobular.Toxic fungiOther plants produce similar lesions, but the toxins have not been identified.", [["hepatic", "ANATOMY", 25, 32], ["centrilobular", "ANATOMY", 86, 99], ["lesions", "ANATOMY", 175, 182], ["poisoning", "DISEASE", 10, 19], ["hepatic failure", "DISEASE", 25, 40], ["necrosis", "DISEASE", 100, 108], ["hepatic", "ORGAN", 25, 32], ["lesions", "PATHOLOGICAL_FORMATION", 175, 182], ["hepatic failure", "PROBLEM", 25, 40], ["typically midzonal vacuolation", "PROBLEM", 51, 81], ["centrilobular necrosis", "PROBLEM", 86, 108], ["Toxic fungiOther plants", "PROBLEM", 135, 158], ["similar lesions", "PROBLEM", 167, 182], ["the toxins", "TEST", 188, 198], ["hepatic", "ANATOMY", 25, 32], ["failure", "OBSERVATION", 33, 40], ["typically", "OBSERVATION_MODIFIER", 51, 60], ["midzonal", "OBSERVATION_MODIFIER", 61, 69], ["vacuolation", "OBSERVATION_MODIFIER", 70, 81], ["centrilobular", "OBSERVATION_MODIFIER", 86, 99], ["necrosis", "OBSERVATION", 100, 108], ["similar", "OBSERVATION_MODIFIER", 167, 174], ["lesions", "OBSERVATION", 175, 182]]], ["Helichrysum blandowskianum is hepatotoxic to cattle and sheep in southern Australia and has caused sudden deaths with centrilobular necrosis.", [["centrilobular", "ANATOMY", 118, 131], ["hepatotoxic", "DISEASE", 30, 41], ["deaths", "DISEASE", 106, 112], ["necrosis", "DISEASE", 132, 140], ["Helichrysum blandowskianum", "ORGANISM", 0, 26], ["cattle", "ORGANISM", 45, 51], ["sheep", "ORGANISM", 56, 61], ["Helichrysum blandowskianum", "SPECIES", 0, 26], ["cattle", "SPECIES", 45, 51], ["sheep", "SPECIES", 56, 61], ["Helichrysum blandowskianum", "SPECIES", 0, 26], ["cattle", "SPECIES", 45, 51], ["sheep", "SPECIES", 56, 61], ["sudden deaths", "PROBLEM", 99, 112], ["centrilobular necrosis", "PROBLEM", 118, 140], ["hepatotoxic", "OBSERVATION_MODIFIER", 30, 41], ["centrilobular", "OBSERVATION_MODIFIER", 118, 131], ["necrosis", "OBSERVATION", 132, 140]]], ["The condition has been reproduced experimentally.", [["experimentally", "OBSERVATION_MODIFIER", 34, 48]]], ["High mortality with acute centrilobular liver necrosis has been reported in cattle grazing sprouting plants of Vernonia rubricaulis in Brazil.", [["liver", "ANATOMY", 40, 45], ["centrilobular liver necrosis", "DISEASE", 26, 54], ["liver", "ORGAN", 40, 45], ["Vernonia rubricaulis", "ORGANISM", 111, 131], ["cattle", "SPECIES", 76, 82], ["Vernonia rubricaulis", "SPECIES", 111, 131], ["cattle", "SPECIES", 76, 82], ["Vernonia rubricaulis", "SPECIES", 111, 131], ["High mortality", "PROBLEM", 0, 14], ["acute centrilobular liver necrosis", "PROBLEM", 20, 54], ["acute", "OBSERVATION_MODIFIER", 20, 25], ["centrilobular", "OBSERVATION_MODIFIER", 26, 39], ["liver", "ANATOMY", 40, 45], ["necrosis", "OBSERVATION", 46, 54], ["cattle", "OBSERVATION_MODIFIER", 76, 82], ["grazing", "OBSERVATION_MODIFIER", 83, 90], ["sprouting", "OBSERVATION_MODIFIER", 91, 100], ["plants", "OBSERVATION_MODIFIER", 101, 107], ["Vernonia rubricaulis", "OBSERVATION", 111, 131]]], ["Similar lesions were reproduced with 3 g/kg of sprouting plants.", [["lesions", "ANATOMY", 8, 15], ["lesions", "PATHOLOGICAL_FORMATION", 8, 15], ["Similar lesions", "PROBLEM", 0, 15], ["sprouting plants", "TREATMENT", 47, 63], ["lesions", "OBSERVATION", 8, 15]]], ["Various species of Asteraceae in South Africa, including Asaemia axillaris, Athanasia trifurcata, Lasiospermum bipinnatum, Hertia pallens, and Pteronia pallens, have been associated with field outbreaks of acute hepatotoxicity in grazing sheep or cattle.", [["hepatotoxicity", "DISEASE", 212, 226], ["Asteraceae", "ORGANISM", 19, 29], ["Asaemia axillaris", "ORGANISM", 57, 74], ["Athanasia trifurcata", "ORGANISM", 76, 96], ["Lasiospermum bipinnatum", "ORGANISM", 98, 121], ["Hertia pallens", "ORGANISM", 123, 137], ["Pteronia pallens", "ORGANISM", 143, 159], ["sheep", "ORGANISM", 238, 243], ["Asaemia axillaris", "SPECIES", 57, 74], ["Athanasia trifurcata", "SPECIES", 76, 96], ["Lasiospermum bipinnatum", "SPECIES", 98, 121], ["Hertia pallens", "SPECIES", 123, 137], ["Pteronia pallens", "SPECIES", 143, 159], ["sheep", "SPECIES", 238, 243], ["cattle", "SPECIES", 247, 253], ["Asaemia axillaris", "SPECIES", 57, 74], ["Athanasia trifurcata", "SPECIES", 76, 96], ["Lasiospermum bipinnatum", "SPECIES", 98, 121], ["Hertia pallens", "SPECIES", 123, 137], ["Pteronia pallens", "SPECIES", 143, 159], ["sheep", "SPECIES", 238, 243], ["cattle", "SPECIES", 247, 253], ["Asaemia axillaris", "PROBLEM", 57, 74], ["Athanasia trifurcata", "PROBLEM", 76, 96], ["Hertia pallens", "PROBLEM", 123, 137], ["Pteronia pallens", "PROBLEM", 143, 159], ["acute hepatotoxicity", "PROBLEM", 206, 226], ["Asteraceae", "OBSERVATION_MODIFIER", 19, 29], ["Athanasia trifurcata", "OBSERVATION", 76, 96], ["Pteronia pallens", "OBSERVATION", 143, 159], ["acute", "OBSERVATION_MODIFIER", 206, 211], ["hepatotoxicity", "OBSERVATION", 212, 226]]], ["Similar liver lesions have been reproduced experimentally.", [["liver lesions", "ANATOMY", 8, 21], ["liver lesions", "DISEASE", 8, 21], ["liver lesions", "CANCER", 8, 21], ["Similar liver lesions", "PROBLEM", 0, 21], ["liver", "ANATOMY", 8, 13], ["lesions", "OBSERVATION", 14, 21], ["experimentally", "OBSERVATION_MODIFIER", 43, 57]]], ["Experimental intoxications by all of these species have, in some animals, produced centrilobular as well as midzonal necrosis.", [["centrilobular", "ANATOMY", 83, 96], ["necrosis", "DISEASE", 117, 125], ["Experimental intoxications", "PROBLEM", 0, 26], ["midzonal necrosis", "PROBLEM", 108, 125], ["intoxications", "OBSERVATION", 13, 26], ["species", "OBSERVATION", 43, 50], ["centrilobular", "OBSERVATION_MODIFIER", 83, 96], ["midzonal", "OBSERVATION_MODIFIER", 108, 116], ["necrosis", "OBSERVATION", 117, 125]]], ["Asaemia axillaris, Athanasia trifurcata, and Lasiospermum bipinnatum are also associated with more chronic liver toxicity with photosensitivity.UlmaceaeTrema tomentosa (T. aspera), the poison peach, has caused severe losses of cattle in Australia.", [["liver", "ANATOMY", 107, 112], ["liver toxicity", "DISEASE", 107, 121], ["photosensitivity", "DISEASE", 127, 143], ["Asaemia axillaris", "ORGANISM", 0, 17], ["Athanasia trifurcata", "ORGANISM", 19, 39], ["Lasiospermum bipinnatum", "ORGANISM", 45, 68], ["liver", "ORGAN", 107, 112], ["UlmaceaeTrema tomentosa", "ORGANISM", 144, 167], ["T. aspera", "ORGANISM", 169, 178], ["cattle", "ORGANISM", 227, 233], ["Asaemia axillaris", "SPECIES", 0, 17], ["Athanasia trifurcata", "SPECIES", 19, 39], ["Lasiospermum bipinnatum", "SPECIES", 45, 68], ["UlmaceaeTrema tomentosa", "SPECIES", 144, 167], ["T. aspera", "SPECIES", 169, 178], ["cattle", "SPECIES", 227, 233], ["Asaemia axillaris", "SPECIES", 0, 17], ["Athanasia trifurcata", "SPECIES", 19, 39], ["Lasiospermum bipinnatum", "SPECIES", 45, 68], ["UlmaceaeTrema tomentosa", "SPECIES", 144, 167], ["T. aspera", "SPECIES", 169, 178], ["cattle", "SPECIES", 227, 233], ["Asaemia", "PROBLEM", 0, 7], ["Athanasia trifurcata", "PROBLEM", 19, 39], ["Lasiospermum bipinnatum", "PROBLEM", 45, 68], ["more chronic liver toxicity", "PROBLEM", 94, 121], ["photosensitivity", "PROBLEM", 127, 143], ["severe losses of cattle in Australia", "PROBLEM", 210, 246], ["Athanasia trifurcata", "OBSERVATION", 19, 39], ["associated with", "UNCERTAINTY", 78, 93], ["more", "OBSERVATION_MODIFIER", 94, 98], ["chronic", "OBSERVATION_MODIFIER", 99, 106], ["liver", "ANATOMY", 107, 112], ["toxicity", "OBSERVATION", 113, 121], ["severe", "OBSERVATION_MODIFIER", 210, 216], ["losses", "OBSERVATION_MODIFIER", 217, 223]]], ["Similar disease has been reported in goats and horses ingesting Trema micrantha in Brazil, and hepatotoxicity has been reproduced in rabbits.", [["hepatotoxicity", "DISEASE", 95, 109], ["goats", "ORGANISM", 37, 42], ["Trema micrantha", "ORGANISM", 64, 79], ["rabbits", "ORGANISM", 133, 140], ["goats", "SPECIES", 37, 42], ["rabbits", "SPECIES", 133, 140], ["goats", "SPECIES", 37, 42], ["Trema micrantha", "SPECIES", 64, 79], ["rabbits", "SPECIES", 133, 140], ["Similar disease", "PROBLEM", 0, 15], ["hepatotoxicity", "PROBLEM", 95, 109], ["disease", "OBSERVATION", 8, 15], ["hepatotoxicity", "OBSERVATION", 95, 109]]], ["The syndrome is acute, there is no photosensitization, and mildly intoxicated animals may recover completely.", [["photosensitization", "DISEASE", 35, 53], ["The syndrome", "PROBLEM", 0, 12], ["photosensitization", "PROBLEM", 35, 53], ["mildly intoxicated animals", "PROBLEM", 59, 85], ["syndrome", "OBSERVATION", 4, 12], ["acute", "OBSERVATION_MODIFIER", 16, 21], ["no", "UNCERTAINTY", 32, 34], ["photosensitization", "OBSERVATION", 35, 53], ["mildly", "OBSERVATION_MODIFIER", 59, 65], ["intoxicated", "OBSERVATION", 66, 77]]], ["The toxic principle is a glycoside, designated trematoxin.", [["trematoxin", "CHEMICAL", 47, 57], ["trematoxin", "CHEMICAL", 47, 57], ["trematoxin", "SIMPLE_CHEMICAL", 47, 57], ["a glycoside", "TREATMENT", 23, 34], ["toxic", "OBSERVATION_MODIFIER", 4, 9]]], ["The pattern of necrosis is consistently centrilobular and is identical in appearance to that of Cestrum and Xanthium poisoning.UlmaceaeThe gross and microscopic pathology of experimental poisoning by Trema, Xanthium pungens, and Cestrum parqui has been shown to be identical in all morphologic respects in the same group of sheep.MyoporaceaeHepatotoxic species of Myoporaceae so far incriminated are Myoporum deserti, M. acuminatum, M. insulare, and M. tetrandum of Australia, and M. laetum in New Zealand, southern Brazil, and Uruguay.", [["centrilobular", "ANATOMY", 40, 53], ["necrosis", "DISEASE", 15, 23], ["Xanthium", "CHEMICAL", 108, 116], ["poisoning", "DISEASE", 117, 126], ["poisoning", "DISEASE", 187, 196], ["Xanthium pungens", "ORGANISM", 207, 223], ["Cestrum parqui", "ORGANISM", 229, 243], ["sheep", "ORGANISM", 324, 329], ["Myoporaceae", "ORGANISM", 364, 375], ["Myoporum deserti", "ORGANISM", 400, 416], ["M. acuminatum", "ORGANISM", 418, 431], ["M. insulare", "ORGANISM", 433, 444], ["M. tetrandum", "ORGANISM", 450, 462], ["Australia", "ORGANISM", 466, 475], ["M. laetum", "ORGANISM", 481, 490], ["Xanthium pungens", "SPECIES", 207, 223], ["Cestrum parqui", "SPECIES", 229, 243], ["sheep", "SPECIES", 324, 329], ["Myoporum deserti", "SPECIES", 400, 416], ["M. acuminatum", "SPECIES", 418, 431], ["M. insulare", "SPECIES", 433, 444], ["M. tetrandum", "SPECIES", 450, 462], ["M. laetum", "SPECIES", 481, 490], ["Xanthium pungens", "SPECIES", 207, 223], ["Cestrum parqui", "SPECIES", 229, 243], ["sheep", "SPECIES", 324, 329], ["Myoporum deserti", "SPECIES", 400, 416], ["M. acuminatum", "SPECIES", 418, 431], ["M. insulare", "SPECIES", 433, 444], ["M. tetrandum", "SPECIES", 450, 462], ["M. laetum", "SPECIES", 481, 490], ["necrosis", "PROBLEM", 15, 23], ["centrilobular", "PROBLEM", 40, 53], ["Xanthium poisoning", "PROBLEM", 108, 126], ["experimental poisoning", "PROBLEM", 174, 196], ["Xanthium pungens", "TREATMENT", 207, 223], ["Cestrum parqui", "TREATMENT", 229, 243], ["MyoporaceaeHepatotoxic species of Myoporaceae", "PROBLEM", 330, 375], ["pattern", "OBSERVATION_MODIFIER", 4, 11], ["necrosis", "OBSERVATION", 15, 23], ["consistently", "OBSERVATION_MODIFIER", 27, 39], ["centrilobular", "OBSERVATION_MODIFIER", 40, 53], ["Xanthium poisoning", "OBSERVATION", 108, 126], ["gross", "OBSERVATION_MODIFIER", 139, 144], ["acuminatum", "OBSERVATION", 421, 431]]], ["The toxic oils are contained in the leaves and branchlets, but within the species, there is variation in the chemical characters and toxicity of the oils; not all strains of toxic species are toxic.", [["oils", "ANATOMY", 10, 14], ["leaves", "ANATOMY", 36, 42], ["branchlets", "ANATOMY", 47, 57], ["oils", "ANATOMY", 149, 153], ["toxicity", "DISEASE", 133, 141], ["leaves", "ORGANISM_SUBDIVISION", 36, 42], ["The toxic oils", "TREATMENT", 0, 14], ["variation in the chemical characters", "PROBLEM", 92, 128], ["toxicity of the oils", "PROBLEM", 133, 153], ["toxic species", "PROBLEM", 174, 187], ["toxic", "OBSERVATION_MODIFIER", 4, 9], ["oils", "OBSERVATION", 10, 14], ["leaves", "ANATOMY_MODIFIER", 36, 42], ["species", "OBSERVATION_MODIFIER", 74, 81], ["variation", "OBSERVATION_MODIFIER", 92, 101], ["chemical characters", "OBSERVATION", 109, 128], ["toxic species", "OBSERVATION", 174, 187], ["toxic", "OBSERVATION_MODIFIER", 192, 197]]], ["There is some delay between ingestion and absorption of the furanosesquiterpenoid oils, the best is available, and the liver, bile, and kidney are the preferred organs for testing.CycadalesMembers of this order have been responsible for chronic hepatotoxicity and neurotoxicity in cattle.", [["furanosesquiterpenoid oils", "ANATOMY", 60, 86], ["liver", "ANATOMY", 119, 124], ["bile", "ANATOMY", 126, 130], ["kidney", "ANATOMY", 136, 142], ["organs", "ANATOMY", 161, 167], ["hepatotoxicity", "DISEASE", 245, 259], ["neurotoxicity", "DISEASE", 264, 277], ["furanosesquiterpenoid", "CHEMICAL", 60, 81], ["furanosesquiterpenoid oils", "SIMPLE_CHEMICAL", 60, 86], ["liver", "ORGAN", 119, 124], ["bile", "MULTI-TISSUE_STRUCTURE", 126, 130], ["kidney", "ORGAN", 136, 142], ["organs", "ORGAN", 161, 167], ["cattle", "ORGANISM", 281, 287], ["cattle", "SPECIES", 281, 287], ["cattle", "SPECIES", 281, 287], ["some delay between ingestion", "PROBLEM", 9, 37], ["the furanosesquiterpenoid oils", "TREATMENT", 56, 86], ["testing", "TEST", 172, 179], ["CycadalesMembers", "TREATMENT", 180, 196], ["chronic hepatotoxicity", "PROBLEM", 237, 259], ["neurotoxicity", "PROBLEM", 264, 277], ["some", "OBSERVATION_MODIFIER", 9, 13], ["delay", "OBSERVATION_MODIFIER", 14, 19], ["liver", "ANATOMY", 119, 124], ["bile", "ANATOMY", 126, 130], ["kidney", "ANATOMY", 136, 142], ["responsible for", "UNCERTAINTY", 221, 236], ["chronic", "OBSERVATION_MODIFIER", 237, 244], ["hepatotoxicity", "OBSERVATION", 245, 259]]], ["Acute hepatotoxicity has been reported in cattle and sheep that have eaten the seeds or young leaves of species of Cycas or Zamiaceae.", [["seeds", "ANATOMY", 79, 84], ["hepatotoxicity", "DISEASE", 6, 20], ["cattle", "ORGANISM", 42, 48], ["sheep", "ORGANISM", 53, 58], ["Zamiaceae", "GENE_OR_GENE_PRODUCT", 124, 133], ["cattle", "SPECIES", 42, 48], ["sheep", "SPECIES", 53, 58], ["cattle", "SPECIES", 42, 48], ["sheep", "SPECIES", 53, 58], ["Acute hepatotoxicity", "PROBLEM", 0, 20], ["Zamiaceae", "TREATMENT", 124, 133], ["hepatotoxicity", "OBSERVATION", 6, 20]]], ["Dogs are intoxicated by eating the seeds of Cycas spp. usually raised as ornamental plants in warmer climates.", [["Dogs", "ORGANISM", 0, 4], ["Cycas spp", "ORGANISM", 44, 53], ["Cycas spp", "PROBLEM", 44, 53], ["ornamental plants", "OBSERVATION", 73, 90]]], ["The toxin responsible is methylazoxymethanol, which is the aglycone of various nontoxic glycosides, including cycasin and macrozamin, in these plants.", [["methylazoxymethanol", "CHEMICAL", 25, 44], ["cycasin", "CHEMICAL", 110, 117], ["macrozamin", "CHEMICAL", 122, 132], ["methylazoxymethanol", "CHEMICAL", 25, 44], ["cycasin", "CHEMICAL", 110, 117], ["macrozamin", "CHEMICAL", 122, 132], ["methylazoxymethanol", "SIMPLE_CHEMICAL", 25, 44], ["aglycone", "SIMPLE_CHEMICAL", 59, 67], ["nontoxic glycosides", "SIMPLE_CHEMICAL", 79, 98], ["cycasin", "SIMPLE_CHEMICAL", 110, 117], ["macrozamin", "SIMPLE_CHEMICAL", 122, 132], ["methylazoxymethanol", "TREATMENT", 25, 44], ["various nontoxic glycosides", "TREATMENT", 71, 98], ["cycasin", "TREATMENT", 110, 117], ["macrozamin", "TREATMENT", 122, 132]]], ["The toxin is split from the glycoside by bacterial metabolism in the gut, and its hepatotoxicity is the result of further metabolism by hepatic CYPs; the pattern of necrosis is thus centrilobular (see Fig. 2-94) .", [["gut", "ANATOMY", 69, 72], ["hepatic", "ANATOMY", 136, 143], ["centrilobular", "ANATOMY", 182, 195], ["hepatotoxicity", "DISEASE", 82, 96], ["necrosis", "DISEASE", 165, 173], ["gut", "ORGANISM_SUBDIVISION", 69, 72], ["hepatic CYPs", "PROTEIN", 136, 148], ["The toxin", "PROBLEM", 0, 9], ["bacterial metabolism in the gut", "PROBLEM", 41, 72], ["its hepatotoxicity", "PROBLEM", 78, 96], ["further metabolism by hepatic CYPs", "PROBLEM", 114, 148], ["necrosis", "PROBLEM", 165, 173], ["bacterial metabolism", "OBSERVATION", 41, 61], ["gut", "ANATOMY", 69, 72], ["hepatotoxicity", "OBSERVATION", 82, 96], ["hepatic", "ANATOMY", 136, 143], ["CYPs", "OBSERVATION", 144, 148], ["necrosis", "OBSERVATION", 165, 173], ["centrilobular", "OBSERVATION_MODIFIER", 182, 195]]], ["The metabolites of the aglycone are apparently potent alkylating agents, and the chronic liver lesions reflect this; there is megalocytosis (which is not as persistent as that of pyrrolizidine alkaloid poisoning), nuclear hyperchromasia, cholestasis, fatty change, and various degrees of diffuse fibrosis.", [["liver lesions", "ANATOMY", 89, 102], ["nuclear", "ANATOMY", 214, 221], ["aglycone", "CHEMICAL", 23, 31], ["alkylating agents", "CHEMICAL", 54, 71], ["chronic liver lesions", "DISEASE", 81, 102], ["megalocytosis", "DISEASE", 126, 139], ["pyrrolizidine alkaloid", "CHEMICAL", 179, 201], ["poisoning", "DISEASE", 202, 211], ["hyperchromasia", "DISEASE", 222, 236], ["cholestasis", "DISEASE", 238, 249], ["fatty change", "DISEASE", 251, 263], ["fibrosis", "DISEASE", 296, 304], ["pyrrolizidine alkaloid", "CHEMICAL", 179, 201], ["aglycone", "SIMPLE_CHEMICAL", 23, 31], ["liver lesions", "PATHOLOGICAL_FORMATION", 89, 102], ["pyrrolizidine alkaloid", "SIMPLE_CHEMICAL", 179, 201], ["nuclear", "CELLULAR_COMPONENT", 214, 221], ["the aglycone", "TREATMENT", 19, 31], ["potent alkylating agents", "TREATMENT", 47, 71], ["the chronic liver lesions", "PROBLEM", 77, 102], ["megalocytosis", "PROBLEM", 126, 139], ["pyrrolizidine alkaloid poisoning", "PROBLEM", 179, 211], ["nuclear hyperchromasia", "PROBLEM", 214, 236], ["cholestasis", "PROBLEM", 238, 249], ["fatty change", "PROBLEM", 251, 263], ["diffuse fibrosis", "PROBLEM", 288, 304], ["potent", "OBSERVATION_MODIFIER", 47, 53], ["alkylating agents", "OBSERVATION", 54, 71], ["chronic", "OBSERVATION_MODIFIER", 81, 88], ["liver", "ANATOMY", 89, 94], ["lesions", "OBSERVATION", 95, 102], ["megalocytosis", "OBSERVATION", 126, 139], ["hyperchromasia", "OBSERVATION", 222, 236], ["cholestasis", "OBSERVATION", 238, 249], ["fatty change", "OBSERVATION", 251, 263], ["various degrees", "OBSERVATION_MODIFIER", 269, 284], ["diffuse", "OBSERVATION_MODIFIER", 288, 295], ["fibrosis", "OBSERVATION", 296, 304]]], ["There is fairly consistent acute renal tubular injury.", [["renal tubular", "ANATOMY", 33, 46], ["renal tubular injury", "DISEASE", 33, 53], ["renal tubular", "MULTI-TISSUE_STRUCTURE", 33, 46], ["acute renal tubular injury", "PROBLEM", 27, 53], ["fairly consistent", "UNCERTAINTY", 9, 26], ["acute", "OBSERVATION_MODIFIER", 27, 32], ["renal", "ANATOMY", 33, 38], ["tubular", "ANATOMY_MODIFIER", 39, 46], ["injury", "OBSERVATION", 47, 53]]], ["Chronic exposure leads to cancer development in the liver, kidney, and intestinal tract of laboratory rodents.CycadalesCycads also produce a neurotoxic amino acid, \u03b2-Nmethylamino-L-alanine (BMAA).", [["cancer", "ANATOMY", 26, 32], ["liver", "ANATOMY", 52, 57], ["kidney", "ANATOMY", 59, 65], ["intestinal tract", "ANATOMY", 71, 87], ["cancer", "DISEASE", 26, 32], ["neurotoxic", "DISEASE", 141, 151], ["amino acid", "CHEMICAL", 152, 162], ["\u03b2-Nmethylamino-L-alanine", "CHEMICAL", 164, 188], ["BMAA", "CHEMICAL", 190, 194], ["amino acid", "CHEMICAL", 152, 162], ["\u03b2-Nmethylamino-L-alanine", "CHEMICAL", 164, 188], ["BMAA", "CHEMICAL", 190, 194], ["cancer", "CANCER", 26, 32], ["liver", "ORGAN", 52, 57], ["kidney", "ORGAN", 59, 65], ["intestinal tract", "ORGANISM_SUBDIVISION", 71, 87], ["amino acid", "AMINO_ACID", 152, 162], ["\u03b2-Nmethylamino-L-alanine", "SIMPLE_CHEMICAL", 164, 188], ["BMAA", "SIMPLE_CHEMICAL", 190, 194], ["Chronic exposure leads", "PROBLEM", 0, 22], ["cancer development in the liver", "PROBLEM", 26, 57], ["a neurotoxic amino acid", "TEST", 139, 162], ["\u03b2-Nmethylamino", "TREATMENT", 164, 178], ["L-alanine (BMAA", "TREATMENT", 179, 194], ["cancer", "OBSERVATION", 26, 32], ["liver", "ANATOMY", 52, 57], ["kidney", "ANATOMY", 59, 65], ["intestinal tract", "ANATOMY", 71, 87]]], ["BMAA is excitotoxic, activating neurotransmission mediated by glutamate receptors, which in excess can lead to cytotoxic influx of calcium ions.", [["BMAA", "CHEMICAL", 0, 4], ["glutamate", "CHEMICAL", 62, 71], ["calcium", "CHEMICAL", 131, 138], ["BMAA", "CHEMICAL", 0, 4], ["glutamate", "CHEMICAL", 62, 71], ["calcium", "CHEMICAL", 131, 138], ["BMAA", "SIMPLE_CHEMICAL", 0, 4], ["glutamate receptors", "GENE_OR_GENE_PRODUCT", 62, 81], ["calcium ions", "SIMPLE_CHEMICAL", 131, 143], ["glutamate receptors", "PROTEIN", 62, 81], ["excitotoxic", "PROBLEM", 8, 19], ["glutamate receptors", "TREATMENT", 62, 81], ["cytotoxic influx of calcium ions", "PROBLEM", 111, 143], ["excitotoxic", "OBSERVATION_MODIFIER", 8, 19]]], ["Chronic cycad poisoning of cattle causes a chronic nervous disorder characterized by a progressive proprioceptive deficit.", [["nervous", "ANATOMY", 51, 58], ["poisoning", "DISEASE", 14, 23], ["chronic nervous disorder", "DISEASE", 43, 67], ["proprioceptive deficit", "DISEASE", 99, 121], ["cattle", "ORGANISM", 27, 33], ["nervous", "ANATOMICAL_SYSTEM", 51, 58], ["cattle", "SPECIES", 27, 33], ["cattle", "SPECIES", 27, 33], ["Chronic cycad poisoning", "PROBLEM", 0, 23], ["a chronic nervous disorder", "PROBLEM", 41, 67], ["a progressive proprioceptive deficit", "PROBLEM", 85, 121], ["chronic", "OBSERVATION_MODIFIER", 43, 50], ["nervous disorder", "OBSERVATION", 51, 67], ["progressive", "OBSERVATION_MODIFIER", 87, 98], ["proprioceptive deficit", "OBSERVATION", 99, 121]]], ["This is the result of axonopathy in upper spinocerebellar and lower corticospinal tracts.", [["upper spinocerebellar", "ANATOMY", 36, 57], ["lower corticospinal tracts", "ANATOMY", 62, 88], ["axonopathy", "DISEASE", 22, 32], ["upper spinocerebellar", "CANCER", 36, 57], ["lower corticospinal", "ORGANISM_SUBDIVISION", 62, 81], ["tracts", "PATHOLOGICAL_FORMATION", 82, 88], ["axonopathy in upper spinocerebellar and lower corticospinal tracts", "PROBLEM", 22, 88], ["axonopathy", "OBSERVATION", 22, 32], ["upper", "ANATOMY_MODIFIER", 36, 41], ["spinocerebellar", "ANATOMY", 42, 57], ["lower", "ANATOMY_MODIFIER", 62, 67], ["corticospinal tracts", "ANATOMY", 68, 88]]], ["The axonopathy, morphologically subtle at first, may eventually progress to frank Wallerian degeneration.SolanaceaeToxic species of the genus Cestrum (jessamine) include Cestrum diurnum, a cause of enzootic calcinosis in cattle attributed to active vitamin D analogs; the other known toxic species all produce similar hepatic disease.", [["Wallerian", "ANATOMY", 82, 91], ["hepatic", "ANATOMY", 318, 325], ["axonopathy", "DISEASE", 4, 14], ["Wallerian degeneration", "DISEASE", 82, 104], ["jessamine", "CHEMICAL", 151, 160], ["Cestrum diurnum", "DISEASE", 170, 185], ["calcinosis", "DISEASE", 207, 217], ["vitamin D", "CHEMICAL", 249, 258], ["hepatic disease", "DISEASE", 318, 333], ["vitamin D", "CHEMICAL", 249, 258], ["Cestrum", "GENE_OR_GENE_PRODUCT", 142, 149], ["jessamine", "SIMPLE_CHEMICAL", 151, 160], ["Cestrum diurnum", "ORGANISM", 170, 185], ["vitamin D analogs", "SIMPLE_CHEMICAL", 249, 266], ["hepatic", "ORGAN", 318, 325], ["Cestrum diurnum", "SPECIES", 170, 185], ["cattle", "SPECIES", 221, 227], ["Cestrum diurnum", "SPECIES", 170, 185], ["cattle", "SPECIES", 221, 227], ["The axonopathy", "PROBLEM", 0, 14], ["frank Wallerian degeneration", "PROBLEM", 76, 104], ["SolanaceaeToxic species", "TREATMENT", 105, 128], ["the genus Cestrum (jessamine)", "TREATMENT", 132, 161], ["Cestrum diurnum", "TREATMENT", 170, 185], ["enzootic calcinosis", "PROBLEM", 198, 217], ["active vitamin D analogs", "TREATMENT", 242, 266], ["the other known toxic species", "PROBLEM", 268, 297], ["similar hepatic disease", "PROBLEM", 310, 333], ["axonopathy", "OBSERVATION", 4, 14], ["morphologically", "OBSERVATION_MODIFIER", 16, 31], ["subtle", "OBSERVATION_MODIFIER", 32, 38], ["frank", "OBSERVATION_MODIFIER", 76, 81], ["Wallerian degeneration", "OBSERVATION", 82, 104], ["genus Cestrum", "OBSERVATION", 136, 149], ["enzootic", "OBSERVATION_MODIFIER", 198, 206], ["calcinosis", "OBSERVATION", 207, 217], ["toxic species", "OBSERVATION", 284, 297], ["hepatic", "ANATOMY", 318, 325], ["disease", "OBSERVATION", 326, 333]]], ["Speciation within the genus is uncertain, partly because of hybridization; however, the species named as hepatotoxic are C. parqui, C. laevigatum, and C. aurantiacum.SolanaceaeCestrum spp. cause acute hepatotoxicity in the field in South America, southern and central Africa, and Australia.", [["hepatotoxic", "DISEASE", 105, 116], ["SolanaceaeCestrum", "CHEMICAL", 166, 183], ["hepatotoxicity", "DISEASE", 201, 215], ["C. parqui", "ORGANISM", 121, 130], ["C. laevigatum", "ORGANISM", 132, 145], ["C. aurantiacum", "ORGANISM", 151, 165], ["SolanaceaeCestrum spp.", "ORGANISM", 166, 188], ["C. parqui", "SPECIES", 121, 130], ["C. laevigatum", "SPECIES", 132, 145], ["C. aurantiacum", "SPECIES", 151, 165], ["SolanaceaeCestrum spp.", "SPECIES", 166, 188], ["C. parqui", "SPECIES", 121, 130], ["C. laevigatum", "SPECIES", 132, 145], ["C. aurantiacum", "SPECIES", 151, 165], ["SolanaceaeCestrum spp.", "SPECIES", 166, 188], ["hybridization", "PROBLEM", 60, 73], ["the species", "PROBLEM", 84, 95], ["hepatotoxic", "PROBLEM", 105, 116], ["SolanaceaeCestrum spp.", "TREATMENT", 166, 188], ["acute hepatotoxicity", "PROBLEM", 195, 215], ["central Africa", "PROBLEM", 260, 274], ["acute", "OBSERVATION_MODIFIER", 195, 200], ["hepatotoxicity", "OBSERVATION", 201, 215], ["central Africa", "OBSERVATION", 260, 274]]], ["Cattle are more frequently poisoned than other species, but sheep and goats are susceptible, and fowl may be if they eat the fruit.", [["fruit", "ANATOMY", 125, 130], ["Cattle", "ORGANISM", 0, 6], ["sheep", "ORGANISM", 60, 65], ["goats", "ORGANISM", 70, 75], ["Cattle", "SPECIES", 0, 6], ["sheep", "SPECIES", 60, 65], ["goats", "SPECIES", 70, 75], ["Cattle", "SPECIES", 0, 6], ["sheep", "SPECIES", 60, 65], ["goats", "SPECIES", 70, 75], ["fowl", "SPECIES", 97, 101], ["more frequently", "OBSERVATION_MODIFIER", 11, 26]]], ["The young leaves and unripened berries are the most toxic parts of the plant.", [["leaves", "ANATOMY", 10, 16], ["berries", "ANATOMY", 31, 38], ["berries", "ORGANISM_SUBDIVISION", 31, 38], ["most toxic", "OBSERVATION_MODIFIER", 47, 57]]], ["In acute hepatoxicity, there is marked centrilobular and midzonal coagulative necrosis and hemorrhage.", [["centrilobular", "ANATOMY", 39, 52], ["hepatoxicity", "DISEASE", 9, 21], ["necrosis", "DISEASE", 78, 86], ["hemorrhage", "DISEASE", 91, 101], ["acute hepatoxicity", "PROBLEM", 3, 21], ["marked centrilobular and midzonal coagulative necrosis", "PROBLEM", 32, 86], ["hemorrhage", "PROBLEM", 91, 101], ["acute", "OBSERVATION_MODIFIER", 3, 8], ["hepatoxicity", "OBSERVATION", 9, 21], ["marked", "OBSERVATION_MODIFIER", 32, 38], ["centrilobular", "OBSERVATION_MODIFIER", 39, 52], ["midzonal", "OBSERVATION_MODIFIER", 57, 65], ["coagulative", "OBSERVATION_MODIFIER", 66, 77], ["necrosis", "OBSERVATION", 78, 86], ["hemorrhage", "OBSERVATION", 91, 101]]], ["There are no records of chronic liver disease caused by this plant, and photosensitization is rarely seen.", [["liver", "ANATOMY", 32, 37], ["liver disease", "DISEASE", 32, 45], ["photosensitization", "DISEASE", 72, 90], ["liver", "ORGAN", 32, 37], ["chronic liver disease", "PROBLEM", 24, 45], ["photosensitization", "TREATMENT", 72, 90], ["no records of", "UNCERTAINTY", 10, 23], ["chronic", "OBSERVATION_MODIFIER", 24, 31], ["liver", "ANATOMY", 32, 37], ["disease", "OBSERVATION", 38, 45]]], ["The toxin is water soluble and has been identified as an atractyloside.Compositae/AsteraceaeXanthium pungens (Noogoora burr) in Australia and Xanthium strumarium (rough cocklebur) in the United States, as well as X. cavanillesii, (the cocklebur) in Brazil and South Africa, have been reported to be hepatotoxic while in the seedling stage because the toxins are concentrated in the cotyledons.", [["cotyledons", "ANATOMY", 382, 392], ["atractyloside", "CHEMICAL", 57, 70], ["hepatotoxic", "DISEASE", 299, 310], ["atractyloside", "CHEMICAL", 57, 70], ["toxin", "SIMPLE_CHEMICAL", 4, 9], ["atractyloside", "SIMPLE_CHEMICAL", 57, 70], ["Compositae", "ORGANISM", 71, 81], ["AsteraceaeXanthium pungens", "ORGANISM", 82, 108], ["Noogoora burr", "ORGANISM", 110, 123], ["Australia", "ORGANISM", 128, 137], ["Xanthium strumarium", "ORGANISM", 142, 161], ["X. cavanillesii", "ORGANISM", 213, 228], ["cotyledons", "ORGAN", 382, 392], ["AsteraceaeXanthium pungens", "SPECIES", 82, 108], ["Xanthium strumarium", "SPECIES", 142, 161], ["X. cavanillesii", "SPECIES", 213, 228], ["AsteraceaeXanthium pungens", "SPECIES", 82, 108], ["Xanthium strumarium", "SPECIES", 142, 161], ["X. cavanillesii", "SPECIES", 213, 228], ["The toxin", "TREATMENT", 0, 9], ["water soluble", "TREATMENT", 13, 26], ["an atractyloside", "TREATMENT", 54, 70], ["Compositae/AsteraceaeXanthium pungens (Noogoora burr", "TREATMENT", 71, 123], ["Xanthium strumarium", "TREATMENT", 142, 161], ["hepatotoxic", "PROBLEM", 299, 310], ["the toxins", "PROBLEM", 347, 357], ["water soluble", "OBSERVATION_MODIFIER", 13, 26], ["Xanthium strumarium", "ANATOMY", 142, 161], ["hepatotoxic", "OBSERVATION", 299, 310], ["concentrated", "OBSERVATION", 362, 374], ["cotyledons", "ANATOMY", 382, 392]]], ["The burrs are also toxic, and although usually too coarse to be grazed, they can be consumed if ground into feeds.", [["toxic", "OBSERVATION_MODIFIER", 19, 24]]], ["Cattle, swine, and sheep are susceptible, and toxicosis typically occurs following a period of feed scarcity, after tralia, the insect species is Lophyrotoma interrupta (Pergidae) or L. zonalis (Pergidae); in Denmark the insect is Arge pullata (Argidae), and in South America a third species, Perreyia flavipes (Pergidae), is incriminated.", [["toxicosis", "DISEASE", 46, 55], ["swine", "ORGANISM", 8, 13], ["sheep", "ORGANISM", 19, 24], ["Lophyrotoma interrupta", "ORGANISM", 146, 168], ["Pergidae)", "ORGANISM", 170, 179], ["L. zonalis", "ORGANISM", 183, 193], ["Arge pullata", "ORGANISM", 231, 243], ["Argidae", "ORGANISM", 245, 252], ["Perreyia flavipes", "ORGANISM", 293, 310], ["Cattle", "SPECIES", 0, 6], ["swine", "SPECIES", 8, 13], ["sheep", "SPECIES", 19, 24], ["Lophyrotoma interrupta", "SPECIES", 146, 168], ["L. zonalis", "SPECIES", 183, 193], ["Arge pullata", "SPECIES", 231, 243], ["Perreyia flavipes", "SPECIES", 293, 310], ["swine", "SPECIES", 8, 13], ["sheep", "SPECIES", 19, 24], ["Lophyrotoma interrupta", "SPECIES", 146, 168], ["L. zonalis", "SPECIES", 183, 193], ["Arge pullata", "SPECIES", 231, 243], ["Perreyia flavipes", "SPECIES", 293, 310], ["toxicosis", "PROBLEM", 46, 55], ["the insect species", "PROBLEM", 124, 142]]], ["In parts of northeastern Australia, the larvae are parasitic on the leaves of the tree Eucalyptus melanophloia, and heavy infestations may occur.", [["leaves", "ANATOMY", 68, 74], ["heavy infestations", "DISEASE", 116, 134], ["leaves", "ORGANISM_SUBDIVISION", 68, 74], ["Eucalyptus melanophloia", "SPECIES", 87, 110], ["parasitic", "PROBLEM", 51, 60], ["heavy infestations", "PROBLEM", 116, 134], ["northeastern", "ANATOMY_MODIFIER", 12, 24], ["Australia", "OBSERVATION", 25, 34], ["parasitic", "OBSERVATION", 51, 60], ["tree", "ANATOMY_MODIFIER", 82, 86], ["Eucalyptus melanophloia", "OBSERVATION", 87, 110], ["heavy", "OBSERVATION_MODIFIER", 116, 121], ["infestations", "OBSERVATION", 122, 134]]], ["L. zonalis has been introduced to Florida to control the spread of Melaleuca quinquenervi.", [["L. zonalis", "ORGANISM", 0, 10], ["Melaleuca quinquenervi", "ORGANISM", 67, 89], ["L. zonalis", "SPECIES", 0, 10], ["Melaleuca quinquenervi", "SPECIES", 67, 89], ["L. zonalis", "SPECIES", 0, 10], ["Melaleuca quinquenervi", "SPECIES", 67, 89], ["Melaleuca quinquenervi", "OBSERVATION", 67, 89]]], ["In Denmark, sawfly larvae feed on birch trees.", [["birch trees", "MULTI-TISSUE_STRUCTURE", 34, 45]]], ["There is a short clinical course following ingestion, and often, affected cattle are found dead.", [["cattle", "ORGANISM", 74, 80], ["cattle", "SPECIES", 74, 80], ["cattle", "SPECIES", 74, 80], ["dead", "PROBLEM", 91, 95], ["short", "OBSERVATION_MODIFIER", 11, 16]]], ["Animals that survive typically develop icterus and secondary photosensitization.", [["icterus", "DISEASE", 39, 46], ["photosensitization", "DISEASE", 61, 79], ["Animals", "ORGANISM", 0, 7], ["icterus", "PROBLEM", 39, 46], ["secondary photosensitization", "PROBLEM", 51, 79], ["icterus", "OBSERVATION", 39, 46], ["secondary photosensitization", "OBSERVATION", 51, 79]]], ["At postmortem examination, ascites, petechiae, and ecchymoses are evident.", [["ascites", "ANATOMY", 27, 34], ["petechiae", "ANATOMY", 36, 45], ["ecchymoses", "ANATOMY", 51, 61], ["ascites", "DISEASE", 27, 34], ["petechiae", "DISEASE", 36, 45], ["ecchymoses", "DISEASE", 51, 61], ["petechiae", "PATHOLOGICAL_FORMATION", 36, 45], ["postmortem examination", "TEST", 3, 25], ["ascites", "PROBLEM", 27, 34], ["petechiae", "PROBLEM", 36, 45], ["ecchymoses", "PROBLEM", 51, 61], ["ascites", "OBSERVATION", 27, 34], ["petechiae", "OBSERVATION", 36, 45], ["ecchymoses", "OBSERVATION", 51, 61]]], ["The liver is enlarged with an accentuated lobular pattern.", [["liver", "ANATOMY", 4, 9], ["lobular", "ANATOMY", 42, 49], ["liver", "ORGAN", 4, 9], ["lobular", "CANCER", 42, 49], ["an accentuated lobular pattern", "PROBLEM", 27, 57], ["liver", "ANATOMY", 4, 9], ["enlarged", "OBSERVATION", 13, 21], ["accentuated", "OBSERVATION_MODIFIER", 30, 41], ["lobular pattern", "OBSERVATION", 42, 57]]], ["Mural edema of the gallbladder may be apparent.", [["Mural edema", "ANATOMY", 0, 11], ["gallbladder", "ANATOMY", 19, 30], ["edema", "DISEASE", 6, 11], ["Mural edema", "PATHOLOGICAL_FORMATION", 0, 11], ["gallbladder", "ORGAN", 19, 30], ["Mural edema of the gallbladder", "PROBLEM", 0, 30], ["edema", "OBSERVATION", 6, 11], ["gallbladder", "ANATOMY", 19, 30], ["may be apparent", "UNCERTAINTY", 31, 46]]], ["Sawfly larvae can be found in the rumen and, on occasion, through to the abomasum.", [["rumen", "ANATOMY", 34, 39], ["abomasum", "ANATOMY", 73, 81], ["rumen", "ORGANISM_SUBDIVISION", 34, 39], ["abomasum", "ORGAN", 73, 81], ["Sawfly larvae", "PROBLEM", 0, 13], ["rumen", "OBSERVATION_MODIFIER", 34, 39], ["abomasum", "ANATOMY", 73, 81]]], ["Histologically, there is centrilobular to massive acute hepatic necrosis.", [["centrilobular", "ANATOMY", 25, 38], ["hepatic", "ANATOMY", 56, 63], ["acute hepatic necrosis", "DISEASE", 50, 72], ["hepatic", "ORGAN", 56, 63], ["centrilobular to massive acute hepatic necrosis", "PROBLEM", 25, 72], ["centrilobular", "OBSERVATION_MODIFIER", 25, 38], ["massive", "OBSERVATION_MODIFIER", 42, 49], ["acute", "OBSERVATION_MODIFIER", 50, 55], ["hepatic", "ANATOMY", 56, 63], ["necrosis", "OBSERVATION", 64, 72]]], ["Outbreaks tend to be seasonal, related to the life cycle of the insects.", [["Outbreaks", "PROBLEM", 0, 9]]], ["The toxic principle is believed to be D-amino acid-containing peptides.", [["D-amino acid-", "CHEMICAL", 38, 51], ["D-amino acid-", "CHEMICAL", 38, 51], ["D-amino acid-", "SIMPLE_CHEMICAL", 38, 51], ["D-amino acid-containing peptides", "PROBLEM", 38, 70], ["toxic", "OBSERVATION_MODIFIER", 4, 9], ["believed to be", "UNCERTAINTY", 23, 37]]], ["The major toxin is an octapeptide, lophyrotomin, present in the in the larvae of Australian and Danish sawflies.", [["lophyrotomin", "CHEMICAL", 35, 47], ["lophyrotomin", "GENE_OR_GENE_PRODUCT", 35, 47], ["an octapeptide", "TREATMENT", 19, 33], ["lophyrotomin", "TREATMENT", 35, 47]]], ["There is a different toxin in the South American sawflies, identified as the heptadecapeptide pergidin.Halogenated hydrocarbonsVarious halogenated hydrocarbons, such as carbon tetrachloride (used historically as a fasciolicide), bromobenzene, hexachloroethane, tetrachloroethylene, and chloroform, are activated by cytochromes P450 to hepatotoxic or nephrotoxic metabolites.", [["pergidin", "CHEMICAL", 94, 102], ["Halogenated hydrocarbons", "CHEMICAL", 103, 127], ["halogenated hydrocarbons", "CHEMICAL", 135, 159], ["carbon tetrachloride", "CHEMICAL", 169, 189], ["fasciolicide", "CHEMICAL", 214, 226], ["bromobenzene", "CHEMICAL", 229, 241], ["hexachloroethane", "CHEMICAL", 243, 259], ["tetrachloroethylene", "CHEMICAL", 261, 280], ["chloroform", "CHEMICAL", 286, 296], ["hepatotoxic", "DISEASE", 335, 346], ["nephrotoxic", "DISEASE", 350, 361], ["pergidin", "CHEMICAL", 94, 102], ["Halogenated hydrocarbons", "CHEMICAL", 103, 127], ["halogenated hydrocarbons", "CHEMICAL", 135, 159], ["carbon tetrachloride", "CHEMICAL", 169, 189], ["fasciolicide", "CHEMICAL", 214, 226], ["bromobenzene", "CHEMICAL", 229, 241], ["hexachloroethane", "CHEMICAL", 243, 259], ["tetrachloroethylene", "CHEMICAL", 261, 280], ["chloroform", "CHEMICAL", 286, 296], ["heptadecapeptide pergidin", "SIMPLE_CHEMICAL", 77, 102], ["halogenated hydrocarbons", "SIMPLE_CHEMICAL", 135, 159], ["carbon tetrachloride", "SIMPLE_CHEMICAL", 169, 189], ["fasciolicide", "SIMPLE_CHEMICAL", 214, 226], ["bromobenzene", "SIMPLE_CHEMICAL", 229, 241], ["hexachloroethane", "SIMPLE_CHEMICAL", 243, 259], ["tetrachloroethylene", "SIMPLE_CHEMICAL", 261, 280], ["chloroform", "SIMPLE_CHEMICAL", 286, 296], ["cytochromes P450", "GENE_OR_GENE_PRODUCT", 315, 331], ["heptadecapeptide pergidin", "PROTEIN", 77, 102], ["cytochromes P450", "PROTEIN", 315, 331], ["a different toxin", "PROBLEM", 9, 26], ["the heptadecapeptide pergidin", "TREATMENT", 73, 102], ["Halogenated hydrocarbons", "PROBLEM", 103, 127], ["Various halogenated hydrocarbons", "TREATMENT", 127, 159], ["carbon tetrachloride", "TREATMENT", 169, 189], ["a fasciolicide)", "TREATMENT", 212, 227], ["bromobenzene", "TREATMENT", 229, 241], ["hexachloroethane", "TREATMENT", 243, 259], ["tetrachloroethylene", "TREATMENT", 261, 280], ["chloroform", "TREATMENT", 286, 296], ["nephrotoxic metabolites", "TREATMENT", 350, 373], ["different", "OBSERVATION_MODIFIER", 11, 20], ["hydrocarbons", "OBSERVATION", 115, 127], ["halogenated hydrocarbons", "OBSERVATION", 135, 159]]], ["They have similar hepatotoxic properties, but these agents are little used now, so few animals encounter them in toxic doses.", [["hepatotoxic", "DISEASE", 18, 29], ["animals", "ORGANISM", 87, 94], ["these agents", "TREATMENT", 46, 58], ["hepatotoxic properties", "OBSERVATION", 18, 40]]], ["However, some of these chemicals have been used experimentally to investigate the mechanisms of hepatotoxicity, so they warrant brief consideration here.", [["hepatotoxicity", "DISEASE", 96, 110], ["hepatotoxicity", "PROBLEM", 96, 110], ["hepatotoxicity", "OBSERVATION", 96, 110]]], ["Carbon tetrachloride is metabolized to trihalomethane, a necrogenic free-radical metabolite, and reactive oxygen radicals are concurrently generated.", [["Carbon tetrachloride", "CHEMICAL", 0, 20], ["trihalomethane", "CHEMICAL", 39, 53], ["oxygen", "CHEMICAL", 106, 112], ["Carbon tetrachloride", "CHEMICAL", 0, 20], ["trihalomethane", "CHEMICAL", 39, 53], ["oxygen", "CHEMICAL", 106, 112], ["Carbon tetrachloride", "SIMPLE_CHEMICAL", 0, 20], ["trihalomethane", "SIMPLE_CHEMICAL", 39, 53], ["free-radical", "SIMPLE_CHEMICAL", 68, 80], ["reactive oxygen radicals", "SIMPLE_CHEMICAL", 97, 121], ["Carbon tetrachloride", "TREATMENT", 0, 20], ["trihalomethane", "TREATMENT", 39, 53], ["reactive oxygen radicals", "PROBLEM", 97, 121], ["radical metabolite", "OBSERVATION", 73, 91], ["reactive", "OBSERVATION_MODIFIER", 97, 105], ["oxygen radicals", "OBSERVATION", 106, 121]]], ["Centrilobular hepatic necrosis with midzonal hydropic change caused by membrane peroxidation occurs within 30 hours of experimental exposures, but lethal toxicity occurs later, when steatosis and the early stages of tissue repair responses are manifest.PhosphorusWhite phosphorus has historically been used for vermin control, and has been implicated in the accidental exposure and deaths of wild waterfowl.", [["hepatic", "ANATOMY", 14, 21], ["membrane", "ANATOMY", 71, 79], ["tissue", "ANATOMY", 216, 222], ["Centrilobular hepatic necrosis", "DISEASE", 0, 30], ["toxicity", "DISEASE", 154, 162], ["steatosis", "DISEASE", 182, 191], ["PhosphorusWhite phosphorus", "CHEMICAL", 253, 279], ["deaths", "DISEASE", 382, 388], ["phosphorus", "CHEMICAL", 269, 279], ["membrane", "CELLULAR_COMPONENT", 71, 79], ["tissue", "TISSUE", 216, 222], ["PhosphorusWhite phosphorus", "SIMPLE_CHEMICAL", 253, 279], ["Centrilobular hepatic necrosis", "PROBLEM", 0, 30], ["midzonal hydropic change", "PROBLEM", 36, 60], ["membrane peroxidation", "PROBLEM", 71, 92], ["experimental exposures", "PROBLEM", 119, 141], ["lethal toxicity", "PROBLEM", 147, 162], ["steatosis", "PROBLEM", 182, 191], ["tissue repair", "TREATMENT", 216, 229], ["PhosphorusWhite phosphorus", "TEST", 253, 279], ["vermin control", "TREATMENT", 311, 325], ["hepatic", "ANATOMY", 14, 21], ["necrosis", "OBSERVATION", 22, 30], ["midzonal", "OBSERVATION_MODIFIER", 36, 44], ["hydropic", "OBSERVATION", 45, 53], ["membrane peroxidation", "OBSERVATION", 71, 92], ["tissue repair", "OBSERVATION", 216, 229]]], ["It may be present in some incendiary devices such as fireworks.", [["some incendiary devices", "TREATMENT", 21, 44], ["may be", "UNCERTAINTY", 3, 9]]], ["As a rodenticide, it is mixed with fat to promote absorption, and much of the dose is transported to the liver shortly after ingestion.", [["fat", "ANATOMY", 35, 38], ["liver", "ANATOMY", 105, 110], ["fat", "TISSUE", 35, 38], ["liver", "ORGAN", 105, 110], ["a rodenticide", "TREATMENT", 3, 16], ["liver", "ANATOMY", 105, 110]]], ["A small amount may be lost by vomition, as elemental phosphorus is directly irritating to the gastrointestinal tract.", [["gastrointestinal tract", "ANATOMY", 94, 116], ["vomition", "DISEASE", 30, 38], ["elemental phosphorus", "CHEMICAL", 43, 63], ["irritating to the gastrointestinal tract", "DISEASE", 76, 116], ["phosphorus", "CHEMICAL", 53, 63], ["phosphorus", "SIMPLE_CHEMICAL", 53, 63], ["gastrointestinal tract", "ORGANISM_SUBDIVISION", 94, 116], ["elemental phosphorus", "TREATMENT", 43, 63], ["small", "OBSERVATION_MODIFIER", 2, 7], ["amount", "OBSERVATION_MODIFIER", 8, 14], ["may be", "UNCERTAINTY", 15, 21], ["lost", "OBSERVATION_MODIFIER", 22, 26], ["gastrointestinal tract", "ANATOMY", 94, 116]]], ["The mechanism of phosphorus hepatotoxicity is uncertain.", [["phosphorus", "CHEMICAL", 17, 27], ["hepatotoxicity", "DISEASE", 28, 42], ["phosphorus", "CHEMICAL", 17, 27], ["phosphorus", "SIMPLE_CHEMICAL", 17, 27], ["phosphorus hepatotoxicity", "PROBLEM", 17, 42], ["phosphorus hepatotoxicity", "OBSERVATION", 17, 42]]], ["It is apparent that metabolism to a toxic intermediate is not necessary, but there is some dispute on the involvement of lipoperoxidation in the hepatocellular injury.", [["hepatocellular", "ANATOMY", 145, 159], ["hepatocellular injury", "DISEASE", 145, 166], ["hepatocellular", "ORGAN", 145, 159], ["the hepatocellular injury", "PROBLEM", 141, 166], ["lipoperoxidation", "OBSERVATION", 121, 137], ["hepatocellular", "ANATOMY", 145, 159], ["injury", "OBSERVATION", 160, 166]]], ["There is evidence that protein synthesis is impaired early and that this is responsible for the lipid accumulation that is a prominent feature.", [["lipid", "SIMPLE_CHEMICAL", 96, 101], ["protein synthesis", "PROBLEM", 23, 40], ["the lipid accumulation", "PROBLEM", 92, 114], ["protein synthesis", "OBSERVATION", 23, 40], ["impaired", "OBSERVATION_MODIFIER", 44, 52], ["responsible for", "UNCERTAINTY", 76, 91], ["lipid accumulation", "OBSERVATION", 96, 114], ["prominent", "OBSERVATION_MODIFIER", 125, 134]]], ["A few hours after ingestion of phosphorus, there is severe colic and vomition.", [["phosphorus", "CHEMICAL", 31, 41], ["colic", "DISEASE", 59, 64], ["vomition", "DISEASE", 69, 77], ["phosphorus", "CHEMICAL", 31, 41], ["phosphorus", "SIMPLE_CHEMICAL", 31, 41], ["phosphorus", "TREATMENT", 31, 41], ["severe colic and vomition", "PROBLEM", 52, 77], ["severe", "OBSERVATION_MODIFIER", 52, 58], ["colic", "OBSERVATION", 59, 64]]], ["If the animal survives this acute phase, there may be apparent recovery for a few days, followed by jaundice and other signs of liver failure, and death by about the fifth day.", [["liver", "ANATOMY", 128, 133], ["jaundice", "DISEASE", 100, 108], ["liver failure", "DISEASE", 128, 141], ["death", "DISEASE", 147, 152], ["liver", "ORGAN", 128, 133], ["jaundice", "PROBLEM", 100, 108], ["liver failure", "PROBLEM", 128, 141], ["death", "PROBLEM", 147, 152], ["jaundice", "OBSERVATION", 100, 108], ["liver", "ANATOMY", 128, 133], ["failure", "OBSERVATION", 134, 141]]], ["At postmortem, there is severe icterus and fatty liver, the latter sometimes being predominantly periportal in distribution.", [["fatty liver", "ANATOMY", 43, 54], ["icterus", "DISEASE", 31, 38], ["fatty liver", "DISEASE", 43, 54], ["liver", "ORGAN", 49, 54], ["severe icterus", "PROBLEM", 24, 38], ["fatty liver", "PROBLEM", 43, 54], ["severe", "OBSERVATION_MODIFIER", 24, 30], ["icterus", "OBSERVATION", 31, 38], ["fatty", "OBSERVATION", 43, 48], ["liver", "ANATOMY", 49, 54], ["predominantly", "OBSERVATION_MODIFIER", 83, 96], ["periportal", "OBSERVATION", 97, 107], ["distribution", "OBSERVATION_MODIFIER", 111, 123]]], ["Hepatocellular known of which is ngaione, which are responsible for intoxication.", [["Hepatocellular", "ANATOMY", 0, 14], ["ngaione", "CHEMICAL", 33, 40], ["Hepatocellular", "CANCER", 0, 14], ["ngaione", "SIMPLE_CHEMICAL", 33, 40], ["intoxication", "PROBLEM", 68, 80], ["responsible for", "UNCERTAINTY", 52, 67]]], ["Twenty-four to 48 hours may elapse before signs of toxicity appear.", [["toxicity", "DISEASE", 51, 59], ["toxicity", "PROBLEM", 51, 59]]], ["Gross lesions include widespread hemorrhage and a pale yellow liver.", [["Gross lesions", "ANATOMY", 0, 13], ["liver", "ANATOMY", 62, 67], ["hemorrhage", "DISEASE", 33, 43], ["Gross lesions", "PATHOLOGICAL_FORMATION", 0, 13], ["liver", "ORGAN", 62, 67], ["Gross lesions", "PROBLEM", 0, 13], ["widespread hemorrhage", "PROBLEM", 22, 43], ["a pale yellow liver", "PROBLEM", 48, 67], ["lesions", "OBSERVATION", 6, 13], ["widespread", "OBSERVATION_MODIFIER", 22, 32], ["hemorrhage", "OBSERVATION", 33, 43], ["pale", "OBSERVATION_MODIFIER", 50, 54], ["yellow", "OBSERVATION", 55, 61], ["liver", "ANATOMY", 62, 67]]], ["Histologically, the pattern is unusual, as the injury to the hepatocytes occurs in periportal or midzonal regions accompanied by biliary hyperplasia (Fig. 2-95A, B) .", [["hepatocytes", "ANATOMY", 61, 72], ["periportal", "ANATOMY", 83, 93], ["midzonal regions", "ANATOMY", 97, 113], ["biliary", "ANATOMY", 129, 136], ["biliary hyperplasia", "DISEASE", 129, 148], ["hepatocytes", "CELL", 61, 72], ["periportal", "MULTI-TISSUE_STRUCTURE", 83, 93], ["biliary hyperplasia", "PATHOLOGICAL_FORMATION", 129, 148], ["hepatocytes", "CELL_TYPE", 61, 72], ["the injury", "PROBLEM", 43, 53], ["biliary hyperplasia", "PROBLEM", 129, 148], ["injury", "OBSERVATION", 47, 53], ["hepatocytes", "ANATOMY", 61, 72], ["periportal", "ANATOMY", 83, 93], ["midzonal", "ANATOMY_MODIFIER", 97, 105], ["regions", "ANATOMY_MODIFIER", 106, 113], ["biliary", "ANATOMY", 129, 136], ["hyperplasia", "OBSERVATION", 137, 148]]], ["Some animals live long enough to become photosensitized; others may die much more rapidly, with pulmonary edema.", [["pulmonary", "ANATOMY", 96, 105], ["pulmonary edema", "DISEASE", 96, 111], ["pulmonary edema", "PATHOLOGICAL_FORMATION", 96, 111], ["pulmonary edema", "PROBLEM", 96, 111], ["pulmonary", "ANATOMY", 96, 105], ["edema", "OBSERVATION", 106, 111]]], ["The edema appears to be a direct effect of the toxin after its metabolism by the club cells (formerly Clara cells) of the airway.PhosphorusLivers from intoxicated sheep may show a striking, broad pattern of variable congestion and even infarction, which is superimposed on the more regular lobular pattern of periportal necrosis.", [["edema", "ANATOMY", 4, 9], ["club cells", "ANATOMY", 81, 91], ["Clara cells", "ANATOMY", 102, 113], ["airway", "ANATOMY", 122, 128], ["lobular", "ANATOMY", 290, 297], ["periportal", "ANATOMY", 309, 319], ["edema", "DISEASE", 4, 9], ["PhosphorusLivers", "CHEMICAL", 129, 145], ["congestion", "DISEASE", 216, 226], ["infarction", "DISEASE", 236, 246], ["necrosis", "DISEASE", 320, 328], ["PhosphorusLivers", "CHEMICAL", 129, 145], ["edema", "PATHOLOGICAL_FORMATION", 4, 9], ["club cells", "CELL", 81, 91], ["Clara cells", "CELL", 102, 113], ["airway", "MULTI-TISSUE_STRUCTURE", 122, 128], ["PhosphorusLivers", "SIMPLE_CHEMICAL", 129, 145], ["sheep", "ORGANISM", 163, 168], ["lobular", "CANCER", 290, 297], ["club cells", "CELL_TYPE", 81, 91], ["formerly Clara cells", "CELL_TYPE", 93, 113], ["sheep", "SPECIES", 163, 168], ["sheep", "SPECIES", 163, 168], ["The edema", "PROBLEM", 0, 9], ["the toxin", "PROBLEM", 43, 52], ["PhosphorusLivers", "TEST", 129, 145], ["variable congestion", "PROBLEM", 207, 226], ["infarction", "PROBLEM", 236, 246], ["periportal necrosis", "PROBLEM", 309, 328], ["edema", "OBSERVATION", 4, 9], ["appears to be", "UNCERTAINTY", 10, 23], ["club cells", "OBSERVATION", 81, 91], ["Clara cells", "OBSERVATION", 102, 113], ["airway", "ANATOMY", 122, 128], ["striking", "OBSERVATION_MODIFIER", 180, 188], ["broad", "OBSERVATION_MODIFIER", 190, 195], ["variable", "OBSERVATION_MODIFIER", 207, 215], ["congestion", "OBSERVATION", 216, 226], ["infarction", "OBSERVATION", 236, 246], ["more", "OBSERVATION_MODIFIER", 277, 281], ["regular", "OBSERVATION_MODIFIER", 282, 289], ["lobular", "OBSERVATION_MODIFIER", 290, 297], ["pattern", "OBSERVATION_MODIFIER", 298, 305], ["periportal", "ANATOMY", 309, 319], ["necrosis", "OBSERVATION", 320, 328]]], ["Sections of these livers reveal acute fibrinoid necrosis of portal vessels, which suggests that the coarser lesions may have a vascular basis.Sawfly larvaeSawfly larval poisoning is an acute hepatotoxicosis documented in cattle and to a lesser extent sheep and goats in various locations, including Australia, Denmark, and South America.", [["livers", "ANATOMY", 18, 24], ["portal vessels", "ANATOMY", 60, 74], ["coarser lesions", "ANATOMY", 100, 115], ["vascular", "ANATOMY", 127, 135], ["necrosis", "DISEASE", 48, 56], ["larval poisoning", "DISEASE", 162, 178], ["hepatotoxicosis", "DISEASE", 191, 206], ["livers", "ORGAN", 18, 24], ["portal vessels", "MULTI-TISSUE_STRUCTURE", 60, 74], ["lesions", "PATHOLOGICAL_FORMATION", 108, 115], ["vascular", "MULTI-TISSUE_STRUCTURE", 127, 135], ["cattle", "ORGANISM", 221, 227], ["sheep", "ORGANISM", 251, 256], ["goats", "ORGANISM", 261, 266], ["cattle", "SPECIES", 221, 227], ["sheep", "SPECIES", 251, 256], ["goats", "SPECIES", 261, 266], ["cattle", "SPECIES", 221, 227], ["sheep", "SPECIES", 251, 256], ["goats", "SPECIES", 261, 266], ["acute fibrinoid necrosis of portal vessels", "PROBLEM", 32, 74], ["the coarser lesions", "PROBLEM", 96, 115], ["Sawfly larvae", "PROBLEM", 142, 155], ["Sawfly larval poisoning", "PROBLEM", 155, 178], ["an acute hepatotoxicosis", "PROBLEM", 182, 206], ["livers", "ANATOMY", 18, 24], ["acute", "OBSERVATION_MODIFIER", 32, 37], ["fibrinoid", "OBSERVATION_MODIFIER", 38, 47], ["necrosis", "OBSERVATION", 48, 56], ["portal vessels", "ANATOMY", 60, 74], ["coarser", "OBSERVATION_MODIFIER", 100, 107], ["lesions", "OBSERVATION", 108, 115], ["vascular", "ANATOMY", 127, 135], ["acute", "OBSERVATION_MODIFIER", 185, 190], ["hepatotoxicosis", "OBSERVATION", 191, 206]]], ["Ingestion of the larval stage of the \"sawfly,\" 1 of 3 insect species that are members of the order Hymenoptera and the suborder Symphyta, produce hepatic injury.", [["sawfly", "ANATOMY", 38, 44], ["hepatic", "ANATOMY", 146, 153], ["hepatic injury", "DISEASE", 146, 160], ["hepatic", "ORGAN", 146, 153], ["3 insect species", "PROBLEM", 52, 68], ["hepatic injury", "PROBLEM", 146, 160], ["hepatic", "ANATOMY", 146, 153], ["injury", "OBSERVATION", 154, 160]]], ["In Aus- A B toxins also varies under different conditions of fungal growth, which is influenced by the quality of the substrate, temperature, relative humidity, moisture content of the substrate, and microbial competition.", [["Aus- A B", "CHEMICAL", 3, 11], ["Aus- A B toxins", "SIMPLE_CHEMICAL", 3, 18], ["A B toxins", "PROBLEM", 8, 18], ["fungal growth", "PROBLEM", 61, 74], ["Aus", "OBSERVATION", 3, 6], ["fungal growth", "OBSERVATION", 61, 74]]], ["Thus the toxicity of moldy feedstuffs is impossible to assess without measurement of toxin production.", [["toxicity", "DISEASE", 9, 17], ["toxin", "SIMPLE_CHEMICAL", 85, 90], ["toxin", "PROTEIN", 85, 90], ["the toxicity of moldy feedstuffs", "PROBLEM", 5, 37], ["toxin production", "PROBLEM", 85, 101], ["moldy feedstuffs", "OBSERVATION", 21, 37]]], ["Aflatoxins can be produced on growing crops in the field, but much greater levels are likely to accumulate in stored or unharvested mature grains, particularly if they are damaged by moisture.", [["grains", "ANATOMY", 139, 145], ["Aflatoxins", "CHEMICAL", 0, 10], ["Aflatoxins", "CHEMICAL", 0, 10], ["Aflatoxins", "SIMPLE_CHEMICAL", 0, 10], ["Aflatoxins", "TREATMENT", 0, 10], ["growing", "OBSERVATION_MODIFIER", 30, 37], ["crops", "OBSERVATION", 38, 43], ["likely to", "UNCERTAINTY", 86, 95]]], ["Various feeds other than grains, ranging from legume stubbles to bread, may be the substrate in outbreaks of aflatoxicosis.", [["grains", "ANATOMY", 25, 31], ["aflatoxicosis", "DISEASE", 109, 122], ["grains", "ORGANISM_SUBDIVISION", 25, 31], ["aflatoxicosis", "CANCER", 109, 122], ["Various feeds", "TREATMENT", 0, 13], ["aflatoxicosis", "PROBLEM", 109, 122], ["aflatoxicosis", "OBSERVATION", 109, 122]]], ["Contaminated grain has been incorporated into commercial dog food, leading to outbreaks of acute toxicity.Sawfly larvaeAflatoxins are metabolized by the hepatic mixed-function oxidase system to various toxic and nontoxic metabolites, the proportions of which vary with the species and age of the animal involved.", [["hepatic", "ANATOMY", 153, 160], ["toxicity", "DISEASE", 97, 105], ["Aflatoxins", "CHEMICAL", 119, 129], ["Aflatoxins", "CHEMICAL", 119, 129], ["dog", "ORGANISM", 57, 60], ["Aflatoxins", "SIMPLE_CHEMICAL", 119, 129], ["oxidase", "GENE_OR_GENE_PRODUCT", 176, 183], ["dog", "SPECIES", 57, 60], ["Contaminated grain", "PROBLEM", 0, 18], ["acute toxicity", "PROBLEM", 91, 105], ["Sawfly larvae", "PROBLEM", 106, 119], ["Aflatoxins", "TREATMENT", 119, 129], ["various toxic and nontoxic metabolites", "PROBLEM", 194, 232], ["acute", "OBSERVATION_MODIFIER", 91, 96], ["toxicity", "OBSERVATION", 97, 105], ["hepatic", "ANATOMY", 153, 160], ["mixed", "OBSERVATION", 161, 166], ["function oxidase", "OBSERVATION", 167, 183], ["toxic", "OBSERVATION_MODIFIER", 202, 207], ["nontoxic metabolites", "OBSERVATION", 212, 232]]], ["The most potent of these is the 8,9-epoxide metabolite of aflatoxin B 1 ; this binds to a variety of cellular proteins causing acute toxicity, and its carcinogenic activity derives primarily from adduct formation with guanine in nucleic acids in sensitive species that lack adequate glutathione S-transferase-mediated resistance.", [["cellular", "ANATOMY", 101, 109], ["8,9-epoxide", "CHEMICAL", 32, 43], ["aflatoxin B", "CHEMICAL", 58, 69], ["toxicity", "DISEASE", 133, 141], ["guanine", "CHEMICAL", 218, 225], ["nucleic acids", "CHEMICAL", 229, 242], ["glutathione", "CHEMICAL", 283, 294], ["8,9-epoxide", "CHEMICAL", 32, 43], ["aflatoxin B 1", "CHEMICAL", 58, 71], ["guanine", "CHEMICAL", 218, 225], ["glutathione", "CHEMICAL", 283, 294], ["S", "CHEMICAL", 295, 296], ["8,9-epoxide", "SIMPLE_CHEMICAL", 32, 43], ["aflatoxin B 1", "GENE_OR_GENE_PRODUCT", 58, 71], ["cellular", "CELL", 101, 109], ["adduct", "SIMPLE_CHEMICAL", 196, 202], ["guanine", "SIMPLE_CHEMICAL", 218, 225], ["nucleic acids", "SIMPLE_CHEMICAL", 229, 242], ["glutathione S-transferase", "GENE_OR_GENE_PRODUCT", 283, 308], ["cellular proteins", "PROTEIN", 101, 118], ["glutathione S-transferase", "PROTEIN", 283, 308], ["aflatoxin B", "TREATMENT", 58, 69], ["cellular proteins", "PROBLEM", 101, 118], ["acute toxicity", "PROBLEM", 127, 141], ["guanine in nucleic acids", "TEST", 218, 242], ["most potent", "OBSERVATION_MODIFIER", 4, 15], ["cellular proteins", "OBSERVATION", 101, 118], ["acute", "OBSERVATION_MODIFIER", 127, 132], ["toxicity", "OBSERVATION", 133, 141], ["carcinogenic activity", "OBSERVATION", 151, 172]]], ["The mutational consequence is a G to T transversion.", [["G to T transversion", "DNA", 32, 51], ["a G to T transversion", "TREATMENT", 30, 51]]], ["Acute toxicity is most evident in dogs, rats, ducks, guinea pigs, and calves, and each species may be fatally intoxicated by a dose rate of <1.0 mg/kg body weight.", [["body", "ANATOMY", 151, 155], ["toxicity", "DISEASE", 6, 14], ["dogs", "ORGANISM", 34, 38], ["rats", "ORGANISM", 40, 44], ["ducks", "ORGANISM", 46, 51], ["guinea pigs", "ORGANISM", 53, 64], ["calves", "ORGANISM", 70, 76], ["body", "ORGANISM_SUBDIVISION", 151, 155], ["dogs", "SPECIES", 34, 38], ["rats", "SPECIES", 40, 44], ["ducks", "SPECIES", 46, 51], ["guinea pigs", "SPECIES", 53, 64], ["calves", "SPECIES", 70, 76], ["guinea pigs", "SPECIES", 53, 64], ["Acute toxicity", "PROBLEM", 0, 14], ["guinea pigs, and calves", "PROBLEM", 53, 76], ["toxicity", "OBSERVATION", 6, 14], ["most evident", "UNCERTAINTY", 18, 30], ["guinea pigs", "OBSERVATION", 53, 64], ["calves", "ANATOMY", 70, 76]]], ["Although cats are also sensitive, they rarely ingest contaminated food.", [["cats", "ORGANISM", 9, 13], ["cats", "SPECIES", 9, 13]]], ["Acute, fulminating liver necrosis is sometimes seen in dogs that eat contaminated bread, dog food, or garbage, which may contain very high concentrations of the toxin.", [["liver", "ANATOMY", 19, 24], ["liver necrosis", "DISEASE", 19, 33], ["liver", "ORGAN", 19, 24], ["dogs", "ORGANISM", 55, 59], ["bread", "ORGANISM_SUBDIVISION", 82, 87], ["dog", "ORGANISM", 89, 92], ["dogs", "SPECIES", 55, 59], ["dog", "SPECIES", 89, 92], ["Acute, fulminating liver necrosis", "PROBLEM", 0, 33], ["the toxin", "PROBLEM", 157, 166], ["fulminating", "OBSERVATION_MODIFIER", 7, 18], ["liver", "ANATOMY", 19, 24], ["necrosis", "OBSERVATION", 25, 33]]], ["Younger animals of all species are much more susceptible and may die within a few hours.", [["all species", "PROBLEM", 19, 30]]], ["The gross postmortem picture is dominated by widespread hemorrhage and massive hepatic necrosis, changes also seen at the microscopic level .", [["hepatic", "ANATOMY", 79, 86], ["hemorrhage", "DISEASE", 56, 66], ["massive hepatic necrosis", "DISEASE", 71, 95], ["hepatic", "ORGAN", 79, 86], ["The gross postmortem picture", "TEST", 0, 28], ["widespread hemorrhage", "PROBLEM", 45, 66], ["massive hepatic necrosis", "PROBLEM", 71, 95], ["gross", "OBSERVATION_MODIFIER", 4, 9], ["postmortem picture", "OBSERVATION", 10, 28], ["dominated", "OBSERVATION_MODIFIER", 32, 41], ["widespread", "OBSERVATION_MODIFIER", 45, 55], ["hemorrhage", "OBSERVATION", 56, 66], ["massive", "OBSERVATION_MODIFIER", 71, 78], ["hepatic", "ANATOMY", 79, 86], ["necrosis", "OBSERVATION", 87, 95]]], ["Large animal species rarely are exposed at sufficient doses by normal dietary intake to develop acute toxicity.", [["toxicity", "DISEASE", 102, 110], ["Large animal species", "PROBLEM", 0, 20], ["acute toxicity", "PROBLEM", 96, 110], ["animal species", "OBSERVATION", 6, 20], ["acute", "OBSERVATION_MODIFIER", 96, 101], ["toxicity", "OBSERVATION", 102, 110]]], ["Sheep and adult cattle are quite resistant to the toxin.Sawfly larvaeProlonged exposure to low concentrations of the toxin is a more common problem than acute toxicity in large animal species, and may merely produce reduced growth rates and moderate enlargement of the liver without any significant hepatic signs.", [["liver", "ANATOMY", 269, 274], ["hepatic", "ANATOMY", 299, 306], ["toxicity", "DISEASE", 159, 167], ["enlargement of the liver", "DISEASE", 250, 274], ["Sheep", "ORGANISM", 0, 5], ["cattle", "ORGANISM", 16, 22], ["liver", "ORGAN", 269, 274], ["hepatic", "ORGAN", 299, 306], ["Sheep", "SPECIES", 0, 5], ["cattle", "SPECIES", 16, 22], ["Sheep", "SPECIES", 0, 5], ["cattle", "SPECIES", 16, 22], ["the toxin", "PROBLEM", 46, 55], ["Sawfly larvae", "PROBLEM", 56, 69], ["Prolonged exposure", "PROBLEM", 69, 87], ["low concentrations", "PROBLEM", 91, 109], ["the toxin", "PROBLEM", 113, 122], ["acute toxicity", "PROBLEM", 153, 167], ["large animal species", "PROBLEM", 171, 191], ["reduced growth rates", "PROBLEM", 216, 236], ["moderate enlargement of the liver", "PROBLEM", 241, 274], ["any significant hepatic signs", "PROBLEM", 283, 312], ["low concentrations", "OBSERVATION_MODIFIER", 91, 109], ["more common", "OBSERVATION_MODIFIER", 128, 139], ["acute", "OBSERVATION_MODIFIER", 153, 158], ["toxicity", "OBSERVATION", 159, 167], ["large", "OBSERVATION_MODIFIER", 171, 176], ["animal species", "OBSERVATION", 177, 191], ["reduced", "OBSERVATION_MODIFIER", 216, 223], ["growth", "OBSERVATION_MODIFIER", 224, 230], ["moderate", "OBSERVATION_MODIFIER", 241, 249], ["enlargement", "OBSERVATION", 250, 261], ["liver", "ANATOMY", 269, 274], ["without", "UNCERTAINTY", 275, 282], ["significant", "OBSERVATION_MODIFIER", 287, 298], ["hepatic", "ANATOMY", 299, 306], ["signs", "OBSERVATION", 307, 312]]], ["The enlargement may be partly the result of hypertrophy of hepatocellular smooth endoplasmic reticulum and some degree of fatty change.", [["hepatocellular smooth endoplasmic reticulum", "ANATOMY", 59, 102], ["hypertrophy", "DISEASE", 44, 55], ["fatty change", "DISEASE", 122, 134], ["hepatocellular smooth", "TISSUE", 59, 80], ["endoplasmic reticulum", "CELLULAR_COMPONENT", 81, 102], ["The enlargement", "PROBLEM", 0, 15], ["hypertrophy of hepatocellular smooth endoplasmic reticulum", "PROBLEM", 44, 102], ["fatty change", "PROBLEM", 122, 134], ["enlargement", "OBSERVATION", 4, 15], ["may be partly", "UNCERTAINTY", 16, 29], ["hypertrophy", "OBSERVATION", 44, 55], ["hepatocellular smooth", "OBSERVATION", 59, 80], ["endoplasmic reticulum", "OBSERVATION", 81, 102], ["some", "OBSERVATION_MODIFIER", 107, 111], ["degree", "OBSERVATION_MODIFIER", 112, 118], ["fatty change", "OBSERVATION", 122, 134]]], ["As the level of aflatoxin in the ration increases (in young pigs, e.g., to 1.0 mg/kg ration), the liver may show all or none of the following changes: pallor, enlargement, bile staining, increased firmness because of fibrogenesis, and fine nodular regenerative hyperplasia.", [["liver", "ANATOMY", 98, 103], ["bile", "ANATOMY", 172, 176], ["nodular regenerative hyperplasia", "ANATOMY", 240, 272], ["aflatoxin", "CHEMICAL", 16, 25], ["pallor", "DISEASE", 151, 157], ["fibrogenesis", "DISEASE", 217, 229], ["hyperplasia", "DISEASE", 261, 272], ["aflatoxin", "CHEMICAL", 16, 25], ["aflatoxin", "SIMPLE_CHEMICAL", 16, 25], ["pigs", "ORGANISM", 60, 64], ["liver", "ORGAN", 98, 103], ["bile", "MULTI-TISSUE_STRUCTURE", 172, 176], ["pigs", "SPECIES", 60, 64], ["pigs", "SPECIES", 60, 64], ["aflatoxin", "TREATMENT", 16, 25], ["pallor", "PROBLEM", 151, 157], ["enlargement", "PROBLEM", 159, 170], ["bile staining", "PROBLEM", 172, 185], ["increased firmness", "PROBLEM", 187, 205], ["fibrogenesis", "PROBLEM", 217, 229], ["fine nodular regenerative hyperplasia", "PROBLEM", 235, 272], ["increases", "OBSERVATION_MODIFIER", 40, 49], ["liver", "ANATOMY", 98, 103], ["pallor", "OBSERVATION", 151, 157], ["enlargement", "OBSERVATION", 159, 170], ["bile", "ANATOMY", 172, 176], ["increased", "OBSERVATION_MODIFIER", 187, 196], ["firmness", "OBSERVATION_MODIFIER", 197, 205], ["fibrogenesis", "OBSERVATION", 217, 229], ["fine", "OBSERVATION_MODIFIER", 235, 239], ["nodular", "OBSERVATION_MODIFIER", 240, 247], ["regenerative", "OBSERVATION_MODIFIER", 248, 260], ["hyperplasia", "OBSERVATION", 261, 272]]], ["There may also be edema of the gallbladder and bile-tinged ascites in more severe cases.", [["edema", "ANATOMY", 18, 23], ["gallbladder", "ANATOMY", 31, 42], ["bile", "ANATOMY", 47, 51], ["ascites", "ANATOMY", 59, 66], ["edema", "DISEASE", 18, 23], ["ascites", "DISEASE", 59, 66], ["edema", "PATHOLOGICAL_FORMATION", 18, 23], ["gallbladder", "ORGAN", 31, 42], ["bile", "PATHOLOGICAL_FORMATION", 47, 51], ["edema of the gallbladder", "PROBLEM", 18, 42], ["bile-tinged ascites", "PROBLEM", 47, 66], ["may also be", "UNCERTAINTY", 6, 17], ["edema", "OBSERVATION", 18, 23], ["gallbladder", "ANATOMY", 31, 42], ["bile", "ANATOMY", 47, 51], ["tinged", "OBSERVATION_MODIFIER", 52, 58], ["ascites", "OBSERVATION", 59, 66], ["more severe", "OBSERVATION_MODIFIER", 70, 81]]], ["Even under experimental conditions, some individuals may show minimal liver lesions, whereas others, under the same levels of exposure, die of liver failure.", [["liver lesions", "ANATOMY", 70, 83], ["liver", "ANATOMY", 143, 148], ["liver lesions", "DISEASE", 70, 83], ["liver failure", "DISEASE", 143, 156], ["liver lesions", "PATHOLOGICAL_FORMATION", 70, 83], ["liver", "ORGAN", 143, 148], ["minimal liver lesions", "PROBLEM", 62, 83], ["liver failure", "PROBLEM", 143, 156], ["minimal", "OBSERVATION_MODIFIER", 62, 69], ["liver", "ANATOMY", 70, 75], ["lesions", "OBSERVATION", 76, 83], ["liver", "ANATOMY", 143, 148], ["failure", "OBSERVATION", 149, 156]]], ["Histologically, affected livers show obvious increase in size of some hepatocytes and their nuclei (megalocytosis) with focal necrosis or apoptosis.", [["livers", "ANATOMY", 25, 31], ["hepatocytes", "ANATOMY", 70, 81], ["nuclei", "ANATOMY", 92, 98], ["necrosis", "DISEASE", 126, 134], ["livers", "ORGAN", 25, 31], ["hepatocytes", "CELL", 70, 81], ["nuclei", "CELLULAR_COMPONENT", 92, 98], ["hepatocytes", "CELL_TYPE", 70, 81], ["obvious increase in size", "PROBLEM", 37, 61], ["some hepatocytes", "PROBLEM", 65, 81], ["their nuclei (megalocytosis)", "PROBLEM", 86, 114], ["focal necrosis", "PROBLEM", 120, 134], ["apoptosis", "PROBLEM", 138, 147], ["livers", "ANATOMY", 25, 31], ["obvious", "OBSERVATION_MODIFIER", 37, 44], ["increase", "OBSERVATION_MODIFIER", 45, 53], ["size", "OBSERVATION_MODIFIER", 57, 61], ["some", "ANATOMY_MODIFIER", 65, 69], ["hepatocytes", "ANATOMY", 70, 81], ["nuclei", "ANATOMY", 92, 98], ["focal", "OBSERVATION_MODIFIER", 120, 125], ["necrosis", "OBSERVATION", 126, 134], ["apoptosis", "OBSERVATION_MODIFIER", 138, 147]]], ["Bile ductules proliferate early, and reticulin and collagen deposition occurs throughout the acinus according to no distinct pattern (Fig. 2-96) .", [["Bile ductules", "ANATOMY", 0, 13], ["acinus", "ANATOMY", 93, 99], ["Bile ductules", "MULTI-TISSUE_STRUCTURE", 0, 13], ["reticulin", "GENE_OR_GENE_PRODUCT", 37, 46], ["collagen", "GENE_OR_GENE_PRODUCT", 51, 59], ["acinus", "ORGAN", 93, 99], ["collagen", "PROTEIN", 51, 59], ["Bile ductules proliferate", "PROBLEM", 0, 25], ["reticulin and collagen deposition", "PROBLEM", 37, 70], ["ductules", "ANATOMY_MODIFIER", 5, 13], ["reticulin", "OBSERVATION_MODIFIER", 37, 46], ["collagen deposition", "OBSERVATION", 51, 70]]], ["Fatty change in affected livers is variable in extent and occurrence, and bile pigments accumulate in canaliculi and hepatocytes in more severely affected livers.", [["livers", "ANATOMY", 25, 31], ["bile pigments", "ANATOMY", 74, 87], ["canaliculi", "ANATOMY", 102, 112], ["hepatocytes", "ANATOMY", 117, 128], ["livers", "ANATOMY", 155, 161], ["livers", "ORGAN", 25, 31], ["bile pigments", "SIMPLE_CHEMICAL", 74, 87], ["canaliculi", "MULTI-TISSUE_STRUCTURE", 102, 112], ["hepatocytes", "CELL", 117, 128], ["livers", "ORGAN", 155, 161], ["hepatocytes", "CELL_TYPE", 117, 128], ["Fatty change in affected livers", "PROBLEM", 0, 31], ["bile pigments accumulate in canaliculi and hepatocytes", "PROBLEM", 74, 128], ["severely affected livers", "PROBLEM", 137, 161], ["change", "OBSERVATION", 6, 12], ["affected", "OBSERVATION_MODIFIER", 16, 24], ["livers", "ANATOMY", 25, 31], ["variable", "OBSERVATION_MODIFIER", 35, 43], ["extent", "OBSERVATION_MODIFIER", 47, 53], ["bile", "ANATOMY", 74, 78], ["canaliculi", "ANATOMY_MODIFIER", 102, 112], ["hepatocytes", "ANATOMY", 117, 128], ["more severely", "OBSERVATION_MODIFIER", 132, 145], ["affected", "OBSERVATION", 146, 154], ["livers", "ANATOMY", 155, 161]]], ["Minor degrees of megalocytosis may be seen in proximal tubular epithelium in the kidney.", [["proximal tubular epithelium", "ANATOMY", 46, 73], ["kidney", "ANATOMY", 81, 87], ["megalocytosis", "DISEASE", 17, 30], ["tubular epithelium", "TISSUE", 55, 73], ["kidney", "ORGAN", 81, 87], ["Minor degrees of megalocytosis", "PROBLEM", 0, 30], ["proximal tubular epithelium in the kidney", "PROBLEM", 46, 87], ["degrees", "OBSERVATION_MODIFIER", 6, 13], ["megalocytosis", "OBSERVATION", 17, 30], ["may be seen", "UNCERTAINTY", 31, 42], ["proximal", "ANATOMY_MODIFIER", 46, 54], ["tubular", "ANATOMY_MODIFIER", 55, 62], ["epithelium", "ANATOMY_MODIFIER", 63, 73], ["kidney", "ANATOMY", 81, 87]]], ["The changes produced resemble those of pyrrolizidine alkaloid toxicosis.", [["pyrrolizidine alkaloid", "CHEMICAL", 39, 61], ["toxicosis", "DISEASE", 62, 71], ["pyrrolizidine alkaloid", "CHEMICAL", 39, 61], ["pyrrolizidine alkaloid", "SIMPLE_CHEMICAL", 39, 61], ["pyrrolizidine alkaloid toxicosis", "PROBLEM", 39, 71], ["pyrrolizidine", "OBSERVATION", 39, 52], ["alkaloid toxicosis", "OBSERVATION", 53, 71]]], ["This can be attributed to the fact that aflatoxin and pyrrolizidine alkaloids inhibit hepatocellular regeneration such that nodules necrosis is not often a prominent feature histologically, notwithstanding the evidence of liver failure.", [["hepatocellular", "ANATOMY", 86, 100], ["nodules", "ANATOMY", 124, 131], ["liver", "ANATOMY", 222, 227], ["aflatoxin", "CHEMICAL", 40, 49], ["pyrrolizidine alkaloids", "CHEMICAL", 54, 77], ["necrosis", "DISEASE", 132, 140], ["liver failure", "DISEASE", 222, 235], ["aflatoxin", "CHEMICAL", 40, 49], ["pyrrolizidine alkaloids", "CHEMICAL", 54, 77], ["aflatoxin", "SIMPLE_CHEMICAL", 40, 49], ["pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 54, 77], ["hepatocellular", "CANCER", 86, 100], ["liver", "ORGAN", 222, 227], ["aflatoxin", "TREATMENT", 40, 49], ["pyrrolizidine alkaloids", "TREATMENT", 54, 77], ["hepatocellular regeneration", "PROBLEM", 86, 113], ["nodules necrosis", "PROBLEM", 124, 140], ["liver failure", "PROBLEM", 222, 235], ["nodules", "OBSERVATION", 124, 131], ["prominent feature", "OBSERVATION_MODIFIER", 156, 173], ["histologically", "OBSERVATION", 174, 188], ["evidence of", "UNCERTAINTY", 210, 221], ["liver", "ANATOMY", 222, 227], ["failure", "OBSERVATION", 228, 235]]], ["Fatty change is also seen in the myocardium and distal nephrons.IronIron-dextran complexes have been widely used in the prevention and treatment of anemia in suckling swine.", [["myocardium", "ANATOMY", 33, 43], ["distal nephrons", "ANATOMY", 48, 63], ["IronIron-dextran", "CHEMICAL", 64, 80], ["anemia", "DISEASE", 148, 154], ["myocardium", "MULTI-TISSUE_STRUCTURE", 33, 43], ["distal nephrons", "MULTI-TISSUE_STRUCTURE", 48, 63], ["IronIron-dextran complexes", "SIMPLE_CHEMICAL", 64, 90], ["swine", "ORGANISM", 167, 172], ["swine", "SPECIES", 167, 172], ["swine", "SPECIES", 167, 172], ["Fatty change", "PROBLEM", 0, 12], ["IronIron-dextran complexes", "TREATMENT", 64, 90], ["anemia", "PROBLEM", 148, 154], ["change", "OBSERVATION", 6, 12], ["myocardium", "ANATOMY", 33, 43], ["distal", "ANATOMY_MODIFIER", 48, 54], ["nephrons", "ANATOMY", 55, 63], ["dextran complexes", "OBSERVATION_MODIFIER", 73, 90], ["anemia", "OBSERVATION", 148, 154]]], ["Very occasionally, severe losses may occur in animals with marginal vitamin E-selenium deficiency; in these cases, there is, apparently, ironcatalyzed lipoperoxidation in hepatocytes and muscle.", [["hepatocytes", "ANATOMY", 171, 182], ["muscle", "ANATOMY", 187, 193], ["vitamin E", "CHEMICAL", 68, 77], ["selenium", "CHEMICAL", 78, 86], ["vitamin E", "CHEMICAL", 68, 77], ["selenium", "CHEMICAL", 78, 86], ["vitamin E", "SIMPLE_CHEMICAL", 68, 77], ["selenium", "SIMPLE_CHEMICAL", 78, 86], ["hepatocytes", "CELL", 171, 182], ["muscle", "ORGAN", 187, 193], ["hepatocytes", "CELL_TYPE", 171, 182], ["severe losses", "PROBLEM", 19, 32], ["marginal vitamin E", "PROBLEM", 59, 77], ["selenium deficiency", "PROBLEM", 78, 97], ["ironcatalyzed lipoperoxidation in hepatocytes and muscle", "PROBLEM", 137, 193], ["severe", "OBSERVATION_MODIFIER", 19, 25], ["losses", "OBSERVATION", 26, 32], ["selenium deficiency", "OBSERVATION", 78, 97], ["lipoperoxidation", "OBSERVATION", 151, 167], ["hepatocytes", "ANATOMY", 171, 182], ["muscle", "ANATOMY", 187, 193]]], ["The result is sudden massive hepatic necrosis similar in many respects to that of hepatosis dietetica.", [["hepatic", "ANATOMY", 29, 36], ["massive hepatic necrosis", "DISEASE", 21, 45], ["hepatosis dietetica", "DISEASE", 82, 101], ["hepatic", "ORGAN", 29, 36], ["hepatosis dietetica", "ORGANISM", 82, 101], ["hepatosis dietetica", "SPECIES", 82, 101], ["sudden massive hepatic necrosis", "PROBLEM", 14, 45], ["hepatosis dietetica", "PROBLEM", 82, 101], ["sudden", "OBSERVATION_MODIFIER", 14, 20], ["massive", "OBSERVATION_MODIFIER", 21, 28], ["hepatic", "ANATOMY", 29, 36], ["necrosis", "OBSERVATION", 37, 45], ["hepatosis", "OBSERVATION", 82, 91]]], ["Large amounts of potassium escape into the circulation from the liver and muscle, and sudden death may result from the cardiotoxicity of this ion.", [["liver", "ANATOMY", 64, 69], ["muscle", "ANATOMY", 74, 80], ["potassium", "CHEMICAL", 17, 26], ["sudden death", "DISEASE", 86, 98], ["cardiotoxicity", "DISEASE", 119, 133], ["potassium", "CHEMICAL", 17, 26], ["potassium", "SIMPLE_CHEMICAL", 17, 26], ["liver", "ORGAN", 64, 69], ["muscle", "ORGAN", 74, 80], ["Large amounts of potassium escape", "PROBLEM", 0, 33], ["sudden death", "PROBLEM", 86, 98], ["the cardiotoxicity", "PROBLEM", 115, 133], ["amounts", "OBSERVATION_MODIFIER", 6, 13], ["potassium escape", "OBSERVATION", 17, 33], ["circulation", "ANATOMY_MODIFIER", 43, 54], ["liver", "ANATOMY", 64, 69], ["muscle", "ANATOMY", 74, 80]]], ["At postmortem, there is staining of subcutaneous tissues and lymph nodes near the site of injection, and there are lesions in the liver or skeletal muscles.", [["subcutaneous tissues", "ANATOMY", 36, 56], ["lymph nodes", "ANATOMY", 61, 72], ["site", "ANATOMY", 82, 86], ["lesions", "ANATOMY", 115, 122], ["liver", "ANATOMY", 130, 135], ["skeletal muscles", "ANATOMY", 139, 155], ["subcutaneous tissues", "TISSUE", 36, 56], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 61, 72], ["lesions", "PATHOLOGICAL_FORMATION", 115, 122], ["liver", "ORGAN", 130, 135], ["skeletal muscles", "ORGAN", 139, 155], ["staining of subcutaneous tissues", "PROBLEM", 24, 56], ["lymph nodes", "PROBLEM", 61, 72], ["injection", "TREATMENT", 90, 99], ["lesions in the liver or skeletal muscles", "PROBLEM", 115, 155], ["subcutaneous tissues", "ANATOMY", 36, 56], ["lymph nodes", "OBSERVATION", 61, 72], ["lesions", "OBSERVATION", 115, 122], ["liver", "ANATOMY", 130, 135], ["skeletal muscles", "ANATOMY", 139, 155]]], ["The liver is of normal size and of normal color or pale, depending on whether or not the animal is anemic.", [["liver", "ANATOMY", 4, 9], ["anemic", "DISEASE", 99, 105], ["liver", "ORGAN", 4, 9], ["anemic", "PROBLEM", 99, 105], ["liver", "ANATOMY", 4, 9], ["normal", "OBSERVATION", 16, 22], ["size", "OBSERVATION_MODIFIER", 23, 27], ["normal", "OBSERVATION", 35, 41], ["color", "OBSERVATION_MODIFIER", 42, 47], ["pale", "OBSERVATION_MODIFIER", 51, 55], ["anemic", "OBSERVATION", 99, 105]]], ["The presence of underlying necrosis may be indicated only by the numerous small or large hemorrhages present on the capsular and cut surface.", [["capsular", "ANATOMY", 116, 124], ["surface", "ANATOMY", 133, 140], ["necrosis", "DISEASE", 27, 35], ["hemorrhages", "DISEASE", 89, 100], ["capsular", "TISSUE", 116, 124], ["surface", "CELLULAR_COMPONENT", 133, 140], ["underlying necrosis", "PROBLEM", 16, 35], ["the numerous small or large hemorrhages", "PROBLEM", 61, 100], ["underlying", "OBSERVATION_MODIFIER", 16, 26], ["necrosis", "OBSERVATION", 27, 35], ["numerous", "OBSERVATION_MODIFIER", 65, 73], ["small", "OBSERVATION_MODIFIER", 74, 79], ["large", "OBSERVATION_MODIFIER", 83, 88], ["hemorrhages", "OBSERVATION", 89, 100], ["capsular", "OBSERVATION_MODIFIER", 116, 124], ["cut", "OBSERVATION_MODIFIER", 129, 132], ["surface", "OBSERVATION_MODIFIER", 133, 140]]], ["Insoluble iron compounds with the staining reactions of hemosiderin are found in mesenchymal cells in many tissues, the largest amounts being in macrophages of the local lymph nodes and in Kupffer cells.", [["mesenchymal cells", "ANATOMY", 81, 98], ["tissues", "ANATOMY", 107, 114], ["macrophages", "ANATOMY", 145, 156], ["lymph nodes", "ANATOMY", 170, 181], ["Kupffer cells", "ANATOMY", 189, 202], ["iron", "CHEMICAL", 10, 14], ["iron", "CHEMICAL", 10, 14], ["iron compounds", "SIMPLE_CHEMICAL", 10, 24], ["hemosiderin", "SIMPLE_CHEMICAL", 56, 67], ["mesenchymal cells", "CELL", 81, 98], ["tissues", "TISSUE", 107, 114], ["macrophages", "CELL", 145, 156], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 170, 181], ["Kupffer cells", "CELL", 189, 202], ["mesenchymal cells", "CELL_TYPE", 81, 98], ["macrophages", "CELL_TYPE", 145, 156], ["Kupffer cells", "CELL_TYPE", 189, 202], ["Insoluble iron compounds", "TREATMENT", 0, 24], ["the staining reactions of hemosiderin", "PROBLEM", 30, 67], ["mesenchymal cells", "PROBLEM", 81, 98], ["iron compounds", "OBSERVATION", 10, 24], ["hemosiderin", "OBSERVATION", 56, 67], ["mesenchymal cells", "OBSERVATION", 81, 98], ["many tissues", "OBSERVATION_MODIFIER", 102, 114], ["largest", "OBSERVATION_MODIFIER", 120, 127], ["amounts", "OBSERVATION_MODIFIER", 128, 135], ["macrophages", "OBSERVATION_MODIFIER", 145, 156], ["local", "OBSERVATION_MODIFIER", 164, 169], ["lymph nodes", "OBSERVATION", 170, 181], ["Kupffer cells", "OBSERVATION", 189, 202]]], ["Death in piglets from hepatic necrosis occurs ~10 hours after administration.", [["hepatic", "ANATOMY", 22, 29], ["Death", "DISEASE", 0, 5], ["hepatic necrosis", "DISEASE", 22, 38], ["piglets", "ORGANISM", 9, 16], ["hepatic", "ORGAN", 22, 29], ["piglets", "SPECIES", 9, 16], ["Death", "PROBLEM", 0, 5], ["hepatic necrosis", "PROBLEM", 22, 38], ["hepatic", "ANATOMY", 22, 29], ["necrosis", "OBSERVATION", 30, 38]]], ["Saccharated iron may produce acute widespread muscle necrosis at ~24 hours, rather than hepatic necrosis in piglets with marginal vitamin E-selenium status.", [["muscle", "ANATOMY", 46, 52], ["hepatic", "ANATOMY", 88, 95], ["iron", "CHEMICAL", 12, 16], ["muscle necrosis", "DISEASE", 46, 61], ["hepatic necrosis", "DISEASE", 88, 104], ["vitamin E", "CHEMICAL", 130, 139], ["selenium", "CHEMICAL", 140, 148], ["iron", "CHEMICAL", 12, 16], ["vitamin E", "CHEMICAL", 130, 139], ["selenium", "CHEMICAL", 140, 148], ["iron", "SIMPLE_CHEMICAL", 12, 16], ["muscle", "ORGAN", 46, 52], ["hepatic", "ORGAN", 88, 95], ["piglets", "ORGANISM", 108, 115], ["vitamin E", "SIMPLE_CHEMICAL", 130, 139], ["selenium", "SIMPLE_CHEMICAL", 140, 148], ["piglets", "SPECIES", 108, 115], ["Saccharated iron", "TREATMENT", 0, 16], ["acute widespread muscle necrosis", "PROBLEM", 29, 61], ["hepatic necrosis in piglets", "PROBLEM", 88, 115], ["marginal vitamin E", "TREATMENT", 121, 139], ["may produce", "UNCERTAINTY", 17, 28], ["acute", "OBSERVATION_MODIFIER", 29, 34], ["widespread", "OBSERVATION_MODIFIER", 35, 45], ["muscle", "ANATOMY", 46, 52], ["necrosis", "OBSERVATION", 53, 61], ["hepatic", "ANATOMY", 88, 95], ["necrosis", "OBSERVATION", 96, 104], ["marginal", "OBSERVATION_MODIFIER", 121, 129]]], ["The myocardium is not affected.IronAcute hepatotoxicity was reported in young foals because of administration of a proprietary paste of iron and yeast products, given as a dietary supplement within a few hours of birth.", [["myocardium", "ANATOMY", 4, 14], ["hepatotoxicity", "DISEASE", 41, 55], ["iron", "CHEMICAL", 136, 140], ["IronAcute", "CHEMICAL", 31, 40], ["iron", "CHEMICAL", 136, 140], ["myocardium", "MULTI-TISSUE_STRUCTURE", 4, 14], ["IronAcute", "SIMPLE_CHEMICAL", 31, 40], ["iron", "SIMPLE_CHEMICAL", 136, 140], ["yeast", "SPECIES", 145, 150], ["yeast", "SPECIES", 145, 150], ["IronAcute hepatotoxicity", "PROBLEM", 31, 55], ["a proprietary paste of iron", "TREATMENT", 113, 140], ["yeast products", "TREATMENT", 145, 159], ["a dietary supplement", "TREATMENT", 170, 190], ["myocardium", "ANATOMY", 4, 14], ["not", "UNCERTAINTY", 18, 21], ["affected", "OBSERVATION", 22, 30], ["hepatotoxicity", "OBSERVATION", 41, 55]]], ["Not all foals so treated became sick, but those that did developed severe acute centrilobular hepatocellular necrosis, resembling the disease in piglets, and dramatic ductular reaction (biliary hyperplasia).IronAcute iron intoxication has also been reported in young cattle administered injectable hematinics containing elemental iron, and rarely in adult horses administered oral vitamin supplements containing ferrous fumarate or ferrous sulfate.", [["hepatocellular", "ANATOMY", 94, 108], ["ductular", "ANATOMY", 167, 175], ["biliary hyperplasia", "ANATOMY", 186, 205], ["oral", "ANATOMY", 376, 380], ["centrilobular hepatocellular necrosis", "DISEASE", 80, 117], ["biliary hyperplasia", "DISEASE", 186, 205], ["iron", "CHEMICAL", 217, 221], ["elemental iron", "CHEMICAL", 320, 334], ["vitamin supplements", "CHEMICAL", 381, 400], ["ferrous fumarate", "CHEMICAL", 412, 428], ["ferrous sulfate", "CHEMICAL", 432, 447], ["iron", "CHEMICAL", 217, 221], ["iron", "CHEMICAL", 330, 334], ["ferrous fumarate", "CHEMICAL", 412, 428], ["ferrous sulfate", "CHEMICAL", 432, 447], ["foals", "ORGANISM", 8, 13], ["hepatocellular", "PATHOLOGICAL_FORMATION", 94, 108], ["piglets", "ORGANISM", 145, 152], ["ductular", "PATHOLOGICAL_FORMATION", 167, 175], ["biliary hyperplasia", "PATHOLOGICAL_FORMATION", 186, 205], ["IronAcute iron", "SIMPLE_CHEMICAL", 207, 221], ["cattle", "ORGANISM", 267, 273], ["hematinics", "SIMPLE_CHEMICAL", 298, 308], ["elemental iron", "SIMPLE_CHEMICAL", 320, 334], ["horses", "ORGANISM", 356, 362], ["oral", "ORGANISM_SUBDIVISION", 376, 380], ["vitamin", "SIMPLE_CHEMICAL", 381, 388], ["ferrous fumarate", "SIMPLE_CHEMICAL", 412, 428], ["ferrous sulfate", "SIMPLE_CHEMICAL", 432, 447], ["piglets", "SPECIES", 145, 152], ["cattle", "SPECIES", 267, 273], ["cattle", "SPECIES", 267, 273], ["sick", "PROBLEM", 32, 36], ["severe acute centrilobular hepatocellular necrosis", "PROBLEM", 67, 117], ["the disease in piglets", "PROBLEM", 130, 152], ["dramatic ductular reaction", "PROBLEM", 158, 184], ["biliary hyperplasia", "PROBLEM", 186, 205], ["IronAcute iron intoxication", "PROBLEM", 207, 234], ["elemental iron", "TREATMENT", 320, 334], ["oral vitamin supplements", "TREATMENT", 376, 400], ["ferrous fumarate", "TREATMENT", 412, 428], ["ferrous sulfate", "TREATMENT", 432, 447], ["severe", "OBSERVATION_MODIFIER", 67, 73], ["acute", "OBSERVATION_MODIFIER", 74, 79], ["centrilobular", "OBSERVATION_MODIFIER", 80, 93], ["hepatocellular", "ANATOMY", 94, 108], ["necrosis", "OBSERVATION", 109, 117], ["disease", "OBSERVATION", 134, 141], ["dramatic", "OBSERVATION_MODIFIER", 158, 166], ["ductular", "OBSERVATION_MODIFIER", 167, 175], ["biliary", "ANATOMY", 186, 193], ["hyperplasia", "OBSERVATION", 194, 205], ["intoxication", "OBSERVATION", 222, 234]]], ["Oversupplementation, low vitamin E or selenium concentrations, or concurrent disease may have contributed to these cases.", [["vitamin E", "CHEMICAL", 25, 34], ["selenium", "CHEMICAL", 38, 46], ["vitamin E", "CHEMICAL", 25, 34], ["selenium", "CHEMICAL", 38, 46], ["vitamin E", "SIMPLE_CHEMICAL", 25, 34], ["selenium", "SIMPLE_CHEMICAL", 38, 46], ["Oversupplementation", "TREATMENT", 0, 19], ["low vitamin E", "PROBLEM", 21, 34], ["selenium concentrations", "PROBLEM", 38, 61], ["concurrent disease", "PROBLEM", 66, 84]]], ["Consumption of elemental iron produces a periportal or panlobular pattern of necrosis.Chronic hepatotoxicity: plant-derived and environmental toxins AflatoxinThe aflatoxins are a group of bisfuranocoumarin compounds produced as metabolites mainly by Aspergillus flavus, A. parasiticus, and Penicillium puberulum.", [["periportal", "ANATOMY", 41, 51], ["elemental iron", "CHEMICAL", 15, 29], ["necrosis", "DISEASE", 77, 85], ["hepatotoxicity", "DISEASE", 94, 108], ["Aflatoxin", "CHEMICAL", 149, 158], ["aflatoxins", "CHEMICAL", 162, 172], ["bisfuranocoumarin", "CHEMICAL", 188, 205], ["iron", "CHEMICAL", 25, 29], ["Aflatoxin", "CHEMICAL", 149, 158], ["aflatoxins", "CHEMICAL", 162, 172], ["bisfuranocoumarin", "CHEMICAL", 188, 205], ["elemental iron", "SIMPLE_CHEMICAL", 15, 29], ["Aflatoxin", "SIMPLE_CHEMICAL", 149, 158], ["aflatoxins", "SIMPLE_CHEMICAL", 162, 172], ["bisfuranocoumarin compounds", "SIMPLE_CHEMICAL", 188, 215], ["Aspergillus flavus", "ORGANISM", 250, 268], ["A. parasiticus", "ORGANISM", 270, 284], ["Penicillium puberulum", "ORGANISM", 290, 311], ["Aspergillus flavus", "SPECIES", 250, 268], ["A. parasiticus", "SPECIES", 270, 284], ["Penicillium puberulum", "SPECIES", 290, 311], ["Aspergillus flavus", "SPECIES", 250, 268], ["A. parasiticus", "SPECIES", 270, 284], ["Penicillium puberulum", "SPECIES", 290, 311], ["elemental iron", "TREATMENT", 15, 29], ["necrosis", "PROBLEM", 77, 85], ["Chronic hepatotoxicity", "PROBLEM", 86, 108], ["environmental toxins Aflatoxin", "TREATMENT", 128, 158], ["a group of bisfuranocoumarin compounds", "TREATMENT", 177, 215], ["Aspergillus flavus", "PROBLEM", 250, 268], ["A. parasiticus, and Penicillium puberulum", "PROBLEM", 270, 311], ["elemental iron", "OBSERVATION", 15, 29], ["periportal", "ANATOMY", 41, 51], ["panlobular", "OBSERVATION_MODIFIER", 55, 65], ["pattern", "OBSERVATION_MODIFIER", 66, 73], ["necrosis", "OBSERVATION", 77, 85], ["hepatotoxicity", "OBSERVATION", 94, 108], ["Aspergillus flavus", "OBSERVATION", 250, 268], ["parasiticus", "OBSERVATION", 273, 284], ["Penicillium puberulum", "OBSERVATION", 290, 311]]], ["The metabolites are designated by the blue or green color they fluoresce when viewed under ultraviolet light and migration patterns during chromatography, and the major ones are B 1 , B 2 , G 1 , and G 2 .", [["B 2", "GENE_OR_GENE_PRODUCT", 184, 187], ["G 1", "GENE_OR_GENE_PRODUCT", 190, 193], ["G 2", "GENE_OR_GENE_PRODUCT", 200, 203], ["ultraviolet light", "TREATMENT", 91, 108], ["migration patterns", "TEST", 113, 131], ["chromatography", "TEST", 139, 153], ["G", "TEST", 190, 191]]], ["A less toxic metabolite, M 1 is found in milk and other dairy products from cattle that ingest B 1 .", [["milk", "ANATOMY", 41, 45], ["M 1", "GENE_OR_GENE_PRODUCT", 25, 28], ["milk", "ORGANISM_SUBSTANCE", 41, 45], ["B 1", "GENE_OR_GENE_PRODUCT", 95, 98], ["cattle", "SPECIES", 76, 82], ["cattle", "SPECIES", 76, 82], ["A less toxic metabolite", "PROBLEM", 0, 23], ["less", "OBSERVATION_MODIFIER", 2, 6], ["toxic", "OBSERVATION_MODIFIER", 7, 12], ["metabolite", "OBSERVATION_MODIFIER", 13, 23]]], ["Many others may be produced in minor amounts in fungal colonies or as metabolic products of the major toxins in animals.", [["colonies", "ANATOMY", 55, 63], ["fungal colonies", "PROBLEM", 48, 63], ["may be", "UNCERTAINTY", 12, 18], ["fungal colonies", "OBSERVATION", 48, 63]]], ["The most significant and best studied of the aflatoxins is B 1 because of its relative abundance and its potency as a hepatotoxin.Chronic hepatotoxicity: plant-derived and environmental toxins AflatoxinStrains of Aspergillus differ in the varieties and amounts of individual toxins produced, indicating that the biosynthesis of the toxins is genetically determined.", [["hepatotoxin", "CHEMICAL", 118, 129], ["hepatotoxicity", "DISEASE", 138, 152], ["AflatoxinStrains", "CHEMICAL", 193, 209], ["aflatoxins", "CHEMICAL", 45, 55], ["aflatoxins", "SIMPLE_CHEMICAL", 45, 55], ["B 1", "GENE_OR_GENE_PRODUCT", 59, 62], ["hepatotoxin", "SIMPLE_CHEMICAL", 118, 129], ["AflatoxinStrains", "SIMPLE_CHEMICAL", 193, 209], ["a hepatotoxin", "TREATMENT", 116, 129], ["Chronic hepatotoxicity", "PROBLEM", 130, 152], ["environmental toxins", "TEST", 172, 192], ["Aspergillus", "PROBLEM", 213, 224], ["individual toxins", "PROBLEM", 264, 281], ["the biosynthesis of the toxins", "PROBLEM", 308, 338], ["most significant", "OBSERVATION_MODIFIER", 4, 20], ["hepatotoxicity", "OBSERVATION", 138, 152], ["Aspergillus", "OBSERVATION", 213, 224]]], ["The production of 333.e1 eFigure 2-27 Acute aflatoxin injury in the liver of a dog, characterized by acute necrosis and hepatic lipidosis in surrounding hepatocytes. evidence of pathologic changes in the lungs, whereas pigs given higher doses showed hepatic necrosis in addition to pulmonary edema.", [["liver", "ANATOMY", 68, 73], ["hepatic", "ANATOMY", 120, 127], ["hepatocytes", "ANATOMY", 153, 164], ["lungs", "ANATOMY", 204, 209], ["hepatic", "ANATOMY", 250, 257], ["pulmonary", "ANATOMY", 282, 291], ["333.e1 eFigure 2-27", "CHEMICAL", 18, 37], ["aflatoxin injury", "DISEASE", 44, 60], ["necrosis", "DISEASE", 107, 115], ["hepatic necrosis", "DISEASE", 250, 266], ["pulmonary edema", "DISEASE", 282, 297], ["aflatoxin", "CHEMICAL", 44, 53], ["liver", "ORGAN", 68, 73], ["dog", "ORGANISM", 79, 82], ["hepatic", "ORGAN", 120, 127], ["hepatocytes", "CELL", 153, 164], ["lungs", "ORGAN", 204, 209], ["pigs", "ORGANISM", 219, 223], ["hepatic", "ORGAN", 250, 257], ["pulmonary edema", "PATHOLOGICAL_FORMATION", 282, 297], ["hepatocytes", "CELL_TYPE", 153, 164], ["dog", "SPECIES", 79, 82], ["pigs", "SPECIES", 219, 223], ["pigs", "SPECIES", 219, 223], ["The production", "TEST", 0, 14], ["eFigure", "TEST", 25, 32], ["Acute aflatoxin injury", "PROBLEM", 38, 60], ["acute necrosis", "PROBLEM", 101, 115], ["hepatic lipidosis in surrounding hepatocytes", "PROBLEM", 120, 164], ["pathologic changes in the lungs", "PROBLEM", 178, 209], ["hepatic necrosis", "PROBLEM", 250, 266], ["pulmonary edema", "PROBLEM", 282, 297], ["Acute", "OBSERVATION_MODIFIER", 38, 43], ["aflatoxin injury", "OBSERVATION", 44, 60], ["liver", "ANATOMY", 68, 73], ["acute", "OBSERVATION_MODIFIER", 101, 106], ["necrosis", "OBSERVATION", 107, 115], ["hepatic", "ANATOMY", 120, 127], ["lipidosis", "OBSERVATION", 128, 137], ["hepatocytes", "ANATOMY", 153, 164], ["pathologic", "OBSERVATION", 178, 188], ["lungs", "ANATOMY", 204, 209], ["hepatic", "ANATOMY", 250, 257], ["necrosis", "OBSERVATION", 258, 266], ["pulmonary", "ANATOMY", 282, 291], ["edema", "OBSERVATION", 292, 297]]], ["The liver changes appear to be reversible upon cessation of exposure.", [["liver", "ANATOMY", 4, 9], ["liver", "ORGAN", 4, 9], ["liver", "ANATOMY", 4, 9], ["appear to be", "UNCERTAINTY", 18, 30], ["reversible", "OBSERVATION", 31, 41]]], ["Gilts fed low levels of fumonisin B 1 for 90 days developed hepatic nodular hyperplasia, along with hyperkeratosis and parakeratosis and hyperplasia of the distal esophageal mucosa.", [["hepatic nodular hyperplasia", "ANATOMY", 60, 87], ["parakeratosis", "ANATOMY", 119, 132], ["distal esophageal mucosa", "ANATOMY", 156, 180], ["fumonisin B", "CHEMICAL", 24, 35], ["hepatic nodular hyperplasia", "DISEASE", 60, 87], ["hyperkeratosis", "DISEASE", 100, 114], ["parakeratosis", "DISEASE", 119, 132], ["hyperplasia of the distal esophageal mucosa", "DISEASE", 137, 180], ["fumonisin B 1", "CHEMICAL", 24, 37], ["fumonisin B 1", "GENE_OR_GENE_PRODUCT", 24, 37], ["hepatic nodular hyperplasia", "PATHOLOGICAL_FORMATION", 60, 87], ["esophageal mucosa", "MULTI-TISSUE_STRUCTURE", 163, 180], ["hepatic nodular hyperplasia", "PROBLEM", 60, 87], ["hyperkeratosis", "PROBLEM", 100, 114], ["parakeratosis", "PROBLEM", 119, 132], ["hyperplasia of the distal esophageal mucosa", "PROBLEM", 137, 180], ["hepatic", "ANATOMY", 60, 67], ["nodular", "OBSERVATION_MODIFIER", 68, 75], ["hyperplasia", "OBSERVATION", 76, 87], ["hyperkeratosis", "OBSERVATION", 100, 114], ["parakeratosis", "OBSERVATION", 119, 132], ["hyperplasia", "OBSERVATION", 137, 148], ["distal", "ANATOMY_MODIFIER", 156, 162], ["esophageal mucosa", "ANATOMY", 163, 180]]], ["Fumonisins are inhibitors of sphingosine and ceramide synthetase, leading to inhibition of sphingolipid biosynthesis.", [["Fumonisins", "CHEMICAL", 0, 10], ["sphingosine", "CHEMICAL", 29, 40], ["ceramide", "CHEMICAL", 45, 53], ["Fumonisins", "CHEMICAL", 0, 10], ["sphingosine", "CHEMICAL", 29, 40], ["ceramide", "CHEMICAL", 45, 53], ["sphingolipid", "CHEMICAL", 91, 103], ["Fumonisins", "SIMPLE_CHEMICAL", 0, 10], ["sphingosine", "SIMPLE_CHEMICAL", 29, 40], ["ceramide synthetase", "GENE_OR_GENE_PRODUCT", 45, 64], ["sphingolipid", "SIMPLE_CHEMICAL", 91, 103], ["ceramide synthetase", "PROTEIN", 45, 64], ["Fumonisins", "TREATMENT", 0, 10], ["inhibitors", "TREATMENT", 15, 25], ["sphingosine and ceramide synthetase", "TREATMENT", 29, 64], ["sphingolipid biosynthesis", "PROBLEM", 91, 116], ["sphingolipid biosynthesis", "OBSERVATION", 91, 116]]], ["As a consequence, there is an accumulation of bioactive intermediates of sphingolipid metabolism (sphinganine and other sphingoid bases and derivatives), as well as the depletion of complex sphingolipids, which interfere with the function of some membrane proteins and may be involved in the toxic hepatic effects.PhomopsinThere are 2 distinct manifestations of toxicity associated with Lupinus spp.; discussed here is the condition formerly known as \"lupinosis,\" which is a true mycotoxic liver disease.", [["membrane", "ANATOMY", 247, 255], ["hepatic", "ANATOMY", 298, 305], ["liver", "ANATOMY", 490, 495], ["sphinganine", "CHEMICAL", 98, 109], ["toxicity", "DISEASE", 362, 370], ["Lupinus spp.", "DISEASE", 387, 399], ["lupinosis", "DISEASE", 452, 461], ["liver disease", "DISEASE", 490, 503], ["sphingolipid", "CHEMICAL", 73, 85], ["sphinganine", "CHEMICAL", 98, 109], ["sphingoid bases", "CHEMICAL", 120, 135], ["sphingolipids", "CHEMICAL", 190, 203], ["sphingolipid", "SIMPLE_CHEMICAL", 73, 85], ["sphinganine", "SIMPLE_CHEMICAL", 98, 109], ["sphingoid", "SIMPLE_CHEMICAL", 120, 129], ["membrane", "CELLULAR_COMPONENT", 247, 255], ["hepatic", "ORGAN", 298, 305], ["Lupinus spp.", "ORGANISM", 387, 399], ["liver", "ORGAN", 490, 495], ["membrane proteins", "PROTEIN", 247, 264], ["Lupinus spp.", "SPECIES", 387, 399], ["Lupinus spp.", "SPECIES", 387, 399], ["sphingolipid metabolism (sphinganine", "TREATMENT", 73, 109], ["other sphingoid bases", "TREATMENT", 114, 135], ["derivatives", "TREATMENT", 140, 151], ["the depletion of complex sphingolipids", "PROBLEM", 165, 203], ["some membrane proteins", "PROBLEM", 242, 264], ["the toxic hepatic effects", "PROBLEM", 288, 313], ["toxicity", "PROBLEM", 362, 370], ["Lupinus spp.", "PROBLEM", 387, 399], ["a true mycotoxic liver disease", "PROBLEM", 473, 503], ["accumulation", "OBSERVATION_MODIFIER", 30, 42], ["bioactive intermediates", "OBSERVATION", 46, 69], ["sphingolipid metabolism", "OBSERVATION", 73, 96], ["sphingoid bases", "OBSERVATION", 120, 135], ["may be", "UNCERTAINTY", 269, 275], ["toxic", "OBSERVATION_MODIFIER", 292, 297], ["hepatic", "ANATOMY", 298, 305], ["liver", "ANATOMY", 490, 495], ["disease", "OBSERVATION", 496, 503]]], ["The teratogenic and neurotoxic effects of some of the isoquinoline alkaloids from the plants themselves are discussed in Vol.", [["neurotoxic", "DISEASE", 20, 30], ["isoquinoline alkaloids", "CHEMICAL", 54, 76], ["isoquinoline alkaloids", "CHEMICAL", 54, 76], ["isoquinoline alkaloids", "SIMPLE_CHEMICAL", 54, 76], ["The teratogenic", "PROBLEM", 0, 15], ["the isoquinoline alkaloids", "TREATMENT", 50, 76], ["teratogenic", "OBSERVATION_MODIFIER", 4, 15], ["neurotoxic", "OBSERVATION_MODIFIER", 20, 30], ["isoquinoline alkaloids", "OBSERVATION", 54, 76]]], ["1, Bones and joints and Vol.", [["joints", "ANATOMY", 13, 19], ["joints", "MULTI-TISSUE_STRUCTURE", 13, 19], ["Bones", "ANATOMY", 3, 8], ["joints", "ANATOMY", 13, 19]]], ["1, Nervous system.PhomopsinThe fungus Diaporthe toxica (formerly Phomopsis leptostromiformis) is parasitic on green Lupinus plants, but it becomes saprophytic after the host plant dies.", [["Nervous system", "ANATOMY", 3, 17], ["Phomopsin", "CHEMICAL", 18, 27], ["Phomopsin", "GENE_OR_GENE_PRODUCT", 18, 27], ["fungus", "ORGANISM", 31, 37], ["Diaporthe toxica", "ORGANISM", 38, 54], ["Phomopsis leptostromiformis", "ORGANISM", 65, 92], ["Lupinus plants", "ORGANISM", 116, 130], ["Diaporthe toxica", "SPECIES", 38, 54], ["Phomopsis leptostromiformis", "SPECIES", 65, 92], ["Diaporthe toxica", "SPECIES", 38, 54], ["Phomopsis leptostromiformis", "SPECIES", 65, 92], ["green Lupinus plants", "SPECIES", 110, 130], ["Phomopsin", "TREATMENT", 18, 27], ["The fungus Diaporthe toxica (formerly Phomopsis leptostromiformis", "PROBLEM", 27, 92], ["parasitic on green Lupinus plants", "PROBLEM", 97, 130], ["saprophytic", "PROBLEM", 147, 158], ["Nervous system", "ANATOMY", 3, 17], ["parasitic", "OBSERVATION_MODIFIER", 97, 106], ["Lupinus plants", "OBSERVATION", 116, 130], ["saprophytic", "OBSERVATION_MODIFIER", 147, 158]]], ["Phomopsins (A or B) are produced if the lupin stubble is moistened, and such stubbles may remain toxic for months.", [["Phomopsins", "SIMPLE_CHEMICAL", 0, 10], ["B", "GENE_OR_GENE_PRODUCT", 17, 18], ["lupin", "ORGANISM", 40, 45], ["Phomopsins (A or B)", "TREATMENT", 0, 19], ["the lupin stubble", "PROBLEM", 36, 53]]], ["Additional toxins are suspected.", [["Additional toxins", "PROBLEM", 0, 17]]], ["Severe acute liver damage has been described in sheep on very toxic stubbles in Western Australia, but in many of these cases, it has been difficult to separate the toxicity of the lupins from that of copper, which in this area is often concentrated in ovine livers (see later section on Copper).PhomopsinThe usual syndrome of phomopsin poisoning is subacute to chronic.", [["liver", "ANATOMY", 13, 18], ["livers", "ANATOMY", 259, 265], ["acute liver damage", "DISEASE", 7, 25], ["toxicity", "DISEASE", 165, 173], ["copper", "CHEMICAL", 201, 207], ["Copper", "CHEMICAL", 288, 294], ["Phomopsin", "CHEMICAL", 296, 305], ["phomopsin", "CHEMICAL", 327, 336], ["poisoning", "DISEASE", 337, 346], ["copper", "CHEMICAL", 201, 207], ["Copper", "CHEMICAL", 288, 294], ["phomopsin", "CHEMICAL", 327, 336], ["liver", "ORGAN", 13, 18], ["sheep", "ORGANISM", 48, 53], ["copper", "SIMPLE_CHEMICAL", 201, 207], ["ovine", "ORGANISM", 253, 258], ["livers", "ORGAN", 259, 265], ["Copper", "SIMPLE_CHEMICAL", 288, 294], ["Phomopsin", "SIMPLE_CHEMICAL", 296, 305], ["sheep", "SPECIES", 48, 53], ["sheep", "SPECIES", 48, 53], ["Severe acute liver damage", "PROBLEM", 0, 25], ["very toxic stubbles", "PROBLEM", 57, 76], ["Phomopsin", "TREATMENT", 296, 305], ["phomopsin poisoning", "PROBLEM", 327, 346], ["acute", "OBSERVATION_MODIFIER", 7, 12], ["liver", "ANATOMY", 13, 18], ["damage", "OBSERVATION", 19, 25], ["very", "OBSERVATION_MODIFIER", 57, 61], ["toxic", "OBSERVATION_MODIFIER", 62, 67], ["stubbles", "OBSERVATION", 68, 76], ["livers", "ANATOMY", 259, 265], ["subacute", "OBSERVATION_MODIFIER", 350, 358], ["chronic", "OBSERVATION_MODIFIER", 362, 369]]], ["Inappetance occurs soon after experimental administration of the toxin is begun; liver damage is clinically inapparent for several days.", [["liver", "ANATOMY", 81, 86], ["Inappetance", "DISEASE", 0, 11], ["liver damage", "DISEASE", 81, 93], ["liver", "ORGAN", 81, 86], ["the toxin", "TREATMENT", 61, 70], ["liver damage", "PROBLEM", 81, 93], ["liver", "ANATOMY", 81, 86], ["damage", "OBSERVATION", 87, 93]]], ["The gross pathologic abnormalities of acutely intoxicated sheep include icterus and modest ascites.", [["ascites", "ANATOMY", 91, 98], ["icterus", "DISEASE", 72, 79], ["ascites", "DISEASE", 91, 98], ["sheep", "ORGANISM", 58, 63], ["sheep", "SPECIES", 58, 63], ["sheep", "SPECIES", 58, 63], ["The gross pathologic abnormalities", "PROBLEM", 0, 34], ["acutely intoxicated sheep", "PROBLEM", 38, 63], ["icterus", "PROBLEM", 72, 79], ["modest ascites", "PROBLEM", 84, 98], ["gross", "OBSERVATION_MODIFIER", 4, 9], ["pathologic", "OBSERVATION", 10, 20], ["acutely", "OBSERVATION_MODIFIER", 38, 45], ["intoxicated", "OBSERVATION_MODIFIER", 46, 57], ["icterus", "OBSERVATION", 72, 79], ["modest", "OBSERVATION_MODIFIER", 84, 90], ["ascites", "OBSERVATION", 91, 98]]], ["The main abnormalities are evident in the liver, which varies from a yellow discoloration because of lipidosis in more acute cases, to a variable ochre to orange discoloration with a firm texture with increasing chronicity (Fig. 2-97A) .", [["liver", "ANATOMY", 42, 47], ["lipidosis", "DISEASE", 101, 110], ["liver", "ORGAN", 42, 47], ["The main abnormalities", "PROBLEM", 0, 22], ["a yellow discoloration", "PROBLEM", 67, 89], ["lipidosis", "PROBLEM", 101, 110], ["a variable ochre", "PROBLEM", 135, 151], ["orange discoloration", "PROBLEM", 155, 175], ["increasing chronicity", "PROBLEM", 201, 222], ["main", "OBSERVATION_MODIFIER", 4, 8], ["abnormalities", "OBSERVATION", 9, 22], ["liver", "ANATOMY", 42, 47], ["yellow discoloration", "OBSERVATION", 69, 89], ["lipidosis", "OBSERVATION", 101, 110], ["more acute", "OBSERVATION_MODIFIER", 114, 124], ["cases", "OBSERVATION", 125, 130], ["variable", "OBSERVATION_MODIFIER", 137, 145], ["ochre", "OBSERVATION", 146, 151], ["orange discoloration", "OBSERVATION", 155, 175], ["firm texture", "OBSERVATION_MODIFIER", 183, 195], ["increasing", "OBSERVATION_MODIFIER", 201, 211], ["chronicity", "OBSERVATION", 212, 222]]], ["Histologically, there is early hepatocyte swelling and accelerated cell death among hepatocytes.", [["hepatocyte", "ANATOMY", 31, 41], ["cell", "ANATOMY", 67, 71], ["hepatocytes", "ANATOMY", 84, 95], ["death", "DISEASE", 72, 77], ["hepatocyte", "CELL", 31, 41], ["cell", "CELL", 67, 71], ["hepatocytes", "CELL", 84, 95], ["hepatocytes", "CELL_TYPE", 84, 95], ["early hepatocyte swelling", "PROBLEM", 25, 50], ["accelerated cell death among hepatocytes", "PROBLEM", 55, 95], ["early", "OBSERVATION_MODIFIER", 25, 30], ["hepatocyte", "ANATOMY", 31, 41], ["swelling", "OBSERVATION", 42, 50], ["accelerated cell death", "OBSERVATION", 55, 77], ["hepatocytes", "ANATOMY", 84, 95]]], ["Increased mitotic activity is soon apparent, although by this time, the liver has become smaller.", [["liver", "ANATOMY", 72, 77], ["liver", "ORGAN", 72, 77], ["Increased mitotic activity", "PROBLEM", 0, 26], ["mitotic activity", "OBSERVATION", 10, 26], ["liver", "ANATOMY", 72, 77], ["smaller", "OBSERVATION_MODIFIER", 89, 96]]], ["The mitotic activity is in fact largely ineffectual, as close examination reveals that many mitotic figures are abnormal.", [["close examination", "TEST", 56, 73], ["many mitotic figures", "PROBLEM", 87, 107], ["mitotic activity", "OBSERVATION", 4, 20], ["largely", "OBSERVATION_MODIFIER", 32, 39], ["ineffectual", "OBSERVATION", 40, 51], ["many", "OBSERVATION_MODIFIER", 87, 91], ["mitotic figures", "OBSERVATION", 92, 107], ["abnormal", "OBSERVATION_MODIFIER", 112, 120]]], ["There is either clumping or dispersal of chromatin, and there appears to be mitotic arrest at late metaphase ( Fig. 2-97B-D) .", [["chromatin", "ANATOMY", 41, 50], ["chromatin", "CELLULAR_COMPONENT", 41, 50], ["metaphase", "CELLULAR_COMPONENT", 99, 108], ["chromatin", "DNA", 41, 50], ["clumping", "PROBLEM", 16, 24], ["dispersal of chromatin", "PROBLEM", 28, 50], ["mitotic arrest", "PROBLEM", 76, 90], ["clumping", "OBSERVATION_MODIFIER", 16, 24], ["dispersal", "OBSERVATION_MODIFIER", 28, 37], ["appears to be", "UNCERTAINTY", 62, 75], ["mitotic arrest", "OBSERVATION", 76, 90]]], ["Remaining hepatocytes swell, their cytoplasm becomes granular, and their nuclei vesicular and may contain vesicular intranuclear pseudoinclusions.", [["hepatocytes", "ANATOMY", 10, 21], ["cytoplasm", "ANATOMY", 35, 44], ["nuclei vesicular", "ANATOMY", 73, 89], ["vesicular intranuclear pseudoinclusions", "ANATOMY", 106, 145], ["hepatocytes", "CELL", 10, 21], ["cytoplasm", "ORGANISM_SUBSTANCE", 35, 44], ["nuclei vesicular", "CELLULAR_COMPONENT", 73, 89], ["hepatocytes", "CELL_TYPE", 10, 21], ["Remaining hepatocytes swell", "PROBLEM", 0, 27], ["granular", "PROBLEM", 53, 61], ["vesicular intranuclear pseudoinclusions", "PROBLEM", 106, 145], ["hepatocytes", "ANATOMY", 10, 21], ["swell", "OBSERVATION", 22, 27], ["cytoplasm", "OBSERVATION_MODIFIER", 35, 44], ["granular", "OBSERVATION_MODIFIER", 53, 61], ["nuclei vesicular", "OBSERVATION", 73, 89], ["may contain", "UNCERTAINTY", 94, 105], ["vesicular", "OBSERVATION", 106, 115], ["intranuclear pseudoinclusions", "OBSERVATION", 116, 145]]], ["There is variably severe fatty change, dependent to a large degree on the fat reserves of the animal.", [["fat", "ANATOMY", 74, 77], ["fat", "TISSUE", 74, 77], ["variably severe fatty change", "PROBLEM", 9, 37], ["variably", "OBSERVATION_MODIFIER", 9, 17], ["severe", "OBSERVATION_MODIFIER", 18, 24], ["fatty change", "OBSERVATION", 25, 37], ["dependent", "OBSERVATION_MODIFIER", 39, 48], ["large", "OBSERVATION_MODIFIER", 54, 59], ["degree", "OBSERVATION_MODIFIER", 60, 66], ["fat reserves", "OBSERVATION", 74, 86]]], ["There is also accumulation of complex pigment in macrophages in portal stroma and about hepatic venules; this granular material contains lipofuscin, ferric iron, and copper at least.", [["macrophages", "ANATOMY", 49, 60], ["portal stroma", "ANATOMY", 64, 77], ["hepatic venules", "ANATOMY", 88, 103], ["granular material", "ANATOMY", 110, 127], ["lipofuscin", "CHEMICAL", 137, 147], ["ferric iron", "CHEMICAL", 149, 160], ["copper", "CHEMICAL", 166, 172], ["ferric iron", "CHEMICAL", 149, 160], ["copper", "CHEMICAL", 166, 172], ["macrophages", "CELL", 49, 60], ["portal stroma", "TISSUE", 64, 77], ["hepatic venules", "MULTI-TISSUE_STRUCTURE", 88, 103], ["lipofuscin", "SIMPLE_CHEMICAL", 137, 147], ["ferric iron", "SIMPLE_CHEMICAL", 149, 160], ["copper", "SIMPLE_CHEMICAL", 166, 172], ["macrophages", "CELL_TYPE", 49, 60], ["hepatic venules", "CELL_TYPE", 88, 103], ["complex pigment in macrophages in portal stroma", "PROBLEM", 30, 77], ["hepatic venules", "PROBLEM", 88, 103], ["this granular material", "PROBLEM", 105, 127], ["ferric iron", "TREATMENT", 149, 160], ["accumulation", "OBSERVATION_MODIFIER", 14, 26], ["complex", "OBSERVATION_MODIFIER", 30, 37], ["pigment", "OBSERVATION_MODIFIER", 38, 45], ["macrophages", "OBSERVATION", 49, 60], ["portal stroma", "ANATOMY", 64, 77], ["hepatic", "ANATOMY", 88, 95], ["venules", "ANATOMY_MODIFIER", 96, 103], ["granular material", "OBSERVATION", 110, 127], ["lipofuscin", "OBSERVATION_MODIFIER", 137, 147]]], ["Bile duct proliferation is also a prominent feature of the chronic disease.", [["Bile duct", "ANATOMY", 0, 9], ["Bile duct", "MULTI-TISSUE_STRUCTURE", 0, 9], ["Bile duct proliferation", "PROBLEM", 0, 23], ["the chronic disease", "PROBLEM", 55, 74], ["duct", "ANATOMY", 5, 9], ["proliferation", "OBSERVATION", 10, 23], ["prominent feature", "OBSERVATION_MODIFIER", 34, 51], ["chronic", "OBSERVATION_MODIFIER", 59, 66], ["disease", "OBSERVATION", 67, 74]]], ["With progression, hepatic fibrosis occurs, predominantly diffuse in distribution, and by this stage, there is usually clinical icterus and anorexia.PhomopsinThe liver continues to shrink, presumably as a result of continued mitotic inhibition and progressive fibrosis.", [["hepatic", "ANATOMY", 18, 25], ["liver", "ANATOMY", 161, 166], ["hepatic fibrosis", "DISEASE", 18, 34], ["icterus", "DISEASE", 127, 134], ["anorexia", "DISEASE", 139, 147], ["Phomopsin", "CHEMICAL", 148, 157], ["fibrosis", "DISEASE", 259, 267], ["hepatic", "ORGAN", 18, 25], ["Phomopsin", "GENE_OR_GENE_PRODUCT", 148, 157], ["liver", "ORGAN", 161, 166], ["hepatic fibrosis", "PROBLEM", 18, 34], ["usually clinical icterus", "PROBLEM", 110, 134], ["anorexia", "PROBLEM", 139, 147], ["Phomopsin", "TREATMENT", 148, 157], ["continued mitotic inhibition", "PROBLEM", 214, 242], ["progressive fibrosis", "PROBLEM", 247, 267], ["progression", "OBSERVATION_MODIFIER", 5, 16], ["hepatic", "ANATOMY", 18, 25], ["fibrosis", "OBSERVATION", 26, 34], ["predominantly", "OBSERVATION_MODIFIER", 43, 56], ["diffuse", "OBSERVATION_MODIFIER", 57, 64], ["distribution", "OBSERVATION_MODIFIER", 68, 80], ["icterus", "OBSERVATION", 127, 134], ["anorexia", "OBSERVATION", 139, 147], ["liver", "ANATOMY", 161, 166], ["mitotic inhibition", "OBSERVATION", 224, 242], ["progressive", "OBSERVATION_MODIFIER", 247, 258], ["fibrosis", "OBSERVATION", 259, 267]]], ["The organ is small, tough, and has a finely granular surface and texture.", [["organ", "ANATOMY", 4, 9], ["granular surface", "ANATOMY", 44, 60], ["organ", "ORGAN", 4, 9], ["granular surface", "CELLULAR_COMPONENT", 44, 60], ["organ", "ANATOMY", 4, 9], ["small", "OBSERVATION_MODIFIER", 13, 18], ["tough", "OBSERVATION_MODIFIER", 20, 25], ["finely", "OBSERVATION_MODIFIER", 37, 43], ["granular", "OBSERVATION_MODIFIER", 44, 52], ["surface", "OBSERVATION_MODIFIER", 53, 60], ["texture", "OBSERVATION_MODIFIER", 65, 72]]], ["It is pale gray-orange but usually retains its shape.", [["pale", "OBSERVATION_MODIFIER", 6, 10], ["orange", "OBSERVATION", 16, 22], ["shape", "OBSERVATION_MODIFIER", 47, 52]]], ["Fibrosis is and ductules regenerate as the liver becomes atrophic.", [["ductules", "ANATOMY", 16, 24], ["liver", "ANATOMY", 43, 48], ["Fibrosis", "DISEASE", 0, 8], ["ductules", "MULTI-TISSUE_STRUCTURE", 16, 24], ["liver", "ORGAN", 43, 48], ["Fibrosis", "PROBLEM", 0, 8], ["atrophic", "PROBLEM", 57, 65], ["ductules", "ANATOMY_MODIFIER", 16, 24], ["liver", "ANATOMY", 43, 48], ["atrophic", "OBSERVATION", 57, 65]]], ["These are also genotoxic and carcinogenic, so they might be involved in the occurrence of liver cancers in animals, as they are in humans.PhomopsinAt higher dose rates of aflatoxin, most centrilobular hepatocytes disappear and are replaced by a mixture of inflammatory cells, fibroblasts, and primitive vascular channels.", [["liver cancers", "ANATOMY", 90, 103], ["centrilobular hepatocytes", "ANATOMY", 187, 212], ["inflammatory cells", "ANATOMY", 256, 274], ["fibroblasts", "ANATOMY", 276, 287], ["vascular", "ANATOMY", 303, 311], ["liver cancers", "DISEASE", 90, 103], ["PhomopsinAt", "CHEMICAL", 138, 149], ["aflatoxin", "CHEMICAL", 171, 180], ["PhomopsinAt", "CHEMICAL", 138, 149], ["aflatoxin", "CHEMICAL", 171, 180], ["liver cancers", "CANCER", 90, 103], ["humans", "ORGANISM", 131, 137], ["PhomopsinAt", "SIMPLE_CHEMICAL", 138, 149], ["aflatoxin", "SIMPLE_CHEMICAL", 171, 180], ["centrilobular hepatocytes", "CELL", 187, 212], ["inflammatory cells", "CELL", 256, 274], ["fibroblasts", "CELL", 276, 287], ["vascular", "MULTI-TISSUE_STRUCTURE", 303, 311], ["centrilobular hepatocytes", "CELL_TYPE", 187, 212], ["inflammatory cells", "CELL_TYPE", 256, 274], ["fibroblasts", "CELL_TYPE", 276, 287], ["humans", "SPECIES", 131, 137], ["humans", "SPECIES", 131, 137], ["liver cancers", "PROBLEM", 90, 103], ["PhomopsinAt", "TREATMENT", 138, 149], ["aflatoxin", "TREATMENT", 171, 180], ["most centrilobular hepatocytes", "PROBLEM", 182, 212], ["inflammatory cells", "PROBLEM", 256, 274], ["fibroblasts", "PROBLEM", 276, 287], ["genotoxic", "OBSERVATION_MODIFIER", 15, 24], ["carcinogenic", "OBSERVATION_MODIFIER", 29, 41], ["liver", "ANATOMY", 90, 95], ["cancers", "OBSERVATION", 96, 103], ["most", "OBSERVATION_MODIFIER", 182, 186], ["centrilobular", "OBSERVATION_MODIFIER", 187, 200], ["hepatocytes", "ANATOMY", 201, 212], ["inflammatory cells", "OBSERVATION", 256, 274], ["fibroblasts", "OBSERVATION", 276, 287], ["primitive", "ANATOMY_MODIFIER", 293, 302], ["vascular channels", "ANATOMY", 303, 320]]], ["The liver may be much smaller than normal, particularly in young animals, presumably because of mitotic inhibition, and focal hepatocellular necrosis is more obvious or may be supplanted by zonal (centrilobular) necrosis.", [["liver", "ANATOMY", 4, 9], ["hepatocellular", "ANATOMY", 126, 140], ["centrilobular", "ANATOMY", 197, 210], ["focal hepatocellular necrosis", "DISEASE", 120, 149], ["necrosis", "DISEASE", 212, 220], ["liver", "ORGAN", 4, 9], ["hepatocellular", "ORGAN", 126, 140], ["mitotic inhibition", "PROBLEM", 96, 114], ["focal hepatocellular necrosis", "PROBLEM", 120, 149], ["zonal (centrilobular) necrosis", "PROBLEM", 190, 220], ["liver", "ANATOMY", 4, 9], ["may be", "UNCERTAINTY", 10, 16], ["much", "OBSERVATION_MODIFIER", 17, 21], ["smaller", "OBSERVATION_MODIFIER", 22, 29], ["normal", "OBSERVATION", 35, 41], ["presumably because of", "UNCERTAINTY", 74, 95], ["mitotic inhibition", "OBSERVATION", 96, 114], ["focal", "OBSERVATION_MODIFIER", 120, 125], ["hepatocellular", "OBSERVATION_MODIFIER", 126, 140], ["necrosis", "OBSERVATION", 141, 149], ["may be", "UNCERTAINTY", 169, 175], ["zonal", "OBSERVATION_MODIFIER", 190, 195], ["centrilobular", "OBSERVATION_MODIFIER", 197, 210], ["necrosis", "OBSERVATION", 212, 220]]], ["Fatty change in these livers may be severe and uniformly distributed.FumonisinFumonisin B 1 , a mycotoxin elaborated by certain strains of Fusarium verticillioides (previously moniliforme) and F. proliferatum in infected corn, induces a pulmonary edema syndrome in pigs, hepatocellular carcinomas in laboratory rats, and leukoencephalomalacia.", [["livers", "ANATOMY", 22, 28], ["corn", "ANATOMY", 221, 225], ["pulmonary edema", "ANATOMY", 237, 252], ["hepatocellular carcinomas", "ANATOMY", 271, 296], ["FumonisinFumonisin B 1", "CHEMICAL", 69, 91], ["Fusarium verticillioides", "DISEASE", 139, 163], ["pulmonary edema syndrome", "DISEASE", 237, 261], ["hepatocellular carcinomas", "DISEASE", 271, 296], ["leukoencephalomalacia", "DISEASE", 321, 342], ["FumonisinFumonisin B", "CHEMICAL", 69, 89], ["Fatty", "SIMPLE_CHEMICAL", 0, 5], ["livers", "ORGAN", 22, 28], ["FumonisinFumonisin B 1", "GENE_OR_GENE_PRODUCT", 69, 91], ["Fusarium verticillioides", "ORGANISM", 139, 163], ["previously moniliforme", "ORGANISM", 165, 187], ["F. proliferatum", "ORGANISM", 193, 208], ["corn", "ORGANISM_SUBDIVISION", 221, 225], ["pulmonary edema", "PATHOLOGICAL_FORMATION", 237, 252], ["pigs", "ORGANISM", 265, 269], ["hepatocellular carcinomas", "CANCER", 271, 296], ["rats", "ORGANISM", 311, 315], ["Fusarium verticillioides", "SPECIES", 139, 163], ["F. proliferatum", "SPECIES", 193, 208], ["corn", "SPECIES", 221, 225], ["pigs", "SPECIES", 265, 269], ["rats", "SPECIES", 311, 315], ["Fusarium verticillioides", "SPECIES", 139, 163], ["F. proliferatum", "SPECIES", 193, 208], ["corn", "SPECIES", 221, 225], ["pigs", "SPECIES", 265, 269], ["Fatty change in these livers", "PROBLEM", 0, 28], ["a mycotoxin", "TREATMENT", 94, 105], ["Fusarium verticillioides", "PROBLEM", 139, 163], ["a pulmonary edema syndrome", "PROBLEM", 235, 261], ["hepatocellular carcinomas in laboratory rats", "PROBLEM", 271, 315], ["leukoencephalomalacia", "PROBLEM", 321, 342], ["change", "OBSERVATION", 6, 12], ["livers", "ANATOMY", 22, 28], ["may be", "UNCERTAINTY", 29, 35], ["severe", "OBSERVATION_MODIFIER", 36, 42], ["uniformly", "OBSERVATION_MODIFIER", 47, 56], ["distributed", "OBSERVATION_MODIFIER", 57, 68], ["infected", "OBSERVATION", 212, 220], ["pulmonary", "ANATOMY", 237, 246], ["edema", "OBSERVATION", 247, 252], ["hepatocellular", "ANATOMY", 271, 285], ["carcinomas", "OBSERVATION", 286, 296], ["leukoencephalomalacia", "OBSERVATION", 321, 342]]], ["Hepatotoxicity occurs in horses and swine.", [["Hepatotoxicity", "DISEASE", 0, 14], ["horses", "ORGANISM_SUBDIVISION", 25, 31], ["swine", "SPECIES", 36, 41], ["swine", "SPECIES", 36, 41], ["Hepatotoxicity", "PROBLEM", 0, 14]]], ["Hepatic toxicity has also been reported in sheep and baboons.", [["Hepatic", "ANATOMY", 0, 7], ["Hepatic toxicity", "DISEASE", 0, 16], ["Hepatic", "MULTI-TISSUE_STRUCTURE", 0, 7], ["sheep", "ORGANISM", 43, 48], ["baboons", "ORGANISM", 53, 60], ["sheep", "SPECIES", 43, 48], ["sheep", "SPECIES", 43, 48], ["Hepatic toxicity", "PROBLEM", 0, 16], ["toxicity", "OBSERVATION", 8, 16]]], ["In horses, hepatoxicity occurs less often than leukoencephalomalacia.", [["hepatoxicity", "DISEASE", 11, 23], ["leukoencephalomalacia", "DISEASE", 47, 68], ["leukoencephalomalacia", "CANCER", 47, 68], ["hepatoxicity", "PROBLEM", 11, 23], ["less often", "OBSERVATION_MODIFIER", 31, 41]]], ["The clinical course is relatively short, with death likely within 5-10 days of the onset of clinical signs, such as anorexia, depression, icterus, and edema of the head.", [["edema", "ANATOMY", 151, 156], ["head", "ANATOMY", 164, 168], ["death", "DISEASE", 46, 51], ["anorexia", "DISEASE", 116, 124], ["depression", "DISEASE", 126, 136], ["icterus", "DISEASE", 138, 145], ["edema", "DISEASE", 151, 156], ["edema", "PATHOLOGICAL_FORMATION", 151, 156], ["head", "ORGAN", 164, 168], ["death", "PROBLEM", 46, 51], ["clinical signs", "PROBLEM", 92, 106], ["anorexia", "PROBLEM", 116, 124], ["depression", "PROBLEM", 126, 136], ["icterus", "PROBLEM", 138, 145], ["edema of the head", "PROBLEM", 151, 168], ["anorexia", "OBSERVATION", 116, 124], ["icterus", "OBSERVATION", 138, 145], ["edema", "OBSERVATION", 151, 156], ["head", "ANATOMY", 164, 168]]], ["Bilirubin and liver enzymes are typically elevated.", [["liver", "ANATOMY", 14, 19], ["Bilirubin", "CHEMICAL", 0, 9], ["Bilirubin", "SIMPLE_CHEMICAL", 0, 9], ["liver", "ORGAN", 14, 19], ["liver enzymes", "PROTEIN", 14, 27], ["Bilirubin", "TEST", 0, 9], ["liver enzymes", "TEST", 14, 27], ["liver", "ANATOMY", 14, 19], ["elevated", "OBSERVATION_MODIFIER", 42, 50]]], ["At postmortem, the liver is typically firm, yellow, and small, with an accentuated lobular pattern.", [["liver", "ANATOMY", 19, 24], ["lobular", "ANATOMY", 83, 90], ["liver", "ORGAN", 19, 24], ["lobular", "CANCER", 83, 90], ["an accentuated lobular pattern", "PROBLEM", 68, 98], ["liver", "ANATOMY", 19, 24], ["typically", "OBSERVATION_MODIFIER", 28, 37], ["firm", "OBSERVATION", 38, 42], ["yellow", "OBSERVATION", 44, 50], ["small", "OBSERVATION_MODIFIER", 56, 61], ["accentuated", "OBSERVATION_MODIFIER", 71, 82], ["lobular pattern", "OBSERVATION", 83, 98]]], ["Histologic lesions include abundant apoptosis that may progress to centrilobular necrosis and variable amounts of fibrosis in the portal tracts.", [["lesions", "ANATOMY", 11, 18], ["centrilobular", "ANATOMY", 67, 80], ["portal tracts", "ANATOMY", 130, 143], ["necrosis", "DISEASE", 81, 89], ["fibrosis", "DISEASE", 114, 122], ["Histologic lesions", "CANCER", 0, 18], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 130, 143], ["Histologic lesions", "PROBLEM", 0, 18], ["abundant apoptosis", "PROBLEM", 27, 45], ["centrilobular necrosis", "PROBLEM", 67, 89], ["fibrosis in the portal tracts", "PROBLEM", 114, 143], ["lesions", "OBSERVATION", 11, 18], ["abundant", "OBSERVATION_MODIFIER", 27, 35], ["apoptosis", "OBSERVATION", 36, 45], ["centrilobular", "OBSERVATION_MODIFIER", 67, 80], ["necrosis", "OBSERVATION", 81, 89], ["variable", "OBSERVATION_MODIFIER", 94, 102], ["amounts", "OBSERVATION_MODIFIER", 103, 110], ["fibrosis", "OBSERVATION", 114, 122], ["portal tracts", "ANATOMY", 130, 143]]], ["Cardiotoxicity is also evident in swine and horses.FumonisinFumonisin B 1 is also a primary hepatotoxin in pigs.", [["Cardiotoxicity", "DISEASE", 0, 14], ["FumonisinFumonisin B", "CHEMICAL", 51, 71], ["FumonisinFumonisin B 1", "CHEMICAL", 51, 73], ["horses", "ORGANISM_SUBDIVISION", 44, 50], ["FumonisinFumonisin B 1", "GENE_OR_GENE_PRODUCT", 51, 73], ["hepatotoxin", "SIMPLE_CHEMICAL", 92, 103], ["pigs", "ORGANISM", 107, 111], ["swine", "SPECIES", 34, 39], ["pigs", "SPECIES", 107, 111], ["swine", "SPECIES", 34, 39], ["pigs", "SPECIES", 107, 111], ["Cardiotoxicity", "PROBLEM", 0, 14], ["a primary hepatotoxin in pigs", "TREATMENT", 82, 111]]], ["Experimental feeding trials with pigs have shown dose-related differences in pathology.", [["pigs", "ORGANISM", 33, 37], ["pigs", "SPECIES", 33, 37], ["pigs", "SPECIES", 33, 37], ["Experimental feeding trials", "TREATMENT", 0, 27], ["pigs", "TREATMENT", 33, 37]]], ["Pigs intubated with a minimum of 16 mg fumonisin B 1 /kg body weight per day developed interlobular edema, variable hydrothorax, and pulmonary edema, whereas pigs intubated with 8 mg/kg per day for 7-8 days, or fed diets containing 200 mg fumonisin B 1 /kg of feed for 21 days, developed marked icterus.", [["body", "ANATOMY", 57, 61], ["interlobular edema", "ANATOMY", 87, 105], ["pulmonary", "ANATOMY", 133, 142], ["fumonisin B", "CHEMICAL", 39, 50], ["interlobular edema", "DISEASE", 87, 105], ["hydrothorax", "DISEASE", 116, 127], ["pulmonary edema", "DISEASE", 133, 148], ["fumonisin B", "CHEMICAL", 239, 250], ["icterus", "DISEASE", 295, 302], ["fumonisin B", "CHEMICAL", 39, 50], ["fumonisin B", "CHEMICAL", 239, 250], ["Pigs", "ORGANISM", 0, 4], ["body", "ORGANISM_SUBDIVISION", 57, 61], ["interlobular edema", "PATHOLOGICAL_FORMATION", 87, 105], ["pulmonary edema", "PATHOLOGICAL_FORMATION", 133, 148], ["pigs", "ORGANISM", 158, 162], ["Pigs", "SPECIES", 0, 4], ["pigs", "SPECIES", 158, 162], ["pigs", "SPECIES", 158, 162], ["Pigs intubated", "TREATMENT", 0, 14], ["interlobular edema", "PROBLEM", 87, 105], ["variable hydrothorax", "PROBLEM", 107, 127], ["pulmonary edema", "PROBLEM", 133, 148], ["marked icterus", "PROBLEM", 288, 302], ["interlobular", "ANATOMY_MODIFIER", 87, 99], ["edema", "OBSERVATION", 100, 105], ["variable", "OBSERVATION_MODIFIER", 107, 115], ["hydrothorax", "OBSERVATION", 116, 127], ["pulmonary", "ANATOMY", 133, 142], ["edema", "OBSERVATION", 143, 148], ["marked", "OBSERVATION_MODIFIER", 288, 294], ["icterus", "OBSERVATION", 295, 302]]], ["Histologic changes included hepatocellular necrosis without a zonal distribution, depletion of centrilobular hepatocytes, lobular disarray, and megalocytosis characterized by large numbers of swollen hepatocytes with abundant granular eosinophilic cytoplasm and occasional large nuclei, randomly interspersed with small angular hepatocytes and scattered necrotic cells.", [["hepatocellular", "ANATOMY", 28, 42], ["centrilobular hepatocytes", "ANATOMY", 95, 120], ["lobular", "ANATOMY", 122, 129], ["hepatocytes", "ANATOMY", 200, 211], ["granular eosinophilic cytoplasm", "ANATOMY", 226, 257], ["nuclei", "ANATOMY", 279, 285], ["hepatocytes", "ANATOMY", 328, 339], ["necrotic cells", "ANATOMY", 354, 368], ["hepatocellular necrosis", "DISEASE", 28, 51], ["megalocytosis", "DISEASE", 144, 157], ["necrotic", "DISEASE", 354, 362], ["hepatocellular", "CANCER", 28, 42], ["centrilobular hepatocytes", "CELL", 95, 120], ["lobular", "PATHOLOGICAL_FORMATION", 122, 129], ["hepatocytes", "CELL", 200, 211], ["cytoplasm", "ORGANISM_SUBSTANCE", 248, 257], ["nuclei", "CELLULAR_COMPONENT", 279, 285], ["hepatocytes", "CELL", 328, 339], ["necrotic cells", "CELL", 354, 368], ["centrilobular hepatocytes", "CELL_TYPE", 95, 120], ["swollen hepatocytes", "CELL_TYPE", 192, 211], ["small angular hepatocytes", "CELL_TYPE", 314, 339], ["scattered necrotic cells", "CELL_TYPE", 344, 368], ["Histologic changes", "PROBLEM", 0, 18], ["hepatocellular necrosis", "PROBLEM", 28, 51], ["centrilobular hepatocytes", "PROBLEM", 95, 120], ["lobular disarray", "PROBLEM", 122, 138], ["megalocytosis", "PROBLEM", 144, 157], ["large numbers of swollen hepatocytes", "PROBLEM", 175, 211], ["abundant granular eosinophilic cytoplasm", "PROBLEM", 217, 257], ["occasional large nuclei", "PROBLEM", 262, 285], ["small angular hepatocytes", "PROBLEM", 314, 339], ["scattered necrotic cells", "PROBLEM", 344, 368], ["hepatocellular", "ANATOMY", 28, 42], ["necrosis", "OBSERVATION", 43, 51], ["zonal", "OBSERVATION_MODIFIER", 62, 67], ["distribution", "OBSERVATION_MODIFIER", 68, 80], ["depletion", "OBSERVATION_MODIFIER", 82, 91], ["centrilobular", "ANATOMY_MODIFIER", 95, 108], ["hepatocytes", "ANATOMY", 109, 120], ["lobular disarray", "OBSERVATION", 122, 138], ["large", "OBSERVATION_MODIFIER", 175, 180], ["numbers", "OBSERVATION_MODIFIER", 181, 188], ["swollen", "OBSERVATION_MODIFIER", 192, 199], ["hepatocytes", "ANATOMY", 200, 211], ["abundant", "OBSERVATION_MODIFIER", 217, 225], ["granular", "OBSERVATION_MODIFIER", 226, 234], ["eosinophilic cytoplasm", "OBSERVATION", 235, 257], ["occasional", "OBSERVATION_MODIFIER", 262, 272], ["large", "OBSERVATION_MODIFIER", 273, 278], ["nuclei", "OBSERVATION", 279, 285], ["small", "OBSERVATION_MODIFIER", 314, 319], ["angular", "ANATOMY_MODIFIER", 320, 327], ["hepatocytes", "ANATOMY", 328, 339], ["scattered", "OBSERVATION_MODIFIER", 344, 353], ["necrotic cells", "OBSERVATION", 354, 368]]], ["These pigs showed noSporidesminThe mycotoxin sporidesmin is produced by the fungus Pithomyces chartarum and concentrated in the conidia (spores); the most important substrate is dead ryegrass (Lolium perenne) that has been moistened in warm weather.", [["conidia", "ANATOMY", 128, 135], ["spores", "ANATOMY", 137, 143], ["noSporidesmin", "CHEMICAL", 18, 31], ["sporidesmin", "CHEMICAL", 45, 56], ["sporidesmin", "CHEMICAL", 45, 56], ["pigs", "ORGANISM", 6, 10], ["noSporidesmin", "SIMPLE_CHEMICAL", 18, 31], ["sporidesmin", "SIMPLE_CHEMICAL", 45, 56], ["fungus", "ORGANISM", 76, 82], ["Pithomyces chartarum", "ORGANISM", 83, 103], ["ryegrass", "ORGANISM_SUBDIVISION", 183, 191], ["Lolium perenne", "ORGANISM", 193, 207], ["pigs", "SPECIES", 6, 10], ["Pithomyces chartarum", "SPECIES", 83, 103], ["Lolium perenne", "SPECIES", 193, 207], ["Pithomyces chartarum", "SPECIES", 83, 103], ["ryegrass", "SPECIES", 183, 191], ["Lolium perenne", "SPECIES", 193, 207], ["These pigs", "TEST", 0, 10], ["noSporidesmin", "TREATMENT", 18, 31], ["The mycotoxin sporidesmin", "PROBLEM", 31, 56], ["the fungus Pithomyces chartarum", "PROBLEM", 72, 103], ["mycotoxin sporidesmin", "OBSERVATION", 35, 56], ["fungus Pithomyces", "OBSERVATION", 76, 93], ["dead ryegrass", "OBSERVATION", 178, 191], ["moistened", "OBSERVATION_MODIFIER", 223, 232]]], ["Intoxication causes chronic liver damage and severe hepatogenous photosensitivity (\"facial eczema\") and is a serious cause of loss of sheep and, to a lesser extent, cattle, goats, and farmed deer on the North Island of New Zealand.", [["liver", "ANATOMY", 28, 33], ["facial", "ANATOMY", 84, 90], ["chronic liver damage", "DISEASE", 20, 40], ["photosensitivity", "DISEASE", 65, 81], ["eczema", "DISEASE", 91, 97], ["liver", "ORGAN", 28, 33], ["sheep", "ORGANISM", 134, 139], ["goats", "ORGANISM", 173, 178], ["sheep", "SPECIES", 134, 139], ["cattle", "SPECIES", 165, 171], ["goats", "SPECIES", 173, 178], ["sheep", "SPECIES", 134, 139], ["cattle", "SPECIES", 165, 171], ["goats", "SPECIES", 173, 178], ["farmed deer", "SPECIES", 184, 195], ["Intoxication", "PROBLEM", 0, 12], ["chronic liver damage", "PROBLEM", 20, 40], ["severe hepatogenous photosensitivity", "PROBLEM", 45, 81], ["facial eczema\"", "PROBLEM", 84, 98], ["loss of sheep", "PROBLEM", 126, 139], ["chronic", "OBSERVATION_MODIFIER", 20, 27], ["liver", "ANATOMY", 28, 33], ["damage", "OBSERVATION", 34, 40], ["severe", "OBSERVATION_MODIFIER", 45, 51], ["hepatogenous photosensitivity", "OBSERVATION", 52, 81], ["facial", "ANATOMY", 84, 90], ["eczema", "OBSERVATION", 91, 97], ["loss", "OBSERVATION", 126, 130]]], ["Sporadic and subclinical intoxication occurs irregularly on the South Island, in southern Australia, and South Africa.", [["Sporadic and subclinical intoxication", "PROBLEM", 0, 37], ["subclinical", "OBSERVATION_MODIFIER", 13, 24], ["intoxication", "OBSERVATION", 25, 37], ["irregularly", "OBSERVATION_MODIFIER", 45, 56]]], ["Although the fungus is found throughout the world, toxigenic strains appear to be limited to New Zealand.", [["the fungus", "PROBLEM", 9, 19], ["toxigenic strains", "PROBLEM", 51, 68], ["fungus", "OBSERVATION", 13, 19]]], ["Sporidesmin intake in conjunction with ingestion of Tribulus terrestris causes another hepatogenous photosensitivity (geeldikkop); this is similar to but distinct from facial eczema, and is described later.SporidesminSporidesmin is concentrated in the fungal spores, and the toxigenicity of pasture is related to the density of the spores in it.", [["facial", "ANATOMY", 168, 174], ["spores", "ANATOMY", 259, 265], ["spores", "ANATOMY", 332, 338], ["Sporidesmin", "CHEMICAL", 0, 11], ["photosensitivity", "DISEASE", 100, 116], ["facial eczema", "DISEASE", 168, 181], ["SporidesminSporidesmin", "CHEMICAL", 206, 228], ["Sporidesmin", "CHEMICAL", 0, 11], ["Sporidesmin", "SIMPLE_CHEMICAL", 0, 11], ["Tribulus terrestris", "ORGANISM", 52, 71], ["SporidesminSporidesmin", "SIMPLE_CHEMICAL", 206, 228], ["Tribulus terrestris", "SPECIES", 52, 71], ["Tribulus terrestris", "SPECIES", 52, 71], ["Tribulus terrestris", "PROBLEM", 52, 71], ["another hepatogenous photosensitivity (geeldikkop)", "PROBLEM", 79, 129], ["facial eczema", "PROBLEM", 168, 181], ["SporidesminSporidesmin", "PROBLEM", 206, 228], ["the fungal spores", "PROBLEM", 248, 265], ["facial", "ANATOMY", 168, 174], ["eczema", "OBSERVATION", 175, 181], ["concentrated", "OBSERVATION_MODIFIER", 232, 244], ["fungal spores", "OBSERVATION", 252, 265], ["pasture", "OBSERVATION", 291, 298], ["density", "OBSERVATION", 317, 324], ["spores", "OBSERVATION", 332, 338]]], ["Sporidesmin is not specifically hepatotoxic.", [["Sporidesmin", "CHEMICAL", 0, 11], ["hepatotoxic", "DISEASE", 32, 43], ["Sporidesmin", "CHEMICAL", 0, 11], ["Sporidesmin", "SIMPLE_CHEMICAL", 0, 11], ["hepatotoxic", "PROBLEM", 32, 43], ["not specifically", "UNCERTAINTY", 15, 31], ["hepatotoxic", "OBSERVATION", 32, 43]]], ["Administration of the toxin does produce rapid disorganization of hepatic cell organelles and triglyceride accumulation, but these are mild and nonspecific changes.", [["hepatic cell organelles", "ANATOMY", 66, 89], ["triglyceride", "CHEMICAL", 94, 106], ["triglyceride", "CHEMICAL", 94, 106], ["hepatic cell", "CELL", 66, 78], ["organelles", "CELLULAR_COMPONENT", 79, 89], ["triglyceride", "SIMPLE_CHEMICAL", 94, 106], ["the toxin", "TEST", 18, 27], ["rapid disorganization of hepatic cell organelles", "PROBLEM", 41, 89], ["triglyceride accumulation", "PROBLEM", 94, 119], ["rapid", "OBSERVATION_MODIFIER", 41, 46], ["disorganization", "OBSERVATION", 47, 62], ["hepatic", "ANATOMY", 66, 73], ["cell organelles", "OBSERVATION", 74, 89], ["triglyceride accumulation", "OBSERVATION", 94, 119], ["mild", "OBSERVATION_MODIFIER", 135, 139], ["nonspecific", "OBSERVATION_MODIFIER", 144, 155]]], ["If administered in suitable dosage, the toxin causes permeability alterations in many tissues and will, for example, produce corneal edema on local application.", [["tissues", "ANATOMY", 86, 93], ["corneal edema", "ANATOMY", 125, 138], ["corneal edema", "DISEASE", 125, 138], ["tissues", "TISSUE", 86, 93], ["corneal edema", "PATHOLOGICAL_FORMATION", 125, 138], ["the toxin", "PROBLEM", 36, 45], ["permeability alterations in many tissues", "PROBLEM", 53, 93], ["corneal edema", "PROBLEM", 125, 138], ["local application", "TREATMENT", 142, 159], ["permeability alterations", "OBSERVATION", 53, 77], ["corneal", "ANATOMY", 125, 132], ["edema", "OBSERVATION", 133, 138]]], ["The hepatobiliary lesions are caused by the excretion initially portal to periportal, but central areas can also become fibrotic.", [["hepatobiliary lesions", "ANATOMY", 4, 25], ["periportal", "ANATOMY", 74, 84], ["hepatobiliary lesions", "DISEASE", 4, 25], ["hepatobiliary lesions", "CANCER", 4, 25], ["The hepatobiliary lesions", "PROBLEM", 0, 25], ["fibrotic", "PROBLEM", 120, 128], ["hepatobiliary", "ANATOMY", 4, 17], ["lesions", "OBSERVATION", 18, 25], ["excretion", "OBSERVATION", 44, 53], ["portal", "ANATOMY", 64, 70], ["periportal", "ANATOMY", 74, 84], ["central", "ANATOMY_MODIFIER", 90, 97], ["fibrotic", "OBSERVATION", 120, 128]]], ["Bridging fibrosis between portal areas and portal to central regions can develop.", [["portal areas", "ANATOMY", 26, 38], ["portal", "ANATOMY", 43, 49], ["central regions", "ANATOMY", 53, 68], ["fibrosis", "DISEASE", 9, 17], ["portal areas", "MULTI-TISSUE_STRUCTURE", 26, 38], ["portal", "MULTI-TISSUE_STRUCTURE", 43, 49], ["Bridging fibrosis between portal areas", "PROBLEM", 0, 38], ["fibrosis", "OBSERVATION", 9, 17], ["portal", "ANATOMY", 26, 32], ["areas", "ANATOMY_MODIFIER", 33, 38], ["portal", "ANATOMY", 43, 49], ["central", "ANATOMY_MODIFIER", 53, 60]]], ["In naturally occurring cases, however, discontinuous intake of the toxin may produce a liver grossly distorted by asymmetrical nodular regeneration and fibrosis.", [["liver", "ANATOMY", 87, 92], ["nodular", "ANATOMY", 127, 134], ["fibrosis", "DISEASE", 152, 160], ["liver", "ORGAN", 87, 92], ["nodular", "TISSUE", 127, 134], ["asymmetrical nodular regeneration", "PROBLEM", 114, 147], ["fibrosis", "PROBLEM", 152, 160], ["liver", "ANATOMY", 87, 92], ["asymmetrical", "OBSERVATION_MODIFIER", 114, 126], ["nodular", "OBSERVATION_MODIFIER", 127, 134], ["regeneration", "OBSERVATION", 135, 147], ["fibrosis", "OBSERVATION", 152, 160]]], ["The atrophic changes are most severe in the left lobe.SporidesminPhotosensitization occurs in phomopsin-poisoned sheep; it may be severe if the animals have access to green feed while under the influence of the toxin.", [["left lobe", "ANATOMY", 44, 53], ["SporidesminPhotosensitization", "CHEMICAL", 54, 83], ["phomopsin", "CHEMICAL", 94, 103], ["left lobe", "MULTI-TISSUE_STRUCTURE", 44, 53], ["phomopsin", "GENE_OR_GENE_PRODUCT", 94, 103], ["sheep", "ORGANISM", 113, 118], ["sheep", "SPECIES", 113, 118], ["sheep", "SPECIES", 113, 118], ["The atrophic changes", "PROBLEM", 0, 20], ["severe in the left lobe", "PROBLEM", 30, 53], ["SporidesminPhotosensitization", "TREATMENT", 54, 83], ["green feed", "TREATMENT", 167, 177], ["the toxin", "TREATMENT", 207, 216], ["atrophic", "OBSERVATION", 4, 12], ["most severe", "OBSERVATION_MODIFIER", 25, 36], ["left lobe", "ANATOMY", 44, 53]]], ["Lupinosis in sheep has also been experimentally observed to induce mild skeletal myopathy, resembling nutritional myopathy.SporidesminPhomopsin poisoning in cattle causes most losses when the animals are lactating or heavily pregnant; in these animals, the syndrome is essentially one of ketosis, to which such cows would be predisposed by the anorexia that is an obvious clinical feature of this intoxication.", [["skeletal", "ANATOMY", 72, 80], ["Lupinosis", "CHEMICAL", 0, 9], ["skeletal myopathy", "DISEASE", 72, 89], ["nutritional myopathy", "DISEASE", 102, 122], ["SporidesminPhomopsin", "CHEMICAL", 123, 143], ["poisoning", "DISEASE", 144, 153], ["ketosis", "DISEASE", 288, 295], ["anorexia", "DISEASE", 344, 352], ["SporidesminPhomopsin", "CHEMICAL", 123, 143], ["sheep", "ORGANISM", 13, 18], ["skeletal", "ORGAN", 72, 80], ["SporidesminPhomopsin", "SIMPLE_CHEMICAL", 123, 143], ["cattle", "ORGANISM", 157, 163], ["animals", "ORGANISM", 192, 199], ["cows", "ORGANISM", 311, 315], ["sheep", "SPECIES", 13, 18], ["cattle", "SPECIES", 157, 163], ["sheep", "SPECIES", 13, 18], ["cattle", "SPECIES", 157, 163], ["mild skeletal myopathy", "PROBLEM", 67, 89], ["nutritional myopathy", "PROBLEM", 102, 122], ["SporidesminPhomopsin poisoning", "PROBLEM", 123, 153], ["the syndrome", "PROBLEM", 253, 265], ["ketosis", "PROBLEM", 288, 295], ["the anorexia", "PROBLEM", 340, 352], ["this intoxication", "PROBLEM", 392, 409], ["mild", "OBSERVATION_MODIFIER", 67, 71], ["skeletal", "ANATOMY", 72, 80], ["myopathy", "OBSERVATION", 81, 89], ["nutritional myopathy", "OBSERVATION", 102, 122], ["most losses", "OBSERVATION_MODIFIER", 171, 182]]], ["Pregnant sheep are less likely to have access to toxic lupin roughage during late gestation; otherwise, ketosis triggered by phomopsin would be expected just as often as in cattle.SporidesminChronic hepatic fibrosis with fine, nodular regeneration may occur infrequently in cattle as the result of chronic phomopsin poisoning.", [["hepatic", "ANATOMY", 199, 206], ["nodular", "ANATOMY", 227, 234], ["ketosis", "DISEASE", 104, 111], ["phomopsin", "CHEMICAL", 125, 134], ["fibrosis", "DISEASE", 207, 215], ["poisoning", "DISEASE", 316, 325], ["sheep", "ORGANISM", 9, 14], ["lupin", "ORGANISM", 55, 60], ["phomopsin", "GENE_OR_GENE_PRODUCT", 125, 134], ["hepatic", "ORGAN", 199, 206], ["cattle", "ORGANISM", 274, 280], ["phomopsin", "SIMPLE_CHEMICAL", 306, 315], ["sheep", "SPECIES", 9, 14], ["cattle", "SPECIES", 173, 179], ["cattle", "SPECIES", 274, 280], ["sheep", "SPECIES", 9, 14], ["cattle", "SPECIES", 173, 179], ["cattle", "SPECIES", 274, 280], ["toxic lupin roughage", "TREATMENT", 49, 69], ["late gestation", "PROBLEM", 77, 91], ["ketosis", "PROBLEM", 104, 111], ["phomopsin", "TREATMENT", 125, 134], ["SporidesminChronic hepatic fibrosis", "PROBLEM", 180, 215], ["fine, nodular regeneration", "PROBLEM", 221, 247], ["chronic phomopsin poisoning", "PROBLEM", 298, 325], ["hepatic", "ANATOMY", 199, 206], ["fibrosis", "OBSERVATION", 207, 215], ["fine", "OBSERVATION_MODIFIER", 221, 225], ["nodular", "OBSERVATION_MODIFIER", 227, 234], ["regeneration", "OBSERVATION", 235, 247], ["chronic", "OBSERVATION_MODIFIER", 298, 305], ["phomopsin", "OBSERVATION", 306, 315]]], ["Similar liver changes may also be seen in horses, in which there may also be hemolytic anemia of unknown pathogenesis.", [["liver", "ANATOMY", 8, 13], ["hemolytic anemia", "DISEASE", 77, 93], ["liver", "ORGAN", 8, 13], ["Similar liver changes", "PROBLEM", 0, 21], ["hemolytic anemia", "PROBLEM", 77, 93], ["unknown pathogenesis", "PROBLEM", 97, 117], ["liver", "ANATOMY", 8, 13], ["may also be seen", "UNCERTAINTY", 22, 38], ["may also be", "UNCERTAINTY", 65, 76], ["hemolytic", "OBSERVATION_MODIFIER", 77, 86]]], ["A B C D edema of the adventitia of the ducts, with active fibroplasia and scarring.", [["adventitia", "ANATOMY", 21, 31], ["ducts", "ANATOMY", 39, 44], ["edema", "DISEASE", 8, 13], ["fibroplasia", "DISEASE", 58, 69], ["scarring", "DISEASE", 74, 82], ["adventitia", "TISSUE", 21, 31], ["ducts", "MULTI-TISSUE_STRUCTURE", 39, 44], ["A B C D edema of the adventitia of the ducts", "PROBLEM", 0, 44], ["active fibroplasia", "PROBLEM", 51, 69], ["scarring", "PROBLEM", 74, 82], ["C D", "OBSERVATION_MODIFIER", 4, 7], ["edema", "OBSERVATION", 8, 13], ["adventitia", "ANATOMY_MODIFIER", 21, 31], ["ducts", "ANATOMY", 39, 44], ["active", "OBSERVATION_MODIFIER", 51, 57], ["fibroplasia", "OBSERVATION", 58, 69], ["scarring", "OBSERVATION", 74, 82]]], ["Inflammatory cells are present, but not in large numbers, and they are chiefly lymphocytes and histiocytes.", [["Inflammatory cells", "ANATOMY", 0, 18], ["lymphocytes", "ANATOMY", 79, 90], ["histiocytes", "ANATOMY", 95, 106], ["Inflammatory cells", "CELL", 0, 18], ["lymphocytes", "CELL", 79, 90], ["histiocytes", "CELL", 95, 106], ["Inflammatory cells", "CELL_TYPE", 0, 18], ["lymphocytes", "CELL_TYPE", 79, 90], ["histiocytes", "CELL_TYPE", 95, 106], ["Inflammatory cells", "PROBLEM", 0, 18], ["histiocytes", "PROBLEM", 95, 106], ["cells", "OBSERVATION", 13, 18], ["large", "OBSERVATION_MODIFIER", 43, 48], ["numbers", "OBSERVATION_MODIFIER", 49, 56], ["chiefly lymphocytes", "OBSERVATION", 71, 90], ["histiocytes", "OBSERVATION", 95, 106]]], ["Injury to the smaller radicles of the bile ducts is less severe, but fibrosis is active.", [["radicles", "ANATOMY", 22, 30], ["bile ducts", "ANATOMY", 38, 48], ["Injury", "DISEASE", 0, 6], ["fibrosis", "DISEASE", 69, 77], ["radicles", "CANCER", 22, 30], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 38, 48], ["Injury", "PROBLEM", 0, 6], ["fibrosis", "PROBLEM", 69, 77], ["smaller", "OBSERVATION_MODIFIER", 14, 21], ["radicles", "ANATOMY_MODIFIER", 22, 30], ["bile ducts", "ANATOMY", 38, 48], ["less", "OBSERVATION_MODIFIER", 52, 56], ["severe", "OBSERVATION", 57, 63], ["fibrosis", "OBSERVATION", 69, 77], ["active", "OBSERVATION_MODIFIER", 81, 87]]], ["The portal tracts are enlarged by fibrous tissue and by the active generation of new bile ducts that follows and which is more prominent in chronic intoxication .", [["portal tracts", "ANATOMY", 4, 17], ["fibrous tissue", "ANATOMY", 34, 48], ["bile ducts", "ANATOMY", 85, 95], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 4, 17], ["fibrous tissue", "TISSUE", 34, 48], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 85, 95], ["fibrous tissue", "PROBLEM", 34, 48], ["the active generation of new bile ducts", "PROBLEM", 56, 95], ["chronic intoxication", "PROBLEM", 140, 160], ["portal tracts", "ANATOMY", 4, 17], ["enlarged", "OBSERVATION", 22, 30], ["fibrous tissue", "OBSERVATION", 34, 48], ["active", "OBSERVATION_MODIFIER", 60, 66], ["generation", "OBSERVATION_MODIFIER", 67, 77], ["new", "OBSERVATION_MODIFIER", 81, 84], ["bile ducts", "ANATOMY", 85, 95], ["more prominent", "OBSERVATION_MODIFIER", 122, 136], ["chronic", "OBSERVATION_MODIFIER", 140, 147], ["intoxication", "OBSERVATION", 148, 160]]], ["Affected camelids appear to be susceptible to florid hyperplasia of the bile ducts.SporidesminIn more severe intoxications, there may be coagulative necrosis of blood vessel walls in the portal triads; when this is incomplete, the most damaged segment of the vessel tends to be that adjacent to the nearest injured bile duct.", [["camelids", "ANATOMY", 9, 17], ["bile ducts", "ANATOMY", 72, 82], ["blood vessel walls", "ANATOMY", 161, 179], ["portal triads", "ANATOMY", 187, 200], ["vessel", "ANATOMY", 259, 265], ["bile duct", "ANATOMY", 315, 324], ["hyperplasia of the bile ducts", "DISEASE", 53, 82], ["SporidesminIn", "CHEMICAL", 83, 96], ["necrosis", "DISEASE", 149, 157], ["SporidesminIn", "CHEMICAL", 83, 96], ["camelids", "CANCER", 9, 17], ["florid hyperplasia", "PATHOLOGICAL_FORMATION", 46, 64], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 72, 82], ["SporidesminIn", "SIMPLE_CHEMICAL", 83, 96], ["blood vessel walls", "MULTI-TISSUE_STRUCTURE", 161, 179], ["portal triads", "MULTI-TISSUE_STRUCTURE", 187, 200], ["vessel", "MULTI-TISSUE_STRUCTURE", 259, 265], ["bile duct", "MULTI-TISSUE_STRUCTURE", 315, 324], ["Affected camelids", "PROBLEM", 0, 17], ["florid hyperplasia of the bile ducts", "PROBLEM", 46, 82], ["SporidesminIn more severe intoxications", "PROBLEM", 83, 122], ["coagulative necrosis of blood vessel walls in the portal triads", "PROBLEM", 137, 200], ["florid", "OBSERVATION_MODIFIER", 46, 52], ["hyperplasia", "OBSERVATION", 53, 64], ["bile ducts", "ANATOMY", 72, 82], ["severe", "OBSERVATION_MODIFIER", 102, 108], ["intoxications", "OBSERVATION", 109, 122], ["may be", "UNCERTAINTY", 130, 136], ["coagulative", "OBSERVATION_MODIFIER", 137, 148], ["necrosis", "OBSERVATION", 149, 157], ["blood vessel", "ANATOMY", 161, 173], ["walls", "ANATOMY_MODIFIER", 174, 179], ["portal triads", "ANATOMY", 187, 200], ["most", "OBSERVATION_MODIFIER", 231, 235], ["damaged", "OBSERVATION", 236, 243], ["segment", "ANATOMY_MODIFIER", 244, 251], ["vessel", "ANATOMY", 259, 265], ["nearest", "ANATOMY_MODIFIER", 299, 306], ["injured", "OBSERVATION", 307, 314], ["bile duct", "ANATOMY", 315, 324]]], ["Both arteries and veins may be affected, and it is possible that necrosis is related to vascular insufficiency as well as to impaired bile drainage.", [["arteries", "ANATOMY", 5, 13], ["veins", "ANATOMY", 18, 23], ["vascular", "ANATOMY", 88, 96], ["bile", "ANATOMY", 134, 138], ["necrosis", "DISEASE", 65, 73], ["vascular insufficiency", "DISEASE", 88, 110], ["impaired bile drainage", "DISEASE", 125, 147], ["arteries", "MULTI-TISSUE_STRUCTURE", 5, 13], ["veins", "MULTI-TISSUE_STRUCTURE", 18, 23], ["vascular", "MULTI-TISSUE_STRUCTURE", 88, 96], ["bile", "PATHOLOGICAL_FORMATION", 134, 138], ["necrosis", "PROBLEM", 65, 73], ["vascular insufficiency", "PROBLEM", 88, 110], ["impaired bile drainage", "PROBLEM", 125, 147], ["arteries", "ANATOMY", 5, 13], ["veins", "ANATOMY", 18, 23], ["may be", "UNCERTAINTY", 24, 30], ["affected", "OBSERVATION", 31, 39], ["necrosis", "OBSERVATION", 65, 73], ["vascular", "ANATOMY", 88, 96], ["insufficiency", "OBSERVATION", 97, 110], ["impaired", "OBSERVATION_MODIFIER", 125, 133], ["bile", "ANATOMY", 134, 138], ["drainage", "OBSERVATION", 139, 147]]], ["Changes in the hepatic parenchyma are minimal and secondary to those in the portal triads.", [["hepatic parenchyma", "ANATOMY", 15, 33], ["portal triads", "ANATOMY", 76, 89], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 15, 33], ["portal triads", "MULTI-TISSUE_STRUCTURE", 76, 89], ["Changes in the hepatic parenchyma", "PROBLEM", 0, 33], ["hepatic", "ANATOMY", 15, 22], ["parenchyma", "ANATOMY_MODIFIER", 23, 33], ["minimal", "OBSERVATION_MODIFIER", 38, 45], ["portal triads", "ANATOMY", 76, 89]]], ["In acute cases, there may be extensive pigmentation of hepatocytes and Kupffer cells by bile pigments, but this is irregular in distribution in the liver.", [["hepatocytes", "ANATOMY", 55, 66], ["Kupffer cells", "ANATOMY", 71, 84], ["bile pigments", "ANATOMY", 88, 101], ["liver", "ANATOMY", 148, 153], ["hepatocytes", "CELL", 55, 66], ["Kupffer cells", "CELL", 71, 84], ["bile pigments", "MULTI-TISSUE_STRUCTURE", 88, 101], ["liver", "ORGAN", 148, 153], ["hepatocytes", "CELL_TYPE", 55, 66], ["Kupffer cells", "CELL_TYPE", 71, 84], ["extensive pigmentation of hepatocytes", "PROBLEM", 29, 66], ["bile pigments", "PROBLEM", 88, 101], ["irregular in distribution in the liver", "PROBLEM", 115, 153], ["acute", "OBSERVATION_MODIFIER", 3, 8], ["cases", "OBSERVATION", 9, 14], ["may be", "UNCERTAINTY", 22, 28], ["extensive", "OBSERVATION_MODIFIER", 29, 38], ["pigmentation", "OBSERVATION", 39, 51], ["hepatocytes", "ANATOMY", 55, 66], ["Kupffer cells", "OBSERVATION", 71, 84], ["bile pigments", "OBSERVATION", 88, 101], ["irregular", "OBSERVATION_MODIFIER", 115, 124], ["distribution", "OBSERVATION_MODIFIER", 128, 140], ["liver", "ANATOMY", 148, 153]]], ["Inspissated bile can be found in the bile ducts and canaliculi.", [["bile", "ANATOMY", 12, 16], ["bile ducts", "ANATOMY", 37, 47], ["canaliculi", "ANATOMY", 52, 62], ["bile", "MULTI-TISSUE_STRUCTURE", 12, 16], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 37, 47], ["canaliculi", "MULTI-TISSUE_STRUCTURE", 52, 62], ["Inspissated bile", "PROBLEM", 0, 16], ["bile", "OBSERVATION", 12, 16], ["bile ducts", "ANATOMY", 37, 47], ["canaliculi", "ANATOMY", 52, 62]]], ["There is some necrosis of hepatocytes adjacent to inflamed portal areas, and other areas of necrosis, focal in type and distribution and probably the result of biliary obstruction, may be numerous.SporidesminOther morbid alterations include great enlargement of the adrenals produced by cortical hypertrophy; sclerotic intimal plaques in the arteries, veins, and lymphatics in the hilus of the liver; and a tendency for the newly formed bile ductules to recanalize occluded ducts.Pyrrolizidine alkaloidsPyrrolizidine alkaloids have been identified in nearly 3% of all plant species, from >6,000 species of 3 families: the Asteraceae (Compositae), Leguminosae (Fabaceae), and Boraginaceae.", [["hepatocytes", "ANATOMY", 26, 37], ["inflamed portal areas", "ANATOMY", 50, 71], ["biliary", "ANATOMY", 160, 167], ["adrenals", "ANATOMY", 266, 274], ["cortical", "ANATOMY", 287, 295], ["intimal plaques", "ANATOMY", 319, 334], ["arteries", "ANATOMY", 342, 350], ["veins", "ANATOMY", 352, 357], ["lymphatics", "ANATOMY", 363, 373], ["hilus", "ANATOMY", 381, 386], ["liver", "ANATOMY", 394, 399], ["bile ductules", "ANATOMY", 437, 450], ["ducts", "ANATOMY", 474, 479], ["necrosis", "DISEASE", 14, 22], ["necrosis", "DISEASE", 92, 100], ["biliary obstruction", "DISEASE", 160, 179], ["enlargement of the adrenals", "DISEASE", 247, 274], ["cortical hypertrophy", "DISEASE", 287, 307], ["Pyrrolizidine alkaloids", "CHEMICAL", 480, 503], ["Pyrrolizidine alkaloids", "CHEMICAL", 503, 526], ["Pyrrolizidine alkaloids", "CHEMICAL", 480, 503], ["Pyrrolizidine alkaloids", "CHEMICAL", 503, 526], ["hepatocytes", "CELL", 26, 37], ["portal areas", "MULTI-TISSUE_STRUCTURE", 59, 71], ["biliary obstruction", "PATHOLOGICAL_FORMATION", 160, 179], ["adrenals", "ORGAN", 266, 274], ["cortical", "MULTI-TISSUE_STRUCTURE", 287, 295], ["intimal plaques", "PATHOLOGICAL_FORMATION", 319, 334], ["arteries", "MULTI-TISSUE_STRUCTURE", 342, 350], ["veins", "MULTI-TISSUE_STRUCTURE", 352, 357], ["lymphatics", "MULTI-TISSUE_STRUCTURE", 363, 373], ["hilus", "MULTI-TISSUE_STRUCTURE", 381, 386], ["liver", "ORGAN", 394, 399], ["bile ductules", "MULTI-TISSUE_STRUCTURE", 437, 450], ["ducts", "MULTI-TISSUE_STRUCTURE", 474, 479], ["Pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 480, 503], ["Pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 503, 526], ["Compositae", "ORGANISM", 634, 644], ["Leguminosae (Fabaceae", "ORGANISM", 647, 668], ["Boraginaceae", "GENE_OR_GENE_PRODUCT", 675, 687], ["hepatocytes", "CELL_TYPE", 26, 37], ["some necrosis of hepatocytes", "PROBLEM", 9, 37], ["inflamed portal areas", "PROBLEM", 50, 71], ["necrosis", "PROBLEM", 92, 100], ["focal in type and distribution", "PROBLEM", 102, 132], ["biliary obstruction", "PROBLEM", 160, 179], ["SporidesminOther morbid alterations", "PROBLEM", 197, 232], ["great enlargement of the adrenals", "PROBLEM", 241, 274], ["cortical hypertrophy", "PROBLEM", 287, 307], ["sclerotic intimal plaques in the arteries, veins, and lymphatics in the hilus of the liver", "PROBLEM", 309, 399], ["the newly formed bile ductules", "PROBLEM", 420, 450], ["occluded ducts", "PROBLEM", 465, 479], ["Pyrrolizidine alkaloids", "TREATMENT", 480, 503], ["Pyrrolizidine alkaloids", "TREATMENT", 503, 526], ["all plant species", "PROBLEM", 564, 581], ["the Asteraceae (Compositae)", "TREATMENT", 618, 645], ["Leguminosae (Fabaceae)", "TREATMENT", 647, 669], ["Boraginaceae", "TREATMENT", 675, 687], ["some", "OBSERVATION_MODIFIER", 9, 13], ["necrosis", "OBSERVATION", 14, 22], ["hepatocytes", "ANATOMY", 26, 37], ["inflamed", "ANATOMY_MODIFIER", 50, 58], ["portal", "ANATOMY", 59, 65], ["areas", "ANATOMY_MODIFIER", 66, 71], ["areas", "OBSERVATION_MODIFIER", 83, 88], ["necrosis", "OBSERVATION", 92, 100], ["focal", "OBSERVATION_MODIFIER", 102, 107], ["type", "OBSERVATION_MODIFIER", 111, 115], ["distribution", "OBSERVATION_MODIFIER", 120, 132], ["probably the result of", "UNCERTAINTY", 137, 159], ["biliary", "ANATOMY", 160, 167], ["obstruction", "OBSERVATION", 168, 179], ["may be", "UNCERTAINTY", 181, 187], ["numerous", "OBSERVATION_MODIFIER", 188, 196], ["morbid", "OBSERVATION", 214, 220], ["great", "OBSERVATION_MODIFIER", 241, 246], ["enlargement", "OBSERVATION", 247, 258], ["adrenals", "ANATOMY", 266, 274], ["cortical", "ANATOMY_MODIFIER", 287, 295], ["hypertrophy", "OBSERVATION", 296, 307], ["sclerotic", "OBSERVATION_MODIFIER", 309, 318], ["intimal", "OBSERVATION_MODIFIER", 319, 326], ["plaques", "OBSERVATION", 327, 334], ["arteries", "ANATOMY", 342, 350], ["veins", "ANATOMY", 352, 357], ["lymphatics", "OBSERVATION", 363, 373], ["hilus", "ANATOMY_MODIFIER", 381, 386], ["liver", "ANATOMY", 394, 399], ["bile ductules", "ANATOMY", 437, 450], ["occluded", "OBSERVATION", 465, 473], ["ducts", "ANATOMY", 474, 479], ["plant species", "OBSERVATION", 568, 581], ["Leguminosae", "ANATOMY", 647, 658]]], ["The main genera responsible for plant toxicoses in domestic mammals are Senecio, Crotalaria, Heliotropium, Cynoglossum, Amsinckia, Echium, and Trichodesma, and are widely distributed around the world.", [["plant toxicoses", "PROBLEM", 32, 47], ["Crotalaria", "TREATMENT", 81, 91], ["Heliotropium", "TREATMENT", 93, 105], ["Cynoglossum", "TREATMENT", 107, 118], ["Amsinckia", "TREATMENT", 120, 129], ["Echium", "TREATMENT", 131, 137], ["main", "OBSERVATION_MODIFIER", 4, 8], ["genera", "OBSERVATION_MODIFIER", 9, 15], ["toxicoses", "OBSERVATION", 38, 47], ["Echium", "ANATOMY", 131, 137], ["widely", "OBSERVATION_MODIFIER", 164, 170]]], ["Intoxication is relatively infrequent because most plants containing pyrrolizidines are unpalatable.", [["Intoxication", "DISEASE", 0, 12], ["pyrrolizidines", "CHEMICAL", 69, 83], ["pyrrolizidines", "CHEMICAL", 69, 83], ["pyrrolizidines", "SIMPLE_CHEMICAL", 69, 83], ["Intoxication", "PROBLEM", 0, 12], ["pyrrolizidines", "TREATMENT", 69, 83]]], ["Contamination of baled or cubed forage with toxic plants is a common route of exposure.", [["toxic plants", "TREATMENT", 44, 56], ["toxic plants", "OBSERVATION", 44, 56]]], ["The seeds are also toxic, and the small seeds of Amsinckia and Crotalaria may, depending on harvesting technique, heavily contaminate other harvested grains used in prepared pig and poultry feeds.", [["seeds", "ANATOMY", 4, 9], ["grains", "ANATOMY", 150, 156], ["Amsinckia", "CHEMICAL", 49, 58], ["Crotalaria", "CHEMICAL", 63, 73], ["Crotalaria", "SIMPLE_CHEMICAL", 63, 73], ["pig", "ORGANISM", 174, 177], ["pig", "SPECIES", 174, 177], ["pig", "SPECIES", 174, 177], ["toxic", "PROBLEM", 19, 24], ["the small seeds of Amsinckia and Crotalaria", "PROBLEM", 30, 73], ["harvesting technique", "TREATMENT", 92, 112], ["poultry feeds", "TREATMENT", 182, 195], ["toxic", "OBSERVATION_MODIFIER", 19, 24], ["small", "OBSERVATION_MODIFIER", 34, 39], ["seeds", "OBSERVATION_MODIFIER", 40, 45]]], ["More than 350 pyrrolizidine alkaloids have been identified chemically, and most of the toxic plant species contain more than one of the alkaloids.", [["pyrrolizidine alkaloids", "CHEMICAL", 14, 37], ["pyrrolizidine alkaloids", "CHEMICAL", 14, 37], ["pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 14, 37], ["350 pyrrolizidine alkaloids", "TREATMENT", 10, 37], ["the toxic plant species", "PROBLEM", 83, 106], ["chemically", "OBSERVATION_MODIFIER", 59, 69], ["toxic", "OBSERVATION_MODIFIER", 87, 92], ["plant species", "OBSERVATION", 93, 106], ["alkaloids", "OBSERVATION", 136, 145]]], ["So far, only a small proportion of the known alkaloids have well-characterized toxicity; these are all esters of 1 of 3 amino alcohol bases (necines) or acids (necic acids).", [["toxicity", "DISEASE", 79, 87], ["amino alcohol", "CHEMICAL", 120, 133], ["necines", "CHEMICAL", 141, 148], ["necic acids", "CHEMICAL", 160, 171], ["esters", "CHEMICAL", 103, 109], ["amino alcohol bases", "CHEMICAL", 120, 139], ["necines", "CHEMICAL", 141, 148], ["necic acids", "CHEMICAL", 160, 171], ["3 amino alcohol bases", "SIMPLE_CHEMICAL", 118, 139], ["necines", "SIMPLE_CHEMICAL", 141, 148], ["necic acids", "SIMPLE_CHEMICAL", 160, 171], ["the known alkaloids", "PROBLEM", 35, 54], ["acids (necic acids", "TREATMENT", 153, 171], ["small", "OBSERVATION_MODIFIER", 15, 20], ["alkaloids", "OBSERVATION", 45, 54], ["well-characterized", "OBSERVATION_MODIFIER", 60, 78], ["toxicity", "OBSERVATION", 79, 87]]], ["The retronecine group includes monocrotaline, retrorsine, retronecine, ridelliine, senecionine, and jacobine, and the heliotridine group includes lasiocarpine and heliotrine.", [["retronecine", "CHEMICAL", 4, 15], ["monocrotaline", "CHEMICAL", 31, 44], ["retrorsine", "CHEMICAL", 46, 56], ["retronecine", "CHEMICAL", 58, 69], ["ridelliine", "CHEMICAL", 71, 81], ["senecionine", "CHEMICAL", 83, 94], ["jacobine", "CHEMICAL", 100, 108], ["heliotridine", "CHEMICAL", 118, 130], ["lasiocarpine", "CHEMICAL", 146, 158], ["heliotrine", "CHEMICAL", 163, 173], ["retronecine", "CHEMICAL", 4, 15], ["monocrotaline", "CHEMICAL", 31, 44], ["retrorsine", "CHEMICAL", 46, 56], ["retronecine", "CHEMICAL", 58, 69], ["ridelliine", "CHEMICAL", 71, 81], ["senecionine", "CHEMICAL", 83, 94], ["jacobine", "CHEMICAL", 100, 108], ["heliotridine", "CHEMICAL", 118, 130], ["lasiocarpine", "CHEMICAL", 146, 158], ["heliotrine", "CHEMICAL", 163, 173], ["retronecine", "SIMPLE_CHEMICAL", 4, 15], ["monocrotaline", "SIMPLE_CHEMICAL", 31, 44], ["retrorsine", "SIMPLE_CHEMICAL", 46, 56], ["retronecine", "SIMPLE_CHEMICAL", 58, 69], ["ridelliine", "SIMPLE_CHEMICAL", 71, 81], ["senecionine", "SIMPLE_CHEMICAL", 83, 94], ["jacobine", "SIMPLE_CHEMICAL", 100, 108], ["heliotridine", "SIMPLE_CHEMICAL", 118, 130], ["lasiocarpine", "SIMPLE_CHEMICAL", 146, 158], ["heliotrine", "SIMPLE_CHEMICAL", 163, 173], ["The retronecine group", "TREATMENT", 0, 21], ["monocrotaline", "TREATMENT", 31, 44], ["retrorsine", "TREATMENT", 46, 56], ["retronecine", "TREATMENT", 58, 69], ["ridelliine", "TREATMENT", 71, 81], ["senecionine", "TREATMENT", 83, 94], ["jacobine", "TREATMENT", 100, 108], ["the heliotridine group", "TREATMENT", 114, 136], ["lasiocarpine", "TREATMENT", 146, 158], ["heliotrine", "TREATMENT", 163, 173], ["monocrotaline", "OBSERVATION", 31, 44]]], ["These toxins must be metabolized to more reactive forms for toxicity.", [["toxicity", "DISEASE", 60, 68], ["These toxins", "PROBLEM", 0, 12], ["toxicity", "PROBLEM", 60, 68]]], ["Cytochromes P450 mediate the N-oxidation of the necine bases.", [["Cytochromes P450", "GENE_OR_GENE_PRODUCT", 0, 16], ["necine", "SIMPLE_CHEMICAL", 48, 54], ["Cytochromes P450", "PROTEIN", 0, 16], ["Cytochromes P450", "TEST", 0, 16], ["N-oxidation", "OBSERVATION", 29, 40], ["bases", "ANATOMY_MODIFIER", 55, 60]]], ["They can also mediate the 2-step hydroxylation of the necine bases at the C3 and C8 positions; this is followed by spontaneous dehydration to the highly reactive dehydropyrrolizidine (DHP) alkaloids.", [["necine", "CHEMICAL", 54, 60], ["dehydration", "DISEASE", 127, 138], ["dehydropyrrolizidine", "CHEMICAL", 162, 182], ["DHP", "CHEMICAL", 184, 187], ["necine bases", "CHEMICAL", 54, 66], ["dehydropyrrolizidine", "CHEMICAL", 162, 182], ["DHP", "CHEMICAL", 184, 187], ["necine", "SIMPLE_CHEMICAL", 54, 60], ["reactive dehydropyrrolizidine (DHP) alkaloids", "SIMPLE_CHEMICAL", 153, 198], ["the 2-step hydroxylation of the necine bases", "TREATMENT", 22, 66], ["spontaneous dehydration", "PROBLEM", 115, 138], ["alkaloids", "TREATMENT", 189, 198], ["bases", "ANATOMY_MODIFIER", 61, 66], ["C3", "ANATOMY_MODIFIER", 74, 76], ["C8", "ANATOMY_MODIFIER", 81, 83], ["reactive", "OBSERVATION_MODIFIER", 153, 161]]], ["The toxic DHP alkaloids are electrophilic and can bind covalently to amino acids, proteins, and nucleic acids at guanine and adenine residues.", [["DHP", "CHEMICAL", 10, 13], ["amino acids", "CHEMICAL", 69, 80], ["nucleic acids", "CHEMICAL", 96, 109], ["guanine", "CHEMICAL", 113, 120], ["adenine", "CHEMICAL", 125, 132], ["DHP alkaloids", "CHEMICAL", 10, 23], ["amino acids", "CHEMICAL", 69, 80], ["guanine", "CHEMICAL", 113, 120], ["adenine", "CHEMICAL", 125, 132], ["DHP alkaloids", "SIMPLE_CHEMICAL", 10, 23], ["amino acids", "AMINO_ACID", 69, 80], ["nucleic acids", "SIMPLE_CHEMICAL", 96, 109], ["guanine", "SIMPLE_CHEMICAL", 113, 120], ["adenine residues", "SIMPLE_CHEMICAL", 125, 141], ["The toxic DHP alkaloids", "PROBLEM", 0, 23], ["electrophilic", "PROBLEM", 28, 41], ["amino acids", "TEST", 69, 80], ["proteins", "TREATMENT", 82, 90], ["nucleic acids at guanine", "TREATMENT", 96, 120], ["adenine residues", "TREATMENT", 125, 141], ["toxic", "OBSERVATION_MODIFIER", 4, 9], ["DHP alkaloids", "OBSERVATION", 10, 23], ["adenine residues", "OBSERVATION", 125, 141]]], ["Acute toxicity derives from damage to cellular proteins.", [["cellular", "ANATOMY", 38, 46], ["toxicity", "DISEASE", 6, 14], ["cellular", "CELL", 38, 46], ["cellular proteins", "PROTEIN", 38, 55], ["Acute toxicity", "PROBLEM", 0, 14], ["damage to cellular proteins", "PROBLEM", 28, 55], ["toxicity", "OBSERVATION", 6, 14], ["cellular proteins", "OBSERVATION", 38, 55]]], ["Antimitotic effects can be exerted via damage to microtubules.", [["microtubules", "ANATOMY", 49, 61], ["microtubules", "CELLULAR_COMPONENT", 49, 61], ["Antimitotic effects", "PROBLEM", 0, 19], ["damage", "OBSERVATION", 39, 45]]], ["The DNA-binding activity is responsible for genotoxicity; the DHP-derived of unconjugated sporidesmin in bile, where its concentration may initiate oxidative injury, likely mediated by the production of a hydroxyl radical.", [["bile", "ANATOMY", 105, 109], ["DHP", "CHEMICAL", 62, 65], ["sporidesmin", "CHEMICAL", 90, 101], ["hydroxyl", "CHEMICAL", 205, 213], ["DHP", "CHEMICAL", 62, 65], ["sporidesmin", "CHEMICAL", 90, 101], ["hydroxyl", "CHEMICAL", 205, 213], ["DNA", "CELLULAR_COMPONENT", 4, 7], ["DHP", "SIMPLE_CHEMICAL", 62, 65], ["unconjugated", "SIMPLE_CHEMICAL", 77, 89], ["sporidesmin", "SIMPLE_CHEMICAL", 90, 101], ["bile", "SIMPLE_CHEMICAL", 105, 109], ["hydroxyl radical", "SIMPLE_CHEMICAL", 205, 221], ["genotoxicity", "PROBLEM", 44, 56], ["the DHP", "TEST", 58, 65], ["unconjugated sporidesmin in bile", "PROBLEM", 77, 109], ["oxidative injury", "PROBLEM", 148, 164], ["a hydroxyl radical", "TREATMENT", 203, 221], ["binding activity", "OBSERVATION", 8, 24], ["bile", "ANATOMY", 105, 109], ["oxidative injury", "OBSERVATION", 148, 164]]], ["Sporidesmin is also excreted in urine, and if the dose is high enough, edema and mucosal hemorrhage occur in the bladder.", [["urine", "ANATOMY", 32, 37], ["edema", "ANATOMY", 71, 76], ["mucosal", "ANATOMY", 81, 88], ["bladder", "ANATOMY", 113, 120], ["Sporidesmin", "CHEMICAL", 0, 11], ["edema", "DISEASE", 71, 76], ["mucosal hemorrhage", "DISEASE", 81, 99], ["Sporidesmin", "CHEMICAL", 0, 11], ["Sporidesmin", "SIMPLE_CHEMICAL", 0, 11], ["urine", "ORGANISM_SUBSTANCE", 32, 37], ["edema", "PATHOLOGICAL_FORMATION", 71, 76], ["mucosal hemorrhage", "PATHOLOGICAL_FORMATION", 81, 99], ["bladder", "ORGAN", 113, 120], ["edema", "PROBLEM", 71, 76], ["mucosal hemorrhage occur in the bladder", "PROBLEM", 81, 120], ["excreted", "OBSERVATION_MODIFIER", 20, 28], ["urine", "OBSERVATION", 32, 37], ["edema", "OBSERVATION", 71, 76], ["mucosal", "ANATOMY", 81, 88], ["hemorrhage", "OBSERVATION", 89, 99], ["bladder", "ANATOMY", 113, 120]]], ["The hepatic lesion is the result of irritation of mesenchymal tissues in the portal triads and surrounding the bile ducts.", [["hepatic lesion", "ANATOMY", 4, 18], ["mesenchymal tissues", "ANATOMY", 50, 69], ["portal triads", "ANATOMY", 77, 90], ["bile ducts", "ANATOMY", 111, 121], ["hepatic lesion", "DISEASE", 4, 18], ["hepatic lesion", "PATHOLOGICAL_FORMATION", 4, 18], ["mesenchymal tissues", "TISSUE", 50, 69], ["portal triads", "MULTI-TISSUE_STRUCTURE", 77, 90], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 111, 121], ["The hepatic lesion", "PROBLEM", 0, 18], ["irritation of mesenchymal tissues in the portal triads", "PROBLEM", 36, 90], ["hepatic", "ANATOMY", 4, 11], ["lesion", "OBSERVATION", 12, 18], ["irritation", "OBSERVATION", 36, 46], ["mesenchymal tissues", "OBSERVATION", 50, 69], ["portal triads", "ANATOMY", 77, 90], ["bile ducts", "ANATOMY", 111, 121]]], ["A high concentration of sporidesmin can injure biliary epithelium, allowing diffusion of the bile duct contents.", [["biliary epithelium", "ANATOMY", 47, 65], ["bile duct", "ANATOMY", 93, 102], ["sporidesmin", "CHEMICAL", 24, 35], ["sporidesmin", "CHEMICAL", 24, 35], ["sporidesmin", "SIMPLE_CHEMICAL", 24, 35], ["biliary epithelium", "TISSUE", 47, 65], ["bile duct", "MULTI-TISSUE_STRUCTURE", 93, 102], ["A high concentration of sporidesmin can injure biliary epithelium", "PROBLEM", 0, 65], ["high concentration", "OBSERVATION_MODIFIER", 2, 20], ["biliary epithelium", "ANATOMY", 47, 65], ["bile duct", "ANATOMY", 93, 102]]], ["Release of toxin, possibly accentuated by the release of bile acids as well, produces irritative lesions and necrosis in the adjacent blood vessels.Pyrrolizidine alkaloidsThe liver in acute forms of the disease is enlarged, with rounded edges, and is finely mottled and discolored yellowgreen by retained bile pigments, although the discoloration may be blotchy.", [["irritative lesions", "ANATOMY", 86, 104], ["blood vessels", "ANATOMY", 134, 147], ["liver", "ANATOMY", 175, 180], ["bile pigments", "ANATOMY", 305, 318], ["bile acids", "CHEMICAL", 57, 67], ["necrosis", "DISEASE", 109, 117], ["Pyrrolizidine alkaloids", "CHEMICAL", 148, 171], ["yellowgreen", "DISEASE", 281, 292], ["bile acids", "CHEMICAL", 57, 67], ["Pyrrolizidine alkaloids", "CHEMICAL", 148, 171], ["bile acids", "SIMPLE_CHEMICAL", 57, 67], ["irritative lesions", "PATHOLOGICAL_FORMATION", 86, 104], ["blood vessels", "MULTI-TISSUE_STRUCTURE", 134, 147], ["Pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 148, 171], ["liver", "ORGAN", 175, 180], ["yellowgreen", "SIMPLE_CHEMICAL", 281, 292], ["bile pigments", "SIMPLE_CHEMICAL", 305, 318], ["toxin", "TREATMENT", 11, 16], ["bile acids", "TREATMENT", 57, 67], ["irritative lesions", "PROBLEM", 86, 104], ["necrosis in the adjacent blood vessels", "PROBLEM", 109, 147], ["Pyrrolizidine alkaloids", "TREATMENT", 148, 171], ["the disease", "PROBLEM", 199, 210], ["rounded edges", "PROBLEM", 229, 242], ["finely mottled", "PROBLEM", 251, 265], ["retained bile pigments", "PROBLEM", 296, 318], ["the discoloration", "PROBLEM", 329, 346], ["blotchy", "PROBLEM", 354, 361], ["bile", "ANATOMY", 57, 61], ["irritative", "OBSERVATION_MODIFIER", 86, 96], ["lesions", "OBSERVATION", 97, 104], ["necrosis", "OBSERVATION", 109, 117], ["adjacent", "ANATOMY_MODIFIER", 125, 133], ["blood vessels", "ANATOMY", 134, 147], ["liver", "ANATOMY", 175, 180], ["acute", "OBSERVATION_MODIFIER", 184, 189], ["disease", "OBSERVATION", 203, 210], ["enlarged", "OBSERVATION", 214, 222], ["rounded", "OBSERVATION_MODIFIER", 229, 236], ["edges", "OBSERVATION_MODIFIER", 237, 242], ["finely", "OBSERVATION_MODIFIER", 251, 257], ["mottled", "OBSERVATION_MODIFIER", 258, 265], ["discolored", "OBSERVATION_MODIFIER", 270, 280], ["yellowgreen", "OBSERVATION_MODIFIER", 281, 292], ["retained", "OBSERVATION_MODIFIER", 296, 304], ["bile pigments", "OBSERVATION", 305, 318], ["discoloration", "OBSERVATION_MODIFIER", 333, 346], ["may be", "UNCERTAINTY", 347, 353], ["blotchy", "OBSERVATION", 354, 361]]], ["There is mild edema and congestion of the wall of the gallbladder, which may be distended with bile of normal quality or with mucin (white bile).", [["edema", "ANATOMY", 14, 19], ["wall", "ANATOMY", 42, 46], ["gallbladder", "ANATOMY", 54, 65], ["bile", "ANATOMY", 95, 99], ["white bile", "ANATOMY", 133, 143], ["edema", "DISEASE", 14, 19], ["edema", "PATHOLOGICAL_FORMATION", 14, 19], ["wall", "TISSUE", 42, 46], ["gallbladder", "ORGAN", 54, 65], ["mucin", "GENE_OR_GENE_PRODUCT", 126, 131], ["bile", "MULTI-TISSUE_STRUCTURE", 139, 143], ["mild edema", "PROBLEM", 9, 19], ["congestion of the wall of the gallbladder", "PROBLEM", 24, 65], ["distended", "PROBLEM", 80, 89], ["mucin (white bile)", "PROBLEM", 126, 144], ["mild", "OBSERVATION_MODIFIER", 9, 13], ["edema", "OBSERVATION", 14, 19], ["congestion", "OBSERVATION", 24, 34], ["wall", "ANATOMY_MODIFIER", 42, 46], ["gallbladder", "ANATOMY", 54, 65], ["may be", "UNCERTAINTY", 73, 79], ["distended", "OBSERVATION", 80, 89], ["bile", "ANATOMY", 95, 99], ["normal", "OBSERVATION", 103, 109], ["quality", "OBSERVATION_MODIFIER", 110, 117]]], ["The extrahepatic ducts are thickened and prominent, and there is edema of the adventitia.", [["extrahepatic ducts", "ANATOMY", 4, 22], ["edema", "ANATOMY", 65, 70], ["adventitia", "ANATOMY", 78, 88], ["edema", "DISEASE", 65, 70], ["extrahepatic ducts", "MULTI-TISSUE_STRUCTURE", 4, 22], ["edema", "PATHOLOGICAL_FORMATION", 65, 70], ["adventitia", "TISSUE", 78, 88], ["thickened", "PROBLEM", 27, 36], ["edema of the adventitia", "PROBLEM", 65, 88], ["extrahepatic ducts", "ANATOMY", 4, 22], ["thickened", "OBSERVATION", 27, 36], ["prominent", "OBSERVATION_MODIFIER", 41, 50], ["edema", "OBSERVATION", 65, 70], ["adventitia", "ANATOMY", 78, 88]]], ["The ductal changes may extend to the papilla of Vater and can be traced by the naked eye deeply into the parenchyma.", [["ductal", "ANATOMY", 4, 10], ["papilla", "ANATOMY", 37, 44], ["Vater", "ANATOMY", 48, 53], ["eye", "ANATOMY", 85, 88], ["parenchyma", "ANATOMY", 105, 115], ["ductal", "MULTI-TISSUE_STRUCTURE", 4, 10], ["papilla", "TISSUE", 37, 44], ["Vater", "MULTI-TISSUE_STRUCTURE", 48, 53], ["eye", "ORGAN", 85, 88], ["parenchyma", "TISSUE", 105, 115], ["The ductal changes", "PROBLEM", 0, 18], ["ductal", "ANATOMY", 4, 10], ["papilla", "ANATOMY_MODIFIER", 37, 44], ["Vater", "ANATOMY", 48, 53], ["parenchyma", "ANATOMY", 105, 115]]], ["In more chronic cases, alterations of size and pigmentation of the liver are variable.", [["liver", "ANATOMY", 67, 72], ["liver", "ORGAN", 67, 72], ["alterations of size and pigmentation of the liver", "PROBLEM", 23, 72], ["more", "OBSERVATION_MODIFIER", 3, 7], ["chronic", "OBSERVATION_MODIFIER", 8, 15], ["cases", "OBSERVATION", 16, 21], ["size", "OBSERVATION_MODIFIER", 38, 42], ["pigmentation", "OBSERVATION", 47, 59], ["liver", "ANATOMY", 67, 72], ["variable", "OBSERVATION_MODIFIER", 77, 85]]], ["Pale areas of capsular thickening, which may be elevated or depressed, are visible.", [["capsular", "ANATOMY", 14, 22], ["depressed", "DISEASE", 60, 69], ["capsular", "TISSUE", 14, 22], ["capsular thickening", "PROBLEM", 14, 33], ["elevated or depressed", "PROBLEM", 48, 69], ["areas", "OBSERVATION_MODIFIER", 5, 10], ["capsular thickening", "OBSERVATION", 14, 33], ["may be", "UNCERTAINTY", 41, 47], ["elevated", "OBSERVATION_MODIFIER", 48, 56], ["depressed", "OBSERVATION_MODIFIER", 60, 69], ["visible", "OBSERVATION_MODIFIER", 75, 82]]], ["On cut surfaces, they extend deeply as wedge-shaped areas in which biliary fibrosis has produced an exaggerated acinar pattern, and the parenchyma is pale and atrophic; these areas are related to occluded bile ducts.Pyrrolizidine alkaloidsThe liver is firm and cuts with increased resistance.", [["biliary", "ANATOMY", 67, 74], ["acinar", "ANATOMY", 112, 118], ["parenchyma", "ANATOMY", 136, 146], ["bile ducts", "ANATOMY", 205, 215], ["liver", "ANATOMY", 243, 248], ["fibrosis", "DISEASE", 75, 83], ["Pyrrolizidine alkaloids", "CHEMICAL", 216, 239], ["Pyrrolizidine alkaloids", "CHEMICAL", 216, 239], ["biliary", "ORGAN", 67, 74], ["acinar", "CANCER", 112, 118], ["parenchyma", "TISSUE", 136, 146], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 205, 215], ["Pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 216, 239], ["liver", "ORGAN", 243, 248], ["biliary fibrosis", "PROBLEM", 67, 83], ["an exaggerated acinar pattern", "PROBLEM", 97, 126], ["atrophic", "PROBLEM", 159, 167], ["occluded bile ducts", "PROBLEM", 196, 215], ["Pyrrolizidine alkaloids", "TREATMENT", 216, 239], ["increased resistance", "PROBLEM", 271, 291], ["deeply", "OBSERVATION_MODIFIER", 29, 35], ["wedge", "OBSERVATION_MODIFIER", 39, 44], ["shaped", "OBSERVATION_MODIFIER", 45, 51], ["areas", "OBSERVATION_MODIFIER", 52, 57], ["biliary", "ANATOMY", 67, 74], ["fibrosis", "OBSERVATION", 75, 83], ["exaggerated", "OBSERVATION_MODIFIER", 100, 111], ["acinar pattern", "OBSERVATION", 112, 126], ["parenchyma", "ANATOMY", 136, 146], ["pale", "OBSERVATION_MODIFIER", 150, 154], ["atrophic", "OBSERVATION", 159, 167], ["occluded", "OBSERVATION", 196, 204], ["bile ducts", "ANATOMY", 205, 215], ["liver", "ANATOMY", 243, 248], ["firm", "OBSERVATION", 252, 256], ["increased", "OBSERVATION_MODIFIER", 271, 280], ["resistance", "OBSERVATION_MODIFIER", 281, 291]]], ["The medium and large caliber intrahepatic ducts are conspicuous.", [["intrahepatic ducts", "ANATOMY", 29, 47], ["intrahepatic ducts", "MULTI-TISSUE_STRUCTURE", 29, 47], ["medium", "OBSERVATION_MODIFIER", 4, 10], ["large", "OBSERVATION_MODIFIER", 15, 20], ["caliber", "OBSERVATION_MODIFIER", 21, 28], ["intrahepatic", "ANATOMY_MODIFIER", 29, 41], ["ducts", "ANATOMY", 42, 47], ["conspicuous", "OBSERVATION_MODIFIER", 52, 63]]], ["There is irregular stenosis of their lumens, some are occluded by cellular debris and inspissated bile or mucin, and in some, cicatrization of the new fibrous tissue causes complete atresia.", [["lumens", "ANATOMY", 37, 43], ["cellular", "ANATOMY", 66, 74], ["bile", "ANATOMY", 98, 102], ["mucin", "ANATOMY", 106, 111], ["fibrous tissue", "ANATOMY", 151, 165], ["fibrous", "DISEASE", 151, 158], ["atresia", "DISEASE", 182, 189], ["lumens", "IMMATERIAL_ANATOMICAL_ENTITY", 37, 43], ["cellular", "CELL", 66, 74], ["bile", "MULTI-TISSUE_STRUCTURE", 98, 102], ["mucin", "GENE_OR_GENE_PRODUCT", 106, 111], ["fibrous tissue", "TISSUE", 151, 165], ["irregular stenosis of their lumens", "PROBLEM", 9, 43], ["cellular debris", "PROBLEM", 66, 81], ["inspissated bile or mucin", "PROBLEM", 86, 111], ["the new fibrous tissue", "PROBLEM", 143, 165], ["complete atresia", "PROBLEM", 173, 189], ["irregular", "OBSERVATION_MODIFIER", 9, 18], ["stenosis", "OBSERVATION", 19, 27], ["lumens", "OBSERVATION_MODIFIER", 37, 43], ["occluded", "OBSERVATION", 54, 62], ["cellular", "OBSERVATION_MODIFIER", 66, 74], ["debris", "OBSERVATION", 75, 81], ["inspissated", "OBSERVATION_MODIFIER", 86, 97], ["bile", "OBSERVATION_MODIFIER", 98, 102], ["mucin", "OBSERVATION_MODIFIER", 106, 111], ["cicatrization", "OBSERVATION_MODIFIER", 126, 139], ["new", "OBSERVATION_MODIFIER", 147, 150], ["fibrous tissue", "OBSERVATION", 151, 165], ["complete", "OBSERVATION_MODIFIER", 173, 181], ["atresia", "OBSERVATION", 182, 189]]], ["Occlusion of the ducts causes the parenchyma served by them to undergo atrophy, necrosis, and fibrosis ( Fig. 2-98) .", [["ducts", "ANATOMY", 17, 22], ["parenchyma", "ANATOMY", 34, 44], ["atrophy", "DISEASE", 71, 78], ["necrosis", "DISEASE", 80, 88], ["fibrosis", "DISEASE", 94, 102], ["ducts", "MULTI-TISSUE_STRUCTURE", 17, 22], ["parenchyma", "TISSUE", 34, 44], ["Occlusion of the ducts", "PROBLEM", 0, 22], ["atrophy", "PROBLEM", 71, 78], ["necrosis", "PROBLEM", 80, 88], ["fibrosis", "PROBLEM", 94, 102], ["ducts", "ANATOMY", 17, 22], ["parenchyma", "ANATOMY_MODIFIER", 34, 44], ["atrophy", "OBSERVATION", 71, 78], ["necrosis", "OBSERVATION", 80, 88], ["fibrosis", "OBSERVATION", 94, 102]]], ["The livers of animals that have survived an attack of cholangitis of this genesis are distorted in shape and size by large nodules of regeneration and persistent areas of atrophy and fibrosis.", [["livers", "ANATOMY", 4, 10], ["nodules", "ANATOMY", 123, 130], ["cholangitis", "DISEASE", 54, 65], ["atrophy", "DISEASE", 171, 178], ["fibrosis", "DISEASE", 183, 191], ["livers", "ORGAN", 4, 10], ["animals", "ORGANISM", 14, 21], ["cholangitis of this genesis", "PROBLEM", 54, 81], ["large nodules of regeneration", "PROBLEM", 117, 146], ["atrophy", "PROBLEM", 171, 178], ["fibrosis", "PROBLEM", 183, 191], ["livers", "ANATOMY", 4, 10], ["attack", "OBSERVATION_MODIFIER", 44, 50], ["cholangitis", "OBSERVATION", 54, 65], ["distorted", "OBSERVATION_MODIFIER", 86, 95], ["shape", "OBSERVATION_MODIFIER", 99, 104], ["size", "OBSERVATION_MODIFIER", 109, 113], ["large", "OBSERVATION_MODIFIER", 117, 122], ["nodules", "OBSERVATION", 123, 130], ["regeneration", "OBSERVATION_MODIFIER", 134, 146], ["persistent", "OBSERVATION_MODIFIER", 151, 161], ["areas", "OBSERVATION_MODIFIER", 162, 167], ["atrophy", "OBSERVATION", 171, 178], ["fibrosis", "OBSERVATION", 183, 191]]], ["The atrophy and fibrosis may affect either lobe, but usually, the left is most severely affected.Pyrrolizidine alkaloidsHistologically, the changes are those of acute cholangitis or cholangiohepatitis to which there is minimal leukocytic reaction.", [["lobe", "ANATOMY", 43, 47], ["leukocytic", "ANATOMY", 227, 237], ["atrophy", "DISEASE", 4, 11], ["fibrosis", "DISEASE", 16, 24], ["Pyrrolizidine alkaloids", "CHEMICAL", 97, 120], ["cholangitis", "DISEASE", 167, 178], ["cholangiohepatitis", "DISEASE", 182, 200], ["Pyrrolizidine alkaloids", "CHEMICAL", 97, 120], ["lobe", "ORGAN", 43, 47], ["Pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 97, 120], ["leukocytic", "CELL", 227, 237], ["The atrophy", "PROBLEM", 0, 11], ["fibrosis", "PROBLEM", 16, 24], ["severely affected", "PROBLEM", 79, 96], ["Pyrrolizidine alkaloids", "TREATMENT", 97, 120], ["acute cholangitis", "PROBLEM", 161, 178], ["cholangiohepatitis", "PROBLEM", 182, 200], ["minimal leukocytic reaction", "PROBLEM", 219, 246], ["atrophy", "OBSERVATION", 4, 11], ["fibrosis", "OBSERVATION", 16, 24], ["lobe", "ANATOMY_MODIFIER", 43, 47], ["left", "ANATOMY_MODIFIER", 66, 70], ["most", "OBSERVATION_MODIFIER", 74, 78], ["severely", "OBSERVATION_MODIFIER", 79, 87], ["affected", "OBSERVATION", 88, 96], ["acute", "OBSERVATION_MODIFIER", 161, 166], ["cholangitis", "OBSERVATION", 167, 178], ["minimal", "OBSERVATION_MODIFIER", 219, 226], ["leukocytic reaction", "OBSERVATION", 227, 246]]], ["There is extensive necrosis of the lining of the larger intrahepatic ducts and the extrahepatic ducts, the epithelium being cast off as debris mixed with a few leukocytes.", [["intrahepatic ducts", "ANATOMY", 56, 74], ["extrahepatic ducts", "ANATOMY", 83, 101], ["epithelium", "ANATOMY", 107, 117], ["leukocytes", "ANATOMY", 160, 170], ["necrosis", "DISEASE", 19, 27], ["intrahepatic ducts", "MULTI-TISSUE_STRUCTURE", 56, 74], ["extrahepatic ducts", "MULTI-TISSUE_STRUCTURE", 83, 101], ["epithelium", "TISSUE", 107, 117], ["leukocytes", "CELL", 160, 170], ["leukocytes", "CELL_TYPE", 160, 170], ["extensive necrosis of the lining of the larger intrahepatic ducts and the extrahepatic ducts", "PROBLEM", 9, 101], ["debris", "PROBLEM", 136, 142], ["a few leukocytes", "PROBLEM", 154, 170], ["extensive", "OBSERVATION_MODIFIER", 9, 18], ["necrosis", "OBSERVATION", 19, 27], ["lining", "ANATOMY_MODIFIER", 35, 41], ["larger", "ANATOMY_MODIFIER", 49, 55], ["intrahepatic", "ANATOMY_MODIFIER", 56, 68], ["ducts", "ANATOMY_MODIFIER", 69, 74], ["extrahepatic ducts", "ANATOMY", 83, 101], ["epithelium", "OBSERVATION_MODIFIER", 107, 117], ["cast", "OBSERVATION", 124, 128], ["debris", "OBSERVATION_MODIFIER", 136, 142], ["mixed", "OBSERVATION_MODIFIER", 143, 148], ["few", "OBSERVATION_MODIFIER", 156, 159], ["leukocytes", "OBSERVATION_MODIFIER", 160, 170]]], ["There is In chronic pyrrolizidine alkaloid poisoning, the liver can become atrophic as hepatocytes are lost faster than they can be replaced.", [["liver", "ANATOMY", 58, 63], ["hepatocytes", "ANATOMY", 87, 98], ["pyrrolizidine alkaloid", "CHEMICAL", 20, 42], ["poisoning", "DISEASE", 43, 52], ["pyrrolizidine alkaloid", "CHEMICAL", 20, 42], ["pyrrolizidine alkaloid", "SIMPLE_CHEMICAL", 20, 42], ["liver", "ORGAN", 58, 63], ["hepatocytes", "CELL", 87, 98], ["hepatocytes", "CELL_TYPE", 87, 98], ["chronic pyrrolizidine alkaloid poisoning", "PROBLEM", 12, 52], ["atrophic", "PROBLEM", 75, 83], ["chronic", "OBSERVATION_MODIFIER", 12, 19], ["pyrrolizidine", "OBSERVATION", 20, 33], ["alkaloid poisoning", "OBSERVATION", 34, 52], ["liver", "ANATOMY", 58, 63], ["atrophic", "OBSERVATION", 75, 83], ["hepatocytes", "ANATOMY", 87, 98]]], ["The atrophy can be compensated to various degrees by megalocytosis and regeneration of small, less inhibited hepatocytes that proliferate in a nodular pattern.", [["hepatocytes", "ANATOMY", 109, 120], ["atrophy", "DISEASE", 4, 11], ["megalocytosis", "DISEASE", 53, 66], ["hepatocytes", "CELL", 109, 120], ["hepatocytes", "CELL_TYPE", 109, 120], ["The atrophy", "PROBLEM", 0, 11], ["megalocytosis", "PROBLEM", 53, 66], ["regeneration of small, less inhibited hepatocytes", "PROBLEM", 71, 120], ["a nodular pattern", "PROBLEM", 141, 158], ["atrophy", "OBSERVATION", 4, 11], ["various degrees", "OBSERVATION_MODIFIER", 34, 49], ["megalocytosis", "OBSERVATION", 53, 66], ["regeneration", "OBSERVATION_MODIFIER", 71, 83], ["small", "OBSERVATION_MODIFIER", 87, 92], ["less inhibited", "OBSERVATION_MODIFIER", 94, 108], ["hepatocytes", "ANATOMY", 109, 120], ["proliferate", "OBSERVATION_MODIFIER", 126, 137], ["nodular", "OBSERVATION_MODIFIER", 143, 150]]], ["Concurrently, there is usually proliferation of bile duct epithelial cells (termed ductular reaction) in the portal triads.", [["bile duct epithelial cells", "ANATOMY", 48, 74], ["ductular", "ANATOMY", 83, 91], ["portal triads", "ANATOMY", 109, 122], ["bile duct epithelial cells", "CELL", 48, 74], ["ductular", "ORGAN", 83, 91], ["portal triads", "MULTI-TISSUE_STRUCTURE", 109, 122], ["bile duct epithelial cells", "CELL_TYPE", 48, 74], ["bile duct epithelial cells", "PROBLEM", 48, 74], ["termed ductular reaction", "PROBLEM", 76, 100], ["usually", "OBSERVATION_MODIFIER", 23, 30], ["proliferation", "OBSERVATION", 31, 44], ["bile duct", "ANATOMY", 48, 57], ["epithelial cells", "OBSERVATION", 58, 74], ["ductular", "OBSERVATION_MODIFIER", 83, 91], ["portal triads", "ANATOMY", 109, 122]]], ["This is largely explained by the propensity of hepatic progenitor cells to proliferate forming ductules when adult hepatocytes cannot respond to the regenerative stimuli that prevail when liver mass is inadequate.", [["hepatic progenitor cells", "ANATOMY", 47, 71], ["ductules", "ANATOMY", 95, 103], ["adult hepatocytes", "ANATOMY", 109, 126], ["liver mass", "ANATOMY", 188, 198], ["hepatic progenitor cells", "CELL", 47, 71], ["ductules", "MULTI-TISSUE_STRUCTURE", 95, 103], ["hepatocytes", "CELL", 115, 126], ["liver", "ORGAN", 188, 193], ["hepatic progenitor cells", "CELL_TYPE", 47, 71], ["adult hepatocytes", "CELL_TYPE", 109, 126], ["hepatic progenitor cells", "TREATMENT", 47, 71], ["adult hepatocytes", "PROBLEM", 109, 126], ["the regenerative stimuli", "TREATMENT", 145, 169], ["liver mass", "PROBLEM", 188, 198], ["hepatic", "ANATOMY", 47, 54], ["progenitor cells", "OBSERVATION", 55, 71], ["liver", "ANATOMY", 188, 193], ["mass", "OBSERVATION", 194, 198]]], ["There may also be some periportal fibroplasia that varies with species and exposure; typically, it is minimal in sheep, moderate in horses, and may be marked in cattle .", [["periportal fibroplasia", "ANATOMY", 23, 45], ["fibroplasia", "DISEASE", 34, 45], ["sheep", "ORGANISM", 113, 118], ["cattle", "ORGANISM", 161, 167], ["sheep", "SPECIES", 113, 118], ["cattle", "SPECIES", 161, 167], ["sheep", "SPECIES", 113, 118], ["cattle", "SPECIES", 161, 167], ["some periportal fibroplasia", "PROBLEM", 18, 45], ["may also be", "UNCERTAINTY", 6, 17], ["some", "OBSERVATION_MODIFIER", 18, 22], ["periportal", "ANATOMY_MODIFIER", 23, 33], ["fibroplasia", "OBSERVATION", 34, 45], ["species", "OBSERVATION_MODIFIER", 63, 70], ["minimal", "OBSERVATION_MODIFIER", 102, 109], ["moderate", "OBSERVATION_MODIFIER", 120, 128], ["may be", "UNCERTAINTY", 144, 150], ["marked", "OBSERVATION_MODIFIER", 151, 157]]], ["In cattle, the fibrous tissue can infiltrate along the sinusoids to dissect lobules, separate individual cells, and link up with the walls of efferent veins.", [["fibrous tissue", "ANATOMY", 15, 29], ["sinusoids", "ANATOMY", 55, 64], ["lobules", "ANATOMY", 76, 83], ["cells", "ANATOMY", 105, 110], ["efferent veins", "ANATOMY", 142, 156], ["cattle", "ORGANISM", 3, 9], ["fibrous tissue", "TISSUE", 15, 29], ["sinusoids", "TISSUE", 55, 64], ["lobules", "MULTI-TISSUE_STRUCTURE", 76, 83], ["cells", "CELL", 105, 110], ["efferent veins", "MULTI-TISSUE_STRUCTURE", 142, 156], ["cattle", "SPECIES", 3, 9], ["cattle", "SPECIES", 3, 9], ["the fibrous tissue", "PROBLEM", 11, 29], ["infiltrate", "PROBLEM", 34, 44], ["fibrous tissue", "OBSERVATION", 15, 29], ["infiltrate", "OBSERVATION", 34, 44], ["sinusoids", "ANATOMY", 55, 64], ["lobules", "ANATOMY_MODIFIER", 76, 83], ["individual cells", "OBSERVATION", 94, 110], ["walls", "ANATOMY_MODIFIER", 133, 138], ["efferent veins", "ANATOMY", 142, 156]]], ["In acute poisoning, in which there is centrilobular necrosis, fibrosis can also develop in a \"veno-occlusive\" pattern around and sometimes obliterating the hepatic venules.", [["centrilobular", "ANATOMY", 38, 51], ["hepatic venules", "ANATOMY", 156, 171], ["poisoning", "DISEASE", 9, 18], ["necrosis", "DISEASE", 52, 60], ["fibrosis", "DISEASE", 62, 70], ["hepatic venules", "MULTI-TISSUE_STRUCTURE", 156, 171], ["hepatic venules", "CELL_TYPE", 156, 171], ["acute poisoning", "PROBLEM", 3, 18], ["centrilobular necrosis", "PROBLEM", 38, 60], ["fibrosis", "PROBLEM", 62, 70], ["a \"veno-occlusive\" pattern", "PROBLEM", 91, 117], ["acute", "OBSERVATION_MODIFIER", 3, 8], ["poisoning", "OBSERVATION", 9, 18], ["centrilobular", "OBSERVATION_MODIFIER", 38, 51], ["necrosis", "OBSERVATION", 52, 60], ["fibrosis", "OBSERVATION", 62, 70], ["occlusive", "OBSERVATION_MODIFIER", 99, 108], ["\"", "OBSERVATION", 108, 109], ["hepatic", "ANATOMY", 156, 163], ["venules", "ANATOMY_MODIFIER", 164, 171]]], ["There is evidence that pyrrolizidine metabolite injury is not restricted to hepatocytes and that endothelial cells are also involved, leading to additional vascular insult and fibrosis in the liver.", [["hepatocytes", "ANATOMY", 76, 87], ["endothelial cells", "ANATOMY", 97, 114], ["vascular", "ANATOMY", 156, 164], ["liver", "ANATOMY", 192, 197], ["pyrrolizidine", "CHEMICAL", 23, 36], ["vascular insult", "DISEASE", 156, 171], ["fibrosis", "DISEASE", 176, 184], ["pyrrolizidine", "CHEMICAL", 23, 36], ["pyrrolizidine", "SIMPLE_CHEMICAL", 23, 36], ["hepatocytes", "CELL", 76, 87], ["endothelial cells", "CELL", 97, 114], ["vascular", "MULTI-TISSUE_STRUCTURE", 156, 164], ["liver", "ORGAN", 192, 197], ["hepatocytes", "CELL_TYPE", 76, 87], ["endothelial cells", "CELL_TYPE", 97, 114], ["pyrrolizidine metabolite injury", "PROBLEM", 23, 54], ["endothelial cells", "PROBLEM", 97, 114], ["additional vascular insult", "PROBLEM", 145, 171], ["fibrosis in the liver", "PROBLEM", 176, 197], ["pyrrolizidine", "OBSERVATION", 23, 36], ["metabolite injury", "OBSERVATION", 37, 54], ["endothelial cells", "OBSERVATION", 97, 114], ["vascular", "ANATOMY", 156, 164], ["insult", "OBSERVATION", 165, 171], ["fibrosis", "OBSERVATION", 176, 184], ["liver", "ANATOMY", 192, 197]]], ["Direct endothelial injury from pyrrolizidines may occur, but an alternative explanation proposes a form of \"bystander\" injury, where toxic metabolites are formed in hepatocytes but are able to damage adjacent endothelial cells.", [["endothelial", "ANATOMY", 7, 18], ["hepatocytes", "ANATOMY", 165, 176], ["endothelial cells", "ANATOMY", 209, 226], ["pyrrolizidines", "CHEMICAL", 31, 45], ["pyrrolizidines", "CHEMICAL", 31, 45], ["endothelial", "TISSUE", 7, 18], ["pyrrolizidines", "SIMPLE_CHEMICAL", 31, 45], ["hepatocytes", "CELL", 165, 176], ["endothelial cells", "CELL", 209, 226], ["hepatocytes", "CELL_TYPE", 165, 176], ["endothelial cells", "CELL_TYPE", 209, 226], ["Direct endothelial injury", "PROBLEM", 0, 25], ["pyrrolizidines", "TREATMENT", 31, 45], ["\"bystander\" injury", "PROBLEM", 107, 125], ["toxic metabolites", "PROBLEM", 133, 150], ["hepatocytes", "PROBLEM", 165, 176], ["endothelial", "ANATOMY", 7, 18], ["injury", "OBSERVATION", 19, 25], ["hepatocytes", "ANATOMY", 165, 176], ["endothelial cells", "OBSERVATION", 209, 226]]], ["This pattern of fibrosis may occur in some field cases in cattle, but is more commonly observed in humans exposed to pyrrolizidine alkaloids in herbal preparations or \"bush teas,\" and it can be produced experimentally after sublethal acute experimental hepatotoxicity.", [["teas", "ANATOMY", 173, 177], ["fibrosis", "DISEASE", 16, 24], ["pyrrolizidine alkaloids", "CHEMICAL", 117, 140], ["hepatotoxicity", "DISEASE", 253, 267], ["pyrrolizidine alkaloids", "CHEMICAL", 117, 140], ["cattle", "ORGANISM", 58, 64], ["humans", "ORGANISM", 99, 105], ["pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 117, 140], ["teas", "ORGANISM_SUBDIVISION", 173, 177], ["cattle", "SPECIES", 58, 64], ["humans", "SPECIES", 99, 105], ["cattle", "SPECIES", 58, 64], ["humans", "SPECIES", 99, 105], ["fibrosis", "PROBLEM", 16, 24], ["pyrrolizidine alkaloids", "TREATMENT", 117, 140], ["herbal preparations", "TREATMENT", 144, 163], ["sublethal acute experimental hepatotoxicity", "PROBLEM", 224, 267], ["fibrosis", "OBSERVATION", 16, 24], ["more commonly", "OBSERVATION_MODIFIER", 73, 86], ["acute", "OBSERVATION_MODIFIER", 234, 239], ["experimental hepatotoxicity", "OBSERVATION", 240, 267]]], ["In fatal cases in cattle, the livers are very tough and nodular, and the nodules have variably efficient biliary drainage and cytochrome expression, so there may be a very striking color pattern, ranging from fatty yellow through green and brown.", [["livers", "ANATOMY", 30, 36], ["nodules", "ANATOMY", 73, 80], ["biliary", "ANATOMY", 105, 112], ["fatty yellow", "CHEMICAL", 209, 221], ["cattle", "ORGANISM", 18, 24], ["livers", "ORGAN", 30, 36], ["nodules", "CANCER", 73, 80], ["biliary", "MULTI-TISSUE_STRUCTURE", 105, 112], ["cytochrome", "GENE_OR_GENE_PRODUCT", 126, 136], ["cattle", "SPECIES", 18, 24], ["cattle", "SPECIES", 18, 24], ["nodular", "PROBLEM", 56, 63], ["the nodules", "PROBLEM", 69, 80], ["biliary drainage", "TREATMENT", 105, 121], ["cytochrome expression", "PROBLEM", 126, 147], ["a very striking color pattern", "PROBLEM", 165, 194], ["fatal", "OBSERVATION_MODIFIER", 3, 8], ["livers", "ANATOMY", 30, 36], ["very", "OBSERVATION_MODIFIER", 41, 45], ["tough", "OBSERVATION_MODIFIER", 46, 51], ["nodular", "OBSERVATION_MODIFIER", 56, 63], ["nodules", "OBSERVATION", 73, 80], ["variably", "OBSERVATION_MODIFIER", 86, 94], ["efficient", "OBSERVATION_MODIFIER", 95, 104], ["biliary", "ANATOMY", 105, 112], ["drainage", "OBSERVATION", 113, 121], ["cytochrome expression", "OBSERVATION", 126, 147], ["may be", "UNCERTAINTY", 158, 164], ["very", "OBSERVATION_MODIFIER", 167, 171], ["striking", "OBSERVATION_MODIFIER", 172, 180], ["color pattern", "OBSERVATION", 181, 194], ["ranging", "OBSERVATION_MODIFIER", 196, 203]]], ["Hepatic fibrosis can result in portal hypertension with ascites, severe mesenteric edema, and diarrhea.", [["Hepatic", "ANATOMY", 0, 7], ["portal", "ANATOMY", 31, 37], ["ascites", "ANATOMY", 56, 63], ["mesenteric", "ANATOMY", 72, 82], ["fibrosis", "DISEASE", 8, 16], ["hypertension", "DISEASE", 38, 50], ["ascites", "DISEASE", 56, 63], ["mesenteric edema", "DISEASE", 72, 88], ["diarrhea", "DISEASE", 94, 102], ["Hepatic", "ORGAN", 0, 7], ["portal", "MULTI-TISSUE_STRUCTURE", 31, 37], ["mesenteric", "MULTI-TISSUE_STRUCTURE", 72, 82], ["Hepatic fibrosis", "PROBLEM", 0, 16], ["portal hypertension", "PROBLEM", 31, 50], ["ascites", "PROBLEM", 56, 63], ["severe mesenteric edema", "PROBLEM", 65, 88], ["diarrhea", "PROBLEM", 94, 102], ["fibrosis", "OBSERVATION", 8, 16], ["portal", "ANATOMY", 31, 37], ["hypertension", "OBSERVATION", 38, 50], ["ascites", "OBSERVATION", 56, 63], ["severe", "OBSERVATION_MODIFIER", 65, 71], ["mesenteric", "ANATOMY", 72, 82], ["edema", "OBSERVATION", 83, 88], ["diarrhea", "OBSERVATION", 94, 102]]], ["Excretory insufficiency with moderate jaundice and photosensitization can also occur.Pyrrolizidine alkaloidsThe disease in sheep is always protracted as a consequence of the relative resistance of this species; indeed, clinical signs may not be seen until after a second season of exposure.", [["Excretory insufficiency", "DISEASE", 0, 23], ["jaundice", "DISEASE", 38, 46], ["photosensitization", "DISEASE", 51, 69], ["Pyrrolizidine alkaloids", "CHEMICAL", 85, 108], ["Pyrrolizidine alkaloids", "CHEMICAL", 85, 108], ["Pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 85, 108], ["sheep", "ORGANISM", 123, 128], ["sheep", "SPECIES", 123, 128], ["sheep", "SPECIES", 123, 128], ["Excretory insufficiency", "PROBLEM", 0, 23], ["moderate jaundice", "PROBLEM", 29, 46], ["photosensitization", "TREATMENT", 51, 69], ["Pyrrolizidine alkaloids", "TREATMENT", 85, 108], ["The disease in sheep", "PROBLEM", 108, 128], ["this species", "PROBLEM", 197, 209], ["insufficiency", "OBSERVATION", 10, 23], ["moderate", "OBSERVATION_MODIFIER", 29, 37], ["jaundice", "OBSERVATION", 38, 46], ["disease", "OBSERVATION", 112, 119]]], ["The plants most often implicated are Heliotropium europaeum and Echium plantagineum.", [["Heliotropium europaeum", "ORGANISM", 37, 59], ["Echium plantagineum", "ORGANISM", 64, 83], ["Heliotropium europaeum", "SPECIES", 37, 59], ["Echium plantagineum", "SPECIES", 64, 83], ["Heliotropium europaeum", "SPECIES", 37, 59], ["Echium plantagineum", "SPECIES", 64, 83], ["Heliotropium europaeum", "TREATMENT", 37, 59], ["Echium plantagineum", "TREATMENT", 64, 83]]], ["The shape of these failed livers is DNA adducts are a common pathway for carcinogenic activity of pyrrolizidine alkaloids.", [["livers", "ANATOMY", 26, 32], ["pyrrolizidine alkaloids", "CHEMICAL", 98, 121], ["pyrrolizidine alkaloids", "CHEMICAL", 98, 121], ["livers", "ORGAN", 26, 32], ["DNA", "CELLULAR_COMPONENT", 36, 39], ["pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 98, 121], ["DNA adducts", "PROBLEM", 36, 47], ["pyrrolizidine alkaloids", "TREATMENT", 98, 121], ["shape", "OBSERVATION_MODIFIER", 4, 9], ["livers", "ANATOMY", 26, 32], ["DNA adducts", "OBSERVATION", 36, 47], ["pyrrolizidine alkaloids", "OBSERVATION", 98, 121]]], ["The DHP metabolites can be detoxified by glutathione conjugation by glutathione S-transferases.", [["DHP", "CHEMICAL", 4, 7], ["glutathione", "CHEMICAL", 41, 52], ["glutathione", "CHEMICAL", 68, 79], ["DHP", "CHEMICAL", 4, 7], ["glutathione", "CHEMICAL", 41, 52], ["glutathione", "CHEMICAL", 68, 79], ["DHP", "SIMPLE_CHEMICAL", 4, 7], ["glutathione", "SIMPLE_CHEMICAL", 41, 52], ["glutathione S-transferases", "GENE_OR_GENE_PRODUCT", 68, 94], ["glutathione S-transferases", "PROTEIN", 68, 94], ["glutathione conjugation", "TREATMENT", 41, 64], ["glutathione S-transferases", "TEST", 68, 94]]], ["Ester linkages at the C7 and C9 positions can be hydrolyzed by carboxylesterases to generate the necine or acid moieties; this is generally considered to be a detoxification pathway.Pyrrolizidine alkaloidsThe toxicity of a pyrrolizidine alkaloid-containing plant depends on many factors.", [["Ester", "CHEMICAL", 0, 5], ["Pyrrolizidine alkaloids", "CHEMICAL", 182, 205], ["toxicity", "DISEASE", 209, 217], ["pyrrolizidine alkaloid", "CHEMICAL", 223, 245], ["Ester", "CHEMICAL", 0, 5], ["necine or acid", "CHEMICAL", 97, 111], ["Pyrrolizidine alkaloids", "CHEMICAL", 182, 205], ["pyrrolizidine alkaloid", "CHEMICAL", 223, 245], ["Ester", "SIMPLE_CHEMICAL", 0, 5], ["carboxylesterases", "SIMPLE_CHEMICAL", 63, 80], ["necine", "SIMPLE_CHEMICAL", 97, 103], ["Pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 182, 205], ["pyrrolizidine alkaloid", "SIMPLE_CHEMICAL", 223, 245], ["Pyrrolizidine alkaloids", "TREATMENT", 182, 205], ["a pyrrolizidine alkaloid", "TREATMENT", 221, 245], ["C7", "ANATOMY_MODIFIER", 22, 24], ["C9", "ANATOMY_MODIFIER", 29, 31], ["pyrrolizidine alkaloid", "OBSERVATION", 223, 245]]], ["The content of toxin varies by species of plant; the stage of growth, as new growth tends to have more toxin in general; and the time of year and environmental factors such as rainfall.", [["toxin", "PROTEIN", 15, 20], ["toxin varies", "PROBLEM", 15, 27]]], ["For an individual pyrrolizidine alkaloid, toxicity depends on the amount of alkaloid that can be converted to reactive metabolites, the rate of cytochrome P450mediated generation of the DHP, and the efficiency of detoxification by glutathione conjugation.", [["pyrrolizidine alkaloid", "CHEMICAL", 18, 40], ["toxicity", "DISEASE", 42, 50], ["DHP", "CHEMICAL", 186, 189], ["glutathione", "CHEMICAL", 231, 242], ["pyrrolizidine alkaloid", "CHEMICAL", 18, 40], ["DHP", "CHEMICAL", 186, 189], ["glutathione", "CHEMICAL", 231, 242], ["pyrrolizidine alkaloid", "SIMPLE_CHEMICAL", 18, 40], ["alkaloid", "SIMPLE_CHEMICAL", 76, 84], ["cytochrome P450mediated", "GENE_OR_GENE_PRODUCT", 144, 167], ["DHP", "SIMPLE_CHEMICAL", 186, 189], ["glutathione", "SIMPLE_CHEMICAL", 231, 242], ["an individual pyrrolizidine alkaloid", "TREATMENT", 4, 40], ["toxicity", "PROBLEM", 42, 50], ["alkaloid", "TREATMENT", 76, 84], ["reactive metabolites", "PROBLEM", 110, 130], ["cytochrome", "TREATMENT", 144, 154], ["the DHP", "PROBLEM", 182, 189], ["glutathione conjugation", "TREATMENT", 231, 254], ["pyrrolizidine alkaloid", "OBSERVATION", 18, 40], ["reactive metabolites", "OBSERVATION", 110, 130]]], ["Toxicity also depends on the species exposed, age and sex of the animal intoxicated, and the metabolic activity and the mitotic stage of its target cells.", [["cells", "ANATOMY", 148, 153], ["Toxicity", "DISEASE", 0, 8], ["cells", "CELL", 148, 153], ["target cells", "CELL_TYPE", 141, 153], ["Toxicity", "PROBLEM", 0, 8], ["metabolic activity", "OBSERVATION", 93, 111], ["target cells", "OBSERVATION", 141, 153]]], ["Grazing animals are more likely to consume plants that contain pyrrolizidine alkaloids, but because the toxins are produced by the plants to deter herbivores, it is unusual for an animal to consume large amounts.", [["pyrrolizidine alkaloids", "CHEMICAL", 63, 86], ["pyrrolizidine alkaloids", "CHEMICAL", 63, 86], ["pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 63, 86], ["pyrrolizidine alkaloids", "TREATMENT", 63, 86], ["the toxins", "PROBLEM", 100, 110], ["more likely", "UNCERTAINTY", 20, 31], ["pyrrolizidine alkaloids", "OBSERVATION", 63, 86]]], ["Ruminants, especially sheep and goats, are much less susceptible than pigs, in part because the toxins can be degraded in the rumen.", [["rumen", "ANATOMY", 126, 131], ["sheep", "ORGANISM", 22, 27], ["goats", "ORGANISM", 32, 37], ["pigs", "ORGANISM", 70, 74], ["rumen", "ORGANISM_SUBDIVISION", 126, 131], ["sheep", "SPECIES", 22, 27], ["goats", "SPECIES", 32, 37], ["pigs", "SPECIES", 70, 74], ["sheep", "SPECIES", 22, 27], ["goats", "SPECIES", 32, 37], ["pigs", "SPECIES", 70, 74], ["the toxins", "PROBLEM", 92, 102]]], ["However, sheep can graze out stands of Senecio that would be lethal to cattle.", [["sheep", "ORGANISM", 9, 14], ["cattle", "ORGANISM", 71, 77], ["sheep", "SPECIES", 9, 14], ["cattle", "SPECIES", 71, 77], ["sheep", "SPECIES", 9, 14], ["cattle", "SPECIES", 71, 77], ["Senecio", "TREATMENT", 39, 46]]], ["Horses and cattle have similar, intermediate susceptibilities.", [["cattle", "ORGANISM", 11, 17], ["cattle", "SPECIES", 11, 17], ["cattle", "SPECIES", 11, 17], ["intermediate susceptibilities", "OBSERVATION", 32, 61]]], ["Most pyrrolizidine alkaloids are hepatotoxic because they are metabolically activated to DHPs in the liver.", [["liver", "ANATOMY", 101, 106], ["pyrrolizidine alkaloids", "CHEMICAL", 5, 28], ["hepatotoxic", "DISEASE", 33, 44], ["DHPs", "CHEMICAL", 89, 93], ["pyrrolizidine alkaloids", "CHEMICAL", 5, 28], ["DHPs", "CHEMICAL", 89, 93], ["pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 5, 28], ["DHPs", "SIMPLE_CHEMICAL", 89, 93], ["liver", "ORGAN", 101, 106], ["Most pyrrolizidine alkaloids", "TREATMENT", 0, 28], ["hepatotoxic", "PROBLEM", 33, 44], ["liver", "ANATOMY", 101, 106]]], ["There are 3 common morphologic expressions of pyrrolizidine poisoning.", [["pyrrolizidine poisoning", "DISEASE", 46, 69], ["pyrrolizidine", "CHEMICAL", 46, 59], ["pyrrolizidine", "SIMPLE_CHEMICAL", 46, 59], ["pyrrolizidine poisoning", "PROBLEM", 46, 69], ["common morphologic", "OBSERVATION_MODIFIER", 12, 30], ["pyrrolizidine poisoning", "OBSERVATION", 46, 69]]], ["First, acute centrilobular to massive necrosis occurs in animals ingesting large amounts of these alkaloids.", [["centrilobular", "ANATOMY", 13, 26], ["necrosis", "DISEASE", 38, 46], ["acute centrilobular to massive necrosis", "PROBLEM", 7, 46], ["these alkaloids", "PROBLEM", 92, 107], ["acute", "OBSERVATION_MODIFIER", 7, 12], ["centrilobular", "OBSERVATION_MODIFIER", 13, 26], ["massive", "OBSERVATION_MODIFIER", 30, 37], ["necrosis", "OBSERVATION", 38, 46], ["large", "OBSERVATION_MODIFIER", 75, 80], ["amounts", "OBSERVATION_MODIFIER", 81, 88], ["alkaloids", "OBSERVATION", 98, 107]]], ["Because the plants responsible are unpalatable, naturally occurring outbreaks of acute poisoning are generally restricted to circumstances where animals face starvation, such as grazing pastures affected by prolonged drought.", [["poisoning", "DISEASE", 87, 96], ["acute poisoning", "PROBLEM", 81, 96], ["prolonged drought", "PROBLEM", 207, 224], ["unpalatable", "OBSERVATION_MODIFIER", 35, 46], ["acute", "OBSERVATION_MODIFIER", 81, 86], ["poisoning", "OBSERVATION", 87, 96]]], ["Ingested dosages in grazing circumstances are usually too low for acute effects; however, acute hemorrhagic centrilobular necrosis has been described after experimental exposures to high doses of pyrrolizidine alkaloids.", [["centrilobular", "ANATOMY", 108, 121], ["hemorrhagic", "DISEASE", 96, 107], ["necrosis", "DISEASE", 122, 130], ["pyrrolizidine alkaloids", "CHEMICAL", 196, 219], ["pyrrolizidine alkaloids", "CHEMICAL", 196, 219], ["pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 196, 219], ["acute effects", "PROBLEM", 66, 79], ["acute hemorrhagic centrilobular necrosis", "PROBLEM", 90, 130], ["pyrrolizidine alkaloids", "TREATMENT", 196, 219], ["acute", "OBSERVATION_MODIFIER", 90, 95], ["hemorrhagic", "OBSERVATION_MODIFIER", 96, 107], ["centrilobular", "OBSERVATION_MODIFIER", 108, 121], ["necrosis", "OBSERVATION", 122, 130], ["high doses", "OBSERVATION_MODIFIER", 182, 192]]], ["The centrilobular pattern of necrosis produced is similar to that caused by many other hepatotoxins that are bioactivated by hepatic cytochromes P450.", [["centrilobular", "ANATOMY", 4, 17], ["hepatic", "ANATOMY", 125, 132], ["necrosis", "DISEASE", 29, 37], ["hepatotoxins", "GENE_OR_GENE_PRODUCT", 87, 99], ["cytochromes P450", "GENE_OR_GENE_PRODUCT", 133, 149], ["hepatic cytochromes P450", "PROTEIN", 125, 149], ["necrosis", "PROBLEM", 29, 37], ["many other hepatotoxins", "PROBLEM", 76, 99], ["centrilobular", "OBSERVATION_MODIFIER", 4, 17], ["necrosis", "OBSERVATION", 29, 37], ["hepatotoxins", "OBSERVATION", 87, 99], ["hepatic", "ANATOMY", 125, 132], ["cytochromes P450", "OBSERVATION", 133, 149]]], ["Second, phasic (usually seasonal) repetitive exposure to these alkaloids leads to hepatic atrophy with formation of regenerative nodules.", [["hepatic", "ANATOMY", 82, 89], ["regenerative nodules", "ANATOMY", 116, 136], ["hepatic atrophy", "DISEASE", 82, 97], ["hepatic", "ORGAN", 82, 89], ["regenerative nodules", "CANCER", 116, 136], ["Second, phasic (usually seasonal) repetitive exposure", "PROBLEM", 0, 53], ["these alkaloids", "PROBLEM", 57, 72], ["hepatic atrophy", "PROBLEM", 82, 97], ["regenerative nodules", "PROBLEM", 116, 136], ["phasic", "OBSERVATION_MODIFIER", 8, 14], ["alkaloids", "OBSERVATION", 63, 72], ["hepatic", "ANATOMY", 82, 89], ["atrophy", "OBSERVATION", 90, 97], ["regenerative", "OBSERVATION_MODIFIER", 116, 128], ["nodules", "OBSERVATION", 129, 136]]], ["This is the most common expression of field exposure to pyrrolizidine alkaloids, and affected livers show a characteristic pattern of hepatocellular polyploidy known as megalocytosis (Fig. 2-99) .", [["livers", "ANATOMY", 94, 100], ["hepatocellular", "ANATOMY", 134, 148], ["pyrrolizidine alkaloids", "CHEMICAL", 56, 79], ["hepatocellular polyploidy", "DISEASE", 134, 159], ["megalocytosis", "DISEASE", 169, 182], ["pyrrolizidine alkaloids", "CHEMICAL", 56, 79], ["pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 56, 79], ["livers", "ORGAN", 94, 100], ["hepatocellular", "CANCER", 134, 148], ["pyrrolizidine alkaloids", "TREATMENT", 56, 79], ["affected livers", "PROBLEM", 85, 100], ["hepatocellular polyploidy", "PROBLEM", 134, 159], ["megalocytosis", "PROBLEM", 169, 182], ["most common", "OBSERVATION_MODIFIER", 12, 23], ["pyrrolizidine alkaloids", "OBSERVATION", 56, 79], ["livers", "ANATOMY", 94, 100], ["hepatocellular polyploidy", "OBSERVATION", 134, 159]]], ["Third, prolonged exposure exclusively to Heliotropium induces firm, fibrotic atrophic livers without nodular regeneration.", [["livers", "ANATOMY", 86, 92], ["nodular", "ANATOMY", 101, 108], ["Heliotropium", "CHEMICAL", 41, 53], ["Heliotropium", "SIMPLE_CHEMICAL", 41, 53], ["livers", "ORGAN", 86, 92], ["fibrotic atrophic livers", "PROBLEM", 68, 92], ["nodular regeneration", "PROBLEM", 101, 121], ["firm", "OBSERVATION_MODIFIER", 62, 66], ["fibrotic", "OBSERVATION_MODIFIER", 68, 76], ["atrophic", "OBSERVATION", 77, 85], ["livers", "ANATOMY", 86, 92], ["without", "UNCERTAINTY", 93, 100], ["nodular", "OBSERVATION_MODIFIER", 101, 108], ["regeneration", "OBSERVATION", 109, 121]]], ["If seasonal exposure to these toxic alkaloids declines, then a remarkable degree of recovery is possible.Pyrrolizidine alkaloidsPyrrolizidine alkaloids inhibit DNA synthesis and mitosis in hepatocytes, but some are able to replicate their DNA without undergoing mitosis, resulting in greatly enlarged hepatocytes with large convoluted polyploid nuclei.", [["hepatocytes", "ANATOMY", 189, 200], ["hepatocytes", "ANATOMY", 301, 312], ["nuclei", "ANATOMY", 345, 351], ["Pyrrolizidine alkaloids", "CHEMICAL", 105, 128], ["Pyrrolizidine alkaloids", "CHEMICAL", 128, 151], ["Pyrrolizidine alkaloids", "CHEMICAL", 105, 128], ["Pyrrolizidine alkaloids", "CHEMICAL", 128, 151], ["Pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 105, 128], ["Pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 128, 151], ["DNA", "CELLULAR_COMPONENT", 160, 163], ["hepatocytes", "CELL", 189, 200], ["DNA", "CELLULAR_COMPONENT", 239, 242], ["mitosis", "CELLULAR_COMPONENT", 262, 269], ["hepatocytes", "CELL", 301, 312], ["nuclei", "CELLULAR_COMPONENT", 345, 351], ["hepatocytes", "CELL_TYPE", 189, 200], ["enlarged hepatocytes", "CELL_TYPE", 292, 312], ["seasonal exposure", "PROBLEM", 3, 20], ["these toxic alkaloids", "PROBLEM", 24, 45], ["Pyrrolizidine alkaloids", "TREATMENT", 105, 128], ["Pyrrolizidine alkaloids", "TREATMENT", 128, 151], ["DNA synthesis", "PROBLEM", 160, 173], ["mitosis in hepatocytes", "PROBLEM", 178, 200], ["greatly enlarged hepatocytes", "PROBLEM", 284, 312], ["large convoluted polyploid nuclei", "PROBLEM", 318, 351], ["toxic", "OBSERVATION_MODIFIER", 30, 35], ["hepatocytes", "ANATOMY", 189, 200], ["greatly", "OBSERVATION_MODIFIER", 284, 291], ["enlarged", "OBSERVATION", 292, 300], ["hepatocytes", "ANATOMY", 301, 312], ["large", "OBSERVATION_MODIFIER", 318, 323], ["convoluted", "OBSERVATION_MODIFIER", 324, 334], ["polyploid nuclei", "OBSERVATION", 335, 351]]], ["Some enlarged nuclei have cytoplasmic invaginations that can become entrapped as intranuclear inclusions.", [["nuclei", "ANATOMY", 14, 20], ["cytoplasmic invaginations", "ANATOMY", 26, 51], ["nuclei", "CELLULAR_COMPONENT", 14, 20], ["cytoplasmic", "ORGANISM_SUBSTANCE", 26, 37], ["invaginations", "CELLULAR_COMPONENT", 38, 51], ["Some enlarged nuclei", "PROBLEM", 0, 20], ["cytoplasmic invaginations", "PROBLEM", 26, 51], ["intranuclear inclusions", "PROBLEM", 81, 104], ["enlarged", "OBSERVATION_MODIFIER", 5, 13], ["nuclei", "ANATOMY", 14, 20], ["cytoplasmic invaginations", "OBSERVATION", 26, 51], ["entrapped", "OBSERVATION_MODIFIER", 68, 77], ["intranuclear", "OBSERVATION_MODIFIER", 81, 93], ["inclusions", "OBSERVATION", 94, 104]]], ["However, many hepatocytes in an affected liver do not become megalocytic.", [["hepatocytes", "ANATOMY", 14, 25], ["liver", "ANATOMY", 41, 46], ["hepatocytes", "CELL", 14, 25], ["liver", "ORGAN", 41, 46], ["hepatocytes", "CELL_TYPE", 14, 25], ["many hepatocytes in an affected liver", "PROBLEM", 9, 46], ["megalocytic", "PROBLEM", 61, 72], ["many", "OBSERVATION_MODIFIER", 9, 13], ["hepatocytes", "OBSERVATION", 14, 25], ["affected", "OBSERVATION", 32, 40], ["liver", "ANATOMY", 41, 46], ["do not become", "UNCERTAINTY", 47, 60], ["megalocytic", "OBSERVATION", 61, 72]]], ["Those that are completely inhibited do not replicate DNA at all, whereas those that are more resistant can replicate more normally and give rise to nodular populations of smaller, more normal hepatocytes.", [["hepatocytes", "ANATOMY", 192, 203], ["DNA", "CELLULAR_COMPONENT", 53, 56], ["hepatocytes", "CELL", 192, 203], ["normal hepatocytes", "CELL_TYPE", 185, 203], ["DNA", "PROBLEM", 53, 56], ["nodular populations", "PROBLEM", 148, 167], ["nodular", "OBSERVATION_MODIFIER", 148, 155], ["smaller", "OBSERVATION_MODIFIER", 171, 178], ["more", "OBSERVATION_MODIFIER", 180, 184], ["normal", "OBSERVATION", 185, 191], ["hepatocytes", "ANATOMY", 192, 203]]], ["Inhibited hepatocytes and megalocytes are long lived but eventually many undergo apoptosis.", [["hepatocytes", "ANATOMY", 10, 21], ["megalocytes", "ANATOMY", 26, 37], ["hepatocytes", "CELL", 10, 21], ["megalocytes", "CELL", 26, 37], ["hepatocytes", "CELL_TYPE", 10, 21], ["megalocytes", "CELL_TYPE", 26, 37], ["Inhibited hepatocytes", "PROBLEM", 0, 21], ["megalocytes", "PROBLEM", 26, 37], ["hepatocytes", "ANATOMY", 10, 21], ["megalocytes", "OBSERVATION", 26, 37], ["apoptosis", "OBSERVATION", 81, 90]]], ["However, L. camara poisoning in grazing animals is manifested as subacute or chronic cholestasis, characterized by severe icterus and photosensitization, most commonly seen in cattle, but rarely in sheep, goats, and horses.", [["poisoning", "DISEASE", 19, 28], ["cholestasis", "DISEASE", 85, 96], ["icterus", "DISEASE", 122, 129], ["photosensitization", "DISEASE", 134, 152], ["L. camara", "ORGANISM", 9, 18], ["cattle", "ORGANISM", 176, 182], ["sheep", "ORGANISM", 198, 203], ["goats", "ORGANISM", 205, 210], ["L. camara", "SPECIES", 9, 18], ["cattle", "SPECIES", 176, 182], ["sheep", "SPECIES", 198, 203], ["goats", "SPECIES", 205, 210], ["L. camara", "SPECIES", 9, 18], ["cattle", "SPECIES", 176, 182], ["sheep", "SPECIES", 198, 203], ["goats", "SPECIES", 205, 210], ["L. camara poisoning", "PROBLEM", 9, 28], ["chronic cholestasis", "PROBLEM", 77, 96], ["severe icterus", "PROBLEM", 115, 129], ["photosensitization", "TREATMENT", 134, 152], ["L.", "OBSERVATION_MODIFIER", 9, 11], ["camara poisoning", "OBSERVATION", 12, 28], ["subacute", "OBSERVATION_MODIFIER", 65, 73], ["chronic", "OBSERVATION_MODIFIER", 77, 84], ["cholestasis", "OBSERVATION", 85, 96], ["severe", "OBSERVATION_MODIFIER", 115, 121], ["icterus", "OBSERVATION", 122, 129], ["photosensitization", "OBSERVATION", 134, 152], ["most commonly", "OBSERVATION_MODIFIER", 154, 167]]], ["Goats are quite susceptible to the toxin, but are less likely to eat the plant.", [["Goats", "ORGANISM", 0, 5], ["the toxin", "PROBLEM", 31, 40]]], ["Neonatal ruminants appear resistant suggesting the rumen may retain the plants and provide longer exposure to the toxins.Pyrrolizidine alkaloidsPhotosensitization is usually severe after 2 days, but jaundice is more severe in chronic cases.", [["Pyrrolizidine alkaloids", "CHEMICAL", 121, 144], ["Photosensitization", "DISEASE", 144, 162], ["jaundice", "DISEASE", 199, 207], ["Pyrrolizidine alkaloids", "CHEMICAL", 121, 144], ["rumen", "ORGANISM_SUBSTANCE", 51, 56], ["Pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 121, 144], ["Pyrrolizidine alkaloids", "TREATMENT", 121, 144], ["Photosensitization", "TREATMENT", 144, 162], ["jaundice", "PROBLEM", 199, 207], ["resistant", "OBSERVATION", 26, 35], ["severe", "OBSERVATION_MODIFIER", 174, 180], ["jaundice", "OBSERVATION", 199, 207], ["more severe", "OBSERVATION_MODIFIER", 211, 222], ["chronic", "OBSERVATION_MODIFIER", 226, 233]]], ["Heavily intoxicated cattle can die within 2 days, but most fatal cases run a course of ~2 weeks.", [["cattle", "ORGANISM", 20, 26], ["cattle", "SPECIES", 20, 26], ["cattle", "SPECIES", 20, 26]]], ["Ruminal stasis and anorexia appear early, and the large bowel contains dark, dry feces.", [["Ruminal", "ANATOMY", 0, 7], ["bowel", "ANATOMY", 56, 61], ["Ruminal stasis", "DISEASE", 0, 14], ["anorexia", "DISEASE", 19, 27], ["Ruminal", "ORGANISM_SUBSTANCE", 0, 7], ["bowel", "ORGAN", 56, 61], ["feces", "ORGANISM_SUBDIVISION", 81, 86], ["Ruminal stasis", "PROBLEM", 0, 14], ["anorexia", "PROBLEM", 19, 27], ["dark, dry feces", "PROBLEM", 71, 86], ["stasis", "OBSERVATION", 8, 14], ["anorexia", "OBSERVATION", 19, 27], ["early", "OBSERVATION_MODIFIER", 35, 40], ["large", "ANATOMY_MODIFIER", 50, 55], ["bowel", "ANATOMY", 56, 61], ["dark", "OBSERVATION_MODIFIER", 71, 75], ["dry feces", "OBSERVATION", 77, 86]]], ["The rumen is a reservoir of toxin that remains active and can perpetuate the intoxication after access to the plant is curtailed.", [["rumen", "ORGANISM_SUBSTANCE", 4, 9], ["a reservoir of toxin", "TREATMENT", 13, 33], ["the intoxication", "PROBLEM", 73, 89], ["rumen", "OBSERVATION_MODIFIER", 4, 9]]], ["The liver is enlarged, pale, and stained yellow, orange, or green-gray by bile pigment.", [["liver", "ANATOMY", 4, 9], ["bile pigment", "ANATOMY", 74, 86], ["liver", "ORGAN", 4, 9], ["bile pigment", "TISSUE", 74, 86], ["enlarged", "PROBLEM", 13, 21], ["liver", "ANATOMY", 4, 9], ["enlarged", "OBSERVATION", 13, 21], ["pale", "OBSERVATION_MODIFIER", 23, 27], ["stained", "OBSERVATION_MODIFIER", 33, 40], ["yellow", "OBSERVATION_MODIFIER", 41, 47], ["bile", "ANATOMY", 74, 78], ["pigment", "OBSERVATION", 79, 86]]], ["The gallbladder is greatly distended with pale, sometimes slightly mucoid, bile.Pyrrolizidine alkaloidsThe severity of the liver changes may be much less than expected from the intensity of the icterus and photosensitization.", [["gallbladder", "ANATOMY", 4, 15], ["mucoid", "ANATOMY", 67, 73], ["bile", "ANATOMY", 75, 79], ["liver", "ANATOMY", 123, 128], ["Pyrrolizidine alkaloids", "CHEMICAL", 80, 103], ["icterus", "DISEASE", 194, 201], ["photosensitization", "DISEASE", 206, 224], ["Pyrrolizidine alkaloids", "CHEMICAL", 80, 103], ["gallbladder", "ORGAN", 4, 15], ["bile", "ORGAN", 75, 79], ["Pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 80, 103], ["liver", "ORGAN", 123, 128], ["greatly distended", "PROBLEM", 19, 36], ["pale", "PROBLEM", 42, 46], ["sometimes slightly mucoid, bile", "PROBLEM", 48, 79], ["Pyrrolizidine alkaloids", "TREATMENT", 80, 103], ["the liver changes", "PROBLEM", 119, 136], ["the icterus", "PROBLEM", 190, 201], ["photosensitization", "TREATMENT", 206, 224], ["gallbladder", "ANATOMY", 4, 15], ["greatly", "OBSERVATION_MODIFIER", 19, 26], ["distended", "OBSERVATION", 27, 36], ["pale", "OBSERVATION", 42, 46], ["slightly", "OBSERVATION_MODIFIER", 58, 66], ["mucoid", "OBSERVATION", 67, 73], ["bile", "ANATOMY", 75, 79], ["severity", "OBSERVATION_MODIFIER", 107, 115], ["liver", "ANATOMY", 123, 128], ["icterus", "OBSERVATION", 194, 201]]], ["The most consistent histologic finding in the liver is hepatocellular enlargement and fine cytoplasmic vacuolation, together with some degree of bile accumulation in canaliculi, hepatocyte cytoplasm, and Kupffer cells.", [["liver", "ANATOMY", 46, 51], ["hepatocellular", "ANATOMY", 55, 69], ["cytoplasmic", "ANATOMY", 91, 102], ["bile", "ANATOMY", 145, 149], ["canaliculi", "ANATOMY", 166, 176], ["hepatocyte cytoplasm", "ANATOMY", 178, 198], ["Kupffer cells", "ANATOMY", 204, 217], ["liver", "ORGAN", 46, 51], ["hepatocellular", "CANCER", 55, 69], ["cytoplasmic", "ORGANISM_SUBSTANCE", 91, 102], ["bile", "SIMPLE_CHEMICAL", 145, 149], ["canaliculi", "MULTI-TISSUE_STRUCTURE", 166, 176], ["hepatocyte", "CELLULAR_COMPONENT", 178, 188], ["cytoplasm", "ORGANISM_SUBSTANCE", 189, 198], ["Kupffer cells", "CELL", 204, 217], ["Kupffer cells", "CELL_TYPE", 204, 217], ["hepatocellular enlargement", "PROBLEM", 55, 81], ["fine cytoplasmic vacuolation", "PROBLEM", 86, 114], ["bile accumulation in canaliculi, hepatocyte cytoplasm", "PROBLEM", 145, 198], ["most consistent", "UNCERTAINTY", 4, 19], ["histologic", "OBSERVATION", 20, 30], ["liver", "ANATOMY", 46, 51], ["hepatocellular", "ANATOMY", 55, 69], ["enlargement", "OBSERVATION", 70, 81], ["fine", "OBSERVATION_MODIFIER", 86, 90], ["cytoplasmic vacuolation", "OBSERVATION", 91, 114], ["bile", "ANATOMY", 145, 149], ["accumulation", "OBSERVATION", 150, 162], ["canaliculi", "ANATOMY", 166, 176], ["hepatocyte", "ANATOMY", 178, 188], ["cytoplasm", "ANATOMY_MODIFIER", 189, 198], ["Kupffer cells", "OBSERVATION", 204, 217]]], ["The canalicular cholestasis is usually more severe in the centrilobular zones, whereas the cytoplasmic vacuolation is often more pronounced in the periportal hepatocytes.", [["canalicular", "ANATOMY", 4, 15], ["centrilobular zones", "ANATOMY", 58, 77], ["cytoplasmic", "ANATOMY", 91, 102], ["periportal hepatocytes", "ANATOMY", 147, 169], ["cholestasis", "DISEASE", 16, 27], ["canalicular", "MULTI-TISSUE_STRUCTURE", 4, 15], ["centrilobular zones", "TISSUE", 58, 77], ["cytoplasmic", "ORGANISM_SUBSTANCE", 91, 102], ["periportal hepatocytes", "CELL", 147, 169], ["periportal hepatocytes", "CELL_TYPE", 147, 169], ["The canalicular cholestasis", "PROBLEM", 0, 27], ["the cytoplasmic vacuolation", "PROBLEM", 87, 114], ["canalicular", "ANATOMY_MODIFIER", 4, 15], ["cholestasis", "OBSERVATION", 16, 27], ["more severe", "OBSERVATION_MODIFIER", 39, 50], ["centrilobular", "ANATOMY_MODIFIER", 58, 71], ["zones", "ANATOMY_MODIFIER", 72, 77], ["cytoplasmic vacuolation", "OBSERVATION", 91, 114], ["more pronounced", "OBSERVATION_MODIFIER", 124, 139], ["periportal", "ANATOMY_MODIFIER", 147, 157], ["hepatocytes", "ANATOMY", 158, 169]]], ["There is usually some bile duct proliferation, and in some cases, there will be a high incidence of periportal apoptosis, focal coagulative necrosis, or hepatocellular dissociation.Pyrrolizidine alkaloidsElectron microscopy reveals an apparent increase in volume of smooth endoplasmic reticulum and a quite characteristic form of collapse of many bile canaliculi.", [["bile duct", "ANATOMY", 22, 31], ["periportal", "ANATOMY", 100, 110], ["focal coagulative", "ANATOMY", 122, 139], ["hepatocellular", "ANATOMY", 153, 167], ["smooth endoplasmic reticulum", "ANATOMY", 266, 294], ["bile canaliculi", "ANATOMY", 347, 362], ["necrosis", "DISEASE", 140, 148], ["Pyrrolizidine alkaloids", "CHEMICAL", 181, 204], ["Pyrrolizidine alkaloids", "CHEMICAL", 181, 204], ["bile duct", "MULTI-TISSUE_STRUCTURE", 22, 31], ["periportal", "MULTI-TISSUE_STRUCTURE", 100, 110], ["hepatocellular", "CANCER", 153, 167], ["Pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 181, 204], ["endoplasmic reticulum", "CELLULAR_COMPONENT", 273, 294], ["bile canaliculi", "MULTI-TISSUE_STRUCTURE", 347, 362], ["some bile duct proliferation", "PROBLEM", 17, 45], ["periportal apoptosis", "PROBLEM", 100, 120], ["focal coagulative necrosis", "PROBLEM", 122, 148], ["hepatocellular dissociation", "PROBLEM", 153, 180], ["Pyrrolizidine alkaloids", "TREATMENT", 181, 204], ["Electron microscopy", "TEST", 204, 223], ["an apparent increase in volume of smooth endoplasmic reticulum", "PROBLEM", 232, 294], ["collapse of many bile canaliculi", "PROBLEM", 330, 362], ["bile duct", "ANATOMY", 22, 31], ["proliferation", "OBSERVATION", 32, 45], ["high", "OBSERVATION_MODIFIER", 82, 86], ["periportal", "ANATOMY", 100, 110], ["apoptosis", "OBSERVATION", 111, 120], ["focal", "OBSERVATION_MODIFIER", 122, 127], ["coagulative", "OBSERVATION_MODIFIER", 128, 139], ["necrosis", "OBSERVATION", 140, 148], ["hepatocellular dissociation", "OBSERVATION", 153, 180], ["apparent", "OBSERVATION_MODIFIER", 235, 243], ["increase", "OBSERVATION_MODIFIER", 244, 252], ["volume", "OBSERVATION_MODIFIER", 256, 262], ["smooth endoplasmic reticulum", "OBSERVATION", 266, 294], ["collapse", "OBSERVATION", 330, 338], ["bile canaliculi", "ANATOMY", 347, 362]]], ["Other canaliculi are distended and have damaged microvilli.", [["canaliculi", "ANATOMY", 6, 16], ["microvilli", "ANATOMY", 48, 58], ["canaliculi", "MULTI-TISSUE_STRUCTURE", 6, 16], ["microvilli", "CELLULAR_COMPONENT", 48, 58], ["distended", "PROBLEM", 21, 30], ["damaged microvilli", "PROBLEM", 40, 58], ["canaliculi", "ANATOMY", 6, 16], ["distended", "OBSERVATION", 21, 30], ["damaged microvilli", "OBSERVATION", 40, 58]]], ["Because much of the bilirubin that accumulates in the plasma of such animals is conjugated, it seems that the cholestasis is due in large measure to direct interference with canalicular transport of bile.", [["plasma", "ANATOMY", 54, 60], ["canalicular", "ANATOMY", 174, 185], ["bile", "ANATOMY", 199, 203], ["bilirubin", "CHEMICAL", 20, 29], ["cholestasis", "DISEASE", 110, 121], ["bilirubin", "CHEMICAL", 20, 29], ["bilirubin", "GENE_OR_GENE_PRODUCT", 20, 29], ["plasma", "ORGANISM_SUBSTANCE", 54, 60], ["canalicular", "MULTI-TISSUE_STRUCTURE", 174, 185], ["bile", "MULTI-TISSUE_STRUCTURE", 199, 203], ["bilirubin", "PROTEIN", 20, 29], ["the bilirubin", "TEST", 16, 29], ["the cholestasis", "PROBLEM", 106, 121], ["cholestasis", "OBSERVATION", 110, 121], ["bile", "ANATOMY", 199, 203]]], ["The mechanisms of cholestasis have not been determined, but damage to the contractile pericanalicular cytoskeleton or its associated cell adhesion molecules required for canalicular integrity are plausible targets (see previous section on Cholestasis and jaundice).Pyrrolizidine alkaloidsAnimals are usually polyuric because of acute tubular injury, resulting in severe dehydration, in part related to a disinclination to drink.", [["contractile pericanalicular cytoskeleton", "ANATOMY", 74, 114], ["cell", "ANATOMY", 133, 137], ["canalicular", "ANATOMY", 170, 181], ["tubular", "ANATOMY", 334, 341], ["cholestasis", "DISEASE", 18, 29], ["jaundice", "DISEASE", 255, 263], ["Pyrrolizidine alkaloids", "CHEMICAL", 265, 288], ["acute tubular injury", "DISEASE", 328, 348], ["dehydration", "DISEASE", 370, 381], ["Pyrrolizidine alkaloids", "CHEMICAL", 265, 288], ["pericanalicular cytoskeleton", "CELLULAR_COMPONENT", 86, 114], ["cell", "CELL", 133, 137], ["canalicular", "MULTI-TISSUE_STRUCTURE", 170, 181], ["Pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 265, 288], ["Animals", "ORGANISM", 288, 295], ["tubular", "MULTI-TISSUE_STRUCTURE", 334, 341], ["associated cell adhesion molecules", "PROTEIN", 122, 156], ["cholestasis", "PROBLEM", 18, 29], ["damage to the contractile pericanalicular cytoskeleton", "PROBLEM", 60, 114], ["its associated cell adhesion molecules", "PROBLEM", 118, 156], ["canalicular integrity", "TREATMENT", 170, 191], ["Cholestasis", "PROBLEM", 239, 250], ["jaundice", "PROBLEM", 255, 263], ["Pyrrolizidine alkaloids", "TREATMENT", 265, 288], ["acute tubular injury", "PROBLEM", 328, 348], ["severe dehydration", "PROBLEM", 363, 381], ["cholestasis", "OBSERVATION", 18, 29], ["contractile", "OBSERVATION_MODIFIER", 74, 85], ["pericanalicular cytoskeleton", "OBSERVATION", 86, 114], ["cell adhesion molecules", "OBSERVATION", 133, 156], ["jaundice", "OBSERVATION", 255, 263], ["acute", "OBSERVATION_MODIFIER", 328, 333], ["tubular", "ANATOMY_MODIFIER", 334, 341], ["injury", "OBSERVATION", 342, 348], ["severe", "OBSERVATION_MODIFIER", 363, 369], ["dehydration", "OBSERVATION", 370, 381]]], ["The kidneys are slightly enlarged and wet on section, and, especially in the more chronic cases, the cortex is pale and the medulla hyperemic.", [["kidneys", "ANATOMY", 4, 11], ["cortex", "ANATOMY", 101, 107], ["medulla", "ANATOMY", 124, 131], ["kidneys", "ORGAN", 4, 11], ["cortex", "CANCER", 101, 107], ["medulla", "ORGAN", 124, 131], ["slightly enlarged", "PROBLEM", 16, 33], ["the medulla hyperemic", "PROBLEM", 120, 141], ["kidneys", "ANATOMY", 4, 11], ["slightly", "OBSERVATION_MODIFIER", 16, 24], ["enlarged", "OBSERVATION", 25, 33], ["wet", "OBSERVATION_MODIFIER", 38, 41], ["more", "OBSERVATION_MODIFIER", 77, 81], ["chronic", "OBSERVATION_MODIFIER", 82, 89], ["cases", "OBSERVATION", 90, 95], ["cortex", "ANATOMY_MODIFIER", 101, 107], ["pale", "OBSERVATION_MODIFIER", 111, 115], ["medulla", "ANATOMY", 124, 131], ["hyperemic", "OBSERVATION_MODIFIER", 132, 141]]], ["The renal lesion is nonspecific acute tubular injury, ranging in severity from mild vacuolar change to patchy tubular necrosis and extensive tubular cast formation.", [["renal lesion", "ANATOMY", 4, 16], ["tubular", "ANATOMY", 38, 45], ["vacuolar", "ANATOMY", 84, 92], ["tubular", "ANATOMY", 110, 117], ["tubular", "ANATOMY", 141, 148], ["renal lesion", "DISEASE", 4, 16], ["acute tubular injury", "DISEASE", 32, 52], ["necrosis", "DISEASE", 118, 126], ["renal lesion", "CANCER", 4, 16], ["tubular", "ORGAN", 38, 45], ["vacuolar", "IMMATERIAL_ANATOMICAL_ENTITY", 84, 92], ["tubular", "PATHOLOGICAL_FORMATION", 110, 117], ["tubular cast", "PATHOLOGICAL_FORMATION", 141, 153], ["The renal lesion", "PROBLEM", 0, 16], ["nonspecific acute tubular injury", "PROBLEM", 20, 52], ["mild vacuolar change", "PROBLEM", 79, 99], ["patchy tubular necrosis", "PROBLEM", 103, 126], ["extensive tubular cast formation", "PROBLEM", 131, 163], ["renal", "ANATOMY", 4, 9], ["lesion", "OBSERVATION", 10, 16], ["nonspecific", "OBSERVATION_MODIFIER", 20, 31], ["acute", "OBSERVATION_MODIFIER", 32, 37], ["tubular", "ANATOMY_MODIFIER", 38, 45], ["injury", "OBSERVATION", 46, 52], ["ranging", "OBSERVATION_MODIFIER", 54, 61], ["mild", "OBSERVATION_MODIFIER", 79, 83], ["vacuolar change", "OBSERVATION", 84, 99], ["patchy", "OBSERVATION_MODIFIER", 103, 109], ["tubular", "OBSERVATION_MODIFIER", 110, 117], ["necrosis", "OBSERVATION", 118, 126], ["extensive", "OBSERVATION_MODIFIER", 131, 140], ["tubular cast formation", "OBSERVATION", 141, 163]]], ["The role of the hyperbilirubinemia in the production of the renal damage has not been assessed.", [["renal", "ANATOMY", 60, 65], ["hyperbilirubinemia", "DISEASE", 16, 34], ["renal damage", "DISEASE", 60, 72], ["renal", "ORGAN", 60, 65], ["the hyperbilirubinemia", "PROBLEM", 12, 34], ["the renal damage", "PROBLEM", 56, 72], ["hyperbilirubinemia", "OBSERVATION", 16, 34], ["renal", "ANATOMY", 60, 65], ["damage", "OBSERVATION", 66, 72]]], ["Severe myocardial necrosis can be produced in sheep by Lantana poisoning, and may be responsible for the early deaths in cattle.Intoxication by steroidal sapogenins: tribulosis and related toxicosesConsumption of Tribulus terrestris, particularly by the grazing of young wilted plants or sometimes hay, causes cholangitis and photosensitization in sheep.", [["myocardial", "ANATOMY", 7, 17], ["myocardial necrosis", "DISEASE", 7, 26], ["poisoning", "DISEASE", 63, 72], ["deaths", "DISEASE", 111, 117], ["Intoxication", "DISEASE", 128, 140], ["steroidal sapogenins", "CHEMICAL", 144, 164], ["tribulosis", "DISEASE", 166, 176], ["cholangitis", "DISEASE", 310, 321], ["photosensitization", "DISEASE", 326, 344], ["steroidal sapogenins", "CHEMICAL", 144, 164], ["myocardial", "MULTI-TISSUE_STRUCTURE", 7, 17], ["sheep", "ORGANISM", 46, 51], ["cattle", "ORGANISM", 121, 127], ["steroidal sapogenins", "SIMPLE_CHEMICAL", 144, 164], ["tribulosis", "SIMPLE_CHEMICAL", 166, 176], ["Tribulus terrestris", "ORGANISM", 213, 232], ["sheep", "ORGANISM", 348, 353], ["sheep", "SPECIES", 46, 51], ["cattle", "SPECIES", 121, 127], ["Tribulus terrestris", "SPECIES", 213, 232], ["sheep", "SPECIES", 348, 353], ["sheep", "SPECIES", 46, 51], ["cattle", "SPECIES", 121, 127], ["Tribulus terrestris", "SPECIES", 213, 232], ["sheep", "SPECIES", 348, 353], ["Severe myocardial necrosis", "PROBLEM", 0, 26], ["Intoxication", "PROBLEM", 128, 140], ["tribulosis", "PROBLEM", 166, 176], ["related toxicoses", "PROBLEM", 181, 198], ["Tribulus terrestris", "PROBLEM", 213, 232], ["cholangitis", "PROBLEM", 310, 321], ["photosensitization in sheep", "TREATMENT", 326, 353], ["myocardial", "ANATOMY", 7, 17], ["necrosis", "OBSERVATION", 18, 26], ["Tribulus terrestris", "OBSERVATION", 213, 232], ["cholangitis", "OBSERVATION", 310, 321]]], ["This plant has caused enormous loss of sheep in South Africa, where the toxicosis is known as geeldikkop (\"yellow bighead,\" because of icterus and marked edema of ears and face).", [["edema", "ANATOMY", 154, 159], ["ears", "ANATOMY", 163, 167], ["toxicosis", "DISEASE", 72, 81], ["icterus", "DISEASE", 135, 142], ["edema", "DISEASE", 154, 159], ["sheep", "ORGANISM", 39, 44], ["edema", "PATHOLOGICAL_FORMATION", 154, 159], ["ears", "ORGAN", 163, 167], ["sheep", "SPECIES", 39, 44], ["sheep", "SPECIES", 39, 44], ["enormous loss of sheep", "PROBLEM", 22, 44], ["the toxicosis", "PROBLEM", 68, 81], ["icterus", "PROBLEM", 135, 142], ["marked edema of ears and face", "PROBLEM", 147, 176], ["enormous", "OBSERVATION_MODIFIER", 22, 30], ["loss", "OBSERVATION", 31, 35], ["icterus", "OBSERVATION", 135, 142], ["marked", "OBSERVATION_MODIFIER", 147, 153], ["edema", "OBSERVATION", 154, 159], ["ears", "ANATOMY", 163, 167], ["face", "ANATOMY", 172, 176]]], ["The disease has been reproduced by oral administration of crude extracts of steroidal normal, but they are small, gray-yellow, fairly smooth, and toughened by condensation of normal stroma rather than by fibroplasia.", [["oral", "ANATOMY", 35, 39], ["extracts", "ANATOMY", 64, 72], ["stroma", "ANATOMY", 182, 188], ["fibroplasia", "DISEASE", 204, 215], ["oral", "ORGANISM_SUBDIVISION", 35, 39], ["extracts", "ORGANISM_SUBSTANCE", 64, 72], ["stroma", "TISSUE", 182, 188], ["The disease", "PROBLEM", 0, 11], ["oral administration of crude extracts of steroidal", "TREATMENT", 35, 85], ["fibroplasia", "PROBLEM", 204, 215], ["disease", "OBSERVATION", 4, 11], ["steroidal normal", "OBSERVATION", 76, 92], ["small", "OBSERVATION_MODIFIER", 107, 112], ["yellow", "OBSERVATION", 119, 125], ["fairly smooth", "OBSERVATION_MODIFIER", 127, 140], ["normal stroma", "OBSERVATION", 175, 188], ["fibroplasia", "OBSERVATION", 204, 215]]], ["If the liver copper content was high before intoxication, toxicity can culminate in copper release and an episode of intravascular hemolysis.", [["liver", "ANATOMY", 7, 12], ["intravascular", "ANATOMY", 117, 130], ["copper", "CHEMICAL", 13, 19], ["toxicity", "DISEASE", 58, 66], ["copper", "CHEMICAL", 84, 90], ["intravascular hemolysis", "DISEASE", 117, 140], ["copper", "CHEMICAL", 13, 19], ["copper", "CHEMICAL", 84, 90], ["liver", "ORGAN", 7, 12], ["copper", "SIMPLE_CHEMICAL", 13, 19], ["copper", "SIMPLE_CHEMICAL", 84, 90], ["intravascular", "IMMATERIAL_ANATOMICAL_ENTITY", 117, 130], ["the liver copper content", "TEST", 3, 27], ["intoxication", "PROBLEM", 44, 56], ["toxicity", "PROBLEM", 58, 66], ["intravascular hemolysis", "PROBLEM", 117, 140], ["liver", "ANATOMY", 7, 12], ["intravascular hemolysis", "OBSERVATION", 117, 140]]], ["In this case, the carcass will be intensely jaundiced, and the kidneys are stained with methemoglobin and bilirubin.", [["carcass", "ANATOMY", 18, 25], ["kidneys", "ANATOMY", 63, 70], ["bilirubin", "CHEMICAL", 106, 115], ["methemoglobin", "CHEMICAL", 88, 101], ["bilirubin", "CHEMICAL", 106, 115], ["carcass", "ORGANISM_SUBDIVISION", 18, 25], ["kidneys", "ORGAN", 63, 70], ["methemoglobin", "SIMPLE_CHEMICAL", 88, 101], ["bilirubin", "SIMPLE_CHEMICAL", 106, 115], ["methemoglobin", "PROTEIN", 88, 101], ["bilirubin", "PROTEIN", 106, 115], ["methemoglobin", "TEST", 88, 101], ["bilirubin", "TEST", 106, 115], ["intensely", "OBSERVATION_MODIFIER", 34, 43], ["jaundiced", "OBSERVATION", 44, 53], ["kidneys", "ANATOMY", 63, 70]]], ["The relationship of chronic copper poisoning to pyrrolizidine alkaloid poisoning is discussed later.Intoxication by steroidal sapogenins: tribulosis and related toxicosesHorses are susceptible to both acute and chronic toxicosis, and liver failure produced in horses by these alkaloids is similar to that seen in cattle.", [["liver", "ANATOMY", 234, 239], ["copper", "CHEMICAL", 28, 34], ["poisoning", "DISEASE", 35, 44], ["pyrrolizidine alkaloid", "CHEMICAL", 48, 70], ["poisoning", "DISEASE", 71, 80], ["Intoxication", "DISEASE", 100, 112], ["steroidal sapogenins", "CHEMICAL", 116, 136], ["tribulosis", "DISEASE", 138, 148], ["toxicosis", "DISEASE", 219, 228], ["liver failure", "DISEASE", 234, 247], ["copper", "CHEMICAL", 28, 34], ["pyrrolizidine alkaloid", "CHEMICAL", 48, 70], ["steroidal sapogenins", "CHEMICAL", 116, 136], ["copper", "SIMPLE_CHEMICAL", 28, 34], ["pyrrolizidine alkaloid", "SIMPLE_CHEMICAL", 48, 70], ["steroidal sapogenins", "SIMPLE_CHEMICAL", 116, 136], ["tribulosis", "SIMPLE_CHEMICAL", 138, 148], ["liver", "ORGAN", 234, 239], ["horses", "ORGANISM", 260, 266], ["cattle", "ORGANISM", 313, 319], ["cattle", "SPECIES", 313, 319], ["cattle", "SPECIES", 313, 319], ["chronic copper poisoning", "PROBLEM", 20, 44], ["pyrrolizidine alkaloid poisoning", "TREATMENT", 48, 80], ["Intoxication", "PROBLEM", 100, 112], ["tribulosis", "PROBLEM", 138, 148], ["related toxicoses", "PROBLEM", 153, 170], ["both acute and chronic toxicosis", "PROBLEM", 196, 228], ["liver failure", "PROBLEM", 234, 247], ["these alkaloids", "PROBLEM", 270, 285], ["chronic", "OBSERVATION_MODIFIER", 20, 27], ["pyrrolizidine", "OBSERVATION", 48, 61], ["alkaloid poisoning", "OBSERVATION", 62, 80], ["both", "OBSERVATION_MODIFIER", 196, 200], ["acute", "OBSERVATION_MODIFIER", 201, 206], ["chronic", "OBSERVATION_MODIFIER", 211, 218], ["toxicosis", "OBSERVATION", 219, 228], ["liver", "ANATOMY", 234, 239], ["failure", "OBSERVATION", 240, 247], ["alkaloids", "OBSERVATION", 276, 285]]], ["Horses are more likely to manifest signs of hepatic encephalopathy with head-pressing and compulsive walking; in some places, these nervous signs give rise to colloquial names such as \"walkabout\" and \"walking disease.\"", [["hepatic", "ANATOMY", 44, 51], ["head", "ANATOMY", 72, 76], ["nervous", "ANATOMY", 132, 139], ["hepatic encephalopathy", "DISEASE", 44, 66], ["compulsive walking", "DISEASE", 90, 108], ["hepatic", "ORGAN", 44, 51], ["head", "ORGANISM_SUBDIVISION", 72, 76], ["nervous", "ANATOMICAL_SYSTEM", 132, 139], ["hepatic encephalopathy", "PROBLEM", 44, 66], ["compulsive walking", "PROBLEM", 90, 108], ["these nervous signs", "PROBLEM", 126, 145], ["more likely", "UNCERTAINTY", 11, 22], ["hepatic", "ANATOMY", 44, 51], ["encephalopathy", "OBSERVATION", 52, 66], ["head", "ANATOMY", 72, 76]]], ["Administration of a high dose of Cynoglossum officinale resulted in severe liver disease within 7 days after dosing, with elevated serum enzymes, altered bile acid metabolism, and extensive hepatocellular necrosis with minimal periportal fibrosis and biliary hyperplasia, and little or no megalocytosis.", [["liver", "ANATOMY", 75, 80], ["serum", "ANATOMY", 131, 136], ["bile", "ANATOMY", 154, 158], ["hepatocellular", "ANATOMY", 190, 204], ["periportal", "ANATOMY", 227, 237], ["biliary", "ANATOMY", 251, 258], ["Cynoglossum officinale", "CHEMICAL", 33, 55], ["liver disease", "DISEASE", 75, 88], ["bile acid", "CHEMICAL", 154, 163], ["necrosis", "DISEASE", 205, 213], ["fibrosis", "DISEASE", 238, 246], ["biliary hyperplasia", "DISEASE", 251, 270], ["megalocytosis", "DISEASE", 289, 302], ["bile acid", "CHEMICAL", 154, 163], ["Cynoglossum officinale", "ORGANISM", 33, 55], ["liver", "ORGAN", 75, 80], ["serum", "ORGANISM_SUBSTANCE", 131, 136], ["bile acid", "SIMPLE_CHEMICAL", 154, 163], ["hepatocellular", "CANCER", 190, 204], ["periportal", "PATHOLOGICAL_FORMATION", 227, 237], ["biliary hyperplasia", "PATHOLOGICAL_FORMATION", 251, 270], ["serum enzymes", "PROTEIN", 131, 144], ["Cynoglossum officinale", "SPECIES", 33, 55], ["Cynoglossum officinale", "SPECIES", 33, 55], ["a high dose of Cynoglossum officinale", "TREATMENT", 18, 55], ["severe liver disease", "PROBLEM", 68, 88], ["elevated serum enzymes", "PROBLEM", 122, 144], ["altered bile acid metabolism", "PROBLEM", 146, 174], ["extensive hepatocellular necrosis", "PROBLEM", 180, 213], ["minimal periportal fibrosis", "PROBLEM", 219, 246], ["biliary hyperplasia", "PROBLEM", 251, 270], ["megalocytosis", "PROBLEM", 289, 302], ["severe", "OBSERVATION_MODIFIER", 68, 74], ["liver", "ANATOMY", 75, 80], ["disease", "OBSERVATION", 81, 88], ["bile", "ANATOMY", 154, 158], ["acid metabolism", "OBSERVATION", 159, 174], ["extensive", "OBSERVATION_MODIFIER", 180, 189], ["hepatocellular", "ANATOMY", 190, 204], ["necrosis", "OBSERVATION", 205, 213], ["minimal", "OBSERVATION_MODIFIER", 219, 226], ["periportal", "ANATOMY_MODIFIER", 227, 237], ["fibrosis", "OBSERVATION", 238, 246], ["biliary", "ANATOMY", 251, 258], ["hyperplasia", "OBSERVATION", 259, 270], ["no", "UNCERTAINTY", 286, 288], ["megalocytosis", "OBSERVATION", 289, 302]]], ["Edema and infarction of the cecum and colon were also present at postmortem.", [["cecum", "ANATOMY", 28, 33], ["colon", "ANATOMY", 38, 43], ["Edema", "DISEASE", 0, 5], ["infarction", "DISEASE", 10, 20], ["cecum", "ORGAN", 28, 33], ["colon", "ORGAN", 38, 43], ["Edema", "PROBLEM", 0, 5], ["infarction of the cecum and colon", "PROBLEM", 10, 43], ["infarction", "OBSERVATION", 10, 20], ["cecum", "ANATOMY", 28, 33], ["colon", "ANATOMY", 38, 43]]], ["Administration of a low dose to horses for 14 days resulted in transient clinical depression and weight loss, transient elevations of serum enzymes and bile acids, and minimal periportal hepatocellular necrosis with fibrosis, developing extensive megalocytosis by week 14.", [["serum", "ANATOMY", 134, 139], ["bile", "ANATOMY", 152, 156], ["periportal hepatocellular", "ANATOMY", 176, 201], ["depression", "DISEASE", 82, 92], ["weight loss", "DISEASE", 97, 108], ["bile acids", "CHEMICAL", 152, 162], ["periportal hepatocellular necrosis", "DISEASE", 176, 210], ["fibrosis", "DISEASE", 216, 224], ["megalocytosis", "DISEASE", 247, 260], ["bile acids", "CHEMICAL", 152, 162], ["serum", "ORGANISM_SUBSTANCE", 134, 139], ["bile acids", "SIMPLE_CHEMICAL", 152, 162], ["hepatocellular", "ORGAN", 187, 201], ["serum enzymes", "PROTEIN", 134, 147], ["a low dose to horses", "TREATMENT", 18, 38], ["transient clinical depression", "PROBLEM", 63, 92], ["weight loss", "PROBLEM", 97, 108], ["transient elevations of serum enzymes", "PROBLEM", 110, 147], ["bile acids", "TEST", 152, 162], ["minimal periportal hepatocellular necrosis", "PROBLEM", 168, 210], ["fibrosis", "PROBLEM", 216, 224], ["developing extensive megalocytosis", "PROBLEM", 226, 260], ["depression", "OBSERVATION", 82, 92], ["weight loss", "OBSERVATION", 97, 108], ["elevations", "OBSERVATION_MODIFIER", 120, 130], ["bile", "ANATOMY", 152, 156], ["minimal", "OBSERVATION_MODIFIER", 168, 175], ["periportal", "ANATOMY_MODIFIER", 176, 186], ["hepatocellular", "ANATOMY", 187, 201], ["necrosis", "OBSERVATION", 202, 210], ["fibrosis", "OBSERVATION", 216, 224], ["extensive", "OBSERVATION_MODIFIER", 237, 246], ["megalocytosis", "OBSERVATION", 247, 260]]], ["The megalocytosis became the most prominent change 6 months after exposure.Intoxication by steroidal sapogenins: tribulosis and related toxicosesMetabolites of pyrrolizidine alkaloids are formed by any cells with adequate cytochrome P450 activity.", [["cells", "ANATOMY", 202, 207], ["megalocytosis", "DISEASE", 4, 17], ["Intoxication", "DISEASE", 75, 87], ["steroidal sapogenins", "CHEMICAL", 91, 111], ["tribulosis", "CHEMICAL", 113, 123], ["pyrrolizidine alkaloids", "CHEMICAL", 160, 183], ["steroidal sapogenins", "CHEMICAL", 91, 111], ["pyrrolizidine alkaloids", "CHEMICAL", 160, 183], ["steroidal sapogenins", "SIMPLE_CHEMICAL", 91, 111], ["tribulosis", "SIMPLE_CHEMICAL", 113, 123], ["pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 160, 183], ["cells", "CELL", 202, 207], ["cytochrome P450", "GENE_OR_GENE_PRODUCT", 222, 237], ["cytochrome P450", "PROTEIN", 222, 237], ["The megalocytosis", "PROBLEM", 0, 17], ["Intoxication", "PROBLEM", 75, 87], ["tribulosis", "PROBLEM", 113, 123], ["related toxicoses", "PROBLEM", 128, 145], ["pyrrolizidine alkaloids", "TREATMENT", 160, 183], ["most prominent", "OBSERVATION_MODIFIER", 29, 43]]], ["Although the liver is the main site of bioactivation, other cells such as proximal convoluted renal tubules and club cells (formerly termed Clara cells) in the lung can generate metabolites that cause local injury.", [["liver", "ANATOMY", 13, 18], ["cells", "ANATOMY", 60, 65], ["convoluted renal tubules", "ANATOMY", 83, 107], ["club cells", "ANATOMY", 112, 122], ["Clara cells", "ANATOMY", 140, 151], ["lung", "ANATOMY", 160, 164], ["liver", "ORGAN", 13, 18], ["cells", "CELL", 60, 65], ["renal tubules", "TISSUE", 94, 107], ["club cells", "CELL", 112, 122], ["Clara cells", "CELL", 140, 151], ["lung", "ORGAN", 160, 164], ["proximal convoluted renal tubules", "CELL_TYPE", 74, 107], ["club cells", "CELL_TYPE", 112, 122], ["Clara cells", "CELL_TYPE", 140, 151], ["other cells", "PROBLEM", 54, 65], ["proximal convoluted renal tubules and club cells", "PROBLEM", 74, 122], ["local injury", "PROBLEM", 201, 213], ["liver", "ANATOMY", 13, 18], ["main", "OBSERVATION_MODIFIER", 26, 30], ["bioactivation", "OBSERVATION", 39, 52], ["proximal", "ANATOMY_MODIFIER", 74, 82], ["convoluted", "ANATOMY_MODIFIER", 83, 93], ["renal", "ANATOMY", 94, 99], ["tubules", "ANATOMY_MODIFIER", 100, 107], ["club cells", "OBSERVATION", 112, 122], ["Clara cells", "OBSERVATION", 140, 151], ["lung", "ANATOMY", 160, 164], ["local", "OBSERVATION_MODIFIER", 201, 206], ["injury", "OBSERVATION", 207, 213]]], ["Death in some instances may be the result of renal damage and in others the result of pulmonary vascular and interstitial lesions.", [["renal", "ANATOMY", 45, 50], ["pulmonary vascular", "ANATOMY", 86, 104], ["interstitial lesions", "ANATOMY", 109, 129], ["Death", "DISEASE", 0, 5], ["renal damage", "DISEASE", 45, 57], ["pulmonary vascular and interstitial lesions", "DISEASE", 86, 129], ["renal", "ORGAN", 45, 50], ["pulmonary vascular", "MULTI-TISSUE_STRUCTURE", 86, 104], ["interstitial lesions", "PATHOLOGICAL_FORMATION", 109, 129], ["Death", "PROBLEM", 0, 5], ["renal damage", "PROBLEM", 45, 57], ["pulmonary vascular and interstitial lesions", "PROBLEM", 86, 129], ["renal", "ANATOMY", 45, 50], ["damage", "OBSERVATION", 51, 57], ["pulmonary", "ANATOMY_MODIFIER", 86, 95], ["vascular", "ANATOMY", 96, 104], ["interstitial", "ANATOMY_MODIFIER", 109, 121], ["lesions", "OBSERVATION", 122, 129]]], ["Variation in the source of the toxin and in the species-based metabolic differences in the affected animals account for the differences in susceptibility of the different tissues.", [["tissues", "ANATOMY", 171, 178], ["tissues", "TISSUE", 171, 178], ["toxin", "PROTEIN", 31, 36], ["the toxin", "PROBLEM", 27, 36], ["the species", "TEST", 44, 55], ["metabolic differences", "OBSERVATION", 62, 83], ["different tissues", "OBSERVATION", 161, 178]]], ["Alkaloids from Crotalaria affect the widest range of tissues in most animals; most notably, monocrotaline causes diffuse lung injury, leading to pulmonary edema progressing to fibrosis.", [["tissues", "ANATOMY", 53, 60], ["lung", "ANATOMY", 121, 125], ["pulmonary", "ANATOMY", 145, 154], ["monocrotaline", "CHEMICAL", 92, 105], ["lung injury", "DISEASE", 121, 132], ["pulmonary edema", "DISEASE", 145, 160], ["fibrosis", "DISEASE", 176, 184], ["monocrotaline", "CHEMICAL", 92, 105], ["Crotalaria", "SIMPLE_CHEMICAL", 15, 25], ["tissues", "TISSUE", 53, 60], ["monocrotaline", "SIMPLE_CHEMICAL", 92, 105], ["lung", "ORGAN", 121, 125], ["pulmonary edema", "PATHOLOGICAL_FORMATION", 145, 160], ["Alkaloids", "PROBLEM", 0, 9], ["Crotalaria affect", "PROBLEM", 15, 32], ["diffuse lung injury", "PROBLEM", 113, 132], ["pulmonary edema", "PROBLEM", 145, 160], ["fibrosis", "PROBLEM", 176, 184], ["widest", "OBSERVATION_MODIFIER", 37, 43], ["most animals", "OBSERVATION_MODIFIER", 64, 76], ["monocrotaline", "ANATOMY", 92, 105], ["diffuse", "OBSERVATION_MODIFIER", 113, 120], ["lung", "ANATOMY", 121, 125], ["injury", "OBSERVATION", 126, 132], ["pulmonary", "ANATOMY", 145, 154], ["edema", "OBSERVATION", 155, 160], ["fibrosis", "OBSERVATION", 176, 184]]], ["Respiratory difficulty has been described in horses eating C. dura, and C. crispata produces similar lesions.", [["lesions", "ANATOMY", 101, 108], ["Respiratory difficulty", "DISEASE", 0, 22], ["horses", "ORGANISM_SUBDIVISION", 45, 51], ["C. dura", "ORGANISM", 59, 66], ["C. crispata", "ORGANISM", 72, 83], ["lesions", "PATHOLOGICAL_FORMATION", 101, 108], ["C. crispata", "SPECIES", 72, 83], ["C. dura", "SPECIES", 59, 66], ["C. crispata", "SPECIES", 72, 83], ["Respiratory difficulty", "PROBLEM", 0, 22], ["similar lesions", "PROBLEM", 93, 108], ["difficulty", "OBSERVATION", 12, 22], ["dura", "ANATOMY", 62, 66], ["similar", "OBSERVATION_MODIFIER", 93, 100], ["lesions", "OBSERVATION", 101, 108]]], ["Sheep develop pulmonary signs after eating C. globifera and C. dura, and pigs after eating Senecio jacobaea.", [["pulmonary", "ANATOMY", 14, 23], ["dura", "ANATOMY", 63, 67], ["pulmonary signs", "DISEASE", 14, 29], ["Sheep", "ORGANISM", 0, 5], ["pulmonary", "ORGAN", 14, 23], ["C. globifera", "ORGANISM", 43, 55], ["C. dura", "ORGANISM", 60, 67], ["pigs", "ORGANISM", 73, 77], ["Senecio jacobaea", "ORGANISM", 91, 107], ["Sheep", "SPECIES", 0, 5], ["C. globifera", "SPECIES", 43, 55], ["C. dura", "SPECIES", 60, 67], ["pigs", "SPECIES", 73, 77], ["Senecio jacobaea", "SPECIES", 91, 107], ["C. globifera", "SPECIES", 43, 55], ["pigs", "SPECIES", 73, 77], ["Senecio jacobaea", "SPECIES", 91, 107], ["pulmonary signs", "PROBLEM", 14, 29], ["C. dura", "PROBLEM", 60, 67], ["pulmonary", "ANATOMY", 14, 23], ["signs", "OBSERVATION", 24, 29], ["dura", "ANATOMY", 63, 67]]], ["The experimental feeding of C. spectabilis to rats or the injection of monocrotaline, extracted from the plant, produces progressive pulmonary disease, pulmonary hypertension, and cor pulmonale, with necrotizing vasculitis of the pulmonary arterioles.", [["pulmonary", "ANATOMY", 133, 142], ["pulmonary", "ANATOMY", 152, 161], ["cor pulmonale", "ANATOMY", 180, 193], ["pulmonary arterioles", "ANATOMY", 230, 250], ["monocrotaline", "CHEMICAL", 71, 84], ["pulmonary disease", "DISEASE", 133, 150], ["pulmonary hypertension", "DISEASE", 152, 174], ["cor pulmonale", "DISEASE", 180, 193], ["vasculitis", "DISEASE", 212, 222], ["monocrotaline", "CHEMICAL", 71, 84], ["C. spectabilis", "ORGANISM", 28, 42], ["rats", "ORGANISM", 46, 50], ["monocrotaline", "SIMPLE_CHEMICAL", 71, 84], ["pulmonary", "ORGAN", 133, 142], ["pulmonary", "ORGAN", 152, 161], ["pulmonale", "ORGAN", 184, 193], ["pulmonary arterioles", "MULTI-TISSUE_STRUCTURE", 230, 250], ["C. spectabilis", "SPECIES", 28, 42], ["rats", "SPECIES", 46, 50], ["C. spectabilis", "SPECIES", 28, 42], ["cor pulmonale", "SPECIES", 180, 193], ["C. spectabilis", "TREATMENT", 28, 42], ["monocrotaline", "TREATMENT", 71, 84], ["progressive pulmonary disease", "PROBLEM", 121, 150], ["pulmonary hypertension", "PROBLEM", 152, 174], ["cor pulmonale", "PROBLEM", 180, 193], ["necrotizing vasculitis of the pulmonary arterioles", "PROBLEM", 200, 250], ["progressive", "OBSERVATION_MODIFIER", 121, 132], ["pulmonary", "ANATOMY", 133, 142], ["disease", "OBSERVATION", 143, 150], ["pulmonary", "ANATOMY", 152, 161], ["hypertension", "OBSERVATION", 162, 174], ["cor pulmonale", "OBSERVATION", 180, 193], ["necrotizing", "OBSERVATION_MODIFIER", 200, 211], ["vasculitis", "OBSERVATION", 212, 222], ["pulmonary arterioles", "ANATOMY", 230, 250]]], ["Emphysema occurs in pigs and is an outstanding feature of the pulmonary disease of horses.", [["pulmonary", "ANATOMY", 62, 71], ["Emphysema", "DISEASE", 0, 9], ["pulmonary disease", "DISEASE", 62, 79], ["pigs", "ORGANISM", 20, 24], ["pulmonary", "ORGAN", 62, 71], ["horses", "ORGANISM_SUBDIVISION", 83, 89], ["pigs", "SPECIES", 20, 24], ["pigs", "SPECIES", 20, 24], ["Emphysema", "PROBLEM", 0, 9], ["the pulmonary disease of horses", "PROBLEM", 58, 89], ["pulmonary", "ANATOMY", 62, 71], ["disease", "OBSERVATION", 72, 79]]], ["The essential reactive lesion is diffuse fibrosis of alveolar and interlobular septa, with patchy epithelialization occurring more slowly.Lantana camaraLantana camara is an attractive ornamental shrub native to the Americas and Africa that grows readily in tropical and subtropical habitats.", [["lesion", "ANATOMY", 23, 29], ["alveolar", "ANATOMY", 53, 61], ["interlobular septa", "ANATOMY", 66, 84], ["fibrosis", "DISEASE", 41, 49], ["reactive lesion", "PATHOLOGICAL_FORMATION", 14, 29], ["alveolar", "TISSUE", 53, 61], ["interlobular septa", "TISSUE", 66, 84], ["Lantana camaraLantana camara", "ORGANISM", 138, 166], ["Lantana camaraLantana camara", "SPECIES", 138, 166], ["Lantana camaraLantana camara", "SPECIES", 138, 166], ["The essential reactive lesion", "PROBLEM", 0, 29], ["diffuse fibrosis of alveolar and interlobular septa", "PROBLEM", 33, 84], ["patchy epithelialization", "PROBLEM", 91, 115], ["Lantana camaraLantana camara", "TREATMENT", 138, 166], ["essential", "OBSERVATION_MODIFIER", 4, 13], ["reactive", "OBSERVATION_MODIFIER", 14, 22], ["lesion", "OBSERVATION", 23, 29], ["diffuse", "OBSERVATION_MODIFIER", 33, 40], ["fibrosis", "OBSERVATION", 41, 49], ["alveolar", "ANATOMY_MODIFIER", 53, 61], ["interlobular", "ANATOMY_MODIFIER", 66, 78], ["septa", "ANATOMY_MODIFIER", 79, 84], ["patchy", "OBSERVATION_MODIFIER", 91, 97], ["epithelialization", "OBSERVATION", 98, 115], ["more", "OBSERVATION_MODIFIER", 126, 130], ["slowly", "OBSERVATION_MODIFIER", 131, 137]]], ["It contains various toxic pentacyclic triterpenes, the most abundant of which are lantadene A, lantadene C, and icterogenin, although metabolites may also be toxic.", [["pentacyclic triterpenes", "CHEMICAL", 26, 49], ["lantadene A", "CHEMICAL", 82, 93], ["lantadene C", "CHEMICAL", 95, 106], ["icterogenin", "CHEMICAL", 112, 123], ["pentacyclic triterpenes", "CHEMICAL", 26, 49], ["lantadene A", "CHEMICAL", 82, 93], ["lantadene C", "CHEMICAL", 95, 106], ["icterogenin", "CHEMICAL", 112, 123], ["pentacyclic triterpenes", "SIMPLE_CHEMICAL", 26, 49], ["lantadene A", "SIMPLE_CHEMICAL", 82, 93], ["lantadene C", "SIMPLE_CHEMICAL", 95, 106], ["icterogenin", "SIMPLE_CHEMICAL", 112, 123], ["various toxic pentacyclic triterpenes", "PROBLEM", 12, 49], ["lantadene C", "TREATMENT", 95, 106], ["icterogenin", "TREATMENT", 112, 123], ["toxic", "PROBLEM", 158, 163], ["various", "OBSERVATION_MODIFIER", 12, 19], ["toxic", "OBSERVATION_MODIFIER", 20, 25], ["pentacyclic triterpenes", "OBSERVATION", 26, 49], ["most abundant", "OBSERVATION_MODIFIER", 55, 68], ["may also be", "UNCERTAINTY", 146, 157], ["toxic", "OBSERVATION_MODIFIER", 158, 163]]], ["Lantadene A appears to be the most toxic; at high doses experimentally, it causes severe acute centrilobular necrosis of the liver.", [["centrilobular", "ANATOMY", 95, 108], ["liver", "ANATOMY", 125, 130], ["Lantadene A", "CHEMICAL", 0, 11], ["necrosis", "DISEASE", 109, 117], ["Lantadene A", "CHEMICAL", 0, 11], ["Lantadene A", "SIMPLE_CHEMICAL", 0, 11], ["liver", "ORGAN", 125, 130], ["Lantadene", "TREATMENT", 0, 9], ["severe acute centrilobular necrosis of the liver", "PROBLEM", 82, 130], ["most toxic", "OBSERVATION_MODIFIER", 30, 40], ["severe", "OBSERVATION_MODIFIER", 82, 88], ["acute", "OBSERVATION_MODIFIER", 89, 94], ["centrilobular", "OBSERVATION_MODIFIER", 95, 108], ["necrosis", "OBSERVATION", 109, 117], ["liver", "ANATOMY", 125, 130]]], ["The mechanism of toxicity is not known, but may be related to the effects of lantadene A on mitochondrial energetics. sapogenins or their glycosides, saponins, of T. terrestris, but which of the various saponins in the plant are responsible for the disease is unknown.", [["mitochondrial", "ANATOMY", 92, 105], ["toxicity", "DISEASE", 17, 25], ["lantadene A", "CHEMICAL", 77, 88], ["sapogenins", "CHEMICAL", 118, 128], ["lantadene A", "CHEMICAL", 77, 88], ["sapogenins", "CHEMICAL", 118, 128], ["saponins", "CHEMICAL", 150, 158], ["saponins", "CHEMICAL", 203, 211], ["lantadene A", "SIMPLE_CHEMICAL", 77, 88], ["mitochondrial", "CELLULAR_COMPONENT", 92, 105], ["sapogenins", "SIMPLE_CHEMICAL", 118, 128], ["saponins", "SIMPLE_CHEMICAL", 150, 158], ["T. terrestris", "ORGANISM", 163, 176], ["saponins", "SIMPLE_CHEMICAL", 203, 211], ["T. terrestris", "SPECIES", 163, 176], ["T. terrestris", "SPECIES", 163, 176], ["toxicity", "PROBLEM", 17, 25], ["lantadene", "TREATMENT", 77, 86], ["mitochondrial energetics", "TREATMENT", 92, 116], ["T. terrestris", "PROBLEM", 163, 176], ["the various saponins", "PROBLEM", 191, 211], ["the disease", "PROBLEM", 245, 256], ["toxicity", "OBSERVATION", 17, 25], ["disease", "OBSERVATION", 249, 256]]], ["The disease has also been reproduced experimentally by co-administration of sporidesmin and T. terrestris, but the liver lesions are histologically distinct from those produced by sporidesmin alone (facial eczema).Lantana camaraIn geeldikkop, the most characteristic gross finding is the presence of a white, semifluid accumulation of fine, crystalline material that can be expressed from the cystic duct and larger intrahepatic ducts.", [["liver lesions", "ANATOMY", 115, 128], ["facial", "ANATOMY", 199, 205], ["cystic duct", "ANATOMY", 393, 404], ["intrahepatic ducts", "ANATOMY", 416, 434], ["sporidesmin", "CHEMICAL", 76, 87], ["liver lesions", "DISEASE", 115, 128], ["sporidesmin", "CHEMICAL", 180, 191], ["facial eczema", "DISEASE", 199, 212], ["sporidesmin", "CHEMICAL", 180, 191], ["sporidesmin", "SIMPLE_CHEMICAL", 76, 87], ["T. terrestris", "ORGANISM", 92, 105], ["liver lesions", "CANCER", 115, 128], ["sporidesmin", "SIMPLE_CHEMICAL", 180, 191], ["cystic duct", "MULTI-TISSUE_STRUCTURE", 393, 404], ["intrahepatic ducts", "MULTI-TISSUE_STRUCTURE", 416, 434], ["T. terrestris", "SPECIES", 92, 105], ["T. terrestris", "SPECIES", 92, 105], ["Lantana camaraIn geeldikkop", "SPECIES", 214, 241], ["The disease", "PROBLEM", 0, 11], ["sporidesmin", "PROBLEM", 76, 87], ["T. terrestris", "PROBLEM", 92, 105], ["the liver lesions", "PROBLEM", 111, 128], ["facial eczema", "PROBLEM", 199, 212], ["a white, semifluid accumulation of fine, crystalline material", "PROBLEM", 300, 361], ["disease", "OBSERVATION", 4, 11], ["terrestris", "OBSERVATION_MODIFIER", 95, 105], ["liver", "ANATOMY", 115, 120], ["lesions", "OBSERVATION", 121, 128], ["histologically", "OBSERVATION_MODIFIER", 133, 147], ["facial", "ANATOMY", 199, 205], ["eczema", "OBSERVATION", 206, 212], ["most characteristic", "OBSERVATION_MODIFIER", 247, 266], ["white", "OBSERVATION_MODIFIER", 302, 307], ["semifluid accumulation", "OBSERVATION", 309, 331], ["fine", "OBSERVATION_MODIFIER", 335, 339], ["crystalline material", "OBSERVATION", 341, 361], ["cystic", "OBSERVATION", 393, 399], ["duct", "ANATOMY_MODIFIER", 400, 404], ["larger", "OBSERVATION_MODIFIER", 409, 415], ["intrahepatic", "ANATOMY_MODIFIER", 416, 428], ["ducts", "ANATOMY", 429, 434]]], ["The gallbladder mucosa is also partly covered with a fine, crystalline deposit.", [["gallbladder mucosa", "ANATOMY", 4, 22], ["gallbladder mucosa", "MULTI-TISSUE_STRUCTURE", 4, 22], ["a fine, crystalline deposit", "TREATMENT", 51, 78], ["gallbladder mucosa", "ANATOMY", 4, 22], ["fine", "OBSERVATION_MODIFIER", 53, 57], ["crystalline deposit", "OBSERVATION", 59, 78]]], ["The gross lesions of geeldikkop are similar to those of facial eczema in that there is generalized icterus, and the liver is discolored by bile pigment and either slightly swollen or distorted, according to the duration of the disease.Lantana camaraIn poisoning by sporidesmin alone, however, there is more obvious edema and fibrosis of bile ducts, and bile infarcts in the parenchyma are more common.", [["gross lesions", "ANATOMY", 4, 17], ["geeldikkop", "ANATOMY", 21, 31], ["facial", "ANATOMY", 56, 62], ["liver", "ANATOMY", 116, 121], ["bile pigment", "ANATOMY", 139, 151], ["edema", "ANATOMY", 315, 320], ["bile ducts", "ANATOMY", 337, 347], ["bile infarcts", "ANATOMY", 353, 366], ["parenchyma", "ANATOMY", 374, 384], ["facial eczema", "DISEASE", 56, 69], ["icterus", "DISEASE", 99, 106], ["poisoning", "DISEASE", 252, 261], ["sporidesmin", "CHEMICAL", 265, 276], ["edema", "DISEASE", 315, 320], ["fibrosis", "DISEASE", 325, 333], ["bile infarcts", "DISEASE", 353, 366], ["sporidesmin", "CHEMICAL", 265, 276], ["gross lesions", "CANCER", 4, 17], ["liver", "ORGAN", 116, 121], ["bile pigment", "ORGANISM_SUBSTANCE", 139, 151], ["Lantana camaraIn", "ORGANISM", 235, 251], ["sporidesmin", "SIMPLE_CHEMICAL", 265, 276], ["edema", "PATHOLOGICAL_FORMATION", 315, 320], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 337, 347], ["bile infarcts", "PATHOLOGICAL_FORMATION", 353, 366], ["parenchyma", "MULTI-TISSUE_STRUCTURE", 374, 384], ["The gross lesions of geeldikkop", "PROBLEM", 0, 31], ["facial eczema", "PROBLEM", 56, 69], ["generalized icterus", "PROBLEM", 87, 106], ["bile pigment", "PROBLEM", 139, 151], ["slightly swollen", "PROBLEM", 163, 179], ["the disease", "PROBLEM", 223, 234], ["edema", "PROBLEM", 315, 320], ["fibrosis of bile ducts", "PROBLEM", 325, 347], ["bile infarcts in the parenchyma", "PROBLEM", 353, 384], ["gross", "OBSERVATION_MODIFIER", 4, 9], ["lesions", "OBSERVATION", 10, 17], ["facial", "ANATOMY", 56, 62], ["eczema", "OBSERVATION", 63, 69], ["generalized", "OBSERVATION_MODIFIER", 87, 98], ["icterus", "OBSERVATION", 99, 106], ["liver", "ANATOMY", 116, 121], ["discolored", "OBSERVATION", 125, 135], ["bile", "ANATOMY", 139, 143], ["pigment", "OBSERVATION", 144, 151], ["slightly", "OBSERVATION_MODIFIER", 163, 171], ["swollen", "OBSERVATION", 172, 179], ["distorted", "OBSERVATION_MODIFIER", 183, 192], ["disease", "OBSERVATION", 227, 234], ["obvious", "OBSERVATION_MODIFIER", 307, 314], ["edema", "OBSERVATION", 315, 320], ["fibrosis", "OBSERVATION", 325, 333], ["bile ducts", "ANATOMY", 337, 347], ["bile", "ANATOMY", 353, 357], ["infarcts", "OBSERVATION", 358, 366], ["parenchyma", "ANATOMY_MODIFIER", 374, 384], ["more common", "OBSERVATION_MODIFIER", 389, 400]]], ["The acute lesion consists of swelling and feathery vacuolation of hepatocytes, and marked hyperplasia of Kupffer cells that may show similar cytoplasmic changes.", [["lesion", "ANATOMY", 10, 16], ["hepatocytes", "ANATOMY", 66, 77], ["Kupffer cells", "ANATOMY", 105, 118], ["cytoplasmic", "ANATOMY", 141, 152], ["swelling", "DISEASE", 29, 37], ["hepatocytes", "CELL", 66, 77], ["Kupffer cells", "CELL", 105, 118], ["cytoplasmic", "ORGANISM_SUBSTANCE", 141, 152], ["hepatocytes", "CELL_TYPE", 66, 77], ["Kupffer cells", "CELL_TYPE", 105, 118], ["The acute lesion", "PROBLEM", 0, 16], ["swelling", "PROBLEM", 29, 37], ["feathery vacuolation of hepatocytes", "PROBLEM", 42, 77], ["marked hyperplasia of Kupffer cells", "PROBLEM", 83, 118], ["similar cytoplasmic changes", "PROBLEM", 133, 160], ["acute", "OBSERVATION_MODIFIER", 4, 9], ["lesion", "OBSERVATION", 10, 16], ["swelling", "OBSERVATION", 29, 37], ["feathery", "OBSERVATION_MODIFIER", 42, 50], ["vacuolation", "OBSERVATION", 51, 62], ["hepatocytes", "ANATOMY", 66, 77], ["marked", "OBSERVATION_MODIFIER", 83, 89], ["hyperplasia", "OBSERVATION", 90, 101], ["Kupffer cells", "OBSERVATION", 105, 118], ["may show", "UNCERTAINTY", 124, 132], ["similar", "OBSERVATION_MODIFIER", 133, 140], ["cytoplasmic changes", "OBSERVATION", 141, 160]]], ["In these acute cases, the presence of acicular crystals may be very difficult to detect ( Fig. 2-100A , B).", [["acicular crystals", "PROBLEM", 38, 55], ["acute", "OBSERVATION_MODIFIER", 9, 14], ["acicular crystals", "OBSERVATION", 38, 55], ["may be", "UNCERTAINTY", 56, 62]]], ["With more chronic intoxication, the most consistent histologic abnormality is the presence in bile ducts of various amounts of crystalline material (Fig. 2-100C ).", [["bile ducts", "ANATOMY", 94, 104], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 94, 104], ["more chronic intoxication", "PROBLEM", 5, 30], ["histologic abnormality", "PROBLEM", 52, 74], ["crystalline material", "TREATMENT", 127, 147], ["chronic", "OBSERVATION_MODIFIER", 10, 17], ["intoxication", "OBSERVATION", 18, 30], ["most consistent", "UNCERTAINTY", 36, 51], ["histologic", "OBSERVATION_MODIFIER", 52, 62], ["abnormality", "OBSERVATION", 63, 74], ["bile ducts", "ANATOMY", 94, 104], ["various", "OBSERVATION_MODIFIER", 108, 115], ["amounts", "OBSERVATION_MODIFIER", 116, 123], ["crystalline material", "OBSERVATION", 127, 147]]], ["The crystals are fine, flat, and are deposited in affected ducts, and, less commonly, in hepatocytes themselves and in renal tubules.", [["ducts", "ANATOMY", 59, 64], ["hepatocytes", "ANATOMY", 89, 100], ["renal tubules", "ANATOMY", 119, 132], ["ducts", "MULTI-TISSUE_STRUCTURE", 59, 64], ["hepatocytes", "CELL", 89, 100], ["renal tubules", "TISSUE", 119, 132], ["hepatocytes", "CELL_TYPE", 89, 100], ["crystals", "OBSERVATION_MODIFIER", 4, 12], ["fine", "OBSERVATION_MODIFIER", 17, 21], ["flat", "OBSERVATION_MODIFIER", 23, 27], ["affected", "OBSERVATION_MODIFIER", 50, 58], ["ducts", "ANATOMY", 59, 64], ["less commonly", "OBSERVATION_MODIFIER", 71, 84], ["hepatocytes", "ANATOMY", 89, 100], ["renal", "ANATOMY", 119, 124], ["tubules", "ANATOMY_MODIFIER", 125, 132]]], ["There may be associated bile ductular proliferation in severe cases, but often the degree of histologic hepatocellular damage is mild compared to the severity of the photosensitization.", [["bile ductular", "ANATOMY", 24, 37], ["hepatocellular", "ANATOMY", 104, 118], ["hepatocellular damage", "DISEASE", 104, 125], ["photosensitization", "DISEASE", 166, 184], ["bile ductular", "PATHOLOGICAL_FORMATION", 24, 37], ["hepatocellular", "CANCER", 104, 118], ["associated bile ductular proliferation in severe cases", "PROBLEM", 13, 67], ["histologic hepatocellular damage", "PROBLEM", 93, 125], ["the photosensitization", "TREATMENT", 162, 184], ["may be", "UNCERTAINTY", 6, 12], ["bile", "ANATOMY", 24, 28], ["ductular", "ANATOMY_MODIFIER", 29, 37], ["proliferation", "OBSERVATION", 38, 51], ["severe", "OBSERVATION_MODIFIER", 55, 61], ["cases", "OBSERVATION", 62, 67], ["histologic", "OBSERVATION_MODIFIER", 93, 103], ["hepatocellular damage", "OBSERVATION", 104, 125], ["mild", "OBSERVATION_MODIFIER", 129, 133]]], ["The cholestasis is not solely the result of mechanical obstruction by the crystals, because photosensitization can occur in such outbreaks in animals whose livers show very little cholangitis and contain very few crystals.", [["livers", "ANATOMY", 156, 162], ["cholestasis", "DISEASE", 4, 15], ["photosensitization", "DISEASE", 92, 110], ["cholangitis", "DISEASE", 180, 191], ["livers", "ORGAN", 156, 162], ["The cholestasis", "PROBLEM", 0, 15], ["mechanical obstruction", "PROBLEM", 44, 66], ["the crystals", "PROBLEM", 70, 82], ["photosensitization", "PROBLEM", 92, 110], ["very little cholangitis", "PROBLEM", 168, 191], ["very few crystals", "PROBLEM", 204, 221], ["cholestasis", "OBSERVATION", 4, 15], ["not solely", "UNCERTAINTY", 19, 29], ["mechanical", "OBSERVATION_MODIFIER", 44, 54], ["obstruction", "OBSERVATION", 55, 66], ["livers", "ANATOMY", 156, 162], ["very", "OBSERVATION_MODIFIER", 168, 172], ["little", "OBSERVATION_MODIFIER", 173, 179], ["cholangitis", "OBSERVATION", 180, 191], ["very", "OBSERVATION_MODIFIER", 204, 208], ["few", "OBSERVATION_MODIFIER", 209, 212], ["crystals", "OBSERVATION", 213, 221]]], ["The severity of peribiliary fibrosis is more variable and probably depends on the relative contribution of sporidesmin to the intoxication.", [["peribiliary", "ANATOMY", 16, 27], ["fibrosis", "DISEASE", 28, 36], ["sporidesmin", "CHEMICAL", 107, 118], ["sporidesmin", "CHEMICAL", 107, 118], ["sporidesmin", "GENE_OR_GENE_PRODUCT", 107, 118], ["peribiliary fibrosis", "PROBLEM", 16, 36], ["sporidesmin", "PROBLEM", 107, 118], ["the intoxication", "PROBLEM", 122, 138], ["severity", "OBSERVATION_MODIFIER", 4, 12], ["peribiliary", "ANATOMY", 16, 27], ["fibrosis", "OBSERVATION", 28, 36], ["more variable", "OBSERVATION_MODIFIER", 40, 53]]], ["There is some hepatocellular degeneration and apoptosis, and there is fairly uniform swelling of cytoplasm.", [["hepatocellular", "ANATOMY", 14, 28], ["cytoplasm", "ANATOMY", 97, 106], ["hepatocellular", "CANCER", 14, 28], ["cytoplasm", "ORGANISM_SUBSTANCE", 97, 106], ["some hepatocellular degeneration", "PROBLEM", 9, 41], ["apoptosis", "PROBLEM", 46, 55], ["fairly uniform swelling of cytoplasm", "PROBLEM", 70, 106], ["some", "OBSERVATION_MODIFIER", 9, 13], ["hepatocellular", "ANATOMY", 14, 28], ["degeneration", "OBSERVATION", 29, 41], ["apoptosis", "OBSERVATION_MODIFIER", 46, 55], ["fairly", "OBSERVATION_MODIFIER", 70, 76], ["uniform", "OBSERVATION_MODIFIER", 77, 84], ["swelling", "OBSERVATION", 85, 93], ["cytoplasm", "OBSERVATION_MODIFIER", 97, 106]]], ["Bile pigment accumulates in Kupffer cells and hepatocyte cytoplasm, but not to any marked extent in canaliculi.", [["Bile pigment", "ANATOMY", 0, 12], ["Kupffer cells", "ANATOMY", 28, 41], ["hepatocyte cytoplasm", "ANATOMY", 46, 66], ["canaliculi", "ANATOMY", 100, 110], ["Bile pigment", "ORGANISM_SUBSTANCE", 0, 12], ["Kupffer cells", "CELL", 28, 41], ["hepatocyte cytoplasm", "ORGANISM_SUBSTANCE", 46, 66], ["canaliculi", "MULTI-TISSUE_STRUCTURE", 100, 110], ["Kupffer cells", "CELL_TYPE", 28, 41], ["Bile pigment", "TEST", 0, 12], ["hepatocyte cytoplasm", "PROBLEM", 46, 66], ["pigment", "OBSERVATION", 5, 12], ["Kupffer cells", "OBSERVATION", 28, 41], ["hepatocyte cytoplasm", "OBSERVATION", 46, 66], ["marked", "OBSERVATION_MODIFIER", 83, 89], ["extent", "OBSERVATION_MODIFIER", 90, 96], ["canaliculi", "ANATOMY", 100, 110]]], ["Focal necrosis of the gallbladder mucosa is often present.", [["gallbladder mucosa", "ANATOMY", 22, 40], ["necrosis", "DISEASE", 6, 14], ["gallbladder mucosa", "MULTI-TISSUE_STRUCTURE", 22, 40], ["Focal necrosis of the gallbladder mucosa", "PROBLEM", 0, 40], ["necrosis", "OBSERVATION", 6, 14], ["gallbladder mucosa", "ANATOMY", 22, 40]]], ["The severity of the hepatic lesion increases with the duration of exposure.Lantana camaraThe biliary crystals from sheep with geeldikkop have been determined to be composed principally of calcium salts of steroidal sapogenins present in T. terrestris.", [["hepatic lesion", "ANATOMY", 20, 34], ["biliary crystals", "ANATOMY", 93, 109], ["hepatic lesion", "DISEASE", 20, 34], ["geeldikkop", "CHEMICAL", 126, 136], ["calcium", "CHEMICAL", 188, 195], ["calcium salts", "CHEMICAL", 188, 201], ["steroidal sapogenins", "CHEMICAL", 205, 225], ["hepatic lesion", "PATHOLOGICAL_FORMATION", 20, 34], ["biliary crystals", "MULTI-TISSUE_STRUCTURE", 93, 109], ["sheep", "ORGANISM", 115, 120], ["calcium salts", "SIMPLE_CHEMICAL", 188, 201], ["steroidal sapogenins", "SIMPLE_CHEMICAL", 205, 225], ["T. terrestris", "ORGANISM", 237, 250], ["sheep", "SPECIES", 115, 120], ["T. terrestris", "SPECIES", 237, 250], ["Lantana camara", "SPECIES", 75, 89], ["sheep", "SPECIES", 115, 120], ["T. terrestris", "SPECIES", 237, 250], ["the hepatic lesion", "PROBLEM", 16, 34], ["Lantana camara", "TREATMENT", 75, 89], ["The biliary crystals", "PROBLEM", 89, 109], ["calcium salts", "TREATMENT", 188, 201], ["steroidal sapogenins", "TREATMENT", 205, 225], ["severity", "OBSERVATION_MODIFIER", 4, 12], ["hepatic", "ANATOMY", 20, 27], ["lesion", "OBSERVATION", 28, 34], ["biliary", "ANATOMY", 93, 100]]], ["Plant saponins are metabolized in the rumen and liver to episapogenin glucuronides, which in the presence of calcium may precipitate, forming the characteristic biliary crystals.", [["rumen", "ANATOMY", 38, 43], ["liver", "ANATOMY", 48, 53], ["biliary crystals", "ANATOMY", 161, 177], ["episapogenin glucuronides", "CHEMICAL", 57, 82], ["calcium", "CHEMICAL", 109, 116], ["saponins", "CHEMICAL", 6, 14], ["episapogenin glucuronides", "CHEMICAL", 57, 82], ["calcium", "CHEMICAL", 109, 116], ["Plant saponins", "CELL", 0, 14], ["rumen", "ORGANISM_SUBDIVISION", 38, 43], ["liver", "ORGAN", 48, 53], ["episapogenin glucuronides", "SIMPLE_CHEMICAL", 57, 82], ["calcium", "SIMPLE_CHEMICAL", 109, 116], ["biliary crystals", "PATHOLOGICAL_FORMATION", 161, 177], ["Plant saponins", "TEST", 0, 14], ["the characteristic biliary crystals", "PROBLEM", 142, 177], ["saponins", "OBSERVATION_MODIFIER", 6, 14], ["rumen", "ANATOMY_MODIFIER", 38, 43], ["liver", "ANATOMY", 48, 53], ["biliary", "ANATOMY", 161, 168], ["crystals", "OBSERVATION", 169, 177]]], ["Cholestasis is likely related to reduced bile acid secretion into the lumen of the canaliculi, rather than biliary occlusion by these plant sapogenins.", [["bile", "ANATOMY", 41, 45], ["lumen", "ANATOMY", 70, 75], ["canaliculi", "ANATOMY", 83, 93], ["biliary", "ANATOMY", 107, 114], ["Cholestasis", "DISEASE", 0, 11], ["bile acid", "CHEMICAL", 41, 50], ["biliary occlusion", "DISEASE", 107, 124], ["bile acid", "CHEMICAL", 41, 50], ["bile acid", "SIMPLE_CHEMICAL", 41, 50], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 70, 75], ["canaliculi", "MULTI-TISSUE_STRUCTURE", 83, 93], ["biliary", "MULTI-TISSUE_STRUCTURE", 107, 114], ["sapogenins", "GENE_OR_GENE_PRODUCT", 140, 150], ["Cholestasis", "PROBLEM", 0, 11], ["reduced bile acid secretion", "PROBLEM", 33, 60], ["biliary occlusion", "PROBLEM", 107, 124], ["these plant sapogenins", "TREATMENT", 128, 150], ["likely related to", "UNCERTAINTY", 15, 32], ["reduced", "OBSERVATION_MODIFIER", 33, 40], ["bile acid secretion", "OBSERVATION", 41, 60], ["lumen", "ANATOMY_MODIFIER", 70, 75], ["canaliculi", "ANATOMY", 83, 93], ["biliary", "ANATOMY", 107, 114], ["occlusion", "OBSERVATION", 115, 124], ["plant sapogenins", "OBSERVATION", 134, 150]]], ["This explains the evidence of cholestasis before crystals can be seen histologically.", [["cholestasis", "DISEASE", 30, 41], ["cholestasis before crystals", "PROBLEM", 30, 57], ["cholestasis", "OBSERVATION", 30, 41]]], ["Other unidentified plant components may also play a role in hepatocellular and biliary injury.", [["hepatocellular", "ANATOMY", 60, 74], ["biliary", "ANATOMY", 79, 86], ["hepatocellular and biliary injury", "DISEASE", 60, 93], ["hepatocellular", "CANCER", 60, 74], ["biliary", "ORGAN", 79, 86], ["Other unidentified plant components", "PROBLEM", 0, 35], ["hepatocellular and biliary injury", "PROBLEM", 60, 93], ["plant components", "OBSERVATION", 19, 35], ["hepatocellular", "ANATOMY", 60, 74], ["biliary", "ANATOMY", 79, 86], ["injury", "OBSERVATION", 87, 93]]], ["It has also been suggested that the toxins responsible may act primarily on the membranes of the bile canaliculi, in a manner similar to that of Lantana poisoning.", [["membranes", "ANATOMY", 80, 89], ["bile canaliculi", "ANATOMY", 97, 112], ["Lantana", "CHEMICAL", 145, 152], ["poisoning", "DISEASE", 153, 162], ["membranes", "CELLULAR_COMPONENT", 80, 89], ["bile canaliculi", "MULTI-TISSUE_STRUCTURE", 97, 112], ["Lantana", "ORGANISM", 145, 152], ["the toxins", "PROBLEM", 32, 42], ["Lantana poisoning", "PROBLEM", 145, 162], ["bile canaliculi", "ANATOMY", 97, 112]]], ["Hepatocellular damage likely also plays a role in phytoporphyrin (phylloerythrin) retention.Lantana camaraSwitchgrass (Panicum virgatum), Kleingrass (P. coloratum), and other Panicum species are associated with hepatogenous photosensitization in grazing animals, including sheep, goats, and horses in the United States, Australia, and other areas of the world.", [["Hepatocellular", "ANATOMY", 0, 14], ["Hepatocellular damage", "DISEASE", 0, 21], ["phytoporphyrin", "CHEMICAL", 50, 64], ["phylloerythrin", "CHEMICAL", 66, 80], ["photosensitization", "DISEASE", 224, 242], ["phytoporphyrin", "CHEMICAL", 50, 64], ["phylloerythrin", "CHEMICAL", 66, 80], ["Hepatocellular", "ORGAN", 0, 14], ["phytoporphyrin", "SIMPLE_CHEMICAL", 50, 64], ["phylloerythrin", "SIMPLE_CHEMICAL", 66, 80], ["Lantana camaraSwitchgrass", "ORGANISM", 92, 117], ["Panicum virgatum", "ORGANISM", 119, 135], ["Kleingrass (P. coloratum", "ORGANISM", 138, 162], ["Panicum species", "ORGANISM", 175, 190], ["sheep", "ORGANISM", 273, 278], ["Panicum virgatum", "SPECIES", 119, 135], ["P. coloratum", "SPECIES", 150, 162], ["sheep", "SPECIES", 273, 278], ["goats", "SPECIES", 280, 285], ["Lantana camaraSwitchgrass", "SPECIES", 92, 117], ["Panicum virgatum", "SPECIES", 119, 135], ["P. coloratum", "SPECIES", 150, 162], ["sheep", "SPECIES", 273, 278], ["goats", "SPECIES", 280, 285], ["Hepatocellular damage", "PROBLEM", 0, 21], ["phytoporphyrin (phylloerythrin) retention", "TREATMENT", 50, 91], ["Lantana camaraSwitchgrass (Panicum virgatum", "TREATMENT", 92, 135], ["Kleingrass (P. coloratum", "TREATMENT", 138, 162], ["other Panicum species", "PROBLEM", 169, 190], ["hepatogenous photosensitization", "TREATMENT", 211, 242], ["damage", "OBSERVATION", 15, 21]]], ["The toxic agent(s) are steroidal sapogenins, and A B C their type and concentration vary with the part of the plant (highest concentrations being in the young growing leaf) and with the environmental conditions.", [["leaf", "ANATOMY", 167, 171], ["steroidal sapogenins, and A B C", "CHEMICAL", 23, 54], ["steroidal sapogenins", "SIMPLE_CHEMICAL", 23, 43], ["A B C", "GENE_OR_GENE_PRODUCT", 49, 54], ["leaf", "ORGAN", 167, 171], ["steroidal sapogenins", "TREATMENT", 23, 43], ["A B C their type and concentration vary", "TREATMENT", 49, 88], ["toxic", "OBSERVATION_MODIFIER", 4, 9]]], ["Hot and dry conditions, have been associated with outbreaks.", [["Hot and dry conditions", "PROBLEM", 0, 22], ["dry conditions", "OBSERVATION_MODIFIER", 8, 22]]], ["Crystals may be produced in the biliary tree, hepatocytes, sinusoids, or Kupffer cells.Lantana camaraOther plants reported occasionally to produce unexpected photosensitivity include Digitaria spp., Cooperia pedunculata, Nidorella foetida, and Chloris spp., and such valuable pasture genera as Medicago, Trifolium, Avena, and Biserrula pelecinus, although the latter species may cause primary photosensitization.NitrosaminesEpizootics of poisoning by dimethylnitrosamine occurred in Norwegian cattle, sheep, and fur-bearing animals, from 1957-1962.", [["biliary tree", "ANATOMY", 32, 44], ["hepatocytes", "ANATOMY", 46, 57], ["sinusoids", "ANATOMY", 59, 68], ["Kupffer cells", "ANATOMY", 73, 86], ["photosensitivity", "DISEASE", 158, 174], ["photosensitization", "DISEASE", 393, 411], ["Nitrosamines", "CHEMICAL", 412, 424], ["poisoning", "DISEASE", 438, 447], ["dimethylnitrosamine", "CHEMICAL", 451, 470], ["Nitrosamines", "CHEMICAL", 412, 424], ["dimethylnitrosamine", "CHEMICAL", 451, 470], ["Crystals", "ORGANISM_SUBSTANCE", 0, 8], ["biliary tree", "MULTI-TISSUE_STRUCTURE", 32, 44], ["hepatocytes", "CELL", 46, 57], ["sinusoids", "CELL", 59, 68], ["Kupffer cells", "CELL", 73, 86], ["Lantana camaraOther plants", "ORGANISM", 87, 113], ["Digitaria spp.", "ORGANISM", 183, 197], ["Cooperia pedunculata", "ORGANISM", 199, 219], ["Nidorella foetida", "ORGANISM", 221, 238], ["Chloris spp.", "ORGANISM", 244, 256], ["Trifolium, Avena", "ORGANISM", 304, 320], ["Biserrula pelecinus", "ORGANISM", 326, 345], ["Nitrosamines", "SIMPLE_CHEMICAL", 412, 424], ["dimethylnitrosamine", "SIMPLE_CHEMICAL", 451, 470], ["cattle", "ORGANISM", 493, 499], ["sheep", "ORGANISM", 501, 506], ["fur", "GENE_OR_GENE_PRODUCT", 512, 515], ["hepatocytes", "CELL_TYPE", 46, 57], ["sinusoids", "CELL_TYPE", 59, 68], ["Kupffer cells", "CELL_TYPE", 73, 86], ["Digitaria spp.", "SPECIES", 183, 197], ["Cooperia pedunculata", "SPECIES", 199, 219], ["Nidorella foetida", "SPECIES", 221, 238], ["Chloris spp.", "SPECIES", 244, 256], ["Avena", "SPECIES", 315, 320], ["Biserrula pelecinus", "SPECIES", 326, 345], ["cattle", "SPECIES", 493, 499], ["sheep", "SPECIES", 501, 506], ["Digitaria spp.", "SPECIES", 183, 197], ["Cooperia pedunculata", "SPECIES", 199, 219], ["Nidorella foetida", "SPECIES", 221, 238], ["Chloris spp.", "SPECIES", 244, 256], ["Biserrula pelecinus", "SPECIES", 326, 345], ["cattle", "SPECIES", 493, 499], ["sheep", "SPECIES", 501, 506], ["Crystals", "TEST", 0, 8], ["Lantana camaraOther plants", "TREATMENT", 87, 113], ["unexpected photosensitivity", "PROBLEM", 147, 174], ["Digitaria spp.", "PROBLEM", 183, 197], ["Cooperia pedunculata", "TREATMENT", 199, 219], ["Nidorella foetida", "TREATMENT", 221, 238], ["Chloris spp.", "TREATMENT", 244, 256], ["Biserrula pelecinus", "PROBLEM", 326, 345], ["the latter species", "PROBLEM", 356, 374], ["primary photosensitization", "PROBLEM", 385, 411], ["Nitrosamines", "TREATMENT", 412, 424], ["dimethylnitrosamine", "TREATMENT", 451, 470], ["may be", "UNCERTAINTY", 9, 15], ["biliary tree", "ANATOMY", 32, 44], ["hepatocytes", "ANATOMY", 46, 57], ["Kupffer cells", "OBSERVATION", 73, 86], ["may cause", "UNCERTAINTY", 375, 384], ["primary photosensitization", "OBSERVATION", 385, 411]]], ["The toxin was present in herring meal and was thought to be a reaction product of trimethylamine and other lower amines with sodium nitrite, added as a preservative, the reacting amines being products of decomposition.", [["trimethylamine", "CHEMICAL", 82, 96], ["amines", "CHEMICAL", 113, 119], ["sodium nitrite", "CHEMICAL", 125, 139], ["amines", "CHEMICAL", 179, 185], ["trimethylamine", "CHEMICAL", 82, 96], ["amines", "CHEMICAL", 113, 119], ["sodium nitrite", "CHEMICAL", 125, 139], ["amines", "CHEMICAL", 179, 185], ["trimethylamine", "SIMPLE_CHEMICAL", 82, 96], ["sodium nitrite", "SIMPLE_CHEMICAL", 125, 139], ["amines", "SIMPLE_CHEMICAL", 179, 185], ["The toxin", "TEST", 0, 9], ["trimethylamine", "TREATMENT", 82, 96], ["sodium nitrite", "TREATMENT", 125, 139], ["a preservative", "TREATMENT", 150, 164], ["thought to be", "UNCERTAINTY", 46, 59]]], ["Animals consumed several pounds of the toxic meal each day before becoming ill.", [["Animals", "ORGANISM", 0, 7]]], ["This intoxication has little importance in livestock now that it is easily prevented.NitrosaminesAt postmortem, there was moderate anasarca and signs of hemorrhagic diathesis.", [["Nitrosamines", "CHEMICAL", 85, 97], ["hemorrhagic diathesis", "DISEASE", 153, 174], ["Nitrosamines", "CHEMICAL", 85, 97], ["Nitrosamines", "SIMPLE_CHEMICAL", 85, 97], ["Nitrosamines", "TREATMENT", 85, 97], ["moderate anasarca", "PROBLEM", 122, 139], ["hemorrhagic diathesis", "PROBLEM", 153, 174], ["moderate", "OBSERVATION_MODIFIER", 122, 130], ["anasarca", "OBSERVATION", 131, 139], ["signs of", "UNCERTAINTY", 144, 152], ["hemorrhagic", "OBSERVATION_MODIFIER", 153, 164], ["diathesis", "OBSERVATION", 165, 174]]], ["Livers affected acutely were enlarged and firm, with mottled discoloration and sometimes a nutmeg appearance.", [["Livers", "ANATOMY", 0, 6], ["Livers", "ORGAN", 0, 6], ["nutmeg", "ORGANISM_SUBDIVISION", 91, 97], ["firm", "PROBLEM", 42, 46], ["mottled discoloration", "PROBLEM", 53, 74], ["enlarged", "OBSERVATION", 29, 37], ["firm", "OBSERVATION_MODIFIER", 42, 46], ["mottled", "OBSERVATION_MODIFIER", 53, 60], ["discoloration", "OBSERVATION", 61, 74], ["nutmeg", "OBSERVATION_MODIFIER", 91, 97]]], ["In chronic intoxication, the liver was small, granular, and very firm.", [["liver", "ANATOMY", 29, 34], ["liver", "ORGAN", 29, 34], ["chronic intoxication", "PROBLEM", 3, 23], ["very firm", "PROBLEM", 60, 69], ["chronic", "OBSERVATION_MODIFIER", 3, 10], ["intoxication", "OBSERVATION", 11, 23], ["liver", "ANATOMY", 29, 34], ["small", "OBSERVATION_MODIFIER", 39, 44], ["granular", "OBSERVATION_MODIFIER", 46, 54], ["very", "OBSERVATION_MODIFIER", 60, 64], ["firm", "OBSERVATION", 65, 69]]], ["A number of cases recovered after prolonged convalescence, and in these, there was atrophy and fibrosis of the left and caudate lobes, and the right lobe was hyperplastic and hemispheric.", [["left", "ANATOMY", 111, 115], ["caudate lobes", "ANATOMY", 120, 133], ["right lobe", "ANATOMY", 143, 153], ["hyperplastic", "ANATOMY", 158, 170], ["atrophy", "DISEASE", 83, 90], ["fibrosis", "DISEASE", 95, 103], ["caudate lobes", "MULTI-TISSUE_STRUCTURE", 120, 133], ["right lobe", "CANCER", 143, 153], ["hyperplastic", "CANCER", 158, 170], ["atrophy", "PROBLEM", 83, 90], ["fibrosis of the left and caudate lobes", "PROBLEM", 95, 133], ["hyperplastic", "PROBLEM", 158, 170], ["atrophy", "OBSERVATION", 83, 90], ["fibrosis", "OBSERVATION", 95, 103], ["left", "ANATOMY_MODIFIER", 111, 115], ["caudate lobes", "ANATOMY", 120, 133], ["right lobe", "ANATOMY", 143, 153], ["hyperplastic", "OBSERVATION", 158, 170], ["hemispheric", "OBSERVATION_MODIFIER", 175, 186]]], ["Histologically, in acute cases, there was widespread hemorrhagic centrilobular necrosis and an unusual degree of intimal and subendothelial reaction in sublobular and hepatic veins.", [["centrilobular", "ANATOMY", 65, 78], ["intimal", "ANATOMY", 113, 120], ["subendothelial", "ANATOMY", 125, 139], ["sublobular", "ANATOMY", 152, 162], ["hepatic veins", "ANATOMY", 167, 180], ["hemorrhagic", "DISEASE", 53, 64], ["necrosis", "DISEASE", 79, 87], ["intimal", "TISSUE", 113, 120], ["subendothelial", "TISSUE", 125, 139], ["sublobular", "CANCER", 152, 162], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 167, 180], ["widespread hemorrhagic centrilobular necrosis", "PROBLEM", 42, 87], ["intimal and subendothelial reaction in sublobular and hepatic veins", "PROBLEM", 113, 180], ["acute", "OBSERVATION_MODIFIER", 19, 24], ["widespread", "OBSERVATION_MODIFIER", 42, 52], ["hemorrhagic", "OBSERVATION_MODIFIER", 53, 64], ["centrilobular", "OBSERVATION_MODIFIER", 65, 78], ["necrosis", "OBSERVATION", 79, 87], ["unusual", "OBSERVATION_MODIFIER", 95, 102], ["degree", "OBSERVATION_MODIFIER", 103, 109], ["intimal", "OBSERVATION", 113, 120], ["subendothelial reaction", "OBSERVATION", 125, 148], ["sublobular", "ANATOMY_MODIFIER", 152, 162], ["hepatic veins", "ANATOMY", 167, 180]]], ["The chronic lesion was dominated by extensive centrilobular fibrosis, with obliterative changes in many central and sublobular veins.", [["lesion", "ANATOMY", 12, 18], ["centrilobular", "ANATOMY", 46, 59], ["sublobular veins", "ANATOMY", 116, 132], ["fibrosis", "DISEASE", 60, 68], ["centrilobular", "PATHOLOGICAL_FORMATION", 46, 59], ["sublobular veins", "MULTI-TISSUE_STRUCTURE", 116, 132], ["The chronic lesion", "PROBLEM", 0, 18], ["extensive centrilobular fibrosis", "PROBLEM", 36, 68], ["obliterative changes in many central and sublobular veins", "PROBLEM", 75, 132], ["chronic", "OBSERVATION_MODIFIER", 4, 11], ["lesion", "OBSERVATION", 12, 18], ["extensive", "OBSERVATION_MODIFIER", 36, 45], ["centrilobular", "OBSERVATION_MODIFIER", 46, 59], ["fibrosis", "OBSERVATION", 60, 68], ["obliterative", "OBSERVATION", 75, 87], ["many", "OBSERVATION_MODIFIER", 99, 103], ["central", "ANATOMY_MODIFIER", 104, 111], ["sublobular veins", "ANATOMY", 116, 132]]], ["Sporadic cases of portal hypertension in Greyhound dogs have been recognized where hepatic veno-occlusive disease is the predominant lesion.", [["portal", "ANATOMY", 18, 24], ["hepatic", "ANATOMY", 83, 90], ["lesion", "ANATOMY", 133, 139], ["portal hypertension", "DISEASE", 18, 37], ["hepatic veno-occlusive disease", "DISEASE", 83, 113], ["portal", "MULTI-TISSUE_STRUCTURE", 18, 24], ["dogs", "ORGANISM", 51, 55], ["hepatic veno-occlusive", "MULTI-TISSUE_STRUCTURE", 83, 105], ["lesion", "CANCER", 133, 139], ["dogs", "SPECIES", 51, 55], ["portal hypertension in Greyhound dogs", "PROBLEM", 18, 55], ["hepatic veno-occlusive disease", "PROBLEM", 83, 113], ["the predominant lesion", "PROBLEM", 117, 139], ["portal", "ANATOMY", 18, 24], ["hypertension", "OBSERVATION", 25, 37], ["Greyhound dogs", "OBSERVATION", 41, 55], ["hepatic", "ANATOMY", 83, 90], ["veno-occlusive disease", "OBSERVATION", 91, 113], ["predominant", "OBSERVATION_MODIFIER", 121, 132], ["lesion", "OBSERVATION", 133, 139]]], ["In these cases, a history of feeding meat treated with large amounts of nitrites or sulfites in an attempt to preserve the color of fresh meat is common, but a causal relationship has not been established.NitrosaminesThe hepatocellular changes are not specific for dimethylnitrosamine or other hepatotoxic nitrosamines.", [["meat", "ANATOMY", 37, 41], ["meat", "ANATOMY", 138, 142], ["hepatocellular", "ANATOMY", 221, 235], ["nitrites", "CHEMICAL", 72, 80], ["sulfites", "CHEMICAL", 84, 92], ["Nitrosamines", "CHEMICAL", 205, 217], ["dimethylnitrosamine", "CHEMICAL", 265, 284], ["nitrosamines", "CHEMICAL", 306, 318], ["nitrites", "CHEMICAL", 72, 80], ["sulfites", "CHEMICAL", 84, 92], ["Nitrosamines", "CHEMICAL", 205, 217], ["dimethylnitrosamine", "CHEMICAL", 265, 284], ["nitrosamines", "CHEMICAL", 306, 318], ["meat", "ORGANISM_SUBDIVISION", 37, 41], ["nitrites", "SIMPLE_CHEMICAL", 72, 80], ["sulfites", "SIMPLE_CHEMICAL", 84, 92], ["meat", "ORGANISM_SUBDIVISION", 138, 142], ["Nitrosamines", "SIMPLE_CHEMICAL", 205, 217], ["hepatocellular", "CANCER", 221, 235], ["dimethylnitrosamine", "SIMPLE_CHEMICAL", 265, 284], ["hepatotoxic nitrosamines", "SIMPLE_CHEMICAL", 294, 318], ["feeding meat", "TREATMENT", 29, 41], ["large amounts of nitrites", "TREATMENT", 55, 80], ["sulfites", "TREATMENT", 84, 92], ["Nitrosamines", "TREATMENT", 205, 217], ["The hepatocellular changes", "PROBLEM", 217, 243], ["dimethylnitrosamine", "TREATMENT", 265, 284], ["hepatotoxic nitrosamines", "TREATMENT", 294, 318], ["hepatocellular", "OBSERVATION", 221, 235]]], ["Nitrosamines are metabolized in the liver and other tissues to reactive alkyl groups that bind covalently to various macromolecules, especially guanine in nucleic acids.", [["liver", "ANATOMY", 36, 41], ["tissues", "ANATOMY", 52, 59], ["Nitrosamines", "CHEMICAL", 0, 12], ["alkyl", "CHEMICAL", 72, 77], ["guanine", "CHEMICAL", 144, 151], ["nucleic acids", "CHEMICAL", 155, 168], ["Nitrosamines", "CHEMICAL", 0, 12], ["guanine", "CHEMICAL", 144, 151], ["Nitrosamines", "SIMPLE_CHEMICAL", 0, 12], ["liver", "ORGAN", 36, 41], ["tissues", "TISSUE", 52, 59], ["guanine", "SIMPLE_CHEMICAL", 144, 151], ["nucleic acids", "SIMPLE_CHEMICAL", 155, 168], ["Nitrosamines", "TREATMENT", 0, 12], ["reactive alkyl groups", "TREATMENT", 63, 84], ["guanine in nucleic acids", "TREATMENT", 144, 168], ["liver", "ANATOMY", 36, 41], ["reactive", "OBSERVATION_MODIFIER", 63, 71], ["alkyl groups", "OBSERVATION", 72, 84], ["nucleic acids", "OBSERVATION", 155, 168]]], ["Hepatotoxicity develops more slowly than in response to toxicants that induce membrane peroxidation, as many hepatocytes with DNA damage undergo apoptosis when stimulated to replicate.", [["membrane", "ANATOMY", 78, 86], ["hepatocytes", "ANATOMY", 109, 120], ["Hepatotoxicity", "DISEASE", 0, 14], ["membrane", "CELLULAR_COMPONENT", 78, 86], ["hepatocytes", "CELL", 109, 120], ["DNA", "CELLULAR_COMPONENT", 126, 129], ["hepatocytes", "CELL_TYPE", 109, 120], ["Hepatotoxicity", "PROBLEM", 0, 14], ["membrane peroxidation", "PROBLEM", 78, 99], ["many hepatocytes", "PROBLEM", 104, 120], ["DNA damage", "PROBLEM", 126, 136], ["apoptosis", "PROBLEM", 145, 154], ["slowly", "OBSERVATION_MODIFIER", 29, 35], ["membrane peroxidation", "OBSERVATION", 78, 99], ["hepatocytes", "ANATOMY", 109, 120], ["apoptosis", "OBSERVATION", 145, 154]]], ["There is some megalocytosis, nuclear vesiculation and nucleolar prominence, cytoplasmic intranuclear inclusions, and variable fatty change and cytoplasmic bile accumulation.", [["nuclear", "ANATOMY", 29, 36], ["nucleolar", "ANATOMY", 54, 63], ["cytoplasmic", "ANATOMY", 76, 87], ["cytoplasmic bile", "ANATOMY", 143, 159], ["megalocytosis", "DISEASE", 14, 27], ["nuclear", "CELLULAR_COMPONENT", 29, 36], ["nucleolar", "CELLULAR_COMPONENT", 54, 63], ["cytoplasmic", "ORGANISM_SUBSTANCE", 76, 87], ["cytoplasmic", "ORGANISM_SUBSTANCE", 143, 154], ["bile", "SIMPLE_CHEMICAL", 155, 159], ["some megalocytosis", "PROBLEM", 9, 27], ["nuclear vesiculation", "PROBLEM", 29, 49], ["nucleolar prominence", "PROBLEM", 54, 74], ["cytoplasmic intranuclear inclusions", "PROBLEM", 76, 111], ["variable fatty change", "PROBLEM", 117, 138], ["cytoplasmic bile accumulation", "PROBLEM", 143, 172], ["some", "OBSERVATION_MODIFIER", 9, 13], ["megalocytosis", "OBSERVATION", 14, 27], ["nuclear", "OBSERVATION_MODIFIER", 29, 36], ["vesiculation", "OBSERVATION_MODIFIER", 37, 49], ["nucleolar prominence", "OBSERVATION", 54, 74], ["cytoplasmic", "OBSERVATION_MODIFIER", 76, 87], ["intranuclear inclusions", "OBSERVATION", 88, 111], ["variable", "OBSERVATION_MODIFIER", 117, 125], ["fatty change", "OBSERVATION", 126, 138], ["cytoplasmic bile accumulation", "OBSERVATION", 143, 172]]], ["The typical effects of chronic experimental nitrosamine hepatotoxicity, such as hepatocellular fibrosis, nodules, and neoplasms, have not been evident in the accidental poisonings.", [["hepatocellular", "ANATOMY", 80, 94], ["nodules", "ANATOMY", 105, 112], ["neoplasms", "ANATOMY", 118, 127], ["nitrosamine", "CHEMICAL", 44, 55], ["hepatotoxicity", "DISEASE", 56, 70], ["hepatocellular fibrosis", "DISEASE", 80, 103], ["neoplasms", "DISEASE", 118, 127], ["poisonings", "DISEASE", 169, 179], ["nitrosamine", "CHEMICAL", 44, 55], ["nitrosamine", "SIMPLE_CHEMICAL", 44, 55], ["hepatocellular", "ORGAN", 80, 94], ["neoplasms", "CANCER", 118, 127], ["chronic experimental nitrosamine hepatotoxicity", "PROBLEM", 23, 70], ["hepatocellular fibrosis", "PROBLEM", 80, 103], ["nodules", "PROBLEM", 105, 112], ["neoplasms", "PROBLEM", 118, 127], ["chronic", "OBSERVATION_MODIFIER", 23, 30], ["experimental", "OBSERVATION_MODIFIER", 31, 43], ["nitrosamine hepatotoxicity", "OBSERVATION", 44, 70], ["hepatocellular", "ANATOMY", 80, 94], ["fibrosis", "OBSERVATION", 95, 103], ["nodules", "OBSERVATION", 105, 112], ["neoplasms", "OBSERVATION", 118, 127]]], ["Dimethylnitrosamineinduced hepatotoxicosis in dogs has been proposed as a model of toxin-induced progressive hepatic disease in this species.IndospicineLegumes of the genus Indigofera have long been known to contain the toxic amino acid indospicine (6-amidino-2hexanoic acid), which is a structural analogue of arginine, and which was shown in early experimental work to be hepatotoxic for rats and other species.", [["hepatic", "ANATOMY", 109, 116], ["Dimethylnitrosamineinduced", "CHEMICAL", 0, 26], ["hepatotoxicosis", "DISEASE", 27, 42], ["hepatic disease", "DISEASE", 109, 124], ["IndospicineLegumes", "CHEMICAL", 141, 159], ["amino acid", "CHEMICAL", 226, 236], ["indospicine", "CHEMICAL", 237, 248], ["6-amidino-2hexanoic acid", "CHEMICAL", 250, 274], ["arginine", "CHEMICAL", 311, 319], ["hepatotoxic", "DISEASE", 374, 385], ["Dimethylnitrosamineinduced", "CHEMICAL", 0, 26], ["amino acid", "CHEMICAL", 226, 236], ["indospicine", "CHEMICAL", 237, 248], ["6-amidino-2hexanoic acid", "CHEMICAL", 250, 274], ["arginine", "CHEMICAL", 311, 319], ["dogs", "ORGANISM", 46, 50], ["hepatic", "ORGAN", 109, 116], ["genus Indigofera", "ORGANISM", 167, 183], ["amino acid", "AMINO_ACID", 226, 236], ["indospicine", "SIMPLE_CHEMICAL", 237, 248], ["6-amidino-2hexanoic acid", "SIMPLE_CHEMICAL", 250, 274], ["arginine", "SIMPLE_CHEMICAL", 311, 319], ["rats", "ORGANISM", 390, 394], ["dogs", "SPECIES", 46, 50], ["rats", "SPECIES", 390, 394], ["Dimethylnitrosamineinduced hepatotoxicosis in dogs", "PROBLEM", 0, 50], ["toxin", "PROBLEM", 83, 88], ["progressive hepatic disease", "PROBLEM", 97, 124], ["this species", "PROBLEM", 128, 140], ["the toxic amino acid indospicine", "TREATMENT", 216, 248], ["amidino-2hexanoic acid", "TREATMENT", 252, 274], ["other species", "PROBLEM", 399, 412], ["progressive", "OBSERVATION_MODIFIER", 97, 108], ["hepatic", "ANATOMY", 109, 116], ["disease", "OBSERVATION", 117, 124], ["toxic", "OBSERVATION_MODIFIER", 220, 225]]], ["The dose rates necessary to cause chronic liver injury in these species were, however, quite high, and field cases of intoxications were only seen in cattle grazing I. spicata, which has the highest naturally occurring Crystal-associated cholangiohepatopathy is not specific for Tribulus or Panicum spp. intoxication.", [["liver", "ANATOMY", 42, 47], ["liver injury", "DISEASE", 42, 54], ["cholangiohepatopathy", "DISEASE", 238, 258], ["liver", "ORGAN", 42, 47], ["cattle", "ORGANISM", 150, 156], ["I. spicata", "ORGANISM", 165, 175], ["Crystal", "GENE_OR_GENE_PRODUCT", 219, 226], ["Panicum spp.", "ORGANISM", 291, 303], ["Crystal", "PROTEIN", 219, 226], ["cattle", "SPECIES", 150, 156], ["I. spicata", "SPECIES", 165, 175], ["Panicum spp.", "SPECIES", 291, 303], ["cattle", "SPECIES", 150, 156], ["I. spicata", "SPECIES", 165, 175], ["Panicum spp.", "SPECIES", 291, 303], ["The dose rates", "TREATMENT", 0, 14], ["chronic liver injury", "PROBLEM", 34, 54], ["intoxications", "PROBLEM", 118, 131], ["Crystal-associated cholangiohepatopathy", "PROBLEM", 219, 258], ["Tribulus", "PROBLEM", 279, 287], ["Panicum spp.", "PROBLEM", 291, 303], ["intoxication", "PROBLEM", 304, 316], ["chronic", "OBSERVATION_MODIFIER", 34, 41], ["liver", "ANATOMY", 42, 47], ["injury", "OBSERVATION", 48, 54], ["not specific for", "UNCERTAINTY", 262, 278]]], ["Similar changes occur in the hepatogenous photosensitivity disease, alveld, in sheep grazing pastures in Norway, the British Isles, and in the Faeroe Islands containing Narthecium ossifragum.", [["photosensitivity disease", "DISEASE", 42, 66], ["sheep", "ORGANISM", 79, 84], ["Narthecium ossifragum", "ORGANISM", 169, 190], ["sheep", "SPECIES", 79, 84], ["Narthecium ossifragum", "SPECIES", 169, 190], ["sheep", "SPECIES", 79, 84], ["Narthecium ossifragum", "SPECIES", 169, 190], ["Similar changes", "PROBLEM", 0, 15], ["the hepatogenous photosensitivity disease", "PROBLEM", 25, 66], ["hepatogenous", "OBSERVATION_MODIFIER", 29, 41], ["photosensitivity disease", "OBSERVATION", 42, 66], ["sheep", "OBSERVATION_MODIFIER", 79, 84], ["grazing", "OBSERVATION_MODIFIER", 85, 92], ["pastures", "OBSERVATION_MODIFIER", 93, 101], ["Norway", "OBSERVATION_MODIFIER", 105, 111], ["British", "OBSERVATION_MODIFIER", 117, 124], ["Isles", "OBSERVATION_MODIFIER", 125, 130], ["Faeroe", "ANATOMY_MODIFIER", 143, 149], ["Islands", "ANATOMY_MODIFIER", 150, 157], ["Narthecium ossifragum", "OBSERVATION", 169, 190]]], ["Similar disease has been reported in ruminants intoxicated by Agave lecheguilla, Nolena texana, and the pasture species Brachiaria decumbens (signal grass) in Brazil.", [["Agave lecheguilla", "ORGANISM", 62, 79], ["Nolena texana", "ORGANISM", 81, 94], ["Brachiaria decumbens", "ORGANISM", 120, 140], ["Agave lecheguilla", "SPECIES", 62, 79], ["Nolena texana", "SPECIES", 81, 94], ["Brachiaria decumbens", "SPECIES", 120, 140], ["ruminants", "SPECIES", 37, 46], ["Agave lecheguilla", "SPECIES", 62, 79], ["Nolena texana", "SPECIES", 81, 94], ["Brachiaria decumbens", "SPECIES", 120, 140], ["Similar disease", "PROBLEM", 0, 15], ["disease", "OBSERVATION", 8, 15]]], ["In New Zealand, crystal deposition in the biliary tree of cattle has been reported following ingestion of Phytolacca octandra (inkweed).", [["biliary tree", "ANATOMY", 42, 54], ["biliary tree", "MULTI-TISSUE_STRUCTURE", 42, 54], ["cattle", "ORGANISM", 58, 64], ["Phytolacca octandra", "ORGANISM", 106, 125], ["inkweed", "CANCER", 127, 134], ["cattle", "SPECIES", 58, 64], ["Phytolacca octandra", "SPECIES", 106, 125], ["cattle", "SPECIES", 58, 64], ["Phytolacca octandra", "SPECIES", 106, 125], ["New Zealand", "TREATMENT", 3, 14], ["crystal deposition in the biliary tree", "PROBLEM", 16, 54], ["Phytolacca octandra", "TREATMENT", 106, 125], ["New", "OBSERVATION_MODIFIER", 3, 6], ["Zealand", "OBSERVATION_MODIFIER", 7, 14], ["crystal deposition", "OBSERVATION", 16, 34], ["biliary", "ANATOMY", 42, 49], ["tree", "ANATOMY_MODIFIER", 50, 54], ["cattle", "OBSERVATION", 58, 64], ["Phytolacca octandra", "OBSERVATION", 106, 125]]], ["In those cases studied (T. terrestris, P. dichotomiflorum, P. schinzii, Narthecium ossifragum), the characteristic crystalloid material deposited in the bile is principally composed of calcium salts of steroidal sapogenins.", [["bile", "ANATOMY", 153, 157], ["calcium salts", "CHEMICAL", 185, 198], ["calcium", "CHEMICAL", 185, 192], ["steroidal sapogenins", "CHEMICAL", 202, 222], ["T. terrestris", "ORGANISM", 24, 37], ["P. dichotomiflorum", "ORGANISM", 39, 57], ["P. schinzii", "ORGANISM", 59, 70], ["Narthecium ossifragum", "ORGANISM", 72, 93], ["bile", "MULTI-TISSUE_STRUCTURE", 153, 157], ["calcium salts", "SIMPLE_CHEMICAL", 185, 198], ["steroidal sapogenins", "SIMPLE_CHEMICAL", 202, 222], ["T. terrestris", "SPECIES", 24, 37], ["P. dichotomiflorum", "SPECIES", 39, 57], ["P. schinzii", "SPECIES", 59, 70], ["Narthecium ossifragum", "SPECIES", 72, 93], ["T. terrestris", "SPECIES", 24, 37], ["P. dichotomiflorum", "SPECIES", 39, 57], ["P. schinzii", "SPECIES", 59, 70], ["Narthecium ossifragum", "SPECIES", 72, 93], ["P. schinzii, Narthecium ossifragum", "TREATMENT", 59, 93], ["the characteristic crystalloid material", "TREATMENT", 96, 135], ["calcium salts", "TREATMENT", 185, 198], ["steroidal sapogenins", "TREATMENT", 202, 222], ["crystalloid material", "OBSERVATION", 115, 135], ["bile", "ANATOMY", 153, 157]]], ["In some cases, crystal formation may not be apparent in bile ducts, and affected Kupffer cells and macrophages are more evident.", [["bile ducts", "ANATOMY", 56, 66], ["Kupffer cells", "ANATOMY", 81, 94], ["macrophages", "ANATOMY", 99, 110], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 56, 66], ["Kupffer cells", "CELL", 81, 94], ["macrophages", "CELL", 99, 110], ["Kupffer cells", "CELL_TYPE", 81, 94], ["macrophages", "CELL_TYPE", 99, 110], ["crystal formation", "PROBLEM", 15, 32], ["macrophages", "PROBLEM", 99, 110], ["crystal formation", "OBSERVATION", 15, 32], ["may not be apparent", "UNCERTAINTY", 33, 52], ["bile ducts", "ANATOMY", 56, 66], ["Kupffer cells", "OBSERVATION", 81, 94], ["macrophages", "OBSERVATION", 99, 110]]], ["There may be differences in the histologic responses of cattle and sheep grazing various sapinogenincontaining plants.", [["cattle", "ORGANISM", 56, 62], ["sheep", "ORGANISM", 67, 72], ["cattle", "SPECIES", 56, 62], ["sheep", "SPECIES", 67, 72], ["cattle", "SPECIES", 56, 62], ["sheep", "SPECIES", 67, 72], ["cattle and sheep grazing various sapinogenincontaining plants", "TREATMENT", 56, 117], ["may be", "UNCERTAINTY", 6, 12]]], ["Foamy Kupffer cells and hepatocytes along with foamy macrophages in mesenteric and hepatic lymph nodes may be a more common response in cattle versus crystal formation within bile ducts in sheep ( Fig. 2-101) .", [["Foamy Kupffer cells", "ANATOMY", 0, 19], ["hepatocytes", "ANATOMY", 24, 35], ["foamy macrophages", "ANATOMY", 47, 64], ["mesenteric", "ANATOMY", 68, 78], ["hepatic lymph nodes", "ANATOMY", 83, 102], ["bile ducts", "ANATOMY", 175, 185], ["Foamy Kupffer cells", "CELL", 0, 19], ["hepatocytes", "CELL", 24, 35], ["foamy macrophages", "CELL", 47, 64], ["mesenteric", "MULTI-TISSUE_STRUCTURE", 68, 78], ["hepatic lymph nodes", "MULTI-TISSUE_STRUCTURE", 83, 102], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 175, 185], ["sheep", "ORGANISM", 189, 194], ["Foamy Kupffer cells", "CELL_TYPE", 0, 19], ["hepatocytes", "CELL_TYPE", 24, 35], ["foamy macrophages", "CELL_TYPE", 47, 64], ["sheep", "SPECIES", 189, 194], ["cattle", "SPECIES", 136, 142], ["sheep", "SPECIES", 189, 194], ["foamy macrophages in mesenteric and hepatic lymph nodes", "PROBLEM", 47, 102], ["crystal formation within bile ducts", "PROBLEM", 150, 185], ["Kupffer cells", "OBSERVATION", 6, 19], ["hepatocytes", "ANATOMY", 24, 35], ["foamy macrophages", "OBSERVATION", 47, 64], ["mesenteric", "ANATOMY", 68, 78], ["hepatic", "ANATOMY", 83, 90], ["lymph nodes", "OBSERVATION", 91, 102], ["bile ducts", "ANATOMY", 175, 185]]], ["To complicate diagnostic efforts, foamy macrophages in the mesenteric and hepatic lymph nodes are also found in healthy cattle and sheep grazing B. decumbens in Brazil.", [["foamy macrophages", "ANATOMY", 34, 51], ["mesenteric", "ANATOMY", 59, 69], ["hepatic lymph nodes", "ANATOMY", 74, 93], ["foamy macrophages", "CELL", 34, 51], ["mesenteric", "MULTI-TISSUE_STRUCTURE", 59, 69], ["hepatic lymph nodes", "MULTI-TISSUE_STRUCTURE", 74, 93], ["cattle", "ORGANISM", 120, 126], ["sheep", "ORGANISM", 131, 136], ["B. decumbens", "ORGANISM", 145, 157], ["foamy macrophages", "CELL_TYPE", 34, 51], ["cattle", "SPECIES", 120, 126], ["sheep", "SPECIES", 131, 136], ["B. decumbens", "SPECIES", 145, 157], ["cattle", "SPECIES", 120, 126], ["sheep", "SPECIES", 131, 136], ["B. decumbens", "SPECIES", 145, 157], ["foamy macrophages in the mesenteric and hepatic lymph nodes", "PROBLEM", 34, 93], ["foamy macrophages", "OBSERVATION", 34, 51], ["mesenteric", "ANATOMY", 59, 69], ["hepatic", "ANATOMY", 74, 81], ["lymph nodes", "OBSERVATION", 82, 93], ["decumbens", "OBSERVATION_MODIFIER", 148, 157]]], ["With the exception of Nolena texana, steroidal sapogenins have been demonstrated in all of these plants.", [["sapogenins", "CHEMICAL", 47, 57], ["steroidal sapogenins", "CHEMICAL", 37, 57], ["Nolena texana", "ORGANISM", 22, 35], ["steroidal sapogenins", "SIMPLE_CHEMICAL", 37, 57], ["Nolena texana", "SPECIES", 22, 35], ["Nolena texana", "SPECIES", 22, 35], ["Nolena texana", "TREATMENT", 22, 35], ["steroidal sapogenins", "TREATMENT", 37, 57], ["steroidal sapogenins", "OBSERVATION", 37, 57]]], ["As with T. terrestris, extracts of B. decumbens containing steroidal saponins produced typical lesions of cholangitis with crystal deposition when orally administered to lambs, with Pithomyces chartarum spore counts below detectable levels.", [["extracts", "ANATOMY", 23, 31], ["lesions", "ANATOMY", 95, 102], ["steroidal saponins", "CHEMICAL", 59, 77], ["cholangitis", "DISEASE", 106, 117], ["steroidal saponins", "CHEMICAL", 59, 77], ["T. terrestris", "ORGANISM", 8, 21], ["extracts", "ORGANISM_SUBSTANCE", 23, 31], ["B. decumbens", "ORGANISM", 35, 47], ["steroidal saponins", "SIMPLE_CHEMICAL", 59, 77], ["lesions", "PATHOLOGICAL_FORMATION", 95, 102], ["lambs", "ORGANISM", 170, 175], ["Pithomyces chartarum", "ORGANISM", 182, 202], ["T. terrestris", "SPECIES", 8, 21], ["B. decumbens", "SPECIES", 35, 47], ["Pithomyces chartarum", "SPECIES", 182, 202], ["T. terrestris", "SPECIES", 8, 21], ["B. decumbens", "SPECIES", 35, 47], ["Pithomyces chartarum", "SPECIES", 182, 202], ["T. terrestris", "PROBLEM", 8, 21], ["B. decumbens", "PROBLEM", 35, 47], ["steroidal saponins", "TREATMENT", 59, 77], ["typical lesions", "PROBLEM", 87, 102], ["cholangitis", "PROBLEM", 106, 117], ["crystal deposition", "PROBLEM", 123, 141], ["Pithomyces chartarum spore counts", "TEST", 182, 215], ["steroidal saponins", "OBSERVATION_MODIFIER", 59, 77], ["typical", "OBSERVATION_MODIFIER", 87, 94], ["lesions", "OBSERVATION", 95, 102], ["cholangitis", "OBSERVATION", 106, 117], ["crystal deposition", "OBSERVATION", 123, 141]]], ["Similarly, analysis of samples of B. decumbens and P. dichotomiflorum on which cattle and goats had recently been photosensitized showed only low levels of P. chartarum spores, and all isolates obtained failed to produce sporidesmin.", [["samples", "ANATOMY", 23, 30], ["sporidesmin", "CHEMICAL", 221, 232], ["sporidesmin", "CHEMICAL", 221, 232], ["B. decumbens", "ORGANISM", 34, 46], ["P. dichotomiflorum", "ORGANISM", 51, 69], ["cattle", "ORGANISM", 79, 85], ["goats", "ORGANISM", 90, 95], ["P. chartarum", "ORGANISM", 156, 168], ["sporidesmin", "SIMPLE_CHEMICAL", 221, 232], ["sporidesmin", "PROTEIN", 221, 232], ["B. decumbens", "SPECIES", 34, 46], ["P. dichotomiflorum", "SPECIES", 51, 69], ["cattle", "SPECIES", 79, 85], ["goats", "SPECIES", 90, 95], ["P. chartarum", "SPECIES", 156, 168], ["B. decumbens", "SPECIES", 34, 46], ["P. dichotomiflorum", "SPECIES", 51, 69], ["cattle", "SPECIES", 79, 85], ["goats", "SPECIES", 90, 95], ["P. chartarum", "SPECIES", 156, 168], ["B. decumbens", "PROBLEM", 34, 46], ["P. dichotomiflorum", "PROBLEM", 51, 69], ["low levels of P. chartarum spores", "PROBLEM", 142, 175], ["all isolates", "TEST", 181, 193], ["sporidesmin", "PROBLEM", 221, 232], ["low levels", "OBSERVATION_MODIFIER", 142, 152], ["chartarum spores", "OBSERVATION", 159, 175]]], ["Despite this, it is also apparent that neither Tribulus nor Panicum stands are at all times dangerous.", [["Tribulus nor Panicum", "ORGANISM", 47, 67]]], ["Levels of saponins have been shown to vary greatly within a species from site to site, and with the age of the plant.", [["saponins", "CHEMICAL", 10, 18], ["saponins", "SIMPLE_CHEMICAL", 10, 18], ["Levels of saponins", "TEST", 0, 18], ["plant", "OBSERVATION", 111, 116]]], ["Additionally, the role of sporadic environmental conditions, such as wilting, which might concentrate the saponins or other unidentified toxins, or the synergistic involvement of endophytic fungi, remains to be determined.", [["saponins", "CHEMICAL", 106, 114], ["sporadic environmental conditions", "PROBLEM", 26, 59], ["the saponins", "PROBLEM", 102, 114], ["other unidentified toxins", "PROBLEM", 118, 143], ["endophytic fungi", "PROBLEM", 179, 195], ["endophytic fungi", "OBSERVATION", 179, 195]]], ["Clinical signs of poisoning initially include mild colic, illthrift, and anorexia, with increasing occurrence of signs of hepatotoxicity with cholestasis.", [["poisoning", "DISEASE", 18, 27], ["colic", "DISEASE", 51, 56], ["illthrift", "DISEASE", 58, 67], ["anorexia", "DISEASE", 73, 81], ["hepatotoxicity", "DISEASE", 122, 136], ["cholestasis", "DISEASE", 142, 153], ["poisoning", "PROBLEM", 18, 27], ["mild colic", "PROBLEM", 46, 56], ["illthrift", "PROBLEM", 58, 67], ["anorexia", "PROBLEM", 73, 81], ["hepatotoxicity", "PROBLEM", 122, 136], ["cholestasis", "PROBLEM", 142, 153], ["poisoning", "OBSERVATION", 18, 27], ["mild", "OBSERVATION_MODIFIER", 46, 50], ["colic", "OBSERVATION", 51, 56], ["anorexia", "OBSERVATION", 73, 81], ["hepatotoxicity", "OBSERVATION", 122, 136], ["cholestasis", "OBSERVATION", 142, 153]]], ["In some there can be icterus and photodynamic dermatitis.", [["icterus", "DISEASE", 21, 28], ["dermatitis", "DISEASE", 46, 56], ["icterus", "PROBLEM", 21, 28], ["photodynamic dermatitis", "PROBLEM", 33, 56], ["icterus", "OBSERVATION", 21, 28], ["photodynamic dermatitis", "OBSERVATION", 33, 56]]], ["Exposure to the plant can occur for a year or more before signs of hepatic insufficiency develop, but cholestatic liver disease can be detected biochemically before horses become ill.", [["hepatic", "ANATOMY", 67, 74], ["liver", "ANATOMY", 114, 119], ["hepatic insufficiency", "DISEASE", 67, 88], ["cholestatic liver disease", "DISEASE", 102, 127], ["hepatic", "ORGAN", 67, 74], ["liver", "ORGAN", 114, 119], ["horses", "SPECIES", 165, 171], ["hepatic insufficiency", "PROBLEM", 67, 88], ["cholestatic liver disease", "PROBLEM", 102, 127], ["hepatic", "ANATOMY", 67, 74], ["insufficiency", "OBSERVATION", 75, 88], ["cholestatic", "OBSERVATION_MODIFIER", 102, 113], ["liver", "ANATOMY", 114, 119], ["disease", "OBSERVATION", 120, 127]]], ["More severely affected horses display neurologic disturbances, either excitement or mania in irregular episodes, or long periods of extreme dullness, anorexia, apparent blindness, forced wandering, head pushing, and yawning.", [["neurologic", "ANATOMY", 38, 48], ["head", "ANATOMY", 198, 202], ["neurologic disturbances", "DISEASE", 38, 61], ["mania", "DISEASE", 84, 89], ["dullness", "DISEASE", 140, 148], ["anorexia", "DISEASE", 150, 158], ["blindness", "DISEASE", 169, 178], ["yawning", "DISEASE", 216, 223], ["horses", "ORGANISM", 23, 29], ["head", "ORGANISM_SUBDIVISION", 198, 202], ["severely affected horses", "PROBLEM", 5, 29], ["neurologic disturbances", "PROBLEM", 38, 61], ["mania", "PROBLEM", 84, 89], ["irregular episodes", "PROBLEM", 93, 111], ["extreme dullness", "PROBLEM", 132, 148], ["anorexia", "PROBLEM", 150, 158], ["apparent blindness", "PROBLEM", 160, 178], ["forced wandering", "PROBLEM", 180, 196], ["head pushing", "PROBLEM", 198, 210], ["yawning", "PROBLEM", 216, 223], ["irregular", "OBSERVATION_MODIFIER", 93, 102], ["dullness", "OBSERVATION", 140, 148], ["anorexia", "OBSERVATION", 150, 158], ["blindness", "OBSERVATION", 169, 178], ["head", "ANATOMY", 198, 202]]], ["Clinical problems related to hypoproteinemia, such as coagulopathy or ascites, are not a feature of this disease, probably because most of the hepatocytes are not directly affected.IndospicineThe lesions of alsike clover poisoning are those of diffuse subacute to chronic biliary hyperplasia (ductular reaction) and fibrosis, with the major lesions within and adjacent to all intrahepatic biliary tracts ( Fig. 2-102) .", [["ascites", "ANATOMY", 70, 77], ["hepatocytes", "ANATOMY", 143, 154], ["lesions", "ANATOMY", 196, 203], ["biliary", "ANATOMY", 272, 279], ["ductular", "ANATOMY", 293, 301], ["lesions", "ANATOMY", 341, 348], ["intrahepatic biliary tracts", "ANATOMY", 376, 403], ["hypoproteinemia", "DISEASE", 29, 44], ["coagulopathy", "DISEASE", 54, 66], ["ascites", "DISEASE", 70, 77], ["Indospicine", "CHEMICAL", 181, 192], ["poisoning", "DISEASE", 221, 230], ["chronic biliary hyperplasia (ductular reaction", "DISEASE", 264, 310], ["fibrosis", "DISEASE", 316, 324], ["hepatocytes", "CELL", 143, 154], ["Indospicine", "SIMPLE_CHEMICAL", 181, 192], ["lesions", "PATHOLOGICAL_FORMATION", 196, 203], ["biliary hyperplasia", "PATHOLOGICAL_FORMATION", 272, 291], ["ductular", "ORGAN", 293, 301], ["lesions", "PATHOLOGICAL_FORMATION", 341, 348], ["intrahepatic biliary", "MULTI-TISSUE_STRUCTURE", 376, 396], ["hepatocytes", "CELL_TYPE", 143, 154], ["Clinical problems", "PROBLEM", 0, 17], ["hypoproteinemia", "PROBLEM", 29, 44], ["coagulopathy", "PROBLEM", 54, 66], ["ascites", "PROBLEM", 70, 77], ["this disease", "PROBLEM", 100, 112], ["The lesions of alsike clover poisoning", "PROBLEM", 192, 230], ["diffuse subacute to chronic biliary hyperplasia", "PROBLEM", 244, 291], ["ductular reaction", "PROBLEM", 293, 310], ["fibrosis", "PROBLEM", 316, 324], ["the major lesions", "PROBLEM", 331, 348], ["hypoproteinemia", "OBSERVATION", 29, 44], ["coagulopathy", "OBSERVATION", 54, 66], ["ascites", "OBSERVATION", 70, 77], ["disease", "OBSERVATION", 105, 112], ["hepatocytes", "ANATOMY", 143, 154], ["not directly", "UNCERTAINTY", 159, 171], ["lesions", "OBSERVATION", 196, 203], ["diffuse", "OBSERVATION_MODIFIER", 244, 251], ["subacute", "OBSERVATION_MODIFIER", 252, 260], ["chronic", "OBSERVATION_MODIFIER", 264, 271], ["biliary", "ANATOMY", 272, 279], ["hyperplasia", "OBSERVATION", 280, 291], ["ductular", "OBSERVATION_MODIFIER", 293, 301], ["fibrosis", "OBSERVATION", 316, 324], ["major", "OBSERVATION_MODIFIER", 335, 340], ["lesions", "OBSERVATION", 341, 348], ["all", "ANATOMY_MODIFIER", 372, 375], ["intrahepatic", "ANATOMY_MODIFIER", 376, 388], ["biliary tracts", "ANATOMY", 389, 403]]], ["The liver may be enlarged, sometimes greatly so, or shrunken, pale, and tough or rubbery in consistency.", [["liver", "ANATOMY", 4, 9], ["liver", "ORGAN", 4, 9], ["enlarged", "PROBLEM", 17, 25], ["shrunken", "PROBLEM", 52, 60], ["liver", "ANATOMY", 4, 9], ["may be", "UNCERTAINTY", 10, 16], ["enlarged", "OBSERVATION", 17, 25], ["shrunken", "OBSERVATION_MODIFIER", 52, 60], ["pale", "OBSERVATION_MODIFIER", 62, 66], ["rubbery", "OBSERVATION_MODIFIER", 81, 88], ["consistency", "OBSERVATION_MODIFIER", 92, 103]]], ["The surface is smooth, but its appearance is mottled.", [["surface", "ANATOMY", 4, 11], ["surface", "CELLULAR_COMPONENT", 4, 11], ["mottled", "PROBLEM", 45, 52], ["surface", "OBSERVATION_MODIFIER", 4, 11], ["smooth", "OBSERVATION", 15, 21], ["mottled", "OBSERVATION", 45, 52]]], ["The mottling is clear on the cut surface and is caused by bands of gray fibrous tissue, distinctly visible to the naked eye, surrounding and compressing each lobule.", [["surface", "ANATOMY", 33, 40], ["gray fibrous tissue", "ANATOMY", 67, 86], ["eye", "ANATOMY", 120, 123], ["lobule", "ANATOMY", 158, 164], ["gray fibrous tissue", "TISSUE", 67, 86], ["eye", "ORGAN", 120, 123], ["lobule", "CANCER", 158, 164], ["The mottling", "PROBLEM", 0, 12], ["bands of gray fibrous tissue", "PROBLEM", 58, 86], ["mottling", "OBSERVATION", 4, 12], ["clear", "OBSERVATION", 16, 21], ["fibrous tissue", "OBSERVATION", 72, 86], ["eye", "ANATOMY", 120, 123], ["lobule", "ANATOMY_MODIFIER", 158, 164]]], ["Near the margins of the liver and in some other areas, scar tissue may completely replace the parenchyma.", [["liver", "ANATOMY", 24, 29], ["scar tissue", "ANATOMY", 55, 66], ["parenchyma", "ANATOMY", 94, 104], ["liver", "ORGAN", 24, 29], ["scar tissue", "TISSUE", 55, 66], ["parenchyma", "TISSUE", 94, 104], ["scar tissue", "PROBLEM", 55, 66], ["margins", "OBSERVATION_MODIFIER", 9, 16], ["liver", "ANATOMY", 24, 29], ["some", "OBSERVATION_MODIFIER", 37, 41], ["scar tissue", "OBSERVATION", 55, 66], ["parenchyma", "ANATOMY_MODIFIER", 94, 104]]], ["Areas of parenchymal atrophy may occur upstream of some occluded ducts.", [["parenchymal", "ANATOMY", 9, 20], ["ducts", "ANATOMY", 65, 70], ["parenchymal atrophy", "DISEASE", 9, 28], ["parenchymal", "MULTI-TISSUE_STRUCTURE", 9, 20], ["ducts", "MULTI-TISSUE_STRUCTURE", 65, 70], ["parenchymal atrophy", "PROBLEM", 9, 28], ["some occluded ducts", "PROBLEM", 51, 70], ["parenchymal", "ANATOMY_MODIFIER", 9, 20], ["atrophy", "OBSERVATION", 21, 28], ["some", "OBSERVATION_MODIFIER", 51, 55], ["occluded", "OBSERVATION", 56, 64], ["ducts", "ANATOMY", 65, 70]]], ["Microscopically, there is pronounced proliferation of fibrous tissue in and around the portal tracts associated with hyperplasia of well-formed bile ducts (ductular reaction).", [["fibrous tissue", "ANATOMY", 54, 68], ["portal tracts", "ANATOMY", 87, 100], ["bile ducts", "ANATOMY", 144, 154], ["ductular", "ANATOMY", 156, 164], ["fibrous tissue", "TISSUE", 54, 68], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 87, 100], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 144, 154], ["ductular", "MULTI-TISSUE_STRUCTURE", 156, 164], ["pronounced proliferation of fibrous tissue", "PROBLEM", 26, 68], ["hyperplasia of well-formed bile ducts (ductular reaction", "PROBLEM", 117, 173], ["pronounced", "OBSERVATION_MODIFIER", 26, 36], ["proliferation", "OBSERVATION", 37, 50], ["fibrous tissue", "OBSERVATION", 54, 68], ["portal tracts", "ANATOMY", 87, 100], ["hyperplasia", "OBSERVATION", 117, 128], ["well", "OBSERVATION_MODIFIER", 132, 136], ["bile ducts", "ANATOMY", 144, 154], ["ductular", "OBSERVATION_MODIFIER", 156, 164]]], ["Some areas have prominent neutrophil infiltration into ducts, but in many areas this does not occur.", [["neutrophil", "ANATOMY", 26, 36], ["ducts", "ANATOMY", 55, 60], ["neutrophil", "CELL", 26, 36], ["ducts", "MULTI-TISSUE_STRUCTURE", 55, 60], ["prominent neutrophil infiltration into ducts", "PROBLEM", 16, 60], ["prominent", "OBSERVATION_MODIFIER", 16, 25], ["neutrophil infiltration", "OBSERVATION", 26, 49], ["ducts", "ANATOMY", 55, 60]]], ["In the early stages, the proliferation of bile ducts is often greater than the proliferation of the fibrous tissue, but later the proportions are reversed.", [["bile ducts", "ANATOMY", 42, 52], ["fibrous tissue", "ANATOMY", 100, 114], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 42, 52], ["fibrous tissue", "TISSUE", 100, 114], ["the proliferation of bile ducts", "PROBLEM", 21, 52], ["proliferation", "OBSERVATION", 25, 38], ["bile ducts", "ANATOMY", 42, 52], ["greater", "OBSERVATION_MODIFIER", 62, 69], ["proliferation", "OBSERVATION_MODIFIER", 79, 92], ["fibrous tissue", "OBSERVATION", 100, 114], ["reversed", "OBSERVATION", 146, 154]]], ["The proliferating tissue extends slowly to connect adjacent portal triads, circumscribing areas that correspond to conventional lobules.", [["tissue", "ANATOMY", 18, 24], ["portal triads", "ANATOMY", 60, 73], ["lobules", "ANATOMY", 128, 135], ["tissue", "TISSUE", 18, 24], ["portal triads", "MULTI-TISSUE_STRUCTURE", 60, 73], ["lobules", "MULTI-TISSUE_STRUCTURE", 128, 135], ["The proliferating tissue", "PROBLEM", 0, 24], ["proliferating tissue", "OBSERVATION", 4, 24], ["slowly", "OBSERVATION_MODIFIER", 33, 39], ["portal triads", "ANATOMY", 60, 73], ["circumscribing", "OBSERVATION_MODIFIER", 75, 89], ["lobules", "OBSERVATION", 128, 135]]], ["The fibrous tissue does not permeate along the sinusoids, and there is gradual and uniform constriction of the parenchyma.IndospicineThe distribution of liver lesions suggests that the harmful factor in alsike clover is excreted into the bile in a form that concentrations of indospicine.", [["fibrous tissue", "ANATOMY", 4, 18], ["sinusoids", "ANATOMY", 47, 56], ["parenchyma", "ANATOMY", 111, 121], ["liver lesions", "ANATOMY", 153, 166], ["bile", "ANATOMY", 238, 242], ["Indospicine", "CHEMICAL", 122, 133], ["liver lesions", "DISEASE", 153, 166], ["indospicine", "CHEMICAL", 276, 287], ["Indospicine", "CHEMICAL", 122, 133], ["indospicine", "CHEMICAL", 276, 287], ["fibrous tissue", "TISSUE", 4, 18], ["sinusoids", "TISSUE", 47, 56], ["parenchyma", "TISSUE", 111, 121], ["Indospicine", "SIMPLE_CHEMICAL", 122, 133], ["liver lesions", "PATHOLOGICAL_FORMATION", 153, 166], ["alsike clover", "ORGANISM", 203, 216], ["bile", "ORGAN", 238, 242], ["indospicine", "SIMPLE_CHEMICAL", 276, 287], ["gradual and uniform constriction of the parenchyma", "PROBLEM", 71, 121], ["liver lesions", "PROBLEM", 153, 166], ["the harmful factor in alsike clover", "PROBLEM", 181, 216], ["indospicine", "TREATMENT", 276, 287], ["fibrous tissue", "OBSERVATION", 4, 18], ["sinusoids", "ANATOMY", 47, 56], ["gradual", "OBSERVATION_MODIFIER", 71, 78], ["uniform", "OBSERVATION_MODIFIER", 83, 90], ["constriction", "OBSERVATION", 91, 103], ["parenchyma", "ANATOMY", 111, 121], ["distribution", "OBSERVATION_MODIFIER", 137, 149], ["liver", "ANATOMY", 153, 158], ["lesions", "OBSERVATION", 159, 166], ["harmful", "OBSERVATION_MODIFIER", 185, 192], ["bile", "ANATOMY", 238, 242]]], ["In Australia, a serious outbreak of fatal liver disease occurred in dogs that had been fed meat from horses that had been grazing I. linnaei, a plant native to the arid zones of Australia that has been known to produce, in horses, a chronic neurologic disorder known as \"Birdsville horse disease.\"", [["liver", "ANATOMY", 42, 47], ["meat", "ANATOMY", 91, 95], ["neurologic", "ANATOMY", 241, 251], ["liver disease", "DISEASE", 42, 55], ["neurologic disorder", "DISEASE", 241, 260], ["Birdsville horse disease", "DISEASE", 271, 295], ["liver", "ORGAN", 42, 47], ["dogs", "ORGANISM", 68, 72], ["meat", "ORGANISM_SUBDIVISION", 91, 95], ["horses", "ORGANISM_SUBDIVISION", 101, 107], ["I. linnaei", "ORGANISM", 130, 140], ["horse", "ORGANISM_SUBDIVISION", 282, 287], ["dogs", "SPECIES", 68, 72], ["I. linnaei", "SPECIES", 130, 140], ["horse", "SPECIES", 282, 287], ["I. linnaei", "SPECIES", 130, 140], ["fatal liver disease", "PROBLEM", 36, 55], ["a chronic neurologic disorder", "PROBLEM", 231, 260], ["Birdsville horse disease", "PROBLEM", 271, 295], ["serious", "OBSERVATION_MODIFIER", 16, 23], ["outbreak", "OBSERVATION_MODIFIER", 24, 32], ["fatal", "OBSERVATION_MODIFIER", 36, 41], ["liver", "ANATOMY", 42, 47], ["disease", "OBSERVATION", 48, 55], ["chronic", "OBSERVATION_MODIFIER", 233, 240], ["neurologic disorder", "OBSERVATION", 241, 260], ["horse disease", "OBSERVATION", 282, 295]]], ["The disease in horses is not associated with liver damage, although these animals do accumulate indospicine in most tissues, including muscle.IndospicineDogs fed indospicine-contaminated meat for several weeks may develop progressive liver damage.", [["liver", "ANATOMY", 45, 50], ["tissues", "ANATOMY", 116, 123], ["muscle", "ANATOMY", 135, 141], ["meat", "ANATOMY", 187, 191], ["liver", "ANATOMY", 234, 239], ["liver damage", "DISEASE", 45, 57], ["indospicine", "CHEMICAL", 96, 107], ["IndospicineDogs", "CHEMICAL", 142, 157], ["indospicine", "CHEMICAL", 162, 173], ["liver damage", "DISEASE", 234, 246], ["indospicine", "CHEMICAL", 96, 107], ["indospicine", "CHEMICAL", 162, 173], ["horses", "ORGANISM", 15, 21], ["liver", "ORGAN", 45, 50], ["indospicine", "SIMPLE_CHEMICAL", 96, 107], ["tissues", "TISSUE", 116, 123], ["muscle", "ORGAN", 135, 141], ["IndospicineDogs", "SIMPLE_CHEMICAL", 142, 157], ["indospicine", "SIMPLE_CHEMICAL", 162, 173], ["meat", "ORGANISM_SUBDIVISION", 187, 191], ["liver", "ORGAN", 234, 239], ["The disease in horses", "PROBLEM", 0, 21], ["liver damage", "PROBLEM", 45, 57], ["progressive liver damage", "PROBLEM", 222, 246], ["disease", "OBSERVATION", 4, 11], ["not associated with", "UNCERTAINTY", 25, 44], ["liver", "ANATOMY", 45, 50], ["damage", "OBSERVATION", 51, 57], ["most tissues", "OBSERVATION_MODIFIER", 111, 123], ["muscle", "ANATOMY", 135, 141], ["progressive", "OBSERVATION_MODIFIER", 222, 233], ["liver", "ANATOMY", 234, 239], ["damage", "OBSERVATION", 240, 246]]], ["Affected livers may be small, firm, and pale, or they may be nodular because of hypertrophy of surviving hepatocytes (eFig.", [["livers", "ANATOMY", 9, 15], ["hepatocytes", "ANATOMY", 105, 116], ["hypertrophy", "DISEASE", 80, 91], ["livers", "ORGAN", 9, 15], ["hepatocytes", "CELL", 105, 116], ["surviving hepatocytes", "CELL_TYPE", 95, 116], ["Affected livers", "PROBLEM", 0, 15], ["small, firm", "PROBLEM", 23, 34], ["pale", "PROBLEM", 40, 44], ["nodular", "PROBLEM", 61, 68], ["hypertrophy of surviving hepatocytes", "PROBLEM", 80, 116], ["livers", "ANATOMY", 9, 15], ["may be", "UNCERTAINTY", 16, 22], ["small", "OBSERVATION_MODIFIER", 23, 28], ["firm", "OBSERVATION", 30, 34], ["pale", "OBSERVATION_MODIFIER", 40, 44], ["may be", "UNCERTAINTY", 54, 60], ["nodular", "OBSERVATION", 61, 68], ["hypertrophy", "OBSERVATION", 80, 91], ["surviving hepatocytes", "OBSERVATION", 95, 116]]], ["2-30A).", [["2-30A", "CHEMICAL", 0, 5], ["2-30A", "SIMPLE_CHEMICAL", 0, 5]]], ["Histologically, lesions begin as vacuolation of a narrow band of centrilobular hepatocytes, followed shortly by accumulation of mononuclear inflammatory cells in this zone and in the stoma of the hepatic venules (eFig.", [["lesions", "ANATOMY", 16, 23], ["centrilobular hepatocytes", "ANATOMY", 65, 90], ["mononuclear inflammatory cells", "ANATOMY", 128, 158], ["zone", "ANATOMY", 167, 171], ["stoma", "ANATOMY", 183, 188], ["hepatic venules", "ANATOMY", 196, 211], ["lesions", "PATHOLOGICAL_FORMATION", 16, 23], ["centrilobular hepatocytes", "CELL", 65, 90], ["mononuclear inflammatory cells", "CELL", 128, 158], ["hepatic venules", "MULTI-TISSUE_STRUCTURE", 196, 211], ["centrilobular hepatocytes", "CELL_TYPE", 65, 90], ["mononuclear inflammatory cells", "CELL_TYPE", 128, 158], ["hepatic venules", "CELL_TYPE", 196, 211], ["lesions", "PROBLEM", 16, 23], ["a narrow band of centrilobular hepatocytes", "PROBLEM", 48, 90], ["mononuclear inflammatory cells in this zone", "PROBLEM", 128, 171], ["lesions", "OBSERVATION", 16, 23], ["vacuolation", "OBSERVATION_MODIFIER", 33, 44], ["narrow band", "OBSERVATION_MODIFIER", 50, 61], ["centrilobular", "ANATOMY_MODIFIER", 65, 78], ["hepatocytes", "ANATOMY", 79, 90], ["mononuclear", "OBSERVATION_MODIFIER", 128, 139], ["inflammatory cells", "OBSERVATION", 140, 158], ["zone", "ANATOMY_MODIFIER", 167, 171], ["stoma", "OBSERVATION", 183, 188], ["hepatic", "ANATOMY", 196, 203], ["venules", "ANATOMY_MODIFIER", 204, 211]]], ["2-30B).", [["2-30B", "CHEMICAL", 0, 5], ["2-30B", "CHEMICAL", 0, 5], ["2-30B", "SIMPLE_CHEMICAL", 0, 5]]], ["Progression of the lesion is marked by scattered necrosis of a widening zone of centrilobular hepatocytes, disorganization, vacuolation because of fatty change, and accumulation of ceroid pigment in macrophages.", [["lesion", "ANATOMY", 19, 25], ["centrilobular hepatocytes", "ANATOMY", 80, 105], ["ceroid pigment", "ANATOMY", 181, 195], ["macrophages", "ANATOMY", 199, 210], ["necrosis", "DISEASE", 49, 57], ["fatty change", "DISEASE", 147, 159], ["ceroid", "DISEASE", 181, 187], ["centrilobular hepatocytes", "CELL", 80, 105], ["ceroid pigment", "CELLULAR_COMPONENT", 181, 195], ["macrophages", "CELL", 199, 210], ["centrilobular hepatocytes", "CELL_TYPE", 80, 105], ["macrophages", "CELL_TYPE", 199, 210], ["the lesion", "PROBLEM", 15, 25], ["scattered necrosis", "PROBLEM", 39, 57], ["a widening zone of centrilobular hepatocytes", "PROBLEM", 61, 105], ["disorganization", "PROBLEM", 107, 122], ["vacuolation", "PROBLEM", 124, 135], ["fatty change", "PROBLEM", 147, 159], ["accumulation of ceroid pigment in macrophages", "PROBLEM", 165, 210], ["lesion", "OBSERVATION", 19, 25], ["marked", "OBSERVATION_MODIFIER", 29, 35], ["scattered", "OBSERVATION_MODIFIER", 39, 48], ["necrosis", "OBSERVATION", 49, 57], ["widening", "OBSERVATION_MODIFIER", 63, 71], ["zone", "OBSERVATION_MODIFIER", 72, 76], ["centrilobular", "ANATOMY_MODIFIER", 80, 93], ["hepatocytes", "ANATOMY", 94, 105], ["disorganization", "OBSERVATION_MODIFIER", 107, 122], ["vacuolation", "OBSERVATION_MODIFIER", 124, 135], ["fatty change", "OBSERVATION", 147, 159], ["accumulation", "OBSERVATION_MODIFIER", 165, 177], ["ceroid pigment", "OBSERVATION", 181, 195], ["macrophages", "OBSERVATION_MODIFIER", 199, 210]]], ["Moderate centrilobular fibrosis is seen in later stages, as well as pronounced canalicular cholestasis.", [["centrilobular", "ANATOMY", 9, 22], ["canalicular", "ANATOMY", 79, 90], ["fibrosis", "DISEASE", 23, 31], ["cholestasis", "DISEASE", 91, 102], ["centrilobular", "MULTI-TISSUE_STRUCTURE", 9, 22], ["canalicular", "MULTI-TISSUE_STRUCTURE", 79, 90], ["Moderate centrilobular fibrosis", "PROBLEM", 0, 31], ["pronounced canalicular cholestasis", "PROBLEM", 68, 102], ["centrilobular", "OBSERVATION_MODIFIER", 9, 22], ["fibrosis", "OBSERVATION", 23, 31], ["later stages", "OBSERVATION_MODIFIER", 43, 55], ["pronounced", "OBSERVATION_MODIFIER", 68, 78], ["canalicular", "ANATOMY_MODIFIER", 79, 90], ["cholestasis", "OBSERVATION", 91, 102]]], ["By this stage, affected animals begin to show icterus, inappetance, and depression.", [["icterus", "DISEASE", 46, 53], ["inappetance", "DISEASE", 55, 66], ["depression", "DISEASE", 72, 82], ["animals", "ORGANISM", 24, 31], ["icterus", "PROBLEM", 46, 53], ["depression", "PROBLEM", 72, 82], ["icterus", "OBSERVATION", 46, 53]]], ["Bile ductular proliferation is not a marked feature.", [["Bile ductular", "ANATOMY", 0, 13], ["Bile ductular", "MULTI-TISSUE_STRUCTURE", 0, 13], ["Bile ductular proliferation", "PROBLEM", 0, 27], ["ductular", "ANATOMY_MODIFIER", 5, 13], ["proliferation", "OBSERVATION", 14, 27], ["marked", "OBSERVATION_MODIFIER", 37, 43]]], ["Death is attended by the usual signs of hepatoencephalopathy and tendency to bleed spontaneously.", [["Death", "DISEASE", 0, 5], ["hepatoencephalopathy", "DISEASE", 40, 60], ["hepatoencephalopathy", "PROBLEM", 40, 60], ["tendency to bleed", "PROBLEM", 65, 82], ["hepatoencephalopathy", "OBSERVATION", 40, 60], ["bleed", "OBSERVATION", 77, 82]]], ["There is no evidence of direct neurologic damage as is seen in horses.", [["neurologic", "ANATOMY", 31, 41], ["neurologic damage", "DISEASE", 31, 48], ["direct neurologic damage", "PROBLEM", 24, 48], ["no evidence of", "UNCERTAINTY", 9, 23], ["neurologic", "OBSERVATION_MODIFIER", 31, 41], ["damage", "OBSERVATION", 42, 48]]], ["More recently, dogs ingesting canned commercial camel meat developed serious and sometimes fatal liver disease.", [["meat", "ANATOMY", 54, 58], ["liver", "ANATOMY", 97, 102], ["liver disease", "DISEASE", 97, 110], ["dogs", "ORGANISM", 15, 19], ["camel", "ORGANISM", 48, 53], ["meat", "ORGANISM_SUBDIVISION", 54, 58], ["liver", "ORGAN", 97, 102], ["dogs", "SPECIES", 15, 19], ["camel", "SPECIES", 48, 53], ["canned", "SPECIES", 30, 36], ["camel", "SPECIES", 48, 53], ["serious and sometimes fatal liver disease", "PROBLEM", 69, 110], ["serious", "OBSERVATION_MODIFIER", 69, 76], ["fatal", "OBSERVATION_MODIFIER", 91, 96], ["liver", "ANATOMY", 97, 102], ["disease", "OBSERVATION", 103, 110]]], ["This may be a concern for dogs with food allergies that are fed nonstandard protein sources in special diets.", [["food allergies", "DISEASE", 36, 50], ["dogs", "ORGANISM", 26, 30], ["dogs", "SPECIES", 26, 30], ["dogs", "PROBLEM", 26, 30], ["food allergies", "PROBLEM", 36, 50]]], ["This intoxication is remarkable by virtue of its unpredictability.", [["This intoxication", "PROBLEM", 0, 17]]], ["Experimental intoxication by pure indospicine has validly been shown to reproduce the naturally occurring intoxication caused by horsemeat feeding; however, liver failure can be produced by either means in only a small proportion of dogs so exposed.", [["liver", "ANATOMY", 157, 162], ["indospicine", "CHEMICAL", 34, 45], ["liver failure", "DISEASE", 157, 170], ["indospicine", "CHEMICAL", 34, 45], ["indospicine", "SIMPLE_CHEMICAL", 34, 45], ["liver", "ORGAN", 157, 162], ["dogs", "ORGANISM", 233, 237], ["Experimental intoxication", "PROBLEM", 0, 25], ["liver failure", "PROBLEM", 157, 170], ["liver", "ANATOMY", 157, 162], ["failure", "OBSERVATION", 163, 170], ["small", "OBSERVATION_MODIFIER", 213, 218]]], ["On the other hand, milder degrees of liver damage are reliably produced by both methods.", [["liver", "ANATOMY", 37, 42], ["liver damage", "DISEASE", 37, 49], ["liver", "ORGAN", 37, 42], ["liver damage", "PROBLEM", 37, 49], ["milder degrees", "OBSERVATION_MODIFIER", 19, 33], ["liver", "ANATOMY", 37, 42], ["damage", "OBSERVATION", 43, 49]]], ["Thus it seems an idiosyncratic response is superimposed upon a more consistent effect of the toxin; the nature of the accompanying inflammatory response suggests that the former may be immunologically mediated.", [["an idiosyncratic response", "PROBLEM", 14, 39], ["the toxin", "PROBLEM", 89, 98], ["idiosyncratic response", "OBSERVATION", 17, 39], ["inflammatory", "OBSERVATION", 131, 143]]], ["This has yet to be established, as has the proposal that the mechanism of the intoxication is the result of competitive inhibition of arginine.Senna (Cassia) occidentalisIngestion of large amounts of seeds from Senna occidentalis in the family Leguminosae can produce acute hepatic necrosis in cattle, pigs, goats, and horses.", [["hepatic", "ANATOMY", 274, 281], ["arginine", "CHEMICAL", 134, 142], ["acute hepatic necrosis", "DISEASE", 268, 290], ["arginine", "CHEMICAL", 134, 142], ["arginine", "SIMPLE_CHEMICAL", 134, 142], ["Senna", "ORGANISM_SUBDIVISION", 143, 148], ["Cassia", "ORGANISM_SUBDIVISION", 150, 156], ["Senna occidentalis", "ORGANISM", 211, 229], ["Leguminosae", "ORGANISM", 244, 255], ["hepatic", "ORGAN", 274, 281], ["pigs", "ORGANISM", 302, 306], ["goats", "ORGANISM", 308, 313], ["Senna occidentalis", "SPECIES", 211, 229], ["cattle", "SPECIES", 294, 300], ["pigs", "SPECIES", 302, 306], ["goats", "SPECIES", 308, 313], ["Senna occidentalis", "SPECIES", 211, 229], ["cattle", "SPECIES", 294, 300], ["pigs", "SPECIES", 302, 306], ["goats", "SPECIES", 308, 313], ["the intoxication", "PROBLEM", 74, 90], ["competitive inhibition of arginine", "PROBLEM", 108, 142], ["Senna (Cassia) occidentalisIngestion of large amounts of seeds", "TREATMENT", 143, 205], ["Senna occidentalis", "TREATMENT", 211, 229], ["acute hepatic necrosis", "PROBLEM", 268, 290], ["large", "OBSERVATION_MODIFIER", 183, 188], ["acute", "OBSERVATION_MODIFIER", 268, 273], ["hepatic", "ANATOMY", 274, 281], ["necrosis", "OBSERVATION", 282, 290]]], ["Hepatic injury is characterized by lesions ranging from vacuolation, to scattered apoptosis and centrilobular necrosis.", [["Hepatic", "ANATOMY", 0, 7], ["lesions", "ANATOMY", 35, 42], ["centrilobular", "ANATOMY", 96, 109], ["Hepatic injury", "DISEASE", 0, 14], ["necrosis", "DISEASE", 110, 118], ["Hepatic", "ORGAN", 0, 7], ["lesions", "PATHOLOGICAL_FORMATION", 35, 42], ["Hepatic injury", "PROBLEM", 0, 14], ["lesions", "PROBLEM", 35, 42], ["vacuolation", "PROBLEM", 56, 67], ["scattered apoptosis", "PROBLEM", 72, 91], ["centrilobular necrosis", "PROBLEM", 96, 118], ["injury", "OBSERVATION", 8, 14], ["lesions", "OBSERVATION", 35, 42], ["vacuolation", "OBSERVATION_MODIFIER", 56, 67], ["scattered", "OBSERVATION_MODIFIER", 72, 81], ["apoptosis", "OBSERVATION_MODIFIER", 82, 91], ["centrilobular", "OBSERVATION_MODIFIER", 96, 109], ["necrosis", "OBSERVATION", 110, 118]]], ["In all species, except for horses, there is significant cardiac and skeletal muscle injury and myoglobinuria that are the predominant lesions, rather than hepatic injury.", [["cardiac", "ANATOMY", 56, 63], ["skeletal muscle", "ANATOMY", 68, 83], ["lesions", "ANATOMY", 134, 141], ["hepatic", "ANATOMY", 155, 162], ["cardiac and skeletal muscle injury", "DISEASE", 56, 90], ["myoglobinuria", "DISEASE", 95, 108], ["hepatic injury", "DISEASE", 155, 169], ["cardiac", "ORGAN", 56, 63], ["skeletal muscle", "TISSUE", 68, 83], ["lesions", "PATHOLOGICAL_FORMATION", 134, 141], ["hepatic", "ORGAN", 155, 162], ["significant cardiac and skeletal muscle injury", "PROBLEM", 44, 90], ["myoglobinuria", "PROBLEM", 95, 108], ["the predominant lesions", "PROBLEM", 118, 141], ["hepatic injury", "PROBLEM", 155, 169], ["significant", "OBSERVATION_MODIFIER", 44, 55], ["cardiac", "ANATOMY", 56, 63], ["skeletal muscle", "ANATOMY", 68, 83], ["injury", "OBSERVATION", 84, 90], ["myoglobinuria", "OBSERVATION", 95, 108], ["predominant", "OBSERVATION_MODIFIER", 122, 133], ["lesions", "OBSERVATION", 134, 141], ["hepatic", "ANATOMY", 155, 162], ["injury", "OBSERVATION", 163, 169]]], ["The toxic agent is not known currently.Trifolium hybridum (alsike clover)Alsike clover is a legume that grows well on wet clay soils in North America, where it is sometimes responsible for outbreaks or single cases of cholangitis in horses that consume it as pasture or hay.", [["cholangitis", "DISEASE", 218, 229], ["Trifolium hybridum", "ORGANISM", 39, 57], ["alsike clover", "ORGANISM", 59, 72], ["Alsike clover", "ORGANISM", 73, 86], ["Trifolium hybridum", "SPECIES", 39, 57], ["Trifolium hybridum", "SPECIES", 39, 57], ["Alsike clover", "SPECIES", 73, 86], ["Trifolium hybridum (alsike clover", "PROBLEM", 39, 72], ["cholangitis in horses", "PROBLEM", 218, 239], ["toxic", "OBSERVATION_MODIFIER", 4, 9], ["cholangitis", "OBSERVATION", 218, 229]]], ["The toxic principle has not been isolated, but it likely is in highest concentrations in the flowering stage used for hay.", [["toxic", "OBSERVATION_MODIFIER", 4, 9]]], ["However, there are evidently contributing factors because, although alsike clover is widespread in cultivation, toxicity is rare.", [["toxicity", "DISEASE", 112, 120], ["alsike clover", "ORGANISM", 68, 81], ["toxicity", "PROBLEM", 112, 120], ["widespread", "OBSERVATION_MODIFIER", 85, 95]]], ["Toxicity usually occurs when alsike clover is aB AThere is significant variation in species susceptibility to copper toxicosis.", [["Toxicity", "DISEASE", 0, 8], ["copper", "CHEMICAL", 110, 116], ["toxicosis", "DISEASE", 117, 126], ["copper", "CHEMICAL", 110, 116], ["copper", "SIMPLE_CHEMICAL", 110, 116], ["Toxicity", "PROBLEM", 0, 8], ["significant variation", "PROBLEM", 59, 80], ["copper toxicosis", "PROBLEM", 110, 126], ["significant", "OBSERVATION_MODIFIER", 59, 70], ["variation", "OBSERVATION_MODIFIER", 71, 80]]], ["Sheep as a species are most prone to copper poisoning, because of reduced biliary excretion of copper.", [["biliary", "ANATOMY", 74, 81], ["copper", "CHEMICAL", 37, 43], ["poisoning", "DISEASE", 44, 53], ["copper", "CHEMICAL", 95, 101], ["copper", "CHEMICAL", 37, 43], ["copper", "CHEMICAL", 95, 101], ["Sheep", "ORGANISM", 0, 5], ["copper", "SIMPLE_CHEMICAL", 37, 43], ["biliary", "MULTI-TISSUE_STRUCTURE", 74, 81], ["copper", "SIMPLE_CHEMICAL", 95, 101], ["Sheep", "SPECIES", 0, 5], ["reduced biliary excretion of copper", "PROBLEM", 66, 101], ["reduced", "OBSERVATION_MODIFIER", 66, 73], ["biliary", "ANATOMY", 74, 81]]], ["Some sheep breeds are more susceptible than others, reflecting differences in the efficiency of intestinal absorption of copper, rather than differences in efficiency of biliary excretion.", [["intestinal", "ANATOMY", 96, 106], ["biliary", "ANATOMY", 170, 177], ["copper", "CHEMICAL", 121, 127], ["copper", "CHEMICAL", 121, 127], ["sheep", "ORGANISM", 5, 10], ["intestinal", "ORGAN", 96, 106], ["copper", "SIMPLE_CHEMICAL", 121, 127], ["biliary", "MULTI-TISSUE_STRUCTURE", 170, 177], ["sheep", "SPECIES", 5, 10], ["sheep", "SPECIES", 5, 10], ["Some sheep breeds", "PROBLEM", 0, 17], ["intestinal absorption of copper", "PROBLEM", 96, 127], ["biliary excretion", "PROBLEM", 170, 187], ["sheep breeds", "OBSERVATION", 5, 17], ["more susceptible", "OBSERVATION_MODIFIER", 22, 38], ["intestinal", "ANATOMY", 96, 106], ["absorption", "OBSERVATION", 107, 117], ["biliary", "ANATOMY", 170, 177], ["excretion", "OBSERVATION", 178, 187]]], ["Altered biliary excretion of copper in sheep does not appear to be associated with alteration in the structure or expression of the gene for ATP7B, the copper transporting P-type ATPase that is defective in Wilson disease, the human autosomal recessive disorder of hepatic copper metabolism.B AExcessive hepatic copper accumulation is important in chronic hepatitis in dogs, and is discussed in further detail in the section Chronic hepatitis in dogs.B AIn cases of chronic hepatitis caused by copper accumulation, the liver is usually small, often with an accentuated lobular pattern; severely affected livers are characterized by architectural distortion, which ranges from a coarsely nodular texture to an end-stage liver.", [["biliary", "ANATOMY", 8, 15], ["hepatic", "ANATOMY", 265, 272], ["hepatic", "ANATOMY", 304, 311], ["liver", "ANATOMY", 519, 524], ["lobular", "ANATOMY", 569, 576], ["livers", "ANATOMY", 604, 610], ["liver", "ANATOMY", 719, 724], ["copper", "CHEMICAL", 29, 35], ["copper", "CHEMICAL", 152, 158], ["Wilson disease", "DISEASE", 207, 221], ["autosomal recessive disorder", "DISEASE", 233, 261], ["copper", "CHEMICAL", 273, 279], ["copper", "CHEMICAL", 312, 318], ["chronic hepatitis", "DISEASE", 348, 365], ["Chronic hepatitis", "DISEASE", 425, 442], ["chronic hepatitis", "DISEASE", 466, 483], ["copper", "CHEMICAL", 494, 500], ["copper", "CHEMICAL", 29, 35], ["copper", "CHEMICAL", 152, 158], ["copper", "CHEMICAL", 273, 279], ["copper", "CHEMICAL", 312, 318], ["copper", "CHEMICAL", 494, 500], ["biliary", "MULTI-TISSUE_STRUCTURE", 8, 15], ["copper", "SIMPLE_CHEMICAL", 29, 35], ["sheep", "ORGANISM", 39, 44], ["ATP7B", "GENE_OR_GENE_PRODUCT", 141, 146], ["copper transporting P-type ATPase", "GENE_OR_GENE_PRODUCT", 152, 185], ["human", "ORGANISM", 227, 232], ["hepatic", "ORGAN", 265, 272], ["copper", "SIMPLE_CHEMICAL", 273, 279], ["B", "GENE_OR_GENE_PRODUCT", 291, 292], ["hepatic", "ORGAN", 304, 311], ["copper", "SIMPLE_CHEMICAL", 312, 318], ["dogs", "ORGANISM", 369, 373], ["dogs", "ORGANISM", 446, 450], ["copper", "SIMPLE_CHEMICAL", 494, 500], ["liver", "ORGAN", 519, 524], ["lobular", "CANCER", 569, 576], ["livers", "ORGAN", 604, 610], ["liver", "ORGAN", 719, 724], ["ATP7B", "PROTEIN", 141, 146], ["copper transporting P-type ATPase", "PROTEIN", 152, 185], ["sheep", "SPECIES", 39, 44], ["human", "SPECIES", 227, 232], ["dogs", "SPECIES", 369, 373], ["dogs", "SPECIES", 446, 450], ["sheep", "SPECIES", 39, 44], ["human", "SPECIES", 227, 232], ["Altered biliary excretion of copper in sheep", "PROBLEM", 0, 44], ["alteration in the structure", "PROBLEM", 83, 110], ["Wilson disease", "PROBLEM", 207, 221], ["the human autosomal recessive disorder", "PROBLEM", 223, 261], ["hepatic copper metabolism", "PROBLEM", 265, 290], ["B AExcessive hepatic copper accumulation", "PROBLEM", 291, 331], ["chronic hepatitis in dogs", "PROBLEM", 348, 373], ["Chronic hepatitis in dogs", "PROBLEM", 425, 450], ["chronic hepatitis", "PROBLEM", 466, 483], ["copper accumulation", "PROBLEM", 494, 513], ["an accentuated lobular pattern", "PROBLEM", 554, 584], ["severely affected livers", "PROBLEM", 586, 610], ["architectural distortion", "PROBLEM", 632, 656], ["a coarsely nodular texture", "PROBLEM", 676, 702], ["an end-stage liver", "PROBLEM", 706, 724], ["biliary", "ANATOMY", 8, 15], ["excretion", "OBSERVATION", 16, 25], ["copper", "OBSERVATION", 29, 35], ["alteration", "OBSERVATION", 83, 93], ["hepatic", "ANATOMY", 265, 272], ["copper metabolism", "OBSERVATION", 273, 290], ["hepatic", "ANATOMY", 304, 311], ["copper accumulation", "OBSERVATION", 312, 331], ["chronic", "OBSERVATION_MODIFIER", 348, 355], ["hepatitis", "OBSERVATION", 356, 365], ["Chronic", "OBSERVATION_MODIFIER", 425, 432], ["hepatitis", "OBSERVATION", 433, 442], ["chronic", "OBSERVATION_MODIFIER", 466, 473], ["hepatitis", "OBSERVATION", 474, 483], ["copper accumulation", "OBSERVATION", 494, 513], ["liver", "ANATOMY", 519, 524], ["usually", "OBSERVATION_MODIFIER", 528, 535], ["small", "OBSERVATION_MODIFIER", 536, 541], ["accentuated", "OBSERVATION_MODIFIER", 557, 568], ["lobular", "OBSERVATION", 569, 576], ["severely", "OBSERVATION_MODIFIER", 586, 594], ["affected", "OBSERVATION", 595, 603], ["livers", "ANATOMY", 604, 610], ["architectural distortion", "OBSERVATION", 632, 656], ["ranges", "OBSERVATION_MODIFIER", 664, 670], ["coarsely", "OBSERVATION_MODIFIER", 678, 686], ["nodular", "OBSERVATION_MODIFIER", 687, 694], ["texture", "OBSERVATION_MODIFIER", 695, 702], ["end", "OBSERVATION_MODIFIER", 709, 712], ["-stage", "OBSERVATION_MODIFIER", 712, 718], ["liver", "ANATOMY", 719, 724]]], ["Chronic hepatitis, depending on the duration of inflammation and injury, is characterized by portal and periportal mononuclear cell inflammation and fibrosis of portal areas that may extend into adjacent periportal areas of the lobule, leading to the prominent lobular pattern.", [["portal", "ANATOMY", 93, 99], ["periportal mononuclear cell", "ANATOMY", 104, 131], ["portal areas", "ANATOMY", 161, 173], ["periportal areas", "ANATOMY", 204, 220], ["lobule", "ANATOMY", 228, 234], ["lobular", "ANATOMY", 261, 268], ["hepatitis", "DISEASE", 8, 17], ["inflammation", "DISEASE", 48, 60], ["fibrosis", "DISEASE", 149, 157], ["portal", "MULTI-TISSUE_STRUCTURE", 93, 99], ["periportal mononuclear cell", "CELL", 104, 131], ["lobule", "MULTI-TISSUE_STRUCTURE", 228, 234], ["lobular", "CANCER", 261, 268], ["Chronic hepatitis", "PROBLEM", 0, 17], ["inflammation", "PROBLEM", 48, 60], ["injury", "PROBLEM", 65, 71], ["portal and periportal mononuclear cell inflammation", "PROBLEM", 93, 144], ["fibrosis of portal areas", "PROBLEM", 149, 173], ["the prominent lobular pattern", "PROBLEM", 247, 276], ["hepatitis", "OBSERVATION", 8, 17], ["inflammation", "OBSERVATION", 48, 60], ["injury", "OBSERVATION", 65, 71], ["portal", "ANATOMY", 93, 99], ["periportal", "ANATOMY_MODIFIER", 104, 114], ["mononuclear cell inflammation", "OBSERVATION", 115, 144], ["fibrosis", "OBSERVATION", 149, 157], ["portal", "ANATOMY", 161, 167], ["periportal", "ANATOMY_MODIFIER", 204, 214], ["lobule", "ANATOMY", 228, 234], ["prominent", "OBSERVATION_MODIFIER", 251, 260], ["lobular pattern", "OBSERVATION", 261, 276]]], ["Small aggregates of pigmented macrophages, containing copper and lipofuscin, surrounded by mononuclear inflammatory cells are a reliable feature of copper excess.", [["pigmented macrophages", "ANATOMY", 20, 41], ["mononuclear inflammatory cells", "ANATOMY", 91, 121], ["copper", "CHEMICAL", 54, 60], ["copper", "CHEMICAL", 148, 154], ["copper", "CHEMICAL", 54, 60], ["copper", "CHEMICAL", 148, 154], ["pigmented macrophages", "CELL", 20, 41], ["copper", "SIMPLE_CHEMICAL", 54, 60], ["lipofuscin", "SIMPLE_CHEMICAL", 65, 75], ["mononuclear inflammatory cells", "CELL", 91, 121], ["copper", "SIMPLE_CHEMICAL", 148, 154], ["pigmented macrophages", "CELL_TYPE", 20, 41], ["mononuclear inflammatory cells", "CELL_TYPE", 91, 121], ["Small aggregates of pigmented macrophages", "PROBLEM", 0, 41], ["copper and lipofuscin", "PROBLEM", 54, 75], ["mononuclear inflammatory cells", "PROBLEM", 91, 121], ["copper excess", "PROBLEM", 148, 161], ["aggregates", "OBSERVATION_MODIFIER", 6, 16], ["pigmented macrophages", "OBSERVATION", 20, 41], ["mononuclear", "OBSERVATION", 91, 102], ["inflammatory cells", "OBSERVATION", 103, 121], ["copper excess", "OBSERVATION", 148, 161]]], ["With progression, hyperplastic nodules and bridging fibrosis develop.B AIn dogs and sheep, toxic amounts of copper can accumulate in the liver, although dietary copper levels are not excessive by standards for other species.", [["hyperplastic nodules", "ANATOMY", 18, 38], ["liver", "ANATOMY", 137, 142], ["fibrosis", "DISEASE", 52, 60], ["copper", "CHEMICAL", 108, 114], ["copper", "CHEMICAL", 161, 167], ["copper", "CHEMICAL", 108, 114], ["copper", "CHEMICAL", 161, 167], ["hyperplastic nodules", "CANCER", 18, 38], ["AIn dogs", "ORGANISM", 71, 79], ["sheep", "ORGANISM", 84, 89], ["copper", "SIMPLE_CHEMICAL", 108, 114], ["liver", "ORGAN", 137, 142], ["copper", "SIMPLE_CHEMICAL", 161, 167], ["dogs", "SPECIES", 75, 79], ["sheep", "SPECIES", 84, 89], ["sheep", "SPECIES", 84, 89], ["hyperplastic nodules", "PROBLEM", 18, 38], ["bridging fibrosis", "PROBLEM", 43, 60], ["dietary copper levels", "TEST", 153, 174], ["other species", "PROBLEM", 210, 223], ["progression", "OBSERVATION_MODIFIER", 5, 16], ["hyperplastic", "OBSERVATION_MODIFIER", 18, 30], ["nodules", "OBSERVATION", 31, 38], ["bridging", "OBSERVATION_MODIFIER", 43, 51], ["fibrosis", "OBSERVATION", 52, 60], ["dogs", "OBSERVATION", 75, 79], ["toxic", "OBSERVATION_MODIFIER", 91, 96], ["liver", "ANATOMY", 137, 142]]], ["Copper poisoning does occur in cattle and pigs, but in these species, it is because of abnormally high intake of the element.", [["Copper", "CHEMICAL", 0, 6], ["poisoning", "DISEASE", 7, 16], ["Copper", "CHEMICAL", 0, 6], ["Copper", "SIMPLE_CHEMICAL", 0, 6], ["cattle", "ORGANISM", 31, 37], ["pigs", "ORGANISM", 42, 46], ["cattle", "SPECIES", 31, 37], ["pigs", "SPECIES", 42, 46], ["cattle", "SPECIES", 31, 37], ["pigs", "SPECIES", 42, 46], ["Copper poisoning", "PROBLEM", 0, 16], ["abnormally high intake of the element", "PROBLEM", 87, 124], ["high intake", "OBSERVATION", 98, 109]]], ["Acute copper poisoning can occur following either the ingestion or injection of excess copper, and animals deficient in vitamin E or molybdenum appear especially susceptible to acute copper poisoning.B AChronic copper toxicosis in sheep occurs as a result of the presence of 3 environmental factors acting alone or in concert.", [["copper", "CHEMICAL", 6, 12], ["poisoning", "DISEASE", 13, 22], ["copper", "CHEMICAL", 87, 93], ["vitamin E", "CHEMICAL", 120, 129], ["molybdenum", "CHEMICAL", 133, 143], ["copper", "CHEMICAL", 183, 189], ["poisoning", "DISEASE", 190, 199], ["copper", "CHEMICAL", 211, 217], ["toxicosis", "DISEASE", 218, 227], ["copper", "CHEMICAL", 6, 12], ["copper", "CHEMICAL", 87, 93], ["vitamin E", "CHEMICAL", 120, 129], ["molybdenum", "CHEMICAL", 133, 143], ["copper", "CHEMICAL", 183, 189], ["copper", "CHEMICAL", 211, 217], ["copper", "SIMPLE_CHEMICAL", 6, 12], ["copper", "SIMPLE_CHEMICAL", 87, 93], ["vitamin E", "SIMPLE_CHEMICAL", 120, 129], ["molybdenum", "SIMPLE_CHEMICAL", 133, 143], ["copper", "SIMPLE_CHEMICAL", 183, 189], ["copper", "SIMPLE_CHEMICAL", 211, 217], ["sheep", "ORGANISM", 231, 236], ["sheep", "SPECIES", 231, 236], ["sheep", "SPECIES", 231, 236], ["Acute copper poisoning", "PROBLEM", 0, 22], ["excess copper", "PROBLEM", 80, 93], ["vitamin E", "TREATMENT", 120, 129], ["acute copper poisoning", "PROBLEM", 177, 199], ["B AChronic copper toxicosis in sheep", "PROBLEM", 200, 236], ["copper", "OBSERVATION_MODIFIER", 211, 217], ["toxicosis", "OBSERVATION", 218, 227]]], ["First, excessive copper intake may occur as a result of contamination of water (naturally occurring or through the use of copper piping or fixtures), pasture or prepared feed; the latter is difficult to avoid when feed mills are preparing rations for different species and is probably partly responsible for the observation that housed sheep are more prone to copper poisoning than animals at pasture.", [["copper", "CHEMICAL", 17, 23], ["copper", "CHEMICAL", 122, 128], ["copper", "CHEMICAL", 360, 366], ["poisoning", "DISEASE", 367, 376], ["copper", "CHEMICAL", 17, 23], ["copper", "CHEMICAL", 122, 128], ["copper", "CHEMICAL", 360, 366], ["copper", "SIMPLE_CHEMICAL", 17, 23], ["copper", "SIMPLE_CHEMICAL", 122, 128], ["sheep", "ORGANISM", 336, 341], ["copper", "SIMPLE_CHEMICAL", 360, 366], ["sheep", "SPECIES", 336, 341], ["sheep", "SPECIES", 336, 341], ["excessive copper intake", "PROBLEM", 7, 30], ["copper piping or fixtures", "TREATMENT", 122, 147], ["probably partly responsible", "UNCERTAINTY", 276, 303]]], ["Second, increased copper accumulation occurs as a result of increased availability of dietary copper; this happens when dietary levels of molybdenum are unusually low.", [["copper", "CHEMICAL", 18, 24], ["copper", "CHEMICAL", 94, 100], ["molybdenum", "CHEMICAL", 138, 148], ["copper", "CHEMICAL", 18, 24], ["copper", "CHEMICAL", 94, 100], ["molybdenum", "CHEMICAL", 138, 148], ["copper", "SIMPLE_CHEMICAL", 18, 24], ["copper", "SIMPLE_CHEMICAL", 94, 100], ["molybdenum", "SIMPLE_CHEMICAL", 138, 148], ["increased copper accumulation", "PROBLEM", 8, 37], ["dietary copper", "TREATMENT", 86, 100], ["increased", "OBSERVATION_MODIFIER", 8, 17], ["copper accumulation", "OBSERVATION", 18, 37], ["unusually", "OBSERVATION_MODIFIER", 153, 162], ["low", "OBSERVATION_MODIFIER", 163, 166]]], ["Molybdenum, in the presence of sufficient sulfate, forms insoluble complexes with copper in the gut and liver, making the copper biologically inert.", [["gut", "ANATOMY", 96, 99], ["liver", "ANATOMY", 104, 109], ["Molybdenum", "CHEMICAL", 0, 10], ["copper", "CHEMICAL", 82, 88], ["copper", "CHEMICAL", 122, 128], ["Molybdenum", "CHEMICAL", 0, 10], ["sulfate", "CHEMICAL", 42, 49], ["copper", "CHEMICAL", 82, 88], ["copper", "CHEMICAL", 122, 128], ["Molybdenum", "SIMPLE_CHEMICAL", 0, 10], ["sulfate", "SIMPLE_CHEMICAL", 42, 49], ["copper", "SIMPLE_CHEMICAL", 82, 88], ["gut", "ORGANISM_SUBDIVISION", 96, 99], ["liver", "ORGAN", 104, 109], ["copper", "SIMPLE_CHEMICAL", 122, 128], ["sufficient sulfate", "TREATMENT", 31, 49], ["insoluble complexes", "PROBLEM", 57, 76], ["gut", "ANATOMY", 96, 99], ["liver", "ANATOMY", 104, 109]]], ["Subterranean clover growing on calcareous soils in southern Australia may be relatively deficient in molybdenum, and in these areas, British breeds of sheep are known to be more susceptible than Merinos to chronic copper poisoning.", [["molybdenum", "CHEMICAL", 101, 111], ["Merinos", "CHEMICAL", 195, 202], ["copper", "CHEMICAL", 214, 220], ["poisoning", "DISEASE", 221, 230], ["molybdenum", "CHEMICAL", 101, 111], ["copper", "CHEMICAL", 214, 220], ["molybdenum", "SIMPLE_CHEMICAL", 101, 111], ["sheep", "ORGANISM", 151, 156], ["copper", "SIMPLE_CHEMICAL", 214, 220], ["sheep", "SPECIES", 151, 156], ["sheep", "SPECIES", 151, 156], ["Subterranean clover", "PROBLEM", 0, 19], ["calcareous soils", "PROBLEM", 31, 47], ["chronic copper poisoning", "PROBLEM", 206, 230], ["clover", "OBSERVATION_MODIFIER", 13, 19], ["growing", "OBSERVATION_MODIFIER", 20, 27], ["calcareous soils", "OBSERVATION", 31, 47]]], ["Other hepatotoxins constitute the third environmental factor that predisposes sheep to outbreaks of chronic copper poisoning.", [["copper poisoning", "DISEASE", 108, 124], ["copper", "CHEMICAL", 108, 114], ["hepatotoxins", "GENE_OR_GENE_PRODUCT", 6, 18], ["sheep", "ORGANISM", 78, 83], ["copper", "SIMPLE_CHEMICAL", 108, 114], ["sheep", "SPECIES", 78, 83], ["sheep", "SPECIES", 78, 83], ["Other hepatotoxins", "PROBLEM", 0, 18], ["chronic copper poisoning", "PROBLEM", 100, 124], ["chronic", "OBSERVATION_MODIFIER", 100, 107], ["copper poisoning", "OBSERVATION", 108, 124]]], ["The most important of these are pyrrolizidine alkaloids (from Heliotropium or Echium) in eastern Australia, and phomopsin from lupins in western Australia and, possibly, South Africa.B AThe basis for chronic copper poisoning in sheep is the peculiar avidity of the liver for copper, coupled with the very limited rate at which this species can excrete the element in the bile.", [["liver", "ANATOMY", 265, 270], ["bile", "ANATOMY", 371, 375], ["pyrrolizidine alkaloids", "CHEMICAL", 32, 55], ["copper", "CHEMICAL", 208, 214], ["poisoning", "DISEASE", 215, 224], ["copper", "CHEMICAL", 275, 281], ["pyrrolizidine alkaloids", "CHEMICAL", 32, 55], ["copper", "CHEMICAL", 208, 214], ["copper", "CHEMICAL", 275, 281], ["pyrrolizidine alkaloids", "SIMPLE_CHEMICAL", 32, 55], ["phomopsin", "GENE_OR_GENE_PRODUCT", 112, 121], ["copper", "SIMPLE_CHEMICAL", 208, 214], ["sheep", "ORGANISM", 228, 233], ["liver", "ORGAN", 265, 270], ["copper", "SIMPLE_CHEMICAL", 275, 281], ["bile", "MULTI-TISSUE_STRUCTURE", 371, 375], ["sheep", "SPECIES", 228, 233], ["sheep", "SPECIES", 228, 233], ["pyrrolizidine alkaloids", "TREATMENT", 32, 55], ["Heliotropium", "TREATMENT", 62, 74], ["Echium", "TREATMENT", 78, 84], ["chronic copper poisoning", "PROBLEM", 200, 224], ["pyrrolizidine alkaloids", "OBSERVATION", 32, 55], ["chronic", "OBSERVATION_MODIFIER", 200, 207], ["poisoning", "OBSERVATION", 215, 224], ["liver", "ANATOMY", 265, 270], ["bile", "ANATOMY", 371, 375]]], ["After intraportal injection of a copper isotope, practically all the damages the ducts.", [["ducts", "ANATOMY", 81, 86], ["copper", "CHEMICAL", 33, 39], ["copper", "CHEMICAL", 33, 39], ["copper", "SIMPLE_CHEMICAL", 33, 39], ["ducts", "MULTI-TISSUE_STRUCTURE", 81, 86], ["a copper isotope", "TREATMENT", 31, 47], ["ducts", "ANATOMY", 81, 86]]], ["However, the biliary proliferation and fibrosis is similar to that observed in areas of the liver that are drained by chronically obstructed bile ducts, so it seems likely some of the later changes are secondary to cholestasis.", [["biliary", "ANATOMY", 13, 20], ["liver", "ANATOMY", 92, 97], ["bile ducts", "ANATOMY", 141, 151], ["fibrosis", "DISEASE", 39, 47], ["chronically obstructed bile ducts", "DISEASE", 118, 151], ["cholestasis", "DISEASE", 215, 226], ["biliary", "MULTI-TISSUE_STRUCTURE", 13, 20], ["liver", "ORGAN", 92, 97], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 141, 151], ["the biliary proliferation", "PROBLEM", 9, 34], ["fibrosis", "PROBLEM", 39, 47], ["chronically obstructed bile ducts", "PROBLEM", 118, 151], ["cholestasis", "PROBLEM", 215, 226], ["biliary", "ANATOMY", 13, 20], ["proliferation", "OBSERVATION", 21, 34], ["fibrosis", "OBSERVATION", 39, 47], ["liver", "ANATOMY", 92, 97], ["drained", "OBSERVATION", 107, 114], ["chronically", "OBSERVATION_MODIFIER", 118, 129], ["obstructed", "OBSERVATION", 130, 140], ["bile ducts", "ANATOMY", 141, 151], ["seems likely", "UNCERTAINTY", 159, 171], ["cholestasis", "OBSERVATION", 215, 226]]], ["Agents that interfere with bile excretion have the potential to interfere with elimination of various potentially injurious substances.", [["bile", "ANATOMY", 27, 31], ["bile", "MULTI-TISSUE_STRUCTURE", 27, 31], ["Agents", "TREATMENT", 0, 6], ["bile excretion", "TREATMENT", 27, 41], ["various potentially injurious substances", "PROBLEM", 94, 134], ["injurious substances", "OBSERVATION", 114, 134]]], ["Thus it is possible that alsike clover ingestion might increase toxicity of other factors in the forage.Tephrosia cinereaTephrosia cinerea is a member of the Leguminosae family and is found in Brazil.", [["toxicity", "DISEASE", 64, 72], ["Tephrosia cinereaTephrosia cinerea", "ORGANISM", 104, 138], ["Leguminosae", "ORGANISM", 158, 169], ["Tephrosia cinereaTephrosia cinerea", "SPECIES", 104, 138], ["Tephrosia cinereaTephrosia cinerea", "SPECIES", 104, 138], ["alsike clover ingestion", "PROBLEM", 25, 48], ["Tephrosia cinereaTephrosia cinerea", "PROBLEM", 104, 138], ["is possible", "UNCERTAINTY", 8, 19]]], ["Prolonged ingestion causes chronic liver disease characterized clinically by wasting, and dramatic ascites in affected sheep.", [["liver", "ANATOMY", 35, 40], ["ascites", "ANATOMY", 99, 106], ["chronic liver disease", "DISEASE", 27, 48], ["wasting", "DISEASE", 77, 84], ["ascites", "DISEASE", 99, 106], ["liver", "ORGAN", 35, 40], ["sheep", "ORGANISM", 119, 124], ["sheep", "SPECIES", 119, 124], ["sheep", "SPECIES", 119, 124], ["Prolonged ingestion", "PROBLEM", 0, 19], ["chronic liver disease", "PROBLEM", 27, 48], ["wasting", "PROBLEM", 77, 84], ["dramatic ascites in affected sheep", "PROBLEM", 90, 124], ["chronic", "OBSERVATION_MODIFIER", 27, 34], ["liver", "ANATOMY", 35, 40], ["disease", "OBSERVATION", 41, 48], ["wasting", "OBSERVATION", 77, 84], ["dramatic", "OBSERVATION_MODIFIER", 90, 98], ["ascites", "OBSERVATION", 99, 106]]], ["Hydrothorax and hydropericardium can also be present.", [["hydropericardium", "ANATOMY", 16, 32], ["Hydrothorax", "DISEASE", 0, 11], ["hydropericardium", "DISEASE", 16, 32], ["hydropericardium", "CANCER", 16, 32], ["Hydrothorax", "PROBLEM", 0, 11], ["hydropericardium", "TREATMENT", 16, 32], ["hydropericardium", "OBSERVATION", 16, 32], ["can also be", "UNCERTAINTY", 33, 44]]], ["Livers are pale with multiple small, ~1-mm diameter nodules.", [["Livers", "ANATOMY", 0, 6], ["nodules", "ANATOMY", 52, 59], ["Livers", "ORGAN", 0, 6], ["nodules", "PATHOLOGICAL_FORMATION", 52, 59], ["multiple small, ~1-mm diameter nodules", "PROBLEM", 21, 59], ["pale", "OBSERVATION", 11, 15], ["multiple", "OBSERVATION_MODIFIER", 21, 29], ["small", "OBSERVATION_MODIFIER", 30, 35], ["~1-mm", "OBSERVATION_MODIFIER", 37, 42], ["diameter", "OBSERVATION_MODIFIER", 43, 51], ["nodules", "OBSERVATION", 52, 59]]], ["The livers are firm, and there is gallbladder edema.", [["livers", "ANATOMY", 4, 10], ["gallbladder edema", "ANATOMY", 34, 51], ["gallbladder edema", "DISEASE", 34, 51], ["livers", "ORGAN", 4, 10], ["gallbladder edema", "PATHOLOGICAL_FORMATION", 34, 51], ["gallbladder edema", "PROBLEM", 34, 51], ["livers", "ANATOMY", 4, 10], ["firm", "OBSERVATION", 15, 19], ["gallbladder", "ANATOMY", 34, 45], ["edema", "OBSERVATION", 46, 51]]], ["Histologically, there is portal fibrosis and biliary hyperplasia that is typically more severe in the subcapsular region.", [["portal", "ANATOMY", 25, 31], ["biliary", "ANATOMY", 45, 52], ["subcapsular region", "ANATOMY", 102, 120], ["fibrosis", "DISEASE", 32, 40], ["biliary hyperplasia", "DISEASE", 45, 64], ["portal", "MULTI-TISSUE_STRUCTURE", 25, 31], ["biliary hyperplasia", "PATHOLOGICAL_FORMATION", 45, 64], ["subcapsular region", "MULTI-TISSUE_STRUCTURE", 102, 120], ["portal fibrosis", "PROBLEM", 25, 40], ["biliary hyperplasia", "PROBLEM", 45, 64], ["portal", "ANATOMY", 25, 31], ["fibrosis", "OBSERVATION", 32, 40], ["biliary", "ANATOMY", 45, 52], ["hyperplasia", "OBSERVATION", 53, 64], ["more severe", "OBSERVATION_MODIFIER", 83, 94], ["subcapsular", "ANATOMY_MODIFIER", 102, 113], ["region", "ANATOMY_MODIFIER", 114, 120]]], ["Most hepatocytes are enlarged because of vacuolation.", [["hepatocytes", "ANATOMY", 5, 16], ["hepatocytes", "CELL", 5, 16], ["hepatocytes", "CELL_TYPE", 5, 16], ["vacuolation", "PROBLEM", 41, 52], ["hepatocytes", "ANATOMY", 5, 16], ["enlarged", "OBSERVATION", 21, 29], ["vacuolation", "OBSERVATION", 41, 52]]], ["Scattered individual necrotic cells are present, and focally, there is evidence of bile stasis.", [["necrotic cells", "ANATOMY", 21, 35], ["bile", "ANATOMY", 83, 87], ["necrotic", "DISEASE", 21, 29], ["bile stasis", "DISEASE", 83, 94], ["necrotic cells", "CELL", 21, 35], ["bile", "PATHOLOGICAL_FORMATION", 83, 87], ["necrotic cells", "CELL_TYPE", 21, 35], ["Scattered individual necrotic cells", "PROBLEM", 0, 35], ["bile stasis", "PROBLEM", 83, 94], ["individual", "OBSERVATION_MODIFIER", 10, 20], ["necrotic cells", "OBSERVATION", 21, 35], ["focally", "OBSERVATION_MODIFIER", 53, 60], ["evidence of", "UNCERTAINTY", 71, 82], ["bile", "ANATOMY", 83, 87], ["stasis", "OBSERVATION", 88, 94]]], ["Inflammation is modest.Brassica rapaTurnip (Brassica rapa) or other Brassica family forage ingestion by cattle on the North Island of New Zealand is incriminated as a cause of hepatogenous photosensitization and biliary injury.", [["hepatogenous", "ANATOMY", 176, 188], ["biliary", "ANATOMY", 212, 219], ["Inflammation", "DISEASE", 0, 12], ["Brassica rapaTurnip", "CHEMICAL", 23, 42], ["photosensitization", "DISEASE", 189, 207], ["biliary injury", "DISEASE", 212, 226], ["Brassica rapaTurnip", "ORGANISM", 23, 42], ["Brassica rapa", "ORGANISM", 44, 57], ["Brassica", "ORGANISM", 68, 76], ["biliary", "ORGAN", 212, 219], ["Brassica rapaTurnip", "SPECIES", 23, 42], ["Brassica rapa", "SPECIES", 44, 57], ["Brassica", "SPECIES", 68, 76], ["cattle", "SPECIES", 104, 110], ["Brassica rapaTurnip", "SPECIES", 23, 42], ["Brassica rapa", "SPECIES", 44, 57], ["cattle", "SPECIES", 104, 110], ["Inflammation", "PROBLEM", 0, 12], ["hepatogenous photosensitization", "PROBLEM", 176, 207], ["biliary injury", "PROBLEM", 212, 226], ["modest", "OBSERVATION_MODIFIER", 16, 22], ["biliary", "ANATOMY", 212, 219], ["injury", "OBSERVATION", 220, 226]]], ["The injury can mimic sporidesmin toxicity clinically with elevated \u03b3-glutamyl transferase (GGT) and phytoporphyrin plasma levels.", [["plasma", "ANATOMY", 115, 121], ["sporidesmin", "CHEMICAL", 21, 32], ["toxicity", "DISEASE", 33, 41], ["phytoporphyrin", "CHEMICAL", 100, 114], ["sporidesmin", "CHEMICAL", 21, 32], ["\u03b3-glutamyl", "CHEMICAL", 67, 77], ["phytoporphyrin", "CHEMICAL", 100, 114], ["sporidesmin", "SIMPLE_CHEMICAL", 21, 32], ["\u03b3-glutamyl transferase", "GENE_OR_GENE_PRODUCT", 67, 89], ["GGT", "SIMPLE_CHEMICAL", 91, 94], ["phytoporphyrin", "SIMPLE_CHEMICAL", 100, 114], ["plasma", "ORGANISM_SUBSTANCE", 115, 121], ["\u03b3-glutamyl transferase", "PROTEIN", 67, 89], ["GGT", "PROTEIN", 91, 94], ["The injury", "PROBLEM", 0, 10], ["sporidesmin toxicity", "PROBLEM", 21, 41], ["elevated \u03b3-glutamyl transferase", "PROBLEM", 58, 89], ["GGT", "TEST", 91, 94], ["phytoporphyrin plasma levels", "TEST", 100, 128], ["injury", "OBSERVATION", 4, 10]]], ["Histologically, bile ducts of smaller caliber than those injured by sporidesmin may be affected following turnip forage ingestion.CopperThe heavy-metal copper is an essential trace element that plays an important role in numerous essential biological processes, including mitochondrial respiration (cytochrome C oxidase), connective-tissue maturation cross-linking (lysyl oxidase), antioxidant defense (superoxide dismutase), melanin synthesis (tyrosinase), iron metabolism (ceruloplasmin), and neurotransmitter biosynthesis (dopamine \u03b2 hydroxylase).", [["bile ducts", "ANATOMY", 16, 26], ["mitochondrial", "ANATOMY", 272, 285], ["tissue", "ANATOMY", 333, 339], ["sporidesmin", "CHEMICAL", 68, 79], ["Copper", "CHEMICAL", 130, 136], ["copper", "CHEMICAL", 152, 158], ["superoxide", "CHEMICAL", 403, 413], ["iron", "CHEMICAL", 458, 462], ["dopamine", "CHEMICAL", 526, 534], ["sporidesmin", "CHEMICAL", 68, 79], ["Copper", "CHEMICAL", 130, 136], ["copper", "CHEMICAL", 152, 158], ["lysyl", "CHEMICAL", 366, 371], ["superoxide", "CHEMICAL", 403, 413], ["iron", "CHEMICAL", 458, 462], ["dopamine", "CHEMICAL", 526, 534], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 16, 26], ["caliber", "IMMATERIAL_ANATOMICAL_ENTITY", 38, 45], ["sporidesmin", "GENE_OR_GENE_PRODUCT", 68, 79], ["turnip", "ORGANISM", 106, 112], ["Copper", "SIMPLE_CHEMICAL", 130, 136], ["heavy-metal copper", "SIMPLE_CHEMICAL", 140, 158], ["mitochondrial", "CELLULAR_COMPONENT", 272, 285], ["cytochrome C oxidase", "GENE_OR_GENE_PRODUCT", 299, 319], ["connective-tissue", "TISSUE", 322, 339], ["lysyl oxidase", "GENE_OR_GENE_PRODUCT", 366, 379], ["antioxidant", "SIMPLE_CHEMICAL", 382, 393], ["superoxide dismutase", "GENE_OR_GENE_PRODUCT", 403, 423], ["melanin", "SIMPLE_CHEMICAL", 426, 433], ["tyrosinase", "GENE_OR_GENE_PRODUCT", 445, 455], ["iron", "SIMPLE_CHEMICAL", 458, 462], ["ceruloplasmin", "GENE_OR_GENE_PRODUCT", 475, 488], ["dopamine \u03b2 hydroxylase", "GENE_OR_GENE_PRODUCT", 526, 548], ["cytochrome C oxidase", "PROTEIN", 299, 319], ["lysyl oxidase", "PROTEIN", 366, 379], ["superoxide dismutase", "PROTEIN", 403, 423], ["tyrosinase", "PROTEIN", 445, 455], ["ceruloplasmin", "PROTEIN", 475, 488], ["dopamine \u03b2 hydroxylase", "PROTEIN", 526, 548], ["turnip", "SPECIES", 106, 112], ["mitochondrial respiration (cytochrome C oxidase)", "TREATMENT", 272, 320], ["connective-tissue maturation cross-linking (lysyl oxidase)", "TREATMENT", 322, 380], ["antioxidant defense (superoxide dismutase)", "TREATMENT", 382, 424], ["melanin synthesis (tyrosinase)", "TREATMENT", 426, 456], ["iron metabolism (ceruloplasmin)", "TREATMENT", 458, 489], ["neurotransmitter biosynthesis (dopamine \u03b2 hydroxylase)", "TREATMENT", 495, 549], ["bile ducts", "ANATOMY", 16, 26], ["smaller", "OBSERVATION_MODIFIER", 30, 37], ["caliber", "OBSERVATION_MODIFIER", 38, 45], ["may be", "UNCERTAINTY", 80, 86], ["heavy", "OBSERVATION_MODIFIER", 140, 145], ["metal copper", "OBSERVATION_MODIFIER", 146, 158], ["essential", "OBSERVATION_MODIFIER", 165, 174], ["trace element", "OBSERVATION", 175, 188]]], ["However, copper is toxic at excess concentrations because of its 2 redox states that can mediate free-radical production, resulting in direct oxidation of cellular components.", [["cellular", "ANATOMY", 155, 163], ["copper", "CHEMICAL", 9, 15], ["copper", "CHEMICAL", 9, 15], ["copper", "SIMPLE_CHEMICAL", 9, 15], ["free-radical", "SIMPLE_CHEMICAL", 97, 109], ["cellular", "CELL", 155, 163], ["toxic at excess concentrations", "PROBLEM", 19, 49], ["direct oxidation of cellular components", "PROBLEM", 135, 174], ["toxic", "OBSERVATION_MODIFIER", 19, 24], ["free", "OBSERVATION_MODIFIER", 97, 101], ["radical production", "OBSERVATION", 102, 120], ["cellular components", "OBSERVATION", 155, 174]]], ["The liver is the major organ involved in the regulation of copper levels, and homeostasis is maintained by the balance of dietary intake and copper excretion via the bile.", [["liver", "ANATOMY", 4, 9], ["organ", "ANATOMY", 23, 28], ["bile", "ANATOMY", 166, 170], ["copper", "CHEMICAL", 59, 65], ["copper", "CHEMICAL", 141, 147], ["copper", "CHEMICAL", 59, 65], ["copper", "CHEMICAL", 141, 147], ["liver", "ORGAN", 4, 9], ["organ", "ORGAN", 23, 28], ["copper", "SIMPLE_CHEMICAL", 59, 65], ["copper", "SIMPLE_CHEMICAL", 141, 147], ["bile", "MULTI-TISSUE_STRUCTURE", 166, 170], ["liver", "ANATOMY", 4, 9], ["copper levels", "OBSERVATION", 59, 72], ["bile", "ANATOMY", 166, 170]]], ["Dietary copper is taken up by the enterocytes of the small intestine by dedicated transporters, divalent metal transporter (DMT1) and copper transporter 1 (Ctr1), and conveyed in the portal blood bound to carrier proteins ceruloplasmin and transcuprein, or in a nonspecific fashion to albumin, to the liver for uptake.", [["enterocytes", "ANATOMY", 34, 45], ["small intestine", "ANATOMY", 53, 68], ["portal blood", "ANATOMY", 183, 195], ["liver", "ANATOMY", 301, 306], ["copper", "CHEMICAL", 8, 14], ["copper", "CHEMICAL", 134, 140], ["transcuprein", "CHEMICAL", 240, 252], ["copper", "CHEMICAL", 8, 14], ["copper", "CHEMICAL", 134, 140], ["transcuprein", "CHEMICAL", 240, 252], ["copper", "SIMPLE_CHEMICAL", 8, 14], ["enterocytes", "MULTI-TISSUE_STRUCTURE", 34, 45], ["small intestine", "ORGAN", 53, 68], ["divalent metal transporter", "GENE_OR_GENE_PRODUCT", 96, 122], ["DMT1", "GENE_OR_GENE_PRODUCT", 124, 128], ["copper transporter 1", "GENE_OR_GENE_PRODUCT", 134, 154], ["Ctr1", "GENE_OR_GENE_PRODUCT", 156, 160], ["blood", "ORGANISM_SUBSTANCE", 190, 195], ["ceruloplasmin", "GENE_OR_GENE_PRODUCT", 222, 235], ["transcuprein", "SIMPLE_CHEMICAL", 240, 252], ["albumin", "GENE_OR_GENE_PRODUCT", 285, 292], ["liver", "ORGAN", 301, 306], ["divalent metal transporter", "PROTEIN", 96, 122], ["DMT1", "PROTEIN", 124, 128], ["copper transporter 1", "PROTEIN", 134, 154], ["Ctr1", "PROTEIN", 156, 160], ["carrier proteins", "PROTEIN", 205, 221], ["ceruloplasmin", "PROTEIN", 222, 235], ["albumin", "PROTEIN", 285, 292], ["Dietary copper", "TREATMENT", 0, 14], ["ceruloplasmin", "TEST", 222, 235], ["transcuprein", "TREATMENT", 240, 252], ["albumin", "TEST", 285, 292], ["small intestine", "ANATOMY", 53, 68], ["portal", "ANATOMY", 183, 189], ["liver", "ANATOMY", 301, 306]]], ["In the hepatocyte, copper is sequestered in metallothionein or glutathione.", [["hepatocyte", "ANATOMY", 7, 17], ["copper", "CHEMICAL", 19, 25], ["glutathione", "CHEMICAL", 63, 74], ["copper", "CHEMICAL", 19, 25], ["glutathione", "CHEMICAL", 63, 74], ["hepatocyte", "CELL", 7, 17], ["copper", "SIMPLE_CHEMICAL", 19, 25], ["metallothionein", "GENE_OR_GENE_PRODUCT", 44, 59], ["glutathione", "SIMPLE_CHEMICAL", 63, 74], ["metallothionein", "PROTEIN", 44, 59], ["hepatocyte", "ANATOMY", 7, 17]]], ["Excretion into the bile or blood is regulated by a series of specific chaperone proteins, such as the coppertransporting ATPase ATP7A.", [["bile", "ANATOMY", 19, 23], ["blood", "ANATOMY", 27, 32], ["bile", "MULTI-TISSUE_STRUCTURE", 19, 23], ["blood", "ORGANISM_SUBSTANCE", 27, 32], ["ATP7A", "GENE_OR_GENE_PRODUCT", 128, 133], ["chaperone proteins", "PROTEIN", 70, 88], ["coppertransporting ATPase", "PROTEIN", 102, 127], ["ATP7A", "PROTEIN", 128, 133], ["Excretion into the bile or blood", "PROBLEM", 0, 32], ["specific chaperone proteins", "TREATMENT", 61, 88], ["bile", "ANATOMY", 19, 23], ["blood", "ANATOMY", 27, 32]]], ["Excess copper is stored in lysosomes.", [["lysosomes", "ANATOMY", 27, 36], ["copper", "CHEMICAL", 7, 13], ["copper", "CHEMICAL", 7, 13], ["copper", "SIMPLE_CHEMICAL", 7, 13], ["lysosomes", "CELLULAR_COMPONENT", 27, 36], ["Excess copper", "PROBLEM", 0, 13]]], ["Copper-induced injury is produced by oxidative processes that initially reduce available glutathione and eventually damages lipids, proteins, and nucleic acids.", [["Copper", "CHEMICAL", 0, 6], ["glutathione", "CHEMICAL", 89, 100], ["nucleic acids", "CHEMICAL", 146, 159], ["Copper", "CHEMICAL", 0, 6], ["glutathione", "CHEMICAL", 89, 100], ["Copper", "SIMPLE_CHEMICAL", 0, 6], ["glutathione", "SIMPLE_CHEMICAL", 89, 100], ["lipids", "SIMPLE_CHEMICAL", 124, 130], ["nucleic acids", "SIMPLE_CHEMICAL", 146, 159], ["Copper-induced injury", "PROBLEM", 0, 21], ["available glutathione", "TREATMENT", 79, 100], ["damages lipids", "TREATMENT", 116, 130], ["proteins", "TREATMENT", 132, 140], ["nucleic acids", "TREATMENT", 146, 159], ["injury", "OBSERVATION", 15, 21]]], ["Cellular metabolism, structural integrity, and energy generation are affected.", [["Cellular", "ANATOMY", 0, 8], ["Cellular", "CELL", 0, 8], ["Cellular metabolism", "PROBLEM", 0, 19], ["metabolism", "OBSERVATION_MODIFIER", 9, 19], ["structural integrity", "OBSERVATION", 21, 41], ["energy generation", "OBSERVATION", 47, 64]]], ["Hepatic copper toxicosis can result from a primary metabolic defect in hepatic copper metabolism, altered hepatic biliary excretion of copper, or from excess dietary intake of the element.Copperpasture.", [["Hepatic", "ANATOMY", 0, 7], ["hepatic", "ANATOMY", 71, 78], ["hepatic biliary", "ANATOMY", 106, 121], ["copper", "CHEMICAL", 8, 14], ["toxicosis", "DISEASE", 15, 24], ["copper", "CHEMICAL", 79, 85], ["copper", "CHEMICAL", 135, 141], ["Copperpasture", "CHEMICAL", 188, 201], ["copper", "CHEMICAL", 8, 14], ["copper", "CHEMICAL", 79, 85], ["copper", "CHEMICAL", 135, 141], ["Hepatic", "ORGAN", 0, 7], ["copper", "SIMPLE_CHEMICAL", 8, 14], ["hepatic", "ORGAN", 71, 78], ["copper", "SIMPLE_CHEMICAL", 79, 85], ["hepatic biliary", "MULTI-TISSUE_STRUCTURE", 106, 121], ["copper", "SIMPLE_CHEMICAL", 135, 141], ["Copperpasture", "SIMPLE_CHEMICAL", 188, 201], ["Hepatic copper toxicosis", "PROBLEM", 0, 24], ["a primary metabolic defect", "PROBLEM", 41, 67], ["hepatic copper metabolism", "PROBLEM", 71, 96], ["altered hepatic biliary excretion of copper", "PROBLEM", 98, 141], ["copper toxicosis", "OBSERVATION", 8, 24], ["primary", "OBSERVATION_MODIFIER", 43, 50], ["metabolic defect", "OBSERVATION", 51, 67], ["hepatic", "ANATOMY", 71, 78], ["copper metabolism", "OBSERVATION", 79, 96], ["altered", "OBSERVATION_MODIFIER", 98, 105], ["hepatic", "ANATOMY_MODIFIER", 106, 113], ["biliary", "ANATOMY", 114, 121]]], ["Hepatic disease associated with copper toxicity in this breed appears to differ morphologically from other domesticated sheep breeds.", [["Hepatic", "ANATOMY", 0, 7], ["Hepatic disease", "DISEASE", 0, 15], ["copper", "CHEMICAL", 32, 38], ["toxicity", "DISEASE", 39, 47], ["copper", "CHEMICAL", 32, 38], ["Hepatic", "ORGAN", 0, 7], ["copper", "SIMPLE_CHEMICAL", 32, 38], ["sheep", "ORGANISM", 120, 125], ["sheep", "SPECIES", 120, 125], ["sheep", "SPECIES", 120, 125], ["Hepatic disease", "PROBLEM", 0, 15], ["copper toxicity", "PROBLEM", 32, 47], ["disease", "OBSERVATION", 8, 15], ["copper", "OBSERVATION_MODIFIER", 32, 38], ["toxicity", "OBSERVATION", 39, 47], ["sheep breeds", "OBSERVATION", 120, 132]]], ["Copper accumulation begins in periportal hepatocytes, accompanied by a mixed inflammatory infiltrate and cholangiolar proliferation.", [["periportal hepatocytes", "ANATOMY", 30, 52], ["cholangiolar", "ANATOMY", 105, 117], ["Copper", "CHEMICAL", 0, 6], ["Copper", "CHEMICAL", 0, 6], ["Copper", "SIMPLE_CHEMICAL", 0, 6], ["periportal hepatocytes", "CELL", 30, 52], ["cholangiolar", "CELL", 105, 117], ["periportal hepatocytes", "CELL_TYPE", 30, 52], ["Copper accumulation", "PROBLEM", 0, 19], ["periportal hepatocytes", "PROBLEM", 30, 52], ["a mixed inflammatory infiltrate", "PROBLEM", 69, 100], ["cholangiolar proliferation", "PROBLEM", 105, 131], ["accumulation", "OBSERVATION", 7, 19], ["periportal", "ANATOMY_MODIFIER", 30, 40], ["hepatocytes", "ANATOMY", 41, 52], ["mixed", "OBSERVATION_MODIFIER", 71, 76], ["inflammatory", "OBSERVATION_MODIFIER", 77, 89], ["infiltrate", "OBSERVATION", 90, 100], ["cholangiolar proliferation", "OBSERVATION", 105, 131]]], ["Characteristic pericellular fibrosis, initially confined to the portal tracts and periportal zones, later extends to diffuse fibrosis and cirrhosis, associated ultrastructurally with numerous hepatic stellate cells.", [["pericellular", "ANATOMY", 15, 27], ["portal tracts", "ANATOMY", 64, 77], ["periportal zones", "ANATOMY", 82, 98], ["hepatic stellate cells", "ANATOMY", 192, 214], ["fibrosis", "DISEASE", 28, 36], ["fibrosis", "DISEASE", 125, 133], ["cirrhosis", "DISEASE", 138, 147], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 64, 77], ["periportal zones", "TISSUE", 82, 98], ["hepatic stellate cells", "CELL", 192, 214], ["hepatic stellate cells", "CELL_TYPE", 192, 214], ["Characteristic pericellular fibrosis", "PROBLEM", 0, 36], ["diffuse fibrosis", "PROBLEM", 117, 133], ["cirrhosis", "PROBLEM", 138, 147], ["numerous hepatic stellate cells", "PROBLEM", 183, 214], ["pericellular", "ANATOMY_MODIFIER", 15, 27], ["fibrosis", "OBSERVATION", 28, 36], ["portal tracts", "ANATOMY", 64, 77], ["periportal", "ANATOMY", 82, 92], ["zones", "ANATOMY_MODIFIER", 93, 98], ["diffuse", "OBSERVATION_MODIFIER", 117, 124], ["fibrosis", "OBSERVATION", 125, 133], ["cirrhosis", "OBSERVATION", 138, 147], ["numerous", "OBSERVATION_MODIFIER", 183, 191], ["hepatic", "ANATOMY", 192, 199], ["stellate cells", "OBSERVATION", 200, 214]]], ["North Ronaldsay sheep have been proposed as a possible animal model for human non-Wilsonian hepatic copper toxicosis and cirrhosis of infancy, and for investigation of copper-associated hepatic fibrogenesis.CopperThe events described in sheep also occur in chronic copper poisoning in pigs and cattle, and acute intravascular hemolysis may be seen, especially in calves.", [["hepatic", "ANATOMY", 92, 99], ["hepatic", "ANATOMY", 186, 193], ["intravascular", "ANATOMY", 312, 325], ["copper", "CHEMICAL", 100, 106], ["toxicosis", "DISEASE", 107, 116], ["cirrhosis", "DISEASE", 121, 130], ["hepatic fibrogenesis", "DISEASE", 186, 206], ["Copper", "CHEMICAL", 207, 213], ["copper", "CHEMICAL", 265, 271], ["poisoning", "DISEASE", 272, 281], ["intravascular hemolysis", "DISEASE", 312, 335], ["copper", "CHEMICAL", 100, 106], ["Copper", "CHEMICAL", 207, 213], ["copper", "CHEMICAL", 265, 271], ["sheep", "ORGANISM", 16, 21], ["human", "ORGANISM", 72, 77], ["hepatic", "ORGAN", 186, 193], ["Copper", "SIMPLE_CHEMICAL", 207, 213], ["sheep", "ORGANISM", 237, 242], ["copper", "SIMPLE_CHEMICAL", 265, 271], ["pigs", "ORGANISM", 285, 289], ["intravascular", "IMMATERIAL_ANATOMICAL_ENTITY", 312, 325], ["calves", "ORGANISM", 363, 369], ["sheep", "SPECIES", 16, 21], ["human", "SPECIES", 72, 77], ["sheep", "SPECIES", 237, 242], ["pigs", "SPECIES", 285, 289], ["cattle", "SPECIES", 294, 300], ["calves", "SPECIES", 363, 369], ["sheep", "SPECIES", 16, 21], ["human", "SPECIES", 72, 77], ["sheep", "SPECIES", 237, 242], ["pigs", "SPECIES", 285, 289], ["cattle", "SPECIES", 294, 300], ["human non-Wilsonian hepatic copper toxicosis", "PROBLEM", 72, 116], ["cirrhosis of infancy", "PROBLEM", 121, 141], ["copper-associated hepatic fibrogenesis", "PROBLEM", 168, 206], ["chronic copper poisoning", "PROBLEM", 257, 281], ["acute intravascular hemolysis", "PROBLEM", 306, 335], ["hepatic", "ANATOMY", 92, 99], ["toxicosis", "OBSERVATION", 107, 116], ["cirrhosis", "OBSERVATION", 121, 130], ["hepatic", "ANATOMY", 186, 193], ["fibrogenesis", "OBSERVATION", 194, 206], ["chronic", "OBSERVATION_MODIFIER", 257, 264], ["acute", "OBSERVATION_MODIFIER", 306, 311], ["intravascular hemolysis", "OBSERVATION", 312, 335], ["may be seen", "UNCERTAINTY", 336, 347], ["calves", "ANATOMY", 363, 369]]], ["Usually, however, there is less of the acute terminal chain reaction in these species, and there is more evidence of chronic liver damage with extensive portal fibrosis and biliary hyperplasia within the triads.CopperAcute copper poisoning is most often seen in ruminants after accidental administration of single large doses of copper, by either the oral or parenteral routes.", [["liver", "ANATOMY", 125, 130], ["portal", "ANATOMY", 153, 159], ["biliary", "ANATOMY", 173, 180], ["oral", "ANATOMY", 351, 355], ["liver damage", "DISEASE", 125, 137], ["fibrosis", "DISEASE", 160, 168], ["biliary hyperplasia", "DISEASE", 173, 192], ["copper", "CHEMICAL", 223, 229], ["poisoning", "DISEASE", 230, 239], ["copper", "CHEMICAL", 329, 335], ["copper", "CHEMICAL", 223, 229], ["copper", "CHEMICAL", 329, 335], ["liver", "ORGAN", 125, 130], ["portal fibrosis", "PATHOLOGICAL_FORMATION", 153, 168], ["biliary hyperplasia", "PATHOLOGICAL_FORMATION", 173, 192], ["CopperAcute copper", "SIMPLE_CHEMICAL", 211, 229], ["copper", "SIMPLE_CHEMICAL", 329, 335], ["oral", "ORGANISM_SUBDIVISION", 351, 355], ["ruminants", "SPECIES", 262, 271], ["the acute terminal chain reaction", "PROBLEM", 35, 68], ["chronic liver damage", "PROBLEM", 117, 137], ["extensive portal fibrosis", "PROBLEM", 143, 168], ["biliary hyperplasia within the triads", "PROBLEM", 173, 210], ["CopperAcute copper poisoning", "PROBLEM", 211, 239], ["single large doses of copper", "TREATMENT", 307, 335], ["parenteral routes", "TREATMENT", 359, 376], ["less", "OBSERVATION_MODIFIER", 27, 31], ["acute", "OBSERVATION_MODIFIER", 39, 44], ["terminal", "OBSERVATION_MODIFIER", 45, 53], ["chain reaction", "OBSERVATION", 54, 68], ["species", "OBSERVATION_MODIFIER", 78, 85], ["more evidence of", "UNCERTAINTY", 100, 116], ["chronic", "OBSERVATION_MODIFIER", 117, 124], ["liver", "ANATOMY", 125, 130], ["damage", "OBSERVATION", 131, 137], ["extensive", "OBSERVATION_MODIFIER", 143, 152], ["portal", "ANATOMY", 153, 159], ["fibrosis", "OBSERVATION", 160, 168], ["biliary", "ANATOMY", 173, 180], ["hyperplasia", "OBSERVATION", 181, 192], ["poisoning", "OBSERVATION", 230, 239], ["most often", "OBSERVATION_MODIFIER", 243, 253]]], ["Iatrogenic copper toxicosis has been induced by administering copper oxide boluses to neonatal calves, and by injection with copper disodium edetate in weanling calves.", [["copper", "CHEMICAL", 11, 17], ["toxicosis", "DISEASE", 18, 27], ["copper oxide", "CHEMICAL", 62, 74], ["copper disodium edetate", "CHEMICAL", 125, 148], ["copper", "CHEMICAL", 11, 17], ["copper oxide", "CHEMICAL", 62, 74], ["copper disodium edetate", "CHEMICAL", 125, 148], ["copper", "SIMPLE_CHEMICAL", 11, 17], ["copper oxide", "SIMPLE_CHEMICAL", 62, 74], ["calves", "ORGANISM", 95, 101], ["copper disodium edetate", "SIMPLE_CHEMICAL", 125, 148], ["calves", "ORGANISM", 161, 167], ["calves", "SPECIES", 95, 101], ["calves", "SPECIES", 161, 167], ["Iatrogenic copper toxicosis", "PROBLEM", 0, 27], ["copper oxide boluses", "TREATMENT", 62, 82], ["neonatal calves", "TREATMENT", 86, 101], ["copper disodium edetate", "TREATMENT", 125, 148], ["toxicosis", "OBSERVATION", 18, 27]]], ["Doses of 20-100 mg/kg can produce acute poisoning in sheep.", [["poisoning", "DISEASE", 40, 49], ["sheep", "ORGANISM", 53, 58], ["sheep", "SPECIES", 53, 58], ["sheep", "SPECIES", 53, 58], ["acute poisoning in sheep", "PROBLEM", 34, 58], ["acute", "OBSERVATION_MODIFIER", 34, 39], ["poisoning", "OBSERVATION", 40, 49]]], ["Copper toxicosis has also been reported in veal calves fed milk replacer supplemented with various copper-containing hematinics.", [["Copper", "CHEMICAL", 0, 6], ["toxicosis", "DISEASE", 7, 16], ["Copper", "CHEMICAL", 0, 6], ["Copper", "SIMPLE_CHEMICAL", 0, 6], ["calves", "ORGANISM", 48, 54], ["milk", "ORGANISM_SUBSTANCE", 59, 63], ["calves", "SPECIES", 48, 54], ["veal", "SPECIES", 43, 47], ["Copper toxicosis", "PROBLEM", 0, 16], ["milk replacer", "TREATMENT", 59, 72], ["various copper-containing hematinics", "TREATMENT", 91, 127], ["toxicosis", "OBSERVATION", 7, 16]]], ["Affected animals develop severe gastroenteritis, abdominal pain, diarrhea, and dehydration.", [["abdominal", "ANATOMY", 49, 58], ["gastroenteritis", "DISEASE", 32, 47], ["abdominal pain", "DISEASE", 49, 63], ["diarrhea", "DISEASE", 65, 73], ["dehydration", "DISEASE", 79, 90], ["abdominal", "ORGANISM_SUBDIVISION", 49, 58], ["Affected animals", "PROBLEM", 0, 16], ["severe gastroenteritis", "PROBLEM", 25, 47], ["abdominal pain", "PROBLEM", 49, 63], ["diarrhea", "PROBLEM", 65, 73], ["dehydration", "PROBLEM", 79, 90], ["severe", "OBSERVATION_MODIFIER", 25, 31], ["gastroenteritis", "OBSERVATION", 32, 47], ["abdominal", "ANATOMY", 49, 58], ["pain", "OBSERVATION", 59, 63], ["diarrhea", "OBSERVATION", 65, 73], ["dehydration", "OBSERVATION", 79, 90]]], ["The liver lesion varies with chronicity of exposure, from nonspecific acute centrilobular necrosis, to cholangiohepatitis with periportal fibrosis.", [["liver lesion", "ANATOMY", 4, 16], ["centrilobular", "ANATOMY", 76, 89], ["periportal", "ANATOMY", 127, 137], ["liver lesion", "DISEASE", 4, 16], ["necrosis", "DISEASE", 90, 98], ["cholangiohepatitis", "DISEASE", 103, 121], ["fibrosis", "DISEASE", 138, 146], ["liver", "ORGAN", 4, 9], ["The liver lesion", "PROBLEM", 0, 16], ["nonspecific acute centrilobular necrosis", "PROBLEM", 58, 98], ["cholangiohepatitis", "PROBLEM", 103, 121], ["periportal fibrosis", "PROBLEM", 127, 146], ["liver", "ANATOMY", 4, 9], ["lesion", "OBSERVATION", 10, 16], ["chronicity", "OBSERVATION_MODIFIER", 29, 39], ["nonspecific", "OBSERVATION_MODIFIER", 58, 69], ["acute", "OBSERVATION_MODIFIER", 70, 75], ["centrilobular", "OBSERVATION_MODIFIER", 76, 89], ["necrosis", "OBSERVATION", 90, 98], ["periportal", "ANATOMY", 127, 137], ["fibrosis", "OBSERVATION", 138, 146]]], ["Intravascular hemolysis may occur if plasma copper levels are sufficiently elevated.Acute bovine liver diseaseAcute bovine liver disease is a poorly understood entity that occurs in southern Australia.", [["Intravascular", "ANATOMY", 0, 13], ["plasma", "ANATOMY", 37, 43], ["liver", "ANATOMY", 97, 102], ["liver", "ANATOMY", 123, 128], ["hemolysis", "DISEASE", 14, 23], ["copper", "CHEMICAL", 44, 50], ["liver disease", "DISEASE", 123, 136], ["copper", "CHEMICAL", 44, 50], ["Intravascular", "IMMATERIAL_ANATOMICAL_ENTITY", 0, 13], ["plasma", "ORGANISM_SUBSTANCE", 37, 43], ["copper", "SIMPLE_CHEMICAL", 44, 50], ["bovine", "ORGANISM", 90, 96], ["liver", "ORGAN", 97, 102], ["bovine", "ORGANISM", 116, 122], ["liver", "ORGAN", 123, 128], ["bovine", "SPECIES", 90, 96], ["bovine", "SPECIES", 116, 122], ["Intravascular hemolysis", "PROBLEM", 0, 23], ["plasma copper levels", "TEST", 37, 57], ["sufficiently elevated", "PROBLEM", 62, 83], ["Acute bovine liver diseaseAcute bovine liver disease", "PROBLEM", 84, 136], ["hemolysis", "OBSERVATION", 14, 23], ["bovine", "ANATOMY_MODIFIER", 90, 96], ["liver", "ANATOMY", 97, 102], ["diseaseAcute bovine", "OBSERVATION", 103, 122], ["liver", "ANATOMY", 123, 128], ["disease", "OBSERVATION", 129, 136]]], ["Outbreaks occur primarily in the spring and the autumn, and all ages of cattle can be affected.", [["cattle", "ORGANISM", 72, 78], ["cattle", "SPECIES", 72, 78], ["cattle", "SPECIES", 72, 78], ["Outbreaks", "PROBLEM", 0, 9]]], ["Sudden death or photosensitization may occur.", [["death", "DISEASE", 7, 12], ["photosensitization", "DISEASE", 16, 34], ["Sudden death", "PROBLEM", 0, 12], ["photosensitization", "PROBLEM", 16, 34]]], ["There is an association with ingestion of Cynosurus echinatus (rough dog's tail).", [["tail", "ANATOMY", 75, 79], ["Cynosurus echinatus", "ORGANISM", 42, 61], ["dog", "ORGANISM_SUBDIVISION", 69, 72], ["tail", "ORGANISM_SUBDIVISION", 75, 79], ["Cynosurus echinatus", "SPECIES", 42, 61], ["dog", "SPECIES", 69, 72], ["Cynosurus echinatus", "SPECIES", 42, 61]]], ["The characteristic histologic lesion involves a periportal hepatocellular necrosis with bile duct proliferation (eFig.", [["lesion", "ANATOMY", 30, 36], ["periportal hepatocellular", "ANATOMY", 48, 73], ["bile duct", "ANATOMY", 88, 97], ["periportal hepatocellular necrosis", "DISEASE", 48, 82], ["periportal hepatocellular necrosis", "CANCER", 48, 82], ["bile duct", "MULTI-TISSUE_STRUCTURE", 88, 97], ["The characteristic histologic lesion", "PROBLEM", 0, 36], ["a periportal hepatocellular necrosis", "PROBLEM", 46, 82], ["bile duct proliferation", "PROBLEM", 88, 111], ["histologic", "OBSERVATION_MODIFIER", 19, 29], ["lesion", "OBSERVATION", 30, 36], ["periportal", "ANATOMY_MODIFIER", 48, 58], ["hepatocellular", "ANATOMY", 59, 73], ["necrosis", "OBSERVATION", 74, 82], ["bile duct", "ANATOMY", 88, 97], ["proliferation", "OBSERVATION", 98, 111]]], ["The presence of mycotoxin(s) produced by the fungus Dreschlera biseptata growing in some plants has been suggested to be the principal toxicant or cofactor in the syndrome.HYPERPLASTIC AND NEOPLASTIC LESIONS OF THE LIVER AND BILE DUCTSRemarkably, the occurrence of fatal liver malignancies is rather uncommon in aged dogs and cats; this suggests that they are either less exposed, or they are more resistant to the etiologic agents responsible for liver neoplasms in humans.", [["liver malignancies", "ANATOMY", 271, 289], ["liver neoplasms", "ANATOMY", 448, 463], ["mycotoxin", "CHEMICAL", 16, 25], ["liver malignancies", "DISEASE", 271, 289], ["liver neoplasms", "DISEASE", 448, 463], ["fungus", "ORGANISM", 45, 51], ["Dreschlera biseptata", "ORGANISM", 52, 72], ["liver", "ORGAN", 271, 276], ["malignancies", "CANCER", 277, 289], ["dogs", "ORGANISM", 317, 321], ["cats", "ORGANISM", 326, 330], ["liver neoplasms", "CANCER", 448, 463], ["humans", "ORGANISM", 467, 473], ["Dreschlera biseptata", "SPECIES", 52, 72], ["dogs", "SPECIES", 317, 321], ["cats", "SPECIES", 326, 330], ["humans", "SPECIES", 467, 473], ["Dreschlera biseptata", "SPECIES", 52, 72], ["humans", "SPECIES", 467, 473], ["mycotoxin(s)", "PROBLEM", 16, 28], ["the fungus Dreschlera biseptata", "PROBLEM", 41, 72], ["cofactor in the syndrome", "PROBLEM", 147, 171], ["HYPERPLASTIC AND NEOPLASTIC LESIONS OF THE LIVER AND BILE DUCTSRemarkably", "PROBLEM", 172, 245], ["fatal liver malignancies", "PROBLEM", 265, 289], ["liver neoplasms in humans", "PROBLEM", 448, 473], ["mycotoxin", "OBSERVATION", 16, 25], ["NEOPLASTIC", "OBSERVATION_MODIFIER", 189, 199], ["LESIONS", "OBSERVATION", 200, 207], ["LIVER", "ANATOMY", 215, 220], ["BILE", "ANATOMY", 225, 229], ["fatal", "OBSERVATION_MODIFIER", 265, 270], ["liver", "ANATOMY", 271, 276], ["malignancies", "OBSERVATION", 277, 289], ["liver", "ANATOMY", 448, 453], ["neoplasms", "OBSERVATION", 454, 463]]], ["Domestic species are not subject to significant chronic oncogenic viral infections, such as the hepatitis B and hepatitis C viruses that account for the majority of human hepatocellular carcinoma. may be related to decreased gallbladder motility, bile stasis, and altered bile composition and viscosity.HYPERPLASTIC AND NEOPLASTIC LESIONS OF THE LIVER AND BILE DUCTSMucosal hyperplasia in the large bile ducts is frequently observed in the long-standing mild cholangiohepatitis of fluke infestation.", [["hepatocellular carcinoma", "ANATOMY", 171, 195], ["gallbladder", "ANATOMY", 225, 236], ["bile", "ANATOMY", 247, 251], ["bile", "ANATOMY", 272, 276], ["bile ducts", "ANATOMY", 399, 409], ["fluke", "ANATOMY", 481, 486], ["viral infections", "DISEASE", 66, 82], ["hepatitis B and hepatitis C viruses", "DISEASE", 96, 131], ["hepatocellular carcinoma", "DISEASE", 171, 195], ["DUCTSMucosal hyperplasia", "DISEASE", 361, 385], ["cholangiohepatitis", "DISEASE", 459, 477], ["fluke infestation", "DISEASE", 481, 498], ["hepatitis B", "ORGANISM", 96, 107], ["hepatitis C viruses", "ORGANISM", 112, 131], ["human", "ORGANISM", 165, 170], ["hepatocellular carcinoma", "CANCER", 171, 195], ["gallbladder", "ORGAN", 225, 236], ["bile", "MULTI-TISSUE_STRUCTURE", 247, 251], ["bile", "MULTI-TISSUE_STRUCTURE", 272, 276], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 399, 409], ["fluke", "ORGAN", 481, 486], ["human", "SPECIES", 165, 170], ["hepatitis B", "SPECIES", 96, 107], ["hepatitis C viruses", "SPECIES", 112, 131], ["human", "SPECIES", 165, 170], ["Domestic species", "PROBLEM", 0, 16], ["significant chronic oncogenic viral infections", "PROBLEM", 36, 82], ["the hepatitis B", "PROBLEM", 92, 107], ["hepatitis C viruses", "PROBLEM", 112, 131], ["human hepatocellular carcinoma", "PROBLEM", 165, 195], ["decreased gallbladder motility", "PROBLEM", 215, 245], ["bile stasis", "PROBLEM", 247, 258], ["altered bile composition and viscosity", "PROBLEM", 264, 302], ["HYPERPLASTIC AND NEOPLASTIC LESIONS OF THE LIVER", "PROBLEM", 303, 351], ["BILE DUCTSMucosal hyperplasia in the large bile ducts", "PROBLEM", 356, 409], ["the long-standing mild cholangiohepatitis of fluke infestation", "PROBLEM", 436, 498], ["not subject to", "UNCERTAINTY", 21, 35], ["significant", "OBSERVATION_MODIFIER", 36, 47], ["chronic", "OBSERVATION_MODIFIER", 48, 55], ["oncogenic", "OBSERVATION_MODIFIER", 56, 65], ["viral infections", "OBSERVATION", 66, 82], ["hepatitis", "OBSERVATION", 96, 105], ["hepatitis", "OBSERVATION", 112, 121], ["hepatocellular carcinoma", "OBSERVATION", 171, 195], ["decreased", "OBSERVATION_MODIFIER", 215, 224], ["gallbladder", "ANATOMY", 225, 236], ["motility", "OBSERVATION", 237, 245], ["bile", "ANATOMY", 247, 251], ["stasis", "OBSERVATION", 252, 258], ["bile", "ANATOMY", 272, 276], ["viscosity", "OBSERVATION_MODIFIER", 293, 302], ["NEOPLASTIC", "OBSERVATION_MODIFIER", 320, 330], ["LESIONS", "OBSERVATION", 331, 338], ["LIVER", "ANATOMY", 346, 351], ["BILE", "ANATOMY", 356, 360], ["DUCTSMucosal", "ANATOMY_MODIFIER", 361, 373], ["hyperplasia", "OBSERVATION", 374, 385], ["large", "ANATOMY_MODIFIER", 393, 398], ["bile ducts", "ANATOMY", 399, 409], ["long-standing", "OBSERVATION_MODIFIER", 440, 453], ["mild", "OBSERVATION_MODIFIER", 454, 458], ["cholangiohepatitis", "OBSERVATION", 459, 477], ["fluke infestation", "OBSERVATION", 481, 498]]], ["The hyperplasia is of microscopic dimensions, but in some instances, it appears histologically to be atypical.", [["hyperplasia", "DISEASE", 4, 15], ["The hyperplasia", "PROBLEM", 0, 15], ["hyperplasia", "OBSERVATION", 4, 15], ["microscopic dimensions", "OBSERVATION_MODIFIER", 22, 44], ["atypical", "OBSERVATION_MODIFIER", 101, 109]]], ["Localized, polypoid foci of cystic hyperplasia are specific changes in cattle poisoned by highly chlorinated naphthalene.Hepatocellular tumorsPrimary epithelial neoplasms of the liver include tumors of either hepatocellular or cholangiocellular origin, and they are uncommon in most species, representing <1% of all neoplasms in cats and dogs.", [["polypoid foci", "ANATOMY", 11, 24], ["cystic hyperplasia", "ANATOMY", 28, 46], ["Hepatocellular tumors", "ANATOMY", 121, 142], ["Primary epithelial neoplasms", "ANATOMY", 142, 170], ["liver", "ANATOMY", 178, 183], ["tumors", "ANATOMY", 192, 198], ["hepatocellular", "ANATOMY", 209, 223], ["cholangiocellular", "ANATOMY", 227, 244], ["neoplasms", "ANATOMY", 316, 325], ["cystic hyperplasia", "DISEASE", 28, 46], ["naphthalene", "CHEMICAL", 109, 120], ["Hepatocellular tumors", "DISEASE", 121, 142], ["epithelial neoplasms of the liver", "DISEASE", 150, 183], ["tumors", "DISEASE", 192, 198], ["neoplasms", "DISEASE", 316, 325], ["naphthalene", "CHEMICAL", 109, 120], ["polypoid foci", "PATHOLOGICAL_FORMATION", 11, 24], ["cystic hyperplasia", "PATHOLOGICAL_FORMATION", 28, 46], ["cattle", "ORGANISM", 71, 77], ["naphthalene", "SIMPLE_CHEMICAL", 109, 120], ["Hepatocellular tumors", "CANCER", 121, 142], ["epithelial neoplasms", "CANCER", 150, 170], ["liver", "ORGAN", 178, 183], ["tumors", "CANCER", 192, 198], ["hepatocellular", "CANCER", 209, 223], ["neoplasms", "CANCER", 316, 325], ["cats", "ORGANISM", 329, 333], ["dogs", "ORGANISM", 338, 342], ["cats", "SPECIES", 329, 333], ["dogs", "SPECIES", 338, 342], ["cattle", "SPECIES", 71, 77], ["polypoid foci", "PROBLEM", 11, 24], ["cystic hyperplasia", "PROBLEM", 28, 46], ["Hepatocellular tumors", "PROBLEM", 121, 142], ["Primary epithelial neoplasms of the liver", "PROBLEM", 142, 183], ["tumors", "PROBLEM", 192, 198], ["all neoplasms in cats and dogs", "PROBLEM", 312, 342], ["polypoid", "OBSERVATION_MODIFIER", 11, 19], ["foci", "OBSERVATION_MODIFIER", 20, 24], ["cystic", "OBSERVATION_MODIFIER", 28, 34], ["hyperplasia", "OBSERVATION", 35, 46], ["highly", "OBSERVATION_MODIFIER", 90, 96], ["chlorinated naphthalene", "OBSERVATION", 97, 120], ["tumors", "OBSERVATION", 136, 142], ["epithelial", "ANATOMY_MODIFIER", 150, 160], ["neoplasms", "OBSERVATION", 161, 170], ["liver", "ANATOMY", 178, 183], ["tumors", "OBSERVATION", 192, 198], ["hepatocellular", "ANATOMY", 209, 223], ["cholangiocellular", "ANATOMY", 227, 244], ["origin", "ANATOMY_MODIFIER", 245, 251], ["most species", "OBSERVATION_MODIFIER", 278, 290], ["all", "OBSERVATION_MODIFIER", 312, 315], ["neoplasms", "OBSERVATION", 316, 325]]], ["Pot-bellied pigs are a possible exception.", [["pigs", "ORGANISM", 12, 16], ["pigs", "SPECIES", 12, 16]]], ["Proportionately, hepatocellular neoplasms are more common in dogs, whereas cholangiocellular tumors predominate in cats.", [["hepatocellular neoplasms", "ANATOMY", 17, 41], ["cholangiocellular tumors", "ANATOMY", 75, 99], ["hepatocellular neoplasms", "DISEASE", 17, 41], ["cholangiocellular tumors", "DISEASE", 75, 99], ["hepatocellular neoplasms", "CANCER", 17, 41], ["dogs", "ORGANISM", 61, 65], ["cholangiocellular tumors", "CANCER", 75, 99], ["cats", "ORGANISM", 115, 119], ["dogs", "SPECIES", 61, 65], ["cats", "SPECIES", 115, 119], ["hepatocellular neoplasms", "PROBLEM", 17, 41], ["cholangiocellular tumors", "PROBLEM", 75, 99], ["hepatocellular", "ANATOMY", 17, 31], ["neoplasms", "OBSERVATION", 32, 41], ["cholangiocellular", "ANATOMY", 75, 92], ["tumors", "OBSERVATION", 93, 99]]], ["Unlike the situation in humans, there are no clear associations in domestic animals between hepatocellular tumors and viruses, chemical carcinogens, mycotoxins, or drugs, such as synthetic steroids.", [["hepatocellular tumors", "ANATOMY", 92, 113], ["hepatocellular tumors", "DISEASE", 92, 113], ["steroids", "CHEMICAL", 189, 197], ["steroids", "CHEMICAL", 189, 197], ["humans", "ORGANISM", 24, 30], ["hepatocellular tumors", "CANCER", 92, 113], ["humans", "SPECIES", 24, 30], ["humans", "SPECIES", 24, 30], ["hepatocellular tumors", "PROBLEM", 92, 113], ["viruses", "PROBLEM", 118, 125], ["chemical carcinogens", "TREATMENT", 127, 147], ["mycotoxins", "TREATMENT", 149, 159], ["drugs", "TREATMENT", 164, 169], ["synthetic steroids", "TREATMENT", 179, 197], ["no", "UNCERTAINTY", 42, 44], ["hepatocellular", "ANATOMY", 92, 106], ["tumors", "OBSERVATION", 107, 113]]], ["With the exception of the occasional association of liver tumors with certain flukes or tapeworm larvae, and the rare adenoma seen in the bovine liver with chronic pyrrolizidine poisoning, hepatobiliary tumors in domestic nodules are often dilated, and foci of hematopoiesis are occasionally observed.", [["liver tumors", "ANATOMY", 52, 64], ["flukes", "ANATOMY", 78, 84], ["larvae", "ANATOMY", 97, 103], ["adenoma", "ANATOMY", 118, 125], ["liver", "ANATOMY", 145, 150], ["hepatobiliary tumors", "ANATOMY", 189, 209], ["nodules", "ANATOMY", 222, 229], ["foci", "ANATOMY", 253, 257], ["liver tumors", "DISEASE", 52, 64], ["tapeworm larvae", "DISEASE", 88, 103], ["adenoma", "DISEASE", 118, 125], ["pyrrolizidine poisoning", "DISEASE", 164, 187], ["hepatobiliary tumors", "DISEASE", 189, 209], ["pyrrolizidine", "CHEMICAL", 164, 177], ["liver tumors", "CANCER", 52, 64], ["flukes", "ORGAN", 78, 84], ["adenoma", "CANCER", 118, 125], ["bovine", "ORGANISM", 138, 144], ["liver", "ORGAN", 145, 150], ["pyrrolizidine", "SIMPLE_CHEMICAL", 164, 177], ["hepatobiliary tumors", "CANCER", 189, 209], ["nodules", "CANCER", 222, 229], ["bovine", "SPECIES", 138, 144], ["bovine", "SPECIES", 138, 144], ["liver tumors", "PROBLEM", 52, 64], ["certain flukes", "PROBLEM", 70, 84], ["tapeworm larvae", "PROBLEM", 88, 103], ["the rare adenoma", "PROBLEM", 109, 125], ["chronic pyrrolizidine poisoning", "PROBLEM", 156, 187], ["hepatobiliary tumors in domestic nodules", "PROBLEM", 189, 229], ["dilated", "PROBLEM", 240, 247], ["foci of hematopoiesis", "PROBLEM", 253, 274], ["occasional", "OBSERVATION_MODIFIER", 26, 36], ["liver", "ANATOMY", 52, 57], ["tumors", "OBSERVATION", 58, 64], ["certain flukes", "OBSERVATION", 70, 84], ["tapeworm larvae", "OBSERVATION", 88, 103], ["rare", "OBSERVATION_MODIFIER", 113, 117], ["adenoma", "OBSERVATION", 118, 125], ["bovine", "ANATOMY_MODIFIER", 138, 144], ["liver", "ANATOMY", 145, 150], ["chronic", "OBSERVATION_MODIFIER", 156, 163], ["pyrrolizidine poisoning", "OBSERVATION", 164, 187], ["hepatobiliary", "ANATOMY", 189, 202], ["tumors", "OBSERVATION", 203, 209], ["domestic", "OBSERVATION_MODIFIER", 213, 221], ["nodules", "OBSERVATION", 222, 229], ["often", "OBSERVATION_MODIFIER", 234, 239], ["dilated", "OBSERVATION", 240, 247], ["foci", "OBSERVATION_MODIFIER", 253, 257], ["hematopoiesis", "OBSERVATION", 261, 274]]], ["Necrosis and hemorrhage in hyperplastic nodules are rare.Hepatocellular tumorsThe significance of hyperplastic nodules in old dogs is usually negligible.", [["hyperplastic nodules", "ANATOMY", 27, 47], ["Hepatocellular tumors", "ANATOMY", 57, 78], ["hyperplastic nodules", "ANATOMY", 98, 118], ["Necrosis", "DISEASE", 0, 8], ["hemorrhage", "DISEASE", 13, 23], ["Hepatocellular tumors", "DISEASE", 57, 78], ["hyperplastic nodules", "CANCER", 27, 47], ["Hepatocellular tumors", "CANCER", 57, 78], ["hyperplastic nodules", "CANCER", 98, 118], ["dogs", "ORGANISM", 126, 130], ["dogs", "SPECIES", 126, 130], ["Necrosis", "PROBLEM", 0, 8], ["hemorrhage", "PROBLEM", 13, 23], ["hyperplastic nodules", "PROBLEM", 27, 47], ["Hepatocellular tumors", "PROBLEM", 57, 78], ["hyperplastic nodules", "PROBLEM", 98, 118], ["old dogs", "PROBLEM", 122, 130], ["hemorrhage", "OBSERVATION", 13, 23], ["hyperplastic", "OBSERVATION_MODIFIER", 27, 39], ["nodules", "OBSERVATION", 40, 47], ["rare", "OBSERVATION_MODIFIER", 52, 56], ["tumors", "OBSERVATION", 72, 78], ["hyperplastic", "OBSERVATION_MODIFIER", 98, 110], ["nodules", "OBSERVATION", 111, 118], ["dogs", "OBSERVATION", 126, 130], ["negligible", "OBSERVATION_MODIFIER", 142, 152]]], ["After acute liver necrosis, these atypical hepatocytes within pre-existing hyperplastic foci and nodules may have phenotypic alterations that confer a survival advantage, and can survive and flourish as larger nodules amid regions of necrosis, so in these instances, they can be beneficial.", [["liver", "ANATOMY", 12, 17], ["hepatocytes", "ANATOMY", 43, 54], ["hyperplastic foci", "ANATOMY", 75, 92], ["nodules", "ANATOMY", 97, 104], ["nodules", "ANATOMY", 210, 217], ["acute liver necrosis", "DISEASE", 6, 26], ["necrosis", "DISEASE", 234, 242], ["liver", "ORGAN", 12, 17], ["hepatocytes", "CELL", 43, 54], ["hyperplastic foci", "CELL", 75, 92], ["nodules", "CANCER", 97, 104], ["atypical hepatocytes", "CELL_TYPE", 34, 54], ["acute liver necrosis", "PROBLEM", 6, 26], ["these atypical hepatocytes", "PROBLEM", 28, 54], ["pre-existing hyperplastic foci", "PROBLEM", 62, 92], ["nodules", "PROBLEM", 97, 104], ["phenotypic alterations", "PROBLEM", 114, 136], ["larger nodules", "PROBLEM", 203, 217], ["necrosis", "PROBLEM", 234, 242], ["acute", "OBSERVATION_MODIFIER", 6, 11], ["liver", "ANATOMY", 12, 17], ["necrosis", "OBSERVATION", 18, 26], ["atypical", "OBSERVATION_MODIFIER", 34, 42], ["hepatocytes", "ANATOMY", 43, 54], ["hyperplastic", "OBSERVATION_MODIFIER", 75, 87], ["foci", "OBSERVATION", 88, 92], ["nodules", "OBSERVATION", 97, 104], ["larger", "OBSERVATION_MODIFIER", 203, 209], ["nodules", "OBSERVATION", 210, 217], ["necrosis", "OBSERVATION", 234, 242]]], ["Although hyperplastic nodules rarely progress to lesions with detrimental impact, they are often found during liver imaging, laparotomy, or biopsy and need to be differentiated from other focal lesions of more significance.", [["hyperplastic nodules", "ANATOMY", 9, 29], ["lesions", "ANATOMY", 49, 56], ["liver", "ANATOMY", 110, 115], ["focal lesions", "ANATOMY", 188, 201], ["hyperplastic nodules", "CANCER", 9, 29], ["lesions", "PATHOLOGICAL_FORMATION", 49, 56], ["liver", "ORGAN", 110, 115], ["focal lesions", "PATHOLOGICAL_FORMATION", 188, 201], ["hyperplastic nodules", "PROBLEM", 9, 29], ["lesions", "PROBLEM", 49, 56], ["liver imaging", "TEST", 110, 123], ["laparotomy", "TREATMENT", 125, 135], ["biopsy", "TEST", 140, 146], ["other focal lesions", "PROBLEM", 182, 201], ["hyperplastic", "OBSERVATION_MODIFIER", 9, 21], ["nodules", "OBSERVATION", 22, 29], ["lesions", "OBSERVATION", 49, 56], ["liver", "ANATOMY", 110, 115], ["laparotomy", "OBSERVATION", 125, 135], ["focal", "OBSERVATION_MODIFIER", 188, 193], ["lesions", "OBSERVATION", 194, 201], ["more significance", "OBSERVATION_MODIFIER", 205, 222]]], ["Because they are atypically differentiated, they are the potential source of secreted products of clinical or diagnostic significance, but their potential in this regard is unexplored.", [["secreted products", "PROTEIN", 77, 94]]], ["The hallmark of nodular hyperplasia, in contrast to the hepatic adenoma and hepatocellular carcinoma, is that it largely retains normal liver architecture, including a modified lobular structure with recognizable central veins and portal triads.", [["nodular hyperplasia", "ANATOMY", 16, 35], ["hepatic adenoma", "ANATOMY", 56, 71], ["hepatocellular carcinoma", "ANATOMY", 76, 100], ["liver", "ANATOMY", 136, 141], ["lobular structure", "ANATOMY", 177, 194], ["central veins", "ANATOMY", 213, 226], ["portal triads", "ANATOMY", 231, 244], ["hyperplasia", "DISEASE", 24, 35], ["hepatic adenoma", "DISEASE", 56, 71], ["hepatocellular carcinoma", "DISEASE", 76, 100], ["nodular hyperplasia", "PATHOLOGICAL_FORMATION", 16, 35], ["hepatic adenoma", "CANCER", 56, 71], ["hepatocellular carcinoma", "CANCER", 76, 100], ["liver", "ORGAN", 136, 141], ["lobular structure", "CANCER", 177, 194], ["central veins", "MULTI-TISSUE_STRUCTURE", 213, 226], ["portal triads", "MULTI-TISSUE_STRUCTURE", 231, 244], ["nodular hyperplasia", "PROBLEM", 16, 35], ["the hepatic adenoma", "PROBLEM", 52, 71], ["hepatocellular carcinoma", "PROBLEM", 76, 100], ["a modified lobular structure", "PROBLEM", 166, 194], ["hallmark", "OBSERVATION_MODIFIER", 4, 12], ["nodular", "OBSERVATION_MODIFIER", 16, 23], ["hyperplasia", "OBSERVATION", 24, 35], ["hepatic", "ANATOMY", 56, 63], ["adenoma", "OBSERVATION", 64, 71], ["hepatocellular", "ANATOMY", 76, 90], ["carcinoma", "OBSERVATION", 91, 100], ["normal", "OBSERVATION", 129, 135], ["liver", "ANATOMY", 136, 141], ["architecture", "OBSERVATION_MODIFIER", 142, 154], ["lobular", "OBSERVATION_MODIFIER", 177, 184], ["central", "ANATOMY_MODIFIER", 213, 220], ["veins", "ANATOMY", 221, 226], ["portal triads", "ANATOMY", 231, 244]]], ["However, this feature may be difficult to appreciate in small biopsies.", [["biopsies", "CANCER", 62, 70], ["small biopsies", "TEST", 56, 70], ["may be", "UNCERTAINTY", 22, 28], ["small", "OBSERVATION_MODIFIER", 56, 61], ["biopsies", "OBSERVATION", 62, 70]]], ["The biological distinction between atypical hyperplasia and neoplasia is sometimes equivocal; in the latter, continued growth that is independent of promoting influences is responsible for enlargement, and the designation of adenoma should apply to lesions that are enlarging.Hepatocellular tumorsCystic mucinous hyperplasia of the mucus-producing glands in the mucosa of the gallbladder has been reported as an incidental lesion in dogs and sheep.", [["atypical hyperplasia", "ANATOMY", 35, 55], ["neoplasia", "ANATOMY", 60, 69], ["adenoma", "ANATOMY", 225, 232], ["lesions", "ANATOMY", 249, 256], ["Hepatocellular tumorsCystic mucinous hyperplasia", "ANATOMY", 276, 324], ["mucus", "ANATOMY", 332, 337], ["glands", "ANATOMY", 348, 354], ["mucosa", "ANATOMY", 362, 368], ["gallbladder", "ANATOMY", 376, 387], ["lesion", "ANATOMY", 423, 429], ["atypical hyperplasia", "DISEASE", 35, 55], ["neoplasia", "DISEASE", 60, 69], ["adenoma", "DISEASE", 225, 232], ["atypical hyperplasia", "PATHOLOGICAL_FORMATION", 35, 55], ["neoplasia", "CANCER", 60, 69], ["adenoma", "CANCER", 225, 232], ["lesions", "CANCER", 249, 256], ["Hepatocellular tumorsCystic mucinous hyperplasia", "PATHOLOGICAL_FORMATION", 276, 324], ["mucus", "TISSUE", 332, 337], ["glands", "ORGAN", 348, 354], ["mucosa", "MULTI-TISSUE_STRUCTURE", 362, 368], ["gallbladder", "ORGAN", 376, 387], ["lesion", "CANCER", 423, 429], ["dogs", "ORGANISM", 433, 437], ["sheep", "ORGANISM", 442, 447], ["dogs", "SPECIES", 433, 437], ["sheep", "SPECIES", 442, 447], ["sheep", "SPECIES", 442, 447], ["atypical hyperplasia", "PROBLEM", 35, 55], ["neoplasia", "PROBLEM", 60, 69], ["enlargement", "PROBLEM", 189, 200], ["adenoma", "PROBLEM", 225, 232], ["lesions", "PROBLEM", 249, 256], ["Hepatocellular tumorsCystic mucinous hyperplasia of the mucus-producing glands in the mucosa of the gallbladder", "PROBLEM", 276, 387], ["an incidental lesion in dogs and sheep", "PROBLEM", 409, 447], ["atypical", "OBSERVATION_MODIFIER", 35, 43], ["hyperplasia", "OBSERVATION", 44, 55], ["neoplasia", "OBSERVATION", 60, 69], ["growth", "OBSERVATION_MODIFIER", 119, 125], ["responsible for", "UNCERTAINTY", 173, 188], ["enlargement", "OBSERVATION", 189, 200], ["adenoma", "OBSERVATION", 225, 232], ["lesions", "OBSERVATION", 249, 256], ["enlarging", "OBSERVATION_MODIFIER", 266, 275], ["mucinous hyperplasia", "OBSERVATION", 304, 324], ["mucus", "OBSERVATION", 332, 337], ["glands", "ANATOMY", 348, 354], ["mucosa", "ANATOMY", 362, 368], ["gallbladder", "ANATOMY", 376, 387], ["incidental", "OBSERVATION_MODIFIER", 412, 422], ["lesion", "OBSERVATION", 423, 429], ["dogs", "OBSERVATION", 433, 437]]], ["These cystic hyperplastic nodules are often numerous, may be sessile or polypoid, and contain mucin (Fig. 2-105) .Hepatocellular tumorsDilation of the gallbladder with accumulated mucoid secretion (gallbladder mucocele) has been reported in dogs and infrequently in cats.", [["cystic hyperplastic nodules", "ANATOMY", 6, 33], ["polypoid", "ANATOMY", 72, 80], ["Hepatocellular", "ANATOMY", 114, 128], ["gallbladder", "ANATOMY", 151, 162], ["mucoid", "ANATOMY", 180, 186], ["gallbladder mucocele", "ANATOMY", 198, 218], ["gallbladder mucocele", "DISEASE", 198, 218], ["cystic hyperplastic nodules", "CANCER", 6, 33], ["polypoid", "CANCER", 72, 80], ["mucin", "GENE_OR_GENE_PRODUCT", 94, 99], ["Hepatocellular", "CANCER", 114, 128], ["gallbladder", "ORGAN", 151, 162], ["mucoid", "IMMATERIAL_ANATOMICAL_ENTITY", 180, 186], ["gallbladder mucocele", "PATHOLOGICAL_FORMATION", 198, 218], ["dogs", "ORGANISM", 241, 245], ["cats", "ORGANISM", 266, 270], ["dogs", "SPECIES", 241, 245], ["cats", "SPECIES", 266, 270], ["These cystic hyperplastic nodules", "PROBLEM", 0, 33], ["polypoid", "PROBLEM", 72, 80], ["mucin (Fig.", "TEST", 94, 105], ["Hepatocellular tumorsDilation of the gallbladder", "PROBLEM", 114, 162], ["accumulated mucoid secretion (gallbladder mucocele", "PROBLEM", 168, 218], ["cystic", "OBSERVATION_MODIFIER", 6, 12], ["hyperplastic", "OBSERVATION_MODIFIER", 13, 25], ["nodules", "OBSERVATION", 26, 33], ["may be", "UNCERTAINTY", 54, 60], ["sessile", "OBSERVATION_MODIFIER", 61, 68], ["polypoid", "OBSERVATION", 72, 80], ["gallbladder", "ANATOMY", 151, 162], ["accumulated", "OBSERVATION_MODIFIER", 168, 179], ["mucoid secretion", "OBSERVATION", 180, 196], ["gallbladder", "ANATOMY", 198, 209], ["mucocele", "OBSERVATION", 210, 218]]], ["Histologically, affected gallbladders display proliferated mucosa with characteristic projecting fronds of epithelium that extend into the lumen of the gallbladder, as well as formation of mucus-filled cysts.", [["gallbladders", "ANATOMY", 25, 37], ["mucosa", "ANATOMY", 59, 65], ["fronds", "ANATOMY", 97, 103], ["epithelium", "ANATOMY", 107, 117], ["lumen", "ANATOMY", 139, 144], ["gallbladder", "ANATOMY", 152, 163], ["mucus", "ANATOMY", 189, 194], ["cysts", "ANATOMY", 202, 207], ["gallbladders", "ORGAN", 25, 37], ["mucosa", "MULTI-TISSUE_STRUCTURE", 59, 65], ["epithelium", "TISSUE", 107, 117], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 139, 144], ["gallbladder", "ORGAN", 152, 163], ["mucus", "PATHOLOGICAL_FORMATION", 189, 194], ["cysts", "PATHOLOGICAL_FORMATION", 202, 207], ["proliferated mucosa", "PROBLEM", 46, 65], ["mucus-filled cysts", "PROBLEM", 189, 207], ["gallbladders", "ANATOMY", 25, 37], ["proliferated mucosa", "OBSERVATION", 46, 65], ["epithelium", "ANATOMY_MODIFIER", 107, 117], ["lumen", "ANATOMY_MODIFIER", 139, 144], ["gallbladder", "ANATOMY", 152, 163], ["mucus", "OBSERVATION_MODIFIER", 189, 194], ["filled", "OBSERVATION_MODIFIER", 195, 201], ["cysts", "OBSERVATION", 202, 207]]], ["Severely affected gallbladders are distended with abnormal semisolid accumulations of mucus or other secretions, and the wall may undergo ischemic necrosis and rupture ( Fig. 2-106) .", [["gallbladders", "ANATOMY", 18, 30], ["mucus", "ANATOMY", 86, 91], ["secretions", "ANATOMY", 101, 111], ["wall", "ANATOMY", 121, 125], ["necrosis", "DISEASE", 147, 155], ["rupture", "DISEASE", 160, 167], ["gallbladders", "MULTI-TISSUE_STRUCTURE", 18, 30], ["mucus", "ORGANISM_SUBSTANCE", 86, 91], ["wall", "TISSUE", 121, 125], ["Severely affected gallbladders", "PROBLEM", 0, 30], ["distended", "PROBLEM", 35, 44], ["abnormal semisolid accumulations of mucus or other secretions", "PROBLEM", 50, 111], ["ischemic necrosis", "PROBLEM", 138, 155], ["rupture", "PROBLEM", 160, 167], ["Fig.", "TEST", 170, 174], ["affected", "OBSERVATION", 9, 17], ["gallbladders", "ANATOMY", 18, 30], ["distended", "OBSERVATION", 35, 44], ["abnormal", "OBSERVATION_MODIFIER", 50, 58], ["semisolid accumulations", "OBSERVATION", 59, 82], ["mucus", "OBSERVATION", 86, 91], ["secretions", "OBSERVATION", 101, 111], ["wall", "ANATOMY_MODIFIER", 121, 125], ["may undergo", "UNCERTAINTY", 126, 137], ["ischemic", "OBSERVATION_MODIFIER", 138, 146], ["necrosis", "OBSERVATION", 147, 155], ["rupture", "OBSERVATION", 160, 167]]], ["Bile-laden mucus may also extend into the cystic, hepatic, and common bile ducts, resulting in variable degrees of extrahepatic biliary obstruction.", [["Bile", "ANATOMY", 0, 4], ["mucus", "ANATOMY", 11, 16], ["cystic", "ANATOMY", 42, 48], ["hepatic", "ANATOMY", 50, 57], ["bile ducts", "ANATOMY", 70, 80], ["extrahepatic biliary", "ANATOMY", 115, 135], ["extrahepatic biliary obstruction", "DISEASE", 115, 147], ["mucus", "ORGANISM_SUBSTANCE", 11, 16], ["cystic", "ORGAN", 42, 48], ["hepatic", "ORGAN", 50, 57], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 70, 80], ["extrahepatic biliary obstruction", "PATHOLOGICAL_FORMATION", 115, 147], ["Bile-laden mucus", "PROBLEM", 0, 16], ["variable degrees of extrahepatic biliary obstruction", "PROBLEM", 95, 147], ["laden", "OBSERVATION_MODIFIER", 5, 10], ["mucus", "OBSERVATION", 11, 16], ["cystic", "OBSERVATION", 42, 48], ["hepatic", "ANATOMY", 50, 57], ["common", "ANATOMY_MODIFIER", 63, 69], ["bile ducts", "ANATOMY", 70, 80], ["variable", "OBSERVATION_MODIFIER", 95, 103], ["degrees", "OBSERVATION_MODIFIER", 104, 111], ["extrahepatic", "ANATOMY_MODIFIER", 115, 127], ["biliary", "ANATOMY", 128, 135], ["obstruction", "OBSERVATION", 136, 147]]], ["The etiology of this condition is unknown, and intravascular spread may extend to the large hepatic veins and vena cava.", [["intravascular", "ANATOMY", 47, 60], ["hepatic veins", "ANATOMY", 92, 105], ["vena cava", "ANATOMY", 110, 119], ["intravascular", "IMMATERIAL_ANATOMICAL_ENTITY", 47, 60], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 92, 105], ["vena cava", "MULTI-TISSUE_STRUCTURE", 110, 119], ["this condition", "PROBLEM", 16, 30], ["intravascular spread", "PROBLEM", 47, 67], ["condition", "OBSERVATION", 21, 30], ["intravascular spread", "OBSERVATION", 47, 67], ["large", "ANATOMY_MODIFIER", 86, 91], ["hepatic veins", "ANATOMY", 92, 105], ["vena cava", "ANATOMY", 110, 119]]], ["Carcinomas occasionally penetrate the capsule to implant on the peritoneum.", [["Carcinomas", "ANATOMY", 0, 10], ["capsule", "ANATOMY", 38, 45], ["peritoneum", "ANATOMY", 64, 74], ["Carcinomas", "DISEASE", 0, 10], ["Carcinomas", "CANCER", 0, 10], ["capsule", "CANCER", 38, 45], ["peritoneum", "MULTI-TISSUE_STRUCTURE", 64, 74], ["Carcinomas", "PROBLEM", 0, 10], ["capsule", "OBSERVATION_MODIFIER", 38, 45], ["implant", "OBSERVATION", 49, 56], ["peritoneum", "ANATOMY", 64, 74]]], ["Metastasis is uncommon in all domestic species but, when present, may be evident in the hepatic lymph node most often.", [["hepatic lymph node", "ANATOMY", 88, 106], ["Metastasis", "DISEASE", 0, 10], ["hepatic lymph node", "MULTI-TISSUE_STRUCTURE", 88, 106], ["Metastasis", "PROBLEM", 0, 10], ["uncommon", "OBSERVATION_MODIFIER", 14, 22], ["all", "OBSERVATION_MODIFIER", 26, 29], ["domestic species", "OBSERVATION", 30, 46], ["may be evident", "UNCERTAINTY", 66, 80], ["hepatic", "ANATOMY", 88, 95], ["lymph node", "OBSERVATION", 96, 106]]], ["Hematogenous metastases occur first in the lungs.", [["Hematogenous metastases", "ANATOMY", 0, 23], ["lungs", "ANATOMY", 43, 48], ["metastases", "DISEASE", 13, 23], ["lungs", "ORGAN", 43, 48], ["Hematogenous metastases", "PROBLEM", 0, 23], ["metastases", "OBSERVATION", 13, 23], ["lungs", "ANATOMY", 43, 48]]], ["Spontaneous rupture is common and may cause fatal blood loss.", [["blood", "ANATOMY", 50, 55], ["Spontaneous rupture", "DISEASE", 0, 19], ["blood loss", "DISEASE", 50, 60], ["blood", "ORGANISM_SUBSTANCE", 50, 55], ["Spontaneous rupture", "PROBLEM", 0, 19], ["fatal blood loss", "PROBLEM", 44, 60], ["rupture", "OBSERVATION", 12, 19], ["may cause", "UNCERTAINTY", 34, 43], ["fatal", "OBSERVATION_MODIFIER", 44, 49], ["blood loss", "OBSERVATION", 50, 60]]], ["This consequence is a much more frequent cause of morbidity and mortality than metastatic disease.", [["metastatic disease", "CANCER", 79, 97], ["morbidity", "PROBLEM", 50, 59], ["metastatic disease", "PROBLEM", 79, 97], ["morbidity", "OBSERVATION", 50, 59], ["metastatic", "OBSERVATION", 79, 89]]], ["Some hepatocellular carcinomas in cattle are scirrhous, hard, and white.", [["hepatocellular carcinomas", "ANATOMY", 5, 30], ["scirrhous", "ANATOMY", 45, 54], ["hepatocellular carcinomas", "DISEASE", 5, 30], ["hepatocellular carcinomas", "CANCER", 5, 30], ["cattle", "ORGANISM", 34, 40], ["scirrhous", "CANCER", 45, 54], ["cattle", "SPECIES", 34, 40], ["cattle", "SPECIES", 34, 40], ["Some hepatocellular carcinomas", "PROBLEM", 0, 30], ["scirrhous", "PROBLEM", 45, 54], ["hepatocellular", "ANATOMY", 5, 19], ["carcinomas", "OBSERVATION", 20, 30], ["cattle", "OBSERVATION_MODIFIER", 34, 40], ["scirrhous", "OBSERVATION_MODIFIER", 45, 54], ["hard", "OBSERVATION_MODIFIER", 56, 60]]], ["Paraneoplastic hypoglycemia may occur in animals with hepatocellular carcinoma.", [["hepatocellular carcinoma", "ANATOMY", 54, 78], ["Paraneoplastic hypoglycemia", "DISEASE", 0, 27], ["hepatocellular carcinoma", "DISEASE", 54, 78], ["hepatocellular carcinoma", "CANCER", 54, 78], ["Paraneoplastic hypoglycemia", "PROBLEM", 0, 27], ["hepatocellular carcinoma", "PROBLEM", 54, 78], ["hepatocellular", "ANATOMY", 54, 68], ["carcinoma", "OBSERVATION", 69, 78]]], ["Hepatocellular carcinomas may be quite variable in histologic appearance, and multiple patterns may occur within a single neoplasm.", [["Hepatocellular carcinomas", "ANATOMY", 0, 25], ["neoplasm", "ANATOMY", 122, 130], ["Hepatocellular carcinomas", "DISEASE", 0, 25], ["neoplasm", "DISEASE", 122, 130], ["Hepatocellular carcinomas", "CANCER", 0, 25], ["neoplasm", "CANCER", 122, 130], ["Hepatocellular carcinomas", "PROBLEM", 0, 25], ["a single neoplasm", "PROBLEM", 113, 130], ["carcinomas", "OBSERVATION", 15, 25], ["variable", "OBSERVATION_MODIFIER", 39, 47], ["histologic", "OBSERVATION", 51, 61], ["multiple", "OBSERVATION_MODIFIER", 78, 86], ["single", "OBSERVATION_MODIFIER", 115, 121], ["neoplasm", "OBSERVATION", 122, 130]]], ["Trabecular carcinomas are the most common histologic pattern (Fig. 2-109 ).", [["Trabecular carcinomas", "ANATOMY", 0, 21], ["Trabecular carcinomas", "DISEASE", 0, 21], ["Trabecular carcinomas", "CANCER", 0, 21], ["Trabecular carcinomas", "PROBLEM", 0, 21], ["carcinomas", "OBSERVATION", 11, 21], ["most common", "OBSERVATION_MODIFIER", 30, 41]]], ["Neoplastic cells resemble normal liver, and grow in irregularly thick plates or trabeculae that vary from few to many cells thick.", [["Neoplastic cells", "ANATOMY", 0, 16], ["liver", "ANATOMY", 33, 38], ["trabeculae", "ANATOMY", 80, 90], ["cells", "ANATOMY", 118, 123], ["Neoplastic cells", "CELL", 0, 16], ["liver", "ORGAN", 33, 38], ["trabeculae", "TISSUE", 80, 90], ["cells", "CELL", 118, 123], ["Neoplastic cells", "CELL_TYPE", 0, 16], ["Neoplastic cells", "PROBLEM", 0, 16], ["irregularly thick plates or trabeculae", "PROBLEM", 52, 90], ["normal", "OBSERVATION", 26, 32], ["liver", "ANATOMY", 33, 38], ["irregularly", "OBSERVATION_MODIFIER", 52, 63], ["thick plates", "OBSERVATION", 64, 76], ["trabeculae", "ANATOMY", 80, 90], ["few", "OBSERVATION_MODIFIER", 106, 109], ["cells thick", "OBSERVATION", 118, 129]]], ["Necrosis may be present, and sinusoids may be dilated, and there may be large ectatic blood-filled spaces.", [["sinusoids", "ANATOMY", 29, 38], ["blood", "ANATOMY", 86, 91], ["Necrosis", "DISEASE", 0, 8], ["sinusoids", "TISSUE", 29, 38], ["blood", "ORGANISM_SUBSTANCE", 86, 91], ["Necrosis", "PROBLEM", 0, 8], ["dilated", "PROBLEM", 46, 53], ["large ectatic blood-filled spaces", "PROBLEM", 72, 105], ["may be", "UNCERTAINTY", 9, 15], ["may be", "UNCERTAINTY", 39, 45], ["dilated", "OBSERVATION", 46, 53], ["may be", "UNCERTAINTY", 65, 71], ["large", "OBSERVATION_MODIFIER", 72, 77], ["ectatic", "OBSERVATION_MODIFIER", 78, 85], ["blood", "OBSERVATION", 86, 91], ["filled spaces", "OBSERVATION", 92, 105]]], ["Other patterns include pseudoglandular (adenoid) carcinomas, characterized by lobular arrangement of neoplastic hepatocytes within scant connective-tissue stroma, and solid carcinomas, characterized by solid sheets of poorly differentiated, often pleomorphic cells that do not form sinusoids ( Fig. 2-110A, B) .", [["pseudoglandular (adenoid) carcinomas", "ANATOMY", 23, 59], ["lobular", "ANATOMY", 78, 85], ["neoplastic hepatocytes", "ANATOMY", 101, 123], ["connective-tissue stroma", "ANATOMY", 137, 161], ["solid carcinomas", "ANATOMY", 167, 183], ["pleomorphic cells", "ANATOMY", 247, 264], ["sinusoids", "ANATOMY", 282, 291], ["adenoid) carcinomas", "DISEASE", 40, 59], ["carcinomas", "DISEASE", 173, 183], ["adenoid) carcinomas", "CANCER", 40, 59], ["neoplastic hepatocytes", "CELL", 101, 123], ["scant connective-tissue stroma", "TISSUE", 131, 161], ["solid carcinomas", "CANCER", 167, 183], ["pleomorphic cells", "CELL", 247, 264], ["sinusoids", "TISSUE", 282, 291], ["B", "CELL", 307, 308], ["neoplastic hepatocytes", "CELL_TYPE", 101, 123], ["pleomorphic cells", "CELL_TYPE", 247, 264], ["pseudoglandular (adenoid) carcinomas", "PROBLEM", 23, 59], ["neoplastic hepatocytes", "PROBLEM", 101, 123], ["scant connective-tissue stroma", "PROBLEM", 131, 161], ["solid carcinomas", "PROBLEM", 167, 183], ["poorly differentiated, often pleomorphic cells", "PROBLEM", 218, 264], ["pseudoglandular", "OBSERVATION_MODIFIER", 23, 38], ["adenoid", "ANATOMY", 40, 47], ["carcinomas", "OBSERVATION", 49, 59], ["lobular", "OBSERVATION_MODIFIER", 78, 85], ["neoplastic hepatocytes", "OBSERVATION", 101, 123], ["scant", "OBSERVATION_MODIFIER", 131, 136], ["connective-tissue stroma", "OBSERVATION", 137, 161], ["solid carcinomas", "OBSERVATION", 167, 183], ["poorly differentiated", "OBSERVATION_MODIFIER", 218, 239], ["pleomorphic cells", "OBSERVATION", 247, 264]]], ["A scirrhous variant has been described in dogs, characterized by multiple foci of cytokeratin 19positive ductular structures embedded in abundant fibrous stroma ( Fig. 2-111A, B) .", [["foci", "ANATOMY", 74, 78], ["ductular structures", "ANATOMY", 105, 124], ["fibrous stroma", "ANATOMY", 146, 160], ["scirrhous", "CANCER", 2, 11], ["dogs", "ORGANISM", 42, 46], ["cytokeratin 19", "GENE_OR_GENE_PRODUCT", 82, 96], ["ductular structures", "TISSUE", 105, 124], ["fibrous stroma", "TISSUE", 146, 160], ["B", "GENE_OR_GENE_PRODUCT", 176, 177], ["cytokeratin 19", "PROTEIN", 82, 96], ["dogs", "SPECIES", 42, 46], ["A scirrhous variant", "PROBLEM", 0, 19], ["cytokeratin 19positive ductular structures", "PROBLEM", 82, 124], ["scirrhous variant", "OBSERVATION", 2, 19], ["multiple", "OBSERVATION_MODIFIER", 65, 73], ["foci", "OBSERVATION", 74, 78], ["cytokeratin 19", "OBSERVATION_MODIFIER", 82, 96], ["positive", "OBSERVATION_MODIFIER", 96, 104], ["ductular structures", "OBSERVATION", 105, 124], ["abundant", "OBSERVATION_MODIFIER", 137, 145], ["fibrous stroma", "OBSERVATION", 146, 160]]], ["A feature of some hepatocellular tumors is the presence of giant cells, quite conspicuous by virtue of a large nucleus, multilobed nuclei, or multiple nuclei.", [["hepatocellular tumors", "ANATOMY", 18, 39], ["giant cells", "ANATOMY", 59, 70], ["nucleus", "ANATOMY", 111, 118], ["nuclei", "ANATOMY", 131, 137], ["nuclei", "ANATOMY", 151, 157], ["hepatocellular tumors", "DISEASE", 18, 39], ["hepatocellular tumors", "CANCER", 18, 39], ["giant cells", "CELL", 59, 70], ["nucleus", "CELLULAR_COMPONENT", 111, 118], ["nuclei", "CELLULAR_COMPONENT", 131, 137], ["nuclei", "CELLULAR_COMPONENT", 151, 157], ["giant cells", "CELL_TYPE", 59, 70], ["some hepatocellular tumors", "PROBLEM", 13, 39], ["giant cells", "PROBLEM", 59, 70], ["a large nucleus, multilobed nuclei", "PROBLEM", 103, 137], ["multiple nuclei", "PROBLEM", 142, 157], ["some", "OBSERVATION_MODIFIER", 13, 17], ["hepatocellular", "ANATOMY", 18, 32], ["tumors", "OBSERVATION", 33, 39], ["giant cells", "OBSERVATION", 59, 70], ["large", "OBSERVATION_MODIFIER", 105, 110], ["nucleus", "ANATOMY_MODIFIER", 111, 118], ["multilobed nuclei", "OBSERVATION", 120, 137], ["multiple", "OBSERVATION_MODIFIER", 142, 150], ["nuclei", "OBSERVATION", 151, 157]]], ["Mitotic figures are more frequent in carcinomas than adenomas, but may not be a prominent feature of well-differentiated carcinomas.", [["carcinomas", "ANATOMY", 37, 47], ["adenomas", "ANATOMY", 53, 61], ["carcinomas", "ANATOMY", 121, 131], ["carcinomas", "DISEASE", 37, 47], ["adenomas", "DISEASE", 53, 61], ["carcinomas", "DISEASE", 121, 131], ["carcinomas", "CANCER", 37, 47], ["adenomas", "CANCER", 53, 61], ["carcinomas", "CANCER", 121, 131], ["Mitotic figures", "PROBLEM", 0, 15], ["carcinomas than adenomas", "PROBLEM", 37, 61], ["well-differentiated carcinomas", "PROBLEM", 101, 131], ["more", "OBSERVATION_MODIFIER", 20, 24], ["frequent", "OBSERVATION_MODIFIER", 25, 33], ["carcinomas", "OBSERVATION", 37, 47], ["adenomas", "OBSERVATION", 53, 61], ["may not be", "UNCERTAINTY", 67, 77], ["prominent", "OBSERVATION_MODIFIER", 80, 89], ["well-differentiated", "OBSERVATION_MODIFIER", 101, 120], ["carcinomas", "OBSERVATION", 121, 131]]], ["Immunohistochemical staining using antibodies that bind a hepatocyte specific antigen, HepPar1, identifies a large proportion of canine and feline hepatocellular carcinomas.", [["hepatocyte", "ANATOMY", 58, 68], ["hepatocellular carcinomas", "ANATOMY", 147, 172], ["feline hepatocellular carcinomas", "DISEASE", 140, 172], ["hepatocyte specific antigen", "GENE_OR_GENE_PRODUCT", 58, 85], ["HepPar1", "GENE_OR_GENE_PRODUCT", 87, 94], ["canine", "ORGANISM", 129, 135], ["feline", "ORGANISM", 140, 146], ["hepatocellular carcinomas", "CANCER", 147, 172], ["antibodies", "PROTEIN", 35, 45], ["hepatocyte specific antigen", "PROTEIN", 58, 85], ["HepPar1", "PROTEIN", 87, 94], ["canine", "SPECIES", 129, 135], ["feline", "SPECIES", 140, 146], ["canine", "SPECIES", 129, 135], ["Immunohistochemical staining", "TEST", 0, 28], ["antibodies", "TEST", 35, 45], ["a hepatocyte specific antigen", "TEST", 56, 85], ["canine and feline hepatocellular carcinomas", "PROBLEM", 129, 172], ["large", "OBSERVATION_MODIFIER", 109, 114], ["canine", "OBSERVATION", 129, 135], ["feline", "OBSERVATION_MODIFIER", 140, 146], ["hepatocellular carcinomas", "OBSERVATION", 147, 172]]], ["However, more aggressive forms of canine hepatocellular carcinoma may not stain with HepPar1, but instead >5% of animals are not obvious successors to recognized antecedent liver diseases.Hepatocellular tumorsHepatocellular adenomas are benign neoplasms of hepatocytes.", [["hepatocellular carcinoma", "ANATOMY", 41, 65], ["liver", "ANATOMY", 173, 178], ["Hepatocellular tumorsHepatocellular adenomas", "ANATOMY", 188, 232], ["benign neoplasms", "ANATOMY", 237, 253], ["hepatocytes", "ANATOMY", 257, 268], ["canine hepatocellular carcinoma", "DISEASE", 34, 65], ["liver diseases", "DISEASE", 173, 187], ["Hepatocellular tumors", "DISEASE", 188, 209], ["Hepatocellular adenomas", "DISEASE", 209, 232], ["neoplasms", "DISEASE", 244, 253], ["canine", "ORGANISM", 34, 40], ["hepatocellular carcinoma", "CANCER", 41, 65], ["HepPar1", "GENE_OR_GENE_PRODUCT", 85, 92], ["liver", "ORGAN", 173, 178], ["Hepatocellular tumors", "CANCER", 188, 209], ["Hepatocellular adenomas", "CANCER", 209, 232], ["benign neoplasms", "CANCER", 237, 253], ["hepatocytes", "CELL", 257, 268], ["HepPar1", "PROTEIN", 85, 92], ["hepatocytes", "CELL_TYPE", 257, 268], ["canine", "SPECIES", 34, 40], ["canine hepatocellular carcinoma", "PROBLEM", 34, 65], ["HepPar1", "TREATMENT", 85, 92], ["antecedent liver diseases", "PROBLEM", 162, 187], ["Hepatocellular tumors", "PROBLEM", 188, 209], ["Hepatocellular adenomas", "PROBLEM", 209, 232], ["benign neoplasms of hepatocytes", "PROBLEM", 237, 268], ["aggressive", "OBSERVATION_MODIFIER", 14, 24], ["hepatocellular carcinoma", "OBSERVATION", 41, 65], ["liver", "ANATOMY", 173, 178], ["diseases", "OBSERVATION", 179, 187], ["tumors", "OBSERVATION", 203, 209], ["Hepatocellular adenomas", "OBSERVATION", 209, 232], ["benign", "OBSERVATION_MODIFIER", 237, 243], ["neoplasms", "OBSERVATION", 244, 253], ["hepatocytes", "ANATOMY", 257, 268]]], ["Hepatocellular adenomas are reported in dogs, cats, cattle, sheep, and pigs, but likely occur in all species.", [["Hepatocellular adenomas", "ANATOMY", 0, 23], ["Hepatocellular adenomas", "DISEASE", 0, 23], ["Hepatocellular adenomas", "CANCER", 0, 23], ["dogs", "ORGANISM", 40, 44], ["cats", "ORGANISM", 46, 50], ["sheep", "ORGANISM", 60, 65], ["pigs", "ORGANISM", 71, 75], ["dogs", "SPECIES", 40, 44], ["cats", "SPECIES", 46, 50], ["cattle", "SPECIES", 52, 58], ["sheep", "SPECIES", 60, 65], ["pigs", "SPECIES", 71, 75], ["cattle", "SPECIES", 52, 58], ["sheep", "SPECIES", 60, 65], ["pigs", "SPECIES", 71, 75], ["Hepatocellular adenomas", "PROBLEM", 0, 23], ["pigs", "TREATMENT", 71, 75], ["adenomas", "OBSERVATION", 15, 23]]], ["Hepatocellular adenomas are typically solitary, but they can be multiple.", [["Hepatocellular adenomas", "ANATOMY", 0, 23], ["Hepatocellular adenomas", "DISEASE", 0, 23], ["Hepatocellular adenomas", "CANCER", 0, 23], ["Hepatocellular adenomas", "PROBLEM", 0, 23], ["adenomas", "OBSERVATION", 15, 23], ["multiple", "OBSERVATION_MODIFIER", 64, 72]]], ["They range from 2-12 cm in diameter and are roughly spherical masses.", [["masses", "CANCER", 62, 68], ["roughly spherical masses", "PROBLEM", 44, 68], ["range", "OBSERVATION_MODIFIER", 5, 10], ["2-12 cm", "OBSERVATION_MODIFIER", 16, 23], ["roughly", "OBSERVATION_MODIFIER", 44, 51], ["spherical", "OBSERVATION_MODIFIER", 52, 61], ["masses", "OBSERVATION", 62, 68]]], ["Typically, they are well demarcated from the adjacent parenchyma because of the compression caused by their expanding growth, but not encapsulated.", [["parenchyma", "ANATOMY", 54, 64], ["parenchyma", "TISSUE", 54, 64], ["the compression", "PROBLEM", 76, 91], ["their expanding growth", "PROBLEM", 102, 124], ["parenchyma", "ANATOMY_MODIFIER", 54, 64], ["compression", "OBSERVATION", 80, 91], ["expanding", "OBSERVATION_MODIFIER", 108, 117], ["growth", "OBSERVATION_MODIFIER", 118, 124], ["not", "UNCERTAINTY", 130, 133], ["encapsulated", "OBSERVATION_MODIFIER", 134, 146]]], ["Hepatocellular adenomas often bulge from the capsular surface, or they can be pedunculated, and in some instances, they may be found entirely within the hepatic parenchyma.", [["Hepatocellular adenomas", "ANATOMY", 0, 23], ["capsular surface", "ANATOMY", 45, 61], ["hepatic parenchyma", "ANATOMY", 153, 171], ["Hepatocellular adenomas", "DISEASE", 0, 23], ["Hepatocellular adenomas", "CANCER", 0, 23], ["capsular surface", "CELLULAR_COMPONENT", 45, 61], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 153, 171], ["Hepatocellular adenomas", "PROBLEM", 0, 23], ["adenomas", "OBSERVATION", 15, 23], ["bulge", "OBSERVATION", 30, 35], ["capsular", "OBSERVATION_MODIFIER", 45, 53], ["surface", "OBSERVATION_MODIFIER", 54, 61], ["pedunculated", "OBSERVATION_MODIFIER", 78, 90], ["hepatic", "ANATOMY", 153, 160], ["parenchyma", "ANATOMY_MODIFIER", 161, 171]]], ["The color of hepatocellular adenomas varies from yellow-brown to dark mahogany red.", [["hepatocellular adenomas", "ANATOMY", 13, 36], ["hepatocellular adenomas", "DISEASE", 13, 36], ["hepatocellular adenomas", "CANCER", 13, 36], ["hepatocellular adenomas", "PROBLEM", 13, 36], ["dark mahogany red", "PROBLEM", 65, 82], ["color", "OBSERVATION_MODIFIER", 4, 9], ["hepatocellular", "ANATOMY", 13, 27], ["adenomas", "OBSERVATION", 28, 36], ["yellow", "OBSERVATION_MODIFIER", 49, 55], ["brown to dark", "OBSERVATION_MODIFIER", 56, 69], ["mahogany red", "OBSERVATION", 70, 82]]], ["Paler adenomas contain lipid or glycogen, and these lesions often have a soft and friable consistency compared to normal liver ( Fig. 2-107) .Hepatocellular tumorsHistologically, the hepatocytes in hepatic adenomas do not differ markedly from normal hepatocytes or those in hyperplastic nodules, and often contain lipid, glycogen, or occasionally protein secretory vacuoles.", [["Paler adenomas", "ANATOMY", 0, 14], ["lesions", "ANATOMY", 52, 59], ["liver", "ANATOMY", 121, 126], ["Hepatocellular tumors", "ANATOMY", 142, 163], ["hepatocytes", "ANATOMY", 183, 194], ["hepatic adenomas", "ANATOMY", 198, 214], ["hepatocytes", "ANATOMY", 250, 261], ["hyperplastic nodules", "ANATOMY", 274, 294], ["secretory vacuoles", "ANATOMY", 355, 373], ["adenomas", "DISEASE", 6, 14], ["Hepatocellular tumors", "DISEASE", 142, 163], ["hepatic adenomas", "DISEASE", 198, 214], ["Paler adenomas", "CANCER", 0, 14], ["lipid", "SIMPLE_CHEMICAL", 23, 28], ["glycogen", "SIMPLE_CHEMICAL", 32, 40], ["lesions", "PATHOLOGICAL_FORMATION", 52, 59], ["liver", "ORGAN", 121, 126], ["Hepatocellular tumors", "CANCER", 142, 163], ["hepatocytes", "CELL", 183, 194], ["hepatic adenomas", "CANCER", 198, 214], ["hepatocytes", "CELL", 250, 261], ["hyperplastic nodules", "CANCER", 274, 294], ["lipid", "SIMPLE_CHEMICAL", 314, 319], ["glycogen", "SIMPLE_CHEMICAL", 321, 329], ["secretory vacuoles", "CELLULAR_COMPONENT", 355, 373], ["hepatocytes", "CELL_TYPE", 183, 194], ["normal hepatocytes", "CELL_TYPE", 243, 261], ["Paler adenomas", "PROBLEM", 0, 14], ["lipid or glycogen", "PROBLEM", 23, 40], ["these lesions", "PROBLEM", 46, 59], ["a soft and friable consistency", "PROBLEM", 71, 101], ["Hepatocellular tumors", "PROBLEM", 142, 163], ["the hepatocytes in hepatic adenomas", "PROBLEM", 179, 214], ["hyperplastic nodules", "PROBLEM", 274, 294], ["lipid, glycogen", "TEST", 314, 329], ["occasionally protein secretory vacuoles", "PROBLEM", 334, 373], ["adenomas", "OBSERVATION", 6, 14], ["lipid", "OBSERVATION_MODIFIER", 23, 28], ["lesions", "OBSERVATION", 52, 59], ["soft", "ANATOMY", 73, 77], ["friable", "OBSERVATION_MODIFIER", 82, 89], ["consistency", "OBSERVATION", 90, 101], ["normal", "OBSERVATION", 114, 120], ["liver", "ANATOMY", 121, 126], ["tumors", "OBSERVATION", 157, 163], ["hepatocytes", "ANATOMY", 183, 194], ["hepatic", "ANATOMY", 198, 205], ["adenomas", "OBSERVATION", 206, 214], ["markedly", "OBSERVATION_MODIFIER", 229, 237], ["normal", "OBSERVATION", 243, 249], ["hepatocytes", "ANATOMY", 250, 261], ["hyperplastic", "OBSERVATION_MODIFIER", 274, 286], ["nodules", "OBSERVATION", 287, 294], ["lipid", "OBSERVATION_MODIFIER", 314, 319], ["secretory vacuoles", "OBSERVATION", 355, 373]]], ["Minimal anisocytosis and increased basophilia of the cytoplasm and prominence of nucleoli can be seen, but mitotic figures are uncommon.", [["cytoplasm", "ANATOMY", 53, 62], ["nucleoli", "ANATOMY", 81, 89], ["cytoplasm", "ORGANISM_SUBSTANCE", 53, 62], ["nucleoli", "CELLULAR_COMPONENT", 81, 89], ["Minimal anisocytosis", "PROBLEM", 0, 20], ["increased basophilia of the cytoplasm", "PROBLEM", 25, 62], ["prominence of nucleoli", "PROBLEM", 67, 89], ["anisocytosis", "OBSERVATION", 8, 20], ["increased", "OBSERVATION_MODIFIER", 25, 34], ["basophilia", "OBSERVATION", 35, 45], ["cytoplasm", "OBSERVATION_MODIFIER", 53, 62], ["prominence", "OBSERVATION_MODIFIER", 67, 77], ["nucleoli", "OBSERVATION", 81, 89], ["can be seen", "UNCERTAINTY", 90, 101], ["mitotic figures", "OBSERVATION", 107, 122]]], ["Cells are arranged in cords or trabeculae that may be several cells thick, but the width tends to be consistent.", [["Cells", "ANATOMY", 0, 5], ["cords", "ANATOMY", 22, 27], ["trabeculae", "ANATOMY", 31, 41], ["cells", "ANATOMY", 62, 67], ["Cells", "CELL", 0, 5], ["cords", "TISSUE", 22, 27], ["trabeculae", "TISSUE", 31, 41], ["cells", "CELL", 62, 67], ["several cells thick", "PROBLEM", 54, 73], ["trabeculae", "ANATOMY", 31, 41], ["may be", "UNCERTAINTY", 47, 53], ["several", "OBSERVATION_MODIFIER", 54, 61], ["cells thick", "OBSERVATION", 62, 73]]], ["There is a discrete welldefined border with adjacent parenchyma (Fig. 2-108) .", [["parenchyma", "ANATOMY", 53, 63], ["parenchyma", "TISSUE", 53, 63], ["a discrete welldefined border", "PROBLEM", 9, 38], ["discrete", "OBSERVATION_MODIFIER", 11, 19], ["welldefined", "OBSERVATION_MODIFIER", 20, 31], ["border", "ANATOMY_MODIFIER", 32, 38], ["parenchyma", "ANATOMY_MODIFIER", 53, 63]]], ["Adenomas lack normal lobular architecture.", [["Adenomas", "ANATOMY", 0, 8], ["lobular", "ANATOMY", 21, 28], ["Adenomas", "CANCER", 0, 8], ["lobular architecture", "MULTI-TISSUE_STRUCTURE", 21, 41], ["Adenomas", "PROBLEM", 0, 8], ["normal", "OBSERVATION", 14, 20], ["lobular architecture", "OBSERVATION", 21, 41]]], ["Essentially all of the blood supplying adenomas comes from the hepatic artery.", [["blood", "ANATOMY", 23, 28], ["adenomas", "ANATOMY", 39, 47], ["hepatic artery", "ANATOMY", 63, 77], ["adenomas", "DISEASE", 39, 47], ["blood", "ORGANISM_SUBSTANCE", 23, 28], ["adenomas", "CANCER", 39, 47], ["hepatic artery", "MULTI-TISSUE_STRUCTURE", 63, 77], ["the blood supplying adenomas", "PROBLEM", 19, 47], ["all", "OBSERVATION_MODIFIER", 12, 15], ["adenomas", "OBSERVATION", 39, 47], ["hepatic artery", "ANATOMY", 63, 77]]], ["As a consequence, rather than portal tracts, isolated arteries, bile ducts, and hepatic veins can be found coursing through the mass.", [["portal tracts", "ANATOMY", 30, 43], ["arteries", "ANATOMY", 54, 62], ["bile ducts", "ANATOMY", 64, 74], ["hepatic veins", "ANATOMY", 80, 93], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 30, 43], ["isolated arteries", "MULTI-TISSUE_STRUCTURE", 45, 62], ["bile ducts", "MULTI-TISSUE_STRUCTURE", 64, 74], ["hepatic veins", "MULTI-TISSUE_STRUCTURE", 80, 93], ["isolated arteries, bile ducts, and hepatic veins", "PROBLEM", 45, 93], ["the mass", "PROBLEM", 124, 132], ["portal tracts", "ANATOMY", 30, 43], ["arteries", "ANATOMY", 54, 62], ["bile ducts", "ANATOMY", 64, 74], ["hepatic veins", "ANATOMY", 80, 93], ["mass", "OBSERVATION", 128, 132]]], ["Usually, no more than a single portal tract may be present, likely entrapped by the expanding hepatocyte population.", [["portal tract", "ANATOMY", 31, 43], ["hepatocyte", "ANATOMY", 94, 104], ["portal tract", "MULTI-TISSUE_STRUCTURE", 31, 43], ["hepatocyte population", "CELL", 94, 115], ["hepatocyte population", "CELL_TYPE", 94, 115], ["no", "UNCERTAINTY", 9, 11], ["portal tract", "ANATOMY", 31, 43], ["entrapped", "OBSERVATION_MODIFIER", 67, 76], ["expanding", "OBSERVATION_MODIFIER", 84, 93], ["hepatocyte population", "OBSERVATION", 94, 115]]], ["Extramedullary hematopoietic foci may sometimes be found in the adenomas, as well as ectatic vascular spaces.", [["Extramedullary hematopoietic foci", "ANATOMY", 0, 33], ["adenomas", "ANATOMY", 64, 72], ["vascular", "ANATOMY", 93, 101], ["adenomas", "DISEASE", 64, 72], ["hematopoietic foci", "CELL", 15, 33], ["adenomas", "CANCER", 64, 72], ["ectatic vascular", "MULTI-TISSUE_STRUCTURE", 85, 101], ["Extramedullary hematopoietic foci", "PROBLEM", 0, 33], ["the adenomas", "PROBLEM", 60, 72], ["ectatic vascular spaces", "PROBLEM", 85, 108], ["hematopoietic", "ANATOMY", 15, 28], ["foci", "OBSERVATION", 29, 33], ["adenomas", "OBSERVATION", 64, 72], ["ectatic", "OBSERVATION", 85, 92], ["vascular", "ANATOMY", 93, 101]]], ["Focal necrosis may occur.Hepatocellular tumorsHepatocellular carcinomas are uncommon, but occur in all veterinary species; they may be single and massive, nodular or diffuse.", [["Hepatocellular tumorsHepatocellular carcinomas", "ANATOMY", 25, 71], ["necrosis", "DISEASE", 6, 14], ["Hepatocellular tumors", "DISEASE", 25, 46], ["Hepatocellular carcinomas", "DISEASE", 46, 71], ["Hepatocellular tumors", "CANCER", 25, 46], ["Hepatocellular carcinomas", "CANCER", 46, 71], ["Focal necrosis", "PROBLEM", 0, 14], ["Hepatocellular tumors", "PROBLEM", 25, 46], ["Hepatocellular carcinomas", "PROBLEM", 46, 71], ["single and massive, nodular", "PROBLEM", 135, 162], ["necrosis", "OBSERVATION", 6, 14], ["tumors", "OBSERVATION", 40, 46], ["Hepatocellular carcinomas", "OBSERVATION", 46, 71], ["may be", "UNCERTAINTY", 128, 134], ["massive", "OBSERVATION_MODIFIER", 146, 153], ["nodular", "OBSERVATION_MODIFIER", 155, 162], ["diffuse", "OBSERVATION_MODIFIER", 166, 173]]], ["Several features suggest malignancy, including the absence of pedunculation or clear demarcation from the adjacent parenchyma and the presence of varied coloration of the cut surface produced by hemorrhage and necrosis (eFig.", [["parenchyma", "ANATOMY", 115, 125], ["surface", "ANATOMY", 175, 182], ["malignancy", "DISEASE", 25, 35], ["hemorrhage", "DISEASE", 195, 205], ["necrosis", "DISEASE", 210, 218], ["parenchyma", "TISSUE", 115, 125], ["malignancy", "PROBLEM", 25, 35], ["pedunculation", "PROBLEM", 62, 75], ["clear demarcation from the adjacent parenchyma", "PROBLEM", 79, 125], ["varied coloration", "PROBLEM", 146, 163], ["hemorrhage", "PROBLEM", 195, 205], ["necrosis", "PROBLEM", 210, 218], ["eFig", "TEST", 220, 224], ["suggest", "UNCERTAINTY", 17, 24], ["malignancy", "OBSERVATION", 25, 35], ["pedunculation", "OBSERVATION", 62, 75], ["clear", "OBSERVATION_MODIFIER", 79, 84], ["demarcation", "OBSERVATION", 85, 96], ["adjacent", "ANATOMY_MODIFIER", 106, 114], ["parenchyma", "ANATOMY", 115, 125], ["varied", "OBSERVATION_MODIFIER", 146, 152], ["coloration", "OBSERVATION", 153, 163], ["cut", "OBSERVATION_MODIFIER", 171, 174], ["surface", "OBSERVATION_MODIFIER", 175, 182], ["hemorrhage", "OBSERVATION", 195, 205], ["necrosis", "OBSERVATION", 210, 218]]], ["Venous invasion is typical of the hepatocellular tumors, and 346.e1 eFigure 2-32 Hepatocellular carcinoma in a dog.Hepatocellular tumorsHepatoblastomas, rare benign tumors putatively originating from primitive hepatic precursor cells, have been reported most often in horses, but also in sheep, dogs, cats, and a llama.", [["Venous", "ANATOMY", 0, 6], ["hepatocellular tumors", "ANATOMY", 34, 55], ["Hepatocellular carcinoma", "ANATOMY", 81, 105], ["Hepatocellular tumors", "ANATOMY", 115, 136], ["benign tumors", "ANATOMY", 158, 171], ["primitive hepatic precursor cells", "ANATOMY", 200, 233], ["hepatocellular tumors", "DISEASE", 34, 55], ["Hepatocellular carcinoma", "DISEASE", 81, 105], ["Hepatocellular tumors", "DISEASE", 115, 136], ["Hepatoblastomas", "DISEASE", 136, 151], ["tumors", "DISEASE", 165, 171], ["Venous", "ORGANISM_SUBSTANCE", 0, 6], ["hepatocellular tumors", "CANCER", 34, 55], ["346.e1 eFigure 2-32", "CANCER", 61, 80], ["Hepatocellular carcinoma", "CANCER", 81, 105], ["dog", "ORGANISM", 111, 114], ["Hepatocellular tumors", "CANCER", 115, 136], ["benign tumors", "CANCER", 158, 171], ["hepatic precursor cells", "CELL", 210, 233], ["horses", "ORGANISM_SUBDIVISION", 268, 274], ["sheep", "ORGANISM", 288, 293], ["dogs", "ORGANISM", 295, 299], ["cats", "ORGANISM", 301, 305], ["primitive hepatic precursor cells", "CELL_TYPE", 200, 233], ["dog", "SPECIES", 111, 114], ["sheep", "SPECIES", 288, 293], ["dogs", "SPECIES", 295, 299], ["cats", "SPECIES", 301, 305], ["sheep", "SPECIES", 288, 293], ["Venous invasion", "PROBLEM", 0, 15], ["the hepatocellular tumors", "PROBLEM", 30, 55], ["eFigure", "TEST", 68, 75], ["Hepatocellular carcinoma", "PROBLEM", 81, 105], ["Hepatocellular tumorsHepatoblastomas", "PROBLEM", 115, 151], ["rare benign tumors", "PROBLEM", 153, 171], ["invasion", "OBSERVATION", 7, 15], ["hepatocellular", "ANATOMY", 34, 48], ["tumors", "OBSERVATION", 49, 55], ["Hepatocellular carcinoma", "OBSERVATION", 81, 105], ["tumors", "OBSERVATION", 130, 136], ["rare", "OBSERVATION_MODIFIER", 153, 157], ["benign", "OBSERVATION_MODIFIER", 158, 164], ["tumors", "OBSERVATION", 165, 171], ["primitive", "ANATOMY_MODIFIER", 200, 209], ["hepatic", "ANATOMY", 210, 217], ["precursor cells", "OBSERVATION", 218, 233], ["llama", "ANATOMY", 313, 318]]], ["Hepatoblastomas in humans are neoplasms of infancy and childhood.", [["Hepatoblastomas", "ANATOMY", 0, 15], ["neoplasms", "ANATOMY", 30, 39], ["Hepatoblastomas", "DISEASE", 0, 15], ["neoplasms", "DISEASE", 30, 39], ["Hepatoblastomas", "CANCER", 0, 15], ["humans", "ORGANISM", 19, 25], ["neoplasms", "CANCER", 30, 39], ["humans", "SPECIES", 19, 25], ["humans", "SPECIES", 19, 25], ["Hepatoblastomas in humans", "PROBLEM", 0, 25], ["neoplasms of infancy", "PROBLEM", 30, 50], ["neoplasms", "OBSERVATION", 30, 39]]], ["Cases in domestic species have been reported in both young and adult animals, but are most frequently reported in foals.", [["foals", "ORGANISM_SUBDIVISION", 114, 119], ["domestic species", "OBSERVATION", 9, 25]]], ["Hepatoblastomas are typically single, firm, lobulated masses with areas of necrosis and hemorrhage.", [["Hepatoblastomas", "ANATOMY", 0, 15], ["lobulated masses", "ANATOMY", 44, 60], ["Hepatoblastomas", "DISEASE", 0, 15], ["necrosis", "DISEASE", 75, 83], ["hemorrhage", "DISEASE", 88, 98], ["Hepatoblastomas", "CANCER", 0, 15], ["lobulated masses", "CANCER", 44, 60], ["Hepatoblastomas", "PROBLEM", 0, 15], ["lobulated masses", "PROBLEM", 44, 60], ["necrosis", "PROBLEM", 75, 83], ["hemorrhage", "PROBLEM", 88, 98], ["firm", "OBSERVATION_MODIFIER", 38, 42], ["lobulated", "OBSERVATION_MODIFIER", 44, 53], ["masses", "OBSERVATION", 54, 60], ["areas", "OBSERVATION_MODIFIER", 66, 71], ["necrosis", "OBSERVATION", 75, 83], ["hemorrhage", "OBSERVATION", 88, 98]]], ["Compression of adjacent parenchyma is evident and, on occasion, invasion can be seen.", [["parenchyma", "ANATOMY", 24, 34], ["parenchyma", "TISSUE", 24, 34], ["Compression of adjacent parenchyma", "PROBLEM", 0, 34], ["invasion", "PROBLEM", 64, 72], ["adjacent", "ANATOMY_MODIFIER", 15, 23], ["parenchyma", "ANATOMY", 24, 34], ["invasion", "OBSERVATION", 64, 72]]], ["The histologic patterns of hepatoblastomas can be epithelial, either fetal or embryonal, or mixed epithelial and mesenchymal.", [["hepatoblastomas", "ANATOMY", 27, 42], ["epithelial", "ANATOMY", 50, 60], ["fetal", "ANATOMY", 69, 74], ["embryonal", "ANATOMY", 78, 87], ["epithelial", "ANATOMY", 98, 108], ["mesenchymal", "ANATOMY", 113, 124], ["hepatoblastomas", "DISEASE", 27, 42], ["hepatoblastomas", "CANCER", 27, 42], ["epithelial", "TISSUE", 50, 60], ["fetal", "TISSUE", 69, 74], ["embryonal", "CANCER", 78, 87], ["epithelial", "CELL", 98, 108], ["mesenchymal", "CELL", 113, 124], ["hepatoblastomas", "PROBLEM", 27, 42], ["epithelial", "PROBLEM", 50, 60], ["fetal or embryonal", "PROBLEM", 69, 87], ["mixed epithelial and mesenchymal", "PROBLEM", 92, 124], ["hepatoblastomas", "OBSERVATION", 27, 42], ["fetal", "OBSERVATION_MODIFIER", 69, 74], ["embryonal", "OBSERVATION_MODIFIER", 78, 87], ["mixed", "OBSERVATION_MODIFIER", 92, 97], ["epithelial", "ANATOMY_MODIFIER", 98, 108], ["mesenchymal", "OBSERVATION_MODIFIER", 113, 124]]], ["Fetal hepatoblastomas are composed of large, polygonal cells, approximately the size of adult hepatocytes, with round to oval nuclei and granular to vacuolated, eosinophilic to amphophilic cytoplasm ( Fig. 2-112A) .", [["Fetal hepatoblastomas", "ANATOMY", 0, 21], ["polygonal cells", "ANATOMY", 45, 60], ["adult hepatocytes", "ANATOMY", 88, 105], ["nuclei", "ANATOMY", 126, 132], ["eosinophilic", "ANATOMY", 161, 173], ["cytoplasm", "ANATOMY", 189, 198], ["Fetal hepatoblastomas", "DISEASE", 0, 21], ["Fetal hepatoblastomas", "CANCER", 0, 21], ["polygonal cells", "CELL", 45, 60], ["hepatocytes", "CELL", 94, 105], ["nuclei", "CELLULAR_COMPONENT", 126, 132], ["cytoplasm", "ORGANISM_SUBSTANCE", 189, 198], ["large, polygonal cells", "CELL_TYPE", 38, 60], ["adult hepatocytes", "CELL_TYPE", 88, 105], ["Fetal hepatoblastomas", "PROBLEM", 0, 21], ["large, polygonal cells", "PROBLEM", 38, 60], ["adult hepatocytes", "PROBLEM", 88, 105], ["round to oval nuclei", "PROBLEM", 112, 132], ["granular to vacuolated", "PROBLEM", 137, 159], ["eosinophilic to amphophilic cytoplasm", "PROBLEM", 161, 198], ["hepatoblastomas", "OBSERVATION", 6, 21], ["large", "OBSERVATION_MODIFIER", 38, 43], ["polygonal cells", "OBSERVATION", 45, 60], ["approximately", "OBSERVATION_MODIFIER", 62, 75], ["size", "OBSERVATION_MODIFIER", 80, 84], ["adult", "ANATOMY_MODIFIER", 88, 93], ["hepatocytes", "ANATOMY", 94, 105], ["round", "OBSERVATION_MODIFIER", 112, 117], ["oval nuclei", "OBSERVATION", 121, 132], ["granular", "OBSERVATION_MODIFIER", 137, 145], ["vacuolated", "OBSERVATION_MODIFIER", 149, 159], ["eosinophilic", "OBSERVATION_MODIFIER", 161, 173], ["amphophilic cytoplasm", "OBSERVATION", 177, 198]]], ["Embryonal hepatoblastomas form ribbons or rosettes of smaller basophilic cells with scant cytoplasm (Fig. 2-112B) .", [["Embryonal hepatoblastomas", "ANATOMY", 0, 25], ["ribbons", "ANATOMY", 31, 38], ["rosettes", "ANATOMY", 42, 50], ["basophilic cells", "ANATOMY", 62, 78], ["cytoplasm", "ANATOMY", 90, 99], ["Embryonal hepatoblastomas", "CANCER", 0, 25], ["ribbons", "CELLULAR_COMPONENT", 31, 38], ["basophilic cells", "CELL", 62, 78], ["cytoplasm", "ORGANISM_SUBSTANCE", 90, 99], ["basophilic cells", "CELL_TYPE", 62, 78], ["Embryonal hepatoblastomas form ribbons", "PROBLEM", 0, 38], ["smaller basophilic cells", "PROBLEM", 54, 78], ["scant cytoplasm", "PROBLEM", 84, 99], ["hepatoblastomas", "OBSERVATION", 10, 25], ["rosettes", "OBSERVATION_MODIFIER", 42, 50], ["smaller", "OBSERVATION_MODIFIER", 54, 61], ["basophilic cells", "OBSERVATION", 62, 78], ["scant cytoplasm", "OBSERVATION", 84, 99]]], ["Mixed epithelial-mesenchymal hepatoblastomas contain variable amounts of fibrous connective tissue or other mesenchymal tissues, including cartilage or bone, in addition to epithelial cells.", [["epithelial-mesenchymal hepatoblastomas", "ANATOMY", 6, 44], ["fibrous connective tissue", "ANATOMY", 73, 98], ["mesenchymal tissues", "ANATOMY", 108, 127], ["cartilage", "ANATOMY", 139, 148], ["bone", "ANATOMY", 152, 156], ["epithelial cells", "ANATOMY", 173, 189], ["epithelial", "CELL", 6, 16], ["fibrous connective tissue", "TISSUE", 73, 98], ["mesenchymal tissues", "TISSUE", 108, 127], ["cartilage", "TISSUE", 139, 148], ["bone", "TISSUE", 152, 156], ["epithelial cells", "CELL", 173, 189], ["epithelial cells", "CELL_TYPE", 173, 189], ["Mixed epithelial-mesenchymal hepatoblastomas", "PROBLEM", 0, 44], ["fibrous connective tissue or other mesenchymal tissues", "PROBLEM", 73, 127], ["cartilage or bone", "PROBLEM", 139, 156], ["epithelial cells", "PROBLEM", 173, 189], ["epithelial", "ANATOMY_MODIFIER", 6, 16], ["mesenchymal hepatoblastomas", "OBSERVATION", 17, 44], ["variable", "OBSERVATION_MODIFIER", 53, 61], ["amounts", "OBSERVATION_MODIFIER", 62, 69], ["fibrous connective tissue", "OBSERVATION", 73, 98], ["mesenchymal tissues", "OBSERVATION", 108, 127], ["cartilage", "ANATOMY", 139, 148], ["bone", "ANATOMY", 152, 156], ["epithelial cells", "OBSERVATION", 173, 189]]], ["Portal tracts are absent.", [["Portal tracts", "ANATOMY", 0, 13], ["Portal tracts", "MULTI-TISSUE_STRUCTURE", 0, 13], ["tracts", "ANATOMY_MODIFIER", 7, 13], ["absent", "OBSERVATION", 18, 24]]], ["Immunohistochemical staining for \u03b1-fetoprotein is typically positive, and HepPar-1 staining is the cells can be stained with antibodies that recognize cytokeratin 19, a marker of hepatic progenitor cells, immature hepatocytes, and biliary epithelial cells.", [["cells", "ANATOMY", 99, 104], ["hepatic progenitor cells", "ANATOMY", 179, 203], ["hepatocytes", "ANATOMY", 214, 225], ["biliary epithelial cells", "ANATOMY", 231, 255], ["\u03b1-fetoprotein", "GENE_OR_GENE_PRODUCT", 33, 46], ["HepPar-1", "GENE_OR_GENE_PRODUCT", 74, 82], ["cells", "CELL", 99, 104], ["cytokeratin 19", "GENE_OR_GENE_PRODUCT", 151, 165], ["hepatic progenitor cells", "CELL", 179, 203], ["hepatocytes", "CELL", 214, 225], ["biliary epithelial cells", "CELL", 231, 255], ["\u03b1-fetoprotein", "PROTEIN", 33, 46], ["HepPar", "PROTEIN", 74, 80], ["antibodies", "PROTEIN", 125, 135], ["cytokeratin 19", "PROTEIN", 151, 165], ["hepatic progenitor cells", "CELL_TYPE", 179, 203], ["immature hepatocytes", "CELL_TYPE", 205, 225], ["biliary epithelial cells", "CELL_TYPE", 231, 255], ["Immunohistochemical staining", "TEST", 0, 28], ["\u03b1-fetoprotein", "TEST", 33, 46], ["HepPar", "TEST", 74, 80], ["the cells", "PROBLEM", 95, 104], ["antibodies", "TEST", 125, 135], ["cytokeratin", "TEST", 151, 162], ["immature hepatocytes", "PROBLEM", 205, 225], ["biliary epithelial cells", "PROBLEM", 231, 255], ["hepatic", "ANATOMY", 179, 186], ["progenitor cells", "OBSERVATION", 187, 203], ["hepatocytes", "ANATOMY", 214, 225], ["biliary epithelial cells", "OBSERVATION", 231, 255]]], ["These canine hepatocellular carcinomas have an aggressive growth pattern, including a markedly increased incidence of intrahepatic and extrahepatic metastasis.A BLesions formerly termed biliary cystadenomas, a subtype commonly seen in cats and occasionally in dogs, are most likely developmental anomalies of the embryonal biliary tree, termed ductal plate anomalies, which is more clearly appreciated when biliary cysts are coincident with cystic renal developmental lesions, although either lesion may occur independently.", [["hepatocellular carcinomas", "ANATOMY", 13, 38], ["intrahepatic", "ANATOMY", 118, 130], ["extrahepatic", "ANATOMY", 135, 147], ["biliary cystadenomas", "ANATOMY", 186, 206], ["embryonal biliary tree", "ANATOMY", 313, 335], ["ductal plate", "ANATOMY", 344, 356], ["biliary cysts", "ANATOMY", 407, 420], ["cystic renal developmental lesions", "ANATOMY", 441, 475], ["lesion", "ANATOMY", 493, 499], ["canine hepatocellular carcinomas", "DISEASE", 6, 38], ["intrahepatic and extrahepatic metastasis", "DISEASE", 118, 158], ["biliary cystadenomas", "DISEASE", 186, 206], ["ductal plate anomalies", "DISEASE", 344, 366], ["biliary cysts", "DISEASE", 407, 420], ["cystic renal developmental lesions", "DISEASE", 441, 475], ["canine", "ORGANISM", 6, 12], ["hepatocellular carcinomas", "CANCER", 13, 38], ["intrahepatic", "CANCER", 118, 130], ["extrahepatic", "ORGAN", 135, 147], ["biliary cystadenomas", "CANCER", 186, 206], ["cats", "ORGANISM", 235, 239], ["dogs", "ORGANISM", 260, 264], ["embryonal biliary tree", "MULTI-TISSUE_STRUCTURE", 313, 335], ["ductal plate", "MULTI-TISSUE_STRUCTURE", 344, 356], ["biliary cysts", "PATHOLOGICAL_FORMATION", 407, 420], ["cystic renal developmental lesions", "PATHOLOGICAL_FORMATION", 441, 475], ["cats", "SPECIES", 235, 239], ["dogs", "SPECIES", 260, 264], ["These canine hepatocellular carcinomas", "PROBLEM", 0, 38], ["an aggressive growth pattern", "PROBLEM", 44, 72], ["a markedly increased incidence of intrahepatic and extrahepatic metastasis", "PROBLEM", 84, 158], ["A BLesions formerly termed biliary cystadenomas", "PROBLEM", 159, 206], ["developmental anomalies of the embryonal biliary tree", "PROBLEM", 282, 335], ["termed ductal plate anomalies", "PROBLEM", 337, 366], ["biliary cysts", "PROBLEM", 407, 420], ["cystic renal developmental lesions", "PROBLEM", 441, 475], ["lesion", "PROBLEM", 493, 499], ["hepatocellular", "ANATOMY", 13, 27], ["carcinomas", "OBSERVATION", 28, 38], ["aggressive", "OBSERVATION_MODIFIER", 47, 57], ["growth pattern", "OBSERVATION", 58, 72], ["markedly", "OBSERVATION_MODIFIER", 86, 94], ["increased", "OBSERVATION_MODIFIER", 95, 104], ["incidence", "OBSERVATION_MODIFIER", 105, 114], ["intrahepatic", "ANATOMY", 118, 130], ["extrahepatic", "ANATOMY", 135, 147], ["metastasis", "OBSERVATION", 148, 158], ["biliary", "ANATOMY", 186, 193], ["cystadenomas", "OBSERVATION", 194, 206], ["subtype commonly", "OBSERVATION_MODIFIER", 210, 226], ["most likely", "UNCERTAINTY", 270, 281], ["developmental", "OBSERVATION_MODIFIER", 282, 295], ["anomalies", "OBSERVATION", 296, 305], ["embryonal", "ANATOMY_MODIFIER", 313, 322], ["biliary", "ANATOMY", 323, 330], ["tree", "ANATOMY_MODIFIER", 331, 335], ["ductal", "ANATOMY_MODIFIER", 344, 350], ["plate anomalies", "OBSERVATION", 351, 366], ["biliary", "ANATOMY", 407, 414], ["cysts", "OBSERVATION", 415, 420], ["cystic", "OBSERVATION_MODIFIER", 441, 447], ["renal", "ANATOMY", 448, 453], ["developmental", "OBSERVATION_MODIFIER", 454, 467], ["lesions", "OBSERVATION", 468, 475], ["lesion", "OBSERVATION", 493, 499]]], ["The ductal plate anomalies can be multilocular and lined by bile duct epithelia that may be flattened by pressure, or in some areas papillary.", [["ductal plate", "ANATOMY", 4, 16], ["bile duct epithelia", "ANATOMY", 60, 79], ["papillary", "ANATOMY", 132, 141], ["ductal plate anomalies", "DISEASE", 4, 26], ["ductal plate", "CANCER", 4, 16], ["bile duct epithelia", "TISSUE", 60, 79], ["papillary", "CANCER", 132, 141], ["The ductal plate anomalies", "PROBLEM", 0, 26], ["multilocular", "PROBLEM", 34, 46], ["bile duct epithelia", "PROBLEM", 60, 79], ["ductal plate", "ANATOMY", 4, 16], ["anomalies", "OBSERVATION", 17, 26], ["multilocular", "OBSERVATION", 34, 46], ["bile duct", "ANATOMY", 60, 69], ["epithelia", "ANATOMY_MODIFIER", 70, 79], ["may be", "UNCERTAINTY", 85, 91], ["flattened", "OBSERVATION_MODIFIER", 92, 101], ["pressure", "OBSERVATION_MODIFIER", 105, 113], ["some", "OBSERVATION_MODIFIER", 121, 125], ["areas", "OBSERVATION_MODIFIER", 126, 131], ["papillary", "OBSERVATION", 132, 141]]], ["The septal stroma is collagenous.", [["septal stroma", "ANATOMY", 4, 17], ["septal stroma", "TISSUE", 4, 17], ["septal", "ANATOMY_MODIFIER", 4, 10], ["stroma", "OBSERVATION", 11, 17], ["collagenous", "OBSERVATION", 21, 32]]], ["Their development later in life may be the result of progressive secretion by the lining epithelial cells, creating cysts only when sufficient fluid has been produced.", [["lining epithelial cells", "ANATOMY", 82, 105], ["cysts", "ANATOMY", 116, 121], ["fluid", "ANATOMY", 143, 148], ["lining epithelial cells", "CELL", 82, 105], ["fluid", "ORGANISM_SUBSTANCE", 143, 148], ["lining epithelial cells", "CELL_TYPE", 82, 105], ["progressive secretion", "PROBLEM", 53, 74], ["the lining epithelial cells", "PROBLEM", 78, 105], ["creating cysts", "PROBLEM", 107, 121], ["sufficient fluid", "PROBLEM", 132, 148], ["progressive", "OBSERVATION_MODIFIER", 53, 64], ["secretion", "OBSERVATION", 65, 74], ["lining epithelial cells", "OBSERVATION", 82, 105], ["cysts", "OBSERVATION", 116, 121], ["fluid", "OBSERVATION", 143, 148]]], ["Entrapped hepatocytes are often present.A BCholangiocarcinomas (cholangiocellular carcinomas) are reported in dogs, cats, sheep, cattle, horses, and goats.", [["hepatocytes", "ANATOMY", 10, 21], ["BCholangiocarcinomas", "ANATOMY", 42, 62], ["cholangiocellular carcinomas", "ANATOMY", 64, 92], ["horses", "ANATOMY", 137, 143], ["cholangiocellular carcinomas", "DISEASE", 64, 92], ["hepatocytes", "CELL", 10, 21], ["BCholangiocarcinomas", "CANCER", 42, 62], ["cholangiocellular carcinomas", "CANCER", 64, 92], ["dogs", "ORGANISM", 110, 114], ["cats", "ORGANISM", 116, 120], ["sheep", "ORGANISM", 122, 127], ["cattle", "ORGANISM", 129, 135], ["horses", "ORGANISM_SUBDIVISION", 137, 143], ["goats", "ORGANISM", 149, 154], ["hepatocytes", "CELL_TYPE", 10, 21], ["dogs", "SPECIES", 110, 114], ["cats", "SPECIES", 116, 120], ["sheep", "SPECIES", 122, 127], ["cattle", "SPECIES", 129, 135], ["goats", "SPECIES", 149, 154], ["sheep", "SPECIES", 122, 127], ["cattle", "SPECIES", 129, 135], ["goats", "SPECIES", 149, 154], ["Entrapped hepatocytes", "PROBLEM", 0, 21], ["A BCholangiocarcinomas (cholangiocellular carcinomas", "PROBLEM", 40, 92], ["hepatocytes", "ANATOMY", 10, 21], ["BCholangiocarcinomas", "OBSERVATION", 42, 62], ["cholangiocellular carcinomas", "OBSERVATION", 64, 92]]], ["Affected livers are usually otherwise normal, with no suggestion as to an underlying cause, although there are associations with chronic fluke infestations in humans and rarely in carnivores.A BCholangiocellular tumors can usually be distinguished from the hepatocellular variety by their multiplicity, firmness, pale beige color produced by more or less abundant stroma, and the typical umbilicate appearance of those that involve the capsule (Fig. 2-115) .", [["livers", "ANATOMY", 9, 15], ["BCholangiocellular tumors", "ANATOMY", 193, 218], ["hepatocellular", "ANATOMY", 257, 271], ["stroma", "ANATOMY", 364, 370], ["capsule", "ANATOMY", 436, 443], ["chronic fluke infestations", "DISEASE", 129, 155], ["tumors", "DISEASE", 212, 218], ["livers", "ORGAN", 9, 15], ["humans", "ORGANISM", 159, 165], ["BCholangiocellular tumors", "CANCER", 193, 218], ["hepatocellular", "CANCER", 257, 271], ["stroma", "TISSUE", 364, 370], ["capsule", "CANCER", 436, 443], ["humans", "SPECIES", 159, 165], ["humans", "SPECIES", 159, 165], ["chronic fluke infestations in humans", "PROBLEM", 129, 165], ["A BCholangiocellular tumors", "PROBLEM", 191, 218], ["the hepatocellular variety", "PROBLEM", 253, 279], ["pale beige color", "PROBLEM", 313, 329], ["livers", "ANATOMY", 9, 15], ["normal", "OBSERVATION", 38, 44], ["no suggestion", "UNCERTAINTY", 51, 64], ["chronic", "OBSERVATION_MODIFIER", 129, 136], ["fluke", "OBSERVATION_MODIFIER", 137, 142], ["infestations", "OBSERVATION", 143, 155], ["BCholangiocellular", "ANATOMY", 193, 211], ["tumors", "OBSERVATION", 212, 218], ["hepatocellular", "ANATOMY", 257, 271], ["multiplicity", "OBSERVATION_MODIFIER", 289, 301], ["firmness", "OBSERVATION_MODIFIER", 303, 311], ["pale", "OBSERVATION_MODIFIER", 313, 317], ["beige color", "OBSERVATION", 318, 329], ["less abundant", "OBSERVATION_MODIFIER", 350, 363], ["stroma", "OBSERVATION", 364, 370], ["capsule", "ANATOMY", 436, 443]]], ["The central depressed area can be the result of necrosis or cavitation-associated collapse of tumor vessels in the usually absent, supporting the view that they arise from precursor cells.Cholangiocellular tumorsCholangiocellular adenomas are uncommon benign neoplasms of biliary epithelium.", [["tumor vessels", "ANATOMY", 94, 107], ["precursor cells", "ANATOMY", 172, 187], ["Cholangiocellular tumorsCholangiocellular adenomas", "ANATOMY", 188, 238], ["benign neoplasms", "ANATOMY", 252, 268], ["biliary epithelium", "ANATOMY", 272, 290], ["depressed", "DISEASE", 12, 21], ["necrosis", "DISEASE", 48, 56], ["tumor", "DISEASE", 94, 99], ["Cholangiocellular tumors", "DISEASE", 188, 212], ["Cholangiocellular adenomas", "DISEASE", 212, 238], ["neoplasms", "DISEASE", 259, 268], ["tumor vessels", "MULTI-TISSUE_STRUCTURE", 94, 107], ["precursor cells", "CELL", 172, 187], ["Cholangiocellular tumorsCholangiocellular adenomas", "CANCER", 188, 238], ["benign neoplasms", "CANCER", 252, 268], ["biliary epithelium", "TISSUE", 272, 290], ["precursor cells", "CELL_TYPE", 172, 187], ["The central depressed area", "PROBLEM", 0, 26], ["necrosis", "PROBLEM", 48, 56], ["cavitation", "PROBLEM", 60, 70], ["collapse of tumor vessels", "PROBLEM", 82, 107], ["Cholangiocellular tumors", "PROBLEM", 188, 212], ["Cholangiocellular adenomas", "PROBLEM", 212, 238], ["uncommon benign neoplasms of biliary epithelium", "PROBLEM", 243, 290], ["central", "OBSERVATION_MODIFIER", 4, 11], ["depressed", "OBSERVATION_MODIFIER", 12, 21], ["necrosis", "OBSERVATION", 48, 56], ["cavitation", "OBSERVATION", 60, 70], ["collapse", "OBSERVATION", 82, 90], ["tumor vessels", "OBSERVATION", 94, 107], ["precursor cells", "OBSERVATION", 172, 187], ["tumors", "OBSERVATION", 206, 212], ["Cholangiocellular adenomas", "OBSERVATION", 212, 238], ["biliary epithelium", "ANATOMY", 272, 290]]], ["Cholangiocellular adenomas are usually solitary, pale gray to white, and well-circumscribed roughly spherical masses that tend to grow by expansion.", [["Cholangiocellular adenomas", "ANATOMY", 0, 26], ["masses", "ANATOMY", 110, 116], ["Cholangiocellular adenomas", "DISEASE", 0, 26], ["Cholangiocellular adenomas", "CANCER", 0, 26], ["masses", "CANCER", 110, 116], ["Cholangiocellular adenomas", "PROBLEM", 0, 26], ["pale gray to white, and well-circumscribed roughly spherical masses", "PROBLEM", 49, 116], ["adenomas", "OBSERVATION", 18, 26], ["solitary", "OBSERVATION_MODIFIER", 39, 47], ["pale gray", "OBSERVATION_MODIFIER", 49, 58], ["white", "OBSERVATION_MODIFIER", 62, 67], ["well-circumscribed", "OBSERVATION_MODIFIER", 73, 91], ["roughly", "OBSERVATION_MODIFIER", 92, 99], ["spherical", "OBSERVATION_MODIFIER", 100, 109], ["masses", "OBSERVATION", 110, 116], ["expansion", "OBSERVATION_MODIFIER", 138, 147]]], ["They may distend the normal outline of the liver, although they can occur as intrahepatic masses.", [["liver", "ANATOMY", 43, 48], ["intrahepatic masses", "ANATOMY", 77, 96], ["intrahepatic masses", "DISEASE", 77, 96], ["liver", "ORGAN", 43, 48], ["intrahepatic masses", "CANCER", 77, 96], ["intrahepatic masses", "PROBLEM", 77, 96], ["normal", "OBSERVATION", 21, 27], ["liver", "ANATOMY", 43, 48], ["intrahepatic", "ANATOMY", 77, 89], ["masses", "OBSERVATION", 90, 96]]], ["Cholangiocellular adenomas are composed of tubules lined with a single layer of welldifferentiated biliary epithelium and a moderate amount of intervening stroma.", [["Cholangiocellular adenomas", "ANATOMY", 0, 26], ["tubules", "ANATOMY", 43, 50], ["biliary epithelium", "ANATOMY", 99, 117], ["stroma", "ANATOMY", 155, 161], ["Cholangiocellular adenomas", "DISEASE", 0, 26], ["Cholangiocellular adenomas", "CANCER", 0, 26], ["tubules", "TISSUE", 43, 50], ["biliary epithelium", "TISSUE", 99, 117], ["stroma", "TISSUE", 155, 161], ["Cholangiocellular adenomas", "PROBLEM", 0, 26], ["tubules lined", "PROBLEM", 43, 56], ["a single layer of welldifferentiated biliary epithelium", "PROBLEM", 62, 117], ["a moderate amount of intervening stroma", "PROBLEM", 122, 161], ["adenomas", "OBSERVATION", 18, 26], ["tubules lined", "OBSERVATION", 43, 56], ["single", "OBSERVATION_MODIFIER", 64, 70], ["layer", "OBSERVATION_MODIFIER", 71, 76], ["welldifferentiated", "OBSERVATION_MODIFIER", 80, 98], ["biliary epithelium", "ANATOMY", 99, 117], ["moderate", "OBSERVATION_MODIFIER", 124, 132], ["amount", "OBSERVATION_MODIFIER", 133, 139], ["intervening stroma", "OBSERVATION", 143, 161]]], ["The tubules may have narrow lumens, and there can be variable amounts of stroma within the mass (Fig. 2-113) .", [["tubules", "ANATOMY", 4, 11], ["lumens", "ANATOMY", 28, 34], ["stroma", "ANATOMY", 73, 79], ["tubules", "TISSUE", 4, 11], ["lumens", "IMMATERIAL_ANATOMICAL_ENTITY", 28, 34], ["stroma", "TISSUE", 73, 79], ["narrow lumens", "PROBLEM", 21, 34], ["stroma within the mass", "PROBLEM", 73, 95], ["narrow", "OBSERVATION_MODIFIER", 21, 27], ["lumens", "OBSERVATION", 28, 34], ["variable", "OBSERVATION_MODIFIER", 53, 61], ["amounts", "OBSERVATION_MODIFIER", 62, 69], ["stroma", "OBSERVATION", 73, 79], ["mass", "OBSERVATION", 91, 95]]], ["Adjacent hepatocytes are usually compressed at the margins, but are not found between tubules.", [["hepatocytes", "ANATOMY", 9, 20], ["tubules", "ANATOMY", 86, 93], ["hepatocytes", "CELL", 9, 20], ["tubules", "TISSUE", 86, 93], ["hepatocytes", "CELL_TYPE", 9, 20], ["Adjacent hepatocytes", "PROBLEM", 0, 20], ["hepatocytes", "ANATOMY", 9, 20], ["margins", "OBSERVATION_MODIFIER", 51, 58], ["not found", "UNCERTAINTY", 68, 77]]], ["The tubules contain a clear watery to viscous fluid.", [["tubules", "ANATOMY", 4, 11], ["viscous fluid", "ANATOMY", 38, 51], ["tubules", "TISSUE", 4, 11], ["watery", "ORGANISM_SUBDIVISION", 28, 34], ["a clear watery to viscous fluid", "PROBLEM", 20, 51], ["clear", "OBSERVATION_MODIFIER", 22, 27], ["watery", "OBSERVATION_MODIFIER", 28, 34], ["viscous fluid", "OBSERVATION", 38, 51]]], ["Cuboidal or flattened neoplastic biliary epithelial cells have a moderate amount of pale eosinophilic cytoplasm.", [["Cuboidal", "ANATOMY", 0, 8], ["neoplastic biliary epithelial cells", "ANATOMY", 22, 57], ["eosinophilic cytoplasm", "ANATOMY", 89, 111], ["neoplastic biliary epithelial cells", "CELL", 22, 57], ["cytoplasm", "ORGANISM_SUBSTANCE", 102, 111], ["Cuboidal or flattened neoplastic biliary epithelial cells", "CELL_TYPE", 0, 57], ["Cuboidal or flattened neoplastic biliary epithelial cells", "PROBLEM", 0, 57], ["pale eosinophilic cytoplasm", "PROBLEM", 84, 111], ["flattened", "OBSERVATION_MODIFIER", 12, 21], ["neoplastic", "OBSERVATION_MODIFIER", 22, 32], ["biliary epithelial cells", "OBSERVATION", 33, 57], ["moderate", "OBSERVATION_MODIFIER", 65, 73], ["amount", "OBSERVATION_MODIFIER", 74, 80], ["pale", "OBSERVATION_MODIFIER", 84, 88], ["eosinophilic cytoplasm", "OBSERVATION", 89, 111]]], ["Nuclei are round to oval, vesicular, and oriented centrally.", [["Nuclei", "ANATOMY", 0, 6], ["vesicular", "ANATOMY", 26, 35], ["Nuclei", "ORGANISM_SUBSTANCE", 0, 6], ["round", "OBSERVATION_MODIFIER", 11, 16], ["oval", "OBSERVATION_MODIFIER", 20, 24], ["vesicular", "OBSERVATION_MODIFIER", 26, 35]]], ["Nucleoli are small or inapparent.", [["small", "OBSERVATION_MODIFIER", 13, 18], ["inapparent", "OBSERVATION_MODIFIER", 22, 32]]], ["There are typically no mitotic figures.Cholangiocellular tumorsExtrahepatic cholangiocellular adenomas are rare, with the exception of gallbladder adenomas reported in abattoir surveys of cattle and rarely in domestic carnivores (Fig. 2-114) .", [["Cholangiocellular tumorsExtrahepatic cholangiocellular adenomas", "ANATOMY", 39, 102], ["gallbladder adenomas", "ANATOMY", 135, 155], ["Cholangiocellular tumors", "DISEASE", 39, 63], ["Extrahepatic cholangiocellular adenomas", "DISEASE", 63, 102], ["gallbladder adenomas", "DISEASE", 135, 155], ["Cholangiocellular tumors", "CANCER", 39, 63], ["Extrahepatic cholangiocellular adenomas", "CANCER", 63, 102], ["gallbladder adenomas", "CANCER", 135, 155], ["cattle", "ORGANISM", 188, 194], ["cattle", "SPECIES", 188, 194], ["cattle", "SPECIES", 188, 194], ["mitotic figures", "PROBLEM", 23, 38], ["Cholangiocellular tumors", "PROBLEM", 39, 63], ["Extrahepatic cholangiocellular adenomas", "PROBLEM", 63, 102], ["gallbladder adenomas", "PROBLEM", 135, 155], ["no", "UNCERTAINTY", 20, 22], ["mitotic figures", "OBSERVATION", 23, 38], ["cholangiocellular adenomas", "OBSERVATION", 76, 102], ["gallbladder", "ANATOMY", 135, 146], ["adenomas", "OBSERVATION", 147, 155]]], ["The smaller specimens may be solid on cut surface and white, but the large specimens, and many of the small ones, are cystic. of poorly differentiated cells within a mass that is predominantly well differentiated.", [["specimens", "ANATOMY", 12, 21], ["surface", "ANATOMY", 42, 49], ["specimens", "ANATOMY", 75, 84], ["cystic", "ANATOMY", 118, 124], ["cells", "ANATOMY", 151, 156], ["mass", "ANATOMY", 166, 170], ["specimens", "CANCER", 12, 21], ["specimens", "CANCER", 75, 84], ["cells", "CELL", 151, 156], ["poorly differentiated cells", "CELL_TYPE", 129, 156], ["the large specimens", "TEST", 65, 84], ["cystic", "PROBLEM", 118, 124], ["poorly differentiated cells", "PROBLEM", 129, 156], ["a mass", "PROBLEM", 164, 170], ["smaller", "OBSERVATION_MODIFIER", 4, 11], ["specimens", "OBSERVATION", 12, 21], ["may be", "UNCERTAINTY", 22, 28], ["solid", "OBSERVATION_MODIFIER", 29, 34], ["white", "OBSERVATION_MODIFIER", 54, 59], ["large", "OBSERVATION_MODIFIER", 69, 74], ["specimens", "OBSERVATION", 75, 84], ["many", "OBSERVATION_MODIFIER", 90, 94], ["small", "OBSERVATION_MODIFIER", 102, 107], ["cystic", "OBSERVATION", 118, 124], ["poorly differentiated", "OBSERVATION_MODIFIER", 129, 150], ["cells", "OBSERVATION", 151, 156], ["mass", "OBSERVATION", 166, 170], ["predominantly", "OBSERVATION_MODIFIER", 179, 192], ["well differentiated", "OBSERVATION_MODIFIER", 193, 212]]], ["Cholangiocellular carcinomas have a highly invasive growth pattern, and frequently metastasize to hepatic lymph nodes, lungs, and the peritoneal cavity.Cholangiocellular tumorsPrimary intrahepatic cholangiocellular carcinoma can be difficult, and often impossible, to distinguish from metastatic adenocarcinomas, especially those of pancreatic or mammary epithelial origin.", [["Cholangiocellular carcinomas", "ANATOMY", 0, 28], ["hepatic lymph nodes", "ANATOMY", 98, 117], ["lungs", "ANATOMY", 119, 124], ["peritoneal cavity", "ANATOMY", 134, 151], ["Cholangiocellular tumors", "ANATOMY", 152, 176], ["Primary intrahepatic cholangiocellular carcinoma", "ANATOMY", 176, 224], ["metastatic adenocarcinomas", "ANATOMY", 285, 311], ["pancreatic", "ANATOMY", 333, 343], ["mammary epithelial", "ANATOMY", 347, 365], ["Cholangiocellular carcinomas", "DISEASE", 0, 28], ["Cholangiocellular tumors", "DISEASE", 152, 176], ["intrahepatic cholangiocellular carcinoma", "DISEASE", 184, 224], ["adenocarcinomas", "DISEASE", 296, 311], ["Cholangiocellular carcinomas", "CANCER", 0, 28], ["hepatic lymph nodes", "MULTI-TISSUE_STRUCTURE", 98, 117], ["lungs", "ORGAN", 119, 124], ["peritoneal cavity", "MULTI-TISSUE_STRUCTURE", 134, 151], ["Cholangiocellular tumors", "CANCER", 152, 176], ["intrahepatic cholangiocellular carcinoma", "CANCER", 184, 224], ["metastatic adenocarcinomas", "CANCER", 285, 311], ["pancreatic", "CANCER", 333, 343], ["mammary epithelial", "TISSUE", 347, 365], ["pancreatic or mammary epithelial origin", "CELL_TYPE", 333, 372], ["Cholangiocellular carcinomas", "PROBLEM", 0, 28], ["a highly invasive growth pattern", "PROBLEM", 34, 66], ["frequently metastasize to hepatic lymph nodes, lungs, and the peritoneal cavity", "PROBLEM", 72, 151], ["Cholangiocellular tumors", "PROBLEM", 152, 176], ["Primary intrahepatic cholangiocellular carcinoma", "PROBLEM", 176, 224], ["metastatic adenocarcinomas", "PROBLEM", 285, 311], ["pancreatic or mammary epithelial origin", "PROBLEM", 333, 372], ["carcinomas", "OBSERVATION", 18, 28], ["highly", "OBSERVATION_MODIFIER", 36, 42], ["invasive", "OBSERVATION_MODIFIER", 43, 51], ["growth pattern", "OBSERVATION", 52, 66], ["frequently", "OBSERVATION_MODIFIER", 72, 82], ["metastasize", "OBSERVATION", 83, 94], ["hepatic", "ANATOMY", 98, 105], ["lymph nodes", "OBSERVATION", 106, 117], ["lungs", "ANATOMY", 119, 124], ["peritoneal cavity", "ANATOMY", 134, 151], ["tumors", "OBSERVATION", 170, 176], ["intrahepatic", "ANATOMY_MODIFIER", 184, 196], ["cholangiocellular", "ANATOMY", 197, 214], ["carcinoma", "OBSERVATION", 215, 224], ["metastatic", "OBSERVATION_MODIFIER", 285, 295], ["adenocarcinomas", "OBSERVATION", 296, 311], ["pancreatic", "ANATOMY", 333, 343], ["mammary", "ANATOMY", 347, 354], ["epithelial", "ANATOMY_MODIFIER", 355, 365], ["origin", "ANATOMY_MODIFIER", 366, 372]]], ["Mucus secretion and intrasinusoidal permeation are more typical of biliary origin.", [["Mucus", "ANATOMY", 0, 5], ["intrasinusoidal", "ANATOMY", 20, 35], ["biliary", "ANATOMY", 67, 74], ["Mucus", "MULTI-TISSUE_STRUCTURE", 0, 5], ["biliary", "ORGAN", 67, 74], ["Mucus secretion and intrasinusoidal permeation", "PROBLEM", 0, 46], ["intrasinusoidal permeation", "OBSERVATION", 20, 46], ["more typical", "OBSERVATION_MODIFIER", 51, 63], ["biliary", "ANATOMY", 67, 74], ["origin", "ANATOMY_MODIFIER", 75, 81]]], ["Distinction from hepatocellular carcinoma of adenoid pattern may be assisted by demonstration of mucin, abundant mitotic figures, and presence of a prominent connective-tissue stroma.Cholangiocellular tumorsExtrahepatic cholangiocellular carcinoma (or biliary cholangiocarcinoma) of the gallbladder or extrahepatic bile ducts is much less frequent than the intrahepatic form, but has been reported in dogs, cats, cattle, and swine.Mixed hepatocellular and cholangiocellular carcinomasRare hepatic carcinomas have the histologic and cytologic characteristics of both hepatocellular carcinoma and cholangiocellular carcinoma.", [["hepatocellular carcinoma", "ANATOMY", 17, 41], ["adenoid", "ANATOMY", 45, 52], ["connective-tissue stroma", "ANATOMY", 158, 182], ["Cholangiocellular tumorsExtrahepatic cholangiocellular carcinoma", "ANATOMY", 183, 247], ["biliary cholangiocarcinoma", "ANATOMY", 252, 278], ["gallbladder", "ANATOMY", 287, 298], ["extrahepatic bile ducts", "ANATOMY", 302, 325], ["intrahepatic form", "ANATOMY", 357, 374], ["hepatocellular", "ANATOMY", 437, 451], ["cholangiocellular carcinomas", "ANATOMY", 456, 484], ["hepatic carcinomas", "ANATOMY", 489, 507], ["hepatocellular carcinoma", "ANATOMY", 566, 590], ["cholangiocellular carcinoma", "ANATOMY", 595, 622], ["hepatocellular carcinoma", "DISEASE", 17, 41], ["tumorsExtrahepatic cholangiocellular carcinoma", "DISEASE", 201, 247], ["biliary cholangiocarcinoma", "DISEASE", 252, 278], ["extrahepatic bile ducts", "DISEASE", 302, 325], ["Mixed hepatocellular and cholangiocellular carcinomas", "DISEASE", 431, 484], ["Rare hepatic carcinomas", "DISEASE", 484, 507], ["hepatocellular carcinoma", "DISEASE", 566, 590], ["cholangiocellular carcinoma", "DISEASE", 595, 622], ["hepatocellular carcinoma", "CANCER", 17, 41], ["adenoid", "ORGAN", 45, 52], ["mucin", "GENE_OR_GENE_PRODUCT", 97, 102], ["connective-tissue stroma", "TISSUE", 158, 182], ["Cholangiocellular tumorsExtrahepatic cholangiocellular carcinoma", "CANCER", 183, 247], ["biliary cholangiocarcinoma", "CANCER", 252, 278], ["gallbladder", "ORGAN", 287, 298], ["extrahepatic bile ducts", "MULTI-TISSUE_STRUCTURE", 302, 325], ["dogs", "ORGANISM", 401, 405], ["cats", "ORGANISM", 407, 411], ["hepatocellular", "CANCER", 437, 451], ["cholangiocellular carcinomas", "CANCER", 456, 484], ["Rare hepatic carcinomas", "CANCER", 484, 507], ["hepatocellular carcinoma", "CANCER", 566, 590], ["cholangiocellular carcinoma", "CANCER", 595, 622], ["dogs", "SPECIES", 401, 405], ["cats", "SPECIES", 407, 411], ["cattle", "SPECIES", 413, 419], ["swine", "SPECIES", 425, 430], ["cattle", "SPECIES", 413, 419], ["swine", "SPECIES", 425, 430], ["hepatocellular carcinoma of adenoid pattern", "PROBLEM", 17, 60], ["mucin, abundant mitotic figures", "PROBLEM", 97, 128], ["a prominent connective-tissue stroma", "PROBLEM", 146, 182], ["Cholangiocellular tumorsExtrahepatic cholangiocellular carcinoma", "PROBLEM", 183, 247], ["biliary cholangiocarcinoma) of the gallbladder or extrahepatic bile ducts", "PROBLEM", 252, 325], ["Mixed hepatocellular", "PROBLEM", 431, 451], ["cholangiocellular carcinomas", "PROBLEM", 456, 484], ["Rare hepatic carcinomas", "PROBLEM", 484, 507], ["both hepatocellular carcinoma", "PROBLEM", 561, 590], ["cholangiocellular carcinoma", "PROBLEM", 595, 622], ["hepatocellular", "ANATOMY", 17, 31], ["carcinoma", "OBSERVATION", 32, 41], ["adenoid", "ANATOMY", 45, 52], ["abundant", "OBSERVATION_MODIFIER", 104, 112], ["mitotic figures", "OBSERVATION", 113, 128], ["prominent", "OBSERVATION_MODIFIER", 148, 157], ["connective-tissue stroma", "OBSERVATION", 158, 182], ["cholangiocellular carcinoma", "OBSERVATION", 220, 247], ["biliary", "ANATOMY", 252, 259], ["cholangiocarcinoma", "OBSERVATION", 260, 278], ["gallbladder", "ANATOMY", 287, 298], ["extrahepatic", "ANATOMY_MODIFIER", 302, 314], ["bile ducts", "ANATOMY", 315, 325], ["less frequent", "OBSERVATION_MODIFIER", 334, 347], ["intrahepatic", "ANATOMY", 357, 369], ["hepatocellular", "OBSERVATION", 437, 451], ["cholangiocellular carcinomas", "OBSERVATION", 456, 484], ["hepatic", "ANATOMY", 489, 496], ["carcinomas", "OBSERVATION", 497, 507], ["both", "OBSERVATION_MODIFIER", 561, 565], ["hepatocellular carcinoma", "OBSERVATION", 566, 590], ["cholangiocellular carcinoma", "OBSERVATION", 595, 622]]], ["These tumors likely arise from bipotential hepatic progenitor cells.", [["tumors", "ANATOMY", 6, 12], ["bipotential hepatic progenitor cells", "ANATOMY", 31, 67], ["tumors", "DISEASE", 6, 12], ["tumors", "CANCER", 6, 12], ["bipotential hepatic progenitor cells", "CELL", 31, 67], ["bipotential hepatic progenitor cells", "CELL_TYPE", 31, 67], ["These tumors", "PROBLEM", 0, 12], ["tumors", "OBSERVATION", 6, 12], ["bipotential", "ANATOMY_MODIFIER", 31, 42], ["hepatic", "ANATOMY", 43, 50], ["progenitor cells", "OBSERVATION", 51, 67]]], ["The hepatocytic nature of some tumor cells can be confirmed with the monoclonal antibody HepPar-1, and cells of biliary phenotype can be stained by immunohistochemistry using antibodies that bind to cytokeratin 7, a typical intermediate filament of biliary epithelium (Fig. 2-117A-C) .Hepatic carcinoidsHepatic carcinoids, presumably arising from the diffuse neuroendocrine cell population found among the biliary epithelium and possibly within the hepatic parenchyma, have been reported in dogs, cats, and cattle.", [["hepatocytic", "ANATOMY", 4, 15], ["tumor cells", "ANATOMY", 31, 42], ["cells", "ANATOMY", 103, 108], ["biliary", "ANATOMY", 112, 119], ["filament", "ANATOMY", 237, 245], ["biliary epithelium", "ANATOMY", 249, 267], ["Hepatic carcinoids", "ANATOMY", 285, 303], ["Hepatic carcinoids", "ANATOMY", 303, 321], ["diffuse neuroendocrine cell", "ANATOMY", 351, 378], ["biliary epithelium", "ANATOMY", 406, 424], ["hepatic parenchyma", "ANATOMY", 449, 467], ["tumor", "DISEASE", 31, 36], ["Hepatic carcinoids", "DISEASE", 285, 303], ["Hepatic carcinoids", "DISEASE", 303, 321], ["tumor cells", "CELL", 31, 42], ["HepPar-1", "GENE_OR_GENE_PRODUCT", 89, 97], ["cells", "CELL", 103, 108], ["biliary", "ORGAN", 112, 119], ["cytokeratin 7", "GENE_OR_GENE_PRODUCT", 199, 212], ["biliary epithelium", "TISSUE", 249, 267], ["Hepatic carcinoids", "CANCER", 285, 303], ["Hepatic carcinoids", "CANCER", 303, 321], ["neuroendocrine cell", "CELL", 359, 378], ["biliary epithelium", "TISSUE", 406, 424], ["hepatic parenchyma", "MULTI-TISSUE_STRUCTURE", 449, 467], ["dogs", "ORGANISM", 491, 495], ["cats", "ORGANISM", 497, 501], ["tumor cells", "CELL_TYPE", 31, 42], ["monoclonal antibody HepPar-1", "PROTEIN", 69, 97], ["antibodies", "PROTEIN", 175, 185], ["cytokeratin 7", "PROTEIN", 199, 212], ["diffuse neuroendocrine cell population", "CELL_TYPE", 351, 389], ["dogs", "SPECIES", 491, 495], ["cats", "SPECIES", 497, 501], ["cattle", "SPECIES", 507, 513], ["cattle", "SPECIES", 507, 513], ["some tumor cells", "PROBLEM", 26, 42], ["the monoclonal antibody HepPar", "TEST", 65, 95], ["biliary phenotype", "PROBLEM", 112, 129], ["immunohistochemistry", "TEST", 148, 168], ["cytokeratin", "TEST", 199, 210], ["Hepatic carcinoids", "PROBLEM", 285, 303], ["Hepatic carcinoids", "PROBLEM", 303, 321], ["the diffuse neuroendocrine cell population", "PROBLEM", 347, 389], ["hepatocytic", "OBSERVATION_MODIFIER", 4, 15], ["some", "OBSERVATION_MODIFIER", 26, 30], ["tumor cells", "OBSERVATION", 31, 42], ["biliary", "ANATOMY", 112, 119], ["intermediate filament", "OBSERVATION_MODIFIER", 224, 245], ["biliary epithelium", "ANATOMY", 249, 267], ["carcinoids", "OBSERVATION", 293, 303], ["carcinoids", "OBSERVATION", 311, 321], ["diffuse", "OBSERVATION_MODIFIER", 351, 358], ["neuroendocrine cell population", "OBSERVATION", 359, 389], ["biliary", "ANATOMY", 406, 413], ["epithelium", "ANATOMY_MODIFIER", 414, 424], ["hepatic", "ANATOMY", 449, 456], ["parenchyma", "ANATOMY_MODIFIER", 457, 467]]], ["They may arise within the liver, in the extrahepatic bile ducts or within the gallbladder.", [["liver", "ANATOMY", 26, 31], ["extrahepatic bile ducts", "ANATOMY", 40, 63], ["gallbladder", "ANATOMY", 78, 89], ["liver", "ORGAN", 26, 31], ["extrahepatic bile ducts", "MULTI-TISSUE_STRUCTURE", 40, 63], ["gallbladder", "ORGAN", 78, 89], ["liver", "ANATOMY", 26, 31], ["extrahepatic", "ANATOMY_MODIFIER", 40, 52], ["bile ducts", "ANATOMY", 53, 63], ["gallbladder", "ANATOMY", 78, 89]]], ["The gross pathologic appearance of carcinoids is typically that of disseminated pale gray to tan small masses within the liver, but on some occasions, only a single mass is formed (eFig.", [["carcinoids", "ANATOMY", 35, 45], ["masses", "ANATOMY", 103, 109], ["liver", "ANATOMY", 121, 126], ["carcinoids", "DISEASE", 35, 45], ["carcinoids", "CANCER", 35, 45], ["masses", "CANCER", 103, 109], ["liver", "ORGAN", 121, 126], ["The gross pathologic appearance of carcinoids", "PROBLEM", 0, 45], ["disseminated pale gray to tan small masses within the liver", "PROBLEM", 67, 126], ["a single mass", "PROBLEM", 156, 169], ["gross", "OBSERVATION_MODIFIER", 4, 9], ["pathologic", "OBSERVATION_MODIFIER", 10, 20], ["carcinoids", "OBSERVATION", 35, 45], ["disseminated", "OBSERVATION_MODIFIER", 67, 79], ["pale", "OBSERVATION_MODIFIER", 80, 84], ["gray", "OBSERVATION_MODIFIER", 85, 89], ["tan", "OBSERVATION_MODIFIER", 93, 96], ["small", "OBSERVATION_MODIFIER", 97, 102], ["masses", "OBSERVATION", 103, 109], ["liver", "ANATOMY", 121, 126], ["single", "OBSERVATION_MODIFIER", 158, 164], ["mass", "OBSERVATION", 165, 169]]], ["Like other neuroendocrine tumors, hepatic carcinoids typically form nests of cells separated by a fine fibrovascular stroma.", [["neuroendocrine tumors", "ANATOMY", 11, 32], ["hepatic carcinoids", "ANATOMY", 34, 52], ["cells", "ANATOMY", 77, 82], ["fibrovascular stroma", "ANATOMY", 103, 123], ["neuroendocrine tumors", "DISEASE", 11, 32], ["hepatic carcinoids", "DISEASE", 34, 52], ["neuroendocrine tumors", "CANCER", 11, 32], ["hepatic carcinoids", "CANCER", 34, 52], ["cells", "CELL", 77, 82], ["fibrovascular stroma", "TISSUE", 103, 123], ["other neuroendocrine tumors", "PROBLEM", 5, 32], ["hepatic carcinoids", "PROBLEM", 34, 52], ["nests of cells", "PROBLEM", 68, 82], ["a fine fibrovascular stroma", "PROBLEM", 96, 123], ["neuroendocrine", "ANATOMY", 11, 25], ["tumors", "OBSERVATION", 26, 32], ["hepatic", "ANATOMY", 34, 41], ["carcinoids", "OBSERVATION", 42, 52], ["fine", "OBSERVATION_MODIFIER", 98, 102], ["fibrovascular stroma", "OBSERVATION", 103, 123]]], ["The cells are oval to spindle shaped, and may form a rosette or pseudolobular pattern ( Fig. 2-118 ).", [["cells", "ANATOMY", 4, 9], ["spindle", "ANATOMY", 22, 29], ["rosette", "ANATOMY", 53, 60], ["cells", "CELL", 4, 9], ["a rosette or pseudolobular pattern", "PROBLEM", 51, 85], ["cells", "ANATOMY", 4, 9], ["oval", "OBSERVATION_MODIFIER", 14, 18], ["spindle shaped", "OBSERVATION_MODIFIER", 22, 36], ["may form", "UNCERTAINTY", 42, 50], ["rosette", "OBSERVATION_MODIFIER", 53, 60], ["pseudolobular pattern", "OBSERVATION", 64, 85]]], ["Mitotic figures are usually frequent.", [["Mitotic figures", "PROBLEM", 0, 15]]], ["Argyrophilic cytoplasmic granules may be detected by silver impregnation stains; more precise identification of carcinoids may require immunohistochemical stains for neurosecretory products, such as neuron-specific enolase or serotonin.", [["cytoplasmic granules", "ANATOMY", 13, 33], ["carcinoids", "ANATOMY", 112, 122], ["neurosecretory products", "ANATOMY", 166, 189], ["neuron", "ANATOMY", 199, 205], ["carcinoids", "DISEASE", 112, 122], ["serotonin", "CHEMICAL", 226, 235], ["silver", "CHEMICAL", 53, 59], ["serotonin", "CHEMICAL", 226, 235], ["cytoplasmic", "ORGANISM_SUBSTANCE", 13, 24], ["granules", "ORGANISM_SUBSTANCE", 25, 33], ["silver", "SIMPLE_CHEMICAL", 53, 59], ["carcinoids", "CANCER", 112, 122], ["neuron-specific enolase", "GENE_OR_GENE_PRODUCT", 199, 222], ["serotonin", "SIMPLE_CHEMICAL", 226, 235], ["neurosecretory products", "PROTEIN", 166, 189], ["neuron-specific enolase", "PROTEIN", 199, 222], ["Argyrophilic cytoplasmic granules", "PROBLEM", 0, 33], ["silver impregnation stains", "TEST", 53, 79], ["carcinoids", "PROBLEM", 112, 122], ["immunohistochemical stains", "TEST", 135, 161], ["neurosecretory products", "TREATMENT", 166, 189], ["serotonin", "PROBLEM", 226, 235], ["cytoplasmic granules", "OBSERVATION", 13, 33], ["may be", "UNCERTAINTY", 34, 40], ["silver impregnation", "OBSERVATION", 53, 72], ["carcinoids", "OBSERVATION", 112, 122]]], ["These are aggressive neoplasms, with frequent intrahepatic spread, and metastasis to local lymph nodes, peritoneum, and lung.Mesodermal tumorsPrimary mesenchymal tumors of the liver are quite uncommon.", [["neoplasms", "ANATOMY", 21, 30], ["intrahepatic", "ANATOMY", 46, 58], ["lymph nodes", "ANATOMY", 91, 102], ["peritoneum", "ANATOMY", 104, 114], ["lung", "ANATOMY", 120, 124], ["Mesodermal tumors", "ANATOMY", 125, 142], ["Primary mesenchymal tumors", "ANATOMY", 142, 168], ["liver", "ANATOMY", 176, 181], ["neoplasms", "DISEASE", 21, 30], ["Mesodermal tumors", "DISEASE", 125, 142], ["Primary mesenchymal tumors of the liver", "DISEASE", 142, 181], ["neoplasms", "CANCER", 21, 30], ["lymph nodes", "MULTI-TISSUE_STRUCTURE", 91, 102], ["peritoneum", "MULTI-TISSUE_STRUCTURE", 104, 114], ["lung", "ORGAN", 120, 124], ["Mesodermal tumors", "CANCER", 125, 142], ["Primary mesenchymal tumors", "CANCER", 142, 168], ["liver", "ORGAN", 176, 181], ["aggressive neoplasms", "PROBLEM", 10, 30], ["frequent intrahepatic spread", "PROBLEM", 37, 65], ["metastasis to local lymph nodes, peritoneum, and lung", "PROBLEM", 71, 124], ["Mesodermal tumors", "PROBLEM", 125, 142], ["Primary mesenchymal tumors of the liver", "PROBLEM", 142, 181], ["aggressive", "OBSERVATION_MODIFIER", 10, 20], ["neoplasms", "OBSERVATION", 21, 30], ["frequent", "OBSERVATION_MODIFIER", 37, 45], ["intrahepatic", "ANATOMY", 46, 58], ["spread", "OBSERVATION", 59, 65], ["metastasis", "OBSERVATION", 71, 81], ["local", "OBSERVATION_MODIFIER", 85, 90], ["lymph nodes", "OBSERVATION", 91, 102], ["peritoneum", "ANATOMY", 104, 114], ["lung", "ANATOMY", 120, 124], ["tumors", "OBSERVATION", 136, 142], ["mesenchymal tumors", "OBSERVATION", 150, 168], ["liver", "ANATOMY", 176, 181], ["uncommon", "OBSERVATION", 192, 200]]], ["Of the mesenchymal tumors, primary hemangiosarcomas are likely the most frequent.", [["mesenchymal tumors", "ANATOMY", 7, 25], ["primary hemangiosarcomas", "ANATOMY", 27, 51], ["mesenchymal tumors", "DISEASE", 7, 25], ["primary hemangiosarcomas", "DISEASE", 27, 51], ["mesenchymal tumors", "CANCER", 7, 25], ["hemangiosarcomas", "CANCER", 35, 51], ["the mesenchymal tumors", "PROBLEM", 3, 25], ["primary hemangiosarcomas", "PROBLEM", 27, 51], ["mesenchymal", "ANATOMY", 7, 18], ["tumors", "OBSERVATION", 19, 25], ["primary hemangiosarcomas", "OBSERVATION", 27, 51]]], ["Primary hepatic hemangiosarcomas occur in dogs, cats, cattle, and sheep.", [["hepatic hemangiosarcomas", "ANATOMY", 8, 32], ["Primary hepatic hemangiosarcomas", "DISEASE", 0, 32], ["hepatic hemangiosarcomas", "CANCER", 8, 32], ["dogs", "ORGANISM", 42, 46], ["cats", "ORGANISM", 48, 52], ["sheep", "ORGANISM", 66, 71], ["dogs", "SPECIES", 42, 46], ["cats", "SPECIES", 48, 52], ["cattle", "SPECIES", 54, 60], ["sheep", "SPECIES", 66, 71], ["cattle", "SPECIES", 54, 60], ["sheep", "SPECIES", 66, 71], ["Primary hepatic hemangiosarcomas", "PROBLEM", 0, 32], ["hepatic", "ANATOMY", 8, 15], ["hemangiosarcomas", "OBSERVATION", 16, 32]]], ["Hemangiosarcoma of the liver should always be considered metastatic until proven otherwise by diligent search.", [["Hemangiosarcoma", "ANATOMY", 0, 15], ["liver", "ANATOMY", 23, 28], ["Hemangiosarcoma of the liver", "DISEASE", 0, 28], ["Hemangiosarcoma", "CANCER", 0, 15], ["liver", "ORGAN", 23, 28], ["Hemangiosarcoma of the liver", "PROBLEM", 0, 28], ["liver", "ANATOMY", 23, 28], ["should always be considered", "UNCERTAINTY", 29, 56], ["metastatic", "OBSERVATION", 57, 67]]], ["Some of these tumors are solitary, large, and gray-white, with scattered hemorrhagic areas, and others are ill defined and cavernous (Fig. 2-119) .", [["tumors", "ANATOMY", 14, 20], ["cavernous", "ANATOMY", 123, 132], ["tumors", "DISEASE", 14, 20], ["hemorrhagic", "DISEASE", 73, 84], ["tumors", "CANCER", 14, 20], ["these tumors", "PROBLEM", 8, 20], ["large, and gray-white", "PROBLEM", 35, 56], ["scattered hemorrhagic areas", "PROBLEM", 63, 90], ["tumors", "OBSERVATION", 14, 20], ["solitary", "OBSERVATION_MODIFIER", 25, 33], ["large", "OBSERVATION_MODIFIER", 35, 40], ["gray", "OBSERVATION_MODIFIER", 46, 50], ["white", "OBSERVATION_MODIFIER", 51, 56], ["scattered", "OBSERVATION_MODIFIER", 63, 72], ["hemorrhagic", "OBSERVATION_MODIFIER", 73, 84], ["areas", "OBSERVATION", 85, 90], ["ill defined", "OBSERVATION_MODIFIER", 107, 118], ["cavernous", "ANATOMY", 123, 132]]], ["The latter may rupture into the peritoneal cavity to produce severe hemorrhage.", [["peritoneal cavity", "ANATOMY", 32, 49], ["hemorrhage", "DISEASE", 68, 78], ["peritoneal cavity", "MULTI-TISSUE_STRUCTURE", 32, 49], ["rupture into the peritoneal cavity", "PROBLEM", 15, 49], ["severe hemorrhage", "PROBLEM", 61, 78], ["rupture", "OBSERVATION", 15, 22], ["peritoneal cavity", "ANATOMY", 32, 49], ["severe", "OBSERVATION_MODIFIER", 61, 67], ["hemorrhage", "OBSERVATION", 68, 78]]], ["Microscopically, hepatic hemangiosarcomas resemble those found in other sites; however, it may be impossible to find malignant cells in or lining cavernous areas.", [["hepatic hemangiosarcomas", "ANATOMY", 17, 41], ["sites", "ANATOMY", 72, 77], ["malignant cells", "ANATOMY", 117, 132], ["cavernous areas", "ANATOMY", 146, 161], ["hepatic hemangiosarcomas", "DISEASE", 17, 41], ["hepatic hemangiosarcomas", "CANCER", 17, 41], ["malignant cells", "CELL", 117, 132], ["cavernous areas", "PATHOLOGICAL_FORMATION", 146, 161], ["malignant cells", "CELL_TYPE", 117, 132], ["hepatic hemangiosarcomas", "PROBLEM", 17, 41], ["malignant cells", "PROBLEM", 117, 132], ["lining cavernous areas", "PROBLEM", 139, 161], ["hepatic", "ANATOMY", 17, 24], ["hemangiosarcomas", "OBSERVATION", 25, 41], ["lining", "ANATOMY_MODIFIER", 139, 145], ["cavernous", "ANATOMY", 146, 155]]], ["At central parts of the tumor nodules.", [["tumor nodules", "ANATOMY", 24, 37], ["tumor", "DISEASE", 24, 29], ["tumor nodules", "CANCER", 24, 37], ["the tumor nodules", "PROBLEM", 20, 37], ["central", "ANATOMY_MODIFIER", 3, 10], ["tumor", "OBSERVATION_MODIFIER", 24, 29], ["nodules", "OBSERVATION", 30, 37]]], ["Even multiple nodules may not cause much enlargement of the liver.", [["nodules", "ANATOMY", 14, 21], ["liver", "ANATOMY", 60, 65], ["enlargement of the liver", "DISEASE", 41, 65], ["nodules", "CANCER", 14, 21], ["liver", "ORGAN", 60, 65], ["multiple nodules", "PROBLEM", 5, 21], ["much enlargement of the liver", "PROBLEM", 36, 65], ["multiple", "OBSERVATION_MODIFIER", 5, 13], ["nodules", "OBSERVATION", 14, 21], ["may not cause", "UNCERTAINTY", 22, 35], ["enlargement", "OBSERVATION", 41, 52], ["liver", "ANATOMY", 60, 65]]], ["In dogs and cats, the tumors are almost always multiple or diffuse.", [["tumors", "ANATOMY", 22, 28], ["tumors", "DISEASE", 22, 28], ["dogs", "ORGANISM", 3, 7], ["cats", "ORGANISM", 12, 16], ["tumors", "CANCER", 22, 28], ["dogs", "SPECIES", 3, 7], ["cats", "SPECIES", 12, 16], ["the tumors", "PROBLEM", 18, 28], ["tumors", "OBSERVATION", 22, 28], ["diffuse", "OBSERVATION_MODIFIER", 59, 66]]], ["The multiple nodules of tumor might represent intrahepatic lymphogenous metastases, but the possibility of multicentric origin must be entertained.", [["nodules", "ANATOMY", 13, 20], ["tumor", "ANATOMY", 24, 29], ["intrahepatic lymphogenous metastases", "ANATOMY", 46, 82], ["tumor", "DISEASE", 24, 29], ["intrahepatic lymphogenous metastases", "DISEASE", 46, 82], ["nodules", "CANCER", 13, 20], ["tumor", "CANCER", 24, 29], ["intrahepatic lymphogenous metastases", "CANCER", 46, 82], ["The multiple nodules of tumor", "PROBLEM", 0, 29], ["intrahepatic lymphogenous metastases", "PROBLEM", 46, 82], ["multicentric origin", "PROBLEM", 107, 126], ["multiple", "OBSERVATION_MODIFIER", 4, 12], ["nodules", "OBSERVATION", 13, 20], ["tumor", "OBSERVATION", 24, 29], ["might represent", "UNCERTAINTY", 30, 45], ["intrahepatic", "ANATOMY_MODIFIER", 46, 58], ["lymphogenous", "OBSERVATION_MODIFIER", 59, 71], ["metastases", "OBSERVATION", 72, 82], ["multicentric", "OBSERVATION", 107, 119]]], ["Hematogenous metastases are unusual, but metastases to the regional nodes are common.", [["Hematogenous metastases", "ANATOMY", 0, 23], ["metastases", "ANATOMY", 41, 51], ["regional nodes", "ANATOMY", 59, 73], ["metastases", "DISEASE", 13, 23], ["metastases", "DISEASE", 41, 51], ["regional nodes", "MULTI-TISSUE_STRUCTURE", 59, 73], ["Hematogenous metastases", "PROBLEM", 0, 23], ["metastases to the regional nodes", "PROBLEM", 41, 73], ["metastases", "OBSERVATION", 13, 23], ["metastases", "OBSERVATION", 41, 51], ["regional", "ANATOMY_MODIFIER", 59, 67], ["nodes", "OBSERVATION", 68, 73]]], ["In cats especially, there is a tendency to invade Glisson's capsule and implant on the peritoneum; the diffuse variety may cause great enlargement, although with retention of shape.Mesodermal tumorsMicroscopically, cholangiocellular carcinomas form ductules and acini, and sometimes papillary formations within the lumen of the neoplastic ducts ( Fig. 2-116) .", [["capsule", "ANATOMY", 60, 67], ["peritoneum", "ANATOMY", 87, 97], ["Mesodermal tumors", "ANATOMY", 181, 198], ["cholangiocellular carcinomas", "ANATOMY", 215, 243], ["ductules", "ANATOMY", 249, 257], ["acini", "ANATOMY", 262, 267], ["papillary", "ANATOMY", 283, 292], ["lumen", "ANATOMY", 315, 320], ["neoplastic ducts", "ANATOMY", 328, 344], ["Mesodermal tumors", "DISEASE", 181, 198], ["cholangiocellular carcinomas", "DISEASE", 215, 243], ["cats", "ORGANISM", 3, 7], ["capsule", "CANCER", 60, 67], ["peritoneum", "MULTI-TISSUE_STRUCTURE", 87, 97], ["Mesodermal tumors", "CANCER", 181, 198], ["cholangiocellular carcinomas", "CANCER", 215, 243], ["ductules", "MULTI-TISSUE_STRUCTURE", 249, 257], ["acini", "MULTI-TISSUE_STRUCTURE", 262, 267], ["papillary formations", "PATHOLOGICAL_FORMATION", 283, 303], ["lumen", "IMMATERIAL_ANATOMICAL_ENTITY", 315, 320], ["neoplastic ducts", "MULTI-TISSUE_STRUCTURE", 328, 344], ["cats", "SPECIES", 3, 7], ["invade Glisson's capsule", "TREATMENT", 43, 67], ["implant on the peritoneum", "PROBLEM", 72, 97], ["the diffuse variety", "PROBLEM", 99, 118], ["great enlargement", "PROBLEM", 129, 146], ["retention of shape", "PROBLEM", 162, 180], ["Mesodermal tumors", "PROBLEM", 181, 198], ["cholangiocellular carcinomas form ductules and acini", "PROBLEM", 215, 267], ["sometimes papillary formations", "PROBLEM", 273, 303], ["implant", "OBSERVATION", 72, 79], ["peritoneum", "ANATOMY", 87, 97], ["diffuse", "OBSERVATION_MODIFIER", 103, 110], ["variety", "OBSERVATION_MODIFIER", 111, 118], ["may cause", "UNCERTAINTY", 119, 128], ["great", "OBSERVATION_MODIFIER", 129, 134], ["enlargement", "OBSERVATION", 135, 146], ["retention", "OBSERVATION_MODIFIER", 162, 171], ["shape", "OBSERVATION_MODIFIER", 175, 180], ["tumors", "OBSERVATION", 192, 198], ["cholangiocellular carcinomas", "OBSERVATION", 215, 243], ["ductules", "ANATOMY_MODIFIER", 249, 257], ["acini", "ANATOMY", 262, 267], ["papillary", "OBSERVATION_MODIFIER", 283, 292], ["formations", "OBSERVATION", 293, 303], ["lumen", "ANATOMY_MODIFIER", 315, 320], ["neoplastic", "OBSERVATION", 328, 338], ["ducts", "ANATOMY", 339, 344]]], ["The cells are cuboidal or columnar, with a small amount of clear or slightly granular cytoplasm.", [["cells", "ANATOMY", 4, 9], ["columnar", "ANATOMY", 26, 34], ["granular cytoplasm", "ANATOMY", 77, 95], ["cells", "CELL", 4, 9], ["cytoplasm", "ORGANISM_SUBSTANCE", 86, 95], ["slightly granular cytoplasm", "PROBLEM", 68, 95], ["cells", "ANATOMY", 4, 9], ["cuboidal", "OBSERVATION_MODIFIER", 14, 22], ["columnar", "OBSERVATION_MODIFIER", 26, 34], ["small", "OBSERVATION_MODIFIER", 43, 48], ["amount", "OBSERVATION_MODIFIER", 49, 55], ["clear", "OBSERVATION", 59, 64], ["slightly", "OBSERVATION_MODIFIER", 68, 76], ["granular cytoplasm", "OBSERVATION", 77, 95]]], ["The nuclei are small and fairly uniform, and nucleoli are not prominent.", [["nuclei", "ANATOMY", 4, 10], ["nucleoli", "ANATOMY", 45, 53], ["nuclei", "CELLULAR_COMPONENT", 4, 10], ["nucleoli", "CELLULAR_COMPONENT", 45, 53], ["nuclei", "ANATOMY", 4, 10], ["small", "OBSERVATION_MODIFIER", 15, 20], ["fairly", "OBSERVATION_MODIFIER", 25, 31], ["uniform", "OBSERVATION_MODIFIER", 32, 39], ["nucleoli", "OBSERVATION", 45, 53], ["not", "UNCERTAINTY", 58, 61], ["prominent", "OBSERVATION_MODIFIER", 62, 71]]], ["Mitotic figures are often abundant.", [["Mitotic figures", "PROBLEM", 0, 15], ["abundant", "OBSERVATION_MODIFIER", 26, 34]]], ["The tubules do not contain bile, but in welldifferentiated specimens may contain mucins.", [["tubules", "ANATOMY", 4, 11], ["bile", "ANATOMY", 27, 31], ["specimens", "ANATOMY", 59, 68], ["tubules", "TISSUE", 4, 11], ["bile", "ORGAN", 27, 31], ["specimens", "CANCER", 59, 68], ["mucins", "GENE_OR_GENE_PRODUCT", 81, 87], ["bile", "ANATOMY", 27, 31], ["mucins", "OBSERVATION", 81, 87]]], ["The epithelial components are separated by fibrous connective-tissue stroma, which may have pronounced collagen deposition, the so-called scirrhous response that gives the tumor a firm texture.", [["epithelial components", "ANATOMY", 4, 25], ["fibrous connective-tissue stroma", "ANATOMY", 43, 75], ["scirrhous", "ANATOMY", 138, 147], ["tumor", "ANATOMY", 172, 177], ["tumor", "DISEASE", 172, 177], ["epithelial components", "TISSUE", 4, 25], ["fibrous connective-tissue stroma", "TISSUE", 43, 75], ["collagen", "GENE_OR_GENE_PRODUCT", 103, 111], ["scirrhous", "CANCER", 138, 147], ["tumor", "CANCER", 172, 177], ["collagen", "PROTEIN", 103, 111], ["fibrous connective-tissue stroma", "PROBLEM", 43, 75], ["pronounced collagen deposition", "PROBLEM", 92, 122], ["the tumor a firm texture", "PROBLEM", 168, 192], ["epithelial", "ANATOMY_MODIFIER", 4, 14], ["fibrous", "OBSERVATION_MODIFIER", 43, 50], ["connective-tissue stroma", "OBSERVATION", 51, 75], ["pronounced", "OBSERVATION_MODIFIER", 92, 102], ["collagen deposition", "OBSERVATION", 103, 122], ["tumor", "OBSERVATION", 172, 177], ["firm", "OBSERVATION_MODIFIER", 180, 184], ["texture", "OBSERVATION_MODIFIER", 185, 192]]], ["In poorly differentiated cholangiocarcinomas, pleomorphic to anaplastic cells can be observed.", [["cholangiocarcinomas", "ANATOMY", 25, 44], ["anaplastic cells", "ANATOMY", 61, 77], ["cholangiocarcinomas", "DISEASE", 25, 44], ["cholangiocarcinomas", "CANCER", 25, 44], ["anaplastic cells", "CELL", 61, 77], ["pleomorphic to anaplastic cells", "CELL_TYPE", 46, 77], ["poorly differentiated cholangiocarcinomas", "PROBLEM", 3, 44], ["pleomorphic to anaplastic cells", "PROBLEM", 46, 77], ["poorly differentiated", "OBSERVATION_MODIFIER", 3, 24], ["cholangiocarcinomas", "OBSERVATION", 25, 44], ["pleomorphic", "OBSERVATION_MODIFIER", 46, 57], ["anaplastic cells", "OBSERVATION", 61, 77]]], ["It is not uncommon to encounter areas sinusoids are spread widely apart, and individual hepatocytes or portions of cords are isolated and appear to be floating freely, surrounded by a thin layer of connective tissue and neoplastic cells.", [["sinusoids", "ANATOMY", 38, 47], ["hepatocytes", "ANATOMY", 88, 99], ["cords", "ANATOMY", 115, 120], ["connective tissue", "ANATOMY", 198, 215], ["neoplastic cells", "ANATOMY", 220, 236], ["sinusoids", "MULTI-TISSUE_STRUCTURE", 38, 47], ["hepatocytes", "CELL", 88, 99], ["cords", "ORGAN", 115, 120], ["connective tissue", "TISSUE", 198, 215], ["neoplastic cells", "CELL", 220, 236], ["hepatocytes", "CELL_TYPE", 88, 99], ["neoplastic cells", "CELL_TYPE", 220, 236], ["a thin layer of connective tissue and neoplastic cells", "PROBLEM", 182, 236], ["not uncommon", "UNCERTAINTY", 6, 18], ["spread", "OBSERVATION_MODIFIER", 52, 58], ["widely", "OBSERVATION_MODIFIER", 59, 65], ["hepatocytes", "ANATOMY", 88, 99], ["portions", "ANATOMY_MODIFIER", 103, 111], ["cords", "ANATOMY", 115, 120], ["appear to be", "UNCERTAINTY", 138, 150], ["thin", "OBSERVATION_MODIFIER", 184, 188], ["layer", "OBSERVATION_MODIFIER", 189, 194], ["connective tissue", "OBSERVATION", 198, 215], ["neoplastic cells", "OBSERVATION", 220, 236]]], ["Differential diagnoses other than metastatic lesions include the syndrome of telangiectasia in Pembroke Welsh Corgi dogs, telangiectatic lesions in older animals, and vascular hamartomas in cattle.", [["metastatic lesions", "ANATOMY", 34, 52], ["telangiectatic lesions", "ANATOMY", 122, 144], ["vascular hamartomas", "ANATOMY", 167, 186], ["telangiectasia", "DISEASE", 77, 91], ["telangiectatic lesions", "DISEASE", 122, 144], ["vascular hamartomas", "DISEASE", 167, 186], ["metastatic lesions", "CANCER", 34, 52], ["telangiectatic lesions", "CANCER", 122, 144], ["vascular hamartomas", "PATHOLOGICAL_FORMATION", 167, 186], ["cattle", "ORGANISM", 190, 196], ["dogs", "SPECIES", 116, 120], ["cattle", "SPECIES", 190, 196], ["cattle", "SPECIES", 190, 196], ["metastatic lesions", "PROBLEM", 34, 52], ["the syndrome", "PROBLEM", 61, 73], ["telangiectasia", "PROBLEM", 77, 91], ["telangiectatic lesions in older animals", "PROBLEM", 122, 161], ["vascular hamartomas", "PROBLEM", 167, 186], ["metastatic", "OBSERVATION_MODIFIER", 34, 44], ["telangiectasia", "OBSERVATION", 77, 91], ["telangiectatic", "OBSERVATION_MODIFIER", 122, 136], ["lesions", "OBSERVATION", 137, 144], ["older animals", "OBSERVATION_MODIFIER", 148, 161], ["vascular", "ANATOMY", 167, 175], ["hamartomas", "OBSERVATION", 176, 186]]], ["Hepatic hemangiomas have been reported in dogs and a pig.Mesodermal tumorsLeiomyomas are occasionally observed in the gallbladder of dogs and cattle.", [["Hepatic hemangiomas", "ANATOMY", 0, 19], ["Mesodermal tumors", "ANATOMY", 57, 74], ["gallbladder", "ANATOMY", 118, 129], ["Hepatic hemangiomas", "DISEASE", 0, 19], ["Mesodermal tumors", "DISEASE", 57, 74], ["Hepatic hemangiomas", "PATHOLOGICAL_FORMATION", 0, 19], ["dogs", "ORGANISM", 42, 46], ["pig", "ORGANISM", 53, 56], ["Mesodermal tumorsLeiomyomas", "CANCER", 57, 84], ["gallbladder", "ORGAN", 118, 129], ["dogs", "ORGANISM", 133, 137], ["dogs", "SPECIES", 42, 46], ["pig", "SPECIES", 53, 56], ["dogs", "SPECIES", 133, 137], ["cattle", "SPECIES", 142, 148], ["pig", "SPECIES", 53, 56], ["cattle", "SPECIES", 142, 148], ["Hepatic hemangiomas", "PROBLEM", 0, 19], ["a pig", "TREATMENT", 51, 56], ["Mesodermal tumorsLeiomyomas", "PROBLEM", 57, 84], ["hemangiomas", "OBSERVATION", 8, 19], ["tumors", "OBSERVATION", 68, 74], ["gallbladder", "ANATOMY", 118, 129], ["dogs", "OBSERVATION", 133, 137]]], ["Leiomyosarcomas and fibrosarcomas have been reported in the liver of cats and dogs, hemangiopericytoma and fibrosarcoma in cattle, and a single case of botryoidtype embryonal rhabdomyosarcoma in a cat.", [["Leiomyosarcomas", "ANATOMY", 0, 15], ["fibrosarcomas", "ANATOMY", 20, 33], ["liver", "ANATOMY", 60, 65], ["hemangiopericytoma", "ANATOMY", 84, 102], ["fibrosarcoma", "ANATOMY", 107, 119], ["embryonal rhabdomyosarcoma", "ANATOMY", 165, 191], ["Leiomyosarcomas", "DISEASE", 0, 15], ["fibrosarcomas", "DISEASE", 20, 33], ["hemangiopericytoma", "DISEASE", 84, 102], ["fibrosarcoma", "DISEASE", 107, 119], ["embryonal rhabdomyosarcoma", "DISEASE", 165, 191], ["Leiomyosarcomas", "CANCER", 0, 15], ["fibrosarcomas", "CANCER", 20, 33], ["liver", "ORGAN", 60, 65], ["cats", "ORGANISM", 69, 73], ["dogs", "ORGANISM", 78, 82], ["hemangiopericytoma", "CANCER", 84, 102], ["fibrosarcoma", "CANCER", 107, 119], ["botryoidtype embryonal rhabdomyosarcoma", "CANCER", 152, 191], ["cat", "ORGANISM", 197, 200], ["cats", "SPECIES", 69, 73], ["dogs", "SPECIES", 78, 82], ["cattle", "SPECIES", 123, 129], ["cat", "SPECIES", 197, 200], ["cattle", "SPECIES", 123, 129], ["Leiomyosarcomas", "PROBLEM", 0, 15], ["fibrosarcomas", "PROBLEM", 20, 33], ["dogs", "PROBLEM", 78, 82], ["hemangiopericytoma", "PROBLEM", 84, 102], ["fibrosarcoma", "PROBLEM", 107, 119], ["botryoidtype embryonal rhabdomyosarcoma", "PROBLEM", 152, 191], ["fibrosarcomas", "OBSERVATION", 20, 33], ["liver", "ANATOMY", 60, 65], ["cats", "OBSERVATION", 69, 73], ["hemangiopericytoma", "OBSERVATION", 84, 102], ["fibrosarcoma", "OBSERVATION", 107, 119], ["embryonal rhabdomyosarcoma", "OBSERVATION", 165, 191]]], ["Other rare mesenchymal tumors reported in either dogs or cats include lymphangioma, plasmacytoma, osteosarcoma, nerve sheath tumor, liposarcoma, and chondrosarcoma.Mesodermal tumorsThe myelolipoma is an unusual tumor that develops in the livers of domestic cats and wild felids.", [["mesenchymal tumors", "ANATOMY", 11, 29], ["lymphangioma", "ANATOMY", 70, 82], ["plasmacytoma", "ANATOMY", 84, 96], ["osteosarcoma", "ANATOMY", 98, 110], ["nerve sheath tumor", "ANATOMY", 112, 130], ["liposarcoma", "ANATOMY", 132, 143], ["chondrosarcoma", "ANATOMY", 149, 163], ["Mesodermal tumors", "ANATOMY", 164, 181], ["myelolipoma", "ANATOMY", 185, 196], ["tumor", "ANATOMY", 211, 216], ["livers", "ANATOMY", 238, 244], ["mesenchymal tumors", "DISEASE", 11, 29], ["lymphangioma", "DISEASE", 70, 82], ["plasmacytoma", "DISEASE", 84, 96], ["osteosarcoma", "DISEASE", 98, 110], ["nerve sheath tumor", "DISEASE", 112, 130], ["liposarcoma", "DISEASE", 132, 143], ["chondrosarcoma", "DISEASE", 149, 163], ["Mesodermal tumors", "DISEASE", 164, 181], ["myelolipoma", "DISEASE", 185, 196], ["tumor", "DISEASE", 211, 216], ["mesenchymal tumors", "CANCER", 11, 29], ["dogs", "ORGANISM", 49, 53], ["cats", "ORGANISM", 57, 61], ["lymphangioma", "CANCER", 70, 82], ["plasmacytoma", "CANCER", 84, 96], ["osteosarcoma", "CANCER", 98, 110], ["nerve sheath tumor", "CANCER", 112, 130], ["liposarcoma", "CANCER", 132, 143], ["chondrosarcoma", "CANCER", 149, 163], ["Mesodermal tumors", "CANCER", 164, 181], ["myelolipoma", "CANCER", 185, 196], ["tumor", "CANCER", 211, 216], ["livers", "ORGAN", 238, 244], ["cats", "ORGANISM", 257, 261], ["dogs", "SPECIES", 49, 53], ["cats", "SPECIES", 57, 61], ["cats", "SPECIES", 257, 261], ["Other rare mesenchymal tumors", "PROBLEM", 0, 29], ["lymphangioma", "PROBLEM", 70, 82], ["plasmacytoma", "PROBLEM", 84, 96], ["osteosarcoma", "PROBLEM", 98, 110], ["nerve sheath tumor", "PROBLEM", 112, 130], ["liposarcoma", "PROBLEM", 132, 143], ["chondrosarcoma", "PROBLEM", 149, 163], ["Mesodermal tumors", "PROBLEM", 164, 181], ["The myelolipoma", "PROBLEM", 181, 196], ["an unusual tumor", "PROBLEM", 200, 216], ["rare", "OBSERVATION_MODIFIER", 6, 10], ["mesenchymal tumors", "OBSERVATION", 11, 29], ["lymphangioma", "OBSERVATION", 70, 82], ["plasmacytoma", "OBSERVATION", 84, 96], ["osteosarcoma", "OBSERVATION", 98, 110], ["nerve", "ANATOMY", 112, 117], ["sheath", "ANATOMY_MODIFIER", 118, 124], ["tumor", "OBSERVATION", 125, 130], ["liposarcoma", "OBSERVATION", 132, 143], ["chondrosarcoma", "OBSERVATION", 149, 163], ["tumors", "OBSERVATION", 175, 181], ["myelolipoma", "OBSERVATION", 185, 196], ["unusual", "OBSERVATION_MODIFIER", 203, 210], ["tumor", "OBSERVATION", 211, 216], ["livers", "ANATOMY", 238, 244], ["domestic cats", "OBSERVATION", 248, 261]]], ["The tumor develops as multiple growths, 0.5-5 cm diameter, in one or more lobes; if they project above the surface of the liver, they are irregularly nodular.", [["tumor", "ANATOMY", 4, 9], ["growths", "ANATOMY", 31, 38], ["lobes", "ANATOMY", 74, 79], ["surface", "ANATOMY", 107, 114], ["liver", "ANATOMY", 122, 127], ["tumor", "DISEASE", 4, 9], ["tumor", "CANCER", 4, 9], ["lobes", "CANCER", 74, 79], ["surface", "CELLULAR_COMPONENT", 107, 114], ["liver", "ORGAN", 122, 127], ["The tumor", "PROBLEM", 0, 9], ["multiple growths", "PROBLEM", 22, 38], ["irregularly nodular", "PROBLEM", 138, 157], ["tumor", "OBSERVATION", 4, 9], ["multiple", "OBSERVATION_MODIFIER", 22, 30], ["growths", "OBSERVATION_MODIFIER", 31, 38], ["0.5-5 cm diameter", "OBSERVATION_MODIFIER", 40, 57], ["more lobes", "ANATOMY_MODIFIER", 69, 79], ["surface", "ANATOMY_MODIFIER", 107, 114], ["liver", "ANATOMY", 122, 127], ["irregularly", "OBSERVATION_MODIFIER", 138, 149], ["nodular", "OBSERVATION", 150, 157]]], ["Myelolipomas are friable, and yellow to orange because of their high fat content.", [["Myelolipomas", "ANATOMY", 0, 12], ["fat", "ANATOMY", 69, 72], ["Myelolipomas", "DISEASE", 0, 12], ["Myelolipomas", "CANCER", 0, 12], ["fat", "TISSUE", 69, 72], ["Myelolipomas", "PROBLEM", 0, 12], ["friable", "PROBLEM", 17, 24], ["their high fat content", "PROBLEM", 58, 80], ["friable", "OBSERVATION", 17, 24], ["yellow to orange", "OBSERVATION_MODIFIER", 30, 46], ["high fat content", "OBSERVATION", 64, 80]]], ["The neoplasm is composed the margins of the tumor, there is a distinctive pattern or growth in which small, solid nodules of malignant cells may be found, or these cells can be found forming capillary structures or invading along pre-existing sinusoids.", [["neoplasm", "ANATOMY", 4, 12], ["tumor", "ANATOMY", 44, 49], ["solid nodules", "ANATOMY", 108, 121], ["malignant cells", "ANATOMY", 125, 140], ["cells", "ANATOMY", 164, 169], ["capillary structures", "ANATOMY", 191, 211], ["sinusoids", "ANATOMY", 243, 252], ["neoplasm", "DISEASE", 4, 12], ["tumor", "DISEASE", 44, 49], ["neoplasm", "CANCER", 4, 12], ["tumor", "CANCER", 44, 49], ["solid nodules", "CANCER", 108, 121], ["malignant cells", "CELL", 125, 140], ["cells", "CELL", 164, 169], ["capillary structures", "TISSUE", 191, 211], ["sinusoids", "TISSUE", 243, 252], ["malignant cells", "CELL_TYPE", 125, 140], ["The neoplasm", "PROBLEM", 0, 12], ["the tumor", "PROBLEM", 40, 49], ["small, solid nodules of malignant cells", "PROBLEM", 101, 140], ["these cells", "PROBLEM", 158, 169], ["neoplasm", "OBSERVATION", 4, 12], ["margins", "OBSERVATION_MODIFIER", 29, 36], ["tumor", "OBSERVATION", 44, 49], ["distinctive", "OBSERVATION_MODIFIER", 62, 73], ["pattern", "OBSERVATION_MODIFIER", 74, 81], ["growth", "OBSERVATION_MODIFIER", 85, 91], ["small", "OBSERVATION_MODIFIER", 101, 106], ["solid", "OBSERVATION_MODIFIER", 108, 113], ["nodules", "OBSERVATION", 114, 121], ["malignant cells", "OBSERVATION", 125, 140]]], ["The latter phenomenon is particularly characteristic.", [["The latter phenomenon", "PROBLEM", 0, 21], ["latter phenomenon", "OBSERVATION", 4, 21], ["particularly characteristic", "UNCERTAINTY", 25, 52]]], ["As the cells invade along the sinusoids, perhaps in single file, they initially produce little distortion of the hepatic cords.", [["cells", "ANATOMY", 7, 12], ["sinusoids", "ANATOMY", 30, 39], ["hepatic cords", "ANATOMY", 113, 126], ["cells", "CELL", 7, 12], ["sinusoids", "TISSUE", 30, 39], ["hepatic cords", "MULTI-TISSUE_STRUCTURE", 113, 126], ["little distortion of the hepatic cords", "PROBLEM", 88, 126], ["sinusoids", "ANATOMY", 30, 39], ["little", "OBSERVATION_MODIFIER", 88, 94], ["distortion", "OBSERVATION", 95, 105], ["hepatic", "ANATOMY", 113, 120], ["cords", "ANATOMY_MODIFIER", 121, 126]]], ["Behind them, the Careful examination is required to distinguish primary from metastatic disease. liver and spleen, and neoplastic lymphocytes are most common within the sinusoids.", [["metastatic disease", "ANATOMY", 77, 95], ["liver", "ANATOMY", 97, 102], ["spleen", "ANATOMY", 107, 113], ["neoplastic lymphocytes", "ANATOMY", 119, 141], ["sinusoids", "ANATOMY", 169, 178], ["metastatic disease", "CANCER", 77, 95], ["liver", "ORGAN", 97, 102], ["spleen", "ORGAN", 107, 113], ["neoplastic lymphocytes", "CELL", 119, 141], ["sinusoids", "TISSUE", 169, 178], ["neoplastic lymphocytes", "CELL_TYPE", 119, 141], ["the Careful examination", "TEST", 13, 36], ["metastatic disease", "PROBLEM", 77, 95], ["neoplastic lymphocytes", "PROBLEM", 119, 141], ["metastatic", "OBSERVATION", 77, 87], ["spleen", "ANATOMY", 107, 113], ["neoplastic lymphocytes", "OBSERVATION", 119, 141], ["sinusoids", "ANATOMY", 169, 178]]], ["Hepatocytotrophic lymphoma is a T-cell lymphoma variant (CD3+, CD11d\u2212) that invades hepatocytes.", [["Hepatocytotrophic lymphoma", "ANATOMY", 0, 26], ["T-cell lymphoma", "ANATOMY", 32, 47], ["CD3+, CD11d\u2212", "ANATOMY", 57, 69], ["hepatocytes", "ANATOMY", 84, 95], ["Hepatocytotrophic lymphoma", "DISEASE", 0, 26], ["T-cell lymphoma", "DISEASE", 32, 47], ["Hepatocytotrophic lymphoma", "CANCER", 0, 26], ["T-cell lymphoma", "CANCER", 32, 47], ["CD3", "GENE_OR_GENE_PRODUCT", 57, 60], ["CD11d\u2212", "GENE_OR_GENE_PRODUCT", 63, 69], ["hepatocytes", "CELL", 84, 95], ["CD3", "PROTEIN", 57, 60], ["hepatocytes", "CELL_TYPE", 84, 95], ["Hepatocytotrophic lymphoma", "PROBLEM", 0, 26], ["a T-cell lymphoma variant", "PROBLEM", 30, 55], ["lymphoma", "OBSERVATION", 18, 26], ["T-cell lymphoma", "OBSERVATION", 32, 47], ["hepatocytes", "ANATOMY", 84, 95]]], ["Diffuse infiltration of the liver in myeloproliferative disorders and mast cell leukemia may also cause extreme enlargement of the organ; the infiltrates localize preferentially in and around the sinusoids (Fig. 2-123) .", [["liver", "ANATOMY", 28, 33], ["mast cell leukemia", "ANATOMY", 70, 88], ["organ", "ANATOMY", 131, 136], ["infiltrates", "ANATOMY", 142, 153], ["sinusoids", "ANATOMY", 196, 205], ["infiltration of the liver", "DISEASE", 8, 33], ["myeloproliferative disorders", "DISEASE", 37, 65], ["mast cell leukemia", "DISEASE", 70, 88], ["liver", "ORGAN", 28, 33], ["mast cell leukemia", "CANCER", 70, 88], ["organ", "ORGAN", 131, 136], ["sinusoids", "TISSUE", 196, 205], ["Diffuse infiltration of the liver", "PROBLEM", 0, 33], ["myeloproliferative disorders", "PROBLEM", 37, 65], ["mast cell leukemia", "PROBLEM", 70, 88], ["extreme enlargement of the organ", "PROBLEM", 104, 136], ["the infiltrates", "PROBLEM", 138, 153], ["infiltration", "OBSERVATION", 8, 20], ["liver", "ANATOMY", 28, 33], ["myeloproliferative disorders", "OBSERVATION", 37, 65], ["mast cell leukemia", "OBSERVATION", 70, 88], ["may also cause", "UNCERTAINTY", 89, 103], ["extreme", "OBSERVATION_MODIFIER", 104, 111], ["enlargement", "OBSERVATION", 112, 123], ["organ", "ANATOMY", 131, 136], ["infiltrates", "OBSERVATION", 142, 153], ["preferentially", "OBSERVATION_MODIFIER", 163, 177], ["sinusoids", "ANATOMY", 196, 205]]], ["Hepatic infiltration may be in discrete nodules 2 cm or more in size, particularly lymphoma in horses, but it is usually diffuse in the connective tissues of the portal triads.Mesodermal tumorsMelanomas and hemangiosarcomas have characteristic gross features in the liver, but most metastatic tumors cannot be distinguished by their gross appearance.", [["Hepatic", "ANATOMY", 0, 7], ["nodules", "ANATOMY", 40, 47], ["lymphoma", "ANATOMY", 83, 91], ["connective tissues", "ANATOMY", 136, 154], ["portal triads", "ANATOMY", 162, 175], ["Mesodermal tumors", "ANATOMY", 176, 193], ["hemangiosarcomas", "ANATOMY", 207, 223], ["liver", "ANATOMY", 266, 271], ["metastatic tumors", "ANATOMY", 282, 299], ["lymphoma", "DISEASE", 83, 91], ["Mesodermal tumors", "DISEASE", 176, 193], ["hemangiosarcomas", "DISEASE", 207, 223], ["tumors", "DISEASE", 293, 299], ["Hepatic", "ORGAN", 0, 7], ["lymphoma", "CANCER", 83, 91], ["connective tissues", "TISSUE", 136, 154], ["portal triads", "MULTI-TISSUE_STRUCTURE", 162, 175], ["Mesodermal tumorsMelanomas", "CANCER", 176, 202], ["hemangiosarcomas", "CANCER", 207, 223], ["liver", "ORGAN", 266, 271], ["metastatic tumors", "CANCER", 282, 299], ["Hepatic infiltration", "PROBLEM", 0, 20], ["discrete nodules", "PROBLEM", 31, 47], ["lymphoma", "PROBLEM", 83, 91], ["Mesodermal tumorsMelanomas", "PROBLEM", 176, 202], ["hemangiosarcomas", "PROBLEM", 207, 223], ["characteristic gross features in the liver", "PROBLEM", 229, 271], ["most metastatic tumors", "PROBLEM", 277, 299], ["infiltration", "OBSERVATION", 8, 20], ["may be", "UNCERTAINTY", 21, 27], ["discrete", "OBSERVATION_MODIFIER", 31, 39], ["nodules", "OBSERVATION", 40, 47], ["2 cm", "OBSERVATION_MODIFIER", 48, 52], ["more", "OBSERVATION_MODIFIER", 56, 60], ["size", "OBSERVATION_MODIFIER", 64, 68], ["particularly", "OBSERVATION_MODIFIER", 70, 82], ["lymphoma", "OBSERVATION", 83, 91], ["horses", "OBSERVATION_MODIFIER", 95, 101], ["diffuse", "OBSERVATION_MODIFIER", 121, 128], ["connective tissues", "ANATOMY", 136, 154], ["portal triads", "ANATOMY", 162, 175], ["tumorsMelanomas", "OBSERVATION", 187, 202], ["gross", "OBSERVATION_MODIFIER", 244, 249], ["features", "OBSERVATION", 250, 258], ["liver", "ANATOMY", 266, 271], ["most", "OBSERVATION_MODIFIER", 277, 281], ["metastatic", "OBSERVATION_MODIFIER", 282, 292], ["tumors", "OBSERVATION", 293, 299], ["cannot be distinguished", "UNCERTAINTY", 300, 323]]], ["Sarcomas do tend to form a few large, smooth-surfaced nodules, and carcinomas do tend to form more nodules and to be umbilicate when in contact with Glisson's capsule.", [["Sarcomas", "ANATOMY", 0, 8], ["nodules", "ANATOMY", 54, 61], ["carcinomas", "ANATOMY", 67, 77], ["nodules", "ANATOMY", 99, 106], ["carcinomas", "DISEASE", 67, 77], ["nodules", "CANCER", 54, 61], ["carcinomas", "CANCER", 67, 77], ["nodules", "CANCER", 99, 106], ["capsule", "CANCER", 159, 166], ["Sarcomas", "PROBLEM", 0, 8], ["a few large, smooth-surfaced nodules", "PROBLEM", 25, 61], ["carcinomas", "PROBLEM", 67, 77], ["more nodules", "PROBLEM", 94, 106], ["Glisson's capsule", "TREATMENT", 149, 166], ["few", "OBSERVATION_MODIFIER", 27, 30], ["large", "OBSERVATION_MODIFIER", 31, 36], ["smooth", "OBSERVATION_MODIFIER", 38, 44], ["-surfaced", "OBSERVATION_MODIFIER", 44, 53], ["nodules", "OBSERVATION", 54, 61], ["carcinomas", "OBSERVATION", 67, 77], ["more", "OBSERVATION_MODIFIER", 94, 98], ["nodules", "OBSERVATION", 99, 106]]], ["Hemangiosarcomas come from the spleen, usually, and may virtually replace the liver with small, blood-filled caverns.", [["Hemangiosarcomas", "ANATOMY", 0, 16], ["spleen", "ANATOMY", 31, 37], ["liver", "ANATOMY", 78, 83], ["blood", "ANATOMY", 96, 101], ["Hemangiosarcomas", "DISEASE", 0, 16], ["spleen", "ORGAN", 31, 37], ["liver", "ORGAN", 78, 83], ["blood", "ORGANISM_SUBSTANCE", 96, 101], ["Hemangiosarcomas", "PROBLEM", 0, 16], ["small, blood-filled caverns", "PROBLEM", 89, 116], ["spleen", "ANATOMY", 31, 37], ["liver", "ANATOMY", 78, 83], ["small", "OBSERVATION_MODIFIER", 89, 94], ["filled", "OBSERVATION_MODIFIER", 102, 108], ["caverns", "OBSERVATION", 109, 116]]], ["Their microscopic appearance is the same as that of the primary tumors.Mesodermal tumorsA non-neoplastic condition, hepatic splenosis, a rare condition in which normal splenic tissue becomes implanted into the liver, can be confused with metastatic disease.", [["primary tumors", "ANATOMY", 56, 70], ["Mesodermal tumorsA non-neoplastic", "ANATOMY", 71, 104], ["hepatic splenosis", "ANATOMY", 116, 133], ["splenic tissue", "ANATOMY", 168, 182], ["liver", "ANATOMY", 210, 215], ["primary tumors", "DISEASE", 56, 70], ["hepatic splenosis", "DISEASE", 116, 133], ["tumors", "CANCER", 64, 70], ["hepatic splenosis", "CANCER", 116, 133], ["splenic tissue", "TISSUE", 168, 182], ["liver", "ORGAN", 210, 215], ["metastatic disease", "CANCER", 238, 256], ["the primary tumors", "PROBLEM", 52, 70], ["Mesodermal tumorsA non-neoplastic condition", "PROBLEM", 71, 114], ["hepatic splenosis", "PROBLEM", 116, 133], ["a rare condition", "PROBLEM", 135, 151], ["metastatic disease", "PROBLEM", 238, 256], ["primary", "OBSERVATION_MODIFIER", 56, 63], ["tumors", "OBSERVATION", 64, 70], ["non-neoplastic", "OBSERVATION", 90, 104], ["hepatic", "ANATOMY", 116, 123], ["splenosis", "OBSERVATION", 124, 133], ["rare", "OBSERVATION_MODIFIER", 137, 141], ["condition", "OBSERVATION", 142, 151], ["normal", "OBSERVATION", 161, 167], ["splenic", "ANATOMY", 168, 175], ["tissue", "OBSERVATION", 176, 182], ["implanted", "OBSERVATION", 191, 200], ["liver", "ANATOMY", 210, 215], ["metastatic", "OBSERVATION", 238, 248]]], ["Normal of normal-appearing, mature adipocytes with a variable admixture of myeloid cells, including both mature and immature cells of the granulocytic, erythrocytic, and megakaryocytic series (Fig. 2-120 ).", [["adipocytes", "ANATOMY", 35, 45], ["myeloid cells", "ANATOMY", 75, 88], ["cells", "ANATOMY", 125, 130], ["granulocytic", "ANATOMY", 138, 150], ["erythrocytic", "ANATOMY", 152, 164], ["adipocytes", "CELL", 35, 45], ["myeloid cells", "CELL", 75, 88], ["cells", "CELL", 125, 130], ["granulocytic", "CELL", 138, 150], ["erythrocytic", "CELL", 152, 164], ["normal-appearing, mature adipocytes", "CELL_TYPE", 10, 45], ["myeloid cells", "CELL_TYPE", 75, 88], ["mature and immature cells", "CELL_TYPE", 105, 130], ["mature adipocytes", "PROBLEM", 28, 45], ["myeloid cells", "PROBLEM", 75, 88], ["erythrocytic", "TEST", 152, 164], ["megakaryocytic series", "TEST", 170, 191], ["Fig.", "TEST", 193, 197], ["normal", "OBSERVATION", 10, 16], ["-appearing", "OBSERVATION_MODIFIER", 16, 26], ["adipocytes", "ANATOMY", 35, 45], ["myeloid cells", "OBSERVATION", 75, 88], ["mature", "OBSERVATION_MODIFIER", 105, 111], ["immature cells", "OBSERVATION", 116, 130], ["granulocytic", "OBSERVATION_MODIFIER", 138, 150], ["erythrocytic", "ANATOMY", 152, 164], ["megakaryocytic series", "OBSERVATION", 170, 191]]], ["In captive wild cats, similar lesions have been seen in the spleen.", [["lesions", "ANATOMY", 30, 37], ["spleen", "ANATOMY", 60, 66], ["cats", "ORGANISM", 16, 20], ["lesions", "CANCER", 30, 37], ["spleen", "ORGAN", 60, 66], ["cats", "SPECIES", 16, 20], ["similar lesions", "PROBLEM", 22, 37], ["similar", "OBSERVATION_MODIFIER", 22, 29], ["lesions", "OBSERVATION", 30, 37], ["spleen", "ANATOMY", 60, 66]]], ["Metastasis to other organs has not been reported.Metastatic neoplasmsThe liver is particularly \"fertile soil,\" as metastatic lesions markedly outnumber primary hepatic neoplasms.", [["organs", "ANATOMY", 20, 26], ["Metastatic neoplasms", "ANATOMY", 49, 69], ["liver", "ANATOMY", 73, 78], ["soil", "ANATOMY", 104, 108], ["metastatic lesions", "ANATOMY", 114, 132], ["primary hepatic neoplasms", "ANATOMY", 152, 177], ["Metastasis", "DISEASE", 0, 10], ["Metastatic neoplasms", "DISEASE", 49, 69], ["primary hepatic neoplasms", "DISEASE", 152, 177], ["organs", "ORGAN", 20, 26], ["Metastatic neoplasms", "CANCER", 49, 69], ["liver", "ORGAN", 73, 78], ["metastatic lesions", "CANCER", 114, 132], ["hepatic neoplasms", "CANCER", 160, 177], ["Metastasis to other organs", "PROBLEM", 0, 26], ["Metastatic neoplasms", "PROBLEM", 49, 69], ["\"fertile soil", "PROBLEM", 95, 108], ["metastatic lesions markedly outnumber primary hepatic neoplasms", "PROBLEM", 114, 177], ["liver", "ANATOMY", 73, 78], ["metastatic", "OBSERVATION_MODIFIER", 114, 124], ["lesions", "OBSERVATION_MODIFIER", 125, 132], ["markedly", "OBSERVATION_MODIFIER", 133, 141], ["outnumber", "OBSERVATION_MODIFIER", 142, 151], ["primary", "OBSERVATION_MODIFIER", 152, 159], ["hepatic", "ANATOMY", 160, 167], ["neoplasms", "OBSERVATION", 168, 177]]], ["Metastatic solid neoplasms may be multiple, but are usually not numerous and usually do not elicit clinical or biochemical evidence of hepatic injury or dysfunction.", [["Metastatic solid neoplasms", "ANATOMY", 0, 26], ["hepatic", "ANATOMY", 135, 142], ["neoplasms", "DISEASE", 17, 26], ["hepatic injury", "DISEASE", 135, 149], ["Metastatic solid neoplasms", "CANCER", 0, 26], ["hepatic", "ORGAN", 135, 142], ["Metastatic solid neoplasms", "PROBLEM", 0, 26], ["hepatic injury", "PROBLEM", 135, 149], ["dysfunction", "PROBLEM", 153, 164], ["neoplasms", "OBSERVATION", 17, 26], ["multiple", "OBSERVATION_MODIFIER", 34, 42], ["hepatic", "ANATOMY", 135, 142], ["injury", "OBSERVATION", 143, 149], ["dysfunction", "OBSERVATION", 153, 164]]], ["Malignancies arriving via the portal vein, such as pancreatic or gastric carcinoma or hemangiosarcomas, may practically replace the liver before producing clinical signs, one of which may be icterus caused either by extrahepatic bile duct obstruction, or by intrahepatic cholestasis, or both.", [["portal vein", "ANATOMY", 30, 41], ["pancreatic", "ANATOMY", 51, 61], ["gastric carcinoma", "ANATOMY", 65, 82], ["hemangiosarcomas", "ANATOMY", 86, 102], ["liver", "ANATOMY", 132, 137], ["extrahepatic bile duct", "ANATOMY", 216, 238], ["intrahepatic", "ANATOMY", 258, 270], ["Malignancies", "DISEASE", 0, 12], ["pancreatic or gastric carcinoma", "DISEASE", 51, 82], ["hemangiosarcomas", "DISEASE", 86, 102], ["icterus", "DISEASE", 191, 198], ["extrahepatic bile duct obstruction", "DISEASE", 216, 250], ["intrahepatic cholestasis", "DISEASE", 258, 282], ["Malignancies", "CANCER", 0, 12], ["portal vein", "MULTI-TISSUE_STRUCTURE", 30, 41], ["pancreatic", "CANCER", 51, 61], ["gastric carcinoma", "CANCER", 65, 82], ["hemangiosarcomas", "CANCER", 86, 102], ["liver", "ORGAN", 132, 137], ["extrahepatic bile duct", "MULTI-TISSUE_STRUCTURE", 216, 238], ["Malignancies", "PROBLEM", 0, 12], ["pancreatic or gastric carcinoma", "PROBLEM", 51, 82], ["hemangiosarcomas", "PROBLEM", 86, 102], ["clinical signs", "TEST", 155, 169], ["icterus", "PROBLEM", 191, 198], ["extrahepatic bile duct obstruction", "PROBLEM", 216, 250], ["intrahepatic cholestasis", "PROBLEM", 258, 282], ["portal vein", "ANATOMY", 30, 41], ["pancreatic", "ANATOMY", 51, 61], ["gastric", "ANATOMY", 65, 72], ["carcinoma", "OBSERVATION", 73, 82], ["hemangiosarcomas", "OBSERVATION", 86, 102], ["liver", "ANATOMY", 132, 137], ["may be", "UNCERTAINTY", 184, 190], ["icterus", "OBSERVATION", 191, 198], ["extrahepatic", "ANATOMY_MODIFIER", 216, 228], ["bile duct", "ANATOMY", 229, 238], ["obstruction", "OBSERVATION", 239, 250], ["intrahepatic", "ANATOMY", 258, 270], ["cholestasis", "OBSERVATION", 271, 282]]], ["In dogs, the most common metastatic hematopoietic, mesenchymal, and epithelial neoplasms are lymphoma, hemangiosarcoma, and pancreatic carcinoma, respectively.", [["metastatic hematopoietic", "ANATOMY", 25, 49], ["mesenchymal", "ANATOMY", 51, 62], ["epithelial neoplasms", "ANATOMY", 68, 88], ["lymphoma", "ANATOMY", 93, 101], ["hemangiosarcoma", "ANATOMY", 103, 118], ["pancreatic carcinoma", "ANATOMY", 124, 144], ["hematopoietic, mesenchymal, and epithelial neoplasms", "DISEASE", 36, 88], ["lymphoma", "DISEASE", 93, 101], ["hemangiosarcoma", "DISEASE", 103, 118], ["pancreatic carcinoma", "DISEASE", 124, 144], ["dogs", "ORGANISM", 3, 7], ["hematopoietic", "CELL", 36, 49], ["mesenchymal", "CELL", 51, 62], ["epithelial neoplasms", "CANCER", 68, 88], ["lymphoma", "CANCER", 93, 101], ["hemangiosarcoma", "CANCER", 103, 118], ["pancreatic carcinoma", "CANCER", 124, 144], ["dogs", "SPECIES", 3, 7], ["the most common metastatic hematopoietic, mesenchymal, and epithelial neoplasms", "PROBLEM", 9, 88], ["lymphoma", "PROBLEM", 93, 101], ["hemangiosarcoma", "PROBLEM", 103, 118], ["pancreatic carcinoma", "PROBLEM", 124, 144], ["most common", "OBSERVATION_MODIFIER", 13, 24], ["metastatic", "OBSERVATION_MODIFIER", 25, 35], ["hematopoietic", "OBSERVATION", 36, 49], ["mesenchymal", "OBSERVATION_MODIFIER", 51, 62], ["epithelial", "ANATOMY_MODIFIER", 68, 78], ["neoplasms", "OBSERVATION", 79, 88], ["lymphoma", "OBSERVATION", 93, 101], ["hemangiosarcoma", "OBSERVATION", 103, 118], ["pancreatic", "ANATOMY", 124, 134], ["carcinoma", "OBSERVATION", 135, 144]]], ["Some of the carcinomas (e.g., thyroid, mammary), melanoma, and sarcomas from more remote sites also metastasize to the liver via the lungs and hepatic artery, and some (e.g., ovarian carcinoma, mesothelioma) implant on the capsular surface from within the peritoneal cavity.Metastatic neoplasmsThe hepatic perisinusoidal and periportal compartments are hospitable to various hematopoietic neoplastic cell types.", [["carcinomas", "ANATOMY", 12, 22], ["thyroid", "ANATOMY", 30, 37], ["mammary", "ANATOMY", 39, 46], ["melanoma", "ANATOMY", 49, 57], ["sarcomas", "ANATOMY", 63, 71], ["sites", "ANATOMY", 89, 94], ["liver", "ANATOMY", 119, 124], ["lungs", "ANATOMY", 133, 138], ["hepatic artery", "ANATOMY", 143, 157], ["ovarian carcinoma", "ANATOMY", 175, 192], ["mesothelioma", "ANATOMY", 194, 206], ["capsular surface", "ANATOMY", 223, 239], ["peritoneal cavity", "ANATOMY", 256, 273], ["Metastatic neoplasms", "ANATOMY", 274, 294], ["hepatic perisinusoidal", "ANATOMY", 298, 320], ["periportal compartments", "ANATOMY", 325, 348], ["hematopoietic neoplastic cell", "ANATOMY", 375, 404], ["carcinomas", "DISEASE", 12, 22], ["melanoma", "DISEASE", 49, 57], ["sarcomas", "DISEASE", 63, 71], ["ovarian carcinoma", "DISEASE", 175, 192], ["mesothelioma", "DISEASE", 194, 206], ["Metastatic neoplasms", "DISEASE", 274, 294], ["carcinomas", "CANCER", 12, 22], ["thyroid", "ORGAN", 30, 37], ["mammary", "ORGAN", 39, 46], ["melanoma", "CANCER", 49, 57], ["sarcomas", "CANCER", 63, 71], ["liver", "ORGAN", 119, 124], ["lungs", "ORGAN", 133, 138], ["hepatic artery", "MULTI-TISSUE_STRUCTURE", 143, 157], ["ovarian carcinoma", "CANCER", 175, 192], ["mesothelioma", "CANCER", 194, 206], ["capsular surface", "MULTI-TISSUE_STRUCTURE", 223, 239], ["peritoneal cavity", "MULTI-TISSUE_STRUCTURE", 256, 273], ["Metastatic neoplasms", "CANCER", 274, 294], ["hepatic perisinusoidal", "MULTI-TISSUE_STRUCTURE", 298, 320], ["periportal compartments", "MULTI-TISSUE_STRUCTURE", 325, 348], ["hematopoietic neoplastic cell", "CELL", 375, 404], ["hematopoietic neoplastic cell types", "CELL_TYPE", 375, 410], ["the carcinomas (e.g., thyroid, mammary)", "PROBLEM", 8, 47], ["melanoma", "PROBLEM", 49, 57], ["sarcomas", "PROBLEM", 63, 71], ["some (e.g., ovarian carcinoma", "PROBLEM", 163, 192], ["mesothelioma) implant", "PROBLEM", 194, 215], ["Metastatic neoplasms", "PROBLEM", 274, 294], ["various hematopoietic neoplastic cell types", "PROBLEM", 367, 410], ["carcinomas", "OBSERVATION", 12, 22], ["thyroid", "ANATOMY", 30, 37], ["mammary", "ANATOMY", 39, 46], ["melanoma", "OBSERVATION", 49, 57], ["sarcomas", "OBSERVATION", 63, 71], ["metastasize", "OBSERVATION", 100, 111], ["liver", "ANATOMY", 119, 124], ["lungs", "ANATOMY", 133, 138], ["hepatic artery", "ANATOMY", 143, 157], ["ovarian", "ANATOMY", 175, 182], ["carcinoma", "OBSERVATION", 183, 192], ["mesothelioma", "OBSERVATION", 194, 206], ["implant", "OBSERVATION_MODIFIER", 208, 215], ["capsular", "OBSERVATION_MODIFIER", 223, 231], ["surface", "OBSERVATION_MODIFIER", 232, 239], ["peritoneal", "ANATOMY", 256, 266], ["cavity", "ANATOMY_MODIFIER", 267, 273], ["hepatic", "ANATOMY", 298, 305], ["perisinusoidal", "ANATOMY_MODIFIER", 306, 320], ["periportal", "ANATOMY", 325, 335], ["various", "OBSERVATION_MODIFIER", 367, 374], ["hematopoietic neoplastic cell types", "OBSERVATION", 375, 410]]], ["Accordingly, malignant histiocytosis, myeloid and erythroid leukemias, and mast cell tumors often localize in the liver along hepatic sinusoids.", [["malignant histiocytosis", "ANATOMY", 13, 36], ["myeloid", "ANATOMY", 38, 45], ["erythroid leukemias", "ANATOMY", 50, 69], ["mast cell tumors", "ANATOMY", 75, 91], ["liver", "ANATOMY", 114, 119], ["hepatic sinusoids", "ANATOMY", 126, 143], ["malignant histiocytosis", "DISEASE", 13, 36], ["myeloid and erythroid leukemias", "DISEASE", 38, 69], ["mast cell tumors", "DISEASE", 75, 91], ["malignant histiocytosis", "CANCER", 13, 36], ["myeloid", "CELL", 38, 45], ["erythroid leukemias", "CANCER", 50, 69], ["mast cell tumors", "CANCER", 75, 91], ["liver", "ORGAN", 114, 119], ["hepatic sinusoids", "MULTI-TISSUE_STRUCTURE", 126, 143], ["malignant histiocytosis", "PROBLEM", 13, 36], ["myeloid", "PROBLEM", 38, 45], ["erythroid leukemias", "PROBLEM", 50, 69], ["mast cell tumors", "PROBLEM", 75, 91], ["malignant histiocytosis", "OBSERVATION", 13, 36], ["myeloid", "ANATOMY", 38, 45], ["erythroid leukemias", "OBSERVATION", 50, 69], ["mast cell tumors", "OBSERVATION", 75, 91], ["liver", "ANATOMY", 114, 119], ["hepatic", "ANATOMY", 126, 133], ["sinusoids", "ANATOMY_MODIFIER", 134, 143]]], ["Some lymphomas, histiocytic sarcomas ( Fig. 2-121) , plasmacytomas (Fig. 2-122) , and mast cell tumors also produce solid sarcoma masses in the liver as primary or metastatic lesions.", [["lymphomas", "ANATOMY", 5, 14], ["histiocytic sarcomas", "ANATOMY", 16, 36], ["plasmacytomas", "ANATOMY", 53, 66], ["mast cell tumors", "ANATOMY", 86, 102], ["solid sarcoma masses", "ANATOMY", 116, 136], ["liver", "ANATOMY", 144, 149], ["primary", "ANATOMY", 153, 160], ["metastatic lesions", "ANATOMY", 164, 182], ["lymphomas", "DISEASE", 5, 14], ["histiocytic sarcomas", "DISEASE", 16, 36], ["plasmacytomas", "DISEASE", 53, 66], ["mast cell tumors", "DISEASE", 86, 102], ["sarcoma", "DISEASE", 122, 129], ["lymphomas", "CANCER", 5, 14], ["histiocytic sarcomas", "CANCER", 16, 36], ["Fig. 2-121", "CANCER", 39, 49], ["plasmacytomas", "CANCER", 53, 66], ["Fig. 2-122", "CANCER", 68, 78], ["mast cell tumors", "CANCER", 86, 102], ["solid sarcoma masses", "CANCER", 116, 136], ["liver", "ORGAN", 144, 149], ["metastatic lesions", "CANCER", 164, 182], ["Some lymphomas", "PROBLEM", 0, 14], ["histiocytic sarcomas", "PROBLEM", 16, 36], ["Fig.", "TEST", 39, 43], ["plasmacytomas", "PROBLEM", 53, 66], ["mast cell tumors", "PROBLEM", 86, 102], ["solid sarcoma masses in the liver", "PROBLEM", 116, 149], ["metastatic lesions", "PROBLEM", 164, 182], ["lymphomas", "OBSERVATION", 5, 14], ["histiocytic sarcomas", "OBSERVATION", 16, 36], ["plasmacytomas", "OBSERVATION", 53, 66], ["mast cell tumors", "OBSERVATION", 86, 102], ["solid", "OBSERVATION_MODIFIER", 116, 121], ["sarcoma", "OBSERVATION", 122, 129], ["liver", "ANATOMY", 144, 149], ["primary", "OBSERVATION_MODIFIER", 153, 160], ["metastatic", "OBSERVATION_MODIFIER", 164, 174], ["lesions", "OBSERVATION", 175, 182]]], ["Lymphoma in the liver is common, especially when the spleen is involved, and occasionally, the liver appears to be the major or primary site affected.", [["Lymphoma", "ANATOMY", 0, 8], ["liver", "ANATOMY", 16, 21], ["spleen", "ANATOMY", 53, 59], ["liver", "ANATOMY", 95, 100], ["primary site", "ANATOMY", 128, 140], ["Lymphoma", "DISEASE", 0, 8], ["Lymphoma", "CANCER", 0, 8], ["liver", "ORGAN", 16, 21], ["spleen", "ORGAN", 53, 59], ["liver", "ORGAN", 95, 100], ["Lymphoma in the liver", "PROBLEM", 0, 21], ["liver", "ANATOMY", 16, 21], ["common", "OBSERVATION_MODIFIER", 25, 31], ["spleen", "ANATOMY", 53, 59], ["involved", "OBSERVATION", 63, 71], ["liver", "ANATOMY", 95, 100], ["major", "OBSERVATION_MODIFIER", 119, 124]]], ["Typically, lymphoma is most apparent in the portal tracts, and the connective tissue surrounding the central veins can also be infiltrated, but late in the course of disease, the sinusoids are affected (eFig.", [["lymphoma", "ANATOMY", 11, 19], ["portal tracts", "ANATOMY", 44, 57], ["connective tissue", "ANATOMY", 67, 84], ["central veins", "ANATOMY", 101, 114], ["sinusoids", "ANATOMY", 179, 188], ["lymphoma", "DISEASE", 11, 19], ["lymphoma", "CANCER", 11, 19], ["portal tracts", "MULTI-TISSUE_STRUCTURE", 44, 57], ["connective tissue", "TISSUE", 67, 84], ["central veins", "MULTI-TISSUE_STRUCTURE", 101, 114], ["sinusoids", "TISSUE", 179, 188], ["lymphoma", "PROBLEM", 11, 19], ["infiltrated", "PROBLEM", 127, 138], ["disease", "PROBLEM", 166, 173], ["lymphoma", "OBSERVATION", 11, 19], ["most apparent", "UNCERTAINTY", 23, 36], ["portal tracts", "ANATOMY", 44, 57], ["connective tissue", "OBSERVATION", 67, 84], ["central", "ANATOMY_MODIFIER", 101, 108], ["veins", "ANATOMY", 109, 114], ["can also be", "UNCERTAINTY", 115, 126], ["infiltrated", "OBSERVATION", 127, 138], ["late", "OBSERVATION_MODIFIER", 144, 148], ["disease", "OBSERVATION", 166, 173], ["sinusoids", "ANATOMY", 179, 188]]], ["Hepatosplenic \u03b3\u03b4 T-cell lymphomas (also CD3+ and CD11d+) in dogs demonstrate preferential involvement of the", [["Hepatosplenic \u03b3\u03b4 T-cell lymphomas", "ANATOMY", 0, 33], ["CD3+", "ANATOMY", 40, 44], ["Hepatosplenic \u03b3\u03b4 T-cell lymphomas", "CANCER", 0, 33], ["CD3", "GENE_OR_GENE_PRODUCT", 40, 43], ["CD11d", "GENE_OR_GENE_PRODUCT", 49, 54], ["dogs", "ORGANISM", 60, 64], ["CD3", "PROTEIN", 40, 43], ["CD11d", "PROTEIN", 49, 54], ["dogs", "SPECIES", 60, 64], ["Hepatosplenic \u03b3\u03b4 T-cell lymphomas", "PROBLEM", 0, 33], ["CD3", "TEST", 40, 43], ["CD11d", "TEST", 49, 54], ["cell lymphomas", "OBSERVATION", 19, 33], ["preferential", "OBSERVATION_MODIFIER", 77, 89], ["involvement", "OBSERVATION", 90, 101]]]], "93562c2ea888ef471dd35c627fff76d1002e698a": [["INTRODUCTIONPoult enteritis and mortality syndrome (PEMS) is an acute, transmissible, infectious, enteric disease that affects young turkeys between 7 and 28 d of age (Barnes et al., 1996 .", [["enteritis", "DISEASE", 18, 27], ["PEMS", "DISEASE", 52, 56], ["enteric disease", "DISEASE", 98, 113], ["turkeys", "ORGANISM", 133, 140], ["turkeys", "SPECIES", 133, 140], ["INTRODUCTIONPoult enteritis", "PROBLEM", 0, 27], ["mortality syndrome", "PROBLEM", 32, 50], ["an acute, transmissible, infectious, enteric disease", "PROBLEM", 61, 113], ["enteritis", "OBSERVATION", 18, 27], ["mortality syndrome", "OBSERVATION", 32, 50], ["acute", "OBSERVATION_MODIFIER", 64, 69], ["infectious", "OBSERVATION_MODIFIER", 86, 96], ["enteric", "OBSERVATION_MODIFIER", 98, 105], ["disease", "OBSERVATION", 106, 113]]], ["The PEMS problem is complicated by the fact that no etiological agents have been identified (Barnes and Guy, 1995; Brown, 1995; Barnes et al., 1996; Barnes, 1997; Edens et al., 1997a,b,c; Qureshi et al., 1997) .INTRODUCTIONDuring the development of this diarrheal disease, many poults experience severe wasting of body musculature.", [["body musculature", "ANATOMY", 314, 330], ["diarrheal disease", "DISEASE", 254, 271], ["wasting of body musculature", "DISEASE", 303, 330], ["poults", "ORGANISM", 278, 284], ["body musculature", "ORGANISM_SUBDIVISION", 314, 330], ["poults", "SPECIES", 278, 284], ["The PEMS problem", "PROBLEM", 0, 16], ["this diarrheal disease", "PROBLEM", 249, 271], ["severe wasting of body musculature", "PROBLEM", 296, 330], ["diarrheal disease", "OBSERVATION", 254, 271], ["severe", "OBSERVATION_MODIFIER", 296, 302], ["wasting", "OBSERVATION", 303, 310], ["body", "ANATOMY_MODIFIER", 314, 318], ["musculature", "ANATOMY", 319, 330]]], ["The wasting of the musculature and loss of nearly all of the adipose tissues suggests that even though the poults are eating some feed, nutrient intake is not sufficient to meet body requirements for maintenance and growth 1 The use of trade names in this publication does not imply endorsement by the North Carolina Agricultural Research Service, Raleigh, NC, of the products named nor criticism of similar products not mentioned.", [["musculature", "ANATOMY", 19, 30], ["adipose tissues", "ANATOMY", 61, 76], ["body", "ANATOMY", 178, 182], ["wasting", "DISEASE", 4, 11], ["musculature", "ORGANISM_SUBDIVISION", 19, 30], ["adipose tissues", "TISSUE", 61, 76], ["poults", "ORGANISM", 107, 113], ["body", "ORGANISM_SUBDIVISION", 178, 182], ["poults", "SPECIES", 107, 113], ["The wasting of the musculature", "PROBLEM", 0, 30], ["Raleigh", "TREATMENT", 348, 355], ["NC", "TREATMENT", 357, 359], ["the products", "TREATMENT", 364, 376], ["wasting", "OBSERVATION", 4, 11], ["musculature", "ANATOMY", 19, 30], ["loss", "OBSERVATION", 35, 39], ["adipose tissues", "ANATOMY", 61, 76]]], ["661 group (control, BC, PEMS, and BC+PEMS).", [["BC", "TEST", 20, 22], ["PEMS", "TEST", 24, 28], ["BC", "TEST", 34, 36]]], ["At 6 d posthatch, each PEMS-designated poult was given a 0.1-mL oral gavage of a 10% suspension of feces from PEMSinfected poults.", [["poult", "ANATOMY", 39, 44], ["oral", "ANATOMY", 64, 68], ["feces", "ANATOMY", 99, 104], ["poult", "ORGANISM", 39, 44], ["oral", "ORGANISM_SUBDIVISION", 64, 68], ["feces", "ORGANISM_SUBSTANCE", 99, 104], ["poults", "ORGANISM", 123, 129], ["poults", "SPECIES", 123, 129], ["a 10% suspension of feces", "TREATMENT", 79, 104], ["PEMSinfected poults", "TREATMENT", 110, 129]]], ["Blood samples were taken via cardiac puncture from four birds per treatment group at 7, 10, 14, 17, and 21 d of age.", [["Blood samples", "ANATOMY", 0, 13], ["cardiac", "ANATOMY", 29, 36], ["Blood samples", "ORGANISM_SUBSTANCE", 0, 13], ["cardiac puncture", "MULTI-TISSUE_STRUCTURE", 29, 45], ["Blood samples", "TEST", 0, 13], ["cardiac puncture", "TEST", 29, 45], ["cardiac", "ANATOMY", 29, 36], ["puncture", "OBSERVATION", 37, 45]]], ["Radioimmunoassays were conducted for plasma insulin, glucagon, thyroxine (T 4 ), and triiodothyronine (T 3 ).", [["plasma", "ANATOMY", 37, 43], ["glucagon", "CHEMICAL", 53, 61], ["thyroxine", "CHEMICAL", 63, 72], ["triiodothyronine", "CHEMICAL", 85, 101], ["thyroxine", "CHEMICAL", 63, 72], ["triiodothyronine (T 3", "CHEMICAL", 85, 106], ["plasma", "ORGANISM_SUBSTANCE", 37, 43], ["insulin", "GENE_OR_GENE_PRODUCT", 44, 51], ["glucagon", "GENE_OR_GENE_PRODUCT", 53, 61], ["thyroxine", "SIMPLE_CHEMICAL", 63, 72], ["T 4", "GENE_OR_GENE_PRODUCT", 74, 77], ["triiodothyronine", "SIMPLE_CHEMICAL", 85, 101], ["T 3", "GENE_OR_GENE_PRODUCT", 103, 106], ["plasma insulin", "PROTEIN", 37, 51], ["Radioimmunoassays", "TEST", 0, 17], ["plasma insulin", "TREATMENT", 37, 51], ["glucagon", "TREATMENT", 53, 61], ["thyroxine", "TREATMENT", 63, 72], ["triiodothyronine", "TREATMENT", 85, 101]]], ["Plasma insulin levels were depressed in PEMS-infected poults from Days 10 through 17, but plasma glucagon levels in the PEMS-infected poults were significantly elevated at 14 and 17 d, after which they returned to control levels in both of the PEMSinfected groups.", [["plasma", "ANATOMY", 90, 96], ["poults", "ANATOMY", 134, 140], ["depressed", "DISEASE", 27, 36], ["PEMS", "CHEMICAL", 40, 44], ["glucagon", "CHEMICAL", 97, 105], ["PEMS", "CHEMICAL", 120, 124], ["Plasma", "ORGANISM_SUBSTANCE", 0, 6], ["insulin", "GENE_OR_GENE_PRODUCT", 7, 14], ["PEMS", "SIMPLE_CHEMICAL", 40, 44], ["poults", "ORGANISM", 54, 60], ["plasma", "ORGANISM_SUBSTANCE", 90, 96], ["glucagon", "GENE_OR_GENE_PRODUCT", 97, 105], ["PEMS", "SIMPLE_CHEMICAL", 120, 124], ["poults", "ORGANISM", 134, 140], ["poults", "SPECIES", 54, 60], ["poults", "SPECIES", 134, 140], ["Plasma insulin levels", "TEST", 0, 21], ["depressed in PEMS", "PROBLEM", 27, 44], ["plasma glucagon levels", "TEST", 90, 112], ["the PEMS", "TEST", 116, 124], ["infected poults", "PROBLEM", 125, 140], ["significantly elevated", "PROBLEM", 146, 168], ["infected", "OBSERVATION", 125, 133], ["elevated", "OBSERVATION_MODIFIER", 160, 168]]], ["The T 3 and T 4 levels were depressed through Day 21 in PEMS-infected poults, but with BC treatment these blood hormone levels rebounded by Day 21.", [["poults", "ANATOMY", 70, 76], ["blood", "ANATOMY", 106, 111], ["depressed", "DISEASE", 28, 37], ["BC", "CHEMICAL", 87, 89], ["T 3", "GENE_OR_GENE_PRODUCT", 4, 7], ["T 4", "GENE_OR_GENE_PRODUCT", 12, 15], ["PEMS", "SIMPLE_CHEMICAL", 56, 60], ["poults", "ORGANISM", 70, 76], ["blood", "ORGANISM_SUBSTANCE", 106, 111], ["poults", "SPECIES", 70, 76], ["The T 3 and T 4 levels", "TEST", 0, 22], ["depressed", "PROBLEM", 28, 37], ["infected poults", "PROBLEM", 61, 76], ["BC treatment", "TREATMENT", 87, 99], ["these blood hormone levels", "TEST", 100, 126], ["infected", "OBSERVATION", 61, 69]]], ["Body weights of PEMS-infected poults were increased significantly by the BC treatment but not to the level of noninfected controls.", [["Body", "ANATOMY", 0, 4], ["poults", "ANATOMY", 30, 36], ["BC", "CHEMICAL", 73, 75], ["Body", "ORGANISM_SUBDIVISION", 0, 4], ["PEMS", "GENE_OR_GENE_PRODUCT", 16, 20], ["poults", "ORGANISM", 30, 36], ["poults", "SPECIES", 30, 36], ["Body weights", "TEST", 0, 12], ["PEMS", "TEST", 16, 20], ["infected poults", "PROBLEM", 21, 36], ["the BC treatment", "TREATMENT", 69, 85], ["PEMS", "OBSERVATION_MODIFIER", 16, 20], ["infected", "OBSERVATION", 21, 29], ["increased", "OBSERVATION_MODIFIER", 42, 51], ["noninfected", "OBSERVATION", 110, 121]]], ["Therefore, malabsorption and metabolic dysfunction could be contributing to the disease.", [["malabsorption", "DISEASE", 11, 24], ["metabolic dysfunction", "DISEASE", 29, 50], ["malabsorption", "PROBLEM", 11, 24], ["metabolic dysfunction", "PROBLEM", 29, 50], ["the disease", "PROBLEM", 76, 87], ["malabsorption", "OBSERVATION", 11, 24], ["metabolic dysfunction", "OBSERVATION", 29, 50], ["disease", "OBSERVATION", 80, 87]]], ["Indeed, absorption of D-xylose was inhibited significantly in PEMS-infected poults (Doerfler et al., 2000) , clearly indicating that part of the wasting syndrome in PEMS is due to their inability to absorb sufficient quantities of nutrients from the gastrointestinal tract.INTRODUCTIONIn field cases of PEMS, hypoglycemia and hypophosphatemia have been suspected as contributors to the disease (Edens and Doerfler, 1997a,b; Doerfler et al., 1998) .", [["gastrointestinal tract", "ANATOMY", 250, 272], ["D-xylose", "CHEMICAL", 22, 30], ["PEMS", "CHEMICAL", 62, 66], ["wasting syndrome", "DISEASE", 145, 161], ["PEMS", "DISEASE", 165, 169], ["PEMS", "DISEASE", 303, 307], ["hypoglycemia", "DISEASE", 309, 321], ["hypophosphatemia", "DISEASE", 326, 342], ["D-xylose", "CHEMICAL", 22, 30], ["D-xylose", "SIMPLE_CHEMICAL", 22, 30], ["PEMS", "SIMPLE_CHEMICAL", 62, 66], ["poults", "ORGANISM", 76, 82], ["gastrointestinal tract", "ORGANISM_SUBDIVISION", 250, 272], ["poults", "SPECIES", 76, 82], ["D-xylose", "TREATMENT", 22, 30], ["the wasting syndrome", "PROBLEM", 141, 161], ["their inability", "PROBLEM", 180, 195], ["PEMS", "PROBLEM", 303, 307], ["hypoglycemia", "PROBLEM", 309, 321], ["hypophosphatemia", "PROBLEM", 326, 342], ["the disease", "PROBLEM", 382, 393], ["wasting syndrome", "OBSERVATION", 145, 161], ["gastrointestinal tract", "ANATOMY", 250, 272]]], ["Providing PEMS-infected poults with sugar and phosphate in drinking water showed that the diseased poults were not able to absorb adequate amounts of either glucose or phosphate from the intestinal tract.", [["intestinal tract", "ANATOMY", 187, 203], ["PEMS", "CHEMICAL", 10, 14], ["phosphate", "CHEMICAL", 46, 55], ["glucose", "CHEMICAL", 157, 164], ["phosphate", "CHEMICAL", 168, 177], ["sugar", "CHEMICAL", 36, 41], ["phosphate", "CHEMICAL", 46, 55], ["glucose", "CHEMICAL", 157, 164], ["phosphate", "CHEMICAL", 168, 177], ["PEMS", "SIMPLE_CHEMICAL", 10, 14], ["poults", "ORGANISM", 24, 30], ["sugar", "SIMPLE_CHEMICAL", 36, 41], ["phosphate", "SIMPLE_CHEMICAL", 46, 55], ["poults", "ORGANISM", 99, 105], ["glucose", "SIMPLE_CHEMICAL", 157, 164], ["phosphate", "SIMPLE_CHEMICAL", 168, 177], ["intestinal tract", "ORGAN", 187, 203], ["poults", "SPECIES", 24, 30], ["poults", "SPECIES", 99, 105], ["poults", "SPECIES", 99, 105], ["sugar", "TREATMENT", 36, 41], ["phosphate", "TREATMENT", 46, 55], ["the diseased poults", "PROBLEM", 86, 105], ["phosphate", "TREATMENT", 168, 177], ["infected", "OBSERVATION", 15, 23], ["diseased", "OBSERVATION", 90, 98], ["intestinal tract", "ANATOMY", 187, 203]]], ["Even more vital, it appeared that PEMS-infected poults had an impaired capability for utilization of glucose from the circu-Abbreviation Key: BC = BioChrome; PEMS = poult enteritis and mortality syndrome; GTF = glucose tolerance factor; T 3 = triiodothyronine; T 4 = thyroxine; IGF = insulin-like growth factor(s); FCR = feed conversion ratio. latory system, which may potentially be attributed to decreased levels of many metabolically active hormones such as insulin and insulin-like growth factors (Edens and Doerfler, 1997a,b; Doerfler et al., 1998) .", [["PEMS", "CHEMICAL", 34, 38], ["glucose", "CHEMICAL", 101, 108], ["poult enteritis", "DISEASE", 165, 180], ["mortality syndrome", "DISEASE", 185, 203], ["triiodothyronine", "CHEMICAL", 243, 259], ["thyroxine", "CHEMICAL", 267, 276], ["glucose", "CHEMICAL", 101, 108], ["glucose", "CHEMICAL", 211, 218], ["triiodothyronine", "CHEMICAL", 243, 259], ["thyroxine", "CHEMICAL", 267, 276], ["PEMS", "SIMPLE_CHEMICAL", 34, 38], ["poults", "ORGANISM", 48, 54], ["glucose", "SIMPLE_CHEMICAL", 101, 108], ["glucose", "SIMPLE_CHEMICAL", 211, 218], ["T 3", "GENE_OR_GENE_PRODUCT", 237, 240], ["triiodothyronine", "SIMPLE_CHEMICAL", 243, 259], ["T 4", "SIMPLE_CHEMICAL", 261, 264], ["thyroxine", "SIMPLE_CHEMICAL", 267, 276], ["IGF", "GENE_OR_GENE_PRODUCT", 278, 281], ["insulin-like growth factor", "GENE_OR_GENE_PRODUCT", 284, 310], ["FCR", "SIMPLE_CHEMICAL", 315, 318], ["insulin", "GENE_OR_GENE_PRODUCT", 461, 468], ["insulin-like growth factors", "GENE_OR_GENE_PRODUCT", 473, 500], ["glucose tolerance factor", "PROTEIN", 211, 235], ["IGF", "PROTEIN", 278, 281], ["insulin", "PROTEIN", 284, 291], ["insulin", "PROTEIN", 461, 468], ["insulin-like growth factors", "PROTEIN", 473, 500], ["poults", "SPECIES", 48, 54], ["infected poults", "PROBLEM", 39, 54], ["glucose", "TEST", 101, 108], ["BC", "TEST", 142, 144], ["PEMS", "PROBLEM", 158, 162], ["poult enteritis", "PROBLEM", 165, 180], ["mortality syndrome", "PROBLEM", 185, 203], ["GTF", "TEST", 205, 208], ["glucose tolerance factor", "TEST", 211, 235], ["T", "TEST", 237, 238], ["triiodothyronine", "TEST", 243, 259], ["T", "TEST", 261, 262], ["thyroxine", "TEST", 267, 276], ["IGF", "TEST", 278, 281], ["insulin", "TEST", 284, 291], ["decreased levels of many metabolically active hormones", "PROBLEM", 398, 452], ["insulin", "TREATMENT", 461, 468], ["insulin", "TREATMENT", 473, 480], ["enteritis", "OBSERVATION", 171, 180], ["mortality syndrome", "OBSERVATION", 185, 203], ["may potentially be attributed to", "UNCERTAINTY", 365, 397], ["decreased", "OBSERVATION", 398, 407]]], ["This assessment was based upon the inability of PEMS-infected poults to synthesize hepatic glycogen or to downregulate hepatic glucose-6-phosphatase, an enzyme that is pivotal in the metabolism of glucose for energy and for glycogen synthesis Edens and Doerfler, 1997a,b; Doerfler et al., 1998) .", [["hepatic", "ANATOMY", 83, 90], ["hepatic", "ANATOMY", 119, 126], ["PEMS", "CHEMICAL", 48, 52], ["glycogen", "CHEMICAL", 91, 99], ["glucose", "CHEMICAL", 127, 134], ["glucose", "CHEMICAL", 197, 204], ["glycogen", "CHEMICAL", 224, 232], ["glucose", "CHEMICAL", 127, 134], ["glucose", "CHEMICAL", 197, 204], ["PEMS", "SIMPLE_CHEMICAL", 48, 52], ["poults", "ORGANISM", 62, 68], ["hepatic", "ORGAN", 83, 90], ["glycogen", "SIMPLE_CHEMICAL", 91, 99], ["glucose-6-phosphatase", "GENE_OR_GENE_PRODUCT", 127, 148], ["glucose", "SIMPLE_CHEMICAL", 197, 204], ["glycogen", "SIMPLE_CHEMICAL", 224, 232], ["hepatic glucose-6-phosphatase", "PROTEIN", 119, 148], ["poults", "SPECIES", 62, 68], ["This assessment", "TEST", 0, 15], ["hepatic glycogen", "TREATMENT", 83, 99], ["hepatic glucose", "TEST", 119, 134], ["phosphatase", "TEST", 137, 148], ["an enzyme", "TEST", 150, 159], ["hepatic", "ANATOMY", 83, 90], ["hepatic", "ANATOMY", 119, 126]]], ["These observations confirmed a severe malabsorption condition (Doerfler et al., 2000) and a serious metabolic dysfunction in PEMS-afflicted poults Edens and Doerfler, 1997a,b; Doerfler et al., 1998) .INTRODUCTIONReduced levels of hepatic glycogen in the affected poults could be due in part to an insulin deficiency.", [["hepatic", "ANATOMY", 230, 237], ["malabsorption", "DISEASE", 38, 51], ["metabolic dysfunction", "DISEASE", 100, 121], ["PEMS", "CHEMICAL", 125, 129], ["glycogen", "CHEMICAL", 238, 246], ["insulin deficiency", "DISEASE", 297, 315], ["poults", "ORGANISM", 140, 146], ["hepatic", "MULTI-TISSUE_STRUCTURE", 230, 237], ["glycogen", "SIMPLE_CHEMICAL", 238, 246], ["poults", "ORGANISM", 263, 269], ["insulin", "GENE_OR_GENE_PRODUCT", 297, 304], ["poults", "SPECIES", 140, 146], ["poults", "SPECIES", 263, 269], ["These observations", "TEST", 0, 18], ["a severe malabsorption condition", "PROBLEM", 29, 61], ["a serious metabolic dysfunction in PEMS", "PROBLEM", 90, 129], ["hepatic glycogen", "TREATMENT", 230, 246], ["an insulin deficiency", "PROBLEM", 294, 315], ["severe", "OBSERVATION_MODIFIER", 31, 37], ["malabsorption", "OBSERVATION", 38, 51], ["serious", "OBSERVATION_MODIFIER", 92, 99], ["metabolic dysfunction", "OBSERVATION", 100, 121], ["hepatic", "ANATOMY", 230, 237], ["insulin deficiency", "OBSERVATION", 297, 315]]], ["Insulin is a hormone that promotes anabolic processes and inhibits catabolic processes in muscle, liver, and adipose tissues.", [["muscle", "ANATOMY", 90, 96], ["liver", "ANATOMY", 98, 103], ["adipose tissues", "ANATOMY", 109, 124], ["Insulin", "CHEMICAL", 0, 7], ["Insulin", "GENE_OR_GENE_PRODUCT", 0, 7], ["muscle", "TISSUE", 90, 96], ["liver", "ORGAN", 98, 103], ["adipose tissues", "TISSUE", 109, 124], ["Insulin", "TREATMENT", 0, 7], ["a hormone", "TREATMENT", 11, 20], ["catabolic processes in muscle, liver, and adipose tissues", "PROBLEM", 67, 124], ["catabolic processes", "OBSERVATION", 67, 86], ["muscle", "ANATOMY", 90, 96], ["liver", "ANATOMY", 98, 103], ["adipose tissues", "ANATOMY", 109, 124]]], ["The action of insulin is stimulated by the glucose tolerance factor (GTF), with Cr as its active component.", [["glucose", "CHEMICAL", 43, 50], ["Cr", "CHEMICAL", 80, 82], ["glucose", "CHEMICAL", 43, 50], ["Cr", "CHEMICAL", 80, 82], ["insulin", "GENE_OR_GENE_PRODUCT", 14, 21], ["glucose", "SIMPLE_CHEMICAL", 43, 50], ["GTF", "GENE_OR_GENE_PRODUCT", 69, 72], ["Cr", "SIMPLE_CHEMICAL", 80, 82], ["insulin", "PROTEIN", 14, 21], ["glucose tolerance factor", "PROTEIN", 43, 67], ["GTF", "PROTEIN", 69, 72], ["Cr", "PROTEIN", 80, 82], ["insulin", "TREATMENT", 14, 21], ["Cr", "TEST", 80, 82], ["active", "OBSERVATION_MODIFIER", 90, 96], ["component", "OBSERVATION_MODIFIER", 97, 106]]], ["Hence, Cr stimulates and regulates the action of insulin, although the underlying mechanism is not clear (Roginski and Mertz, 1969; Kahn, 1978) .", [["Cr", "CHEMICAL", 7, 9], ["Cr", "CHEMICAL", 7, 9], ["Cr", "SIMPLE_CHEMICAL", 7, 9], ["insulin", "GENE_OR_GENE_PRODUCT", 49, 56], ["Cr", "PROTEIN", 7, 9], ["insulin", "PROTEIN", 49, 56], ["insulin", "TREATMENT", 49, 56], ["clear", "OBSERVATION", 99, 104]]], ["However, Evans and Bowman (1992) have shown that Cr facilitates insulin internalization in cells in vitro, as well as an increase in the uptake of glucose and leucine.", [["cells", "ANATOMY", 91, 96], ["Cr", "CHEMICAL", 49, 51], ["glucose", "CHEMICAL", 147, 154], ["leucine", "CHEMICAL", 159, 166], ["Cr", "CHEMICAL", 49, 51], ["glucose", "CHEMICAL", 147, 154], ["leucine", "CHEMICAL", 159, 166], ["Cr", "SIMPLE_CHEMICAL", 49, 51], ["insulin", "GENE_OR_GENE_PRODUCT", 64, 71], ["cells", "CELL", 91, 96], ["glucose", "SIMPLE_CHEMICAL", 147, 154], ["leucine", "AMINO_ACID", 159, 166], ["insulin", "PROTEIN", 64, 71], ["Cr", "TEST", 49, 51], ["insulin internalization", "TREATMENT", 64, 87], ["the uptake of glucose and leucine", "PROBLEM", 133, 166], ["increase", "OBSERVATION_MODIFIER", 121, 129]]], ["Chromium is an essential trace element required for the normal metabolism of both lipids and carbohydrates.", [["Chromium", "CHEMICAL", 0, 8], ["Chromium", "CHEMICAL", 0, 8], ["carbohydrates", "CHEMICAL", 93, 106], ["Chromium", "SIMPLE_CHEMICAL", 0, 8], ["lipids", "SIMPLE_CHEMICAL", 82, 88], ["carbohydrates", "SIMPLE_CHEMICAL", 93, 106], ["an essential trace element", "PROBLEM", 12, 38], ["essential", "OBSERVATION_MODIFIER", 15, 24], ["trace element", "OBSERVATION", 25, 38]]], ["The status of Cr in animals can be diminished by poor availability in the feed, feed quality with high levels of simple sugars, infection, physical trauma, and elevated excretion due to stress associated with a diarrheal disease (Anderson, 1986 (Anderson, , 1994 .INTRODUCTIONChromium deficiency can disrupt carbohydrate and protein metabolism, reduce insulin sensitivity in peripheral tissues, impair growth rate, and cause animals to be very susceptible to many different types of stressors (Doisy, 1978; Anderson, 1986 Anderson, , 1994 Mowat, 1994; Mowat et al., 1995; Pagan et al., 1995; Lindeman, 1996) .", [["peripheral tissues", "ANATOMY", 375, 393], ["Cr", "CHEMICAL", 14, 16], ["infection", "DISEASE", 128, 137], ["trauma", "DISEASE", 148, 154], ["diarrheal disease", "DISEASE", 211, 228], ["Cr", "CHEMICAL", 14, 16], ["sugars", "CHEMICAL", 120, 126], ["carbohydrate", "CHEMICAL", 308, 320], ["Cr", "SIMPLE_CHEMICAL", 14, 16], ["insulin", "GENE_OR_GENE_PRODUCT", 352, 359], ["peripheral tissues", "TISSUE", 375, 393], ["Cr", "TEST", 14, 16], ["simple sugars", "PROBLEM", 113, 126], ["infection", "PROBLEM", 128, 137], ["physical trauma", "PROBLEM", 139, 154], ["elevated excretion", "PROBLEM", 160, 178], ["stress", "PROBLEM", 186, 192], ["a diarrheal disease", "PROBLEM", 209, 228], ["deficiency", "PROBLEM", 285, 295], ["protein metabolism", "TEST", 325, 343], ["insulin sensitivity in peripheral tissues", "PROBLEM", 352, 393], ["impair growth rate", "PROBLEM", 395, 413], ["diminished", "OBSERVATION", 35, 45], ["peripheral tissues", "ANATOMY", 375, 393]]], ["Anderson (1986) reported that supplementation of Cr to normal individuals often leads to improved glucose tolerance, serum lipids, insulin, and insulin binding.", [["serum", "ANATOMY", 117, 122], ["Cr", "CHEMICAL", 49, 51], ["glucose", "CHEMICAL", 98, 105], ["Cr", "CHEMICAL", 49, 51], ["glucose", "CHEMICAL", 98, 105], ["Cr", "SIMPLE_CHEMICAL", 49, 51], ["glucose", "SIMPLE_CHEMICAL", 98, 105], ["serum", "ORGANISM_SUBSTANCE", 117, 122], ["lipids", "SIMPLE_CHEMICAL", 123, 129], ["insulin", "GENE_OR_GENE_PRODUCT", 131, 138], ["insulin", "GENE_OR_GENE_PRODUCT", 144, 151], ["supplementation of Cr", "TREATMENT", 30, 51], ["improved glucose tolerance", "PROBLEM", 89, 115], ["serum lipids", "TEST", 117, 129], ["insulin", "TREATMENT", 131, 138], ["insulin binding", "TREATMENT", 144, 159]]], ["Anderson (1986 Anderson ( , 1994 further noted that Cr normalizes blood sugar levels.", [["blood", "ANATOMY", 66, 71], ["Cr", "CHEMICAL", 52, 54], ["Cr", "CHEMICAL", 52, 54], ["sugar", "CHEMICAL", 72, 77], ["Cr", "SIMPLE_CHEMICAL", 52, 54], ["blood", "ORGANISM_SUBSTANCE", 66, 71], ["sugar", "SIMPLE_CHEMICAL", 72, 77], ["Cr", "TEST", 52, 54], ["blood sugar levels", "TEST", 66, 84]]], ["In individuals with hyperglycemia following a glucose load, Cr supplementation causes a decrease in blood glucose levels.", [["blood", "ANATOMY", 100, 105], ["hyperglycemia", "DISEASE", 20, 33], ["glucose", "CHEMICAL", 46, 53], ["Cr", "CHEMICAL", 60, 62], ["glucose", "CHEMICAL", 106, 113], ["glucose", "CHEMICAL", 46, 53], ["Cr", "CHEMICAL", 60, 62], ["glucose", "CHEMICAL", 106, 113], ["glucose", "SIMPLE_CHEMICAL", 46, 53], ["Cr", "SIMPLE_CHEMICAL", 60, 62], ["blood", "ORGANISM_SUBSTANCE", 100, 105], ["glucose", "SIMPLE_CHEMICAL", 106, 113], ["hyperglycemia", "PROBLEM", 20, 33], ["a glucose load", "TEST", 44, 58], ["Cr supplementation", "TREATMENT", 60, 78], ["a decrease in blood glucose levels", "PROBLEM", 86, 120], ["hyperglycemia", "OBSERVATION", 20, 33], ["decrease", "OBSERVATION_MODIFIER", 88, 96]]], ["Conversely, hypoglycemics respond to Cr by increased blood glucose levels, increased insulin binding, and alleviation of hypoglycemia signs.INTRODUCTIONOrganic Cr sources provide more bioavailability (25 to 30%) than inorganic Cr sources, of which only about 0.5 to 3.0% is absorbed (Mowat, 1994) .", [["blood", "ANATOMY", 53, 58], ["hypoglycemics", "DISEASE", 12, 25], ["Cr", "CHEMICAL", 37, 39], ["glucose", "CHEMICAL", 59, 66], ["hypoglycemia", "DISEASE", 121, 133], ["Cr", "CHEMICAL", 160, 162], ["Cr", "CHEMICAL", 227, 229], ["Cr", "CHEMICAL", 37, 39], ["glucose", "CHEMICAL", 59, 66], ["Cr", "CHEMICAL", 160, 162], ["Cr", "CHEMICAL", 227, 229], ["hypoglycemics", "SIMPLE_CHEMICAL", 12, 25], ["Cr", "SIMPLE_CHEMICAL", 37, 39], ["blood", "ORGANISM_SUBSTANCE", 53, 58], ["glucose", "SIMPLE_CHEMICAL", 59, 66], ["insulin", "GENE_OR_GENE_PRODUCT", 85, 92], ["inorganic Cr", "SIMPLE_CHEMICAL", 217, 229], ["hypoglycemics", "PROBLEM", 12, 25], ["Cr", "TEST", 37, 39], ["increased blood glucose levels", "PROBLEM", 43, 73], ["increased insulin binding", "PROBLEM", 75, 100], ["hypoglycemia signs", "PROBLEM", 121, 139], ["inorganic Cr sources", "TEST", 217, 237], ["increased", "OBSERVATION_MODIFIER", 75, 84], ["insulin binding", "OBSERVATION", 85, 100]]], ["Furthermore, the trivalent Cr found in BioChrome ,3 (BC) has very low toxicity and is often supplemented in diets for athletes or in diets for people subjected to stress (Mordenti et al., 1997) .", [["Cr", "CHEMICAL", 27, 29], ["BioChrome", "CHEMICAL", 39, 48], ["BC", "CHEMICAL", 53, 55], ["toxicity", "DISEASE", 70, 78], ["Cr", "CHEMICAL", 27, 29], ["Cr", "SIMPLE_CHEMICAL", 27, 29], ["BioChrome", "SIMPLE_CHEMICAL", 39, 48], ["people", "ORGANISM", 143, 149], ["people", "SPECIES", 143, 149], ["the trivalent Cr", "TEST", 13, 29], ["BC", "TEST", 53, 55], ["very low toxicity", "PROBLEM", 61, 78], ["very", "OBSERVATION_MODIFIER", 61, 65], ["low toxicity", "OBSERVATION_MODIFIER", 66, 78]]], ["In an attempt to ameliorate the devastating effects caused by PEMS, BC, a chromium yeast, was incorporated into 3 Alltech, Inc., Alltech Biotechnology Center, 3031 Catnip Hill Pike, Nicholasville, KY 40356. the diet of control and PEMS-exposed turkey poults.", [["PEMS", "CHEMICAL", 62, 66], ["BC", "CHEMICAL", 68, 70], ["chromium", "CHEMICAL", 74, 82], ["KY 40356", "CHEMICAL", 197, 205], ["PEMS", "CHEMICAL", 231, 235], ["chromium", "CHEMICAL", 74, 82], ["PEMS", "SIMPLE_CHEMICAL", 62, 66], ["BC", "SIMPLE_CHEMICAL", 68, 70], ["PEMS", "SIMPLE_CHEMICAL", 231, 235], ["turkey", "ORGANISM", 244, 250], ["poults", "ORGANISM", 251, 257], ["yeast", "SPECIES", 83, 88], ["turkey", "SPECIES", 244, 250], ["poults", "SPECIES", 251, 257], ["yeast", "SPECIES", 83, 88], ["turkey", "SPECIES", 244, 250], ["BC", "TEST", 68, 70], ["a chromium yeast", "PROBLEM", 72, 88], ["chromium yeast", "OBSERVATION", 74, 88]]], ["We hypothesized that addition of BC to the diets of PEMSinfected turkeys, known to suffer from hypoglycemia and other disturbances in glucose metabolism Edens and Doerfler, 1997a,b; Doerfler et al., 1998) , might provide the additional nutrients and energy necessary to sustain them through the most severe phase of the disease.Animal WelfareThis project was approved and conducted under the supervision of the North Carolina State University Animal Care and Use Committee, which has adopted Animal Care and Use Guidelines governing all animal use in experimental procedures.Poults and HusbandryHybrid female turkey poults were obtained and transported from a commercial hatchery to North Carolina State University.", [["BC", "CHEMICAL", 33, 35], ["hypoglycemia", "DISEASE", 95, 107], ["glucose", "CHEMICAL", 134, 141], ["glucose", "CHEMICAL", 134, 141], ["turkeys", "ORGANISM", 65, 72], ["glucose", "SIMPLE_CHEMICAL", 134, 141], ["turkey", "ORGANISM", 609, 615], ["poults", "ORGANISM", 616, 622], ["turkeys", "SPECIES", 65, 72], ["turkey", "SPECIES", 609, 615], ["poults", "SPECIES", 616, 622], ["turkeys", "SPECIES", 65, 72], ["turkey", "SPECIES", 609, 615], ["BC", "TREATMENT", 33, 35], ["hypoglycemia", "PROBLEM", 95, 107], ["other disturbances in glucose metabolism Edens", "PROBLEM", 112, 158], ["the additional nutrients", "TREATMENT", 221, 245], ["the disease", "PROBLEM", 316, 327], ["experimental procedures", "TREATMENT", 551, 574], ["disease", "OBSERVATION", 320, 327]]], ["These day-old poults were wingbanded, weighed, and placed into pens in heated metal battery brooders with raised wire floors, where water and turkey starter feed (North Carolina Agricultural Research Service: 2,915 kcal/kg metabolizable energy and 28.13% crude protein) with or without BC (400 ppb as a dry powder blended into the feed) were provided ad libitum.", [["BC", "CHEMICAL", 286, 288], ["poults", "ORGANISM", 14, 20], ["poults", "SPECIES", 14, 20], ["turkey", "SPECIES", 142, 148], ["turkey", "SPECIES", 142, 148], ["heated metal battery brooders", "TREATMENT", 71, 100], ["raised wire floors", "TREATMENT", 106, 124], ["metabolizable energy", "TEST", 223, 243], ["BC", "PROBLEM", 286, 288], ["a dry powder blended into the feed", "TREATMENT", 301, 335]]], ["With the exception of the Cr in BC, Cr was not added to the diets of these turkeys.", [["Cr", "CHEMICAL", 26, 28], ["Cr", "CHEMICAL", 36, 38], ["Cr", "CHEMICAL", 26, 28], ["Cr", "CHEMICAL", 36, 38], ["Cr", "SIMPLE_CHEMICAL", 26, 28], ["BC", "SIMPLE_CHEMICAL", 32, 34], ["Cr", "SIMPLE_CHEMICAL", 36, 38], ["turkeys", "ORGANISM", 75, 82], ["turkeys", "SPECIES", 75, 82], ["turkeys", "SPECIES", 75, 82], ["the Cr in BC", "TEST", 22, 34], ["Cr", "TEST", 36, 38]]], ["Dietary content of Cr was not ascertained.Poults and HusbandryFifteen poults were housed in each pen within each brooding battery, and there were eight pens of 15 poults per treatment.", [["Cr", "CHEMICAL", 19, 21], ["Cr", "CHEMICAL", 19, 21], ["Cr", "SIMPLE_CHEMICAL", 19, 21], ["poults", "ORGANISM", 70, 76], ["poults", "ORGANISM", 163, 169], ["poults", "SPECIES", 70, 76], ["poults", "SPECIES", 163, 169], ["Cr", "TEST", 19, 21], ["Poults", "TREATMENT", 42, 48], ["HusbandryFifteen poults", "TREATMENT", 53, 76], ["treatment", "TREATMENT", 174, 183]]], ["The poults were not subjected to hatchery services such as beak or toe trimming, antibiotic administrations, or vaccinations.", [["poults", "ORGANISM", 4, 10], ["toe", "ORGANISM_SUBDIVISION", 67, 70], ["poults", "SPECIES", 4, 10], ["beak or toe trimming", "PROBLEM", 59, 79], ["antibiotic administrations", "TREATMENT", 81, 107], ["vaccinations", "TREATMENT", 112, 124], ["toe", "ANATOMY", 67, 70]]], ["Continuous lighting was provided by incandescent lamps in the ceiling of each room and on each deck of the brooding battery.", [["the brooding battery", "TREATMENT", 103, 123]]], ["At the time of placement, the control and PEMS-exposure designated poults were assigned to separate, but identical, controlled-environment isolation rooms.Brooding TemperaturesAmbient temperature for brooding was maintained by room air conditioning with a thermostatically controlled hot-and-cold water heat exchange system mediated by forced draft.", [["PEMS", "CHEMICAL", 42, 46], ["poults", "ORGANISM", 67, 73], ["poults", "SPECIES", 67, 73], ["placement", "TREATMENT", 15, 24], ["Brooding TemperaturesAmbient temperature", "PROBLEM", 155, 195], ["brooding", "PROBLEM", 200, 208], ["cold water heat exchange system", "TREATMENT", 292, 323]]], ["Initial room brooding temperature for the control and PEMS rooms was set at 34 C, and this temperature was decreased 3 C in each room at 7, 14, and 21 d of brooding.", [["this temperature", "TEST", 86, 102]]], ["Humidity in the experimental rooms was not controlled and varied from 47 to 63% relative humidity.Experimental DesignThe experiment utilized a factorially arranged 2 (control vs. PEMS) \u00d7 2 (with or without BC) \u00d7 8 (replicates perPEMS ExposureAt 5 d posthatch, each poult in the PEMS-exposed groups was given a 0.1-mL oral gavage of a 10% suspension of feces from PEMS-positive, Coronavirus-negative poults maintained at the College of Veterinary Medicine at North Carolina State University.MeasurementsIn Experiments 1 and 2, BW were taken at placement and at 7-d intervals through 21 d of age.", [["oral", "ANATOMY", 317, 321], ["feces", "ANATOMY", 352, 357], ["PEMS", "CHEMICAL", 278, 282], ["PEMS", "CHEMICAL", 363, 367], ["oral", "ORGANISM_SUBDIVISION", 317, 321], ["feces", "ORGANISM_SUBDIVISION", 352, 357], ["Coronavirus", "ORGANISM", 378, 389], ["poults", "ORGANISM", 399, 405], ["poults", "SPECIES", 399, 405], ["Humidity", "TREATMENT", 0, 8], ["PEMS", "TEST", 363, 367], ["Coronavirus", "TEST", 378, 389]]], ["Blood samples for plasma from the ulnar vein in the wing were obtained twice weekly from four birds per treatment group, and these were analyzed for a series of metabolically active hormones and other blood chemistries.", [["Blood samples", "ANATOMY", 0, 13], ["plasma", "ANATOMY", 18, 24], ["ulnar vein", "ANATOMY", 34, 44], ["wing", "ANATOMY", 52, 56], ["blood", "ANATOMY", 201, 206], ["Blood samples", "ORGANISM_SUBSTANCE", 0, 13], ["plasma", "ORGANISM_SUBSTANCE", 18, 24], ["ulnar vein", "MULTI-TISSUE_STRUCTURE", 34, 44], ["blood", "ORGANISM_SUBSTANCE", 201, 206], ["Blood samples", "TEST", 0, 13], ["plasma", "TEST", 18, 24], ["other blood chemistries", "TEST", 195, 218], ["ulnar vein", "ANATOMY", 34, 44]]], ["Blood samples were collected from full-fed poults.", [["Blood samples", "ANATOMY", 0, 13], ["Blood samples", "ORGANISM_SUBSTANCE", 0, 13], ["poults", "ORGANISM", 43, 49], ["poults", "SPECIES", 43, 49], ["Blood samples", "TEST", 0, 13]]], ["The samples were collected in sodium heparin in blood collection vials.", [["samples", "ANATOMY", 4, 11], ["blood", "ANATOMY", 48, 53], ["sodium heparin", "CHEMICAL", 30, 44], ["sodium", "CHEMICAL", 30, 36], ["sodium heparin", "SIMPLE_CHEMICAL", 30, 44], ["blood", "ORGANISM_SUBSTANCE", 48, 53], ["The samples", "TEST", 0, 11], ["sodium heparin", "TREATMENT", 30, 44], ["blood collection vials", "TEST", 48, 70]]], ["Plasma samples for glucagon assays were stored in the presence of aprotinin.", [["Plasma samples", "ANATOMY", 0, 14], ["aprotinin", "CHEMICAL", 66, 75], ["Plasma samples", "ORGANISM_SUBSTANCE", 0, 14], ["glucagon", "GENE_OR_GENE_PRODUCT", 19, 27], ["aprotinin", "GENE_OR_GENE_PRODUCT", 66, 75], ["Plasma samples", "TEST", 0, 14], ["glucagon assays", "TEST", 19, 34], ["aprotinin", "TREATMENT", 66, 75], ["aprotinin", "OBSERVATION", 66, 75]]], ["4 Radioimmunoassays for thyroxine (T 4 ) and triiodothyronine (T 3 ) were conducted by using procedures for turkeys as reported by Edens et al. (1991) .", [["thyroxine", "CHEMICAL", 24, 33], ["T 4 )", "CHEMICAL", 35, 40], ["triiodothyronine", "CHEMICAL", 45, 61], ["thyroxine (T 4", "CHEMICAL", 24, 38], ["triiodothyronine (T 3", "CHEMICAL", 45, 66], ["thyroxine", "SIMPLE_CHEMICAL", 24, 33], ["T 4", "SIMPLE_CHEMICAL", 35, 38], ["triiodothyronine", "SIMPLE_CHEMICAL", 45, 61], ["T 3", "CELL", 63, 66], ["turkeys", "ORGANISM", 108, 115], ["turkeys", "SPECIES", 108, 115], ["turkeys", "SPECIES", 108, 115], ["Radioimmunoassays", "TEST", 2, 19], ["thyroxine (T", "TREATMENT", 24, 36], ["triiodothyronine", "TREATMENT", 45, 61]]], ["Double antibody radioimmunoassays for insulin (McMurtry et al., 1983) , insulin-like growth factor (IGF)-I (McMurtry et al., 1994) , and IGF-II ) and a commercial kit for glucagon 5 (using porcine glucagon antibody that cross-reacts with avian glucagon) were conducted in the laboratory of John P. McMurtry at USDA-ARS, Beltsville, MD.", [["glucagon 5", "CHEMICAL", 171, 181], ["glucagon", "CHEMICAL", 197, 205], ["glucagon", "CHEMICAL", 244, 252], ["insulin", "GENE_OR_GENE_PRODUCT", 38, 45], ["insulin-like growth factor", "GENE_OR_GENE_PRODUCT", 72, 98], ["IGF)-I", "GENE_OR_GENE_PRODUCT", 100, 106], ["IGF-II", "GENE_OR_GENE_PRODUCT", 137, 143], ["glucagon 5", "GENE_OR_GENE_PRODUCT", 171, 181], ["porcine", "ORGANISM", 189, 196], ["glucagon antibody", "GENE_OR_GENE_PRODUCT", 197, 214], ["glucagon", "GENE_OR_GENE_PRODUCT", 244, 252], ["insulin", "PROTEIN", 38, 45], ["insulin-like growth factor", "PROTEIN", 72, 98], ["IGF", "PROTEIN", 100, 103], ["IGF-II", "PROTEIN", 137, 143], ["porcine glucagon antibody", "PROTEIN", 189, 214], ["porcine", "SPECIES", 189, 196], ["Double antibody radioimmunoassays", "TEST", 0, 33], ["insulin", "TREATMENT", 38, 45], ["insulin", "TREATMENT", 72, 79], ["glucagon", "TEST", 171, 179], ["porcine glucagon antibody", "TREATMENT", 189, 214], ["avian glucagon", "TREATMENT", 238, 252]]], ["All samples were assayed in one assay to avoid interassay variation.", [["samples", "ANATOMY", 4, 11], ["All samples", "TEST", 0, 11]]], ["Birds that died during the week were weighed, and their weight gain was included in calculations of weekly feed conversion ratios (FCR; g feed/g BW gain). plasma and BW data for the two experiments were combined and subjected to analysis of variance with the general linear models procedure of SAS software (SAS Institute, 1996) .", [["plasma", "ANATOMY", 155, 161], ["plasma", "ORGANISM_SUBSTANCE", 155, 161], ["plasma and BW data", "TEST", 155, 173], ["the two experiments", "PROBLEM", 178, 197], ["the general linear models procedure", "TREATMENT", 255, 290]]], ["Statements of significance were based on P \u2264 0.05 as a minimum level of significance.RESULTS AND DISCUSSIONThe use of BC in diets of control and PEMS-infected poults did not affect mortality rates, and as expected, PEMS mortality rates were elevated significantly (Table 1 ).", [["BC", "CHEMICAL", 118, 120], ["PEMS", "CHEMICAL", 145, 149], ["PEMS", "ORGANISM", 145, 149], ["poults", "ORGANISM", 159, 165], ["poults", "SPECIES", 159, 165], ["BC in diets of control", "TREATMENT", 118, 140], ["infected poults", "PROBLEM", 150, 165], ["PEMS mortality rates", "TEST", 215, 235]]], ["In control poults, BC did not influence BW, but in PEMS-infected poults, BC induced a small, but significant, increase in BW by the time the birds were 21 d of age (Table 1) .", [["PEMS", "CHEMICAL", 51, 55], ["BC", "CHEMICAL", 73, 75], ["poults", "ORGANISM", 11, 17], ["PEMS", "SIMPLE_CHEMICAL", 51, 55], ["poults", "ORGANISM", 65, 71], ["birds", "ORGANISM", 141, 146], ["poults", "SPECIES", 11, 17], ["poults", "SPECIES", 65, 71], ["poults", "SPECIES", 11, 17], ["poults", "SPECIES", 65, 71], ["BC", "TEST", 19, 21], ["infected poults", "PROBLEM", 56, 71], ["BC", "PROBLEM", 73, 75], ["infected", "OBSERVATION", 56, 64], ["small", "OBSERVATION_MODIFIER", 86, 91], ["significant", "OBSERVATION_MODIFIER", 97, 108], ["increase", "OBSERVATION_MODIFIER", 110, 118]]], ["We determined the influence of BC on feed to BW FCR in normal and PEMS-infected poults.", [["PEMS", "CHEMICAL", 66, 70], ["poults", "ORGANISM", 80, 86], ["poults", "SPECIES", 80, 86], ["BC", "TEST", 31, 33], ["FCR", "TEST", 48, 51], ["infected", "OBSERVATION", 71, 79]]], ["These FCR data confirmed that BC had improved FCR in the PEMSinfected poults.", [["poults", "ORGANISM", 70, 76], ["poults", "SPECIES", 70, 76], ["These FCR data", "TEST", 0, 14], ["BC", "TEST", 30, 32]]], ["The BC-treated, PEMS-infected poults ate less feed but were more efficient in converting it to body mass, possibly indicating improved carbohydrate and lipid metabolism and improved nutrient uptake from the intestine.", [["body", "ANATOMY", 95, 99], ["intestine", "ANATOMY", 207, 216], ["BC", "CHEMICAL", 4, 6], ["PEMS", "CHEMICAL", 16, 20], ["carbohydrate", "CHEMICAL", 135, 147], ["BC", "SIMPLE_CHEMICAL", 4, 6], ["PEMS", "SIMPLE_CHEMICAL", 16, 20], ["poults", "ORGANISM", 30, 36], ["body", "ORGANISM_SUBDIVISION", 95, 99], ["carbohydrate", "SIMPLE_CHEMICAL", 135, 147], ["lipid", "SIMPLE_CHEMICAL", 152, 157], ["intestine", "ORGAN", 207, 216], ["poults", "SPECIES", 30, 36], ["poults", "SPECIES", 30, 36], ["The BC", "TEST", 0, 6], ["PEMS", "PROBLEM", 16, 20], ["body mass", "PROBLEM", 95, 104], ["improved carbohydrate and lipid metabolism", "PROBLEM", 126, 168], ["improved nutrient uptake from the intestine", "PROBLEM", 173, 216], ["body", "ANATOMY", 95, 99], ["mass", "OBSERVATION", 100, 104], ["possibly indicating", "UNCERTAINTY", 106, 125], ["improved carbohydrate", "OBSERVATION", 126, 147], ["lipid metabolism", "OBSERVATION", 152, 168], ["improved", "OBSERVATION_MODIFIER", 173, 181], ["nutrient uptake", "OBSERVATION", 182, 197], ["intestine", "ANATOMY", 207, 216]]], ["This response would not account for a significant FCR increase in BC alone or PEMS with BC supplementation.", [["BC", "CHEMICAL", 66, 68], ["PEMS", "CHEMICAL", 78, 82], ["BC", "CHEMICAL", 88, 90], ["PEMS", "SIMPLE_CHEMICAL", 78, 82], ["BC", "SIMPLE_CHEMICAL", 88, 90], ["a significant FCR increase in BC", "PROBLEM", 36, 68], ["PEMS", "PROBLEM", 78, 82], ["BC supplementation", "TREATMENT", 88, 106], ["not account for", "UNCERTAINTY", 20, 35], ["significant", "OBSERVATION_MODIFIER", 38, 49], ["FCR", "OBSERVATION_MODIFIER", 50, 53], ["increase", "OBSERVATION_MODIFIER", 54, 62]]], ["The significantly elevated FCR in PEMS alone was related to diarrhea, decreased feed intake, and malabsorption of nutrients.", [["PEMS", "CHEMICAL", 34, 38], ["diarrhea", "DISEASE", 60, 68], ["malabsorption", "DISEASE", 97, 110], ["The significantly elevated FCR in PEMS", "PROBLEM", 0, 38], ["diarrhea", "PROBLEM", 60, 68], ["decreased feed intake", "PROBLEM", 70, 91], ["malabsorption of nutrients", "PROBLEM", 97, 123], ["significantly", "OBSERVATION_MODIFIER", 4, 17], ["elevated", "OBSERVATION_MODIFIER", 18, 26], ["FCR", "OBSERVATION_MODIFIER", 27, 30], ["diarrhea", "OBSERVATION", 60, 68], ["decreased", "OBSERVATION_MODIFIER", 70, 79], ["feed intake", "OBSERVATION", 80, 91]]], ["However, the increase in FCR associated with BC supplementation probably was related to elevated levels of metabolically active hormones such as the thyroid hormones (Table 2 ; Figures 3 and 4) , which were greater in control and BC-treated poults than in PEMS alone.", [["BC", "CHEMICAL", 45, 47], ["BC", "CHEMICAL", 230, 232], ["PEMS", "CHEMICAL", 256, 260], ["thyroid", "ORGAN", 149, 156], ["BC", "SIMPLE_CHEMICAL", 230, 232], ["poults", "ORGANISM", 241, 247], ["PEMS", "SIMPLE_CHEMICAL", 256, 260], ["poults", "SPECIES", 241, 247], ["the increase in FCR", "PROBLEM", 9, 28], ["BC supplementation", "PROBLEM", 45, 63], ["elevated levels of metabolically active hormones", "PROBLEM", 88, 136], ["the thyroid hormones", "TEST", 145, 165], ["Figures", "TEST", 177, 184], ["BC", "TEST", 230, 232], ["increase", "OBSERVATION_MODIFIER", 13, 21], ["metabolically active hormones", "OBSERVATION", 107, 136], ["thyroid", "ANATOMY", 149, 156], ["greater", "OBSERVATION_MODIFIER", 207, 214]]], ["Hepatic glycogen was being synthesized (Table 3) , IGF-I and -II were elevated (Table 2 and Figures 5 and 6) , and BW of BC-fed, PEMS-infected poults were elevated by nearly 132% (Table 2) in comparison with PEMS-infected poults without BC.", [["Hepatic", "ANATOMY", 0, 7], ["poults", "ANATOMY", 143, 149], ["BC", "ANATOMY", 237, 239], ["glycogen", "CHEMICAL", 8, 16], ["PEMS", "CHEMICAL", 208, 212], ["Hepatic", "ORGAN", 0, 7], ["glycogen", "SIMPLE_CHEMICAL", 8, 16], ["IGF-I", "GENE_OR_GENE_PRODUCT", 51, 56], ["-II", "GENE_OR_GENE_PRODUCT", 61, 64], ["PEMS", "SIMPLE_CHEMICAL", 129, 133], ["poults", "ORGANISM", 143, 149], ["poults", "ORGANISM", 222, 228], ["BC", "CANCER", 237, 239], ["IGF-I and -II", "PROTEIN", 51, 64], ["poults", "SPECIES", 143, 149], ["poults", "SPECIES", 222, 228], ["poults", "SPECIES", 222, 228], ["Hepatic glycogen", "TREATMENT", 0, 16], ["IGF", "TEST", 51, 54], ["Figures", "TEST", 92, 99], ["BC", "TEST", 121, 123], ["PEMS", "TEST", 129, 133], ["BC", "PROBLEM", 237, 239], ["infected", "OBSERVATION", 213, 221]]], ["These changes in the levels of metabolically active hormones, metabolites, and BW account for the significant interaction among treatments noted for each measurement.", [["These changes", "PROBLEM", 0, 13], ["metabolically", "OBSERVATION_MODIFIER", 31, 44], ["active", "OBSERVATION_MODIFIER", 45, 51], ["significant", "OBSERVATION_MODIFIER", 98, 109], ["interaction", "OBSERVATION", 110, 121]]], ["For these observations to be made, PEMS-infected poults with BC supplementation had have more efficient feed use to meet metabolic needs for energy production and weight accretion.RESULTS AND DISCUSSIONIn control and PEMS treatments, BC supplementation in the feed did not affect overall plasma insulin levels ( Table 2 ), but a time effect showed that plasma insulin in PEMS-infected poults was depressed significantly from FIGURE 1.", [["plasma", "ANATOMY", 288, 294], ["plasma", "ANATOMY", 353, 359], ["PEMS", "CHEMICAL", 35, 39], ["BC", "CHEMICAL", 61, 63], ["PEMS", "CHEMICAL", 217, 221], ["BC", "CHEMICAL", 234, 236], ["insulin", "CHEMICAL", 360, 367], ["PEMS", "CHEMICAL", 371, 375], ["depressed", "DISEASE", 396, 405], ["PEMS", "SIMPLE_CHEMICAL", 35, 39], ["poults", "ORGANISM", 49, 55], ["BC", "SIMPLE_CHEMICAL", 234, 236], ["plasma", "ORGANISM_SUBSTANCE", 288, 294], ["insulin", "GENE_OR_GENE_PRODUCT", 295, 302], ["plasma", "ORGANISM_SUBSTANCE", 353, 359], ["insulin", "GENE_OR_GENE_PRODUCT", 360, 367], ["PEMS", "SIMPLE_CHEMICAL", 371, 375], ["poults", "ORGANISM", 385, 391], ["plasma insulin", "PROTEIN", 353, 367], ["poults", "SPECIES", 49, 55], ["poults", "SPECIES", 385, 391], ["poults", "SPECIES", 49, 55], ["BC supplementation", "TREATMENT", 61, 79], ["weight accretion", "PROBLEM", 163, 179], ["DISCUSSIONIn control and PEMS treatments", "TREATMENT", 192, 232], ["BC supplementation in the feed", "TREATMENT", 234, 264], ["plasma insulin levels", "TEST", 288, 309], ["plasma insulin", "TREATMENT", 353, 367], ["infected poults", "PROBLEM", 376, 391], ["depressed", "PROBLEM", 396, 405]]], ["Time course of plasma insulin responses for control, BioChrome, PEMS, and BioChrome+PEMS treatment groups.", [["plasma", "ANATOMY", 15, 21], ["PEMS", "CHEMICAL", 64, 68], ["BioChrome", "CHEMICAL", 74, 83], ["PEMS", "CHEMICAL", 84, 88], ["plasma", "ORGANISM_SUBSTANCE", 15, 21], ["insulin", "GENE_OR_GENE_PRODUCT", 22, 29], ["BioChrome", "SIMPLE_CHEMICAL", 53, 62], ["PEMS", "SIMPLE_CHEMICAL", 64, 68], ["BioChrome+PEMS", "SIMPLE_CHEMICAL", 74, 88], ["plasma insulin responses", "TREATMENT", 15, 39], ["BioChrome", "TREATMENT", 53, 62], ["PEMS", "TREATMENT", 64, 68], ["BioChrome+PEMS treatment groups", "TREATMENT", 74, 105]]], ["Poults in the PEMS-exposed groups were given a single oral inoculation when they were 6 d of age. a,b Within days of age, significant differences (P \u2264 0.05) among treatment groups are indicated by different lowercase letter headings.RESULTS AND DISCUSSIONDays 10 to 21 in comparison to noninfected poults ( Figure 1) .", [["oral", "ANATOMY", 54, 58], ["PEMS", "CHEMICAL", 14, 18], ["PEMS", "SIMPLE_CHEMICAL", 14, 18], ["oral", "ORGANISM_SUBDIVISION", 54, 58], ["poults", "ORGANISM", 298, 304], ["poults", "SPECIES", 298, 304], ["a single oral inoculation", "TREATMENT", 45, 70], ["significant differences", "PROBLEM", 122, 145], ["among treatment groups", "TREATMENT", 157, 179], ["significant", "OBSERVATION_MODIFIER", 122, 133]]], ["A significant elevation in plasma glucagon in BCtreated control poults from 7 to 21 d of age was mirrored by elevated glucagon levels in BC-treated, PEMS-infected poults from 10 to 21 d of age (Table 2; Figure 2 ).", [["plasma", "ANATOMY", 27, 33], ["glucagon", "CHEMICAL", 34, 42], ["glucagon", "CHEMICAL", 118, 126], ["BC", "CHEMICAL", 137, 139], ["PEMS", "CHEMICAL", 149, 153], ["plasma", "ORGANISM_SUBSTANCE", 27, 33], ["glucagon", "GENE_OR_GENE_PRODUCT", 34, 42], ["poults", "ORGANISM", 64, 70], ["glucagon", "GENE_OR_GENE_PRODUCT", 118, 126], ["BC", "SIMPLE_CHEMICAL", 137, 139], ["PEMS", "CELL", 149, 153], ["poults", "ORGANISM", 163, 169], ["poults", "SPECIES", 64, 70], ["poults", "SPECIES", 163, 169], ["A significant elevation", "PROBLEM", 0, 23], ["plasma glucagon", "TREATMENT", 27, 42], ["BCtreated control poults", "TREATMENT", 46, 70], ["elevated glucagon levels in BC", "PROBLEM", 109, 139], ["significant", "OBSERVATION_MODIFIER", 2, 13], ["elevation", "OBSERVATION", 14, 23]]], ["By Day 21, plasma glucagon in PEMS-infected poults without BC treatment was also increasing but not to the same extent as the PEMS-infected poults with BC treatment (Figure 2) .", [["plasma", "ANATOMY", 11, 17], ["glucagon", "CHEMICAL", 18, 26], ["PEMS", "CHEMICAL", 30, 34], ["BC", "CHEMICAL", 59, 61], ["PEMS", "CHEMICAL", 126, 130], ["BC", "CHEMICAL", 152, 154], ["plasma", "ORGANISM_SUBSTANCE", 11, 17], ["glucagon", "GENE_OR_GENE_PRODUCT", 18, 26], ["PEMS", "SIMPLE_CHEMICAL", 30, 34], ["poults", "ORGANISM", 44, 50], ["PEMS", "SIMPLE_CHEMICAL", 126, 130], ["poults", "ORGANISM", 140, 146], ["poults", "SPECIES", 44, 50], ["poults", "SPECIES", 140, 146], ["plasma glucagon in PEMS", "TEST", 11, 34], ["infected poults", "PROBLEM", 35, 50], ["BC treatment", "TREATMENT", 59, 71], ["BC treatment", "TREATMENT", 152, 164], ["infected", "OBSERVATION", 35, 43], ["infected", "OBSERVATION", 131, 139]]], ["These observations explain a significant time \u00d7 treatment interaction for plasma glucagon.RESULTS AND DISCUSSIONThe use of BC in the feed of control poults was associated with elevated levels of plasma T 4 and T 3 (Table 2; FIGURE 2.", [["plasma", "ANATOMY", 74, 80], ["plasma", "ANATOMY", 195, 201], ["glucagon", "CHEMICAL", 81, 89], ["BC", "CHEMICAL", 123, 125], ["plasma", "ORGANISM_SUBSTANCE", 74, 80], ["glucagon", "GENE_OR_GENE_PRODUCT", 81, 89], ["BC", "CANCER", 123, 125], ["poults", "ORGANISM", 149, 155], ["plasma", "ORGANISM_SUBSTANCE", 195, 201], ["T 3", "GENE_OR_GENE_PRODUCT", 210, 213], ["poults", "SPECIES", 149, 155], ["plasma glucagon", "TREATMENT", 74, 89], ["BC", "TREATMENT", 123, 125], ["elevated levels", "PROBLEM", 176, 191], ["plasma T", "TEST", 195, 203]]], ["Time course of plasma glucagon responses for control, BioChrome, PEMS, and BioChrome+PEMS treatment groups.", [["plasma", "ANATOMY", 15, 21], ["glucagon", "CHEMICAL", 22, 30], ["PEMS", "CHEMICAL", 65, 69], ["BioChrome", "CHEMICAL", 75, 84], ["PEMS", "CHEMICAL", 85, 89], ["plasma", "ORGANISM_SUBSTANCE", 15, 21], ["glucagon", "SIMPLE_CHEMICAL", 22, 30], ["BioChrome", "SIMPLE_CHEMICAL", 54, 63], ["PEMS", "SIMPLE_CHEMICAL", 65, 69], ["BioChrome+PEMS", "SIMPLE_CHEMICAL", 75, 89], ["plasma glucagon responses", "TEST", 15, 40], ["BioChrome", "TREATMENT", 54, 63], ["PEMS", "TREATMENT", 65, 69], ["BioChrome+PEMS treatment groups", "TREATMENT", 75, 106]]], ["Poults in the PEMS-exposed groups were given a single oral inoculation when they were 6 d of age. a-d Within days of age, significant differences (P \u2264 0.05) among treatment groups are indicated by different lowercase letter headings.", [["oral", "ANATOMY", 54, 58], ["PEMS", "CHEMICAL", 14, 18], ["PEMS", "SIMPLE_CHEMICAL", 14, 18], ["oral", "ORGANISM_SUBDIVISION", 54, 58], ["a single oral inoculation", "TREATMENT", 45, 70], ["significant differences", "PROBLEM", 122, 145], ["among treatment groups", "TREATMENT", 157, 179], ["significant", "OBSERVATION_MODIFIER", 122, 133]]], ["Figures 3 and 4, respectively) .", [["Figures", "TEST", 0, 7]]], ["The PEMS infection from Days 10 through 21 of age caused decreased plasma T 4 and T 3 (Table 2 ; Figures 3 and 4 , respectively) levels that did not rebound after birds appeared to have overcome the infection.", [["plasma", "ANATOMY", 67, 73], ["infection", "DISEASE", 9, 18], ["infection", "DISEASE", 199, 208], ["T 3", "GENE_OR_GENE_PRODUCT", 82, 85], ["The PEMS infection", "PROBLEM", 0, 18], ["decreased plasma T", "PROBLEM", 57, 75], ["T", "TEST", 82, 83], ["Figures", "TEST", 97, 104], ["the infection", "PROBLEM", 195, 208], ["PEMS", "OBSERVATION_MODIFIER", 4, 8], ["infection", "OBSERVATION", 9, 18], ["infection", "OBSERVATION", 199, 208]]], ["BioChrome supplementation to the feed ameliorated the PEMS-associated decreases in plasma T 4 and T 3 (Figures 3 and 4, respectively) to the level of noninfected controls for T 3 at 21 d but not for T 4 .", [["plasma", "ANATOMY", 83, 89], ["BioChrome", "CHEMICAL", 0, 9], ["PEMS", "CHEMICAL", 54, 58], ["BioChrome", "CHEMICAL", 0, 9], ["BioChrome", "SIMPLE_CHEMICAL", 0, 9], ["plasma", "ORGANISM_SUBSTANCE", 83, 89], ["T 4", "CELL", 90, 93], ["T 3", "GENE_OR_GENE_PRODUCT", 98, 101], ["T 3", "GENE_OR_GENE_PRODUCT", 175, 178], ["BioChrome supplementation", "TREATMENT", 0, 25], ["the PEMS", "TEST", 50, 58], ["plasma T", "TEST", 83, 91], ["T", "TEST", 98, 99], ["Figures", "TEST", 103, 110], ["decreases", "OBSERVATION_MODIFIER", 70, 79]]], ["In previous studies, PEMS infection was associated with significantly decreased plasma levels of insulin, T 4 , and T 3 and elevated levels of plasma glucagon (Edens and Doerfler, 1997a; Doerfler et al., 1998) .", [["plasma", "ANATOMY", 80, 86], ["plasma", "ANATOMY", 143, 149], ["PEMS", "CHEMICAL", 21, 25], ["infection", "DISEASE", 26, 35], ["glucagon", "CHEMICAL", 150, 158], ["PEMS", "SIMPLE_CHEMICAL", 21, 25], ["plasma", "ORGANISM_SUBSTANCE", 80, 86], ["insulin", "GENE_OR_GENE_PRODUCT", 97, 104], ["T 4", "GENE_OR_GENE_PRODUCT", 106, 109], ["T 3", "GENE_OR_GENE_PRODUCT", 116, 119], ["plasma", "ORGANISM_SUBSTANCE", 143, 149], ["glucagon", "GENE_OR_GENE_PRODUCT", 150, 158], ["insulin", "PROTEIN", 97, 104], ["previous studies", "TEST", 3, 19], ["PEMS infection", "PROBLEM", 21, 35], ["significantly decreased plasma levels", "PROBLEM", 56, 93], ["insulin", "TEST", 97, 104], ["T", "TEST", 106, 107], ["T", "TEST", 116, 117], ["elevated levels", "PROBLEM", 124, 139], ["plasma glucagon", "TEST", 143, 158], ["PEMS", "OBSERVATION_MODIFIER", 21, 25], ["infection", "OBSERVATION", 26, 35]]], ["There were significant time \u00d7 treatment interactions for T 4 and T 3 .RESULTS AND DISCUSSIONFeed supplemented with BC resulted in elevated plasma IGF-I in control poults ( Figure 5 ).", [["plasma", "ANATOMY", 139, 145], ["BC", "CHEMICAL", 115, 117], ["T 4", "GENE_OR_GENE_PRODUCT", 57, 60], ["T 3", "GENE_OR_GENE_PRODUCT", 65, 68], ["BC", "CANCER", 115, 117], ["plasma", "ORGANISM_SUBSTANCE", 139, 145], ["IGF-I", "GENE_OR_GENE_PRODUCT", 146, 151], ["poults", "ORGANISM", 163, 169], ["plasma IGF-I", "PROTEIN", 139, 151], ["poults", "SPECIES", 163, 169], ["BC", "TEST", 115, 117], ["elevated plasma IGF", "PROBLEM", 130, 149], ["significant", "OBSERVATION_MODIFIER", 11, 22]]], ["BioChrome influenced plasma IGF-II in only one instance, at 10 d of age ( Figure 6 ).", [["plasma", "ANATOMY", 21, 27], ["BioChrome", "CHEMICAL", 0, 9], ["BioChrome", "CHEMICAL", 0, 9], ["BioChrome", "SIMPLE_CHEMICAL", 0, 9], ["plasma", "ORGANISM_SUBSTANCE", 21, 27], ["IGF-II", "GENE_OR_GENE_PRODUCT", 28, 34], ["plasma IGF-II", "PROTEIN", 21, 34], ["plasma IGF", "TEST", 21, 31]]], ["In the PEMS-infected poults (Figures 5 and 6 , respectively), BC supplementation elicited significant elevation in plasma IGF-I and IGF-II to a level similar to and even exceeding noninfected controls at 21 d of age.", [["plasma", "ANATOMY", 115, 121], ["PEMS", "CHEMICAL", 7, 11], ["BC", "CHEMICAL", 62, 64], ["poults", "ORGANISM", 21, 27], ["BC", "SIMPLE_CHEMICAL", 62, 64], ["plasma", "ORGANISM_SUBSTANCE", 115, 121], ["IGF-I", "GENE_OR_GENE_PRODUCT", 122, 127], ["IGF-II", "GENE_OR_GENE_PRODUCT", 132, 138], ["plasma IGF-I", "PROTEIN", 115, 127], ["IGF-II", "PROTEIN", 132, 138], ["poults", "SPECIES", 21, 27], ["Figures", "TEST", 29, 36], ["BC supplementation", "TEST", 62, 80], ["significant elevation", "PROBLEM", 90, 111], ["plasma IGF", "TEST", 115, 125], ["IGF", "TEST", 132, 135], ["infected", "OBSERVATION", 12, 20], ["significant", "OBSERVATION_MODIFIER", 90, 101], ["elevation", "OBSERVATION", 102, 111]]], ["The PEMS infection without supplemental BC significantly depressed IGF-I and IGF-II ( Figures 5 and 6 , respectively).", [["infection", "DISEASE", 9, 18], ["BC", "CHEMICAL", 40, 42], ["depressed", "DISEASE", 57, 66], ["IGF-I", "GENE_OR_GENE_PRODUCT", 67, 72], ["IGF-II", "GENE_OR_GENE_PRODUCT", 77, 83], ["IGF-I", "PROTEIN", 67, 72], ["IGF-II", "PROTEIN", 77, 83], ["The PEMS infection", "PROBLEM", 0, 18], ["supplemental BC", "TEST", 27, 42], ["IGF", "TEST", 67, 70], ["Figures", "TEST", 86, 93], ["PEMS", "OBSERVATION_MODIFIER", 4, 8], ["infection", "OBSERVATION", 9, 18]]], ["Significant time \u00d7 treatment interactions were found for IGF-I and IGF-II.RESULTS AND DISCUSSIONPlasma glucose was elevated in PEMS-exposed poults that had survived the high mortality period of the disease (Table 2; Figure 7 ).", [["glucose", "CHEMICAL", 103, 110], ["PEMS", "CHEMICAL", 127, 131], ["glucose", "CHEMICAL", 103, 110], ["IGF-I", "GENE_OR_GENE_PRODUCT", 57, 62], ["IGF-II.", "GENE_OR_GENE_PRODUCT", 67, 74], ["glucose", "SIMPLE_CHEMICAL", 103, 110], ["PEMS", "SIMPLE_CHEMICAL", 127, 131], ["poults", "ORGANISM", 140, 146], ["IGF-I", "PROTEIN", 57, 62], ["IGF", "PROTEIN", 67, 70], ["poults", "SPECIES", 140, 146], ["IGF", "TEST", 57, 60], ["DISCUSSIONPlasma glucose", "TEST", 86, 110], ["the disease", "PROBLEM", 194, 205], ["disease", "OBSERVATION", 198, 205]]], ["Plasma glucose was not affected by feed supplemented with BC (Table 2, Figure 7) .", [["glucose", "CHEMICAL", 7, 14], ["glucose", "CHEMICAL", 7, 14], ["Plasma", "ORGANISM_SUBSTANCE", 0, 6], ["glucose", "SIMPLE_CHEMICAL", 7, 14], ["Plasma glucose", "TEST", 0, 14]]], ["However, an interesting BC effect was found in the hepatic glycogen response to PEMS (Table 3 ).", [["hepatic", "ANATOMY", 51, 58], ["glycogen", "CHEMICAL", 59, 67], ["PEMS", "CHEMICAL", 80, 84], ["PEMS", "CHEMICAL", 80, 84], ["BC", "CANCER", 24, 26], ["hepatic", "ORGAN", 51, 58], ["glycogen", "SIMPLE_CHEMICAL", 59, 67], ["an interesting BC effect", "PROBLEM", 9, 33], ["BC effect", "OBSERVATION", 24, 33], ["hepatic", "ANATOMY", 51, 58], ["glycogen response", "OBSERVATION", 59, 76]]], ["In earlier studies we reported a significant depression in hepatic glycogen in PEMSinfected poults (Doerfler et al., 1998) , and in the current study a similar response was observed.", [["hepatic", "ANATOMY", 59, 66], ["depression", "DISEASE", 45, 55], ["glycogen", "CHEMICAL", 67, 75], ["hepatic", "ORGAN", 59, 66], ["glycogen", "SIMPLE_CHEMICAL", 67, 75], ["poults", "ORGANISM", 92, 98], ["poults", "SPECIES", 92, 98], ["a significant depression in hepatic glycogen in PEMSinfected poults", "PROBLEM", 31, 98], ["the current study", "TEST", 132, 149], ["significant", "OBSERVATION_MODIFIER", 33, 44], ["depression", "OBSERVATION", 45, 55], ["hepatic", "ANATOMY", 59, 66], ["glycogen", "ANATOMY_MODIFIER", 67, 75]]], ["However, in the BC-supplemented, PEMS-infected poults, hepatic glycogen levels were comparable to levels found in noninfected controls.", [["poults", "ANATOMY", 47, 53], ["hepatic", "ANATOMY", 55, 62], ["BC", "CHEMICAL", 16, 18], ["PEMS", "CHEMICAL", 33, 37], ["glycogen", "CHEMICAL", 63, 71], ["BC", "SIMPLE_CHEMICAL", 16, 18], ["PEMS", "SIMPLE_CHEMICAL", 33, 37], ["poults", "ORGANISM", 47, 53], ["hepatic", "ORGAN", 55, 62], ["glycogen", "SIMPLE_CHEMICAL", 63, 71], ["poults", "SPECIES", 47, 53], ["the BC", "TEST", 12, 18], ["PEMS", "TEST", 33, 37], ["hepatic glycogen levels", "TEST", 55, 78], ["infected", "OBSERVATION", 38, 46], ["hepatic", "ANATOMY", 55, 62], ["noninfected controls", "OBSERVATION", 114, 134]]], ["In view of the observation that plasma glucose can be decreased with injections of IGF-I and IGF-II (McMurtry et al., 1996 (McMurtry et al., , 1997 , one must assume that the glucose uptake in the liver of PEMS-infected poults treated with BC had to be facilitated by the BC-elevated IGF.", [["plasma", "ANATOMY", 32, 38], ["liver", "ANATOMY", 197, 202], ["poults", "ANATOMY", 220, 226], ["glucose", "CHEMICAL", 39, 46], ["glucose", "CHEMICAL", 175, 182], ["glucose", "CHEMICAL", 39, 46], ["glucose", "CHEMICAL", 175, 182], ["plasma", "ORGANISM_SUBSTANCE", 32, 38], ["glucose", "SIMPLE_CHEMICAL", 39, 46], ["IGF-I", "GENE_OR_GENE_PRODUCT", 83, 88], ["IGF-II", "GENE_OR_GENE_PRODUCT", 93, 99], ["glucose", "SIMPLE_CHEMICAL", 175, 182], ["liver", "ORGAN", 197, 202], ["PEMS", "SIMPLE_CHEMICAL", 206, 210], ["poults", "ORGANISM", 220, 226], ["IGF", "GENE_OR_GENE_PRODUCT", 284, 287], ["IGF-I", "PROTEIN", 83, 88], ["IGF-II", "PROTEIN", 93, 99], ["IGF", "PROTEIN", 284, 287], ["poults", "SPECIES", 220, 226], ["plasma glucose", "TEST", 32, 46], ["the glucose uptake", "PROBLEM", 171, 189], ["infected poults", "TREATMENT", 211, 226], ["BC", "TREATMENT", 240, 242], ["the BC", "TEST", 268, 274], ["elevated IGF", "PROBLEM", 275, 287], ["liver", "ANATOMY", 197, 202], ["elevated", "OBSERVATION", 275, 283]]], ["Hepatic glucose-6-phosphatase activity in PEMS survivor poults was near the levels found in noninfected control poults (Table 3 ).", [["Hepatic", "ANATOMY", 0, 7], ["glucose-6-phosphatase", "CHEMICAL", 8, 29], ["glucose", "CHEMICAL", 8, 15], ["Hepatic", "MULTI-TISSUE_STRUCTURE", 0, 7], ["glucose-6-phosphatase", "GENE_OR_GENE_PRODUCT", 8, 29], ["poults", "ORGANISM", 56, 62], ["Hepatic glucose-6-phosphatase", "PROTEIN", 0, 29], ["poults", "SPECIES", 56, 62], ["poults", "SPECIES", 112, 118], ["Hepatic glucose", "TEST", 0, 15], ["phosphatase activity in PEMS survivor poults", "PROBLEM", 18, 62]]], ["The decrease in hepatic glucose-6-phosphatase activity would be expected if glucose uptake was mediated by elevated blood glucose or by stimulation of insulin receptors by insulin or IGF (McMurtry et al., 1996 (McMurtry et al., , 1997 .", [["hepatic", "ANATOMY", 16, 23], ["blood", "ANATOMY", 116, 121], ["glucose", "CHEMICAL", 24, 31], ["glucose", "CHEMICAL", 76, 83], ["glucose", "CHEMICAL", 122, 129], ["glucose", "CHEMICAL", 24, 31], ["glucose", "CHEMICAL", 76, 83], ["glucose", "CHEMICAL", 122, 129], ["hepatic", "MULTI-TISSUE_STRUCTURE", 16, 23], ["glucose-6-phosphatase", "GENE_OR_GENE_PRODUCT", 24, 45], ["glucose", "SIMPLE_CHEMICAL", 76, 83], ["blood", "ORGANISM_SUBSTANCE", 116, 121], ["glucose", "SIMPLE_CHEMICAL", 122, 129], ["insulin receptors", "GENE_OR_GENE_PRODUCT", 151, 168], ["insulin", "GENE_OR_GENE_PRODUCT", 172, 179], ["IGF", "GENE_OR_GENE_PRODUCT", 183, 186], ["hepatic glucose-6-phosphatase", "PROTEIN", 16, 45], ["insulin receptors", "PROTEIN", 151, 168], ["insulin", "PROTEIN", 172, 179], ["IGF", "PROTEIN", 183, 186], ["hepatic glucose", "TEST", 16, 31], ["glucose uptake", "PROBLEM", 76, 90], ["elevated blood glucose", "PROBLEM", 107, 129], ["stimulation of insulin receptors", "TREATMENT", 136, 168], ["decrease", "OBSERVATION_MODIFIER", 4, 12], ["hepatic", "ANATOMY", 16, 23]]], ["Therefore, BC-related increases in IGF may have stimulated hepatic uptake of glucose in PEMSinfected poults, resulting in a significant decrease in glucose-6-phosphatase activity.RESULTS AND DISCUSSIONAlthough BC did not reduce mortality associated with PEMS, a small but significant increase occurred in BW of the infected poults given the feed supplement (Table 1) .", [["hepatic", "ANATOMY", 59, 66], ["BC", "CHEMICAL", 11, 13], ["glucose", "CHEMICAL", 77, 84], ["glucose", "CHEMICAL", 148, 155], ["PEMS", "DISEASE", 254, 258], ["glucose", "CHEMICAL", 77, 84], ["glucose", "CHEMICAL", 148, 155], ["IGF", "GENE_OR_GENE_PRODUCT", 35, 38], ["hepatic", "MULTI-TISSUE_STRUCTURE", 59, 66], ["glucose", "SIMPLE_CHEMICAL", 77, 84], ["poults", "ORGANISM", 101, 107], ["glucose", "SIMPLE_CHEMICAL", 148, 155], ["poults", "ORGANISM", 324, 330], ["IGF", "PROTEIN", 35, 38], ["glucose-6-phosphatase", "PROTEIN", 148, 169], ["poults", "SPECIES", 101, 107], ["poults", "SPECIES", 324, 330], ["poults", "SPECIES", 324, 330], ["BC", "TEST", 11, 13], ["increases in IGF", "PROBLEM", 22, 38], ["stimulated hepatic uptake of glucose in PEMSinfected poults", "PROBLEM", 48, 107], ["a significant decrease in glucose", "PROBLEM", 122, 155], ["BC", "TEST", 210, 212], ["PEMS", "PROBLEM", 254, 258], ["significant increase", "PROBLEM", 272, 292], ["the infected poults", "TREATMENT", 311, 330], ["the feed supplement", "TREATMENT", 337, 356], ["increases", "OBSERVATION_MODIFIER", 22, 31], ["hepatic", "ANATOMY", 59, 66], ["significant", "OBSERVATION_MODIFIER", 124, 135], ["decrease", "OBSERVATION_MODIFIER", 136, 144], ["small", "OBSERVATION_MODIFIER", 262, 267], ["significant", "OBSERVATION_MODIFIER", 272, 283], ["increase", "OBSERVATION_MODIFIER", 284, 292]]], ["This increase in BW appeared to be related to altered levels of metabolically active plasma hormones.", [["plasma", "ANATOMY", 85, 91], ["plasma", "ORGANISM_SUBSTANCE", 85, 91], ["altered levels of metabolically active plasma hormones", "PROBLEM", 46, 100], ["increase", "OBSERVATION_MODIFIER", 5, 13]]], ["The hormones of primary interest in this study were the thyroid hormones and insulin.", [["thyroid", "ORGAN", 56, 63], ["insulin", "GENE_OR_GENE_PRODUCT", 77, 84], ["insulin", "PROTEIN", 77, 84], ["this study", "TEST", 36, 46], ["insulin", "TREATMENT", 77, 84], ["thyroid", "ANATOMY", 56, 63]]], ["In a previous study (Doerfler et al., 1998) , severe hypothermia, hypothyrosis, and hypoglycemia were documented for the first time in PEMS- Insulin, ng/mL 1.6 \u00b1 0.15 a 1.6 \u00b1 0.11 a 0.8 \u00b1 0.21 b 0.9 \u00b1 18 b Glucagon, pg/mL 151 \u00b1 12 b 192 \u00b1 9 a 91 \u00b1 15 c 132 \u00b1 14 b Thyroxine, ng/mL 7.6 \u00b1 0.5 b 10.3 \u00b1 1.0 a 1.9 \u00b1 0.5 c 5.7 \u00b1 0.7 b Triiodothyronine, ng/mL 1.8 \u00b1 0.2 b 2.5 \u00b1 0.3 a 0.8 \u00b1 0.4 c 2.3 \u00b1 0.3 a IGF 2 -I, ng/mL 3.2 \u00b1 0.5 c 5.4 \u00b1 0.4 a 0.7 \u00b1 0.3 d 4.9 \u00b1 0.3 b IGF-II, ng/mL 13.0 \u00b1 1.7 a 13.7 \u00b1 1.9 a 7.3 \u00b1 2.1 b 15.2 \u00b1 2.5 a Glucose, mg/dL 200 \u00b1 15 b 210 \u00b1 12 b 242 \u00b1 17 a 221 \u00b1 11 ab a\u2212d In a row, means with unlike superscripts differ significantly (P \u2264 0.05).", [["hypothermia", "DISEASE", 53, 64], ["hypothyrosis", "DISEASE", 66, 78], ["hypoglycemia", "DISEASE", 84, 96], ["Thyroxine", "CHEMICAL", 264, 273], ["Glucose", "CHEMICAL", 531, 538], ["Thyroxine", "CHEMICAL", 264, 273], ["Triiodothyronine", "CHEMICAL", 330, 346], ["Glucose", "CHEMICAL", 531, 538], ["Insulin", "GENE_OR_GENE_PRODUCT", 141, 148], ["Glucagon", "GENE_OR_GENE_PRODUCT", 206, 214], ["Thyroxine", "SIMPLE_CHEMICAL", 264, 273], ["Triiodothyronine", "SIMPLE_CHEMICAL", 330, 346], ["IGF 2 -I", "GENE_OR_GENE_PRODUCT", 402, 410], ["IGF-II", "GENE_OR_GENE_PRODUCT", 466, 472], ["Glucose", "SIMPLE_CHEMICAL", 531, 538], ["IGF", "PROTEIN", 466, 469], ["a previous study", "TEST", 3, 19], ["severe hypothermia", "PROBLEM", 46, 64], ["hypothyrosis", "PROBLEM", 66, 78], ["hypoglycemia", "PROBLEM", 84, 96], ["Insulin", "TREATMENT", 141, 148], ["Glucagon", "TEST", 206, 214], ["a", "TEST", 241, 242], ["c", "TEST", 251, 252], ["\u00b1", "TEST", 257, 258], ["b", "TEST", 262, 263], ["Thyroxine", "TEST", 264, 273], ["ng/mL", "TEST", 275, 280], ["b", "TEST", 291, 292], ["a", "TEST", 304, 305], ["c", "TEST", 316, 317], ["\u00b1", "TEST", 322, 323], ["b", "TEST", 328, 329], ["Triiodothyronine", "TEST", 330, 346], ["ng/mL", "TEST", 348, 353], ["a", "TEST", 376, 377], ["c", "TEST", 388, 389], ["a IGF", "TEST", 400, 405], ["ng/mL", "TEST", 412, 417], ["c", "TEST", 428, 429], ["a", "TEST", 440, 441], ["d", "TEST", 452, 453], ["\u00b1", "TEST", 458, 459], ["IGF", "TEST", 466, 469], ["II", "TEST", 470, 472], ["ng/mL", "TEST", 474, 479], ["a", "TEST", 491, 492], ["a", "TEST", 504, 505], ["b", "TEST", 516, 517], ["a Glucose", "TEST", 529, 538], ["mg/dL", "TEST", 540, 545], ["ab a\u2212d", "TEST", 588, 594], ["unlike superscripts", "PROBLEM", 616, 635], ["severe", "OBSERVATION_MODIFIER", 46, 52], ["hypothermia", "OBSERVATION", 53, 64]]], ["1 n = 20 per observation. infected poults.", [["poults", "ORGANISM", 35, 41], ["poults", "SPECIES", 35, 41], ["infected poults", "PROBLEM", 26, 41]]], ["Additionally, Edens and Doerfler (1997a,b) and Doerfler et al. (1998) reported that PEMSinfected poults appear unable to absorb glucose from the intestine and to utilize blood glucose in the liver.", [["intestine", "ANATOMY", 145, 154], ["blood", "ANATOMY", 170, 175], ["liver", "ANATOMY", 191, 196], ["glucose", "CHEMICAL", 128, 135], ["glucose", "CHEMICAL", 176, 183], ["glucose", "CHEMICAL", 128, 135], ["glucose", "CHEMICAL", 176, 183], ["poults", "ORGANISM", 97, 103], ["glucose", "SIMPLE_CHEMICAL", 128, 135], ["intestine", "ORGAN", 145, 154], ["blood", "ORGANISM_SUBSTANCE", 170, 175], ["glucose", "SIMPLE_CHEMICAL", 176, 183], ["liver", "ORGAN", 191, 196], ["poults", "SPECIES", 97, 103], ["PEMSinfected poults", "PROBLEM", 84, 103], ["blood glucose", "TEST", 170, 183], ["intestine", "ANATOMY", 145, 154], ["liver", "ANATOMY", 191, 196]]], ["These problems were attributed to the decreased level of metabolically active hormones in the circulatory system.", [["circulatory system", "ANATOMY", 94, 112], ["circulatory system", "ANATOMICAL_SYSTEM", 94, 112], ["the decreased level of metabolically active hormones in the circulatory system", "PROBLEM", 34, 112], ["decreased", "OBSERVATION_MODIFIER", 38, 47], ["metabolically", "OBSERVATION_MODIFIER", 57, 70], ["active hormones", "OBSERVATION", 71, 86], ["circulatory system", "ANATOMY", 94, 112]]], ["This condition in PEMS creates a paradox because PEMS-related hypoglycemia inhibits insulin secretion.", [["PEMS", "DISEASE", 18, 22], ["PEMS", "CHEMICAL", 49, 53], ["hypoglycemia", "DISEASE", 62, 74], ["PEMS", "SIMPLE_CHEMICAL", 49, 53], ["insulin", "GENE_OR_GENE_PRODUCT", 84, 91], ["PEMS", "PROBLEM", 49, 53], ["hypoglycemia", "PROBLEM", 62, 74], ["insulin secretion", "PROBLEM", 84, 101]]], ["Normally, in the liver and under the influence of insulin, glucose is converted to fatty acids, but in PEMS this does not appear to occur (Edens and Doerfler, 1997a) .", [["liver", "ANATOMY", 17, 22], ["glucose", "CHEMICAL", 59, 66], ["fatty acids", "CHEMICAL", 83, 94], ["glucose", "CHEMICAL", 59, 66], ["fatty acids", "CHEMICAL", 83, 94], ["liver", "ORGAN", 17, 22], ["insulin", "GENE_OR_GENE_PRODUCT", 50, 57], ["glucose", "SIMPLE_CHEMICAL", 59, 66], ["fatty acids", "SIMPLE_CHEMICAL", 83, 94], ["insulin", "PROTEIN", 50, 57], ["insulin", "TREATMENT", 50, 57], ["glucose", "TEST", 59, 66], ["fatty acids", "TEST", 83, 94], ["liver", "ANATOMY", 17, 22]]], ["In PEMS-infected poults, liver weights are decreased and hepatic mitochondria are severely damaged (Edens and Doerfler, 1997b) .", [["poults", "ANATOMY", 17, 23], ["liver", "ANATOMY", 25, 30], ["hepatic mitochondria", "ANATOMY", 57, 77], ["PEMS", "CHEMICAL", 3, 7], ["PEMS", "SIMPLE_CHEMICAL", 3, 7], ["poults", "ORGANISM", 17, 23], ["liver", "ORGAN", 25, 30], ["hepatic mitochondria", "MULTI-TISSUE_STRUCTURE", 57, 77], ["poults", "SPECIES", 17, 23], ["liver weights", "TEST", 25, 38], ["severely damaged", "PROBLEM", 82, 98], ["infected poults", "OBSERVATION", 8, 23], ["liver", "ANATOMY", 25, 30], ["decreased", "OBSERVATION", 43, 52], ["hepatic", "ANATOMY", 57, 64], ["mitochondria", "ANATOMY_MODIFIER", 65, 77], ["severely", "OBSERVATION_MODIFIER", 82, 90], ["damaged", "OBSERVATION", 91, 98]]], ["Insulin inhibits proteolysis and enhances protein and amino acid sequestration in all target tissues (Berne and Levy, 1993) .", [["tissues", "ANATOMY", 93, 100], ["Insulin", "CHEMICAL", 0, 7], ["amino acid", "CHEMICAL", 54, 64], ["amino acid", "CHEMICAL", 54, 64], ["Insulin", "GENE_OR_GENE_PRODUCT", 0, 7], ["amino acid", "AMINO_ACID", 54, 64], ["tissues", "TISSUE", 93, 100], ["Insulin inhibits proteolysis", "TREATMENT", 0, 28], ["enhances protein", "TEST", 33, 49], ["amino acid sequestration", "TEST", 54, 78]]], ["In PEMS-infected poults, muscle wasting and lipolysis are evident (Edens and Doerfler, 1997a,b) , suggesting that insulin is not functioning properly or that it is decreased significantly as reported herein.", [["poults", "ANATOMY", 17, 23], ["muscle", "ANATOMY", 25, 31], ["PEMS", "CHEMICAL", 3, 7], ["muscle wasting", "DISEASE", 25, 39], ["PEMS", "SIMPLE_CHEMICAL", 3, 7], ["poults", "ORGANISM", 17, 23], ["muscle", "ORGAN", 25, 31], ["insulin", "GENE_OR_GENE_PRODUCT", 114, 121], ["poults", "SPECIES", 17, 23], ["infected poults", "PROBLEM", 8, 23], ["muscle wasting", "PROBLEM", 25, 39], ["lipolysis", "PROBLEM", 44, 53], ["insulin", "TREATMENT", 114, 121], ["infected poults", "OBSERVATION", 8, 23], ["muscle", "ANATOMY", 25, 31], ["wasting", "OBSERVATION", 32, 39], ["lipolysis", "OBSERVATION", 44, 53], ["decreased", "OBSERVATION_MODIFIER", 164, 173]]], ["The plasma insulin profile in PEMS-infected poults noted in this study strongly suggests that wasting and FIGURE 3.", [["plasma", "ANATOMY", 4, 10], ["PEMS", "CHEMICAL", 30, 34], ["wasting", "DISEASE", 94, 101], ["plasma", "ORGANISM_SUBSTANCE", 4, 10], ["insulin", "GENE_OR_GENE_PRODUCT", 11, 18], ["PEMS", "SIMPLE_CHEMICAL", 30, 34], ["poults", "ORGANISM", 44, 50], ["poults", "SPECIES", 44, 50], ["The plasma insulin profile", "TEST", 0, 26], ["infected poults", "PROBLEM", 35, 50], ["this study", "TEST", 60, 70], ["infected", "OBSERVATION", 35, 43], ["wasting", "OBSERVATION", 94, 101]]], ["Time course of plasma thyroxine responses for Control, BioChrome, PEMS, and BioChrome+PEMS treatment groups.", [["plasma", "ANATOMY", 15, 21], ["thyroxine", "CHEMICAL", 22, 31], ["PEMS", "CHEMICAL", 66, 70], ["BioChrome", "CHEMICAL", 76, 85], ["PEMS", "CHEMICAL", 86, 90], ["thyroxine", "CHEMICAL", 22, 31], ["BioChrome", "CHEMICAL", 55, 64], ["BioChrome", "CHEMICAL", 76, 85], ["PEMS", "CHEMICAL", 86, 90], ["plasma", "ORGANISM_SUBSTANCE", 15, 21], ["thyroxine", "SIMPLE_CHEMICAL", 22, 31], ["BioChrome", "SIMPLE_CHEMICAL", 55, 64], ["PEMS", "SIMPLE_CHEMICAL", 66, 70], ["BioChrome+PEMS", "SIMPLE_CHEMICAL", 76, 90], ["plasma thyroxine responses", "TREATMENT", 15, 41], ["BioChrome", "TREATMENT", 55, 64], ["PEMS", "TREATMENT", 66, 70], ["BioChrome+PEMS treatment groups", "TREATMENT", 76, 107]]], ["Poults in the PEMS-exposed groups were given a single oral inoculation when they were 6 d of age. a-d Within days of age, significant differences (P \u2264 0.05) among treatment groups are indicated by different lowercase letter headings. reduced growth of the infected poults are attributed to low levels of insulin.", [["oral", "ANATOMY", 54, 58], ["PEMS", "CHEMICAL", 14, 18], ["PEMS", "SIMPLE_CHEMICAL", 14, 18], ["oral", "ORGANISM_SUBDIVISION", 54, 58], ["poults", "ORGANISM", 265, 271], ["insulin", "GENE_OR_GENE_PRODUCT", 304, 311], ["insulin", "PROTEIN", 304, 311], ["poults", "SPECIES", 265, 271], ["a single oral inoculation", "TREATMENT", 45, 70], ["significant differences", "PROBLEM", 122, 145], ["among treatment groups", "TREATMENT", 157, 179], ["reduced growth", "PROBLEM", 234, 248], ["the infected poults", "PROBLEM", 252, 271], ["insulin", "TREATMENT", 304, 311], ["significant", "OBSERVATION_MODIFIER", 122, 133], ["growth", "OBSERVATION_MODIFIER", 242, 248], ["infected", "OBSERVATION", 256, 264], ["low levels", "OBSERVATION_MODIFIER", 290, 300]]], ["However, the supplementation of BC in the diet of these PEMS-infected poults did not elevate plasma insulin, but BW did have a small but significant increase in the BC-supplemented birds.", [["plasma", "ANATOMY", 93, 99], ["BC", "CHEMICAL", 32, 34], ["PEMS", "CHEMICAL", 56, 60], ["BC", "CHEMICAL", 165, 167], ["BC", "SIMPLE_CHEMICAL", 32, 34], ["PEMS", "SIMPLE_CHEMICAL", 56, 60], ["poults", "ORGANISM", 70, 76], ["plasma", "ORGANISM_SUBSTANCE", 93, 99], ["insulin", "GENE_OR_GENE_PRODUCT", 100, 107], ["BC", "SIMPLE_CHEMICAL", 165, 167], ["birds", "ORGANISM", 181, 186], ["poults", "SPECIES", 70, 76], ["the supplementation of BC", "TREATMENT", 9, 34], ["these PEMS", "TEST", 50, 60], ["infected poults", "PROBLEM", 61, 76], ["plasma insulin", "TREATMENT", 93, 107], ["a small but significant increase in the BC", "PROBLEM", 125, 167], ["small", "OBSERVATION_MODIFIER", 127, 132], ["significant", "OBSERVATION_MODIFIER", 137, 148], ["increase", "OBSERVATION_MODIFIER", 149, 157]]], ["In addition, hepatic glycogen levels were elevated and hepatic glucose-6-phosphatase activity decreased in the PEMSinfected, BC-supplemented poults, indicating that they had likely responded to BC by becoming more sensitive to the lower levels of available plasma insulin.RESULTS AND DISCUSSIONInsulin, along with growth hormone, regulates the transcription of related growth factors, such as IGF-I and IGF-II (Houston and O'Neill, 1991) .", [["hepatic", "ANATOMY", 13, 20], ["hepatic", "ANATOMY", 55, 62], ["plasma", "ANATOMY", 257, 263], ["glycogen", "CHEMICAL", 21, 29], ["glucose", "CHEMICAL", 63, 70], ["BC", "CHEMICAL", 125, 127], ["glucose", "CHEMICAL", 63, 70], ["hepatic", "ORGAN", 13, 20], ["glycogen", "SIMPLE_CHEMICAL", 21, 29], ["glucose-6-phosphatase", "GENE_OR_GENE_PRODUCT", 63, 84], ["BC", "SIMPLE_CHEMICAL", 125, 127], ["poults", "ORGANISM", 141, 147], ["plasma", "ORGANISM_SUBSTANCE", 257, 263], ["insulin", "GENE_OR_GENE_PRODUCT", 264, 271], ["IGF-I", "GENE_OR_GENE_PRODUCT", 393, 398], ["IGF-II", "GENE_OR_GENE_PRODUCT", 403, 409], ["phosphatase", "PROTEIN", 73, 84], ["plasma insulin", "PROTEIN", 257, 271], ["growth factors", "PROTEIN", 369, 383], ["IGF-I", "PROTEIN", 393, 398], ["IGF-II", "PROTEIN", 403, 409], ["poults", "SPECIES", 141, 147], ["hepatic glycogen levels", "TEST", 13, 36], ["elevated", "PROBLEM", 42, 50], ["hepatic glucose", "TEST", 55, 70], ["phosphatase activity", "TEST", 73, 93], ["BC", "TEST", 125, 127], ["BC", "TEST", 194, 196], ["available plasma insulin", "TREATMENT", 247, 271], ["related growth factors", "PROBLEM", 361, 383], ["hepatic", "ANATOMY", 13, 20], ["hepatic", "ANATOMY", 55, 62]]], ["Additionally, receptors for insulin will recognize IGF (IGF-I and IGF-II) and insulin because of close structural similarities (Rechler, 1985; Prosser, 1991; McMurtry et al., 1996 McMurtry et al., , 1997 .", [["insulin", "GENE_OR_GENE_PRODUCT", 28, 35], ["IGF", "GENE_OR_GENE_PRODUCT", 51, 54], ["IGF-I", "GENE_OR_GENE_PRODUCT", 56, 61], ["IGF-II", "GENE_OR_GENE_PRODUCT", 66, 72], ["insulin", "GENE_OR_GENE_PRODUCT", 78, 85], ["insulin", "PROTEIN", 28, 35], ["IGF", "PROTEIN", 51, 54], ["IGF-I", "PROTEIN", 56, 61], ["IGF-II", "PROTEIN", 66, 72], ["insulin", "PROTEIN", 78, 85], ["insulin", "TREATMENT", 28, 35], ["IGF", "TEST", 51, 54], ["IGF", "TEST", 56, 59], ["insulin", "TREATMENT", 78, 85]]], ["Fasting, protein deprivation, and insulin deficiency all lead to diminished synthesis and secretion of the IGF (McMurtry et al., 1996 (McMurtry et al., , 1997 McMurtry, 1998) .", [["Fasting", "ORGANISM_SUBSTANCE", 0, 7], ["insulin", "GENE_OR_GENE_PRODUCT", 34, 41], ["IGF", "GENE_OR_GENE_PRODUCT", 107, 110], ["IGF", "PROTEIN", 107, 110], ["Fasting, protein deprivation", "TEST", 0, 28], ["insulin deficiency", "PROBLEM", 34, 52], ["diminished synthesis", "PROBLEM", 65, 85], ["protein deprivation", "OBSERVATION", 9, 28], ["insulin deficiency", "OBSERVATION", 34, 52]]], ["A significant depression in plasma levels of IGF-I and IGF-II were found in PEMS-infected poults in this study.", [["plasma", "ANATOMY", 28, 34], ["depression", "DISEASE", 14, 24], ["PEMS", "CHEMICAL", 76, 80], ["plasma", "ORGANISM_SUBSTANCE", 28, 34], ["IGF-I", "GENE_OR_GENE_PRODUCT", 45, 50], ["IGF-II", "GENE_OR_GENE_PRODUCT", 55, 61], ["PEMS", "SIMPLE_CHEMICAL", 76, 80], ["poults", "ORGANISM", 90, 96], ["IGF-I", "PROTEIN", 45, 50], ["IGF-II", "PROTEIN", 55, 61], ["poults", "SPECIES", 90, 96], ["A significant depression in plasma levels", "PROBLEM", 0, 41], ["IGF", "TEST", 45, 48], ["this study", "TEST", 100, 110], ["significant", "OBSERVATION_MODIFIER", 2, 13], ["depression", "OBSERVATION", 14, 24], ["infected", "OBSERVATION", 81, 89]]], ["Time course of plasma triiodothyronine responses for Control, BioChrome, PEMS, and BioChrome+PEMS treatment groups.", [["plasma", "ANATOMY", 15, 21], ["triiodothyronine", "CHEMICAL", 22, 38], ["PEMS", "CHEMICAL", 73, 77], ["BioChrome", "CHEMICAL", 83, 92], ["PEMS", "CHEMICAL", 93, 97], ["triiodothyronine", "CHEMICAL", 22, 38], ["BioChrome", "CHEMICAL", 62, 71], ["BioChrome", "CHEMICAL", 83, 92], ["PEMS", "CHEMICAL", 93, 97], ["plasma", "ORGANISM_SUBSTANCE", 15, 21], ["triiodothyronine", "SIMPLE_CHEMICAL", 22, 38], ["BioChrome", "SIMPLE_CHEMICAL", 62, 71], ["PEMS", "SIMPLE_CHEMICAL", 73, 77], ["BioChrome+PEMS", "SIMPLE_CHEMICAL", 83, 97], ["plasma triiodothyronine responses", "TREATMENT", 15, 48], ["BioChrome", "TREATMENT", 62, 71], ["PEMS", "TREATMENT", 73, 77], ["BioChrome+PEMS treatment groups", "TREATMENT", 83, 114]]], ["Poults in the PEMS-exposed groups were given a single oral inoculation when they were 6 d of age. a-c Within days of age, significant differences (P \u2264 0.05) among treatment groups are indicated by different lowercase letter headings.", [["oral", "ANATOMY", 54, 58], ["PEMS", "CHEMICAL", 14, 18], ["PEMS", "SIMPLE_CHEMICAL", 14, 18], ["oral", "ORGANISM_SUBDIVISION", 54, 58], ["a single oral inoculation", "TREATMENT", 45, 70], ["significant differences", "PROBLEM", 122, 145], ["treatment groups", "TREATMENT", 163, 179], ["significant", "OBSERVATION_MODIFIER", 122, 133]]], ["Poults in the PEMS-exposed groups were given a single oral inoculation when they were 6 d of age. a-d Within days of age, significant differences (P \u2264 0.05) among treatment groups are indicated by different lowercase letter headings.RESULTS AND DISCUSSIONof BC, IGF levels increased in PEMS-infected poults comparable to noninfected levels.", [["oral", "ANATOMY", 54, 58], ["PEMS", "CHEMICAL", 14, 18], ["PEMS", "CHEMICAL", 286, 290], ["PEMS", "SIMPLE_CHEMICAL", 14, 18], ["oral", "ORGANISM_SUBDIVISION", 54, 58], ["BC", "CANCER", 258, 260], ["IGF", "GENE_OR_GENE_PRODUCT", 262, 265], ["PEMS", "SIMPLE_CHEMICAL", 286, 290], ["poults", "ORGANISM", 300, 306], ["IGF", "PROTEIN", 262, 265], ["poults", "SPECIES", 300, 306], ["a single oral inoculation", "TREATMENT", 45, 70], ["significant differences", "PROBLEM", 122, 145], ["among treatment groups", "TREATMENT", 157, 179], ["BC", "TEST", 258, 260], ["IGF levels", "TEST", 262, 272], ["infected poults", "PROBLEM", 291, 306], ["significant", "OBSERVATION_MODIFIER", 122, 133], ["infected", "OBSERVATION", 291, 299]]], ["The increase in IGF in the BC-treated, PEMS-infected poults may account for the small but significant increase in BW in this group, because it has been shown that IGF function through insulin receptors (Rechler, 1985; Prosser, 1991; McMurtry et al., 1996 McMurtry et al., , 1997 .", [["BC", "CHEMICAL", 27, 29], ["PEMS", "CHEMICAL", 39, 43], ["IGF", "GENE_OR_GENE_PRODUCT", 16, 19], ["BC", "CELL", 27, 29], ["PEMS", "SIMPLE_CHEMICAL", 39, 43], ["poults", "ORGANISM", 53, 59], ["IGF", "GENE_OR_GENE_PRODUCT", 163, 166], ["insulin receptors", "GENE_OR_GENE_PRODUCT", 184, 201], ["IGF", "PROTEIN", 16, 19], ["IGF", "PROTEIN", 163, 166], ["insulin receptors", "PROTEIN", 184, 201], ["poults", "SPECIES", 53, 59], ["The increase in IGF in the BC", "PROBLEM", 0, 29], ["PEMS", "PROBLEM", 39, 43], ["infected poults", "PROBLEM", 44, 59], ["increase", "OBSERVATION_MODIFIER", 4, 12], ["IGF", "OBSERVATION_MODIFIER", 16, 19], ["infected", "OBSERVATION", 44, 52], ["may account for", "UNCERTAINTY", 60, 75], ["small", "OBSERVATION_MODIFIER", 80, 85], ["significant", "OBSERVATION_MODIFIER", 90, 101], ["increase", "OBSERVATION_MODIFIER", 102, 110]]], ["These observations support the hypothesis that BC in PEMS-infected poults sensitized insulin receptors, permitting the infected poults to develop a metabolic condition that could better sustain them during the stress response caused by the disease.", [["BC", "CHEMICAL", 47, 49], ["PEMS", "CHEMICAL", 53, 57], ["BC", "CANCER", 47, 49], ["PEMS", "SIMPLE_CHEMICAL", 53, 57], ["poults", "ORGANISM", 67, 73], ["insulin receptors", "GENE_OR_GENE_PRODUCT", 85, 102], ["poults", "ORGANISM", 128, 134], ["insulin receptors", "PROTEIN", 85, 102], ["poults", "SPECIES", 67, 73], ["poults", "SPECIES", 128, 134], ["poults", "SPECIES", 128, 134], ["the hypothesis", "PROBLEM", 27, 41], ["BC in PEMS", "PROBLEM", 47, 57], ["infected poults sensitized insulin receptors", "TREATMENT", 58, 102], ["the infected poults", "PROBLEM", 115, 134], ["a metabolic condition", "PROBLEM", 146, 167], ["the stress response", "PROBLEM", 206, 225], ["the disease", "PROBLEM", 236, 247], ["disease", "OBSERVATION", 240, 247]]], ["Time course of plasma insulin-like growth factor-II (IGF-II) responses for Control, BioChrome, PEMS, and BioChrome+PEMS treatment groups.", [["plasma", "ANATOMY", 15, 21], ["PEMS", "CHEMICAL", 95, 99], ["BioChrome", "CHEMICAL", 105, 114], ["PEMS", "CHEMICAL", 115, 119], ["plasma", "ORGANISM_SUBSTANCE", 15, 21], ["insulin-like growth factor-II", "GENE_OR_GENE_PRODUCT", 22, 51], ["IGF-II", "GENE_OR_GENE_PRODUCT", 53, 59], ["BioChrome", "SIMPLE_CHEMICAL", 84, 93], ["PEMS", "SIMPLE_CHEMICAL", 95, 99], ["BioChrome+PEMS", "SIMPLE_CHEMICAL", 105, 119], ["plasma insulin", "PROTEIN", 15, 29], ["plasma insulin", "TEST", 15, 29], ["growth factor", "TEST", 35, 48], ["BioChrome, PEMS", "TREATMENT", 84, 99], ["BioChrome+PEMS treatment groups", "TREATMENT", 105, 136]]], ["Poults in the PEMS-exposed groups were given a single oral inoculation when they were 6 d of age. a-c Within days of age, significant differences (P \u2264 0.05) among treatment groups are indicated by different lowercase letter headings.FIGURE 7.Time course of plasma glucose responses for Control, BioChrome, PEMS, and BioChrome+PEMS treatment groups.", [["oral", "ANATOMY", 54, 58], ["plasma", "ANATOMY", 257, 263], ["PEMS", "CHEMICAL", 14, 18], ["glucose", "CHEMICAL", 264, 271], ["PEMS", "CHEMICAL", 306, 310], ["BioChrome", "CHEMICAL", 316, 325], ["PEMS", "CHEMICAL", 326, 330], ["glucose", "CHEMICAL", 264, 271], ["BioChrome", "CHEMICAL", 316, 325], ["PEMS", "CHEMICAL", 326, 330], ["PEMS", "SIMPLE_CHEMICAL", 14, 18], ["oral", "ORGANISM_SUBDIVISION", 54, 58], ["plasma", "ORGANISM_SUBSTANCE", 257, 263], ["glucose", "SIMPLE_CHEMICAL", 264, 271], ["BioChrome", "SIMPLE_CHEMICAL", 295, 304], ["PEMS", "SIMPLE_CHEMICAL", 306, 310], ["BioChrome+PEMS", "SIMPLE_CHEMICAL", 316, 330], ["a single oral inoculation", "TREATMENT", 45, 70], ["significant differences", "PROBLEM", 122, 145], ["treatment groups", "TREATMENT", 163, 179], ["plasma glucose responses", "TEST", 257, 281], ["BioChrome", "TREATMENT", 295, 304], ["PEMS", "TREATMENT", 306, 310], ["BioChrome+PEMS treatment groups", "TREATMENT", 316, 347], ["significant", "OBSERVATION_MODIFIER", 122, 133]]], ["Poults in the PEMS-exposed groups were given a single oral inoculation when they were 6 d of age. a,b Within days of age, significant differences (P \u2264 0.05) among treatment groups are indicated by different lowercase letter headings.FIGURE 7.Thyroid hormones have been reported to decrease significantly in PEMS-infected poults (Edens and Doerfler, 1997a,b; Doerfler et al., 1998) ; in this study T 4 and T 3 were decreased significantly by the infection.", [["oral", "ANATOMY", 54, 58], ["Thyroid", "ANATOMY", 242, 249], ["PEMS", "CHEMICAL", 14, 18], ["PEMS", "CHEMICAL", 307, 311], ["infection", "DISEASE", 445, 454], ["PEMS", "SIMPLE_CHEMICAL", 14, 18], ["oral", "ORGANISM_SUBDIVISION", 54, 58], ["Thyroid", "ORGAN", 242, 249], ["poults", "ORGANISM", 321, 327], ["T 4", "CELL", 397, 400], ["T 3", "GENE_OR_GENE_PRODUCT", 405, 408], ["poults", "SPECIES", 321, 327], ["a single oral inoculation", "TREATMENT", 45, 70], ["significant differences", "PROBLEM", 122, 145], ["among treatment groups", "TREATMENT", 157, 179], ["this study T", "TEST", 386, 398], ["the infection", "PROBLEM", 441, 454], ["significant", "OBSERVATION_MODIFIER", 122, 133], ["decrease", "OBSERVATION_MODIFIER", 281, 289], ["significantly", "OBSERVATION_MODIFIER", 290, 303], ["infected", "OBSERVATION", 312, 320], ["infection", "OBSERVATION", 445, 454]]], ["Nevertheless, in PEMS-infected poults with BC supplementation, both of these plasma hormones were elevated to levels significantly greater than the levels found in PEMS without BC.", [["plasma", "ANATOMY", 77, 83], ["PEMS", "ANATOMY", 164, 168], ["PEMS", "CHEMICAL", 17, 21], ["BC", "CHEMICAL", 43, 45], ["PEMS", "SIMPLE_CHEMICAL", 17, 21], ["poults", "ORGANISM", 31, 37], ["BC", "SIMPLE_CHEMICAL", 43, 45], ["plasma", "ORGANISM_SUBSTANCE", 77, 83], ["poults", "SPECIES", 31, 37], ["poults", "SPECIES", 31, 37], ["BC supplementation", "TREATMENT", 43, 61], ["these plasma hormones", "TEST", 71, 92], ["BC", "PROBLEM", 177, 179], ["infected", "OBSERVATION", 22, 30]]], ["The most obvious effects of thyroid hormones in domestic fowl are the increases in the rate of oxygen utilization and basal heat production (Hendrich and Turner, 1967) .", [["thyroid", "ANATOMY", 28, 35], ["oxygen", "CHEMICAL", 95, 101], ["oxygen", "CHEMICAL", 95, 101], ["thyroid", "ORGAN", 28, 35], ["oxygen", "SIMPLE_CHEMICAL", 95, 101], ["thyroid hormones", "PROBLEM", 28, 44], ["oxygen utilization", "TREATMENT", 95, 113], ["basal heat production", "PROBLEM", 118, 139], ["most obvious", "OBSERVATION_MODIFIER", 4, 16], ["thyroid", "ANATOMY", 28, 35], ["hormones", "OBSERVATION", 36, 44], ["increases", "OBSERVATION_MODIFIER", 70, 79], ["heat production", "OBSERVATION", 124, 139]]], ["The decrease in body temperature in PEMS, therefore, can be related directly to the hypothyrosis that normally occurs with this disease (Doerfler et al., 1998) .", [["body", "ANATOMY", 16, 20], ["hypothyrosis", "DISEASE", 84, 96], ["body", "ORGANISM_SUBDIVISION", 16, 20], ["The decrease in body temperature in PEMS", "PROBLEM", 0, 40], ["the hypothyrosis", "PROBLEM", 80, 96], ["this disease", "PROBLEM", 123, 135], ["decrease", "OBSERVATION_MODIFIER", 4, 12], ["body temperature", "OBSERVATION_MODIFIER", 16, 32]]], ["In this study, the increase in plasma thyroid hormones in response to BC supplementation apparently resulted in a metabolic energy demand.", [["plasma", "ANATOMY", 31, 37], ["BC", "CHEMICAL", 70, 72], ["plasma", "ORGANISM_SUBSTANCE", 31, 37], ["thyroid", "ORGAN", 38, 45], ["this study", "TEST", 3, 13], ["the increase in plasma thyroid hormones", "PROBLEM", 15, 54], ["BC supplementation", "TREATMENT", 70, 88], ["a metabolic energy demand", "PROBLEM", 112, 137], ["increase", "OBSERVATION_MODIFIER", 19, 27], ["thyroid", "ANATOMY", 38, 45], ["metabolic energy demand", "OBSERVATION", 114, 137]]], ["Even though the PEMS-infected poults responded positively to the BC supplementation, BW were not corrected during the study.FIGURE 7.Feed consumption during the peak of the PEMS infection (7 to 9 d after challenge) was reduced to approximately 25% of the control feed intake, which would further reduce the ameliorating effects of BC.", [["PEMS", "CHEMICAL", 16, 20], ["BC", "CHEMICAL", 65, 67], ["PEMS", "CHEMICAL", 173, 177], ["infection", "DISEASE", 178, 187], ["BC", "CHEMICAL", 331, 333], ["PEMS", "SIMPLE_CHEMICAL", 16, 20], ["poults", "ORGANISM", 30, 36], ["poults", "SPECIES", 30, 36], ["poults", "SPECIES", 30, 36], ["infected poults", "PROBLEM", 21, 36], ["the BC supplementation", "TREATMENT", 61, 83], ["BW", "TEST", 85, 87], ["the study", "TEST", 114, 123], ["the PEMS infection", "PROBLEM", 169, 187], ["the ameliorating effects of BC", "PROBLEM", 303, 333], ["infected", "OBSERVATION", 21, 29]]], ["This observation clearly indicated that there were different levels of BC intake in control vs. PEMS-infected poults.", [["poults", "ANATOMY", 110, 116], ["BC", "CHEMICAL", 71, 73], ["PEMS", "CHEMICAL", 96, 100], ["BC", "SIMPLE_CHEMICAL", 71, 73], ["PEMS", "SIMPLE_CHEMICAL", 96, 100], ["poults", "ORGANISM", 110, 116], ["poults", "SPECIES", 110, 116], ["BC intake", "PROBLEM", 71, 80], ["infected poults", "OBSERVATION", 101, 116]]], ["These data suggest that less BC can affect many of the metabolically active factors of this study.", [["These data", "TEST", 0, 10], ["less BC", "PROBLEM", 24, 31], ["this study", "TEST", 87, 97]]], ["One could speculate that whether a fourfold increase in BC intake in the PEMSinfected poults during the peak of the disease might lessen the signs and effects of the disease.FIGURE 7.The effects of BC in poultry species are not well documented, but poultry appear to respond in a manner similar to mammals.", [["BC", "CHEMICAL", 56, 58], ["BC", "CHEMICAL", 198, 200], ["BC", "SIMPLE_CHEMICAL", 56, 58], ["poults", "ORGANISM", 86, 92], ["BC", "MULTI-TISSUE_STRUCTURE", 198, 200], ["poults", "SPECIES", 86, 92], ["a fourfold increase in BC intake", "PROBLEM", 33, 65], ["the disease", "PROBLEM", 112, 123], ["the disease", "PROBLEM", 162, 173], ["BC in poultry species", "PROBLEM", 198, 219], ["fourfold", "OBSERVATION_MODIFIER", 35, 43], ["increase", "OBSERVATION_MODIFIER", 44, 52], ["BC intake", "OBSERVATION", 56, 65], ["disease", "OBSERVATION", 116, 123], ["disease", "OBSERVATION", 166, 173], ["BC", "OBSERVATION", 198, 200]]], ["Specifically, BC appears to exert its effects through sensitization of insulin receptors and through its influence on glucose metabolism (Mooradian and Morley, 1987; Anderson, 1986 Anderson, , 1994 .", [["BC", "CHEMICAL", 14, 16], ["glucose", "CHEMICAL", 118, 125], ["glucose", "CHEMICAL", 118, 125], ["insulin receptors", "GENE_OR_GENE_PRODUCT", 71, 88], ["glucose", "SIMPLE_CHEMICAL", 118, 125], ["insulin receptors", "PROTEIN", 71, 88], ["BC", "TEST", 14, 16], ["insulin receptors", "TREATMENT", 71, 88]]], ["This mediation TABLE 3.", [["TABLE 3", "PROTEIN", 15, 22]]], ["Influence of BioChrome (BC) on hepatic glycogen and glucose-6-phosphatase activity in poult enteritis and mortality syndrome (PEMS)-infected 21-d-old female turkey poults 1 Treatment groups Hepatic chemistry Control BC PEMS PEMS+BC Glycogen, mg/g liver 5.1 \u00b1 0.3 a 5.6 \u00b1 0.2 a 4.3 \u00b1 0.3 b 5.7 \u00b1 0.4 a Glucose-6-phosphatase, mol P/min 24.0 \u00b1 4.5 a 23.7 \u00b1 3.9 a 6.5 \u00b1 3.5 b 19.1 \u00b1 3.7 a a,bFIGURE 7.Within a row, means with unlike superscripts differ significantly (P \u2264 0.05).", [["hepatic", "ANATOMY", 31, 38], ["liver", "ANATOMY", 247, 252], ["BioChrome", "CHEMICAL", 13, 22], ["glycogen", "CHEMICAL", 39, 47], ["glucose", "CHEMICAL", 52, 59], ["poult enteritis", "DISEASE", 86, 101], ["mortality syndrome", "DISEASE", 106, 124], ["PEMS", "DISEASE", 126, 130], ["Glucose", "CHEMICAL", 301, 308], ["glucose", "CHEMICAL", 52, 59], ["Glucose", "CHEMICAL", 301, 308], ["BioChrome", "SIMPLE_CHEMICAL", 13, 22], ["hepatic", "ORGAN", 31, 38], ["glycogen", "SIMPLE_CHEMICAL", 39, 47], ["glucose-6-phosphatase", "GENE_OR_GENE_PRODUCT", 52, 73], ["turkey", "ORGANISM", 157, 163], ["poults", "ORGANISM", 164, 170], ["Glycogen", "SIMPLE_CHEMICAL", 232, 240], ["liver", "ORGAN", 247, 252], ["Glucose-6-phosphatase", "SIMPLE_CHEMICAL", 301, 322], ["glucose-6-phosphatase", "PROTEIN", 52, 73], ["Glucose-6-phosphatase", "PROTEIN", 301, 322], ["turkey", "SPECIES", 157, 163], ["poults", "SPECIES", 164, 170], ["turkey", "SPECIES", 157, 163], ["BioChrome (BC", "TEST", 13, 26], ["hepatic glycogen", "TEST", 31, 47], ["glucose", "TEST", 52, 59], ["poult enteritis", "PROBLEM", 86, 101], ["mortality syndrome", "PROBLEM", 106, 124], ["PEMS", "TEST", 126, 130], ["Hepatic chemistry", "TEST", 190, 207], ["BC PEMS", "TEST", 216, 223], ["PEMS", "TEST", 224, 228], ["BC", "TEST", 229, 231], ["Glycogen", "TEST", 232, 240], ["mg", "TEST", 242, 244], ["liver", "TEST", 247, 252], ["a", "TEST", 263, 264], ["a", "TEST", 275, 276], ["b", "TEST", 287, 288], ["a Glucose", "TEST", 299, 308], ["phosphatase", "TEST", 311, 322], ["a", "TEST", 345, 346], ["a", "TEST", 358, 359], ["b", "TEST", 370, 371], ["\u00b1", "TEST", 377, 378], ["a a,bFIGURE", "TEST", 383, 394], ["hepatic", "ANATOMY", 31, 38], ["Hepatic", "ANATOMY", 190, 197], ["liver", "ANATOMY", 247, 252]]], ["1 n = 10 per observation.FIGURE 7.of glucose metabolism in PEMS-infected poults appears to occur through stimulation of the thyroid hormones.", [["thyroid", "ANATOMY", 124, 131], ["glucose", "CHEMICAL", 37, 44], ["PEMS", "CHEMICAL", 59, 63], ["glucose", "CHEMICAL", 37, 44], ["glucose", "SIMPLE_CHEMICAL", 37, 44], ["PEMS", "SIMPLE_CHEMICAL", 59, 63], ["poults", "ORGANISM", 73, 79], ["thyroid", "ORGAN", 124, 131], ["poults", "SPECIES", 73, 79], ["glucose metabolism in PEMS", "PROBLEM", 37, 63], ["infected poults", "PROBLEM", 64, 79], ["glucose metabolism", "OBSERVATION", 37, 55], ["infected", "OBSERVATION", 64, 72], ["thyroid", "ANATOMY", 124, 131]]], ["Furthermore, Cr in mammals is recognized as an antistress agent (Mowat, 1994; Pagan et al., 1995; Mallard and Borgs, 1997 ) and, therefore, may have a potential role in the PEMS infection.", [["Cr", "CHEMICAL", 13, 15], ["infection", "DISEASE", 178, 187], ["Cr", "CHEMICAL", 13, 15], ["Cr", "SIMPLE_CHEMICAL", 13, 15], ["PEMS", "CANCER", 173, 177], ["Cr", "PROTEIN", 13, 15], ["Cr", "TEST", 13, 15], ["the PEMS infection", "PROBLEM", 169, 187], ["PEMS", "ANATOMY", 173, 177], ["infection", "OBSERVATION", 178, 187]]], ["Nutritional interventions into the PEMS problem appear to have a potential that is greater than the use of antibiotics, which is important because many of the bacterial pathogens isolated from PEMS-infected poults are antibiotic resistant or develop resistance very rapidly.", [["PEMS", "CHEMICAL", 193, 197], ["PEMS", "SIMPLE_CHEMICAL", 193, 197], ["poults", "ORGANISM", 207, 213], ["poults", "SPECIES", 207, 213], ["poults", "SPECIES", 207, 213], ["Nutritional interventions", "TREATMENT", 0, 25], ["the PEMS problem", "PROBLEM", 31, 47], ["antibiotics", "TREATMENT", 107, 118], ["the bacterial pathogens", "PROBLEM", 155, 178], ["PEMS", "PROBLEM", 193, 197], ["infected poults", "TREATMENT", 198, 213], ["antibiotic", "TREATMENT", 218, 228], ["greater", "OBSERVATION_MODIFIER", 83, 90]]], ["It is believed that the pathogens that cause PEMS also induce pathology via disruption of the normal biochemical and physiological mechanisms that establish the individual bird's homeostatic condition and subsequently contribute to its eventual demise.", [["PEMS", "DISEASE", 45, 49], ["PEMS", "CHEMICAL", 45, 49], ["PEMS", "SIMPLE_CHEMICAL", 45, 49], ["the pathogens", "PROBLEM", 20, 33], ["PEMS", "PROBLEM", 45, 49], ["its eventual demise", "PROBLEM", 232, 251], ["normal", "OBSERVATION", 94, 100]]], ["The lack of assimilation of nutrients and the inability to utilize the nutrients that are absorbed from the intestinal tract are two of the primary contributors to the mortality and lack of growth in PEMSafflicted poults.", [["intestinal tract", "ANATOMY", 108, 124], ["intestinal tract", "ORGANISM_SUBDIVISION", 108, 124], ["poults", "SPECIES", 214, 220], ["the nutrients", "TREATMENT", 67, 80], ["PEMSafflicted poults", "TREATMENT", 200, 220], ["intestinal tract", "ANATOMY", 108, 124]]], ["Although there was only a small improvement in BW and FCR and no significant improvement in mortality for BC-fed, PEMS-infected poults, the data collected in these initial studies suggest that nutritional supplements may alleviate the intensity of the some of the symptoms of intestinal pathogenesis caused by bacterial or viral infection, may modulate the immune system, and may provide a stimulus to the metabolism of PEMS-afflicted poults.", [["intestinal", "ANATOMY", 276, 286], ["immune system", "ANATOMY", 357, 370], ["PEMS", "CHEMICAL", 114, 118], ["infection", "DISEASE", 329, 338], ["PEMS", "CHEMICAL", 420, 424], ["PEMS", "SIMPLE_CHEMICAL", 114, 118], ["poults", "ORGANISM", 128, 134], ["intestinal", "ORGAN", 276, 286], ["PEMS", "SIMPLE_CHEMICAL", 420, 424], ["poults", "ORGANISM", 435, 441], ["poults", "SPECIES", 128, 134], ["poults", "SPECIES", 435, 441], ["a small improvement in BW", "PROBLEM", 24, 49], ["FCR", "TEST", 54, 57], ["BC", "TEST", 106, 108], ["PEMS", "PROBLEM", 114, 118], ["the data", "TEST", 136, 144], ["these initial studies", "TEST", 158, 179], ["nutritional supplements", "TREATMENT", 193, 216], ["the symptoms", "PROBLEM", 260, 272], ["intestinal pathogenesis", "PROBLEM", 276, 299], ["bacterial or viral infection", "PROBLEM", 310, 338], ["small", "OBSERVATION_MODIFIER", 26, 31], ["improvement", "OBSERVATION_MODIFIER", 32, 43], ["no", "UNCERTAINTY", 62, 64], ["significant", "OBSERVATION_MODIFIER", 65, 76], ["improvement", "OBSERVATION_MODIFIER", 77, 88], ["infected", "OBSERVATION", 119, 127], ["intestinal", "ANATOMY", 276, 286], ["bacterial", "OBSERVATION_MODIFIER", 310, 319], ["viral", "OBSERVATION_MODIFIER", 323, 328], ["infection", "OBSERVATION", 329, 338]]]], "b6deb91c6796184b969f10b262910634eeff4a33": [["IntroductionIn most solid tumors the tumor interior displays a high cellular density with multiple cell types, both malignant and normal (stromal) cells, interdigitated by strands of extracellular matrix (ECM) and other poorly defined tissue.", [["solid tumors", "ANATOMY", 20, 32], ["tumor interior", "ANATOMY", 37, 51], ["cellular", "ANATOMY", 68, 76], ["cell", "ANATOMY", 99, 103], ["malignant", "ANATOMY", 116, 125], ["stromal) cells", "ANATOMY", 138, 152], ["extracellular matrix", "ANATOMY", 183, 203], ["ECM", "ANATOMY", 205, 208], ["tissue", "ANATOMY", 235, 241], ["tumors", "DISEASE", 26, 32], ["tumor", "DISEASE", 37, 42], ["solid tumors", "CANCER", 20, 32], ["tumor", "CANCER", 37, 42], ["cellular", "CELL", 68, 76], ["cell", "CELL", 99, 103], ["stromal) cells", "CELL", 138, 152], ["extracellular matrix", "CELLULAR_COMPONENT", 183, 203], ["ECM", "CELLULAR_COMPONENT", 205, 208], ["tissue", "TISSUE", 235, 241], ["malignant and normal (stromal) cells", "CELL_TYPE", 116, 152], ["IntroductionIn most solid tumors", "PROBLEM", 0, 32], ["a high cellular density", "PROBLEM", 61, 84], ["multiple cell types", "PROBLEM", 90, 109], ["other poorly defined tissue", "PROBLEM", 214, 241], ["solid", "OBSERVATION_MODIFIER", 20, 25], ["tumors", "OBSERVATION", 26, 32], ["tumor", "OBSERVATION", 37, 42], ["high", "OBSERVATION_MODIFIER", 63, 67], ["cellular", "OBSERVATION_MODIFIER", 68, 76], ["density", "OBSERVATION", 77, 84], ["multiple", "OBSERVATION_MODIFIER", 90, 98], ["cell types", "OBSERVATION", 99, 109], ["both", "OBSERVATION_MODIFIER", 111, 115], ["malignant", "OBSERVATION_MODIFIER", 116, 125], ["normal", "OBSERVATION", 130, 136], ["stromal) cells", "OBSERVATION", 138, 152], ["interdigitated", "OBSERVATION_MODIFIER", 154, 168], ["strands", "OBSERVATION_MODIFIER", 172, 179], ["extracellular", "OBSERVATION_MODIFIER", 183, 196], ["matrix", "OBSERVATION_MODIFIER", 197, 203], ["poorly defined", "OBSERVATION_MODIFIER", 220, 234], ["tissue", "OBSERVATION", 235, 241]]], ["Stromal cells typically consist of fibroblasts, macrophages, neutrophils and other immune cell types.", [["Stromal cells", "ANATOMY", 0, 13], ["fibroblasts", "ANATOMY", 35, 46], ["macrophages", "ANATOMY", 48, 59], ["neutrophils", "ANATOMY", 61, 72], ["immune cell", "ANATOMY", 83, 94], ["Stromal cells", "CELL", 0, 13], ["fibroblasts", "CELL", 35, 46], ["macrophages", "CELL", 48, 59], ["neutrophils", "CELL", 61, 72], ["immune cell", "CELL", 83, 94], ["Stromal cells", "CELL_TYPE", 0, 13], ["fibroblasts", "CELL_TYPE", 35, 46], ["macrophages", "CELL_TYPE", 48, 59], ["neutrophils", "CELL_TYPE", 61, 72], ["immune cell types", "CELL_TYPE", 83, 100], ["Stromal cells", "PROBLEM", 0, 13], ["fibroblasts", "PROBLEM", 35, 46], ["macrophages", "PROBLEM", 48, 59], ["neutrophils", "TEST", 61, 72], ["fibroblasts", "OBSERVATION", 35, 46], ["macrophages", "OBSERVATION_MODIFIER", 48, 59], ["neutrophils", "OBSERVATION_MODIFIER", 61, 72], ["immune cell types", "OBSERVATION", 83, 100]]], ["Tumor-associated fibroblasts are a source of the bulk acellular tissue in tumors [1] , which is largely made up of polysugars and glycoproteins, such as collagens, laminins, fibronectins, proteoglycans, hyaluronan and water, forming a dense matrix around and between the cancer cells [2] .", [["Tumor", "ANATOMY", 0, 5], ["fibroblasts", "ANATOMY", 17, 28], ["acellular tissue", "ANATOMY", 54, 70], ["tumors", "ANATOMY", 74, 80], ["matrix", "ANATOMY", 241, 247], ["cancer cells", "ANATOMY", 271, 283], ["tumors", "DISEASE", 74, 80], ["cancer", "DISEASE", 271, 277], ["Tumor-associated fibroblasts", "CELL", 0, 28], ["acellular tissue", "TISSUE", 54, 70], ["tumors [1]", "CELL", 74, 84], ["polysugars", "SIMPLE_CHEMICAL", 115, 125], ["collagens", "GENE_OR_GENE_PRODUCT", 153, 162], ["laminins", "GENE_OR_GENE_PRODUCT", 164, 172], ["fibronectins", "GENE_OR_GENE_PRODUCT", 174, 186], ["proteoglycans", "GENE_OR_GENE_PRODUCT", 188, 201], ["hyaluronan", "GENE_OR_GENE_PRODUCT", 203, 213], ["water", "SIMPLE_CHEMICAL", 218, 223], ["matrix", "CELLULAR_COMPONENT", 241, 247], ["cancer cells", "CELL", 271, 283], ["Tumor-associated fibroblasts", "CELL_TYPE", 0, 28], ["polysugars", "PROTEIN", 115, 125], ["glycoproteins", "PROTEIN", 130, 143], ["collagens", "PROTEIN", 153, 162], ["laminins", "PROTEIN", 164, 172], ["fibronectins", "PROTEIN", 174, 186], ["proteoglycans", "PROTEIN", 188, 201], ["cancer cells", "CELL_TYPE", 271, 283], ["Tumor-associated fibroblasts", "PROBLEM", 0, 28], ["the bulk acellular tissue in tumors", "PROBLEM", 45, 80], ["polysugars and glycoproteins", "PROBLEM", 115, 143], ["collagens, laminins", "TREATMENT", 153, 172], ["fibronectins", "TREATMENT", 174, 186], ["proteoglycans", "TREATMENT", 188, 201], ["hyaluronan", "TREATMENT", 203, 213], ["water", "TREATMENT", 218, 223], ["a dense matrix", "PROBLEM", 233, 247], ["the cancer cells", "PROBLEM", 267, 283], ["fibroblasts", "OBSERVATION", 17, 28], ["bulk", "OBSERVATION_MODIFIER", 49, 53], ["acellular tissue", "OBSERVATION", 54, 70], ["tumors", "OBSERVATION", 74, 80], ["dense", "OBSERVATION_MODIFIER", 235, 240], ["matrix", "OBSERVATION_MODIFIER", 241, 247], ["cancer cells", "OBSERVATION", 271, 283]]], ["This matrix provides structural support but also haptotactic and chemotactic guidance for cancer cells [3] .", [["matrix", "ANATOMY", 5, 11], ["cancer cells", "ANATOMY", 90, 102], ["cancer", "DISEASE", 90, 96], ["matrix", "CELLULAR_COMPONENT", 5, 11], ["cancer cells", "CELL", 90, 102], ["cancer cells", "CELL_TYPE", 90, 102], ["This matrix", "TREATMENT", 0, 11], ["structural support", "TREATMENT", 21, 39], ["haptotactic and chemotactic guidance", "TREATMENT", 49, 85], ["cancer cells", "PROBLEM", 90, 102]]], ["Moreover, the prevailing tumor interstitium is rich in soluble angiogenic factors, such as members of the vascular endothelial growth factor (VEGF) family [4] , cellular growth factors, including endothelial growth factor (EGF), basic fibroblast growth factor (FGF), platelet-derived growth factor (PDGF) and pleiotrophic factors, particularly transforming growth factor (TGF) beta [5] .", [["tumor interstitium", "ANATOMY", 25, 43], ["cellular", "ANATOMY", 161, 169], ["tumor", "DISEASE", 25, 30], ["tumor interstitium", "TISSUE", 25, 43], ["vascular endothelial growth factor (VEGF) family [4", "GENE_OR_GENE_PRODUCT", 106, 157], ["cellular", "CELL", 161, 169], ["endothelial growth factor", "GENE_OR_GENE_PRODUCT", 196, 221], ["EGF", "GENE_OR_GENE_PRODUCT", 223, 226], ["basic fibroblast growth factor", "GENE_OR_GENE_PRODUCT", 229, 259], ["FGF", "GENE_OR_GENE_PRODUCT", 261, 264], ["platelet-derived growth factor", "GENE_OR_GENE_PRODUCT", 267, 297], ["PDGF", "GENE_OR_GENE_PRODUCT", 299, 303], ["pleiotrophic factors", "GENE_OR_GENE_PRODUCT", 309, 329], ["transforming growth factor (TGF) beta", "GENE_OR_GENE_PRODUCT", 344, 381], ["angiogenic factors", "PROTEIN", 63, 81], ["vascular endothelial growth factor (VEGF) family", "PROTEIN", 106, 154], ["cellular growth factors", "PROTEIN", 161, 184], ["endothelial growth factor", "PROTEIN", 196, 221], ["EGF", "PROTEIN", 223, 226], ["basic fibroblast growth factor", "PROTEIN", 229, 259], ["FGF", "PROTEIN", 261, 264], ["platelet-derived growth factor", "PROTEIN", 267, 297], ["PDGF", "PROTEIN", 299, 303], ["pleiotrophic factors", "PROTEIN", 309, 329], ["transforming growth factor (TGF) beta", "PROTEIN", 344, 381], ["the prevailing tumor interstitium", "PROBLEM", 10, 43], ["the vascular endothelial growth factor", "PROBLEM", 102, 140], ["cellular growth factors", "PROBLEM", 161, 184], ["endothelial growth factor", "PROBLEM", 196, 221], ["basic fibroblast growth factor", "PROBLEM", 229, 259], ["FGF", "TEST", 261, 264], ["platelet", "TEST", 267, 275], ["pleiotrophic factors", "PROBLEM", 309, 329], ["tumor interstitium", "OBSERVATION", 25, 43], ["rich", "OBSERVATION_MODIFIER", 47, 51], ["soluble angiogenic factors", "OBSERVATION", 55, 81], ["vascular endothelial", "ANATOMY", 106, 126]]], ["Additionally, both tumor-and stromal cells secrete cytokines and chemokines, such as interleukin (IL) 6, IL 10, tumor necrosis factor (TNF) alpha, stromal cell-derived factor (SDF) 1, macrophage migration inhibitory factor (MIF) 1, which on one hand recruit more stromal and progenitor cells into the tumors and on the other hand curb the activity of antigen-presenting cells and anti-tumor T cells [6] [7] [8] .", [["tumor", "ANATOMY", 19, 24], ["stromal cells", "ANATOMY", 29, 42], ["hand", "ANATOMY", 245, 249], ["stromal", "ANATOMY", 263, 270], ["progenitor cells", "ANATOMY", 275, 291], ["tumors", "ANATOMY", 301, 307], ["hand", "ANATOMY", 325, 329], ["antigen-presenting cells", "ANATOMY", 351, 375], ["anti-tumor T cells", "ANATOMY", 380, 398], ["tumor", "DISEASE", 19, 24], ["necrosis", "DISEASE", 118, 126], ["tumors", "DISEASE", 301, 307], ["tumor", "CANCER", 19, 24], ["stromal cells", "CELL", 29, 42], ["interleukin (IL) 6", "GENE_OR_GENE_PRODUCT", 85, 103], ["IL 10", "GENE_OR_GENE_PRODUCT", 105, 110], ["tumor necrosis factor (TNF) alpha", "GENE_OR_GENE_PRODUCT", 112, 145], ["stromal cell-derived factor (SDF) 1", "GENE_OR_GENE_PRODUCT", 147, 182], ["macrophage migration inhibitory factor (MIF) 1", "GENE_OR_GENE_PRODUCT", 184, 230], ["stromal", "CELL", 263, 270], ["progenitor cells", "CELL", 275, 291], ["tumors", "CANCER", 301, 307], ["cells", "CELL", 370, 375], ["anti-tumor T cells", "CELL", 380, 398], ["tumor-and stromal cells", "CELL_TYPE", 19, 42], ["cytokines", "PROTEIN", 51, 60], ["chemokines", "PROTEIN", 65, 75], ["interleukin (IL) 6", "PROTEIN", 85, 103], ["IL 10", "PROTEIN", 105, 110], ["tumor necrosis factor (TNF) alpha", "PROTEIN", 112, 145], ["stromal cell-derived factor (SDF) 1", "PROTEIN", 147, 182], ["macrophage migration inhibitory factor (MIF) 1", "PROTEIN", 184, 230], ["stromal and progenitor cells", "CELL_TYPE", 263, 291], ["antigen-presenting cells", "CELL_TYPE", 351, 375], ["anti-tumor T cells", "CELL_TYPE", 380, 398], ["both tumor", "PROBLEM", 14, 24], ["stromal cells secrete cytokines", "PROBLEM", 29, 60], ["chemokines", "TEST", 65, 75], ["interleukin (IL)", "TREATMENT", 85, 101], ["IL", "TEST", 105, 107], ["tumor necrosis factor", "PROBLEM", 112, 133], ["stromal cell", "PROBLEM", 147, 159], ["the tumors", "PROBLEM", 297, 307], ["anti-tumor T cells", "TEST", 380, 398], ["both", "OBSERVATION_MODIFIER", 14, 18], ["tumor", "OBSERVATION", 19, 24], ["stromal cells", "OBSERVATION", 29, 42], ["secrete cytokines", "OBSERVATION", 43, 60], ["tumor", "OBSERVATION_MODIFIER", 112, 117], ["necrosis", "OBSERVATION", 118, 126], ["stromal cell", "OBSERVATION", 147, 159], ["progenitor cells", "OBSERVATION", 275, 291], ["tumors", "OBSERVATION", 301, 307]]], ["In several independent cancer types, high serum levels of IL 6 and IL 10 are indicators of poor prognosis [9] .IntroductionAberrant tumor and stromal growth combined with an overproduction of matrix leads to high interstitial pressure in the tumor, preventing lateral diffusion of therapeutic compounds within the tumor.", [["cancer", "ANATOMY", 23, 29], ["serum", "ANATOMY", 42, 47], ["tumor", "ANATOMY", 132, 137], ["stromal", "ANATOMY", 142, 149], ["matrix", "ANATOMY", 192, 198], ["interstitial", "ANATOMY", 213, 225], ["tumor", "ANATOMY", 242, 247], ["tumor", "ANATOMY", 314, 319], ["cancer", "DISEASE", 23, 29], ["tumor", "DISEASE", 132, 137], ["tumor", "DISEASE", 242, 247], ["tumor", "DISEASE", 314, 319], ["cancer", "CANCER", 23, 29], ["serum", "ORGANISM_SUBSTANCE", 42, 47], ["IL 6", "GENE_OR_GENE_PRODUCT", 58, 62], ["IL 10", "GENE_OR_GENE_PRODUCT", 67, 72], ["tumor", "CANCER", 132, 137], ["stromal", "CELL", 142, 149], ["matrix", "CELLULAR_COMPONENT", 192, 198], ["interstitial", "IMMATERIAL_ANATOMICAL_ENTITY", 213, 225], ["tumor", "CANCER", 242, 247], ["tumor", "CANCER", 314, 319], ["IL 6", "PROTEIN", 58, 62], ["IL 10", "PROTEIN", 67, 72], ["several independent cancer types", "PROBLEM", 3, 35], ["high serum levels of IL", "PROBLEM", 37, 60], ["poor prognosis", "PROBLEM", 91, 105], ["Aberrant tumor", "PROBLEM", 123, 137], ["stromal growth", "PROBLEM", 142, 156], ["an overproduction of matrix", "PROBLEM", 171, 198], ["high interstitial pressure in the tumor", "PROBLEM", 208, 247], ["lateral diffusion of therapeutic compounds within the tumor", "PROBLEM", 260, 319], ["several", "OBSERVATION_MODIFIER", 3, 10], ["independent", "OBSERVATION_MODIFIER", 11, 22], ["cancer", "OBSERVATION", 23, 29], ["Aberrant", "OBSERVATION_MODIFIER", 123, 131], ["tumor", "OBSERVATION", 132, 137], ["stromal growth", "OBSERVATION", 142, 156], ["overproduction", "OBSERVATION", 174, 188], ["high", "OBSERVATION_MODIFIER", 208, 212], ["interstitial", "OBSERVATION_MODIFIER", 213, 225], ["pressure", "OBSERVATION_MODIFIER", 226, 234], ["tumor", "OBSERVATION", 242, 247], ["lateral", "OBSERVATION_MODIFIER", 260, 267], ["diffusion", "OBSERVATION_MODIFIER", 268, 277], ["therapeutic compounds", "OBSERVATION", 281, 302], ["tumor", "OBSERVATION", 314, 319]]], ["Tight cellular compactness combined with a high tumor proliferation rate also causes physical crowding and puts constraints on oxygenation, which due to aberrant angiogenesis and rupture of the haphazard vessels is mostly incomplete and results in chronic tissue hypoxia toward the tumor cores.", [["cellular", "ANATOMY", 6, 14], ["tumor", "ANATOMY", 48, 53], ["haphazard vessels", "ANATOMY", 194, 211], ["tissue", "ANATOMY", 256, 262], ["tumor cores", "ANATOMY", 282, 293], ["tumor", "DISEASE", 48, 53], ["rupture", "DISEASE", 179, 186], ["hypoxia", "DISEASE", 263, 270], ["tumor", "DISEASE", 282, 287], ["cellular", "CELL", 6, 14], ["tumor", "CANCER", 48, 53], ["haphazard vessels", "MULTI-TISSUE_STRUCTURE", 194, 211], ["tissue", "TISSUE", 256, 262], ["tumor cores", "CANCER", 282, 293], ["Tight cellular compactness", "PROBLEM", 0, 26], ["a high tumor proliferation rate", "PROBLEM", 41, 72], ["physical crowding", "PROBLEM", 85, 102], ["oxygenation", "TREATMENT", 127, 138], ["aberrant angiogenesis", "PROBLEM", 153, 174], ["rupture of the haphazard vessels", "PROBLEM", 179, 211], ["chronic tissue hypoxia", "PROBLEM", 248, 270], ["the tumor cores", "PROBLEM", 278, 293], ["cellular compactness", "OBSERVATION", 6, 26], ["high", "OBSERVATION_MODIFIER", 43, 47], ["tumor proliferation", "OBSERVATION", 48, 67], ["crowding", "OBSERVATION_MODIFIER", 94, 102], ["aberrant", "OBSERVATION_MODIFIER", 153, 161], ["angiogenesis", "OBSERVATION", 162, 174], ["rupture", "OBSERVATION", 179, 186], ["haphazard", "ANATOMY_MODIFIER", 194, 203], ["vessels", "ANATOMY", 204, 211], ["chronic", "OBSERVATION_MODIFIER", 248, 255], ["tissue", "OBSERVATION_MODIFIER", 256, 262], ["hypoxia", "OBSERVATION", 263, 270], ["tumor", "OBSERVATION", 282, 287]]], ["As cancer cells exist in a crowding/hypoxic-and cytokine/growth factor-perpetuated chronic state of stress, they upregulate a number of key cellular molecules that function as a collective defense against a wide range of therapies, including oncolytic viruses.", [["cancer cells", "ANATOMY", 3, 15], ["cellular", "ANATOMY", 140, 148], ["cancer", "DISEASE", 3, 9], ["cancer cells", "CELL", 3, 15], ["cellular", "CELL", 140, 148], ["oncolytic viruses", "ORGANISM", 242, 259], ["cancer cells", "CELL_TYPE", 3, 15], ["cytokine", "PROTEIN", 48, 56], ["cancer cells", "PROBLEM", 3, 15], ["a crowding/hypoxic", "PROBLEM", 25, 43], ["cytokine/growth factor", "PROBLEM", 48, 70], ["stress", "PROBLEM", 100, 106], ["a wide range of therapies", "TREATMENT", 205, 230], ["oncolytic viruses", "PROBLEM", 242, 259], ["hypoxic", "OBSERVATION_MODIFIER", 36, 43], ["chronic", "OBSERVATION_MODIFIER", 83, 90], ["oncolytic viruses", "OBSERVATION", 242, 259]]], ["The properties of oncolytic viruses and their status in clinical development as well as various delivery options have been reviewed elsewhere [10] [11] [12] [13] .", [["[10] [11] [12] [13]", "SIMPLE_CHEMICAL", 142, 161], ["oncolytic viruses", "TREATMENT", 18, 35], ["various delivery options", "TREATMENT", 88, 112], ["oncolytic viruses", "OBSERVATION", 18, 35]]], ["In this review, we provide an overview of two of the main intratumoral barriers to oncolytic virus spread; the extracellular tumor make-up and the intracellular antiviral defense mechanisms.Physical Barriers to Oncolytic VirusesIn this chapter we introduce the principal physical obstacles for successful oncolytic virotherapy and discuss ways to overcome them.", [["extracellular tumor", "ANATOMY", 111, 130], ["intracellular", "ANATOMY", 147, 160], ["tumor", "DISEASE", 125, 130], ["extracellular tumor", "CANCER", 111, 130], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 147, 160], ["oncolytic virus spread", "PROBLEM", 83, 105], ["the extracellular tumor", "PROBLEM", 107, 130], ["Oncolytic Viruses", "TREATMENT", 211, 228], ["successful oncolytic virotherapy", "TREATMENT", 294, 326], ["tumor", "OBSERVATION", 125, 130], ["antiviral defense", "OBSERVATION", 161, 178]]], ["As viruses lack autonomous motility and may potentially adsorb to any surfaces that display their specific receptors, they may only infect the physically delimited regions where they first entered and they may be prone to unfruitful sequestration by already dead cells.", [["cells", "ANATOMY", 263, 268], ["cells", "CELL", 263, 268], ["dead cells", "CELL_TYPE", 258, 268], ["already dead cells", "PROBLEM", 250, 268], ["dead cells", "OBSERVATION", 258, 268]]], ["Nevertheless, oncolytic viruses vary in size and some are small enough to fit even through tight ECM networks, and efforts have been made through genetic engineering of the viruses to minimize their non-specific binding properties.", [["ECM networks", "ANATOMY", 97, 109], ["ECM networks", "CELLULAR_COMPONENT", 97, 109], ["oncolytic viruses", "PROBLEM", 14, 31], ["the viruses", "PROBLEM", 169, 180], ["their non-specific binding properties", "PROBLEM", 193, 230], ["oncolytic", "OBSERVATION_MODIFIER", 14, 23], ["viruses", "OBSERVATION", 24, 31], ["size", "OBSERVATION_MODIFIER", 40, 44], ["small", "OBSERVATION_MODIFIER", 58, 63]]], ["Most interestingly, viruses may be engineered to express enzymes that directly break down the physical barriers to oncolytic viruses.Interstitial Fluid PressureTumor cellular structure and composition may in concert with abundant extracellular matrix (ECM) deposition pose a severe hurdle for systemic virus entry and propagation of infection within the tumor.", [["Interstitial", "ANATOMY", 133, 145], ["cellular", "ANATOMY", 166, 174], ["extracellular matrix", "ANATOMY", 230, 250], ["ECM", "ANATOMY", 252, 255], ["tumor", "ANATOMY", 354, 359], ["infection", "DISEASE", 333, 342], ["tumor", "DISEASE", 354, 359], ["extracellular matrix", "CELLULAR_COMPONENT", 230, 250], ["ECM", "CELLULAR_COMPONENT", 252, 255], ["tumor", "CANCER", 354, 359], ["enzymes", "PROTEIN", 57, 64], ["enzymes", "TEST", 57, 64], ["oncolytic viruses", "PROBLEM", 115, 132], ["Interstitial Fluid PressureTumor cellular structure", "PROBLEM", 133, 184], ["abundant extracellular matrix (ECM) deposition", "TREATMENT", 221, 267], ["a severe hurdle", "PROBLEM", 273, 288], ["systemic virus entry", "PROBLEM", 293, 313], ["infection within the tumor", "PROBLEM", 333, 359], ["viruses", "OBSERVATION", 20, 27], ["Fluid", "OBSERVATION", 146, 151], ["PressureTumor cellular structure", "OBSERVATION", 152, 184], ["abundant", "OBSERVATION_MODIFIER", 221, 229], ["extracellular", "OBSERVATION_MODIFIER", 230, 243], ["matrix", "OBSERVATION_MODIFIER", 244, 250], ["severe", "OBSERVATION_MODIFIER", 275, 281], ["infection", "OBSERVATION", 333, 342], ["tumor", "OBSERVATION", 354, 359]]], ["The extracellular matrix is a complex dense network consisting of multiple proteins, glycoproteins and polysaccharides including collagens, laminins, fibronectins, proteoglycans and hyaluronic acid [14] .", [["extracellular matrix", "ANATOMY", 4, 24], ["hyaluronic acid", "CHEMICAL", 182, 197], ["extracellular matrix", "CELLULAR_COMPONENT", 4, 24], ["collagens", "GENE_OR_GENE_PRODUCT", 129, 138], ["laminins", "GENE_OR_GENE_PRODUCT", 140, 148], ["fibronectins", "GENE_OR_GENE_PRODUCT", 150, 162], ["proteoglycans", "GENE_OR_GENE_PRODUCT", 164, 177], ["hyaluronic acid", "SIMPLE_CHEMICAL", 182, 197], ["multiple proteins", "PROTEIN", 66, 83], ["glycoproteins", "PROTEIN", 85, 98], ["collagens", "PROTEIN", 129, 138], ["laminins", "PROTEIN", 140, 148], ["fibronectins", "PROTEIN", 150, 162], ["proteoglycans", "PROTEIN", 164, 177], ["a complex dense network", "PROBLEM", 28, 51], ["multiple proteins", "PROBLEM", 66, 83], ["glycoproteins", "TREATMENT", 85, 98], ["polysaccharides", "TREATMENT", 103, 118], ["collagens, laminins", "TREATMENT", 129, 148], ["fibronectins", "TREATMENT", 150, 162], ["proteoglycans", "TREATMENT", 164, 177], ["hyaluronic acid", "TREATMENT", 182, 197], ["extracellular matrix", "OBSERVATION", 4, 24], ["complex", "OBSERVATION_MODIFIER", 30, 37], ["dense", "OBSERVATION", 38, 43], ["multiple", "OBSERVATION_MODIFIER", 66, 74], ["proteins", "OBSERVATION", 75, 83]]], ["The interstitial fluid pressure (IFP) in the tumor surrounding blood and lymphatic vessels is mainly created by the high cell density that forms an increased physical pressure outwards and does not allow free diffusion of therapeutics [15] [16] [17] .", [["interstitial fluid", "ANATOMY", 4, 22], ["tumor", "ANATOMY", 45, 50], ["blood", "ANATOMY", 63, 68], ["lymphatic vessels", "ANATOMY", 73, 90], ["cell", "ANATOMY", 121, 125], ["tumor", "DISEASE", 45, 50], ["interstitial fluid", "TISSUE", 4, 22], ["tumor", "CANCER", 45, 50], ["blood", "ORGANISM_SUBSTANCE", 63, 68], ["lymphatic vessels", "MULTI-TISSUE_STRUCTURE", 73, 90], ["cell", "CELL", 121, 125], ["[15] [16] [17]", "SIMPLE_CHEMICAL", 235, 249], ["The interstitial fluid pressure", "TEST", 0, 31], ["the high cell density", "PROBLEM", 112, 133], ["an increased physical pressure outwards", "PROBLEM", 145, 184], ["interstitial", "ANATOMY_MODIFIER", 4, 16], ["fluid pressure", "OBSERVATION", 17, 31], ["tumor", "OBSERVATION", 45, 50], ["blood", "OBSERVATION_MODIFIER", 63, 68], ["lymphatic vessels", "ANATOMY", 73, 90], ["high cell density", "OBSERVATION", 116, 133], ["increased", "OBSERVATION_MODIFIER", 148, 157], ["physical", "OBSERVATION_MODIFIER", 158, 166], ["pressure", "OBSERVATION_MODIFIER", 167, 175]]], ["A high IFP generally predicts an aggressive tumor phenotype as tumor cells tend to escape from tumor margins where the pressure drops, thus facilitating spread of metastatic cells [18] .", [["tumor", "ANATOMY", 44, 49], ["tumor cells", "ANATOMY", 63, 74], ["tumor margins", "ANATOMY", 95, 108], ["metastatic cells", "ANATOMY", 163, 179], ["tumor", "DISEASE", 44, 49], ["tumor", "DISEASE", 63, 68], ["tumor", "DISEASE", 95, 100], ["IFP", "CANCER", 7, 10], ["tumor", "CANCER", 44, 49], ["tumor cells", "CELL", 63, 74], ["tumor", "CANCER", 95, 100], ["cells", "CELL", 174, 179], ["tumor cells", "CELL_TYPE", 63, 74], ["metastatic cells", "CELL_TYPE", 163, 179], ["A high IFP", "PROBLEM", 0, 10], ["an aggressive tumor phenotype", "PROBLEM", 30, 59], ["tumor cells", "PROBLEM", 63, 74], ["tumor margins", "PROBLEM", 95, 108], ["the pressure drops", "TREATMENT", 115, 133], ["metastatic cells", "PROBLEM", 163, 179], ["aggressive", "OBSERVATION_MODIFIER", 33, 43], ["tumor", "OBSERVATION", 44, 49], ["tumor", "OBSERVATION", 95, 100], ["margins", "OBSERVATION_MODIFIER", 101, 108], ["pressure", "OBSERVATION_MODIFIER", 119, 127], ["drops", "OBSERVATION_MODIFIER", 128, 133], ["spread", "OBSERVATION_MODIFIER", 153, 159], ["metastatic cells", "OBSERVATION", 163, 179]]], ["On the other hand, for therapeutic virus, interstitial fluid concentration gradients may pose a hurdle as passive diffusion in viable regions, typically the rim, may occur mainly outward [19] .", [["interstitial fluid", "ANATOMY", 42, 60], ["interstitial", "IMMATERIAL_ANATOMICAL_ENTITY", 42, 54], ["fluid", "ORGANISM_SUBSTANCE", 55, 60], ["therapeutic virus", "PROBLEM", 23, 40], ["interstitial fluid concentration gradients", "PROBLEM", 42, 84], ["passive diffusion in viable regions", "PROBLEM", 106, 141], ["interstitial", "ANATOMY_MODIFIER", 42, 54], ["fluid concentration", "OBSERVATION", 55, 74], ["rim", "OBSERVATION_MODIFIER", 157, 160]]], ["Given the limited arsenal of known chemicals alleviating tumor compactness and the poor penetration drugs in general into the tumor tissue, this is a considerable problem that may not be easy to tackle.", [["tumor", "ANATOMY", 57, 62], ["tumor tissue", "ANATOMY", 126, 138], ["tumor", "DISEASE", 57, 62], ["tumor", "DISEASE", 126, 131], ["tumor", "CANCER", 57, 62], ["tumor tissue", "TISSUE", 126, 138], ["tumor compactness", "PROBLEM", 57, 74], ["the poor penetration drugs", "TREATMENT", 79, 105], ["the tumor tissue", "PROBLEM", 122, 138], ["tumor", "OBSERVATION", 57, 62], ["poor", "OBSERVATION_MODIFIER", 83, 87], ["penetration", "OBSERVATION_MODIFIER", 88, 99], ["tumor tissue", "OBSERVATION", 126, 138], ["may not be", "UNCERTAINTY", 176, 186]]], ["Some strategies are discussed below.Extracellular Matrix DepositsViruses are passive particles and rely either on radial cell-to-cell spread or on soluble diffusion across concentration gradients to reach their target cells and to propagate the infection.", [["cell", "ANATOMY", 121, 125], ["cell", "ANATOMY", 129, 133], ["cells", "ANATOMY", 218, 223], ["infection", "DISEASE", 245, 254], ["Extracellular Matrix DepositsViruses", "GENE_OR_GENE_PRODUCT", 36, 72], ["cell", "CELL", 121, 125], ["cell", "CELL", 129, 133], ["cells", "CELL", 218, 223], ["target cells", "CELL_TYPE", 211, 223], ["Extracellular Matrix DepositsViruses", "PROBLEM", 36, 72], ["passive particles", "PROBLEM", 77, 94], ["radial cell", "TEST", 114, 125], ["cell spread", "PROBLEM", 129, 140], ["soluble diffusion", "PROBLEM", 147, 164], ["the infection", "PROBLEM", 241, 254], ["Matrix", "OBSERVATION_MODIFIER", 50, 56], ["DepositsViruses", "OBSERVATION", 57, 72], ["passive", "OBSERVATION_MODIFIER", 77, 84], ["particles", "OBSERVATION_MODIFIER", 85, 94], ["radial", "ANATOMY_MODIFIER", 114, 120], ["cell", "ANATOMY", 121, 125], ["cell spread", "OBSERVATION", 129, 140], ["target cells", "OBSERVATION", 211, 223], ["infection", "OBSERVATION", 245, 254]]], ["Tumor matrix is critical in this regard, as it can block both forms of spread.", [["Tumor matrix", "ANATOMY", 0, 12], ["Tumor", "CANCER", 0, 5], ["Tumor matrix", "PROBLEM", 0, 12], ["spread", "OBSERVATION", 71, 77]]], ["Passively diffusing viruses may physically not fit through the strands of the ECM.", [["ECM", "ANATOMY", 78, 81], ["ECM", "CELLULAR_COMPONENT", 78, 81], ["ECM", "PROTEIN", 78, 81], ["Passively diffusing viruses", "PROBLEM", 0, 27], ["viruses", "OBSERVATION", 20, 27]]], ["This was shown for oncolytic herpes virus, which has an outer diameter of over 100 nm, and whose spreading could be improved by matrix-degrading bacterial collagenase co-injection [20] .", [["herpes virus", "DISEASE", 29, 41], ["oncolytic", "ORGANISM", 19, 28], ["herpes virus", "ORGANISM", 29, 41], ["matrix", "CELLULAR_COMPONENT", 128, 134], ["collagenase", "GENE_OR_GENE_PRODUCT", 155, 166], ["collagenase", "PROTEIN", 155, 166], ["oncolytic herpes virus", "SPECIES", 19, 41], ["oncolytic herpes virus", "SPECIES", 19, 41], ["oncolytic herpes virus", "PROBLEM", 19, 41], ["bacterial collagenase co-injection", "TREATMENT", 145, 179], ["outer", "OBSERVATION_MODIFIER", 56, 61], ["diameter", "OBSERVATION_MODIFIER", 62, 70], ["100 nm", "OBSERVATION_MODIFIER", 79, 85]]], ["Bilbao and coworkers showed that adenovirus entry into experimental hepatocellular carcinoma nodules in the livers of immunocompetent rats following intravenous or intraportal injection was directly related to the thickness of the ECM capsule enveloping the nodules [21] .", [["hepatocellular carcinoma nodules", "ANATOMY", 68, 100], ["livers", "ANATOMY", 108, 114], ["intravenous", "ANATOMY", 149, 160], ["ECM capsule", "ANATOMY", 231, 242], ["nodules", "ANATOMY", 258, 265], ["hepatocellular carcinoma", "DISEASE", 68, 92], ["adenovirus", "ORGANISM", 33, 43], ["hepatocellular carcinoma nodules", "CANCER", 68, 100], ["livers", "ORGAN", 108, 114], ["rats", "ORGANISM", 134, 138], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 149, 160], ["ECM capsule", "CELLULAR_COMPONENT", 231, 242], ["rats", "SPECIES", 134, 138], ["adenovirus", "SPECIES", 33, 43], ["adenovirus entry into experimental hepatocellular carcinoma nodules", "PROBLEM", 33, 100], ["intravenous or intraportal injection", "TREATMENT", 149, 185], ["the nodules", "PROBLEM", 254, 265], ["hepatocellular", "ANATOMY", 68, 82], ["carcinoma", "OBSERVATION", 83, 92], ["livers", "ANATOMY", 108, 114], ["immunocompetent", "OBSERVATION", 118, 133], ["capsule", "OBSERVATION_MODIFIER", 235, 242], ["nodules", "OBSERVATION", 258, 265]]], ["On the other hand, we found using Semliki Forest virus, which has an outer diameter of about 60 nm, that even upon intratumoral injection spread was blocked by ECM, which formed a physical barrier for virus infection ( Figure 1 ).Extracellular Matrix DepositsThe foremost option to reduce interstitial fluid pressure and to remove physical molecule barriers imposed by the ECM is to use matrix-degrading enzymes.", [["intratumoral", "ANATOMY", 115, 127], ["ECM", "ANATOMY", 160, 163], ["interstitial fluid", "ANATOMY", 289, 307], ["ECM", "ANATOMY", 373, 376], ["infection", "DISEASE", 207, 216], ["Semliki Forest virus", "ORGANISM", 34, 54], ["ECM", "CELLULAR_COMPONENT", 160, 163], ["interstitial", "IMMATERIAL_ANATOMICAL_ENTITY", 289, 301], ["fluid", "ORGANISM_SUBSTANCE", 302, 307], ["ECM", "CELLULAR_COMPONENT", 373, 376], ["matrix-degrading enzymes", "GENE_OR_GENE_PRODUCT", 387, 411], ["ECM", "PROTEIN", 160, 163], ["matrix-degrading enzymes", "PROTEIN", 387, 411], ["Semliki Forest virus", "SPECIES", 34, 54], ["Semliki Forest virus", "TREATMENT", 34, 54], ["a physical barrier", "TREATMENT", 178, 196], ["virus infection", "PROBLEM", 201, 216], ["Extracellular Matrix Deposits", "PROBLEM", 230, 259], ["The foremost option", "TREATMENT", 259, 278], ["interstitial fluid pressure", "TEST", 289, 316], ["physical molecule barriers", "TREATMENT", 331, 357], ["Semliki", "OBSERVATION", 34, 41], ["Forest virus", "OBSERVATION", 42, 54], ["outer", "OBSERVATION_MODIFIER", 69, 74], ["diameter", "OBSERVATION_MODIFIER", 75, 83], ["60 nm", "OBSERVATION_MODIFIER", 93, 98], ["Matrix Deposits", "OBSERVATION", 244, 259], ["interstitial", "ANATOMY_MODIFIER", 289, 301], ["fluid pressure", "OBSERVATION", 302, 316]]], ["These act by digesting collagen-, fibrinand other types of fibrillar matrix deposits, creating more space between cell clusters, and glycosaminoglycan polymers, known to limit fluid movement in tumors.", [["fibrillar matrix", "ANATOMY", 59, 75], ["cell clusters", "ANATOMY", 114, 127], ["fluid", "ANATOMY", 176, 181], ["tumors", "ANATOMY", 194, 200], ["glycosaminoglycan polymers", "CHEMICAL", 133, 159], ["tumors", "DISEASE", 194, 200], ["collagen", "GENE_OR_GENE_PRODUCT", 23, 31], ["fibrillar matrix", "CELLULAR_COMPONENT", 59, 75], ["cell", "CELL", 114, 118], ["glycosaminoglycan polymers", "SIMPLE_CHEMICAL", 133, 159], ["tumors", "CANCER", 194, 200], ["collagen", "PROTEIN", 23, 31], ["fibrillar matrix deposits", "PROBLEM", 59, 84], ["glycosaminoglycan polymers", "TREATMENT", 133, 159], ["fluid movement in tumors", "PROBLEM", 176, 200], ["fibrillar matrix deposits", "OBSERVATION", 59, 84], ["more space", "OBSERVATION_MODIFIER", 95, 105], ["cell clusters", "OBSERVATION", 114, 127], ["glycosaminoglycan polymers", "OBSERVATION", 133, 159], ["fluid movement", "OBSERVATION", 176, 190], ["tumors", "OBSERVATION", 194, 200]]], ["Simultaneously, such strategies may also expose more cell surface to viruses, increasing the likelihood of infection.", [["cell surface", "ANATOMY", 53, 65], ["infection", "DISEASE", 107, 116], ["cell surface", "CELLULAR_COMPONENT", 53, 65], ["viruses", "PROBLEM", 69, 76], ["infection", "PROBLEM", 107, 116], ["viruses", "OBSERVATION", 69, 76], ["infection", "OBSERVATION", 107, 116]]], ["In a study by Kuriyama, trypsin or collagenase/dispase was injected into subcutaneous U87 and U251 glioma xenografts in immunocompromised mice, followed by a reporter adenovirus [22] .", [["subcutaneous U87", "ANATOMY", 73, 89], ["U251 glioma xenografts", "ANATOMY", 94, 116], ["trypsin", "GENE_OR_GENE_PRODUCT", 24, 31], ["collagenase", "GENE_OR_GENE_PRODUCT", 35, 46], ["dispase", "GENE_OR_GENE_PRODUCT", 47, 54], ["U87", "CELL", 86, 89], ["U251 glioma xenografts", "CANCER", 94, 116], ["mice", "ORGANISM", 138, 142], ["adenovirus", "ORGANISM", 167, 177], ["trypsin", "PROTEIN", 24, 31], ["collagenase", "PROTEIN", 35, 46], ["subcutaneous U87", "CELL_LINE", 73, 89], ["mice", "SPECIES", 138, 142], ["mice", "SPECIES", 138, 142], ["a study", "TEST", 3, 10], ["trypsin", "TREATMENT", 24, 31], ["collagenase/dispase", "TREATMENT", 35, 54], ["subcutaneous U87 and U251 glioma xenografts", "TREATMENT", 73, 116], ["a reporter adenovirus", "TREATMENT", 156, 177], ["U251 glioma xenografts", "OBSERVATION", 94, 116]]], ["Both types of ECM-degrading enzymes increased tumor transduction by the virus, but when doses got too high, transduction efficacy suffered, demonstrating a balance between ECM-degradation and oncolytic virus efficacy.", [["ECM", "ANATOMY", 14, 17], ["tumor", "ANATOMY", 46, 51], ["ECM", "ANATOMY", 172, 175], ["tumor", "DISEASE", 46, 51], ["ECM", "CELLULAR_COMPONENT", 14, 17], ["tumor", "CANCER", 46, 51], ["ECM", "CELLULAR_COMPONENT", 172, 175], ["ECM", "PROTEIN", 14, 17], ["degrading enzymes", "PROTEIN", 18, 35], ["ECM", "PROTEIN", 172, 175], ["degrading enzymes increased tumor transduction", "PROBLEM", 18, 64], ["the virus", "PROBLEM", 68, 77], ["a balance between ECM-degradation", "PROBLEM", 154, 187], ["oncolytic virus efficacy", "TREATMENT", 192, 216], ["increased", "OBSERVATION_MODIFIER", 36, 45], ["tumor", "OBSERVATION", 46, 51]]], ["In another study, treatment of PC3 tumors with vaccinia virus producing matrix metalloprotease (MMP) 9 resulted in reduction of collagen IV fibrils and increase in virus penetration into tumor, which yielded elevated virus titers [23] .", [["PC3 tumors", "ANATOMY", 31, 41], ["tumor", "ANATOMY", 187, 192], ["tumors", "DISEASE", 35, 41], ["tumor", "DISEASE", 187, 192], ["PC3 tumors", "CANCER", 31, 41], ["vaccinia virus", "ORGANISM", 47, 61], ["matrix metalloprotease (MMP) 9", "GENE_OR_GENE_PRODUCT", 72, 102], ["collagen IV fibrils", "GENE_OR_GENE_PRODUCT", 128, 147], ["tumor", "CANCER", 187, 192], ["matrix metalloprotease (MMP) 9", "PROTEIN", 72, 102], ["collagen IV fibrils", "PROTEIN", 128, 147], ["vaccinia virus", "SPECIES", 47, 61], ["another study", "TEST", 3, 16], ["PC3 tumors", "PROBLEM", 31, 41], ["vaccinia virus producing matrix metalloprotease (MMP)", "TREATMENT", 47, 100], ["collagen IV fibrils", "TREATMENT", 128, 147], ["increase in virus penetration into tumor", "PROBLEM", 152, 192], ["elevated virus titers", "PROBLEM", 208, 229], ["PC3", "ANATOMY", 31, 34], ["tumors", "OBSERVATION", 35, 41], ["collagen", "OBSERVATION", 128, 136], ["IV fibrils", "OBSERVATION_MODIFIER", 137, 147], ["increase", "OBSERVATION_MODIFIER", 152, 160], ["virus penetration", "OBSERVATION", 164, 181], ["tumor", "OBSERVATION", 187, 192]]], ["Hong et al. targeted orthotopic neuroblastoma xenografts engineered to express MMP9 with oncolytic HSV, achieving increased virus distribution compared to control tumors [24] .", [["orthotopic neuroblastoma xenografts", "ANATOMY", 21, 56], ["tumors", "ANATOMY", 163, 169], ["orthotopic neuroblastoma", "DISEASE", 21, 45], ["tumors", "DISEASE", 163, 169], ["neuroblastoma xenografts", "CANCER", 32, 56], ["MMP9", "GENE_OR_GENE_PRODUCT", 79, 83], ["HSV", "ORGANISM", 99, 102], ["tumors", "CANCER", 163, 169], ["orthotopic neuroblastoma xenografts", "CELL_LINE", 21, 56], ["MMP9", "PROTEIN", 79, 83], ["HSV", "SPECIES", 99, 102], ["targeted orthotopic neuroblastoma xenografts", "TREATMENT", 12, 56], ["MMP9", "PROBLEM", 79, 83], ["oncolytic HSV", "PROBLEM", 89, 102], ["increased virus distribution", "PROBLEM", 114, 142], ["orthotopic", "OBSERVATION", 21, 31], ["neuroblastoma xenografts", "OBSERVATION", 32, 56], ["increased", "OBSERVATION_MODIFIER", 114, 123], ["virus", "OBSERVATION", 124, 129]]], ["Similar results were obtained when human soft tissue sarcoma HSTS26T overexpressing MMP1 or MMP8 were injected with oncolytic HSV [19] .", [["soft tissue sarcoma HSTS26T", "ANATOMY", 41, 68], ["sarcoma", "DISEASE", 53, 60], ["human", "ORGANISM", 35, 40], ["soft tissue sarcoma", "CANCER", 41, 60], ["MMP1", "GENE_OR_GENE_PRODUCT", 84, 88], ["MMP8", "GENE_OR_GENE_PRODUCT", 92, 96], ["HSV", "ORGANISM", 126, 129], ["MMP1", "PROTEIN", 84, 88], ["MMP8", "PROTEIN", 92, 96], ["human", "SPECIES", 35, 40], ["human", "SPECIES", 35, 40], ["HSV", "SPECIES", 126, 129], ["human soft tissue sarcoma", "PROBLEM", 35, 60], ["overexpressing MMP1", "PROBLEM", 69, 88], ["MMP8", "TEST", 92, 96], ["oncolytic HSV", "TREATMENT", 116, 129], ["soft tissue", "OBSERVATION_MODIFIER", 41, 52], ["sarcoma", "OBSERVATION", 53, 60]]], ["MMP1/8-expressing tumors contained significantly less sulfated glycosaminoglycans compared to control tumors. antibodies (in brown) shows that even following intratumoral injection, virus infection is delimited by non-permissive stromal cells and the extracellular matrix (collectively called stroma).", [["tumors", "ANATOMY", 18, 24], ["tumors", "ANATOMY", 102, 108], ["stromal cells", "ANATOMY", 229, 242], ["extracellular matrix", "ANATOMY", 251, 271], ["stroma", "ANATOMY", 293, 299], ["tumors", "DISEASE", 18, 24], ["tumors", "DISEASE", 102, 108], ["infection", "DISEASE", 188, 197], ["MMP1", "GENE_OR_GENE_PRODUCT", 0, 4], ["8", "GENE_OR_GENE_PRODUCT", 5, 6], ["tumors", "CANCER", 18, 24], ["glycosaminoglycans", "SIMPLE_CHEMICAL", 63, 81], ["tumors", "CANCER", 102, 108], ["intratumoral", "IMMATERIAL_ANATOMICAL_ENTITY", 158, 170], ["stromal cells", "CELL", 229, 242], ["extracellular matrix", "CELLULAR_COMPONENT", 251, 271], ["stroma", "TISSUE", 293, 299], ["MMP1/8", "PROTEIN", 0, 6], ["antibodies", "PROTEIN", 110, 120], ["non-permissive stromal cells", "CELL_TYPE", 214, 242], ["MMP1", "TEST", 0, 4], ["expressing tumors", "PROBLEM", 7, 24], ["significantly less sulfated glycosaminoglycans", "PROBLEM", 35, 81], ["antibodies", "TEST", 110, 120], ["intratumoral injection", "PROBLEM", 158, 180], ["virus infection", "PROBLEM", 182, 197], ["non-permissive stromal cells", "PROBLEM", 214, 242], ["tumors", "OBSERVATION", 18, 24], ["tumors", "OBSERVATION", 102, 108], ["non-permissive stromal cells", "OBSERVATION", 214, 242]]], ["We have studied these barriers in detail previously [25] .Extracellular Matrix DepositsOther enzymes and protein effectors, either engineered into virus expression cassettes or provided exogenously, include hyaluronidase, decorin, various other MMPs, and notably relaxin-a peptide hormone normally expressed during particular phase of pregnancy that does not possess tissue-degrading activity itself, but instead induces a number of key collagen-degrading proteases seemingly in a tumor-specific manner [26] .", [["tissue", "ANATOMY", 367, 373], ["tumor", "ANATOMY", 481, 486], ["tumor", "DISEASE", 481, 486], ["Extracellular Matrix DepositsOther enzymes", "GENE_OR_GENE_PRODUCT", 58, 100], ["hyaluronidase", "GENE_OR_GENE_PRODUCT", 207, 220], ["decorin", "GENE_OR_GENE_PRODUCT", 222, 229], ["MMPs", "GENE_OR_GENE_PRODUCT", 245, 249], ["relaxin", "GENE_OR_GENE_PRODUCT", 263, 270], ["tissue", "TISSUE", 367, 373], ["collagen", "GENE_OR_GENE_PRODUCT", 437, 445], ["tumor", "CANCER", 481, 486], ["Extracellular Matrix DepositsOther enzymes", "PROTEIN", 58, 100], ["protein effectors", "PROTEIN", 105, 122], ["virus expression cassettes", "DNA", 147, 173], ["hyaluronidase", "PROTEIN", 207, 220], ["decorin", "PROTEIN", 222, 229], ["MMPs", "PROTEIN", 245, 249], ["relaxin", "PROTEIN", 263, 270], ["collagen", "PROTEIN", 437, 445], ["proteases", "PROTEIN", 456, 465], ["Extracellular Matrix DepositsOther enzymes", "TEST", 58, 100], ["protein effectors", "PROBLEM", 105, 122], ["virus expression cassettes", "TREATMENT", 147, 173], ["hyaluronidase", "TREATMENT", 207, 220], ["decorin", "TREATMENT", 222, 229], ["relaxin", "TREATMENT", 263, 270], ["a peptide hormone", "PROBLEM", 271, 288], ["protein effectors", "OBSERVATION", 105, 122]]], ["Beyer showed that relaxin expressed by murine stem cells improved trastuzumab penetrance and therapy outcome in syngeneic tumor models [27] .", [["stem cells", "ANATOMY", 46, 56], ["tumor", "ANATOMY", 122, 127], ["trastuzumab", "CHEMICAL", 66, 77], ["tumor", "DISEASE", 122, 127], ["relaxin", "GENE_OR_GENE_PRODUCT", 18, 25], ["murine", "ORGANISM", 39, 45], ["stem cells", "CELL", 46, 56], ["trastuzumab", "SIMPLE_CHEMICAL", 66, 77], ["syngeneic tumor", "CANCER", 112, 127], ["relaxin", "PROTEIN", 18, 25], ["murine stem cells", "CELL_TYPE", 39, 56], ["murine", "SPECIES", 39, 45], ["relaxin", "TREATMENT", 18, 25], ["trastuzumab penetrance", "TREATMENT", 66, 88], ["therapy outcome in syngeneic tumor models", "TREATMENT", 93, 134]]], ["In another study, chimeric adenovirus Ad5/35 expressing relaxin showed increased tumor transduction and virus dissemination [28] .Extracellular Matrix DepositsSeveral other strategies to increase penetration of therapeutics in tumors have been developed [29] .", [["tumor", "ANATOMY", 81, 86], ["tumors", "ANATOMY", 227, 233], ["tumor", "DISEASE", 81, 86], ["tumors", "DISEASE", 227, 233], ["adenovirus", "ORGANISM", 27, 37], ["Ad5/35", "ORGANISM", 38, 44], ["relaxin", "GENE_OR_GENE_PRODUCT", 56, 63], ["tumor", "CANCER", 81, 86], ["tumors", "CANCER", 227, 233], ["adenovirus Ad5/35", "SPECIES", 27, 44], ["another study", "TEST", 3, 16], ["chimeric adenovirus Ad5", "TREATMENT", 18, 41], ["increased tumor transduction", "PROBLEM", 71, 99], ["virus dissemination", "PROBLEM", 104, 123], ["Extracellular Matrix DepositsSeveral other strategies", "TREATMENT", 130, 183], ["increase penetration of therapeutics in tumors", "PROBLEM", 187, 233], ["increased", "OBSERVATION_MODIFIER", 71, 80], ["tumor", "OBSERVATION", 81, 86], ["Matrix", "OBSERVATION_MODIFIER", 144, 150], ["increase", "OBSERVATION_MODIFIER", 187, 195], ["penetration", "OBSERVATION_MODIFIER", 196, 207], ["tumors", "OBSERVATION", 227, 233]]], ["While the stromal/ECM capsule of tumor nodules acts as a physical barrier to virus entry following intravenous injection, it was possible to improve tumor infection by administering vaso-active compounds (angiotensin II, histamine, nitroglycerine) before the virus [21] .", [["stromal", "ANATOMY", 10, 17], ["ECM capsule", "ANATOMY", 18, 29], ["tumor nodules", "ANATOMY", 33, 46], ["intravenous", "ANATOMY", 99, 110], ["tumor", "ANATOMY", 149, 154], ["tumor", "DISEASE", 33, 38], ["tumor", "DISEASE", 149, 154], ["infection", "DISEASE", 155, 164], ["angiotensin II", "CHEMICAL", 205, 219], ["histamine", "CHEMICAL", 221, 230], ["nitroglycerine", "CHEMICAL", 232, 246], ["histamine", "CHEMICAL", 221, 230], ["nitroglycerine", "CHEMICAL", 232, 246], ["stromal", "CELL", 10, 17], ["ECM capsule", "CELLULAR_COMPONENT", 18, 29], ["tumor nodules", "CANCER", 33, 46], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 99, 110], ["tumor", "CANCER", 149, 154], ["angiotensin II", "GENE_OR_GENE_PRODUCT", 205, 219], ["histamine", "SIMPLE_CHEMICAL", 221, 230], ["nitroglycerine", "SIMPLE_CHEMICAL", 232, 246], ["the stromal/ECM capsule", "TREATMENT", 6, 29], ["tumor nodules", "PROBLEM", 33, 46], ["intravenous injection", "TREATMENT", 99, 120], ["tumor infection", "PROBLEM", 149, 164], ["vaso-active compounds (angiotensin II", "TREATMENT", 182, 219], ["histamine", "TREATMENT", 221, 230], ["nitroglycerine", "TREATMENT", 232, 246], ["the virus", "PROBLEM", 255, 264], ["stromal", "ANATOMY", 10, 17], ["tumor", "OBSERVATION_MODIFIER", 33, 38], ["nodules", "OBSERVATION", 39, 46], ["tumor", "OBSERVATION", 149, 154]]], ["This is interesting, as vasculature per se would not be expected to alter or influence the physical composition of the ECM, such as collagen strand thickness.", [["vasculature", "ANATOMY", 24, 35], ["ECM", "ANATOMY", 119, 122], ["vasculature", "MULTI-TISSUE_STRUCTURE", 24, 35], ["ECM", "CELLULAR_COMPONENT", 119, 122], ["collagen", "GENE_OR_GENE_PRODUCT", 132, 140], ["collagen", "PROTEIN", 132, 140], ["vasculature", "ANATOMY", 24, 35]]], ["Instead, virus access to the tumor was improved, most likely by increased access from the blood via tumor-stromal-adjoining vessels.", [["tumor", "ANATOMY", 29, 34], ["blood", "ANATOMY", 90, 95], ["tumor", "ANATOMY", 100, 105], ["stromal", "ANATOMY", 106, 113], ["vessels", "ANATOMY", 124, 131], ["tumor", "DISEASE", 29, 34], ["tumor", "DISEASE", 100, 105], ["tumor", "CANCER", 29, 34], ["blood", "ORGANISM_SUBSTANCE", 90, 95], ["tumor-stromal-adjoining vessels", "TISSUE", 100, 131], ["virus access", "TREATMENT", 9, 21], ["the tumor", "PROBLEM", 25, 34], ["the blood via tumor", "PROBLEM", 86, 105], ["tumor", "OBSERVATION", 29, 34], ["improved", "OBSERVATION_MODIFIER", 39, 47], ["most likely", "UNCERTAINTY", 49, 60], ["increased", "OBSERVATION_MODIFIER", 64, 73], ["access", "OBSERVATION", 74, 80], ["tumor", "OBSERVATION", 100, 105], ["stromal", "OBSERVATION", 106, 113], ["adjoining", "ANATOMY_MODIFIER", 114, 123], ["vessels", "ANATOMY", 124, 131]]], ["Interestingly, in a study with oncolytic herpes virus, anti-VEGF monoclonal antibody Bevacizumab given before intravenous virus injection gave poorer anti-tumor efficacy than when given after the virus [30] .", [["intravenous", "ANATOMY", 110, 121], ["oncolytic herpes virus", "DISEASE", 31, 53], ["Bevacizumab", "CHEMICAL", 85, 96], ["oncolytic", "ORGANISM", 31, 40], ["herpes virus", "ORGANISM", 41, 53], ["anti-VEGF", "GENE_OR_GENE_PRODUCT", 55, 64], ["Bevacizumab", "SIMPLE_CHEMICAL", 85, 96], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 110, 121], ["anti-tumor", "CANCER", 150, 160], ["anti-VEGF monoclonal antibody", "PROTEIN", 55, 84], ["oncolytic herpes virus", "SPECIES", 31, 53], ["oncolytic herpes virus", "SPECIES", 31, 53], ["a study", "TEST", 18, 25], ["oncolytic herpes virus", "TREATMENT", 31, 53], ["anti-VEGF monoclonal antibody Bevacizumab", "TREATMENT", 55, 96], ["intravenous virus injection", "TREATMENT", 110, 137], ["poorer anti-tumor efficacy", "TREATMENT", 143, 169], ["the virus", "PROBLEM", 192, 201]]], ["The study showed that stroma tumor while HSV is able to enter and infect tumors better through their leaky vasculature compared to Bevacizumab-normalized vasculature, vascular normalization by Bevacizumab still gave superior combination efficacy when the virus was already in the tumor.", [["stroma tumor", "ANATOMY", 22, 34], ["tumors", "ANATOMY", 73, 79], ["vasculature", "ANATOMY", 107, 118], ["vasculature", "ANATOMY", 154, 165], ["vascular", "ANATOMY", 167, 175], ["tumor", "ANATOMY", 280, 285], ["tumor", "DISEASE", 29, 34], ["tumors", "DISEASE", 73, 79], ["Bevacizumab", "CHEMICAL", 131, 142], ["Bevacizumab", "CHEMICAL", 193, 204], ["tumor", "DISEASE", 280, 285], ["Bevacizumab", "CHEMICAL", 131, 142], ["Bevacizumab", "CHEMICAL", 193, 204], ["stroma tumor", "CANCER", 22, 34], ["HSV", "ORGANISM", 41, 44], ["tumors", "CANCER", 73, 79], ["leaky vasculature", "MULTI-TISSUE_STRUCTURE", 101, 118], ["Bevacizumab", "SIMPLE_CHEMICAL", 131, 142], ["vasculature", "MULTI-TISSUE_STRUCTURE", 154, 165], ["vascular", "MULTI-TISSUE_STRUCTURE", 167, 175], ["Bevacizumab", "SIMPLE_CHEMICAL", 193, 204], ["tumor", "CANCER", 280, 285], ["HSV", "SPECIES", 41, 44], ["The study", "TEST", 0, 9], ["stroma tumor", "PROBLEM", 22, 34], ["HSV", "PROBLEM", 41, 44], ["infect tumors", "PROBLEM", 66, 79], ["their leaky vasculature", "PROBLEM", 95, 118], ["Bevacizumab", "TEST", 131, 142], ["normalized vasculature", "PROBLEM", 143, 165], ["Bevacizumab", "TREATMENT", 193, 204], ["the virus", "PROBLEM", 251, 260], ["the tumor", "PROBLEM", 276, 285], ["stroma", "OBSERVATION_MODIFIER", 22, 28], ["tumor", "OBSERVATION", 29, 34], ["tumors", "OBSERVATION", 73, 79], ["vasculature", "ANATOMY", 107, 118], ["vasculature", "ANATOMY", 154, 165], ["vascular", "ANATOMY", 167, 175], ["normalization", "OBSERVATION", 176, 189], ["virus", "OBSERVATION", 255, 260], ["tumor", "OBSERVATION", 280, 285]]], ["This effect was likely dependent on altering both physical and biological properties of the tumor, including interstitial pressure and oxygenation.", [["tumor", "ANATOMY", 92, 97], ["interstitial", "ANATOMY", 109, 121], ["tumor", "DISEASE", 92, 97], ["tumor", "CANCER", 92, 97], ["interstitial", "MULTI-TISSUE_STRUCTURE", 109, 121], ["the tumor", "PROBLEM", 88, 97], ["interstitial pressure", "TEST", 109, 130], ["likely", "UNCERTAINTY", 16, 22], ["dependent", "OBSERVATION_MODIFIER", 23, 32], ["tumor", "OBSERVATION", 92, 97], ["interstitial", "ANATOMY_MODIFIER", 109, 121], ["pressure", "OBSERVATION_MODIFIER", 122, 130], ["oxygenation", "OBSERVATION_MODIFIER", 135, 146]]], ["In another study, anti-VEGF-A antibody injections in nude mice harboring U251 human glioma xenografts led to an increase in MMP2 expression and reduction in collagen fiber content, facilitating improved distribution of oncolytic adenovirus within the tumor tissue [31] .", [["U251", "ANATOMY", 73, 77], ["glioma xenografts", "ANATOMY", 84, 101], ["collagen fiber", "ANATOMY", 157, 171], ["tumor tissue", "ANATOMY", 251, 263], ["anti-VEGF-A", "CHEMICAL", 18, 29], ["glioma", "DISEASE", 84, 90], ["tumor", "DISEASE", 251, 256], ["anti-VEGF-A antibody", "GENE_OR_GENE_PRODUCT", 18, 38], ["nude mice", "ORGANISM", 53, 62], ["U251", "CELL", 73, 77], ["human", "ORGANISM", 78, 83], ["glioma xenografts", "CANCER", 84, 101], ["MMP2", "GENE_OR_GENE_PRODUCT", 124, 128], ["collagen", "GENE_OR_GENE_PRODUCT", 157, 165], ["adenovirus", "ORGANISM", 229, 239], ["tumor tissue", "TISSUE", 251, 263], ["anti-VEGF-A antibody", "PROTEIN", 18, 38], ["U251 human glioma xenografts", "CELL_LINE", 73, 101], ["MMP2", "PROTEIN", 124, 128], ["collagen", "PROTEIN", 157, 165], ["mice", "SPECIES", 58, 62], ["human", "SPECIES", 78, 83], ["mice", "SPECIES", 58, 62], ["human", "SPECIES", 78, 83], ["another study", "TEST", 3, 16], ["anti-VEGF", "TREATMENT", 18, 27], ["A antibody injections", "TREATMENT", 28, 49], ["nude mice harboring U251 human glioma xenografts", "TREATMENT", 53, 101], ["an increase in MMP2 expression", "TREATMENT", 109, 139], ["reduction in collagen fiber content", "TREATMENT", 144, 179], ["oncolytic adenovirus within the tumor tissue", "PROBLEM", 219, 263], ["glioma xenografts", "OBSERVATION", 84, 101], ["increase", "OBSERVATION_MODIFIER", 112, 120], ["MMP2 expression", "OBSERVATION", 124, 139], ["reduction", "OBSERVATION_MODIFIER", 144, 153], ["collagen fiber content", "OBSERVATION", 157, 179], ["improved", "OBSERVATION_MODIFIER", 194, 202], ["distribution", "OBSERVATION_MODIFIER", 203, 215], ["oncolytic adenovirus", "OBSERVATION", 219, 239], ["tumor tissue", "OBSERVATION", 251, 263]]], ["In general, targeting tumor vasculature by oncolytic viruses and including agents that affect tumor vasculature in combination regimens is gaining interest [32] , and it will be interesting to see more specific studies on how vascular-acting agents may affect the physical barriers to oncolytic viruses.", [["tumor vasculature", "ANATOMY", 22, 39], ["tumor vasculature", "ANATOMY", 94, 111], ["vascular", "ANATOMY", 226, 234], ["tumor", "DISEASE", 22, 27], ["tumor", "DISEASE", 94, 99], ["tumor vasculature", "MULTI-TISSUE_STRUCTURE", 22, 39], ["tumor vasculature", "MULTI-TISSUE_STRUCTURE", 94, 111], ["vascular", "MULTI-TISSUE_STRUCTURE", 226, 234], ["targeting tumor vasculature", "PROBLEM", 12, 39], ["oncolytic viruses", "PROBLEM", 43, 60], ["agents", "TREATMENT", 75, 81], ["tumor vasculature", "PROBLEM", 94, 111], ["combination regimens", "TREATMENT", 115, 135], ["tumor", "OBSERVATION", 22, 27], ["oncolytic viruses", "OBSERVATION", 43, 60], ["tumor", "OBSERVATION", 94, 99]]], ["Some viruses do not need an extracellular step for propagating infection, such as members of the herpes and poxvirus families, and may be able to spread from cell-to-cell.", [["extracellular", "ANATOMY", 28, 41], ["cell", "ANATOMY", 158, 162], ["cell", "ANATOMY", 166, 170], ["infection", "DISEASE", 63, 72], ["herpes", "DISEASE", 97, 103], ["extracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 28, 41], ["herpes", "ORGANISM", 97, 103], ["poxvirus", "ORGANISM", 108, 116], ["cell", "CELL", 158, 162], ["cell", "CELL", 166, 170], ["Some viruses", "PROBLEM", 0, 12], ["an extracellular step", "TREATMENT", 25, 46], ["propagating infection", "PROBLEM", 51, 72], ["the herpes", "PROBLEM", 93, 103], ["viruses", "OBSERVATION", 5, 12], ["infection", "OBSERVATION", 63, 72]]], ["For example, HSV-1 is able to infect neighboring cells via lateral tight junctions in a manner dependent on its glycoproteins E and I [33] .", [["cells", "ANATOMY", 49, 54], ["lateral tight junctions", "ANATOMY", 59, 82], ["HSV-1", "ORGANISM", 13, 18], ["cells", "CELL", 49, 54], ["lateral tight junctions", "CELLULAR_COMPONENT", 59, 82], ["glycoproteins E", "GENE_OR_GENE_PRODUCT", 112, 127], ["neighboring cells", "CELL_TYPE", 37, 54], ["glycoproteins E", "PROTEIN", 112, 127], ["HSV-1", "SPECIES", 13, 18], ["HSV-1", "SPECIES", 13, 18], ["HSV", "TEST", 13, 16], ["lateral", "ANATOMY_MODIFIER", 59, 66], ["tight junctions", "OBSERVATION", 67, 82]]], ["Vaccinia virus, on the other hand, induces so called actin-tails, which are actin-filament-driven membranous protrusions of the plasma membrane harboring a single virus particle at the outer tip.", [["membranous protrusions", "ANATOMY", 98, 120], ["plasma membrane", "ANATOMY", 128, 143], ["outer tip", "ANATOMY", 185, 194], ["Vaccinia virus", "ORGANISM", 0, 14], ["actin", "GENE_OR_GENE_PRODUCT", 53, 58], ["actin", "GENE_OR_GENE_PRODUCT", 76, 81], ["filament", "CELLULAR_COMPONENT", 82, 90], ["plasma membrane", "CELLULAR_COMPONENT", 128, 143], ["outer tip", "CELLULAR_COMPONENT", 185, 194], ["actin-tails", "PROTEIN", 53, 64], ["actin", "PROTEIN", 76, 81], ["Vaccinia virus", "SPECIES", 0, 14], ["Vaccinia virus", "SPECIES", 0, 14], ["Vaccinia virus", "PROBLEM", 0, 14], ["membranous protrusions", "PROBLEM", 98, 120], ["the plasma membrane", "TREATMENT", 124, 143], ["a single virus particle", "PROBLEM", 154, 177], ["virus", "OBSERVATION", 9, 14], ["membranous", "OBSERVATION_MODIFIER", 98, 108], ["protrusions", "OBSERVATION", 109, 120], ["plasma membrane", "ANATOMY", 128, 143], ["virus", "OBSERVATION", 163, 168], ["outer", "ANATOMY_MODIFIER", 185, 190], ["tip", "OBSERVATION_MODIFIER", 191, 194]]], ["These actin tails actively deliver and deposit virus particles onto or even into neighboring cells [34, 35] .", [["cells", "ANATOMY", 93, 98], ["actin", "GENE_OR_GENE_PRODUCT", 6, 11], ["cells", "CELL", 93, 98], ["actin tails", "PROTEIN", 6, 17], ["neighboring cells", "CELL_TYPE", 81, 98], ["These actin tails", "TREATMENT", 0, 17], ["deposit virus particles", "TREATMENT", 39, 62]]], ["Because lateral spread without an extracellular step may circumvent neutralizing immunity as well as some of the physical obstacles the tumor microenvironment imposes, this ability has been engineered into viruses that normally do not possess it.", [["extracellular", "ANATOMY", 34, 47], ["tumor", "ANATOMY", 136, 141], ["tumor", "DISEASE", 136, 141], ["extracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 34, 47], ["tumor", "CANCER", 136, 141], ["lateral spread", "PROBLEM", 8, 22], ["an extracellular step", "TREATMENT", 31, 52], ["tumor", "OBSERVATION", 136, 141]]], ["A promising strategy is to engineer OVs to express membrane-fusogenic genes (MFGs), such as gibbon ape leukemia virus (GALV) glycoprotein, reptilian reovirus p14 protein (FAST) or the membrane glycoproteins H and F of measles virus [36, 37] .", [["membrane", "ANATOMY", 51, 59], ["membrane", "ANATOMY", 184, 192], ["OVs", "GENE_OR_GENE_PRODUCT", 36, 39], ["membrane", "CELLULAR_COMPONENT", 51, 59], ["MFGs", "GENE_OR_GENE_PRODUCT", 77, 81], ["gibbon ape leukemia virus", "ORGANISM", 92, 117], ["GALV", "ORGANISM", 119, 123], ["reptilian reovirus", "ORGANISM", 139, 157], ["p14", "GENE_OR_GENE_PRODUCT", 158, 161], ["FAST", "GENE_OR_GENE_PRODUCT", 171, 175], ["measles virus", "ORGANISM", 218, 231], ["OVs", "PROTEIN", 36, 39], ["membrane-fusogenic genes", "DNA", 51, 75], ["MFGs", "DNA", 77, 81], ["gibbon ape leukemia virus (GALV) glycoprotein", "PROTEIN", 92, 137], ["reptilian reovirus p14 protein", "PROTEIN", 139, 169], ["FAST", "PROTEIN", 171, 175], ["membrane glycoproteins H", "PROTEIN", 184, 208], ["F", "PROTEIN", 213, 214], ["gibbon ape leukemia virus", "SPECIES", 92, 117], ["reptilian reovirus", "SPECIES", 139, 157], ["measles virus", "SPECIES", 218, 231], ["gibbon ape leukemia virus", "SPECIES", 92, 117], ["GALV", "SPECIES", 119, 123], ["measles virus", "SPECIES", 218, 231], ["fusogenic genes (MFGs)", "PROBLEM", 60, 82], ["gibbon ape leukemia virus", "PROBLEM", 92, 117], ["GALV) glycoprotein", "TEST", 119, 137], ["reptilian reovirus p14 protein", "TEST", 139, 169], ["measles virus", "PROBLEM", 218, 231], ["fusogenic genes", "OBSERVATION", 60, 75], ["leukemia virus", "OBSERVATION", 103, 117]]], ["Quite intriguingly, expression of several different MFGs by oncolytic adenovirus synergized with chemotherapy in anti-tumor efficacy both in vitro and in vivo [38] , suggesting that membrane fusion facilitated lateral spread of also chemotherapeutics, which otherwise would not have occurred in a compact tumor.", [["anti-tumor", "ANATOMY", 113, 123], ["membrane", "ANATOMY", 182, 190], ["tumor", "ANATOMY", 305, 310], ["tumor", "DISEASE", 305, 310], ["MFGs", "GENE_OR_GENE_PRODUCT", 52, 56], ["oncolytic adenovirus", "ORGANISM", 60, 80], ["anti-tumor", "CANCER", 113, 123], ["membrane", "CELLULAR_COMPONENT", 182, 190], ["tumor", "CANCER", 305, 310], ["MFGs", "PROTEIN", 52, 56], ["several different MFGs", "PROBLEM", 34, 56], ["oncolytic adenovirus synergized", "TREATMENT", 60, 91], ["chemotherapy in anti-tumor efficacy", "TREATMENT", 97, 132], ["membrane fusion", "PROBLEM", 182, 197], ["chemotherapeutics", "TREATMENT", 233, 250], ["a compact tumor", "PROBLEM", 295, 310], ["membrane fusion", "OBSERVATION", 182, 197], ["tumor", "OBSERVATION", 305, 310]]], ["The potential limitation of cell-to-cell-dependent spread, however, may be that membrane-free physical barriers, such as the ECM, may still pose a barrier to spread.", [["cell", "ANATOMY", 28, 32], ["cell", "ANATOMY", 36, 40], ["membrane", "ANATOMY", 80, 88], ["ECM", "ANATOMY", 125, 128], ["cell", "CELL", 28, 32], ["cell", "CELL", 36, 40], ["membrane", "CELLULAR_COMPONENT", 80, 88], ["ECM", "CELLULAR_COMPONENT", 125, 128], ["cell-to-cell", "OBSERVATION_MODIFIER", 28, 40], ["dependent", "OBSERVATION_MODIFIER", 41, 50], ["spread", "OBSERVATION", 51, 57], ["may be", "UNCERTAINTY", 68, 74], ["free", "OBSERVATION_MODIFIER", 89, 93]]], ["Also, it is unclear whether MFGs or other mechanisms of lateral spread may assist in reaching distant tumor nests.Extracellular Matrix DepositsSome other strategies to alleviate matrix-imposed restrictions to oncolytic viruses have been discussed elsewhere [26, 29] .Tight Junctions Block Virus Penetrance and Hide Virus ReceptorsTumors of epithelial origin mostly retain the firm cellular integrity seen in their original adhesive intercellular configuration.", [["tumor nests", "ANATOMY", 102, 113], ["matrix", "ANATOMY", 178, 184], ["epithelial", "ANATOMY", 340, 350], ["cellular", "ANATOMY", 381, 389], ["intercellular", "ANATOMY", 432, 445], ["tumor", "DISEASE", 102, 107], ["MFGs", "GENE_OR_GENE_PRODUCT", 28, 32], ["tumor nests", "CANCER", 102, 113], ["matrix", "CELLULAR_COMPONENT", 178, 184], ["epithelial", "TISSUE", 340, 350], ["cellular", "CELL", 381, 389], ["MFGs", "PROBLEM", 28, 32], ["lateral spread", "PROBLEM", 56, 70], ["Extracellular Matrix DepositsSome other strategies", "TREATMENT", 114, 164], ["alleviate matrix", "PROBLEM", 168, 184], ["oncolytic viruses", "PROBLEM", 209, 226], ["Tight Junctions Block Virus Penetrance", "PROBLEM", 267, 305], ["Hide Virus ReceptorsTumors", "TREATMENT", 310, 336], ["tumor", "OBSERVATION", 102, 107], ["Junctions Block", "OBSERVATION", 273, 288], ["Virus Penetrance", "OBSERVATION", 289, 305], ["Virus ReceptorsTumors", "OBSERVATION", 315, 336], ["epithelial origin", "OBSERVATION", 340, 357], ["firm", "OBSERVATION_MODIFIER", 376, 380], ["cellular integrity", "OBSERVATION", 381, 399], ["original", "OBSERVATION_MODIFIER", 414, 422], ["adhesive", "OBSERVATION_MODIFIER", 423, 431], ["intercellular configuration", "OBSERVATION", 432, 459]]], ["Several viruses use cellular receptors which are located in paracellular tight junctions, which may be problematic in tightly packed tumors [11] .", [["cellular", "ANATOMY", 20, 28], ["paracellular tight junctions", "ANATOMY", 60, 88], ["tumors", "ANATOMY", 133, 139], ["tumors", "DISEASE", 133, 139], ["cellular", "CELL", 20, 28], ["paracellular tight junctions", "CELLULAR_COMPONENT", 60, 88], ["tumors", "CANCER", 133, 139], ["cellular receptors", "PROTEIN", 20, 38], ["cellular receptors", "TREATMENT", 20, 38], ["tightly packed tumors", "PROBLEM", 118, 139], ["viruses", "OBSERVATION", 8, 15], ["cellular receptors", "OBSERVATION", 20, 38], ["paracellular", "ANATOMY_MODIFIER", 60, 72], ["tight junctions", "OBSERVATION", 73, 88], ["may be", "UNCERTAINTY", 96, 102], ["problematic", "OBSERVATION_MODIFIER", 103, 114], ["packed", "OBSERVATION_MODIFIER", 126, 132], ["tumors", "OBSERVATION", 133, 139]]], ["Adenovirus C group viruses use coxsackie-adenovirus receptor (CAR) as their primary entry point, whereas adenovirus B1 group members and measles virus Edmonston use CD46 complement binding molecule as their cellular receptor [39] .", [["cellular", "ANATOMY", 207, 215], ["Adenovirus C group viruses", "ORGANISM", 0, 26], ["coxsackie-adenovirus receptor", "ORGANISM", 31, 60], ["CAR", "GENE_OR_GENE_PRODUCT", 62, 65], ["adenovirus B1", "ORGANISM", 105, 118], ["measles virus Edmonston", "ORGANISM", 137, 160], ["CD46 complement binding molecule", "GENE_OR_GENE_PRODUCT", 165, 197], ["cellular", "CELL", 207, 215], ["coxsackie-adenovirus receptor", "PROTEIN", 31, 60], ["CAR", "PROTEIN", 62, 65], ["adenovirus B1 group members", "PROTEIN", 105, 132], ["CD46 complement binding molecule", "PROTEIN", 165, 197], ["Adenovirus C group", "SPECIES", 0, 18], ["coxsackie-adenovirus", "SPECIES", 31, 51], ["measles virus Edmonston", "SPECIES", 137, 160], ["measles virus", "SPECIES", 137, 150], ["Adenovirus C group viruses", "PROBLEM", 0, 26], ["coxsackie-adenovirus receptor", "TREATMENT", 31, 60], ["measles virus Edmonston", "TREATMENT", 137, 160]]], ["Adenovirus B2 group (serotypes 3, 7, 11 and 14) entry occurs using desmoglein-2 (DSG-2) [40] .", [["DSG-2)", "CHEMICAL", 81, 87], ["Adenovirus B2", "ORGANISM", 0, 13], ["DSG-2", "GENE_OR_GENE_PRODUCT", 81, 86], ["desmoglein-2", "PROTEIN", 67, 79], ["Adenovirus B2 group", "SPECIES", 0, 19], ["Adenovirus B2 group (serotypes", "TEST", 0, 30], ["desmoglein-2 (DSG", "TREATMENT", 67, 84]]], ["Of these, CAR and DSG-2 are preferentially located within tight junctions and are hidden from virus binding [41] .", [["tight junctions", "ANATOMY", 58, 73], ["CAR", "GENE_OR_GENE_PRODUCT", 10, 13], ["DSG-2", "GENE_OR_GENE_PRODUCT", 18, 23], ["tight junctions", "CELLULAR_COMPONENT", 58, 73], ["CAR", "PROTEIN", 10, 13], ["CAR and DSG", "TREATMENT", 10, 21], ["DSG", "ANATOMY", 18, 21], ["tight junctions", "OBSERVATION", 58, 73]]], ["Also the complement receptor CD46 was ascribed a role in maintenance of epithelial cell integrity by interactions with the E-cadherin/catenin network [42] .", [["epithelial cell", "ANATOMY", 72, 87], ["CD46", "GENE_OR_GENE_PRODUCT", 29, 33], ["epithelial cell", "CELL", 72, 87], ["E-cadherin", "GENE_OR_GENE_PRODUCT", 123, 133], ["catenin", "GENE_OR_GENE_PRODUCT", 134, 141], ["complement receptor CD46", "PROTEIN", 9, 33], ["E-cadherin", "PROTEIN", 123, 133], ["catenin network", "PROTEIN", 134, 149], ["the complement receptor CD46", "TREATMENT", 5, 33], ["epithelial cell integrity", "TREATMENT", 72, 97], ["epithelial cell integrity", "OBSERVATION", 72, 97]]], ["These observations imply that before reaching the potential entry site on the tumor cell the virus must find its way into the junctional space.", [["tumor cell", "ANATOMY", 78, 88], ["junctional space", "ANATOMY", 126, 142], ["tumor", "DISEASE", 78, 83], ["tumor cell", "CELL", 78, 88], ["the tumor cell the virus", "PROBLEM", 74, 98], ["tumor cell", "OBSERVATION", 78, 88], ["junctional space", "ANATOMY", 126, 142]]], ["Moreover, it has become increasingly clear that for example glioma tumors traditionally targeted by Ad5 serotype adenoviruses often express only low levels of CAR and instead much higher levels of CD46 [43, 44] .Tight Junctions Block Virus Penetrance and Hide Virus ReceptorsBeyond that tight junctions hide multiple virus receptors, they contain a network of adhesion molecules, including ZO-1, cadherins, claudins and occludin, which, if perturbed, is associated with more aggressive disease in many types of cancer [45, 46] .", [["glioma tumors", "ANATOMY", 60, 73], ["tight junctions", "ANATOMY", 287, 302], ["cancer", "ANATOMY", 511, 517], ["glioma tumors", "DISEASE", 60, 73], ["aggressive disease", "DISEASE", 475, 493], ["cancer", "DISEASE", 511, 517], ["glioma tumors", "CANCER", 60, 73], ["Ad5 serotype adenoviruses", "ORGANISM", 100, 125], ["CAR", "GENE_OR_GENE_PRODUCT", 159, 162], ["CD46", "GENE_OR_GENE_PRODUCT", 197, 201], ["tight junctions", "CELLULAR_COMPONENT", 287, 302], ["ZO-1", "GENE_OR_GENE_PRODUCT", 390, 394], ["cadherins", "GENE_OR_GENE_PRODUCT", 396, 405], ["claudins", "GENE_OR_GENE_PRODUCT", 407, 415], ["occludin", "GENE_OR_GENE_PRODUCT", 420, 428], ["cancer", "CANCER", 511, 517], ["CAR", "PROTEIN", 159, 162], ["CD46", "PROTEIN", 197, 201], ["Hide Virus Receptors", "PROTEIN", 255, 275], ["virus receptors", "PROTEIN", 317, 332], ["adhesion molecules", "PROTEIN", 360, 378], ["ZO-1", "PROTEIN", 390, 394], ["cadherins", "PROTEIN", 396, 405], ["claudins", "PROTEIN", 407, 415], ["occludin", "PROTEIN", 420, 428], ["Ad5", "SPECIES", 100, 103], ["example glioma tumors", "PROBLEM", 52, 73], ["Ad5 serotype adenoviruses", "TREATMENT", 100, 125], ["low levels of CAR", "PROBLEM", 145, 162], ["Tight Junctions Block Virus Penetrance", "TREATMENT", 212, 250], ["Hide Virus Receptors", "TREATMENT", 255, 275], ["adhesion molecules", "TREATMENT", 360, 378], ["more aggressive disease", "PROBLEM", 470, 493], ["cancer", "PROBLEM", 511, 517], ["increasingly", "OBSERVATION_MODIFIER", 24, 36], ["clear", "OBSERVATION", 37, 42], ["glioma tumors", "OBSERVATION", 60, 73], ["low levels", "OBSERVATION_MODIFIER", 145, 155], ["Junctions Block", "OBSERVATION", 218, 233], ["Virus Penetrance", "OBSERVATION", 234, 250], ["adhesion molecules", "OBSERVATION", 360, 378], ["aggressive", "OBSERVATION_MODIFIER", 475, 485], ["cancer", "OBSERVATION", 511, 517]]], ["Since tight junctions also contain important receptors that mediate tumor-promoting signaling and which have been targeted by monoclonal antibodies, notably Her2, it would be highly useful to develop strategies that temporarily loosen the tight junction contacts-even at cost of a transient increase in tumor metastatic risk.", [["tight junctions", "ANATOMY", 6, 21], ["tumor", "ANATOMY", 68, 73], ["tight junction", "ANATOMY", 239, 253], ["tumor", "ANATOMY", 303, 308], ["tumor", "DISEASE", 68, 73], ["tumor", "DISEASE", 303, 308], ["tight junctions", "CELLULAR_COMPONENT", 6, 21], ["tumor", "CANCER", 68, 73], ["Her2", "GENE_OR_GENE_PRODUCT", 157, 161], ["tumor", "CANCER", 303, 308], ["monoclonal antibodies", "PROTEIN", 126, 147], ["Her2", "PROTEIN", 157, 161], ["mediate tumor", "PROBLEM", 60, 73], ["monoclonal antibodies", "TEST", 126, 147], ["a transient increase in tumor metastatic risk", "PROBLEM", 279, 324], ["tumor", "OBSERVATION", 68, 73], ["transient", "OBSERVATION_MODIFIER", 281, 290], ["increase", "OBSERVATION_MODIFIER", 291, 299], ["tumor", "OBSERVATION", 303, 308], ["metastatic risk", "OBSERVATION", 309, 324]]], ["One of the most interesting approaches has been to exploit the natural propensity of adenovirus serotype 3, which as part of its natural life cycle creates dodecahedral particles (PtDd) consisting of viral capsid proteins, penton base and fiber that open tight junctions by binding to and dissolving desmoglein-2 dimers and reducing E-cadherin expression, to develop a specific tight-junction opening molecule, JO-1 [40, 47, 48] .", [["tight junctions", "ANATOMY", 255, 270], ["tight-junction", "ANATOMY", 378, 392], ["adenovirus serotype 3", "ORGANISM", 85, 106], ["dodecahedral particles", "SIMPLE_CHEMICAL", 156, 178], ["PtDd", "SIMPLE_CHEMICAL", 180, 184], ["fiber", "CELLULAR_COMPONENT", 239, 244], ["tight junctions", "CELLULAR_COMPONENT", 255, 270], ["desmoglein-2", "GENE_OR_GENE_PRODUCT", 300, 312], ["E-cadherin", "GENE_OR_GENE_PRODUCT", 333, 343], ["JO-1", "GENE_OR_GENE_PRODUCT", 411, 415], ["dodecahedral particles", "CELL_TYPE", 156, 178], ["PtDd", "PROTEIN", 180, 184], ["viral capsid proteins", "PROTEIN", 200, 221], ["desmoglein-2 dimers", "PROTEIN", 300, 319], ["E", "PROTEIN", 333, 334], ["cadherin", "PROTEIN", 335, 343], ["tight-junction opening molecule", "PROTEIN", 378, 409], ["adenovirus serotype", "PROBLEM", 85, 104], ["viral capsid proteins", "TREATMENT", 200, 221], ["penton base and fiber", "TREATMENT", 223, 244], ["desmoglein", "TEST", 300, 310], ["reducing E-cadherin expression", "TREATMENT", 324, 354], ["adenovirus", "OBSERVATION", 85, 95], ["viral capsid proteins", "OBSERVATION", 200, 221], ["tight junctions", "OBSERVATION", 255, 270]]], ["Adenovirus type 3 uses PtDds to promote its own infection, opening the tight junctions ahead of infection to maximize access to desmoglein-2.", [["tight junctions", "ANATOMY", 71, 86], ["infection", "DISEASE", 48, 57], ["infection", "DISEASE", 96, 105], ["Adenovirus type 3", "ORGANISM", 0, 17], ["PtDds", "GENE_OR_GENE_PRODUCT", 23, 28], ["desmoglein-2", "GENE_OR_GENE_PRODUCT", 128, 140], ["PtDds", "PROTEIN", 23, 28], ["desmoglein", "PROTEIN", 128, 138], ["Adenovirus type 3", "PROBLEM", 0, 17], ["PtDds", "TREATMENT", 23, 28], ["own infection", "PROBLEM", 44, 57], ["infection", "PROBLEM", 96, 105], ["desmoglein", "TEST", 128, 138], ["infection", "OBSERVATION", 48, 57], ["infection", "OBSERVATION", 96, 105]]], ["Analogously, when administered to human tumor xenografts, JO-1 facilitated penetration of trastuzumab much deeper into the tumor tissue than when the monoclonal antibody was administered on its own [47] .", [["tumor xenografts", "ANATOMY", 40, 56], ["tumor tissue", "ANATOMY", 123, 135], ["tumor", "DISEASE", 40, 45], ["trastuzumab", "CHEMICAL", 90, 101], ["tumor", "DISEASE", 123, 128], ["human", "ORGANISM", 34, 39], ["tumor xenografts", "CANCER", 40, 56], ["JO-1", "GENE_OR_GENE_PRODUCT", 58, 62], ["trastuzumab", "SIMPLE_CHEMICAL", 90, 101], ["tumor tissue", "TISSUE", 123, 135], ["monoclonal antibody", "PROTEIN", 150, 169], ["human", "SPECIES", 34, 39], ["human", "SPECIES", 34, 39], ["human tumor xenografts", "TREATMENT", 34, 56], ["trastuzumab", "TREATMENT", 90, 101], ["the monoclonal antibody", "TREATMENT", 146, 169], ["tumor", "OBSERVATION", 123, 128]]], ["Moreover, JO-1 synergized with several chemotherapeutics in solid tumor models [48] .", [["solid tumor", "ANATOMY", 60, 71], ["JO-1", "CHEMICAL", 10, 14], ["tumor", "DISEASE", 66, 71], ["JO-1", "GENE_OR_GENE_PRODUCT", 10, 14], ["solid tumor", "CANCER", 60, 71], ["several chemotherapeutics in solid tumor models", "PROBLEM", 31, 78], ["tumor", "OBSERVATION", 66, 71]]], ["Backed by our own findings with oncolytic SFV, showing that both extracellular matrix and tumor cell compactness restrict virus spread and oncolytic efficacy, we believe combination approaches that target both tight junctions and extracellular matrix will prove effective in future virotherapy development ( Figure 2 ).Tight Junctions Block Virus Penetrance and Hide Virus ReceptorsAn alternative approach to increasing tumor penetration by oncolytic viruses is to alter tumor cell morphology and status.", [["extracellular matrix", "ANATOMY", 65, 85], ["tumor cell", "ANATOMY", 90, 100], ["tight junctions", "ANATOMY", 210, 225], ["extracellular matrix", "ANATOMY", 230, 250], ["tumor", "ANATOMY", 420, 425], ["tumor cell", "ANATOMY", 471, 481], ["tumor", "DISEASE", 90, 95], ["tumor", "DISEASE", 420, 425], ["tumor", "DISEASE", 471, 476], ["SFV", "ORGANISM", 42, 45], ["extracellular matrix", "CELLULAR_COMPONENT", 65, 85], ["tumor cell", "CELL", 90, 100], ["tight junctions", "CELLULAR_COMPONENT", 210, 225], ["extracellular matrix", "CELLULAR_COMPONENT", 230, 250], ["tumor", "CANCER", 420, 425], ["tumor cell", "CELL", 471, 481], ["SFV", "SPECIES", 42, 45], ["oncolytic SFV", "TREATMENT", 32, 45], ["both extracellular matrix", "PROBLEM", 60, 85], ["tumor cell compactness", "TREATMENT", 90, 112], ["virus spread", "PROBLEM", 122, 134], ["target both tight junctions and extracellular matrix", "TREATMENT", 198, 250], ["virotherapy development", "TREATMENT", 282, 305], ["Tight Junctions Block Virus Penetrance", "TREATMENT", 319, 357], ["Hide Virus ReceptorsAn", "TREATMENT", 362, 384], ["alternative approach", "TREATMENT", 385, 405], ["increasing tumor penetration", "PROBLEM", 409, 437], ["oncolytic viruses", "PROBLEM", 441, 458], ["extracellular matrix", "ANATOMY", 65, 85], ["tumor cell compactness", "OBSERVATION", 90, 112], ["tight junctions", "OBSERVATION", 210, 225], ["Virus Penetrance", "OBSERVATION", 341, 357], ["increasing", "OBSERVATION_MODIFIER", 409, 419], ["tumor", "OBSERVATION", 420, 425]]], ["Notably, cell death and in particular the type of cell death induced by virus has been shown to affect virus distribution within a tumor mass; in a study by Nagano et al., administration of apoptosis-inducing paclitaxel before injecting oncolytic herpes simplex virus increased virus dissemination in the tumor, allowing its diffuse in \"tunnels\" created by shrinking/dying tumor cells [49] .Tight Junctions Block Virus Penetrance and Hide Virus ReceptorsMaintenance of physiological adherence is essential for proper ECM function and for retaining cellular integrity.", [["cell", "ANATOMY", 9, 13], ["cell", "ANATOMY", 50, 54], ["tumor mass", "ANATOMY", 131, 141], ["tumor", "ANATOMY", 305, 310], ["tumor cells", "ANATOMY", 373, 384], ["ECM", "ANATOMY", 517, 520], ["cellular", "ANATOMY", 548, 556], ["death", "DISEASE", 14, 19], ["death", "DISEASE", 55, 60], ["tumor", "DISEASE", 131, 136], ["paclitaxel", "CHEMICAL", 209, 219], ["herpes simplex", "DISEASE", 247, 261], ["tumor", "DISEASE", 305, 310], ["tumor", "DISEASE", 373, 378], ["paclitaxel", "CHEMICAL", 209, 219], ["cell", "CELL", 9, 13], ["cell", "CELL", 50, 54], ["tumor", "CANCER", 131, 136], ["paclitaxel", "SIMPLE_CHEMICAL", 209, 219], ["oncolytic", "ORGANISM", 237, 246], ["herpes simplex virus", "ORGANISM", 247, 267], ["tumor", "CANCER", 305, 310], ["tumor cells", "CELL", 373, 384], ["ECM", "CELLULAR_COMPONENT", 517, 520], ["cellular", "CELL", 548, 556], ["dying tumor cells", "CELL_TYPE", 367, 384], ["herpes simplex virus", "SPECIES", 247, 267], ["herpes simplex virus", "SPECIES", 247, 267], ["cell death", "PROBLEM", 9, 19], ["cell death", "PROBLEM", 50, 60], ["virus", "PROBLEM", 72, 77], ["a tumor mass", "PROBLEM", 129, 141], ["a study", "TEST", 146, 153], ["apoptosis", "PROBLEM", 190, 199], ["paclitaxel", "TREATMENT", 209, 219], ["oncolytic herpes simplex virus increased virus dissemination in the tumor", "PROBLEM", 237, 310], ["its diffuse in \"tunnels", "PROBLEM", 321, 344], ["shrinking/dying tumor cells", "PROBLEM", 357, 384], ["Tight Junctions Block Virus Penetrance", "TREATMENT", 391, 429], ["Hide Virus Receptors", "TREATMENT", 434, 454], ["physiological adherence", "TREATMENT", 469, 492], ["cell death", "OBSERVATION", 9, 19], ["cell death", "OBSERVATION", 50, 60], ["tumor", "OBSERVATION_MODIFIER", 131, 136], ["mass", "OBSERVATION", 137, 141], ["virus dissemination", "OBSERVATION", 278, 297], ["tumor", "OBSERVATION", 305, 310], ["diffuse", "OBSERVATION_MODIFIER", 325, 332], ["tumor cells", "OBSERVATION", 373, 384], ["Virus Penetrance", "OBSERVATION", 413, 429], ["physiological adherence", "OBSERVATION", 469, 492], ["cellular integrity", "OBSERVATION", 548, 566]]], ["Therefore, a potential caveat of using ECM degrading proteolytic enzymes or tight-junction openers is the risk of neoplastic cell detachment from the tumor ECM and increased risk of metastasis.", [["ECM", "ANATOMY", 39, 42], ["tight-junction", "ANATOMY", 76, 90], ["neoplastic cell", "ANATOMY", 114, 129], ["tumor ECM", "ANATOMY", 150, 159], ["tumor", "DISEASE", 150, 155], ["metastasis", "DISEASE", 182, 192], ["ECM", "CELLULAR_COMPONENT", 39, 42], ["neoplastic cell", "CELL", 114, 129], ["tumor", "CANCER", 150, 155], ["ECM", "CELLULAR_COMPONENT", 156, 159], ["ECM", "PROTEIN", 39, 42], ["proteolytic enzymes", "PROTEIN", 53, 72], ["proteolytic enzymes", "TEST", 53, 72], ["tight-junction openers", "TREATMENT", 76, 98], ["neoplastic cell detachment", "PROBLEM", 114, 140], ["the tumor ECM", "PROBLEM", 146, 159], ["metastasis", "PROBLEM", 182, 192], ["risk of", "UNCERTAINTY", 106, 113], ["neoplastic cell detachment", "OBSERVATION", 114, 140], ["tumor", "OBSERVATION", 150, 155], ["increased", "OBSERVATION_MODIFIER", 164, 173], ["metastasis", "OBSERVATION", 182, 192]]], ["While ECM-degradation or tight junction opening may operate innocuously, there is also a chance that loss of E-cadherins via proteases or via non-specific deregulation of tight junction integrity during ECM-modulating therapy could trigger pro-tumorigenic Wnt/\u03b2-catenin signaling, possibly driving epithelial-to-mesenchymal transition [50] .", [["ECM", "ANATOMY", 6, 9], ["tight junction", "ANATOMY", 25, 39], ["tight junction", "ANATOMY", 171, 185], ["ECM", "ANATOMY", 203, 206], ["epithelial", "ANATOMY", 298, 308], ["mesenchymal", "ANATOMY", 312, 323], ["ECM", "CELLULAR_COMPONENT", 6, 9], ["tight junction", "CELLULAR_COMPONENT", 25, 39], ["E-cadherins", "GENE_OR_GENE_PRODUCT", 109, 120], ["tight junction", "CELLULAR_COMPONENT", 171, 185], ["ECM", "CELLULAR_COMPONENT", 203, 206], ["Wnt", "GENE_OR_GENE_PRODUCT", 256, 259], ["\u03b2-catenin", "GENE_OR_GENE_PRODUCT", 260, 269], ["epithelial", "CELL", 298, 308], ["mesenchymal", "CELL", 312, 323], ["ECM", "PROTEIN", 6, 9], ["E-cadherins", "PROTEIN", 109, 120], ["proteases", "PROTEIN", 125, 134], ["ECM", "PROTEIN", 203, 206], ["\u03b2-catenin", "PROTEIN", 260, 269], ["tight junction opening", "PROBLEM", 25, 47], ["loss of E", "PROBLEM", 101, 110], ["proteases", "TREATMENT", 125, 134], ["tight junction integrity", "TREATMENT", 171, 195], ["modulating therapy", "TREATMENT", 207, 225], ["pro-tumorigenic Wnt", "PROBLEM", 240, 259], ["catenin signaling", "PROBLEM", 262, 279], ["tight junction", "OBSERVATION", 171, 185]]], ["One study showed that ectopic relaxin expression stimulated MMP expression and enhanced breast cancer invasiveness [51] , whereas another paper found short term relaxin exposure to increase breast cancer cell motility whereas long term expression reduced both motility and cancer invasiveness [52] .", [["breast cancer", "ANATOMY", 88, 101], ["breast cancer cell", "ANATOMY", 190, 208], ["cancer", "ANATOMY", 273, 279], ["breast cancer", "DISEASE", 88, 101], ["breast cancer", "DISEASE", 190, 203], ["cancer", "DISEASE", 273, 279], ["relaxin", "GENE_OR_GENE_PRODUCT", 30, 37], ["MMP", "GENE_OR_GENE_PRODUCT", 60, 63], ["breast cancer", "CANCER", 88, 101], ["relaxin", "GENE_OR_GENE_PRODUCT", 161, 168], ["breast cancer cell", "CELL", 190, 208], ["cancer", "CANCER", 273, 279], ["MMP", "PROTEIN", 60, 63], ["breast cancer cell", "CELL_TYPE", 190, 208], ["One study", "TEST", 0, 9], ["ectopic relaxin expression", "TREATMENT", 22, 48], ["MMP expression", "PROBLEM", 60, 74], ["enhanced breast cancer invasiveness", "PROBLEM", 79, 114], ["short term relaxin exposure", "PROBLEM", 150, 177], ["increase breast cancer cell motility", "PROBLEM", 181, 217], ["cancer invasiveness", "PROBLEM", 273, 292], ["ectopic", "OBSERVATION", 22, 29], ["breast", "ANATOMY", 88, 94], ["cancer", "OBSERVATION", 95, 101], ["breast", "ANATOMY", 190, 196], ["cancer", "OBSERVATION", 197, 203]]], ["In the context of oncolytic viruses, Lavilla-Alonso tested several proteases, including hyaluronidase, relaxin, and macrophage metalloelastase, and showed they all could assist adenovirus entry into tumors, yet, the authors did not detect treatment-induced metastases or increase in tumor invasiveness [53] .", [["macrophage", "ANATOMY", 116, 126], ["tumors", "ANATOMY", 199, 205], ["metastases", "ANATOMY", 257, 267], ["tumor", "ANATOMY", 283, 288], ["tumors", "DISEASE", 199, 205], ["metastases", "DISEASE", 257, 267], ["tumor", "DISEASE", 283, 288], ["Lavilla-Alonso", "ORGANISM", 37, 51], ["hyaluronidase", "GENE_OR_GENE_PRODUCT", 88, 101], ["relaxin", "GENE_OR_GENE_PRODUCT", 103, 110], ["macrophage", "CELL", 116, 126], ["adenovirus", "ORGANISM", 177, 187], ["tumors", "CANCER", 199, 205], ["tumor", "CANCER", 283, 288], ["proteases", "PROTEIN", 67, 76], ["hyaluronidase", "PROTEIN", 88, 101], ["relaxin", "PROTEIN", 103, 110], ["macrophage metalloelastase", "PROTEIN", 116, 142], ["adenovirus", "SPECIES", 177, 187], ["oncolytic viruses", "PROBLEM", 18, 35], ["Lavilla", "TEST", 37, 44], ["several proteases", "TREATMENT", 59, 76], ["hyaluronidase", "TREATMENT", 88, 101], ["relaxin", "TREATMENT", 103, 110], ["macrophage metalloelastase", "PROBLEM", 116, 142], ["induced metastases", "PROBLEM", 249, 267], ["increase in tumor invasiveness", "PROBLEM", 271, 301], ["oncolytic viruses", "OBSERVATION", 18, 35], ["macrophage metalloelastase", "OBSERVATION", 116, 142], ["tumors", "OBSERVATION", 199, 205], ["metastases", "OBSERVATION", 257, 267], ["increase", "OBSERVATION_MODIFIER", 271, 279], ["tumor", "OBSERVATION", 283, 288]]], ["Another strategy possibly balancing some of the putative risks of tight-junction disruption could be to use Wnt-dependent oncolytic viruses [54] .Figure 2.Schematic illustration of some physical barriers to oncolytic viruses and ways to overcome them.", [["tight-junction", "ANATOMY", 66, 80], ["Wnt-", "GENE_OR_GENE_PRODUCT", 108, 112], ["tight-junction disruption", "PROBLEM", 66, 91], ["Wnt-dependent oncolytic viruses", "PROBLEM", 108, 139], ["oncolytic viruses", "TREATMENT", 207, 224], ["tight", "OBSERVATION_MODIFIER", 66, 71], ["junction disruption", "OBSERVATION", 72, 91]]], ["Tumor nests are often surrounded by extracellular matrix (ECM), which prevents viruses from reaching the tumor cells (see also Figure 1 ).", [["Tumor nests", "ANATOMY", 0, 11], ["extracellular matrix", "ANATOMY", 36, 56], ["ECM", "ANATOMY", 58, 61], ["tumor cells", "ANATOMY", 105, 116], ["tumor", "DISEASE", 105, 110], ["Tumor nests", "CANCER", 0, 11], ["extracellular matrix", "CELLULAR_COMPONENT", 36, 56], ["ECM", "CELLULAR_COMPONENT", 58, 61], ["tumor cells", "CELL", 105, 116], ["tumor cells", "CELL_TYPE", 105, 116], ["Tumor nests", "PROBLEM", 0, 11], ["viruses", "PROBLEM", 79, 86], ["the tumor cells", "PROBLEM", 101, 116], ["extracellular matrix", "OBSERVATION", 36, 56], ["viruses", "OBSERVATION", 79, 86], ["tumor", "OBSERVATION", 105, 110]]], ["Another problem is that tight junctions hide virus receptors and limit diffusion of viruses into the tumor tissue.", [["tight junctions", "ANATOMY", 24, 39], ["tumor tissue", "ANATOMY", 101, 113], ["tumor", "DISEASE", 101, 106], ["tight junctions", "CELLULAR_COMPONENT", 24, 39], ["tumor tissue", "TISSUE", 101, 113], ["virus receptors", "PROTEIN", 45, 60], ["tight junctions hide virus receptors", "PROBLEM", 24, 60], ["limit diffusion of viruses into the tumor tissue", "PROBLEM", 65, 113], ["tumor tissue", "OBSERVATION", 101, 113]]], ["Newly developed tight junction openers [40, 47, 48] may facilitate virus infection by exposing the hidden receptors, and virus-encoded proteases may degrade the stromal shield surrounding tumor nests [26] .Stromal Cells Hinder VirusesTumors are invariably fenestrated by host fibroblasts, myeloid cells and other non-transformed cells, which driven by cancer-induced cues can adopt various reprogrammed phenotypes to promote tumor angiogenesis and growth and to alter tumor responses to therapies [1, 55] .", [["tight junction", "ANATOMY", 16, 30], ["stromal", "ANATOMY", 161, 168], ["tumor nests", "ANATOMY", 188, 199], ["Stromal Cells", "ANATOMY", 206, 219], ["fibroblasts", "ANATOMY", 276, 287], ["myeloid cells", "ANATOMY", 289, 302], ["cells", "ANATOMY", 329, 334], ["cancer", "ANATOMY", 352, 358], ["tumor", "ANATOMY", 425, 430], ["tumor", "ANATOMY", 468, 473], ["40, 47, 48]", "CHEMICAL", 40, 51], ["infection", "DISEASE", 73, 82], ["tumor", "DISEASE", 188, 193], ["cancer", "DISEASE", 352, 358], ["tumor", "DISEASE", 425, 430], ["tumor", "DISEASE", 468, 473], ["stromal shield", "TISSUE", 161, 175], ["tumor", "CANCER", 188, 193], ["Stromal Cells", "CELL", 206, 219], ["fibroblasts", "CELL", 276, 287], ["myeloid cells", "CELL", 289, 302], ["non-transformed cells", "CELL", 313, 334], ["cancer", "CANCER", 352, 358], ["tumor", "CANCER", 425, 430], ["tumor", "CANCER", 468, 473], ["hidden receptors", "PROTEIN", 99, 115], ["virus-encoded proteases", "PROTEIN", 121, 144], ["host fibroblasts", "CELL_TYPE", 271, 287], ["myeloid cells", "CELL_TYPE", 289, 302], ["non-transformed cells", "CELL_TYPE", 313, 334], ["Newly developed tight junction openers", "PROBLEM", 0, 38], ["virus infection", "PROBLEM", 67, 82], ["the hidden receptors", "PROBLEM", 95, 115], ["virus", "PROBLEM", 121, 126], ["Stromal Cells Hinder VirusesTumors", "PROBLEM", 206, 240], ["myeloid cells", "PROBLEM", 289, 302], ["other non-transformed cells", "PROBLEM", 307, 334], ["various reprogrammed phenotypes", "PROBLEM", 382, 413], ["tumor angiogenesis", "PROBLEM", 425, 443], ["tight", "OBSERVATION_MODIFIER", 16, 21], ["junction openers", "OBSERVATION", 22, 38], ["virus infection", "OBSERVATION", 67, 82], ["stromal shield", "OBSERVATION_MODIFIER", 161, 175], ["tumor", "OBSERVATION", 188, 193], ["host fibroblasts", "OBSERVATION", 271, 287], ["myeloid cells", "OBSERVATION", 289, 302], ["non-transformed cells", "OBSERVATION", 313, 334], ["tumor", "OBSERVATION", 425, 430]]], ["As most of them normally play a role in immune homeostasis and pathogen sensing, they also respond to and influence oncolytic virus infection of tumors.Stromal Cells Hinder VirusesFulci et al. reported that injection of oncolytic HSV-1 directly into glioblastoma tumor parenchyma triggered upregulation of CD68 and CD163 monocytic markers and rapid clearance of virus, likely executed by infiltrating phagocytic cells [56] .", [["tumors", "ANATOMY", 145, 151], ["Cells", "ANATOMY", 160, 165], ["glioblastoma tumor parenchyma", "ANATOMY", 250, 279], ["monocytic", "ANATOMY", 321, 330], ["phagocytic cells", "ANATOMY", 401, 417], ["infection", "DISEASE", 132, 141], ["tumors", "DISEASE", 145, 151], ["glioblastoma", "DISEASE", 250, 262], ["tumor", "DISEASE", 263, 268], ["oncolytic virus", "ORGANISM", 116, 131], ["tumors", "CANCER", 145, 151], ["Stromal Cells", "CELL", 152, 165], ["HSV-1", "ORGANISM", 230, 235], ["glioblastoma tumor parenchyma", "TISSUE", 250, 279], ["CD68", "GENE_OR_GENE_PRODUCT", 306, 310], ["CD163", "GENE_OR_GENE_PRODUCT", 315, 320], ["phagocytic cells", "CELL", 401, 417], ["CD68", "PROTEIN", 306, 310], ["CD163 monocytic markers", "PROTEIN", 315, 338], ["infiltrating phagocytic cells", "CELL_TYPE", 388, 417], ["HSV-1", "SPECIES", 230, 235], ["HSV-1", "SPECIES", 230, 235], ["immune homeostasis", "PROBLEM", 40, 58], ["pathogen sensing", "TREATMENT", 63, 79], ["influence oncolytic virus infection of tumors", "PROBLEM", 106, 151], ["Stromal Cells", "PROBLEM", 152, 165], ["oncolytic HSV", "TEST", 220, 233], ["glioblastoma tumor parenchyma", "PROBLEM", 250, 279], ["CD68", "TEST", 306, 310], ["monocytic markers", "TEST", 321, 338], ["rapid clearance of virus", "PROBLEM", 343, 367], ["infiltrating phagocytic cells", "PROBLEM", 388, 417], ["tumors", "OBSERVATION", 145, 151], ["glioblastoma", "ANATOMY", 250, 262], ["tumor", "OBSERVATION", 263, 268], ["infiltrating", "OBSERVATION_MODIFIER", 388, 400], ["phagocytic cells", "OBSERVATION", 401, 417]]], ["When clodronate liposomes were used to deplete macrophages in vivo, the authors observed a 5-fold increase in virus titers in the brain tumors concomitant with an 80% reduction in peripheral CD163 + macrophages in animal spleens, suggesting that CD163 + cells migrate into the tumors upon virus injection and limit overall oncolytic efficacy.", [["macrophages", "ANATOMY", 47, 58], ["brain tumors", "ANATOMY", 130, 142], ["peripheral CD163 + macrophages", "ANATOMY", 180, 210], ["spleens", "ANATOMY", 221, 228], ["CD163 + cells", "ANATOMY", 246, 259], ["tumors", "ANATOMY", 277, 283], ["clodronate", "CHEMICAL", 5, 15], ["tumors", "DISEASE", 136, 142], ["tumors", "DISEASE", 277, 283], ["clodronate", "CHEMICAL", 5, 15], ["clodronate liposomes", "SIMPLE_CHEMICAL", 5, 25], ["macrophages", "CELL", 47, 58], ["brain tumors", "CANCER", 130, 142], ["CD163", "GENE_OR_GENE_PRODUCT", 191, 196], ["macrophages", "CELL", 199, 210], ["spleens", "ORGAN", 221, 228], ["CD163", "GENE_OR_GENE_PRODUCT", 246, 251], ["tumors", "CANCER", 277, 283], ["macrophages", "CELL_TYPE", 47, 58], ["CD163", "PROTEIN", 191, 196], ["macrophages", "CELL_TYPE", 199, 210], ["CD163", "PROTEIN", 246, 251], ["clodronate liposomes", "TREATMENT", 5, 25], ["a 5-fold increase in virus titers", "PROBLEM", 89, 122], ["the brain tumors", "PROBLEM", 126, 142], ["peripheral CD163", "TEST", 180, 196], ["macrophages in animal spleens", "PROBLEM", 199, 228], ["CD163 + cells", "PROBLEM", 246, 259], ["the tumors", "PROBLEM", 273, 283], ["virus injection", "TREATMENT", 289, 304], ["virus titers", "OBSERVATION", 110, 122], ["brain", "ANATOMY", 130, 135], ["tumors", "OBSERVATION", 136, 142], ["peripheral", "ANATOMY_MODIFIER", 180, 190], ["CD163", "ANATOMY", 191, 196], ["macrophages", "OBSERVATION", 199, 210], ["spleens", "ANATOMY", 221, 228], ["tumors", "OBSERVATION", 277, 283]]], ["While CD68 + cells were not reduced by peripheral macrophage depletion, arguing that these cells had been recruited to the tumors before the treatment, they could be eliminated in live glioma slices ex vivo, resulting in a 10-fold increase in virus replication.", [["CD68 + cells", "ANATOMY", 6, 18], ["peripheral macrophage", "ANATOMY", 39, 60], ["cells", "ANATOMY", 91, 96], ["tumors", "ANATOMY", 123, 129], ["glioma slices", "ANATOMY", 185, 198], ["tumors", "DISEASE", 123, 129], ["glioma", "DISEASE", 185, 191], ["CD68", "GENE_OR_GENE_PRODUCT", 6, 10], ["peripheral macrophage", "CELL", 39, 60], ["cells", "CELL", 91, 96], ["tumors", "CANCER", 123, 129], ["glioma slices", "CANCER", 185, 198], ["CD68", "PROTEIN", 6, 10], ["peripheral macrophage depletion", "PROBLEM", 39, 70], ["these cells", "PROBLEM", 85, 96], ["the tumors", "PROBLEM", 119, 129], ["the treatment", "TREATMENT", 137, 150], ["a 10-fold increase in virus replication", "PROBLEM", 221, 260], ["not", "UNCERTAINTY", 24, 27], ["reduced", "OBSERVATION_MODIFIER", 28, 35], ["peripheral", "ANATOMY_MODIFIER", 39, 49], ["macrophage depletion", "OBSERVATION", 50, 70], ["tumors", "OBSERVATION", 123, 129], ["virus replication", "OBSERVATION", 243, 260]]], ["Macrophages may secrete antiviral type I interferon constitutively at very low (subnanomolar) levels [57] and recently Liu et al. showed that tumor-resident CD68 + macrophages induced a protective antiviral state in ovarian and breast tumors which led to resistance to oncolytic vesicular stomatitis virus (VSV) infection [58] .", [["Macrophages", "ANATOMY", 0, 11], ["tumor", "ANATOMY", 142, 147], ["CD68 + macrophages", "ANATOMY", 157, 175], ["ovarian", "ANATOMY", 216, 223], ["breast tumors", "ANATOMY", 228, 241], ["tumor", "DISEASE", 142, 147], ["ovarian and breast tumors", "DISEASE", 216, 241], ["vesicular stomatitis virus (VSV) infection", "DISEASE", 279, 321], ["Macrophages", "CELL", 0, 11], ["type I interferon", "GENE_OR_GENE_PRODUCT", 34, 51], ["tumor", "CANCER", 142, 147], ["CD68", "GENE_OR_GENE_PRODUCT", 157, 161], ["ovarian", "CANCER", 216, 223], ["breast tumors", "CANCER", 228, 241], ["oncolytic", "ORGANISM", 269, 278], ["vesicular stomatitis virus", "ORGANISM", 279, 305], ["VSV", "ORGANISM", 307, 310], ["Macrophages", "CELL_TYPE", 0, 11], ["antiviral type I interferon", "PROTEIN", 24, 51], ["tumor-resident CD68 + macrophages", "CELL_TYPE", 142, 175], ["vesicular stomatitis virus", "SPECIES", 279, 305], ["VSV", "SPECIES", 307, 310], ["Macrophages", "TREATMENT", 0, 11], ["secrete antiviral type I interferon constitutively", "TREATMENT", 16, 66], ["tumor", "PROBLEM", 142, 147], ["CD68", "TEST", 157, 161], ["macrophages", "PROBLEM", 164, 175], ["a protective antiviral state", "PROBLEM", 184, 212], ["ovarian and breast tumors", "PROBLEM", 216, 241], ["oncolytic vesicular stomatitis virus (VSV) infection", "PROBLEM", 269, 321], ["tumor", "OBSERVATION", 142, 147], ["protective antiviral", "OBSERVATION", 186, 206], ["ovarian", "ANATOMY", 216, 223], ["breast", "ANATOMY", 228, 234], ["tumors", "OBSERVATION", 235, 241], ["oncolytic", "OBSERVATION_MODIFIER", 269, 278], ["vesicular stomatitis", "OBSERVATION", 279, 299]]], ["Type I IFN signaling (JAK1/2) inhibitor Ruxolitinib reversed the resistance, facilitating VSV replication in the macrophage-protected cancer cells.", [["macrophage", "ANATOMY", 113, 123], ["cancer cells", "ANATOMY", 134, 146], ["Ruxolitinib", "CHEMICAL", 40, 51], ["cancer", "DISEASE", 134, 140], ["Ruxolitinib", "CHEMICAL", 40, 51], ["Type I IFN", "GENE_OR_GENE_PRODUCT", 0, 10], ["JAK1/2", "GENE_OR_GENE_PRODUCT", 22, 28], ["Ruxolitinib", "SIMPLE_CHEMICAL", 40, 51], ["VSV", "ORGANISM", 90, 93], ["macrophage", "CELL", 113, 123], ["cancer cells", "CELL", 134, 146], ["Type I IFN signaling (JAK1/2", "PROTEIN", 0, 28], ["macrophage-protected cancer cells", "CELL_TYPE", 113, 146], ["VSV", "SPECIES", 90, 93], ["Type I IFN signaling (JAK1/2) inhibitor", "TREATMENT", 0, 39], ["Ruxolitinib", "TREATMENT", 40, 51], ["the resistance", "PROBLEM", 61, 75], ["facilitating VSV replication", "TREATMENT", 77, 105], ["protected cancer cells", "PROBLEM", 124, 146], ["VSV replication", "OBSERVATION", 90, 105], ["macrophage", "ANATOMY", 113, 123], ["cancer cells", "OBSERVATION", 134, 146]]], ["It is tempting to speculate that tumor-resident macrophages also rendered syngeneic GL261 and DBT mouse gliomas completely refractory to VA7 oncolytic alphavirus, as these cells were quite infectable in vitro and live glioma slices regained their sensitivity to virus within 24 h, indicating dilution of IFN-I [59, 60] .Stromal Cells Hinder VirusesMacrophages or the closely related myeloid suppressor cells are the predominant stromal cell type in many tumors and are actively recruited during cancer progression [61, 62] .", [["tumor", "ANATOMY", 33, 38], ["macrophages", "ANATOMY", 48, 59], ["GL261", "ANATOMY", 84, 89], ["gliomas", "ANATOMY", 104, 111], ["cells", "ANATOMY", 172, 177], ["glioma slices", "ANATOMY", 218, 231], ["Stromal Cells", "ANATOMY", 320, 333], ["Macrophages", "ANATOMY", 348, 359], ["myeloid suppressor cells", "ANATOMY", 383, 407], ["stromal cell type", "ANATOMY", 428, 445], ["tumors", "ANATOMY", 454, 460], ["cancer", "ANATOMY", 495, 501], ["tumor", "DISEASE", 33, 38], ["gliomas", "DISEASE", 104, 111], ["tumors", "DISEASE", 454, 460], ["cancer", "DISEASE", 495, 501], ["tumor", "CANCER", 33, 38], ["macrophages", "CELL", 48, 59], ["syngeneic GL261", "CELL", 74, 89], ["mouse", "ORGANISM", 98, 103], ["gliomas", "CANCER", 104, 111], ["VA7 oncolytic alphavirus", "ORGANISM", 137, 161], ["cells", "CELL", 172, 177], ["glioma slices", "CANCER", 218, 231], ["IFN-I", "GENE_OR_GENE_PRODUCT", 304, 309], ["Stromal Cells", "CELL", 320, 333], ["Macrophages", "CELL", 348, 359], ["myeloid", "CELL", 383, 390], ["cells", "CELL", 402, 407], ["stromal cell type", "CELL", 428, 445], ["tumors", "CANCER", 454, 460], ["cancer", "CANCER", 495, 501], ["tumor-resident macrophages", "CELL_TYPE", 33, 59], ["IFN", "PROTEIN", 304, 307], ["Macrophages", "CELL_TYPE", 348, 359], ["myeloid suppressor cells", "CELL_TYPE", 383, 407], ["mouse", "SPECIES", 98, 103], ["mouse", "SPECIES", 98, 103], ["syngeneic GL261", "TREATMENT", 74, 89], ["DBT mouse gliomas", "PROBLEM", 94, 111], ["VA7 oncolytic alphavirus", "TREATMENT", 137, 161], ["vitro and live glioma slices", "TREATMENT", 203, 231], ["IFN", "TEST", 304, 307], ["Stromal Cells Hinder VirusesMacrophages", "PROBLEM", 320, 359], ["the closely related myeloid suppressor cells", "PROBLEM", 363, 407], ["many tumors", "PROBLEM", 449, 460], ["cancer progression", "PROBLEM", 495, 513], ["tumor", "OBSERVATION", 33, 38], ["gliomas", "OBSERVATION", 104, 111], ["VirusesMacrophages", "OBSERVATION", 341, 359], ["myeloid suppressor cells", "OBSERVATION", 383, 407], ["predominant", "OBSERVATION_MODIFIER", 416, 427], ["stromal cell type", "OBSERVATION", 428, 445], ["many", "OBSERVATION_MODIFIER", 449, 453], ["tumors", "OBSERVATION", 454, 460]]], ["Heavy macrophage presence in the tumors indicates that such tumors may be resistant to oncolytic virotherapy, unless depleting preconditioning would be used.", [["macrophage", "ANATOMY", 6, 16], ["tumors", "ANATOMY", 33, 39], ["tumors", "ANATOMY", 60, 66], ["tumors", "DISEASE", 33, 39], ["tumors", "DISEASE", 60, 66], ["macrophage", "CELL", 6, 16], ["tumors", "CANCER", 33, 39], ["tumors", "CANCER", 60, 66], ["Heavy macrophage presence in the tumors", "PROBLEM", 0, 39], ["such tumors", "PROBLEM", 55, 66], ["oncolytic virotherapy", "TREATMENT", 87, 108], ["depleting preconditioning", "TREATMENT", 117, 142], ["macrophage", "OBSERVATION", 6, 16], ["tumors", "OBSERVATION", 33, 39], ["tumors", "OBSERVATION", 60, 66], ["oncolytic virotherapy", "OBSERVATION", 87, 108]]], ["Moreover, as part of the early immune response to virus infection, monocytic cells are rapidly recruited to tumors following intratumoral virus injection.", [["monocytic cells", "ANATOMY", 67, 82], ["tumors", "ANATOMY", 108, 114], ["infection", "DISEASE", 56, 65], ["tumors", "DISEASE", 108, 114], ["monocytic cells", "CELL", 67, 82], ["tumors", "CANCER", 108, 114], ["monocytic cells", "CELL_TYPE", 67, 82], ["virus infection", "PROBLEM", 50, 65], ["monocytic cells", "PROBLEM", 67, 82], ["tumors", "PROBLEM", 108, 114], ["intratumoral virus injection", "TREATMENT", 125, 153], ["monocytic cells", "OBSERVATION", 67, 82]]], ["In one study, depletion of either CD11b + cells or VEGF secreted by these cells in mice treated with oncolytic HSV-1 greatly increased oncolytic efficacy, tentatively linking pro-tumorigenic and antiviral angiogenic mechanisms [63] .Stromal Cells Hinder VirusesAnother key pro-tumorigenic signaling employed by many tumors is up-regulation of CXCR4, the receptor for chemokine CXCL12 (also known as SDF-1), and recruitment of stromal cells expressing CXCL12 which maintain the tumor and recruit additional cells to support tumor expansion and invasion, such as endothelial cell progenitors which contribute to neovascularization [64] .", [["CD11b + cells", "ANATOMY", 34, 47], ["cells", "ANATOMY", 74, 79], ["Stromal Cells", "ANATOMY", 233, 246], ["tumors", "ANATOMY", 316, 322], ["stromal cells", "ANATOMY", 426, 439], ["tumor", "ANATOMY", 477, 482], ["cells", "ANATOMY", 506, 511], ["tumor", "ANATOMY", 523, 528], ["endothelial cell progenitors", "ANATOMY", 561, 589], ["tumors", "DISEASE", 316, 322], ["tumor", "DISEASE", 477, 482], ["tumor", "DISEASE", 523, 528], ["neovascularization", "DISEASE", 610, 628], ["CD11", "GENE_OR_GENE_PRODUCT", 34, 38], ["VEGF", "GENE_OR_GENE_PRODUCT", 51, 55], ["cells", "CELL", 74, 79], ["mice", "ORGANISM", 83, 87], ["oncolytic HSV-1", "ORGANISM", 101, 116], ["Stromal Cells", "CELL", 233, 246], ["tumors", "CANCER", 316, 322], ["CXCR4", "GENE_OR_GENE_PRODUCT", 343, 348], ["CXCL12", "GENE_OR_GENE_PRODUCT", 377, 383], ["SDF-1", "GENE_OR_GENE_PRODUCT", 399, 404], ["stromal cells", "CELL", 426, 439], ["CXCL12", "GENE_OR_GENE_PRODUCT", 451, 457], ["tumor", "CANCER", 477, 482], ["cells", "CELL", 506, 511], ["tumor", "CANCER", 523, 528], ["endothelial cell progenitors", "CELL", 561, 589], ["CD11b", "PROTEIN", 34, 39], ["VEGF", "PROTEIN", 51, 55], ["CXCR4", "PROTEIN", 343, 348], ["chemokine", "PROTEIN", 367, 376], ["CXCL12", "PROTEIN", 377, 383], ["SDF-1", "PROTEIN", 399, 404], ["stromal cells", "CELL_TYPE", 426, 439], ["CXCL12", "PROTEIN", 451, 457], ["endothelial cell progenitors", "CELL_TYPE", 561, 589], ["mice", "SPECIES", 83, 87], ["HSV-1", "SPECIES", 111, 116], ["mice", "SPECIES", 83, 87], ["HSV-1", "SPECIES", 111, 116], ["one study", "TEST", 3, 12], ["CD11b + cells", "PROBLEM", 34, 47], ["VEGF secreted", "PROBLEM", 51, 64], ["oncolytic HSV", "TREATMENT", 101, 114], ["greatly increased oncolytic efficacy", "PROBLEM", 117, 153], ["antiviral angiogenic mechanisms", "PROBLEM", 195, 226], ["Stromal Cells Hinder Viruses", "PROBLEM", 233, 261], ["many tumors", "PROBLEM", 311, 322], ["CXCR4", "TEST", 343, 348], ["chemokine CXCL12", "TEST", 367, 383], ["stromal cells expressing CXCL12", "PROBLEM", 426, 457], ["the tumor", "PROBLEM", 473, 482], ["additional cells", "PROBLEM", 495, 511], ["tumor expansion", "PROBLEM", 523, 538], ["invasion", "PROBLEM", 543, 551], ["endothelial cell progenitors", "PROBLEM", 561, 589], ["neovascularization", "PROBLEM", 610, 628], ["many", "OBSERVATION_MODIFIER", 311, 315], ["tumors", "OBSERVATION", 316, 322], ["stromal cells", "OBSERVATION", 426, 439], ["tumor", "OBSERVATION", 477, 482], ["tumor", "OBSERVATION", 523, 528], ["invasion", "OBSERVATION_MODIFIER", 543, 551], ["endothelial cell progenitors", "OBSERVATION", 561, 589], ["neovascularization", "OBSERVATION", 610, 628]]], ["Indeed, high CXCR4 expression is a negative prognostic factor for many cancers.", [["cancers", "ANATOMY", 71, 78], ["cancers", "DISEASE", 71, 78], ["CXCR4", "GENE_OR_GENE_PRODUCT", 13, 18], ["cancers", "CANCER", 71, 78], ["CXCR4", "PROTEIN", 13, 18], ["many cancers", "PROBLEM", 66, 78], ["high CXCR4", "OBSERVATION_MODIFIER", 8, 18], ["cancers", "OBSERVATION", 71, 78]]], ["Oncolytic vaccinia virus engineered to express a soluble antagonist of CXCR4 showed improved intratumoral virus replication, increased vascular disruption and a markedly reduced infiltration of the tumors by putative immune-suppressive and tumor promoting stromal cells [65] .", [["vascular", "ANATOMY", 135, 143], ["tumors", "ANATOMY", 198, 204], ["tumor", "ANATOMY", 240, 245], ["stromal cells", "ANATOMY", 256, 269], ["tumors", "DISEASE", 198, 204], ["tumor", "DISEASE", 240, 245], ["Oncolytic", "ORGANISM", 0, 9], ["vaccinia virus", "ORGANISM", 10, 24], ["CXCR4", "GENE_OR_GENE_PRODUCT", 71, 76], ["vascular", "MULTI-TISSUE_STRUCTURE", 135, 143], ["tumors", "CANCER", 198, 204], ["tumor", "CELL", 240, 245], ["stromal cells", "CELL", 256, 269], ["CXCR4", "PROTEIN", 71, 76], ["tumor promoting stromal cells", "CELL_TYPE", 240, 269], ["vaccinia virus", "SPECIES", 10, 24], ["Oncolytic vaccinia virus", "TREATMENT", 0, 24], ["a soluble antagonist of CXCR4", "TREATMENT", 47, 76], ["improved intratumoral virus replication", "PROBLEM", 84, 123], ["increased vascular disruption", "PROBLEM", 125, 154], ["a markedly reduced infiltration of the tumors", "PROBLEM", 159, 204], ["putative immune-suppressive", "TREATMENT", 208, 235], ["tumor promoting stromal cells", "PROBLEM", 240, 269], ["intratumoral virus replication", "OBSERVATION", 93, 123], ["increased", "OBSERVATION_MODIFIER", 125, 134], ["vascular", "ANATOMY", 135, 143], ["markedly", "OBSERVATION_MODIFIER", 161, 169], ["reduced", "OBSERVATION_MODIFIER", 170, 177], ["infiltration", "OBSERVATION", 178, 190], ["tumors", "OBSERVATION", 198, 204], ["stromal cells", "OBSERVATION", 256, 269]]], ["This study highlights how reducing pro-tumor stromal cell effects may alleviate antiviral resistance and yield increased overall therapeutic efficacy.", [["pro-tumor stromal cell", "ANATOMY", 35, 57], ["pro-tumor stromal cell", "CELL", 35, 57], ["This study", "TEST", 0, 10], ["reducing pro-tumor stromal cell effects", "PROBLEM", 26, 65], ["antiviral resistance", "PROBLEM", 80, 100], ["stromal cell", "OBSERVATION", 45, 57], ["antiviral resistance", "OBSERVATION", 80, 100], ["increased", "OBSERVATION_MODIFIER", 111, 120], ["overall", "OBSERVATION_MODIFIER", 121, 128], ["therapeutic", "OBSERVATION_MODIFIER", 129, 140]]], ["On the other hand, if the paracrine antiviral effects of tumor-homing monocytic cells could be selectively abrogated these cells could favorably be used to ferry oncolytic viruses into tumors.", [["tumor", "ANATOMY", 57, 62], ["monocytic cells", "ANATOMY", 70, 85], ["cells", "ANATOMY", 123, 128], ["tumors", "ANATOMY", 185, 191], ["tumor", "DISEASE", 57, 62], ["tumors", "DISEASE", 185, 191], ["tumor-homing monocytic cells", "CELL", 57, 85], ["cells", "CELL", 123, 128], ["tumors", "CANCER", 185, 191], ["tumor-homing monocytic cells", "CELL_TYPE", 57, 85], ["the paracrine antiviral effects", "TREATMENT", 22, 53], ["tumor", "PROBLEM", 57, 62], ["homing monocytic cells", "TREATMENT", 63, 85], ["oncolytic viruses into tumors", "PROBLEM", 162, 191], ["tumor", "OBSERVATION", 57, 62]]], ["Indeed, a significant delay in metastatic tumor potential was achieved when macrophages were harnessed to deliver a tumor-specific oncolytic adenovirus [66] .Tumor Cellular Defenses against VirusesImproved oncolytic efficacy by means of increased tumor transduction is dependent on getting the viruses into the tumors and then on how many tumor cells are infected.", [["metastatic tumor", "ANATOMY", 31, 47], ["macrophages", "ANATOMY", 76, 87], ["tumor", "ANATOMY", 116, 121], ["Tumor", "ANATOMY", 158, 163], ["tumor", "ANATOMY", 247, 252], ["tumors", "ANATOMY", 311, 317], ["tumor cells", "ANATOMY", 339, 350], ["tumor", "DISEASE", 42, 47], ["tumor", "DISEASE", 116, 121], ["tumor", "DISEASE", 247, 252], ["tumors", "DISEASE", 311, 317], ["tumor", "DISEASE", 339, 344], ["tumor", "CANCER", 42, 47], ["macrophages", "CELL", 76, 87], ["tumor", "CANCER", 116, 121], ["adenovirus", "ORGANISM", 141, 151], ["Tumor", "CANCER", 158, 163], ["tumor", "CANCER", 247, 252], ["tumors", "CANCER", 311, 317], ["tumor cells", "CELL", 339, 350], ["macrophages", "CELL_TYPE", 76, 87], ["tumor cells", "CELL_TYPE", 339, 350], ["a significant delay in metastatic tumor", "PROBLEM", 8, 47], ["macrophages", "PROBLEM", 76, 87], ["a tumor-specific oncolytic adenovirus", "PROBLEM", 114, 151], ["Tumor Cellular Defenses", "PROBLEM", 158, 181], ["VirusesImproved oncolytic efficacy", "TREATMENT", 190, 224], ["increased tumor transduction", "PROBLEM", 237, 265], ["the tumors", "PROBLEM", 307, 317], ["many tumor cells", "PROBLEM", 334, 350], ["significant", "OBSERVATION_MODIFIER", 10, 21], ["delay", "OBSERVATION_MODIFIER", 22, 27], ["metastatic", "OBSERVATION_MODIFIER", 31, 41], ["tumor", "OBSERVATION", 42, 47], ["increased", "OBSERVATION_MODIFIER", 237, 246], ["tumor", "OBSERVATION", 247, 252], ["tumors", "OBSERVATION", 311, 317], ["tumor cells", "OBSERVATION", 339, 350], ["infected", "OBSERVATION_MODIFIER", 355, 363]]], ["Additionally, host immune status and the kinetics of the ensuing antiviral immune response are critical determinants of therapeutic efficacy with OVs.", [["OVs", "SIMPLE_CHEMICAL", 146, 149], ["the ensuing antiviral immune response", "TREATMENT", 53, 90]]], ["In order to improve virus infection of tumor cells and/or to limit infection of normal off-target cells, viruses may themselves be modified for increased receptor binding or uptake.", [["tumor cells", "ANATOMY", 39, 50], ["cells", "ANATOMY", 98, 103], ["infection", "DISEASE", 26, 35], ["tumor", "DISEASE", 39, 44], ["infection", "DISEASE", 67, 76], ["tumor cells", "CELL", 39, 50], ["cells", "CELL", 98, 103], ["tumor cells", "CELL_TYPE", 39, 50], ["normal off-target cells", "CELL_TYPE", 80, 103], ["virus infection of tumor cells", "PROBLEM", 20, 50], ["infection", "PROBLEM", 67, 76], ["viruses", "PROBLEM", 105, 112], ["increased receptor binding", "PROBLEM", 144, 170], ["tumor cells", "OBSERVATION", 39, 50]]], ["Such strategies, summarized in greater detail elsewhere [67] , include incorporation of receptor-binding motifs on the virion spikes, diverting infection to desired receptor-expressing (cancer) cells.", [["cancer) cells", "ANATOMY", 186, 199], ["infection", "DISEASE", 144, 153], ["cancer", "DISEASE", 186, 192], ["cancer) cells", "CELL", 186, 199], ["receptor-binding motifs", "PROTEIN", 88, 111], ["receptor-expressing (cancer) cells", "CELL_TYPE", 165, 199], ["receptor-binding motifs", "TREATMENT", 88, 111], ["the virion spikes", "PROBLEM", 115, 132], ["diverting infection", "PROBLEM", 134, 153], ["expressing (cancer) cells", "PROBLEM", 174, 199], ["diverting", "OBSERVATION_MODIFIER", 134, 143], ["infection", "OBSERVATION", 144, 153]]], ["Another strategy is to ferry the viruses in on the surface of or inside various secondary carrier entities, such as stem-or immune cells, which may enter the tumor from the circulation while paradoxically shielding the viruses from immune detection or antibody neutralization [68] .", [["surface", "ANATOMY", 51, 58], ["stem", "ANATOMY", 116, 120], ["immune cells", "ANATOMY", 124, 136], ["tumor", "ANATOMY", 158, 163], ["tumor", "DISEASE", 158, 163], ["surface", "CELLULAR_COMPONENT", 51, 58], ["stem", "CELL", 116, 120], ["immune cells", "CELL", 124, 136], ["tumor", "CANCER", 158, 163], ["stem-or immune cells", "CELL_TYPE", 116, 136], ["the viruses", "PROBLEM", 29, 40], ["immune cells", "PROBLEM", 124, 136], ["the tumor", "PROBLEM", 154, 163], ["the viruses", "PROBLEM", 215, 226], ["immune detection", "TEST", 232, 248], ["antibody neutralization", "PROBLEM", 252, 275], ["viruses", "OBSERVATION", 33, 40], ["secondary carrier entities", "OBSERVATION", 80, 106], ["immune cells", "OBSERVATION", 124, 136], ["tumor", "OBSERVATION", 158, 163]]], ["While these strategies ultimately increase the amount of virus that reaches the tumor bed, they are unlikely to alter tumor intracellular permissiveness to virus, which is still a prerequisite for oncolysis and likely primary determinant of virus-induced anti-tumor immune responses.", [["tumor bed", "ANATOMY", 80, 89], ["tumor intracellular", "ANATOMY", 118, 137], ["anti-tumor", "ANATOMY", 255, 265], ["tumor", "DISEASE", 80, 85], ["tumor", "DISEASE", 118, 123], ["tumor bed", "MULTI-TISSUE_STRUCTURE", 80, 89], ["tumor", "CANCER", 118, 123], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 124, 137], ["anti-tumor", "CANCER", 255, 265], ["virus", "PROBLEM", 57, 62], ["tumor intracellular permissiveness to virus", "PROBLEM", 118, 161], ["oncolysis", "PROBLEM", 197, 206], ["virus", "PROBLEM", 241, 246], ["increase", "OBSERVATION_MODIFIER", 34, 42], ["amount", "OBSERVATION_MODIFIER", 47, 53], ["virus", "OBSERVATION", 57, 62], ["tumor", "OBSERVATION", 80, 85], ["unlikely to", "UNCERTAINTY", 100, 111], ["tumor", "OBSERVATION", 118, 123]]], ["In other words, tumor cells must allow viruses to replicate, otherwise there is no oncolysis and no therapy.Tumor Cellular Defenses against VirusesCentral to cancer resistance to oncolytic viruses is the capacity to mount antiviral defense, and the quality of that defense.", [["tumor cells", "ANATOMY", 16, 27], ["Tumor", "ANATOMY", 108, 113], ["cancer", "ANATOMY", 158, 164], ["tumor", "DISEASE", 16, 21], ["cancer", "DISEASE", 158, 164], ["tumor cells", "CELL", 16, 27], ["Tumor", "CANCER", 108, 113], ["cancer", "CANCER", 158, 164], ["tumor cells", "CELL_TYPE", 16, 27], ["tumor cells", "PROBLEM", 16, 27], ["viruses", "PROBLEM", 39, 46], ["oncolysis", "PROBLEM", 83, 92], ["therapy", "TREATMENT", 100, 107], ["Tumor Cellular Defenses", "PROBLEM", 108, 131], ["VirusesCentral to cancer resistance", "PROBLEM", 140, 175], ["oncolytic viruses", "PROBLEM", 179, 196], ["tumor cells", "OBSERVATION", 16, 27], ["no", "UNCERTAINTY", 80, 82], ["oncolysis", "OBSERVATION", 83, 92], ["cancer", "OBSERVATION", 158, 164], ["oncolytic viruses", "OBSERVATION", 179, 196], ["antiviral defense", "OBSERVATION", 222, 239]]], ["All human viruses have co-evolved with their hosts to achieve productive co-existence, and while innate antiviral defenses protect normal tissue from excessive virus replication, with the signaling and mechanisms described in great detail elsewhere [69, 70] , in tumors such defenses are an undesirable element that may restrict therapeutic efficacy.", [["tissue", "ANATOMY", 138, 144], ["tumors", "ANATOMY", 263, 269], ["tumors", "DISEASE", 263, 269], ["human", "ORGANISM", 4, 9], ["tissue", "TISSUE", 138, 144], ["tumors", "CANCER", 263, 269], ["human", "SPECIES", 4, 9], ["human viruses", "SPECIES", 4, 17], ["All human viruses", "PROBLEM", 0, 17], ["excessive virus replication", "PROBLEM", 150, 177], ["tumors such defenses", "PROBLEM", 263, 283], ["tumors", "OBSERVATION", 263, 269]]], ["Propagating the defense are soluble cytokines, with type I (alpha and beta species) interferons playing an essential role against most viruses and type II (gamma) interferon providing a non-redundant auxiliary protective role in controlling pathogenesis of certain viruses.", [["type I (alpha", "GENE_OR_GENE_PRODUCT", 52, 65], ["beta species) interferons", "GENE_OR_GENE_PRODUCT", 70, 95], ["type II (gamma) interferon", "GENE_OR_GENE_PRODUCT", 147, 173], ["cytokines", "PROTEIN", 36, 45], ["type I (alpha and beta species", "PROTEIN", 52, 82], ["interferons", "PROTEIN", 84, 95], ["type II (gamma) interferon", "PROTEIN", 147, 173], ["soluble cytokines", "PROBLEM", 28, 45], ["type I (alpha and beta species) interferons", "PROBLEM", 52, 95], ["type II (gamma) interferon", "TREATMENT", 147, 173], ["a non-redundant auxiliary protective role", "TREATMENT", 184, 225], ["certain viruses", "PROBLEM", 257, 272], ["soluble cytokines", "OBSERVATION", 28, 45]]], ["Mice knocked out for the type I IFN receptor (IFNAR) typically succumb within a day of multi-organ infection when challenged with viruses that may not even be pathogenic in normal adult hosts [71, 72] .", [["multi-organ", "ANATOMY", 87, 98], ["multi-organ infection", "DISEASE", 87, 108], ["Mice", "ORGANISM", 0, 4], ["type I IFN receptor", "GENE_OR_GENE_PRODUCT", 25, 44], ["IFNAR", "GENE_OR_GENE_PRODUCT", 46, 51], ["type I IFN receptor", "PROTEIN", 25, 44], ["IFNAR", "PROTEIN", 46, 51], ["Mice", "SPECIES", 0, 4], ["multi-organ infection", "PROBLEM", 87, 108], ["viruses", "PROBLEM", 130, 137], ["multi-organ", "ANATOMY", 87, 98], ["infection", "OBSERVATION", 99, 108]]], ["There have been no reported cases of genetic defects in the type I IFN receptor in humans, but three unrelated cases of complete signal transducer and activator of T cells (STAT) 1, the essential signaling mediator of type I IFNs, deficiency in humans have been recorded to date, all of which were lethal due to multi-organ virus infection [73, 74] .", [["T cells", "ANATOMY", 164, 171], ["multi-organ virus infection", "DISEASE", 312, 339], ["type I IFN receptor", "GENE_OR_GENE_PRODUCT", 60, 79], ["humans", "ORGANISM", 83, 89], ["signal transducer and activator of T cells (STAT) 1", "GENE_OR_GENE_PRODUCT", 129, 180], ["type I IFNs", "GENE_OR_GENE_PRODUCT", 218, 229], ["humans", "ORGANISM", 245, 251], ["multi-organ virus", "ORGANISM", 312, 329], ["type I IFN receptor", "PROTEIN", 60, 79], ["signal transducer and activator of T cells (STAT) 1", "PROTEIN", 129, 180], ["type I IFNs", "PROTEIN", 218, 229], ["humans", "SPECIES", 83, 89], ["humans", "SPECIES", 245, 251], ["humans", "SPECIES", 83, 89], ["humans", "SPECIES", 245, 251], ["genetic defects", "PROBLEM", 37, 52], ["type I IFNs", "PROBLEM", 218, 229], ["deficiency in humans", "PROBLEM", 231, 251], ["multi-organ virus infection", "PROBLEM", 312, 339], ["no", "UNCERTAINTY", 16, 18], ["defects", "OBSERVATION", 45, 52], ["multi-organ", "ANATOMY", 312, 323], ["virus", "OBSERVATION", 324, 329]]], ["While genetic defects in either type I or type II IFN genes are extremely rare in humans, genetic mutation of the IFN gamma receptor has been documented on some occasions, with the patients displaying high sensitivity to mycobacterial infections [75] .Tumor Cellular Defenses against VirusesSome interferon-like proteins, such as limitin [76] , and many unrelated and structurally diverse \"danger\"-associated endogenous molecules, including HMGB1 and heat-shock proteins, collectively called alarmins [77] , likely signal via the type I IFN receptor or induce its expression, and therefore, in the coming chapters we consider tumor defense against viruses as an equation of the degree of type I IFN responsiveness.", [["Tumor", "ANATOMY", 252, 257], ["tumor", "ANATOMY", 626, 631], ["mycobacterial infections", "DISEASE", 221, 245], ["tumor", "DISEASE", 626, 631], ["type I", "GENE_OR_GENE_PRODUCT", 32, 38], ["type II IFN", "GENE_OR_GENE_PRODUCT", 42, 53], ["humans", "ORGANISM", 82, 88], ["IFN gamma receptor", "GENE_OR_GENE_PRODUCT", 114, 132], ["patients", "ORGANISM", 181, 189], ["Tumor", "CANCER", 252, 257], ["interferon-like proteins", "GENE_OR_GENE_PRODUCT", 296, 320], ["limitin [76]", "GENE_OR_GENE_PRODUCT", 330, 342], ["HMGB1", "GENE_OR_GENE_PRODUCT", 441, 446], ["heat-shock proteins", "GENE_OR_GENE_PRODUCT", 451, 470], ["alarmins [77", "GENE_OR_GENE_PRODUCT", 492, 504], ["type I IFN receptor", "GENE_OR_GENE_PRODUCT", 530, 549], ["tumor", "CANCER", 626, 631], ["type I IFN", "GENE_OR_GENE_PRODUCT", 688, 698], ["type I or type II IFN genes", "DNA", 32, 59], ["IFN gamma receptor", "PROTEIN", 114, 132], ["interferon-like proteins", "PROTEIN", 296, 320], ["endogenous molecules", "PROTEIN", 409, 429], ["HMGB1", "PROTEIN", 441, 446], ["heat-shock proteins", "PROTEIN", 451, 470], ["type I IFN receptor", "PROTEIN", 530, 549], ["IFN", "PROTEIN", 695, 698], ["humans", "SPECIES", 82, 88], ["patients", "SPECIES", 181, 189], ["humans", "SPECIES", 82, 88], ["genetic defects", "PROBLEM", 6, 21], ["type I", "PROBLEM", 32, 38], ["type II IFN genes", "PROBLEM", 42, 59], ["genetic mutation", "PROBLEM", 90, 106], ["the IFN gamma receptor", "TREATMENT", 110, 132], ["high sensitivity to mycobacterial infections", "PROBLEM", 201, 245], ["Tumor Cellular Defenses", "PROBLEM", 252, 275], ["Viruses", "PROBLEM", 284, 291], ["Some interferon-like proteins", "PROBLEM", 291, 320], ["endogenous molecules", "PROBLEM", 409, 429], ["HMGB1", "PROBLEM", 441, 446], ["shock proteins", "PROBLEM", 456, 470], ["tumor defense", "PROBLEM", 626, 639], ["viruses", "PROBLEM", 648, 655], ["type I IFN responsiveness", "PROBLEM", 688, 713], ["defects", "OBSERVATION", 14, 21], ["diverse", "OBSERVATION_MODIFIER", 381, 388], ["endogenous molecules", "OBSERVATION", 409, 429], ["tumor", "OBSERVATION", 626, 631]]], ["For tumors to be sufficiently infected by OVs to reach \"reasonable\" efficacy, some defects in tumor antiviral defenses are a prerequisite.", [["tumors", "ANATOMY", 4, 10], ["tumor", "ANATOMY", 94, 99], ["tumors", "DISEASE", 4, 10], ["tumor", "DISEASE", 94, 99], ["tumors", "CANCER", 4, 10], ["tumor", "CANCER", 94, 99], ["tumors", "PROBLEM", 4, 10], ["some defects in tumor antiviral defenses", "PROBLEM", 78, 118], ["tumors", "OBSERVATION", 4, 10], ["defects", "OBSERVATION", 83, 90], ["tumor", "OBSERVATION", 94, 99], ["antiviral defenses", "OBSERVATION", 100, 118]]], ["Nevertheless, oncolytic viruses exert their efficacy not only by destructive replication in tumor cells but also by stimulating anti-tumor immune responses, and therefore overall efficacy of oncolytic viruses may be difficult to gauge based solely on capacity to replicate in cancer cells.Innate Antiviral Defenses in Tumor CellsWhat is the antiviral status in human cancer?", [["tumor cells", "ANATOMY", 92, 103], ["cancer cells", "ANATOMY", 276, 288], ["Tumor Cells", "ANATOMY", 318, 329], ["cancer", "ANATOMY", 367, 373], ["tumor", "DISEASE", 92, 97], ["cancer", "DISEASE", 276, 282], ["cancer", "DISEASE", 367, 373], ["oncolytic viruses", "ORGANISM", 14, 31], ["tumor cells", "CELL", 92, 103], ["anti-tumor", "CANCER", 128, 138], ["cancer cells", "CELL", 276, 288], ["Tumor Cells", "CELL", 318, 329], ["human", "ORGANISM", 361, 366], ["cancer", "CANCER", 367, 373], ["tumor cells", "CELL_TYPE", 92, 103], ["cancer cells", "CELL_TYPE", 276, 288], ["Tumor Cells", "CELL_TYPE", 318, 329], ["human", "SPECIES", 361, 366], ["human", "SPECIES", 361, 366], ["oncolytic viruses", "PROBLEM", 14, 31], ["destructive replication in tumor cells", "PROBLEM", 65, 103], ["oncolytic viruses", "PROBLEM", 191, 208], ["cancer cells", "PROBLEM", 276, 288], ["Innate Antiviral Defenses in Tumor Cells", "TREATMENT", 289, 329], ["human cancer", "PROBLEM", 361, 373], ["destructive", "OBSERVATION_MODIFIER", 65, 76], ["tumor cells", "OBSERVATION", 92, 103], ["cancer cells", "OBSERVATION", 276, 288], ["Antiviral Defenses", "OBSERVATION", 296, 314], ["Tumor Cells", "OBSERVATION", 318, 329], ["cancer", "OBSERVATION", 367, 373]]], ["Recent analyses from different normal cells that occupy the same organ reveal striking functional variation in components of the type I IFN signaling pathway that correlate with the tissue tropism and virulence of some virus strains [78, 79] .", [["cells", "ANATOMY", 38, 43], ["organ", "ANATOMY", 65, 70], ["tissue", "ANATOMY", 182, 188], ["cells", "CELL", 38, 43], ["organ", "ORGAN", 65, 70], ["type I IFN", "GENE_OR_GENE_PRODUCT", 129, 139], ["tissue", "TISSUE", 182, 188], ["normal cells", "CELL_TYPE", 31, 43], ["IFN", "PROTEIN", 136, 139], ["Recent analyses", "TEST", 0, 15], ["the type I IFN signaling pathway", "PROBLEM", 125, 157], ["the tissue tropism", "PROBLEM", 178, 196], ["some virus strains", "PROBLEM", 214, 232], ["normal cells", "OBSERVATION", 31, 43], ["striking", "OBSERVATION_MODIFIER", 78, 86], ["functional variation", "OBSERVATION", 87, 107]]], ["Can similar variation in such components be found in cancer cells, or do cancer cells make an exception?Innate Antiviral Defenses in Tumor CellsTransformed cells undergo selective elimination by the immune system before becoming cancerous, termed immunoediting, based on observations of differential capacity of immunocompetent mice to reject tumors previously grown in immunocompromised hosts versus syngeneic animals [80] .", [["cancer cells", "ANATOMY", 53, 65], ["cancer cells", "ANATOMY", 73, 85], ["Tumor Cells", "ANATOMY", 133, 144], ["cells", "ANATOMY", 156, 161], ["immune system", "ANATOMY", 199, 212], ["cancerous", "ANATOMY", 229, 238], ["tumors", "ANATOMY", 343, 349], ["cancer", "DISEASE", 53, 59], ["cancer", "DISEASE", 73, 79], ["tumors", "DISEASE", 343, 349], ["cancer cells", "CELL", 53, 65], ["cancer cells", "CELL", 73, 85], ["Tumor CellsTransformed cells", "CELL", 133, 161], ["immune system", "ANATOMICAL_SYSTEM", 199, 212], ["cancerous", "CANCER", 229, 238], ["mice", "ORGANISM", 328, 332], ["tumors", "CANCER", 343, 349], ["syngeneic animals", "ORGANISM", 401, 418], ["cancer cells", "CELL_TYPE", 53, 65], ["cancer cells", "CELL_TYPE", 73, 85], ["Tumor Cells", "CELL_TYPE", 133, 144], ["mice", "SPECIES", 328, 332], ["mice", "SPECIES", 328, 332], ["cancer cells", "PROBLEM", 53, 65], ["cancer cells", "PROBLEM", 73, 85], ["Innate Antiviral Defenses in Tumor Cells", "TREATMENT", 104, 144], ["selective elimination", "TREATMENT", 170, 191], ["cancerous", "PROBLEM", 229, 238], ["immunocompetent mice", "TREATMENT", 312, 332], ["reject tumors", "PROBLEM", 336, 349], ["syngeneic animals", "PROBLEM", 401, 418], ["variation", "OBSERVATION_MODIFIER", 12, 21], ["cancer cells", "OBSERVATION", 53, 65], ["Antiviral Defenses", "OBSERVATION", 111, 129], ["Tumor Cells", "OBSERVATION", 133, 144], ["cancerous", "OBSERVATION", 229, 238]]], ["Cancer cell responsiveness to type I and type II IFNs plays a role during immunoediting: cancer cells that eventually progress to form a tumor display reduced capacity to respond to IFN gamma, which otherwise would upregulate MHC class I molecules and render the tumors amenable to CD8 + T cell-mediated destruction, whereas responsiveness to type I interferon initially helps tumors avoid immune purging during the editing phase and is then irrelevant [81] .", [["Cancer cell", "ANATOMY", 0, 11], ["cancer cells", "ANATOMY", 89, 101], ["tumor", "ANATOMY", 137, 142], ["tumors", "ANATOMY", 263, 269], ["CD8 + T cell", "ANATOMY", 282, 294], ["tumors", "ANATOMY", 377, 383], ["Cancer", "DISEASE", 0, 6], ["cancer", "DISEASE", 89, 95], ["tumor", "DISEASE", 137, 142], ["tumors", "DISEASE", 263, 269], ["tumors", "DISEASE", 377, 383], ["Cancer cell", "CELL", 0, 11], ["type I", "GENE_OR_GENE_PRODUCT", 30, 36], ["type II IFNs", "GENE_OR_GENE_PRODUCT", 41, 53], ["cancer cells", "CELL", 89, 101], ["tumor", "CANCER", 137, 142], ["IFN gamma", "GENE_OR_GENE_PRODUCT", 182, 191], ["tumors", "CANCER", 263, 269], ["CD8", "GENE_OR_GENE_PRODUCT", 282, 285], ["type I interferon", "GENE_OR_GENE_PRODUCT", 343, 360], ["tumors", "CANCER", 377, 383], ["type I and type II IFNs", "PROTEIN", 30, 53], ["cancer cells", "CELL_TYPE", 89, 101], ["IFN gamma", "PROTEIN", 182, 191], ["MHC class I molecules", "PROTEIN", 226, 247], ["CD8", "PROTEIN", 282, 285], ["type I interferon", "PROTEIN", 343, 360], ["Cancer cell responsiveness", "PROBLEM", 0, 26], ["type I", "PROBLEM", 30, 36], ["type II IFNs", "PROBLEM", 41, 53], ["cancer cells", "PROBLEM", 89, 101], ["a tumor", "PROBLEM", 135, 142], ["reduced capacity", "PROBLEM", 151, 167], ["IFN gamma", "PROBLEM", 182, 191], ["the tumors", "PROBLEM", 259, 269], ["CD8", "TEST", 282, 285], ["T cell-mediated destruction", "PROBLEM", 288, 315], ["type I interferon", "PROBLEM", 343, 360], ["helps tumors", "PROBLEM", 371, 383], ["immune purging", "PROBLEM", 390, 404], ["cancer", "OBSERVATION", 89, 95], ["tumor", "OBSERVATION", 137, 142], ["tumors", "OBSERVATION", 263, 269], ["destruction", "OBSERVATION", 304, 315]]], ["Of note, the anti-tumor effects of type I IFN, still exploited today in several cancers, were shown to depend on host NK cells, and mice in which IFNAR was blocked by monoclonal antibody failed to reject even highly immunogenic tumors, as opposed to mice treated with control antibody, who all rejected the immunogenic tumor challenge [82] .", [["cancers", "ANATOMY", 80, 87], ["NK cells", "ANATOMY", 118, 126], ["tumors", "ANATOMY", 228, 234], ["tumor", "ANATOMY", 319, 324], ["cancers", "DISEASE", 80, 87], ["tumors", "DISEASE", 228, 234], ["tumor", "DISEASE", 319, 324], ["anti-tumor", "CANCER", 13, 23], ["type I IFN", "GENE_OR_GENE_PRODUCT", 35, 45], ["cancers", "CANCER", 80, 87], ["host NK cells", "CELL", 113, 126], ["mice", "ORGANISM", 132, 136], ["IFNAR", "GENE_OR_GENE_PRODUCT", 146, 151], ["tumors", "CANCER", 228, 234], ["mice", "ORGANISM", 250, 254], ["tumor", "CANCER", 319, 324], ["type I IFN", "PROTEIN", 35, 45], ["host NK cells", "CELL_TYPE", 113, 126], ["IFNAR", "PROTEIN", 146, 151], ["monoclonal antibody", "PROTEIN", 167, 186], ["mice", "SPECIES", 132, 136], ["mice", "SPECIES", 250, 254], ["mice", "SPECIES", 132, 136], ["mice", "SPECIES", 250, 254], ["type I IFN", "PROBLEM", 35, 45], ["several cancers", "PROBLEM", 72, 87], ["monoclonal antibody", "TEST", 167, 186], ["highly immunogenic tumors", "PROBLEM", 209, 234], ["control antibody", "TREATMENT", 268, 284], ["cancers", "OBSERVATION", 80, 87], ["tumors", "OBSERVATION", 228, 234], ["tumor", "OBSERVATION", 319, 324]]], ["Thus, whereas tumor responsiveness to type I IFN is not predetermined after immunoediting, other factors post immunoediting may influence it.Innate Antiviral Defenses in Tumor CellsIn several tumor types, varying levels of expression of components of the type I IFN signaling cascade have been detected, and in some tumor types these components have been found to have prognostic value, whereas in others they do not seem to influence survival [83, 84] .", [["tumor", "ANATOMY", 14, 19], ["Tumor Cells", "ANATOMY", 170, 181], ["tumor", "ANATOMY", 192, 197], ["tumor", "ANATOMY", 316, 321], ["tumor", "DISEASE", 14, 19], ["tumor", "DISEASE", 192, 197], ["tumor", "DISEASE", 316, 321], ["tumor", "CANCER", 14, 19], ["type I IFN", "GENE_OR_GENE_PRODUCT", 38, 48], ["Tumor Cells", "CELL", 170, 181], ["tumor", "CANCER", 192, 197], ["type I IFN", "GENE_OR_GENE_PRODUCT", 255, 265], ["tumor", "CANCER", 316, 321], ["type I IFN", "PROTEIN", 38, 48], ["Tumor Cells", "CELL_TYPE", 170, 181], ["IFN", "PROTEIN", 262, 265], ["tumor responsiveness", "PROBLEM", 14, 34], ["type I IFN", "PROBLEM", 38, 48], ["other factors post immunoediting", "PROBLEM", 91, 123], ["Innate Antiviral Defenses in Tumor Cells", "TREATMENT", 141, 181], ["several tumor types", "PROBLEM", 184, 203], ["the type I IFN signaling cascade", "PROBLEM", 251, 283], ["tumor", "OBSERVATION", 14, 19], ["Antiviral Defenses", "OBSERVATION", 148, 166], ["Tumor Cells", "OBSERVATION", 170, 181], ["several", "OBSERVATION_MODIFIER", 184, 191], ["tumor", "OBSERVATION", 192, 197], ["varying", "OBSERVATION_MODIFIER", 205, 212], ["levels", "OBSERVATION_MODIFIER", 213, 219], ["components", "OBSERVATION_MODIFIER", 237, 247], ["tumor", "OBSERVATION", 316, 321]]], ["However, emerging data suggests that antiviral genes may predict poor survival because they increase treatment resistance.", [["antiviral genes", "DNA", 37, 52], ["antiviral genes", "PROBLEM", 37, 52], ["treatment resistance", "TREATMENT", 101, 121]]], ["In one study, poor prognosis of several types of cancer due to genotoxic treatment resistance was found to correlate with increased activity of IFN-I-pathway genes [85] .", [["cancer", "ANATOMY", 49, 55], ["cancer", "DISEASE", 49, 55], ["cancer", "CANCER", 49, 55], ["IFN-I", "GENE_OR_GENE_PRODUCT", 144, 149], ["IFN-I-pathway genes", "DNA", 144, 163], ["one study", "TEST", 3, 12], ["cancer", "PROBLEM", 49, 55], ["genotoxic treatment resistance", "PROBLEM", 63, 93], ["increased activity of IFN", "PROBLEM", 122, 147], ["cancer", "OBSERVATION", 49, 55]]], ["In this study, a triad of type I IFN-signaling pathway genes, STAT1, ISG15, and IFIT1, formed a pan-tumor-type negative prognostic factor, and a broader seven-gene cluster established negative prognostic criteria for treatment-resistant breast cancer.", [["pan-tumor", "ANATOMY", 96, 105], ["breast cancer", "ANATOMY", 237, 250], ["breast cancer", "DISEASE", 237, 250], ["type I IFN", "GENE_OR_GENE_PRODUCT", 26, 36], ["STAT1", "GENE_OR_GENE_PRODUCT", 62, 67], ["ISG15", "GENE_OR_GENE_PRODUCT", 69, 74], ["IFIT1", "GENE_OR_GENE_PRODUCT", 80, 85], ["breast cancer", "CANCER", 237, 250], ["type I IFN-signaling pathway genes", "DNA", 26, 60], ["STAT1", "PROTEIN", 62, 67], ["ISG15", "DNA", 69, 74], ["IFIT1", "DNA", 80, 85], ["pan-tumor-type negative prognostic factor", "PROTEIN", 96, 137], ["this study", "TEST", 3, 13], ["signaling pathway genes", "PROBLEM", 37, 60], ["ISG15", "TEST", 69, 74], ["a pan-tumor-type negative prognostic factor", "PROBLEM", 94, 137], ["treatment", "TREATMENT", 217, 226], ["resistant breast cancer", "PROBLEM", 227, 250], ["resistant", "OBSERVATION_MODIFIER", 227, 236], ["breast", "ANATOMY", 237, 243], ["cancer", "OBSERVATION", 244, 250]]], ["Treatment-resistance was subsequently shown to depend on STAT1 signaling; STAT1-expressing tumor clones were positively selected in animals in vivo, demonstrating increased proliferation and metastatic potential, and STAT1-expression mediated resistance against genotoxic assault by doxorubicin or ionizing radiation (knockdown of STAT1 resulted in lower proliferation rate and metastatic capacity and increased sensitivity to genotoxic stress) [86, 87] .", [["tumor clones", "ANATOMY", 91, 103], ["tumor", "DISEASE", 91, 96], ["doxorubicin", "CHEMICAL", 283, 294], ["doxorubicin", "CHEMICAL", 283, 294], ["STAT1", "GENE_OR_GENE_PRODUCT", 57, 62], ["STAT1", "GENE_OR_GENE_PRODUCT", 74, 79], ["tumor clones", "CELL", 91, 103], ["STAT1", "GENE_OR_GENE_PRODUCT", 217, 222], ["doxorubicin", "SIMPLE_CHEMICAL", 283, 294], ["STAT1", "GENE_OR_GENE_PRODUCT", 331, 336], ["STAT1", "PROTEIN", 57, 62], ["STAT1", "PROTEIN", 74, 79], ["expressing tumor clones", "CELL_LINE", 80, 103], ["STAT1", "PROTEIN", 217, 222], ["STAT1", "PROTEIN", 331, 336], ["STAT1 signaling", "PROBLEM", 57, 72], ["expressing tumor clones", "PROBLEM", 80, 103], ["increased proliferation", "PROBLEM", 163, 186], ["genotoxic assault", "PROBLEM", 262, 279], ["doxorubicin", "TREATMENT", 283, 294], ["ionizing radiation", "TREATMENT", 298, 316], ["knockdown of STAT1", "TREATMENT", 318, 336], ["lower proliferation rate", "PROBLEM", 349, 373], ["metastatic capacity", "PROBLEM", 378, 397], ["increased sensitivity", "PROBLEM", 402, 423], ["genotoxic stress", "TEST", 427, 443], ["tumor clones", "OBSERVATION", 91, 103], ["increased", "OBSERVATION_MODIFIER", 163, 172], ["proliferation", "OBSERVATION", 173, 186], ["metastatic", "OBSERVATION_MODIFIER", 191, 201], ["lower proliferation", "OBSERVATION_MODIFIER", 349, 368], ["metastatic", "OBSERVATION_MODIFIER", 378, 388]]], ["In another study, resistance to epigenetic DNA modifiers 5-AZA-dC, a methyltransferase inhibitor, and LBH589 or MGCD0103, both histone deacetylase (HDAC) inhibitors, was correlated with increased expression of IFN-I-pathway genes in small lung cancer cells [88] .", [["small lung cancer cells", "ANATOMY", 233, 256], ["5-AZA-dC", "CHEMICAL", 57, 65], ["LBH589", "CHEMICAL", 102, 108], ["MGCD0103", "CHEMICAL", 112, 120], ["lung cancer", "DISEASE", 239, 250], ["5-AZA-dC", "CHEMICAL", 57, 65], ["LBH589", "CHEMICAL", 102, 108], ["MGCD0103", "CHEMICAL", 112, 120], ["DNA", "CELLULAR_COMPONENT", 43, 46], ["5-AZA-dC", "SIMPLE_CHEMICAL", 57, 65], ["LBH589", "SIMPLE_CHEMICAL", 102, 108], ["MGCD0103", "SIMPLE_CHEMICAL", 112, 120], ["histone deacetylase", "GENE_OR_GENE_PRODUCT", 127, 146], ["HDAC", "GENE_OR_GENE_PRODUCT", 148, 152], ["IFN-I", "GENE_OR_GENE_PRODUCT", 210, 215], ["small lung cancer cells", "CELL", 233, 256], ["histone deacetylase", "PROTEIN", 127, 146], ["HDAC", "PROTEIN", 148, 152], ["IFN-I-pathway genes", "DNA", 210, 229], ["small lung cancer cells", "CELL_TYPE", 233, 256], ["another study", "TEST", 3, 16], ["epigenetic DNA modifiers", "TREATMENT", 32, 56], ["AZA", "TREATMENT", 59, 62], ["a methyltransferase inhibitor", "TREATMENT", 67, 96], ["LBH589", "TREATMENT", 102, 108], ["MGCD0103", "TREATMENT", 112, 120], ["both histone deacetylase (HDAC) inhibitors", "TREATMENT", 122, 164], ["small lung cancer cells", "PROBLEM", 233, 256], ["small", "OBSERVATION_MODIFIER", 233, 238], ["lung", "ANATOMY", 239, 243], ["cancer", "OBSERVATION", 244, 250]]], ["Basal IFN-related gene expression in several different SML cell lines was upregulated.Innate Antiviral Defenses in Tumor CellsInterestingly, in many cancers, STAT proteins are not phosphorylated and persist in unphosphorylated form (U-STAT).", [["SML cell lines", "ANATOMY", 55, 69], ["Tumor Cells", "ANATOMY", 115, 126], ["cancers", "ANATOMY", 149, 156], ["cancers", "DISEASE", 149, 156], ["Basal IFN", "GENE_OR_GENE_PRODUCT", 0, 9], ["SML cell lines", "CELL", 55, 69], ["Tumor Cells", "CELL", 115, 126], ["cancers", "CANCER", 149, 156], ["STAT", "GENE_OR_GENE_PRODUCT", 158, 162], ["U-STAT", "GENE_OR_GENE_PRODUCT", 233, 239], ["IFN", "PROTEIN", 6, 9], ["SML cell lines", "CELL_LINE", 55, 69], ["Tumor Cells", "CELL_TYPE", 115, 126], ["STAT proteins", "PROTEIN", 158, 171], ["unphosphorylated form", "PROTEIN", 210, 231], ["STAT", "PROTEIN", 235, 239], ["Basal IFN", "PROBLEM", 0, 9], ["gene expression", "PROBLEM", 18, 33], ["several different SML cell lines", "TREATMENT", 37, 69], ["Innate Antiviral Defenses in Tumor Cells", "PROBLEM", 86, 126], ["many cancers", "PROBLEM", 144, 156], ["STAT proteins", "TEST", 158, 171], ["phosphorylated", "PROBLEM", 180, 194], ["gene expression", "OBSERVATION", 18, 33], ["several", "OBSERVATION_MODIFIER", 37, 44], ["different", "OBSERVATION_MODIFIER", 45, 54], ["SML cell lines", "OBSERVATION", 55, 69], ["Antiviral Defenses", "OBSERVATION", 93, 111], ["Tumor Cells", "OBSERVATION", 115, 126], ["many", "OBSERVATION_MODIFIER", 144, 148], ["cancers", "OBSERVATION", 149, 156]]], ["Like its phosphorylated counterpart, U-STAT-1 increases expression of genes contributing to resistance to DNA damaging agents [89] .", [["U-STAT-1", "GENE_OR_GENE_PRODUCT", 37, 45], ["DNA", "CELLULAR_COMPONENT", 106, 109], ["STAT-1", "PROTEIN", 39, 45], ["DNA damaging agents", "TREATMENT", 106, 125]]], ["While it is currently unknown why cancers may prefer to use unphosphorylated forms, it is known that U-STATs activate distinct signals compared to their phosphorylated counterparts.", [["cancers", "ANATOMY", 34, 41], ["cancers", "DISEASE", 34, 41], ["cancers", "CANCER", 34, 41], ["U-STATs", "GENE_OR_GENE_PRODUCT", 101, 108], ["STATs", "PROTEIN", 103, 108]]], ["However, importantly for oncolytic viruses, in many tumors, constant expression and release of type I IFN leads to a constitutively high level of unphosphorylated forms of STAT1, STAT2 and IRF9, which together form an unphosphorylated but functional ISGF3-like complex that relocalizes to the nucleus and drives expression of a specific set of ISGs distinct from acute IFN I exposure [58] .", [["tumors", "ANATOMY", 52, 58], ["nucleus", "ANATOMY", 293, 300], ["tumors", "DISEASE", 52, 58], ["tumors", "CANCER", 52, 58], ["type I IFN", "GENE_OR_GENE_PRODUCT", 95, 105], ["STAT1", "GENE_OR_GENE_PRODUCT", 172, 177], ["STAT2", "GENE_OR_GENE_PRODUCT", 179, 184], ["IRF9", "GENE_OR_GENE_PRODUCT", 189, 193], ["ISGF3", "GENE_OR_GENE_PRODUCT", 250, 255], ["nucleus", "CELLULAR_COMPONENT", 293, 300], ["IFN I", "GENE_OR_GENE_PRODUCT", 369, 374], ["type I IFN", "PROTEIN", 95, 105], ["STAT1", "PROTEIN", 172, 177], ["STAT2", "PROTEIN", 179, 184], ["IRF9", "PROTEIN", 189, 193], ["ISGF3", "PROTEIN", 250, 255], ["ISGs", "PROTEIN", 344, 348], ["IFN I", "PROTEIN", 369, 374], ["oncolytic viruses", "PROBLEM", 25, 42], ["many tumors", "PROBLEM", 47, 58], ["type I IFN leads", "PROBLEM", 95, 111], ["IRF9", "TEST", 189, 193], ["an unphosphorylated", "PROBLEM", 215, 234], ["functional ISGF3-like complex", "PROBLEM", 239, 268], ["ISGs distinct", "PROBLEM", 344, 357], ["acute IFN I exposure", "PROBLEM", 363, 383], ["many", "OBSERVATION_MODIFIER", 47, 51], ["tumors", "OBSERVATION", 52, 58], ["ISGF3", "OBSERVATION", 250, 255], ["nucleus", "ANATOMY", 293, 300], ["acute", "OBSERVATION_MODIFIER", 363, 368]]], ["These ISGs are sufficient to maintain a functional antiviral defense and they play a critical role in resistance to DNA damaging agents.Innate Antiviral Defenses in Tumor CellsOn a cellular level, virus replication is controlled by antiviral defense molecules [70] , which in turn are primarily controlled by type I IFN signaling.", [["Tumor", "ANATOMY", 165, 170], ["cellular", "ANATOMY", 181, 189], ["DNA", "CELLULAR_COMPONENT", 116, 119], ["Tumor CellsOn", "CELL", 165, 178], ["cellular", "CELL", 181, 189], ["type I IFN", "GENE_OR_GENE_PRODUCT", 309, 319], ["ISGs", "PROTEIN", 6, 10], ["antiviral defense molecules", "PROTEIN", 232, 259], ["type I IFN", "PROTEIN", 309, 319], ["DNA damaging agents", "TREATMENT", 116, 135], ["Innate Antiviral Defenses", "TREATMENT", 136, 161], ["Tumor CellsOn", "TREATMENT", 165, 178], ["a cellular level", "PROBLEM", 179, 195], ["virus replication", "TREATMENT", 197, 214], ["antiviral defense molecules", "TREATMENT", 232, 259], ["Antiviral Defenses", "OBSERVATION", 143, 161], ["Tumor", "OBSERVATION", 165, 170]]], ["In addition to classical type I IFN-or cytokine-induced antiviral signaling, tumors may employ other antiviral defense mechanisms.", [["tumors", "ANATOMY", 77, 83], ["tumors", "DISEASE", 77, 83], ["type I IFN", "GENE_OR_GENE_PRODUCT", 25, 35], ["tumors", "CANCER", 77, 83], ["IFN", "PROTEIN", 32, 35], ["cytokine", "PROTEIN", 39, 47], ["classical type I IFN", "PROBLEM", 15, 35], ["cytokine", "PROBLEM", 39, 47], ["antiviral signaling", "PROBLEM", 56, 75], ["tumors", "PROBLEM", 77, 83]]], ["For example, stromal cells may secrete peptides with antiviral properties called defensins [90, 91] .", [["stromal cells", "ANATOMY", 13, 26], ["stromal cells", "CELL", 13, 26], ["defensins", "GENE_OR_GENE_PRODUCT", 81, 90], ["stromal cells", "CELL_TYPE", 13, 26], ["defensins", "PROTEIN", 81, 90], ["stromal cells", "PROBLEM", 13, 26], ["stromal cells", "OBSERVATION", 13, 26]]], ["The defensins are amphiphatic and typically 29-42 amino acids in length and interfere with viruses by physically binding to and disrupting virus particles and/or by inducing antiviral responses in target cells via pattern recognition receptors.", [["cells", "ANATOMY", 204, 209], ["amino acids", "CHEMICAL", 50, 61], ["amino acids", "CHEMICAL", 50, 61], ["defensins", "GENE_OR_GENE_PRODUCT", 4, 13], ["amino acids", "AMINO_ACID", 50, 61], ["cells", "CELL", 204, 209], ["pattern recognition receptors", "GENE_OR_GENE_PRODUCT", 214, 243], ["defensins", "PROTEIN", 4, 13], ["target cells", "CELL_TYPE", 197, 209], ["pattern recognition receptors", "PROTEIN", 214, 243], ["amino acids in length", "TREATMENT", 50, 71], ["viruses", "PROBLEM", 91, 98], ["physically binding", "PROBLEM", 102, 120], ["disrupting virus particles", "PROBLEM", 128, 154], ["defensins", "OBSERVATION", 4, 13], ["viruses", "OBSERVATION", 91, 98]]], ["At least oral squamous cell carcinomas were found to overexpress defensins compared to normal control tissues [91] .", [["oral squamous cell carcinomas", "ANATOMY", 9, 38], ["tissues", "ANATOMY", 102, 109], ["squamous cell carcinomas", "DISEASE", 14, 38], ["oral squamous cell carcinomas", "CANCER", 9, 38], ["tissues", "TISSUE", 102, 109], ["defensins", "PROTEIN", 65, 74], ["oral squamous cell carcinomas", "PROBLEM", 9, 38], ["overexpress defensins", "PROBLEM", 53, 74], ["least", "OBSERVATION_MODIFIER", 3, 8], ["oral", "OBSERVATION_MODIFIER", 9, 13], ["squamous cell carcinomas", "OBSERVATION", 14, 38]]], ["While the role of defensins in oncolytic virus infection of tumors is unclear, one study showed that the immune-stimulating properties of defensins may be exploited to increase overall therapeutic efficacy.", [["tumors", "ANATOMY", 60, 66], ["infection", "DISEASE", 47, 56], ["tumors", "DISEASE", 60, 66], ["defensins", "GENE_OR_GENE_PRODUCT", 18, 27], ["oncolytic virus", "ORGANISM", 31, 46], ["tumors", "CANCER", 60, 66], ["defensins", "PROTEIN", 138, 147], ["defensins in oncolytic virus infection of tumors", "PROBLEM", 18, 66], ["one study", "TEST", 79, 88], ["the immune", "TREATMENT", 101, 111], ["defensins", "TREATMENT", 138, 147], ["tumors", "OBSERVATION", 60, 66]]], ["In this study, expression of beta 2 defensin from a conditionally replicating adenovirus yielded a superior therapeutic entity compared to the unarmed parental virus via enhanced anti-tumor immune responses mediated by TLR4-dependent activation of dendritic cells [92] .Innate Antiviral Defenses in Tumor CellsIn summary, human cancers display varying degrees of expression of antiviral proteins or their signaling regulators at baseline.", [["dendritic cells", "ANATOMY", 248, 263], ["Tumor CellsIn", "ANATOMY", 299, 312], ["cancers", "ANATOMY", 328, 335], ["human cancers", "DISEASE", 322, 335], ["beta 2 defensin", "GENE_OR_GENE_PRODUCT", 29, 44], ["adenovirus", "ORGANISM", 78, 88], ["anti-tumor", "CANCER", 179, 189], ["TLR4", "GENE_OR_GENE_PRODUCT", 219, 223], ["dendritic cells", "CELL", 248, 263], ["Tumor CellsIn", "CANCER", 299, 312], ["human", "ORGANISM", 322, 327], ["cancers", "CANCER", 328, 335], ["beta 2 defensin", "PROTEIN", 29, 44], ["TLR4", "PROTEIN", 219, 223], ["dendritic cells", "CELL_TYPE", 248, 263], ["antiviral proteins", "PROTEIN", 377, 395], ["signaling regulators", "PROTEIN", 405, 425], ["human", "SPECIES", 322, 327], ["adenovirus", "SPECIES", 78, 88], ["human", "SPECIES", 322, 327], ["this study", "TEST", 3, 13], ["beta 2 defensin", "PROBLEM", 29, 44], ["a conditionally replicating adenovirus", "PROBLEM", 50, 88], ["a superior therapeutic entity", "PROBLEM", 97, 126], ["the unarmed parental virus", "PROBLEM", 139, 165], ["enhanced anti-tumor immune responses", "TREATMENT", 170, 206], ["dendritic cells", "PROBLEM", 248, 263], ["Innate Antiviral Defenses", "TREATMENT", 270, 295], ["human cancers", "PROBLEM", 322, 335], ["antiviral proteins", "PROBLEM", 377, 395], ["dendritic cells", "OBSERVATION", 248, 263], ["Antiviral Defenses", "OBSERVATION", 277, 295], ["varying degrees", "OBSERVATION_MODIFIER", 344, 359], ["antiviral proteins", "OBSERVATION", 377, 395]]], ["Some of these may increase in response to genotoxic anti-cancer treatments.", [["genotoxic anti-cancer treatments", "TREATMENT", 42, 74], ["may", "UNCERTAINTY", 14, 17], ["increase", "OBSERVATION_MODIFIER", 18, 26], ["response to", "OBSERVATION", 30, 41], ["genotoxic anti-cancer treatments", "OBSERVATION", 42, 74]]], ["In the next chapter we will highlight some of the consequences to oncolytic virotherapy of the heterogeneity in type I IFN responsiveness in tumor cells.Oncolytic Virus Restriction by Innate DefensesAll oncolytic viruses tested to date display variable infectivity in different cancer cell lines.", [["tumor cells", "ANATOMY", 141, 152], ["cancer cell lines", "ANATOMY", 278, 295], ["tumor", "DISEASE", 141, 146], ["cancer", "DISEASE", 278, 284], ["type I IFN", "GENE_OR_GENE_PRODUCT", 112, 122], ["tumor cells", "CELL", 141, 152], ["cancer cell lines", "CELL", 278, 295], ["IFN", "PROTEIN", 119, 122], ["tumor cells", "CELL_TYPE", 141, 152], ["cancer cell lines", "CELL_LINE", 278, 295], ["oncolytic virotherapy", "TREATMENT", 66, 87], ["the heterogeneity", "PROBLEM", 91, 108], ["type I IFN responsiveness in tumor cells", "PROBLEM", 112, 152], ["Oncolytic Virus Restriction", "TREATMENT", 153, 180], ["All oncolytic viruses", "PROBLEM", 199, 220], ["variable infectivity in different cancer cell lines", "PROBLEM", 244, 295], ["tumor cells", "OBSERVATION", 141, 152], ["oncolytic viruses", "OBSERVATION", 203, 220], ["variable", "OBSERVATION_MODIFIER", 244, 252], ["infectivity", "OBSERVATION_MODIFIER", 253, 264], ["different", "OBSERVATION_MODIFIER", 268, 277], ["cancer cell lines", "OBSERVATION", 278, 295]]], ["This variability is likely at least partly dependent on type I IFN as most oncolytic viruses are IFN-sensitive.", [["IFN", "CHEMICAL", 97, 100], ["type I IFN", "GENE_OR_GENE_PRODUCT", 56, 66], ["IFN", "GENE_OR_GENE_PRODUCT", 97, 100], ["type I IFN", "PROTEIN", 56, 66], ["IFN", "PROTEIN", 97, 100], ["type I IFN", "PROBLEM", 56, 66], ["most oncolytic viruses", "PROBLEM", 70, 92], ["IFN", "TEST", 97, 100], ["likely", "UNCERTAINTY", 20, 26], ["at least", "OBSERVATION_MODIFIER", 27, 35]]], ["IFN-secretion follows virus sensing by the cells via Toll-like receptors expressed on both the plasma membrane and in endocytotic vesicles, NOD-like receptors, STING, AIM2, NLP inflammosome and other danger sensing molecules, summarized elsewhere [93, 94] .", [["cells", "ANATOMY", 43, 48], ["plasma membrane", "ANATOMY", 95, 110], ["endocytotic vesicles", "ANATOMY", 118, 138], ["IFN", "CHEMICAL", 0, 3], ["IFN", "GENE_OR_GENE_PRODUCT", 0, 3], ["cells", "CELL", 43, 48], ["Toll-like receptors", "GENE_OR_GENE_PRODUCT", 53, 72], ["plasma membrane", "CELLULAR_COMPONENT", 95, 110], ["endocytotic vesicles", "CELLULAR_COMPONENT", 118, 138], ["NOD-like receptors", "GENE_OR_GENE_PRODUCT", 140, 158], ["STING", "GENE_OR_GENE_PRODUCT", 160, 165], ["AIM2", "GENE_OR_GENE_PRODUCT", 167, 171], ["NLP inflammosome", "GENE_OR_GENE_PRODUCT", 173, 189], ["IFN", "PROTEIN", 0, 3], ["Toll-like receptors", "PROTEIN", 53, 72], ["NOD-like receptors", "PROTEIN", 140, 158], ["STING", "PROTEIN", 160, 165], ["AIM2", "PROTEIN", 167, 171], ["NLP inflammosome", "PROTEIN", 173, 189], ["danger sensing molecules", "PROTEIN", 200, 224], ["plasma membrane", "ANATOMY", 95, 110], ["endocytotic vesicles", "ANATOMY", 118, 138]]], ["While all viruses carry an arsenal of counteracting molecules [69, 95] , no virus goes completely undetected.", [["virus", "PROBLEM", 76, 81], ["viruses", "OBSERVATION", 10, 17], ["no", "UNCERTAINTY", 73, 75], ["virus", "OBSERVATION", 76, 81]]], ["Even HSV amplicons, which are devoid of functional virus genes, induce a type I IFN response that mediates a STAT-1-dependent system-wide antiviral defense in mice within one hour of intravenous vector injection, resulting in significant reduction of transgene expression compared to expression in STAT-1 knockout animals [96] .Oncolytic Virus Restriction by Innate DefensesDuring our own studies with attenuated SFV vector VA7 it became apparent that the dramatic and lasting therapeutic efficacy achieved following mere single intravenous (or intratumoral) injection of the virus in immunocompromised mice bearing human A2058 melanoma or U87 glioma xenografts [25, 97] was not going to be recapitulated easily in immunocompetent animals [59, 60, 98] .", [["intravenous", "ANATOMY", 183, 194], ["intravenous", "ANATOMY", 529, 540], ["A2058 melanoma", "ANATOMY", 622, 636], ["U87 glioma xenografts", "ANATOMY", 640, 661], ["melanoma", "DISEASE", 628, 636], ["glioma", "DISEASE", 644, 650], ["HSV", "ORGANISM", 5, 8], ["type I IFN", "GENE_OR_GENE_PRODUCT", 73, 83], ["STAT-1", "GENE_OR_GENE_PRODUCT", 109, 115], ["mice", "ORGANISM", 159, 163], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 183, 194], ["STAT-1", "GENE_OR_GENE_PRODUCT", 298, 304], ["SFV", "ORGANISM", 413, 416], ["intravenous", "IMMATERIAL_ANATOMICAL_ENTITY", 529, 540], ["intratumoral", "IMMATERIAL_ANATOMICAL_ENTITY", 545, 557], ["mice", "ORGANISM", 603, 607], ["human", "ORGANISM", 616, 621], ["A2058 melanoma", "CANCER", 622, 636], ["U87 glioma xenografts", "CANCER", 640, 661], ["HSV amplicons", "DNA", 5, 18], ["functional virus genes", "DNA", 40, 62], ["IFN", "PROTEIN", 80, 83], ["STAT-1", "PROTEIN", 109, 115], ["STAT", "PROTEIN", 298, 302], ["mice", "SPECIES", 159, 163], ["mice", "SPECIES", 603, 607], ["human", "SPECIES", 616, 621], ["HSV", "SPECIES", 5, 8], ["mice", "SPECIES", 159, 163], ["SFV", "SPECIES", 413, 416], ["mice", "SPECIES", 603, 607], ["human", "SPECIES", 616, 621], ["HSV amplicons", "PROBLEM", 5, 18], ["functional virus genes", "PROBLEM", 40, 62], ["a type I IFN response", "PROBLEM", 71, 92], ["dependent system", "PROBLEM", 116, 132], ["intravenous vector injection", "TREATMENT", 183, 211], ["transgene expression", "PROBLEM", 251, 271], ["Oncolytic Virus Restriction", "TREATMENT", 328, 355], ["attenuated SFV vector VA7", "PROBLEM", 402, 427], ["mere single intravenous (or intratumoral) injection", "TREATMENT", 517, 568], ["the virus", "PROBLEM", 572, 581], ["immunocompromised mice bearing human A2058 melanoma", "TREATMENT", 585, 636], ["U87 glioma xenografts", "TREATMENT", 640, 661], ["HSV amplicons", "OBSERVATION", 5, 18], ["significant", "OBSERVATION_MODIFIER", 226, 237], ["reduction", "OBSERVATION_MODIFIER", 238, 247], ["transgene expression", "OBSERVATION", 251, 271], ["dramatic", "OBSERVATION_MODIFIER", 456, 464]]], ["The paradox in our studies was that while oncolytic SFV vector VA7 effectively replicated in and destroyed a variety of IFN-responsive cancer cell lines in vitro, it consistently failed to eradicate tumors generated from the same cell types in vivo, even if large doses of virus were injected directly into the tumor mass and even if the tumors were void of visible physical barriers ( Figure 3) .", [["cancer cell lines", "ANATOMY", 135, 152], ["tumors", "ANATOMY", 199, 205], ["cell", "ANATOMY", 230, 234], ["tumor mass", "ANATOMY", 311, 321], ["tumors", "ANATOMY", 338, 344], ["IFN", "CHEMICAL", 120, 123], ["cancer", "DISEASE", 135, 141], ["tumors", "DISEASE", 199, 205], ["tumor", "DISEASE", 311, 316], ["tumors", "DISEASE", 338, 344], ["SFV", "ORGANISM", 52, 55], ["VA7", "CELL", 63, 66], ["IFN", "GENE_OR_GENE_PRODUCT", 120, 123], ["cancer cell lines", "CELL", 135, 152], ["tumors", "CANCER", 199, 205], ["cell", "CELL", 230, 234], ["tumor", "CANCER", 311, 316], ["tumors", "CANCER", 338, 344], ["IFN-responsive cancer cell lines", "CELL_LINE", 120, 152], ["SFV", "SPECIES", 52, 55], ["our studies", "TEST", 15, 26], ["oncolytic SFV vector VA7", "TREATMENT", 42, 66], ["IFN-responsive cancer cell lines", "TREATMENT", 120, 152], ["tumors", "PROBLEM", 199, 205], ["large doses of virus", "PROBLEM", 258, 278], ["the tumor mass", "PROBLEM", 307, 321], ["the tumors", "PROBLEM", 334, 344], ["cancer cell lines", "OBSERVATION", 135, 152], ["tumor", "OBSERVATION_MODIFIER", 311, 316], ["mass", "OBSERVATION", 317, 321], ["tumors", "OBSERVATION", 338, 344]]], ["Conversely, only tumors generated from IFN-unresponsive cancer cells have seemed infectable in vivo by VA7 so far.", [["tumors", "ANATOMY", 17, 23], ["cancer cells", "ANATOMY", 56, 68], ["tumors", "DISEASE", 17, 23], ["IFN", "CHEMICAL", 39, 42], ["cancer", "DISEASE", 56, 62], ["tumors", "CANCER", 17, 23], ["IFN", "GENE_OR_GENE_PRODUCT", 39, 42], ["cancer cells", "CELL", 56, 68], ["IFN-unresponsive cancer cells", "CELL_LINE", 39, 68], ["tumors", "PROBLEM", 17, 23], ["IFN", "PROBLEM", 39, 42], ["unresponsive cancer cells", "PROBLEM", 43, 68], ["tumors", "OBSERVATION", 17, 23], ["cancer", "OBSERVATION", 56, 62]]], ["In light of earlier findings by others, showing that type I IFN receptor knockout mice are highly susceptible to SFV infection and quickly succumb to multi-organ systemic infection [71] , the parameters for oncolytic SFV efficacy seem clear: tumor cells must be defective in type I IFN response for the virus to be effective.Oncolytic Virus Restriction by Innate DefensesThese findings are in line with emerging data from other groups, showing a remarkably strict dependence of oncolytic virus replication on defective type I IFN responsiveness, a dogma introduced at the turn of the 21st century [99] .", [["multi-organ", "ANATOMY", 150, 161], ["tumor cells", "ANATOMY", 242, 253], ["infection", "DISEASE", 117, 126], ["multi-organ systemic infection", "DISEASE", 150, 180], ["tumor", "DISEASE", 242, 247], ["type I IFN receptor", "GENE_OR_GENE_PRODUCT", 53, 72], ["mice", "ORGANISM", 82, 86], ["SFV", "ORGANISM", 113, 116], ["SFV", "ORGANISM", 217, 220], ["tumor cells", "CELL", 242, 253], ["type I IFN", "GENE_OR_GENE_PRODUCT", 275, 285], ["type I IFN", "GENE_OR_GENE_PRODUCT", 519, 529], ["type I IFN receptor", "PROTEIN", 53, 72], ["tumor cells", "CELL_TYPE", 242, 253], ["IFN", "PROTEIN", 282, 285], ["IFN", "PROTEIN", 526, 529], ["mice", "SPECIES", 82, 86], ["mice", "SPECIES", 82, 86], ["SFV", "SPECIES", 113, 116], ["SFV", "SPECIES", 217, 220], ["type I IFN receptor knockout mice", "PROBLEM", 53, 86], ["SFV infection", "PROBLEM", 113, 126], ["multi-organ systemic infection", "PROBLEM", 150, 180], ["the parameters", "TEST", 188, 202], ["oncolytic SFV efficacy", "TREATMENT", 207, 229], ["tumor cells", "PROBLEM", 242, 253], ["type I IFN response", "PROBLEM", 275, 294], ["the virus", "PROBLEM", 299, 308], ["Oncolytic Virus Restriction", "TREATMENT", 325, 352], ["oncolytic virus replication", "TREATMENT", 478, 505], ["defective type I IFN responsiveness", "PROBLEM", 509, 544], ["a dogma", "TREATMENT", 546, 553], ["SFV", "OBSERVATION_MODIFIER", 113, 116], ["infection", "OBSERVATION", 117, 126], ["systemic", "ANATOMY", 162, 170], ["infection", "OBSERVATION", 171, 180], ["tumor cells", "OBSERVATION", 242, 253], ["oncolytic virus", "OBSERVATION", 478, 493]]], ["For example, sarcomas and melanomas display differing permissiveness to oncolytic VSV, an obstacle which may be overcome by blocking type I IFN signaling [100, 101] .", [["sarcomas", "ANATOMY", 13, 21], ["melanomas", "ANATOMY", 26, 35], ["sarcomas", "DISEASE", 13, 21], ["melanomas", "DISEASE", 26, 35], ["sarcomas", "CANCER", 13, 21], ["melanomas", "CANCER", 26, 35], ["VSV", "ORGANISM", 82, 85], ["type I IFN", "GENE_OR_GENE_PRODUCT", 133, 143], ["IFN", "PROTEIN", 140, 143], ["VSV", "SPECIES", 82, 85], ["sarcomas", "PROBLEM", 13, 21], ["melanomas", "PROBLEM", 26, 35], ["oncolytic VSV", "TREATMENT", 72, 85], ["sarcomas", "OBSERVATION", 13, 21], ["melanomas", "OBSERVATION", 26, 35], ["oncolytic VSV", "OBSERVATION", 72, 85], ["may be", "UNCERTAINTY", 105, 111]]], ["In eight sarcoma cell lines, basal up-regulation of RIG-I and IFIT1 and rapid induction of STAT1 phosphorylation upon IFN I treatment correlated with resistance to oncolytic measles virus [102] .", [["sarcoma cell lines", "ANATOMY", 9, 27], ["sarcoma", "DISEASE", 9, 16], ["IFN I", "CHEMICAL", 118, 123], ["sarcoma cell lines", "CELL", 9, 27], ["RIG-I", "GENE_OR_GENE_PRODUCT", 52, 57], ["IFIT1", "GENE_OR_GENE_PRODUCT", 62, 67], ["STAT1", "GENE_OR_GENE_PRODUCT", 91, 96], ["IFN I", "GENE_OR_GENE_PRODUCT", 118, 123], ["oncolytic", "ORGANISM", 164, 173], ["measles virus", "ORGANISM", 174, 187], ["sarcoma cell lines", "CELL_LINE", 9, 27], ["RIG-I", "PROTEIN", 52, 57], ["IFIT1", "PROTEIN", 62, 67], ["STAT1", "PROTEIN", 91, 96], ["IFN I", "PROTEIN", 118, 123], ["oncolytic measles virus", "SPECIES", 164, 187], ["measles virus", "SPECIES", 174, 187], ["eight sarcoma cell lines", "PROBLEM", 3, 27], ["basal up", "TEST", 29, 37], ["IFIT1", "TREATMENT", 62, 67], ["STAT1 phosphorylation", "TREATMENT", 91, 112], ["IFN I treatment", "TREATMENT", 118, 133], ["oncolytic measles virus", "TREATMENT", 164, 187], ["eight", "OBSERVATION_MODIFIER", 3, 8], ["sarcoma cell lines", "OBSERVATION", 9, 27], ["basal", "OBSERVATION_MODIFIER", 29, 34], ["RIG", "OBSERVATION_MODIFIER", 52, 55], ["-I", "ANATOMY_MODIFIER", 55, 57], ["rapid", "OBSERVATION_MODIFIER", 72, 77]]], ["In other studies, human pancreatic and ovarian cancer cells display resistance against Rb-dependent oncolytic adenovirus, strongly correlating with intracellular levels of MxA, and acquired resistance to repeated oncolytic adenovirus injections in an intraperitoneal ovarian carcinoma model was associated with an increase in MxA as well as several other key ISGs in the tumors [103, 104] .", [["pancreatic", "ANATOMY", 24, 34], ["ovarian cancer cells", "ANATOMY", 39, 59], ["intracellular", "ANATOMY", 148, 161], ["intraperitoneal ovarian carcinoma", "ANATOMY", 251, 284], ["tumors", "ANATOMY", 371, 377], ["pancreatic and ovarian cancer", "DISEASE", 24, 53], ["ovarian carcinoma", "DISEASE", 267, 284], ["tumors", "DISEASE", 371, 377], ["human", "ORGANISM", 18, 23], ["pancreatic", "CELL", 24, 34], ["ovarian cancer cells", "CELL", 39, 59], ["Rb", "GENE_OR_GENE_PRODUCT", 87, 89], ["oncolytic adenovirus", "ORGANISM", 100, 120], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 148, 161], ["MxA", "GENE_OR_GENE_PRODUCT", 172, 175], ["adenovirus", "ORGANISM", 223, 233], ["ovarian carcinoma", "CANCER", 267, 284], ["MxA", "GENE_OR_GENE_PRODUCT", 326, 329], ["tumors", "CANCER", 371, 377], ["human pancreatic and ovarian cancer cells", "CELL_TYPE", 18, 59], ["Rb", "PROTEIN", 87, 89], ["MxA", "PROTEIN", 172, 175], ["MxA", "PROTEIN", 326, 329], ["ISGs", "DNA", 359, 363], ["human", "SPECIES", 18, 23], ["human", "SPECIES", 18, 23], ["other studies", "TEST", 3, 16], ["human pancreatic and ovarian cancer cells", "PROBLEM", 18, 59], ["Rb-dependent oncolytic adenovirus", "PROBLEM", 87, 120], ["intracellular levels", "TEST", 148, 168], ["MxA", "TEST", 172, 175], ["repeated oncolytic adenovirus injections", "TREATMENT", 204, 244], ["an intraperitoneal ovarian carcinoma model", "PROBLEM", 248, 290], ["an increase in MxA", "PROBLEM", 311, 329], ["pancreatic", "ANATOMY", 24, 34], ["ovarian", "ANATOMY", 39, 46], ["cancer", "OBSERVATION", 47, 53], ["dependent", "OBSERVATION_MODIFIER", 90, 99], ["oncolytic adenovirus", "OBSERVATION", 100, 120], ["intraperitoneal", "ANATOMY", 251, 266], ["ovarian carcinoma", "OBSERVATION", 267, 284], ["increase", "OBSERVATION_MODIFIER", 314, 322], ["ISGs", "OBSERVATION", 359, 363], ["tumors", "OBSERVATION", 371, 377]]], ["A study comparing normal human or mouse melanocytes to a panel of melanoma cells revealed strong correlation between permissiveness to oncolytic VSV and capacity to mount antiviral defense in response to type I IFN [105] .", [["melanocytes", "ANATOMY", 40, 51], ["melanoma cells", "ANATOMY", 66, 80], ["melanoma", "DISEASE", 66, 74], ["human", "ORGANISM", 25, 30], ["mouse", "ORGANISM", 34, 39], ["melanocytes", "CELL", 40, 51], ["melanoma cells", "CELL", 66, 80], ["VSV", "ORGANISM", 145, 148], ["normal human or mouse melanocytes", "CELL_TYPE", 18, 51], ["melanoma cells", "CELL_TYPE", 66, 80], ["human", "SPECIES", 25, 30], ["mouse", "SPECIES", 34, 39], ["human", "SPECIES", 25, 30], ["mouse", "SPECIES", 34, 39], ["VSV", "SPECIES", 145, 148], ["A study", "TEST", 0, 7], ["melanoma cells", "PROBLEM", 66, 80], ["oncolytic VSV", "TREATMENT", 135, 148], ["type I IFN", "PROBLEM", 204, 214], ["melanoma", "OBSERVATION", 66, 74]]], ["In this study, VSV-rp30, harboring two mutations in P and L genes, was superior to several other tested oncolytic VSV strains, but the dependence on defective IFN responsiveness was still retained.", [["VSV", "ORGANISM", 15, 18], ["rp30", "GENE_OR_GENE_PRODUCT", 19, 23], ["VSV", "ORGANISM", 114, 117], ["IFN", "GENE_OR_GENE_PRODUCT", 159, 162], ["rp30", "DNA", 19, 23], ["P and L genes", "DNA", 52, 65], ["IFN", "PROTEIN", 159, 162], ["VSV-rp30", "SPECIES", 15, 23], ["VSV", "SPECIES", 114, 117], ["this study", "TEST", 3, 13], ["VSV", "TEST", 15, 18], ["harboring two mutations in P and L genes", "PROBLEM", 25, 65], ["oncolytic VSV strains", "PROBLEM", 104, 125], ["defective IFN responsiveness", "PROBLEM", 149, 177]]], ["In yet another study, oncolytic VSV replicated in four out of twelve mesothelioma cell lines which were unable to mount antiviral defense upon IFN-beta pretreatment or to respond to infection by up-regulation of PKR, MxA or 2'5'-OAS mRNA [106] .", [["mesothelioma cell lines", "ANATOMY", 69, 92], ["mesothelioma", "DISEASE", 69, 81], ["infection", "DISEASE", 182, 191], ["VSV", "ORGANISM", 32, 35], ["mesothelioma cell lines", "CELL", 69, 92], ["IFN-beta", "GENE_OR_GENE_PRODUCT", 143, 151], ["PKR", "GENE_OR_GENE_PRODUCT", 212, 215], ["MxA", "GENE_OR_GENE_PRODUCT", 217, 220], ["2'5'-OAS", "GENE_OR_GENE_PRODUCT", 224, 232], ["mesothelioma cell lines", "CELL_LINE", 69, 92], ["IFN", "PROTEIN", 143, 146], ["PKR", "PROTEIN", 212, 215], ["MxA", "PROTEIN", 217, 220], ["2'5", "PROTEIN", 224, 227], ["VSV", "SPECIES", 32, 35], ["another study", "TEST", 7, 20], ["oncolytic VSV", "TREATMENT", 22, 35], ["twelve mesothelioma cell lines", "TREATMENT", 62, 92], ["IFN", "TREATMENT", 143, 146], ["beta pretreatment", "TREATMENT", 147, 164], ["infection", "PROBLEM", 182, 191], ["PKR", "TEST", 212, 215], ["MxA", "TEST", 217, 220], ["mesothelioma cell lines", "OBSERVATION", 69, 92], ["infection", "OBSERVATION", 182, 191]]], ["In contrast, the non-permissive mesothelioma cells mounted antiviral defense, associated with PKR, MxA or 2'5'-OAS mRNA up-regulation, in response to infection or to exogenous type I IFN.", [["mesothelioma cells", "ANATOMY", 32, 50], ["mesothelioma", "DISEASE", 32, 44], ["infection", "DISEASE", 150, 159], ["mesothelioma cells", "CELL", 32, 50], ["PKR", "GENE_OR_GENE_PRODUCT", 94, 97], ["MxA", "GENE_OR_GENE_PRODUCT", 99, 102], ["2'5'-OAS", "GENE_OR_GENE_PRODUCT", 106, 114], ["type I IFN", "GENE_OR_GENE_PRODUCT", 176, 186], ["non-permissive mesothelioma cells", "CELL_LINE", 17, 50], ["PKR", "PROTEIN", 94, 97], ["exogenous type I IFN", "PROTEIN", 166, 186], ["the non-permissive mesothelioma cells mounted antiviral defense", "PROBLEM", 13, 76], ["PKR", "TEST", 94, 97], ["MxA", "TEST", 99, 102], ["OAS mRNA", "TEST", 111, 119], ["infection", "PROBLEM", 150, 159], ["non-permissive", "OBSERVATION_MODIFIER", 17, 31], ["mesothelioma cells mounted", "OBSERVATION", 32, 58], ["antiviral defense", "OBSERVATION", 59, 76], ["infection", "OBSERVATION", 150, 159]]], ["The authors of this study further linked the observed pattern of virus resistance to clinical mesothelioma samples, where in a mesothelioma tissue array, significant variance in immunoreactivity against PKR-, p48-and/or IFNAR was observed, with only a few samples displaying lack of reactivity against all three components, arguing that most tumors in clinical settings would display at least some level of resistance to oncolytic VSV. showing that SFV predominantly infects normal brain parenchymal cells rather than glioma cells.", [["mesothelioma samples", "ANATOMY", 94, 114], ["mesothelioma tissue", "ANATOMY", 127, 146], ["samples", "ANATOMY", 256, 263], ["tumors", "ANATOMY", 342, 348], ["brain parenchymal cells", "ANATOMY", 482, 505], ["glioma cells", "ANATOMY", 518, 530], ["mesothelioma", "DISEASE", 94, 106], ["mesothelioma", "DISEASE", 127, 139], ["tumors", "DISEASE", 342, 348], ["glioma", "DISEASE", 518, 524], ["mesothelioma samples", "CANCER", 94, 114], ["mesothelioma tissue", "TISSUE", 127, 146], ["PKR", "GENE_OR_GENE_PRODUCT", 203, 206], ["p48", "GENE_OR_GENE_PRODUCT", 209, 212], ["IFNAR", "GENE_OR_GENE_PRODUCT", 220, 225], ["tumors", "CANCER", 342, 348], ["VSV", "ORGANISM", 431, 434], ["SFV", "ORGANISM", 449, 452], ["brain parenchymal cells", "CELL", 482, 505], ["glioma cells", "CELL", 518, 530], ["PKR", "PROTEIN", 203, 206], ["p48", "PROTEIN", 209, 212], ["IFNAR", "PROTEIN", 220, 225], ["normal brain parenchymal cells", "CELL_TYPE", 475, 505], ["glioma cells", "CELL_TYPE", 518, 530], ["VSV", "SPECIES", 431, 434], ["SFV", "SPECIES", 449, 452], ["this study", "TEST", 15, 25], ["virus resistance", "PROBLEM", 65, 81], ["clinical mesothelioma samples", "PROBLEM", 85, 114], ["a mesothelioma tissue array", "TEST", 125, 152], ["immunoreactivity", "TEST", 178, 194], ["PKR", "TEST", 203, 206], ["p48", "TEST", 209, 212], ["oncolytic VSV", "TREATMENT", 421, 434], ["SFV", "PROBLEM", 449, 452], ["glioma cells", "PROBLEM", 518, 530], ["virus resistance", "OBSERVATION", 65, 81], ["mesothelioma", "OBSERVATION", 94, 106], ["mesothelioma", "OBSERVATION", 127, 139], ["significant", "OBSERVATION_MODIFIER", 154, 165], ["most", "OBSERVATION_MODIFIER", 337, 341], ["tumors", "OBSERVATION", 342, 348], ["oncolytic VSV", "OBSERVATION", 421, 434], ["SFV", "OBSERVATION_MODIFIER", 449, 452], ["predominantly", "OBSERVATION_MODIFIER", 453, 466], ["infects", "OBSERVATION_MODIFIER", 467, 474], ["normal", "OBSERVATION", 475, 481], ["brain", "ANATOMY", 482, 487], ["parenchymal cells", "OBSERVATION", 488, 505], ["glioma cells", "OBSERVATION", 518, 530]]], ["DBT tumors are homogeneous and void of thick extracellular matrix deposits, as seen in Figure 1 , arguing that tumor cells resist virus infection by other intracellular means [60] .TUMOR NORMALOncolytic adenoviruses are often deleted for E1A, which normally binds Rb and prevents it from sequestering E2F, which results in the viruses being unable to replicate in normal cells.", [["DBT tumors", "ANATOMY", 0, 10], ["extracellular matrix", "ANATOMY", 45, 65], ["tumor cells", "ANATOMY", 111, 122], ["intracellular", "ANATOMY", 155, 168], ["cells", "ANATOMY", 371, 376], ["DBT", "CHEMICAL", 0, 3], ["tumors", "DISEASE", 4, 10], ["tumor", "DISEASE", 111, 116], ["infection", "DISEASE", 136, 145], ["DBT tumors", "CANCER", 0, 10], ["extracellular matrix", "CELLULAR_COMPONENT", 45, 65], ["tumor cells", "CELL", 111, 122], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 155, 168], ["adenoviruses", "ORGANISM", 203, 215], ["E1A", "GENE_OR_GENE_PRODUCT", 238, 241], ["Rb", "GENE_OR_GENE_PRODUCT", 264, 266], ["E2F", "GENE_OR_GENE_PRODUCT", 301, 304], ["cells", "CELL", 371, 376], ["tumor cells", "CELL_TYPE", 111, 122], ["E1A", "PROTEIN", 238, 241], ["Rb", "PROTEIN", 264, 266], ["E2F", "PROTEIN", 301, 304], ["normal cells", "CELL_TYPE", 364, 376], ["DBT tumors", "PROBLEM", 0, 10], ["thick extracellular matrix deposits", "PROBLEM", 39, 74], ["tumor cells", "PROBLEM", 111, 122], ["virus infection", "PROBLEM", 130, 145], ["TUMOR NORMALOncolytic adenoviruses", "PROBLEM", 181, 215], ["E1A", "PROBLEM", 238, 241], ["Rb", "PROBLEM", 264, 266], ["sequestering E2F", "PROBLEM", 288, 304], ["the viruses", "PROBLEM", 323, 334], ["tumors", "OBSERVATION", 4, 10], ["homogeneous", "OBSERVATION_MODIFIER", 15, 26], ["thick", "OBSERVATION_MODIFIER", 39, 44], ["extracellular matrix deposits", "OBSERVATION", 45, 74], ["tumor cells", "OBSERVATION", 111, 122], ["viruses", "OBSERVATION", 327, 334], ["normal cells", "OBSERVATION", 364, 376]]], ["However, since adenovirus, as with all viruses, contains elements that antagonize antiviral defenses, such elements have also been targets for deletion to render the virus sensitive to innate antiviral defenses (which would be expected to remain intact only in normal cells).", [["cells", "ANATOMY", 268, 273], ["adenovirus", "ORGANISM", 15, 25], ["cells", "CELL", 268, 273], ["normal cells", "CELL_TYPE", 261, 273], ["adenovirus", "SPECIES", 15, 25], ["adenovirus", "PROBLEM", 15, 25], ["all viruses", "PROBLEM", 35, 46], ["antagonize antiviral defenses", "PROBLEM", 71, 100], ["deletion", "PROBLEM", 143, 151], ["the virus", "PROBLEM", 162, 171], ["innate antiviral defenses", "TREATMENT", 185, 210], ["viruses", "OBSERVATION", 39, 46], ["antiviral defenses", "OBSERVATION", 192, 210]]], ["Cancer cells expressing Ras may down-regulate protein kinase R and inhibit type I IFN induction by interfering with RIG-I signaling [107, 108] .", [["Cancer cells", "ANATOMY", 0, 12], ["Cancer", "DISEASE", 0, 6], ["Cancer cells", "CELL", 0, 12], ["Ras", "GENE_OR_GENE_PRODUCT", 24, 27], ["protein kinase R", "GENE_OR_GENE_PRODUCT", 46, 62], ["type I IFN", "GENE_OR_GENE_PRODUCT", 75, 85], ["RIG-I", "GENE_OR_GENE_PRODUCT", 116, 121], ["Cancer cells", "CELL_TYPE", 0, 12], ["Ras", "PROTEIN", 24, 27], ["protein kinase R", "PROTEIN", 46, 62], ["type I IFN", "PROTEIN", 75, 85], ["RIG", "PROTEIN", 116, 119], ["Cancer cells", "PROBLEM", 0, 12], ["Ras", "TEST", 24, 27], ["protein kinase", "TEST", 46, 60], ["type I IFN induction", "TREATMENT", 75, 95]]], ["Also, select interferon stimulated genes appear to be repressed by the Ras/MEK/ERK signaling cascade [109] .", [["interferon", "GENE_OR_GENE_PRODUCT", 13, 23], ["Ras", "GENE_OR_GENE_PRODUCT", 71, 74], ["MEK", "GENE_OR_GENE_PRODUCT", 75, 78], ["ERK", "GENE_OR_GENE_PRODUCT", 79, 82], ["interferon stimulated genes", "DNA", 13, 40], ["Ras", "PROTEIN", 71, 74], ["MEK", "PROTEIN", 75, 78], ["ERK", "PROTEIN", 79, 82], ["select interferon stimulated genes", "TREATMENT", 6, 40]]], ["PKR activation shuts down E2F-dependent translation, including translation of virus messenger RNAs.", [["PKR", "GENE_OR_GENE_PRODUCT", 0, 3], ["E2F", "GENE_OR_GENE_PRODUCT", 26, 29], ["PKR", "PROTEIN", 0, 3], ["E2F", "PROTEIN", 26, 29], ["virus messenger RNAs", "RNA", 78, 98], ["PKR activation", "TEST", 0, 14], ["dependent translation", "PROBLEM", 30, 51], ["virus messenger RNAs", "PROBLEM", 78, 98]]], ["Therefore, an adenovirus deleted for VA RNA, which antagonizes PKR, should be capable of replicating in Ras-overexpressing (tumor) cells.", [["Ras-overexpressing (tumor) cells", "ANATOMY", 104, 136], ["tumor", "DISEASE", 124, 129], ["adenovirus", "ORGANISM", 14, 24], ["PKR", "GENE_OR_GENE_PRODUCT", 63, 66], ["Ras-overexpressing (tumor) cells", "CELL", 104, 136], ["VA RNA", "RNA", 37, 43], ["PKR", "PROTEIN", 63, 66], ["Ras-overexpressing (tumor) cells", "CELL_LINE", 104, 136], ["adenovirus", "SPECIES", 14, 24], ["an adenovirus", "TREATMENT", 11, 24], ["VA RNA", "PROBLEM", 37, 43], ["PKR", "TEST", 63, 66], ["Ras-overexpressing (tumor) cells", "PROBLEM", 104, 136]]], ["However, while this was seemingly the case [110] , it was later discovered that Ras is not an obligatory determinant for PKR-inactivation and that virus replication was halted even in Ras overexpressing cells via functional PKR-mediated E2F phosphorylation, implying that the parameters of VA RNA-deleted adenovirus replication had to be revised [111] .", [["cells", "ANATOMY", 203, 208], ["Ras", "GENE_OR_GENE_PRODUCT", 80, 83], ["PKR", "GENE_OR_GENE_PRODUCT", 121, 124], ["Ras", "GENE_OR_GENE_PRODUCT", 184, 187], ["cells", "CELL", 203, 208], ["PKR", "GENE_OR_GENE_PRODUCT", 224, 227], ["E2F", "GENE_OR_GENE_PRODUCT", 237, 240], ["adenovirus", "ORGANISM", 305, 315], ["Ras", "PROTEIN", 80, 83], ["PKR", "PROTEIN", 121, 124], ["Ras overexpressing cells", "CELL_LINE", 184, 208], ["PKR", "PROTEIN", 224, 227], ["E2F", "PROTEIN", 237, 240], ["VA RNA", "RNA", 290, 296], ["PKR", "PROBLEM", 121, 124], ["inactivation", "PROBLEM", 125, 137], ["virus replication", "PROBLEM", 147, 164], ["Ras overexpressing cells", "PROBLEM", 184, 208], ["functional PKR", "TREATMENT", 213, 227], ["E2F phosphorylation", "TREATMENT", 237, 256], ["VA RNA", "TREATMENT", 290, 296], ["deleted adenovirus replication", "PROBLEM", 297, 327]]], ["Similar findings were obtained with oncolytic reovirus, against which Ras-independent tumor resistance emerged in vivo [112] .", [["tumor", "ANATOMY", 86, 91], ["tumor", "DISEASE", 86, 91], ["oncolytic reovirus", "ORGANISM", 36, 54], ["tumor", "CANCER", 86, 91], ["oncolytic reovirus", "TREATMENT", 36, 54]]], ["Thus, under some circumstances even tumor cells over-expressing Ras may respond to type I IFN or to stimulants of pattern recognition receptors, activating PKR and inhibiting virus translation.", [["tumor cells", "ANATOMY", 36, 47], ["tumor", "DISEASE", 36, 41], ["tumor cells", "CELL", 36, 47], ["Ras", "GENE_OR_GENE_PRODUCT", 64, 67], ["type I IFN", "GENE_OR_GENE_PRODUCT", 83, 93], ["pattern recognition receptors", "GENE_OR_GENE_PRODUCT", 114, 143], ["PKR", "GENE_OR_GENE_PRODUCT", 156, 159], ["tumor cells", "CELL_TYPE", 36, 47], ["Ras", "PROTEIN", 64, 67], ["type I IFN", "PROTEIN", 83, 93], ["pattern recognition receptors", "PROTEIN", 114, 143], ["PKR", "PROTEIN", 156, 159], ["tumor cells", "PROBLEM", 36, 47], ["activating PKR", "PROBLEM", 145, 159], ["inhibiting virus translation", "PROBLEM", 164, 192], ["tumor", "OBSERVATION", 36, 41]]], ["To complicate matters, MEK-inhibitors have been shown restore antiviral signaling capacity in Ras overexpressing tumors [108, 109] .", [["tumors", "ANATOMY", 113, 119], ["tumors", "DISEASE", 113, 119], ["MEK", "GENE_OR_GENE_PRODUCT", 23, 26], ["Ras", "GENE_OR_GENE_PRODUCT", 94, 97], ["tumors", "CANCER", 113, 119], ["MEK", "PROTEIN", 23, 26], ["Ras", "PROTEIN", 94, 97], ["MEK-inhibitors", "TREATMENT", 23, 37], ["Ras overexpressing tumors", "PROBLEM", 94, 119], ["overexpressing", "OBSERVATION_MODIFIER", 98, 112], ["tumors", "OBSERVATION", 113, 119]]], ["This implies that human tumors treated with MEK-inhibitors, such as Trametinib which was recently approved for treatment of BRAF-mutated melanoma, may be poor targets for oncolytic viruses as antiviral signaling capacity in such tumors may be restored.TUMOR NORMALSome oncolytic viruses, such as members of the poxvirus family, are seemingly resistant to the antiviral effects of type I IFNs in vitro and may be controlled by other cellular factors [113] [114] [115] [116] .", [["tumors", "ANATOMY", 24, 30], ["melanoma", "ANATOMY", 137, 145], ["tumors", "ANATOMY", 229, 235], ["cellular", "ANATOMY", 432, 440], ["tumors", "DISEASE", 24, 30], ["Trametinib", "CHEMICAL", 68, 78], ["BRAF-mutated melanoma", "DISEASE", 124, 145], ["tumors", "DISEASE", 229, 235], ["Trametinib", "CHEMICAL", 68, 78], ["human", "ORGANISM", 18, 23], ["tumors", "CANCER", 24, 30], ["MEK", "GENE_OR_GENE_PRODUCT", 44, 47], ["Trametinib", "SIMPLE_CHEMICAL", 68, 78], ["BRAF", "GENE_OR_GENE_PRODUCT", 124, 128], ["melanoma", "CANCER", 137, 145], ["tumors", "CANCER", 229, 235], ["type I IFNs", "GENE_OR_GENE_PRODUCT", 380, 391], ["cellular", "CELL", 432, 440], ["MEK", "PROTEIN", 44, 47], ["type I IFNs", "PROTEIN", 380, 391], ["cellular factors", "PROTEIN", 432, 448], ["human", "SPECIES", 18, 23], ["human", "SPECIES", 18, 23], ["human tumors", "PROBLEM", 18, 30], ["MEK-inhibitors", "TREATMENT", 44, 58], ["Trametinib", "TREATMENT", 68, 78], ["BRAF", "PROBLEM", 124, 128], ["mutated melanoma", "PROBLEM", 129, 145], ["oncolytic viruses", "PROBLEM", 171, 188], ["antiviral signaling capacity", "PROBLEM", 192, 220], ["such tumors", "PROBLEM", 224, 235], ["TUMOR NORMALSome oncolytic viruses", "PROBLEM", 252, 286], ["type I IFNs", "PROBLEM", 380, 391], ["tumors", "OBSERVATION", 24, 30], ["BRAF", "OBSERVATION", 124, 128], ["melanoma", "OBSERVATION", 137, 145], ["tumors", "OBSERVATION", 229, 235], ["oncolytic viruses", "OBSERVATION", 269, 286]]], ["However, in most cases, sensitivity or resistance to type I IFN is assessed in vitro and using only one cytokine, which may mask synergies with other factors present in vivo.", [["type I IFN", "GENE_OR_GENE_PRODUCT", 53, 63], ["type I IFN", "PROTEIN", 53, 63], ["cytokine", "PROTEIN", 104, 112]]], ["One possible explanation for the in vitro-in vivo discrepancy is the tumor micro-environment, which not only imposes physical barriers to oncolytic viruses but also alters intracellular antiviral defenses.", [["tumor", "ANATOMY", 69, 74], ["intracellular", "ANATOMY", 172, 185], ["tumor", "DISEASE", 69, 74], ["tumor", "CANCER", 69, 74], ["intracellular", "IMMATERIAL_ANATOMICAL_ENTITY", 172, 185], ["the in vitro-in vivo discrepancy", "PROBLEM", 29, 61], ["the tumor micro-environment", "PROBLEM", 65, 92], ["oncolytic viruses", "PROBLEM", 138, 155], ["possible explanation for", "UNCERTAINTY", 4, 28], ["tumor", "OBSERVATION", 69, 74], ["antiviral defenses", "OBSERVATION", 186, 204]]], ["For example, glioma cells were found in the brain to spontaneously secrete type I IFN, which conferred resistance against oncolytic HSV.", [["glioma cells", "ANATOMY", 13, 25], ["brain", "ANATOMY", 44, 49], ["glioma", "DISEASE", 13, 19], ["glioma cells", "CELL", 13, 25], ["brain", "ORGAN", 44, 49], ["type I IFN", "GENE_OR_GENE_PRODUCT", 75, 85], ["HSV", "ORGANISM", 132, 135], ["glioma cells", "CELL_TYPE", 13, 25], ["type I IFN", "PROTEIN", 75, 85], ["HSV", "SPECIES", 132, 135], ["glioma cells", "PROBLEM", 13, 25], ["oncolytic HSV", "PROBLEM", 122, 135], ["glioma cells", "OBSERVATION", 13, 25], ["brain", "ANATOMY", 44, 49]]], ["Resistance was linked to ECM protein CCN1 interaction with glioma cell surface receptor alpha 6 beta 1 integrin, which activated interferon secretion [117] .", [["ECM", "ANATOMY", 25, 28], ["glioma cell surface", "ANATOMY", 59, 78], ["ECM", "CELLULAR_COMPONENT", 25, 28], ["CCN1", "GENE_OR_GENE_PRODUCT", 37, 41], ["glioma cell surface receptor alpha 6 beta 1 integrin", "GENE_OR_GENE_PRODUCT", 59, 111], ["interferon", "GENE_OR_GENE_PRODUCT", 129, 139], ["ECM protein", "PROTEIN", 25, 36], ["CCN1", "PROTEIN", 37, 41], ["glioma cell surface receptor alpha 6 beta 1 integrin", "PROTEIN", 59, 111], ["interferon", "PROTEIN", 129, 139], ["glioma cell surface", "TEST", 59, 78], ["alpha", "TEST", 88, 93], ["beta 1 integrin", "TREATMENT", 96, 111], ["activated interferon secretion", "PROBLEM", 119, 149], ["protein CCN1", "OBSERVATION", 29, 41], ["glioma cell", "OBSERVATION", 59, 70]]], ["It is tempting to speculate whether this or a similar ECM-glioma-interaction could have contributed to the resistance of syngeneic glioma cells we observed in vivo but not in vitro to both oncolytic SFV and vaccinia virus (FIG2; [60] ).", [["ECM-glioma", "ANATOMY", 54, 64], ["glioma cells", "ANATOMY", 131, 143], ["glioma", "DISEASE", 58, 64], ["glioma", "DISEASE", 131, 137], ["ECM", "CELLULAR_COMPONENT", 54, 57], ["glioma", "CANCER", 58, 64], ["syngeneic glioma cells", "CELL", 121, 143], ["oncolytic SFV", "ORGANISM", 189, 202], ["vaccinia virus", "ORGANISM", 207, 221], ["syngeneic glioma cells", "CELL_TYPE", 121, 143], ["SFV", "SPECIES", 199, 202], ["vaccinia virus", "SPECIES", 207, 221], ["glioma", "PROBLEM", 58, 64], ["syngeneic glioma cells", "PROBLEM", 121, 143], ["oncolytic SFV", "TREATMENT", 189, 202], ["vaccinia virus", "TREATMENT", 207, 221], ["glioma", "OBSERVATION", 58, 64], ["syngeneic glioma cells", "OBSERVATION", 121, 143]]], ["Also, while critical in many respects, antiviral signaling may occur without signaling via type I IFN receptor (IFNAR).", [["type I IFN receptor", "GENE_OR_GENE_PRODUCT", 91, 110], ["IFNAR", "GENE_OR_GENE_PRODUCT", 112, 117], ["type I IFN receptor", "PROTEIN", 91, 110], ["IFNAR", "PROTEIN", 112, 117], ["antiviral signaling", "PROBLEM", 39, 58]]], ["For instance, upon infection of IFNAR KO mice with murine hepatitis virus (MHV), brain cells were found to have upregulated antiviral GTPase TGTP and IFITm1 and IFITm3, all of which have confirmed antiviral activity in vivo against a variety of viruses [118] .", [["brain cells", "ANATOMY", 81, 92], ["infection", "DISEASE", 19, 28], ["murine hepatitis virus", "DISEASE", 51, 73], ["IFNAR KO mice", "ORGANISM", 32, 45], ["murine hepatitis virus", "ORGANISM", 51, 73], ["MHV", "ORGANISM", 75, 78], ["brain cells", "CELL", 81, 92], ["TGTP", "GENE_OR_GENE_PRODUCT", 141, 145], ["IFITm1", "GENE_OR_GENE_PRODUCT", 150, 156], ["IFITm3", "GENE_OR_GENE_PRODUCT", 161, 167], ["IFNAR", "PROTEIN", 32, 37], ["brain cells", "CELL_TYPE", 81, 92], ["antiviral GTPase", "PROTEIN", 124, 140], ["TGTP", "PROTEIN", 141, 145], ["IFITm1", "PROTEIN", 150, 156], ["IFITm3", "PROTEIN", 161, 167], ["mice", "SPECIES", 41, 45], ["murine", "SPECIES", 51, 57], ["hepatitis virus", "SPECIES", 58, 73], ["mice", "SPECIES", 41, 45], ["murine hepatitis virus", "SPECIES", 51, 73], ["MHV", "SPECIES", 75, 78], ["murine hepatitis virus", "PROBLEM", 51, 73], ["brain cells", "PROBLEM", 81, 92], ["upregulated antiviral GTPase TGTP", "PROBLEM", 112, 145], ["IFITm3", "PROBLEM", 161, 167], ["brain", "ANATOMY", 81, 86], ["antiviral GTPase", "OBSERVATION", 124, 140], ["antiviral activity", "OBSERVATION", 197, 215]]], ["In these cases, IFN gamma and TNF alpha likely account for at least part of the observed ISG activity, where e.g., TGTP is upregulated by IFN-\uf067 signaling and TNF\u03b1 has been shown to induce ISG15 independently of IFNAR [119] .TUMOR NORMALInterestingly, while most cancers are heterogeneous in antiviral defence signaling, one broad class of tumors in particular may display consistently low capacity to ward off oncolytic viruses; oncovirus-induced cancers.", [["cancers", "ANATOMY", 262, 269], ["tumors", "ANATOMY", 339, 345], ["cancers", "ANATOMY", 447, 454], ["cancers", "DISEASE", 262, 269], ["tumors", "DISEASE", 339, 345], ["oncovirus", "CHEMICAL", 429, 438], ["cancers", "DISEASE", 447, 454], ["IFN gamma", "GENE_OR_GENE_PRODUCT", 16, 25], ["TNF alpha", "GENE_OR_GENE_PRODUCT", 30, 39], ["ISG", "GENE_OR_GENE_PRODUCT", 89, 92], ["TGTP", "GENE_OR_GENE_PRODUCT", 115, 119], ["IFN-\uf067", "GENE_OR_GENE_PRODUCT", 138, 143], ["TNF\u03b1", "GENE_OR_GENE_PRODUCT", 158, 162], ["ISG15", "GENE_OR_GENE_PRODUCT", 188, 193], ["IFNAR [119]", "GENE_OR_GENE_PRODUCT", 211, 222], ["cancers", "CANCER", 262, 269], ["tumors", "CANCER", 339, 345], ["oncovirus", "SIMPLE_CHEMICAL", 429, 438], ["cancers", "CANCER", 447, 454], ["IFN gamma", "PROTEIN", 16, 25], ["TNF alpha", "PROTEIN", 30, 39], ["TGTP", "PROTEIN", 115, 119], ["IFN", "PROTEIN", 138, 141], ["TNF\u03b1", "PROTEIN", 158, 162], ["ISG15", "PROTEIN", 188, 193], ["IFN gamma", "TEST", 16, 25], ["TNF alpha", "TEST", 30, 39], ["IFN", "TEST", 138, 141], ["TNF", "TEST", 158, 161], ["TUMOR NORMALInterestingly", "PROBLEM", 224, 249], ["most cancers", "PROBLEM", 257, 269], ["heterogeneous in antiviral defence signaling", "PROBLEM", 274, 318], ["tumors", "PROBLEM", 339, 345], ["consistently low capacity", "PROBLEM", 372, 397], ["oncolytic viruses", "PROBLEM", 410, 427], ["oncovirus-induced cancers", "PROBLEM", 429, 454], ["ISG activity", "OBSERVATION", 89, 101], ["most", "OBSERVATION_MODIFIER", 257, 261], ["cancers", "OBSERVATION", 262, 269], ["heterogeneous", "OBSERVATION_MODIFIER", 274, 287], ["antiviral defence", "OBSERVATION", 291, 308], ["broad", "OBSERVATION_MODIFIER", 324, 329], ["tumors", "OBSERVATION", 339, 345], ["low capacity", "OBSERVATION_MODIFIER", 385, 397], ["cancers", "OBSERVATION", 447, 454]]], ["This is because oncoviruses, as all viruses, carry a complement of factors that abrogate antiviral sensors and effectors, which may result in tumors that are uniformly devoid of antiviral signaling.", [["tumors", "ANATOMY", 142, 148], ["tumors", "DISEASE", 142, 148], ["oncoviruses", "GENE_OR_GENE_PRODUCT", 16, 27], ["tumors", "CANCER", 142, 148], ["oncoviruses", "PROBLEM", 16, 27], ["all viruses", "PROBLEM", 32, 43], ["antiviral sensors", "TREATMENT", 89, 106], ["tumors", "PROBLEM", 142, 148], ["antiviral signaling", "PROBLEM", 178, 197], ["tumors", "OBSERVATION", 142, 148], ["antiviral signaling", "OBSERVATION", 178, 197]]], ["In an intriguing study, oncolytic VSV infected and destroyed human papilloma virus (HPV)-positive cervical carcinoma cells more effectively than HPV-negative head-and neck cancer cells due to HPV E6-mediated suppression of antiviral signaling [120] .", [["cervical carcinoma cells", "ANATOMY", 98, 122], ["head-and neck cancer cells", "ANATOMY", 158, 184], ["VSV infected", "DISEASE", 34, 46], ["human papilloma virus (HPV)-positive cervical carcinoma", "DISEASE", 61, 116], ["head-and neck cancer", "DISEASE", 158, 178], ["VSV", "ORGANISM", 34, 37], ["human papilloma virus", "ORGANISM", 61, 82], ["HPV", "ORGANISM", 84, 87], ["cervical carcinoma cells", "CELL", 98, 122], ["HPV", "ORGANISM", 145, 148], ["head-and neck cancer cells", "CELL", 158, 184], ["HPV", "ORGANISM", 192, 195], ["E6", "GENE_OR_GENE_PRODUCT", 196, 198], ["human papilloma virus (HPV)-positive cervical carcinoma cells", "CELL_TYPE", 61, 122], ["HPV-negative head-and neck cancer cells", "CELL_TYPE", 145, 184], ["E6", "PROTEIN", 196, 198], ["VSV", "SPECIES", 34, 37], ["human", "SPECIES", 61, 66], ["papilloma virus", "SPECIES", 67, 82], ["VSV", "SPECIES", 34, 37], ["human papilloma virus", "SPECIES", 61, 82], ["HPV", "SPECIES", 84, 87], ["HPV", "SPECIES", 145, 148], ["an intriguing study", "TEST", 3, 22], ["oncolytic VSV infected", "PROBLEM", 24, 46], ["destroyed human papilloma virus", "PROBLEM", 51, 82], ["positive cervical carcinoma cells", "PROBLEM", 89, 122], ["HPV", "TEST", 145, 148], ["head-and neck cancer cells", "PROBLEM", 158, 184], ["HPV E6", "TREATMENT", 192, 198], ["antiviral signaling", "TREATMENT", 223, 242], ["papilloma virus", "OBSERVATION", 67, 82], ["cervical", "ANATOMY", 98, 106], ["carcinoma", "OBSERVATION", 107, 116], ["head", "ANATOMY", 158, 162], ["neck", "ANATOMY", 167, 171], ["cancer", "OBSERVATION", 172, 178]]], ["HPV-positive or E6-expressing xenografts were efficiently eradicated from nude mice following VSV injection.", [["xenografts", "ANATOMY", 30, 40], ["HPV", "ORGANISM", 0, 3], ["E6", "GENE_OR_GENE_PRODUCT", 16, 18], ["xenografts", "CANCER", 30, 40], ["nude mice", "ORGANISM", 74, 83], ["VSV", "ORGANISM", 94, 97], ["E6", "PROTEIN", 16, 18], ["mice", "SPECIES", 79, 83], ["HPV", "SPECIES", 0, 3], ["mice", "SPECIES", 79, 83], ["VSV", "SPECIES", 94, 97], ["HPV", "TEST", 0, 3], ["E6-expressing xenografts", "TREATMENT", 16, 40], ["VSV injection", "TREATMENT", 94, 107], ["positive", "OBSERVATION", 4, 12]]], ["The potential of this approach is that even oncolytic viruses that are extremely sensitive to type I IFN, such as attenuated SFV or M-mutated VSV, may function well against oncovirus-induced cancers where the oncovirus machinery ensures the lack of antiviral defense.Exogenous Combination Therapy to Overcome Innate DefensesWhile on first thought it would appear counterintuitive to antagonize the very factors that keep oncolytic viruses tumor-specific, emerging data shows that this can be accomplished in a safe way.", [["cancers", "ANATOMY", 191, 198], ["tumor", "ANATOMY", 439, 444], ["oncovirus", "CHEMICAL", 173, 182], ["cancers", "DISEASE", 191, 198], ["tumor", "DISEASE", 439, 444], ["type I IFN", "GENE_OR_GENE_PRODUCT", 94, 104], ["SFV", "ORGANISM", 125, 128], ["VSV", "ORGANISM", 142, 145], ["oncovirus", "ORGANISM", 173, 182], ["cancers", "CANCER", 191, 198], ["tumor", "CANCER", 439, 444], ["type I IFN", "PROTEIN", 94, 104], ["SFV", "SPECIES", 125, 128], ["VSV", "SPECIES", 142, 145], ["this approach", "TREATMENT", 17, 30], ["oncolytic viruses", "PROBLEM", 44, 61], ["type I IFN", "PROBLEM", 94, 104], ["attenuated SFV", "PROBLEM", 114, 128], ["M-mutated VSV", "PROBLEM", 132, 145], ["oncovirus-induced cancers", "PROBLEM", 173, 198], ["Exogenous Combination Therapy", "TREATMENT", 267, 296], ["oncolytic viruses tumor", "PROBLEM", 421, 444], ["cancers", "OBSERVATION", 191, 198], ["antiviral defense", "OBSERVATION", 249, 266]]], ["One of the foremost strategies to increase oncolytic virus efficacy is to combine them with drugs that lower tumor antiviral defenses.", [["tumor", "ANATOMY", 109, 114], ["tumor", "DISEASE", 109, 114], ["tumor", "CANCER", 109, 114], ["oncolytic virus efficacy", "TREATMENT", 43, 67], ["drugs", "TREATMENT", 92, 97], ["lower tumor antiviral defenses", "PROBLEM", 103, 133], ["tumor", "OBSERVATION", 109, 114], ["antiviral defenses", "OBSERVATION", 115, 133]]], ["In this regard, a primary target for interference is the prototypical type I IFN signaling cascade.", [["type I IFN", "GENE_OR_GENE_PRODUCT", 70, 80], ["IFN", "PROTEIN", 77, 80]]], ["While small molecular inhibitors against IFNAR are not available, activity of downstream signaling transducers may effectively be blocked.", [["IFNAR", "GENE_OR_GENE_PRODUCT", 41, 46], ["IFNAR", "PROTEIN", 41, 46], ["small molecular inhibitors", "TREATMENT", 6, 32], ["downstream signaling transducers", "TREATMENT", 78, 110]]], ["Human pancreatic cancer cells were shown to constitutively express high levels of MxA and OAS and to mount type I IFN-dependent resistance to oncolytic VSV.", [["pancreatic cancer cells", "ANATOMY", 6, 29], ["pancreatic cancer", "DISEASE", 6, 23], ["Human", "ORGANISM", 0, 5], ["pancreatic cancer cells", "CELL", 6, 29], ["MxA", "GENE_OR_GENE_PRODUCT", 82, 85], ["type I IFN", "GENE_OR_GENE_PRODUCT", 107, 117], ["VSV", "ORGANISM", 152, 155], ["Human pancreatic cancer cells", "CELL_TYPE", 0, 29], ["MxA", "PROTEIN", 82, 85], ["OAS", "PROTEIN", 90, 93], ["IFN", "PROTEIN", 114, 117], ["Human", "SPECIES", 0, 5], ["Human", "SPECIES", 0, 5], ["VSV", "SPECIES", 152, 155], ["Human pancreatic cancer cells", "PROBLEM", 0, 29], ["high levels of MxA and OAS", "PROBLEM", 67, 93], ["dependent resistance", "PROBLEM", 118, 138], ["oncolytic VSV", "TREATMENT", 142, 155], ["pancreatic", "ANATOMY", 6, 16], ["cancer", "OBSERVATION", 17, 23]]], ["Resistance could be overcome by blocking activity of IFNAR-associated Janus kinase (JAK) 1 [100, 113] .", [["IFNAR", "GENE_OR_GENE_PRODUCT", 53, 58], ["Janus kinase (JAK) 1", "GENE_OR_GENE_PRODUCT", 70, 90], ["IFNAR", "PROTEIN", 53, 58], ["Janus kinase (JAK) 1", "PROTEIN", 70, 90]]], ["Similarly, JAK1/2 inhibitor ruxolitinib overcame type I IFN-dependent resistance of human SCC25 head and neck cancer cells against oncolytic VSV [121] .", [["SCC25 head and neck cancer cells", "ANATOMY", 90, 122], ["ruxolitinib", "CHEMICAL", 28, 39], ["head and neck cancer", "DISEASE", 96, 116], ["ruxolitinib", "CHEMICAL", 28, 39], ["JAK1/2", "GENE_OR_GENE_PRODUCT", 11, 17], ["ruxolitinib", "SIMPLE_CHEMICAL", 28, 39], ["type I IFN", "GENE_OR_GENE_PRODUCT", 49, 59], ["human", "ORGANISM", 84, 89], ["SCC25 head and neck cancer cells", "CELL", 90, 122], ["VSV", "ORGANISM", 141, 144], ["JAK1", "PROTEIN", 11, 15], ["IFN", "PROTEIN", 56, 59], ["human SCC25 head and neck cancer cells", "CELL_TYPE", 84, 122], ["human", "SPECIES", 84, 89], ["human", "SPECIES", 84, 89], ["VSV", "SPECIES", 141, 144], ["JAK1/2 inhibitor ruxolitinib", "TREATMENT", 11, 39], ["type I IFN", "PROBLEM", 49, 59], ["dependent resistance of human SCC25 head and neck cancer cells", "PROBLEM", 60, 122], ["oncolytic VSV", "PROBLEM", 131, 144], ["head", "ANATOMY", 96, 100], ["neck", "ANATOMY", 105, 109], ["cancer", "OBSERVATION", 110, 116]]], ["Ruxolitinib also successfully abrogated type I IFN-mediated antiviral effects elicited by macrophages [58] , highlighting that this drug might also alleviate type I IFN-dependent tumor resistance to oncolytic viruses imposed by stromal cells.", [["macrophages", "ANATOMY", 90, 101], ["tumor", "ANATOMY", 179, 184], ["stromal cells", "ANATOMY", 228, 241], ["Ruxolitinib", "CHEMICAL", 0, 11], ["tumor", "DISEASE", 179, 184], ["Ruxolitinib", "CHEMICAL", 0, 11], ["Ruxolitinib", "SIMPLE_CHEMICAL", 0, 11], ["type I IFN", "GENE_OR_GENE_PRODUCT", 40, 50], ["macrophages", "CELL", 90, 101], ["type I IFN", "GENE_OR_GENE_PRODUCT", 158, 168], ["tumor", "CANCER", 179, 184], ["stromal cells", "CELL", 228, 241], ["type I IFN", "PROTEIN", 40, 50], ["macrophages", "CELL_TYPE", 90, 101], ["IFN", "PROTEIN", 165, 168], ["stromal cells", "CELL_TYPE", 228, 241], ["Ruxolitinib", "TREATMENT", 0, 11], ["antiviral effects", "TREATMENT", 60, 77], ["type I IFN", "PROBLEM", 158, 168], ["dependent tumor resistance", "PROBLEM", 169, 195], ["oncolytic viruses", "PROBLEM", 199, 216], ["stromal cells", "PROBLEM", 228, 241], ["dependent", "OBSERVATION_MODIFIER", 169, 178], ["tumor", "OBSERVATION", 179, 184], ["oncolytic viruses", "OBSERVATION", 199, 216], ["stromal cells", "OBSERVATION", 228, 241]]], ["However, the obvious downside to using JAK1-inhibitors is their effects on critical host defense mechanisms, which may result in increased infection of normal cells.", [["cells", "ANATOMY", 159, 164], ["infection", "DISEASE", 139, 148], ["JAK1", "GENE_OR_GENE_PRODUCT", 39, 43], ["cells", "CELL", 159, 164], ["JAK1", "PROTEIN", 39, 43], ["normal cells", "CELL_TYPE", 152, 164], ["JAK1-inhibitors", "TREATMENT", 39, 54], ["increased infection of normal cells", "PROBLEM", 129, 164], ["host defense", "OBSERVATION_MODIFIER", 84, 96], ["increased", "OBSERVATION_MODIFIER", 129, 138], ["infection", "OBSERVATION", 139, 148], ["normal cells", "OBSERVATION", 152, 164]]], ["Moreover, JAK1-inhibitors may reduce anti-tumor immune responses elicited by oncolytic virotherapy.", [["JAK1", "GENE_OR_GENE_PRODUCT", 10, 14], ["anti-tumor", "CANCER", 37, 47], ["JAK1", "PROTEIN", 10, 14], ["JAK1-inhibitors", "TREATMENT", 10, 25], ["anti-tumor immune responses", "PROBLEM", 37, 64], ["oncolytic virotherapy", "TREATMENT", 77, 98]]], ["For example, ruxolitinib was shown to impair the capacity of dendritic cells promote CD8 T cell responses against model tumor antigens [122] .", [["dendritic cells", "ANATOMY", 61, 76], ["CD8 T cell", "ANATOMY", 85, 95], ["tumor", "ANATOMY", 120, 125], ["ruxolitinib", "CHEMICAL", 13, 24], ["tumor", "DISEASE", 120, 125], ["ruxolitinib", "CHEMICAL", 13, 24], ["ruxolitinib", "SIMPLE_CHEMICAL", 13, 24], ["dendritic cells", "CELL", 61, 76], ["CD8 T cell", "CELL", 85, 95], ["tumor", "CANCER", 120, 125], ["dendritic cells", "CELL_TYPE", 61, 76], ["ruxolitinib", "TREATMENT", 13, 24], ["dendritic cells", "PROBLEM", 61, 76], ["model tumor antigens", "PROBLEM", 114, 134], ["ruxolitinib", "OBSERVATION", 13, 24], ["dendritic cells", "OBSERVATION", 61, 76], ["tumor", "OBSERVATION", 120, 125]]], ["On the other hand, in this study clearance of adenovirus was delayed in ruxolitinib-treated normal animals, which makes it difficult to predict the overall impact of JAK1-inhibitors on tumor therapy where prolonged virus presence might translate to better therapeutic efficacy.", [["tumor", "ANATOMY", 185, 190], ["ruxolitinib", "CHEMICAL", 72, 83], ["tumor", "DISEASE", 185, 190], ["ruxolitinib", "CHEMICAL", 72, 83], ["adenovirus", "ORGANISM", 46, 56], ["ruxolitinib", "SIMPLE_CHEMICAL", 72, 83], ["JAK1", "GENE_OR_GENE_PRODUCT", 166, 170], ["tumor", "CANCER", 185, 190], ["JAK1", "PROTEIN", 166, 170], ["adenovirus", "SPECIES", 46, 56], ["adenovirus", "PROBLEM", 46, 56], ["ruxolitinib", "TREATMENT", 72, 83], ["JAK1-inhibitors", "TREATMENT", 166, 181], ["tumor therapy", "TREATMENT", 185, 198], ["prolonged virus presence", "PROBLEM", 205, 229]]], ["Also, while the immune-stimulating and anti-tumor effects of type I and type II interferons may be adversely affected by JAK-inhibitors, central tumor-promoting cascades mediated by JAKs, such as IL-6-STAT3, may also be inhibited [123] , yielding a difficult-to-predict net therapeutic outcome.", [["tumor", "ANATOMY", 145, 150], ["tumor", "DISEASE", 145, 150], ["anti-tumor", "CANCER", 39, 49], ["type I", "GENE_OR_GENE_PRODUCT", 61, 67], ["type II interferons", "GENE_OR_GENE_PRODUCT", 72, 91], ["JAK", "GENE_OR_GENE_PRODUCT", 121, 124], ["tumor", "CANCER", 145, 150], ["JAKs", "GENE_OR_GENE_PRODUCT", 182, 186], ["IL-6", "GENE_OR_GENE_PRODUCT", 196, 200], ["STAT3", "GENE_OR_GENE_PRODUCT", 201, 206], ["type I and type II interferons", "PROTEIN", 61, 91], ["JAK", "PROTEIN", 121, 124], ["JAKs", "PROTEIN", 182, 186], ["IL-6", "PROTEIN", 196, 200], ["STAT3", "PROTEIN", 201, 206], ["the immune-stimulating", "TREATMENT", 12, 34], ["type I", "PROBLEM", 61, 67], ["type II interferons", "TREATMENT", 72, 91], ["JAK-inhibitors", "TREATMENT", 121, 135], ["central tumor", "PROBLEM", 137, 150], ["central", "OBSERVATION_MODIFIER", 137, 144], ["tumor", "OBSERVATION", 145, 150]]], ["At the moment, more studies are needed to establish the overall impact of interference with JAK1/2 signaling in cancer therapy.Exogenous Combination Therapy to Overcome Innate DefensesSpurred by earlier reports of oncovirus reactivation and promoter enhancement by histone deacetylase (HDAC) inhibitors, this class of agents was assessed for capacity to enhance oncolytic virus potency by inhibiting antiviral responses.", [["cancer", "ANATOMY", 112, 118], ["cancer", "DISEASE", 112, 118], ["JAK1", "GENE_OR_GENE_PRODUCT", 92, 96], ["2", "GENE_OR_GENE_PRODUCT", 97, 98], ["cancer", "CANCER", 112, 118], ["oncovirus", "GENE_OR_GENE_PRODUCT", 214, 223], ["histone deacetylase", "GENE_OR_GENE_PRODUCT", 265, 284], ["HDAC", "GENE_OR_GENE_PRODUCT", 286, 290], ["JAK1", "PROTEIN", 92, 96], ["histone deacetylase", "PROTEIN", 265, 284], ["HDAC", "PROTEIN", 286, 290], ["cancer therapy", "TREATMENT", 112, 126], ["Exogenous Combination Therapy", "TREATMENT", 127, 156], ["oncovirus reactivation", "PROBLEM", 214, 236], ["promoter enhancement", "PROBLEM", 241, 261], ["histone deacetylase (HDAC) inhibitors", "TREATMENT", 265, 302], ["agents", "TREATMENT", 318, 324], ["capacity", "PROBLEM", 342, 350], ["oncolytic virus potency", "TREATMENT", 362, 385], ["cancer", "OBSERVATION", 112, 118]]], ["Indeed, such enhancement was observed with oncolytic VSV and SFV, and while it has been difficult to pinpoint the exact mechanisms that underlie HDAC-inhibitor enhancement of oncolytic virus replication in cancer cells, antiviral defenses in general are inhibited-for yet unknown reasons mainly in cancer cells and not in normal cells, which indirectly facilitates virus replication [124] .", [["cancer cells", "ANATOMY", 206, 218], ["cancer cells", "ANATOMY", 298, 310], ["cells", "ANATOMY", 329, 334], ["cancer", "DISEASE", 206, 212], ["cancer", "DISEASE", 298, 304], ["VSV", "ORGANISM", 53, 56], ["SFV", "ORGANISM", 61, 64], ["HDAC", "GENE_OR_GENE_PRODUCT", 145, 149], ["oncolytic virus", "ORGANISM", 175, 190], ["cancer cells", "CELL", 206, 218], ["cancer cells", "CELL", 298, 310], ["cells", "CELL", 329, 334], ["HDAC", "PROTEIN", 145, 149], ["cancer cells", "CELL_TYPE", 206, 218], ["cancer cells", "CELL_TYPE", 298, 310], ["normal cells", "CELL_TYPE", 322, 334], ["VSV", "SPECIES", 53, 56], ["SFV", "SPECIES", 61, 64], ["such enhancement", "PROBLEM", 8, 24], ["oncolytic VSV", "TREATMENT", 43, 56], ["HDAC-inhibitor enhancement", "TREATMENT", 145, 171], ["oncolytic virus replication", "TREATMENT", 175, 202], ["cancer cells", "PROBLEM", 206, 218], ["antiviral defenses", "TREATMENT", 220, 238], ["cancer cells", "PROBLEM", 298, 310], ["SFV", "ANATOMY", 61, 64], ["oncolytic virus", "OBSERVATION", 175, 190], ["cancer cells", "OBSERVATION", 206, 218], ["cancer cells", "OBSERVATION", 298, 310], ["normal cells", "OBSERVATION", 322, 334]]], ["Interestingly, combination of HDAC inhibitors with conditionally replicating \u039424 E1A-deleted adenovirus gave improved virus replication rate and therapeutic efficacy in subcutaneous xenograft models only when the inhibitors were given before the virus, otherwise inhibition of replication was observed [125] .", [["subcutaneous xenograft", "ANATOMY", 169, 191], ["HDAC", "GENE_OR_GENE_PRODUCT", 30, 34], ["E1A", "GENE_OR_GENE_PRODUCT", 81, 84], ["adenovirus", "ORGANISM", 93, 103], ["xenograft", "CANCER", 182, 191], ["HDAC", "PROTEIN", 30, 34], ["\u039424 E1A", "DNA", 77, 84], ["HDAC inhibitors", "TREATMENT", 30, 45], ["deleted adenovirus", "PROBLEM", 85, 103], ["improved virus replication rate", "PROBLEM", 109, 140], ["subcutaneous xenograft models", "TREATMENT", 169, 198], ["the inhibitors", "TREATMENT", 209, 223], ["the virus", "PROBLEM", 242, 251], ["therapeutic", "OBSERVATION_MODIFIER", 145, 156], ["efficacy", "OBSERVATION_MODIFIER", 157, 165], ["subcutaneous xenograft", "OBSERVATION", 169, 191]]], ["Similarly, HDAC inhibitors increased replication and oncolytic efficacy of HSV when given before the virus but not when given at the same time [126, 127] .", [["HDAC", "GENE_OR_GENE_PRODUCT", 11, 15], ["HSV", "ORGANISM", 75, 78], ["HDAC", "PROTEIN", 11, 15], ["HSV", "SPECIES", 75, 78], ["HDAC inhibitors", "TREATMENT", 11, 26], ["HSV", "PROBLEM", 75, 78], ["the virus", "PROBLEM", 97, 106]]], ["With nuclear DNA viruses, such as adenovirus and HSV, it is possible that HDAC inhibitors also alter virus genome accessibility to transcription factors, resulting in reduced replication or other adverse effects, implying that with these viruses HDAC inhibitors should be administered before the viruses.Exogenous Combination Therapy to Overcome Innate DefensesRecently, it was found that HDAC inhibitor vorinostat activates Nf\uf06bB signaling by facilitating hyperacetylation of the p65 subunit, which in turn activates cellular autophagy [128] .", [["nuclear", "ANATOMY", 5, 12], ["cellular", "ANATOMY", 517, 525], ["vorinostat", "CHEMICAL", 404, 414], ["vorinostat", "CHEMICAL", 404, 414], ["nuclear", "CELLULAR_COMPONENT", 5, 12], ["DNA", "CELLULAR_COMPONENT", 13, 16], ["adenovirus", "ORGANISM", 34, 44], ["HSV", "ORGANISM", 49, 52], ["HDAC", "GENE_OR_GENE_PRODUCT", 74, 78], ["HDAC", "GENE_OR_GENE_PRODUCT", 246, 250], ["HDAC", "GENE_OR_GENE_PRODUCT", 389, 393], ["vorinostat", "SIMPLE_CHEMICAL", 404, 414], ["Nf\uf06bB", "GENE_OR_GENE_PRODUCT", 425, 429], ["p65", "GENE_OR_GENE_PRODUCT", 480, 483], ["cellular", "CELL", 517, 525], ["transcription factors", "PROTEIN", 131, 152], ["Nf\uf06bB", "PROTEIN", 425, 429], ["p65 subunit", "PROTEIN", 480, 491], ["adenovirus", "SPECIES", 34, 44], ["HSV", "SPECIES", 49, 52], ["nuclear DNA viruses", "PROBLEM", 5, 24], ["adenovirus", "PROBLEM", 34, 44], ["HSV", "PROBLEM", 49, 52], ["HDAC inhibitors", "TREATMENT", 74, 89], ["reduced replication", "PROBLEM", 167, 186], ["other adverse effects", "PROBLEM", 190, 211], ["these viruses HDAC inhibitors", "TREATMENT", 232, 261], ["the viruses", "PROBLEM", 292, 303], ["Exogenous Combination Therapy", "TREATMENT", 304, 333], ["HDAC inhibitor vorinostat", "TREATMENT", 389, 414], ["hyperacetylation of the p65 subunit", "TREATMENT", 456, 491], ["cellular autophagy", "TEST", 517, 535], ["DNA viruses", "OBSERVATION", 13, 24]]], ["Autophagy was in another study shown to be important for VSV replication, presumably by inhibiting antiviral signaling.", [["VSV", "ORGANISM", 57, 60], ["VSV", "SPECIES", 57, 60], ["another study", "TEST", 17, 30], ["VSV replication", "TREATMENT", 57, 72]]], ["This is interesting, as a previous study revealed enhancement of VSV replication by inhibiting TNF-alpha-induced antiviral signaling mediated by p65 using Nf\uf06bB inhibitors BMS-345541 or TPCA-1 [129] .", [["BMS-345541", "CHEMICAL", 171, 181], ["TPCA-1", "CHEMICAL", 185, 191], ["BMS-345541", "CHEMICAL", 171, 181], ["VSV", "ORGANISM", 65, 68], ["TNF-alpha", "GENE_OR_GENE_PRODUCT", 95, 104], ["p65", "GENE_OR_GENE_PRODUCT", 145, 148], ["Nf\uf06bB", "SIMPLE_CHEMICAL", 155, 159], ["BMS-345541", "SIMPLE_CHEMICAL", 171, 181], ["TPCA-1", "GENE_OR_GENE_PRODUCT", 185, 191], ["TNF-alpha", "PROTEIN", 95, 104], ["p65", "PROTEIN", 145, 148], ["VSV", "SPECIES", 65, 68], ["a previous study", "TEST", 24, 40], ["VSV replication", "TREATMENT", 65, 80], ["TNF", "TEST", 95, 98], ["alpha", "TEST", 99, 104], ["Nf\uf06bB inhibitors", "TREATMENT", 155, 170], ["BMS", "TEST", 171, 174], ["TPCA", "TEST", 185, 189], ["VSV replication", "OBSERVATION", 65, 80]]], ["In this study, neither inhibitor had an effect on STAT1 or STAT2 phosphorylation or their nuclear relocalization in response to type I IFN but the authors observed clear induction of ISG15, GBP1 and MX1 in response to type I IFN in U87 glioma cells, with the latter two being dependent on Nf\u03baB signaling.", [["nuclear", "ANATOMY", 90, 97], ["U87 glioma cells", "ANATOMY", 232, 248], ["glioma", "DISEASE", 236, 242], ["STAT1", "GENE_OR_GENE_PRODUCT", 50, 55], ["STAT2", "GENE_OR_GENE_PRODUCT", 59, 64], ["nuclear", "CELLULAR_COMPONENT", 90, 97], ["type I IFN", "GENE_OR_GENE_PRODUCT", 128, 138], ["ISG15", "GENE_OR_GENE_PRODUCT", 183, 188], ["GBP1", "GENE_OR_GENE_PRODUCT", 190, 194], ["MX1", "GENE_OR_GENE_PRODUCT", 199, 202], ["type I IFN", "GENE_OR_GENE_PRODUCT", 218, 228], ["U87 glioma cells", "CELL", 232, 248], ["Nf\u03baB", "GENE_OR_GENE_PRODUCT", 289, 293], ["STAT1", "PROTEIN", 50, 55], ["STAT2", "PROTEIN", 59, 64], ["type I IFN", "PROTEIN", 128, 138], ["ISG15", "PROTEIN", 183, 188], ["GBP1", "PROTEIN", 190, 194], ["MX1", "PROTEIN", 199, 202], ["type I IFN", "PROTEIN", 218, 228], ["U87 glioma cells", "CELL_LINE", 232, 248], ["Nf\u03baB", "PROTEIN", 289, 293], ["this study", "TEST", 3, 13], ["STAT2 phosphorylation", "TREATMENT", 59, 80], ["type I IFN", "PROBLEM", 128, 138], ["ISG15", "TEST", 183, 188], ["GBP1", "TEST", 190, 194], ["type I IFN in U87 glioma cells", "PROBLEM", 218, 248], ["U87 glioma cells", "OBSERVATION", 232, 248]]], ["Taken together, Nf\u03baB pathway activation may result in different antiviral responses in different cancer types, and inhibition or enhancement of oncolytic viruses by Nf\uf06bB inhibitors is dependent on other concomitant cellular mechanisms, such as autophagy.Exogenous Combination Therapy to Overcome Innate DefensesSince HDAC inhibitors modulate promoter activity/accessibility, it is conceivable other epigenetic or promoter modifying agents could work in a similar manner to repress antiviral defense induction and enhance oncolytic viruses [130] .", [["cancer", "ANATOMY", 97, 103], ["cellular", "ANATOMY", 215, 223], ["cancer", "DISEASE", 97, 103], ["Nf\u03baB", "GENE_OR_GENE_PRODUCT", 16, 20], ["cancer", "CANCER", 97, 103], ["oncolytic viruses", "ORGANISM", 144, 161], ["Nf\uf06bB", "GENE_OR_GENE_PRODUCT", 165, 169], ["cellular", "CELL", 215, 223], ["HDAC", "GENE_OR_GENE_PRODUCT", 317, 321], ["Nf\u03baB", "PROTEIN", 16, 20], ["different antiviral responses", "PROBLEM", 54, 83], ["different cancer types", "PROBLEM", 87, 109], ["oncolytic viruses", "PROBLEM", 144, 161], ["Nf\uf06bB inhibitors", "TREATMENT", 165, 180], ["other concomitant cellular mechanisms", "PROBLEM", 197, 234], ["Exogenous Combination Therapy", "TREATMENT", 254, 283], ["Innate DefensesSince HDAC inhibitors", "TREATMENT", 296, 332], ["promoter modifying agents", "TREATMENT", 413, 438], ["antiviral defense induction", "TREATMENT", 481, 508], ["enhance oncolytic viruses", "PROBLEM", 513, 538], ["antiviral responses", "OBSERVATION", 64, 83], ["different", "OBSERVATION_MODIFIER", 87, 96], ["cancer", "OBSERVATION", 97, 103], ["oncolytic viruses", "OBSERVATION", 144, 161]]], ["DNA demethylating agents 5-azacytidine (5-Aza) and decitabine synergized with oncolytic herpes simplex type 1 virus in glioma models in vitro and in vivo, as did HDAC inhibitor valproic acid (VPA), which was already shown before to work well with oncolytic HSV as well as several other oncolytic viruses [131] .", [["glioma", "ANATOMY", 119, 125], ["5-azacytidine", "CHEMICAL", 25, 38], ["5-Aza", "CHEMICAL", 40, 45], ["decitabine", "CHEMICAL", 51, 61], ["herpes simplex type 1 virus", "DISEASE", 88, 115], ["glioma", "DISEASE", 119, 125], ["valproic acid", "CHEMICAL", 177, 190], ["VPA", "CHEMICAL", 192, 195], ["5-azacytidine", "CHEMICAL", 25, 38], ["5-Aza", "CHEMICAL", 40, 45], ["decitabine", "CHEMICAL", 51, 61], ["valproic acid", "CHEMICAL", 177, 190], ["VPA", "CHEMICAL", 192, 195], ["DNA", "CELLULAR_COMPONENT", 0, 3], ["5-azacytidine", "SIMPLE_CHEMICAL", 25, 38], ["5-Aza", "SIMPLE_CHEMICAL", 40, 45], ["decitabine", "SIMPLE_CHEMICAL", 51, 61], ["oncolytic", "ORGANISM", 78, 87], ["herpes simplex type 1 virus", "ORGANISM", 88, 115], ["glioma", "CANCER", 119, 125], ["HDAC", "GENE_OR_GENE_PRODUCT", 162, 166], ["valproic acid", "SIMPLE_CHEMICAL", 177, 190], ["VPA", "SIMPLE_CHEMICAL", 192, 195], ["HSV", "ORGANISM", 257, 260], ["HDAC", "PROTEIN", 162, 166], ["herpes simplex type 1 virus", "SPECIES", 88, 115], ["herpes simplex type 1 virus", "SPECIES", 88, 115], ["HSV", "SPECIES", 257, 260], ["DNA demethylating agents", "TREATMENT", 0, 24], ["azacytidine", "TREATMENT", 27, 38], ["Aza)", "TREATMENT", 42, 46], ["decitabine synergized", "TREATMENT", 51, 72], ["oncolytic herpes simplex type 1 virus in glioma models", "PROBLEM", 78, 132], ["HDAC inhibitor valproic acid (VPA)", "TREATMENT", 162, 196], ["oncolytic HSV", "TREATMENT", 247, 260]]], ["Moreover, inhibition of cancer antiviral defenses, specifically RNAseL and PKR, resulted when cancer cells were exposed to sunitinib, a multi-tyrosine kinase inhibitor originally developed as an inhibitor of VEGF-R and PDGF-R signaling, yielding strong anti-tumor synergy with IFN-sensitive oncolytic VSV [132] .", [["cancer", "ANATOMY", 24, 30], ["cancer cells", "ANATOMY", 94, 106], ["cancer", "DISEASE", 24, 30], ["cancer", "DISEASE", 94, 100], ["sunitinib", "CHEMICAL", 123, 132], ["tyrosine", "CHEMICAL", 142, 150], ["IFN", "CHEMICAL", 277, 280], ["sunitinib", "CHEMICAL", 123, 132], ["tyrosine", "CHEMICAL", 142, 150], ["cancer", "CANCER", 24, 30], ["RNAseL", "GENE_OR_GENE_PRODUCT", 64, 70], ["PKR", "GENE_OR_GENE_PRODUCT", 75, 78], ["cancer cells", "CELL", 94, 106], ["sunitinib", "SIMPLE_CHEMICAL", 123, 132], ["VEGF-R", "GENE_OR_GENE_PRODUCT", 208, 214], ["PDGF-R", "GENE_OR_GENE_PRODUCT", 219, 225], ["anti-tumor", "CANCER", 253, 263], ["IFN", "GENE_OR_GENE_PRODUCT", 277, 280], ["VSV", "ORGANISM", 301, 304], ["RNAseL", "PROTEIN", 64, 70], ["PKR", "PROTEIN", 75, 78], ["cancer cells", "CELL_TYPE", 94, 106], ["VEGF", "PROTEIN", 208, 212], ["PDGF", "PROTEIN", 219, 223], ["IFN", "PROTEIN", 277, 280], ["cancer antiviral defenses", "PROBLEM", 24, 49], ["RNAseL", "TEST", 64, 70], ["PKR", "TEST", 75, 78], ["cancer cells", "PROBLEM", 94, 106], ["sunitinib", "TREATMENT", 123, 132], ["a multi-tyrosine kinase inhibitor", "TREATMENT", 134, 167], ["VEGF", "TEST", 208, 212], ["PDGF", "TEST", 219, 223], ["strong anti-tumor synergy", "PROBLEM", 246, 271], ["IFN", "TEST", 277, 280], ["cancer", "OBSERVATION", 24, 30], ["antiviral defenses", "OBSERVATION", 31, 49]]], ["Since sunitinib is approved for renal cell carcinoma and imatinib-resistant gastric cancers, combination with oncolytic VSV constitutes a promising and clinically relevant approach warranting further investigation.", [["renal cell carcinoma", "ANATOMY", 32, 52], ["gastric cancers", "ANATOMY", 76, 91], ["sunitinib", "CHEMICAL", 6, 15], ["renal cell carcinoma", "DISEASE", 32, 52], ["imatinib", "CHEMICAL", 57, 65], ["gastric cancers", "DISEASE", 76, 91], ["sunitinib", "CHEMICAL", 6, 15], ["imatinib", "CHEMICAL", 57, 65], ["sunitinib", "SIMPLE_CHEMICAL", 6, 15], ["renal cell carcinoma", "CANCER", 32, 52], ["imatinib", "SIMPLE_CHEMICAL", 57, 65], ["gastric cancers", "CANCER", 76, 91], ["VSV", "ORGANISM", 120, 123], ["VSV", "SPECIES", 120, 123], ["sunitinib", "TREATMENT", 6, 15], ["renal cell carcinoma", "PROBLEM", 32, 52], ["imatinib-resistant gastric cancers", "PROBLEM", 57, 91], ["oncolytic VSV", "TREATMENT", 110, 123], ["further investigation", "TEST", 192, 213], ["renal", "ANATOMY", 32, 37], ["cell carcinoma", "OBSERVATION", 38, 52], ["resistant", "OBSERVATION_MODIFIER", 66, 75], ["gastric", "ANATOMY", 76, 83], ["cancers", "OBSERVATION", 84, 91]]], ["Interstingly, sunitinib as well as several other receptor tyrosine kinase inhibitors displayed antiviral effects against polyomavirus BK [133] , arguing that these compounds are not universal virus enhancers.Exogenous Combination Therapy to Overcome Innate DefensesCyclophosphamide (CPA) is a general immunosuppressant used to minimize Treg presence during immunotherapy and also oncolytic virotherapy.", [["Treg", "ANATOMY", 336, 340], ["sunitinib", "CHEMICAL", 14, 23], ["tyrosine", "CHEMICAL", 58, 66], ["DefensesCyclophosphamide", "CHEMICAL", 257, 281], ["CPA", "CHEMICAL", 283, 286], ["sunitinib", "CHEMICAL", 14, 23], ["tyrosine", "CHEMICAL", 58, 66], ["DefensesCyclophosphamide", "CHEMICAL", 257, 281], ["CPA", "CHEMICAL", 283, 286], ["sunitinib", "SIMPLE_CHEMICAL", 14, 23], ["polyomavirus BK", "ORGANISM", 121, 136], ["DefensesCyclophosphamide", "SIMPLE_CHEMICAL", 257, 281], ["CPA", "SIMPLE_CHEMICAL", 283, 286], ["Treg", "CELL", 336, 340], ["virus enhancers", "DNA", 192, 207], ["sunitinib", "TREATMENT", 14, 23], ["several other receptor tyrosine kinase inhibitors", "TREATMENT", 35, 84], ["antiviral effects", "TREATMENT", 95, 112], ["polyomavirus BK", "PROBLEM", 121, 136], ["universal virus enhancers", "PROBLEM", 182, 207], ["Exogenous Combination Therapy", "TREATMENT", 208, 237], ["Innate DefensesCyclophosphamide (CPA)", "TREATMENT", 250, 287], ["a general immunosuppressant", "TREATMENT", 291, 318], ["immunotherapy", "TREATMENT", 357, 370], ["oncolytic virotherapy", "TREATMENT", 380, 401], ["sunitinib", "OBSERVATION", 14, 23], ["oncolytic virotherapy", "OBSERVATION", 380, 401]]], ["CPA may, however, also enhance replication and efficacy of oncolytic viruses by diminishing cytokine secretion by stromal cells, including type I IFN [134] .", [["stromal cells", "ANATOMY", 114, 127], ["CPA", "CHEMICAL", 0, 3], ["CPA", "SIMPLE_CHEMICAL", 0, 3], ["oncolytic viruses", "ORGANISM", 59, 76], ["stromal cells", "CELL", 114, 127], ["type I IFN", "GENE_OR_GENE_PRODUCT", 139, 149], ["cytokine", "PROTEIN", 92, 100], ["stromal cells", "CELL_TYPE", 114, 127], ["oncolytic viruses", "PROBLEM", 59, 76], ["diminishing cytokine secretion", "PROBLEM", 80, 110], ["stromal cells", "PROBLEM", 114, 127], ["stromal cells", "OBSERVATION", 114, 127]]], ["Another compound enhancing oncolytic virus efficacy by lowering cell responsiveness to type I IFN is triptolide, which acts downstream of IRF-3 activation [135] .", [["cell", "ANATOMY", 64, 68], ["type I IFN", "CHEMICAL", 87, 97], ["triptolide", "CHEMICAL", 101, 111], ["triptolide", "CHEMICAL", 101, 111], ["cell", "CELL", 64, 68], ["type I IFN", "GENE_OR_GENE_PRODUCT", 87, 97], ["triptolide", "SIMPLE_CHEMICAL", 101, 111], ["IRF-3", "GENE_OR_GENE_PRODUCT", 138, 143], ["type I IFN", "PROTEIN", 87, 97], ["IRF", "PROTEIN", 138, 141], ["Another compound enhancing oncolytic virus efficacy", "PROBLEM", 0, 51], ["lowering cell responsiveness", "PROBLEM", 55, 83], ["triptolide", "TREATMENT", 101, 111], ["compound", "OBSERVATION_MODIFIER", 8, 16], ["enhancing", "OBSERVATION_MODIFIER", 17, 26], ["oncolytic virus", "OBSERVATION", 27, 42], ["lowering cell responsiveness", "OBSERVATION", 55, 83]]], ["Further, the kinase mammalian target of rapamycin (mTOR) enhances the antiviral effects of type I IFN by activation of its effector proteins 4E-BP, which binds and inactivates translation factor eIF4E, and S6K, which carries out cell-type specific signaling functions of type I IFN, such as activation of eukaryotic translation initiation factor 4B and promotion of ISG15 transcription.", [["cell", "ANATOMY", 229, 233], ["rapamycin", "CHEMICAL", 40, 49], ["rapamycin", "CHEMICAL", 40, 49], ["mammalian target of rapamycin", "GENE_OR_GENE_PRODUCT", 20, 49], ["mTOR", "GENE_OR_GENE_PRODUCT", 51, 55], ["type I IFN", "GENE_OR_GENE_PRODUCT", 91, 101], ["4E-BP", "GENE_OR_GENE_PRODUCT", 141, 146], ["eIF4E", "GENE_OR_GENE_PRODUCT", 195, 200], ["S6K", "GENE_OR_GENE_PRODUCT", 206, 209], ["cell", "CELL", 229, 233], ["type I IFN", "GENE_OR_GENE_PRODUCT", 271, 281], ["eukaryotic translation initiation factor 4B", "GENE_OR_GENE_PRODUCT", 305, 348], ["ISG15", "GENE_OR_GENE_PRODUCT", 366, 371], ["kinase mammalian target of rapamycin", "PROTEIN", 13, 49], ["mTOR", "PROTEIN", 51, 55], ["type I IFN", "PROTEIN", 91, 101], ["effector proteins", "PROTEIN", 123, 140], ["4E", "PROTEIN", 141, 143], ["BP", "PROTEIN", 144, 146], ["translation factor", "PROTEIN", 176, 194], ["eIF4E", "PROTEIN", 195, 200], ["S6K", "PROTEIN", 206, 209], ["type I IFN", "PROTEIN", 271, 281], ["eukaryotic translation initiation factor 4B", "PROTEIN", 305, 348], ["ISG15", "PROTEIN", 366, 371], ["rapamycin (mTOR)", "TREATMENT", 40, 56], ["the antiviral effects", "TREATMENT", 66, 87], ["type I IFN", "PROBLEM", 91, 101], ["BP", "TEST", 144, 146], ["type I IFN", "PROBLEM", 271, 281], ["eukaryotic translation", "TREATMENT", 305, 327], ["ISG15 transcription", "TREATMENT", 366, 385], ["antiviral effects", "OBSERVATION", 70, 87]]], ["Consequently, rapamycin was able to enhance oncolytic VSV replication and anti-tumor efficacy by inhibiting type I IFN-mediated antiviral signaling via mTOR [136] .Exogenous Combination Therapy to Overcome Innate DefensesSeveral other compounds synergizing with oncolytic viruses have been identified via high-throughput drug library screening, many of which seem to act by antagonizing antiviral defenses.", [["rapamycin", "CHEMICAL", 14, 23], ["rapamycin", "CHEMICAL", 14, 23], ["rapamycin", "SIMPLE_CHEMICAL", 14, 23], ["VSV", "ORGANISM", 54, 57], ["anti-tumor", "CANCER", 74, 84], ["type I IFN", "GENE_OR_GENE_PRODUCT", 108, 118], ["mTOR", "GENE_OR_GENE_PRODUCT", 152, 156], ["type I IFN", "PROTEIN", 108, 118], ["mTOR", "PROTEIN", 152, 156], ["VSV", "SPECIES", 54, 57], ["rapamycin", "TREATMENT", 14, 23], ["oncolytic VSV replication", "TREATMENT", 44, 69], ["anti-tumor efficacy", "TREATMENT", 74, 93], ["inhibiting type I IFN", "PROBLEM", 97, 118], ["Exogenous Combination Therapy", "TREATMENT", 164, 193], ["Innate Defenses", "PROBLEM", 206, 221], ["Several other compounds synergizing", "PROBLEM", 221, 256], ["oncolytic viruses", "PROBLEM", 262, 279], ["library screening", "TEST", 326, 343]]], ["For instance, a novel virus sensitizer, Vse1, was found to greatly diminish antiviral effects of type I IFN against oncolytic VSV in several cancer cell types, and the drug also synergized with the virus in subcutaneous mouse tumor models [137] .", [["cancer cell", "ANATOMY", 141, 152], ["tumor", "ANATOMY", 226, 231], ["Vse1", "CHEMICAL", 40, 44], ["type I IFN", "CHEMICAL", 97, 107], ["cancer", "DISEASE", 141, 147], ["tumor", "DISEASE", 226, 231], ["Vse1", "SIMPLE_CHEMICAL", 40, 44], ["type I IFN", "GENE_OR_GENE_PRODUCT", 97, 107], ["oncolytic VSV", "ORGANISM", 116, 129], ["cancer cell", "CELL", 141, 152], ["mouse", "ORGANISM", 220, 225], ["tumor", "CANCER", 226, 231], ["type I IFN", "PROTEIN", 97, 107], ["cancer cell types", "CELL_TYPE", 141, 158], ["mouse", "SPECIES", 220, 225], ["VSV", "SPECIES", 126, 129], ["mouse", "SPECIES", 220, 225], ["a novel virus sensitizer", "TEST", 14, 38], ["type I IFN", "PROBLEM", 97, 107], ["oncolytic VSV", "TREATMENT", 116, 129], ["several cancer cell types", "PROBLEM", 133, 158], ["the virus in subcutaneous mouse tumor models", "PROBLEM", 194, 238], ["antiviral", "OBSERVATION", 76, 85], ["several", "OBSERVATION_MODIFIER", 133, 140], ["cancer cell types", "OBSERVATION", 141, 158]]], ["For many of these new compounds, the mechanism of action is still poorly understood, necessitating extensive safety studies to exclude undesirable effects against normal cells.Exogenous Combination Therapy to Overcome Innate DefensesApart from classical type I IFN-induced antiviral defenses, which typically prevent virus translation and degrade virus genomes, other cellular machineries regulate oncolytic virus efficacy.", [["cells", "ANATOMY", 170, 175], ["cellular", "ANATOMY", 368, 376], ["cells", "CELL", 170, 175], ["type I IFN", "GENE_OR_GENE_PRODUCT", 254, 264], ["cellular", "CELL", 368, 376], ["normal cells", "CELL_TYPE", 163, 175], ["IFN", "PROTEIN", 261, 264], ["extensive safety studies", "TEST", 99, 123], ["Exogenous Combination Therapy", "TREATMENT", 176, 205], ["Innate Defenses", "PROBLEM", 218, 233], ["classical type I IFN", "PROBLEM", 244, 264], ["antiviral defenses", "PROBLEM", 273, 291], ["virus translation", "PROBLEM", 317, 334], ["degrade virus genomes", "PROBLEM", 339, 360], ["new", "OBSERVATION_MODIFIER", 18, 21], ["compounds", "OBSERVATION", 22, 31], ["antiviral defenses", "OBSERVATION", 273, 291], ["virus genomes", "OBSERVATION", 347, 360], ["oncolytic virus", "OBSERVATION", 398, 413]]], ["Notably, strategies to increase cancer cell death in response to oncolytic viruses have been tested.", [["cancer cell", "ANATOMY", 32, 43], ["cancer", "DISEASE", 32, 38], ["death", "DISEASE", 44, 49], ["cancer cell", "CELL", 32, 43], ["increase cancer cell death", "PROBLEM", 23, 49], ["oncolytic viruses", "TREATMENT", 65, 82], ["increase", "OBSERVATION_MODIFIER", 23, 31], ["cancer cell death", "OBSERVATION", 32, 49], ["oncolytic viruses", "OBSERVATION", 65, 82]]], ["In a recent study, a class of compounds called SMAC mimetics synergized in several cancer models with oncolytic VSV by removing cancer cell block to apoptosis in response to virus-induced type I IFN, TNF-\u03b1 or TRAIL [138] .", [["cancer", "ANATOMY", 83, 89], ["cancer cell", "ANATOMY", 128, 139], ["cancer", "DISEASE", 83, 89], ["cancer", "DISEASE", 128, 134], ["SMAC", "GENE_OR_GENE_PRODUCT", 47, 51], ["cancer", "CANCER", 83, 89], ["VSV", "ORGANISM", 112, 115], ["cancer cell", "CELL", 128, 139], ["type I IFN", "GENE_OR_GENE_PRODUCT", 188, 198], ["TNF-\u03b1", "GENE_OR_GENE_PRODUCT", 200, 205], ["TRAIL", "GENE_OR_GENE_PRODUCT", 209, 214], ["type I IFN", "PROTEIN", 188, 198], ["TNF", "PROTEIN", 200, 203], ["TRAIL", "PROTEIN", 209, 214], ["VSV", "SPECIES", 112, 115], ["a recent study", "TEST", 3, 17], ["SMAC mimetics synergized", "TREATMENT", 47, 71], ["several cancer models", "PROBLEM", 75, 96], ["oncolytic VSV", "TREATMENT", 102, 115], ["cancer cell block", "PROBLEM", 128, 145], ["apoptosis", "PROBLEM", 149, 158], ["virus", "TEST", 174, 179], ["type I IFN", "PROBLEM", 188, 198], ["TNF", "TEST", 200, 203], ["cancer", "OBSERVATION", 83, 89], ["cancer cell block", "OBSERVATION", 128, 145]]], ["Interestingly, since virus infection-triggered cytokines act on nearby non-infected cells, SMAC mimetics may in combination with oncolytic viruses also cause significant bystander tumor-destruction.", [["cells", "ANATOMY", 84, 89], ["tumor", "ANATOMY", 180, 185], ["infection", "DISEASE", 27, 36], ["tumor", "DISEASE", 180, 185], ["cells", "CELL", 84, 89], ["SMAC", "GENE_OR_GENE_PRODUCT", 91, 95], ["tumor", "CANCER", 180, 185], ["cytokines", "PROTEIN", 47, 56], ["virus infection", "PROBLEM", 21, 36], ["cytokines", "PROBLEM", 47, 56], ["nearby non-infected cells", "TREATMENT", 64, 89], ["SMAC mimetics", "TREATMENT", 91, 104], ["oncolytic viruses", "PROBLEM", 129, 146], ["significant bystander tumor-destruction", "PROBLEM", 158, 197], ["virus infection", "OBSERVATION", 21, 36], ["significant", "OBSERVATION_MODIFIER", 158, 169], ["tumor", "OBSERVATION", 180, 185], ["destruction", "OBSERVATION", 186, 197]]], ["Normal cells are not affected by the IFN-SMAC mimetic synergy, providing an important safety aspect.", [["cells", "ANATOMY", 7, 12], ["cells", "CELL", 7, 12], ["IFN-SMAC", "GENE_OR_GENE_PRODUCT", 37, 45], ["Normal cells", "CELL_TYPE", 0, 12], ["IFN", "PROTEIN", 37, 40], ["SMAC", "PROTEIN", 41, 45], ["SMAC mimetic synergy", "TREATMENT", 41, 61], ["cells", "OBSERVATION", 7, 12]]], ["In another study, blocking the ER stress response circuitry triggered by oncolytic rhabdovirus infection by a small molecular inhibitor of serine/threonine protein kinase and endoribonuclease IRE1\u03b1, which was identified in a genome-wide siRNA screen, greatly enhanced cytotoxicity via caspase-2-induced apoptosis and increased oncolytic efficacy in refractory tumor models in mice [139] .", [["tumor", "ANATOMY", 360, 365], ["infection", "DISEASE", 95, 104], ["tumor", "DISEASE", 360, 365], ["serine", "CHEMICAL", 139, 145], ["threonine", "CHEMICAL", 146, 155], ["ER", "GENE_OR_GENE_PRODUCT", 31, 33], ["oncolytic rhabdovirus", "ORGANISM", 73, 94], ["serine/threonine protein kinase", "GENE_OR_GENE_PRODUCT", 139, 170], ["IRE1\u03b1", "GENE_OR_GENE_PRODUCT", 192, 197], ["caspase-2", "GENE_OR_GENE_PRODUCT", 285, 294], ["tumor", "CANCER", 360, 365], ["mice", "ORGANISM", 376, 380], ["ER", "PROTEIN", 31, 33], ["serine/threonine protein kinase", "PROTEIN", 139, 170], ["IRE1\u03b1", "PROTEIN", 192, 197], ["mice", "SPECIES", 376, 380], ["mice", "SPECIES", 376, 380], ["another study", "TEST", 3, 16], ["the ER stress response circuitry", "PROBLEM", 27, 59], ["oncolytic rhabdovirus infection", "PROBLEM", 73, 104], ["serine/threonine protein kinase", "TEST", 139, 170], ["endoribonuclease IRE1\u03b1", "TEST", 175, 197], ["a genome-wide siRNA screen", "PROBLEM", 223, 249], ["greatly enhanced cytotoxicity", "PROBLEM", 251, 280], ["caspase", "TEST", 285, 292], ["apoptosis", "PROBLEM", 303, 312], ["increased oncolytic efficacy", "PROBLEM", 317, 345], ["refractory tumor models", "PROBLEM", 349, 372], ["oncolytic rhabdovirus infection", "OBSERVATION", 73, 104], ["increased", "OBSERVATION_MODIFIER", 317, 326], ["oncolytic efficacy", "OBSERVATION", 327, 345], ["refractory", "OBSERVATION_MODIFIER", 349, 359], ["tumor", "OBSERVATION", 360, 365]]], ["This effect was independent on induction or responsiveness to type I IFN.Exogenous Combination Therapy to Overcome Innate DefensesConversely, inhibitors of nucleoside transporter-1 (ENT1) were discovered from a high-throughput screen of enhancers of oncolytic HSV, and to date such inhibitors have not been reported to alter cellular antiviral responses [140] .", [["cellular", "ANATOMY", 325, 333], ["nucleoside", "CHEMICAL", 156, 166], ["nucleoside", "CHEMICAL", 156, 166], ["type I IFN", "GENE_OR_GENE_PRODUCT", 62, 72], ["nucleoside transporter-1", "GENE_OR_GENE_PRODUCT", 156, 180], ["ENT1", "GENE_OR_GENE_PRODUCT", 182, 186], ["oncolytic HSV", "ORGANISM", 250, 263], ["cellular", "CELL", 325, 333], ["type I IFN", "PROTEIN", 62, 72], ["nucleoside transporter", "PROTEIN", 156, 178], ["ENT1", "PROTEIN", 182, 186], ["enhancers", "DNA", 237, 246], ["HSV", "SPECIES", 260, 263], ["Exogenous Combination Therapy", "TREATMENT", 73, 102], ["Innate Defenses", "TREATMENT", 115, 130], ["nucleoside transporter", "TEST", 156, 178], ["oncolytic HSV", "PROBLEM", 250, 263]]], ["Other compounds, such as common chemotherapeutics, and their mechanisms synergizing with oncolytic viruses have been discussed elsewhere-for most of them the possible role of antiviral defense antagonism in enhancing oncolytic virus efficacy remains to be studied [141] .Exogenous Combination Therapy to Overcome Innate DefensesThus, many compounds are available to interfere with tumor antiviral defenses.", [["tumor", "ANATOMY", 381, 386], ["tumor", "DISEASE", 381, 386], ["tumor", "CANCER", 381, 386], ["common chemotherapeutics", "TREATMENT", 25, 49], ["oncolytic viruses", "PROBLEM", 89, 106], ["antiviral defense antagonism", "TREATMENT", 175, 203], ["enhancing oncolytic virus efficacy", "TREATMENT", 207, 241], ["Exogenous Combination Therapy", "TREATMENT", 271, 300]]], ["The outstanding question for most of them, however, seems to be why such compounds do not render normal cells sensitive to oncolytic viruses.", [["cells", "ANATOMY", 104, 109], ["cells", "CELL", 104, 109], ["normal cells", "CELL_TYPE", 97, 109], ["oncolytic viruses", "PROBLEM", 123, 140]]], ["Elucidation of the exact mechanisms of action and the differences between normal and cancer cells constitute a worthy goal for studies in the near future.Virus Engineering and Combination to Overcome Innate DefensesAlready in the 1950s it became clear that using certain pathogenic wildtype viruses, such as West Nile virus and Bunyamwera virus, in cancer patients would result in off-target toxicity [142, 143] .", [["cancer cells", "ANATOMY", 85, 97], ["cancer", "ANATOMY", 349, 355], ["cancer", "DISEASE", 85, 91], ["cancer", "DISEASE", 349, 355], ["toxicity", "DISEASE", 392, 400], ["cancer cells", "CELL", 85, 97], ["wildtype viruses", "ORGANISM", 282, 298], ["West Nile virus", "ORGANISM", 308, 323], ["Bunyamwera virus", "ORGANISM", 328, 344], ["cancer", "CANCER", 349, 355], ["patients", "ORGANISM", 356, 364], ["normal and cancer cells", "CELL_TYPE", 74, 97], ["West Nile virus", "SPECIES", 308, 323], ["Bunyamwera virus", "SPECIES", 328, 344], ["patients", "SPECIES", 356, 364], ["West Nile virus", "SPECIES", 308, 323], ["Bunyamwera virus", "SPECIES", 328, 344], ["the differences between normal and cancer cells", "PROBLEM", 50, 97], ["Virus Engineering", "TREATMENT", 154, 171], ["certain pathogenic wildtype viruses", "PROBLEM", 263, 298], ["West Nile virus", "PROBLEM", 308, 323], ["Bunyamwera virus", "PROBLEM", 328, 344]]], ["Characteristic for pathogenic viruses is a greater ability to circumvent or antagonize cellular innate antiviral defenses than attenuated strains.", [["cellular", "ANATOMY", 87, 95], ["cellular", "CELL", 87, 95], ["pathogenic viruses", "PROBLEM", 19, 37], ["attenuated strains", "PROBLEM", 127, 145], ["pathogenic", "OBSERVATION_MODIFIER", 19, 29], ["viruses", "OBSERVATION", 30, 37], ["antiviral defenses", "OBSERVATION", 103, 121]]], ["For example, unlike the prototypical oncolytic reovirus strain type 3 Dearing, the T1L strain of reovirus causes accumulation of IRF9 in the nucleus and inhibits activation of a select group of ISGs-yet because of this property the T1L strain is myocarditic unlike the oncolytic type 3 Dearing strain [78] .", [["nucleus", "ANATOMY", 141, 148], ["oncolytic reovirus strain type 3 Dearing", "ORGANISM", 37, 77], ["T1L strain", "ORGANISM", 83, 93], ["reovirus", "ORGANISM", 97, 105], ["IRF9", "GENE_OR_GENE_PRODUCT", 129, 133], ["nucleus", "CELLULAR_COMPONENT", 141, 148], ["ISGs", "GENE_OR_GENE_PRODUCT", 194, 198], ["T1L", "GENE_OR_GENE_PRODUCT", 232, 235], ["myocarditic", "CANCER", 246, 257], ["IRF9", "PROTEIN", 129, 133], ["ISGs", "DNA", 194, 198], ["the T1L strain of reovirus", "PROBLEM", 79, 105], ["IRF9 in the nucleus", "PROBLEM", 129, 148], ["ISGs", "TREATMENT", 194, 198], ["the T1L strain", "PROBLEM", 228, 242], ["myocarditic", "PROBLEM", 246, 257], ["oncolytic reovirus", "OBSERVATION", 37, 55], ["accumulation of IRF9", "OBSERVATION", 113, 133], ["nucleus", "ANATOMY", 141, 148]]], ["For these reasons, many oncolytic viruses used today, such as reovirus type 3 Dearing, oncolytic strains of Newcastle disease virus and M-mutated VSV have either a stronger capacity to induce or a weaker capacity to resist antiviral type I IFN than the corresponding wildtype strains [78, 144, 145] .Virus Engineering and Combination to Overcome Innate DefensesAn open question, however, is whether strain-specific or virus-specific differences that relate to specific components of the cellular antiviral machinery may be exploited for greater anti-tumor efficacy, i.e., if one virus fails, could another be used in its stead?", [["cellular", "ANATOMY", 487, 495], ["anti-tumor", "ANATOMY", 545, 555], ["Newcastle disease", "DISEASE", 108, 125], ["reovirus type 3", "ORGANISM", 62, 77], ["oncolytic strains", "ORGANISM", 87, 104], ["Newcastle disease virus", "ORGANISM", 108, 131], ["VSV", "ORGANISM", 146, 149], ["type I IFN", "GENE_OR_GENE_PRODUCT", 233, 243], ["cellular", "CELL", 487, 495], ["anti-tumor", "CANCER", 545, 555], ["antiviral type I IFN", "PROTEIN", 223, 243], ["Newcastle disease virus", "SPECIES", 108, 131], ["Newcastle disease virus", "SPECIES", 108, 131], ["VSV", "SPECIES", 146, 149], ["many oncolytic viruses", "PROBLEM", 19, 41], ["Newcastle disease virus", "PROBLEM", 108, 131], ["mutated VSV", "PROBLEM", 138, 149], ["a stronger capacity", "PROBLEM", 162, 181], ["a weaker capacity", "PROBLEM", 195, 212], ["the corresponding wildtype strains", "PROBLEM", 249, 283], ["Virus Engineering", "TREATMENT", 300, 317], ["strain", "PROBLEM", 399, 405], ["virus", "PROBLEM", 418, 423], ["the cellular antiviral machinery", "TREATMENT", 483, 515], ["oncolytic viruses", "OBSERVATION", 24, 41], ["cellular antiviral", "OBSERVATION", 487, 505]]], ["While Ras expression was critical for oncolytic reovirus replication in cells overexpressing CUG2 oncogene, oncolytic vesicular stomatitis virus was unable to replicate in the same cells due to increased activation of STAT1 and OASL2 [146, 147] .", [["cells", "ANATOMY", 72, 77], ["cells", "ANATOMY", 181, 186], ["vesicular stomatitis", "DISEASE", 118, 138], ["Ras", "GENE_OR_GENE_PRODUCT", 6, 9], ["oncolytic reovirus", "ORGANISM", 38, 56], ["cells", "CELL", 72, 77], ["CUG2", "GENE_OR_GENE_PRODUCT", 93, 97], ["oncolytic vesicular stomatitis virus", "ORGANISM", 108, 144], ["cells", "CELL", 181, 186], ["STAT1", "GENE_OR_GENE_PRODUCT", 218, 223], ["OASL2", "GENE_OR_GENE_PRODUCT", 228, 233], ["Ras", "PROTEIN", 6, 9], ["CUG2 oncogene", "DNA", 93, 106], ["STAT1", "PROTEIN", 218, 223], ["OASL2", "PROTEIN", 228, 233], ["vesicular stomatitis virus", "SPECIES", 118, 144], ["oncolytic reovirus replication in cells overexpressing CUG2 oncogene", "TREATMENT", 38, 106], ["oncolytic vesicular stomatitis virus", "PROBLEM", 108, 144], ["increased activation of STAT1", "PROBLEM", 194, 223], ["increased", "OBSERVATION_MODIFIER", 194, 203]]], ["Thus, in these cells reovirus was not affected by STAT1 or OASL2, and it therefore remains interesting to see which other antiviral effectors may have been lacking in the CUG2-expressing cells and, conversely, how reovirus and VSV differ in terms of sensitivity to antiviral effectors.", [["cells", "ANATOMY", 15, 20], ["cells", "ANATOMY", 187, 192], ["cells", "CELL", 15, 20], ["reovirus", "ORGANISM", 21, 29], ["STAT1", "GENE_OR_GENE_PRODUCT", 50, 55], ["OASL2", "GENE_OR_GENE_PRODUCT", 59, 64], ["CUG2", "GENE_OR_GENE_PRODUCT", 171, 175], ["cells", "CELL", 187, 192], ["reovirus", "ORGANISM", 214, 222], ["VSV", "ORGANISM", 227, 230], ["STAT1", "PROTEIN", 50, 55], ["OASL2", "PROTEIN", 59, 64], ["antiviral effectors", "PROTEIN", 122, 141], ["CUG2-expressing cells", "CELL_LINE", 171, 192], ["antiviral effectors", "PROTEIN", 265, 284], ["VSV", "SPECIES", 227, 230], ["these cells reovirus", "PROBLEM", 9, 29], ["VSV", "PROBLEM", 227, 230], ["antiviral effectors", "TREATMENT", 265, 284], ["cells reovirus", "OBSERVATION", 15, 29], ["antiviral effectors", "OBSERVATION", 265, 284]]], ["While several oncolytic viruses have been compared to each other in terms of replication rate and cytotoxicity, systematic studies with regard to tumor antiviral defenses have not been conducted.Virus Engineering and Combination to Overcome Innate DefensesAs any attenuated virus is likely to replicate effectively only in its own niche (i.e., to be restricted by a specific set of ISGs), and as wild type strains may be too toxic for use in humans, a compromise may be achieved by incorporating select elements from wild type viruses into oncolytic virus backbones.", [["tumor", "ANATOMY", 146, 151], ["tumor", "DISEASE", 146, 151], ["tumor", "CANCER", 146, 151], ["humans", "ORGANISM", 442, 448], ["wild type viruses", "ORGANISM", 517, 534], ["oncolytic virus", "ORGANISM", 540, 555], ["ISGs", "PROTEIN", 382, 386], ["humans", "SPECIES", 442, 448], ["humans", "SPECIES", 442, 448], ["several oncolytic viruses", "PROBLEM", 6, 31], ["replication rate", "TEST", 77, 93], ["cytotoxicity", "PROBLEM", 98, 110], ["systematic studies", "TEST", 112, 130], ["tumor antiviral defenses", "PROBLEM", 146, 170], ["Virus Engineering", "TREATMENT", 195, 212], ["Innate DefensesAs any attenuated virus", "PROBLEM", 241, 279], ["wild type strains", "PROBLEM", 396, 413], ["wild type viruses into oncolytic virus backbones", "PROBLEM", 517, 565], ["oncolytic viruses", "OBSERVATION", 14, 31], ["tumor", "OBSERVATION", 146, 151], ["virus", "OBSERVATION", 274, 279], ["oncolytic virus", "OBSERVATION", 540, 555]]], ["Indeed, several chimeric and recombinant viruses have been generated that harbor specific elements of wild type strains or even of other unrelated viruses in order to better resist cancer antiviral defenses ( Table 1) .", [["cancer", "ANATOMY", 181, 187], ["cancer", "DISEASE", 181, 187], ["recombinant viruses", "ORGANISM", 29, 48], ["cancer", "CANCER", 181, 187], ["several chimeric and recombinant viruses", "PROBLEM", 8, 48], ["wild type strains", "PROBLEM", 102, 119], ["other unrelated viruses", "PROBLEM", 131, 154], ["viruses", "OBSERVATION", 41, 48], ["viruses", "OBSERVATION", 147, 154]]], ["As an example of introducing wild type elements into attenuated viruses, Haralambieva reported on a measles virus Edmonston vaccine strain in which P gene was replaced with the counterpart from the wild type IC-B strain [148] .", [["Haralambieva", "CHEMICAL", 73, 85], ["measles virus", "ORGANISM", 100, 113], ["Edmonston vaccine", "ORGANISM", 114, 131], ["wild type elements", "DNA", 29, 47], ["P gene", "DNA", 148, 154], ["measles virus Edmonston vaccine", "SPECIES", 100, 131], ["measles virus", "SPECIES", 100, 113], ["attenuated viruses", "PROBLEM", 53, 71], ["Haralambieva", "TREATMENT", 73, 85], ["a measles virus Edmonston vaccine strain", "TREATMENT", 98, 138], ["attenuated", "OBSERVATION_MODIFIER", 53, 63], ["viruses", "OBSERVATION", 64, 71]]], ["Later, Meng et al. included N, P, and L genes from wild type measles in Edmonston backbone, producing an enhanced but still safe oncolytic virus [149] .", [["measles", "DISEASE", 61, 68], ["wild type measles", "ORGANISM", 51, 68], ["N, P, and L genes", "DNA", 28, 45], ["N, P, and L genes", "PROBLEM", 28, 45], ["wild type measles in Edmonston backbone", "PROBLEM", 51, 90], ["still safe oncolytic virus", "PROBLEM", 118, 144]]], ["Edmonston vaccine virus induces a more robust IFN-response compared to wild type measles virus partly due to the weaker ability of V protein to suppress MDA5-mediated activation of IRF-3 and IFN-I induction [150, 151] .", [["Edmonston vaccine virus", "ORGANISM", 0, 23], ["IFN", "GENE_OR_GENE_PRODUCT", 46, 49], ["wild type measles virus", "ORGANISM", 71, 94], ["V protein", "GENE_OR_GENE_PRODUCT", 131, 140], ["MDA5", "GENE_OR_GENE_PRODUCT", 153, 157], ["IRF-3", "GENE_OR_GENE_PRODUCT", 181, 186], ["IFN-I", "GENE_OR_GENE_PRODUCT", 191, 196], ["IFN", "PROTEIN", 46, 49], ["V protein", "PROTEIN", 131, 140], ["MDA5", "PROTEIN", 153, 157], ["IRF", "PROTEIN", 181, 184], ["IFN", "PROTEIN", 191, 194], ["Edmonston vaccine virus", "SPECIES", 0, 23], ["Edmonston vaccine virus", "SPECIES", 0, 23], ["measles virus", "SPECIES", 81, 94], ["Edmonston vaccine virus", "TREATMENT", 0, 23], ["wild type measles virus", "PROBLEM", 71, 94], ["MDA5", "TEST", 153, 157], ["IRF", "TEST", 181, 184]]], ["In vivo, P-gene encoded proteins, particularly V, control the quality of the cytokine response to measles so that vaccine strains qualitatively induce a stronger inflammatory response compared to WT strains (where WT V protein suppresses multiple cytokine secretion).", [["measles", "DISEASE", 98, 105], ["measles", "ORGANISM", 98, 105], ["WT strains", "ORGANISM", 196, 206], ["WT V protein", "GENE_OR_GENE_PRODUCT", 214, 226], ["P-gene", "DNA", 9, 15], ["cytokine", "PROTEIN", 77, 85], ["WT V protein", "PROTEIN", 214, 226], ["cytokine", "PROTEIN", 247, 255], ["vaccine strains", "PROBLEM", 114, 129], ["a stronger inflammatory response", "PROBLEM", 151, 183], ["WT strains", "PROBLEM", 196, 206], ["WT V protein", "TEST", 214, 226], ["multiple cytokine secretion", "PROBLEM", 238, 265]]], ["V protein short cytoplasmic tail has been shown to bind and inactivate STAT2, IRF7, MDA5 and the Rel homology domain of the Nf\u03baB subunit p65 but not of p50 [152] .", [["cytoplasmic tail", "ANATOMY", 16, 32], ["V", "GENE_OR_GENE_PRODUCT", 0, 1], ["cytoplasmic", "ORGANISM_SUBSTANCE", 16, 27], ["STAT2", "GENE_OR_GENE_PRODUCT", 71, 76], ["IRF7", "GENE_OR_GENE_PRODUCT", 78, 82], ["MDA5", "GENE_OR_GENE_PRODUCT", 84, 88], ["Rel", "GENE_OR_GENE_PRODUCT", 97, 100], ["Nf\u03baB", "GENE_OR_GENE_PRODUCT", 124, 128], ["p65", "GENE_OR_GENE_PRODUCT", 137, 140], ["p50", "GENE_OR_GENE_PRODUCT", 152, 155], ["V protein", "PROTEIN", 0, 9], ["cytoplasmic tail", "PROTEIN", 16, 32], ["STAT2", "PROTEIN", 71, 76], ["IRF7", "PROTEIN", 78, 82], ["MDA5", "PROTEIN", 84, 88], ["Rel homology domain", "PROTEIN", 97, 116], ["Nf\u03baB subunit p65", "PROTEIN", 124, 140], ["p50", "PROTEIN", 152, 155], ["V protein short cytoplasmic tail", "PROBLEM", 0, 32], ["STAT2", "TEST", 71, 76], ["IRF7", "TEST", 78, 82], ["the Nf\u03baB subunit p65", "TEST", 120, 140]]], ["Also, V causes LGP2 protein to bind and inactivate RIG-I [153] , but it seemingly does not interfere with TICAM-1 (TRIF, multiple TLR adaptor, including TLR3)-mediated IFN-\u03b2 induction.", [["LGP2", "GENE_OR_GENE_PRODUCT", 15, 19], ["RIG-I", "GENE_OR_GENE_PRODUCT", 51, 56], ["TICAM-1", "GENE_OR_GENE_PRODUCT", 106, 113], ["TRIF", "GENE_OR_GENE_PRODUCT", 115, 119], ["TLR", "GENE_OR_GENE_PRODUCT", 130, 133], ["TLR3", "GENE_OR_GENE_PRODUCT", 153, 157], ["IFN-\u03b2", "GENE_OR_GENE_PRODUCT", 168, 173], ["LGP2 protein", "PROTEIN", 15, 27], ["RIG", "PROTEIN", 51, 54], ["TICAM-1", "PROTEIN", 106, 113], ["TRIF", "PROTEIN", 115, 119], ["TLR adaptor", "PROTEIN", 130, 141], ["TLR3", "PROTEIN", 153, 157], ["IFN", "PROTEIN", 168, 171], ["\u03b2", "PROTEIN", 172, 173], ["LGP2 protein to bind", "PROBLEM", 15, 35], ["TICAM", "TEST", 106, 111], ["multiple TLR adaptor", "TREATMENT", 121, 141], ["TLR3)", "TREATMENT", 153, 158], ["IFN-\u03b2 induction", "TREATMENT", 168, 183]]], ["Thus, if cancer and normal cells would differ with regard to TICAM-1 or IRF-3, then such a virus could potentially target specifically cancer cells rather than normal cells.", [["cancer", "ANATOMY", 9, 15], ["cells", "ANATOMY", 27, 32], ["cancer cells", "ANATOMY", 135, 147], ["cells", "ANATOMY", 167, 172], ["cancer", "DISEASE", 9, 15], ["cancer", "DISEASE", 135, 141], ["cancer", "CANCER", 9, 15], ["cells", "CELL", 27, 32], ["TICAM-1", "GENE_OR_GENE_PRODUCT", 61, 68], ["IRF-3", "GENE_OR_GENE_PRODUCT", 72, 77], ["cancer cells", "CELL", 135, 147], ["cells", "CELL", 167, 172], ["cancer and normal cells", "CELL_TYPE", 9, 32], ["TICAM", "PROTEIN", 61, 66], ["IRF-3", "PROTEIN", 72, 77], ["cancer cells", "CELL_TYPE", 135, 147], ["normal cells", "CELL_TYPE", 160, 172], ["cancer", "PROBLEM", 9, 15], ["TICAM", "TEST", 61, 66], ["IRF", "PROBLEM", 72, 75], ["a virus", "PROBLEM", 89, 96], ["cancer cells", "PROBLEM", 135, 147]]], ["So far, the measles Edmonston-WT chimeras have proven safe in animals.", [["measles", "ORGANISM", 12, 19], ["Edmonston-WT chimeras", "ORGANISM", 20, 41]]], ["Similar to the VSV recombinant but with the enhanced oncolytic capacity of the Maraba backbone.", [["VSV", "ORGANISM", 15, 18], ["VSV", "SPECIES", 15, 18], ["the Maraba backbone", "TREATMENT", 75, 94], ["VSV recombinant", "OBSERVATION_MODIFIER", 15, 30]]], ["Virus was safe in mice [159] As an example of heterologous virus constructs, lentogenic Newcastle disease virus engineered to express influenza virus PR8 (H1N1) NS1 showed enhanced oncolytic efficacy in vivo due to dampening of antiviral responses [154] .", [["Newcastle disease", "DISEASE", 88, 105], ["Virus", "ORGANISM", 0, 5], ["mice", "ORGANISM", 18, 22], ["lentogenic Newcastle disease virus", "ORGANISM", 77, 111], ["influenza virus PR8 (H1N1) NS1", "ORGANISM", 134, 164], ["NS1", "PROTEIN", 161, 164], ["mice", "SPECIES", 18, 22], ["Newcastle disease virus", "SPECIES", 88, 111], ["influenza virus PR8", "SPECIES", 134, 153], ["mice", "SPECIES", 18, 22], ["Newcastle disease virus", "SPECIES", 88, 111], ["influenza virus PR8 (H1N1)", "SPECIES", 134, 160], ["Virus", "PROBLEM", 0, 5], ["heterologous virus constructs", "PROBLEM", 46, 75], ["lentogenic Newcastle disease virus", "PROBLEM", 77, 111], ["influenza virus PR8", "TREATMENT", 134, 153], ["NS1", "PROBLEM", 161, 164], ["enhanced oncolytic efficacy", "TREATMENT", 172, 199], ["dampening of antiviral responses", "PROBLEM", 215, 247]]], ["While such a virus did not display enhanced pathogenicity in that study, a mesogenic NDV virus harboring NS1 from influenza strain H1N1/09 did show increased pathogenicity in chickens as well as an increased ability to replicate in human cells [155] , raising some cautionary warnings for future engineering of similar replicative viruses.", [["cells", "ANATOMY", 238, 243], ["mesogenic", "ORGANISM", 75, 84], ["NDV virus", "ORGANISM", 85, 94], ["NS1", "ORGANISM", 105, 108], ["influenza strain", "ORGANISM", 114, 130], ["H1N1/09", "ORGANISM", 131, 138], ["chickens", "ORGANISM", 175, 183], ["human", "ORGANISM", 232, 237], ["cells", "CELL", 238, 243], ["NS1", "PROTEIN", 105, 108], ["human cells", "CELL_TYPE", 232, 243], ["mesogenic NDV virus", "SPECIES", 75, 94], ["chickens", "SPECIES", 175, 183], ["human", "SPECIES", 232, 237], ["NDV virus", "SPECIES", 85, 94], ["chickens", "SPECIES", 175, 183], ["human", "SPECIES", 232, 237], ["a virus", "PROBLEM", 11, 18], ["enhanced pathogenicity", "PROBLEM", 35, 57], ["that study", "TEST", 61, 71], ["a mesogenic NDV virus harboring NS1", "PROBLEM", 73, 108], ["influenza strain", "PROBLEM", 114, 130], ["increased pathogenicity in chickens", "PROBLEM", 148, 183], ["an increased ability", "PROBLEM", 195, 215], ["similar replicative viruses", "PROBLEM", 311, 338], ["enhanced", "OBSERVATION_MODIFIER", 35, 43], ["pathogenicity", "OBSERVATION", 44, 57], ["increased", "OBSERVATION_MODIFIER", 148, 157], ["pathogenicity", "OBSERVATION", 158, 171], ["increased", "OBSERVATION_MODIFIER", 198, 207], ["replicative viruses", "OBSERVATION", 319, 338]]], ["As another example, vaccinia virus soluble type I IFN scavenger B19R (NOTE: B18R is often used in the literature) has been engineered into both oncolytic HSV and oncolytic rhabdoviruses, resulting in all cases in more effective therapy agents without loss of tumor specificity [157, 159] .", [["tumor", "ANATOMY", 259, 264], ["tumor", "DISEASE", 259, 264], ["vaccinia virus", "ORGANISM", 20, 34], ["type I IFN scavenger B19R", "GENE_OR_GENE_PRODUCT", 43, 68], ["HSV", "ORGANISM", 154, 157], ["tumor", "CANCER", 259, 264], ["vaccinia virus soluble type I IFN scavenger B19R", "PROTEIN", 20, 68], ["NOTE", "PROTEIN", 70, 74], ["B18R", "PROTEIN", 76, 80], ["vaccinia virus", "SPECIES", 20, 34], ["HSV", "SPECIES", 154, 157], ["vaccinia virus soluble", "TREATMENT", 20, 42], ["oncolytic rhabdoviruses", "TREATMENT", 162, 185], ["effective therapy agents", "TREATMENT", 218, 242], ["loss of tumor specificity", "PROBLEM", 251, 276], ["oncolytic HSV", "OBSERVATION", 144, 157]]], ["Oncolytic \u03b334.5 gene deleted HSV was complemented by two different PKR-antagonists from human cytomegalovirus, TRS1 and IRS1, generating a chimera capable of reaching wild type virus replication levels in cancer cells in vitro and in tumor models in vivo [158] .Virus Engineering and Combination to Overcome Innate DefensesThe selection of various viral IFN-I-antagonists that potentially could be used to augment attenuated oncolytic viruses is vast [69, 95] .", [["cancer cells", "ANATOMY", 205, 217], ["tumor", "ANATOMY", 234, 239], ["cancer", "DISEASE", 205, 211], ["tumor", "DISEASE", 234, 239], ["Oncolytic \u03b334.5", "GENE_OR_GENE_PRODUCT", 0, 15], ["HSV", "ORGANISM", 29, 32], ["PKR", "GENE_OR_GENE_PRODUCT", 67, 70], ["human", "ORGANISM", 88, 93], ["cytomegalovirus", "ORGANISM", 94, 109], ["TRS1", "GENE_OR_GENE_PRODUCT", 111, 115], ["IRS1", "GENE_OR_GENE_PRODUCT", 120, 124], ["wild type virus", "ORGANISM", 167, 182], ["cancer cells", "CELL", 205, 217], ["tumor", "CANCER", 234, 239], ["IFN-I", "GENE_OR_GENE_PRODUCT", 354, 359], ["Oncolytic \u03b334.5 gene", "DNA", 0, 20], ["PKR", "PROTEIN", 67, 70], ["TRS1", "PROTEIN", 111, 115], ["IRS1", "PROTEIN", 120, 124], ["cancer cells", "CELL_TYPE", 205, 217], ["IFN", "PROTEIN", 354, 357], ["human", "SPECIES", 88, 93], ["HSV", "SPECIES", 29, 32], ["human cytomegalovirus", "SPECIES", 88, 109], ["Oncolytic \u03b3", "TREATMENT", 0, 11], ["gene deleted HSV", "PROBLEM", 16, 32], ["antagonists", "TREATMENT", 71, 82], ["human cytomegalovirus", "PROBLEM", 88, 109], ["TRS1 and IRS1", "TREATMENT", 111, 124], ["a chimera capable", "TREATMENT", 137, 154], ["cancer cells", "PROBLEM", 205, 217], ["Virus Engineering", "TREATMENT", 262, 279], ["Innate Defenses", "TREATMENT", 308, 323], ["various viral IFN-I-antagonists", "TREATMENT", 340, 371], ["attenuated oncolytic viruses", "PROBLEM", 414, 442], ["cancer cells", "OBSERVATION", 205, 217], ["tumor", "OBSERVATION", 234, 239]]], ["For example, increased replication of several viruses, including HIV-1, Sindbis virus and E1-deleted adenovirus in mammalian cells was observed when the cells were engineered to express vaccinia virus E3L protein, influenza A virus NS1 protein, ebola virus VP35 protein or HIV-1 Tat protein [160] .", [["mammalian cells", "ANATOMY", 115, 130], ["cells", "ANATOMY", 153, 158], ["HIV-1", "ORGANISM", 65, 70], ["Sindbis virus", "ORGANISM", 72, 85], ["E1", "GENE_OR_GENE_PRODUCT", 90, 92], ["adenovirus", "ORGANISM", 101, 111], ["mammalian cells", "CELL", 115, 130], ["cells", "CELL", 153, 158], ["vaccinia virus", "ORGANISM", 186, 200], ["E3L", "GENE_OR_GENE_PRODUCT", 201, 204], ["influenza A virus", "ORGANISM", 214, 231], ["NS1", "ORGANISM", 232, 235], ["ebola virus", "ORGANISM", 245, 256], ["VP35", "ORGANISM", 257, 261], ["HIV-1", "GENE_OR_GENE_PRODUCT", 273, 278], ["mammalian cells", "CELL_TYPE", 115, 130], ["vaccinia virus E3L protein", "PROTEIN", 186, 212], ["influenza A virus NS1 protein", "PROTEIN", 214, 243], ["ebola virus VP35 protein", "PROTEIN", 245, 269], ["HIV-1 Tat protein", "PROTEIN", 273, 290], ["HIV-1", "SPECIES", 65, 70], ["Sindbis virus", "SPECIES", 72, 85], ["vaccinia virus", "SPECIES", 186, 200], ["influenza A virus", "SPECIES", 214, 231], ["ebola virus VP35", "SPECIES", 245, 261], ["HIV-1", "SPECIES", 273, 278], ["HIV-1", "SPECIES", 65, 70], ["Sindbis virus", "SPECIES", 72, 85], ["vaccinia virus", "SPECIES", 186, 200], ["influenza A virus", "SPECIES", 214, 231], ["ebola virus VP35", "SPECIES", 245, 261], ["HIV-1", "SPECIES", 273, 278], ["increased replication", "PROBLEM", 13, 34], ["several viruses", "PROBLEM", 38, 53], ["HIV", "TEST", 65, 68], ["Sindbis virus", "PROBLEM", 72, 85], ["E1-deleted adenovirus", "TREATMENT", 90, 111], ["mammalian cells", "PROBLEM", 115, 130], ["the cells", "PROBLEM", 149, 158], ["vaccinia virus E3L protein", "TEST", 186, 212], ["influenza A virus NS1 protein", "TEST", 214, 243], ["ebola virus VP35 protein", "TEST", 245, 269], ["HIV", "TEST", 273, 276], ["Tat protein", "TEST", 279, 290], ["increased", "OBSERVATION_MODIFIER", 13, 22], ["replication", "OBSERVATION_MODIFIER", 23, 34], ["several", "OBSERVATION_MODIFIER", 38, 45], ["viruses", "OBSERVATION", 46, 53], ["mammalian cells", "OBSERVATION", 115, 130]]], ["The choice of antagonist must primarily be made with safety in mind, but virus-specific and cell-specific differences in antagonist functions may potentially be exploited rationally when considering the overall combination.", [["cell", "ANATOMY", 92, 96], ["cell", "CELL", 92, 96], ["antagonist", "TREATMENT", 14, 24], ["virus", "PROBLEM", 73, 78]]], ["For example, vaccinia virus E3L is able to rescue VSV but not EMCV from exogenous IFN, whereas vaccinia virus K3L partially rescued EMCV but not VSV [161] .Virus Engineering and Combination to Overcome Innate DefensesIn anticipation of systematic, perhaps bioinformatically guided, \"super-chimera\" studies, two or more viruses that may complement each other's shortcomings in antiviral defense antagonism have been considered.", [["vaccinia virus E3L", "ORGANISM", 13, 31], ["VSV", "ORGANISM", 50, 53], ["EMCV", "ORGANISM", 62, 66], ["IFN", "GENE_OR_GENE_PRODUCT", 82, 85], ["vaccinia virus K3L", "ORGANISM", 95, 113], ["EMCV", "ORGANISM", 132, 136], ["VSV", "ORGANISM", 145, 148], ["exogenous IFN", "PROTEIN", 72, 85], ["vaccinia virus", "SPECIES", 13, 27], ["vaccinia virus", "SPECIES", 95, 109], ["vaccinia virus", "SPECIES", 13, 27], ["VSV", "SPECIES", 50, 53], ["EMCV", "SPECIES", 62, 66], ["vaccinia virus", "SPECIES", 95, 109], ["EMCV", "SPECIES", 132, 136], ["VSV", "SPECIES", 145, 148], ["vaccinia virus E3L", "TREATMENT", 13, 31], ["EMCV", "PROBLEM", 62, 66], ["exogenous IFN", "TREATMENT", 72, 85], ["vaccinia virus K3L", "TREATMENT", 95, 113], ["Virus Engineering", "TREATMENT", 156, 173], ["antiviral defense antagonism", "TREATMENT", 376, 404], ["EMCV", "OBSERVATION", 62, 66]]], ["Notably, vaccinia virus was favorably combined with IFN-I-sensitive oncolytic VSV and SFV, yielding tumor-model-dependent increases in overall therapy efficacy that were dependent on vaccinia virus antagonism of type I IFN responses, which increased the replication of the IFN-sensitive viruses [37, 60] .", [["tumor", "ANATOMY", 100, 105], ["IFN-I", "CHEMICAL", 52, 57], ["tumor", "DISEASE", 100, 105], ["IFN", "CHEMICAL", 273, 276], ["vaccinia virus", "ORGANISM", 9, 23], ["IFN-I", "GENE_OR_GENE_PRODUCT", 52, 57], ["oncolytic", "ORGANISM", 68, 77], ["VSV", "ORGANISM", 78, 81], ["SFV", "ORGANISM", 86, 89], ["tumor", "CANCER", 100, 105], ["vaccinia virus", "ORGANISM", 183, 197], ["type I IFN", "GENE_OR_GENE_PRODUCT", 212, 222], ["IFN", "GENE_OR_GENE_PRODUCT", 273, 276], ["IFN", "PROTEIN", 52, 55], ["IFN", "PROTEIN", 219, 222], ["IFN", "PROTEIN", 273, 276], ["vaccinia virus", "SPECIES", 9, 23], ["VSV", "SPECIES", 78, 81], ["SFV", "SPECIES", 86, 89], ["vaccinia virus", "SPECIES", 183, 197], ["vaccinia virus", "PROBLEM", 9, 23], ["IFN", "TEST", 52, 55], ["SFV", "PROBLEM", 86, 89], ["tumor", "PROBLEM", 100, 105], ["dependent increases", "PROBLEM", 112, 131], ["overall therapy efficacy", "TREATMENT", 135, 159], ["vaccinia virus antagonism", "TREATMENT", 183, 208], ["type I IFN responses", "PROBLEM", 212, 232], ["the IFN", "TEST", 269, 276], ["sensitive viruses", "PROBLEM", 277, 294], ["vaccinia virus", "OBSERVATION", 9, 23], ["SFV", "ANATOMY", 86, 89], ["tumor", "OBSERVATION", 100, 105], ["dependent", "OBSERVATION_MODIFIER", 112, 121], ["increases", "OBSERVATION_MODIFIER", 122, 131], ["overall therapy", "OBSERVATION", 135, 150]]], ["Such heterologous virotherapy approaches may also be used to generate immunological synergy, similar to heterologous prime-boost vaccination; anti-tumor immune responses may be increased due to targeting of the tumor by two different viruses (on two separate occasions), but anti-virus immune responses would be generated against different viruses each time, avoiding the problem of neutralizing immunity to and predominance of antivirus immune responses [162] .", [["tumor", "ANATOMY", 211, 216], ["tumor", "DISEASE", 211, 216], ["anti-tumor", "CANCER", 142, 152], ["tumor", "CANCER", 211, 216], ["Such heterologous virotherapy approaches", "TREATMENT", 0, 40], ["immunological synergy", "PROBLEM", 70, 91], ["heterologous prime", "TREATMENT", 104, 122], ["boost vaccination", "TREATMENT", 123, 140], ["anti-tumor immune responses", "TREATMENT", 142, 169], ["the tumor", "PROBLEM", 207, 216], ["two different viruses", "PROBLEM", 220, 241], ["anti-virus immune responses", "TREATMENT", 275, 302], ["neutralizing immunity", "TREATMENT", 383, 404], ["antivirus immune responses", "PROBLEM", 428, 454], ["tumor", "OBSERVATION", 211, 216], ["different", "OBSERVATION_MODIFIER", 224, 233], ["viruses", "OBSERVATION", 234, 241]]], ["Some other ideas explored experimentally include engineering oncolytic viruses to express other oncolytic viruses.", [["engineering oncolytic viruses", "PROBLEM", 49, 78], ["other oncolytic viruses", "PROBLEM", 90, 113]]], ["For example, the entire oncolytic parvovirus H-1 genome was placed under a regulatable promoter in oncolytic adenovirus, resulting in a more effective therapeutic entity than either virus alone without loss of tumor-specificity [163] .", [["tumor", "ANATOMY", 210, 215], ["tumor", "DISEASE", 210, 215], ["parvovirus H-1", "ORGANISM", 34, 48], ["adenovirus", "ORGANISM", 109, 119], ["tumor", "CANCER", 210, 215], ["oncolytic parvovirus H-1 genome", "DNA", 24, 55], ["regulatable promoter", "DNA", 75, 95], ["parvovirus H-1", "SPECIES", 34, 48], ["H-1", "SPECIES", 45, 48], ["adenovirus", "SPECIES", 109, 119], ["the entire oncolytic parvovirus H", "TREATMENT", 13, 46], ["a regulatable promoter in oncolytic adenovirus", "TREATMENT", 73, 119], ["loss of tumor", "PROBLEM", 202, 215], ["tumor", "OBSERVATION", 210, 215]]], ["The genetic material of Semliki Forest virus replicons has been engineered into adenovirus and vaccinia virus backbones [164] [165] [166] and several other virus chimeras have been constructed [167] .", [["Semliki Forest virus", "ORGANISM", 24, 44], ["adenovirus", "ORGANISM", 80, 90], ["vaccinia virus", "ORGANISM", 95, 109], ["Semliki", "SPECIES", 24, 31], ["Semliki Forest virus", "SPECIES", 24, 44], ["vaccinia virus", "SPECIES", 95, 109], ["Semliki Forest virus replicons", "TREATMENT", 24, 54], ["vaccinia virus backbones", "PROBLEM", 95, 119], ["several other virus chimeras", "TEST", 142, 170], ["Semliki Forest", "OBSERVATION", 24, 38]]], ["However, the effects on tumor antiviral defenses of such a constructs remain to be studied.ConclusionsThe attribute \"oncolytic\" implies for a virus that it infects and, indeed, lyses the infected tumor.", [["tumor", "ANATOMY", 24, 29], ["tumor", "ANATOMY", 196, 201], ["tumor", "DISEASE", 24, 29], ["infected tumor", "DISEASE", 187, 201], ["tumor", "CANCER", 24, 29], ["tumor", "CANCER", 196, 201], ["tumor antiviral defenses", "TREATMENT", 24, 48], ["a virus", "PROBLEM", 140, 147], ["the infected tumor", "PROBLEM", 183, 201], ["tumor", "OBSERVATION", 24, 29], ["antiviral defenses", "OBSERVATION", 30, 48], ["infected", "OBSERVATION_MODIFIER", 187, 195], ["tumor", "OBSERVATION", 196, 201]]], ["This property is primarily tested in vitro in cultured tumor cells.", [["tumor cells", "ANATOMY", 55, 66], ["tumor", "DISEASE", 55, 60], ["tumor cells", "CELL", 55, 66], ["cultured tumor cells", "CELL_LINE", 46, 66], ["tumor cells", "OBSERVATION", 55, 66]]], ["We have learned, however, that in the native tumor microenvironment in living hosts many viruses are no longer able to infect tumor cells or to kill them even if they manage to infect them.", [["tumor", "ANATOMY", 45, 50], ["tumor cells", "ANATOMY", 126, 137], ["tumor", "DISEASE", 45, 50], ["tumor", "DISEASE", 126, 131], ["tumor", "CANCER", 45, 50], ["tumor cells", "CELL", 126, 137], ["tumor cells", "CELL_TYPE", 126, 137], ["tumor cells", "PROBLEM", 126, 137], ["tumor", "OBSERVATION", 45, 50]]], ["Tightly packed tumor cells and the network of supportive molecules of the extracellular matrix form a physical barrier to virus particle diffusion.", [["tumor cells", "ANATOMY", 15, 26], ["extracellular matrix", "ANATOMY", 74, 94], ["tumor", "DISEASE", 15, 20], ["tumor cells", "CELL", 15, 26], ["extracellular matrix", "CELLULAR_COMPONENT", 74, 94], ["Tightly packed tumor cells", "CELL_TYPE", 0, 26], ["Tightly packed tumor cells", "PROBLEM", 0, 26], ["packed", "OBSERVATION_MODIFIER", 8, 14], ["tumor cells", "OBSERVATION", 15, 26], ["supportive molecules", "OBSERVATION", 46, 66], ["extracellular matrix", "OBSERVATION", 74, 94]]], ["It has also become evident that the tumor cells themselves may be much more capable of thwarting oncolytic virus advances than previously thought, with some tumor cells residing in a seemingly permanent non-permissive antiviral state.", [["tumor cells", "ANATOMY", 36, 47], ["tumor cells", "ANATOMY", 157, 168], ["tumor", "DISEASE", 36, 41], ["tumor", "DISEASE", 157, 162], ["tumor cells", "CELL", 36, 47], ["tumor cells", "CELL", 157, 168], ["tumor cells", "CELL_TYPE", 36, 47], ["tumor cells", "CELL_TYPE", 157, 168], ["the tumor cells", "PROBLEM", 32, 47], ["some tumor cells", "PROBLEM", 152, 168], ["a seemingly permanent non-permissive antiviral state", "PROBLEM", 181, 233], ["tumor", "OBSERVATION", 36, 41], ["tumor cells", "OBSERVATION", 157, 168], ["permanent non-permissive", "OBSERVATION_MODIFIER", 193, 217], ["antiviral state", "OBSERVATION", 218, 233]]], ["Tumors harbor multiple cell types in addition to the neoplastic cells, which may promote and propagate both physical and cellular virus resistance.", [["Tumors", "ANATOMY", 0, 6], ["cell", "ANATOMY", 23, 27], ["neoplastic cells", "ANATOMY", 53, 69], ["cellular", "ANATOMY", 121, 129], ["Tumors", "CANCER", 0, 6], ["cell", "CELL", 23, 27], ["neoplastic cells", "CELL", 53, 69], ["cellular", "CELL", 121, 129], ["neoplastic cells", "CELL_TYPE", 53, 69], ["Tumors harbor multiple cell types", "PROBLEM", 0, 33], ["the neoplastic cells", "PROBLEM", 49, 69], ["multiple cell types", "OBSERVATION", 14, 33], ["neoplastic cells", "OBSERVATION", 53, 69], ["cellular virus resistance", "OBSERVATION", 121, 146]]], ["As the efficacy of virotherapy in human cancer patients still falls shy of the achievements in animal models, it appears quite plausible that one or more of the barriers described in this review indeed constitute a real and formidable obstacle for oncolytic virus advancement into routine clinical use.", [["cancer", "ANATOMY", 40, 46], ["cancer", "DISEASE", 40, 46], ["human", "ORGANISM", 34, 39], ["cancer", "CANCER", 40, 46], ["patients", "ORGANISM", 47, 55], ["human", "SPECIES", 34, 39], ["patients", "SPECIES", 47, 55], ["human", "SPECIES", 34, 39], ["virotherapy in human cancer", "TREATMENT", 19, 46], ["oncolytic virus advancement", "TREATMENT", 248, 275], ["cancer", "OBSERVATION", 40, 46]]], ["Our task is now to separate the wheat from the chaff and to systematically evaluate the proposed combination regimens that will yield the best results without compromising patient safety.", [["wheat", "ORGANISM", 32, 37], ["patient", "ORGANISM", 172, 179], ["wheat", "SPECIES", 32, 37], ["patient", "SPECIES", 172, 179], ["wheat", "SPECIES", 32, 37], ["the proposed combination regimens", "TREATMENT", 84, 117]]]], "c5fa97f3c08e5b88b1081d261c675cf9f0fea73b": [["M iddle East respiratory syndrome coronavirus(MERS-CoV) was first reported in September 2012 (1); since then, >1,600 confirmed cases have been reported to the World Health Organization (http://www.who.int/csr/ don/29-february-2016-mers-saudi-arabia/en).", [["respiratory syndrome coronavirus", "DISEASE", 13, 45], ["M iddle East respiratory syndrome coronavirus", "ORGANISM", 0, 45], ["MERS-CoV", "ORGANISM", 46, 54], ["M iddle East respiratory syndrome coronavirus", "SPECIES", 0, 45], ["MERS-CoV", "SPECIES", 46, 54], ["East respiratory syndrome coronavirus", "PROBLEM", 8, 45], ["respiratory syndrome", "OBSERVATION", 13, 33]]], ["The role of domestic animals as an intermediate host for humans was initially suggested by case histories of infected patients who had visited farms or tended sick animals shortly before onset of infection (2) .", [["infection", "DISEASE", 196, 205], ["humans", "ORGANISM", 57, 63], ["patients", "ORGANISM", 118, 126], ["humans", "SPECIES", 57, 63], ["patients", "SPECIES", 118, 126], ["humans", "SPECIES", 57, 63], ["infection", "PROBLEM", 196, 205], ["infection", "OBSERVATION", 196, 205]]], ["This suggestion was given credence by a study of camel serum samples that showed high levels of neutralizing antibodies in disparate camel populations (3) ; the findings were subsequently confirmed by virus detection and sequencing (4) .M iddle East respiratory syndrome coronavirusInfection trials in camels have been limited (5, 6) , mainly because of difficulties in housing and handling the animals in a high-containment facility, which is necessary because the virus has a Biosafety Level 3 classification (7) .", [["serum samples", "ANATOMY", 55, 68], ["respiratory syndrome coronavirus", "DISEASE", 250, 282], ["camel", "ORGANISM", 49, 54], ["serum samples", "ORGANISM_SUBSTANCE", 55, 68], ["M iddle East respiratory syndrome coronavirus", "ORGANISM", 237, 282], ["camels", "ORGANISM", 302, 308], ["neutralizing antibodies", "PROTEIN", 96, 119], ["camel", "SPECIES", 49, 54], ["M iddle East respiratory syndrome coronavirus", "SPECIES", 237, 282], ["a study", "TEST", 38, 45], ["camel serum samples", "TEST", 49, 68], ["high levels of neutralizing antibodies", "PROBLEM", 81, 119], ["virus detection", "TEST", 201, 216], ["East respiratory syndrome", "PROBLEM", 245, 270], ["coronavirusInfection", "PROBLEM", 271, 291], ["the virus", "PROBLEM", 462, 471], ["neutralizing antibodies", "OBSERVATION", 96, 119], ["respiratory syndrome", "OBSERVATION", 250, 270], ["coronavirusInfection", "OBSERVATION", 271, 291]]], ["However, the alpaca, a close relative within the Camelidae family, may provide a temperamentally suitable and valuable animal model for MERS-CoV infection, particularly for developing and testing vaccine candidates for camels.", [["MERS-CoV infection", "DISEASE", 136, 154], ["alpaca", "ORGANISM", 13, 19], ["Camelidae", "GENE_OR_GENE_PRODUCT", 49, 58], ["MERS-CoV", "ORGANISM", 136, 144], ["camels", "ORGANISM", 219, 225], ["MERS-CoV", "SPECIES", 136, 144], ["camels", "SPECIES", 219, 225], ["MERS", "PROBLEM", 136, 140], ["CoV infection", "PROBLEM", 141, 154], ["alpaca", "OBSERVATION", 13, 19], ["infection", "OBSERVATION", 145, 154]]], ["We sought to assess whether alpacas could be infected by means of a natural (oronasal) route, to determine whether viral shedding occurred after reinfection, and to evaluate the development of serologic markers of protection.The StudyWe obtained 3 adult female alpacas (Vicugna pacos) from a commercial supplier in Victoria, Australia, and housed them in the Biosafety Level 3 containment facility at the CSIRO Australian Animal Health Laboratory.", [["alpacas", "ORGANISM", 28, 35], ["oronasal", "ORGANISM_SUBDIVISION", 77, 85], ["alpacas", "ORGANISM", 261, 268], ["Vicugna pacos", "ORGANISM", 270, 283], ["Vicugna pacos", "SPECIES", 270, 283], ["Vicugna pacos", "SPECIES", 270, 283], ["alpacas", "PROBLEM", 28, 35], ["a natural (oronasal) route", "TREATMENT", 66, 92], ["viral shedding", "PROBLEM", 115, 129], ["reinfection", "PROBLEM", 145, 156], ["serologic markers", "TEST", 193, 210]]], ["Before experiments, the alpacas were allowed to acclimatize for 6 days; during this time, intrauterine temperature data loggers were implanted according to a previously published procedure (8) .", [["alpacas", "ORGANISM", 24, 31], ["intrauterine temperature data loggers", "TREATMENT", 90, 127], ["a previously published procedure", "TREATMENT", 156, 188]]], ["We found no previous MERS-CoV challenge trial reported in alpacas, so we chose a preliminary dose and rechallenge time on the basis of our experience with other virus infection trials for other emerging infectious diseases (8) .The StudyWe used a camel isolate of MERS-CoV (Dromedary_ MERS-CoV_Al-Hasa_KFU-HKU13/2013; GenBank accession nos.", [["infection", "DISEASE", 167, 176], ["infectious diseases", "DISEASE", 203, 222], ["alpacas", "ORGANISM", 58, 65], ["camel", "ORGANISM", 247, 252], ["MERS-CoV", "ORGANISM", 264, 272], ["camel", "SPECIES", 247, 252], ["MERS-CoV", "SPECIES", 264, 272], ["other virus infection trials", "TREATMENT", 155, 183], ["other emerging infectious diseases", "PROBLEM", 188, 222], ["no", "UNCERTAINTY", 9, 11], ["infectious", "OBSERVATION", 203, 213]]], ["KJ650295-KJ650297) for infection; the isolate was prepared in Vero cells as described (9) .", [["Vero cells", "ANATOMY", 62, 72], ["KJ650295-KJ650297", "CHEMICAL", 0, 17], ["infection", "DISEASE", 23, 32], ["KJ650297", "CHEMICAL", 9, 17], ["Vero cells", "CELL", 62, 72], ["Vero cells", "CELL_LINE", 62, 72], ["infection", "PROBLEM", 23, 32], ["the isolate", "PROBLEM", 34, 45], ["infection", "OBSERVATION", 23, 32], ["Vero cells", "OBSERVATION", 62, 72]]], ["The 3 alpacas were exposed oronasally to a 10 6 50% tissue culture infective dose of MERS-CoV in 5 mL of phosphate-buffered saline.", [["tissue", "ANATOMY", 52, 58], ["phosphate", "CHEMICAL", 105, 114], ["phosphate", "CHEMICAL", 105, 114], ["alpacas", "ORGANISM", 6, 13], ["tissue", "TISSUE", 52, 58], ["MERS-CoV", "GENE_OR_GENE_PRODUCT", 85, 93], ["phosphate-buffered saline", "SIMPLE_CHEMICAL", 105, 130], ["MERS-CoV", "SPECIES", 85, 93], ["phosphate-buffered saline", "TREATMENT", 105, 130]]], ["The animals were monitored for 21 days, reexposed to a replicate challenge of MERS-CoV, and observed for 14 more days.", [["animals", "ORGANISM", 4, 11], ["MERS-CoV", "GENE_OR_GENE_PRODUCT", 78, 86], ["MERS-CoV", "SPECIES", 78, 86]]], ["Clinical samples of blood (in EDTA for obtaining serum) and swabs (deep and superficial nasal, oral, rectal, and urogenital) were collected immediately before inoculation and thereafter on days 3, 5, 7, 10, 12, 14, 21, 26, 28, 31, 33, and 35.", [["samples", "ANATOMY", 9, 16], ["blood", "ANATOMY", 20, 25], ["serum", "ANATOMY", 49, 54], ["swabs", "ANATOMY", 60, 65], ["superficial nasal", "ANATOMY", 76, 93], ["oral", "ANATOMY", 95, 99], ["rectal", "ANATOMY", 101, 107], ["urogenital", "ANATOMY", 113, 123], ["EDTA", "CHEMICAL", 30, 34], ["blood", "ORGANISM_SUBSTANCE", 20, 25], ["serum", "ORGANISM_SUBSTANCE", 49, 54], ["swabs", "ORGANISM_SUBDIVISION", 60, 65], ["superficial nasal", "MULTI-TISSUE_STRUCTURE", 76, 93], ["oral", "ORGANISM_SUBDIVISION", 95, 99], ["rectal", "ORGAN", 101, 107], ["urogenital", "ORGAN", 113, 123], ["serum", "TEST", 49, 54], ["swabs", "TEST", 60, 65], ["deep and superficial nasal, oral, rectal, and urogenital)", "TEST", 67, 124], ["superficial nasal", "ANATOMY", 76, 93], ["rectal", "ANATOMY", 101, 107], ["urogenital", "ANATOMY", 113, 123]]], ["Alpacas were electively euthanized, 1 on day 33 and the others on day 35.The StudyThe animals remained clinically healthy except for a reduced condition score that occurred by day 18 in 1 animal (alpaca 2); no signs of upper or lower respiratory tract disease appeared in any animal.", [["lower respiratory tract", "ANATOMY", 228, 251], ["respiratory tract disease", "DISEASE", 234, 259], ["animals", "ORGANISM", 86, 93], ["upper", "ORGANISM_SUBDIVISION", 219, 224], ["lower", "ORGANISM_SUBDIVISION", 228, 233], ["respiratory tract", "ORGANISM_SUBDIVISION", 234, 251], ["Alpacas", "TREATMENT", 0, 7], ["The Study", "TEST", 73, 82], ["a reduced condition score", "PROBLEM", 133, 158], ["upper or lower respiratory tract disease", "PROBLEM", 219, 259], ["no signs of", "UNCERTAINTY", 207, 218], ["upper", "ANATOMY_MODIFIER", 219, 224], ["lower", "ANATOMY_MODIFIER", 228, 233], ["respiratory tract", "ANATOMY", 234, 251], ["disease", "OBSERVATION", 252, 259]]], ["Increased temperature was noted in alpaca 2 during days 17-20, but fever (rectal temperature >39\u00b0C) was not recorded.", [["rectal", "ANATOMY", 74, 80], ["fever", "DISEASE", 67, 72], ["rectal", "ORGANISM_SUBDIVISION", 74, 80], ["Increased temperature", "PROBLEM", 0, 21], ["fever", "PROBLEM", 67, 72], ["rectal temperature", "TEST", 74, 92], ["temperature", "OBSERVATION_MODIFIER", 10, 21]]], ["Gross abnormalities at postmortem examination were found only in alpaca 2 and comprised extensive adhesions of the caudal sac of compartment 1 of the stomach to the umbilicus; clinical findings in this animal were attributed to this lesion.The StudyRNA extraction and real-time PCR were performed by following specimen-handling procedures established for Hendra virus (8) and were used to identify shedding patterns after each challenge.", [["adhesions", "ANATOMY", 98, 107], ["caudal sac", "ANATOMY", 115, 125], ["stomach", "ANATOMY", 150, 157], ["umbilicus", "ANATOMY", 165, 174], ["lesion", "ANATOMY", 233, 239], ["specimen", "ANATOMY", 310, 318], ["caudal sac", "MULTI-TISSUE_STRUCTURE", 115, 125], ["stomach", "ORGAN", 150, 157], ["umbilicus", "ORGAN", 165, 174], ["lesion", "CANCER", 233, 239], ["Hendra virus", "ORGANISM", 355, 367], ["Hendra virus", "SPECIES", 355, 367], ["Hendra virus", "SPECIES", 355, 367], ["Gross abnormalities", "PROBLEM", 0, 19], ["postmortem examination", "TEST", 23, 45], ["this lesion", "PROBLEM", 228, 239], ["The StudyRNA extraction", "TREATMENT", 240, 263], ["real-time PCR", "TEST", 268, 281], ["specimen", "TEST", 310, 318], ["handling procedures", "TEST", 319, 338], ["Hendra virus", "PROBLEM", 355, 367], ["abnormalities", "OBSERVATION", 6, 19], ["extensive", "OBSERVATION_MODIFIER", 88, 97], ["adhesions", "OBSERVATION", 98, 107], ["caudal", "ANATOMY_MODIFIER", 115, 121], ["sac", "ANATOMY_MODIFIER", 122, 125], ["compartment 1", "ANATOMY_MODIFIER", 129, 142], ["stomach", "ANATOMY", 150, 157], ["umbilicus", "ANATOMY", 165, 174], ["lesion", "OBSERVATION", 233, 239]]], ["After initial challenge, (Table 1) .Experimental Infection and Response to Rechallenge of Alpacas with Middle East Respiratory Syndrome CoronavirusVirus isolation was undertaken with Vero cells by using published protocols (9) and was successful for all 3 animals from all types of samples.", [["Vero cells", "ANATOMY", 183, 193], ["samples", "ANATOMY", 282, 289], ["Vero cells", "CELL", 183, 193], ["samples", "CANCER", 282, 289], ["Vero cells", "CELL_LINE", 183, 193], ["Middle East Respiratory Syndrome CoronavirusVirus", "SPECIES", 103, 152], ["Experimental Infection", "PROBLEM", 36, 58], ["Rechallenge of Alpacas", "TREATMENT", 75, 97], ["Middle East Respiratory Syndrome", "PROBLEM", 103, 135], ["CoronavirusVirus isolation", "TREATMENT", 136, 162], ["Vero cells", "TREATMENT", 183, 193], ["published protocols", "TREATMENT", 203, 222], ["Infection", "OBSERVATION", 49, 58], ["Respiratory Syndrome", "OBSERVATION", 115, 135]]], ["Virus recovery was successful from oral and superficial nasal swab samples through day 12; deep nasal swab samples were positive only through day 10.", [["oral", "ANATOMY", 35, 39], ["nasal swab samples", "ANATOMY", 56, 74], ["nasal swab samples", "ANATOMY", 96, 114], ["Virus", "ORGANISM", 0, 5], ["oral", "ORGANISM_SUBDIVISION", 35, 39], ["nasal swab samples", "ORGANISM_SUBSTANCE", 56, 74], ["nasal swab samples", "ORGANISM_SUBSTANCE", 96, 114], ["Virus recovery", "PROBLEM", 0, 14], ["oral and superficial nasal swab samples", "TEST", 35, 74], ["deep nasal swab samples", "TEST", 91, 114], ["superficial nasal", "ANATOMY", 44, 61], ["deep", "ANATOMY_MODIFIER", 91, 95], ["nasal", "ANATOMY", 96, 101]]], ["All urogenital and rectal swab samples were negative by both real-time PCR and virus isolation.", [["urogenital", "ANATOMY", 4, 14], ["rectal swab samples", "ANATOMY", 19, 38], ["urogenital", "ORGAN", 4, 14], ["rectal swab samples", "CANCER", 19, 38], ["All urogenital and rectal swab samples", "TEST", 0, 38], ["virus isolation", "TREATMENT", 79, 94], ["urogenital", "ANATOMY", 4, 14], ["rectal", "ANATOMY", 19, 25]]], ["After rechallenge, viral RNA was not detected with confidence from any sample (Figure) .Experimental Infection and Response to Rechallenge of Alpacas with Middle East Respiratory Syndrome CoronavirusSerum samples were assessed for immunologic responses by using a virus neutralization test (VNT) and a Luminex bead assay to the nucleocapsid protein.", [["viral RNA", "RNA", 19, 28], ["nucleocapsid protein", "PROTEIN", 328, 348], ["Middle East Respiratory Syndrome CoronavirusSerum", "SPECIES", 155, 204], ["viral RNA", "PROBLEM", 19, 28], ["Experimental Infection", "PROBLEM", 88, 110], ["Rechallenge of Alpacas", "TREATMENT", 127, 149], ["Middle East Respiratory Syndrome", "PROBLEM", 155, 187], ["CoronavirusSerum samples", "TEST", 188, 212], ["a virus neutralization test", "TEST", 262, 289], ["a Luminex bead assay", "TEST", 300, 320], ["viral RNA", "OBSERVATION", 19, 28], ["Infection", "OBSERVATION", 101, 110]]], ["We used in-house assays modeled after those previously developed to assess the serologic status of feral camels in central Australia (10) .", [["central", "ANATOMY_MODIFIER", 115, 122]]], ["All animals were seronegative by both Luminex and VNT before challenge.", [["animals", "ORGANISM", 4, 11], ["VNT", "TREATMENT", 50, 53]]], ["Antibody was first detected by Luminex on day 10 or day 12 in each animal ( Table 2) ; neutralizing antibody titers were 1:20 to 1:40 in alpaca 2 from day 10.", [["Antibody", "TEST", 0, 8], ["neutralizing antibody titers", "TEST", 87, 115]]], ["Neutralizing antibody titers of 1:10 to 1:20 were detected in alpaca 1 from day 21 on but not in alpaca 3 at any time during the study.", [["Neutralizing antibody titers", "TEST", 0, 28], ["the study", "TEST", 125, 134]]], ["For controls, we used MERS-CoV positive and negative serum samples from Egypt and Australia (online Technical Appendix Table, http://wwwnc.cdc.gov/EID/article/22/6/16-0007-Techapp1.pdf).ConclusionsOur study confirms that alpacas are susceptible to MERS-CoV infection; this finding is consistent with a previous report showing that alpaca kidney cell lines possessing the dipeptidyl peptidase-4 receptor could be infected in vitro (11) .", [["serum samples", "ANATOMY", 53, 66], ["kidney cell lines", "ANATOMY", 338, 355], ["infection", "DISEASE", 257, 266], ["MERS-CoV", "GENE_OR_GENE_PRODUCT", 22, 30], ["serum", "ORGANISM_SUBSTANCE", 53, 58], ["alpacas", "ORGANISM", 221, 228], ["MERS-CoV", "ORGANISM", 248, 256], ["alpaca", "ORGANISM", 331, 337], ["kidney cell lines", "CELL", 338, 355], ["dipeptidyl peptidase-4 receptor", "GENE_OR_GENE_PRODUCT", 371, 402], ["alpaca kidney cell lines", "CELL_LINE", 331, 355], ["dipeptidyl peptidase-4 receptor", "PROTEIN", 371, 402], ["MERS-CoV", "SPECIES", 22, 30], ["MERS-CoV", "SPECIES", 248, 256], ["MERS", "TEST", 22, 26], ["CoV positive", "TEST", 27, 39], ["serum samples", "TEST", 53, 66], ["ConclusionsOur study", "TEST", 186, 206], ["alpacas", "PROBLEM", 221, 228], ["MERS", "PROBLEM", 248, 252], ["CoV infection", "PROBLEM", 253, 266], ["alpaca kidney cell lines", "TREATMENT", 331, 355], ["the dipeptidyl peptidase", "TREATMENT", 367, 391], ["CoV", "OBSERVATION_MODIFIER", 253, 256], ["infection", "OBSERVATION", 257, 266], ["consistent with", "UNCERTAINTY", 284, 299], ["kidney", "ANATOMY", 338, 344], ["cell lines", "OBSERVATION", 345, 355], ["infected", "OBSERVATION", 412, 420]]], ["Our challenge/rechallenge trial was planned as a first stage in the assessment of the alpaca as a potential surrogate for camels for MERS-CoV vaccine testing.", [["alpaca", "ORGANISM", 86, 92], ["camels", "ORGANISM", 122, 128], ["MERS-CoV", "GENE_OR_GENE_PRODUCT", 133, 141], ["camels", "SPECIES", 122, 128], ["MERS-CoV", "SPECIES", 133, 141], ["Our challenge/rechallenge trial", "TREATMENT", 0, 31], ["the assessment", "TEST", 64, 78], ["MERS", "PROBLEM", 133, 137], ["CoV vaccine testing", "TEST", 138, 157]]], ["Consequently, the trial was not designed for direct comparison with 2 previous MERS-CoV challenge trials reported in camels (5,6).", [["CoV challenge trials", "TREATMENT", 84, 104]]], ["Our trial used a lower challenge dose and a different timeframe for observation; nevertheless, some preliminary comparative observations may be useful.", [["a lower challenge dose", "TREATMENT", 15, 37]]], ["In the previous studies, as in ours, the animals were inoculated by the oronasal route, and live virus was detected through day 7 postinfection.", [["animals", "ORGANISM", 41, 48], ["the previous studies", "TEST", 3, 23], ["live virus", "PROBLEM", 92, 102]]], ["Similarly, neutralizing antibodies were detected beginning 7-8 days postinfection.", [["neutralizing antibodies", "PROTEIN", 11, 34], ["neutralizing antibodies", "TEST", 11, 34], ["neutralizing antibodies", "OBSERVATION", 11, 34]]], ["However, findings in the trials with camels differed considerably from findings in our trial.", [["camels", "ORGANISM", 37, 43]]], ["The trials with camels detected live virus from nasal washes at days 1-3, a nasal discharge, and transient temperature rises; viral RNA was detected by real-time PCR for an extended period.", [["nasal", "ANATOMY", 48, 53], ["nasal", "ANATOMY", 76, 81], ["camels", "ORGANISM", 16, 22], ["nasal", "ORGANISM_SUBDIVISION", 48, 53], ["nasal", "ORGANISM_SUBDIVISION", 76, 81], ["viral RNA", "RNA", 126, 135], ["camels", "TREATMENT", 16, 22], ["nasal washes", "TREATMENT", 48, 60], ["a nasal discharge", "PROBLEM", 74, 91], ["transient temperature rises", "PROBLEM", 97, 124], ["viral RNA", "PROBLEM", 126, 135], ["nasal", "ANATOMY", 76, 81]]], ["Furthermore, the VNT titers for camels were much higher than those for the alpacas in our study.", [["VNT", "GENE_OR_GENE_PRODUCT", 17, 20], ["camels", "ORGANISM", 32, 38], ["VNT", "PROTEIN", 17, 20], ["the VNT titers", "TEST", 13, 27], ["our study", "TEST", 86, 95]]], ["These differences possibly represent underlying dissimilarities in immune responses to MERS-CoV for the 2 species but may also result from the higher infecting dose (10 7 50% tissue culture infective dose) used in the camel studies.ConclusionsOur study showed that alpacas secreted live virus after oronasal infection and that the immune response to the initial infection prevented further excretion following reinfection.", [["tissue culture", "ANATOMY", 175, 189], ["oronasal", "ANATOMY", 299, 307], ["oronasal infection", "DISEASE", 299, 317], ["infection", "DISEASE", 362, 371], ["MERS-CoV", "GENE_OR_GENE_PRODUCT", 87, 95], ["tissue", "TISSUE", 175, 181], ["camel", "ORGANISM", 218, 223], ["alpacas", "ORGANISM", 265, 272], ["oronasal", "ORGAN", 299, 307], ["MERS-CoV", "SPECIES", 87, 95], ["camel", "SPECIES", 218, 223], ["underlying dissimilarities", "PROBLEM", 37, 63], ["the 2 species", "PROBLEM", 100, 113], ["the camel studies", "TEST", 214, 231], ["Our study", "TEST", 243, 252], ["alpacas secreted live virus", "PROBLEM", 265, 292], ["oronasal infection", "PROBLEM", 299, 317], ["the initial infection", "PROBLEM", 350, 371], ["reinfection", "PROBLEM", 410, 421], ["possibly represent", "UNCERTAINTY", 18, 36], ["immune responses", "OBSERVATION", 67, 83], ["infection", "OBSERVATION", 308, 317], ["infection", "OBSERVATION", 362, 371]]], ["An underlying assumption in our trial is that the initial infection equates to natural vaccination and that the lack of viral excretion thus follows an induced immune memory response.", [["infection", "DISEASE", 58, 67], ["the initial infection", "PROBLEM", 46, 67], ["natural vaccination", "TREATMENT", 79, 98], ["viral excretion", "PROBLEM", 120, 135], ["infection", "OBSERVATION", 58, 67]]], ["However, our results indicate that this immunologic response is complex; although a strong serologic response developed in only 1 alpaca, all 3 alpacas were refractory to reinfection.ConclusionsThis study has several limitations.", [["alpaca", "ORGANISM", 130, 136], ["alpacas", "ORGANISM", 144, 151], ["a strong serologic response", "PROBLEM", 82, 109], ["reinfection", "PROBLEM", 171, 182], ["This study", "TEST", 194, 204], ["reinfection", "OBSERVATION", 171, 182]]], ["First, it was a preliminary study with only 3 animals and functioned more as proof of concept than a definitive study of the use of alpacas as a model for studying infection dynamics of MERS-CoV in camelids.", [["infection", "DISEASE", 164, 173], ["alpacas", "ORGANISM", 132, 139], ["MERS-CoV", "ORGANISM", 186, 194], ["camelids", "ORGANISM", 198, 206], ["MERS-CoV", "SPECIES", 186, 194], ["a preliminary study", "TEST", 14, 33], ["a definitive study", "TEST", 99, 117]]], ["Second, our observation period of 21 days before rechallenge is informative but does not provide complete information on duration of protective immunity.", [["protective immunity", "TREATMENT", 133, 152]]], ["Future studies should have a larger sample and a longer period of study postinoculation.", [["Future studies", "TEST", 0, 14], ["study postinoculation", "TEST", 66, 87]]], ["Third, our study did not seek to understand the pathogenesis of infection; we did not conduct histopathology or immunohistochemistry to understand the site of initial viral replication and the role of mucosal immunity in mounting an effective immune response upon infection.ConclusionsNotwithstanding these limitations, we believe that the alpaca might be a useful model that could greatly facilitate the development and testing of vaccine candidates.", [["mucosal", "ANATOMY", 201, 208], ["infection", "DISEASE", 64, 73], ["infection", "DISEASE", 264, 273], ["mucosal", "ORGAN", 201, 208], ["alpaca", "ORGANISM", 340, 346], ["our study", "TEST", 7, 16], ["infection", "PROBLEM", 64, 73], ["histopathology", "TEST", 94, 108], ["immunohistochemistry", "TEST", 112, 132], ["initial viral replication", "PROBLEM", 159, 184], ["mucosal immunity", "TREATMENT", 201, 217], ["infection", "PROBLEM", 264, 273], ["the alpaca", "PROBLEM", 336, 346], ["vaccine candidates", "TREATMENT", 432, 450], ["infection", "OBSERVATION", 64, 73], ["viral replication", "OBSERVATION", 167, 184], ["infection", "OBSERVATION", 264, 273], ["alpaca", "OBSERVATION", 340, 346]]], ["We recommend further research and trials to substantiate this potential.", [["trials", "TREATMENT", 34, 40]]], ["Experimental Infection of Alpacas with MERS-CoV", [["Infection of Alpacas", "DISEASE", 13, 33], ["MERS-CoV", "SPECIES", 39, 47], ["Experimental Infection of Alpacas", "PROBLEM", 0, 33], ["Infection", "OBSERVATION", 13, 22]]]], "PMC6166599": [["IntroductionViral acute respiratory infections (ARIs) are a common cause of morbidity in children, either on their own or in synergy with bacterial pathogens.1 Virus-positive ARIs early in life are associated with developing wheeze and asthma during childhood and adolescence.2 Community-based studies from the 1950s to 1960s examining the aetiology of ARIs by traditional laboratory detection methods remain the template for understanding childhood respiratory virus epidemiology.3 Advances in molecular diagnostics, including PCR testing, have improved virus detection in those with ARIs.4 However, this increased test sensitivity has also resulted in viruses being detected in asymptomatic individuals.4 5 The clinical significance of finding respiratory viruses is not always straightforward, and a better understanding of the proportion of infections that are symptomatic for individual viruses is needed.IntroductionThe attributable fraction in the exposed (AFE) provides information about the percentage of cases among exposed individuals that can be attributed to the exposure.", [["respiratory", "ANATOMY", 24, 35], ["acute respiratory infections", "DISEASE", 18, 46], ["ARIs", "DISEASE", 48, 52], ["wheeze", "DISEASE", 225, 231], ["asthma", "DISEASE", 236, 242], ["ARIs", "DISEASE", 353, 357], ["ARIs", "DISEASE", 585, 589], ["respiratory viruses", "DISEASE", 746, 765], ["infections", "DISEASE", 845, 855], ["children", "ORGANISM", 89, 97], ["1 Virus", "ORGANISM", 158, 165], ["children", "SPECIES", 89, 97], ["IntroductionViral acute respiratory infections (ARIs)", "PROBLEM", 0, 53], ["morbidity", "PROBLEM", 76, 85], ["bacterial pathogens", "PROBLEM", 138, 157], ["1 Virus", "PROBLEM", 158, 165], ["positive ARIs", "PROBLEM", 166, 179], ["wheeze", "PROBLEM", 225, 231], ["asthma", "PROBLEM", 236, 242], ["Community-based studies", "TEST", 278, 301], ["ARIs", "PROBLEM", 353, 357], ["traditional laboratory detection", "TEST", 361, 393], ["the template", "TREATMENT", 409, 421], ["understanding childhood respiratory virus epidemiology", "PROBLEM", 426, 480], ["molecular diagnostics", "TEST", 495, 516], ["PCR testing", "TEST", 528, 539], ["improved virus detection", "PROBLEM", 546, 570], ["ARIs", "PROBLEM", 585, 589], ["this increased test sensitivity", "PROBLEM", 601, 632], ["viruses", "PROBLEM", 654, 661], ["respiratory viruses", "PROBLEM", 746, 765], ["infections", "PROBLEM", 845, 855], ["symptomatic", "PROBLEM", 865, 876], ["individual viruses", "PROBLEM", 881, 899], ["acute", "OBSERVATION_MODIFIER", 18, 23], ["respiratory", "ANATOMY", 24, 35], ["infections", "OBSERVATION", 36, 46], ["morbidity", "OBSERVATION", 76, 85], ["bacterial pathogens", "OBSERVATION", 138, 157], ["positive ARIs", "OBSERVATION_MODIFIER", 166, 179], ["associated with", "UNCERTAINTY", 198, 213], ["wheeze", "OBSERVATION", 225, 231], ["asthma", "OBSERVATION", 236, 242], ["respiratory virus", "OBSERVATION", 450, 467], ["viruses", "OBSERVATION", 654, 661], ["respiratory viruses", "OBSERVATION", 746, 765], ["infections", "OBSERVATION", 845, 855], ["fraction", "OBSERVATION_MODIFIER", 939, 947]]], ["In our study, the AFE measures the percentage of ARIs in virus-positive children attributable to that particular virus.", [["ARIs", "GENE_OR_GENE_PRODUCT", 49, 53], ["children", "ORGANISM", 72, 80], ["children", "SPECIES", 72, 80], ["our study", "TEST", 3, 12], ["the AFE", "TEST", 14, 21], ["ARIs in virus", "PROBLEM", 49, 62], ["particular virus", "PROBLEM", 102, 118]]], ["The AFE does not inform on the aetiology at an individual level, but is a key population-level metric for interpreting positive specimen results.", [["specimen", "ANATOMY", 128, 136]]], ["It assists with estimation of the true burden of disease, thus guiding preventative strategies for respiratory infections, such as immunisation.", [["respiratory", "ANATOMY", 99, 110], ["respiratory infections", "DISEASE", 99, 121], ["the true burden of disease", "PROBLEM", 30, 56], ["preventative strategies", "TREATMENT", 71, 94], ["respiratory infections", "PROBLEM", 99, 121], ["disease", "OBSERVATION", 49, 56], ["infections", "OBSERVATION", 111, 121]]], ["Virus-specific AFE estimates for ARI in children are reported infrequently, with most studies reporting AFEs having important methodological limitations.", [["ARI", "DISEASE", 33, 36], ["Virus", "ORGANISM", 0, 5], ["children", "ORGANISM", 40, 48], ["children", "SPECIES", 40, 48], ["Virus", "PROBLEM", 0, 5], ["ARI", "PROBLEM", 33, 36]]], ["Except for one community study,5 these investigations recruited either highly selected hospitalised children or outpatients as study cases,6\u20138 or used controls from outpatient clinics.6 7 A meta-analysis of 23 studies that calculated virus-specific AFEs included 22 studies employing hospital-based case ascertainment and only three using community-based controls.9 Other studies comparing symptomatic and asymptomatic groups calculated odds ratios (ORs),10\u201312 or relative risks,13 without calculating AFEs.", [["children", "ORGANISM", 100, 108], ["children", "SPECIES", 100, 108], ["outpatients", "SPECIES", 112, 123], ["one community study", "TEST", 11, 30], ["these investigations", "TEST", 33, 53], ["study cases", "TEST", 127, 138], ["A meta-analysis", "TEST", 188, 203], ["23 studies", "TEST", 207, 217], ["calculated virus", "PROBLEM", 223, 239], ["Other studies", "TEST", 366, 379], ["symptomatic and asymptomatic groups", "PROBLEM", 390, 425]]], ["Moreover, several studies focused solely either on specific viruses10 12 or outcomes.6 11\u201313IntroductionLongitudinal, community-based studies employing sensitive molecular-based assays with regular and frequent sampling, irrespective of illness, are best suited to explore the relationship between respiratory virus detections and ARI symptoms, especially as they represent most ARI episodes.", [["respiratory virus detections", "DISEASE", 298, 326], ["ARI", "DISEASE", 331, 334], ["ARI", "DISEASE", 379, 382], ["several studies", "TEST", 10, 25], ["community-based studies", "TEST", 118, 141], ["illness", "PROBLEM", 237, 244], ["respiratory virus detections", "PROBLEM", 298, 326], ["ARI symptoms", "PROBLEM", 331, 343], ["most ARI episodes", "PROBLEM", 374, 391]]], ["The aim of our study was to examine the disease-pathogen associations of respiratory viruses in infants participating in a community-based birth cohort project14 and to calculate their virus-specific AFE values.Study population ::: MethodsThe Observational Research in Childhood Infectious Diseases (ORChID) project (clinicaltrials.gov: NCT01304914) is an observational, longitudinal community-based birth cohort study of ARI episodes in children until their second birthday.14 Participants were able to leave the study temporarily (such as during family holidays) and rejoin at a later date.", [["respiratory viruses", "DISEASE", 73, 92], ["Infectious Diseases", "DISEASE", 279, 298], ["ARI", "DISEASE", 422, 425], ["infants", "ORGANISM", 96, 103], ["children", "ORGANISM", 438, 446], ["infants", "SPECIES", 96, 103], ["children", "SPECIES", 438, 446], ["Participants", "SPECIES", 478, 490], ["our study", "TEST", 11, 20], ["the disease", "PROBLEM", 36, 47], ["respiratory viruses", "PROBLEM", 73, 92], ["their virus", "TEST", 179, 190], ["Methods", "TREATMENT", 232, 239], ["ARI episodes", "PROBLEM", 422, 434], ["respiratory viruses", "OBSERVATION", 73, 92], ["Infectious", "OBSERVATION_MODIFIER", 279, 289]]], ["It was conducted in the subtropical city of Brisbane, Australia (latitude 27\u00b0 South, average monthly maximum temperature range 22\u00b0C\u201330\u00b0C, maximum rainfall in December-February, population 2.2 million) between September 2010 and October 2014.", [["maximum temperature", "TEST", 101, 120], ["subtropical", "OBSERVATION_MODIFIER", 24, 35]]], ["For enrolment, infants needed to be healthy, without congenital abnormalities or underlying chronic disorders, and to be born at term (36\u201342 weeks).", [["congenital abnormalities", "DISEASE", 53, 77], ["chronic disorders", "DISEASE", 92, 109], ["infants", "ORGANISM", 15, 22], ["infants", "SPECIES", 15, 22], ["congenital abnormalities", "PROBLEM", 53, 77], ["underlying chronic disorders", "PROBLEM", 81, 109], ["chronic", "OBSERVATION_MODIFIER", 92, 99], ["disorders", "OBSERVATION", 100, 109]]], ["Recruitment was progressive over 2 years at one of two metropolitan hospitals (one private and one government-funded).", [["progressive", "OBSERVATION_MODIFIER", 16, 27]]], ["Detailed methods of recruitment, study design and sample and data collection are described elsewhere.14 The Children\u2019s Health Queensland, Royal Brisbane and Women\u2019s Hospital, and The University of Queensland Human Research Ethics Committees approved the study.Sociodemographic and clinical characteristics ::: MethodsFollowing recruitment, parents provided their sociodemographic and health history, pregnancy and birth details.", [["Human", "ORGANISM", 208, 213], ["Children", "SPECIES", 108, 116], ["Women", "SPECIES", 157, 162], ["Human", "SPECIES", 208, 213], ["study design", "TEST", 33, 45], ["sample and data collection", "TEST", 50, 76], ["the study", "TEST", 250, 259]]], ["Childcare was categorised as formal (regulated care outside the child\u2019s home) or informal (non-regulated care provided by family or friends).15 The duration of exclusive breast feeding was from birth to the introduction of either any milk formula or solids.Symptom data collection ::: MethodsParents were trained to recognise respiratory symptoms and provided with diary cards designed in a tick-box format and listed with predefined respiratory symptoms or diagnoses to be completed daily and returned by regular mail monthly.", [["breast", "ANATOMY", 170, 176], ["milk", "ANATOMY", 234, 238], ["respiratory", "ANATOMY", 326, 337], ["respiratory", "ANATOMY", 434, 445], ["respiratory symptoms", "DISEASE", 326, 346], ["breast", "ORGANISM_SUBDIVISION", 170, 176], ["milk", "ORGANISM_SUBSTANCE", 234, 238], ["exclusive breast feeding", "TREATMENT", 160, 184], ["respiratory symptoms", "PROBLEM", 326, 346], ["predefined respiratory symptoms", "PROBLEM", 423, 454]]], ["The diary cards were modified from a prior study16 and used successfully elsewhere.17Virus detection ::: MethodsViruses were identified from parent-collected anterior nose swabs at the infant\u2019s birth, and weekly thereafter.18 Specimens were mailed to the laboratory, taking a median of 3 (IQR 2\u20134) days, and where they were processed and stored at \u221280\u00b0C until further analysis.14 19Virus detection ::: MethodsSwabs were batch-tested for 17 respiratory viruses: human rhinovirus (HRV), influenza A and B (IFV-A, IFV-B), respiratory syncytial virus A and B (RSV-A, RSV-B), parainfluenza viruses 1\u20133 (PIV-1, PIV-2, PIV-3), human coronaviruses (HCoV) OC43, NL63, 229E and HKU1, human metapneumovirus (HMPV), adenovirus (AdV), human polyomaviruses WU (WU-PyV) and KI (KI-PyV) and human bocavirus-1 (HBoV-1), using previously validated real-time PCR assays.14 Details of sample collection, processing, PCR assay parameters, quality control measures and HRV typing into species A, B and C are outlined in the online supplementary text and E-table 1.", [["anterior nose swabs", "ANATOMY", 158, 177], ["respiratory viruses", "DISEASE", 440, 459], ["respiratory syncytial virus", "DISEASE", 519, 546], ["parainfluenza viruses", "DISEASE", 571, 592], ["human metapneumovirus", "DISEASE", 674, 695], ["anterior nose swabs", "MULTI-TISSUE_STRUCTURE", 158, 177], ["human", "ORGANISM", 461, 466], ["rhinovirus", "ORGANISM", 467, 477], ["influenza A", "ORGANISM", 485, 496], ["B", "ORGANISM", 501, 502], ["IFV-A, IFV-B", "ORGANISM", 504, 516], ["respiratory syncytial virus A", "ORGANISM", 519, 548], ["B", "ORGANISM", 553, 554], ["RSV-A,", "ORGANISM", 556, 562], ["RSV-B", "ORGANISM", 563, 568], ["parainfluenza viruses 1\u20133", "ORGANISM", 571, 596], ["PIV-1", "ORGANISM", 598, 603], ["PIV-2", "ORGANISM", 605, 610], ["PIV-3", "ORGANISM", 612, 617], ["human", "ORGANISM", 620, 625], ["coronaviruses", "ORGANISM", 626, 639], ["HCoV", "ORGANISM", 641, 645], ["OC43", "GENE_OR_GENE_PRODUCT", 647, 651], ["NL63", "GENE_OR_GENE_PRODUCT", 653, 657], ["229E", "GENE_OR_GENE_PRODUCT", 659, 663], ["HKU1", "GENE_OR_GENE_PRODUCT", 668, 672], ["human metapneumovirus", "ORGANISM", 674, 695], ["HMPV", "ORGANISM", 697, 701], ["adenovirus", "ORGANISM", 704, 714], ["AdV", "ORGANISM", 716, 719], ["human", "ORGANISM", 722, 727], ["polyomaviruses WU", "ORGANISM", 728, 745], ["WU-PyV", "ORGANISM", 747, 753], ["KI (KI-PyV", "ORGANISM", 759, 769], ["human bocavirus-1", "ORGANISM", 775, 792], ["HBoV", "ORGANISM", 794, 798], ["-1", "ORGANISM", 798, 800], ["E-table 1", "DNA", 1032, 1041], ["infant", "SPECIES", 185, 191], ["human", "SPECIES", 461, 466], ["rhinovirus", "SPECIES", 467, 477], ["respiratory syncytial virus", "SPECIES", 519, 546], ["RSV", "SPECIES", 556, 559], ["RSV", "SPECIES", 563, 566], ["parainfluenza", "SPECIES", 571, 584], ["human", "SPECIES", 620, 625], ["human", "SPECIES", 674, 679], ["metapneumovirus", "SPECIES", 680, 695], ["human", "SPECIES", 722, 727], ["human", "SPECIES", 775, 780], ["bocavirus-1", "SPECIES", 781, 792], ["human rhinovirus", "SPECIES", 461, 477], ["HRV", "SPECIES", 479, 482], ["IFV-A", "SPECIES", 504, 509], ["respiratory syncytial virus A", "SPECIES", 519, 548], ["RSV-A", "SPECIES", 556, 561], ["RSV", "SPECIES", 563, 566], ["PIV-1", "SPECIES", 598, 603], ["human coronaviruses", "SPECIES", 620, 639], ["HCoV", "SPECIES", 641, 645], ["human metapneumovirus", "SPECIES", 674, 695], ["HMPV", "SPECIES", 697, 701], ["adenovirus", "SPECIES", 704, 714], ["AdV", "SPECIES", 716, 719], ["human polyomaviruses WU (WU-PyV", "SPECIES", 722, 753], ["human bocavirus-1", "SPECIES", 775, 792], ["HBoV-1", "SPECIES", 794, 800], ["a prior study16", "TEST", 35, 50], ["further analysis", "TEST", 360, 376], ["MethodsSwabs", "TEST", 402, 414], ["batch", "TEST", 420, 425], ["17 respiratory viruses", "PROBLEM", 437, 459], ["human rhinovirus", "TEST", 461, 477], ["HRV", "TEST", 479, 482], ["influenza A", "TEST", 485, 496], ["IFV", "TEST", 504, 507], ["IFV", "TEST", 511, 514], ["respiratory syncytial virus", "PROBLEM", 519, 546], ["RSV", "TEST", 556, 559], ["RSV", "TEST", 563, 566], ["parainfluenza viruses", "PROBLEM", 571, 592], ["PIV", "TEST", 598, 601], ["PIV", "TEST", 605, 608], ["PIV", "TEST", 612, 615], ["human coronaviruses", "TEST", 620, 639], ["OC43", "TEST", 647, 651], ["NL63", "TEST", 653, 657], ["HKU1", "TEST", 668, 672], ["human metapneumovirus", "PROBLEM", 674, 695], ["HMPV", "PROBLEM", 697, 701], ["adenovirus", "PROBLEM", 704, 714], ["human polyomaviruses", "TEST", 722, 742], ["KI", "TEST", 759, 761], ["KI", "TEST", 763, 765], ["human bocavirus", "TEST", 775, 790], ["HBoV", "TEST", 794, 798], ["sample collection", "TEST", 865, 882], ["PCR assay parameters", "TEST", 896, 916], ["quality control measures", "TREATMENT", 918, 942], ["HRV typing", "TEST", 947, 957], ["respiratory syncytial", "ANATOMY", 519, 540], ["metapneumovirus", "OBSERVATION", 680, 695]]], ["Specimen quality was assessed by testing for a marker of human genomic DNA, endogenous retrovirus-3 (ERV-3).20 Swabs with ERV-3 cycle-threshold (Ct) values >38 (including undetectable Ct values) were deemed to be of lesser quality and excluded from parts of the analysis.21New virus detection episode ::: Definitions ::: MethodsWhen a new virus (different virus or new species/subtype of the same genus or species, respectively) was detected in a swab by PCR testing, or the same virus was detected after at least two negative intervening swabs, or the same virus was detected at least 30 days from the last positive swab.Symptomatic new virus detection episode ::: Definitions ::: MethodsWhen symptoms were reported 7 days before or 7 days after detecting a new virus.ARI episode ::: Definitions ::: MethodsARI was defined as a new episode of respiratory symptoms of the upper and/or lower respiratory tracts demarcated by a window of \u22653 symptom-free days.17 22Upper respiratory tract infection ::: Definitions ::: MethodsParent-reported runny nose/nasal congestion, dry cough or doctor-diagnosed otitis media.22Lower respiratory tract infection ::: Definitions ::: MethodsParent-reported rattly breathing, moist cough, shortness of breath, wheeze or doctor-diagnosed pneumonia.22Lower respiratory tract infection ::: Definitions ::: MethodsARIs were subcategorised hierarchically as either a lower respiratory tract infection (LRTI) or upper respiratory tract infection (URTI), respectively.Analysis ::: MethodsThe incidence rate of single new virus detection episodes (VDEs) per 100 child-years was calculated using Poisson regression.", [["swab", "ANATOMY", 447, 451], ["swabs", "ANATOMY", 539, 544], ["respiratory", "ANATOMY", 844, 855], ["upper", "ANATOMY", 872, 877], ["lower respiratory tracts", "ANATOMY", 885, 909], ["nasal", "ANATOMY", 1050, 1055], ["lower respiratory tract", "ANATOMY", 1394, 1417], ["upper respiratory tract", "ANATOMY", 1438, 1461], ["ARI", "DISEASE", 769, 772], ["respiratory tract infection", "DISEASE", 968, 995], ["nasal congestion", "DISEASE", 1050, 1066], ["dry cough", "DISEASE", 1068, 1077], ["otitis", "DISEASE", 1098, 1104], ["respiratory tract infection", "DISEASE", 1119, 1146], ["cough", "DISEASE", 1214, 1219], ["shortness of breath", "DISEASE", 1221, 1240], ["wheeze", "DISEASE", 1242, 1248], ["pneumonia", "DISEASE", 1269, 1278], ["respiratory tract infection", "DISEASE", 1287, 1314], ["respiratory tract infection", "DISEASE", 1400, 1427], ["LRTI", "DISEASE", 1429, 1433], ["upper respiratory tract infection", "DISEASE", 1438, 1471], ["URTI", "DISEASE", 1473, 1477], ["human", "ORGANISM", 57, 62], ["DNA", "CELLULAR_COMPONENT", 71, 74], ["endogenous retrovirus-3", "ORGANISM", 76, 99], ["ERV-3", "ORGANISM", 101, 106], ["upper", "ORGANISM_SUBDIVISION", 872, 877], ["nose", "ORGANISM_SUBDIVISION", 1045, 1049], ["nasal", "ORGANISM_SUBDIVISION", 1050, 1055], ["22Lower respiratory tract", "ORGANISM", 1111, 1136], ["22Lower respiratory tract", "ORGANISM", 1279, 1304], ["respiratory tract", "ORGANISM_SUBDIVISION", 1400, 1417], ["upper respiratory", "ORGANISM_SUBDIVISION", 1438, 1455], ["tract", "ORGANISM_SUBDIVISION", 1456, 1461], ["human genomic DNA", "DNA", 57, 74], ["endogenous retrovirus-3 (ERV-3).20 Swabs", "DNA", 76, 116], ["ERV", "DNA", 122, 125], ["human", "SPECIES", 57, 62], ["human", "SPECIES", 57, 62], ["Specimen quality", "TEST", 0, 16], ["testing", "TEST", 33, 40], ["human genomic DNA", "PROBLEM", 57, 74], ["endogenous retrovirus", "TEST", 76, 97], ["ERV", "TEST", 101, 104], ["Swabs", "TEST", 111, 116], ["ERV", "TEST", 122, 125], ["Ct) values", "TEST", 145, 155], ["undetectable Ct values", "TEST", 171, 193], ["the analysis", "TEST", 258, 270], ["a new virus (different virus", "PROBLEM", 333, 361], ["new species", "PROBLEM", 365, 376], ["a swab by PCR testing", "TEST", 445, 466], ["the same virus", "PROBLEM", 471, 485], ["the same virus", "PROBLEM", 549, 563], ["the last positive swab", "PROBLEM", 599, 621], ["Symptomatic new virus detection episode", "PROBLEM", 622, 661], ["MethodsWhen symptoms", "PROBLEM", 682, 702], ["a new virus", "PROBLEM", 757, 768], ["ARI episode", "PROBLEM", 769, 780], ["respiratory symptoms", "PROBLEM", 844, 864], ["the upper and/or lower respiratory tracts", "PROBLEM", 868, 909], ["22Upper respiratory tract infection", "PROBLEM", 960, 995], ["runny nose", "PROBLEM", 1039, 1049], ["nasal congestion", "PROBLEM", 1050, 1066], ["dry cough", "PROBLEM", 1068, 1077], ["otitis media", "PROBLEM", 1098, 1110], ["respiratory tract infection", "PROBLEM", 1119, 1146], ["rattly breathing", "PROBLEM", 1190, 1206], ["moist cough", "PROBLEM", 1208, 1219], ["shortness of breath", "PROBLEM", 1221, 1240], ["wheeze", "PROBLEM", 1242, 1248], ["pneumonia", "PROBLEM", 1269, 1278], ["respiratory tract infection", "PROBLEM", 1287, 1314], ["MethodsARIs", "TREATMENT", 1335, 1346], ["a lower respiratory tract infection", "PROBLEM", 1392, 1427], ["LRTI", "PROBLEM", 1429, 1433], ["upper respiratory tract infection", "PROBLEM", 1438, 1471], ["single new virus detection episodes", "PROBLEM", 1535, 1570], ["new", "OBSERVATION_MODIFIER", 335, 338], ["virus", "OBSERVATION", 339, 344], ["new", "OBSERVATION_MODIFIER", 634, 637], ["virus", "OBSERVATION", 638, 643], ["new", "OBSERVATION_MODIFIER", 759, 762], ["virus", "OBSERVATION", 763, 768], ["new", "OBSERVATION_MODIFIER", 829, 832], ["respiratory symptoms", "OBSERVATION", 844, 864], ["upper", "ANATOMY_MODIFIER", 872, 877], ["lower", "ANATOMY_MODIFIER", 885, 890], ["respiratory tracts", "ANATOMY", 891, 909], ["respiratory tract", "ANATOMY", 968, 985], ["infection", "OBSERVATION", 986, 995], ["nasal", "ANATOMY", 1050, 1055], ["congestion", "OBSERVATION", 1056, 1066], ["cough", "OBSERVATION", 1072, 1077], ["respiratory tract", "ANATOMY", 1119, 1136], ["infection", "OBSERVATION", 1137, 1146], ["pneumonia", "OBSERVATION", 1269, 1278], ["respiratory tract", "ANATOMY", 1287, 1304], ["infection", "OBSERVATION", 1305, 1314], ["lower", "ANATOMY_MODIFIER", 1394, 1399], ["respiratory tract", "ANATOMY", 1400, 1417], ["infection", "OBSERVATION", 1418, 1427], ["upper", "ANATOMY_MODIFIER", 1438, 1443], ["respiratory tract", "ANATOMY", 1444, 1461], ["infection", "OBSERVATION", 1462, 1471]]], ["To account analytically for the differing lengths of time children remained in the study, the natural logarithm of the number of swabs returned was included in the model as an offset.", [["children", "ORGANISM", 58, 66], ["children", "SPECIES", 58, 66], ["the study", "TEST", 79, 88], ["swabs", "TEST", 129, 134]]], ["Swabs were removed from incidence rate calculations for individual viruses when the participant was not at risk of a new VDE (a positive consecutive swab following the initial positive swab, and two swabs after the last positive swab, as per our definition of a new VDE), or the swabs were of lesser quality (to avoid underestimating incidence rates).21 When calculating incidence rates for \u2018any virus\u2019, we assumed children were at risk of being positive for new viruses in every swab.Analysis ::: MethodsThe virus-specific risk and AFE of single VDEs in cases of ARI and LRTI were estimated using a generalised linear model with binomial family and log link.", [["swab", "ANATOMY", 185, 189], ["swab", "ANATOMY", 480, 484], ["ARI", "DISEASE", 564, 567], ["LRTI", "DISEASE", 572, 576], ["VDE", "CANCER", 121, 124], ["children", "ORGANISM", 415, 423], ["participant", "SPECIES", 84, 95], ["children", "SPECIES", 415, 423], ["Swabs", "TREATMENT", 0, 5], ["incidence rate calculations", "TREATMENT", 24, 51], ["individual viruses", "PROBLEM", 56, 74], ["a new VDE", "PROBLEM", 115, 124], ["the initial positive swab", "TEST", 164, 189], ["two swabs", "TEST", 195, 204], ["the last positive swab", "PROBLEM", 211, 233], ["the swabs", "TEST", 275, 284], ["underestimating incidence rates", "PROBLEM", 318, 349], ["any virus", "PROBLEM", 392, 401], ["new viruses in every swab", "PROBLEM", 459, 484], ["Analysis", "TEST", 485, 493], ["Methods", "TREATMENT", 498, 505], ["The virus", "PROBLEM", 505, 514], ["ARI", "PROBLEM", 564, 567], ["LRTI", "PROBLEM", 572, 576], ["viruses", "OBSERVATION", 463, 470], ["virus", "OBSERVATION", 509, 514]]], ["Robust variance estimates were calculated using sandwich estimators to account for repeated measures within children.", [["children", "ORGANISM", 108, 116], ["children", "SPECIES", 108, 116], ["Robust variance estimates", "PROBLEM", 0, 25], ["sandwich estimators", "TREATMENT", 48, 67]]], ["We analysed LRTIs separately as children with these infections are more likely to visit family physicians, present to hospital and receive antibiotics.22 The AFE was calculated as 100%\u00d7(1\u2212RR\u22121), where risk ratio (RR) is the proportion of children positive for a virus with ARI symptoms, divided by the proportion of children negative for the virus who have ARI symptoms (see online supplementary text 2).", [["infections", "DISEASE", 52, 62], ["ARI", "DISEASE", 273, 276], ["ARI", "DISEASE", 357, 360], ["children", "ORGANISM", 32, 40], ["children", "ORGANISM", 238, 246], ["children", "ORGANISM", 316, 324], ["children", "SPECIES", 32, 40], ["children", "SPECIES", 238, 246], ["children", "SPECIES", 316, 324], ["these infections", "PROBLEM", 46, 62], ["antibiotics", "TREATMENT", 139, 150], ["The AFE", "TEST", 154, 161], ["RR", "TEST", 188, 190], ["RR", "TEST", 213, 215], ["a virus", "PROBLEM", 260, 267], ["ARI symptoms", "PROBLEM", 273, 285], ["the virus", "PROBLEM", 338, 347], ["ARI symptoms", "PROBLEM", 357, 369]]], ["Only virus-negative swabs of lesser quality (Ct >38) were excluded in these analyses of association, as swab quality of positive swabs did not modify the association between VDEs and ARI symptoms (see online supplementary E-table 2).Analysis ::: MethodsThe association between potential risk factors (age, sex, type of delivery, gestational age at birth, season, family history of asthma or eczema, tobacco smoke exposure, household size, maternal education status, mode of feeding, category of childcare attendance) and symptomatic and asymptomatic virus detection was examined using mixed-effects logistic regression with the child entered as a random effect to account for repeated measurements within children.", [["swabs", "ANATOMY", 20, 25], ["ARI", "DISEASE", 183, 186], ["asthma", "DISEASE", 381, 387], ["eczema", "DISEASE", 391, 397], ["smoke", "CHEMICAL", 407, 412], ["tobacco", "ORGANISM", 399, 406], ["children", "ORGANISM", 705, 713], ["children", "SPECIES", 705, 713], ["virus", "TEST", 5, 10], ["Ct", "TEST", 45, 47], ["swab", "TEST", 104, 108], ["positive swabs", "PROBLEM", 120, 134], ["VDEs", "PROBLEM", 174, 178], ["ARI symptoms", "PROBLEM", 183, 195], ["asthma", "PROBLEM", 381, 387], ["eczema", "PROBLEM", 391, 397], ["symptomatic and asymptomatic virus detection", "PROBLEM", 521, 565], ["virus", "OBSERVATION", 5, 10], ["negative", "OBSERVATION_MODIFIER", 11, 19], ["lesser", "OBSERVATION_MODIFIER", 29, 35]]], ["Both univariable and multivariable analyses were conducted.", [["multivariable analyses", "TEST", 21, 43]]], ["Breast feeding and childcare attendance were analysed as time-varying variables.", [["Breast", "ANATOMY", 0, 6], ["Breast", "ORGANISM_SUBDIVISION", 0, 6]]], ["Multivariable models included all the above risk factors with no forward or backward selection.", [["forward or backward selection", "PROBLEM", 65, 94]]], ["Only virus-negative lesser quality swabs were excluded in these analyses.", [["virus", "TEST", 5, 10], ["these analyses", "TEST", 58, 72], ["virus", "OBSERVATION", 5, 10], ["negative", "OBSERVATION_MODIFIER", 11, 19], ["lesser", "OBSERVATION_MODIFIER", 20, 26]]], ["As it was not possible to determine individual virus contributions to ARI symptoms during virus codetections, samples with more than one virus detected were analysed descriptively (see online supplementary E-table 3).", [["samples", "ANATOMY", 110, 117], ["ARI", "DISEASE", 70, 73], ["individual virus", "PROBLEM", 36, 52], ["ARI symptoms", "PROBLEM", 70, 82], ["virus codetections", "TEST", 90, 108], ["one virus", "PROBLEM", 133, 142]]], ["Data were analysed using Stata V.12.1 (StataCorp, College Station, Texas, USA).Cohort characteristics ::: ResultsOf 891 potential participants approached, 165 (18.5%) eligible singleton infants from 163 families were enrolled (two families enrolled two siblings) (figure 1).", [["participants", "ORGANISM", 130, 142], ["infants", "ORGANISM", 186, 193], ["participants", "SPECIES", 130, 142], ["infants", "SPECIES", 186, 193]]], ["Seven were excluded subsequently; one from ineligibility (born <36 weeks) and six for failing to provide any swabs.", [["swabs", "ANATOMY", 109, 114], ["any swabs", "TREATMENT", 105, 114]]], ["Of the remaining children, 158 provided 11 125 swabs (figure 1; 68.3% of maximum expected; median 84.5, range 1\u2013104) from birth until their second birthday, and 154 infants provided 87 547 child-days of symptom diaries (77.9% of maximum expected days; median 726 (range 1\u2013730 days)) with 67% followed until at least age 23 months (see online supplementary E-figure).", [["children", "ORGANISM", 17, 25], ["infants", "ORGANISM", 165, 172], ["children", "SPECIES", 17, 25], ["infants", "SPECIES", 165, 172], ["symptom diaries", "TEST", 203, 218]]], ["One or more respiratory symptoms were recorded on 16 877 (19.3%) days, and corresponded to 1641 discrete ARI episodes.Cohort characteristics ::: ResultsDemographic and social characteristics are reported in table 1.", [["respiratory", "ANATOMY", 12, 23], ["ARI", "DISEASE", 105, 108], ["more respiratory symptoms", "PROBLEM", 7, 32], ["discrete ARI episodes", "PROBLEM", 96, 117], ["discrete", "OBSERVATION_MODIFIER", 96, 104], ["ARI", "OBSERVATION", 105, 108]]], ["Compared with the general population of Brisbane and the state of Queensland, study children were from smaller families of advantaged backgrounds (see online supplementary E-table 4).Virus detections ::: ResultsWhen calculating incidence rates, of the 11 192 total swabs submitted by all children, 3025 (27.2%) lesser-quality swabs (346 virus-positive and 2679 virus-negative) were removed from the analyses, as were 67 swabs submitted after the child\u2019s second birthday, leaving 8100 swabs from 157 infants (figure 1).", [["swabs", "ANATOMY", 484, 489], ["children", "ORGANISM", 84, 92], ["Virus", "ORGANISM", 183, 188], ["children", "ORGANISM", 288, 296], ["infants", "ORGANISM", 499, 506], ["children", "SPECIES", 84, 92], ["children", "SPECIES", 288, 296], ["infants", "SPECIES", 499, 506], ["total swabs", "TEST", 259, 270], ["lesser-quality swabs", "TEST", 311, 331], ["virus", "TEST", 337, 342], ["virus", "TEST", 361, 366]]], ["Overall, 2646/8100 (32.7%) swabs were positive for respiratory viruses (table 2), of which 1520 were new VDEs.Virus detections ::: ResultsThe incidence of new VDEs increased in the first 9 months of life, with symptomatic episodes dominating after 6 months of age (figure 2).", [["swabs", "ANATOMY", 27, 32], ["respiratory viruses", "DISEASE", 51, 70], ["VDEs", "DISEASE", 105, 109], ["Virus", "ORGANISM", 110, 115], ["swabs", "TEST", 27, 32], ["respiratory viruses", "PROBLEM", 51, 70], ["new VDEs", "PROBLEM", 155, 163], ["symptomatic episodes", "PROBLEM", 210, 230], ["respiratory viruses", "OBSERVATION", 51, 70], ["new", "OBSERVATION_MODIFIER", 155, 158], ["VDEs", "OBSERVATION_MODIFIER", 159, 163], ["increased", "OBSERVATION_MODIFIER", 164, 173], ["symptomatic", "OBSERVATION_MODIFIER", 210, 221]]], ["There was an overall incidence rate of 978 new VDEs per 100 child-years (95% CI 930 to 1029, table 2).", [["VDEs", "DISEASE", 47, 51]]], ["More than one virus was detected in 275/8100 (3.4%) specimens.", [["specimens", "ANATOMY", 52, 61], ["specimens", "CANCER", 52, 61], ["one virus", "PROBLEM", 10, 19], ["specimens", "TEST", 52, 61]]], ["HRV was the most commonly detected virus (2058/2646 detections, 77.8% of all positive detections, mean rate of 1002 new VDEs per 100 child-years, 95% CI 942 to 1066), followed by HBoV-1 (60 new VDEs per 100 child-years, 95% CI 49 to 73) and KI-PyV (56 new VDEs per 100 child-years, 95% CI 45 to 69) (table 2).Virus-positive ARIs and asymptomatic episodes ::: ResultsWhen considering virus-positive ARIs and asymptomatic episodes, we retained 346 virus-positive swabs with ERV-3 Ct values >38, but removed a further 244 swabs with missing symptom data, to give a final dataset of 8202 swabs from 151 participants (3 participants submitted swabs of high or no Ct values or swabs with no corresponding symptom data before withdrawing early in the study) (tables 3\u20135).Virus-positive ARIs and asymptomatic episodes ::: ResultsOf 8202 swabs, 3894 (47.5%) were taken during symptomatic periods and 4308 (52.5%) from asymptomatic periods.", [["swabs", "ANATOMY", 461, 466], ["VDEs", "DISEASE", 120, 124], ["ARIs", "DISEASE", 324, 328], ["HBoV", "ORGANISM", 179, 183], ["Virus", "ORGANISM", 309, 314], ["Virus", "ORGANISM", 764, 769], ["participants", "SPECIES", 599, 611], ["participants", "SPECIES", 615, 627], ["HBoV-1", "SPECIES", 179, 185], ["HRV", "PROBLEM", 0, 3], ["mean rate", "TEST", 98, 107], ["HBoV", "TEST", 179, 183], ["CI", "TEST", 224, 226], ["KI", "TEST", 241, 243], ["PyV", "TEST", 244, 247], ["CI", "TEST", 286, 288], ["Virus", "TEST", 309, 314], ["positive ARIs", "PROBLEM", 315, 328], ["asymptomatic episodes", "PROBLEM", 333, 354], ["virus", "PROBLEM", 383, 388], ["positive ARIs", "PROBLEM", 389, 402], ["asymptomatic episodes", "PROBLEM", 407, 428], ["346 virus", "PROBLEM", 442, 451], ["ERV", "TEST", 472, 475], ["Ct values", "TEST", 478, 487], ["missing symptom data", "PROBLEM", 530, 550], ["swabs", "TEST", 638, 643], ["Ct values", "TEST", 658, 667], ["swabs", "TEST", 671, 676], ["corresponding symptom data", "PROBLEM", 685, 711], ["the study", "TEST", 740, 749], ["Virus", "TEST", 764, 769], ["positive ARIs", "PROBLEM", 770, 783], ["asymptomatic episodes", "PROBLEM", 788, 809], ["swabs", "TEST", 829, 834], ["positive ARIs", "OBSERVATION_MODIFIER", 315, 328], ["positive ARIs", "OBSERVATION_MODIFIER", 389, 402], ["positive ARIs", "OBSERVATION_MODIFIER", 770, 783]]], ["Of all swabs taken any time during symptomatic periods, 1903/3894 (48.9%) were positive for a virus, and 1120/3894 (28.8%) were new VDEs.", [["swabs", "ANATOMY", 7, 12], ["VDEs", "DISEASE", 132, 136], ["VDEs", "PATHOLOGICAL_FORMATION", 132, 136], ["all swabs", "TEST", 3, 12], ["a virus", "PROBLEM", 92, 99], ["new VDEs", "PROBLEM", 128, 136]]], ["Overall, 984/4308 (22.8%) swabs taken during asymptomatic periods were positive for a virus, of which 562 (57.1%) were new VDEs and 491/562 (87.4%) were new single virus detections (tables 3 and 4).Virus-positive ARIs and asymptomatic episodes ::: Results", [["swabs", "ANATOMY", 26, 31], ["ARIs", "DISEASE", 213, 217], ["VDEs", "CANCER", 123, 127], ["Virus", "ORGANISM", 198, 203], ["swabs", "TEST", 26, 31], ["asymptomatic periods", "PROBLEM", 45, 65], ["a virus", "PROBLEM", 84, 91], ["new VDEs", "TEST", 119, 127], ["new single virus detections", "TEST", 153, 180], ["Virus", "TEST", 198, 203], ["positive ARIs", "PROBLEM", 204, 217], ["asymptomatic episodes", "PROBLEM", 222, 243], ["positive ARIs", "OBSERVATION_MODIFIER", 204, 217]]]], "b21aca731b8f0115e51fe86c4fba9d30364628c0": [["Robert PhillpottsMRC Common Cold Unit, Coombe Road, Solisbuty, Wil~chire SP2 8BW, UK, Interferon is a potential prophylactic agent for the common cold.", [["Interferon", "GENE_OR_GENE_PRODUCT", 86, 96], ["Interferon", "TREATMENT", 86, 96], ["a potential prophylactic agent", "TREATMENT", 100, 130], ["the common cold", "PROBLEM", 135, 150]]], ["But there are problems.", [["problems", "PROBLEM", 14, 22]]], ["The present levels of side-effects that have been observed don't justify its use in the long term. l~'obert Phillpotts describe~ the mechanism of interferon action and the future hopes and developments for its use in preventing colds.Robert PhillpottsInterferon appears to be the ideal antiviral drug for use in preventing colds; it is extremely potent, and active against a wide range of viruses.", [["colds", "DISEASE", 228, 233], ["Phillpotts", "CHEMICAL", 241, 251], ["colds", "DISEASE", 323, 328], ["interferon", "GENE_OR_GENE_PRODUCT", 146, 156], ["interferon", "PROTEIN", 146, 156], ["l~'obert Phillpotts", "TREATMENT", 99, 118], ["interferon action", "TREATMENT", 146, 163], ["colds", "PROBLEM", 228, 233], ["Robert PhillpottsInterferon", "TREATMENT", 234, 261], ["colds", "PROBLEM", 323, 328], ["viruses", "OBSERVATION", 389, 396]]], ["However, it is too toxic for systemic use in minor respiratory illnesses, and when taken in adequate doses intranasaHy it causes a mild inflammation of the mucosa.", [["respiratory", "ANATOMY", 51, 62], ["mucosa", "ANATOMY", 156, 162], ["respiratory illnesses", "DISEASE", 51, 72], ["intranasaHy", "CHEMICAL", 107, 118], ["inflammation of the mucosa", "DISEASE", 136, 162], ["intranasaHy", "CHEMICAL", 107, 118], ["mucosa", "MULTI-TISSUE_STRUCTURE", 156, 162], ["minor respiratory illnesses", "PROBLEM", 45, 72], ["a mild inflammation of the mucosa", "PROBLEM", 129, 162], ["respiratory illnesses", "OBSERVATION", 51, 72], ["mild", "OBSERVATION_MODIFIER", 131, 135], ["inflammation", "OBSERVATION", 136, 148], ["mucosa", "ANATOMY", 156, 162]]], ["Current research is directed towards overcoming this problem.Robert PhillpottsFor most people the common cold is a mild, self-limiting illness.", [["people", "ORGANISM", 87, 93], ["people", "SPECIES", 87, 93], ["a mild, self-limiting illness", "PROBLEM", 113, 142], ["mild", "OBSERVATION_MODIFIER", 115, 119]]], ["However, the high incidence of colds, and their ability to cause an exacerbation of chronic underlying respiratory disease leads to considerable morbidity.", [["respiratory", "ANATOMY", 103, 114], ["colds", "DISEASE", 31, 36], ["respiratory disease", "DISEASE", 103, 122], ["colds", "PROBLEM", 31, 36], ["chronic underlying respiratory disease", "PROBLEM", 84, 122], ["considerable morbidity", "PROBLEM", 132, 154], ["high", "OBSERVATION_MODIFIER", 13, 17], ["colds", "OBSERVATION", 31, 36], ["exacerbation", "OBSERVATION", 68, 80], ["chronic", "OBSERVATION_MODIFIER", 84, 91], ["respiratory disease", "OBSERVATION", 103, 122], ["considerable", "OBSERVATION_MODIFIER", 132, 144], ["morbidity", "OBSERVATION", 145, 154]]], ["Research has established that over 200 serologicaily distinct viruses can cause a cold, and there is little hope that infectica can be controlled by vaccination.", [["infectica", "DISEASE", 118, 127], ["a cold", "PROBLEM", 80, 86], ["infectica", "PROBLEM", 118, 127], ["viruses", "OBSERVATION", 62, 69]]], ["Therefore control by means of a broad-spectrmn antivizal agent is the most rational approach, and interferon is without doubt the most pote=t, and broadly active antiviral agent yet discovered.", [["interferon", "GENE_OR_GENE_PRODUCT", 98, 108], ["interferon", "PROTEIN", 98, 108], ["a broad-spectrmn antivizal agent", "TREATMENT", 30, 62], ["interferon", "TREATMENT", 98, 108], ["broadly active antiviral agent", "TREATMENT", 147, 177], ["active", "OBSERVATION_MODIFIER", 155, 161], ["antiviral", "OBSERVATION", 162, 171]]], ["C~ course there are limitations upon the k~nd of medication which could be used to prevent a cold.", [["medication", "TREATMENT", 49, 59], ["a cold", "PROBLEM", 91, 97], ["cold", "OBSERVATION", 93, 97]]], ["I What is interferen?", [["I", "PROTEIN", 0, 1]]], ["I Human interferons (HulFN) are pro-/ teins or glycoproteins of which there are: 3 principal types, a, 13, and \"y.", [["Human", "ORGANISM", 2, 7], ["interferons", "GENE_OR_GENE_PRODUCT", 8, 19], ["HulFN", "GENE_OR_GENE_PRODUCT", 21, 26], ["I Human interferons", "PROTEIN", 0, 19], ["HulFN", "PROTEIN", 21, 26], ["pro-/ teins", "PROTEIN", 32, 43], ["Human", "SPECIES", 2, 7], ["I Human interferons (HulFN)", "TREATMENT", 0, 27]]], ["HulFN a and p: ~re both produced by cel~s after exposure to a virus: WN a by\" leucocytes and LFN 13 by fibroblast,,,.", [["leucocytes", "ANATOMY", 78, 88], ["fibroblast", "ANATOMY", 103, 113], ["WN", "ORGANISM", 69, 71], ["leucocytes", "CELL", 78, 88], ["LFN 13", "GENE_OR_GENE_PRODUCT", 93, 99], ["fibroblast", "CELL", 103, 113], ["leucocytes", "CELL_TYPE", 78, 88], ["LFN 13", "PROTEIN", 93, 99], ["fibroblast", "CELL_TYPE", 103, 113], ["LFN", "TEST", 93, 96], ["fibroblast", "TEST", 103, 113]]], ["HulFN ~ is also produced by fibroblasts exposed to double-stranded RNA, while IFN ~/is produced by lymphocytes only in response to an antigenic or mitogenic stimulus.", [["fibroblasts", "ANATOMY", 28, 39], ["lymphocytes", "ANATOMY", 99, 110], ["HulFN", "CHEMICAL", 0, 5], ["HulFN", "GENE_OR_GENE_PRODUCT", 0, 5], ["fibroblasts", "CELL", 28, 39], ["IFN", "GENE_OR_GENE_PRODUCT", 78, 81], ["lymphocytes", "CELL", 99, 110], ["HulFN", "PROTEIN", 0, 5], ["fibroblasts", "CELL_TYPE", 28, 39], ["double-stranded RNA", "RNA", 51, 70], ["IFN", "PROTEIN", 78, 81], ["lymphocytes", "CELL_TYPE", 99, 110], ["HulFN", "TREATMENT", 0, 5], ["double-stranded RNA", "TREATMENT", 51, 70], ["IFN", "PROBLEM", 78, 81], ["lymphocytes", "PROBLEM", 99, 110], ["an antigenic or mitogenic stimulus", "TEST", 131, 165], ["fibroblasts", "OBSERVATION", 28, 39], ["double-stranded RNA", "OBSERVATION_MODIFIER", 51, 70], ["lymphocytes", "OBSERVATION", 99, 110], ["mitogenic stimulus", "OBSERVATION", 147, 165]]], ["Interferons do not directly inhibit virus growth, but exposure of :mittfected cells to interferon makes them resistant to attack by viruses, interferon is not internalized by cells but binds to cell surface receptors (there is one receptor for IFN a and [3, and another receptor for IFN y) triggering off a series of events within the cell.", [["cells", "ANATOMY", 78, 83], ["cells", "ANATOMY", 175, 180], ["cell surface", "ANATOMY", 194, 206], ["cell", "ANATOMY", 335, 339], ["cells", "CELL", 78, 83], ["interferon", "GENE_OR_GENE_PRODUCT", 87, 97], ["interferon", "GENE_OR_GENE_PRODUCT", 141, 151], ["cells", "CELL", 175, 180], ["cell", "CELL", 194, 198], ["IFN", "GENE_OR_GENE_PRODUCT", 244, 247], ["cell", "CELL", 335, 339], ["Interferons", "PROTEIN", 0, 11], ["mittfected cells", "CELL_TYPE", 67, 83], ["interferon", "PROTEIN", 87, 97], ["interferon", "PROTEIN", 141, 151], ["cell surface receptors", "PROTEIN", 194, 216], ["IFN", "PROTEIN", 244, 247], ["IFN", "PROTEIN", 283, 286], ["Interferons", "TREATMENT", 0, 11], ["directly inhibit virus growth", "PROBLEM", 19, 48], ["mittfected cells", "PROBLEM", 67, 83], ["interferon", "TREATMENT", 87, 97], ["interferon", "TREATMENT", 141, 151], ["IFN a and [3", "TREATMENT", 244, 256]]], ["Multiple effects have been observed in cells, including the inhibition of penetration and maturation of certain viruses.", [["cells", "ANATOMY", 39, 44], ["cells", "CELL", 39, 44], ["Multiple effects", "PROBLEM", 0, 16], ["penetration", "PROBLEM", 74, 85], ["maturation of certain viruses", "PROBLEM", 90, 119], ["certain viruses", "OBSERVATION", 104, 119]]], ["However, the principal effect of interferon treatrnent seems to be to inhibit viral protein synthesis t.", [["interferon", "PROTEIN", 33, 43], ["viral protein", "PROTEIN", 78, 91], ["interferon treatrnent", "TREATMENT", 33, 54], ["viral protein synthesis", "PROBLEM", 78, 101]]], ["A system of interferoninduced enzymes has been described, some of which are activated by doublestranded RNA molecules such as those produced during the replication of RNA 'druses.", [["interferoninduced enzymes", "PROTEIN", 12, 37], ["doublestranded RNA molecules", "PROTEIN", 89, 117], ["A system of interferoninduced enzymes", "TEST", 0, 37], ["doublestranded RNA molecules", "PROBLEM", 89, 117], ["RNA 'druses", "PROBLEM", 167, 178]]], ["The effect of these enzymes is to inhibit the initiation of viral protein synthesis, and to increase the rate at which viral mRNA is degraded within the cell (see Fig. 1 ).", [["cell", "ANATOMY", 153, 157], ["cell", "CELL", 153, 157], ["viral protein", "PROTEIN", 60, 73], ["viral mRNA", "RNA", 119, 129], ["these enzymes", "TEST", 14, 27], ["viral protein synthesis", "TREATMENT", 60, 83], ["viral mRNA", "OBSERVATION", 119, 129]]], ["Future research will mldoubtedly disclose other mechanisms by which virus growth is prevented. \"[here is already evidence to suggest that I[FN ~ has a different mechanism of tion from IFNs a and 13, as combinations of IFN ~ with IFN ct or IFN 13 (but not IFN a with IFN 13) exhibit synergy.Robert PhillpottsThe potency of various interferon preparations may therefore be compared in terms of units of antiviral activity.", [["I[FN", "GENE_OR_GENE_PRODUCT", 138, 142], ["IFN", "GENE_OR_GENE_PRODUCT", 218, 221], ["IFN ct", "GENE_OR_GENE_PRODUCT", 229, 235], ["IFN 13", "GENE_OR_GENE_PRODUCT", 239, 245], ["FN", "PROTEIN", 140, 142], ["IFNs", "PROTEIN", 184, 188], ["IFN", "PROTEIN", 218, 221], ["IFN", "PROTEIN", 229, 232], ["IFN 13", "PROTEIN", 239, 245], ["IFN", "PROTEIN", 255, 258], ["IFN 13", "PROTEIN", 266, 272], ["interferon", "PROTEIN", 330, 340], ["IFN", "PROBLEM", 218, 221], ["IFN ct", "TEST", 229, 235], ["IFN", "PROBLEM", 239, 242], ["synergy", "PROBLEM", 282, 289], ["various interferon preparations", "TREATMENT", 322, 353], ["antiviral activity", "TREATMENT", 401, 419], ["antiviral activity", "OBSERVATION", 401, 419]]], ["There is species specificity in this process v ,'11, while not absolute, means in practice that human interferon must be used to treat human cells.Robert PhillpottsHuman interferon may be produced from cells cultured in vitro.", [["cells", "ANATOMY", 141, 146], ["cells", "ANATOMY", 202, 207], ["human", "ORGANISM", 96, 101], ["human", "ORGANISM", 135, 140], ["cells", "CELL", 141, 146], ["Human", "ORGANISM", 164, 169], ["interferon", "GENE_OR_GENE_PRODUCT", 170, 180], ["cells", "CELL", 202, 207], ["human interferon", "PROTEIN", 96, 112], ["human cells", "CELL_TYPE", 135, 146], ["interferon", "PROTEIN", 170, 180], ["human", "SPECIES", 96, 101], ["human", "SPECIES", 135, 140], ["Human", "SPECIES", 164, 169], ["human", "SPECIES", 96, 101], ["human", "SPECIES", 135, 140], ["human interferon", "TREATMENT", 96, 112], ["human cells", "PROBLEM", 135, 146], ["Robert PhillpottsHuman interferon", "TREATMENT", 147, 180]]], ["A partially purified human leucocyte (a) interferon is produced by the Finnish Red Cross from huffy coat cells (derived from blood donations) which have been stimulated with Sendal virus.", [["leucocyte", "ANATOMY", 27, 36], ["huffy coat cells", "ANATOMY", 94, 110], ["blood", "ANATOMY", 125, 130], ["human", "ORGANISM", 21, 26], ["leucocyte", "CELL", 27, 36], ["interferon", "GENE_OR_GENE_PRODUCT", 41, 51], ["huffy coat cells", "CELL", 94, 110], ["blood", "ORGANISM_SUBSTANCE", 125, 130], ["Sendal virus", "ORGANISM", 174, 186], ["human leucocyte", "CELL_TYPE", 21, 36], ["interferon", "PROTEIN", 41, 51], ["huffy coat cells", "CELL_TYPE", 94, 110], ["human", "SPECIES", 21, 26], ["human", "SPECIES", 21, 26], ["Sendal virus", "SPECIES", 174, 186], ["A partially purified human leucocyte", "PROBLEM", 0, 36], ["a) interferon", "TREATMENT", 38, 51], ["huffy coat cells", "TREATMENT", 94, 110], ["blood donations", "TEST", 125, 140], ["Sendal virus", "TREATMENT", 174, 186], ["human leucocyte", "OBSERVATION", 21, 36]]], ["However, this procedure is expensive, and the amount of interferon which can be produced is limited by the availability of buffy coat cells.", [["buffy coat cells", "ANATOMY", 123, 139], ["interferon", "GENE_OR_GENE_PRODUCT", 56, 66], ["buffy coat cells", "CELL", 123, 139], ["interferon", "PROTEIN", 56, 66], ["buffy coat cells", "CELL_TYPE", 123, 139], ["this procedure", "TREATMENT", 9, 23], ["interferon", "TREATMENT", 56, 66], ["buffy coat cells", "PROBLEM", 123, 139], ["interferon", "OBSERVATION", 56, 66], ["buffy coat cells", "OBSERVATION", 123, 139]]], ["More recently, DNA copies of the mRNAs coding of all 3 types of HulFN have been synthesized, and inserted into plasmid vectors downstream from a suitable prokaryotic promoter.", [["DNA", "CELLULAR_COMPONENT", 15, 18], ["HulFN", "GENE_OR_GENE_PRODUCT", 64, 69], ["DNA copies", "DNA", 15, 25], ["mRNAs", "RNA", 33, 38], ["HulFN", "DNA", 64, 69], ["plasmid vectors", "DNA", 111, 126], ["prokaryotic promoter", "DNA", 154, 174], ["HulFN", "TREATMENT", 64, 69], ["a suitable prokaryotic promoter", "TREATMENT", 143, 174], ["prokaryotic promoter", "OBSERVATION", 154, 174]]], ["Such plasmis are introduced into bacteria by transfection, where they multiply, and high levels of expression of the interferon gene sequence can be cheap, costs will undoubtedly be further reduced.Robert Phillpottsintranasal interferon prevents colds In an initial experiment at the Common Cold Unit in Wiltshire, UK, intranasal administration of partially purified human leucocyte interferon to volunteers was shown to prevent colds caused by rhinovirus type 4 (Ref.", [["leucocyte", "ANATOMY", 373, 382], ["Phillpottsintranasal interferon", "CHEMICAL", 205, 236], ["colds", "DISEASE", 246, 251], ["colds", "DISEASE", 429, 434], ["plasmis", "GENE_OR_GENE_PRODUCT", 5, 12], ["Phillpottsintranasal interferon", "GENE_OR_GENE_PRODUCT", 205, 236], ["human", "ORGANISM", 367, 372], ["leucocyte interferon", "GENE_OR_GENE_PRODUCT", 373, 393], ["volunteers", "ORGANISM", 397, 407], ["rhinovirus type 4", "ORGANISM", 445, 462], ["interferon gene sequence", "DNA", 117, 141], ["interferon", "PROTEIN", 226, 236], ["human leucocyte interferon", "PROTEIN", 367, 393], ["human", "SPECIES", 367, 372], ["human", "SPECIES", 367, 372], ["Such plasmis", "PROBLEM", 0, 12], ["the interferon gene sequence", "TREATMENT", 113, 141], ["Robert Phillpottsintranasal interferon", "TREATMENT", 198, 236], ["colds", "PROBLEM", 246, 251], ["intranasal administration", "TREATMENT", 319, 344], ["partially purified human leucocyte interferon", "TREATMENT", 348, 393], ["colds", "PROBLEM", 429, 434], ["rhinovirus type 4", "PROBLEM", 445, 462], ["bacteria", "OBSERVATION_MODIFIER", 33, 41], ["rhinovirus", "OBSERVATION", 445, 455]]], ["Rhinoviruses cause approximately 50% of colds.", [["Rhinoviruses", "DISEASE", 0, 12], ["colds", "DISEASE", 40, 45], ["Rhinoviruses", "PROBLEM", 0, 12], ["colds", "PROBLEM", 40, 45]]], ["However, leucocytes from 30-50 donations of blood were required to produce the 14 MU of interferon used to treat each volunteer.", [["leucocytes", "ANATOMY", 9, 19], ["blood", "ANATOMY", 44, 49], ["leucocytes", "CELL", 9, 19], ["blood", "ORGANISM_SUBSTANCE", 44, 49], ["leucocytes", "CELL_TYPE", 9, 19], ["interferon", "PROTEIN", 88, 98], ["leucocytes", "TEST", 9, 19], ["interferon", "TREATMENT", 88, 98], ["leucocytes", "ANATOMY", 9, 19]]], ["Furthermore, the use of partially purified material in which only about 1% of the protein was interferon also raised the question of whether interferon itself was responsible for preventing rhinovirus infection.", [["rhinovirus infection", "DISEASE", 190, 210], ["interferon", "GENE_OR_GENE_PRODUCT", 94, 104], ["interferon", "GENE_OR_GENE_PRODUCT", 141, 151], ["rhinovirus", "ORGANISM", 190, 200], ["interferon", "PROTEIN", 94, 104], ["interferon", "PROTEIN", 141, 151], ["partially purified material", "PROBLEM", 24, 51], ["interferon", "TREATMENT", 94, 104], ["interferon itself", "PROBLEM", 141, 158], ["rhinovirus infection", "PROBLEM", 190, 210], ["rhinovirus", "OBSERVATION_MODIFIER", 190, 200], ["infection", "OBSERVATION", 201, 210]]], ["Could the activity have been due to contaminating, biologically active molecules also derived from human leucocytes?", [["leucocytes", "ANATOMY", 105, 115], ["human", "ORGANISM", 99, 104], ["leucocytes", "CELL", 105, 115], ["human leucocytes", "CELL_TYPE", 99, 115], ["human", "SPECIES", 99, 104], ["human", "SPECIES", 99, 104]]], ["This question was answered in a further experiment carried out in 1982, in which HulFN a, purified to virtual homogeneity on a monoclonal antibody affinity column was shown to prevent colds caused by another rhinovirus, type 9 (Ref.", [["colds", "DISEASE", 184, 189], ["rhinovirus", "ORGANISM", 208, 218], ["a monoclonal antibody affinity column", "TREATMENT", 125, 162], ["colds", "PROBLEM", 184, 189], ["another rhinovirus", "PROBLEM", 200, 218], ["rhinovirus", "OBSERVATION", 208, 218]]], ["There was a dramatic reduction in the frequency of colds in the interferon treated group (Table 1) .", [["colds", "DISEASE", 51, 56], ["interferon", "CHEMICAL", 64, 74], ["interferon", "PROTEIN", 64, 74], ["a dramatic reduction", "PROBLEM", 10, 30], ["colds", "PROBLEM", 51, 56], ["the interferon treated group", "TREATMENT", 60, 88], ["dramatic", "OBSERVATION_MODIFIER", 12, 20], ["reduction", "OBSERVATION_MODIFIER", 21, 30]]], ["This was accompanied by lesser reductions in the number of volunteers who shed virus, or who had an increase in serum neutralizing antibody to the challenge virus.", [["serum", "ANATOMY", 112, 117], ["volunteers", "ORGANISM", 59, 69], ["serum", "ORGANISM_SUBSTANCE", 112, 117], ["serum neutralizing antibody", "PROTEIN", 112, 139], ["lesser reductions", "PROBLEM", 24, 41], ["serum neutralizing antibody", "TREATMENT", 112, 139], ["the challenge virus", "TREATMENT", 143, 162], ["lesser", "OBSERVATION_MODIFIER", 24, 30], ["reductions", "OBSERVATION_MODIFIER", 31, 41], ["increase", "OBSERVATION_MODIFIER", 100, 108]]], ["In a further experiment conducted under an identical protocol, closely similar results were achieved using highly purified, HulFN a-2, pro-duced in Escherichia coil 7 (manufactured by Schering Plough).", [["Escherichia coil 7", "ORGANISM", 148, 166], ["an identical protocol", "TEST", 40, 61], ["HulFN", "TEST", 124, 129], ["Escherichia coil", "TREATMENT", 148, 164], ["Escherichia coil", "OBSERVATION", 148, 164]]], ["This experiment clearly demonstrated that interferons produced in bacteria by recombinant DNA techniques could be as active as those produced by human celk.Robert PhillpottsHow can interferon be used in prm'tke?Robert PhillpottsIn these experiments, interferon was given intranasally in large doses by a physidan.", [["celk", "ANATOMY", 151, 155], ["interferon", "CHEMICAL", 250, 260], ["DNA", "CELLULAR_COMPONENT", 90, 93], ["human", "ORGANISM", 145, 150], ["celk", "CELL", 151, 155], ["interferon", "GENE_OR_GENE_PRODUCT", 250, 260], ["interferons", "PROTEIN", 42, 53], ["interferon", "PROTEIN", 181, 191], ["interferon", "PROTEIN", 250, 260], ["human", "SPECIES", 145, 150], ["human", "SPECIES", 145, 150], ["interferons", "TREATMENT", 42, 53], ["bacteria", "PROBLEM", 66, 74], ["recombinant DNA techniques", "TREATMENT", 78, 104], ["interferon", "TREATMENT", 250, 260], ["interferon", "OBSERVATION", 250, 260]]], ["Therefore ffinterferon is to find application as a prophylactic against the common cold. two questions have to be answered.", [["ffinterferon", "CHEMICAL", 10, 22], ["ffinterferon", "CHEMICAL", 10, 22], ["ffinterferon", "SIMPLE_CHEMICAL", 10, 22], ["a prophylactic", "TREATMENT", 49, 63]]], ["Firstly, could people treat themselves with interferon using a simple design of nasal spray?", [["nasal", "ANATOMY", 80, 85], ["people", "ORGANISM", 15, 21], ["nasal", "ORGANISM_SUBDIVISION", 80, 85], ["interferon", "PROTEIN", 44, 54], ["people", "SPECIES", 15, 21], ["interferon", "TREATMENT", 44, 54], ["a simple design of nasal spray", "TREATMENT", 61, 91]]], ["Sc-condly, what is the minimum quantity of interferon necessary to protect against infection with cold viruses?", [["infection", "DISEASE", 83, 92], ["interferon", "GENE_OR_GENE_PRODUCT", 43, 53], ["cold viruses", "ORGANISM", 98, 110], ["interferon", "PROTEIN", 43, 53], ["interferon", "TREATMENT", 43, 53], ["infection", "PROBLEM", 83, 92], ["cold viruses", "PROBLEM", 98, 110]]], ["Answers to these questions were sought in a dose-ranging study, in which volunteers gave themselves various doses of HulFN a-2 using a finger-actuated nasal spray s .", [["finger", "ANATOMY", 135, 141], ["nasal", "ANATOMY", 151, 156], ["HulFN a-2", "CHEMICAL", 117, 126], ["volunteers", "ORGANISM", 73, 83], ["finger", "ORGANISM_SUBDIVISION", 135, 141], ["nasal", "ORGANISM_SUBDIVISION", 151, 156], ["ranging study", "TEST", 49, 62], ["HulFN a", "TREATMENT", 117, 124], ["a finger-actuated nasal spray s", "TREATMENT", 133, 164]]], ["Interferon was given for one day before, and 3 days after, challenge with virulent human rhinoviruses.", [["Interferon", "CHEMICAL", 0, 10], ["human rhinoviruses", "DISEASE", 83, 101], ["Interferon", "GENE_OR_GENE_PRODUCT", 0, 10], ["human", "ORGANISM", 83, 88], ["rhinoviruses", "ORGANISM", 89, 101], ["Interferon", "PROTEIN", 0, 10], ["human", "SPECIES", 83, 88], ["human", "SPECIES", 83, 88], ["Interferon", "TREATMENT", 0, 10], ["virulent human rhinoviruses", "PROBLEM", 74, 101], ["rhinoviruses", "OBSERVATION", 89, 101]]], ["Not only was the dose of interferon varied, but also the time of virus challenge in relation to a dose, so that the period of maximum vulnerability to virus infection could be identified.", [["infection", "DISEASE", 157, 166], ["interferon", "GENE_OR_GENE_PRODUCT", 25, 35], ["interferon", "PROTEIN", 25, 35], ["interferon", "TREATMENT", 25, 35], ["virus challenge", "TREATMENT", 65, 80], ["maximum vulnerability to virus infection", "PROBLEM", 126, 166]]], ["The results of this study suggest that at least 3-4 MU of IFN a-2 self-administered intranasally 3 times daily are necessary to protect against experimental rhino~rus infection.", [["rhino~rus infection", "DISEASE", 157, 176], ["-2", "GENE_OR_GENE_PRODUCT", 63, 65], ["IFN", "PROTEIN", 58, 61], ["this study", "TEST", 15, 25], ["IFN a-2 self-administered intranasally", "TREATMENT", 58, 96], ["experimental rhino~rus infection", "PROBLEM", 144, 176], ["infection", "OBSERVATION", 167, 176]]], ["Subsequent experiments have shown that 3-4 MU of HuiFN a-A (a similar molecule to HulFN a-, produced by Roche) can protect against experimental infect/on with a human respnratory coronavtrus (see Fig. 2 )\".", [["HuiFN a-A", "CHEMICAL", 49, 58], ["HuiFN a-A", "CHEMICAL", 49, 58], ["HulFN", "CHEMICAL", 82, 87], ["HuiFN a-A", "SIMPLE_CHEMICAL", 49, 58], ["human", "ORGANISM", 161, 166], ["human", "SPECIES", 161, 166], ["human respnratory coronavtrus", "SPECIES", 161, 190]]], ["Coronaviruses are the ~econd most frequently encouatered cause of a L.oid. and are responsible for 15-20e/r of cases.Robert PhillpottsHowever. one more requirement must be. met by a prophylactic against the common cold -almost complete freedom from unpleasant snde-effects, it is here that research has run into difficulties.", [["Coronaviruses", "GENE_OR_GENE_PRODUCT", 0, 13], ["Coronaviruses", "PROBLEM", 0, 13]]], ["Further studies have shown that while regimens of IFN a similar to that proposed seem to he necessa~\" for protection against natural colds, such doses are also toxi=, and produce a mild inflammation of the nasal mucosa.", [["nasal mucosa", "ANATOMY", 206, 218], ["IFN", "CHEMICAL", 50, 53], ["colds", "DISEASE", 133, 138], ["inflammation", "DISEASE", 186, 198], ["IFN", "GENE_OR_GENE_PRODUCT", 50, 53], ["nasal mucosa", "MULTI-TISSUE_STRUCTURE", 206, 218], ["IFN", "PROTEIN", 50, 53], ["Further studies", "TEST", 0, 15], ["IFN", "TREATMENT", 50, 53], ["protection", "TREATMENT", 106, 116], ["natural colds", "PROBLEM", 125, 138], ["a mild inflammation of the nasal mucosa", "PROBLEM", 179, 218], ["mild", "OBSERVATION_MODIFIER", 181, 185], ["inflammation", "OBSERVATION", 186, 198], ["nasal mucosa", "ANATOMY", 206, 218]]], ["In a recent stuly from the University of Virginia, prclorge.d intranasal administration of the HulF?,~ or-2 was associated with muxr~d irritation in 23% ot recipients\"L Histologically, marked epithelial acute t qfiammation with ulceration occurr,'d in 19%, and 58% had pronounced submucosal l.~anphoq,/tic and mononuclear cell ~filtrates.", [["epithelial", "ANATOMY", 192, 202], ["submucosal", "ANATOMY", 280, 290], ["mononuclear cell", "ANATOMY", 310, 326], ["irritation", "DISEASE", 135, 145], ["ulceration", "DISEASE", 228, 238], ["tic", "DISEASE", 302, 305], ["epithelial", "TISSUE", 192, 202], ["mononuclear cell", "CELL", 310, 326], ["muxr~d irritation", "PROBLEM", 128, 145], ["marked epithelial acute t qfiammation", "PROBLEM", 185, 222], ["ulceration", "PROBLEM", 228, 238], ["pronounced submucosal l.~anphoq", "PROBLEM", 269, 300], ["tic and mononuclear cell ~filtrates", "PROBLEM", 302, 337], ["marked", "OBSERVATION_MODIFIER", 185, 191], ["epithelial", "OBSERVATION_MODIFIER", 192, 202], ["acute", "OBSERVATION_MODIFIER", 203, 208], ["ulceration", "OBSERVATION", 228, 238], ["submucosal", "ANATOMY", 280, 290], ["mononuclear cell", "OBSERVATION", 310, 326], ["filtrates", "OBSERVATION", 328, 337]]], ["Although these abnormalities re'solved within 8 weeks after stopping treatment, long-term administration of IFN a would not be acceptable.", [["IFN", "CHEMICAL", 108, 111], ["IFN", "PROTEIN", 108, 111], ["these abnormalities", "PROBLEM", 9, 28], ["treatment", "TREATMENT", 69, 78], ["long-term administration of IFN", "TREATMENT", 80, 111], ["abnormalities", "OBSERVATION", 15, 28]]], ["However. there has been little sign of irritation of volumeers Wen interferon f~r 4 days.", [["interferon", "PROTEIN", 67, 77], ["irritation of volumeers", "PROBLEM", 39, 62], ["little sign of", "UNCERTAINTY", 24, 38], ["irritation", "OBSERVATION", 39, 49]]], ["Therefore interferon prophylaxis could be used when the time of exposure to virus (or fear of exposure to virus) can be predicted.", [["interferon", "CHEMICAL", 10, 20], ["interferon", "GENE_OR_GENE_PRODUCT", 10, 20], ["interferon", "PROTEIN", 10, 20], ["interferon prophylaxis", "TREATMENT", 10, 32], ["virus", "PROBLEM", 76, 81], ["exposure to virus", "PROBLEM", 94, 111]]], ["Examples of this situation would be contact with a cold sufferer, or before an examination or some other important event.Future research trendsThere is eveR' reason to believe that the problem of poor tolerance to intranasal interferon will be overcome.", [["interferon", "PROTEIN", 225, 235], ["an examination", "TEST", 76, 90], ["poor tolerance", "PROBLEM", 196, 210], ["intranasal interferon", "TREATMENT", 214, 235]]], ["Only a very. small number of interferons have been tested for antiviral activity and toxicity in the nose, and it is conceivable that a molecular subspecies of HulFN c~.", [["nose", "ANATOMY", 101, 105], ["toxicity", "DISEASE", 85, 93], ["nose", "ORGAN", 101, 105], ["HulFN c", "GENE_OR_GENE_PRODUCT", 160, 167], ["interferons", "PROTEIN", 29, 40], ["HulFN c~", "PROTEIN", 160, 168], ["interferons", "TREATMENT", 29, 40], ["antiviral activity", "PROBLEM", 62, 80], ["toxicity in the nose", "PROBLEM", 85, 105], ["very", "OBSERVATION_MODIFIER", 7, 11], ["number", "OBSERVATION_MODIFIER", 19, 25], ["interferons", "OBSERVATION", 29, 40], ["nose", "ANATOMY", 101, 105]]], ["HuIFN t~ or HulFN -\u00a2, or a hybrid interferon molecule prepared from these, may have an improved therapeutic ratio.", [["HuIFN", "GENE_OR_GENE_PRODUCT", 0, 5], ["HulFN -\u00a2", "SIMPLE_CHEMICAL", 12, 20], ["HuIFN", "PROTEIN", 0, 5], ["HulFN", "PROTEIN", 12, 17], ["\u00a2", "PROTEIN", 19, 20], ["hybrid interferon molecule", "PROTEIN", 27, 53], ["HulFN", "TEST", 12, 17], ["a hybrid interferon molecule", "TREATMENT", 25, 53]]], ["Interferon could then be taken for prolonged periods as a prophylactic against the common cold by patients with underlying chronic respiratory disease, such as bronchitis or asthma.", [["respiratory", "ANATOMY", 131, 142], ["chronic respiratory disease", "DISEASE", 123, 150], ["bronchitis", "DISEASE", 160, 170], ["asthma", "DISEASE", 174, 180], ["Interferon", "GENE_OR_GENE_PRODUCT", 0, 10], ["patients", "ORGANISM", 98, 106], ["Interferon", "PROTEIN", 0, 10], ["patients", "SPECIES", 98, 106], ["Interferon", "TREATMENT", 0, 10], ["a prophylactic", "TREATMENT", 56, 70], ["underlying chronic respiratory disease", "PROBLEM", 112, 150], ["bronchitis", "PROBLEM", 160, 170], ["asthma", "PROBLEM", 174, 180], ["chronic", "OBSERVATION_MODIFIER", 123, 130], ["respiratory disease", "OBSERVATION", 131, 150], ["bronchitis", "OBSERVATION", 160, 170], ["asthma", "OBSERVATION", 174, 180]]], ["The question of whether interferon can be used to treat a cold also remains open.", [["interferon", "CHEMICAL", 24, 34], ["interferon", "GENE_OR_GENE_PRODUCT", 24, 34], ["interferon", "PROTEIN", 24, 34], ["interferon", "TREATMENT", 24, 34], ["a cold", "PROBLEM", 56, 62], ["interferon", "OBSERVATION", 24, 34]]], ["The relatively short course of the illness suggests that virus replication in the nose oomns rapidly, and may even be essentially complete by the time symptoms have begun.", [["nose oomns", "ANATOMY", 82, 92], ["nose", "ORGANISM_SUBDIVISION", 82, 86], ["the illness", "PROBLEM", 31, 42], ["virus replication", "TREATMENT", 57, 74], ["the time symptoms", "PROBLEM", 142, 159], ["relatively", "OBSERVATION_MODIFIER", 4, 14], ["short", "OBSERVATION_MODIFIER", 15, 20], ["virus replication", "OBSERVATION", 57, 74]]], ["However, this pessimistic view has yet to be confirmed, and there is some evidence to suggest that even a relatively we~k antiviral agent, such as Enviroxime (registered trade name, produced by Eli Lilly and Company), administered locally after virus infection can affect the course of a cold tt.", [["Enviroxime", "CHEMICAL", 147, 157], ["infection", "DISEASE", 251, 260], ["Enviroxime", "CHEMICAL", 147, 157], ["Enviroxime", "SIMPLE_CHEMICAL", 147, 157], ["this pessimistic view", "TEST", 9, 30], ["a relatively we~k antiviral agent", "TREATMENT", 104, 137], ["virus infection", "PROBLEM", 245, 260], ["a cold tt", "TREATMENT", 286, 295]]], ["Perhaps a suitable preparation of interferon, which could be over 1 000 times more potent than Enviroxime in vitro, could prove clinically useful. as modulators of appetite.", [["interferon", "CHEMICAL", 34, 44], ["Enviroxime", "CHEMICAL", 95, 105], ["Enviroxime", "CHEMICAL", 95, 105], ["interferon", "GENE_OR_GENE_PRODUCT", 34, 44], ["Enviroxime", "SIMPLE_CHEMICAL", 95, 105], ["interferon", "PROTEIN", 34, 44], ["a suitable preparation of interferon", "TREATMENT", 8, 44], ["Enviroxime", "TREATMENT", 95, 105]]], ["The intiuen~es of other neurotransmitters and the physicochemical properties of food will, therefore, receive less prominence.", [["prominence", "OBSERVATION", 115, 125]]], ["At the outset it should be stres~d that the complexities of appetite regulation make it extremely unlikely that any single agent will prove to be the Holy Grail of appetite suppressants.", [["appetite suppressants", "CHEMICAL", 164, 185], ["appetite suppressants", "TREATMENT", 164, 185]]], ["Future pharmacological approaches will need to take cognizance of this fact and attempt to tailor the treatment to the individual rather than the individual to the treatment.", [["Future pharmacological approaches", "TREATMENT", 0, 33], ["the treatment", "TREATMENT", 98, 111], ["the treatment", "TREATMENT", 160, 173]]], ["This is particularly important in view of the fact that the majority of peptides appear to have multiple effects, making it likely that the indiscriminate use of these agents, in subjects in whom a deficit or an excess has not been demonstrated, will lead to an unacceptably high incidence of side effects. opuad reading m A large body of evidence has now accumulated supporting a role for opioid peptides in the modulation of feeding behavior t.", [["opioid peptides", "GENE_OR_GENE_PRODUCT", 390, 405], ["these agents", "TREATMENT", 162, 174], ["a deficit", "PROBLEM", 196, 205], ["side effects", "PROBLEM", 293, 305], ["opioid peptides", "TREATMENT", 390, 405], ["large", "OBSERVATION_MODIFIER", 325, 330]]], ["In particular, the relatively specific opioid antagonist, naloxone, has been demonstrated to decrease fe~ding under a variety of conditions in many species including humans.", [["naloxone", "CHEMICAL", 58, 66], ["naloxone", "CHEMICAL", 58, 66], ["naloxone", "SIMPLE_CHEMICAL", 58, 66], ["humans", "ORGANISM", 166, 172], ["humans", "SPECIES", 166, 172], ["humans", "SPECIES", 166, 172], ["opioid antagonist", "TREATMENT", 39, 56], ["naloxone", "TREATMENT", 58, 66]]], ["In humans, however, the major effect o! opioid blockade with naloxone appears to be to reduce carbohydrate intake rather than to produce an absolute reduction in calories.", [["naloxone", "CHEMICAL", 61, 69], ["naloxone", "CHEMICAL", 61, 69], ["carbohydrate", "CHEMICAL", 94, 106], ["humans", "ORGANISM", 3, 9], ["naloxone", "SIMPLE_CHEMICAL", 61, 69], ["carbohydrate", "SIMPLE_CHEMICAL", 94, 106], ["humans", "SPECIES", 3, 9], ["humans", "SPECIES", 3, 9], ["opioid blockade", "TREATMENT", 40, 55], ["naloxone", "TREATMENT", 61, 69], ["an absolute reduction in calories", "TREATMENT", 137, 170], ["absolute", "OBSERVATION_MODIFIER", 140, 148], ["reduction", "OBSERVATION", 149, 158]]], ["This reduction is offset by an increase in fat intake.", [["fat", "ANATOMY", 43, 46], ["fat", "TISSUE", 43, 46], ["This reduction", "TREATMENT", 0, 14], ["an increase in fat intake", "PROBLEM", 28, 53], ["offset", "OBSERVATION_MODIFIER", 18, 24], ["increase", "OBSERVATION_MODIFIER", 31, 39], ["fat intake", "OBSERVATION", 43, 53]]], ["In addition, the first ion 8 term study in humans by Atkinson 2 using the long-acting opiate antagonist, naltrexone, produced disap-", [["naltrexone", "CHEMICAL", 105, 115], ["disap-", "CHEMICAL", 126, 132], ["naltrexone", "CHEMICAL", 105, 115], ["humans", "ORGANISM", 43, 49], ["naltrexone", "SIMPLE_CHEMICAL", 105, 115], ["humans", "SPECIES", 43, 49], ["humans", "SPECIES", 43, 49], ["the long-acting opiate antagonist", "TREATMENT", 70, 103], ["naltrexone", "TREATMENT", 105, 115]]]], "e1eb29c0a697c2ffbf1d81746482b084b54f4df0": [["IntroductionCoronaviruses were first described as aetiological agents of human disease in the mid-1960s when isolated from natural common colds (Tyrrell and Bynoe, 1965; Hamre and Procknow, 1966) .", [["human disease", "DISEASE", 73, 86], ["colds", "DISEASE", 138, 143], ["Coronaviruses", "GENE_OR_GENE_PRODUCT", 12, 25], ["human", "ORGANISM", 73, 78], ["human", "SPECIES", 73, 78], ["human", "SPECIES", 73, 78], ["IntroductionCoronaviruses", "PROBLEM", 0, 25], ["human disease", "PROBLEM", 73, 86]]], ["They derive their name from their characteristic 'crown-like' appearance in electron micrographs imbued by a fringe of club shaped spike (or peplomer) proteins inserted into the viral envelope.", [["club shaped spike (or peplomer) proteins", "PROTEIN", 119, 159], ["electron micrographs", "TEST", 76, 96], ["club shaped spike", "PROBLEM", 119, 136], ["peplomer) proteins", "TREATMENT", 141, 159], ["viral envelope", "OBSERVATION", 178, 192]]], ["Virions are lipid enveloped and are approximately 80-120 nm in diameter; there is a single stranded genome of positive sense RNA approximately 30 kb in length.", [["Virions", "GENE_OR_GENE_PRODUCT", 0, 7], ["positive sense RNA", "RNA", 110, 128], ["a single stranded genome of positive sense RNA", "PROBLEM", 82, 128], ["lipid", "OBSERVATION_MODIFIER", 12, 17], ["enveloped", "OBSERVATION_MODIFIER", 18, 27], ["approximately", "OBSERVATION_MODIFIER", 36, 49], ["80-120 nm", "OBSERVATION_MODIFIER", 50, 59], ["diameter", "OBSERVATION_MODIFIER", 63, 71], ["single", "OBSERVATION_MODIFIER", 84, 90], ["stranded", "OBSERVATION_MODIFIER", 91, 99], ["genome", "OBSERVATION", 100, 106], ["positive", "OBSERVATION_MODIFIER", 110, 118], ["sense RNA", "OBSERVATION_MODIFIER", 119, 128], ["approximately", "OBSERVATION_MODIFIER", 129, 142], ["30 kb", "OBSERVATION_MODIFIER", 143, 148], ["length", "OBSERVATION_MODIFIER", 152, 158]]], ["They also have a characteristic replication strategy, in that the positive sense genomic RNA is first transcribed into negative sense intermediate RNAs (by a virus encoded transcriptase) from which a nested 3% co-terminus set of five to eight subgenomic mR-NAs (six subgenomic RNAs for human coronaviruses) are transcribed.", [["mR-NAs", "GENE_OR_GENE_PRODUCT", 254, 260], ["human", "ORGANISM", 286, 291], ["positive sense genomic RNA", "RNA", 66, 92], ["negative sense intermediate RNAs", "RNA", 119, 151], ["virus encoded transcriptase", "PROTEIN", 158, 185], ["subgenomic mR-NAs", "DNA", 243, 260], ["subgenomic RNAs", "RNA", 266, 281], ["human", "SPECIES", 286, 291], ["human coronaviruses", "SPECIES", 286, 305], ["a characteristic replication strategy", "TREATMENT", 15, 52], ["the positive sense genomic RNA", "PROBLEM", 62, 92], ["a virus encoded transcriptase", "TREATMENT", 156, 185], ["a nested 3% co-terminus set", "TREATMENT", 198, 225], ["subgenomic mR", "TEST", 243, 256], ["replication", "OBSERVATION", 32, 43], ["genomic RNA", "OBSERVATION", 81, 92], ["intermediate RNAs", "OBSERVATION", 134, 151]]], ["The subgenomic mRNAs have identical 3% ends but extend for different lengths in the 5% direction (Lai, 1990) .IntroductionAntigenically, coronaviruses may be divided into two major serogroups and one minor serogroup.", [["coronaviruses", "ORGANISM", 137, 150], ["subgenomic mRNAs", "RNA", 4, 20], ["coronaviruses", "PROBLEM", 137, 150], ["subgenomic mRNAs", "OBSERVATION", 4, 20], ["ends", "OBSERVATION_MODIFIER", 39, 43], ["different", "OBSERVATION_MODIFIER", 59, 68], ["lengths", "OBSERVATION_MODIFIER", 69, 76], ["minor", "OBSERVATION_MODIFIER", 200, 205], ["serogroup", "OBSERVATION", 206, 215]]], ["The two major antigenic serogroups are designated coronavirus serogroup 1 (including human coronavirus 229E) and coronavirus serogroup 2 (which includes human coronavirus OC43).", [["coronavirus serogroup 1", "ORGANISM", 50, 73], ["human", "ORGANISM", 85, 90], ["coronavirus 229E", "ORGANISM", 91, 107], ["coronavirus serogroup 2", "ORGANISM", 113, 136], ["human", "ORGANISM", 153, 158], ["coronavirus OC43", "ORGANISM", 159, 175], ["coronavirus serogroup 1", "SPECIES", 50, 73], ["human", "SPECIES", 85, 90], ["coronavirus", "SPECIES", 91, 102], ["coronavirus serogroup", "SPECIES", 113, 134], ["human", "SPECIES", 153, 158], ["coronavirus", "SPECIES", 159, 170], ["coronavirus serogroup 1", "SPECIES", 50, 73], ["human coronavirus 229E", "SPECIES", 85, 107], ["human coronavirus", "SPECIES", 153, 170], ["The two major antigenic serogroups", "PROBLEM", 0, 34], ["coronavirus serogroup", "TEST", 50, 71], ["human coronavirus", "TEST", 85, 102], ["coronavirus serogroup 2", "PROBLEM", 113, 136], ["two", "OBSERVATION_MODIFIER", 4, 7], ["major", "OBSERVATION_MODIFIER", 8, 13], ["antigenic serogroups", "OBSERVATION", 14, 34]]], ["The minor antigenic serogroup (coronavirus serogroup 3) currently only contains a single member, avian infectious bronchitis virus (Siddell, 1995) .IntroductionAll coronaviruses possess three major proteins: the nucleocapsid (N), membrane (M) and spike (S); a minor protein (sM); with some coronaviruses also possessing a haemagglutinin-esterase (HE) glycoprotein (Siddell, 1995) .", [["membrane", "ANATOMY", 230, 238], ["infectious bronchitis virus", "DISEASE", 103, 130], ["coronavirus serogroup 3", "ORGANISM", 31, 54], ["avian infectious bronchitis virus", "ORGANISM", 97, 130], ["nucleocapsid (N)", "GENE_OR_GENE_PRODUCT", 212, 228], ["membrane", "CELLULAR_COMPONENT", 230, 238], ["haemagglutinin-esterase (HE) glycoprotein", "GENE_OR_GENE_PRODUCT", 322, 363], ["nucleocapsid (N), membrane (M)", "PROTEIN", 212, 242], ["spike (S)", "PROTEIN", 247, 256], ["minor protein", "PROTEIN", 260, 273], ["haemagglutinin-esterase (HE) glycoprotein", "PROTEIN", 322, 363], ["Siddell", "PROTEIN", 365, 372], ["coronavirus serogroup", "SPECIES", 31, 52], ["avian infectious bronchitis virus", "SPECIES", 97, 130], ["infectious bronchitis virus", "SPECIES", 103, 130], ["The minor antigenic serogroup (coronavirus serogroup", "PROBLEM", 0, 52], ["avian infectious bronchitis virus", "PROBLEM", 97, 130], ["the nucleocapsid (N), membrane (M)", "TEST", 208, 242], ["spike (S", "PROBLEM", 247, 255], ["a minor protein (sM", "PROBLEM", 258, 277], ["some coronaviruses", "PROBLEM", 285, 303], ["minor", "OBSERVATION_MODIFIER", 4, 9], ["antigenic", "OBSERVATION_MODIFIER", 10, 19], ["serogroup", "OBSERVATION_MODIFIER", 20, 29], ["infectious", "OBSERVATION_MODIFIER", 103, 113], ["bronchitis", "OBSERVATION", 114, 124], ["coronaviruses", "OBSERVATION", 290, 303]]], ["The spike glycoprotein is of particular importance in the infectious process because: (a) it is the site for the virus anti-receptor (Collins et al., 1982) ; (b) it has fusion activity (De Groot et al., 1989) ; and (c) it contains sites against which major neutralising antibodies are directed (Jimenez et al., 1986) .", [["spike glycoprotein", "PROTEIN", 4, 22], ["neutralising antibodies", "PROTEIN", 257, 280], ["The spike glycoprotein", "PROBLEM", 0, 22], ["fusion activity", "PROBLEM", 169, 184], ["infectious", "OBSERVATION", 58, 68]]], ["The composition of the spike glycoprotein is therefore very relevant to the ability of the virus to evade the hosts' immune system (La Monica et al., 1991) .IntroductionHuman coronaviruses have a world-wide distribution (Hruskova et al., 1990; Matsumoto and Kawana, 1992) and infect all age groups (Gwaltney, 1980) .", [["IntroductionHuman coronaviruses", "ORGANISM", 157, 188], ["spike glycoprotein", "PROTEIN", 23, 41], ["the spike glycoprotein", "PROBLEM", 19, 41], ["the virus", "PROBLEM", 87, 96]]], ["There is evidence to suggest a role for human coronaviruses in the aetiology of enteric (Payne et al., 1986) , neurological (Stewart et al., 1992) but, primarily, respiratory disease (Myint, 1995) .", [["respiratory", "ANATOMY", 163, 174], ["respiratory disease", "DISEASE", 163, 182], ["human", "ORGANISM", 40, 45], ["human", "SPECIES", 40, 45], ["human coronaviruses", "SPECIES", 40, 59], ["human coronaviruses", "PROBLEM", 40, 59], ["respiratory disease", "PROBLEM", 163, 182], ["coronaviruses", "OBSERVATION", 46, 59], ["enteric", "ANATOMY", 80, 87], ["respiratory disease", "OBSERVATION", 163, 182]]], ["Indeed, human coronaviruses are though to be responsible for approximately 20% of common colds (McIntosh et al., 1970) , as well as lower respiratory tract infections in infants (McIntosh et al., 1974) and the exacerbation of asthma (Johnston et al., 1995) .", [["lower respiratory tract", "ANATOMY", 132, 155], ["colds", "DISEASE", 89, 94], ["respiratory tract infections", "DISEASE", 138, 166], ["asthma", "DISEASE", 226, 232], ["human", "ORGANISM", 8, 13], ["coronaviruses", "ORGANISM", 14, 27], ["respiratory tract", "ORGANISM_SUBDIVISION", 138, 155], ["infants", "ORGANISM", 170, 177], ["human", "SPECIES", 8, 13], ["infants", "SPECIES", 170, 177], ["human coronaviruses", "SPECIES", 8, 27], ["human coronaviruses", "PROBLEM", 8, 27], ["lower respiratory tract infections", "PROBLEM", 132, 166], ["asthma", "PROBLEM", 226, 232], ["coronaviruses", "OBSERVATION", 14, 27], ["lower", "ANATOMY_MODIFIER", 132, 137], ["respiratory tract", "ANATOMY", 138, 155], ["infections", "OBSERVATION", 156, 166], ["asthma", "OBSERVATION", 226, 232]]], ["Prospective studies have indi-cated that such human coronavirus induced respiratory infections tend to occur in cycles, with a periodicity of approximately 3 years (Monto and Lim, 1974) .IntroductionRespiratory re-infections with human coronaviruses are common (Monto and Lim, 1974) .", [["respiratory", "ANATOMY", 72, 83], ["coronavirus", "DISEASE", 52, 63], ["respiratory infections", "DISEASE", 72, 94], ["human coronaviruses", "DISEASE", 230, 249], ["human", "ORGANISM", 46, 51], ["coronavirus", "ORGANISM", 52, 63], ["human", "ORGANISM", 230, 235], ["human", "SPECIES", 46, 51], ["human", "SPECIES", 230, 235], ["human coronavirus", "SPECIES", 46, 63], ["human coronaviruses", "SPECIES", 230, 249], ["Prospective studies", "TEST", 0, 19], ["human coronavirus induced respiratory infections", "PROBLEM", 46, 94], ["human coronaviruses", "PROBLEM", 230, 249], ["infections", "OBSERVATION", 84, 94]]], ["The mechanism facilitating re-infection is, however, unclear.", [["re-infection", "PROBLEM", 27, 39], ["re-infection", "OBSERVATION", 27, 39]]], ["Macnaughton (1982) indicated that coronavirus antibodies raised against human coronavirus 229E strains (serogroup 1) may not be protective against human coronavirus OC43 strains (serogroup 2) and vice versa.", [["coronavirus antibodies", "DISEASE", 34, 56], ["coronavirus", "ORGANISM", 34, 45], ["human", "ORGANISM", 72, 77], ["coronavirus 229E strains", "ORGANISM", 78, 102], ["serogroup 1", "ORGANISM", 104, 115], ["human", "ORGANISM", 147, 152], ["coronavirus OC43 strains", "ORGANISM", 153, 177], ["coronavirus antibodies", "PROTEIN", 34, 56], ["coronavirus", "SPECIES", 34, 45], ["human", "SPECIES", 72, 77], ["coronavirus", "SPECIES", 78, 89], ["human", "SPECIES", 147, 152], ["coronavirus", "SPECIES", 153, 164], ["coronavirus", "SPECIES", 34, 45], ["human coronavirus", "SPECIES", 72, 89], ["human coronavirus", "SPECIES", 147, 164], ["coronavirus antibodies", "PROBLEM", 34, 56], ["human coronavirus 229E strains", "PROBLEM", 72, 102], ["human coronavirus OC43 strains", "PROBLEM", 147, 177]]], ["The existence of pre-existing coronavirus antibody directed to the same serotype is not protective against further coronavirus infection (Callow, 1985) .", [["coronavirus infection", "DISEASE", 115, 136], ["coronavirus", "ORGANISM", 30, 41], ["coronavirus", "ORGANISM", 115, 126], ["pre-existing coronavirus antibody", "PROTEIN", 17, 50], ["coronavirus", "SPECIES", 30, 41], ["pre-existing coronavirus antibody", "TREATMENT", 17, 50], ["further coronavirus infection", "PROBLEM", 107, 136], ["coronavirus antibody", "OBSERVATION", 30, 50], ["not protective", "UNCERTAINTY", 84, 98], ["coronavirus", "OBSERVATION_MODIFIER", 115, 126], ["infection", "OBSERVATION", 127, 136]]], ["Natural antibodies against a particular serotype of coronavirus were protective for approximately four months only, after which time re-infection by the same serotype of human coronavirus could occur.IntroductionIn this study preliminary evidence was obtained that significant variation in the S protein of the virus that is unlikely to explain the basis of re-infections.", [["coronavirus", "DISEASE", 52, 63], ["coronavirus", "DISEASE", 176, 187], ["coronavirus", "ORGANISM", 52, 63], ["human", "ORGANISM", 170, 175], ["coronavirus", "ORGANISM", 176, 187], ["Natural antibodies", "PROTEIN", 0, 18], ["S protein", "PROTEIN", 294, 303], ["human", "SPECIES", 170, 175], ["coronavirus", "SPECIES", 176, 187], ["human coronavirus", "SPECIES", 170, 187], ["Natural antibodies", "TREATMENT", 0, 18], ["coronavirus", "PROBLEM", 52, 63], ["human coronavirus", "PROBLEM", 170, 187], ["this study", "TEST", 215, 225], ["significant variation", "PROBLEM", 265, 286], ["the S protein of the virus", "PROBLEM", 290, 316], ["re-infections", "PROBLEM", 358, 371], ["coronavirus", "OBSERVATION", 52, 63], ["significant", "OBSERVATION_MODIFIER", 265, 276], ["variation", "OBSERVATION_MODIFIER", 277, 286], ["unlikely to explain", "UNCERTAINTY", 325, 344]]], ["A reverse transcription PCR sequencing strategy was developed which allows sequence data from the spike genes of several geographically and chronologically distinct human coronaviruses 229E to be collated and compared.", [["human", "ORGANISM", 165, 170], ["coronaviruses", "ORGANISM", 171, 184], ["spike genes", "DNA", 98, 109], ["human", "SPECIES", 165, 170], ["human coronaviruses", "SPECIES", 165, 184], ["A reverse transcription PCR sequencing strategy", "TEST", 0, 47], ["sequence data", "TEST", 75, 88], ["the spike genes", "TEST", 94, 109], ["chronologically distinct human coronaviruses", "PROBLEM", 140, 184], ["human coronaviruses", "OBSERVATION", 165, 184]]], ["By predicting the corresponding amino acid sequences of these spike genes, it has been possible to make a preliminary assessment of the degree of variation within the corresponding spike protein sequences of these isolates and those published previously.Viruses and cellsHuman coronavirus 229E strain VR-74 was purchased from the American Type Culture Collection, MD, USA.", [["amino acid", "CHEMICAL", 32, 42], ["VR-74", "CHEMICAL", 301, 306], ["amino acid", "CHEMICAL", 32, 42], ["amino acid", "AMINO_ACID", 32, 42], ["cellsHuman coronavirus 229E", "ORGANISM", 266, 293], ["VR-74", "ORGANISM", 301, 306], ["spike genes", "DNA", 62, 73], ["spike protein sequences", "DNA", 181, 204], ["cellsHuman coronavirus 229E", "SPECIES", 266, 293], ["cellsHuman coronavirus 229E strain VR-74", "SPECIES", 266, 306], ["the corresponding amino acid sequences", "TEST", 14, 52], ["a preliminary assessment", "TEST", 104, 128], ["these isolates", "TEST", 208, 222], ["Viruses", "PROBLEM", 254, 261], ["cellsHuman coronavirus", "TEST", 266, 288], ["strain VR", "TEST", 294, 303]]], ["Strain LRI 281 was isolated from nasal washings obtained in 1990 from a child with asthma at the Leicester Royal Infirmary, Leicester, UK.", [["nasal washings", "ANATOMY", 33, 47], ["LRI 281", "CHEMICAL", 7, 14], ["asthma", "DISEASE", 83, 89], ["nasal washings", "MULTI-TISSUE_STRUCTURE", 33, 47], ["child", "SPECIES", 72, 77], ["Strain LRI", "TEST", 0, 10], ["nasal washings", "TEST", 33, 47], ["asthma", "PROBLEM", 83, 89], ["asthma", "OBSERVATION", 83, 89]]], ["Strain A162 was isolated from nasal secretions obtained in 1995 from an adult presenting with the common cold at Kumasi, Ghana, West Africa.", [["nasal secretions", "ANATOMY", 30, 46], ["A162", "CHEMICAL", 7, 11], ["Strain A162", "CELL", 0, 11], ["nasal secretions", "ORGANISM_SUBSTANCE", 30, 46], ["Strain A162", "PROBLEM", 0, 11], ["nasal secretions", "PROBLEM", 30, 46], ["nasal", "ANATOMY", 30, 35], ["secretions", "OBSERVATION", 36, 46]]], ["All specimens were transported to the laboratory on dry ice, aliquoted into 100 ml quantities and stored at \u2212 70\u00b0C until required.PrimersSpike gene reverse transcription and PCR primers were designed from consensus regions of the spike genes of several coronaviruses 229E utilising published data (Wesseling et al., 1994) .", [["specimens", "ANATOMY", 4, 13], ["coronaviruses", "ORGANISM", 253, 266], ["PrimersSpike gene", "DNA", 130, 147], ["PCR primers", "DNA", 174, 185], ["consensus regions", "DNA", 205, 222], ["spike genes", "DNA", 230, 241], ["dry ice", "TREATMENT", 52, 59], ["PCR primers", "TEST", 174, 185], ["several coronaviruses", "PROBLEM", 245, 266]]], ["Spike gene sequencing primers were designed by a 'primer walking' method utilising human coronavirus 229E strain ATCC VR-74 as template.", [["Spike", "GENE_OR_GENE_PRODUCT", 0, 5], ["human", "ORGANISM", 83, 88], ["coronavirus 229E", "ORGANISM", 89, 105], ["human coronavirus 229E strain ATCC VR-74", "DNA", 83, 123], ["human", "SPECIES", 83, 88], ["coronavirus", "SPECIES", 89, 100], ["human coronavirus 229E strain ATCC VR-74", "SPECIES", 83, 123], ["Spike gene sequencing primers", "PROBLEM", 0, 29], ["human coronavirus", "TEST", 83, 100], ["ATCC VR", "TEST", 113, 120]]], ["All primers were prepared using i-cyanoethyl phosphoramidite (CEP) chemistry at the Protein and Nucleic Acid Laboratory at the University of Leicester, Leicester, UK.Extraction of human corona6irus 229E RNAThe extraction of human coronavirus 229E RNA was based on guanidium isothiocyanate methodology (Chomczynski and Sacchi, 1987) using RNAzol B (Biogenesis Ltd, Poole, UK).", [["i-cyanoethyl phosphoramidite", "CHEMICAL", 32, 60], ["guanidium isothiocyanate", "CHEMICAL", 264, 288], ["RNAzol B", "CHEMICAL", 338, 346], ["i-cyanoethyl phosphoramidite", "CHEMICAL", 32, 60], ["guanidium isothiocyanate", "CHEMICAL", 264, 288], ["RNAzol B", "CHEMICAL", 338, 346], ["i-cyanoethyl phosphoramidite", "SIMPLE_CHEMICAL", 32, 60], ["human", "ORGANISM", 180, 185], ["human", "ORGANISM", 224, 229], ["coronavirus 229E", "ORGANISM", 230, 246], ["guanidium isothiocyanate", "SIMPLE_CHEMICAL", 264, 288], ["RNAzol B", "GENE_OR_GENE_PRODUCT", 338, 346], ["UK", "GENE_OR_GENE_PRODUCT", 371, 373], ["human coronavirus 229E RNA", "RNA", 224, 250], ["human", "SPECIES", 180, 185], ["human", "SPECIES", 224, 229], ["coronavirus", "SPECIES", 230, 241], ["human", "SPECIES", 180, 185], ["human coronavirus", "SPECIES", 224, 241], ["All primers", "TREATMENT", 0, 11], ["i-cyanoethyl phosphoramidite", "TREATMENT", 32, 60], ["Extraction", "TREATMENT", 166, 176], ["human coronavirus 229E RNA", "PROBLEM", 224, 250]]], ["Once extracted, the total RNA pellet was allowed to dry for approximately 25 min at room temperature and then resuspended in 30 ml of RNAse free ultra-high quality (UHQ) water containing 20 U/ ml of RNAse inhibitor (Promega).Re6erse transcription of human corona6irus 229E RNAAll reverse transcription reactions were carried out in a final volume of 20 ml.", [["RNAse", "GENE_OR_GENE_PRODUCT", 199, 204], ["human", "ORGANISM", 250, 255], ["human", "SPECIES", 250, 255], ["human", "SPECIES", 250, 255], ["the total RNA pellet", "TREATMENT", 16, 36], ["RNAse free ultra-high quality (UHQ) water", "TREATMENT", 134, 175], ["RNAse inhibitor", "TREATMENT", 199, 214], ["human corona6irus", "TREATMENT", 250, 267]]], ["Negative controls comprised RNAse free UHQ water which had undergone RNA extraction.Re6erse transcription of human corona6irus 229E RNAInitially, for each RNA extraction to be reverse transcribed, a reverse transcription supermix containing 2 ml of 10\u00d7 MMLV reverse transcription (RT) buffer (Stratagene, Cambridge, UK), 2 ml of a 5 mM mix of deoxynucleotide triphosphates (dNTPs), 0.5 ml of 100 mM dithiothreitol (Sigma, Poole, UK), 1 ml of 10 mg/ml gelatin, 3 ml of UHQ RNAse free water and 1 ml of downstream primer LPS2 (see Table 1 ) at a stock concentration of 25 pmoles was prepared.", [["deoxynucleotide triphosphates", "CHEMICAL", 343, 372], ["dNTPs", "CHEMICAL", 374, 379], ["dithiothreitol", "CHEMICAL", 399, 413], ["deoxynucleotide triphosphates", "CHEMICAL", 343, 372], ["dNTPs", "CHEMICAL", 374, 379], ["dithiothreitol", "CHEMICAL", 399, 413], ["RNAse", "GENE_OR_GENE_PRODUCT", 28, 33], ["human", "ORGANISM", 109, 114], ["MMLV", "ORGANISM", 253, 257], ["deoxynucleotide triphosphates", "SIMPLE_CHEMICAL", 343, 372], ["dNTPs", "SIMPLE_CHEMICAL", 374, 379], ["dithiothreitol", "SIMPLE_CHEMICAL", 399, 413], ["gelatin", "SIMPLE_CHEMICAL", 451, 458], ["RNAse", "PROTEIN", 28, 33], ["human corona6irus 229E RNAInitially", "DNA", 109, 144], ["human", "SPECIES", 109, 114], ["human corona6irus 229E", "SPECIES", 109, 131], ["RNAse free UHQ water", "TREATMENT", 28, 48], ["RNA extraction", "TREATMENT", 69, 83], ["each RNA extraction", "TREATMENT", 150, 169], ["a reverse transcription supermix", "TREATMENT", 197, 229], ["a 5 mM mix of deoxynucleotide triphosphates (dNTPs", "TREATMENT", 329, 379], ["100 mM dithiothreitol (Sigma, Poole, UK)", "TREATMENT", 392, 432], ["gelatin", "TREATMENT", 451, 458], ["UHQ RNAse free water", "TREATMENT", 468, 488], ["downstream primer LPS2", "TREATMENT", 501, 523], ["RNA extraction", "OBSERVATION", 69, 83]]], ["Of this RT-super mix, 9.5 ml was then transferred to a labelled 0.5 ml sterile RNAse free Eppendorf and overlaid with sterile (2) Spike gene nested PCR primers 5% AATAATTG-Re6erse transcription of human corona6irus 229E RNAwere placed immediately on ice for 5 min and 0.5 ml of MMLV (Stratagene, Cambridge, UK) reverse transcriptase then added to each reaction mix.", [["human", "ORGANISM", 197, 202], ["MMLV", "ORGANISM", 278, 282], ["sterile (2) Spike gene nested PCR primers", "DNA", 118, 159], ["human corona6irus 229E RNAwere", "DNA", 197, 227], ["Stratagene, Cambridge, UK) reverse transcriptase", "PROTEIN", 284, 332], ["human", "SPECIES", 197, 202], ["human corona6irus 229E", "SPECIES", 197, 219], ["MMLV", "SPECIES", 278, 282], ["this RT-super mix", "TREATMENT", 3, 20], ["a labelled 0.5 ml sterile RNAse free Eppendorf", "TREATMENT", 53, 99], ["sterile (2) Spike gene nested PCR primers", "TREATMENT", 118, 159], ["AATAATTG", "TEST", 163, 171], ["human corona6irus", "TREATMENT", 197, 214], ["MMLV", "TREATMENT", 278, 282], ["reverse transcriptase", "TREATMENT", 311, 332]]], ["The reaction mixes were then placed in a pre-heated Trio-block thermocycler (Biometra, Maidstone, UK) at 37\u00b0C for 1 h.", [["The reaction mixes", "TREATMENT", 0, 18], ["a pre-heated Trio-block thermocycler", "TREATMENT", 39, 75]]], ["After 1 h the reverse transcription/RNA mixes were heated to 95\u00b0C for 5 min and then cooled to 4\u00b0C prior to use in the human coronavirus 229E nested spike gene PCR.Human corona6irus 229E spike gene nested PCRAll first and second round PCR reactions were carried out in a final volume of 50 ml.", [["human", "ORGANISM", 119, 124], ["Human", "ORGANISM", 164, 169], ["human coronavirus 229E nested spike gene PCR", "DNA", 119, 163], ["Human corona6irus 229E spike gene", "DNA", 164, 197], ["PCRAll", "DNA", 205, 211], ["human", "SPECIES", 119, 124], ["coronavirus", "SPECIES", 125, 136], ["Human", "SPECIES", 164, 169], ["human coronavirus", "SPECIES", 119, 136], ["Human corona6irus 229E", "SPECIES", 164, 186], ["the reverse transcription/RNA mixes", "TREATMENT", 10, 45], ["the human coronavirus", "TREATMENT", 115, 136], ["gene PCR", "TEST", 155, 163], ["Human corona6irus 229E spike", "TEST", 164, 192], ["second round PCR reactions", "TEST", 222, 248]]], ["All stock primers had a concentration of 25 pmoles.First round PCR protocolInitially, a first round PCR supermix was prepared containing 31.6 ml of sterile UHQ water, 5 ml of 10\u00d7 Thermus icelandicus PCR buffer (Advanced Biotechnologies, Leatherhead, UK), 6 ml of 25 mM magnesium chloride, 0.4 ml of a 5 mM mix of dNTPs, 1 ml of primer LPS1 (see Table 1 ) and 1 ml of primer LPS2 (see Table 1 ) per reverse transcribed specimen to be PCR amplified.", [["specimen", "ANATOMY", 418, 426], ["magnesium chloride", "CHEMICAL", 269, 287], ["dNTPs", "CHEMICAL", 313, 318], ["magnesium chloride", "CHEMICAL", 269, 287], ["dNTPs", "CHEMICAL", 313, 318], ["magnesium chloride", "SIMPLE_CHEMICAL", 269, 287], ["primer LPS2", "DNA", 367, 378], ["Thermus icelandicus", "SPECIES", 179, 198], ["Thermus icelandicus", "SPECIES", 179, 198], ["All stock primers", "TREATMENT", 0, 17], ["First round PCR protocol", "TREATMENT", 51, 75], ["a first round PCR supermix", "TREATMENT", 86, 112], ["sterile UHQ water", "TREATMENT", 148, 165], ["25 mM magnesium chloride", "TREATMENT", 263, 287], ["a 5 mM mix of dNTPs", "TREATMENT", 299, 318], ["primer LPS1", "TREATMENT", 328, 339], ["primer LPS2", "TREATMENT", 367, 378], ["PCR", "TEST", 433, 436]]], ["This PCR supermix (44.8 ml) was then pipetted into a labelled 0.5-ml Eppendorf and overlaid with sterile mineral oil.", [["This PCR supermix", "TEST", 0, 17], ["sterile mineral oil", "TREATMENT", 97, 116]]], ["Reverse transcribed human coronavirus 229E spike gene cDNA (or negative control cDNA) (5 ml) was then added to its respective Eppendorf and the first round PCR reaction mixes transferred to a pre-heated (95\u00b0C) Trioblock thermocycler and subjected to a 'hot start' and 'touchdown' PCR protocol with 0.2 ml 'Red Hot' Thermus icelandicus DNA polymerase (Advanced Biotechnologies, Leatherhead, UK).", [["human", "ORGANISM", 20, 25], ["coronavirus 229E", "ORGANISM", 26, 42], ["human coronavirus 229E spike gene cDNA", "DNA", 20, 58], ["negative control cDNA", "DNA", 63, 84], ["human", "SPECIES", 20, 25], ["coronavirus", "SPECIES", 26, 37], ["Thermus icelandicus", "SPECIES", 315, 334], ["human coronavirus", "SPECIES", 20, 37], ["Thermus icelandicus", "SPECIES", 315, 334], ["Reverse transcribed human coronavirus", "PROBLEM", 0, 37], ["gene cDNA", "TEST", 49, 58], ["Trioblock thermocycler", "TREATMENT", 210, 232], ["'touchdown' PCR protocol", "TREATMENT", 268, 292], ["Red Hot' Thermus icelandicus DNA polymerase", "TREATMENT", 306, 349]]], ["The initial phase consisted of 20 cycles of 92\u00b0C for 30 s, thermal ramp to 65\u00b0C for 1 min, thermal ramp to 72\u00b0C for 4 min then thermal ramp to 92\u00b0C. This was followed by ten cycles of 92\u00b0C for 30 s, thermal ramp to 55\u00b0C for 1 min, thermal ramp to 72\u00b0C for 4 min, then a thermal ramp to 92\u00b0C. PCR products were then cooled to 4\u00b0C and stored until second round reaction mixes had been prepared.First round PCR protocolmineral oil (Sigma, Poole, UK).", [["C", "SIMPLE_CHEMICAL", 327, 328], ["oil", "ORGANISM_SUBSTANCE", 424, 427], ["thermal ramp", "TEST", 59, 71], ["thermal ramp", "TEST", 91, 103], ["thermal ramp", "TEST", 127, 139], ["thermal ramp", "TREATMENT", 199, 211], ["thermal ramp", "TEST", 231, 243], ["a thermal ramp", "TREATMENT", 268, 282], ["PCR products", "TREATMENT", 292, 304]]], ["RNA extract (10 ml) was then added to its respective Eppendorf and the resultant RT/RNA mixes heated to 70\u00b0C for 5 min.", [["RNA extract", "CHEMICAL", 0, 11], ["RNA extract", "TREATMENT", 0, 11], ["the resultant RT/RNA mixes", "TREATMENT", 67, 93], ["RNA mixes", "OBSERVATION", 84, 93]]], ["After this time, the RT/RNA mixesSecond round PCR protocolIn the second round of the human coronavirus 229E spike gene PCR, 5 'second round reaction mixes' were prepared for each of the first round PCR amplification products to be re-amplified.", [["human", "ORGANISM", 85, 90], ["human coronavirus 229E spike gene PCR", "DNA", 85, 122], ["human", "SPECIES", 85, 90], ["coronavirus", "SPECIES", 91, 102], ["human coronavirus", "SPECIES", 85, 102], ["the RT/RNA mixes", "TREATMENT", 17, 33], ["Second round PCR protocol", "TREATMENT", 33, 58], ["the human coronavirus", "TEST", 81, 102], ["gene PCR", "TEST", 114, 122], ["5 'second round reaction mixes", "TREATMENT", 124, 154], ["the first round PCR amplification products", "TREATMENT", 182, 224]]], ["Initially, a second round supermix containing 33 ml of sterile UHQ water, 5 ml of 10\u00d7 Thermus icelandicus PCR buffer (Advanced Biotechnologies), 6ml of 25 mM magnesium chloride and 0.4 ml of a 5 mM mix of dNTPs was prepared for each first round PCR amplification undertaken.", [["magnesium chloride", "CHEMICAL", 158, 176], ["dNTPs", "CHEMICAL", 205, 210], ["magnesium chloride", "CHEMICAL", 158, 176], ["dNTPs", "CHEMICAL", 205, 210], ["magnesium chloride", "SIMPLE_CHEMICAL", 158, 176], ["dNTPs", "SIMPLE_CHEMICAL", 205, 210], ["Thermus icelandicus", "SPECIES", 86, 105], ["Thermus icelandicus", "SPECIES", 86, 105], ["a second round supermix", "TREATMENT", 11, 34], ["sterile UHQ water", "TREATMENT", 55, 72], ["25 mM magnesium chloride", "TREATMENT", 152, 176], ["a 5 mM mix of dNTPs", "TREATMENT", 191, 210], ["each first round PCR amplification", "TREATMENT", 228, 262]]], ["This second round supermix (44.4 ml) was then aliquoted into labelled sterile 0.5-ml Eppendorfs.", [["round", "OBSERVATION_MODIFIER", 12, 17]]], ["Next, five separate 'primer pair mixes' were prepared containing either (i) 0.2 ml of primer JH1 and 0.2 ml of primer JH2; (ii) 0.2 ml of primer JH3 and 0.2 ml of primer JH4; (iii) 0.2 ml of primer JH5 and 0.2 ml of primer JH6; (iv) 0.2 ml of primer JH16 and 0.2 ml of primer JH24; and (v) 0.2 ml of primer JH14 and 0.2 ml of primer JH28 (see Table 1 ) per first round PCR amplification undertaken.", [["JH1", "CHEMICAL", 93, 96], ["JH2", "CHEMICAL", 118, 121], ["JH3", "CHEMICAL", 145, 148], ["primer JH1", "DNA", 86, 96], ["primer JH2", "DNA", 111, 121], ["primer JH3", "DNA", 138, 148], ["primer JH4", "DNA", 163, 173], ["primer JH5", "DNA", 191, 201], ["primer JH6", "DNA", 216, 226], ["primer JH16", "DNA", 243, 254], ["primer JH24", "DNA", 269, 280], ["primer JH14", "DNA", 300, 311], ["primer JH28", "DNA", 326, 337], ["five separate 'primer pair mixes'", "TREATMENT", 6, 39], ["primer JH1", "TREATMENT", 86, 96], ["primer JH2", "TREATMENT", 111, 121], ["primer JH3", "TREATMENT", 138, 148], ["primer JH4", "TREATMENT", 163, 173], ["primer JH5", "TREATMENT", 191, 201], ["primer JH6", "TREATMENT", 216, 226], ["primer JH16", "TREATMENT", 243, 254], ["primer JH24", "TREATMENT", 269, 280], ["primer JH14", "TREATMENT", 300, 311], ["primer JH28", "TREATMENT", 326, 337], ["first round PCR amplification", "TREATMENT", 357, 386]]], ["Each of these primer pair mixes (0.4 ml) was then added to their respective second round supermix aliquot and the resulting 'complete mixes' overlaid with sterile mineral oil.", [["these primer pair mixes", "TREATMENT", 8, 31], ["their respective second round supermix aliquot", "TREATMENT", 59, 105], ["the resulting 'complete mixes'", "TREATMENT", 110, 140], ["sterile mineral oil", "TREATMENT", 155, 174]]], ["A 1:10 (v/v) dilution of the first round amplification products was then prepared in sterile UHQ water and 5 ml of the resultant PCR product dilution added to each of its five respective complete second round reaction mixes.", [["A 1:10 (v/v) dilution", "TREATMENT", 0, 21], ["the first round amplification products", "TREATMENT", 25, 63], ["sterile UHQ water", "TREATMENT", 85, 102], ["the resultant PCR product dilution", "TREATMENT", 115, 149], ["round", "OBSERVATION_MODIFIER", 203, 208], ["reaction mixes", "OBSERVATION", 209, 223]]], ["Round 2 PCR reaction mixes were then transferred to a pre-heated (95\u00b0C) Trioblock thermocycler and subjected to a 'hot start' and 'touchdown' PCR protocol as already described for the first round.", [["Trioblock thermocycler", "TREATMENT", 72, 94], ["'touchdown' PCR protocol", "TREATMENT", 130, 154]]], ["After completion of this second round PCR cycling regime, PCR products were cooled to 4\u00b0C and amplified PCR products observed by gel electrophoresis and ethidium bromide staining.", [["ethidium bromide", "CHEMICAL", 153, 169], ["ethidium bromide", "CHEMICAL", 153, 169], ["C", "GENE_OR_GENE_PRODUCT", 88, 89], ["ethidium bromide", "SIMPLE_CHEMICAL", 153, 169], ["PCR products", "DNA", 58, 70], ["this second round PCR cycling regime", "TREATMENT", 20, 56], ["PCR products", "TREATMENT", 58, 70], ["C and amplified PCR products", "TREATMENT", 88, 116], ["gel electrophoresis", "TEST", 129, 148], ["ethidium bromide staining", "TREATMENT", 153, 178]]], ["Fig. 1 indicates schematically the region of the human coronavirus 229E spike gene amplified by this reverse transcription and nested PCR protocol.Cycle sequencing protocolHuman coronavirus 229E spike gene PCR product sequencing was undertaken using the PRISM\u2122 di-deoxy terminator cycle sequencing kit (Applied Biosystems, Foster City, USA).", [["human", "ORGANISM", 49, 54], ["coronavirus 229E", "ORGANISM", 55, 71], ["human coronavirus 229E spike gene", "DNA", 49, 82], ["human", "SPECIES", 49, 54], ["coronavirus", "SPECIES", 55, 66], ["coronavirus", "SPECIES", 178, 189], ["human coronavirus", "SPECIES", 49, 66], ["protocolHuman coronavirus", "SPECIES", 164, 189], ["the human coronavirus", "PROBLEM", 45, 66], ["nested PCR protocol", "TEST", 127, 146], ["Cycle sequencing protocolHuman coronavirus", "TEST", 147, 189], ["PCR product sequencing", "TEST", 206, 228], ["the PRISM\u2122 di-deoxy terminator cycle", "TREATMENT", 250, 286]]], ["Sequencing of both the sense and antisense strands of the human coronavirus 229E spike gene PCR DNA was undertaken, with some sequencing primers being used more than once to increase the accuracy of generated sequence data at a particular locus.Cleaning second round PCR productsPrior to sequencing, amplified human coronavirus 229E PCR products were cleaned using 'Qiaquick' spin columns as detailed by the manufacturer (Qiagen, Hilden, Germany).Cycle sequencingEach individual cycle sequencing mix contained 8 ml of pre-prepared dye-terminator mix, 0.05 -0.1 mg cleaned human coronavirus 229E second round PCR product, 3.2 pmol of the relevant sequencing primer and the correct volume of UHQ water to make a total cycle sequencing reaction mix volume of 20 ml.", [["human", "ORGANISM", 58, 63], ["coronavirus 229E", "ORGANISM", 64, 80], ["DNA", "CELLULAR_COMPONENT", 96, 99], ["human", "ORGANISM", 310, 315], ["coronavirus", "ORGANISM", 316, 327], ["human", "ORGANISM", 572, 577], ["coronavirus", "ORGANISM", 578, 589], ["human coronavirus 229E spike gene PCR DNA", "DNA", 58, 99], ["PCR products", "DNA", 267, 279], ["amplified human coronavirus 229E PCR products", "DNA", 300, 345], ["human", "SPECIES", 58, 63], ["coronavirus", "SPECIES", 64, 75], ["human", "SPECIES", 310, 315], ["coronavirus", "SPECIES", 316, 327], ["human", "SPECIES", 572, 577], ["coronavirus", "SPECIES", 578, 589], ["human coronavirus", "SPECIES", 58, 75], ["human coronavirus", "SPECIES", 310, 327], ["human coronavirus", "SPECIES", 572, 589], ["the human coronavirus", "TEST", 54, 75], ["PCR DNA", "TEST", 92, 99], ["some sequencing primers", "TREATMENT", 121, 144], ["Cleaning second round PCR products", "TREATMENT", 245, 279], ["sequencing", "TEST", 288, 298], ["amplified human coronavirus 229E PCR products", "TREATMENT", 300, 345], ["'Qiaquick' spin columns", "TREATMENT", 365, 388], ["Cycle sequencing", "TEST", 447, 463], ["pre-prepared dye-terminator mix", "TREATMENT", 518, 549], ["human coronavirus", "TEST", 572, 589], ["the relevant sequencing primer", "TREATMENT", 633, 663], ["the correct volume of UHQ water", "TREATMENT", 668, 699], ["a total cycle sequencing reaction mix volume", "TREATMENT", 708, 752]]], ["Once prepared, the cycle sequencing mix was overlaid with mineral oil and placed in a pre-heated (96\u00b0C) Trioblock thermocycler.", [["oil", "ANATOMY", 66, 69], ["the cycle sequencing mix", "TREATMENT", 15, 39], ["mineral oil", "TREATMENT", 58, 69], ["Trioblock thermocycler", "TREATMENT", 104, 126]]], ["A cycle sequencing temperature regime was then undertaken with 25 cycles of 96\u00b0C for 10 s, thermal ramp to 50\u00b0C in 64 s for 5 s, thermal ramp to 55\u00b0C in 30 s for 241 s, then thermal ramp to 94\u00b0C in 54 s, followed by cooling to 4\u00b0C.Cleaning cycle sequencing productsThe removal of unincorporated nucleotides and enzymes from cycle sequencing products was achieved using a standard phenol/chloroform/isoamyl alcohol extraction and sodium acetate (pH 4.5)/ethanol precipitation methodology.Assimilation of sequence data and generation of consensus sequencesCleaned cycle sequencing products were run on an ABI 373 DNA sequencer (Applied Biosystems, Foster City, USA).", [["phenol/chloroform/isoamyl alcohol", "CHEMICAL", 380, 413], ["sodium acetate", "CHEMICAL", 429, 443], ["ethanol", "CHEMICAL", 453, 460], ["nucleotides", "CHEMICAL", 295, 306], ["phenol", "CHEMICAL", 380, 386], ["chloroform", "CHEMICAL", 387, 397], ["isoamyl alcohol", "CHEMICAL", 398, 413], ["sodium acetate", "CHEMICAL", 429, 443], ["ethanol", "CHEMICAL", 453, 460], ["phenol", "SIMPLE_CHEMICAL", 380, 386], ["chloroform", "SIMPLE_CHEMICAL", 387, 397], ["isoamyl alcohol", "SIMPLE_CHEMICAL", 398, 413], ["sodium acetate", "SIMPLE_CHEMICAL", 429, 443], ["ethanol", "SIMPLE_CHEMICAL", 453, 460], ["DNA", "CELLULAR_COMPONENT", 611, 614], ["enzymes", "PROTEIN", 311, 318], ["consensus sequences", "DNA", 535, 554], ["A cycle sequencing temperature regime", "TREATMENT", 0, 37], ["thermal ramp", "TEST", 91, 103], ["thermal ramp", "TEST", 129, 141], ["thermal ramp", "TEST", 174, 186], ["Cleaning cycle sequencing products", "TREATMENT", 231, 265], ["The removal of unincorporated nucleotides", "TREATMENT", 265, 306], ["enzymes", "TEST", 311, 318], ["cycle sequencing products", "TREATMENT", 324, 349], ["a standard phenol/chloroform", "TREATMENT", 369, 397], ["isoamyl alcohol extraction", "TREATMENT", 398, 424], ["sodium acetate", "TREATMENT", 429, 443], ["pH", "TEST", 445, 447], ["ethanol precipitation methodology", "TREATMENT", 453, 486], ["sequence data", "TEST", 503, 516], ["consensus sequences", "TEST", 535, 554], ["Cleaned cycle sequencing products", "TREATMENT", 554, 587], ["an ABI", "TEST", 600, 606], ["DNA sequencer", "TEST", 611, 624]]], ["Resultant chromatograms were examined using Sequence Editor\u2122 software (Applied Biosystems) and a library of text only sequences generated.", [["Resultant chromatograms", "TEST", 0, 23]]], ["Each individual human coronavirus 229E spike gene library was then assembled using AutoAssembler\u2122 software (Applied Biosystems) to generate a human coronavirus 229E spike gene consensus sequence for that particular human coronavirus 229E isolate.ResultsIn total, 33 sequencing primers were designed and used to sequence approximately 90% of the spike genes of human coronavirus 229E isolates ATCC VR-74, LRI 281 and A162 (when compared to the published human coronavirus 229E 'LP' spike gene sequence Raabe et al., 1990) .", [["human", "ORGANISM", 16, 21], ["coronavirus", "ORGANISM", 22, 33], ["human", "ORGANISM", 142, 147], ["human", "ORGANISM", 215, 220], ["coronavirus 229E", "ORGANISM", 221, 237], ["human", "ORGANISM", 360, 365], ["coronavirus 229E isolates ATCC VR-74", "ORGANISM", 366, 402], ["LRI 281", "CELL", 404, 411], ["human", "ORGANISM", 453, 458], ["human coronavirus 229E spike gene library", "DNA", 16, 57], ["human coronavirus 229E spike gene consensus sequence", "DNA", 142, 194], ["spike genes", "DNA", 345, 356], ["human coronavirus 229E 'LP' spike gene sequence", "DNA", 453, 500], ["human", "SPECIES", 16, 21], ["coronavirus", "SPECIES", 22, 33], ["human", "SPECIES", 142, 147], ["coronavirus", "SPECIES", 148, 159], ["human", "SPECIES", 215, 220], ["coronavirus", "SPECIES", 221, 232], ["human", "SPECIES", 360, 365], ["coronavirus", "SPECIES", 366, 377], ["human", "SPECIES", 453, 458], ["human coronavirus", "SPECIES", 16, 33], ["human coronavirus", "SPECIES", 142, 159], ["human coronavirus", "SPECIES", 215, 232], ["human coronavirus", "SPECIES", 360, 377], ["ATCC VR-74", "SPECIES", 392, 402], ["human coronavirus", "SPECIES", 453, 470], ["Each individual human coronavirus", "PROBLEM", 0, 33], ["a human coronavirus", "PROBLEM", 140, 159], ["sequencing primers", "TEST", 266, 284], ["human coronavirus", "TEST", 360, 377], ["ATCC VR", "TEST", 392, 399], ["LRI", "TEST", 404, 407]]], ["Six of these 33 sequencing primers (i.e. JH1, JH2, JH3, JH4, JH5 and JH6) were also used in the initial human coronavirus 229E spike gene PCR protocol, whilst the remaining 27 primers were used as sequencing primers alone.", [["JH4", "GENE_OR_GENE_PRODUCT", 56, 59], ["JH5", "GENE_OR_GENE_PRODUCT", 61, 64], ["JH6", "GENE_OR_GENE_PRODUCT", 69, 72], ["human", "ORGANISM", 104, 109], ["JH1", "DNA", 41, 44], ["JH2", "DNA", 46, 49], ["JH3", "DNA", 51, 54], ["JH4", "DNA", 56, 59], ["JH5", "DNA", 61, 64], ["JH6", "DNA", 69, 72], ["human", "SPECIES", 104, 109], ["human coronavirus", "SPECIES", 104, 121], ["these 33 sequencing primers", "TEST", 7, 34], ["JH1", "TEST", 41, 44], ["JH2", "TEST", 46, 49], ["JH3", "TEST", 51, 54], ["JH4", "TEST", 56, 59], ["PCR protocol", "TEST", 138, 150], ["the remaining 27 primers", "TREATMENT", 159, 183], ["sequencing primers", "TEST", 197, 215]]], ["Sequence data was collected from both the sense and antisense strands of human coronavirus 229E spike gene PCR products.Human corona6irus 229E strain ATCC VR-74Forty one individual primer sequences were used to construct a human coronavirus 229E strain ATCC VR-74 consensus sequence (Au-toAssembler software) comprising 3122 nucleotides.", [["nucleotides", "CHEMICAL", 325, 336], ["human", "ORGANISM", 73, 78], ["Human", "ORGANISM", 120, 125], ["VR-74Forty", "CELL", 155, 165], ["human", "ORGANISM", 223, 228], ["human coronavirus 229E spike gene PCR products", "DNA", 73, 119], ["Human corona6irus 229E strain ATCC VR-74Forty one individual primer sequences", "DNA", 120, 197], ["human coronavirus 229E strain ATCC VR-74 consensus sequence", "DNA", 223, 282], ["human", "SPECIES", 73, 78], ["coronavirus", "SPECIES", 79, 90], ["Human", "SPECIES", 120, 125], ["human", "SPECIES", 223, 228], ["coronavirus", "SPECIES", 229, 240], ["human coronavirus", "SPECIES", 73, 90], ["Human corona6irus 229E strain ATCC VR-74Forty", "SPECIES", 120, 165], ["human coronavirus", "SPECIES", 223, 240], ["ATCC VR-74", "SPECIES", 253, 263], ["Sequence data", "TEST", 0, 13], ["human coronavirus", "TEST", 73, 90], ["gene PCR products", "TREATMENT", 102, 119], ["Human corona6irus", "TEST", 120, 137], ["ATCC VR", "TEST", 150, 157], ["a human coronavirus", "TEST", 221, 240], ["ATCC VR", "TEST", 253, 260], ["consensus sequence", "TEST", 264, 282], ["nucleotides", "TEST", 325, 336]]], ["This 3122-nucleotide consensus sequence was assembled from a total library of 13 021 individual nucleotides.", [["nucleotides", "CHEMICAL", 96, 107], ["3122-nucleotide consensus sequence", "DNA", 5, 39], ["nucleotide consensus sequence", "TEST", 10, 39], ["a total library", "TEST", 59, 74]]], ["Forty nine of these 13 021 nucleotides were deemed to have been included via mis-incorporation errors by the Thermus icelandicus and MMLV reverse transcriptase enzymes (mis-incorporation errors deemed to have occurred when the nucleotide at a particular locus within the total spike gene assemblage differed from that of the same locus in the spike gene consensus sequence and where this nucleotide difference occurred in either the sense or antisense strand only).", [["nucleotide", "CHEMICAL", 227, 237], ["nucleotide", "CHEMICAL", 388, 398], ["nucleotides", "CHEMICAL", 27, 38], ["nucleotide", "CHEMICAL", 227, 237], ["nucleotide", "CHEMICAL", 388, 398], ["Thermus icelandicus", "ORGANISM", 109, 128], ["MMLV reverse transcriptase enzymes", "GENE_OR_GENE_PRODUCT", 133, 167], ["Thermus icelandicus and MMLV reverse transcriptase enzymes", "PROTEIN", 109, 167], ["total spike gene assemblage", "DNA", 271, 298], ["spike gene consensus sequence", "DNA", 343, 372], ["Thermus icelandicus", "SPECIES", 109, 128], ["Thermus icelandicus", "SPECIES", 109, 128], ["nucleotides", "TREATMENT", 27, 38], ["transcriptase enzymes", "TEST", 146, 167], ["incorporation errors", "PROBLEM", 173, 193], ["the nucleotide", "PROBLEM", 223, 237], ["the total spike gene assemblage", "PROBLEM", 267, 298], ["this nucleotide difference", "PROBLEM", 383, 409]]], ["Similarly, 24 nucleotides within the 13 021 total nucleotide assemblage were deemed to contain nucleotide additions and 16 loci nucleotide deletions (data not shown).", [["nucleotide", "CHEMICAL", 50, 60], ["nucleotide", "CHEMICAL", 95, 105], ["nucleotides", "CHEMICAL", 14, 25], ["nucleotide", "CHEMICAL", 50, 60], ["nucleotide", "CHEMICAL", 95, 105], ["nucleotide", "CHEMICAL", 128, 138], ["13 021 total nucleotide assemblage", "DNA", 37, 71], ["16 loci nucleotide deletions", "DNA", 120, 148], ["nucleotides", "TEST", 14, 25], ["total nucleotide assemblage", "TREATMENT", 44, 71], ["nucleotide additions", "TREATMENT", 95, 115], ["16 loci nucleotide deletions", "PROBLEM", 120, 148]]], ["From this data an overall mis-incorporation rate for the human coronavirus 229E reverse transcription nested spike gene PCR of 0.7% was calculated.", [["human", "ORGANISM", 57, 62], ["human coronavirus 229E reverse transcription nested spike gene", "DNA", 57, 119], ["human", "SPECIES", 57, 62], ["coronavirus", "SPECIES", 63, 74], ["human coronavirus", "SPECIES", 57, 74], ["the human coronavirus", "TREATMENT", 53, 74], ["gene PCR", "TEST", 115, 123]]], ["Fig. 2 . shows the amino acid sequence obtained upon translation of the human coronavirus 229E strain ATCC VR-74 spike gene consensus sequence.Human corona6irus 229E LRI 281Forty six individual primer sequences were employed to construct a human coronavirus 229E LRI S gene 281 consensus sequence.", [["amino acid", "CHEMICAL", 19, 29], ["amino acid", "CHEMICAL", 19, 29], ["amino acid", "AMINO_ACID", 19, 29], ["human", "ORGANISM", 72, 77], ["coronavirus 229E", "ORGANISM", 78, 94], ["VR-74", "GENE_OR_GENE_PRODUCT", 107, 112], ["Human", "ORGANISM", 143, 148], ["human", "ORGANISM", 240, 245], ["human coronavirus 229E strain ATCC VR-74 spike gene consensus sequence", "DNA", 72, 142], ["primer sequences", "DNA", 194, 210], ["human coronavirus 229E LRI S gene 281 consensus sequence", "DNA", 240, 296], ["human", "SPECIES", 72, 77], ["coronavirus", "SPECIES", 78, 89], ["Human", "SPECIES", 143, 148], ["human", "SPECIES", 240, 245], ["coronavirus", "SPECIES", 246, 257], ["human coronavirus", "SPECIES", 72, 89], ["ATCC VR-74", "SPECIES", 102, 112], ["Human corona6irus 229E LRI 281", "SPECIES", 143, 173], ["human coronavirus", "SPECIES", 240, 257], ["the amino acid sequence", "TEST", 15, 38], ["the human coronavirus", "TEST", 68, 89], ["ATCC VR", "TEST", 102, 109], ["spike gene consensus sequence", "PROBLEM", 113, 142], ["Human corona6irus", "TEST", 143, 160], ["LRI", "TEST", 166, 169], ["a human coronavirus", "TEST", 238, 257]]], ["A different number of primers were used for this strain because the read length from individual sequences varied with some reactions not generating the required number of bases.", [["A different number of primers", "TREATMENT", 0, 29], ["this strain", "PROBLEM", 44, 55], ["individual sequences", "TEST", 85, 105], ["some reactions", "PROBLEM", 118, 132], ["bases", "ANATOMY_MODIFIER", 171, 176]]], ["Comparison of the predicted amino acid sequence for he spike proteins of several human coronaviruses 229E.", [["amino acid", "CHEMICAL", 28, 38], ["amino acid", "CHEMICAL", 28, 38], ["amino acid", "AMINO_ACID", 28, 38], ["human", "ORGANISM", 81, 86], ["coronaviruses 229E", "ORGANISM", 87, 105], ["spike proteins", "PROTEIN", 55, 69], ["human coronaviruses 229E", "PROTEIN", 81, 105], ["human", "SPECIES", 81, 86], ["human coronaviruses", "SPECIES", 81, 100], ["the predicted amino acid sequence", "TEST", 14, 47], ["several human coronaviruses", "PROBLEM", 73, 100]]], ["LP, human coronavirus 229E isolate LP (Raabe et al., 1990) ; ATCC VR-74, human coronavirus 229E ATCC VR-74 (EMBL Accession No.", [["human", "ORGANISM", 4, 9], ["coronavirus 229E", "ORGANISM", 10, 26], ["ATCC VR-74", "ORGANISM", 61, 71], ["human", "ORGANISM", 73, 78], ["coronavirus 229E ATCC VR-74", "ORGANISM", 79, 106], ["human coronavirus 229E ATCC VR-74", "DNA", 73, 106], ["human", "SPECIES", 4, 9], ["coronavirus", "SPECIES", 10, 21], ["human", "SPECIES", 73, 78], ["coronavirus", "SPECIES", 79, 90], ["human coronavirus", "SPECIES", 4, 21], ["ATCC VR-74", "SPECIES", 61, 71], ["human coronavirus 229E ATCC VR-74", "SPECIES", 73, 106], ["LP", "TEST", 0, 2], ["human coronavirus", "TEST", 4, 21], ["LP", "TEST", 35, 37], ["ATCC VR", "TEST", 61, 68], ["human coronavirus", "TEST", 73, 90], ["ATCC VR", "TEST", 96, 103]]], ["Y09923); LRI 281, human coronavirus 229E isolate LRI 281 (EMBL Accession No.", [["Y09923", "CHEMICAL", 0, 6], ["human", "ORGANISM", 18, 23], ["coronavirus 229E", "ORGANISM", 24, 40], ["human", "SPECIES", 18, 23], ["coronavirus", "SPECIES", 24, 35], ["human coronavirus", "SPECIES", 18, 35], ["LRI", "TEST", 9, 12], ["human coronavirus", "TEST", 18, 35], ["LRI", "TEST", 49, 52]]], ["Y10052); A162, human coronavirus 229E isolate A162 (EMBL Accession No.", [["Y10052", "CHEMICAL", 0, 6], ["Y10052", "SIMPLE_CHEMICAL", 0, 6], ["human", "ORGANISM", 15, 20], ["coronavirus 229E", "ORGANISM", 21, 37], ["human", "SPECIES", 15, 20], ["coronavirus", "SPECIES", 21, 32], ["human coronavirus 229E isolate A162", "SPECIES", 15, 50], ["human coronavirus", "TEST", 15, 32]]], ["Y10051); \u00b7 \u00b7 \u00b7 , regions of homology between translated spike protein sequences; *, spike protein loci with an absence of conservation; }{, spike gene region sequences.Human Corona6irus 229E A162Forty one individual primer sequences were employed to construct a human coronavirus 229E A162 consensus sequence some 3046 nucleotides in length.", [["Y10051", "CHEMICAL", 0, 6], ["Y10051", "CHEMICAL", 0, 6], ["nucleotides", "CHEMICAL", 319, 330], ["Y10051", "SIMPLE_CHEMICAL", 0, 6], ["Human", "ORGANISM", 168, 173], ["human", "ORGANISM", 262, 267], ["spike protein sequences", "DNA", 56, 79], ["spike protein loci", "DNA", 84, 102], ["spike gene region sequences", "DNA", 140, 167], ["Human Corona6irus 229E A162Forty", "DNA", 168, 200], ["primer sequences", "DNA", 216, 232], ["human coronavirus 229E A162 consensus sequence", "DNA", 262, 308], ["Human", "SPECIES", 168, 173], ["human", "SPECIES", 262, 267], ["coronavirus", "SPECIES", 268, 279], ["Human Corona6irus 229E A162Forty", "SPECIES", 168, 200], ["human coronavirus 229E A162", "SPECIES", 262, 289], ["spike protein sequences", "TEST", 56, 79], ["spike protein loci", "PROBLEM", 84, 102], ["spike gene region sequences", "PROBLEM", 140, 167], ["Human Corona6irus", "TEST", 168, 185], ["a human coronavirus", "TEST", 260, 279]]], ["This 3046 nucleotide consensus sequence was constructed from 13 974 individual nucleotides.", [["nucleotide", "CHEMICAL", 10, 20], ["nucleotide", "CHEMICAL", 10, 20], ["nucleotides", "CHEMICAL", 79, 90], ["3046 nucleotide consensus sequence", "DNA", 5, 39], ["nucleotide consensus sequence", "TEST", 10, 39]]], ["Mis-incorporation errors were deemed to have occurred at 31 positions within this 13 974 total nucleotide assemblage, with 21 positions deemed to contain nucleotide additions and 36 positions nucleotide deletions (data not shown).", [["nucleotide", "CHEMICAL", 95, 105], ["nucleotide", "CHEMICAL", 154, 164], ["nucleotide", "CHEMICAL", 95, 105], ["nucleotide", "CHEMICAL", 154, 164], ["nucleotide", "CHEMICAL", 192, 202], ["13 974 total nucleotide assemblage", "DNA", 82, 116], ["Mis-incorporation errors", "PROBLEM", 0, 24], ["total nucleotide assemblage", "TREATMENT", 89, 116], ["nucleotide additions", "TREATMENT", 154, 174], ["36 positions nucleotide deletions", "PROBLEM", 179, 212]]], ["Fig. 2. shows the amino acid sequence obtained upon translation of the human coronavirus 229E A162 spike gene consensus sequence.Human Corona6irus 229E A162During the sequencing of the human coronavirus 229E A162 spike gene it was found that sequence data could not be obtained from three of the 33 sequencing primers used successfully in the human coronavirus 229E strain ATCC VR-74 and human coronavirus 229E LRI 281 spike gene sequencing protocols.", [["amino acid", "CHEMICAL", 18, 28], ["amino acid", "CHEMICAL", 18, 28], ["amino acid", "AMINO_ACID", 18, 28], ["human", "ORGANISM", 71, 76], ["A162", "GENE_OR_GENE_PRODUCT", 94, 98], ["Human", "ORGANISM", 129, 134], ["Corona6irus 229E A162During", "ORGANISM", 135, 162], ["human", "ORGANISM", 185, 190], ["coronavirus 229E", "ORGANISM", 191, 207], ["A162", "GENE_OR_GENE_PRODUCT", 208, 212], ["human", "ORGANISM", 343, 348], ["coronavirus 229E", "ORGANISM", 349, 365], ["ATCC VR-74", "ORGANISM", 373, 383], ["human", "ORGANISM", 388, 393], ["human coronavirus 229E A162 spike gene consensus sequence", "DNA", 71, 128], ["Human Corona6irus 229E A162During", "DNA", 129, 162], ["human coronavirus 229E A162 spike gene", "DNA", 185, 223], ["human coronavirus 229E strain ATCC VR-74", "DNA", 343, 383], ["human coronavirus 229E LRI 281 spike gene", "DNA", 388, 429], ["human", "SPECIES", 71, 76], ["coronavirus", "SPECIES", 77, 88], ["Human", "SPECIES", 129, 134], ["human", "SPECIES", 185, 190], ["coronavirus", "SPECIES", 191, 202], ["human", "SPECIES", 343, 348], ["coronavirus", "SPECIES", 349, 360], ["human", "SPECIES", 388, 393], ["coronavirus", "SPECIES", 394, 405], ["human coronavirus", "SPECIES", 71, 88], ["Human Corona6irus 229E A162During", "SPECIES", 129, 162], ["human coronavirus", "SPECIES", 185, 202], ["human coronavirus", "SPECIES", 343, 360], ["ATCC VR-74", "SPECIES", 373, 383], ["human coronavirus", "SPECIES", 388, 405], ["the amino acid sequence", "TEST", 14, 37], ["the human coronavirus", "TEST", 67, 88], ["Human Corona6irus", "TEST", 129, 146], ["the human coronavirus", "TEST", 181, 202], ["sequence data", "TEST", 242, 255], ["sequencing primers", "TEST", 299, 317], ["the human coronavirus", "TEST", 339, 360], ["ATCC VR", "TEST", 373, 380], ["human coronavirus", "TEST", 388, 405], ["LRI", "TEST", 411, 414], ["spike gene sequencing protocols", "TREATMENT", 419, 450]]], ["Upon assembly of the human coronavirus 229E A162 spike gene consensus sequence, however, it was determined that nucleotide differences within the human coronavirus 229E A162 spike gene consensus sequence (as compared to the spike gene consensus sequences of human coronavirus 229E strain ATCC VR-74 and human coronavirus 229E LRI 281) may have affected the primer binding sites for these particular sequencing primers.", [["nucleotide", "CHEMICAL", 112, 122], ["nucleotide", "CHEMICAL", 112, 122], ["human", "ORGANISM", 21, 26], ["coronavirus 229E", "ORGANISM", 27, 43], ["A162", "GENE_OR_GENE_PRODUCT", 44, 48], ["human", "ORGANISM", 146, 151], ["coronavirus 229E", "ORGANISM", 152, 168], ["A162", "GENE_OR_GENE_PRODUCT", 169, 173], ["human", "ORGANISM", 258, 263], ["coronavirus 229E strain ATCC VR-74", "ORGANISM", 264, 298], ["human coronavirus 229E LRI 281", "ORGANISM", 303, 333], ["human coronavirus 229E A162 spike gene consensus sequence", "DNA", 21, 78], ["human coronavirus 229E A162 spike gene consensus sequence", "DNA", 146, 203], ["spike gene consensus sequences", "DNA", 224, 254], ["primer binding sites", "DNA", 357, 377], ["human", "SPECIES", 21, 26], ["coronavirus", "SPECIES", 27, 38], ["human", "SPECIES", 146, 151], ["coronavirus", "SPECIES", 152, 163], ["human", "SPECIES", 258, 263], ["coronavirus", "SPECIES", 264, 275], ["human", "SPECIES", 303, 308], ["coronavirus", "SPECIES", 309, 320], ["human coronavirus", "SPECIES", 21, 38], ["human coronavirus", "SPECIES", 146, 163], ["human coronavirus", "SPECIES", 258, 275], ["ATCC VR-74", "SPECIES", 288, 298], ["human coronavirus 229E LRI 281", "SPECIES", 303, 333], ["the human coronavirus", "TEST", 17, 38], ["nucleotide differences", "PROBLEM", 112, 134], ["the human coronavirus", "TEST", 142, 163], ["spike gene consensus sequence", "PROBLEM", 174, 203], ["human coronavirus", "TEST", 258, 275], ["ATCC VR", "TEST", 288, 295], ["human coronavirus", "TEST", 303, 320], ["the primer binding sites", "PROBLEM", 353, 377], ["these particular sequencing primers", "TREATMENT", 382, 417]]], ["Fig. 3 shows the effect of human coronavirus 229E A162 spike gene sequence changes on the primer binding capacity of these three failed sequencing primers.DiscussionIn this study touchdown PCR methodology was used due to the fact that sequentially decreasing the annealing temperature (from a preset maxi-mum to a preset minimum) allows PCR amplification reactions to be attempted using a wide range of PCR primers even if these primers are somewhat mis-matched with regard to their predicted annealing temperatures (Roux, 1994) .", [["human", "ORGANISM", 27, 32], ["human coronavirus 229E A162 spike gene sequence", "DNA", 27, 74], ["PCR primers", "DNA", 403, 414], ["human", "SPECIES", 27, 32], ["human coronavirus", "SPECIES", 27, 44], ["human coronavirus", "PROBLEM", 27, 44], ["gene sequence changes", "PROBLEM", 61, 82], ["sequencing primers", "TREATMENT", 136, 154], ["this study touchdown PCR methodology", "TEST", 168, 204], ["the annealing temperature", "PROBLEM", 259, 284], ["a preset maxi-mum", "TREATMENT", 291, 308], ["PCR amplification reactions", "PROBLEM", 337, 364], ["a wide range of PCR primers", "TREATMENT", 387, 414], ["these primers", "PROBLEM", 423, 436]]], ["Also, it was envisaged that the use of a touchdown PCR methodology would help to circumvent any nonspecific priming (Don et al., 1991) ; this was considered particularly important because the human coronavirus 229E spike gene PCR primer design protocol utilised limited the number of possible primer sequences available for spike gene amplification.", [["human", "ORGANISM", 192, 197], ["coronavirus 229E", "ORGANISM", 198, 214], ["primer sequences", "DNA", 293, 309], ["human", "SPECIES", 192, 197], ["coronavirus", "SPECIES", 198, 209], ["human coronavirus", "SPECIES", 192, 209], ["a touchdown PCR methodology", "TREATMENT", 39, 66], ["any nonspecific priming", "PROBLEM", 92, 115], ["the human coronavirus", "PROBLEM", 188, 209], ["PCR primer design protocol", "TEST", 226, 252], ["primer sequences", "TEST", 293, 309], ["spike gene amplification", "PROBLEM", 324, 348]]], ["Touchdown PCR methodology did not inhibit, however, the production of extraneous PCR products during the first round of the human coronavirus 229E spike gene PCR.", [["human", "ORGANISM", 124, 129], ["human coronavirus 229E spike gene PCR", "DNA", 124, 161], ["human", "SPECIES", 124, 129], ["coronavirus", "SPECIES", 130, 141], ["human coronavirus", "SPECIES", 124, 141], ["Touchdown PCR methodology", "TEST", 0, 25], ["extraneous PCR products", "TREATMENT", 70, 93], ["the human coronavirus", "TEST", 120, 141], ["gene PCR", "TEST", 153, 161]]], ["In effect, this meant that a nested PCR methodology had to be employed.DiscussionExtraneous first round PCR products were produced in such quantities that after addition of 'neat' first round PCR product to second round reaction mixes and subsequent second round PCR cycling, the extraneous first round PCR products could still be detected in the background of second round PCR products.", [["a nested PCR methodology", "TREATMENT", 27, 51], ["Extraneous first round PCR products", "TREATMENT", 81, 116], ["'neat' first round PCR product", "TREATMENT", 173, 203], ["second round reaction mixes", "TREATMENT", 207, 234], ["subsequent second round PCR cycling", "TREATMENT", 239, 274], ["the extraneous first round PCR products", "PROBLEM", 276, 315], ["second round PCR products", "TREATMENT", 361, 386], ["round", "OBSERVATION_MODIFIER", 368, 373], ["PCR products", "OBSERVATION", 374, 386]]], ["More importantly, this background of extraneous first round PCR products tended to interfere with subsequent sequencing reactions, with the result that sequence data could not be obtained from second round PCR mixes to which neat first round PCR products had been added.", [["extraneous first round PCR products", "PROBLEM", 37, 72], ["subsequent sequencing reactions", "PROBLEM", 98, 129], ["sequence data", "TEST", 152, 165], ["second round PCR mixes", "TREATMENT", 193, 215], ["neat first round PCR products", "TREATMENT", 225, 254]]], ["By diluting the first round PCR products 1:10 (v/v) in sterile UHQ water, this problem was overcome and sequence data could be readily obtained.DiscussionAn automated sequencing methodology was chosen over manual methods due to the relatively large number of sequencing reactions required to generate human coronavirus 229E spike gene consensus sequences and the relatively high throughput rates achievable with automated sequencing.DiscussionThe use of automated dye-terminator sequencing chemistry per se was favoured over the use of automated dye-primer sequencing chemistry due to the fact that: (a) unadulterated PCR (or sequencing) primers can be utilised in dye-terminator automated sequencing chemistry without the need to label the primers with fluorescent dye tags (greatly reducing costs); (b) dye-terminator sequencing reactions are carried out in a single tube whilst dye-primer sequencing reactions are carried out in four separate reaction tubes (again reducing sequencing costs); (c) false termination products are not detected using dye-terminator chemistry as a labelled dye-terminator must be incorporated into the DNA chain in order for the DNA to be detected; and (d) dye-terminator sequencing chemistry requires lower concentrations of template DNA allowing several sets of sequence data to be generated with several different sequencing primers from a single human coronavirus 229E PCR reaction (DNA Sequencing: Chemistry Guide, 1995) .DiscussionAutomated dye-terminator sequencing does however have its drawbacks.", [["human", "ORGANISM", 301, 306], ["coronavirus 229E", "ORGANISM", 307, 323], ["tube", "TISSUE", 869, 873], ["DNA", "CELLULAR_COMPONENT", 1134, 1137], ["DNA", "CELLULAR_COMPONENT", 1161, 1164], ["DNA", "CELLULAR_COMPONENT", 1267, 1270], ["human", "ORGANISM", 1382, 1387], ["DNA", "CELLULAR_COMPONENT", 1419, 1422], ["human coronavirus 229E spike gene consensus sequences", "DNA", 301, 354], ["DNA chain", "PROTEIN", 1134, 1143], ["template DNA", "DNA", 1258, 1270], ["human", "SPECIES", 301, 306], ["human", "SPECIES", 1382, 1387], ["human coronavirus", "SPECIES", 301, 318], ["human coronavirus", "SPECIES", 1382, 1399], ["the first round PCR products", "TREATMENT", 12, 40], ["sterile UHQ water", "TREATMENT", 55, 72], ["sequence data", "TEST", 104, 117], ["manual methods", "TREATMENT", 206, 220], ["sequencing reactions", "PROBLEM", 259, 279], ["human coronavirus 229E spike gene consensus sequences", "PROBLEM", 301, 354], ["automated sequencing", "TEST", 412, 432], ["automated dye-primer sequencing chemistry", "TEST", 536, 577], ["a) unadulterated PCR", "PROBLEM", 601, 621], ["fluorescent dye tags", "PROBLEM", 754, 774], ["b) dye-terminator sequencing reactions", "TREATMENT", 802, 840], ["a single tube", "TREATMENT", 860, 873], ["dye-primer sequencing reactions", "PROBLEM", 881, 912], ["four separate reaction tubes", "TREATMENT", 932, 960], ["(c) false termination products", "PROBLEM", 996, 1026], ["a labelled dye-terminator", "TREATMENT", 1078, 1103], ["the DNA", "PROBLEM", 1157, 1164], ["lower concentrations of template DNA", "TREATMENT", 1234, 1270], ["sequence data", "TEST", 1296, 1309], ["several different sequencing primers", "PROBLEM", 1331, 1367], ["a single human coronavirus", "TEST", 1373, 1399], ["large", "OBSERVATION_MODIFIER", 243, 248], ["reaction tubes", "OBSERVATION", 946, 960]]], ["In particular, both a reduced sequencing accuracy rate (Naeve et al., 1995) and the generation of artifactual chromatogram peaks (Parker et al., 1995) have been associated with the use of such chemistry.", [["artifactual chromatogram peaks", "PROBLEM", 98, 128], ["such chemistry", "TREATMENT", 188, 202], ["reduced", "OBSERVATION_MODIFIER", 22, 29]]], ["Indeed, Parker et al. (1995) indicated that the use of automated dye-terminator sequencing chemistry resulted in chromatogram artifactual peaks whose presence was determined by the nucleotide sequence immediately 5% (i.e. downstream) to the artefact itself.", [["nucleotide", "CHEMICAL", 181, 191], ["nucleotide", "CHEMICAL", 181, 191], ["nucleotide sequence", "DNA", 181, 200], ["automated dye-terminator sequencing chemistry", "TEST", 55, 100], ["chromatogram artifactual peaks", "PROBLEM", 113, 143], ["the nucleotide sequence", "TEST", 177, 200]]], ["Interestingly, it was noted that the nucleotide sequences immediately 5% to chromatogram artefactual peaks in this project did not correspond with the 5% nucleotide sequences generating artefactual peaks indicated by Parker et al. (1995) (even though automated dye-terminator sequencing chemistry was utilised in both projects).", [["nucleotide", "CHEMICAL", 37, 47], ["nucleotide", "CHEMICAL", 154, 164], ["nucleotide", "CHEMICAL", 37, 47], ["nucleotide", "CHEMICAL", 154, 164], ["nucleotide sequences", "DNA", 37, 57], ["5% nucleotide sequences", "DNA", 151, 174], ["the nucleotide sequences", "TEST", 33, 57], ["chromatogram artefactual peaks", "TEST", 76, 106], ["the 5% nucleotide sequences", "TEST", 147, 174], ["artefactual peaks", "PROBLEM", 186, 203], ["automated dye-terminator sequencing chemistry", "TEST", 251, 296]]], ["This apparent discrepancy was brought about by the fact that Parker et al. utilised Amplitaq enzyme (Perkin Elmer) in their dye-terminator sequencing reactions, whereas in this project Amplitaq FS (FS, fluorescent sequencing) enzyme (Perkin Elmer) was utilised.", [["Perkin Elmer", "GENE_OR_GENE_PRODUCT", 101, 113], ["Amplitaq enzyme", "PROTEIN", 84, 99], ["enzyme", "PROTEIN", 226, 232], ["Amplitaq enzyme", "TEST", 84, 99], ["their dye-terminator sequencing reactions", "PROBLEM", 118, 159], ["FS", "TEST", 198, 200], ["fluorescent sequencing", "TEST", 202, 224], ["enzyme", "TEST", 226, 232], ["discrepancy", "OBSERVATION", 14, 25]]], ["The conclusion therefore being that the pattern of chromatogram artefactual peaks generated in dye-terminator sequencing chemistry reactions by these two enzymes is somewhat different.DiscussionTaking the comments made about the methodology into account, the results from the sequencing of the spike genes of the human coronavirus 229E isolates presented in this paper suggest that only minor spike protein variation exists between these chronologically and geographically distinct isolates.", [["human", "ORGANISM", 313, 318], ["coronavirus 229E isolates", "ORGANISM", 319, 344], ["enzymes", "PROTEIN", 154, 161], ["spike genes", "DNA", 294, 305], ["human", "SPECIES", 313, 318], ["coronavirus", "SPECIES", 319, 330], ["human coronavirus", "SPECIES", 313, 330], ["chromatogram artefactual peaks", "PROBLEM", 51, 81], ["dye-terminator sequencing chemistry reactions", "PROBLEM", 95, 140], ["these two enzymes", "TEST", 144, 161], ["the human coronavirus", "PROBLEM", 309, 330], ["minor spike protein variation", "PROBLEM", 387, 416], ["somewhat", "OBSERVATION_MODIFIER", 165, 173], ["different", "OBSERVATION_MODIFIER", 174, 183]]], ["This appears to contrast with another member of the same coronavirus serogroup as human coronaviruses 229E, canine coronavirus (Horsburgh and Brown, 1995) in which heterogeneity was distributed throughout the spike gene sequences of two geographically distinct (one British and one American) isolates.", [["canine coronavirus", "DISEASE", 108, 126], ["coronavirus serogroup", "ORGANISM", 57, 78], ["human coronaviruses 229E", "ORGANISM", 82, 106], ["canine coronavirus", "ORGANISM", 108, 126], ["spike gene sequences", "DNA", 209, 229], ["coronavirus", "SPECIES", 57, 68], ["human", "SPECIES", 82, 87], ["coronaviruses", "SPECIES", 88, 101], ["canine coronavirus", "SPECIES", 108, 126], ["human coronaviruses", "SPECIES", 82, 101], ["canine coronavirus", "SPECIES", 108, 126], ["human coronaviruses", "TEST", 82, 101]]], ["Also, a high degree of genome recombination events has been observed during mixed infections with different murine coronavirus strains (Lai et al., 1985) and different avian infectious bronchitis virus strains (Kusters et al., 1990) .", [["infections", "DISEASE", 82, 92], ["infectious bronchitis virus", "DISEASE", 174, 201], ["murine coronavirus", "ORGANISM", 108, 126], ["avian", "ORGANISM", 168, 173], ["infectious bronchitis virus", "ORGANISM", 174, 201], ["murine", "SPECIES", 108, 114], ["avian infectious bronchitis virus", "SPECIES", 168, 201], ["murine coronavirus", "SPECIES", 108, 126], ["infectious bronchitis virus", "SPECIES", 174, 201], ["genome recombination events", "PROBLEM", 23, 50], ["mixed infections", "PROBLEM", 76, 92], ["different murine coronavirus strains", "PROBLEM", 98, 134], ["different avian infectious bronchitis virus strains", "PROBLEM", 158, 209], ["high degree", "OBSERVATION_MODIFIER", 8, 19], ["genome recombination", "OBSERVATION", 23, 43], ["mixed", "OBSERVATION_MODIFIER", 76, 81], ["infections", "OBSERVATION", 82, 92], ["coronavirus strains", "OBSERVATION", 115, 134], ["infectious", "OBSERVATION_MODIFIER", 174, 184], ["bronchitis", "OBSERVATION", 185, 195]]], ["Moreover, there is evidence to suggest that in the absence of selection pressure these recombination events occur in a random manner .", [["selection pressure these recombination events", "PROBLEM", 62, 107]]], ["As only minor changes are seen in the translated spike protein sequences obtained in this project, it may be possible that during human coronavirus 229E infections selection pressure plays a dominant role in limiting the degree of spike gene variation (alternatively, multiple human coronavirus 229E infections may be a relatively rare event).DiscussionOne possible explanation for the degree of homology observed between the translated spike protein sequences of human coronavirus 229E 'LP' and human coronavirus 229E strain ATCC VR-74 relies upon the fact that both of these viruses were adapted to tissue culture by serial passaging.", [["tissue culture", "ANATOMY", 601, 615], ["infections", "DISEASE", 153, 163], ["infections", "DISEASE", 300, 310], ["human", "ORGANISM", 130, 135], ["coronavirus 229E", "ORGANISM", 136, 152], ["human", "ORGANISM", 277, 282], ["coronavirus 229E", "ORGANISM", 283, 299], ["human coronavirus 229E 'LP'", "ORGANISM", 464, 491], ["human coronavirus 229E strain ATCC VR-74", "ORGANISM", 496, 536], ["tissue culture", "CELL", 601, 615], ["translated spike protein sequences", "DNA", 38, 72], ["translated spike protein sequences", "PROTEIN", 426, 460], ["human", "SPECIES", 130, 135], ["coronavirus", "SPECIES", 136, 147], ["human", "SPECIES", 277, 282], ["human", "SPECIES", 464, 469], ["coronavirus", "SPECIES", 470, 481], ["human", "SPECIES", 496, 501], ["coronavirus", "SPECIES", 502, 513], ["human coronavirus", "SPECIES", 130, 147], ["human coronavirus", "SPECIES", 277, 294], ["human coronavirus", "SPECIES", 464, 481], ["human coronavirus 229E strain ATCC VR-74", "SPECIES", 496, 536], ["protein sequences", "TEST", 55, 72], ["human coronavirus 229E infections selection pressure", "TREATMENT", 130, 182], ["spike gene variation", "PROBLEM", 231, 251], ["multiple human coronavirus 229E infections", "PROBLEM", 268, 310], ["human coronavirus", "TREATMENT", 464, 481], ["human coronavirus", "TEST", 496, 513], ["ATCC VR", "TEST", 526, 533], ["these viruses", "PROBLEM", 571, 584], ["tissue culture", "TEST", 601, 615], ["serial passaging", "TEST", 619, 635], ["minor", "OBSERVATION_MODIFIER", 8, 13], ["changes", "OBSERVATION", 14, 21], ["may be possible", "UNCERTAINTY", 102, 117], ["dominant", "OBSERVATION_MODIFIER", 191, 199], ["viruses", "OBSERVATION", 577, 584]]], ["In particular, MRC5 (Medical Research Council No. 5) human embryonic lung fibroblasts were the final replicative host for human coronavirus 229E strain ATCC VR-74, whilst Clone 16 human embryonic lung fibroblasts (the 16th clone of heteroploid MRC-c cells Philpotts, 1983) were the final replicative host for human coronavirus 229E 'LP' (Raabe et al., 1990) .", [["MRC5", "ANATOMY", 15, 19], ["embryonic lung fibroblasts", "ANATOMY", 59, 85], ["ATCC VR-74", "ANATOMY", 152, 162], ["embryonic lung fibroblasts", "ANATOMY", 186, 212], ["16th clone", "ANATOMY", 218, 228], ["heteroploid MRC-c cells", "ANATOMY", 232, 255], ["MRC5", "CELL", 15, 19], ["human", "ORGANISM", 53, 58], ["embryonic lung fibroblasts", "CELL", 59, 85], ["human", "ORGANISM", 122, 127], ["coronavirus 229E strain ATCC VR-74", "ORGANISM", 128, 162], ["human", "ORGANISM", 180, 185], ["embryonic lung fibroblasts", "CELL", 186, 212], ["clone", "CELL", 223, 228], ["heteroploid MRC-c cells Philpotts", "CELL", 232, 265], ["human", "ORGANISM", 309, 314], ["human embryonic lung fibroblasts", "CELL_TYPE", 53, 85], ["Clone 16 human embryonic lung fibroblasts", "CELL_LINE", 171, 212], ["heteroploid MRC-c cells", "CELL_LINE", 232, 255], ["human", "SPECIES", 53, 58], ["human", "SPECIES", 122, 127], ["coronavirus", "SPECIES", 128, 139], ["human", "SPECIES", 180, 185], ["human", "SPECIES", 309, 314], ["coronavirus", "SPECIES", 315, 326], ["human", "SPECIES", 53, 58], ["human coronavirus 229E strain ATCC VR-74", "SPECIES", 122, 162], ["human", "SPECIES", 180, 185], ["human coronavirus", "SPECIES", 309, 326], ["human embryonic lung fibroblasts", "PROBLEM", 53, 85], ["human coronavirus", "TEST", 122, 139], ["ATCC VR", "TEST", 152, 159], ["human embryonic lung fibroblasts", "PROBLEM", 180, 212], ["human coronavirus", "TREATMENT", 309, 326], ["lung", "ANATOMY", 69, 73], ["fibroblasts", "OBSERVATION", 74, 85], ["lung", "ANATOMY", 196, 200], ["fibroblasts", "OBSERVATION", 201, 212]]], ["As MRC5 and MRC-c cells are closely related, it may feasible that adaptation of human coronaviruses 229E to these similar cell lines may facilitate similar spike protein conformations.", [["MRC5", "ANATOMY", 3, 7], ["MRC-c cells", "ANATOMY", 12, 23], ["cell lines", "ANATOMY", 122, 132], ["MRC5", "CELL", 3, 7], ["MRC-c cells", "CELL", 12, 23], ["human", "ORGANISM", 80, 85], ["coronaviruses 229E", "ORGANISM", 86, 104], ["cell lines", "CELL", 122, 132], ["MRC5", "CELL_LINE", 3, 7], ["MRC-c cells", "CELL_LINE", 12, 23], ["human", "SPECIES", 80, 85], ["human coronaviruses", "SPECIES", 80, 99], ["MRC5 and MRC-c cells", "TEST", 3, 23], ["human coronaviruses", "PROBLEM", 80, 99], ["these similar cell lines", "TREATMENT", 108, 132], ["similar spike protein conformations", "PROBLEM", 148, 183], ["cell lines", "OBSERVATION", 122, 132]]], ["These similar spike protein conformations would be expected to have similar protein sequences and by reverse translation, similar spike gene sequences.", [["spike gene sequences", "DNA", 130, 150], ["These similar spike protein conformations", "PROBLEM", 0, 41], ["similar protein sequences", "TEST", 68, 93]]], ["Further, if such 'convergent evolution' does indeed occur, then it is possible that the spike gene sequences obtained from serially passaged, tissue culture adapted human coronaviruses 229E may differ from the spike gene sequences of the original isolates.", [["tissue culture", "ANATOMY", 142, 156], ["human", "ORGANISM", 165, 170], ["coronaviruses 229E", "ORGANISM", 171, 189], ["spike gene sequences", "DNA", 88, 108], ["spike gene sequences", "DNA", 210, 230], ["human", "SPECIES", 165, 170], ["human coronaviruses", "SPECIES", 165, 184], ["the spike gene sequences", "PROBLEM", 84, 108], ["tissue culture", "TEST", 142, 156], ["human coronaviruses 229E", "PROBLEM", 165, 189]]], ["In this case, the accuracy of spike gene sequence data from human coronaviruses 229E which had been isolated by serial passage in tissue culture may be called into question.", [["tissue culture", "ANATOMY", 130, 144], ["human coronaviruses 229E", "ORGANISM", 60, 84], ["tissue", "TISSUE", 130, 136], ["spike gene sequence", "DNA", 30, 49], ["human", "SPECIES", 60, 65], ["human coronaviruses", "SPECIES", 60, 79], ["spike gene sequence data", "TEST", 30, 54], ["human coronaviruses", "PROBLEM", 60, 79], ["tissue culture", "TEST", 130, 144]]], ["In this project, spike gene PCR amplification of human coronavirus 229E isolates LRI 281 and A162 was undertaken directly from clinical specimens.DiscussionThough comparatively few changes were observed between the human coronavirus 229E translated spike proteins compared in this project, the majority of such changes were observed in the 5% half of the spike protein sequence.", [["specimens", "ANATOMY", 136, 145], ["human", "ORGANISM", 49, 54], ["coronavirus 229E", "ORGANISM", 55, 71], ["A162", "CANCER", 93, 97], ["human", "ORGANISM", 215, 220], ["coronavirus 229E", "ORGANISM", 221, 237], ["human coronavirus 229E translated spike proteins", "PROTEIN", 215, 263], ["spike protein sequence", "DNA", 355, 377], ["human", "SPECIES", 49, 54], ["coronavirus", "SPECIES", 55, 66], ["human", "SPECIES", 215, 220], ["coronavirus", "SPECIES", 221, 232], ["human coronavirus", "SPECIES", 49, 66], ["human coronavirus", "SPECIES", 215, 232], ["spike gene PCR", "TEST", 17, 31], ["human coronavirus", "TEST", 49, 66], ["isolates LRI", "TEST", 72, 84], ["clinical specimens", "TEST", 127, 145], ["the human coronavirus", "PROBLEM", 211, 232], ["spike proteins", "PROBLEM", 249, 263], ["such changes", "PROBLEM", 306, 318], ["the spike protein sequence", "TEST", 351, 377]]], ["This point is illustrated most obviously upon examination of the translated spike protein sequence of human coronavirus 229E A162, where three apparent clusters of nucleotide variation were observed, all in the 5% half of the translated spike protein sequence.", [["nucleotide", "CHEMICAL", 164, 174], ["nucleotide", "CHEMICAL", 164, 174], ["human", "ORGANISM", 102, 107], ["coronavirus 229E A162", "ORGANISM", 108, 129], ["translated spike protein sequence", "PROTEIN", 65, 98], ["translated spike protein sequence", "DNA", 226, 259], ["human", "SPECIES", 102, 107], ["coronavirus", "SPECIES", 108, 119], ["human coronavirus 229E A162", "SPECIES", 102, 129], ["examination", "TEST", 46, 57], ["human coronavirus", "TEST", 102, 119], ["nucleotide variation", "PROBLEM", 164, 184], ["human coronavirus", "ANATOMY", 102, 119], ["nucleotide variation", "OBSERVATION", 164, 184]]], ["Interestingly, research by , working with mouse hepatitis virus, indicated that the 5% end of the murine coronavirus spike gene may be the preferred site for RNA recombination events for this particular coronavirus.", [["hepatitis virus", "DISEASE", 48, 63], ["mouse hepatitis virus", "ORGANISM", 42, 63], ["murine coronavirus", "ORGANISM", 98, 116], ["coronavirus", "ORGANISM", 203, 214], ["murine coronavirus spike gene", "DNA", 98, 127], ["mouse", "SPECIES", 42, 47], ["murine", "SPECIES", 98, 104], ["mouse hepatitis virus", "SPECIES", 42, 63], ["murine coronavirus", "SPECIES", 98, 116], ["mouse hepatitis virus", "PROBLEM", 42, 63], ["the murine coronavirus spike gene", "TREATMENT", 94, 127], ["RNA recombination events", "PROBLEM", 158, 182], ["this particular coronavirus", "PROBLEM", 187, 214], ["coronavirus spike", "OBSERVATION", 105, 122]]], ["Moreover, comparisons of the spike protein sequences of avian infectious bronchitis virus, feline infectious peritonitis virus, murine hepatitis virus and transmissible gastro-enteritis virus have indicated that the 3% (C-terminal) portion of the spike protein is rather more conserved than the corresponding 5% (amino-terminal portion) portion of the spike gene (Cavanagh, 1995) .DiscussionIn theory, it is possible that minor variations in the translated sequences of human coronavirus 229E spike proteins may facilitate a relatively major change to the antigenicity of the spike protein.", [["infectious bronchitis virus", "DISEASE", 62, 89], ["feline infectious peritonitis", "DISEASE", 91, 120], ["murine hepatitis virus", "DISEASE", 128, 150], ["gastro-enteritis", "DISEASE", 169, 185], ["amino", "CHEMICAL", 313, 318], ["avian infectious bronchitis virus", "ORGANISM", 56, 89], ["feline infectious peritonitis virus", "ORGANISM", 91, 126], ["murine hepatitis virus", "ORGANISM", 128, 150], ["transmissible gastro-enteritis virus", "ORGANISM", 155, 191], ["human", "ORGANISM", 470, 475], ["coronavirus 229E", "ORGANISM", 476, 492], ["spike protein sequences", "DNA", 29, 52], ["spike protein", "PROTEIN", 247, 260], ["amino-terminal portion", "PROTEIN", 313, 335], ["spike gene", "DNA", 352, 362], ["human coronavirus 229E spike proteins", "PROTEIN", 470, 507], ["spike protein", "PROTEIN", 576, 589], ["avian infectious bronchitis virus", "SPECIES", 56, 89], ["feline infectious peritonitis virus", "SPECIES", 91, 126], ["murine", "SPECIES", 128, 134], ["hepatitis virus", "SPECIES", 135, 150], ["gastro-enteritis virus", "SPECIES", 169, 191], ["human", "SPECIES", 470, 475], ["infectious bronchitis virus", "SPECIES", 62, 89], ["feline infectious peritonitis virus", "SPECIES", 91, 126], ["murine hepatitis virus", "SPECIES", 128, 150], ["gastro-enteritis virus", "SPECIES", 169, 191], ["human coronavirus", "SPECIES", 470, 487], ["the spike protein sequences", "TEST", 25, 52], ["avian infectious bronchitis virus", "PROBLEM", 56, 89], ["feline infectious peritonitis virus", "PROBLEM", 91, 126], ["murine hepatitis virus", "PROBLEM", 128, 150], ["transmissible gastro-enteritis virus", "PROBLEM", 155, 191], ["the 3% (C-terminal) portion of the spike protein", "PROBLEM", 212, 260], ["minor variations", "PROBLEM", 422, 438], ["human coronavirus 229E spike proteins", "PROBLEM", 470, 507], ["the spike protein", "PROBLEM", 572, 589], ["infectious", "OBSERVATION_MODIFIER", 62, 72], ["bronchitis", "OBSERVATION", 73, 83], ["infectious", "OBSERVATION_MODIFIER", 98, 108], ["peritonitis", "OBSERVATION", 109, 120], ["hepatitis virus", "OBSERVATION", 135, 150], ["gastro", "ANATOMY", 169, 175], ["enteritis", "OBSERVATION", 176, 185]]], ["However, comparison of the predicted antigenic indices of the translated spike proteins of human coronaviruses 229E strain ATCC VR-74, LRI 281 and A162 (data not shown) using the 'peptidestructure' and 'plotstructure' computer applications (Genetics Computer Group Inc. v8.0., Madison WI, USA) showed that no major changes in predicted antigenic indexes were observed between the translated spike protein sequences of the aforementioned human coronavirus 229E isolates.DiscussionTaken as a whole, these results indicate that variation in the spike proteins of chronologically and geographically distinct human coronaviruses 229E may be rather limited.", [["human", "ORGANISM", 91, 96], ["coronaviruses 229E strain ATCC VR-74", "ORGANISM", 97, 133], ["human", "ORGANISM", 437, 442], ["coronavirus 229E isolates", "ORGANISM", 443, 468], ["human", "ORGANISM", 604, 609], ["coronaviruses 229E", "ORGANISM", 610, 628], ["translated spike proteins", "PROTEIN", 62, 87], ["spike proteins", "PROTEIN", 542, 556], ["human", "SPECIES", 91, 96], ["human", "SPECIES", 437, 442], ["coronavirus", "SPECIES", 443, 454], ["human", "SPECIES", 604, 609], ["human coronaviruses 229E strain ATCC VR-74", "SPECIES", 91, 133], ["human coronavirus", "SPECIES", 437, 454], ["human coronaviruses", "SPECIES", 604, 623], ["human coronaviruses", "TEST", 91, 110], ["strain ATCC VR", "TEST", 116, 130], ["LRI", "TEST", 135, 138], ["the 'peptidestructure'", "TREATMENT", 175, 197], ["major changes in predicted antigenic indexes", "PROBLEM", 309, 353], ["protein sequences", "TEST", 397, 414], ["the spike proteins", "PROBLEM", 538, 556], ["geographically distinct human coronaviruses", "PROBLEM", 580, 623]]], ["Such an interpretation would tend to suggest that spike protein variation does not play a major role in the aetiology of human coronavirus 229E re-infection.", [["human", "ORGANISM", 121, 126], ["coronavirus 229E", "ORGANISM", 127, 143], ["human", "SPECIES", 121, 126], ["human coronavirus", "SPECIES", 121, 138], ["spike protein variation", "PROBLEM", 50, 73], ["human coronavirus 229E re-infection", "PROBLEM", 121, 156]]], ["However, in order to assess fully the role that spike protein variation has upon human coronavirus 229E re-infection, further work is required.", [["human", "ORGANISM", 81, 86], ["coronavirus 229E", "ORGANISM", 87, 103], ["human", "SPECIES", 81, 86], ["human coronavirus", "SPECIES", 81, 98], ["spike protein variation", "PROBLEM", 48, 71], ["human coronavirus 229E re-infection", "PROBLEM", 81, 116]]], ["In particular, sequencing of the spike genes from other chronologically and geographically distinct human coronaviruses 229E should be undertaken.", [["human", "ORGANISM", 100, 105], ["coronaviruses", "ORGANISM", 106, 119], ["spike genes", "DNA", 33, 44], ["human", "SPECIES", 100, 105], ["human coronaviruses", "SPECIES", 100, 119], ["the spike genes", "PROBLEM", 29, 44], ["geographically distinct human coronaviruses 229E", "PROBLEM", 76, 124]]], ["Further, by cloning and expressing the spike proteins of human coronaviruses 229E in vitro, it may be possible to assess the role of the immune system in the aetiology of human coronavirus 229E re-infection.", [["coronavirus 229E re-infection", "DISEASE", 177, 206], ["human", "ORGANISM", 57, 62], ["coronaviruses 229E", "ORGANISM", 63, 81], ["human", "ORGANISM", 171, 176], ["coronavirus 229E", "ORGANISM", 177, 193], ["spike proteins", "PROTEIN", 39, 53], ["human", "SPECIES", 57, 62], ["human", "SPECIES", 171, 176], ["human coronaviruses", "SPECIES", 57, 76], ["human coronavirus", "SPECIES", 171, 188], ["human coronaviruses", "PROBLEM", 57, 76], ["human coronavirus 229E re-infection", "PROBLEM", 171, 206]]]], "PMC7314259": [["This is a brief response to Rosie Meade\u2019s editorial in the Community Development Journal (55, 3), which identifies challenges to community development presented by the Covid-19 pandemic.", [["Covid-19", "ORGANISM", 168, 176]]], ["As Rosie comments, while the implications of the pandemic are unpredictable, the crisis is infiltrating every aspect our lives.", [["the crisis", "PROBLEM", 77, 87]]], ["As I write this at the beginning of May, 2020, we are still living in a context of fear and panic.", [["panic", "DISEASE", 92, 97], ["panic", "PROBLEM", 92, 97]]]], "f47f984b05e369c688d07524db6bcfaad81c1e2b": [["Introduction:The WHO categorized coronavirus disease 2019 (COVID-19) as a pandemic due to its high contagion rate and widespread infectivity in February 2020.", [["coronavirus disease", "DISEASE", 33, 52], ["COVID-19", "CHEMICAL", 59, 67], ["coronavirus", "ORGANISM", 33, 44], ["coronavirus disease", "PROBLEM", 33, 52], ["COVID", "TEST", 59, 64], ["a pandemic", "PROBLEM", 72, 82], ["its high contagion rate", "PROBLEM", 90, 113], ["widespread", "OBSERVATION_MODIFIER", 118, 128], ["infectivity", "OBSERVATION_MODIFIER", 129, 140]]], ["1 In the US, one of the public health concerns is the adequacy of resources to treat infected cases.", [["infected cases", "PROBLEM", 85, 99]]], ["2 This novel coronavirus, SARS-CoV-2, which originated in China's Hubei province, has caused global outbreaks through its spread via respiratory droplets or direct contact in asymptomatic and symptomatic humans.", [["respiratory droplets", "ANATOMY", 133, 153], ["SARS", "DISEASE", 26, 30], ["coronavirus", "ORGANISM", 13, 24], ["SARS-CoV-2", "ORGANISM", 26, 36], ["humans", "ORGANISM", 204, 210], ["coronavirus", "SPECIES", 13, 24], ["humans", "SPECIES", 204, 210], ["SARS-CoV", "SPECIES", 26, 34], ["humans", "SPECIES", 204, 210], ["This novel coronavirus", "PROBLEM", 2, 24], ["global outbreaks", "PROBLEM", 93, 109], ["respiratory droplets", "PROBLEM", 133, 153], ["direct contact in asymptomatic and symptomatic humans", "PROBLEM", 157, 210], ["coronavirus", "OBSERVATION", 13, 24], ["global", "OBSERVATION_MODIFIER", 93, 99], ["outbreaks", "OBSERVATION", 100, 109], ["respiratory droplets", "OBSERVATION", 133, 153]]], ["3 .Introduction:The clinical manifestations of COVID-19 infection are varied based on population, with pediatric COVID-19 demonstrating a milder disease course and better prognosis than adults.", [["infection", "DISEASE", 56, 65], ["COVID-19", "ORGANISM", 47, 55], ["COVID-19 infection", "PROBLEM", 47, 65], ["pediatric COVID", "TEST", 103, 118], ["a milder disease course", "PROBLEM", 136, 159], ["infection", "OBSERVATION", 56, 65], ["milder", "OBSERVATION_MODIFIER", 138, 144], ["disease", "OBSERVATION", 145, 152]]], ["4 As of April 2020, 1.7% of laboratory confirmed cases of COVID-19 in the United States occurred in patients under the age of 18.", [["COVID-19", "CHEMICAL", 58, 66], ["patients", "ORGANISM", 100, 108], ["patients", "SPECIES", 100, 108], ["COVID", "TEST", 58, 63]]], ["5 The symptoms in pediatric cases include fatigue, fever, cough, myalgia, typically seen in acute respiratory infections, and, some gastrointestinal manifestations such as abdominal pain, nausea, vomiting and diarrhea.", [["respiratory", "ANATOMY", 98, 109], ["gastrointestinal", "ANATOMY", 132, 148], ["abdominal", "ANATOMY", 172, 181], ["fatigue", "DISEASE", 42, 49], ["fever", "DISEASE", 51, 56], ["cough", "DISEASE", 58, 63], ["myalgia", "DISEASE", 65, 72], ["acute respiratory infections", "DISEASE", 92, 120], ["abdominal pain", "DISEASE", 172, 186], ["nausea", "DISEASE", 188, 194], ["vomiting", "DISEASE", 196, 204], ["diarrhea", "DISEASE", 209, 217], ["gastrointestinal", "ORGANISM_SUBDIVISION", 132, 148], ["abdominal", "ORGANISM_SUBDIVISION", 172, 181], ["The symptoms", "PROBLEM", 2, 14], ["fatigue", "PROBLEM", 42, 49], ["fever", "PROBLEM", 51, 56], ["cough", "PROBLEM", 58, 63], ["myalgia", "PROBLEM", 65, 72], ["acute respiratory infections", "PROBLEM", 92, 120], ["some gastrointestinal manifestations", "PROBLEM", 127, 163], ["abdominal pain", "PROBLEM", 172, 186], ["nausea", "PROBLEM", 188, 194], ["vomiting", "PROBLEM", 196, 204], ["diarrhea", "PROBLEM", 209, 217], ["myalgia", "OBSERVATION", 65, 72], ["acute", "OBSERVATION_MODIFIER", 92, 97], ["respiratory", "ANATOMY", 98, 109], ["infections", "OBSERVATION", 110, 120], ["gastrointestinal", "ANATOMY", 132, 148], ["manifestations", "OBSERVATION", 149, 163], ["abdominal", "ANATOMY", 172, 181], ["pain", "OBSERVATION", 182, 186], ["nausea", "OBSERVATION", 188, 194]]], ["6 In addition to identifying possible COVID-19 positive contacts symptoms during the exam, chest imaging an important clinical criteria for diagnosing COVID-19 in pediatric cases.", [["chest", "ANATOMY", 91, 96], ["chest", "ORGANISM_SUBDIVISION", 91, 96], ["COVID", "TEST", 38, 43], ["positive contacts symptoms", "PROBLEM", 47, 73], ["the exam", "TEST", 81, 89], ["chest imaging", "TEST", 91, 104], ["diagnosing COVID", "TEST", 140, 156], ["chest", "ANATOMY", 91, 96]]], ["6 Lung POCUS (Point-of-care ultrasound) is documented as an accurate diagnostic tool for pediatric pneumonia and potentially offers a fast and portable method of imaging for patients with COVID-19.", [["Lung", "ANATOMY", 2, 6], ["pneumonia", "DISEASE", 99, 108], ["Lung", "ORGAN", 2, 6], ["patients", "ORGANISM", 174, 182], ["patients", "SPECIES", 174, 182], ["Lung POCUS", "TEST", 2, 12], ["ultrasound", "TEST", 28, 38], ["pediatric pneumonia", "PROBLEM", 89, 108], ["imaging", "TEST", 162, 169], ["COVID", "TEST", 188, 193], ["Lung", "ANATOMY", 2, 6], ["POCUS", "OBSERVATION", 7, 12], ["pneumonia", "OBSERVATION", 99, 108]]], ["[7] [8] To perform a lung POCUS, a linear or phased array transducer is placed in multiple locations on the anterior, lateral, and posterior chest walls to ensure imaging of all lobes of each lung.", [["lung", "ANATOMY", 21, 25], ["anterior", "ANATOMY", 108, 116], ["lateral", "ANATOMY", 118, 125], ["posterior chest walls", "ANATOMY", 131, 152], ["lobes", "ANATOMY", 178, 183], ["lung", "ANATOMY", 192, 196], ["lung", "ORGAN", 21, 25], ["anterior", "MULTI-TISSUE_STRUCTURE", 108, 116], ["lateral", "MULTI-TISSUE_STRUCTURE", 118, 125], ["lobes", "ORGAN", 178, 183], ["lung", "ORGAN", 192, 196], ["a lung POCUS", "TEST", 19, 31], ["a linear or phased array transducer", "TREATMENT", 33, 68], ["imaging", "TEST", 163, 170], ["lung", "ANATOMY", 21, 25], ["POCUS", "OBSERVATION", 26, 31], ["linear", "OBSERVATION_MODIFIER", 35, 41], ["multiple", "OBSERVATION_MODIFIER", 82, 90], ["anterior", "ANATOMY_MODIFIER", 108, 116], ["lateral", "ANATOMY_MODIFIER", 118, 125], ["posterior", "ANATOMY_MODIFIER", 131, 140], ["chest", "ANATOMY", 141, 146], ["walls", "ANATOMY_MODIFIER", 147, 152], ["all lobes", "ANATOMY_MODIFIER", 174, 183], ["each", "ANATOMY_MODIFIER", 187, 191], ["lung", "ANATOMY", 192, 196]]], ["This is typically done in a sliding technique to accomplish performance in a timely fashion.", [["a sliding technique", "TREATMENT", 26, 45]]], ["Specifically, the transducer is placed on the chest in a sagittal manner and the areas imaged are the anterior lung (transducer on the chest wall), lateral lung (transducer on the mid-axillary line of the chest), and posterior lung (placed on the back).", [["chest", "ANATOMY", 46, 51], ["anterior lung", "ANATOMY", 102, 115], ["chest wall", "ANATOMY", 135, 145], ["lateral lung", "ANATOMY", 148, 160], ["mid-axillary line", "ANATOMY", 180, 197], ["chest", "ANATOMY", 205, 210], ["posterior lung", "ANATOMY", 217, 231], ["back", "ANATOMY", 247, 251], ["chest", "ORGAN", 46, 51], ["anterior lung", "MULTI-TISSUE_STRUCTURE", 102, 115], ["chest wall", "MULTI-TISSUE_STRUCTURE", 135, 145], ["lung", "ORGAN", 156, 160], ["chest", "ORGAN", 205, 210], ["lung", "ORGAN", 227, 231], ["back", "ORGANISM_SUBDIVISION", 247, 251], ["the transducer", "TREATMENT", 14, 28], ["chest", "ANATOMY", 46, 51], ["anterior", "ANATOMY_MODIFIER", 102, 110], ["lung", "ANATOMY", 111, 115], ["chest", "ANATOMY", 135, 140], ["wall", "ANATOMY_MODIFIER", 141, 145], ["lateral", "ANATOMY_MODIFIER", 148, 155], ["lung", "ANATOMY", 156, 160], ["chest", "ANATOMY", 205, 210], ["posterior", "ANATOMY_MODIFIER", 217, 226], ["lung", "ANATOMY", 227, 231]]], ["Image video clips are saved with attention to the ribs, the pleural line, the subpleural space, and the lung parenchyma.", [["ribs", "ANATOMY", 50, 54], ["pleural line", "ANATOMY", 60, 72], ["subpleural space", "ANATOMY", 78, 94], ["lung parenchyma", "ANATOMY", 104, 119], ["ribs", "ORGAN", 50, 54], ["pleural line", "CELL", 60, 72], ["subpleural space", "MULTI-TISSUE_STRUCTURE", 78, 94], ["lung parenchyma", "MULTI-TISSUE_STRUCTURE", 104, 119], ["Image video clips", "TREATMENT", 0, 17], ["clips", "OBSERVATION", 12, 17], ["ribs", "ANATOMY", 50, 54], ["pleural", "ANATOMY", 60, 67], ["line", "OBSERVATION", 68, 72], ["subpleural", "ANATOMY_MODIFIER", 78, 88], ["lung", "ANATOMY", 104, 108], ["parenchyma", "ANATOMY_MODIFIER", 109, 119]]], ["The linear transducer allows enhanced imaging of the more superficial pleura.", [["superficial pleura", "ANATOMY", 58, 76], ["superficial pleura", "MULTI-TISSUE_STRUCTURE", 58, 76], ["enhanced imaging", "TEST", 29, 45], ["linear", "OBSERVATION_MODIFIER", 4, 10], ["superficial", "ANATOMY_MODIFIER", 58, 69], ["pleura", "ANATOMY", 70, 76]]], ["An abdominal transducer or phased array may be used to allow for visualization of deeper structures; because it allows deeper penetration into the chest and lung parenchyma it is useful in looking for pleural effusions above the diaphragms.Case Report:A previously healthy, morbidly obese, 9-year-old male initially complained of abdominal pain, nausea, vomiting, shortness of breath and cough with chest pain.", [["abdominal", "ANATOMY", 3, 12], ["chest", "ANATOMY", 147, 152], ["lung parenchyma", "ANATOMY", 157, 172], ["pleural effusions", "ANATOMY", 201, 218], ["diaphragms", "ANATOMY", 229, 239], ["abdominal", "ANATOMY", 330, 339], ["chest", "ANATOMY", 399, 404], ["pleural effusions", "DISEASE", 201, 218], ["abdominal pain", "DISEASE", 330, 344], ["nausea", "DISEASE", 346, 352], ["vomiting", "DISEASE", 354, 362], ["shortness of breath", "DISEASE", 364, 383], ["cough", "DISEASE", 388, 393], ["chest pain", "DISEASE", 399, 409], ["abdominal", "ORGAN", 3, 12], ["chest", "ORGAN", 147, 152], ["lung parenchyma", "MULTI-TISSUE_STRUCTURE", 157, 172], ["pleural effusions", "PATHOLOGICAL_FORMATION", 201, 218], ["diaphragms", "MULTI-TISSUE_STRUCTURE", 229, 239], ["male", "ORGANISM", 301, 305], ["abdominal", "ORGANISM_SUBDIVISION", 330, 339], ["chest", "ORGANISM_SUBDIVISION", 399, 404], ["An abdominal transducer", "TREATMENT", 0, 23], ["deeper penetration into the chest and lung parenchyma", "PROBLEM", 119, 172], ["pleural effusions", "PROBLEM", 201, 218], ["abdominal pain", "PROBLEM", 330, 344], ["nausea", "PROBLEM", 346, 352], ["vomiting", "PROBLEM", 354, 362], ["shortness of breath", "PROBLEM", 364, 383], ["cough", "PROBLEM", 388, 393], ["chest pain", "PROBLEM", 399, 409], ["abdominal", "ANATOMY", 3, 12], ["chest", "ANATOMY", 147, 152], ["lung", "ANATOMY", 157, 161], ["parenchyma", "ANATOMY_MODIFIER", 162, 172], ["pleural", "ANATOMY", 201, 208], ["effusions", "OBSERVATION", 209, 218], ["diaphragms", "ANATOMY", 229, 239], ["abdominal", "ANATOMY", 330, 339], ["pain", "OBSERVATION", 340, 344], ["nausea", "OBSERVATION", 346, 352], ["cough", "OBSERVATION", 388, 393], ["chest", "ANATOMY", 399, 404]]], ["The patient had a history of close contact with multiple family members who were positive for COVID-19, including the recent death of his grandfather due to the infection.", [["death", "DISEASE", 125, 130], ["infection", "DISEASE", 161, 170], ["patient", "ORGANISM", 4, 11], ["patient", "SPECIES", 4, 11], ["COVID", "TEST", 94, 99], ["the infection", "PROBLEM", 157, 170], ["infection", "OBSERVATION", 161, 170]]], ["His initial vital signs were: BP 128/70 P 101 T 100.6 F RR 22.", [["His initial vital signs", "TEST", 0, 23], ["BP", "TEST", 30, 32], ["P", "TEST", 40, 41], ["T", "TEST", 46, 47], ["RR", "TEST", 56, 58]]], ["He was found to be intermittently hypoxic with a SpO2 as low as 71%.", [["He", "ORGANISM", 0, 2], ["intermittently hypoxic", "PROBLEM", 19, 41], ["a SpO2", "TEST", 47, 53], ["intermittently", "OBSERVATION_MODIFIER", 19, 33], ["hypoxic", "OBSERVATION", 34, 41]]], ["A physical exam revealed that the patient had a BMI of 43.93, and was uncomfortable though not ill-appearing.", [["patient", "ORGANISM", 34, 41], ["patient", "SPECIES", 34, 41], ["A physical exam", "TEST", 0, 15], ["a BMI", "TEST", 46, 51], ["uncomfortable", "PROBLEM", 70, 83]]], ["He had tender cervical adenopathy, dry mucous membranes, pale skin, and abdominal tenderness.", [["cervical", "ANATOMY", 14, 22], ["mucous membranes", "ANATOMY", 39, 55], ["skin", "ANATOMY", 62, 66], ["abdominal", "ANATOMY", 72, 81], ["adenopathy", "DISEASE", 23, 33], ["abdominal tenderness", "DISEASE", 72, 92], ["cervical", "ORGAN", 14, 22], ["mucous membranes", "MULTI-TISSUE_STRUCTURE", 39, 55], ["skin", "ORGAN", 62, 66], ["abdominal", "ORGANISM_SUBDIVISION", 72, 81], ["tender cervical adenopathy", "PROBLEM", 7, 33], ["dry mucous membranes", "PROBLEM", 35, 55], ["pale skin", "PROBLEM", 57, 66], ["abdominal tenderness", "PROBLEM", 72, 92], ["tender", "OBSERVATION_MODIFIER", 7, 13], ["cervical", "ANATOMY", 14, 22], ["adenopathy", "OBSERVATION", 23, 33], ["dry", "OBSERVATION_MODIFIER", 35, 38], ["mucous membranes", "OBSERVATION", 39, 55], ["pale", "OBSERVATION_MODIFIER", 57, 61], ["skin", "ANATOMY", 62, 66], ["abdominal", "ANATOMY", 72, 81], ["tenderness", "OBSERVATION", 82, 92]]], ["A lung POCUS (Figures 1-2) was concerning for thickening of pleural line, B lines, and consolidation.", [["lung", "ANATOMY", 2, 6], ["pleural line", "ANATOMY", 60, 72], ["B lines", "ANATOMY", 74, 81], ["lung", "ORGAN", 2, 6], ["pleural line", "CELL", 60, 72], ["B lines", "CELL", 74, 81], ["B lines", "CELL_LINE", 74, 81], ["A lung POCUS", "TEST", 0, 12], ["thickening of pleural line", "PROBLEM", 46, 72], ["B lines", "TREATMENT", 74, 81], ["consolidation", "PROBLEM", 87, 100], ["lung", "ANATOMY", 2, 6], ["concerning for", "UNCERTAINTY", 31, 45], ["thickening", "OBSERVATION", 46, 56], ["pleural", "ANATOMY", 60, 67], ["line", "OBSERVATION", 68, 72], ["B lines", "OBSERVATION", 74, 81], ["consolidation", "OBSERVATION", 87, 100]]], ["A CXR suggested multifocal or viral pneumonia, with patchy bilateral ground glass opacities and bilateral perihilar interstitial prominence.", [["perihilar interstitial", "ANATOMY", 106, 128], ["pneumonia", "DISEASE", 36, 45], ["CXR", "PROTEIN", 2, 5], ["A CXR", "TEST", 0, 5], ["multifocal or viral pneumonia", "PROBLEM", 16, 45], ["patchy bilateral ground glass opacities", "PROBLEM", 52, 91], ["bilateral perihilar interstitial prominence", "PROBLEM", 96, 139], ["multifocal", "OBSERVATION_MODIFIER", 16, 26], ["viral", "OBSERVATION_MODIFIER", 30, 35], ["pneumonia", "OBSERVATION", 36, 45], ["patchy", "OBSERVATION_MODIFIER", 52, 58], ["bilateral", "ANATOMY_MODIFIER", 59, 68], ["ground glass opacities", "OBSERVATION", 69, 91], ["bilateral", "ANATOMY_MODIFIER", 96, 105], ["perihilar", "ANATOMY_MODIFIER", 106, 115], ["interstitial", "ANATOMY_MODIFIER", 116, 128], ["prominence", "OBSERVATION", 129, 139]]], ["(Figure 3 ) His WBC was 2.7 thou/cmm, with an absolute lymphocyte count of 0.7 thou/cmm.", [["lymphocyte", "ANATOMY", 55, 65], ["lymphocyte", "CELL", 55, 65], ["His WBC", "TEST", 12, 19], ["an absolute lymphocyte count", "TEST", 43, 71], ["absolute lymphocyte count", "OBSERVATION", 46, 71]]], ["He was thrombocytopenic with a platelet count of 181 thou/cmm.", [["platelet", "ANATOMY", 31, 39], ["thrombocytopenic", "DISEASE", 7, 23], ["He", "ORGANISM", 0, 2], ["platelet", "CELL", 31, 39], ["thrombocytopenic", "PROBLEM", 7, 23], ["a platelet count", "TEST", 29, 45], ["thrombocytopenic", "OBSERVATION", 7, 23], ["platelet count", "OBSERVATION_MODIFIER", 31, 45]]], ["His d-dimer was 1.01 ug/mL, which alongside his morbid obesity, increased his risk for pediatric venous thromboembolism (VTE).Case Report:The presumed COVID-19 positive patient was admitted to the PICU for the possibility of worsening respiratory status.Case Report:The patient eventually had a positive SARS-CoV-2 polymerase chain reaction, IgG antibody test.", [["venous", "ANATOMY", 97, 103], ["respiratory", "ANATOMY", 235, 246], ["obesity", "DISEASE", 55, 62], ["venous thromboembolism", "DISEASE", 97, 119], ["VTE", "DISEASE", 121, 124], ["venous", "PATHOLOGICAL_FORMATION", 97, 103], ["patient", "ORGANISM", 169, 176], ["patient", "ORGANISM", 270, 277], ["IgG antibody", "PROTEIN", 342, 354], ["patient", "SPECIES", 169, 176], ["patient", "SPECIES", 270, 277], ["His d-dimer", "TEST", 0, 11], ["his morbid obesity", "PROBLEM", 44, 62], ["pediatric venous thromboembolism", "PROBLEM", 87, 119], ["VTE", "PROBLEM", 121, 124], ["COVID", "TEST", 151, 156], ["worsening respiratory status", "PROBLEM", 225, 253], ["a positive SARS", "PROBLEM", 293, 308], ["CoV", "TEST", 309, 312], ["2 polymerase chain reaction", "PROBLEM", 313, 340], ["IgG antibody test", "TEST", 342, 359], ["morbid obesity", "OBSERVATION", 48, 62], ["venous", "ANATOMY", 97, 103], ["thromboembolism", "OBSERVATION", 104, 119], ["worsening", "OBSERVATION_MODIFIER", 225, 234], ["respiratory status", "OBSERVATION", 235, 253]]], ["He was managed with a 5-day course of remdesivir, supplemental oxygen via nasal cannula for hypoxia, enoxaparin due to increased risk for VTE.", [["nasal", "ANATOMY", 74, 79], ["remdesivir", "CHEMICAL", 38, 48], ["oxygen", "CHEMICAL", 63, 69], ["hypoxia", "DISEASE", 92, 99], ["enoxaparin", "CHEMICAL", 101, 111], ["VTE", "DISEASE", 138, 141], ["remdesivir", "CHEMICAL", 38, 48], ["oxygen", "CHEMICAL", 63, 69], ["enoxaparin", "CHEMICAL", 101, 111], ["remdesivir", "SIMPLE_CHEMICAL", 38, 48], ["oxygen", "SIMPLE_CHEMICAL", 63, 69], ["nasal cannula", "MULTI-TISSUE_STRUCTURE", 74, 87], ["enoxaparin", "SIMPLE_CHEMICAL", 101, 111], ["remdesivir", "TREATMENT", 38, 48], ["supplemental oxygen", "TREATMENT", 50, 69], ["nasal cannula", "TREATMENT", 74, 87], ["hypoxia", "PROBLEM", 92, 99], ["enoxaparin", "TREATMENT", 101, 111], ["VTE", "PROBLEM", 138, 141], ["nasal cannula", "ANATOMY", 74, 87]]], ["Over the course of his 6-day hospital stay, his vitals and labs improved.", [["his vitals", "TEST", 44, 54], ["labs", "TEST", 59, 63]]], ["He was able to tolerate oral intake, and was discharged home after resolution of hypoxia.Discussion:Lung POCUS has emerged as a useful modality in diagnosing and monitoring the severity of COVID-19 lung involvement among adult patients.", [["oral", "ANATOMY", 24, 28], ["Lung", "ANATOMY", 100, 104], ["lung", "ANATOMY", 198, 202], ["hypoxia", "DISEASE", 81, 88], ["He", "ORGANISM", 0, 2], ["oral", "ORGANISM_SUBDIVISION", 24, 28], ["Lung", "ORGAN", 100, 104], ["lung", "ORGAN", 198, 202], ["patients", "ORGANISM", 227, 235], ["patients", "SPECIES", 227, 235], ["hypoxia", "PROBLEM", 81, 88], ["COVID", "TEST", 189, 194], ["hypoxia", "OBSERVATION", 81, 88], ["Lung", "ANATOMY", 100, 104], ["lung", "ANATOMY", 198, 202]]], ["9-10 Perhaps due to the limited number of reported pediatric cases in hospital settings, the use of lung POCUS in this patient population is not well documented.", [["lung", "ANATOMY", 100, 104], ["lung", "ORGAN", 100, 104], ["patient", "ORGANISM", 119, 126], ["patient", "SPECIES", 119, 126], ["lung POCUS", "TREATMENT", 100, 110], ["lung", "ANATOMY", 100, 104], ["POCUS", "OBSERVATION", 105, 110]]], ["A previous report of lung POCUS in adult patients found a pattern of (1) thickened and/or irregular pleural lines, (2) isolated B lines, (3) subpleural consolidations and (4) air bronchograms.", [["lung", "ANATOMY", 21, 25], ["pleural lines", "ANATOMY", 100, 113], ["B lines", "ANATOMY", 128, 135], ["subpleural", "ANATOMY", 141, 151], ["lung POCUS", "CANCER", 21, 31], ["patients", "ORGANISM", 41, 49], ["pleural lines", "CELL", 100, 113], ["B lines", "CELL", 128, 135], ["subpleural", "TISSUE", 141, 151], ["B lines", "CELL_LINE", 128, 135], ["patients", "SPECIES", 41, 49], ["thickened and/or irregular pleural lines", "PROBLEM", 73, 113], ["isolated B lines, (3) subpleural consolidations and (4) air bronchograms", "PROBLEM", 119, 191], ["lung", "ANATOMY", 21, 25], ["POCUS", "OBSERVATION", 26, 31], ["thickened", "OBSERVATION", 73, 82], ["irregular", "OBSERVATION_MODIFIER", 90, 99], ["pleural", "ANATOMY", 100, 107], ["lines", "OBSERVATION", 108, 113], ["B lines", "OBSERVATION", 128, 135], ["subpleural", "ANATOMY_MODIFIER", 141, 151], ["consolidations", "OBSERVATION", 152, 166], ["air bronchograms", "OBSERVATION", 175, 191]]], ["11 Notably, in our patient three of the four patterns were found: B lines, bilateral pleural thickening and right-sided consolidation.", [["B lines", "ANATOMY", 66, 73], ["pleural", "ANATOMY", 85, 92], ["patient", "ORGANISM", 19, 26], ["B lines", "CELL", 66, 73], ["pleural", "ORGAN", 85, 92], ["B lines", "CELL_LINE", 66, 73], ["patient", "SPECIES", 19, 26], ["B lines", "TREATMENT", 66, 73], ["bilateral pleural thickening", "PROBLEM", 75, 103], ["right-sided consolidation", "PROBLEM", 108, 133], ["lines", "OBSERVATION_MODIFIER", 68, 73], ["bilateral", "ANATOMY_MODIFIER", 75, 84], ["pleural", "ANATOMY", 85, 92], ["thickening", "OBSERVATION", 93, 103], ["right", "ANATOMY_MODIFIER", 108, 113], ["sided", "ANATOMY_MODIFIER", 114, 119], ["consolidation", "OBSERVATION", 120, 133]]], ["Current literature suggests that lung POCUS findings in children and adults with coronavirus lung pathology appear similar.", [["lung", "ANATOMY", 33, 37], ["lung", "ANATOMY", 93, 97], ["coronavirus lung pathology", "DISEASE", 81, 107], ["lung", "ORGAN", 33, 37], ["children", "ORGANISM", 56, 64], ["coronavirus", "ORGANISM", 81, 92], ["lung", "ORGAN", 93, 97], ["children", "SPECIES", 56, 64], ["coronavirus", "SPECIES", 81, 92], ["coronavirus lung pathology", "PROBLEM", 81, 107], ["lung", "ANATOMY", 33, 37], ["coronavirus", "OBSERVATION", 81, 92], ["lung", "ANATOMY", 93, 97], ["pathology", "OBSERVATION", 98, 107], ["similar", "OBSERVATION_MODIFIER", 115, 122]]], ["A case series on lung POCUS in presumed neonatal COVID-19 patients did not observe respiratory deterioration with the emergence of consolidation and coalescent B-lines, as has been reported in literature on adult cases.", [["lung", "ANATOMY", 17, 21], ["respiratory", "ANATOMY", 83, 94], ["B-lines", "ANATOMY", 160, 167], ["respiratory deterioration", "DISEASE", 83, 108], ["lung", "ORGAN", 17, 21], ["patients", "ORGANISM", 58, 66], ["B-lines", "CELL", 160, 167], ["patients", "SPECIES", 58, 66], ["A case series", "TEST", 0, 13], ["lung POCUS", "TEST", 17, 27], ["respiratory deterioration", "PROBLEM", 83, 108], ["consolidation", "PROBLEM", 131, 144], ["coalescent B-lines", "TREATMENT", 149, 167], ["lung", "ANATOMY", 17, 21], ["consolidation", "OBSERVATION", 131, 144], ["coalescent", "OBSERVATION_MODIFIER", 149, 159], ["B-lines", "OBSERVATION", 160, 167]]], ["[13] [14] Of note, the patient's obesity made it more challenging to obtain POCUS images so we used an abdominal transducer in place of the higher frequency linear transducer.", [["abdominal", "ANATOMY", 103, 112], ["obesity", "DISEASE", 33, 40], ["patient", "ORGANISM", 23, 30], ["abdominal", "ORGANISM_SUBDIVISION", 103, 112], ["patient", "SPECIES", 23, 30], ["the patient's obesity", "PROBLEM", 19, 40], ["POCUS images", "TEST", 76, 88], ["an abdominal transducer", "TREATMENT", 100, 123], ["the higher frequency linear transducer", "TREATMENT", 136, 174], ["obesity", "OBSERVATION", 33, 40], ["abdominal", "ANATOMY", 103, 112]]], ["We were able to identify the structures, but the need for depth was vital in imaging.", [["vital in imaging", "TEST", 68, 84]]], ["Although abdominal and phased array transducers allow deeper visualization, it becomes more difficult to see higher definition.Discussion:Despite the lung POCUS findings, our patient responded well to supplemental oxygen and did not require further imaging investigation during his hospital stay.", [["abdominal", "ANATOMY", 9, 18], ["lung", "ANATOMY", 150, 154], ["oxygen", "CHEMICAL", 214, 220], ["oxygen", "CHEMICAL", 214, 220], ["abdominal", "MULTI-TISSUE_STRUCTURE", 9, 18], ["lung", "ORGAN", 150, 154], ["patient", "ORGANISM", 175, 182], ["oxygen", "SIMPLE_CHEMICAL", 214, 220], ["patient", "SPECIES", 175, 182], ["abdominal and phased array transducers", "TREATMENT", 9, 47], ["deeper visualization", "TEST", 54, 74], ["supplemental oxygen", "TREATMENT", 201, 220], ["further imaging investigation", "TEST", 241, 270], ["abdominal", "ANATOMY", 9, 18], ["lung", "ANATOMY", 150, 154]]], ["The advantages of lung POCUS span beyond its function as a highly sensitive and specific technique to diagnose viral pneumonia.", [["lung", "ANATOMY", 18, 22], ["pneumonia", "DISEASE", 117, 126], ["lung", "ORGAN", 18, 22], ["lung POCUS span", "TEST", 18, 33], ["diagnose viral pneumonia", "PROBLEM", 102, 126], ["lung", "ANATOMY", 18, 22], ["viral", "OBSERVATION_MODIFIER", 111, 116], ["pneumonia", "OBSERVATION", 117, 126]]], ["The lack of ionizing radiation exposure, lower cost, portability and better patient cooperation makes it a desirable tool in the pediatric population.", [["patient", "ORGANISM", 76, 83], ["patient", "SPECIES", 76, 83], ["ionizing radiation exposure", "TREATMENT", 12, 39], ["ionizing radiation exposure", "OBSERVATION", 12, 39], ["lower", "OBSERVATION_MODIFIER", 41, 46]]], ["15 Further research is needed to accurately correspond the lung POCUS findings to the disease course in pediatric patients suspected of SARS-CoV-2.", [["lung", "ANATOMY", 59, 63], ["SARS", "DISEASE", 136, 140], ["lung", "ORGAN", 59, 63], ["patients", "ORGANISM", 114, 122], ["patients", "SPECIES", 114, 122], ["SARS-CoV", "SPECIES", 136, 144], ["SARS", "PROBLEM", 136, 140], ["CoV", "TEST", 141, 144], ["lung", "ANATOMY", 59, 63]]], ["As the COVID-19 pandemic has spread across both resource-poor and rich areas and placed stress on current healthcare infrastructure, finding alternative means of diagnosing and monitoring the disease has potential to improve management.", [["the COVID", "TEST", 3, 12], ["pandemic", "PROBLEM", 16, 24], ["the disease", "PROBLEM", 188, 199]]], ["This case highlights the need to expand the evidence surrounding the use of lung POCUS in pediatric patients with COVID-19, and also highlights the advantage of an efficient means of diagnosing and managing the infection.Patient ConsentWe confirm that written, informed consent for publication of this case was obtained from the patient.", [["lung", "ANATOMY", 76, 80], ["infection", "DISEASE", 211, 220], ["lung", "ORGAN", 76, 80], ["patients", "ORGANISM", 100, 108], ["patient", "ORGANISM", 329, 336], ["patients", "SPECIES", 100, 108], ["Patient", "SPECIES", 221, 228], ["patient", "SPECIES", 329, 336], ["COVID", "TEST", 114, 119], ["the infection", "PROBLEM", 207, 220], ["lung", "ANATOMY", 76, 80], ["infection", "OBSERVATION", 211, 220]]]], "00bf962783de4cdf5a1d7a3602af87f34428a481": [["I. INTRODUCTIONB IOLOGICAL signals can contain a wealth of information.I. INTRODUCTIONIn particular, to evaluate a person's physiological condition we can extract information from a variety of biological signals such as ECG, respiratory signals, blood pressure, and circadian rhythm [1] - [8] .", [["respiratory", "ANATOMY", 225, 236], ["blood", "ANATOMY", 246, 251], ["blood", "ORGANISM_SUBSTANCE", 246, 251], ["person", "SPECIES", 115, 121], ["ECG", "TEST", 220, 223], ["respiratory signals", "TEST", 225, 244], ["blood pressure", "TEST", 246, 260], ["circadian rhythm", "TEST", 266, 282]]], ["Many of the measured signals are oscillatory, and one particular and common technique is to focus on the oscillatory features.", [["oscillatory", "OBSERVATION_MODIFIER", 33, 44], ["oscillatory features", "OBSERVATION", 105, 125]]], ["The fundamental quantity describing the oscillation is its period, which is defined to be the time needed for an observer to observe a \"complete and intact oscillation\"; this can be expressed by the frequency, which qualitatively is the inverse of the period, that is, it gives the number of oscillations per unit time period.", [["fundamental", "OBSERVATION_MODIFIER", 4, 15], ["quantity", "OBSERVATION_MODIFIER", 16, 24]]], ["For example, the periods of the ECG signal, the respiratory signal, and the circadian rhythm are about 1 s, 5 s, and 24 h, corresponding to 1 Hz, 0.2 Hz, and 11.6 mHz, respectively [2] - [5] .", [["respiratory", "ANATOMY", 48, 59], ["the ECG signal", "TEST", 28, 42], ["the respiratory signal", "TEST", 44, 66], ["the circadian rhythm", "TEST", 72, 92], ["Hz", "TEST", 142, 144], ["Hz", "TEST", 150, 152], ["mHz", "TEST", 163, 166], ["respiratory signal", "OBSERVATION", 48, 66]]], ["In recent years, growing evidence suggests that information extracted from biological signals with oscillatory features has diagnostic and prognostic value in various diseases [1] , [2] , [4] - [6] , [9] , [10] .I. INTRODUCTIONMathematically, frequency analysis is typically studied via the Fourier transform when the signal can be assumed to be stationary.", [["[2] , [4] - [6] , [9] , [10] .I.", "SIMPLE_CHEMICAL", 182, 214], ["oscillatory features", "TEST", 99, 119]]], ["However, it has been long observed that the stationarity assumption is too restrictive for physiological signals, and more information of the physiological system can be extracted if one allows time dependence in the frequency or period.", [["too restrictive", "OBSERVATION_MODIFIER", 71, 86]]], ["For example, the variability of the time intervals between sequential heart beats, or heart rate variability (HRV) [2] , [4] , observed in ECG signals, and the variability of the time intervals between sequential breath intakes, or respiratory rate variability (RRV) [3] , [10] - [16] are well known to be related to physiological dynamics.", [["heart", "ANATOMY", 70, 75], ["heart", "ANATOMY", 86, 91], ["heart", "ORGAN", 70, 75], ["heart", "ORGAN", 86, 91], ["[10] - [16]", "SIMPLE_CHEMICAL", 273, 284], ["sequential heart beats", "TEST", 59, 81], ["heart rate variability", "PROBLEM", 86, 108], ["ECG signals", "TEST", 139, 150], ["sequential breath intakes", "TEST", 202, 227], ["respiratory rate variability", "PROBLEM", 232, 260], ["heart", "ANATOMY", 86, 91]]], ["Accurate extraction of this type of time-varying information improves diagnostic accuracy and treatment quality [3] , [4] , [9] , [10] and much effort has been put on this direction.", [["diagnostic accuracy", "TEST", 70, 89]]], ["A well-known example is the analysis of R-peak to R-peak intervals (RRI) to reveal HRV information [4] , [9] , [17] .", [["the analysis", "TEST", 24, 36], ["RRI", "TEST", 68, 71], ["HRV information", "TEST", 83, 98]]], ["Many techniques have been introduced, including spectral methods and nonlinear dynamical analysis, such as Poincare map, entropy analysis, fractal analysis, to analyze these oscillation-tooscillation intervals [10] - [17] .I. INTRODUCTIONThese established analysis techniques have at least the following three limitations, however, in their use for the study of Fig. 1 .", [["spectral methods", "TEST", 48, 64], ["nonlinear dynamical analysis", "TEST", 69, 97], ["Poincare map", "TEST", 107, 119], ["entropy analysis", "TEST", 121, 137], ["fractal analysis", "TEST", 139, 155], ["the study", "TEST", 349, 358]]], ["Typical recorded respiratory signal from an intensive care unit patient with support from a ventilator.", [["respiratory", "ANATOMY", 17, 28], ["patient", "ORGANISM", 64, 71], ["patient", "SPECIES", 64, 71], ["a ventilator", "TREATMENT", 90, 102], ["respiratory signal", "OBSERVATION", 17, 35]]], ["The arrows with a mark R indicate times in the signal where it would be difficult to identify a basic oscillation if only peaks were taken into consideration; the arrow with a mark B indicates a brief machine recalibration; the arrow with a mark G indicates an invalid respiratory trigger.", [["respiratory", "ANATOMY", 269, 280], ["mark B", "PROTEIN", 176, 182], ["a brief machine recalibration", "TREATMENT", 193, 222], ["a mark G", "TREATMENT", 239, 247], ["an invalid respiratory trigger", "PROBLEM", 258, 288], ["invalid", "OBSERVATION", 261, 268], ["respiratory trigger", "OBSERVATION", 269, 288]]], ["This patient succeeded in ventilator weaning. physiological signals.", [["patient", "ORGANISM", 5, 12], ["patient", "SPECIES", 5, 12], ["ventilator weaning", "TREATMENT", 26, 44], ["ventilator weaning", "OBSERVATION", 26, 44]]], ["A first limitation is the (relatively) large number of oscillations that must be observed.", [["large", "OBSERVATION_MODIFIER", 39, 44], ["number", "OBSERVATION_MODIFIER", 45, 51], ["oscillations", "OBSERVATION", 55, 67], ["must be observed", "UNCERTAINTY", 73, 89]]], ["For example, for analysis of respiratory signals, at least 300 and 100-1000 oscillations are needed for methods that use a Poincare map [10] , [14] , [15] or approximate entropy [12] , [18] , respectively.", [["respiratory signals", "TEST", 29, 48], ["a Poincare map", "TEST", 121, 135]]], ["It is feasible to collect many points for the ECG signal, since this requires only a continuous recording for about 5 min, a reasonable length for a bedside observation.", [["the ECG signal", "TEST", 42, 56], ["a bedside observation", "TEST", 147, 168]]], ["For signals that function on larger time scales than the ECG signal, the story is different.", [["the ECG signal", "TEST", 53, 67], ["different", "OBSERVATION_MODIFIER", 82, 91]]], ["For example, for respiratory signals, we normally need at least 20 min or longer to collect the necessary amount of data, which is usually difficult in certain clinical settings such as patients in intensive care unit [10] , [12] , [14] - [16] or newborns [18] .", [["patients", "ORGANISM", 186, 194], ["[14] - [16]", "SIMPLE_CHEMICAL", 232, 243], ["patients", "SPECIES", 186, 194], ["respiratory signals", "TEST", 17, 36]]], ["The situation would be even worse if we wanted to analyze larger time-scale physiological signals such as circadian rhythm [5] , [7] .I. INTRODUCTIONThe second limitation is that it is not always straightforward to determine the oscillation-to-oscillation time series from the given oscillatory signal.", [["circadian rhythm", "TEST", 106, 122], ["oscillatory signal", "TEST", 283, 301]]], ["Given a suitable definition of this repeating pattern, the oscillation-to-oscillation time series is determined by finding the landmarks for each oscillation.", [["the oscillation", "TEST", 55, 70]]], ["For example, for the ECG signal, the pattern is related to the electrophysiological activity of a normal heart beat and the landmark is defined to be the R peak, and the RRI-time series is based on the R-peak detection [4] , [9] , [17] .", [["heart", "ANATOMY", 105, 110], ["heart", "ORGAN", 105, 110], ["the ECG signal", "TEST", 17, 31], ["the R peak", "TEST", 150, 160], ["the RRI", "TEST", 166, 173], ["the R-peak detection", "TEST", 198, 218], ["normal", "OBSERVATION", 98, 104], ["heart", "ANATOMY", 105, 110]]], ["For example, although we can provide a definition for respiratory signals, in practice determining the landmarks is not easy, specifically when there is invalid or doubly triggered respiration (see Fig. 1 ).", [["respiratory", "ANATOMY", 54, 65], ["respiratory signals", "TEST", 54, 73], ["doubly triggered respiration", "PROBLEM", 164, 192]]], ["This difficulty can be mitigated to some extent by noise removal or noise reduction algorithms [17] , but even then no reliable determination of the \"true\" landmarks can be guaranteed.", [["noise removal", "TREATMENT", 51, 64], ["noise reduction algorithms", "TEST", 68, 94], ["the \"true\" landmarks", "PROBLEM", 145, 165]]], ["Sometimes it is hard to even provide a universally accepted definition of a landmark, e.g., for the electroesophagographic signal.I. INTRODUCTIONThe third limitation is the overreduction of the information inside the physiological signals by retaining only the oscillationto-oscillation time series.", [["the electroesophagographic signal", "TEST", 96, 129], ["third", "OBSERVATION_MODIFIER", 149, 154], ["limitation", "OBSERVATION_MODIFIER", 155, 165]]], ["For example, respiratory signal information is hidden in the time varying amplitude of the ECG signal [19] , which is lost in the RRI time series.", [["the ECG signal", "TEST", 87, 101]]], ["Indeed, the basic pattern of the oscillation of the ECG signal itself also varies according to time due to the cardiac axis rotation induced by the respiration and other effects.I. INTRODUCTIONTo address these limitations, we propose in this paper a descriptive model featuring a more fine-grained description of the oscillatory physiological signal than given by the time intervals between sequential oscillations.", [["cardiac", "ANATOMY", 111, 118], ["the ECG signal", "TEST", 48, 62], ["the cardiac axis rotation", "PROBLEM", 107, 132], ["the respiration", "PROBLEM", 144, 159], ["oscillation", "OBSERVATION", 33, 44], ["cardiac axis", "ANATOMY", 111, 123]]], ["The model is characterized by the wave-shape function, which is defined to replace the definition of an oscillation and the landmark, the instantaneous frequency, the variability of which is defined to be a proxy for the physiological dynamics, and the amplitude modulation, which is aimed to capture more physiological information.", [["the wave-shape function", "PROBLEM", 30, 53], ["an oscillation", "PROBLEM", 101, 115], ["the amplitude modulation", "TEST", 249, 273], ["wave", "OBSERVATION_MODIFIER", 34, 38], ["shape function", "OBSERVATION", 39, 53], ["oscillation", "OBSERVATION", 104, 115], ["instantaneous", "OBSERVATION_MODIFIER", 138, 151]]], ["The companion algorithm, referred to as the synchrosqueezing transform (SST), is introduced to provide an accurate estimation of the instantaneous frequency and the amplitude modulation [20] , [21] .I. INTRODUCTIONWe recently reported [14] , [15] that small variabilities of respiratory parameters including rate and flow are associated with a high incidence of weaning failure in intensive care unit patients, and these variabilities may serve as reliable predictors for weaning patients from mechanical ventilation.", [["weaning failure", "DISEASE", 362, 377], ["patients", "ORGANISM", 401, 409], ["patients", "ORGANISM", 480, 488], ["patients", "SPECIES", 401, 409], ["patients", "SPECIES", 480, 488], ["small variabilities of respiratory parameters", "PROBLEM", 252, 297], ["weaning failure", "PROBLEM", 362, 377], ["mechanical ventilation", "TREATMENT", 494, 516], ["small", "OBSERVATION_MODIFIER", 252, 257], ["respiratory parameters", "OBSERVATION", 275, 297], ["mechanical ventilation", "OBSERVATION", 494, 516]]], ["As an testbed of the proposed model and algorithm, we analyze the respiratory signals collected from patients in one of our recent studies [15] .", [["patients", "ORGANISM", 101, 109], ["patients", "SPECIES", 101, 109], ["the respiratory signals", "TEST", 62, 85], ["our recent studies", "TEST", 120, 138]]], ["We show that the variation of the recorded respiratory signal, monitored for as brief a period as 3 min, together with the tidal volume information, can be used to define a weaning index (WIN) that predicts weaning process outcome with a success rate quantitatively as high as with the area under curve (AUC) of 0.76 when analyzed by the receiver operation characteristic (ROC).A. ModelIn this section, we provide a phenomenological model describing general oscillatory physiological signals.", [["WIN", "CHEMICAL", 188, 191], ["the tidal volume information", "TREATMENT", 119, 147], ["a success rate", "TEST", 236, 250], ["AUC", "TEST", 304, 307]]], ["We will show by example in the next section that these parameters and indices in the model contain information that can provide insight into the functioning of the underlying physiology.A. ModelThe major characteristic pattern of an oscillatory physiological signal is that it is a (fairly) periodic phenomenon; we therefore model it (without noise) asA.", [["asA", "PROTEIN", 350, 353], ["these parameters", "TEST", 49, 65], ["an oscillatory physiological signal", "PROBLEM", 230, 265], ["a (fairly) periodic phenomenon", "PROBLEM", 280, 310], ["asA", "TREATMENT", 350, 353], ["oscillatory physiological signal", "OBSERVATION", 233, 265]]], ["Modelwhere s(\u00b7) is a continuously differentiable periodic function we call the wave shape function, s(t + 2\u03c0) = s(t) for all t; it is an oscillating function that satisfies some mild technical conditions [22] (Note that to make the discussion clear, we assume that the signal has just one component, unlike [22] , where superpositions of several components were considered.)", [["a continuously differentiable periodic function", "PROBLEM", 19, 66], ["the wave shape function", "TEST", 75, 98], ["some mild technical conditions", "PROBLEM", 173, 203]]], ["Likewise, the amplitude A(t) should be positive, but is allowed to vary slightly as well, i.e., |A (t)| \u2264 \u03c6 (t).", [["positive", "OBSERVATION", 39, 47]]], ["In summary, we have the following conditions for all t \u2208 R:A. Model(2) For the identifiability problem raised in this model and hence the terminologies instantaneous frequency and amplitude modulation, we refer the reader to [21] for the discussion.A. ModelIn reality, the recorded physiological signal g(t) is contaminated by noise or measurement error, and we model the deviated physiological signal as [21] , [23]A. Modelwhere \u03a6(t) is a generalized stationary random process with finite variance and \u03c3(t) is a slowly varying smooth function which capture the heteroscedasticity of the error.", [["[23]A", "SIMPLE_CHEMICAL", 412, 417], ["the identifiability problem", "PROBLEM", 75, 102], ["amplitude modulation", "PROBLEM", 180, 200], ["a generalized stationary random process", "PROBLEM", 438, 477], ["a slowly varying smooth function", "PROBLEM", 511, 543], ["smooth function", "OBSERVATION", 528, 543]]], ["Although the possible noise appearing in the medical signal is versatile, our model covers a large portion of it, for example, the time-dependent noise, the Poisson noise and even \"slightly\" nonstationary noise.", [["slightly\" nonstationary noise", "PROBLEM", 181, 210], ["possible", "UNCERTAINTY", 13, 21], ["noise", "OBSERVATION_MODIFIER", 22, 27], ["large", "OBSERVATION_MODIFIER", 93, 98], ["portion", "OBSERVATION_MODIFIER", 99, 106]]], ["Note that the commonly used Gaussian white noise model is when \u03c3(t) = 1 and \u03a6(t) is the derivative of the Brownian motion.B. MethodologyGiven the model (1) for the oscillatory physiological signal f (t), we want to capture the time-varying quantities of the signal, including the instantaneous frequency \u03c6 (t) and the amplitude modulation A(t), when the signal is contaminated by noise as the model (3).", [["Gaussian white noise model", "TEST", 28, 54], ["Brownian motion", "OBSERVATION", 106, 121]]], ["It is well known that the continuous wavelet transform (CWT) and short time Fourier transform (STFT) provide profound information about these time-varying quantities, in particular the instantaneous frequency, but accurate extraction via these methods remains an issue, even after many years of research.", [["the continuous wavelet transform (CWT)", "TREATMENT", 22, 60], ["accurate extraction", "TREATMENT", 214, 233], ["these methods", "TEST", 238, 251]]], ["In general, these methods reallocate the wavelet coefficients or STFT coefficients according to some \"regrouping\" rule, making it possible to read the instantaneous frequency from the resulting time-frequency plane representation.B. MethodologySynchrosqueezing transform (SST) is a recently introduced novel reallocation technique introduced in [27] in order to analyze speech signals; it was theoretically proved to enjoy several nice properties, useful in our analysis of [20] - [23] .", [["[20] - [23]", "SIMPLE_CHEMICAL", 474, 485], ["STFT coefficients", "TREATMENT", 65, 82], ["novel reallocation technique", "TREATMENT", 302, 330]]], ["Specifically, the instantaneous frequency \u03c6 (t) and the amplitude modulation A(t) can be accurately estimated and the estimation does not depend on whether or not the wave-shape function is a cosine [22] ; moreover, the SST is robust to several different types of noise, like the white or colored Gaussian noise [23] or almost stationary generalized random process [21] .", [["the white or colored Gaussian noise", "PROBLEM", 276, 311], ["instantaneous", "OBSERVATION_MODIFIER", 18, 31]]], ["Furthermore, the analysis result is adaptive to the data in the sense that the error is dependent only on the first three moments of the chosen mother wavelet and its derivative instead of the profile of the mother wavelet.", [["the analysis", "TEST", 13, 25]]], ["We summarize the reallocation technique and SST in Appendix A and its numerical implementation in Appendix B. 1 For the sake of convenience, in what follows we shall use the acronyms SSTIF (for SynchroSqueezing Transform-derived Instantaneous Frequency) to refer to the SST-estimated instantaneous frequency, and SSTAM (SynchroSqueezing Transformderived Amplitude Modulation) to refer to the SST-estimated amplitude modulation.III. TESTBED: VENTILATOR WEANING PROBLEMMaking a weaning decision for a patient on a ventilator is clinically an important issue.", [["patient", "ORGANISM", 499, 506], ["SSTIF", "PROTEIN", 183, 188], ["patient", "SPECIES", 499, 506], ["the reallocation technique", "TEST", 13, 39], ["SynchroSqueezing Transform", "TREATMENT", 194, 220], ["the SST", "TEST", 266, 273], ["SSTAM (SynchroSqueezing Transformderived Amplitude Modulation", "TREATMENT", 313, 374], ["the SST", "TEST", 388, 395], ["VENTILATOR WEANING", "TREATMENT", 441, 459], ["a ventilator", "TREATMENT", 510, 522], ["Appendix", "ANATOMY", 51, 59], ["Appendix", "ANATOMY", 98, 106]]], ["The RRV has proved to be helpful in predicting the outcome of weaning intubated patients from the ventilator [14] - [16] .", [["RRV", "ORGANISM", 4, 7], ["patients", "ORGANISM", 80, 88], ["patients", "SPECIES", 80, 88], ["RRV", "SPECIES", 4, 7], ["weaning intubated", "TREATMENT", 62, 79], ["the ventilator", "TREATMENT", 94, 108]]], ["Extended intubation has many negative side effects, such as an increased risk for infection [28] , [29] ; ideally physicians seek to extubate as soon as medically possible.", [["infection", "DISEASE", 82, 91], ["Extended intubation", "TREATMENT", 0, 19], ["many negative side effects", "PROBLEM", 24, 50], ["infection", "PROBLEM", 82, 91], ["negative side effects", "OBSERVATION_MODIFIER", 29, 50], ["increased", "OBSERVATION_MODIFIER", 63, 72], ["infection", "OBSERVATION", 82, 91]]], ["Yet, weaning too early carries risk as well: reintubation leads to stress to patients or a higher mortality rate [28] , [29] ).", [["patients", "ORGANISM", 77, 85], ["patients", "SPECIES", 77, 85], ["reintubation", "TREATMENT", 45, 57]]], ["It is thus important to decide accurately when patients can be weaned from the ventilator.", [["patients", "ORGANISM", 47, 55], ["patients", "SPECIES", 47, 55], ["the ventilator", "TREATMENT", 75, 89]]], ["To increase the weaning success, the present common practice is to conduct spontaneous breathing trials before a weaning attempt; the final weaning decision is based on the patient's performance during spontaneous breathing trials, characterized by parameters derived directly from the respiration signal, such as the rapid shallow breathing index (RSBI) [30] , and subjective evaluation by the clinician.", [["patient", "ORGANISM", 173, 180], ["patient", "SPECIES", 173, 180], ["the weaning success", "TREATMENT", 12, 31], ["spontaneous breathing trials", "TREATMENT", 75, 103], ["a weaning attempt", "TREATMENT", 111, 128], ["spontaneous breathing trials", "TREATMENT", 202, 230], ["the respiration signal", "TEST", 282, 304], ["the rapid shallow breathing index", "TEST", 314, 347], ["RSBI", "TEST", 349, 353], ["subjective evaluation", "TEST", 366, 387]]], ["Unfortunately, weaning failure still occurs in a significant percentage of patients who are judged ready-to-wean [28] , [29] .", [["patients", "ORGANISM", 75, 83], ["patients", "SPECIES", 75, 83], ["weaning failure", "PROBLEM", 15, 30]]], ["Recently, several RRV-based predictors have been proposed to increase the rate of success weaning in this context; these newer predictors are reported to have a higher accuracy than RSBI in predicting weaning success or failure [10] , [14] - [16] .", [["RRV", "ORGANISM", 18, 21], ["[14] - [16]", "SIMPLE_CHEMICAL", 235, 246], ["RRV", "SPECIES", 18, 21], ["success weaning", "TREATMENT", 82, 97], ["RSBI", "TEST", 182, 186], ["failure", "PROBLEM", 220, 227]]], ["Since the oscillation-to-oscillation time series is the focus of RRV analysis, observation of the respiration signal usually takes at least 20 min to guarantee highly significant prediction accuracy [13] - [15] .", [["RRV analysis", "TEST", 65, 77], ["the respiration signal", "PROBLEM", 94, 116]]], ["In addition, these more accurate RRV-based predictors rely on accurate timing of breath intake \"peaks\", and are thus likely subject to stability issues caused by the inevitable noise.III. TESTBED: VENTILATOR WEANING PROBLEMTo mitigate these limitations, we analyze the respiratory signal by the approach proposed in Section II.", [["RRV", "ORGANISM", 33, 36], ["RRV", "SPECIES", 33, 36], ["the inevitable noise", "PROBLEM", 162, 182], ["VENTILATOR WEANING PROBLEMTo", "TREATMENT", 197, 225], ["the respiratory signal", "TEST", 265, 287]]], ["First, we model the respiratory signal R(t) (without noise) asIII.", [["respiratory", "ANATOMY", 20, 31], ["asIII", "PROTEIN", 60, 65]]], ["Fig. 2 illustrates the role of the different constituents of f(t) modeling the respiratory signal.III. TESTBED: VENTILATOR WEANING PROBLEMIn reality, the recorded respiration signal Resp(t) is noisy, and we model it asIII.", [["respiratory", "ANATOMY", 79, 90], ["asIII", "PROTEIN", 216, 221], ["the respiratory signal", "TEST", 75, 97], ["respiratory signal", "OBSERVATION", 79, 97]]], ["The SST result of the recorded respiratory signal demonstrated in Fig. 1 is shown in Fig. 3 .A. Study MaterialTo validate the combination of the model and the SST algorithm in deriving the dynamics of a physiological signal with large oscillatory scale, we consider the following database collected in a recent study [15] for the purpose of studying the ventilator weaning problem.A. Study MaterialAll protocols in that study [15] were approved by the Institutional Review Board of Taipei Veterans General Hospital, Taipei, Taiwan, and written informed consent was obtained from patients.", [["patients", "ORGANISM", 579, 587], ["patients", "SPECIES", 579, 587], ["The SST", "TEST", 0, 7], ["the recorded respiratory signal", "TEST", 18, 49], ["Study Material", "TEST", 96, 110], ["the SST algorithm", "TREATMENT", 155, 172], ["large oscillatory scale", "TREATMENT", 229, 252], ["a recent study", "TEST", 302, 316], ["the ventilator weaning problem", "TREATMENT", 350, 380]]], ["The study subjects were 68 ready-for-weaning intubated patients collected in the intensive care unit of Taipei Veterans General Hospital, Taipei, Taiwan.", [["patients", "ORGANISM", 55, 63], ["patients", "SPECIES", 55, 63], ["The study", "TEST", 0, 9], ["intubated", "TREATMENT", 45, 54]]], ["In particular, all subjects are with RSBI \u2264110 breaths/min/L since we excluded patients not ready for weaning with RSBI >110 breaths/min/L before spontaneous breathing trial (SBT) due to the restriction from the Institutional Review Board.", [["patients", "ORGANISM", 79, 87], ["patients", "SPECIES", 79, 87], ["RSBI", "TEST", 37, 41], ["RSBI", "TEST", 115, 119], ["spontaneous breathing trial", "TREATMENT", 146, 173], ["SBT", "TREATMENT", 175, 178]]], ["For each subject, we continuously recorded a 30 min flow signal at the sampling rate 100 Hz during SBT under the T-piece ventilator mode.", [["the sampling rate", "TEST", 67, 84], ["the T-piece ventilator mode", "TREATMENT", 109, 136]]], ["The characteristics of these patients and the protocol to perform SBT are described in detail in [15] .", [["patients", "ORGANISM", 29, 37], ["patients", "SPECIES", 29, 37], ["the protocol", "TREATMENT", 42, 54], ["SBT", "TREATMENT", 66, 69]]], ["These 68 subjects are divided into weaning success (n = 45) and failure (n = 23) groups, based upon their extubation outcomes.", [["failure (n = 23) groups", "PROBLEM", 64, 87]]], ["Extubation was defined to be successful if patients did not need the ventilator again for at least 48 h after extubation.", [["patients", "ORGANISM", 43, 51], ["patients", "SPECIES", 43, 51], ["Extubation", "TREATMENT", 0, 10], ["the ventilator", "TREATMENT", 65, 79]]], ["Reinstitution of either noninvasive or invasive mechanical ventilation within 48 h of extubation was considered an extubation failure.", [["invasive mechanical ventilation", "TREATMENT", 39, 70], ["extubation", "TREATMENT", 86, 96], ["an extubation failure", "PROBLEM", 112, 133], ["invasive", "OBSERVATION_MODIFIER", 39, 47], ["mechanical ventilation", "OBSERVATION", 48, 70], ["extubation failure", "OBSERVATION", 115, 133]]], ["In [15] , the data show no difference between the success and failure groups in the mean values of six clinically used weaning predictors measured before subject inclusion, and also in the mean values of three breathing pattern parameters measured after subject inclusion; in other words, the mean values of these nine clinically used weaning predictors could not allow us to discriminate success cases from failures.B. WIN IndexWe now define the WIN index capturing the breathing pattern variability.", [["WIN", "CHEMICAL", 420, 423], ["WIN", "CHEMICAL", 447, 450], ["WIN", "SIMPLE_CHEMICAL", 447, 450], ["the data", "TEST", 10, 18], ["failure groups", "PROBLEM", 62, 76], ["weaning predictors", "TREATMENT", 119, 137], ["weaning predictors", "TREATMENT", 335, 353], ["failures", "PROBLEM", 408, 416], ["no", "UNCERTAINTY", 24, 26], ["failure", "OBSERVATION", 62, 69]]], ["Given the respiratory signal Resp(t), we apply SST to get the SSTIF and SSTAM.", [["respiratory", "ANATOMY", 10, 21], ["SSTAM", "PROTEIN", 72, 77], ["the SSTIF and SSTAM", "TREATMENT", 58, 77]]], ["In the respiratory signal, the SSTAM can be understood as the instantaneous tidal volume.", [["respiratory", "ANATOMY", 7, 18], ["SSTAM", "PROTEIN", 31, 36], ["the instantaneous tidal volume", "TEST", 58, 88], ["respiratory signal", "ANATOMY", 7, 25], ["tidal volume", "OBSERVATION", 76, 88]]], ["Then, we define the WIN index shown in Fig. 5 .", [["WIN", "CHEMICAL", 20, 23], ["WIN", "CHEMICAL", 20, 23], ["the WIN index", "TEST", 16, 29]]], ["As shown, the cut-off value of WIN index could allow us to separate a majority of patients with success weaning procedure from those with failure weaning procedure.", [["WIN", "CHEMICAL", 31, 34], ["WIN", "SIMPLE_CHEMICAL", 31, 34], ["patients", "ORGANISM", 82, 90], ["patients", "SPECIES", 82, 90], ["success weaning procedure", "TREATMENT", 96, 121], ["failure weaning procedure", "TREATMENT", 138, 163]]], ["Accordingly, this cut-off value of WIN index might be helpful for the physicians to make decision which patients merit weaning from mechanical ventilation.", [["WIN", "CHEMICAL", 35, 38], ["WIN", "SIMPLE_CHEMICAL", 35, 38], ["patients", "ORGANISM", 104, 112], ["patients", "SPECIES", 104, 112], ["mechanical ventilation", "TREATMENT", 132, 154], ["mechanical ventilation", "OBSERVATION", 132, 154]]], ["Notice that our method requires only three consecutive minutes of respiratory signal observation.", [["respiratory signal observation", "TEST", 66, 96]]], ["It is important to note that the occurrence, during the observation windows, of machine calibration or some breathing irregularities, such as coughs, invalid trigger, etc., which normally require special attention in the existing analyses, is not an impediment for our method.", [["coughs", "DISEASE", 142, 148], ["the observation windows", "TEST", 52, 75], ["machine calibration", "TREATMENT", 80, 99], ["some breathing irregularities", "PROBLEM", 103, 132], ["coughs", "PROBLEM", 142, 148], ["invalid trigger", "PROBLEM", 150, 165], ["our method", "TEST", 265, 275], ["breathing irregularities", "OBSERVATION", 108, 132]]], ["These properties of the SST for a patient in the success group are shown in Fig. 3 for demonstration.IV. DISCUSSIONIn this paper, we introduced a phenomenological model and the synchrosqueezing transform (SST) to alleviate the limitations of traditional methods for the analysis of oscillatory physiological signals.", [["patient", "ORGANISM", 34, 41], ["patient", "SPECIES", 34, 41], ["a phenomenological model", "TREATMENT", 144, 168], ["the synchrosqueezing transform", "TREATMENT", 173, 203], ["traditional methods", "TREATMENT", 242, 261], ["the analysis", "TEST", 266, 278], ["oscillatory physiological signals", "PROBLEM", 282, 315]]], ["The usefulness of this combination is shown by applying it to the study of the ventilator weaning problem.", [["the study", "TEST", 62, 71], ["the ventilator weaning problem", "TREATMENT", 75, 105], ["ventilator weaning", "OBSERVATION", 79, 97]]], ["Our results show that the SSTIF and SSTAM and their derived quantity WIN from the respiratory signal provide a suitable criterion for clinical use to predict weaning outcome, with an ROC-AUC of 0.76.IV. DISCUSSIONAt first sight, this result does not improve upon what has been reported for RRV-based predictions [14] - [16] .", [["WIN", "CHEMICAL", 69, 72], ["WIN", "CHEMICAL", 69, 72], ["WIN", "SIMPLE_CHEMICAL", 69, 72], ["SSTIF", "DNA", 26, 31], ["SSTAM", "PROTEIN", 36, 41], ["the SSTIF", "TEST", 22, 31], ["an ROC", "TEST", 180, 186], ["AUC", "TEST", 187, 190], ["IV", "TREATMENT", 199, 201]]], ["First, the WIN requires only 3 min of consecutively recorded data rather than the at least 20 min typically required for the RRV-based indices; since a 3 min-observation is entirely feasible in clinical practice, whereas a 20 min-observation is much less so this is a crucial difference.", [["WIN", "CHEMICAL", 11, 14], ["WIN", "CHEMICAL", 11, 14], ["WIN", "SIMPLE_CHEMICAL", 11, 14]]], ["Second, the definition of an oscillation and its landmark are not critical in the analysis.", [["an oscillation", "PROBLEM", 26, 40], ["the analysis", "TEST", 78, 90], ["oscillation", "OBSERVATION", 29, 40]]], ["Note that even if the definition of an oscillation and its landmark are precisely given, the landmark detection is typically not robust under perturbations by noise, e.g., invalid breathing in the respiratory signal.", [["respiratory", "ANATOMY", 197, 208], ["an oscillation", "PROBLEM", 36, 50], ["the landmark detection", "TEST", 89, 111], ["invalid breathing in the respiratory signal", "PROBLEM", 172, 215], ["respiratory signal", "OBSERVATION", 197, 215]]], ["Although the necessarily noisy signal can be \"denoised,\" existing noise removal or noise reduction algorithms cannot guarantee a reliable determination of the \"true\" landmarks.", [["existing noise removal", "TREATMENT", 57, 79], ["noise reduction algorithms", "TREATMENT", 83, 109], ["the \"true\" landmarks", "PROBLEM", 155, 175]]], ["Even if \"oscillation-based segmentation\" could be carried out perfectly on a long enough recorded physiological signal so that enough oscillations are collected, it is not straightforward to obtain such an uninterrupted signal, in practice, especially when the period of each oscillation is large than, say, 2 s.", [["oscillation", "PROBLEM", 9, 20], ["large", "OBSERVATION_MODIFIER", 291, 296]]], ["Different kinds of interruptions during the signal record, for example, machine calibration, coughs, suction, irritation, and so on, require the signal analyst to artificially cut-and-stitch together pieces of signal so that the oscillation-to-oscillation intervals can be defined, as needed for the traditional method, even though there is no theoretical support to show that the dynamical variabilities evaluated from such manipulated time series are still as trustworthy.", [["machine calibration", "TREATMENT", 72, 91], ["coughs", "PROBLEM", 93, 99], ["suction", "TREATMENT", 101, 108], ["irritation", "PROBLEM", 110, 120], ["stitch", "TREATMENT", 184, 190], ["the oscillation", "TEST", 225, 240], ["the traditional method", "TEST", 296, 318], ["the dynamical variabilities", "TEST", 377, 404]]], ["Similar potential disruptions typically occur in other oscillatory physiological signals.", [["Similar potential disruptions", "PROBLEM", 0, 29], ["disruptions", "OBSERVATION", 18, 29], ["oscillatory physiological signals", "OBSERVATION", 55, 88]]], ["We therefore expect that the combination of the proposed phenomenological model and the analysis method, SST, have great potential in dealing with broader physiological signals than the traditional approaches, especially when the scale of the signal is large and the determination of the landmarks is not easy.IV. DISCUSSIONIn the introduction, we identified three drawbacks of presently used methods.", [["the analysis method", "TEST", 84, 103], ["broader physiological signals", "PROBLEM", 147, 176], ["large", "OBSERVATION_MODIFIER", 253, 258]]], ["The importance of keeping a richer description is illustrated by our method's use of variation in both frequency and amplitude in the ventilator weaning example.IV. DISCUSSIONPhysiologically, the respiration is not only controlled by the neural respiratory center, but also controlled by the arterial chemoreceptors, lung vagal sensory receptors, lung mechanics, etc. In a normal subject, these control factors are integrated in a complex way which leads to the RRV [12] , [14] , [15] .", [["neural respiratory center", "ANATOMY", 238, 263], ["arterial chemoreceptors", "ANATOMY", 292, 315], ["lung", "ANATOMY", 317, 321], ["lung", "ANATOMY", 347, 351], ["arterial chemoreceptors", "MULTI-TISSUE_STRUCTURE", 292, 315], ["lung", "ORGAN", 317, 321], ["lung", "ORGAN", 347, 351], ["[14] , [15]", "SIMPLE_CHEMICAL", 473, 484], ["lung vagal sensory receptors", "PROTEIN", 317, 345], ["the ventilator weaning", "TREATMENT", 130, 152], ["the arterial chemoreceptors", "TEST", 288, 315], ["lung vagal sensory receptors", "PROBLEM", 317, 345], ["lung mechanics", "PROBLEM", 347, 361], ["not only", "UNCERTAINTY", 211, 219], ["neural", "ANATOMY_MODIFIER", 238, 244], ["respiratory", "ANATOMY", 245, 256], ["arterial", "ANATOMY", 292, 300], ["lung", "ANATOMY", 317, 321], ["vagal", "ANATOMY_MODIFIER", 322, 327], ["sensory receptors", "OBSERVATION", 328, 345], ["lung", "ANATOMY", 347, 351], ["mechanics", "OBSERVATION", 352, 361], ["normal", "OBSERVATION", 373, 379]]], ["Although we do not have a definite evidence, based on the reasoning about the relationship between the decreased HRV (or RRV) and the severity of disease [2] , [4] , [14] - [16] , we hypothesize that the distinguishing power of WIN is a consequence of the possible disintegrity of the respiratory control factors, and this disintegrity leads to the decreased variability in the breathing pattern.", [["WIN", "CHEMICAL", 228, 231], ["WIN", "CHEMICAL", 228, 231], ["[4]", "SIMPLE_CHEMICAL", 160, 163], ["[14] - [16]", "SIMPLE_CHEMICAL", 166, 177], ["WIN", "SIMPLE_CHEMICAL", 228, 231], ["respiratory control factors", "PROTEIN", 285, 312], ["RRV", "SPECIES", 121, 124], ["the decreased HRV", "PROBLEM", 99, 116], ["the severity of disease", "PROBLEM", 130, 153], ["the respiratory control factors", "PROBLEM", 281, 312], ["this disintegrity", "PROBLEM", 318, 335], ["the decreased variability in the breathing pattern", "PROBLEM", 345, 395], ["decreased", "OBSERVATION_MODIFIER", 103, 112], ["disease", "OBSERVATION", 146, 153], ["respiratory control", "OBSERVATION", 285, 304], ["decreased", "OBSERVATION_MODIFIER", 349, 358], ["variability", "OBSERVATION_MODIFIER", 359, 370], ["breathing pattern", "OBSERVATION", 378, 395]]], ["This hypothesis indicates that the subject with decreased WIN is not completely ready for weaning, and explains why we observe the different patterns in the two groups.", [["WIN", "CHEMICAL", 58, 61], ["WIN", "CHEMICAL", 58, 61], ["WIN", "SIMPLE_CHEMICAL", 58, 61]]], ["Also note that RRV is a different notion compared with the descriptive breathing parameters, like total volume, peak respiratory flow, total breath duration, and so on, which quantify the average behavior of one breath but not the complex integrity of the control factors.IV. DISCUSSIONThis discussion would not be complete without listing the shortcomings of our approach.", [["respiratory", "ANATOMY", 117, 128], ["RRV", "ORGANISM", 15, 18], ["control factors", "PROTEIN", 256, 271], ["RRV", "SPECIES", 15, 18], ["the descriptive breathing parameters", "TEST", 55, 91], ["total volume", "TEST", 98, 110], ["peak respiratory flow", "TEST", 112, 133], ["total breath duration", "TEST", 135, 156], ["peak", "OBSERVATION_MODIFIER", 112, 116], ["respiratory flow", "OBSERVATION", 117, 133]]], ["First, the phenomenological nature of our analysis limits the possibility to extract detailed underlying mechanisms leading to the variability and hence the prediction outcome.", [["our analysis", "TEST", 38, 50]]], ["For example, we are not able (nor did we attempt) to distinguish if the observed variability is purely neural in origin, or if mechanical factors also play a role; finer modeling is needed to decide this, if possible.", [["neural", "ANATOMY", 103, 109], ["mechanical factors", "PROBLEM", 127, 145]]], ["Second, from the viewpoint of estimating physiological dynamics, monitoring variability from the signal of one physiological subsystem, for example, the respiratory signal, is not sufficient: the physiological dynamics is the outcome of the complicated interactions between different physiological subsystems.", [["respiratory", "ANATOMY", 153, 164], ["monitoring variability", "TEST", 65, 87], ["the respiratory signal", "TEST", 149, 171]]], ["Incorporating different simultaneously recorded biomedical signals, such as electrocardiograms, respiratory signal, blood pressure, and so on, should lead to a more informative description of the systematic dynamics.", [["blood", "ANATOMY", 116, 121], ["blood", "ORGANISM_SUBSTANCE", 116, 121], ["electrocardiograms", "TEST", 76, 94], ["respiratory signal", "TEST", 96, 114], ["blood pressure", "TEST", 116, 130]]], ["A study of how to extract the information on the interaction between different subsystems via the combination of the existing model and the SST algorithm is now ongoing.", [["A study", "TEST", 0, 7], ["the SST algorithm", "TEST", 136, 153]]], ["Specifically, although we now have a suitable method to extract information from different oscillatory physiological signals of different scales, finding their interactions and inferring more information remains an open problem.", [["an open problem", "PROBLEM", 212, 227]]], ["Indeed, it is an intrinsic limitation of the SST that its estimation of the instantaneous frequency is less reliable when this instantaneous frequency has large local variations.", [["large local variations", "PROBLEM", 155, 177], ["intrinsic", "OBSERVATION_MODIFIER", 17, 26], ["limitation", "OBSERVATION_MODIFIER", 27, 37], ["large", "OBSERVATION_MODIFIER", 155, 160], ["local variations", "OBSERVATION", 161, 177]]], ["Finally, the study in the testbed has two limitations: it is retrospective, and the data have been collected for a small clinical population only, although the group of patients is homogeneous, in the sense that all patients are confirmed to be ready for weaning based on the RSBI.", [["patients", "ORGANISM", 169, 177], ["patients", "ORGANISM", 216, 224], ["patients", "SPECIES", 169, 177], ["patients", "SPECIES", 216, 224], ["the study", "TEST", 9, 18], ["the data", "TEST", 80, 88], ["a small clinical population", "PROBLEM", 113, 140], ["the RSBI", "TEST", 272, 280], ["small", "OBSERVATION_MODIFIER", 115, 120], ["homogeneous", "OBSERVATION_MODIFIER", 181, 192]]], ["Yet it certainly warrants a follow-up prospective and large-scale clinical study to investigate its clinical applicability.IV. DISCUSSIONDespite these shortcomings, our example supports that the criterion we propose (in the form of the WIN) has the potential to assist physicians in assessing weaning readiness.", [["WIN", "CHEMICAL", 236, 239], ["clinical study", "TEST", 66, 80], ["IV", "TREATMENT", 123, 125]]], ["The result encourages its application to other different kinds of oscillatory signals, in particular to those with (relatively) long periods.IV. DISCUSSIONIn conclusion, the proposed model and algorithm together efficiently relieve the difficulty shared by the traditional methods presently used to analyze physiological dynamics or more general oscillatory signals-the data length needed for analyzing the dynamics is significantly shortened, the effect of the inevitable noise is reduced, and the pattern of the oscillatory phenomenon does not play a significant role.APPENDIX A REALLOCATION TECHNIQUE AND SYNCHROSQUEEZING TRANSFORMThe main mathematical tool we apply to analyze the oscillatory physiological signal is the newly developed, mathematically rigorous proved, and adaptive time-frequency (TF) analysis referred to as the synchrosqueezing transform (SST) [20] , [21] , [23] , [27] , [31] - [34] .APPENDIX A REALLOCATION TECHNIQUE AND SYNCHROSQUEEZING TRANSFORMBesides the traditional analytic approach, for example, the Hilbert transform, there are many existing TF analysis method available to estimate \u03c6 (t) of the signal expressed in (9) [35] .", [["[21] , [23] , [27] , [31] - [34]", "SIMPLE_CHEMICAL", 875, 907], ["TF", "PROTEIN", 1076, 1078], ["oscillatory signals", "TEST", 66, 85], ["analyzing the dynamics", "TEST", 393, 415], ["the inevitable noise", "PROBLEM", 458, 478], ["the oscillatory phenomenon", "PROBLEM", 510, 536], ["TF analysis", "TEST", 1076, 1087], ["significantly shortened", "OBSERVATION_MODIFIER", 419, 442], ["reduced", "OBSERVATION_MODIFIER", 482, 489], ["oscillatory phenomenon", "OBSERVATION", 514, 536]]], ["Due to the Heisenberg uncertainty principal, the ambiguity in the TF representation is inevitable, and the reallocation technique was proposed for the sake of sharpening the TF representation [24] - [26] , [34] - [36] .", [["[24] - [26]", "SIMPLE_CHEMICAL", 192, 203], ["[34] - [36]", "SIMPLE_CHEMICAL", 206, 217], ["TF", "PROTEIN", 66, 68], ["TF", "PROTEIN", 174, 176], ["the reallocation technique", "TREATMENT", 103, 129]]], ["SST is a special reallocation technique.", [["a special reallocation technique", "TREATMENT", 7, 39]]], ["In the following, we start from giving the precise conditions and definitions about the functional class modeling the oscillatory physiological signal, and then discuss the reallocation technique and its special case SST.", [["the reallocation technique", "TEST", 169, 195]]], ["We mention that we can also consider STFT, but here we focus on the CWT to simplify the discussion.APPENDIX A REALLOCATION TECHNIQUE AND SYNCHROSQUEEZING TRANSFORMFix a Schwartz function \u03c8 so that supp \u03c8 \u2282 [1 \u2212 \u0394, 1 + \u0394], where 0 < \u0394 < 1 which is commonly called the mother wavelet.", [["a Schwartz function", "TEST", 167, 186], ["supp", "TEST", 197, 201]]], ["Recall that the CWT [37] of a given f (t) \u2208 S is defined byAPPENDIX A REALLOCATION TECHNIQUE AND SYNCHROSQUEEZING TRANSFORMwhere a > 0 and b \u2208 R. Here, we follow the convention in the wavelet literature that a means scale and b means time.APPENDIX A REALLOCATION TECHNIQUE AND SYNCHROSQUEEZING TRANSFORMTo ease the notation, the moments of \u03c8 are denoted as IA continuous function is called an nonharmonic intrinsic mode function if it satisfieswhereA continuous function is called an nonharmonic intrinsic mode function if it satisfiesand is a small parameter chosen in the model; II) s : [0, 1] \u2192 R is C 1,\u03b1 , where \u03b1 > 1/2, and 1-periodic function with unit L 2 norm, | s(k)| \u2264 \u03b4| s(1)| for all k = 1, where \u03b4 \u2265 0 is a small parameter, and n> D |n s(n)| \u2264 \u03b8 for some small parameter \u03b8 \u2265 0 and D \u2208 N. Note that we assume that the signal has just one component, unlike the case in previous studies wherein the signals were considered to include several components [22] .", [["\u03c8", "PROTEIN", 340, 341], ["C", "TEST", 603, 604], ["\u03b1", "TEST", 607, 608], ["\u03b1", "TEST", 617, 618], ["periodic function", "TEST", 632, 649], ["s", "TEST", 683, 684], ["k", "TEST", 697, 698], ["\u03b4", "TEST", 710, 711], ["a small parameter", "TEST", 719, 736], ["some small parameter", "TEST", 764, 784], ["previous studies", "TEST", 881, 897]]], ["Next, we model the measured physiological signal asA continuous function is called an nonharmonic intrinsic mode function if it satisfieswhere s(t), A(t), and \u03c6(t) satisfy (I) and (II) and the following condition is satisfied: III) T : R \u2192 R is in C 1 (R) so that its Fourier transform exists in the distribution sense, and |T (\u03c8 a,b )|, |T (\u03c8 a,b )| \u2264 C T for all b \u2208 R and a \u2208 (0, 1+\u0394 c 1 ], for some C T \u2265 0 [21] .", [["Fourier transform", "TEST", 268, 285], ["T", "TEST", 339, 340], ["a", "TEST", 344, 345], ["b", "TEST", 346, 347], ["\u2264", "TEST", 351, 352], ["C", "TEST", 353, 354], ["T", "TEST", 355, 356], ["all", "TEST", 361, 364], ["R", "TEST", 369, 370], ["c", "TEST", 387, 388], ["some C T \u2265", "TEST", 398, 408]]], ["IV) \u03a6(t) is a stationary generalized random process (GRP) or \"almost\" stationary GRP [21] independent of A(t)s(\u03c6(t)), which is introduced to model the measurement error.", [["\u03a6(t)", "PROTEIN", 4, 8], ["a stationary generalized random process", "PROBLEM", 12, 51], ["stationary GRP", "TEST", 70, 84], ["A(t)s", "TEST", 105, 110]]], ["To be more specific, the power spectrum d\u03b7 of the given GRP \u03a6 satisfies (1 + |\u03be|) \u22122l d\u03b7 < \u221e for some l > 0.", [["GRP \u03a6", "PROTEIN", 56, 61]]], ["Also assume \u03c3 \u2208 C \u221e so that \u03c3 L \u221e 1 and \u03c3 := max =1,...,max{1,l} { \u03c3 ( ) L \u221e } 1, and var\u03a6(\u03c8) = 1.", [["\u03c3", "PROTEIN", 12, 13], ["C \u221e", "PROTEIN", 16, 19], ["\u03c3", "PROTEIN", 40, 41], ["max", "TEST", 45, 48], ["max{1", "TEST", 56, 61], ["l}", "TEST", 62, 64], ["\u03c3", "TEST", 67, 68], ["var\u03a6", "TEST", 86, 90]]], ["Now we discuss the reallocation technique and the SST.", [["the reallocation technique", "TEST", 15, 41]]], ["Take the CWT of a given observation Y in (9)A continuous function is called an nonharmonic intrinsic mode function if it satisfiesNote that (10) is well defined since \u03c3(t)\u03a6(t) is GRP and by the assumption of T .", [["GRP", "GENE_OR_GENE_PRODUCT", 179, 182], ["GRP", "PROTEIN", 179, 182]]], ["In contrast to the reallocation technique, in the SST, W Y is reallocated from (t, \u03be) to a different point (t, \u03be ) according to a different reassignment rules which only reallocates the frequency axis and preserves the time information.", [["W Y", "DNA", 55, 58]]], ["Second, calculate the reallocation rule \u03c9 Y defined on R + \u00d7 R:A continuous function is called an nonharmonic intrinsic mode function if it satisfiesThird, the SST of Y (t) is defined by reallocating the coefficients of W Y (a, b) according to the reallocation rule \u03c9 f (a, b):A continuous function is called an nonharmonic intrinsic mode function if it satisfieswhere (b, \u03be) \u2208 R \u00d7 R + , \u0393 > 0 is the threshold chosen by the user, h is a kernel function which is smooth enough and decays fast enough.", [["R \u00d7 R", "GENE_OR_GENE_PRODUCT", 378, 383], ["smooth", "OBSERVATION_MODIFIER", 463, 469]]], ["As is shown in [20] - [22] , S \u0393 Y (b, \u03be) will only have dominant values around \u03c6 (b).", [["[20] - [22]", "SIMPLE_CHEMICAL", 15, 26], ["dominant", "OBSERVATION", 57, 65]]], ["This property allows us an accurate estimate of \u03c6 by, for example, the curve extraction technique.", [["the curve extraction technique", "TREATMENT", 67, 97]]], ["The estimated \u03c6 is denoted by \u03c6 .A continuous function is called an nonharmonic intrinsic mode function if it satisfiesWith the estimated \u03c6 , we can estimate A(t) and \u03c6(t) in (9) by the following reconstruction formula.", [["\u03c6", "DNA", 14, 15]]], ["DefineA continuous function is called an nonharmonic intrinsic mode function if it satisfieswhere R \u03c8 := \u03c8 (\u03b6 ) \u03b6 d\u03b6 and Re means taking the real part.", [["\u03c8", "PROTEIN", 100, 101], ["d\u03b6", "PROTEIN", 114, 116]]], ["Based on the theorem in [20] - [22] , the estimator of A(t) is defined as A(t) := | R(t)|.", [["[20] - [22]", "SIMPLE_CHEMICAL", 24, 35]]], ["3.1] , these estimators are accurate and are robust to the existence of the trend T (t) and noise \u03c3(t)\u03a6(t).A continuous function is called an nonharmonic intrinsic mode function if it satisfiesNotice that we can interpret (13) as an adaptive band-pass filter.", [["an adaptive band-pass filter", "TREATMENT", 230, 258], ["pass filter", "OBSERVATION", 247, 258]]], ["Then, the reconstruction of the physiological signal at time t is based on the chosen frequency band with bandwidth 1/3 .A continuous function is called an nonharmonic intrinsic mode function if it satisfiesWe summarize the theoretical results of SST relevant to this paper, and refer the reader to [20] , [21] , [23] for the precise statement of the theorem.", [["the reconstruction", "TREATMENT", 6, 24]]], ["P 1 : SST is robust to the several different kinds of noise, which might be slightly nonstationary.", [["P 1", "DNA", 0, 3], ["noise", "OBSERVATION", 54, 59], ["might be", "UNCERTAINTY", 67, 75], ["slightly", "OBSERVATION_MODIFIER", 76, 84]]], ["P 2 : Since SST is local in nature, we are able to detect components that do not exist all the time and hence the dynamical behavior of the signal [20] , [21] .", [["P 2", "DNA", 0, 3]]], ["P 3 : The time-frequency representation S \u0393 Y (b, \u03be) is visually informative.", [["P 3", "DNA", 0, 3]]], ["P 4 : SST is \"adaptive\" to the data in the sense that the error in the estimation depends only on the first three moments of the mother wavelet instead of the profile of the mother wavelet.", [["P 4", "DNA", 0, 3]]], ["See [23, Fig. 6 ] for a visual demonstration.", [["a visual demonstration", "TEST", 22, 44]]], ["P 5 : The existence of the trend modeled in (9) do not interfere with the SST.", [["P 5", "DNA", 0, 3]]], ["Thus, we are able to separate the trend and periodic components.", [["periodic", "OBSERVATION_MODIFIER", 44, 52], ["components", "OBSERVATION_MODIFIER", 53, 63]]], ["Note that a smooth function T \u2208 C \u221e \u2229 S so that its Fourier transform T is compactly supported in a small interval around 0 is a special case.APPENDIX B NUMERICAL IMPLEMENTATION OF SSTIn this section, we provide the numerical implementation detail of SST.", [["a smooth function", "TEST", 10, 27], ["small", "OBSERVATION_MODIFIER", 100, 105]]], ["The MATLAB code is available in http://sites. google.com/site/hautiengwu/ and we refer the readers to [23] for more implementation details.APPENDIX B NUMERICAL IMPLEMENTATION OF SSTTake a discretization of (9), denoted as Y \u2208 R N , with the sampling period \u03c4 > 0 from time \u03c4 to time N\u03c4 , that is, Y (n) = Y (n\u03c4 ).", [["MATLAB code", "DNA", 4, 15]]], ["Here, we have to be careful about the meaning of Y (n\u03c4 ) when \u03a6 is a GRP.", [["GRP", "GENE_OR_GENE_PRODUCT", 69, 72], ["\u03a6", "PROTEIN", 62, 63], ["GRP", "PROTEIN", 69, 72]]], ["Theoretically, when \u03a6 is in the general sense, for example, the differentiation of the standard Brownian motion, it does not make sense to directly evaluate \u03a6 at a particular time [38] .", [["\u03a6", "PROTEIN", 20, 21], ["\u03a6", "PROTEIN", 157, 158], ["Brownian motion", "OBSERVATION", 96, 111]]], ["For example, not every autoregressive and moving average time series (ARMA) can be embedded into a continuous ARMA random process.", [["a continuous ARMA random process", "PROBLEM", 97, 129]]], ["Thus, in the discrete case, sometimes the random error term needs to be modeled separately, that is,APPENDIX B NUMERICAL IMPLEMENTATION OF SSTwhere n = 1, . . . , N, f, T and \u03c3 satisfy conditions (I), (II) and (III), and \u03a8 is a zero-mean stationary time series, which can be taken as an ARAM time series, generalized autoregressive conditional heteroskedasticity time series, etc. In the following, to simplify the discussion, we assume that the discretization of (9) can be carried out directly, and refer the reader to [21] for more theoretical results about discretization.APPENDIX B NUMERICAL IMPLEMENTATION OF SSTIn practice, to prevent boundary effects, we pad Y on both sides by reflecting the signal near the boundary so that its length is N = 2 L +1 , where L is the minimal integer such that N > N. Although it works well in practice, we emphasize that doing so is not the optimal solution.", [["\u03a8", "PROTEIN", 221, 222], ["generalized autoregressive conditional heteroskedasticity time series", "PROBLEM", 305, 374], ["SSTIn practice", "TREATMENT", 615, 629], ["boundary effects", "PROBLEM", 642, 658]]], ["To ease the notation, in the following, we use the same notation Y to denote the padded signal and N to indicate the length of the padded signal.A. Step 1: Numerically Implement the CWTFor the sake of implementing (10), we take the scales a j = 2 j /n v \u03c4, j = 1, . . . , Ln v , where n v is the \"voice number\" chosen by the user.", [["Ln v", "GENE_OR_GENE_PRODUCT", 272, 276], ["the padded signal and N", "PROBLEM", 77, 100]]], ["The \u03c9 Y (a, b) is then implemented as a N \u00d7 n a matrix \u03c9 Y by the following entrywise calculation:B. Step 2: Numerically Implement \u03c9 Y (a, b)Note that although W Y (i, j) = 0 is numerically unstable, but this unstability will be taken care in the next step.C.Step 3: Numerically Implement S \u0393 Y (b, \u03be).", [["numerically unstable", "PROBLEM", 178, 198], ["unstable", "OBSERVATION", 190, 198]]], ["To implement the Synchrosqueezing transform S \u0393 Y (b, \u03be) (12), we discretize the frequency domain [ 1 N \u03c4 , 1 2\u03c4 ] by equally spaced intervals of length \u0394 \u03be = 1 N \u03c4 .", [["the Synchrosqueezing transform S", "TEST", 13, 45], ["the frequency domain", "TEST", 77, 97], ["length", "TEST", 146, 152], ["\u03be", "TEST", 155, 156], ["\u03c4", "TEST", 163, 164]]], ["Here, 1 N \u03c4 and 1 2\u03c4 are the minimal and maximal frequencies detectable by the Fourier transform theorem.", [["minimal", "OBSERVATION_MODIFIER", 29, 36]]], ["Denote n \u03be =C., which is the number of the discretization of the frequency axis.", [["frequency axis", "OBSERVATION_MODIFIER", 65, 79]]], ["Fix \u0393 > 0, the discretized S \u0393 Y (b, \u03be), denoted by a N \u00d7 n \u03be matrix S Y , is evaluated byC.where i = 1, . . . , N and j = 1, . . . , n \u03be .", [["Fix", "TEST", 0, 3]]], ["Notice that the number \u0393 is a hard thresholding parameter, which is chosen to reduce the influence of noise and numerical error encountered when W Y (i, j) is small.", [["small", "OBSERVATION_MODIFIER", 159, 164]]], ["We choose \u0393 = 1e \u2212 3 in this study.", [["this study", "TEST", 24, 34]]], ["If the error is Gaussian white noise, the choice of \u0393 is suggested in [23] .", [["\u0393", "DNA", 52, 53], ["Gaussian white noise", "PROBLEM", 16, 36]]], ["In general, more study is needed to adaptively choose \u0393 from a given time series.C.To visually see the time frequency representation of the SST, we may directly plot the N \u00d7 n \u03be matrix R Y defined by R Y (i, j) := |S Y (i, j)| 2 for all i = 1, . . . , N and j = 1, . . . , n \u03be , and observe its behavior.D. Step 4: Estimate IF, AM, and Trend From S YAccording to the theoretical statement, the SST time frequency representation will be dominant in the IF [21] , [23] .", [["C", "GENE_OR_GENE_PRODUCT", 81, 82], ["the SST", "TEST", 136, 143], ["all i", "TEST", 233, 238]]], ["Thus, we estimate IF by fitting a discretized curve c * \u2208 Z N n \u03be , where Z n \u03be = {1, . . . , n \u03be } indexes the discretized frequency axis, to the dominant area of S Y .", [["IF", "PROTEIN", 18, 20], ["a discretized curve", "TEST", 32, 51], ["Z", "TEST", 58, 59], ["\u03be", "TEST", 64, 65], ["Z", "TEST", 74, 75], ["\u03be", "TEST", 96, 97], ["the discretized frequency axis", "PROBLEM", 108, 138], ["discretized", "OBSERVATION", 112, 123], ["frequency axis", "OBSERVATION", 124, 138], ["dominant", "OBSERVATION_MODIFIER", 147, 155]]], ["Precisely, we maximize the following functional over c \u2208 Z N n \u03be :D. Step 4: Estimate IF, AM, and Trend From S Ywhere \u03bb > 0 determines the regularity of the estimated curve.", [["Trend From S Ywhere \u03bb", "TEST", 98, 119]]], ["In this study, we simply choose \u03bb = 1.D. Step 4: Estimate IF, AM, and Trend From S YDenote the maximizer of the functional in (14) as c * \u2208 R N .", [["this study", "TEST", 3, 13]]], ["Then SSTIF, denoted as \u03c6 \u2208 R N , is given by where n = 1, . . . , N, f 1 (n) \u2208 C, and is the real part.", [["N, f 1 (n) \u2208 C", "CHEMICAL", 66, 80], ["SSTIF", "PROTEIN", 5, 10]]], ["The phase function \u03c6 is then estimated by unwrapping f 1 (n)/|f 1 (n)|.", [["The phase function", "TEST", 0, 18]]], ["Note that estimating the phase by integrating the estimated IF is not recommended since the error might be accumulated.", [["IF", "PROTEIN", 60, 62]]]]}